<SEC-DOCUMENT>0001193125-21-019984.txt : 20210128
<SEC-HEADER>0001193125-21-019984.hdr.sgml : 20210128
<ACCEPTANCE-DATETIME>20210128075642
ACCESSION NUMBER:		0001193125-21-019984
CONFORMED SUBMISSION TYPE:	S-1/A
PUBLIC DOCUMENT COUNT:		59
FILED AS OF DATE:		20210128
DATE AS OF CHANGE:		20210128

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sana Biotechnology, Inc.
		CENTRAL INDEX KEY:			0001770121
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-252061
		FILM NUMBER:		21562064

	BUSINESS ADDRESS:	
		STREET 1:		188 EAST BLAINE STREET, SUIT 400
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98102
		BUSINESS PHONE:		(206) 701-7914

	MAIL ADDRESS:	
		STREET 1:		188 EAST BLAINE STREET, SUIT 400
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98102
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1/A
<SEQUENCE>1
<FILENAME>d60414ds1a.htm
<DESCRIPTION>AMENDMENT NO. 1 TO FORM S-1
<TEXT>
<HTML><HEAD>
<TITLE>Amendment No. 1 to Form S-1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>As filed with the Securities and Exchange Commission on January 28, 2021 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="right"><B>Registration <FONT STYLE="white-space:nowrap">No.&nbsp;333-252061</FONT></B></P>
<P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:3.00pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>  <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B>Amendment
No. 1 to </B></P>  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT STYLE="white-space:nowrap">S-1</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B>REGISTRATION STATEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>UNDER </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>THE SECURITIES ACT
OF 1933 </B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">(Exact Name of Registrant as Specified in Its Charter) </P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B>2836</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><B><FONT STYLE="white-space:nowrap">83-1381173</FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">(State or Other Jurisdiction of<BR></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Incorporation or Organization)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">(Primary Standard Industrial<BR></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Classification Code Number)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">(I.R.S. Employer<BR>Identification Number)</TD></TR></TABLE> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>188 East Blaine Street, Suite 400 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Seattle, Washington 98102 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">(206) <FONT STYLE="white-space:nowrap">701-7914</FONT> (Address, Including Zip Code, and Telephone Number, Including Area Code, of
Registrant&#146;s Principal Executive Offices) </P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Steven D. Harr,
M.D. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>President and Chief Executive Officer </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>188 East Blaine Street, Suite 400 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Seattle, Washington 98102 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(206) <FONT STYLE="white-space:nowrap">701-7914</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">(Name, Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent For Service) </P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><I>Copies to: </I></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>Brian J. Cuneo<BR>B. Shayne Kennedy<BR>Latham&nbsp;&amp; Watkins LLP<BR>140 Scott Drive<BR>Menlo Park, California 94025<BR>(650) <FONT STYLE="white-space:nowrap">328-4600</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>James J. MacDonald</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Executive Vice President, General Counsel&nbsp;&amp; Corporate Secretary</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc.</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>188 East Blaine Street, Suite 400</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Seattle, Washington 98102</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(206) <FONT STYLE="white-space:nowrap">701-7914</FONT></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Charles S. Kim</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Kristin VanderPas</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Dave
Peinsipp</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Denny Won</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Cooley LLP</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>440 Eastgate
Mall</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>San Diego, California 92121</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(858) <FONT STYLE="white-space:nowrap">550-6000</FONT></B></P></TD></TR>
</TABLE> <P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman" ALIGN="justify"><B>Approximate date of commencement of proposed sale to the public:</B> As soon as practicable
after the effective date of this Registration Statement. </P> <P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman" ALIGN="justify">If any of the securities being registered on this form are to be
offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box.&nbsp;&nbsp;&#9744; </P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman" ALIGN="justify">If this form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, check
the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744; </P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman" ALIGN="justify">If this form is a <FONT STYLE="white-space:nowrap">post-effective</FONT> amendment filed pursuant to Rule 462(c) under the
Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744; </P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman" ALIGN="justify">If this form is a <FONT STYLE="white-space:nowrap">post-effective</FONT> amendment filed pursuant to Rule 462(d) under the
Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744; </P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman" ALIGN="justify">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a <FONT
STYLE="white-space:nowrap">non-accelerated</FONT> filer, a smaller reporting company or an emerging growth company. See the definitions of &#147;large accelerated filer,&#148; &#147;accelerated filer,&#148; &#147;smaller reporting company,&#148; and
&#147;emerging growth company&#148; in Rule <FONT STYLE="white-space:nowrap">12b-2</FONT> of the Exchange Act. </P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="23%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="25%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="25%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="24%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top">Large accelerated filer&nbsp;&nbsp;&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Accelerated filer&nbsp;&nbsp;&#9744;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="white-space:nowrap">Non-accelerated</FONT> filer&nbsp;&nbsp;&#9746;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Smaller reporting company&nbsp;&nbsp;&#9744;</TD></TR>
</TABLE> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Emerging growth company&nbsp;&nbsp;&#9746; </P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman" ALIGN="justify">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section&nbsp;7(a)(2)(B) of the Securities Act. &#9744; </P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>CALCULATION OF
REGISTRATION FEE </B></P> <P STYLE="font-size:9pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="40%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="14%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="14%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="14%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="14%"></TD></TR>


<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000"><B>Title of each class of<BR>securities to be registered</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><B>Amount<BR>to&nbsp;be<BR>registered<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>Proposed&nbsp;maximum</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Times New Roman" ALIGN="center"><B>aggregate&nbsp;offering<BR>price&nbsp;per&nbsp;share</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><B>Proposed&nbsp;maximum<BR>aggregate&nbsp;offering<BR>price<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><B>Amount&nbsp;of<BR>registration&nbsp;fee<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Common Stock, $0.0001 par value per share</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">17,250,000</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$23.00</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$396,750,000</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$43,286</TD></TR>
<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1px; ">
<TD COLSPAN="9" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
</TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">Includes 2,250,000 shares of common stock that the underwriters have the option to purchase.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(a)
under the Securities Act of 1933, as amended. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">The registrant previously paid a total of $16,365 in connection with the previous filing of the registration
statement. </P></TD></TR></TABLE>  <P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:4%; font-size:8pt; font-family:Times New Roman" ALIGN="justify"><B>The Registrant hereby amends this registration statement on such date or dates as may
be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section&nbsp;8(a) of the Securities Act of
1933, or until the registration statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section&nbsp;8(a), may determine. </B></P>
<P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1.00pt solid #000000">&nbsp;</P>
<P STYLE="line-height:5.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:3.00pt solid #000000">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial Narrow" ALIGN="justify"><FONT COLOR="#cc062a"><B>The information in this preliminary prospectus is not complete and
may be changed. We may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities and we are not soliciting offers
to buy these securities in any jurisdiction where the offer or sale is not permitted. </B></FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#cc062a"><B>SUBJECT TO COMPLETION, DATED JANUARY 28, 2021 </B></FONT></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>15,000,000 Shares </B></P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g60414g14k99.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This is an
initial public offering of shares of common stock of Sana Biotechnology, Inc. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are offering 15,000,000 shares of our common stock.
Prior to this offering, there has been no public market for our common stock. It is currently estimated that the initial public offering price per share will be between $20.00 and $23.00. We have applied to list our common stock on the Nasdaq Global
Select Market under the symbol &#147;SANA.&#148; </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are an emerging growth company under the federal securities laws and, as such,
have elected to comply with certain reduced public company reporting requirements. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Investing in
our common stock involves a high degree of risk. See the section titled &#147;<A HREF="#toc60414_2">Risk Factors</A>&#148; beginning on page 19. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Per</B><br><B>Share</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Initial public offering price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Underwriting discounts and
commissions<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds, before expenses, to us</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">See the section titled &#147;Underwriting&#148; for additional disclosure regarding the estimated
underwriting discounts and commissions and estimated offering expenses. </P></TD></TR></TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have granted the underwriters the right
to purchase up to an additional 2,250,000 shares of common stock solely to cover over-allotments, if any. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The underwriters expect to
deliver the shares against payment in New York, New York on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2021. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or
determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense. </B></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:13pt" ALIGN="center">


<TR>

<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="19%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:13pt">
<TD VALIGN="top" COLSPAN="7"><B>Morgan Stanley</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>Goldman&nbsp;Sachs&nbsp;&amp;&nbsp;Co.&nbsp;LLC</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>J.P.&nbsp;Morgan</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><B>BofA&nbsp;Securities</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2021
</B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="position:relative;float:left; width:48%;padding-right:0%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc60414_1">Prospectus Summary</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><A HREF="#toc60414_1"></A>&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><A HREF="#toc60414_1"></A>1</TD>
<TD NOWRAP VALIGN="bottom"><A HREF="#toc60414_1"></A>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc60414_23a">The Offering </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc60414_2">Risk Factors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><A HREF="#toc60414_2"></A>&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><A HREF="#toc60414_2"></A>19</TD>
<TD NOWRAP VALIGN="bottom"><A HREF="#toc60414_2"></A>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc60414_3">Special Note Regarding <FONT STYLE="white-space:nowrap">Forward-Looking</FONT> Statements
</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><A HREF="#toc60414_3"></A>&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><A HREF="#toc60414_3"></A>90</TD>
<TD NOWRAP VALIGN="bottom"><A HREF="#toc60414_3"></A>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc60414_4">Industry and Market Data</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><A HREF="#toc60414_4"></A>&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><A HREF="#toc60414_4"></A>92</TD>
<TD NOWRAP VALIGN="bottom"><A HREF="#toc60414_4"></A>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc60414_5">Use of Proceeds</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><A HREF="#toc60414_5"></A>&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><A HREF="#toc60414_5"></A>93</TD>
<TD NOWRAP VALIGN="bottom"><A HREF="#toc60414_5"></A>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc60414_6">Dividend Policy</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><A HREF="#toc60414_6"></A>&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><A HREF="#toc60414_6"></A>95</TD>
<TD NOWRAP VALIGN="bottom"><A HREF="#toc60414_6"></A>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc60414_7">Capitalization</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><A HREF="#toc60414_7"></A>&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><A HREF="#toc60414_7"></A>96</TD>
<TD NOWRAP VALIGN="bottom"><A HREF="#toc60414_7"></A>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc60414_8">Dilution</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><A HREF="#toc60414_8"></A>&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><A HREF="#toc60414_8"></A>98</TD>
<TD NOWRAP VALIGN="bottom"><A HREF="#toc60414_8"></A>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc60414_9">Selected Consolidated Financial Data</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><A HREF="#toc60414_9"></A>&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><A HREF="#toc60414_9"></A>101</TD>
<TD NOWRAP VALIGN="bottom"><A HREF="#toc60414_9"></A>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc60414_10">Management&#146;s Discussion and Analysis of Financial Condition and Results
 of Operations</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><A HREF="#toc60414_10"></A>&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><A HREF="#toc60414_10"></A>103</TD>
<TD NOWRAP VALIGN="bottom"><A HREF="#toc60414_10"></A>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc60414_11">Business</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">123</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
</DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:49%;padding-right:0%;padding-bottom:8pt;overflow:hidden;padding-top:3pt">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc60414_12">Management</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">212</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc60414_13">Executive and Director Compensation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">223</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc60414_14">Certain Relationships and <FONT STYLE="white-space:nowrap">Related-Party</FONT> Transactions
</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">240</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc60414_15">Principal Stockholders</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">245</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc60414_16">Description of Capital Stock</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">248</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc60414_17">Material U.S. Federal Income Tax Consequences For <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> Holders of Common Stock</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">256</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc60414_18">Shares Eligible For Future Sale</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">260</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc60414_19">Underwriting</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">262</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc60414_20">Legal Matters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">272</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc60414_21">Experts</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">272</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc60414_22">Where You Can Find More Information</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">272</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc60414_23">Index to Consolidated Financial Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">F-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>  </div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>
 <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In this prospectus, &#147;Sana Biotechnology,&#148; &#147;Sana,&#148; the &#147;Company,&#148; &#147;we,&#148; &#147;us,&#148;
and &#147;our&#148; refer to Sana Biotechnology, Inc. and its subsidiaries. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We and the underwriters have not
authorized anyone to provide any information or to make any representations other than those contained in this prospectus or in any free writing prospectuses prepared by us or on our behalf. We and the underwriters take no responsibility for, and
can provide no assurance as to the reliability of, any other information that others may provide you. We are offering to sell, and seeking offers to buy, shares of common stock only in jurisdictions where offers and sales are permitted. The
information contained in this prospectus is accurate only as of the date of this prospectus, regardless of the time of delivery of this prospectus or of any sale of the common stock. Our business, financial condition, results of operations, and
future growth prospects may have changed since that date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">&#147;SANA,&#148; the Sana logos, and other trade names,
trademarks, or service marks of Sana Biotechnology appearing in this prospectus are the property of Sana Biotechnology. Other trade names, trademarks, or service marks appearing in this prospectus are the property of their respective holders. Solely
for convenience, trade names, trademarks, and service marks referred to in this prospectus appear without the <SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>, <SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> and <SUP
STYLE="font-size:85%; vertical-align:top">SM</SUP> symbols, but those references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or that the applicable owner will not assert
its rights, to these trade names, trademarks, and service marks. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Until&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2021 (the 25th day
after the date of this prospectus), all dealers that effect transactions in these securities, whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to the dealers&#146; obligation to deliver a
prospectus when acting as underwriters and with respect to their unsold allotments or subscriptions. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc60414_1"></A>PROSPECTUS SUMMARY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>This summary highlights information contained elsewhere in this prospectus. This summary may not contain all of the
information that you should consider before deciding to invest in our common stock. You should read this entire prospectus carefully, including &#147;Risk Factors,&#148; &#147;Management&#146;s Discussion and Analysis of Financial Condition and
Results of Operations,&#148; and &#147;Business,&#148; and our audited consolidated financial statements and unaudited condensed consolidated financial statements and related notes included elsewhere in this prospectus before making an investment
decision. </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We were founded on the belief that engineered cells will be one of the most important transformations in medicine over the next
several decades. The burden of diseases that can be addressed at their root cause through engineered cells is significant. We view engineered cells as having the potential to be as therapeutically disruptive as biologics to clinical practice. Our
long-term aspirations are to be able to control or modify any gene in the body, to replace any cell that is damaged or missing, and to markedly improve access to cellular and gene-based medicines. We have brought together an experienced group of
scientists, engineers, and company builders and combined them with the necessary technologies to move this vision forward. We are developing <I>in vivo</I> and <I>ex vivo</I> cell engineering platforms to revolutionize treatment across a broad array
of therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system (CNS) disorders, cardiovascular diseases, and genetic disorders, among others. While our current product candidates are all in preclinical
development, our goal is to file multiple investigational new drug applications (INDs) both in 2022 and 2023. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The process
of repairing and controlling genes in the body, referred to as gene therapy or <I>in vivo </I>cell engineering, requires <I>in vivo</I> delivery of a therapeutic payload and modification of the genome. Of these, we believe delivery of a therapeutic
payload represents the greatest unmet need and is thus at the core of our strategic focus, with our ultimate goal being the delivery of any payload to any cell in a specific and repeatable way. Our initial effort is on cell-specific delivery and
increasing the diversity and size of payloads. Using our fusogen technology, we have shown in preclinical studies that we can specifically target numerous cell surface receptors that, when combined with delivery vehicles to form fusosomes, allow
cell-specific delivery across multiple different cell types. We have initially chosen to focus this technology on delivering payloads to T&nbsp;cells, hepatocytes, and hematopoietic stem cells (HSCs). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Frequently in disease, cells are damaged or missing entirely, and an effective therapy needs to replace the entire cell, an
approach referred to as cell therapy or <I>ex vivo </I>cell engineering. A successful therapeutic requires an ability to manufacture cells at scale that engraft, function, and have the necessary persistence in the body. Of these, long-term
persistence related to overcoming immunologic rejection of another person&#146;s cells has been the most challenging, which has led many to focus on autologous, or a patient&#146;s own, cells as the therapeutic source. However, autologous therapies
require a complex process of harvesting cells from the patients, manipulating them outside the body, and returning them to the patient. Products utilizing this approach have had to manage significant challenges such as scalability, product
variability, product quality, cost, patient accessibility, and a limited number of cell types being amenable to this approach. Given these limitations, rather than utilizing autologous cells to overcome immune rejection, we have invested in creating
a hypoimmune cells that can &#147;hide&#148; from the patient&#146;s immune system. We are striving to make therapies utilizing pluripotent stem cells with our hypoimmune genetic modifications as the starting material, which we then differentiate
into a specific cell type, such as a pancreatic beta cell, before treating the patient. Additionally, for cell types for which effective differentiation protocols from a stem cell have not yet been developed, such as T cells, instead of starting
from a pluripotent stem cell, we can utilize an allogeneic cell, differentiated cells sourced from a donor, as the starting material to which we then apply our hypoimmune genetic modifications. </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We believe the time is right to develop engineered cell therapies across a
broad range of therapeutic areas. Substantial progress in the understanding of genetics, gene editing, gene control, protein engineering, stem cell biology, immunology, process analytics, and computational biology have converged to create an
opportunity to markedly increase the breadth and depth of the potential impact of genetic and cellular medicines. We are focused on creating transformative <I>in vivo</I> and <I>ex vivo</I> engineered cell therapies across a range of therapeutic
areas. We are in the early stages of development across a broad pipeline of product candidates, all of which are currently in the preclinical stage of development and are summarized below: </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>  <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g60414g55l64.jpg" ALT="LOGO">
 </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our People and Values </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our people are the most important strength of the company. We have assembled a diverse group of experienced company builders,
scientists, manufacturing scientists, engineers, and operators to execute our business plan. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Experienced Company Builders</B>. Our founder and Chief Executive Officer, Dr.&nbsp;Steve Harr, was
previously CFO of Juno Therapeutics, helping to build the company and its chimeric antigen receptor (CAR) T cell therapy platform until its acquisition. He is a physician-scientist with experience in basic research, clinical medicine, finance,
company building, and operations. Our Chairman of the Board and <FONT STYLE="white-space:nowrap">co-founder,</FONT> Hans Bishop, is an experienced company builder and operator with success across a number of companies. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Leading Scientists</B>. Our leadership team includes multiple individuals with deep experience building
high growth, disruptive companies as well as world-class scientists, including researchers who have made seminal discoveries in gene delivery, immunology, CAR T cells, gene editing, and stem cell biology such as Drs. Richard Mulligan, Terry Fry, Ed
Rebar, Chuck Murry, Sonja Schrepfer, Steve Goldman, and Jagesh Shah. We have surrounded this team of discovery scientists with a team of drug developers experienced in advancing drug product candidates through the drug development process. These
include Drs. Sunil Agarwal, Donna Dambach, Ke Liu, Paul Brunetta, and Ms. Farah Anwar. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Experienced Manufacturing Scientists, Engineers, and Operators</B>. Since our founding, we have proactively
assembled manufacturing sciences and operations expertise on our board, on our executive team, and across the company. Our manufacturing organization is led by Dr.&nbsp;Stacey Ma, an
</P></TD></TR></TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
experienced executive with over two decades in manufacturing leadership, contributing to the commercialization of over ten products across multiple modalities. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Board of Directors and Investors with Shared Long-Term Vision</B>. Our board of directors is composed of
renowned company builders, operators, leaders, scientists, drug developers, and investors with experience across a diverse array of companies.<B> </B>This team is supported by investors who share our long-term vision around building the leading
company of the cell engineering era including ARCH Venture Partners, Flagship Pioneering, Canadian Pension Plan Investment Board, Baillie Gifford, The Alaska Permanent Fund, The Public Sector Pension Investment Board, F Prime, GV, and ADIA, amongst
others. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>We aspire to a core set of values that drive us every day: </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Lead from every seat</B>. We have a humble and unrelenting commitment to deliver for patients and our
community&#151;we seek to understand, act with honesty, and engage in the crucial conversations. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Thrive as a team</B>. We make each other better than we ever thought possible&#151;we hire amazing people,
are intensely curious, and cultivate inclusion and personal connectivity. </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Make it happen</B>. We make great choices with urgency and integrity&#151;we value vigorous debate,
alignment around our decisions, and resilient execution. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Strategy and Capabilities </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our vision is to build the <FONT STYLE="white-space:nowrap">pre-eminent</FONT> company focused on engineered cells to create
medicines for patients. Our mission is to do so at a scale that allows broad accessibility for patients so that we can democratize access to curative therapies. To achieve this, we have strategically focused on the key limitations for generating
engineered cell therapies, whether the cell modulation occurs <I>in vivo </I>or <I>ex vivo</I>. We also continue to aggregate the people and technologies that will allow us to research, develop, manufacture, and ultimately commercialize
differentiated products across a range of diseases. To execute on this strategy and tackle the most critical limitations of engineering cells, we have built deep internal capabilities and technologies across a wide range of areas including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Gene Delivery</B>. We believe our delivery technologies have broad potential, with both near-term and
long-term applications across a number of indications. We are investing in technologies that allow payload delivery to specific cell types, increase the diversity and size of payloads, enable repeat dosing of patients, and increase the volume of
distribution inside the body in order to target and access more diverse cells. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Gene Modification</B>. The ability to <FONT STYLE="white-space:nowrap">knock-out,</FONT> <FONT
STYLE="white-space:nowrap">knock-in,</FONT> modify, and control expression of genes is fundamental to our platforms&#146; success. We have hired world-class scientists with experience in all of these capabilities and across multiple modalities. We
are building internal capabilities that enable high throughput cell engineering and gene editing and control using multiple technologies through use of natural systems, protein engineering, and synthetic biology. Our capabilities across multiple
modalities allow us to utilize the appropriate system for the biologic problem of interest. We are developing proprietary gene editing capabilities as well as seeking strategic partnerships in key areas. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Immunology</B>. The immune system can be harnessed to treat multiple diseases, and it can also limit the
therapeutic effect of most cell- and gene-based therapies. Understanding and harnessing the immune system can have a broad impact across our <I>in vivo</I> and <I>ex vivo</I> cell engineering portfolio. We are investing in our people and
technologies to harness the immune system, particularly T cells, for the treatment of cancer and other diseases. Additionally, our hypoimmune technology has the potential to hide cells from the immune system, unlocking the potential of allogeneic
<I>ex vivo</I> therapies for the treatment of numerous diseases. </P></TD></TR></TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Stem Cell and Disease Biology</B>. Developing our platforms into therapies for patients requires a deep
understanding of both cell and disease biology. Furthermore, we are investing significantly in our people and the technologies that enable the differentiation of pluripotent stem cells into mature cells that can be used as therapeutics. In each
therapeutic area we intend to pursue, we have brought senior world-class scientists into the company to lead our efforts, and our research teams have significant experience in various areas of biology. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We also are investing early in building differentiated capabilities in key areas of manufacturing sciences and operations.
These include process development, product characterization, and process analytics from the time candidates are in early research phases. Our investments also include scaled research solutions, scaled infrastructure, and novel technologies to
improve efficiency, characterization, and scalability of manufacturing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our portfolio strategy seeks to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">minimize biology risk where there is platform risk, or in other words, prioritize opportunities where success
with our platform should lead to success in addressing the underlying disease; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prioritize program investments in diseases where the strengths of our <I>in vivo</I> and <I>ex vivo</I>
platforms can address key limitations of existing therapeutic approaches; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">focus on conditions of high unmet need, including the most grievous diseases; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prioritize efforts where success in one area begets success in others. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our </B><B><I>in vivo</I></B><B> Cell Engineering Platform and Programs </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Cell-specific delivery of genetic payloads inside the body has the potential to transform the treatment of a number of
diseases. For example, CAR T cells have shown impressive potential in oncology, but the current need to genetically modify T cells outside of the body, and then transplant the cells into a patient under conditions where the cells will engraft,
limits the breadth of application of the technology. Similarly, while there has been early clinical success using several gene editing technologies to modify hemoglobin expression and provide potentially curative treatments to patients with sickle
cell disease and beta-thalassemia, the breadth of application of these approaches has been significantly limited by the need to genetically modify HSCs outside of the body and transplant the cells back into the patient using chemotherapy regimens.
Our fusogen technology is designed to enable the delivery of payloads specifically to the target cells in the patient <I>in vivo</I>, as illustrated in the figure below, thereby bypassing manipulation of cells out of the body and the need for
transplantation. This technology has broad potential applicability, including in for CAR T and HSCs where it could eliminate both the complicated cell manufacturing and the need for high-dose chemotherapy. </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Our Fusogen Technology </U></B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g60414g05i05.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:8pt; font-family:Times New Roman" ALIGN="justify"><I>We are developing our fusogen technology to enable the delivery of any payload to
specific cells by first, enabling recognition of a specific target membrane (Step 1) and second, by promoting membrane fusion by acting as thermodynamic engines for opposing membranes, pulling them together and thereby promoting fusion (Step 2).
</I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Once we have achieved the desired specificity and potency for a certain cell type, we have the ability to deliver a
variety of payloads to that cell. This feature of the technology should allow us to create multiple therapies targeting a variety of diseases with each successful fusogen. As a result, we believe success with any initial therapy targeting a given
cell type could meaningfully advance lead candidate selection for other indications and increases our confidence that we will be successful with subsequent therapies targeting that same cell type. </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our most advanced fusosome programs target T cells, either CD8+ T cells,
which are also known as cytotoxic T cells, or CD4+ T cells, which are also known as helper T cells. Targeting these cells, we believe we can deliver a genetic payload with a single intravenous injection, with the goal of transforming some of a
patient&#146;s T&nbsp;cells into therapeutic CAR T cells. These T&nbsp;cells that are modified to express a CAR are programmed to target specific cells, including cancer cells. Our most advanced fusosome CAR&nbsp;T product candidates (SG242, SG295)
target cancer cells which express CD19, a cell surface antigen that is present across several B cell malignancies, including <FONT STYLE="white-space:nowrap">non-Hodgkin</FONT> lymphoma (NHL), chronic lymphocytic leukemia (CLL), and acute
lymphoblastic leukemia (ALL). Together, NHL, CLL, and ALL result in over 70,000 deaths per year in the United States and Europe. While currently approved CAR T therapies targeting CD19, such as Novartis&#146; Kymriah (tisagenlecleucel) and
Gilead&#146;s Yescarta (axicabtagene ciloleucel), have demonstrated impressive response rates in relapsed or refractory (R/R) disease, the delivery of these therapies requires a complex and costly manufacturing process, as well as toxic conditioning
regimens, which have limited patient access. Our goal is to make a therapy which is at least as effective as autologous CAR T therapies but avoids the aforementioned manufacturing complexities and conditioning-regimen associated toxicities. Our
preclinical data demonstrate that we can make a CAR T cell <I>in vivo</I> with a single intravenous injection and no conditioning chemotherapy, and effectively clear B cell tumors in a commonly used human xenograft mouse model for leukemia (Nalm-6).
In healthy non-human primate (NHP) studies we have demonstrated that a CD8 targeting fusosome is well tolerated and does not cause infusion or CAR-related toxicity, while showing evidence of activity, causing B cell depletion in the majority of the
NHPs. For our CD19 fusosome CAR programs, we expect to file an IND for SG295 as early as 2022 and for SG242 as early as 2023. We also intend to develop CAR T therapies against other antigens, including BCMA for the treatment of multiple myeloma
(SG221, SG239), with the goal of filing INDs for multiple therapies in a spectrum of cancers over the coming years. </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Delivery of CD19 CAR to CD8 Cells Leads to </U></B><B><I><U>in vivo</U></I></B><B><U>
Killing of Leukemia Cells in a Human Xenograft Mouse Model </U></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g60414g32m72.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:8pt; font-family:Times New Roman" ALIGN="justify"><I>Panel demonstrates activity of CD8 fusosome delivering CD19 CAR to human T cells in a
murine leukemia xenograft model <FONT STYLE="white-space:nowrap">(Nalm-6).</FONT> Note that when compared to untreated controls, fusosome delivery results in eradication of leukemia cells. Activated T cells were cultured with CD3/CD28 beads for
three days prior to injection. CD8 fusosome delivery of the CD19 CAR is effective regardless of activation status of T cells at time of injection. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We also have fusosome programs focused on delivering payloads to hepatocytes (SG328) and to HSCs (SG418). While several
modalities exist that enable delivery of genetic material to liver cells, including adeno-associated virus (AAV) and lipid nanoparticles (LNPs), these approaches have limitations, including the inability to provide for the stable integration of a
genetic payload, a limited payload size, <FONT STYLE="white-space:nowrap">pre-existing</FONT> immunity, and a lack of cell specificity. Our fusogen technology, which can enable delivery of a payload specifically to hepatocytes in the liver, can
potentially address these limitations. We have developed fusosomes that, in <I>in vivo </I>mouse studies, transduce a meaningful percentage of hepatocytes in a dose dependent fashion and in a range that we believe will allow us to treat a myriad of
genetic disorders. We have chosen to initially focus on severe genetic diseases where we believe treating pediatric patients is likely to lead to significant clinical benefit. Our </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
technology can integrate the desired genetic payload, DNA in this case, into a target cell&#146;s chromosomal DNA, thereby, in contrast to <FONT STYLE="white-space:nowrap">non-integrating</FONT>
gene transfer systems, providing for sustained payload expression as the hepatocytes of the pediatric patient divide and amplify during organ growth. We are developing our lead hepatocyte fusosome product candidate, SG328, for ornithine
transcarbamylase (OTC) deficiency, the most common defect in urea metabolism with clinical manifestations of neurologic damage and severe multi-organ failure, affecting approximately 10,000 patients worldwide, including approximately 3,000 patients
in the United States. Our goal is to file an IND as early as 2022. We intend to develop our <FONT STYLE="white-space:nowrap">HSC-targeted</FONT> fusosomes to repair genetic abnormalities underlying diseases such as sickle cell disease and
beta-thalassemia (SG418), with the goal of achieving preclinical proof of concept as early as 2023. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our </B><B><I>ex vivo</I></B><B> Cell Engineering
Platform and Programs </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Cell death leads to the manifestations of many of the most serious and common diseases, such as
heart disease, Type I diabetes, and advanced multiple sclerosis. We believe that the most effective mechanism to treat these patients is to replace their missing or damaged cells. Our goal is to manufacture genetically modified cells that are
capable of both replacing missing cells and evading a patient&#146;s immune system, which otherwise would recognize these cells as foreign and reject them. We believe our hypoimmune technology will enable us to manufacture cells cost-effectively, at
scale, with product consistency, providing the potential for global patient access. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Creating Hypoimmune Therapeutic Cells from Human
Induced Pluripotent Stem Cells (iPSCs) </U></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g60414g86j37.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:8pt; font-family:Times New Roman" ALIGN="justify"><I>Our hypoimmune technology combines the three gene modifications below to hide cells from
the host immune system: Disruption of MHC class I and class II expression (which inactivates adaptive immune responses), and overexpression of CD47 (which hides cells from the innate immune system, including macrophages and natural killer (NK)
cells). Pluripotent stem cells from healthy donors are used as the starting material and are then genetically modified with the hypoimmune edits. These edited cells are then differentiated into cell types of therapeutic interest, which are
administered to the patient as &#147;off the shelf&#148; therapies. </I></P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have shown across multiple species preclinically that our hypoimmune
cells are able to hide from the immune system and avoid immune rejection, and we are now developing this technology to make <I>ex vivo</I> therapies to treat multiple diseases. NHP iPSCs modified with hypoimmune edits can survive <I>in vivo</I> when
transplanted into an allogeneic recipient. Notably, the transplanted cells completely evade immune responses despite the presence of a fully intact immune system and absence of immunosuppression. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Allogeneic Hypoimmune iPSC Survive </U></B><B><I><U>in vivo</U></I></B><B><U> in NHPs with an Intact Immune System </U></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g60414g46f85.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:8pt; font-family:Times New Roman" ALIGN="justify"><I>Unmodified (wild type, wt) NHP iPSCs (top row) or hypoimmune NHP iPSCs (bottom row) were
introduced via intramuscular injection into allogeneic NHPs. iPSC survival is followed over time in vivo using bioluminescence imaging (BLI). BLI signal on the day of transplantation is &#147;D0&#148; and defined as 100%. NHPs are analyzed weekly
and cell survival is calculated over time. Data are representative for three NHPs receiving HIP iPSCs and two NHPs receiving unmodified wt iPSCs. Experiments were conducted in a staggered fashion. </I></P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Absence of T Cell, B Cell, or NK Cell Responses Following the First Delivery
</U></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>of Hypoimmune NHP iPSCs into NHPs </U></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g60414g36l36.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:8pt; font-family:Times New Roman" ALIGN="justify"><I>Immune cells from animals receiving unmodified (wild type, wt) NHP iPSCs show robust T
cell interferon responses when exposed to wt iPSCs in vitro (Row&nbsp;1). In contrast, immune cells from animals receiving hypoimmune iPSCs showed no response when exposed to hypoimmune iPSCs in vitro (Row&nbsp;2). Delivery of wt iPSCs activated B
cells, as evidenced by production of IgM and IgG (increased mean fluorescent intensity, MFI) (Row&nbsp;1). Delivery of hypoimmune iPSCs did not induce antibody production above background (Row&nbsp;2). Neither unmodified nor hypoimmune-edited cells
were susceptible to killing by natural killer (NK) cells, indicating protection from the &#147;missing self&#148; signal. Data above from a single NHP; data are representative for three NHPs receiving HIP iPSCs and two NHPs receiving unmodified wt
iPSCs; experiments were conducted in a staggered fashion. Dotted line denotes background level of assay. </I></P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our most advanced hypoimmune product candidates are allogeneic CAR T cells
for cancer (SC291, SC255). In order to make an effective allogeneic CAR T cell, we must overcome two different biologic barriers. First, the allogeneic CAR T cell must be prevented from causing graft versus host disease (GvHD), which occurs when
transplanted T cells attack a patient&#146;s cells. Preventing this adverse reaction is relatively straightforward through gene edits such as deleting the <FONT STYLE="white-space:nowrap">TCR-alpha</FONT> gene. Second, an allogeneic CAR T cell must
evade host versus graft disease (HvGD), which occurs when a patient&#146;s immune system tries to kill the transplanted T cells, thereby limiting the potential benefit of the therapy. One approach to avoid HvGD has been to eliminate a patient&#146;s
immune system, which both puts the patient at risk for severe infections and may limit the effectiveness of the therapy, as recovery of the immune system will lead to elimination of the CAR T cells. Our hypoimmune technology is designed to hide
cells from the patient&#146;s immune system, giving our allogeneic CAR T cell program the potential to avoid these issues. Our lead allogeneic CAR T product candidate (SC291) is a CD19 directed CAR T cell for NHL, CLL, and ALL. When tested in a
commonly used humanized mouse model, our hypoimmune donor-derived CD19 CAR T cells were protected from immune system rejection, with no evidence of either adaptive or innate immune system activation. By contrast, unmodified CD19 CAR T induced both
the adaptive and innate HvG response. Meanwhile, in the human xenograft mouse model for leukemia (Nalm-6), these hypoimmune CD19 CAR T cells clear B cell tumors at equivalent levels to the unmodified CD19 CAR T, suggesting that the hypoimmune edits
do not interfere with CAR T killing activity. We believe that our allogeneic CAR T program has the potential to serve a different, later-stage patient population than our fusosome CD19 CAR T program. We expect to file an IND for this program as
early as 2022. We also intend to develop other CAR T therapies, including BCMA for the treatment of multiple myeloma (SC255), with a goal of developing multiple CAR T therapies for a spectrum of cancers over the coming years. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are also utilizing our hypoimmune technology to develop pancreatic beta cells for the treatment of diabetes, with an
initial focus on Type I diabetes mellitus (T1DM). Almost 1.6&nbsp;million people in the United States, and 2.4&nbsp;million in Europe have T1DM. T1DM is a disease in which a patient&#146;s immune system attacks and kills pancreatic beta cells,
leading to complete loss of insulin production in affected individuals. Patients need to take multiple insulin shots every day for life, and, while insulin has a profoundly positive impact on patients, people with T1DM have approximately 15 years
shorter life expectancies than people without diabetes and are consistently at risk for complications such as coma, stroke, kidney failure, and blindness from poorly controlled blood glucose. We and our collaborators have shown that we can develop
high quality beta cells that, when transplanted, normalize blood glucose and cure diabetes in animal models. We have also shown that our hypoimmune cells induce no systemic immune response, even in NHPs with a
<FONT STYLE="white-space:nowrap">pre-existing</FONT> immune response to <FONT STYLE="white-space:nowrap">non-hypoimmune</FONT> cells. As a result, we believe our stem cell derived hypoimmune pancreatic cells have the potential to create a disruptive
treatment for T1DM, offering patients life-long normal blood glucose. We are working through the process development and <FONT STYLE="white-space:nowrap">IND-enabling</FONT> studies to allow for an IND filing for SC451 as early as 2023. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">There are also a number of CNS disorders in which the primary manifestations are caused by missing cells. We are developing
stem cell-derived allogeneic glial progenitor cells (GPCs) to treat various diseases of the white matter in the brain. GPCs are part of the support system of the brain and can differentiate into either myelin-producing oligodendrocytes or astrocytic
support cells for neurons. These GPC cells have the potential to treat a host of childhood myelin diseases, such as congenital leukodystrophies, as well as more common adult diseases of the glia and myelin such as multiple sclerosis and
Huntington&#146;s disease. In the United States and Europe, multiple sclerosis affects approximately 1.6&nbsp;million people, Huntington&#146;s disease affects approximately 90,000 people, and in aggregate congenital leukodystrophies affect 1 in
7,600 births. We and our collaborators have shown that injecting GPCs into the brain can reverse some or all of the CNS manifestations of these diseases in animal models. We expect to file three INDs for SC379 with an initial focus on <FONT
STYLE="white-space:nowrap">Pelizaeus-Merzbacher</FONT> disease (PMD), secondary progressive MS (SPMS), and Huntington&#146;s disease as early as 2023. </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Heart disease remains the most common cause of death worldwide and results
in over $280 billion in direct medical costs in the United States. Despite this unmet need, there has been little progress in treating diseases of the heart over the past several decades. After a myocardial infarction, or heart attack, patients have
dead heart tissue that reduces pump volume in each cardiac cycle, leaving them at risk for heart failure. To this end, we are developing stem-cell derived cardiomyocytes as a treatment for these patients. We and our collaborators have shown that
injecting these cells into animal hearts after a heart attack can meaningfully improve heart function, potentially even returning it to normal. We intend to initially develop our cardiomyocytes for patients who have had a recent myocardial
infarction and are at high-risk of developing severe heart failure, a disease that affects approximately 1.4&nbsp;million in the United States and Europe annually. Success in this indication may allow us to treat the larger market of severe chronic
heart failure, which impacts millions more patients in the United States and Europe. We expect to file an IND for SC187 as early as 2023. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SanaX
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our goal is to lead both the present and future of cell engineering and we are committed to making significant
investments in research and other activities that will ensure a leadership position throughout the next decade. Towards this end we have established SanaX as a distinct research arm. SanaX research efforts are aimed at making fundamental
improvements of existing technology and establishing new paradigms for gene and cell delivery that will ultimately lead to the development of completely new therapeutic modalities. Current SanaX research activities are focused on areas such as:
cells as delivery vehicles, novel viral vectors, novel production approaches to current viral vectors, novel methods for enabling the exogenous control of transgene expression via small molecule drugs, and new paradigms for genetically manipulating
specific immune response in order to engender immunological tolerance to specific antigens, cells, and organs. SanaX is currently also involved in <FONT STYLE="white-space:nowrap">COVID-19</FONT> related research focused on the delivery of specific
antibodies for severe acute respiratory syndrome coronavirus 2 <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">(SARS-CoV-2)</FONT></FONT> and the evaluation of novel direct anti-viral strategies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Dr.&nbsp;Mulligan, our Executive Vice-Chairman and Head of SanaX, directly oversees the SanaX research effort. SanaX maintains
an independent research budget in order to ensure that these longer-term, disruptive priorities are not sacrificed for near-term needs. Once SanaX develops an understanding of how a technology can translate into the clinic, a program will move from
SanaX into our internal R&amp;D and manufacturing organization or partnered externally. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Certain Preliminary Financial Information (Unaudited)
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As of December 31, 2020, we had approximately $412.0 million in cash, cash equivalents, and marketable securities.
This estimate of our cash, cash equivalents, and marketable securities is preliminary and subject to completion, including the completion of audit procedures as of and for the year ended December 31, 2020. As a result, the unaudited preliminary
cash, cash equivalents, and marketable securities set forth above reflects our preliminary estimate with respect to such information, based on information currently available to management, and may vary from our actual financial position as of
December 31, 2020. Further, this preliminary estimate is not a comprehensive statement or estimate of our financial results or financial condition as of and for the year ended December 31, 2020. The unaudited preliminary cash, cash equivalents, and
marketable securities included herein has been prepared by, and is the responsibility of, management. Ernst &amp; Young LLP, our independent registered public accounting firm, has not audited, reviewed, compiled or performed any procedures with
respect to the unaudited preliminary cash, cash equivalents, and marketable securities. Accordingly, Ernst &amp; Young LLP does not express an opinion or any other form of assurance with respect thereto. It is possible that we or Ernst &amp; Young
LLP may identify items that require us to make adjustments to the financial information set forth above. We expect to complete our audited consolidated financial statements for the year ended December 31, 2020 subsequent to the completion of this
offering. This estimate should not be viewed as a substitute for financial statements prepared in accordance with accounting principles generally accepted in the United States and they </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
are not necessarily indicative of the results to be achieved in any future period. Accordingly, you should not draw any conclusions based on the foregoing estimate and should not place undue
reliance on this preliminary estimate. We assume no duty to update this preliminary estimate except as required by law. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Associated with Our
Business </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our business is subject to a number of risks of which you should be aware before making a decision to invest
in our common stock.&nbsp;These risks are more fully described in the section titled &#147;Risk Factors&#148; immediately following this prospectus summary. These risks include, among others, the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We are a preclinical-stage biotechnology company and have incurred significant losses since our inception, and
we expect to incur losses for the foreseeable future. We have no products approved for commercial sale and may never achieve or maintain profitability. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our limited operating history may make it difficult for you to evaluate our prospects and likelihood of
success. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our <I>in vivo</I> and <I>ex vivo</I> cell engineering platforms are based on novel technologies that are
unproven and may not result in approvable or marketable products, which exposes us to unforeseen risks and makes it difficult for us to predict the time and cost of product development and potential for regulatory approval, and we may not be
successful in our efforts to use and expand our technology platforms to build a pipeline of product candidates. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">All of our product candidates are in preclinical development and have not commenced clinical development.
Preclinical and clinical drug development is a lengthy and expensive process with uncertain timelines and uncertain outcomes. If preclinical studies or clinical trials of a product candidate are prolonged or delayed, we may be unable to obtain
required regulatory approvals, and therefore be unable to commercialize our product candidates on a timely basis or at all. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The development and commercialization of biopharmaceutical products is subject to extensive regulation, and
the regulatory approval processes of the U.S. Food and Drug Administration (FDA) and comparable foreign authorities are lengthy, time-consuming, and inherently unpredictable. If we are ultimately unable to obtain regulatory approval for our product
candidates on a timely basis if at all, our business will be substantially harmed. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our clinical trials may fail to demonstrate substantial evidence of the safety and efficacy of our product
candidates or any future product candidates, which would prevent or delay or limit the scope of regulatory approval and commercialization. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We may encounter difficulties in managing our growth, which could disrupt our operations.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The outbreak of the novel coronavirus disease, <FONT STYLE="white-space:nowrap">COVID-19,</FONT> could
materially and adversely affect our preclinical studies and development, any clinical trials we subsequently commence, and our business, financial condition, and results of operations. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Even if this offering is successful, we will require additional funding in order to finance operations. If we
are unable to raise capital when needed, or on acceptable terms, we could be forced to delay, reduce, or eliminate our product development programs or commercialization efforts. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our success payment and contingent consideration obligations may result in dilution to our stockholders, may
be a drain on our cash resources, or may cause us to incur debt obligations to satisfy the payment obligations. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">If we are unable to successfully identify, develop, and commercialize any product candidates, or experience
significant delays in doing so, our business, financial condition, and results of operations will be materially adversely affected. </P></TD></TR></TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Our success depends on our ability to protect our intellectual property and our proprietary technologies.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We depend on intellectual property licensed from third parties and if we breach our obligations under these
agreements or if any of these agreements is terminated, we may be required to pay damages, lose our rights to such intellectual property and technology, or both, which would harm our business. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">While we believe our pipeline will yield multiple INDs, we may not be able to file INDs to commence clinical
trials on the timelines we expect, and even if we are able to, the FDA may not permit us to proceed. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Corporate and Other Information
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We were founded in July 2018 as a Delaware corporation. Our principal executive offices are located at 188 East Blaine
Street, Suite 400, Seattle, Washington 98102, and our telephone number is (206) <FONT STYLE="white-space:nowrap">701-7914.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our website address is www.sana.com. The information on, or that can be accessed through, our website is not part of this
prospectus and is not incorporated by reference herein. We have included our website address as an inactive textual reference only. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Implications of
Being an Emerging Growth Company </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are an emerging growth company as defined in the Jumpstart Our Business Startups
Act of 2012 (the JOBS Act). We will remain an emerging growth company until the earliest of: (i)&nbsp;the last day of the fiscal year following the fifth anniversary of the consummation of this offering; (ii)&nbsp;the last day of the fiscal year in
which we have total annual gross revenue of at least $1.07&nbsp;billion; (iii)&nbsp;the last day of the fiscal year in which we are deemed to be a &#147;large accelerated filer&#148; as defined in Rule <FONT STYLE="white-space:nowrap">12b-2</FONT>
under the Securities Exchange Act of 1934, as amended (the Exchange Act), which would occur if the market value of our common stock held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> exceeded $700.0&nbsp;million as of the last business
day of the second fiscal quarter of such year; or (iv)&nbsp;the date on which we have issued more than $1.0&nbsp;billion in <FONT STYLE="white-space:nowrap">non-convertible</FONT> debt securities during the prior three-year period. An emerging
growth company may take advantage of specified reduced reporting requirements and is relieved of certain other significant requirements that are otherwise generally applicable to public companies. As an emerging growth company: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we will present in this prospectus only two years of audited annual financial statements, plus any required
unaudited financial statements, and related management&#146;s discussion and analysis of financial condition and results of operations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we will avail ourselves of the exemption from the requirement to obtain an attestation and report from our
independent registered public accounting firm on the assessment of our internal control over financial reporting pursuant to the Sarbanes-Oxley Act of 2002; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we will provide less extensive disclosure about our executive compensation arrangements; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we will not require stockholder <FONT STYLE="white-space:nowrap">non-binding</FONT> advisory votes on
executive compensation or golden parachute arrangements. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition, the JOBS Act provides that an
emerging growth company can take advantage of an extended transition period for complying with new or revised accounting standards. This provision allows an emerging growth company to delay the adoption of some accounting standards until those
standards would otherwise apply to private companies. We have elected to use the extended transition period for any other new or revised accounting standards during the period in which we remain an emerging growth company; however, we may adopt
certain new or revised accounting standards early. </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc60414_23a"></A>The Offering </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common stock offered by us</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">15,000,000 shares.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Underwriters&#146; over-allotment option</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">2,250,000 shares.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common stock to be outstanding immediately after this offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:pt"><BR></P> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">175,314,776 shares (or 177,564,776 shares if the
underwriters exercise their over-allotment option to purchase additional shares in full).</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Use of proceeds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We estimate that the net proceeds to us from this offering will be approximately $296.2&nbsp;million (or approximately
$341.2&nbsp;million if the underwriters exercise their over-allotment option to purchase additional shares in full) assuming an initial public offering price of $21.50 per share, which is the midpoint of the price range set forth on the cover page
of this prospectus, and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us.</P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We currently intend to use the net proceeds from this offering, together with our existing cash, cash equivalents and marketable securities, to
fund the ongoing development of our <I>in vivo</I> cell engineering platform and product candidates, which we anticipate will allow us to complete preclinical studies on each of our current product candidates and advance at least three <I>in
vivo</I> product candidates through human proof of concept studies; to fund the ongoing development of our <I>ex vivo</I> cell engineering platform and product candidates, which we believe will allow us to complete preclinical studies on each of our
current product candidates and advance at least three <I>ex vivo</I> product candidates through human proof of concept studies; to fund research efforts focused on advancing and broadening the scope of our <I>ex vivo</I> and <I>in vivo</I> cell
engineering platforms; to continue developing manufacturing capabilities for our product candidates; and the remainder, if any, for working capital and other general corporate purposes. We may also use a portion of the net proceeds to in-license,
acquire, or invest in, complementary technologies, assets, or intellectual property. We periodically evaluate strategic opportunities; however, we have no current commitments to enter into any such acquisitions or make any such investments. See the
section titled &#147;Use of Proceeds.&#148;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk factors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">See the section titled &#147;Risk Factors&#148; beginning on page 19 and other information included in this prospectus for
a discussion of factors you should carefully consider before deciding whether to invest in our common stock.</P></TD></TR></TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Directed share program</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">At our request, the underwriters have reserved for sale, at the initial public offering price, up to 2% of the shares
offered hereby for directors, officers, employees, business associates and other persons related to us who have expressed an interest in purchasing common stock in the offering. Shares purchased by our directors and officers will be
subject</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proposed Nasdaq trading symbol</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;SANA&#148;</P></TD></TR>
</TABLE>   <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Unless we specifically state otherwise or the context otherwise requires, the number
of shares of our common stock to be outstanding after this offering is based on 160,314,776&nbsp;shares of common stock outstanding as of September&nbsp;30, 2020 (including (i)&nbsp;the automatic conversion of all of our shares of convertible
preferred stock outstanding as of September&nbsp;30, 2020 into an aggregate of 134,112,712&nbsp;shares of our common stock immediately prior to the completion of this offering and (ii) 11,951,698&nbsp;shares of unvested restricted common stock
outstanding as of September&nbsp;30, 2020) and excludes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">9,677,280&nbsp;shares of common stock issuable upon exercise of stock options outstanding as of
September&nbsp;30, 2020, with a weighted-average exercise price of $2.32 per share; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">6,139,302&nbsp;shares of common stock issuable upon exercise of stock options granted subsequent to
September&nbsp;30, 2020, with a weighted-average exercise price of $7.92 per share; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">325,672&nbsp;restricted stock units subject to vesting conditions, and as of September&nbsp;30, 2020, (of
which, 146,249&nbsp;shares have satisfied the vesting conditions), and which will become outstanding six months after the effective date of the completion of this offering; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">356,630&nbsp;shares reserved for future issuance under our 2018 Equity Incentive Plan, as of
September&nbsp;30, 2020; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">234,065&nbsp;shares reserved for future issuance under our 2018 Equity Incentive Plan, which was increased
subsequent to September&nbsp;30, 2020; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a number of shares of our common stock equal to 8% of our outstanding common stock after this offering
reserved for future issuance under our 2021 Incentive Award Plan (the 2021 Plan), which will become effective on the date immediately prior to the date our registration statement relating to this offering becomes effective, as well as any future
increases in the number of shares of common stock reserved for issuance under the 2021 Plan; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a number of shares of our common stock equal to 1% of our outstanding common stock after this offering
reserved for future issuance under our Employee Stock Purchase Plan (the ESPP), which will become effective on the date immediately prior to the date our registration statement relating to this offering becomes effective, as well as any future
increases in the number of shares of common stock reserved for issuance under the ESPP. </P></TD></TR></TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Unless we
specifically state otherwise or the context otherwise requires, this prospectus reflects and assumes the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the adoption, filing and effectiveness of our amended and restated certificate of incorporation and bylaws
immediately prior to the completion of this offering; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the conversion of all outstanding shares of our convertible preferred stock outstanding into
134,112,712&nbsp;shares of our common stock immediately prior to the completion of this offering; </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">no exercise of outstanding stock options; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a <FONT STYLE="white-space:nowrap">1-for-4</FONT> reverse stock split of our capital stock effected on January
27, 2021; and </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">no exercise by the underwriters of their over-allotment option. </P></TD></TR></TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Summary Consolidated Financial Data </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following tables summarize our consolidated financial data for the periods and as of the dates indicated. We have derived
the summary consolidated statements of operations data for the period from July&nbsp;13, 2018 (inception) to December&nbsp;31, 2018 and the year ended December&nbsp;31, 2019, except for pro forma amounts, from our audited consolidated financial
statements and related notes included elsewhere in this prospectus. We have derived the summary consolidated statements of operations data for the nine months ended September&nbsp;30, 2019 and 2020, except for pro forma amounts, and the summary
consolidated balance sheet data as of September&nbsp;30, 2020, except for pro forma amounts, from our unaudited condensed consolidated financial statements and related notes included elsewhere in this prospectus. Our unaudited condensed consolidated
financial statements as of and for the nine months ended September&nbsp;30, 2019 and 2020 were prepared on a basis consistent with our audited consolidated financial statements and include, in our opinion, all adjustments of a normal and recurring
nature that are necessary for the fair statement of the financial information set forth in those statements included elsewhere in this prospectus. Our historical results are not necessarily indicative of results that may be expected in the future
and our interim results are not necessarily indicative of results that may be expected for the full year. You should read the following summary consolidated financial data together with our audited consolidated financial statements and our unaudited
condensed consolidated financial statements, and the related notes included elsewhere in this prospectus and the information in the sections titled &#147;Selected Consolidated Financial Data&#148; and &#147;Management&#146;s Discussion and Analysis
of Financial Condition and Results of Operations.&#148; </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Period&nbsp;from&nbsp;July&nbsp;13,<BR>2018 (Inception) to<BR>December&nbsp;31, 2018</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended<BR>December&nbsp;31,&nbsp;2019</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Nine Months Ended</B><br><B>September&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><B>(in thousands, except share and per share data)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Consolidated Statements of Operations Data:</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">9,040</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">119,375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">80,101</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">153,762</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,206</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,777</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,959</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,063</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,246</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">141,152</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">96,060</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">172,825</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(13,246</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(141,152</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(96,060</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(172,825</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest income, net</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,856</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,175</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">622</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other (expense) income, net</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(29</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(52</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss before income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(13,247</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(138,325</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(93,937</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(172,135</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Benefit from income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,547</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,204</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(13,247</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(130,778</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(87,733</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(172,135</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss per share, basic and
diluted<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(13.91</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(26.68</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(24.24</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(14.05</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average shares outstanding used in computing net loss per share, basic and diluted<SUP
STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">952,086</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,902,642</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,620,021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,249,482</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma net loss per share, basic and diluted (unaudited)<SUP
STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(1.32</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(1.32</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average shares outstanding used in computing pro forma net loss per share, basic and
diluted (unaudited)<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">99,300,062</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">130,266,762</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">Research and development expense for the year ended December&nbsp;31, 2019 and the nine months ended
September&nbsp;30, 2019 and 2020 included <FONT STYLE="white-space:nowrap">non-cash</FONT> expense of $1.9&nbsp;million, $1.4&nbsp;million, and $40.6&nbsp;million for the success payment liabilities, respectively, and
</P></TD></TR></TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:8pt">
$17.9&nbsp;million, $15.6&nbsp;million, and $16.7&nbsp;million for contingent consideration, respectively. Research and development expense for the year ended December&nbsp;31, 2019 and the nine
months ended September&nbsp;30, 2019 and 2020 included <FONT STYLE="white-space:nowrap">non-cash</FONT> expense of $11.9&nbsp;million, $11.9&nbsp;million, and $0.4&nbsp;million, respectively, in connection with license agreements. See Note&nbsp;3,
Acquisitions, Note&nbsp;5, License and collaboration agreements, and Note&nbsp;7, Fair value measurements to each of our audited consolidated financial statements and our unaudited condensed consolidated financial statements included elsewhere in
this prospectus, and the subsection titled &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#148; for more detail on the success payments and contingent consideration. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">See Note&nbsp;15, Net loss per share to each of our audited consolidated financial statements and our
unaudited condensed consolidated financial statements included elsewhere in this prospectus for an explanation of the calculations of our basic and diluted net loss per share, and the weighted-average number of shares outstanding used in the
computation of the per share amounts. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">See the subsection titled &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results
of Operations&#151;Unaudited Pro Forma Information&#148; for an explanation of the calculations of our basic and diluted pro forma net loss per share, and the weighted-average number of shares outstanding used in the computation of the per share
amounts. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>September&nbsp;30, 2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Actual</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro&nbsp;Forma<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro&nbsp;Forma&nbsp;as<BR>Adjusted<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Consolidated Balance Sheet Data:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash, cash equivalents and marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">459,070</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">459,070</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">755,256</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Working capital<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">429,031</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">429,031</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">725,217</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">767,715</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">767,715</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,063,901</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">852,897</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(316,262</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(316,262</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(316,262</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stockholders&#146; (deficit) equity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(311,175</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">541,722</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">837,908</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>  <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">The pro forma consolidated balance sheet data gives effect to: (i)&nbsp;the filing and effectiveness of our
amended and restated certificate of incorporation, which will be in effect immediately prior to the completion of this offering, and (ii)&nbsp;the automatic conversion of all of our outstanding convertible preferred stock into an aggregate of
134,112,712&nbsp;shares of our common stock immediately prior to the completion of the offering. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">The pro forma as adjusted consolidated balance sheet data gives effect to: (i)&nbsp;the pro forma adjustments
set forth in footnote (1)&nbsp;above; and (ii)&nbsp;the sale of shares of our common stock in this offering at the assumed initial public offering price of $21.50 per share, the midpoint of the price range set forth on the cover page of this
prospectus, after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. The pro forma as adjusted consolidated balance sheet data discussed above is illustrative only and will depend on the actual
initial public offering price and other terms of this offering determined at pricing. Each $1.00 increase or decrease in the assumed initial public offering price of $21.50 per share, the midpoint of the price range set forth on the cover page of
this prospectus, would increase or decrease, as applicable, each of our pro forma as adjusted cash, cash equivalents, and marketable securities, working capital, total assets, and total stockholders&#146; equity (deficit) by approximately $14.0
million, assuming the number of shares of common stock offered by us, as set forth on the cover page of this prospectus, remains the same, and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable
by us. Similarly, each increase or decrease of 1.0&nbsp;million shares of common stock offered by us would increase or decrease, as applicable, each of our pro forma as adjusted cash, cash equivalents, and marketable securities, working capital,
total assets, and total stockholders&#146; equity (deficit) by approximately $20.0 million, assuming the assumed initial public offering price of $21.50 per share remains the same, and after deducting estimated underwriting discounts and commissions
and estimated offering expenses payable by us. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">We define working capital as current assets less current liabilities. See our consolidated financial
statements and the related notes included elsewhere in this prospectus for further details regarding our current assets and current liabilities. </P></TD></TR></TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc60414_2"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Investing in shares of our common stock involves a high degree of risk. You should carefully consider the following risks
and uncertainties, together with all of the other information contained in this prospectus, including our financial statements and related notes included elsewhere in this prospectus, before making an investment decision. The risks described below
are not the only ones facing us. Many of the following risks and uncertainties are, and will be, exacerbated by the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic and any worsening of the global business and economic environment as a
result. The occurrence of any of the following risks, or of additional risks and uncertainties not presently known to us or that we currently believe to be immaterial, could materially and adversely affect our business, financial condition,
reputation, or results of operations. In such case, the trading price of shares of our common stock could decline, and you may lose all or part of your investment. </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Our Limited Operating History, Financial Condition and Need for Additional Capital </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>We are a preclinical-stage biotechnology company and have incurred significant losses since our inception, and we expect to incur losses
for the foreseeable future. We have no products approved for commercial sale and may never achieve or maintain profitability. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are a preclinical-stage biotechnology company with a limited operating history. Biotechnology product development is a
highly speculative undertaking and involves a substantial degree of risk. We have incurred significant losses since inception, have not generated any revenue from product sales, and have financed our operations principally through private
financings. We expect that it will be several years, if ever, before we have a commercialized product and generate revenue from product sales. Our net losses were $13.2&nbsp;million and $130.8&nbsp;million for the period from July&nbsp;13, 2018
(inception) to December&nbsp;31, 2018 and for the year ended December&nbsp;31, 2019, respectively, and $87.7&nbsp;million and $172.1&nbsp;million for the nine months ended September&nbsp;30, 2019 and 2020, respectively. As of September&nbsp;30,
2020, we had an accumulated deficit of $316.3&nbsp;million. Our losses have resulted principally from expenses incurred for the research and development of our <I>in vivo</I> and <I>ex vivo</I> cell engineering platforms and from management and
administrative costs and other expenses that we have incurred while building our business infrastructure. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We expect our
expenses and operating losses will continue to increase substantially for the foreseeable future as we expand our research and development efforts, expand the capabilities of our cell engineering platforms, identify product candidates, complete
preclinical studies and commence clinical trials, seek regulatory approval and commercialization of our product candidates, and operate as a public company. We anticipate that our expenses will increase substantially as we: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">continue to advance our <I>in vivo</I> and <I>ex vivo</I> cell engineering platforms; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">continue preclinical development of our current and future product candidates and initiate additional
preclinical studies; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">commence clinical studies of our current and future product candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establish our manufacturing capability, including developing our contract development and manufacturing
organization (CDMO) relationships and building our internal manufacturing facilities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">acquire and license technologies aligned with our <I>in vivo</I> and <I>ex vivo</I> cell engineering
platforms; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">seek regulatory approval of our current and future product candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expand our operational, financial, and management systems and increase personnel, including personnel to
support our preclinical and clinical development, manufacturing, and commercialization efforts; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">continue to develop, perfect, and defend our intellectual property portfolio; and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">incur additional legal, accounting, or other expenses in operating our business, including the additional
costs associated with operating as a public company. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have devoted a significant portion of our
financial resources and efforts to building our organization, developing our <I>in vivo</I> and <I>ex vivo</I> cell engineering platforms, identifying and developing potential product candidates, executing preclinical studies, acquiring technology,
organizing and staffing the company, business planning, establishing our intellectual property portfolio, raising capital, and providing general and administrative support for these operations. We are in the early stages of development of our
product candidates, have not yet commenced any clinical trials for any of our product candidates, and have not completed development and commercialization of any product candidate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">To become and remain profitable, we must succeed in identifying, developing, getting regulatory approval for and eventually
commercializing products that generate significant revenue. This will require us to be successful in a range of challenging activities, including completing preclinical studies and clinical trials of our product candidates, continuing to discover
and develop additional product candidates, obtaining regulatory approval for any product candidates that successfully complete clinical trials, accessing manufacturing capacity, establishing marketing capabilities, commercializing and ultimately
selling any products for which we may obtain regulatory approval. We may never succeed in any or all of these activities and, even if we do, we may never generate revenue that is sufficient to achieve profitability. Even if we do achieve
profitability, we may not be able to sustain profitability or meet outside expectations for our profitability. If we are unable to achieve or sustain profitability or to meet outside expectations for our profitability, the value of our shares of
common stock could be materially adversely affected. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Because of the numerous risks and uncertainties associated with
pharmaceutical products and biological development, we are unable to accurately predict the timing or amount of increased expenses or when, or if, we will be able to achieve profitability. If we are required by the U.S. Food and Drug Administration
(FDA) or comparable foreign regulatory authorities to perform studies in addition to those we currently anticipate, or if there are any delays in commencing or completing our clinical trials or the development of any of our product candidates, our
expenses could increase and commercial revenue could be further delayed and more uncertain, which will have a material adverse impact on our business. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Even if this offering is successful, we will require additional funding in order to finance operations. If we are unable to raise
capital when needed, or on acceptable terms, we could be forced to delay, reduce, or eliminate our product development programs or commercialization efforts. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Developing biopharmaceutical products, including conducting preclinical studies and clinical trials, is a very time-consuming,
expensive and uncertain process that takes years to complete. Our operations have consumed substantial amounts of cash since inception, and we expect our expenses to increase in connection with our ongoing activities, particularly as we conduct
clinical trials of, and seek regulatory and marketing approval for, our product candidates. Even if one or more of our product candidates is approved for commercial sale, we anticipate incurring significant costs associated with commercializing any
approved product candidate. To date, we have funded our operations primarily through private financings. We expect our expenses to increase in connection with our ongoing activities, particularly as we continue the preclinical development of our
<I>in vivo</I> and <I>ex vivo</I> platforms and product candidates, commence clinical studies for any product candidates, initiate clinical trials, and continue to research, develop, and conduct preclinical studies of other potential product
candidates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition, if we obtain regulatory approval for any of our product candidates, we expect to incur
significant commercialization expenses related to product manufacturing, marketing, sales, and distribution. Furthermore, upon the completion of this offering, we expect to incur additional costs associated with operating as a public company.
Accordingly, we will need to obtain substantial additional funding in connection with our continuing operations. If we are unable to raise capital when needed or on attractive terms, we could be forced to delay, reduce, or eliminate our research and
development programs or any future commercialization efforts. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As of September&nbsp;30, 2020, we had $459.1&nbsp;million in cash, cash
equivalents and marketable securities. Based on our current business plans, we believe that the net proceeds from this offering, together with our existing cash, cash equivalents and marketable securities, will be sufficient to fund our operating
expenses and capital expenditure requirements for at least the next 36 months. We have based this estimate on assumptions that may prove to be wrong, and we could use our capital resources sooner than we currently expect, requiring us to seek
additional funds sooner than planned, through public or private equity or debt financings or other sources, such as strategic collaborations. In addition, we may seek additional capital due to favorable market conditions or strategic considerations
even if we believe we have sufficient funds for our current or future operating plans. Attempting to secure additional financing may divert our management from our
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> activities, which may adversely affect our ability to develop our product candidates. Our future capital requirements will depend on many factors, including:
</P>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the scope, timing, progress, costs, and results of discovery, preclinical development, and clinical trials for
our current or future product candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the number of clinical trials required for regulatory approval of our current or future product candidates;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the costs, timing, and outcome of regulatory review of any of our current or future product candidates;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the cost of manufacturing clinical and commercial supplies of our current or future product candidates;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the costs and timing of future commercialization activities, including manufacturing, marketing, sales, and
distribution, for any of our product candidates for which we receive marketing approval; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the costs and timing of preparing, filing, and prosecuting patent applications, maintaining and enforcing our
intellectual property rights, and defending any intellectual property-related claims, including any claims by third parties that we are infringing upon their intellectual property rights; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to maintain existing, and establish new, strategic collaborations, licensing, or other
arrangements and the financial terms of any such agreements, including the timing and amount of any future milestone, royalty, or other payments due under any such agreement; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the revenue, if any, received from commercial sales of our product candidates for which we receive marketing
approval; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expenses to attract, hire, and retain skilled personnel; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the costs of operating as a public company; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to establish a commercially viable pricing structure and obtain approval for coverage and adequate
reimbursement from third-party and government payers; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">addressing any potential interruptions or delays resulting from factors related to the <FONT
STYLE="white-space:nowrap">COVID-19</FONT> pandemic; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the effect of competing technological and market developments; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the extent to which we acquire or invest in businesses, products, and technologies. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our ability to raise additional funds will depend on financial, economic, political and market conditions and other factors,
over which we may have no or limited control. Market volatility resulting from the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic or other factors could also adversely impact our ability to access capital as and when needed. Additional
funds may not be available when we need them, on terms that are acceptable to us, or at all. If adequate funds are not available to us on a timely basis, we could be required to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delay, limit, reduce, or terminate preclinical studies, clinical trials, or other research and development
activities, or eliminate one or more of our development programs altogether; and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delay, limit, reduce, or terminate our efforts to access manufacturing capacity, establish sales and marketing
capabilities or other activities that may be necessary to commercialize our product candidates, or reduce our flexibility in developing or maintaining our sales and marketing strategy. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Our success payment and contingent consideration obligations in our license and acquisition agreements may result in dilution to our
stockholders, may be a drain on our cash resources, or may cause us to incur debt obligations to satisfy the payment obligations. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We agreed to make success payments in cash pursuant to our license agreement with the President and Fellows of Harvard College
(Harvard) and contingent consideration and success payments, payable in cash or stock at our discretion, pursuant to the terms and conditions of our acquisition agreement with Cobalt Biomedicine, Inc. (Cobalt). The success payments to Harvard
(Harvard Success Payments) are based on increases in the fair value of our Series A convertible preferred stock, or any security into which such stock has been converted or exchanged, payable in cash. The potential Harvard Success Payments are based
on multiples of increased value ranging from 5x to 40x based on a comparison of the fair value of our Series A convertible preferred stock relative to the original $4.00 issuance price at <FONT STYLE="white-space:nowrap">pre-determined</FONT>
valuation measurement dates. The amount of the Harvard Success Payments does not exceed an aggregate of $175.0&nbsp;million which would only occur upon a 40x increase in value. The Harvard Success Payments can be achieved over a maximum of 12 years
from the effective date of the agreement. The valuation measurement dates for the Harvard Success Payments are triggered by events which include: an equity financing prior to an initial public offering (IPO) of more than $25.0&nbsp;million, the one
year anniversary of an IPO, and periodically thereafter, a merger, an asset sale, the sale of the majority of the shares held by our Series&nbsp;A convertible preferred stockholders, and the last day of the term of the success payments. If a higher
success payment tier is met at the same time a lower tier is first met, both tiers will be owed. Any previous success payments made to Harvard are credited against the success payment owed as of any valuation measurement date so that Harvard does
not receive multiple success payments in connection with the same threshold. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The contingent consideration related to
the Cobalt acquisition (Cobalt Contingent Consideration) is up to an aggregate of $500.0&nbsp;million upon the achievement of certain <FONT STYLE="white-space:nowrap">pre-defined</FONT> development milestones. The success payment to Cobalt (Cobalt
Success Payment) of $500.0&nbsp;million is payable if, at <FONT STYLE="white-space:nowrap">pre-determined</FONT> valuation measurement dates, our value is equal to or exceeds three times our value at the time of the Series B convertible preferred
stock issuance and we have a program based on the fusogen technology in a clinical trial pursuant to an investigational new drug application (IND), or have filed for, or received approval for, a biologics license application (BLA) or new drug
application (NDA). The valuation measurement dates for the Cobalt Success Payment are triggered by an arms&#146; length equity financing, or an IPO, and periodically thereafter. In addition to an arms&#146; length equity financing and an IPO, a
valuation measurement date is triggered upon a change of control when at least one of our programs based on the fusogen technology is the subject of an active research program. If there is a change of control and our valuation falls below three
times our value at the time of the Series&nbsp;B convertible preferred stock issuance the amount of the potential Cobalt Success Payment will decrease and the amount of potential Cobalt Contingent Consideration will increase. The term of the Cobalt
Success Payment is 20 years from the date of acquisition. See Note&nbsp;3, Acquisitions, to each of our audited consolidated financial statements and our unaudited condensed consolidated financial statements included elsewhere in this prospectus for
details on the different Company valuation thresholds and impact to the value of the potential Cobalt Success Payment and potential Cobalt Contingent Consideration if there is a change of control. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In order to satisfy our obligations to make these success payments, if and when they are triggered, we may issue equity or
convertible debt securities that may cause dilution to our stockholders, or we may use our existing cash or incur debt obligations to satisfy the success payment obligation in cash, which may adversely affect our financial position. In addition,
these success payments may impede our ability to raise money in future public offerings of debt or equity securities or to obtain a third party line of credit. We expect the first valuation </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
measurement date for the Harvard Success Payments to be the one-year anniversary of an IPO. See Note&nbsp;5, License and collaboration agreements, to each of our audited consolidated financial
statements and our unaudited condensed consolidated financial statements included elsewhere in this prospectus for the Series A convertible preferred stock prices that trigger a Harvard Success Payment and the corresponding payment amount. We expect
the first valuation measurement date for the Cobalt Success Payment to be an IPO, but we do not expect to owe a Cobalt Success Payment upon an IPO or within one year of an IPO. However, such payment is dependent on the stock price which is
unpredictable and may fluctuate significantly from quarter to quarter and year to year. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>The contingent consideration and success
payment obligations in our license and acquisition agreements may cause operating results to fluctuate significantly from quarter to quarter and year to year, which may reduce the usefulness of our financial statements. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our success payment and contingent consideration obligations under our license and acquisition agreements are recorded as
liabilities on our consolidated balance sheets. Under U.S. generally accepted accounting principles (GAAP), we are required to estimate the fair value of these liabilities as of each quarter end, with changes in the estimated fair value recorded in
research and development expense. Factors that may lead to increases or decreases in the estimated fair value of the success payment liabilities include, among others, changes in the value of our Series A convertible preferred stock, changes in our
estimated future value implied by the per share value of our Series B convertible preferred stock at issuance, changes in volatility, the estimated number and timing of valuation measurement dates, the term of the success payments, and changes in
the risk free interest rate. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Factors that may lead to increases or decreases in the estimated fair value of
contingent consideration include, among others, the estimated likelihood and timing in which milestones may be achieved and the estimated discount rates. A small change in the inputs and related assumptions for success payment liabilities and
contingent consideration may have a relatively large change in the estimated valuation and associated liabilities and resulting expense or gain. As a result, our operating results and financial condition as reported by GAAP may fluctuate
significantly from quarter to quarter and year to year and may reduce the usefulness of our GAAP financial statements. The estimated fair value of the Cobalt Success Payment liability was $2.4&nbsp;million and $37.6&nbsp;million as of
December&nbsp;31, 2019 and September&nbsp;30, 2020, respectively, and as of December&nbsp;31, 2019 and September&nbsp;30, 2020, the estimated fair value of the Harvard Success Payment liability was $1.9&nbsp;million and $7.4&nbsp;million,
respectively. The estimated fair value of the Cobalt Contingent Consideration was $69.1&nbsp;million and $85.8&nbsp;million as of December&nbsp;31, 2019 and September&nbsp;30, 2020, respectively. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Our limited operating history may make it difficult for you to evaluate our prospects and likelihood of success. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are a preclinical-stage biopharmaceutical company with a limited operating history upon which you can evaluate our business
and prospects. Since our inception in July 2018, we have devoted substantially all of our resources and efforts to building our organization, developing our <I>in vivo</I> and <I>ex vivo</I> cell engineering platforms, identifying and developing
potential product candidates, executing preclinical studies, acquiring technology, organizing and staffing the company, business planning, establishing and securing our intellectual property portfolio, raising capital, and providing general and
administrative support for these operations. All of our product candidates are still in preclinical stage of development, we have not yet demonstrated our ability to successfully commence or complete any clinical trials (including Phase 3 or other
pivotal clinical trials), obtain regulatory approvals, manufacture a commercial scale product or arrange for a third party to do so on our behalf, or conduct sales and marketing activities necessary for successful product commercialization.
Additionally, we expect our financial condition and operating results to continue to fluctuate significantly from period to period due to a variety of factors, many of which are beyond our control. Consequently, any predictions you may make about
our future success or viability may not be as accurate as they could be if we had a longer operating history. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In
addition, we may encounter unforeseen expenses, difficulties, complications, delays and other known and unknown factors and risks frequently experienced by preclinical-stage biopharmaceutical companies in rapidly
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
evolving fields. We also may need to transition from a company with a research focus to a company capable of supporting commercial activities. If we do not adequately address these risks and
difficulties or successfully make such a transition, it could have a material adverse impact on our business. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Our Business </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Our in vivo and ex vivo platforms are based on novel technologies that are unproven and may not result in approvable or marketable
products, which exposes us to unforeseen risks and makes it difficult for us to predict the time and cost of product development and potential for regulatory approval, and we may not be successful in our efforts to use and expand our technology
platforms to build a pipeline of product candidates. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are seeking to identify and develop a broad pipeline of
product candidates using our <I>in vivo</I> and <I>ex vivo</I> cell engineering platforms. We have not commenced clinical trials for any product candidates developed with these platforms. The scientific research that forms the basis of our efforts
to develop product candidates with our platforms is still ongoing. We are not aware of any FDA approved therapeutics utilizing fusogen technology or that are iPSC-derived cell products. Further, the scientific evidence to support the feasibility of
developing therapeutic treatments based on our platforms is both preliminary and limited. As a result, we are exposed to a number of unforeseen risks and it is difficult to predict the types of challenges and risks that we may encounter during
development of our product candidates. For example, we have not tested any of the product candidates being developed using our cell engineering platforms in humans, and our current data is limited to animal models and preclinical cell lines, the
results of which may not translate into humans. Further, relevant animal models and assays may not accurately predict the safety and efficacy of our product candidates in humans, and we may encounter significant challenges creating appropriate
models and assays for demonstrating the safety and purity of our product candidates. In addition, our fusogen and hypoimmune technologies have potential safety risks related to, but not limited to, genotoxicity associated with the delivery of genome
modifying payloads. Furthermore, our hypoimmune technology has potential safety risks related to, but not limited to, the potential risk of a hypoimmune cell becoming infected with a virus or undergoing oncogenic transformation. As a result, it is
possible that safety events or concerns could negatively affect the development of our product candidates, including adversely affecting patient enrollment among the patient populations that we intend to treat. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Given the novelty of our technologies, we intend to work closely with the FDA and comparable foreign regulatory authorities to
perform the requisite scientific analyses and evaluation of our methods to obtain regulatory approval for our product candidates; however, due to a lack of comparable experiences, the regulatory pathway with the FDA and comparable regulatory
authorities may be more complex and time-consuming relative to other more well-known therapeutics. Even if we obtain human data to support our product candidates, the FDA or comparable foreign regulatory agencies may lack experience in evaluating
the safety and efficacy of our product candidates developed using our platforms, which could result in a longer than expected regulatory review process, increase our expected development costs, and delay or prevent commercialization of our product
candidates. The validation process takes time and resources, may require independent third-party analyses, and may not be accepted or approved by the FDA and comparable foreign regulatory authorities. We cannot be certain that our approach will lead
to the development of approvable or marketable products, alone or in combination with other therapies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Additionally, a
key element of our strategy is to use and expand our <I>in vivo</I> and <I>ex vivo</I> cell engineering platforms to build a pipeline of product candidates and progress those product candidates through clinical development for the treatment of a
variety of different types of diseases. Although our research and development efforts to date have been focused on identifying a pipeline of product candidates directed at various disease types, we may not be able to develop product candidates that
are safe and effective. Even if we are successful in building our pipeline, the potential product candidates that we identify may not be suitable for clinical development, including as a result of being shown to have harmful side effects or other
characteristics that indicate that they are unlikely to be approvable or marketable products that will receive marketing approval and achieve market acceptance. If we do not continue to successfully develop, get approval for and begin to
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
commercialize any product candidates, we will face difficulty in obtaining product revenue in future periods, which could result in significant harm to our financial position and adversely affect
our share price. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>If we are unable to successfully identify, develop, and commercialize any product candidates, or experience
significant delays in doing so, our business, financial condition, and results of operations will be materially adversely affected. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our ability to generate revenue from sales of any of our approved product candidates, which we do not expect will occur for at
least the next several years, if ever, will depend heavily on the successful identification, development, regulatory approval and eventual commercialization of any product candidates, which may never occur. We have never generated revenue from sales
of any products, and we may never be able to develop, obtain regulatory approval for or commercialize a marketable product. We are in preclinical development and all of our product candidates will require significant clinical development; management
of preclinical, clinical and manufacturing activities; regulatory approval in multiple jurisdictions; establishing manufacturing supply, including commercial manufacturing supply; and require us to build a commercial organization and make
substantial investment and significant marketing efforts before we generate any revenue from product sales. We are not permitted to market or promote any of our product candidates before we receive regulatory approval from the FDA or comparable
foreign regulatory authorities, and we may never receive such regulatory approval for any of our product candidates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The
successful development of our product candidates will depend on several factors, including the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">successful and timely completion of preclinical studies and clinical trials for which the FDA, or any
comparable foreign regulatory authority, agree with the design, endpoints, or implementation; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">sufficiency of our financial and other resources to complete the necessary preclinical studies and clinical
trials; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">receiving regulatory approvals or authorizations for conducting future clinical trials; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">initiation and successful patient enrollment in, and completion of, clinical trials on a timely basis;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to demonstrate to the satisfaction of the FDA or any comparable foreign regulatory authority that
the applicable product candidate is safe and efficacious as a treatment for our targeted indications or, in the case of an applicable product candidate which is regulated as a biological product, that the applicable product has suitable purity and
is safe and potent for our targeted indications; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to demonstrate to the satisfaction of the FDA or any comparable foreign regulatory authority that
the applicable product candidate&#146;s risk-benefit ratio for its proposed indication is acceptable; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">timely receipt of marketing approvals for our product candidates from applicable regulatory authorities;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">addressing any potential interruptions or delays resulting from factors related to the <FONT
STYLE="white-space:nowrap">COVID-19</FONT> pandemic; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the extent of any required post-marketing approval commitments to applicable regulatory authorities; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establishing, scaling up and scaling out, either alone or with third-party manufacturers, manufacturing
capabilities of clinical supply for our clinical trials and commercial manufacturing (including licensure), if any of our product candidates are approved. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If we do not achieve one or more of these factors in a timely manner or at all, we could experience significant delays or an
inability to successfully develop and commercialize our product candidates, which would materially adversely affect our business, financial condition, and results of operations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Additionally, clinical or regulatory setbacks to other companies developing
similar products or within adjacent fields, including those in gene editing and gene therapy and allogenic cell-based therapies, may impact the clinical development of and regulatory pathway for our current or future product candidates, or may
negatively impact the perceptions of value or risk of our technologies. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>We expect to continue to expand our development and
regulatory capabilities, and as a result, we may encounter difficulties in managing our growth, which could disrupt our operations. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have experienced rapid growth since our inception in July 2018. As of December&nbsp;31, 2018, we had 37 full-time employees
and, as of September&nbsp;30, 2020, we grew to 240 full-time employees. We expect continued growth in the number of our employees and the scope of our operations, particularly to continue our <FONT STYLE="white-space:nowrap">IND-enabling</FONT>
studies, establish regulatory, quality, and clinical operations, and begin manufacturing supply chain logistics. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">To
manage our anticipated future growth, we will continue to implement and improve our managerial, operational, and financial systems, expand our facilities, and continue to recruit and train additional qualified personnel. Due to our limited financial
resources and the complexity in managing a company with such anticipated growth, we may not be able to effectively manage the expansion of our operations or recruit and train additional qualified personnel. In addition, we have limited experience in
managing the manufacturing processes necessary for making cell and gene therapies. The expansion of our operations may lead to significant costs and may divert our management and business development resources. Any inability to manage growth could
delay the execution of our business plans or disrupt our operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition, future growth imposes significant added
responsibilities on members of management, including: identifying, recruiting, integrating, maintaining, and motivating additional employees; managing our internal development efforts effectively, including the clinical and FDA review process for
our product candidates, while complying with our contractual obligations to contractors and other third parties; and improving our operational, financial and management controls, reporting systems, and procedures. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We currently rely on certain independent organizations, advisors, and consultants to provide certain services, including
strategic, financial, business development, and research and development services, as well as certain aspects of regulatory approval and manufacturing. There can be no assurance that the services of independent organizations, advisors, and
consultants will continue to be available to us on a timely basis when needed, or that we can find qualified replacements. In addition, if we are unable to effectively manage our outsourced activities or if the quality or accuracy of the services
provided by consultants or contract manufacturing organizations is compromised for any reason, our clinical trials may be extended, delayed, or terminated, and we may not be able to obtain regulatory approval of our product candidates or otherwise
advance our business. There can be no assurance that we will be able to manage our existing consultants or find other competent outside contractors and consultants on reasonable terms, or at all. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>The outbreak of the novel coronavirus disease, <FONT STYLE="white-space:nowrap">COVID-19,</FONT> could materially and adversely affect
our preclinical studies and development, any clinical trials we subsequently commence, and our business, financial condition, and results of operations. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In December&nbsp;2019, the coronavirus disease, <FONT STYLE="white-space:nowrap">COVID-19,</FONT> was identified in Wuhan,
China. Since then, <FONT STYLE="white-space:nowrap">COVID-19</FONT> has spread globally. In March 2020, the World Health Organization declared <FONT STYLE="white-space:nowrap">COVID-19</FONT> a global pandemic and the United States declared a
national emergency with respect to <FONT STYLE="white-space:nowrap">COVID-19.</FONT> In response to the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, &#147;shelter in place&#148; orders and other public health guidance measures have
been implemented across much of the United States, including in the locations of our offices and those of key vendors and partners. As a result of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, or similar pandemics, and related
&#147;shelter in place&#148; orders and other public health guidance measures, we have and may in the future experience disruptions that could materially and adversely impact our preclinical studies and development, any clinical trials we
subsequently </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
commence, and our business, financial condition, and results of operations. In response to the spread of <FONT STYLE="white-space:nowrap">COVID-19,</FONT> we have closed our executive offices
with our administrative employees continuing their work outside of our offices and limited the number of staff in any given research and development laboratory and have taken other precautionary measures as well, including the periodic testing of
our employees. We also established a cross-functional task force and implemented business continuity plans designed to address and mitigate the impact of the ongoing <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic on our business.
Potential disruptions to our preclinical development efforts include, but are not limited to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delays or disruptions in preclinical experiments and <FONT STYLE="white-space:nowrap">IND-enabling</FONT>
studies due to restrictions of <FONT STYLE="white-space:nowrap">on-site</FONT> staff, limited or no access to animal facilities, and unforeseen circumstances at contract research organizations (CROs) and vendors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">limitations on employee or other resources that would otherwise be focused on the conduct of our preclinical
work and any clinical trials we subsequently commence, including because of sickness of employees or their families, the desire of employees to avoid travel or contact with large groups of people, an increased reliance on working from home, school
closures, or mass transit disruptions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delays in necessary interactions with regulators, ethics committees, and other important agencies and
contractors due to limitations in employee resources or forced furlough of government or contractor personnel; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">limitations in maintaining our corporate culture that facilitates the transfer of institutional knowledge
within our organization and fosters innovation, teamwork, and a focus on execution. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have not yet
commenced clinical trial activities for any of our product candidates. If we commence clinical trials for one or more of our product candidates, potential disruptions of those clinical activities as a result of
<FONT STYLE="white-space:nowrap">COVID-19</FONT> or similar pandemics include, but are not limited to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">interruption of key clinical trial activities, such as clinical trial site data monitoring and efficacy,
safety and translational data collection, processing and analyses, due to limitations on travel imposed or recommended by federal, state, or local governments, employers and others or interruption of clinical trial subject visits, which may impact
the collection and integrity of subject data and clinical study endpoints; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delays or difficulties in initiating or expanding clinical trials, including delays or difficulties with
clinical site initiation and recruiting clinical site investigators and clinical site staff; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delays or difficulties in enrolling and retaining patients in our clinical trials; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">increased rates of patients withdrawing from our clinical trials following enrollment as a result of
contracting <FONT STYLE="white-space:nowrap">COVID-19</FONT> or other health conditions or being forced to quarantine; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">interruption of, or delays in receiving, supplies of our product candidates from our contract manufacturing
organizations due to staffing shortages, production slowdowns, or stoppages and disruptions in materials and reagents; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">diversion of healthcare resources away from the conduct of clinical trials, including the diversion of
hospitals serving as our clinical trial sites and hospital staff supporting the conduct of our clinical trials; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">interruption or delays in the operations of the FDA and comparable foreign regulatory agencies;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in regulations as part of a response to the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic
which may require us to change the ways in which our clinical trials are conducted, which may result in unexpected costs, or to discontinue the clinical trials altogether; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delays in receiving approval from local regulatory authorities to initiate our planned clinical trials;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">limitations on employee resources that would otherwise be focused on the conduct of our preclinical studies
and clinical trials, including because of sickness of employees or their families or the desire of employees to avoid contact with large groups of people; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">interruption of, or delays in receiving, supplies of our product candidates from our contract manufacturing
organizations due to staffing shortages, production slowdowns or stoppages and disruptions in delivery systems; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">refusal of the FDA or comparable regulatory authorities to accept data from clinical trials in affected
geographies; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">additional delays, difficulties or interruptions as a result of current or future shutdowns due to the <FONT
STYLE="white-space:nowrap">COVID-19</FONT> pandemic in countries where we or our third-party service providers operate. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The <FONT STYLE="white-space:nowrap">COVID-19</FONT> global pandemic continues to rapidly evolve. Although many countries,
including certain countries in Europe and the United States, have <FONT STYLE="white-space:nowrap">re-opened,</FONT> rises in new cases have caused certain countries to <FONT STYLE="white-space:nowrap">re-initiate</FONT> restrictions. The extent to
which the outbreak may affect our preclinical studies, clinical trials, business, financial condition, and results of operations will depend on future developments, which are highly uncertain and cannot be predicted at this time, such as the
ultimate geographic spread of the disease, the duration of the outbreak, travel restrictions, and actions to contain the outbreak or treat its impact, such as social distancing and quarantines or lock-downs in the United States and other countries,
business closures, or business disruptions and the effectiveness of actions taken in the United States and other countries to contain and treat the disease. Additionally, we are unable to predict if a different pandemic could have similar or
different impacts on our business, financial condition, or share price. Future developments in these and other areas present material uncertainty and risk with respect to our clinical trials, business, financial condition, and results of operations.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Our ability to develop our cell engineering platforms and products and our future growth depends on retaining our key personnel and
recruiting additional qualified personnel. </I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our success depends upon the continued contributions of our key
management, scientific, and technical personnel, many of whom have been instrumental for us and have substantial experience with our cell engineering platforms, underlying technologies and related product candidates. Given the specialized nature of
our <I>in vivo </I>and <I>ex vivo</I> cell engineering and the fact that these are novel and emerging fields, there is an inherent scarcity of experienced personnel in these fields. As we continue developing our product candidates in our pipeline,
we will require personnel with medical, scientific, or technical qualifications specific to each program. The loss of key managers and senior scientists could delay our research and development activities. Despite our efforts to retain valuable
employees, members of our management, scientific, and development teams may terminate their employment with us on short notice. Although we have employment agreements with certain of our key employees, these employment agreements provide for <FONT
STYLE="white-space:nowrap">at-will</FONT> employment, which means that any of our employees could leave our employment at any time, with or without notice. Further, certain of our key employees, including Drs.&nbsp;Fry, Goldman and Murry, retain
partial employment at academic institutions; Dr.&nbsp;Goldman currently devotes approximately 60% of his time to the University of Rochester and the University of Copenhagen, Dr.&nbsp;Murry currently devotes approximately 25% to his time to the
University of Washington, and Dr.&nbsp;Fry currently devotes approximately 25% of his time to the University of Colorado until August 2021 when Dr.&nbsp;Fry plans to devote 100% of his time to us. These arrangements may expose us to increased
potential for these individuals to return to their academic positions full-time or devote less of their attention to us than is optimal, and, potentially, expose us to claims of intellectual property ownership or co-ownership by the respective
academic institutions. The competition for qualified personnel in the biotechnology and pharmaceutical industries is intense, and our future success depends upon our ability to attract, retain, and motivate highly skilled scientific, technical, and
managerial employees. We face competition for personnel from other companies, universities, public and private research institutions, and other organizations. If our recruitment and retention efforts are unsuccessful in the future, it may be
difficult for us to implement our business strategy, which could have a material adverse effect on our business. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In
addition, our research and development programs, clinical operations and sales and marketing efforts depend on our ability to attract and retain highly skilled scientists, engineers and sales professionals. Competition for skilled personnel in our
market is intense, and we have from time to time experienced, and we expect to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
continue to experience, difficulty in hiring and retaining employees with appropriate qualifications on acceptable terms, or at all. Many of the companies with which we compete for experienced
personnel have greater resources than we do, and any of our employees may terminate their employment with us at any time. If we hire employees from competitors or other companies, their former employers may attempt to assert that these employees or
we have breached legal obligations, resulting in a diversion of our time and resources and, potentially, damages. In addition, job candidates and existing employees often consider the value of the stock awards they receive in connection with their
employment. If the perceived benefits of our stock awards decline, it may harm our ability to recruit and retain highly skilled employees. If we fail to attract new personnel or fail to retain and motivate our current personnel, our business and
future growth prospects would be harmed. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>While we believe our pipeline will yield multiple INDs, we may not be able to file INDs to
commence clinical trials on the timelines we expect, and even if we are able to, the FDA may not permit us to proceed. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We expect our pipeline to yield multiple INDs beginning as early as 2022, including INDs for our fusosome CAR T product
candidates from our <I>in vivo</I> cell engineering platform and our allogenic CAR T cell product candidates from our <I>ex vivo</I> cell engineering platform. We cannot be sure that submission of an IND will result in the FDA allowing testing and
clinical trials to begin, or that, once begun, issues will not arise that suspend or terminate such clinical trials.&nbsp;The manufacturing of our product candidates, including our CAR T <I>ex vivo</I> cell engineering product candidates, remains an
emerging and evolving field. Accordingly, we expect chemistry, manufacturing and control related topics, including product specifications, will be a focus of IND reviews, which may delay the clearance of INDs. Additionally, even if such regulatory
authorities agree with the design and implementation of the clinical trials set forth in an IND or clinical trial application, we cannot guarantee that such regulatory authorities will not change their requirements in the future. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>We may not realize the benefits of technologies that we have acquired, or will acquire in the future, or other strategic transactions
that we have or will consummate. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our <I>in vivo</I> and <I>ex vivo</I> cell engineering technology represents an
aggregation of years of innovation and technology from multiple academic institutions and companies, including our fusogen technology acquired from Cobalt, our <I>ex vivo</I> cell engineering programs focused on replacing damaged cells in the heart
and certain brain disorders acquired from Cytocardia Inc. (Cytocardia) and Oscine Corp. (Oscine), respectively, and hypoimmune technology licensed from Harvard and The Regents of the University of California (UCSF), amongst others. Further, a key
component of our strategy is to acquire and <FONT STYLE="white-space:nowrap">in-license</FONT> technologies to support our mission of using engineered cells as medicines. As such, we actively evaluate various strategic transactions on an ongoing
basis. We may acquire other businesses, products or technologies, as well as pursue joint ventures or investments in complementary businesses. The success of our strategic transactions and any future strategic transactions depends on the risks and
uncertainties involved including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">unanticipated liabilities related to acquired companies or joint ventures; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">difficulties integrating acquired personnel, technologies, and operations into our existing business;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">retention of key employees; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">diversion of management time and focus from operating our business to management of acquisition and
integration efforts, strategic alliances or joint ventures challenges; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">increases in our expenses and reductions in our cash available for operations and other uses;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">disruption in our relationships with collaborators or suppliers as a result of such a transaction;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">possible write-offs or impairment charges relating to acquired businesses or joint ventures; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">challenges resulting from the <FONT STYLE="white-space:nowrap">COVD-19</FONT> pandemic making it more
difficult to integrate acquisitions into our business. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If any of these risks or uncertainties occur, we may not realize the
anticipated benefit of any acquisition or strategic transaction. Additionally, foreign acquisitions and joint ventures are subject to additional risks, including those related to integration of operations across different cultures and languages,
currency risks, potentially adverse tax consequences of overseas operations, and the particular economic, political and regulatory risks associated with specific countries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Future acquisitions or dispositions could result in potentially dilutive issuances of our equity securities, the incurrence of
debt, contingent liabilities or amortization expenses or write-offs of goodwill, any of which could harm our financial condition. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>We intend to build and operate our own manufacturing facility, which will require significant resources, and we may fail to successfully
operate our facility, which could adversely affect our clinical trials and the commercial viability of our product candidates. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The manufacture of biopharmaceutical products is complex and requires significant expertise, including the development of
advanced manufacturing techniques and process controls. Manufacturers of <I>ex vivo</I> cell engineering products often encounter difficulties in production, particularly in scaling up, scaling out, validating initial production, ensuring the
absence of contamination, and ensuring process robustness after initial production. These problems include difficulties with production costs and yields, quality control, including stability of the product, quality assurance testing, operator error,
shortages of qualified personnel, as well as compliance with strictly enforced federal, state, and foreign regulations. As a result of the complexities, the cost to manufacture biologics in general, and our cell-based product candidates in
particular, is generally higher than traditional small molecule chemical compounds, and the manufacturing process is less reliable and is more difficult to reproduce. The application of new regulatory guidelines or parameters, such as those related
to control strategy testing, may also adversely affect our ability to manufacture our product candidates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A key to our
strategy is operating our own manufacturing facility. We are investing early in building world class capabilities in key areas of manufacturing sciences and operations, including development of our <I>in vivo</I> and <I>ex vivo</I> cell engineering
platforms, product characterization, and process analytics from the time candidates are in early research phases. Our investments also include scaled research solutions, scaled infrastructure, and novel technologies to improve efficiency,
characterization, and scalability of manufacturing. However, we have limited experience in managing the manufacturing processes necessary for making cell and gene therapies. We cannot be sure that the manufacturing processes employed by us or the
technologies that we incorporate for manufacturing will result in viable or scalable yields of <I>in vivo</I> and <I>ex vivo </I>cell engineering product candidates that will be safe, be effective, and meet market demand. Any commercial
manufacturing facilities we build will also require FDA or comparable foreign regulatory authority approval, which we may never obtain. Even if approved, we would be subject to ongoing periodic unannounced inspection by the FDA, the Drug Enforcement
Administration, corresponding state agencies, and comparable foreign regulatory authority to ensure strict compliance with current good manufacturing practices (cGMPs), current good tissue practices (cGTPs) and other government regulations. We also
may make changes to our manufacturing process at various points during development, and even after commercialization, for various reasons, such as controlling costs, achieving scale, decreasing processing time, increasing manufacturing success rate,
or other reasons. Such changes carry the risk that they will not achieve their intended objectives, and any of these changes could cause our product candidates to perform differently and affect the results of our ongoing clinical trials, future
clinical trials, or the performance of the product, once commercialized. In some circumstances, changes in the manufacturing process may require us to perform comparability studies and to collect additional data from patients prior to undertaking
more advanced clinical trials. For instance, changes in our process during the course of clinical development may require us to show the comparability of the product used in earlier clinical phases or at earlier portions of a trial to the product
used in later clinical phases or later portions of the trial. We may also make further changes to our manufacturing process before or after commercialization, and such changes may require us to show the comparability of the resulting product to the
product used in the clinical trials using earlier processes. We may be required to collect additional clinical data from any modified process prior to obtaining marketing approval for </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
the product candidate produced with such modified process. If clinical data are not ultimately comparable to that seen in the earlier trials in terms of safety or efficacy, we may be required to
make further changes to our process and/or undertake additional clinical testing, either of which could significantly delay the clinical development or commercialization of the associated product candidate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Furthermore, if contaminants are discovered in our supply of product candidates or in the manufacturing facilities, such
supply may have to be discarded and our manufacturing facilities may need to be closed for an extended period of time to investigate and remedy the contamination. We cannot assure you that any stability or other issues relating to the manufacture of
our product candidates will not occur in the future. We may not be able to manufacture our product candidates as a result of not meeting regulatory requirements and may not be able to scale up or scale out our manufacturing to meet market demand.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>We may expend our limited resources to pursue a particular product candidate or indication and fail to capitalize on product
candidates or indications that may be more profitable or for which there is a greater likelihood of success. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Because we have limited financial and managerial resources, we focus on research programs, therapeutic platforms, and product
candidates that we identify for specific indications. Additionally, we have contractual commitments under our collaboration agreements to use commercially reasonable efforts to develop certain programs and, thus, do not have unilateral discretion to
vary from such agreed to efforts. In addition, we have contractual commitments to conduct certain development plans, and thus may not have discretion to modify such development plans, including clinical trial designs, without agreement from our
collaboration partners. As a result, we may forego or delay pursuit of opportunities with other therapeutic platforms or product candidates or for other indications that later prove to have greater commercial potential. Our resource allocation
decisions may cause us to fail to capitalize on viable commercial products or profitable market opportunities. Our spending on current and future research and development programs, therapeutic platforms, and product candidates for specific
indications may not yield any commercially viable products. If we do not accurately evaluate the commercial potential or target market for a particular product candidate, we may relinquish valuable rights to that product candidate through
collaboration, licensing, or other royalty arrangements in cases in which it would have been more advantageous for us to retain sole development and commercialization rights. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>The use of human stem cells exposes us to a number of risks in the development of our human stem cell derived products, including
restrictions on the use of human stem cells, as well as ethical, legal and social implications of research on the use of stem cells, any of which could prevent us from completing the development or gaining acceptance for commercially viable products
derived from human stem cells. </I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We use human stem cells in our research and development, including embryonic
stem cells (ESCs), and one or more of our <I>ex vivo</I> cell engineering product candidates may be derived from human stem cells. The use of such cells in our research, or as starting cell lines in the manufacture of one or more of our product
candidates, exposes us to a number of risks. These risks include securing sufficient and viable stem cells as starting material, potential difficulties in recruiting patients for our trials, as well as managing a multitude of legal and regulatory
restrictions on the sourcing and use of these cells. In particular, in some states, use of embryonic tissue as a source of stem cells is prohibited and many research institutions have adopted policies regarding the ethical use of human embryonic
tissue. If these policies or restrictions have the effect of limiting the scope of research conducted using our stem cells, our ability to develop our <I>ex vivo</I> cell engineering product candidates may be impaired and could have an adverse
material effect on our business. Further, the use of stem cells, and particularly embryonic stem cells, has social, legal and ethical implications. Certain political and religious groups continue to voice opposition to the use of human stem cells in
drug research, development, and manufacture. Adverse publicity due to ethical and social controversies surrounding the use of stem cells could lead to negative public opinion, difficulties enrolling patients in our clinical trials, increased
regulation and stricter policies regarding the use of such cells, which could harm our business and may limit market acceptance of our product candidates. In addition, clinical experience with stem cells, including induced pluripotent stem cells
(iPSCs) and ESCs, is limited. We are not aware of any products that utilize iPSCs or ESCs as a starting material that have </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
received marketing approval from the FDA or a comparable foreign regulatory body. Therefore, we may experience unexpected side effects or unexpected regulatory delays during clinical trials,
prior to approval, or after regulatory approval if an approval were to occur. Furthermore, our <I>ex vivo</I> stem cell-derived products will rely on starting materials donated by human sources. If the consent, authorization or process for the
donation of those materials is not obtained or conducted in accordance with applicable legal, ethical or regulatory requirements, we could face delays in the clinical testing and approval of these products, or, potentially, we could face claims by
such human sources which could expose us to damages. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Negative public opinion and increased regulatory scrutiny of research and
therapies involving gene editing or other in vivo or ex vivo cell engineering technologies may damage public perception of our product candidates or adversely affect our ability to conduct our business or obtain regulatory approvals for our product
candidates. </I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Certain aspects of our cell engineering platforms rely on the ability to edit genes. Public
perception may be influenced by claims that gene editing is unsafe, and products incorporating gene editing may not gain the acceptance of the public or the medical community. In particular, our success will depend upon physicians specializing in
our targeted diseases prescribing our product candidates as treatments in lieu of, or in addition to, existing, more familiar, treatments for which greater clinical data may be available. Any increase in negative perceptions of gene editing may
result in fewer physicians prescribing our treatments or may reduce the willingness of patients to utilize our treatments or participate in clinical trials for our product candidates. In addition, given the novel nature of <I>in vivo</I> and <I>ex
vivo</I> cell engineering technologies, governments may place import, export or other restrictions in order to retain control or limit the use of the technologies. Increased negative public opinion or more restrictive government regulations either
in the United States or internationally, would have a negative effect on our business or financial condition and may delay or impair the development and commercialization of our product candidates or demand for such product candidates. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to the Development and Clinical Testing of Our Product Candidates </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Results of preclinical studies of any product candidates may not be predictive of the results of future preclinical studies or clinical
trials. </I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">To obtain the requisite regulatory approvals to market and sell any of our product candidates, we or
any collaborator for such product candidate must demonstrate through extensive preclinical studies and clinical trials that the product candidate is safe, pure, and potent in humans. Before an IND can be submitted to the FDA and become effective,
which is a prerequisite for conducting clinical trials on human subjects, a product candidate must successfully progress through extensive preclinical studies, which include preclinical laboratory testing, animal studies, and formulation studies in
accordance with good laboratory practices (GLP). </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Success in preclinical studies does not ensure that later
preclinical studies or clinical trials will be successful. A number of companies in the biotechnology and pharmaceutical industries have suffered significant setbacks in clinical trials, even after positive results in earlier preclinical studies.
These setbacks have been caused by, among other things, preclinical findings made while clinical trials were underway and safety or efficacy observations made in clinical trials, including previously unreported adverse events. The design of a
clinical trial can determine whether its results will support approval of a product, and flaws in the design of a clinical trial may not become apparent until the clinical trial is well advanced. In addition, preclinical and clinical data are often
susceptible to varying interpretations and analyses. Notwithstanding any potential promising results in earlier studies, we cannot be certain that we will not face similar setbacks. In addition, the results of our preclinical animal studies,
including our <FONT STYLE="white-space:nowrap">non-human</FONT> primate studies, may not be predictive of the results of outcomes in subsequent clinical trials on human subjects. Product candidates in clinical trials may fail to show the desired
pharmacological properties or safety and efficacy traits despite having progressed through preclinical studies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If we
fail to receive positive results in preclinical studies or clinical trials of any product candidate, the development timeline and regulatory approval and commercialization prospects for that product candidate, and, correspondingly, our business and
financial prospects, would be negatively impacted. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>All of our product candidates are in preclinical development and have not commenced
clinical development. Preclinical and clinical drug development is a lengthy and expensive process with uncertain timelines and uncertain outcomes. If preclinical studies or clinical trials of a product candidate are prolonged or delayed, we may be
unable to obtain required regulatory approvals, and therefore be unable to commercialize our product candidates on a timely basis or at all. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Preclinical studies and clinical testing are expensive and can take many years to complete, and their outcomes are inherently
uncertain. Failure can occur at any time during this process. Product candidates in later stages of clinical trials may fail to produce the same results or to show the desired safety and efficacy traits despite having progressed through preclinical
studies and initial clinical trials. Our future clinical trial results may not be successful. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Additionally, some of our
trials, may be open-label trials in which both the patient and investigator know whether the patient is receiving the investigational product candidate or an existing approved therapy. Open-label clinical trials are subject to various limitations
that may exaggerate any therapeutic effect, as patients in open-label clinical trials are aware when they are receiving treatment. In addition, open-label clinical trials may be subject to an &#147;investigator bias&#148; where those assessing and
reviewing the physiological outcomes of the clinical trials are aware of which patients have received treatment and may interpret the information of the treated group more favorably given this knowledge. Therefore, it is possible that positive
results observed in open-label trials will not be replicated in later placebo-controlled trials. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">To date, we have not
commenced any clinical trials required for the approval of a product candidate. We do not know whether planned clinical trials will begin on time, need to be redesigned, enroll patients on time, or be completed on schedule, if at all. Clinical
trials can be delayed, suspended, or terminated for a variety of reasons, including the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delays in or failure to obtain regulatory authorization to commence a trial; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delays in or failure to obtain institutional review board, or IRB, approval at each site;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delays in or failure to reach agreement on acceptable terms with prospective CROs and clinical trial sites,
the terms of which can be subject to extensive negotiation and may vary significantly among different CROs and trial sites; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">difficulty in recruiting clinical trial investigators of appropriate competencies and experience;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">lack of sufficient availability of donor material suitable from eligible and qualified donors for certain of
our product candidates for the manufacture of product candidates from our <I>ex vivo</I> cell engineering platform; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delays in establishing the appropriate dosage levels in clinical trials; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delays in or failure to recruit and enroll suitable patients to participate in a trial, particularly
considering study inclusion and exclusion criteria and patients&#146; prior lines of therapy and treatment; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the difficulty in certain countries in identifying the <FONT STYLE="white-space:nowrap">sub-populations</FONT>
that we are trying to treat in a particular trial, which may delay enrollment and reduce the power of a clinical trial to detect statistically significant results; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">lower than anticipated retention rates of patients in clinical trials; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">failure to have patients complete a trial or return for post-treatment
<FONT STYLE="white-space:nowrap">follow-up;</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">clinical sites deviating from trial protocol or dropping out of a trial; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delays adding new investigators or clinical trial sites; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">safety or tolerability concerns could cause us or governmental authorities, as applicable, to suspend or
terminate a trial if it is found that the participants are being exposed to unacceptable health risks, </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
undesirable side effects, or other unfavorable characteristics of the product candidate, or if such undesirable effects or risks are found to be caused by a chemically or mechanistically similar
therapeutic or therapeutic candidate; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our third-party research contractors failing to comply with regulatory requirements or meet their contractual
obligations to us in a timely manner, or at all; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in regulatory requirements, policies, and guidelines; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">manufacturing sufficient quantities of a product candidate for use in clinical trials; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the quality or stability of a product candidate falling below acceptable standards; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in the treatment landscape for our target indications that may make our product candidates no longer
relevant; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">third-party actions claiming infringement by our product candidates in clinical trials outside the United
States and obtaining injunctions interfering with our progress; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">business interruptions resulting from <FONT STYLE="white-space:nowrap">geo-political</FONT> actions, including
war and terrorism, natural disasters including earthquakes, typhoons, floods, and fires, or disease, including the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition, disruptions caused by the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic may increase the likelihood
that we encounter such difficulties or delays in initiating, enrolling, conducting, or completing our planned clinical trials. Moreover, while we plan to submit INDs for our potential product candidates, we may not be able to file such INDs on the
timeline we expect. For example, we may experience manufacturing delays or other delays with <FONT STYLE="white-space:nowrap">IND-enabling</FONT> preclinical studies. Moreover, we cannot be sure that submission of an IND will result in the FDA
allowing clinical trials to begin, or that, once begun, issues will not arise that suspend or terminate clinical trials. Additionally, even if such regulatory authorities agree with the design and implementation of the clinical trials set forth in
an IND, we cannot guarantee that such regulatory authorities will not change their requirements in the future. These considerations also apply to new clinical trials we may submit as amendments to existing INDs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Clinical trials must be conducted in accordance with the FDA and comparable foreign regulatory authorities&#146; legal
requirements, regulations or guidelines, and are subject to oversight by these governmental agencies and IRBs or Ethics Committees at the medical institutions where the clinical trials are conducted. We could encounter delays if a clinical trial is
suspended or terminated by us, by the IRBs or Ethics Committees of the institutions in which such trials are being conducted, by the Data Review Committee or Data Safety Monitoring Board for such trial or by the FDA, or comparable foreign regulatory
authorities. Such authorities may impose such a suspension or termination due to a number of factors, including failure to conduct the clinical trial in accordance with regulatory requirements or our clinical protocols, inspection of the clinical
trial operations or trial site by the FDA or comparable foreign regulatory authorities resulting in the imposition of a clinical hold, unforeseen safety issues or adverse side effects, failure to demonstrate a benefit from using a drug, changes in
governmental regulations or administrative actions, or lack of adequate funding to continue the clinical trial. If we experience delays in the completion of, or termination of, any clinical trial of our product candidates, the commercial prospects
of our product candidates will be harmed, and our ability to generate product revenues from any of these product candidates will be delayed. In addition, any delays in completing our clinical trials will increase our costs, slow down our product
candidate development and approval process, and jeopardize our ability to commence product sales and generate revenues. Significant clinical trial delays could also allow our competitors to bring products to market before we do or shorten any
periods during which we have the exclusive right to commercialize our product candidates and impair our ability to commercialize our product candidates and may harm our business and results of operations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition, clinical trials must be conducted with supplies of our product candidates produced under cGMP and, if applicable,
cGTP requirements and other regulations. Furthermore, we rely on CROs and clinical trial </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
sites to ensure the proper and timely conduct of our clinical trials and while we have agreements governing their committed activities, we have limited influence over their actual performance. We
depend on medical institutions and CROs to conduct our clinical trials in compliance with good clinical practice (GCP) requirements. To the extent the CROs fail to enroll participants for our clinical trials, fail to conduct the study in accordance
with GCP, or are delayed for a significant time in the execution of trials, including achieving full enrollment, we may be affected by increased costs, program delays, or both, which may harm our business. In addition, clinical trials that are
conducted in countries outside the United States may subject us to further delays and expenses as a result of increased shipment and distribution costs, additional regulatory requirements, and the engagement of
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> CROs, as well as expose us to risks associated with clinical investigators who are unknown to the FDA, and different standards of diagnosis, screening, and medical care. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Our clinical trials may fail to demonstrate substantial evidence of the safety and efficacy of our product candidates or any future
product candidates, which would prevent or delay or limit the scope of regulatory approval and commercialization. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">To obtain the requisite regulatory approvals to market and sell any of our product candidates and any other future product
candidates, we must demonstrate through clinical trials that our product candidates are safe and effective for use in each targeted indication. Clinical testing is expensive and can take many years to complete, and its outcome is inherently
uncertain. Failure can occur at any time during the clinical development process. Most product candidates that begin clinical trials are never approved by regulatory authorities for commercialization. We may be unable to establish clinical endpoints
that applicable regulatory authorities would consider clinically meaningful, and a clinical trial can fail at any stage of testing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Further, the process of obtaining regulatory approval is expensive, often takes many years following the commencement of
clinical trials, and can vary substantially based upon the type, complexity, and novelty of the product candidates involved, as well as the target indications, patient population, and regulatory agency. Prior to obtaining approval to commercialize
our product candidates and any future product candidates in the United States or abroad, we or our potential future collaborators must demonstrate with substantial evidence from adequate and well-controlled clinical trials, and to the satisfaction
of the FDA or comparable foreign regulatory authorities, that such product candidates are safe and effective for their intended uses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Clinical trials that we conduct may not demonstrate the efficacy and safety necessary to obtain regulatory approval to market
our product candidates. In some instances, there can be significant variability in safety or efficacy results between different clinical trials of the same product candidate due to numerous factors, including changes in trial procedures set forth in
protocols, differences in the size and type of the patient populations, changes in and adherence to the clinical trial protocols, and the rate of dropout among clinical trial participants. If the results of our ongoing or future clinical trials are
inconclusive with respect to the efficacy of our product candidates, if we do not meet the clinical endpoints with statistical and clinically meaningful significance, or if there are safety concerns associated with our product candidates, we may be
delayed in obtaining marketing approval, if at all. Additionally, any safety concerns observed in any one of our clinical trials in our targeted indications could limit the prospects for regulatory approval of our product candidates in those and
other indications. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Even if the trials are successfully completed, clinical data are often susceptible to varying
interpretations and analyses, and we cannot guarantee that the FDA or comparable foreign regulatory authorities will interpret the results as we do, and more trials could be required before we submit our product candidates for approval. We cannot
guarantee that the FDA or comparable foreign regulatory authorities will view our product candidates as having efficacy even if positive results are observed in clinical trials. The FDA or comparable foreign regulatory authorities may not agree with
our manufacturing strategy or find comparability between our clinical trial product candidates and proposed commercial product candidates even if positive results are observed in clinical trials, which may result in regulatory delays or a need to
perform additional clinical studies. Moreover, results acceptable to support approval in one jurisdiction may be deemed inadequate by another regulatory authority to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
support regulatory approval in that other jurisdiction. To the extent that the results of the trials are not satisfactory to the FDA or comparable foreign regulatory authorities for support of a
marketing application, approval of our product candidates and any future product candidates may be significantly delayed, or we may be required to expend significant additional resources, which may not be available to us, to conduct additional
trials in support of potential approval of our product candidates. Even if regulatory approval is secured for a product candidate, the terms of such approval may limit the scope and use of the specific product candidate, which may also limit its
commercial potential. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Interim, topline, or preliminary data from our clinical trials that we announce or publish from time to time
may change as more patient data becomes available or as we make changes to our manufacturing processes and are subject to audit and verification procedures that could result in material changes in the final data. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">From time to time, we may publicly disclose interim, topline, or preliminary data from our preclinical studies and clinical
trials, which is based on a preliminary analysis of then-available data, and the results and related findings and conclusions are subject to change following a more comprehensive review of the data related to the particular study or trial. We also
make assumptions, estimations, calculations, and conclusions as part of our analyses of data, and we may not have received or had the opportunity to fully and carefully evaluate all data. Further, modifications or improvements to our manufacturing
processes for a therapy may result in changes to the characteristics or behavior of the product candidate that could cause our product candidates to perform differently and affect the results of our ongoing clinical trials. As a result, the topline
results that we report may differ from future results of the same studies, or different conclusions or considerations may qualify such results, once additional data have been received and fully evaluated. Topline data also remain subject to audit
and verification procedures that may result in the final data being materially different from the preliminary data we previously published. As a result, topline data should be viewed with caution until the final data are available. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">From time to time, we may also disclose preliminary or interim data from our preclinical studies and clinical trials.
Preliminary or interim data from clinical trials are subject to the risk that one or more of the clinical outcomes may materially change as patient enrollment continues and more patient data become available. Adverse differences between preliminary
or interim data and final data could significantly harm our business prospects. Additionally, disclosure of preliminary or interim data by us or by our competitors could result in volatility in the price of our common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Further, others, including regulatory agencies, may not accept or agree with our assumptions, estimates, calculations,
conclusions, or analyses or may interpret or weigh the importance of data differently, which could impact the value of the particular program, the approvability or commercialization of the particular product candidate, and our company in general. If
the interim, topline, or preliminary data that we report differ from actual results, or if others, including regulatory authorities, disagree with the conclusions reached, our ability to obtain approval for, and commercialize, any of our potential
product candidates may be harmed, which could harm our business, operating results, prospects, or financial condition. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Our product
candidates may have serious adverse, undesirable, or unacceptable side effects or other properties that may delay or prevent marketing approval. If such side effects are identified following approval, if any, the commercial profile of any approved
label may be limited, or we may be subject to other significant negative consequences following marketing approval, if any. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Undesirable side effects that may be caused by our product candidates could cause us or regulatory authorities to interrupt,
delay, or halt clinical trials and could result in a more restrictive label or the delay or denial of regulatory approval by the FDA or comparable foreign authorities. We have not commenced clinical trials for any of our product candidates, and we
do not have any clinical data to fully anticipate side effects. Accordingly, we may experience unexpected side effects and/or higher levels of known side effects in clinical trials, including adverse events known in the classes of therapeutics.
These include the potential for, among others, infusion reaction, cytokine release syndrome (CRS), graft-versus-host disease (GvHD), neurotoxicities and certain cancers. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Results of our clinical trials could reveal a high and unacceptable severity
and prevalence of these or other side effects. In such an event, our clinical trials could be suspended or terminated and the FDA or comparable foreign regulatory authorities could order us to cease further development of or deny approval of our
product candidates for any or all targeted indications. The drug-related side effects could affect patient recruitment or the ability of enrolled patients to complete the clinical trial or result in potential product liability claims. Any of these
occurrences may harm our business, financial condition, and prospects significantly. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Further, clinical trials by their
nature utilize a sample of the potential patient population. With a limited number of patients and limited duration of exposure, rare and severe side effects of our product candidates may only be uncovered with a significantly larger number of
patients exposed to the product candidate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In the event that any of our product candidates receives marketing approval
and we or others later identify undesirable or unacceptable side effects caused by such products, a number of potentially significant negative consequences could result, including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">regulatory authorities may withdraw or limit approvals of such products and require us to take our approved
product off the market; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">regulatory authorities may require the addition of labeling statements, specific warnings, a contraindication
or field alerts to physicians and pharmacies, or issue other communications containing warnings or other safety information about the product; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">regulatory authorities may require a medication guide outlining the risks of such side effects for
distribution to patients, or that we implement a risk evaluation and mitigation strategy, or REMS, plan to ensure that the benefits of the product outweigh its risks; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may be required to change the dose or the way the product is administered, conduct additional clinical
trials, or change the labeling of the product; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may be subject to limitations on how we may promote or manufacture the product; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">sales of the product may decrease significantly; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may be subject to litigation or product liability claims; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our reputation may suffer. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Any of these events could prevent us or our potential future partners from achieving or maintaining market acceptance of the
affected product or could substantially increase commercialization costs and expenses, which in turn could delay or prevent us from generating significant revenue from the sale of any products. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>The manufacture of our product candidates is complex. Our third-party manufacturers may encounter difficulties in production, which
could delay or entirely halt their ability to supply our product candidates for clinical trials or, if approved, for commercial sale. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our product candidates are considered to be biologics and the process of manufacturing biologics is complex and requires
significant expertise and capital investment, including the development of advanced manufacturing techniques and process controls. We do not yet own or operate any cGMP manufacturing facilities. We rely, and expect for some period of time to
continue to rely, on third-party contract development and manufacturing organizations for the manufacture of our product candidates for preclinical and clinical testing. To date, we and our contract manufacturers have limited experience in the
manufacturing of cGMP batches of our product candidates. Our contract manufacturers must comply with cGMPs, regulations, and guidelines for the manufacturing of biologics used in clinical trials and, if approved, marketed products. To date, we have
not scaled the manufacturing process for later-stage clinical trials and commercialization. Larger scale manufacturing will require the development of new processes, including for the removal of impurities that are a normal byproduct of the
manufacturing process. The nature of our product candidates requires the development </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
of novel manufacturing processes and analytical technologies, which could cause delays in the scaling of manufacturing, as well as greater costs that could negatively impact the financial
viability of our product candidates. We cannot be sure that the manufacturing processes employed by our third-party manufacturers or the technologies that our third-party manufacturers incorporate for manufacturing will result in viable or scalable
yields of <I>in vivo</I> and <I>ex vivo </I>cell engineering product candidates that will be safe, be effective, and meet market demand. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The process of manufacturing our biologic product candidates is extremely susceptible to product loss due to contamination,
equipment failure, or improper installation or operation of equipment, vendor or operator error, inconsistency in yields, variability in product characteristics, and difficulties in scaling the production process. Even minor deviations from normal
manufacturing processes could result in reduced production yields, product defects, and other supply disruptions. If microbial, viral, or other contaminations are discovered in our product candidates or in the manufacturing facilities in which our
product candidates are made, this could lead to withdrawal of our products from clinical trials and the market, and such manufacturing facilities may need to be closed for an extended period of time to investigate and remedy the contamination.
Moreover, if the FDA or comparable foreign regulatory authorities determine that our third-party manufacturers are not in compliance with laws and regulations, including those governing cGMPs, the FDA or comparable foreign regulatory authority may
not approve a Biologics License Application (BLA), marketing authorisation application (MAA), or comparable authorization until the deficiencies are corrected or we replace the manufacturer in our applications with a manufacturer that is in
compliance. Third-party manufacturers may not be able to manufacture our product candidates as a result of not meeting regulatory requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Any adverse developments affecting manufacturing operations for our product candidates, if any are approved, may result in
shipment delays, inventory shortages, lot failures, product withdrawals or recalls, or other interruptions in the supply of our products. We may also have to take inventory write-offs and incur other charges and expenses for products that fail to
meet specifications as a result of defects or storage over an extended period of time, undertake costly remediation efforts, or seek more costly manufacturing alternatives. As part of our process development efforts, we also may make changes to our
manufacturing processes at various points during development, for various reasons, such as controlling costs, achieving scale, decreasing processing time, increasing manufacturing success rate, or other reasons. Such changes carry the risk that they
will not achieve their intended objectives, and any of these changes could cause our product candidates to perform differently and affect the results of our ongoing clinical trials or future clinical trials. In some circumstances, changes in the
manufacturing process may require us to perform comparability studies and to collect additional data from patients prior to undertaking more advanced clinical trials. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>We are exposed to a number of risks related to our supply chain for the materials required to manufacture our product candidates.
</I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Manufacturing our product candidates is highly complex and requires sourcing specialty materials. Many of the
risks associated with the complexity of manufacturing our final products are applicable to the manufacture and supply of the raw materials. In particular, these starting materials are subject to inconsistency in yields, variability in
characteristics, contamination, difficulties in scaling the production process and defects. Similar minor deviations in the manufacturing process for these starting materials could result in supply disruption and reduced production yields for our
final product. In addition, we rely on third parties for the supply of these materials exposing us to similar risks of reliance on third parties as described above with respect to the manufacturing and supply of our drug products. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our manufacturing processes requires many reagents, which are drug substance intermediates used in our manufacturing processes
to bring about chemical or biological reactions, and other specialty materials and equipment, some of which are manufactured or supplied by small companies with limited resources and experience to support commercial biologics production. We
currently depend on a limited number of vendors for certain materials and equipment used in the manufacture of our product candidates. Some of these suppliers may not have the capacity to support commercial products manufactured under cGMP by
biopharmaceutical firms or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
may otherwise be <FONT STYLE="white-space:nowrap">ill-equipped</FONT> to support our needs. Reagents and other key materials from these suppliers may have inconsistent attributes and introduce
variability into our manufactured product candidates, which may contribute to variable patient outcomes and possible adverse events. We also do not have supply contracts with many of these suppliers and may not be able to obtain supply contracts
with them on acceptable terms or at all. Accordingly, we may experience delays in receiving key materials and equipment to support clinical or commercial manufacturing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For some of these reagents, equipment, and materials, we rely and may in the future rely on sole source vendors or a limited
number of vendors. An inability to continue to source product from any of these suppliers, which could be due to regulatory actions or requirements affecting the supplier, adverse financial or other strategic developments experienced by a supplier,
labor disputes or shortages, unexpected demands, or quality issues, could adversely affect our ability to satisfy demand for our product candidates, which could adversely and materially affect our product sales and operating results or our ability
to conduct clinical trials, either of which could significantly harm our business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As we continue to develop and scale
our manufacturing process, we expect that we will need to obtain rights to and supplies of certain materials and equipment to be used as part of that process. We may not be able to obtain rights to such materials on commercially reasonable terms, or
at all, and if we are unable to alter our process in a commercially viable manner to avoid the use of such materials or find a suitable substitute, it would have a material adverse effect on our business. Even if we are able to alter our process so
as to use other materials or equipment, such a change may lead to a delay in our clinical development and/or commercialization plans. If such a change occurs for product candidate that is already in clinical testing, the change may require us to
perform both&nbsp;comparability studies and to collect additional data from patients prior to undertaking more advanced clinical trials. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>We will depend on enrollment and retention of patients in our clinical trials for our product candidates. If we experience delays or
difficulties enrolling or retaining patients in our clinical trials, our research and development efforts and business, financial condition, and results of operations could be materially adversely affected. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Successful and timely completion of clinical trials will require that we enroll and retain a sufficient number of patient
candidates. Any clinical trials we conduct may be subject to delays for a variety of reasons, including as a result of patient enrollment taking longer than anticipated, patient withdrawal, or adverse events. These types of developments could cause
us to delay the trial or halt further development. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our clinical trials will compete with other clinical trials that are
in the same therapeutic areas as our product candidates, and this competition reduces the number and types of patients available to us, as some patients who might have opted to enroll in our trials may instead opt to enroll in a trial being
conducted by one of our competitors. Moreover, enrolling patients in clinical trials for diseases in which there is an approved standard of care is challenging, as patients will first receive the applicable standard of care. Many patients who
respond positively to the standard of care do not enroll in clinical trials. This may limit the number of eligible patients able to enroll in our clinical trials who have the potential to benefit from our product candidates and could extend
development timelines or increase costs for these programs. Patients who fail to respond positively to the standard of care treatment will be eligible for clinical trials of unapproved drug candidates. However, these prior treatment regimens may
render our therapies less effective in clinical trials. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Because the number of qualified clinical investigators and
clinical trial sites is limited, we expect to conduct some of our clinical trials at the same clinical trial sites that some of our competitors use, which will reduce the number of patients who are available for our clinical trials at such clinical
trial sites. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Patient enrollment depends on many factors, including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the size and nature of the patient population; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the severity of the disease under investigation; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">eligibility criteria for the trial; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the proximity of patients to clinical sites; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the design of the clinical protocol; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ability to obtain and maintain patient consents; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">perceived risks and benefits of the product candidate under evaluation, including any perceived risks
associated with iPSC-derived product candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the ability to recruit clinical trial investigators with the appropriate competencies and experience;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risk that patients enrolled in clinical trials will drop out of the trials before the administration of
our product candidates or trial completion; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the availability of competing clinical trials; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the availability of such patients during the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the availability of new drugs approved for the indication the clinical trial is investigating; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">clinicians&#146; and patients&#146; perceptions as to the potential advantages of the drug being studied in
relation to other available therapies. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">These factors may make it difficult for us to enroll enough
patients to complete our clinical trials in a timely and cost-effective manner. Delays in the completion of any clinical trial of our product candidates will increase our costs, slow down our product candidate development and approval process, and
delay or potentially jeopardize our ability to commence product sales and generate revenue. In addition, some of the factors that cause, or lead to, a delay in the commencement or completion of clinical trials may also ultimately lead to the denial
of regulatory approval of our product candidates. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>We may become exposed to costly and damaging liability claims, either when
testing our product candidates in the clinic or at the commercial stage, and our product liability insurance may not cover all damages from such claims. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are exposed to potential product liability and professional indemnity risks that are inherent in the research, development,
manufacturing, marketing, and use of pharmaceutical products. While we currently have no products that have commenced clinical trials or been approved for commercial sale, the future use of product candidates by us in clinical trials, and the sale
of any approved products in the future, may expose us to liability claims. These claims might be made by patients that use the product, healthcare providers, pharmaceutical companies, or others selling such products. Any claims against us,
regardless of their merit, could be difficult and costly to defend and could materially adversely affect the market for our product candidates or any prospects for commercialization of our product candidates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Although the clinical trial process is designed to identify and assess potential side effects, it is always possible that a
drug, even after regulatory approval, may exhibit unforeseen side effects. If any of our product candidates were to cause adverse side effects during clinical trials or after approval of the product candidate, we may be exposed to substantial
liabilities. Physicians and patients may not comply with any warnings that identify known potential adverse effects and patients who should not use our product candidates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Even successful defense against product liability claims would require significant financial and management resources.
Regardless of the merits or eventual outcome, liability claims may result in: decreased demand for our product candidates; injury to our reputation; withdrawal of clinical trial participants; initiation of investigations by regulators; costs to
defend the related litigation; a diversion of management&#146;s time and our resources; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
substantial monetary awards to trial participants or patients; product recalls, withdrawals or labeling, marketing or promotional restrictions; loss of revenue; exhaustion of any available
insurance and our capital resources; the inability to commercialize any product candidate; and a decline in our share price. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Although we maintain adequate product liability insurance for our product candidates, it is possible that our liabilities
could exceed our insurance coverage. We intend to expand our insurance coverage to include the sale of commercial products if we obtain marketing approval for any of our product candidates. However, we may be unable to maintain insurance coverage at
a reasonable cost or obtain insurance coverage that will be adequate to satisfy any liability that may arise. If a successful product liability claim or series of claims is brought against us for uninsured liabilities or in excess of insured
liabilities, our assets may not be sufficient to cover such claims, and our business operations could be impaired. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Our Regulatory
Environment </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>The development and commercialization of biopharmaceutical products is subject to extensive regulation, and the
regulatory approval processes of the FDA and comparable foreign authorities are lengthy, time-consuming, and inherently unpredictable. If we are ultimately unable to obtain regulatory approval for our product candidates on a timely basis if at all,
our business will be substantially harmed. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The clinical development, manufacturing, labeling, packaging, storage,
recordkeeping, advertising, promotion, export, import, marketing, distribution, adverse event reporting, including the submission of safety and other post-marketing information and reports, and other possible activities relating to our product
candidates are subject to extensive regulation. In the United States, marketing approval of biologics requires the submission of a BLA to the FDA, and we are not permitted to market any product candidate in the United States until we obtain approval
from the FDA of the BLA for that product candidate. A BLA must be supported by extensive clinical and preclinical data, as well as extensive information regarding pharmacology, chemistry, manufacturing, and controls. Outside the United States, many
comparable foreign regulatory authorities employ similar approval processes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have not previously submitted a BLA to
the FDA or similar regulatory approval filings to comparable foreign authorities, for any product candidate, and we cannot be certain that any of our product candidates will receive regulatory approval. We are not permitted to market our product
candidates in the United States or in other countries until we receive approval of a BLA from the FDA or marketing approval from applicable regulatory authorities outside the United States. Obtaining approval of a BLA can be a lengthy, expensive,
and uncertain process, and as a company we have no experience with the preparation of a BLA submission or any other application for marketing approval. Further, the FDA has not yet granted approval for a therapeutics derived from stem cells, which
we believe may increase the complexity, uncertainty and length of the regulatory approval process for certain of our product candidates derived from our <I>ex vivo</I> cell engineering platform.&nbsp;In addition, the FDA has the authority to require
a risk evaluation and mitigation strategies, or REMS, plan as part of a BLA or after approval, which may impose further requirements or restrictions on the distribution or use of an approved biologic, such as limiting prescribing to certain
physicians or medical centers that have undergone specialized training, limiting treatment to patients who meet certain <FONT STYLE="white-space:nowrap">safe-use</FONT> criteria and requiring treated patients to enroll in a registry. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our product candidates could fail to receive regulatory approval for many reasons, including the following:</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the FDA or comparable foreign regulatory authorities may disagree with the design or implementation of our
clinical trials; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may be unable to demonstrate to the satisfaction of the FDA or comparable foreign regulatory authorities
that a product candidate is safe and effective for its proposed indication; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the results of clinical trials may not meet the level of statistical significance required by the FDA or
comparable foreign regulatory authorities for approval; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may be unable to demonstrate that a product candidate&#146;s clinical and other benefits outweigh its
safety risks; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the FDA or comparable foreign regulatory authorities may disagree with our interpretation of data from
preclinical studies or clinical trials; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the data collected from clinical trials of our product candidates may not be sufficient to support the
submission of a BLA or other submission or to obtain regulatory approval in the United States or elsewhere, or regulatory authorities may not accept a submission due to, among other reasons, the content or formatting of the submission;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the FDA or comparable foreign regulatory authorities may fail to approve our manufacturing processes or
facilities or those of third-party manufacturers with which we contract for clinical and commercial supplies; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the approval policies or regulations of the FDA or comparable foreign regulatory authorities may significantly
change in a manner rendering our clinical data insufficient for approval. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This lengthy approval
process, as well as the unpredictability of future clinical trial results, may result in our failing to obtain regulatory approval to market any of our product candidates, which would significantly harm our business, results of operations, and
prospects. The FDA and comparable foreign regulatory authorities have substantial discretion in the approval process, and determining when or whether regulatory approval will be obtained for any of our product candidates. For example, regulatory
authorities in various jurisdictions have in the past had, and may in the future have, differing requirements for, interpretations of and opinions on our preclinical and clinical data. As a result, we may be required to conduct additional
preclinical studies, alter our proposed clinical trial designs, or conduct additional clinical trials to satisfy the regulatory authorities in each of the jurisdictions in which we hope to conduct clinical trials and develop and market our products,
if approved. Further, even if we believe the data collected from clinical trials of our product candidates are promising, such data may not be sufficient to support approval by the FDA or any comparable foreign regulatory authority. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition, even if we were to obtain approval, regulatory authorities may approve any of our product candidates for fewer or
more limited indications than we request, may not approve the price we intend to charge for our products, may grant approval contingent on the performance of costly post-marketing clinical trials, or may approve a product candidate with a label that
does not include the labeling claims necessary or desirable for the successful commercialization of that product candidate. Notably, to date, the FDA has required that any patient receiving a gene therapy be followed for 15 years post-treatment.
This post-treatment <FONT STYLE="white-space:nowrap">follow-up</FONT> increases the cost and complexity of commercializing gene therapy products. Any of the foregoing scenarios could materially harm the commercial prospects for our product
candidates. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Even if our product candidates obtain regulatory approval, we will be subject to ongoing obligations and continued
regulatory review, which may result in significant additional expense. Additionally, our product candidates, if approved, could be subject to labeling and other restrictions and market withdrawal and we may be subject to penalties if we fail to
comply with regulatory requirements or experience unanticipated problems with our products. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If the FDA or a
comparable foreign regulatory authority approves any of our product candidates, the manufacturing processes, testing, labeling, packaging, distribution, import, export, adverse event reporting, storage, advertising, promotion, and recordkeeping for
the product will be subject to extensive and ongoing regulatory requirements. These requirements include submissions of safety and other post-marketing information and reports, registration, as well as continued compliance with cGMPs and GCPs for
any clinical trials that we conduct post-approval, all of which may result in significant expense and limit our ability to commercialize such products. In addition, any regulatory approvals that we receive for our product candidates may also be
subject to limitations on the approved indicated uses for which the product may be marketed or to the conditions of approval, or contain requirements for potentially costly post-marketing testing, including Phase 4 clinical trials, and surveillance
to monitor the safety and efficacy of the product candidate. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Manufacturers and manufacturers&#146; facilities are required to comply with
extensive FDA and comparable foreign regulatory authority requirements, including ensuring that quality control and manufacturing procedures conform to cGMP regulations, as well as, for the manufacture of certain of our product candidates, the
FDA&#146;s cGTPs for the use of human cellular and tissue products to prevent the introduction, transmission or spread of communicable diseases. As such, we and our contract manufacturers will be subject to continual review and inspections to assess
compliance with cGMP, cGTPs and adherence to commitments made in any approved marketing application. Accordingly, we and others with whom we work must continue to expend time, money, and effort in all areas of regulatory compliance, including
manufacturing, quality control, and distribution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If there are changes in the application of legislation or regulatory
policies, or if problems are discovered with a product or our manufacture of a product, or if we or one of our distributors, licensees or <FONT STYLE="white-space:nowrap">co-marketers</FONT> fails to comply with regulatory requirements, the
regulators could take various actions. These include issuing warning letters or untitled letters, imposing fines on us, imposing restrictions on the product or its manufacture, and requiring us to recall or remove the product from the market. The
regulators could also suspend or withdraw our marketing authorizations, requiring us to conduct additional clinical trials, change our product labeling, or submit additional applications for marketing authorization. If any of these events occurs,
our ability to sell such product may be impaired, and we may incur substantial additional expense to comply with regulatory requirements, which could materially adversely affect our business, financial condition, and results of operations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition, if we have any product candidate approved, our product labeling, advertising, and promotion will be subject to
regulatory requirements and continuing regulatory review. In the United States, the FDA and the Federal Trade Commission, or FTC, strictly regulate the promotional claims that may be made about pharmaceutical products to ensure that any claims about
such products are consistent with regulatory approvals, not misleading or false in any particular, and adequately substantiated by clinical data. The promotion of a drug product in a manner that is false, misleading, unsubstantiated, or for
unapproved (or <FONT STYLE="white-space:nowrap">off-label)</FONT> uses may result in enforcement letters, inquiries and investigations, and civil and criminal sanctions by the FDA or the FTC. In particular, a product may not be promoted for uses
that are not approved by the FDA as reflected in the product&#146;s approved labeling. If we receive marketing approval for a product candidate, physicians may nevertheless prescribe it to their patients in a manner that is inconsistent with the
approved label. If we are found to have promoted such <FONT STYLE="white-space:nowrap">off-label</FONT> uses, we may become subject to significant liability. The FDA and other agencies actively enforce the laws and regulations prohibiting the
promotion of <FONT STYLE="white-space:nowrap">off-label</FONT> uses, and a company that is found to have improperly promoted <FONT STYLE="white-space:nowrap">off-label</FONT> uses may be subject to significant sanctions and may result in false
claims litigation under federal and state statutes, which can lead to consent decrees, civil monetary penalties, restitution, criminal fines and imprisonment, and exclusion from participation in Medicare, Medicaid, and other federal and state
healthcare programs. The federal government has levied large civil and criminal fines against companies for alleged improper promotion and has enjoined several companies from engaging in <FONT STYLE="white-space:nowrap">off-label</FONT> promotion.
The FDA has also requested that companies enter into consent decrees or permanent injunctions under which specified promotional conduct is changed or curtailed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If a regulatory agency discovers previously unknown problems with a product, such as adverse events of unanticipated severity
or frequency, or problems with the facility where the product is manufactured, or disagrees with the promotion, marketing or labeling of a product, such regulatory agency may impose restrictions on that product or us, including requiring withdrawal
of the product from the market. If we fail to comply with applicable regulatory requirements, a regulatory agency or enforcement authority may, among other things:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">issue warning letters; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">issue, or require us to issue, safety-related communications, such as safety alerts, field alerts, &#147;Dear
Doctor&#148; letters to healthcare professionals, or import alerts; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">impose civil or criminal penalties; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">suspend, limit, or withdraw regulatory approval; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">suspend any of our preclinical studies and clinical trials; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">refuse to approve pending applications or supplements to approved applications submitted by us;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">impose restrictions on our operations, including closing our and our contract manufacturers&#146; facilities;
or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">seize or detain products, refuse to permit the import or export of products, or require us to conduct a
product recall. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Any government investigation of alleged violations of law could require us to expend
significant time and resources in response and could generate negative publicity. Any failure to comply with ongoing regulatory requirements may significantly and adversely affect our ability to commercialize and generate revenue from our products,
if approved. If regulatory sanctions are applied or if regulatory approval is withdrawn, the value of our company and our operating results will be adversely affected. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Moreover, the policies of the FDA and of comparable foreign regulatory authorities may change and additional government
regulations may be enacted that could prevent, limit, or delay regulatory approval of our product candidates. We cannot predict the likelihood, nature, or extent of government regulation that may arise from future legislation or administrative or
executive action, either in the United States or abroad. For example, certain policies of the Trump administration may impact our business and industry. Namely, the Trump administration has taken several executive actions, including the issuance of
a number of Executive Orders, that could impose significant burdens on, or otherwise materially delay, the FDA&#146;s ability to engage in routine oversight activities such as implementing statutes through rulemaking, issuance of guidance, and
review and approval of marketing applications. It is difficult to predict how these orders will be implemented, and the extent to which they will impact the FDA&#146;s ability to exercise its regulatory authority. If these executive actions impose
restrictions on the FDA&#146;s ability to engage in oversight and implementation activities in the normal course, our business may be negatively impacted. In addition, if we are slow or unable to adapt to changes in existing requirements or the
adoption of new requirements or policies, or if we are not able to maintain regulatory compliance, we may lose any marketing approval that we may have obtained and we may not achieve or sustain profitability. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Disruptions at the FDA and other government agencies caused by funding shortages or global health concerns could hinder their ability to
hire, retain, or deploy key leadership and other personnel, or otherwise prevent new or modified products from being developed, approved, or commercialized in a timely manner or at all, which could negatively impact our business. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The ability of the FDA to review and approve new products can be affected by a variety of factors, including government budget
and funding levels, statutory, regulatory, and policy changes, the FDA&#146;s ability to hire and retain key personnel and accept the payment of user fees, and other events that may otherwise affect the FDA&#146;s ability to perform routine
functions. Average review times at the FDA have fluctuated in recent years as a result. In addition, government funding of other government agencies that fund research and development activities is subject to the political process, which is
inherently fluid and unpredictable. Disruptions at the FDA and other agencies may also slow the time necessary for new biologics or modifications to licensed biologics to be reviewed and/or approved by necessary government agencies, which would
adversely affect our business. For example, over the last several years, including for 35 days beginning on December&nbsp;22, 2018, the U.S. government has shut down several times and certain regulatory agencies, such as the FDA, have had to
furlough critical FDA employees and stop critical activities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Separately, in response to the <FONT
STYLE="white-space:nowrap">COVID-19</FONT> pandemic, on March&nbsp;10, 2020 the FDA announced its intention to postpone most inspections of foreign manufacturing facilities, and on March&nbsp;18, 2020, the FDA temporarily postponed routine
surveillance inspections of domestic manufacturing facilities. Subsequently, on July&nbsp;10, 2020, the FDA announced its intention to resume certain <FONT STYLE="white-space:nowrap">on-site</FONT> inspections of domestic manufacturing facilities
subject to a risk-based prioritization system. The FDA intends to use this risk-based assessment system to identify the categories of regulatory activity that can occur within a given geographic area, ranging from mission
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
critical inspections to resumption of all regulatory activities.&nbsp;Regulatory authorities outside the United States may adopt similar restrictions or other policy measures in response to the <FONT
STYLE="white-space:nowrap">COVID-19</FONT> pandemic. If a prolonged government shutdown occurs, or if global health concerns continue to prevent the FDA or comparable foreign regulatory authorities from conducting their regular inspections, reviews,
or other regulatory activities, it could significantly impact the ability of the FDA or comparable foreign regulatory authorities to timely review and process our regulatory submissions, which could have a material adverse effect on our business.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Our research and development activities could be affected or delayed as a result of possible restrictions on animal testing.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Certain laws and regulations require us to test our product candidates on animals before initiating clinical
trials involving humans. Animal testing activities have been the subject of controversy and adverse publicity. Animal rights groups and other organizations and individuals have attempted to stop animal testing activities by pressing for legislation
and regulation in these areas and by disrupting these activities through protests and other means. To the extent the activities of these groups are successful, our research and development activities may be interrupted, delayed, or become more
expensive. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Our business operations and current and future relationships with healthcare professionals, principal investigators,
consultants, vendors, customers, and third-party payors in the United States and elsewhere are subject to applicable anti-kickback, fraud and abuse, false claims, physician payment transparency, and other healthcare laws and regulations, which could
expose us to substantial penalties, contractual damages, reputation harm, administrative burdens, and diminished profits. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Healthcare providers, healthcare facilities and institutions, physicians, and third-party payors in the United States and
elsewhere will play a primary role in the recommendation and prescription of any product candidates for which we obtain marketing approval. Our current and future arrangements with healthcare professionals, healthcare facilities and institutions,
principal investigators, consultants, customers, and third-party payors may expose us to broadly applicable fraud and abuse and other healthcare laws, including, without limitation, the federal Anti-Kickback Statute and the federal False Claims Act,
that may constrain the business or financial arrangements and relationships through which we research, sell, market, and distribute any product candidates for which we obtain marketing approval. In addition, we may be subject to physician payment
transparency laws and regulation by the federal government and by the states and foreign jurisdictions in which we conduct our business. The applicable federal, state, and foreign healthcare laws that affect our ability to operate include, but are
not limited to, the following:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the federal Anti-Kickback Statute, which prohibits, among other things, persons or entities from knowingly and
willfully soliciting, offering, receiving, or providing any remuneration (including any kickback, bribe, or certain rebate), directly or indirectly, overtly or covertly, in cash or in kind, to induce or reward, or in return for, either the referral
of an individual for, or the purchase, lease, order or recommendation of, any good, facility, item or service, for which payment may be made, in whole or in part, under any U.S. federal healthcare program, such as Medicare and Medicaid. The term
&#147;remuneration&#148; has been broadly interpreted to include anything of value, including stock options. The federal Anti-Kickback Statute has also been interpreted to apply to arrangements between pharmaceutical manufacturers on the one hand
and prescribers, purchasers and formulary managers on the other hand. There are a number of statutory exceptions and regulatory safe harbors protecting some common activities from prosecution, but the exceptions and safe harbors are drawn narrowly
and require strict compliance in order to offer protection. Any arrangements with prescribers must be for <I>bona fide</I> services and compensated at fair market value. There are a number of statutory exceptions and regulatory safe harbors
protecting some common activities from prosecution, but the exceptions and safe harbors are drawn narrowly and require strict compliance in order to offer protection. A person or entity does not need to have actual knowledge of the statute or
specific intent to violate it in order to have committed a violation; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the U.S. federal civil and criminal false claims laws, including without limitation, the civil False Claims
Act, which can be enforced by private citizens on behalf of the U.S. federal government through civil whistleblower or <I>qui tam</I> actions, and the federal civil monetary penalties law which prohibit, among other things, individuals or entities
from knowingly presenting, or causing to be presented, to the U.S. federal government, claims for payment or approval that are false or fraudulent, knowingly making, using, or causing to be made or used, a false record or statement material to a
false or fraudulent claim, or from knowingly making a false statement to avoid, decrease, or conceal an obligation to pay money to the U.S. federal government. Pharmaceutical manufacturers can cause false claims to be presented to the U.S. federal
government by, among other things, engaging in impermissible marketing practices, such as the <FONT STYLE="white-space:nowrap">off-label</FONT> promotion of a product for an indication for which it has not received FDA approval. Further,
pharmaceutical manufacturers can be held liable under the civil False Claims Act even when they do not submit claims directly to government payors if they are deemed to &#147;cause&#148; the submission of false or fraudulent claims. In addition, the
government may assert that a claim including items and services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the civil False Claims Act; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the federal Health Insurance Portability and Accountability Act of 1996 (HIPAA), which imposes criminal and
civil liability for, among other things, knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program, or knowingly and willfully falsifying, concealing, or covering up a material fact or making any
materially false statement, in connection with the delivery of, or payment for, healthcare benefits, items, or services. Similar to the federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge of the healthcare fraud
statute implemented under HIPAA or specific intent to violate it in order to have committed a violation; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the U.S. Federal Food, Drug, and Cosmetic Act (the FDCA), which prohibits, among other things, the
adulteration or misbranding of drugs, biologics, and medical devices; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the U.S. Public Health Service Act, which prohibits, among other things, the introduction into interstate
commerce of a biological product unless a biologics license is in effect for that product; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the U.S. Physician Payments Sunshine Act and its implementing regulations, which requires, among other things,
certain manufacturers of drugs, devices, biologics, and medical supplies that are reimbursable under Medicare, Medicaid, or the Children&#146;s Health Insurance Program, with specific exceptions, to report annually to the Centers for Medicare and
Medicaid Services, or CMS, information related to certain payments and other transfers of value to physicians, as defined by statute, and teaching hospitals, as well as ownership and investment interests held by such physicians and their immediate
family members. Beginning in 2022, such obligations will include the reporting of payments and other transfers of value provided in the previous year to certain other healthcare professionals, including physician assistants, nurse practitioners,
clinical nurse specialists, certified nurse anesthetists, anesthesiologist assistants, and certified nurse-midwives; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">analogous U.S. state laws and regulations, including: state anti-kickback and false claims laws, which may
apply to our business practices, including but not limited to, research, distribution, sales and marketing arrangements, and claims involving healthcare items or services reimbursed by any third-party payor, including private insurers; state laws
that require pharmaceutical companies to comply with the pharmaceutical industry&#146;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the U.S. federal government, or otherwise restrict payments that may be made
to healthcare providers and other potential referral sources; state laws and regulations that require drug manufacturers to file reports relating to pricing and marketing information, which requires tracking gifts and other remuneration and items of
value provided to healthcare professionals and entities; and state and local laws requiring the registration of pharmaceutical sales representatives; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">similar healthcare laws and regulations in foreign jurisdictions, including reporting requirements detailing
interactions with and payments to healthcare providers. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Ensuring that our internal operations and future business arrangements with
third parties comply with applicable healthcare laws and regulations will involve substantial costs. It is not always possible to identify and deter employee misconduct or business noncompliance, and the precautions we take to detect and prevent
inappropriate conduct may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to be in compliance with such laws or
regulations. Efforts to ensure that our business arrangements will comply with applicable healthcare laws may involve substantial costs. We have entered into consulting and scientific advisory board arrangements with physicians and other healthcare
providers, including some who could influence the use of our product candidates, if approved. Compensation under some of these arrangements includes the provision of stock or stock options in addition to cash consideration. Because of the complex
and <FONT STYLE="white-space:nowrap">far-reaching</FONT> nature of these laws, it is possible that governmental authorities could conclude that our payments to physicians may not be fair market value for <I>bona fide</I> services or that our
business practices do not comply with current or future statutes, regulations, agency guidance or case law involving applicable fraud and abuse or other healthcare laws and regulations. If our operations are found to be in violation of any of the
laws described above or any other governmental laws and regulations that may apply to us, we may be subject to significant penalties, including civil, criminal, and administrative penalties, damages, fines, exclusion from government-funded
healthcare programs, such as Medicare and Medicaid, or similar programs in other countries or jurisdictions, integrity oversight and reporting obligations to resolve allegations of noncompliance, disgorgement, imprisonment, contractual damages,
reputational harm, diminished profits, and the curtailment or restructuring of our operations. If any of the physicians or other providers or entities with whom we expect to do business are found to not be in compliance with applicable laws, they
may be subject to criminal, civil or administrative sanctions, including exclusions from government funded healthcare programs and imprisonment, which could affect our ability to operate our business. Further, defending against any such actions can
be costly, time-consuming and may require significant personnel resources. Therefore, even if we are successful in defending against any such actions that may be brought against us, our business may be impaired. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Our employees, independent contractors, principal investigators, consultants, commercial partners, and vendors may engage in misconduct
or other improper activities, including noncompliance with regulatory standards and requirements. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are exposed
to the risk of employee fraud or other misconduct. We cannot ensure that our compliance controls, policies, and procedures will in every instance protect us from acts committed by our employees, agents, contractors, or collaborators that would
violate the laws or regulations of the jurisdictions in which we operate, including, without limitation, employment, foreign corrupt practices, trade restrictions and sanctions, environmental, competition, and patient privacy and other privacy laws
and regulations. Misconduct by employees could include failures to comply with FDA regulations, provide accurate information to the FDA, comply with manufacturing standards we may establish, comply with federal and state healthcare fraud and abuse
laws and regulations, report financial information or data accurately, or disclose unauthorized activities to us. In particular, sales, marketing, and business arrangements in the healthcare industry are subject to extensive laws and regulations
intended to prevent fraud, kickbacks, self-dealing, and other abusive practices. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, labeling, marketing and promotion, sales commission, customer incentive
programs, and other business arrangements. Employee misconduct could also involve the improper use of information obtained in the course of clinical trials, which could result in regulatory sanctions and serious harm to our reputation. It is not
always possible to identify and deter employee misconduct, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations
or other actions or lawsuits stemming from a failure to be in compliance with such laws or regulations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If any such
actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a material and adverse effect on our business, financial condition, results of operations and prospects, including
the imposition of significant civil, criminal and administrative penalties, damages, monetary fines, individual imprisonment, disgorgement of profits, possible exclusion from </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
participation in Medicare, Medicaid and other federal healthcare programs, contractual damages, reputational harm, diminished profits and future earnings, additional reporting or oversight
obligations if we become subject to a corporate integrity agreement or other agreement to resolve allegations of noncompliance with the law, and curtailment or restructuring of our operations, any of which could adversely affect our ability to
operate our business and pursue our strategy. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Current and future legislation may increase the difficulty and cost for us and any
future collaborators to obtain marketing approval of and commercialize our product candidates and affect the prices we, or they, may obtain. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In the United States and other jurisdictions, there have been, and we expect there will continue to be, a number of legislative
and regulatory changes and proposed changes to the healthcare system that could affect our future results of operations. In particular, there have been and continue to be a number of initiatives at the U.S. federal and state levels that seek to
reduce healthcare costs and improve the quality of healthcare. For example, in March 2010, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act, or collectively the ACA, was enacted, which
substantially changed the way healthcare is financed by both governmental and private payors. Among the provisions of the ACA of importance to the pharmaceutical and biotechnology industries, which includes biologics, are the following:</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">manufacturers and importers of certain branded prescription drugs, including certain biologics, with annual
sales of more than $5&nbsp;million made to or covered by specified federal healthcare programs are required to pay an annual, nondeductible fee according to their market share of all such sales; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an increase in the statutory minimum rebates a manufacturer must pay under the Medicaid Drug Rebate Program,
to 23.1% of the average manufacturer price for most branded drugs, biologics, and biosimilars and to 13.0% for generic drug, and cap of the total rebate amount for innovator drugs at 100% of the Average Manufacturer Price, or AMP;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a new methodology by which rebates owed by manufacturers under the Medicaid Drug Rebate Program are calculated
for certain drugs and biologics, including our product candidates, that are inhaled, infused, instilled, implanted, or injected; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">extension of manufacturers&#146; Medicaid rebate liability to covered drugs dispensed to individuals who are
enrolled in Medicaid managed care organizations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expansion of eligibility criteria for Medicaid programs by, among other things, allowing states to offer
Medicaid coverage to additional individuals and by adding new mandatory eligibility categories for individuals with income at or below 133% of the federal poverty level, thereby potentially increasing manufacturers&#146; Medicaid rebate liability;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expansion of the entities eligible for discounts under the Public Health program, commonly referred to as the
&#147;340B Program;&#148; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a new requirement to annually report drug samples that manufacturers and distributors provide to physicians,
also known as the &#147;Physician Payments Sunshine Act;&#148; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a new Patient-Centered Outcomes Research Institute to oversee, identify priorities in, and conduct comparative
clinical effectiveness research, along with funding for such research; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establishment of a Center for Medicare Innovation at CMS to test innovative payment and service delivery
models to lower Medicare and Medicaid spending, potentially including prescription drug spending; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a licensure framework for <FONT STYLE="white-space:nowrap">follow-on</FONT> biologic products.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Since its enactment, there have been judicial and Congressional challenges to certain aspects of the
ACA, and we expect there will be additional challenges and amendments to the ACA in the future. For example, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
legislation enacted in 2017 informally titled the Tax Cuts and Jobs Act of 2017, repealed the <FONT STYLE="white-space:nowrap">tax-based</FONT> shared responsibility payment imposed by the ACA on
certain individuals who fail to maintain qualifying health coverage that is commonly referred to as the &#147;individual mandate.&#148; In December 2019, a U.S. District Court upheld a ruling that the ACA is unconstitutional in its entirety because
the &#147;individual mandate&#148; was repealed by Congress. In March 2020, the Supreme Court of the United States agreed to hear the appeal of this decision, but it is uncertain when the Supreme Court will rule on this case. It is unclear how this
and other efforts to challenge, repeal, or replace the ACA will impact the ACA or our business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition, other
legislative changes have been proposed and adopted in the United States since the ACA was enacted which, among other things, have reduced Medicare payments to several types of providers, including hospitals and cancer treatment centers. These new
laws or any other similar laws introduced in the future, as well as regulatory actions that may be taken by CMS, may result in additional reductions in Medicare and other healthcare funding, which could negatively affect our customers and
accordingly, our financial operations. Moreover, payment methodologies may be subject to changes in healthcare legislation and regulatory initiatives. Additionally, individual states in the United States have passed legislation and implemented
regulations designed to control pharmaceutical and biological product pricing and costs. Similar developments have occurred outside of the United States, including in the European Union where healthcare budgetary constraints have resulted in
restrictions on the pricing and reimbursement of medicines by relevant health service providers. To obtain reimbursement or pricing approval in some European Union member states, we may be required to conduct studies that compare the
cost-effectiveness of our product candidates to other therapies that are considered the local standard of care. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">It is
also possible that additional governmental action is taken in response to address the COVID-19 pandemic. We cannot predict the likelihood, nature, or extent of government regulation that may arise from future legislation or administrative action in
the United States, particularly as a result of the recent presidential election, or any other jurisdiction. If we or any third parties we may engage are slow or unable to adapt to changes in existing requirements or the adoption of new requirements
or policies, or if we or such third parties are not able to maintain regulatory compliance, our product candidates may lose any regulatory approval that may have been obtained and we may not achieve or sustain profitability. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Even if we are able to commercialize any product candidate, coverage and adequate reimbursement may not be available or such product
candidate may become subject to unfavorable pricing regulations or third-party coverage and reimbursement policies, which would harm our business. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The regulations that govern regulatory approvals, pricing, and reimbursement for drug products vary widely from country to
country. Some countries require approval of the sale price of a drug product before it can be marketed. In many countries, the pricing review period begins after marketing approval is granted. In some foreign markets, prescription drug product
pricing remains subject to continuing governmental control even after initial approval is granted. As a result, we might obtain regulatory approval for a product in a particular country, but then be subject to price regulations that delay our
commercial launch of the product, possibly for lengthy time periods, and negatively impact the revenues we are able to generate from the sale of the product in that country. Adverse pricing limitations may hinder our ability to recoup our investment
in one or more product candidates, even if our product candidates obtain regulatory approval. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our ability to
commercialize any products successfully also will depend in part on the extent to which coverage and adequate reimbursement for these products and related treatments will be available from third-party payors, such as government authorities, private
health insurers, and other organizations. Even if we succeed in bringing one or more products to the market, these products may not be considered cost-effective, and the amount reimbursed for any products may be insufficient to allow us to sell our
products on a competitive basis. Because our programs are in the early stages of development, we are unable at this time to determine their cost effectiveness or the likely level or method of coverage and reimbursement. Increasingly, the third-party
payors who reimburse patients or healthcare providers are requiring that drug companies provide them with predetermined discounts from list prices, and are seeking to reduce the prices charged or the amounts reimbursed
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
for drug products. If the price we are able to charge for any products we develop, or the coverage and reimbursement provided for such products, is inadequate in light of our development and
other costs, our return on investment could be affected adversely. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">There may be significant delays in obtaining
reimbursement for newly-approved drug products, and coverage may be more limited than the purposes for which the drug product is approved by the FDA or comparable foreign regulatory authorities. Moreover, eligibility for reimbursement does not imply
that any drugs product will be reimbursed in all cases or at a rate that covers our costs, including research, development, manufacture, sale, and distribution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Interim reimbursement levels for new drug products, if applicable, may also be insufficient to cover our costs and may not be
made permanent. Reimbursement rates may be based on payments allowed for lower cost drug products that are already reimbursed, may be incorporated into existing payments for other services and may reflect budgetary constraints or imperfections in
Medicare data. Net prices for drug products may be reduced by mandatory discounts or rebates required by third-party payors and by any future relaxation of laws that presently restrict imports of drug products from countries where they may be sold
at lower prices than in the United States. Obtaining coverage and adequate reimbursement for our product candidates may be particularly difficult because of the higher prices often associated with drugs administered under the supervision of a
physician. Similarly, because our product candidates are physician-administered injectables, separate reimbursement for the product itself may or may not be available. Instead, the administering physician may or may not be reimbursed for providing
the treatment or procedure in which our product is used. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Further, no uniform policy for coverage and reimbursement exists
in the United States, and coverage and reimbursement can differ significantly from payor to payor. Third-party payors often follow Medicare coverage policy and payment limitations in setting their own reimbursement rates, but also have their own
methods and approval process apart from Medicare determinations. As a result, the coverage determination process is often a time-consuming and costly process that will require us to provide scientific and clinical support for the use of our product
candidates to each payor separately, with no assurance that coverage and adequate reimbursement will be applied consistently or obtained in the first instance. Decisions regarding the extent of coverage and amount of reimbursement to be provided for
any product candidates that we develop will be made on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">payor-by-payor</FONT></FONT> basis. One payor&#146;s determination to provide coverage for a drug does not assure that other
payors will also provide coverage and adequate reimbursement for the drug. Additionally, a third-party payor&#146;s decision to provide coverage for a therapy does not imply that an adequate reimbursement rate will be approved. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">There have been, and likely will continue to be, legislative and regulatory proposals at the foreign, federal, and state
levels directed at broadening the availability of healthcare and containing or lowering the cost of healthcare. We cannot predict the initiatives that may be adopted in the future, including repeal, replacement, or significant revisions to the
Affordable Care Act. The continuing efforts of the government, insurance companies, managed care organizations, and other payors of healthcare services to contain or reduce costs of healthcare and/or impose price controls may adversely affect:</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the demand for our product candidates, if we obtain regulatory approval; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to set a price that we believe is fair for our products; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to obtain coverage and reimbursement approval for a product; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to generate revenue and achieve or maintain profitability; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the level of taxes that we are required to pay; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the availability of capital. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our inability to promptly obtain coverage and adequate reimbursement from both third-party payors for the product candidates
that we may develop and for which we obtain regulatory approval could have a material and adverse effect on our business, financial condition, results of operations, and prospects. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>We face potential liability related to the privacy of personal information, including
health information we utilize in the development of products developed from our ex vivo cell engineering platform, as well as information we obtain from clinical trials sponsored by us from research institutions and directly from individuals.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We and our partners and vendors are subject to various federal, state, and foreign data protection laws and
regulations. If we fail to comply with these laws and regulations, we may be subject to litigation, regulatory investigations, enforcement notices, enforcement actions, fines, and criminal or civil penalties, as well as negative publicity,
reputational harm, and a potential loss of business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In the United States, numerous federal and state laws and
regulations, including state data breach notification laws and federal and state data privacy laws and regulations that govern the collection, use, disclosure, and protection of health information and other personal information apply to our
operations and the operations of our partners. For example, most healthcare providers, including research institutions from which we obtain patient health information, are subject to data privacy and security regulations promulgated under HIPAA, as
amended by the Health Information Technology for Economic and Clinical Health Act of 2009 (HITECH). Depending on the facts and circumstances, we could be subject to significant penalties if we violate HIPAA. For example, under HIPAA, we could
potentially face substantial criminal or civil penalties if we knowingly receive protected health information from a HIPAA-covered healthcare provider or research institution that has not satisfied HIPAA&#146;s requirements for disclosure of such
health information, or otherwise violate applicable HIPAA requirements related to the protection of such information. Even when HIPAA does not apply, failing to take appropriate steps to keep consumers&#146; personal information secure may
constitute a violation of the Federal Trade Commission Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Certain of the research materials we use in our therapeutic
research and development efforts, as well as stem cell lines used as starting material in our <I>ex vivo cell engineering product candidates are derived from human sources, which potentially contain sensitive identifiable personal information
regarding the donor. In addition, once we commence clinical trials, we may maintain sensitive identifiable personal information, including health information, that we receive throughout the clinical trial process, in the course of our research
collaborations, and directly from individuals (or their healthcare providers) who enroll in our patient assistance programs. As such, we may become subject to further obligations under HIPAA. In addition, our collection of personal information
generally (e.g., of employees currently and/or of patients in the future) may subject us to state data privacy laws governing the processing of personal information and requiring notification of affected individuals and state regulators in the event
of a breach of such personal information. These state laws include the California Consumer Privacy Act&nbsp;(CCPA) and its related regulations, and (once effective) the recently approved California Privacy Rights Act amending the CCPA which
establish additional data privacy rights for residents of the State of California, with corresponding obligations on businesses related to transparency, deletion rights, and opt-out of the selling of personal information, and grants a private right
of action for individuals in the event of certain security breaches. Similar laws relating to data privacy and security have been proposed in other states and at the federal level, and if passed, such laws may have potentially conflicting
requirements that would make compliance challenging, require us to expend significant resources to come into compliance, and restrict our ability to process certain personal information. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Further, California voters approved a new privacy law, the California Privacy Rights Act, or CPRA, in the November 3, 2020
election. Effective starting on January 1, 2023, the CPRA will significantly modify the CCPA, including by expanding consumers&#146; rights with respect to certain sensitive personal information. The CPRA also creates a new state agency that will be
vested with authority to implement and enforce the CCPA and the CPRA. New legislation proposed or enacted in various other states will continue to shape the data privacy environment nationally. Certain state laws may be more stringent or broader in
scope, or offer greater individual rights, with respect to confidential, sensitive and personal information than federal, international or other state laws, and such laws may differ from each other, which may complicate compliance efforts. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Any clinical trial programs and research collaborations that we engage in outside the United States may implicate
international data protection laws, including, in Europe, the General Data Protection Regulation </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
(GDPR). The GDPR imposes stringent operational requirements for data processors and controllers of personal data. Among other things, the GDPR requires detailed notices for clinical trial
subjects and investigators, as well as the security of personal data, and notification of data processing obligations or security incidents to appropriate data protection authorities or data subjects. Further, following the United Kingdom&#146;s
withdrawal from the European Union effective as of December&nbsp;31, 2020, we will have to comply with the GDPR and the GDPR as incorporated into United Kingdom national law, which may have differing requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">One particularly sensitive issue under these European Union data privacy laws involves European Economic Area (EEA) laws on
data export if we begin to transfer personal data from the EEA to other jurisdictions. Recent legal developments in Europe have created complexity and uncertainty regarding transfers of personal data from the EEA to the United States. For example,
on July&nbsp;16, 2020, the Court of Justice of the European Union, or CJEU, invalidated the <FONT STYLE="white-space:nowrap">EU-US</FONT> Privacy Shield Framework, or Privacy Shield, under which personal data could previously be transferred from the
EEA to United States entities who had self-certified under the Privacy Shield scheme. The CJEU decision also created additional obligations and uncertainty around the ability to use standard contractual clauses for such data transfers. As government
authorities issue further guidance on personal data export mechanisms or start aggressively taking enforcement action based on such guidance or the CJEU decision, we could suffer additional costs, complaints, and/or regulatory investigations or
fines. If we are otherwise unable to transfer personal data between and among countries and regions in which we operate, it could affect the manner in which we provide our services, the geographical location or segregation of our relevant systems
and operations, and adversely affect our financial results. These international laws and regulations may apply not only to us, but also to vendors that store or otherwise process personal data on our behalf, such as information technology vendors.
If our data privacy and/or security measures fail to comply with European Union and United Kingdom data privacy laws, or if a vendor misuses data we have provided to it or fails to safeguard such data, we may be subject to litigation, regulatory
investigations, enforcement notices, and/or enforcement actions imposing fines and/or requiring us to change the way we use personal data, as well as negative publicity, reputational harm, and a potential loss of business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are likely to be required to expend significant capital and other resources to ensure ongoing compliance with applicable
data privacy and security laws. Claims that we have violated individuals&#146; privacy rights or breached our contractual obligations, even if we are not found liable, could be expensive and time-consuming to defend, and could result in adverse
publicity that could harm our business. Moreover, even if we take all necessary action to comply with legal and regulatory requirements, we could be subject to a data breach or other unauthorized access of personal information, which could subject
us to fines and penalties, as well as litigation and reputational damage. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If we fail to keep apprised of and comply with
applicable international, federal, state, or local regulatory requirements, we could be subject to a range of regulatory actions that could affect our or any collaborators&#146; ability to seek to commercialize our clinical candidates. Any
threatened or actual government enforcement action or litigation where private rights of action are available could also generate adverse publicity, damage our reputation, result in liabilities, fines and loss of business, and require that we devote
substantial resources that could otherwise be used in other aspects of our business. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Commercialization of Our Product Candidates
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>We operate in highly competitive and rapidly changing industries, which may result in others discovering, developing or
commercializing competing products before or more successfully than we do. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The biotechnology and pharmaceutical
industries are highly competitive and subject to significant and rapid technological change. Our success is highly dependent on our ability to discover, develop and obtain marketing approval for new and innovative products on a cost-effective basis
and to market them successfully. In doing so, we face and will continue to face intense competition from a variety of businesses, including large pharmaceutical and biotechnology companies, academic institutions, government agencies and other public
and private research organizations. These organizations may have significantly greater resources than we do and conduct similar research, seek patent protection and establish collaborative arrangements for research,
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
development, manufacturing, and marketing of products that compete with our product candidates. Mergers and acquisitions in the biotechnology and pharmaceutical industries may result in even more
resources being concentrated in our competitors. Competition may increase further as a result of advances in the commercial applicability of technologies and greater availability of capital for investment in these industries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">With the proliferation of new drugs and therapies for our target indications, we expect to face increasingly intense
competition as new technologies become available. If we fail to stay at the forefront of technological change, we may be unable to compete effectively. Any product candidates that we successfully develop and commercialize will compete with existing
therapies and new therapies that may become available in the future. The highly competitive nature of and rapid technological changes in the biotechnology and pharmaceutical industries could render our product candidates or our technology obsolete,
less competitive or uneconomical. Our competitors may, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">have significantly greater financial, manufacturing, marketing, drug development, technical, and human
resources than we do; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">develop and commercialize products that are safer, more effective, less expensive, more convenient or easier
to administer, or have fewer or less severe side effects; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">obtain quicker regulatory approval; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establish superior proprietary positions covering our products and technologies; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">implement more effective approaches to sales and marketing; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">form more advantageous strategic alliances. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Should any of these factors occur, our business, financial condition, and results of operations could be materially adversely
affected. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition, any collaborators may decide to market and sell products that compete with the product candidates
that we have agreed to license to them, and any competition by our collaborators could also have a material adverse effect on our future business, financial condition, and results of operations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Smaller and other early stage companies may also prove to be significant competitors, particularly through collaborative
arrangements with large and established companies. These third parties compete with us in recruiting and retaining qualified scientific and management personnel, establishing clinical trial sites and patient registration for clinical trials, as well
as in acquiring technologies complementary to, or necessary for, our programs. See the subsection titled &#147;Business&#151;Competition.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>The estimates of market opportunity and forecasts of market growth included in this prospectus may prove to be smaller than we believe,
and even if the markets in which we compete achieve the forecasted growth, our business may not grow at similar rates, or at all. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We intend to initially focus our product candidate development on treatments for various diseases caused by missing or damaged
cells. Our projections of addressable patient populations within any particular disease state that may benefit from treatment with our product candidates are based on our estimates. Market opportunity estimates and growth forecasts included in this
prospectus are subject to significant uncertainty and are based on assumptions and estimates. These estimates, which have been derived from a variety of sources, including scientific literature, surveys of clinics, patient foundations, and market
research, may prove to be incorrect. Further, new studies may change the estimated incidence or prevalence of these diseases. Additionally, the potentially addressable patient population for our product candidates may not ultimately be amenable to
treatment with our product candidates. Our market opportunity may also be limited by future competitor treatments that enter the market. If any of our estimates prove to be inaccurate, the market opportunity for any product candidate that we or our
strategic partners develop could be significantly diminished and have an adverse material impact on our business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In
particular, certain of our product candidates are intended to address cancer, and, in particular, B cell malignancies. Cancer therapies are sometimes characterized as first line, second line, or third line, and the FDA
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
often approves new therapies initially only for a particular line of use. When cancer is detected early enough, first line therapy is sometimes adequate to cure the cancer or prolong life without
a cure. Whenever first line therapy, usually chemotherapy, antibody drugs, tumor-targeted small molecules, hormone therapy, radiation therapy, surgery, or a combination of these, proves unsuccessful, second line therapy may be administered. Second
line therapies often consist of more chemotherapy, radiation, antibody drugs, tumor-targeted small molecules, or a combination of these. Third line therapies can include chemotherapy, antibody drugs and small molecule tumor-targeted therapies, more
invasive forms of surgery and new technologies. The use of CAR T therapies has been limited to the relapsed/refractory patient subset. Our projections of both the number of people who have the cancers we are targeting, as well as the subset of
people with these cancers in a position to receive a particular line of therapy and who have the potential to benefit from treatment with our product candidates, are based on our beliefs and estimates. Consequently, even if our product candidates
are approved for a later line of therapy, the number of patients that may be eligible for treatment with our product candidates may turn out to be much lower than expected. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>We currently have no marketing, sales, or distribution infrastructure and we intend to either establish a sales and marketing
infrastructure or outsource this function to a third party. Either of these commercialization strategies carries substantial risks to us. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We currently have no marketing, sales, and distribution capabilities because all of our product candidates are still in
preclinical development. If any of our product candidates complete clinical development and are approved, we intend to either establish a sales and marketing organization with technical expertise and supporting distribution capabilities to
commercialize our product candidates in a legally compliant manner, or to outsource this function to a third party. There are risks involved if we decide to establish our own sales and marketing capabilities or enter into arrangements with third
parties to perform these services. To the extent that we enter into collaboration agreements with respect to marketing, sales or distribution, our product revenue may be lower than if we directly marketed or sold any approved products. Such
collaborative arrangements with partners may place the commercialization of our products outside of our control and would make us subject to a number of risks including that we may not be able to control the amount or timing of resources that our
collaborative partner devotes to our products or that our collaborator&#146;s willingness or ability to complete its obligations, and our obligations under our arrangements may be adversely affected by business combinations or significant changes in
our collaborator&#146;s business strategy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If we are unable to enter into these arrangements on acceptable terms or at
all, we may not be able to successfully commercialize any approved products. If we are not successful in commercializing any approved products, either on our own or through collaborations with one or more third parties, our future product revenue
will suffer and we may incur significant additional losses, which would have a material adverse effect on our business, financial condition, and results of operations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Our product candidates for which we intend to seek approval as biologic products may face competition sooner than anticipated.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The ACA includes a subtitle called the Biologics Price Competition and Innovation Act of 2009 (BPCIA), which
created an abbreviated approval pathway for biological products that are biosimilar to or interchangeable with an <FONT STYLE="white-space:nowrap">FDA-licensed</FONT> reference biological product. Under the BPCIA, an application for a highly similar
or &#147;biosimilar&#148; product may not be submitted to the FDA until four years following the date that the reference product was first approved by the FDA. In addition, the approval of a biosimilar product may not be made effective by the FDA
until 12 years from the date on which the reference product was first approved. During this <FONT STYLE="white-space:nowrap">12-year</FONT> period of exclusivity, another company may still market a competing version of the reference product if the
FDA approves a full BLA for the competing product containing the sponsor&#146;s own preclinical data and data from adequate and well-controlled clinical trials to demonstrate the safety, purity, and potency of their product. The law is complex and
is still being interpreted and implemented by the FDA. As a result, its ultimate impact, implementation, and meaning are subject to uncertainty. In addition, complexities associated with the larger, and often more complex, structures of biological
products such as cell and gene products we are developing, as well as the processes by which such products are manufactured, pose significant hurdles to implementation of the abbreviated approval pathway that are still being worked out by the FDA.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We believe that any of our product candidates approved as a biological
product under a BLA should qualify for the <FONT STYLE="white-space:nowrap">12-year</FONT> period of exclusivity. However, there is a risk that this exclusivity could be shortened due to congressional action or otherwise, or that the FDA will not
consider our product candidates to be reference products for competing products, potentially creating the opportunity for competition sooner than anticipated. Other aspects of the BPCIA, some of which may impact the BPCIA exclusivity provisions,
have also been the subject of recent litigation. Moreover, the extent to which a biosimilar, once approved, will be substituted for any one of our reference products in a way that is similar to traditional generic substitution for <FONT
STYLE="white-space:nowrap">non-biological</FONT> products is not yet clear, and will depend on a number of marketplace and regulatory factors that are still developing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Jurisdictions in addition to the United States have established abbreviated pathways for regulatory approval of biological
products that are biosimilar to earlier approved reference products. For example, the European Union has had an established regulatory pathway for biosimilars since 2004. However, biosimilars can only be authorized once the period of data
exclusivity on the reference biological medicine has expired. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The increased likelihood of biosimilar competition has
increased the risk of loss of innovators&#146; market exclusivity. Due to this risk, and uncertainties regarding patent protection, if our clinical candidates are approved for marketing, it is not possible to predict the length of market exclusivity
for any particular product with certainty based solely on the expiration of the relevant patent(s) or the current forms of regulatory exclusivity. It is also not possible to predict changes in United States regulatory law that might reduce
biological product regulatory exclusivity. The loss of market exclusivity for a product would likely materially and negatively affect revenues and we may not generate adequate or sufficient revenues from them or be able to reach or sustain
profitability. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Our Dependence on Third Parties </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>We rely on third-parties to manufacture our product candidates. Any failure by a third-party manufacturer to produce acceptable raw
materials or product candidates for us or to obtain authorization from the FDA or comparable foreign regulatory authorities may delay or impair our ability to initiate or complete our clinical trials, obtain regulatory approvals or commercialize
approved products. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We do not currently own or operate any GMP manufacturing facilities nor do we have any <FONT
STYLE="white-space:nowrap">in-house</FONT> GMP manufacturing capabilities. We rely on multiple third-party contract manufacturers to produce sufficient quantities of materials required for the manufacture of our product candidates for preclinical
testing and clinical trials, in compliance with applicable regulatory and quality standards, and intend to do so for the commercial manufacture of our products, if approved. If we are unable to arrange for such third-party manufacturing sources, or
fail to do so on commercially reasonable terms, we may not be able to successfully produce sufficient supply of product candidate or we may be delayed in doing so. Such failure or substantial delay could materially harm our business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We rely on third parties for biological materials that are used in our discovery and development programs. These materials can
be difficult to produce and occasionally have variability from the product specifications. Any disruption in the supply of these biological materials consistent with our product specifications could materially adversely affect our business. Although
we have control processes and screening procedures, biological materials are susceptible to damage and contamination and may contain active pathogens. We may also have lower yields in manufacturing batches, which can increase our costs and slow our
development timelines. Improper storage of these materials, by us or any third-party suppliers, may require us to destroy some of our biological raw materials or product candidates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Reliance on third-party manufacturers entails risks to which we would not be subject if we manufactured product candidates
ourselves, including reliance on the third party for regulatory compliance and quality control and assurance, volume production, the possibility of breach of the manufacturing agreement by the third party
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
because of factors beyond our control (including a failure to synthesize and manufacture our product candidates in accordance with our product specifications) and the possibility of termination
or nonrenewal of the agreement by the third party at a time that is costly or damaging to us. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition, the FDA and
comparable foreign regulatory authorities require that our product candidates be manufactured according to cGMPs and similar foreign standards relating to methods, facilities, and controls used in the manufacturing, processing, and packing of the
product, which are intended to ensure that biological products are safe and that they consistently meet applicable requirements and specifications. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Pharmaceutical manufacturers are required to register their facilities and products manufactured at the time of submission of
the marketing application and then annually thereafter with the FDA and certain state and foreign agencies. If the FDA or a comparable foreign regulatory authority does not approve our proposed contract manufacturer&#146;s facilities for the
manufacture of our product candidates or if it withdraws any such approval in the future, we may need to find alternative manufacturing facilities, which would significantly impact our ability to develop, obtain regulatory approval for, or market
our product candidates, if approved. Any discovery of problems with a product, or a manufacturing or laboratory facility used by us or our strategic partners, may result in restrictions on the product or on the manufacturing or laboratory facility,
including marketed product recall, suspension of manufacturing, product seizure, or a voluntary withdrawal of the drug from the market. We may have little to no control regarding the occurrence of third-party manufacturer incidents. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If we were unable to find an adequate replacement or another acceptable solution in time, our clinical trials could be
delayed, or our commercial activities could be harmed. In addition, the fact that we are dependent on our collaborators, our suppliers, and other third parties for the manufacture, filling, storage, and distribution of our product candidates means
that we are subject to the risk that the products may have manufacturing defects that we have limited ability to prevent or control. The sale of products containing such defects could adversely affect our business, financial condition, and results
of operations. Any failure by our third-party manufacturers to comply with cGMP or failure to scale up manufacturing processes, including any failure to deliver sufficient quantities of product candidates in a timely manner, could lead to a delay
in, or failure to obtain, regulatory approval of any of our product candidates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Pharmaceutical manufacturers are also
subject to extensive post-marketing oversight by the FDA and comparable regulatory authorities in the jurisdictions where the product is marketed, which include periodic unannounced and announced inspections by the FDA to assess compliance with cGMP
requirements. If an FDA inspection of a manufacturer&#146;s facilities reveals conditions that the FDA determines not to comply with applicable regulatory requirements, the FDA may issue observations through a Notice of Inspectional Observations,
commonly referred to as a &#147;Form FDA 483&#148; report. If observations in the Form FDA 483 report are not addressed in a timely manner and to the FDA&#146;s satisfaction, the FDA may issue a Warning Letter or proceed directly to other forms of
enforcement action. Any failure by one of our contract manufacturers to comply with cGMP or to provide adequate and timely corrective actions in response to deficiencies identified in a regulatory inspection could result in further enforcement
action that could lead to a shortage of products and harm our business, including withdrawal of approvals previously granted, seizure, injunction or other civil or criminal penalties. The failure of a manufacturer to address any concerns raised by
the FDA or foreign regulators could also lead to plant shutdown or the delay or withholding of product approval by the FDA in additional indications, or by foreign regulators in any indication. Certain countries may impose additional requirements on
the manufacturing of drug products or drug substances, and on manufacturers, as part of the regulatory approval process for products in such countries. The failure by our third-party manufacturers to satisfy such requirements could impact our
ability to obtain or maintain approval of our products in such countries. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>If we are unable to obtain sufficient raw and
intermediate materials on a timely basis or if we experience other manufacturing or supply difficulties, our business may be adversely affected. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The manufacture of certain of our product candidates requires the timely delivery of sufficient amounts of raw and intermediate
materials. We work closely with our suppliers to ensure the continuity of supply but cannot </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
guarantee these efforts will always be successful. Further, while efforts are made to diversify our sources of raw and intermediate materials, in certain instances we acquire raw and intermediate
materials from a sole supplier. While we believe that alternative sources of supply exist where we rely on sole supplier relationships, there can be no assurance that we will be able to quickly establish additional or replacement sources for some
materials. A reduction or interruption in supply, and an inability to develop alternative sources for such supply, could adversely affect our ability to manufacture our product candidates in a timely or cost-effective manner. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Supply sources could be interrupted from time to time and, if interrupted, there is no guarantee that supplies could be resumed within a
reasonable time frame and at an acceptable cost or at all. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We rely on our manufacturers to purchase from
third-party suppliers the materials necessary to produce our product candidates for our preclinical studies and intend to continue to rely on these third parties for any clinical trials that we undertake. There are a limited number of suppliers for
raw materials that we use to manufacture our drugs and there may be a need to assess alternate suppliers to prevent a possible disruption of the manufacture of the materials necessary to produce our product candidates for our preclinical studies,
clinical trials, and if approved, ultimately for commercial sale. We do not have any control over the process or timing of the acquisition of these raw materials by our manufacturers. Moreover, we currently do not have any agreements for the
commercial production of these raw materials. We cannot be sure that these suppliers will remain in business, or that they will not be purchased by one of our competitors or another company that is not interested in continuing to produce these
materials for our intended purpose. In addition, the lead time needed to establish a relationship with a new supplier can be lengthy, and we may experience delays in meeting demand in the event a new supplier must be used. The time and effort to
qualify a new supplier could result in additional costs, diversion of resources, or reduced manufacturing yields, any of which would negatively impact our operating results. Although we generally do not begin a clinical trial unless we believe we
have a sufficient supply of a product candidate to complete the clinical trial, any significant delay in the supply of a product candidate, or the raw material components thereof, for an ongoing clinical trial due to the need to replace a
third-party manufacturer could considerably delay completion of our clinical trials, product testing, and potential regulatory approval of our product candidates. If our manufacturers or we are unable to purchase these raw materials after regulatory
approval has been obtained for our product candidates, the commercial launch of our product candidates would be delayed or there would be a shortage in supply, which would impair our ability to generate revenues from the sale of our product
candidates. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>We rely, and expect to continue to rely, on third parties, including independent clinical investigators and CROs, to
conduct our preclinical studies and clinical trials. If these third parties do not successfully carry out their contractual duties, comply with applicable regulatory requirements, or meet expected deadlines, we may not be able to obtain regulatory
approval for or commercialize our product candidates and our business could be substantially harmed. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have
relied upon and plan to continue to rely upon third parties, including independent clinical investigators and third-party CROs, to conduct our preclinical studies and clinical trials and to monitor and manage data for our ongoing preclinical and
clinical programs. We rely on these parties for execution of our preclinical studies and clinical trials, and control only certain aspects of their activities. Nevertheless, we are responsible for ensuring that each of our studies and trials is
conducted in accordance with the applicable protocol, legal, regulatory, and scientific standards, and our reliance on these third parties does not relieve us of our regulatory responsibilities. We and our third-party contractors and CROs are
required to comply with GCP requirements, which are regulations and guidelines enforced by the FDA and comparable foreign regulatory authorities for all of our products candidates in clinical development. Regulatory authorities enforce these GCPs
through periodic inspections of trial sponsors, principal investigators, and trial sites. If we or any of our CROs fail to comply with applicable GCPs, the clinical data generated in our clinical trials may be deemed unreliable and the FDA or
comparable foreign regulatory authorities may require us to perform additional clinical trials before approving our marketing applications. We cannot assure you that upon inspection by a given regulatory authority, such regulatory authority will
determine that any of our clinical trials comply with GCP regulations. In </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
addition, our clinical trials must be conducted with product produced under cGMP regulations. Our failure to comply with these regulations may require us to repeat clinical trials, which would
delay the regulatory approval process. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Further, these investigators and CROs are not our employees and we will not be
able to control, other than by contract, the amount of resources, including time, which they devote to our product candidates and clinical trials. If independent investigators or CROs fail to devote sufficient resources to the development of our
product candidates, or if their performance is substandard, it may delay or compromise the prospects for approval and commercialization of any product candidates that we develop. In addition, the use of third-party service providers may require us
to disclose our proprietary information to these parties, which could increase the risk that this information will be misappropriated. Additionally, disruptions caused by the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic may increase the
likelihood that our CROs encounter difficulties or delays in initiating, enrolling, conducting, or completing our planned clinical trials. In particular, as a result of the pandemic, we have experienced difficulty in accessing animal models,
specifically <FONT STYLE="white-space:nowrap">non-human</FONT> primate models, for the preclinical evaluation of our product candidates. Delays caused by the inability to access these models may cause our development timeline to be extended beyond
what we anticipate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our CROs have the right to terminate their agreements with us in the event of an uncured material
breach. In addition, some of our CROs have an ability to terminate their respective agreements with us if it can be reasonably demonstrated that the safety of the subjects participating in our clinical trials warrants such termination, if we make a
general assignment for the benefit of our creditors, or if we are liquidated. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">There is a limited number of third-party
service providers that specialize or have the expertise required to achieve our business objectives. If any of our relationships with these third-party laboratories, CROs or clinical investigators terminate, we may not be able to enter into
arrangements with alternative laboratories, CROs, or investigators or to do so in a timely manner or on commercially reasonable terms. If laboratories, CROs, or clinical investigators do not successfully carry out their contractual duties or
obligations or meet expected deadlines, if they need to be replaced or if the quality or accuracy of the clinical data they obtain is compromised due to the failure to adhere to our preclinical or clinical protocols, regulatory requirements or for
other reasons, our preclinical or clinical trials may be extended, delayed, or terminated and we may not be able to obtain regulatory approval for or successfully commercialize our product candidates. As a result, our results of operations and the
commercial prospects for our product candidates would be harmed, our costs could increase, and our ability to generate revenues could be delayed. Switching or adding additional laboratories or CROs (or investigators) involves additional cost and
requires management time and focus. In addition, there is a natural transition period when a new laboratory or CRO commences work. As a result, delays occur, which can materially impact our ability to meet our desired clinical development timelines.
Additionally, CROs may lack the capacity to absorb higher workloads or take on additional capacity to support our needs. Though we carefully manage our relationships with our contracted laboratories and CROs, there can be no assurance that we will
not encounter similar challenges or delays in the future or that these delays or challenges will not have a material adverse impact on our business, financial condition, and prospects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition, clinical investigators may serve as scientific advisors or consultants to us from time to time and may receive
cash or equity compensation in connection with such services. If these relationships and any related compensation result in perceived or actual conflicts of interest, or the FDA concludes that the financial relationship may have affected the
interpretation of the preclinical study or clinical trial, the integrity of the data generated at the applicable preclinical study or clinical trial site may be questioned and the utility of the preclinical study or clinical trial itself may be
jeopardized, which could result in the delay or rejection by the FDA. Any such delay or rejection could prevent us from commercializing our clinical-stage product candidate or any future product candidates. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>We may not realize the benefits of any collaborative or licensing arrangement, and if
we fail to enter into new strategic relationships our business, financial condition, commercialization prospects, and results of operations may be materially adversely affected. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our product development programs and the potential commercialization of our product candidates will require substantial
additional cash to fund expenses. Therefore, for some of our product candidates, we may decide to enter into collaborations with pharmaceutical or biopharmaceutical companies for the development and potential commercialization of those product
candidates. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We face significant competition in seeking appropriate collaborators. Collaborations are complex and
time-consuming to negotiate and document. We may also be restricted under existing and future collaboration agreements from entering into agreements on certain terms with other potential collaborators. We may not be able to negotiate collaborations
on acceptable terms, or at all. If our strategic collaborations do not result in the successful development and commercialization of product candidates, or if one of our collaborators terminates its agreement with us, we may not receive any future
research funding or milestone or royalty payments under the collaboration or the research, development and commercialization product that is the subject of the collaboration may be delayed. Moreover, our estimates of the potential revenue we are
eligible to receive under our strategic collaborations may include potential payments related to therapeutic programs for which our collaborators have discontinued development or may discontinue development in the future. If that were to occur, we
may have to curtail the development of a particular product candidate, reduce or delay its development program or one or more of our other development programs, delay its potential commercialization or reduce the scope of our sales or marketing
activities, or increase our expenditures and undertake development or commercialization activities at our own expense. If we elect to increase our expenditures to fund development or commercialization activities on our own, we may need to obtain
additional capital, which may not be available to us on acceptable terms or at all. If we do not have sufficient funds, we will not be able to bring our product candidates to market and generate product revenue. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In instances where we do enter into collaborations, we could be subject to the following risks, each of which may materially
harm our business, commercialization prospects, and financial condition: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may not be able to control the amount and timing of resources that is required of us to complete our
development obligations or that the collaboration partner devotes to the product development or marketing programs; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the collaboration partner may experience financial difficulties; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">collaborators may delay clinical trials, provide insufficient funding for a clinical trial program, stop a
clinical trial or abandon a product candidate, repeat or conduct new clinical trials, or require a new formulation of a product candidate for clinical testing; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may be required to relinquish important rights such as marketing, distribution, and intellectual property
rights; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">collaborators may not properly maintain or defend our intellectual property rights or may use our proprietary
information in such a way as to invite litigation that could jeopardize or invalidate our intellectual property or proprietary information or expose us to litigation or potential liability; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">collaborators may infringe the intellectual property rights of third parties, which may expose us to
litigation and potential liability; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a collaborator could move forward with a competing product developed either independently or in collaboration
with third parties, including our competitors; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we and our collaboration partner may disagree regarding the development plan for product candidates on which
we are collaborating (for example, we may disagree with a collaboration partner regarding target indications, inclusion or exclusion criteria for a clinical trial, or the decision to seek front line therapy approval versus second, third, or fourth
line therapy approval); </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">59 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">disputes may arise between the collaborators and us that result in the delay or termination of the research,
development or commercialization of our product candidates or that result in costly litigation or arbitration that diverts management attention and resources; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">business combinations or significant changes in a collaborator&#146;s business strategy may adversely affect
our willingness to complete our obligations under any arrangement; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">collaborations may be terminated and, if terminated, may result in a need for additional capital to pursue
further development or commercialization of the applicable product candidates. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If we license products
or businesses, we may not be able to realize the benefit of such transactions if we are unable to successfully integrate them with our existing operations and company culture. We cannot be certain that, following a strategic transaction or license,
we will achieve the results, revenue, or specific net income that justifies such transaction. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Intellectual Property and Information
Technology </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>We depend on intellectual property licensed from third parties and if we breach our obligations under these
agreements or if any of these agreements is terminated, we may be required to pay damages, lose our rights to such intellectual property and technology, or both, which would harm our business. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are dependent on patents, <FONT STYLE="white-space:nowrap">know-how,</FONT> and proprietary technology, both our own and
licensed from others. We are a party to a number of intellectual property license agreements and acquisition agreements pursuant to which we have acquired our core intellectual property rights. In the future, we expect to enter into additional
license agreements. For example, with respect to our <I>ex vivo</I> cell engineering platform relying on hypoimmune technology, we have licensed certain intellectual property from Harvard, UCSF, and Washington University. Additionally, we acquired
our <I>in vivo</I> cell engineering platform, which is based on fusogen technology, from Cobalt, which included several license agreements and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">options-to-license,</FONT></FONT> as
well as our glial progenitor cell and cardiomyocyte programs from Oscine and Cytocardia, respectively, both of which came with <FONT STYLE="white-space:nowrap">in-licenses.</FONT> These license and acquisition agreements impose, and we expect that
future license and acquisition agreements will impose, various diligence, milestone payment, royalty and other obligations on us. If we fail to comply with our obligations under these agreements, we may be required to pay damages and the licensor
may have the right to terminate the license. Any termination of these licenses could result in the loss of significant rights and could harm our ability to develop or advance one of our cell engineering platforms, or develop, manufacture and/or
commercialize one of our product candidates. See the section titled &#147;Business &#150; Key Intellectual Property Agreements&#148; elsewhere in this prospectus for additional information regarding these key agreements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition, the agreements under which we license intellectual property or technology to or from third parties are complex,
and certain provisions in such agreements may be susceptible to multiple interpretations. The resolution of any contract interpretation disagreement that may arise could narrow what we believe to be the scope of our rights to the relevant
intellectual property or technology or increase what we believe to be our financial or other obligations under the relevant agreement, either of which could have a material adverse effect on our business, financial condition, results of operations
and prospects. Moreover, if disputes over intellectual property that we have licensed prevent or impair our ability to maintain our current licensing arrangements on commercially acceptable terms, we may be unable to successfully develop and
commercialize the affected product candidates. Our business also would suffer if any current or future licensors fail to abide by the terms of the license, if the licensors fail to enforce licensed patents against infringing third parties, if the
licensed patents or other rights are found to be invalid or unenforceable, or if we are unable to enter into necessary licenses on acceptable terms. Moreover, our licensors may own or control intellectual property that has not been licensed to us
and, as a result, we may be subject to claims, regardless of their merit, that we are infringing or otherwise violating the licensor&#146;s rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition, while we cannot currently determine the amount of the royalty obligations we would be required to pay on sales of
future products, if any, the amounts may be significant. The amount of our future royalty </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">60 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
obligations will depend on the technology and intellectual property we use in products that we successfully develop and commercialize, if any. Therefore, even if we successfully develop and
commercialize products, we may be unable to achieve or maintain profitability. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If we are unable to successfully obtain
rights to required third-party intellectual property rights or maintain the existing intellectual property rights we have, we may have to abandon development of the relevant research programs or product candidates and our business, financial
condition, results of operations and prospects could suffer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Licensing of intellectual property is of critical importance
to our business and involves complex legal, business and scientific issues and is complicated by the rapid pace of scientific discovery in our industry. Disputes may also arise between us and our licensors regarding intellectual property subject to
a license agreement, including those relating to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the scope of rights granted under the license agreement and other interpretation-related issues;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether and the extent to which our technology and processes infringe on intellectual property of the licensor
that is not subject to the license agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our right to sublicense patent and other rights to third parties under collaborative development
relationships; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether we are complying with our diligence obligations with respect to the use of the licensed technology in
relation to our development and commercialization of our product candidates, and what activities satisfy those diligence obligations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the priority of invention of patented technology; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the amount and timing of payments owed under license agreements; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the allocation of ownership of inventions and <FONT STYLE="white-space:nowrap">know-how</FONT> resulting from
the joint creation or use of intellectual property by our licensors and by us and our partners. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If
disputes over intellectual property that we have licensed prevent or impair our ability to maintain our current licensing arrangements on acceptable terms, we may be unable to successfully develop and commercialize the affected product candidates.
We are generally also subject to all of the same risks with respect to protection of intellectual property that we license as we are for intellectual property that we own, which are described below. If we or our licensors fail to adequately protect
this intellectual property, our ability to commercialize our products could suffer. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>We depend, in part, on our licensors to file,
prosecute, maintain, defend, and enforce certain patents and patent applications that are material to our business. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Certain patents relating to our product candidates are owned or controlled by certain of our licensors. Each of our licensors
generally has rights to file, prosecute, maintain, and defend the patents we have licensed from such licensor in their name, generally with our right to comment on such filing, prosecution, maintenance, and defense, with some obligation for the
licensor to consider or incorporate our comments, for our exclusively licensed patents. We generally have the first right to enforce our exclusively licensed patent rights against third parties, although our ability to settle such claims often
requires the consent of the licensor. If our licensors or any future licensees having rights to file, prosecute, maintain, and defend our patent rights fail to conduct these activities for patents or patent applications covering any of our product
candidates, including due to the impact of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic on our licensors&#146; business operations, our ability to develop and commercialize those product candidates may be adversely affected and we
may not be able to prevent competitors from making, using, or selling competing products. We cannot be certain that such activities by our licensors have been or will be conducted in compliance with applicable laws and regulations or will result in
valid and enforceable patents or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">61 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
other intellectual property rights. Pursuant to the terms of the license agreements with some of our licensors, the licensors may have the right to control enforcement of our licensed patents or
defense of any claims asserting the invalidity of these patents and, even if we are permitted to pursue such enforcement or defense, we cannot ensure the cooperation of our licensors. We cannot be certain that our licensors will allocate sufficient
resources or prioritize their or our enforcement of such patents or defense of such claims to protect our interests in the licensed patents. Even if we are not a party to these legal actions, an adverse outcome could harm our business because it
might prevent us from continuing to license intellectual property that we may need to operate our business. In addition, even when we have the right to control patent prosecution of licensed patents and patent applications, enforcement of licensed
patents, or defense of claims asserting the invalidity of those patents, we may still be adversely affected or prejudiced by actions or inactions of our licensors and their counsel that took place prior to or after our assuming control. In the event
we breach any of our obligations related to such prosecution, we may incur significant liability to our licensing partners. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Given
the breadth of the application of our cell engineering platforms, in order to increase our ability to exploit our technologies, we may enter into collaborations and/or strategic partnerships in the future, and we may not realize the anticipated
benefits of such collaborations or partnerships. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Research and development collaborations and strategic
partnerships are prevalent in the biotechnology industry. The breadth of the application of our <I>in vivo</I> and <I>ex vivo</I> cell engineering platforms are attractive technologies for potential collaborations. These transactions are subject to
numerous risks, which may include the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">collaborators have significant discretion in determining the efforts and resources that they will apply to a
collaboration, and may not commit sufficient efforts and resources, or may misapply those efforts and resources; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">collaborators may not pursue development and commercialization of collaboration product candidates or may
elect not to continue or renew development or commercialization programs based on clinical trial results or changes in their strategic focus; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">collaborators may delay, provide insufficient resources to, or modify or stop clinical trials for
collaboration product candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">collaborators could develop or acquire products outside of the collaboration that compete directly or
indirectly with our products or product candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">collaborators may not properly maintain or defend our intellectual property rights or may use our intellectual
property or proprietary information in a way that gives rise to actual or threatened litigation that could jeopardize or invalidate our intellectual property or proprietary information or expose us to potential liability; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">disputes may arise between us and a collaborator that cause the delay or termination of the research,
development or commercialization of our product candidates, or that result in costly litigation or arbitration that diverts management attention and resources; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">collaborations may be terminated and, if terminated, may result in a need for additional capital and personnel
to pursue further development or commercialization of the applicable product candidates; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">collaborators may own or <FONT STYLE="white-space:nowrap">co-own</FONT> intellectual property covering our
products that results from our collaborating with them, and in such cases, we may not have the exclusive right to commercialize such intellectual property. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The development and potential commercialization of our product candidates will require substantial additional capital to fund
expenses. We may form or seek further strategic alliances, create joint ventures or collaborations, or enter into additional licensing arrangements with third parties that we believe will complement </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">62 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
or augment our development and commercialization efforts with respect to our product candidates and any future product candidates that we may develop, including in territories outside the United
States or for certain indications. These transactions can entail numerous operational and financial risks, including exposure to unknown liabilities, disruption of our business and diversion of our management&#146;s time and attention in order to
manage a collaboration or develop acquired products, product candidates or technologies, incurrence of substantial debt or dilutive issuances of equity securities to pay transaction consideration or costs, higher than expected collaboration,
acquisition or integration costs, write-downs of assets or goodwill or impairment charges, increased amortization expenses, difficulty and cost in facilitating the collaboration or combining the operations and personnel of any acquired business,
impairment of relationships with key suppliers, manufacturers or customers of any acquired business due to changes in management and ownership and the inability to retain key employees of any acquired business. As a result, if we enter into
acquisition or <FONT STYLE="white-space:nowrap">in-license</FONT> agreements or strategic collaborations, we may not be able to realize the benefit of such transactions if we are unable to successfully integrate them with our existing operations and
company culture, or if there are materially adverse impacts on our or the counterparty&#146;s operations resulting from <FONT STYLE="white-space:nowrap">COVID-19,</FONT> which could delay our timelines or otherwise adversely affect our business. We
also cannot be certain that, following a strategic transaction or license, we will achieve the revenue or specific net income that justifies such transaction or such other benefits that led us to enter into the arrangement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition, we face significant competition in seeking appropriate strategic partners and the negotiation process is
time-consuming and complex. We may not be successful in our efforts to establish a strategic partnership or other alternative arrangements for our product candidates because they may be deemed to be at too early of a stage of development for
collaborative effort and third parties may not view our product candidates as having the requisite potential to demonstrate safety and efficacy. If and when we collaborate with a third-party for development and commercialization of a product
candidate, we can expect to relinquish some or all of the control over the future success of that product candidate to the third-party. Our ability to reach a definitive agreement for a collaboration will depend, among other things, upon our
assessment of the collaborator&#146;s resources and expertise, the terms and conditions of the proposed collaboration and the proposed collaborator&#146;s evaluation of our technologies, product candidates and market opportunities. The collaborator
may also consider alternative product candidates or technologies for similar indications that may be available to collaborate on and whether such a collaboration could be more attractive than the one with us for our product candidate. We may also be
restricted under any license agreements from entering into agreements on certain terms or at all with potential collaborators. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As a result of these risks, we may not be able to realize the benefit of our existing collaborations or any future
collaborations or licensing agreements we may enter into. In addition, there have been a significant number of recent business combinations among large pharmaceutical companies that have resulted in a reduced number of potential future collaborators
and changes to the strategies of the combined company. As a result, we may not be able to negotiate collaborations on a timely basis, on acceptable terms, or at all. If we are unable to do so, we may have to curtail the development of such product
candidate, reduce or delay one or more of our other development programs, delay the potential commercialization or reduce the scope of any planned sales or marketing activities for such product candidate, or increase our expenditures and undertake
development, manufacturing or commercialization activities at our own expense. If we elect to increase our expenditures to fund development, manufacturing or commercialization activities on our own, we may need to obtain additional capital, which
may not be available to us on acceptable terms or at all. If we do not have sufficient funds, we may not be able to further develop our product candidates or bring them to market and generate product revenue. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our product candidates may also require specific components to work effectively and efficiently, and rights to those
components may be held by others. We may be unable to <FONT STYLE="white-space:nowrap">in-license</FONT> any compositions, methods of use, processes or other third party intellectual property rights from third parties that we identify. We may fail
to obtain any of these licenses at a reasonable cost or on reasonable terms, which would harm our business. Even if we are able to obtain a license, it may be <FONT STYLE="white-space:nowrap">non-exclusive,</FONT> thereby giving our competitors
access to the same technologies licensed to us. In that event, we may be required to expend significant time and resources to develop </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">63 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
or license replacement technology. Any delays in entering into new collaborations or strategic partnership agreements related to our product candidates could delay the development and
commercialization of our product candidates in certain geographies, which could harm our business prospects, financial condition, and results of operations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Moreover, some of our owned and <FONT STYLE="white-space:nowrap">in-licensed</FONT> patents or patent applications or future
patents are or may be <FONT STYLE="white-space:nowrap">co-owned</FONT> with third parties. If we are unable to obtain an exclusive license to any such third-party <FONT STYLE="white-space:nowrap">co-owners&#146;</FONT> interest in such patents or
patent applications, such <FONT STYLE="white-space:nowrap">co-owners</FONT> may be able to license their rights to other third parties, including our competitors, and our competitors could market competing products and technology. In addition, we
may need the cooperation of any such <FONT STYLE="white-space:nowrap">co-owners</FONT> of our patents in order to enforce such patents against third parties, and such cooperation may not be provided to us. Furthermore, our owned and <FONT
STYLE="white-space:nowrap">in-licensed</FONT> patents may be subject to a reservation of rights by one or more third parties. Any of the foregoing could have a material adverse effect on our competitive position, business, financial conditions,
results of operations and prospects. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>We may not be successful in obtaining or maintaining necessary rights to product components
and processes for our product development pipeline which may cause us to operate our business in a more costly or otherwise adverse manner that was not anticipated. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We own or license from third parties certain intellectual property rights necessary to develop our product candidates. The
growth of our business will likely depend in part on our ability to acquire or <FONT STYLE="white-space:nowrap">in-license</FONT> additional proprietary rights, including to advance our research or allow commercialization of our product candidates.
In that event, we may be required to expend considerable time and resources to develop or license replacement technology. For example, our programs may involve additional technologies or product candidates that may require the use of additional
proprietary rights held by third parties. Furthermore, other pharmaceutical companies and academic institutions may also have filed or are planning to file patent applications potentially relevant to our business. Our product candidates may also
require specific formulations or other technology to work effectively and efficiently. These formulations or technology may be covered by intellectual property rights held by others. From time to time, in order to avoid infringing these third-party
patents, we may be required to license technology from additional third parties to further develop or commercialize our product candidates. We may be unable to acquire or <FONT STYLE="white-space:nowrap">in-license</FONT> any relevant third-party
intellectual property rights, including any such intellectual property rights required to manufacture, use or sell our product candidates, that we identify as necessary or important to our business operations. We may fail to obtain any of these
licenses at a reasonable cost or on reasonable terms, if at all, and as a result we may be unable to develop or commercialize the affected product candidates, which would harm our business. We may need to cease use of the compositions or methods
covered by such third-party intellectual property rights, and may need to seek to develop alternative approaches that do not infringe on such intellectual property rights which may entail additional costs and development delays, even if we were able
to develop such alternatives, which may not be feasible. Even if we are able to obtain a license under such intellectual property rights, any such license may be <FONT STYLE="white-space:nowrap">non-exclusive,</FONT> which may allow our
competitors&#146; access to the same technologies licensed to us. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Additionally, we sometimes collaborate with academic
institutions to accelerate our preclinical research or development under written agreements with these institutions. Typically, these institutions provide us with an option to negotiate a license to any of the institution&#146;s rights in technology
resulting from the collaboration. Regardless of such option, we may be unable to negotiate a license within the specified timeframe or under terms that are acceptable to us. If we are unable to do so, the institution may offer the intellectual
property rights to other parties, potentially blocking our ability to pursue our program. If we are unable to successfully obtain rights to required third-party intellectual property or to maintain the existing intellectual property rights we have,
we may have to abandon development of such program and our business and financial condition could suffer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The licensing
and acquisition of third-party intellectual property rights is a competitive practice, and companies that may be more established, or have greater resources than we do, may also be pursuing strategies to
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">64 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
license or acquire third-party intellectual property rights that we may consider necessary or attractive in order to commercialize our product candidates. More established companies may have a
competitive advantage over us due to their larger size and cash resources or greater clinical development and commercialization capabilities. There can be no assurance that we will be able to successfully complete such negotiations and ultimately
acquire the rights to the intellectual property surrounding the additional product candidates that we may seek to acquire. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>We may
be dependent on intellectual property licensed or sublicensed to us from, or for which development was funded or otherwise assisted by, government agencies, such as the National Institutes of Health, for development of our technology and product
candidates. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Government agencies have provided and may in the future provide funding, facilities, personnel or
other assistance in connection with the development of the intellectual property rights owned by or licensed to us. Such government agencies may have retained rights in such intellectual property, including the right to grant or require us to grant
mandatory licenses or sublicenses to such intellectual property to third parties under certain specified circumstances, including if it is necessary to meet health and safety needs that we are not reasonably satisfying or if it is necessary to meet
requirements for public use specified by federal regulations, or to manufacture products in the United States. Any exercise of such rights, including with respect to any such required sublicense of these licenses could result in the loss of
significant rights and could harm our ability to commercialize or continue commercializing licensed products. For example, at least one of our in-licensed patent cases related to each of our ex vivo cell engineering and in vivo cell engineering
platforms has been funded at least in part by the U.S. government. As a result, these patent cases are subject to certain federal regulations pursuant to the Bayh-Dole Act of 1980 (Bayh-Dole Act). In particular, the federal government retains a
&#147;nonexclusive, nontransferable, irrevocable, paid-up license&#148; for its own benefit to inventions produced with its financial assistance. The Bayh-Dole Act also provides federal agencies with &#147;march-in rights.&#148; March-in rights
allow the government, in specified circumstances, to require the contractor or successors in title to the patent to grant a &#147;nonexclusive, partially exclusive, or exclusive license&#148; to a &#147;responsible applicant or applicants.&#148; If
the patent owner refuses to do so, the government may grant the license itself. Intellectual property discovered under government-funded programs are also subject to certain reporting requirements, compliance with which may require us or our
licensors to expend substantial resources and failure to comply may lead to loss of rights. Such intellectual property is also subject to a preference for U.S. industry, which may limit our ability to contract with foreign product manufacturers for
products covered by such intellectual property. Moreover, we sometimes collaborate with academic institutions to accelerate our preclinical research or development, and we cannot be sure that any co-developed intellectual property will be free from
government rights pursuant to the Bayh-Dole Act. If, in the future, we co-own or license in technology which is critical to our business that is developed in whole or in part with federal funds subject to the Bayh-Dole Act, our ability to enforce or
otherwise exploit patents covering such technology may be adversely affected. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>If we are unable to obtain and maintain sufficient
intellectual property protection for our platform technologies and product candidates, or if the scope of the intellectual property protection is not sufficiently broad, our competitors could develop and commercialize products similar or identical
to ours, and our ability to successfully commercialize our products may be adversely affected. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We anticipate that
we will file additional patent applications both in the United States and in other countries, as appropriate. However, we cannot predict: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if and when any patents will issue; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the degree and range of protection any issued patents will afford us against competitors, including whether
third parties will find ways to invalidate or otherwise circumvent our patents; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether others will apply for or obtain patents claiming aspects similar to those covered by our patents and
patent applications; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether we will need to initiate litigation or administrative proceedings to defend our patent rights, which
may be costly whether we win or lose; or </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">65 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether the patent applications that we own, or <FONT STYLE="white-space:nowrap">in-license</FONT> will result
in issued patents with claims that cover our product candidates or uses thereof in the United States or in other foreign countries. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our success depends in large part on our ability to obtain and maintain patent protection in the United States and other
countries with respect to our platform technologies and product candidates. We seek to protect our proprietary position by filing patent applications in the United States and abroad related to our novel discoveries and technologies that are
important to our business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Obtaining and enforcing patents is expensive and time-consuming, and we may not be able to
file and prosecute all necessary or desirable patent applications or maintain and/or enforce patents that may issue based on our patent applications, at a reasonable cost or in a timely manner, including as a result of the <FONT
STYLE="white-space:nowrap">COVID-19</FONT> pandemic impacting our or our licensors&#146; operations. It is also possible that we will fail to identify patentable aspects of our research and development results before it is too late to obtain patent
protection. Although we enter into <FONT STYLE="white-space:nowrap">non-disclosure</FONT> and confidentiality agreements with parties who have access to patentable aspects of our research and development output, such as our employees, corporate
collaborators, outside scientific collaborators, contract research organizations, contract manufacturers, consultants, advisors and other third parties, any of these parties may breach these agreements and disclose such results before a patent
application is filed, thereby jeopardizing our ability to seek patent protection. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Composition of matter patents for
biological and pharmaceutical products such as <I>in vivo</I> and <I>ex vivo</I> cell engineering product candidates often provide a strong form of intellectual property protection for those types of products, as such patents provide protection
without regard to any method of use. We cannot be certain, however, that the claims in our pending patent applications covering the composition of matter of our product candidates will be considered patentable by the USPTO, or by patent offices in
foreign countries, or that the claims in any of our issued patents will be considered valid and enforceable by courts in the United States or foreign countries. Method of use patents protect the use of a product for the specified method. This type
of patent does not prevent a competitor from making and marketing a product that is identical to our product for an indication that is outside the scope of the patented method. Moreover, even if competitors do not actively promote their product for
our targeted indications, physicians may prescribe these products <FONT STYLE="white-space:nowrap">&#147;off-label&#148;</FONT> for those uses that are covered by our method of use patents. Although <FONT STYLE="white-space:nowrap">off-label</FONT>
prescriptions may infringe or contribute to the infringement of method of use patents, the practice is common and such infringement is difficult to prevent or prosecute. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The strength of patents in the biotechnology and pharmaceutical field can be uncertain, and evaluating the scope of such
patents involves complex legal, factual and scientific analyses and has in recent years been the subject of much litigation, resulting in court decisions, including Supreme Court decisions, which have increased uncertainties as to the ability to
enforce patent rights in the future. The patent applications that we own or <FONT STYLE="white-space:nowrap">in-license</FONT> may fail to result in issued patents with claims that cover our product candidates or uses thereof in the United States or
in other foreign countries. Even if the patents do successfully issue, third parties may challenge the validity, enforceability, or scope thereof, which may result in such patents being narrowed, invalidated, or held unenforceable. In the event of
litigation or administrative proceedings, we cannot be certain that the claims in any of our issued patents will be considered valid by courts in the United States or foreign countries. Furthermore, even if they are unchallenged, our patents and
patent applications may not adequately protect our intellectual property or prevent others from designing their products to avoid being covered by our claims. If the breadth or strength of protection provided by the patent applications we hold with
respect to our product candidates is threatened, this could dissuade companies from collaborating with us to develop, and could threaten our ability to commercialize, our product candidates. In addition, the laws of foreign countries may not protect
our rights to the same extent as the laws of the United States, or vice versa. Further, if we encounter delays in our clinical trials, the period of time during which we could market our product candidates under patent protection would be reduced.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">66 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>We may not identify relevant third-party patents or may incorrectly interpret the
relevance, scope or expiration of a third-party patent, which might adversely affect our ability to develop and market our products. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We cannot guarantee that any of our patent searches or analyses, including the identification of relevant patents, the scope of
patent claims or the expiration of relevant patents, are complete or thorough, nor can we be certain that we have identified each and every third-party patent and pending application in the United States and abroad that is relevant to or necessary
for the commercialization of our product candidates in any jurisdiction. The scope of a patent claim is determined by an interpretation of the law, the written disclosure in a patent and the patent&#146;s prosecution history. Our interpretation of
the relevance or the scope of a patent or a pending application may be incorrect, which may negatively impact our ability to market our products. We may incorrectly determine that our products are not covered by a third-party patent or may
incorrectly predict whether a third-party&#146;s pending application will issue with claims of relevant scope. Our determination of the expiration date of any patent in the United States or abroad that we consider relevant may be incorrect, which
may negatively impact our ability to develop and market our product candidates. Our failure to identify and correctly interpret relevant patents may negatively impact our ability to develop and market our products. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">One aspect of the determination of patentability of our inventions depends on the scope and content of the &#147;prior
art,&#148; information that was or is deemed available to a person of skill in the relevant art prior to the priority date of the claimed invention. There may be prior art of which we are not aware that may affect the patentability of our patent
claims or, if issued, affect the validity or enforceability of a patent claim. Further, we may not be aware of all third-party intellectual property rights potentially relating to our product candidates or their intended uses, and as a result the
impact of such third-party intellectual property rights upon the patentability of our own patents and patent applications, as well as the impact of such third-party intellectual property upon our freedom to operate, is highly uncertain. Because
patent applications in the United States and most other countries are confidential for typically a period of 18 months after filing, or may not be published at all, we cannot be certain that we were the first to file any patent application related
to our product candidates. As a result, the issuance, scope, validity, enforceability and commercial value of our patent rights are highly uncertain. Furthermore, for U.S. applications in which all claims are entitled to a priority date before
March&nbsp;16, 2013, an interference proceeding can be provoked by a third party or instituted by the USPTO to determine who was the first to invent any of the subject matter covered by the patent claims of our applications. For U.S. applications
containing a claim not entitled to priority before March&nbsp;16, 2013, there is a greater level of uncertainty in the patent law in view of the passage of the America Invents Act, which brought into effect significant changes to the U.S. patent
laws, including new procedures for challenging pending patent applications and issued patents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our patents or pending
patent applications may be challenged in the courts or patent offices in the United States and abroad. For example, we may be subject to a third-party <FONT STYLE="white-space:nowrap">pre-issuance</FONT> submission of prior art to the USPTO or
become involved in post-grant review procedures, oppositions, derivations, reexaminations, or <I>inter partes</I> review proceedings, in the United States or elsewhere, challenging our patent rights or the patent rights of others. An adverse
determination in any such challenges may result in loss of exclusivity or in patent claims being narrowed, invalidated, or held unenforceable, in whole or in part, which could limit our ability to stop others from using or commercializing similar or
identical technology and products, or limit the duration of the patent protection of our technology and products. In addition, given the amount of time required for the development, testing and regulatory review of new product candidates, patents
protecting such candidates might expire before or shortly after such candidates are commercialized. Any failure to obtain or maintain patent protection with respect to our product candidates could have a material adverse effect on our business,
financial condition, results of operations and prospects. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">67 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Intellectual property rights do not necessarily address all potential threats to our
competitive advantage. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The degree of future protection afforded by our intellectual property rights is uncertain
because intellectual property rights have limitations and may not adequately protect our business or permit us to maintain our competitive advantage. For example: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">others may be able to make product candidates that are similar to ours but that are not covered by the claims
of the patents that we own or have exclusively licensed; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we or our licensors or future collaborators might not have been the first to make the inventions covered by
the issued patent or pending patent application that we own or have exclusively licensed; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we or our licensors or future collaborators might not have been the first to file patent applications covering
certain of our inventions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">others may independently develop similar or alternative technologies or duplicate any of our technologies
without infringing our intellectual property rights; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">it is possible that our pending patent applications will not lead to issued patents; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">issued patents that we own or have exclusively licensed may be held invalid or unenforceable, as a result of
legal challenges by our competitors; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our competitors might conduct research and development activities in countries where we do not have patent
rights and then use the information learned from such activities to develop competitive products for sale in our major commercial markets; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may not develop additional proprietary technologies that are patentable; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we cannot predict the scope of protection of any patent issuing based on our patent applications, including
whether the patent applications that we own or <FONT STYLE="white-space:nowrap">in-license</FONT> will result in issued patents with claims that cover our product candidates or uses thereof in the United States or in other foreign countries;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the claims of any patent issuing based on our patent applications may not provide protection against
competitors or any competitive advantages, or may be challenged by third parties; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if enforced, a court may not hold that our patents are valid, enforceable and infringed;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may need to initiate litigation or administrative proceedings to enforce and/or defend our patent rights
which will be costly whether we win or lose; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may choose not to file a patent in order to maintain certain trade secrets or <FONT
STYLE="white-space:nowrap">know-how,</FONT> and a third party may subsequently file a patent covering such intellectual property; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may fail to adequately protect and police our trademarks and trade secrets; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the patents of others may have an adverse effect on our business, including if others obtain patents claiming
subject matter similar to or improving that covered by our patents and patent applications. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Should any
of these events occur, they could significantly harm our business, results of operations and prospects. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Confidentiality agreements
with employees and third parties may not prevent unauthorized disclosure of trade secrets and other proprietary information. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition to the protection afforded by patents, we seek to rely on trade secret protection and confidentiality agreements to
protect proprietary <FONT STYLE="white-space:nowrap">know-how</FONT> that is not patentable or that we elect not to patent, processes for which patents are difficult to enforce, and any other elements of our product candidates, technology and
product discovery and development processes that involve proprietary <FONT STYLE="white-space:nowrap">know-how,</FONT> information, or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">68 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
technology that is not covered by patents. Any disclosure, either intentional or unintentional, by our employees, the employees of third parties with whom we share our facilities or third-party
consultants and vendors that we engage to perform research, clinical trials or manufacturing activities, or misappropriation by third parties (such as through a cybersecurity breach) of our trade secrets or proprietary information could enable
competitors to duplicate or surpass our technological achievements, thus eroding our competitive position in our market. Because we expect to rely on third parties in the development and manufacture of our product candidates, we must, at times,
share trade secrets with them. Our reliance on third parties requires us to share our trade secrets, which increases the possibility that a competitor will discover them or that our trade secrets will be misappropriated or disclosed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Trade secrets and confidential information, however, may be difficult to protect. We seek to protect our trade secrets, <FONT
STYLE="white-space:nowrap">know-how</FONT> and confidential information, including our proprietary processes, in part, by entering into confidentiality agreements with our employees, consultants, outside scientific advisors, contractors, and
collaborators. We require our employees to enter into written employment agreements containing provisions of confidentiality and obligations to assign to us any inventions generated in the course of their employment. With our consultants,
contractors, and outside scientific collaborators, these agreements typically include invention assignment obligations. We cannot guarantee that we have entered into such agreements with each party that may have or has had access to our trade
secrets or proprietary technology and processes. Although we use reasonable efforts to protect our trade secrets, our employees, consultants, outside scientific advisors, contractors, and collaborators might intentionally or inadvertently disclose
our trade secret information to competitors. In addition, competitors may otherwise gain access to our trade secrets or independently develop substantially equivalent information and techniques. Despite these efforts, any of these parties may breach
the agreements and disclose our proprietary information, including our trade secrets, and we may not be able to obtain adequate remedies for such breaches. Enforcing a claim that a party illegally disclosed or misappropriated a trade secret is
difficult, expensive and time-consuming, and the outcome is unpredictable. If any of our trade secrets were to be lawfully obtained or independently developed by a competitor or other third-party, we would have no right to prevent them from using
that technology or information to compete with us. Furthermore, the laws of some foreign countries do not protect proprietary rights to the same extent or in the same manner as the laws of the United States. As a result, we may encounter significant
problems in protecting and defending our intellectual property both in the United States and abroad. If we are unable to prevent unauthorized material disclosure of our intellectual property to third parties, or misappropriation of our intellectual
property by third parties, we will not be able to establish or maintain a competitive advantage in our market, which could materially adversely affect our business, operating results, and financial condition. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Third-party claims of intellectual property infringement against us or our collaborators may prevent or delay our product discovery and
development efforts. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our commercial success depends in part on our avoiding infringement of the patents and
proprietary rights of third parties. There is a substantial amount of litigation involving patents and other intellectual property rights in the biotechnology and pharmaceutical industries, as well as administrative proceedings for challenging
patents, including interference, derivation, <I>inter partes</I> review, post-grant review and reexamination proceedings before the USPTO or oppositions and other comparable proceedings in foreign jurisdictions. Furthermore, patent reform and
changes to patent laws add uncertainty to the possibility of challenge to our patents in the future. We cannot assure you that our product candidates and other proprietary technologies we may develop will not infringe existing or future patents
owned by third parties. Litigation or other legal proceedings relating to intellectual property claims, with or without merit, is unpredictable and generally expensive and time consuming and, even if resolved in our favor, is likely to divert
significant resources from our core business, including distracting our technical and management personnel from their normal responsibilities. Such litigation or proceedings could substantially increase our operating losses and reduce the resources
available for development activities or any future sales, marketing or distribution activities. We may not have sufficient financial or other resources to adequately conduct such litigation or proceedings. Some of our competitors may be able to
sustain the costs of such litigation or proceedings more effectively than we can because of their greater financial </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">69 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
resources and more mature and developed intellectual property portfolios. Uncertainties resulting from the initiation and continuation of patent litigation or other proceedings could have a
material adverse effect on our ability to compete in the marketplace. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Numerous U.S. and foreign issued patents and
pending patent applications owned by third parties exist in the fields in which we are developing our product candidates. We cannot provide any assurances that third-party patents do not exist which might be enforced against our current product
candidates or future products, resulting in either an injunction prohibiting our sales, or, with respect to our sales, an obligation on our part to pay royalties and/or other forms of compensation to third parties. As the biotechnology and
pharmaceutical industries expand and more patents are issued, the risk increases that our product candidates may give rise to claims of infringement of the patent rights of others. Third parties may assert that we infringe their patents or other
intellectual property, or that we are otherwise employing their proprietary technology without authorization, and may sue us. There may be third-party patents of which we are currently unaware with claims to compositions, formulations, methods of
manufacture, or methods of use or treatment that cover our product candidates. It is also possible that patents owned by third parties of which we are aware, but which we do not believe are relevant to our product candidates and other proprietary
technologies we may develop, could be found to be infringed by our product candidate. Because patent applications can take many years to issue, there may be currently pending patent applications that may later result in issued patents that our
product candidates may infringe. In addition, third parties, our competitors in both the United States and abroad, many of which have substantially greater resources and have made substantial investments in patent portfolios and competing
technologies, may obtain patents in the future that may prevent, limit or otherwise interfere with our ability to make, use and sell our product candidates, and may claim that use of our technologies or the manufacture, use, or sale of our product
candidates infringes upon these patents. If any such third-party patents were held by a court of competent jurisdiction to cover our technologies or product candidates, or if we are found to otherwise infringe a third-party&#146;s intellectual
property rights, the holders of any such patents may be able to block, including by court order, our ability to develop, manufacture or commercialize the applicable product candidate unless we obtain a license under the applicable patents or other
intellectual property, or until such patents expire or are finally determined to be held invalid or unenforceable. Such a license may not be available on commercially reasonable terms or at all. Even if we were able to obtain a license, it could be <FONT
STYLE="white-space:nowrap">non-exclusive,</FONT> thereby giving our competitors access to the same technologies licensed to us. If we are unable to obtain a necessary license to a third-party patent on commercially reasonable terms, our ability to
commercialize our product candidates may be impaired or delayed, which could in turn significantly harm our business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The
pharmaceutical and biotechnology industries have produced a considerable number of patents, and it may not always be clear to industry participants, including us, which patents cover various types of products or methods of use. The coverage of
patents is subject to interpretation by the courts, and the interpretation is not always uniform. If we were sued for patent infringement, we would need to demonstrate that our product candidates, products or methods either do not infringe the
patent claims of the relevant patent or that the patent claims are invalid or unenforceable, and we may not be able to do this. Proving invalidity may be difficult. For example, in the United States, proving invalidity in court requires a showing of
clear and convincing evidence to overcome the presumption of validity enjoyed by issued patents, and there is no assurance that a court of competent jurisdiction would invalidate the claims of any such U.S. patent. Even if we are successful in these
proceedings, we may incur substantial costs and the time and attention of our management and scientific personnel could be diverted in pursuing these proceedings, which could have a material adverse effect on our business and operations. In
addition, we may not have sufficient resources to bring these actions to a successful conclusion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Third parties asserting
their patent or other intellectual property rights against us may seek and obtain injunctive or other equitable relief, which could effectively block our ability to further develop and commercialize our product candidates or force us to cease some
of our business operations. Defense of these claims, regardless of their merit, would involve substantial litigation expense and would be a substantial diversion of management and other employee resources from our business, cause development delays,
and may </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">70 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
impact our reputation. In the event of a successful claim of infringement against us, we may have to pay substantial damages, including treble damages and attorneys&#146; fees for willful
infringement, obtain one or more licenses from third parties, pay royalties, or redesign our infringing products, which may be impossible on a cost-effective basis or require substantial time and monetary expenditure. In that event, we would be
unable to further develop and commercialize our product candidates, which could harm our business significantly. Claims that we have misappropriated the confidential information or trade secrets of third parties could have a similar negative impact
on our business. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Issued patents covering our product candidates could be found invalid or unenforceable if challenged in court or
before the USPTO or comparable foreign authority. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If we or one of our licensing partners initiate legal
proceedings against a third party to enforce a patent covering one of our product candidates, the defendant could counterclaim we infringe their patents or that the patent covering our product candidate is invalid or unenforceable, or both. In
patent litigation in the United States, defendant counterclaims alleging invalidity or unenforceability are commonplace, and there are numerous grounds upon which a third party can assert invalidity or unenforceability of a patent, including lack of
novelty, obviousness, <FONT STYLE="white-space:nowrap">non-enablement</FONT> or insufficient written description or that that someone connected with prosecution of the patent withheld relevant information from the USPTO or made a misleading
statement during prosecution. Third parties may also raise similar claims before administrative bodies in the United States or abroad, even outside the context of litigation. Such mechanisms include
<FONT STYLE="white-space:nowrap">re-examination,</FONT> <I>inter partes</I> review, post-grant review, and equivalent proceedings in foreign jurisdictions, such as opposition or derivation proceedings. Such proceedings could result in revocation or
amendment to our patents in such a way that they no longer cover and protect our product candidates. The outcome following legal assertions of invalidity and unenforceability is unpredictable. In any patent infringement proceeding, there is a risk
that a court will decide that a patent of ours is invalid or unenforceable, in whole or in part, and that we do not have the right to stop the other party from using the invention at issue. There is also a risk that, even if the validity of such
patents is upheld, the court will construe the patent&#146;s claims narrowly or decide that we do not have the right to stop the other party from using the invention at issue on the grounds that our patent claims do not cover the invention, or
decide that the other party&#146;s use of our patented technology falls under the safe harbor to patent infringement under 35 U.S.C. &#167;271(e)(1). With respect to the validity of our patents, for example, we cannot be certain that there is no
invalidating prior art of which we, our patent counsel, and the patent examiner were unaware during prosecution. If a defendant were to prevail on a legal assertion of invalidity and/or unenforceability, we would lose at least part, and perhaps all,
of the patent protection on our product candidates and such an outcome may limit our ability to assert our patents against those parties or other competitors and may curtail or preclude our ability to exclude third parties from making and selling
similar or competitive products. Such a loss of patent protection could have a material adverse impact on our business. Similarly, if we assert trademark infringement claims, a court may determine that the marks we have asserted are invalid or
unenforceable, or that the party against whom we have asserted trademark infringement has superior rights to the marks in question. In this case, we could ultimately be forced to cease use of such trademarks. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Obtaining and maintaining our patent protection depends on compliance with various procedural, document submission, fee payment, and
other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for <FONT STYLE="white-space:nowrap">non-compliance</FONT> with these requirements. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Periodic maintenance fees on any issued patent are due to be paid to the USPTO and foreign patent agencies in several stages
over the lifetime of the patent. The USPTO and various foreign governmental patent agencies require compliance with a number of procedural, documentary, fee payment, and other similar provisions during the patent application process. Although an
inadvertent lapse, including due to the effect of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic on us or our patent maintenance vendors, can in many cases be cured by payment of a late fee or by other means in accordance with the
applicable rules, there are situations in which noncompliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. Noncompliance events that
could result in abandonment or lapse of a patent or patent </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">71 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
application include failure to respond to official actions within prescribed time limits, <FONT STYLE="white-space:nowrap">non-payment</FONT> of fees, and failure to properly legalize and submit
formal documents. In any such event, our competitors might be able to enter the market, which would have a material adverse effect on our business. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>The lives of our patents may not be sufficient to effectively protect our products and business. </I></B></P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Patents have a limited lifespan. In the United States, if all maintenance fees are paid timely, the natural expiration of a
patent is generally 20 years after its first effective nonprovisional filing date. Although various extensions may be available, the life of a patent, and the protection it affords, is limited. Given the amount of time required for the development,
testing and regulatory review of new product candidates, patents protecting such candidates might expire before or shortly after such product candidates are commercialized. Even if patents covering our product candidates are obtained, once the
patent life has expired for a product, we may be open to competition from biosimilar or generic medications. As a result, our patent portfolio may not provide us with sufficient rights to exclude others from commercializing product candidates
similar or identical to ours. Our patents issued as of October&nbsp;30, 2020 will expire on dates ranging from 2023 to 2037, subject to any patent extensions that may be available for such patents. If patents are issued on our patent applications
pending as of October&nbsp;30, 2020, the resulting patents are projected to expire on dates ranging from 2023 to 2041. In addition, although upon issuance in the United States a patent&#146;s life can be increased based on certain delays caused by
the USPTO, this increase can be reduced or eliminated based on certain delays caused by the patent applicant during patent prosecution. A patent term extension based on regulatory delay may be available in the United States. However, only a single
patent can be extended for each marketing approval, and any patent can be extended only once, for a single product. Moreover, the scope of protection during the period of the patent term extension does not extend to the full scope of the claim, but
instead only to the scope of the product as approved. Laws governing analogous patent term extensions in foreign jurisdictions vary widely, as do laws governing the ability to obtain multiple patents from a single patent family. Additionally, we may
not receive an extension if we fail to exercise due diligence during the testing phase or regulatory review process, apply within applicable deadlines, fail to apply prior to expiration of relevant patents or otherwise fail to satisfy applicable
requirements. If we are unable to obtain patent term extension or restoration, or the term of any such extension is less than we request, the period during which we will have the right to exclusively market our product will be shortened and our
competitors may obtain approval of competing products following our patent expiration and may take advantage of our investment in development and clinical trials by referencing our clinical and preclinical data to launch their product earlier than
might otherwise be the case, and our revenue could be reduced, possibly materially. If we do not have sufficient patent life to protect our products, our business and results of operations will be adversely affected. </P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>We may be subject to claims challenging the inventorship or ownership of our patents and other intellectual property. </I></B></P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We may be subject to claims that former employees, collaborators, or other third parties have an interest in our patents or
other intellectual property as an inventor or <FONT STYLE="white-space:nowrap">co-inventor.</FONT> The failure to name the proper inventors on a patent application can result in the patents issuing thereon being unenforceable. Inventorship disputes
may arise from conflicting views regarding the contributions of different individuals named as inventors, the effects of foreign laws where foreign nationals are involved in the development of the subject matter of the patent, conflicting
obligations of third parties involved in developing our product candidates or as a result of questions regarding <FONT STYLE="white-space:nowrap">co-ownership</FONT> of potential joint inventions. For example, we may have inventorship disputes arise
from conflicting obligations of consultants or others who are involved in developing our product candidates. Alternatively, or additionally, we may enter into agreements to clarify the scope of our rights in such intellectual property. Litigation
may be necessary to defend against these and other claims challenging inventorship. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights, such as exclusive ownership of,
or right to use, valuable intellectual property. Such an outcome could have a material adverse effect on our business. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to
management and other employees. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">72 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We or our licensors may have relied on third-party consultants or
collaborators or on funds from third parties, such as the U.S. government, such that we or our licensors are not the sole and exclusive owners of the patents we <FONT STYLE="white-space:nowrap">in-licensed.</FONT> If other third parties have
ownership rights or other rights to our patents, including <FONT STYLE="white-space:nowrap">in-licensed</FONT> patents, they may be able to license such patents to our competitors, and our competitors could market competing products and technology.
This could have a material adverse effect on our competitive position, business, financial conditions, results of operations, and prospects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition, while it is our policy to require our employees and contractors who may be involved in the conception or
development of intellectual property to execute agreements assigning such intellectual property to us, we may be unsuccessful in executing such an agreement with each party who, in fact, conceives or develops intellectual property that we regard as
our own. The assignment of intellectual property rights may not be self-executing, or the assignment agreements may be breached, and we may be forced to bring claims against third parties, or defend claims that they may bring against us, to
determine the ownership of what we regard as our intellectual property. Such claims could have a material adverse effect on our business, financial condition, results of operations, and prospects. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>If our trademarks and trade names are not adequately protected, then we may not be able to build name recognition in our markets of
interest and our business may be adversely affected. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our current or future trademarks or trade names may be
challenged, infringed, circumvented or declared generic or descriptive determined to be infringing on other marks. We may not be able to protect our rights to these trademarks and trade names or may be forced to stop using these names, which we need
for name recognition by potential partners or customers in our markets of interest. During trademark registration proceedings, we may receive rejections of our applications by the USPTO or in other foreign jurisdictions. Although we would be given
an opportunity to respond to those rejections, we may be unable to overcome such rejections. In addition, in the USPTO and in comparable agencies in many foreign jurisdictions, third parties are given an opportunity to oppose pending trademark
applications and to seek to cancel registered trademarks. Opposition or cancellation proceedings may be filed against our trademarks, and our trademarks may not survive such proceedings. If we are unable to establish name recognition based on our
trademarks and trade names, we may not be able to compete effectively and our business may be adversely affected. We may license our trademarks and trade names to third parties, such as distributors. Though these license agreements may provide
guidelines for how our trademarks and trade names may be used, a breach of these agreements or misuse of our trademarks and tradenames by our licensees may jeopardize our rights in or diminish the goodwill associated with our trademarks and trade
names. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Moreover, any name we have proposed to use with our product candidate in the United States must be approved by the
FDA, regardless of whether we have registered it, or applied to register it, as a trademark. Similar requirements exist in Europe. The FDA typically conducts a review of proposed product names, including an evaluation of potential for confusion with
other product names. If the FDA (or an equivalent administrative body in a foreign jurisdiction) objects to any of our proposed proprietary product names, it may be required to expend significant additional resources in an effort to identify a
suitable substitute name that would qualify under applicable trademark laws, not infringe the existing rights of third parties and be acceptable to the FDA. Furthermore, in many countries, owning and maintaining a trademark registration may not
provide an adequate defense against a subsequent infringement claim asserted by the owner of a senior trademark. At times, competitors or other third parties may adopt trade names or trademarks similar to ours, thereby impeding our ability to build
brand identity and possibly leading to market confusion. In addition, there could be potential trade name or trademark infringement claims brought by owners of other registered trademarks or trademarks that incorporate variations of our registered
or unregistered trademarks or trade names. If we assert trademark infringement claims, a court may determine that the marks we have asserted are invalid or unenforceable, or that the party against whom we have asserted trademark infringement has
superior rights to the marks in question. In this case, we could ultimately be forced to cease use of such trademarks. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">73 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Our internal computer systems, or those used by our third-party research institution
collaborators, CROs, CDMOs, or other contractors or consultants, may fail or suffer security breaches. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are
increasingly dependent upon information technology systems, infrastructure and data to operate our business. In the ordinary course of business, we collect, store and transmit confidential information (including but not limited to intellectual
property, proprietary business information and personal information). It is critical that we do so in a secure manner to maintain the confidentiality and integrity of such confidential information. We also have outsourced elements of our operations
to third parties, and as a result we manage a number of third-party contractors who have access to our confidential information, including third party vendors of IT and data security systems and services. While we generally have agreements requiring
such vendors to use industry standard practices for data security, we have no operational control over them. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Despite the
implementation of security measures (including edge technology designed to identify and protect our network from infiltration by third party systems), our internal computer systems and those of our future CROs and CDMOs, and other contractors and
consultants as well as third party vendors of IT and data security systems and services, are vulnerable to damage and interruptions from security breaches, computer viruses, fraud and similar incidents involving the loss or unauthorized access of
confidential information. One such third party vendor is SolarWinds Corporation (SolarWinds), a provider of IT monitoring and management products and services, including its Orion Platform products, which are used by over 30,000 businesses including
ours. SolarWinds experienced a cyberattack that appears likely to be the result of a supply chain attack by an outside nation state. SolarWinds has stated that, as a result of the attack, software updates related to its Orion Platform products
delivered between March and June 2020 included vulnerabilities, and that its investigation is ongoing. Since being notified of the attack, we have taken steps to mitigate the vulnerabilities identified within the Orion Platform products. Although
investigations remain ongoing regarding the extent to which our confidential information was accessed, lost or stolen as a result of this cyberattack on SolarWinds, any such access, loss or theft could have a materially adverse effect on our
business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">While we have not to our knowledge experienced any material system failure, accident or security breach to
date, because techniques used to obtain unauthorized access or to sabotage systems are constantly evolving, change frequently, and generally are not recognized until they are launched against a target, we cannot be sure that our continued data
protection efforts and investment in information technology will prevent future significant breakdowns, data leakages, breaches in our systems or the systems of our third party contractors and collaborators, or other cyber incidents that could have
a material adverse effect upon our reputation, business, operations or financial condition. If such an event were to occur and cause interruptions in our operations, it could result in a material disruption of our programs and the development of our
product candidates could be delayed. For example, the loss of or inability to access clinical trial data for our product candidates could result in delays in further development and commercialization of our product candidates and in our regulatory
and marketing approval efforts and significantly increase our costs to recover or reproduce the data. Furthermore, significant disruptions or security breaches of our internal information technology systems or our third party contractors and
collaborators&#146; information technology systems could result in the loss, misappropriation, and/or unauthorized access, use, or disclosure of, or the prevention of access to, our confidential information (including trade secrets or other
intellectual property, proprietary business information, and personal information), which could also result in financial, legal, business, and reputational harm to us. Any such event that leads to unauthorized access, use, or disclosure of personal
information, including personal information regarding our clinical trial subjects or employees, could delay further development and commercialization of our product candidates, harm our reputation directly, compel us to comply with federal and/or
state breach notification laws and foreign law equivalents, subject us to mandatory corrective action, and otherwise subject us to liability under laws and regulations that protect the privacy and security of personal information, which could result
in significant legal and financial exposure and reputational damages that could potentially have an adverse effect on our business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have and will enter into collaboration, license, contract research and/or manufacturing relationships with contract
organizations that operate in certain countries that are at heightened risk of theft of technology, data and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">74 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
intellectual property through direct intrusion by private parties or foreign actors, including those affiliated with or controlled by state actors. Accordingly, our efforts to protect and enforce
our intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license, and we may be at heightened risk of losing our proprietary intellectual
property rights around the world, including outside of such countries, to the extent such theft or intrusion destroy the proprietary nature of our intellectual property. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Ownership of Our Common Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Our principal stockholders and management own a significant percentage of our stock and will be able to exert significant control over
matters subject to stockholder approval. </I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Prior to this offering, as of December 31, 2020, our executive
officers, directors, holders of 5% or more of our capital stock and their respective affiliates owned approximately 42.2% of our outstanding voting stock and, upon the closing of this offering, that same group will own approximately 38.6% of our
outstanding voting stock (assuming no exercise of the underwriters&#146; option to purchase additional shares and without giving effect to any purchases that certain of these holders may make through our directed share program or otherwise in this
offering). Therefore, even after this offering these stockholders will have the ability to influence us through this ownership position. These stockholders may be able to determine all matters requiring stockholder approval. For example, these
stockholders may be able to control elections of directors, amendments of our organizational documents, or approval of any merger, sale of assets, or other major corporate transaction. In addition, certain of our principal stockholders, including
ARCH Venture Partners and Flagship Pioneering, have designated certain of our directors for election to the Board. This may prevent or discourage unsolicited acquisition proposals or offers for our common stock that you may feel are in your best
interest as one of our stockholders. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Future sales of our common stock in the public market could cause our common stock price
to fall. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our common stock price could decline as a result of sales of a large number of shares of common stock
after this offering or the perception that these sales could occur. These sales, or the possibility that these sales may occur, might also make it more difficult for us to sell equity securities in the future at a time and price that we deem
appropriate. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Upon the completion of this offering, 175,341,776 shares of common stock will be outstanding (or
177,564,776 shares if the underwriters exercise their over-allotment option to purchase additional shares from us in full), based on the number of shares outstanding as of September&nbsp;30, 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Substantially all shares of common stock expected to be sold in this offering (excluding any shares sold to our directors or
officers in the directed share program) will be freely tradable without restriction or further registration under the Securities Act unless held by our &#147;affiliates&#148; as defined in Rule 144 under the Securities Act. The resale of the
remaining 160,314,776 shares, or 91.4% of our outstanding shares of common stock following this offering, is currently prohibited or otherwise restricted as a result of securities law provisions, market standoff agreements entered into by certain of
our stockholders with us or <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements entered into by our stockholders with the underwriters in connection with this offering. However, subject to applicable securities law restrictions, these shares
will be able to be sold in the public market beginning 181 days after the date of this prospectus. Shares issued upon the exercise of stock options outstanding under our equity incentive plans or pursuant to future awards granted under those plans
will become available for sale in the public market to the extent permitted by the provisions of applicable vesting schedules, market <FONT STYLE="white-space:nowrap">stand-off</FONT> agreements and/or <FONT STYLE="white-space:nowrap">lock-up</FONT>
agreements, as well as Rules 144 and 701 under the Securities Act. For more information, see the section titled &#147;Shares Eligible for Future Sale.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Upon the completion of this offering, the holders of approximately 134.1 million shares, or 76.5% of our outstanding shares
following this offering, of our common stock will have rights, subject to some conditions, to require us to file registration statements covering the sale of their shares or to include their shares in registration statements that we may file for
ourselves or our other stockholders. We also intend to register the offer and sale </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">75 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
of all shares of common stock that we may issue under our equity compensation plans. Once we register the offer and sale of shares for the holders of registration rights and shares that may be
issued under our equity incentive plans, these shares will be able to be sold in the public market upon issuance, subject to the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements described under &#147;Underwriting.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition, in the future, we may issue additional shares of common stock, or other equity or debt securities convertible
into common stock, in connection with a financing, acquisition, employee arrangement, or otherwise. Any such issuance could result in substantial dilution to our existing stockholders and could cause the price of our common stock to decline. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>There has been no prior public market for our common stock, and an active trading market may not develop or be sustained. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">There has been no public market for our common stock prior to this offering. The IPO price for our common stock was determined
through negotiations among the underwriters and us and may vary from the market price of our common stock following this offering. An active or liquid market in our common stock may not develop upon closing of this offering or, if it does develop,
it may not be sustainable. The lack of an active market may impair the value of your shares, your ability to sell your shares at the time you wish to sell them and the prices that you may obtain for your shares. An inactive market may also impair
our ability to raise capital by selling our common stock and our ability to acquire other companies, products, or technologies by using our common stock as consideration. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>If you purchase shares of our common stock in our initial public offering, you will experience substantial and immediate dilution.
</I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The assumed initial public offering price of $21.50 per share, which is the midpoint of the price range set
forth on the cover page of this prospectus, is substantially higher than the net tangible book value per share of our outstanding common stock immediately following the completion of this offering. If you purchase shares of common stock in this
offering, you will experience substantial and immediate dilution in the pro forma net tangible book value per share of $16.72 as of September 30, 2020. That is because the price that you pay will be substantially greater than the pro forma net
tangible book value per share of the common stock that you acquire. This dilution is due in large part to the fact that our earlier investors paid substantially less than the assumed initial public offering price when they purchased their shares of
our capital stock. You will experience additional dilution when those holding stock options exercise their right to purchase common stock under our equity incentive plans or when we otherwise issue additional shares of common stock. For additional
details see the section titled &#147;Dilution.&#148; </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>We do not currently intend to pay dividends on our common stock and,
consequently, our stockholders&#146; ability to achieve a return on their investment will depend on appreciation of the value of our common stock. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have never declared or paid cash dividends on our common stock. We currently intend to retain all available funds and any
future earnings to support operations and to finance the growth and development of our business. We do not intend to declare or pay any cash dividends on our capital stock in the foreseeable future. As a result, any investment return on our common
stock will depend upon increases in the value for our common stock, which is not certain. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Participation in this offering by our
existing stockholders and their affiliated entities may reduce the public float for our common stock. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">To the
extent certain of our existing stockholders and their affiliated entities participate in this offering, such purchases would reduce the <FONT STYLE="white-space:nowrap">non-affiliate</FONT> public float of our shares, meaning the number of shares of
our common stock that are not held by officers, directors and controlling stockholders. A reduction in the public float could </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">76 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
reduce the number of shares that are available to be traded at any given time, thereby adversely impacting the liquidity of our common stock and depressing the price at which you may be able to
sell shares of common stock purchased in this offering. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Provisions in our amended and restated certificate of incorporation and our
amended and restated bylaws and Delaware law might discourage, delay or prevent a change in control of our company or changes in our management and, therefore, depress the market price of our common stock. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our amended and restated certificate of incorporation and amended and restated bylaws, each to be in effect immediately prior
to the completion of this offering, will contain provisions that could depress the market price of our common stock by acting to discourage, delay, or prevent a change in control of our company or changes in our management that the stockholders of
our company may deem advantageous. These provisions, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establish a staggered Board divided into three classes serving staggered three-year terms, such that not all
members of the Board will be elected at one time; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">authorize our Board to issue new series of preferred stock without stockholder approval and create, subject to
applicable law, a series of preferred stock with preferential rights to dividends or our assets upon liquidation, or with superior voting rights to our existing common stock; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">eliminate the ability of our stockholders to call special meetings of stockholders; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">eliminate the ability of our stockholders to fill vacancies on our Board; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establish advance notice requirements for nominations for election to our Board or for proposing matters that
can be acted upon by stockholders at our annual stockholder meetings; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">permit our Board to establish the number of directors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">provide that our Board is expressly authorized to make, alter or repeal our amended bylaws;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">provide that stockholders can remove directors only for cause and only upon the approval of not less than 66
2/3%&nbsp;of all outstanding shares of our voting stock; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">require the approval of not less than 66 2/3%&nbsp;of all outstanding shares of our voting stock to amend our
bylaws and specific provisions of our certificate of incorporation; and </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the jurisdictions in which certain stockholder litigation may be brought.</P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As a Delaware corporation, we will be subject to the anti-takeover provisions of Section&nbsp;203 of the Delaware General
Corporation Law, which prohibits a Delaware corporation from engaging in a business combination specified in the statute with an interested stockholder (as defined in the statute) for a period of three years after the date of the transaction in
which the person first becomes an interested stockholder, unless the business combination is approved in advance by a majority of the independent directors or by the holders of at <FONT STYLE="white-space:nowrap">least&nbsp;two-thirds&nbsp;of</FONT>
the outstanding disinterested shares. The application of Section&nbsp;203 of the Delaware General Corporation Law could also have the effect of delaying or preventing a change of control of our company. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Our current certificate of incorporation provides, and our amended and restated certificate of incorporation will provide that the Court
of Chancery of the State of Delaware will be the exclusive forum for substantially all disputes between us and our stockholders, which could limit our stockholders&#146; ability to obtain a favorable judicial forum for disputes with us or our
directors, officers or employees. </I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our amended and restated certificate of incorporation to be in effect upon
the completion of this offering will provide that, unless we consent in writing to the selection of an alternative forum, the sole and exclusive forum, to the fullest extent permitted by law, for (i)&nbsp;any derivative action or proceeding brought
on our behalf, (ii)&nbsp;any action asserting a breach of a fiduciary duty owed by any director, officer or other employee to us or our </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">77 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
stockholders, (iii)&nbsp;any action asserting a claim against us or any director, officer, or other employee arising pursuant to the Delaware General Corporation Law, (iv)&nbsp;any action to
interpret, apply, enforce, or determine the validity of our second amended and restated certificate of incorporation or amended and restated bylaws, or (v)&nbsp;any other action asserting a claim that is governed by the internal affairs doctrine,
shall be the Court of Chancery of the State of Delaware (or another state court or the federal court located within the State of Delaware if the Court of Chancery does not have or declines to accept jurisdiction), in all cases subject to the
court&#146;s having jurisdiction over indispensable parties named as defendants. In addition, our amended and restated certificate of incorporation will provide that the federal district courts of the United States will be the exclusive forum for
resolving any complaint asserting a cause of action arising under the Securities Act but that the forum selection provision will not apply to claims brought to enforce a duty or liability created by the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Although we believe these provisions benefit us by providing increased consistency in the application of Delaware law for the
specified types of actions and proceedings, the provisions may have the effect of discouraging lawsuits against us or our directors and officers. Alternatively, if a court were to find the choice of forum provision contained in our amended and
restated certificate of incorporation to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could harm our business, financial condition, and operating
results. For example, under the Securities Act, federal courts have concurrent jurisdiction over all suits brought to enforce any duty or liability created by the Securities Act, and investors cannot waive compliance with the federal securities laws
and the rules and regulations thereunder. Any person or entity purchasing or otherwise acquiring any interest in our shares of capital stock shall be deemed to have notice of and consented to this exclusive forum provision, but will not be deemed to
have waived our compliance with the federal securities laws and the rules and regulations thereunder. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Our ability to use our net
operating loss carryforwards and certain other tax attributes may be limited. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Under the Tax Cuts and Jobs Act of
2017, as modified by the Coronavirus Aid, Relief, and Economic Stability Act, or CARES Act, our federal net operating losses, or NOLs, generated in tax years beginning after December 31, 2017, may be carried forward indefinitely, but the
deductibility of such federal NOLs in tax years beginning after December 31, 2020, is limited to 80% of taxable income. It is uncertain if and to what extent various states will conform to the Tax Cuts and Jobs Act of 2017, or the CARES Act. In
addition. under Sections 382 and 383 of the Internal Revenue Code of 1986, as amended, if a corporation undergoes an &#147;ownership change,&#148; generally defined as a greater than 50 percentage point change (by value) in its equity ownership by
certain stockholders over a three-year period, the corporation&#146;s ability to use <FONT STYLE="white-space:nowrap">its&nbsp;pre-change&nbsp;net</FONT> operating loss carryforwards, or NOLs, and
<FONT STYLE="white-space:nowrap">other&nbsp;pre-change&nbsp;tax</FONT> attributes (such as research and development tax credits) to offset its post-change income or taxes may be limited. We may have experienced ownership changes in the past and may
experience ownership changes as a result of this offering and/or subsequent shifts in our stock ownership (some of which are outside our control). As a result, our ability to use <FONT STYLE="white-space:nowrap">our&nbsp;pre-change&nbsp;NOLs</FONT>
and tax credits to offset post-change taxable income, if any, could be subject to limitations. Similar provisions of state tax law may also apply. In addition, at the state level, there may be periods during which the use of NOLs is suspended or
otherwise limited, which could accelerate or permanently increase state taxes owed. For example, California recently imposed limits on the usability of California state NOLs and tax credits to offset California taxable income in tax years beginning
after 2019 and before 2023. As a result, even if we attain profitability, we may be unable to use a material portion of our NOLs and tax credits. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General Risk Factors </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Raising
additional capital may cause dilution to our stockholders, restrict our operations, or require us to relinquish rights to our technologies or product candidates. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Until such time, if ever, as we can generate substantial product revenue, we expect to finance our operations with our existing
cash, cash equivalents, and marketable securities, the net proceeds from this offering, any future </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">78 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
equity or debt financings, and upfront, milestone, and royalties payments, if any, received under any future licenses or collaborations. If we raise additional capital through the sale of equity
or convertible debt securities, your ownership interest will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect your rights as a holder of our common stock. In addition, the possibility
of such issuance may cause the market price of our common stock to decline. Debt financing, if available, may result in increased fixed payment obligations and involve agreements that include covenants limiting or restricting our ability to take
specific actions, such as incurring additional debt, making capital expenditures, declaring dividends, or acquiring, selling, or licensing intellectual property rights or assets, which could adversely impact our ability to conduct our business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If we raise additional funds through collaborations, strategic alliances or marketing, distribution, or licensing arrangements
with third parties, we may have to relinquish valuable rights to our intellectual property, technologies, future revenue streams, or product candidates or grant licenses on terms that may not be favorable to us. We could also be required to seek
funds through arrangements with collaborators or others at an earlier stage than otherwise would be desirable. Any of these occurrences may have a material adverse effect on our business, operating results, and prospects. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>We or the third parties upon whom we depend may be adversely affected by earthquakes or other natural disasters, and our business
continuity and disaster recovery plans may not adequately protect us from a serious disaster. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our corporate
headquarters and other facilities are located in areas that have experienced significant natural disasters, including the San Francisco Bay Area and Seattle, Washington, which has experienced severe effects from wildfires and, in the case of San
Francisco, severe earthquakes. We do not carry earthquake insurance. Earthquakes, wildfires or other natural disasters could severely disrupt our operations, and could materially and adversely affect our business, financial condition, results of
operations and prospects. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If a natural disaster, power outage or other event occurred that prevented us from using all or
a significant portion of our headquarters, that damaged critical infrastructure or that otherwise disrupted operations, it may be difficult or, in certain cases, impossible, for us to continue our business for a substantial period of time. The
disaster recovery and business continuity plans we have in place currently are limited and are unlikely to prove adequate in the event of a serious disaster or similar event. We may incur substantial expenses as a result of the limited nature of our
disaster recovery and business continuity plans, which, particularly when taken together with our lack of earthquake insurance, could have a material adverse effect on our business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Furthermore, integral parties in our supply chain are similarly vulnerable to natural disasters or other sudden, unforeseen
and severe adverse events. If such an event were to affect our supply chain, it could have a material adverse effect on our business. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>We are subject to U.S. and certain foreign export and import controls, sanctions, embargoes, anti-corruption laws, and anti-money
laundering laws and regulations. Compliance with these legal standards could impair our ability to compete in domestic and international markets. We can face criminal liability and other serious consequences for violations, which can harm our
business. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are subject to export control and import laws and regulations, including the U.S. Export
Administration Regulations, U.S. Customs regulations, various economic and trade sanctions regulations administered by the U.S. Treasury Department&#146;s Office of Foreign Assets Controls, the U.S. Foreign Corrupt Practices Act of 1977, as amended
(FCPA), the U.S. domestic bribery statute contained in 18 U.S.C. &#167; 201, the U.S. Travel Act, the USA PATRIOT Act, and other state and national anti-bribery and anti-money laundering laws in the countries in which we conduct activities.
Anti-corruption laws are interpreted broadly and prohibit companies and their employees, agents, contractors, and other collaborators from authorizing, promising, offering, or providing, directly or indirectly, improper payments or anything else of
value to recipients in the public or private sector. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">79 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
We may engage third parties to sell our products outside the United States, to conduct clinical trials, and/or to obtain necessary permits, licenses, patent registrations, and other regulatory
approvals. We have direct or indirect interactions with officials and employees of government agencies or government-affiliated hospitals, universities, and other organizations. We can be held liable for the corrupt or other illegal activities of
our employees, agents, contractors, and other collaborators, even if we do not explicitly authorize or have actual knowledge of such activities. Any violations of the laws and regulations described above may result in substantial civil and criminal
fines and penalties, imprisonment, the loss of export or import privileges, debarment, tax reassessments, breach of contract and fraud litigation, reputational harm, and other consequences. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>The withdrawal of the United Kingdom from the European Union, commonly referred to as &#147;Brexit,&#148; may adversely impact our
ability to obtain regulatory approvals of our product candidates in the European Union, result in restrictions or imposition of taxes and duties for importing our product candidates into the European Union, and may require us to incur additional
expenses in order to develop, manufacture and commercialize our product candidates in the European Union. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Following the result of a referendum in 2016, the United Kingdom left the European Union on January&nbsp;31, 2020, commonly
referred to as &#147;Brexit.&#148; Pursuant to the formal withdrawal arrangements agreed between the United Kingdom and the European Union, the United Kingdom will be subject to a transition period until December&nbsp;31, 2020 (the Transition
Period), during which EU rules will continue to apply. Negotiations between the United Kingdom and the European Union are expected to continue in relation to the customs and trading relationship between the United Kingdom and the European Union
following the expiry of the Transition Period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Since a significant proportion of the regulatory framework in the United
Kingdom applicable to our business and our product candidates is derived from EU directives and regulations, Brexit, following the Transition Period, could materially impact the regulatory regime with respect to the development, manufacture,
importation, approval and commercialization of our product candidates in the United Kingdom or the European Union. For example, as a result of the uncertainty surrounding Brexit, the EMA relocated to Amsterdam from London. Following the Transition
Period, the United Kingdom will no longer be covered by the centralized procedures for obtaining <FONT STYLE="white-space:nowrap">EU-wide</FONT> marketing authorization from the EMA and, unless a specific agreement is entered into, a separate
process for authorization of drug products, including our product candidates, will be required in the United Kingdom, the potential process for which is currently unclear. Any delay in obtaining, or an inability to obtain, any marketing approvals,
as a result of Brexit or otherwise, would prevent us from commercializing our product candidates in the United Kingdom or the European Union and restrict our ability to generate revenue and achieve and sustain profitability. In addition, we may be
required to pay taxes or duties or be subjected to other hurdles in connection with the importation of our product candidates into the European Union, or we may incur expenses in establishing a manufacturing facility in the European Union in order
to circumvent such hurdles. If any of these outcomes occur, we may be forced to restrict or delay efforts to seek regulatory approval in the United Kingdom or the European Union for our product candidates, or incur significant additional expenses to
operate our business, which could significantly and materially harm or delay our ability to generate revenues or achieve profitability of our business. Any further changes in international trade, tariff and import/export regulations as a result of
Brexit or otherwise may impose unexpected duty costs or other <FONT STYLE="white-space:nowrap">non-tariff</FONT> barriers on us. These developments, or the perception that any of them could occur, may significantly reduce global trade and, in
particular, trade between the impacted nations and the United Kingdom. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">From the beginning of 2021 (when the transitional
period following the United&nbsp;Kingdom&#146;s withdrawal from the European Union expires), we have to comply with the GDPR as well as the UK GDPR. Each regime has the ability to fine us up to the greater of &#128;20&nbsp;million
(&pound;17.5&nbsp;million) or 4% of global turnover for non-compliance. The relationship between the UK and the EU in relation to transfers of personal data from the EU to the UK is not fully settled by the Brexit Trade and Cooperation
Agreement&nbsp;(TCA). Instead, the TCA establishes a four- to six-month grace period during which transfers of personal data from the EU to the UK can continue without additional safeguards, provided that the UK maintains its pre-TCA data protection
laws. During this time, the European Commission may adopt a UK adequacy decision which organizations can then rely on for EU to UK </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">80 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
personal data transfers but, if no UK adequacy decision is adopted, the UK will be considered a third country at the end of the grace period and we will be required to implement additional
safeguards for personal data transfers&#151;some of which are subject currently being scrutinized or challenged&#151;which could lead to additional costs and increase our overall risk exposure. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Even if approved, our products may not gain market acceptance, in which case we may not be able to generate product revenues, which will
materially adversely affect our business, financial condition, and results of operations. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Even if the FDA or any
comparable foreign regulatory authority approves the marketing of any product candidates that we develop, physicians, healthcare providers, patients, or the medical community may not accept or use them. Additionally, the product candidates that we
are developing are based on our proprietary platforms, which are new technologies. If these products do not achieve an adequate level of acceptance, we may not generate significant product revenues or any profits from operations. The degree of
market acceptance of any of our product candidates will depend on a variety of factors, including:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the timing of market introduction; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the terms of any approvals and the countries in which approvals are obtained; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the number and clinical profile of competing products; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to provide acceptable evidence of safety and efficacy; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the prevalence and severity of any side effects; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">relative convenience and ease of administration; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">cost-effectiveness; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">patient diagnostics and screening infrastructure in each market; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">marketing and distribution support; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">adverse publicity about our product candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">availability of coverage, adequate reimbursement and sufficient payment from health maintenance organizations
and other insurers, both public and private, for our product candidates, or the procedures utilizing our product candidates, if approved; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the willingness of patients to pay
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> in the absence of coverage by third-party payors and government authorities; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">other potential advantages over alternative treatment methods. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition, although we are not utilizing replication competent vectors, adverse publicity due to the ethical and social
controversies surrounding the therapeutic use of such technology, and reported side effects from any clinical trials using these technologies or the failure of such trials to demonstrate that these therapies are safe and effective may limit market
acceptance of our product candidates. If our product candidates are approved but fail to achieve market acceptance among physicians, patients, hospitals, cancer treatment centers or others in the medical community, we will not be able to generate
significant revenue. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If our product candidates fail to gain market acceptance, this will have a material adverse impact
on our ability to generate revenues to provide a satisfactory, or any, return on our investments. Even if some products achieve market acceptance, the market may prove not to be large enough to allow us to generate significant revenues. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>We may not be able to protect our intellectual property rights throughout the world. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Patents are of national or regional effect, and filing, prosecuting, maintaining and defending patents on product candidates in
all countries throughout the world would be prohibitively expensive, and our intellectual property rights in some countries outside the United States can have a different scope and strength than do those
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">81 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
in the United States. In addition, the laws of some foreign countries, particularly certain developing countries, do not protect intellectual property rights to the same extent as federal and
state laws in the United States. Consequently, we may not be able to prevent third parties from practicing our inventions in all countries outside the United States, or from selling or importing products made using our inventions in and into the
United States or other jurisdictions. Competitors may use our technologies in jurisdictions where we have not obtained patent protection to develop their own products and further, may export otherwise infringing products to territories where we have
patent protection, but enforcement rights are not as strong as those in the United States. These products may compete with our products and our patents or other intellectual property rights may not be effective or adequate to prevent them from
competing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Many companies have encountered significant problems in protecting and defending intellectual property rights
in foreign jurisdictions. The legal systems of certain countries, particularly certain developing countries, do not favor the enforcement of patents, trade secrets and other intellectual property, particularly those relating to biopharmaceutical
products, which could make it difficult in those jurisdictions for us to stop the infringement or misappropriation of our patents or other intellectual property rights, or the marketing of competing products in violation of our proprietary rights.
Proceedings to enforce our patent and other intellectual property rights in foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business. Furthermore, such proceedings could put our
patents at risk of being invalidated, held unenforceable, or interpreted narrowly, could put our patent applications at risk of not issuing, and could provoke third parties to assert claims of infringement or misappropriation against us. We may not
prevail in any lawsuits that we initiate and the damages or other remedies awarded, if any, may not be commercially meaningful. Similarly, if our trade secrets are disclosed in a foreign jurisdiction, competitors worldwide could have access to our
proprietary information and we may be without satisfactory recourse. Such disclosure could have a material adverse effect on our business. Moreover, our ability to protect and enforce our intellectual property rights may be adversely affected by
unforeseen changes in foreign intellectual property laws. In addition, certain developing countries, including China and India, have compulsory licensing laws under which a patent owner may be compelled to grant licenses to third parties. In those
countries, we and our licensors may have limited remedies if patents are infringed or if we or our licensors are compelled to grant a license to a third-party, which could materially diminish the value of those patents. In addition, many countries
limit the enforceability of patents against government agencies or government contractors. This could limit our potential revenue opportunities. Accordingly, our efforts to enforce our intellectual property rights around the world may be inadequate
to obtain a significant commercial advantage from the intellectual property that we develop or license. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Because of the
expense and uncertainty of litigation, we may conclude that even if a third-party is infringing our issued patents, any patents that may be issued as a result of our pending or future patent applications or other intellectual property rights, the
risk-adjusted cost of bringing and enforcing such a claim or action, which typically last for years before they are concluded, may be too high or not in the best interest of our company or our stockholders, or it may be otherwise impractical or
undesirable to enforce our intellectual property against some third parties. Our competitors or other third parties may be able to sustain the costs of complex patent litigation or proceedings more effectively than we can because of their greater
financial resources and more mature and developed intellectual property portfolios. In such cases, we may decide that the monetary cost of such litigation and the diversion of the attention of our management and scientific personnel could outweigh
any benefit we receive as a result of the proceedings and that the more prudent course of action is to simply monitor the situation or initiate or seek some other <FONT STYLE="white-space:nowrap">non-litigious</FONT> action or solution. In addition,
the uncertainties associated with litigation could compromise our ability to raise the funds necessary to continue our clinical trials, continue our internal research programs, <FONT STYLE="white-space:nowrap">in-license</FONT> needed technology or
other product candidates, or enter into development partnerships that would help us bring our product candidates to market. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>We may
be involved in lawsuits to protect or enforce our patents or other intellectual property or the intellectual property of our licensors, which could be expensive, time-consuming, and unsuccessful. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Competitors may infringe our patents or other intellectual property or the intellectual property of our licensors. To cease
such infringement or unauthorized use, we may be required to file patent infringement claims, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">82 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
which can be expensive and time-consuming and divert the time and attention of our management and scientific personnel. Our pending patent applications cannot be enforced against third parties
practicing the technology claimed in such applications unless and until a patent issues from such applications. In addition, in an infringement proceeding or a declaratory judgment action, a court may decide that one or more of our patents is not
valid or is unenforceable, or may refuse to stop the other party from using the technology at issue on the grounds that our patents do not cover the technology in question. An adverse result in any litigation or defense proceeding could put one or
more of our patents at risk of being invalidated, held unenforceable, or interpreted narrowly and could put our patent applications at risk of not issuing. Defense of these claims, regardless of their merit, would involve substantial litigation
expense and would be a substantial diversion of employee resources from our business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Interference or derivation
proceedings provoked by third parties or brought by the USPTO may be necessary to determine the priority of inventions with respect to, or the correct inventorship of, our patents or patent applications or those of our licensors. An unfavorable
outcome could result in a loss of our current patent rights and could require us to cease using the related technology or to attempt to license rights to it from the prevailing party. Our business could be harmed if the prevailing party does not
offer us a license on commercially reasonable terms. Litigation, interference, derivation or other proceedings may result in a decision adverse to our interests and, even if we are successful, may result in substantial costs and distract our
management and other employees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Even if we establish infringement, the court may decide not to grant an injunction
against further infringing activity and instead award only monetary damages, which may or may not be an adequate remedy. Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there
is a risk that some of our confidential information could be compromised by disclosure during this type of litigation. In addition, there could be public announcements of the results of hearings, motions or other interim proceedings or developments.
If securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of our common stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Changes in U.S. patent law could diminish the value of patents in general, thereby impairing our ability to protect our products.
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As is the case with other biopharmaceutical companies, our success is heavily dependent on intellectual property,
particularly patents. Obtaining and enforcing patents in the biopharmaceutical industry involves, both technological and legal complexity, and is therefore costly, time-consuming, and inherently uncertain. Changes in either the patent laws or
interpretation of the patent laws in the United States could increase the uncertainties and costs, and may diminish our ability to protect our inventions, obtain, maintain, and enforce our intellectual property rights and, more generally, could
affect the value of our intellectual property or narrow the scope of our owned and licensed patents. Recent patent reform legislation in the United States and other countries, including the Leahy-Smith America Invents Act, or the Leahy-Smith Act,
signed into law on September&nbsp;16, 2011, could increase those uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents. The Leahy-Smith Act includes a number of
significant changes to U.S. patent law. These include provisions that affect the way patent applications are prosecuted, redefine prior art and provide more efficient and cost-effective avenues for competitors to challenge the validity of patents.
These include allowing third-party submission of prior art to the USPTO during patent prosecution and additional procedures to attack the validity of a patent by USPTO administered post-grant proceedings, including post-grant review, <I>inter
partes</I> review, and derivation proceedings. After March 2013, under the Leahy-Smith Act, the United States transitioned to a first inventor to file system in which, assuming that the other statutory requirements are met, the first inventor to
file a patent application will be entitled to the patent on an invention regardless of whether a third-party was the first to invent the claimed invention. A third party that files a patent application in the USPTO after March 2013, but before we
file an application covering the same invention, could therefore be awarded a patent covering an invention of ours even if we had made the invention before it was made by such third party. This will require us to be cognizant going forward of the
time from invention to filing </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">83 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
of a patent application. Since patent applications in the United States and most other countries are confidential for a period of time after filing or until issuance, we cannot be certain that we
or our licensors were the first to either (i)&nbsp;file any patent application related to our product candidates and other proprietary technologies we may develop or (ii)&nbsp;invent any of the inventions claimed in our or our licensor&#146;s
patents or patent applications. Even where we have a valid and enforceable patent, we may not be able to exclude others from practicing the claimed invention where the other party can show that they used the invention in commerce before our filing
date or the other party benefits from a compulsory license. However, the Leahy-Smith Act and its implementation could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our
issued patents, all of which could have a material adverse effect on our business, financial condition, results of operations and prospects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Recent U.S. Supreme Court rulings have narrowed the scope of patent protection available in certain circumstances and weakened
the rights of patent owners in certain situations. In addition to increasing uncertainty with regard to our ability to obtain patents in the future, this combination of events has created uncertainty with respect to the value of patents once
obtained. Depending on decisions by Congress, the federal courts, the USPTO and the relevant <FONT STYLE="white-space:nowrap">law-making</FONT> bodies in other countries, the laws and regulations governing patents could change in unpredictable ways
that would weaken our ability to obtain new patents or to enforce our existing patents and patents that we might obtain in the future. For example, in the 2013 case <I>Assoc. for Molecular Pathology</I><I></I><I>&nbsp;v. Myriad Genetics, Inc.</I>,
the U.S. Supreme Court held that certain claims to naturally-occurring substances are not patentable. Although we do not believe that any of the patents owned or licensed by us will be found invalid based on this decision, we cannot predict how
future decisions by Congress, the federal courts or the USPTO may impact the value of our patents. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>We may be subject to claims that
our employees, consultants, or independent contractors have wrongfully used or disclosed confidential information of third parties. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have received confidential and proprietary information from third parties. In addition, we employ individuals who were
previously employed at other biotechnology or pharmaceutical companies. We may be subject to claims that we or our employees, consultants, or independent contractors have inadvertently or otherwise used or disclosed confidential information of these
third parties or our employees&#146; former employers, or that we caused an employee to breach the terms of his or her <FONT STYLE="white-space:nowrap">non-competition</FONT> or <FONT STYLE="white-space:nowrap">non-solicitation</FONT> agreement.
Litigation may be necessary to defend against these claims. Even if we are successful in defending against these claims, litigation could result in substantial cost and be a distraction to our management and employees. If our defenses to these
claims fail, in addition to requiring us to pay monetary damages, a court could prohibit us from using technologies or features that are essential to our product candidates, if such technologies or features are found to incorporate or be derived
from the trade secrets or other proprietary information of the former employers. Moreover, any such litigation or the threat thereof may adversely affect our reputation, our ability to form strategic alliances or sublicense our rights to
collaborators, engage with scientific advisors or hire employees or consultants, each of which would have an adverse effect on our business, results of operations and financial condition. Even if we are successful in defending against such claims,
litigation could result in substantial costs and be a distraction to management. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Our stock price may be volatile or may decline
regardless of our operating performance, resulting in substantial losses for investors. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The market price of our
common stock may be highly volatile and may fluctuate substantially as a result of a variety of factors, some of which are related in complex ways. The market price of our common stock may fluctuate significantly in response to numerous factors,
many of which are beyond our control, including the factors listed below and other factors describe in this &#147;Risk Factors&#148; section: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the commencement, enrollment, or results of current and future preclinical studies and clinical trials and
trials we may conduct, or changes in the development status of our product candidates; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">84 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any delay in our regulatory filings for our product candidates and any adverse development or perceived
adverse development with respect to the applicable regulatory authority&#146;s review of such filings, including, without limitation, the issuance by the FDA of a &#147;refusal to file&#148; letter or a request for additional information;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">adverse results or delays in clinical trials; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our decision to initiate a preclinical study or clinical trial, not to initiate a preclinical study or
clinical trial or to terminate an existing preclinical study or clinical trial; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">adverse actions taken by regulatory agencies with respect to our preclinical studies or clinical trials,
manufacturing supply chain or sales and marketing activities, including failure to receive regulatory approval of our product candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in laws or regulations, including, but not limited to, preclinical study or clinical trial
requirements for approvals; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any adverse changes to our relationship with manufacturers or suppliers; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">manufacturing, supply or distribution shortages; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our failure to commercialize our product candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in the structure of healthcare payment systems; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">additions or departures of key scientific or management personnel; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">unanticipated serious safety concerns related to the use of our product candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">disputes or other developments relating to proprietary rights, including patents, litigation matters, and our
ability to obtain patent protection for our technologies; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">variations in our results of operations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our cash position; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our failure to meet the estimates and projections of the investment community or that we may otherwise provide
to the public; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">publication of research reports about us or our industry, or <I>in vivo</I> and <I>ex vivo</I> cell
engineering products in particular, or positive or negative recommendations or withdrawal of research coverage by securities analysts; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">announcements made by us or our competitors of new product and service offerings, acquisitions, strategic
relationships, joint ventures, or capital commitments; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our inability to establish collaborations, if needed; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to effectively manage our growth; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the size and growth of our initial target markets; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in the market valuations of similar companies; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">press reports, whether or not true, about our business; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">sales or perceived potential sales of our common stock by us or our stockholders in the future;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">overall fluctuations in the equity markets; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">ineffectiveness of our internal controls; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in accounting practices or principles; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes or developments in the global regulatory environment; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">litigation involving us, our industry or both, or investigations by regulators into our operations or those of
our competitors; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">85 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">general political and economic conditions; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">other events or factors, many of which are beyond our control. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition, the stock market in general and biopharmaceutical companies in particular, have experienced extreme price and
volume fluctuations that have often been unrelated or disproportionate to the operating performance of these companies. Broad market and industry factors may negatively affect the market price of our common stock, regardless of our actual operating
performance. If the market price of our common stock after this offering does not exceed the initial public offering price, you may not realize any return on, and may lose some or all of, your investment. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Our quarterly operating results may fluctuate significantly or may fall below the expectations of investors or securities analysts, each
of which may cause our stock price to fluctuate or decline. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We expect our operating results to be subject to
quarterly fluctuations. Our net loss and other operating results will be affected by numerous factors, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">timing and variations in the level of expense related to the current or future development of our programs;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">timing and status of enrollment for our clinical trials; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">impacts from the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic on us or third parties with which
we engage; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">results of clinical trials, or the addition or termination of clinical trials or funding support by us or
potential future partners; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our execution of any collaboration, licensing or similar arrangements, and the timing of payments we may make
or receive under potential future arrangements or the termination or modification of any such potential future arrangements; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any intellectual property infringement, misappropriation or violation lawsuit or opposition, interference or
cancellation proceeding in which we may become involved; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">additions and departures of key personnel; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">strategic decisions by us or our competitors, such as acquisitions, divestitures, spin-offs, joint ventures,
strategic investments or changes in business strategy; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if any product candidate we may develop receive regulatory approval, the timing and terms of such approval and
market acceptance and demand for such product candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the timing and cost to establish a sales, marketing and distribution infrastructure to commercialize any
products for which we may obtain marketing approval and intend to commercialize on our own or jointly with current or future collaborators; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">regulatory developments affecting current or future product candidates or those of our competitors;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the amount of expense or gain associated with the change in value of the success payments and contingent
consideration; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in general market and economic conditions. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If our quarterly operating results fall below the expectations of investors or securities analysts, the price of our common
stock could decline substantially. Furthermore, any quarterly fluctuations in our operating results may, in turn, cause the price of our stock to fluctuate substantially. We believe that quarterly comparisons of our financial results are not
necessarily meaningful and should not be relied upon as an indication of our future performance. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>We could be subject to securities
class action litigation. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In the past, securities class action litigation has often been instituted against
companies following periods of volatility in the market price of a company&#146;s securities. This type of litigation, if instituted, could result in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">86 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
substantial costs and a diversion of management&#146;s attention and resources, which would harm our business, operating results, or financial condition. Additionally, the dramatic increase in
the cost of directors&#146; and officers&#146; liability insurance may cause us to opt for lower overall policy limits or to forgo insurance that we may otherwise rely on to cover significant defense costs, settlements, and damages awarded to
plaintiffs. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Our management team has broad discretion to use the net proceeds from this offering and its investment of these
proceeds may not yield a favorable return. They may invest the net proceeds from this offering in ways with which investors disagree. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our management will have broad discretion over the use of net proceeds from this offering, and could spend the net proceeds in
ways our stockholders may not agree with or that do not yield a favorable return, if at all. If we do not invest or apply the net proceeds from this offering in ways that improve our operating results, we may fail to achieve expected financial
results, which could cause our stock price to decline. For additional details see the section titled &#147;Use of Proceeds.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>If securities or industry analysts either do not publish research about us or publish inaccurate or unfavorable research about us, our
business or our market, or if they change their recommendations regarding our common stock adversely, the trading price or trading volume of our common stock could decline. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The trading market for our common stock will be influenced in part by the research and reports that securities or industry
analysts may publish about us, our business, our market, or our competitors. If one or more of these analysts initiate research with an unfavorable rating or downgrade our common stock, provide a more favorable recommendation about our competitors
or publish inaccurate or unfavorable research about our business, our common stock price would likely decline. If any analyst who may cover us were to cease coverage of us or fail to regularly publish reports on us, we could lose visibility in the
financial markets, which in turn could cause the trading price or trading volume of our common stock to decline. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>We are an emerging
growth company, and any decision on our part to comply only with certain reduced reporting and disclosure requirements applicable to emerging growth companies could make our common stock less attractive to investors. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are an &#147;emerging growth company&#148; as defined in the JOBS Act and, for as long as we continue to be an emerging
growth company, we may choose to take advantage of exemptions from various reporting requirements applicable to other public companies but not to emerging growth companies, including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">not being required to have our independent registered public accounting firm audit our internal control over
financial reporting under Section&nbsp;404 of the Sarbanes-Oxley Act; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduced disclosure obligations regarding executive compensation in our periodic reports and annual report on
Form <FONT STYLE="white-space:nowrap">10-K;</FONT> and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">exemptions from the requirements of holding <FONT STYLE="white-space:nowrap">non-binding</FONT> advisory votes
on executive compensation and stockholder approval of any golden parachute payments not previously approved. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We could be an emerging growth company for up to five years following the completion of our initial public offering. Our
status as an emerging growth company will end as soon as any of the following takes place: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the last day of the fiscal year in which we have more than $1.07&nbsp;billion in annual revenue;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the date we qualify as a &#147;large accelerated filer,&#148; with at least $700&nbsp;million of equity
securities held by <FONT STYLE="white-space:nowrap">non-affiliates;</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the date on which we have issued, in any three-year period, more than $1.0&nbsp;billion in <FONT
STYLE="white-space:nowrap">non-convertible</FONT> debt securities; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the last day of the fiscal year ending after the fifth anniversary of the completion of our initial public
offering. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">87 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We cannot predict if investors will find our common stock less attractive if
we choose to rely on any of the exemptions afforded to emerging growth companies. If some investors find our common stock less attractive because we rely on any of these exemptions, there may be a less active trading market for our common stock and
the market price of our common stock may be more volatile. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Under the JOBS Act, emerging growth companies can also delay
adopting new or revised accounting standards until such time as those standards apply to private companies. We have elected to use this extended transition period for any new or revised accounting standards during the period in which we remain an
emerging growth company (or we&nbsp;affirmatively and irrevocably opt out of the extended transition period); however, we may adopt certain new or revised accounting standards early. As a result, these financial statements may not be comparable to
companies that comply with the new or revised accounting pronouncements as of public company effective dates. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>The requirements of
being a public company may strain our resources, result in more litigation, and divert management&#146;s attention. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As a public company, we will be subject to the reporting requirements of the Exchange Act, the Sarbanes-Oxley Act, the
Dodd-Frank Wall Street Reform and Consumer Protection Act, or the Dodd-Frank Act, the listing requirements of Nasdaq, and other applicable securities rules and regulations. Complying with these rules and regulations has increased and will increase
our legal and financial compliance costs, make some activities more difficult, time consuming or costly, and increase demand on our systems and resources. The Exchange Act requires, among other things, that we file annual, quarterly, and current
reports with respect to our business and operating results. The Sarbanes-Oxley Act requires, among other things, that we maintain effective disclosure controls and procedures and internal control over financial reporting. We are required to disclose
changes made in our internal control and procedures on a quarterly basis. In order to maintain and, if required, improve our disclosure controls and procedures and internal control over financial reporting to meet this standard, significant
resources and management oversight may be required. As a result, management&#146;s attention may be diverted from other business concerns, which could adversely affect our business and operating results. We may also need to hire additional employees
or engage outside consultants to comply with these requirements, which will increase our costs and expenses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition,
changing laws, regulations, and standards relating to corporate governance and public disclosure are creating uncertainty for public companies, increasing legal and financial compliance costs, and making some activities more time consuming. These
laws, regulations, and standards are subject to varying interpretations, in many cases due to their lack of specificity and, as a result, their application in practice may evolve over time as new guidance is provided by regulatory and governing
bodies. This could result in continuing uncertainty regarding compliance matters and higher costs necessitated by ongoing revisions to disclosure and governance practices. We intend to invest resources to comply with evolving laws, regulations, and
standards, and this investment may result in increased general and administrative expenses and a diversion of management&#146;s time and attention from revenue-generating activities to compliance activities. If our efforts to comply with new laws,
regulations, and standards differ from the activities intended by regulatory or governing bodies due to ambiguities related to their application and practice, regulatory authorities may initiate legal proceedings against us and our business may be
adversely affected. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">These new rules and regulations may make it more expensive for us to obtain director and officer
liability insurance and, in the future, we may be required to accept reduced coverage or incur substantially higher costs to obtain coverage. These factors could also make it more difficult for us to attract and retain qualified members of our
Board, particularly to serve on our audit committee and compensation committee, and qualified executive officers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">By
disclosing information in this prospectus and in future filings required of a public company, our business and financial condition will become more visible, which we believe may result in threatened or actual litigation,
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">88 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
including by competitors and other third parties. If those claims are successful, our business could be seriously harmed. Even if the claims do not result in litigation or are resolved in our
favor, the time and resources needed to resolve them could divert our management&#146;s resources and seriously harm our business. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>If we fail to maintain proper and effective internal controls over financial reporting our ability to produce accurate and timely
financial statements could be impaired. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Pursuant to Section&nbsp;404 of the Sarbanes-Oxley Act, our management
will be required to report upon the effectiveness of our internal control over financial reporting beginning with the annual report for our fiscal year ending December&nbsp;31, 2021. When we lose our status as an &#147;emerging growth company&#148;
and become an &#147;accelerated filer&#148; or a &#147;large accelerated filer,&#148; our independent registered public accounting firm will be required to attest to the effectiveness of our internal control over financial reporting. The rules
governing the standards that must be met for management to assess our internal control over financial reporting are complex and require significant documentation, testing, and possible remediation. To comply with the requirements of being a
reporting company under the Securities Exchange Act of 1934, as amended (the Exchange Act), we will need to implement additional financial and management controls, reporting systems, procedures, and hire additional accounting and finance staff. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We cannot assure you that there will not be material weaknesses or significant deficiencies in our internal control over
financial reporting in the future. Any failure to maintain internal control over financial reporting could severely inhibit our ability to accurately report our financial condition, results of operations, or cash flows. If we are unable to conclude
that our internal control over financial reporting is effective, or if our independent registered public accounting firm determines we have a material weakness or significant deficiency in our internal control over financial reporting, investors may
lose confidence in the accuracy and completeness of our financial reports, the market price of our common stock could decline, and we could be subject to sanctions or investigations by Nasdaq, the SEC, or other regulatory authorities. Failure to
remedy any material weakness in our internal control over financial reporting, or to implement or maintain other effective control systems required of public companies, could also restrict our future access to the capital markets. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Our disclosure controls and procedures may not prevent or detect all errors or acts of fraud. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Upon the completion of this offering, we will become subject to the periodic reporting requirements of the Exchange Act. We
must design our disclosure controls and procedures to reasonably assure that information we must disclose in reports we file or submit under the Exchange Act is accumulated and communicated to management, and recorded, processed, summarized, and
reported within the time periods specified in the rules and forms of the SEC. We believe that any disclosure controls and procedures or internal controls and procedures, no matter how well-conceived and operated, can provide only reasonable, not
absolute, assurance that the objectives of the control system are met. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake. For example,
our directors or executive officers could inadvertently fail to disclose a new relationship or arrangement causing us to fail to make a required related party transaction disclosure. Additionally, controls can be circumvented by the individual acts
of some persons, by collusion of two or more people or by an unauthorized override of the controls. Accordingly, because of the inherent limitations in our control system, misstatements due to error or fraud may occur and not be detected. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">89 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc60414_3"></A>SPECIAL NOTE REGARDING
<FONT STYLE="white-space:nowrap">FORWARD-LOOKING</FONT> STATEMENTS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This prospectus contains <FONT
STYLE="white-space:nowrap">forward-looking</FONT> statements, particularly in the sections titled &#147;Prospectus Summary,&#148; &#147;Risk Factors,&#148; &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of
Operations,&#148; and &#147;Business.&#148; In some cases, you can identify these statements by <FONT STYLE="white-space:nowrap">forward-looking</FONT> words such as &#147;aim,&#148; &#147;anticipate,&#148; &#147;believe,&#148; &#147;continue,&#148;
&#147;could,&#148; &#147;estimate,&#148; &#147;expect,&#148; &#147;intend,&#148; &#147;may,&#148; &#147;might,&#148; &#147;plan,&#148; &#147;potential,&#148; &#147;predict,&#148; &#147;should,&#148; &#147;would,&#148; or &#147;will,&#148; the
negative of these terms, and other comparable terminology. These <FONT STYLE="white-space:nowrap">forward-looking</FONT> statements, which are subject to risks, include, but are not limited to, statements about: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our expectations regarding the potential market size and size of the potential patient populations for our
product candidates and any future product candidates, if approved for commercial use; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our clinical and regulatory development plans; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our expectations with regard to the results of our clinical studies, preclinical studies and research and
development programs, including the timing and availability of data from such studies; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the timing of commencement of future nonclinical studies and clinical trials and research and development
programs; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to acquire, discover, develop and advance product candidates into, and successfully complete,
clinical trials; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our intentions and our ability to establish collaborations and/or partnerships; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the timing or likelihood of regulatory filings and approvals for our product candidates;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our commercialization, marketing and manufacturing, including the buildout of our own manufacturing facility,
capabilities and expectations; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">impact from future regulatory, judicial, and legislative changes or developments in the United States and
foreign countries; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our intentions with respect to the commercialization of our product candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the pricing and reimbursement of our product candidates, if approved; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the potential effects of public health crises, such as the <FONT STYLE="white-space:nowrap">COVID-19</FONT>
pandemic, on our preclinical and clinical programs and business; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our expectations regarding the impact of the COVID-19 pandemic on our business; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the implementation of our business model and strategic plans for our business and product candidates,
including additional indications for which we may pursue; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to effectively manage our growth, including our ability to retain and recruit personnel, and
maintain our culture; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the scope of protection we are able to establish and maintain for intellectual property rights covering our
product candidates, including the projected terms of patent protection; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">estimates of our expenses, future revenue, capital requirements, our needs for additional financing and our
ability to obtain additional capital; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our expected use of proceeds from this offering; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the performance of our third-party suppliers and manufacturers; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our future financial performance; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our expectations regarding the time during which we will be an emerging growth company under the JOBS Act; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">developments and projections relating to our competitors and our industry, including competing products.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">90 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have based these <FONT STYLE="white-space:nowrap">forward-looking</FONT>
statements largely on our current expectations, estimates, forecasts and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. In light
of the significant uncertainties in these <FONT STYLE="white-space:nowrap">forward-looking</FONT> statements, you should not rely upon <FONT STYLE="white-space:nowrap">forward-looking</FONT> statements as predictions of future events. Although we
believe that we have a reasonable basis for each <FONT STYLE="white-space:nowrap">forward-looking</FONT> statement contained in this prospectus, we cannot guarantee that the future results, levels of activity, performance or events and circumstances
reflected in the <FONT STYLE="white-space:nowrap">forward-looking</FONT> statements will be achieved or occur at all. You should refer to the section titled &#147;Risk Factors&#148; for a discussion of important factors that may cause our actual
results to differ materially from those expressed or implied by our <FONT STYLE="white-space:nowrap">forward-looking</FONT> statements. Furthermore, if our <FONT STYLE="white-space:nowrap">forward-looking</FONT> statements prove to be inaccurate,
the inaccuracy may be material. Except as required by law, we undertake no obligation to publicly update any <FONT STYLE="white-space:nowrap">forward-looking</FONT> statements, whether as a result of new information, future events or otherwise. The
Private Securities Litigation Reform Act of 1995 and Section&nbsp;27A of the Securities Act do not protect any <FONT STYLE="white-space:nowrap">forward-looking</FONT> statements that we make in connection with this offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">You should read this prospectus and the documents that we reference in this prospectus and have filed as exhibits to the
registration statement, of which this prospectus is a part, completely and with the understanding that our actual future results may be materially different from what we expect. We qualify all of the
<FONT STYLE="white-space:nowrap">forward-looking</FONT> statements in this prospectus by these cautionary statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">91 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc60414_4"></A>INDUSTRY AND MARKET DATA </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Unless otherwise indicated, information contained in this prospectus concerning our industry and the markets in which we
operate, including our general expectations and market position, market opportunity, and market size, is based on information from various sources on assumptions that we have made that are based on such information and other, similar sources and on
our knowledge of, and expectations about, the markets for our products. In some cases, we do not expressly refer to the sources from which this data is derived. This information involves a number of assumptions and limitations, and you are cautioned
not to give undue weight to such estimates. While we believe the market position, market opportunity, and market size information included in this prospectus is generally reliable, such information is inherently imprecise. In addition, projections,
assumptions, and estimates of our future performance and the future performance of the industry in which we operate is necessarily subject to a high degree of uncertainty and risk due to a variety of factors, including those described in &#147;Risk
Factors&#148; and elsewhere in this prospectus. These and other factors could cause results to differ materially from those expressed in the estimates made by independent third parties and by us. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">92 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc60414_5"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We estimate that the net proceeds from this offering will be approximately $296.2 million, (or approximately $341.2 million if
the underwriters exercise their over-allotment option to purchase additional shares in full), assuming an initial public offering price of $21.50 per share, which is the midpoint of the price range set forth on the cover page of this prospectus,
after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Each
$1.00 increase or decrease in the initial public offering price per share would increase or decrease, as applicable, our net proceeds, after deducting estimated underwriting discounts and commissions, by $14.0&nbsp;million (assuming no exercise of
the underwriters&#146; option to purchase additional shares). Each increase or decrease of 1.0&nbsp;million shares in the number of shares offered by us would increase or decrease, as applicable, our net proceeds by $20.0 million, assuming an
initial public offering price of $21.50 per share, which is the midpoint of the price range set forth on the cover page of this prospectus, and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable
by us. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The principal purposes of this offering are to obtain additional capital to fund our operations, create a
public market for our common stock, facilitate our future access to the public equity markets, and increase awareness of our company among potential partners. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We currently intend to use the net proceeds from this offering, together with our existing cash, cash equivalents and
marketable securities, as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approximately $190.0 million to fund the ongoing development of our <I>in vivo</I> cell engineering platform
and product candidates, which we believe will allow us to complete preclinical studies on each of our current product candidates and advance at least three <I>in vivo </I>product candidates through human proof of concept studies;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approximately $190.0 million to fund the ongoing development of our <I>ex&nbsp;vivo</I> cell engineering
platform and product candidates, which we believe will allow us to complete preclinical studies on each of our current product candidates and advance at least three <I>ex</I><I>&nbsp;vivo </I>product candidates through human proof of concept
studies; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approximately $80.0 million to continue developing manufacturing capabilities for our product candidates;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approximately $40.0 million to fund research and development efforts focused on advancing and broadening the
scope of our <I>ex&nbsp;vivo</I> and <I>in&nbsp;vivo</I> cell engineering platforms; and </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the remainder, if any, for working capital and other general corporate purposes. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We may also use a portion of the net proceeds to <FONT STYLE="white-space:nowrap">in-license,</FONT> acquire, or invest in,
complementary technologies, assets, or intellectual property. We periodically evaluate strategic opportunities; however, we have no current commitments to enter into any such acquisitions or make any such investments. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Based on our current operating plan, we believe that our existing cash, cash equivalents and marketable securities, together
with the net proceeds from this offering, will be sufficient to meet our working capital and capital expenditure needs for at least the next 36 months. Our expected use of net proceeds from this offering represents our current intentions based upon
present plans and business conditions. The net proceeds from this offering, together with our existing cash, cash equivalents and marketable securities, will not be sufficient to fund any of our product candidates through regulatory approval, and we
anticipate needing to raise additional capital to complete the development of and commercialize our product candidates. As of the date of this prospectus, we cannot predict with certainty all of the particular uses for the net proceeds to be
received upon the completion of this offering, or the amounts that we will actually spend on the uses set forth above. The amounts and timing of any expenditures will vary depending on numerous factors, including the progress of our ongoing and
planned clinical studies, the amount of cash used by our operations, competitive and scientific developments, the rate of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">93 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
growth, if any, of our business, and other factors described in the section titled &#147;Risk Factors.&#148; Accordingly, our management will have significant discretion and flexibility in
applying the net proceeds from this offering, and investors will be relying on the judgment of our management regarding the application of these net proceeds. Due to the many inherent uncertainties in the development of our product candidates, the
amounts and timing of our actual expenditures may vary significantly depending on numerous factors, including the progress of our research and development, our ability to obtain additional financing, the cost and results of our preclinical
activities, the timing of clinical studies we may commence in the future, the timing of regulatory submissions, any collaborations that we may enter into with third parties for our product candidates or strategic opportunities that become available
to us, and any unforeseen cash needs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Pending the uses described above, we intend to invest the net proceeds from this
offering in <FONT STYLE="white-space:nowrap">interest-bearing</FONT> obligations, <FONT STYLE="white-space:nowrap">investment-grade</FONT> instruments, certificates of deposit, or direct or guaranteed obligations of the U.S. government. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">94 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc60414_6"></A>DIVIDEND POLICY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have never declared or paid any cash dividends on our capital stock and do not anticipate paying any cash dividends in the
foreseeable future. We currently anticipate that we will retain all available funds for use in the operation and expansion of our business. Any future determination to pay dividends on our common stock will be made at the discretion of our board of
directors and will depend upon, among other factors, our financial condition, results from operations, current and anticipated cash needs, plans for expansion, and other factors that our board of directors may deem relevant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">95 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc60414_7"></A>CAPITALIZATION </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following table sets forth our cash, cash equivalents, and marketable securities, and total capitalization as of
September&nbsp;30, 2020: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">on an actual basis; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">on a pro forma basis to reflect the following immediately prior to the completion of this offering:
(i)&nbsp;the filing and effectiveness of our amended and restated certificate of incorporation, which will be in effect immediately prior to the completion of this offering, and (ii)&nbsp;the automatic conversion of all of our outstanding
convertible preferred stock into and aggregate of 134,112,712 shares of our common stock immediately prior to the completion of the offering; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">on a pro forma as adjusted basis to reflect: (i)&nbsp;the pro forma adjustments set forth above, and
(ii)&nbsp;the issuance and sale of 15,000,000 shares of common stock by us in this offering at an assumed initial public offering price of $21.50 per share, which is the midpoint of the price range set forth on the cover page of this prospectus,
after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This table should be read in conjunction with the sections titled &#147;Selected Consolidated Financial Data&#148; and
&#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations,&#148; and our unaudited condensed consolidated financial statements and related notes included elsewhere in this prospectus. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>September&nbsp;30, 2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Actual</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro Forma</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Pro&nbsp;Forma&nbsp;as<BR>Adjusted<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(in thousands, except share and per share<BR>amounts)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash, cash equivalents, and marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">459,070</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">459,070</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">755,256</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Convertible preferred stock, $0.0001 par value per share; 537,786,206 shares authorized,
134,112,712 shares issued and outstanding, actual; no shares authorized, issued or outstanding, pro forma and pro forma as adjusted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">852,897</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stockholders&#146; (deficit) equity:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preferred stock, $0.0001 par value per share; no shares authorized, issued or outstanding,
50,000,000 actual; shares, authorized, no shares issued and outstanding pro forma and pro forma as adjusted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common stock, $0.0001 par value per share; 700,000,000 shares authorized<B><SUP
STYLE="font-size:85%; vertical-align:top">(2)</SUP></B>, 14,250,366 shares issued and outstanding, actual<SUP STYLE="font-size:85%; vertical-align:top"><FONT STYLE="font-size:6.5pt"><B>(3)</B></FONT></SUP><FONT STYLE="font-size:6.5pt">; 750,000,000
shares authorized and 148,363,078 shares issued and outstanding, pro forma</FONT><B></B>; 750,000,000 shares authorized and 163,363,078 shares issued and outstanding, pro forma as adjusted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,031</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">857,914</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,154,099</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated other comprehensive income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(316,262</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(316,262</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(316,262</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stockholders&#146; (deficit) equity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(311,175</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">541,722</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">837,908</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total capitalization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">541,722</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">541,722</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">837,908</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">The pro forma as adjusted information discussed above is illustrative only and will depend on the actual
initial offering price and other terms of this offering determined at pricing. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">In December 2020, we amended and restated our certificate of incorporation to increase our authorized capital
stock to 707,000,000 shares. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">Does not include 11,951,698 shares of our unvested restricted shares of common stock. </P></TD></TR></TABLE>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">96 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Each $1.00 increase or decrease in the assumed initial public offering
price of $21.50 per share, the midpoint of the price range set forth on the cover page of this prospectus, would increase or decrease, as applicable, each of pro forma as adjusted cash, cash equivalents, and marketable securities, additional paid-in
capital, total stockholders&#146; equity and total capitalization by approximately $14.0 million, assuming that the number of shares of common stock offered by us, as set forth on the cover page of this prospectus, remains the same, and after
deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. Similarly, each increase or decrease of 1.0&nbsp;million shares of common stock offered by us would increase or decrease, as applicable, each
of pro forma as adjusted cash, cash equivalents, and marketable securities, additional paid-in capital, total stockholders&#146; equity, and total capitalization by approximately $20.0&nbsp;million, assuming that the assumed initial public offering
price of $21.50 per share, the midpoint of the price range set forth on the cover page of this prospectus, remains the same, and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If the underwriters&#146; exercise their over-allotment option to purchase additional shares of our common stock in full, our
pro forma as adjusted cash, cash equivalents, and marketable securities, additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital, total stockholders&#146; equity, total capitalization, and shares of common stock outstanding as of
September&nbsp;30, 2020 would be $800.2 million, $1,199.1 million, $882.9 million, $882.9 million, and 163,363,078 shares, respectively. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The number of shares of our common stock to be outstanding after this offering on a pro forma and pro forma as adjusted basis
is based on 148,363,078 shares of common stock outstanding as of September&nbsp;30, 2020 (after giving effect to the automatic conversion of all of our shares of convertible preferred stock outstanding as of September&nbsp;30, 2020 into an aggregate
of 134,112,712 shares of our common stock immediately prior to the completion of this offering) and excludes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">11,951,698 shares of our unvested common stock as of September&nbsp;30, 2020; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">9,677,280 shares of common stock issuable upon exercise of stock options outstanding as of September&nbsp;30,
2020, with a <FONT STYLE="white-space:nowrap">weighted-average</FONT> exercise price of $2.32 per share; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">6,139,302 shares of common stock issuable upon exercise of stock options granted subsequent to
September&nbsp;30, 2020, with a <FONT STYLE="white-space:nowrap">weighted-average</FONT> exercise price of $7.92 per share; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">325,672 restricted stock units subject to vesting conditions and, as of September&nbsp;30, 2020, (of which
146,249 shares have satisfied the vesting conditions), and will become outstanding six months after the effective date of the completion of this offering; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">356,630 shares reserved for future issuance under our 2018 Equity Incentive Plan, as of September&nbsp;30,
2020; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">234,065 shares reserved for future issuance under our 2018 Equity Incentive Plan, which was increased
subsequent to September&nbsp;30, 2020; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a number of shares of our common stock equal to 8% of our outstanding common stock after this offering
reserved for future issuance under our 2021 Incentive Award Plan (the 2021 Plan), which will become effective on the date immediately prior to the date our registration statement relating to this offering becomes effective, as well as any future
increases in the number of shares of common stock reserved for issuance under the 2021 Plan; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a number of shares of our common stock equal to 1% of our outstanding common stock after this offering
reserved for future issuance under our Employee Stock Purchase Plan (the ESPP), which will become effective on the date immediately prior to the date our registration statement relating to this offering becomes effective, as well as any future
increases in the number of shares of common stock reserved for issuance under the ESPP. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">97 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc60414_8"></A>DILUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If you purchase shares of our common stock in this offering, your ownership interest will be diluted to the extent of the
difference between the initial public offering price per share of our common stock in this offering and the pro forma as adjusted net tangible book value per share of our common stock immediately after this offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As of September&nbsp;30, 2020, our historical net tangible book value (deficit) was ($311.2) million, or ($11.88) per share of
our common stock, based on 26,202,064 shares of common stock issued and outstanding as of such date (including 11,951,698 shares of unvested restricted stock). Our historical net tangible book value per share represents tangible assets, less
liabilities and convertible preferred stock, divided by the aggregate number of shares of common stock outstanding as of September&nbsp;30, 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our pro forma net tangible book value as of September&nbsp;30, 2020 was $541.7&nbsp;million, or $3.38 per share of common
stock. Pro forma net tangible book value per share represents tangible assets, less liabilities, divided by the aggregate number of shares of common stock outstanding, after giving effect to the automatic conversion of all of our outstanding
convertible preferred stock into 134,112,712 shares of our common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">After giving further effect to the sale by us
of&nbsp;15,000,000 shares of common stock in this offering at an assumed initial public offering price of $21.50&nbsp;per share, which is the midpoint of the price range set forth on the cover page of this prospectus, and after deducting estimated
underwriting discounts and commissions and estimated offering expenses payable by us, our pro forma as adjusted net tangible book value as of September&nbsp;30, 2020 would have been $837.9&nbsp;million or $4.78&nbsp;per share. This represents an
immediate increase in pro forma net tangible book value to existing stockholders of $1.40&nbsp;per share and an immediate dilution in pro forma net tangible book value to new investors of $16.72&nbsp;per share. Dilution per share represents the
difference between the price per share to be paid by new investors for the shares of common stock sold in this offering and the pro forma as adjusted net tangible book value per share immediately after this offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following table illustrates this dilution on a per share basis: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="85%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assumed initial public offering price per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">21.50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Historical net tangible book deficit per share as of September&nbsp;30, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(11.88</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma increase in net tangible book value per share as of September&nbsp;30, 2020 attributable
to the pro forma transactions described above</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15.26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma net tangible book value per share as of September&nbsp;30, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.38</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Increase in pro forma net tangible book value per share attributable to new investors
participating in this offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma as adjusted net tangible book value per share after this offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.78</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dilution per share to new investors participating in this offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">16.72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>   <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Each $1.00 increase or decrease in the assumed initial public offering price of
$21.50 per share, which is the midpoint of the price range set forth on the cover page of this prospectus, would increase or decrease, as applicable our pro forma as adjusted net tangible book value per share after this offering by $0.08&nbsp;per
share and the dilution in pro forma per share to investors participating in this offering by $0.92&nbsp;per share, assuming that the number of shares of common stock offered by us, as set forth on the cover page of this prospectus, remains the same,
and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. Similarly, each 1.0&nbsp;million share increase or decrease in the number of shares offered by us would increase or decrease, as
applicable our pro forma as adjusted net tangible book value per share after this offering by $0.09&nbsp;per share and the dilution in pro forma as adjusted net tangible book value per share to investors participating in this offering by
$0.09&nbsp;per share, assuming the initial public offering price of $21.50&nbsp;per </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">98 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
share remains the same, and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If the underwriters exercise their over-allotment option to purchase additional shares of our common stock in full, the pro
forma as adjusted net tangible book value per share of our common stock after this offering would be $0.19 per share, and the dilution in pro forma net tangible book value per share to investors participating in this offering would be
$16.53&nbsp;per share of common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following table sets forth, on the pro forma basis described above, as of
September&nbsp;30, 2020, the number of shares of common stock purchased from us, the total consideration paid, or to be paid, and the weighted-average price per share paid, or to be paid, by existing stockholders and by the new investors, at an
assumed initial public offering price of $21.50 per share, which is the midpoint of the price range set forth on the cover page of this prospectus, before deducting estimated underwriting discounts and commissions and estimated offering expenses
payable by us: </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="49%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares Purchased</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total Consideration</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Weighted-<BR>Average<BR>Price Per<BR>Share</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percent</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percent</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center"><B>(in thousands, except share, per share, and percent data)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Existing stockholders before this
offering<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">160,314,776</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">91.4</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">853,765</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">72.6</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5.33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">New investors purchasing shares in this offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">322,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27.4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">21.50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">175,314,776</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;100.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,176,265</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;100.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>  <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">Includes <FONT STYLE="white-space:nowrap">non-cash</FONT> consideration of $148.3&nbsp;million.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">The presentation in this table regarding ownership by existing stockholders does not give effect to any
purchases that existing stockholders may make through our directed share program or otherwise purchase in this offering. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Each $1.00 increase or decrease in the assumed initial public offering price per share, which is the midpoint of the price
range set forth on the cover page of this prospectus, would increase or decrease, as applicable, the total consideration paid by new investors, by approximately $15.0 million, and in the case of an increase, would increase the the percentage of
total consideration paid by new investors to 28.3% and, in the case of a decrease, would decrease the percentage of total consideration paid by new investors to 26.5%, assuming that the number of shares of common stock offered by us, as set forth on
the cover page of this prospectus, remains the same, and before deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. Similarly, each 1.0&nbsp;million share increase or decrease in the number of
shares offered by us would increase or decrease, as applicable, the total consideration paid by new investors by approximately $21.5 million, and in the case of an increase, would increase the the percentage of total consideration paid by new
investors to 28.7% and, in the case of a decrease, would decrease the percentage of total consideration paid by new investors to 26.1%, assuming the initial public offering price of $21.50 per share remains the same, and before deducting estimated
underwriting discounts and commissions and estimated offering expenses payable by us. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The foregoing tables assume no
exercise of the underwriters&#146; option to purchase additional shares or of outstanding stock options after September&nbsp;30, 2020. If the underwriters&#146; exercise their over-allotment option to purchase additional shares in full, the number
of shares of common stock held by our existing stockholders will represent approximately&nbsp;90.3% of the total number of shares of our common stock outstanding after this offering and the number of shares held by new investors will represent
approximately&nbsp;9.7% of the total number of shares of our common stock outstanding after this offering. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In
addition, to the extent any outstanding stock options or other equity awards are exercised, RSUs are settled, or we issue additional equity or convertible securities in the future, investors participating in this offering will experience further
dilution. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The foregoing tables and calculations (other than historical net tangible book value) are based on
160,314,776 shares of common stock outstanding as of September&nbsp;30, 2020 ((i) including 11,951,698 shares of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">99 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
unvested restricted common stock, and (ii)&nbsp;after giving effect to the automatic conversion of all of our shares of convertible preferred stock outstanding as of September&nbsp;30, 2020 into
an aggregate of 134,112,712 shares of our common stock immediately prior to the completion of this offering) and excludes: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">9,677,280 shares of common stock issuable upon exercise of stock options outstanding as of September&nbsp;30,
2020, with a <FONT STYLE="white-space:nowrap">weighted-average</FONT> exercise price of $2.32 per share; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">6,139,302 shares of common stock issuable upon exercise of stock options granted subsequent to
September&nbsp;30, 2020, with a <FONT STYLE="white-space:nowrap">weighted-average</FONT> exercise price of $7.92 per share; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">325,672 restricted stock units subject to vesting conditions and, as of September&nbsp;30, 2020, (of which
146,249 shares have satisfied the vesting conditions), and will become outstanding six months after the effective date of the completion of this offering; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">356,630 shares reserved for future issuance under our 2018 Equity Incentive Plan, as of September&nbsp;30,
2020; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">234,065 shares reserved for future issuance under our 2018 Equity Incentive Plan, which was increased
subsequent to September&nbsp;30, 2020; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a number of shares of our common stock equal to 8% of our outstanding common stock after this offering
reserved for future issuance under our 2021 Incentive Award Plan (the 2021 Plan), which will become effective on the date immediately prior to the date our registration statement relating to this offering becomes effective, as well as any future
increases in the number of shares of common stock reserved for issuance under the 2021 Plan; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a number of shares of our common stock equal to 1% of our outstanding common stock after this offering
reserved for future issuance under our Employee Stock Purchase Plan (the ESPP), which will become effective on the date immediately prior to the date our registration statement relating to this offering becomes effective, as well as any future
increases in the number of shares of common stock reserved for issuance under the ESPP. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">100 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc60414_9"></A>SELECTED CONSOLIDATED FINANCIAL DATA </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following tables set forth our selected consolidated financial data for the periods and as of the dates indicated. We have
derived the selected consolidated statements of operations data for the period from July&nbsp;13, 2018 (inception) to December&nbsp;31, 2018 and the year ended December&nbsp;31, 2019, except for pro forma amounts, and the selected consolidated
balance sheet data as of December&nbsp;31, 2018 and 2019 from our audited consolidated financial statements and related notes included elsewhere in this prospectus. We have derived the selected consolidated statements of operations data for the nine
months ended September&nbsp;30, 2019 and 2020, except for pro forma amounts, and the selected consolidated balance sheet data as of September&nbsp;30, 2020, except for pro forma amounts, from our unaudited condensed consolidated financial statements
and related notes included elsewhere in this prospectus. Our unaudited condensed consolidated financial statements were prepared on a basis consistent with our audited consolidated financial statements and include, in our opinion, all adjustments of
a normal and recurring nature that are necessary for the fair statement of the financial information set forth in those statements included elsewhere in this prospectus. Our historical results are not necessarily indicative of the results that may
be expected in the future and our interim results are not necessarily indicative of the results that may be expected for the full year. You should read the following consolidated financial data together with our audited consolidated financial
statements and our unaudited condensed consolidated financial statements and the related notes included elsewhere in this prospectus and the information in the section titled &#147;Management&#146;s Discussion and Analysis of Financial Condition and
Results of Operations.&#148; </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="46%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Period&nbsp;from&nbsp;July&nbsp;13,<BR>2018 (Inception) to<BR>December&nbsp;31, 2018</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended</B><br><B>December&nbsp;31,&nbsp;2019</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;Nine&nbsp;Months&nbsp;Ended&nbsp;September&nbsp;30,&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><B>(in thousands, except share and per share data)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Consolidated Statements of Operations Data:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">9,040</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">119,375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">80,101</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">153,762</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,206</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,777</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,959</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,063</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,246</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">141,152</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">96,060</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">172,825</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(13,246</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(141,152</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(96,060</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(172,825</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest income, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,856</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,175</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">622</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other (expense) income, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(29</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(52</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss before income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(13,247</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(138,325</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(93,937</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(172,135</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Benefit from income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,547</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,204</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(13,247</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(130,778</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(87,733</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(172,135</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss per share, basic and
diluted<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(13.91</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(26.68</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(24.24</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(14.05</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average shares outstanding used in computing net loss per share, basic and diluted<SUP
STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;952,086</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;4,902,642</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,620,021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,249,482</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma net loss per share, basic and diluted (unaudited)<SUP
STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(1.32</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(1.32</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average shares outstanding used in computing pro forma net loss per share, basic and
diluted (unaudited)<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">99,300,062</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">130,266,762</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">Research and development expense for the year ended December&nbsp;31, 2019 and the nine months ended
September&nbsp;30, 2019 and 2020 included <FONT STYLE="white-space:nowrap">non-cash</FONT> expense of $1.9&nbsp;million, $1.4&nbsp;million, and $40.6&nbsp;million for the success payment liabilities, respectively, and $17.9&nbsp;million,
$15.6&nbsp;million, and $16.7&nbsp;million for contingent consideration, respectively. Research and development expense for the year ended December&nbsp;31, 2019 and the nine months ended September 30, 2020 included
<FONT STYLE="white-space:nowrap">non-cash</FONT> expense of $11.9&nbsp;million and $0.4 </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">101 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:8pt">
million, respectively, in connection with license agreements. See Note&nbsp;3, Acquisitions, Note&nbsp;5, License and collaboration agreements, and Note&nbsp;7, Fair value measurements to each of
our audited consolidated financial statements and our unaudited condensed consolidated financial statements included elsewhere in this prospectus, and the subsection titled &#147;Management&#146;s Discussion and Analysis of Financial Condition and
Results of Operations&#148; for more detail on the success payments and contingent consideration. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">See Note&nbsp;15, Net loss per share to each of our audited consolidated financial statements and our
unaudited condensed consolidated financial statements included elsewhere in this prospectus for an explanation of the calculations of our basic and diluted net loss per share, and the weighted-average number of shares outstanding used in the
computation of the per share amounts. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">See the subsection titled &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results
of Operations&#151;Unaudited Pro Forma Information&#148; for an explanation of the calculations of our basic and diluted pro forma net loss per share, and the weighted-average number of shares outstanding used in the computation of the per share
amounts. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="65%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>September&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Consolidated Balance Sheet Data:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash, cash equivalents, and marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">30,630</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">138,982</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">459,070</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Working capital<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,811</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">124,434</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">429,031</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">415,698</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">767,715</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;45,721</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;417,359</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;852,897</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(13,247</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(144,127</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(316,262</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stockholders&#146; deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(13,188</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(142,542</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(311,175</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">We define working capital as current assets less current liabilities. See our consolidated financial
statements and unaudited condensed consolidated financial statements and the related notes included elsewhere in this prospectus for further details regarding our current assets and current liabilities. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">102 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc60414_10"></A>MANAGEMENT&#146;S DISCUSSION AND ANALYSIS OF </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FINANCIAL CONDITION AND RESULTS OF OPERATIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>You should read the following discussion and analysis of our financial condition and results of operations together with
the section titled &#147;Selected Consolidated Financial Data,&#148; and our audited consolidated financial statements and unaudited condensed consolidated financial statements and the related notes included elsewhere in this prospectus. This
discussion and analysis and other parts of this prospectus contain forward-looking statements based upon current beliefs, plans and expectations related to future events and our future financial performance that involve risks, uncertainties and
assumptions, such as statements regarding our intentions, plans, objectives and expectations for our business. Our actual results and the timing of selected events could differ materially from those described in or implied by these forward-looking
statements as a result of several factors, including those set forth in the section titled &#147;Risk Factors.&#148; See also the section titled &#147;Special Note Regarding Forward-Looking Statements.&#148; </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We were
founded on the belief that engineered cells will be one of the most important transformations in medicine over the next several decades. The burden of diseases that can be addressed at their root cause through engineered cells is significant. We
view engineered cells as having the potential to be as therapeutically disruptive as biologics to clinical practice. Our long-term aspirations are to be able to control or modify any gene in the body, to replace any cell that is damaged or missing,
and to markedly improve access to cellular and gene-based medicines. We have brought together an experienced group of scientists, engineers, and company builders and combined them with the necessary technologies to move this vision forward. We are
developing <I>in vivo</I> and <I>ex vivo</I> cell engineering platforms to revolutionize treatment across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system, cardiovascular diseases,
and genetic disorders, among others. While our current product candidates are all in preclinical development, our goal is to file multiple investigational new drug applications (INDs) both in 2022 and 2023. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The process of repairing and controlling genes in the body, referred to as gene therapy or <I>in vivo</I> cell engineering,
requires <I>in vivo</I> delivery of a therapeutic payload and modification of the genome. Of these, we believe delivery of a therapeutic payload represents the greatest unmet need and is thus at the core of our strategic focus, with our ultimate
goal being the delivery of any payload to any cell in a specific and repeatable way. Our initial effort is on cell-specific delivery and increasing the diversity and size of payloads. Using fusogen technology, we have shown in preclinical studies
that we can specifically target numerous cell surface receptors that, when combined with delivery vehicles to form fusosomes, allow cell-specific delivery across multiple different cell types. We have initially chosen to focus this technology on
delivering payloads to T cells, hepatocytes, and hematopoietic stem cells. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Frequently in disease, cells are damaged or
missing entirely, and an effective therapy needs to replace the entire cell, an approach referred to as cell therapy or <I>ex vivo</I> cell engineering. A successful therapeutic requires an ability to manufacture cells at scale that engraft,
function, and have the necessary persistence in the body. Of these, long-term persistence related to overcoming immunologic rejection of another person&#146;s cells has been the most challenging, which has led many to focus on autologous, or a
patient&#146;s own, cells as the therapeutic source. However, autologous therapies require a complex process of harvesting cells from the patients, manipulating them outside the body, and returning them to the patient. Products utilizing this
approach have had to manage significant challenges such as scalability, product variability, product quality, cost, patient accessibility, and a limited number of cell types being amenable to this approach. Given these limitations, rather than
utilizing autologous cells to overcome immune rejection, we have invested in creating hypoimmune cells that can &#147;hide&#148; from the patient&#146;s immune system. We are striving to make therapies utilizing pluripotent stem cells with our
hypoimmune genetic modifications as the starting material, which we then differentiate into a specific cell type, such as a pancreatic beta cell, before treating the patient. Additionally, for cell types for which effective differentiation protocols
from a stem cell have not yet been developed, such as T cells, instead of starting from a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">103 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
pluripotent stem cell, we can utilize an allogeneic cell, differentiated cells sourced from a donor, as the starting material to which we then apply our hypoimmune genetic modifications. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our <I>in vivo</I> and <I>ex vivo</I> cell engineering platforms combined with early investment in manufacturing have the
potential to treat a broad set of diseases and will require significant investment over the coming years to move them toward and then conduct clinical trials. We are in the early stages of development across a broad pipeline of product candidates,
all of which are currently in the preclinical stage of development and are summarized below: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>  <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g60414g55l64.jpg" ALT="LOGO">
 </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our <I>ex vivo</I> and <I>in vivo</I> technology represents an aggregation of years of
innovation and technology from multiple academic institutions and companies, including our fusogen technology acquired from Cobalt Biomedicines Inc. (Cobalt), our <I>ex vivo</I> cell engineering programs focused on replacing damaged cells in the
heart and certain brain disorders acquired from Cytocardia Inc. (Cytocardia) and Oscine Corp. (Oscine), respectively, and hypoimmune technology licensed from the President and Fellows of Harvard College (Harvard) and The Regents of the University of
California (UCSF), amongst others. See the subsections titled &#147;<I> &#151;</I>License and Collaboration Agreements&#148; and &#147;<I> &#151;</I>Acquisitions&#148; and Note&nbsp;3, Acquisitions and Note&nbsp;5, License and collaboration
agreements to each of our audited consolidated financial statements and unaudited condensed consolidated financial statements included elsewhere in this prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We were incorporated in July 2018 and commenced operations thereafter. Our operations to date have included developing our
<I>in vivo</I> and <I>ex vivo</I> cell engineering platforms, identifying and developing potential product candidates, executing preclinical studies, acquiring technology, organizing and staffing the company, business planning, establishing our
intellectual property portfolio, raising capital, and providing general and administrative support for these operations. All of our programs are currently in the development stage, and we do not have any products approved for sale. Since our
inception, we have incurred net losses each year. Our net losses were $13.2&nbsp;million and $130.8&nbsp;million for the period from July&nbsp;13, 2018 (inception) to December&nbsp;31, 2018 and for the year ended December&nbsp;31, 2019,
respectively, and $87.7&nbsp;million and $172.1&nbsp;million for the nine months ended September&nbsp;30, 2019 and 2020, respectively. As of September&nbsp;30, 2020, we had an accumulated deficit of $316.3&nbsp;million. Our net losses resulted
primarily from our research and development programs and, to a lesser extent, general and administrative costs associated with our operations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">To date, we have funded our operations from the issuance and sale of our convertible preferred stock and have not generated
any revenues. From July&nbsp;13, 2018 (inception) through September&nbsp;30, 2020, we raised an </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">104 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
aggregate of $705.5&nbsp;million in gross proceeds from the sales of our convertible preferred stock. Most recently, in June 2020, we closed our Series B convertible preferred stock financing and
raised an aggregate of $435.6&nbsp;million. As of September&nbsp;30, 2020, we had cash, cash equivalents, and marketable securities of $459.1&nbsp;million. Based on our current operating plan, we believe that our existing cash, cash equivalents, and
marketable securities, together with the net proceeds from this offering, will be sufficient to meet our working capital and capital expenditure needs for at least the next 36 months. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We anticipate that our expenses and operating losses will increase substantially over the foreseeable future. The expected
increase in expenses will be driven in large part by our ongoing activities, if and as we: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">continue to advance our <I>in vivo</I> and <I>ex vivo</I> cell engineering platforms; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">continue preclinical development of our current and future product candidates and initiate additional
preclinical studies; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">commence clinical studies of our current and future product candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establish our manufacturing capability, including developing our contract development and manufacturing
relationships, and building our internal manufacturing facilities; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">acquire and license technologies aligned with our <I>in vivo</I> and <I>ex vivo</I> cell engineering
platforms; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">seek regulatory approval of our current and future product candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expand our operational, financial, and management systems and increase personnel, including personnel to
support our preclinical and clinical development, manufacturing, and commercialization efforts; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">continue to develop, grow, perfect, and defend our intellectual property portfolio; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">incur additional legal, accounting, or other expenses in operating our business, including the additional
costs associated with operating as a public company. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are also investing early in building world
class capabilities in key areas of manufacturing sciences and operations, including development of our <I>in vivo</I> and <I>ex vivo</I> cell engineering platforms, product characterization, and process analytics from the time candidates are in
early research phases. Our investments also include scaled research solutions, scaled infrastructure, and novel technologies to improve efficiency, characterization, and scalability of manufacturing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The global <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic continues to evolve rapidly, and we will continue to
monitor it closely. The extent of the impact of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic on our business, operations, and clinical development timelines and plans remains uncertain and will depend on certain developments,
including the duration and spread of the outbreak and its impact on our clinical trial enrollment, trial sites, CROs, contract manufacturing organizations, and other third parties with whom we do business, as well as its impact on regulatory
authorities and our key scientific and management personnel. We have experienced modest delays in our discovery and development activities as a result of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic, primarily due to temporary and
partial shutdowns at certain of our CROs and academic institutions that have since resumed operations, and due to the Washington, California and Massachusetts
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">stay-at-home</FONT></FONT> orders where our operations are located. However, to the extent possible, we are conducting business as usual, with necessary or advisable modifications to
employee travel and most of our <FONT STYLE="white-space:nowrap">non-laboratory</FONT> employees working remotely. We will continue to actively monitor the situation related to <FONT STYLE="white-space:nowrap">COVID-19</FONT> and may take further
actions that alter our operations, including those that may be required by federal, state, or local authorities, or that we determine are in the best interests of our employees and other third parties with whom we do business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We anticipate that we will need to raise additional financing in the future to fund our operations, including the
commercialization of any approved product candidates. Until such time, if ever, as we can generate </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">105 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
significant product revenue, we expect to finance our operations with our existing cash, cash equivalents, and marketable securities, the net proceeds from this offering, any future equity or
debt financings, and upfront and milestone and royalties payments, if any, received under future licenses or collaborations. We may not be able to raise additional capital on terms acceptable to us or at all. If we are unable to raise additional
capital when desired, our business, results of operations, and financial condition would be adversely affected. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>License and Collaboration
Agreements </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Harvard </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In March&nbsp;2019, we entered into an exclusive license agreement with Harvard (the Harvard Agreement) to access certain
intellectual property for the development of hypoimmune cells. Under this agreement, we paid $3.0&nbsp;million in cash and issued 2,244,412 shares of our <FONT STYLE="white-space:nowrap">Series&nbsp;A-2</FONT> convertible preferred stock, valued at
$4.00 per share, for total consideration of $12.0&nbsp;million, which was recorded in research and development expense for the year ended December&nbsp;31, 2019. Additionally, we agreed to pay Harvard $6.0&nbsp;million in cash contingent upon the
closing of our Series B convertible preferred stock financing. As of December&nbsp;31, 2019, the estimated fair value of this contingent payment was $4.6&nbsp;million and was recorded in research and development expense with a corresponding
liability on our balance sheet. We closed the Series B convertible preferred stock financing in June 2020 and paid the $6.0&nbsp;million contingent payment to Harvard. As a result, an additional $1.4&nbsp;million was recorded in research and
development expense for the nine months ended September&nbsp;30, 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Pursuant to the Harvard Agreement we may be
required to make certain <FONT STYLE="white-space:nowrap">pre-specified</FONT> development and regulatory milestone payments up to an aggregate of up to $76.0&nbsp;million, which would double if we undergo a change of control. We do not expect to
make any payments for the pre-specified development milestones under the Harvard Agreement upon an IPO or within one year of an IPO. Additionally, we may be required to make success payments (Harvard Success Payments) up to an aggregate of
$175.0&nbsp;million based on increases in the fair value of our Series A convertible preferred stock, or any security into which such stock has been converted or exchanged. The potential Harvard Success Payments are based on multiples of increased
value ranging from 5x to 40x based on a comparison of the fair value of the Series A convertible preferred stock relative to its original $4.00 issuance price at <FONT STYLE="white-space:nowrap">pre-determined</FONT> valuation measurement dates. The
Harvard Success Payments can be achieved over a maximum of 12 years from the effective date of the agreement. The following table summarizes the potential success payments, which are payable in cash: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="63%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Multiple of Equity Value at Issuance</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>5x</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>10x</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>20x</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>30x</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>40x</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Per share Series A convertible preferred stock price required for payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">20.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">40.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">80.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">120.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">160.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Success payment(s) (in millions)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">30.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">50.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">75.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The valuation measurement dates are triggered by events which include: an equity
financing prior to an IPO of more than $25.0&nbsp;million, the one year anniversary of an IPO, and periodically thereafter, a merger, an asset sale, the sale of the majority of the shares held by Series A convertible preferred stockholders, and the
last day of the term of the success payments. If a higher success payment tier is met at the same time a lower tier is met, both tiers will be owed. Any previous success payments made under the Harvard Agreement are credited against the success
payment owed as of any valuation measurement date, so that Harvard does not receive multiple success payments in connection with the same threshold. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our liability for the Harvard Success Payments is carried at fair value with the initial valuation and subsequent changes in
value recognized in research and development expense. As of December&nbsp;31, 2019 and September&nbsp;30, 2020, the estimated fair value of the Harvard Success Payment liability was $1.9&nbsp;million and $7.4&nbsp;million, respectively. We recorded
research and development expense of $1.9&nbsp;million and $5.5&nbsp;million for the year ended December&nbsp;31, 2019 and the nine months ended September&nbsp;30, 2020, respectively, in connection with the Harvard Success Payments. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">106 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>The Regents of the University of California </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In January 2019, we entered into an exclusive license agreement with UCSF (the UCSF Agreement), as amended in December 2020, to
access certain intellectual property for the development of immunoengineered pluripotent cells. Pursuant to this agreement, we paid $0.1&nbsp;million in cash and issued 737,515 shares of our <FONT STYLE="white-space:nowrap">Series&nbsp;A-2</FONT>
convertible preferred stock, valued at $4.00 per share, for total consideration of $3.1&nbsp;million. The $3.1&nbsp;million was recorded in research and development expense for year ended December&nbsp;31, 2019. In addition, in December 2020,
pursuant to the amendment, we issued 37,500 shares of our common stock, valued at $7.80 per share, for total consideration of $0.3&nbsp;million. The $0.3&nbsp;million will be recorded as research and development expense for year ended
December&nbsp;31, 2020. Under the agreement, we may be required to make certain <FONT STYLE="white-space:nowrap">pre-specified</FONT> development milestone payments up to an aggregate of $22.4&nbsp;million. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Oscine Corp. </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In November 2018, we entered into a collaboration, license, and option to purchase agreement with Oscine (the Oscine Agreement)
to pursue research related to Oscine&#146;s glial progenitor <I>ex vivo</I> cell engineering programs focused on brain disorders. We paid a $5.0&nbsp;million <FONT STYLE="white-space:nowrap">non-refundable</FONT> upfront fee, which was recorded in
research and development expense for the period from July&nbsp;13, 2018 (inception) to December&nbsp;31, 2018. We recorded research and development expense of $0.2&nbsp;million, $4.2&nbsp;million and $3.4&nbsp;million for the period from
July&nbsp;13, 2018 (inception) to December&nbsp;31, 2018, the year ended December&nbsp;31, 2019 and the nine months ended September&nbsp;30, 2020, respectively. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In September 2020, we acquired Oscine for a total purchase price of $8.5&nbsp;million. See the subsection titled
&#147;&#151;Acquisitions&#148; for more information. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Acquisitions </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have completed the acquisitions summarized below. For further details regarding these acquisitions, see Note 3, Acquisitions
to each of our audited consolidated financial statements and unaudited condensed consolidated financial statements included elsewhere in this prospectus. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Oscine Corp. </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In September 2020, we acquired all of the outstanding equity of Oscine, a privately-held early-stage biotechnology company
developing glial progenitor <I>ex vivo</I> cell engineering programs focused on brain disorders for a purchase price of $8.5&nbsp;million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The transaction was accounted for as an asset acquisition of <FONT STYLE="white-space:nowrap">in-process</FONT> research and
development (IPR&amp;D) with the purchase price of $8.5&nbsp;million recorded in research and development expense for the nine months ended September&nbsp;30, 2020. Of the total purchase price, $7.6&nbsp;million was an upfront cash payment, and
$0.9&nbsp;million was set aside (the Oscine Holdback Amount) to satisfy certain general representations and warranties as set forth in the stock purchase agreement. The Oscine Holdback Amount will be held for 15 months, until December 2021, at which
time the remainder of the balance, after payment of any claims, will be released to the prior stockholders of Oscine. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We
are required to pay the prior stockholders of Oscine future milestone payments of up to an aggregate of $225.8&nbsp;million upon the achievement of certain <FONT STYLE="white-space:nowrap">pre-specified</FONT> development and commercial milestones.
No milestones had been achieved as of September&nbsp;30, 2020, and therefore no related amounts were recognized during the nine months ended September&nbsp;30, 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We incurred transaction costs of approximately $0.5&nbsp;million in connection with the Oscine acquisition. These costs were
included in general and administrative expense for the nine months ended September&nbsp;30, 2020. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">107 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Cytocardia, Inc. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In November 2019, we acquired all of the outstanding equity in Cytocardia, a privately-held early-stage biotechnology company
whose primary asset was <FONT STYLE="white-space:nowrap">in-process</FONT> research and development related to its <I>ex vivo</I> cell engineering programs focused on replacement of damaged heart cells. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The transaction was accounted for as an asset acquisition of IPR&amp;D with the purchase price of $8.0&nbsp;million recorded
as research and development expense for the year ended December&nbsp;31, 2019. Of the total purchase price, $6.8&nbsp;million was an upfront cash payment, and $1.2&nbsp;million was set aside (the Cytocardia Holdback Amount) to satisfy certain
general representations and warranties as set forth in the stock purchase agreement. The Cytocardia Holdback Amount will be held for 15 months, until February 2021, at which time the remainder of the balance, after payment of any claims, will be
released to the <FONT STYLE="white-space:nowrap">co-founders.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are required to pay the <FONT
STYLE="white-space:nowrap">co-founders</FONT> of Cytocardia future milestone payments of up to an aggregate of $140.0&nbsp;million upon the achievement of certain <FONT STYLE="white-space:nowrap">pre-specified</FONT> development, regulatory and
commercial milestones. No milestones had been achieved as of September&nbsp;30, 2020, and therefore no related amounts were recognized during the year ended December&nbsp;31, 2019 or the nine months ended September&nbsp;30, 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We incurred transaction costs of approximately $0.2&nbsp;million in connection with the Cytocardia acquisition. These costs
were included in general and administrative expense for the year ended December&nbsp;31, 2019. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Cobalt Biomedicine, Inc. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In February 2019, we acquired all of the outstanding equity in Cobalt, a privately-held early-stage biotechnology company
developing a platform technology using its fusogen technology to specifically and consistently deliver various biological payloads to cells. The Cobalt acquisition added <I>in vivo</I> cell engineering technology to complement our <I>ex vivo</I>
cell engineering technology. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The transaction was accounted for as an acquisition of a business with total
consideration of $189.7&nbsp;million. We issued 36,441,583 shares of our Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock, valued at $136.0&nbsp;million, and paid $28,000 in cash. Of the 36,441,583 shares of Series <FONT
STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock issued, 12,147,192&nbsp;shares were restricted until the achievement of a preclinical milestone, which was achieved in July 2019, at which time the restriction was lifted.
Additionally, 691,636 restricted stock awards and 345,814 restricted stock units were granted to former employees of Cobalt. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We also agreed to pay contingent consideration (Cobalt Contingent Consideration) of up to an aggregate of $500.0&nbsp;million
upon the achievement of certain <FONT STYLE="white-space:nowrap">pre-specified</FONT> development milestones, and a success payment (Cobalt Success Payment) of up to $500.0&nbsp;million. The Cobalt Success Payment will only be paid if, at <FONT
STYLE="white-space:nowrap">pre-determined</FONT> valuation measurement dates, our value is equal to or exceeds three times our implied value based on the per share value of the Series B convertible preferred stock at issuance, or any security into
which such stock has been converted or exchanged, and we have a program based on the fusogen technology in a clinical trial pursuant to an IND, or have filed for, or received approval for, a BLA or new drug application (NDA). The valuation
measurement dates for the Cobalt Success Payment are triggered by an arms&#146; length equity financing, or an IPO, and periodically thereafter. In addition to an arms&#146; length equity financing and an IPO, a valuation measurement date is
triggered upon a change of control when at least one of our programs based on the fusogen technology is the subject of an active research program. If there is a change of control and our valuation implied by the per share value of our Series&nbsp;B
convertible preferred stock at issuance, or any security into which such stock has been converted or exchanged falls below certain thresholds, the amount of the potential Cobalt Success Payment will decrease and the amount of potential Cobalt
Contingent Consideration will increase. See Note&nbsp;3, Acquisitions to each of our audited consolidated financial statements and our unaudited condensed consolidated financial statements included elsewhere in this prospectus for details on the
different Company valuation thresholds and impact to the value of the potential Cobalt Success Payment and potential Cobalt Contingent Consideration if there is a change of control. The Cobalt Contingent Consideration and Cobalt
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">108 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
Success Payment are payable in cash or stock, at our discretion. We expect the first valuation measurement date for the Cobalt Success Payment to be an IPO, but we do not expect to owe a Cobalt
Success Payment upon an IPO or within one year of an IPO. However, such payment is dependent on the future stock price which is unpredictable and may fluctuate significantly from quarter to quarter and year to year. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The estimated fair value of the Cobalt Contingent Consideration related to the
<FONT STYLE="white-space:nowrap">pre-specified</FONT> development milestones was $69.1&nbsp;million and $85.8&nbsp;million as of December&nbsp;31, 2019 and September&nbsp;30, 2020, respectively. For the year ended December&nbsp;31, 2019 and for the
nine months ended September&nbsp;30, 2020 we recorded research and development expense of $17.9&nbsp;million and $16.7&nbsp;million, respectively, in connection with the Cobalt Contingent Consideration. The estimated fair value of the Cobalt Success
Payment liability was $2.4&nbsp;million and $37.6&nbsp;million as of December&nbsp;31, 2019 and September&nbsp;30, 2020, respectively. The change in value of the Cobalt Success Payment liability from the acquisition date to December&nbsp;31, 2019
was immaterial. We recorded research and development expense of $35.2&nbsp;million for the nine months ended September&nbsp;30, 2020 in connection with the Cobalt Success Payment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The components of the $189.7&nbsp;million purchase price included an intangible asset of $59.2&nbsp;million, a deferred tax
liability of $7.5&nbsp;million, and net liabilities assumed of $2.6&nbsp;million, with the remaining amount of $140.6&nbsp;million recorded as goodwill. The estimated fair value of the intangible asset was determined using the replacement cost
method. The intangible asset is classified as an indefinite-lived asset until it becomes finite-lived upon the successful completion or the abandonment of the associated research and development technology. Accordingly, during the development period
after the date of acquisition, this asset will not be amortized until regulatory approval is obtained in a major market, typically either the United States or the European Union. At that time, we will determine the useful life of the asset and begin
amortization. If the associated research and development technology is abandoned, the related intangible asset will be <FONT STYLE="white-space:nowrap">written-off</FONT> and an impairment charge recorded. None of the goodwill is expected to be
deductible for income tax purposes. We have not recognized an impairment of goodwill or the intangible asset since inception.&nbsp;&nbsp;&nbsp;&nbsp; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We incurred $0.4&nbsp;million of transaction costs related to the Cobalt acquisition. These costs were included in general and
administrative expense for the year ended December&nbsp;31, 2019. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Components of Operating Results </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Operating Expenses </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Research and
Development </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">To date, research and development expenses have related primarily to discovery and development of our
platform technology and product candidates. Research and development expenses are recognized as incurred and payments made prior to the receipt of goods or services to be used in research and development are recorded as prepaid expenses until the
goods or services are received. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Research and development expenses consist of personnel-related costs, including salaries,
benefits, and <FONT STYLE="white-space:nowrap">non-cash</FONT> stock-based compensation, external research and development expenses incurred under arrangements with third parties, laboratory supplies, costs to acquire and license technologies
aligned with our goal of translating engineered cells to medicines, facility and other allocated expenses, including rent, depreciation, and allocated overhead costs, and other research and development expenses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Research and development expenses also include the change in the estimated fair value of the liabilities associated with our
success payments and contingent consideration. Research and development expense related to our success payment liabilities and contingent consideration is unpredictable and may vary significantly from quarter to quarter and year to year due to
changes in our assumptions used in the calculation. In addition, we may incur research and development expense to acquire and license technologies in the future, and the timing and amount of those expenses cannot be estimated with reliability and
may also fluctuate from quarter to quarter and year to year. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">109 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We deploy our employee and infrastructure resources across multiple research
and development programs for developing our <I>in vivo</I> and <I>ex vivo</I> cell engineering platforms, identifying and developing product candidates, and establishing manufacturing capabilities. Due to the number of ongoing projects and our
ability to use resources across several projects, the vast majority of our research and development costs are not recorded on a program-specific basis. These include costs for personnel, laboratory, and other indirect facility and operating costs.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Research and development activities account for a significant portion of our operating expenses. Excluding amounts
attributable to changes in the estimated fair value of our success payment liabilities and contingent consideration, we anticipate that our research and development expenses will increase over the foreseeable future as we expand our research and
development efforts including expanding the capabilities of our cell engineering platforms, identifying product candidates, completing preclinical studies and commencing clinical trials, seeking regulatory approval of our product candidates, and
incurring costs to acquire and license technologies aligned with our goal of translating engineered cells to medicines. A change in the outcome of any of these variables could mean a significant change in the costs and timing associated with the
development of our product candidates. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>General and Administrative </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">General and administrative expenses consist of personnel-related costs, including salaries, benefits, and <FONT
STYLE="white-space:nowrap">non-cash</FONT> stock-based compensation, for our employees in executive, legal, finance, human resources, information technology, and other administrative functions, legal fees, consulting fees, recruiting costs, and
facility costs not otherwise included in research and development expenses. Legal fees include those related to corporate and patent matters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We anticipate that our general and administrative expenses will increase over the foreseeable future to support our continued
research and development activities, operations generally, future business development opportunities, consulting fees, as well as due to the increased costs of operating as a public company. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Interest Income, Net </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Interest income, net consists of interest earned on our cash, cash equivalents and investment balance. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Benefit from Income Taxes </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Benefit from income taxes consists of the partial release of the valuation allowance on net deferred tax assets triggered by
the deferred tax liabilities recorded as a result of the acquisition of Cobalt in 2019. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">110 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Results of Operations </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Comparison of the Nine Months Ended September&nbsp;30, 2019 and 2020 </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following table summarizes our results of operations for the periods presented: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="57%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Nine&nbsp;Months&nbsp;Ended<BR>September&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">80,101</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">153,762</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">73,661</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,959</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,063</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,104</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;96,060</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;172,825</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;76,765</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(96,060</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(172,825</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(76,765</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest income, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,175</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">622</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,553</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income (expense), net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(52</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">120</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss before income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(93,937</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(172,135</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(78,198</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Benefit from income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,204</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,204</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(87,733</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(172,135</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(84,402</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Research and Development Expenses </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following table summarizes the components of our research and development expenses for the periods presented: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="58%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Nine Months Ended</B><br><B>September 30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Success payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,427</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">40,637</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">39,210</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Personnel</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,582</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33,288</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,706</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and laboratory</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,580</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,918</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,338</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Facility and other allocated costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,525</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,249</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,724</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Collaborations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,347</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,535</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,188</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contingent consideration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,564</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,672</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,108</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquisition and licensing of technology</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,473</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,352</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,121</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,603</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,111</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">508</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total research and development expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;80,101</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;153,762</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;73,661</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Research and development expenses were $80.1&nbsp;million and $153.8&nbsp;million for the nine
months ended September&nbsp;30, 2019 and 2020, respectively. The increase of $73.7&nbsp;million was primarily due to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an increase of $39.2&nbsp;million for the change in the estimated fair value of our Cobalt Success Payment and
Harvard Success Payment liabilities in aggregate; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">increased personnel-related expenses of $15.7&nbsp;million, including
<FONT STYLE="white-space:nowrap">non-cash</FONT> stock-based compensation of $1.7&nbsp;million, which was primarily attributable to an increase in headcount to expand our research and development capabilities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an increase of $15.3&nbsp;million in research and laboratory costs, including laboratory supplies, preclinical
studies, and other external research expenses; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">111 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an increase of $8.7&nbsp;million of facility and other allocated costs, including rent, depreciation, and
allocated overhead costs; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an increase of $1.2&nbsp;million for collaborative arrangements; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an increase of $1.1&nbsp;million for the change in the estimated fair value of the Cobalt Contingent
Consideration. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">These increases were partially offset by a decline in costs to acquire and license
technology of $8.1&nbsp;million due to costs incurred under the Harvard Agreement and UCSF Agreement in 2019, partially offset by the cost of the Oscine acquisition in 2020. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>General and Administrative Expenses </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">General and administrative expense were $16.0&nbsp;million and $19.1&nbsp;million for the nine months ended September&nbsp;30,
2019 and 2020, respectively. The increase of $3.1&nbsp;million was primarily due to increased personnel-related expenses of $1.6&nbsp;million primarily attributable to an increase in headcount to build our infrastructure, increased information
technology and facility costs including rent of $0.7&nbsp;million, and increased business taxes and insurance of $0.5&nbsp;million. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Interest Income, Net </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Interest income, net was $2.2&nbsp;million and $0.6&nbsp;million for the nine months ended September&nbsp;30, 2019 and 2020,
respectively. The decrease of $1.6&nbsp;million was due to lower interest rates on cash and investment balances. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Benefit from Income
Taxes </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Benefit from income taxes was $6.2&nbsp;million for the nine months ended September&nbsp;30, 2019, which was due
to a deferred tax liability of $7.5&nbsp;million associated with the intangible asset from the Cobalt acquisition. We recognized an income tax benefit of $6.2&nbsp;million for the release of valuation allowance on existing U.S. deferred tax assets
for the nine months ended September&nbsp;30, 2019. There was no benefit from income taxes for the nine months ended September&nbsp;30, 2020. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Comparison of the Period from July&nbsp;13, 2018 (Inception) to December&nbsp;31, 2018 and the Year Ended December&nbsp;31, 2019
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following table summarizes our results of operations for the periods presented: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="52%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Period&nbsp;from&nbsp;July&nbsp;13,<BR>2018 (Inception) to<BR>December 31, 2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year&nbsp;Ended<BR>December&nbsp;31,&nbsp;2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">9,040</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">119,375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">110,335</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,206</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,777</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,571</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,246</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">141,152</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">127,906</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(13,246</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(141,152</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(127,906</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest income, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,856</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,856</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other expense, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(29</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(28</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss before income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(13,247</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(138,325</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(125,078</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Benefit from income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,547</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,547</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(13,247</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(130,778</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(117,531</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">112 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Research and Development Expenses </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following table summarizes the components of our research and development expenses for the periods presented: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="55%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Period&nbsp;from&nbsp;July&nbsp;13,<BR>2018 (Inception) to<BR>December 31, 2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended<BR>December&nbsp;31,&nbsp;2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Change</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Personnel</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,073</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">30,378</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">28,305</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquisition and licensing of technology</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,773</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,748</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contingent consideration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,860</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,860</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Facility and other allocated costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,360</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,246</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,886</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and laboratory</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,302</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,269</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Collaborations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">199</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,543</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,344</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Consulting</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">327</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,038</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,711</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,235</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,212</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total research and development expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9,040</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;119,375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;110,335</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Research and development expenses were $9.0&nbsp;million for the period from July&nbsp;13,
2018 (inception) to December&nbsp;31, 2018 and $119.4&nbsp;million for the year ended December&nbsp;31, 2019. The increase of $110.4&nbsp;million was primarily due to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">increased personnel-related expenses of $28.3&nbsp;million, including
<FONT STYLE="white-space:nowrap">non-cash</FONT> stock-based compensation of $1.2&nbsp;million, which was primarily attributable to an increase in headcount to expand our research and development capabilities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an increase of $22.7&nbsp;million in costs to acquire and license technology associated with the Harvard
Agreement, UCSF Agreement, and the Cytocardia acquisition in 2019, partially offset by costs incurred in 2018 related to the Oscine Agreement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an increase of $17.9&nbsp;million for the change in the estimated fair value of the Cobalt Contingent
Consideration; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an increase of $16.9&nbsp;million of facility and other allocated costs, including rent, depreciation, and
allocated overhead costs; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an increase of $13.3&nbsp;million in research and laboratory costs, including laboratory supplies, preclinical
studies, and other external research expenses; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an increase of $6.3&nbsp;million for collaborative arrangements; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an increase of $2.7&nbsp;million in consulting fees. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>General and Administrative Expenses </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">General and administrative expenses were $4.2&nbsp;million for the period from July&nbsp;13, 2018 (inception) to
December&nbsp;31, 2018 and $21.8&nbsp;million for the year ended December&nbsp;31, 2019. The increase of $17.6&nbsp;million was primarily due increased personnel-related expenses of $9.1&nbsp;million primarily attributable to an increase in
headcount to build our infrastructure, increased consulting and legal fees of $4.0&nbsp;million, and increased information technology and facility costs, including rent, of $3.9&nbsp;million. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Interest Income, Net </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Interest income, net was $2.9&nbsp;million for the year ended December&nbsp;31, 2019, which included interest earned on our
cash, cash equivalents, and short-term investment balances. There was no interest income, net for the period from July&nbsp;13, 2018 (inception) to December&nbsp;31, 2018. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">113 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Benefit from Income Taxes </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Benefit from income taxes was $7.5&nbsp;million for the year ended December&nbsp;31, 2019, which was due to a deferred tax
liability of $7.5&nbsp;million associated with the intangible asset from the Cobalt acquisition. We recognized an income tax benefit of $7.5&nbsp;million for the release of valuation allowance on existing U.S. deferred tax assets for the year ended
December&nbsp;31, 2019. There was no benefit from income taxes for the period from July&nbsp;13, 2018 (inception) to December&nbsp;31, 2018. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Unaudited
Pro Forma Information </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Immediately prior to the completion of this offering, all outstanding shares of our
convertible preferred stock will automatically convert into shares of our common stock assuming the sale of shares in this offering at the assumed public offering price of $21.50 per share, the midpoint of the price range set forth on the cover page
of this prospectus. The unaudited pro forma basic and diluted net loss per share for the year ended December&nbsp;31, 2019 and the nine months ended September&nbsp;30, 2020 were computed using the weighted-average number of shares of common stock
outstanding, including the pro forma effect of the conversion of all outstanding shares of convertible preferred stock into shares of common stock, as if such conversion had occurred at the beginning of the period, or their issuance dates if later.
Pro forma net loss per share does not include the shares expected to be sold in this offering. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following table
sets forth the computation of the unaudited pro forma basic and diluted net loss per share of common stock for the periods presented: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended<BR>December&nbsp;31,&nbsp;2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Nine&nbsp;Months&nbsp;Ended<BR>September&nbsp;30,&nbsp;2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(in&nbsp;thousands,&nbsp;except&nbsp;share&nbsp;and&nbsp;per&nbsp;share&nbsp;data)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Numerator:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss used in calculating pro forma net loss per share, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(130,778</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(172,135</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Denominator:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average common shares outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,902,642</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,249,482</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">94,397,420</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">118,017,279</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma weighted-average shares outstanding, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">99,300,062</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">130,266,761</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma net loss per share, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(1.32</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(1.32</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Liquidity, Capital Resources, and Capital Requirements </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Sources of Liquidity </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Since our inception, we have funded our operations through the sale and issuance of convertible preferred stock. From
July&nbsp;13, 2018 (inception) through September&nbsp;30, 2020, we raised an aggregate of $705.5&nbsp;million in gross proceeds from the sales of our convertible preferred stock. Most recently, in June 2020, we closed our Series B convertible
preferred stock financing and raised an aggregate of $435.6&nbsp;million. As of September&nbsp;30, 2020, we had $459.1&nbsp;million in cash, cash equivalents, and marketable securities. Since our inception, we have not generated any revenue from
product sales or any other sources, and we have incurred significant operating losses. We have not yet commercialized any products and we do not expect to generate revenue from sales of any product candidates for a number of years, if ever. We had
an accumulated deficit of $316.3&nbsp;million as of September&nbsp;30, 2020. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Future Funding Requirements </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We expect to incur additional losses in the foreseeable future as we conduct and expand our research and development efforts,
including conducting preclinical studies and clinical trials, developing new product </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">114 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
candidates, establishing internal and external manufacturing capabilities, and funding our operations generally. Based on our current operating plan, we believe that our existing cash, cash
equivalents, and marketable securities, together with the net proceeds from this offering, will be sufficient to meet our working capital and capital expenditure needs for at least the next 36 months. However, we anticipate that we will need to
raise additional financing in the future to fund our operations, including the commercialization of any approved product candidates. We are subject to the risks typically related to the development of new products, and we may encounter unforeseen
expenses, difficulties, complications, delays, and other unknown factors that may adversely affect our business. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our
future capital requirements will depend on many factors, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the scope, timing, progress, costs, and results of discovery, preclinical development, and clinical trials for
our current and future product candidates; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the number of clinical trials required for regulatory approval of our current and future product candidates;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the costs, timing, and outcome of regulatory review of any of our current and future product candidates;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the cost of manufacturing clinical and commercial supplies of our current and future product candidates;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the costs and timing of future commercialization activities, including manufacturing, marketing, sales, and
distribution, for any of our product candidates for which we receive marketing approval; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the costs and timing of preparing, filing, and prosecuting patent applications, maintaining and enforcing our
intellectual property rights, and defending any intellectual property-related claims, including any claims by third parties that we are infringing upon their intellectual property rights; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to maintain existing, and establish new, strategic collaborations, licensing, or other
arrangements and the financial terms of any such agreements, including the timing and amount of any future milestone, royalty, or other payments due under any such agreement; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the revenue, if any, received from commercial sales of our product candidates for which we receive marketing
approval; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expenses to attract, hire and retain, skilled personnel; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the costs of operating as a public company; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to establish a commercially viable pricing structure and obtain approval for coverage and adequate
reimbursement from third-party and government payers; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">addressing any potential interruptions or delays resulting from factors related to the <FONT
STYLE="white-space:nowrap">COVID-19</FONT> pandemic; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the effect of competing technological and market developments; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the extent to which we acquire or invest in businesses, products, and technologies. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Until such time as we can generate significant revenue from product sales, if ever, we expect to finance our operations from
the sale of additional equity or debt financings, or other capital which come in the form of strategic collaborations, licensing, or other arrangements. In the event that additional financing is required, we may not be able to raise it on terms
acceptable to us, or at all. If we raise additional funds through the issuance of equity or convertible debt securities, it may result in dilution to our existing stockholders. Debt financing or preferred equity financing, if available, may result
in increased fixed payment obligations, and the existence of securities with rights that may be senior to those of our common stock. If we incur indebtedness, we could become subject to covenants that would restrict our operations. If we raise funds
through strategic collaboration, licensing </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">115 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
or other arrangements, we may relinquish significant rights or grant licenses on terms that are not favorable to us. Our ability to raise additional funds may be adversely impacted by potential
worsening global economic conditions and the recent disruptions to, and volatility in, the credit and financial markets in the United States and worldwide resulting from the ongoing <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic and
otherwise. If we are unable to raise additional capital when desired, our business, results of operations, and financial condition would be adversely affected. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Cash Flows </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The
following table summarizes our cash flows for the periods indicated: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="44%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Period&nbsp;from&nbsp;July&nbsp;13,<BR>2018 (Inception) to</B><br><B>December 31,&nbsp;2018</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Year&nbsp;Ended</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>December&nbsp;31,&nbsp;2019</B></P></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Nine Months Ended<BR>September 30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash provided by (used in):</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(13,495</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(85,504</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(51,708</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(100,423</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investing activities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(780</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(87,861</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(114,644</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(265,604</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financing activities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,721</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">223,726</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">215,911</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">435,584</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net increase in cash, cash equivalents, and restricted cash</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;31,446</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;50,361</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">49,559</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">69,557</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Operating Activities </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">During the nine months ended September&nbsp;30, 2020, net cash used in operating activities was $100.4&nbsp;million, consisting
primarily of our net loss of $172.1&nbsp;million partially offset by <FONT STYLE="white-space:nowrap">non-cash</FONT> charges of $68.2&nbsp;million and an increase in our net operating assets of $3.5&nbsp;million. The
<FONT STYLE="white-space:nowrap">non-cash</FONT> charges of $68.2&nbsp;million consisted of $40.6&nbsp;million for revaluation of our success payment liabilities, $16.7&nbsp;million for revaluation of contingent consideration, depreciation expense
of $4.2&nbsp;million, <FONT STYLE="white-space:nowrap">non-cash</FONT> stock-based compensation expense of $3.0&nbsp;million, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets lease expense of
$2.9&nbsp;million, and other <FONT STYLE="white-space:nowrap">non-cash</FONT> charges of $0.8&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">During the
nine months ended September&nbsp;30, 2019, net cash used in operating activities was $51.7&nbsp;million, consisting primarily of our net loss of $87.7&nbsp;million and a tax benefit of $6.2&nbsp;million recorded in connection with the Cobalt
acquisition, partially offset by <FONT STYLE="white-space:nowrap">non-cash</FONT> charges of $36.3&nbsp;million and an increase in our net operating assets of $5.9&nbsp;million. The <FONT STYLE="white-space:nowrap">non-cash</FONT> charges of
$36.3&nbsp;million consisted primarily of $15.6&nbsp;million for revaluation of contingent consideration, $11.9&nbsp;million for the issuance of stock in connection with license agreements, $5.8&nbsp;million for revaluation of our success payment
liabilities and contingent liabilities, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets lease expense of $1.6&nbsp;million, and other <FONT STYLE="white-space:nowrap">non-cash</FONT> charges of
$1.4&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">During the year ended December&nbsp;31, 2019, net cash used in operating activities was
$85.5&nbsp;million, consisting primarily of our net loss of $130.8&nbsp;million and a tax benefit of $7.5&nbsp;million recorded in connection with the Cobalt acquisition, partially offset by <FONT STYLE="white-space:nowrap">non-cash</FONT> charges
of $42.3&nbsp;million and an increase in our net operating assets of $10.5&nbsp;million. The <FONT STYLE="white-space:nowrap">non-cash</FONT> charges of $42.3&nbsp;million consisted of $17.9&nbsp;million for revaluation of contingent consideration,
$11.9&nbsp;million for the issuance of stock in connection with license agreements, $6.5&nbsp;million for revaluation of success payment and contingent liabilities, depreciation expense of $1.8&nbsp;million, and other
<FONT STYLE="white-space:nowrap">non-cash</FONT> charges of $4.2&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">During the period from July&nbsp;13, 2018
(inception) to December&nbsp;31, 2018, net cash used in operating activities was $13.5&nbsp;million, consisting primarily of our net loss of $13.2&nbsp;million. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Investing Activities </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">During the nine months ended September&nbsp;30, 2020, cash used in investing activities was $265.6&nbsp;million, consisting
primarily of net purchases, sales, and maturities of marketable securities of $251.0&nbsp;million and purchases of property and equipment of $14.6&nbsp;million. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">116 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">During the nine months ended September&nbsp;30, 2019, cash used in investing
activities was $114.6&nbsp;million, consisting primarily of net purchases and maturities of marketable securities of $91.0&nbsp;million, purchases of property and equipment of $20.4&nbsp;million, and net cash used for an acquisition of
$3.2&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">During the year ended December&nbsp;31, 2019, cash used in investing activities was
$87.9&nbsp;million, consisting primarily of net purchases and maturities of marketable securities of $58.5&nbsp;million, purchases of property and equipment of $26.2&nbsp;million, and net cash used for an acquisition of $3.2&nbsp;million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">During the period from July&nbsp;13, 2018 (inception) to December&nbsp;31, 2018, cash used in investing activities was
$0.8&nbsp;million, consisting of purchases of property and equipment of $0.5&nbsp;million and the issuance of a promissory note of $0.3&nbsp;million. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Financing Activities </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">During the nine months ended September&nbsp;30, 2020, cash provided by financing activities was $435.6&nbsp;million, consisting
primarily of net proceeds from the sale of our convertible preferred stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">During the nine months ended
September&nbsp;30, 2019, cash provided by financing activities was $215.9&nbsp;million, consisting primarily of net proceeds from the sale of our convertible preferred stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">During the year ended December&nbsp;31, 2019, cash provided by financing activities was $223.7&nbsp;million, consisting
primarily of net proceeds from the sale of our convertible preferred stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">During the period from July&nbsp;13, 2018
(inception) to December&nbsp;31, 2018, cash provided by financing activities was $45.7&nbsp;million, consisting primarily of net proceeds from the sale of our convertible preferred stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Contractual Obligations and Commitments </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following table summarizes our significant contractual obligations and commitments as of December&nbsp;31, 2019: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Payments Due by Period</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Less&nbsp;than&nbsp;1&nbsp;Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>1&nbsp;to&nbsp;3&nbsp;Years</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>3&nbsp;to&nbsp;5&nbsp;Years</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>More&nbsp;than&nbsp;5&nbsp;Years</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating leases<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;6,624</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;17,429</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;18,580</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;41,494</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;84,127</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">This table does not include the operating leases we entered into in Seattle, WA in September 2020 and
Cambridge, MA in January and May 2020. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Other than as disclosed in the table above, the payment
obligations under our license, collaboration, and acquisition agreements as of December&nbsp;31, 2019 are contingent upon future events such as our achievement of pre-defined development, regulatory, and commercial milestones, or royalties on net
product sales. See the section titled &#147;Business<I>&#151;</I>Key Intellectual Property Agreements&#148; for more information about these payment obligations. We are also obligated to make a Cobalt Success Payment of up to $500.0&nbsp;million if,
at <FONT STYLE="white-space:nowrap">pre-determined</FONT> valuation measurement dates, the value of our company meets or exceeds certain thresholds and we have an active program based on the fusogen technology in a clinical trial pursuant to an IND,
or have filed for or received approval for, a BLA or NDA. We may also make Harvard Success Payments up to an aggregate of $175.0&nbsp;million based on increases in the fair value of our Series A convertible preferred stock at <FONT
STYLE="white-space:nowrap">pre-defined</FONT> valuation measurement dates. See the subsection titled &#147;<I>&#151;</I>Critical Accounting Policies and Significant Judgments and Estimates&#151;Success Payments.&#148; The Cobalt Success Payment is
payable in cash or stock, at our discretion, and the Harvard Success Payments are payable in cash. As of December&nbsp;31, 2019, the timing and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">117 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
likelihood of achieving the milestones and success payments and generating future product sales are uncertain and therefore, any related payments are not included in the table above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We also enter into agreements in the normal course of business for sponsored research, preclinical studies, contract
manufacturing, and other services and products for operating purposes, which are generally cancelable upon written notice. These obligations and commitments are not included in the table above. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Off-Balance&nbsp;Sheet</FONT> Arrangements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Since our inception, we have not engaged in <FONT STYLE="white-space:nowrap">any&nbsp;off-balance&nbsp;sheet</FONT>
arrangements as defined under the rules and regulations of the SEC. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Quantitative and Qualitative Disclosures About Market Risk </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are exposed to market risks in the ordinary course of our business. These risks primarily include interest rate
sensitivities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Interest Rate Risk </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We had cash, cash equivalents, and restricted cash of $151.4&nbsp;million as of September&nbsp;30, 2020, which consisted of
bank deposits and money market funds. We also had marketable securities of $309.8&nbsp;million as of September&nbsp;30, 2020. The primary objective of our investment activities is to preserve capital to fund our operations while earning a low risk
return. Because our marketable securities are primarily short-term in duration, we believe that our exposure to interest rate risk is not significant, and a hypothetical 1% change in market interest rates during any of the periods presented would
not have had a significant impact on the total value of our portfolio. We had no debt outstanding as of September&nbsp;30, 2020. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>JOBS Act Accounting
Election </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are an &#147;emerging growth company,&#148; as defined in the Jumpstart Our Business Startups Act of 2012
(the JOBS Act). For so long as we remain an emerging growth company, we are permitted and intend to rely on certain exemptions from various public company reporting requirements, including not being required to have our internal control over
financial reporting audited by our independent registered public accounting firm pursuant to Section&nbsp;404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements,
and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and any golden parachute payments not previously approved. In particular, in this prospectus, we have provided only two years of audited financial
statements and have not included all of the executive compensation-related information that would be required if we were not an emerging growth company. Accordingly, the information contained herein may be different than the information you receive
from other public companies in which you hold stock. In addition, under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those
standards apply to private companies. We have elected to use the extended transition period for any new or revised accounting standards during the period in which we remain an emerging growth company; however, we may adopt certain new or revised
accounting standards early. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Critical Accounting Policies and Significant Judgments and Estimates </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our audited consolidated financial statements and our unaudited condensed consolidated financial statements are prepared in
accordance with generally accepted accounting principles in the United States. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure
of contingent assets and liabilities at the date of the audited consolidated financial statements and the unaudited condensed consolidated financial statements, as well as the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">118 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
reported expenses incurred during the reporting periods. Our estimates are based on our historical experience and on various other factors that we believe are reasonable under the circumstances,
the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.
While our significant accounting policies are described in more detail in the notes to our audited consolidated financial statements and our unaudited condensed consolidated financial statements included elsewhere in this prospectus, we believe that
the following accounting policies are critical to understanding our historical and future performance, as these policies relate to the more significant areas involving management&#146;s judgments and estimates. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Research and Development Expenses </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We record research and development costs in the periods in which they are incurred. We accrue for research and development
costs based on the estimated services performed, but not yet invoiced, pursuant to contracts with research institutions or other service providers that conduct and manage preclinical studies and other research services on our behalf and record these
costs in accrued and other current liabilities. We make judgments and estimates in determining the accrued liabilities balance at each reporting period. Payments made prior to the receipt of goods or services to be used in research and development
are recorded as prepaid expenses until the goods or services are received. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Research and development costs also include
the estimated fair value of the potential liabilities associated with our Harvard Success Payments, Cobalt Success Payment, and Cobalt Contingent Consideration. See the subsections titled &#147;&#151;Contingent Consideration&#148; and
&#147;&#151;Success Payments.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">To date, we have not experienced any material differences between accrued costs and
actual costs incurred. However, the status and timing of actual services performed may vary from our estimates, resulting in adjustments to expense in future periods. Changes in these estimates that result in material changes to our accruals could
materially affect our results of operations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Acquisitions </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We account for business combinations using the acquisition method of accounting, which requires the assets acquired, including
IPR&amp;D, and liabilities assumed, be recorded at their fair values as of the acquisition date. Any excess of the purchase price over the fair value of net assets acquired is recorded as goodwill. The determination of the estimated fair value of
these items requires us to make significant estimates and assumptions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If we determine the acquisition does not meet the
definition of a business combination under the acquisition method of accounting, the transaction is accounted for as an asset acquisition and no goodwill or contingent consideration are recognized at the acquisition date. In an asset acquisition, <FONT
STYLE="white-space:nowrap">up-front</FONT> payments allocated to IPR&amp;D are recorded in research and development expense if there is no alternative future use, and subsequent milestone payments are recorded in research and development expense
when achieved. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Intangible Assets and Goodwill </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Accounting for business combinations requires us to make significant estimates and assumptions with respect to tangible and
intangible assets acquired and assumed liabilities. We use our best estimates and assumptions to accurately assign fair value to the tangible and intangible assets acquired and liabilities assumed at the acquisition date as well as the useful lives
of those acquired intangible assets. Intangible assets are reviewed for impairment annually and upon the occurrence of triggering events or substantive changes in circumstances that could indicate a potential impairment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">119 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Goodwill represents the excess of the purchase price over the estimated fair
value of the identifiable assets acquired and liabilities assumed in a business combination. We evaluate goodwill for impairment annually and upon the occurrence of triggering events or substantive changes in circumstances that could indicate a
potential impairment. Our evaluation includes assessing qualitative factors or performing a quantitative analysis to determine whether it is <FONT STYLE="white-space:nowrap">more-likely-than-not</FONT> that the fair value of net assets are below the
carrying amounts. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Contingent Consideration </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">At the acquisition date of a business combination and at each subsequent balance sheet date, contingent consideration
obligations are remeasured to fair value. Any changes in fair value between balance sheet dates are recognized in research and development expense. We utilize significant estimates and assumptions in determining the estimated contingent
consideration and associated expense or gain at each balance sheet date including assumptions regarding the progress toward achieving milestones. The valuation of contingent consideration uses assumptions we believe would be made by a market
participant. In evaluating the fair value of contingent consideration, judgment is required to interpret the market data used to develop the estimates. We assess these estimates on an <FONT STYLE="white-space:nowrap">on-going</FONT> basis as
additional data impacting the assumptions are obtained. Contingent consideration may change significantly as development progresses and additional data are obtained, impacting our assumptions regarding probabilities of successful achievement of the
related milestones used to estimate the fair value of the liability and the timing in which they are expected to be achieved. Accordingly, the use of different market assumptions and/or different valuation techniques could result in materially
different fair value estimates. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Success Payments </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We granted rights to success payments to Cobalt and Harvard pursuant to the terms of our acquisition agreement and license
agreement with each of those entities, respectively. Pursuant to the terms of the Cobalt Agreement, we may be required to make a success payment, if, at pre-determined valuation measurement dates, our value is equal to or exceeds three times our
implied value based on the per share value of our Series B convertible preferred stock at issuance, or any security into which such stock has been converted or exchanged, and we have an active program based on the fusogen technology in a clinical
trial pursuant to an IND, or have filed for, or received approval for, a BLA or NDA. The payment can be made in cash or stock, at our discretion. Pursuant to the terms of the Harvard Agreement, we may be required to make success payments in cash
based on increases in the per share value of our Series A convertible preferred stock at <FONT STYLE="white-space:nowrap">pre-determined</FONT> valuation measurement dates. The Cobalt and Harvard Success Payments are accounted for under Accounting
Standards Codification 815, <I>Derivatives and Hedging</I>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Success payment liabilities are estimated at fair value at
inception and at each subsequent balance sheet date with changes recorded in research and development expense. To determine the estimated fair value of the success payment liabilities we use a Monte Carlo simulation methodology which models the
value of the liability based on several key variables, including the estimated number and timing of valuation measurement dates on the basis of which payments may be triggered, expected volatility, term of the success payments, and the risk-free
interest rate. Additionally, the Cobalt Success Payment liability incorporates our estimated future value implied by the per share value of the Series B convertible preferred stock at issuance, or any security into which such stock has been
converted or exchanged. The Harvard Success Payment liability incorporates the estimated future fair value of our Series A convertible preferred stock. The computation of expected volatility is estimated using peer company stocks for a time period
matching the expected term assumption. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stock-Based Compensation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We recognize compensation costs related to restricted stock awards, restricted stock units, and stock options granted to
employees and nonemployees based on the estimated fair value of the awards on the date of grant, and we recognize forfeitures as they occur. For restricted stock awards the fair value of our common stock is used to determine the resulting
stock-based compensation expense. For stock options we estimate the grant date fair </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">120 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
value, and the resulting stock-based compensation expense, using the Black-Scholes option pricing model. The fair value of the stock-based awards is recognized as an expense on a straight-line
basis over the requisite service period, which is generally the vesting period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Black-Scholes option pricing model
requires the use of highly subjective assumptions to determine the fair value of stock-based awards. These assumptions include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Fair Value of </I><I>Common</I><I> Stock</I>&#151;See the subsection titled &#147;&#151;Common Stock
Valuations.&#148; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Expected Term</I>&#151;The expected term represents the period that the stock-based awards are expected to
be outstanding. We use the simplified method to determine the expected term, which is based on the average of the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">time-to-vesting</FONT></FONT> and the contractual life of the
options. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Expected Volatility</I>&#151;Since we are not yet a public company and do not have any trading history for
our common stock, the expected volatility is estimated based on the average historical volatilities of common stock of comparable publicly traded entities over a time period equal to the expected term of the stock option grants. The comparable
companies are chosen based on their size, stage in the product development cycle, and area of specialty. We will continue to apply this process until sufficient historical information regarding the volatility of our own stock price becomes
available. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Risk-Free Interest Rate</I>&#151;The risk-free interest rate is based on the U.S. Treasury yield in effect
at the time of grant for <FONT STYLE="white-space:nowrap">zero-coupon</FONT> U.S. Treasury notes with maturities approximately equal to the expected term of the awards. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Expected Dividend</I>&#151;We have never paid dividends on our common stock and have no plans to pay
dividends on our common stock. Therefore, we used an expected dividend yield of zero. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">See Note 13,
Stock-based compensation to each of our audited consolidated financial statements and our unaudited condensed consolidated financial statements included elsewhere in this prospectus for information concerning certain of the specific assumptions we
used in applying the Black-Scholes option pricing model to determine the estimated fair value of our stock options granted in the period from July&nbsp;13, 2018 (inception) to December&nbsp;31, 2018, the year ended December&nbsp;31, 2019, and the
nine months ended September&nbsp;30, 2020. Such assumptions involve inherent uncertainties and the application of significant judgment. As a result, if factors or expected outcomes change and we use significantly different assumptions or estimates,
our stock-based compensation could be materially different. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The intrinsic value of all outstanding options as of
September&nbsp;30, 2020 was approximately $264.1 million, based on the assumed IPO price of $21.50 per share, which is the midpoint of the estimated IPO price range set forth on the cover page of this prospectus, of which approximately $25.5 million
is related to vested options and approximately $238.6 million is related to unvested options. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Common Stock Valuations </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Prior to this offering, we were a privately-held company with no active public market for our common stock. Therefore, our
board of directors, with the assistance and upon the recommendation of management, has for financial reporting purposes periodically determined the estimated per share fair value of our common stock on the date of grant in part using contemporaneous
independent third-party valuations consistent with the American Institute of Certified Public Accountants Practice Aid, <I>Valuation of Privately-Held Company Equity Securities Issued as Compensation</I> (Practice Aid). Within the contemporaneous
valuations performed by our board of directors, a range of factors, assumptions, and methodologies were used. The significant objective and subjective factors included, but are not limited to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our most recently available valuations of our common stock performed by an independent third-party valuation
firm; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the prices of shares of our convertible preferred stock sold to investors in arm&#146;s length transactions,
and the rights, preferences and privileges of our convertible preferred stock relative to our common stock; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">121 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">committed future rounds of funding; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our stage of development and material risks related to our business; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our results of operations and financial position, including our levels of available capital resources;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">progress of our research and development activities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the lack of marketability of our common stock as a private company; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the hiring of key personnel and the experience of management; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the likelihood of achieving a liquidity event for our securityholders, such as an IPO or a sale of our
company, given prevailing market conditions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the valuation of publicly traded companies in the life sciences and biotechnology sectors, as well as recently
completed mergers and acquisitions of peer companies; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the status of strategic transactions, including the acquisition of intellectual property and technology;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">trends and developments in our industry; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">external market conditions affecting the life sciences and biotechnology industry sectors.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our board of directors exercises significant judgment in estimating the fair value of our common stock.
Such estimates involve inherent uncertainties and the application of significant judgment. As a result, if factors or expected outcomes change and we use significantly different assumptions or estimates, our equity-based compensation could be
materially different. Changes in judgments could have a material impact on our results of operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For our valuations
performed prior to September&nbsp;30, 2020, in accordance with the Practice Aid, we determined the option pricing model (OPM) backsolve method was the most appropriate method for determining the fair value of our common stock based on our stage of
development and other relevant factors. In an OPM framework, the backsolve method for inferring the equity value implied by a recent financing transaction involves making assumptions for the expected time to liquidity, volatility, discount for lack
of marketability, and risk-free rate and then solving for the value of equity such that value for the most recent financing equals the amount paid. This method was selected as management concluded that the contemporaneous financing transactions were
arms&#146;-length transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For our valuations performed on or subsequent to September&nbsp;30, 2020, in accordance
with the Practice Aid, we determined the hybrid method of the OPM and the Probability-Weighted Expected Return Method (PWERM) was the most appropriate method for determining the fair value of our common stock based on our stage of development and
other relevant factors. The PWERM considers various potential liquidity outcomes. Our approach included assumptions for different timing of IPO scenarios, the sale of our company, and dissolution. Under the hybrid OPM and PWERM method, the per share
value calculated under the OPM and PWERM are weighted based on expected exit outcomes and the quality of the information specific to each allocation methodology to arrive at a final estimated fair value per share value of the common stock before a
discount for lack of marketability is applied. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Following the closing of this offering, our board of directors will
determine the fair market value of our common stock based on its closing price as reported on the date of grant on the primary stock exchange on which our common stock is traded. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recently Adopted and Recent Accounting Pronouncements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">See Note&nbsp;2, Summary of significant accounting policies to each of our audited consolidated financial statements and
unaudited condensed consolidated financial statements included elsewhere in this prospectus for information about recent accounting pronouncements, the timing of their adoption, and our assessment, to the extent we have made one yet, of their
potential impact on our financial condition or results of operations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">122 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc60414_11"></A>BUSINESS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We were founded
on the belief that engineered cells will be one of the most important transformations in medicine over the next several decades. The burden of diseases that can be addressed at their root cause through engineered cells is significant. We view
engineered cells as having the potential to be as therapeutically disruptive as biologics to clinical practice. Our long-term aspirations are to be able to control or modify any gene in the body, to replace any cell that is damaged or missing, and
to markedly improve access to cellular and gene-based medicines. We have brought together an experienced group of scientists, engineers, and company builders and combined them with the necessary technologies to move this vision forward. We are
developing <I>in vivo</I> and <I>ex vivo </I>cell engineering platforms to revolutionize treatment across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system (CNS) disorders,
cardiovascular diseases, and genetic disorders, among others. While our current product candidates are all in preclinical development, our goal is to file multiple investigational new drug applications (INDs) both in 2022 and 2023. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We believe the time is right to develop engineered cell therapies across a broad range of therapeutic areas. The field has
seen initial clinical proof of concept for gene and cell replacement approaches across multiple diseases, including cancer and certain genetic disorders, through the application of adeno-associated virus (AAV) based gene therapies, autologous CAR T
cell therapies, and autologous and allogeneic grafts/transplants. While such existing approaches have limitations, they provide evidence that a broad range of <I>in vivo</I> and <I>ex vivo</I> engineered cells can have transformative clinical
potential in at least a subset of patients. Substantial progress in the understanding of genetics, gene editing, gene control, protein engineering, stem cell biology, immunology, process analytics, and computational biology have converged to create
an opportunity to markedly increase the breadth and depth of the potential impact of genetic and cellular medicines. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We
are seeking to overcome these existing limitations of gene and cell therapy through our <I>in vivo</I> and <I>ex vivo</I> cell engineering platforms, both of which may facilitate the development of therapies that can transform the lives of patients
by repairing cells in the body when possible and replacing them when needed. For <I>in vivo</I> therapies, where the desire is to repair and control genes in the body, a successful product candidate requires both gene modification and <I>in vivo</I>
delivery of the therapeutic payload. Of these, we view effective <I>in vivo </I>delivery as the greatest limitation to dramatically expanding the impact of this class of therapeutics. To this end, our initial focus is on cell-specific delivery as
well as increasing the diversity and size of payloads. For <I>ex vivo</I> therapies, where diseased cells are damaged or missing entirely and an effective therapy needs to replace the entire cell, a successful therapeutic requires large-scale
manufacturing of cells that engraft, function, and persist in the body. Of these, we view persistence as the greatest limitation to dramatically expanding the impact of this class of therapeutics. We believe that product candidates developed with
our <I>ex vivo</I> cell engineering platform, which utilizes hypoimmune allogeneic cells that can &#147;hide&#148; from the patient&#146;s immune system, can address this fundamental limitation and unlock a wave of disruptive therapeutics. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We believe we have the potential to develop transformative engineered cells as medicines because of our people and our
capabilities: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our <B>people</B> are the most important strength of the company. We have assembled a diverse group of
experienced company builders, scientists, manufacturing scientists, engineers, and operators to execute our business plan. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Experienced Company Builders</B>. We have numerous individuals with vast experience in building disruptive
biotech companies. Our Founder and Chief Executive Officer, Dr.&nbsp;Steve Harr, was previously CFO of Juno Therapeutics, helping to build the company and its CAR T cell therapy platform until its acquisition. He is a physician-scientist with
experience in basic research, clinical medicine, finance, company building, and operations. Our Chairman of the Board and <FONT STYLE="white-space:nowrap">co-founder,</FONT> Hans Bishop, is an experienced company builder and operator with success
across a number of </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">123 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
companies. Our executive team is composed of multiple individuals with deep experience building high growth, disruptive companies, including Christian Hordo, Chief Business Officer, who
previously ran Business Development and the Myeloma program at Juno Therapeutics, and Robin Andrulevich, Chief People Officer, who has held key senior leadership roles at Amazon, Google, and Juno Therapeutics. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Leading Scientists</B>. We believe that in order to be successful in drug development for engineered cells,
significant investments in infrastructure and cross-functional capabilities need to be coupled with deep scientific expertise in the cell types of interest within each program. Our leadership team includes multiple world-class scientists, including
researchers who have made seminal discoveries in gene delivery, immunology, CAR T cells, gene editing, and stem cell biology. These include Drs. Richard Mulligan, Terry Fry, Ed Rebar, Chuck Murry, Sonja Schrepfer, Steve Goldman, and Jagesh Shah.<SUP
STYLE="font-size:85%; vertical-align:top"> </SUP>We have surrounded this team of discovery scientists with drug developers experienced in advancing product candidates through the development process with expertise in areas such as pharmacology,
toxicology, regulatory, clinical development, and clinical operations. These include Drs.&nbsp;Sunil Agarwal, Donna Dambach, Ke Liu, Paul Brunetta, and Ms.&nbsp;Farah Anwar. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Experienced Manufacturing Scientists, Engineers, and Operators</B>. Since our founding, we have proactively
assembled manufacturing sciences and operations expertise on our board, on our executive team, and across the company. Our manufacturing organization is led by Dr.&nbsp;Stacey Ma, an experienced executive with over two decades of in manufacturing
leadership, contributing to the commercialization of over ten products across multiple modalities. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Board and Investors with Shared Long-Term Vision</B>. Our board of directors is composed of renowned
company builders, scientists, drug developers, and investors, including Dr.&nbsp;Joshua&nbsp;H. Bilenker, Mr.&nbsp;Hans Bishop, Dr.&nbsp;Doug Cole, Dr.&nbsp;Steve Harr, Dr.&nbsp;Richard Mulligan, Mr.&nbsp;Robert Nelsen, Dr.&nbsp;Alise&nbsp;S.
Reicin, Ms.&nbsp;Michelle Seitz, Dr.&nbsp;Geoffrey von Maltzahn, Ms.&nbsp;Maggie Wilderotter, and Dr.&nbsp;Patrick Yang. We have raised $705.5&nbsp;million of capital to date and are supported by a group of renowned institutional investors such as
ARCH Venture Partners, Flagship Pioneering, Canadian Pension Plan Investment Board, Baillie Gifford, The Alaska Permanent Fund, The Public Sector Pension Investment Board, F Prime, GV, and ADIA, amongst others. Our investors share our long-term
vision of advancing engineered cells as medicine to change the lives of patients. This has enabled our strategy of consolidating technologies, assets, and people to expand the potential impact of our long-term vision. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our <B>capabilities</B> enable us to take a comprehensive approach to the most important and difficult aspects of engineering
cells. We are pursuing <I>in vivo</I> and <I>ex vivo</I> cell engineering and can leverage the synergistic proficiencies required to succeed in both approaches. We believe we can capitalize on the shared expertise and infrastructure between the
platforms to maximize the potential success and the reach of our transformative therapies. We have built deep internal capabilities across a wide range of areas focused on solving the most critical limitations in engineering cells including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Gene Delivery</B><I>. </I>We believe our delivery technologies have broad potential, with both near-term
and long-term applications across a number of indications. We are investing in technologies that allow payload delivery to specific cell types, increase the diversity and size of payloads, enable repeat dosing of patients, and increase the volume of
distribution inside the body in order to target and access more diverse cells. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Gene Modification</B><I>. </I>The ability to <FONT STYLE="white-space:nowrap">knock-out,</FONT> <FONT
STYLE="white-space:nowrap">knock-in,</FONT> modify, and control expression of genes is fundamental to our platforms&#146; success. We have hired world-class scientists with experience in all of these capabilities and across multiple modalities. We
are building internal capabilities that enable high throughput cell engineering and gene editing and control using multiple technologies through use of natural systems, protein engineering, and synthetic biology. We believe our capabilities across
multiple modalities will allow us to utilize the appropriate system for the biologic problem of interest. We are developing proprietary gene editing capabilities as well as seeking strategic partnerships in key areas. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">124 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Immunology</B><I>. </I>The immune system can be harnessed to treat multiple diseases, and it can also limit
the therapeutic effect of most cell- and gene-based therapies. Understanding and harnessing the immune system can have a broad impact across our <I>in vivo</I> and <I>ex vivo</I> cell engineering portfolio. We are investing in our people and
technologies to harness the immune system, particularly T cells, for the treatment of cancer and other diseases. Additionally, our hypoimmune technology has the potential to hide cells from the immune system, unlocking the potential of allogeneic
<I>ex vivo</I> therapies for the treatment of numerous diseases. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Stem Cell and Disease Biology</B><I>. </I>Developing our platforms into therapies for patients requires a
deep understanding of both cell and disease biology. Furthermore, we are investing significantly in our people and the technologies that enable the differentiation of pluripotent stem cells into mature cells that can be used as therapeutics. In each
therapeutic area we intend to pursue, we have brought <FONT STYLE="white-space:nowrap">in-house</FONT> senior world-class scientists to lead our efforts, and our research teams have significant experience in various areas of biology.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our in vivo and ex vivo Cell Engineering Platforms </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The advent of recombinant DNA technology in the 1970s ushered in a new era of therapeutics, enabling the synthetic manufacture
of human protein therapies at scale for the first time. However, the critical inflection point occurred when key technological advancements eventually enabled the broad development of monoclonal antibodies with suitable therapeutic properties. These
advancements, combined with progress in understanding disease biology, allowed biologics to become the second largest therapeutic class. We believe engineered cells are at a similar inflection point, with key recent technological advancements
providing the potential for the broad applicability of this therapeutic class. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>In vivo cell engineering </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Engineering cells <I>in vivo</I> requires the development of both an appropriate delivery vector as well as a payload to
effectively modify the cell. Advances in gene editing, gene regulation, and RNA biology have provided scientists with diverse payload options to modulate genome sequence and gene expression. These payloads need to be delivered in the form of DNA,
RNA, proteins, and their complexes; however, the delivery of sufficient amounts of these novel payloads specifically to the desired cells <I>in vivo</I> remains a key limitation. AAV and LNPs have proven to be successful vectors for limited payloads
and for some cell types in certain diseases, but their application is limited by issues related to lack of specificity, limited payload size and diversity, complex manufacturing, and immunogenicity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our goal for <I>in vivo</I> cell engineering is to repair and control the genes of any cell in the body. Our ultimate aim is
to achieve the delivery of any payload, to any cell, in a specific and repeatable way. We believe that success in any one of these areas has the potential to unlock whole novel categories of medicines to treat a diversity of diseases. Our initial
focus is on cell-specific delivery and on increasing the diversity and size of payloads. Our <I>in vivo</I> cell engineering platform harnesses fusogen technology, which targets cell surface receptors, and thereby can enable cell specific delivery
for a meaningful number of different cell types. Using our fusogen technology, we have shown in preclinical studies that we can specifically target numerous cell surface receptors that, when combined with delivery vehicles to form fusosomes, allow
cell-specific delivery across multiple different cell types. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Ex vivo cell engineering </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Engineering cells <I>ex vivo</I> requires the ability to engineer and manufacture cells at scale and then deliver them to the
patient, so that they engraft, function appropriately, and have the necessary persistence in the body. Advances in understanding cellular biology have led to successful, but limited, applications including bone marrow transplants and autologous CAR
T cells. However, autologous therapies require a complex process of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">125 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
harvesting cells from the patients, manipulating them outside the body, and returning them to the patient. Products utilizing this approach have had to grapple with significant challenges such as
scalability, product variability, product quality, cost, and patient accessibility. More recently, scientific advances have led to the ability to generate induced pluripotent stem cells (iPSCs) and differentiate these iPSCs into functional cells for
a range of cell types. In addition, some approaches use allogeneic cells, or cells derived from another person, to address some of the manufacturing challenges of autologous therapy. However, current efforts to translate these approaches into
therapies typically require the use of immunosuppression to promote the necessary persistence of cells in the body, which in turn significantly limit their therapeutic potential. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our goal for <I>ex vivo</I> cell engineering is to replace any cell in the body with cells that engraft, function, and persist
over time, and to manufacture those cells cost-effectively at scale. Our <I>ex vivo </I>cell engineering platform utilizes our hypoimmune technology to create cells that can &#147;hide&#148; from the patient&#146;s immune system to enable
persistence of allogeneic cells. We are striving to make therapies utilizing pluripotent stem cells with our hypoimmune genetic modifications as the starting material, which we then differentiate into a specific cell type, such as a pancreatic beta
cell, before treating the patient. Additionally, for cell types for which effective differentiation protocols from a stem cell have not yet been developed, such as T cells, instead of starting from a pluripotent stem cell, we can utilize a
allogeneic cell, differentiated cells sourced from a donor, as the starting material to which we then apply our hypoimmune genetic modifications. Our goal is to manufacture genetically modified cells that are capable of both replacing the missing
cell and evading the patient&#146;s immune system. We are now applying our technologies to make cell products for the treatment of multiple diseases. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our <I>in vivo</I> and <I>ex vivo</I> cell engineering technologies are built upon decades of foundational research at
world-renowned academic centers of excellence such as Cornell, &Eacute;cole normale sup&eacute;rieure de Lyon, Harvard, Inserm, Paul Ehrlich Institute, UCLA, UCSF, University of Rochester, University of Washington, and Washington University in St.
Louis as well as many years of research and discovery at Flagship Pioneering. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our Portfolio Strategy </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We believe the potential applications of our platforms are vast. To prioritize programs for our <I>in vivo</I> and <I>ex
vivo</I> engineering pipeline we have used the following strategies: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">minimize biology risk where there is platform risk, or in other words, prioritize opportunities where success
with our platform should lead to success in addressing the underlying disease; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prioritize program investments in diseases where the strengths of our <I>in vivo</I> and <I>ex vivo</I> cell
engineering platforms can address the key limitations of existing therapeutic approaches; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">focus on conditions of high unmet need, including the most grievous diseases; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">prioritize efforts where success in one area begets success in others. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our Pipeline </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We
are developing a broad pipeline of product candidates focused on creating transformative <I>in vivo</I> and <I>ex vivo</I> engineered cell therapies across a range of therapeutic areas. We are in the early stages of development across a broad
pipeline of product candidates, all of which are currently in the preclinical stage of development and are summarized below: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">126 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g60414g55l64.jpg" ALT="LOGO">
 </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>SanaX </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our goal is to lead both the present and future of cell engineering and we are committed to making significant investments in
research and other activities that will ensure a leadership position throughout the next decade. Towards this end we have established SanaX as a distinct research arm. SanaX research efforts are aimed at making fundamental improvements of existing
technology and establishing new paradigms for gene and cell delivery that will ultimately lead to the development of completely new therapeutic modalities. Current SanaX research activities are focused on areas including cells as delivery vehicles,
novel viral vectors, novel production approaches to current viral vectors, novel methods for enabling the exogenous control of transgene expression via small molecule drugs, and new paradigms for genetically manipulating specific immune response in
order to engender immunological tolerance to specific antigens, cells, and organs. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our </B><B><I>in vivo</I></B><B> Cell Engineering Platform </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Overview </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>In
vivo</I> cell engineering aims to treat human disease by delivering a therapeutic payload to cells inside a patient&#146;s body to repair or control genes. Historically there have been four key challenges to <I>in vivo </I>cell engineering: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Delivering any payload (such as DNA, RNA, proteins, organelles, integrating versus <FONT
STYLE="white-space:nowrap">non-integrating,</FONT> size), </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to any cell (by increasing the volume of distribution), </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in a specific (for instance just T cells), and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">repeatable way (such as achieving limited immunogenicity to allow
<FONT STYLE="white-space:nowrap">re-dosing).</FONT> </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our <I>in vivo</I> cell engineering platform is
focused on engineering fusogens that, when combined with delivery vehicles, can effectively deliver a payload to a desired cell or location in the appropriate quantities <I>in vivo</I>. The combination of a fusogen with a delivery vehicle referred
to as a fusosome. We believe our platform provides us with the flexibility to deliver a wide range of payloads to make different modifications for different diseases, as well as delivery vehicle options to address volume of distribution and <FONT
STYLE="white-space:nowrap">re-dosing,</FONT> which could fundamentally expand the treatment potential of <I>in vivo</I> therapies. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">127 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our Approach to Building our in vivo Cell Engineering Platform </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have approached the development of our <I>in vivo</I> cell<I> </I>engineering platform by investing in solutions to overcome
the key challenges outlined above: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Delivery.</B> We believe the critical limitation for <I>in vivo </I>cell engineering is delivery, and
therefore, we are investing significantly in delivery technologies, including our fusogen technology, which is designed to enable both cell-specific delivery and delivery of diverse payloads. We were founded with core technology in this area which
was the product of a multi-year effort by a Flagship Labs innovation team at Flagship Pioneering led by Dr.&nbsp;Geoffrey von Maltzahn, one of our board members. This effort is led by Dr.&nbsp;Jagesh Shah, our VP, Gene Therapy Technologies.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Gene modification.</B> There has been substantial recent progress in gene modification and the field is now
at the point where virtually any desired modification can be performed <I>in vitro</I>. However, no single technology or platform is optimal for all possible applications. To this end, we are developing capabilities across multiple technologies and
investing to develop our own novel technologies to be applied on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">case-by-case</FONT></FONT> basis, an effort that is led by Dr.&nbsp;Ed Rebar, our Senior Vice President, Chief
Technology Officer. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Manufacturing.</B> We are investing proactively in process development, analytical development, CMC
regulatory, and other manufacturing sciences in order to enable scalable manufacturing of our <I>in vivo</I> therapies and ensure broad access. This effort is led by Dr.&nbsp;Stacey Ma, our Executive Vice President, Technical Operations.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our Approach to Building our in vivo Cell Engineering Portfolio </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have prioritized cell types for our programs where: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">existing proof of concept in humans and animal models demonstrates that <I>in vivo</I> cell engineering should
have a clinical benefit; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">high unmet need can be addressed by modifying a particular cell type; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delivery is the most critical bottleneck, such that delivering payloads specifically to the target cell type
could lead to highly differentiated and transformative therapeutics; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an opportunity to apply the technology more broadly exists, which creates the potential for more medicines if
successful (for example, delivery to hepatocytes unlocks potential to treat many diseases with different payloads). </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Based on this prioritization, we are initially focused on the following cell types: </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>T Cells </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Autologous CAR T therapy has shown impressive potential in oncology, but complexity in manufacturing, amongst other things, has
limited its broad impact. Our fusosomes have the potential to deliver a CAR specifically to the patient&#146;s cells <I>in vivo</I>. This approach would essentially use the patient&#146;s body as a bioreactor to manufacture the CAR T cell, thereby
addressing the manufacturing complexities of existing approaches. It may also avoid the safety issues associated with lymphodepletion prior to CAR delivery, which is required for <I>ex vivo</I> CAR T therapy. Finally, because we do not need to
manipulate, grow, and cryopreserve the T cells outside the body during the manufacturing process, we have the potential for more consistent and higher quality CAR T cells. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Hepatocytes </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">While multiple modalities exist that enable delivery of genetic material to liver cells, including AAV and LNPs, these
approaches have limitations, including a <FONT STYLE="white-space:nowrap">non-integrating</FONT> payload, limited payload size, <FONT STYLE="white-space:nowrap">pre-existing</FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">128 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
immunity, and lack of cell specificity. Our fusogen technology, which can enable delivery of a payload specifically to hepatocytes in the liver, can potentially address all or some of these
limitations. We have initially chosen to focus on severe genetic diseases where treating a pediatric patient is likely to lead to a significant clinical benefit, as our technology can integrate the new DNA into the target cell&#146;s chromosomal DNA
providing sustained payload expression as the hepatocytes of the pediatric patient divide and amplify during organ growth. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Hematopoietic Stem Cells </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">There has been early clinical success across several gene editing platforms in modifying hemoglobin expression and providing a
potentially curative treatment to patients with sickle cell disease and beta-thalassemia. However, complicated manufacturing processes and high-dose conditioning chemotherapy requirements may limit their clinical impact. Our technology has the
potential to deliver the payload to modify hemoglobin production directly to the cells inside a patient&#146;s body, eliminating both the complicated cell manufacturing and the need for high-dose chemotherapy. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>History of in vivo Cell Engineering and Current Limitations </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Starting several decades ago, the nascent field of gene therapy focused on experimenting with different means of transmitting
genetic payloads via viral vectors. Seminal work by Dr.&nbsp;Richard Mulligan, our Executive Vice-Chairman and Head of SanaX, and colleagues established the promise of gene therapy by delivering genes into host chromosomes, thereby correcting
genetic deficits. In the late 1990s and early 2000s, an incomplete understanding of virus/vector-biology resulted in serious safety setbacks, which stunted progress in the field. More recently, significant investments have resulted in improved
safety and efficacy of viral vectors. However, most approaches continue to concentrate on adapting the innate capabilities of various viruses to transmit these payloads. Currently, over one hundred clinical trials that utilize viral vectors are
underway for a variety of monogenic diseases, infectious diseases, complex neurodegenerative disorders, and cancers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Profound benefits have been realized in cases where there is direct correlation between the biological activity transmitted by
the therapy and the genetic activity that is missing in the patient. An example of this is providing the missing activity of a gene in a patient with a monogenic recessive disorder. This understanding of disease biology has led to the development
and commercialization of three <I>in vivo </I>cell engineering therapies since 2012: Glybera (alipogene tiparvovec), which was approved by the European Medicines Agency in 2012 for the treatment of LPL deficiency; Luxturna (voretigene neparvovec),
which was approved by the U.S. Food and Drug Administration (FDA) in 2017 for the treatment of a rare retinal disease; and Zolgensma (onasemnogene abeparvovec), which was approved by the FDA in 2019 for the treatment of the most severe form of
spinal muscular atrophy. All three therapies use AAV vectors, which are broadly used by gene therapy researchers due to their broad tissue tropism, lack of pathogenicity, and ability to target both dividing and
<FONT STYLE="white-space:nowrap">non-dividing</FONT> cells. While these therapies have had a categorical impact on their target patient populations, they have only scratched the surface of the potential of <I>in vivo</I> cell engineering, with
success limited to a small number of patients. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Broad impact of gene therapies has been limited by challenges within three
key areas: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Payload delivery </I>is limited by<I>:</I> </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Limited Cell Specificity</B>. Most commonly used AAV vectors have broad tissue specificities. If a specific
type of cell needs to be targeted within a tissue or organ to achieve the desired therapeutic effect, a lack of targeting specificity can result in a limited amount of payload reaching the desired cell. Moreover, the transduction of <FONT
STYLE="white-space:nowrap">non-target</FONT> cells can necessitate the use of high doses of vector to achieve the maximal therapeutic effect in the desired target tissue, which in turn can lead to toxicities due to the transduction of <FONT
STYLE="white-space:nowrap">non-target</FONT> cells. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Limited Volume of Distribution</B>. Volume of distribution refers to the ability of a therapeutic to reach
various tissues. While AAV vectors can be used to systemically deliver payloads to certain tissues, </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">129 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
such as muscle, in the case of other therapeutically important targets, such as cells of the CNS, only a small proportion of cells can be transduced. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Immunogenicity</B>. Most viruses used as vectors elicit an immune response in the patient, causing the
patient&#146;s immune system to attack the vector. Previous exposure to the virus used as a vector increases the immune response and may limit the benefit or create safety issues for the patient. Many patients, for example, demonstrate <FONT
STYLE="white-space:nowrap">pre-existing</FONT> antibodies to specific AAV serotypes which can limit transduction efficiencies, and therefore clinical benefit. Furthermore, once an AAV vector is administered to a patient, in most cases the infection
leads to an immune response that precludes the ability to <FONT STYLE="white-space:nowrap">re-dose.</FONT> </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Genome modification</I> is limited by: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Payload Size and Type Restrictions</B>. The natural genome size of a virus vector imposes a discrete limit
on the amount of biological information that can be transmitted. Currently, there exist a number of important disease targets that require the delivery of payloads too large for AAV, which has a maximum payload capacity between <FONT
STYLE="white-space:nowrap">4.5-5kb.</FONT> In addition to the need to deliver sequences encoding a desired protein that may not fit into an AAV vector, the increasing interest in the use of gene-editing machinery to correct specific gene defect via
homologous recombination or transposition will require delivery vehicles capable of a larger payload capacity than is currently available. For most viruses currently used for <I>in vivo</I> therapy, the payload type is generally limited to the
specific genetic material of the virus (e.g. DNA or RNA). The ability to deliver additional payloads, such as proteins, could unlock novel therapeutic opportunities. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Durability Limitations</B>. Obtaining the persistence of the desired level of expression over long periods
of times can be problematic, due to both immune reactions and the silencing of vector expression. In cases where the target cells are undergoing replication, as can be the case in pediatric patients for example, durability of expression by <FONT
STYLE="white-space:nowrap">non-integrating</FONT> vectors can also be limited by the gradual loss of vector sequences as infected cells replicate. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Execution in manufacturing </I>is limited by: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Complex manufacturing</B>. Today, the adage of &#147;the process is the product&#148; applies with
particular relevance to these <I>in vivo</I> therapies. These therapies are relatively more complex to characterize and control during manufacturing compared to other common biologically derived modalities such as recombinant proteins and
antibodies. Similarly, process and analytical sciences that can enable significant <FONT STYLE="white-space:nowrap">scale-up</FONT> for <I>in vivo</I> therapies are still well behind that of proteins and antibodies. Current vector manufacturing has
limited scale and yield, which limits access for patients. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our Solution &#150; Fusogen Technology </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">To address some of the existing challenges of <I>in vivo</I> cell engineering, we are developing our fusogen technology by
engineering proteins found in nature to enable the delivery of any payload to specific cells. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Background on Fusogens </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Fusogens are a well-studied class of naturally occurring proteins that mediate the trillions of
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">cell-to-cell</FONT></FONT> and intracellular fusion events occurring in the human body every second. In 2013, the Nobel Prize in Physiology or Medicine was awarded for the elucidation
of the roles of fusogens in mediating intracellular trafficking in nature. First, fusogens enable recognition of a specific target membrane. Second, they promote membrane fusion by acting as thermodynamic engines for opposing membranes, pulling them
together and thereby promoting fusion. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">130 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Our Fusogen Technology </U></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g60414g02f71.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Fusogens are widely used by enveloped viruses to confer target specificity and to drive the
process of introducing material in target cells. A well-known current example of a viral fusogen is the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">SARS-CoV-2</FONT></FONT> coronavirus that causes COVID 19. This virus uses its
spike glycoprotein to target cells expressing the ACE2 receptor and to fuse with the cell membrane of host cells and release the viral genome into the cell. Many other biological processes utilizing fusogens for the delivery of complex, diverse, and
large payloads to specific cell types have also been found. For example, the process of fertilization occurs as a result of a sperm fusing specifically with the egg and the transfer of the paternal genetic material to the oocyte. Similarly, the
fusion of myoblasts with other myoblasts is essential for the formation, growth, and regeneration of skeletal muscle. The myoblast delivers an entire novel nucleus to the muscle cell, highlighting the utility of this system to deliver quite large
and complex payloads. These and a myriad of other processes rely on this vast class of protein machines. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">131 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Applying fusogens to in vivo cell engineering </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Building on both our team&#146;s deep understanding of fusogen biology and extensive research in protein engineering, we are
developing a technology designed to allow us to engineer the biological properties of these naturally occurring proteins. In doing so, we are developing a highly modular system that can specifically target numerous cell surface receptors and thereby
deliver diverse therapeutic payloads to a variety of cell types. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our current programs use fusogens derived from a virus
from the paramyxoviridae family. The fusogen protein complex is comprised of two proteins: the receptor recognition G protein and membrane fusion F protein. The combination of a fusogen with a delivery vehicle such as a gene therapy vector or lipid
vesicle is referred to as a fusosome. The diagram below depicts the mechanism of fusogen-mediated membrane fusion. This protein complex is found on the outer membrane of the fusosome (1). As the fusosome interacts with cells, only those with the
target receptor will engage the G protein of the fusogen complex (2). The binding of the G protein to the receptor stimulates the F protein to initiate its membrane fusion activity. The F protein first partially unfolds to bind to the target
membrane (3)&nbsp;and then refolds to bring the target and fusosome membranes in proximity (4), to ultimately promote membrane fusion (5), and subsequent payload delivery. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Mechanism of Fusogen-Mediated Membrane Fusion </U></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g60414g21f34.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The G protein has the potential to be engineered for a high degree of cell selectivity. To
accomplish this, we first engineer the G protein so that its natural binding domain is no longer functional. We then add a targeting scaffold to the G protein that <FONT STYLE="white-space:nowrap">re-directs</FONT> the fusogen to a cell-specific
receptor. The targeting scaffold can be any one of naturally occurring or synthetic single chain affinity binders, such as single chain variable fragment </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">132 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
(scFvs), camelid single-domain antibodies (VHHs), or designed ankyrin repeat proteins (DARPins). Finally, we iteratively rebuild our fusogen using insights from protein engineering to improve
titers, or potency. By serially swapping different targeting scaffolds we believe we can target multiple different cell surface receptors, giving us the ability to target many different cell types. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><FONT STYLE="white-space:nowrap">Re-targeting</FONT> the specificity of the <FONT STYLE="white-space:nowrap">G-protein</FONT>
is a challenging protein engineering problem, since altering the protein structure directly impacts all aspects of biological function. However, once we have achieved the desired specificity and potency for a certain cell type, we have the ability
to deliver a variety of payloads to that cell. This feature of the technology should allow us to create multiple therapies targeting a variety of diseases with each successful fusogen. As a result, we believe success with any initial therapy
targeting a given cell type could meaningfully advance lead candidate selection for other indications and increases our confidence that we will be successful with subsequent therapies targeting that same cell type. For example, a successful
hepatocyte-targeting fusogen applied to a fusosome for a given monogenic liver disease meaningfully accelerates lead candidate selection and increases our confidence that we will be successful with subsequent therapies targeting hepatocytes. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g60414g23y10.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I></I><B></B><B><I></I></B><I>Addressing key in vivo cell engineering
challenges</I><B><I></I></B><B></B><I> </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We believe that our <I>in vivo </I>cell engineering platform enables us to
address key challenges associated with successful <I>in vivo</I> cell engineering &#150; payload delivery, genome modification, and execution in manufacturing: </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Payload delivery </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>High cell specificity for diverse cell types</B>. We believe we can engineer fusogens with cell specificity to maximize <FONT
STYLE="white-space:nowrap">on-target</FONT> effects, while reducing or eliminating <FONT STYLE="white-space:nowrap">off-target</FONT> risk. In our research, we have used fusogens to successfully target numerous cell surface receptors and cell types.
As an example, in preclinical studies, we have demonstrated that our fusogens can specifically target CD8, CD4, or CD3 T cells (see the subsection titled </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">133 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
&#147;Our <I>in vivo</I> Cell Engineering Pipeline&#151;T cell Fusosome Program&#148;), potentially enabling delivery of a payload <I>in </I><I>vivo</I> to transduce specific T cell populations
and enabling targeted cell killing through the creation of CAR T cells. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Engineering Fusogens to Target a Variety of Cell Types
</U></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g60414g23y11.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:8pt; font-family:Times New Roman" ALIGN="justify"><I>Figure A depicts the increased transduction efficiency (measured in titer) of a fusogen
engineered for targeting CD20 on receptor enriched B cells as compared to B cells that were negative for the receptor. Similar transduction efficiency was also observed in an engineered fusogen targeting a neuronal surface protein, GRIA4, as
depicted in Figure B. Neuronal-specific transduction of the Green Fluorescent Protein (GFP) payload in the murine hippocampal region was observed using a fusosome specific for GRIA4 when injected into the hippocampal space (as depicted by the green
coloring in Figure D) compared to widespread transduction when using a <FONT STYLE="white-space:nowrap">VSV-G</FONT> fusogen (Figure C). Confirmation of neuron-specific targeting of the fusogen can be observed by the colocalization of GFP positive
cells (green, Figure E) with the presence of a neuron-specific protein (NeuN in red, Figure F) and considering the high degree of overlap (colocalization seen as yellow, Figure G). Figures <FONT STYLE="white-space:nowrap">C-G</FONT> from Anliker et
al, Nature Methods, 2010. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">134 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Broad volume of distribution</B>. Our SanaX business unit is actively
working on next generation approaches to broaden the volume of distribution, including exploring cells as fusosome delivery vehicles. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Immunogenicity</B>. We have initially focused our efforts on selecting fusogens for which the general population does not
have <FONT STYLE="white-space:nowrap">pre-existing</FONT> immunity. We are also working with a number of fusogens that exist naturally in humans, as neither these native fusogens nor <FONT STYLE="white-space:nowrap">re-targeted</FONT> versions are
likely to induce an immune response, making <FONT STYLE="white-space:nowrap">re-dosing</FONT> more readily attainable. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Genome
modification </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>High degree of payload flexibility</B>. We have successfully delivered a variety of payloads including
DNA, RNA, and proteins, using viral delivery methods and have used cells engineered to express specific fusogens to deliver organelles to a broad range of target cells. We believe this provides us the opportunity to potentially intervene in a wide
range of human diseases. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Diverse Payload Delivery via Fusosomes </U></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g60414g23y12.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:8pt; font-family:Times New Roman" ALIGN="justify"><I>Cre protein loaded cell-based fusosomes delivered recombinase activity to cells that
activated the expression of a red fluorescent protein in cells already expressing green fluorescent protein, seen as orange cells (Figures A,B). In contrast, fusosomes in which the fusogen is not included, but only contain Cre protein, showed no
recombinase activity, or no orange cells (Figure C). Fusosomes loaded with fluorescently labeled RNA showed cellular localization and green fluorescense consistent with cytoplasmic delivery and translation of delivered RNA (Figures <FONT
STYLE="white-space:nowrap">D-G).</FONT> Flow cytometric analysis showed cellular uptake of fluorescent RNA (Cy5, Y axis) and </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">135 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:8pt; font-family:Times New Roman" ALIGN="justify"><I>
GFP expression from the RNA (GFP, X axis) (Figure H). Importantly, the inclusion of a fusogen in the fusosome dramatically increased GFP expression due to the translation of the RNA. Cell-based
fusosomes delivered red fluorescent mitochondria with respiration activity to cells with respiration-negative green mitochondria, (Rho0 cells) shown in Figure I. An increased oxygen consumption rate (OCR), due to respiration, was seen in Rho0 cells
after Fusosome-mediated delivery of active mitochondria using two distinct fusogens (Figure J). </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Expanded payload
capacity</B>. Our current fusosome has approximately twice the genetic capacity of the commonly used AAV vectors. This greater payload size increases the potential of addressing defects in larger genes or conditions where delivery of multiple genes
may be required. Our research efforts include other fusosomes with even larger payload capacities. For example, utilizing a cell as the delivery vehicle can confer an almost limitless capacity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Durability limitations</B>. We can engineer our fusosomes to integrate into the target cell genome or to deliver <FONT
STYLE="white-space:nowrap">non-integrating</FONT> payloads. Integrated payloads allow the genetic information transmitted by the vector to be propagated durably with the genetic material of the target cell when it undergoes cell division. Thus,
conditions that require this type of genetic propagation, such as genetic diseases in essential genes functioning in growing tissues or in T cells expanding after recognizing a target antigen, can be better addressed by this approach. Our
preclinical studies have also demonstrated the ability to deliver gene-editing machinery, such as CRISPR, with this system. In this case, the entire payload does not integrate, but instead, it transiently delivers the machinery to permanently modify
the DNA in the target cell. Thus, we are able to make targeted, specific, and durable repairs to the genome of the target cell. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Execution in Manufacturing </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Manufacturing of cell and gene therapies remains complex due to incumbent challenges in areas such as product consistency,
process robustness, and scalability. Our fusosome approach has significant advantages over current solutions. Targeted delivery of complex payloads <I>in vivo </I>has the potential to create autologous, gene-modified cells without the complexities
of <I>ex vivo</I> manufacturing. We believe that these therapies have the potential to have greater product consistency, improved scale, and lower costs than current autologous solutions. Currently, there are a number of therapies either approved or
in development for <I>ex vivo</I> modification of autologous T cells and autologous HSCs. Additionally, vectors that deliver payload to random or off target cells not only create the risk for toxicities, but they necessitate meaningfully larger
doses in order to ensure adequate delivery to the targeted cells. Our targeted delivery offers the potential for meaningfully lower doses, which could decrease scale needs in manufacturing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Further, we are investing across a number of areas to improve manufacturing scale, costs, consistency, and product quality in
the near-term and long-term. Manufacturing novel fusosome compositions is complex. Since our inception, we have invested in scientific and process engineering expertise to improve manufacturing of our therapies. Examples include novel stable
producer cell lines, novel processes and analytical technology, as well as incorporating suspension bioreactors into our process early in the research phase. By building out these capabilities early, we hope to improve the probability of technical
success for our programs and have a thoughtful approach to deliver consistent supply while managing cost of goods with the goal of improving patient access. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our </B><B><I>in vivo</I></B><B> Cell Engineering Pipeline </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>T cell Fusosome Program </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our most advanced CAR T cell fusosome product candidates (SG242, SG295) target CD19+ cancer cells, including NHL, CLL, and ALL.
We intend to develop these product candidates with the goal of filing an IND as early as 2022. In parallel with the CD19 CAR product candidates we are developing other CAR T cell therapies, including BCMA product candidates for the treatment of
multiple myeloma (SG221, SG239) as well as other targets on a spectrum of cancers. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">136 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Background on B Cell Malignancies </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">B cell malignancies represent a spectrum of cancers including <FONT STYLE="white-space:nowrap">non-Hodgkin</FONT> lymphoma
(NHL), chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia (ALL) and multiple myeloma (MM)&nbsp;and result in over 100,000 deaths per year in the United States and Europe. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">NHL is the most common cancer of the lymphatic system. NHL is not a single disease, but rather a group of several closely
related cancers. Although the various types of NHL have some things in common, they differ in appearance under the microscope, genetics, growth patterns, prognosis, and treatment. Over 77,000 cases of NHL are diagnosed annually in the United States,
and 85% derive from B cell lineages, which express CD19. B cell NHLs are a large group of cancers that are typically divided into aggressive (fast-growing) and indolent (slow-growing) types. The most common histologic type of aggressive lymphoma,
and most common subtype of NHL overall, is diffuse large B cell lymphoma (DLBCL), representing approximately 40% of new cases annually. Unlike indolent lymphomas, which have a median survival time as long as 20 years, DLBCL, if left untreated, may
have survival measured in weeks or months. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">CLL is the most common type of leukemia, and it occurs most frequently in
older individuals, with diagnoses in persons under 30 years of age occurring only rarely. Each year, approximately 20,000 patients are diagnosed with CLL in the United States. Nearly all CLL develops from B cells that express CD19. Approximately
75&#150;80% of individuals with CLL have standard risk disease at diagnosis, and for these patients the level of disease burden determines both prognosis and the need for immediate treatment or &#147;watchful waiting&#148; before the initiation of
any therapy. Over time, CLL develops poor risk features, including expression of CD38, ZAP70, unmutated immunoglobulin heavy chain sequences, cytogenetic abnormalities, or gene mutations. Approximately 20&#150;25% of CLL patients can initially
present with poor risk disease. Median progression-free survival in these high-risk groups is often less than 12 to 18 months after frontline therapy, and less than 12 months in R/R disease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">ALL is an uncontrolled proliferation of lymphoblasts, which are immature white blood cells. The lymphoblasts, which are
produced in the bone marrow, cause damage and death by inhibiting the production of normal cells. Approximately 6,000 patients are diagnosed with ALL in the United States each year, and although just under half of the new diagnoses are in adult
patients, the vast majority of the approximately 1,500 deaths per year occur in adults. There are two main types of ALL, B cell ALL and T cell ALL. Approximately 80% of cases of ALL in the United States and Europe are B cell ALL, which almost always
express the CD19 protein. The five-year overall survival in adults over the age of 60 with ALL is approximately 20%, and in patients with R/R ALL after two or more lines of therapy, the median disease-free survival is less than six months. B cell
ALL is the most common cancer in children. Although children with ALL fare better than adults, children with R/R disease have poor outcomes. Because of the frequency, ALL remains a leading cause of death due to cancer in children. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Multiple myeloma is a cancer of the plasma cells, which typically express a protein called B Cell Maturational Antigen (BCMA).
Plasma cells are B cells that have matured to specialize in the production of antibodies. As plasma cells are primarily found in the bone marrow, cancerous plasma cells usually generate tumors in bone, and infrequently appear elsewhere. Multiple
myeloma is a condition in which these plasma cells become malignant, with a single clone growing at an uncontrolled pace. These myeloma cells secrete large quantities of the same antibody, and patient symptoms can develop from the myeloma cells
crowding out other plasma and bone marrow cells, leading to increased risk of infection, risk of bone destruction, and kidney disease. Multiple myeloma is the second most common hematologic malignancy making up approximately 2% of all cancers,
accounting for over 32,000 new cases per year. Despite many recent advances in therapy, there is a lack of curative treatments. Thus, this form of cancer represents an area of high unmet medical need, with greater than 12,800 deaths estimated to
occur in 2020. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">137 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Current Treatment Landscape and Unmet Need </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">First line therapy for NHL typically consists of multi-agent cytotoxic drugs in combination with the monoclonal antibody
Rituxan. In younger patients with NHL who have good organ function, high dose chemotherapy followed by stem cell transplantation is often used. Patients often relapse, however, and over the last three years, several therapeutics have been approved
in the United States for the treatment of patients with R/R NHL who have received prior therapies. These approved therapies include CD19 CAR T therapies tisagenlecleucel and axicabtagene ciloleucel, CD19 antibody drug conjugate therapy polatuzumab
vedotin, and CD19 antibody tafasitamab. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Newly diagnosed CLL patients are often treated with targeted therapies such as
BTK inhibitors, PIK3 inhibitors, <FONT STYLE="white-space:nowrap">BCL-2</FONT> inhibitors, or monoclonal antibodies targeting CD20, or CD52 in combination with chemotherapy. However, most patients treated with these regimens become refractory.
Numerous drug candidates are in clinical development for the refractory patients, including next-generation kinase inhibitors and both autologous and allogeneic CAR T therapies targeting CD20 and CD19. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Cure rates for ALL patients have continued to increase over the last four decades, with pediatric ALL cure rates reaching
greater than 80% in developed countries. This progress has been enabled by advances in combination chemotherapy, monitoring of minimal residual disease, expanded use of kinase inhibitors for Philadelphia chromosome&#150;positive ALL, and the recent
approval of Kymriah for R/R pediatric ALL. Adult patients fare much worse, however, with <FONT STYLE="white-space:nowrap">5-year</FONT> overall survival rates of approximately 20%, and there are still significant challenges managing R/R disease
across all age groups. Multiple therapeutic candidates are in development for these R/R patients, including proteasome inhibitors, antimetabolites, JAK inhibitors, monoclonal antibodies, as well as autologous and allogeneic CAR T candidates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">First line therapy for MM is induction and high-dose chemotherapy followed by a potential stem cell transplant. There are no
curative treatment options for MM patients and the standard of care for R/R MM includes immunomodulary agents, proteasome inhibitors, monoclonal antibodies, cytotoxic agents, and hematopoietic stem cell transplant. Despite the recent advancement in
available therapies for disease management, the <FONT STYLE="white-space:nowrap">5-year</FONT> overall survival rate remains approximately 50%. To this end, several groups are investigating autologous and allogeneic CAR T cell therapies for R/R MM.
BCMA is among the most promising antigens used to target MM, with multiple late-stage clinical trials ongoing. Novel treatments with other mechanisms of action are also under development, including bispecific T cell engagers, <FONT
STYLE="white-space:nowrap">next-gen</FONT> antibodies, and antibody drug conjugates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As highlighted above, recent
therapeutic advances across R/R B cell malignancies have led to a variety of treatment options and better patient outcomes. In particular, autologous surface protein directed CAR T therapies have been highly effective in certain subsets of patients
with R/R disease. However, not all patients have access to novel therapies, and even with them, many patients will ultimately relapse and succumb to their cancer, resulting in 100,000 deaths per year in the United States and Europe across these
indications. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">There are two outstanding challenges that have limited utilization of these CAR T therapies and their impact
on broader groups of patients. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Relapse</B>. The emerging post-approval data with tisagenlecleucel and axicabtagene
ciloleucel have indicated that there are two broad categories of relapse. One involves loss of CD19 on malignant cells resulting in tumor escape. This finding was initially established for ALL and is the cause of relapse after CAR T cells for
roughly half of patients. More recent data indicate that low antigen expression contributes to the lack of response in some patients with NHL. The second pattern of relapse relates to suboptimal CAR T cell functionality (poor expansion, poor
persistence, T cell exhaustion) resulting in relapse of cancer that retains the targeted antigen. Unfortunately, <FONT STYLE="white-space:nowrap">re-infusion</FONT> of the same CAR T cell product has had limited benefit in these patients although
treatment with a different CAR T cell has demonstrated some promise in the context of ongoing clinical trials. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">138 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Manufacturing</B>. The manufacturing process for a patient-specific
product is complex, leading to limited access due to both infrastructure and cost considerations. As such, approved CAR T cell therapies have not been available to all patients in need of these highly effective therapies. Even for patients who are
fortunate enough to have access, inevitable delays (often a month or more) in manufacturing may prevent use of therapy in patients with rapidly progressing malignancies. There are groups that are seeking to overcome access limitations by using
healthy donor-derived, or allogeneic, CAR T cells instead of patient T cells., This approach yields <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">off-the-shelf</FONT></FONT> therapeutics that can be manufactured consistently, but
questions remain around efficacy and durability, largely due to the inability to effectively control the host versus graft response with concern for eventual rejection of these products. As will be discussed in the subsection titled &#147;&#151;Our
<I>ex vivo</I> Cell Engineering Pipeline,&#148; our <I>ex vivo</I> allogeneic T cell program also seeks to address this host versus graft response. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Our T Cell Fusosome Approach </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our T cell fusosome approach provides us with an opportunity to develop potential product candidates to expand access to CAR T
cell therapy to many more patients in need. In addition, we believe the ability to deliver a payload encoding a CAR to a T cell inside the body has the potential to improve effectiveness over <I>ex vivo</I> manufactured CAR T cell products.
Experience thus far has demonstrated that both CD8+ and CD4+ T cells contribute to the CAR T cell response. Thus, the fusosome programs we are developing will deliver the CAR gene using fusogens that directly and specifically target the CD8 <FONT
STYLE="white-space:nowrap">co-receptor</FONT> or the CD4 <FONT STYLE="white-space:nowrap">co-receptor</FONT> on T cells following a single intravenous injection. These approaches should result in the generation of therapeutically active CAR T cells
without the complexities and delays associated with the process of T cell collection and <I>ex vivo</I> manufacturing. Furthermore, the <I>ex vivo</I> expansion in the presence of high cytokine concentrations, while necessary for the manufacture of
approved CAR T cell products, also contributes to marked changes in T cell quality that may not be therapeutically beneficial. The generation of a CAR T cell within the natural physiological environment has the potential to improve the quality of
the CAR T cell generated, potentially improving both efficacy and the side effect profile. Finally, the effectiveness of <I>ex vivo</I> manufactured CAR T cells is dependent on the administration of a lymphodepleting preparative regimen prior to
infusion to facilitate expansion of the CAR T cell product, which can have meaningful adverse safety implications. We do not expect to need a lymphodepleting regimen prior to <I>in vivo</I> delivery of the CAR gene, as our goal is to expose our
fusosomes to as many T cells in the body as possible. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Preclinical Data </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our preclinical data have demonstrated that fusosomes can deliver a genetic payload specifically and efficiently to human T
cells in culture and in immunodeficient mice with intraperitoneally injected human peripheral blood mononuclear cells (PBMC) and fused with a single dose of a fusosome. The T cells can be categorized into functional subsets based on the expression
pattern of cell surface molecules. CD3 is a protein expressed on all T cells, CD4 is expressed on the Helper T cells that primarily activate T and B cells to carry out their function, and CD8 is found on cytotoxic T cells that primarily kill
cancerous or virally infected cells. We generated fusogens against these three cell-surface molecules and have demonstrated that we can deliver a marker gene to cells bearing these cell surface proteins <I>in vitro</I>. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">139 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Fusogens Demonstrate the Ability to Target Multiple T Cell Subtypes </U></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g60414g23y13.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:8pt; font-family:Times New Roman" ALIGN="justify"><I>Fusosomes containing a gene that encodes a fluorescent marker protein called GFP (used to
identify cells have been genetically modified by the fusogen) can efficiently and specifically deliver GFP to T cells in culture (CD8, CD4, and CD3). Expression of GFP is restricted to the population of T cells that express the specific T cell
receptor targeted by the fusogen (CD8, CD4, or CD3). </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">140 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have further established that fusosome delivery of a CD19 CAR gene to CD4
or CD8 T cells results in killing of human B cells and CD19+ leukemia cells in culture: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Delivery of CD19 CAR to CD4 T Cells Leads to
</U></B><B><I><U>in vitro</U></I></B><B><U> Killing of B Cells and CD19+ Leukemia Cells </U></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g60414g14k89.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:8pt; font-family:Times New Roman" ALIGN="justify"><I>Demonstrates that the fusosome-generated CD4 CAR is functional and eradicates both
nonmalignant B cells <FONT STYLE="white-space:nowrap">(CD19+/RFP-)</FONT> as well as CD19+ leukemia cells expressing <FONT STYLE="white-space:nowrap">NALM6-RFP.</FONT> </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">141 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have also validated, <I>in vivo</I>, the tumor-killing activity of CD8 T
cells to which CD19 CAR has been delivered via a fusosome. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Delivery of CD19 CAR to CD8 Cells Leads to </U></B><B><I><U>in
vivo</U></I></B><B><U> Killing of Leukemia Cells in a Human Xenograft Mouse Model </U></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g60414g89g69.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Left panel: demonstrates activity of CD8 fusosome delivering CD19 CAR to human T cells in a murine
leukemia xenograft model <FONT STYLE="white-space:nowrap">(Nalm-6).</FONT> Note that when compared to untreated controls, fusosome delivery results in eradication of leukemia cells. Activated T cells were cultured with CD3/CD28 beads for 3 days
prior to injection. CD8 fusosome delivering the CD19 CAR is effective regardless of activation status of T cells at time of injection. Right panel: represents quantification of luminescence (representing leukemic burden) from mice shown in left
panel. Both cohorts of fusosome treated mice had significantly reduced tumor burden when compared to control as early as D10 (p</I><FONT STYLE="FONT-FAMILY:SYMBOL">&#163;</FONT><I></I><I>.0001; <FONT STYLE="white-space:nowrap">One-way</FONT> ANOVA
Bonnferroni) Experimental note: Tumors injected on Day Zero, Donor T cells injected on Day Three and Fusosome injected on Day Four. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Using a human xenograft mouse model for leukemia <FONT STYLE="white-space:nowrap">(Nalm-6),</FONT> we observed both prolonged
survival and clearance of the leukemic cells. During the manufacture of autologous <FONT STYLE="white-space:nowrap">CAR-Ts,</FONT> cytokine signaling has to be activated in order to successfully produce functional CAR T cells. In our mouse
experiments the CD8 fusosome was able to generate CD19 CAR cells just as effectively with activated as <FONT STYLE="white-space:nowrap">non-activated</FONT> donor T cells. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Several of our human T cell fusogens cross-react on non-human primate (NHP) T cells including our lead candidate CD8 fusogen.
We have used the fusogen to deliver a CD20 CAR into six NHPs (the CD20 CAR was chosen as the CD19 CAR to be used for our clinical programs does not cross-react with NHP B cells). As shown below, a single intravenous administration of our CD8 fusogen
containing a CD20 CAR was associated with B cell depletion in four out of six NHPs, occurring between day seven and fourteen. This result is consistent with reported observations that peak expansion of <I>ex vivo</I> manufactured CAR T cells
typically occurs during the second week. Importantly, there was no infusion-related toxicity or evidence for CAR-associated toxicity (cytokine release syndrome or neurotoxicity) other than the intended B cell depletion. The ability to deliver
fusogen without toxicity and with evidence for activity in NHP are critical milestones for the program In addition, the NHPs received no T&nbsp;cell activating agent or lymphodepletion. The latter potentially supports a path for the fusogen platform
to enable delivery of CAR therapy without the lymphodepletion regimens used by existing <I>ex vivo </I>approaches, which have toxic side-effects. This and future NHP experiments will also provide important information on dosing parameters,
durability of the effect, and provide pharmacokinetic, pharmacodynamic, and toxicology data. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">142 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Delivery of CD20 CAR to CD8 Cells Causes B Cell Depletion in NHPs </U></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g60414g29a76.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Graph demonstrates activity of CD8 fusosome delivering CD20 CAR in NHPs. CD8 fusosome was delivered as a
single intravenous infusion. B cell counts were quantified in peripheral blood using flow cytometry for CD20+ cells. Given expected NHP-to-NHP variability in baseline counts, data is represented as single lines per NHP and is shown as deviation from
baseline level for each NHP at Day Fourteen (when maximal expansion of CAR T cells are expected). Significant B cell depletion is observed in four out of six NHPs. Note that no T cell activation was provided prior to fusosome delivery. </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Development Plan and Key Next Steps </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are currently conducting experiments to validate the ability of a systemically administered fusosome to transduce T cells in
an NHP and for these CAR T cells to deplete B cells. These NHP studies are also expected to inform preclinical pharmacology and toxicology. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As a next step, we intend to focus first on good laboratory practices (GLP) production for our
<FONT STYLE="white-space:nowrap">IND-enabling</FONT> studies. While these studies are ongoing, we intend to scale our GMP manufacturing and finalize our initial development plan. We intend to file an IND in NHL with SG295 as early as 2022 and with
SG242 as early as 2023. For our BCMA programs in MM, we intend to file an IND for SG239 as early as 2022 and for SG221 as early as 2023. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Numerous genetic metabolic diseases arise from gene defects that manifest in the liver and, in particular, in the hepatocyte.
Additionally, hepatocytes can serve as protein manufacturing sites to deliver proteins to other cells in the body. Multiple modalities exist that enable delivery of genetic material to liver cells, including AAV and LNPs. However, these approaches
have limitations, including <FONT STYLE="white-space:nowrap">non-integrating</FONT> payloads, payload size, lack of cell specificity, and, in the case of AAV, immunogenicity. Our fusogen technology, which we expect will be able to deliver a payload
specifically to hepatocytes in the liver, has the potential to address these limitations. Success with this heaptocyte-targeting technology may allow us to generate therapies for a number of genetic disorders. We are developing our lead product
candidate, SG328, for ornithine transcarbamylase (OTC) deficiency, and we expect to file an IND as early as 2022. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">143 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Hepatocyte Targeting Capability </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Targeting the hepatocyte with a fusogen can enable specific delivery of either integrating or
<FONT STYLE="white-space:nowrap">non-integrating</FONT> payloads. It can also be used to deliver the machinery of gene editing and gene modification tools to these cells. Since we anticipate that hepatocytes transduced with fusosomes will harbor the
novel genetic construct in their genome, all progeny of that cell will also have the genetic construct. Thus, the natural turnover and organ growth will not dilute the genetic construct, providing the potential for long-term expression and efficacy
even when the fusosome is delivered during infancy, childhood, or when it is delivered to treat a disease where the disorder can cause rapid hepatocyte turnover. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We believe that success with an initial hepatocyte-targeted fusosome will meaningfully accelerate our future hepatocyte
programs. Once a hepatocyte-targeting fusosome is established, our subsequent programs will require only substituting the relevant payload to correct for the defective gene in question, opening up the possibility to address multiple inherited liver
diseases. Our initial focus is on monogenic diseases with clear biology linking the missing activity of a gene in hepatocytes to a disease outcome. Proof of concept in these initial diseases will enable expansion to other diseases, such as
hemophilia, where we may be able to address an unmet need by providing a durable <I>in vivo </I>therapy in the hepatocyte<I>.</I> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">144 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">According to the National Institute of Health, over 30 genetic disorders of
the liver exist, impacting over 10,000 births annually around the world. Many of these disorders lead to death in the first few years or cause long term disabilities. The following table identifies examples of these genetic disorders: </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Examples of Genetic Disorders of the Liver </U></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1.00pt solid #0028b2; BORDER-RIGHT:1px solid #75a8c9; BORDER-BOTTOM:1px solid #75a8c9; padding-left:8pt">Biotinidase deficiency</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1.00pt solid #0028b2; BORDER-BOTTOM:1px solid #75a8c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1.00pt solid #0028b2; BORDER-BOTTOM:1px solid #75a8c9">Hereditary angioedema</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #75a8c9; BORDER-BOTTOM:1px solid #75a8c9; padding-left:8pt">Holocarboxylase synthetase deficiency</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #75a8c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #75a8c9">Acute intermittent porphyria</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #75a8c9; BORDER-BOTTOM:1px solid #75a8c9; padding-left:8pt">Pyruvate carboxylase deficiency</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #75a8c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #75a8c9">D-bifunctional protein deficiency</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #75a8c9; BORDER-BOTTOM:1px solid #75a8c9; padding-left:8pt">Lysinuric protein intolerance</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #75a8c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #75a8c9">Porphyria cutanea tarda</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #75a8c9; BORDER-BOTTOM:1px solid #75a8c9; padding-left:8pt">Carnitine palmitoyltransferase type II (CPT II) deficiency</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #75a8c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #75a8c9">Lipoprotein lipase deficiency</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #75a8c9; BORDER-BOTTOM:1px solid #75a8c9; padding-left:8pt">Medium chain acyl-CoA dehydrogenase (MCAD) deficiency</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #75a8c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #75a8c9">N-acetylglutamate synthase (NAGS) deficiency</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #75a8c9; BORDER-BOTTOM:1px solid #75a8c9; padding-left:8pt">Short chain acyl-CoA (SCAD) dehydrogenase deficiency</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #75a8c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #75a8c9">Cobalamin A deficiency (methylmalonic acidemia)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #75a8c9; BORDER-BOTTOM:1px solid #75a8c9; padding-left:8pt">Very long chain acyl-CoA dehydrogenase (VLCAD) deficiency</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #75a8c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #75a8c9">Cobalamin B deficiency (methylmalonic acidemia)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #75a8c9; BORDER-BOTTOM:1px solid #75a8c9; padding-left:8pt">Glycogen storage disease (GSD) IXa/b/c</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #75a8c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #75a8c9">Cobalamin C deficiency (methylmalonic acidemia)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #75a8c9; BORDER-BOTTOM:1px solid #75a8c9; padding-left:8pt">GSD IIIa/b</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #75a8c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #75a8c9">Cobalamin D deficiency (methylmalonic acidemia)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #75a8c9; BORDER-BOTTOM:1px solid #75a8c9; padding-left:8pt">GSD Ia (Von Gierke disease)/GSD Ib</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #75a8c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #75a8c9">Citrullinemia type I</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #75a8c9; BORDER-BOTTOM:1px solid #75a8c9; padding-left:8pt">GSD IV (Andersen disease, Brancher enzyme)</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #75a8c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #75a8c9">Citrin Deficiency</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #75a8c9; BORDER-BOTTOM:1px solid #75a8c9; padding-left:8pt">PMM2-CDG</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #75a8c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #75a8c9">Phenylketonuria (PKU)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #75a8c9; BORDER-BOTTOM:1px solid #75a8c9; padding-left:8pt">Cystathionine beta-synthase deficiency (classic homocystinuria)</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #75a8c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #75a8c9">Progressive familial intrahepatic cholestasis Type 1 (PFIC1)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #75a8c9; BORDER-BOTTOM:1px solid #75a8c9; padding-left:8pt">Tyrosinemia type II</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #75a8c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #75a8c9">Progressive familial intrahepatic cholestasis Type 2 (PFIC2)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #75a8c9; BORDER-BOTTOM:1px solid #75a8c9; padding-left:8pt">Galactosemia</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #75a8c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #75a8c9">Progressive familial intrahepatic cholestasis Type 3 (PFIC3)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #75a8c9; BORDER-BOTTOM:1px solid #75a8c9; padding-left:8pt">Glucose-6-phosphate dehydrogenase (G6PD) deficiency</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #75a8c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #75a8c9">Progressive familial intrahepatic cholestasis Type 4 (PFIC4)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #75a8c9; BORDER-BOTTOM:1px solid #75a8c9; padding-left:8pt">Cystinuria</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #75a8c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #75a8c9">OTC</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #75a8c9; BORDER-BOTTOM:1px solid #75a8c9; padding-left:8pt">Wilson disease</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #75a8c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #75a8c9">Crigler-Najjar</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #75a8c9; BORDER-BOTTOM:1px solid #75a8c9; padding-left:8pt">Lesch-Nyhan syndrome</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #75a8c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #75a8c9">CMSUD</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #75a8c9; BORDER-BOTTOM:1px solid #75a8c9; padding-left:8pt">Hemochromatosis, type IIa/b</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #75a8c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #75a8c9">MMA</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #75a8c9; BORDER-BOTTOM:1px solid #75a8c9; padding-left:8pt">Alagille syndrome 1</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #75a8c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #75a8c9">Propionic Acidemia</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #75a8c9; BORDER-BOTTOM:1px solid #75a8c9; padding-left:8pt">Familial TTR amyloidoisis</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #75a8c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #75a8c9">Hereditary Tyrosinemia Type 1 (HTT1)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #75a8c9; BORDER-BOTTOM:1px solid #75a8c9; padding-left:8pt">Primary hyperoxaluria type I/II/III</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #75a8c9">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #75a8c9">CPS1</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #75a8c9; BORDER-BOTTOM:1.00pt solid #0028b2; padding-left:8pt">Lysosomal acid lipase deficiency</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #0028b2">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.00pt solid #0028b2">HoFH</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Preclinical Data </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our ability to use our hepatocyte-targeting fusosomes in relevant animal models is limited by a lack of cross-species
transduction. To address this, we first developed murine disease models and introduced the therapeutic payload utilizing a conventional lentivirus pseudotyped with <FONT STYLE="white-space:nowrap">VSV-G.</FONT> The
<FONT STYLE="white-space:nowrap">VSV-G</FONT> fusogen targets the LDL receptor which is highly expressed in hepatocytes providing a potent <I>in vivo</I> delivery vehicle for hepatocytes. These models established proof of concept to treat these
diseases through genomic integration of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">145 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
corrected gene as well as transduction efficiency in the range that would be needed for efficacy. However, the LDL receptor is found on a significant number of other cell types resulting in
extensive <FONT STYLE="white-space:nowrap">off-target</FONT> transduction. We do not intend to move forward with this <FONT STYLE="white-space:nowrap">non-specific</FONT> lentivirus construct, as its lack of specificity creates potential challenges
in humans. However, it does provide a preclinical model system for us to understand the percentage of hepatocytes, as well as the expression level of the novel genetic material that are required for the intended therapeutic effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In parallel, we have developed and improved hepatocyte-specific fusosomes for high on target transduction efficiency (as
measured by titer), with the goal of achieving potency comparable to or better than what we see with conventional lentivirus. Engineering of hepatocyte specificity is generated through the choice of target receptor selectively expressed in human
hepatocytes. Through an iterative process focusing on multiple hepatocyte-selective cell surface protein targets, diverse binders, and protein engineering, we have developed constructs that have met our potency goals. We have tested these constructs
<I>in vivo </I>in mouse models and shown that they can transduce human hepatocytes at levels comparable to conventional lentivirus with significantly lower frequency of off-target transduction. Furthermore, the transduction occurs in a
dose-dependent manner. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Improved Targeted Fusogens Exhibit High </U></B><B><I><U>in vitro </U></I></B><B><U>Transduction of Primary
Human Hepatocytes (PHHs) </U></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g60414g23y16.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:8pt; font-family:Times New Roman" ALIGN="justify"><I>Improved hepatocyte-targeted fusosomes show levels of in vitro transduction similar to
conventional lentivirus. Protein engineering of Fusogen 1b resulted in new sets of fusogens with significantly increased titer on PHHs. The most potent of these approach the hepatocyte titer of conventional lentivirus. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">146 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Improved Targeted Fusogens Can Transduce Hepatocytes </U></B><B><I><U>in
vivo</U></I></B><B><U> in a Humanized Liver Mouse (FRG) at Comparable Levels to Conventional Lentivirus and in a Dose-Dependent Fashion </U></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g60414g94u59.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:8pt; font-family:Times New Roman" ALIGN="justify"><I>Hepatocyte-targeted fusosomes show levels of in vivo transduction similar to conventional
lentivirus and dose dependence. Fusosomes were delivered by intravenous injection (tail vein) into humanized liver mice (FRG, or FAH- immunodeficient mice, repopulated with primary human hepatocytes). Dose for lentivirus was 1.4 10<SUP
STYLE="font-size:85%; vertical-align:top">11</SUP> TU/kg (# of transducing units per kilogram mouse body weight, tested on primary human hepatocytes). Highest dose for the hepatocyte-targeted fusosome was 1.1 10<SUP
STYLE="font-size:85%; vertical-align:top">10</SUP> TU/kg (1X) and lower doses were at one-third (0.33X) and one-tenth (0.1X) of the highest dose. Liver cells were harvested from injected mice seven days after injection, separated into hepatocytes
and non-parenchymal cells (non-hepatocytes) and analyzed for GFP expression and species (human or mouse). </I></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Background on OTC
Deficiency </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">OTC deficiency is the most common inherited disorder of the urea cycle, the process by which the body
detoxifies ammonia and produces urea. It is the only urea cycle disorder that is <FONT STYLE="white-space:nowrap">X-linked,</FONT> leading to more severe disease in males. OTC deficiency occurs in approximately 1 in 50,000 births, and there are
approximately 10,000 patients worldwide. A deficiency of the OTC enzyme leads to accumulation of ammonia, which can lead to neurotoxicity manifesting early as vomiting and anorexia, before progressing to a progressive lethargy, seizures,
intellectual impairment, coma, and death. The severity and age of onset of OTC deficiency can vary with the most severely affected, typically males, presenting shortly after birth. In this severe, neonatal onset of OTC deficiency, patients present
with an overwhelming illness that rapidly progresses with up to 90% mortality rate despite advances in standard of care treatments. In less severely affected patients who present later in childhood or as adults, severe elevations of ammonia and
resulting neurotoxicity still occur, primarily precipitated by an illness or excessive protein intake. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>OTC Deficiency: Current
Treatment Landscape and Unmet Need </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The standard of care for patients with OTC deficiency includes a low protein diet,
nutrient supplementation, and the use of ammonia scavengers such as benzoate, phenylacetate, or phenylbutyrate. While these ammonia scavengers provide an alternate pathway for ammonia excretion resulting in some improved outcomes, they are not
curative, have a possibility of neurotoxicity, have inconvenient dosing regiments, and must be used </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">147 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
cautiously in patients with cardiac, renal, or hepatic dysfunction. Maintaining a very low protein diet is also challenging for patients and results in a reduced quality of life. Despite all of
these measures, patients may still experience acute hyperammonemia crises particularly in the setting of increased protein catabolism that can be induced by viral illness or certain medications. These acute crises are treated with supportive care
including kidney dialysis for rapid ammonia reduction. The frequency and duration of hyperammonemia crises has been directly linked to poor long-term outcomes and intellectual disability. The only curative therapy available is liver transplantation,
which has become more common as surgical techniques and supportive care have improved over time. In those patients with severe, neonatal onset of OTC deficiency, liver transplantation is commonly performed before the age of five and, in some cases,
can occur before one year of age. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition to the standard of care therapies noted above, therapies to replace the
defective OTC gene have been pursued. Recent trials have primarily utilized AAVs to deliver a corrected OTC gene. While these viruses have to date been generally well tolerated, they are still associated with significant immunogenicity that can
preclude use in the up to one third of patients with <FONT STYLE="white-space:nowrap">pre-existing</FONT> antibodies to AAV and can lead to systemic symptoms, including elevated liver enzymes. Beyond the challenge of
<FONT STYLE="white-space:nowrap">pre-existing</FONT> antibodies, the primary drawback is the potential for transient efficacy as the gene replacement via AAV would not be expected to be permanent if replication of the target cell occurs. While the
durability of an AAV delivered gene replacement for OTC deficiency depends on many factors, one of the key determinants is the rate of hepatocyte turnover. This is especially relevant in pediatric patients with growing livers and rapid cell
turnover. This dilution of effect has been supported by animal studies where AAV delivered gene replacement was successful in adult animals but not successful in younger animals. The most severe form of OTC deficiency presents in the neonatal period
and, if a donor is available, may be treated with liver transplantation, a permanent gene therapy that provides long lasting benefit to patients is required to address the greatest unmet need from OTC deficiency. Additionally, as hepatocytes
continue to divide approximately once a year even in adults, a durable gene therapy would also be expected to provide an advantage even in adult patients where an AAV delivered gene therapy is likely to lose function over time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We believe our approach of pursuing a permanent gene replacement therapy has the potential to improve morbidity, mortality,
and quality of life even in the youngest, most severely ill patients. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Development Plan and Key Next Steps </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are conducting mouse studies to establish proof of concept and inform the dose profile of our lead hepatocyte fusosome. In
the near term, we are seeking to finalize the hepatocyte-targeted fusosome candidate and begin GLP production. Dose and safety of our lead fusosome compositions for OTC will be further informed through NHP studies, and we expect to yield an IND for
SG328 as early as 2022. We are currently evaluating whether our technology offers differentiated solutions to additional liver-specific gene therapies targeting genetic diseases such as Hemophilia and Alpha-1 antitrypsin deficiency. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>HSC Fusosome Program </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are developing hematopoietic stem cell (HSC) targeted fusosomes, designed to target and repair genetic abnormalities
underlying diseases such as sickle cell disease and beta-thalassemia (SG418), with the goal of achieving preclinical proof of concept as early as 2023. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Background on hemoglobinopathies </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Devastating inherited hematologic disorders, including sickle cell disease, beta-thalassemia, and other hemoglobinopathies, are
caused by a monogenic variant, and patients suffering from these diseases are candidates for <I>in vivo</I> cell engineering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Sickle cell disease (SCD) is caused by a single point mutation in the beta globin gene (HbB). The resulting mutant form of the
protein, referred to as HbS, is prone to aggregate into long, rigid molecules that deform red </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">148 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
blood cells (RBCs) into a sickle shape, obstructing blood vessels and undergoing premature lysis. The consequences are severe pain (sickle cell crisis), tissue infarction, infection, anemia,
stroke, and early death. SCD is the most common inherited blood disorder in the United States, affecting an estimated 100,000 individuals, and 134,000 individuals in Europe. The global prevalence of SCD is estimated to be approximately
4.4&nbsp;million individuals and is most common among people of African, Middle Eastern and South Asian descent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Beta-thalassemia is an inherited blood disorder caused by any one of over 200 mutations in HbB which results in reduced
production of functional hemoglobin. Transfusion-dependent beta-thalassemia (TDBT) is the most severe form of this disease, often requiring multiple transfusions per year. Patients with TDBT suffer from failure to thrive, persistent infections, and
life-threatening anemia. Frequent blood transfusions can lead to iron overload that then require iron chelation therapy, which itself is associated with significant toxicities, resulting in low levels of adherence. Even with frequent transfusions,
patients with TDBT continue to suffer from failure to thrive, persistent infections, and life-threatening anemia. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The
prevalence of beta-thalassemia globally is estimated to be 288,000. The total combined prevalence of beta-thalassemia in the United States and Europe is estimated to be approximately 19,000 patients, mostly in Europe. Of the patients currently
treated in the United States and Europe, we believe approximately 50% and 10%, respectively, are transfusion dependent. Beta-thalassemia is especially prevalent in developing countries of Africa, South Asia, Southeast Asia, the Mediterranean region
and the Middle East. Although historically prevalent in Mediterranean North Africa and South Asia, thalassemias are now encountered in other regions as a result of changing migration patterns. As such, there is a growing focus on developing new
therapeutics aimed at improving quality of life for this significant unmet medical need. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Correction of the causal
monogenic defects could potentially provide a <FONT STYLE="white-space:nowrap">one-time,</FONT> curative treatment approach, rather than the current lifelong, multidisciplinary standard of care treatment. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Current Treatment Landscape and Unmet Need </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Despite its clear and well-known genetic nature, SCD remains underserved, with existing treatment strategies mostly supportive
in nature. Allogeneic HSC transplantation (HSCT) is currently the only potentially curative therapy available. However, HSCT is limited by donor availability (approximately <FONT STYLE="white-space:nowrap">15-30%</FONT> worldwide). </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Furthermore, chronic graft-versus-host disease is a major risk that contributes to the long-term morbidities associated with allogeneic HSCT.
Otherwise, treatment options largely manage disease symptoms, including analgesia during crises, hydroxyurea, <FONT STYLE="white-space:nowrap">L-glutamine,</FONT> and anti-infectives. Recently, two disease-modifying treatments were approved by the
FDA, crizanlizumab and voxelotor. Crizanlizumab was approved for treating crises in SCD patients who are unresponsive to either hydroxyurea or <FONT STYLE="white-space:nowrap">L-glutamine.</FONT> Voxelotor is an oral small molecule inhibitor of HbS
polymerization, which compared to placebo, was associated with a reduction in acute crises. While these agents represent a meaningful advance in the treatment of SCD, they focus on supportive care and do not address the mutation in the gene that is
the root cause of the disease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As in SCD, there are limited treatment options available for TDBT, and those that exist
are supportive in nature. Allogeneic HSCT is similarly potentially curative but is also limited by donor availability, the risk of GVHD, and other comorbidities that result from the procedure. Because of the need for recurring blood transfusions,
patients require ongoing chelation therapy to avoid iron load from the transfusions and its associated organ damage. However, this treatment is burdensome and associated with significant toxicities, and consequently, has low adherence. Currently,
there is only one FDA approved therapy for beta-thalassemia, luspatercept, which significantly reduces the frequency of blood transfusions needed. However, safety concerns remain with a possible increased risk for hypertension and thromboembolic
events. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">There are several therapies in development to treat diseases of the hematopoietic system that have demonstrated
clinical proof of concept through <I>ex vivo</I> gene modification. These approaches directly address the genetic activity missing in SCD and TDBT by supplying a novel gene to the patient&#146;s cell or by editing the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">149 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
genome to enhance hemoglobin expression. The <I>ex vivo</I> process begins with the mobilization and removal of cells from the blood, a process known as leukapheresis.&nbsp;Next, these cells
undergo a process to enrich for cells expressing an HSC marker, CD34.&nbsp;The enrichment of CD34 cells increases the percentage of long-lived HSCs, the key stem cell that is both persistent and can differentiate into all the cells of the blood.
However, even under enrichment, long-lived HSCs make up less than 1% of all the CD34 cells. CD34+ cells are transduced with either a novel gene or genome editing complexes, each having a distinct therapeutic action. The cells are then cryopreserved
and sent back to the patient. Before transplantation, the patients receive conditioning chemotherapy to prepare the body so that the gene-modified cells engraft after <FONT STYLE="white-space:nowrap">re-infusion.</FONT> The current conditioning
regimens are toxic, with significant risks and side effects, although less toxic regimens are in development. Key questions remain regarding durability and safety, particularly over time, for transplanting these <I>ex vivo</I> modified HSCs.
Furthermore, manufacturing complexities, cost, and the complications from the myeloablative conditioning chemotherapy regimens remain significant obstacles to widespread adoption.&nbsp;There are multiple ongoing efforts to improve this approach by
focusing on HSC procurement, transduction, gene-editing, milder conditioning regimens, and transplantation efficiency. We believe that the most meaningful opportunity to improve outcomes is to eliminate the complex <I>ex vivo</I> modification and
transplantation steps by utilizing our fusogen technology to develop fusosomes that specifically target HSC and other key hematopoietic cells via <I>in vivo</I> delivery. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Our HSC Fusosome Approach </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The use of an <I>in vivo</I> fusosome-based delivery system bypasses the requirement for <I>ex vivo</I> manufacturing and would
require no conditioning chemotherapy.&nbsp;Without the manufacturing complexity and the requisite hospital stay for a patient who has undergone conditioning, as well as the concomitant costs and risks of each, <I>in vivo</I> therapies have the
potential to meaningfully increase the number of patients that receive these therapies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Targeting HSCs <I>in vivo</I>
using fusogens requires identifying the appropriate cells and their corresponding cell surface receptors.&nbsp;HSCs have no single specific marker, but there are a number of cell surface proteins that are highly enriched on HSCs.&nbsp;Some of these
markers also appear on erythrocytic, or red blood cell, progenitors, which may help establish both short-term and long-term efficacy. We have an ongoing program to discover fusogens with appropriate target specificity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In parallel, we are establishing our capability to deliver different payloads utilizing the fusosome system. Our goal is to
establish the appropriate cell specificity with the ability to utilize the appropriate gene modification system to achieve the right outcome for patients. With successful cell-specific targeting, we have an opportunity to deliver the therapeutic
payload to the right cell without the need for complex <I>ex vivo</I> manufacturing or toxic conditioning chemotherapy. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Development
Plan and Key Next Steps </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The next major milestones are to identify candidate fusogens for specific HSC targeting and
fusosome compositions with relevant genome modification payloads. Our goal is to achieve preclinical proof of concept for SG418 as early as 2023. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our
</B><B><I>ex vivo</I></B><B> Cell Engineering Platform </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Overview </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Ex vivo</I> cell engineering aims to treat human disease by engrafting new cells to replace diseased cells that are damaged
or missing in patients. Historically there have been four key challenges to <I>ex vivo</I> cell engineering: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">engraftment of the right cell in the right environment; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">appropriate function of the cells, necessitating an understanding of and ability to produce the desired cell
phenotype; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">150 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persistence of the cells in the host, particularly by overcoming immune rejection; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">manufacturing the desired cell in the quantities required. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our <I>ex vivo</I> cell engineering platform seeks to address these four challenges and is focused on engineering hypoimmune
cells that engraft, function, and persist in patients by evading immune rejection. These are derived from cell sources that are scalable and we believe that continued progress with this platform has the potential to create broad access for patients.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Our Approach to Building our ex vivo Cell Engineering Platform </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have approached the development of our <I>ex vivo</I> cell<I> </I>engineering platform by investing in solutions to address
the key challenges outlined above: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Stem cell and disease biology.</B> We believe that it is critical to have expertise in the developmental
biology of stem cell differentiation and a deep understanding of the desired cell phenotype biology of stem cell differentiation in order to generate cells that function appropriately, as well as a deep understanding of the desired cell phenotype.
The latter requires expertise in normal and disease biology. Furthermore, clinical understandings of disease pathology and transplant medicine are required to determine how to engraft the right cell in the right environment. Each of our programs is
led by a prominent clinician-scientist with deep expertise in both cell therapy and disease biology, including Dr.&nbsp;Terry Fry, our Senior Vice President, Head of T Cell Therapeutics, for T cells, Dr.&nbsp;Steve Goldman, our Senior Vice
President, Head of CNS Therapy, for glial cells, and Dr.&nbsp;Chuck Murry, our Senior Vice President, Head of Cardiometabolic Cell Therapy, for cardiomyocytes and beta cells. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Immunology and gene modification.</B> We believe that a deep understanding of the immunological response to
engineered cells is essential to unlocking the potential of <I>ex vivo</I> therapies. This effort is led by Dr.&nbsp;Sonja Schrepfer, our Senior Vice President, Head of Hypoimmune Platform, and draws from decades of research. We have licensed
technologies from University of California San Francisco, Harvard University, Washington University, and others to enable this effort. In addition, in order to create successful hypoimmune cells, we are investing in building out our gene editing,
modification, and insertion capabilities, led by Dr.&nbsp;Ed Rebar, our Senior Vice President, Chief Technology Officer. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Manufacturing.</B> We are investing proactively in process development, including scale up and optimization
of differentiation protocols, analytical development for product characterization, CMC/regulatory, and other manufacturing sciences in order to develop processes that can enable scalable manufacturing of cell therapies and broad patient access. We
are also investing to access high quality, <FONT STYLE="white-space:nowrap">GMP-grade</FONT> pluripotent stem cell lines for our programs. This manufacturing effort is led by Dr.&nbsp;Stacey Ma, our Executive Vice President, Technical Operations.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Our Approach to Building our ex vivo Cell Engineering Portfolio </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have prioritized cell types for our programs where: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">high unmet need can be addressed by cell replacement; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">existing proof of concept in humans and/or animal models demonstrating that cell transplantation should have a
clinical benefit; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">evidence exists that the cell type can be successfully differentiated from pluripotent stem cells and that
such stem cell-derived cells can function appropriately <I>in vivo;</I> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">there has been the ability to hire or partner with one of the world experts in the field to ensure our
programs are rooted in a deep understanding of the underlying cell and disease biology; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">evading immune system rejection via the hypoimmune technology is either not required initially but would be
disruptive over time (such as cardiomyocytes) or is the critical missing element to developing a cell therapy (such as beta cells). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">151 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Based on this prioritization, we are initially focused on four cell types:
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>T Cells </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">While autologous CAR T therapy has had a transformative impact on certain patients with hematological malignancies, there
remains substantial unmet need, including a lack of access to these therapies due to manufacturing complexities. A safe and effective allogeneic <I>ex vivo</I> therapy could address this unmet need, and we believe we have a potential differentiated
allogeneic approach with our hypoimmune technology. This approach addresses both adaptive and innate immune response, and thus has the potential to improve cell persistence and thereby treatment durability. We are investing in the capabilities to
utilize allogeneic donor T cells and, in the future, iPSC-derived T cells. Allogeneic donor T cells have significantly greater near-term applicability. Although iPSC-derived T cells are biologically complex and progress is needed to make them
readily viable, they have the potential to simplify and improve production long-term. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Beta cells </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Type 1 diabetes represents a substantial unmet need with a large patient population that faces major challenges with the
current standard of care. Cadaveric-donor islet transplantation in humans has been successful in reversing the disease course of diabetes, providing a robust proof of concept, but it has limited scalability and durability. Our approach of
transplanting hypoimmune stem cell-derived beta cells has the potential to provide a scalable, durable, disruptive solution to both generation of functional beta cells and evasion of immune system rejection. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>GPCs </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Myelin and astrocytic disorders, including leukodystrophies and multiple sclerosis, have limited treatment options which, when
available, only address the downstream consequences of disease. Our approach more directly addresses the primary biologic manifestation of these diseases by directly replacing lost or damaged glial cells, thus providing an opportunity to address
major unmet need across substantial patient populations. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Cardiomyocytes </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Heart failure represents one of society&#146;s most substantial unmet medical needs, with a lack of treatment options that
address the underlying deficiencies in heart function as a result of lost or damaged cardiomyocytes. Our cardiomyocyte program aims to directly regenerate the heart, by replacing lost cardiomyocytes with stem cell-derived cardiomyocytes, with the
goal of restoring heart muscle and increase function. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Historical context of ex vivo therapy </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Blood transfusions have been a standard treatment for many patients for over 100 years. The first successful kidney transplant
occurred in 1954, followed by the first successful heart transplant in 1967, demonstrating the transformative clinical potential of replacing damaged or missing cells in the body. Surgical enhancements have improved the success of engraftment, but
lack of organ access, a complex surgical procedure, and immune rejection of the donated organs have limited the impact of these procedures. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Progress in immunosuppressive regimens, such as the development of cyclosporine, has improved organ survival rates. However,
substantial side effects and the fact that many patients are ineligible or <FONT STYLE="white-space:nowrap">non-compliant</FONT> has reduced their impact. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Ultimately, the field has looked for a scalable source of therapeutic cells that can be accessed broadly at a manageable cost,
as well as cells that can evade immune rejection without immunosuppression. The advent of stem cell technology and subsequent improvements in methods to generate functional differentiated cells at scale
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">152 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
have the potential to address the shortage of donor tissues and organs. In addition, over the past decade a deeper understanding of the immunology of host versus graft responses, coupled with
novel techniques to manipulate the immunological profile of cells via gene editing, have raised the prospect that <I>ex vivo</I> engineered cells can significantly benefit patients without the requirement for significant immunosuppression. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Sources of allogeneic cells </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">There are three main potential sources of allogeneic cells, or cells that do not originate from the patient, and therefore have
the potential to be manufactured and supplied at scale. These are embryonic stem cells (ESCs), iPSCs, and donor-derived cells. Our portfolio currently reflects a mix of sources, with the ambition of transitioning primarily to iPSCs over time. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Embryonic Stem Cells </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The recognition that every cell in the body originates from a zygote, or fertilized egg, led to the research and ultimate
discovery of human ESCs, with the derivation of the first human ESC line in 1998. ESCs are pluripotent stem cells which can potentially differentiate into any cell type and are derived from the inner cell mass of a blastocyst or <FONT
STYLE="white-space:nowrap">pre-implantation</FONT> stage embryo. They are typically cultured <I>in vitro</I> and grown through cycles of cell division, known as passages, until a line of cells is established that can proliferate without
differentiating, and retain their pluripotency while remaining well characterized, including free from potentially deleterious genetic mutations. Because pluripotent stem cells can divide indefinitely without exhaustion, an ESC line can be used to
generate cell banks, consisting of large numbers of well-characterized vials of cells, that can be frozen and stored for future use. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Induced Pluripotent Stem Cells </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The discovery that mature, differentiated cells can be reprogrammed to be the equivalent of an ESC and capable of generating
any cell type in the body, has led to the research and ultimate development of human iPSCs, providing an alternative option as a source of stem cells for use in <I>ex vivo</I> engineered cells. A key scientific step was the discovery, in 1962, that
the differentiation of cells into specialized cell types is reversible, via nuclear transfer, also known as cloning. A second key step was a breakthrough in 2006, demonstrating that mature cells could be reprogrammed via the expression of a small
number of genes to result in pluripotent cells. This has led to the development of iPSCs reprogrammed using a small number of transcription factors. These iPSCs have similar potential to ESCs to be used as an indefinitely renewable cell bank for
manufacturing of cell-based therapies. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Donor-Derived Allogeneic Cells </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Another source of cells, which we utilize in our T cell program, comes from mature donor-derived allogeneic cells. While these
cells are neither pluripotent nor from an infinitely renewable source, T cells can be obtained as mature cells from human donors at scale. The use of donor-derived cells for our T cell program should allow us to most rapidly advance the program
towards the clinic with the implementation of our hypoimmune technology. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Approach to Sources of Allogeneic Cells </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are primarily focused on iPSCs as the starting material for our programs, which offers regulatory and cultural advantages to
ESCs, and scale and product consistency advantages to donor-derived allogeneic cells. Our portfolio currently reflects a mix of sources, which is primarily driven by historical factors. For example, our GPC program, which is more advanced, is
currently based on ESCs. Similarly, our T cell program is initially based on donor-derived allogeneic T cells, given the aforementioned challenges in generating pluripotent-stem cell derived T cells. Other programs either use or are being
transitioned to iPSCs where the technology allows it. Our ambition is to transition primarily to iPSCs over time. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">153 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Crucial aspects of developing allogeneic cells from any source include the
thorough characterization of the cells, a comprehensive understanding of the global regulatory environment, and an ability to maintain cells under the required conditions, such as current Good Manufacturing Practices (GMP), at various stages of the
manufacturing processes. We believe our early investment in building capabilities in the science and manufacturing of these cells will increase our likelihood of success. This investment is anticipated to yield sources of cells suitable for the
global clinical development and commercialization of <I>ex vivo</I> engineered cells for a broad patient population, in line with our vision to democratize access. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Background on Immunological Barriers to ex vivo Therapies and Current Limitations </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Starting with studies in renal transplantation in the early 1900s, it became clear that there were immunological factors
preventing successful transplantation. Initially, it was suspected to be mediated by an antibody response, but in the 1950s it was discovered that cell-mediated immune pathways also play a critical role in transplant rejection. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Further studies established T cells as playing a key role in the host immune response to transplant. T cells belong to the
&#147;adaptive&#148; immune system, recognizing and eliminating <FONT STYLE="white-space:nowrap">&#147;non-self&#148;</FONT> cells via recognition of differences in cell-surface proteins encoded by the major histocompatibility (MHC) locus. There are
two types of MHC molecules: MHC class I, expressed on the surface of almost all nucleated cells, and MHC class II, expressed constitutively on professional antigen presenting cells (APC), including macrophages and dendritic cells. Expression of MHC
class II is also induced in many additional cells in the context of inflammation. MHC class I molecules typically display peptides on the cell surface from degraded intracellular proteins. Cells display peptides from normal &#147;self&#148; proteins
on MHC class I, which typically will not activate an immune response due to a process called tolerance, where the body recognizes these peptides as &#147;self&#148;. However, if a cell displays a peptide from a foreign or mutated protein on MHC
class I, for example as a result of a protein mutation, it may result in the activation of a cytotoxic T cell response specific to the <FONT STYLE="white-space:nowrap">peptide-MHC</FONT> complex via the T cell receptor (TCR) on the T cell surface.
The activated T cell then eliminates the cell. MHC class II molecules typically display peptides derived from phagocytosis of extracellular proteins on the surface of APCs. These <FONT STYLE="white-space:nowrap">peptide-MHC</FONT> complexes interact
with TCRs on helper T cells, such as CD4+ T cells, resulting in a downstream cellular and humoral immune response. The humoral immune response leads to antibody production against foreign proteins. In allogeneic transplants, the cellular and humoral
processes can recognize proteins from the donor as &#147;foreign&#148;, resulting in an immune response to the transplant including potential elimination of the transplanted cells. In the allogeneic setting, MHC proteins can be highly immunogenic
due to their inherent polymorphism, increasing the risk of the recognition of transplants as &#147;foreign&#148;. This underlies the basis for MHC typing and matching to assess and reduce the risk of organ transplant rejection. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Many groups have attempted to engineer cells that can evade the adaptive immune system, typically by downregulating or
eliminating expression of MHC molecules on the surface of cells. While this can reduce the adaptive immune response to donor cells, the human immune system has evolved so that parts of the innate immune system will recognize cells missing MHC
molecules and eliminate them. For example, natural killer (NK) cells express receptors known as inhibitory killer-cell immunoglobulin-like receptors (inhibitory KIRs). KIRs recognize self MHC class I molecules on the surface of cells and provide
inhibitory signals to the NK cells to prevent their activation. Cells missing MHC class I molecules are corresponding eliminated by NK cells because of the lack of inhibitory KIR signaling and a resulting cytolytic activation. Known as the
&#147;missing self-hypothesis,&#148; this important redundancy in immunology enables the elimination of virally infected or transformed cells that have downregulated MHC class I, but also has complicated the development of allogeneic cells as
broadly applicable therapeutics. Our hypoimmune technology seeks to engineer cells to avoid immune rejection by addressing both the adaptive and innate immune response. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">154 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">There are three key strategies that have been utilized to date to overcome
immune rejection, with limited success: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Immune Suppression</B>. Cyclosporine and other molecules that suppress T cell responses are commonly used,
and many patients have been helped by the approaches in areas such as an organ transplantation. However, immune suppression often leads to significant systemic side effects, including a decreased ability to
<FONT STYLE="white-space:nowrap">fight-off</FONT> infections, increased susceptibility to cancer, and a wide variety of organ toxicities. Furthermore, patients typically require these on a lifelong basis, and any disruption in immunosuppression can
rapidly trigger rejection. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Matching HLA Type</B>. A second approach to overcoming immune rejection is to find a donor with a matched
HLA type. HLA stands for human leukocyte antigen which, in humans, is a synonym for MHC. This approach addresses the root of the mechanism that the immune system uses to identify <FONT STYLE="white-space:nowrap">&#147;non-self&#148;</FONT> cells and
has achieved some success. Finding a matched donor, however, can be difficult and is usually limited to close relatives who are willing and able to donate. While some have advocated for creating large banks of cells that match a wide variety of HLA
types, even with fully matched HLA class I and class II donors and recipients, there is a need for at least some immune suppression due to the presence of numerous minor antigen mismatches. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Autologous Approaches</B>. More recently, researchers have pursued autologous approaches, where a
patient&#146;s own cells are modified and introduced back as a graft. These cells may avoid immune rejection as they would be recognized as &#147;self.&#148; Autologous approaches have demonstrated effectiveness in certain diseases, such as
autologous CAR Ts for hematological malignancies, but these are limited in their adoption due to manufacturing cost and complexity. Furthermore, autologous approaches are generally are limited to cells that exist in the patient in suspension, such
as blood cells, and they cannot be applied to treat acute illnesses, such as myocardial infarction or stroke, due to the time it takes to prepare these cells for administration. </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our Solution &#150; Hypoimmune Technology </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">To address the challenge of immune rejection with allogeneic cell transplantation, we are developing our hypoimmune technology,
utilizing gene modification to introduce permanent changes to the cells. We are applying the hypoimmune technology to both iPSCs, which can then be differentiated into multiple cell types, and to donor-derived allogeneic T cells, which has the goal
of making potent CAR T cells at scale. Our goal with this technology is to transplant allogeneic cells into patients without the need for systemic immune suppression. We believe that enabling this capability has the potential to enable <I>ex
vivo</I> engineered cells to become an important therapeutic modality alongside small molecules, protein biologics, and <I>in vivo</I> engineered cells. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Some of our scientific founders, including Dr.&nbsp;Sonja Schrepfer, our Senior Vice President, Head of Hypoimmune Platform,
and their collaborators have worked on creating hypoimmune cells for well over a decade. A key insight was focusing on the phenomenon of fetomaternal tolerance during pregnancy. The fetus, despite having half its genetic material from the father, is
not rejected by the mother&#146;s immune system. However, after birth, few if any children would qualify as a matched donor for a cell or organ transplant for their mother. These scientists categorized the differences of the maternal-fetal border
and systematically tested them to understand which, if any, of these were most important to immune evasion. They have tested these changes in both <I>in vitro</I> and <I>in vivo </I>animal models. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Designing Hypoimmune Cells </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our goal is to create a universal cell that is able to evade immune detection, regardless of cell type or transplant location.
Our first-generation technology, which is progressing through late-stage animal confirmatory studies, combines the three gene modifications below to hide these cells from the host immune system: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">disruption of MHC class I expression; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">155 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">disruption of MHC class II expression; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">overexpression of CD47, a protein that hides cells from the innate immune system, including macrophages and NK
cells. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Preclinical Development of Hypoimmune Cells </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We and our licensors have carried out a series of experiments in various model systems of increasing immunological complexity.
These included (i)&nbsp;transplanting undifferentiated mouse hypoimmune iPSCs- into MHC mismatched allogeneic mice, (ii)&nbsp;transplanting mouse hypoimmune iPSC-derived differentiated cells, such as endothelial cells, into MHC mismatched allogeneic
mice, (iii)&nbsp;transplanting human hypoimmune iPSCs into MHC mismatched humanized allogeneic mice; and (iv)&nbsp;transplanting human hypoimmune iPSCs into <FONT STYLE="white-space:nowrap">non-human</FONT> primates (NHPs). We are currently carrying
out experiments transplanting NHP hypoimmune iPSC cells into NHPs as well as transplanting NHP hypoimmune iPSC-derived differentiated cells, such as beta cells, into allogeneic NHPs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Each mouse experiment, evaluated: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether hypoimmune cells can be successfully transplanted into the recipient without the need for
immunosuppression and without eliciting an immune response; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">whether differentiated cells derived from our hypoimmune cells were successfully engrafted in the recipient
without needing immunosuppression and without eliciting an immune response. </P></TD></TR></TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are investigating
both human iPSCs in NHPs as well as NHP iPSCs in NHPs, as we want insights into how the NHP immune system reacts to each of these species. We have largely completed the study of human iPSCs and have early results from the NHP hypoimmune iPSC
transplantation experiments. We are encouraged by data to date across species, with the NHP immune system most closely resembling the human immune system, representing the strictest test outside of testing these cells in humans. We are evaluating
both iPSCs as well as differentiated cells transplanted into the microenvironment we intend to target in humans. Based on the results of these NHP studies, we expect to test these hypoimmune cells in humans as a next step. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Mouse iPSC-derived hypoimmune cells transplanted into MHC mismatched allogeneic mouse </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Mouse hypoimmune iPSCs transplanted into an MHC mismatched allogeneic mouse were protected from the mouse immune system, and no
evidence was seen of either adaptive or innate immune system activation. The control arm transplanted <FONT STYLE="white-space:nowrap">non-edited</FONT> mouse iPSCs into MHC mismatched allogeneic mice, and, as expected, these <FONT
STYLE="white-space:nowrap">non-edited</FONT> mouse iPSCs were rapidly rejected by the recipient&#146;s immune system with a robust adaptive immune response. In another experiment, the genes that lead to for MHC class I and MHC class II expression
were knocked out. These modifications protected the cells from the recipient mouse&#146;s adaptive immune system, but NK cells rapidly killed the transplanted cells. These data highlight the importance of making all three gene modifications in order
to protect cells from the immune system with an allogeneic transplant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Next, to ensure that hypoimmune gene modifications
protected differentiated cells and that these modifications did not impact the ability of iPSCs to differentiate into various cell types, commonly referred to as pluripotency, it was tested whether the hypoimmune iPSCs cells could be differentiate
into three different cell types, function <I>in vivo</I>, and evade the host immune system. The three cell types were cardiomyocytes, endothelial cells, and smooth muscle cells. It was observed that hypoimmune iPSCs could successfully differentiate
into all three cell types, the cells functioned in the mouse, and the transplanted cells survived for the full standard observation period with no evidence of immune system activations despite any immune suppression. Differentiated cells derived
from <FONT STYLE="white-space:nowrap">non-edited</FONT> iPSC cells led to immune activation in the host mouse, and they did not survive. These data provide initial proof of concept that iPSCs can be genetically modified, and differentiated into
target cells that can engraft, function, and evade the recipient&#146;s immune system following transportation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">156 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Human iPSC-derived hypoimmune cells transplanted into MHC mismatched allogeneic humanized
mouse </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Having demonstrated the ability of mouse iPSC-derived hypoimmune cells to satisfy each of three testing
criteria, the experiments were advanced to evaluate human hypoimmune cells. This was evaluated using a &#147;humanized&#148; mouse system, generated by grafting a functioning human immune system in place of the mouse immune system. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition to evaluating the three primary criteria&#151;immune response to the human hypoimmune cells, pluripotency and
differentiation of the human hypoimmune cells, and immune response to cells differentiated from the human hypoimmune cells&#151;the ability to successfully engineer human hypoimmune cells from human iPSCs and whether differentiated cells derived
from human hypoimmune cells retain biological function were also evaluated. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Creating Hypoimmune Therapeutic Cells from Human iPSCs
</U></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g60414g23y17.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:8pt; font-family:Times New Roman" ALIGN="justify"><I>Our hypoimmune technology combines the three gene modifications below to hide cells from
the host immune system: Disruption of MHC class I and class II expression (which inactivates adaptive immune responses), and overexpression of CD47 (which hides cells from the innate immune system, including macrophages and natural killer (NK)
cells). Pluripotent stem cells from healthy donors are used as the starting material and are then genetically modified with the hypoimmune edits. These edited cells are then differentiated into cell types of therapeutic interest, which are
administered to the patient as &#147;off the shelf&#148; therapies. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">First, the foregoing three edits were replicated
in human iPSCs to engineer a human hypoimmune cell line that had comparable properties to the mouse hypoimmune cells <I>in vitro</I>. Next, <FONT STYLE="white-space:nowrap">non-edited</FONT> human iPSCs were transplanted into MHC mismatched
humanized mice. It was observed that these <FONT STYLE="white-space:nowrap">non-edited</FONT> human iPSCs were rapidly rejected. Human hypoimmune cells were then transplanted into MHC mismatched humanized mice. It was observed that the human
hypoimmune cells survived the full length of the experiment and failed to elicit any type of immune response. From this, it was concluded that, in humanized mice, the human hypoimmune cells can evade the immune system. Pluripotency of human
hypoimmune cells was confirmed by differentiation into two different cell types, endothelial cells and cardiomyocytes. These differentiated cells exhibited the characteristics </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">157 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
of normal endothelial cells and cardiomyocytes. Finally, to test whether these the differentiated cell types derived from human hypoimmune cells continue to evade the immune system, the
differentiated cells were transplanted into humanized mice, and the transplanted cells survived for the full standard observation period. In contrast, differentiated cells derived from <FONT STYLE="white-space:nowrap">non-edited</FONT> human iPSC
cells did not survive after being transplanted, as anticipated. It was also observed that the hypoimmune endothelial cells formed primitive vasculature with active blood flow and the hypoimmune cardiomyocyte cells matured into functional-looking
heart cells. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Absence of T and B Cell Activation Following Transplantation of Hypoimmune-Edited Human iPSCs into Mismatched Humanized
Mice </U></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g60414g23y18.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:8pt; font-family:Times New Roman" ALIGN="justify"><I>Left panels: T cell activation was measured by EliSpot counts for interferon-gamma
production. Immune cells from mice that received wild type (wt) iPSC grafts show a brisk interferon response when tested against allogeneic wt iPSC grafts. In contrast, immune cells from mice that received hypoimmune-edited (MHC class I/II
disruption, CD47 tg) cells show only minimal interferon production when exposed to allogeneic hypoimmune cells, comparable to background frequency in non-immunized mice. Right panels: B cell activation was measured by antibody binding to each cell
type, shown as mean fluorescence intensity (MFI). Wild type cells exhibit significant antibody binding when incubated with serum from mice that received wt cells. In contrast, hypoimmune-edited cells show only background levels of binding when
treated with serum from mice that received hypoimmune-edited cells. Adapted from Deuse et al, Nature Biotechnology 2019. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">158 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>CD47 is Required to Protect Hypoimmune-Edited Cells from Killing by Human NK Cells
</U></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g60414g23y19.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:8pt; font-family:Times New Roman" ALIGN="justify"><I>Human iPSCs were differentiated into endothelial cells (hiECs) and plated as a monolayer
in a multielectrode system. After exposure to NK cells, monolayer viability was measured electrical impedance, indicated here as normalized cell index. As expected, wt cells were not killed by NK cells. In contrast, cells lacking MHC class I and II
(but not expressing CD47 tg; MHC class I/II disruption) were rapidly killed. Addition of CD47 tg prevented killing by NK cells. A blocking antibody to CD47 abolished protection from NK cells, affirming the importance of CD47 overexpression in
protection from innate immune cell killing. From Deuse et al, Nature Biotechnology 2019. </I></P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Survival of Hypoimmune-Edited Human
iPSC Grafts in <FONT STYLE="white-space:nowrap">MHC-Mismatched</FONT> Humanized Mice </U></B></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g60414g58r91.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:8pt; font-family:Times New Roman" ALIGN="justify"><I>Wild type (wt) and hypoimmune-edited (MCH class I/II disruption CD47 tg) iPSCs were
engineered to express firefly luciferase before transplantation. Emission of light was used as an index of graft cell viability. Sequential light emission scans from the same representative animal receiving wt cells show progressive loss of graft
viability, indicating graft rejection, confirmed quantitatively in the line tracings below. In contrast, mice receiving hypoimmune-edited cells show graft expansion over the course of the experiment, indicating immune evasion. From Deuse et al,
Nature Biotechnology 2019. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">159 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Human hypoimmune cells transplanted into NHPs </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">To further evaluate the immune evasion properties of the human hypoimmune cells, we transplanted human hypoimmune iPSCs and WT <FONT
STYLE="white-space:nowrap">non-edited</FONT> iPSCs into NHPs. This experiment allowed us to explore whether these hypoimmune gene modifications can protect cells from both allogeneic rejection as well as xenogeneic, or cross-species, rejection. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The study was a randomized, blinded, parallel group study involving eight NHPs in two cohorts. The first cohort received an
initial subcutaneous injection of <FONT STYLE="white-space:nowrap">non-edited</FONT> human iPSCs, a reinjection of <FONT STYLE="white-space:nowrap">non-edited</FONT> human iPSCs, and a final injection of human hypoimmune cells (i.e., a crossover
design). The second cohort received an initial injection of human hypoimmune cells, a subsequent reinjection of human hypoimmune cells, and a final injection of <FONT STYLE="white-space:nowrap">non-edited</FONT> human iPSCs. The injections in both
arms were separated temporally by approximately four months. The first injection allowed us to test the immune evasion in a naive recipient and the second injection allowed us to explore the potential for
<FONT STYLE="white-space:nowrap">re-treatment</FONT> and the impact of previous exposure. The cross-over injections allowed us to understand the impact of injecting hypoimmune cells into an NHP with a
<FONT STYLE="white-space:nowrap">pre-existing</FONT> immune response to <FONT STYLE="white-space:nowrap">non-edited</FONT> cells, essentially replicating aspects of auto-immune disorders. The following diagram summarizes the study design: </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Design for Xenotransplantation Study Involving Wild Type (Unmodified) and Hypoimmune iPSC Delivery to NHPs </U></B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g60414g90l07.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">When human hypoimmune cells were grafted into NHPs without immunosuppression, we saw no
evidence of a systemic immune response, including no T cell activation and no antibody formation. Additionally, macrophages and NK cells did not recognize or kill these hypoimmune cells. In contrast, iPSCs without the hypoimmune edits generated a
robust systemic immune response, including T cells and both IgM and IgG antibodies. Neither hypoimmune nor the <FONT STYLE="white-space:nowrap">non-edited</FONT> cells survived long-term. While there was no systemic immune response to the hypoimmune
cells, we did see a local neutrophil infiltration, likely due to a xenogeneic response both to the cells and murine proteins in the matrix used to deliver the cells. We have seen similar local infiltrates of neutrophils in xenogeneic transplants
across every species we have studied to date. We do not intend to introduce xenogeneic cells in any human therapeutic. Early results from ongoing allogeneic studies exploring NHP iPSCs transplanted into
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">160 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
NHPs to confirm that this infiltrate was likely due to human proteins introduced into an NHP, a xenogeneic issue which would not be relevant in the context of the therapies we intend to move
forward. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following figure depicts the systemic immune results observed following the initial injection of human
hypoimmune cells and <FONT STYLE="white-space:nowrap">non-edited</FONT> human iPSCs. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Absence of T Cell, B Cell, or NK Cell Responses
Following the First Delivery of Hypoimmune Human iPSCs into NHPs </U></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g60414g93j37.jpg" ALT="LOGO">
 </P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:8pt; font-family:Times New Roman" ALIGN="justify"><I>Immune cells from animals receiving unmodified (wt) human iPSCs show robust T cell
interferon responses when exposed to wt iPSCs in vitro. In contrast, immune cells from animals receiving hypoimmune iPSCs showed no response when exposed to hypoimmune iPSCs in vitro. Delivery of wt iPSCs activated B cells, as evidenced by
production of IgM, IgG, and by binding of these antibodies to the surface of donor cells (increased mean fluorescent intensity, MFI). Delivery of hypoimmune iPSCs did not induce antibody production above background, and no binding of IgM or IgG to
the cell surface was seen. Neither unmodified nor hypoimmune-edited cells were susceptible to killing by NK cells, indicating protection from the &#147;missing self&#148; signal. Data above from a single NHP; results representative of studies in
four NHPs. Dotted lines, background level of assay. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">161 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">To evaluate if the NHP immune system retained any immunological memory of
its encounter with the human cells, we <FONT STYLE="white-space:nowrap">re-dosed</FONT> NHPs with the same type of cells they received in their initial dose. As with the first injection, the human hypoimmune cells induced no systemic immune
response, including no T cell activation and no antibody production. In contrast, <FONT STYLE="white-space:nowrap">non-edited</FONT> human iPSCs elicited a robust and rapid T cell and antibody response, suggesting immune memory to these cells from
the previous injection. Again, the human hypoimmune cells did not survive long-term, as there was a similar local infiltration of neutrophils. These results, if confirmed with better graft survival with hypoimmune NHP iPSCs, raise the possibility of
<FONT STYLE="white-space:nowrap">re-dosing</FONT> human hypoimmune cells as part of future therapies. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">162 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The results of the redosing experiment are depicted below: </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Absence of T Cell, B Cell, or NK Cell Response to a Second Dose of Human Hypoimmune-Edited iPSCs in NHPs </U></B></P>
<P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g60414g75d41.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:8pt; font-family:Times New Roman" ALIGN="justify"><I>A second dose of unmodified human iPSCs induced a robust T cell response (EliSpot assay
for interferon production) as well as strong induction of antibody production from B cells, as indicated by increased IgM and IgG levels, along with increased antibody binding to donor cells. In sharp distinction,
<FONT STYLE="white-space:nowrap">re-administration</FONT> of hypoimmune iPSCs induced no T cell or B cell activation. As before, neither cell population was susceptible to NK cell killing. Data above from a single NHP; results representative of
studies in four NHPs. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">To evaluate whether <FONT STYLE="white-space:nowrap">pre-existing</FONT> immunity to <FONT
STYLE="white-space:nowrap">non-edited</FONT> human iPSCs adversely impacts immune evasion of human hypoimmune cells, we then performed the crossover portion of this experiment, injecting human hypoimmune cells into NHPs that had previously been
dosed with unmodified human iPSCs. Recall, these NHPs </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">163 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
had all demonstrated a robust T cell and antibody responses to the unmodified iPSCs. As indicated in the figure below, human hypoimmune cells again elicited no systemic immune response despite <FONT
STYLE="white-space:nowrap">pre-existing</FONT> T cells and antibodies to the <FONT STYLE="white-space:nowrap">non-edited</FONT> versions of these cells. These data suggest that human hypoimmune cells may be able to evade immune detection even in
patients with <FONT STYLE="white-space:nowrap">pre-existing</FONT> immune responses to that cell type, opening the opportunity to explore auto-immune diseases. We also injected NHPs that had been twice dosed with human hypoimmune cells with human
iPSCs. In contrast to when these NHPs received hypoimmune iPSCs, injection of the unmodified iPSCs led to a strong T cell and antibody responses, suggesting that the NHPs immune systems were intact. Again, there was no long-term graft survival due
to the local xenogeneic inflammatory response. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Hypoimmune-Edited iPSCs do not Elicit T Cell, B Cell, or NK Cell Activation when
Administered to NHPs <FONT STYLE="white-space:nowrap">Pre-Sensitized</FONT> with Unmodified Cells </U></B></P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g60414g19f75.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:8pt; font-family:Times New Roman" ALIGN="justify"><I>The top row shows absence of T cell (EliSpot) or B cell (IgM and IgG production and
binding) activation when hypoimmune iPSCs were given to NHPs that had been administered two doses of unmodified cells. The bottom row shows activation of T cells and B cells by unmodified iPSCs in animals whose immune system had previously been
quiescent following delivery of hypoimmune iPSCs. This indicates that there is no immunosuppression resulting from hypoimmune cell delivery. As before, there was no NK cell killing of hypoimmune iPSCs following the crossover dose. Data above from a
single NHP; results representative of studies in four NHPs. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">164 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>NHP hypoimmune cells transplanted into NHPs </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I></I>To evaluate immune evasion properties of the hypoimmune cells without the limitations of the xenogeneic barrier, we have
begun testing the immune response to and survival of hypoimmune iPSCs from NHPs by transplantation into an allogeneic NHP recipient. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In an ongoing pilot experiment, a single NHP was dosed intramuscularly with hypoimmune iPSCs. We not only observed cell
survival but also proliferation of the transplanted cells for at least five weeks post-transplant. We found no evidence of a systemic immune response, including no T cell activation and no antibody formation to the transplanted cell. Furthermore,
macrophages and NK cells did not recognize or kill these hypoimmune cells. By contrast, the control arm of non-edited NHP iPSCs injected into a separate cohort of NHPs are not detectable three weeks post transplantation and elicit a robust systemic
immune response, including T&nbsp;cells as well as both IgM and IgG antibodies. </P>  <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Allogeneic Hypoimmune iPSC Survive
</U></B><B><I><U>in vivo</U></I></B><B><U> in NHPs with an Intact Immune System </U></B></P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g60414g46f85.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:8pt; font-family:Times New Roman" ALIGN="justify"><I>Unmodified (wild type, wt) NHP iPSCs (top row) or hypoimmune NHP iPSCs (bottom row) were
introduced via intramuscular injection into allogeneic NHPs. iPSC survival is followed over time in vivo using bioluminescence imaging (BLI). BLI signal on the day of transplantation is &#147;D0&#148; and defined as 100%. NHPs are analyzed weekly
and cell survival is calculated over time. Data are representative for three NHPs receiving HIP iPSCs and two NHPs receiving unmodified wt iPSCs. Experiments were conducted in a staggered fashion. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">165 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Absence of T Cell, B Cell, or NK Cell Responses Following the First Delivery of
Hypoimmune NHP iPSCs into NHPs </U></B></P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g60414g36l36.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:8pt; font-family:Times New Roman" ALIGN="justify"><I>Immune cells from animals receiving unmodified (wild type, wt) NHP iPSCs show robust
T&nbsp;cell interferon responses when exposed to wt iPSCs in vitro (Row&nbsp;1). In contrast, immune cells from animals receiving hypoimmune iPSCs showed no response when exposed to hypoimmune iPSCs in vitro (Row&nbsp;2). Delivery of wt iPSCs
activated B&nbsp;cells, as evidenced by production of IgM and IgG (increased mean fluorescent intensity, MFI) (Row&nbsp;1). Delivery of hypoimmune iPSCs did not induce antibody production above background (Row&nbsp;2). Neither unmodified nor
hypoimmune-edited cells were susceptible to killing by natural killer (NK) cells, indicating protection from the &#147;missing self&#148; signal. Data above from a single NHP; data are representative for three NHPs receiving HIP iPSCs and two NHPs
receiving unmodified wt iPSCs; experiments were conducted in a staggered fashion. Dotted line denotes background level of assay. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In ongoing and planned experiments, we aim to determine the full extent of cell survival and immune evasion for these cells.
Going forward, we also plan to investigate the potential for redosing and to test the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">166 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
hypoimmune technology in a more therapeutically relevant context&#151;the appropriate cell type, in the appropriate microenvironment, in an allogeneic NHP transplant setting. We expect to have
data from this series of experiments in 2021. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In light of our preclinical data to date, we believe our hypoimmune
technology has the potential to address the most fundamental limitation of <I>ex vivo </I>therapies, persistence, and thereby unlock waves of potentially disruptive therapies across a variety of cell types. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We also have an ongoing program to further refine our hypoimmune technology. Our research teams are working on additional
modifications to expand our toolkit, as different microenvironments and different immune states may require additional modifications. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Safety Switch
for Hypoimmune Cells </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are actively investigating approaches to control hypoimmune cells after administration
into the patient. If necessary, the aim of these &#147;safety switches&#148; would be to provide a mechanism to eliminate hypoimmune cells within the body in a targeted fashion, in scenarios where the cells are not in a location where physical
removal is viable. Such a safety switch would be beneficial to mitigate the potential risk of a hypoimmune cell becoming infected with a virus or undergoing oncogenic transformation, in light of the immune evasion modifications to these cells. One
approach we are exploring as a safety switch is to re-sensitize the hypoimmune cells to innate cell killing via administration of a blocking anti-CD47 antibody. In mouse experiments we have shown that treatment with an anti-CD47 antibody resulted in
the loss of immune evasion and the rapid killing of transplanted human hypoimmune cells. We have identified several safety switches with <I>in vivo</I> activity and intend to continue to explore them. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Anti-CD47 Administration Results in the Rapid Clearance of Human iPSCs in a Humanized Mouse Model </U></B></P>
<P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g60414g03b67.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:8pt; font-family:Times New Roman" ALIGN="justify"><I>On left: Human iPSC proliferate (as visualized by luminescence of live cells) and form
teratoma in NSG mice (n=3) with adoptive transferred human NK cells. Administration of isotype control has no impact on HIP survival. On right: Blocking of CD47 in vivo results in killing of HIP iPSCs (as visualized by luminescence of live cells) in
NSG mice (n=5) with adoptive transferred human NK cells. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">167 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our </B><B><I>ex vivo</I></B><B> Cell Engineering Pipeline </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Allogeneic T Cell Program (SC291, SC255) </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our allogeneic T cell program utilizes T cells from healthy donors to generate CAR T therapies that will initially target CD19,
a protein expressed on the cell surface of B cell malignancies, to treat patients with refractory lymphoma. We believe that applying the hypoimmune technology to allogeneic T cells gives us an opportunity to create differentiated allogeneic CAR T
therapies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We believe our allogeneic T cell and T cell fusosome discovery programs provide us with two potentially
disruptive programs to address the limitations of adoptive T cell therapy for cancer, each with idiosyncratic risks and opportunities. We also believe each approach can address separate and valuable opportunities if they are both successful.
Specifically, our allogeneic T cell program offers the opportunity to perform multiple gene edits in a T cell, which may allow us to make intentional modifications to control T cell function or to deliver more complex chimeric receptors and signal
integration machinery to enable the T cell to distinguish tumor cells based on surface antigen combinations to improve the specificity of targeting. These approaches may prove especially valuable in targeting solid tumors, which have remained
largely refractory to CAR T approaches to date. We also have an earlier-stage program looking to differentiate hypoimmune iPSCs into T cells. While we are still working to successfully create the appropriate T cells from an iPSC, we expect that
progress with our allogeneic T cell program will also inform the iPSC T cell program. Separately, the fusogen technology allows for the <I>in vivo</I> generation of CAR T cells in a patient, offering a distinct advantage in terms of
manufacturability and scalability that may enable the introduction of gene-modified T cells earlier in the course of a patient&#146;s therapy. Additionally, modifying the T cells inside the body without the need for <I>ex vivo </I>manipulation of
the cells may generate CAR T cells with more favorable attributes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We intend to develop our CD19 allogeneic T cell
therapies with the goal of filing an IND for SC291 as early as 2022. We are also advancing an allogeneic T cell program targeting BCMA for multiple myeloma, with the goal of filing an IND for SC255 as early as 2022 . </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Background on B cell Malignancies </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">B cell malignancies represent a spectrum of cancers including <FONT STYLE="white-space:nowrap">non-Hodgkin</FONT> Lymphoma
(NHL), chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia (ALL), and multiple myeloma (MM)&nbsp;and result in over 100,000 deaths per year in the United States and Europe. See the subsection titled &#147;&#151;in vivo Cell Engineering
Pipeline&#151;Background on B Cell Malignancies&#148; for further background discussion. In addition to our<I>&nbsp;in vivo</I>&nbsp;cell engineering technology, we believe our<I>&nbsp;ex vivo</I>&nbsp;cell engineering technology also has the
potential to address B cell malignancies. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Current Treatment Landscape and Unmet Need </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We believe our hypoimmune edited cells have the potential to create a differentiated platform for developing allogeneic T
cells. There are two major hurdles to the use of allogeneic T cells. The first is the risk of graft versus host disease, in which the allogenic donor T cells target and kill recipient tissues. Multiple CAR T cell product candidates in clinical
development have managed to prevent this reaction through gene edits targeting components of the T cell receptor such as <FONT STYLE="white-space:nowrap">TCR-alpha</FONT> gene. The more significant challenge has been host versus graft disease, in
which the patient&#146;s immune system kills the transplanted T cells. One strategy to approach this challenge has been to essentially eliminate the patient&#146;s immune system, neutering its ability to find and destroy the transplanted allogeneic
CAR T cells. This strategy has two limitations. First, the patient is at risk of severe infections during this period of substantial immune suppression. Second, as the immune system returns, it will inevitably reject the allogeneic CAR T cells,
limiting the duration that these therapeutic cells are in the body. Experience with autologous CAR T cells in patients with B cell malignancies has demonstrated that persistence of CAR T cells is important for the durability of response. Thus, the
ability to effectively prevent </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">168 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
long term rejection of an allogeneic CAR T therapy without significant immune suppression would be a major advance. We are aware of other efforts to develop allogeneic CAR T cell products that
focus on overcoming the adaptive immune system (T and B cells). Our technology addresses rejection mediated by both the adaptive and innate immune systems, giving us the potential to create a differentiated allogeneic CAR T solution. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Our Allogeneic T Cell Program Approach </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our hypoimmune technology is designed to hide the cell from the patient&#146;s immune system, and we are applying this
technology to manufacture allogeneic CAR T cells. We intend to utilize T cells from healthy donors into which we will introduce the CAR gene and make the gene modifications necessary to overcome graft versus host disease and to incorporate our
hypoimmune technology in an effort to address host versus graft disease. We then intend to expand these cells <I>ex vivo</I>, with a goal of making many batches from a single donor as well as creating comparable CAR T cells from various healthy
donors. These allogeneic CAR T therapies could be frozen and delivered as an &#147;off the shelf&#148; product for cancer patients without the need for severe immunosuppression. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">169 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Preclinical Data </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For our preclinical studies, human donor-derived T cells were genetically modified <I>ex vivo,</I> to generate cells bearing
the hypoimmune edits (disruption of MHC class&nbsp;I/class&nbsp;II; overexpression of CD47), TCR-alpha disruption (to mitigate graft versus host disease) and the expression of a CD19 CAR. These cells were then tested <I>in vivo</I> for their
tumor-killing activity in a human xenograft mouse model for leukemia (Nalm-6). These preclinical data suggest that the hypoimmune edits do not interfere with CAR T killing activity. We observed clearance of the leukemic cells by the hypoimmune CD19
CAR T cells and the potency of these cells was comparable to unmodified CD19 CAR T cells, which are similar to CAR T cells currently in clinical use. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Hypoimmune Donor-Derived CD19 CAR T Cells Clear Leukemia Cells in a Human Xenograft Mouse Model at Levels Comparable to Unmodified CD19
CAR T Cells </U></B></P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g60414g70n10.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:8pt; font-family:Times New Roman" ALIGN="justify"><I>Activity of hypoimmune donor-derived CD19 CAR T</I><B></B><I> in a mouse leukemia
xenograft model (Nalm-6). Note that when compared to untreated controls, infusion of unmodified CD19 CAR T or hypoimmune CAR T results in eradication of leukemia cells. Both cohorts of CAR&nbsp;T treated mice had significantly reduced tumor burden
when compared to control as early as D7 (p</I><FONT STYLE="FONT-FAMILY:SYMBOL">&#163;</FONT><I></I><I>0.0001; One-way ANOVA Bonferroni) with no significant difference between either of the treatment arms. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">170 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Furthermore, the hypoimmune CD19 CAR T cells were protected from immune
system rejection in humanized mice, and no evidence was observed of either adaptive or innate immune system activation, in contrast to the unmodified CAR-T cells: </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Absence of T Cell, B Cell, NK Cell, and Macrophage Responses in a Human Xenograft Mouse Model Following Injection of Hypoimmune
Donor-Derived CD19 CAR T Cells </U></B></P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g60414g96c86.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:8pt; font-family:Times New Roman" ALIGN="justify"><I>Immune cells from humanized animals receiving hypoimmune donor-derived CD19 CAR
T</I><B></B><I> showed no response when exposed to hypoimmune CAR T cells in vitro. Delivery of hypoimmune cells did not result in production of donor-specific antibodies, as evidenced by binding of IgM antibodies to the surface of donor cells
(increased mean fluorescent intensity, MFI). Hypoimmune-edited cells were not susceptible to killing by NK cells nor macrophages, indicating protection from the &#147;missing self&#148; signal. </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Development Plan and Key Next Steps </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Process development work is ongoing within the Technical Operations team to develop manufacturing processes to generate
high-quality and consistent allogeneic T cell product candidates at sufficient scale. In parallel, our cell engineering team is developing scaled, efficient, and specific gene editing processes to enable manufacturing of our allogeneic T cell
product candidates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The next major milestone is to complete GLP production and manufacturing <FONT
STYLE="white-space:nowrap">scale-up</FONT> with the goal of filing an IND for SC291 as early as 2022. We are also advancing an allogeneic T cell program targeting BCMA for multiple myeloma, with the goal of filing an IND for SC255 as early as 2022.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">171 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Beta Cell Program </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our beta cell program aims to restore lifelong glucose control in Type I diabetes mellitus (T1DM), patients by transplanting
hypoimmune iPSC-derived beta cells. Current therapies for T1DM require continual management, and we believe that effectively restoring beta cell functionality will meaningfully improve patient outcomes for patients with T1DM. We intend to develop
this program with the goal of filing an IND for SC451 as early as 2023. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Background on Type 1 Diabetes </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">T1DM is an autoimmune disease in which the patient&#146;s immune system destroys its own pancreatic beta cells. The destruction
of these cells leads to complete loss of insulin production and a metabolic disease wherein patients are unable to control their blood glucose levels. Often called &#147;juvenile diabetes&#148;, this disease commonly has its onset in adolescence.
Beta cells reside in specialized hormone-producing clusters within the pancreas called the Islets of Langerhans. In T1DM, activated T lymphocytes infiltrate the islets and selectively kill the beta cells, progressively reducing the body&#146;s
capacity to produce insulin. Once the reserve capacity of beta cells is exhausted, blood glucose rises, and the patient will have a life-long battle to control blood glucose levels. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">T1DM affects 1.6&nbsp;million adults in the United States, and there are approximately 20,000 new cases diagnosed per year in
patients under the age of 20. In Europe there are an estimated 2.4&nbsp;million adults with T1DM, and 300,000 under the age 20, with 31,000 new cases of T1DM diagnosed each year. Combining prevalence in the United States and Europe yields a pool of
approximately 4&nbsp;million patients with T1DM. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Current Treatment Landscape and Unmet Need </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Insulin injection is the main treatment option for T1DM. Despite significant advances in types of insulins, glucose monitoring,
and insulin pumps, life expectancy for T1DM is still approximately 15 years shorter than for people without diabetes. Patients are at risk from acute complications of hyperglycemia, including diabetic ketoacidosis and coma. Conversely, they are also
at risk of hypoglycemic episodes, particularly at night, which can lead to the &#147;dead in bed&#148; syndrome, thought to result from cardiac arrhythmias induced by low glucose. Long term elevations in blood glucose levels have particularly
devastating effects on arteries and capillaries, resulting in premature myocardial infarction, stroke, limb ischemia, gangrene, kidney failure, and blindness due to diabetic retinopathy. &#147;Insulin pumps,&#148; which feature a computerized system
for sensing blood glucose and delivering appropriate doses of insulin, have improved glycemic control. However, when implanted chronically, they elicit a foreign body scarring reaction around the sensor, and this barrier introduces a lag between
changes in glucose in the blood and at the sensor. Newer systems use short term implantable sensors on the tips of needles but require frequent punctures and are associated with injection site reactions. Notably, data from the FDA indicate that
issues with insulin pumps are among the most frequently reported problems in their database. All current therapies require patients to carefully monitor their dietary intake, which, while inconvenient in adults, is a frequent point of failure in
adolescents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Pancreas transplantation for uncontrollable diabetes was first performed in the 1960s, and this established
the principle that replacing the beta cells (here in the context of the whole pancreas) could restore physiological glucose control. Pancreas transplants are complicated surgical interventions, require lifelong immunosuppression, and are limited due
to organ availability. Nevertheless, some 30,000 pancreas transplants have been performed worldwide to date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Because of
these challenges, the biomedical community began exploring pancreatic islet transplantation in the 1970s. This process involves enzymatic digestion of a donor pancreas and isolation of the Islets of Langerhans followed by delivery of these cells to
an appropriate site in the body where the islets can engraft and become well vascularized. Multiple sites have been shown to support islet engraftment and glucose control, including kidney, liver, and skeletal muscle. The major lessons from islet
transplantation have been that glucose </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">172 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
homeostasis can be restored, insulin-independence can be achieved, hemoglobin A1C levels (a marker of long-term glucose levels) can be normalized, and severe episodes of hypoglycemia can be
reduced. As with an organ transplant, patients must be immune suppressed to prevent immune rejection of the transplanted cells. In addition to complications from this immune suppression and the lack of cell availability, the principal limitation of
islet transplantation has been the therapy&#146;s durability. Most patients lose glucose control over months to years and eventually become insulin-dependent again, primarily due to immune rejection of the allogeneic islets. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Our Beta Cell Program Approach </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The goal of our beta cell hypoimmune program is to restore lifelong glucose control in T1DM patients by transplanting
hypoimmune iPSC-derived beta cells, including beta cells. Our goal is to create a therapy that restores the body&#146;s normal beta cell mass, giving patients physiologically appropriate glucose sensing ability and insulin secretion. We believe this
therapy could reduce, or even eliminate, hypoglycemia and hyperglycemia, potentially enabling less onerous and costly treatment, fewer complications, and longer life expectancy, resulting in a meaningfully improved quality of life. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We aim to develop a disruptive therapy that builds on lessons from pancreatic islet transplantation, recent advances in
understanding pancreatic islet developmental biology, and our hypoimmune technology. Deriving beta cells from iPSCs has the potential to solve limitations associated with donor pancreases and improve the overall product quality and product
consistency. iPSCs have the potential to create a virtually limitless supply of these cells. Our program uses proprietary differentiation protocols to generate mature beta cells with glucose control comparable to primary human islets, as evidenced
by our animal studies. Finally, we intend to modify the genes of the iPSCs in order to apply our hypoimmune technology. If successful, the hypoimmune gene modifications will protect these cells from both auto-immune and allogeneic rejection by the
patient&#146;s immune system. Hypoimmunity should also eliminate the need for physical separation of the beta cells from the rest of the body by a device or encapsulation technology, which may allow for tighter control of glucose by eliminating the
lag time between glucose sensing and insulin secretion. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Preclinical Data </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are developing a proprietary protocol that will differentiate hypoimmune iPSCs into mature, glucose-sensitive,
insulin-secreting beta cells based on licensed technology from Washington University in St. Louis. This technology enables differentiation of beta cells at a greater purity and with superior function compared to published stem cell-based protocols.
The principal function of beta cells is to maintain steady levels of glucose in circulation. The beta cells sense when glucose levels rise in the bloodstream and release insulin in response. <I>In vitro</I>, our beta cells respond to glucose and
robustly secrete insulin at an equivalent level to primary human islets, as depicted in the figure below. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">173 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Human iPSC-Derived Beta Cells Exhibit Glucose-Induced Insulin Release </U></B></P>
<P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g60414g38s95.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:8pt; font-family:Times New Roman" ALIGN="justify"><I>Human islets from cadaveric pancreases (gold standard) exhibit robust insulin secretion
in response to an increase in glucose levels. Human iPSC-derived beta cells using technology licensed from Washington University in St. Louis show similar dynamics of insulin secretion to the cadaveric islets. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">These stem cell-derived beta cells were tested in a mouse model of Type I diabetes induced by the beta cell toxin,
streptozotocin. When transplanted into the kidney of the diabetic mice, these beta cells normalize glucose levels in an equivalent fashion to primary human islets. The diabetic glucose levels return when the grafts are surgically excised
(nephrectomy). Similar to the human phenotype, diabetic mice cannot normalize circulating glucose levels following a glucose injection. Following transplantation of our beta cells, these mice rapidly normalized blood glucose in an equivalent fashion
to both <FONT STYLE="white-space:nowrap">non-diabetic</FONT> mice and diabetic mice that received human primary islet transplants. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">174 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U></U></B><B><I><U>In vivo</U></I></B><B><U> Performance of iPSC-Derived Beta Cells in a
Mouse Model of T1DM</U> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g60414g83s13.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:8pt; font-family:Times New Roman" ALIGN="justify"><I>Top: Normalization of blood glucose levels after transplantation of cadaveric human islet
cells or iPSC-derived islet cells obtained by planar or suspension differentiation (Washington University technology). Note the rapid normalization of blood glucose with cadaveric and stem cell-derived islets with the planar protocol, with slower
normalization using the suspension protocol. In all groups, removal of the graft by nephrectomy <FONT STYLE="white-space:nowrap">re-induced</FONT> diabetes, indicating the correction resulted from the transplant. STZ, streptozotocin, is a toxin for
beta-islet cells that induces diabetes in animal models. Bottom: Normalization of blood glucose after glucose injection by transplantation of cadaveric islet cells or iPSC-derived islet cells. Note the more complete normalization using the planar
protocol. Groups are defined by the same symbols shown in the middle panel. From Hogrebe et al, Nature Biotechnology 2020. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">An important challenge for any beta cell program is protecting the pancreatic islet cells from the immune system, particularly
given that T1DM patients already have a <FONT STYLE="white-space:nowrap">pre-existing</FONT> immune response to the pancreatic beta cell. We believe we may have a differentiated ability to address this challenge given our hypoimmune technology.
Importantly, data from the cross-over portion of our hypoimmune NHP study shown previously highlights the potential of the hypoimmune technology to prevent systemic immune activation even in the scenario where there are preexisting T cells and
antibodies reactive to the cell. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Development Plan and Key Next Steps </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our next important milestone is to make beta cells from hypoimmune modified NHP iPSCs and transplant them into NHPs. These data
should provide substantial insight into the potential of the hypoimmune edits to protect beta cells from allogeneic rejection. We are also working on our scaled manufacturing process to create a robust, consistent, and scaled therapy. Making the
hypoimmune gene edits requires early investment in GMP iPSCs and GMP gene modification reagents. We are working through the process development and <FONT STYLE="white-space:nowrap">IND-enabling</FONT> studies to allow for an IND filing for SC451 as
early as 2023. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>GPC Program </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our GPC program aims to deliver healthy allogeneic GPCs, the precursors to both astroglia and myelin-producing
oligodendrocytes. This program has the potential to treat myelin and glial-based disorders, which </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">175 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
represent a broad group of debilitating neurological disorders, such as multiple sclerosis and a number of neurodegenerative disorders, none of which have effective treatment alternatives. We
intend to develop our stem cell derived GPC therapies for secondary progressive multiple sclerosis, <FONT STYLE="white-space:nowrap">Pelizaeus-Merzbacher</FONT> disease other disorders of myelin, Huntington&#146;s disease, and other astrocytic
diseases. Our goal is to file three INDs for SC379 as early as 2023. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Background on Myelin and Glial Based Disorders </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Glial cells are the support cells of the human CNS, within which they are the most abundant cells. The two major types of <FONT
STYLE="white-space:nowrap">CNS-derived</FONT> glial cells are oligodendrocytes&#151;the cells that produce myelin, the insulating substance of the brain&#146;s white matter that enables neural conduction and astrocytes, the support cells of neurons
and their synapses. These two kinds of glial cells arise from human GPCs (hGPCs), which are the major dividing cell type of the adult brain and are responsible for remyelination in the injured and demyelinated adult brain and spinal cord. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Diseases of glial cells are among the most prevalent and disabling conditions in neurology. These disorders include the
disorders of oligodendrocyte loss and myelin failure&#151;such as progressive multiple sclerosis, vascular white matter loss, and the childhood leukodystrophies &#150; and the disorders of astrocytes, which include a number of neurodegenerative and
psychiatric disorders, that include Huntington disease (HD), amyotrophic lateral sclerosis (ALS), and frontotemporal dementia (FTD), among others. What all these disorders have in common is a significant glial contribution to their pathogenesis, and
a lack of disease-modifying treatment options. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Congenital Leukodystrophies. A number of hereditary disorders of
oligodendrocyte loss or dysfunction are characterized by a failure in myelin synthesis or structural stability. Tens of thousands of children in the United States suffer from diseases of myelin loss. These include the metabolic demyelinations such
as adrenoleukodystrophy; the lysosomal storage disorders, such as metachromatic leukodystrophy; the hypomyelinating diseases, such as <FONT STYLE="white-space:nowrap">Pelizaeus-Merzbacher</FONT> disease; the myelinoclastic disorders, including
vanishing white matter disease, and most commonly of all, cerebral palsy. The most prototypic example of this class of diseases is <FONT STYLE="white-space:nowrap">Pelizaeus-Merzbacher</FONT> disease (PMD), an
<FONT STYLE="white-space:nowrap">X-linked</FONT> leukodystrophy most often manifesting in male infants and young boys, caused by mutations in the oligodendrocytic PLP1 gene, which results in widespread hypomyelination. There is no treatment for PMD,
which is typically fatal in childhood. We intend to deliver intracerebral transplants of stem <FONT STYLE="white-space:nowrap">cell-derived</FONT> GPCs to the brains of PMD patients, with the goal of replacing PLP1 mutant oligodendrocytes with
healthy cells capable of producing normally compact myelin. Prevalence of PMD in the general population is estimated to be approximately 1 in 100,000 in the United States. While we are initially targeting PMD as our proof of concept, congenital
leukodystrophies as a group affect a more significant population, or about 1 in 7,600 births. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Multiple Sclerosis
(MS)</B>. MS is a debilitating disease characterized by both inflammatory myelinolysis and degenerative axonal loss. There are two major forms, the initial relapsing remitting form, known as RRMS, and its later progressive neurodegenerative phase
designated secondary progressive MS (SPMS). RRMS is characterized by clearly defined attacks with new or increasing neurologic symptoms. In contrast, SPMS is characterized by progressive neurodegeneration with a loss of neurons, including those that
were previously demyelinated during the RRMS phase of the disease. The demyelination occurs in a diffuse fashion throughout the adult brain and appears to reflect a loss of axonal support by local oligodendrocytes. The delivery of GPCs into such
chronically demyelinated brain may offer tangible benefits through the oligodendrocytic engagement of axons, as well as by myelin repair. MS is highly prevalent, with estimates of up to 1.0&nbsp;million in the United States, 600,000 in Europe, and
2.8&nbsp;million patients globally. Approximately 85% of MS patients receive a diagnosis of RRMS initially while 15% of patients are diagnosed with primary progressive MS (PPMS). Up to a third of RRMS patients transition to secondary progressive MS
within a decade if untreated, and most will progress to SPMS within <FONT STYLE="white-space:nowrap">20-25</FONT> years of diagnosis. Success with a stem cell derived GPC product in SPMS, and especially with a hypoimmune product, could enable
further expansion into the RRMS patient population. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">176 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Huntington&#146;s Disease (HD)</B>. HD is a neurodegenerative disorder in
which glial pathology appears to make a significant causal contribution. It is an autosomal dominant disorder characterized by abnormally long CAG repeat expansions in the first exon of the Huntingtin gene. The encoded polyglutamine expansions of
mutant huntingtin protein disrupt its normal functions and protein-protein interactions, ultimately yielding widespread neuropathology, most rapidly evident in the neostriatum. We have found that glial pathology is a major contributor to the
functional deficits of HD and repairing the glial pathology has significant and positive effects in animal models. There are approximately 41,000 symptomatic Americans and more than 200,000 <FONT STYLE="white-space:nowrap">at-risk</FONT> of
inheriting HD. In Europe, there are approximately 50,000 patients with HD. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Current Treatment Landscape and Unmet Need </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Congenital Leukodystrophies.</B> There are no viable treatment options for these conditions, only supportive and palliative
therapies for symptoms as they present. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>MS</B>. Current treatments for MS as are largely limited to treatments for
RRMS; few treatments are approved for SPMS, and these have at best marginal efficacy in delaying disease progression; none are restorative. Currently approved treatments for RRMS may be divided into three broad categories of disease modifying
therapies: (i)&nbsp;first line injectables (such as beta-interferons, Copaxone), (ii) newer oral agents (such as Tecfidera, Gilenya, Mayzent, Zeposia), and (iii)&nbsp;high-efficacy agents (such as Tysabri, Lemtrada, Ocrevus). Many neurologists have
adopted anti-CD20 <FONT STYLE="white-space:nowrap">B-cell</FONT> therapies like Ocrevus as a first line therapy in an effort to treat MS aggressively upfront. While these therapies are very potent immunosuppressive agents, there are significant
associated side effects, including depletion of <FONT STYLE="white-space:nowrap">B-cells,</FONT> which can result in increased risk of infections. Furthermore, the majority of therapeutics are only approved and effective in RRMS; while Ocrevus and
Mayzent have been approved in progressive forms of MS, their efficacy in SPMS is limited to slowing disease progression. Despite many recently successful drug launches in the RRMS space, these drugs still only slow the progression of disease and aid
in the recovery from attacks, and there remains no treatment that confers functional restoration or effective cure for this disease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>HD</B>. Currently, there is no treatment to stop or reverse Huntington&#146;s disease. Treatment is limited to several
medications that can help minimize symptoms, including the drug tetrabenazine, antipsychotic drugs, antidepressants, and tranquilizers. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Our GPC Program Approach </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our approach to treat myelin and neurodegenerative disorders is via the delivery of healthy allogeneic stem cell-derived GPCs.
We have developed the methods for producing and isolating these cells from pluripotent stem cells and delivering them in the purity and quantities necessary for their replacement of endogenous diseased cells. We believe that both the myelin
disorders and glial-based neurodegenerative conditions have compelling potential for our <I>ex vivo</I> therapy. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">177 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Preclinical Data </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>Congenital Leukodystrophies</B>. The capacity of stem cell-derived GPCs for remyelination has been conducted in animal
models of congenital hypomyelination. Our collaborators used newborn <I>shiverer</I> mice that have a genetic defect in myelin basic protein (MBP), resulting in their neurons being hypomyelinated and the mice having a shortened lifespan. When
iPSC-derived hGPCs were transplanted into these mice, the cells spread widely throughout the brain, developing as astrocytes and oligodendrocytes. These oligodendrocytes generated mature myelin that effectively restored neuronal conductance and
prolonged survival in the transplanted mice. We believe that these data suggest the feasibility of iPSC-derived hGPC implantation in treating childhood disorders of myelin formation and maintenance, as depicted in the figure below: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g60414g19p60.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:8pt; font-family:Times New Roman" ALIGN="justify"><I>hGPCs myelinate widely to greatly extend the survival of hypomyelinated mice. A, Dot map
indicating distribution of human iPSC-derived GPCs at 7 months of age, following neonatal engraftment in a shiverer mouse brain. Widespread colonization and chimerization of the host brains by iPSC-derived hGPCs is evident (human nuclear antigen,
red). B, iPSC-derived hGPC-derived myelination in shiverer forebrain, at 7 months; section 1 mm lateral to A. Myelin basic protein (MBP)-immunoreactivity (green) is all human donor-derived. C, D. Myelination in sagittal sections taken at different
mediolateral levels from 2 additional 7 <FONT STYLE="white-space:nowrap">month-old</FONT> mice, each engrafted with iPSC-derived hGPCs at birth. E, Kaplan-Meier plot of survival of <FONT STYLE="white-space:nowrap">iPSC-OPC</FONT> implanted (n=22)
vs. saline-injected (n=19) control mice. Scale: <FONT STYLE="white-space:nowrap">A-B,</FONT> 2 mm. Adapted from Wang, Cell SC 2013. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>MS</B>. Our prior studies established the ability of stem-cell derived hGPCs to myelinate the developing <I>shiverer</I>
brain and rescue the afflicted mice; however, the experimental subjects were neonates, not adults. Until recently, it was unclear whether GPCs are able to migrate extensively in adult brain tissue, as would be required for the repair of diffusely
demyelinated adult brains. To explore whether the introduction of stem-cell derived </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">178 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
hGPCs delivered directly into the adult brain could remyelinate axons in the setting of diffuse demyelination, as might be encountered clinically in multiple sclerosis and other causes of diffuse
adult demyelination, our collaborators studied three different biologic models. First, it was shown that stem-cell derived hGPCs can disperse within and myelinate the brains of adult <I>shiverer</I> mice (as depicted in the figure below). Second, it
was shown that neonatally-engrafted hGPCs engrafted as a neonate can generate new oligodendrocytes and remyelinate demyelinated axons after chemically induced demyelination. This result demonstrated the ability of already-resident hGPCs to
remyelinate previously myelinated axons after a new demyelinating insult as an adult, as well as the ability of transplanted hGPCs to reside as a functional reservoir of new myelinogenic cells in the host brains. Third, it was shown that hGPCs
transplanted into the adult brain after chemically induced demyelination can remyelinate denuded axons. These data indicate that transplanted hGPCs can disperse broadly and differentiate as myelinogenic cells in the adult brain, and that they are
able to remyelinate demyelinated axons and white matter lesions of the brain after an insult as an adult. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>hGPCs Mediate Robust
Myelination After Transplantation into the Adult </U></B><B><I><U>Shiverer </U></I></B><B><U>Brain </U></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g60414g64p33.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:8pt; font-family:Times New Roman" ALIGN="justify"><I>Human GPCs proved both highly migratory and robustly myelinogenic, after delivery to the
hypomyelinated adult shiverer x rag2-/- brain. A, By <FONT STYLE="white-space:nowrap">19-20</FONT> weeks of age (mice were injected as post-weaning adults, at <FONT STYLE="white-space:nowrap">4-6</FONT> wks) the injected cells had dispersed broadly
throughout the forebrain white matter. B, hGPCs delivered to myelin wild-type rag2-/- mice distributed throughout both gray and white matter. C, Oligodendrocyte differentiation and myelinogenesis by donor hGPCs was robust, with myelination of brain
regions that would typically be demyelinated in shiverer mice D, a higher power image of C shows the high proportion of donor cells in those brain regions. Note that DAPI marks all nuclei, hN marks the hGPCs, and MBP marks the remyelinated regions
in C and D. From Windrem et al, Cell Reports 2020. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">179 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>HD</B>. Our collaborators explored the cellular basis for HD related
glial pathology and identified significant defects in potassium channel and glutamate uptake mechanisms in HD glia, which appeared to account for both the glial pathology and its deleterious effects on synaptic function. Together, these studies
indicated a critical role for glial pathology in the progression of HD and suggested the potential for glial cell replacement as a therapeutic strategy in HD, and more broadly, to other neurodegenerative diseases in which glial pathology might be
causally contributory. It was confirmed in preclinical mouse studies that stem-cell derived hGPC transplant ameliorated both the neuronal and glial pathology of HD by restoring synaptic homeostasis and normal synaptic function to the most affected
regions of the host brain. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The majority of the studies with human GPCs thus far have been xenogeneic grafts of human GPCs
to neonatal or adult mice or rats (and in a small sample POC study limited to adult tissue-derived hGPCs, NHPs). Our collaborators have also performed studies with murine GPCs transplanted into both developing and adult mice, which have confirmed
allogeneic GPC migration and integration. However, we have no assurance that human GPC engraftment of human brain will result in the widespread migration and colonization of host brain that is seen with xenogeneic grafts. To better model the <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">human-to-human</FONT></FONT> graft paradigm, our collaborators have therefore established a new model, whereby neonatal mice are first colonized with human hGPCs genetically tagged via
CRISPR/Cas insertion of a fluorescent reporter, and then allowed to grow to adulthood. The human cells outcompete the resident mouse GPC population to largely humanize the host white matter. Human hGPCs tagged with a different color are then
transplanted the already glial-humanized adult mice to assess the ability of the newly introduced human GPCs to compete with the human glia already resident in the host mouse brain. This model allows observation of the competitive interactions of
the two separately tagged human GPC populations. The human-into-human grafts expanded and integrated well in their humanized host, with competitive interactions whose outcomes appear dictated by their respective cellular ages, disease phenotype, and
metabolic efficiencies. As might be anticipated in the clinical setting of healthy cells being transplanted for the purpose of replacing lost or diseased hGPCs, the healthy donor cells outcompete both diseased and older cells to ultimately colonize
the hosts. The recent establishment of this model, and its resultant data, have provided preclinical assurance of the fundamental premise of our approach, that healthy human donor cells can replace lost or diseased human cells <I>in vivo</I>. That
said, this determination remains to be made in patients. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>GMP Grade Stem Cell Derived hGPCs for Clinical Studies </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A protocol to direct differentiation of human ESCs, as well as iPSCs, to hGPCs has been established. These hGPCs cells remain
bipotential for astrocytes and oligodendrocytes, and they differentiate to either fate depending on local signaling. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This
protocol has been transferred to a GMP facility in order to enable production of clinical grade cells for both safety and efficacy testing. These cells have been validated to robustly remyelinate <I>shiverer</I> mouse brains upon intracerebral
transplantation. We plan to use these cells for our <FONT STYLE="white-space:nowrap">IND-enabling</FONT> studies and initial clinical trial material. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Development Plan and Key Next Steps </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Progression of SC379 to IND is planned to follow completion of definitive safety and toxicology studies. Of note, in our
studies to date, now spanning several thousand mice engrafted with hGPCs using our differentiation protocols, we have observed no evidence of tumorigenesis. Definitive preclinical efficacy studies using the anticipated clinical product are also
planned and will replicate studies that we have published. We have already held <FONT STYLE="white-space:nowrap">pre-IND</FONT> meetings with the FDA for SPMS and HD. We expect to file IND applications for SC379 for SPMS, PMD, and HD beginning as
early as 2023. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">180 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Cardiomyocyte Program </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Background on Heart Failure </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Heart failure (HF) is a classic example of a disease of cell loss, ideally suited to the application of <I>ex vivo</I>
engineered cells. The clear but ambitious goal of our program is to replace missing cells after a myocardial infarction, commonly known as a heart attack, in an attempt to restore heart function and improve outcomes for patients. HF is a
life-threatening syndrome, and patients with HF have a mortality rate of 20-30% within one year of diagnosis and a mortality rate of around 50% within five years of diagnosis. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">HF with reduced ejection fraction (HFrEF), is a severe form of HF where heart muscle is unable to contract, and therefore
pump, adequately. HFrEF is most frequently a consequence of a loss of heart muscle cells (cardiomyocytes), following a myocardial infarction. In the United States, there were approximately 380,000 deaths associated with HF in 2018 according to the
United States Centers for Disease Control and an overall prevalence of approximately 6&nbsp;million people with HF, with similar numbers in Europe. The heart is one of the least regenerative organs in the human body, and when cardiomyocytes are lost
following a heart attack, they are replaced by scar tissue, which results in further diminished pump function. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In
general, HF has been a challenging area for drug and device development, including only one new drug, Entresto, approved in the last 20 years, and a limited number of devices introduced including electrical resynchronization therapy and implantation
of left ventricular assistance devices (LVADs). These approaches provide only symptomatic relief and do not address the underlying loss of cardiomyocytes associated with HFrEF. As a result, HFrEF currently remains a progressive and deadly disease
with a large unmet need worldwide. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">To date, efforts to develop cell-based therapies to address this unmet need have
provided little evidence of clinical benefit. Importantly, these attempts have typically utilized cells such as bone marrow-derived mononuclear cells and mesenchymal stromal cells where any potential benefit would be limited to paracrine mechanisms
and not the direct replacement of lost cardiomyocytes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our cardiomyocyte program aims to directly regenerate the heart,
by replacing lost cardiomyocytes with iPSC-derived cardiomyocytes, with the goal of restoring heart muscle and increasing ejection fraction, which is the percentage of blood the heart pumps with each heartbeat. Replacement of lost cardiomyocytes
with iPSC-derived cardiomyocytes that engraft and function correctly has the potential to prevent or even reverse the progression of HFrEF. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Developing an ideal stem cell-derived cardiomyocyte therapy involves many steps, including: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">differentiating cardiomyocytes at scale that engraft upon transplantation, beat in synchrony with the host
heart muscle, and improve heart function; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">engineering cardiomyocytes to avoid rejection due to the host immune response to the transplanted cells,
without requiring immunosuppression; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">addressing the risks associated with potential transient arrhythmias, or temporary abnormal heart beats,
following transplantation. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Differentiating Cardiomyocytes at Scale that Engraft, Beat Correctly and in Synchrony
with the Host Heart Muscle, and Improve Host Heart Function </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Scientists, including Dr.&nbsp;Chuck Murry, our Senior
Vice President, Head of Cardiometabolic Cell Therapy, have been working for over 20&nbsp;years towards developing a regenerative therapy for HFrEF with the goal of transplanting cardiomyocytes derived from human pluripotent stem cells that engraft,
function, and persist in<I> </I>the human heart <I>in vivo</I>. The groundwork for potential future clinical development has been laid by key breakthroughs such as the ability </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">181 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
to direct the differentiation of stem cells selectively into cardiomyocytes, including producing pharmaceutical grade cardiomyocytes at large scale in bioreactors, and the ability to transplant
such cardiomyocytes to induce remuscularization of injured hearts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Initial preclinical attempts to remuscularize the
infarcted heart were unsuccessful due to death of the transplanted cells within a few days of delivery. None of the animals with failed engraftment showed improvement in cardiac function, indicating that engraftment is essential for functional
improvement. Our collaborators developed a <FONT STYLE="white-space:nowrap">pro-survival</FONT> cocktail that kept cells alive through the rigors of transplantation, allowing the cardiomyocytes to self-assemble into new muscle tissue and induce
ingrowth of new blood vessels and connective tissue from the surrounding heart muscle. Once engraftment was successful, cardiac function improved. As our collaborators&#146; capabilities to scale cell manufacturing increased, studies progressed from
mice to rats to guinea pigs, all showing improved function: </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Human <FONT STYLE="white-space:nowrap">ESC-Cardiomyocytes</FONT> Improve
Function in Injured Rat and Guinea Pig Hearts </U></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g60414g53x35.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:8pt; font-family:Times New Roman" ALIGN="justify"><I>Left panel: functional rescue in rat. All groups showed comparably reduced fractional
shortening after infarction at 2 days <FONT STYLE="white-space:nowrap">pre-transplantation</FONT> <FONT STYLE="white-space:nowrap">(Pre-Tx).</FONT> At 28 days post-transplantation there was preservation of fractional shortening in animals receiving
hESC-cardiomyocytes, with deterioration of function in all other groups. PSC, <FONT STYLE="white-space:nowrap">pro-survival</FONT> cocktail. SFM, serum-free media. **p&lt;0.01; # p&lt;0.05 vs. 2 days <FONT STYLE="white-space:nowrap">Pre-Tx.</FONT>
Right panel: functional rescue in guinea pig. Following cardiac injury at 2 days before transplantation, all groups showed comparably reduced fractional shortening. At 28 days post-transplantation there was preservation of function in animals
receiving hESC-cardiomyocytes <FONT STYLE="white-space:nowrap">(hESC-CM),</FONT> with deterioration of function in other groups. *p&lt;0.05. **p&lt;0.01. &#134;p&lt;0.05 vs 2 days <FONT STYLE="white-space:nowrap">Pre-Tx.</FONT> From Laflamme et al,
Nature Biotechnology 2007 (left) and Shiba et al, Nature 2012 (right). </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Current methods demonstrate regeneration of
the hearts of large animals including pigs and NHPs by transplanting human <FONT STYLE="white-space:nowrap">ESC-derived</FONT> cardiomyocytes <FONT STYLE="white-space:nowrap">(hESC-CM).</FONT> The figure below shows low magnification microscopic
images from NHP hearts that were infarcted and then received either <FONT STYLE="white-space:nowrap">hESC-CM</FONT> or saline controls. The replacement of heart muscle by scar tissue is evident in the saline-treated heart, whereas human heart muscle
has repopulated the infarct in the <FONT STYLE="white-space:nowrap">hESC-CM</FONT> treated group. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">182 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Remuscularization of the Heart of an NHP by
<FONT STYLE="white-space:nowrap">hESC-CM</FONT> Transplantation </U></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g60414g55y66.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:8pt; font-family:Times New Roman" ALIGN="justify"><I>The saline-treated heart (left) shows infarct scar tissue (blue) replacing the myocardium
lost to infarction. The <FONT STYLE="white-space:nowrap">hESC-CM</FONT> treated heart (right) shows a large graft of human heart muscle (green) replacing the myocardium lost to infarction. From Liu et al, Nature Biotechnology 2018. Scale bar, 5 mm.
</I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We conducted an experiment to help us understand the mechanism of action and learn whether the transplanted muscle
beat in synchrony with the host heart muscle. <FONT STYLE="white-space:nowrap">hESC-CMs</FONT> were genome-edited to express a protein that fluoresced green with each contraction, and their behavior was studied after transplantation into an
infarcted macaque heart. <FONT STYLE="white-space:nowrap">hESC-CMs</FONT> showed 1:1 synchrony with the host heart, indicating that the graft follows the heart&#146;s natural pacemaker, an essential result for heart regeneration. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A final question was whether this regeneration improves the function of the injured heart. To assess this, engrafted NHP
hearts were studied by magnetic resonance imaging (MRI), the gold standard for assessing cardiac contractile function. As illustrated in the figure below, myocardial infarction induced a <FONT STYLE="white-space:nowrap">25-point</FONT> drop in left
ventricular ejection fraction, the fraction of blood ejected from the heart with each beat. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Control animals receiving a
saline injection showed no significant improvement at 4 or 12 weeks, as expected. In contrast, four weeks after receiving <FONT STYLE="white-space:nowrap">hESC-CMs,</FONT> ejection fraction improved by approximately 10 points, and by 12 weeks, it
had improved by a total of approximately 22 points. While the number of animals followed out 12 weeks is limited, cardiac remuscularization in this study restored ventricular function back into the normal range. In contrast, the current standard of
care for myocardial infarction, including reperfusion via angioplasty, ACE inhibitors, and beta blockers, increases ejection fraction by approximately 6 points. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">183 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>Restoration of Cardiac Function in NHPs by Transplantation of Human <FONT
STYLE="white-space:nowrap">ESC-derived</FONT> Cardiomyocytes <FONT STYLE="white-space:nowrap">(hESC-CM)</FONT> </U></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g60414g57l65.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:8pt; font-family:Times New Roman" ALIGN="justify"><I>Myocardial infarction reduces ejection fraction (a measure of cardiac function), and
there is no spontaneous recovery in control animals receiving a saline injection (gray). All animals receiving <FONT STYLE="white-space:nowrap">hESC-CM</FONT> (blue) showed significant improvement by 4 weeks, and by 12 weeks after treatment, cardiac
function was restored to the normal range. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In summary, structural data demonstrating extensive remuscularization of
the infarcted heart in conjunction with physiologic and pharmacodynamic data provide evidence that the transplanted cardiomyocytes directly restore heart contractile function. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Engineering the cells to avoid rejection due to the host immune response to the transplanted cells </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Initially, we plan to establish safety with
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-in-human</FONT></FONT> clinical trials of our cardiomyocyte cell therapy using immunosuppression to reduce the risk of a host immune response to allogeneic transplanted cells
and the potential immune rejection. Our collaborators have studied immunosuppressive regimens in NHP by transplanting rhesus cardiomyocytes derived from stem cells into the hearts of mismatched recipient NHP. An immunosuppressive regimen was
identified that keeps the allogeneic grafts alive long term and is considerably less toxic than regimens used for heart transplantation. However, an approach that obviates the need for an immunosuppression regimen has the potential to improve safety
and patient eligibility. Therefore, as part of our program lifecycle we intend to switch to a hypoimmune stem cell-derived cardiomyocyte over time, as this should allow us to eliminate or reduce the immune suppression required for durable
maintenance of these cells. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">184 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Addressing the risks associated with potential transient arrhythmias, or abnormal heart
beats, following cell transplantation </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The term engraftment arrhythmia refers to a transient period of unstable
electrical activity that occurs in some species over approximately four weeks following cardiomyocyte transplantation. Engraftment arrhythmias were not observed in mice, rats, or guinea pigs, but they are observed in NHPs, where they cause mild
symptoms, and farm pigs, where they cause more significant symptoms. The arrhythmias follow a stereotypical course, where they increase in frequency and duration, plateau for a variable period, and then wane until the heart has normal rhythm once
again. Once the heart rhythm stabilizes, the arrhythmias seem to disappear permanently. We are planning to explore three ways to address engraftment arrhythmias: pharmaceutical interventions, genetic modifications to the cardiomyocytes, and
adjusting the stage of differentiation of the cardiomyocytes. Because we do not yet know the impact of the potential for these arrhythmias in humans, we plan to do our first human studies in patients with an implanted left-ventricular assist device
(LVAD) in order to mitigate any clinical sequalae if they emerge. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Development Plan and Key Next Steps </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our key milestones include completing GLP toxicology studies and additional efficacy and safety studies in NHPs and pigs, with
the goal of filing an IND for SC187 as early as 2023. We plan to begin clinical testing, starting with patients suffering from advanced heart failure who receive a LVAD as a bridge to heart transplantation. The goal of this initial study to assess
the safety of stem-cell derived cardiomyocytes in humans. Based upon safety results of initial clinical studies, we may have the opportunity to explore this therapy in earlier-stage patients, including patients with acute heart failure after
significant myocardial infarction. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>SanaX </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Despite the significant advances in the development of successful cell and gene therapies that have been made to date, there
remain a number of fundamental limitations of existing technologies that prevent achieving the maximal breadth of application of these new therapeutic approaches. We wish to lead both the present and future of cell and gene therapy, and we are
therefore committed to investing in research and other activities that will ensure a leadership position for the long-term. Towards this end, we have established SanaX as a distinct research arm. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In contrast to the industry&#146;s traditional research activities which are focused primarily on near-term product
development using existing technologies, SanaX is devoted to finding solutions to the limitations of today&#146;s technology in order to expand the breadth of therapeutic opportunities. SanaX research efforts are aimed at making fundamental
improvements to existing technologies and establishing new paradigms for gene and cell delivery that will ultimately lead to the development of completely new therapeutic modalities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Truly novel technology development requires the unique ability to thoughtfully marry rigorous experimental science with
specific technical goals. Often, fundamental biological problems must be understood in depth in order to define the pathway to a new technological and therapeutic capability. SanaX has established a unique physical and cultural environment with
individuals that possess the requisite intellectual and technical capabilities essential for success. One characteristic of the SanaX research environment that we believe will be extremely valuable is a &#147;nimbleness&#148; that enables the team
to immediately embrace new technical or scientific information and/or meet specific unanticipated therapeutic needs. In addition, several collaborative efforts with outside investigators possessing specific biological sector expertise have been
established to enhance our internal efforts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Current SanaX research activities are focused in several areas where we
believe advances in technology are most critical. Some of these efforts include: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">evaluating the use of cells, rather than viruses, as delivery vehicles; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">185 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">re-purposing</FONT> several different virus vector systems to expand the
therapeutic payloads that may be delivered by the different viruses; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">developing novel approaches to the production of different viral vectors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">developing novel methods for enabling the exogenous control of transgene expression via small molecule drugs;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">developing new paradigms for genetically manipulating specific arms of the immune response in order to
engender immunological tolerance to specific antigens, cells, and organs; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">COVID-19</FONT> related research focused on the delivery of specific <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">anti-SARS-Cov-2</FONT></FONT> antibodies and the evaluation of novel direct anti-viral strategies. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Dr.&nbsp;Mulligan, our Executive Vice-Chairman and Head of SanaX, directly oversees the SanaX research effort. SanaX maintains
an independent research budget in order to ensure that these longer-term, disruptive priorities are not sacrificed for near-term needs. Once SanaX develops an understanding of how a technology can translate into the clinic, a program will move from
SanaX into our internal R&amp;D and manufacturing organization or partnered externally. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Manufacturing Strategy and Approach </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">While the field of cell and gene therapy has had a number of successes with innovative therapies, the challenges of
manufacturing at industrial scale have limited access for patients in need. As was the case during the initial development of recombinant biologics, an improvement to our ability to characterize these products will be essential to increasing patient
access. It is especially critical to have an <FONT STYLE="white-space:nowrap">in-depth</FONT> understanding of the impact of manufacturing processes on the product quality attributes and resulting clinical performance of the product. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">From inception, we have recognized the key role manufacturing plays in enabling the access of these innovative engineered
cells as medicines. Two areas of particular focus are product analytical and biological characterization, leading to a better definition of critical product attributes, as well as process understanding, leading to better control the impact of
process parameters on these critical product attributes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have developed a manufacturing strategy that supports our
vision of democratizing access with early investments in people, technology, and infrastructure: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establishing a team with diverse, experienced talents with extensive knowledge of both the process and
analytical sciences in the field of cell and gene therapy, as well as CMC product development expertise from preclinical to global commercialization; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establishing multiple manufacturing platforms for our diverse portfolio; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establishing infrastructure from lab bench to a GMP manufacturing network and supply chain.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">To support our <I>in vivo</I> and <I>ex vivo</I> development pipeline, we are initially establishing
three manufacturing platforms: viral vector, allogeneic T cells, and PSC-derived. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">While the three manufacturing platforms
are very different in terms of the manufacturing process and supply chain, they also share some common challenges and opportunities. For example, product characterization and analytical development are critical, and these capabilities are fungible
across platforms. In addition, we are focusing on some of the key areas in each of the platforms to enable scaled manufacturing. For the viral vector platform, we are starting early in the research phase with suspension culture process in
bioreactors similar to protein biologics to maximize process yield and batch to batch process robustness at scale. Transfer to these bioreactors later in development can complicate product comparability assessments. For the allogeneic T cell
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">186 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
program, we are focusing on scaling the multiplex gene editing process and understanding of the impact of the variability of the starting material from healthy donors to on product quality. For
stem-cell derived therapies, such as beta cells, cardiomyocytes, and glial progenitor cells, we are focusing on developing a scalable process and analytical technologies to characterize stability of the starting cells, end cell products, and
critical product quality attributes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">To establish our manufacturing capability, we started with a <FONT
STYLE="white-space:nowrap">non-GMP</FONT> pilot plant for <I>in</I> <I>vivo</I> and <I>ex</I> <I>vivo</I> engineered cell platform processes with up to 200L bioreactor scale. This provides the infrastructure for process and technology development,
technology transfer support, and production for <FONT STYLE="white-space:nowrap">non-GMP</FONT> material such as GLP toxicology study material. In addition, we are taking a hybrid approach to establish our <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">end-to-end</FONT></FONT> supply chains for the three manufacturing platforms, leveraging a combination of internal manufacturing capability and external contract development and manufacturing organizations (CDMOs) for
clinical supplies, in a staged manner: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we will utilize CDMOs for GMP supplies initially to support the upcoming INDs and clinical supplies; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we intend to build the internal manufacturing facilities needed to support late-stage clinical trials and
commercialization of therapies across our pipeline. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Competition </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">There are other companies that have stated that they are developing cell and gene therapies that may address oncology,
diabetes, CNS disorders, and cardiovascular diseases. Some of these companies may have substantially greater financial and other resources than we have, such as larger research and development staff and well-established marketing and salesforces, or
may operate in jurisdictions where lower standards of evidence are required to bring products to market. For example, we are aware that some of our competitors, including Novartis, Gilead, BMS, Novo Nordisk, Johnson&nbsp;&amp; Johnson, Allogene,
CRISPR Therapeutics, Precision Biosciences, Caribou, Fate Therapeutics, Century Therapeutics, Bluebird Bio, Orchard Therapeutics, Aruvant, Sanofi Pasteur, Editas, Beam, Viacyte, Vertex, Eli Lilly, Astellas, and Bayer might be conducting large-scale
clinical trials for therapies that could be competitive with our <I>ex vivo</I> and <I>in vivo</I> programs. Among companies pursuing <I>ex vivo </I>and <I>in vivo</I> cell engineering, we believe we are substantially differentiated by our robust
intellectual property portfolio, extensive research, rigorous and objective approach, and multidisciplinary capabilities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Intellectual Property
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We strive to protect and enhance the proprietary technology, inventions, and improvements that are commercially
important to our business, including seeking, maintaining, and defending patent rights, whether developed internally or licensed from our collaborators or other third parties. Our policy is to seek to protect our proprietary position by, among other
methods, filing patent applications in the United States and in jurisdictions outside of the United States related to our proprietary technology, inventions, improvements, and product candidates that are important to the development and
implementation of our business. We also rely on trade secrets and know-how relating to our proprietary technology and product candidates, continuing innovation, and in-licensing opportunities to develop, strengthen, and maintain our proprietary
position in the field of cell and gene therapy. We additionally plan to rely on data exclusivity, market exclusivity, and patent term extensions when available, and plan to seek and rely on regulatory protection afforded through orphan drug
designations. Our commercial success may depend in part on our ability to obtain and maintain patent and other proprietary protection for our technology, inventions, and improvements; to preserve the confidentiality of our trade secrets; to maintain
our licenses to use intellectual property owned by third parties; to defend and enforce our proprietary rights, including our patents; and to operate without infringing on the valid and enforceable patents and other proprietary rights of third
parties. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">187 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have in-licensed and developed numerous patents and patent
applications, which include claims directed to compositions, methods of use, processes, dosing and formulations, and possess substantial know-how and trade secrets relating to the development and commercialization of our cell engineering platforms
and related product candidates, including related manufacturing processes. As of December&nbsp;31, 2020, our in-licensed and owned patent portfolio consists of approximately 26&nbsp;licensed U.S. issued patents, approximately 43&nbsp;licensed U.S.
pending patent applications, and approximately 18&nbsp;owned U.S. pending patent applications, as well as approximately 33&nbsp;licensed patents issued in jurisdictions outside of the United States, approximately 151&nbsp;licensed patent
applications pending in jurisdictions outside of the United States (including approximately 19&nbsp;licensed pending Patent Cooperation Treaty (PCT) applications), and approximately three&nbsp;owned patent applications pending in jurisdictions
outside of the United States (including approximately three&nbsp;owned pending PCT applications) that, in many cases, are counterparts to the foregoing U.S. patents and patent applications. The patents and patent applications outside of the United
States in our portfolio are held primarily in Europe, Canada, Japan, and Australia. For information related to our in-licensed intellectual property, see the subsection titled under &#147;&#151;Key Intellectual Property Agreements.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As for the product candidates and related manufacturing processes we develop and commercialize, in the normal course of
business, we intend to pursue, when possible, composition, method of use, process, dosing and formulation patent protection. We may also pursue patent protection with respect to manufacturing and drug development processes and technology and with
respect to our technology platform. When available to expand market exclusivity, our strategy is to obtain, or license additional intellectual property related to current or contemplated development platforms, core elements of technology and/or
product candidates. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Individual patents extend for varying periods of time, depending upon the date of filing of the
patent application, the date of patent issuance, and the legal term of patents in the countries in which they are obtained. Generally, patents issued for applications filed in the United States are effective for 20 years from the earliest
nonprovisional filing date. In the United States, a patent&#146;s term may be lengthened by patent term adjustment, which compensates a patentee for administrative delays by the Unites States Patent and Trademark Office (USPTO) in examining and
granting a patent, or may be shortened if a patent is terminally disclaimed over an earlier filed patent or delays on the part of a patentee. In addition, in certain instances, the patent term of a U.S. patent that covers an FDA-approved drug may
also be eligible to be extended to recapture a portion of the term effectively lost as a result of the FDA regulatory review period. The restoration period cannot be longer than five years and the total patent term, including the restoration period,
must not exceed 14 years following FDA approval, however there is no guarantee that the applicable authorities, including the FDA in the United States, will agree with our assessment of whether such extensions should be granted, and if granted, the
length of such extensions. Similar provisions are available in Europe and other foreign jurisdictions to extend the term of a patent that covers an approved drug. The duration of patents outside of the United States varies in accordance with
provisions of applicable local law, but typically is also 20 years from the earliest non-provisional filing date. Our patents issued as of December&nbsp;31, 2020, will expire on dates ranging from 2023 to 2039. If patents are issued on our patent
applications pending as of December&nbsp;31, 2020, the resulting patents are projected to expire on dates ranging from 2023 to 2041. However, the actual protection afforded by a patent varies on a product-by-product basis, from country-to-country,
and depends upon many factors, including the type of patent, the scope of its coverage, the availability of regulatory-related extensions, the availability of legal remedies in a particular country, and the validity and enforceability of the patent.
</P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In some instances, we submit patent applications directly with the USPTO as provisional patent applications.
Provisional applications for patents were designed to provide a lower-cost first patent filing in the United States. Corresponding non-provisional patent applications must be filed not later than 12 months after the provisional application filing
date. The corresponding non-provisional application benefits in that the priority date(s) of the patent application is/are the earlier provisional application filing date(s), and the patent term of the finally issued patent is calculated from the
later non-provisional application filing date. This system allows us to obtain an early priority date, add material to the patent application(s) during the priority year, obtain a later start to the patent term and to delay prosecution costs, which
may be useful in the event that we decide not to pursue </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">188 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
examination in an application. While we intend to timely file nonprovisional patent applications relating to our provisional patent applications, we cannot predict whether any such patent
applications will result in the issuance of patents that provide us with any competitive advantage. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We file U.S.
nonprovisional applications and PCT applications that claim the benefit of the priority date of earlier filed provisional applications, when applicable. The PCT system allows a single application to be filed within 12 months of the original priority
date of the patent application, and to designate all of the 153 PCT member states in which national patent applications can later be pursued based on the international patent application filed under the PCT. The PCT searching authority performs a
patentability search and issues a non-binding patentability opinion which can be used to evaluate the chances of success for the national applications in foreign countries prior to having to incur the filing fees. Although a PCT application does not
issue as a patent, it allows the applicant to seek protection in any of the member states through national-phase applications. At the end of the period of two and a half years from the first priority date of the patent application, separate patent
applications can be pursued in any of the PCT member states either by direct national filing or, in some cases by filing through a regional patent organization, such as the European Patent Organization. The PCT system delays expenses, allows a
limited evaluation of the chances of success for national/regional patent applications and enables substantial savings where applications are abandoned within the first two and a half years of filing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For all patent applications, we determine claiming strategy on a case-by-case basis. Advice of counsel and our business model
and needs are always considered. We file patents containing claims for protection of all useful applications of our proprietary technologies and any products, as well as all new applications and/or uses we discover for existing technologies and
products, assuming these are strategically valuable. We continuously reassess the number and type of patent applications, as well as the pending and issued patent claims, to help ensure that maximum coverage and value are obtained for our processes,
and compositions, given existing patent office rules and regulations. Further, claims may be modified during patent prosecution to meet our intellectual property and business needs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We recognize that the ability to obtain patent protection and the degree of such protection depends on a number of factors,
including the extent of the prior art, the novelty and non-obviousness of the invention, and the ability to satisfy the enablement requirement of the patent laws. In addition, the coverage claimed in a patent application can be significantly reduced
before the patent is issued, and its scope can be reinterpreted or further altered even after patent issuance. Consequently, we may not obtain or maintain adequate patent protection for any of our future product candidates or for our technology
platform. We cannot predict whether the patent applications we are currently pursuing will issue as patents in any particular jurisdiction or whether the claims of any issued patents will provide sufficient proprietary protection from competitors.
Any patents that we hold may be challenged, circumvented or invalidated by third parties. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The patent positions of
companies like ours are generally uncertain and involve complex legal and factual questions. No consistent policy regarding the scope of claims allowable in patents in the field of cell and gene therapy has emerged in the United States. The patent
situation outside of the United States is even more uncertain. Changes in either the patent laws or their interpretation in the United States and other countries may diminish our ability to protect our inventions and enforce our intellectual
property rights, and more generally could affect the value of our intellectual property. In particular, our ability to stop third parties from making, using, selling, offering to sell, or importing products that infringe our intellectual property
will depend in part on our success in obtaining and enforcing patent claims that cover our technology, inventions, and improvements. With respect to both licensed and company-owned intellectual property, we cannot be sure that patents will be
granted with respect to any of our pending patent applications or with respect to any patent applications filed by us in the future, nor can we be sure that any of our existing patents or any patents that may be granted to us in the future will be
commercially useful in protecting our products and the methods used to manufacture those products. Moreover, even our issued patents do not guarantee us the right to practice our technology in relation to the commercialization of our products. The
area of patent and other intellectual property rights in biotechnology is an evolving one with many risks and uncertainties, and third parties may have blocking patents that could be </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">189 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
used to prevent us from commercializing our patented product candidates and practicing our proprietary technology. It is uncertain whether the issuance of any third-party patent would require us
to alter our development or commercial strategies, or our products or processes, obtain licenses or cease certain activities. Our breach of any license agreements or our failure to obtain a license to proprietary rights required to develop or
commercialize our future products may have a material adverse impact on us. If third parties prepare and file patent applications in the United States that also claim technology to which we have rights, we may have to participate in interference or
derivation proceedings in the USPTO to determine priority of invention. Our issued patents and those that may issue in the future may be challenged, invalidated, or circumvented, which could limit our ability to stop competitors from marketing
related products or limit the length of the term of patent protection that we may have for our product candidates. In addition, the rights granted under any issued patents may not provide us with protection or competitive advantages against
competitors with similar technology. Furthermore, our competitors may independently develop similar technologies. For these reasons, we may have competition for our product candidates. Moreover, because of the extensive time required for
development, testing and regulatory review of a potential product, it is possible that, before any particular product candidate can be commercialized, any related patent may expire or remain in force for only a short period following
commercialization, thereby reducing any advantage of the patent. Our commercial success will also depend in part on not infringing upon the proprietary rights of third parties. Patent disputes are sometimes interwoven into other business disputes.
</P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As of December 31, 2020, our registered trademark portfolio currently contains approximately 22 registered trademarks
and pending trademark applications, consisting of approximately two pending trademark applications in the United States, and approximately six registered trademarks and approximately 14 pending trademark applications in the following countries
through both national filings and under the Madrid Protocol: Australia, Canada, China, European Union, India, Japan, Republic of Korea, Singapore, and Switzerland. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We may also rely, in some circumstances, on trade secrets to protect our technology. However, trade secrets are difficult to
protect. We seek to protect our technology and product candidates, in part, by entering into confidentiality agreements with those who have access to our confidential information, including our employees, contractors, consultants, collaborators, and
advisors. We also seek to preserve the integrity and confidentiality of our proprietary technology and processes by maintaining physical security of our premises and physical and electronic security of our information technology systems. Although we
have confidence in these individuals, organizations, and systems, agreements or security measures may be breached and we may not have adequate remedies for any breach. In addition, our trade secrets may otherwise become known or may be independently
discovered by competitors. To the extent that our employees, contractors, consultants, collaborators, and advisors use intellectual property owned by others in their work for us, disputes may arise as to the rights in related or resulting know-how
and inventions. For this and more comprehensive risks related to our proprietary technology, inventions, improvements and products, see the subsection titled &#147;Risk Factors &#151;Risks Related to Intellectual Property and Information
Technology.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Key Intellectual Property Agreements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following describes the key agreements by which we have acquired and maintained certain technology related to our <I>in
vivo</I> and <I>ex vivo</I> cell engineering platforms and therapeutic programs. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>In Vivo Cell Engineering Platform </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Cobalt Acquisition </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In February 2019, we acquired all of the outstanding equity interests in Cobalt Biomedicine, Inc. (Cobalt), a privately-held
early-stage biotechnology company founded by a Flagship Labs innovation team within Flagship Pioneering led by Dr. Geoffrey von Maltzahn developing a fusogen technology platform to specifically and consistently deliver diverse
payloads&#151;including DNA, RNA, and proteins&#151;to targeted cells <I>in vivo</I>, in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">190 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
consideration of the issuance of 36,441,583 shares of our Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock, valued at $136.0&nbsp;million. Of the 36,441,583 shares
of Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock issued, 12,147,192 shares were contingent on the achievement of a <FONT STYLE="white-space:nowrap">pre-specified</FONT> development milestone, which was achieved in
July 2019. We also agreed to pay contingent consideration of up to an aggregate of $500.0&nbsp;million upon the achievement of certain <FONT STYLE="white-space:nowrap">pre-specified</FONT> development milestones and a success payment of up to
$500.0&nbsp;million (the Cobalt Success Payment), which we may elect to pay in cash or in stock. The payout of the Cobalt Success Payment will only be paid if, at pre-determined valuation measurement dates, our value is equal to or exceeds three
times our value at the time of our Series B convertible preferred stock issuance and we have an active program based on the fusogen technology in a clinical trial pursuant to an IND, or have filed for, or received approval for, a BLA or NDA. The
valuation measurement dates for the Cobalt Success Payments are triggered by an arms&#146; length equity financing, or an IPO, and periodically thereafter. An additional valuation measurement date is triggered upon a change of control when at least
one company product utilizing technology acquired from Cobalt is the subject of an active research program. As a result of the Cobalt transaction, we obtained licenses to various technologies and intellectual property rights that relate to the
development of our fusogen technology and related fusosome programs, including exclusive license agreements with Flagship Pioneering Innovations V, Inc. (Flagship) and La Societe Pulsalys (Pulsalys), as well as several exclusive options to enter
into exclusive license agreements, including one such option with The Regents of the University of California acting through The Technology Development Group of the University of California, Los Angeles (UCLA), with whom we later entered into an
exclusive license agreement. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>License Agreement with Flagship </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In February 2016, Cobalt entered into an agreement (the Flagship Agreement), with Flagship, as amended in February 2019,
pursuant to which (i)&nbsp;Cobalt irrevocably and unconditionally assigned to Flagship all of its right, title and interest in and to certain foundational intellectual property developed by Flagship Pioneering, Inc. (Flagship Management) during the
exploration and/or proto-company phase of Cobalt prior to its <FONT STYLE="white-space:nowrap">spin-out</FONT> from Flagship (the Managerial Agreement) as set forth in the Flagship Agreement (such foundational intellectual property, the Fusogen
Foundational IP) and (ii)&nbsp;Cobalt obtained an exclusive, worldwide, royalty-bearing, sublicensable, transferable license from Flagship under such Fusogen Foundational IP to develop, manufacture and commercialize any product or process or
component thereof, the development, manufacturing and commercialization of which would infringe at least one valid claim of Fusogen Foundational IP absent the license granted under the Flagship Agreement (Fusogen Products) in the field of human
therapeutics during the term of the Flagship Agreement. In addition, Flagship irrevocably and unconditionally assigned to Cobalt all of its right, title and interest in and to any and all patents claiming any inventions conceived (i)&nbsp;solely by
Flagship Management or jointly by Flagship Management and Cobalt, (ii)&nbsp;after Cobalt&#146;s spinout from Flagship, and (iii)&nbsp;as a result of activities conducted pursuant the Managerial Agreement or other participation of Flagship Management
in Cobalt&#146;s affairs, but excluding Fusogen Foundational IP. We utilize the rights granted by Flagship under the Flagship Agreement in our fusogen platform and related therapeutic product candidates. The license granted to Fusogen Foundational
IP is contingent upon Cobalt&#146;s compliance with its obligations under the Flagship Agreement. Under the Flagship Agreement, Cobalt also granted Flagship a <FONT STYLE="white-space:nowrap">non-exclusive,</FONT> worldwide, royalty-free, fully
paid, sublicensable license to practice the Fusogen Foundational IP within the field of human therapeutics solely to perform under the Managerial Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Pursuant to the Flagship Agreement, Cobalt is obligated to pay, on a Fusogen <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Product-by-Fusogen</FONT></FONT> product and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">jurisdiction-by-jurisdiction</FONT></FONT> basis, royalties in the low single-digit percentage on net sales of
Fusogen Products. The Flagship Agreement will terminate on the last to expire royalty term, which is determined on a Fusogen <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Product-by-Fusogen</FONT></FONT> Product and <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">jurisdiction-by-jurisdiction</FONT></FONT> basis, and is the earlier of (i)&nbsp;the expiration of the last valid claim of any Fusogen Foundational IP covering such Fusogen Product or (ii)
the date on which the last applicable additional milestone payment has been made in accordance with that certain merger agreement under which we acquired Cobalt, which we expect to be in 2039. Upon expiration of the royalty term with respect to a
Fusogen Product in any jurisdiction and payment in full of all amounts owed under the Flagship Agreement for such Fusogen Product, the license granted to us will automatically convert into a <FONT STYLE="white-space:nowrap">non-exclusive,</FONT>
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">191 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
fully paid up license for such Fusogen Product in such jurisdiction. We have the right to terminate the Flagship Agreement in its entirety for convenience upon 60 days of written notice. Either
party may terminate the Flagship Agreement upon a material breach by the other party that is not cured within 30 days after receiving written notice. Also, Flagship may terminate the Flagship Agreement (i)&nbsp;upon 30 days&#146; written notice if
we cease to carry on our business with respect to the rights granted in the Flagship Agreement, (ii)&nbsp;upon written notice if we experience an event of bankruptcy, or (iii)&nbsp;immediately upon written notice if we challenge the validity,
patentability, or enforceability of any Fusogen Foundational IP or participate in any such challenge. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Sublicense Agreement with
Pulsalys </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In August 2018, Cobalt entered into an exclusive sublicense agreement (the Pulsalys Agreement), with
Pulsalys, as amended and assigned by Cobalt to us in May 2020, pursuant to which we obtained an exclusive, worldwide, sublicensable license from Pulsalys of the exclusive license rights granted to Pulsalys by &Eacute;cole normale sup&eacute;rieure
de Lyon (ENS Lyon) on behalf of itself and Institut National de la Sant&eacute; et de la Recherche M&eacute;dicale (Inserm), Centre National de la Recherche Scientifique (CNRS) and Universit&eacute; Claude Bernard Lyon 1 (collectively, the <FONT
STYLE="white-space:nowrap">Co-Owners)</FONT> under certain patent rights relating to methods to selectively modulate the activity of distinct subtypes of immune cells using engineered virus-like particles. In addition, Pulsalys grants us the first
right to negotiate an exclusive license to patent rights covering certain improvements to the licensed patent rights and which are owned or held by Pulsalys. We utilize the rights granted under the Pulsalys Agreement in our <I>in vivo</I> fusogenic
platform and related fusosome programs. We are obligated to use commercially reasonable efforts to develop and commercialize the licensed products, which efforts will be demonstrated by the achievement of the following diligence milestones:
(i)&nbsp;minimum annual spend of $1.0&nbsp;million for each of five years after the effective date and (ii)&nbsp;IND filing within five years of the effective date. Under the Pulsalys Agreement, the <FONT STYLE="white-space:nowrap">Co-Owners</FONT>
will retain the right to practice the licensed patent rights for <FONT STYLE="white-space:nowrap">non-commercial</FONT> research purposes, alone or in collaboration with third parties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Pursuant to the Pulsalys Agreement, Cobalt paid Pulsalys an upfront fee of 18,000 EUR. We are required to pay an annual
license maintenance fee of 18,000 EUR until the first commercial sale of a licensed product. We are also required to pay Pulsalys up to an aggregate of 575,000 EUR upon the achievement of certain clinical and regulatory milestones for each of the
first three distinct licensed products. In addition, we are obligated to pay an annual royalty in the low single-digit percentage on net sales of the licensed products, with the royalty rate being subject to reduction upon certain events. Lastly, we
are obligated to pay annual fees in the low single-digit percentage on certain sublicense income. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Pulsalys Agreement
will terminate, on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">country-by-country</FONT></FONT> and licensed <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">product-by-licensed</FONT></FONT> product basis,
upon the last to expire valid claim within the licensed patent rights covering the making, the using, the sale and the import of such licensed product in such country, or any patent term extension or supplementary protection certificate thereof
covering the sale of such licensed product in the country, which we expect to be in 2037. We also have the right to terminate the Pulsalys Agreement in its entirety upon notice if we determine, in our sole discretion, that continued pursuit of
development of the licensed patent rights is not feasible or desirable in the context of (i)&nbsp;resources available to us or due to external factors such as competition, market forces, access or license to other reasonably useful intellectual
property, or (ii)&nbsp;change of direction of our business focus. Either party may terminate the Pulsalys Agreement upon a material breach by the other party that is not cured within 90 days after receiving written notice. Pulsalys may terminate the
Pulsalys Agreement (i)&nbsp;in the case of the cessation of business, dissolution or voluntary liquidation of us, (ii)&nbsp;if we challenge the validity of the licensed patents, provided that such termination will be with respect to the claims
within the licensed patents that are the subject of the challenge, or (iii)&nbsp;in full or in part, if we fail to achieve the diligence milestones and if the parties have not extended such milestones after good faith negotiations, and subject to
our ability to cure such failure within 90 days after notice of the same. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">192 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>License Agreement with UCLA </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In March 2019, we entered into a license agreement (the UCLA Agreement) with UCLA, upon the exercise of an option originally
granted by UCLA to Cobalt in April 2018. Under the UCLA Agreement, UCLA granted us an exclusive, sublicensable, transferable (subject to certain conditions) license in the licensed territory in the field of human therapeutics under certain patent
rights relating to certain virus envelope pseudotyped lentiviruses and methods of their use to (i)&nbsp;research, make, have made, use, sell, offer for sale, have sold and import licensed products and (ii)&nbsp;practice licensed methods for the
purposes of researching, manufacturing, and using licensed products but not to perform services for a fee. The licensed territory under the UCLA Agreement is all countries of the world in which the licensed patent rights have or will be filed. UCLA
agreed not to grant any rights under the licensed patents regarding licensed methods to third parties without first offering us an opportunity to remove the restrictions regarding the use of licensed methods to perform services for a fee. In
addition, we agreed not to commercialize any licensed product that is not administered directly to a patient for therapeutic purposes without first negotiating with UCLA for possible development milestones, royalties, or other payments applicable to
such licensed products. We utilize the rights granted under the UCLA Agreement in our <I>in vivo</I> fusogenic platform and related fusosome programs. We are obligated to use commercially reasonable and diligent efforts to (i)&nbsp;develop licensed
products, (ii)&nbsp;market licensed products, and (ii)&nbsp;manufacture and sell licensed products in quantities sufficient to meet the market demands. We are also required to satisfy certain development and commercial milestones with respect to at
least one licensed product that is administered directly to a patient for therapeutic purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The license granted
pursuant to the UCLA Agreement is subject to certain rights retained by the California Institute for Regenerative Medicine (CIRM) and the U.S. government, including a <FONT STYLE="white-space:nowrap">non-exclusive,</FONT> royalty-free license
granted to the U.S. government in accordance with 35 U.S.C. <FONT STYLE="white-space:nowrap">&#167;200-212.</FONT> If CIRM exercises its rights under Title 17, California Code of Regulations, Section&nbsp;100600, and the scope of our exclusive
license under the UCLA Agreement is impacted, then our financial obligations therein will be reduced by 50%. Otherwise, rights retained by CIRM do not limit our ability to pursue our programs and product candidates. In addition, UCLA retains the
right to (i)&nbsp;use the licensed patent rights for educational and research purposes and research sponsored by commercial entities, (ii)&nbsp;publicly disclose research results, (iii)&nbsp;use the licensed patent rights to offer and perform
clinical diagnostic and prognostic care solely within the University of California system, and (iv)&nbsp;allow other <FONT STYLE="white-space:nowrap">non-profit</FONT> and academic institutions to use the licensed patent rights for educational and
research purposes and research sponsored by commercial entities, as well as to publicly disclose research results. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Pursuant to the UCLA Agreement, we paid UCLA an upfront license issue fee of $25,000. We also reimbursed UCLA its past patent
costs, and there is a continuing obligation to reimburse UCLA for its patent costs during the term of the UCLA Agreement. For licensed products that are administered directly to a patient for therapeutic purposes, we are required to pay UCLA up to
an aggregate of (i) $825,000 upon the achievement of certain <FONT STYLE="white-space:nowrap">pre-specified</FONT> development milestones for each of the first three such licensed products and (ii) $15.0&nbsp;million upon the achievement of certain <FONT
STYLE="white-space:nowrap">pre-specified</FONT> commercial milestones for such licensed products. In addition, we are obligated to pay an annual license maintenance fee beginning on the first anniversary of the UCLA Agreement until the first
commercial sale. The license maintenance fee for the first anniversary will be $10,000 and subsequently will increase by $10,000 per anniversary up to a maximum annual license maintenance fee of $100,000. We are also required to pay, on a <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">country-by-country</FONT></FONT> basis, earned royalty in the low single-digit percentage on net sales of the licensed products, with the royalty rate being subject to reduction upon
certain events. Under the UCLA Agreement, we are obligated to pay a minimum annual royalty of $100,000 beginning with the first full calendar year after the first commercial sale, and the minimum annual royalty will be credited against the earned
royalty made during the same calendar year. If any claim within the licensed patent rights is held invalid or unenforceable in a final decision by a court of competent jurisdiction, all royalty obligations with respect to that claim or any claim
patentably indistinct from it will expire as of the date of that final decision. No royalties will be collected or paid on licensed products sold to the U.S. government to the extent required by law, and we will have to reduce the amount charged for
licensed products distributed to the U.S. government by the amount of the royalty that otherwise would have been paid. Furthermore, we are </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">193 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
obligated to pay UCLA tiered fees on a percentage of certain sublicense income in the low single-digit to low double-digit percentage range. Lastly, if we challenge the validity of any licensed
patent rights, we agree to pay UCLA all royalties and other amounts due in view of our activities under the UCLA Agreement during the period of challenge. If we fail such challenge, we are required to pay two times the royalty rate paid during the
period of such challenge for the remaining term of the UCLA Agreement and all of UCLA&#146;s legal verifiable <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> fees and costs incurred in defending such
challenge, including attorney&#146;s fees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The UCLA Agreement will terminate on the later of the life of the <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">last-to-expire</FONT></FONT> patent or last to be abandoned patent application in the licensed patent rights, which we expect to be in 2033. We also have the right to terminate the UCLA
Agreement in its entirety or with respect to any portion of the licensed patent rights for any reason upon 90 days prior written notice to UCLA. UCLA may terminate the UCLA Agreement upon a material breach by us that is not cured within 90 days
after receiving written notice. If the breach is incapable of being cured within such period, then UCLA will consider our efforts to avoid, and to take reasonable steps to cure, such breach when determining whether to terminate the UCLA Agreement.
Also, UCLA has the right and option, at its sole discretion, to either terminate the UCLA Agreement or reduce our exclusive license to a <FONT STYLE="white-space:nowrap">non-exclusive</FONT> license if we fail to (i)&nbsp;exercise commercially
reasonable and diligent efforts to develop, market, manufacture and sell licensed products, or (ii)&nbsp;achieve certain development milestones set forth in the UCLA Agreement, subject to our ability to extend such milestones in accordance with
terms set forth in the UCLA Agreement. Upon termination of the UCLA Agreement by us, we may continue to sell any previously manufactured licensed products for 180 days after the effective date of termination. Upon termination of the UCLA Agreement
by UCLA for our failure to reimburse UCLA for certain patent costs after the applicable cure period, we may continue to sell all previously made licensed products for 180 days after the effective date of the notice of termination; however, this
right is not available if the UCLA Agreement is terminated for any other causes. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Ex Vivo Cell Engineering Platform </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>License Agreement with Harvard </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In March 2019, we entered into a license agreement, as amended in June 2019 and in December 2020, (the Harvard Agreement) with
the President and Fellows of Harvard College (Harvard), pursuant to which we obtained an exclusive, worldwide, <FONT STYLE="white-space:nowrap">sub-licensable</FONT> license under certain patent rights controlled by Harvard to make, have made, use,
offer for sale, sell, have sold and import (i)&nbsp;products and services covered by the patent rights and (ii)&nbsp;products containing stem cells, pluripotent cells or cells derived from modified stem cells or pluripotent cells with certain
specified genetic modifications ((i) and (ii)&nbsp;together, Harvard Products) or otherwise practice under and exploit the licensed patent rights, for the treatment of disease in humans or, in the case of certain other patent rights, for
applications that involve the use of cells derived <I>ex vivo</I> from stem cells in the treatment of disease in humans. We also obtained a <FONT STYLE="white-space:nowrap">non-exclusive,</FONT> <FONT STYLE="white-space:nowrap">sub-licensable</FONT>
license under certain other patent rights in the United States, and a <FONT STYLE="white-space:nowrap">non-exclusive,</FONT> <FONT STYLE="white-space:nowrap">sub-licensable,</FONT> worldwide license under
<FONT STYLE="white-space:nowrap">know-how</FONT> pertaining to the licensed patent rights, to make, have made, use, offer for sale, sell, have sold and import the Harvard Products, or otherwise practice under and exploit the licensed patent rights
and <FONT STYLE="white-space:nowrap">know-how,</FONT> for the treatment of disease in humans. We have the option to obtain such <FONT STYLE="white-space:nowrap">non-exclusive</FONT> rights in additional jurisdictions if Harvard is successful in
obtaining the right to grant such from the third-party <FONT STYLE="white-space:nowrap">co-owner</FONT> of such patent rights. We utilize these license rights in our <I>ex vivo</I> cell engineering program relying on our hypoimmune technology. </P>
 <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are obligated to use commercially reasonable efforts to develop Harvard Products in accordance with a written
development plan, to market the Harvard Products following receipt of regulatory approval and to achieve certain specified development and regulatory milestones within specified time periods, as such period may be extended, for at least two Harvard
Products. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The licenses granted pursuant to the Harvard Agreement are subject to certain rights retained by Harvard and
the rights of the U.S. government. The retained rights of Harvard pertain only to the ability of Harvard and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">194 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
other <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">not-for-profit</FONT></FONT> research organizations to conduct academic research, educational and scholarly activities, and
do not limit our ability to pursue our programs and product candidates. We agreed that we will not use any of the licensed patent rights for human germline modification, including intentionally modifying the DNA of human embryos or human
reproductive cells. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Pursuant to the Harvard Agreement, we paid Harvard an upfront fee of $3.0&nbsp;million, and we
issued 2,244,412 shares of our Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock to Harvard as partial consideration for the licenses granted in the Harvard Agreement. Additionally, we paid $6.0&nbsp;million to Harvard
in connection with the issuance of shares of our Series B convertible preferred stock. We are required to pay Harvard annual license maintenance fees of $25,000 for 2019, $50,000 for 2020 and $100,000 for each calendar year thereafter for the
remainder of the term. We are required to pay Harvard up to an aggregate of $15.2 million per Harvard Product upon the achievement of certain <FONT STYLE="white-space:nowrap">pre-specified</FONT> development and regulatory milestones for up to a
total of five Harvard Products, or an aggregate total of $76.0 million for all five Harvard Products. These milestone payments would double if we undergo a change of control. We are also obligated to pay, on a <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">product-by-product</FONT></FONT> and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">country-by-country</FONT></FONT> basis, royalties in the low single-digit percentage range on quarterly net sales of
Harvard Products covered by licensed patent rights, and a lower single-digit percentage royalty on quarterly net sales of Harvard Products not covered by licensed patent rights. The royalty rates with respect to Harvard Products covered by licensed
patent rights are also subject to specified and capped reductions for loss of market exclusivity and for payments owed to third parties with respect to patent rights which cover Harvard Products in the territory. We are also obligated to pay Harvard
a percentage of certain sublicense income ranging from high single-digit to low double-digit percentage range. We are obligated to pay success payments up to a potential amount of $175.0&nbsp;million based on increases in the fair value of our
Series A convertible preferred stock at pre-specified valuation dates including the closing date of an equity financing prior to an IPO of more than $25.0&nbsp;million, the one year anniversary of an IPO and periodically thereafter, the closing date
of an asset sale, or merger, stock sale and the last day of the term of the success payments. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Harvard Agreement
will expire on the expiration of the last to expire valid claim within the licensed patent rights or, if later, at the end of the final royalty term, which is determined on a Harvard
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Product-by-</FONT></FONT> Harvard Product and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">country-by-country</FONT></FONT> basis, and is the later of
(i)&nbsp;the date on which the last valid claim within the licensed patent rights covering such Harvard Product in such country, (ii)&nbsp;expiry of regulatory exclusivity for such Harvard Product in such country expires, or (iii)&nbsp;ten years
from the first commercial sale of such Harvard Product in such country, which we expect to be in 2039. We also have the right to terminate the Harvard Agreement in its entirety for any reason upon 45 days&#146; prior written notice to Harvard.
Either party may terminate the Harvard Agreement upon a material breach by the other party that is not cured within 60 days after receiving written notice. Harvard may terminate the Harvard Agreement upon giving written notice in the event of our
bankruptcy, insolvency or similar proceedings. If we terminate the Harvard Agreement for convenience, the obligations to pay milestones and royalties with respect to Harvard Products that are not then covered by licensed patent rights will survive
for the remainder for the applicable royalty term. If the Harvard Agreement is terminated for any reason, then sublicensees other than our affiliates or sublicensees in material default or at fault for the termination have the right to enter into a
direct license from Harvard on substantially the same <FONT STYLE="white-space:nowrap">non-economic</FONT> terms and on economic terms providing for the payment to Harvard of the consideration that would otherwise have been payable if the Harvard
Agreement and the sublicense were not terminated. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>License Agreement with UCSF </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In January 2019, we entered into a license agreement (the UCSF Agreement), as amended in December 2020, with The Regents of the
University of California (The Regents) acting through its Office of Technology Management, University of California San Francisco (UCSF) pursuant to which we obtained an exclusive license to inventions related to immunoengineered pluripotent cells
and derivatives claimed in U.S. and international patents and patent applications (UCSF Patent Rights) by The Regents. The license is to make, have made, use, sell, offer for sale and import licensed products that are covered by such UCSF Patent
Rights, provide licensed services, practice licensed methods and otherwise practice under the UCSF Patent Rights, for use in humans </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">195 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
only, in the United States and other countries where The Regents is not prohibited by applicable law from granting such UCSF Patent Rights. We have the right to sublicense our rights granted
under the UCSF Agreement to third parties subject to terms and conditions. We utilize these license rights in our <I>ex vivo</I> cell engineering platform program relying on our hypoimmune technology. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are obligated, directly or through affiliates or <FONT STYLE="white-space:nowrap">sub-licensees,</FONT> to use commercially
reasonable efforts to develop, manufacture and sell one or more licensed product and licensed services and to bring one or more licensed products or licensed services to market. We are required to use commercially reasonable efforts to obtain all
necessary governmental approvals in each country where licensed products or licensed services are manufactured, used, sold, offered for sale, or imported. We are required to spend at least $30.0&nbsp;million towards research, development and
commercialization of licensed products within five years after the closing of <FONT STYLE="white-space:nowrap">Series&nbsp;A-2</FONT> convertible preferred stock financing. In addition, we are required to achieve certain specified development and
regulatory milestones within specified time periods. We have the ability to extend the time periods for achievement of development and regulatory milestones under certain terms set forth in the UCSF Agreement, including payment of extension fees. If
we are unable to complete any of the specified milestones by the completion date, or extended completion date, for such milestone, then The Regents has the right and option to either terminate the Agreement, subject to our ability to cure the
applicable breach, or convert our exclusive license to a <FONT STYLE="white-space:nowrap">non-exclusive</FONT> license. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Regents reserves and retains the right to make, use and practice the invention and any related technology and to make and
use any products and to practice any process that is the subject of the UCSF Patent Rights (and to grant any of the foregoing rights to other educational and <FONT STYLE="white-space:nowrap">non-profit</FONT> institutions) for educational and <FONT
STYLE="white-space:nowrap">non-commercial</FONT> research purposes, including publications and other communication of other research results. This does not limit our ability to pursue our programs and product candidates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Pursuant to the UCSF Agreement, we paid an upfront license fee of $100,000, and we issued The Regents 737,515 shares of our
Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock. In addition, pursuant to the amendment, we issued 37,500 shares of our common stock. We are required to pay license maintenance fees ranging from $10,000 on the first
anniversary of the date of the UCSF Agreement to $40,000 on the sixth anniversary and continuing annually thereafter. This fee shall not be due if we are selling or exploiting licensed products or licensed services and paying an earned royalty to
The Regents on net sales of such licensed products or licensed service. We are required to pay The Regents up to an aggregate of $2.45 million per licensed product upon the achievement of certain pre-specified development and regulatory milestones
for the first 5 licensed products and half such amount for the second 5 licensed products, for an aggregate total of $18.4 million in development and regulatory milestone payments. Additionally, we are required to pay The Regents up to an aggregate
of $0.5 million per licensed product upon the achievement of certain commercial milestones for the first 5 licensed products and half such amount for the second 5 licensed products, for an aggregate total of $3.75&nbsp;million in commercial
milestone payments. With respect to each licensed product, licensed service or licensed method, we are obligated to pay on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">country-by-country</FONT></FONT> basis, tiered royalties
in the low single-digit percentage on net sales. The royalty rates are subject to specified capped reductions for payments owed to unaffiliated third parties in consideration for patent rights, or patent rights together with <FONT
STYLE="white-space:nowrap">know-how,</FONT> in order to practice licensed methods or to make, have made, use sell, offer to sell or import licensed products or licensed services. We are required to pay to The Regents a minimum annual royalty of
$100,000 beginning with the year of the first sale of licensed product or licensed service and ending upon the expiration of the last UCSF Patent Right. This will be credited against any earned royalty due for the upcoming twelve-month period for
which the minimum payment was made, and <FONT STYLE="white-space:nowrap">pro-rated.</FONT> We are also obligated to pay The Regents a percentage of certain non-royalty sublicense income ranging from the low double-digit to mid-twenty percentage
range. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The UCSF Agreement will expire on expiration or abandonment of the last valid claims within the UCSF Patent
Rights licensed under hereunder, which we expect to be in 2040. The Regents has the right to terminate the Agreement if we fail to cure or discontinue a material breach within 60 days of receiving a notice of default. We also have the right to
terminate the UCSF Agreement in its entirety or under certain UCSF Patent Rights on a country-by country basis at any time by providing 60 days&#146; notice of termination to The Regents. The UCSF </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">196 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
Agreement will automatically terminate in the event of our bankruptcy that is not dismissed within a specified time period. The Regents may immediately terminate the Agreement upon written notice
if we file a non-defensive patent challenge. The termination of the UCSF Agreement will not relieve us of obligations to pay any fees, royalties or other payments owed to The Regents at the time of such termination or expiration, including the right
to receive earned royalties. If the UCSF Agreement is terminated for any reason, then, upon the request of any sublicensee, The Regents will enter into a direct license from The Regents to such sublicensee on the same terms as the UCSF Agreement,
taking into account any difference in license scope, territory and duration of sublicense grant, provided that such sublicensee is not at the time of such termination in breach of its sublicensing agreement and is not at the time of such termination
an opposing party in any legal proceeding against The Regents. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>2019 Exclusive License Agreement with Washington University </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In November 2019, we entered into a license agreement (the 2019 WU Agreement) with Washington University, pursuant to which we
obtained an exclusive sublicensable, <FONT STYLE="white-space:nowrap">non-transferable,</FONT> worldwide license under certain Washington University patent rights related to genetically engineered hypoimmunogenic stem cells to research, develop,
make, have made and sell products the manufacture, use, sale or import of which by us or our sublicensees would, in the absence of the 2019 WU Agreement, infringe, at least one valid claim of the licensed patent rights (WU Hypoimmune Products). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are obligated to use commercially reasonable efforts to (i)&nbsp;develop, manufacture, promote and sell WU Hypoimmune
Products and (ii)&nbsp;to achieve certain development, regulatory and commercial diligence milestones within specified time periods. We have the ability to extend the time periods for achievement of such milestones under certain terms set forth in
the 2019 WU Agreement, including payment of extension fees. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Washington University retains the right to make, have
made, use and import WU Hypoimmune Products in fields relating to diagnosis, prevention and treatment of human disease or disorders for research and educational purposes, including collaboration with other nonprofit entities but excluding any
commercial purposes, and such retained rights do not limit our ability to pursue our programs and product candidates. Washington University retains all rights not granted to us under the patents. In addition, the 2019 WU Agreement is subject to
certain rights retained by the U.S. government, including the requirement that licensed products sold in the U.S. be substantially manufactured in the U.S. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Pursuant to the 2019 WU Agreement, we paid Washington University an upfront fee of $75,000. We are required to pay Washington
University up to $100,000 in license maintenance fees on each anniversary of the 2019 WU Agreement&#146;s effective date, until the first commercial sale of a WU Hypoimmune Product. Upon the achievement of certain development and, regulatory
milestones, we are required to pay Washington University up to an aggregate of $2.0&nbsp;million per WU Hypoimmune Product for the first three WU Hypoimmune Products, for an aggregate total of $6 million. Additionally, upon the achievement of
certain commercial milestones, we are required to pay Washington University up to an aggregate of $2.5 million per WU Hypoimmune Product for the first three WU Hypoimmune Products, for an aggregate total of $7.5 million. We are also obligated to pay
royalties at a low single-digit percentage on annual net sales, subject to a minimum amount payable in advance. The minimum annual royalty for the first anniversary of the effective date following the first commercial sale will be $100,000 and
subsequently will increase up to a maximum minimum annual royalty of $750,000 on the fourth anniversary of the effective date following the first commercial sale. The royalties are payable provided there is at least one valid claim of licensed
patent rights present in the country of manufacture or sale. The royalty rates are also subject to specified and capped reduction upon certain other events. Furthermore, we are obligated to pay Washington University a percentage of certain
non-royalty sublicense income ranging from the lower double-digit percentage range. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The 2019 WU Agreement will expire
upon the last to expire valid claim in the licensed patent rights, which we expect to be in 2038. We also have the right to terminate the 2019 WU Agreement for any reason upon </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">197 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
90&nbsp;days prior written notice to Washington University. Washington University may terminate the 2019 WU Agreement upon a material breach by us that is not cured within 30 days after receiving
written notice. In addition, Washington University may terminate the 2019 WU Agreement (i) upon 30 days written notice if we fail to achieve certain development, regulatory or commercial diligence milestones and are unable to resolve Washington
University&#146;s concerns through good faith negotiations in accordance with the 2019 WU Agreement, (ii)&nbsp;upon our bankruptcy or insolvency, or (iii)&nbsp;if an order is made or a notice issued convening a meeting of shareholders to consider
the passing of a resolution of our winding up or a resolution is passed for our winding up (in each case, other than for the purpose of amalgamation or reconstruction). If the 2019 WU Agreement terminates prior to the expiration of the
last-to-expire licensed patent rights, we agree (i)&nbsp;to promptly discontinue the exportation of licensed products, (ii)&nbsp;to promptly discontinue the manufacture, sale and distribution of the licensed products, (iii)&nbsp;to promptly destroy
all licensed products in inventory, and (iv)&nbsp;not to manufacture, sell or distribute licensed products until the expiration of the applicable last-to-expire licensed patent rights. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>2020 License Agreement with Washington University </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In September 2020, we entered into an exclusive license agreement (the 2020 WU Agreement) with Washington University for
certain patent rights relating to the methods and compositions of generating cells of endodermal lineage and beta cells and uses thereof. Under the 2020 WU Agreement, we obtained an exclusive, worldwide,
<FONT STYLE="white-space:nowrap">non-transferable</FONT> and royalty-bearing license under the patent rights to research, develop, make, have made, sell, offer for sale, have sold, use, have used, export and import licensed products the manufacture,
use, sale or import of which by us or our sublicensees would, in the absence of the 2020 WU Agreement, infringe, at least one valid claim of the licensed patent rights, solely in fields relating to diagnosis, prevention and treatment of human
disease or disorders. We utilize these license rights in our <I>ex vivo</I> cell engineering platform program relying on our hypoimmune technology, including our beta cell program. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are obligated to use commercially reasonable efforts to (i)&nbsp;develop, manufacture, promote and sell licensed products
and (ii)&nbsp;to achieve certain development, regulatory and commercial diligence milestones within specified time periods. We have the ability to extend the time periods for achievement of such milestones under certain terms set forth in the 2020
WU Agreement, including payment of extension fees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Washington University retains the right to use the licensed patent
rights to make, have made, use, and import licensed products worldwide in fields relating to diagnosis, prevention and treatment of human disease or disorders for research and educational purposes, including collaboration with other nonprofit
entities, but expressly excluding any commercial purposes and such retained rights do not limit our ability to pursue our programs and product candidates. In addition, the 2020 WU Agreement is subject to certain rights retained by the U.S.
government, including the requirement that licensed products sold in the U.S. be substantially manufactured in the U.S. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Pursuant to the 2020 WU Agreement, we paid Washington University an upfront license issue fee of $150,000. We are required to
pay annual license maintenance fees on each anniversary of the 2020 WU Agreement&#146;s effective date, until the first commercial sale of a licensed product. The license maintenance fee for the first and second anniversaries of the effective date
will be $25,000 and subsequently will increase by $25,000&nbsp;per two anniversaries up to a maximum annual license maintenance fee of $100,000. We are also required to pay Washington University up to an aggregate of $2.0 million upon the
achievement of certain <FONT STYLE="white-space:nowrap">pre-specified</FONT> development and regulatory milestones per licensed product for the first three licensed products, for an aggregate total of $6 million. Additionally, we are required to pay
Washington University up to an aggregate of $4.5 million upon the achievement of certain pre-specified commercial milestones per licensed product for the first three licensed products, for an aggregate total of $13.5 million. We are also required to
pay, for each licensed product made or sold by or for us worldwide, earned royalty at a low single-digit percentage on net sales of the licensed products, with the royalty rate being subject to specified and capped reduction upon certain events.
Under the 2020 WU Agreement, we are obligated to pay a minimum annual royalty commencing with the first anniversary of the effective date following the first commercial sale of the licensed product, which will be paid as an advance against the
earned royalties paid to Washington University over the ensuing 12 month period. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">198 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
The minimum annual royalty for the first anniversary of the effective date following the first commercial sale will be $100,000 and subsequently will increase up to a maximum minimum annual
royalty of $750,000 on the fourth anniversary of the effective date following the first commercial sale. The royalties are payable provided there is at least one valid claim of the licensed patent rights present in the country of manufacture or
sale. Furthermore, we are obligated to pay Washington University a percentage of certain non-royalty sublicense income ranging from the lower double-digit percentage range. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The 2020 WU Agreement will expire upon the last to expire valid claim in the licensed patent rights, which we expect to be in
2038. We also have the right to terminate the 2020 WU Agreement for any reason upon 90 days prior written notice to Washington University. Washington University may terminate the 2020 WU Agreement upon a material breach by us that is not cured
within 30 days after receiving written notice. In addition, Washington University may terminate the 2020 WU Agreement (i)&nbsp;upon 30 days written notice if we fail to achieve certain development, regulatory or commercial diligence milestones and
are unable to resolve Washington University&#146;s concerns through good faith negotiations in accordance with the 2020 WU Agreement, (ii)&nbsp;upon our bankruptcy or insolvency, or (iii)&nbsp;if an order is made or a notice issued convening a
meeting of shareholders to consider the passing of a resolution of our winding up or a resolution is passed for our winding up (in each case, other than for the purpose of amalgamation or reconstruction). If the 2020 WU Agreement terminates prior to
the expiration of the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">last-to-expire</FONT></FONT> licensed patent rights, we agree (i)&nbsp;to promptly discontinue the exportation of licensed products, (ii)&nbsp;to promptly
discontinue the manufacture, sale and distribution of the licensed products, (iii)&nbsp;to promptly destroy all licensed products in inventory, and (iv)&nbsp;not to manufacture, sell or distribute licensed products until the expiration of the
applicable <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">last-to-expire</FONT></FONT> licensed patent rights. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Oscine Acquisition </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In September 2020, we acquired Oscine Corp. (Oscine), a privately-held early-stage biotechnology company pursing a glial
progenitor <I>ex vivo</I> cell engineering program, in exchange for $8.5&nbsp;million in cash, net of certain expenses. Of the total purchase price, $7.6&nbsp;million was an upfront cash payment, and $0.9&nbsp;million was set aside (the Oscine
Holdback Amount) to satisfy certain general representations and warranties as set forth in the stock purchase agreement. We had originally entered into a collaboration, license and option to purchase agreement with Oscine in November 2018. That
agreement was terminated upon the closing of the acquisition of Oscine. As part of the Oscine acquisition we also agreed to pay additional amounts of up to an aggregate of $225.8&nbsp;million upon achievement of certain <FONT
STYLE="white-space:nowrap">pre-specified</FONT> development and commercial milestones, which we may pay in cash or in shares of our common stock subject to certain conditions. As a result of the Oscine acquisition, we entered into, or obtained and
amended, licenses to various technologies related to our glial progenitor <I>ex vivo</I> cell-based therapy program, including a license agreement with University of Rochester and a seed bank supply agreement with Hadasit Medical Research Services
and Development Ltd. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>License Agreement with University of Rochester </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Effective as of the closing of the Oscine acquisition, we entered into an amended and restated exclusive license agreement (the
Rochester Agreement) with the University of Rochester, which amended and restated a prior license agreement between Oscine and its affiliates and the University of Rochester and assigned Oscine&#146;s rights and obligations in the license agreement
to us. Under the Rochester Agreement we obtained an exclusive, royalty-bearing, sublicensable, worldwide license under certain patents, and a <FONT STYLE="white-space:nowrap">non-exclusive,</FONT> royalty-free license under <FONT
STYLE="white-space:nowrap">know-how,</FONT> to research, develop import, make, have made, use, sell, offer to sell, commercialize and otherwise exploit cell-based therapies for the treatment of human central nervous system disease and disorders. We
utilize these license rights in our glial progenitor cell-based therapy program. We granted the University of Rochester a license to practice any patent rights that cover inventions in the field of cell-based therapies for human central nervous
system diseases and disorders, which inventions are first conceived and reduced to practice solely by Dr.&nbsp;Steven Goldman acting in his capacity as our employee, or jointly with any of our employees reporting to Dr.&nbsp;Goldman, solely for
Dr.&nbsp;Goldman or any of his lab members at the University of Rochester to practice such patent rights within Dr.&nbsp;Goldman&#146;s laboratory at the University of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">199 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
Rochester solely for internal academic research purposes. University of Rochester granted us an automatic royalty-free <FONT STYLE="white-space:nowrap">non-exclusive</FONT> license, and the
option to obtain exclusive rights, to any patent rights or inventions conceived or reduced to practice by Dr.&nbsp;Goldman or members of his laboratory at the University of Rochester within a certain timeframe in connection with the internal
academic research license granted by us to the University of Rochester. We are obligated to use commercially reasonable efforts to proceed with the commercial exploitation of the patents, to create a reasonable supply of licensed products to meet
demand, and to adhere to a specified commercial development plan for development of stem cells therapy products, with <FONT STYLE="white-space:nowrap">pre-specified</FONT> development milestones, including obtaining government approvals to market at
least one licensed product, and to market such product within twelve months of receiving such approval. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The licenses
granted pursuant to the Rochester Agreement are subject to certain rights retained by the University of Rochester and the rights of the U.S. government. The retained rights of the University of Rochester pertain only to its ability to conduct
internal academic research other than clinical research and for teaching, education and other <FONT STYLE="white-space:nowrap">non-commercial</FONT> research activities, in publications related to its scientific research and findings, and for any
other <FONT STYLE="white-space:nowrap">non-clinical</FONT> and <FONT STYLE="white-space:nowrap">non-commercial</FONT> purpose that is not inconsistent with the rights granted to us under the Rochester Agreement. These retained rights do not limit
our ability to pursue our programs and product candidates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Pursuant to the Rochester Agreement, we will pay minimum
annual royalties beginning in January&nbsp;2023. Such payments will be $20,000 in 2023, escalating to $50,000 in 2025 and then to $70,000 in 2028 and beyond. The minimum annual royalty payment is creditable against tiered royalties in the low
single-digit percentage range on annual net sales. The royalty rates are also subject to reduction upon certain other events. We are also required to pay University of Rochester up to an aggregate of $950,000 upon the achievement of certain <FONT
STYLE="white-space:nowrap">pre-specified</FONT> development and commercial milestones for each licensed product. We are also required to pay a tiered <FONT STYLE="white-space:nowrap">mid-single</FONT> digit to
<FONT STYLE="white-space:nowrap">mid-double</FONT> digit percentage of revenue arising from any sublicenses granted by us to third parties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Rochester Agreement will terminate on the last to expire of the licensed patents, which we expect to be in 2038. We also
have the right to terminate the Rochester Agreement in its entirety for any reason upon 90 days&#146; prior written notice to the University of Rochester. The University of Rochester may terminate the Rochester Agreement upon material breach by us
that is not cured within 30 days of receiving written notice, or immediately in the event of our bankruptcy. The University of Rochester may also terminate the Rochester Agreement, or at its sole discretion terminate the exclusivity of the license
granted, upon our failure to meet its diligence obligations that is not cured within 90 days or such longer reasonable time at the University of Rochester&#146;s discretion an subject to a good faith negotiation mechanism included in the Rochester
Agreement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Supply Agreement with Hadasit Medical Research Services and Development Ltd. </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In July 2018, Oscine Therapeutics (U.S.) Inc., an affiliate of Oscine, entered into a supply agreement (the Hadasit Agreement)
with Hadasit Medical Research Services and Development Ltd. (Hadasit), pursuant to which Oscine obtained a quantity of seed bank cells and accompanying regulatory information on a <FONT STYLE="white-space:nowrap">non-exclusive</FONT> basis for the
sole purpose of developing, manufacturing and selling cell therapy products for the treatment or prevention of central nervous system disorders in humans, which cell therapy products are derived using the Oscine proprietary differentiation
technology from a certain human ESC line provided by Hadasit under the Hadasit Agreement. We utilize these cells and information in our glial progenitor cell program. Concurrently with our acquisition of Oscine in September 2020, the Hadasit
Agreement was assigned by Oscine Therapeutics (U.S.) Inc. to Oscine, we amended the Hadasit Agreement effective as of the closing of the Oscine acquisition and we subsequently assigned the Hadasit Agreement from Oscine to us. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Pursuant to the Hadasit Agreement, Oscine Therapeutics (U.S.) Inc. paid Hadasit an upfront fee of $24,000. We are required to
pay Hadasit up to an aggregate of $1.1&nbsp;million upon the achievement of certain development milestones for the first product. We are also obligated to pay tiered royalties in the low single-digit percentage
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">200 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
range on annual net sales of the relevant products worldwide, which obligation shall commence upon the first commercial sale of a relevant product and shall expire after 15 years on a <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">product-by-product</FONT></FONT> and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">country-by-country</FONT></FONT> basis. The royalty rates are also subject to
reduction upon certain other events. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Hadasit Agreement will continue until terminated in accordance with its terms.
Hadasit may terminate the Hadasit Agreement upon giving 30 days&#146; written notice if the Company fails to make any payment due and does not cure the remedy within 30 days&#146; notice, or upon 60 days&#146; written notice if the Company ceases to
use the seed bank cells for the development and manufacture of its products, subject to our ability to dispute Hadasit&#146;s claim and resolution of such dispute in accordance with a process set forth in the Hadasit Agreement. Either party may
terminate the Hadasit Agreement upon a material breach by the other party that is not cured within 60 days after receiving written notice, or upon giving written notice in the event of the other party&#146;s bankruptcy. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Cytocardia Acquisition </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In November 2019, we acquired Cytocardia, Inc. (Cytocardia), a privately-held early-stage biotechnology company developing
<I>ex vivo</I> cell engineering programs focused on replacement of damaged heart cells, in exchange for $8.0&nbsp;million in cash, net of certain indebtedness and expenses, of which $6.8&nbsp;million was an upfront cash payment, and
$1.2&nbsp;million was set aside (Cytocardia Holdback Amount) to satisfy certain general representations and warranties as set forth in the stock purchase agreement. We also agreed to pay additional amounts of up to an aggregate of $75.0&nbsp;million
upon the achievement of certain <FONT STYLE="white-space:nowrap">pre-specified</FONT> development milestones and up to an aggregate of $65.0&nbsp;million in <FONT STYLE="white-space:nowrap">pre-specified</FONT> commercial milestones. As a result of
that transaction, we obtained licenses to various intellectual property and technologies, including intellectual property and technology related to our cardiomyocyte program that we rely on for development of our cardiac cell therapy product
candidates. These included a license agreement with the University of Washington. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>University of Washington </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In October 2018, Cytocardia entered into an exclusive <FONT STYLE="white-space:nowrap">start-up</FONT> license agreement (the
UW Agreement), with the University of Washington (UW), pursuant to which Cytocardia obtained an exclusive license under certain patents relating to stem cell-derived cardiomyocytes and heart regeneration owned solely by UW or jointly by UW and the
University of Cambridge for which UW has the sole right to control the protection and licensing pursuant an inter-institutional agreement between UW and the University of Cambridge. We amended the UW Agreement in November 2019, concurrently with the
closing of our acquisition of Cytocardia and in July 2020 assigned the UW Agreement from Cytocardia to us. We further amended the UW Agreement in January 2021. The scope of the license is to make, have made, use, offer to sell, sell, offer to lease
or lease, import, or otherwise offer to dispose of products worldwide (i)&nbsp;for any use, with respect to certain specified licensed patents, (ii)&nbsp;for the production of cardiomyocytes having an atrial/ventricular phenotype, with respect to
other specified licensed patents, and (iii)&nbsp;heart regeneration therapy, with respect to other specified licensed patents. Additionally, UW granted us a <FONT STYLE="white-space:nowrap">non-exclusive,</FONT> worldwide license to use certain
related <FONT STYLE="white-space:nowrap">know-how,</FONT> clinical trial information and program materials. We may sublicense the exclusively licensed rights under the UW Agreement. We may also sublicense its rights in
<FONT STYLE="white-space:nowrap">non-exclusively</FONT> licensed rights, but only for the purpose of using them in conjunction with exclusively licensed rights. We utilize intellectual property in our cardiomyocyte program. For a period of 12 months
after the effective date of the UW Agreement, UW agreed to provide reasonable written notice to us of any improvements to the licensed patents upon notice to UW. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have the option to add such improvements to the licensed patents. Pursuant to the UW Agreement, We are required to use our
commercially reasonable efforts, consistent with sound and reasonable business practices and judgment, to commercialize the licensed rights and to make and sell licensed products as soon as practicable and to maximize sales thereof. We are also
obligated to achieve specified development, regulatory and commercial milestones within specified time periods. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Inventions covered in the licensed patents have arisen, in whole or in part, from federally supported research by the U.S.
federal government and the licenses granted pursuant to the UW Agreement are subject to certain </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">201 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
rights of the U.S. government. UW has retained for itself as well as for Cambridge University and for any other
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">not-for-profit</FONT></FONT> academic research institution, an irrevocable, nonexclusive right to practice the licensed rights for academic research, instructional, or any other
academic or <FONT STYLE="white-space:nowrap">non-commercial</FONT> purpose. UW has retained for itself an irrevocable, nonexclusive license to practice licensed rights for clinical purposes. Cambridge University has also retained for itself an
irrevocable, nonexclusive license to practice certain rights <FONT STYLE="white-space:nowrap">co-owned</FONT> with UW for clinical purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Pursuant to the UW Agreement, we will pay to UW a low single-digit royalty on net sales of products, with the royalty rate
being subject to specified and capped reduction upon certain events. We will pay minimum annual fees for the term of the UW Agreement to be creditable against running royalty payments for the preceding calendar year on a noncumulative basis. These
minimum annual fees are due following the second anniversary of the effective date of the UW Agreement and continue during the term of the UW Agreement, ranging from $5,000 up to $50,000 for the years following the second anniversary of the first
commercial sale of an <FONT STYLE="white-space:nowrap">FDA-approved</FONT> licensed product. We will also pay to UW <FONT STYLE="white-space:nowrap">non-cumulative,</FONT> <FONT STYLE="white-space:nowrap">non-creditable,</FONT> and <FONT
STYLE="white-space:nowrap">non-refundable</FONT> development milestone payments of up to $175,000 and commercial milestone payments of up to $700,000, for the first licensed product to achieve each such event. Furthermore, pursuant to the UW
Agreement, we are obligated to pay UW a percentage of certain non-royalty sublicense income ranging from the low single-digits to middle double-digit percentage range, depending on the stage of development at the time of execution of the sublicense
agreement. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The UW Agreement will expire, without further action by the parties, when all valid claims of the
licensed patents have expired, and we have sold all licensed products manufactured prior to the expiration of such valid claims, which we expect to be in 2040. UW may terminate the UW Agreement if we (i)&nbsp;permanently cease operations,
(ii)&nbsp;voluntarily file or have filed against us a petition under applicable bankruptcy or insolvency laws that we fail to have released within 30 days after filing, (iii)&nbsp;propose any dissolution, composition, or financial reorganization
with creditors or if a receiver, trustee, custodian, or similar agent is appointed, (iv)&nbsp;make a general assignment for the benefit of creditors, (v)&nbsp;if we challenge the validity of the licensed patents or (vi) if we breach our material
obligations under the UW Agreement and do not cure such breach within 60 days. We may terminate the UW Agreement at any time by delivering to UW a written notice of termination at least 60 days prior to the effective date of termination. In
addition, we may propose to terminate certain of our licensed rights hereunder by delivering to UW a written notice of termination accompanied by a proposed written amendment to this Agreement at least 60 days prior to the effective date of
termination of such licensed rights. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Government Regulation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The FDA and other regulatory authorities at federal, state, and local levels, as well as in foreign countries, extensively
regulate, among other things, the research, development, testing, manufacture, quality control, import, export, safety, effectiveness, labeling, packaging, storage, distribution, record keeping, approval, advertising, promotion, marketing, <FONT
STYLE="white-space:nowrap">post-approval</FONT> monitoring, and <FONT STYLE="white-space:nowrap">post-approval</FONT> reporting of biologics such as those we are developing. We, along with <FONT STYLE="white-space:nowrap">third-party</FONT>
contractors, will be required to navigate the various preclinical, clinical and commercial approval requirements of the governing regulatory agencies of the countries in which we wish to conduct studies or seek approval or licensure of our product
candidates. The process of obtaining regulatory approvals and the subsequent compliance with applicable federal, state, local and foreign statutes and regulations require the expenditure of substantial time and financial resources. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>U.S. Biologics Regulation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In the United States, biological products are subject to regulation under the Federal Food, Drug, and Cosmetic Act, the Public
Health Service Act, and other federal, state, local and foreign statutes and regulations. The process required by the FDA before biologics may be marketed in the United States generally involves the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">completion of preclinical laboratory tests and animal studies performed in accordance with the FDA&#146;s Good
Laboratory Practice requirements (GLPs); </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">202 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">submission to the FDA of an Investigational new drug application (IND), which must become effective before
clinical trials may begin; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approval by an institutional review board (IRB), or ethics committee at each clinical site before the trial is
commenced; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">performance of adequate and <FONT STYLE="white-space:nowrap">well-controlled</FONT> human clinical trials to
establish the safety, purity and potency of the proposed biologic product candidate for its intended purpose; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">preparation of and submission to the FDA of a biologics license application (BLA), after completion of all
pivotal clinical trials; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">satisfactory completion of an FDA Advisory Committee review, if applicable; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a determination by the FDA within 60 days of its receipt of a BLA to file the application for review;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">satisfactory completion of an FDA <FONT STYLE="white-space:nowrap">pre-approval</FONT> inspection of the
manufacturing facility or facilities at which the proposed product is produced to assess compliance with current Good Manufacturing Practices (cGMP), and to assure that the facilities, methods and controls are adequate to preserve the biological
product&#146;s continued safety, purity and potency and, if applicable, to assess compliance with the FDA&#146;s current Good Tissue Practice (cGTP) requirements for the use of human cellular and tissue products, and of selected clinical
investigation sites to assess compliance with Good Clinical Practices (GCPs); and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">FDA review and approval of the BLA to permit commercial marketing of the product for particular indications
for use in the United States. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Prior to beginning the first clinical trial with a product candidate in
the United States, we must submit an IND to the FDA. An IND is a request for authorization from the FDA to administer an investigational new drug to humans. The central focus of an IND submission is on the general investigational plan and the
protocol(s) for clinical studies. The IND also includes results of animal and <I>in vitro</I> studies assessing the toxicology, pharmacokinetics, pharmacology, and pharmacodynamic characteristics of the product; chemistry, manufacturing, and
controls information; and any available human data or literature to support the use of the investigational product. An IND must become effective before human clinical trials may begin. The IND automatically becomes effective 30 days after receipt by
the FDA, unless the FDA, within the <FONT STYLE="white-space:nowrap">30-day</FONT> time period, raises safety concerns or questions about the proposed clinical trial. In such a case, the IND may be placed on clinical hold and the IND sponsor and the
FDA must resolve any outstanding concerns or questions before the clinical trial can begin. Submission of an IND therefore may or may not result in FDA authorization to begin a clinical trial. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition to the IND submission process, under the National Institutes of Health (NIH), Guidelines for Research Involving
Recombinant DNA Molecules, or the NIH Guidelines, supervision of human gene transfer trials includes evaluation and assessment by an institutional biosafety committee (IBC), a local institutional committee that reviews and oversees research
utilizing recombinant or synthetic nucleic acid molecules at that institution. The IBC assesses the safety of the research and identifies any potential risk to public health or the environment, and such review may result in some delay before
initiation of a clinical trial. While the NIH Guidelines are not mandatory unless the research in question is being conducted at or sponsored by institutions receiving NIH funding of recombinant or synthetic nucleic acid molecule research, many
companies and other institutions not otherwise subject to the NIH Guidelines voluntarily follow them. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Clinical trials
involve the administration of the investigational product to human subjects under the supervision of qualified investigators in accordance with GCPs, which include the requirement that all research subjects provide their informed consent for their
participation in any clinical study. Clinical trials are conducted under protocols detailing, among other things, the objectives of the study, the parameters to be used in monitoring safety and the effectiveness criteria to be evaluated. A separate
submission to the existing IND must </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">203 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
be made for each successive clinical trial conducted during product development and for any subsequent protocol amendments. Furthermore, an independent IRB for each site proposing to conduct the
clinical trial must review and approve the plan for any clinical trial and its informed consent form before the clinical trial begins at that site, and must monitor the study until completed. Regulatory authorities, the IRB or the sponsor may
suspend a clinical trial at any time on various grounds, including a finding that the subjects are being exposed to an unacceptable health risk or that the trial is unlikely to meet its stated objectives. Some studies also include oversight by an
independent group of qualified experts organized by the clinical study sponsor, known as a data safety monitoring board, which provides authorization for whether or not a study may move forward at designated check points based on access to certain
data from the study and may halt the clinical trial if it determines that there is an unacceptable safety risk for subjects or other grounds, such as no demonstration of efficacy. There are also requirements governing the reporting of ongoing
clinical studies and clinical study results to public registries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For purposes of BLA approval, human clinical trials are
typically conducted in three sequential phases that may overlap or be combined: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Phase 1&#151;The investigational product is initially introduced into healthy human subjects or patients with
the target disease or condition. These studies are designed to test the safety, dosage tolerance, absorption, metabolism and distribution of the investigational product in humans, the side effects associated with increasing doses, and, if possible,
to gain early evidence on effectiveness. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Phase 2&#151;The investigational product is administered to a limited patient population with a specified
disease or condition to evaluate the preliminary efficacy, optimal dosages and dosing schedule and to identify possible adverse side effects and safety risks. Multiple Phase 2 clinical trials may be conducted to obtain information prior to beginning
larger and more expensive Phase 3 clinical trials. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Phase 3&#151;The investigational product is administered to an expanded patient population to further evaluate
dosage, to provide statistically significant evidence of clinical efficacy and to further test for safety, generally at multiple geographically dispersed clinical trial sites. These clinical trials are intended to establish the overall risk/benefit
ratio of the investigational product and to provide an adequate basis for product approval. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In some
cases, the FDA may require, or companies may voluntarily pursue, additional clinical trials after a product is approved to gain more information about the product. These <FONT STYLE="white-space:nowrap">so-called</FONT> Phase 4 studies may also be
made a condition to approval of the BLA. Concurrent with clinical trials, companies may complete additional animal studies and develop additional information about the biological characteristics of the product candidate, and must finalize a process
for manufacturing the product in commercial quantities in accordance with cGMP requirements. The manufacturing process must be capable of consistently producing quality batches of the product candidate and, among other things, must develop methods
for testing the identity, strength, quality and purity of the final product. Additionally, appropriate packaging must be selected and tested, and stability studies must be conducted to demonstrate that the product candidate does not undergo
unacceptable deterioration over its shelf life. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>BLA Submission and Review by the FDA </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Assuming successful completion of all required testing in accordance with all applicable regulatory requirements, the results
of product development, nonclinical studies and clinical trials are submitted to the FDA as part of a BLA requesting approval to market the product for one or more indications. The BLA must include all relevant data available from preclinical and
clinical studies, including negative or ambiguous results as well as positive findings, together with detailed information relating to the product&#146;s chemistry, manufacturing, controls, and proposed labeling, among other things. Data can come
from <FONT STYLE="white-space:nowrap">company-sponsored</FONT> clinical studies intended to test the safety and effectiveness of a use of the product, or from a number of alternative sources, including studies initiated by independent investigators.
The submission of a BLA requires payment of a substantial application user fee to the FDA, unless a waiver or exemption applies. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">204 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Within 60 days following submission of the application, the FDA reviews a
BLA submitted to determine if it is substantially complete before the FDA accepts it for filing. The FDA may refuse to file any BLA that it deems incomplete or not properly reviewable at the time of submission and may request additional information.
In this event, the BLA must be resubmitted with the additional information. Once a BLA has been accepted for filing, the FDA&#146;s goal is to review standard applications within ten months after the filing date, or, if the application qualifies for
priority review, six months after the FDA accepts the application for filing. In both standard and priority reviews, the review process may also be extended by FDA requests for additional information or clarification. The FDA reviews a BLA to
determine, among other things, whether a product is safe, pure and potent and the facility in which it is manufactured, processed, packed or held meets standards designed to assure the product&#146;s continued safety, purity and potency. The FDA may
also convene an advisory committee to provide clinical insight on application review questions. The FDA is not bound by the recommendations of an advisory committee, but it considers such recommendations carefully when making decisions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Before approving a BLA, the FDA will typically inspect the facility or facilities where the product is manufactured. The FDA
will not approve an application unless it determines that the manufacturing processes and facilities are in compliance with cGMP and adequate to assure consistent production of the product within required specifications. For a product candidate that
is also a human cellular or tissue product, the FDA also will not approve the application if the manufacturer is not in compliance with cGTPs. These are FDA regulations that govern the methods used in, and the facilities and controls used for, the
manufacture of human cells, tissues, and cellular and tissue based products (HCT/Ps) which are human cells or tissue intended for implantation, transplant, infusion, or transfer into a human recipient. The primary intent of the GTP requirements is
to ensure that cell and tissue based products are manufactured in a manner designed to prevent the introduction, transmission and spread of communicable disease. FDA regulations also require tissue establishments to register and list their HCT/Ps
with the FDA and, when applicable, to evaluate donors through screening and testing. Additionally, before approving a BLA, the FDA will typically inspect one or more clinical sites to assure compliance with GCP. If the FDA determines that the
application, manufacturing process or manufacturing facilities are not acceptable, it will outline the deficiencies in the submission and often will request additional testing or information. Notwithstanding the submission of any requested
additional information, the FDA ultimately may decide that the application does not satisfy the regulatory criteria for approval. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">After the FDA evaluates a BLA and conducts inspections of manufacturing facilities where the investigational product and/or
its drug substance will be produced, the FDA may issue an approval letter or a Complete Response Letter (CRL). An approval letter authorizes commercial marketing of the product with specific prescribing information for specific indications. A CRL
will describe all of the deficiencies that the FDA has identified in the BLA, except that where the FDA determines that the data supporting the application are inadequate to support approval, the FDA may issue the CRL without first conducting
required inspections, testing submitted product lots, and/or reviewing proposed labeling. In issuing the CRL, the FDA may recommend actions that the applicant might take to place the BLA in condition for approval, including requests for additional
information or clarification. The FDA may delay or refuse approval of a BLA if applicable regulatory criteria are not satisfied, require additional testing or information and/or require <FONT STYLE="white-space:nowrap">post-marketing</FONT> testing
and surveillance to monitor safety or efficacy of a product. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If regulatory approval of a product is granted, such
approval will be granted for particular indications and may entail limitations on the indicated uses for which such product may be marketed. For example, the FDA may approve the BLA with a Risk Evaluation and Mitigation Strategy (REMS), to ensure
the benefits of the product outweigh its risks. A REMS is a safety strategy implemented to manage a known or potential serious risk associated with a product and to enable patients to have continued access to such medicines by managing their safe
use, and could include medication guides, physician communication plans, or elements to assure safe use, such as restricted distribution methods, patient registries and other risk minimization tools. The FDA also may condition approval on, among
other things, changes to proposed labeling or the development of adequate controls and specifications. Once approved, the FDA may withdraw the product approval if compliance with <FONT STYLE="white-space:nowrap">pre-</FONT> and
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">205 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
<FONT STYLE="white-space:nowrap">post-marketing</FONT> requirements is not maintained or if problems occur after the product reaches the marketplace. The FDA may require one or more Phase 4 <FONT
STYLE="white-space:nowrap">post-market</FONT> studies and surveillance to further assess and monitor the product&#146;s safety and effectiveness after commercialization, and may limit further marketing of the product based on the results of these <FONT
STYLE="white-space:nowrap">post-marketing</FONT> studies. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Expedited development and review programs </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The FDA offers a number of expedited development and review programs for qualifying product candidates. For example, the fast
track program is intended to expedite or facilitate the process for reviewing new products that are intended to treat a serious or <FONT STYLE="white-space:nowrap">life-threatening</FONT> disease or condition and demonstrate the potential to address
unmet medical needs for the disease or condition. Fast track designation applies to the combination of the product and the specific indication for which it is being studied. The sponsor of a fast track product has opportunities for more frequent
interactions with the applicable FDA review team during product development and, once a BLA is submitted, the product candidate may be eligible for priority review. A fast track product may also be eligible for rolling review, where the FDA may
consider for review sections of the BLA on a rolling basis before the complete application is submitted, if the sponsor provides a schedule for the submission of the sections of the BLA, the FDA agrees to accept sections of the BLA and determines
that the schedule is acceptable, and the sponsor pays any required user fees upon submission of the first section of the BLA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A product candidate intended to treat a serious or <FONT STYLE="white-space:nowrap">life-threatening</FONT> disease or
condition may also be eligible for breakthrough therapy designation to expedite its development and review. A product candidate can receive breakthrough therapy designation if preliminary clinical evidence indicates that the product candidate, alone
or in combination with one or more other drugs or biologics, may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical
development. The designation includes all of the fast track program features, as well as more intensive FDA interaction and guidance beginning as early as Phase 1 and an organizational commitment to expedite the development and review of the product
candidate, including involvement of senior managers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Any marketing application for a drug or biologic submitted to the
FDA for approval, including a product candidate with a fast track designation and/or breakthrough therapy designation, may be eligible for other types of FDA programs intended to expedite the FDA review and approval process, such as priority review
and accelerated approval. A product candidate is eligible for priority review if it is designed to treat a serious or <FONT STYLE="white-space:nowrap">life-threatening</FONT> disease or condition, and if approved, would provide a significant
improvement in safety or effectiveness compared to available alternatives for such disease or condition. For original BLAs, priority review designation means the FDA&#146;s goal is to take action on the marketing application within six months of the
<FONT STYLE="white-space:nowrap">60-day</FONT> filing date (as compared to ten months under standard review). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Additionally, product candidates studied for their safety and effectiveness in treating serious or <FONT
STYLE="white-space:nowrap">life-threatening</FONT> diseases or conditions may receive accelerated approval upon a determination that the product has an effect on a surrogate endpoint that is reasonably likely to predict clinical benefit, or on a
clinical endpoint that can be measured earlier than irreversible morbidity or mortality, that is reasonably likely to predict an effect on irreversible morbidity or mortality or other clinical benefit, taking into account the severity, rarity, or
prevalence of the condition and the availability or lack of alternative treatments. As a condition of accelerated approval, the FDA will generally require the sponsor to perform adequate and <FONT STYLE="white-space:nowrap">well-controlled</FONT> <FONT
STYLE="white-space:nowrap">post-marketing</FONT> clinical studies to verify and describe the anticipated effect on irreversible morbidity or mortality or other clinical benefit. Products receiving accelerated approval may be subject to expedited
withdrawal procedures if the sponsor fails to conduct the required <FONT STYLE="white-space:nowrap">post-marketing</FONT> studies or if such studies fail to verify the predicted clinical benefit. In addition, the FDA currently requires as a
condition for accelerated approval <FONT STYLE="white-space:nowrap">pre-approval</FONT> of promotional materials, which could adversely impact the timing of the commercial launch of the product. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In 2017, the FDA established a new regenerative medicine advanced therapy (RMAT), designation as part of its implementation of
the 21st Century Cures Act. The RMAT designation program is intended to fulfill the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">206 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
21st Century Cures Act requirement that the FDA facilitate an efficient development program for, and expedite review of, any drug or biologic that meets the following criteria: (i)&nbsp;the drug
or biologic qualifies as a RMAT, which is defined as a cell therapy, therapeutic tissue engineering product, human cell and tissue product, or any combination product using such therapies or products, with limited exceptions; (ii)&nbsp;the drug or
biologic is intended to treat, modify, reverse, or cure a serious or <FONT STYLE="white-space:nowrap">life-threatening</FONT> disease or condition; and (iii)&nbsp;preliminary clinical evidence indicates that the drug or biologic has the potential to
address unmet medical needs for such a disease or condition. RMAT designation provides all the benefits of breakthrough therapy designation, including more frequent meetings with the FDA to discuss the development plan for the product candidate and
eligibility for rolling review and priority review. Product candidates granted RMAT designation may also be eligible for accelerated approval on the basis of a surrogate or intermediate endpoint reasonably likely to predict <FONT
STYLE="white-space:nowrap">long-term</FONT> clinical benefit, or reliance upon data obtained from a meaningful number of clinical trial sites, including through expansion of trials to additional sites. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Fast track designation, breakthrough therapy designation, priority review, accelerated approval, and RMAT designation do not
change the standards for approval but may expedite the development or approval process. Even if a product candidate qualifies for one or more of these programs, the FDA may later decide that the product no longer meets the conditions for
qualification or decide that the time period for FDA review or approval will not be shortened. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Orphan drug designation and exclusivity
</I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Under the Orphan Drug Act, the FDA may grant orphan designation to a drug or biologic intended to treat a rare disease
or condition, defined as a disease or condition with a patient population of fewer than 200,000 individuals in the United States, or a patient population greater than 200,000 individuals in the United States and when there is no reasonable
expectation that the cost of developing and making available the drug or biologic in the United States will be recovered from sales in the United States for that drug or biologic. Orphan drug designation must be requested before submitting a BLA.
After the FDA grants orphan drug designation, the generic identity of the therapeutic agent and its potential orphan use are disclosed publicly by the FDA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If a product that has orphan drug designation subsequently receives the first FDA approval for a particular active ingredient
for the disease for which it has such designation, the product is entitled to orphan product exclusivity, which means that the FDA may not approve any other applications, including a full BLA, to market the same biologic for the same indication for
seven years, except in limited circumstances, such as a showing of clinical superiority to the product with orphan drug exclusivity or if the FDA finds that the holder of the orphan drug exclusivity has not shown that it can assure the availability
of sufficient quantities of the orphan drug to meet the needs of patients with the disease or condition for which the drug was designated. Orphan drug exclusivity does not prevent the FDA from approving a different drug or biologic for the same
disease or condition, or the same drug or biologic for a different disease or condition. Among the other benefits of orphan drug designation are tax credits for certain research and a waiver of the BLA application user fee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A designated orphan drug may not receive orphan drug exclusivity if it is approved for a use that is broader than the
indication for which it received orphan designation. In addition, orphan drug exclusive marketing rights in the United States may be lost if the FDA later determines that the request for designation was materially defective or, as noted above, if a
second applicant demonstrates that its product is clinically superior to the approved product with orphan exclusivity or the manufacturer of the approved product is unable to assure sufficient quantities of the product to meet the needs of patients
with the rare disease or condition. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">Post-approval</FONT> requirements </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Biologics are subject to pervasive and continuing regulation by the FDA, including, among other things, requirements relating
to <FONT STYLE="white-space:nowrap">record-keeping,</FONT> reporting of adverse experiences, periodic reporting, product sampling and distribution, and advertising and promotion of the product. After approval, most changes to the approved
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">207 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
product, such as adding new indications or other labeling claims, are subject to prior FDA review and approval. There also are continuing, annual program fees for any marketed products. Biologic
manufacturers and their subcontractors are required to register their establishments with the FDA and certain state agencies, and are subject to periodic unannounced inspections by the FDA and certain state agencies for compliance with cGMP, which
impose certain procedural and documentation requirements up. Changes to the manufacturing process are strictly regulated, and, depending on the significance of the change, may require prior FDA approval before being implemented. FDA regulations also
require investigation and correction of any deviations from cGMP and impose reporting requirements. Accordingly, manufacturers must continue to expend time, money and effort in the area of production and quality control to maintain compliance with
cGMP and other aspects of regulatory compliance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The FDA may withdraw approval if compliance with regulatory requirements
and standards is not maintained or if problems occur after the product reaches the market. Later discovery of previously unknown problems with a product, including adverse events of unanticipated severity or frequency, or with manufacturing
processes, or failure to comply with regulatory requirements, may result in revisions to the approved labeling to add new safety information; imposition of <FONT STYLE="white-space:nowrap">post-market</FONT> studies or clinical studies to assess new
safety risks; or imposition of distribution restrictions or other restrictions under a REMS program. Other potential consequences include, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">restrictions on the marketing or manufacturing of the product, complete withdrawal of the product from the
market or product recalls; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">fines, warning letters, or untitled letters; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">clinical holds on clinical studies; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">refusal of the FDA to approve pending applications or supplements to approved applications, or suspension or
revocation of product license approvals; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">product seizure or detention, or refusal to permit the import or export of products; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">consent decrees, corporate integrity agreements, debarment or exclusion from federal healthcare programs;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">mandated modification of promotional materials and labeling and the issuance of corrective information;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the issuance of safety alerts, Dear Healthcare Provider letters, press releases and other communications
containing warnings or other safety information about the product; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">injunctions or the imposition of civil or criminal penalties. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The FDA closely regulates the marketing, labeling, advertising and promotion of biologics. A company can make only those
claims relating to safety and efficacy, purity and potency that are approved by the FDA and in accordance with the provisions of the approved label. The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion of <FONT
STYLE="white-space:nowrap">off-label</FONT> uses. Failure to comply with these requirements can result in, among other things, adverse publicity, warning letters, corrective advertising and potential civil and criminal penalties. Physicians may
prescribe legally available products for uses that are not described in the product&#146;s labeling and that differ from those tested and approved by the FDA. Such <FONT STYLE="white-space:nowrap">off-label</FONT> uses are common across medical
specialties. Physicians may believe that such <FONT STYLE="white-space:nowrap">off-label</FONT> uses are the best treatment for many patients in varied circumstances. The FDA does not regulate the behavior of physicians in their choice of
treatments. The FDA does, however, restrict manufacturer&#146;s communications on the subject of <FONT STYLE="white-space:nowrap">off-label</FONT> use of their products. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Biosimilars and reference product exclusivity </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Affordable Care Act, signed into law in 2010, includes a subtitle called the Biologics Price Competition and Innovation Act
(BPCIA), which created an abbreviated approval pathway for biological products that are </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">208 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
biosimilar to or interchangeable with an <FONT STYLE="white-space:nowrap">FDA-licensed</FONT> reference biological product. The FDA has issued several guidance documents outlining an approach to
review and approval of biosimilars. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Biosimilarity, which requires that there be no clinically meaningful differences
between the biological product and the reference product in terms of safety, purity, and potency, can be shown through analytical studies, animal studies, and a clinical study or studies. Interchangeability requires that a product is biosimilar to
the reference product and the product must demonstrate that it can be expected to produce the same clinical results as the reference product in any given patient and, for products that are administered multiple times to an individual, the biologic
and the reference biologic may be alternated or switched after one has been previously administered without increasing safety risks or risks of diminished efficacy relative to exclusive use of the reference biologic. However, complexities associated
with the larger, and often more complex, structures of biological products, as well as the processes by which such products are manufactured, pose significant hurdles to implementation of the abbreviated approval pathway that are still being worked
out by the FDA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Under the BPCIA, an application for a biosimilar product may not be submitted to the FDA until four years
following the date that the reference product was first licensed by the FDA. In addition, the approval of a biosimilar product may not be made effective by the FDA until 12 years from the date on which the reference product was first licensed.
During this <FONT STYLE="white-space:nowrap">12-year</FONT> period of exclusivity, another company may still market a competing version of the reference product if the FDA approves a full BLA for the competing product containing that
applicant&#146;s own preclinical data and data from adequate and <FONT STYLE="white-space:nowrap">well-controlled</FONT> clinical trials to demonstrate the safety, purity and potency of its product. The BPCIA also created certain exclusivity periods
for biosimilars approved as interchangeable products. At this juncture, it is unclear whether products deemed &#147;interchangeable&#148; by the FDA will, in fact, be readily substituted by pharmacies, which are governed by state pharmacy law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A biological product can also obtain pediatric market exclusivity in the United States. Pediatric exclusivity, if granted,
adds six months to existing exclusivity periods and patent terms. This <FONT STYLE="white-space:nowrap">six-month</FONT> exclusivity, which runs from the end of other exclusivity protection or patent term, may be granted based on the voluntary
completion of a pediatric study in accordance with an <FONT STYLE="white-space:nowrap">FDA-issued</FONT> &#147;Written Request&#148; for such a study. The BPCIA is complex and continues to be interpreted and implemented by the FDA. In addition,
government proposals have sought to reduce the <FONT STYLE="white-space:nowrap">12-year</FONT> reference product exclusivity period. Other aspects of the BPCIA, some of which may impact the BPCIA exclusivity provisions, have also been the subject of
recent litigation. As a result, the ultimate impact, implementation, and impact of the BPCIA is subject to significant uncertainty. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Other Healthcare Laws </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Pharmaceutical companies are subject to additional healthcare regulation and enforcement by the federal government and by
authorities in the states and foreign jurisdictions in which they conduct their business and may constrain the financial arrangements and relationships through which we research, as well as, sell, market and distribute any products for which we
obtain marketing approval. Such laws include, without limitation, federal and state <FONT STYLE="white-space:nowrap">anti-kickback,</FONT> fraud and abuse, false claims, data privacy and security and physician and other health care provider
transparency laws and regulations. If our significant operations are found to be in violation of any of such laws or any other governmental regulations that apply, they may be subject to penalties, including, without limitation, administrative,
civil and criminal penalties, damages, fines, disgorgement, the curtailment or restructuring of operations, integrity oversight and reporting obligations, exclusion from participation in federal and state healthcare programs and imprisonment. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Coverage and Reimbursement </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Sales of any product depend, in part, on the extent to which such product will be covered by
<FONT STYLE="white-space:nowrap">third-party</FONT> payors, such as federal, state, and foreign government healthcare programs, commercial insurance and managed healthcare organizations, and the level of reimbursement for such product by <FONT
STYLE="white-space:nowrap">third-party</FONT> payors. Decisions regarding the extent of coverage and amount of reimbursement to be provided are made on a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">plan-by-plan</FONT></FONT>
basis. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">209 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
These <FONT STYLE="white-space:nowrap">third-party</FONT> payors are increasingly reducing reimbursements for medical products, drugs and services. In addition, the U.S. government, state
legislatures and foreign governments have continued implementing <FONT STYLE="white-space:nowrap">cost-containment</FONT> programs, including price controls, restrictions on coverage and reimbursement and requirements for substitution of generic
products. Adoption of price controls and <FONT STYLE="white-space:nowrap">cost-containment</FONT> measures, and adoption of more restrictive policies in jurisdictions with existing controls and measures, could further limit sales of any product.
Decreases in <FONT STYLE="white-space:nowrap">third-party</FONT> reimbursement for any product or a decision by a <FONT STYLE="white-space:nowrap">third-party</FONT> payor not to cover a product could reduce physician usage and patient demand for
the product and also have a material adverse effect on sales. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Healthcare Reform </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In March 2010, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act,
each as amended, collectively known as the ACA, was enacted, which substantially changed the way healthcare is financed by both governmental and private insurers, and significantly affected the pharmaceutical industry. The ACA contains a number of
provisions, including those governing enrollment in federal healthcare programs, reimbursement adjustments and changes to fraud and abuse laws. For example, the ACA: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">increased the minimum level of Medicaid rebates payable by manufacturers of brand name drugs from 15.1% to
23.1% of the average manufacturer price; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">required collection of rebates for drugs paid by Medicaid managed care organizations; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">required manufacturers to participate in a coverage gap discount program, under which they must agree to offer
70&nbsp;percent <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">point-of-sale</FONT></FONT> discounts off negotiated prices of applicable brand drugs to eligible beneficiaries during their coverage gap period, as a condition for
the manufacturer&#146;s outpatient drugs to be covered under Medicare Part D; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">imposed a <FONT STYLE="white-space:nowrap">non-deductible</FONT> annual fee on pharmaceutical manufacturers or
importers who sell &#147;branded prescription drugs&#148; to specified federal government programs. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Since its enactment, there have been judicial and Congressional challenges to certain aspects of the ACA, and we expect there
will be additional challenges and amendments to the ACA in the future. For example, on March&nbsp;2, 2020 the United States Supreme Court granted the petitions for writs of certiorari to review the U.S. Court of Appeals for the 5th Circuit ruling
that the individual mandate was unconstitutional and to determine the constitutionality of the ACA in its entirety. It is uncertain when the Supreme Court will rule on this case. Other legislative changes have been proposed and adopted since the ACA
was enacted, including aggregate reductions of Medicare payments to providers of 2% per fiscal year, which was temporarily suspended from May&nbsp;1, 2020 through March&nbsp;31, 2021 due to the COVID-19 pandemic, and reduced payments to several
types of Medicare providers. Moreover, there has recently been heightened governmental scrutiny over the manner in which manufacturers set prices for their marketed products, which has resulted in several Congressional inquiries, proposed and
enacted legislation and executive orders issued by the President designed to, among other things, bring more transparency to product pricing, review the relationship between pricing and manufacturer patient programs, and reform government program
reimbursement methodologies for drug products. It is also possible that additional governmental action is taken in response to the COVID-19 pandemic. Individual states in the United States have also become increasingly active in implementing
regulations designed to control pharmaceutical product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases,
designed to encourage importation from other countries and bulk purchasing. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Facilities </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Washington </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our corporate headquarters are located in Seattle, Washington, where we lease approximately 25,898 square feet of office and
laboratory space pursuant to a lease agreement which was executed in November 2018 and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">210 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
expires in December&nbsp;2026. We also lease approximately 22,188 square feet of space which we intend to build out into laboratory space, pursuant to a sublease agreement which commenced in
September 2020 and expires in April 2028. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>California </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We occupy approximately 66,075 square feet of research and development, laboratory, and office space in South San Francisco,
California, pursuant to a lease agreement which commenced in November 2018 for 32,978 square feet and was amended to include an additional 33,097 of square feet in December 2019, and expires in April 2030. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Massachusetts </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We lease approximately 24,386 square feet of research and development, laboratory, and office space pursuant to the lease
agreement executed in September 2018 and expiring in June 2027, and sublease an additional 31,563 square feet of similar space in an adjacent building in Cambridge, Massachusetts pursuant to a lease agreement executed in January 2020 and expiring in
February 2028. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We believe that our existing facilities are sufficient for our near-term needs but expect to need
additional space as we grow. We believe that suitable additional alternative spaces will be available in the future on commercially reasonable terms, if required. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Employees and Human Capital Resources </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As of September&nbsp;30, 2020, we had 240 employees, 186 of whom were primarily engaged in research and development activities.
A total of 152 employees have an advanced degree. None of our employees are represented by a labor union or party to a collective bargaining agreement. We consider our relationship with our employees to be good. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our human capital resources objectives include, as applicable, identifying, recruiting, retaining, incentivizing and
integrating our existing and additional employees. The principal purposes of our equity incentive plans are to attract, retain and motivate selected employees, consultants and directors through the granting of stock-based compensation awards and
cash-based performance bonus awards. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Research and Development </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Total research and development expenses were $9.0&nbsp;million for the period of July&nbsp;13, 2018 (inception) through
December&nbsp;31, 2018, $119.4&nbsp;million for the year ended December&nbsp;31, 2019, and $153.8&nbsp;million for the nine months ended September&nbsp;30, 2020. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Legal Proceedings </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We are
not currently a party to any material legal proceedings. From time to time, we may, however, in the ordinary course of business face various claims brought by third parties, and we may, from time to time, make claims or take legal actions to assert
our rights, including intellectual property rights as well as claims relating to employment matters and the safety or efficacy of our products. Any of these claims could subject us to costly litigation, and, while we generally believe that we have
adequate insurance to cover many different types of liabilities, our insurance carriers may deny coverage, may be inadequately capitalized to pay on valid claims, or our policy limits may be inadequate to fully satisfy any damage awards or
settlements. If this were to happen, the payment of any such awards could have a material adverse effect on our operations, cash flows and financial position. Additionally, any such claims, whether or not successful, could damage our reputation and
business. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">211 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc60414_12"></A>MANAGEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Executive Officers, Directors, and Significant Employees </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following table sets forth information regarding our executive officers, directors, and significant employees as of
December 31, 2020: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="37%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="58%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Executive Officers</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Age</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Position</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Steven D. Harr, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">President, Chief Executive Officer, and Director</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard Mulligan, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Head of SanaX and Executive Vice-Chairman</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Christian Hordo</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">38</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Senior Vice President, Chief Business Officer</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nathan Hardy</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">45</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Senior Vice President, Chief Financial Officer</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James J. MacDonald</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Executive Vice President, General Counsel, and Corporate&nbsp;Secretary</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sunil Agarwal, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">51</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Executive Vice President, Head of Development and Chief Medical Officer</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="7"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" COLSPAN="7" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B><FONT STYLE="white-space:nowrap">Non-Employee</FONT>
Directors</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joshua H. Bilenker, M.D.<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">49</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hans Bishop<SUP STYLE="font-size:85%; vertical-align:top">(1)(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">56</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chairman of the Board</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Douglas Cole, M.D.<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert Nelsen<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alise S. Reicin, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michelle Seitz, CFA<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top">55</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Geoffrey von Maltzahn, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mary Agnes (Maggie)
Wilderotter<SUP STYLE="font-size:85%; vertical-align:top">(1)(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Patrick Yang, Ph.D.<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">72</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="7"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" COLSPAN="7" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Significant Employees</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robin Andrulevich</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Executive Vice President, Chief People Officer</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Terry Fry, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Senior Vice President, Head of T Cell Therapeutics</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Steven Goldman, M.D., Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Senior Vice President, Head of CNS Therapy</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stacey Ma, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Executive Vice President, Head of Technical Operations</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chuck Murry, M.D., Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Senior Vice President, Head of Cardiometabolic Cell Therapy</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Ed Rebar, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Senior Vice President, Chief Technology Officer</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sonja Schrepfer, M.D., Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Senior Vice President, Head of Hypoimmune Platform</P></TD></TR>
</TABLE>  <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">Member of the audit committee </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">Member of the compensation committee </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">Member of the nominating and corporate governance committee </P></TD></TR></TABLE>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Executive Officers </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Steven D. Harr, M.D.</I></B> has served as our President and Chief Executive Officer since September 2018 and has served
as a member of our board of directors (Board) since October 2018. Dr.&nbsp;Harr was Chief Financial Officer and Head of Corporate Development at Juno Therapeutics, Inc. (Juno), a biopharmaceutical company developing cancer immunotherapies, from
April 2014 until its acquisition by Celgene in March 2018. At Juno he was responsible for the overall financial and operational strategy of the company. Prior to Juno, Dr.&nbsp;Harr was Managing Director and Head of Biotechnology Investment Banking
at Morgan Stanley, a public multinational investment bank and financial services company, from May 2010 until April 2014, and prior to his investment banking role was the Lead Biotech Research Analyst and
<FONT STYLE="white-space:nowrap">Co-head</FONT> of Global Healthcare Research. Dr.&nbsp;Harr was a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">212 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
member of the board of directors of Loxo Oncology, a biopharmaceutical company, from November 2016 until its acquisition by Eli Lilly in February 2019. Dr.&nbsp;Harr was also a <FONT
STYLE="white-space:nowrap">co-founder</FONT> and member of the board of directors of JW Therapeutics, a cell therapy company in China, from February 2016 to June 2018. Dr.&nbsp;Harr has served on the board of Repertoire Immune Medicines, a
biotechnology company, since March 2020. Dr.&nbsp;Harr obtained a B.A. in Economics from the College of the Holy Cross in 1993 and an M.D. from The Johns Hopkins University School of Medicine in 1998. Dr.&nbsp;Harr was a resident in internal
medicine at the University of California, San Francisco from 1998 to 2000. We believe Dr.&nbsp;Harr is qualified to serve on our Board because of his extensive management and leadership experience with biopharmaceutical and life sciences companies.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Richard Mulligan, Ph.D.</I></B> has served as the Head of SanaX and Executive Vice-Chairman of our Board of
Directors since November 2018. Dr.&nbsp;Mulligan is currently the Mallinckrodt Professor of Genetics, Emeritus, at Harvard Medical School, and has been Visiting Scientist at the Massachusetts Institute of Technology since March 2017. Dr. Mulligan
currently serves on the board of directors of Biogen Inc., a public biotechnology company. From 1996-2013, Dr Mulligan served as the Mallinckrodt Professor of Genetics at Harvard and Director of the Harvard Gene Therapy Initiative. Prior to that, he
was Professor of Molecular Biology at the Massachusetts Institute of Technology, and a member of the Whitehead Institute for Biomedical Research. From May 2013 to December 2016, Dr.&nbsp;Mulligan was Founding Partner and Senior Managing Director of
Sarissa Capital Management LP, a registered investment advisor, and from March 2017 to October 2018 he served as Portfolio Manager at Icahn Capital LP. We believe Dr.&nbsp;Mulligan is qualified to serve on our Board because of his extensive
experience in the biotechnology and life sciences industries and his substantial academic experience. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Christian
Hordo</I></B> has served as our Senior Vice President, Chief Business Officer since October 2018. Prior to Sana, Mr.&nbsp;Hordo served Juno as Vice President, Myeloma Program Lead from January 2017 to October 2018 and before that as Vice President,
Head of Business Development from March 2015 to April 2018. At Juno Mr.&nbsp;Hordo built a team and led negotiations on multiple successfully executed transactions, including the broad strategic collaboration with Celgene. Prior to Juno,
Mr.&nbsp;Hordo served in various roles at Genentech, most recently as Project Team Leader from December 2013 to February 2015. Christian obtained his M.B.A. from Harvard Business School, graduating with high distinction as a Baker Scholar, a M.Sc.
in medical genetics and microbiology from the University of Toronto, and a B.S. in psychology at McGill University. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Sunil Agarwal, M.D.</I></B> is a co-founder of Sana and has served as our Executive Vice President and Head of
Development and Chief Medical Officer since July 2018. Dr. Agarwal is responsible for the overall strategy and execution of our pipeline, building Sana&#146;s development capabilities and helping to define and execute the overall corporate strategy.
Prior to Sana, Dr. Agarwal was the President of Research and Development at Juno from April 2017 to May 2018, where he was responsible for <B></B>the overall research and development strategy and execution. Prior to Juno, Dr. Agarwal served as
partner at Sofinnova Ventures from August 2016 to April 2017. Dr. Agarwal also worked as the Chief Medical Officer and Executive Vice President of Ultragenyx Pharmaceutical Inc., a public biopharmaceutical company, from July 2014 to August 2016,
where he was responsible for managing the company&#146;s clinical development and operations, regulatory affairs, biometrics, pharmacovigilance, medical affairs, pharmacology, and toxicology functions. Dr. Agarwal also served in various leadership
roles at Genentech, Inc. (acquired by Roche Holdings, Inc.) from 2003 to 2014, including Senior Vice President and Global Head of Clinical Development for ophthalmology, metabolism, neurosciences, immunology, and infectious diseases. Dr. Agarwal
currently serves on the board of directors for Calithera Biosciences, Inc., a public biotechnology company, and previously served on the board of MyoKardia, Inc., a public biopharmaceutical company. Dr. Agarwal completed his residency at
Children&#146;s National Medical Center (CNMC), Washington, D.C., and practiced in the CNMC Pediatric Emergency Department. He obtained a B.S. in neurobiology from Cornell University and an M.D. from Tufts University School of Medicine. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Nathan Hardy</I></B> has served as our Senior Vice President, Chief Financial Officer since September 2018. From August
2017 to June 2018, Mr.&nbsp;Hardy served as the Vice President of Finance at Juno where he led the Business, Financial Planning and Treasury organizations. Mr.&nbsp;Hardy worked at Amgen Inc., a biopharmaceutical company, from February 2007 to
August 2017, and served in a variety of senior finance and operations leadership positions, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">213 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
culminating as the Executive Director and Head of Corporate Finance. At Juno and Amgen, Mr.&nbsp;Hardy led resource allocation activities across the organizations, helped drive large-scale
business transformation at Amgen, and was part of various acquisitions and divestitures. Prior to Amgen, Mr.&nbsp;Hardy held various finance positions at General Electric Co. and Sprint Corporation, a public telecommunications company.
Mr.&nbsp;Hardy obtained a B.S. in finance from the University of Utah and an M.B.A. from the University of Notre Dame. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>James J. MacDonald</I></B> has served as our Executive Vice President, General Counsel, and Corporate Secretary since
September 2018. Prior to Sana, Mr.&nbsp;MacDonald was Senior Vice President and Chief Intellectual Property Officer at Juno from March 2014 to May 2018, where he was responsible for all worldwide intellectual property activities, including strategy,
development, transactions, litigation and counseling. From March 2009 to March 2014, Mr.&nbsp;MacDonald held both legal and business roles at Tessera, Inc. (a subsidiary of Xperi Corporation) and its affiliates, a technology company, and most
recently was Executive Vice President of Intellectual Property&nbsp;&amp; Business Development, responsible for business development, licensing and litigation. Prior to Tessera, Mr.&nbsp;MacDonald held senior roles at BigBand Networks, a provider of
platforms for broadband multimedia services (acquired by ARRIS Group), and Tumbleweed Communications, a secure internet communication solutions company (acquired by Axway), practiced law at Wilson Sonsini Goodrich&nbsp;&amp; Rosati PC in Palo Alto,
California, and was a research and development engineer at The Procter&nbsp;&amp; Gamble Company. Mr.&nbsp;MacDonald obtained a J.D. from Vanderbilt University Law School and a B.S. in chemical engineering from Stanford University. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Joshua H. Bilenker, M.D.</I></B> has served as a member of our Board since December 2020. He has served as Chief
Executive Officer of Loxo Oncology at Lilly, a research and development group of Eli Lilly and Company, since December 2019 and served as founding Chief Executive Officer of Loxo Oncology, Inc. from July 2013 until the acquisition of Loxo Oncology
by Eli Lilly in February 2019. Prior to Loxo Oncology, Dr.&nbsp;Bilenker joined Aisling Capital LLC in April 2006, and has served as an Operating Partner since November 2013. Previously, Dr. Bilenker served as a medical officer in the Office of
Oncology Drug Products at the FDA from August 2004 to April 2006. Dr.&nbsp;Bilenker serves on the board of Gossamer Bio, Inc., a public biopharmaceutical company, and previously served on the board of directors of a number of public companies
including Loxo Oncology from July 2013 until the acquisition of Loxo Oncology by Eli Lilly, ViewRay, Inc. from January 2008 to June 2017, T2&nbsp;Biosystems, Inc. from August 2011 to January 2017 and Roka Bioscience, Inc. from January 2012 to March
2015. Dr.&nbsp;Bilenker formerly served as a board member of the NCCN Foundation and BioEnterprise. Dr. Bilenker obtained an M.D. from the Johns Hopkins School of Medicine and an A.B. in English from Princeton University. We believe Dr. Bilenker is
qualified to serve on our Board because of his extensive experience and service as a director or officer of, and as an investor in, public biopharmaceutical and life sciences companies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Hans E. Bishop </I></B>has served as a member of our Board since October 2018. Mr.&nbsp;Bishop has more than 30 years of
experience in the biotechnology industry and has served as the Chief Executive Officer of GRAIL, Inc., a healthcare company, since June 2019. Mr.&nbsp;Bishop founded Juno in July 2013 and served as President and Chief Executive Officer until the
company was acquired by Celgene in March 2018. Prior to Juno, Mr.&nbsp;Bishop served as Executive in Residence at Warburg Pincus, a multinational private equity firm. Earlier in his career, Mr.&nbsp;Bishop served as Executive Vice President and
Chief Operating Officer for Dendreon, Inc., a public biopharmaceutical company developing cancer immunotherapies. Prior to Dendreon Mr.&nbsp;Bishop served as President of Specialty Medicine at Bayer Healthcare, a multinational pharmaceutical and
life sciences company, and before that served as Senior Vice President of Global Commercial Operations at Chiron Corporation, a multinational biotechnology company, where he was also Vice President and General Manager of European Biopharmaceuticals.
He currently serves as a director of Agilent Technologies, a public instrumentation manufacturing company; Lyell Immunopharma, a cellular therapy company; and JW Therapeutics. Mr.&nbsp;Bishop obtained a B.A. in chemistry from Brunel University in
London. We believe Mr.&nbsp;Bishop is qualified to serve on our Board because of his extensive management experience with the pharmaceutical and biotechnology industries and his significant academic training. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">214 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Douglas Cole, M.D.</I></B> has served as a member of our Board since
April 2020. Dr. Cole joined Flagship Pioneering, which conceives, creates, resources and develops first-in-category life sciences companies, in 2001, and is currently a Managing Partner focused on life science investments. Dr. Cole currently serves
on the board of directors of Denali Therapeutics, Foghorn Therapeutics, Sigilon Therapeutics and a number of private companies. In the past five years, Dr. Cole served on the boards of directors of Quanterix Corporation and Editas Medicine. Dr. Cole
received his M.D. from the University of Pennsylvania School of Medicine and his B.A. in English from Dartmouth College. We believe Dr. Cole is qualified to sit on our board of directors given his substantial experience as an investor in emerging
biopharmaceutical and life sciences companies as well as his experience serving on the boards of directors of multiple public and private biopharmaceutical companies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Alise S. Reicin, M.D.</I></B> has served as a member of our Board since December 2020. Dr. Reicin served has served as
Chief Executive Officer and President of Tectonic Therapeutic, Inc., a biotechnology company, since August 2020. Prior to Tectonic Therapeutic, she served as President, Global Clinical Development at Celgene Corporation, a public pharmaceutical
company, from November 2018 to December 2019. Prior to Celgene, she served as Head of Global Clinical Development at EMD Serono, a pharmaceutical company, from May 2015 to October 2018 and prior to that served as Vice President, Program and Pipeline
Leadership, Oncology at Merck and Co., a public pharmaceutical company. Prior to Merck, she was a faculty member at Columbia Medical School and a physician and researcher at Columbia Presbyterian Hospital. Dr.&nbsp;Reicin serves on the board of
directors of Homology Medicines, Inc., a public clinical stage biopharmaceutical company. Dr.&nbsp;Reicin obtained an M.D. from Harvard Medical School and a B.A. in Biochemistry from Barnard College of Columbia University. We believe Dr. Reicin is
qualified to serve on our Board because of her extensive clinical expertise and leadership experience with biopharmaceutical companies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Michelle Seitz, CFA</I></B> has served as a member of our Board since December 2020. Ms. Seitz has served as Chairman
and Chief Executive Officer of Russell Investments, a global investment solutions provider, since September 2017, and as Chairman since January 2018. Previously, Ms. Seitz worked in various positions at William Blair, a global investment banking and
wealth management firm, from February 1996 to August 2017, most recently serving as the Chief Executive Officer of William Blair Investment Management, Chairman and President of William Blair Funds, and as a Board Member from June 2001 to August
2017. Ms.&nbsp;Seitz currently serves on the board of directors of the Washington Roundtable and on the Dean&#146;s Council of Kelley School of Business at Indiana University, and a member of Challenge Seattle, an alliance of chief executive
officers of multinational companies within the Seattle region. Ms.&nbsp;Seitz is a past director of the Financial Accounting Foundation, providing oversight of FASB and GASB. Ms.&nbsp;Seitz obtained a B.S. in accounting from the Indiana University
Kelley School of Business and her Chartered Financial Analyst designation in 1990. We believe Ms. Seitz is qualified to serve on our Board because of her extensive finance and industry experience and her experience serving boards of directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Geoffrey von Maltzahn, Ph.D.</I></B> is a co-founder of Sana Biotechnology and has served as a member of our Board since
February 2019. Dr. von Maltzahn is a General Partner at Flagship Pioneering focusing on innovation and company origination and has been with Flagship since November 2009. Dr. von Maltzahn led a Flagship Labs innovation team at Flagship Pioneering in
founding Cobalt Biomedicine, where he served as its CEO and a board member, until it merged with Sana Biotechnology in February 2019. Dr. von Maltzahn currently serves as CEO and director of Tessera Therapeutics and co-CEO of Generate Biomedicines.
Previously, Dr. von Maltzahn served as Kaleido&#146;s Chief Executive Officer from 2015 to 2017 and serves on the company&#146;s board of directors. Dr. von Maltzahn also serves as the Chief Innovation Officer and a director of Indigo Agriculture,
Inc., an agriculture biotechnology company he co-founded in 2013 as part of Flagship Pioneering&#146;s Flagship Labs innovation foundry. Dr. von Maltzahn was a co-founder of Seres Therapeutics, Inc. in 2010, and he served as Chief Technology Officer
at Seres until 2012. Dr. von Maltzahn was awarded a Ph.D. in biomedical engineering and medical physics from MIT, a M.S. in bioengineering from the University of California, San Diego, and an S.B. in chemical engineering from MIT. We believe Dr. von
Maltzahn is qualified to serve on our Board due to his extensive experience co-founding and leading numerous biotechnology companies. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">215 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Robert Nelsen</I></B> has served as a member of our Board since
October 2018. Mr.&nbsp;Nelsen has served as <FONT STYLE="white-space:nowrap">co-founder</FONT> and Managing Director of ARCH Venture Partners, a venture capital firm focused on early-stage technology companies, since 1994, and has played a
significant role in the early sourcing, financing and development of more than 30 biopharmaceutical companies. Mr. Nelsen currently serves on the board of directors of several public biotechnology and biopharmaceutical companies including Beam
Therapeutics, Denali Therapeutics Inc., Hua Medicine, Karuna Therapeutics, Unity Biotechnology, Inc., Vir Biotechnology and several private companies, including Apex Neuro, Brii Biosciences, Inc., Encoded Genomics, Gideon Health, GRAIL, Inc.,
Insitro, Lyell Immunopharma, Inc., Maze Therapeutics, Inc., Nutcracker Therapeutics, Inc., Prime Medicine, and SciNeuro Pharmaceuticals. Mr.&nbsp;Nelsen previously served on the board of directors of several public biotechnology and
biopharmaceutical companies including Adolor Corporation, Agios Pharmaceuticals, Bellerophon Therapeutics, Fate Therapeutics, Illumina, Inc., Juno, KYTHERA Biopharmaceuticals, Inc., NeurogesX, Inc., Sage Therapeutics, Sienna Biopharmaceuticals,
Inc., and Syros Pharmaceuticals. He also previously served as Trustee of the Fred Hutchinson Cancer Research Center, and as a director of the National Venture Capital Association. Mr.&nbsp;Nelsen obtained an M.B.A. from the University of Chicago
Booth School of Business and a B.S. with majors in economics and biology from the University of Puget Sound. We believe Mr.&nbsp;Nelsen is qualified to serve on our Board because of his venture capital and industry experience, his extensive
experience serving boards of directors of public biotechnology companies and his significant academic experience. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Mary Agnes (Maggie) Wilderotter</I></B> has served as a member of our Board since May 2020. Ms.&nbsp;Wilderotter has
served as the Chief Executive Officer and Chairman of the Grand Reserve Inn, a luxury resort and vineyard, since August 2016. From November 2004 to April 2016, Ms.&nbsp;Wilderotter served in a number of roles at Frontier Communications Corporation,
a public telecommunications company, including as Executive Chairman of the board of directors from April 2015 to April 2016, Chairman and Chief Executive Officer from January 2006 to April 2015, and President, Chief Executive Officer and director
from 2004 to 2006. Ms.&nbsp;Wilderotter currently serves on the board of directors of Lyft, Inc., a public multinational ridesharing company; Costco Wholesale Corporation, a public wholesale retailer; Hewlett Packard Enterprise Company, a public
enterprise information technology company; and DocuSign, Inc., a public digital transaction management services company where she serves as Chairman. Ms.&nbsp;Wilderotter has served on many public company boards of directors, and in the past five
years, was a director of Cadence Design Systems, Inc., an electronic design automation software and engineering services company; Xerox Corporation, a document management technology solutions company; DreamWorks Animation SKG, Inc., an entertainment
company; The Procter&nbsp;&amp; Gamble Company, a consumer goods company; DXC Technology Company, an IT services company; and Juno. Ms.&nbsp;Wilderotter obtained a B.A. in Economics from the College of the Holy Cross and two honorary degrees from
Stevens Institute of Technology and the University of Rochester. We believe Ms.&nbsp;Wilderotter is qualified to serve on our Board because of her extensive leadership experience in technology and serving as a director of public companies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Patrick Y. Yang, Ph.D.</I></B> has served as a member of our Board since October 2018. Dr.&nbsp;Yang served as Executive
Vice President and Special Advisor of Juno from September 2017 to January 2019. Since 2013, Dr. Yang has been a biotechnology and biopharmaceutical industry consultant. From January 2010 to March 2013, Dr.&nbsp;Yang served as Executive Vice
President and Global Head of Technical Operations for F. <FONT STYLE="white-space:nowrap">Hoffmann-La</FONT> Roche Ltd. (Roche), a healthcare company, where he was responsible for the company&#146;s pharmaceutical process development, engineering,
quality, technical regulatory, supply chain, and all manufacturing plants. Before joining Roche, Dr.&nbsp;Yang worked for Genentech Inc., a biotechnology company; Merck&nbsp;&amp; Co., a public pharmaceutical company; General Electric Co., a public
industrial company; and Life Systems, Inc., a life science research and development company; during which time he developed significant experience with pharmaceuticals and biotechnology manufacturing, engineering, technology, and supply chain
management. Dr.&nbsp;Yang served on the board of directors of Tesoro Corporation, a public independent petroleum refining and marketing company, from December 2010 to October 2018. He currently serves on the board of Amyris, Inc., a public
biotechnology company; Codexis Inc., a public biotechnology company; Antheia, Inc., a synthetic biology company; National Resilience, Inc., a biomanufacturing company; and PharmaEssentia, a biopharmaceutical company, and serves as Chairman at
AltruBio, Inc., a biopharmaceutical company; Acepodia, a public biotechnology company; and Archigen Biotech, a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">216 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
biopharmaceutical company. Dr.&nbsp;Yang obtained a B.S. in Engineering from the National Chiaotung University in Taiwan, a M.Sc. in Electrical Engineering from the University of Cincinnati and a
Ph.D. in engineering from the Ohio State University. We believe Dr.&nbsp;Yang is qualified to serve on our Board because of his extensive background and expertise in the biotechnology industry and his previous and current experience serving as a
director of various public companies. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Significant Employees </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Robin Andrulevich </I></B>has served as our Executive Vice President and Chief People Officer since September 2018.
Ms.&nbsp;Andrulevich is also a Founder of 9Lives HR Consulting, which provides consulting services, and has served as a Principal Consultant for the company since November 2011. Prior to Sana, Ms.&nbsp;Andrulevich worked at Juno as Senior Vice
President, People from October 2014 to April 2018. Ms.&nbsp;Andrulevich currently serves as a Director of Life Science Washington, a <FONT STYLE="white-space:nowrap">non-profit</FONT> association providing support to life science entrepreneurs and <FONT
STYLE="white-space:nowrap">start-up</FONT> companies, and has held this role since December 2017. Ms.&nbsp;Andrulevich studied human rights at Columbia University and obtained a B.A. in communications science from the University of Connecticut. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Terry Fry, M.D. </I></B>has served as our Senior Vice President, Head of T Cell Therapeutics since August 2020. From
February 2018 to August 2020 Dr.&nbsp;Fry was Professor of Pediatrics, Hematology and Immunology at the University of Colorado Anschutz Medical Campus and held the Robert and Kathleen Clark Endowed Chair in Pediatric Cancer Therapeutics at the
Children&#146;s Hospital in Colorado, where he was responsible for building the cell therapy program and CAR T translational research lab. From August 2010 to January 2018 Dr.&nbsp;Fry was the Head of the Hematologic Malignancies Section in the
Pediatric Oncology Branch of the National Cancer Institutes. Dr.&nbsp;Fry obtained an M.D. from Georgetown University and a B.A. in biology at Colgate University. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Steven Goldman, M.D., Ph.D. </I></B>has served as our Senior Vice President, Head of CNS Therapy since October 2020.
Dr.&nbsp;Goldman has also served as Professor of Neurology since September 2003, Chairman of the Department of Neurology between September 2008 and August 2012, and Chief of the Division of Cell and Gene Therapy since September 2003 at the
University of Rochester Medical Center. Prior to that he was the Nathan Cummings Professor of Neurology at Cornell University Medical Center, where he was employed from July 1988 through August 2003. Additionally, he has served as <FONT
STYLE="white-space:nowrap">Co-Director</FONT> of Rochester&#146;s Center for Translational Neuromedicine since July 2007; this center is a joint enterprise with the University of Copenhagen Faculty of Health and Medical Sciences, whose faculty he
joined part-time as a Professor of Neuroscience and Neurology in March 2014. Previously, Dr.&nbsp;Goldman served as a voting member of the U.S. Food and Drug Administration&#146;s (FDA&#146;s) Cellular, Tissue, and Gene Therapy Advisory Committee
from July 2010 to June 2014. Dr.&nbsp;Goldman completed his internship in internal medicine and residency in neurology at New York Hospital-Cornell Medical Center and the Memorial Sloan-Kettering Cancer Center in June 1988. Dr.&nbsp;Goldman obtained
a Ph.D. in cellular neurobiology from Rockefeller University, an M.D. from Cornell University, and a B.A. in Biology and Psychology from the University of Pennsylvania. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Stacey Ma, Ph.D.</I></B> has served as our Executive Vice President and Head of Technical Operations since March 2019.
Prior to Sana, Dr.&nbsp;Ma held various roles at Genentech, Inc. / E. Hoffman-La Roche Ltd. from July 1996 to March 2019. Most recently, Dr.&nbsp;Ma worked as the Global Head of Pharma Technical Innovation&nbsp;&amp; MSAT from February 2018 to March
2019 and as Global Head of IMP Quality, Pharma Technical Development from May 2015 to February 2018. Dr.&nbsp;Ma is an American Institute for Medical and Biological Engineering (AIMBE) fellow and has
<FONT STYLE="white-space:nowrap">co-chaired</FONT> many international scientific conferences and workshops related to CMC development strategies, including several <FONT STYLE="white-space:nowrap">co-sponsored</FONT> by the FDA, European Medicines
Agency and Chinese Food and Drug Administration. Dr.&nbsp;Ma obtained a B.S. in chemical engineering from the University of Minnesota and a Ph.D., M.Phil. and M.S. in chemical engineering from Yale University. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Chuck Murry, M.D., Ph.D.</I></B> has served as our Senior Vice President of Cardiac Cell Therapy Research since November
2019 and as our Head of Cardiometabolic Cell Therapy since May 2020. Dr.&nbsp;Murry joined the University of Washington faculty in 1996 and has worked as a professor since 2004. He founded the University
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">217 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
of Washington&#146;s Center for Cardiovascular Biology in 2005 and <FONT STYLE="white-space:nowrap">co-founded</FONT> the Institute for Stem Cell and Regenerative Medicine in 2006. Dr.&nbsp;Murry
is an elected fellow of the American Association for the Advancement of Science, the Association of American Physicians, the American Institute for Medical and Biological Engineering, and the Washington State Academy of Sciences. Dr.&nbsp;Murry is
currently a member of the Board of Directors and serves on the Clinical Translation Committee of the International Society for Stem Cell Research. Dr.&nbsp;Murry obtained a B.S. in chemistry from the University of North Dakota, and an M.D. and a
Ph.D. in Medicine and Pathology from Duke University. Dr.&nbsp;Murry completed his residency in diagnostic and experimental pathology at the University of Washington. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Edward Rebar, Ph.D.</I></B> has served as our Senior Vice President and Chief Technology Officer since March 2020.
Dr.&nbsp;Rebar worked at Sangamo Therapeutics, Inc., a public biotechnology company, from July 1998 to April 2020, to develop the company&#146;s zinc finger protein platform for therapeutic applications in genome editing, gene regulation and cell
engineer. Dr.&nbsp;Rebar held roles of increasing responsibility at Sangamo Therapeutics, Inc., including most recently as Chief Technology Officer. Dr.&nbsp;Rebar was a post-doctoral fellow at the University of California, Berkeley, from 1997 to
1998. Dr.&nbsp;Rebar obtained a B.S. in biochemistry from Rutgers University and a Ph.D. in biophysics and structural biology from MIT. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B><I>Sonja Schrepfer, M.D., Ph.D. </I></B>has served as our Senior Vice President, Head of the Hypoimmune Platform since
February 2019. Dr.&nbsp;Schrepfer has been a professor at the University of California, San Francisco (UCSF) in the Department of Surgery since December 2015. Dr. Schrepfer is also currently advisor of the Central Ethics Commission for Stem Cell
Research in Germany. From October 2017 to October 2018 she served as founder of Phoenics Inc., a startup company on immune editing. In February 2009, Dr. Schrepfer became the youngest Heisenberg Professor in Medicine in Germany and led the Stem Cell
Immunology program at the University of Hamburg until her recruitment to UCSF in 2015. Previously, from January 2007 to February 2009, she was Faculty at Stanford University School of Medicine, where she founded the Transplant and Stem Cell
Immunobiology laboratory. Dr.&nbsp;Schrepfer obtained an M.D., a Doctoral Thesis from the University of Wuerzburg, received cardiac and transplant surgery training from the Universities Munich and Hamburg, a Ph.D. in immunology from the University
of Hamburg, and received Postdoctoral training from Stanford University. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Family Relationships </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">There are no family relationships among any of our executive officers or directors. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board Structure and Composition </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Director
Independence </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our board of directors currently consists of eleven members. Our board of directors has determined
that all of our directors, other than Drs. Harr and Mulligan, qualify as independent directors in accordance with the Nasdaq Stock Market LLC (Nasdaq), Marketplace Rules, or the Nasdaq Listing Rules. Drs. Harr and Mulligan are not considered
independent by virtue of their positions as executive officers of the Company. Under the Nasdaq Listing Rules, the definition of independence includes a series of objective tests, such as that the director is not, and has not been for at least three
years, one of our employees and that neither the director nor any of his or her family members has engaged in various types of business dealings with us. In addition, as required by the Nasdaq Listing Rules, our board of directors has made a
subjective determination as to each independent director that no relationships exists that, in the opinion of our board of directors, would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. In
making these determinations, our board of directors reviewed and discussed information provided by the directors and us with regard to each director&#146;s relationships as they may relate to us and our management. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Classified Board of Directors </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In accordance with our amended and restated certificate of incorporation, which will be effective immediately prior to the
completion of this offering, our board of directors will be divided into three classes with </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">218 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
staggered <FONT STYLE="white-space:nowrap">three-year</FONT> terms. At each annual general meeting of stockholders, the successors to directors whose terms then expire will be elected to serve
from the time of election and qualification until the third annual meeting following election. Our directors will be divided among the three classes as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Class&nbsp;I directors will be Drs. Cole, Harr and Yang and Ms. Seitz, and their terms will expire at the
annual meeting of stockholders to be held in 2022; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Class&nbsp;II directors will be Messrs. Bishop and Mr. Nelsen, Drs. Reicin and von Maltzahn, and their
terms will expire at the annual meeting of stockholders to be held in 2023; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The Class&nbsp;III directors will be Drs. Bilenker and Mulligan and Ms. Wilderotter, and their terms will
expire at the annual meeting of stockholders to be held in 2024. </P></TD></TR></TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We expect that any additional
directorships resulting from an increase in the number of directors will be distributed among the three classes so that, as nearly as possible, each class will consist <FONT STYLE="white-space:nowrap">of&nbsp;one-third&nbsp;of</FONT> the directors.
The division of our board of directors into three classes with staggered <FONT STYLE="white-space:nowrap">three-year</FONT> terms may delay or prevent a change of our management or a change in control. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Voting Arrangements </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The election of the members of our board of directors is currently governed by the amended and restated voting agreement that
we entered into with certain holders of our common stock and convertible preferred stock and the related provisions of our amended and restated certificate of incorporation. Pursuant to our amended and restated voting agreement and amended and
restated certificate of incorporation, our current directors were elected as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Mr.&nbsp;Nelsen and Ms.&nbsp;Wilderotter were elected as the designees of ARCH Venture Partners;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Drs. Cole and von Maltzahn were elected as the designees of Flagship Pioneering; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Mr.&nbsp;Bishop was elected and designated by the holders of a majority of our common stock;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Dr.&nbsp;Harr was elected and designated as our then serving and current Chief Executive Officer; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Ms.&nbsp;Seitz was elected and designated by the Board, which designation rights had been delegated to the
Board by F-Prime; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Drs. Bilenker, Mulligan, Reicin and Yang were elected and designated by the holders of a majority of our
common stock and convertible preferred stock. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our amended and restated voting agreement will terminate
and the provisions of our current amended and restated certificate of incorporation by which our directors were elected will be amended and restated in connection with this offering. After this offering, the number of directors will be fixed by our
board of directors, subject to the terms of our amended and restated certificate of incorporation and amended and restated bylaws that will become effective immediately prior to the completion of this offering. Each of our current directors will
continue to serve as a director until the election and qualification of his or her successor, or until his or her earlier death, resignation or removal. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Leadership Structure of the Board </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our amended and restated bylaws and corporate governance guidelines provide our board of directors with flexibility to combine
or separate the positions of Chairman of the board of directors and Chief Executive Officer. Mr.&nbsp;Bishop currently serves as the Chairman of the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our board of directors has concluded that our current leadership structure is appropriate at this time. However, our board of
directors will continue to periodically review our leadership structure and may make such changes in the future as it deems appropriate. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">219 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Role of Board in Risk Oversight Process </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Risk assessment and oversight are an integral part of our governance and management processes. Our board of directors
encourages management to promote a culture that incorporates risk management into our corporate strategy <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">and&nbsp;day-to-day&nbsp;business</FONT></FONT> operations. Management
discusses strategic and operational risks at regular management meetings, and conducts specific strategic planning and review sessions during the year that include a focused discussion and analysis of the risks facing us. Throughout the year, senior
management reviews these risks with the board of directors at regular board meetings as part of management presentations that focus on particular business functions, operations or strategies, and presents the steps taken by management to mitigate or
eliminate such risks. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our board of directors does not have a standing risk management committee, but rather administers
this oversight function directly through our board of directors as a whole, as well as through various standing committees of our board of directors that address risks inherent in their respective areas of oversight. While our board of directors is
responsible for monitoring and assessing strategic risk exposure, our audit committee is responsible for overseeing our major financial risk exposures and the steps our management has taken to monitor and control these exposures. The audit committee
also approves or disapproves any related person transactions. Our nominating and corporate governance committee monitors the effectiveness of our corporate governance guidelines. Our compensation committee assesses and monitors whether any of our
compensation policies and programs has the potential to encourage excessive <FONT STYLE="white-space:nowrap">risk-taking.</FONT> </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board Committees
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our board of directors has three standing committees: the audit committee; the compensation committee; and the
nominating and corporate governance committee. Each committee is governed by a charter that will be available on our website following completion of this offering. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Audit Committee </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Effective as of the date the registration statement of which this prospectus forms a part is declared effective by the SEC, the
members of our audit committee will consist of Mary Agnes (Maggie) Wilderotter, Hans Bishop, and Michelle Seitz. Mary Agnes (Maggie) Wilderotter will be the chairperson of our audit committee. The composition of our audit committee meets the
requirements for independence under the current Nasdaq listing standards and Rule <FONT STYLE="white-space:nowrap">10A-3</FONT> of the Exchange Act. Each member of our audit committee is financially literate. In addition, our board of directors has
determined that Mary Agnes (Maggie) Wilderotter is an &#147;audit committee financial expert&#148; within the meaning of the SEC rules. This designation does not impose on such directors any duties, obligations, or liabilities that are greater than
are generally imposed on members of our audit committee and our board of directors. Our audit committee is directly responsible for, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">appointing, retaining, compensating, and overseeing the work of our independent registered public accounting
firm; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">discussing with our independent registered public accounting firm their objectivity and independence;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing with our independent registered public accounting firm the scope and results of the firm&#146;s
annual audit of our financial statements; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">overseeing the financial reporting process and discussing with management and our independent registered
public accounting firm the financial statements that we will file with the SEC; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">pre-approving</FONT> all audit and permissible
<FONT STYLE="white-space:nowrap">non-audit</FONT> services to be performed by our independent registered public accounting firm; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing policies related to risk assessment and risk management; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing our accounting and financial reporting policies; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">220 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing, overseeing, approving, or disapproving any <FONT STYLE="white-space:nowrap">related-person</FONT>
transactions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing with our management the scope and results of management&#146;s evaluation of our disclosure controls
and procedures and management&#146;s assessment of our internal control over financial reporting, including the related certifications to be included in the periodic reports we will file with the SEC; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establishing procedures for the confidential anonymous submission of concerns regarding questionable
accounting, internal controls. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Compensation Committee </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Effective as of the date the registration statement of which this prospectus forms a part is declared effective by the SEC, the
members of our compensation committee will consist of Hans Bishop, Douglas Cole, M.D., and Robert Nelsen. Hans Bishop will be the chairperson of our compensation committee. Each of Hans Bishop, Douglas Cole, M.D., and Robert Nelsen is a <FONT
STYLE="white-space:nowrap">non-employee</FONT> director, as defined by Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> promulgated under the Exchange Act and meets the requirements for independence under the current Nasdaq listing standard. Our
compensation committee is responsible for, among other things: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and making recommendations to our board of directors regarding the compensation of executive
officers; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">authority to act as an administrator of our equity incentive plans; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and making recommendations to our board of directors with respect to, incentive compensation and
equity plans; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and recommending that our board of directors approve the compensation for our <FONT
STYLE="white-space:nowrap">non-employee</FONT> board members; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establishing and reviewing general policies relating to compensation and benefits of our employees.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Nominating and Corporate Governance Committee </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Effective as of the date the registration statement of which this prospectus forms a part is declared effective by the SEC, the
members of our nominating and corporate governance committee will consist of Mary Agnes (Maggie) Wilderotter, Joshua Bilenker and Patrick Yang. Mary Agnes (Maggie Wilderotter) will be the chairperson of our nominating and corporate governance
committee. Mary Agnes (Maggie) Wilderotter, Joshua Bilenker and Patrick Yang meet the requirements for independence under the current Nasdaq listing standards. Our nominating and corporate governance committee is responsible for, among other things:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">identifying and recommending candidates for membership on our board of directors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">developing and recommending our corporate governance guidelines and policies; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and recommending changes to the leadership structure of our board of directors;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">overseeing periodic self-evaluations of our board of directors and its committees; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">making recommendations to our board of directors regarding corporate governance matters.
</P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Code of Business Conduct and Ethics </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In connection with this offering, our board of directors will adopt a code of business conduct and ethics that applies to all
of our employees, officers, and directors, including our Chief Executive Officer, Chief Financial Officer, and other executive and senior financial officers. Upon completion of this offering, the full text of our code of business conduct and ethics
will be posted on the investor relations section of our website. We intend to disclose future amendments to our code of business conduct and ethics, or any waivers of such code, on our website or in public filings. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">221 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Compensation Committee Interlocks and Insider Participation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">None of our executive officers has served as a member of a compensation committee (or if no committee performs that function,
the board of directors) of any other entity that has an executive officer serving as a member of our board of directors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">222 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc60414_13"></A>EXECUTIVE AND DIRECTOR COMPENSATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This section discusses the material components of the executive compensation program for our named executive officers (NEOs)
who are named in the subsection titled &#147;&#151;2020 Summary Compensation Table.&#148; In 2020, our NEOs and their positions were as follows: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Steven D. Harr, M.D., <I>President and Chief Executive Officer</I>; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Richard Mulligan, Ph.D., <I>Executive Vice-Chairman and Head of SanaX</I>; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Christian Hordo, <I>Senior Vice President and Chief Business Officer</I>. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This discussion may contain <FONT STYLE="white-space:nowrap">forward-looking</FONT> statements that are based on our current
plans, considerations, expectations and determinations regarding future compensation programs. Actual compensation programs and policies that we implement following the completion of this offering may differ materially from the currently planned
programs summarized in this discussion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As an &#147;emerging growth company&#148; as defined in the JOBS Act, we are not
required to include a Compensation Discussion and Analysis section and have elected to comply with the scaled disclosure requirements applicable to emerging growth companies. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Summary Compensation Table </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following table sets forth information concerning the compensation awarded to or earned by our NEOs during our fiscal year
ended December&nbsp;31, 2020. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2020 SUMMARY COMPENSATION TABLE </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:9pt" ALIGN="center">


<TR>

<TD WIDTH="38%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name and Principal Position</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Salary<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Bonus<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock<BR>Awards<BR>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Awards<BR>($)<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Non-</FONT> Equity<BR>Incentive
Plan<BR>Compensation<BR>($)<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All Other<BR>Compensation<BR>($)<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total ($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Steven D. Harr, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">535,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,015,947</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,550,947</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">President and Chief Executive Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Richard Mulligan, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">418,674</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,144,357</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">337,780</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,900,811</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Executive Vice-Chairman and Head of
SanaX<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Christian Hordo</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">350,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,105,346</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,455,546</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:9pt; font-family:Times New Roman">Senior Vice President and Chief Business Officer</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">The amounts shown represent the grant date fair values of option awards granted in 2020 as computed in
accordance with Financial Accounting Standards Board (FASB) Accounting Standard Codification (ASC) Topic 718. See Note 13, Stock-based compensation to our condensed consolidated financial statements included elsewhere in this prospectus for a
discussion of the assumptions used in the calculation of these amounts. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">As of the date of this filing, annual performance-based cash bonus amounts for 2020 have not been finalized
by the board of directors. Annual bonuses are expected to be finalized by the board of directors in February 2021 based on the achievement of certain corporate performance objectives and individual performance will be determined in connection with
completing our financial statements for the year ended December 31, 2020 and will be disclosed in a subsequent filing under Form 8-K. Please see the descriptions of the annual performance bonuses paid to our named executive officers under &#147;2020
Bonuses&#148; below. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">Amount comprised of $337,780 of principal and interest accrued on a promissory note we forgave in November
2020. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">Dr. Mulligan served as a consultant prior to becoming employed as Head of SanaX in April 2020. Amount
reported in the salary column for Dr. Mulligan includes $124,443 earned while providing consulting services, in 2020. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Narrative to
Summary Compensation Table </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>2020 Salaries </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The named executive officers receive a base salary to compensate them for services rendered to our company. The base salary
payable to each named executive officer is intended to provide a fixed component of compensation reflecting the executive&#146;s skill set, experience, role and responsibilities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">223 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For 2020, Dr. Harr&#146;s annual base salary was $535,000 and Mr.
Hordo&#146;s annual base salary was $350,200. Until April 23, 2020, Dr. Mulligan served as a consultant and was paid a monthly retainer of $33,333. Our board of directors established Dr. Mulligan&#146;s annual base salary at $450,000 in connection
with his commencement of employment with us. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>2020 Bonuses </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We maintain an annual performance-based cash bonus program in which each of our named executive officers participated in 2020.
Each of our named executive officers&#146; target bonus is expressed as a percentage of base salary. The 2020 annual bonuses for Dr.&nbsp;Harr, Dr. Mulligan and Mr. Hordo were targeted at 50%, 40% and 35% of their respective annual base salaries,
pro-rated, in the case of Dr. Mulligan, for his partial year of employment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For 2020, our named executive officers were
eligible to earn annual cash bonuses based on the achievement of certain corporate performance objectives approved by our board of directors and its compensation committee, as well as individual performance for Dr. Mulligan and Mr. Hordo. Dr.
Harr&#146;s annual cash bonus is determined solely based on certain corporate performance objectives. In February 2021, our board of directors and its compensation committee will review and approve the achievement of our 2020 corporate goals. Based
on this level of achievement, and adjustments for individual 2020 performance for Dr. Mulligan and Mr. Hordo, the actual bonus payouts for our named executive officers will be determined by our board of directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Until April 23, 2020, Dr. Mulligan served as a consultant to us and was eligible to earn a discretionary fee of up to 40% of
his monthly retainer for services performed in 2019. In March 2020, we paid Dr. Mulligan $160,000 based on our board of director&#146;s assessment of Dr. Mulligan&#146;s service as a consultant. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Equity Compensation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have granted stock options to our employees, including our named executive officers, in order to attract and retain them, as
well as to align their interests with the interests of our stockholders. In order to provide a long-term incentive, these stock options generally vest over four years subject to continued service to the company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In January 2020, we granted to Dr. Harr and Mr. Hordo an option to purchase 590,000 and 137,500 shares of our common stock,
respectively, which vest as to 25% of the shares underlying the options on February 14, 2021 and as to 1/48th of the shares underlying the options monthly thereafter, subject to continued service. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In April 2020, in connection with his commencement of employment with us, we granted to Dr. Mulligan an option to purchase
112,500 shares of common stock, which vests as to 25% of the shares underlying the option on April 23, 2021 and as to 1/48th of the shares underlying the option monthly thereafter, subject to continued service. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In November 2020, we granted to Dr. Harr, Dr. Mulligan and Mr. Hordo an option to purchase 1,118,723, 200,000 and 200,000
shares of our common stock, respectively. Dr. Mulligan and Mr. Hordo&#146;s options vest as to 25% of the shares underlying the options on February 15, 2022 and as to 1/48th of the shares underlying the options monthly thereafter, subject to
continued service. Dr. Harr&#146;s stock option vests (a)&nbsp;with respect to 50% of the shares underlying the award over a four year period with 25% vesting on February&nbsp;15, 2022 and as to the remaining portion on a monthly basis thereafter,
subject to continued service through the applicable vesting date and (b) with respect to the remaining 50% of the shares underlying the award over a four year period commencing with 25% vesting on the later of the satisfaction of certain performance
conditions or February&nbsp;15, 2022 and as to the remaining portion on a monthly basis following the one-year anniversary of the vesting commencement date, subject to continued service through the applicable vesting date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">224 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In connection with this offering, we have adopted the 2021 Incentive Award
Plan, referred to below as the 2021 Plan, in order to facilitate the grant of cash and equity incentives to directors, employees (including our named executive officers) and consultants of our company and certain of its affiliates and to enable us
to obtain and retain services of these individuals, which is essential to our long-term success. The 2021 Plan became effective on the date immediately prior to the date the registration statement relating to this offering became effective. For
additional information about the 2021 Plan, please see the section titled &#147;Equity Incentive Plans&#148; below. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Other Elements of Compensation
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Retirement Plans </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We maintain a <FONT STYLE="white-space:nowrap">tax-qualified</FONT> 401(k) retirement savings plan for our employees, including
our named executive officers, who satisfy certain eligibility requirements. Our named executive officers are eligible to participate in the 401(k) plan on the same terms generally as other eligible, full-time employees. U.S. Internal Revenue Code of
1986 (The Code) allows eligible employees to defer a portion of their compensation, within prescribed limits, on a <FONT STYLE="white-space:nowrap">pre-tax</FONT> basis through contributions to the 401(k) plan. We believe that providing a vehicle
for <FONT STYLE="white-space:nowrap">tax-deferred</FONT> retirement savings though our 401(k) plan adds to the overall desirability of our executive compensation package and further incentivizes our employees, including our named executive officers,
in accordance with our compensation policies. We have not made any employer contributions under our 401(k) plan since inception. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Employee Benefits and Perquisites </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Health and Welfare Plans and Perquisites<I>. </I>All of our current named executive officers are eligible to participate in our
employee benefit plans, including our medical, dental, vision, disability and life insurance plans, in each case on the same basis as all of our other employees. We generally do not provide perquisites or personal benefits to our named executive
officers. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>No Tax <FONT STYLE="white-space:nowrap">Gross-Ups</FONT> </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We do not make <FONT STYLE="white-space:nowrap">gross-up</FONT> payments to cover our named executive officers&#146; personal
income taxes that may pertain to any of the compensation or perquisites paid or provided by our company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">225 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Outstanding Equity Awards at Fiscal Year End </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following table sets forth information concerning the number of shares of common stock underlying outstanding equity
incentive awards for each named executive officer as of December&nbsp;31, 2020. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Vesting<BR>Commencement<BR>Date<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options<BR>Exercisable&nbsp;(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options<BR>Unexercisable<BR>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option&nbsp;Exercise<BR>Price&nbsp;($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Expiration&nbsp;Date</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Shares&nbsp;or&nbsp;Units<BR>of&nbsp;Stock&nbsp;not&nbsp;yet<BR>Vested (#)<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Market&nbsp;Value&nbsp;of<BR>Shares or Units<BR>not yet<BR>Vested&nbsp;($)<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Steven D. Harr, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9/4/2018</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;<BR></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,612,695</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38,145,347</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/14/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">590,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/29/2030</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/15/2021</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,118,723</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11/9/2030</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard Mulligan Ph.&nbsp;D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12/1/2018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,499,060</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,886,276</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4/23/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">112,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4/22/2030</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/15/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11/8/2030</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Christian Hordo</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11/19/2018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">467,187</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,820,930</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/14/2020</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">137,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/26/2030</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2/15/2021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11/8/2030</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>  <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">Except as otherwise noted, each restricted stock award and option vests as to 25% of the shares initially
underlying the option on the first anniversary of the vesting commencement date and as to 1/48th of the shares initially underlying the option each month thereafter until fully vested on the fourth anniversary of the vesting commencement date,
subject to continued service to us through the applicable vesting date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">Constitute restricted common shares that are subject to repurchase at their original purchase price upon a
termination of service. The repurchase right lapses over the vesting schedule, subject to continued service to us through the applicable vesting date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">Amounts are calculated by multiplying the number of shares shown in the table by $14.60, the estimated fair
market value of our common stock as of December 31, 2020. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">The restricted shares vest as to 12.5% of the shares initially underlying the shares on the vesting
commencement date and as to 87.5% of the shares initially underlying the shares each month in equal monthly installments thereafter until fully vested on the fourth anniversary of the vesting commencement date, subject to continued service to us
through the applicable vesting date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">Includes 261,269 unvested restricted shares of Harr Family Irrevocable Trust of 2015 dtd 12/28/2015.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">The stock option vests (a) with respect to 50% of the shares underlying the award over a four year period
with 25% vesting on February 15, 2022 and as to the remaining portion on a monthly basis thereafter, subject to continued service through the applicable vesting date and (b) with respect to the remaining 50% of the shares underlying the award over a
four year period commencing with 25% vesting on the later of the satisfaction of certain performance conditions or February&nbsp;15, 2022 and as to the remaining portion on a monthly basis following the one-year anniversary of the vesting
commencement date, subject to continued service through the applicable vesting date. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Executive Compensation Arrangements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Below is a description of the material terms of each employment contract, agreement, plan or arrangement that provides for the
employment of and payments to our NEOs (including such payments to be made at, following or in connection with the resignation, retirement or other termination of an NEO, or following a change in control). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Steven D. Harr, M.D. </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In
September 2018 we entered into an offer letter with Steven D. Harr, M.D., providing for <FONT STYLE="white-space:nowrap">at-will</FONT> employment, an annual base salary, and eligibility to participate in our employee benefit plans. In addition,
Dr.&nbsp;Harr is eligible to earn an annual cash bonus targeted at 50% of his base salary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Under Dr.&nbsp;Harr&#146;s
offer letter, upon a termination without cause or resignation for good reason (each such term as defined below), other than during the three months prior to a change in control and ending 12&nbsp;months after the change in control, Dr.&nbsp;Harr is
entitled to receive (i) 12 months of his base salary and target bonus and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">226 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
(ii)&nbsp;reimbursement for continued health, vision, and dental coverage through COBRA for a period of twelve months, subject Dr.&nbsp;Harr providing us a general release of claims. On the day
of any such termination or resignation, we may enter into a consulting agreement with Dr.&nbsp;Harr for a period of twelve months that provides for (i)&nbsp;annual consulting fees equal to his annual base salary in effect at the time of the
termination or resignation, (ii)&nbsp;continued vesting of equity awards held by him for a period of 12 months, and (iii)&nbsp;the right to exercise any vested stock options held by him for a period of 90 days following the term of the consulting
agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In the event Dr.&nbsp;Harr&#146;s employment with us is terminated by us without cause or he resigns for good
reason during the period commencing 3 months prior to a change in control and ending 12 months after a change in control, Dr.&nbsp;Harr is entitled to receive (i)&nbsp;his base salary in effect at the time of termination for a period of
18&nbsp;months and 1.5 times his target annual bonus, (ii)&nbsp;reimbursement for COBRA coverage for a period of 18&nbsp;months and (iii)&nbsp;accelerated vesting of all equity awards held by him, subject to Dr.&nbsp;Harr providing a general release
of claims against us. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If Dr.&nbsp;Harr is terminated due to his death, his estate or beneficiary shall be entitled to any
unpaid bonus for a year prior to the year of termination and a pro rata annual bonus for the year of termination, in each case, to be paid as soon as administratively practicable following the date of such termination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For purposes of Dr. Harr&#146;s offer letter, the following terms will have the following meanings: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;cause&#148; means: (i) a willful act of dishonesty made by Dr. Harr in connection with his
responsibilities as an employee; (ii) Dr. Harr&#146;s conviction of, or plea of <I>nolo contendere</I> to, a felony or any crime involving fraud, embezzlement or a material violation of federal or state law by him, any of which that our board of
directors reasonably determines in good faith has had or will have a material detrimental effect on the Company&#146;s reputation or business; (iii) Dr. Harr&#146;s willful and material unauthorized use or disclosure of any proprietary information
or trade secrets of the Company or any other party to whom he owes an obligation of nondisclosure as a result of his relationship with the Company; (iv)&nbsp;Dr.&nbsp;Harr&#146;s willful material breach of any obligations under any written agreement
or covenant with the Company; or (v) Dr. Harr&#146;s continued substantial failure to perform his employment duties (other than as a result of his physical or mental incapacity). No termination for cause under (iv) or (v) shall be effectuated until
after Dr. Harr has received a written demand of performance from our board of directors that specifically sets forth the factual basis for our board of directors&#146; determination that Dr.&nbsp;Harr has not substantially performed his duties and
has failed to cure such non-performance to our board of directors&#146; reasonable satisfaction within thirty (30) business days after receiving such notice. For purposes of this definition, no act or failure to act shall be considered willful
unless it is done in bad faith and without reasonable intent that the act or failure to act was in the best interest of the Company. Any act, or failure to act, based upon authority or instructions given to Dr. Harr pursuant to a resolution duly
adopted by our board of directors or based on the advice of counsel for the Company will be conclusively presumed to be done or omitted to be done Dr. Harr in good faith and in the best interest of the Company. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;good reason&#148; means Dr. Harr&#146;s resignation within 30 days following expiration of any Cure
Period (as defined below) following the occurrence of one or more of the following, without his written consent: (i) a material reduction in Dr. Harr&#146;s base salary or target annual bonus; (ii) a material diminution of Dr. Harr&#146;s title,
duties, responsibilities or reporting lines; (iii) a change in the location of Dr. Harr&#146;s employment of more than 50 miles; (iv) failure by the Company to timely grant certain equity awards promised in Dr. Harr&#146;s offer letter; or (v) Dr.
Harr not being elected or re-elected as a member of our board of directors. No event will be considered good reason unless (a) Dr. Harr has given written notice to the Company of his intention to terminate his employment for good reason, describing
the grounds for such action, no later than 90 days after the first occurrence of such circumstances, (b) Dr. Harr has provided the Company with at least 30 days in which to cure the circumstances (the &#147;Cure Period&#148;), and (c) if the Company
is not successful in curing the circumstance, Dr. Harr ends his employment within 30 days after the end of the Cure Period. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">227 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Richard Mulligan, Ph.D. </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In April 2020, we entered into an offer letter with Richard Mulligan, Ph.D., providing for
<FONT STYLE="white-space:nowrap">at-will</FONT> employment, an annual base salary, and eligibility to participate in our employee benefit plans. In addition, Dr.&nbsp;Mulligan is eligible to earn an annual cash bonus targeted at 40% of his base
salary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Under Dr.&nbsp;Mulligan&#146;s offer letter, upon Dr.&nbsp;Mulligan&#146;s termination of employment by us for
other than cause or his resignation for good reason (each such term as defined below), in each case outside of the period commencing 3 months prior to a change in control and ending 12 months after a change in control, he is entitled to receive
(i)&nbsp;nine months of base salary and 75% of his target bonus and (ii)&nbsp;reimbursement for COBRA coverage for a period of nine months, subject to Dr.&nbsp;Mulligan providing a general release of claims against us. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Prior to his employment with us, Dr.&nbsp;Mulligan served as a consultant to us pursuant to a consulting agreement. Under the
consulting agreement, Dr.&nbsp;Mulligan was paid a monthly retainer of $33,333 and was eligible for a discretionary fee of up to 40% of the retainer paid to him based on our board of director&#146;s assessment of his performance under the consulting
agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For purposes of Dr. Mulligan&#146;s offer letter, the following terms will have the following meanings: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;cause&#148; means: (i) a willful act of dishonesty made by Dr. Mulligan in connection with his
responsibilities as an employee; (ii) Dr. Mulligan&#146;s conviction of, or plea of <I>nolo contendere</I> to, a felony or any crime involving fraud, embezzlement or a material violation of federal or state law by him, any of which that our board of
directors reasonably determines in good faith has had or will have a material detrimental effect on the Company&#146;s reputation or business; (iii) Dr. Mulligan&#146;s willful and material unauthorized use or disclosure of any proprietary
information or trade secrets of the Company or any other party to whom he owes an obligation of nondisclosure as a result of his relationship with the Company; (iv) Dr. Mulligan&#146;s willful material breach of any obligations under any written
agreement or covenant with the Company; or (v) Dr. Mulligan&#146;s continued substantial failure to perform his employment duties (other than as a result of his physical or mental incapacity). No termination for cause under (iv) or (v) shall be
effectuated until after Dr. Mulligan has received a written demand of performance from our chief executive officer that specifically sets forth the factual basis for our chief executive officer&#146;s determination that Dr. Mulligan has not
substantially performed his duties and has failed to cure such non-performance to our chief executive officer&#146;s reasonable satisfaction within thirty (30) business days after receiving such notice. For purposes of this definition, no act or
failure to act shall be considered willful unless it is done in bad faith and without reasonable intent that the act or failure to act was in the best interest of the Company. Any act, or failure to act, based upon authority or instructions given to
Dr. Mulligan pursuant to a resolution duly adopted by our chief executive officer or based on the advice of counsel for the Company will be conclusively presumed to be done or omitted to be done Dr. Mulligan in good faith and in the best interest of
the Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;good reason&#148; means Dr. Mulligan&#146;s resignation within 30 days following expiration of any Cure
Period (as defined below) following the occurrence of one or more of the following, without his written consent: (i) a material reduction in Dr. Mulligan&#146;s base salary or target annual bonus; (ii) a material diminution of Dr. Mulligan&#146;s
title, duties, responsibilities or reporting lines; or (iii) a change in the location of Dr. Mulligan&#146;s employment of more than 50 miles. No event will be considered good reason unless (a) Dr. Mulligan has given written notice to the Company of
his intention to terminate his employment for good reason, describing the grounds for such action, no later than 90 days after the first occurrence of such circumstances, (b) Dr. Mulligan has provided the Company with at least 30&nbsp;days in which
to cure the circumstances (the &#147;Cure Period&#148;), and (c) if the Company is not successful in curing the circumstance, Dr. Mulligan ends his employment within 30 days after the end of the Cure Period. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">228 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Christian Hordo </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">On November&nbsp;9, 2018, we entered into an offer letter with Christian Hordo, providing for
<FONT STYLE="white-space:nowrap">at-will</FONT> employment, an annual base salary, and eligibility to participate in our employee benefit plans. In addition, Christian Hordo is eligible to earn an annual cash bonus targeted at 35% of his base
salary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Under Mr.&nbsp;Hordo&#146;s offer letter, upon Mr.&nbsp;Hordo&#146;s termination of employment by us for other
than cause or his resignation for good reason (each such term as defined below), in each case outside of the period commencing 3 months prior to a change in control and ending 12 months after a change in control, he is entitled to receive
(i)&nbsp;nine months of base salary and 75% of his target bonus and (ii)&nbsp;reimbursement for COBRA coverage for a period of nine months, subject to Mr.&nbsp;Hordo providing a general release of claims against us. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For purposes of Mr. Hordo&#146;s offer letter, the following terms will have the following meanings: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;cause&#148; means: (i) a willful act of dishonesty made by Mr. Hordo in connection with his
responsibilities as an employee; (ii) Mr. Hordo&#146;s conviction of, or plea of <I>nolo contendere</I> to, a felony or any crime involving fraud, embezzlement or a material violation of federal or state law by him, any of which that our board of
directors reasonably determines in good faith has had or will have a material detrimental effect on the Company&#146;s reputation or business; (iii) Mr. Hordo&#146;s willful and material unauthorized use or disclosure of any proprietary information
or trade secrets of the Company or any other party to whom he owes an obligation of nondisclosure as a result of his relationship with the Company; (iv) Mr. Hordo&#146;s willful material breach of any obligations under any written agreement or
covenant with the Company; or (v) Mr. Hordo&#146;s continued substantial failure to perform his employment duties (other than as a result of his physical or mental incapacity). No termination for cause under (iv) or (v) shall be effectuated until
after Mr. Hordo has received a written demand of performance from our chief executive officer that specifically sets forth the factual basis for our chief executive officer&#146;s determination that Mr. Hordo has not substantially performed his
duties and has failed to cure such non-performance to our chief executive officer&#146;s reasonable satisfaction within thirty (30) business days after receiving such notice. For purposes of this definition, no act or failure to act shall be
considered willful unless it is done in bad faith and without reasonable intent that the act or failure to act was in the best interest of the Company. Any act, or failure to act, based upon authority or instructions given to Mr. Hordo pursuant to a
resolution duly adopted by our chief executive officer or based on the advice of counsel for the Company will be conclusively presumed to be done or omitted to be done Mr. Hordo in good faith and in the best interest of the Company.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;good reason&#148; means Mr. Hordo&#146;s resignation within 30 days following expiration of any Cure
Period (as defined below) following the occurrence of one or more of the following, without his written consent: (i) a material reduction in Mr. Hordo&#146;s base salary or target annual bonus; (ii) a material diminution of Mr. Hordo&#146;s title,
duties, responsibilities or reporting lines; or (iii) a change in the location of Mr. Hordo&#146;s employment of more than 50 miles; or (iv) failure by the Company to timely grant certain equity awards promised in Mr Hordo&#146;s offer letter. No
event will be considered good reason unless (a) Mr. Hordo has given written notice to the Company of his intention to terminate his employment for good reason, describing the grounds for such action, no later than 90 days after the first occurrence
of such circumstances, (b) Mr. Hordo has provided the Company with at least 30 days in which to cure the circumstances (the &#147;Cure Period&#148;), and (c) if the Company is not successful in curing the circumstance, Mr. Hordo ends his employment
within 30 days after the end of the Cure Period. </P></TD></TR></TABLE>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>Change in Control Severance Plan </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Each of Dr.&nbsp;Mulligan and Mr.&nbsp;Hordo are eligible to participate in our change in control severance plan. Under the
change in control severance plan, in the event the executive&#146;s employment with us is terminated by us without cause or he resigns for good reason during the period commencing 3 months prior to a change in control
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">229 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
and ending 12 months after a change in control, the executive is entitled to receive (i)&nbsp;his base salary in effect at the time of termination for a period of 12 months and 1 times his target
annual bonus, (ii)&nbsp;reimbursement for COBRA coverage for a period of 12 months and (iii)&nbsp;accelerated vesting of all equity awards held by him, subject to the executive providing a general release of claims against us. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For purposes of our the following terms have the following meanings: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;cause&#148; means the occurrence of any of the following: (a) an act of dishonesty made by the
applicable executive in connection with such executive&#146;s responsibilities as an employee; (b) the applicable executive&#146;s conviction of, or plea of <I>nolo contendere</I> to, a felony or any crime involving fraud, embezzlement or any other
act of moral turpitude, or a material violation of federal or state law by such executive that our board of directors reasonably determines has had or will have a material detrimental effect on the Company&#146;s reputation or business; (c) the
applicable executive&#146;s gross misconduct; (d)&nbsp;the applicable executive&#146;s willful and material unauthorized use or disclosure of any proprietary information or trade secrets of the Company or any other party to whom the applicable
executive owes an obligation of nondisclosure as a result of the applicable executive&#146;s relationship with the Company; (e) the applicable executive&#146;s willful breach of any material obligations under any written agreement or covenant with
the Company; or (f) the applicable executive&#146;s continued substantial failure to perform such executive&#146;s employment duties (other than as a result of such executive&#146;s physical or mental incapacity) after such executive has received a
written demand of performance from our chief executive officer or such executive&#146;s supervisor that specifically sets forth the factual basis for our chief executive officer&#146;s or such executive&#146;s supervisor&#146;s determination that
the applicable executive has not substantially performed such executive&#146;s duties and has failed to cure such non-performance to our chief executive officer&#146;s or such executive&#146;s supervisor&#146;s reasonable satisfaction within 30
business days after receiving such notice. No act or failure to act shall be considered willful unless it is done in bad faith and without reasonable intent that the act or failure to act was in the best interest of the Company or required by law.
Any act, or failure to act, based upon authority or instructions given to the applicable executive pursuant to a direct instruction from our chief executive officer or based on the advice of counsel for the Company will be conclusively presumed to
be done or omitted to be done by the applicable executive in good faith and in the best interest of the Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;good reason&#148; means, the applicable executive&#146;s resignation within 30 days following the end of
the Cure Period (as defined below), without the applicable executive&#146;s express written consent, of one or more of the following: (a) a material reduction by the Company in the applicable executive&#146;s then-current annual base salary; (b) a
material diminution of the applicable executive&#146;s authority, duties, or responsibilities relative to the applicable executive&#146;s authority, duties, or responsibilities in effect immediately prior to such reduction; (c) a change in the
location of the applicable executive&#146;s employment of more than 50 miles; or (d) the Company&#146;s material breach of the terms of any material written agreement or covenant with the applicable executive related to the applicable
executive&#146;s provision of services to the Company. In order for an event to qualify as good reason, the applicable executive must not terminate employment with the Company without first providing the Company with written notice of the acts or
omissions constituting the grounds for &#147;good reason&#148; within 90 days of the initial existence of the grounds for &#147;good reason&#148; and a reasonable cure period of 30 days following the date of written notice (the &#147;Cure
Period&#148;), and such grounds must not have been cured during such time. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">230 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Director Compensation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>2020 Director Compensation Program </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Historically, our directors have not received compensation for their service. The following table contains information
concerning the compensation of our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors in 2020: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="55%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP>
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Fees&nbsp;Earned<BR>or Paid in<BR>Cash</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock<BR>Awards</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Option<BR>Awards</B><br><B>($)<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>All Other<BR>Compensation</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>($)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hans E. Bishop</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert Nelsen</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><B></B>&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><B>&#151;</B></TD>
<TD NOWRAP VALIGN="bottom"><B></B>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mary Agnes (Maggie) Wilderotter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">140,363</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">140,363</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michelle Seitz</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">456,766</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">456,766</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joshua H. Bilenker, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">456,766</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">456,766</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alise S. Reicin, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">456,766</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">456,766</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Geoffrey von Maltzahn, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Patrick Y. Yang, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Douglas Cole, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">Steven D. Harr, M.D., our President and Chief Executive Officer, and Richard Mulligan, Ph.D, our Executive
Vice-Chairman and Head of SanaX, are not included in this table as they are employees of the company. All compensation paid to Drs. Harr and Mulligan for the period they served as directors during 2020 is reflected in the section titled
&#147;&#151;2020 Summary Compensation Table.&#148; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">The amounts shown represent the grant date fair values of option awards granted in 2020 as computed in
accordance with FASB ASC Topic 718. See Note 13, Stock-based compensation to our condensed consolidated financial statements included elsewhere in this prospectus for a discussion of the assumptions used in the calculation of these.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have approved a compensation policy for our non-employee directors, or the Director Compensation
Program, to be effective in connection with the consummation of this offering. Pursuant to the Director Compensation Program, our non-employee directors will receive cash compensation as follows: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Each non-employee director will receive an annual cash retainer in the amount of $40,000 per year.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Any Non-Executive Chairperson will receive an additional annual cash retainer in the amount of $30,000 per
year. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The chairperson of the audit committee will receive additional annual cash compensation in the amount of
$20,000 per year for such chairperson&#146;s service on the audit committee. Each non-chairperson member of the audit committee will receive additional annual cash compensation in the amount of $10,000 per year for such member&#146;s service on the
audit committee. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The chairperson of the compensation committee will receive additional annual cash compensation in the amount
of $15,000 per year for such chairperson&#146;s service on the compensation committee. Each non-chairperson member of the compensation committee will receive additional annual cash compensation in the amount of $7,500 per year for such member&#146;s
service on the compensation committee. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The chairperson of the nominating and corporate governance committee will receive additional annual cash
compensation in the amount of $10,000 per year for such chairperson&#146;s service on the nominating and corporate governance committee. Each non-chairperson member of the nominating and corporate governance committee will receive additional annual
cash compensation in the amount of $5,000 per year for such member&#146;s service on the nominating and corporate governance committee. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Each non-employee director may also elect to receive all or part of his or her annual cash retainer in the
form of restricted stock units under our 2021 Incentive Award Plan. Elections to convert all or a portion of the annual cash retainer into restricted stock units must generally be made on or prior to December&nbsp;31 of the year prior to the year in
which the annual cash retainer is scheduled to be paid, or such earlier deadline as established by our board of directors or compensation committee. Each </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">231 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
individual who first becomes a non-employee director is permitted to elect to convert the annual cash retainer payments scheduled to be paid in the same calendar year into restricted stock units,
provided that the election is made prior to the date the individual becomes a non-employee director. Restricted stock units granted in lieu of all or a portion of the annual cash retainer are issued fully vested on the date of grant, and have a
grant date fair value equal to the amount of the applicable portion of the annual cash retainer. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Additionally, if permitted by our board of directors or the compensation committee, non-employee directors may
elect to defer all or part of the settlement of their restricted stock units issuable in lieu of all or a portion of the annual cash retainer. Any such deferral election is subject to the rules, conditions and procedures as determined by our board
of directors or the compensation committee in its sole discretion, which are intended to comply with the requirements of Section&nbsp;409A of the Internal Revenue Code. Timing of the settlement of any deferred restricted stock units is made in
accordance with the terms of the applicable deferral election. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Under the Director Compensation Program,
each non-employee director will automatically be granted (i)&nbsp;an option to purchase that number of shares of our common stock calculated by dividing (a)&nbsp;$700,000 by (b) the per share grant date fair value of the option, calculated based on
the closing trading price of our common stock as of the date of grant (or if the date of grant is not a trading day, the immediately preceding trading day) and using assumptions published in our most recent periodic report as of the date of grant,
rounded down to the nearest whole share, upon the director&#146;s initial appointment or election to our board of directors, referred to as the Initial Grant, and (ii)&nbsp;for each non-employee director who has served for at least four&nbsp;months
as of the date of each annual stockholder&#146;s meeting, an option to purchase that number of shares of our common stock calculated by dividing (a)&nbsp;$350,000 by (b)&nbsp;the per share grant date fair value of the option, calculated based on the
closing trading price of our common stock as of the date of grant (or if the date of grant is not a trading day, the immediately preceding trading day) and using assumptions published in our most recent periodic report as of the date of grant,
rounded down to the nearest whole share, automatically on the date of each annual stockholder&#146;s meeting thereafter, referred to as the Annual Grant. The Initial Grant will vest and become exercisable as to 1/36th of the underlying shares on a
monthly basis over three years, subject to continued service through each applicable vesting date. The Annual Grant will vest and become exercisable on the first anniversary of the date of grant, provided, that if our annual stockholder&#146;s
meeting immediately following the date of grant takes place prior to the first anniversary of the date of grant, the Annual Grant will vest and become exercisable immediately prior to our annual stockholder&#146;s meeting following the date of
grant, subject to continued service through each applicable vesting date. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In the event of a change in control (as
defined in the Director Compensation Policy), each Initial Option and Annual Option, along with any other stock options or equity-based awards held by any non-employee director, will vest and become exercisable immediately prior to such change in
control. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Incentive Compensation Plans </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following summarizes the material terms of the 2021 Incentive Award Plan and the 2021 Employee Stock Purchase Plan, which
will be the long-term incentive compensation plans in which our directors and named executive officers are eligible to participate following the consummation of this offering, the 2019 Restricted Stock Unit Plan, and the 2018 Equity Incentive Plan,
under which we have previously made periodic grants of equity and equity-based awards to our directors and named executive officers. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>2021 Incentive
Award Plan </I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We adopted the 2021 Plan, which will be effective on the date immediately prior to the date our
registration statement relating to this offering becomes effective. The principal purpose of the 2021 Plan is to attract, retain and motivate selected employees, consultants and directors through the granting of stock-based compensation awards and
cash-based performance bonus awards. The material terms of the 2021 Plan, as it is currently contemplated, are summarized below. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">232 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Share Reserve</I>. Under the 2021 Plan, a number of shares of our
common stock equal to 8% of our outstanding common stock after this offering will be initially reserved for issuance pursuant to a variety of stock-based compensation awards, including stock options, stock appreciation rights, or SARs, restricted
stock awards, restricted stock unit awards, performance bonus awards, performance stock unit awards, dividend equivalents, or other stock or cash based awards. The number of shares initially reserved for issuance or transfer pursuant to awards under
the 2021 Plan will be increased by (i)&nbsp;the number of shares represented by awards outstanding under our 2018 Plan, or 2018 Plan Awards, that become available for issuance under the counting provisions described below following the effective
date and (ii)&nbsp;an annual increase on the first day of each fiscal year beginning in 2022 and ending in 2031, equal to the lesser of (A) 5% of the shares of stock outstanding (on an as converted basis) on the last day of the immediately preceding
fiscal year and (B)&nbsp;such smaller number of shares of stock as determined by our board of directors; provided, however, that no more than&nbsp;127,170,664 shares of stock may be issued upon the exercise of incentive stock options. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following counting provisions will be in effect for the share reserve under the 2021 Plan: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to the extent that an award (including a 2018 Plan Award) expires, lapses or is terminated, converted into an
award in respect of shares of another entity in connection with a <FONT STYLE="white-space:nowrap">spin-off</FONT> or other similar event, exchanged for cash, surrendered, repurchased, canceled, in any case, in a manner that results in us acquiring
the underlying shares at a price not greater than the price paid by the participant or not issuing the underlying shares, such unused shares subject to the award at such time will be available for future grants under the 2021 Plan;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to the extent shares are tendered or withheld to satisfy the grant, exercise price or tax withholding
obligation with respect to any award under the 2021 Plan or 2018 Plan Award, such tendered or withheld shares will be available for future grants under the 2021 Plan; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to the extent shares subject to stock appreciation rights are not issued in connection with the stock
settlement of stock appreciation rights on exercise thereof, such shares will be available for future grants under the 2021 Plan; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the payment of dividend equivalents in cash in conjunction with any outstanding awards or 2018 Plan Awards
will not be counted against the shares available for issuance under the 2021 Plan; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">shares issued in assumption of, or in substitution for, any outstanding awards of any entity acquired in any
form of combination by us or any of our subsidiaries will not be counted against the shares available for issuance under the 2021 Plan. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition, the sum of the grant date fair value of all equity-based awards and the maximum that may become payable pursuant
to a cash-based award to any individual for services as a <FONT STYLE="white-space:nowrap">non-employee</FONT> director during any calendar year may not exceed $1,500,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Administration</I>. The compensation committee of our board of directors is expected to administer the 2021 Plan unless our
board of directors assumes authority for administration. The board of directors may delegate its powers to a committee, which, to the extent required to comply with Rule <FONT STYLE="white-space:nowrap">16b-3,</FONT> is intended to be comprised of <FONT
STYLE="white-space:nowrap">&#147;non-employee</FONT> directors&#148; for purposes of Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> under the Exchange Act. The 2021 Plan provides that the board or compensation committee may delegate its
authority to grant awards other than to individuals subject to Section&nbsp;16 of the Exchange Act or officers or directors to whom authority to grant awards has been delegated. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Subject to the terms and conditions of the 2021 Plan, the administrator has the authority to select the persons to whom awards
are to be made, to determine the number of shares to be subject to awards and the terms and conditions of awards, and to make all other determinations and to take all other actions necessary or advisable for the administration of the 2021 Plan. The
administrator is also authorized to adopt, amend or rescind rules relating to administration of the 2021 Plan. Our board of directors may at any time remove the compensation committee as the administrator and revest in itself the authority to
administer the 2021 Plan. The full board of directors will administer the 2021 Plan with respect to awards to <FONT STYLE="white-space:nowrap">non-employee</FONT> directors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">233 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Eligibility</I>. Awards under the 2021 Plan may be granted to individuals
who are then our officers, employees or consultants or are the officers, employees or consultants of certain of our subsidiaries. Such awards also may be granted to our directors. However, only employees of our company or certain of our subsidiaries
may be granted incentive stock options, or ISOs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Awards</I>. The 2021 Plan provides that the administrator may grant
or issue stock options, SARs, restricted stock, restricted stock units, performance bonus awards, performance stock units, other stock- or cash-based awards and dividend equivalents, or any combination thereof. Each award will be set forth in a
separate agreement with the person receiving the award and will indicate the type, terms and conditions of the award. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Nonstatutory Stock Options</I>, or NSOs, will provide for the right to purchase shares of our common stock
at a specified price which may not be less than fair market value on the date of grant, and usually will become exercisable (at the discretion of the administrator) in one or more installments after the grant date, subject to the participant&#146;s
continued employment or service with us and/or subject to the satisfaction of corporate performance targets and individual performance targets established by the administrator. NSOs may be granted for any term specified by the administrator that
does not exceed ten years. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Incentive Stock Options</I>, or ISOs, will be designed in a manner intended to comply with the provisions
of Section&nbsp;422 of the Code and will be subject to specified restrictions contained in the Code. Among such restrictions, ISOs must have an exercise price of not less than the fair market value of a share of common stock on the date of grant,
may only be granted to employees, and must not be exercisable after a period of ten years measured from the date of grant. In the case of an ISO granted to an individual who owns (or is deemed to own) at least 10% of the total combined voting power
of all classes of our capital stock, the 2021 Plan provides that the exercise price must be at least 110% of the fair market value of a share of common stock on the date of grant and the ISO must not be exercisable after a period of five years
measured from the date of grant. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Restricted Stock</I> may be granted to any eligible individual and made subject to such restrictions as may
be determined by the administrator. Restricted stock, typically, may be forfeited for no consideration or repurchased by us at the original purchase price if the conditions or restrictions on vesting are not met. In general, restricted stock may not
be sold or otherwise transferred until restrictions are removed or expire. Purchasers of restricted stock, unlike recipients of options, will have voting rights and will have the right to receive dividends, if any, prior to the time when the
restrictions lapse, however, extraordinary dividends will generally be placed in escrow, and will not be released until restrictions are removed or expire. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Restricted Stock Units</I> may be awarded to any eligible individual, typically without payment of
consideration, but subject to vesting conditions based on continued employment or service or on performance criteria established by the administrator. Like restricted stock, restricted stock units may not be sold, or otherwise transferred or
hypothecated, until vesting conditions are removed or expire. Unlike restricted stock, stock underlying restricted stock units will not be issued until the restricted stock units have vested, and recipients of restricted stock units generally will
have no voting or dividend rights prior to the time when vesting conditions are satisfied. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Stock Appreciation Rights</I>, or SARs, may be granted in connection with stock options or other awards, or
separately. SARs granted in connection with stock options or other awards typically will provide for payments to the holder based upon increases in the price of our common stock over a set exercise price. The exercise price of any SAR granted under
the 2021 Plan must be at least 100% of the fair market value of a share of our common stock on the date of grant. SARs under the 2021 Plan will be settled in cash or shares of our common stock, or in a combination of both, at the election of the
administrator. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Performance Bonus Awards and Performance Stock Units</I> are denominated in cash or shares/unit
equivalents, respectively, and may be linked to one or more performance or other criteria as determined by the administrator. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Other Stock or Cash Based Awards</I> are awards of cash, fully vested shares of our common stock and other
awards valued wholly or partially by referring to, or otherwise based on, shares of our common </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">234 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
stock. Other stock or cash based awards may be granted to participants and may also be available as a payment form in the settlement of other awards, as standalone payments and as payment in lieu
of base salary, bonus, fees or other cash compensation otherwise payable to any individual who is eligible to receive awards. The administrator will determine the terms and conditions of other stock or cash based awards, which may include vesting
conditions based on continued service, performance and/or other conditions. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Dividend Equivalents</I> represent the right to receive the equivalent value of dividends paid on shares of
our common stock and may be granted alone or in tandem with awards other than stock options or SARs. Dividend equivalents are converted to cash or shares by such formula and such time as determined by the administrator. In addition, dividend
equivalents with respect to an awards subject to vesting will either (i)&nbsp;to the extent permitted by applicable law, not be paid or credited or (ii)&nbsp;be accumulated and subject to vesting to the same extent as the related award.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Any award may be granted as a performance award, meaning that the award will be subject to vesting
and/or payment based on the attainment of specified performance goals. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Change in Control</I>. In the event of a
change in control, unless the administrator elects to terminate an award in exchange for cash, rights or other property, or cause an award to accelerate in full prior to the change in control, such award will continue in effect or be assumed or
substituted by the acquirer, provided that any performance-based portion of the award will be subject to the terms and conditions of the applicable award agreement; provided, however, that an award holder experiences a termination of service during
the period beginning three months prior to and ending 12 months following the closing of a change in control that is effected by the Company without cause or by such holder for good reason, then, the award(s) held by such person shall become fully
vested and, if applicable, exercisable and all forfeiture restrictions on such award(s) shall lapse as of immediately prior to the consummation of such change in control or, if later, the date of such termination of service. In the event the
acquirer refuses to assume or replace awards granted, prior to the consummation of such transaction, awards issued under the 2021 Plan (other than any portion subject to performance-based vesting) will be subject to accelerated vesting such that
100% of such awards will become vested and exercisable or payable, as applicable. The administrator may also make appropriate adjustments to awards under the 2021 Plan and is authorized to provide for the acceleration,
<FONT STYLE="white-space:nowrap">cash-out,</FONT> termination, assumption, substitution or conversion of such awards in the event of a change in control or certain other unusual or nonrecurring events or transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Adjustments of Awards</I>. The administrator has broad discretion to take action under the 2021 Plan, as well as make
adjustments to the terms and conditions of existing and future awards, to prevent the dilution or enlargement of intended benefits and facilitate necessary or desirable changes in the event of certain transactions and events affecting our common
stock, such as stock dividends, stock splits, mergers, acquisitions, consolidations and other corporate transactions. In addition, in the event of certain <FONT STYLE="white-space:nowrap">non-reciprocal</FONT> transactions with our stockholders
known as &#147;equity restructurings,&#148; the administrator will make equitable adjustments to the 2021 Plan and outstanding awards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Amendment and Termination</I>. The administrator may terminate, amend or modify the 2021 Plan at any time and from time to
time. However, we must generally obtain stockholder approval to the extent required by applicable law, rule or regulation (including any applicable stock exchange rule), and generally no amendment may materially and adversely affect any outstanding
award without the affected participant&#146;s consent. Notwithstanding the foregoing, an option may be amended to reduce the per share exercise price below the per share exercise price of such option on the grant date and options may be granted in
exchange for, or in connection with, the cancellation or surrender of options having a higher per share exercise price without receiving additional stockholder approval. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">No incentive stock options may be granted pursuant to the 2021 Plan after the tenth anniversary of the effective date of the
2021 Plan, and no additional annual share increases to the 2021 Plan&#146;s aggregate share limit will occur from and after such anniversary. Any award that is outstanding on the termination date of the 2021 Plan will remain in force according to
the terms of the 2021 Plan and the applicable award agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">235 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>2021 Employee Stock Purchase Plan </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We adopted the 2021 Employee Stock Purchase Plan, which we refer to as our ESPP, which will be effective on the date
immediately prior to the date the registration statement relating to this offering becomes effective. The ESPP is designed to allow our eligible employees to purchase shares of our common stock, at periodic intervals, with their accumulated payroll
deductions. The ESPP is intended to qualify under Section&nbsp;423 of the Code. The material terms of the ESPP, as it is currently contemplated, are summarized below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Administration</I>. Subject to the terms and conditions of the ESPP, our compensation committee will administer the ESPP.
Our compensation committee can delegate administrative tasks under the ESPP to the services of an agent and/or employees to assist in the administration of the ESPP. The administrator will have the discretionary authority to administer and interpret
the ESPP. Interpretations and constructions of the administrator of any provision of the ESPP or of any rights thereunder will be conclusive and binding on all persons. We will bear all expenses and liabilities incurred by the ESPP administrator.
</P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Share Reserve</I>. The maximum number of our shares of our common stock which will be authorized for sale under
the ESPP is equal to the sum of (i)&nbsp;a number of shares of common stock equal to 1% of our outstanding common stock after this offering and (ii)&nbsp;an annual increase on the first day of each year beginning in 2022 and ending in 2031, equal to
the lesser of (A) 1% of the shares of common stock outstanding (on an as converted basis) on the last day of the immediately preceding fiscal year and (B)&nbsp;such number of shares of common stock as determined by our board of directors; provided,
however, no more than 26,033,561 shares of our common stock may be issued under the ESPP. The shares reserved for issuance under the ESPP may be authorized but unissued shares or reacquired shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Eligibility</I>. Employees eligible to participate in the ESPP for a given offering period generally include employees who
are employed by us or one of our subsidiaries on the first day of the offering period, or the enrollment date. Our employees (and, if applicable, any employees of our subsidiaries) who customarily work less than five months in a calendar year or are
customarily scheduled to work less than 20 hours per week will not be eligible to participate in the ESPP. Finally, an employee who owns (or is deemed to own through attribution) 5% or more of the combined voting power or value of all our classes of
stock or of one of our subsidiaries will not be allowed to participate in the ESPP. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Participation</I>. Employees will
enroll under the ESPP by completing a payroll deduction form permitting the deduction from their compensation of at least 1% of their compensation but not more than 15% of their compensation. Such payroll deductions may be expressed as either a
whole number percentage or a fixed dollar amount, and the accumulated deductions will be applied to the purchase of shares on each purchase date. However, a participant may not purchase more than 100,000 shares in each offering period and may not
accrue the right to purchase shares of common stock at a rate that exceeds $25,000 in fair market value of shares of our common stock (determined at the time the option is granted) for each calendar year the option is outstanding (as determined in
accordance with Section&nbsp;423 of the Code). The ESPP administrator has the authority to change these limitations for any subsequent offering period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Offering</I>. Under the ESPP, participants are offered the option to purchase shares of our common stock at a discount
during a series of successive offering periods, the duration and timing of which will be determined by the ESPP administrator. However, in no event may an offering period be longer than 27 months in length. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The option purchase price will be the lower of 85% of the closing trading price per share of our common stock on the first
trading date of an offering period in which a participant is enrolled or 85% of the closing trading price per share on the purchase date, which will occur on the last trading day of each offering period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Unless a participant has previously canceled his or her participation in the ESPP before the purchase date, the participant
will be deemed to have exercised his or her option in full as of each purchase date. Upon exercise, the participant will purchase the number of whole shares that his or her accumulated payroll deductions will buy at the option purchase price,
subject to the participation limitations listed above. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">236 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A participant may cancel his or her payroll deduction authorization at any
time prior to the end of the offering period. Upon cancellation, the participant will have the option to either (i)&nbsp;receive a refund of the participant&#146;s account balance in cash without interest or (ii)&nbsp;exercise the participant&#146;s
option for the current offering period for the maximum number of shares of common stock on the applicable purchase date, with the remaining account balance refunded in cash without interest. Following at least one payroll deduction, a participant
may also decrease (but not increase) his or her payroll deduction authorization once during any offering period. If a participant wants to increase or decrease the rate of payroll withholding, he or she may do so effective for the next offering
period by submitting a new form before the offering period for which such change is to be effective. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A participant may
not assign, transfer, pledge or otherwise dispose of (other than by will or the laws of descent and distribution) payroll deductions credited to a participant&#146;s account or any rights to exercise an option or to receive shares of our common
stock under the ESPP, and during a participant&#146;s lifetime, options in the ESPP shall be exercisable only by such participant. Any such attempt at assignment, transfer, pledge or other disposition will not be given effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Adjustments upon Changes in Recapitalization, Dissolution, Liquidation, Merger or Asset Sale</I>. In the event of any
increase or decrease in the number of issued shares of our common stock resulting from a stock split, reverse stock split, stock dividend, combination or reclassification of the common stock, or any other increase or decrease in the number of shares
of common stock effected without receipt of consideration by us, we will proportionately adjust the aggregate number of shares of our common stock offered under the ESPP, the number and price of shares which any participant has elected to purchase
under the ESPP and the maximum number of shares which a participant may elect to purchase in any single offering period. If there is a proposal to dissolve or liquidate us, then the ESPP will terminate immediately prior to the consummation of such
proposed dissolution or liquidation, and any offering period then in progress will be shortened by setting a new purchase date to take place before the date of our dissolution or liquidation. We will notify each participant of such change in writing
at least 10 business days prior to the new exercise date. If we undergo a merger with or into another corporation or sell all or substantially all of our assets, each outstanding option will be assumed or an equivalent option substituted by the
successor corporation or the parent or subsidiary of the successor corporation. If the successor corporation refuses to assume the outstanding options or substitute equivalent options, then any offering period then in progress will be shortened by
setting a new purchase date to take place before the date of our proposed sale or merger. We will notify each participant of such change in writing at least 10 business days prior to the new exercise date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Amendment and Termination</I>. Our board of directors may amend, suspend or terminate the ESPP at any time. However, the
board of directors may not amend the ESPP without obtaining stockholder approval within 12&nbsp;months before or after such amendment to the extent required by applicable laws. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>2019 Restricted Stock Unit Plan </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>General</I>. In March 2019, in connection with the acquisition of Cobalt Biomedicine Inc. (&#147;Cobalt&#148;), our board of
directors adopted a restricted stock unit plan (the &#147;RSU Plan&#148;) under which we granted restricted stock units to certain of our employees and consultants. No additional awards may be granted under the RSU Plan. Generally, outstanding
awards under the RSU Plan vest based on satisfaction of three requirements: (i) a service-based vesting requirement pursuant to which 1/16th of the restricted stock units subject to an applicable award will vest on each quarterly anniversary of the
applicable vesting commencement date, (ii) a milestone-based vesting requirement, which was satisfied in July of 2019, and (iii) a liquidity event-based vesting requirement, which will be satisfied on the six-month anniversary of the effective date
of the completion of this offering. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Share Reserve</I>. 349,254 shares of our common stock were reserved for
issuance under the RSU Plan. As of September 30, 2020, there were restricted stock unit awards covering an aggregate of 325,672 shares of our common stock outstanding under the RSU Plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">237 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Administration</I>. Our board of directors administers the RSU Plan. Our
board of directors has the authority to determine which service providers will receive an award under the RSU Plan, to grant awards under the RSU Plan and to set the terms and conditions of such awards including, but not limited to, vesting and
forfeiture provisions, In addition, our board has discretion to take all actions and make all determinations contemplated by the RSU Plan and to adopt, amend and repeal such administrative rules, guidelines and practices relating to the RSU Plan as
it shall deem advisable. Our board of directors may correct any defect or ambiguity, supply any omission or reconcile any inconsistency in the RSU Plan or any award granted thereunder in the manner and to the extent it shall deem necessary or
appropriate to carry the RSU Plan and any such awards into effect, as determined by our board of directors in its discretion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Awards</I>. Under the RSU Plan, restricted stock units may be granted to eligible service providers of the Company. Each
restricted stock unit represents the right to receive a share of our common stock upon vesting. Our board of directors determines the terms and conditions of restricted stock units including any vesting criteria and forfeiture conditions, which may
include accomplishing specified performance criteria or continued service to us, and the form and timing of payment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Change in Control</I>. In the event of a change in control, our board of directors may (i) cause any outstanding awards to
terminate in exchange for cash or other property with a value equal to the amount that could have been obtained upon settlement of the vested portion of such award, (ii) provide for full accelerated vesting of outstanding awards, (iii) to provide
that outstanding awards will be assumed, substituted or replaced, or (iv)&nbsp;provide that outstanding awards will be terminated and may not vest or become payable following the consummation of such change in control; provided however, that if a
change in control occurs and awards are not continued, converted, assumed or replaced with a substantially similar awards, and further provided that the participant is still a service provider of the company, then immediately prior to the change in
control such awards shall become fully vested, exercisable and/or payable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Transferability</I>. Except as otherwise
provided by our board of directors or as set forth in an applicable award agreement, restricted stock units granted under the RSU Plan may not be transferred except by will or the laws of descent and distribution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Amendment or Termination</I>. Our board of directors has the authority to amend, suspend or terminate the RSU Plan,
provided that no such amendment may materially and adversely effect any outstanding award without the holder&#146;s consent and that such action is approved by our stockholders to the extent stockholder approval is necessary. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>2018 Equity Incentive Plan </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>General</I>. Our board of directors adopted, and our stockholders approved our 2018 Equity Incentive Plan (2018 Plan) in
October 2018. We have subsequently amended our 2018 Plan in February 2019 and November 2020, the purpose of which was to increase the number of shares available for issuance under our 2018 Plan. Our stockholders approved the amendment in February
2019 and November 2020, respectively. Our 2018 Plan will be terminated prior to the completion of this offering in connection with our adoption of our 2021 Plan; however, awards outstanding under our 2018 Plan continue in full effect in accordance
with their existing terms. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Share Reserve</I>. 16,149,910 shares of our common stock were reserved for issuance
under our 2018 Plan. As of September&nbsp;30, 2020, options to purchase 9,241,796 shares of common stock, at exercise prices ranging from $1.44 to $6.20 per share, or a weighted-average exercise price of $2.32 per share, and 669,919 shares of
restricted common stock were outstanding under our 2018 Plan. Subsequent to September 30, 2020, we granted an additional 6,139,302 shares of common stock with a weighted average exercise price of $7.92 per share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Administration</I>. Our board of directors administers our 2018 Plan. Our board of directors has the authority to determine
which service providers will receive an award under the 2018 Plan, to grant awards under the 2018 Plan and to set the terms and conditions of such awards including, but not limited to, vesting and forfeiture provisions, In
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">238 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
addition, to take all actions and make all determinations contemplated by our 2018 Plan and to adopt, amend and repeal such administrative rules, guidelines and practices relating to our 2018
Plan as it shall deem advisable. Our board of directors may correct any defect or ambiguity, supply any omission or reconcile any inconsistency in our 2018 Plan or any award granted thereunder in the manner and to the extent it shall deem necessary
or appropriate to carry the 2018 Plan and any such awards into effect, as determined by our board of directors in its discretion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Types of Awards</I>. Our 2018 Plan provides for the grant of incentive stock options and nonstatutory stock options to
purchase shares of our common stock, restricted stock awards, restricted stock units and other stock-based awards to employees, members of our board of directors and consultants. Incentive stock options may be granted only to employees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Options</I>. Options to purchase shares of our common stock at a specified exercise price may be granted under the 2018
Plan, subject to such conditions and limitations as deemed necessary or desirable by our board of directors. The exercise price of options granted under our 2018 Plan may not be less than 100% of the fair market value of our common stock on the
grant date. Options granted under the 2018 Plan are exercisable at such times and subject to such conditions as determined by our board of directors and specified in an applicable award agreement and expire at the time determined by our board of
directors, but in no event more than 10 years after they are granted, and generally expire earlier if the option holder&#146;s service terminates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Restricted Stock</I>. Restricted stock awards may be granted under the 2018 Plan. Restricted stock awards are grants of
shares of our common stock that are subject to various restrictions, including restrictions on transferability and forfeiture provisions. Shares of restricted stock will vest, and the restrictions on such shares will lapse, in accordance with terms
and conditions established by our board of directors and set forth in an applicable award agreement. Recipients of restricted stock awards will generally have rights equivalent to those of a stockholder with respect to such shares upon grant without
regard to vesting; provided that any dividends paid with respect to shares of restricted stock will be subject to the same restrictions and forfeitability as the underlying shares of restricted stock with respect to which they were paid. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Restricted Stock Units</I>. Restricted stock units may be granted under the 2018 Plan. Each restricted stock unit
represents the right to receive a share of our common stock upon vesting. Our board of directors determines the terms and conditions of restricted stock units including any vesting criteria and forfeiture conditions, which may include accomplishing
specified performance criteria or continued service to us, and the form and timing of payment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Change in Control</I>.
In the event of a change in control, our board of directors may (i) cause any outstanding awards to terminate in exchange for cash or other property with a value equal to the amount that could have been obtained upon settlement of the vested portion
of such award, (ii) provide for full accelerated vesting of outstanding awards, (iii) to provide that outstanding awards will be assumed, substituted or replaced, or (iv) provide that outstanding awards will be terminated and may not vest or become
payable following the consummation of such change in control; provided however, that if a change in control occurs and awards are not continued, converted, assumed or replaced with a substantially similar awards, and further provided that the
participant is still a service provider of the company, then immediately prior to the change in control such awards shall become fully vested, exercisable and/or payable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Transferability</I>. Except as otherwise provided by our board of directors or as set forth in an applicable award
agreement, awards granted under the 2018 Plan may not be transferred except by will or the laws of descent and distribution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>Plan Amendment or Termination</I>. Our board of directors has the authority to amend, suspend or terminate our 2018 Plan,
provided that no such amendment may materially and adversely effect any outstanding award without the holder&#146;s consent and that such action is approved by our stockholders to the extent stockholder approval is necessary. As described above, our
2018 Plan will terminate upon the effective date of our 2021 Plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">239 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc60414_14"></A>CERTAIN RELATIONSHIPS AND
<FONT STYLE="white-space:nowrap">RELATED-PARTY</FONT> TRANSACTIONS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following includes a summary of transactions
since July&nbsp;13, 2018 (our date of inception) and any currently proposed transactions, to which we were or are to be a participant, in which (i)&nbsp;the amount involved exceeded or will exceed $120,000; and (ii)&nbsp;any of our directors,
executive officers or holders of more than 5% of our capital stock, or any affiliate or member of the immediate family of the foregoing persons, had or will have a direct or indirect material interest, other than compensation and other arrangements
that are described under the section titled &#147;Executive and Director Compensation&#148; above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We believe the terms
obtained or consideration that we paid or received, as applicable, in connection with the transactions described below were comparable to terms available or the amounts that we would pay or receive, as applicable, in
<FONT STYLE="white-space:nowrap">arm&#146;s-length</FONT> transactions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Common Stock Issuance </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In July 2018 we entered into a stock subscription agreement pursuant to which we issued 29 shares of our common stock at a
price of $0.0004 per share to ARCH Venture Fund IX, L.P. (ARCH IX). In July 2018, ARCH IX transferred 14 of such shares to ARCH Venture Fund IX Overage, L.P. (ARCH IX Overage). In August 2018, we effected a <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">10,000-for-1</FONT></FONT> forward stock split of our common stock, and as a result, ARCH IX owned 147,500 shares of our common stock and ARCH IX Overage owned 145,000 shares of our common stock. In September 2018 we
entered into a stock subscription agreement pursuant to which we issued 58,750 shares of our common stock at a price of $0.0004 per share to <FONT STYLE="white-space:nowrap">F-Prime</FONT> Capital Partners Healthcare Fund V LP <FONT
STYLE="white-space:nowrap">(F-Prime</FONT> Fund V). </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The table below sets forth the number of shares of our common
stock acquired by entities affiliated with ARCH Venture Partners, L.P., <FONT STYLE="white-space:nowrap">F-Prime</FONT> Capital Partners, who are holders of more than 5% of our capital stock, and our directors and executive officers. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="90%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Common<BR>Stock</B><br><B>(#)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with ARCH Venture
Partners<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">292,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">F-Prime</FONT> Capital Partners Life Sciences Fund VI<SUP
STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Steven D. Harr, M.D.<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,825,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hans E. Bishop<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,705,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Sunil Agarwal<SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,610,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James J. MacDonald<SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">585,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nathan Hardy<SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">511,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">Robert Nelsen, a member of our board of directors, was designated to our board by ARCH Venture Partners. For
further details, see the information provided in footnote (1) to the table in the section titled &#147;Principal Stockholders.&#148; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify"><FONT STYLE="white-space:nowrap">F-Prime</FONT> Capital Partners Life Sciences Advisors Fund VI LP <FONT
STYLE="white-space:nowrap">(F-Prime</FONT> Advisors) is the general partner of F-Prime Capital Partners Life Sciences Fund VI LP (F-Prime Fund VI). F-Prime Advisors is solely managed by Impresa Management LLC, the managing member of its general
partner and its investment manager. Impresa Management LLC is owned, directly or indirectly, by various shareholders and employees of FMR LLC. Stephen Knight, M.D., a former member of our board of directors affiliated with these entities, resigned
as a member of our board of directors in October 2020. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">Consists of (i) 6,142,500 shares of restricted common stock of which 3,791,074 had vested as of December 31,
2020 and (ii) 682,500 shares of common stock held by the Harr Family Irrevocable Trust of 2015 dtd 12/28/2015, of which 421,230 had vested as of December&nbsp;31, 2020. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">Consists of 3,705,000 shares of restricted common stock of which 2,470,000 had vested as of December 31,
2020. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">Consists of 1,610,000 shares of restricted common stock of which 972,708 had vested as of December 31, 2020.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">Consists of (i) 335,000 shares of restricted common stock of which 103,437 had vested as of December 31,
2020; (ii) 125,000 shares of common stock held by NMM Trust; and (iii) 125,000 shares of common stock held by KOM Trust. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">Consists of 511,250 shares of restricted common stock of which 308,880 had vested as of December 31, 2020.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">240 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Convertible Preferred Stock Financings </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Convertible Note Purchase Agreement </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In September 2018, we entered into a convertible note purchase agreement for $2.5&nbsp;million of which we drew down
$0.8&nbsp;million with ARCH IX and $0.3&nbsp;million with <FONT STYLE="white-space:nowrap">F-Prime</FONT> Fund V. The notes accrued interest at 6% per annum and automatically converted into our Series <FONT STYLE="white-space:nowrap">A-1</FONT>
preferred stock financing upon closing. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Series <FONT STYLE="white-space:nowrap">A-1</FONT> Convertible Preferred Stock Financing </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In October 2018, we entered into a Series <FONT STYLE="white-space:nowrap">A-1</FONT> convertible preferred stock purchase
agreement with various investors, pursuant to which we issued an aggregate of 11,462,500 shares of our Series <FONT STYLE="white-space:nowrap">A-1</FONT> convertible preferred stock at a price per share of $4.00 for gross cash proceeds of
$45.9&nbsp;million, including the conversion of the $1.1&nbsp;million convertible notes. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Series <FONT STYLE="white-space:nowrap">A-2</FONT>
Convertible Preferred Stock Financing </I></B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In February 2019, we entered into a Series <FONT
STYLE="white-space:nowrap">A-2</FONT> and Series B convertible preferred stock purchase agreement (Series <FONT STYLE="white-space:nowrap">A-2/B</FONT> Purchase Agreement), with various investors, pursuant to which we issued an aggregate of
54,036,865 shares of Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock at $4.00 per share for gross cash proceeds of $216.1&nbsp;million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In October 2019, we entered into an amendment to the Series <FONT STYLE="white-space:nowrap">A-2/B</FONT> Purchase pursuant to
which we issued an aggregate of 1,966,667 shares of Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock at $4.00 per share for gross proceeds of $7.9&nbsp;million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Series <FONT STYLE="white-space:nowrap">A-2/B</FONT> Purchase Agreement also committed these investors to a Series B
convertible preferred stock financing with the issuance of up to 27,556,926 shares of our Series B convertible preferred stock at a price of $16.00 per share contingent upon the occurrence of certain clinical milestones or the unanimous approval of
the Company&#146;s board of directors. Additionally, in the event the clinical milestones were not achieved, the agreement stated at least two large Series B convertible preferred stock investors, defined as investors with at least a
$29.0&nbsp;million Series B convertible preferred stock investment, had the right to object to the board of directors&#146; decision to call the Series B convertible preferred stock closing within seven days. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Concurrently with the Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock financing, in February
2019 we acquired Cobalt Biomedicine, Inc. (Cobalt) and issued 36,441,583 shares of Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock in consideration, valued at $136.0&nbsp;million. Of the 36,441,583 shares of Series <FONT
STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock issued, 12,147,192 shares were restricted based on the achievement of a <FONT STYLE="white-space:nowrap">pre-specified</FONT> development milestone, which was achieved in July 2019.
</P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Series B Convertible Preferred Stock Financing </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In June 2020, we issued an aggregate of 27,223,170 shares of Series B convertible preferred stock at $16.00 per share for gross
proceeds of $435.6&nbsp;million pursuant to the Series <FONT STYLE="white-space:nowrap">A-2/B</FONT> Purchase Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">241 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The table below sets forth the number of shares of our Series <FONT
STYLE="white-space:nowrap">A-1,</FONT> Series <FONT STYLE="white-space:nowrap">A-2</FONT> and Series B convertible preferred stock purchased by our executive officers, directors, holders of more than 5% of our capital stock and their affiliated
entities or immediate family members. Each share of Series <FONT STYLE="white-space:nowrap">A-1,</FONT> Series A2 and Series B convertible preferred stock in the table below will convert into one share of our common stock upon the completion of this
offering. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="57%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Series <FONT STYLE="white-space:nowrap">A-1</FONT><BR>Convertible<BR>Preferred</B><br><B>Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Series <FONT STYLE="white-space:nowrap">A-2</FONT></B><br><B>Convertible<BR>Preferred</B><br><B>Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Series B</B><br><B>Convertible<BR>Preferred</B><br><B>Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Aggregate<BR>Purchase&nbsp;Price</B><br><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with ARCH Venture
Partners<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,375,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,125,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with Flagship Pioneering
Funds<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34,239,018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CPP Investment Board <FONT STYLE="white-space:nowrap">PMI-1</FONT> Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,166,667</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,208,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">F-Prime</FONT> Fund VI<SUP
STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,750,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">625,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Steven D. Harr, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,075,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">800,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">156,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hans E. Bishop</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,075,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">800,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">156,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Geoffrey von Maltzahn, Ph.D.<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,830,610</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">James J. MacDonald<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">93,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,812</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">Robert Nelsen, a member of our board of directors, was designated to our board by ARCH Venture Partners. For
further details, see the information provided in footnote (1) to the table in the section titled &#147;Principal Stockholders.&#148; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock issued in connection with the
acquisition of Cobalt. Douglas Cole, M.D. and Geoffrey von Maltzahn, Ph.D., members of our board of directors, were designated to our board by the Flagship Pioneering Funds. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify"><FONT STYLE="white-space:nowrap">F-Prime</FONT> Advisors is the general partner of <FONT
STYLE="white-space:nowrap">F-Prime</FONT> Fund VI. F-Prime Advisors is solely managed by Impresa Management LLC, the managing member of its general partner and its investment manager. Impresa Management LLC is owned, directly or indirectly, by
various shareholders and employees of FMR LLC. Stephen Knight, M.D., a former member of our board of directors affiliated with these entities, resigned in October 2020. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">The 7,812 shares of Series B convertible preferred stock are held by the The James J. MacDonald and Rena Chng
Trust, dated January&nbsp;15, 2010, which are deemed beneficially owned by Mr.&nbsp;MacDonald. </P></TD></TR></TABLE>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investors&#146; Rights,
Management Rights, Voting and <FONT STYLE="white-space:nowrap">Co-Sale</FONT> Agreements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In connection with our
convertible preferred stock financings, we entered into investors&#146; rights, management rights, voting and right of first refusal and <FONT STYLE="white-space:nowrap">co-sale</FONT> agreements containing registration rights, information rights,
rights of first offer, voting rights and rights of first refusal, among other things, with certain holders of our capital stock. The holders of more than 5% of our capital stock that are party to these agreements are entities affiliated with ARCH
Venture Partners, CPP Investment Board <FONT STYLE="white-space:nowrap">PM1-Inc.,</FONT> and <FONT STYLE="white-space:nowrap">F-Prime</FONT> Fund VI. In connection with our acquisition of Cobalt, former stockholders of Cobalt, including certain
affiliates of the Flagship Pioneering Funds, became parties to the investors&#146; rights, voting and right of first refusal and <FONT STYLE="white-space:nowrap">co-sale</FONT> agreements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">These stockholder agreements will terminate upon the closing of this offering, except for the registration rights granted
under our investors&#146; rights agreement, which will terminate upon the earliest of (i)&nbsp;the closing of a deemed liquidation event, as defined in our amended and restated certificate of incorporation as currently in effect; (ii)&nbsp;with
respect to each stockholder, the date when such stockholder can sell all of its registrable shares without limitation during a three-month period without registration pursuant to Rule 144 of the Securities Act, or Rule 144, or another similar
exemption under the Securities Act; and (iii)&nbsp;five years after the completion of this offering. For a description of the registration rights, see the section titled &#147;Description of Capital Stock&#151;Registration Rights.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Relationship with Richard Mulligan, Ph.D. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In December 2018, Dr.&nbsp;Mulligan became a member of our board of directors and we entered into a consulting agreement
pursuant to which Dr.&nbsp;Mulligan provided general advisory services to us in exchange for an annual fee of $400,000, paid monthly and was eligible to receive a bonus of $160,000 paid annually. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">242 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
Dr.&nbsp;Mulligan received 2,998,121 restricted shares of common stock, vesting 25% at the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary and monthly thereafter, subject to
Dr.&nbsp;Mulligan remaining a service provider. Additionally, we issued a promissory note to Dr.&nbsp;Mulligan, for a principal amount of $0.3&nbsp;million, with an interest rate of 3.0% per annum. In April 2020, Dr.&nbsp;Mulligan became an employee
and his consulting relationship ended. In November 2020, the promissory note and accrued interest of $0.3&nbsp;million was forgiven by the board of directors and the promissory note was exinguished. For further description of
Dr.&nbsp;Mulligan&#146;s compensation, see the subsection titled &#147;Executive and Director Compensation&#151;Executive Compensation Arrangements.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Directed Share Program </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">At our request, the underwriters have reserved up to 2% of the shares of common stock offered hereby, at the initial public
offering price, to offer to directors, officers, employees, business associates and other persons related to us. The underwriters will receive the same underwriting discount on any shares purchased pursuant to this program as they will on any other
shares sold to the public in this offering. The number of shares of common stock available for sale to the general public will be reduced to the extent these individuals purchase such reserved shares. Any reserved shares that are not so purchased
will be offered by the underwriters to the general public on the same basis as the other shares offered by this prospectus. Shares purchased by our directors and officers will be subject to the 180-day lock-up restriction described in the
&#147;Underwriting&#151;Directed Share Program&#148; section. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Other Transactions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have entered into offer letter agreements with our executive officers that, among other things, provide for certain
compensatory and change in control benefits, as well as severance benefits. For a description of these agreements with our named executive officers, see the subsection titled &#147;Executive and Director Compensation&#151;Executive Compensation
Arrangements.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have also granted stock options and restricted stock to our executive officers and certain of our
directors. For a description of these equity awards, see the subsection titled &#147;Executive and Director Compensation&#151;Equity Compensation.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Director and Officer Indemnification </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have entered into indemnification agreements with certain of our current directors and executive officers, and intend to
enter into new indemnification agreements with each of our current directors and executive officers before the completion of this offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our amended and restated certificate of incorporation also provides that, to the fullest extent permitted by law, we will
indemnify any officer or director of our company against all damages, claims, and liabilities arising out of the fact that the person is or was our director or officer, or served any other enterprise at our request as a director or officer. Amending
this provision will not reduce our indemnification obligations relating to actions taken before an amendment. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Related Person Transaction Policy
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have a written <FONT STYLE="white-space:nowrap">related-person</FONT> transaction policy, to be effective upon the
closing of this offering, that applies to our executive officers, directors, director nominees, holders of more than five percent of any class of our voting securities, and any member of the immediate family of, and any entity affiliated with, any
of the foregoing persons. Such persons will not be permitted to enter into a related person transaction with us without the prior consent of our audit committee, or other independent members of our board of directors in the event it is inappropriate
for our audit committee to review such transaction due to a conflict of interest. Any request for us to enter into a transaction with an executive officer, director, director nominee, principal stockholder, or any of
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">243 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
their immediate family members or affiliates, in which the amount involved exceeds $120,000 must first be presented to our audit committee for review, consideration, and approval. In approving or
rejecting any such proposal, our audit committee will consider the relevant facts and circumstances available and deemed relevant to our audit committee, including, but not limited to, the commercial reasonableness of the terms of the transaction
and the materiality and character of the related person&#146;s direct or indirect interest in the transaction. All of the transactions described in this section occurred prior to the adoption of this policy. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">244 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc60414_15"></A>PRINCIPAL STOCKHOLDERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following table sets forth information regarding beneficial ownership of our common stock as of December&nbsp;31, 2020 by:
</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each person whom we know to beneficially own more than 5% of our common stock; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each of our directors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each of our named executive officers; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">all directors and executive officers as a group. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In accordance with the rules of the SEC, beneficial ownership includes voting or investment power with respect to securities
and includes the shares issuable pursuant to stock options that are exercisable within 60 days of December&nbsp;31, 2020. Shares issuable pursuant to stock options are deemed outstanding for computing the percentage of the person holding such
options but are not outstanding for computing the percentage of any other person. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have based our calculation of
the percentage of beneficial ownership prior to this offering on 160,359,276 shares of our common stock outstanding and held of record by approximately 150 stockholders as of December&nbsp;31, 2020, which gives effect to (i)&nbsp;the filing and
effectiveness of our amended and restated certificate of incorporation; and (ii)&nbsp;the conversion of shares of all outstanding convertible preferred stock into shares of our common stock, as if such filing and effectiveness and conversion had
taken place as of December&nbsp;31, 2020. We have based our calculation of the percentage of beneficial ownership after this offering on 175,359,276 shares of our common stock outstanding as of December&nbsp;31, 2020, which gives effect to the
adjustments described in the prior sentence and further reflects the issuance of 15,000,000 shares of common stock in this offering, assuming that the underwriters will not exercise their over-allotment option to purchase up to an additional
2,250,000 shares of our common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The below table does not reflect any shares of common stock that may be purchased
in this offering or pursuant to our directed share program described under &#147;Underwriting&#151;Directed Share Program.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Unless otherwise indicated, the address for each listed stockholder is: c/o&nbsp;Sana Biotechnology, Inc., 188&nbsp;East
Blaine Street, Suite&nbsp;400, Seattle, Washington 98102. To our knowledge, except as indicated in the footnotes to this table and pursuant to applicable community property laws, the persons named in the table have sole voting and investment power
with respect to all shares of common stock. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number of<BR>Shares<BR>Beneficially<BR>Owned</B><br><B>(#)</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Percentage of Shares<BR>Beneficially Owned</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name of Beneficial Owner</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Before&nbsp;Offering<BR>(%)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>After&nbsp;Offering<BR>(%)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Greater than 5% Owner:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with ARCH Venture
Partners<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44,042,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with Flagship Pioneering
Funds<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34,239,018</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21.4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">CPP Investment Board <FONT STYLE="white-space:nowrap">PMI-1</FONT> Inc.<SUP
STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,375,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">F-Prime</FONT> Fund VI<SUP
STYLE="font-size:85%; vertical-align:top">(4)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,183,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4.7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Named Executive Officers and Directors:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Robert Nelsen<SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44,042,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Steven D. Harr, M.D.<SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,003,750</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Hans E. Bishop<SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,736,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Richard Mulligan, Ph.D.<SUP STYLE="font-size:85%; vertical-align:top">(8)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,998,121</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Geoffrey von Maltzahn, Ph.D.<SUP STYLE="font-size:85%; vertical-align:top">(9)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,830,610</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Christian Hordo<SUP STYLE="font-size:85%; vertical-align:top">(10)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,009,375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Patrick Y. Yang, Ph.D.<SUP STYLE="font-size:85%; vertical-align:top">(11)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">146,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Douglas Cole, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Mary Agnes (Maggie) Wilderotter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michelle Seitz</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Joshua H. Bilenker, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Alise S. Reicin, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All executive officers and directors as a group (15&nbsp;persons)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,694,980</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42.2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">245 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">Less than 1%. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">Consists of (i) 147,500 shares of common stock held by ARCH Venture Fund IX, L.P. (ARCH IX), (ii) 3,687,500
shares of common stock issuable upon the conversion of Series <FONT STYLE="white-space:nowrap">A-1</FONT> convertible preferred stock held by ARCH IX, (iii) 5,687,500 shares of common stock issuable upon the conversion of Series <FONT
STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock held by ARCH IX, (iv) 781,250 shares of common stock issuable upon the conversion of Series B convertible preferred stock held by ARCH IX, (v) 145,000 shares of common stock held by
ARCH Venture Fund IX, Overage L.P. (ARCH IX Overage), (vi) 3,687,000 shares of common stock issuable upon the conversion of Series <FONT STYLE="white-space:nowrap">A-1</FONT> convertible preferred stock held by ARCH IX Overage, (vii) 5,687,500
shares of common stock issuable upon the conversion of Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock held by ARCH IX Overage, and (viii) 781,250 of common stock issuable upon the conversion of Series B convertible
preferred stock held by ARCH IX Overage, (ix) 9,375,000 shares of common stock issuable upon the conversion of Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock held by ARCH Venture Fund X, L.P. (ARCH X), (x) 2,343,750
of common stock issuable upon the conversion of Series B convertible preferred stock held by ARCH X, (xi)&nbsp;9,375,000 shares of common stock issuable upon the conversion of Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred
stock held by ARCH Venture Fund X Overage, L.P. (ARCH X Overage), and (xii) 2,343,750 of common stock issuable upon the conversion of Series B convertible preferred stock held by ARCH X Overage.ARCH Venture Partners IX, L.P. (AVP IX LP) is the sole
general partner of ARCH IX. ARCH Venture Partners IX Overage, L.P. (AVP IX Overage LP) is the sole general partner of ARCH IX Overage. ARCH Venture Partners IX, LLC (AVP IX LLC) is the sole general partner of each of AVP IX LP and AVP IX Overage LP.
Keith Crandell, Clinton Bybee, and Robert Nelsen are managing directors of AVP IX LLC (the AVP IX MDs). AVP IX LP and AVP IX Overage LP may be deemed to beneficially own the shares held by ARCH IX and ARCH IX Overage, respectively, AVP IX LLC may be
deemed to beneficially own the shares held by ARCH IX and ARCH IX Overage, and each of the AVP IX MDs may be deemed to share the power to direct the disposition and vote of the shares held by ARCH IX and ARCH IX Overage. AVP IX LP, AVP IX Overage
LP, AVP IX LLC, and the AVP IX MDs each disclaim beneficial ownership except to any pecuniary interest therein. ARCH Venture Partners X, L.P. (AVP X LP) is the sole general partner of ARCH X. ARCH Venture Partners X Overage, L.P. (AVP X Overage LP)
is the sole general partner of ARCH X Overage. ARCH Venture Partners X, LLC (AVP X LLC) is the sole general partner of each of AVP X LP and AVP X Overage LP. Keith Crandell, Kristina Burow, Steven&nbsp;Gilles and Robert Nelsen comprise the
investment committee of AVP X LLC (the AVP X Committee Members). AVP X LP and AVP X&nbsp;Overage LP may be deemed to beneficially own the shares held by ARCH X and ARCH X Overage, respectively, AVP X LLC may be deemed to beneficially own the shares
held by ARCH X and ARCH X Overage, and each of the AVP X Committee Members may be deemed to share the power to direct the disposition and vote of the shares held by ARCH X and ARCH X Overage. AVP X LP, AVP X Overage LP, AVP X LLC, and the AVP X
Committee Members each disclaim beneficial ownership except to any pecuniary interest therein. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">Consists of (a) 11,585,199 shares of common stock issuable upon conversion of Series <FONT
STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock held by Flagship Ventures Fund V, L.P. (Flagship Fund V), (b) 11,441,326 shares of common stock issuable upon conversion of Series <FONT STYLE="white-space:nowrap">A-2</FONT>
convertible preferred stock held by Flagship VentureLabs V LLC (VentureLabs V), (c) 9,725,122 shares of common stock issuable upon conversion of Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock held by Flagship
Pioneering Fund VI, L.P. (Flagship Pioneering VI), and (d)&nbsp;1,487,371 shares of common stock issuable upon conversion of Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock held by Flagship V VentureLabs Rx Fund, L.P.
(Flagship Fund V Rx and, together with Flagship Pioneering VI, Flagship Fund V and VentureLabs V, the Flagship Pioneering Funds). Flagship Fund V is a member of VentureLabs V. VentureLabs V Manager LLC (VentureLabs V Manager) is the manager of
VentureLabs V. Flagship Pioneering, Inc. (Flagship Pioneering) is the manager of VentureLabs V Manager. The General Partner of Flagship Pioneering VI is Flagship Pioneering Fund VI General Partner LLC (Flagship Pioneering VI GP). The manager of
Flagship Pioneering VI GP is Flagship Pioneering. The General Partner of Flagship Fund V and Flagship Fund V Rx is Flagship Ventures Fund V General Partner LLC (Flagship V GP and, together with VentureLabs V Manager, Flagship Pioneering, and
Flagship Pioneering VI GP, the Flagship General Partners). Noubar B. Afeyan, Ph.D. is the sole Director of Flagship Pioneering and may be deemed to have sole voting and investment control over all the shares held by VentureLabs V and Flagship Fund
VI. In addition, Noubar B. Afeyan, Ph.D. serves as the sole manager of Flagship V GP and may be deemed to possess sole voting and investment control over all the shares held by Flagship Fund V and Flagship Fund V Rx. None of the Flagship General
Partners nor Noubar B. Afeyan, Ph.D. directly own any of the shares held by the Flagship Pioneering Funds, and each of the Flagship General Partners and Dr. Noubar Afeyan, Ph.D. disclaims beneficial ownership of such shares except to the extent of
its or his pecuniary interest therein. The mailing address of the Flagship Funds is 55 Cambridge Parkway, Suite 800E, Cambridge, MA 02142. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">Consists of (i) 4,166,667 shares of common stock issuable upon the conversion of Series <FONT
STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock, and (ii)&nbsp;5,208,333 shares of common stock issuable upon the conversion of Series B convertible preferred stock. CPP Investment Board
<FONT STYLE="white-space:nowrap">PMI-1</FONT> Inc. (CPPIB) is a wholly owned subsidiary of Canada Pension Plan Investment Board. Canada Pension Plan Investment Board is overseen by a board of directors. None of the directors of that board of
directors has sole voting or dispositive power with respect to the shares of the common stock owned by CPPIB. The mailing address of each of CPPIB and Canada Pension Plan Investment Board is c/o Canada Pension Plan Investment Board, One Queen Street
East, Suite 2500, Toronto, ON, M5C 2W5. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">Consists of (i) 1,750,000 shares of common stock issuable upon the conversion of Series <FONT
STYLE="white-space:nowrap">A-1</FONT> convertible preferred stock, (ii) 5,750,000 shares of common stock issuable upon the conversion of Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock, and (iii) 625,000 shares of
common stock issuable upon the conversion of Series B convertible preferred stock, and (iv) 58,750 shares of common stock. The portion of shares beneficially owned by <FONT STYLE="white-space:nowrap">F-Prime</FONT> Fund VI in excess of 4.99% of our
total outstanding voting securities are subject to a voting limitation, which does not permit <FONT STYLE="white-space:nowrap">F-Prime</FONT> Fund VI or its related parties to vote on certain matters with respect to the shares in excess of the
beneficial ownership limitation. <FONT STYLE="white-space:nowrap">F-Prime</FONT> Advisors is the general partner of <FONT STYLE="white-space:nowrap">F-Prime</FONT> Fund VI. F-Prime Advisors is solely managed by Impresa Management LLC, the managing
member of its general partner and its investment manager. Impresa Management LLC is owned, directly or indirectly, by various shareholders and employees of FMR LLC. Impresa Management LLC is managed on a
day-to-</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">246 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:8pt">
day basis by its President, B. Lane MacDonald, and as such, Mr. MacDonald may be deemed to have voting and dispositive power with respect to all shares held by F-Prime Fund VI. Stephen Knight,
M.D., a former member of our board of directors affiliated with these entities, resigned as a member of our board of directors in October 2020. Each of the individuals and entities listed above expressly disclaims beneficial ownership of the shares
held by F-Prime Fund VI, except to the extent of any pecuniary interest therein, if any. The mailing address of <FONT STYLE="white-space:nowrap">F-Prime</FONT> is 245 Summer Street, Boston, Massachusetts 02210. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">Mr.&nbsp;Nelsen is an AVP IX MD and an AVP X Committee Member and may be deemed to beneficially own the
shares held by, ARCH IX, ARCH IX Overage, ARCH X, and ARCH X Overage as discussed in footnote (1). Mr.&nbsp;Nelsen disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein, if any. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">Consists of (i) 1,075,000 shares of common stock issuable upon the conversion of Series <FONT
STYLE="white-space:nowrap">A-1</FONT> convertible preferred stock, (ii) 800,000 shares of common stock issuable upon the conversion of Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock, (iii)&nbsp;156,250 shares of
common stock issuable upon the conversion of Series B convertible preferred stock; (iv) 6,142,500 shares of restricted common stock of which 3,791,074 had vested as of December 31, 2020 and which remaining unvested portion remains subject to
repurchase; (v)&nbsp;682,500 shares of restricted common stock held by the Harr Family Irrevocable Trust of 2015 dtd 12/28/2015, of which 421,230 had vested as of December 31, 2020 and which remaining unvested portion remains subject to repurchase;
(vi)&nbsp;147,500 shares of common stock issuable upon exercise of stock options held by Dr.&nbsp;Harr that are exercisable within 60 days of December&nbsp;31, 2020. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">Consists of (i) 1,075,000 shares of common stock issuable upon the conversion of Series <FONT
STYLE="white-space:nowrap">A-1</FONT> convertible preferred stock, (ii) 800,000 shares of common stock issuable upon the conversion of Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock, (iii) 156,250 shares of common
stock issuable upon the conversion of Series B convertible preferred stock; (iv) 3,705,000 shares of restricted common stock of which 2,470,000 had vested as of December 31, 2020 and which remaining unvested portion remains subject to repurchase.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">Consists of 2,998,121 shares of restricted common stock of which 1,499,060 had vested as of December 31, 2020
and which remaining unvested portion remains subject to repurchase. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">Consists of 1,830,610 shares of common stock issuable upon the conversion of Series <FONT
STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock of which 732,244 are held by Maxine Sharkey Giammo and 366,122 are held by Geoffrey A. von Maltzahn 2020 GRAT. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">Consists of (i) 975,000 shares of restricted common stock of which 507,812 had vested as of December 31, 2020
and which remaining unvested portion remains subject to repurchase; (ii) 34,375 shares of common stock issuable upon exercise of stock options held by Mr. Hordo that are exercisable within 60 days of December 31, 2020. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(11)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">Consists of 146,250 shares of restricted common stock of which 88,359 had vested as of December&nbsp;31, 2020
and which remaining unvested portion remains subject to repurchase. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">247 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc60414_16"></A>DESCRIPTION OF CAPITAL STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><I>The following summary describes our capital stock and the material provisions of our amended and restated certificate of
incorporation and our amended and restated bylaws, which will become effective immediately prior to the completion of this offering, the amended and restated investors&#146; rights agreement to which we and certain of our stockholders are parties
and of the Delaware General Corporation Law. Because the following is only a summary, it does not contain all of the information that may be important to you. For a complete description, you should refer to our amended and restated certificate of
incorporation, amended and restated bylaws and amended and restated investors&#146; rights agreement, copies of which have been filed as exhibits to the registration statement of which this prospectus is part. </I></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Upon the
completion of this offering and the filing of our amended and restated certificate of incorporation, our authorized capital stock will consist of 750,000,000 shares of common stock, par value $0.0001 per share, and&nbsp;50,000,000 shares of
preferred stock, par value $0.0001 per share. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Common Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Outstanding Shares </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As of September&nbsp;30, 2020, we had 160,314,776 shares of common stock outstanding, held of record by 134 stockholders,
assuming the automatic conversion of all of our outstanding shares of convertible preferred stock into 134,112,712 shares of common stock immediately prior to the completion of this offering. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Voting Rights </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Each holder of common stock is entitled to one vote for each share on all matters submitted to a vote of the stockholders,
including the election of directors. Our stockholders do not have cumulative voting rights in the election of directors. Accordingly, holders of a majority of the voting shares are able to elect all of the directors. In addition, the affirmative
vote of holders of 66 2/3% of the voting power of all of the then outstanding voting stock will be required to take certain actions, including amending certain provisions of our amended and restated certificate of incorporation, including the
provisions relating to amending our amended and restated bylaws, the classified board and director liability. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Dividends </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Subject to preferences that may be applicable to any then outstanding preferred stock, holders of our common stock are entitled
to receive dividends as may be declared from time to time by our board of directors out of legally available funds. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Liquidation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In the event of our liquidation, dissolution or winding up, holders of our common stock will be entitled to share ratably in
the net assets legally available for distribution to stockholders after the payment of all of our debts and other liabilities, subject to the satisfaction of any liquidation preference granted to the holders of any then outstanding shares of
preferred stock. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Rights, Preferences, and Privileges </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Holders of our common stock have no preemptive, conversion or subscription rights, and there are no redemption or sinking fund
provisions applicable to our common stock. The rights, preferences and privileges of the holders of our common stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of our preferred stock that we
may designate and issue in the future. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">248 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Fully Paid and Nonassessable </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">All of our outstanding shares of common stock are, and the shares of common stock to be issued in this offering will be, fully
paid and nonassessable. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Preferred Stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Upon the completion of this offering, all of our currently outstanding shares of convertible preferred stock will convert into
common stock and we will not have any shares of preferred stock outstanding. Immediately prior to the completion of this offering, our amended and restated certificate of incorporation will be amended and restated to delete all references to such
shares of convertible preferred stock. From and after the consummation of this offering, our board of directors will have the authority, without further action by our stockholders, to issue up to 50,000,000 shares of preferred stock in one or more
series and to fix the rights, preferences, privileges and restrictions thereof. These rights, preferences and privileges could include dividend rights, conversion rights, voting rights, terms of redemption, liquidation preferences, sinking fund
terms and the number of shares constituting, or the designation of, such series, any or all of which may be greater than the rights of our common stock. The issuance of our preferred stock could adversely affect the voting power of holders of common
stock and the likelihood that such holders will receive dividend payments and payments upon our liquidation. In addition, the issuance of preferred stock could have the effect of delaying, deferring or preventing a change in control of our company
or other corporate action. Immediately after consummation of this offering, no shares of preferred stock will be outstanding, and we have no present plan to issue any shares of preferred stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Stock Options </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As of
September&nbsp;30, 2020, we had outstanding options to purchase an aggregate of 9,677,280 shares of our common stock, with a <FONT STYLE="white-space:nowrap">weighted-average</FONT> exercise price of $2.32 per share. Subsequent to September 30,
2020, we granted an additional 6,139,302 shares of common stock with a weighted-average exercise price of $7.92 per share. For additional information regarding terms of our equity incentive plans, see the section titled &#147;Executive and Director
Compensation&#151;Equity Incentive Plans.&#148; </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Registration Rights </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Upon the completion of this offering and subject to <FONT STYLE="white-space:nowrap">the&nbsp;lock-up&nbsp;agreements</FONT>
entered into in connection with this offering and federal securities laws, certain holders of shares of our common stock, including those shares of our common stock that will be issued upon the conversion of our convertible preferred stock in
connection with this offering, will initially be entitled to certain rights with respect to registration of such shares under the Securities Act. These shares are referred to as registrable securities. The holders of these registrable securities
possess registration rights pursuant to the terms of our amended and restated investors&#146; rights agreement and are described in additional detail below. The registration of shares of our common stock pursuant to the exercise of the registration
rights described below would enable the holders to trade these shares without restriction under the Securities Act when the applicable registration statement is declared effective. We will pay the registration expenses, other than underwriting
discounts, selling commissions and stock transfer taxes, of the shares registered pursuant to the demand, piggyback and <FONT STYLE="white-space:nowrap">Form&nbsp;S-3&nbsp;registrations</FONT> described below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Generally, in an underwritten offering, the managing underwriter, if any, has the right, subject to specified conditions and
limitations, to limit the number of shares the holders may include. The demand, piggyback <FONT STYLE="white-space:nowrap">and&nbsp;Form&nbsp;S-3&nbsp;registration</FONT> rights described below will terminate upon the earliest of (i)&nbsp;with
respect to each stockholder, such date, on or after the closing of this offering, on which all registrable shares held by such stockholder may immediately be sold during any <FONT STYLE="white-space:nowrap">90-day</FONT> period pursuant to Rule 144
of the Securities Act, or Rule&nbsp;144; and (ii)&nbsp;the occurrence of a deemed liquidation event, as defined in our amended and restated certificate of incorporation, as currently in effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">249 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Demand Registration Rights </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Upon the completion of this offering, holders of approximately 134.1&nbsp;million shares of our common stock issuable upon
conversion of outstanding convertible preferred stock will be entitled to certain demand registration rights. Beginning 180 days following the effectiveness of the registration statement of which this prospectus is a part, certain major investors
holding, collectively, holding at least 40% of registrable securities may, on not more than two occasions, request that we register all or a portion of their shares, subject to certain specified exceptions. If any of these holders exercises its
demand registration rights, then holders of approximately 134.1&nbsp;million shares of our common stock issuable upon the shares of our convertible preferred stock in connection with this offering will be entitled to register their shares, subject
to specified conditions and limitations in the corresponding offering. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Piggyback Registration Rights </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In connection with this offering, holders of approximately 134.1&nbsp;million shares of our common stock issuable upon
conversion of outstanding convertible preferred stock are entitled to their rights to notice of this offering and to include their shares of registrable securities in this offering. The requisite percentage of these stockholders are expected to
waive all such stockholders&#146; rights to notice of this offering and to include their shares of registrable securities in this offering. In the event that we propose to register any of our securities under the Securities Act in another offering,
either for our own account or for the account of other security holders, the holders of registrable securities will be entitled to certain &#147;piggyback&#148; registration rights allowing them to include their shares in such registration, subject
to specified conditions and limitations. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I><FONT STYLE="white-space:nowrap">S-3&nbsp;Registration</FONT> Rights </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Upon the completion of this offering, the holders of approximately 134.1&nbsp;million shares of our common stock issuable upon
conversion of outstanding convertible preferred stock will initially be entitled to <FONT STYLE="white-space:nowrap">certain&nbsp;Form&nbsp;S-3&nbsp;registration</FONT> rights. Certain major investors holding at least 25% of registrable securities
may, on not more than two registrations <FONT STYLE="white-space:nowrap">on&nbsp;Form&nbsp;S-3&nbsp;within</FONT> <FONT STYLE="white-space:nowrap">any&nbsp;12-month&nbsp;period,</FONT> request that we register all or a portion of their shares <FONT
STYLE="white-space:nowrap">on&nbsp;Form&nbsp;S-3&nbsp;if</FONT> we are qualified to file a registration statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-3,&nbsp;subject</FONT> to specified exceptions. Such request for registration <FONT
STYLE="white-space:nowrap">on&nbsp;Form&nbsp;S-3&nbsp;must</FONT> cover securities with an aggregate offering price which equals or exceeds $15.0&nbsp;million, net of selling expenses. The right to have such shares registered <FONT
STYLE="white-space:nowrap">on&nbsp;Form&nbsp;S-3&nbsp;is</FONT> further subject to other specified conditions and limitations. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Election and
Removal of Directors; Vacancies </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our board of directors will consist of between five and&nbsp;fifteen&nbsp;directors.
The exact number of directors will be fixed from time to time by resolution of the board. Directors will be elected by a plurality of the votes of the shares of our capital stock present in person or represented by proxy at the meeting and entitled
to vote on the election of directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">No director may be removed except for cause, and directors may be removed for cause
only by an affirmative vote of shares representing not less than a majority of the shares then entitled to vote at an election of directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Any vacancy occurring on the board of directors and any newly created directorship may be filled only by a majority of the
remaining directors in office. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Staggered Board </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Upon the closing of this offering, our board of directors will be divided into three classes serving staggered <FONT
STYLE="white-space:nowrap">three-year</FONT> terms. Class&nbsp;I, Class&nbsp;II, and Class&nbsp;III directors will serve until our annual meetings of stockholders in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">250 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
2022, 2023, and 2024, respectively. At each annual meeting of stockholders, directors will be elected to succeed the class of directors whose terms have expired. This classification of our board
of directors could have the effect of increasing the length of time necessary to change the composition of a majority of the board of directors. In general, at least two annual meetings of stockholders will typically be necessary for stockholders to
effect a change in a majority of the members of the board of directors. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Limitation on Action by Written Consent </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our amended and restated certificate of incorporation and our amended and restated bylaws provide that holders of our common
stock will not be able to act by written consent without a meeting. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Stockholder Meetings </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our amended and restated certificate of incorporation and our amended and restated bylaws provide that special meetings of our
stockholders may be called only by a the chairman of the board, our chief executive officer (or president, in the absence of a chief executive officer) or a majority of the directors. Our amended and restated certificate of incorporation and our
amended and restated bylaws specifically deny any power of any other person to call a special meeting. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Amendment of Certificate of Incorporation
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The provisions of our amended and restated certificate of incorporation described under &#147;&#151;Election and
Removal of Directors; Vacancies,&#148; &#147;&#151;Stockholder Meetings,&#148; &#147;&#151;Limitation on Action by Written Consent,&#148; &#147;&#151;Limitation of Liability of Directors and Officers,&#148; &#147;&#151;Common Stock&#151;Voting
Rights,&#148; and &#147;&#151;Forum Selection&#148; and provisions relating to amendments to our amended and restated certificate of incorporation may be amended only by the affirmative vote of holders of at least&nbsp;66 2/3% of the voting power of
our outstanding shares of voting stock. The affirmative vote of holders of at least a majority of the voting power of our outstanding shares of stock will generally be required to amend other provisions of our amended and restated certificate of
incorporation. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Amendment of Bylaws </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Certain provisions of our amended and restated bylaws may generally be altered, amended, or repealed, and new bylaws may be
adopted, with the affirmative vote of a majority of directors present at any regular or special meeting of the board of directors called for that purpose, provided that any alteration, amendment, or repeal of, or adoption of any bylaw inconsistent
with specified provisions of the bylaws, including those related to special and annual meetings of stockholders, action of stockholders by written consent, nomination of directors, transfers of capital stock and dividends requires the affirmative
vote of at least&nbsp;66 2/3% of all directors in office at a meeting called for that purpose. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">All other provisions of
our amended and restated bylaws may generally be altered, amended, or repealed, and new bylaws may be adopted, with the affirmative vote of holders of&nbsp;66 2/3% of the voting power of our outstanding shares of voting stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Other Limitations on Stockholder Actions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our amended and restated bylaws impose some procedural requirements on stockholders who wish to: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">make nominations in the election of directors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">propose that a director be removed; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">propose any repeal or change in our amended and restated bylaws; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">propose any other business to be brought before an annual or special meeting of stockholders.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">251 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Under these procedural requirements, in order to bring a proposal before a
meeting of stockholders, a stockholder must deliver timely notice of a proposal pertaining to a proper subject for presentation at the meeting to our corporate secretary along with the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a description of the business or nomination to be brought before the meeting and the reasons for conducting
such business at the meeting; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the stockholder&#146;s name and address; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any material interest of the stockholder in the proposal; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the number of shares beneficially owned by the stockholder and evidence of such ownership; and
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the names and addresses of all persons with whom the stockholder is acting in concert and a description of all
arrangements and understandings with those persons, and the number of shares such persons beneficially own. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">To be timely, a stockholder must generally deliver notice: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in connection with an annual meeting of stockholders, not less than 120 nor more than 150 days prior to the
date on which the annual meeting of stockholders was held in the immediately preceding year, but in the event that the date of the annual meeting is more than 30 days before or more than 70 days after the anniversary date of the preceding annual
meeting of stockholders, a stockholder notice will be timely if received by us not later than the close of business on the later of (i)&nbsp;not less than 70 nor more than 120 days prior to the date of the annual meeting and (ii)&nbsp;the 10th day
following the day on which we first publicly announce the date of the annual meeting; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in connection with the election of a director at a special meeting of stockholders, during the period not less
than 120 nor more than 150 days prior to the date of the special meeting, or the 10th day following the day on which a notice of the date of the special meeting was mailed to the stockholders or the public disclosure of that date was made.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In order to submit a nomination for our board of directors, a stockholder must also submit all
information with respect to the nominee that would be required to be included in a proxy statement, as well as other information. If a stockholder fails to follow the required procedures, the stockholder&#146;s proposal or nominee will be ineligible
and will not be voted on by our stockholders. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Limitation of Liability of Directors and Officers </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our amended and restated certificate of incorporation provides that no director will be personally liable to us or our
stockholders for monetary damages for breach of fiduciary duty as a director, except as required by applicable law, as in effect from time to time. Section&nbsp;102(b)(7) of the Delaware General Corporation Law permits a corporation to provide in
its certificate of incorporation that a director of the corporation shall not be personally liable to the corporation or its stockholders for monetary damages for breach of fiduciary duty as a director, except for liability for: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any breach of the director&#146;s duty of loyalty to our company or our stockholders; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any act or omission not in good faith or which involved intentional misconduct or a knowing violation of law;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">unlawful payments of dividends or unlawful stock repurchases or redemptions as provided in Section&nbsp;174 of
the Delaware General Corporation Law; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any transaction from which the director derived an improper personal benefit. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As a result, neither we nor our stockholders have the right, through stockholders&#146; derivative suits on our behalf, to
recover monetary damages against a director for breach of fiduciary duty as a director, including breaches resulting from grossly negligent behavior, except in the situations described above. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">252 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our amended and restated certificate of incorporation also provides that, to
the fullest extent permitted by law, we will indemnify any officer or director of our company against all damages, claims, and liabilities arising out of the fact that the person is or was our director or officer, or served any other enterprise at
our request as a director or officer. Amending this provision will not reduce our indemnification obligations relating to actions taken before an amendment. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forum Selection </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our
current certificate of incorporation provides, and our amended and restated certificate of incorporation will provide that the Court of Chancery of the State of Delaware will be the sole and exclusive forum for the following types of actions or
proceedings under Delaware statutory or common law: (i)&nbsp;any derivative action or proceeding brought on behalf of us; (ii)&nbsp;any action asserting a claim of breach of fiduciary duty owed by any director, officer, or other employee of our
company to us or our stockholders; (iii)&nbsp;any action asserting a claim arising pursuant to any provision of the Delaware General Corporation Law or our amended and restated certificate of incorporation and bylaws; or (iv)&nbsp;any action
asserting a claim governed by the internal affairs doctrine. This provision would not apply to claims brought to enforce a duty or liability created by the Securities Exchange Act of 1934, as amended, or any other claim for which the federal courts
have exclusive jurisdiction. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Furthermore, our amended and restated certificate of incorporation will also provide
that unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities
Act of 1933, as amended. Any person or entity purchasing or otherwise acquiring any interest in our shares of capital stock shall be deemed to have notice of and consented to the foregoing forum selection provisions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our exclusive forum provision will not relieve us of our duties to comply with the federal securities laws and the rules and
regulations thereunder, and our stockholders will not be deemed to have waived our compliance with these laws, rules and regulations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The enforceability of similar federal court choice of forum provisions in other companies&#146; certificates of incorporation
has been challenged in legal proceedings, and it is possible that a court could find this type of provision to be inapplicable or unenforceable. If a court were to find either of the choice of forum provisions contained in our amended and restated
certificate of incorporation or amended and restated bylaws to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The choice of forum provisions may limit a stockholder&#146;s ability to bring a claim in a judicial forum that it finds
favorable for disputes with the company or its directors, officers or other employees, which may discourage such lawsuits against the company and its directors, officers and other employees and result in increased costs for investors to bring a
claim. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Delaware Business Combination Statute </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have elected to be subject to Section&nbsp;203 of the Delaware General Corporation Law. Section&nbsp;203 prevents an
&#147;interested stockholder,&#148; which is defined generally as a person owning 15% or more of a corporation&#146;s voting stock, or any affiliate or associate of that person, from engaging in a broad range of &#147;business combinations&#148;
with the corporation for three years after becoming an interested stockholder unless: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the board of directors of the corporation had previously approved either the business combination or the
transaction that resulted in the stockholder becoming an interested stockholder; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">upon completion of the transaction that resulted in the stockholder becoming an interested stockholder, that
person owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, other than statutorily excluded shares; or </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">253 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">following the transaction in which that person became an interested stockholder, the business combination is
approved by the board of directors of the corporation and holders of at least <FONT STYLE="white-space:nowrap">two-thirds</FONT> of the outstanding voting stock not owned by the interested stockholder. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Under Section&nbsp;203, the restrictions described above also do not apply to specific business combinations proposed by an
interested stockholder following the announcement or notification of designated extraordinary transactions involving the corporation and a person who had not been an interested stockholder during the previous three years or who became an interested
stockholder with the approval of a majority of the corporation&#146;s directors, if such extraordinary transaction is approved or not opposed by a majority of the directors who were directors prior to any person becoming an interested stockholder
during the previous three years or were recommended for election or elected to succeed such directors by a majority of such directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;203 may make it more difficult for a person who would be an interested stockholder to effect various business
combinations with a corporation for a <FONT STYLE="white-space:nowrap">three-year</FONT> period. Section&nbsp;203 also may have the effect of preventing changes in our management and could make it more difficult to accomplish transactions that our
stockholders may otherwise deem to be in their best interests. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Washington Business Corporation Act </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The laws of Washington, where our principal executive offices are located, impose restrictions on certain transactions between
certain foreign corporations and significant stockholders. In particular, the Washington Business Corporation Act (WBCA), prohibits a &#147;target corporation,&#148; with certain exceptions, from engaging in certain &#147;significant business
transactions&#148; with a person or group of persons which beneficially owns 10% or more of the voting securities of the target corporation, an &#147;acquiring person,&#148; for a period of five years after such acquisition, unless the transaction
or acquisition of shares is approved by a majority of the members of the target corporation&#146;s board of directors prior to the time of acquisition. Such prohibited transactions may include, among other things: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any merger or consolidation with, disposition of assets to, or issuance or redemption of stock to or from, the
acquiring person; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any termination of 5% or more of the employees of the target corporation as a result of the acquiring
person&#146;s acquisition of 10% or more of the shares; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">allowing the acquiring person to receive any disproportionate benefit as a stockholder. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">After the <FONT STYLE="white-space:nowrap">five-year</FONT> period, a significant business transaction may take place as long
as it complies with certain fair price provisions of the statute or is approved at an annual or special meeting of stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We will be considered a &#147;target corporation&#148; so long as our principal executive office is located in Washington,
and: (i)&nbsp;a majority of our employees are residents of the state of Washington or we employ more than one thousand residents of the state of Washington; (ii)&nbsp;a majority of our tangible assets, measured by market value, are located in the
state of Washington or we have more than $50.0&nbsp;million worth of tangible assets located in the state of Washington; and (iii)&nbsp;any one of the following: (a)&nbsp;more than 10% of our stockholders of record are resident in the state of
Washington; (b)&nbsp;more than 10% of our shares are owned of record by state residents; or (c)&nbsp;1,000 or more of our stockholders of record are resident in the state. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If we meet the definition of a target corporation, the WBCA may have the effect of delaying, deferring or preventing a change
of control. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">254 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Anti-Takeover</FONT> Effects of Some Provisions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Certain provisions of our amended and restated certificate of incorporation and amended and restated bylaws could make the
following more difficult: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">acquisition of control of us by means of a proxy contest, tender offer, or otherwise; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">removal of our incumbent officers and directors. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">These provisions, as well as our ability to issue preferred stock, are designed to discourage coercive takeover practices and
inadequate takeover bids. These provisions are also designed to encourage persons seeking to acquire control of us to first negotiate with our board of directors. We believe that the benefits of increased protection give us the potential ability to
negotiate with the proponent of an unfriendly or unsolicited proposal to acquire or restructure us, and that the benefits of this increased protection outweigh the disadvantages of discouraging those proposals, because negotiation of those proposals
could result in an improvement of their terms. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Listing </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have applied to list our common stock on the Nasdaq Global Select Market under the symbol &#147;SANA.&#148; </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Transfer Agent and Registrar </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The transfer agent and registrar for the common stock will be American Stock Transfer &amp; Trust Company, LLC. The transfer
agent&#146;s address is 6201 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> Avenue, Brooklyn, NY 11219. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">255 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc60414_17"></A>MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES FOR <FONT
STYLE="white-space:nowrap">NON-U.S.</FONT> HOLDERS OF COMMON STOCK </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following discussion is a summary of the
material U.S. federal income tax consequences <FONT STYLE="white-space:nowrap">to&nbsp;Non-U.S.&nbsp;Holders</FONT> (as defined below) of the purchase, ownership, and disposition of our common stock issued pursuant to this offering, but does not
purport to be a complete analysis of all potential tax effects. The effects of other U.S. federal tax laws, such as estate and gift tax laws, and any applicable state, local, or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> tax laws are not
discussed. This discussion is based on the U.S. Internal Revenue Code of 1986, as amended (the Code), Treasury Regulations promulgated thereunder, judicial decisions, and published rulings and administrative pronouncements of the U.S. Internal
Revenue Service (the IRS), in each case in effect as of the date hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">These authorities may change or be subject to
differing interpretations. Any such change or differing interpretation may be applied retroactively in a manner that could adversely affect <FONT STYLE="white-space:nowrap">a&nbsp;Non-U.S.&nbsp;Holder.</FONT> We have not sought and will not seek any
rulings from the IRS regarding the matters discussed below. There can be no assurance the IRS or a court will not take a contrary position to that discussed below regarding the tax consequences of the purchase, ownership, and disposition of our
common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This discussion is limited <FONT STYLE="white-space:nowrap">to&nbsp;Non-U.S.&nbsp;Holders</FONT> that hold
our common stock as a &#147;capital asset&#148; within the meaning of Section&nbsp;1221 of the Code (generally, property held for investment). This discussion does not address all U.S. federal income tax consequences relevant to <FONT
STYLE="white-space:nowrap">a&nbsp;Non-U.S.&nbsp;Holder&#146;s</FONT> particular circumstances, including the impact of the Medicare contribution tax on net investment income or the alternative minimum tax. In addition, it does not address
consequences relevant <FONT STYLE="white-space:nowrap">to&nbsp;Non-U.S.&nbsp;Holders</FONT> subject to special rules, including, without limitation: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">U.S. expatriates and former citizens <FONT STYLE="white-space:nowrap">or&nbsp;long-term&nbsp;residents</FONT>
of the United States; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons holding our common stock as part of a hedge, straddle, or other risk reduction strategy or as part of
a conversion transaction or other integrated investment; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">banks, insurance companies, and other financial institutions; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">brokers, dealers, or traders in securities; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;controlled foreign corporations,&#148; &#147;passive foreign investment companies,&#148; and
corporations that accumulate earnings to avoid U.S. federal income tax; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">partnerships or other entities or arrangements treated as partnerships for U.S. federal income tax purposes
(and investors therein); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">tax-exempt&nbsp;organizations</FONT> or governmental organizations;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons deemed to sell our common stock under the constructive sale provisions of the Code;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">persons who hold or receive our common stock pursuant to the exercise of any employee stock option or
otherwise as compensation; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">tax-qualified&nbsp;retirement</FONT> plans; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">&#147;qualified foreign pension funds&#148; as defined in Section&nbsp;897(l)(2) of the Code and entities all
of the interests of which are held by qualified foreign pension funds. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If an entity treated as a
partnership for U.S. federal income tax purposes holds our common stock, the tax treatment of a partner in the partnership will depend on the status of the partner, the activities of the partnership, and certain determinations made at the partner
level. Accordingly, partnerships holding our common stock and the partners in such partnerships should consult their tax advisors regarding the U.S. federal income tax consequences to them. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">256 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">THIS DISCUSSION IS NOT TAX ADVICE. INVESTORS SHOULD CONSULT THEIR TAX
ADVISORS WITH RESPECT TO THE APPLICATION OF THE U.S. FEDERAL INCOME TAX LAWS TO THEIR PARTICULAR SITUATIONS AS WELL AS ANY TAX CONSEQUENCES OF THE PURCHASE, OWNERSHIP, AND DISPOSITION OF OUR COMMON STOCK ARISING UNDER THE U.S. FEDERAL ESTATE OR GIFT
TAX LAWS OR UNDER THE LAWS OF ANY STATE, LOCAL <FONT STYLE="white-space:nowrap">OR&nbsp;NON-U.S.&nbsp;TAXING</FONT> JURISDICTION OR UNDER ANY APPLICABLE INCOME TAX TREATY. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Definition of <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For purposes of this discussion, <FONT STYLE="white-space:nowrap">a&nbsp;&#147;Non-U.S.&nbsp;Holder&#148;</FONT> is any
beneficial owner of our common stock that is neither a &#147;U.S. person&#148; nor an entity treated as a partnership for U.S. federal income tax purposes. A U.S. person is any person that, for U.S. federal income tax purposes, is or is treated as
any of the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an individual who is a citizen or resident of the United States; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a corporation created or organized under the laws of the United States, any state thereof, or the District of
Columbia; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an estate, the income of which is subject to U.S. federal income tax regardless of its source; or
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a trust that (i)&nbsp;is subject to the primary supervision of a U.S. court and all substantial decisions of
which are subject to the control of one or more &#147;United States persons&#148; (within the meaning of Section&nbsp;7701(a)(30) of the Code), or (ii)&nbsp;has a valid election in effect to be treated as a United States person for U.S. federal
income tax purposes. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Distributions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As described in the section titled &#147;Dividend Policy,&#148; we have never declared or paid cash dividends on our capital
stock, and we do not anticipate paying any cash dividends in the foreseeable future. However, if we do make distributions of cash or property on our common stock, such distributions will constitute dividends for U.S. federal income tax purposes to
the extent paid from our current or accumulated earnings and profits, as determined under U.S. federal income tax principles. Amounts not treated as dividends for U.S. federal income tax purposes will constitute returns of capital and first be
applied against and reduce <FONT STYLE="white-space:nowrap">a&nbsp;Non-U.S.&nbsp;Holder&#146;s</FONT> adjusted tax basis in its common stock, but not below zero. Any excess will be treated as capital gain and will be treated as described below under
&#147;&#151;Sale or Other Taxable Disposition.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Subject to the discussion below regarding effectively connected
income, dividends paid to <FONT STYLE="white-space:nowrap">a&nbsp;Non-U.S.&nbsp;Holder</FONT> will be subject to U.S. federal withholding tax at a rate of 30% of the gross amount of the dividends (or such lower rate specified by an applicable income
tax treaty, provided <FONT STYLE="white-space:nowrap">the&nbsp;Non-U.S.&nbsp;Holder</FONT> furnishes a valid IRS <FONT STYLE="white-space:nowrap">Form&nbsp;W-8BEN&nbsp;or</FONT> IRS
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Form&nbsp;W-8BEN-E&nbsp;(or</FONT></FONT> other applicable documentation) certifying qualification for the lower treaty rate).
<FONT STYLE="white-space:nowrap">A&nbsp;Non-U.S.&nbsp;Holder</FONT> that does not timely furnish the required documentation, but that qualifies for a reduced treaty rate, may obtain a refund of any excess amounts withheld by timely filing an
appropriate claim for refund with the <FONT STYLE="white-space:nowrap">IRS.&nbsp;Non-U.S.&nbsp;Holders</FONT> should consult their tax advisors regarding their entitlement to benefits under any applicable tax treaties. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If dividends paid to <FONT STYLE="white-space:nowrap">a&nbsp;Non-U.S.&nbsp;Holder</FONT> are effectively connected with <FONT
STYLE="white-space:nowrap">the&nbsp;Non-U.S.&nbsp;Holder&#146;s</FONT> conduct of a trade or business within the United States (and, if required by an applicable income tax treaty,
<FONT STYLE="white-space:nowrap">the&nbsp;Non-U.S.&nbsp;Holder</FONT> maintains a permanent establishment in the United States to which such dividends are attributable), <FONT STYLE="white-space:nowrap">the&nbsp;Non-U.S.&nbsp;Holder</FONT> will be
exempt from the U.S. federal withholding tax described above. To claim the exemption, <FONT STYLE="white-space:nowrap">the&nbsp;Non-U.S.&nbsp;Holder</FONT> must furnish to the applicable withholding agent a valid IRS
<FONT STYLE="white-space:nowrap">Form&nbsp;W-8ECI,&nbsp;certifying</FONT> that the dividends are effectively connected with <FONT STYLE="white-space:nowrap">the&nbsp;Non-U.S.&nbsp;Holder&#146;s</FONT> conduct of a trade or business within the United
States. Any such effectively connected dividends will be subject to U.S. federal income tax on a net income basis at the regular rates applicable to United States persons. <FONT STYLE="white-space:nowrap">A&nbsp;Non-U.S.&nbsp;Holder</FONT> that is a
corporation also may be subject to a branch profits tax at a rate of 30% (or such </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">257 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
lower rate specified by an applicable income tax treaty) on such effectively connected dividends, as adjusted for certain <FONT STYLE="white-space:nowrap">items.&nbsp;Non-U.S.&nbsp;Holders</FONT>
should consult their tax advisors regarding any applicable tax treaties that may provide for different rules. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Sale or Other Taxable Disposition
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Subject to the discussion below regarding backup withholding,
<FONT STYLE="white-space:nowrap">a&nbsp;Non-U.S.&nbsp;Holder</FONT> will not be subject to U.S. federal income tax on any gain realized upon the sale or other taxable disposition of our common stock unless: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the gain is effectively connected with
<FONT STYLE="white-space:nowrap">the&nbsp;Non-U.S.&nbsp;Holder&#146;s</FONT> conduct of a trade or business within the United States (and, if required by an applicable income tax treaty,
<FONT STYLE="white-space:nowrap">the&nbsp;Non-U.S.&nbsp;Holder</FONT> maintains a permanent establishment in the United States to which such gain is attributable); </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">the&nbsp;Non-U.S.&nbsp;Holder</FONT> is a nonresident alien individual
present in the United States for 183 days or more during the taxable year of the disposition and certain other requirements are met; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our common stock constitutes a U.S. real property interest (USRPI) by reason of our status as a U.S. real
property holding corporation (USRPHC) for U.S. federal income tax purposes. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Gain described in the first
bullet point above generally will be subject to U.S. federal income tax on a net income basis at the regular rates applicable to United States persons. <FONT STYLE="white-space:nowrap">A&nbsp;Non-U.S.&nbsp;Holder</FONT> that is a corporation also
may be subject to a branch profits tax at a rate of 30% (or such lower rate specified by an applicable income tax treaty) on such effectively connected gain, as adjusted for certain items. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder described in the second bullet point above will be subject to U.S.
federal income tax at a rate of 30% (or such lower rate specified by an applicable income tax treaty) on gain realized upon the sale or other taxable disposition of our common stock, which may be offset by
<FONT STYLE="white-space:nowrap">certain&nbsp;U.S.-source&nbsp;capital</FONT> losses of <FONT STYLE="white-space:nowrap">the&nbsp;Non-U.S.&nbsp;Holder</FONT> (even though the individual is not considered a resident of the United States), provided <FONT
STYLE="white-space:nowrap">the&nbsp;Non-U.S.&nbsp;Holder</FONT> has timely filed U.S. federal income tax returns with respect to such losses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">With respect to the third bullet point above, we believe we currently are not, and do not anticipate becoming, a USRPHC.
Because the determination of whether we are a USRPHC depends, however, on the fair market value of our USRPIs relative to the fair market value of <FONT STYLE="white-space:nowrap">our&nbsp;non-U.S.&nbsp;real</FONT> property interests and our other
business assets, there can be no assurance that we currently are not a USRPHC or will not become one in the future. Even if we are or were to become a USRPHC, gain arising from the sale or other taxable disposition of our common stock by <FONT
STYLE="white-space:nowrap">a&nbsp;Non-U.S.&nbsp;Holder</FONT> will not be subject to U.S. federal income tax if our common stock is &#147;regularly traded,&#148; as defined by applicable Treasury Regulations, on an established securities market, and
<FONT STYLE="white-space:nowrap">such&nbsp;Non-U.S.&nbsp;Holder</FONT> owned, actually and constructively, 5% or less of our common stock throughout the shorter of <FONT STYLE="white-space:nowrap">the&nbsp;five-year&nbsp;period</FONT> ending on the
date of the sale or other taxable disposition or <FONT STYLE="white-space:nowrap">the&nbsp;Non-U.S.&nbsp;Holder&#146;s</FONT> holding period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><FONT STYLE="white-space:nowrap">Non-U.S.&nbsp;Holders</FONT> should consult their tax advisors regarding any applicable tax
treaties that may provide for different rules. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Information Reporting and Backup Withholding </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Payments of dividends on our common stock will not be subject to backup withholding, provided
<FONT STYLE="white-space:nowrap">the&nbsp;Non-U.S.&nbsp;Holder</FONT> certifies <FONT STYLE="white-space:nowrap">its&nbsp;non-U.S.&nbsp;status,</FONT> such as by furnishing a valid IRS
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Form&nbsp;W-8BEN,&nbsp;W-8BEN-E,</FONT></FONT></FONT> <FONT STYLE="white-space:nowrap">or&nbsp;W-8ECI,&nbsp;or</FONT> otherwise establishes an
exemption. However, information returns are required to be filed with the IRS in connection with any distributions on our common stock paid to <FONT STYLE="white-space:nowrap">the&nbsp;Non-U.S.&nbsp;Holder,</FONT> regardless of whether any tax was
actually withheld. In addition, proceeds of the sale or other taxable disposition of our common stock within the United States or conducted through <FONT STYLE="white-space:nowrap">certain&nbsp;U.S.-related&nbsp;brokers</FONT> generally will not be
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">258 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
subject to backup withholding or information reporting if the applicable withholding agent receives the certification described above or
<FONT STYLE="white-space:nowrap">the&nbsp;Non-U.S.&nbsp;Holder</FONT> otherwise establishes an exemption. Proceeds of a disposition of our common stock conducted through <FONT STYLE="white-space:nowrap">a&nbsp;non-U.S.&nbsp;office</FONT> of <FONT
STYLE="white-space:nowrap">a&nbsp;non-U.S.&nbsp;broker</FONT> that does not have certain enumerated relationships with the United States generally will not be subject to backup withholding or information reporting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Copies of information returns that are filed with the IRS may also be made available under the provisions of an applicable
treaty or agreement to the tax authorities of the country in which <FONT STYLE="white-space:nowrap">the&nbsp;Non-U.S.&nbsp;Holder</FONT> resides or is established. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules may be allowed as a
refund or a credit against <FONT STYLE="white-space:nowrap">a&nbsp;Non-U.S.&nbsp;Holder&#146;s</FONT> U.S. federal income tax liability, provided the required information is timely furnished to the IRS. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Additional Withholding Tax on Payments Made to Foreign Accounts </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Withholding taxes may be imposed under Sections 1471 to 1474 of the Code (such Sections commonly referred to as the Foreign
Account Tax Compliance Act (FATCA)) on certain types of payments made <FONT STYLE="white-space:nowrap">to&nbsp;non-U.S.&nbsp;financial</FONT> institutions and certain <FONT STYLE="white-space:nowrap">other&nbsp;non-U.S.&nbsp;entities.</FONT>
Specifically, a 30% withholding tax may be imposed on dividends on, or (subject to the proposed Treasury Regulations discussed below) gross proceeds from the sale or other disposition of, our common stock paid to a &#147;foreign financial
institution&#148; or <FONT STYLE="white-space:nowrap">a&nbsp;&#147;non-financial&nbsp;foreign</FONT> entity&#148; (each as defined in the Code), unless (i)&nbsp;the foreign financial institution undertakes certain diligence and reporting
obligations, <FONT STYLE="white-space:nowrap">(ii)&nbsp;the&nbsp;non-financial&nbsp;foreign</FONT> entity either certifies it does not have any &#147;substantial United States owners&#148; (as defined in the Code) or furnishes identifying
information regarding each substantial United States owner, or (iii)&nbsp;the foreign financial institution <FONT STYLE="white-space:nowrap">or&nbsp;non-financial&nbsp;foreign</FONT> entity otherwise qualifies for an exemption from these rules. If
the payee is a foreign financial institution and is subject to the diligence and reporting requirements in (i)&nbsp;above, it must enter into an agreement with the U.S. Department of the Treasury requiring, among other things, that it undertakes to
identify accounts held by certain &#147;specified United States persons&#148; or &#147;United States owned foreign entities&#148; (each as defined in the Code), annually reports certain information about such accounts, and withholds 30% on certain
payments <FONT STYLE="white-space:nowrap">to&nbsp;non-compliant&nbsp;foreign</FONT> financial institutions and certain other account holders. Foreign financial institutions located in jurisdictions that have an intergovernmental agreement with the
United States governing FATCA may be subject to different rules. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Under the applicable Treasury Regulations and
administrative guidance, withholding under FATCA generally applies to payments of dividends on our common stock. While withholding under FATCA would have applied also to payments of gross proceeds from the sale or other disposition of stock on or
after January&nbsp;1, 2019, proposed Treasury Regulations eliminate FATCA withholding on payments of gross proceeds entirely. Taxpayers generally may rely on these proposed Treasury Regulations until final Treasury Regulations are issued. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Prospective investors should consult their tax advisors regarding the potential application of withholding under FATCA to
their investment in our common stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">259 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc60414_18"></A>SHARES ELIGIBLE FOR FUTURE SALE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Prior to this offering, there has been no public market for our common stock. Future sales of substantial amounts of our
common stock in the public market could adversely affect market prices prevailing from time to time. Furthermore, because only a limited number of shares will be available for sale shortly after this offering due to existing contractual and legal
restrictions on resale as described below, there may be sales of substantial amounts of our common stock in the public market after the restrictions lapse. This may adversely affect the prevailing market price and our ability to raise equity capital
in the future. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Based on the number of shares of our common stock outstanding as of September&nbsp;30, 2020, upon
completion of this offering, we will have 175,314,776 shares of common stock outstanding, assuming no exercise of the underwriters&#146; option to purchase additional shares and no exercise of any options after September&nbsp;30, 2020. Of these
shares, 15,000,000 shares, or 17,250,000 shares if the underwriters exercise their over-allotment option to purchase additional shares in full, sold in this offering (excluding any shares sold to affiliates in the directed share program) will be
freely transferable without restriction or registration under the Securities Act, except for any shares purchased by one of our existing &#147;affiliates,&#148; as that term is defined in Rule 144 under the Securities Act. The remaining 160,314,776
shares of common stock outstanding will bear &#147;restricted shares&#148; as defined in Rule&nbsp;144. Restricted shares and the shares of common stock into which such securities are convertible may be sold in the public market only if registered
or if they qualify for an exemption from registration under Rules&nbsp;144 or 701 of the Securities Act, which rules are summarized below. As a result of the contractual <FONT STYLE="white-space:nowrap">lock-up</FONT> period ending 180 days after
the date of this prospectus described below and the provisions of Rules 144 and 701, these shares will be available for sale in the public market as follows: </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="47%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Number of Shares</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Date</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">160,314,776</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">After 180 days from the date of this prospectus</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">(subject, in some cases, to volume limitations)</P></TD></TR>
</TABLE>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Rule 144 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In general, a person who has beneficially owned restricted shares of our common stock for at least six months would be entitled
to sell such securities, provided that (i)&nbsp;such person is not deemed to have been one of our affiliates at the time of, or at any time during the 90 days preceding, a sale; and (ii)&nbsp;we are subject to the Exchange Act periodic reporting
requirements for at least 90 days before the sale. Persons who have beneficially owned restricted shares of our common stock for at least six months but who are our affiliates at the time of, or any time during the 90 days preceding, a sale, would
be subject to additional restrictions, by which such person would be entitled to sell within any <FONT STYLE="white-space:nowrap">three-month</FONT> period only a number of securities that does not exceed the greater of either of the following: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">1% of the number of shares of our common stock then outstanding, which will equal approximately shares
immediately after this offering, assuming no exercise of the underwriters&#146; option to purchase additional shares; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the average weekly trading volume of shares of our common stock on the Nasdaq Global Select Market during the
four calendar weeks preceding the filing of a notice on Form 144 with respect to the sale; </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">provided, in each case, that
we are subject to the Exchange Act periodic reporting requirements for at least 90 days before the sale. Such sales both by affiliates and by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> must also comply with the manner of sale, current
public information, and notice provisions of Rule 144 to the extent applicable. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Rule 701 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In general, under Rule 701 as currently in effect, any of our employees, directors, officers, consultants or advisors who
acquired common stock from us in connection with a written compensatory stock or option plan or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">260 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
other written agreement in compliance with Rule 701 before the effective date of the registration statement of which this prospectus is a part (to the extent such common stock is not subject to <FONT
STYLE="white-space:nowrap">a&nbsp;lock-up&nbsp;agreement)</FONT> and who are not our &#147;affiliates&#148; as defined in Rule 144 during the immediately preceding 90 days, is entitled to rely on Rule 701 to resell such shares beginning 90 days
after the date of this prospectus in reliance on Rule 144, but without complying with the notice, manner of sale, public information requirements or volume limitation provisions of Rule 144. Persons who are our &#147;affiliates&#148; may resell
those shares beginning 90 days after the date of this prospectus without compliance with minimum holding period requirements under Rule 144 (subject to the terms of <FONT STYLE="white-space:nowrap">the&nbsp;lock-up&nbsp;agreement</FONT> referred to
below, if applicable). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Lock-Up&nbsp;Agreements</FONT> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In connection with this offering, we, our directors, our executive officers and holders of substantially all of our other
outstanding shares of common stock or securities convertible into or exchangeable for shares of our common stock outstanding upon the completion of this offering, have entered into or will enter into lock-up agreements with the underwriters, subject
to certain exceptions more fully described under the section titled &#147;Underwriting,&#148; not to dispose of or hedge any of their common stock or securities convertible into or exchangeable for shares of common stock during the period from the
date of this prospectus continuing through the date 180 days after the date of this prospectus, except with the prior consent of Morgan Stanley &amp; Co. LLC, Goldman Sachs &amp; Co. LLC, J.P. Morgan Securities LLC and BofA Securities, Inc. See the
section titled &#147;Underwriting&#148; for additional information. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Registration Rights </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Upon the completion of this offering, the holders of approximately 134.1&nbsp;million shares of our common stock will be
entitled to rights with respect to the registration of their shares under the Securities Act, subject to <FONT STYLE="white-space:nowrap">the&nbsp;lock-up&nbsp;agreements</FONT> described
<FONT STYLE="white-space:nowrap">under&nbsp;&#147;&#151;Lock-Up&nbsp;Agreements&#148;</FONT> above. Registration of these shares under the Securities Act would result in the shares becoming freely tradable without restriction under the Securities
Act, except for shares purchased by affiliates, immediately upon the effectiveness of the registration statement of which this prospectus is a part. Any sales of securities by these stockholders could have a material adverse effect on the trading
price of our common stock. The requisite percentage of these stockholders will waive all such stockholders&#146; rights to notice of this offering and to include their shares of registrable securities in this offering. See the section titled
&#147;Description of Capital Stock&#151;Registration Rights.&#148; </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Equity Incentive Plans </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We intend to file with the SEC a registration statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-8&nbsp;under</FONT> the
Securities Act covering the shares of common stock reserved for issuance under our 2018 Plan, 2021 Plan and our ESPP. Such registration statement is expected to be filed and become effective as soon as practicable after the completion of this
offering. Accordingly, shares registered under such registration statement will be available for sale in the open market following its effective date, subject to Rule&nbsp;144 volume limitations and
<FONT STYLE="white-space:nowrap">the&nbsp;lock-up&nbsp;agreements</FONT> described above, if applicable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">261 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc60414_19"></A>UNDERWRITING </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Under the terms and subject to the conditions in an underwriting agreement dated the date of this prospectus, the underwriters
named below, for whom Morgan Stanley&nbsp;&amp; Co. LLC, Goldman Sachs&nbsp;&amp; Co. LLC, J.P. Morgan Securities LLC, and BofA Securities, Inc. are acting as representatives, have severally agreed to purchase, and we have agreed to sell to them,
severally, the number of shares indicated below: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="75%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="83%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Number&nbsp;of<BR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shares&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Morgan Stanley&nbsp;&amp; Co. LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goldman Sachs&nbsp;&amp; Co. LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BofA Securities, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The underwriters and the representatives are collectively referred to as the
&#147;underwriters&#148; and the &#147;representatives,&#148; respectively. The underwriters are offering the shares of common stock subject to their acceptance of the shares from us and subject to prior sale. The underwriting agreement provides
that the obligations of the several underwriters to pay for and accept delivery of the shares of common stock offered by this prospectus are subject to the approval of certain legal matters by their counsel and to certain other conditions. The
underwriters are obligated to take and pay for all of the shares of common stock offered by this prospectus if any such shares are taken. However, the underwriters are not required to take or pay for the shares covered by the underwriters&#146;
over-allotment option described below. The offering of the shares of common stock by the underwriters is subject to receipt and acceptance and subject to the underwriters&#146; right to reject any order in whole or in part. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The underwriters initially propose to offer part of the shares of common stock directly to the public at the offering price
listed on the cover page of this prospectus and part to certain dealers at a price that represents a concession not in excess of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share under the public offering price.
After the initial offering of the shares of common stock, the offering price and other selling terms may from time to time be varied by the representatives. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have granted to the underwriters an option, exercisable for 30 days from the date of this prospectus, to purchase up to
2,250,000 additional shares of common stock at the public offering price listed on the cover page of this prospectus, less underwriting discounts and commissions. The underwriters may exercise this option solely for the purpose of covering
over-allotments, if any, made in connection with the offering of the shares of common stock offered by this prospectus. To the extent the option is exercised, each underwriter will become obligated, subject to certain conditions, to purchase about
the same percentage of the additional shares of common stock as the number listed next to the underwriter&#146;s name in the preceding table bears to the total number of shares of common stock listed next to the names of all underwriters in the
preceding table. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following table shows the per share and total public offering price, underwriting discounts and
commissions, and proceeds before expenses to us. These amounts are shown assuming both no exercise and full exercise of the underwriters&#146; option to purchase up to an additional 2,250,000 shares of our common stock. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Per&nbsp;Share</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>No&nbsp;Exercise</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Full&nbsp;Exercise</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Initial public offering price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Underwriting discounts and commissions to be paid by us:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds, before expenses, to us</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">262 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The estimated offering expenses payable by us, exclusive of the
underwriting discounts and commissions, are approximately $3.8&nbsp;million. We have also agreed to reimburse the underwriters for expense relating to clearance of this offering with the Financial Industry Regulatory Authority up to $40,000. </P>
 <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The underwriters have informed us that they do not intend sales to discretionary accounts to exceed 5% of the total
number of shares of common stock offered by them. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have applied to list our common stock on the Nasdaq Global Select
Market under the trading symbol&nbsp;&#147;SANA&#148;. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We and all of our directors and officers and the holders of
substantially all of our outstanding securities have agreed that, without the prior written consent of Morgan Stanley&nbsp;&amp; Co. LLC, Goldman Sachs&nbsp;&amp; Co. LLC, J.P. Morgan Securities LLC, and BofA Securities, Inc. on behalf of the
underwriters, we and they will not, and will not publicly disclose an intention to, during the period ending 180 days after the date of this prospectus (the Restricted Period): </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or
contract to sell, grant any option, right or warrant to purchase, lend or otherwise transfer, or dispose of, directly or indirectly, any shares of common stock or any securities convertible into or exercisable or exchangeable for shares of common
stock; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">submit or file any registration statement with the SEC relating to the offering of any shares of common stock
or any securities convertible into or exercisable or exchangeable for common stock; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic
consequences of ownership of the common stock. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Whether any such transaction described above is to be settled by
delivery of common stock or such other securities, in cash or otherwise. In addition, we and each such person have agreed that, without the prior written consent of Morgan Stanley&nbsp;&amp; Co. LLC, Goldman Sachs&nbsp;&amp; Co. LLC, J.P. Morgan
Securities LLC, and BofA Securities, Inc. on behalf of the underwriters, we or such other person will not, during the restricted period, make any demand for, or exercise any right with respect to, the registration of any shares of common stock or
any security convertible into or exercisable or exchangeable for common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The restrictions described in the
immediately preceding paragraph do not apply to us with respect to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="right">(a)</TD>
<TD WIDTH="2%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">shares sold pursuant to the underwriting agreement; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="right">(b)</TD>
<TD WIDTH="2%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">issuance of securities upon the exercise of options or warrants or conversion of any securities outstanding on
the date of this prospectus; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="right">(c)</TD>
<TD WIDTH="2%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">grants of options, restricted stock or other equity awards and issuance of securities to employees, officers,
directors, advisors, or consultants of our company pursuant to a plan in effect on the date of this prospectus, provided that the recipient such grants shall sign and deliver a lock-up agreement; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="right">(d)</TD>
<TD WIDTH="2%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">filing of a Form&nbsp;S-8; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="right">(e)</TD>
<TD WIDTH="2%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">securities issued in connection with any merger, joint venture, strategic alliances, commercial or other
collaborative transaction or the acquisition or licenses of the business, property, technology or other assets of another individual or entity or the assumption of an employee benefit plan in connection with a merger or acquisition, provided
aggregate number of securities that we may issue or agree to issue shall not exceed 10% of our total share capital following this offering, and the recipient of such securities shall sign and deliver a lock-up agreement; or </P></TD></TR></TABLE>
 <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="right">(f)</TD>
<TD WIDTH="2%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">facilitating the establishment of a Rule&nbsp;10b5-1 trading plan on behalf of a securityholder, officer or
director of our company, provided such plan does not provide for the transfer of securities during the </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">263 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
Restricted Period and to the extent a public announcement or filing under the Exchange Act, if any, is required of or voluntarily made, such announcement or filing shall include a statement to
the effect that no transfer of securities may be made under such plan during the Restricted Period. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The
restrictions described above do not apply to our directors, officers and securityholders with respect to: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="right">(a)</TD>
<TD WIDTH="2%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">transactions relating to our securities acquired in open market transactions or those purchased in this
offering after the completion of this offering, provided that no filing under Section&nbsp;16(a) of the Exchange Act or other public announcement shall be required or shall be voluntarily made in connection with subsequent sales of securities
acquired in such open market transactions; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="right">(b)</TD>
<TD WIDTH="2%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">transfers of our securities as a bona fide gift or to a charitable organization or educational institution in
a transfer not involving a disposition for value; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="right">(c)</TD>
<TD WIDTH="2%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">distributions or transfers of our securities to partners, members, stockholders or affiliates of the
securityholder; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="right">(d)</TD>
<TD WIDTH="2%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">facilitating the establishment of a trading plan on behalf of a shareholder, officer, or director of the
company pursuant to Rule 10b5-1 under the Exchange Act for the transfer of shares of our securities, provided that (i) such plan does not provide for the transfer of our securities during the restricted period and (ii) no filing or notification by
any party under the Exchange Act or other public announcement shall be required or shall be made voluntarily in connection with such transfer or distribution; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="right">(e)</TD>
<TD WIDTH="2%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">transfers or dispositions of our securities to any member of the immediate family of the securityholder or any
trust for the direct or indirect benefit of the securityholder or the immediate family of the securityholder in a transaction not involving a disposition for value; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="right">(f)</TD>
<TD WIDTH="2%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">transfers or dispositions of our securities (i) by will, other testamentary document or intestate succession
to the legal representative, heir, beneficiary or a member of the immediate family of the securityholder upon the death of the securityholder, provided no filing or notification by any party under the Exchange Act or other public announcement shall
be required or shall be made voluntarily in connection with such transfer or distribution, and (ii) by operation of law pursuant to orders of a court, in connection with a negotiated divorce settlement or pursuant to a qualified domestic relations
order, provided no public filing, report or announcement shall be voluntarily made and if any filing under Section 16(a) of the Exchange Act reporting a reduction in beneficial ownership of our securities is required, it shall indicate in the
footnotes thereto the nature and conditions of such transfer; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="right">(g)</TD>
<TD WIDTH="2%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">transfers or dispositions of our securities to any corporation, partnership, limited liability company or
other entity all of the beneficial ownership interests of which are held by the securityholder or the immediate family of the securityholder; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="right">(h)</TD>
<TD WIDTH="2%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">transfers to the securityholder&#146;s affiliates or to any investment fund or other entity controlled or
managed by, controlling or managing, or under common control with, the securityholder; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="right">(i)</TD>
<TD WIDTH="2%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">transfers or dispositions of our securities to the Company pursuant to any contractual arrangement in effect
on the date of this prospectus and disclosed in this prospectus that provides for the repurchase of the securityholder&#146;s common stock or other securities by us or in connection with the termination of the securityholder&#146;s employment with
or service to us; provided that (i) the repurchase price for any such shares or securities shall not exceed the original purchase price (subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar
recapitalization) paid, and (ii) no public filing, report or announcement reporting a reduction in beneficial ownership of our securities shall be required or shall be voluntarily made during the restricted period within 75 days after the date the
securityholder ceases to provide services to us, and after such 75th day, if the securityholder is required to file a report reporting a reduction in beneficial ownership of shares of common stock during the restricted period, the securityholder
shall clearly indicate in the footnotes thereto that the filing relates to the circumstances described in this clause and no public filing, report or announcement shall be voluntarily made; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">264 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="right">(j)</TD>
<TD WIDTH="2%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">transfers or dispositions of our securities to us in connection with the exercise of any option or warrant
for, shares of our common stock (by way of &#147;net&#148; or &#147;cashless&#148; exercise solely to cover withholding tax obligations in connection with such exercise or transfer to the Company for the payment of taxes as a result of such
exercise) or transfers or dispositions of our securities to cover tax withholding obligations of the securityholder in connection with a vesting of our securities, in each case as disclosed in this prospectus; provided that (i) any such shares of
common stock received by the securityholder shall be subject to the terms of the lock-up agreement and (ii) no public filing, report or announcement reporting a reduction in beneficial ownership of shares of common stock shall be required or shall
be voluntarily made during the restricted period within 60 days after the date of this prospectus, and after such 60th day, if the securityholder is required to file a report reporting a reduction in beneficial ownership of shares of our common
stock during the restricted period, the securityholder shall clearly indicate in the footnotes thereto that the filing relates to the circumstances described in this clause and that the shares of common stock received upon exercise of the stock
option or warrant or vesting event are subject to the lock-up agreement, and no public filing, report or announcement shall be voluntarily made; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="right">(k)</TD>
<TD WIDTH="2%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the exercise on a cash basis of options to purchase shares of our common stock granted under any stock
incentive plan or stock purchase plan of the company disclosed in this prospectus, provided that the underlying shares shall continue to be subject to the restrictions on transfer set forth in the lock-up agreement, and provided further that any
filing under Section 16(a) of the Exchange Act with regard to this clause (k) shall clearly indicate in the footnotes thereto that the filing relates to the circumstances described in this clause (k) and no public filings, report or announcement
shall be voluntarily made; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="right">(l)</TD>
<TD WIDTH="2%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">transfers of our securities pursuant to a bona fide third-party tender offer, merger, consolidation or other
similar transaction made to all holders of our common stock and involving a change of control of our company approved by our board of directors, provided that in the event that the tender offer, merger, consolidation or other such transaction is not
completed, the common stock owned by the securityholder shall remain subject to the restrictions contained in the lock-up agreement; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="right">(m)</TD>
<TD WIDTH="2%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the conversion of any outstanding shares of preferred stock into common stock in connection with this
offering, provided that any such securities received upon such conversion shall be subject to the terms of the lock-up agreement and any required filing under Section 16(a) of the Exchange Act shall indicate by footnote disclosure regarding the
circumstances of the conversion and that the shares of common stock received upon such conversion remain subject to the lock-up agreement; </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">provided that in the case of any transfer or distribution pursuant to clauses&nbsp;(b), (c), (e), (f), (g) or (h), (x) each transferee, donee
or distributee shall sign and deliver a lock-up agreement, (y) no filing or notification by any party (donor, donee, devisee, transferor, transferee, distributer or distributee) under the Exchange Act or other public announcement shall be required
or shall be made voluntarily in connection with such transfer or distribution and (z) such transfer shall not involve a disposition for value. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Morgan Stanley&nbsp;&amp; Co. LLC, Goldman Sachs&nbsp;&amp; Co. LLC, J.P. Morgan Securities LLC, and BofA Securities, Inc., in
their sole discretion, may release the common stock and other securities subject to the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements described above in whole or in part at any time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In order to facilitate the offering of the common stock, the underwriters may engage in transactions that stabilize, maintain
or otherwise affect the price of the common stock. Specifically, the underwriters may sell more shares than they are obligated to purchase under the underwriting agreement, creating a short position. A short sale is covered if the short position is
no greater than the number of shares available for purchase by the underwriters under the over-allotment option. The underwriters can close out a covered short sale by exercising the over-allotment option or purchasing shares in the open market. In
determining the source of shares to close out a covered short sale, the underwriters will consider, among other things, the open market price of shares compared to the price available under the over-allotment option. The underwriters may also sell
shares in excess of the over-allotment option, creating a naked short position. The underwriters must close out any naked short </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">265 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
position by purchasing shares in the open market. A naked short position is more likely to be created if the underwriters are concerned that there may be downward pressure on the price of the
common stock in the open market after pricing that could adversely affect investors who purchase in this offering. As an additional means of facilitating this offering, the underwriters may bid for, and purchase, shares of common stock in the open
market to stabilize the price of the common stock. These activities may raise or maintain the market price of the common stock above independent market levels or prevent or retard a decline in the market price of the common stock. The underwriters
are not required to engage in these activities and may end any of these activities at any time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We and the underwriters
have agreed to indemnify each other against certain liabilities, including liabilities under the Securities Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A
prospectus in electronic format may be made available on websites maintained by one or more underwriters, or selling group members, if any, participating in this offering. The representatives may agree to allocate a number of shares of common stock
to underwriters for sale to their online brokerage account holders. Internet distributions will be allocated by the representatives to underwriters that may make Internet distributions on the same basis as other allocations. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Directed Share Program </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">At our request, the underwriters have reserved up to 2% of the shares of common stock offered hereby, at the initial public
offering price, to offer to directors, officers, employees, business associates and other persons related to us. The underwriters will receive the same underwriting discount on any shares purchased pursuant to this program as they will on any other
shares sold to the public in this offering. The number of shares of common stock available for sale to the general public will be reduced to the extent these individuals purchase such reserved shares. Any reserved shares that are not so purchased
will be offered by the underwriters to the general public on the same basis as the other shares offered by this prospectus. Shares purchased by our directors and officers will be subject to the 180-day lock-up restriction described elsewhere in this
&#147;Underwriting&#148; section. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Other Relationships </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The underwriters and their respective affiliates are full service financial institutions engaged in various activities, which
may include securities trading, commercial and investment banking, financial advisory, investment management, investment research, principal investment, hedging, financing, and brokerage activities. Certain of the underwriters and their respective
affiliates have, from time to time, performed, and may in the future perform, various financial advisory and investment banking services for us, for which they received or will receive customary fees and expenses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition, in the ordinary course of their various business activities, the underwriters and their respective affiliates may
make or hold a broad array of investments and actively trade debt and equity securities (or related derivative securities) and financial instruments (including bank loans) for their own account and for the accounts </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">of their customers and may at any time hold long and short positions in such securities and instruments. Such investment and securities
activities may involve our securities and instruments. The underwriters and their respective affiliates may also make investment recommendations or publish or express independent research views in respect of such securities or instruments and may at
any time hold, or recommend to clients that they acquire, long or short positions in such securities and instruments. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Pricing of the Offering </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Prior to this offering, there has been no public market for our common stock. The initial public offering price was determined
by negotiations between us and the representatives. Among the factors considered in determining the initial public offering price were our future prospects and those of our industry in general, our </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">266 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
sales, earnings, and certain other financial and operating information in recent periods, and the price-earnings ratios, price-sales ratios, market prices of securities, and certain financial and
operating information of companies engaged in activities similar to ours. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Selling Restrictions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Canada </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The shares
may be sold only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined in National <FONT STYLE="white-space:nowrap">Instrument&nbsp;45-106</FONT><I></I><I>&nbsp;Prospectus Exemptions</I>&nbsp;or
subsection 73.3(1) of the<I></I><I>&nbsp;Securities Act</I>&nbsp;(Ontario), and are permitted clients, as defined in National <FONT STYLE="white-space:nowrap">Instrument&nbsp;31-103</FONT><I></I><I>&nbsp;Registration Requirements, Exemptions and
Ongoing Registrant Obligations</I>. Any resale of the shares must be made in accordance with an exemption from, or in a transaction not subject to, the prospectus requirements of applicable securities laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Securities legislation in certain provinces or territories of Canada may provide a purchaser with remedies for rescission or
damages if this prospectus (including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser within the time limit prescribed by the securities legislation of the
purchaser&#146;s province or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser&#146;s province or territory for particulars of these rights or consult with a legal advisor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Pursuant to section 3A.3 (or, in the case of securities issued or guaranteed by the government of a <FONT
STYLE="white-space:nowrap">non-Canadian</FONT> jurisdiction, section 3A.4) of National <FONT STYLE="white-space:nowrap">Instrument&nbsp;33-105</FONT><I></I><I>&nbsp;Underwriting
Conflicts</I><FONT STYLE="white-space:nowrap">&nbsp;(NI&nbsp;33-105),&nbsp;the</FONT> underwriters are not required to comply with the disclosure requirements of <FONT STYLE="white-space:nowrap">NI&nbsp;33-105&nbsp;regarding</FONT> underwriter
conflicts of interest in connection with this offering. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>European Economic Area </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In relation to each Member State of the European Economic Area (each a Relevant State), no shares have been offered or will be
offered pursuant to the offering to the public in that Relevant State prior to the publication of a prospectus in relation to the shares which has been approved by the competent authority in that Relevant State or, where appropriate, approved in
another Relevant State and notified to the competent authority in that Relevant State, all in accordance with the Prospectus Regulation, except that the shares may be offered to the public in that Relevant State at any time: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="right">(i)</TD>
<TD WIDTH="2%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to any legal entity which is a qualified investor as defined under Article 2 of the Prospectus Regulation;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="right">(ii)</TD>
<TD WIDTH="2%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to fewer than 150 natural or legal persons (other than qualified investors as defined under Article 2 of the
Prospectus Regulation), subject to obtaining the prior consent of representatives for any such offer; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="right">(iii)</TD>
<TD WIDTH="2%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in any other circumstances falling within Article 1(4) of the Prospectus Regulation, </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">provided that no such offer of the shares shall require us or any of the representatives to publish a prospectus pursuant to Article 3 of the
Prospectus Regulation or supplement a prospectus pursuant to Article 23 of the Prospectus Regulation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For the purposes of
this provision, the expression an &#147;offer to the public&#148; in relation to the shares in any Relevant State means the communication in any form and by any means of sufficient information on the terms of the offer and any shares to be offered
so as to enable an investor to decide to purchase or subscribe for any shares, and the expression &#147;Prospectus Regulation&#148; means Regulation (EU) 2017/1129. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">267 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>United Kingdom </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">No shares have been offered or will be offered pursuant to the offering to the public in the United Kingdom prior to the
publication of a prospectus in relation to the Shares which has been approved by the Financial Conduct Authority, except that the shares may be offered to the public in the United Kingdom at any time: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="right">(i)</TD>
<TD WIDTH="2%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to any legal entity which is a qualified investor as defined under Article 2 of the UK Prospectus Regulation;
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="right">(ii)</TD>
<TD WIDTH="2%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">to fewer than 150 natural or legal persons (other than qualified investors as defined under Article 2 of the
UK Prospectus Regulation), subject to obtaining the prior consent of the representatives for any such offer; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="right">(iii)</TD>
<TD WIDTH="2%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in any other circumstances falling within Section 86 of the FSMA, </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">provided that no such offer of the shares shall require the Issuer or any Manager to publish a prospectus pursuant to Section 85 of the FSMA
or supplement a prospectus pursuant to Article 23 of the UK Prospectus Regulation. For the purposes of this provision, the expression an &#147;offer to the public&#148; in relation to the shares in the United Kingdom means the communication in any
form and by any means of sufficient information on the terms of the offer and any shares to be offered so as to enable an investor to decide to purchase or subscribe for any shares and the expression &#147;UK Prospectus Regulation&#148; means
Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Hong Kong </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Shares of our common stock may not be offered or sold by means of any document other than (i)&nbsp;in circumstances which do
not constitute an offer to the public within the meaning of the Companies Ordinance (Cap.32, Laws of Hong Kong); (ii) to &#147;professional investors&#148; within the meaning of the Securities and Futures Ordinance (Cap.571, Laws of Hong Kong) and
any rules made thereunder; or (iii)&nbsp;in other circumstances which do not result in the document being a &#147;prospectus&#148; within the meaning of the Companies Ordinance (Cap.32, Laws of Hong Kong), and no advertisement, invitation or
document relating to shares of our common stock may be issued or may be in the possession of any person for the purpose of issue (in each case whether in Hong Kong or elsewhere), which is directed at, or the contents of which are likely to be
accessed or read by, the public in Hong Kong (except if permitted to do so under the laws of Hong Kong) other than with respect to shares of our common stock which are or are intended to be disposed of only to persons outside Hong Kong or only to
&#147;professional investors&#148; within the meaning of the Securities and Futures Ordinance (Cap.571, Laws of Hong Kong) and any rules made thereunder. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Japan </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">No
registration pursuant to Article 4, paragraph 1 of the Financial Instruments and Exchange Law of Japan (Law No.&nbsp;25 of 1948, as amended) (the FIEL) has been made or will be made with respect to the solicitation of the application for the
acquisition of the shares of common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Accordingly, the shares of common stock have not been, directly or indirectly,
offered or sold and will not be, directly or indirectly, offered or sold in Japan or to, or for the benefit of, any resident of Japan (which term as used herein means any person resident in Japan, including any corporation or other entity organized
under the laws of Japan) or to others <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">for&nbsp;re-offering&nbsp;or&nbsp;re-sale,&nbsp;directly</FONT></FONT> or indirectly, in Japan or to, or for the benefit of, any resident of
Japan except pursuant to an exemption from the registration requirements, and otherwise in compliance with, the FIEL and the other applicable laws and regulations of Japan. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>For Qualified Institutional Investors (QII) </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Please note that the solicitation for newly-issued or secondary securities (each as described in Paragraph&nbsp;2,
Article&nbsp;4 of the FIEL) in relation to the shares of common stock constitutes either a &#147;QII only private placement&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">268 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
or a &#147;QII only secondary distribution&#148; (each as described in Paragraph&nbsp;1, <FONT STYLE="white-space:nowrap">Article&nbsp;23-13&nbsp;of</FONT> the FIEL). Disclosure regarding any
such solicitation, as is otherwise prescribed in Paragraph&nbsp;1, Article&nbsp;4 of the FIEL, has not been made in relation to the shares of common stock.&nbsp;The shares of common stock may only be transferred to QIIs. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">For&nbsp;Non-QII&nbsp;Investors</FONT> </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Please note that the solicitation for newly-issued or secondary securities (each as described in Paragraph 2, Article 4 of the
FIEL) in relation to the shares of common stock constitutes either a &#147;small number private placement&#148; or a &#147;small number private secondary distribution&#148; (each as is described in Paragraph 4,
<FONT STYLE="white-space:nowrap">Article&nbsp;23-13&nbsp;of</FONT> the FIEL). Disclosure regarding any such solicitation, as is otherwise prescribed in Paragraph 1, Article 4 of the FIEL, has not been made in relation to the shares of common
stock.&nbsp;The shares of common stock may only be transferred en bloc without subdivision to a single investor. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Singapore </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This prospectus has not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, this prospectus
and any other document or material in connection with the offer or sale, or invitation for subscription or purchase, of shares of our common stock may not be circulated or distributed, nor may the shares of our common stock be offered or sold, or be
made the subject of an invitation for subscription or purchase, whether directly or indirectly, to persons in Singapore other than (i)&nbsp;to an institutional investor under Section&nbsp;274 of the Securities and Futures Act, Chapter 289 of
Singapore (the SFA); (ii)&nbsp;to a relevant person, or any person pursuant to Section&nbsp;275(1A), and in accordance with the conditions, specified in Section&nbsp;275 of the SFA; or (iii)&nbsp;otherwise pursuant to, and in accordance with the
conditions of, any other applicable provision of the SFA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Where shares of our common stock are subscribed or purchased
under Section&nbsp;275 by a relevant person which is: (i)&nbsp;a corporation (which is not an accredited investor) the sole business of which is to hold investments and the entire share capital of which is owned by one or more individuals, each of
whom is an accredited investor; or (ii)&nbsp;a trust (where the trustee is not an accredited investor) whose sole purpose is to hold investments and each beneficiary is an accredited investor, shares, debentures and units of shares and debentures of
that corporation or the beneficiaries&#146; rights and interest in that trust shall not be transferable for 6 months after that corporation or that trust has acquired shares of our common stock under Section&nbsp;275 except: (a)&nbsp;to an
institutional investor under Section&nbsp;274 of the SFA or to a relevant person, or any person pursuant to Section&nbsp;275(1A), and in accordance with the conditions, specified in Section&nbsp;275 of the SFA; (b)&nbsp;where no consideration is
given for the transfer; or (c)&nbsp;by operation of law. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Switzerland </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The shares may not be publicly offered in Switzerland and will not be listed on the SIX Swiss Exchange, or SIX, or on any other
stock exchange or regulated trading facility in Switzerland. This document has been prepared without regard to the disclosure standards for issuance prospectuses under art. 652a or art. 1156 of the Swiss Code of Obligations or the disclosure
standards for listing prospectuses under art. 27 ff. of the SIX Listing Rules or the listing rules of any other stock exchange or regulated trading facility in Switzerland. Neither this document nor any other offering or marketing material relating
to the shares or the offering may be publicly distributed or otherwise made publicly available in Switzerland. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Neither
this document nor any other offering or marketing material relating to the offering, the Company or the shares have been or will be filed with or approved by any Swiss regulatory authority. In particular, this document will not be filed with, and
the offer of shares will not be supervised by, the Swiss Financial Market Supervisory Authority FINMA (FINMA), and the offer of shares has not been and will not be authorized under </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">269 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
the Swiss Federal Act on Collective Investment Schemes (CISA). The investor protection afforded to acquirers of interests in collective investment schemes under the CISA does not extend to
acquirers of shares. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Dubai International Financial Centre </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This prospectus relates to an Exempt Offer in accordance with the Offered Securities Rules of the Dubai Financial Services
Authority (DFSA). This prospectus is intended for distribution only to persons of a type specified in the Offered Securities Rules of the DFSA. It must not be delivered to, or relied on by, any other person. The DFSA has no responsibility for
reviewing or verifying any documents in connection with Exempt Offers. The DFSA has not approved this prospectus nor taken steps to verify the information set forth herein and has no responsibility for the prospectus. The shares to which this
prospectus relates may be illiquid and/or subject to restrictions on their resale. Prospective purchasers of the shares offered should conduct their own due diligence on the shares. If you do not understand the contents of this prospectus you should
consult an authorized financial advisor. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Australia </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">No placement document, prospectus, product disclosure statement or other disclosure document has been lodged with the
Australian Securities and Investments Commission, in relation to the offering. This prospectus does not constitute a prospectus, product disclosure statement or other disclosure document under the Corporations Act 2001 (Corporations Act), and does
not purport to include the information required for a prospectus, product disclosure statement or other disclosure document under the Corporations Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Any offer in Australia of the shares may only be made to persons (Exempt Investors) who are &#147;sophisticated
investors&#148; (within the meaning of section&nbsp;708(8) of the Corporations Act), &#147;professional investors&#148; (within the meaning of section&nbsp;708(11) of the Corporations Act), or otherwise pursuant to one or more exemptions contained
in section&nbsp;708 of the Corporations Act so that it is lawful to offer the shares without disclosure to investors under Chapter&nbsp;6D of the Corporations Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The shares applied for by Exempt Investors in Australia must not be offered for sale in Australia in the period of 12 months
after the date of allotment under the offering, except in circumstances where disclosure to investors under Chapter 6D of the Corporations Act would not be required pursuant to an exemption under section 708 of the Corporations Act or otherwise or
where the offer is pursuant to a disclosure document which complies with Chapter 6D of the Corporations Act. Any person acquiring shares must observe such Australian <FONT STYLE="white-space:nowrap">on-sale</FONT> restrictions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">This prospectus contains general information only and does not take account of the investment objectives, financial situation
or particular needs of any particular person. It does not contain any securities recommendations or financial product advice. Before making an investment decision, investors need to consider whether the information in this prospectus is appropriate
to their needs, objectives and circumstances, and, if necessary, seek expert advice on those matters. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Israel </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In the State of Israel this prospectus shall not be regarded as an offer to the public to purchase shares of common stock under
the Israeli Securities Law, 5728 - 1968, which requires a prospectus to be published and authorized by the Israel Securities Authority, if it complies with certain provisions of Section&nbsp;15 of the Israeli Securities Law, 5728 - 1968, including,
inter alia, if: (i)&nbsp;the offer is made, distributed or directed to not more than 35 investors, subject to certain conditions (the Addressed Investors); or (ii)&nbsp;the offer is made, distributed or directed to certain qualified investors
defined in the First Addendum of the Israeli Securities Law, 5728 - 1968, subject to certain conditions (the Qualified Investors). The Qualified Investors shall not be taken into account in the count of the Addressed Investors and may be offered to
purchase securities in addition to the 35 Addressed </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">270 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
Investors. The company has not and will not take any action that would require it to publish a prospectus in accordance with and subject to the Israeli Securities Law, 5728 - 1968. We have not
and will not distribute this prospectus or make, distribute or direct an offer to subscribe for our common stock to any person within the State of Israel, other than to Qualified Investors and up to 35 Addressed Investors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Qualified Investors may have to submit written evidence that they meet the definitions set out in of the First Addendum to the
Israeli Securities Law, 5728 - 1968. In particular, we may request, as a condition to be offered common stock, that Qualified Investors will each represent, warrant and certify to us and/or to anyone acting on our behalf: (i)&nbsp;that it is an
investor falling within one of the categories listed in the First Addendum to the Israeli Securities Law, 5728 - 1968; (ii)&nbsp;which of the categories listed in the First Addendum to the Israeli Securities Law, 5728 - 1968 regarding Qualified
Investors is applicable to it; (iii)&nbsp;that it will abide by all provisions set forth in the Israeli Securities Law, 5728 - 1968 and the regulations promulgated thereunder in connection with the offer to be issued common stock; (iv)&nbsp;that the
shares of common stock that it will be issued are, subject to exemptions available under the Israeli Securities Law, 5728 - 1968: (a)&nbsp;for its own account, (b)&nbsp;for investment purposes only, and (c)&nbsp;not issued with a view to resale
within the State of Israel, other than in accordance with the provisions of the Israeli Securities Law, 5728 - 1968; and (v)&nbsp;that it is willing to provide further evidence of its Qualified Investor status. Addressed Investors may have to submit
written evidence in respect of their identity and may have to sign and submit a declaration containing, inter alia, the Addressed Investor&#146;s name, address and passport number or Israeli identification number. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">271 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc60414_20"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The validity of the issuance of the shares of common stock offered hereby will be passed upon for Sana Biotechnology, Inc. by
Latham&nbsp;
&amp; Watkins LLP, Menlo Park, California. Cooley LLP, San Diego, California, is representing the underwriters. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc60414_21"></A>EXPERTS
 </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Ernst&nbsp;&amp; Young LLP, independent registered public accounting firm, has audited our consolidated financial
statements at December&nbsp;31, 2019 and 2018, and for the year ended December&nbsp;31, 2019 and the period from July&nbsp;13, 2018 (inception) to December 31, 2018, as set forth in their report. We&#146;ve included our financial statements in the
prospectus and elsewhere in the registration statement in reliance on Ernst&nbsp;&amp; Young LLP&#146;s report, given on their authority as experts in accounting and auditing. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc60414_22"></A>WHERE YOU CAN FIND MORE INFORMATION </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have filed with the SEC a registration statement on Form <FONT STYLE="white-space:nowrap">S-1</FONT> under the Securities
Act with respect to the common stock offered hereby. This prospectus does not contain all of the information set forth in the registration statement and the exhibits and schedules thereto. For further information with respect to the Company and its
common stock, reference is made to the registration statement and the exhibits and any schedules filed therewith. Statements contained in this prospectus as to the contents of any contract or other document referred to are not necessarily complete
and in each instance, if such contract or document is filed as an exhibit, reference is made to the copy of such contract or other document filed as an exhibit to the registration statement, each statement being qualified in all respects by such
reference. The SEC maintains a website at www.sec.gov, from which interested persons can electronically access the registration statement, including the exhibits and any schedules thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As a result of the offering, we will be required to file periodic reports and other information with the SEC. We also maintain
a website at https://sana.com, at which, following this offering, you may access these materials free of charge as soon as reasonably practicable after they are electronically filed with or furnished to the SEC. Our website and the information
contained therein or connected thereto shall not be deemed to be incorporated into this prospectus or the registration statement of which it forms a part. We have included our website address as an inactive textual reference only. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">272 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="index"></A>SANA BIOTECHNOLOGY, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc60414_23"></A>INDEX TO CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Audited Consolidated Financial Statements:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin60414_1">Report of Independent Registered Public Accounting Firm</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">F-2</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin60414_2">Consolidated Balance Sheets</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">F-3</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin60414_3">Consolidated Statements of Operations</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">F-4</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin60414_4">Consolidated Statements of Comprehensive Loss</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">F-5</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin60414_5">Consolidated Statements of Convertible Preferred Stock and Stockholders&#146; Deficit
</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">F-6</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin60414_6">Consolidated Statements of Cash Flows</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">F-7</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin60414_7">Notes to Consolidated Financial Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">F-8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Unaudited Condensed Consolidated Financial Statements:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin60414_8">Condensed Consolidated Balance Sheets </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">F-34</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin60414_9">Condensed Consolidated Statements of Operations </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">F-35</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin60414_10">Condensed Consolidated Statements of Comprehensive Loss </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">F-36</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin60414_11">Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders&#146;
 Deficit </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">F-37</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin60414_12">Condensed Consolidated Statements of Cash Flows </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">F-39</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin60414_13">Notes to Condensed Consolidated Financial Statements </A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">F-40</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin60414_1"></A>Report of Independent Registered Public Accounting Firm </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:9.5pt; font-family:Times New Roman" ALIGN="justify">To the Stockholders and the Board of Directors of Sana Biotechnology, Inc. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:9.5pt; font-family:Times New Roman"><B>Opinion on the Financial Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We have audited the accompanying consolidated balance sheets of Sana Biotechnology, Inc. (the Company) as of December&nbsp;31,
2019 and 2018, the related consolidated statements of operations, comprehensive loss, convertible preferred stock and stockholders&#146; deficit and cash flows for the year ended December&nbsp;31, 2019 and the period from July&nbsp;13, 2018
(inception) to December&nbsp;31, 2018, and the related notes (collectively referred to as the &#147;consolidated financial statements&#148;). In our opinion, the consolidated financial statements present fairly, in all material respects, the
financial position of the Company at December&nbsp;31, 2019 and 2018, and the results of its operations and its cash flows for year ended December&nbsp;31, 2019 and the period from July&nbsp;13, 2018 (inception) to December&nbsp;31, 2018 in
conformity with U.S. generally accepted accounting principles. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Basis for Opinion </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">These financial statements are the responsibility of the Company&#146;s management. Our responsibility is to express an opinion
on the Company&#146;s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in
accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">We conducted our audits in accordance with the auditing standards of the PCAOB. Those standards require that we plan and
perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of
its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#146;s
internal control over financial reporting. Accordingly, we express no such opinion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Our audits included performing
procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence
regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated
financial statements. We believe that our audits provide a reasonable basis for our opinion. </P>  <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">/s/ Ernst&nbsp;&amp; Young LLP </P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:9.5pt; font-family:Times New Roman" ALIGN="justify">We have served as the Company&#146;s auditor since 2019. </P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:9.5pt; font-family:Times New Roman" ALIGN="justify">Seattle, Washington </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9.5pt; font-family:Times New Roman" ALIGN="justify">April&nbsp;22, 2020, </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9.5pt; font-family:Times New Roman" ALIGN="justify">except for the last four paragraphs of Note 17, as to which the date is </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9.5pt; font-family:Times New Roman" ALIGN="justify">January&nbsp;28, 2021 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin60414_2"></A>Consolidated Balance Sheets </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(in thousands, except share and per share amounts) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="71%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2018&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2019&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ASSETS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current assets:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">30,630</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">80,030</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58,952</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses and other current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,966</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,281</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32,596</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">144,263</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property and equipment, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">585</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,911</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,403</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Restricted cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">816</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,777</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intangible asset</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59,195</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goodwill</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">140,627</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other <FONT STYLE="white-space:nowrap">non-current</FONT> assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">336</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">522</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">TOTAL ASSETS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">34,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">415,698</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">LIABILITIES, CONVERTIBLE PREFERRED STOCK, AND STOCKHOLDERS&#146; DEFICIT</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">289</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">811</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,094</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued expenses and other current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">685</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,887</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,848</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,785</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,829</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease liabilities, net of current portion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46,359</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contingent consideration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">69,108</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Success payment liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,352</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other <FONT STYLE="white-space:nowrap">non-current</FONT> liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,233</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,800</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">140,881</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Commitments and contingencies (Note 10)</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Convertible preferred stock, $0.0001 par value; 45,850,000 and 537,786,206 shares authorized as of
December&nbsp;31, 2018 and 2019, respectively; 11,462,500 and 106,889,542 shares issued and outstanding as of December&nbsp;31, 2018 and 2019, respectively; aggregate liquidation preference of $46,536 and $450,837 as of December&nbsp;31, 2018 and
2019, respectively</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,721</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">417,359</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stockholders&#146; deficit:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common stock, $0.0001 par value; 187,250,000 and 700,000,000 shares authorized as of
December&nbsp;31, 2018 and 2019, respectively; 1,577,616 and 10,003,329 shares issued and outstanding as of December&nbsp;31, 2018 and 2019, respectively</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,558</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated other comprehensive income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(13,247</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(144,127</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stockholders&#146; deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(13,188</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(142,542</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">TOTAL LIABILITIES, CONVERTIBLE PREFERRED STOCK, AND STOCKHOLDERS&#146; DEFICIT</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;34,333</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;415,698</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>The accompanying notes are an integral part of these financial statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin60414_3"></A>Consolidated Statements of Operations </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(in thousands, except share and per share amounts) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="69%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Period&nbsp;from&nbsp;July&nbsp;13,<BR>2018 (Inception) to<BR>December&nbsp;31, 2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended<BR>December&nbsp;31,&nbsp;2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">9,040</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">119,375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,206</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,777</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,246</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">141,152</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(13,246</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(141,152</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest income, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,856</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other expense, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(29</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss before income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(13,247</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(138,325</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Benefit from income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,547</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(13,247</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(130,778</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss per share, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(13.91</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(26.68</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average shares outstanding, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">952,086</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,902,642</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:118pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>The accompanying notes are an integral part of these financial statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin60414_4"></A>Consolidated Statements of Comprehensive Loss </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(in thousands) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="69%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Period&nbsp;from&nbsp;July&nbsp;13,<BR>2018 (Inception) to<BR>December&nbsp;31, 2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended<BR>December&nbsp;31,&nbsp;2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(13,247</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(130,778</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other comprehensive income, net of tax:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net unrealized gain on marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total other comprehensive income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(13,247</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(130,752</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:90pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:120pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>The accompanying notes are an integral part of these financial
statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin60414_5"></A>Consolidated Statements of Convertible Preferred Stock and Stockholders&#146; Deficit </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(in thousands, except share amounts) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Convertible&nbsp;Preferred&nbsp;Stock&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Common Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Additional</B><br><B><FONT STYLE="white-space:nowrap">Paid-In</FONT></B><br><B>Capital</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated</B><br><B>Other</B><br><B>Comprehensive</B><br><B>Income</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated</B><br><B>Deficit</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>Stockholders&#146;</B><br><B>Deficit</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of July&nbsp;13, 2018 (inception)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of common stock</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">351,250</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of Series <FONT STYLE="white-space:nowrap">A-1</FONT> convertible preferred stock, net of
issuance costs of $100</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,462,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,721</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,226,366</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(13,247</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(13,247</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of December&nbsp;31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,462,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">45,721</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,577,616</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(13,247</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(13,188</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjustment to beginning accumulated deficit from adoption of ASC 842</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(102</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(102</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock, net of
issuance costs of $300</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,003,532</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">223,739</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock for
acquisition, <FONT STYLE="white-space:nowrap">non-cash</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,441,583</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">135,971</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock in
connection with license agreements</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,981,927</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,928</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,425,088</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,498</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,499</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercise of stock options</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">625</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other comprehensive income, net</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(130,778</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(130,778</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">106,889,542</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;417,359</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,003,329</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1,558</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;(144,127</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;(142,542</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:80pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>The accompanying notes are an integral part of these financial statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin60414_6"></A>Consolidated Statements of Cash Flows </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(in thousands) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="72%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Period&nbsp;from&nbsp;July&nbsp;13,<BR>2018 (Inception) to<BR>December&nbsp;31, 2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended<BR>December&nbsp;31,&nbsp;2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">OPERATING ACTIVITIES:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(13,247</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(130,778</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjustments to reconcile net loss to net cash used in operating activities:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,826</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred income tax</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,547</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,497</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value of contingent consideration</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,860</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value of success payment liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,924</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-cash</FONT> expense for equity issuance in connection with
license agreements</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,928</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-cash</FONT> expense in connection with license
agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,557</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-cash</FONT> expense in connection with asset
acquisition</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,200</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-cash</FONT> <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets lease expense</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,095</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other <FONT STYLE="white-space:nowrap">non-cash</FONT> items</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(592</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Changes in operating assets and liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses and other assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,982</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,300</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets and liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,697</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">289</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(421</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued expenses and other liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,385</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,550</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(13,495</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(85,504</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">INVESTING ACTIVITIES:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchases of marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(141,519</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from maturities of marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">82,977</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchases of property and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(460</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(26,183</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquisitions, net of cash acquired</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,195</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from disposal of assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of promissory note</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(320</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in investing activities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(780</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(87,861</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">FINANCING ACTIVITIES:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from issuance of convertible preferred stock, net of issuance costs</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,721</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">223,739</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from issuance of common stock</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payment of contingent consideration</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(14</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash provided by financing activities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,721</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">223,726</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net increase in cash, cash equivalents, and restricted cash</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,446</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,361</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash, cash equivalents, and restricted cash at beginning of period</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,446</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash, cash equivalents, and restricted cash at end of period</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;31,446</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;81,807</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SUPPLEMENTAL CASH FLOW DISCLOSURES:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchases of property and equipment included in accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">126</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,495</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of convertible preferred stock for acquisition</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">135,971</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Right-of-use</FONT></FONT>
assets obtained in exchange for operating lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">48,863</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash received from lessor for tenant improvement allowance</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,697</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tenant improvement allowance included in contra-lease liability</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,575</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>The accompanying notes are an integral part of these financial statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin60414_7"></A>Notes to Consolidated Financial Statements </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>1. Organization </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Sana
Biotechnology, Inc. (the Company or Sana) was incorporated in Delaware on July&nbsp;13, 2018 (inception) as FD Therapeutics, Inc., and changed its name to Sana Biotechnology, Inc. on September&nbsp;17, 2018. The Company is a biotechnology company,
focusing on utilizing engineered cells as medicines. The Company&#146;s operations to date have included identifying and developing potential product candidates, executing preclinical studies, acquiring technology, organizing and staffing the
Company, business planning, establishing the Company&#146;s intellectual property portfolio, raising capital, and providing general and administrative support for these operations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In February 2019, the Company acquired 100% of the outstanding equity in Cobalt Biomedicine, Inc. (Cobalt), a privately-held
early-stage biotechnology company developing a platform technology using its fusogen technology to specifically and consistently deliver various biological payloads to cells. The Cobalt acquisition adds
<I><FONT STYLE="white-space:nowrap">in-vivo</FONT></I> cell engineering technology to complement the Company&#146;s existing <I><FONT STYLE="white-space:nowrap">ex-vivo</FONT></I> cell engineering technology. See Note 3, Acquisitions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In November 2019, the Company acquired Cytocardia, Inc. (Cytocardia), a privately-held early-stage biotechnology company whose
primary asset was <FONT STYLE="white-space:nowrap">in-process</FONT> research and development related to <I></I>its<I> ex vivo</I> cell engineering programs focused on replacement of damaged heart cells. See Note 3, Acquisitions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company is subject to a number of risks similar to other biotechnology companies in the development stage including, but
not limited to, the need to obtain adequate additional funding, possible failure of preclinical testing or clinical trials, the need to obtain marketing approval for its product candidates, competitors developing new technological innovations, the
need to successfully commercialize and gain market acceptance of the Company&#146;s products, protect the Company&#146;s intellectual property and proprietary technology, and the need to attract and retain key scientific and management personnel. If
the Company does not successfully commercialize or partner any of its product candidates, it will be unable to generate product revenue or achieve profitability. Through December&nbsp;31, 2019, the Company has financed its operations through the
sale and issuance of convertible preferred stock. The Company intends to raise additional capital through the issuance of equity or strategic alliances with third parties. As of December&nbsp;31, 2019, the Company had an accumulated deficit of
$144.1&nbsp;million and cash, cash equivalents, and marketable securities of $139.0&nbsp;million. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2. Summary of significant accounting policies
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Basis of presentation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. The
Company&#146;s consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (GAAP). Certain prior period amounts have been reclassified to conform to current period
presentation. </P> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Use of estimates </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that
affect the amounts reported in the consolidated financial statements and accompanying notes. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and
assumptions when facts and circumstances dictate. Actual results could materially differ from those estimates. The most significant estimates in the Company&#146;s consolidated financial statements relate to business combinations, accrued expenses,
the valuation of common stock, and the valuation of success payments and contingent consideration. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company utilizes
significant estimates and assumptions in determining the fair value of its common stock. The Company recorded expense for restricted stock awards (RSAs), stock options and restricted stock </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Consolidated Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
units (RSUs) at prices not less than the fair market value of its common stock as determined by management with consideration of the American Institute of Certified Public Accountants Technical
Practice Aid, <I>Valuation of Privately-Held Company Equity Securities Issued as Compensation, </I>(AICPA Guide)<I>.</I> The estimated fair value of the Company&#146;s common stock is based on a number of objective and subjective factors, including
the most recently available valuations of the Company&#146;s common stock performed by an independent third-party valuation firm, the prices of shares of convertible preferred stock sold to investors in arm&#146;s length transactions, committed
future rounds of funding, the superior rights and preferences of securities senior to the Company&#146;s common stock at the time, the Company&#146;s stage of development, results of operation and financial position, material risks to the
Company&#146;s business, the lack of marketability of the common stock, and external market conditions affecting the biotechnology industry sector. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company also uses significant estimates and assumptions in determining the estimated fair value of the success payment and
contingent consideration liabilities, which are measured at issuance and at each balance sheet date, with changes in fair value recognized in research and development expense. A small change in the estimated future value of the Company&#146;s Series
A convertible preferred stock price or the estimated future value of the Company implied by the estimated future per share value of the Series B convertible preferred stock may have a relatively large change in the estimated fair value of the
success payment liability and associated expense or gain. Changes in the probabilities and estimated timing of milestones used in the calculation of the contingent consideration liability may have a relatively large impact on the resulting liability
and associated expense or gain. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Cash and cash equivalents </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Cash and cash equivalents include cash and highly liquid investments with original maturities of three months or less at
acquisition. Cash equivalents include investments in money market funds with commercial banks and financial institutions and are stated at fair value. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Marketable securities </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Marketable securities are classified as
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> debt securities and are carried at fair value. Unrealized gains and losses, if any, are reported as a component of comprehensive income (loss).
Amortization, accretion, interest and dividends, realized gains and losses, and declines in value judged to be other than-temporary are included in other income (expense). The cost of securities sold is based on the specific-identification method.
Investments in securities with maturities of less than one year, or those which management intends to use to fund current operations, are included in current assets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company evaluates whether an investment is other-than-temporarily impaired based on the specific facts and circumstances.
Factors that are considered in determining whether an other-than-temporary decline in value has occurred include the market value of the security in relation to its cost basis, the financial condition of the investee, and the intent and ability to
retain the investment for a sufficient period of time to allow for recovery in the market value of the investment. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Concentrations of credit risk
and <FONT STYLE="white-space:nowrap">off-balance</FONT> sheet risk </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company maintains its cash, cash
equivalents, and marketable securities with high quality, accredited financial institutions. These amounts, at times, may exceed federally insured limits. The Company has not experienced any credit losses in such accounts and does not believe it is
exposed to significant risk on these funds. The&nbsp;Company has no <FONT STYLE="white-space:nowrap">off-balance</FONT> sheet concentrations of credit risk, such as foreign currency exchange contracts, option contracts or other hedging arrangements.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Consolidated Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Fair value of financial instruments </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company is required to disclose information on all assets and liabilities reported at fair value that enables an assessment
of the inputs used in determining the reported fair values. The fair value hierarchy prioritizes valuation inputs based on the observable nature of those inputs. The hierarchy applies only to the valuation inputs used to determine the reported fair
value of the investments and is not a measure of the investment credit quality. The hierarchy defines three levels of valuation inputs: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Level&nbsp;1&nbsp;&#150;&nbsp;Quoted prices in active markets for identical assets or liabilities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Level&nbsp;2&nbsp;&#150;&nbsp;Inputs other than quoted prices included within Level&nbsp;1 that are observable for the asset or
liability, either directly or indirectly. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Level&nbsp;3&nbsp;&#150;&nbsp;Unobservable inputs that reflect the
Company&#146;s own assumptions about the assumptions market participants would use in pricing the asset or liability. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The
Company&#146;s financial instruments include cash and cash equivalents, marketable securities, note receivable, accounts payable, contingent consideration, success payment liabilities, contingent license liability, and other accrued liabilities. The
carrying amounts of cash, cash equivalents, accounts payable, and accrued liabilities approximate fair value due to the short-term nature of these instruments. To the extent the valuation of financial instruments is based on models or inputs that
are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized in
Level&nbsp;3. See Note 7, Fair value measurements. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Property and equipment, net </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Property and equipment are stated at cost, net of accumulated depreciation. Depreciation of property and equipment is computed
using the straight-line method over the estimated useful lives of the respective assets, generally three to five years. Leasehold improvements are depreciated over the lesser of their useful lives or the remaining life of the lease. When assets are
retired or otherwise disposed of, the cost and related accumulated depreciation and amortization are removed from the balance sheet and the resulting gain or loss is reflected in operations in the period realized. Maintenance and repairs are charged
to operations as incurred. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Impairment of long-lived assets </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company reviews the carrying value and estimated lives of its long-lived assets whenever events or circumstances indicate
the carrying values may not be recoverable. Should an impairment exist, the impairment loss would be measured based on the excess of the asset&#146;s carrying amount over its fair value. The Company has not recognized any impairment losses since
inception. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Acquisitions </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company accounts for business combinations using the acquisition method of accounting, which requires the assets acquired,
including <FONT STYLE="white-space:nowrap">in-process</FONT> research and development (IPR&amp;D), and liabilities assumed be recorded at their fair values as of the acquisition date. Any excess of the purchase price over the fair value of net
assets acquired is recorded as goodwill. The determination of the estimated fair value of these items requires us to make significant estimates and assumptions. Transaction costs associated with business combinations are recorded in general and
administrative expense as they are incurred. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">If the Company determines the acquisition does not meet the definition of a
business combination under the acquisition method of accounting, the transaction is accounted for as an asset acquisition and no goodwill or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Consolidated Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
contingent consideration are recognized at the acquisition date. In an asset acquisition, <FONT STYLE="white-space:nowrap">up-front</FONT> payments allocated to IPR&amp;D are recorded in research
and development expense if there is no alternative future use, and subsequent milestone payments are recorded in research and development expense when achieved. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Goodwill and intangible assets </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Goodwill represents the excess of the purchase price over the estimated fair value of the identifiable assets acquired and
liabilities assumed in a business combination. The Company evaluates goodwill for impairment annually or when a triggering event occurs that could indicate a potential impairment. The evaluation for impairment includes assessing qualitative factors
or performing a quantitative analysis to determine whether it is <FONT STYLE="white-space:nowrap">more-likely-than-not</FONT> that the fair value of net assets is below the carrying amount. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Intangible assets acquired in a business combination are recognized separately from goodwill and are initially recognized at
their fair value at the acquisition date. The fair value of the IPR&amp;D has been estimated using the replacement cost method. Under this method, the Company estimated the cost to recreate the technology and derived an estimated value to develop
the technology. IPR&amp;D assets are required to be classified as indefinite-lived assets and are not amortized until they become finite-lived assets, upon the successful completion of the associated research and development technology. At that
time, the useful life of the asset will be determined, and amortization will begin. If the associated research and development technology is abandoned, the related IPR&amp;D asset will be <FONT STYLE="white-space:nowrap">written-off</FONT> and an
impairment charge recorded. Intangible assets are reviewed for impairment at least annually or when a triggering event occurs that could indicate a potential impairment. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Contingent consideration from business combinations </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">At and subsequent to the acquisition date of a business combination, contingent consideration obligations are remeasured to
fair value at each balance sheet date with changes in fair value recognized in research and development expense. Changes in fair values reflect changes to the Company&#146;s assumptions regarding probabilities of successful achievement of related
milestones, the timing in which the milestones are expected to be achieved, and the discount rate used to estimate the fair value of the obligation. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Success payments </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company granted rights to a success payment to Cobalt (Cobalt Success Payment) pursuant to the terms of its acquisition
agreement and to the President and Fellows of Harvard College (Harvard) pursuant to the terms of its exclusive license agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company may be required to make a Cobalt Success Payment in cash or stock, at its discretion, based on an increase in
value of the Company implied by the per share value of the Company&#146;s Series B convertible preferred stock at issuance, or any security into which such stock has been converted or exchanged, and the Company has an active program based on the
fusogen technology in a clinical trial pursuant to an investigational new drug application (IND), or have filed for, or received approval for, a biologics license application (BLA) or new drug application (NDA). The Company may be required to make
success payments to Harvard (Harvard Success Payments) in cash based on increases in the per share value of the Company&#146;s Series A convertible preferred stock, or any security into which such stock has been converted or exchanged. The success
payments are accounted for under Accounting Standards Codification (ASC) 815, <I>Derivatives and Hedging.</I> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Success
payment liabilities are estimated at fair value at inception and at each subsequent balance sheet date with changes recorded in research and development expense. To determine the estimated fair value of the success payments the Company uses a Monte
Carlo simulation methodology which models the value of the liability </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Consolidated Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
based on several key variables including the term of the success payments, expected volatility, risk-free interest rate, and estimated number and timing of valuation measurement dates on the
basis of which payments may be triggered. Additionally, the Cobalt Success Payment liability incorporates the estimated future value of the Company implied by the estimated future per share value of the Company&#146;s Series B convertible preferred
stock at issuance, and the Harvard Success Payment liability incorporates the estimated future fair value of the Company&#146;s Series A convertible preferred stock. The computation of expected volatility is estimated using peer company stocks for a
time period matching the expected term assumption. After an initial public offering (IPO), the Cobalt Success Payment of $500.0 million is payable if, at predetermined valuation measurement dates, the Company&#146;s value is equal to or exceeds
three times the Company&#146;s value at the time of the Series B convertible preferred stock issuance. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Leases </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In February 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) <FONT
STYLE="white-space:nowrap">2016-02,</FONT><I>&nbsp;Leases</I> (ASC 842).&nbsp;The new guidance requires lessees to recognize the assets and liabilities arising from leases on the balance sheet, unless the lease is a short-term lease, defined as
having a term of twelve-months or less. Additional qualitative and quantitative disclosures are also required.&nbsp;The Company early adopted this standard on January&nbsp;1, 2019 using the prospective transition method. Under this method, the
Company did not restate the prior comparative periods and initially applied ASC 842 on January&nbsp;1, 2019 and recorded an immaterial entry to the opening balance in accumulated stockholders&#146; deficit. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company elected to apply the practical expedient election as permitted under the transition guidance, which must be
elected as a package and applied consistently to all leases at the transition date. The Company did not reassess the lease classification of existing leases, whether any expired or existing contracts are or contain leases, the initial direct costs
for any existing leases, or separate lease and <FONT STYLE="white-space:nowrap">non-lease</FONT> components. The adoption resulted in the recognition of an operating lease
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> (ROU) asset and operating lease liability of $8.9&nbsp;million on the Company&#146;s consolidated balance sheet as of January&nbsp;1, 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company determines if a contract contains a lease at the inception of the contract. The Company currently has leases
related to its facilities for office and laboratory space, which are classified as operating leases. These leases result in operating ROU assets and current and <FONT STYLE="white-space:nowrap">non-current</FONT> operating lease liabilities on the
balance sheet. The Company does not have any financing leases. Leases with a term of 12 months or less are considered short-term and a ROU asset and lease obligation are not recognized. Payments associated with short-term leases are expensed as
incurred. Rent expense for operating leases is recognized on a straight-line basis over the lease term. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Lease liabilities
represent an obligation to make lease payments arising from the lease. ROU assets represent the right to use the underlying asset identified in the lease for the lease term. Lease liabilities are measured at the present value of the remaining future
lease payments over the lease term discounted using the incremental borrowing rate (IBR) for the lease established at the lease commencement date. ROU assets are based on the measurement of the lease liability and include any prepaid lease payments
made prior to or on the lease commencement date and exclude any lease incentives received and initial direct costs incurred. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">To determine the present value of lease payments at the lease inception the Company determines an IBR which reflects the fixed
rate at which the Company could borrow the amount of the lease payments, on a collateralized basis, for a similar term, and economic environment. The lease terms may include the impact of options to extend or terminate the lease when it is
reasonably certain that the Company will exercise the option. Assumptions made by the Company at the commencement date are <FONT STYLE="white-space:nowrap">re-evaluated</FONT> upon occurrence of certain events, including a lease modification. When a
lease modification results in a separate contract, it is accounted for in the same manner as a new lease. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Consolidated Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Claims and contingencies </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">From time to time, the Company may become involved in litigation and proceedings relating to claims arising from the ordinary
course of business. The Company accrues a liability if the likelihood of an adverse outcome is probable and the amount can be reasonably estimated. If the likelihood of an adverse outcome is only reasonably possible (as opposed to probable), or if
an estimate is not determinable, the Company provides disclosure of a material claim or contingency. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Convertible preferred stock </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The carrying value of the Company&#146;s Series <FONT STYLE="white-space:nowrap">A-1</FONT> and Series <FONT
STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock is adjusted to reflect dividends if and when declared by the Company&#146;s board of directors. No dividends have been declared by the board of directors since inception. The Company
classifies its convertible preferred stock outside of permanent equity, as the redemption of such stock is not solely under the control of the Company. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stock-based compensation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company grants share based compensation to employees, directors, and <FONT STYLE="white-space:nowrap">non-employees,</FONT>
including consultants, in the form of stock options, RSAs, and RSUs. The Company accounts for stock-based compensation awards in accordance with ASC Topic 718,<I>&nbsp;Compensation&#151;Stock Compensation</I> (ASC 718) by measuring the fair value of
the award on the date of grant. Expense is recognized on a straight-line basis over the requisite service period, which is generally the vesting period of the respective award. Forfeitures are recognized as they occur. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Generally, stock option awards granted by the Company vest over four years and have an exercise price equal to the estimated
fair value of the common stock as determined by the board of directors with consideration given to contemporaneous valuations of the Company&#146;s common stock prepared by an independent third party valuation firm in accordance with the guidance
provided by the AICPA Guide. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company accounts for share-based awards issued to
<FONT STYLE="white-space:nowrap">non-employees</FONT> under ASU <FONT STYLE="white-space:nowrap">2018-07,</FONT> <I>Compensation&#151;Stock Compensation,</I> using the measurement date at the date of grant without subsequent changes in the fair
value of the award. Share-based compensation costs for <FONT STYLE="white-space:nowrap">non-employees</FONT> are recognized as expense over the requisite service period, which is the vesting period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The fair value of stock options is estimated at the date of grant using a Black-Scholes option pricing model which requires
management to apply judgment and make estimates, including: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Fair Value of Common Stock</I>&#151;The Company&#146;s board of directors, with the assistance and upon the
recommendation of management, has for financial reporting purposes periodically determined the estimated per share fair value of the Company&#146;s common stock on the grant date in part using contemporaneous independent third-party valuations
consistent with the AICPA Guide. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Expected Term</I>&#151;The expected term represents the period that the stock-based awards are expected to
be outstanding. The Company uses the simplified method to determine the expected term, which is based on the average of the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">time-to-vesting</FONT></FONT> and the contractual life of
the options. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Expected Volatility</I>&#151;Since the Company is not yet a public company and does not have any trading
history for its common stock, the expected volatility is estimated based on the average historical volatilities of common stock of comparable publicly traded entities over a period equal to the expected term of the stock option grants. The
comparable companies are chosen based on their size, stage in the product development cycle or area of specialty. The Company will continue to apply this process until sufficient historical information regarding the volatility of its own stock price
becomes available. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Consolidated Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Risk-Free Interest Rate&#151;</I>The risk-free interest rate is based on the U.S. Treasury yield in effect
at the time of grant for <FONT STYLE="white-space:nowrap">zero-coupon</FONT> U.S. Treasury notes with maturities approximately equal to the expected term of the awards. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Expected Dividend&#151;</I>The Company has never paid dividends on its common stock and has no plans to pay
dividends on its common stock. Therefore, the Company used an expected dividend yield of zero. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Research and development expense
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company records expense for research and development costs as incurred. Nonrefundable, advance payments for
goods or contracts for services are deferred, and expense is recognized in the period in which the goods are received, or the services are rendered. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Research and development expense consist of costs incurred by the Company for the discovery and development of the
Company&#146;s platform technology and product candidates and contain personnel costs, including salaries, benefits, and <FONT STYLE="white-space:nowrap">non-cash</FONT> stock-based compensation, external research and development expenses incurred
under arrangements with third parties, laboratory supplies, costs to acquire and license technologies aligned with the Company&#146;s goal of translating engineered cells to medicine, changes in the estimated fair value of the success payment and
contingent consideration liabilities, and other expenses, which include facility and other allocated expenses, including rent, depreciation, and allocated overhead costs, and other research and development costs. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>General and administrative expenses </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">General and administrative expenses consist of personnel costs, including salaries, benefits, and <FONT
STYLE="white-space:nowrap">non-cash</FONT> stock-based compensation, for our employees in executive, legal, finance, human resources, information technology, and other administrative functions, legal fees, consulting fees, recruiting costs, and
facility costs not otherwise included in research and development expenses. Legal fees include those related to corporate and patent matters. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Income taxes </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The
Company determines its deferred tax assets and liabilities based on the differences between the financial statement and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to
reverse. A valuation allowance is recorded when it is more likely than not that the deferred tax asset will not be recovered. The Company applies judgment in the determination of the financial statement recognition and measurement of a tax position
taken or expected to be taken in a tax return. The Company recognizes any material interest and penalties related to unrecognized tax benefits in income tax expense. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company is required to file income tax returns in the United States (U.S.) federal jurisdiction, and other state and local
jurisdictions. The Company currently is not under examination by the Internal Revenue Service or other jurisdictions for any tax years. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Segments
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Operating segments are identified as components of an enterprise about which separate discrete financial
information is available for evaluation by the chief operating decision-maker in making decisions regarding resource allocation and assessing performance. The Company views its operations and manages its business in one operating segment. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Consolidated Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Recent accounting pronouncements </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Recently adopted </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2019-12,</FONT><I> Income Taxes (Topic 740): Simplifying the Accounting for
Income Taxes</I> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In December 2019, the FASB issued ASU <FONT STYLE="white-space:nowrap">2019-12,</FONT> <I>Simplifying
the Accounting for Income Taxes</I>. The objective of the standard is to improve areas of GAAP by removing certain exceptions permitted by ASC Topic&nbsp;740, <I>Income Taxes,</I> and clarifying existing guidance to facilitate consistent
application. Early adoption of the new standard is permitted for companies for periods for which financial statements have not yet been issued. The Company early adopted the standard beginning on January&nbsp;1, 2019. The adoption of this standard
did not have an impact on the financial condition, results of operations and cash flows, or financial statement disclosures. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Not yet
adopted </I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2016-13,</FONT> <I>Financial Instruments&#151;Credit Losses
(Topic 362): Measurement of Credit Losses on Financial Statements,</I> ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2019-05,</FONT> <I>Financial Instruments&#151;Credit Losses (Topic 326): Targeted Transition Relief,</I> ASU <FONT
STYLE="white-space:nowrap">No.&nbsp;2019-11,</FONT> <I>Codification Improvements to Topic 326, Financial Instruments&#151;Credit Losses</I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In June 2016, the FASB issued ASU <FONT STYLE="white-space:nowrap">2016-13,</FONT> <I>Financial Instruments&#151;Credit Losses
(Topic 362):</I> <I>Measurement of Credit Losses on Financial Statements</I> (ASU <FONT STYLE="white-space:nowrap">2016-13).</FONT> The new standard requires that expected credit losses relating to financial assets measured on an amortized cost
basis and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> debt securities be recorded through an allowance for credit losses. It also limits the amount of credit losses to be recognized for <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> debt securities to the amount by which carrying value exceeds fair value and also requires the reversal of previously recognized credit losses if fair value
increases. The targeted transition relief standard allows companies an option to irrevocably elect the fair value option of ASC <FONT STYLE="white-space:nowrap">825-10,</FONT> <I>Financial Instruments-Overall</I>, applied on an <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">instrument-by-instrument</FONT></FONT> basis for eligible instruments. The new standard will be effective for the Company beginning January&nbsp;1, 2023. The Company is currently evaluating
the potential impact ASU <FONT STYLE="white-space:nowrap">2016-13,</FONT> and related updates, will have on its financial position and results of operations upon adoption. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2017-04</FONT><I>, Intangibles&#151;Goodwill and Other (Topic 350): Simplifying
the Test for Goodwill Impairment</I> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In January 2017, the FASB issued ASU
<FONT STYLE="white-space:nowrap">2017-04,</FONT> <I>Intangibles&#151;Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment </I>(ASU <FONT STYLE="white-space:nowrap">2017-04).</FONT> To address concerns over the cost and
complexity of the <FONT STYLE="white-space:nowrap">two-step</FONT> goodwill impairment test, the<I> </I>amendments in this ASU remove the second step of the test. An entity will instead apply a <FONT STYLE="white-space:nowrap">one-step</FONT>
quantitative test and record the<I> </I>amount of goodwill impairment as the excess of a reporting unit&#146;s carrying amount over its fair value, not to exceed the total amount of<I> </I>goodwill allocated to the reporting unit. The new guidance
does not amend the optional qualitative assessment of goodwill impairment. The new standard will be effective beginning January&nbsp;1, 2023. The adoption of ASU <FONT STYLE="white-space:nowrap">2017-04</FONT> is not expected to have a material
impact on the Company&#146;s financial position or results of operations upon adoption. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">ASU <FONT
STYLE="white-space:nowrap">No.&nbsp;2018-13,</FONT> <I>Fair Value Measurement (Topic 820): Disclosure Framework&#151;Changes to the Disclosure Requirements for Fair Value Measurement</I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In August 2018, the FASB issued ASU <FONT STYLE="white-space:nowrap">2018-13,</FONT> <I>Fair Value Measurement (Topic 820):
Disclosure Framework&#151;Changes to the Disclosure Requirements for Fair Value Measurement</I>, (ASU <FONT STYLE="white-space:nowrap">2018-13).</FONT> The new standard removes certain disclosures, modifies certain disclosures and adds additional
disclosures related to fair value measurement. The new standard will be effective beginning January&nbsp;1, 2023. The Company is currently evaluating the potential impact ASU <FONT STYLE="white-space:nowrap">2018-13</FONT> may have on its
disclosures upon adoption. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Consolidated Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>3. Acquisitions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Cobalt Biomedicine, Inc. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In February 2019, the Company acquired 100% of the outstanding equity in Cobalt, a privately-held early-stage biotechnology
company developing a platform technology using its fusogen technology to specifically and consistently deliver various biological payloads to cell. The Company issued 36,441,583 shares of its Series <FONT STYLE="white-space:nowrap">A-2</FONT>
convertible preferred stock in consideration, valued at $136.0&nbsp;million. Of the 36,441,583 shares of Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock issued, 12,147,192 shares were restricted based on the
achievement of a <FONT STYLE="white-space:nowrap">pre-specified</FONT> development milestone, which was achieved in July 2019. Additionally, 691,636 RSAs and 345,814 RSUs were granted to former employees of Cobalt. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The elements of the purchase consideration are as follows (in thousands): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="91%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock issued<SUP
STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">97,178</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">First milestone&#151;restricted Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible
preferred stock<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38,769</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Success payment<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,428</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of contingent
consideration<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51,248</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total consideration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">189,689</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">The purchase consideration included 24,294,391 shares of the Company&#146;s Series <FONT
STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock. The value of the stock was $4.00 per share, equivalent to the purchase price per share of the Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock financing
that occurred in February 2019. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">The Company concluded the value of the first milestone, to be paid in restricted shares, met the definition
of being indexed to common stock. The restricted Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred shares were recorded in convertible preferred stock valued at $38.8&nbsp;million based on the estimated probability and timing
of the milestone achievement on the date of acquisition, and is not subject to remeasurement upon achievement. In July 2019, the first milestone was achieved, and the Company issued a total of 12,147,192 shares of its Series <FONT
STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">The fair value of the Cobalt Success Payment was determined using a Monte Carlo simulation methodology which
models the estimated future value of the Company based on several key variables including the term of the success payment, expected volatility, risk-free interest rate, and estimated number and timing of valuation measurement dates on the basis of
which payment may be triggered. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">The fair value of the contingent consideration was determined by calculating the probability-weighted
estimated value of the milestone payments based on the assessment of the likelihood and estimated timing that certain milestones would be achieved and estimated using discount rates ranging from 15.3% to 17.6%. The discount rate captures the credit
risk associated with the payment of the contingent consideration when earned and due. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company
accounted for the Cobalt acquisition using the acquisition method of accounting. Under this method, the assets acquired and liabilities assumed in a business combination are measured at fair value as of the acquisition date. The results of
operations of Cobalt are included in the Company&#146;s results of operations from the date of acquisition. Pro forma results of operations have not been presented because the effects of the acquisition were not material to the Company&#146;s
financial results. The allocation of the purchase price is based on the estimated fair value of assets acquired and liabilities assumed as of the date of acquisition. The components of the purchase price allocation are as follows (in thousands):
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="91%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net working capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(3,275</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">689</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net liabilities assumed</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,586</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred tax liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,547</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquired <FONT STYLE="white-space:nowrap">in-process</FONT> research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59,195</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goodwill</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">140,627</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total consideration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">189,689</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Consolidated Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As part of the Cobalt acquisition, the Company recorded an IPR&amp;D asset of
$59.2&nbsp;million and $140.6&nbsp;million in goodwill. IPR&amp;D is required to be classified as an indefinite-lived asset until it becomes a finite-lived asset upon the successful completion or the abandonment of the associated research and
development technology. The Company is actively developing the fusogen technology and accordingly, this asset will not be amortized until regulatory approval is obtained in a major market, typically either the U.S. or the European Union, subject to
management judgment.</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The goodwill recognized as a result of the Cobalt acquisition is primarily attributable to the value
the acquisition provides the Company by complementing its <I><FONT STYLE="white-space:nowrap">ex-vivo</FONT></I> portfolio with <I><FONT STYLE="white-space:nowrap">in-vivo</FONT></I> cell engineering technology and furthers the continued research in
using engineered cells as medicines. The goodwill is not expected to be deductible for income tax purposes. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The
Company also agreed to pay contingent consideration of up to an aggregate of $500.0&nbsp;million upon the achievement of certain <FONT STYLE="white-space:nowrap">pre-specified</FONT> development milestones (Cobalt Contingent Consideration), and a
success payment of up to $500.0&nbsp;million, if, at <FONT STYLE="white-space:nowrap">pre-determined</FONT> valuation measurement dates, the value of the Company is equal to or exceeds three times the value of the Company implied by the per share
value of the Company&#146;s Series&nbsp;B convertible preferred stock at issuance, or any security into which such stock has been converted or exchanged, and we have an active program based on the fusogen technology in a clinical trial pursuant to
an IND, or have filed for, or received approval for, a BLA or NDA. The Cobalt Contingent Consideration and Cobalt Success Payment are payable in cash or stock, at the Company&#146;s discretion. A success payment can be achieved over a maximum of 20
years but could be shorter upon the occurrence of certain events. The valuation measurement dates for the Cobalt Success Payment are triggered by an arms&#146; length equity financing, or an IPO, and periodically thereafter. In addition to an
arms&#146; length equity financing or an IPO, a valuation measurement date is triggered upon a change of control when at least one company product utilizing technology acquired from Cobalt is the subject of an active research program. If there is a
change of control and the Company valuation implied by the per share value of the Company&#146;s Series&nbsp;B convertible preferred stock at issuance, or any security into which such stock has been converted or exchanged, falls below certain
thresholds as shown below, the amount of the Cobalt Success Payment will decrease and the amount of potential Cobalt Contingent Consideration will increase. The following table sets forth the different Company valuation thresholds and resulting
potential success payment and additional potential Cobalt Contingent Consideration upon a change of control: </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Company valuation at change of control date as calculated using a multiple of the Series
B<BR>convertible preferred stock price at issuance, or any security into which such stock has been<BR>converted or exchanged</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Success<BR>&nbsp;&nbsp;&nbsp;&nbsp;Payment&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Additional<BR>Potential<BR>Cobalt<BR>Contingent<BR>Consideration</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(in millions)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equal to or exceeds a multiple of three (3x)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equal to or exceeds a multiple of two and three-quarters (2.75x), but less than
three&nbsp;(3x)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;350</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equal to or exceeds a multiple of two and a half (2.50x), but less than two and <FONT
STYLE="white-space:nowrap">three-quarters</FONT> (2.75x)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less than a multiple of two and a half (2.50x)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company&#146;s liabilities for the Cobalt Success Payment and Cobalt Contingent
Consideration are carried at fair value with changes recognized in research and development expense. As of December&nbsp;31, 2019, the estimated fair value of the Cobalt Success Payment liability and Cobalt Contingent Consideration was
$2.4&nbsp;million and $69.1&nbsp;million, respectively. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Consolidated Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Cytocardia, Inc. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In November 2019, the Company acquired 100% of the outstanding equity in Cytocardia for a purchase price of $8.0&nbsp;million,
of which $6.8&nbsp;million was an upfront cash payment, and $1.2&nbsp;million was set aside (Cytocardia Holdback Amount) to satisfy certain general representations and warranties as set forth in the stock purchase agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The primary asset acquired in the acquisition was IPR&amp;D related to its <I>ex vivo</I> cell engineering programs focused on
replacement of damaged heart cells. The Company evaluated the acquisition and determined the screen test, as permitted under ASC 805, <I>Business Combinations</I>, was met as the $8.0&nbsp;million purchase price represented consideration for a
single identifiable asset related to the technology. The Company concluded the assets acquired did not meet the accounting definition of a business as inputs were acquired, but no processes or outputs were acquired, and the assets had no alternative
future use. The transaction was accounted for as an asset acquisition and the purchase price was recorded in research and development expense for the year ended December&nbsp;31, 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Cytocardia Holdback Amount will be held for 15 months, until February 2021, at which time the remainder of the balance,
after payment of any claims, will be released to the <FONT STYLE="white-space:nowrap">co-founders.</FONT> In addition to cash paid, the Company is required to make future milestone payments of up to an aggregate of $140.0&nbsp;million upon the
achievement of certain <FONT STYLE="white-space:nowrap">pre-specified</FONT> development and commercial milestones. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>4. Goodwill and intangible asset
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following table summarizes the changes in the carrying amount of goodwill (in thousands): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of December&nbsp;31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goodwill acquired</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">140,627</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;140,627</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The intangible asset consists of IPR&amp;D acquired from the Cobalt acquisition which is
classified as indefinite-lived until the successful completion of the associated research and development technology, at which point it becomes a finite-lived asset that will be amortized over its estimated useful life. The following table
summarizes the gross carrying amount, accumulated amortization and the net carrying amount of the intangible asset: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="61%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31, 2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Gross</B><br><B>Carrying</B><br><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated</B><br><B>Amortization</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Intangible</B><br><B>Asset</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Indefinite-lived intangible asset:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquired <FONT STYLE="white-space:nowrap">in-process</FONT> research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">59,195</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">59,195</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total identifiable intangible asset</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;59,195</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;59,195</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">There were no impairments of goodwill or the intangible asset since inception. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Consolidated Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>5. License and collaboration agreements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Oscine Corp. </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In
November&nbsp;2018, the Company entered into a collaboration, license and option to purchase agreement with Oscine Corp. (Oscine) to pursue research related to Oscine&#146;s <I>ex vivo</I> glial progenitor cell programs focused on brain disorders.
The Company paid a $5.0&nbsp;million <FONT STYLE="white-space:nowrap">non-refundable</FONT> upfront fee, which was recorded in research and development expense for the period from July&nbsp;13, 2018 (inception) to December&nbsp;31, 2018. The Company
provided $5.5&nbsp;million to Oscine in additional research funding through December&nbsp;31, 2019. Oscine is eligible to receive future pre-specified development and commercial milestone payments up to an aggregate of $180.8&nbsp;million, payable
in cash or stock. The Company also has the option to purchase Oscine after the achievement of certain clinical milestones. The agreement terminates at the end of the option to acquire window, the timing of which is dependent upon clinical progress.
The Company can terminate the agreement at will upon advance written notice. The Company recognized $0.2&nbsp;million and $4.2&nbsp;million of research and development expenses in connection with its collaboration agreement with Oscine for the
period from July&nbsp;13, 2018 (inception) to December&nbsp;31, 2018 and the year ended December&nbsp;31, 2019, respectively, and as of December&nbsp;31, 2019 $1.1&nbsp;million was included in prepaid expenses and other current assets. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The Regents of the University of California </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In January 2019, the Company entered into an exclusive license agreement with the Regents of the University of California to
access certain intellectual property for the development of immunoengineered pluripotent cells. Under this agreement, the Company paid $0.1&nbsp;million in cash and issued 737,515 shares of its Series <FONT STYLE="white-space:nowrap">A-2</FONT>
convertible preferred stock, valued at $4.00 per share, for total consideration of $3.1&nbsp;million. The Company determined that the licensed technology has no alternative future use and therefore the $3.1&nbsp;million was recorded in research and
development expense for year ended December&nbsp;31, 2019. Under the agreement, the Company may be required to make certain <FONT STYLE="white-space:nowrap">pre-specified</FONT> development milestone payments up to an aggregate of
$22.4&nbsp;million. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Harvard College </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In March&nbsp;2019, the Company entered into an exclusive license agreement with Harvard to access certain intellectual
property for the development of hypo-immune cells. Under this agreement, the Company paid $3.0&nbsp;million in cash and issued 2,244,412 shares of its Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock, valued at $4.00
per share, for total consideration of $12.0&nbsp;million. The Company determined the licensed technology has no alternative future use and therefore the $12.0&nbsp;million was recorded in research and development expense for the year ended
December&nbsp;31, 2019. Additionally, the Company agreed to pay Harvard $6.0&nbsp;million in cash contingent upon the closing of the Company&#146;s Series B convertible preferred stock financing. Under the agreement, the Company may be required to
make certain <FONT STYLE="white-space:nowrap">pre-specified</FONT> development and regulatory milestone payments up to an aggregate of $76.0&nbsp;million, which would double upon a change of control, as well as success payments up to an aggregate of
$175.0&nbsp;million based on increases in the fair value of the Company&#146;s Series A convertible preferred stock at <FONT STYLE="white-space:nowrap">pre-defined</FONT> thresholds. The contingent $6.0&nbsp;million license payment and success
payments are accounted for as derivatives under ASC 815, <I>Derivatives and Hedging</I>, and will be <FONT STYLE="white-space:nowrap">re-valued</FONT> each reporting period. See Note 7, Fair value measurements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As of December&nbsp;31, 2019, the estimated fair value of the contingent license payment to Harvard was $4.6&nbsp;million. The
Company recorded research and development expense of $4.6&nbsp;million for the year ended December&nbsp;31, 2019 and a corresponding liability on the balance sheet. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Consolidated Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company granted Harvard rights to certain success payments, payable
in cash. Under the terms of this arrangement, the Company may be required to make success payments to Harvard based on increases in the fair value of the Company&#146;s Series A convertible preferred stock, or any security into which such stock has
been converted or exchanged. The potential payments are based on multiples of increased value ranging from 5x to 40x based on a comparison of the fair value of the Company&#146;s Series A convertible preferred stock relative to its original $4.00
issuance price at <FONT STYLE="white-space:nowrap">pre-determined</FONT> valuation measurement dates. The aggregate amount of the Harvard Success Payments does not exceed an aggregate of $175.0&nbsp;million which would only occur upon a 40x increase
in value. The Harvard Success Payments can be achieved over a maximum of 12 years from the effective date of the contract. The following table summarizes the potential success payments: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="63%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Multiple of Equity Value at Issuance</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>5x</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>10x</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>20x</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>30x</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>40x</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Per share Series A preferred stock price required for payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">20.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">40.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">80.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">120.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">160.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Success payment(s) (in millions)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">30.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">50.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">75.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The valuation measurement dates are triggered by events which include: an equity
financing prior to an IPO of more than $25.0&nbsp;million, the one year anniversary of an IPO and periodically thereafter, a merger, an asset sale, the sale of the majority of the shares held by the Company&#146;s Series A convertible preferred
stockholders, or the last day of the term of the success payments. If a higher success payment tier is met at the same time a lower tier is first met, both tiers will be owed. Any previous success payments made to Harvard are credited against the
success payment owed as of any valuation measurement date so that Harvard does not receive multiple success payments in connection with the same threshold. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company&#146;s liability for the Harvard Success Payments is carried at fair value with changes recognized in research and
development expense. To determine the estimated fair value of the success payment liability, the Company uses a Monte Carlo simulation methodology which models the future movement of its Series A convertible preferred stock price based on several
key variables. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As of December&nbsp;31, 2019, the estimated fair value of the Harvard Success Payment liability was
$1.9&nbsp;million. The Company recorded research and development expense of $1.9&nbsp;million for the year ended December&nbsp;31, 2019 and a corresponding liability on the balance sheet. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>6. Restricted cash </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As of
December&nbsp;31, 2018, and 2019, the Company maintained standby letters of credit of $0.8&nbsp;million and $1.8&nbsp;million, respectively. Standby letters of credit are collateralized with a bank account at a financial institution in accordance
with the lease agreements as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2018&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2019&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">South San Francisco, CA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;816</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">816</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cambridge, MA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">961</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total restricted cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">816</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1,777</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Consolidated Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>7. Fair value measurements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following tables summarizes Company&#146;s financial assets and liabilities measured at fair value on a recurring basis by
level based on the three-tier fair value hierarchy: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="58%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31, 2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Valuation</B><br><B>Hierarchy</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amortized</B><br><B>Cost</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Gross</B><br><B>Unrealized</B><br><B>Holding</B><br><B>Gains</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Gross</B><br><B>Unrealized</B><br><B>Holding</B><br><B>Losses</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Estimated</B><br><B>Fair&nbsp;Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financial assets:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash equivalents:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Money market funds</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Level&nbsp;1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">49,420</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">49,420</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">U.S. government and agency securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Level&nbsp;2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,682</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,683</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Corporate debt securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Level&nbsp;2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,433</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,433</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">76,535</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">76,536</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Short-term marketable securities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">U.S. government and agency securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Level&nbsp;2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42,449</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42,466</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Corporate debt securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Level&nbsp;2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,477</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,486</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58,926</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58,952</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total financial assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">135,461</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(3</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">135,488</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financial liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contingent license payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Level&nbsp;3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,557</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,557</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contingent consideration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Level&nbsp;3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">69,108</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">69,108</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Success payment liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Level&nbsp;3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,352</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,352</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total financial liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">78,017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">78,017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company evaluated its securities for other-than-temporary impairment and considers the
decline in market value for the securities to be primarily attributable to current economic and market conditions. Securities in an unrealized loss position have been in an unrealized loss position for less than one year. For the debt securities, it
is not <FONT STYLE="white-space:nowrap">more-likely-than-not</FONT> that the Company will be required to sell the securities, and the Company does not intend to do so prior to the recovery of the amortized cost basis. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">All marketable securities have an effective maturity date of two years or less. Investments in securities with maturities of
less than one year, or those for which management intends to use the investments to fund current operations, are included in current assets and are available for use and therefore classified as <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">available-for-sale.</FONT></FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company measures the fair value of money market funds
based on quoted prices in active markets for identical assets or liabilities. The Level&nbsp;2 marketable securities include U.S. government, agency securities and corporate debt securities and are valued either based on recent trades of securities
in inactive markets or based on quoted market prices of similar instruments and other significant inputs derived from or corroborated by observable market data. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Consolidated Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following table sets forth a summary of the changes in the fair value of
the Company&#146;s Level&nbsp;3 financial liabilities: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Contingent</B><br><B>License</B><br><B>Payment</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Contingent</B><br><B>Consideration</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Success</B><br><B>Payment</B><br><B>Liabilities</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of December&nbsp;31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,989</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51,248</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,192</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Changes in fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">568</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,860</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">160</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4,557</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;69,108</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4,352</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The initial recognition of the Cobalt Contingent Consideration and Cobalt Success Payment
liability was recorded as part of the purchase price as an increase to goodwill and accrued liabilities. Subsequent changes in the fair value of the Cobalt Contingent Consideration and Cobalt Success Payment liability are recorded in research and
development expense. The fair value of the Harvard Success Payments and Harvard contingent license payment are recorded in research and development expense. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Contingent license payment </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company utilizes estimates and assumptions in determining the estimated contingent license liability and associated expense
at each balance sheet date. The assumptions used to calculate the fair value of the contingent license payment are subject to a significant amount of judgment including the expected probability of the Series B financing occurring and estimated
timing of achievement. A small change in the assumptions, such as the timing of the Series B financing, may have a relatively large change in the estimated valuation and associated liability and expense. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Contingent consideration </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In connection with the acquisition of Cobalt, the Company may be required to pay future consideration that is contingent upon
the achievement of certain <FONT STYLE="white-space:nowrap">pre-specified</FONT> development milestones. The valuation of the Cobalt Contingent Consideration uses assumptions the Company believes would be made by a market participant. The fair value
of the Cobalt Contingent Consideration was determined by calculating the probability-weighted estimated value of the pre-specified development milestone payments based on the assessment of the likelihood and estimated timing that certain milestones
would be achieved, and the estimated discount rates. The discount rate captures the credit risk associated with the payment of the contingent consideration when earned and due. The Company assesses these estimates on an <FONT
STYLE="white-space:nowrap">on-going</FONT> basis as additional data impacting the assumptions is obtained. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As of
December&nbsp;31, 2019, the fair value of the Cobalt Contingent Consideration was calculated using the following unobservable inputs: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="71%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Unobservable Input</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Range</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Weighted-Average</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Discount rates</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">14.6%&nbsp;-&nbsp;15.6%</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Probability of milestone achievement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.9%&nbsp;-&nbsp;47.5%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The weighted-average unobservable inputs were based on the relative value of the Cobalt
Contingent Consideration. The estimated fair value of the Cobalt Contingent Consideration may change significantly as development progresses and additional data are obtained, impacting the assumptions regarding probabilities of
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Consolidated Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
successful achievement of the milestones used to estimate the fair value of the liability and the timing in which they are expected to be achieved. In evaluating the fair value information,
judgment is required to interpret the market data used to develop the estimates. The estimates of fair value may not be indicative of the amounts that could be realized in a current market exchange. Accordingly, the use of different market
assumptions and/or different valuation techniques could result in materially different fair value estimates. Significant increases or decreases in any of the inputs would result in a significantly higher or lower fair value measurement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Success payments </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company utilizes significant estimates and assumptions in determining the estimated success payment liability and
associated expense or gain at each balance sheet date. The assumptions used to calculate the fair value of the success payments are subject to a significant amount of judgment including the estimated future value of the Company&#146;s Series A
convertible preferred stock, the estimated future value of the Company implied by the estimated future per share value of the Company&#146;s Series B convertible preferred stock at issuance, the expected volatility, estimated term, and estimated
number and timing of valuation measurement dates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As of December&nbsp;31, 2019, the fair value of the Cobalt and Harvard
Success Payments were calculated using the following unobservable inputs: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Unobservable Input</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;Cobalt&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;Harvard&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected term (years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A small change in the assumptions and other inputs used to calculate the estimated fair value
of the success payments may result in a relatively large change in the estimated valuation and associated liability and expense or gain. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>8. Property
and equipment, net </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Property and equipment, net consists of the following: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2018&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2019&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Laboratory equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">57</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15,046</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leasehold improvements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,624</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Construction in progress</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">529</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,421</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Computer equipment, software and other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">636</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total property and equipment, at cost</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">586</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,727</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: Accumulated depreciation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,816</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property and equipment, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;585</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27,911</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Depreciation expense related to property and equipment was immaterial for the period from
July&nbsp;13, 2018 (inception) to December&nbsp;31, 2018, and $1.8&nbsp;million for the year ended December&nbsp;31, 2019. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Consolidated Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>9. Accrued liabilities </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Accrued compensation and accrued expenses and other current liabilities consist of the following: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="79%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2018&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;2019&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued compensation:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued bonuses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">540</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">6,035</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other accrued compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">271</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,059</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total accrued compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">811</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8,094</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued expenses and other current liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued contingent license payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,557</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued property and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,257</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued professional fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">321</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,131</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">364</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,942</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total accrued expenses and other current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;685</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;9,887</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>10. Commitments and contingencies </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Lease commitments </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company&#146;s lease portfolio is primarily comprised of operating leases for office and laboratory space located in
Seattle, WA, Cambridge, MA, and South San Francisco, CA. These leases contain various rent abatement periods, after which they require monthly lease payments that may be subject to annual increases throughout the lease term. The Seattle and South
San Francisco lease agreements provide the Company with the option to renew for an additional period of five years. The Company is not reasonably certain it will renew these leases, and therefore the renewal options are not considered in the
remaining lease term. Certain leases provide the Company the right to make tenant improvements, including the addition of laboratory space, and include a lease incentive allowance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following table is a summary of the Company&#146;s operating leases in which a ROU asset and lease liability were
recognized: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="31%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Location</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Approximate</B><br><B>Square&nbsp;Footage</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Lease</B><br><B>Commencement</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Rent</B><br><B>Commencement</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Lease</B><br><B>Expiration</B></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Seattle, WA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,898</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">March&nbsp;2019</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">December 2019</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">December&nbsp;2026</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cambridge, MA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24,386</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">March 2019</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">July 2019</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">June 2027</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">South San Francisco, CA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66,075</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">November&nbsp;2018&nbsp;amended<BR>December 2019</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">November&nbsp;2018&nbsp;and<BR>September 2020</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">April 2030</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Throughout the term of the lease agreements, the Company is responsible for paying certain
operating costs, in addition to rent, such as common area maintenance, taxes, utilities, and insurance. These additional charges are considered variable lease costs and are recognized in the period in which the costs are incurred. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For the year ended December&nbsp;31, 2019, the weighted-average remaining lease term was 9.09 years and the weighted-average
IBR was 11.24%. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Consolidated Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Rent expense for the period from July&nbsp;13, 2018 (inception) to
December&nbsp;31, 2018 was $1.1&nbsp;million and consisted primarily of short-term leases and the Company&#146;s South San Francisco lease. Rent expense for the Company&#146;s operating leases was $8.6&nbsp;million for the year ended
December&nbsp;31, 2019, which consisted of $4.9&nbsp;million straight-line recognition of fixed payments and $3.7&nbsp;million associated with short-term leases. Variable lease payments for operating expenses were $0.1&nbsp;million and
$1.5&nbsp;million for the period from July&nbsp;13, 2018 (inception) to December&nbsp;31, 2018 and for the years ended December&nbsp;31, 2019, respectively. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following table presents the scheduled maturities of the Company&#146;s operating lease liabilities by fiscal year and the
present value of those lease liabilities as of December&nbsp;31, 2019 (in thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">6,763</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,579</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,858</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,146</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,443</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2025 and thereafter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,338</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total lease payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">84,127</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: imputed interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(33,345</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: tenant improvement allowances</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,575</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Present value of lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;48,207</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>11. Convertible preferred stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Series <FONT STYLE="white-space:nowrap">A-1</FONT> convertible preferred stock financing </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In October&nbsp;2018, the Company executed an agreement to sell up to 11,462,500 shares of its
<FONT STYLE="white-space:nowrap">Series&nbsp;A-1</FONT> convertible preferred stock at a price of $4.00 per share. The Company issued 11,462,500 shares in October and November 2018 for gross proceeds of $45.9&nbsp;million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Upon certain change in control events that are outside of the Company&#146;s control, holders of the convertible preferred
stock can cause its redemption. This requires the Company&#146;s convertible preferred stock to be classified outside of stockholders&#146; deficit on the accompanying consolidated balance sheets. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Series <FONT STYLE="white-space:nowrap">A-2</FONT> and Series B convertible preferred stock financing </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In February 2019, the Company executed an agreement for 54,036,865 shares of its
<FONT STYLE="white-space:nowrap">Series&nbsp;A-2</FONT> convertible preferred stock at a price of $4.00 per share, for gross proceeds of $216.1&nbsp;million. In October 2019, an additional 1,966,667 the Company&#146;s Series <FONT
STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock were sold at a price of $4.00 per share, for gross proceeds of $7.9&nbsp;million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred agreement also commits these investors to a
Series B convertible preferred stock financing with the issuance of up to 27,556,926 shares of the Company&#146;s Series B convertible preferred stock at a price of $16.00 per share, contingent upon the occurrence of certain clinical milestones or
the unanimous approval of the Company&#146;s board of directors. Additionally, in the event the clinical milestones are not achieved, the agreement states at least two large Series B convertible preferred stock investors, defined as investors with
at least a $29.0&nbsp;million Series B convertible preferred stock investment, have the right to object to a the board of director&#146;s decision to call the Series B convertible preferred stock closing within seven days. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Consolidated Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In connection with this financing, the Company amended and restated its
certificate of incorporation and amended the investors&#146; rights agreement and voting agreement with its stockholders.&nbsp;Under the amended and restated certificate of incorporation, the authorized capital stock of the Company increased to
700,000,000 shares, each with a par value of $0.0001 per share. The authorized shares consisted of 162,213,794&nbsp;shares designated as common stock and 537,786,206 shares designated as convertible preferred stock. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Rights issued with <FONT STYLE="white-space:nowrap">Series&nbsp;A-1</FONT> and Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred
stock </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company assessed the <FONT STYLE="white-space:nowrap">Series&nbsp;A-1</FONT> and Series <FONT
STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock for any beneficial conversion features or embedded derivatives, including the conversion option, that would require bifurcation from the convertible preferred stock and receive
separate accounting treatment. On the dates of the issuances, the fair value of the common stock into which the convertible preferred stock was convertible was less than the effective conversion price of the
<FONT STYLE="white-space:nowrap">Series&nbsp;A-1</FONT> and Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock; as such, there was no intrinsic value of the conversion option on the commitment date. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Conversion </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Shares of the Company&#146;s <FONT STYLE="white-space:nowrap">Series&nbsp;A-1</FONT> and Series
<FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock are convertible into shares of the Company&#146;s common stock based on a defined conversion ratio, set at
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">one-for-one,</FONT></FONT> adjustable for certain dilutive events. The conversion ratio for the convertible preferred stock is subject to change in accordance with anti-dilution
provisions contained in the Company&#146;s certificate of incorporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company&#146;s <FONT
STYLE="white-space:nowrap">Series&nbsp;A-1</FONT> and Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock is convertible at the option of the holder at any time without any additional consideration. The convertible
preferred stock will automatically convert into shares of the Company&#146;s common stock at the then effective applicable conversion rate, upon the closing of the sale of shares of common stock to the public in an underwritten public offering at a
price that generates at least $75.0&nbsp;million in gross proceeds pursuant to an effective registration statement under the Securities Act of 1933, as amended, provided that the Company&#146;s common stock is listed for trading on a national
securities exchange. In addition, the convertible preferred stock will automatically convert into shares of common stock upon the vote or written consent of the holders of at least 70% of the outstanding Series
<FONT STYLE="white-space:nowrap">A-1</FONT> convertible preferred stock and Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock, voting together as a single class on an <FONT STYLE="white-space:nowrap">as-converted</FONT>
basis. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Dividends </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Each holder of the Company&#146;s <FONT STYLE="white-space:nowrap">Series&nbsp;A-1</FONT> and Series <FONT
STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock is entitled to receive <FONT STYLE="white-space:nowrap">non-cumulative</FONT> dividends, when and if declared by the Company&#146;s board of directors, at an annual rate of 6% of the
original issue price prior to and in preference to the payment of a dividend on common stock. Any additional dividends shall be distributed among the holders of common stock pro rata based on the number of shares of common stock (on an <FONT
STYLE="white-space:nowrap">as-converted</FONT> basis). No dividends have been declared to date. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Liquidation preference </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company may be liquidated voluntarily by the Company&#146;s board of directors with consent of the holders of at least 70%
of the outstanding Series <FONT STYLE="white-space:nowrap">A-1</FONT> convertible preferred stock and Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock, voting together as a single class on an <FONT
STYLE="white-space:nowrap">as-converted</FONT> basis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In the event that the Company is liquidated either voluntarily or
involuntarily, or if any event occurs that is deemed a liquidation under the Company&#146;s certificate of incorporation, each holder of the Company&#146;s Series <FONT STYLE="white-space:nowrap">A-1</FONT> and Series
<FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock will be entitled to receive a liquidation preference out of any proceeds from the liquidation before any distributions are made to the holders of common stock. The liquidation
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Consolidated Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
preference for each share of the Series <FONT STYLE="white-space:nowrap">A-1</FONT> and Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred is equal to the greater of a) the
original issue price (plus any declared but unpaid dividends), or b) such amount per share as would have been payable had all the Series <FONT STYLE="white-space:nowrap">A-1</FONT> and Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible
preferred stock been converted into common stock immediately prior to a liquidation event. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Voting rights </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Each of the Company&#146;s Series <FONT STYLE="white-space:nowrap">A-1</FONT> and Series
<FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock vote (on an <FONT STYLE="white-space:nowrap">as-converted</FONT> to common stock basis) with the other voting stock of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The consent of the holders of at least 70% of the Company&#146;s outstanding Series
<FONT STYLE="white-space:nowrap">A-1</FONT> convertible preferred stock and Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock, voting together as a single class on an <FONT STYLE="white-space:nowrap">as-converted</FONT>
basis, is required for any of the following actions: the amendment or waiver of any provision of the certificate of incorporation or bylaws of the Company in a manner that adversely affects the rights, preferences or privileges of the Series <FONT
STYLE="white-space:nowrap">A-1</FONT> and Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock; any change in the authorized number of Series <FONT STYLE="white-space:nowrap">A-1</FONT> and Series <FONT
STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock, or any other class of stock of the Company; the creation of any new class or series of shares having rights, preferences or privileges senior to or on a parity with the Series <FONT
STYLE="white-space:nowrap">A-1</FONT> and Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock; the approval of any change in control event; the redemption of any securities of the Company, other than repurchases of common
stock upon termination of a consultant, director or employee approved by the Company&#146;s board of directors; any increase or decrease in the authorized size of the Company&#146;s board of directors; the declaration or payment of any dividend or
distribution on the Series <FONT STYLE="white-space:nowrap">A-1</FONT> and Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock (except as provided in the certificate of incorporation) or common stock; or the liquidation or
dissolution of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition, the stockholders of the Company have entered into a voting agreement pursuant to
which the Company&#146;s Series <FONT STYLE="white-space:nowrap">A-1</FONT> and Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock and common stockholders each elected five members to its board of directors, respectively.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Reorganization </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Any change in control event, including any change in the holders of a majority of the equity of the Company by merger,
consolidation, reorganization or otherwise, or any sale or exclusive license of substantially all the assets of the Company, will be deemed a liquidation under the Company&#146;s certificate of incorporation unless waived the holders of at least 70%
of Company&#146;s the outstanding Series <FONT STYLE="white-space:nowrap">A-1</FONT> convertible preferred stock and Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock, voting together as a single class on an <FONT
STYLE="white-space:nowrap">as-converted</FONT> basis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">After liquidation preferences for the Company&#146;s Series <FONT
STYLE="white-space:nowrap">A-1</FONT> and Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock described above have been satisfied, any additional proceeds from any deemed liquidation will be distributed among the holders
of common stock pro rata based on the number of shares of common stock (on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>12. Common
stock </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As of December&nbsp;31, 2019, there were 10,003,329 shares of the Company&#146;s common stock outstanding,
excluding the 17,140,131 shares of restricted common stock outstanding that are subject to vesting requirements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As of
December&nbsp;31, 2019, the Company had reserved 106,889,542 shares of its common stock for future issuance upon the conversion of its Series <FONT STYLE="white-space:nowrap">A-1</FONT> and Series <FONT STYLE="white-space:nowrap">A-2</FONT>
convertible preferred stock outstanding. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Consolidated Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>13. Stock-based compensation </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Equity Incentive Plan </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In October&nbsp;2018, the Company adopted the 2018 Equity Incentive Plan (the 2018 Plan) under which it may grant incentive
stock options, <FONT STYLE="white-space:nowrap">non-statutory</FONT> stock options, RSAs, RSUs, and other stock-based awards to any person, including officers, directors, and consultants. Terms of stock agreements, including vesting requirements,
are determined by the Company&#146;s board of directors, or by a committee appointed by the board of directors, subject to the provisions of the 2018 Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Generally, awards granted by the Company vest over four years and have an exercise price equal to the estimated fair value of
the common stock as determined by the board of directors with consideration given to contemporaneous valuations of the Company&#146;s common stock prepared by an independent third party valuation firm in accordance with the guidance provided by the
AICPA Guide. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As of December&nbsp;31, 2019, there were 2,403,500 shares available for future issuance under the 2018
Plan. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>RSU Plan </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In March 2019, pursuant to the terms of the Cobalt merger agreement, the Company adopted a restricted stock unit plan (RSU
Plan) under which it may grant RSUs to certain employees and consultants. The RSU Plan provides for up to 349,254 shares of common stock to be awarded. As of December&nbsp;31, 2019, there were 4,309 shares available for future issuance under the RSU
Plan. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B><I>Stock-based compensation expense </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Stock-based compensation expense is recognized in the consolidated statements of operations as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="63%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Period&nbsp;from&nbsp;July&nbsp;13,</B><br><B>2018&nbsp;(Inception)&nbsp;to</B><br><B>December&nbsp;31, 2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year&nbsp;Ended</B><br><B>December&nbsp;31,&nbsp;2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1,246</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">251</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,497</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Unrecognized stock-based compensation costs related to unvested awards and the
weighted-average period over which the costs are expected to be recognized as of December&nbsp;31, 2019 are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock&nbsp;Options</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>RSAs</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unrecognized&nbsp;stock-based&nbsp;compensation&nbsp;expense&nbsp;(thousands)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2,802</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4,885</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected
weighted-average&nbsp;period&nbsp;compensation&nbsp;costs&nbsp;to&nbsp;be&nbsp;recognized&nbsp;(years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As of December&nbsp;31, 2019, the Company had $0.5&nbsp;million of unrecognized stock-based
compensation costs related to RSUs originating from the Cobalt acquisition that are subject to (i)&nbsp;service-based vesting over four years, (ii)&nbsp;achievement of the first milestone which occurred in July 2019, and (iii)&nbsp;a liquidity
event. The estimated compensation expense will be recognized ratably over the service period, or remaining service period, if and when it becomes probable that the vesting conditions will be satisfied. As of December&nbsp;31, 2019, no stock-based
compensation expense was recognized related to RSUs. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Consolidated Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stock options </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A summary of the Company&#146;s stock option activity is as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock&nbsp;Options</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Weighted-Average</FONT></B><br><B>Exercise&nbsp;Price</B><br><B>per&nbsp;Share</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Weighted-Average</FONT></B><br><B>Remaining</B><br><B>Contractual</B><br><B>Life&nbsp;(years)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Aggregate</B><br><B>Intrinsic&nbsp;Value</B><br><B>(in&nbsp;thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outstanding as of December&nbsp;31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Granted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,638,899</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercised</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(625</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Forfeited/Cancelled</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(89,285</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outstanding as of December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,548,989</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;142</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercisable as of December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">57,747</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The fair value of stock options granted to employees, directors, and consultants was
estimated on the date of grant using the Black-Scholes option pricing model using the following assumptions: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Assumptions</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;December&nbsp;31,&nbsp;2019&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk-free interest rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">1.53%&nbsp;-&nbsp;2.62</FONT></TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected term (years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">6.02&nbsp;-&nbsp;6.25</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected dividend</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">During the year ended December&nbsp;31, 2019 the weighted-average grant date fair value of
the options granted was $0.92 per share. No stock options were granted in 2018. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Restricted stock awards </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A summary of the Company&#146;s RSA activity is as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="75%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>RSAs</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Weighted-Average</FONT></B><br><B>Grant&nbsp;Date&nbsp;Fair</B><br><B>Value&nbsp;per&nbsp;Share</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unvested shares as of July&nbsp;13, 2018 (inception)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Granted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,076,363</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.08</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vested</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,226,366</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Forfeited</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,750</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unvested shares as of December&nbsp;31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,846,247</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.08</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Granted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,491,644</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vested</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,425,088</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Forfeited</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,772,672</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.04</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unvested shares as of December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,140,131</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The fair value of vested RSAs was immaterial for the period from July&nbsp;13, 2018
(inception) to December&nbsp;31, 2018 and $1.0&nbsp;million for the year ended December&nbsp;31, 2019. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">During the
year ended December&nbsp;31, 2019, there were 345,814 RSUs granted, zero vested, and 877 cancelled. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Consolidated Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>14. Income taxes </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As of December&nbsp;31, 2018 and 2019, the Company had U.S. federal <FONT STYLE="white-space:nowrap">tax-effected</FONT> net
operating loss (NOL) carryforwards of $1.9&nbsp;million and $22.6&nbsp;million, respectively, which are available to reduce future taxable income. The Company also had state <FONT STYLE="white-space:nowrap">tax-effected</FONT> NOL carryforwards of
$0.1&nbsp;million and $3.5&nbsp;million as of December&nbsp;31, 2018 and 2019, respectively. At December&nbsp;31, 2019, the Company also had federal and state research tax credits of $2.9&nbsp;million and $1.6&nbsp;million, respectively, which may
be used to offset future tax liabilities. The federal NOL carries forward indefinitely and the federal tax credit carryforward will begin to expire in 2038. The state NOL will begin to expire in 2038 and the California state tax credit will carry
forward indefinitely. The NOL and tax credit carryforwards may become subject to an annual limitation in the event of certain cumulative changes in the ownership interest. This could limit the amount of tax attributes that can be utilized annually
to offset future taxable income or tax liabilities. Subsequent ownership changes may further affect the limitation in future years. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In connection with the 2019 Cobalt acquisition, the Company recorded a deferred tax liability of $7.5&nbsp;million associated
with the acquired intangible asset. For the year ended December&nbsp;31, 2019, the Company recorded a tax benefit of $7.5&nbsp;million related to the release of valuation allowance on U.S. deferred tax assets as a result of deferred tax liabilities
established for intangible assets from the acquisition of Cobalt. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A reconciliation of income taxes computed using the
U.S. federal statutory rate to that reflected in operations follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Period&nbsp;from&nbsp;July&nbsp;13,</B><br><B>2018 (Inception) to</B><br><B>December&nbsp;31, 2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended</B><br><B>December&nbsp;31,&nbsp;2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Federal statutory tax</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21.00</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21.00</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Valuation allowance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(23.60</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(16.32</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contingent liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2.71</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">In-process</FONT> research&nbsp;&amp; development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1.21</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax credits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.01</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.93</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.77</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Effective income tax rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.00</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.46</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Consolidated Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The principal components of the Company&#146;s net deferred tax assets are as
follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred tax assets:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net operating loss carryforwards</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1,984</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;26,116</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,391</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tax credit carryforwards</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">196</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,527</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued liabilities and allowances</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,620</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Business transactions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,308</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,204</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intangibles</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">159</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">453</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross deferred tax assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,669</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,311</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Valuation allowance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,127</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(25,791</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred tax assets, net of valuation allowance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">542</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,520</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred tax liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Right-of-use</FONT></FONT>
assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9,664</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intangibles</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,340</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(530</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,145</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fixed assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(12</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(371</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred tax liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(542</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(19,520</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net deferred taxes assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The valuation allowance relates primarily to net U.S. deferred tax assets from operating
losses, research tax credit carryforwards, and amounts paid and accrued to enter into various agreements for which the tax treatment requires capitalization and amortization. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company maintains a full valuation allowance on its net U.S. deferred tax assets. The assessment regarding whether a
valuation allowance is required considers both positive and negative evidence when determining whether it is more likely than not that deferred tax assets are recoverable. In making this assessment, significant weight is given to evidence that can
be objectively verified. In its evaluation, the Company considered its cumulative loss in the first year of operation and its forecasted losses in the near term as significant negative evidence. Based upon a review of the four sources of income
identified within ASC 740, <I>Accounting for Income Taxes</I>, the Company determined that the negative evidence outweighed the positive evidence and a full valuation allowance on its net deferred tax assets will be maintained. The Company will
continue to assess the realizability of its deferred tax assets going forward and will adjust the valuation allowance as needed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company determines its uncertain tax positions based on a determination of whether and how much of a tax benefit taken by
the Company in its tax filings or positions is more likely than not to be sustained upon examination by the relevant income tax authorities. The Company is generally subject to examination by U.S. federal and local income tax authorities for all tax
years in which the loss carryforward is available. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company applies judgment in the determination of the financial
statement recognition and measurement of tax positions taken or expected to be taken in a tax return. As of December&nbsp;31, 2018, and 2019, the Company had no uncertain tax positions. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Consolidated Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>15. Net loss per share </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Basic and diluted net loss per common share is calculated by dividing net loss applicable to common stockholders by the
weighted-average number of common shares outstanding during the period, without consideration for common stock equivalents. The Company was in a loss position for all periods presented, therefore basic net loss per share was the same as diluted net
loss per share for all periods as the inclusion of all potential common securities outstanding would have been anti-dilutive. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following table sets forth the computation of basic and diluted net loss per share of common stock: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="65%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Period&nbsp;from&nbsp;July&nbsp;13,</B><br><B>2018 (Inception) to</B><br><B>December&nbsp;31, 2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Year Ended</B><br><B>December&nbsp;31,&nbsp;2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(in&nbsp;thousands,&nbsp;except&nbsp;share&nbsp;and&nbsp;per&nbsp;share&nbsp;data)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss applicable to common stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(13,247</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(130,778</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average common shares used in net loss per share applicable to common stockholders, basic
and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;952,086</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4,902,642</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss per share applicable to common stockholders, basic and&nbsp;diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(13.91</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(26.68</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The amounts in the table below were excluded from the calculation of diluted net loss per
share, prior to the use of the treasury stock method, due to their anti-dilutive effect: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2018</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series <FONT STYLE="white-space:nowrap">A-1</FONT> convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,462,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,462,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">95,427,042</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unvested restricted common stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,846,247</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,140,131</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Options to purchase common stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,548,989</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unvested RSUs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">344,937</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37,308,747</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">127,923,599</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>16. Employee benefit plan </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In January&nbsp;2019, the Company adopted a 401(k) retirement and savings plan (the 401(k) Plan) covering all employees. The
401(k) Plan allows employees to make <FONT STYLE="white-space:nowrap">pre-</FONT> and <FONT STYLE="white-space:nowrap">post-tax</FONT> contributions up to the maximum allowable amount set by the IRS. As of December&nbsp;31, 2019, the Company has not
made any matching contributions to the 401(k) Plan on behalf of participants. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Consolidated Financial Statements </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>17. Subsequent events </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Cambridge Massachusetts sublease </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In January 2020, the Company entered into a sublease agreement for office and laboratory space in Cambridge Massachusetts. As
of December&nbsp;31, 2019, the Company maintains a letter of credit for the benefit of the landlord in the amount of $0.9 million. See Note 6, Restricted cash. The Company has the right to make tenant improvements, including the addition of
laboratory space, with a lease incentive allowance of $1.3 million. The rent payments began in May 2020 after an abatement period of three months. Upon obtaining access to the building in January 2020, the Company recognized a lease asset and lease
liability of $14.3 million. The lease term is eight years. The landlord has a right to terminate the lease after five years. If the lease is terminated by the landlord, the Company would receive an early termination fee calculated as a percentage of
constructed tenant improvements, net of the tenant improvement allowance. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Series B convertible preferred stock financing </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In June 2020, the Company completed the Series B convertible preferred stock financing and issued 27,223,170 shares of its
Series B convertible preferred stock at $16.00 per share for gross proceeds of $435.6 million pursuant to the Series A-2/B Purchase Agreement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Oscine Corp. acquisition </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In September 2020, the Company acquired Oscine, for a purchase price of $8.5 million, of which $7.6 million was an upfront cash
payment, and $0.9 million was set aside to satisfy certain general representations and warranties as set forth in the stock purchase agreement. The transaction was accounted for as an asset acquisition of IPR&amp;D with the purchase price of $8.5
million recorded in research and development expense. We are required to pay the prior stockholders of Oscine future milestone payments of up to an aggregate of $225.8 million upon the achievement of certain pre-specified development and commercial
milestones. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Authorized shares </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In December 2020, the Company amended and restated its certificate of incorporation to increase the authorized capital stock of
the Company to 707,000,000 shares, each with a par value of $0.0001 per share.<B><I> </I></B></P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Reverse stock spilt </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In January 2021, the board of directors of the Company approved an amendment to the Company&#146;s certificate of incorporation
to effect a reverse split of shares of the Company&#146;s common stock and convertible preferred stock on a 1-for-4 basis, which was effected on January&nbsp;27, 2021. All references to convertible preferred stock, common stock, options to purchase
common stock, restricted stock awards, restricted stock units, per share amounts and related information contained in the financial statements have been retroactively adjusted to reflect the effect of the reverse stock split for all periods
presented. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin60414_8"></A>Condensed Consolidated Balance Sheets </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(in thousands, except share and per share amounts) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,&nbsp;2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>September&nbsp;30,&nbsp;2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>(unaudited)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">ASSETS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current assets:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">80,030</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">149,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58,952</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">301,640</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses and other current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,281</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,707</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total current assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">144,263</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">455,568</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property and equipment, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,911</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39,770</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,403</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61,965</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Restricted cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,777</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,143</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Long-term marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,209</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Intangible asset</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59,195</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59,195</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goodwill</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">140,627</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">140,627</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other <FONT STYLE="white-space:nowrap">non-current</FONT> assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">522</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">238</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">TOTAL ASSETS</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">415,698</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">767,715</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">LIABILITIES,&nbsp;CONVERTIBLE PREFERRED&nbsp;STOCK, AND STOCKHOLDERS&#146; DEFICIT</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,889</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,094</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,912</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued expenses and other current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,887</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,547</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,848</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,189</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,829</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,537</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease liabilities, net of current portion</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46,359</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">67,461</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contingent consideration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">69,108</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85,780</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Success payment liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,352</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44,989</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other <FONT STYLE="white-space:nowrap">non-current</FONT> liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,233</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,226</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">140,881</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">225,993</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>Commitments and contingencies (Note 10)</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Convertible preferred stock, $0.0001 par value; 537,786,206&nbsp;shares authorized as of
December&nbsp;31, 2019 and September&nbsp;30, 2020; 106,889,542 and 134,112,712&nbsp;shares issued and outstanding as of December&nbsp;31, 2019 and September&nbsp;30, 2020, respectively; aggregate liquidation preference of $450,837 and $913,613 as
of December 31, 2019 and September&nbsp;30, 2020, respectively</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">417,359</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">852,897</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stockholders&#146; deficit:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common stock, $0.0001 par value; 700,000,000 shares authorized as of December&nbsp;31, 2019 and
September&nbsp;30, 2020; 10,003,329 and 14,250,366&nbsp;shares issued and outstanding as of December&nbsp;31, 2019 and&nbsp;September 30, 2020, respectively</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,558</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,031</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated other comprehensive income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(144,127</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(316,262</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stockholders&#146; deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(142,542</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(311,175</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">TOTAL LIABILITIES,&nbsp;CONVERTIBLE PREFERRED&nbsp;STOCK,&nbsp;AND STOCKHOLDERS&#146;
DEFICIT</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;415,698</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;767,715</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>The accompanying notes are an integral part of these financial statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin60414_9"></A>Condensed Consolidated Statements of Operations </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(in thousands, except share and per share amounts) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="69%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Nine&nbsp;Months&nbsp;Ended September&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">80,101</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">153,762</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,959</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,063</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">96,060</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">172,825</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(96,060</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(172,825</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest income, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,175</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">622</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other (expense) income, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(52</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss before income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(93,937</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(172,135</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Benefit from income taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,204</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(87,733</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(172,135</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss per share, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(24.24</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(14.05</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average shares outstanding, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3,620,021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12,249,482</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:342pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>The accompanying notes are an integral part of these financial statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin60414_10"></A>Condensed Consolidated Statements of Comprehensive Loss </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(in thousands) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="73%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Nine&nbsp;Months&nbsp;Ended September&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2019&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2020&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(87,733</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(172,135</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other comprehensive income, net of tax:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net unrealized gain on marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total other comprehensive income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(87,689</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(172,106</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:446pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>The accompanying notes are an integral part of these financial statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin60414_11"></A>Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders&#146; Deficit </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(in thousands, except share amounts) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Convertible Preferred Stock</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Common Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Additional</B><br><B><FONT STYLE="white-space:nowrap">Paid-In</FONT></B><br><B>Capital</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated</B><br><B>Other</B><br><B>Comprehensive</B><br><B>Income</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated</B><br><B>Deficit</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>Stockholders&#146;</B><br><B>Deficit</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;Shares&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;Amount&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of December&nbsp;31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,462,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">45,721</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,577,616</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(13,247</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(13,188</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjustment to beginning accumulated deficit from adoption of ASC 842</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(102</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(102</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock, net of
issuance costs of $224</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;54,036,865</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">215,924</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock for
acquisition, <FONT STYLE="white-space:nowrap">non-cash</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,441,583</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">135,971</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock in
connection with license agreements</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,981,927</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,928</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,023,086</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,011</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,012</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercise of stock options</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">625</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other comprehensive income, net</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(87,733</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(87,733</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of September&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;104,922,875</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;409,544</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;7,601,327</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1,071</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(101,082</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(99,966</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Convertible Preferred&nbsp;Stock</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Common Stock</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Additional</B><br><B><FONT STYLE="white-space:nowrap">Paid-In</FONT></B><br><B>Capital</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated</B><br><B>Other</B><br><B>Comprehensive</B><br><B>Income</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Accumulated</B><br><B>Deficit</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Total</B><br><B>Stockholders&#146;</B><br><B>Deficit</B></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;Shares&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;Amount&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">106,889,542</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">417,359</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,003,329</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,558</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(144,127</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(142,542</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of Series B convertible preferred stock, net of issuance costs of $33</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,223,170</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">435,538</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of common stock in connection with license agreement</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">388</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">388</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,152,376</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,039</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,039</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercise of stock options</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">32,161</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other comprehensive income, net</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;29</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(172,135</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(172,135</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of September&nbsp;30, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;134,112,712</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;852,897</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;14,250,366</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5,031</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;55</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(316,262</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(311,175</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>The accompanying notes are an integral part of these financial statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-38 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin60414_12"></A>Condensed Consolidated Statements of Cash Flows </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(in thousands) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="71%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Nine Months Ended September&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">OPERATING ACTIVITIES:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(87,733</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(172,135</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjustments to reconcile net loss to net cash used in operating activities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">798</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,166</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred income tax</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,204</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,010</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,037</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value of contingent consideration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,564</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,672</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in fair value of success payment liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,427</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,637</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-cash</FONT> expense for equity issuance in connection with
license agreements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,928</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">388</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-cash</FONT> expense in connection with license
agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,364</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-cash</FONT> expense in connection with asset
acquisition</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">850</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-cash</FONT> <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets lease expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,559</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,889</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other <FONT STYLE="white-space:nowrap">non-cash</FONT> items</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(313</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(419</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Changes in operating assets and liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses and other assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,528</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">682</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating lease
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> assets and liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,791</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">91</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">469</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,414</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued expenses and other liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,160</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,748</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payment of contingent liability in connection with license agreement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,443</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(51,708</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(100,423</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">INVESTING ACTIVITIES:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchases of marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(130,395</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(307,398</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from sales and maturities of marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">39,340</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchases of property and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(20,453</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(14,606</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquisitions, net of cash acquired</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,195</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from disposal of assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in investing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(114,644</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(265,604</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">FINANCING ACTIVITIES:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from issuance of convertible preferred stock, net of issuance costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">215,924</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">435,538</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from issuance of common stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payment of contingent consideration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(14</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash provided by financing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">215,911</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">435,584</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net increase in cash, cash equivalents, and restricted cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,559</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">69,557</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash, cash equivalents, and restricted cash at beginning of period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">31,446</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">81,807</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash, cash equivalents, and restricted cash at end of period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;81,005</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;151,364</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SUPPLEMENTAL CASH FLOW DISCLOSURES:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchases of property and equipment included in accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">988</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,238</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of convertible preferred stock for acquisition</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">135,971</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Right-of-use</FONT></FONT>
assets obtained in exchange for operating lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">28,023</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">23,049</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Tenant improvement allowance included in contra-lease liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,058</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8,515</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash received from lessor for tenant improvement allowance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,791</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">91</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>The accompanying notes are an integral part of these financial statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-39 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin60414_13"></A>Notes to Unaudited Condensed Consolidated Financial Statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>1. Organization </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Sana
Biotechnology, Inc. (the Company or Sana) was incorporated in Delaware on July&nbsp;13, 2018 (inception) as FD Therapeutics, Inc., and changed its name to Sana Biotechnology, Inc. on September&nbsp;17, 2018. The Company is a biotechnology company,
focusing on utilizing engineered cells as medicines. The Company&#146;s operations to date have included identifying and developing potential product candidates, executing preclinical studies, acquiring technology, organizing and staffing the
Company, business planning, establishing the Company&#146;s intellectual property portfolio, raising capital, and providing general and administrative support for these operations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In September 2020, the Company acquired 100% of the outstanding shares of common stock of Oscine Corp. (Oscine), a
privately-held early-stage biotechnology company developing <I>ex vivo</I> glial progenitor cell programs focused on brain disorders. The acquisition of Oscine complements the Company&#146;s <I>ex vivo</I> cell engineering portfolio. See Note 3,
Acquisitions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company is subject to a number of risks similar to other biotechnology companies in the development
stage including, but not limited to, the need to obtain adequate additional funding, possible failure of preclinical testing or clinical trials, the need to obtain marketing approval for its product candidates, competitors developing new
technological innovations, the need to successfully commercialize and gain market acceptance of the Company&#146;s products, protect the Company&#146;s intellectual property and proprietary technology, and the need to attract and retain key
scientific and management personnel. If the Company does not successfully commercialize or partner any of its product candidates, it will be unable to generate product revenue or achieve profitability. Through September&nbsp;30, 2020, the Company
has financed its operations through the sale and issuance of convertible preferred stock. The Company intends to raise additional capital through the issuance of equity or strategic alliances with third parties. As of September&nbsp;30, 2020, the
Company had an accumulated deficit of $316.3&nbsp;million and cash, cash equivalents, and marketable securities of $459.1&nbsp;million. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2. Summary of
significant accounting policies </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Basis of presentation </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. The
Company&#146;s consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (GAAP). Certain prior period amounts have been reclassified to conform to current period
presentation. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Use of estimates </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that
affect the amounts reported in the consolidated financial statements and accompanying notes. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and
assumptions when facts and circumstances dictate. Actual results could materially differ from those estimates. The most significant estimates in the Company&#146;s consolidated financial statements relate to business combinations, accrued expenses,
the valuation of common stock, and the valuation of success payments and contingent consideration. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company utilizes
significant estimates and assumptions in determining the fair value of its common stock. The Company recorded expense for restricted stock awards (RSAs), stock options and restricted stock units (RSUs) at prices not less than the fair market value
of its common stock as determined by management with consideration of the American Institute of Certified Public Accountants Technical Practice Aid, <I>Valuation of</I> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-40 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Unaudited Condensed Consolidated Financial Statements </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify">
<I>Privately-Held Company Equity Securities Issued as Compensation, </I>(AICPA Guide)<I>.</I> The estimated fair value of the Company&#146;s common stock is based on a number of objective and
subjective factors, including the most recently available valuations of the Company&#146;s common stock performed by an independent third-party valuation firm, the prices of shares of convertible preferred stock sold to investors in arm&#146;s
length transactions, the superior rights and preferences of securities senior to the Company&#146;s common stock at the time, the Company&#146;s stage of development, results of operation and financial position, material risks to the Company&#146;s
business, the lack of marketability of the common stock, and external market conditions affecting the biotechnology industry sector. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company also uses significant estimates and assumptions in determining the estimated fair value of the success payment and
contingent consideration liabilities, which are measured at issuance and at each balance sheet date, with changes in fair value recognized in research and development expense. A small change in the estimated future value of the Company&#146;s Series
A convertible preferred stock price or the estimated future value of the Company implied by the estimated future per share value of the Series B convertible preferred stock may have a relatively large impact on the change in the estimated fair value
of the success payment liability and associated expense or gain. Changes in the probabilities and estimated timing of milestones used in the calculation of the contingent consideration liability may have a relatively large impact on the resulting
liability and associated expense or gain. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Unaudited interim condensed consolidated financial statements </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The interim condensed consolidated balance sheet as of September&nbsp;30, 2020, and the condensed consolidated statements of
operations, comprehensive loss, cash flows, and convertible preferred stock and stockholders&#146; deficit for the nine months ended September&nbsp;30, 2019 and 2020 are unaudited. The unaudited interim condensed consolidated financial statements
have been prepared on the same basis as the annual consolidated financial statements and reflect, in the opinion of management, all adjustments of a normal and recurring nature that are necessary for the fair presentation of the Company&#146;s
financial position as of September&nbsp;30, 2020 and its results of operations, convertible preferred stock and stockholders&#146; deficit, and cash flows for the nine months ended September&nbsp;30, 2019 and 2020. The financial data and the other
financial information disclosed in these notes to the condensed consolidated financial statements related to the nine-month periods are also unaudited. The condensed consolidated results of operations for the nine months ended September&nbsp;30,
2020 are not necessarily indicative of the results to be expected for the year ended December&nbsp;31, 2020 or for any other future annual or interim period. The consolidated balance sheet as of December&nbsp;31, 2019 included herein was derived
from the audited consolidated financial statements as of that date. These interim condensed consolidated financial statements should be read in conjunction with the Company&#146;s audited consolidated financial statements included elsewhere in this
prospectus. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Deferred offering costs </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Deferred offering costs, consisting of legal, accounting and filing fees relating to an initial public offering (IPO), are
capitalized. The deferred offering costs will be offset against offering proceeds upon the completion of the offering. In the event the offering is terminated, or delayed, deferred offering costs will be expensed. As of September&nbsp;30, 2020, the
Company had incurred an immaterial amount in deferred offering costs related to the planned IPO. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Recent accounting pronouncements </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Recently adopted </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Accounting Standards Update (ASU) <FONT STYLE="white-space:nowrap">No.&nbsp;2018-13,</FONT> <I>Fair Value Measurement (Topic
820): Disclosure Framework&#151;Changes to the Disclosure Requirements for Fair Value Measurement</I> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-41 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Unaudited Condensed Consolidated Financial Statements </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In August 2018, the Financial Accounting Standards Board (FASB) issued ASU <FONT
STYLE="white-space:nowrap">2018-13,</FONT> <I>Fair Value Measurement (Topic 820):</I> <I>Disclosure Framework&#151;Changes to the Disclosure Requirements for Fair Value</I> <I>Measurement,</I> (ASU <FONT STYLE="white-space:nowrap">2018-13).</FONT>
The new standard removes certain disclosures, modifies certain disclosures and adds additional disclosures related to fair value measurement. The Company adopted ASU <FONT STYLE="white-space:nowrap">2018-13</FONT> on January&nbsp;1, 2020 and the
adoption resulted in additional disclosures related to the Company&#146;s Level&nbsp;3 financial instruments. See Note 7, Fair value measurements. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Not yet adopted </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2016-13,</FONT> <I>Financial Instruments&#151;Credit Losses (Topic 362):
Measurement of Credit Losses on Financial Statements,</I> ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2019-05</FONT> <I>Financial Instruments&#151;Credit Losses (Topic 326): Targeted Transition Relief,</I> ASU
<FONT STYLE="white-space:nowrap">No.&nbsp;2019-11,</FONT> <I>Codification Improvements to Topic 326, Financial Instruments&#151;Credit Losses</I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In June 2016, the FASB issued ASU <FONT STYLE="white-space:nowrap">2016-13,</FONT> <I>Financial Instruments&#151;Credit Losses
(Topic 362): Measurement of Credit Losses on Financial Statements </I>(ASU <FONT STYLE="white-space:nowrap">2016-13).</FONT> The new standard requires that expected credit losses relating to financial assets measured on an amortized cost basis and <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> debt securities be recorded through an allowance for credit losses. It also limits the amount of credit losses to be recognized for <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> debt securities to the amount by which carrying value exceeds fair value and also requires the reversal of previously recognized credit losses if fair value
increases. The targeted transition relief standard allows companies an option to irrevocably elect the fair value option of Accounting Standards Codification (ASC) <FONT STYLE="white-space:nowrap">825-10,</FONT> Financial Instruments-Overall,
applied on an <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">instrument-by-instrument</FONT></FONT> basis for eligible instruments. The new standard will be effective beginning January&nbsp;1, 2023. The adoption of ASU <FONT
STYLE="white-space:nowrap">2016-13</FONT> is not expected to have a material impact on the Company&#146;s condensed consolidated financial statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2017-04</FONT><I>, Intangibles&#151;Goodwill and Other (Topic 350): Simplifying
the Test for Goodwill Impairment</I> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In January 2017, the FASB issued ASU
<FONT STYLE="white-space:nowrap">2017-04,</FONT> <I>Intangibles&#151;Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment </I>(ASU <FONT STYLE="white-space:nowrap">2017-04).</FONT> To address concerns over the cost and
complexity of the <FONT STYLE="white-space:nowrap">two-step</FONT> goodwill impairment test, the<I> </I>amendments in this ASU remove the second step of the test. An entity will instead apply a <FONT STYLE="white-space:nowrap">one-step</FONT>
quantitative test and record the<I> </I>amount of goodwill impairment as the excess of a reporting unit&#146;s carrying amount over its fair value, not to exceed the total amount of<I> </I>goodwill allocated to the reporting unit. The new guidance
does not amend the optional qualitative assessment of goodwill impairment. The new standard will be effective beginning January&nbsp;1, 2023. The adoption of ASU <FONT STYLE="white-space:nowrap">2017-04</FONT> is not expected to have a material
impact on the Company&#146;s condensed consolidated financial statements. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>3. Acquisitions </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Cobalt Biomedicine, Inc. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In February 2019, the Company acquired 100% of the outstanding equity in Cobalt Biomedicine, Inc. (Cobalt), a privately-held
early-stage biotechnology company developing a platform technology using its fusogen technology to specifically and consistently deliver various biological payloads to cells. The Company issued 36,441,583 shares of its Series <FONT
STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock in consideration, valued at $136.0&nbsp;million. Of the 36,441,583 shares of Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock, issued 12,147,192 shares
were restricted based on the achievement of a <FONT STYLE="white-space:nowrap">pre-specified</FONT> development milestone, which was achieved in July 2019. Additionally, 691,636 RSAs and 345,814 RSUs were granted to former employees of Cobalt. </P>

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-42 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Unaudited Condensed Consolidated Financial Statements </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The elements of the purchase consideration are as follows (in thousands):
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="91%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock issued<SUP
STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">97,178</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">First milestone&#151;restricted Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible
preferred stock<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38,769</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Success payment<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,428</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of contingent
consideration<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">51,248</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total consideration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">189,689</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">The purchase consideration included 24,294,391 shares of the Company&#146;s Series <FONT
STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock. The value of the stock was $4.00 per share, equivalent to the purchase price per share of the Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock financing
that occurred in February 2019. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">The Company concluded the value of the first milestone, to be paid in restricted shares, met the definition
of being indexed to common stock. The restricted Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred shares were recorded in convertible preferred stock valued at $38.8&nbsp;million based on the estimated probability and timing
of the milestone achievement on the date of acquisition, and is not subject to remeasurement upon achievement. In July 2019, the first milestone was achieved, and the Company issued a total of 12,147,192 shares of its Series <FONT
STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">The fair value of the success payment was determined using a Monte Carlo simulation methodology which models
the estimated future value of the Company based on several key variables including the term of the success payment, expected volatility, risk-free interest rate, and estimated number and timing of valuation measurement dates on the basis of which
payment may be triggered. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">The fair value of the contingent consideration was determined by calculating the probability-weighted
estimated value of the milestone payments based on the assessment of the likelihood and estimated timing that certain milestones would be achieved and estimated using discount rates ranging from 15.3% to 17.6%. The discount rate captures the credit
risk associated with the payment of the contingent consideration when earned and due. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company
accounted for the Cobalt acquisition using the acquisition method of accounting. Under this method the assets acquired and liabilities assumed in a business combination are measured at their fair value as of the acquisition date. The results of
operations of Cobalt are included in the Company&#146;s results of operations from the date of acquisition. Pro forma results of operations have not been presented because the effects of the acquisition were not material to the Company&#146;s
financial results. The allocation of the purchase price is based on estimates of the fair value of assets acquired and liabilities assumed as of the date of acquisition. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The components of the purchase price allocation are as follows (in thousands): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="91%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net working capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(3,275</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">689</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net liabilities assumed</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,586</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred tax liability</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(7,547</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Acquired <FONT STYLE="white-space:nowrap">in-process</FONT> research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59,195</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goodwill</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">140,627</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total consideration</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">189,689</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As part of the Cobalt acquisition, the Company recorded an IPR&amp;D asset of
$59.2&nbsp;million and $140.6&nbsp;million in goodwill. IPR&amp;D is required to be classified as an indefinite-lived asset until it becomes a finite-lived asset upon the successful completion or the abandonment of the associated research and
development technology. The Company is actively developing the fusogen technology, and accordingly, this asset will not be amortized until regulatory approval is obtained in a major market, typically either the United States (U.S.) or the European
Union, subject to management judgment.</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-43 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Unaudited Condensed Consolidated Financial Statements </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The goodwill recognized as a result of the Cobalt acquisition is primarily
attributable to the value the acquisition provides the Company by complementing its <I><FONT STYLE="white-space:nowrap">ex-vivo</FONT></I> portfolio with <I><FONT STYLE="white-space:nowrap">in-vivo</FONT></I> cell engineering technology and furthers
the continued research in using engineered cells as medicines. The goodwill is not expected to be deductible for income tax purposes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company also agreed to pay contingent consideration of up to an aggregate of $500.0&nbsp;million upon the achievement of
certain <FONT STYLE="white-space:nowrap">pre-specified</FONT> development milestones (Cobalt Contingent Consideration), and a success payment (Cobalt Success Payment) of up to $500.0&nbsp;million, if, at
<FONT STYLE="white-space:nowrap">pre-determined</FONT> valuation measurement dates, the value of the Company is equal to or exceeds three times the value of the Company implied by the per share value of the Company&#146;s Series B convertible
preferred stock at issuance, or any security into which such stock has been converted or exchanged, and we have an active program based on the fusogen technology in a clinical trial pursuant to an investigational new drug application (IND), or have
filed for, or received approval for, a biologics license application (BLA) or new drug application (NDA). The Cobalt Contingent Consideration and Cobalt Success Payment are payable in cash or stock, at the Company&#146;s discretion. The success
payment can be achieved over a maximum of 20 years but could be shorter upon the occurrence of certain events. The valuation measurement dates for the Cobalt Success Payment are triggered by an arms&#146; length equity financing, or an IPO, and
periodically thereafter. In addition to an arms&#146; length equity financing or an IPO, a valuation measurement date is triggered upon a change of control when at least one company product utilizing technology acquired from Cobalt is the subject of
an active research program. If there is a change of control and the Company valuation implied by the per share value of the Company&#146;s Series B convertible preferred stock at issuance, or any security into which such stock has been converted or
exchanged falls below certain thresholds as shown below, the amount of the potential Cobalt Success Payment will decrease and the amount of potential Cobalt Contingent Consideration will increase. The following table sets forth the different Company
valuation thresholds and resulting potential success payment and additional potential Cobalt Contingent Consideration upon a change of control: </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman"><B>Company valuation at change of control date as calculated using a multiple of the
Series B<BR>convertible preferred stock price at issuance, or any security into which such stock has been<BR>converted or exchanged</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Success<BR>Payment</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Additional<BR>Potential<BR>Cobalt<BR>Contingent<BR>Consideration</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(in millions)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equal to or exceeds a multiple of three (3x)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">$&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equal to or exceeds a multiple of two and three-quarters (2.75x), but less than
three&nbsp;(3x)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;350</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Equal to or exceeds a multiple of two and a half (2.50x), but less than two and <FONT
STYLE="white-space:nowrap">three-quarters</FONT> (2.75x)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">400</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less than a multiple of two and a half (2.50x)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company&#146;s liabilities for the Cobalt Success Payment and contingent consideration are
carried at fair value with changes recognized in research and development expense. As of December&nbsp;31, 2019 and September&nbsp;30, 2020, the estimated fair value of the Cobalt Success Payment liability was $2.4&nbsp;million and
$37.6&nbsp;million, respectively. As of December&nbsp;31, 2019 and September&nbsp;30, 2020, the estimated fair value of the Cobalt Contingent Consideration was $69.1&nbsp;million and $85.8&nbsp;million, respectively. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Cytocardia, Inc. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In November 2019, the Company acquired 100% of the outstanding equity in Cytocardia, Inc. (Cytocardia) for a purchase price of
$8.0&nbsp;million, of which $6.8&nbsp;million was an upfront cash payment, and $1.2&nbsp;million was set aside (Cytocardia Holdback Amount) to satisfy certain general representations and warranties as set forth in the stock purchase agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-44 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Unaudited Condensed Consolidated Financial Statements </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The primary asset acquired in the acquisition was IPR&amp;D related to its
<I>ex vivo</I> cell engineering programs focused on replacement of damaged heart cells. The Company evaluated the acquisition and determined the screen test, as permitted under ASC 805, <I>Business Combinations</I>, was met as the $8.0&nbsp;million
purchase price represented consideration for a single identifiable asset related to the technology. The Company concluded the assets acquired did not meet the accounting definition of a business as inputs were acquired, but no processes or outputs
were acquired, and the asset had no alternative future use. The transaction was accounted for as an asset acquisition and the purchase price was recorded in research and development expense for the year ended December&nbsp;31, 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Cytocardia Holdback Amount will be held for 15 months, until February 2021, at which time the remainder of the balance,
after payment of any claims, will be released to the <FONT STYLE="white-space:nowrap">co-founders.</FONT> In addition to cash paid, the Company is required to make future milestone payments of up to an aggregate of $140.0&nbsp;million upon the
achievement of certain <FONT STYLE="white-space:nowrap">pre-specified</FONT> development and commercial milestones. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Oscine Corp. </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In November&nbsp;2018, the Company entered into a collaboration, license, and option to purchase agreement with Oscine to
pursue research related to Oscine&#146;s glial progenitor <I>ex vivo</I> cell engineering programs focused on brain disorders (the Oscine Collaboration Agreement) and paid a $5.0&nbsp;million <FONT STYLE="white-space:nowrap">non-refundable</FONT>
upfront fee, which was recognized in research and development expense for the period from July&nbsp;13, 2018 (inception) to December&nbsp;31, 2018. In connection with its Oscine Collaboration Agreement, the Company recognized $3.0&nbsp;million and
$3.4&nbsp;million in research and development expenses for the nine months ended September&nbsp;30, 2019 and 2020, respectively. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In September 2020, the Company entered into a stock purchase agreement to acquire all of the outstanding equity of Oscine for
a purchase price of $8.5&nbsp;million (the Oscine Stock Purchase Agreement), of which $7.6&nbsp;million was an upfront cash payment, and $0.9&nbsp;million was set aside (Oscine Holdback Amount) to satisfy certain general representations and
warranties as set forth in the Oscine Stock Purchase Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The primary asset acquired in the acquisition was
IPR&amp;D related to its glial progenitor <I>ex vivo</I> cell engineering programs focused on brain disorders. The Company evaluated the acquisition and concluded it should be accounted for as an asset acquisition as the technology was determined to
be one single identifiable asset under the screen test, and did not meet the definition of a business under ASC 805, <I>Business Combinations</I>, and the asset had no alternative future use. The purchase price of $8.5&nbsp;million was recorded in
research and development expense for the nine months ended September&nbsp;30, 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Oscine Holdback Amount will be
held for 15 months, until December 2021, at which time the remainder of the balance, after payment of any claims, will be released. In addition to cash paid, the Company is required to make up to an aggregate of $225.8&nbsp;million in future
milestone payments upon the achievement of certain development and commercial milestones. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"><B>4. Goodwill and intangible asset</B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As of September&nbsp;30, 2020, the Company had goodwill of $140.6&nbsp;million, which represents the excess of the purchase
price over the estimated fair value of the net assets acquired from Cobalt. As of September&nbsp;30, 2020, the Company had an intangible asset of $59.2&nbsp;million, which consists of IPR&amp;D acquired from the Cobalt acquisition which is
classified as indefinite-lived until the successful completion of the associated research and development technology, at which point it becomes a finite-lived asset that will be amortized over its estimated useful life. There were no impairments of
goodwill or the intangible asset since inception. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-45 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Unaudited Condensed Consolidated Financial Statements </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>5. License and collaboration agreements</B><B><I> </I></B><B> </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The Regents of the University of California </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In January 2019, the Company entered into an exclusive license agreement with the Regents of the University of California to
access certain intellectual property for the development of immunoengineered pluripotent cells. Under this agreement, the Company paid $0.1&nbsp;million in cash and issued 737,515 shares of its Series <FONT STYLE="white-space:nowrap">A-2</FONT>
convertible preferred stock, valued at $4.00 per share, for total consideration of $3.1&nbsp;million. The Company determined that the licensed technology has no alternative future use and therefore the $3.1&nbsp;million was recorded in research and
development expense for the nine months ended September&nbsp;30, 2019. Under the agreement, the Company may be required to make certain <FONT STYLE="white-space:nowrap">pre-specified</FONT> development milestone payments up to an aggregate of
$22.4&nbsp;million. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Harvard College </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In March&nbsp;2019, the Company entered into an exclusive license agreement with the President and Fellows of Harvard College
(Harvard) to access certain intellectual property for the development of hypo-immune cells (the Harvard Agreement). Under this agreement, the Company paid $3.0&nbsp;million in cash and issued 2,244,412 shares of its Series <FONT
STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock, valued at $4.00 per share, for total consideration of $12.0&nbsp;million. The Company determined the licensed technology has no alternative future use and therefore the
$12.0&nbsp;million was recorded in research and development expense for the year ended December&nbsp;31, 2019. Additionally, the Company agreed to pay Harvard $6.0&nbsp;million in cash contingent upon the closing of the Company&#146;s Series B
convertible preferred stock financing. Under the Harvard Agreement, the Company may be required to make certain <FONT STYLE="white-space:nowrap">pre-specified</FONT> development and regulatory milestone payments up to an aggregate of
$76.0&nbsp;million, which would double upon a change of control, as well as success payments up to an aggregate of $175.0&nbsp;million based on increases in the fair value of the Company&#146;s Series A convertible preferred stock at <FONT
STYLE="white-space:nowrap">pre-defined</FONT> thresholds. The contingent $6.0&nbsp;million license payment and success payments are accounted for as derivatives under ASC 815, <I>Derivatives and Hedging</I>, and will be <FONT
STYLE="white-space:nowrap">re-valued</FONT> each reporting period. See Note 7, Fair value measurements. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As of
December&nbsp;31, 2019, the estimated fair value of the contingent license payment to Harvard was $4.6&nbsp;million. The Series B convertible preferred stock financing closed in June 2020, and the Company paid Harvard $6.0&nbsp;million cash, and
recognized an additional $1.4&nbsp;million in research and development expense for the nine months ended September&nbsp;30, 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company granted Harvard rights to certain success payments (Harvard Success Payments), payable in cash. Under the terms of
this arrangement, the Company may be required to make success payments to Harvard based on increases in the fair value of the Company&#146;s Series A convertible preferred stock, or any security into which such stock has been converted or exchanged.
The potential payments are based on multiples of increased value ranging from 5x to 40x based on a comparison of the fair value of the Company&#146;s Series A convertible preferred stock relative to its original $4.00 issuance price at <FONT
STYLE="white-space:nowrap">pre-determined</FONT> valuation measurement dates. The aggregate amount of the Harvard Success Payments does not exceed an aggregate of $175.0&nbsp;million which would only occur upon a 40x increase in value. The Harvard
Success Payments can be achieved over a maximum of 12 years from the effective date of the agreement. The following table summarizes the potential success payments: </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="63%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Multiple of Equity Value at Issuance</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>5x</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>10x</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>20x</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>30x</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>40x</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Per share Series A preferred stock price required for payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">20.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">40.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">80.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">120.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">160.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Success payment(s) (in millions)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">30.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">50.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">75.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-46 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Unaudited Condensed Consolidated Financial Statements </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The valuation measurement dates are triggered by events which include: an
equity financing prior to an IPO of more than $25.0&nbsp;million, the one year anniversary of an IPO and periodically thereafter, a merger, an asset sale, the sale of the majority of the shares held by the Company&#146;s Series A convertible
preferred stockholders, and the last day of the term of the success payments. If a higher success payment tier is first met at the same time a lower tier is first met, both tiers will be owed. Any previous success payments made to Harvard are
credited against the success payment owed as of any valuation measurement date, so that Harvard does not receive multiple success payments in connection with the same threshold. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company&#146;s liability for the Harvard Success Payments is carried at fair value with changes recognized in research and
development expense. To determine the estimated fair value of the success payment liability the Company uses a Monte Carlo simulation methodology which models the future movement of its Series A convertible preferred stock price based on several key
variables. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As of December&nbsp;31, 2019 and September&nbsp;30, 2020, the estimated fair value of the Harvard Success
Payment liability was $1.9&nbsp;million and $7.4&nbsp;million, respectively. The Company recorded research and development expense of $1.7&nbsp;million and $5.5&nbsp;million for the nine months ended September&nbsp;30, 2019 and 2020, respectively.
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>6. Restricted cash </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As of December&nbsp;31, 2019, and September&nbsp;30, 2020, the Company maintained standby letters of credit of
$1.8&nbsp;million and $2.1&nbsp;million, respectively. Standby letters of credit are collateralized with a bank account at a financial institution in accordance with the lease agreements as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,&nbsp;2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>September&nbsp;30,&nbsp;2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">South San Francisco, CA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">816</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">816</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cambridge, MA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">961</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">961</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Seattle, WA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">366</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total restricted cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1,777</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2,143</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-47 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Unaudited Condensed Consolidated Financial Statements </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>7. Fair value measurements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following table summarize the Company&#146;s financial assets and liabilities measured at fair value on a recurring basis
based on the three-tier fair value hierarchy: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="52%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31, 2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Valuation</B><br><B>Hierarchy</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amortized<BR>Cost</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Gross</B><br><B>Unrealized</B><br><B>Holding<BR>Gains</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Gross</B><br><B>Unrealized</B><br><B>Holding<BR>Losses</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Estimated<BR>Fair</B><br><B>Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financial assets:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash equivalents:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Money market funds</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Level&nbsp;1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">49,420</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">49,420</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">U.S. government and agency securities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Level&nbsp;2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,682</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,683</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Corporate debt securities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Level&nbsp;2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,433</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,433</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">76,535</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">76,536</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Short-term marketable securities:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">U.S. government and agency securities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Level&nbsp;2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42,449</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">42,466</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Corporate debt securities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Level&nbsp;2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,477</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,486</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58,926</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58,952</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total financial assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;135,461</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;30</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(3</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;135,488</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financial liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contingent license payment</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Level&nbsp;3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,557</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,557</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contingent consideration</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Level&nbsp;3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">69,108</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">69,108</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Success payment liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Level&nbsp;3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,352</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,352</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total financial liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">78,017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">78,017</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>September&nbsp;30, 2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Valuation</B><br><B>Hierarchy</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amortized<BR>Cost</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Gross</B><br><B>Unrealized</B><br><B>Holding<BR>Gains</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Gross</B><br><B>Unrealized</B><br><B>Holding<BR>Losses</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Estimated<BR>Fair</B><br><B>Value</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financial assets:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash equivalents:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Money market funds</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Level&nbsp;1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">93,258</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">93,258</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">U.S. government and agency securities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Level&nbsp;2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,202</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">41,203</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Corporate debt securities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Level&nbsp;2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,257</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,256</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">137,717</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">137,717</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Short-term marketable securities:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">U.S. government and agency securities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Level&nbsp;2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">281,222</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">281,260</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Corporate debt securities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Level&nbsp;2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,366</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,380</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;301,588</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;301,640</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Long-term marketable securities:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">U.S. government and agency securities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Level&nbsp;2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,206</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,209</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total long-term marketable securities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,206</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,209</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total financial assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">447,511</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(3</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">447,566</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financial liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Contingent consideration</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Level&nbsp;3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">85,780</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">85,780</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Success payment liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">Level&nbsp;3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44,989</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44,989</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total financial liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">130,769</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">130,769</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-48 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Unaudited Condensed Consolidated Financial Statements </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company evaluated its securities for other-than-temporary impairment and
considers the decline in market value for the securities to be primarily attributable to current economic and market conditions. Securities in an unrealized loss position have been in an unrealized loss position for less than one year. For the debt
securities, it is not <FONT STYLE="white-space:nowrap">more-likely-than-not</FONT> that the Company will be required to sell the securities, and the Company does not intend to do so prior to the recovery of the amortized cost basis. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As of September&nbsp;30, 2020, all marketable securities had an effective maturity date of two years or less. Investments in
securities with maturities of less than one year, or those for which management intends to use the investments to fund current operations, are included in current assets and are available for use and therefore classified as <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale.</FONT></FONT> As of September&nbsp;30, 2020, the balance in the Company&#146;s accumulated other comprehensive loss includes activity related to the Company&#146;s <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">available-for-sale</FONT></FONT> debt securities. There were no material realized gains or losses recognized on the sale or maturity of <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">available-for-sale</FONT></FONT> securities during the nine months ended September&nbsp;30, 2019 or 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company measures the fair value of money market funds based on quoted prices in active markets for identical assets or
liabilities. The Level&nbsp;2 marketable securities include U.S. government, agency securities and corporate debt securities and are valued either based on recent trades of securities in inactive markets or based on quoted market prices of similar
instruments and other significant inputs derived from or corroborated by observable market data. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following table sets
forth a summary of the changes in the fair value of the Company&#146;s Level&nbsp;3 financial liabilities: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="58%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Contingent</B><br><B>License&nbsp;Payment</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Contingent</B><br><B>Consideration</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Success</B><br><B>Payment&nbsp;Liabilities</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,557</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">69,108</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,352</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(6,000</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Changes in fair value</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1,443</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,672</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40,637</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance as of September&nbsp;30, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;85,780</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;44,989</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The initial recognition of the Cobalt Contingent Consideration and Cobalt Success Payment
liability was recorded as part of the purchase price as an increase to goodwill and accrued liabilities. Subsequent changes in fair value of the Cobalt Contingent Consideration and Cobalt Success Payment liability is recorded in research and
development expense. The fair value of the Harvard Success Payment and contingent license payment are recorded in research and development expense. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Contingent license payment </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company utilized estimates and assumptions in determining the estimated contingent license liability and associated expense
at each balance sheet date. The assumptions used to calculate the fair value of the contingent license payment were subject to a significant amount of judgment including the expected probability of the Company&#146;s Series B convertible preferred
stock financing occurring and estimated timing of achievement. The Series B convertible preferred stock financing closed in June 2020, and the Company paid Harvard $6.0&nbsp;million in cash, and recognized an additional $1.4&nbsp;million in research
and development expense for the nine months ended September&nbsp;30, 2020. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-49 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Unaudited Condensed Consolidated Financial Statements </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Contingent consideration </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In connection with the acquisition of Cobalt, the Company may be required to pay future consideration that is contingent upon
the achievement of certain <FONT STYLE="white-space:nowrap">pre-specified</FONT> development milestones. The valuation of contingent consideration uses assumptions the Company believes would be made by a market participant. The fair value of the
Cobalt Contingent Consideration was determined by calculating the probability-weighted estimated value of the pre-specified development milestone payments based on the assessment of the likelihood and estimated timing that certain milestones would
be achieved, and the estimated discount rates. The discount rate captures the credit risk associated with the payment of the contingent consideration when earned and due. The Company assesses these estimates on an
<FONT STYLE="white-space:nowrap">on-going</FONT> basis as additional data impacting the assumptions is obtained. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As of
September&nbsp;30, 2020, the fair value of the Cobalt Contingent Consideration was calculated using the following unobservable inputs: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="63%"></TD>

<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Unobservable Input</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Range</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Weighted-Average</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Discount rates</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">14.4%-15.5%</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Probability of milestone achievement</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.5%-50.0%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22%</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The weighted-average unobservable inputs were based on the relative value of the Cobalt
Contingent Consideration. The estimated fair value of the Cobalt Contingent Consideration may change significantly as development progresses and additional data are obtained, impacting the assumptions regarding probabilities of successful
achievement of the milestones used to estimate the fair value of the liability and the timing in which they are expected to be achieved. In evaluating the fair value information, judgment is required to interpret the market data used to develop the
estimates. The estimates of fair value may not be indicative of the amounts that could be realized in a current market exchange. Accordingly, the use of different market assumptions and/or different valuation techniques could result in materially
different fair value estimates. Significant increases or decreases in any of the inputs would result in a significantly higher or lower fair value measurement. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Success payments </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The estimated fair value of the Cobalt and Harvard Success Payments was determined using a Monte Carlo simulation model in
which the Company utilizes significant estimates and assumptions in determining the estimated success payment liability and associated expense or gain at each balance sheet date. The assumptions used to calculate the fair value of the success
payments are subject to a significant amount of judgment including the estimated future value of the Company&#146;s Series A convertible preferred stock, the estimated future value of the Company implied by the estimated future per share value of
the Company&#146;s Series B convertible preferred stock at issuance, the expected volatility, estimated term, and estimated number and timing of valuation measurement dates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As of September&nbsp;30, 2020, the fair value of the Cobalt and Harvard Success Payments was calculated using the following
unobservable inputs: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="86%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Unobservable Input</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Cobalt</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Harvard</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected stock price volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected term (years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A small change in the assumptions and other inputs used to calculate the estimated fair value
of the success payments may result in a relatively large change in the estimated valuation and associated liability and expense or gain. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-50 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Unaudited Condensed Consolidated Financial Statements </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>8. Property and equipment, net </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Property and equipment, net consists of the following: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="72%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>September&nbsp;30,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Laboratory equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15,046</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">23,558</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leasehold improvements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,624</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,061</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Construction in progress</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,421</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,424</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Computer equipment, software and other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">636</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">709</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total property and equipment, at cost</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,727</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,752</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: Accumulated depreciation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,816</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,982</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property and equipment, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;27,911</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;39,770</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Depreciation expense related to property and equipment was $0.8&nbsp;million and
$4.2&nbsp;million for the nine months ended September&nbsp;30, 2019 and 2020, respectively. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>9. Accrued liabilities </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Accrued compensation and accrued expenses and other current liabilities consist of the following: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="73%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>December&nbsp;31,<BR>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>September&nbsp;30,<BR>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued compensation:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued bonuses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6,035</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">6,696</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other accrued compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,059</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,216</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total accrued compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8,094</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10,912</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued expenses and other current liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued contingent license payment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,557</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued property and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,257</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,196</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued professional fees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,131</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,550</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">309</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,530</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,633</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,271</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total accrued expenses and other current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">9,887</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">8,547</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>10. Commitments and contingencies </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Lease commitments </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company&#146;s lease portfolio is primarily comprised of operating leases for office and laboratory space located in
Seattle, WA, Cambridge, MA, and South San Francisco, CA with contractual periods expiring between November 2025 and April 2030. In January and September 2020, the Company entered into two new leases for 31,563 and 22,188 square feet of office and
laboratory space in Cambridge, MA and Seattle, WA, and expire in February and April 2028, respectively. The new leases provide the right to make tenant improvements and include lease incentive allowances. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-51 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Unaudited Condensed Consolidated Financial Statements </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Throughout the term of the lease agreements, the Company is responsible for
paying certain operating costs, in addition to rent, such as common area maintenance, taxes, utilities, and insurance. These additional charges are considered variable lease costs and are recognized in the period in which the costs are incurred.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">For the nine months ended September&nbsp;30, 2019, rent expense for the Company&#146;s operating leases was
$6.7&nbsp;million, which consisted of $3.5&nbsp;million for straight-line recognition of fixed payments and $3.2&nbsp;million associated with short-term leases. For the nine months ended September&nbsp;30, 2020, rent expense for the Company&#146;s
operating leases was $9.3&nbsp;million, which consisted of $7.9&nbsp;million straight-line recognition of fixed payments and $1.4&nbsp;million associated with short-term leases. Variable lease payments for operating expenses were $1.1&nbsp;million
and $2.3&nbsp;million for the nine months ended September&nbsp;30, 2019 and 2020, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following table
presents the scheduled maturities of the Company&#146;s operating lease liabilities by fiscal year and the present value of those lease liabilities as of September&nbsp;30, 2020 (in thousands): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="91%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2020 (remaining 3 months)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,110</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,897</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,438</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2023</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,892</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2024</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,361</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2025 and thereafter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58,236</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total lease payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">119,934</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: imputed interest</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(40,769</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: tenant improvement allowances</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,515</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Present value of lease liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">70,650</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>11. Convertible preferred stock </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Series <FONT STYLE="white-space:nowrap">A-1</FONT> convertible preferred stock financing </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In October&nbsp;2018, the Company executed an agreement to sell up to 11,462,500 shares of its
<FONT STYLE="white-space:nowrap">Series&nbsp;A-1</FONT> convertible preferred stock at a price of $4.00 per share. The Company issued 11,462,500 shares in October 2018 for gross proceeds of $45.9&nbsp;million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Upon certain change in control events that are outside of the Company&#146;s control, holders of the convertible preferred
stock can cause its redemption. This requires the Company&#146;s convertible preferred stock to be classified outside of stockholders&#146; deficit on the accompanying condensed consolidated balance sheets. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Series <FONT STYLE="white-space:nowrap">A-2</FONT> and Series B convertible preferred stock financing </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In February 2019, the Company executed an agreement for 54,036,865 shares of its
<FONT STYLE="white-space:nowrap">Series&nbsp;A-2</FONT> convertible preferred stock at a price of $4.00 per share, for gross proceeds of $216.1&nbsp;million. In October 2019, an additional 1,966,667 the Company&#146;s Series <FONT
STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock were sold at a price of $4.00 per share, for gross proceeds of $7.9&nbsp;million. The Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred agreement also committed
these investors to a Series B convertible preferred stock financing with the issuance of up to 27,556,926 shares of the Company&#146;s Series B convertible preferred stock at a price of $16.00 per share contingent upon the occurrence of certain
clinical milestones or the unanimous approval of the Company&#146;s board of directors. Additionally, in the event the clinical milestones were not achieved, the agreement stated at least two large Series B convertible preferred stock investors,
defined as investors with at least a $29.0&nbsp;million Series B convertible preferred stock investment, have the right to object to the board of directors&#146; decision to call the Series B convertible preferred stock closing within seven days.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-52 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Unaudited Condensed Consolidated Financial Statements </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In connection with this financing, the Company amended and restated its
certificate of incorporation and amended the investors&#146; rights agreement and voting agreement with its stockholders.&nbsp;Under the amended and restated certificate of incorporation, the authorized capital stock of the Company increased to
700,000,000 shares, each with a par value of $0.0001 per share. The authorized shares consisted of 162,213,794&nbsp;shares designated as common stock and 537,786,206 shares designated as convertible preferred stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In June 2020, the Company completed the Series B convertible preferred stock financing selling 27,223,170&nbsp;shares of
Series B convertible preferred stock at $16.00 per share for gross proceeds of $435.6&nbsp;million. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company
recorded its convertible preferred stock at the issuance price on the dates of issuance, net of issuance costs. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Rights issued with <FONT
STYLE="white-space:nowrap">Series&nbsp;A-1,</FONT> Series <FONT STYLE="white-space:nowrap">A-2,</FONT> and Series B convertible preferred stock </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company assessed the Series <FONT STYLE="white-space:nowrap">A-1,</FONT> Series
<FONT STYLE="white-space:nowrap">A-2,</FONT> and Series B convertible preferred stock for any beneficial conversion features or embedded derivatives, including the conversion option, that would require bifurcation from the convertible preferred
stock and receive separate accounting treatment. On the dates of the issuances, the fair value of the common stock into which the convertible preferred stock was convertible was less than the effective conversion price of the Series <FONT
STYLE="white-space:nowrap">A-1,</FONT> Series <FONT STYLE="white-space:nowrap">A-2,</FONT> and Series B convertible preferred stock; as such, there was no intrinsic value of the conversion option on the commitment date. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Conversion </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Shares of the Company&#146;s Series <FONT STYLE="white-space:nowrap">A-1,</FONT> Series
<FONT STYLE="white-space:nowrap">A-2,</FONT> and Series B convertible preferred stock are convertible into shares of the Company&#146;s common stock based on a defined conversion ratio, set at <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">one-for-one,</FONT></FONT> adjustable for certain dilutive events. The conversion ratio for the convertible preferred stock is subject to change in accordance with anti-dilution provisions contained in the Company&#146;s
certificate of incorporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company&#146;s Series <FONT STYLE="white-space:nowrap">A-1,</FONT> Series <FONT
STYLE="white-space:nowrap">A-2,</FONT> and Series B convertible preferred stock is convertible at the option of the holder at any time without any additional consideration. The convertible preferred stock will automatically convert into shares of
the Company&#146;s common stock at the then effective applicable conversion rate, upon the closing of the sale of shares of common stock to the public in an underwritten public offering at a price that generates at least $75.0&nbsp;million in gross
proceeds pursuant to an effective registration statement under the Securities Act of 1933, as amended, provided that the Company&#146;s common stock is listed for trading on a national securities exchange. In addition, the convertible preferred
stock will automatically convert into shares of common stock upon the vote or written consent of the holders of at least 61% of the outstanding convertible preferred stock, voting together as a single class on an
<FONT STYLE="white-space:nowrap">as-converted</FONT> basis, and which must include a majority of the Series B preferred stock then held by the<B> </B>Series B investors that purchased at least $29.0&nbsp;million in the Series&nbsp;B convertible
preferred stock financing (Series B Large Investors). </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Dividends </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Each holder of the Company&#146;s Series <FONT STYLE="white-space:nowrap">A-1,</FONT> Series
<FONT STYLE="white-space:nowrap">A-2,</FONT> and Series B convertible preferred stock is entitled to receive <FONT STYLE="white-space:nowrap">non-cumulative</FONT> dividends, when and if declared by the Company&#146;s board of directors, at an
annual rate of 6% of the original issue price prior to and in preference to the payment of a dividend on common stock. Any additional dividends shall be distributed among the holders of common stock pro rata based on the number of shares of common
stock (on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis). No dividends have been declared to date. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-53 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Unaudited Condensed Consolidated Financial Statements </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Liquidation preference </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company may be liquidated voluntarily by the Company&#146;s board of directors with consent of the holders of at least 61%
of the outstanding convertible preferred stock, voting together as a single class on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis, and which must include the holders of at least a majority of the Series B preferred stock then held
by the Series B Large Investors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In the event that the Company is liquidated either voluntarily or involuntarily, or if
any event occurs that is deemed a liquidation under the Company&#146;s certificate of incorporation, each holder of the Company&#146;s Series <FONT STYLE="white-space:nowrap">A-1,</FONT> Series <FONT STYLE="white-space:nowrap">A-2,</FONT> and Series
B convertible preferred stock will be entitled to receive a liquidation preference out of any proceeds from the liquidation before any distributions are made to the holders of common stock. The liquidation preference for each share of the Series <FONT
STYLE="white-space:nowrap">A-1,</FONT> Series <FONT STYLE="white-space:nowrap">A-2</FONT> and Series B convertible preferred stock is equal to the greater of a) the original issue price (plus any declared but unpaid dividends), or b) such amount per
share as would have been payable had all the Series <FONT STYLE="white-space:nowrap">A-1,</FONT> Series <FONT STYLE="white-space:nowrap">A-2,</FONT> and Series B convertible preferred stock been converted into common stock immediately prior to a
liquidation event. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Voting rights </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Each of the Company&#146;s Series <FONT STYLE="white-space:nowrap">A-1,</FONT> Series
<FONT STYLE="white-space:nowrap">A-2,</FONT> and Series B convertible preferred stock vote (on an <FONT STYLE="white-space:nowrap">as-converted</FONT> to common stock basis) with the other voting stock of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The consent of the holders of at least 61% of the Company&#146;s outstanding convertible preferred stock, voting together as a
single class on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis, and which must include the holders of at least a majority of the Series B preferred stock then held by the Series B Large Investors, is required for any of the following
actions: the amendment or waiver of any provision of the certificate of incorporation or bylaws of the Company in a manner that adversely affects the rights, preferences or privileges of the Series <FONT STYLE="white-space:nowrap">A-1,</FONT> Series
<FONT STYLE="white-space:nowrap">A-2,</FONT> and Series B convertible preferred stock; any change in the authorized number of Series <FONT STYLE="white-space:nowrap">A-1,</FONT> Series <FONT STYLE="white-space:nowrap">A-2,</FONT> and Series B
convertible preferred stock, or any other class of stock of the Company; the creation of any new class or series of shares having rights, preferences or privileges senior to or on a parity with the Series <FONT STYLE="white-space:nowrap">A-1,</FONT>
Series <FONT STYLE="white-space:nowrap">A-2,</FONT> and Series B convertible preferred stock; the approval of any change in control event; the redemption of any securities of the Company, other than repurchases of common stock upon termination of a
consultant, director or employee approved by the Company&#146;s board of directors; any increase or decrease in the authorized size of the Company&#146;s board of directors; the declaration or payment of any dividend or distribution on the Series <FONT
STYLE="white-space:nowrap">A-1,</FONT> Series <FONT STYLE="white-space:nowrap">A-2,</FONT> and Series B convertible preferred stock (except as provided in the certificate of incorporation) or common stock; or the liquidation or dissolution of the
Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In addition, the stockholders of the Company have entered into a voting agreement pursuant to which the
Company&#146;s Series <FONT STYLE="white-space:nowrap">A-1,</FONT> Series <FONT STYLE="white-space:nowrap">A-2,</FONT> and Series B convertible preferred stock and common stockholders each elected five members to its board of directors,
respectively. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><I>Reorganization </I></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Any change in control event, including any change in the holders of a majority of the equity of the Company by merger,
consolidation, reorganization or otherwise, or any sale or exclusive license of substantially all the assets of the Company, will be deemed a liquidation under the Company&#146;s certificate of incorporation unless waived by the holders of at least
61% of the Company&#146;s outstanding convertible preferred stock, voting together as a single class on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis, and which must include the holders of at least a majority of the Series&nbsp;B
preferred stock then held by the Series B Large Investors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-54 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Unaudited Condensed Consolidated Financial Statements </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">After liquidation preferences for the Company&#146;s Series <FONT
STYLE="white-space:nowrap">A-1,</FONT> Series <FONT STYLE="white-space:nowrap">A-2,</FONT> and Series B convertible preferred stock described above have been satisfied, any additional proceeds from any deemed liquidation will be distributed among
the holders of common stock pro rata based on the number of shares of common stock (on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>12. Common stock </B></P>  <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As
of September&nbsp;30, 2020, there were 14,250,366 shares of the Company&#146;s common stock outstanding, excluding the 11,951,698 shares of restricted common stock outstanding that are subject to vesting requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As of September&nbsp;30, 2020, the Company had reserved 134,112,712 shares of its common stock for future issuance upon the
conversion of its Series <FONT STYLE="white-space:nowrap">A-1,</FONT> Series <FONT STYLE="white-space:nowrap">A-2,</FONT> and Series B convertible preferred stock outstanding. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>13. Stock-based compensation </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Equity Incentive Plan
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In October&nbsp;2018, the Company adopted the 2018 Equity Incentive Plan (the 2018 Plan) under which it may grant
incentive stock options, <FONT STYLE="white-space:nowrap">non-statutory</FONT> stock options, RSAs, RSUs, and other stock-based awards to any person, including officers, directors, and consultants. Terms of stock agreements, including vesting
requirements, are determined by the Company&#146;s board of directors, or by a committee appointed by the board of directors, subject to the provisions of the 2018 Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Generally, awards granted by the Company vest over four years and have an exercise price equal to the estimated fair value of
the common stock as determined by the board of directors with consideration given to contemporaneous valuations of the Company&#146;s common stock prepared by an independent third party valuation firm in accordance with the guidance provided by the
AICPA Guide. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As of September&nbsp;30, 2020, there were 356,630 shares available for future issuance under the 2018
Plan. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>RSU Plan </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In March 2019, pursuant to the terms of the Cobalt merger agreement, the Company adopted a restricted stock unit plan (RSU
Plan) under which it may grant RSUs to certain employees and consultants. The RSU Plan provides for up to 349,254 shares of common stock to be awarded. As of September&nbsp;30, 2020, there were 23,575&nbsp;shares available for future issuance under
the RSU Plan. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stock-based compensation expense </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Stock-based compensation expense is recognized in the condensed consolidated statements of operations as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Nine&nbsp;Months&nbsp;Ended<BR>September&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2019&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2020&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">833</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,555</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">177</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">482</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1,010</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3,037</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-55 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Unaudited Condensed Consolidated Financial Statements </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Unrecognized stock-based compensation costs related to unvested awards and
the weighted-average period over which the costs are expected to be recognized as of September&nbsp;30, 2020 are as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock&nbsp;Options</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>RSAs</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unrecognized stock-based compensation expense (thousands)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">14,578</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,673</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected weighted-average period compensation costs to be recognized (years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">As of September&nbsp;30, 2020, the Company had $0.5&nbsp;million of unrecognized stock-based
compensation costs related to RSUs originating from the Cobalt acquisition that are subject to (i)&nbsp;service-based vesting over four years, (ii)&nbsp;achievement of the first milestone which occurred in July 2019, and (iii)&nbsp;a liquidity
event. The estimated compensation expense will be recognized ratably over the service period, or remaining service period, if and when it becomes probable that the vesting conditions will be satisfied. As of September&nbsp;30, 2020, no stock-based
compensation expense was recognized related to RSUs. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stock options </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A summary of the Company&#146;s stock option activity is as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="44%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Stock&nbsp;Options</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Weighted-Average</FONT></B><br><B>Exercise&nbsp;Price</B><br><B>per Share</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Weighted-Average</FONT></B><br><B>Remaining</B><br><B>Contractual&nbsp;Life</B><br><B>(years)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Aggregate</B><br><B>Intrinsic&nbsp;Value</B><br><B>(in&nbsp;thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outstanding as of December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,548,989</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.6</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">142</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Granted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,292,153</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.76</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercised</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(32,161</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Forfeited/Cancelled</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(131,701</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Outstanding as of September&nbsp;30, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,677,280</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.32</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.3</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;53,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercisable as of September&nbsp;30, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">989,318</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.44</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8.5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">6,292</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The fair value of stock options granted to employees, directors, and consultants was
estimated on the date of grant using the Black-Scholes option pricing model using the following assumptions: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="72%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Nine&nbsp;Months&nbsp;Ended<BR>September&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Assumptions</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk free interest rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">1.53%-2.62</FONT></TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">0.36%-1.51</FONT></TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected term (years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">6.25-6.75</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected dividend</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">During the nine months ended September&nbsp;30, 2019 and 2020, the weighted-average grant
date fair value of the options granted was $0.92 and $2.16 per share, respectively. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-56 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Unaudited Condensed Consolidated Financial Statements </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Restricted stock awards </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">A summary of the Company&#146;s RSAs activity is as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="75%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>RSAs</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B><FONT STYLE="white-space:nowrap">Weighted-Average</FONT></B><br><B>Grant Date Fair</B><br><B>Value per Share</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unvested shares as of December&nbsp;31, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,140,131</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;0.28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vested</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,152,376</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Forfeited</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,036,057</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unvested shares as of September&nbsp;30, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,951,698</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">0.36</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The fair value of vested RSAs was $0.3&nbsp;million and $0.6&nbsp;million for the nine
months ended September&nbsp;30, 2019 and 2020, respectively. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">During the nine months ended September&nbsp;30, 2020,
there were zero RSUs granted, zero vested, and 19,265 cancelled. As of September&nbsp;30, 2020 there are 325,672 RSUs unvested. </P>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>14. Income taxes
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The Company&#146;s income tax provision for interim periods is determined using an estimate of the Company&#146;s
annual effective tax rate, adjusted for discrete items arising in the quarter. The Company&#146;s effective tax rate differs from the U.S. statutory tax rate primarily due to valuation allowances on the deferred tax assets in all jurisdictions as it
is more likely than not that the Company&#146;s deferred tax assets will not be realized. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In connection with the 2019
Cobalt acquisition, the Company recorded a deferred tax liability of $7.5&nbsp;million associated with the acquired intangible asset. During the nine months ended September&nbsp;30, 2019, the Company recorded a tax benefit of $6.2&nbsp;million
related to the release of valuation allowance on U.S. deferred tax assets as a result of deferred tax liabilities established for intangible assets from the acquisition of Cobalt. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>15. Net loss per share </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Basic and diluted net loss per common share is calculated by dividing net loss applicable to common stockholders by the
weighted-average number of common shares outstanding during the period, without consideration for common stock equivalents. The Company was in a loss position for all periods presented, therefore basic net loss per share was the same as diluted net
loss per share for all periods as the inclusion of all potential common securities outstanding would have been anti-dilutive. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following table sets forth the computation of basic and diluted net loss per share of common stock: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="67%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Nine Months Ended<BR>September&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(in&nbsp;thousands,&nbsp;except&nbsp;share&nbsp;and per&nbsp;share<BR>amounts)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss applicable to common stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(87,733</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(172,135</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average common shares used in net loss per share applicable to common stockholders, basic
and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3,620,021</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12,249,482</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss per share applicable to common stockholders, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(24.24</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(14.05</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-57 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Notes to Unaudited Condensed Consolidated Financial Statements </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The amounts in the table below were excluded from the calculation of diluted
net loss per share, prior to the use of the treasury stock method, due to their anti-dilutive effect: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>September&nbsp;30,</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>2020</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series <FONT STYLE="white-space:nowrap">A-1</FONT> convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,462,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,462,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series <FONT STYLE="white-space:nowrap">A-2</FONT> convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">93,460,375</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">95,427,042</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series B convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">27,223,170</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unvested restricted common stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,761,559</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,951,698</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Options to purchase common stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,809,749</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,677,280</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unvested RSUs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">344,937</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">325,672</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">125,839,120</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">156,067,362</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>16. Employee benefit plan </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In January&nbsp;2019, the Company adopted a 401(k) retirement and savings plan (the 401(k) Plan) covering all employees. The
401(k) Plan allows employees to make <FONT STYLE="white-space:nowrap">pre-</FONT> and <FONT STYLE="white-space:nowrap">post-tax</FONT> contributions up to the maximum allowable amount set by the IRS. As of September&nbsp;30, 2020, the Company has
not made any matching contributions to the 401(k) Plan on behalf of participants. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>17. Subsequent events </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Authorized shares and stock option grants </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In December 2020, the Company amended and restated its certificate of incorporation to increase the authorized capital stock of
the Company to 707,000,000 shares, each with a par value of $0.0001 per share. In addition, the Company&#146;s board of directors granted stock options from October to December 2020 to purchase an aggregate of 6,139,302 shares of common stock with a
weighted average exercise price of $7.92 per share, after which there were 234,065 shares available for future issuance under the 2018 Plan. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Reverse stock split </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">In January 2021, the board of directors of the Company approved an amendment to the Company&#146;s certificate of incorporation
to effect a reverse split of shares of the Company&#146;s common stock and convertible preferred stock on a 1-for-4 basis, which was effected on January&nbsp;27, 2021. All references to convertible preferred stock, common stock, options to purchase
common stock, restricted stock awards, restricted stock units, per share amounts and related information contained in the financial statements have been retroactively adjusted to reflect the effect of the reverse stock split for all periods
presented. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-58 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>15,000,000 Shares </B></P>
<P STYLE="font-size:72pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g60414g31r68.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:72pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P>
<P STYLE="margin-top:72pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Prospectus </B></P> <P STYLE="font-size:72pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:13pt" ALIGN="center">


<TR>

<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="43%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="19%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:13pt">
<TD VALIGN="top"><B>Morgan&nbsp;Stanley</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>Goldman&nbsp;Sachs&nbsp;&amp;&nbsp;Co.&nbsp;LLC</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>J.P.&nbsp;Morgan</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><B>BofA&nbsp;Securities</B></TD></TR>
</TABLE> <P STYLE="margin-top:72pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2021 </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PART II </B></P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INFORMATION NOT REQUIRED IN PROSPECTUS </B></P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item 13. Other Expenses of Issuance and Distribution </B></P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The following table sets forth the estimated costs and expenses, other than underwriting discounts and commissions, payable by
us in connection with the sale of the common stock being registered. </P>  <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Amount&nbsp;Paid&nbsp;or<BR>to&nbsp;Be&nbsp;Paid</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SEC registration fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">43,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">FINRA filing fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,013</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nasdaq listing fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transfer agent&#146;s fees and expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Printing and engraving expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">375,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Legal fees and expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,800,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounting fees and expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Miscellaneous</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,755,013</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>    <P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item 14. Indemnification of Directors and Officers </B></P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;145 of the Delaware General Corporation Law provides that a corporation may indemnify directors and officers as
well as other employees and individuals against expenses (including attorneys&#146; fees), judgments, fines, and amounts paid in settlement actually and reasonably incurred by such person in connection with any threatened, pending, or completed
actions, suits, or proceedings in which such person is made a party by reason of such person being or having been a director, officer, employee, or agent to the registrant. The Delaware General Corporation Law provides that Section&nbsp;145 is not
exclusive of other rights to which those seeking indemnification may be entitled under any bylaw, agreement, vote of stockholders or disinterested directors or otherwise. Article&nbsp;9 of the registrant&#146;s amended and restated certificate of
incorporation provides for indemnification by the registrant of its directors, officers, and employees to the fullest extent permitted by the Delaware General Corporation Law. The registrant has entered into indemnification agreements with each of
its current directors, executive officers, and certain other officers to provide these directors and officers additional contractual assurances regarding the scope of the indemnification set forth in the registrant&#146;s amended and restated
certificate of incorporation and amended and restated bylaws and to provide additional procedural protections. There is no pending litigation or proceeding involving a director or executive officer of the registrant for which indemnification is
sought. </P> <P STYLE="margin-top:10pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Section&nbsp;102(b)(7) of the Delaware General Corporation Law permits a corporation to provide in its
certificate of incorporation that a director of the corporation shall not be personally liable to the corporation or its stockholders for monetary damages for breach of fiduciary duty as a director, except for liability (i)&nbsp;for any breach of
the director&#146;s duty of loyalty to the corporation or its stockholders, (ii)&nbsp;for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (iii)&nbsp;for unlawful payments of dividends or
unlawful stock repurchases, redemptions, or other distributions, or (iv)&nbsp;for any transaction from which the director derived an improper personal benefit. The registrant&#146;s amended and restated certificate of incorporation provides for such
limitation of liability. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The registrant maintains standard policies of insurance under which coverage is provided
(a)&nbsp;to its directors and officers against loss rising from claims made by reason of breach of duty or other wrongful act, and (b)&nbsp;to the registrant with respect to payments that may be made by the registrant to such officers and directors
pursuant to the above indemnification provision or otherwise as a matter of law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The proposed form of underwriting agreement to be filed as Exhibit&nbsp;1.1
to this registration statement provide for indemnification of directors and officers of the registrant by the underwriters against certain liabilities. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item 15. Recent Sales of Unregistered Securities </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Since its inception in July 2018, the registrant has sold the following securities without registration under the Securities
Act of 1933: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="right">(a)</TD>
<TD WIDTH="2%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">From July 2018 to September 2018, the registrant issued 22,388,250 shares of its common stock for proceeds of
approximately $1,000. </P></TD></TR></TABLE>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="right">(b)</TD>
<TD WIDTH="2%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In September 2018, the registrant issued convertible promissory notes for an aggregate principal amount of
$1.1&nbsp;million. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="right">(c)</TD>
<TD WIDTH="2%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In October 2018, the registrant issued 11,462,500 shares of its
<FONT STYLE="white-space:nowrap">Series&nbsp;A-1</FONT> convertible preferred stock at a price of $4.00 per share for aggregate proceeds of $45.9&nbsp;million, including conversion of the convertible promissory notes of an aggregate principal amount
of $1.1&nbsp;million issued in September 2018. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="right">(d)</TD>
<TD WIDTH="2%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In February 2019, the registrant issued 54,036,865 shares of its
<FONT STYLE="white-space:nowrap">Series&nbsp;A-2</FONT> convertible preferred stock at $4.00 per share for gross proceeds of $216.1&nbsp;million, issued 36,441,583 shares of its <FONT STYLE="white-space:nowrap">Series&nbsp;A-2</FONT> convertible
preferred stock, and 691,636 shares of its restricted common stock awards in connection with its acquisition of Cobalt Biomedicine, Inc. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="right">(e)</TD>
<TD WIDTH="2%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In February and March 2019, the registrant issued an aggregate of 2,981,927 shares of its <FONT
STYLE="white-space:nowrap">Series&nbsp;A-2</FONT> convertible preferred stock in connection with the entry into certain intellectual property license arrangements. </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="right">(f)</TD>
<TD WIDTH="2%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In October 2019, the registrant issued 1,966,667 shares of its
<FONT STYLE="white-space:nowrap">Series&nbsp;A-2</FONT> convertible preferred stock at $4.00 per share for gross proceeds of $7.9&nbsp;million. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="right">(g)</TD>
<TD WIDTH="2%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In June 2020, the registrant issued 27,223,170 shares of its Series&nbsp;B convertible preferred stock at
$16.00 per share for gross proceeds of $435.6&nbsp;million. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="right">(h)</TD>
<TD WIDTH="2%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">In June and December 2020, the registrant issued 100,000 shares of its common stock in connection with
intellectual property license arrangements. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="right">(i)</TD>
<TD WIDTH="2%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The registrant has granted equity awards to 302 individuals consisting of its directors, officers, employees,
and consultants, which awards consisted of 15,774,442 options to purchase an aggregate of 15,774,442 shares of its common stock at exercise prices ranging from $1.44 to $10.12 per share, 6,839,371 restricted stock awards issued at prices ranging
from $0.48 to $1.44 per share, and 345,814 restricted stock units at $1.44 per share; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="right">(j)</TD>
<TD WIDTH="2%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the registrant has issued an aggregate of 129,344 shares of its common stock upon the exercise of options for
aggregate proceeds of approximately $186,693. </P></TD></TR></TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The offers, sales, and issuances of the securities
described in Item&nbsp;15(a) through 15(e) were exempt from registration under the Securities Act in reliance upon Section&nbsp;4(a)(2) of the Securities Act or Regulation&nbsp;D promulgated thereunder as transactions by an issuer not involving any
public offering. The recipients of the securities in each of these transactions represented their intentions to acquire the securities for investment only and not with a view to or for sale in connection with any distribution thereof, and
appropriate legends were placed upon the stock certificates issued in these transactions. All recipients had adequate access, through their relationships with us, to information about our company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">The offers, sales, and issuances of the securities described in
Item&nbsp;15(f) through 15(g) were exempt from registration under the Securities Act under either Rule&nbsp;701, in that the transaction were under compensatory benefit plans and contracts relating to compensation, or under Section&nbsp;4(a)(2) of
the Securities Act in that the transactions were between an issuer and members of its senior executive management and did not involve any public offering within the meaning of Section&nbsp;4(a)(2). The recipients of such securities were our
employees, directors or consultants. Appropriate legends were affixed to the securities issued in these transactions. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item 16. Exhibits and Financial
Statement Schedules </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">See the Exhibit Index attached to this registration statement, which Exhibit Index is incorporated
herein by reference. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Schedules not listed above have been omitted because the information required to be set forth
therein is not applicable or is shown in the financial statements or notes thereto. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item 17. Undertakings </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="right">(a)</TD>
<TD WIDTH="2%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors,
officers, and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as
expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer, or controlling
person of the registrant in the successful defense of any action, suit, or proceeding) is asserted by such director, officer, or controlling person in connection with the securities being registered hereunder, the registrant will, unless in the
opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question of whether such indemnification by it is against public policy as expressed in the Securities Act and will be
governed by the final adjudication of such issue. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="right">(b)</TD>
<TD WIDTH="2%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The undersigned registrant hereby undertakes that: </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="right">(i)</TD>
<TD WIDTH="2%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">For purposes of determining any liability under the Securities Act, the information omitted from the form of
prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4)&nbsp;or 497(h) under the Securities Act shall be deemed to be part of
this registration statement as of the time it was declared effective. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="right">(ii)</TD>
<TD WIDTH="2%" VALIGN="top" STYLE="font-size:8pt">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">For the purpose of determining any liability under the Securities Act, each
<FONT STYLE="white-space:nowrap">post-effective</FONT> amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall
be deemed to be the initial bona fide offering thereof. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="2" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Number</B></P></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2" NOWRAP ALIGN="center">
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Exhibit&nbsp;Description</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;1.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d60414dex11.htm">Form of Underwriting Agreement </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;2.1(a)+</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001770121/000119312521007483/d60414dex21a.htm">Agreement and Plan of Merger, dated as of December&nbsp;
20, 2018, by and among the Registrant, Sana Biotechnology IV, Inc. (Merger Sub), Cobalt Biomedicine, Inc. (Cobalt), and VentureLabs VI, Inc., solely in its capacity as the Stockholders&#146; Representative (the Stockholders&#146; Representative)
</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;2.1(b)+</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001770121/000119312521007483/d60414dex21b.htm">First Amendment to Agreement and Plan of Merger, dated as of January&nbsp;
29, 2019, by and among the Registrant, Merger Sub, Cobalt, and the Stockholders&#146; Representative </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;2.1(c)+</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001770121/000119312521007483/d60414dex21c.htm">Second Amendment to Agreement and Plan of Merger, dated as of February&nbsp;
8, 2019, by and among the Registrant, Merger Sub, Cobalt, and the Stockholders&#146; Representative </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;2.2+</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001770121/000119312521007483/d60414dex22.htm">Stock Purchase Agreement, dated as of November&nbsp;
12, 2019, by and among the Registrant, Cytocardia, Inc. (Cytocardia), each of the stockholders of Cytocardia, and Scott Thies, as Sellers&#146; Representative </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;2.3+</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001770121/000119312521007483/d60414dex23.htm">Stock Purchase Agreement, dated as of September&nbsp;
10, 2020, by and among the Registrant, Oscine Holdings, LLC (Oscine), and each of the members of Oscine </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;3.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d60414dex31.htm">Amended and Restated Certificate of Incorporation, as amended, currently in effect </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;3.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d60414dex32.htm">Form of Amended and Restated Certificate of Incorporation, to be in effect immediately prior to the completion of this offering </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;3.3+</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001770121/000119312521007483/d60414dex33.htm">Bylaws, as amended, currently in effect </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;3.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d60414dex34.htm">Form of Amended and Restated Bylaws, to be in effect immediately prior to the completion of this offering </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;4.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Reference is made to Exhibits&nbsp;3.1 through 3.4</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;4.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d60414dex42.htm">Form of Common Stock Certificate</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;5.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d60414dex51.htm">Opinion of Latham&nbsp;&amp; Watkins&nbsp;LLP </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.1+</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001770121/000119312521007483/d60414dex101.htm">Amended and Restated Investors&#146; Rights Agreement, dated February&nbsp;
13, 2019, by and among the Registrant and the investors listed therein</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d60414dex102.htm">Form of Indemnification and Advancement Agreement for directors and officers</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.3(a)#+</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001770121/000119312521007483/d60414dex103a.htm">2018 Equity Incentive Plan, as amended </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.3(b)#+</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001770121/000119312521007483/d60414dex103b.htm">First Amendment to 2018 Equity Incentive Plan, dated as of November&nbsp;9, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.3(c)#+</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001770121/000119312521007483/d60414dex103c.htm">Second Amendment to 2018 Equity Incentive Plan, dated as of December&nbsp;4, 2020 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.3(d)#+</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001770121/000119312521007483/d60414dex103d.htm">Form of Stock Option Agreement under 2018 Equity Incentive Plan </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.4(a)#</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d60414dex104a.htm">2021 Incentive Award Plan </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.4(b)#</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d60414dex104b.htm">Form of Stock Option Grant Notice and Stock Option Agreement under the 2021 Incentive Award Plan</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.4(c)#</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d60414dex104c.htm">Form of Restricted Stock Award Grant Notice and Restricted Stock Award Agreement under the 2021 Incentive Award Plan</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.4(d)#</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d60414dex104d.htm">Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement under the 2021 Incentive Award Plan</A></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="2" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Number</B></P></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2" NOWRAP ALIGN="center">
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Exhibit&nbsp;Description</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.5#</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d60414dex105.htm">Employee Stock Purchase Plan</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.6#+</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001770121/000119312521007483/d60414dex106.htm">Offer Letter and Employment Agreement by and between the Registrant and Steven D. Harr, M.D., dated as of September&nbsp;27, 2018
</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.7#+</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001770121/000119312521007483/d60414dex107.htm">Offer Letter and Employment Agreement by and between the Registrant and Richard Mulligan, Ph.D., dated as of April&nbsp;23, 2020
</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.8#+</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001770121/000119312521007483/d60414dex108.htm">Offer Letter and Employment Agreement by and between the Registrant and Christian Hordo, dated as of November&nbsp;10, 2018
</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.9#+</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001770121/000119312521007483/d60414dex109.htm">Offer Letter and Employment Agreement by and between the Registrant and Nathan Hardy, dated as of October&nbsp;8, 2018 </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.10#+</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001770121/000119312521007483/d60414dex1010.htm">Offer Letter and Employment Agreement by and between the Registrant and James J. MacDonald, dated as of October&nbsp;2, 2018
</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.11#</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d60414dex1011.htm"><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director Compensation Program</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.12(a)&#134;+</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001770121/000119312521007483/d60414dex1012a.htm">License Agreement, effective as of February&nbsp;
17, 2016, by and between Flagship Pioneering Innovations V, Inc. (Flagship Innovations V) and Cobalt Biomedicine, Inc. (Cobalt) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.12(b)&#134;+</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001770121/000119312521007483/d60414dex1012b.htm">First Amendment to License Agreement, dated as of February&nbsp;14, 2019, by and between Flagship Innovations V and Cobalt
</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.13(a)&#134;+</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001770121/000119312521007483/d60414dex1013a.htm">Patents <FONT STYLE="white-space:nowrap">Sub-License</FONT> Agreement, dated August&nbsp;
16, 2018, by and between La Societe Pulsalys (Pulsalys) and Cobalt </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.13(b)&#134;+</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001770121/000119312521007483/d60414dex1013b.htm">Amendment No.&nbsp;1 to Patents <FONT STYLE="white-space:nowrap">Sub-License</FONT> Agreement, dated May&nbsp;
26, 2020, by and between Pulsalys and Cobalt </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.14&#134;+</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001770121/000119312521007483/d60414dex1014.htm">Exclusive License Agreement, dated March&nbsp;
22, 2019, by and between the Registrant and the Regents of the University of California (The Regents) acting through the Technology Development Group of the University of California, Los Angeles (UCLA) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.15(a)&#134;+</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001770121/000119312521007483/d60414dex1015a.htm">License Agreement, dated as of March&nbsp;
19, 2019, by and between the Registrant and President and Fellows of Harvard College (Harvard) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.15(b)&#134;+</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001770121/000119312521007483/d60414dex1015b.htm">Amendment No.&nbsp;1 to License Agreement, dated as of June&nbsp;10, 2019, by and between the Registrant and Harvard </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.15(c)&#134;+</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001770121/000119312521007483/d60414dex1015c.htm">Amendment No.&nbsp;2 to License Agreement, dated as of December&nbsp;15, 2020, by and between the Registrant and Harvard
</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.16(a)&#134;+</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001770121/000119312521007483/d60414dex1016a.htm">Exclusive License Agreement, effective on January&nbsp;
2, 2019, by and between the Registrant and The Regents, acting through its Office of Technology Management, University of California San Francisco (UCSF) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.16(b)&#134;+</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001770121/000119312521007483/d60414dex1016b.htm">Amendment No.&nbsp;1 to Exclusive License Agreement, effective on December&nbsp;3, 2020, by and between the Registrant and UCSF
</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.17&#134;+</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001770121/000119312521007483/d60414dex1017.htm">Exclusive License Agreement, effective on November&nbsp;14, 2019, by and between the Registrant and Washington University
</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.18&#134;+</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001770121/000119312521007483/d60414dex1018.htm">Exclusive License Agreement, effective on September&nbsp;1, 2020, by and between the Registrant and Washington University
</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.19&#134;+</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001770121/000119312521007483/d60414dex1019.htm">Amended and Restated Exclusive Patent License Agreement, dated September&nbsp;
10, 2020, by and among the Registrant, Oscine Corp., and University of Rochester </A></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="88%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="2" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Number</B></P></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2" NOWRAP ALIGN="center">
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Exhibit&nbsp;Description</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt"></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.20(a)&#134;+</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001770121/000119312521007483/d60414dex1020a.htm">Seed Bank Supply Agreement, dated as of July&nbsp;
9, 2018, by and between Oscine Therapeutics (U.S.) Inc. (Oscine Affiliate) and Hadasit Medical Research Services and Development Ltd. (Hadasit) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.20(b)&#134;+</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001770121/000119312521007483/d60414dex1020b.htm">Amendment No.&nbsp;1 to Seed Bank Supply Agreement, dated as of July&nbsp;
9, 2018, by and among the Registrant, Oscine Affiliate, and Hadasit </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.20(c)&#134;+</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001770121/000119312521007483/d60414dex1020c.htm">Amendment No.&nbsp;2 to Seed Bank Supply Agreement, dated as of January&nbsp;
6, 2021, by and among the Registrant, Oscine Affiliate, and Hadasit</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.21(a)&#134;+</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001770121/000119312521007483/d60414dex1021a.htm">Exclusive <FONT STYLE="white-space:nowrap">Start-Up</FONT> License Agreement, effective on October&nbsp;
9, 2018, by and between Cytocardia, Inc. (Cytocardia) and the University of Washington, acting through UW CoMotion (UW) </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.21(b)&#134;+</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001770121/000119312521007483/d60414dex1021b.htm">Amendment No.&nbsp;1 to Exclusive <FONT STYLE="white-space:nowrap">Start-Up</FONT> License Agreement, effective on November&nbsp;
6, 2019, by and between Cytocardia and UW </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.21(c)&#134;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d60414dex1021c.htm">Amendment No.&nbsp;2 to Exclusive Start-Up License Agreement, effective on July&nbsp;16, 2020, by and between Cytocardia and UW </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.21(d)&#134;+</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001770121/000119312521007483/d60414dex1021d.htm">Assignment of Exclusive Start-Up License Agreement, effective on November&nbsp;
11, 2020, by and among UW, Cytocardia and the Registrant </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.21(e)&#134;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d60414dex1021e.htm">Amendment No.&nbsp;4 to Exclusive Start-Up License Agreement, effective on January&nbsp;21, 2021 by and between the Registrant and UW </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">10.22#+</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001770121/000119312521007483/d60414dex1022.htm">Offer Letter and Employment Agreement by and between the Registrant and Sunil Agarwal, M.D., dated as of May&nbsp;20, 2019
</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">21.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d60414dex211.htm">List of subsidiaries</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">23.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d60414dex231.htm">Consent of Independent Registered Public Accounting Firm </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">23.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d60414dex51.htm">Consent of Latham&nbsp;&amp; Watkins&nbsp;LLP (included in Exhibit&nbsp;5.1)</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">24.1+</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="#sig">Power of Attorney (reference is made to the signature page to the Registration Statement) </A></TD></TR>
</TABLE>  <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">+</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">Previously filed. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">#</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">Indicates management contract or compensatory plan. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#134;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="justify">Certain portions of this document that constitute confidential information have been redacted in accordance
with Regulation <FONT STYLE="white-space:nowrap">S-K,</FONT> Item 601(b)(10). </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>

<h5 align="left"><a href="#INDEX">Index to Financial Statements</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="sig"></A>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be
signed on its behalf by the undersigned, thereunto duly authorized, in the City of Seattle, State of Washington, on the 28th day of January, 2021. </P>  <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="79%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">SANA BIOTECHNOLOGY, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Steven D. Harr, M.D.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Steven D. Harr, M.D.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">President and Chief Executive Officer</TD></TR>
</TABLE></DIV>   <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman" ALIGN="justify">Pursuant to the requirements of the Securities Act of 1933, this registration
statement has been signed by the following persons in the capacities and on the dates indicated. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="39%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="39%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="18%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Signature</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Title</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Date</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ Steven D. Harr, M.D.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Steven D. Harr, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chief Executive Officer and Director (principal executive officer)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">January&nbsp;28, 2021</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ Nathan Hardy</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Nathan Hardy</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chief Financial Officer (principal financial and accounting officer)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">January&nbsp;28, 2021</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">*</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Hans E. Bishop</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chairman of the Board</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">January&nbsp;28, 2021</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">*</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Joshua H. Bilenker, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">January&nbsp;28, 2021</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">*</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Douglas Cole, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">January&nbsp;28, 2021</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">*</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Richard Mulligan, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">January&nbsp;28, 2021</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">*</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Robert Nelsen</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">January&nbsp;28, 2021</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">*</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Alise S. Reicin, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">January&nbsp;28, 2021</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">*</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Michelle Seitz</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">January&nbsp;28, 2021</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">*</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Geoffrey von Maltzahn, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">January&nbsp;28, 2021</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">*</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Mary Agnes (Maggie) Wilderotter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">January&nbsp;28, 2021</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">*</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Patrick Y. Yang, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">January&nbsp;28, 2021</TD></TR>
</TABLE>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="89%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">*By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Steven D. Harr, M.D.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Steven D. Harr, M.D.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Attorney-in-Fact</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>d60414dex11.htm
<DESCRIPTION>EX-1.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-1.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 1.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>[&#149;] Shares </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SANA
BIOTECHNOLOGY, INC. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COMMON STOCK, PAR VALUE $0.0001 PER SHARE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>UNDERWRITING AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">February [&#149;], 2021 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">February [&#149;], 2021 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Morgan Stanley&nbsp;&amp; Co. LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Goldman Sachs&nbsp;&amp; Co.
LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BofA Securities, Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o Morgan Stanley&nbsp;&amp; Co. LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1585 Broadway </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;New York, New York 10036 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o
Goldman Sachs&nbsp;&amp; Co. LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;200 West Street </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;New York, New York 10282 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o J.P.
Morgan Securities LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;383 Madison Avenue </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;New York, New York 10179 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o BofA
Securities, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;One Bryant Park </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;New York, New York 10036 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies
and Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Sana Biotechnology, Inc., a Delaware corporation (the &#147;<B>Company</B>&#148;), proposes, subject to the terms and
conditions stated in this agreement (this &#147;<B>Agreement</B>&#148;), to issue and sell to the several Underwriters named in Schedule I hereto (the &#147;<B>Underwriters</B>&#148;), for whom Morgan Stanley&nbsp;&amp; Co. LLC, Goldman
Sachs&nbsp;&amp; Co. LLC, J.P. Morgan Securities LLC and BofA Securities, Inc. are acting as representatives (the &#147;<B>Representatives</B>&#148;), [&#149;] shares of its common stock, par value $0.0001 per share (the &#147;<B>Firm
Shares</B>&#148;). The Company also proposes to issue and sell to the several Underwriters not more than an additional [&#149;] shares of its common stock, par value $0.0001 per share (the &#147;<B>Additional Shares</B>&#148;), if and to the extent
that the Representatives shall have determined to exercise, on behalf of the Underwriters, the right to purchase such shares of common stock granted to the Underwriters in Section&nbsp;2 hereof. The Firm Shares and the Additional Shares are
hereinafter collectively referred to as the &#147;<B>Shares.</B>&#148; The shares of common stock, par value $0.0001 per share, of the Company to be outstanding after giving effect to the sales contemplated hereby are hereinafter referred to as the
&#147;<B>Common Stock</B>.&#148; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company has filed with the Securities and Exchange Commission (the
&#147;<B>Commission</B>&#148;) a registration statement on Form <FONT STYLE="white-space:nowrap">S-1</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-252061),</FONT> including a preliminary prospectus, relating to the Shares. The
registration statement as amended at the time it becomes effective, including the information (if any) deemed to be part of the registration statement at the time of effectiveness pursuant to Rule&nbsp;430A under the Securities Act of 1933, as
amended (the &#147;<B>Securities Act</B>&#148;), is hereinafter referred to as the &#147;<B>Registration Statement</B>&#148;; the prospectus in the form first used to confirm sales of Shares (or in the form first made available to the Underwriters
by the Company to meet requests of purchasers pursuant to Rule 173 under the Securities Act) is hereinafter referred to as the &#147;<B>Prospectus</B><B>.</B>&#148; If the Company has filed an abbreviated registration statement to register
additional shares of Common Stock pursuant to Rule&nbsp;462(b) under the Securities Act (the &#147;<B>Rule</B><B></B><B>&nbsp;462</B><B> Registration Statement</B>&#148;), then any reference herein to the term &#147;<B>Registration
Statement</B>&#148; shall be deemed to include such Rule&nbsp;462 Registration Statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this Agreement, &#147;<B>free
writing prospectus</B>&#148; has the meaning set forth in Rule 405 under the Securities Act, &#147;<B>preliminary prospectus</B>&#148; shall mean each prospectus used prior to the effectiveness of the Registration Statement, and each prospectus that
omitted information pursuant to Rule 430A under the Securities Act that was used after such effectiveness and prior to the execution and delivery of this Agreement, &#147;<B>Time of Sale Prospectus</B>&#148; means the preliminary prospectus
contained in the Registration Statement at the time of its effectiveness together with the documents and pricing information set forth in Schedule II hereto, and &#147;<B>broadly available road show</B>&#148; means a &#147;bona fide electronic road
show&#148; as defined in Rule 433(h)(5) under the Securities Act that has been made available without restriction to any person. As used herein, the terms &#147;Registration Statement,&#148; &#147;preliminary prospectus,&#148; &#147;Time of Sale
Prospectus&#148; and &#147;Prospectus&#148; shall include the documents, if any, incorporated by reference therein as of the date hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Morgan Stanley&nbsp;&amp; Co. LLC (&#147;<B>Morgan Stanley</B>&#148;) has agreed to reserve a portion of the Shares to be purchased by it
under this Agreement for sale to the Company&#146;s directors, officers, employees and business associates and other parties related to the Company (collectively, &#147;<B>Participants</B>&#148;), as set forth in each of the Time of Sale Prospectus
and the Prospectus under the heading &#147;Underwriters&#148; (the &#147;<B>Directed Share Program</B>&#148;). The Shares to be sold by Morgan Stanley and its affiliates pursuant to the Directed Share Program, at the direction of the Company, are
referred to hereinafter as the &#147;<B>Directed Shares</B>&#148;. Any Directed Shares not orally confirmed for purchase by any Participant by the end of the business day on which this Agreement is executed will be offered to the public by the
Underwriters as set forth in the Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. <I>Representations and Warranties</I>. The Company represents and warrants to and agrees
with each of the Underwriters that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) The Registration Statement has become effective; no stop order suspending the
effectiveness of the Registration Statement is in effect, and no proceedings for such purpose or pursuant to Section&nbsp;8A under the Securities Act are pending before or, to the Company&#146;s knowledge, threatened by the Commission. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) (i) The Registration Statement, when it became effective, did not
contain and, as amended or supplemented, if applicable, as of the date of such amendment or supplement, will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the
statements therein not misleading, (ii)&nbsp;the Registration Statement and the Prospectus comply and, as amended or supplemented, if applicable, as of the date of such amendment or supplement, will comply in all material respects with the
Securities Act and the applicable rules and regulations of the Commission thereunder, (iii)&nbsp;the Time of Sale Prospectus does not, and at the time of each sale of the Shares in connection with the offering when the Prospectus is not yet
available to prospective purchasers and at the Closing Date (as defined in Section&nbsp;4), the Time of Sale Prospectus, as then amended or supplemented by the Company, if applicable, will not, contain any untrue statement of a material fact or omit
to state a material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading, (iv)&nbsp;each broadly available road show, if any, does not contain any information that conflicts with
the information contained in the Registration Statement, the Time of Sale Prospectus or the Prospectus, and when considered together with the Time of Sale Prospectus, does not contain any untrue statement of a material fact or omit to state a
material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading and (v)&nbsp;the Prospectus, as of its date, does not contain and, as amended or supplemented, if applicable, as of
the date of such amendment or supplement or as of the Closing Date and each Option Closing Date (as defined in Section&nbsp;2), will not contain any untrue statement of a material fact or omit to state a material fact necessary to make the
statements therein, in the light of the circumstances under which they were made, not misleading, except that the representations and warranties set forth in this paragraph do not apply to statements or omissions in the Registration Statement, the
Time of Sale Prospectus or the Prospectus based upon information relating to any Underwriter furnished to the Company in writing by or on behalf of such Underwriter through the Representatives expressly for use therein, it being understood and
agreed upon that the only such information furnished by any Underwriter consists of the Underwriting Information, as defined below. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) The Company is not an &#147;ineligible issuer&#148; in connection with the offering pursuant to Rules 164, 405 and 433
under the Securities Act. Any free writing prospectus that the Company is required to file pursuant to Rule 433(d) under the Securities Act has been, or will be, filed with the Commission in accordance with the requirements of the Securities Act and
the applicable rules and regulations of the Commission thereunder. Each free writing prospectus that the Company has filed, or is required to file, pursuant to Rule 433(d) under the Securities Act or that was prepared by or on behalf of or used or
referred to by the Company complies or will comply, as of the date of such filing, in all material respects with the applicable requirements of the Securities Act and the applicable rules and regulations of the Commission thereunder. Except for the
free writing prospectuses, if any, identified in Schedule II hereto, and electronic road shows, if any, each furnished to the Representatives before first use, the Company has not prepared, used or referred to, and will not, without the prior
consent of the Representatives, prepare, use or refer to, any free writing prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) The Company has been duly incorporated, is validly existing as a
corporation in good standing under the laws of the jurisdiction of its incorporation, has the corporate power and authority to own or lease its property and to conduct its business as described in each of the Registration Statement, the Time of Sale
Prospectus and the Prospectus and is duly qualified to transact business and is in good standing in each jurisdiction in which the conduct of its business or its ownership or leasing of property requires such qualification, except to the extent that
the failure to be so qualified or be in good standing would reasonably be expected to have a material adverse effect on the Company and its subsidiaries, taken as a whole. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) Each subsidiary of the Company has been duly incorporated, is validly existing as a corporation in good standing under the
laws of the jurisdiction of its incorporation, has the corporate power and authority to own or lease its property and to conduct its business as described in each of the Registration Statement, the Time of Sale Prospectus and the Prospectus and is
duly qualified to transact business and is in good standing in each jurisdiction (to the extent the concept of good standing is applicable in such jurisdiction) in which the conduct of its business or its ownership or leasing of property requires
such qualification, except to the extent that the failure to be so qualified or be in good standing would not, singly or in the aggregate, reasonably be expected to have a material adverse effect on the Company and its subsidiaries, taken as a
whole; all of the issued shares of capital stock of each subsidiary of the Company have been duly and validly authorized and issued, are fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> (to the extent that such concepts are
applicable in such jurisdiction) and are owned directly or indirectly by the Company, free and clear of all liens, encumbrances, equities or claims. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) This Agreement has been duly authorized, executed and delivered by the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) The authorized capital stock of the Company conforms as to legal matters, in all material respects, to the description
thereof contained in each of the Registration Statement, the Time of Sale Prospectus and the Prospectus. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) The shares of
Common Stock outstanding prior to the issuance of the Shares have been duly authorized and are validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable.</FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) The Shares have been duly authorized and, when issued, delivered and paid for in accordance with the terms of this
Agreement, will be validly issued, fully paid and <FONT STYLE="white-space:nowrap">non-assessable,</FONT> and the issuance of the Shares will not be subject to any preemptive or similar rights that have not been validly waived. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) With respect to the stock options granted pursuant to the stock-based
compensation plans of the Company and its subsidiaries (the &#147;<B>Company Stock Plans</B>&#148;), (i) each grant of a stock option was duly authorized no later than the date on which the grant of such stock option was by its terms to be effective
by all necessary corporate action, including, as applicable, approval by the board of directors of the Company (or a duly constituted and authorized committee thereof) and any required stockholder approval by the necessary number of votes or written
consents, and the award agreement governing such grant (if any) was duly executed and delivered by each party thereto, and (ii)&nbsp;each such grant was made in accordance with the terms of the Company Stock Plans and all applicable laws and
regulatory rules or requirements, including any applicable federal securities laws. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) The execution and delivery by the
Company of, and the performance by the Company of its obligations under, this Agreement will not contravene (i)&nbsp;any provision of applicable law, (ii)&nbsp;the certificate of incorporation or <FONT STYLE="white-space:nowrap">by-laws</FONT> of
the Company, (iii)&nbsp;any agreement or other instrument binding upon the Company or any of its subsidiaries that is material to the Company and its subsidiaries, taken as a whole, or (iv)&nbsp;any judgment, order or decree of any governmental
body, agency or court having jurisdiction over the Company or any subsidiary, except in this case of clauses (i), (iii) and (iv), where such contravention would not, individually or in the aggregate, reasonably be expected to have a material adverse
effect on the Company and its subsidiaries, taken as a whole, and no consent, approval, authorization or order of, or qualification with, any governmental body or agency is required for the performance by the Company of its obligations under this
Agreement, except such as have been obtained or waived or as may be required by the securities or Blue Sky laws of the various states or foreign jurisdictions or the rules and regulations of the Financial Industry Regulatory Authority
(&#147;FINRA&#148;) in connection with the offer and sale of the Shares. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) There has not occurred any material adverse
change, or any development involving a prospective material adverse change, in the condition, financial or otherwise, or in the earnings, business or operations of the Company and its subsidiaries, taken as a whole, from that set forth in the Time
of Sale Prospectus. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) Neither the Company nor any of its subsidiaries is (i)&nbsp;in violation of its respective
certificate of incorporation or bylaws; (ii)&nbsp;in default, and no event has occurred that, with notice or lapse of time or both, would constitute such a default, in the due performance or observance of any term, covenant or condition contained in
any indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which the Company or any of its subsidiaries is a party or by which the Company or any of its subsidiaries is bound or to which any of the property or assets
of the Company or any of its subsidiaries is subject; or (iii)&nbsp;in violation of any law or statute or any judgment, order, rule or regulation of any court or arbitrator or governmental or regulatory authority applicable to the Company, any of
its subsidiaries or their respective businesses and properties, except, in the case of clauses (ii)&nbsp;and (iii) above, for any such default or violation that would not, individually or in the aggregate, have a material adverse effect on the
Company and its subsidiaries, taken as a whole. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) There are no legal or governmental proceedings pending or, to the
Company&#146;s knowledge, threatened to which the Company or any of its subsidiaries is a party or to which any of the properties of the Company or any of its subsidiaries is subject (i)&nbsp;other than proceedings accurately described in all
material respects in each of the Registration Statements, the Time of Sale Prospectus and the Prospectus and proceedings that would not, singly or in the aggregate, reasonably be expected to have a material adverse effect on the Company and its
subsidiaries, taken as a whole, or on the power or ability of the Company to perform its obligations under this Agreement or to consummate the transactions contemplated by each of the Registration Statements, the Time of Sale Prospectus and the
Prospectus or (ii)&nbsp;that are required to be described in the Registration Statement, the Time of Sale Prospectus or the Prospectus and are not so described in all material respects; and there are no statutes, regulations, contracts or other
documents to which the Company or any of its subsidiaries is subject or by which the Company or any of its subsidiaries is bound that are required to be described in the Registration Statement, the Time of Sale Prospectus or the Prospectus or to be
filed as exhibits to the Registration Statement that are not described in all material respects or filed as required. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o)
Each preliminary prospectus filed as part of the Registration Statement as originally filed or as part of any amendment thereto, or filed pursuant to Rule&nbsp;424 under the Securities Act, complied when so filed in all material respects with the
applicable requirements of the Securities Act and the applicable rules and regulations of the Commission thereunder. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p)
The Company is not, and after giving effect to the offering and sale of the Shares and the application of the proceeds thereof as described in each of the Registration Statements, the Time of Sale Prospectus and the Prospectus will not be, required
to register as an &#147;investment company&#148; as such term is defined in the Investment Company Act of 1940, as amended. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(q) The Company and each of its subsidiaries (i)&nbsp;are in compliance with any and all applicable foreign, federal, state and
local laws and regulations relating to the protection of human health and safety, the environment or hazardous or toxic substances or wastes, pollutants or contaminants (&#147;<B>Environmental Laws</B>&#148;), (ii) have received all permits,
licenses or other approvals required of them under applicable Environmental Laws to conduct their respective businesses and (iii)&nbsp;are in compliance with all terms and conditions of any such permit, license or approval, except where such
noncompliance with Environmental Laws, failure to receive required permits, licenses or other approvals or failure to comply with the terms and conditions of such permits, licenses or approvals would not, singly or in the aggregate, reasonably be
expected to have a material adverse effect on the Company and its subsidiaries, taken as a whole. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(r) There are no costs or liabilities associated with Environmental Laws
(including, without limitation, any capital or operating expenditures required for <FONT STYLE="white-space:nowrap">clean-up,</FONT> closure of properties or compliance with Environmental Laws or any permit, license or approval, any related
constraints on operating activities and any potential liabilities to third parties) which would, singly or in the aggregate, reasonably be expected to have a material adverse effect on the Company and its subsidiaries, taken as a whole. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(s) There are no contracts, agreements or understandings between the Company and any person granting such person the right to
require the Company to file a registration statement under the Securities Act with respect to any securities of the Company or to require the Company to include such securities with the Shares registered pursuant to the Registration Statement,
except as otherwise have been validly waived in connection with the issuance and sale of the Shares contemplated hereby and as described in the Time of Sale Prospectus and the Prospectus. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(t) (i) None of the Company or any of its subsidiaries or controlled affiliates, or any director or officer thereof, nor, to
the Company&#146;s knowledge, any employee, agent or representative of the Company or of any of its subsidiaries or controlled affiliates, has taken or will take any action in furtherance of an offer, payment, promise to pay, or authorization or
approval of the payment, giving or receipt of money, property, gifts or anything else of value, directly or indirectly, to any government official (including any officer or employee of a government or government-owned or controlled entity or of a
public international organization, or any person acting in an official capacity for or on behalf of any of the foregoing, or any political party or party official or candidate for political office) (&#147;<B>Government Official</B>&#148;) in order
to obtain, retain, or direct business or influence official action, or to any person in violation of any applicable anti-corruption laws (ii)&nbsp;the Company and each of its subsidiaries and affiliates have conducted their businesses in compliance
with applicable anti-corruption laws and have instituted and maintained and will continue to maintain policies and procedures reasonably designed to promote and achieve compliance with such laws and with the representations and warranties contained
herein; and (iii)&nbsp;neither the Company nor any of its subsidiaries will use, directly or indirectly, the proceeds of the offering in furtherance of an offer, payment, promise to pay, or authorization of the payment or giving of money, or
anything else of value, to any person in violation of any applicable anti-corruption laws. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(u) The operations of the
Company and each of its subsidiaries are and have been conducted at all times in material compliance with all applicable financial recordkeeping and reporting requirements, including those of the Bank Secrecy Act, as amended by Title III of the
Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001 (USA PATRIOT Act), and the applicable anti-money laundering statutes of jurisdictions where the Company and each of its
subsidiaries conduct business, the rules and regulations thereunder and any related or similar rules, regulations or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
guidelines, issued, administered or enforced by any governmental or regulatory agency (collectively, the &#147;<B>Anti-Money Laundering Laws</B>&#148;), and no action, suit or proceeding by or
before any court or governmental or regulatory agency, authority or body or any arbitrator involving the Company or any of its subsidiaries with respect to the Anti-Money Laundering Laws is pending or, to the knowledge of the Company, threatened.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) (i) None of the Company, any of its subsidiaries, or any director or officer of the Company nor,, to the
Company&#146;s knowledge, any employee, agent, controlled affiliate or representative of the Company or any of its subsidiaries, is an individual or entity (&#147;<B>Person</B>&#148;) that is, or is owned or controlled by one or more Persons that
are: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) the subject of any sanctions administered or enforced by the U.S. Department of the Treasury&#146;s Office of
Foreign Assets Control, the United Nations Security Council, the European Union, Her Majesty&#146;s Treasury or other relevant sanctions authority (collectively, &#147;<B>Sanctions</B>&#148;), or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) located, organized or resident in a country or territory that is the subject of Sanctions (including, without limitation,
Crimea, Cuba, Iran, North Korea and Syria). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) The Company will not, directly or indirectly, use the proceeds of the
offering, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other Person: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(A) to fund or facilitate any activities or business of or with any Person or in any country or territory that, at the time of
such funding or facilitation, is the subject of Sanctions; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:13%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(B) in any other manner that will result in a violation of
Sanctions by any Person (including any Person participating in the offering, whether as underwriter, advisor, investor or otherwise). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) The Company and each of its subsidiaries have not knowingly engaged in, are not now knowingly engaged in, and will not
engage in, any dealings or transactions with any Person, or in any country or territory, that at the time of the dealing or transaction is or was the subject of Sanctions. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(w) Subsequent to the respective dates as of which information is given in each of the Registration Statement, the Time of Sale
Prospectus and the Prospectus, (i)&nbsp;the Company and its subsidiaries, taken as a whole, have not incurred any material liability or obligation, direct or contingent, nor entered into any material transaction; (ii)&nbsp;the Company has not
purchased any of its outstanding capital stock (other than from its employees or other service providers in connection </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
with the termination of their service pursuant to the terms of the equity compensation plans or agreements described in the Time of Sale Prospectus, or from former employees), nor declared, paid
or otherwise made any dividend or distribution of any kind on its capital stock other than ordinary and customary dividends; and (iii)&nbsp;there has not been any material change in the capital stock,
<FONT STYLE="white-space:nowrap">short-term</FONT> debt or <FONT STYLE="white-space:nowrap">long-term</FONT> debt of the Company and its subsidiaries, taken as a whole, except in each case as described in each of the Registration Statement, the Time
of Sale Prospectus and the Prospectus, respectively. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(x) The Company and each of its subsidiaries have good and marketable
title in fee simple to all real property and good and marketable title to all personal property owned by them which is material to the business of the Company and its subsidiaries, in each case free and clear of all liens, encumbrances and defects
except such as are described in the Time of Sale Prospectus or such as do not materially affect the value of such property and do not materially interfere with the use made and proposed to be made of such property by the Company and its
subsidiaries; and any real property and buildings held under lease by the Company and its subsidiaries are held by them under valid, subsisting and enforceable leases with such exceptions as are not material and do not interfere with the use made
and proposed to be made of such property and buildings by the Company and its subsidiaries. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(y) Except as described in the
Registration Statement, Time of Sale Prospectus and the Prospectus, and to the Company&#146;s knowledge, the Company and its subsidiaries own, can acquire on reasonable terms or have licensed rights to all material patents, patent applications,
patent rights, inventions, copyrights, know how (including trade secrets and other unpatented and/or unpatentable proprietary or confidential information, inventions, systems or procedures), trademarks, service marks, trade names and other
intellectual property rights and registrations, and applications for registrations of any of the foregoing, necessary to the conduct of its business as now conducted and as proposed to be conducted by the Company or any of its subsidiaries as
described in the Registration Statement, Time of Sale Prospectus and the Prospectus (the &#147;<B>Company Intellectual Property</B>&#148;). Except as described in the Registration Statement, Time of Sale Prospectus and the Prospectus: (i)&nbsp;to
the Company&#146;s knowledge, there are no third parties who have rights to any Company Intellectual Property, except for the retained rights of the <FONT STYLE="white-space:nowrap">co-owners,</FONT> owners and/or licensors of the Company
Intellectual Property which is licensed to the Company and its subsidiaries or the rights of third party licensees of Company Intellectual Property licensed by the Company or any of its subsidiaries in the ordinary course of business; (ii)&nbsp;to
the Company&#146;s knowledge, there is no pending or threatened action, suit, proceeding or claim by others (a)&nbsp;challenging the validity, enforceability or scope of any Company Intellectual Property or (b)&nbsp;challenging the Company&#146;s
rights or any of its subsidiaries&#146; rights in or to any Company Intellectual Property; (iii)&nbsp;to the Company&#146;s knowledge, there is no pending or threatened action, suit, proceeding or claim by others that the Company or any of its
subsidiaries infringes or misappropriates, or would infringe or misappropriate upon the commercialization of any product or service described in the Registration Statement, Time of Sale </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
Prospectus and the Prospectus as under development by the Company or its subsidiaries, any intellectual property or other proprietary rights of others; (iv)&nbsp;to the Company&#146;s knowledge,
none of the Company Intellectual Property used by the Company or its subsidiaries which is necessary to the conduct of its business as now conducted and as proposed to be conducted by the Company or any of its subsidiaries as described in the
Registration Statement, Time of Sale Prospectus and the Prospectus has been obtained or is being used by the Company and its subsidiaries in violation of any contractual obligation binding on the Company or its subsidiaries; (v)&nbsp;to the
Company&#146;s knowledge, there is no infringement or misappropriation by others of any Company Intellectual Property owned by the Company or any of its subsidiaries; (vi)&nbsp;to the Company&#146;s knowledge, the Company and its subsidiaries have
materially complied with the material terms of each agreement pursuant to which Company Intellectual Property has been licensed to the Company or any subsidiary, and all such agreements are in full force and effect; (vii)&nbsp;[Reserved];
(viii)&nbsp;the Company has taken commercially reasonable steps to protect, maintain and safeguard the Company Intellectual Property, including the execution of appropriate nondisclosure, confidentiality, and invention assignment agreements with
founders, key employees and any other employees involved in the development of material Company Intellectual Property for the Company or any of its subsidiaries; (ix)&nbsp;to the Company&#146;s knowledge, no employee of the Company and its
subsidiaries is in or has been in violation of any material term of any written employment contract, patent disclosure agreement, invention assignment agreement, <FONT STYLE="white-space:nowrap">non-competition</FONT> agreement, <FONT
STYLE="white-space:nowrap">non-solicitation</FONT> agreement, nondisclosure agreement, or restrictive covenant agreement with a former employer where the basis of such violation relates to (a)&nbsp;such employee&#146;s employment with the Company
and (b)&nbsp;the ownership by the Company or its subsidiaries of any Company Intellectual Property; (x)&nbsp;to the Company&#146;s knowledge, none of the Company Intellectual Property employed by the Company or its subsidiaries has been obtained or
is being used by the Company or its subsidiary in violation of any contractual obligation binding on the Company or its subsidiaries or any of their respective officers, directors or employees ; and (xi)&nbsp;to the Company&#146;s knowledge, the
duties of candor and good faith required by, and owed by the Company, its subsidiaries, and its licensors to the United States Patent and Trademark Office during the prosecution of the United States patents and patent applications included in the
Company Intellectual Property have been complied with. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(z) Except as would not, individually or in the aggregate,
reasonably be expected to result in a material adverse effect on the Company and its subsidiaries, taken as a whole, (A)&nbsp;each Plan (as defined below) has been maintained in compliance with its terms and the requirements of any applicable
statutes, orders, rules and regulations, including but not limited to the Employee Retirement Income Security Act of 1974, as amended (&#147;<B>ERISA</B>&#148;) and the Internal Revenue Code of 1986, as amended (the &#147;<B>Code</B>&#148;);
(B)&nbsp;no <FONT STYLE="white-space:nowrap">non-exempt</FONT> prohibited transaction, within </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
the meaning of Section&nbsp;406 of&nbsp;ERISA&nbsp;or Section&nbsp;4975 of the Code, has occurred with respect to any Plan; (C)&nbsp;for each Plan, no failure to satisfy the minimum funding
standards (within the meaning of Section&nbsp;412 of the Code or Section&nbsp;302 of&nbsp;ERISA), whether or not waived, has occurred or is reasonably expected to occur; (D)&nbsp;no &#147;reportable event&#148; (within the meaning of
Section&nbsp;4043(c) of ERISA, other than those events as to which notice is waived) has occurred or is reasonably expected to occur with respect to any Plan or Multiemployer Plan; and (E)&nbsp;neither the Company nor any member of its
&#147;Controlled Group&#148; (defined as any organization which is a member of a controlled group of corporations within the meaning of Section&nbsp;414 of the Code) has incurred, nor is reasonably expected to incur, any liability under Title IV
of&nbsp;ERISA&nbsp;(other than contributions to any Plan or any Multiemployer Plan or premiums to the PBGC, in the ordinary course and without default) in respect of a Plan or a Multiemployer Plan. For purposes of this paragraph, (x)&nbsp;the term
&#147;Plan&#148; means an employee benefit plan, within the meaning of Section&nbsp;3(3) of&nbsp;ERISA, subject to Title IV of&nbsp;ERISA, but excluding any Multiemployer Plan, for which the Company has any liability (whether absolute or contingent,
including any liability as a result of any members of its &#147;Controlled Group&#148;) and (y)&nbsp;the term &#147;Multiemployer Plan&#148; means a multiemployer plan within the meaning of Section&nbsp;4001(a)(3) of&nbsp;ERISA for which the Company
has any liability (whether absolute or contingent, including any liability as a result of any member of its &#147;Controlled Group&#148;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(aa) No material labor dispute with the employees of the Company or any of its subsidiaries exists, or, to the knowledge of the
Company, is imminent, and the Company has no knowledge of any existing, threatened or imminent labor disturbance by the employees of any of its principal suppliers, manufacturers or contractors that could, singly or in the aggregate, have a material
adverse effect on the Company and its subsidiaries, taken as a whole. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(bb) The Company and each of its subsidiaries are
insured by insurers of recognized financial responsibility against such losses and risks and in such amounts as in the Company&#146;s reasonable judgment are prudent and customary in the businesses in which they are engaged; neither the Company nor
any of its subsidiaries has been refused any insurance coverage sought or applied for; and neither the Company nor any of its subsidiaries has any reason to believe that it will not be able to renew its existing insurance coverage as and when such
coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business at a cost that would not, singly or in the aggregate, reasonably be expected to have a material adverse effect on the Company and its
subsidiaries, taken as a whole. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(cc) Except as would not reasonably be expected to have a material adverse effect on the
Company and its subsidiaries, taken as a whole, the Company and each of its subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal, state or foreign regulatory authorities necessary to conduct their
respective businesses Neither the Company nor any of its subsidiaries has received any written notice of proceedings relating to the revocation or modification of any such certificate, authorization or permit which, singly or in the aggregate, if
the subject of an unfavorable decision, ruling or finding, would reasonably be expected to have a material adverse effect on the Company and its subsidiaries, taken as a whole. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(dd) The Company and each of its subsidiaries maintain a system of internal
accounting controls sufficient to provide reasonable assurance that (i)&nbsp;transactions are executed in accordance with management&#146;s general or specific authorizations; (ii)&nbsp;transactions are recorded as necessary to permit preparation of
financial statements in conformity with U.S. generally accepted accounting principles (&#147;<B>U.S. GAAP</B>&#148;) and to maintain asset accountability; (iii)&nbsp;access to assets is permitted only in accordance with management&#146;s general or
specific authorization; and (iv)&nbsp;the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. Since the end of the Company&#146;s most
recent audited fiscal year, there has been (i)&nbsp;no material weakness in the Company&#146;s internal control over financial reporting (whether or not remediated) and (ii)&nbsp;no change in the Company&#146;s internal control over financial
reporting that has materially affected, or is reasonably likely to materially affect, the Company&#146;s internal control over financial reporting. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ee) The financial statements included in each of the Registration Statement, Time of Sale Prospectus and the Prospectus,
together with the related schedules and notes thereto, comply as to form in all material respects with the applicable accounting requirements of the Securities Act and present fairly in all material respects the consolidated financial position of
the Company and its subsidiaries as of the dates shown and its results of operations and cash flows for the periods shown, and such financial statements have been prepared in conformity with U.S. GAAP applied on a consistent basis throughout the
periods covered thereby. The other financial information included in the Registration Statement, the Time of Sale Prospectus and the Prospectus has been derived from the accounting or other records of the Company and its consolidated subsidiaries
and presents fairly in all material respects the information shown thereby. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ff) Ernst&nbsp;&amp; Young LLP, which has
certified certain financial statements of the Company and its subsidiaries and delivered its report with respect to the audited consolidated financial statements and schedules, filed with the Commission as part of the Registration Statement and
included in each of the Registration Statement, the Time of Sale Prospectus and the Prospectus, is an independent registered public accounting firm with respect to the Company within the applicable rules and regulations of the Commission and the
Public Company Accounting Oversight Board (United States) and as required by the Securities Act. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(gg) The statistical,
industry and market related data included in the Registration Statement, the Time of Sale Prospectus and the Prospectus are based on or derived from sources that the Company reasonably and in good faith believes to be reliable and accurate. To the
Company&#146;s knowledge, it does not require the consent of any third party for the use of any such data. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(hh) To the extent required under applicable rules, the Company maintains
disclosure controls and procedures that comply with the requirements of the Securities Exchange Act of 1934, as amended (the &#147;<B>Exchange Act</B>&#148;); such disclosure controls and procedures have been designed to ensure that material
information relating to the Company and its subsidiaries is made known to the Company&#146;s principal executive officer and principal financial officer by others within those entities; and such disclosure controls and procedures are effective. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) Except as described in the Time of Sale Prospectus and the Registration Statement, the Company has not sold, issued or
distributed any shares of Common Stock during the <FONT STYLE="white-space:nowrap">six-month</FONT> period preceding the date hereof, including any sales pursuant to Rule&nbsp;144A under, or Regulation&nbsp;D or S of, the Securities Act, other than
shares issued pursuant to employee benefit plans, qualified stock option plans or other employee compensation plans or pursuant to outstanding options, rights or warrants. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(jj) The Registration Statement, the Prospectus, the Time of Sale Prospectus and any preliminary prospectus comply, and any
amendments or supplements thereto will comply, with any applicable laws or regulations of foreign jurisdictions in which the Prospectus, the Time of Sale Prospectus or any preliminary prospectus, as amended or supplemented, if applicable, are
distributed in connection with the Directed Share Program. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(kk) No consent, approval, authorization or order of, or
qualification with, any governmental body or agency, other than those obtained, is required in connection with the offering of the Directed Shares in any jurisdiction where the Directed Shares are being offered. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ll) The Company has not offered, or caused Morgan Stanley or any Morgan Stanley Entity as defined in Section&nbsp;9 to offer,
Shares to any person pursuant to the Directed Share Program with the specific intent to unlawfully influence (i)&nbsp;a customer or supplier of the Company to alter the customer&#146;s or supplier&#146;s level or type of business with the Company,
or (ii)&nbsp;a trade journalist or publication to write or publish favorable information about the Company or its products. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(mm) The Company and each of its subsidiaries have filed all federal, state, local and foreign tax returns required to be filed
or have requested extensions thereof (except where the failure to file would not reasonably be expected to, singly or in the aggregate, have a material adverse effect on the Company and its subsidiaries, taken as a whole) and have paid all taxes
required to be paid thereon (except for cases in which the failure to file or pay would not reasonably be expected to, singly or in the aggregate, have a material adverse effect on the Company and its subsidiaries, taken as a whole, or except as
currently being </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
contested in good faith and for which reserves required by U.S. GAAP have been created in the financial statements of the Company), and no tax deficiency has been determined adversely to the
Company or any of its subsidiaries which, singly or in the aggregate, has had (nor does the Company nor any of its subsidiaries have any notice or knowledge of any tax deficiency which could reasonably be expected to be determined adversely to the
Company or its subsidiaries and which could reasonably be expected to have) a material adverse effect on the Company and its subsidiaries, taken as a whole. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(nn) The Company has taken all necessary actions to ensure that, upon the effectiveness of the Registration Statement, it will
be in compliance with all provisions of the Sarbanes-Oxley Act of 2002, as amended (the &#147;<B>Sarbanes-Oxley Act</B>&#148;), and all rules and regulations promulgated thereunder applicable to the Company at such time, and is taking steps designed
to ensure that it will be in compliance, at all times, with the other provisions of the Sarbanes-Oxley Act when they become applicable to the Company after the effectiveness of the Registration Statement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(oo) The Company has not taken, directly or indirectly, any action designed to, or that would reasonably be expected to, cause
or result in any stabilization or manipulation of the price of the Shares. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(pp) From the time of initial confidential
submission of the Registration Statement to the Commission through the date hereof, the Company has been and is an &#147;emerging growth company,&#148; as defined in Section&nbsp;2(a) of the Securities Act (an &#147;<B>Emerging Growth
Company</B>&#148;). <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;Testing-the-Waters</FONT></FONT> Communication&#148; means any oral or written communication with potential investors undertaken in reliance on
Section&nbsp;5(d) or Rule 163B of the Securities Act. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(qq) The Company (i)&nbsp;has not engaged in any <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication other than <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communications with entities
that are reasonably believed to be qualified institutional buyers within the meaning of Rule 144A under the Securities Act or institutions that are reasonably believed to be accredited investors within the meaning of Rule 501 under the Securities
Act and (ii)&nbsp;has not authorized anyone other than the Representatives to engage in <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communications. The Company reconfirms that the
Representatives have been authorized to act on its behalf in undertaking <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communications. The Company has not distributed any Written <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication. that is a written communication within the meaning of Rule 405 under the Securities Act (a &#147;Written Testing the Waters
Communication&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(rr) As of the time of each sale of the Shares in connection with the offering when the Prospectus
is not yet available to prospective purchasers, none of (A)&nbsp;the Time of Sale Prospectus, (B)&nbsp;any free writing prospectus, when considered together with the Time of Sale Prospectus, and (C)&nbsp;any individual Written <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication, when considered together with the Time of Sale Prospectus, included, includes or will include an untrue statement of a material fact or
omitted, omits or will omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ss) The preclinical tests and other studies (collectively,
&#147;<B>Studies</B>&#148;) that are described in, or the results of which are referred to in, the Registration Statement, the Time of Sale Prospectus or the Prospectus were and, if still pending, are being conducted in all material respects in
accordance with all applicable Health Care Laws; each description of the results of such Studies is accurate in all material respects, and the Company has no material knowledge of any other Studies, the results of which are inconsistent with or
otherwise call into question, the results described or referred to in the Registration Statement, the Time of Sale Prospectus or the Prospectus; the Company has made all such filings and obtained all such approvals or authorizations as may be
required by the Food and Drug Administration of the U.S. Department of Health and Human Services or from any other U.S. or foreign government or drug or medical device regulatory agency, or health care facility Institutional Review Board
(collectively, the &#147;<B>Regulatory Agencies</B>&#148;) for the conduct of such tests and studies, except where the failure to make such filing or obtain such approval would not reasonably be expected to, individually or in the aggregate, result
in a material adverse effect on the Company and its subsidiaries, taken as a whole; except as described in the Registration Statement, the Time of Sale Prospectus and the Prospectus, the Company has not received any written notice of, or written
correspondence from, any Regulatory Agency requiring the termination or suspension of any tests or studies that are described or referred to in the Registration Statement, the Time of Sale Prospectus, nor is the Company aware of any reasonable
grounds for such written notice or correspondence. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(tt) The Company and its subsidiaries are, and since January&nbsp;1,
2019 have been, in compliance with all applicable statutes, rules and regulations applicable to the Health Care Laws (as defined below), except where failures to so comply, whether individually or in the aggregate, would not reasonably be expected
to have a material adverse effect on the Company and its subsidiaries, taken as a whole. For purposes of this Agreement, &#147;Health Care Laws&#148; means: (i)&nbsp;the Federal Food, Drug, and Cosmetic Act (21 U.S.C. &#167;&#167; 301 et seq.), the
Public Health Service Act (42 U.S.C. &#167;&#167; 201 et seq.) and the regulations promulgated thereunder; (ii)&nbsp;all applicable federal, state, local and all applicable foreign health care related fraud and abuse laws, including, without
limitation, the U.S. Anti-Kickback Statute (42 U.S.C. &#167; <FONT STYLE="white-space:nowrap">1320a-7b(b)),</FONT> the U.S. False Statements Law (42 U.S.C. &#167; <FONT STYLE="white-space:nowrap">1320a-7b(a)),</FONT> the Civil Monetary Penalties Law
(42 U.S.C. <FONT STYLE="white-space:nowrap">&#167;1320a-7a),</FONT> the U.S. Civil False Claims Act (31 U.S.C. &#167; 3729 et seq.), all criminal laws relating to health care fraud and abuse, including but not limited to 18 U.S.C. &#167;&#167; 286
and 287, and the health care fraud criminal provisions under the U.S. Health Insurance Portability and Accountability Act of 1996 (&#147;<B>HIPAA</B>&#148;) (42 U.S.C. &#167;&#167;1320d et seq.), the Physician Payments Sunshine Act (42 U.S.C. &#167;
<FONT STYLE="white-space:nowrap">1320a-7h),</FONT> the exclusions law (42 U.S.C. &#167; <FONT STYLE="white-space:nowrap">1320a-7),</FONT> Medicare (Title XVIII of the Social Security Act) and Medicaid (Title XIX
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
of the Social Security Act); and (iii)&nbsp;the Standards for Privacy of Individually Identifiable Health Information, the Security Standards for the Protection of Electronic Protected Health
Information, and the Standards for Electronic Transactions and Code Sets promulgated under HIPAA, the Health Information Technology for Economic and Clinical Health Act (&#147;<B>HITECH Act</B>&#148;) (42 U.S.C. &#167;&#167; 17921 et seq.), and the
regulations promulgated thereunder and any applicable state or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> counterpart thereof. Since January&nbsp;1, 2019, neither the Company nor its subsidiaries has received written notice of any claim,
action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action from any court or arbitrator or governmental or regulatory authority or third party alleging that any product operation or activity is in material violation
of any Health Care Laws, and, to the Company&#146;s knowledge, no such claim, action, suit, proceeding, hearing, enforcement, investigation, arbitration or other action is threatened. Neither the Company nor its subsidiaries is a party to any
corporate integrity agreements, monitoring agreements, consent decrees, settlement orders, or similar agreements with or imposed by any governmental or regulatory authority. Additionally, since January&nbsp;1, 2018, none of the Company, its
subsidiaries or its respective directors, officers, employees, or, to the knowledge of the Company, contractors or agents, has been excluded, suspended or debarred from participation in any U.S. federal health care program or human clinical research
or, to the knowledge of the Company, is subject to a governmental inquiry, investigation, proceeding, or other similar action that could reasonably be expected to result in debarment, suspension, or exclusion. Since January&nbsp;1, 2019, the Company
and its subsidiaries have filed, obtained, maintained or submitted all material reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments as required by the Health Care Laws, and all such reports,
documents, forms, notices, applications, records, claims, submissions and supplements or amendments were timely, complete, accurate and not misleading on the date filed in all material respects (or were corrected or supplemented by a subsequent
submission). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(uu) The Company and each of its subsidiaries are, and at all prior times since January&nbsp;1, 2019 were, in
material compliance with all applicable data privacy and security laws and regulations regarding the collection, use, transfer, storage, protection, disposal or disclosure of Personal Data (as defined below) collected from or provided by third
parties, including, without limitation, the European Union General Data Protection Regulation (&#147;<B>GDPR</B>&#148;) (EU 2016/679) (collectively, the &#147;<B>Privacy Laws</B>&#148;). &#147;<B>Personal Data</B>&#148; means (i)&nbsp;any
information that identifies, relates to, describes, is reasonably capable of being associated with, or could reasonably be linked with a particular individual, including the following information if it identifies, relates to, describes, is
reasonably capable of being associated with, or could be reasonably linked, directly or indirectly, with a particular individual: a natural person&#146;s name, street address, telephone number, <FONT STYLE="white-space:nowrap">e-mail</FONT> address,
photograph, social security number or tax identification number, driver&#146;s license number, passport number, credit card number, bank information, or customer or account number; (ii) &#147;personal data&#148; as defined by GDPR (to the extent the
GDPR applies), and (iii)&nbsp;other information that identifies such natural person, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
or his or her family, except any &#147;protected health information&#148; as defined by HIPAA. To the extent required by Privacy Laws, the Company and its subsidiaries have in place, materially
comply with, and take appropriate steps to ensure compliance with their (i)&nbsp;policies and procedures relating to data privacy and security and the collection, storage, use, disclosure, handling, and analysis of Personal Data, and
(ii)&nbsp;security policies (collectively, the &#147;<B>Policies</B>&#148;). At all times since January&nbsp;1, 2018, the Company has provided notice of its Policies then in effect to its customers, employees, third party vendors and representatives
as required by the Privacy Laws. Each of the Company&#146;s Policies provides materially accurate and sufficient notice of the Company&#146;s then-current privacy practices relating to its subject matter and such Company Policies do not contain any
material omissions of the Company&#146;s then-current privacy practices to the extent such omission would violate Privacy Laws. None of such disclosures made or contained in any of the Policies have been materially inaccurate, misleading, deceptive.
The execution, delivery and performance of this Agreement or any other agreement referred to in this Agreement will not result in a breach of violation of any Privacy Laws or Policies. Neither the Company nor any of its subsidiaries: (i)&nbsp;has
received written notice of any actual or potential material liability under or relating to, or actual or alleged material violation of, any of the Privacy Laws; or (ii)&nbsp;is a party to any order, decree, or judgement that imposes any obligation
or liability under any Privacy Law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vv) The Company and its subsidiaries&#146; information technology assets and
equipment, computers, technology systems and other systems, networks, hardware, software, websites, applications, and databases (collectively, &#147;<B>IT Systems</B>&#148;) are materially adequate for, and operate and perform in all material
respects as required in connection with the operation of the business of the Company and its subsidiaries as currently conducted, free and clear of all material bugs, errors, defects, Trojan horses, time bombs, malware and other corruptants. The
Company and its subsidiaries have implemented and maintained controls, policies, procedures, and safeguards designed to maintain and protect its confidential information and the integrity, continuous operation, redundancy and security of all
material IT Systems (all Personal Data and data the Company is legally obligated to keep confidential, collectively, the &#147;<B>Confidential Data</B>&#148;). The Company and its subsidiaries have used commercially reasonable efforts to establish,
and have established, commercially reasonable disaster recovery and security plans, procedures and facilities for the business, including, without limitation, for the information technology systems and data held or used by or for the Company or any
of its subsidiaries. To the Company&#146;s knowledge, there have been no security breaches or attacks, violations, outages or unauthorized uses of or accesses to the Confidential Data, or any other compromises of Confidential Data. The Company and
its subsidiaries are presently in material compliance with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and contractual
obligations relating to the privacy and security of its IT Systems and the protection of Confidential Data from unauthorized use, access, misappropriation or modification. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. <I>Agreements to Sell and Purchase. </I>The Company hereby agrees to sell to the several
Underwriters, and each Underwriter, upon the basis of the representations and warranties herein contained, but subject to the terms and conditions hereinafter stated, agrees, severally and not jointly, to purchase from the Company the respective
numbers of Firm Shares set forth in Schedule&nbsp;I hereto opposite its name at $[&#149;] a share (the &#147;<B>Purchase Price</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the basis of the representations and warranties contained in this Agreement, and subject to its terms and conditions, the Company agrees to
sell to the Underwriters the Additional Shares, and the Underwriters shall have the right to purchase, severally and not jointly, up to [&#149;] Additional Shares at the Purchase Price, provided, however, that the amount paid by the Underwriters for
any Additional Shares shall be reduced by an amount per share equal to any dividends declared by the Company and payable on the Firm Shares but not payable on such Additional Shares. The Representatives may exercise this right on behalf of the
Underwriters in whole or from time to time in part by giving written notice not later than 30 days after the date of this Agreement. Any exercise notice shall specify the number of Additional Shares to be purchased by the Underwriters and the date
on which such shares are to be purchased. Each purchase date must be at least one business day after the written notice is given and may not be earlier than the closing date for the Firm Shares or later than ten business days after the date of such
notice. Additional Shares may be purchased as provided in Section&nbsp;4 hereof solely for the purpose of covering over-allotments made in connection with the offering of the Firm Shares. On each day, if any, that Additional Shares are to be
purchased (an &#147;<B>Option Closing Date</B>&#148;), each Underwriter agrees, severally and not jointly, to purchase the number of Additional Shares (subject to such adjustments to eliminate fractional shares as the Representatives may determine)
that bears the same proportion to the total number of Additional Shares to be purchased on such Option Closing Date as the number of Firm Shares set forth in Schedule&nbsp;I hereto opposite the name of such Underwriter bears to the total number of
Firm Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. <I>Terms of Public Offering</I>. The Company is advised by the Representatives that the Underwriters propose to make a
public offering of their respective portions of the Shares as soon after the Registration Statement and this Agreement have become effective as in the judgment of the Representatives is advisable. The Company is further advised by the
Representatives that the Shares are to be offered to the public initially at $[&#149;] a share (the &#147;<B>Public Offering Price</B>&#148;) and to certain dealers selected by the Representatives at a price that represents a concession not in
excess of $[&#149;] a share under the Public Offering Price, and that any Underwriter may allow, and such dealers may reallow, a concession, not in excess of $[_____] a share, to any Underwriter or to certain other dealers. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4. <I>Payment and Delivery. </I>Payment for the Firm Shares shall be made to the Company in
Federal or other funds immediately available in New York City against delivery of such Firm Shares for the respective accounts of the several Underwriters at 10:00 a.m., New York City time, on [&#149;], 2021, or at such other time on the same or
such other date, not later than [&#149;], 2021, as shall be designated in writing by the Representatives. The time and date of such payment are hereinafter referred to as the &#147;<B>Closing Date</B>.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Payment for any Additional Shares shall be made to the Company in Federal or other funds immediately available in New York City against
delivery of such Additional Shares for the respective accounts of the several Underwriters at 10:00 a.m., New York City time, on the date specified in the corresponding notice described in Section&nbsp;2 or at such other time on the same or on such
other date, in any event not later than [&#149;], 2021, as shall be designated in writing by the Representatives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Firm Shares and
Additional Shares shall be registered in such names and in such denominations as Morgan Stanley shall request not later than one full business day prior to the Closing Date or the applicable Option Closing Date, as the case may be. The Firm Shares
and Additional Shares shall be delivered to Morgan Stanley on the Closing Date or an Option Closing Date, as the case may be, for the respective accounts of the several Underwriters, with any transfer taxes payable in connection with the transfer of
the Shares to the Underwriters duly paid, against payment of the Purchase Price therefor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5. <I>Conditions to the
Underwriters</I><I>&#146;</I><I> Obligations</I>. The obligations of the Company to sell the Shares to the Underwriters and the several obligations of the Underwriters to purchase and pay for the Shares on the Closing Date are subject to the
condition that the Registration Statement shall have become effective not later than [5:00 p.m.] (New York City time) on the date hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The several obligations of the Underwriters are subject to the following further conditions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) Subsequent to the execution and delivery of this Agreement and prior to the Closing Date: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) no order suspending the effectiveness of the Registration Statement shall be in effect, and no proceeding for such purpose
or pursuant to Section&nbsp;8A under the Securities Act shall be pending before or threatened by the Commission; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)
there shall not have occurred any downgrading, nor shall any notice have been given of any intended or potential downgrading or of any review for a possible change that does not indicate the direction of the possible change, in the rating accorded
any of the securities of the Company or any of its subsidiaries by any &#147;nationally recognized statistical rating organization,&#148; as such term is defined in Section&nbsp;3(a)(62) of the Exchange Act; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) there shall not have occurred any change, or any development involving
a prospective change, in the condition, financial or otherwise, or in the earnings, business or operations of the Company and its subsidiaries, taken as a whole, from that set forth in the Time of Sale Prospectus and the Prospectus that, in the
judgment of the Representatives, is material and adverse and that makes it, in the judgment of the Representatives, impracticable to market the Shares on the terms and in the manner contemplated in the Time of Sale Prospectus and the Prospectus.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The Underwriters shall have received on the Closing Date a certificate, dated the Closing Date and signed by an
executive officer of the Company, to the effect set forth in Sections&nbsp;5(a)(i) and 5(a)(ii) above and to the effect that the representations and warranties of the Company contained in this Agreement are true and correct as of the Closing Date
and that the Company has complied with all of the agreements and satisfied all of the conditions on its part to be performed or satisfied hereunder on or before the Closing Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The officer signing and delivering such certificate may rely upon the best of his or her knowledge as to proceedings threatened. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) The Underwriters shall have received on the Closing Date an opinion and negative assurance letter of Latham&nbsp;&amp;
Watkins, LLP, outside counsel for the Company, in form and substance reasonably satisfactory to the Representatives. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)
The Underwriters shall have received on the Closing Date an opinion and negative assurance letter of Cooley LLP, counsel for the Underwriters, dated the Closing Date, in form and substance reasonably satisfactory to the Underwriters. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) The Underwriters shall have received on the Closing Date an opinion from each of Seed Intellectual Property Law Group LLP
and Morrison&nbsp;&amp; Foerster LLP, intellectual property counsel for the Company, dated the Closing Date, in form and substance reasonably satisfactory to the Underwriters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">With respect to the negative assurance letters to be delivered pursuant to Sections 5(c) and (d)&nbsp;above, Latham&nbsp;&amp; Watkins, LLP
and Cooley LLP may state that their opinions and beliefs are based upon their participation in the preparation of the Registration Statement, the Time of Sale Prospectus and the Prospectus and any amendments or supplements thereto and review and
discussion of the contents thereof, but are without independent check or verification, except as specified. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The opinion and negative assurance letter of Latham&nbsp;&amp; Watkins, LLP described in
Section 5(c)<SUP STYLE="font-size:85%; vertical-align:top"> </SUP>above shall be rendered to the Underwriters at the request of the Company and shall so state therein. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) The Underwriters shall have received, on each of the date hereof and the Closing Date, a letter dated the date hereof or
the Closing Date, as the case may be, in form and substance satisfactory to the Underwriters, from Ernst&nbsp;&amp; Young LLP, independent public accountants, containing statements and information of the type ordinarily included in accountants&#146;
&#147;comfort letters&#148; to underwriters with respect to the financial statements and certain financial information contained in the Registration Statement, the Time of Sale Prospectus and the Prospectus; <I>provided</I> that the letter delivered
on the Closing Date shall use a <FONT STYLE="white-space:nowrap">&#147;cut-off</FONT> date&#148; not earlier than the date hereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) The <FONT STYLE="white-space:nowrap">&#147;lock-up&#148;</FONT> agreements, each substantially in the form of Exhibit A
hereto, executed by substantially all securityholders, and all officers and directors of the Company relating to restrictions on sales and certain other dispositions of shares of Common Stock or certain other securities, delivered to the
Representatives on or before the date hereof (the &#147;<B><FONT STYLE="white-space:nowrap">Lock-up</FONT> Agreements</B>&#148;), shall be in full force and effect on the Closing Date. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) The Shares shall have been approved for listing on the Nasdaq Global Market. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) The chief financial officer of the Company shall have delivered to the Underwriters, on each of the date hereof and on the
Closing Date, a certificate in a form reasonably acceptable to the Representatives. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) The several obligations of the
Underwriters to purchase Additional Shares hereunder are subject to the delivery to the Representatives on the applicable Option Closing Date of the following: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) a certificate, dated the Option Closing Date and signed by an executive officer of the Company, confirming that the
certificate delivered on the Closing Date pursuant to Section&nbsp;5(b) hereof remains true and correct as of such Option Closing Date; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii) an opinion and negative assurance letter of Latham&nbsp;&amp; Watkins, LLP, outside counsel for the Company, dated the
Option Closing Date, relating to the Additional Shares to be purchased on such Option Closing Date and otherwise to the same effect as the opinion required by Section&nbsp;5(c) hereof; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii) an opinion and negative assurance letter of Cooley LLP, counsel for the Underwriters, dated the Option Closing Date,
relating to the Additional Shares to be purchased on such Option Closing Date and otherwise to the same effect as the opinion required by Section&nbsp;5(d) hereof; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv) an opinion and negative assurance letter from each of Seed Intellectual
Property Law Group LLP and Morrison&nbsp;&amp; Foerster LLP, intellectual property counsel for the Company, dated the Option Closing Date, relating to the Additional Shares to be purchased on such Option Closing Date and otherwise to the same effect
as the opinion required by Section&nbsp;5(e) hereof; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v) a letter dated the Option Closing Date, in form and substance
satisfactory to the Underwriters, from Ernst&nbsp;&amp; Young LLP, independent public accountants, substantially in the same form and substance as the letter furnished to the Underwriters pursuant to Section&nbsp;5(f) hereof; <I>provided</I> that
the letter delivered on the Option Closing Date shall use a <FONT STYLE="white-space:nowrap">&#147;cut-off</FONT> date&#148; not earlier than two business days prior to such Option Closing Date; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi) a certificate, dated the Option Closing Date and signed by the chief financial officer of the Company substantially in the
same form and substance as the letter furnished to the Underwriters pursuant to Section&nbsp;5(i) hereof; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vii) such
other documents as the Representatives may reasonably request with respect to the good standing of the Company, the due authorization and issuance of the Additional Shares to be sold on such Option Closing Date and other matters related to the
issuance of such Additional Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6. <I>Covenants of the Company</I>. The Company covenants with each Underwriter as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) To furnish to the Representatives, upon written request, without charge, two signed copies of the Registration Statement
(including exhibits thereto) and for delivery to each other Underwriter a conformed copy of the Registration Statement (without exhibits thereto) and to furnish to the Representatives in New York City, without charge, prior to 10:00&nbsp;a.m. New
York City time on the business day next succeeding the date of this Agreement and during the period mentioned in Section&nbsp;6(e) or 6(f) below, as many copies of the Time of Sale Prospectus, the Prospectus and any supplements and amendments
thereto or to the Registration Statement as the Representatives may reasonably request. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Before amending or
supplementing the Registration Statement, the Time of Sale Prospectus or the Prospectus, to furnish to the Representatives a copy of each such proposed amendment or supplement and not to file any such proposed amendment or supplement to which the
Representatives reasonably object in writing, and to file with the Commission within the applicable period specified in Rule&nbsp;424(b) under the Securities Act any prospectus required to be filed pursuant to such Rule. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) To furnish to the Representatives a copy of each proposed free writing
prospectus to be prepared by or on behalf of, used by, or referred to by the Company and not to use or refer to any proposed free writing prospectus to which the Representatives reasonably object. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Not to take any action that would result in an Underwriter or the Company being required to file with the Commission
pursuant to Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of the Underwriter that the Underwriter otherwise would not have been required to file thereunder. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) If the Time of Sale Prospectus is being used to solicit offers to buy the Shares at a time when the Prospectus is not yet
available to prospective purchasers and any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Time of Sale Prospectus in order to make the statements therein, in the light of the circumstances under
which they were made, not misleading, or if any event shall occur or condition exist as a result of which the Time of Sale Prospectus conflicts with the information contained in the Registration Statement then on file, or if, in the reasonable
opinion of counsel for the Underwriters, it is necessary to amend or supplement the Time of Sale Prospectus to comply with applicable law, forthwith to prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to any
dealer upon request, either amendments or supplements to the Time of Sale Prospectus so that the statements in the Time of Sale Prospectus as so amended or supplemented will not, in the light of the circumstances when the Time of Sale Prospectus is
delivered to a prospective purchaser, be misleading or so that the Time of Sale Prospectus, as amended or supplemented, will no longer conflict with the Registration Statement, or so that the Time of Sale Prospectus, as amended or supplemented, will
comply with applicable law. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) If, during such period after the first date of the public offering of the Shares as in the
opinion of counsel for the Underwriters the Prospectus (or in lieu thereof the notice referred to in Rule 173(a) of the Securities Act) is required by law to be delivered in connection with sales by an Underwriter or dealer (the &#147;Prospectus
Delivery Period&#148;), any event shall occur or condition exist as a result of which it is necessary to amend or supplement the Prospectus in order to make the statements therein, in the light of the circumstances when the Prospectus (or in lieu
thereof the notice referred to in Rule 173(a) of the Securities Act) is delivered to a purchaser, not misleading, or if, in the opinion of counsel for the Underwriters, it is necessary to amend or supplement the Prospectus to comply with applicable
law, forthwith to prepare, file with the Commission and furnish, at its own expense, to the Underwriters and to the dealers (whose names and addresses the Representatives will furnish to the Company) to which Shares may have been sold by the
Representatives on behalf of the Underwriters and to any other dealers upon </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
request, either amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will not, in the light of the circumstances when the Prospectus
(or in lieu thereof the notice referred to in Rule 173(a) of the Securities Act) is delivered to a purchaser, be misleading or so that the Prospectus, as amended or supplemented, will comply with applicable law. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) To endeavor to qualify the Shares for offer and sale under the securities or Blue Sky laws of such jurisdictions as the
Representatives shall reasonably request, <I>provided</I> that the Company shall not be required to (i)&nbsp;qualify as a foreign corporation or other entity as a deal in securities in any such jurisdiction where it would not otherwise be required
to so qualify, (ii)&nbsp;file any general consent to service of process in any such jurisdiction or (iii)&nbsp;subject itself to taxation in any such jurisdiction if it is not otherwise so subject. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) To make generally available (which may be satisfied by filing with the Commission on its Electronic Data Gathering,
Analysis and Retrieval System) to the Company&#146;s security holders and to the Representatives as soon as practicable an earnings statement covering a period of at least twelve months beginning with the first fiscal quarter of the Company
occurring after the date of this Agreement which shall satisfy the provisions of Section&nbsp;11(a) of the Securities Act and the rules and regulations of the Commission thereunder. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) To comply with all applicable securities and other laws, rules and regulations in each jurisdiction in which the Directed
Shares are offered in connection with the Directed Share Program. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) Whether or not the transactions contemplated in this
Agreement are consummated or this Agreement is terminated, to pay or cause to be paid all expenses incident to the performance of its obligations under this Agreement, including: (i)&nbsp;the fees, disbursements and expenses of the Company&#146;s
counsel and the Company&#146;s accountants in connection with the registration and delivery of the Shares under the Securities Act and all other fees or expenses in connection with the preparation and filing of the Registration Statement, any
preliminary prospectus, the Time of Sale Prospectus, the Prospectus, any free writing prospectus prepared by or on behalf of, used by, or referred to by the Company and amendments and supplements to any of the foregoing, including all printing costs
associated therewith, and the mailing and delivering of copies thereof to the Underwriters and dealers, in the quantities hereinabove specified, (ii)&nbsp;all costs and expenses related to the transfer and delivery of the Shares to the Underwriters,
including any transfer or other taxes payable thereon, (iii)&nbsp;the cost of printing or producing any Blue Sky or Legal Investment memorandum in connection with the offer and sale of the Shares under state securities laws and all expenses in
connection with the qualification of the Shares for offer and sale under state securities laws as provided in Section&nbsp;6(g) hereof, including filing fees and the reasonable fees and disbursements of counsel for the Underwriters in connection
with such qualification and in connection with the Blue Sky or Legal Investment memorandum, (iv)&nbsp;all filing fees and the reasonable fees and disbursements of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
counsel to the Underwriters incurred in connection with the review and qualification of the offering of the Shares by FINRA (provided that the fees and expenses of counsel with respect to clauses
(iii)&nbsp;and (iv) above shall not exceed $40,000 in the aggregate) , (v) all fees and expenses in connection with the preparation and filing of the registration statement on <FONT STYLE="white-space:nowrap">Form&nbsp;8-A</FONT> relating to the
Common Stock and all costs and expenses incident to listing the Shares on the Nasdaq Global Market, (vi)&nbsp;the cost of printing certificates representing the Shares, (vii)&nbsp;the costs and charges of any transfer agent, registrar or depositary,
(viii)&nbsp;the costs and expenses of the Company relating to investor presentations on any &#147;road show&#148; undertaken in connection with the marketing of the offering of the Shares, including, without limitation, expenses associated with the
preparation or dissemination of any electronic road show, expenses associated with the production of road show slides and graphics, fees and expenses of any consultants engaged in connection with the road show presentations with the prior approval
of the Company, travel and lodging expenses of the officers of the Company and any such consultants, and 50% of the cost of any aircraft chartered in connection with the road show with the remaining 50% of the cost of such aircraft to be paid by the
Underwriters, (ix)&nbsp;the document production charges and expenses associated with printing this Agreement, (x)&nbsp;all fees and disbursements of counsel incurred by the Underwriters in connection with the Directed Share Program and stamp duties,
similar taxes or duties or other taxes, if any, incurred by the Underwriters in connection with the Directed Share Program and (xi)&nbsp;all other costs and expenses incident to the performance of the obligations of the Company hereunder for which
provision is not otherwise made in this Section. It is understood, however, that except as provided in this Section, Section&nbsp;8 entitled &#147;Indemnity and Contribution&#148;, Section&nbsp;9 entitled &#147;Directed Share Program
Indemnification&#148; and the last paragraph of Section&nbsp;11 below, the Underwriters will pay all of their costs and expenses, including fees and disbursements of their counsel, stock transfer taxes payable on resale of any of the Shares by them
and any advertising expenses connected with any offers they may make and all travel and other expenses of the Underwriters or any of their employees incurred by them in connection with participation in investor presentations on any &#147;road
show&#148; undertaken in connection with the marketing of the offering of the Shares; <I>provided</I> that this clause (x)&nbsp;does not include the cost of any chartered aircraft, which shall be paid 50% by the Company as described in clause
(viii). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) The Company will promptly notify the Representatives if the Company ceases to be an Emerging Growth Company at
any time prior to the later of (a)&nbsp;completion of the distribution of the Shares within the meaning of the Securities Act and (b)&nbsp;completion of the Restricted Period (as defined in this Section&nbsp;6). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) If at any time during the Prospectus Delivery Period and following the distribution of any Written <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication there occurred or occurs an event or development as a result of which such
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication included or would include an untrue statement of a material fact or omitted or would omit to state a material fact necessary in order to
make the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
statements therein, in the light of the circumstances existing at that subsequent time, not misleading, the Company will promptly notify the Representatives and will promptly amend or supplement,
at its own expense, such Written <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication to eliminate or correct such untrue statement or omission. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) The Company will deliver to each Underwriter (or its agent), on the date of execution of this Agreement, a properly
completed and executed Certification Regarding Beneficial Owners of Legal Entity Customers, together with copies of identifying documentation, and the Company undertakes to provide such additional supporting documentation as each Underwriter may
reasonably request in connection with the verification of the foregoing Certification. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company also covenants with each Underwriter
that, without the prior written consent of Morgan Stanley&nbsp;&amp; Co. LLC, Goldman Sachs&nbsp;&amp; Co. LLC, J.P. Morgan Securities LLC and BofA Securities, Inc., it will not, and will not publicly disclose an intention to, during the period
ending 180 days after the date of the Prospectus (the &#147;<B>Restricted Period</B>&#148;) (1)&nbsp;offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or
warrant to purchase, lend, or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock or (2)&nbsp;enter into any swap or other
arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of the Common Stock, whether any such transaction described in clause&nbsp;(1) or (2)&nbsp;above is to be settled by delivery of Common Stock
or such other securities, in cash or otherwise or (3)&nbsp;confidentially submit any draft registration statement or file any registration statement with the Commission relating to the offering of any shares of Common Stock or any securities
convertible into or exercisable or exchangeable for Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The restrictions contained in the preceding paragraph shall not apply
to (a)&nbsp;the Shares to be sold hereunder, (b)&nbsp;the issuance by the Company of shares of Common Stock upon the exercise of an option or warrant or the conversion of a security outstanding on the date hereof, (c)&nbsp;grants of options,
restricted stock or other equity awards and the issuance of Common Stock or securities convertible into or exercisable for Common Stock (whether upon the exercise of stock options or otherwise) to employees, officers, directors, advisors or
consultants of the Company pursuant to the terms of a plan in effect on the date hereof and as described in the Time of Sale Prospectus, provided that the Company shall cause each recipient of such grant to execute and deliver to the Representatives
an agreement substantially in the form of Exhibit A hereto if such recipient has not already delivered one, (d)&nbsp;the filing of a registration of Form <FONT STYLE="white-space:nowrap">S-8</FONT> to register Common Stock issuable pursuant to any
employee benefit plans, qualified stock option plans or other employee compensation plans, described in the Time of Sale Prospectus, (e)&nbsp;Common Stock or any securities convertible into, or exercisable or exchangeable for, Common Stock, or the
entrance into an agreement to issue Common Stock or any securities convertible into, or exercisable or exchangeable for, Common Stock, in connection with any merger, joint venture, strategic alliances, commercial or other collaborative transaction
or the acquisition or licenses of the business, property, technology or other assets of another individual or entity or the assumption of an employee benefit plan in connection with a merger or acquisition; <I>provided</I> that the aggregate number
of Common Stock or any other securities convertible </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
into, or exercisable or exchangeable for, Common Stock that the Company may issue or agree to issue pursuant to this clause (e)&nbsp;shall not exceed 10% of the total outstanding share capital of
the Company immediately following the issuance of the Shares; and provided further, that the recipients of any such shares of Common Stock and securities issued pursuant to this clause (e)&nbsp;during the
<FONT STYLE="white-space:nowrap">180-day</FONT> restricted period described above shall enter into an agreement substantially in the form of Exhibit A hereto on or prior to such issuance or (f)&nbsp;facilitating the establishment of a trading plan
on behalf of a shareholder, officer or director of the Company pursuant to Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> under the Exchange Act for the transfer of shares of Common Stock, <I>provided</I> that (i)&nbsp;such plan does not
provide for the transfer of Common Stock during the Restricted Period and (ii)&nbsp;to the extent a public announcement or filing under the Exchange Act, if any, is required of or voluntarily made by the Company regarding the establishment of such
plan, such announcement or filing shall include a statement to the effect that no transfer of Common Stock may be made under such plan during the Restricted Period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the Representatives, in their sole discretion, agree to release or waive the restrictions on the transfer of Shares set forth in a <FONT
STYLE="white-space:nowrap">Lock-up</FONT> Agreement for an officer or director of the Company and provide the Company with notice of the impending release or waiver at least three business days before the effective date of the release or waiver, the
Company agrees to announce the impending release or waiver by a press release substantially in the form of Exhibit B hereto through a major news service at least two business days before the effective date of the release or waiver. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7. <I>Covenants of the Underwriters</I>. Each Underwriter severally and not jointly, covenants with the Company not to take any action that
would result in the Company being required to file with the Commission under Rule 433(d) a free writing prospectus prepared by or on behalf of such Underwriter that otherwise would not be required to be filed by the Company thereunder, but for the
action of the Underwriter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8. <I>Indemnity and Contribution.</I> (a)&nbsp;The Company agrees to indemnify and hold harmless each
Underwriter, each person, if any, who controls any Underwriter within the meaning of either Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act and each affiliate of any Underwriter within the meaning of Rule&nbsp;405 under
the Securities Act from and against any and all losses, claims, damages and liabilities (including, without limitation, any legal or other expenses reasonably incurred in connection with defending or investigating any such action or claim) that
arise out of, or are based upon, any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement or any amendment thereof, any preliminary prospectus, the Time of Sale Prospectus or any amendment or
supplement thereto, any issuer free writing prospectus as defined in Rule 433(h) under the Securities Act, any Company information that the Company has filed, or is required to file, pursuant to Rule 433(d) under the Securities Act, any road show as
defined in Rule 433(h) under the Securities Act (a &#147;road show&#148;), or the Prospectus or any amendment or supplement thereto, or any Written <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT>
Communication, or arise out of, or are based upon, any omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, except insofar as such losses, claims,
damages or liabilities arise out of, or are based upon, any such untrue statement or omission or alleged untrue statement </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or omission made in reliance upon and in conformity with any information relating to any Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly
for use therein, it being understood and agreed that the only such information furnished by the Underwriters through the Representatives consists of the information described as such in paragraph (b)&nbsp;below.<SUP
STYLE="font-size:85%; vertical-align:top"> </SUP>The Company agrees and confirms that references to &#147;affiliates&#148; of Morgan Stanley that appear in this Agreement shall be understood to include Mitsubishi UFJ Morgan Stanley Securities Co.,
Ltd. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) Each Underwriter agrees, severally and not jointly, to indemnify and hold harmless the Company, its directors,
its officers who sign the Registration Statement and each person, if any, who controls the Company within the meaning of either Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act to the same extent as the foregoing
indemnity from the Company to such Underwriter, but only with reference to information relating to such Underwriter furnished to the Company in writing by such Underwriter through the Representatives expressly for use in the Registration Statement,
any preliminary prospectus, the Time of Sale Prospectus, any issuer free writing prospectus, road show or the Prospectus or any amendment or supplement thereto; provided that the only such information furnished by any Underwriter through the
Representatives consists of the following information in the Prospectus: [the concession figure in the [&#149;] paragraph and the information set forth in the [&#149;] and [&#149;] paragraphs, in each case under the caption &#147;Underwriting.&#148;
(the &#147;<B>Underwriting Information</B>&#148;)]. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) In case any proceeding (including any governmental investigation)
shall be instituted involving any person in respect of which indemnity may be sought pursuant to Section&nbsp;8(a) or 8(b), such person (the &#147;<B>indemnified party</B>&#148;) shall promptly notify the person against whom such indemnity may be
sought (the &#147;<B>indemnifying party</B>&#148;) in writing and the indemnifying party, upon request of the indemnified party, shall retain counsel reasonably satisfactory to the indemnified party to represent the indemnified party and any others
the indemnifying party may designate in such proceeding and shall pay the reasonably incurred fees and disbursements of such counsel related to such proceeding. In any such proceeding, any indemnified party shall have the right to retain its own
counsel, but the fees and expenses of such counsel shall be at the expense of such indemnified party unless (i)&nbsp;the indemnifying party and the indemnified party shall have mutually agreed to the retention of such counsel or (ii)&nbsp;the named
parties to any such proceeding (including any impleaded parties) include both the indemnifying party and the indemnified party and representation of both parties by the same counsel would be inappropriate due to actual or potential differing
interests between them. It is understood that the indemnifying party shall not, in respect of the legal expenses of any indemnified party in connection with any proceeding or related proceedings in the same jurisdiction, be liable for the fees and
expenses of more than one separate firm (in addition to any local counsel) for all such indemnified parties and that all such fees and expenses shall be reimbursed as they are incurred. Such firm shall be designated in writing by the
Representatives, in the case of parties indemnified pursuant to Section&nbsp;8(a), and by the Company, in the case of parties indemnified pursuant to Section&nbsp;8(b). The indemnifying party shall not be liable for any
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
settlement of any proceeding effected without its written consent, but if settled with such consent or if there be a final judgment for the plaintiff, the indemnifying party agrees to indemnify
the indemnified party from and against any loss or liability by reason of such settlement or judgment. Notwithstanding the foregoing sentence, if at any time an indemnified party shall have requested an indemnifying party to reimburse the
indemnified party for fees and expenses of counsel as contemplated by the second and third sentences of this paragraph, the indemnifying party agrees that it shall be liable for any settlement of any proceeding effected without its written consent
if (i)&nbsp;such settlement is entered into more than 60 days after receipt by such indemnifying party of the aforesaid request and (ii)&nbsp;such indemnifying party shall not have reimbursed the indemnified party in accordance with such request
prior to the date of such settlement. No indemnifying party shall, without the prior written consent of the indemnified party, effect any settlement of any pending or threatened proceeding in respect of which any indemnified party is or could have
been a party and indemnity could have been sought hereunder by such indemnified party, unless such settlement includes an unconditional release of such indemnified party from all liability on claims that are the subject matter of such proceeding and
(ii)&nbsp;does not include a statement as to or an admission of fault, culpability or a failure to act by or on behalf of any indemnified party. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) To the extent the indemnification provided for in Section&nbsp;8(a) or 8(b) is unavailable to an indemnified party or
insufficient in respect of any losses, claims, damages or liabilities referred to therein, then each indemnifying party under such paragraph, in lieu of indemnifying such indemnified party thereunder, shall contribute to the amount paid or payable
by such indemnified party as a result of such losses, claims, damages or liabilities (i)&nbsp;in such proportion as is appropriate to reflect the relative benefits received by the Company on the one hand and the Underwriters on the other hand from
the offering of the Shares or (ii)&nbsp;if the allocation provided by clause&nbsp;8(d)(i) above is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause&nbsp;8(d)(i)
above but also the relative fault of the Company on the one hand and of the Underwriters on the other hand in connection with the statements or omissions that resulted in such losses, claims, damages or liabilities, as well as any other relevant
equitable considerations. The relative benefits received by the Company on the one hand and the Underwriters on the other hand in connection with the offering of the Shares shall be deemed to be in the same respective proportions as the net proceeds
from the offering of the Shares (before deducting expenses) received by the Company and the total underwriting discounts and commissions received by the Underwriters, in each case as set forth in the table on the cover of the Prospectus, bear to the
aggregate Public Offering Price of the Shares. The relative fault of the Company on the one hand and the Underwriters on the other hand shall be determined by reference to, among other things, whether the untrue or alleged untrue statement of a
material fact or the omission or alleged omission to state a material fact relates to information supplied by the Company or by the Underwriters and the parties&#146; relative intent, knowledge, access to information and opportunity to correct or
prevent such statement or omission. The Underwriters&#146; respective obligations to contribute pursuant to this Section&nbsp;8 are several in proportion to the respective number of Shares they have purchased hereunder, and not joint. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) The Company and the Underwriters agree that it would not be just or
equitable if contribution pursuant to this Section&nbsp;8 were determined by <I>pro rata</I> allocation (even if the Underwriters were treated as one entity for such purpose) or by any other method of allocation that does not take account of the
equitable considerations referred to in Section&nbsp;8(d). The amount paid or payable by an indemnified party as a result of the losses, claims, damages and liabilities referred to in Section&nbsp;8(d) shall be deemed to include, subject to the
limitations set forth above, any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim. Notwithstanding the provisions of this Section&nbsp;8, no Underwriter
shall be required to contribute any amount in excess of the amount by which the total price at which the Shares underwritten by it and distributed to the public were offered to the public exceeds the amount of any damages that such Underwriter has
otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within the meaning of Section&nbsp;11(f) of the Securities Act) shall be entitled
to contribution from any person who was not guilty of such fraudulent misrepresentation. The remedies provided for in this Section&nbsp;8 are not exclusive and shall not limit any rights or remedies which may otherwise be available to any
indemnified party at law or in equity. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) The indemnity and contribution provisions contained in this Section&nbsp;8 and
the representations, warranties and other statements of the Company contained in this Agreement shall remain operative and in full force and effect regardless of (i)&nbsp;any termination of this Agreement, (ii)&nbsp;any investigation made by or on
behalf of any Underwriter, any person controlling any Underwriter or any affiliate of any Underwriter or by or on behalf of the Company, its officers or directors or any person controlling the Company and (iii)&nbsp;acceptance of and payment for any
of the Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9. <I>Directed Share Program Indemnification.</I> (a)&nbsp;The Company agrees to indemnify and hold harmless Morgan
Stanley, each person, if any, who controls Morgan Stanley within the meaning of either Section&nbsp;15 of the Securities Act or Section&nbsp;20 of the Exchange Act and each affiliate of Morgan Stanley within the meaning of Rule&nbsp;405 of the
Securities Act (&#147;<B>Morgan Stanley Entities</B>&#148;) from and against any and all losses, claims, damages and liabilities (including, without limitation, any legal or other expenses reasonably incurred in connection with defending or
investigating any such action or claim)&nbsp;(i) that arise out of, or are based upon, any untrue statement or alleged untrue statement of a material fact contained in any material prepared by or with the consent of the Company for distribution to
Participants in connection with the Directed Share Program or arise out of, or are based upon, any omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not
misleading; (ii)&nbsp;that arise out of, or are based upon, the failure of any Participant to pay for and accept delivery of Directed Shares that the Participant agreed to purchase; or (iii)&nbsp;related to, arising out of, or in connection with the
Directed Share Program, other than losses, claims, damages or liabilities (or expenses relating thereto) that are finally judicially determined to have resulted from the bad faith or gross negligence of Morgan Stanley Entities. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) In case any proceeding (including any governmental investigation) shall
be instituted involving any Morgan Stanley Entity in respect of which indemnity may be sought pursuant to Section&nbsp;9(a), the Morgan Stanley Entity seeking indemnity, shall promptly notify the Company in writing and the Company, upon request of
the Morgan Stanley Entity, shall retain counsel reasonably satisfactory to the Morgan Stanley Entity to represent the Morgan Stanley Entity and any others the Company may designate in such proceeding and shall pay the fees and disbursements of such
counsel related to such proceeding. In any such proceeding, any Morgan Stanley Entity shall have the right to retain its own counsel, but the fees and expenses of such counsel shall be at the expense of such Morgan Stanley Entity unless (i)&nbsp;the
Company shall have agreed to the retention of such counsel or (ii)&nbsp;the named parties to any such proceeding (including any impleaded parties) include both the Company and the Morgan Stanley Entity and representation of both parties by the same
counsel would be inappropriate due to actual or potential differing interests between them. The Company shall not, in respect of the legal expenses of the Morgan Stanley Entities in connection with any proceeding or related proceedings in the same
jurisdiction, be liable for the fees and expenses of more than one separate firm (in addition to any local counsel) for all Morgan Stanley Entities. Any such separate firm for the Morgan Stanley Entities shall be designated in writing by Morgan
Stanley. The Company shall not be liable for any settlement of any proceeding effected without its written consent, but if settled with such consent or if there be a final judgment for the plaintiff, the Company agrees to indemnify the Morgan
Stanley Entities from and against any loss or liability by reason of such settlement or judgment. Notwithstanding the foregoing sentence, if at any time a Morgan Stanley Entity shall have requested the Company to reimburse it for fees and expenses
of counsel as contemplated by the second and third sentences of this paragraph, the Company agrees that it shall be liable for any settlement of any proceeding effected without its written consent if (i)&nbsp;such settlement is entered into more
than 60 days after receipt by the Company of the aforesaid request and (ii)&nbsp;the Company shall not have reimbursed the Morgan Stanley Entity in accordance with such request prior to the date of such settlement. The Company shall not, without the
prior written consent of Morgan Stanley, effect any settlement of any pending or threatened proceeding in respect of which any Morgan Stanley Entity is or could have been a party and indemnity could have been sought hereunder by such Morgan Stanley
Entity, unless such settlement includes an unconditional release of the Morgan Stanley Entities from all liability on claims that are the subject matter of such proceeding. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) To the extent the indemnification provided for in Section&nbsp;9(a) is unavailable to a Morgan Stanley Entity or
insufficient in respect of any losses, claims, damages or liabilities referred to therein, then the Company in lieu of indemnifying the Morgan Stanley Entity thereunder, shall contribute to the amount paid or payable by the Morgan Stanley Entity as
a result of such losses, claims, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
damages or liabilities (i)&nbsp;in such proportion as is appropriate to reflect the relative benefits received by the Company on the one hand and the Morgan Stanley Entities on the other hand
from the offering of the Directed Shares or (ii)&nbsp;if the allocation provided by clause&nbsp;9(c)(i) above is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in
clause&nbsp;9(c)(i) above but also the relative fault of the Company on the one hand and of the Morgan Stanley Entities on the other hand in connection with any statements or omissions that resulted in such losses, claims, damages or liabilities, as
well as any other relevant equitable considerations. The relative benefits received by the Company on the one hand and the Morgan Stanley Entities on the other hand in connection with the offering of the Directed Shares shall be deemed to be in the
same respective proportions as the net proceeds from the offering of the Directed Shares (before deducting expenses) and the total underwriting discounts and commissions received by the Morgan Stanley Entities for the Directed Shares, bear to the
aggregate Public Offering Price of the Directed Shares. If the loss, claim, damage or liability is caused by an untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact, the relative fault of
the Company on the one hand and the Morgan Stanley Entities on the other hand shall be determined by reference to, among other things, whether the untrue or alleged untrue statement or the omission or alleged omission relates to information supplied
by the Company or by the Morgan Stanley Entities and the parties&#146; relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) The Company and the Morgan Stanley Entities agree that it would not be just or equitable if contribution pursuant to this
Section&nbsp;9 were determined by pro rata allocation (even if the Morgan Stanley Entities were treated as one entity for such purpose) or by any other method of allocation that does not take account of the equitable considerations referred to in
Section&nbsp;9(c). The amount paid or payable by the Morgan Stanley Entities as a result of the losses, claims, damages and liabilities referred to in the immediately preceding paragraph shall be deemed to include, subject to the limitations set
forth above, any legal or other expenses reasonably incurred by the Morgan Stanley Entities in connection with investigating or defending any such action or claim. Notwithstanding the provisions of this Section&nbsp;9, no Morgan Stanley Entity shall
be required to contribute any amount in excess of the amount by which the total price at which the Directed Shares distributed to the public were offered to the public exceeds the amount of any damages that such Morgan Stanley Entity has otherwise
been required to pay. The remedies provided for in this Section&nbsp;9 are not exclusive and shall not limit any rights or remedies which may otherwise be available to any indemnified party at law or in equity. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) The indemnity and contribution provisions contained in this Section&nbsp;9 shall remain operative and in full force and
effect regardless of (i)&nbsp;any termination of this Agreement, (ii)&nbsp;any investigation made by or on behalf of any Morgan Stanley Entity or the Company, its officers or directors or any person controlling the Company and (iii)&nbsp;acceptance
of and payment for any of the Directed Shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10. <I>Termination</I>. The Underwriters may terminate this Agreement by notice given by the
Representatives to the Company, if after the execution and delivery of this Agreement and prior to or on the Closing Date or any Option Closing Date, as the case may be, (i)&nbsp;trading generally shall have been suspended or materially limited on,
or by, as the case may be, any of the New York Stock Exchange, the NYSE MKT, the Nasdaq Global Market, the Chicago Board of Options Exchange, the Chicago Mercantile Exchange or the Chicago Board of Trade or other relevant exchanges,
(ii)&nbsp;trading of any securities of the Company shall have been suspended on any exchange or in any <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market, (iii)&nbsp;a material disruption in
securities settlement, payment or clearance services in the United States or other relevant jurisdiction shall have occurred, (iv)&nbsp;any moratorium on commercial banking activities shall have been declared by Federal or New York State authorities
or (v)&nbsp;there shall have occurred any outbreak or escalation of hostilities, or any change in financial markets or any calamity or crisis that, in the judgment of the Representatives, is material and adverse and which, singly or together with
any other event specified in this clause&nbsp;(v), makes it, in the judgment of the Representatives, impracticable or inadvisable to proceed with the offer, sale or delivery of the Shares on the terms and in the manner contemplated in the Time of
Sale Prospectus or the Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11. <I>Effectiveness; Defaulting Underwriters</I>. This Agreement shall become effective upon the
execution and delivery hereof by the parties hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If, on the Closing Date or an Option Closing Date, as the case may be, any one or
more of the Underwriters shall fail or refuse to purchase Shares that it has or they have agreed to purchase hereunder on such date, and the aggregate number of Shares which such defaulting Underwriter or Underwriters agreed but failed or refused to
purchase is not more than <FONT STYLE="white-space:nowrap">one-tenth</FONT> of the aggregate number of the Shares to be purchased on such date, the other Underwriters shall be obligated severally in the proportions that the number of Firm Shares set
forth opposite their respective names in Schedule&nbsp;I bears to the aggregate number of Firm Shares set forth opposite the names of all such <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters, or in such other proportions as the
Representatives may specify, to purchase the Shares which such defaulting Underwriter or Underwriters agreed but failed or refused to purchase on such date; <I>provided</I> that in no event shall the number of Shares that any Underwriter has agreed
to purchase pursuant to this Agreement be increased pursuant to this Section&nbsp;11 by an amount in excess of <FONT STYLE="white-space:nowrap">one-ninth</FONT> of such number of Shares without the written consent of such Underwriter. If, on the
Closing Date, any Underwriter or Underwriters shall fail or refuse to purchase Firm Shares and the aggregate number of Firm Shares with respect to which such default occurs is more than <FONT STYLE="white-space:nowrap">one-tenth</FONT> of the
aggregate number of Firm Shares to be purchased on such date, and arrangements satisfactory to the Representatives and the Company for the purchase of such Firm Shares are not made within 36 hours after such default, this Agreement shall terminate
without liability on the part of any <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriter or the Company. In any such case either the Representatives or the Company shall have the right to postpone the Closing Date, but in no event for
longer than seven days, in order that the required changes, if any, in the Registration Statement, in the Time of Sale Prospectus, in the Prospectus or in any other </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
documents or arrangements may be effected. If, on an Option Closing Date, any Underwriter or Underwriters shall fail or refuse to purchase Additional Shares and the aggregate number of Additional
Shares with respect to which such default occurs is more than <FONT STYLE="white-space:nowrap">one-tenth</FONT> of the aggregate number of Additional Shares to be purchased on such Option Closing Date, the
<FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters shall have the option to (i)&nbsp;terminate their obligation hereunder to purchase the Additional Shares to be sold on such Option Closing Date or (ii)&nbsp;purchase not less than
the number of Additional Shares that such <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters would have been obligated to purchase in the absence of such default. Any action taken under this paragraph shall not relieve any
defaulting Underwriter from liability in respect of any default of such Underwriter under this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If this Agreement shall be
terminated by the Underwriters, or any of them, because of any failure or refusal on the part of the Company to comply with the terms or to fulfill any of the conditions of this Agreement, or if for any reason the Company shall be unable to perform
its obligations under this Agreement other than by reason of a default by the Underwriters or following termination of this Agreement pursuant to clauses (i), (iii), (iv) or (v)&nbsp;of Section&nbsp;10, the Company will reimburse the Underwriters or
such Underwriters as have so terminated this Agreement with respect to themselves, severally, for all <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses (including the reasonably incurred fees and
disbursements of their counsel) reasonably incurred by such Underwriters in connection with this Agreement or the offering contemplated hereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">12. <I>Entire Agreement</I>. (a)&nbsp;This Agreement, together with any contemporaneous written agreements and any prior written agreements
(to the extent not superseded by this Agreement) that relate to the offering of the Shares, represents the entire agreement between the Company and the Underwriters with respect to the preparation of any preliminary prospectus, the Time of Sale
Prospectus, the Prospectus, the conduct of the offering, and the purchase and sale of the Shares. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) The Company
acknowledges that in connection with the offering of the Shares: (i)&nbsp;the Underwriters have acted at arm&#146;s length, are not agents of, and owe no fiduciary duties to, the Company or any other person, (ii)&nbsp;the Underwriters owe the
Company only those duties and obligations set forth in this Agreement, any contemporaneous written agreements and prior written agreements (to the extent not superseded by this Agreement), if any, (iii)&nbsp;the Underwriters may have interests that
differ from those of the Company, and (iv)&nbsp;none of the activities of the Underwriters in connection with the transactions contemplated herein constitutes a recommendation, investment advice, or solicitation of any action by the Underwriters
with respect to any entity or natural person. The Company waives to the full extent permitted by applicable law any claims it may have against the Underwriters arising from an alleged breach of fiduciary duty in connection with the offering of the
Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">13. <I>Counterparts</I>. This Agreement may be signed in two or more counterparts, each of which shall be an original, with the
same effect as if the signatures thereto and hereto were upon the same instrument. Counterparts may be delivered via facsimile, electronic mail (including any electronic signature complying with the U.S. federal ESIGN Act of 2000, Uniform Electronic
Transactions Act or other applicable law, e.g., www. Docusign.com) or other transmission method any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">14. <I>Recognition of the U.S. Special Resolution Regimes</I>. (a)&nbsp;In the event that
any Underwriter that is a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to
the same extent as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) In the event that any Underwriter that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a
proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S.
Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of this Section
a &#147;<B>BHC Act Affiliate</B>&#148; has the meaning assigned to the term &#147;affiliate&#148; in, and shall be interpreted in accordance with, 12 U.S.C. &#167; 1841(k). &#147;<B>Covered Entity</B>&#148; means any of the following: (i)&nbsp;a
&#147;covered entity&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 252.82(b); (ii) a &#147;covered bank&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 47.3(b); or
(iii)&nbsp;a &#147;covered FSI&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 382.2(b). &#147;<B>Default Right</B>&#148; has the meaning assigned to that term in, and shall be interpreted in accordance with,
12 C.F.R. &#167;&#167; 252.81, 47.2 or 382.1, as applicable. &#147;<B>U.S. Special Resolution Regime</B>&#148; means each of (i)&nbsp;the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii)&nbsp;Title II of the
Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">15. <I>Applicable Law</I>. This
Agreement, any claim, controversy or disputes arising under or related to this Agreement and any transaction contemplated by this Agreement shall be governed by and construed in accordance with the internal laws of the State of New York. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">16. <I>Headings</I>. The headings of the sections of this Agreement have been inserted for convenience of reference only and shall not be
deemed a part of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">17. <I>Notices</I>. All communications hereunder shall be in writing and effective only upon receipt and
if to the Underwriters shall be delivered, mailed or sent to the Representatives in care of Morgan Stanley&nbsp;&amp;&nbsp;Co. LLC, 1585&nbsp;Broadway, New York, New York&nbsp;10036, Attention: Equity Syndicate Desk, with a copy to the Legal
Department; Goldman Sachs&nbsp;&amp; Co. LLC, 200 West Street, New York, New York 10282-2198, Attention: Registration Department; J.P. Morgan Securities LLC, 383 Madison Avenue, New York, New York 10179, Facsimile: (212) <FONT
STYLE="white-space:nowrap">622-8358,</FONT> Attention: Equity Syndicate </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Desk and BofA Securities, Inc., One Bryant Park, New York, New York 10036, Facsimile: (646) <FONT STYLE="white-space:nowrap">855-3073,</FONT> Attention: Syndicate Department, with a copy to
Facsimile: (212) <FONT STYLE="white-space:nowrap">230-8730,</FONT> Attention: ECM Legal, and if to the Company shall be delivered, mailed or sent to Sana Biotechnology, Inc., 188 East Blaine Street, Suite 400, Seattle, Washington 98102, Attention:
General Counsel. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature page follows] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>SANA BIOTECHNOLOGY, INC.</B></TD></TR></TABLE></DIV> <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Accepted as of the date hereof </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Morgan Stanley&nbsp;&amp; Co. LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Goldman Sachs&nbsp;&amp; Co.
LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BofA Securities, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Acting severally on behalf of themselves and </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">the several
Underwriters named in </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Schedule I hereto. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Morgan Stanley&nbsp;&amp; Co. LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Goldman Sachs&nbsp;&amp; Co. LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">J.P. Morgan Securities LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">BofA Securities, Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>SCHEDULE I </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="12%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Underwriter</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Number&nbsp;of&nbsp;Firm&nbsp;Shares&nbsp;To<BR>Be Purchased</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Morgan Stanley&nbsp;&amp; Co. LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goldman Sachs&nbsp;&amp; Co. LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BofA Securities, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">I-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>SCHEDULE II </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Time of Sale Prospectus </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Preliminary Prospectus issued [&#149;], 2021 </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">[identify all free writing prospectuses filed by the Company under Rule 433(d) of the Securities Act]
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">[free writing prospectus containing a description of terms that does not reflect final terms, if the Time of
Sale Prospectus does not include a final term sheet] </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">[orally communicated pricing information such as price per share and size of offering if a Rule 134 pricing
term sheet is used at the time of sale instead of a pricing term sheet filed by the Company under Rule 433(d) as a free writing prospectus] </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>SCHEDULE III </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communications </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sana Biotechnology, Inc. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Presentation </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">III-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXHIBIT A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FORM OF <FONT STYLE="white-space:nowrap">LOCK-UP</FONT> AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">_____________, 2020 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Morgan Stanley&nbsp;&amp;
Co. LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Goldman Sachs&nbsp;&amp; Co. LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J.P. Morgan
Securities LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BofA Securities, Inc. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">c/o</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Morgan Stanley&nbsp;&amp; Co. LLC </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">1585 Broadway </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">New York, NY 10036 </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">c/o</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Goldman Sachs&nbsp;&amp; Co. LLC </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">200 West Street </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">New York, NY 10282 </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">c/o</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">J.P. Morgan Securities LLC </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">383 Madison Avenue </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">New York, NY 10179 </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">c/o</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">BofA Securities, Inc. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">One Bryant Park </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">New York, NY 10036 </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned
understands that Morgan Stanley&nbsp;&amp; Co. LLC (&#147;<B>Morgan Stanley</B>&#148;), Goldman Sachs&nbsp;&amp; Co. LLC (&#147;<B>Goldman</B>&#148;), J.P. Morgan Securities LLC (&#147;<B>J.P. Morgan</B>&#148;) and BofA Securities, Inc.
(&#147;<B>BofA</B>&#148;) proposes to enter into an Underwriting Agreement (the &#147;<B>Underwriting Agreement</B>&#148;) with Sana Biotechnology, Inc., a Delaware corporation (the &#147;<B>Company</B>&#148;), providing for the public offering (the
&#147;<B>Public Offering</B>&#148;) by the several Underwriters, including Morgan Stanley, Goldman, J.P Morgan and BofA (the &#147;<B>Underwriters</B>&#148;), of shares (the &#147;<B>Shares</B>&#148;) of the common stock, par value $0.0001 per share
(the &#147;<B>Common Stock</B>&#148;), of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To induce the Underwriters that may participate in the Public Offering to continue
their efforts in connection with the Public Offering, the undersigned hereby agrees that, without the prior written consent of the Representatives on behalf of the Underwriters (the &#147;<B>Representatives</B>&#148;), it will not, and will not
publicly disclose an intention to, during the period commencing on the date hereof and ending 180 days after the date of the final prospectus (the &#147;<B>Restricted Period</B>&#148;) relating to the Public Offering (the
&#147;<B>Prospectus</B>&#148;), (1)&nbsp;offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock beneficially owned (as such term is used in Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> of the
Securities Exchange Act of 1934, as amended (the &#147;<B>Exchange Act</B>&#148;)), by the undersigned or any other securities so owned convertible into or exercisable or exchangeable for Common Stock or (2)&nbsp;enter into any swap or other
arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of the Common Stock, whether any such transaction described in clause&nbsp;(1) or (2)&nbsp;above is to be settled by delivery of Common Stock
or such other securities, in cash or otherwise. The foregoing sentence shall not apply to: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(a) transactions relating to shares of Common Stock or other
securities acquired in open market transactions after the completion of the Public Offering, <I>provided</I> that no filing under Section&nbsp;16(a) of the Exchange Act or other public announcement shall be required or shall be voluntarily made in
connection with subsequent sales of Common Stock or other securities acquired in such open market transactions; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(b) transfers of shares of Common Stock
or any security convertible into or exercisable or exchangeable for Common Stock as a bona fide gift or to a charitable organization or educational institution in a transfer not involving a disposition for value; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(c) distributions or transfers of shares of Common Stock or any security convertible into shares of Common Stock to partners, members, stockholders or
affiliates of the undersigned; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) facilitating the establishment of a trading plan on behalf of a shareholder, officer, or director of the Company
pursuant to Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> under the Exchange Act for the transfer of shares of Common Stock, <I>provided</I> that (i)&nbsp;such plan does not provide for the transfer of Common Stock during the Restricted Period
and (ii)&nbsp;no filing or notification by any party under the Exchange Act or other public announcement shall be required or shall be made voluntarily in connection with such transfer or distribution; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(e) transfers or dispositions of shares of Common Stock or any security convertible into or exercisable or exchangeable for Common Stock to any member of the
immediate family of the undersigned or any trust for the direct or indirect benefit of the undersigned or the immediate family of the undersigned in a transaction not involving a disposition for value; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(f) transfers or dispositions of shares of Common Stock or any security convertible into or exercisable or exchangeable for Common Stock (i)&nbsp;by will,
other testamentary document or intestate succession to the legal representative, heir, beneficiary or a member of the immediate family of the undersigned upon the death of the undersigned or, provided no filing or notification by any party under the
Exchange Act or other public announcement shall be required or shall be made voluntarily in connection with such transfer or distribution, and (ii)&nbsp;by operation of law pursuant to orders of a court, in connection with a negotiated divorce
settlement or pursuant to a qualified domestic relations order, <I>provided</I> no public filing, report or announcement shall be voluntarily </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
made and if any filing under Section&nbsp;16(a) of the Exchange Act reporting a reduction in beneficial ownership of Common Stock is required, it shall indicate in the footnotes thereto the
nature and conditions of such transfer; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(g) transfers or dispositions of shares of Common Stock to any corporation, partnership, limited liability
company or other entity all of the beneficial ownership interests of which are held by the undersigned or the immediate family of the undersigned; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(h)
transfers to the undersigned&#146;s affiliates or to any investment fund or other entity controlled or managed by, controlling or managing, or under common control with, the undersigned; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(i) transfers or dispositions of shares of Common Stock or any security convertible into or exercisable or exchangeable for Common Stock to the Company
pursuant to any contractual arrangement in effect on the date of this agreement and disclosed in the Prospectus that provides for the repurchase of the undersigned&#146;s Common Stock or other securities by the Company or in connection with the
termination of the undersigned&#146;s employment with or service to the Company; <I>provided</I> that (i)&nbsp;the repurchase price for any such shares or securities shall not exceed the original purchase price (subject to appropriate adjustment in
the event of any stock dividend, stock split, combination or other similar recapitalization) paid, and (ii)&nbsp;no public filing, report or announcement reporting a reduction in beneficial ownership of shares of Common Stock shall be required or
shall be voluntarily made during the Restricted Period within 75 days after the date the undersigned ceases to provide services to the Company, and after such 75th day, if the undersigned is required to file a report reporting a reduction in
beneficial ownership of shares of Common Stock during the Restricted Period, the undersigned shall clearly indicate in the footnotes thereto that the filing relates to the circumstances described in this clause and no public filing, report or
announcement shall be voluntarily made; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(j) transfers or dispositions of shares of Common Stock or other securities to the Company in connection with the
exercise of any option or warrant for, shares of Common Stock (by way of &#147;net&#148; or &#147;cashless&#148; exercise solely to cover withholding tax obligations in connection with such exercise or transfer to the Company for the payment of
taxes as a result of such exercise) or transfers or dispositions of shares of Common Stock or other securities to cover tax withholding obligations of the undersigned in connection with a vesting of the Company&#146;s securities, in each case as
disclosed in the Prospectus; <I>provided</I> that (i)&nbsp;any such shares of Common Stock received by the undersigned shall be subject to the terms of this agreement and (ii)&nbsp;no public filing, report or announcement reporting a reduction in
beneficial ownership of shares of Common Stock shall be required or shall be voluntarily made during the Restricted Period within 60 days after the date of the Prospectus, and after such 60th day, if the undersigned is required to file a report
reporting a reduction in beneficial ownership of shares of Common Stock during the Restricted Period, the undersigned shall clearly indicate in the footnotes thereto that the filing relates to the circumstances described in this clause and that the
shares of Common Stock received upon exercise of the stock option or warrant or vesting event are subject to this agreement, and no public filing, report or announcement shall be voluntarily made; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(k) the exercise on a cash basis of options to purchase shares of Common Stock granted under any stock
incentive plan or stock purchase plan of the Company disclosed in the Prospectus, <I>provided</I> that the underlying shares shall continue to be subject to the restrictions on transfer set forth in this agreement, and <I>provided further</I> that
any filing under Section&nbsp;16(a) of the Exchange Act with regard to this clause (k)&nbsp;shall clearly indicate in the footnotes thereto that the filing relates to the circumstances described in this clause (k)&nbsp;and no public filings, report
or announcement shall be voluntarily made; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(l) transfers of shares of Common Stock or any security convertible into or exercisable or exchangeable for
Common Stock pursuant to a bona fide third-party tender offer, merger, consolidation or other similar transaction made to all holders of the Common Stock and involving a change of control of the Company approved by the board of directors of the
Company, <I>provided</I> that in the event that the tender offer, merger, consolidation or other such transaction is not completed, the Common Stock owned by the undersigned shall remain subject to the restrictions contained in this agreement; or
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(m) the conversion of any outstanding shares of preferred stock into Common Stock in connection with the Public Offering, provided that any such
securities received upon such conversion shall be subject to the terms of this agreement and any required filing under Section&nbsp;16(a) of the Exchange Act shall indicate by footnote disclosure regarding the circumstances of the conversion and
that the shares of Common Stock received upon such conversion are subject to this agreement; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>provided</I> that in the case of any transfer or
distribution pursuant to clauses&nbsp;(b), (c), (e), (f), (g) or (h), (x) each transferee, donee or distributee shall sign and deliver a <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement substantially in the form of this agreement,
(y)&nbsp;no filing or notification by any party (donor, donee, devisee, transferor, transferee, distributer or distributee) under the Exchange Act or other public announcement shall be required or shall be made voluntarily in connection with such
transfer or distribution and (z)&nbsp;such transfer shall not involve a disposition for value. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this agreement,
&#147;immediate family&#148; shall mean any relationship by blood, marriage, domestic partnership or adoption, not more remote than first cousin. For purposes of this agreement, &#147;affiliate&#148; shall have the meaning set forth in Rule 405
under the Securities Act of 1933, as amended, including without limitation any general partner, limited partner, managing member, manager, member, employee, officer, director or trustee of such entity or natural person, or any trust for the benefit
of any of the foregoing or any affiliate of the foregoing, or any investment fund or other entity controlled or managed by the foregoing or affiliates of the foregoing and &#147;change of control&#148; shall mean the transfer (whether by tender
offer, merger, consolidation or other similar transaction), in one transactions or a series of related transactions, to a person or group of affiliated persons (other than an underwriter pursuant to the Public Offering), of the Company&#146;s voting
securities if, after such transfer, such person or group of affiliated persons would hold at least 50% of the outstanding voting securities of the Company (or the surviving entity), provided that, for the avoidance of doubt, the Public Offering
shall not constitute a change of control. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, the undersigned agrees that, without the prior written consent of the
Representatives on behalf of the Underwriters, it will not, and will not publicly disclose an intention to, during the Restricted Period, make any demand for or exercise any right with respect to, the registration of any shares of Common Stock or
any security convertible into or exercisable or exchangeable for Common Stock. The undersigned also agrees and consents to the entry of stop transfer instructions with the Company&#146;s transfer agent and registrar against the transfer of the
undersigned&#146;s shares of Common Stock except in compliance with the foregoing restrictions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the undersigned is an officer or
director of the Company, the undersigned further agrees that the foregoing restrictions shall be equally applicable to any issuer-directed Shares the undersigned may purchase in the Public Offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the undersigned is an officer or director of the Company, (i)&nbsp;the Representatives agree that, at least three business days before the
effective date of any release or waiver of the foregoing restrictions in connection with a transfer of shares of Common Stock, the Representatives will notify the Company of the impending release or waiver, and (ii)&nbsp;the Company will agree or
has agreed in the Underwriting Agreement to announce the impending release or waiver by press release through a major news service at least two business days before the effective date of the release or waiver. Any release or waiver granted by the
Representatives hereunder to any such officer or director shall only be effective two business days after the publication date of such press release. The provisions of this paragraph will not apply if (a)&nbsp;the release or waiver is effected
solely to permit a transfer not for consideration and (b)&nbsp;the transferee has agreed in writing to be bound by the same terms described in this agreement to the extent and for the duration that such terms remain in effect at the time of the
transfer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned understands that the Company and the Underwriters are relying upon this agreement in proceeding toward
consummation of the Public Offering. The undersigned further understands that this agreement is irrevocable and shall be binding upon the undersigned&#146;s heirs, legal representatives, successors and assigns. This agreement may be delivered via
facsimile, electronic mail (including pdf or any electronic signature complying with the U.S. federal ESIGN Act of 2000, <I>e.g.</I>, <U>www.docusign.com</U> or <U>www.echosign.com</U>) or other transmission method and any counterpart so delivered
shall be deemed to have been duly and validly delivered and be valid and effective for all purposes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned acknowledges and
agrees that the Underwriters have not provided any recommendation or investment advice nor have the Underwriters solicited any action from the undersigned with respect to the Public Offering of the Shares and the undersigned has consulted their own
legal, accounting, financial, regulatory and tax advisors to the extent deemed appropriate. The undersigned further acknowledges and agrees that, although the Underwriters may provide certain Regulation Best Interest and
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Form CRS disclosures or other related documentation to you in connection with the Public Offering, the Underwriters are not making a recommendation to&nbsp;you to participate in the Public
Offering or sell any Shares at the price determined in the Public Offering, and nothing set forth in such disclosures or documentation is intended to suggest that any Underwriter is making such a recommendation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Whether or not the Public Offering actually occurs depends on a number of factors, including market conditions. Any Public Offering will only
be made pursuant to an Underwriting Agreement, the terms of which are subject to negotiation between the Company and the Underwriters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This agreement shall be governed by and construed in accordance with the laws of the State of New York. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This agreement (and for the avoidance of doubt, the Restricted Period described herein) and related restrictions shall automatically terminate
upon the earliest to occur, if any, of (i)&nbsp;the Company advising the Representative in writing prior to the execution of the Underwriting Agreement that it has determined not to proceed with the Public Offering, (ii)&nbsp;the termination of the
Underwriting Agreement before the sale of any Shares to the Underwriters, (iii)&nbsp;the registration statement filed with the SEC with respect to the Public Offering contemplated by the Underwriting Agreement is withdrawn or
(iv)&nbsp;April&nbsp;30, 2021, in the event the closing of the Public Offering shall not have occurred on or before such date (provided, however, that the undersigned agrees that this agreement shall be automatically extended by three months if the
Company provides written notice to the undersigned that the Company is still pursuing the Public Offering contemplated by the Underwriting Agreement). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature page follows] </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD COLSPAN="3" VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER-TOP:1px solid #000000">Name of Securityholder <I>(Print exact name</I>)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Signature</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">If not signing in an individual capacity:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD COLSPAN="3" VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER-TOP:1px solid #000000">Name of Authorized Signatory <I>(Print</I>)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD COLSPAN="3" VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3" STYLE="BORDER-TOP:1px solid #000000">Title of Authorized Signatory <I>(Print</I>)</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><I>(indicate capacity of person signing if signing as custodian, trustee, or on behalf of an entity)</I></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreement] </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>EXHIBIT B </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FORM OF WAIVER OF <FONT STYLE="white-space:nowrap">LOCK-UP</FONT> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:55%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">_____________, 20__ </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[Name
and Address of </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Officer or Director </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Requesting Waiver] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Mr./Ms.&nbsp;[Name]: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This letter is being
delivered to you in connection with the offering by Sana Biotechnology, Inc. (the &#147;<B>Company</B>&#148;) of [&#149;] shares of common stock, $0.0001 par value per share (the &#147;<B>Common Stock</B>&#148;), of the Company and the <FONT
STYLE="white-space:nowrap">lock-up</FONT> agreement dated ____, 2020 (the &#147;<B><FONT STYLE="white-space:nowrap">Lock-up</FONT> </B>Agreement&#148;), executed by you in connection with such offering, and your request for a [waiver] [release]
dated ____, 20__, with respect to ____ shares of Common Stock (the &#147;<B>Shares</B>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Morgan Stanley&nbsp;&amp; Co. LLC, Goldman
Sachs&nbsp;&amp; Co. LLC, J.P. Morgan Securities LLC and BofA Securities, Inc. hereby agrees to [waive] [release] the transfer restrictions set forth in the <FONT STYLE="white-space:nowrap">Lock-up</FONT> Agreement, but only with respect to the
Shares, effective _____, 20__; provided, however, that such [waiver] [release] is conditioned on the Company announcing the impending [waiver] [release] by press release through a major news service at least two business days before effectiveness of
such [waiver] [release]. This letter will serve as notice to the Company of the impending [waiver] [release]. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as expressly
[waived] [released] hereby, the <FONT STYLE="white-space:nowrap">Lock-up</FONT> Agreement shall remain in full force and effect. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="65%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="34%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Very truly yours,</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Morgan Stanley&nbsp;&amp; Co. LLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Goldman Sachs&nbsp;&amp; Co.
LLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BofA Securities, Inc.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Acting severally on behalf of itself and the<BR>several Underwriters named in Schedule I<BR>hereto</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
<DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Morgan Stanley&nbsp;&amp; Co. LLC</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name:</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title:</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Goldman Sachs&nbsp;&amp; Co. LLC</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name:</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title:</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">J.P. Morgan Securities LLC</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">By:</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name:</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title:</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BofA Securities, Inc.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Name:</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Title:</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">cc: Sana Biotechnology, Inc. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FORM OF PRESS RELEASE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sana Biotechnology, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[Date] </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sana Biotechnology, Inc. (the &#147;<B>Company</B>&#148;) announced today that Morgan Stanley&nbsp;&amp; Co. LLC, Goldman Sachs&nbsp;&amp; Co. LLC, J.P.
Morgan Securities LLC and BofA Securities, Inc., a lead book-running manager in the Company&#146;s recent public sale of [&#149;] shares of common stock is [waiving][releasing] a <FONT STYLE="white-space:nowrap">lock-up</FONT> restriction with
respect to ____ shares of the Company&#146;s common stock held by [certain officers or directors] [an officer or director] of the Company. The [waiver][release] will take effect on ____, 20__ , and the shares may be sold on or after such date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>This press release is not an offer for sale of the securities in the United States or in any other jurisdiction where such offer is prohibited, and such
securities may not be offered or sold in the United States absent registration or an exemption from registration under the United States Securities Act of 1933, as amended.</B> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-3 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>3
<FILENAME>d60414dex31.htm
<DESCRIPTION>EX-3.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-3.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 3.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">AMENDED AND RESTATED </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CERTIFICATE
OF INCORPORATION </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">OF </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SANA
BIOTECHNOLOGY, INC. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(Pursuant to Sections 242 and 245 of the </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">General Corporation Law of the State of Delaware) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Sana Biotechnology, Inc., a corporation organized and existing under and by virtue of the provisions of the General Corporation Law of the
State of Delaware (the &#147;<B>General Corporation Law</B>&#148;), </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>DOES HEREBY CERTIFY: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>1.</B> That the name of this corporation is Sana Biotechnology, Inc., and that this corporation was originally incorporated pursuant to the
General Corporation Law on July&nbsp;13, 2018 under the name FD Therapeutics, Inc. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>2.</B> That the Board of Directors duly adopted
resolutions proposing to amend and restate the Certificate of Incorporation of this corporation, declaring said amendment and restatement to be advisable and in the best interests of this corporation and its stockholders, and authorizing the
appropriate officers of this corporation to solicit the consent of the stockholders therefor, which resolution setting forth the proposed amendment and restatement is as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>RESOLVED</B>, that the Certificate of Incorporation of this corporation be amended and restated in its entirety to read as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>FIRST: </B>The name of this corporation is Sana Biotechnology, Inc. (the &#147;<B>Corporation</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>SECOND: </B>The address of the registered office of the Corporation in the State of Delaware is 251 Little Falls Drive, Wilmington, County
of New Castle 19808. The name of its registered agent at such address is Corporation Service Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>THIRD: </B>The nature of the
business or purposes to be conducted or promoted is to engage in any lawful act or activity for which corporations may be organized under the General Corporation Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>FOURTH: </B>Effective upon the filing of this Amended and Restated Certificate of Incorporation (the &#147;<B>Restated
Certificate</B>&#148;) with the Secretary of State of Delaware (the &#147;Effective Time&#148;), each four (4)&nbsp;shares of Common Stock (as defined below) issued and outstanding immediately prior to the Effective Time, shall, automatically and
without any further action on the part of any stockholders of the Corporation, be reclassified as one (1)&nbsp;share of Common Stock and each four (4)&nbsp;shares of Series <FONT STYLE="white-space:nowrap">A-1</FONT> Preferred Stock, Series <FONT
STYLE="white-space:nowrap">A-2</FONT> Preferred Stock and Series B Preferred Stock (each, as defined below) issued and outstanding immediately prior to the Effective Time shall, automatically and without any further action on the part of any
stockholders of the Corporation, be reclassified as one (1)&nbsp;share of Series <FONT STYLE="white-space:nowrap">A-1</FONT> Preferred Stock, Series <FONT STYLE="white-space:nowrap">A-2</FONT> Preferred Stock and Series B Preferred Stock,
respectively (the &#147;<B>Reverse Stock Split</B>&#148;). </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each stock certificate (or book entry shares) representing shares of any class of series of
Common Stock or Preferred Stock (as defined below) immediately prior to the Effective Time shall, from and after the Effective Time, represent that number of shares shall have been reclassified pursuant to the Reverse Stock Split; provided, however,
that each holder of any stock certificate(s) that represented shares of Common Stock or Preferred Stock immediately prior to the Effective Time shall be entitled to receive, upon surrender of such certificate(s), one or more certificates (or book
entry shares) evidencing and representing the number of shares of Common Stock or Preferred Stock into which the shares represented by such certificate(s) (or book entries) shall have been reclassified pursuant to the Reverse Stock Split. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No fractional shares shall be issued for shares of Common Stock or Preferred Stock pursuant to the Reverse Stock Split. If the Reverse Stock
Split would result in the issuance of any fractional share of any class or series of Common Stock or Preferred Stock, the Corporation shall, in lieu of issuing any such fractional share, pay cash in an amount equal to the fair value of such
fractional share (as determined in good faith by the Corporation&#146;s Board of Directors (the &#147;<B>Board of Directors</B>&#148;)). All share, per share and dollar reference in this Restated Certificate shall be adjusted for the Reverse Stock
Split only as explicitly provided herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The total number of shares of all classes of stock which the Corporation shall have authority
to issue is (i) 707,000,000 shares of Common Stock, $0.0001 par value per share (&#147;<B>Common Stock</B>&#148;) and (ii) 537,786,206 shares of Preferred Stock, $0.0001 par value per share (&#147;<B>Preferred Stock</B>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The following is a statement of the designations and the powers, privileges and rights, and the qualifications, limitations or restrictions
thereof in respect of each class of capital stock of the Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A. COMMON STOCK </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">1. <U>General</U>. The voting, dividend and liquidation rights of the holders of the Common Stock are subject to and qualified by the rights,
powers and preferences of the holders of the Preferred Stock set forth herein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2. <U>Voting</U>. The holders of the Common Stock are
entitled to one vote for each share of Common Stock held at all meetings of stockholders (and written actions in lieu of meetings); <U>provided</U>, <U>however</U>, that, except as otherwise required by law, holders of Common Stock, as such, shall
not be entitled to vote on any amendment to the Certificate of Incorporation that relates solely to the terms of one or more outstanding series of Preferred Stock if the holders of such affected series are entitled, either separately or together
with the holders of one or more other such series, to vote thereon pursuant to the Certificate of Incorporation or pursuant to the General Corporation Law. There shall be no cumulative voting. The number of authorized shares of Common Stock may be
increased or decreased (but not below the number of shares thereof then outstanding) by (in addition to any vote of the holders of one or more series of Preferred Stock that may be required by the terms of the Certificate of Incorporation) the
affirmative vote of the holders of shares of capital stock of the Corporation representing a majority of the votes represented by all outstanding shares of capital stock of the Corporation entitled to vote, irrespective of the provisions of
Section&nbsp;242(b)(2) of the General Corporation Law. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">B. PREFERRED STOCK </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">45,850,000 shares of the authorized Preferred Stock of the Corporation are hereby designated &#147;<B>S</B><B>eries <FONT
STYLE="white-space:nowrap">A-1</FONT> Preferred Stock</B>,&#148; 381,708,500 shares of the authorized Preferred Stock of the Corporation are hereby designated &#147;<B>Series <FONT STYLE="white-space:nowrap">A-2</FONT> Preferred Stock</B>&#148; and
110,227,706 shares of the authorized Preferred Stock of the Corporation are hereby designated &#147;<B>Series B Preferred Stock</B>,&#148; each with the following rights, preferences, powers, privileges and restrictions, qualifications and
limitations. Unless otherwise indicated, references to &#147;sections&#148; or &#147;subsections&#148; in this Part B of this Article Fourth refer to sections and subsections of Part B of this Article Fourth. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">1. <U>Dividends</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">1.1
<U>Treatment of Preferred Stock</U>. The holders of shares of Preferred Stock shall be entitled to receive, on a <I>pari passu</I> basis, dividends equal to 6% of the applicable Original Issue Price (as defined below) per annum, payable in cash or
in kind at the election of the Board of Directors, out of any assets at the time legally available therefor, when, as and if declared by the Board of Directors, prior and in preference to the Common Stock. No dividends other than those payable
solely in Common Stock shall be paid on any Common Stock unless and until (i)&nbsp;the aforementioned dividend is paid on each outstanding share of Preferred Stock, and (ii)&nbsp;a dividend is paid with respect to all outstanding shares of Preferred
Stock in an amount equal to or greater than the aggregate amount of dividends which would be payable to the holder of Preferred Stock if, immediately prior to the record date set for such dividend payment on Common Stock, such share of Preferred
Stock had been converted into Common Stock at the then-effective conversion rate. The Board of Directors is under no obligation to declare dividends, no rights shall accrue to the holders of Preferred Stock if dividends are not declared, and any
dividends on the Preferred Stock shall be noncumulative. As used in this Certificate of Incorporation, &#147;<B>Original Issue Price</B>&#148; shall mean (i) $4.00 for each outstanding share of Series <FONT STYLE="white-space:nowrap">A-1</FONT>
Preferred Stock and Series <FONT STYLE="white-space:nowrap">A-2</FONT> Preferred Stock, and (ii) $16.00 for each outstanding share of Series B Preferred Stock (in each case as adjusted for stock splits, combinations, reorganizations and the like
with respect to the each applicable series of Preferred Stock occurring after the Effective Time). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">1.2 <U>Treatment of Common Stock</U>.
If, after dividends in the full preferential amounts specified in Section&nbsp;1.1 for the Preferred Stock have been paid or declared and set apart in any calendar year of the Corporation, the Board of Directors shall declare additional dividends
out of funds legally available therefor in that calendar year, then such additional dividends shall be declared pro rata on the Common Stock and the Preferred Stock on a <I>pari passu</I> basis according to the number of shares of Common Stock held
by such holders, where each holder of shares of Preferred Stock is to be treated for this purpose as holding the greatest whole number of shares of Common Stock then issuable upon conversion of all shares of Preferred Stock held by such holder
pursuant to Sections 4 and 5 hereof. The Corporation shall make no Distribution (as defined below) to the holders of shares of Common Stock except in accordance with (i)&nbsp;Section&nbsp;1.1 and this Section&nbsp;1.2 or (ii)&nbsp;Section&nbsp;2.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">1.3 <U>Distribution</U>. &#147;<B>Distribution</B>&#148; means the transfer of cash, property or securities without consideration,
whether by way of dividend or otherwise, or the purchase of shares of the Corporation (other than in connection with (i)&nbsp;the repurchase of shares of Common Stock issued to or held by employees, consultants, officers or directors at a price not
greater than the amount paid by such persons for such shares upon termination of their employment or services pursuant to agreements providing for the right of said repurchase or (ii)&nbsp;upon exercise of a right of first refusal approved by the
Board of Directors) for cash or property. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">2. <U>Liquidation, Dissolution or Winding Up; Certain Mergers, Consolidations and Asset
Sales</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">2.1 <U>Preferential Payments to Holders of Preferred Stock</U>. In the event of any voluntary or involuntary liquidation,
dissolution or winding up of the Corporation or Deemed Liquidation Event, the holders of shares of Preferred Stock then outstanding, on a <I>pari</I><I> </I><I>passu</I> basis, shall be entitled to be paid out of the assets of the Corporation
available for distribution to its stockholders before any payment shall be made to the holders of Common Stock by reason of their ownership thereof, an amount per share equal to the greater of (i)&nbsp;the applicable Original Issue Price, plus any
dividends declared but unpaid thereon or (ii)&nbsp;such amount per share as would have been payable had all shares of the applicable series of Preferred Stock been converted into Common Stock pursuant to Section&nbsp;4 immediately prior to such
liquidation, dissolution, winding up or Deemed Liquidation Event (the amount payable pursuant to this sentence is hereinafter referred to as the &#147;<B>Liquidation Amoun</B>t&#148;). If upon any such liquidation, dissolution or winding up of the
Corporation or Deemed Liquidation Event, the assets of the Corporation available for distribution to its stockholders shall be insufficient to pay the holders of shares of Preferred Stock the full amount to which they shall be entitled under this
<U>Subsection</U><U></U><U>&nbsp;2.1</U>, the holders of shares of Preferred Stock shall share ratably in any distribution of the assets available for distribution in proportion to the respective amounts which would otherwise be payable in respect
of the shares held by them upon such distribution if all amounts payable on or with respect to such shares were paid in full. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">2.2
<U>Payments to Holders of Common Stock</U>. In the event of any voluntary or involuntary liquidation, dissolution or winding up of the Corporation or Deemed Liquidation Event, after the payment of all preferential amounts required to be paid to the
holders of shares of Preferred Stock, the remaining assets of the Corporation available for distribution to its stockholders shall be distributed among the holders of shares of Common Stock, pro rata based on the number of shares held by each such
holder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">2.3 <U>Deemed Liquidation Events</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">2.3.1 <U>Definition</U>. Each of the following events shall be considered a &#147;<B>Deemed Liquidation Event</B>&#148; unless the holders of
at least 61% of the outstanding Preferred Stock, voting together as a single class on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis (the &#147;<B>Requisite Holders</B>&#148;), which must include, in this instance, the holders of at
least a majority of the Series B Preferred Stock then held by the Series B Large Investors (as defined in the Series <FONT STYLE="white-space:nowrap">A-2/B</FONT> Preferred Stock Purchase Agreement dated as of February&nbsp;13, 2019, as the same may
be amended from time to time (the &#147;<B>Purchase Agreement</B>&#148;)), elect otherwise by written notice sent to the Corporation at least 15 days prior to the effective date of any such event: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(a) a merger or consolidation in which </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="26%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the Corporation is a constituent party or </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="25%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a subsidiary of the Corporation is a constituent party and the Corporation issues shares of its capital stock
pursuant to such merger or consolidation, </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">except any such merger or consolidation involving the Corporation or a subsidiary in which
the shares of capital stock of the Corporation outstanding immediately prior to such merger or consolidation continue to represent, or are converted into or exchanged for shares of capital stock that represent, immediately following such merger or
consolidation, at least a majority, by voting power, of the capital stock of (1)&nbsp;the surviving or resulting corporation; or (2)&nbsp;if the surviving or resulting corporation is a wholly owned subsidiary of another corporation immediately
following such merger or consolidation, the parent corporation of such surviving or resulting corporation; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(b) the sale, lease,
transfer, exclusive license (other than an exclusive license in a field of use not central to the Company&#146;s business plan, as determined in good faith by the Board of Directors, including at least three of the Preferred Directors (as defined
herein)) or other disposition, in a single transaction or series of related transactions, by the Corporation or any subsidiary of the Corporation of all or substantially all the assets of the Corporation and its subsidiaries taken as a whole, or the
sale or disposition (whether by merger, consolidation or otherwise) of one or more subsidiaries of the Corporation if substantially all of the assets of the Corporation and its subsidiaries taken as a whole are held by such subsidiary or
subsidiaries, except where such sale, lease, transfer, exclusive license or other disposition is to a wholly owned subsidiary of the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">2.3.2 <U>Effecting a Deemed Liquidation Event</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(a) The Corporation shall not have the power to effect a Deemed Liquidation Event referred to in <U>Subsection
2.3.1(a</U><U>)(</U><U>i</U><U>)</U> unless the agreement or plan of merger or consolidation for such transaction (the &#147;<B>Merger Agreement</B>&#148;) provides that the consideration payable to the stockholders of the Corporation shall be
allocated among the holders of capital stock of the Corporation in accordance with <U>Subsections 2.1</U> and <U>2.2</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(b) In the
event of a Deemed Liquidation Event referred to in <U>Subsection 2.3.1(a)(ii)</U> or <U>2.3.1(b)</U>, if the Corporation does not effect a dissolution of the Corporation under the General Corporation Law within ninety (90)&nbsp;days after such
Deemed Liquidation Event, then (i)&nbsp;the Corporation shall send a written notice to each holder of Preferred Stock (the &#147;<B>Redemption Notice</B>&#148;) no later than the ninetieth (90<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>)
day after the Deemed Liquidation Event advising such holders of their right (and the requirements to be met to secure such right) pursuant to the terms of the following clause; (ii)&nbsp;to require the redemption of such shares of Preferred Stock,
and (iii)&nbsp;if the Requisite Holders so request in a written instrument delivered to the Corporation not later than one hundred twenty (120)&nbsp;days after such Deemed Liquidation Event, the Corporation shall use the consideration received by
the Corporation for such Deemed Liquidation Event (net of any retained liabilities associated with the assets sold or technology licensed, as determined in good faith by the Board of Directors of the Corporation)<B>, </B>together with any other
assets of the Corporation available for distribution to its stockholders, all to the extent permitted by Delaware law governing distributions to stockholders (the &#147;<B>Available</B><B> Proceeds</B>&#148;), on the one hundred fiftieth (150<SUP
STYLE="font-size:85%; vertical-align:top">th</SUP>) day after such Deemed Liquidation Event, to redeem all outstanding shares of Preferred Stock at a price per share equal to the applicable Liquidation Amount. Notwithstanding the foregoing, in the
event of a redemption pursuant to the </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
preceding sentence, if the Available Proceeds are not sufficient to redeem all outstanding shares of Preferred Stock, the Corporation shall ratably redeem each holder&#146;s shares of Preferred
Stock to the fullest extent of such Available Proceeds based on the respective amounts which would otherwise be payable in respect of the shares to be redeemed if the Available Proceeds were sufficient to redeem such shares, and shall redeem the
remaining shares as soon as it may lawfully do so under Delaware law governing distributions to stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:26%; font-size:10pt; font-family:Times New Roman">(i) Each Redemption Notice
shall state: (1)&nbsp;the number of shares of Preferred Stock held by the holder that the Corporation shall redeem; (2)&nbsp;the date of redemption (the &#147;<B>Redemption Date</B>&#148;) and the amount to be paid to such holder; and (3)&nbsp;for
holders of shares in certificated form, that the holder is to surrender to the Corporation, in the manner and at the place designated, his, her or its certificate or certificates representing the shares of Preferred Stock to be redeemed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:26%; font-size:10pt; font-family:Times New Roman">(ii) On or before the Redemption Date, each holder of shares of Preferred Stock to be redeemed shall surrender the certificate or
certificates representing such shares (or, if such registered holder alleges that such certificate has been lost, stolen or destroyed, a lost certificate affidavit and agreement reasonably acceptable to the Corporation to indemnify the Corporation
against any claim that may be made against the Corporation on account of the alleged loss, theft or destruction of such certificate) to the Corporation, in the manner and at the place designated in the Redemption Notice, and thereupon the Available
Proceeds for such shares shall be payable to the order of the person whose name appears on such certificate or certificates as the owner thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Prior to the distribution or redemption provided for in this <U>Subsection 2.3.2(b)</U>, the Corporation shall not expend or dissipate the
consideration received for such Deemed Liquidation Event, except to discharge expenses incurred in connection with such Deemed Liquidation Event or in the ordinary course of business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">2.3.3 <U>Amount Deemed Paid or Distributed</U>. The amount deemed paid or distributed to the holders of capital stock of the Corporation upon
any such merger, consolidation, sale, transfer, exclusive license, other disposition or redemption shall be the cash or the value of the property, rights or securities paid or distributed to such holders pursuant to such Deemed Liquidation Event.
The value of such property, rights or securities shall be determined in good faith by the Board of Directors of the Corporation, including at least three of the Preferred Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">2.3.4 <U>Allocation of Escrow and Contingent Consideration</U>. In the event of a Deemed Liquidation Event pursuant to <U>Subsection
2.3.1(a)(</U><U>i</U><U>)</U>, if any portion of the consideration payable to the stockholders of the Corporation is payable only upon satisfaction of contingencies (the &#147;<B>Additional Consideration</B>&#148;), the Merger Agreement shall
provide that (a)&nbsp;the portion of such consideration that is not Additional Consideration (such portion, the &#147;<B>Initial Consideration</B>&#148;) shall be allocated among the holders of capital stock of the Corporation in accordance with
<U>Subsections 2.1</U> and <U>2.2</U> as if the Initial Consideration were the only consideration payable in connection with such Deemed Liquidation Event; and (b)&nbsp;any Additional Consideration which becomes payable to the stockholders of the
Corporation upon satisfaction of such contingencies shall be allocated among the holders of capital stock of the Corporation in accordance with <U>Subsections 2.1</U> and <U>2.2</U> after taking into account the previous payment of the Initial
Consideration as part of the same transaction. For the purposes of this <U>Subsection 2.3.4</U>, consideration placed into escrow or retained as holdback to be available for satisfaction of indemnification or similar obligations in connection with
such Deemed Liquidation Event shall be deemed to be Additional Consideration.<SUP STYLE="font-size:85%; vertical-align:top"> </SUP> </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">3. <U>Voting</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">3.1 <U>General</U>. On any matter presented to the stockholders of the Corporation for their action or consideration at any meeting of
stockholders of the Corporation (or by written consent of stockholders in lieu of meeting), each holder of outstanding shares of Preferred Stock shall be entitled to cast the number of votes equal to the number of whole shares of Common Stock into
which the shares of Preferred Stock held by such holder are convertible as of the record date for determining stockholders entitled to vote on such matter. Except as provided by law or by the other provisions of the Certificate of Incorporation,
holders of Preferred Stock shall vote together with the holders of Common Stock as a single class. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">3.2 <U>Election of Directors</U>. The
Requisite Holders shall be entitled to elect five (5)&nbsp;directors of the Corporation (the &#147;<B>Preferred</B><B> Directors</B>&#148;) and the holders of record of the shares of Common Stock, exclusively and as a separate class, shall be
entitled to elect one (1)&nbsp;director of the Corporation. Any director elected as provided in the preceding sentence may be removed without cause by, and only by, the affirmative vote of the holders of the shares of the class or series of capital
stock entitled to elect such director or directors, given either at a special meeting of such stockholders duly called for that purpose or pursuant to a written consent of stockholders. If the holders of shares of Preferred Stock or Common Stock, as
the case may be, fail to elect a sufficient number of directors to fill all directorships for which they are entitled to elect directors, voting exclusively and as a separate class, pursuant to the first sentence of this
<U>Subsection</U><U></U><U>&nbsp;3.2</U>, then any directorship not so filled shall remain vacant until such time as the holders of the Preferred Stock or Common Stock, as the case may be, elect a person to fill such directorship by vote or written
consent in lieu of a meeting; and no such directorship may be filled by stockholders of the Corporation other than by the stockholders of the Corporation that are entitled to elect a person to fill such directorship, voting exclusively and as a
separate<B> </B>class.<B> </B>The holders of record of the shares of Common Stock and of any other class or series of voting stock (including the Preferred Stock), exclusively and voting together as a single class and on an <FONT
STYLE="white-space:nowrap">as-converted</FONT> basis, shall be entitled to elect the balance of the total number of directors of the Corporation. At any meeting held for the purpose of electing a director, the presence in person or by proxy of the
holders of a majority of the outstanding shares of the class or series entitled to elect such director shall constitute a quorum for the purpose of electing such director. Except as otherwise provided in this
<U>Subsection</U><U></U><U>&nbsp;3.2</U>,<B> </B>a vacancy in any directorship filled by the holders of any class or series shall be filled only by vote or written consent in lieu of a meeting of the holders of such class or series or by any
remaining director or directors elected by the holders of such class or series pursuant to this <U>Subsection</U><U></U><U>&nbsp;3.2</U>. The rights of the holders of the Preferred Stock and the rights of the holders of the Common Stock under the
first sentence of this <U>Subsection</U><U></U><U>&nbsp;3.2</U> shall terminate on the first date on which there are less than 2,500,000 shares of Preferred Stock (subject to appropriate adjustment in the event of any stock dividend, stock split,
combination, or other similar recapitalization with respect to the Preferred Stock occurring after the Effective Time) issued and outstanding. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">3.3 <U>Preferred Stock Protective Provisions</U>. At any time when any shares of Preferred
Stock are outstanding, the Corporation shall not, either directly or indirectly by amendment, merger, consolidation or otherwise, do any of the following without (in addition to any other vote required by law or the Certificate of Incorporation) the
written consent or affirmative vote of the Requisite Holders (which, following the issuance of Series B Preferred Stock must include the holders of at least a majority of the Series B Preferred Stock then held by the Series B Large Investors), given
in writing or by vote at a meeting, consenting or voting (as the case may be) separately as a class, and any such&nbsp;act or transaction entered into without such consent or vote shall be null and void <I>ab initio</I>, and of no force or effect:
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">3.3.1 liquidate, dissolve or <FONT STYLE="white-space:nowrap">wind-up</FONT> the business and affairs of the Corporation, effect any
merger or consolidation or any other Deemed Liquidation Event, or consent to any of the foregoing; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">3.3.2 amend, waive, alter or repeal
any provision of the Certificate of Incorporation or Bylaws of the Corporation; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">3.3.3 other than as contemplated by the Agreement and
Plan of Merger by and among the Company, Sana Biotechnology IV, Inc., Cobalt Biomedicine, Inc., and VentureLabs VI, Inc., dated as of December&nbsp;20, 2018, as amended (the &#147;<B>Cobalt Merger Agreement</B>&#148;), create, or authorize the
creation of (by reclassification or otherwise), or issue or obligate itself to issue shares of any additional class or series of capital stock unless the same ranks junior to each series of Preferred Stock with respect to the distribution of assets
on the liquidation, dissolution or winding up of the Corporation, the payment of dividends and rights of redemption, or increase the authorized number of shares of Preferred Stock or any series thereof or increase the authorized number of shares of
any additional class or series of capital stock unless the same ranks junior to each series of Preferred Stock with respect to the distribution of assets on the liquidation, dissolution or winding up of the Corporation, the payment of dividends and
rights of redemption; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">3.3.4 (i) reclassify, alter or amend any existing security of the Corporation that is <I>pari passu</I> with any
series of Preferred Stock in respect of the distribution of assets on the liquidation, dissolution or winding up of the Corporation, the payment of dividends or rights of redemption, if such reclassification, alteration or amendment would render
such other security senior to any series of Preferred Stock in respect of any such right, preference, or privilege or (ii)&nbsp;reclassify, alter or amend any existing security of the Corporation that is junior to any series of Preferred Stock in
respect of the distribution of assets on the liquidation, dissolution or winding up of the Corporation, the payment of dividends or rights of redemption, if such reclassification, alteration or amendment would render such other security senior to or
<I>pari passu</I> with any series of Preferred Stock in respect of any such right, preference or privilege; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">3.3.5 purchase or redeem
(or permit any subsidiary to purchase or redeem) or pay or declare any dividend or make any distribution on, any shares of capital stock of the Corporation other than (i)&nbsp;redemptions of or dividends or distributions on the Preferred Stock as
expressly authorized herein, (ii)&nbsp;dividends or other distributions payable on the Common Stock solely in the form of additional shares of Common Stock, and (iii)&nbsp;repurchases of stock from former employees, officers, directors, consultants
or other persons who performed services for the Corporation or any subsidiary in connection with the cessation of such employment or service at the lower of the original purchase price or the then-current fair market value thereof. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">3.3.6 create, or hold capital stock in, any subsidiary that is not wholly owned (either
directly or through one or more other subsidiaries) by the Corporation, or permit any subsidiary to create, or authorize the creation of, or issue or obligate itself to issue, any shares of any class or series of capital stock, or sell, transfer or
otherwise dispose of any capital stock of any direct or indirect subsidiary of the Corporation, or permit any direct or indirect subsidiary to sell, lease, transfer, exclusively license or otherwise dispose (in a single transaction or series of
related transactions) of all or substantially all of the assets of such subsidiary; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">3.3.7 increase or decrease the authorized number of
directors constituting the Board of Directors; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">3.3.8 create, or authorize the creation of, or issue, or authorize the issuance of any
debt security or create any lien or security interest (except for purchase money liens or statutory liens of landlords, mechanics, materialmen, workmen, warehousemen and other similar persons arising or incurred in the ordinary course of business)
or incur other indebtedness for borrowed money, or permit any subsidiary to take any such action with respect to any debt security lien, security interest or other indebtedness for borrowed money, if the aggregate indebtedness of the Corporation and
its subsidiaries for borrowed money following such action would exceed $25,000,000, unless such debt security has received the prior approval of the Board of Directors, including the approval of at least three of the Preferred Directors; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">3.3.9 enter into an agreement to do any of the foregoing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">3.4 <U>Series A Preferred Stock Protective Provisions</U>. At any time when shares of Series <FONT STYLE="white-space:nowrap">A-1</FONT>
Preferred Stock or Series <FONT STYLE="white-space:nowrap">A-2</FONT> Preferred Stock (collectively, the &#147;<B>Series A Preferred Stock</B>&#148;) are outstanding, the Corporation shall not, either directly or indirectly by amendment, merger,
consolidation or otherwise, amend, alter or repeal any provision of the Certificate of Incorporation or Bylaws of the Corporation in a manner that adversely affects the powers, preferences or rights of the Series A Preferred Stock without (in
addition to any other vote required by law or the Certificate of Incorporation) the written consent or affirmative vote of the holders of a majority of the then outstanding shares of Series A Preferred Stock, given in writing or by vote at a
meeting, consenting or voting (as the case may be) separately as a class, and any such act or transaction entered into without such consent or vote shall be null and void <I>ab initio</I>, and of no force or effect (acknowledging, for purposes of
clarity, that the creation or issuance of a senior class or series of security shall not be deemed to adversely affect the powers, preferences or rights of the Series A Preferred Stock). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">3.5 <U>Series B Preferred Stock Protective Provisions</U>. At any time when shares of Series B Preferred Stock are outstanding, the
Corporation shall not, either directly or indirectly by amendment, merger, consolidation or otherwise, amend, alter or repeal any provision of the Certificate of Incorporation or Bylaws of the Corporation in a manner that adversely affects the
powers, preferences or rights of the Series B Preferred Stock without (in addition to any other vote required by law or the Certificate of Incorporation) the written consent or affirmative vote of (i)&nbsp;at any time when shares of Series B
Preferred Stock are outstanding, the holders of a majority of the then outstanding shares of Series B Preferred Stock, which must include the holders of at least a majority of the Series B Preferred Stock then held by the Series B Large Investors,
or (ii)&nbsp;at any time prior to the issuance of shares of Series B Preferred Stock, the Series B Large Investors representing at least a majority of the Series B Preferred Stock that all Series B Large Investors have committed to purchase pursuant
to the Purchase Agreement, in either case given in writing or by vote at a meeting, consenting or voting (as the case may be) separately as a class, and any such act or transaction entered into without such consent or vote shall be null and void
<I>ab initio</I>, and of no force or effect (acknowledging, for purposes of clarity, that the creation or issuance of a senior class or series of security shall not be deemed to adversely affect the powers, preferences or rights of the Series B
Preferred Stock). </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">4. <U>Optional</U><U> Conversion</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The holders of the Preferred Stock shall have conversion rights as follows (the &#147;<B>Conversion Rights</B>&#148;): </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">4.1 <U>Right to Convert</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">4.1.1 <U>Conversion Ratio</U>. Each share of Preferred Stock shall be convertible, at the option of the holder thereof, at any time and from
time to time, and without the payment of additional consideration by the holder thereof, into such number of fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> shares of Common Stock as is determined by dividing the applicable
Original Issue Price by the applicable Conversion Price (as defined below) in effect at the time of conversion. As of the Effective Time, the &#147;<B>Conversion Price</B>&#148; is equal to the applicable Original Issue Price. Such initial
Conversion Price, and the rate at which shares of Preferred Stock may be converted into shares of Common Stock, shall be subject to adjustment as provided below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">4.1.2 <U>Termination of Conversion Rights</U>. In the event of a liquidation, dissolution or winding up of the Corporation or a Deemed
Liquidation Event, the Conversion Rights shall terminate at the close of business on the last full day preceding the date fixed for the payment of any such amounts distributable on such event to the holders of Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">4.2 <U>Fractional Shares</U>. No fractional shares of Common Stock shall be issued upon conversion of the Preferred Stock. In lieu of any
fractional shares to which the holder would otherwise be entitled, the Corporation shall pay cash equal to such fraction multiplied by the fair market value of a share of Common Stock as determined in good faith by the Board of Directors of the
Corporation. Whether or not fractional shares would be issuable upon such conversion shall be determined on the basis of the total number of shares of Preferred Stock the holder is at the time converting into Common Stock and the aggregate number of
shares of Common Stock issuable upon such conversion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">4.3 <U>Mechanics of Conversion</U>.<SUP STYLE="font-size:85%; vertical-align:top">
</SUP> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">4.3.1 <U>Notice of Conversion</U>. In order for a holder of Preferred Stock to voluntarily convert shares of Preferred Stock into
shares of Common Stock, such holder shall (a)&nbsp;provide written notice to the Corporation&#146;s transfer agent at the office of the transfer agent for the applicable series of Preferred Stock (or at the principal office of the Corporation if the
Corporation serves as its own transfer agent) that such holder elects to convert all or any number of such holder&#146;s shares of Preferred Stock and, if applicable, any event on which such conversion is contingent and (b), if such holder&#146;s
shares are certificated, surrender the certificate or certificates for such shares of Preferred Stock (or, if such registered holder alleges that such certificate has been lost, stolen or destroyed, a lost certificate affidavit and agreement
reasonably acceptable to the Corporation to indemnify the Corporation against any claim that may be made against the Corporation on account of the alleged loss, theft or destruction of such certificate), at the office of the transfer agent for the
applicable series of Preferred Stock (or at the principal office of the Corporation if the Corporation serves as its own transfer agent). Such notice shall state such </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
holder&#146;s name or the names of the nominees in which such holder wishes the shares of Common Stock to be issued. If required by the Corporation, any certificates surrendered for conversion
shall be endorsed or accompanied by a written instrument or instruments of transfer, in form satisfactory to the Corporation, duly executed by the registered holder or his, her or its attorney duly authorized in writing. The close of business on the
date of receipt by the transfer agent (or by the Corporation if the Corporation serves as its own transfer agent) of such notice and, if applicable, certificates (or lost certificate affidavit and agreement) shall be the time of conversion (the
&#147;<B>Conversion Time</B>&#148;), and the shares of Common Stock issuable upon conversion of the specified shares shall be deemed to be outstanding of record as of such date. The Corporation shall, as soon as practicable after the Conversion Time
(i)&nbsp;issue and deliver to such holder of Preferred Stock, or to his, her or its nominees, a certificate or certificates for the number of full shares of Common Stock issuable upon such conversion in accordance with the provisions hereof and a
certificate for the number (if any) of the shares of Preferred Stock represented by the surrendered certificate that were not converted into Common Stock, (ii)&nbsp;pay in cash such amount as provided in <U>Subsection</U><U></U><U>&nbsp;4.2</U> in
lieu of any fraction of a share of Common Stock otherwise issuable upon such conversion and (iii)&nbsp;pay all declared but unpaid dividends on the shares of Preferred Stock converted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">4.3.2 <U>Reservation of Shares</U>. The Corporation shall at all times when the Preferred Stock shall be outstanding, reserve and keep
available out of its authorized but unissued capital stock, for the purpose of effecting the conversion of the Preferred Stock, such number of its duly authorized shares of Common Stock as shall from time to time be sufficient to effect the
conversion of all outstanding Preferred Stock; and if at any time the number of authorized but unissued shares of Common Stock shall not be sufficient to effect the conversion of all then outstanding shares of Preferred Stock, the Corporation shall
take such corporate action as may be necessary to increase its authorized but unissued shares of Common Stock to such number of shares as shall be sufficient for such purposes, including, without limitation, engaging in best efforts to obtain the
requisite stockholder approval of any necessary amendment to the Certificate of Incorporation. Before taking any action which would cause an adjustment reducing any Conversion Price below the then par value of the shares of Common Stock issuable
upon conversion of the corresponding series of Preferred Stock, the Corporation will take any corporate action which may, in the opinion of its counsel, be necessary in order that the Corporation may validly and legally issue fully paid and <FONT
STYLE="white-space:nowrap">non-assessable</FONT> shares of Common Stock at such adjusted Conversion Price. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">4.3.3 <U>Effect of
Conversion</U>. All shares of Preferred Stock which shall have been surrendered for conversion as herein provided shall no longer be deemed to be outstanding and all rights with respect to such shares shall immediately cease and terminate at the
Conversion Time, except only the right of the holders thereof to receive shares of Common Stock in exchange therefor, to receive payment in lieu of any fraction of a share otherwise issuable upon such conversion as provided in
<U>Subsection</U><U></U><U>&nbsp;4.2</U> and to receive payment of any dividends declared but unpaid thereon. Any shares of Preferred Stock so converted shall be retired and cancelled and may not be reissued as shares of such series, and the
Corporation may thereafter take such appropriate action (without the need for stockholder action) as may be necessary to reduce the authorized number of shares of Preferred Stock (and each applicable corresponding series thereof) accordingly. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">4.3.4 <U>No Further Adjustment</U>. Upon any such conversion, no adjustment to the
applicable Conversion Price shall be made for any declared but unpaid dividends on the Preferred Stock surrendered for conversion or on the Common Stock delivered upon conversion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">4.3.5 <U>Taxes</U>. The Corporation shall pay any and all issue and other similar taxes that may be payable in respect of any issuance or
delivery of shares of Common Stock upon conversion of shares of Preferred Stock pursuant to this <U>Section</U><U></U><U>&nbsp;4</U>. The Corporation shall not, however, be required to pay any tax which may be payable in respect of any transfer
involved in the issuance and delivery of shares of Common Stock in a name other than that in which the shares of Preferred Stock so converted were registered, and no such issuance or delivery shall be made unless and until the person or entity
requesting such issuance has paid to the Corporation the amount of any such tax or has established, to the satisfaction of the Corporation, that such tax has been paid. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">4.4 <U>Adjustments</U><U> to Conversion Price for Diluting Issues</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">4.4.1 <U>Special Definitions</U>. For purposes of this Article Fourth, the following definitions shall apply: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(a) &#147;<B>Option</B>&#148; shall mean rights, options or warrants to subscribe for, purchase or otherwise acquire Common Stock or
Convertible Securities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(b) &#147;<B>Convertible Securities</B>&#148; shall mean any evidences of indebtedness, shares or other
securities directly or indirectly convertible into or exchangeable for Common Stock, but excluding Options. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(c) &#147;<B>Additional
Shares of Common Stock</B>&#148; shall mean all shares of Common Stock issued (or, pursuant to <U>Subsection</U><U></U><U>&nbsp;4.4.3</U> below, deemed to be issued) by the Corporation after the Effective Time, other than (1)&nbsp;the following
shares of Common Stock and (2)&nbsp;shares of Common Stock deemed issued pursuant to the following Options and Convertible Securities (clauses (1)&nbsp;and (2), collectively, &#147;<B>Exempted Securities</B>&#148;): </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="26%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">shares of Common Stock, Options or Convertible Securities issued as a dividend or distribution on Preferred
Stock; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="26%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">shares of Common Stock, Options or Convertible Securities issued by reason of a dividend, stock split, <FONT
STYLE="white-space:nowrap">split-up</FONT> or other distribution on shares of Common Stock for which an adjustment to any Conversion Price is made pursuant to <U>Subsection 4.5</U>, <U>4.6</U>, <U>4.7</U> or <U>4.8</U>; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="26%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">shares of Common Stock or Options issued to employees or directors of, or consultants or advisors to, the
Corporation or any of its subsidiaries pursuant to a plan, agreement or arrangement approved by the Board of Directors, including at least three of the Preferred Directors; </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="26%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">shares of Common Stock or Convertible Securities actually issued upon the exercise of Options or shares of
Common Stock actually issued upon the conversion or exchange of Convertible Securities, in each case provided such issuance is pursuant to the terms of such Option or Convertible Security; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="26%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">shares of Common Stock, Options or Convertible Securities issued to banks, equipment lessors or other financial
institutions, or to real property lessors, pursuant to a debt financing, equipment leasing or real property leasing transaction approved by the Board of Directors, including at least three of the Preferred Directors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="26%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(vi)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">shares of Common Stock, Options or Convertible Securities issued pursuant to the acquisition of another
corporation by the Corporation by merger, purchase of substantially all of the assets or other reorganization or to a joint venture agreement, <U>provided</U> that such issuances are approved by the Board of Directors, including at least three of
the Preferred Directors; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="26%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(vii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">shares of Common Stock, Options or Convertible Securities issued in connection with sponsored research,
collaboration, technology license, development, marketing or other similar agreements or strategic partnerships approved by the Board of Directors, including at least three of the Preferred Directors; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="26%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(viii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">shares of Common Stock or Series <FONT STYLE="white-space:nowrap">A-2</FONT> Preferred Stock issued pursuant to
the Cobalt Merger Agreement; or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="26%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ix)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">shares of Common Stock issued in an underwritten public offering of the Corporation&#146;s Common Stock
pursuant to a registration statement under the Securities Act of 1933, as amended. </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">4.4.2 <U>No Adjustment of Conversion Price</U>. No adjustment in any Conversion Price shall
be made as the result of the issuance or deemed issuance of Additional Shares of Common Stock if the Corporation receives written notice from the Requisite Holders agreeing that no such adjustment shall be made as the result of the issuance or
deemed issuance of such Additional Shares of Common Stock. Notwithstanding the foregoing, in the event that the issuance or deemed issuance of Additional Shares of Common Stock is at a price per share that is less than the Series B Original Issue
Price but greater than the Series <FONT STYLE="white-space:nowrap">A-2</FONT> Original Issue Price, any waiver to the adjustment of the Series B Conversion Price in connection with such issuance or deemed issuance shall require the prior written
consent of the Requisite Holders which must include, in this instance, the holders of at least a majority of the Series B Preferred Stock then held by the Series B Large Investors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">4.4.3 <U>Deemed Issue of Additional Shares of Common Stock</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(a) If the Corporation at any time or from time to time after the Effective Time shall issue any Options or Convertible Securities (excluding
Options or Convertible Securities which are themselves Exempted Securities) or shall fix a record date for the determination of holders of any class of securities entitled to receive any such Options or Convertible Securities, then the maximum
number of shares of Common Stock (as set forth in the instrument relating thereto, assuming the satisfaction of any conditions to exercisability, convertibility or exchangeability but without regard to any provision contained therein for a
subsequent adjustment of such number) issuable upon the exercise of such Options or, in the case of Convertible Securities and Options therefor, the conversion or exchange of such Convertible Securities, shall be deemed to be Additional Shares of
Common Stock issued as of the time of such issue or, in case such a record date shall have been fixed, as of the close of business on such record date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(b) If the terms of any Option or Convertible Security, the issuance of which resulted in an adjustment to any Conversion Price pursuant to
the terms of <U>Subsection 4.4.4</U>, are revised as a result of an amendment to such terms or any other adjustment pursuant to the provisions of such Option or Convertible Security (but excluding automatic adjustments to such terms pursuant to
anti-dilution or similar provisions of such Option or Convertible Security) to provide for either (1)&nbsp;any increase or decrease in the number of shares of Common Stock issuable upon the exercise, conversion and/or exchange of any such Option or
Convertible Security or (2)&nbsp;any increase or decrease in the consideration payable to the Corporation upon such exercise, conversion and/or exchange, then, effective upon such increase or decrease becoming effective, the applicable Conversion
Price computed upon the original issue of such Option or Convertible Security (or upon the occurrence of a record date with respect thereto) shall be readjusted to such Conversion Price as would have obtained had such revised terms been in effect
upon the original date of issuance of such Option or Convertible Security. Notwithstanding the foregoing, no readjustment pursuant to this clause&nbsp;(b) shall have the effect of increasing the applicable Conversion Price to an amount which exceeds
the lower of (i)&nbsp;the applicable Conversion Price in effect immediately prior to the original adjustment made as a result of the issuance of such Option or Convertible Security, or (ii)&nbsp;the applicable Conversion Price that would have
resulted from any issuances of Additional Shares of Common Stock (other than deemed issuances of Additional Shares of Common Stock as a result of the issuance of such Option or Convertible Security) between the original adjustment date and such
readjustment date. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(c) If the terms of any Option or Convertible Security (excluding Options or Convertible
Securities which are themselves Exempted Securities), the issuance of which did not result in an adjustment to any Conversion Price pursuant to the terms of <U>Subsection 4.4.4</U> (either because the consideration per share (determined pursuant to
<U>Subsection 4.4.5</U>) of the Additional Shares of Common Stock subject thereto was equal to or greater than each Conversion Price then in effect, or because such Option or Convertible Security was issued before the Effective Time), are revised
after the Effective Time as a result of an amendment to such terms or any other adjustment pursuant to the provisions of such Option or Convertible Security (but excluding automatic adjustments to such terms pursuant to anti-dilution or similar
provisions of such Option or Convertible Security) to provide for either (1)&nbsp;any increase in the number of shares of Common Stock issuable upon the exercise, conversion or exchange of any such Option or Convertible Security or (2)&nbsp;any
decrease in the consideration payable to the Corporation upon such exercise, conversion or exchange, then such Option or Convertible Security, as so amended or adjusted, and the Additional Shares of Common Stock subject thereto (determined in the
manner provided in <U>Subsection 4.4.3(a)</U>) shall be deemed to have been issued effective upon such increase or decrease becoming effective. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(d) Upon the expiration or termination of any unexercised Option or unconverted or unexchanged Convertible Security (or portion thereof)
which resulted (either upon its original issuance or upon a revision of its terms) in an adjustment to any Conversion Price pursuant to the terms of <U>Subsection</U><U></U><U>&nbsp;4.4.4</U>, the applicable Conversion Price shall be readjusted to
such Conversion Price as would have obtained had such Option or Convertible Security (or portion thereof) never been issued. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(e) If the
number of shares of Common Stock issuable upon the exercise, conversion and/or exchange of any Option or Convertible Security, or the consideration payable to the Corporation upon such exercise, conversion and/or exchange, is calculable at the time
such Option or Convertible Security is issued or amended but is subject to adjustment based upon subsequent events, any adjustment to any Conversion Price provided for in this <U>Subsection</U><U></U><U>&nbsp;4.4.3</U> shall be effected at the time
of such issuance or amendment based on such number of shares or amount of consideration without regard to any provisions for subsequent adjustments (and any subsequent adjustments shall be treated as provided in clauses (b)&nbsp;and (c) of this
<U>Subsection</U><U></U><U>&nbsp;4.4.3</U>). If the number of shares of Common Stock issuable upon the exercise, conversion and/or exchange of any Option or Convertible Security, or the consideration payable to the Corporation upon such exercise,
conversion and/or exchange, cannot be calculated at all at the time such Option or Convertible Security is issued or amended, any adjustment to any Conversion Price that would result under the terms of this <U>Subsection</U><U></U><U>&nbsp;4.4.3</U>
at the time of such issuance or amendment shall instead be effected at the time such number of shares and/or amount of consideration is first calculable (even if subject to subsequent adjustments), assuming for purposes of calculating such
adjustment to the applicable Conversion Price that such issuance or amendment took place at the time such calculation can first be made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">4.4.4 <U>Adjustment of Conversion Price </U><U>Upon</U><U> Issuance of Additional Shares of Common Stock</U>. In the event the Corporation
shall at any time after the Effective Time issue Additional Shares of Common Stock (including Additional Shares of Common Stock deemed to be issued pursuant to <U>Subsection</U><U></U><U>&nbsp;4.4.3</U>), without consideration or for a
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
consideration per share less than any Conversion Price in effect immediately prior to such issue (for a series of Preferred Stock with shares then-outstanding), then the applicable Conversion
Price shall be reduced, concurrently with such issue, to a price (calculated to the nearest <FONT STYLE="white-space:nowrap">one-hundredth</FONT> of a cent) determined in accordance with the following formula: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">CP<SUB STYLE="font-size:85%; vertical-align:bottom">2</SUB> = CP<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB>* (A + B) &divide; (A
+ C). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of the foregoing formula, the following definitions shall apply: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(a) &#147;CP<SUB STYLE="font-size:85%; vertical-align:bottom">2</SUB>&#148; shall mean the Conversion Price in effect immediately after such
issue of Additional Shares of Common Stock </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(b) &#147;CP<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB>&#148; shall mean the
Conversion Price in effect immediately prior to such issue of Additional Shares of Common Stock; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(c) &#147;A&#148; shall mean the number
of shares of Common Stock outstanding immediately prior to such issue of Additional Shares of Common Stock (treating for this purpose as outstanding all shares of Common Stock issuable upon exercise of Options outstanding immediately prior to such
issue or upon conversion or exchange of Convertible Securities (including the Preferred Stock) outstanding (assuming exercise of any outstanding Options therefor) immediately prior to such issue); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(d) &#147;B&#148; shall mean the number of shares of Common Stock that would have been issued if such Additional Shares of Common Stock had
been issued at a price per share equal to CP<SUB STYLE="font-size:85%; vertical-align:bottom">1</SUB> (determined by dividing the aggregate consideration received by the Corporation in respect of such issue by CP<SUB
STYLE="font-size:85%; vertical-align:bottom">1</SUB>); and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(e) &#147;C&#148; shall mean the number of such Additional Shares of Common
Stock issued in such transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">4.4.5 <U>Determination of Consideration</U>. For purposes of this <U>Subsection 4.4</U>, the
consideration received by the Corporation for the issue of any Additional Shares of Common Stock shall be computed as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(a)
<U>Cash and Property</U>: Such consideration shall: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="26%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">insofar as it consists of cash, be computed at the aggregate amount of cash received by the Corporation,
excluding amounts paid or payable for accrued interest; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="26%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">insofar as it consists of property other than cash, be computed at the fair market value thereof at the time of
such issue, as determined in good faith by the Board of Directors of the Corporation; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="26%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in the event Additional Shares of Common Stock are issued together with other shares or securities or other
assets of the Corporation for consideration which covers both, be the proportion of such consideration so received, computed as provided in clauses (i)&nbsp;and (ii) above, as determined in good faith by the Board of Directors of the Corporation.
</P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(b) <U>Options and Convertible Securities</U>. The consideration per share received by the
Corporation for Additional Shares of Common Stock deemed to have been issued pursuant to <U>Subsection</U><U></U><U>&nbsp;4.4.3</U>, relating to Options and Convertible Securities, shall be determined by dividing: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="26%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The total amount, if any, received or receivable by the Corporation as consideration for the issue of such
Options or Convertible Securities, plus the minimum aggregate amount of additional consideration (as set forth in the instruments relating thereto, without regard to any provision contained therein for a subsequent adjustment of such consideration)
payable to the Corporation upon the exercise of such Options or the conversion or exchange of such Convertible Securities, or in the case of Options for Convertible Securities, the exercise of such Options for Convertible Securities and the
conversion or exchange of such Convertible Securities, by </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="26%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">the maximum number of shares of Common Stock (as set forth in the instruments relating thereto, without regard
to any provision contained therein for a subsequent adjustment of such number) issuable upon the exercise of such Options or the conversion or exchange of such Convertible Securities, or in the case of Options for Convertible Securities, the
exercise of such Options for Convertible Securities and the conversion or exchange of such Convertible Securities. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">4.4.6 <U>Multiple Closing Dates</U>. In the event the Corporation shall issue on more than one date Additional Shares of Common Stock that
are a part of one transaction or a series of related transactions and that would result in an adjustment to any Conversion Price pursuant to the terms of <U>Subsection 4.4.4</U>, and such issuance dates occur within a period of no more than ninety
(90)&nbsp;days from the first such issuance to the final such issuance, then, upon the final such issuance, the applicable Conversion Price shall be readjusted to give effect to all such issuances as if they occurred on the date of the first such
issuance (and without giving effect to any additional adjustments as a result of any such subsequent issuances within such period). </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">4.5 <U>Adjustment for Stock Splits and Combinations</U>. If the Corporation shall at any
time or from time to time after the Effective Time effect a subdivision of the outstanding Common Stock, each Conversion Price in effect immediately before that subdivision shall be proportionately decreased so that the number of shares of Common
Stock issuable on conversion of each share of such series shall be increased in proportion to such increase in the aggregate number of shares of Common Stock outstanding. If the Corporation shall at any time or from time to time after the Effective
Time combine the outstanding shares of Common Stock, each Conversion Price in effect immediately before the combination shall be proportionately increased so that the number of shares of Common Stock issuable on conversion of each share of such
series shall be decreased in proportion to such decrease in the aggregate number of shares of Common Stock outstanding. Any adjustment under this subsection shall become effective at the close of business on the date the subdivision or combination
becomes effective. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">4.6 <U>Adjustment for Certain Dividends and Distributions</U>. In the event the Corporation at any time or from time
to time after the Effective Time shall make or issue, or fix a record date for the determination of holders of Common Stock entitled to receive, a dividend or other distribution payable on the Common Stock in additional shares of Common Stock, then
and in each such event each Conversion Price in effect immediately before such event shall be decreased as of the time of such issuance or, in the event such a record date shall have been fixed, as of the close of business on such record date, by
multiplying each Conversion Price then in effect by a fraction: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(1) the numerator of which shall be the total number of shares of Common
Stock issued and outstanding immediately prior to the time of such issuance or the close of business on such record date, and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(2) the
denominator of which shall be the total number of shares of Common Stock issued and outstanding immediately prior to the time of such issuance or the close of business on such record date plus the number of shares of Common Stock issuable in payment
of such dividend or distribution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing (a)&nbsp;if such record date shall have been fixed and such dividend is not fully paid or
if such distribution is not fully made on the date fixed therefor, each Conversion Price shall be recomputed accordingly as of the close of business on such record date and thereafter each Conversion Price shall be adjusted pursuant to this
subsection as of the time of actual payment of such dividends or distributions; and (b)&nbsp;that no such adjustment shall be made if the holders of each series of Preferred Stock simultaneously receive a dividend or other distribution of shares of
Common Stock in a number equal to the number of shares of Common Stock as they would have received if all outstanding shares of Preferred Stock had been converted into Common Stock on the date of such event. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">4.7 <U>Adjustments for Other Dividends and Distributions</U>. In the event the Corporation at any time or from time to time after the
Effective Time shall make or issue, or fix a record date for the determination of holders of Common Stock entitled to receive, a dividend or other distribution payable in securities of the Corporation (other than a distribution of shares of Common
Stock in respect of outstanding shares of Common Stock) or in other property and the provisions of <U>Section</U><U></U><U>&nbsp;1</U> do not apply to such dividend or distribution, then and in each such event the holders of Preferred Stock shall
receive, simultaneously with the distribution to the holders of Common Stock, a dividend or other distribution of such securities or other property in an amount equal to the amount of such securities or other property as they would have received if
all outstanding shares of Preferred Stock had been converted into Common Stock on the date of such event. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">4.8 <U>Adjustment for Merger or Reorganization, etc</U>. Subject to the provisions of
<U>Subsection 2.3</U>, if there shall occur any reorganization, recapitalization, reclassification, consolidation or merger involving the Corporation in which the Common Stock (but not the Preferred Stock) is converted into or exchanged for
securities, cash or other property (other than a transaction covered by <U>Subsections 4.4</U>, <U>4.6</U> or <U>4.7</U>), then, following any such reorganization, recapitalization, reclassification, consolidation or merger, each share of Preferred
Stock shall thereafter be convertible in lieu of the Common Stock into which it was convertible prior to such event into the kind and amount of securities, cash or other property which a holder of the number of shares of Common Stock of the
Corporation issuable upon conversion of one share of Preferred Stock immediately prior to such reorganization, recapitalization, reclassification, consolidation or merger would have been entitled to receive pursuant to such transaction; and, in such
case, appropriate adjustment (as determined in good faith by the Board of Directors of the Corporation) shall be made in the application of the provisions in this <U>Section</U><U></U><U>&nbsp;4</U> with respect to the rights and interests
thereafter of the holders of the Preferred Stock, to the end that the provisions set forth in this <U>Section</U><U></U><U>&nbsp;4</U> (including provisions with respect to changes in and other adjustments of the Conversion Price) shall thereafter
be applicable, as nearly as reasonably may be, in relation to any securities or other property thereafter deliverable upon the conversion of the Preferred Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">4.9 <U>Certificate as to Adjustments</U>. Upon the occurrence of each adjustment or readjustment of any Conversion Price pursuant to this
<U>Section</U><U></U><U>&nbsp;4</U>, the Corporation at its expense shall, as promptly as reasonably practicable but in any event not later than ten (10)&nbsp;days thereafter, compute such adjustment or readjustment in accordance with the terms
hereof and furnish to each holder of Preferred Stock a certificate setting forth such adjustment or readjustment (including the kind and amount of securities, cash or other property into which the Preferred Stock is convertible) and showing in
detail the facts upon which such adjustment or readjustment is based. The Corporation shall, as promptly as reasonably practicable after the written request at any time of any holder of Preferred Stock (but in any event not later than ten
(10)&nbsp;days thereafter), furnish or cause to be furnished to such holder a certificate setting forth (i)&nbsp;each Conversion Price then in effect, and (ii)&nbsp;the number of shares of Common Stock and the amount, if any, of other securities,
cash or property which then would be received upon the conversion of Preferred Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">4.10 <U>Notice of Record Date</U>. In the event:
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(a) the Corporation shall take a record of the holders of its Common Stock (or other capital stock or securities at the time issuable
upon conversion of the Preferred Stock) for the purpose of entitling or enabling them to receive any dividend or other distribution, or to receive any right to subscribe for or purchase any shares of capital stock of any class or any other
securities, or to receive any other security; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(b) of any capital reorganization of the Corporation, any reclassification of the
Common Stock of the Corporation, or any Deemed Liquidation Event; or </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:22%; font-size:10pt; font-family:Times New Roman">(c) of the voluntary or involuntary dissolution, liquidation or <FONT
STYLE="white-space:nowrap">winding-up</FONT> of the Corporation, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">then, and in each such case, the Corporation will send or cause to be sent to the
holders of the Preferred Stock a notice specifying, as the case may be, (i)&nbsp;the record date for such dividend, distribution or right, and the amount and character of such dividend, distribution or right, or (ii)&nbsp;the effective date on which
such reorganization, reclassification, consolidation, merger, transfer, dissolution, liquidation or <FONT STYLE="white-space:nowrap">winding-up</FONT> is proposed to take place, and the time, if any is to be fixed, as of which the holders of record
of Common Stock (or such other capital stock or securities at the time issuable upon the conversion of the Preferred Stock) shall be entitled to exchange their shares of Common Stock (or such other capital stock or securities) for securities or
other property deliverable upon such reorganization, reclassification, consolidation, merger, transfer, dissolution, liquidation or <FONT STYLE="white-space:nowrap">winding-up,</FONT> and the amount per share and character of such exchange
applicable to the Preferred Stock and the Common Stock. Such notice shall be sent at least ten (10)&nbsp;days prior to the record date or effective date for the event specified in such notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">5. <U>Mandatory Conversion</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">5.1 <U>Trigger Events</U>. Upon either (a)&nbsp;the point in time immediately prior to the closing of the sale of shares of Common Stock in a
firm-commitment underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933, as amended, resulting in at least $75,000,000 of gross proceeds to the Corporation, provided, that, following the first
issuance of shares of Series B Preferred Stock, the sale of such shares of Common Stock are at a price to the public of at least $16.00 per share (subject to appropriate adjustment in the event of any stock dividend, stock split, combination or
other similar recapitalization with respect to the Common Stock occurring after the Effective Time) (a &#147;<B>Qualified IPO</B>&#148;) or (b)&nbsp;the date and time, or the occurrence of an event, specified by vote or written consent of the
Requisite Holders; provided, that, following the first issuance of shares of Series B Preferred Stock, in the event that the price per share of the Common Stock immediately following the proposed conversion of Preferred Stock is less than the Series
B Original Issue Price but greater than the Series <FONT STYLE="white-space:nowrap">A-2</FONT> Original Issue Price (for purposes of clarity (x)&nbsp;in the event that the conversion is in connection with an initial public offering, the price per
share of Common Stock shall be deemed to be the initial offering price to the public, (y)&nbsp;in the event such conversion is in connection with a Deemed Liquidation Event, the price per share of Common Stock shall be deemed to be the consideration
per share of Common Stock payable in such Deemed Liquidation Event, and (z)&nbsp;in any other event, the price per share of Common Stock shall be the fair market value as reasonably determined in good faith by the Board of Directors), the prior
written consent of the holders of at least a majority of the Series B Preferred Stock then held by the Series B Large Investors shall be required in addition to the vote or written consent of the Requisite Holders (the time of such closing or the
date and time specified or the time of the event specified in such vote or written consent is referred to herein as the &#147;<B>Mandatory Conversion Time</B>&#148;), then (i)&nbsp;all outstanding shares of Preferred Stock shall automatically be
converted into shares of Common Stock, at the then effective conversion rate as calculated pursuant to <U>Subsection 4.1.1.</U> and (ii)&nbsp;such shares may not be reissued by the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">5.2 <U>Procedural Requirements</U>. All holders of record of shares of Preferred Stock shall be sent written notice of the Mandatory
Conversion Time and the place designated for mandatory conversion of all such shares of Preferred Stock pursuant to this <U>Section</U><U></U><U>&nbsp;5</U>. Such notice need not be sent in advance of the occurrence of the Mandatory Conversion Time.
Upon receipt of such notice, each holder of shares of Preferred Stock in certificated form shall surrender his, her or its certificate or certificates for all such shares (or, if such holder alleges that
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
such certificate has been lost, stolen or destroyed, a lost certificate affidavit and agreement reasonably acceptable to the Corporation to indemnify the Corporation against any claim that may be
made against the Corporation on account of the alleged loss, theft or destruction of such certificate) to the Corporation at the place designated in such notice. If so required by the Corporation, any certificates surrendered for conversion shall be
endorsed or accompanied by written instrument or instruments of transfer, in form satisfactory to the Corporation, duly executed by the registered holder or by his, her or its attorney duly authorized in writing. All rights with respect to the
Preferred Stock converted pursuant to <U>Subsection 5.1</U>, including the rights, if any, to receive notices and vote (other than as a holder of Common Stock), will terminate at the Mandatory Conversion Time (notwithstanding the failure of the
holder or holders thereof to surrender any certificates at or prior to such time), except only the rights of the holders thereof, upon surrender of any certificate or certificates of such holders (or lost certificate affidavit and agreement)
therefor, to receive the items provided for in the next sentence of this <U>Subsection 5.2</U>. As soon as practicable after the Mandatory Conversion Time and, if applicable, the surrender of any certificate or certificates (or lost certificate
affidavit and agreement) for Preferred Stock, the Corporation shall (a)&nbsp;issue and deliver to such holder, or to his, her or its nominees, a certificate or certificates for the number of full shares of Common Stock issuable on such conversion in
accordance with the provisions hereof and (b)&nbsp;pay cash as provided in <U>Subsection</U><U></U><U>&nbsp;4.2</U> in lieu of any fraction of a share of Common Stock otherwise issuable upon such conversion and the payment of any declared but unpaid
dividends on the shares of Preferred Stock converted. Such converted Preferred Stock shall be retired and cancelled and may not be reissued as shares of such series, and the Corporation may thereafter take such appropriate action (without the need
for stockholder action) as may be necessary to reduce the authorized number of shares of Preferred Stock and each series thereof accordingly. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">6. <U>Redemption</U>. The Preferred Stock is not redeemable upon demand by the holders of the Preferred Stock except in accordance with
Subsection 2.3.2(b). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">7. <U>Redeemed or Otherwise Acquired Shares</U>. Any shares of Preferred Stock that are redeemed or otherwise
acquired by the Corporation or any of its subsidiaries shall be automatically and immediately cancelled and retired and shall not be reissued, sold or transferred. Neither the Corporation nor any of its subsidiaries may exercise any voting or other
rights granted to the holders of Preferred Stock following redemption. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">8. <U>Waiver</U>. Any of the rights, powers, preferences and other
terms of the Preferred Stock set forth herein may be waived on behalf of all holders of Preferred Stock by the affirmative written consent or vote of the Requisite Holders (which, following the issuance of Series B Preferred Stock must include the
holders of at least a majority of the Series B Preferred Stock then held by the Series B Large Investors). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">9. <U>Notices</U>. Any notice
required or permitted by the provisions of this Article Fourth to be given to a holder of shares of Preferred Stock shall be mailed, postage prepaid, to the post office address last shown on the records of the Corporation, or given by electronic
communication in compliance with the provisions of the General Corporation Law, and shall be deemed sent upon such mailing or electronic transmission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>FIFTH: </B>Subject to any additional vote required by the Certificate of Incorporation or Bylaws, in furtherance and not in limitation of
the powers conferred by statute, the Board of Directors is expressly authorized to make, repeal, alter, amend and rescind any or all of the Bylaws of the Corporation. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>SIXTH: </B>Subject to any additional vote required by the Certificate of Incorporation,
the number of directors of the Corporation shall be determined in the manner set forth in the Bylaws of the Corporation. Each director shall be entitled to one vote on each matter presented to the Board of Directors; provided, however, that, so long
as the holders of Preferred Stock are entitled to elect a Preferred Director, the affirmative vote of the lesser of (i)&nbsp;three Preferred Directors, or (ii)&nbsp;all then-serving Preferred Directors, shall be required for the authorization by the
Board of Directors of any of the matters set forth in Section&nbsp;5.4 of the Amended and Restated Investors&#146; Rights Agreement, dated February&nbsp;13, 2019, by and among the Corporation and the other parties thereto, as such agreement may be
amended from time to time </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>SEVENTH: </B>Elections of directors need not be by written ballot unless the Bylaws of the Corporation shall
so provide. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>EIGHTH: </B>Meetings of stockholders may be held within or without the State of Delaware, as the Bylaws of the Corporation
may provide. The books of the Corporation may be kept outside the State of Delaware at such place or places as may be designated from time to time by the Board of Directors or in the Bylaws of the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>NINTH: </B>To the fullest extent permitted by law, a director of the Corporation shall not be personally liable to the Corporation or its
stockholders for monetary damages for breach of fiduciary duty as a director. If the General Corporation Law or any other law of the State of Delaware is amended after approval by the stockholders of this Article Ninth to authorize corporate action
further eliminating or limiting the personal liability of directors, then the liability of a director of the Corporation shall be eliminated or limited to the fullest extent permitted by the General Corporation Law as so amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any repeal or modification of the foregoing provisions of this Article Ninth by the stockholders of the Corporation shall not adversely affect
any right or protection of a director of the Corporation existing at the time of, or increase the liability of any director of the Corporation with respect to any acts or omissions of such director occurring prior to, such repeal or modification.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>TENTH: </B>To the fullest extent permitted by applicable law, the Corporation is authorized to provide indemnification of (and
advancement of expenses to) directors, officers and agents of the Corporation (and any other persons to which General Corporation Law permits the Corporation to provide indemnification) through Bylaw provisions, agreements with such agents or other
persons, vote of stockholders or disinterested directors or otherwise, in excess of the indemnification and advancement otherwise permitted by <U>Section</U><U></U><U>&nbsp;145</U> of the General Corporation Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Any amendment, repeal or modification of the foregoing provisions of this Article Tenth shall not adversely affect any right or protection of
any director, officer or other agent of the Corporation existing at the time of such amendment, repeal or modification. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>ELEVENTH: </B>The Corporation renounces, to the fullest extent permitted by law, any
interest or expectancy of the Corporation in, or in being offered an opportunity to participate in, any Excluded Opportunity. An &#147;<B>Excluded Opportunity</B>&#148; is any matter, transaction or interest that is presented to, or acquired,
created or developed by, or which otherwise comes into the possession of (i)&nbsp;any director of the Corporation who is not an employee of the Corporation or any of its subsidiaries, or (ii)&nbsp;any holder of Preferred Stock or any partner,
member, director, stockholder, employee, affiliate or agent of any such holder, other than someone who is an employee of the Corporation or any of its subsidiaries (collectively, the persons referred to in clauses (i)&nbsp;and (ii) are
&#147;<B>Covered Persons</B>&#148;), unless such matter, transaction or interest is presented to, or acquired, created or developed by, or otherwise comes into the possession of, a Covered Person expressly and solely in such Covered Person&#146;s
capacity as a director of the Corporation while such Covered Person is performing services in such capacity. Any repeal or modification of this Article Eleventh will only be prospective and will not affect the rights under this Article Eleventh in
effect at the time of the occurrence of any actions or omissions to act giving rise to liability. Notwithstanding anything to the contrary contained elsewhere in this Amended and Restated Certificate of Incorporation, the affirmative vote of the
Requisite Holders will be required to amend or repeal, or to adopt any provisions inconsistent with this Article Eleventh. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>TWELFTH:
</B>Unless the Corporation consents in writing to the selection of an alternative forum, (a)&nbsp;the Court of Chancery in the State of Delaware shall be the sole and exclusive forum for any stockholder (including a beneficial owner) to bring
(i)&nbsp;any derivative action or proceeding brought on behalf of the Corporation, (ii)&nbsp;any action asserting a claim of breach of fiduciary duty owed by any director, officer or other employee of the Corporation to the Corporation or the
Corporation&#146;s stockholders, (iii)&nbsp;any action asserting a claim against the Corporation, its directors, officers or employees arising pursuant to any provision of the Delaware General Corporation Law or the Corporation&#146;s certificate of
incorporation or bylaws or (iv)&nbsp;any action asserting a claim against the Corporation, its directors, officers or employees governed by the internal affairs doctrine; and (b)&nbsp;subject to the preceding provisions of this Article Twelfth, the
federal district courts of the United States of America shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act of 1933, as amended. If any action the subject matter of which is
within the scope of clause (a)&nbsp;of the immediately preceding sentence is filed in a court other than the courts in the State of Delaware (a &#147;<B>Foreign Action</B>&#148;) in the name of any stockholder, such stockholder shall be deemed to
have consented to (x)&nbsp;the personal jurisdiction of the state and federal courts in the State of Delaware in connection with any action brought in any such court to enforce the provisions of clause (a)&nbsp;of the immediately preceding sentence
and (y)&nbsp;having service of process made upon such stockholder in any such action by service upon such stockholder&#146;s counsel in the Foreign Action as agent for such stockholder. If any provision or provisions of this Article Twelfth shall be
held to be invalid, illegal or unenforceable as applied to any person or entity or circumstance for any reason whatsoever, then, to the fullest extent permitted by law, the validity, legality and enforceability of such provisions in any other
circumstance and of the remaining provisions of this Article Twelfth (including, without limitation, each portion of any sentence of this Article Twelfth containing any such provision held to be invalid, illegal or unenforceable that is not itself
held to be invalid, illegal or unenforceable) and the application of such provision to other persons or entities and circumstances shall not in any way be affected or impaired thereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>THIRTEENTH: </B>For purposes of Section&nbsp;500 of the California Corporations Code (to the extent applicable), in connection with any
repurchase of shares of Common Stock permitted under this Certificate of Incorporation from employees, officers, directors or consultants of the Corporation in connection with a termination of employment or services pursuant to agreements
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or arrangements approved by the Board of Directors (in addition to any other consent required under this Certificate of Incorporation), such repurchase may be made without regard to any
&#147;preferential dividends arrears amount&#148; or &#147;preferential rights amount&#148; (as those terms are defined in Section&nbsp;500 of the California Corporations Code).&nbsp;Accordingly, for purposes of making any calculation under
California Corporations Code Section&nbsp;500 in connection with such repurchase, the amount of any &#147;preferential dividends arrears amount&#148; or &#147;preferential rights amount&#148; (as those terms are defined therein) shall be deemed to
be zero (0). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">*&nbsp;&nbsp;&nbsp;&nbsp; *&nbsp;&nbsp;&nbsp;&nbsp; * </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>3.</B> That the foregoing amendment and restatement was approved by the holders of the requisite number of shares of this corporation in
accordance with Section&nbsp;228 of the General Corporation Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman"><B>4.</B> That this Amended and Restated Certificate of Incorporation,
which restates and integrates and further amends the provisions of this Corporation&#146;s Certificate of Incorporation, has been duly adopted in accordance with Sections 242 and 245 of the General Corporation Law. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, this Amended and Restated Certificate of Incorporation has been
executed by a duly authorized officer of this corporation on this 27th day of January, 2021. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Steven D. Harr, M.D.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Name: Steven D. Harr, M.D.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Title: Chief Executive Officer</TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.2
<SEQUENCE>4
<FILENAME>d60414dex32.htm
<DESCRIPTION>EX-3.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-3.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 3.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SANA BIOTECHNOLOGY, INC. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND RESTATED CERTIFICATE OF INCORPORATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Sana Biotechnology, Inc. (the &#147;<B><I>Corporation</I></B>&#148;), a corporation organized and existing under and by virtue of the Delaware
General Corporation Law, hereby certifies as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The name of the Corporation is Sana Biotechnology, Inc. The original Certificate of
Incorporation of the Corporation was filed with the Secretary of State of the State of Delaware on July&nbsp;13, 2018 under the name FD Therapeutics, Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Amended and Restated Certificate of Incorporation in the form of <U>Exhibit</U><U></U><U>&nbsp;A</U> attached hereto has been duly adopted
in accordance with the provisions of Sections 242, 245 and 228 of the Delaware General Corporation Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The text of the Amended and
Restated Certificate of Incorporation as heretofore amended or supplemented is hereby restated and further amended to read in its entirety as set forth in <U>Exhibit</U><U></U><U>&nbsp;A</U> attached hereto. The Amended and Restated Certificate of
Incorporation shall be effective as of 9:00 a.m. Eastern Time on February &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U></U>, 2021. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>IN WITNESS WHEREOF</B>, this Amended and Restated Certificate of Incorporation has been signed this
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;day of February, 2021. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>SANA BIOTECHNOLOGY, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Steven D. Harr</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Chief Executive
Officer</P></TD></TR>
</TABLE></DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>EXHIBIT A </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED AND RESTATED </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CERTIFICATE OF INCORPORATION OF </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SANA BIOTECHNOLOGY, INC. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>ARTICLE I </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NAME
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The name of the corporation is Sana Biotechnology, Inc. (the &#147;<B><I>Corporation</I></B>&#148;). </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>ARTICLE II </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>REGISTERED OFFICE AND AGENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The address of the Corporation&#146;s registered office in the State of Delaware is 251&nbsp;Little Falls Drive, Wilmington, County of
New&nbsp;Castle, 19801. The name of its registered agent at such address is Corporation Service Company. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>ARTICLE III </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PURPOSE AND DURATION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
purpose of the Corporation is to engage in any lawful act or activity for which a corporation may be organized under the Delaware General Corporation Law. The Corporation is to have a perpetual existence. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>ARTICLE IV </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CAPITAL STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;1.</B>&nbsp;&nbsp;&nbsp;&nbsp;This Corporation is authorized to issue two classes of capital stock which shall
be designated, respectively, &#147;Common Stock&#148; and &#147;Preferred Stock.&#148; The total number of shares that the Corporation is authorized to issue is 800,000,000, of which 750,000,000 shares shall be Common Stock and 50,000,000 shares
shall be Preferred Stock. The Common Stock shall have a par value of $0.0001 per share and the Preferred Stock shall have a par value of $0.0001 per share. Subject to the rights of the holders of any series of Preferred Stock, the number of
authorized shares of any of the Common Stock or Preferred Stock may be increased or decreased (but not below the number of shares thereof then outstanding) by the affirmative vote of the holders of a majority in voting power of the stock of the
Corporation with the power to vote thereon irrespective of the provisions of Section&nbsp;242(b)(2) of the Delaware General Corporation Law or any successor provision thereof, and no vote of the holders of any of the Common Stock or Preferred Stock
voting separately as a class shall be required therefor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;2.</B>&nbsp;&nbsp;&nbsp;&nbsp;Shares of Preferred
Stock may be issued from time to time in one or more series. The Board of Directors of the Corporation (the &#147;<B><I>Board of Directors</I></B>&#148;) is hereby authorized to provide from time to time by resolution or resolutions for the creation
and issuance, out of the authorized and unissued shares of Preferred Stock, of one or more series of Preferred Stock by filing a certificate (a &#147;<B><I>Certificate of Designation</I></B>&#148;) pursuant to the Delaware General Corporation Law,
setting forth such resolution and, with respect to each such series, establishing </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the designation of such series and the number of shares to be included in such series and fixing the voting powers (full or limited, or no voting power), preferences and relative, participating,
optional or other special rights, and the qualifications, limitations and restrictions thereof, of the shares of each such series. Without limiting the generality of the foregoing, the resolution or resolutions providing for the establishment of any
series of Preferred Stock may, to the extent permitted by law, provide that such series shall be superior to, rank equally with or be junior to the Preferred Stock of any other series. The powers, preferences and relative, participating, optional
and other special rights of each series of Preferred Stock, and the qualifications, limitations or restrictions thereof, if any, may be different from those of any and all other series at any time outstanding. Except as otherwise expressly provided
in the resolution or resolutions providing for the establishment of any series of Preferred Stock, no vote of the holders of shares of Preferred Stock or Common Stock shall be a prerequisite to the issuance of any shares of any series of the
Preferred Stock so authorized in accordance with this Amended and Restated Certificate of Incorporation. Unless otherwise provided in the Certificate of Designation establishing a series of Preferred Stock, the Board of Directors may, by resolution
or resolutions, increase or decrease (but not below the number of shares of such series then outstanding) the number of shares of such series and, if the number of shares of such series shall be so decreased, the shares constituting such decrease
shall resume the status that they had prior to the adoption of the resolution originally fixing the number of shares of such series. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>ARTICLE V </U></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>BOARD
OF DIRECTORS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the management of the business and for the conduct of the affairs of the Corporation it is further provided that:
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;1. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;The management of the business and the conduct of the affairs of the Corporation shall be vested in the Board of
Directors. The number of directors which shall constitute the whole Board of Directors shall be fixed exclusively by one or more resolutions adopted from time to time by the Board of Directors. Except as otherwise expressly delegated by resolution
of the Board of Directors, the Board of Directors shall have the exclusive power and authority to appoint and remove officers of the Corporation. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;Other than any directors elected by the separate vote of the holders of one or more series of Preferred Stock, the
Board of Directors shall be and is divided into three classes, designated as Class&nbsp;I, Class&nbsp;II and Class&nbsp;III, as nearly equal in number as possible. Directors shall be assigned to each class in accordance with a resolution or
resolutions adopted by the Board of Directors. At the first annual meeting of stockholders following the effectiveness of this Amended and Restated Certificate of Incorporation (the &#147;<B><I>Qualifying Record Date</I></B>&#148;), the term of
office of the Class&nbsp;I directors shall expire and Class&nbsp;I directors shall be elected for a full term of three years. At the second annual meeting of stockholders following the Qualifying Record Date, the term of office of the Class&nbsp;II
directors shall expire and Class&nbsp;II directors shall be elected for a full term of three years. At the third annual meeting of stockholders following the Qualifying Record Date, the term of office of the Class&nbsp;III directors
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
shall expire and Class&nbsp;III directors shall be elected for a full term of three years. Subject to the special rights of the holders of one or more series of Preferred Stock to elect
directors, at each succeeding annual meeting of stockholders, directors shall be elected for a full term of three years to succeed the directors of the class whose terms expire at such annual meeting. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing provisions of this Article&nbsp;V, Section&nbsp;1(b), each director shall serve until his or her successor is
duly elected and qualified or until his or her earlier death, resignation or removal. No decrease in the number of directors constituting the Board of Directors shall shorten the term of any incumbent director. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;Subject to the special rights of the holders of one or more series of Preferred Stock to elect directors, the Board
of Directors or any individual director may be removed from office at any time, but only for cause and only by the affirmative vote of the holders of <FONT STYLE="white-space:nowrap">sixty-six</FONT> and
<FONT STYLE="white-space:nowrap">two-thirds</FONT> percent <FONT STYLE="white-space:nowrap">(66-2/3%)</FONT> of the voting power of all the then outstanding shares of voting stock of the Corporation with the power to vote at an election of directors
(the &#147;<B><I>Voting Stock</I></B>&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;Subject to the special rights of the holders of one or more
series of Preferred Stock to elect directors, any vacancies on the Board of Directors resulting from death, resignation or removal and any newly created directorships resulting from any increase in the number of directors shall, unless the Board of
Directors determines by resolution that any such vacancies or newly created directorships shall be filled by the stockholders, and except as otherwise provided by law, be filled only by the affirmative vote of a majority of the directors then in
office, even though less than a quorum, or by a sole remaining director, and shall not be filled by the stockholders. Any director appointed in accordance with the preceding sentence shall hold office for a term that shall coincide with the
remaining term of the class to which the director shall have been appointed and until such director&#146;s successor shall have been elected and qualified or until his or her earlier death, resignation or removal. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section&nbsp;2. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;In furtherance and not in limitation of the powers conferred by statute, the Board of Directors is expressly
authorized to make, alter or repeal Bylaws of the Corporation. In addition to any vote of the holders of any class or series of stock of the Corporation required by applicable law or by this Amended and Restated Certificate of Incorporation
(including any Certificate of Designation in respect of one or more series of Preferred Stock), the adoption, amendment or repeal of the Bylaws of the Corporation by the stockholders of the Corporation shall require the affirmative vote of the
holders of at least <FONT STYLE="white-space:nowrap">sixty-six</FONT> and <FONT STYLE="white-space:nowrap">two-thirds</FONT> percent <FONT STYLE="white-space:nowrap">(66-2/3%)</FONT> of the voting power of all the then-outstanding shares of the
Voting Stock, voting together as a single class. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;The directors of the Corporation need not be elected by
written ballot unless the Bylaws so provide. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>ARTICLE VI </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>STOCKHOLDERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;1.</B>&nbsp;&nbsp;&nbsp;&nbsp;Subject to the special rights of the holders of one or more series of Preferred
Stock, any action required or permitted to be taken by the stockholders of the Corporation must be effected at a duly called annual or special meeting of the stockholders of the Corporation, and the taking of any action by written consent of the
stockholders in lieu of a meeting of the stockholders is specifically denied. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;2.</B>&nbsp;&nbsp;&nbsp;&nbsp;Subject to the special rights of the holders of one or more series of Preferred
Stock, special meetings of the stockholders of the Corporation may be called, for any purpose or purposes, at any time by the Board of Directors, but such special meetings may not be called by stockholders or any other person or persons. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;3.</B> &nbsp;&nbsp;&nbsp;&nbsp;Advance notice of stockholder nominations for the election of directors and of
other business proposed to be brought by stockholders before any meeting of the stockholders of the Corporation shall be given in the manner provided in the Bylaws of the Corporation. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>ARTICLE VII </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>LIABILITY AND INDEMNIFICATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;1.</B>&nbsp;&nbsp;&nbsp;&nbsp;To the fullest extent permitted by the Delaware General Corporation Law, as the
same exists or as may hereafter be amended, a director of the Corporation shall not be personally liable to the Corporation or its stockholders for monetary damages for breach of fiduciary duty as a director. If the Delaware General Corporation Law
is amended after approval by the stockholders of this Article VII to authorize corporate action further eliminating or limiting the personal liability of directors, then the liability of a director of the Corporation shall be eliminated or limited
to the fullest extent permitted by the Delaware General Corporation Law as so amended, automatically and without further action, upon the date of such amendment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;2.</B>&nbsp;&nbsp;&nbsp;&nbsp;The Corporation, to the fullest extent permitted by law, shall indemnify and
advance expenses to any person made or threatened to be made a party to an action, suit or proceeding, whether criminal, civil, administrative or investigative, by reason of the fact that he or she, or his or her testator or intestate, is or was a
director or officer of the Corporation or any predecessor of the Corporation, or serves or served at any other enterprise as a director or officer at the request of the Corporation or any predecessor to the Corporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;3.</B>&nbsp;&nbsp;&nbsp;&nbsp;The Corporation, to the fullest extent permitted by law, may indemnify and advance
expenses to any person made or threatened to be made a party to an action, suit or proceeding, whether criminal, civil, administrative or investigative, by reason of the fact that he or she, or his or her testator or intestate, is or was an employee
or agent of the Corporation or any predecessor of the Corporation, or serves or served at any other enterprise as an employee or agent at the request of the Corporation or any predecessor to the Corporation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Section</B><B></B><B>&nbsp;4.</B>&nbsp;&nbsp;&nbsp;&nbsp;Neither any amendment nor repeal
of this Article VII, nor the adoption by amendment of this Amended and Restated Certificate of Incorporation of any provision inconsistent with this Article VII, shall eliminate or reduce the effect of this Article VII in respect of any matter
occurring, or any action or proceeding accruing or arising (or that, but for this Article VII, would accrue or arise) prior to such amendment or repeal or adoption of an inconsistent provision. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>ARTICLE VIII </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXCLUSIVE FORUM </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless
the Corporation consents in writing to the selection of an alternative forum, (a)&nbsp;the Court of Chancery (the &#147;<B><I>Chancery Court</I></B>&#148;) of the State of Delaware (or, in the event that the Chancery Court does not have
jurisdiction, the federal district court for the District of Delaware or other state courts of the State of Delaware) shall, to the fullest extent permitted by law, be the sole and exclusive forum for (i)&nbsp;any derivative action, suit or
proceeding brought on behalf of the Corporation, (ii)&nbsp;any action, suit or proceeding asserting a claim of breach of a fiduciary duty owed by any director, officer<B> </B>or stockholder of the Corporation to the Corporation or to the
Corporation&#146;s stockholders, (iii)&nbsp;any action, suit or proceeding arising pursuant to any provision of the Delaware General Corporation Law or the bylaws of the Corporation or this Amended and Restated Certificate of Incorporation (as
either may be amended from time to time) or (iv)&nbsp;any action, suit or proceeding asserting a claim against the Corporation governed by the internal affairs doctrine; and (b)&nbsp;subject to the preceding provisions of this Article VIII, the
federal district courts of the United&nbsp;States of America shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act of 1933, as amended. If any action the subject matter of which
is within the scope of clause (a)&nbsp;of the immediately preceding sentence is filed in a court other than the courts in the State of Delaware (a &#147;<B><I>Foreign Action</I></B>&#148;) in the name of any stockholder, such stockholder shall be
deemed to have consented to (x)&nbsp;the personal jurisdiction of the state and federal courts in the State of Delaware in connection with any action brought in any such court to enforce the provisions of clause (a)&nbsp;of the immediately preceding
sentence and (y)&nbsp;having service of process made upon such stockholder in any such action by service upon such stockholder&#146;s counsel in the Foreign Action as agent for such stockholder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any person or entity purchasing or otherwise acquiring any interest in any security of the Corporation shall be deemed to have notice of and
consented to this Article&nbsp;VIII. Notwithstanding the foregoing, the provisions of this Article&nbsp;VIII shall not apply to suits brought to enforce any liability or duty created by the Securities Exchange Act of 1934, as amended, or any other
claim for which the federal courts of the United&nbsp;States have exclusive jurisdiction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any provision or provisions of this
Article&nbsp;VIII shall be held to be invalid, illegal or unenforceable as applied to any circumstance for any reason whatsoever, (a)&nbsp;the validity, legality and enforceability of such provisions in any other circumstance and of the remaining
provisions of this Article&nbsp;VIII (including, without limitation, each portion of any paragraph of this Article VIII containing any such provision held to be invalid, illegal or unenforceable that is not itself held to be invalid, illegal or
unenforceable) shall not in any way be affected or impaired thereby and (b)&nbsp;the application of such provision to other persons or entities and circumstances shall not in any way be affected or impaired thereby. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>ARTICLE IX </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding any other provisions of this Amended and Restated Certificate of Incorporation or any provision of law which might otherwise
permit a lesser vote or no vote, but in addition to any affirmative vote of the holders of any particular class or series of the Voting Stock required by law or by this Amended and Restated Certificate of Incorporation (including any Certificate of
Designation in respect of one or more series of Preferred Stock), the affirmative vote of the holders of at least <FONT STYLE="white-space:nowrap">sixty-six</FONT> and <FONT STYLE="white-space:nowrap">two-thirds</FONT> percent <FONT
STYLE="white-space:nowrap">(66-2/3%)</FONT> of the voting power of all of the then-outstanding shares of the Voting Stock, voting together as a single class, shall be required to alter, amend or repeal Articles&nbsp;V, VI, VII and VIII and this
Article&nbsp;IX. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">* * * * </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-6 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.4
<SEQUENCE>5
<FILENAME>d60414dex34.htm
<DESCRIPTION>EX-3.4
<TEXT>
<HTML><HEAD>
<TITLE>EX-3.4</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 3.4 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Amended and Restated Bylaws of </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(a Delaware corporation) </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Table of Contents </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article I&#151;Corporate Offices</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Registered Office</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">1.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Other Offices</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article II&#151;Meetings of Stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Place of Meetings</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Annual Meeting</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Special Meeting</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Advance Notice Procedures for Business Brought before a Meeting</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.5</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Advance Notice Procedures for Nominations of Directors</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.6</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Notice of Stockholders&#146; Meetings</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.7</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Manner of Giving Notice; Affidavit of Notice</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.8</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Quorum</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.9</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Adjourned Meeting; Notice</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.10</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Conduct of Business</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.11</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Voting</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.12</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Record Date for Stockholder Meetings and Other Purposes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.13</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Proxies</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.14</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">List of Stockholders Entitled to Vote</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2.15</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Inspectors of Election</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article III&#151;Directors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Powers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Number of Directors</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Election, Qualification and Term of Office of Directors</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Resignation and Vacancies</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.5</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Place of Meetings; Meetings by Telephone</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.6</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Regular Meetings</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.7</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Special Meetings; Notice</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.8</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Quorum</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.9</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Board Action by Written Consent without a Meeting</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">3.10</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Fees and Compensation of Directors</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article IV&#151;Committees</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Committees of Directors</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Committee Minutes</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">4.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Meetings and Action of Committees</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article V&#151;Officers</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Officers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Appointment of Officers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Subordinate Officers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Removal and Resignation of Officers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.5</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Vacancies in Offices</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">i </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Table of Contents </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(continued) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"><B>Page</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.6</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Representation of Shares of Other Corporations</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">5.7</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Authority and Duties of Officers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article VI&#151;Records</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article VII&#151;General Matters</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Execution of Corporate Contracts and Instruments</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Stock Certificates; Partly Paid Shares</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Lost Certificates</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Shares Without Certificates</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.5</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Construction; Definitions</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.6</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Dividends</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.7</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Fiscal Year</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.8</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Seal</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.9</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Transfer of Stock</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.10</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Stock Transfer Agreements</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.11</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Registered Stockholders</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">7.12</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Waiver of Notice</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article VIII&#151;Notice by Electronic Transmission</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Notice by Electronic Transmission</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">8.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Definition of Electronic Transmission</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article IX&#151;Indemnification</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.1</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Indemnification of Directors and Officers</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.2</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Indemnification of Others</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.3</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Prepayment of Expenses</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.4</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Determination; Claim</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.5</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="white-space:nowrap">Non-Exclusivity</FONT> of Rights</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.6</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Insurance</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.7</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Other Indemnification</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.8</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Continuation of Indemnification</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">9.9</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Amendment or Repeal; Interpretation</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article X&#151;Amendments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" COLSPAN="3"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Article XI&#151;Forum Selection</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ii </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Amended and Restated Bylaws of </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article I&#151;Corporate Offices </B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Registered Office</U>.</P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The address of the registered office of Sana Biotechnology, Inc. (the &#147;<U>Corporation</U>&#148;) in the State of Delaware, and the name of
its registered agent at such address, shall be as set forth in the Corporation&#146;s certificate of incorporation, as the same may be amended and/or restated from time to time (the &#147;<U>Certificate of Incorporation</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.2 <U>Other Offices</U>.</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
Corporation may have additional offices at any place or places, within or outside the State of Delaware, as the Corporation&#146;s board of directors (the &#147;<U>Board</U>&#148;) may from time to time establish or as the business of the
Corporation may require. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article II&#151;Meetings of Stockholders </B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Place of Meetings</U>.</P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Meetings of stockholders shall be held at such place, if any, within or outside the State of Delaware, designated by the Board. The Board may,
in its sole discretion, determine that a meeting of stockholders shall not be held at any place, but may instead be held solely by means of remote communication as authorized by Section&nbsp;211(a)(2) of the General Corporation Law of the State of
Delaware (the &#147;<U>DGCL</U>&#148;). In the absence of any such designation or determination, stockholders&#146; meetings shall be held at the Corporation&#146;s principal executive office. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Annual Meeting</U>.</P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board shall designate the date and time of the annual meeting. At the annual meeting, directors shall be elected and other proper business
properly brought before the meeting in accordance with Section&nbsp;2.4 may be transacted. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Special Meeting</U>.</P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Special meetings of the stockholders may be called only by such Persons and only in such manner as set forth in the Certificate of
Incorporation. As used in these bylaws, &#147;Person&#148; means any individual, general partnership, limited partnership, limited liability company, corporation, trust, business trust, joint stock company, joint venture, unincorporated association,
cooperative or association or any other legal entity or organization of whatever nature, and shall include any successor (by merger or otherwise) of such entity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No business may be transacted at any special meeting of stockholders other than the business specified in the notice of such meeting. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Advance Notice Procedures</U><U> for Business Brought before a Meeting</U>.</P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) At an annual meeting of the stockholders, only such business shall be conducted as shall have been properly brought before the meeting. To
be properly brought before an annual meeting, business must be (a)&nbsp;specified in a notice of meeting given by or at the direction of the Board, (b)&nbsp;if not specified in a notice of meeting, otherwise brought before the meeting by the Board
or the chairperson of the meeting, or (c)&nbsp;otherwise properly brought before the meeting by a stockholder present in Person who (A)(1) was a stockholder of the Corporation both at the time of giving the notice provided for in this
Section&nbsp;2.4 and at the time of the meeting, (2)&nbsp;is entitled to vote at the meeting and (3)&nbsp;has complied with this Section&nbsp;2.4 or (B)&nbsp;properly made such proposal in accordance with Rule
<FONT STYLE="white-space:nowrap">14a-8</FONT> under the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (as so amended and inclusive of such rules and regulations, the &#147;<U>Exchange Act</U>&#148;), which
proposal has been included in the proxy statement for the annual meeting. The foregoing clause&nbsp;(c) shall be the exclusive means for a stockholder to propose business to be brought before an annual meeting of the stockholders. The only matters
that may be brought before a special meeting are the matters specified in the Corporation&#146;s notice of meeting given by or at the direction of the Person calling the meeting pursuant to the Certificate of Incorporation and Section&nbsp;2.3 of
these bylaws. For purposes of this Section&nbsp;2.4 and Section&nbsp;2.5 of these bylaws, &#147;present in Person&#148; shall mean that the stockholder proposing that the business be brought before the annual or special meeting of the Corporation,
or, if the proposing stockholder is not an individual, a qualified representative of such proposing stockholder, appear at such annual meeting, and a &#147;qualified representative&#148; of such proposing stockholder shall be, if such proposing
stockholder is (x)&nbsp;a general or limited partnership, any general partner or Person who functions as a general partner of the general or limited partnership or who controls the general or limited partnership, (y)&nbsp;a corporation or a limited
liability company, any officer or Person who functions as an officer of the corporation or limited liability company or any officer, director, general partner or Person who functions as an officer, director or general partner of any entity
ultimately in control of the corporation or limited liability company or (z)&nbsp;a trust, any trustee of such trust. This Section&nbsp;2.4 shall apply to any business that may be brought before an annual or special meeting of stockholders other
than nominations for election to the Board at an annual meeting, which shall be governed by Section&nbsp;2.5 of these bylaws. Stockholders seeking to nominate Persons for election to the Board must comply with Section&nbsp;2.5 of these bylaws, and
this Section&nbsp;2.4 shall not be applicable to nominations for election to the Board except as expressly provided in Section&nbsp;2.5 of these bylaws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) Without qualification, for business to be properly brought before an annual meeting by a stockholder, the stockholder must
(a)&nbsp;provide Timely Notice (as defined below) thereof in writing and in proper form to the Secretary of the Corporation and (b)&nbsp;provide any updates or supplements to such notice at the times and in the forms required by this
Section&nbsp;2.4. To be timely, a stockholder&#146;s notice must be delivered to, or mailed and received at, the principal executive offices of the Corporation not less than ninety (90)&nbsp;days nor more than one hundred twenty (120)&nbsp;days
prior to the <FONT STYLE="white-space:nowrap">one-year</FONT> anniversary of the preceding year&#146;s annual meeting; <I>provided, however</I>, that if the date of the annual meeting is more than thirty (30)&nbsp;days before or more than sixty
(60)&nbsp;days after such anniversary date, notice by the stockholder to be timely must be so delivered, or mailed and received, not later than the ninetieth (90<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>) day prior to such annual
meeting or, if later, the tenth (10<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>) day following the day on which public disclosure of the date of such annual meeting was first made (such notice within such time periods, &#147;<U>Timely
Notice</U>&#148;). In no event shall any adjournment or postponement of an annual meeting or the announcement thereof commence a new time period for the giving of Timely Notice as described above. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) To be in proper form for purposes of this Section&nbsp;2.4, a stockholder&#146;s
notice to the Secretary shall set forth: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) As to each Proposing Person (as defined below), (A) the name and address of
such Proposing Person (including, if applicable, the name and address that appear on the Corporation&#146;s books and records); and (B)&nbsp;the number of shares of each class or series of stock of the Corporation that are, directly or indirectly,
owned of record or beneficially owned (within the meaning of Rule <FONT STYLE="white-space:nowrap">13d-3</FONT> under the Exchange Act) by such Proposing Person, except that such Proposing Person shall in all events be deemed to beneficially own any
shares of any class or series of stock of the Corporation as to which such Proposing Person has a right to acquire beneficial ownership at any time in the future (the disclosures to be made pursuant to the foregoing clauses (A)&nbsp;and (B) are
referred to as &#147;<U>Stockholder Information</U>&#148;); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) As to each Proposing Person, (A)&nbsp;the full notional
amount of any securities that, directly or indirectly, underlie any &#147;derivative security&#148; (as such term is defined in Rule <FONT STYLE="white-space:nowrap">16a-1(c)</FONT> under the Exchange Act) that constitutes a &#147;call equivalent
position&#148; (as such term is defined in Rule <FONT STYLE="white-space:nowrap">16a-1(b)</FONT> under the Exchange Act) (&#147;<U>Synthetic Equity Position</U>&#148;) and that is, directly or indirectly, held or maintained by such Proposing Person
with respect to any shares of any class or series of stock of the Corporation; <I>provided</I> that, for the purposes of the definition of &#147;Synthetic Equity Position,&#148; the term &#147;derivative security&#148; shall also include any
security or instrument that would not otherwise constitute a &#147;derivative security&#148; as a result of any feature that would make any conversion, exercise or similar right or privilege of such security or instrument becoming determinable only
at some future date or upon the happening of a future occurrence, in which case the determination of the amount of securities into which such security or instrument would be convertible or exercisable shall be made assuming that such security or
instrument is immediately convertible or exercisable at the time of such determination; and, <I>provided</I>, <I>further</I>, that any Proposing Person satisfying the requirements of Rule <FONT STYLE="white-space:nowrap">13d-1(b)(1)</FONT> under the
Exchange Act (other than a Proposing Person that so satisfies Rule <FONT STYLE="white-space:nowrap">13d-1(b)(1)</FONT> under the Exchange Act solely by reason of Rule <FONT STYLE="white-space:nowrap">13d-1(b)(1)(ii)(E))</FONT> shall not be deemed to
hold or maintain the notional amount of any securities that underlie a Synthetic Equity Position held by such Proposing Person as a hedge with respect to a bona fide derivatives trade or position of such Proposing Person arising in the ordinary
course of such Proposing Person&#146;s business as a derivatives dealer, (B)&nbsp;any rights to dividends on the shares of any class or series of stock of the Corporation owned beneficially by such Proposing Person that are separated or separable
from the underlying shares of the Corporation, (C)&nbsp;any material pending or threatened legal proceeding in which such Proposing Person is a party or material participant involving the Corporation or any of its officers or directors, or any
affiliate of the Corporation, (D)&nbsp;any other material relationship between such Proposing Person, on the one hand, and the Corporation or any affiliate of the Corporation, on the other hand, (E)&nbsp;any direct or indirect material interest in
any material contract or agreement of such Proposing Person with the Corporation or any affiliate of the Corporation (including, in any such case, any employment agreement, collective bargaining agreement or consulting agreement) and (F)&nbsp;any
other information relating to such Proposing Person that would be required to be disclosed in a proxy statement or other filing required to be made in connection with solicitations of proxies or consents by such Proposing Person in support of the
business proposed to be brought before the meeting pursuant to Section&nbsp;14(a) of the Exchange Act (the disclosures to be made pursuant to the foregoing clauses (A)&nbsp;through (F) are referred to as &#147;<U>Disclosable Interests</U>&#148;);
<I>provided</I>, <I>however</I>, that Disclosable Interests shall not include any such disclosures with respect to the ordinary course business activities of any broker, dealer, commercial bank, trust company or other nominee who is a Proposing
Person solely as a result of being the stockholder directed to prepare and submit the notice required by these bylaws on behalf of a beneficial owner; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) As to each item of business that the stockholder proposes to bring
before the annual meeting, (A)&nbsp;a brief description of the business desired to be brought before the annual meeting, the reasons for conducting such business at the annual meeting and any material interest in such business of each Proposing
Person, (B)&nbsp;the text of the proposal or business (including the text of any resolutions proposed for consideration), (C) a reasonably detailed description of all agreements, arrangements and understandings (x)&nbsp;between or among any of the
Proposing Persons or (y)&nbsp;between or among any Proposing Person and any other Person or entity (including their names) in connection with the proposal of such business by such stockholder and (D)&nbsp;any other information relating to such item
of business that would be required to be disclosed in a proxy statement or other filing required to be made in connection with solicitations of proxies in support of the business proposed to be brought before the meeting pursuant to
Section&nbsp;14(a) of the Exchange Act; <I>provided</I>, <I>however</I>, that the disclosures required by this Section&nbsp;2.4(iii) shall not include any disclosures with respect to any broker, dealer, commercial bank, trust company or other
nominee who is a Proposing Person solely as a result of being the stockholder directed to prepare and submit the notice required by these bylaws on behalf of a beneficial owner. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) For purposes of this Section&nbsp;2.4, the term &#147;<U>Proposing Person</U>&#148;<I> </I>shall mean (a)&nbsp;the stockholder providing
the notice of business proposed to be brought before an annual meeting, (b)&nbsp;the beneficial owner or beneficial owners, if different, on whose behalf the notice of the business proposed to be brought before the annual meeting is made,
(c)&nbsp;any participant (as defined in paragraphs (a)(ii)-(vi) of Instruction 3 to Item 4 of Schedule 14A) with such stockholder in such solicitation or (d)&nbsp;any associate (within the meaning of Rule
<FONT STYLE="white-space:nowrap">12b-2</FONT> under the Exchange Act for the purposes of these bylaws) of such stockholder, beneficial owner or any other participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) A Proposing Person shall update and supplement its notice to the Corporation of its intent to propose business at an annual meeting, if
necessary, so that the information provided or required to be provided in such notice pursuant to this Section&nbsp;2.4 shall be true and correct as of the record date for notice of the meeting and as of the date that is ten (10)&nbsp;business days
prior to the meeting or any adjournment or postponement thereof, and such update and supplement shall be delivered to, or mailed and received by, the Secretary at the principal executive offices of the Corporation not later than five
(5)&nbsp;business days after the record date for notice of the meeting (in the case of the update and supplement required to be made as of such record date), and not later than eight (8)&nbsp;business days prior to the date for the meeting or, if
practicable, any adjournment or postponement thereof (and, if not practicable, on the first practicable date prior to the date to which the meeting has been adjourned or postponed) (in the case of the update and supplement required to be made as of
ten (10)&nbsp;business days prior to the meeting or any adjournment or postponement thereof). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vi) Notwithstanding anything in these
bylaws to the contrary, no business shall be conducted at an annual meeting that is not properly brought before the meeting in accordance with this Section&nbsp;2.4. The presiding officer of the meeting shall, if the facts warrant, determine that
the business was not properly brought before the meeting in accordance with this Section&nbsp;2.4, and if he or she should so determine, he or she shall so declare to the meeting and any such business not properly brought before the meeting shall
not be transacted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vii) In addition to the requirements of this Section&nbsp;2.4 with respect to any business proposed to be brought
before an annual meeting, each Proposing Person shall comply with all applicable requirements of the Exchange Act with respect to any such business. Nothing in this Section&nbsp;2.4 shall be deemed to affect the rights of stockholders to request
inclusion of proposals in the Corporation&#146;s proxy statement pursuant to Rule <FONT STYLE="white-space:nowrap">14a-8</FONT> under the Exchange Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(viii) For purposes of these bylaws, &#147;<U>public disclosure</U>&#148; shall mean
disclosure in a press release reported by a national news service or in a document publicly filed by the Corporation with the Securities and Exchange Commission pursuant to Section&nbsp;13, 14 or 15(d) of the Exchange Act. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Advance Notice Procedures for Nominations of Directors</U>. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Nominations of any Person for election to the Board at an annual meeting may be made at such meeting only (a)&nbsp;by or at the direction
of the Board, including by any committee or Persons authorized to do so by the Board or these bylaws, or (b)&nbsp;by a stockholder present in Person (as defined in Section&nbsp;2.4) (1) who was a beneficial owner of shares of the Corporation both at
the time of giving the notice provided for in this Section&nbsp;2.5 and at the time of the meeting, (2)&nbsp;is entitled to vote at the meeting and (3)&nbsp;has complied with this Section&nbsp;2.5 as to such notice and nomination. The foregoing
clause (b)&nbsp;shall be the exclusive means for a stockholder to make any nomination of a Person or Persons for election to the Board at any annual meeting of stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) Without qualification, for a stockholder to make any nomination of a Person or Persons for election to the Board at an annual meeting,
the stockholder must (a)&nbsp;provide Timely Notice (as defined in Section&nbsp;2.4(ii) of these bylaws) thereof in writing and in proper form to the Secretary of the Corporation, (b)&nbsp;provide the information, agreements and questionnaires with
respect to such stockholder and its candidate for nomination as required to be set forth by this Section&nbsp;2.5, and (c)&nbsp;provide any updates or supplements to such notice at the times and in the forms required by this Section&nbsp;2.5. In no
event shall any adjournment or postponement of an annual meeting or the announcement thereof commence a new time period for the giving of a stockholder&#146;s notice as described above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) To be in proper form for purposes of this Section&nbsp;2.5, a stockholder&#146;s notice to the Secretary shall set forth: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) As to each Nominating Person (as defined below), the Stockholder Information (as defined in Section&nbsp;2.4(iii)(a) of
these bylaws) except that for purposes of this Section&nbsp;2.5, the term &#147;Nominating Person&#148; shall be substituted for the term &#147;Proposing Person&#148; in all places it appears in Section&nbsp;2.4(iii)(a); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) As to each Nominating Person, any Disclosable Interests (as defined in Section&nbsp;2.4(iii)(b), except that for purposes
of this Section&nbsp;2.5 the term &#147;Nominating Person&#148; shall be substituted for the term &#147;Proposing Person&#148; in all places it appears in Section&nbsp;2.4(iii)(b) and the disclosure with respect to the business to be brought before
the meeting in Section&nbsp;2.4(iii)(c) shall be made with respect to nomination of each Person for election as a director at the meeting); and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) As to each candidate whom a Nominating Person proposes to nominate for election as a director, (A)&nbsp;all information
with respect to such candidate for nomination that would be required to be set forth in a stockholder&#146;s notice pursuant to this Section&nbsp;2.5 if such candidate for nomination were a Nominating Person, (B)&nbsp;all information relating to
such candidate for nomination that is required to be disclosed in a proxy statement or other filings required to be made in connection with solicitations of proxies for election of directors in a </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
contested election pursuant to Section&nbsp;14(a) under the Exchange Act (including such candidate&#146;s written consent to being named in the proxy statement as a nominee and to serving as a
director if elected), (C) a description of any direct or indirect material interest in any material contract or agreement between or among any Nominating Person, on the one hand, and each candidate for nomination or his or her respective associates
or any other participants in such solicitation, on the other hand, including, without limitation, all information that would be required to be disclosed pursuant to Item 404 under Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> if such
Nominating Person were the &#147;registrant&#148; for purposes of such rule and the candidate for nomination were a director or executive officer of such registrant (the disclosures to be made pursuant to the foregoing clauses (A)&nbsp;through (C)
are referred to as &#147;<U>Nominee Information</U>&#148;), and (D)&nbsp;a completed and signed questionnaire, representation and agreement as provided in Section&nbsp;2.5(vi). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) For purposes of this Section&nbsp;2.5, the term &#147;<U>Nominating Person</U>&#148;<I> </I>shall mean (a)&nbsp;the stockholder providing
the notice of the nomination proposed to be made at the meeting, (b)&nbsp;the beneficial owner or beneficial owners, if different, on whose behalf the notice of the nomination proposed to be made at the meeting is made, (c)&nbsp;any other
participant in such solicitation and (d)&nbsp;any associate of such stockholder or beneficial owner or any other participant in such solicitation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) A stockholder providing notice of any nomination proposed to be made at a meeting shall further update and supplement such notice, if
necessary, so that the information provided or required to be provided in such notice pursuant to this Section&nbsp;2.5 shall be true and correct as of the record date for notice of the meeting and as of the date that is ten (10)&nbsp;business days
prior to the meeting or any adjournment or postponement thereof, and such update and supplement shall be delivered to, or mailed and received by, the Secretary at the principal executive offices of the Corporation not later than five
(5)&nbsp;business days after the record date for notice of the meeting (in the case of the update and supplement required to be made as of such record date), and not later than eight (8)&nbsp;business days prior to the date for the meeting or, if
practicable, any adjournment or postponement thereof (and, if not practicable, on the first practicable date prior to the date to which the meeting has been adjourned or postponed) (in the case of the update and supplement required to be made as of
ten (10)&nbsp;business days prior to the meeting or any adjournment or postponement thereof). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vi) To be eligible to be a candidate for
election as a director of the Corporation at an annual meeting, a candidate must be nominated in the manner prescribed in this Section&nbsp;2.5 and the candidate for nomination, whether nominated by the Board or by a stockholder of record, must have
previously delivered (in accordance with the time period prescribed for delivery in a notice to such candidate given by or on behalf of the Board), to the Secretary at the principal executive offices of the Corporation, (a)&nbsp;a completed written
questionnaire (in the form provided by the Corporation) with respect to the background, qualifications, stock ownership and independence of such candidate for nomination and (b)&nbsp;a written representation and agreement (in the form provided by
the Corporation) that such candidate for nomination (A)&nbsp;is not, and will not become a party to, any agreement, arrangement or understanding with any Person or entity other than the Corporation with respect to any direct or indirect compensation
or reimbursement for service as a director of the Corporation that has not been disclosed therein and (B)&nbsp;if elected as a director of the Corporation, will comply with all applicable corporate governance, conflict of interest, confidentiality,
stock ownership and trading and other policies and guidelines of the Corporation applicable to all directors and in effect during such Person&#146;s term in office as a director (and, if requested by any candidate for nomination, the Secretary of
the Corporation shall provide to such candidate for nomination all such policies and guidelines then in effect). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vii) The Board may also require any proposed candidate for nomination as a Director to
furnish such other information as may reasonably be requested by the Board in writing prior to the meeting of stockholders at which such candidate&#146;s nomination is to be acted upon in order for the Board to determine the eligibility of such
candidate for nomination to be an independent director of the Corporation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(viii) In addition to the requirements of this
Section&nbsp;2.5 with respect to any nomination proposed to be made at a meeting, each Proposing Person shall comply with all applicable requirements of the Exchange Act with respect to any such nominations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ix) No candidate shall be eligible for nomination as a director of the Corporation unless such candidate for nomination and the Nominating
Person seeking to place such candidate&#146;s name in nomination has complied with this Section&nbsp;2.5, as applicable. The presiding officer at the meeting shall, if the facts warrant, determine that a nomination was not properly made in
accordance with this Section&nbsp;2.5, and if he or she should so determine, he or she shall so declare such determination to the meeting, the defective nomination shall be disregarded and any ballots cast for the candidate in question (but in the
case of any form of ballot listing other qualified nominees, only the ballots case for the nominee in question) shall be void and of no force or effect. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(x) Notwithstanding anything in these bylaws to the contrary, no candidate for nomination shall be eligible to be seated as a director of the
Corporation unless nominated and elected in accordance with this Section&nbsp;2.5. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.6</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Notice of Stockholders</U><U>&#146;</U><U> Meetings</U>. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise provided by law, the Certificate of Incorporation or these bylaws, the notice of any meeting of stockholders shall be sent or
otherwise given in accordance with either Section&nbsp;2.7 or Section&nbsp;8.1 of these bylaws not less than ten (10)&nbsp;nor more than sixty (60)&nbsp;days before the date of the meeting to each stockholder entitled to vote at such meeting. The
notice shall specify the place, if any, date and hour of the meeting, the means of remote communication, if any, by which stockholders and proxy holders may be deemed to be present in Person and vote at such meeting, and, in the case of a special
meeting, the purpose or purposes for which the meeting is called. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.7</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Manner of Giving Notice; Affidavit of Notice</U>.</P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notice of any meeting of stockholders shall be deemed given: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) if mailed, when deposited in the U.S. mail, postage prepaid, directed to the stockholder at his or her address as it appears on the
Corporation&#146;s records; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) if electronically transmitted as provided in Section&nbsp;8.1 of these bylaws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An affidavit of the secretary or an assistant secretary of the Corporation or of the transfer agent or any other agent of the Corporation that
the notice has been given by mail or by a form of electronic transmission, as applicable, shall, in the absence of fraud, be prima facie evidence of the facts stated therein. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.8</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Quorum</U>.</P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise provided by law, the Certificate of Incorporation or these bylaws, the holders of a majority in voting power of the stock
issued and outstanding and entitled to vote, present in Person, or by remote communication, if applicable, or represented by proxy, shall constitute a quorum for the transaction of business at all meetings of the stockholders. If, however, a quorum
is not present or represented at any meeting of the stockholders, then either (i)&nbsp;the chairperson of the meeting or (ii)&nbsp;a majority in voting power of the stockholders entitled to vote at the meeting, present in Person, or by remote
communication, if applicable, or represented by proxy, shall have power to adjourn the meeting from time to time in the manner provided in Section&nbsp;2.9 of these bylaws until a quorum is present or represented. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.9</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Adjourned Meeting; Notice</U>.</P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">When a meeting is adjourned to another time or place, if any, notice need not be given of the adjourned meeting if the time, place, if any,
thereof, and the means of remote communications, if any, by which stockholders and proxy holders may be deemed to be present in Person and vote at such adjourned meeting are announced at the meeting at which the adjournment is taken. At any
adjourned meeting, the Corporation may transact any business which might have been transacted at the original meeting. If the adjournment is for more than thirty (30)&nbsp;days, a notice of the adjourned meeting shall be given to each stockholder of
record entitled to vote at the meeting. If after the adjournment a new record date for determination of stockholders entitled to vote is fixed for the adjourned meeting, the Board shall fix as the record date for determining stockholders entitled to
notice of such adjourned meeting the same or an earlier date as that fixed for determination of stockholders entitled to vote at the adjourned meeting, and shall give notice of the adjourned meeting to each stockholder of record as of the record
date so fixed for notice of such adjourned meeting. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.10</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Conduct of Business</U>.</P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The date and time of the opening and the closing of the polls for each matter upon which the stockholders will vote at a meeting shall be
announced at the meeting by the Person presiding over the meeting. The Board may adopt by resolution such rules and regulations for the conduct of the meeting of stockholders as it shall deem appropriate. Except to the extent inconsistent with such
rules and regulations as adopted by the Board, the chairperson of any meeting of stockholders shall have the right and authority to convene and (for any or no reason) to recess and/or adjourn the meeting, to prescribe such rules, regulations and
procedures and to do all such acts as, in the judgment of such chairperson, are appropriate for the proper conduct of the meeting. Such rules, regulations or procedures, whether adopted by the Board or prescribed by the chairperson of the meeting,
may include, without limitation, the following: (i)&nbsp;the establishment of an agenda or order of business for the meeting; (ii)&nbsp;rules and procedures for maintaining order at the meeting and the safety of those present; (iii)&nbsp;limitations
on attendance at or participation in the meeting to stockholders entitled to vote at the meeting, their duly authorized and constituted proxies or such other Persons as the chairperson of the meeting shall determine; (iv)&nbsp;restrictions on entry
to the meeting after the time fixed for the commencement thereof; and (v)&nbsp;limitations on the time allotted to questions or comments by participants. Unless and to the extent determined by the Board or the chairperson of the meeting, meetings of
stockholders shall not be required to be held in accordance with the rules of parliamentary procedure. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.11</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Voting</U>.</P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as may be otherwise provided in the Certificate of Incorporation, these bylaws or the DGCL, each stockholder shall be entitled to one
(1)&nbsp;vote for each share of capital stock held by such stockholder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise provided by the Certificate of Incorporation, at all duly called or
convened meetings of stockholders at which a quorum is present, for the election of directors, a plurality of the votes cast shall be sufficient to elect a director. Except as otherwise provided by the Certificate of Incorporation, these bylaws, the
rules or regulations of any stock exchange applicable to the Corporation, or applicable law or pursuant to any regulation applicable to the Corporation or its securities, each other matter presented to the stockholders at a duly called or convened
meeting at which a quorum is present shall be decided by the affirmative vote of the holders of a majority of the votes cast (excluding abstentions and broker <FONT STYLE="white-space:nowrap">non-votes)</FONT> on such matter. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.12</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Record Date for Stockholder Meetings and Other Purposes</U>.</P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order that the Corporation may determine the stockholders entitled to notice of or to vote at any meeting of stockholders or any
adjournment thereof, the Board may fix a record date, which record date shall not precede the date upon which the resolution fixing the record date is adopted by the Board, and which record date shall not be more than sixty (60)&nbsp;days nor less
than ten (10)&nbsp;days before the date of such meeting. If the Board so fixes a date, such date shall also be the record date for determining the stockholders entitled to vote at such meeting unless the Board determines, at the time it fixes such
record date, that a later date on or before the date of the meeting shall be the date for making such determination. If no record date is fixed by the Board, the record date for determining stockholders entitled to notice of or to vote at a meeting
of stockholders shall be the close of business on the next day preceding the day on which notice is first given, or, if notice is waived, at the close of business on the day next preceding the day on which the meeting is held. A determination of
stockholders of record entitled to notice of or to vote at a meeting of stockholders shall apply to any adjournment of the meeting; <I>provided, however</I>, that the Board may fix a new record date for the adjourned meeting; and in such case shall
also fix as the record date for stockholders entitled to notice of such adjourned meeting the same or an earlier date as that fixed for determination of stockholders entitled to vote in accordance herewith at the adjourned meeting. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In order that the Corporation may determine the stockholders entitled to receive payment of any dividend or other distribution or allotment or
any rights or the stockholders entitled to exercise any rights in respect of any change, conversion or exchange of capital stock, or for the purposes of any other lawful action, the Board may fix a record date, which record date shall not precede
the date upon which the resolution fixing the record date is adopted, and which record date shall be not more than sixty (60)&nbsp;days prior to such action. If no record date is fixed, the record date for determining stockholders for any such
purpose shall be at the close of business on the day on which the Board adopts the resolution relating thereto. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.13</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Proxies</U>.</P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each stockholder entitled to vote at a meeting of stockholders may authorize another Person or Persons to act for such stockholder by proxy
authorized by an instrument in writing or by a transmission permitted by law filed in accordance with the procedure established for the meeting, but, no such proxy shall be voted or acted upon after three (3)&nbsp;years from its date, unless the
proxy provides for a longer period. The revocability of a proxy that states on its face that it is irrevocable shall be governed by the provisions of Section&nbsp;212 of the DGCL. A proxy may be in the form of a telegram, cablegram or other means of
electronic transmission which sets forth or is submitted with information from which it can be determined that the telegram, cablegram or other means of electronic transmission was authorized by the stockholder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.14</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>List of Stockholders Entitled to Vote</U>.</P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation shall prepare, at least ten (10)&nbsp;days before every meeting of stockholders, a complete list of the stockholders entitled
to vote at the meeting (<I>provided, however</I>, that if the record date for determining the stockholders entitled to vote is less than ten (10)&nbsp;days before the date of the meeting, the list shall reflect the stockholders entitled to vote as
of the tenth (10th) day before the meeting date), arranged in alphabetical order, and showing the address of each stockholder and the number of shares registered in the name of each stockholder. The Corporation shall not be required to include
electronic mail addresses or other electronic contact information on such list. Such list shall be open to the examination of any stockholder, for any purpose germane to the meeting for a period of at least ten (10)&nbsp;days prior to the meeting:
(i)&nbsp;on a reasonably accessible electronic network, provided that the information required to gain access to such list is provided with the notice of the meeting, or (ii)&nbsp;during ordinary business hours, at the Corporation&#146;s principal
executive office. In the event that the Corporation determines to make the list available on an electronic network, the Corporation may take reasonable steps to ensure that such information is available only to stockholders of the Corporation. If
the meeting is to be held at a place, then the list shall be produced and kept at the time and place of the meeting during the whole time thereof, and may be inspected by any stockholder who is present. If the meeting is to be held solely by means
of remote communication, then the list shall also be open to the examination of any stockholder during the whole time of the meeting on a reasonably accessible electronic network, and the information required to access such list shall be provided
with the notice of the meeting. Such list shall presumptively determine the identity of the stockholders entitled to vote at the meeting and the number of shares held by each of them. Except as otherwise provided by law, the stock ledger shall be
the only evidence as to who are the stockholders entitled to examine the list of stockholders required by this Section&nbsp;2.14 or to vote in Person or by proxy at any meeting of stockholders. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.15</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Inspectors of Election</U>. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Before any meeting of stockholders, the Corporation shall appoint an inspector or inspectors of election to act at the meeting or its
adjournment and make a written report thereof. The Corporation may designate one or more Persons as alternate inspectors to replace any inspector who fails to act. If any Person appointed as inspector or any alternate fails to appear or fails or
refuses to act, then the chairperson of the meeting shall appoint a Person to fill that vacancy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Such inspectors shall: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) determine the number of shares outstanding and the voting power of each, the number of shares represented at the meeting and the validity
of any proxies and ballots; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) count all votes or ballots; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) count and tabulate all votes; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) determine and retain for a reasonable period a record of the disposition of any challenges made to any determination by the inspector(s);
and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) certify its or their determination of the number of shares represented at the meeting and its or their count of all votes and
ballots. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each inspector, before entering upon the discharge of the duties of inspector, shall take
and sign an oath faithfully to execute the duties of inspection with strict impartiality and according to the best of such inspector&#146;s ability. Any report or certificate made by the inspectors of election is prima facie evidence of the facts
stated therein. The inspectors of election may appoint such Persons to assist them in performing their duties as they determine. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article III&#151;Directors </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Powers</U>.</P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as otherwise provided by the certificate of incorporation or the DGCL, the business and affairs of the Corporation shall be managed by
or under the direction of the Board. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Number of Directors</U>.</P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the Certificate of Incorporation, the total number of directors constituting the Board shall be determined from time to time by
resolution of the Board. No reduction of the authorized number of directors shall have the effect of removing any director before that director&#146;s term of office expires. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Election, Qualification and Term of Office of Directors</U>.</P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Except as provided in Section&nbsp;3.4 of these bylaws, each director, including a director elected to fill a vacancy or newly created
directorship, shall hold office until the expiration of the term of the class, if any, for which elected and until such director&#146;s successor is elected and qualified or until such director&#146;s earlier death, resignation or removal. Directors
need not be stockholders. The Certificate of Incorporation or these bylaws may prescribe qualifications for directors. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Resignation and Vacancies</U>.</P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any director may resign at any time upon notice given in writing or by electronic transmission to the Corporation. The resignation shall take
effect at the time specified therein or upon the happening of an event specified therein, and if no time or event is specified, at the time of its receipt. When one or more directors so resigns and the resignation is effective at a future date or
upon the happening of an event to occur on a future date, a majority of the directors then in office, including those who have so resigned, shall have power to fill such vacancy or vacancies, the vote thereon to take effect when such resignation or
resignations shall become effective, and each director so chosen shall hold office as provided in this section in the filling of other vacancies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise provided in the Certificate of Incorporation or these bylaws, vacancies and newly created directorships resulting from any
increase in the authorized number of directors shall be filled only by a majority of the directors then in office, although less than a quorum, or by a sole remaining director. Any director appointed in accordance with the preceding sentence shall
hold office for the remainder of the term of the class, if any, to which the director is appointed and until such director&#146;s successor shall have been elected and qualified. A vacancy in the Board shall be deemed to exist under these bylaws in
the case of the death, removal or resignation of any director. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Place of Meetings; Meetings by Telephone</U>.</P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board may hold meetings, both regular and special, either within or outside the State of Delaware. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise restricted by the Certificate of Incorporation or these bylaws, members of the Board, or any committee designated by the
Board, may participate in a meeting of the Board, or any committee, by means of conference telephone or other communications equipment by means of which all Persons participating in the meeting can hear each other, and such participation in a
meeting pursuant to this bylaw shall constitute presence in Person at the meeting. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.6</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Regular Meetings</U>.</P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Regular meetings of the Board may be held without notice at such time and at such place as shall from time to time be determined by the Board.
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.7</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Special Meetings; Notice</U>.</P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Special meetings of the Board for any purpose or purposes may be called at any time by a majority of the total number of directors
constituting the Board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notice of the time and place of special meetings shall be: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) delivered personally by hand, by courier or by telephone; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) sent by United States first-class mail, postage prepaid; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) sent by facsimile or electronic mail; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) sent by other means of electronic transmission, </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">directed to each director at that director&#146;s address, telephone number, facsimile number or electronic mail address, or other address for electronic
transmission, as the case may be, as shown on the Corporation&#146;s records. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the notice is (i)&nbsp;delivered personally by hand, by
courier or by telephone, (ii)&nbsp;sent by facsimile or electronic mail, or (iii)&nbsp;sent by other means of electronic transmission, it shall be delivered or sent at least twenty-four (24)&nbsp;hours before the time of the holding of the meeting.
If the notice is sent by U.S. mail, it shall be deposited in the U.S. mail at least four (4)&nbsp;days before the time of the holding of the meeting. The notice need not specify the place of the meeting (if the meeting is to be held at the
Corporation&#146;s principal executive office) nor the purpose of the meeting. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.8</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Quorum</U>.</P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At all meetings of the Board, a majority of the total number of directors shall constitute a quorum for the transaction of business. The vote
of a majority of the directors present at any meeting at which a quorum is present shall be the act of the Board, except as may be otherwise specifically provided by statute, the Certificate of Incorporation or these bylaws. If a quorum is not
present at any meeting of the Board, then the directors present thereat may adjourn the meeting from time to time, without notice other than announcement at the meeting, until a quorum is present. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A meeting at which a quorum is initially present may continue to transact business
notwithstanding the withdrawal of directors, if any action taken is approved by at least a majority of the required quorum for that meeting. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.9</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Board Action by Written Consent without a Meeting</U>.</P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise restricted by the Certificate of Incorporation or these bylaws, any action required or permitted to be taken at any meeting
of the Board, or of any committee thereof, may be taken without a meeting if all members of the Board or committee, as the case may be, consent thereto in writing or by electronic transmission and the writing or writings or electronic transmission
or transmissions are filed with the minutes of proceedings of the Board or committee. Such filing shall be in paper form if the minutes are maintained in paper form and shall be in electronic form if the minutes are maintained in electronic form.
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.10</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Fees and Compensation of Directors</U>.</P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless otherwise restricted by the Certificate of Incorporation or these bylaws, the Board shall have the authority to fix the compensation,
including fees and reimbursement of expenses, of directors for services to the Corporation in any capacity. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article IV&#151;Committees
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Committees of Directors</U>.</P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board may designate one (1)&nbsp;or more committees, each committee to consist, of one (1)&nbsp;or more of the directors of the
Corporation. The Board may designate one (1)&nbsp;or more directors as alternate members of any committee, who may replace any absent or disqualified member at any meeting of the committee. In the absence or disqualification of a member of a
committee, the member or members thereof present at any meeting and not disqualified from voting, whether or not such member or members constitute a quorum, may unanimously appoint another member of the Board to act at the meeting in the place of
any such absent or disqualified member. Any such committee, to the extent provided in the resolution of the Board or in these bylaws, shall have and may exercise all the powers and authority of the Board in the management of the business and affairs
of the Corporation, and may authorize the seal of the Corporation to be affixed to all papers that may require it; but no such committee shall have the power or authority to (i)&nbsp;approve or adopt, or recommend to the stockholders, any action or
matter expressly required by the DGCL to be submitted to stockholders for approval, or (ii)&nbsp;adopt, amend or repeal any bylaw of the Corporation. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Committee Minutes</U>.</P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each committee shall keep regular minutes of its meetings and report the same to the Board when required. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Meetings and Actions of Committees</U>.</P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Meetings and actions of committees shall be governed by, and held and taken in accordance with, the provisions of: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) Section&nbsp;3.5 (place of meetings and meetings by telephone); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) Section&nbsp;3.6 (regular meetings); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) Section&nbsp;3.7 (special meetings and notice); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) Section&nbsp;3.9 (action without a meeting); and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) Section 7.12 (waiver of notice), </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">with such
changes in the context of those bylaws as are necessary to substitute the committee and its members for the Board and its members. <I>However</I>: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) the time of regular meetings of committees may be determined either by resolution of the Board or by resolution of the committee; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) special meetings of committees may also be called by resolution of the Board or the chairperson of the applicable committee; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) the Board may adopt rules for the governance of any committee to override the provisions that would otherwise apply to the committee
pursuant to this Section&nbsp;4.3, provided that such rules do not violate the provisions of the Certificate of Incorporation or applicable law. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article V&#151;Officers </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Officers</U>.</P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The officers of the Corporation shall include a president and a secretary. The Corporation may also have, at the discretion of the Board, a
chairperson of the Board, a vice chairperson of the Board, a chief executive officer, a chief financial officer, a treasurer, one (1)&nbsp;or more vice presidents, one (1)&nbsp;or more assistant vice presidents, one (1)&nbsp;or more assistant
treasurers, one (1)&nbsp;or more assistant secretaries, and any such other officers as may be appointed in accordance with the provisions of these bylaws. Any number of offices may be held by the same Person. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Appointment of Officers</U>.</P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board shall appoint the officers of the Corporation, except such officers as may be appointed in accordance with the provisions of
Section&nbsp;5.3 of these bylaws. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Subordinate Officers</U>.</P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board may appoint, or empower the chief executive officer or, in the absence of a chief executive officer, the president, to appoint, such
other officers and agents as the business of the Corporation may require. Each of such officers and agents shall hold office for such period, have such authority, and perform such duties as are provided in these bylaws or as the Board may from time
to time determine. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Removal and Resignation of Officers</U>.</P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the rights, if any, of an officer under any contract of employment, any officer may be removed, either with or without cause, by
the Board or, except in the case of an officer chosen by the Board, by any officer upon whom such power of removal may be conferred by the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any officer may resign at any time by giving written notice to the Corporation. Any resignation shall take effect at the date of the receipt
of that notice or at any later time specified in that notice. Unless otherwise specified in the notice of resignation, the acceptance of the resignation shall not be necessary to make it effective. Any resignation is without prejudice to the rights,
if any, of the Corporation under any contract to which the officer is a party. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Vacancies in Offices</U>.</P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any vacancy occurring in any office of the Corporation shall be filled by the Board or as provided in Section&nbsp;5.2. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.6</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Representation of Shares of Other Corporations</U>.</P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The chairperson of the Board, the chief executive officer, the president, any vice president, the treasurer, the secretary or assistant
secretary of this Corporation, or any other Person authorized by the Board, the chief executive officer, the president or a vice president, is authorized to vote, represent and exercise on behalf of this Corporation all rights incident to any and
all shares or other ownership interests of any other corporation or corporations or other entity or entities standing in the name of this Corporation. The authority granted herein may be exercised either by such Person directly or by any other
Person authorized to do so by proxy or power of attorney duly executed by such Person having the authority. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.7</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Authority and Duties of Officers</U>.</P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All officers of the Corporation shall respectively have such authority and perform such duties in the management of the business of the
Corporation as may be provided herein or designated from time to time by the Board and, to the extent not so provided, as generally pertain to their respective offices, subject to the control of the Board. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article VI&#151;Records </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A stock ledger consisting of one or more records in which the names of all of the Corporation&#146;s stockholders of record, the address and
number of shares registered in the name of each such stockholder, and all issuances and transfers of stock of the corporation are recorded in accordance with Section&nbsp;224 of the DGCL shall be administered by or on behalf of the Corporation. Any
records administered by or on behalf of the Corporation in the regular course of its business, including its stock ledger, books of account and minute books, may be kept on, or by means of, or be in the form of, any information storage device, or
method, or one or more electronic networks or databases (including one or more distributed electronic networks or databases), provided that the records so kept can be converted into clearly legible paper form within a reasonable time and, with
respect to the stock ledger, that the records so kept (i)&nbsp;can be used to prepare the list of stockholders specified in Sections 219 and 220 of the DGCL, (ii)&nbsp;record the information specified in Sections 156, 159, 217(a) and 218 of the
DGCL, and (iii)&nbsp;record transfers of stock as governed by Article 8 of the Uniform Commercial Code. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article VII&#151;General Matters </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">7.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Execution of Corporate Contracts and Instruments</U>.</P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board, except as otherwise provided in these bylaws, may authorize any officer or officers, or agent or agents, to enter into any contract
or execute any instrument in the name of and on behalf of the Corporation; such authority may be general or confined to specific instances. Unless so authorized or ratified by the Board or within the agency power of an officer, no officer, agent or
employee shall have any power or authority to bind the Corporation by any contract or engagement or to pledge its credit or to render it liable for any purpose or for any amount. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">7.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Stock Certificates</U>.</P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The shares of the Corporation shall be represented by certificates, provided that the Board by resolution may provide that some or all of the
shares of any class or series of stock of the Corporation shall be uncertificated. Certificates for the shares of stock, if any, shall be in such form as is consistent with the Certificate of Incorporation and applicable law. Every holder of stock
represented by a certificate shall be entitled to have a certificate signed by, or in the name of the Corporation by, any two officers authorized to sign stock certificates representing the number of shares registered in certificate form. The
chairperson or vice chairperson of the Board, the president, vice president, the treasurer, any assistant treasurer, the secretary or any assistant secretary of the Corporation shall be specifically authorized to sign stock certificates. Any or all
of the signatures on the certificate may be a facsimile. In case any officer, transfer agent or registrar who has signed or whose facsimile signature has been placed upon a certificate has ceased to be such officer, transfer agent or registrar
before such certificate is issued, it may be issued by the Corporation with the same effect as if he or she were such officer, transfer agent or registrar at the date of issue. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">7.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Lost Certificates</U>.</P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation may issue a new certificate of stock or uncertificated shares in the place of any certificate theretofore issued by it,
alleged to have been lost, stolen or destroyed, and the Corporation may require the owner of the lost, stolen or destroyed certificate, or such owner&#146;s legal representative, to give the Corporation a bond sufficient to indemnify it against any
claim that may be made against it on account of the alleged loss, theft or destruction of any such certificate or the issuance of such new certificate or uncertificated shares. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">7.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Shares Without Certificates</U>. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation may adopt a system of issuance, recordation and transfer of its shares of stock by electronic or other means not involving the
issuance of certificates, provided the use of such system by the Corporation is permitted in accordance with applicable law. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">7.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Construction; Definitions</U>.</P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless the context requires otherwise, the general provisions, rules of construction and definitions in the DGCL shall govern the construction
of these bylaws. Without limiting the generality of this provision, the singular number includes the plural and the plural number includes the singular. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">7.6</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Dividends</U>.</P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board, subject to any restrictions contained in either (i)&nbsp;the DGCL or (ii)&nbsp;the Certificate of Incorporation, may declare and
pay dividends upon the shares of its capital stock. Dividends may be paid in cash, in property or in shares of the Corporation&#146;s capital stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board may set apart out of any of the funds of the Corporation available for dividends a reserve or reserves for any proper purpose and
may abolish any such reserve. Such purposes shall include but not be limited to equalizing dividends, repairing or maintaining any property of the Corporation, and meeting contingencies. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">7.7</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Fiscal Year</U>.</P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The fiscal year of the Corporation shall be fixed by resolution of the Board and may be changed by the Board. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">7.8</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Seal</U>.</P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation may adopt a corporate seal, which shall be adopted and which may be altered by the Board. The Corporation may use the
corporate seal by causing it or a facsimile thereof to be impressed or affixed or in any other manner reproduced. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">7.9</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Transfer of Stock</U>.</P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Shares of the Corporation shall be transferable in the manner prescribed by law and in these bylaws. Shares of stock of the Corporation shall
be transferred on the books of the Corporation only by the holder of record thereof or by such holder&#146;s attorney duly authorized in writing, upon surrender to the Corporation of the certificate or certificates representing such shares endorsed
by the appropriate Person or Persons (or by delivery of duly executed instructions with respect to uncertificated shares), with such evidence of the authenticity of such endorsement or execution, transfer, authorization and other matters as the
Corporation may reasonably require, and accompanied by all necessary stock transfer stamps. No transfer of stock shall be valid as against the Corporation for any purpose until it shall have been entered in the stock records of the Corporation by an
entry showing the names of the Persons from and to whom it was transferred. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">7.10</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Stock Transfer Agreements</U>.</P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation shall have power to enter into and perform any agreement with any number of stockholders of any one or more classes or series
of stock of the Corporation to restrict the transfer of shares of stock of the Corporation of any one or more classes owned by such stockholders in any manner not prohibited by the DGCL. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">7.11</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Registered Stockholders</U>.</P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) shall be
entitled to recognize the exclusive right of a Person registered on its books as the owner of shares to receive dividends and to vote as such owner; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) shall not be bound to recognize any equitable or other claim to or interest in such
share or shares on the part of another Person, whether or not it shall have express or other notice thereof, except as otherwise provided by the laws of the State of Delaware. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">7.12</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Waiver of Notice</U>.</P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Whenever notice is required to be given under any provision of the DGCL, the Certificate of Incorporation or these bylaws, a written waiver,
signed by the Person entitled to notice, or a waiver by electronic transmission by the Person entitled to notice, whether before or after the time of the event for which notice is to be given, shall be deemed equivalent to notice. Attendance of a
Person at a meeting shall constitute a waiver of notice of such meeting, except when the Person attends a meeting for the express purpose of objecting at the beginning of the meeting, to the transaction of any business because the meeting is not
lawfully called or convened. Neither the business to be transacted at, nor the purpose of, any regular or special meeting of the stockholders need be specified in any written waiver of notice or any waiver by electronic transmission unless so
required by the Certificate of Incorporation or these bylaws. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article VIII&#151;Notice by Electronic Transmission </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">8.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Notice by Electronic Transmission</U>.</P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Without limiting the manner by which notice otherwise may be given effectively to stockholders pursuant to the DGCL, the Certificate of
Incorporation or these bylaws, any notice to stockholders given by the Corporation under any provision of the DGCL, the Certificate of Incorporation or these bylaws shall be effective if given by a form of electronic transmission consented to by the
stockholder to whom the notice is given. Any such consent shall be revocable by the stockholder by written notice to the Corporation. Any such consent shall be deemed revoked if: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) the Corporation is unable to deliver by electronic transmission two (2)&nbsp;consecutive notices given by the Corporation in accordance
with such consent; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) such inability becomes known to the secretary or an assistant secretary of the Corporation or to the transfer
agent, or other Person responsible for the giving of notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">However, the inadvertent failure to treat such inability as a revocation shall not
invalidate any meeting or other action. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any notice given pursuant to the preceding paragraph shall be deemed given: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if by facsimile telecommunication, when directed to a number at which the stockholder has consented to receive
notice; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if by electronic mail, when directed to an electronic mail address at which the stockholder has consented to
receive notice; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if by a posting on an electronic network together with separate notice to the stockholder of such specific
posting, upon the later of (A)&nbsp;such posting and (B)&nbsp;the giving of such separate notice; and </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">if by any other form of electronic transmission, when directed to the stockholder. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An affidavit of the secretary or an assistant secretary or of the transfer agent or other agent of the Corporation that the notice has been
given by a form of electronic transmission shall, in the absence of fraud, be prima facie evidence of the facts stated therein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.2
<U>Definition of Electronic Transmission</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">An &#147;electronic transmission&#148; means any form of communication, not directly
involving the physical transmission of paper, including the use of, or participation in, one or more electronic networks or databases (including one or more distributed electronic networks or databases), that creates a record that may be retained,
retrieved and reviewed by a recipient thereof, and that may be directly reproduced in paper form by such a recipient through an automated process. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article IX&#151;Indemnification </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">9.1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Indemnification of Directors and Officers</U>. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation shall indemnify and hold harmless, to the fullest extent permitted by the DGCL as it presently exists or may hereafter be
amended, any director or officer of the Corporation who was or is made or is threatened to be made a party or is otherwise involved in any action, suit or proceeding, whether civil, criminal, administrative or investigative (a
&#147;<U>Proceeding</U>&#148;) by reason of the fact that he or she, or a Person for whom he or she is the legal representative, is or was a director or officer of the Corporation or, while serving as a director or officer of the Corporation, is or
was serving at the request of the Corporation as a director, officer, employee or agent of another corporation or of a partnership, joint venture, trust, <FONT STYLE="white-space:nowrap">non-profit</FONT> entity or other enterprise, including
service with respect to employee benefit plans, against all liability and loss suffered and expenses (including attorneys&#146; fees, judgments, fines, ERISA excise taxes or penalties and amounts paid in settlement) reasonably incurred by such
Person in connection with any such Proceeding. Notwithstanding the preceding sentence, except as otherwise provided in Section&nbsp;9.4, the Corporation shall be required to indemnify a Person in connection with a Proceeding initiated by such Person
only if the Proceeding was authorized in the specific case by the Board. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">9.2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Indemnification of Others</U>. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation shall have the power to indemnify and hold harmless, to the fullest extent permitted by applicable law as it presently exists
or may hereafter be amended, any employee or agent of the Corporation who was or is made or is threatened to be made a party or is otherwise involved in any Proceeding by reason of the fact that he or she, or a Person for whom he or she is the legal
representative, is or was an employee or agent of the Corporation or is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation or of a partnership, joint venture, trust, <FONT
STYLE="white-space:nowrap">non-profit</FONT> entity or other enterprise, including service with respect to employee benefit plans, against all liability and loss suffered and expenses reasonably incurred by such Person in connection with any such
Proceeding. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">9.3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Prepayment of Expenses</U>. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation shall to the fullest extent not prohibited by applicable law pay the expenses (including attorneys&#146; fees) incurred by any
officer or director of the Corporation, and may pay the expenses incurred by any employee or agent of the Corporation, in defending any Proceeding in advance of its final disposition; <I>provided, however</I>, that, to the extent required by law,
such payment of expenses in advance of the final disposition of the Proceeding shall be made only upon receipt of an undertaking by the Person to repay all amounts advanced if it should be ultimately determined that the Person is not entitled to be
indemnified under this Article IX or otherwise. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">9.4</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Determination; Claim</U>. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If a claim for indemnification (following the final disposition of such Proceeding) under this Article IX is not paid in full within sixty
(60)&nbsp;days, or a claim for advancement of expenses under this Article IX is not paid in full within thirty (30)&nbsp;days, after a written claim therefor has been received by the Corporation the claimant may thereafter (but not before) file suit
to recover the unpaid amount of such claim and, if successful in whole or in part, shall be entitled to be paid the expense of prosecuting such claim to the fullest extent permitted by law. In any such action the Corporation shall have the burden of
proving that the claimant was not entitled to the requested indemnification or payment of expenses under applicable law. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">9.5</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U><FONT STYLE="white-space:nowrap">Non-Exclusivity</FONT> of Rights</U>. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The rights conferred on any Person by this Article IX shall not be exclusive of any other rights which such Person may have or hereafter
acquire under any statute, provision of the Certificate of Incorporation, these bylaws, agreement, vote of stockholders or disinterested directors or otherwise. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">9.6</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Insurance</U>. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation may purchase and maintain insurance on behalf of any Person who is or was a director, officer, employee or agent of the
Corporation, or is or was serving at the request of the Corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust, <FONT STYLE="white-space:nowrap">non-profit</FONT> entity or other enterprise
against any liability asserted against him or her and incurred by him or her in any such capacity, or arising out of his or her status as such, whether or not the Corporation would have the power to indemnify him or her against such liability under
the provisions of the DGCL. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">9.7</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Other Indemnificatio</U><U>n</U>. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Corporation&#146;s obligation, if any, to indemnify or advance expenses to any Person who was or is serving at its request as a director,
officer, employee or agent of another corporation, partnership, joint venture, trust, <FONT STYLE="white-space:nowrap">non-profit</FONT> entity or other enterprise shall be reduced by any amount such Person may collect as indemnification or
advancement of expenses from such other corporation, partnership, joint venture, trust, <FONT STYLE="white-space:nowrap">non-profit</FONT> entity or other enterprise. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">9.8</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Continuation of Indemnification</U>. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The rights to indemnification and to prepayment of expenses provided by, or granted pursuant to, this Article IX shall continue
notwithstanding that the Person has ceased to be a director or officer of the Corporation and shall inure to the benefit of the estate, heirs, executors, administrators, legatees and distributees of such Person. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">9.9</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Amendment or Repeal</U><U>; Interpretation</U>. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The provisions of this Article IX shall constitute a contract between the Corporation, on the one hand, and, on the other hand, each
individual who serves or has served as a director or officer of the Corporation (whether before or after the adoption of these bylaws), in consideration of such Person&#146;s performance of such services, and pursuant to this Article IX the
Corporation intends to be legally bound to each such current or former director or officer of the Corporation. With respect to current and former directors and officers of the Corporation, the rights conferred under this Article IX are present
contractual rights and such rights are fully vested, and shall be deemed to have vested fully, immediately upon adoption of theses bylaws. With respect to any directors or officers of the Corporation who commence service following adoption of these
bylaws, the rights conferred under this provision shall be present contractual rights and such rights shall fully vest, and be deemed to have vested fully, immediately upon such director or officer commencing service as a director or officer of the
Corporation. Any repeal or modification of the foregoing provisions of this Article IX shall not adversely affect any right or protection (i)&nbsp;hereunder of any Person in respect of any act or omission occurring prior to the time of such repeal
or modification or (ii)&nbsp;under any agreement providing for indemnification or advancement of expenses to an officer or director of the Corporation in effect prior to the time of such repeal or modification. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any reference to an officer of the Corporation in this Article IX shall be deemed to refer exclusively to the chairperson of the Board, a vice
chairperson of the Board, a chief executive officer, a chief financial officer, a treasurer appointed pursuant to Article V of these bylaws, and to any vice president, assistant secretary, assistant treasurer or other officer of the Corporation
appointed by (x)&nbsp;the Board pursuant to Article V of these Bylaws or (y)&nbsp;an officer to whom the Board has delegated the power to appoint officers pursuant to Article V of these bylaws, and any reference to an officer of any other
corporation, partnership, joint venture, trust, employee benefit plan, <FONT STYLE="white-space:nowrap">non-profit</FONT> entity or other enterprise shall be deemed to refer exclusively to an officer appointed by the board of directors (or
equivalent governing body) of such other entity pursuant to the Certificate of Incorporation and bylaws (or equivalent organizational documents) of such other corporation, partnership, joint venture, trust, employee benefit plan, <FONT
STYLE="white-space:nowrap">non-profit</FONT> entity or other enterprise. The fact that any Person who is or was an employee of the Corporation or an employee of any other corporation, partnership, joint venture, trust, employee benefit plan, <FONT
STYLE="white-space:nowrap">non-profit</FONT> entity or other enterprise has been given or has used the title of &#147;vice president&#148; or any other title that could be construed to suggest or imply that such Person is or may be an officer of the
Corporation or of such other corporation, partnership, joint venture, trust, employee benefit plan, <FONT STYLE="white-space:nowrap">non-profit</FONT> entity or other enterprise shall not result in such Person being constituted as, or being deemed
to be, an officer of the Corporation or of such other corporation, partnership, joint venture, trust, employee benefit plan, <FONT STYLE="white-space:nowrap">non-profit</FONT> entity or other enterprise for purposes of this Article IX. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article X&#151;Amendments </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Board is expressly empowered to adopt, amend or repeal the bylaws of the Corporation. The stockholders also shall have power to adopt,
amend or repeal the bylaws of the Corporation; <I>provided, however</I>, that, in addition to any vote of the holders of any class or series of stock of the Corporation required by law or by the Certificate of Incorporation, such action by
stockholders shall require the affirmative vote of the holders of at least 66 2/3% of the voting power of all the then-outstanding shares of voting stock of the Corporation with the power to vote at an election of directors, voting together as a
single class. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Article XI&#151;Forum Selection </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless the Corporation consents in writing to the selection of an alternative forum, (a)&nbsp;the Court of Chancery (the &#147;<U>Chancery
Court</U>&#148;) of the State of Delaware (or, in the event that the Chancery Court does not have jurisdiction, the federal district court for the District of Delaware or other state courts of the State of Delaware) shall, to the fullest extent
permitted by law, be the sole and exclusive forum for (i)&nbsp;any derivative action, suit or proceeding brought on behalf of the Corporation, (ii)&nbsp;any action, suit or proceeding asserting a claim of breach of a fiduciary duty owed by any
director, officer<B> </B>or stockholder of the Corporation to the Corporation or to the Corporation&#146;s stockholders, (iii)&nbsp;any action, suit or proceeding arising pursuant to any provision of the DGCL or the Certificate of Incorporation or
these bylaws (as either may be amended from time to time) or (iv)&nbsp;any action, suit or proceeding asserting a claim against the Corporation governed by the internal affairs doctrine; and (b)&nbsp;subject to the preceding provisions of this
Article XI, the federal district courts of the United States of America shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act of 1933, as amended. If any action the subject
matter of which is within the scope of clause (a)&nbsp;of the immediately preceding sentence is filed in a court other than the courts in the State of Delaware (a &#147;Foreign Action&#148;) in the name of any stockholder, such stockholder shall be
deemed to have consented to (x)&nbsp;the personal jurisdiction of the state and federal courts in the State of Delaware in connection with any action brought in any such court to enforce the provisions of clause (a)&nbsp;of the immediately preceding
sentence and (y)&nbsp;having service of process made upon such stockholder in any such action by service upon such stockholder&#146;s counsel in the Foreign Action as agent for such stockholder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any person or entity purchasing or otherwise acquiring any interest in any security of the Corporation shall be deemed to have notice of and
consented to this Article XI. Notwithstanding the foregoing, the provisions of this Article XI shall not apply to suits brought to enforce any liability or duty created by the Securities Exchange Act of 1934, as amended, or any other claim for which
the federal courts of the United States have exclusive jurisdiction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If any provision or provisions of this Article XI shall be held to
be invalid, illegal or unenforceable as applied to any circumstance for any reason whatsoever, (a)&nbsp;the validity, legality and enforceability of such provisions in any other circumstance and of the remaining provisions of this Article XI
(including, without limitation, each portion of any paragraph of this Article XI containing any such provision held to be invalid, illegal or unenforceable that is not itself held to be invalid, illegal or unenforceable) shall not in any way be
affected or impaired thereby and (b)&nbsp;the application of such provision to other persons or entities and circumstances shall not in any way be affected or impaired thereby. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Sana Biotechnology, Inc. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Certificate of Amendment and Restatement of Bylaws </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned hereby certifies that he is the duly elected, qualified, and acting Secretary of Sana Biotechnology, Inc., a Delaware
corporation (the &#147;<U>Corporation</U>&#148;), and that the foregoing bylaws were approved on [January __], 2021, effective as of February [__], 2021, by the Corporation&#146;s board of directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the undersigned has hereunto set his hand this ___ day of February, 2021. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">James J. MacDonald</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Secretary</TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>6
<FILENAME>d60414dex42.htm
<DESCRIPTION>EX-4.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.2 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g63033dsp1b.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">Exhibit 4.2 </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Sana Biotechnology </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">NUMBER </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">SB
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">SHARES </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">CUSIP 799566 10 4 </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">SEE REVERSE FOR CERTAIN DEFINITIONS AND LEGENDS </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">This certifies that </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">is the record holder of </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">FULLY PAID AND NONASSESSABLE SHARES OF COMMON STOCK, $0.0001 PAR VALUE PER SHARE, OF </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">SANA
BIOTECHNOLOGY, INC. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">transferable on the books of the Corporation in person or by duly authorized attorney upon surrender of this Certificate properly endorsed.
This Certificate is not valid until countersigned by the Transfer Agent and registered by the Registrar. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">WITNESS the facsimile seal of the Corporation and the
facsimile signatures of its duly authorized officers. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Dated:
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">PRESIDENT&nbsp;&amp; CHIEF EXECUTIVE OFFICER </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">CORPORATE SECRETARY </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">SANA BIOTECHNOLOGY, INC </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">DELAWARE </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">CORPORATE </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">SEAL </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">July&nbsp;13, 2018 </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">COUNTERSIGNED AND REGISTERED: </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">AMERICAN STOCK TRANSFER&nbsp;&amp; TRUST COMPANY, LLC </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">(BROOKLYN, NY) </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">TRANSFER AGENT AND REGISTRAR </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">BY: </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">AUTHORIZED SIGNATURE </FONT></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g63033dsp2new.jpg" ALT="LOGO">
 </P> <P STYLE="font-family:Times New Roman; font-size:0.5pt"><FONT COLOR="#FFFFFF">The Corporation shall furnish without charge to each stockholder who so requests a statement of the powers, designations, preferences
and relative, participating, optional or other special rights of each class of stock of the Corporation or series thereof and the qualifications, limitations or restrictions of such preferences and/or rights. Such requests shall be made to the
Corporation&#146;s Secretary at the principal office of the Corporation. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">KEEP THIS CERTIFICATE IN A SAFE PLACE. IF IT IS LOST, STOLEN, OR DESTROYED THE CORPORATION
WILL REQUIRE A BOND INDEMNITY AS A CONDITION TO THE ISSUANCE OF A REPLACEMENT CERTIFICATE. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">The following abbreviations, when used in the inscription on the face of
this certificate, shall be construed as though they were written out in full according to applicable laws or regulations: </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">TEN COM &#150; as tenants in common
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">TEN ENT &#150; as tenants by the entireties </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">JT TEN &#150; as joint tenants
with right of survivorship and not as tenants in common </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">COM PROP &#150; as community property </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">UNIF GIFT MIN ACT &#150; Custodian </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">(Cust) (Minor) </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">under Uniform Gifts to Minors </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Act </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">(State) </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">UNIF TRF MIN ACT &#150; Custodian (until age) </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">(Cust) </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">under Uniform Transfer </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">(Minor) </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">to Minors Act </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">(State) </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Additional abbreviations may also be used though not in the above list. </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">FOR VALUE RECEIVED, hereby sell(s), assign(s) and transfer(s) unto </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">PLEASE INSERT SOCIAL
SECURITY OR OTHER IDENTIFYING NUMBER OF ASSIGNEE </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">(PLEASE PRINT OR TYPEWRITE NAME AND ADDRESS, INCLUDING ZIP CODE, OF ASSIGNEE) </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">shares of the capital stock represented by within Certificate, and do hereby irrevocably constitute and appoint </FONT><br><FONT
STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorney-in-fact</FONT></FONT> to transfer the said stock on the books of the within named Corporation with full
power of the substitution in the premises. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Dated </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">Signature(s) Guaranteed:
</FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">NOTICE: THE SIGNATURE TO THIS ASSIGNMENT MUST CORRESPOND WITH THE NAME AS WRITTEN UPON THE FACE OF THE CERTIFICATE IN EVERY PARTICULAR, WITHOUT ALTERATION OR
ENLARGEMENT OR ANY CHANGE WHATSOEVER. </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">By </FONT><br><FONT STYLE="font-family:Times New Roman; font-size:0.5pt" COLOR="#FFFFFF">THE SIGNATURE(S) SHOULD BE
GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION, (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM), PURSUANT TO S.E.C. RULE
<FONT STYLE="white-space:nowrap">17Ad-15.</FONT> GUARANTEES BY A NOTARY PUBLIC ARE NOT ACCEPTABLE. SIGNATURE GUARANTEES MUST NOT BE DATED. </FONT></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>7
<FILENAME>d60414dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="67%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="15%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">140 Scott Drive</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">Menlo Park, California 94025</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tel:&nbsp;+1.650.328.4600&nbsp;Fax:&nbsp;+1.650.463.2600</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">www.lw.com</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ROWSPAN="4">


<IMG SRC="g63033g0128091809718.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">FIRM / AFFILIATE OFFICES</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Beijing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Moscow</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Boston</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Munich</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Brussels</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">New York</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Century City</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Orange County</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="middle" ROWSPAN="3">January&nbsp;28, 2021</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chicago</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Paris</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Dubai</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Riyadh</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">D&uuml;sseldorf</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">San Diego</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Frankfurt</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">San Francisco</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Hamburg</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Seoul</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Hong Kong</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Shanghai</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Houston</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Silicon Valley</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">London</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Singapore</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Los Angeles</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Tokyo</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Madrid</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Washington, D.C.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Milan</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sana Biotechnology, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">188
East Blaine Street, Suite 400 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Seattle, Washington 98102 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">Re:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><U>Registration Statement No.</U><U></U><U><FONT STYLE="white-space:nowrap">&nbsp;333-252061;</FONT> Up to
17,250,000 shares of common stock of Sana Biotechnology, Inc.</U> </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have acted as special counsel to Sana Biotechnology, Inc., a Delaware corporation (the &#147;<B><I>Company</I></B>&#148;), in connection
with the proposed registration of up to 17,250,000 shares (the &#147;<B><I>Shares</I></B>&#148;) of the Company&#146;s common stock, par value $0.0001 per share, including 2,250,000 shares pursuant to the exercise of the underwriters&#146; option to
purchase additional shares of common stock. The Shares are included in a registration statement on Form <FONT STYLE="white-space:nowrap">S-1</FONT> under the Securities Act of 1933, as amended (the &#147;<B><I>Act</I></B>&#148;), initially filed
with the Securities and Exchange Commission (the &#147;<B><I>Commission</I></B>&#148;) on January&nbsp;13, 2021 (Registration <FONT STYLE="white-space:nowrap">No.&nbsp;333-252061)</FONT> (as amended, the &#147;<B><I>Registration
Statement</I></B>&#148;). The term &#147;Shares&#148; shall include any additional shares of common stock registered by the Company pursuant to Rule 462(b) under the Act in connection with the offering contemplated by the Registration Statement.
This opinion is being furnished in connection with the requirements of Item 601(b)(5) of Regulation <FONT STYLE="white-space:nowrap">S-K</FONT> under the Act, and no opinion is expressed herein as to any matter pertaining to the contents of the
Registration Statement or related prospectus, other than as expressly stated herein with respect to the issue of the Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As such
counsel, we have examined such matters of fact and questions of law as we have considered appropriate for purposes of this letter. With your consent, we have relied upon certificates and other assurances of officers of the Company and others as to
factual matters without having independently verified such factual matters. We are opining herein as to General Corporation Law of the State of Delaware, and we express no opinion with respect to any other laws. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>January 28, 2021 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Page 2 </B></P> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g63033g0128091810023.jpg" ALT="LOGO">
 </P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the foregoing and the other matters set forth herein, it is our opinion that, as
of the date hereof, when the amended and restated certificate of incorporation of the Company in the form most recently filed as an exhibit to the Registration Statement (the &#147;<B><I>Amended and </I></B><B><I>Restated Certificate of
Incorporation</I></B>&#148;) has been duly filed with the Secretary of State of the State of Delaware and when the Shares shall have been duly registered on the books of the transfer agent and registrar therefor in the name or on behalf of the
purchasers and have been issued by the Company against payment therefor (not less than par value) in the circumstances contemplated by the form of underwriting agreement most recently filed as an exhibit to the Registration Statement, the issue and
sale of the Shares will have been duly authorized by all necessary corporate action of the Company and the Shares will be validly issued, fully paid and nonassessable. In rendering the foregoing opinion, we have assumed that the Company will comply
with all applicable notice requirements regarding uncertificated shares provided in the General Corporation Law of the State of Delaware. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This opinion is for your benefit in connection with the Registration Statement and may be relied upon by you and by persons entitled to rely
upon it pursuant to the applicable provisions of the Act. We consent to your filing this opinion as an exhibit to the Registration Statement and to the reference to our firm in the Prospectus under the heading &#147;Legal Matters.&#148; We further
consent to the incorporation by reference of this letter and consent into any registration statement filed pursuant to Rule 462(b) with respect to the Shares. In giving such consent, we do not thereby admit that we are in the category of persons
whose consent is required under Section&nbsp;7 of the Act or the rules and regulations of the Commission thereunder. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="99%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">/s/ Latham&nbsp;&amp; Watkins LLP</TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>8
<FILENAME>d60414dex102.htm
<DESCRIPTION>EX-10.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>INDEMNIFICATION AND ADVANCEMENT AGREEMENT </U></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Indemnification and Advancement Agreement (&#147;<B>Agreement</B>&#148;) is made as of ________ __, 20__ by and between Sana
Biotechnology, Inc., a Delaware corporation (the &#147;<B>Company</B>&#148;), and ______________, [a member of the Board of Directors/an officer/an employee] of the Company (&#147;<B>Indemnitee</B>&#148;). This Agreement supersedes and replaces any
and all previous Agreements between the Company and Indemnitee covering indemnification and advancement. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RECITALS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Board of Directors of the Company (the &#147;<B>Board</B>&#148;) believes that highly competent persons have become more
reluctant to serve publicly-held corporations as directors, officers, or in other capacities unless they are provided with adequate protection through insurance or adequate indemnification and advancement of expenses against inordinate risks of
claims and actions against them arising out of their service to and activities on behalf of the corporation; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Board has
determined that, in order to attract and retain qualified individuals, the Company will attempt to maintain on an ongoing basis, at its sole expense, liability insurance to protect persons serving the Company and its subsidiaries from certain
liabilities. Although the furnishing of such insurance has been a customary and widespread practice among United States-based corporations and other business enterprises, the Company believes that, given current market conditions and trends, such
insurance may be available to it in the future only at higher premiums and with more exclusions. At the same time, directors, officers, and other persons in service to corporations or business enterprises are being increasingly subjected to
expensive and time-consuming litigation relating to, among other things, matters that traditionally would have been brought only against the Company or business enterprise itself. The Bylaws and Certificate of Incorporation of the Company require
indemnification of the officers and directors of the Company. Indemnitee may also be entitled to indemnification pursuant to the General Corporation Law of the State of Delaware (the &#147;<B>DGCL</B>&#148;). The Bylaws, Certificate of
Incorporation, and the DGCL expressly provide that the indemnification provisions set forth therein are not exclusive, and thereby contemplate that contracts may be entered into between the Company and members of the board of directors, officers and
other persons with respect to indemnification and advancement of expenses; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the uncertainties relating to such insurance, to
indemnification, and to advancement of expenses may increase the difficulty of attracting and retaining such persons; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Board
has determined that the increased difficulty in attracting and retaining such persons is detrimental to the best interests of the Company and its stockholders and that the Company should act to assure such persons that there will be increased
certainty of such protection in the future; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, it is reasonable, prudent and necessary for the Company contractually to obligate
itself to indemnify, and to advance expenses on behalf of, such persons to the fullest extent permitted by applicable law so that they will serve or continue to serve the Company free from undue concern that they will not be so indemnified; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, this Agreement is a supplement to and in furtherance of the Bylaws, Certificate of
Incorporation and any resolutions adopted pursuant thereto, and is not a substitute therefor, nor diminishes or abrogates any rights of Indemnitee thereunder; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, Indemnitee does not regard the protection available under the Bylaws, Certificate of Incorporation, DGCL and insurance as adequate in
the present circumstances, and may not be willing to serve or continue to serve as an officer, director or employee without adequate additional protection, and the Company desires Indemnitee to serve or continue to serve in such capacity. Indemnitee
is willing to serve, continue to serve and to take on additional service for or on behalf of the Company on the condition that Indemnitee be so indemnified and be advanced expenses. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the premises and the covenants contained herein, the Company and Indemnitee do hereby covenant and agree
as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1. <U>Services to the Company.</U> Indemnitee agrees to serve as a [director/officer/employee] of the Company.
Indemnitee may at any time and for any reason resign from such position (subject to any other contractual obligation or any obligation imposed by operation of law). This Agreement does not create any obligation on the Company to continue Indemnitee
in such position and is not an employment contract between the Company (or any of its subsidiaries or any Enterprise) and Indemnitee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2. <U>Definitions.</U> As used in this Agreement: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) &#147;<B>Agent</B>&#148; means any person who is authorized by the Company or an Enterprise to act for or represent the interests of the
Company or an Enterprise, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) A &#147;<B>Change in Control</B>&#148; occurs upon the earliest to occur after the date of
this Agreement of any of the following events: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">i. <U>Acquisition of Stock by Third Party</U>. Any Person (as defined below) is or becomes
the Beneficial Owner (as defined below), directly or indirectly, of securities of the Company representing fifteen percent (15%) or more of the combined voting power of the Company&#146;s then outstanding securities unless the change in relative
beneficial ownership of the Company&#146;s securities by any Person results solely from a reduction in the aggregate number of outstanding shares of securities entitled to vote generally in the election of directors; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">ii. <U>Change in Board of Directors</U>. During any period of two (2)&nbsp;consecutive years (not including any period prior to the execution
of this Agreement), individuals who at the beginning of such period constitute the Board, and any new director (other than a director designated by a person who has entered into an agreement with the Company to effect a transaction described in
Sections 2(b)(i), 2(b)(iii) or 2(b)(iv)) whose election by the Board or nomination for election by the Company&#146;s stockholders was approved by a vote of at least <FONT STYLE="white-space:nowrap">two-thirds</FONT> of the directors then still in
office who either were directors at the beginning of the period or whose election or nomination for election was previously so approved, cease for any reason to constitute at least a majority of the members of the Board; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">iii. <U>Corporate Transactions</U>. The effective date of a merger or consolidation of the
Company with any other entity, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior to such merger or consolidation continuing to represent (either by remaining outstanding or
by being converted into voting securities of the surviving entity) more than 51% of the combined voting power of the voting securities of the surviving entity outstanding immediately after such merger or consolidation and with the power to elect at
least a majority of the board of directors or other governing body of such surviving entity; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">iv. <U>Liquidation</U>. The approval by the
stockholders of the Company of a complete liquidation of the Company or an agreement for the sale or disposition by the Company of all or substantially all of the Company&#146;s assets; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">v. <U>Other Events</U>. There occurs any other event of a nature that would be required to be reported in response to Item 6(e) of Schedule
14A of Regulation 14A (or a response to any similar item on any similar schedule or form) promulgated under the Exchange Act (as defined below), whether or not the Company is then subject to such reporting requirement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">vi. For purposes of this Section&nbsp;2(b), the following terms have the following meanings: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Exchange Act</B>&#148; means the Securities Exchange Act of 1934, as amended from time to time.
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Person</B>&#148; has the meaning as set forth in Sections 13(d) and 14(d) of the Exchange Act;
provided, however, that Person excludes (i)&nbsp;the Company, (ii)&nbsp;any trustee or other fiduciary holding securities under an employee benefit plan of the Company, and (iii)&nbsp;any corporation owned, directly or indirectly, by the
stockholders of the Company in substantially the same proportions as their ownership of stock of the Company. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="13%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">&#147;<B>Beneficial Owner</B>&#148; has the meaning given to such term in Rule
<FONT STYLE="white-space:nowrap">13d-3</FONT> under the Exchange Act; provided, however, that Beneficial Owner excludes any Person otherwise becoming a Beneficial Owner by reason of the stockholders of the Company approving a merger of the Company
with another entity. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) &#147;<B>Corporate Status</B>&#148; describes the status of a person who is or was acting as a
director, officer, employee, fiduciary, or Agent of the Company or an Enterprise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) &#147;<B>Disinterested Director</B>&#148; means a
director of the Company who is not and was not a party to the Proceeding in respect of which indemnification is sought by Indemnitee. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) &#147;<B>Enterprise</B>&#148; means any other corporation, limited liability company,
partnership, joint venture, trust, employee benefit plan or other entity for which Indemnitee is or was serving at the request of the Company as a director, officer, employee, or Agent. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) &#147;<B>Expenses</B>&#148; includes all reasonable attorneys&#146; fees, retainers, court costs, transcript costs, fees of experts and
other professionals, witness fees, travel expenses, duplicating costs, printing and binding costs, telephone charges, postage, delivery service fees, any federal, state, local or foreign taxes imposed on Indemnitee as a result of the actual or
deemed receipt of any payments under this Agreement, ERISA excise taxes and penalties, and all other disbursements or expenses of the types customarily incurred in connection with prosecuting, defending, preparing to prosecute or defend,
investigating, being or preparing to be a witness in, or otherwise participating in, a Proceeding. Expenses also include (i)<B></B>&nbsp;Expenses incurred in connection with any appeal resulting from any Proceeding, including without limitation the
premium, security for, and other costs relating to any cost bond, supersedeas bond, or other appeal bond or its equivalent, and (ii)&nbsp;for purposes of Section&nbsp;14(d) only, Expenses incurred by Indemnitee in connection with the interpretation,
enforcement or defense of Indemnitee&#146;s rights under this Agreement, by litigation or otherwise. The parties agree that for the purposes of any advancement of Expenses for which Indemnitee has made written demand to the Company in accordance
with this Agreement, all Expenses included in such demand that are certified by affidavit of Indemnitee&#146;s counsel as being reasonable in the good faith judgment of such counsel will be presumed conclusively to be reasonable. Expenses, however,
do not include amounts paid in settlement by Indemnitee or the amount of judgments or fines against Indemnitee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) &#147;<B>Independent
Counsel</B>&#148; means a law firm, or a member of a law firm, that is experienced in matters of corporation law and neither presently is, nor in the past five years has been, retained to represent: (i)&nbsp;the Company or Indemnitee in any matter
material to either such party (other than with respect to matters concerning the Indemnitee under this Agreement, or of other indemnitees under similar indemnification agreements), or (ii)&nbsp;any other party to the Proceeding giving rise to a
claim for indemnification hereunder. Notwithstanding the foregoing, the term &#147;Independent Counsel&#148; does not include any person who, under the applicable standards of professional conduct then prevailing, would have a conflict of interest
in representing either the Company or Indemnitee in an action to determine Indemnitee&#146;s rights under this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h)
&#147;<B>Potential Change in Control</B>&#148; means the occurrence of any of the following events: (i)&nbsp;the Company enters into any written or oral agreement, undertaking or arrangement, the consummation of which would result in the occurrence
of a Change in Control; (ii)&nbsp;any Person or the Company publicly announces an intention to take or consider taking actions which if consummated would constitute a Change in Control; (iii)&nbsp;any Person who becomes the Beneficial Owner,
directly or indirectly, of securities of the Company representing 5% or more of the combined voting power of the Company&#146;s then outstanding securities entitled to vote generally in the election of directors increases his beneficial ownership of
such securities by 5% or more over the percentage so owned by such Person on the date hereof; or (iv)&nbsp;the Board adopts a resolution to the effect that, for purposes of this Agreement, a Potential Change in Control has occurred.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) The term &#147;<B>Proceeding</B>&#148; includes any threatened, pending or completed
action, suit, claim, counterclaim, cross claim, arbitration, mediation, alternate dispute resolution mechanism, investigation, inquiry, administrative hearing or any other actual, threatened or completed proceeding, whether brought in the right of
the Company or otherwise and whether of a civil, criminal, administrative, legislative, or investigative (formal or informal) nature, including any appeal therefrom, in which Indemnitee was, is or will be involved as a party, potential party, <FONT
STYLE="white-space:nowrap">non-party</FONT> witness or otherwise by reason of Indemnitee&#146;s Corporate Status or by reason of any action taken by Indemnitee (or a failure to take action by Indemnitee) or of any action (or failure to act) on
Indemnitee&#146;s part while acting pursuant to Indemnitee&#146;s Corporate Status, in each case whether or not serving in such capacity at the time any liability or Expense is incurred for which indemnification, reimbursement, or advancement of
Expenses can be provided under this Agreement. A Proceeding also includes a situation the Indemnitee believes in good faith may lead to or culminate in the institution of a Proceeding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3. <U>Indemnity in Third-Party Proceedings.</U> The Company will indemnify Indemnitee in accordance with the provisions of this
Section&nbsp;3 if Indemnitee is, or is threatened to be made, a party to or a participant in any Proceeding, other than a Proceeding by or in the right of the Company to procure a judgment in its favor. Pursuant to this Section&nbsp;3, the Company
will indemnify Indemnitee to the fullest extent permitted by applicable law against all Expenses, judgments, fines and amounts paid in settlement (including all interest, assessments and other charges paid or payable in connection with or in respect
of such Expenses, judgments, fines and amounts paid in settlement) actually and reasonably incurred by Indemnitee or on Indemnitee&#146;s behalf in connection with such Proceeding or any claim, issue or matter therein, if Indemnitee acted in good
faith and in a manner Indemnitee reasonably believed to be in or not opposed to the best interests of the Company and, in the case of a criminal Proceeding had no reasonable cause to believe that Indemnitee&#146;s conduct was unlawful. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4. <U>Indemnity in Proceedings by or in the Right of the Company.</U> The Company will indemnify Indemnitee in accordance with
the provisions of this Section&nbsp;4 if Indemnitee is, or is threatened to be made, a party to or a participant in any Proceeding by or in the right of the Company to procure a judgment in its favor. Pursuant to this Section&nbsp;4, the Company
will indemnify Indemnitee to the fullest extent permitted by applicable law against all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee&#146;s behalf in connection with such Proceeding or any claim, issue or matter therein,
if Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in or not opposed to the best interests of the Company. The Company will not indemnify Indemnitee for Expenses under this Section&nbsp;4 related to any claim,
issue or matter in a Proceeding for which Indemnitee has been finally adjudged by a court to be liable to the Company, unless, and only to the extent that, the Delaware Court of Chancery or any court in which the Proceeding was brought determines
upon application by Indemnitee that, despite the adjudication of liability but in view of all the circumstances of the case, Indemnitee is fairly and reasonably entitled to indemnification. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5. <U>Indemnification for Expenses of a Party Who is Wholly or Partly Successful.</U> Notwithstanding any other provisions of
this Agreement, to the fullest extent permitted by applicable law, the Company will indemnify Indemnitee against all Expenses actually and reasonably incurred by Indemnitee in connection with any Proceeding the extent that Indemnitee is successful,
on the merits or otherwise. If Indemnitee is not wholly successful in such Proceeding but is successful, on the merits or otherwise, as to one or more but less than all claims, issues or matters in such Proceeding, the Company will indemnify
Indemnitee against all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee&#146;s behalf in connection with or related to each successfully resolved claim, issue or matter to the fullest extent permitted by law. For purposes of
this Section&nbsp;5 and without limitation, the termination of any claim, issue or matter in such a Proceeding by dismissal, with or without prejudice, will be deemed to be a successful result as to such claim, issue or matter. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6. <U>Indemnification For Expenses of a Witness.</U> Notwithstanding any other
provision of this Agreement and to the fullest extent permitted by applicable law, the Company will indemnify Indemnitee against all Expenses actually and reasonably incurred by Indemnitee or on Indemnitee&#146;s behalf in connection with any
Proceeding to which Indemnitee is not a party but to which Indemnitee is a witness, deponent, interviewee, or otherwise asked to participate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7. <U>Partial Indemnification.</U> If Indemnitee is entitled under any provision of this Agreement to indemnification by the
Company for some or a portion of Expenses, but not, however, for the total amount thereof, the Company will indemnify Indemnitee for the portion thereof to which Indemnitee is entitled. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;8. <U>Additional Indemnification.</U> Notwithstanding any limitation in Sections 3, 4, or 5, the Company will indemnify
Indemnitee to the fullest extent permitted by applicable law (including but not limited to, the DGCL and any amendments to or replacements of the DGCL adopted after the date of this Agreement that expand the Company&#146;s ability to indemnify its
officers and directors) if Indemnitee is a party to or threatened to be made a party to any Proceeding (including a Proceeding by or in the right of the Company to procure a judgment in its favor). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;9. <U>Exclusions.</U> Notwithstanding any provision in this Agreement, the Company is not obligated under this Agreement to make
any indemnification payment to Indemnitee in connection with any Proceeding: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) for which payment has actually been made to or on behalf
of Indemnitee under any insurance policy or other indemnity provision, except to the extent provided in Section&nbsp;16(b) of the Exchange Act (as defined in Section&nbsp;2(b) hereof) and except with respect to any excess beyond the amount paid
under any insurance policy or other indemnity provision; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) for (i)&nbsp;an accounting of profits made from the purchase and sale (or
sale and purchase) by Indemnitee of securities of the Company within the meaning of Section&nbsp;16(b) of the Exchange Act or similar provisions of state statutory law or common law, (ii)&nbsp;any reimbursement of the Company by the Indemnitee of
any bonus or other incentive-based or equity-based compensation or of any profits realized by the Indemnitee from the sale of securities of the Company, as required in each case under the Exchange Act (including any such reimbursements that arise
from an accounting restatement of the Company pursuant to Section&nbsp;304 of the Sarbanes-Oxley Act of 2002 (the &#147;<B>Sarbanes-Oxley Act</B>&#148;), or the payment to the Company of profits arising from the purchase and sale by Indemnitee of
securities in violation of Section&nbsp;306 of the Sarbanes-Oxley Act) or (iii)&nbsp;any reimbursement of the Company by Indemnitee of any compensation pursuant to any compensation recoupment or clawback policy adopted by the Board or the
compensation committee of the Board, including but not limited to any such policy adopted to comply with stock exchange listing requirements implementing Section&nbsp;10D of the Exchange Act; or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) initiated by Indemnitee, including any Proceeding (or any part of any Proceeding)
initiated by Indemnitee against the Company or its directors, officers, employees or other indemnitees, unless (i)&nbsp;the Proceeding or part of any Proceeding is to enforce Indemnitee&#146;s rights to indemnification or advancement, of Expenses,
including a Proceeding (or any part of any Proceeding) initiated pursuant to Section&nbsp;14 of this Agreement, (ii)&nbsp;the Board authorized the Proceeding (or any part of any Proceeding) prior to its initiation or (iii)&nbsp;the Company provides
the indemnification, in its sole discretion, pursuant to the powers vested in the Company under applicable law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;10.
<U>Advances of Expenses.</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company will advance, to the extent not prohibited by law, the Expenses incurred by Indemnitee in
connection with any Proceeding (or any part of any Proceeding) not initiated by Indemnitee or any Proceeding (or any part of any Proceeding) initiated by Indemnitee if (i)&nbsp;the Proceeding or part of any Proceeding is to enforce Indemnitee&#146;s
rights to obtain indemnification or advancement of Expenses from the Company or Enterprise, including a proceeding initiated pursuant to Section&nbsp;14 or (ii)&nbsp;the Board authorized the Proceeding (or any part of any Proceeding) prior to its
initiation. The Company will advance the Expenses within thirty (30)&nbsp;days after the receipt by the Company of a statement or statements requesting such advances from time to time, whether prior to or after final disposition of any Proceeding.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Advances will be unsecured and interest free. Indemnitee undertakes to repay the amounts advanced (without interest) to the extent
that it is ultimately determined that Indemnitee is not entitled to be indemnified by the Company, thus Indemnitee qualifies for advances upon the execution of this Agreement and delivery to the Company. No other form of undertaking is required
other than the execution of this Agreement. The Company will make advances without regard to Indemnitee&#146;s ability to repay the Expenses and without regard to Indemnitee&#146;s ultimate entitlement to indemnification under the other provisions
of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;11. <U>Procedure for Notification of Claim for Indemnification or Advancement.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Indemnitee will notify the Company in writing of any Proceeding with respect to which Indemnitee intends to seek indemnification or
advancement of Expenses hereunder as soon as reasonably practicable following the receipt by Indemnitee of written notice thereof. Indemnitee will include in the written notification to the Company a description of the nature of the Proceeding and
the facts underlying the Proceeding and provide such documentation and information as is reasonably available to Indemnitee and is reasonably necessary to determine whether and to what extent Indemnitee is entitled to indemnification following the
final disposition of such Proceeding. Indemnitee&#146;s failure to notify the Company will not relieve the Company from any obligation it may have to Indemnitee under this Agreement, and any delay in so notifying the Company will not constitute a
waiver by Indemnitee of any rights under this Agreement. The Secretary of the Company will, promptly upon receipt of such a request for indemnification, advise the Board in writing that Indemnitee has requested indemnification or advancement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company will be entitled to participate in the Proceeding at its own expense. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;12. <U>Procedure Upon Application for Indemnification.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Unless a Change of Control has occurred, the determination of Indemnitee&#146;s entitlement to indemnification will be made: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">i. by a majority vote of the Disinterested Directors, even though less than a quorum of the Board; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">ii. by a committee of Disinterested Directors designated by a majority vote of the Disinterested Directors, even though less than a quorum of
the Board; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">iii. if there are no such Disinterested Directors or, if such Disinterested Directors so direct, by written opinion provided
by Independent Counsel selected by the Board; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">iv. if so directed by the Board, by the stockholders of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) If a Change in Control has occurred, the determination of Indemnitee&#146;s entitlement to indemnification will be made by written opinion
provided by Independent Counsel selected by Indemnitee (unless Indemnitee requests such selection be made by the Board). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The party
selecting Independent Counsel pursuant to subsection (a)(iii) or (b)&nbsp;of this Section&nbsp;12 will provide written notice of the selection to the other party. The notified party may, within ten (10)&nbsp;days after receiving written notice of
the selection of Independent Counsel, deliver to the selecting party a written objection to such selection; <U>provided</U>, <U>however</U>, that such objection may be asserted only on the ground that the Independent Counsel so selected does not
meet the requirements of &#147;Independent Counsel&#148; as defined in Section&nbsp;2 of this Agreement, and the objection will set forth with particularity the factual basis of such assertion. Absent a proper and timely objection, the person so
selected will act as Independent Counsel. If such written objection is so made and substantiated, the Independent Counsel so selected may not serve as Independent Counsel unless and until such objection is withdrawn or the Delaware Court has
determined that such objection is without merit. If, within thirty (30)&nbsp;days after the later of submission by Indemnitee of a written request for indemnification pursuant to Section&nbsp;11(a) hereof and the final disposition of the Proceeding,
Independent Counsel has not been selected or, if selected, any objection to has not been resolved, either the Company or Indemnitee may petition the Delaware Court for the appointment as Independent Counsel of a person selected by such court or by
such other person as such court designates. Upon the due commencement of any judicial proceeding or arbitration pursuant to Section&nbsp;14(a) of this Agreement, Independent Counsel will be discharged and relieved of any further responsibility in
such capacity (subject to the applicable standards of professional conduct then prevailing). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Indemnitee will cooperate with the
person, persons or entity making the determination with respect to Indemnitee&#146;s entitlement to indemnification, including providing to such person, persons or entity upon reasonable advance request any documentation or information which is not
privileged or otherwise protected from disclosure and which is reasonably available to Indemnitee and reasonably necessary to such determination. The Company will advance and pay any Expenses incurred by Indemnitee in so cooperating with the person,
persons or entity making the indemnification determination irrespective of the determination as to Indemnitee&#146;s entitlement to indemnification and the Company hereby indemnifies and agrees to hold Indemnitee harmless therefrom. The Company
promptly will advise Indemnitee in writing of the determination that Indemnitee is or is not entitled to indemnification, including a description of any reason or basis for which indemnification has been denied and providing a copy of any written
opinion provided to the Board by Independent Counsel. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) If it is determined that Indemnitee is entitled to indemnification, the Company will
make payment to Indemnitee within ten (10)&nbsp;days after such determination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;13. <U>Presumptions and Effect of Certain
Proceedings.</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) In making a determination with respect to entitlement to indemnification hereunder, the person or persons or entity
making such determination will, to the fullest extent not prohibited by law, presume Indemnitee is entitled to indemnification under this Agreement if Indemnitee has submitted a request for indemnification in accordance with Section&nbsp;11(a) of
this Agreement, and the Company will, to the fullest extent not prohibited by law, have the burden of proof to overcome that presumption. Neither the failure of the Company (including by its directors or Independent Counsel) to have made a
determination prior to the commencement of any action pursuant to this Agreement that indemnification is proper in the circumstances because Indemnitee has met the applicable standard of conduct, nor an actual determination by the Company (including
by its directors or Independent Counsel) that Indemnitee has not met such applicable standard of conduct, will be a defense to the action or create a presumption that Indemnitee has not met the applicable standard of conduct. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) If the determination of the Indemnitee&#146;s entitlement to indemnification has not made pursuant to Section&nbsp;12 within sixty
(60)&nbsp;days after the latter of (i)&nbsp;receipt by the Company of Indemnitee&#146;s request for indemnification pursuant to Section&nbsp;11(a) and (ii)&nbsp;the final disposition of the Proceeding for which Indemnitee requested Indemnification
(the &#147;<B>Determination Period</B>&#148;), the requisite determination of entitlement to indemnification will, to the fullest extent not prohibited by law, be deemed to have been made and Indemnitee will be entitled to such indemnification,
absent (i)&nbsp;a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee&#146;s statement not materially misleading, in connection with the request for indemnification, or (ii)&nbsp;a
prohibition of such indemnification under applicable law. The Determination Period may be extended for a reasonable time, not to exceed an additional thirty (30)&nbsp;days, if the person, persons or entity making the determination with respect to
entitlement to indemnification in good faith requires such additional time for the obtaining or evaluating of documentation and/or information relating thereto; and provided, further, the Determination Period may be extended an additional fifteen
(15)&nbsp;days if the determination of entitlement to indemnification is to be made by the stockholders pursuant to Section&nbsp;12(a)(iv) of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The termination of any Proceeding or of any claim, issue or matter therein, by judgment, order, settlement or conviction, or upon a plea
of <U>nolo</U> <U>contendere</U> or its equivalent, will not (except as otherwise expressly provided in this Agreement) of itself adversely affect the right of Indemnitee to indemnification or create a presumption that Indemnitee did not act in good
faith and in a manner which Indemnitee reasonably believed to be in or not opposed to the best interests of the Company or, with respect to any criminal Proceeding, that Indemnitee had reasonable cause to believe that Indemnitee&#146;s conduct was
unlawful. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) For purposes of any determination of good faith, Indemnitee will be deemed to have acted
in good faith if Indemnitee acted based on the records or books of account of the Company, its subsidiaries, or an Enterprise, including financial statements, or on information supplied to Indemnitee by the directors or officers of the Company, its
subsidiaries, or an Enterprise in the course of their duties, or on the advice of legal counsel for the Company, its subsidiaries, or an Enterprise or on information or records given or reports made to the Company or an Enterprise by an independent
certified public accountant or by an appraiser, financial advisor or other expert selected with reasonable care by or on behalf of the Company, its subsidiaries, or an Enterprise. Further, Indemnitee will be deemed to have acted in a manner
&#147;not opposed to the best interests of the Company,&#148; as referred to in this Agreement if Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in the best interests of the participants and beneficiaries of an
employee benefit plan. The provisions of this Section&nbsp;13(d) is not exclusive and does not limit in any way the other circumstances in which the Indemnitee may be deemed to have met the applicable standard of conduct set forth in this Agreement.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The knowledge and/or actions, or failure to act, of any director, officer, trustee, partner, managing member, fiduciary, agent or
employee of the Enterprise may not be imputed to Indemnitee for purposes of determining Indemnitee&#146;s right to indemnification under this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;14. <U>Remedies of Indemnitee.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Indemnitee may commence litigation against the Company in the Delaware Court of Chancery to obtain indemnification or advancement of
Expenses provided by this Agreement in the event that (i)&nbsp;a determination is made pursuant to Section&nbsp;12 of this Agreement that Indemnitee is not entitled to indemnification under this Agreement, (ii)&nbsp;the Company does not advance
Expenses pursuant to Section&nbsp;10 of this Agreement, (iii)&nbsp;the determination of entitlement to indemnification is not made pursuant to Section&nbsp;12 of this Agreement within the Determination Period, (iv)&nbsp;the Company does not
indemnify Indemnitee pursuant to Section&nbsp;5 or 6 or the second to last sentence of Section&nbsp;12(d) of this Agreement within ten (10)&nbsp;days after receipt by the Company of a written request therefor, (v)&nbsp;the Company does not indemnify
Indemnitee pursuant to Section&nbsp;3, 4, 7, or 8 of this Agreement within ten (10)&nbsp;days after a determination has been made that Indemnitee is entitled to indemnification, or (vi)&nbsp;in the event that the Company or any other person takes or
threatens to take any action to declare this Agreement void or unenforceable, or institutes any litigation or other action or Proceeding designed to deny, or to recover from, the Indemnitee the benefits provided or intended to be provided to the
Indemnitee hereunder. Alternatively, Indemnitee, at Indemnitee&#146;s option, may seek an award in arbitration to be conducted by a single arbitrator pursuant to the Commercial Arbitration Rules of the American Arbitration Association. Indemnitee
must commence such Proceeding seeking an adjudication or an award in arbitration within 180 days following the date on which Indemnitee first has the right to commence such Proceeding pursuant to this Section&nbsp;14(a); <U>provided</U>,
<U>however</U>, that the foregoing clause does not apply in respect of a Proceeding brought by Indemnitee to enforce Indemnitee&#146;s rights under Section&nbsp;5 of this Agreement. The Company will not oppose Indemnitee&#146;s right to seek any
such adjudication or award in arbitration. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) If a determination is made pursuant to Section&nbsp;12 of this Agreement that Indemnitee
is not entitled to indemnification, any judicial proceeding or arbitration commenced pursuant to this Section&nbsp;14 will be conducted in all respects as a <I>de novo</I> trial, or arbitration, on the merits and Indemnitee may not be prejudiced by
reason of that adverse determination. In any judicial proceeding or arbitration commenced pursuant to this Section&nbsp;14 the Company will have the burden of proving Indemnitee is not entitled to indemnification or advancement of Expenses, as the
case may be and will not introduce evidence of the determination made pursuant to Section&nbsp;12 of this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) If a determination is made pursuant to Section&nbsp;12 of this Agreement that Indemnitee
is entitled to indemnification, the Company will be bound by such determination in any judicial proceeding or arbitration commenced pursuant to this Section&nbsp;14, absent (i)&nbsp;a misstatement by Indemnitee of a material fact, or an omission of
a material fact necessary to make Indemnitee&#146;s statement not materially misleading, in connection with the request for indemnification, or (ii)&nbsp;a prohibition of such indemnification under applicable law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Company is, to the fullest extent not prohibited by law, precluded from asserting in any judicial proceeding or arbitration commenced
pursuant to this Section&nbsp;14 that the procedures and presumptions of this Agreement are not valid, binding and enforceable and will stipulate in any such court or before any such arbitrator that the Company is bound by all the provisions of this
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) It is the intent of the Company that, to the fullest extent permitted by law, the Indemnitee not be required to incur
legal fees or other Expenses associated with the interpretation, enforcement or defense of Indemnitee&#146;s rights under this Agreement by litigation or otherwise because the cost and expense thereof would substantially detract from the benefits
intended to be extended to the Indemnitee hereunder. The Company, to the fullest extent permitted by law, will (within ten (10)&nbsp;days after receipt by the Company of a written request therefor) advance to Indemnitee such Expenses which are
incurred by Indemnitee in connection with any action concerning this Agreement, Indemnitee&#146;s right to indemnification or advancement of Expenses from the Company, or concerning any directors&#146; and officers&#146; liability insurance policies
maintained by the Company, and will indemnify Indemnitee against any and all such Expenses unless the court determines that each of the Indemnitee&#146;s claims in such Proceeding were made in bad faith or were frivolous or are prohibited by law.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;15. <U>Establishment of Trust.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) In the event of a Potential Change in Control or a Change in Control, the Company will, upon written request by Indemnitee, create a trust
for the benefit of Indemnitee (the &#147;<B>Trust</B>&#148;) and from time to time upon written request of Indemnitee will fund such Trust in an amount sufficient to satisfy the reasonably anticipated indemnification and advancement obligations of
the Company to the Indemnitee in connection with any Proceeding for which Indemnitee has demanded indemnification and/or advancement prior to the Potential Change in Control or Change in Control (the &#147;<B>Funding Obligation</B>&#148;). The
trustee of the Trust (the &#147;<B>Trustee</B>&#148;) will be a bank or trust company or other individual or entity chosen by the Indemnitee and reasonably acceptable to the Company. Nothing in this Section&nbsp;15 relieves the Company of any of its
obligations under this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The amount or amounts to be deposited in the Trust pursuant to the Funding Obligation will be
determined by mutual agreement of the Indemnitee and the Company or, if the Company and the Indemnitee are unable to reach such an agreement, by Independent Counsel selected in accordance with Section&nbsp;12(b) of this Agreement. The terms of the
Trust will provide that, except upon the consent of both the Indemnitee and the Company, upon a Change in Control: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(i) the Trust may not be revoked, or the principal thereof invaded, without the written consent of the Indemnitee; (ii)&nbsp;the Trustee will advance, to the fullest extent permitted by
applicable law, within two (2)&nbsp;business days of a request by the Indemnitee; (iii)&nbsp;the Company will continue to fund the Trust in accordance with the Funding Obligation; (iv)&nbsp;the Trustee will promptly pay to the Indemnitee all amounts
for which the Indemnitee is entitled to indemnification pursuant to this Agreement or otherwise; and (v)&nbsp;all unexpended funds in such Trust revert to the Company upon mutual agreement by the Indemnitee and the Company or, if the Indemnitee and
the Company are unable to reach such an agreement, by Independent Counsel selected in accordance with Section&nbsp;12(b) of this Agreement, that the Indemnitee has been fully indemnified under the terms of this Agreement. New York law (without
regard to its conflicts of laws rules) governs the Trust and the Trustee will consent to the exclusive jurisdiction of Delaware Court of Chancery, in accordance with Section&nbsp;25 of this Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;16. <U><FONT STYLE="white-space:nowrap">Non-exclusivity;</FONT> Survival of Rights; Insurance; Subrogation.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The indemnification and advancement of Expenses provided by this Agreement are not exclusive of any other rights to which Indemnitee may
at any time be entitled under applicable law, the Certificate of Incorporation, the Bylaws, any agreement, a vote of stockholders or a resolution of directors, or otherwise. The indemnification and advancement of Expenses provided by this Agreement
may not be limited or restricted by any amendment, alteration or repeal of this Agreement in any way with respect to any action taken or omitted by Indemnitee in Indemnitee&#146;s Corporate Status occurring prior to any amendment, alteration or
repeal of this Agreement. To the extent that a change in Delaware law, whether by statute or judicial decision, permits greater indemnification or advancement of Expenses than would be afforded currently under the Bylaws, Certificate of
Incorporation, or this Agreement, it is the intent of the parties hereto that Indemnitee enjoy by this Agreement the greater benefits so afforded by such change. No right or remedy herein conferred is intended to be exclusive of any other right or
remedy, and every other right and remedy is cumulative and in addition to every other right and remedy given hereunder or now or hereafter existing at law or in equity or otherwise. The assertion or employment of any right or remedy hereunder, or
otherwise, will not prevent the concurrent assertion or employment of any other right or remedy. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Company hereby acknowledges that
Indemnitee may have certain rights to indemnification, advancement of Expenses and/or insurance provided by one or more Persons with whom or which Indemnitee may be associated [(including, without limitation, [Fund] and certain of its affiliates,
collectively, the &#147;Fund Indemnitors&#148;)]). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">i. The Company hereby acknowledges and agrees: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">1) the Company is the indemnitor of first resort with respect to any request for indemnification or advancement of Expenses made pursuant to
this Agreement concerning any Proceeding arising from or related to Indemnitee&#146;s Corporate Status with the Company; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">2) the Company
is primarily liable for all indemnification and indemnification or advancement of Expenses obligations for any Proceeding arising from or related to Indemnitee&#146;s Corporate Status, whether created by law, organizational or constituent documents,
contract (including this Agreement) or otherwise; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">3) any obligation of any other Persons with whom or which Indemnitee may be associated
[(including, without limitation, any Fund Indemnitor)] to indemnify Indemnitee and/or advance Expenses to Indemnitee in respect of any proceeding are secondary to the obligations of the Company&#146;s obligations; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">4) the Company will indemnify Indemnitee and advance Expenses to Indemnitee hereunder to the fullest extent provided herein without regard to
any rights Indemnitee may have against any other Person with whom or which Indemnitee may be associated [(including any Fund Indemnitor)] or insurer of any such Person; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">ii. the Company irrevocably waives, relinquishes and releases [(A)] any other Person with whom or which Indemnitee may be associated
[(including, without limitation, any Fund Indemnitor)] from any claim of contribution, subrogation, reimbursement, exoneration or indemnification, or any other recovery of any kind in respect of amounts paid by the Company to Indemnitee pursuant to
this Agreement [and (B)&nbsp;any right to participate in any claim or remedy of Indemnitee against any Fund Indemnitor (or former Fund Indemnitor)], whether or not such claim, remedy or right arises in equity or under contract, statute or common
law[, including, without limitation, the right to take or receive from any Fund Indemnitor (or former Fund Indemnitor), directly or indirectly, in cash or other property or by <FONT STYLE="white-space:nowrap">set-off</FONT> or in any other manner,
payment or security on account of such claim, remedy or right]. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">iii. In the event any other Person with whom or which Indemnitee may be
associated [(including, without limitation, any Fund Indemnitor)] or their insurers advances or extinguishes any liability or loss for Indemnitee, the payor has a right of subrogation against the Company or its insurers for all amounts so paid which
would otherwise be payable by the Company or its insurers under this Agreement. In no event will payment by any other Person with whom or which Indemnitee may be associated [(including, without limitation, any Fund Indemnitor)] or their insurers
affect the obligations of the Company hereunder or shift primary liability for the Company&#146;s obligation to indemnify or advance of Expenses to any other Person with whom or which Indemnitee may be associated [(including, without limitation, any
Fund Indemnitor)]. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">iv. Any indemnification or advancement of Expenses provided by any other Person with whom or which Indemnitee may be
associated [(including, without limitation, any Fund Indemnitor)] is specifically in excess over the Company&#146;s obligation to indemnify and advance Expenses or any valid and collectible insurance (including but not limited to any malpractice
insurance or professional errors and omissions insurance) provided by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) To the extent that the Company maintains an
insurance policy or policies providing liability insurance for directors, officers, employees, or agents of the Enterprise, the Company will obtain a policy or policies covering Indemnitee to the maximum extent of the coverage available for any such
director, officer, employee or agent under such policy or policies, including coverage in the event the Company does not or cannot, for any reason, indemnify or advance Expenses to Indemnitee as required by this Agreement. If, at the time of the
receipt of a notice of a claim pursuant to this Agreement, the Company has director and officer liability insurance in effect, the Company will give prompt notice of such claim or of the commencement of a Proceeding, as the case may be, to the
insurers in accordance with the procedures set forth in the respective policies. The Company will thereafter take all necessary or desirable action to cause such insurers to pay, on behalf of the Indemnitee, all amounts payable as a result of such
Proceeding in accordance with the terms of such policies. Indemnitee agrees to assist the Company efforts to cause the insurers to pay such amounts and will comply with the terms of such policies, including selection of approved panel counsel, if
required. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Company&#146;s obligation to indemnify or advance Expenses hereunder to Indemnitee
for any Proceeding concerning Indemnitee&#146;s Corporate Status with an Enterprise will be reduced by any amount Indemnitee has actually received as indemnification or advancement of Expenses from such Enterprise. The Company and Indemnitee intend
that any such Enterprise (and its insurers) be the indemnitor of first resort with respect to indemnification and advancement of Expenses for any Proceeding related to or arising from Indemnitee&#146;s Corporate Status with such Enterprise. The
Company&#146;s obligation to indemnify and advance Expenses to Indemnitee is secondary to the obligations the Enterprise or its insurers owe to Indemnitee. Indemnitee agrees to take all reasonably necessary and desirable action to obtain from an
Enterprise indemnification and advancement of Expenses for any Proceeding related to or arising from Indemnitee&#146;s Corporate Status with such Enterprise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) In the event of any payment made by the Company under this Agreement, the Company will be subrogated to the extent of such payment to all
of the rights of recovery of Indemnitee from any Enterprise or insurance carrier. Indemnitee will execute all papers required and take all action necessary to secure such rights, including execution of such documents as are necessary to enable the
Company to bring suit to enforce such rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;17. <U>Duration of Agreement.</U> This Agreement continues until and
terminates upon the later of: (a)&nbsp;ten (10) years after the date that Indemnitee ceases to serve as a [director /officer/employee] of the Company or (b)&nbsp;one (1) year after the final termination of any Proceeding then pending in respect of
which Indemnitee is granted rights of indemnification or advancement of Expenses hereunder and of any Proceeding commenced by Indemnitee pursuant to Section&nbsp;14 of this Agreement relating thereto. The indemnification and advancement of Expenses
rights provided by or granted pursuant to this Agreement are binding upon and be enforceable by the parties hereto and their respective successors and assigns (including any direct or indirect successor by purchase, merger, consolidation or
otherwise to all or substantially all of the business or assets of the Company), continue as to an Indemnitee who has ceased to be a director, officer, employee or agent of the Company or of any other Enterprise, and inure to the benefit of
Indemnitee and Indemnitee&#146;s spouse, assigns, heirs, devisees, executors and administrators and other legal representatives. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;18. <U>Severability.</U> If any provision or provisions of this Agreement is held to be invalid, illegal or unenforceable for any
reason whatsoever: (a)&nbsp;the validity, legality and enforceability of the remaining provisions of this Agreement (including without limitation, each portion of any section of this Agreement containing any such provision held to be invalid,
illegal or unenforceable, that is not itself invalid, illegal or unenforceable) will not in any way be affected or impaired thereby and remain enforceable to the fullest extent permitted by law; (b)&nbsp;such provision or provisions will be deemed
reformed to the extent necessary to conform to applicable law and to give the maximum effect to the intent of the parties hereto; and (c)&nbsp;to the fullest extent possible, the provisions of this Agreement (including, without limitation, each
portion of any section of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) will be construed so as to give effect to the intent manifested thereby. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;19. <U>Interpretation.</U> Any ambiguity in the terms of this Agreement will be
resolved in favor of Indemnitee and in a manner to provide the maximum indemnification and advancement of Expenses permitted by law. The Company and Indemnitee intend that this Agreement provide to the fullest extent permitted by law for
indemnification in excess of that expressly provided, without limitation, by the Certificate of Incorporation, the Bylaws, vote of the Company stockholders or disinterested directors, or applicable law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;20. <U>Enforcement.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Company expressly confirms and agrees that it has entered into this Agreement and assumed the obligations imposed on it hereby in
order to induce Indemnitee to serve as a director or officer of the Company, and the Company acknowledges that Indemnitee is relying upon this Agreement in serving or continuing to serve as a director or officer of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) This Agreement constitutes the entire agreement between the parties hereto with respect to the subject matter hereof and supersedes all
prior agreements and understandings, oral, written and implied, between the parties hereto with respect to the subject matter hereof; provided, however, that this Agreement is a supplement to and in furtherance of the Certificate of Incorporation,
the Bylaws and applicable law, and is not a substitute therefor, nor to diminish or abrogate any rights of Indemnitee thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;21. <U>Modification and Waiver.</U> No supplement, modification or amendment of this Agreement is binding unless executed in
writing by the parties hereto. No waiver of any of the provisions of this Agreement will be deemed or constitutes a waiver of any other provisions of this Agreement nor will any waiver constitute a continuing waiver. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;22. <U>Notice by Indemnitee.</U> Indemnitee agrees promptly to notify the Company in writing upon being served with any summons,
citation, subpoena, complaint, indictment, information or other document relating to any Proceeding or matter which may be subject to indemnification or advancement of Expenses covered hereunder. The failure of Indemnitee to so notify the Company
does not relieve the Company of any obligation which it may have to the Indemnitee under this Agreement or otherwise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;23.
<U>Notices.</U> All notices, requests, demands and other communications under this Agreement will be in writing and will be deemed to have been duly given if (a)&nbsp;delivered by hand to the other party, (b)&nbsp;sent by reputable overnight courier
to the other party or (c)&nbsp;sent by facsimile transmission or electronic mail, with receipt of oral confirmation that such communication has been received: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) If to Indemnitee, at the address indicated on the signature page of this Agreement, or such other address as Indemnitee provides to the
Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) If to the Company to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Name: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sana Biotechnology, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Address: &nbsp;&nbsp;&nbsp;&nbsp;188 East Blaine Street, Suite 400 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Seattle, Washington
98102 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Attention: &nbsp;&nbsp;Corporate Secretary </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">Email: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;legalnotices@sana.com </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">or to any other address as may have been furnished to Indemnitee by the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;24. <U>Contribution.</U> To the fullest extent permissible under applicable
law, if the indemnification provided for in this Agreement is unavailable to Indemnitee for any reason whatsoever, the Company, in lieu of indemnifying Indemnitee, will contribute to the amount incurred by Indemnitee, whether for judgments, fines,
penalties, excise taxes, amounts paid or to be paid in settlement and/or for Expenses, in connection with any claim relating to an indemnifiable event under this Agreement, in such proportion as is deemed fair and reasonable in light of all of the
circumstances of such Proceeding in order to reflect (i)&nbsp;the relative benefits received by the Company and Indemnitee as a result of the event(s) and/or transaction(s) giving cause to such Proceeding; and/or (ii)&nbsp;the relative fault of the
Company (and its directors, officers, employees and agents) and Indemnitee in connection with such event(s) and/or transaction(s). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;25. <U>Applicable Law and Consent to Jurisdiction.</U> This Agreement and the legal relations among the parties are governed by,
and construed and enforced in accordance with, the laws of the State of Delaware, without regard to its conflict of laws rules. Except with respect to any arbitration commenced by Indemnitee pursuant to Section&nbsp;14(a) of this Agreement, the
Company and Indemnitee hereby irrevocably and unconditionally (i)&nbsp;agree that any action or Proceeding arising out of or in connection with this Agreement may be brought only in the Delaware Court of Chancery and not in any other state or
federal court in the United States of America or any court in any other country, (ii)&nbsp;consent to submit to the exclusive jurisdiction of the Delaware Court for purposes of any action or Proceeding arising out of or in connection with this
Agreement, (iii)&nbsp;waive any objection to the laying of venue of any such action or Proceeding in the Delaware Court, and (iv)&nbsp;waive, and agree not to plead or to make, any claim that any such action or Proceeding brought in the Delaware
Court has been brought in an improper or inconvenient forum. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;26. <U>Identical Counterparts.</U> This Agreement may be
executed in one or more counterparts, each of which will for all purposes be deemed to be an original but all of which together constitutes one and the same Agreement. Only one such counterpart signed by the party against whom enforceability is
sought needs to be produced to evidence the existence of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;27. <U>Headings.</U> The headings of this Agreement
are inserted for convenience only and do not constitute part of this Agreement or affect the construction thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties have caused this Agreement to be signed as of the day and
year first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="40%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="40%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">SANA BIOTECHNOLOGY, INC.</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">INDEMNITEE</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">By:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Name:</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Name:</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Office:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Address:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature Page to
Indemnification Agreement</I>] </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4(A)
<SEQUENCE>9
<FILENAME>d60414dex104a.htm
<DESCRIPTION>EX-10.4(A)
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.4(a)</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.4(a) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SANA BIOTECHNOLOGY, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2021 INCENTIVE AWARD PLAN </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE I. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PURPOSE
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Plan&#146;s purpose is to enhance the Company&#146;s ability to attract, retain and motivate persons who make (or are expected to
make) important contributions to the Company by providing these individuals with equity ownership opportunities. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE II. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DEFINITIONS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As used in
the Plan, the following words and phrases have the meanings specified below, unless the context clearly indicates otherwise: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.1
&#147;<B><I>Administrator</I></B>&#148; means the Board or a Committee to the extent that the Board&#146;s powers or authority under the Plan have been delegated to such Committee. With reference to the Board&#146;s or a Committee&#146;s powers or
authority under the Plan that have been delegated to one or more officers pursuant to Section&nbsp;4.2, the term &#147;Administrator&#148; shall refer to such officer(s) unless and until such delegation has been revoked. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.2 &#147;<B><I>Applicable Law</I></B>&#148; means any applicable law, including without limitation: (a)&nbsp;provisions of the Code, the
Securities Act, the Exchange Act and any rules or regulations thereunder; (b)&nbsp;corporate, securities, tax or other laws, statutes, rules, requirements or regulations, whether federal, state, local or foreign; and (c)&nbsp;rules of any securities
exchange or automated quotation system on which the Shares are listed, quoted or traded. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.3 &#147;<B><I>Award</I></B>&#148; means an
Option, Stock Appreciation Right, Restricted Stock award, Restricted Stock Unit award, Performance Bonus Award, Performance Stock Unit award, Dividend Equivalents award or Other Stock or Cash Based Award granted to a Participant under the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.4 &#147;<B><I>Award Agreement</I></B>&#148; means an agreement evidencing an Award, which may be written or electronic, that contains such
terms and conditions as the Administrator determines, consistent with and subject to the terms and conditions of the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.5
&#147;<B><I>Board</I></B>&#148; means the Board of Directors of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.6 &#147;<B><I>Cause</I></B>&#148; shall have the meaning
ascribed to such term, or term of similar effect, in any offer letter, employment, severance or similar agreement, including any Award Agreement, between the Participant and the Company; provided, that in the absence of an offer letter, employment,
severance or similar agreement containing such definition, Cause means, with respect to a Participant, the occurrence of any of the following: (a)&nbsp;an act of dishonesty made by the Participant in connection with the Participant&#146;s
responsibilities as Service Provider; (b)&nbsp;the Participant&#146;s conviction of, or plea of nolo contendere to, a felony or any crime involving fraud, embezzlement or any other act of moral turpitude, or a material violation of federal or state
law by the Participant that the Administrator reasonably determines has had or will have a material detrimental effect on the Company&#146;s reputation or business; (c)&nbsp;the Participant&#146;s gross misconduct; (d)&nbsp;the Participant&#146;s
willful and material unauthorized use or disclosure of any proprietary information or trade secrets of the Company or any other party to whom the Participant owes an obligation of nondisclosure as a result of the Participant&#146;s relationship with
the Company; (e)&nbsp;the Participant&#146;s willful breach of any material obligations under any written agreement or covenant with the Company; or (f)&nbsp;the </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Participant&#146;s continued substantial failure to perform the Participant&#146;s duties as a Service Provider (other than as a result of the Participant&#146;s physical or mental incapacity)
after the Participant has received a written demand for performance that specifically sets forth the factual basis for the determination that the Participant has not substantially performed the Participant&#146;s duties and has failed to cure such <FONT
STYLE="white-space:nowrap">non-performance</FONT> to the Administrator&#146;s reasonable satisfaction within 30 business days after receiving such notice. For purposes of this Section&nbsp;2.6, no act or failure to act shall be considered willful
unless it is done in bad faith and without reasonable intent that the act or failure to act was in the best interest of the Company or required by law. Any act, or failure to act, based upon authority or instructions given to the Participant
pursuant to a direct instruction from the Company&#146;s chief executive officer or based on the advice of counsel for the Company will be conclusively presumed to be done or omitted to be done by the Participant in good faith and in the best
interest of the Company.<U> </U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.7 &#147;<B><I>Change in Control</I></B>&#148; means any of the following: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) A transaction or series of transactions (other than an offering of Common Stock to the general public through a registration statement
filed with the Securities and Exchange Commission) whereby any &#147;person&#148; or related &#147;group&#148; of &#147;persons&#148; (as such terms are used in Sections 13(d) and 14(d)(2) of the Exchange Act) directly or indirectly acquires
beneficial ownership (within the meaning of Rules <FONT STYLE="white-space:nowrap">13d-3</FONT> and <FONT STYLE="white-space:nowrap">13d-5</FONT> under the Exchange Act) of the Company&#146;s securities possessing more than 50% of the total combined
voting power of the Company&#146;s securities outstanding immediately after such acquisition; provided, however, that the following acquisitions shall not constitute a Change in Control: (i)&nbsp;any acquisition by the Company or any of its
Subsidiaries; (ii)&nbsp;any acquisition by an employee benefit plan maintained by the Company or any of its Subsidiaries, (iii)&nbsp;any acquisition which complies with Sections 2.6(c)(i), 2.6(c)(ii) and 2.6(c)(iii); or (iv)&nbsp;in respect of an
Award held by a particular Participant, any acquisition by the Participant or any group of persons including the Participant (or any entity controlled by the Participant or any group of persons including the Participant); </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Incumbent Directors cease for any reason to constitute a majority of the Board; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The consummation by the Company (whether directly involving the Company or indirectly involving the Company through one or more
intermediaries) of (x)&nbsp;a merger, consolidation, reorganization, or business combination, (y)&nbsp;a sale or other disposition of all or substantially all of the Company&#146;s assets in any single transaction or series of related transactions
or (z)&nbsp;the acquisition of assets or stock of another entity, in each case other than a transaction: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) which results in the
Company&#146;s voting securities outstanding immediately before the transaction continuing to represent (either by remaining outstanding or by being converted into voting securities of the Company or the person that, as a result of the transaction,
controls, directly or indirectly, the Company or owns, directly or indirectly, all or substantially all of the Company&#146;s assets or otherwise succeeds to the business of the Company (the Company or such person, the &#147;<B><I>Successor
Entity</I></B>&#148;)) directly or indirectly, at least a majority of the combined voting power of the Successor Entity&#146;s outstanding voting securities immediately after the transaction; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) after which no person or group beneficially owns voting securities representing 50% or more of the combined voting power of the
Successor Entity; provided<I>, </I>however, that no person or group shall be treated for purposes of this Section&nbsp;2.6(c)(ii) as beneficially owning 50% or more of the combined voting power of the Successor Entity solely as a result of the
voting power held in the Company prior to the consummation of the transaction; and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) after which at least a majority of the members of the board of directors (or the
analogous governing body) of the Successor Entity were Board members at the time of the Board&#146;s approval of the execution of the initial agreement providing for such transaction; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The completion of a liquidation or dissolution of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, if a Change in Control constitutes a payment event with respect to any Award (or any portion of an Award) that provides for the
deferral of compensation that is subject to Section&nbsp;409A, to the extent required to avoid the imposition of additional taxes under Section&nbsp;409A, the transaction or event described in subsection (a), (b), (c) or (d)&nbsp;of this
Section&nbsp;2.6 with respect to such Award (or portion thereof) shall only constitute a Change in Control for purposes of the payment timing of such Award if such transaction also constitutes a &#147;change in control event,&#148; as defined in
Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-3(i)(5).</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Administrator shall have full and final authority, which
shall be exercised in its sole discretion, to determine conclusively whether a Change in Control has occurred pursuant to the above definition, the date of such Change in Control and any incidental matters relating thereto; provided that any
exercise of authority in conjunction with a determination of whether a Change in Control is a &#147;change in control event&#148; as defined in Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.409A-3(i)(5)</FONT> shall be
consistent with such regulation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.8 &#147;<B><I>Code</I></B>&#148; means the U.S. Internal Revenue Code of 1986, as amended, and all
regulations, guidance, compliance programs and other interpretative authority issued thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.9 &#147;<B><I>Committee</I></B>&#148;
means one or more committees or subcommittees of the Board, which may include one or more Company directors or executive officers, to the extent permitted by Applicable Law. To the extent required to comply with the provisions of Rule <FONT
STYLE="white-space:nowrap">16b-3,</FONT> it is intended that each member of the Committee will be, at the time the Committee takes any action with respect to an Award that is subject to Rule <FONT STYLE="white-space:nowrap">16b-3,</FONT> a <FONT
STYLE="white-space:nowrap">&#147;non-employee</FONT> director&#148; within the meaning of Rule <FONT STYLE="white-space:nowrap">16b-3;</FONT> however, a Committee member&#146;s failure to qualify as a
<FONT STYLE="white-space:nowrap">&#147;non-employee</FONT> director&#148; within the meaning of Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> will not invalidate any Award granted by the Committee that is otherwise validly granted under the
Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.10 &#147;<B><I>Common Stock</I></B>&#148; means the common stock of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.11 &#147;<B><I>Company</I></B>&#148; means Sana Biotechnology, Inc., a Delaware corporation, or any successor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.12 &#147;<B><I>Consultant</I></B>&#148; means any person, including any adviser, engaged by the Company or a Subsidiary to render services
to such entity if the consultant or adviser: (i)&nbsp;renders bona fide services to the Company or a Subsidiary; (ii)&nbsp;renders services not in connection with the offer or sale of securities in a capital-raising transaction and does not directly
or indirectly promote or maintain a market for the Company&#146;s securities; and (iii)&nbsp;is a natural person. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.13
&#147;<B><I>Designated Beneficiary</I></B>&#148; means, if permitted by the Company, the beneficiary or beneficiaries the Participant designates, in a manner the Company determines, to receive amounts due or exercise the Participant&#146;s rights if
the Participant dies. Without a Participant&#146;s effective designation, &#147;Designated Beneficiary&#148; will mean the Participant&#146;s estate or legal heirs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.14 &#147;<B><I>Director</I></B>&#148; means a Board member. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.15 &#147;<B><I>Disability</I></B>&#148; means a permanent and total disability under Section&nbsp;22(e)(3) of the Code. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.16 &#147;<B><I>Dividend Equivalents</I></B>&#148; means a right granted to a Participant
to receive the equivalent value (in cash or Shares) of dividends paid on a specified number of Shares. Such Dividend Equivalent shall be converted to cash or additional Shares, or a combination of cash and Shares, by such formula and at such time
and subject to such limitations as may be determined by the Administrator. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.17 &#147;<B><I>DRO</I></B>&#148; means a &#147;domestic
relations order&#148; as defined by the Code or Title I of the Employee Retirement Income Security Act of 1974, as amended, or the rules thereunder. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.18 &#147;<B><I>Effective Date</I></B>&#148; has the meaning set forth in Section&nbsp;11.3. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.19 &#147;<B><I>Employee</I></B>&#148; means any employee of the Company or any of its Subsidiaries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.20 &#147;<B><I>Equity Restructuring</I></B>&#148; means a nonreciprocal transaction between the Company and its stockholders, such as a
stock dividend, stock split (including a reverse stock split), <FONT STYLE="white-space:nowrap">spin-off</FONT> or recapitalization through a large, nonrecurring cash dividend, that affects the number or kind of Shares (or other Company securities)
or the share price of Common Stock (or other Company securities) and causes a change in the per share value of the Common Stock underlying outstanding Awards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.21 &#147;<B><I>Exchange Act</I></B>&#148; means the U.S. Securities Exchange Act of 1934, as amended, and all regulations, guidance and
other interpretative authority issued thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.22 &#147;<B><I>Fair Market Value</I></B>&#148; means, as of any date, the value of a
Share determined as follows: (i)&nbsp;if the Common Stock is listed on any established stock exchange, the value of a Share will be the closing sales price for a Share as quoted on such exchange for such date, or if no sale occurred on such date,
the last day preceding such date during which a sale occurred, as reported in <I>The Wall Street Journal</I> or another source the Administrator deems reliable; (ii)&nbsp;if the Common Stock is not listed on an established stock exchange but is
quoted on a national market or other quotation system, the value of a Share will be the closing sales price for a Share on such date, or if no sales occurred on such date, then on the last date preceding such date during which a sale occurred, as
reported in The Wall Street Journal or another source the Administrator deems reliable; or (iii)&nbsp;if the Common Stock is not listed on any established stock exchange or quoted on a national market or other quotation system, the value established
by the Administrator in its sole discretion. Notwithstanding the foregoing, with respect to any Award granted on or after the effectiveness of the Company&#146;s registration statement relating to its initial public offering and prior to the Public
Trading Date, the Fair Market Value means the initial public offering price of a Share as set forth in the Company&#146;s final prospectus relating to its initial public offering filed with the Securities and Exchange Commission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.23 &#147;<B><I>Good Reason</I></B>&#148; shall have the meaning ascribed to such term, or term of similar effect, in any offer letter,
employment, severance or similar agreement, including any Award Agreement, between the Participant and the Company; provided, that in the absence of an offer letter, employment, severance or similar agreement containing such definition, Good Reason
means the occurrence of one or more of the following without the Participant&#146;s consent: (i)&nbsp;a material reduction in the Participant&#146;s base compensation, or (ii)&nbsp;a relocation of the principal place at which the Participant must
perform services by more than 50 miles. In order to establish Good Reason, the Participant must provide the Administrator with notice of the event giving rise to Good Reason within 30 days of the occurrence of such event, the event shall remain
uncured 30 days thereafter and the Participant must actually terminate services with 30 days following the end of such cure period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.24
&#147;<B><I>Greater Than 10% Stockholder</I></B>&#148; means an individual then owning (within the meaning of Section&nbsp;424(d) of the Code) more than 10% of the total combined voting power of all classes of stock of the Company or any parent
corporation or subsidiary corporation of the Company, as determined in accordance with in Section&nbsp;424(e) and (f)&nbsp;of the Code, respectively. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.25 &#147;<B><I>Incentive Stock Option</I></B>&#148; means an Option that meets the
requirements to qualify as an &#147;incentive stock option&#148; as defined in Section&nbsp;422 of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.26 &#147;<B><I>Incumbent
Directors&#148;</I></B> means, for any period of 12 consecutive months, individuals who, at the beginning of such period, constitute the Board together with any new Director(s) (other than a Director designated by a person who shall have entered
into an agreement with the Company to effect a transaction described in Section&nbsp;2.6(a) or 2.6(c)) whose election or nomination for election to the Board was approved by a vote of at least a majority (either by a specific vote or by approval of
the proxy statement of the Company in which such person is named as a nominee for Director without objection to such nomination) of the Directors then still in office who either were Directors at the beginning of the
<FONT STYLE="white-space:nowrap">12-month</FONT> period or whose election or nomination for election was previously so approved. No individual initially elected or nominated as a director of the Company as a result of an actual or threatened
election contest with respect to Directors or as a result of any other actual or threatened solicitation of proxies by or on behalf of any person other than the Board shall be an Incumbent Director. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.27 &#147;<B><I>Nonqualified Stock Option</I></B>&#148; means an Option that is not an Incentive Stock Option. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.28 &#147;<B><I>Option</I></B>&#148; means a right granted under Article VI to purchase a specified number of Shares at a specified price per
Share during a specified time period. An Option may be either an Incentive Stock Option or a Nonqualified Stock Option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.29
&#147;<B><I>Other Stock or Cash Based Awards</I></B>&#148; means cash awards, awards of Shares, and other awards valued wholly or partially by referring to, or are otherwise based on, Shares or other property. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.30 &#147;<B><I>Overall Share Limit</I></B>&#148; means the sum of (i) [______]<SUP STYLE="font-size:85%; vertical-align:top">1</SUP> Shares;
(ii)&nbsp;any Shares that are subject to Prior Plan Awards that become available for issuance under the Plan pursuant to Article V; and (iii)&nbsp;an annual increase on the first day of each year beginning in 2022 and ending in 2031, equal to the
lesser of (A) 5% of the Shares outstanding on the last day of the immediately preceding fiscal year and (B)&nbsp;such smaller number of Shares as determined by the Board or the Committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.31 &#147;<B><I>Participant</I></B>&#148; means a Service Provider who has been granted an Award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.32 &#147;<B><I>Performance Bonus Award</I></B>&#148; has the meaning set forth in Section&nbsp;8.3. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.33 &#147;<B><I>Performance Stock Unit</I></B>&#148; means a right granted to a Participant pursuant to Section&nbsp;8.1 and subject to
Section&nbsp;8.2, to receive Shares, the payment of which is contingent upon achieving certain performance goals or other performance-based targets established by the Administrator. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.34 &#147;<B><I>Permitted Transferee</I></B>&#148; means, with respect to a Participant, any &#147;family member&#148; of the Participant, as
defined in the General Instructions to Form <FONT STYLE="white-space:nowrap">S-8</FONT> Registration Statement under the Securities Act (or any successor form thereto), or any other transferee specifically approved by the Administrator after taking
into account Applicable Law. </P> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Amount will be equal to 8% of the outstanding common stock after this offering. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.35 &#147;<B><I>Plan</I></B>&#148; means this 2021 Incentive Award Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.36 &#147;<B><I>Prior Plan</I></B>&#148; means the Company&#146;s 2018 Equity Incentive Plan, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.37 &#147;<B><I>Prior Plan Award</I></B>&#148; means an award outstanding under the Prior Plan as of the Effective Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.38 &#147;<B><I>Public Trading Date</I></B>&#148; means the first date upon which Common Stock is listed (or approved for listing) upon
notice of issuance on any securities exchange or designated (or approved for designation) upon notice of issuance as a national market security on an interdealer quotation system. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.39 &#147;<B><I>Restricted Stock</I></B>&#148; means Shares awarded to a Participant under Article VII, subject to certain vesting conditions
and other restrictions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.40 &#147;<B><I>Restricted Stock Unit</I></B>&#148; means an unfunded, unsecured right to receive, on the
applicable settlement date, one Share or an amount in cash or other consideration determined by the Administrator to be of equal value as of such settlement date, subject to certain vesting conditions and other restrictions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.41 &#147;<B><I>Rule <FONT STYLE="white-space:nowrap">16b-3</FONT></I></B>&#148; means Rule <FONT STYLE="white-space:nowrap">16b-3</FONT>
promulgated under the Exchange Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.42 &#147;<B><I>Section</I></B><B><I></I></B><B><I>&nbsp;409A</I></B>&#148; means Section&nbsp;409A
of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.43 &#147;<B><I>Securities Act</I></B>&#148; means the Securities Act of 1933, as amended, and all regulations, guidance
and other interpretative authority issued thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.44 &#147;<B><I>Service Provider</I></B>&#148; means an Employee, Consultant or
Director. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.45 &#147;<B><I>Shares</I></B>&#148; means shares of Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.46 &#147;<B><I>Stock Appreciation Right</I></B>&#148; or &#147;<B><I>SAR</I></B>&#148; means a right granted under Article VI to receive a
payment equal to the excess of the Fair Market Value of a specified number of Shares on the date the right is exercised over the exercise price set forth in the applicable Award Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.47 &#147;<B><I>Subsidiary</I></B>&#148; means any entity (other than the Company), whether U.S. or
<FONT STYLE="white-space:nowrap">non-U.S.,</FONT> in an unbroken chain of entities beginning with the Company if each of the entities other than the last entity in the unbroken chain beneficially owns, at the time of the determination, securities or
interests representing at least 50% of the total combined voting power of all classes of securities or interests in one of the other entities in such chain. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.48 &#147;<B><I>Substitute Awards</I></B>&#148; means Awards granted or Shares issued by the Company in assumption of, or in substitution or
exchange for, awards previously granted, or the right or obligation to make future awards, in each case by a company or other entity acquired by the Company or any Subsidiary or with which the Company or any Subsidiary combines. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.49 &#147;<B><I><FONT STYLE="white-space:nowrap">Tax-Related</FONT> Items</I></B>&#148; means any U.S. and
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> federal, state and/or local taxes (including, without limitation, income tax, social insurance contributions, fringe benefit tax, employment tax, stamp tax and any employer tax liability which has
been transferred to a Participant) for which a Participant is liable in connection with Awards and/or Shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.50 &#147;<B><I>Termination of Service</I></B>&#148; means: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) As to a Consultant, the time when the engagement of a Participant as a Consultant to the Company or a Subsidiary is terminated for any
reason, with or without cause, including, without limitation, by resignation, discharge, death or retirement, but excluding terminations where the Consultant simultaneously commences or remains in employment or service with the Company or any
Subsidiary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) As to a <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director, the time when a Participant who is a <FONT
STYLE="white-space:nowrap">Non-Employee</FONT> Director ceases to be a Director for any reason, including, without limitation, a termination by resignation, failure to be elected, death or retirement, but excluding terminations where the Participant
simultaneously commences or remains in employment or service with the Company or any Subsidiary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) As to an Employee, the time when the
employee-employer relationship between a Participant and the Company or any Subsidiary is terminated for any reason, including, without limitation, a termination by resignation, discharge, death, disability or retirement; but excluding terminations
where the Participant simultaneously commences or remains in employment or service with the Company or any Subsidiary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company, in
its sole discretion, shall determine the effect of all matters and questions relating to any Termination of Service, including, without limitation, whether a Termination of Service has occurred, whether a Termination of Service resulted from a
discharge for &#147;cause&#148; and all questions of whether particular leaves of absence constitute a Termination of Service. For purposes of the Plan, a Participant&#146;s employee-employer relationship or consultancy relationship shall be deemed
to be terminated in the event that the Subsidiary employing or contracting with such Participant ceases to remain a Subsidiary following any merger, sale of stock or other corporate transaction or event (including, without limitation, a <FONT
STYLE="white-space:nowrap">spin-off),</FONT> even though the Participant may subsequently continue to perform services for that entity. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE III. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ELIGIBILITY </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Service
Providers are eligible to be granted Awards under the Plan, subject to the limitations described herein. No Service Provider shall have any right to be granted an Award pursuant to the Plan and neither the Company nor the Administrator is obligated
to treat Service Providers, Participants or any other persons uniformly. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IV. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ADMINISTRATION AND DELEGATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.1 <U>Administration</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a)
The Plan is administered by the Administrator. The Administrator has authority to determine which Service Providers receive Awards, grant Awards and set Award terms and conditions, subject to the conditions and limitations in the Plan. The
Administrator also has the authority to take all actions and make all determinations under the Plan, to interpret the Plan and Award Agreements and to adopt, amend and repeal Plan administrative rules, guidelines and practices as it deems advisable.
The Administrator may correct defects and ambiguities, supply omissions, reconcile inconsistencies in the Plan or any Award and make all other determinations that it deems necessary or appropriate to administer the Plan and any Awards. The
Administrator (and each member thereof) is entitled to, in good faith, rely or act upon any report or other information furnished to it, him or her by any officer or other employee of the Company or any Subsidiary, the Company&#146;s independent
certified public accountants, or any executive compensation consultant or other professional retained by the Company to assist in the administration of the Plan. The Administrator&#146;s determinations under the Plan are in its sole discretion and
will be final, binding and conclusive on all persons having or claiming any interest in the Plan or any Award. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Without limiting the foregoing, the Administrator has the exclusive power, authority and
sole discretion to: (i)&nbsp;designate Participants; (ii)&nbsp;determine the type or types of Awards to be granted to each Participant; (iii)&nbsp;determine the number of Awards to be granted and the number of Shares to which an Award will relate;
(iv)&nbsp;subject to the limitations in the Plan, determine the terms and conditions of any Award and related Award Agreement, including, but not limited to, the exercise price, grant price, purchase price, any performance criteria, any restrictions
or limitations on the Award, any schedule for vesting, lapse of forfeiture restrictions or restrictions on the exercisability of an Award, and accelerations, waivers or amendments thereof; (v)&nbsp;determine whether, to what extent, and under what
circumstances an Award may be settled in, or the exercise price of an Award may be paid in cash, Shares, or other property, or an Award may be canceled, forfeited, or surrendered; and (vi)&nbsp;make all other decisions and determinations that may be
required pursuant to the Plan or as the Administrator deems necessary or advisable to administer the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.2 <U>Delegation of
Authority</U>. To the extent permitted by Applicable Law, the Board or any Committee may delegate any or all of its powers under the Plan to one or more Committees or officers of the Company or any of its Subsidiaries; provided,<I> </I>however, that
in no event shall an officer of the Company or any of its Subsidiaries be delegated the authority to grant Awards to, or amend Awards held by, the following individuals: (a)&nbsp;individuals who are subject to Section&nbsp;16 of the Exchange Act, or
(b)&nbsp;officers of the Company or any of its Subsidiaries or Directors to whom authority to grant or amend Awards has been delegated hereunder. Any delegation hereunder shall be subject to the restrictions and limits that the Board or Committee
specifies at the time of such delegation or that are otherwise included in the applicable organizational documents, and the Board or Committee, as applicable, may at any time rescind the authority so delegated or appoint a new delegatee. At all
times, the delegatee appointed under this Section&nbsp;4.2<B> </B>shall serve in such capacity at the pleasure of the Board or the Committee, as applicable, and the Board or the Committee may abolish any committee at any time and <FONT
STYLE="white-space:nowrap">re-vest</FONT> in itself any previously delegated authority. Further, regardless of any delegation, the Board or a Committee may, in its discretion, exercise any and all rights and duties as the Administrator under the
Plan delegated thereby, except with respect to Awards that are required to be determined in the sole discretion of the Committee under the rules of any securities exchange or automated quotation system on which the Shares are listed, quoted or
traded. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE V. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>STOCK AVAILABLE FOR AWARDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.1 <U>Number of Shares</U>. Subject to adjustment under Article IX and the terms of this Article&nbsp;V, Awards may be made under the Plan
covering up to the Overall Share Limit. As of the Effective Date, the Company will cease granting awards under the Prior Plan; however, Prior Plan Awards will remain subject to the terms of the Prior Plan. Shares issued or delivered under the Plan
may consist of authorized but unissued Shares, Shares purchased on the open market or treasury Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.2 <U>Share Recycling</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) If all or any part of an Award or Prior Plan Award expires, lapses or is terminated, converted into an award in respect of shares of
another entity in connection with a <FONT STYLE="white-space:nowrap">spin-off</FONT> or other similar event, exchanged for cash, surrendered, repurchased, canceled without having been fully exercised or forfeited, in any case, in a manner that
results in the Company acquiring Shares covered by the Award or Prior Plan Award at a price not greater than the price (as adjusted to reflect any Equity Restructuring) paid by the Participant for such Shares or not issuing any Shares covered by the
Award or Prior Plan Award, the unused Shares covered by the Award or Prior Plan Award will, as applicable, become or again be available for Awards under the Plan. The payment of Dividend Equivalents in cash in conjunction with any outstanding Awards
or Prior Plan Awards shall not count against the Overall Share Limit. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In addition, the following Shares shall be available for future grants of Awards:
(i)&nbsp;Shares tendered by a Participant or withheld by the Company in payment of the exercise price of an Option or any stock option granted under the Prior Plan; (ii)&nbsp;Shares tendered by the Participant or withheld by the Company to satisfy
any tax withholding obligation with respect to an Award or any Prior Plan Award; and (iii)&nbsp;Shares subject to a Stock Appreciation Right that are not issued in connection with the stock settlement of the Stock Appreciation Right on exercise
thereof. Notwithstanding the provisions of this Section&nbsp;5.2(b), no Shares may again be optioned, granted or awarded pursuant to an Incentive Stock Option if such action would cause such Option to fail to qualify as an incentive stock option
under Section&nbsp;422 of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.3 <U>Incentive Stock Option Limitations</U>. Notwithstanding anything to the contrary herein, no
more than [_______]<SUP STYLE="font-size:85%; vertical-align:top">2</SUP> Shares (as adjusted to reflect any Equity Restructuring) may be issued pursuant to the exercise of Incentive Stock Options. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.4 <U>Substitute Awards</U>. In connection with an entity&#146;s merger or consolidation with the Company or any Subsidiary or the
Company&#146;s or any Subsidiary&#146;s acquisition of an entity&#146;s property or stock, the Administrator may grant Awards in substitution for any options or other stock or stock-based awards granted before such merger or consolidation by such
entity or its affiliate. Substitute Awards may be granted on such terms and conditions as the Administrator deems appropriate, notwithstanding limitations on Awards in the Plan. Substitute Awards will not count against the Overall Share Limit (nor
shall Shares subject to a Substitute Award be added to the Shares available for Awards under the Plan as provided above), except that Shares acquired by exercise of substitute Incentive Stock Options will count against the maximum number of Shares
that may be issued pursuant to the exercise of Incentive Stock Options under the Plan. Additionally, in the event that a company acquired by the Company or any Subsidiary or with which the Company or any Subsidiary combines has shares available
under a <FONT STYLE="white-space:nowrap">pre-existing</FONT> plan approved by stockholders and not adopted in contemplation of such acquisition or combination, the shares available for grant pursuant to the terms of such <FONT
STYLE="white-space:nowrap">pre-existing</FONT> plan (as appropriately adjusted to reflect the transaction) may be used for Awards under the Plan and shall not reduce the Shares authorized for grant under the Plan (and Shares subject to such Awards
may again become available for Awards under the Plan as provided under Section&nbsp;5.2 above); provided that Awards using such available shares shall not be made after the date awards or grants could have been made under the terms of the <FONT
STYLE="white-space:nowrap">pre-existing</FONT> plan, absent the acquisition or combination, and shall only be made to individuals who were not employees or directors of the Company or any of its Subsidiaries prior to such acquisition or combination.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.5 <U><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director Award Limit</U>. Notwithstanding any provision to the contrary in
the Plan or in any policy of the Company regarding <FONT STYLE="white-space:nowrap">non-employee</FONT> director compensation, the sum of the grant date fair value (determined as of the grant date in accordance with Financial Accounting Standards
Board Accounting Standards Codification Topic 718, or any successor thereto) of all equity-based Awards and the maximum amount that may become payable pursuant to all cash-based Awards that may be granted to a Service Provider as compensation for
services as a <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director during any calendar year shall not exceed $1,500,000. </P> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">2</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Amount will be equal to 72.5% of the shares outstanding immediately following the IPO.
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>
ARTICLE VI. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>STOCK OPTIONS AND STOCK APPRECIATION RIGHTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.1 <U>General</U>. The Administrator may grant Options or Stock Appreciation Rights to one or more Service Providers, subject to such terms
and conditions not inconsistent with the Plan as the Administrator shall determine. The Administrator will determine the number of Shares covered by each Option and Stock Appreciation Right, the exercise price of each Option and Stock Appreciation
Right and the conditions and limitations applicable to the exercise of each Option and Stock Appreciation Right. A Stock Appreciation Right will entitle the Participant (or other person entitled to exercise the Stock Appreciation Right) to receive
from the Company upon exercise of the exercisable portion of the Stock Appreciation Right an amount determined by multiplying the excess, if any, of the Fair Market Value of one Share on the date of exercise over the exercise price per Share of the
Stock Appreciation Right by the number of Shares with respect to which the Stock Appreciation Right is exercised, subject to any limitations of the Plan or that the Administrator may impose and payable in cash, Shares valued at Fair Market Value on
the date of exercise or a combination of the two as the Administrator may determine or provide in the Award Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.2 <U>Exercise
Price</U>. The Administrator will establish each Option&#146;s and Stock Appreciation Right&#146;s exercise price and specify the exercise price in the Award Agreement. Subject to Section&nbsp;6.6, the exercise price will not be less than 100% of
the Fair Market Value on the grant date of the Option or Stock Appreciation Right. Notwithstanding the foregoing, in the case of an Option or Stock Appreciation Right that is a Substitute Award, the exercise price per share of the Shares subject to
such Option or Stock Appreciation Right, as applicable, may be less than the Fair Market Value per share on the date of grant; provided that the exercise price of any Substitute Award shall be determined in accordance with the applicable
requirements of Section&nbsp;424 and 409A of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.3 <U>Duration of Options</U>. Subject to Section&nbsp;6.6, each Option or Stock
Appreciation Right will be exercisable at such times and as specified in the Award Agreement, provided that the term of an Option or Stock Appreciation Right will not exceed ten years; provided, further, that, unless otherwise determined by the
Administrator or specified in the Award Agreement, (a)&nbsp;no portion of an Option or Stock Appreciation Right which is unexercisable at a Participant&#146;s Termination of Service shall thereafter become exercisable and (b)&nbsp;the portion of an
Option or Stock Appreciation Right that is unexercisable at a Participant&#146;s Termination of Service shall automatically expire on the date of such Termination of Service. In addition, in no event shall an Option or Stock Appreciation Right
granted to an Employee who is a <FONT STYLE="white-space:nowrap">non-exempt</FONT> employee for purposes of overtime pay under the U.S. Fair Labor Standards Act of 1938 be exercisable earlier than six (6)&nbsp;months after its date of grant.
Notwithstanding the foregoing, if the Participant, prior to the end of the term of an Option or Stock Appreciation Right, commits an act of &#147;cause&#148; (as determined by the Administrator), or violates any
<FONT STYLE="white-space:nowrap">non-competition,</FONT> <FONT STYLE="white-space:nowrap">non-solicitation</FONT> or confidentiality provisions of any employment contract, confidentiality and nondisclosure agreement or other agreement between the
Participant and the Company or any of its Subsidiaries, the right to exercise the Option or Stock Appreciation Right, as applicable, may be terminated by the Company and the Company may suspend the Participant&#146;s right to exercise the Option or
Stock Appreciation Right when it reasonably believes that the Participant may have participated in any such act or violation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.4
<U>Exercise</U>. Options and Stock Appreciation Rights may be exercised by delivering to the Company (or such other person or entity designated by the Administrator) a notice of exercise, in a form and manner the Company approves (which may be
written, electronic or telephonic and may contain representations and warranties deemed advisable by the Administrator), signed or authenticated by the person authorized to exercise the Option or Stock Appreciation Right, together with, as
applicable, (a)&nbsp;payment in full of the exercise price for the number of Shares for which the Option is exercised in a manner specified in Section&nbsp;6.5 and (b)&nbsp;satisfaction in full of any withholding obligation for <FONT
STYLE="white-space:nowrap">Tax-Related</FONT> Items in a manner specified in Section&nbsp;10.5. The Administrator may, in its discretion, limit exercise with respect to fractional Shares and require that any partial exercise of an Option or Stock
Appreciation Right be with respect to a minimum number of Shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.5 <U>Payment Upon Exercise</U>. The Administrator shall determine the methods by which
payment of the exercise price of an Option shall be made, including, without limitation: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Cash, check or wire transfer of immediately
available funds; provided that the Company may limit the use of one of the foregoing methods if one or more of the methods below is permitted; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) If there is a public market for Shares at the time of exercise, unless the Company otherwise determines, (A)&nbsp;delivery (including
electronically or telephonically to the extent permitted by the Company) of a notice that the Participant has placed a market sell order with a broker acceptable to the Company with respect to Shares then issuable upon exercise of the Option and
that the broker has been directed to deliver promptly to the Company funds sufficient to pay the exercise price, or (B)&nbsp;the Participant&#146;s delivery to the Company of a copy of irrevocable and unconditional instructions to a broker
acceptable to the Company to deliver promptly to the Company an amount sufficient to pay the exercise price by cash, wire transfer of immediately available funds or check; provided that such amount is paid to the Company at such time as may be
required by the Company; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) To the extent permitted by the Administrator, delivery (either by actual delivery or attestation) of Shares
owned by the Participant valued at their Fair Market Value on the date of delivery; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) To the extent permitted by the Administrator,
surrendering Shares then issuable upon the Option&#146;s exercise valued at their Fair Market Value on the exercise date; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) To the
extent permitted by the Administrator, delivery of a promissory note or any other lawful consideration; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) To the extent permitted by
the Administrator, any combination of the above payment forms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.6 <U>Additional Terms of Incentive Stock Options</U>. The Administrator
may grant Incentive Stock Options only to employees of the Company, any of its present or future parent or subsidiary corporations, as defined in Sections&nbsp;424(e) or (f)&nbsp;of the Code, respectively, and any other entities the employees of
which are eligible to receive Incentive Stock Options under the Code. If an Incentive Stock Option is granted to a Greater Than 10% Stockholder, the exercise price will not be less than 110% of the Fair Market Value on the Option&#146;s grant date,
and the term of the Option will not exceed five years. All Incentive Stock Options (and Award Agreements related thereto) will be subject to and construed consistently with Section&nbsp;422 of the Code. By accepting an Incentive Stock Option, the
Participant agrees to give prompt notice to the Company of dispositions or other transfers (other than in connection with a Change in Control) of Shares acquired under the Option made within (a)&nbsp;two years from the grant date of the Option or
(b)&nbsp;one year after the transfer of such Shares to the Participant, specifying the date of the disposition or other transfer and the amount the Participant realized, in cash, other property, assumption of indebtedness or other consideration, in
such disposition or other transfer. Neither the Company nor the Administrator will be liable to a Participant, or any other party, if an Incentive Stock Option fails or ceases to qualify as an &#147;incentive stock option&#148; under
Section&nbsp;422 of the Code. Any Incentive Stock Option or portion thereof that fails to qualify as an &#147;incentive stock option&#148; under Section&nbsp;422 of the Code for any reason, including becoming exercisable with respect to Shares
having a fair market value exceeding the $100,000 limitation under Treasury Regulation <FONT STYLE="white-space:nowrap">Section&nbsp;1.422-4,</FONT> will be a Nonqualified Stock Option. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VII. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RESTRICTED STOCK; RESTRICTED STOCK UNITS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.1 <U>General</U>. The Administrator may grant Restricted Stock, or the right to purchase Restricted Stock, to any Service Provider, subject
to forfeiture or the Company&#146;s right to repurchase all or part of such shares at their issue price or other stated or formula price from the Participant if conditions the Administrator specifies in the Award Agreement are not satisfied before
the end of the applicable restriction period or periods that the Administrator establishes for such Award. In addition, the Administrator may grant Restricted Stock Units, which may be subject to vesting and forfeiture conditions during the
applicable restriction period or periods, as set forth in an Award Agreement, to Service Providers. The Administrator shall establish the purchase price, if any, and form of payment for Restricted Stock and Restricted Stock Units; provided, however,
that if a purchase price is charged, such purchase price shall be no less than the par value, if any, of the Shares to be purchased, unless otherwise permitted by Applicable Law. In all cases, legal consideration shall be required for each issuance
of Restricted Stock and Restricted Stock Units to the extent required by Applicable Law. The Award Agreement for each Award of Restricted Stock and Restricted Stock Units shall set forth the terms and conditions not inconsistent with the Plan as the
Administrator shall determine. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.2 <U>Restricted Stock</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>Stockholder Rights</I>. Unless otherwise determined by the Administrator, each Participant holding shares of Restricted Stock will be
entitled to all the rights of a stockholder with respect to such Shares, subject to the restrictions in the Plan and the applicable Award Agreement, including the right to receive all dividends and other distributions paid or made with respect to
the Shares to the extent such dividends and other distributions have a record date that is on or after the date on which such Participant becomes the record holder of such Shares; provided, however, that with respect to a share of Restricted Stock
subject to restrictions or vesting conditions as described in Section&nbsp;8.3, except in connection with a <FONT STYLE="white-space:nowrap">spin-off</FONT> or other similar event as otherwise permitted under Section&nbsp;9.2, dividends which are
paid to Company stockholders prior to the removal of restrictions and satisfaction of vesting conditions shall only be paid to the Participant to the extent that the restrictions are subsequently removed and the vesting conditions are subsequently
satisfied and the share of Restricted Stock vests. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Stock Certificates</I>. The Company may require that the Participant deposit in
escrow with the Company (or its designee) any stock certificates issued in respect of shares of Restricted Stock, together with a stock power endorsed in blank. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <I>Section 83(b) Election</I>. If a Participant makes an election under Section&nbsp;83(b) of the Code to be taxed with respect to the
Restricted Stock as of the date of transfer of the Restricted Stock rather than as of the date or dates upon which such Participant would otherwise be taxable under Section&nbsp;83(a) of the Code, such Participant shall be required to deliver a copy
of such election to the Company promptly after filing such election with the Internal Revenue Service along with proof of the timely filing thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.3 <U>Restricted Stock Units</U>. The Administrator may provide that settlement of Restricted Stock Units will occur upon or as soon as
reasonably practicable after the Restricted Stock Units vest or will instead be deferred, on a mandatory basis or at the Participant&#146;s election, subject to compliance with Applicable Law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE VIII. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OTHER TYPES OF AWARDS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.1
<U>General</U>. The Administrator may grant Performance Stock Unit awards, Performance Bonus Awards, Dividend Equivalents or Other Stock or Cash Based Awards, to one or more Service Providers, in such amounts and subject to such terms and conditions
not inconsistent with the Plan as the Administrator shall determine. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.2 <U>Performance Stock Unit Awards</U>. Each Performance Stock
Unit award shall be denominated in a number of Shares or in unit equivalents of Shares or units of value (including a dollar value of Shares) and may be linked to any one or more of performance or other specific criteria, including service to the
Company or Subsidiaries, determined to be appropriate by the Administrator, in each case on a specified date or dates or over any period or periods determined by the Administrator. In making such determinations, the Administrator may consider (among
such other factors as it deems relevant in light of the specific type of award) the contributions, responsibilities and other compensation of the particular Participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.3 <U>Performance Bonus Awards</U>. Each right to receive a bonus granted under this Section&nbsp;8.3 shall be denominated in the form of
cash (but may be payable in cash, stock or a combination thereof) (a &#147;<B><I>Performance Bonus Award</I></B>&#148;) and shall be payable upon the attainment of performance goals that are established by the Administrator and relate to one or more
of performance or other specific criteria, including service to the Company or Subsidiaries, in each case on a specified date or dates or over any period or periods determined by the Administrator. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.4 <U>Dividend Equivalents</U>. If the Administrator provides, an Award (other than an Option or Stock Appreciation Right) may provide a
Participant with the right to receive Dividend Equivalents. Dividend Equivalents may be paid currently or credited to an account for the Participant, settled in cash or Shares and subject to the same restrictions on transferability and
forfeitability as the Award with respect to which the Dividend Equivalents are granted and subject to other terms and conditions as set forth in the Award Agreement. Notwithstanding anything to the contrary herein, Dividend Equivalents with respect
to an Award subject to vesting shall either (i)&nbsp;to the extent permitted by Applicable Law, not be paid or credited or (ii)&nbsp;be accumulated and subject to vesting to the same extent as the related Award. All such Dividend Equivalents shall
be paid at such time as the Administrator shall specify in the applicable Award Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">8.5 <U>Other Stock or Cash Based Awards</U>.
Other Stock or Cash Based Awards may be granted to Participants, including Awards entitling Participants to receive cash or Shares to be delivered in the future and annual or other periodic or long-term cash bonus awards (whether based on specified
performance criteria or otherwise), in each case subject to any conditions and limitations in the Plan. Such Other Stock or Cash Based Awards will also be available as a payment form in the settlement of other Awards, as standalone payments and as
payment in lieu of compensation to which a Participant is otherwise entitled. Other Stock or Cash Based Awards may be paid in Shares, cash or other property, as the Administrator determines. Subject to the provisions of the Plan, the Administrator
will determine the terms and conditions of each Other Stock or Cash Based Award, including any purchase price, performance goal(s), transfer restrictions, and vesting conditions, which will be set forth in the applicable Award Agreement. Except in
connection with a <FONT STYLE="white-space:nowrap">spin-off</FONT> or other similar event as otherwise permitted under Article IX, dividends that are paid prior to vesting of any Other Stock or Cash Based Award shall only be paid to the applicable
Participant to the extent that the vesting conditions are subsequently satisfied and the Other Stock or Cash Based Award vests. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE IX. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ADJUSTMENTS FOR CHANGES IN COMMON STOCK </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AND CERTAIN OTHER EVENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.1 <U>Equity Restructuring</U><U>(a) </U>. In connection with any Equity Restructuring, notwithstanding anything to the contrary in this
Article IX the Administrator will equitably adjust the terms of the Plan and each outstanding Award as it deems appropriate to reflect the Equity Restructuring, which may include (i)&nbsp;adjusting the number and type of securities subject to each
outstanding Award or with respect to which Awards may be granted under the Plan (including, but not limited to, adjustments of the limitations in Article V hereof on the maximum number and kind of shares that may be issued); (ii)&nbsp;adjusting the
terms and conditions of (including the grant or exercise price), and the performance goals or other criteria included in, outstanding Awards; and (iii)&nbsp;granting new Awards or making cash payments to Participants. The adjustments provided under
this Section&nbsp;9.1 will be nondiscretionary and final and binding on all interested parties, including the affected Participant and the Company; provided that the Administrator will determine whether an adjustment is equitable. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.2 <U>Corporate Transactions</U>. In the event of any dividend or other distribution (whether in the form of cash, Common Stock, other
securities, or other property), reorganization, merger, consolidation, <FONT STYLE="white-space:nowrap">split-up,</FONT> spin off, combination, amalgamation, repurchase, recapitalization, liquidation, dissolution, or sale, transfer, exchange or
other disposition of all or substantially all of the assets of the Company, or sale or exchange of Common Stock or other securities of the Company, Change in Control, issuance of warrants or other rights to purchase Common Stock or other securities
of the Company, other similar corporate transaction or event, other unusual or nonrecurring transaction or event affecting the Company or its financial statements or any change in any Applicable Law or accounting principles, the Administrator, on
such terms and conditions as it deems appropriate, either by the terms of the Award or by action taken prior to the occurrence of such transaction or event (except that action to give effect to a change in Applicable Law or accounting principles may
be made within a reasonable period of time after such change) and either automatically or upon the Participant&#146;s request, is hereby authorized to take any one or more of the following actions whenever the Administrator determines that such
action is appropriate in order to (x)&nbsp;prevent dilution or enlargement of the benefits or potential benefits intended by the Company to be made available under the Plan or with respect to any Award granted or issued under the Plan, (y)&nbsp;to
facilitate such transaction or event or (z)&nbsp;give effect to such changes in Applicable Law or accounting principles: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) To provide
for the cancellation of any such Award in exchange for either an amount of cash or other property with a value equal to the amount that could have been obtained upon the exercise or settlement of the vested portion of such Award or realization of
the Participant&#146;s rights under the vested portion of such Award, as applicable; provided that, if the amount that could have been obtained upon the exercise or settlement of the vested portion of such Award or realization of the
Participant&#146;s rights, in any case, is equal to or less than zero, then the Award may be terminated without payment; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) To provide
that such Award shall vest and, to the extent applicable, be exercisable as to all Shares (or other property) covered thereby, notwithstanding anything to the contrary in the Plan or the provisions of such Award; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) To provide that such Award be assumed by the successor or survivor corporation or entity, or a parent or subsidiary thereof, or shall be
substituted for by awards covering the stock of the successor or survivor corporation or entity, or a parent or subsidiary thereof, with appropriate adjustments as to the number and kind of shares and applicable exercise or purchase price, in all
cases, as determined by the Administrator; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) To make adjustments in the number and type of shares of Common Stock (or other
securities or property) subject to outstanding Awards or with respect to which Awards may be granted under the Plan (including, but not limited to, adjustments of the limitations in Article V hereof on the maximum number and kind of shares which may
be issued) or in the terms and conditions of (including the grant or exercise price), and the criteria included in, outstanding Awards; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) To replace such Award with other rights or property selected by the Administrator; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) To provide that the Award will terminate and cannot vest, be exercised or become payable after the applicable event. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.3 <U>Change in Control</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Notwithstanding any other provision of the Plan, in the event of a Change in Control, unless the Administrator elects to
(i)&nbsp;terminate an Award in exchange for cash, rights or property, or (ii)&nbsp;cause an Award to become fully exercisable and no longer subject to any forfeiture restrictions prior to the consummation of a Change in Control, pursuant to
Section&nbsp;9.2, (A) such Award (other than any portion subject to performance-based vesting) shall continue in effect or be assumed or an equivalent Award substituted by the successor corporation or a parent or subsidiary of the successor
corporation and (B)&nbsp;the portion of such Award subject to performance-based vesting shall be subject to the terms and conditions of the applicable Award Agreement and, in the absence of applicable terms and conditions, the Administrator&#146;s
discretion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) In the event that the successor corporation in a Change in Control refuses to assume or substitute for an Award (other
than any portion subject to performance-based vesting), the Administrator shall cause such Award to become fully vested and, if applicable, exercisable immediately prior to the consummation of such transaction and all forfeiture restrictions on such
Award to lapse and, to the extent unexercised upon the consummation of such transaction, to terminate in exchange for cash, rights or other property. The Administrator shall notify the Participant of any Award that becomes exercisable pursuant to
the preceding sentence that such Award shall be fully exercisable for a period of 15 days from the date of such notice, contingent upon the occurrence of the Change in Control, and such Award shall terminate upon the consummation of the Change in
Control in accordance with the preceding sentence. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) For the purposes of this Section&nbsp;9.3, an Award shall be considered assumed
if, following the Change in Control, the Award confers the right to purchase or receive, for each Share subject to the Award immediately prior to the Change in Control, the consideration (whether stock, cash, or other securities or property)
received in the Change in Control by holders of Common Stock for each Share held on the effective date of the transaction (and if holders were offered a choice of consideration, the type of consideration chosen by the holders of a majority of the
outstanding Shares); provided, however, that if such consideration received in the Change in Control was not solely common stock of the successor corporation or its parent, the Administrator may, with the consent of the successor corporation,
provide for the consideration to be received upon the exercise of the Award, for each Share subject to an Award, to be solely common stock of the successor corporation or its parent equal in fair market value to the
<FONT STYLE="white-space:nowrap">per-share</FONT> consideration received by holders of Common Stock in the Change in Control. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d)
Notwithstanding anything to the contrary herein, if a Participant experiences a Termination of Service during the period beginning three months prior to and ending 12 months following the closing of a Change in Control that is effected by the
Company without Cause or by the Participant for Good Reason, then, the Award(s) held by such Participant shall become fully vested and, if applicable, exercisable and all forfeiture restrictions on such Award(s) shall lapse as of immediately prior
to the consummation of such Change in Control or, if later, the date of such Termination of Service. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.4 <U>Administrative Stand Still</U>. In the event of any pending stock dividend, stock
split, combination or exchange of shares, merger, consolidation or other distribution (other than normal cash dividends) of Company assets to stockholders, or any other extraordinary transaction or change affecting the Shares or the share price of
Common Stock (including any Equity Restructuring or any securities offering or other similar transaction) or for reasons of administrative convenience or to facilitate compliance with any Applicable Law, the Company may refuse to permit the exercise
or settlement of one or more Awards for such period of time as the Company may determine to be reasonably appropriate under the circumstances. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">9.5 <U>General</U>. Except as expressly provided in the Plan or the Administrator&#146;s action under the Plan, no Participant will have any
rights due to any subdivision or consolidation of Shares of any class, dividend payment, increase or decrease in the number of Shares of any class or dissolution, liquidation, merger, or consolidation of the Company or other corporation. Except as
expressly provided with respect to an Equity Restructuring under Section&nbsp;9.1 above or the Administrator&#146;s action under the Plan, no issuance by the Company of Shares of any class, or securities convertible into Shares of any class, will
affect, and no adjustment will be made regarding, the number of Shares subject to an Award or the Award&#146;s grant or exercise price. The existence of the Plan, any Award Agreements and the Awards granted hereunder will not affect or restrict in
any way the Company&#146;s right or power to make or authorize (i)&nbsp;any adjustment, recapitalization, reorganization or other change in the Company&#146;s capital structure or its business, (ii)&nbsp;any merger, consolidation, spinoff,
dissolution or liquidation of the Company or sale of Company assets or (iii)&nbsp;any sale or issuance of securities, including securities with rights superior to those of the Shares or securities convertible into or exchangeable for Shares. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE X. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROVISIONS
APPLICABLE TO AWARDS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.1 <U>Transferability</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) No Award may be sold, assigned, transferred, pledged or otherwise encumbered, either voluntarily or by operation of law, except by will or
the laws of descent and distribution, or, subject to the Administrator&#146;s consent, pursuant to a DRO, unless and until such Award has been exercised or the Shares underlying such Award have been issued, and all restrictions applicable to such
Shares have lapsed. During the life of a Participant, Awards will be exercisable only by the Participant, unless it has been disposed of pursuant to a DRO. After the death of a Participant, any exercisable portion of an Award may, prior to the time
when such portion becomes unexercisable under the Plan or the applicable Award Agreement, be exercised by the Participant&#146;s personal representative or by any person empowered to do so under the deceased Participant&#146;s will or under the
then-Applicable Law of descent and distribution. References to a Participant, to the extent relevant in the context, will include references to a transferee approved by the Administrator. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Notwithstanding Section&nbsp;10.1(a), the Administrator, in its sole discretion, may determine to permit a Participant or a Permitted
Transferee of such Participant to transfer an Award other than an Incentive Stock Option (unless such Incentive Stock Option is intended to become a Nonqualified Stock Option) to any one or more Permitted Transferees of such Participant, subject to
the following terms and conditions: (i)&nbsp;an Award transferred to a Permitted Transferee shall not be assignable or transferable by the Permitted Transferee other than (A)&nbsp;to another Permitted Transferee of the applicable Participant or
(B)&nbsp;by will or the laws of descent and distribution or, subject to the consent of the Administrator, pursuant to a domestic relations order; (ii)&nbsp;an Award transferred to a Permitted Transferee shall continue to be subject
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
to all the terms and conditions of the Award as applicable to the original Participant (other than the ability to further transfer the Award to any Person other than another Permitted Transferee
of the applicable Participant); (iii) the Participant (or transferring Permitted Transferee) and the receiving Permitted Transferee shall execute any and all documents requested by the Administrator, including, without limitation documents to
(A)&nbsp;confirm the status of the transferee as a Permitted Transferee, (B)&nbsp;satisfy any requirements for an exemption for the transfer under Applicable Law and (C)&nbsp;evidence the transfer; and (iv)&nbsp;any transfer of an Award to a
Permitted Transferee shall be without consideration, except as required by Applicable Law. In addition, and further notwithstanding Section&nbsp;10.1(a), the Administrator, in its sole discretion, may determine to permit a Participant to transfer
Incentive Stock Options to a trust that constitutes a Permitted Transferee if, under Section&nbsp;671 of the Code and other Applicable Law, the Participant is considered the sole beneficial owner of the Incentive Stock Option while it is held in the
trust. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding Section&nbsp;10.1(a), if permitted by the Administrator, a Participant may, in the manner determined by the
Administrator, designate a Designated Beneficiary. A Designated Beneficiary, legal guardian, legal representative, or other person claiming any rights pursuant to the Plan is subject to all terms and conditions of the Plan and any Award Agreement
applicable to the Participant and any additional restrictions deemed necessary or appropriate by the Administrator. If the Participant is married or a domestic partner in a domestic partnership qualified under Applicable Law and resides in a
community property state, a designation of a person other than the Participant&#146;s spouse or domestic partner, as applicable, as the Participant&#146;s Designated Beneficiary with respect to more than 50% of the Participant&#146;s interest in the
Award shall not be effective without the prior written or electronic consent of the Participant&#146;s spouse or domestic partner. Subject to the foregoing, a beneficiary designation may be changed or revoked by a Participant at any time; provided
that the change or revocation is delivered in writing to the Administrator prior to the Participant&#146;s death. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.2
<U>Documentation</U>. Each Award will be evidenced in an Award Agreement in such form as the Administrator determines in its discretion. Each Award may contain such terms and conditions as are determined by the Administrator in its sole discretion,
to the extent not inconsistent with those set forth in the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.3 <U>Discretion</U>. Except as the Plan otherwise provides, each
Award may be made alone or in addition or in relation to any other Award. The terms of each Award to a Participant need not be identical, and the Administrator need not treat Participants or Awards (or portions thereof) uniformly. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.4 <U>Changes in Participant&#146;s Status</U>. The Administrator will determine how the disability, death, retirement, authorized leave of
absence or any other change or purported change in a Participant&#146;s Service Provider status affects an Award and the extent to which, and the period during which, the Participant, the Participant&#146;s legal representative, conservator,
guardian or Designated Beneficiary may exercise rights under the Award, if applicable. Except to the extent otherwise required by law or expressly authorized by the Company or by the Company&#146;s written policy on leaves of absence, no Service
credit shall be given for vesting purposes for any period the Participant is on a leave of absence. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.5 <U>Withholding</U>. Each
Participant must pay the Company or a Subsidiary, as applicable, or make provision satisfactory to the Administrator for payment of, any <FONT STYLE="white-space:nowrap">Tax-Related</FONT> Items required by Applicable Law to be withheld in
connection with such Participant&#146;s Awards and/or Shares by the date of the event creating the liability for <FONT STYLE="white-space:nowrap">Tax-Related</FONT> Items. At the Company&#146;s discretion and subject to any Company insider trading
policy (including <FONT STYLE="white-space:nowrap">black-out</FONT> periods), any withholding obligation for <FONT STYLE="white-space:nowrap">Tax-Related</FONT> Items may be satisfied by (i)&nbsp;deducting an amount sufficient to satisfy such
withholding obligation from any payment of any kind otherwise due to a Participant; (ii)&nbsp;accepting a payment from the Participant in cash, by wire transfer of immediately available funds, or by check made payable to the order of the Company or
a Subsidiary, as applicable; (iii)&nbsp;accepting the delivery of Shares, including Shares delivered </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
by attestation; (iv)&nbsp;retaining Shares from the Award creating the withholding obligation for <FONT STYLE="white-space:nowrap">Tax-Related</FONT> Items, valued on the date of delivery,
(v)&nbsp;if there is a public market for Shares at the time the withholding obligation for <FONT STYLE="white-space:nowrap">Tax-Related</FONT> Items is satisfied, selling Shares issued pursuant to the Award creating the withholding obligation for <FONT
STYLE="white-space:nowrap">Tax-Related</FONT> Items, either voluntarily by the Participant or mandatorily by the Company; (vi)&nbsp;accepting delivery of a promissory note or any other lawful consideration; or (vii)&nbsp;any combination of the
foregoing payment forms. The amount withheld pursuant to any of the foregoing payment forms shall be determined by the Company and may be up to, but no greater than, the aggregate amount of such obligations based on the maximum statutory withholding
rates in the applicable Participant&#146;s jurisdiction for all <FONT STYLE="white-space:nowrap">Tax-Related</FONT> Items that are applicable to such taxable income. If any tax withholding obligation will be satisfied under clause (v)&nbsp;of the
preceding paragraph, each Participant&#146;s acceptance of an Award under the Plan will constitute the Participant&#146;s authorization to the Company and instruction and authorization to any brokerage firm selected by the Company to effect the sale
to complete the transactions described in clause (v). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.6 <U>Amendment of Award; Repricing</U>. The Administrator may amend, modify or
terminate any outstanding Award, including by substituting another Award of the same or a different type, changing the exercise or settlement date, and converting an Incentive Stock Option to a Nonqualified Stock Option. The Participant&#146;s
consent to such action will be required unless (i)&nbsp;the action, taking into account any related action, does not materially and adversely affect the Participant&#146;s rights under the Award, or (ii)&nbsp;the change is permitted under Article IX
or pursuant to Section&nbsp;11.6. In addition, the Administrator shall, without the approval of the stockholders of the Company, have the authority to (a)&nbsp;amend any outstanding Option or Stock Appreciation Right to reduce its exercise price per
Share, or (b)&nbsp;cancel any Option or Stock Appreciation Right in exchange for cash or another Award. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.7 <U>Conditions on Delivery of
Stock</U>. The Company will not be obligated to deliver any Shares under the Plan or remove restrictions from Shares previously delivered under the Plan until (i)&nbsp;all Award conditions have been met or removed to the Company&#146;s satisfaction,
(ii)&nbsp;as determined by the Company, all other legal matters regarding the issuance and delivery of such Shares have been satisfied, including, without limitation, any applicable securities laws and stock exchange or stock market rules and
regulations, (iii)&nbsp;any approvals from governmental agencies that the Company determines are necessary or advisable have been obtained, and (iv)&nbsp;the Participant has executed and delivered to the Company such representations or agreements as
the Administrator deems necessary or appropriate to satisfy Applicable Law. The inability or impracticability of the Company to obtain or maintain authority from any regulatory body having jurisdiction, which authority is deemed by the
Company&#146;s counsel to be necessary to the lawful issuance and sale of any Shares hereunder, shall relieve the Company of any liability in respect of the failure to issue or sell such Shares as to which such requisite authority shall not have
been obtained, and shall constitute circumstances in which the Administrator may determine to amend or cancel Awards pertaining to such Shares, with or without consideration to the Participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">10.8 <U>Acceleration</U>. The Administrator may at any time provide that any Award will become immediately vested and fully or partially
exercisable, free of some or all restrictions or conditions, or otherwise fully or partially realizable. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE XI. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>MISCELLANEOUS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.1 <U>No
Right to Employment or Other Status</U>. No person will have any claim or right to be granted an Award, and the grant of an Award will not be construed as giving a Participant the right to continue employment or any other relationship with the
Company or a Subsidiary. The Company and its Subsidiaries expressly reserve the right at any time to dismiss or otherwise terminate its relationship with a Participant free from any liability or claim under the Plan or any Award, except as expressly
provided in an Award Agreement or other written agreement between the Participant and the Company or any Subsidiary. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.2 <U>No Rights as Stockholder; Certificates</U>. Subject to the Award Agreement, no
Participant or Designated Beneficiary will have any rights as a stockholder with respect to any Shares to be distributed under an Award until becoming the record holder of such Shares. Notwithstanding any other provision of the Plan, unless the
Administrator otherwise determines or Applicable Law requires, the Company will not be required to deliver to any Participant certificates evidencing Shares issued in connection with any Award and instead such Shares may be recorded in the books of
the Company (or, as applicable, its transfer agent or stock plan administrator). The Company may place legends on any share certificate or book entry to reference restrictions applicable to the Shares (including, without limitation, restrictions
applicable to Restricted Stock). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.3 <U>Effective Date</U>. The Plan will become effective on the date immediately prior to the date the
Company&#146;s registration statement relating to the initial public offering of its Common Stock becomes effective (the &#147;<B><I>Effective Date</I></B>&#148;). No Incentive Stock Option may be granted pursuant to the Plan after the tenth
anniversary of the earlier of (i)&nbsp;the date the Plan was approved by the Board and (ii)&nbsp;the date the Plan was approved by the Company&#146;s stockholders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.4 <U>Amendment of Plan</U>. The Board may amend, suspend or terminate the Plan at any time and from time to time; provided that (a)&nbsp;no
amendment requiring stockholder approval to comply with Applicable Law shall be effective unless approved by the Board, and (b)&nbsp;no amendment, other than an increase to the Overall Share Limit or pursuant to Article IX or Section&nbsp;11.6, may
materially and adversely affect any Award outstanding at the time of such amendment without the affected Participant&#146;s consent. No Awards may be granted under the Plan during any suspension period or after Plan termination. Awards outstanding
at the time of any Plan suspension or termination will continue to be governed by the Plan and the Award Agreement, as in effect before such suspension or termination. The Board will obtain stockholder approval of any Plan amendment to the extent
necessary to comply with Applicable Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.5 <U>Provisions for Foreign Participants</U>. The Administrator may modify Awards granted to
Participants who are nationals of a country other than the United States or employed or residing outside the United States, establish subplans or procedures under the Plan or take any other necessary or appropriate action to address Applicable Law,
including (a)&nbsp;differences in laws, rules, regulations or customs of such jurisdictions with respect to tax, securities, currency, employee benefit or other matters, (b)&nbsp;listing and other requirements of any
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> securities exchange, and (c)&nbsp;any necessary local governmental or regulatory exemptions or approvals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.6 <U>Section</U><U></U><U>&nbsp;409A</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>General</I>. The Company intends that all Awards be structured to comply with, or be exempt from, Section&nbsp;409A, such that no
adverse tax consequences, interest, or penalties under Section&nbsp;409A apply. Notwithstanding anything in the Plan or any Award Agreement to the contrary, the Administrator may, without a Participant&#146;s consent, amend this Plan or Awards,
adopt policies and procedures, or take any other actions (including amendments, policies, procedures and retroactive actions) as are necessary or appropriate to preserve the intended tax treatment of Awards, including any such actions intended to
(A)&nbsp;exempt this Plan or any Award from Section&nbsp;409A, or (B)&nbsp;comply with Section&nbsp;409A, including regulations, guidance, compliance programs and other interpretative authority that may be issued after an Award&#146;s grant date.
The Company makes no representations or warranties as to an Award&#146;s tax treatment under Section&nbsp;409A or otherwise. The Company will have no obligation under this Section&nbsp;11.6 or otherwise to avoid the taxes, penalties or interest
under Section&nbsp;409A with respect to any Award and will have no liability to any Participant or any other person if any Award, compensation or other benefits under the Plan are determined to constitute noncompliant &#147;nonqualified deferred
compensation&#148; subject to taxes, penalties or interest under Section&nbsp;409A. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Separation from Service</I>. If an Award constitutes &#147;nonqualified deferred
compensation&#148; under Section&nbsp;409A, any payment or settlement of such Award upon a Participant&#146;s Termination of Service will, to the extent necessary to avoid taxes under Section&nbsp;409A, be made only upon the Participant&#146;s
&#147;separation from service&#148; (within the meaning of Section&nbsp;409A), whether such &#147;separation from service&#148; occurs upon or after the Participant&#146;s Termination of Service. For purposes of this Plan or any Award Agreement
relating to any such payments or benefits, references to a &#147;termination,&#148; &#147;termination of employment&#148; or like terms means a &#147;separation from service.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <I>Payments to Specified Employees</I>. Notwithstanding any contrary provision in the Plan or any Award Agreement, any payment(s) of
&#147;nonqualified deferred compensation&#148; required to be made under an Award to a &#147;specified employee&#148; (as defined under Section&nbsp;409A and as the Administrator determines) due to his or her &#147;separation from service&#148;
will, to the extent necessary to avoid taxes under Section&nbsp;409A(a)(2)(B)(i) of the Code, be delayed for the <FONT STYLE="white-space:nowrap">six-month</FONT> period immediately following such &#147;separation from service&#148; (or, if earlier,
until the specified employee&#146;s death) and will instead be paid (as set forth in the Award Agreement) on the day immediately following such <FONT STYLE="white-space:nowrap">six-month</FONT> period or as soon as administratively practicable
thereafter (without interest). Any payments of &#147;nonqualified deferred compensation&#148; under such Award payable more than six months following the Participant&#146;s &#147;separation from service&#148; will be paid at the time or times the
payments are otherwise scheduled to be made. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.7 <U>Limitations on Liability</U>. Notwithstanding any other provisions of the Plan, no
individual acting as a director, officer or other employee of the Company or any Subsidiary will be liable to any Participant, former Participant, spouse, beneficiary, or any other person for any claim, loss, liability, or expense incurred in
connection with the Plan or any Award, and such individual will not be personally liable with respect to the Plan because of any contract or other instrument executed in his or her capacity as an Administrator, director, officer or other employee of
the Company or any Subsidiary. The Company will indemnify and hold harmless each director, officer or other employee of the Company or any Subsidiary that has been or will be granted or delegated any duty or power relating to the Plan&#146;s
administration or interpretation, against any cost or expense (including attorneys&#146; fees) or liability (including any sum paid in settlement of a claim with the Administrator&#146;s approval) arising from any act or omission concerning this
Plan unless arising from such person&#146;s own fraud or bad faith; provided that he or she gives the Company an opportunity, at its own expense, to handle and defend the same before he or she undertakes to handle and defend it on his or her own
behalf. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.8 <U>Data Privacy</U>. As a condition for receiving any Award, each Participant explicitly and unambiguously consents to the
collection, use and transfer, in electronic or other form, of personal data as described in this Section by and among the Company and its Subsidiaries and affiliates exclusively for implementing, administering and managing the Participant&#146;s
participation in the Plan. The Company and its Subsidiaries and affiliates may hold certain personal information about a Participant, including the Participant&#146;s name, address and telephone number; birthdate; social security, insurance number
or other identification number; salary; nationality; job title(s); any Shares held in the Company or its Subsidiaries and affiliates; and Award details, to implement, manage and administer the Plan and Awards (the &#147;<B><I>Data</I></B>&#148;).
The Company and its Subsidiaries and affiliates may transfer the Data amongst themselves as necessary to implement, administer and manage a Participant&#146;s participation in the Plan, and the Company and its Subsidiaries and affiliates may
transfer the Data to third parties assisting the Company with Plan implementation, administration and management. These recipients may be located in the Participant&#146;s country, or elsewhere, and the Participant&#146;s country may have different
data privacy laws and protections than the recipients&#146; country. By accepting an Award, each Participant authorizes such recipients to receive, possess, use, retain and transfer the Data, in electronic or other form, to implement, administer and
manage </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the Participant&#146;s participation in the Plan, including any required Data transfer to a broker or other third party with whom the Company or the Participant may elect to deposit any Shares.
The Data related to a Participant will be held only as long as necessary to implement, administer, and manage the Participant&#146;s participation in the Plan. A Participant may, at any time, view the Data that the Company holds regarding such
Participant, request additional information about the storage and processing of the Data regarding such Participant, recommend any necessary corrections to the Data regarding the Participant or refuse or withdraw the consents in this
Section&nbsp;11.8 in writing, without cost, by contacting the local human resources representative. The Company may cancel Participant&#146;s ability to participate in the Plan and, in the Administrator&#146;s sole discretion, the Participant may
forfeit any outstanding Awards if the Participant refuses or withdraws the consents in this Section&nbsp;11.8. For more information on the consequences of refusing or withdrawing consent, Participants may contact their local human resources
representative. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.9 <U>Severability</U>. If any portion of the Plan or any action taken under it is held illegal or invalid for any
reason, the illegality or invalidity will not affect the remaining parts of the Plan, and the Plan will be construed and enforced as if the illegal or invalid provisions had been excluded, and the illegal or invalid action will be null and void.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.10 <U>Governing Documents</U>. If any contradiction occurs between the Plan and any Award Agreement or other written agreement between
a Participant and the Company (or any Subsidiary), the Plan will govern, unless such Award Agreement or other written agreement was approved by the Administrator and expressly provides that a specific provision of the Plan will not apply. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.11 <U>Governing Law</U>. The Plan and all Awards will be governed by and interpreted in accordance with the laws of the State of Delaware,
without regard to the conflict of law rules thereof or of any other jurisdiction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.12 <U>Clawback Provisions</U>. All Awards (including
the gross amount of any proceeds, gains or other economic benefit the Participant actually or constructively receives upon receipt or exercise of any Award or the receipt or resale of any Shares underlying the Award) will be subject to recoupment by
the Company to the extent required to comply with Applicable Law or any policy of the Company providing for the reimbursement of incentive compensation, whether or not such policy was in place at the time of grant of an Award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.13 <U>Titles and Headings</U>. The titles and headings in the Plan are for convenience of reference only and, if any conflict, the
Plan&#146;s text, rather than such titles or headings, will control. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.14 <U>Conformity to Applicable Law</U>. Participant acknowledges
that the Plan is intended to conform to the extent necessary with Applicable Law. Notwithstanding anything herein to the contrary, the Plan and all Awards will be administered only in a manner intended to conform with Applicable Law. To the extent
Applicable Law permits, the Plan and all Award Agreements will be deemed amended as necessary to conform to Applicable Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.15
<U>Relationship to Other Benefits</U>. No payment under the Plan will be taken into account in determining any benefits under any pension, retirement, savings, profit sharing, group insurance, welfare or other benefit plan of the Company or any
Subsidiary, except as expressly provided in writing in such other plan or an agreement thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.16 <U>Unfunded Status of
Awards</U>. The Plan is intended to be an &#147;unfunded&#148; plan for incentive compensation. With respect to any payments not yet made to a Participant pursuant to an Award, nothing contained in the Plan or Award Agreement shall give the
Participant any rights that are greater than those of a general creditor of the Company or any Subsidiary. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.17 <U>Limitations Applicable to Section</U><U></U><U>&nbsp;16 Persons</U>.
Notwithstanding any other provision of the Plan, the Plan and any Award granted or awarded to any individual who is then subject to Section&nbsp;16 of the Exchange Act shall be subject to any additional limitations set forth in any applicable
exemptive rule under Section&nbsp;16 of the Exchange Act (including Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> of the Exchange Act and any amendments thereto) that are requirements for the application of such exemptive rule. To the extent
permitted by Applicable Law, the Plan and Awards granted or awarded hereunder shall be deemed amended to the extent necessary to conform to such applicable exemptive rule. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.18 <U>Prohibition on Executive Officer Loans</U>. Notwithstanding any other provision of the Plan to the contrary, no Participant who is a
Director or an &#147;executive officer&#148; of the Company within the meaning of Section&nbsp;13(k) of the Exchange Act shall be permitted to make payment with respect to any Awards granted under the Plan, or continue any extension of credit with
respect to such payment, with a loan from the Company or a loan arranged by the Company in violation of Section&nbsp;13(k) of the Exchange Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">11.19 <U>Broker-Assisted Sales</U>. In the event of a broker-assisted sale of Shares in connection with the payment of amounts owed by a
Participant under or with respect to the Plan or Awards, including amounts to be paid under the final sentence of Section&nbsp;10.5: (a) any Shares to be sold through the broker-assisted sale will be sold on the day the payment first becomes due, or
as soon thereafter as practicable; (b)&nbsp;such Shares may be sold as part of a block trade with other Participants in the Plan in which all Participants receive an average price; (c)&nbsp;the applicable Participant will be responsible for all
broker&#146;s fees and other costs of sale, and by accepting an Award, each Participant agrees to indemnify and hold the Company harmless from any losses, costs, damages, or expenses relating to any such sale; (d)&nbsp;to the extent the Company or
its designee receives proceeds of such sale that exceed the amount owed, the Company will pay such excess in cash to the applicable Participant as soon as reasonably practicable; (e)&nbsp;the Company and its designees are under no obligation to
arrange for such sale at any particular price; and (f)&nbsp;in the event the proceeds of such sale are insufficient to satisfy the Participant&#146;s applicable obligation, the Participant may be required to pay immediately upon demand to the
Company or its designee an amount in cash sufficient to satisfy any remaining portion of the Participant&#146;s obligation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>*&nbsp;&nbsp;&nbsp;&nbsp; *&nbsp;&nbsp;&nbsp;&nbsp; *&nbsp;&nbsp;&nbsp;&nbsp; *&nbsp;&nbsp;&nbsp;&nbsp; * </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4(B)
<SEQUENCE>10
<FILENAME>d60414dex104b.htm
<DESCRIPTION>EX-10.4(B)
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.4(b)</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.4(b) </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SANA BIOTECHNOLOGY, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2021 INCENTIVE AWARD PLAN </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>STOCK OPTION GRANT NOTICE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Sana Biotechnology, Inc., a Delaware corporation, (the &#147;<B><I>Company</I></B>&#148;), pursuant to its 2021 Incentive Award Plan, as may
be amended from time to time (the &#147;<B><I>Plan</I></B>&#148;), hereby grants to the holder listed below (&#147;<B><I>Participant</I></B>&#148;), an option to purchase the number of shares of the Company&#146;s Common Stock (the
&#147;<B><I>Shares</I></B>&#148;), set forth below (the &#147;<B><I>Option</I></B>&#148;). This Option is subject to all of the terms and conditions set forth herein, as well as in the Plan and the Stock Option Agreement attached hereto as
<B>Exhibit A</B> (the &#147;<B><I>Stock Option Agreement</I></B>&#148;), each of which are incorporated herein by reference. Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in this Grant Notice and
the Stock Option Agreement. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="72%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><FONT STYLE="font-size:11pt"><B>Participant:</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[____________]</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><FONT STYLE="font-size:11pt"><B>Grant Date:</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[____________]</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><FONT STYLE="font-size:11pt"><B>Vesting&nbsp;Commencement&nbsp;Date:</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[____________]</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><FONT STYLE="font-size:11pt"><B>Exercise Price per Share:</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">$[___________]</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><FONT STYLE="font-size:11pt"><B>Total Exercise Price:</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[____________]</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><FONT STYLE="font-size:11pt"><B>Total Number of Shares Subject to the Option:</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[____________]</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><FONT STYLE="font-size:11pt"><B>Expiration Date:</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[____________]</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><FONT STYLE="font-size:11pt"><B>Vesting Schedule:</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[____________]</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Type of Option: </B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9744;&nbsp;&nbsp;&nbsp;&nbsp;Incentive Stock
Option&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9744;&nbsp;&nbsp;&nbsp;&nbsp;Nonqualified Stock Option </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">By his or her signature and the Company&#146;s signature below, Participant agrees to be bound by the terms and conditions of the Plan, the
Stock Option Agreement and this Grant Notice. Participant has reviewed the Plan, the Stock Option Agreement and this Grant Notice in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Grant Notice and
fully understands all provisions of the Plan, the Stock Option Agreement and this Grant Notice. Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Administrator upon any questions arising
under the Plan, the Stock Option Agreement or this Grant Notice. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-size:11pt"><B>SANA BIOTECHNOLOGY, INC.:</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3">&nbsp;&nbsp;&nbsp;&nbsp;<B>PARTICIPANT:</B></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="37%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="37%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Print&nbsp;Name:</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Print&nbsp;Name:</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Title:</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Address:</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-size:10pt">Address:</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT A </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TO STOCK OPTION GRANT NOTICE </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>STOCK OPTION AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Stock Option Grant Notice (the &#147;<B><I>Grant Notice</I></B>&#148;) to which this Stock Option Agreement (this
&#147;<B><I>Agreement</I></B>&#148;) is attached, Sana Biotechnology, Inc., a Delaware corporation (the &#147;<B><I>Company</I></B>&#148;), has granted to the Participant an Option under the Company&#146;s 2021 Incentive Award Plan, as may be
amended from time to time (the &#147;<B><I>Plan</I></B>&#148;), to purchase the number of Shares indicated in the Grant Notice. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE
1. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>GENERAL </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.1
<U>Defined Terms</U>. Capitalized terms not specifically defined herein shall have the meanings specified in the Plan and the Grant Notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.2 <U>Incorporation of Terms of Plan</U>. The Option is subject to the terms and conditions of the Plan which are incorporated herein by
reference. In the event of any inconsistency between the Plan and this Agreement, the terms of the Plan shall control. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 2.
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>GRANT OF OPTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.1 <U>Grant of Option</U>. In consideration of the Participant&#146;s past or continued employment with or service to the Company or any
Subsidiary and for other good and valuable consideration, effective as of the Grant Date set forth in the Grant Notice (the &#147;<B><I>Grant Date</I></B>&#148;), the Company irrevocably grants to the Participant the Option to purchase any part or
all of an aggregate of the number of Shares set forth in the Grant Notice, upon the terms and conditions set forth in the Plan and this Agreement, subject to adjustments as provided in Article IX of the Plan. Unless designated as a Nonqualified
Stock Option in the Grant Notice, the Option shall be an Incentive Stock Option to the maximum extent permitted by law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.2 <U>Exercise
Price</U>. The exercise price of the Shares subject to the Option shall be as set forth in the Grant Notice, without commission or other charge; <I>provided</I>, <I>however</I>, that the price per share of the Shares subject to the Option shall not
be less than 100% of the Fair Market Value of a Share on the Grant Date. Notwithstanding the foregoing, if this Option is designated as an Incentive Stock Option and the Participant is a Greater Than 10% Stockholder as of the Grant Date, the
exercise price per share of the Shares subject to the Option shall not be less than 110% of the Fair Market Value of a Share on the Grant Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.3 <U>Consideration to the Company</U>. In consideration of the grant of the Option by the Company, the Participant agrees to render faithful
and efficient services to the Company or any Subsidiary. Nothing in the Plan or this Agreement shall confer upon the Participant any right to continue in the employ or service of the Company or any Subsidiary or shall interfere with or restrict in
any way the rights of the Company and its Subsidiaries, which rights are hereby expressly reserved, to discharge or terminate the services of the Participant at any time for any reason whatsoever, with or without cause, except to the extent
expressly provided otherwise in a written agreement between the Company or a Subsidiary and the Participant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 3. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PERIOD OF EXERCISABILITY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1 <U>Commencement of Exercisability</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Subject to Sections 3.2, 3.3, 5.11 and 5.17 hereof, the Option shall become vested and exercisable in such amounts and at such times as
are set forth in the Grant Notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) No portion of the Option which has not become vested and exercisable at the date of the
Participant&#146;s Termination of Service shall thereafter become vested and exercisable, except as may be otherwise provided by the Administrator or as set forth in a written agreement between the Company and the Participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding Section&nbsp;3.1(a) hereof and the Grant Notice, but subject to Section&nbsp;3.1(b) hereof, in the event of a Change in
Control the Option shall be treated pursuant to Sections 9.2 and 9.3 of the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.2 <U>Duration of Exercisability</U>. The installments
provided for in the vesting schedule set forth in the Grant Notice are cumulative. Each such installment which becomes vested and exercisable pursuant to the vesting schedule set forth in the Grant Notice shall remain vested and exercisable until it
becomes unexercisable under Section&nbsp;3.3 hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.3 <U>Expiration of Option</U>. The Option may not be exercised to any extent by
anyone after the first to occur of the following events: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Expiration Date set forth in the Grant Notice, which shall in no event be
more than ten years from the Grant Date; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) If this Option is designated as an Incentive Stock Option and the Participant, at the time
the Option was granted, was a Greater Than 10% Stockholder, the expiration of five years from the Grant Date; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The expiration of three
months from the date of the Participant&#146;s Termination of Service, unless such termination occurs by reason of the Participant&#146;s death or Disability; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The expiration of one year from the date of the Participant&#146;s Termination of Service by reason of the Participant&#146;s death or
Disability. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.4 <U>Special Tax Consequences</U>. The Participant acknowledges that, to the extent that the aggregate Fair Market Value
(determined as of the time the Option is granted) of all Shares with respect to which Incentive Stock Options, including the Option (if applicable), are exercisable for the first time by the Participant in any calendar year exceeds $100,000, the
Option and such other options shall be Nonqualified Stock Options to the extent necessary to comply with the limitations imposed by Section&nbsp;422(d) of the Code. The Participant further acknowledges that the rule set forth in the preceding
sentence shall be applied by taking the Option and other &#147;incentive stock options&#148; into account in the order in which they were granted, as determined under Section&nbsp;422(d) of the Code and the Treasury Regulations thereunder. The
Participant also acknowledges that an Incentive Stock Option exercised more than three months after the Participant&#146;s Termination of Employment, other than by reason of death or Disability, will be taxed as a Nonqualified Stock Option. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>3.5 Tax Indemnity.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Participant agrees to indemnify and keep indemnified the Company, any Subsidiary and the Participant&#146;s employing company, if
different, from and against any liability for or obligation to pay any Tax Liability (a &#147;<B><I>Tax Liability</I></B>&#148; being any liability for income tax, withholding tax and any other employment related taxes or social security
contributions in any jurisdiction) that is attributable to (1)&nbsp;the grant or exercise of, or any benefit derived by the Participant from, the Option, (2)&nbsp;the acquisition by the Participant of the Shares on exercise of the Option or
(3)&nbsp;the disposal of any Shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The Option cannot be exercised until the Participant has made such arrangements as the Company
may require for the satisfaction of any Tax Liability that may arise in connection with the exercise of the Option or the acquisition of the Shares by the Participant. The Company shall not be required to issue, allot or transfer Shares until the
Participant has satisfied this obligation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Participant hereby acknowledges that the Company (i)&nbsp;makes no representations or
undertakings regarding the treatment of any Tax Liabilities in connection with any aspect of the Option and (ii)&nbsp;does not commit to and is under no obligation to structure the terms of the grant or any aspect of any Award, including the Option,
to reduce or eliminate the Participant&#146;s liability for Tax Liabilities or achieve any particular tax result. Furthermore, if the Participant becomes subject to tax in more than one jurisdiction between the date of grant of an Award, including
the Option, and the date of any relevant taxable event, the Participant acknowledges that the Company may be required to withhold or account for Tax Liabilities in more than one jurisdiction. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 4. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXERCISE OF
OPTION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.1 <U>Person Eligible to Exercise</U>. Except as provided in Section&nbsp;5.3 hereof, during the lifetime of the Participant,
only the Participant may exercise the Option or any portion thereof, unless it has been disposed of pursuant to a DRO. After the death of the Participant, any exercisable portion of the Option may, prior to the time when the Option becomes
unexercisable under Section&nbsp;3.3 hereof, be exercised by the deceased Participant&#146;s personal representative or by any person empowered to do so under the deceased Participant&#146;s will or under the then applicable laws of descent and
distribution. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.2 <U>Partial Exercise</U>. Any exercisable portion of the Option or the entire Option, if then wholly exercisable, may be
exercised in whole or in part at any time prior to the time when the Option or portion thereof becomes unexercisable under Section&nbsp;3.3 hereof. However, the Option shall not be exercisable with respect to fractional Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.3 <U>Manner of Exercise</U>. The Option, or any exercisable portion thereof, may be exercised solely by delivery to the Secretary of the
Company (or any third party administrator or other person or entity designated by the Company; for the avoidance of doubt, delivery shall include electronic delivery), during regular business hours, of all of the following prior to the time when the
Option or such portion thereof becomes unexercisable under Section&nbsp;3.3 hereof: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) An exercise notice in a form specified by the
Administrator, stating that the Option or portion thereof is thereby exercised, such notice complying with all applicable rules established by the Administrator. The notice shall be signed by the Participant or other person then entitled to exercise
the Option or such portion of the Option; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The receipt by the Company of full payment for the Shares with respect to which the
Option or portion thereof is exercised, including payment of any applicable withholding tax, which shall be made by deduction from other compensation payable to the Participant or in such other form of consideration permitted under Section&nbsp;4.4
hereof that is acceptable to the Company; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Any other written representations or documents as may be required in the
Administrator&#146;s sole discretion to evidence compliance with the Securities Act, the Exchange Act or any other applicable law, rule or regulation; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) In the event the Option or portion thereof shall be exercised pursuant to Section&nbsp;4.1 hereof by any person or persons other than the
Participant, appropriate proof of the right of such person or persons to exercise the Option. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding any of the foregoing, the Company shall
have the right to specify all conditions of the manner of exercise, which conditions may vary by country and which may be subject to change from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.4 <U>Method of Payment</U>. Payment of the exercise price shall be by any of the following, or a combination thereof, at the election of the
Participant: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Cash or check; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) With the consent of the Administrator, surrender of Shares (including, without limitation, Shares otherwise issuable upon exercise of the
Option) held for such period of time as may be required by the Administrator in order to avoid adverse accounting consequences and having a Fair Market Value on the date of delivery equal to the aggregate exercise price of the Option or exercised
portion thereof; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Other legal consideration acceptable to the Administrator (including, without limitation, through the delivery of
a notice that the Participant has placed a market sell order with a broker with respect to Shares then issuable upon exercise of the Option, and that the broker has been directed to pay a sufficient portion of the net proceeds of the sale to the
Company in satisfaction of the Option exercise price; <I>provided</I> that payment of such proceeds is then made to the Company at such time as may be required by the Company, but in any event not later than the settlement of such sale). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.5 <U>Conditions to Issuance of Shares</U>. The Shares deliverable upon the exercise of the Option, or any portion thereof, may be either
previously authorized but unissued Shares or issued Shares which have then been reacquired by the Company. Such Shares shall be fully paid and nonassessable. The Company shall not be required to issue or deliver any Shares purchased upon the
exercise of the Option or portion thereof prior to fulfillment of all of the conditions in Section&nbsp;10.7 of the Plan and following conditions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The admission of such Shares to listing on all stock exchanges on which such Shares are then listed; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) The completion of any registration or other qualification of such Shares under any state or federal law or under rulings or regulations of
the Securities and Exchange Commission or of any other governmental regulatory body, which the Administrator shall, in its absolute discretion, deem necessary or advisable; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The obtaining of any approval or other clearance from any state or federal governmental
agency which the Administrator shall, in its absolute discretion, determine to be necessary or advisable; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The receipt by the Company
of full payment for such Shares, including payment of any applicable withholding tax, which may be in one or more of the forms of consideration permitted under Section&nbsp;4.4 hereof; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) The lapse of such reasonable period of time following the exercise of the Option as the Administrator may from time to time establish for
reasons of administrative convenience. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.6 <U>Rights as Stockholder</U>. The holder of the Option shall not be, nor have any of the
rights or privileges of, a stockholder of the Company, including, without limitation, voting rights and rights to dividends, in respect of any Shares purchasable upon the exercise of any part of the Option unless and until such Shares shall have
been issued by the Company and held of record by such holder (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company). No adjustment will be made for a dividend or other right for
which the record date is prior to the date the Shares are issued, except as provided in Article IX of the Plan. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 5. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OTHER PROVISIONS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.1
<U>Administration</U>. The Administrator shall have the power to interpret the Plan and this Agreement and to adopt such rules for the administration, interpretation and application of the Plan as are consistent therewith and to interpret, amend or
revoke any such rules. All actions taken and all interpretations and determinations made by the Administrator in good faith shall be final and binding upon the Participant, the Company and all other interested persons. No member of the Committee or
the Board shall be personally liable for any action, determination or interpretation made in good faith with respect to the Plan, this Agreement or the Option. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.2 <U>Whole Shares</U>. The Option may only be exercised for whole Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.3 <U>Transferability</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Subject to Section&nbsp;4.1 hereof, the Option may not be sold, pledged, assigned or transferred in any manner other than by will or the
laws of descent and distribution or, subject to the consent of the Administrator, pursuant to a DRO, unless and until the Option has been exercised and the Shares underlying the Option have been issued, and all restrictions applicable to such Shares
have lapsed. Neither the Option nor any interest or right therein shall be liable for the debts, contracts or engagements of the Participant or his or her successors in interest or shall be subject to disposition by transfer, alienation,
anticipation, pledge, hypothecation, encumbrance, assignment or any other means whether such disposition be voluntary or involuntary or by operation of law by judgment, levy, attachment, garnishment or any other legal or equitable proceedings
(including bankruptcy) unless and until the Option has been exercised, and any attempted disposition thereof prior to exercise shall be null and void and of no effect, except to the extent that such disposition is permitted by the preceding
sentence. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) During the lifetime of the Participant, only the Participant may exercise the Option (or any portion thereof), unless it
has been disposed of pursuant to a DRO; after the death of the Participant, any exercisable portion of the Option may, prior to the time when such portion becomes unexercisable under the Plan or this Agreement, be exercised by the Participant&#146;s
personal representative or by any person empowered to do so under the deceased Participant&#146;s will or under the then-applicable laws of descent and distribution. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Notwithstanding any other provision in this Agreement, the Participant may, in the
manner determined by the Administrator, designate a beneficiary to exercise the rights of the Participant and to receive any distribution with respect to the Option upon the Participant&#146;s death. A beneficiary, legal guardian, legal
representative, or other person claiming any rights pursuant to the Plan is subject to all terms and conditions of the Plan and this Agreement, except to the extent the Plan and this Agreement otherwise provide, and to any additional restrictions
deemed necessary or appropriate by the Administrator. If the Participant is married or a domestic partner in a domestic partnership qualified under Applicable Law and resides in a community property state, a designation of a person other than the
Participant&#146;s spouse or domestic partner, as applicable, as his or her beneficiary with respect to more than 50% of the Participant&#146;s interest in the Option shall not be effective without the prior written consent of the Participant&#146;s
spouse or domestic partner. If no beneficiary has been designated or survives the Participant, payment shall be made to the person entitled thereto pursuant to the Participant&#146;s will or the laws of descent and distribution. Subject to the
foregoing, a beneficiary designation may be changed or revoked by the Participant at any time provided the change or revocation is filed with the Administrator prior to the Participant&#146;s death. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.4 <U>Tax Consultation</U>. The Participant understands that the Participant may suffer adverse tax consequences as a result of the grant,
vesting or exercise of the Option, or with the purchase or disposition of the Shares subject to the Option. The Participant represents that the Participant has consulted with any tax consultants the Participant deems advisable in connection with the
purchase or disposition of such Shares and that the Participant is not relying on the Company for any tax advice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.5 <U>Binding
Agreement</U>. Subject to the limitation on the transferability of the Option contained herein, this Agreement will be binding upon and inure to the benefit of the heirs, legatees, legal representatives, successors and assigns of the parties hereto.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.6 <U>Adjustments Upon Specified Events</U>. The Administrator may accelerate the vesting of the Option in such circumstances as it, in
its sole discretion, may determine. In addition, upon the occurrence of certain events relating to the Shares contemplated by Article IX of the Plan (including, without limitation, an extraordinary cash dividend on such Shares), the Administrator
shall make such adjustments the Administrator deems appropriate in the number of Shares subject to the Option, the exercise price of the Option and the kind of securities that may be issued upon exercise of the Option. The Participant acknowledges
that the Option is subject to adjustment, modification and termination in certain events as provided in this Agreement and Article IX of the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.7 <U>Notices</U>. Any notice to be given under the terms of this Agreement to the Company shall be addressed to the Company in care of the
Secretary of the Company at the Company&#146;s principal office, and any notice to be given to the Participant shall be addressed to the Participant at the Participant&#146;s last address reflected on the Company&#146;s records. By a notice given
pursuant to this Section&nbsp;5.7, either party may hereafter designate a different address for notices to be given to that party. Any notice which is required to be given to the Participant shall, if the Participant is then deceased, be given to
the person entitled to exercise his or her Option pursuant to Section&nbsp;4.1 hereof by written notice under this Section&nbsp;5.7. Any notice shall be deemed duly given when sent via email or when sent by certified mail (return receipt requested)
and deposited (with postage prepaid) in a post office or branch post office regularly maintained by the United States Postal Service. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.8
<U>Titles</U>. Titles are provided herein for convenience only and are not to serve as a basis for interpretation or construction of this Agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.9 <U>Governing Law</U>. The laws of the State of Delaware shall govern the interpretation,
validity, administration, enforcement and performance of the terms of this Agreement regardless of the law that might be applied under principles of conflicts of laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.10 <U>Conformity to Securities Laws</U>. The Participant acknowledges that the Plan and this Agreement are intended to conform to the extent
necessary with all provisions of the Securities Act and the Exchange Act and any and all Applicable Law and regulations and rules promulgated by the Securities and Exchange Commission thereunder, and state securities laws and regulations.
Notwithstanding anything herein to the contrary, the Plan shall be administered, and the Option is granted and may be exercised, only in such a manner as to conform to such Applicable Law. To the extent permitted by applicable law, the Plan and this
Agreement shall be deemed amended to the extent necessary to conform to such Applicable Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.11 <U>Amendment, Suspension and
Termination</U>. To the extent permitted by the Plan, this Agreement may be wholly or partially amended or otherwise modified, suspended or terminated at any time or from time to time by the Administrator or the Board;<I> provided, however,</I>
that, except as may otherwise be provided by the Plan, no amendment, modification, suspension or termination of this Agreement shall adversely affect the Option in any material way without the prior written consent of the Participant.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.12 <U>Successors and Assigns</U>. The Company may assign any of its rights under this Agreement to single or multiple assignees, and this
Agreement shall inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer herein set forth in Section&nbsp;5.3 hereof, this Agreement shall be binding upon the Participant and his or her heirs,
executors, administrators, successors and assigns. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.13 <U>Notification of Disposition</U>. If this Option is designated as an Incentive
Stock Option, the Participant shall give prompt notice to the Company of any disposition or other transfer of any Shares acquired under this Agreement if such disposition or transfer is made (a)&nbsp;within two years from the Grant Date with respect
to such Shares or (b)&nbsp;within one year after the transfer of such Shares to the Participant. Such notice shall specify the date of such disposition or other transfer and the amount realized, in cash, other property, assumption of indebtedness or
other consideration, by the Participant in such disposition or other transfer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.14 <U>Limitations Applicable to
Section</U><U></U><U>&nbsp;16 Persons</U>. Notwithstanding any other provision of the Plan or this Agreement, if the Participant is subject to Section&nbsp;16 of the Exchange Act, the Plan, the Option and this Agreement shall be subject to any
additional limitations set forth in any applicable exemptive rule under Section&nbsp;16 of the Exchange Act (including any amendment to Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> of the Exchange Act) that are requirements for the application
of such exemptive rule. To the extent permitted by applicable law, this Agreement shall be deemed amended to the extent necessary to conform to such applicable exemptive rule. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.15 <U>Not a Contract of Service Relationship</U>. Nothing in this Agreement or in the Plan shall confer upon the Participant any right to
continue to serve as an employee or other service provider of the Company or any of its Subsidiaries or interfere with or restrict in any way with the right of the Company or any of its Subsidiaries, which rights are hereby expressly reserved, to
discharge or to terminate for any reason whatsoever, with or without cause, the services of the Participant&#146;s at any time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.16
<U>Entire Agreement</U>. The Plan, the Grant Notice and this Agreement constitute the entire agreement of the parties and supersede in their entirety all prior undertakings and agreements of the Company and the Participant with respect to the
subject matter hereof, provided that the Option shall be subject to any accelerated vesting provisions in any written agreement between the Participant and the Company or a Company plan pursuant to which the Participant participates, in each case,
in accordance with the terms therein. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.17 <U>Section 409A</U>. This Option is not intended to constitute &#147;nonqualified
deferred compensation&#148; within the meaning of Section&nbsp;409A of the Code (together with any Department of Treasury regulations and other interpretive guidance issued thereunder, including without limitation any such regulations or other
guidance that may be issued after the date hereof, &#147;<B><I>Section</I></B><B><I></I></B><B><I>&nbsp;409A</I></B>&#148;). However, notwithstanding any other provision of the Plan, the Grant Notice or this Agreement, if at any time the
Administrator determines that the Option (or any portion thereof) may be subject to Section&nbsp;409A, the Administrator shall have the right in its sole discretion (without any obligation to do so or to indemnify the Participant or any other person
for failure to do so) to adopt such amendments to the Plan, the Grant Notice or this Agreement, or adopt other policies and procedures (including amendments, policies and procedures with retroactive effect), or take any other actions, as the
Administrator determines are necessary or appropriate either for the Option to be exempt from the application of Section&nbsp;409A or to comply with the requirements of Section&nbsp;409A. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.18 <U>Limitation on the Participant&#146;s Rights</U>. Participation in the Plan confers no rights or interests other than as herein
provided. This Agreement creates only a contractual obligation on the part of the Company as to amounts payable and shall not be construed as creating a trust. Neither the Plan nor any underlying program, in and of itself, has any assets. The
Participant shall have only the rights of a general unsecured creditor of the Company with respect to amounts credited and benefits payable, if any, with respect to the Option, and rights no greater than the right to receive the Shares as a general
unsecured creditor with respect to options, as and when exercised pursuant to the terms hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">*&nbsp;&nbsp;&nbsp;&nbsp;*&nbsp;&nbsp;&nbsp;&nbsp;*&nbsp;&nbsp;&nbsp;&nbsp;*&nbsp;&nbsp;&nbsp;&nbsp;* </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-8 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4(C)
<SEQUENCE>11
<FILENAME>d60414dex104c.htm
<DESCRIPTION>EX-10.4(C)
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.4(c)</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.4(c) </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SANA BIOTECHNOLOGY, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2021 INCENTIVE AWARD PLAN </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RESTRICTED STOCK AWARD GRANT NOTICE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Sana Biotechnology, Inc., a Delaware corporation, (the &#147;<B><I>Company</I></B>&#148;), pursuant to its 2021 Incentive Award Plan, as
amended from time to time (the &#147;<B><I>Plan</I></B>&#148;), hereby grants to the holder listed below (the &#147;<B><I>Participant</I></B>&#148;) the number of shares of the Company&#146;s Common Stock set forth below (the
&#147;<B><I>Shares</I></B>&#148;) subject to all of the terms and conditions as set forth herein and in the Restricted Stock Award Agreement attached hereto as <B>Exhibit A</B> (the &#147;<B><I>Agreement</I></B>&#148;) (including without limitation
the Restrictions on the Shares set forth in the Agreement) and the Plan, each of which is incorporated herein by reference. Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in this Restricted Stock
Award Grant Notice (the &#147;<B><I>Grant Notice</I></B>&#148;) and the Agreement. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="64%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Participant:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">[_________________]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Grant Date:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">[_________________]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Total&nbsp;Number&nbsp;of&nbsp;Shares&nbsp;of&nbsp;Restricted&nbsp;Stock:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">[_________________]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Vesting Commencement Date:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">[_________________]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Vesting Schedule:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">[_________________]</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>Termination:</B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">If the Participant experiences a Termination of Service, any Shares that have not become vested on or prior to the date of such Termination of Service will thereupon be automatically forfeited by the Participant, and the
Participant&#146;s rights in such Shares shall thereupon lapse and expire.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">By his or her signature and the Company&#146;s signature below, the Participant agrees to be bound by the
terms and conditions of the Plan, the Agreement and this Grant Notice. The Participant has reviewed the Plan, the Agreement and this Grant Notice in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Grant
Notice and fully understands all provisions of the Plan, Agreement and this Grant Notice. The Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Administrator upon any questions arising under
the Plan, the Agreement or this Grant Notice. In addition, by signing below, the Participant also agrees that the Company, in its sole discretion, may satisfy any withholding obligations in accordance with Section&nbsp;2.2(c) of the Agreement by
(i)&nbsp;withholding shares of Common Stock otherwise issuable to the Participant upon vesting of the Shares, (ii)&nbsp;instructing a broker on the Participant&#146;s behalf to sell Shares upon vesting and submit the proceeds of such sale to the
Company, or (iii)&nbsp;using any other method permitted by Section&nbsp;2.2(c) of the Agreement or the Plan. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>SANA BIOTECHNOLOGY, INC.:</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>&nbsp;&nbsp;&nbsp;&nbsp;PARTICIPANT:</B></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="37%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="37%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Print&nbsp;Name:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Print&nbsp;Name:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Address:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Address:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT A </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TO RESTRICTED STOCK AWARD GRANT NOTICE </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RESTRICTED STOCK AWARD AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Restricted Stock Award Grant Notice (the &#147;<B><I>Grant Notice</I></B>&#148;) to which this Restricted Stock Award
Agreement (this &#147;<B><I>Agreement</I></B>&#148;) is attached, Sana Biotechnology, Inc., a Delaware corporation, (the &#147;<B><I>Company</I></B>&#148;) has granted to the Participant the number of shares of Restricted Stock (the
&#147;<B><I>Shares</I></B>&#148;) under the Company&#146;s 2021 Incentive Award Plan, as amended from time to time (the &#147;<B><I>Plan</I></B>&#148;), as set forth in the Grant Notice. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE I. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>GENERAL
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.1 <U>Defined Terms</U>. Capitalized terms not specifically defined herein shall have the meanings specified in the Plan and the
Grant Notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.2 <U>Incorporation of Terms of Plan</U>. The Award (as defined below) is subject to the terms and conditions of the Plan,
which are incorporated herein by reference. In the event of any inconsistency between the Plan and this Agreement, the terms of the Plan shall control. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE II. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AWARD OF
RESTRICTED STOCK </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.1 <U>Award of Restricted Stock</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>Award</I>. Pursuant to the Grant Notice and upon the terms and conditions set forth in the Plan and this Agreement, effective as of the
Grant Date set forth in the Grant Notice, the Company has granted to the Participant an award of Restricted Stock (the &#147;<B><I>Award</I></B>&#148;) under the Plan in consideration of the Participant&#146;s past or continued employment with or
service to the Company or any Subsidiary, and for other good and valuable consideration. The number of Shares subject to the Award is set forth in the Grant Notice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Escrow</I>. The Participant, by acceptance of the Award, shall be deemed to appoint, and does so appoint, the Secretary of the Company
or such other escrow holder as the Administrator may appoint to hold the Shares in escrow as the Participant&#146;s <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorney(s)-in-fact</FONT></FONT> to effect any transfer of
unvested forfeited Shares (or Shares otherwise reacquired by the Company hereunder) to the Company as may be required pursuant to the Plan or this Agreement and to execute such documents as the Company or such representatives deem necessary or
advisable in connection with any such transfer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <I>Removal of Notations</I>. As soon as administratively practicable after the
vesting of any Shares subject to the Award pursuant to Section&nbsp;2.2(b) hereof, the Company shall remove the notations on any Shares subject to the Award which have vested (or such lesser number of Shares as may be permitted pursuant to
Section&nbsp;10.7 of the Plan). The Participant (or the beneficiary or personal representative of the Participant in the event of the Participant&#146;s death or incapacity, as the case may be) shall deliver to the Company any representations or
other documents or assurances required by the Company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.2 <U>Restrictions</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>Forfeiture</I>. Notwithstanding any contrary provision of this Agreement, except as may otherwise be provided by the Administrator or
as set forth in a written agreement between the Company and the Participant, upon the Participant&#146;s Termination of Service for any or no reason, any Shares subject to Restrictions shall thereupon be forfeited immediately and without any further
action by the Company, and the Participant&#146;s rights in such Shares shall thereupon lapse and expire. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Vesting and Lapse of
Restrictions</I>. As of the Grant Date, 100% of the Shares shall be subject to the risk of forfeiture set forth in Section&nbsp;2.2(a) hereof and the transfer restrictions set forth in Section&nbsp;3.3 hereof (collectively, such risk of forfeiture
and such transfer restrictions, the &#147;<B><I>Restrictions</I></B>&#148;). The Award shall vest and Restrictions shall lapse in accordance with the vesting schedule set forth in the Grant Notice (rounding down to the nearest whole Share). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <I>Tax Withholding</I>. As set forth in Section&nbsp;10.5 of the Plan, the Company shall have the authority and the right to deduct or
withhold, or to require the Participant to remit to the Company, an amount sufficient to satisfy all applicable federal, state and local taxes required by law to be withheld with respect to any taxable event arising in connection with the Award. The
Company shall not be obligated to transfer Shares held in escrow to the Participant or the Participant&#146;s legal representative until the Participant or the Participant&#146;s legal representative shall have paid or otherwise satisfied in full
the amount of all federal, state and local taxes applicable to the taxable income of the Participant resulting from the grant or vesting of the Award or the issuance of Shares.<U> </U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <I>Stop Transfer Instructions</I>. To ensure compliance with the Restrictions, the provisions of the charter documents of the Company and
Applicable Law, and for other proper purposes, the Company may issue appropriate &#147;stop transfer&#148; and other instructions to its transfer agent with respect to the Restricted Stock. The Company shall notify the transfer agent as and when the
Restrictions lapse. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.3 <U>Consideration to the Company</U>. In consideration of the grant of the Award pursuant hereto, the Participant
agrees to render faithful and efficient services to the Company or any Subsidiary. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE III. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OTHER PROVISIONS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1
<U>Section 83(b) Election</U>. If the Participant makes an election under Section&nbsp;83(b) of the Code to be taxed with respect to the Restricted Stock as of the date of transfer of the Restricted Stock rather than as of the date or dates upon
which the Participant would otherwise be taxable under Section&nbsp;83(a) of the Code, the Participant hereby agrees to deliver a copy of such election to the Company promptly after filing such election with the Internal Revenue Service. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.2 <U>Administration</U>. The Administrator shall have the power to interpret the Plan and this Agreement and to adopt such rules for the
administration, interpretation and application of the Plan as are consistent therewith and to interpret, amend or revoke any such rules. All actions taken and all interpretations and determinations made by the Administrator in good faith shall be
final and binding upon the Participant, the Company and all other interested persons. No member of the Administrator or the Board shall be personally liable for any action, determination or interpretation made in good faith with respect to the Plan,
this Agreement or the Award. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.3 <U>Transferability</U>. Until the Restrictions hereunder lapse or expire pursuant to this Agreement and
the Shares vest, the Restricted Stock (including any Shares or other securities or property received by the Participant with respect to Restricted Stock as a result of stock dividends, stock splits or any other form of recapitalization) shall be
subject to the restrictions on transferability set forth in Section&nbsp;10.1 of the Plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.4 <U>Rights as Stockholder</U>. Except as otherwise provided herein, upon the Grant Date,
the Participant shall have all the rights of a stockholder of the Company with respect to the Shares, subject to the Restrictions, including, without limitation, voting rights and rights to receive any cash or stock dividends, in respect of the
Shares subject to the Award and deliverable hereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.5 <U>Tax Consultation</U>. The Participant understands that the Participant may
suffer adverse tax consequences in connection with the Restricted Stock granted pursuant to this Agreement (and the Shares issuable with respect thereto). The Participant represents that the Participant has consulted with any tax consultants the
Participant deems advisable in connection with the Restricted Stock and that the Participant is not relying on the Company for any tax advice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.6 <U>Adjustments Upon Specified Events</U>. The Administrator may accelerate the vesting of the Restricted Stock in such circumstances as
it, in its sole discretion, may determine. The Participant acknowledges that the Restricted Stock is subject to adjustment, modification and termination in certain events as provided in this Agreement and Article IX of the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.7 <U>Notices</U>. Any notice to be given under the terms of this Agreement to the Company shall be addressed to the Company in care of the
Secretary of the Company at the Company&#146;s principal office, and any notice to be given to the Participant shall be addressed to the Participant at the Participant&#146;s last address reflected on the Company&#146;s records. By a notice given
pursuant to this Section&nbsp;3.7, either party may hereafter designate a different address for notices to be given to that party. Any notice shall be deemed duly given when sent via email or when sent by certified mail (return receipt requested)
and deposited (with postage prepaid) in a post office or branch post office regularly maintained by the United States Postal Service. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.8
<U>Participant&#146;s Representations</U>. If the Shares issuable hereunder have not been registered under the Securities Act or any applicable state laws on an effective registration statement at the time of such issuance, the Participant shall, if
required by the Company, concurrently with such issuance, make such written representations as are deemed necessary or appropriate by the Company or its counsel. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.9 <U>Titles</U>. Titles are provided herein for convenience only and are not to serve as a basis for interpretation or construction of this
Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.10 <U>Governing Law</U>. The laws of the State of Delaware shall govern the interpretation, validity, administration,
enforcement and performance of the terms of this Agreement regardless of the law that might be applied under principles of conflicts of laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.11 <U>Conformity to Securities Laws</U>. The Participant acknowledges that the Plan and this Agreement are intended to conform to the extent
necessary with all provisions of the Securities Act and the Exchange Act, and any and all Applicable Law. Notwithstanding anything herein to the contrary, the Plan shall be administered, and the Award is granted, only in such a manner as to conform
to such Applicable Law. To the extent permitted by Applicable Law, the Plan and this Agreement shall be deemed amended to the extent necessary to conform to such Applicable Law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.12 <U>Amendment, Suspension and Termination</U>. To the extent permitted by the Plan, this Agreement may be wholly or partially amended or
otherwise modified, suspended or terminated at any time or from time to time by the Administrator or the Board;<I> provided, however</I>, that, except as may otherwise be provided by the Plan, no amendment, modification, suspension or termination of
this Agreement shall adversely affect the Award in any material way without the prior written consent of the Participant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.13 <U>Successors and Assigns</U>. The Company or any Subsidiary may assign any of its
rights under this Agreement to single or multiple assignees, and this Agreement shall inure to the benefit of the successors and assigns of the Company and its Subsidiaries. Subject to the restrictions on transfer set forth in Section&nbsp;3.3
hereof, this Agreement shall be binding upon the Participant and his or her heirs, executors, administrators, successors and assigns. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.14 <U>Limitations Applicable to Section</U><U></U><U>&nbsp;16 Persons</U>. Notwithstanding any other provision of the Plan or this
Agreement, if the Participant is subject to Section&nbsp;16 of the Exchange Act, then the Plan, the Award and this Agreement shall be subject to any additional limitations set forth in any applicable exemptive rule under Section&nbsp;16 of the
Exchange Act (including any amendment to Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> of the Exchange Act) that are requirements for the application of such exemptive rule. To the extent permitted by applicable law, this Agreement shall be
deemed amended to the extent necessary to conform to such applicable exemptive rule. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.15 <U>Not a Contract of Service Relationship</U>.
Nothing in this Agreement or in the Plan shall confer upon the Participant any right to continue to serve as an Employee or other service provider of the Company or any of its Subsidiaries or shall interfere with or restrict in any way the rights of
the Company and its Subsidiaries, which rights are hereby expressly reserved, to discharge or terminate the services of the Participant at any time for any reason whatsoever, with or without cause, except to the extent expressly provided otherwise
in a written agreement between the Company or a Subsidiary and the Participant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.16 <U>Entire Agreement</U>. The Plan, the Grant Notice
and this Agreement (including all Exhibits thereto, if any) constitute the entire agreement of the parties and supersede in their entirety all prior undertakings and agreements of the Company and its Subsidiaries and the Participant with respect to
the subject matter hereof, provided that the Shares shall be subject to any accelerated vesting provisions in any written agreement between the Participant and the Company or a Company plan pursuant to which the Participant participates, in each
case, in accordance with the terms therein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.17 <U>Limitation on the Participant&#146;s Rights</U>. Participation in the Plan confers no
rights or interests other than as herein provided. This Agreement creates only a contractual obligation on the part of the Company as to amounts payable and shall not be construed as creating a trust. Neither the Plan nor any underlying program, in
and of itself, has any assets. The Participant shall have only the rights of a general unsecured creditor of the Company and its Subsidiaries with respect to amounts credited and benefits payable, if any, with respect to the Shares issuable
hereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">*&nbsp;&nbsp;&nbsp;&nbsp; *&nbsp;&nbsp;&nbsp;&nbsp;*&nbsp;&nbsp;&nbsp;&nbsp;*&nbsp;&nbsp;&nbsp;&nbsp;* </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-4 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4(D)
<SEQUENCE>12
<FILENAME>d60414dex104d.htm
<DESCRIPTION>EX-10.4(D)
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.4(d)</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.4(d) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SANA BIOTECHNOLOGY, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2021 INCENTIVE AWARD PLAN </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RESTRICTED STOCK UNIT AWARD GRANT NOTICE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Sana Biotechnology, Inc., a Delaware corporation, (the &#147;<B><I>Company</I></B>&#148;), pursuant to its 2021 Incentive Award Plan, as
amended from time to time (the &#147;<B><I>Plan</I></B>&#148;), hereby grants to the holder listed below (the &#147;<B><I>Participant</I></B>&#148;), an award of restricted stock units (&#147;<B><I>Restricted Stock Units</I></B>&#148;<B>
</B>or<B><I> </I></B>&#147;<B><I>RSUs</I></B>&#148;). Each vested Restricted Stock Unit represents the right to receive, in accordance with the Restricted Stock Unit Award Agreement attached hereto as <B>Exhibit A</B> (the
&#147;<B><I>Agreement</I></B>&#148;), one share of Common Stock (&#147;<B><I>Share</I></B>&#148;). This award of Restricted Stock Units is subject to all of the terms and conditions set forth herein and in the Agreement and the Plan, each of which
are incorporated herein by reference. Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in this Restricted Stock Unit Award Grant Notice (the &#147;<B><I>Grant Notice</I></B>&#148;) and the
Agreement. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt" ALIGN="center">


<TR>

<TD WIDTH="26%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="72%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><FONT STYLE="font-size:11pt"><B>Participant:</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[__________________________]</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><FONT STYLE="font-size:11pt"><B>Grant Date:</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[__________________________]</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><FONT STYLE="font-size:11pt"><B>Total Number of RSUs:</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[_____________]</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><FONT STYLE="font-size:11pt"><B>Vesting&nbsp;Commencement&nbsp;Date:</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[_____________]</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><FONT STYLE="font-size:11pt"><B>Vesting Schedule:</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">[_____________]</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><FONT STYLE="font-size:11pt"><B>Termination:</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">If the Participant experiences a Termination of Service, all RSUs that have not become vested on or prior to the date of such Termination of Service will thereupon be automatically forfeited by the Participant without payment of
any consideration therefor.</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">By his or her signature and the Company&#146;s signature below, the Participant agrees to be bound by the
terms and conditions of the Plan, the Agreement and this Grant Notice. The Participant has reviewed the Plan, the Agreement and this Grant Notice in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Grant
Notice and fully understands all provisions of the Plan, the Agreement and this Grant Notice. The Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Administrator upon any questions arising
under the Plan, the Agreement or this Grant Notice. In addition, by signing below, the Participant also agrees that the Company, in its sole discretion, may satisfy any withholding obligations in accordance with Section&nbsp;2.6(b) of the Agreement
by (i)&nbsp;withholding shares of Common Stock otherwise issuable to the Participant upon vesting of the RSUs, (ii)&nbsp;instructing a broker on the Participant&#146;s behalf to sell shares of Common Stock otherwise issuable to the Participant upon
vesting of the RSUs and submit the proceeds of such sale to the Company, or (iii)&nbsp;using any other method permitted by Section&nbsp;2.6(b) of the Agreement or the Plan. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>SANA BIOTECHNOLOGY, INC.:</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>&nbsp;&nbsp;&nbsp;&nbsp;PARTICIPANT:</B></TD></TR></TABLE>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="37%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="37%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Print&nbsp;Name:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Print&nbsp;Name:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Address:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Address:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT A </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TO RESTRICTED STOCK UNIT AWARD GRANT NOTICE </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RESTRICTED STOCK UNIT AWARD AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the Restricted Stock Unit Award Grant Notice (the &#147;<B><I>Grant Notice</I></B>&#148;) to which this Restricted Stock Unit
Award Agreement (this &#147;<B><I>Agreement</I></B>&#148;) is attached, Sana Biotechnology, Inc., a Delaware corporation (the &#147;<B><I>Company</I></B>&#148;), has granted to the Participant the number of restricted stock units
(&#147;<B><I>Restricted Stock Units</I></B>&#148;<B> </B>or<B><I> </I></B>&#147;<B><I>RSUs</I></B>&#148;) set forth in the Grant Notice under the Company&#146;s 2021 Incentive Award Plan, as amended from time to time (the
&#147;<B><I>Plan</I></B>&#148;). Each Restricted Stock Unit represents the right to receive one share of Common Stock (a &#147;<B><I>Share</I></B>&#148;) upon vesting. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE I. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>GENERAL
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.1 <U>Defined Terms</U>. Capitalized terms not specifically defined herein shall have the meanings specified in the Plan and the
Grant Notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1.2 <U>Incorporation of Terms of Plan</U>. The RSUs are subject to the terms and conditions of the Plan, which are
incorporated herein by reference. In the event of any inconsistency between the Plan and this Agreement, the terms of the Plan shall control. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE II. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>GRANT OF
RESTRICTED STOCK UNITS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.1 <U>Grant of RSUs</U>. Pursuant to the Grant Notice and upon the terms and conditions set forth in the Plan
and this Agreement, effective as of the Grant Date set forth in the Grant Notice, the Company hereby grants to the Participant an award of RSUs under the Plan in consideration of the Participant&#146;s past or continued employment with or service to
the Company or any Subsidiaries and for other good and valuable consideration. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.2 <U>Unsecured Obligation to RSUs</U>. Unless and until
the RSUs have vested in the manner set forth in Article 2 hereof, the Participant will have no right to receive Common Stock under any such RSUs. Prior to actual payment of any vested RSUs, such RSUs will represent an unsecured obligation of the
Company, payable (if at all) only from the general assets of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.3 <U>Vesting Schedule</U>. Subject to Section&nbsp;2.5
hereof, the RSUs shall vest and become nonforfeitable with respect to the applicable portion thereof according to the vesting schedule set forth in the Grant Notice (rounding down to the nearest whole Share). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.4 <U>Consideration to the Company</U>. In consideration of the grant of the award of RSUs pursuant hereto, the Participant agrees to render
faithful and efficient services to the Company or any Subsidiary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.5 <U>Forfeiture, Termination and Cancellation upon Termination of
Service</U>. Notwithstanding any contrary provision of this Agreement or the Plan, upon the Participant&#146;s Termination of Service for any or no reason, all Restricted Stock Units which have not vested prior to or in connection with such
Termination of Service shall thereupon automatically be forfeited, terminated and cancelled as of the applicable termination date without payment of any consideration by the Company, and the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Participant, or the Participant&#146;s beneficiary or personal representative, as the case may be, shall have no further rights hereunder. No portion of the RSUs which has not become vested as of
the date on which the Participant incurs a Termination of Service shall thereafter become vested, except as may otherwise be provided by the Administrator or as set forth in a written agreement between the Company and the Participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.6 <U>Issuance of Common Stock upon Vesting</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) As soon as administratively practicable following the vesting of any Restricted Stock Units pursuant to Section&nbsp;2.3 hereof, but in no
event later than 30 days after such vesting date (for the avoidance of doubt, this deadline is intended to comply with the &#147;short term deferral&#148; exemption from Section&nbsp;409A of the Code), the Company shall deliver to the Participant
(or any transferee permitted under Section&nbsp;3.2 hereof) a number of Shares equal to the number of RSUs subject to this Award that vest on the applicable vesting date. Notwithstanding the foregoing, in the event Shares cannot be issued pursuant
to Section&nbsp;10.7 of the Plan, the Shares shall be issued pursuant to the preceding sentence as soon as administratively practicable after the Administrator determines that Shares can again be issued in accordance with such Section. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) As set forth in Section&nbsp;10.5 of the Plan, the Company shall have the authority and the right to deduct or withhold, or to require the
Participant to remit to the Company, an amount sufficient to satisfy all applicable federal, state and local taxes required by law to be withheld with respect to any taxable event arising in connection with the Restricted Stock Units. The Company
shall not be obligated to deliver any Shares to the Participant or the Participant&#146;s legal representative unless and until the Participant or the Participant&#146;s legal representative shall have paid or otherwise satisfied in full the amount
of all federal, state and local taxes applicable to the taxable income of the Participant resulting from the grant or vesting of the Restricted Stock Units or the issuance of Shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.7 <U>Conditions to Delivery of Shares</U>. The Shares deliverable hereunder may be either previously authorized but unissued Shares,
treasury Shares or issued Shares which have then been reacquired by the Company. Such Shares shall be fully paid and nonassessable. The Company shall not be required to issue Shares deliverable hereunder prior to fulfillment of the conditions set
forth in Section&nbsp;10.7 of the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.8 <U>Rights as Stockholder</U>. The holder of the RSUs shall not be, nor have any of the rights
or privileges of, a stockholder of the Company, including, without limitation, voting rights and rights to dividends, in respect of the RSUs and any Shares underlying the RSUs and deliverable hereunder unless and until such Shares shall have been
issued by the Company and held of record by such holder (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company). No adjustment shall be made for a dividend or other right for which
the record date is prior to the date the Shares are issued, except as provided in Article IX of the Plan. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE III. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OTHER PROVISIONS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1
<U>Administration</U>. The Administrator shall have the power to interpret the Plan and this Agreement and to adopt such rules for the administration, interpretation and application of the Plan as are consistent therewith and to interpret, amend or
revoke any such rules. All actions taken and all interpretations and determinations made by the Administrator in good faith shall be final and binding upon the Participant, the Company and all other interested persons. No member of the Administrator
or the Board shall be personally liable for any action, determination or interpretation made in good faith with respect to the Plan, this Agreement or the RSUs. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.2 <U>Transferability</U>. The RSUs shall be subject to the restrictions on transferability
set forth in Section&nbsp;10.1 of the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.3 <U>Tax Consultation</U>. The Participant understands that the Participant may suffer
adverse tax consequences in connection with the RSUs granted pursuant to this Agreement (and the Shares issuable with respect thereto). The Participant represents that the Participant has consulted with any tax consultants the Participant deems
advisable in connection with the RSUs and the issuance of Shares with respect thereto and that the Participant is not relying on the Company for any tax advice. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.4 <U>Binding Agreement</U>. Subject to the limitation on the transferability of the RSUs contained herein, this Agreement will be binding
upon and inure to the benefit of the heirs, legatees, legal representatives, successors and assigns of the parties hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.5
<U>Adjustments Upon Specified Events</U>. The Administrator may accelerate the vesting of the RSUs in such circumstances as it, in its sole discretion, may determine. The Participant acknowledges that the RSUs are subject to adjustment, modification
and termination in certain events as provided in this Agreement and Article IX of the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.6 <U>Notices</U>. Any notice to be given
under the terms of this Agreement to the Company shall be addressed to the Company in care of the Secretary of the Company at the Company&#146;s principal office, and any notice to be given to the Participant shall be addressed to the Participant at
the Participant&#146;s last address reflected on the Company&#146;s records. By a notice given pursuant to this Section&nbsp;3.6, either party may hereafter designate a different address for notices to be given to that party. Any notice shall be
deemed duly given when sent via email or when sent by certified mail (return receipt requested) and deposited (with postage prepaid) in a post office or branch post office regularly maintained by the United States Postal Service. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.7 <U>Participant&#146;s Representations</U>. If the Shares issuable hereunder have not been registered under the Securities Act or any
applicable state laws on an effective registration statement at the time of such issuance, the Participant shall, if required by the Company, concurrently with such issuance, make such written representations as are deemed necessary or appropriate
by the Company or its counsel. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.8 <U>Titles</U>. Titles are provided herein for convenience only and are not to serve as a basis for
interpretation or construction of this Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.9 <U>Governing Law</U>. The laws of the State of Delaware shall govern the
interpretation, validity, administration, enforcement and performance of the terms of this Agreement regardless of the law that might be applied under principles of conflicts of laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.10 <U>Conformity to Securities Laws</U>. The Participant acknowledges that the Plan and this Agreement are intended to conform to the extent
necessary with all provisions of the Securities Act and the Exchange Act and any other Applicable Law. Notwithstanding anything herein to the contrary, the Plan shall be administered, and the RSUs are granted, only in such a manner as to conform to
Applicable Law. To the extent permitted by Applicable Law, the Plan and this Agreement shall be deemed amended to the extent necessary to conform to such Applicable Law. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.11 <U>Amendment, Suspension and Termination</U>. To the extent permitted by the Plan, this
Agreement may be wholly or partially amended or otherwise modified, suspended or terminated at any time or from time to time by the Administrator or the Board; <I>provided, however,</I> that, except as may otherwise be provided by the Plan, no
amendment, modification, suspension or termination of this Agreement shall adversely affect the RSUs in any material way without the prior written consent of the Participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.12 <U>Successors and Assigns</U>. The Company may assign any of its rights under this Agreement to single or multiple assignees, and this
Agreement shall inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer herein set forth in Section&nbsp;3.2 hereof, this Agreement shall be binding upon the Participant and his or her heirs,
executors, administrators, successors and assigns. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.13 <U>Limitations Applicable to Section</U><U></U><U>&nbsp;16 Persons</U>.
Notwithstanding any other provision of the Plan or this Agreement, if the Participant is subject to Section&nbsp;16 of the Exchange Act, then the Plan, the RSUs and this Agreement shall be subject to any additional limitations set forth in any
applicable exemptive rule under Section&nbsp;16 of the Exchange Act (including any amendment to Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> of the Exchange Act) that are requirements for the application of such exemptive rule. To the extent
permitted by Applicable Law, this Agreement shall be deemed amended to the extent necessary to conform to such applicable exemptive rule. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.14 <U>Not a Contract of Service Relationship</U>. Nothing in this Agreement or in the Plan shall confer upon Participant any right to
continue to serve as an employee or other service provider of the Company or any of its Subsidiaries or interfere with or restrict in any way with the right of the Company or any of its Subsidiaries, which rights are hereby expressly reserved, to
discharge or to terminate for any reason whatsoever, with or without cause, the services of the Participant at any time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.15 <U>Entire
Agreement</U>. The Plan, the Grant Notice and this Agreement (including all Exhibits thereto, if any) constitute the entire agreement of the parties and supersede in their entirety all prior undertakings and agreements of the Company and the
Participant with respect to the subject matter hereof, provided that the RSUs shall be subject to any accelerated vesting provisions in any written agreement between the Participant and the Company or a Company plan pursuant to which the Participant
participates, in each case, in accordance with the terms therein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.16 <U>Section 409A</U>. This Award is not intended to constitute
&#147;nonqualified deferred compensation&#148; within the meaning of Section&nbsp;409A of the Code (together with any Department of Treasury regulations and other interpretive guidance issued thereunder, including without limitation any such
regulations or other guidance that may be issued after the date hereof, &#147;<B><I>Section</I></B><B><I></I></B><B><I>&nbsp;409A</I></B>&#148;). However, notwithstanding any other provision of the Plan, the Grant Notice or this Agreement, if at any
time the Administrator determines that this Award (or any portion thereof) may be subject to Section&nbsp;409A, the Administrator shall have the right in its sole discretion (without any obligation to do so or to indemnify Participant or any other
person for failure to do so) to adopt such amendments to the Plan, the Grant Notice or this Agreement, or adopt other policies and procedures (including amendments, policies and procedures with retroactive effect), or take any other actions, as the
Administrator determines are necessary or appropriate for this Award either to be exempt from the application of Section&nbsp;409A or to comply with the requirements of Section&nbsp;409A. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.17 <U>Limitation on Participant&#146;s Rights</U>. Participation in the Plan confers no rights or interests other than as herein provided.
This Agreement creates only a contractual obligation on the part of the Company as to amounts payable and shall not be construed as creating a trust. Neither the Plan nor any underlying program, in and of itself, has any assets. The Participant
shall have only the rights of a general unsecured creditor of the Company and its Subsidiaries with respect to amounts credited and benefits payable, if any, with respect to the RSUs, and rights no greater than the right to receive the Common Stock
as a general unsecured creditor with respect to RSUs, as and when payable hereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">*&nbsp;&nbsp;&nbsp;&nbsp; *&nbsp;&nbsp;&nbsp;&nbsp;
*&nbsp;&nbsp;&nbsp;&nbsp; *&nbsp;&nbsp;&nbsp;&nbsp; * </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-4 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>13
<FILENAME>d60414dex105.htm
<DESCRIPTION>EX-10.5
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.5</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.5 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SANA BIOTECHNOLOGY, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>2021 EMPLOYEE STOCK PURCHASE PLAN </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 1 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PURPOSE
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Plan&#146;s purpose is to assist employees of the Company and its Designated Subsidiaries in acquiring a stock ownership interest in the Company,
and to help such employees provide for their future security and to encourage them to remain in the employment of the Company and its Subsidiaries. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The
Plan consists of two components: the Section&nbsp;423 Component and the <FONT STYLE="white-space:nowrap">Non-Section</FONT> 423 Component. The Section&nbsp;423 Component is intended to qualify as an &#147;employee stock purchase plan&#148; under
Section&nbsp;423 of the Code and shall be administered, interpreted and construed in a manner consistent with the requirements of Section&nbsp;423 of the Code. In addition, this Plan authorizes the grant of Options under the <FONT
STYLE="white-space:nowrap">Non-Section</FONT> 423 Component, which need not qualify as Options granted pursuant to an &#147;employee stock purchase plan&#148; under Section&nbsp;423 of the Code; such Options granted under the <FONT
STYLE="white-space:nowrap">Non-Section</FONT> 423 Component shall be granted pursuant to separate Offerings containing such <FONT STYLE="white-space:nowrap">sub-plans,</FONT> appendices, rules or procedures as may be adopted by the Administrator and
designed to achieve tax, securities laws or other objectives for Eligible Employees and the Designated Subsidiaries in locations outside of the United States. Except as otherwise provided herein, the
<FONT STYLE="white-space:nowrap">Non-Section</FONT> 423 Component will operate and be administered in the same manner as the Section&nbsp;423 Component. Offerings intended to be made under the <FONT STYLE="white-space:nowrap">Non-Section</FONT> 423
Component will be designated as such by the Administrator at or prior to the time of such Offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of this Plan, the Administrator may
designate separate Offerings under the Plan, the terms of which need not be identical, in which Eligible Employees will participate, even if the dates of the applicable Offering Period(s) in each such Offering is identical, provided that the terms
of participation are the same within each separate Offering under the Section&nbsp;423 Component as determined under Section&nbsp;423 of the Code. Solely by way of example and without limiting the foregoing, the Company could, but shall not be
required to, provide for simultaneous Offerings under the Section&nbsp;423 Component and the <FONT STYLE="white-space:nowrap">Non-Section</FONT> 423 Component of the Plan. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 2 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>DEFINITIONS
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As used in the Plan, the following words and phrases have the meanings specified below, unless the context clearly indicates otherwise: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.1 &#147;<B><I>Administrator</I></B>&#148; means the Committee, or such individuals to which authority to administer the Plan has been
delegated under Section&nbsp;7.1 hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.2 &#147;<B><I>Agent</I></B>&#148; means the brokerage firm, bank or other financial
institution, entity or person(s), if any, engaged, retained, appointed or authorized to act as the agent of the Company or an Employee with regard to the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.3 &#147;<B><I>Board</I></B>&#148; means the Board of Directors of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.4 &#147;<B><I>Code</I></B>&#148; means the U.S. Internal Revenue Code of 1986, as amended, and all regulations, guidance, compliance
programs and other interpretative authority issued thereunder. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.5 &#147;<B><I>Committee</I></B>&#148; means the Compensation Committee of the Board. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.6 &#147;<B><I>Common Stock</I></B>&#148; means the common stock of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.7 &#147;<B><I>Company</I></B>&#148; means Sana Biotechnology, Inc., a Delaware corporation, or any successor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.8 &#147;<B><I>Compensation</I></B>&#148; of an Employee means the regular earnings or base salary, bonuses and commissions paid to the
Employee from the Company on each Payday as compensation for services to the Company or any Designated Subsidiary, before deduction for any salary deferral contributions made by the Employee to any
<FONT STYLE="white-space:nowrap">tax-qualified</FONT> or nonqualified deferred compensation plan, including overtime, shift differentials, vacation pay, salaried production schedule premiums, holiday pay, jury duty pay, funeral leave pay, paid time
off, military pay, prior week adjustments and weekly bonus, but excluding education or tuition reimbursements, imputed income arising under any group insurance or benefit program, travel expenses, business and moving reimbursements, including tax
gross ups and taxable mileage allowance, income received in connection with any stock options, restricted stock, restricted stock units or other compensatory equity awards and all contributions made by the Company or any Designated Subsidiary for
the Employee&#146;s benefit under any employee benefit plan now or hereafter established. Such Compensation shall be calculated before deduction of any income or employment tax withholdings, but shall be withheld from the Employee&#146;s net income.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.9 &#147;<B><I>Designated Subsidiary</I></B>&#148; means each Subsidiary, including any Subsidiary in existence on the Effective Date
and any Subsidiary formed or acquired following the Effective Date, that has been designated by the Board or Committee from time to time in its sole discretion as eligible to participate in the Plan, in accordance with Section&nbsp;7.2 hereof, such
designation to specify whether such participation is in the Section&nbsp;423 Component or <FONT STYLE="white-space:nowrap">Non-Section</FONT> 423 Component. A Designated Subsidiary may participate in either the Section&nbsp;423 Component or <FONT
STYLE="white-space:nowrap">Non-Section</FONT> 423 Component, but not both. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.10 &#147;<B><I>Effective Date</I></B>&#148; means the date
immediately prior to the date the Company&#146;s registration statement relating to its initial public offering becomes effective, <I>provided</I> that the Board has adopted the Plan prior to or on such date, subject to approval of the Plan by the
Company&#146;s stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.11 &#147;<B><I>Eligible Employee</I></B>&#148; means an Employee: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) who is customarily scheduled to work at least 20 hours per week; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) whose customary employment is more than five months in a calendar year; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) who, after the granting of the Option, would not be deemed for purposes of Section&nbsp;423(b)(3) of the Code to possess 5% or more of the
total combined voting power or value of all classes of stock of the Company or any Subsidiary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of clause (c), the rules of
Section&nbsp;424(d) of the Code with regard to the attribution of stock ownership shall apply in determining the stock ownership of an individual, and stock which an Employee may purchase under outstanding options shall be treated as stock owned by
the Employee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, the Administrator may exclude from participation in the Section&nbsp;423 Component as an Eligible Employee:
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(x) any Employee that is a &#147;highly compensated employee&#148; of the Company or any Designated Subsidiary (within the meaning of
Section&nbsp;414(q) of the Code), or that is such a &#147;highly compensated employee&#148; (A) with compensation above a specified level, (B)&nbsp;who is an officer or (C)&nbsp;who is subject to the disclosure requirements of Section&nbsp;16(a) of
the Exchange Act; or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(y) any Employee who is a citizen or resident of a foreign jurisdiction (without regard to
whether they are also a citizen of the United States or a resident alien (within the meaning of Section&nbsp;7701(b)(1)(A) of the Code)) if either (A)&nbsp;the grant of the Option is prohibited under the laws of the jurisdiction governing such
Employee, or (B)&nbsp;compliance with the laws of the foreign jurisdiction would cause the Section&nbsp;423 Component, any Offering thereunder or an Option granted thereunder to violate the requirements of Section&nbsp;423 of the Code; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>provided</I> that any exclusion in clauses (x)&nbsp;or (y) shall be applied in an identical manner under each Offering to all Employees of the Company and
all Designated Subsidiaries, in accordance with Treas. Reg. &#167; <FONT STYLE="white-space:nowrap">1.423-2(e).</FONT> Further notwithstanding the foregoing, with respect to the <FONT STYLE="white-space:nowrap">Non-Section</FONT> 423 Component, the
first sentence in this definition shall apply in determining who is an &#147;Eligible Employee,&#148; except (a)&nbsp;the Administrator may limit eligibility further within the Company or a Designated Subsidiary so as to only designate some
Employees of the Company or a Designated Subsidiary as Eligible Employees, and (b)&nbsp;to the extent the restrictions in the first sentence in this definition are not consistent with applicable local laws, the applicable local laws shall control.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.12 &#147;<B><I>Employee</I></B>&#148; means any person who renders services to the Company or a Designated Subsidiary in the status of
an employee within the meaning of Section&nbsp;3401(c) of the Code. &#147;Employee&#148; shall not include any director of the Company or a Designated Subsidiary who does not render services to the Company or a Designated Subsidiary in the status of
an employee within the meaning of Section&nbsp;3401(c) of the Code. For purposes of the Plan, the employment relationship shall be treated as continuing intact while the individual is on military leave, sick leave or other leave of absence approved
by the Company or a Designated Subsidiary and meeting the requirements of Treas. Reg. &#167; <FONT STYLE="white-space:nowrap">1.421-1(h)(2).</FONT> Where the period of leave exceeds three months, or such other period specified in Treas. Reg. &#167; <FONT
STYLE="white-space:nowrap">1.421-1(h)(2),</FONT> and the individual&#146;s right to reemployment is not guaranteed either by statute or by contract, the employment relationship shall be deemed to have terminated on the first day immediately
following such three-month period, or such other period specified in Treas. Reg. &#167; <FONT STYLE="white-space:nowrap">1.421-1(h)(2).</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.13 &#147;<B><I>Enrollment Date</I></B>&#148; means the first date of each Offering Period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.14 &#147;<B><I>Exercise Date</I></B>&#148; means the last day of each Purchase Period, except as provided in Section&nbsp;5.2 hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.15 &#147;<B><I>Exchange Act</I></B>&#148; means the Securities Exchange Act of 1934, as amended. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.16 &#147;<B><I>Fair Market Value</I></B>&#148; means, as of any date, the value of Common Stock determined as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) If the Common Stock is (i)&nbsp;listed on any established securities exchange (such as the New York Stock Exchange or Nasdaq Stock Market),
(ii) listed on any national market system or (iii)&nbsp;listed, quoted or traded on any automated quotation system, its Fair Market Value shall be the closing sales price for a share of Common Stock as quoted on such exchange or system for such date
or, if there is no closing sales price for a share of Common Stock on the date in question, the closing sales price for a share of Common Stock on the last preceding date for which such quotation exists, as reported in <I>The Wall Street Journal</I>
or such other source as the Administrator deems reliable; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) If the Common Stock is not listed on an established securities exchange, national market
system or automated quotation system, but the Common Stock is regularly quoted by a recognized securities dealer, its Fair Market Value shall be the mean of the high bid and low asked prices for such date or, if there are no high bid and low asked
prices for a share of Common Stock on such date, the high bid and low asked prices for a share of Common Stock on the last preceding date for which such information exists, as reported in <I>The Wall Street Journal</I> or such other source as the
Administrator deems reliable; or </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) If the Common Stock is neither listed on an established securities exchange, national market system
or automated quotation system nor regularly quoted by a recognized securities dealer, its Fair Market Value shall be established by the Administrator in good faith. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, the Fair Market Value on the Initial Grant Date shall be initial public offering price of a share as set forth in the
Company&#146;s final prospectus relating to its initial public offering filed with the U.S. Securities and Exchange Commission. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.17
&#147;<B><I>Grant Date</I></B>&#148; means the first day of an Offering Period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.18 &#147;<B><I>Initial Grant Date</I></B>&#148; means
the date the Company&#146;s registration statement relating to its initial public offering becomes effective, provided that the Board has adopted, and the stockholders approved, the Plan prior to or on such date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.19 &#147;<B><I>New Exercise Date</I></B>&#148; has the meaning set forth in Section&nbsp;5.2(b) hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.20 &#147;<B><I><FONT STYLE="white-space:nowrap">Non-Section</FONT> 423 Component</I></B>&#148; means those Offerings under the Plan,
together with the <FONT STYLE="white-space:nowrap">sub-plans,</FONT> appendices, rules or procedures, if any, adopted by the Administrator as a part of this Plan, in each case, pursuant to which Options may be granted to <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> Eligible Employees that need not satisfy the requirements for Options granted pursuant to an &#147;employee stock purchase plan&#148; that are set forth under Section&nbsp;423 of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.21 &#147;<B><I>Offering</I></B>&#148; means an offer under the Plan of an Option that may be exercised during an Offering Period as further
described in Section&nbsp;4 hereof. Unless otherwise specified by the Administrator, each Offering to the Eligible Employees of the Company or a Designated Subsidiary shall be deemed a separate Offering, even if the dates and other terms of the
applicable Exercise Periods of each such Offering are identical and the provisions of the Plan will separately apply to each Offering. To the extent permitted by Treas. Reg. &#167; <FONT STYLE="white-space:nowrap">1.423-2(a)(1),</FONT> the terms of
each separate Offering under the Section&nbsp;423 Component need not be identical, provided that the terms of the Section&nbsp;423 Component and an Offering thereunder together satisfy Treas. Reg. &#167;
<FONT STYLE="white-space:nowrap">1.423-2(a)(2)</FONT> and (a)(3). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.22 &#147;<B><I>Offering Period</I></B>&#148;<SUP
STYLE="font-size:85%; vertical-align:top"> </SUP>means each consecutive, overlapping twenty-four (24)&nbsp;month period commencing on each May&nbsp;16 and November&nbsp;16, and with respect to which Options shall be granted to Participants,
provided, that the first Offering Period (the &#147;<B><I>Initial Offering Period</I></B>&#148;) shall commence on the Initial Grant Date and shall end on November&nbsp;15, 2022. The duration and timing of Offering Periods may be established or
changed by the Board or Committee at any time, in its sole discretion. Notwithstanding the foregoing, in no event may an Offering Period exceed 27 months. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.23 &#147;<B><I>Option</I></B>&#148; means the right to purchase shares of Common Stock pursuant to the Plan during each Offering Period.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.24 &#147;<B><I>Option Price</I></B>&#148; means the purchase price of a share of Common Stock hereunder as provided in Section&nbsp;4.2
hereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.25 &#147;<B><I>Parent</I></B>&#148; means any entity that is a parent corporation of the
Company within the meaning of Section&nbsp;424 of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.26 &#147;<B><I>Participant</I></B>&#148; means any Eligible Employee who
elects to participate in the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.27 &#147;<B><I>Payday</I></B>&#148; means the regular and recurring established day for payment of
Compensation to an Employee of the Company or any Designated Subsidiary. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.28 &#147;<B><I>Plan</I></B>&#148; means this 2021 Employee
Stock Purchase Plan, including both the Section&nbsp;423 Component and <FONT STYLE="white-space:nowrap">Non-Section</FONT> 423 Component and any other <FONT STYLE="white-space:nowrap">sub-plans</FONT> or appendices hereto, as amended from time to
time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.29 &#147;<B><I>Plan Account</I></B>&#148; means a bookkeeping account established and maintained by the Company in the name of
each Participant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.30 &#147;<B><I>Purchase Period</I></B>&#148; means each consecutive six (6)-month period commencing on each
May&nbsp;16 and November&nbsp;16 within each Offering Period, provided that the first Purchase Period hereunder shall commence under the Initial Offering Period on the Initial Grant Date and end on November&nbsp;15, 2021 (the &#147;<B><I>Initial
Purchase Period</I></B>&#148;). The first Purchase Period of each Offering Period shall commence on the Grant Date and end with the next Exercise Date, within each Offering Period. The duration and timing of Purchase Periods may be established or
changed by the Board or Committee at any time, in its sole discretion. Notwithstanding the foregoing, in no event may a Purchase Period exceed the duration of the Offering Period under which it is established. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.31 &#147;<B><I>Section</I></B><B><I></I></B><B><I>&nbsp;409A</I></B>&#148; means Section&nbsp;409A of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.32 &#147;<B><I>Section</I></B><B><I></I></B><B><I>&nbsp;423 Component</I></B>&#148; means those Offerings under the Plan that are intended
to meet the requirements under Section&nbsp;423(b) of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.33 &#147;<B><I>Subsidiary</I></B>&#148; means any entity that is a
subsidiary corporation of the Company within the meaning of Section&nbsp;424 of the Code. In addition, with respect to the <FONT STYLE="white-space:nowrap">Non-Section</FONT> 423 Component, Subsidiary shall include any corporate or noncorporate
entity in which the Company has a direct or indirect equity interest or significant business relationship. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.34 &#147;<B><I>Treas.
Reg.</I></B>&#148; means U.S. Department of the Treasury regulations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.35 &#147;<B><I>Withdrawal Election</I></B>&#148; has the meaning
set forth in Section&nbsp;6.1(a) hereof. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 3 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PARTICIPATION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1
<U>Eligibility</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Any Eligible Employee who is employed by the Company or a Designated Subsidiary on a given Enrollment Date for an
Offering Period shall be eligible to participate in the Plan during such Offering Period, subject to the requirements of Articles 4 and 5 hereof, and, for the Section&nbsp;423 Component, the limitations imposed by Section&nbsp;423(b) of the Code.
Notwithstanding the foregoing, each Eligible Employee who is employed by the Company or a Designated Subsidiary on the Initial Grant Date shall be eligible to participate in the Initial Offering Period, subject to the requirements of Articles 4 and
5 hereof, and, for the Section&nbsp;423 Component, the limitations imposed by Section&nbsp;423(b) of the Code. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) No Eligible Employee shall be granted an Option under the Section&nbsp;423 Component
which permits the Participant&#146;s rights to purchase shares of Common Stock under the Plan, and to purchase stock under all other employee stock purchase plans of the Company, any Parent or any Subsidiary subject to Section&nbsp;423 of the Code,
to accrue at a rate which exceeds $25,000 of fair market value of such stock (determined at the time such Option is granted) for each calendar year in which such Option is outstanding at any time. The limitation under this Section&nbsp;3.1(b) shall
be applied in accordance with Section&nbsp;423(b)(8) of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.2 <U>Election to Participate; Payroll Deductions</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Except as provided in Sections 3.2(e) and 3.3 hereof, an Eligible Employee may become a Participant in the Plan only by means of payroll
deduction. Each individual who is an Eligible Employee as of an Offering Period&#146;s Enrollment Date may elect to participate in such Offering Period and the Plan by delivering to the Company a payroll deduction authorization no later than the
period of time prior to (i)&nbsp;the applicable Enrollment Date or (ii)&nbsp;solely in respect of the Initial Offering Period, the last day of the Initial Purchase Period, in each case, that is determined by the Administrator, in its sole
discretion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) Subject to Section&nbsp;3.1(b) hereof and except as may otherwise be determined by the Administrator, payroll deductions
(i)&nbsp;shall equal at least 1% of the Participant&#146;s Compensation as of each Payday of the Offering Period following the Enrollment Date, but not more than 15%<B> </B>of the Participant&#146;s Compensation as of each Payday of the Offering
Period following the Enrollment Date; and (ii)&nbsp;may be expressed either as (A)&nbsp;a whole number percentage, or (B)&nbsp;a fixed dollar amount. Amounts deducted from a Participant&#146;s Compensation with respect to an Offering Period pursuant
to this Section&nbsp;3.2 shall be deducted each Payday through payroll deduction and credited to the Participant&#146;s Plan Account; provided that for the Initial Offering Period, payroll deductions shall not begin until such date determined by the
Board or Committee, in its sole discretion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Following at least one payroll deduction, a Participant may decrease (to as low as zero)
the amount deducted from such Participant&#146;s Compensation only once during an Offering Period upon ten calendar days&#146; prior written notice to the Company. After the Initial Offering Period, a Participant may not increase the amount deducted
from such Participant&#146;s Compensation during an Offering Period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Upon the completion of an Offering Period, each Participant in
such Offering Period shall automatically participate in the immediately following Offering Period at the same payroll deduction percentage or fixed amount as in effect at the termination of such Offering Period, unless such Participant delivers to
the Company a different election with respect to the successive Offering Period in accordance with Section&nbsp;3.2(a) hereof, or unless such Participant becomes ineligible for participation in the Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) Notwithstanding any other provisions of the Plan to the contrary, in <FONT STYLE="white-space:nowrap">non-U.S.</FONT> jurisdictions where
participation in the Plan through payroll deductions is prohibited, the Administrator may provide that an Eligible Employee may elect to participate through contributions to the Participant&#146;s account under the Plan in a form acceptable to the
Administrator in lieu of or in addition to payroll deductions; provided, however, that, for any Offering under the Section&nbsp;423 Component, the Administrator must determine that any alternative method of contribution is applied on an equal and
uniform basis to all Eligible Employees in the Offering. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) Notwithstanding anything in this Section&nbsp;3.2 to the contrary, each Eligible
Employee who is employed by the Company or a Designated Subsidiary on the Initial Grant Date shall automatically become a Participant in the Plan with respect to the Initial Offering Period. Each such Participant shall be granted an Option to
purchase the maximum number of shares of Common Stock purchasable assuming the maximum amount of contributions permitted to be made by such Participant for such Initial Offering Period pursuant to the terms of this Plan. Following the Initial Grant
Date (but in no event prior to the date on which the Company&#146;s registration statement on Form <FONT STYLE="white-space:nowrap">S-8</FONT> is filed with the Securities and Exchange Commission in respect of the Plan), each such Participant may,
during the period designated from time to time by the Administrator for such purpose, (i)&nbsp;elect to make such contributions (or a lesser amount of contributions) for the Initial Offering Period by payroll deductions in accordance with the Plan,
such payroll deductions not to exceed 15% of such Participant&#146;s Compensation for the Paydays occurring during the Initial Purchase Period, provided that an individual payroll deduction may exceed 15% of such Participant&#146;s Compensation for
the applicable Payday or (ii)&nbsp;elect to make no contributions for such Initial Offering Period; provided, however, that, to make contributions by payroll deductions, such Participant must deliver the election form provided by the Company or an
agent designated by the Company for the Initial Offering Period under this Plan on or prior to the date designated by the Administrator for such purpose. If any Participant fails to deliver the election form provided by the Company or an agent
designated by the Company for the Initial Offering Period on or prior to the date designated by the Administrator for such purpose, such Participant shall be deemed to have withdrawn from the Initial Offering Period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.3 <U>Leave of Absence</U>. During leaves of absence approved by the Company meeting the requirements of Treas. Reg. &#167; <FONT
STYLE="white-space:nowrap">1.421-1(h)(2),</FONT> a Participant may continue participation in the Plan by making cash payments to the Company on the Participant&#146;s normal payday equal to the Participant&#146;s authorized payroll deduction. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 4 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PURCHASE OF
SHARES </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.1 <U>Grant of Option</U>. The Company may make one or more Offerings under the Plan, which may be successive or overlapping
with one another, until the earlier of: (i)&nbsp;the date on which the shares of Common Stock available under the Plan have been sold or (ii)&nbsp;the date on which the Plan is suspended or terminates. The Administrator shall designate the terms and
conditions of each Offering in writing, including without limitation, the Offering Period and the Purchase Periods. Each Participant shall be granted an Option with respect to an Offering Period on the applicable Grant Date. Subject to the
limitations of Section&nbsp;3.1(b) hereof, the number of shares of Common Stock subject to a Participant&#146;s Option shall be determined by dividing (a)&nbsp;such Participant&#146;s payroll deductions accumulated prior to an Exercise Date and
retained in the Participant&#146;s Plan Account on such Exercise Date by (b)&nbsp;the applicable Option Price; <I>provided</I> that in no event shall a Participant be permitted to purchase during each Offering Period more than 100,000 shares of
Common Stock (subject to any adjustment pursuant to Section&nbsp;5.2 hereof). The Administrator may, for future Offering Periods, increase or decrease, in its absolute discretion, the maximum number of shares of Common Stock that a Participant may
purchase during such future Offering Periods. Each Option shall expire on the last Exercise Date for the applicable Offering Period immediately after the automatic exercise of the Option in accordance with Section&nbsp;4.3 hereof, unless such Option
terminates earlier in accordance with Article 6 hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.2 <U>Option Price</U>. The &#147;<B><I>Option Price</I></B>&#148; per share of
Common Stock to be paid by a Participant upon exercise of the Participant&#146;s Option on an Exercise Date for an Offering Period shall equal 85% of the lesser of the Fair Market Value of a share of Common Stock on (a)&nbsp;the applicable Grant
Date and (b)&nbsp;the applicable Exercise Date, or such other price designated by the Administrator; <I>provided</I> that in no event shall the Option Price per share of Common Stock be less than the par value per share of the Common Stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.3 <U>Purchase of Shares</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) On each Exercise Date for an Offering Period, each Participant shall automatically and without any action on such Participant&#146;s part
be deemed to have exercised the Participant&#146;s Option to purchase at the applicable per share Option Price the largest number of whole shares of Common Stock which can be purchased with the amount in the Participant&#146;s Plan Account. Any
balance less than the per share Option Price that is remaining in the Participant&#146;s Plan Account (after exercise of such Participant&#146;s Option) as of the Exercise Date shall be carried forward to the next Purchase Period or Offering Period,
unless the Participant has elected to withdraw from the Plan pursuant to Section&nbsp;6.1 hereof or, pursuant to Section&nbsp;6.2 hereof, such Participant has ceased to be an Eligible Employee. Any balance not carried forward to the next Purchase
Period or Offering Period in accordance with the prior sentence shall be promptly refunded to the applicable Participant. In no event shall an amount greater than or equal to the per share Option Price as of an Exercise Date be carried forward to
the next Purchase Period or Offering Period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) As soon as practicable following each Exercise Date, the number of shares of Common
Stock purchased by such Participant pursuant to Section&nbsp;4.3(a) hereof shall be delivered (either in share certificate or book entry form), in the Company&#146;s sole discretion, to either (i)&nbsp;the Participant or (ii)&nbsp;an account
established in the Participant&#146;s name at a stock brokerage or other financial services firm designated by the Company. If the Company is required to obtain from any commission or agency authority to issue any such shares of Common Stock, the
Company shall seek to obtain such authority. Inability of the Company to obtain from any such commission or agency authority which counsel for the Company deems necessary for the lawful issuance of any such shares shall relieve the Company from
liability to any Participant except to refund to the Participant such Participant&#146;s Plan Account balance, without interest thereon. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Subject to Sections 5.3(b) and 5.3(c), no shares of Common Stock issued upon exercise of an Option under this Plan may be assigned,
transferred, pledged or otherwise disposed of in any way by the Participant until the ninetieth (90<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>) day after the Exercise Date upon which such shares of Common Stock were purchased.
Notwithstanding the foregoing, in the event a Participant ceases to be an Eligible Employee for any reason, this Section&nbsp;4.3(c) shall no longer apply to any shares of Common Stock then held by such Participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.4 <U>Automatic Termination of Offering Period</U>. If the Fair Market Value of a share of Common Stock on any Exercise Date (except the
final scheduled Exercise Date of any Offering Period) is lower than the Fair Market Value of a share of Common Stock on the Grant Date for an Offering Period, then such Offering Period shall terminate on such Exercise Date after the automatic
exercise of the Option in accordance with Section&nbsp;4.3 hereof, and each Participant shall automatically be enrolled in the Offering Period that commences immediately following such Exercise Date and such Participant&#146;s payroll deduction
authorization shall remain in effect for such Offering Period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">4.5 <U>Transferability of Rights</U>. An Option granted under the Plan
shall not be transferable, other than by will or the applicable laws of descent and distribution, and is exercisable during the Participant&#146;s lifetime only by the Participant. No option or interest or right to the Option shall be available to
pay off any debts, contracts or engagements of the Participant or the Participant&#146;s successors in interest or shall be subject to disposition by pledge, encumbrance, assignment or any other means whether such disposition be voluntary or
involuntary or by operation of law by judgment, levy, attachment, garnishment or any other legal or equitable proceedings (including bankruptcy), and any attempt at disposition of the Option shall have no effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 5 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PROVISIONS RELATING TO COMMON STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.1 <U>Common Stock Reserved</U>. Subject to adjustment as provided in Section&nbsp;5.2 hereof, the maximum number of shares of Common Stock
that shall be made available for sale under the Plan shall be the sum of (a) [________]<SUP STYLE="font-size:85%; vertical-align:top">1</SUP> shares and (b)&nbsp;an annual increase on the first day of each year beginning in 2022 and ending in 2031
equal to the lesser of (i) 1% of the shares outstanding (on an as converted basis) on the last day of the immediately preceding fiscal year and (ii)&nbsp;such number of shares as may be determined by the Board; <I>provided, however</I>, no more than
[_________]<SUP STYLE="font-size:85%; vertical-align:top">2</SUP> shares may be issued under the Plan. Shares made available for sale under the Plan may be authorized but unissued shares, treasury shares of Common Stock, or reacquired shares
reserved for issuance under the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.2 <U>Adjustments Upon Changes in Capitalization, Dissolution, Liquidation, Merger or Asset
Sale</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <U>Changes in Capitalization</U>. Subject to any required action by the stockholders of the Company, the number of shares
of Common Stock which have been authorized for issuance under the Plan but not yet placed under Option, as well as the price per share and the number of shares of Common Stock covered by each Option under the Plan which has not yet been exercised
shall be proportionately adjusted for any increase or decrease in the number of issued shares of Common Stock resulting from a stock split, reverse stock split, stock dividend, combination or reclassification of the Common Stock, or any other
increase or decrease in the number of shares of Common Stock effected without receipt of consideration by the Company; <I>provided</I>, <I>however</I>, that conversion of any convertible securities of the Company shall not be deemed to have been
&#147;effected without receipt of consideration.&#148; Such adjustment shall be made by the Administrator, whose determination in that respect shall be final, binding and conclusive. Except as expressly provided herein, no issuance by the Company of
shares of stock of any class, or securities convertible into shares of stock of any class, shall affect, and no adjustment by reason thereof shall be made with respect to, the number or price of shares of Common Stock subject to an Option. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <U>Dissolution or Liquidation</U>. In the event of the proposed dissolution or liquidation of the Company, the Offering Periods then in
progress shall be shortened by setting a new Exercise Date (the &#147;<B><I>New Exercise Date</I></B>&#148;), and shall terminate immediately prior to the consummation of such proposed dissolution or liquidation, unless provided otherwise by the
Administrator. The New Exercise Date shall be before the date of the Company&#146;s proposed dissolution or liquidation. The Administrator shall notify each Participant in writing prior to the New Exercise Date, that the Exercise Date for the
Participant&#146;s Option has been changed to the New Exercise Date and that the Participant&#146;s Option shall be exercised automatically on the New Exercise Date, unless prior to such date the Participant has withdrawn from the Offering Period as
provided in Section&nbsp;6.1 hereof or the Participant has ceased to be an Eligible Employee as provided in Section&nbsp;6.2 hereof. </P>
<P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">1</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Amount will be equal to 1% of the outstanding common stock after this offering. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><SUP STYLE="font-size:85%; vertical-align:top">2</SUP>&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Amount will be equal to 13.75% of the outstanding common stock after this offering. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <U>Merger or Asset Sale</U>. In the event of a proposed sale of all or substantially all
of the assets of the Company, or the merger of the Company with or into another corporation, each outstanding Option shall be assumed or an equivalent Option substituted by the successor corporation or a Parent or Subsidiary of the successor
corporation. If the successor corporation refuses to assume or substitute for the Option, any Offering Periods then in progress shall be shortened by setting a New Exercise Date and any Offering Periods then in progress shall end on the New Exercise
Date. The New Exercise Date shall be before the date of the Company&#146;s proposed sale or merger. The Administrator shall notify each Participant in writing prior to the New Exercise Date, that the Exercise Date for the Participant&#146;s Option
has been changed to the New Exercise Date and that the Participant&#146;s Option shall be exercised automatically on the New Exercise Date, unless prior to such date the Participant has withdrawn from the Offering Period as provided in
Section&nbsp;6.1 hereof or the Participant has ceased to be an Eligible Employee as provided in Section&nbsp;6.2 hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.3
<U>Insufficient Shares</U>. If the Administrator determines that, on a given Exercise Date, the number of shares of Common Stock with respect to which Options are to be exercised may exceed the number of shares of Common Stock remaining available
for sale under the Plan on such Exercise Date, the Administrator shall make a pro rata allocation of the shares of Common Stock available for issuance on such Exercise Date in as uniform a manner as shall be practicable and as it shall determine in
its sole discretion to be equitable among all Participants exercising Options to purchase Common Stock on such Exercise Date, and unless additional shares are authorized for issuance under the Plan, no further Offering Periods shall take place and
the Plan shall terminate pursuant to Section&nbsp;7.5 hereof. If an Offering Period is so terminated, then the balance of the amount credited to the Participant&#146;s Plan Account which has not been applied to the purchase of shares of Common Stock
shall be paid to such Participant in one lump sum in cash within 30 days after such Exercise Date, without any interest thereon. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">5.4
<U>Rights as Stockholders</U>. With respect to shares of Common Stock subject to an Option, a Participant shall not be deemed to be a stockholder of the Company and shall not have any of the rights or privileges of a stockholder. A Participant shall
have the rights and privileges of a stockholder of the Company when, but not until, shares of Common Stock have been deposited in the designated brokerage account following exercise of the Participant&#146;s Option. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 6 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TERMINATION
OF PARTICIPATION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.1 <U>Cessation of Contributions; Voluntary Withdrawal</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) A Participant may cease payroll deductions during an Offering Period and elect to withdraw from the Plan by delivering written notice of
such election to the Company in such form and at such time prior to the Exercise Date for such Offering Period as may be established by the Administrator (a &#147;<B><I>Withdrawal Election</I></B>&#148;). A Participant electing to withdraw from the
Plan may elect to either (i)&nbsp;withdraw all of the funds then credited to the Participant&#146;s Plan Account as of the date on which the Withdrawal Election is received by the Company, in which case amounts credited to such Plan Account shall be
returned to the Participant in one <FONT STYLE="white-space:nowrap">lump-sum</FONT> payment in cash within 30 days after such election is received by the Company, without any interest thereon, and the Participant shall cease to participate in the
Plan and the Participant&#146;s Option for such Offering Period shall terminate; or (ii)&nbsp;exercise the Option for the maximum number of whole shares of Common Stock on the applicable Exercise Date with any remaining Plan Account balance returned
to the Participant in one <FONT STYLE="white-space:nowrap">lump-sum</FONT> payment in cash within 30 days after such Exercise Date, without any interest thereon, and after such exercise cease to participate in the Plan. Upon receipt of a Withdrawal
Election, the Participant&#146;s payroll deduction authorization and the Participant&#146;s Option shall terminate. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) A Participant&#146;s withdrawal from the Plan shall not have any effect upon the
Participant&#146;s eligibility to participate in any similar plan which may hereafter be adopted by the Company or in succeeding Offering Periods which commence after the termination of the Offering Period from which the Participant withdraws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) A Participant who ceases contributions to the Plan during any Offering Period shall not be permitted to resume contributions to the Plan
during that Offering Period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">6.2 <U>Termination of Eligibility</U>. Upon a Participant&#146;s ceasing to be an Eligible Employee, for any
reason, such Participant&#146;s Option for the applicable Offering Period shall automatically terminate, the Participant shall be deemed to have elected to withdraw from the Plan, and such Participant&#146;s Plan Account shall be paid to such
Participant or, in the case of the Participant&#146;s death, to the person or persons entitled thereto pursuant to applicable law, within 30 days after such cessation of being an Eligible Employee, without any interest thereon. If a Participant
transfers employment from the Company or any Designated Subsidiary participating in the Section&nbsp;423 Component to any Designated Subsidiary participating in the <FONT STYLE="white-space:nowrap">Non-Section</FONT> 423 Component, such transfer
shall not be treated as a termination of employment, but the Participant shall immediately cease to participate in the Section&nbsp;423 Component; however, any contributions made for the Offering Period in which such transfer occurs shall be
transferred to the <FONT STYLE="white-space:nowrap">Non-Section</FONT> 423 Component, and such Participant shall immediately join the then-current Offering under the <FONT STYLE="white-space:nowrap">Non-Section</FONT> 423 Component upon the same
terms and conditions in effect for the Participant&#146;s participation in the Section&nbsp;423 Component, except for such modifications otherwise applicable for Participants in such Offering. A Participant who transfers employment from any
Designated Subsidiary participating in the <FONT STYLE="white-space:nowrap">Non-Section</FONT> 423 Component to the Company or any Designated Subsidiary participating in the Section&nbsp;423 Component shall not be treated as terminating the
Participant&#146;s employment and shall remain a Participant in the <FONT STYLE="white-space:nowrap">Non-Section</FONT> 423 Component until the earlier of (i)&nbsp;the end of the current Offering Period under the
<FONT STYLE="white-space:nowrap">Non-Section</FONT> 423 Component, or (ii)&nbsp;the Enrollment Date of the first Offering Period in which the Participant is eligible to participate following such transfer. Notwithstanding the foregoing, the
Administrator may establish different rules to govern transfers of employment between companies participating in the Section&nbsp;423 Component and the <FONT STYLE="white-space:nowrap">Non-Section</FONT> 423 Component, consistent with the applicable
requirements of Section&nbsp;423 of the Code. </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ARTICLE 7 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>GENERAL PROVISIONS </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.1
<U>Administration</U>. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Plan shall be administered by the Committee, which shall be composed of members of the Board. The
Committee may delegate administrative tasks under the Plan to the services of an Agent or Employees to assist in the administration of the Plan, including establishing and maintaining an individual securities account under the Plan for each
Participant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) It shall be the duty of the Administrator to conduct the general administration of the Plan in accordance with the
provisions of the Plan. The Administrator shall have the power, subject to, and within the limitations of, the express provisions of the Plan: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(i) To establish and terminate Offerings; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(ii) To determine when and how Options shall be granted and the provisions and terms of each Offering (which need not be identical); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(iii) To select Designated Subsidiaries in accordance with Section&nbsp;7.2 hereof; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(iv) To impose a mandatory holding period pursuant to which Participants may not dispose of or transfer shares of Common Stock purchased
under the Plan for a period of time determined by the Administrator in its discretion; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(v) To construe and interpret the Plan, the
terms of any Offering and the terms of the Options and to adopt such rules for the administration, interpretation, and application of the Plan as are consistent therewith and to interpret, amend or revoke any such rules. The Administrator, in the
exercise of this power, may correct any defect, omission or inconsistency in the Plan, any Offering or any Option, in a manner and to the extent it shall deem necessary or expedient to administer the Plan, subject to Section&nbsp;423 of the Code for
the Section&nbsp;423 Component. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Administrator may adopt rules or procedures relating to the operation and administration of the
Plan to accommodate the specific requirements of local laws and procedures. Without limiting the generality of the foregoing, the Administrator is specifically authorized to adopt rules and procedures regarding handling of participation elections,
payroll deductions, payment of interest, conversion of local currency, payroll tax, withholding procedures and handling of stock certificates which vary with local requirements. In its absolute discretion, the Board may at any time and from time to
time exercise any and all rights and duties of the Administrator under the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) The Administrator may adopt <FONT
STYLE="white-space:nowrap">sub-plans</FONT> applicable to particular Designated Subsidiaries or locations, which <FONT STYLE="white-space:nowrap">sub-plans</FONT> may be designed to be outside the scope of Section&nbsp;423 of the Code. The rules of
such <FONT STYLE="white-space:nowrap">sub-plans</FONT> may take precedence over other provisions of this Plan, with the exception of Section&nbsp;5.1 hereof, but unless otherwise superseded by the terms of such sub-plan, the provisions of this Plan
shall govern the operation of such sub-plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) All expenses and liabilities incurred by the Administrator in connection with the
administration of the Plan shall be borne by the Company. The Administrator may, with the approval of the Committee, employ attorneys, consultants, accountants, appraisers, brokers or other persons. The Administrator, the Company and its officers
and directors shall be entitled to rely upon the advice, opinions or valuations of any such persons. All actions taken and all interpretations and determinations made by the Administrator in good faith shall be final and binding upon all
Participants, the Company and all other interested persons. No member of the Board or Administrator shall be personally liable for any action, determination or interpretation made in good faith with respect to the Plan or the options, and all
members of the Board or Administrator shall be fully protected by the Company in respect to any such action, determination, or interpretation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.2 <U>Designation of Subsidiary Corporations</U>. The Board or Administrator shall designate from time to time the Subsidiaries that shall
constitute Designated Subsidiaries, and determine whether such Designated Subsidiaries shall participate in the Section&nbsp;423 Component or <FONT STYLE="white-space:nowrap">Non-Section</FONT> 423 Component. The Board or Administrator may designate
a Subsidiary, or terminate the designation of a Subsidiary, without the approval of the stockholders of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.3 <U>Reports</U>.
Individual accounts shall be maintained for each Participant in the Plan. Statements of Plan Accounts shall be given to Participants at least annually, which statements shall set forth the amounts of payroll deductions, the Option Price, the number
of shares purchased and the remaining cash balance, if any. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.4 <U>No Right to Employment</U>. Nothing in the Plan shall be construed to give any person
(including any Participant) the right to remain in the employ of the Company, a Parent or a Subsidiary or to affect the right of the Company, any Parent or any Subsidiary to terminate the employment of any person (including any Participant) at any
time, with or without cause, which right is expressly reserved. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.5 <U>Amendment and Termination of the Plan</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The Board may, in its sole discretion, amend, suspend or terminate the Plan at any time and from time to time. To the extent necessary to
comply with Section&nbsp;423 of the Code (or any successor rule or provision), with respect to the Section&nbsp;423 Component, or any other applicable law, regulation or stock exchange rule, the Company shall obtain stockholder approval of any such
amendment to the Plan in such a manner and to such a degree as required by Section&nbsp;423 of the Code or such other law, regulation or rule. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) If the Administrator determines that the ongoing operation of the Plan may result in unfavorable financial accounting consequences, the
Administrator may in its discretion modify or amend the Plan to reduce or eliminate such accounting consequence including, but not limited to: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(i) altering the Option Price for any Offering Period including an Offering Period underway at the time of the change in Option Price; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(ii) shortening any Offering Period so that the Offering Period ends on a new Exercise Date, including an Offering Period underway at the
time of the Administrator action; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:18%; font-size:10pt; font-family:Times New Roman">(iii) allocating shares of Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Such modifications or amendments shall not require stockholder approval or the consent of any Participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Upon termination of the Plan, the balance in each Participant&#146;s Plan Account shall be refunded as soon as practicable after such
termination, without any interest thereon. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.6 <U>Use of Funds; No Interest Paid</U>. All funds received by the Company by reason of
purchase of shares of Common Stock under the Plan shall be included in the general funds of the Company free of any trust or other restriction and may be used for any corporate purpose. No interest shall be paid to any Participant or credited under
the Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.7 <U>Term; Approval by Stockholders</U>. No Option may be granted during any period of suspension of the Plan or after
termination of the Plan. The Plan shall be submitted for the approval of the Company&#146;s stockholders within 12 months after the date of the Board&#146;s initial adoption of the Plan. Options may be granted prior to such stockholder approval;
<I>provided</I>, <I>however</I>, that such Options shall not be exercisable prior to the time when the Plan is approved by the stockholders; <I>provided</I>, <I>further</I> that if such approval has not been obtained by the end of the <FONT
STYLE="white-space:nowrap">12-month</FONT> period, all Options previously granted under the Plan shall thereupon terminate and be canceled and become null and void without being exercised. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.8 <U>Effect Upon Other Plans</U>. The adoption of the Plan shall not affect any other compensation or incentive plans in effect for the
Company, any Parent or any Subsidiary. Nothing in the Plan shall be construed to limit the right of the Company, any Parent or any Subsidiary (a)&nbsp;to establish any other forms of incentives or compensation for Employees of the Company or any
Parent or any </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Subsidiary, or (b)&nbsp;to grant or assume Options otherwise than under the Plan in connection with any proper corporate purpose, including, but not by way of limitation, the grant or assumption
of options in connection with the acquisition, by purchase, lease, merger, consolidation or otherwise, of the business, stock or assets of any corporation, firm or association. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.9 <U>Conformity to Securities Laws</U>. Notwithstanding any other provision of the Plan, the Plan and the participation in the Plan by any
individual who is then subject to Section&nbsp;16 of the Exchange Act shall be subject to any additional limitations set forth in any applicable exemption rule under Section&nbsp;16 of the Exchange Act (including any amendment to Rule <FONT
STYLE="white-space:nowrap">16b-3</FONT> of the Exchange Act) that are requirements for the application of such exemptive rule. To the extent permitted by applicable law, the Plan shall be deemed amended to the extent necessary to conform to such
applicable exemptive rule. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.10 <U>Notice of Disposition of Shares</U>. Each Participant shall give the Company prompt notice of any
disposition or other transfer of any shares of Common Stock, acquired pursuant to the exercise of an Option granted under the Section&nbsp;423 Component, if such disposition or transfer is made (a)&nbsp;within two years after the applicable Grant
Date or (b)&nbsp;within one year after the transfer of such shares of Common Stock to such Participant upon exercise of such Option. The Company may direct that any certificates evidencing shares acquired pursuant to the Plan refer to such
requirement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.11 <U>Tax Withholding</U>. The Company or any Parent or any Subsidiary shall be entitled to require payment in cash or
deduction from other compensation payable to each Participant of any sums required by federal, state or local tax law to be withheld with respect to any purchase of shares of Common Stock under the Plan or any sale of such shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.12 <U>Governing Law</U>. The Plan and all rights and obligations thereunder shall be construed and enforced in accordance with the laws of
the State of Delaware, without regard to the conflict of law rules thereof or of any other jurisdiction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.13 <U>Notices</U>. All notices
or other communications by a Participant to the Company under or in connection with the Plan shall be deemed to have been duly given when received in the form specified by the Company at the location, or by the person, designated by the Company for
the receipt thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.14 <U>Conditions To Issuance of Shares</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) Notwithstanding anything herein to the contrary, the Company shall not be required to issue or deliver any certificates or make any book
entries evidencing shares of Common Stock pursuant to the exercise of an Option by a Participant, unless and until the Board or the Committee has determined, with advice of counsel, that the issuance of such shares of Common Stock is in compliance
with all applicable laws, regulations of governmental authorities and, if applicable, the requirements of any securities exchange or automated quotation system on which the shares of Common Stock are listed or traded, and the shares of Common Stock
are covered by an effective registration statement or applicable exemption from registration. In addition to the terms and conditions provided herein, the Board or the Committee may require that a Participant make such reasonable covenants,
agreements, and representations as the Board or the Committee, in its discretion, deems advisable in order to comply with any such laws, regulations, or requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) All certificates for shares of Common Stock delivered pursuant to the Plan and all shares of Common Stock issued pursuant to book entry
procedures are subject to any stop-transfer orders and other restrictions as the Committee deems necessary or advisable to comply with federal, state, or foreign securities or other laws, rules and regulations and the rules of any securities
exchange or automated quotation system on which the shares of Common Stock are listed, quoted, or traded. The Committee may place legends on any certificate or book entry evidencing shares of Common Stock to reference restrictions applicable to the
shares of Common Stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The Committee shall have the right to require any Participant to comply with any timing
or other restrictions with respect to the settlement, distribution or exercise of any Option, including a window-period limitation, as may be imposed in the sole discretion of the Committee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Notwithstanding any other provision of the Plan, unless otherwise determined by the Committee or required by any applicable law, rule or
regulation, the Company may, in lieu of delivering to any Participant certificates evidencing shares of Common Stock issued in connection with any Option, record the issuance of shares of Common Stock in the books of the Company (or, as applicable,
its transfer agent or stock plan administrator). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.15 <U>Equal Rights and Privileges</U>. All Eligible Employees of the Company (or of
any Designated Subsidiary) granted Options pursuant to an Offering under the Section&nbsp;423 Component shall have equal rights and privileges under this Plan to the extent required under Section&nbsp;423 of the Code so that the Section&nbsp;423
Component qualifies as an &#147;employee stock purchase plan&#148; within the meaning of Section&nbsp;423 of the Code. Any provision of the Section&nbsp;423 Component that is inconsistent with Section&nbsp;423 of the Code shall, without further act
or amendment by the Company or the Board, be reformed to comply with the equal rights and privileges requirement of Section&nbsp;423 of the Code. Eligible Employees participating in the <FONT STYLE="white-space:nowrap">Non-Section</FONT> 423
Component need not have the same rights and privileges as Eligible Employees participating in the Section&nbsp;423 Component. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.16
<U>Rules Particular to Specific Countries</U>. Notwithstanding anything herein to the contrary, the terms and conditions of the Plan with respect to Participants who are tax residents of a particular <FONT STYLE="white-space:nowrap">non-U.S.</FONT>
country or who are foreign nationals or employed in <FONT STYLE="white-space:nowrap">non-U.S.</FONT> jurisdictions may be subject to an addendum to the Plan in the form of an appendix or <FONT STYLE="white-space:nowrap">sub-plan</FONT> (which
appendix or <FONT STYLE="white-space:nowrap">sub-plan</FONT> may be designed to govern Offerings under the Section&nbsp;423 Component or the <FONT STYLE="white-space:nowrap">Non-Section</FONT> 423 Component, as determined by the Administrator). To
the extent that the terms and conditions set forth in an appendix or <FONT STYLE="white-space:nowrap">sub-plan</FONT> conflict with any provisions of the Plan, the provisions of the appendix or <FONT STYLE="white-space:nowrap">sub-plan</FONT> shall
govern. The adoption of any such appendix or <FONT STYLE="white-space:nowrap">sub-plan</FONT> shall be pursuant to Section&nbsp;7.1 above. Without limiting the foregoing, the Administrator is specifically authorized to adopt rules and procedures,
with respect to Participants who are foreign nationals or employed in <FONT STYLE="white-space:nowrap">non-U.S.</FONT> jurisdictions, regarding the exclusion of particular Subsidiaries from participation in the Plan, eligibility to participate, the
definition of Compensation, handling of payroll deductions or other contributions by Participants, payment of interest, conversion of local currency, data privacy security, payroll tax, withholding procedures, establishment of bank or trust accounts
to hold payroll deductions or contributions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">7.17 <U>Section 409A</U>. The Section&nbsp;423 Component of the Plan and the Options granted
pursuant to Offerings thereunder are intended to be exempt from the application of Section&nbsp;409A. Neither the <FONT STYLE="white-space:nowrap">Non-Section</FONT> 423 Component nor any Option granted pursuant to an Offering thereunder is intended
to constitute or provide for &#147;nonqualified deferred compensation&#148; within the meaning of Section&nbsp;409A. Notwithstanding any provision of the Plan to the contrary, if the Administrator determines that any Option granted under the Plan
may be or become subject to Section&nbsp;409A or that any provision of the Plan may cause an Option granted under the Plan to be or become subject to Section&nbsp;409A, the Administrator may adopt such amendments to the Plan and/or adopt other
policies and procedures (including amendments, policies and procedures with retroactive effect), or take any other actions as the Administrator determines are necessary or appropriate to avoid the imposition of taxes under Section&nbsp;409A, either
through compliance with the requirements of Section&nbsp;409A or with an available exemption therefrom. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">*&nbsp;&nbsp;&nbsp;&nbsp;*&nbsp;&nbsp;&nbsp;&nbsp;*&nbsp;&nbsp;&nbsp;&nbsp;*&nbsp;&nbsp;&nbsp;&nbsp;* </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.11
<SEQUENCE>14
<FILENAME>d60414dex1011.htm
<DESCRIPTION>EX-10.11
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.11</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.11 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SANA BIOTECHNOLOGY, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">NON-EMPLOYEE</FONT> DIRECTOR COMPENSATION PROGRAM </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Sana Biotechnology, Inc. (the &#147;<B><I>Company</I></B>&#148;) <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director Compensation Program (this
&#147;<B><I>Program</I></B>&#148;) has been adopted under the Company&#146;s 2021 Incentive Award Plan (the &#147;<B><I>Plan</I></B>&#148;) and shall be effective upon the closing of the Company&#146;s initial public offering of its common stock
(the &#147;<B><I>IPO</I></B>&#148;). Capitalized terms not otherwise defined herein shall have the meaning ascribed in the Plan. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Cash Compensation
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Effective upon the IPO, annual retainers will be paid in the following amounts to <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors:
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="93%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">40,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Non-Executive</FONT> Chair:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">30,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit Committee Chair:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">20,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Compensation Committee Chair:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nominating and Corporate Governance Committee Chair:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit Committee Member <FONT STYLE="white-space:nowrap">(non-Chair):</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Compensation Committee Member <FONT STYLE="white-space:nowrap">(non-Chair):</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">7,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nominating and Corporate Governance Committee Member
<FONT STYLE="white-space:nowrap">(non-Chair):</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All annual retainers will be paid in cash quarterly in arrears promptly following the end of the applicable calendar quarter,
but in no event more than 30 days after the end of such quarter. In the event a <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director does not serve as a <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director, or in the applicable
positions described above, for an entire calendar quarter, the retainer paid to such <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director shall be prorated for the portion of such calendar quarter actually served as a <FONT
STYLE="white-space:nowrap">Non-Employee</FONT> Director, or in such position, as applicable. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Election to Receive Restricted Stock Units In Lieu of
Annual Retainer </I></B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="21%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="78%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">General:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Each <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director may elect to convert all or a portion of his or her annual retainer into a number of Restricted Stock Units (&#147;<B><I>Retainer RSUs</I></B>&#148;) granted under
the Plan or any other applicable Company equity incentive plan then-maintained by the Company covering a number of shares of Common Stock calculated by dividing (i)&nbsp;the amount of the annual retainer that would have otherwise been paid to such <FONT
STYLE="white-space:nowrap">Non-Employee</FONT> Director on the applicable grant date by (ii)&nbsp;the per share Fair Market Value as of the date of grant (such election, a &#147;<B><I>Retainer RSU
Election</I></B>&#148;).</TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="21%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="78%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Each award of Retainer RSUs will be granted on the fifth day of the
month immediately following the end of the quarter for which the corresponding portion of the annual retainer was earned, except that if such fifth day of the month is not a trading day, the applicable award of Retainer RSUs will be granted on the
next trading day following such date. Each award of Retainer RSUs will be fully vested on the date of grant.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Election Method:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each Retainer RSU Election must be submitted to Company in the form and manner specified by the Board of Directors of the Company (the
&#147;<B><I>Board</I></B>&#148;) or Compensation Committee of the Board (the &#147;<B><I>Compensation Committee</I></B>&#148;). An individual who fails to make a timely Retainer RSU Election shall not receive Retainer RSUs and instead shall receive
the applicable annual retainer in cash. Retainer RSU Elections must comply with the following timing requirements:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;<U>Initial Election</U>. Each individual who first becomes a
<FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director may make a Retainer RSU Election with respect to annual retainer payments scheduled to be paid in the same calendar year as such individual first becomes a
<FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director (the &#147;<B><I>Initial Election</I></B>&#148;). The Initial Election must be submitted to the Company on or prior to the date that the individual first becomes a <FONT
STYLE="white-space:nowrap">Non-Employee</FONT> Director (the &#147;<B><I>Initial Election Deadline</I></B>&#148;), and the Initial Election shall become final and irrevocable as of the Initial Election Deadline.</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:4.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;<U>Annual Election</U>. No
later than December&nbsp;31 of each calendar year, or such earlier deadline as may be established by the Board or the Compensation Committee, in its discretion (the &#147;<B><I>Annual Election Deadline</I></B>&#148;), each individual who is a <FONT
STYLE="white-space:nowrap">Non-Employee</FONT> Director as of immediately prior to the Annual Election Deadline may make a Retainer RSU Election with respect to the annual retainer relating to services to be performed in the following calendar year
(the &#147;<B><I>Annual Election</I></B>&#148;). The Annual Election must be submitted to the Company on or prior to the applicable Annual Election Deadline and shall become effective and irrevocable as of the Annual Election
Deadline.</P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="21%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="78%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:4.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&#8195;&#8202;<U>Deferral
of Proceeds</U>. The Board, the Compensation Committee or their respective authorized designee may, in its discretion, provide an individual who is a <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director with the opportunity to defer the
delivery of the shares underlying Retainer RSUs that would otherwise be delivered to the individual hereunder. Any such deferral election shall be subject to such rules, conditions and procedures as shall be determined by the Board or the
Compensation Committee, in its sole discretion, which rules, conditions and procedures shall at all times comply with the requirements of Section&nbsp;409A of the Code, unless otherwise specifically determined by the Board or the Compensation
Committee. If an individual elects to defer the delivery of the shares underlying Retainer RSUs in accordance herewith, settlement of the deferred Retainer RSUs shall be made in accordance with the terms of the Retainer RSU Election.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B><I>Equity Compensation</I></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Initial&nbsp;Stock&nbsp;Option&nbsp;Grant:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Each <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director who is initially elected or appointed to serve on the Board after the IPO
shall be granted an Option under the Plan or any other applicable Company equity incentive plan then-maintained by the Company to purchase that number of shares of Common Stock calculated by dividing (i) $700,000 by (ii)&nbsp;the per share grant
date fair value of the Option, calculated based on the closing trading price of the Common Stock as of the date of grant (or if the date of grant is not a trading day, the immediately preceding trading day) and using assumptions published in the
Company&#146;s most recent periodic report as of the date of grant, rounded down to the nearest whole share (the &#147;<B><I>Initial Option</I></B>&#148;).</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">The Initial Option will be automatically granted on the date on which such <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director commences service on
the Board, and will vest as to 1/36<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> of the shares subject thereto on each monthly anniversary of the applicable date of grant such that the shares subject to the Initial Option are fully vested
on the third anniversary of the date of grant, subject to the <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director continuing in service on the Board through each such vesting date.</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Annual&nbsp;Stock&nbsp;Option&nbsp;Grant:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Each <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director who (i)&nbsp;has been serving on the Board for at least four months as of each meeting of the Company&#146;s stockholders after the IPO (each, an &#147;<B><I>Annual
Meeting</I></B>&#148;) and (ii)&nbsp;will continue to serve as a <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director immediately following such meeting, shall be granted an Option under the Plan or any other applicable Company equity
incentive plan then-maintained by the Company to purchase a number of shares of Common Stock calculated by dividing (i) $350,000 by (ii)&nbsp;the per share grant date fair value of the Option, calculated based on the closing trading price of the
Common Stock as of the trading day immediately preceding the date of grant and using assumptions published in the Company&#146;s most recent periodic report as of the date of grant, rounded down to the nearest whole share (the &#147;<B><I>Annual
Option</I></B>&#148;).</TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="21%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="78%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">The Annual Option will be automatically granted on the date of the
applicable Annual Meeting, and will vest in full on the earlier of (i)&nbsp;the first anniversary of the date of grant and (ii)&nbsp;immediately prior to the Annual Meeting following the date of grant, subject to the
<FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director continuing in service on the Board through such vesting date.</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The per share exercise price of each Option granted to a <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director shall
equal the Fair Market Value of a share of Common Stock on the date the Option is granted. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The term of each Option granted to a <FONT
STYLE="white-space:nowrap">Non-Employee</FONT> Director shall be ten years from the date the Option is granted. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">No portion of an Initial Option or Annual
Option which is unvested or unexercisable at the time of a <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director&#146;s termination of service on the Board shall become vested and exercisable thereafter. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Members of the Board who are employees of the Company or any parent or subsidiary of the Company who subsequently terminate their service with the Company and
any parent or subsidiary of the Company and remain on the Board will not receive an Initial Option, but to the extent that they are otherwise eligible, will be eligible to receive, after termination from service with the Company and any parent or
subsidiary of the Company, Annual Options as described above. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Change in Control </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Upon a Change in Control of the Company, all outstanding equity awards granted under the Plan and any other equity incentive plan maintained by the Company
that are held by a <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director shall become fully vested and/or exercisable, irrespective of any other provisions of the <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director&#146;s Award
Agreement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Reimbursements </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company shall
reimburse each <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director for all reasonable, documented, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> travel and other business expenses incurred by
such <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director in the performance of his or her duties to the Company in accordance with the Company&#146;s applicable expense reimbursement policies and procedures as in effect from time to time.
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Miscellaneous </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The other provisions of the Plan shall apply to the Options granted automatically pursuant to this Program, except to the extent such other provisions are
inconsistent with this Program. All applicable terms of the Plan apply to this Program as if fully set forth herein, and all grants of Options hereby are subject in all respects to the terms of the Plan. The grant of any Option under this Program
shall be made solely by and subject to the terms set forth in a written agreement in a form to be approved by the Board and duly executed by an executive officer of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>*&nbsp;*&nbsp;*&nbsp;*&nbsp;* </B></P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.21(C)
<SEQUENCE>15
<FILENAME>d60414dex1021c.htm
<DESCRIPTION>EX-10.21(C)
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.21(c)</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.21(c) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>CERTAIN CONFIDENTIAL INFORMATION IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I)&nbsp;NOT MATERIAL AND (II)&nbsp;WOULD BE
COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED </B></P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDMENT NO. 2 TO </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXCLUSIVE <FONT STYLE="white-space:nowrap">START-UP</FONT> LICENSE AGREEMENT BETWEEN </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CYTOCARDIA, INC. AND UNIVERSITY OF WASHINGTON </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THIS AMENDMENT NO. 2 (&#147;<U>Amendment No.</U><U></U><U>&nbsp;2</U>&#148;), with an effective date of July&nbsp;16, 2020 (&#147;<U>Amendment
No.</U><U></U><U>&nbsp;2 Effective Date</U>&#148;), is entered into by and between Cytocardia, Inc. (&#147;<U>Company</U>&#148;) and University of Washington (&#147;<U>University</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WHEREAS, COMPANY and UNIVERSITY have entered into an Exclusive <FONT STYLE="white-space:nowrap">Start-Up</FONT> License Agreement for [***], dated
October&nbsp;9, 2018 (the &#147;<U>Original Agreement</U>&#148;), and amended on November&nbsp;7, 2019 (&#147;<U>Amendment No.</U><U></U><U>&nbsp;1</U>&#148;); and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WHEREAS, by this Amendment No.&nbsp;2, the Parties wish to amend the Original Agreement and Amendment No.&nbsp;1, as set forth in Section&nbsp;2 herein; and
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WHEREAS, the Parties desire that all other terms and conditions of the Original Agreement and Amendment No.&nbsp;1 remain in full force and effect; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, COMPANY and UNIVERSITY hereby agree as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. Capitalized terms used in this Amendment No.&nbsp;2 shall have the same meaning as those in the Original Agreement and Amendment No.&nbsp;1, as the case
may be, unless specifically defined otherwise in this Amendment No.&nbsp;2. All article and section references shall refer to the corresponding Article and Section in the Original Agreement and Amendment No.&nbsp;1. All references to the
&#147;Agreement&#148; in the Original Agreement, Amendment No.&nbsp;1, and this Amendment No.&nbsp;2 shall mean the Original Agreement as amended hereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. <U>Amendment</U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.1 <U>Exhibit D
&#147;Licensed Program Materials.&#148;</U> Exhibit D of the Agreement is hereby amended to list new items. The following is added to the table listing Licensed Program Materials. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">[***] </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. <U>Miscellaneous</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1 <U>Effect and Interpretation</U>. This Amendment No.&nbsp;2 shall be effective for all purposes as of the Amendment No.&nbsp;2 Effective
Date. To the extent that there are any inconsistencies between this Amendment No.&nbsp;2 and the Original Agreement and Amendment No.&nbsp;1, the terms of this Amendment No.&nbsp;2 shall supersede those set forth in the Original Agreement and
Amendment No.&nbsp;1. Except as otherwise expressly modified by this Amendment No.&nbsp;2, the Original Agreement and Amendment No.&nbsp;1 shall remain in full force and effect in accordance with their terms. As of the Amendment No.&nbsp;2 Effective
Date, the term &#147;Agreement&#148; (as used herein and in the Original Agreement and Amendment No.&nbsp;1) shall mean the Original Agreement and Amendment No.&nbsp;1 as amended by this Amendment No.&nbsp;2. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.2 <U>Counterparts</U>. This Amendment No. 2&nbsp;may be executed in one or more
counterparts by original, facsimile or PDF signature, each of which shall be deemed to be an original, but all of which together shall constitute one and the same instrument. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[SIGNATURE PAGE TO FOLLOW] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, COMPANY and UNIVERSITY have caused this Amendment No.&nbsp;2 to be executed by their
respective duly authorized representatives as of the Amendment No.&nbsp;2 Effective Date. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="41%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="41%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom" COLSPAN="3"><B>CYTOCARDIA, INC.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3"><B>UNIVERSITY OF WASHINGTON</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Nathan Hardy</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Fiona Wills</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Nathan Hardy</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Fiona Wills</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Chief Financial Officer, Cytocardia</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">Associate Vice Provost, Innovation Development</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">Date:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">July&nbsp;16, 2020</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Date:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">July&nbsp;17, 2020</P></TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.21(E)
<SEQUENCE>16
<FILENAME>d60414dex1021e.htm
<DESCRIPTION>EX-10.21(E)
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.21(e)</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.21(e) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>CONFIDENTIAL </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>CERTAIN CONFIDENTIAL
INFORMATION IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS BOTH (I)&nbsp;NOT MATERIAL AND (II)&nbsp;WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>AMENDMENT NO. 4 TO </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXCLUSIVE <FONT STYLE="white-space:nowrap">START-UP</FONT> LICENSE AGREEMENT BETWEEN </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SANA BIOTECHNOLOGY, INC. AND UNIVERSITY OF WASHINGTON </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THIS AMENDMENT NO. 4 (&#147;<U>Amendment No.</U><U></U><U>&nbsp;4</U>&#148;), with an effective date of January&nbsp;21, 2021 (&#147;<U>Amendment
No.</U><U></U><U>&nbsp;4 Effective Date</U>&#148;), is entered into by and between Sana Biotechnology, Inc. (&#147;<U>Company</U>&#148;) and University of Washington (&#147;<U>University</U>&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WHEREAS, Cytocardia, Inc. (&#147;<U>Cytocardia</U>&#148;) (a subsidiary of and predecessor in interest under this Agreement to COMPANY) and UNIVERSITY entered
into an Exclusive <FONT STYLE="white-space:nowrap">Start-Up</FONT> License Agreement for [***], dated October&nbsp;9, 2018 (the &#147;<U>Original Agreement</U>&#148;), and amended on November&nbsp;6, 2019 (&#147;<U>Amendment
No.</U><U></U><U>&nbsp;1</U>&#148;), July&nbsp;16, 2020 (&#147;<U>Amendment No.</U><U></U><U>&nbsp;2</U>&#148;), and November&nbsp;11, 2020 (&#147;Assignment of License Agreement&#148;); and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WHEREAS, Cytocardia assigned the Original Agreement, as amended by Amendment No.&nbsp;1 and Amendment No.&nbsp;2, to COMPANY via the Assignment of License
Agreement (&#147;Amendment No.&nbsp;3&#148;), dated November&nbsp;11, 2020; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WHEREAS, by this Amendment No.&nbsp;4, the Parties wish to amend the
Original Agreement, Amendment No.&nbsp;1, Amendment No.&nbsp;2 and Amendment No.&nbsp;3, as set forth in Section&nbsp;2 herein; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WHEREAS, the Parties
desire that all other terms and conditions of the Original Agreement, Amendment No.&nbsp;1, Amendment No.&nbsp;2, and Amendment No.&nbsp;3 remain in full force and effect; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, COMPANY and UNIVERSITY hereby agree as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1. Capitalized terms used in this Amendment No.&nbsp;4 shall have the same meaning as those in the Original Agreement, Amendment No.&nbsp;1, Amendment
No.&nbsp;2, and Amendment No.&nbsp;3 as the case may be, unless specifically defined otherwise in this Amendment No.&nbsp;4. All article and section references shall refer to the corresponding Article and Section in the Original Agreement as amended
by Amendment No.&nbsp;1, Amendment No.&nbsp;2, and Amendment No.&nbsp;3. All references to the &#147;Agreement&#148; in the Original Agreement, Amendment No.&nbsp;1, Amendment No.&nbsp;2, Amendment No.&nbsp;3, and this Amendment No.&nbsp;4 shall
mean the Original Agreement as amended hereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2. <U>Amendments</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.1 <U>Section 2.1; Patent License</U>. Section&nbsp;2.1 (Patent License) of the Original Agreement is hereby amended and restated in its
entirety as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;2.1 Patent License. University hereby grants to Company an exclusive (subject only to any rights of the
government described in Section&nbsp;2.6 &#147;The United States Government&#146;s Rights&#148; and to rights of University and Cambridge, described in Section&nbsp;3 &#147;Rights of University, Limitations&#148;) license under the Licensed Patents
to make, have made on Company&#146;s behalf, use, offer to sell, sell, offer to lease or lease, import, or otherwise offer to dispose of Licensed Products in the Territory in the Field of Use. Unless otherwise terminated under Section&nbsp;9
(Termination), the term of this patent license will begin on the Effective Date and will continue </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
until all Valid Claims expire or are held invalid or unenforceable by a court of competent jurisdiction from which no appeal can be taken. For the avoidance of doubt and notwithstanding anything
in this Agreement to the contrary, the above grant of rights, and any other rights granted, obligations of University, or representations or warranties made by University, for Licensed Patents of UW reference number [***] are for University&#146;s
rights in such Licensed Patents only and not for any rights which may be owned by [***].&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2.2 <U>Exhibit A, Section A1.1 (Licensed
Patents)</U>. After the end of the table listing Licensed Patents, Group 1 in Exhibit A, Section A1.1 of the Original Agreement, the following is hereby inserted: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">[***] </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3. <U>Miscellaneous</U>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.1 <U>Amendment Fee</U>. Company will pay University a <FONT STYLE="white-space:nowrap">one-time</FONT> fee of [***] ($[***]) in
consideration for the additional rights granted to Company under this Third Amendment, payable within thirty (30)&nbsp;days of the Amendment No.&nbsp;4 Effective Date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.2 <U>Effect and Interpretation</U>. This Amendment No.&nbsp;3 shall be effective for all purposes as of the Amendment No.&nbsp;4 Effective
Date. To the extent that there are any inconsistencies between this Amendment No.&nbsp;4 and the Original Agreement as amended by Amendment No.&nbsp;1, Amendment No.&nbsp;2, and Amendment No.&nbsp;3, the terms of this Amendment No.&nbsp;4 shall
supersede those set forth in the Original Agreement, Amendment No.&nbsp;1, Amendment No.&nbsp;2, and Amendment No.&nbsp;3. Except as otherwise expressly modified by this Amendment No.&nbsp;4, the Original Agreement as amended by Amendment
No.&nbsp;1, Amendment No.&nbsp;2, and Amendment No.&nbsp;3 shall remain in full force and effect in accordance with its terms. As of the Amendment No.&nbsp;4 Effective Date, the term &#147;Agreement&#148; (as used herein and in the Original
Agreement, Amendment No.&nbsp;1, Amendment No.&nbsp;2, and Amendment No.&nbsp;3) shall mean the Original Agreement, Amendment No.&nbsp;1, Amendment No.&nbsp;2, and Amendment No.&nbsp;3 as amended by this Amendment No.&nbsp;4. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3.3 <U>Counterparts</U>. This Amendment No. 4&nbsp;may be executed in one or more counterparts by original, facsimile or PDF signature, each
of which shall be deemed to be an original, but all of which together shall constitute one and the same instrument. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, COMPANY and
UNIVERSITY have caused this Amendment No.&nbsp;4 to be executed by their respective duly authorized representatives as of the Amendment No.&nbsp;4 Effective Date. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="41%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="41%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>SANA BIOTECHNOLOGY, INC.</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="3"><B>UNIVERSITY OF WASHINGTON</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Chris Pritchard</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Fiona Wills</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chris Pritchard</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Fiona Wills</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">VP, Business Development</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Associate Vice Provost</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">January 21, 2021</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Date:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">January 21, 2021</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">

<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="5">Amendment 4 to the Exclusive License between Sana Biotechnology, Inc. and University of Washington</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">UW CoMotion #37004A</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center">Page 2 of 2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR></TABLE>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>17
<FILENAME>d60414dex211.htm
<DESCRIPTION>EX-21.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-21.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 21.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>List of Subsidiaries </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cobalt Biomedicine,
Inc. (Delaware) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Oscine Corp. (Delaware) </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cytocardia, Inc.
(Delaware) </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>18
<FILENAME>d60414dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-23.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">



<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 23.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Consent of Independent Registered Public Accounting Firm </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We consent to the reference to our firm under the caption &#147;Experts&#148;&nbsp;and to the use of our report dated April&nbsp;22, 2020 (except for the last
four paragraphs of Note 17, as to which the date is January 28, 2021) in Amendment No.&nbsp;1 to the Registration Statement <FONT STYLE="white-space:nowrap">(Form&nbsp;S-1</FONT> No. <FONT STYLE="white-space:nowrap">333-252061)&nbsp;and</FONT>
related Prospectus of Sana Biotechnology, Inc. for the registration of its common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ Ernst&nbsp;&amp; Young LLP </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Seattle, Washington </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">January&nbsp;28, 2021 </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>g60414g02f71.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g60414g02f71.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2-.4&AO=&]S:&]P(#,N,  X0DE-! 0
M    (S*^D! X0DE-! 0       \< 5H  QLE1QP"   "    .$))300E
M   0S<_Z?:C'O@D%<':NKP7#3CA"24T$.@      Y0   !     !       +
M<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0    !)
M;G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I;G1E
M<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    , %
M<@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !     $)L
M=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M  (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7     $-P
M=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B;V]L
M      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L      !%
M;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0       %)'
M0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M      !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
M     $)L9"!5;G1&(U)L=                %)S;'15;G1&(U!X;$!P2XU0
M        "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0    !09U!S
M %!G4$,     3&5F=%5N=$8C4FQT                5&]P(%5N=$8C4FQT
M                4V-L(%5N=$8C4')C0%D            08W)O<%=H96Y0
M<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O
M<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M"V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  $#O_XU
M  (  3A"24T$)@      #@             _@   .$))300-       $
M'CA"24T$&0      !    !XX0DE- _,       D           $ .$))32<0
M       *  $          3A"24T#]0      2  O9F8  0!L9F8 !@
M 0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U     0 M
M    !@       3A"24T#^       <   ____________________________
M_P/H     /____________________________\#Z     #_____________
M________________ ^@     _____________________________P/H   X
M0DE-! @      !     !   "0    D      .$))300>       $     #A"
M24T$&@     #-0    8             !BP   9L          $
M                 0             &;   !BP
M 0                         0     0       &YU;&P    "    !F)O
M=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M $QE9G1L;VYG          !"=&]M;&]N9P  !BP     4F=H=&QO;F<   9L
M    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(    '
M<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG:6YE
M;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y<&5E
M;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC     0
M     %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M    0G1O;6QO;F<   8L     %)G:'1L;VYG   &;     -U<FQ415A4
M 0       &YU;&Q415A4     0       $US9V5415A4     0      !F%L
M=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC96QL
M5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(;W)Z
M06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC959E
M<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%4VQI
M8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M"FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M  MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
M #A"24T$$0       0$ .$))3004       $     SA"24T$#      9'
M  $   "@    F@   >   2#    9   8  '_V/_M  Q!9&]B95]#30 "_^X
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M0^RP8S=[6!E; WT3;+O>_(=ZG]3V?S:1S?K3O('3:=FNT^L)^DV ?^M[O?\
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MK*POK!U#J#+FX
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MK!019?\ M)/6X,3Y':GAQ6*TJ5Q14F$+&9P<5CDTN2-308>J;E34X+MGXO\
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MFJ0W$9&:E T0V9.;6@9TS0P \'(V^L5;HA4*VPJMUDXFDU]%[6A[F9ND>&9
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M1-$31$T1-$7 THLXLPDTN@PHVBLLPLRD*RZZ*Z1IKHKHJ ::J:Z1&FJD0Q4
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M+Q)VL:,F*6?[GXBDP7BA:'[RXVIDU0T*EA]"B"NYJAE?21;=S"XDTG!INTD
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MMNT,CDK)3.*DVX9Y[;6H6T,2OA^N=>MA"&E(7/Q+WDRJ %-R],O2 5A76G2
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M1NXJ'1EMO.K3ME-2%"Q-+:@;DL)G[JWEM+*D:FT%:)M<_NOW\'0]U@U'.$&
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M$6D#P[/Y:8JV\5(9UZQ_MVL?4QAKNY2M"*7TC>LBY=1[;%CU=--+BH.2OQ6
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M.AL>$[BC^Z>D],>XI4S@@J]*:"IM5J&ER)3J! JLP49E8DTE5DUF6+2T G>
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M+,IJ+-*KJHKI$*J:AI$!UPC8ZS%CW$CY0O0"XG32.PB3YKU=0I4#L&V_UO\
M#1->7=/U'CNU@Q!U'RG@ZXBSYO,GR/&V[,;'B<322,:E3.I$U.)""22=U?4I
M1R9-"%M"1244X!0H+3K3BA. RNFNOQ#4/W7 ?'OPJS9FS\+BJ>T>EP^SL!A,
M2T8#"U:;WX3"4<.\ASL:PU&$TI:YU-IRP($0/AV.^ _B:IM''8K#U,$VE7QV
M+Q.'(QM:G48,17J50XAN'ZM2'G,QKBR9-SUC3IG!=Q,'&F'')[5''&U55F&F
MW#DAIAE8B(U55F&6[JKJJ$<"(CD?7TVV_P!(7PBUK6M_RNUK8RM;L_"-  @
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M:#@")U 'BKL^ ?BRG)I5, PD0<F*KLEIC,"YE(%P= !DW$VT@'!KQ04IJT=
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M7U\5)V8  !U^J29(M>1?4S]]X(-(+B6D@DD")OY ;K]XB)%AWOAHXDFJV_\
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MGX6V%\05L'B-K8"CC:N <788U2[*V7-<6O#2!49F:":;\S"=6E:^X-Q)<,7
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MJ6O%S^$V:)KXQUF:BP,=9?"T#:O8+T6]1T!348I43"TSQ*BF=#0&5,L;HQ4
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MY?%^(3B4.+"JMO6/C>IK7\/EHU9E-51!ZMTE:$;N/[:;37]W9H)&:5(>ADA
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M-91 2!1<.K-)QC4]4ZWD3E M?=,[@%M,QV.HG+6I4\0V+U:66D]PL""QT-=
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M=!LEGTF55$I&>.HCZ2S3'5:UHE=Z3!5>&AP ) ),0+[SFX:\%CJO--CG99<
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M/0+4*YC<$S<Y.Z1"<$IME-J*"G2D4JAM7.'%PF)HXZA+0+6?3,2TR8L(.[4
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M0]0WU,;FSS1]<4L*<8X\M;@"RGOX79>TZ.SQMJ@6C#-J9'-SPXB8+G-L"S,
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M6IL;4AK0T0+\2=3[]WDJ7.+B. $!5KJRJFB)HB:(FB)HB:(FB)HB:(H$ $!
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M0\1-N.((J/S?AMO!-[266ER#B!DUN8*P??YJSW,G=NJ8;:242F.&+/NXN++
MF]WEX0U[&.2]AKD+*X+BE#@UMS+1T?B7:^%^(/B/&;6PE,.PU-@P6'K,:&FN
MR@[+T[VF"2\YG-=KT9;($+E;&V?B-D;$PVS,2^*[G'$U*;G2*=2LXN=3!DRU
MG5!%@'21JMK/!I>:&<?/%)*[],S9)D%O>%:,)[?6QCTK:Z$BNF[ER"%IUTIR
MO! H=&0IR98HB98!'DA;NJ<4)*Z:J#2D_P"TP+)\OCJV:&-T%CQ)U([K>)XE
M=W 4 TYB28M.@U(/'PXZZ +<KKFKIIHB:(FB)HB:(FB)HB:(FB)HB:(FB)HB
M:(L9N*KAX:^(2T<RC3=2VQ^Z%+:W/5K+CTHB ?(3<B#.M$OMH^IW2@K]H4-[
M+,T:14N;RC@(6MJIW0&E5DN2J@W)3>:;VN&@-Q,>*QU:8>QP(N1 /9,?,^*P
M0ETLE'$EP?P3B+MXR_LWB+L6[HKPQZ*%U&TKV&^EDW!R8[MV=4@6-"H"906A
MN#:)Q).#PJVV1EK:BC*:D]6NSB*3<7A7LUSLD#^*)$'2SK2)T(7$H5'X3%,,
MV8Z9WP8!$F_&?19<\7E_VN<\"J>YEG;G4QAQO#"X+/+=DLTB,9;@SF(+E<<E
M4IBUORFD^F2K)DXPDYS;2$,:H%ZI<#J6\E0VGJ*5J;RFS&T*>T<.,;2Z3#-J
MAM=C@<N4R)=!$@$@D3I*]!\1?Y1K[ VBW8M<4-J5<'4.!JB+5LL@-)(@D M:
MZ1#B#( )7Y_^&K[1;B$@]^";<1"4W0D]G':X$#B+*Y2H5<FB"&;N2TUJE[6Z
M/4Z.52EF8S5[E&F=?0A/1L4<=*%;O50B-.>W#7TK$;&^'L5AL9CJ>$(P].@<
MV(HD4VLJ=&\AU*FUPSM86M#P*8$R";"?SG@/BK^D/9V*V-LG%[7+MK8C'"J[
M9>/IL?6Q&$K5:+:=*O5J4GNIO<UN(?38:]-[6Y(-P#^R6@:AII&H "H::1J
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M6Q&]EG $0&ZUN $!$*J1FT: :1 <"%0"Y@(#W#F'777_ ,WMO&XV+M:#<?\
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M/?R4VM$\]!X:KB:70<762<66:4914684;13668772--=!E%5(TUT5@(TU4U
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M8C"5CB]KXBD<S<1CY#FX1[Q_\1@\'2=4PP87.I5JKZKG%W5(^+Y6?#']AO\
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M?M'-WEI.[CP Y?*]X&RKZ[? .6N*NVFB)HB^9W_%&[9'T=8  <Q$:1  U9L
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M!\07$GQ*J^(F<,\<XF'*V2>.0[A+6\);E>6Y=VK-.ES&R;-S*I?94NX:[?\
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MJMB98X:3NW+6/?FYR&6<*O#-QAM)A2E!;6>\-G$JM-)&D/0PY[4-T;N;0-=
MB!%2*WEPYC]]+J'":M&=0I+I%/46'N<0.DP[BTR2T.&\1;0R-!/AO*\-AB:.
M); C*X@B1ON0>Z!N!F!HMQ5%5-=%!E-5-=!E(5TUTB%5-=-0 (54U!D!"H!
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MFD+%CFY*L"/RU+,,"Q+KZ2=9LN8IX5N*J:DH7)/,+'<5<-1@8E(6?MFP'%C
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M%(7%.=H-2UJ[T2*]-R9*W,=\6YR_>U-2S1Q@1NKRTJ90>ZTI&1HCM(5J1E?
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MVA5#W4G& ]L$.;,&#!D&#!@KD;>V6[;6Q]H;+;B7X1^-P[J3,33G/0J2',J
M @D!S1F:",S<S9$K0LQ_8:RRW[K(Z+;W#M6WQNXJ=L12YO=&&4#^[W[)3KV^
MAU:$U%:RJ9F+D"ZCTC.[N45+0&)*2"'I0E444(O<.^.*(9B&4]FN+:U,@&M5
M#R'NI]$2^<Y>T,_*"\P28AIA?%Z?]"^.J/V76QOQ--;9V(>_-AL(:<T'5F5@
MVFYM2EEK$M+7/R!I&20XMD[UII8V'W*L*\</=PZG"70^1VYHMS(5SFHR^.B2
MAF):0?ZW"FGQD20M002]I74D*3TCV22X)QH.)+JI^?-J.;4%1G5<'9FP=+S
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MN;;(?V^PF.LH]"FS,@9"7AW5J!T. @EK[$&)-PX0-=#:%I/:XYG4Z50%QHY
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M%,R),MW2L IQ;Z>R*UL1B,QL2].\E2<.-RT4(?+A</\ >;B'6.LV?[MW0/\
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MW'?OU]V38<;[CN&X]0[?EVWU%_+S]]NZVJBXFVEC8;COMQ\4P'G_ -8>?O\
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M=.8^BF6SEEN:]@1.AFVNDSRE6DFO$U:R%RUN@M+F=+Y>YM%RW6E@@Y[(_N2
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M'LNYK3N;?K/<,K)FX= _1I]F!>)CN5P[?N8S6^AEL2K'/]%M4T4@7WXF- R
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M2:$GQQX4BBA]:AV1SV1HTH/#79G/:9+B!N!<"))!!B($ =6Q!.B/I.=3RTZ
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MG$A81;>V'4TJ4PWMX6V0^7)'!N\ 4^EG7#\Y+U-QHZM.3^EJ< A-=RF0PP#
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MX^77KST26WN#:#)X3Z[MVB>$1Z#R[8QO[/R'.1Z[Z)F .HUXS-N_YB(&ZRC
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MX8SN/LY:EKNV_,<8[>!M:YM:QU+6!^7>8''MGY\3*U\<2-Y+@3ZY9/"5PZ2
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M7U--$31$T1-$31$T1-$31$T1-$31$T1-$31$T1-$31%;I?G[\LP ?ZR?U_\
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M*='>A!]]2N46;53O4II42D]LI4'4&E-B56IYOQFS!TL=0P^$P_X9U/#M<_\
M9BE(JP]C<K;#+#A()F5W/Z(*FV<5L+&X[:NU#M5F*Q[SA:IQ(Q!I"FW+68'
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MMA%FR%P9D3,$;:*#:43>FJ.-Q6>;6>H/4*5)ARM6J4'F5FGJE1YQYM=6:S!
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MMR_L_I^6IX^_7Y)UIUU_B^_S4X ?]GGU&GYA]>T,O?OWN22-^G/T/ON,-@V
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MWD=8<MZUMD?9C77N'(.(VXU_[WVN77*O9PI37A49CK*V1_AM%&AHF9_[05W
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ML=BT(NTK=C7]Q7R1[4UK559)9*5.3#JG2!O5@-; <1+M;23K&[@-3:^:E0-
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M2Z@B/2D1]H?/4JP WN [CZ)D>P_#YZ=_K[[D@<1Y^B9\A^'SU&D]VX^N_@/
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MH15V8<G5UC; U0V&1&-1-L3/2QY7J)>^D-=4H?S:DI1SP2W-3.WMT=(;Y6-
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M*VR_#PVG&.%O+=4T5>+[E(G\51D\N0)($5*9.ZIVQ2113'4H4WJ& *;"2UI
M<?U._>=(C?&774FUUKX=CGN=B:EGU!%,#]RF#+*>_K7!<Z;& 0L[LT]?"/K'
MX\]8]_#2XWQN^<_<QM0X:!P\5'X/[/PTW_?WX7%IU3K_ ,7FGX/[/PU-^/A]
MY[?=W7_B\T_!_9^&B=?^+S3\/]G^[_/3QM[W)U_XO-/P_P!GX?77XZ>7OO\
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MOKMJ5DRB=/GZ^^*GQ#U$0]0!\.77S]7+2!PY=W!,HW 'M)\]=W+MU4>.KO\
ME\O\-$R-X?/U_FI\=7+/NQ[^6_PT3*WAXD^MO-/'5W_+;GMU\O,.6BC(WA\[
MZ7W<^1U3Q59#?._;F'NSOZM$RM@VBW'0^,6[4\=7\N77O^>B9&_77=P^2>(1
MSOCM[.GJ'N(]-^>B90(M/'OW]HX ;[:*/%5W^'QY?6=%.5O#S\M?<)XJN_Y:
M)E;P^:D*AY"/MVVSU_Q\P]106C4#NO>-W\N1[8\=7?X!\M%.1O#S/JI\=6V_
M?I[O;ZO+;GDHR-O;AO\ 'N[>=](>*KOCRP&?RV]NB96\)YR8^=^Y/%5W]X!T
M^?L\M$RMX>!._P!._FGBJ[]NG?&W+U^OW:)E;PX[^!-]>R>'BH\=7?X!]>[I
MYZ*<C>'F??COY*?&/?X!W]0=/7\B9!P\SP[3O[/5XJM]\^H ]_+OCI[M$RMX
M1/$F>S7A._Q3Q59_E@/EHF5L?63ZIXQSMRSL'Y<M_CHHR"+ZQ<_/6WDGBJ[^
MO8/K^>=M%.5O#LN??TBZ>*KO[,!G'N^L:*,K>'?)B?'W*>*KOGV;[XY8[=-$
M+6\([[6G6>.]1XJN_P"6BG*WA\U/BJYYVZ<O+R\_+1,K=(OOUY\^7-1XZN_P
M#Y:)D;P\SZJ?%5W]P>?F'UMYZ)E;P\3RY'W?DGCJWWY^KY;]-$R-X?/U4>.K
MGGZ]WU[M")L4RMX>^=_?BGBJ[_7L_P 0T3*WA[[_ .14^*K??\OE]"(8T3*V
MUOGZ^P#*CQ5=_@&B96\/,J?%4/7U;!S[<MORSY9'106M&[MN=..M_G'. H\5
M7?X!\M%.5O#S/JGBJ[_ /EHF5O#S/JGBJ[_EY\\?7PT3*V]OGRTGWYIXJN_7
MV]=OK(<@\M$RMX;N[=?W!U/-<%2I*@2*5Z]40B1(TYJM8L5G%)DJ1,G+J-4*
M%*@ZJ@HA.05168<<;706473577532 U!!D& "7.L  22; "!),DP !<GFL9@
M GJAK=23%KWDF+"Y)T X+6Y(.)&[/%JZNMLN!DXEBMXD6JF*XG&W(6NE?!F*
MH@T4KJR<.L?6TT%7BG1-5*E.$P,$NU\84E HJ<I*K%.WCERMI!KJTN)$MIB"
M':V>6S'^[,FUEI.K5,0XT\(<K,P:[$P<K=Y# ^ \D1#@" =\@!99V!X=+8\-
M414Q2W+8M,6/;@;()S.9,X'2&X=S)>L_$Z3*X,M6@+E(Y"YGC6<:>=44C1TU
M@B:D3>W%$HRZ.<:ADV'[K02&M;P ,6[KB-5M4,/3HT\HN3=SC=Q/-QOFFY$D
M#06A7T\0]\>S_$?KGJ%GRC>)[S)._A[W*!JJVW_+U?7K =$#6WMXSV^^PA/%
M5MO_ "_+F&B96WM]?GH4\57?'L^0#HF5O">_U(3QU=^_;Y?XZ)D;PX<?7^2>
M*KO\ ^6B96\/,^JGQU=P[]/=];\\\M%&1O \-_C[MI&J>*KH/P /Y;>\0T4Y
M6[QYD_6_@"GBJ[_ /ECXZ)E;P\SZSY)XQWW]7+GMGI[OK!1D%K<9UTO&_P ?
M<@J'J/?MVVZ>7Q#VD+1N'#CQOOY^1[H\57?GY!\L?X:*<K;VTYGUG^:>*KO^
M7U\M$RMX?/WZIXJN_P  ^7UUT3*WAYGU][E/C'O[^GN .7M_EHHR#AX;_$G7
MN^JCQ5=_RT4Y6\/FGCJ^@^O5^NB9&^S[[?LI\50]0#V![^7UT#1,K1N)[SX:
M^]Y3QCW#V!O[<[>[]-%&0<#WGTOX_=/%5W#X?7N'13E;P^?OQ776(T;HC6-K
MDD2N#<X)%")>@6$%*4:U&K*K(4I%:8ZFLE2F4$&5DJ"#:*RS2ZJBZZ1IJ',1
M!D2#N()GE)OOY&.P6JYH((BQFQT(WVTO&F\3W:C%D?6< T^;H.YGK%?!;<Z0
ME-=JI*N.,64\,\^?E-5*.S\J6G^*I/9R5KC136ID*NNHB&O1Y, >3Z6Y9&UP
M9C^W;U8%5@!+6B,[8NX:3%I[9)G6F$Q)P3FT*I<<+4>12J&3T#B9;1=()-)Q
MZC1HV;E>[!IJ?]GK<,]88-=7 S=>3 ;)T!0#4DX3KFR5?BN;MA5(5?=+$7 >
M%@!-D!5-"&VLH4E2M'0EC+M(:4%"WIVF/[5O+^T %QVMBQB^G!8=H8(X-W3T
M0]V'>X"HP $8=SB2*D:FDX\(+=2 --T8NS6!:$T7) !3H)8-A@JTX4.(G%>F
M)!#6)GA5B:5_2E G$P3"_P = #3D=:JTP9 /'3U[UZ&BE-$31$T1-$31$T1-
M$31$T16W<!H^_+,@ C]Y/Z;_ /&5!K.W0=BZ-,/R,@D#*W?;1=01H#H'N]FI
M]E6 >=Y\>]/%1V#KT^N?^.-.>^.)CWSB4ROXG=O]Z?RE/%1V]P8Z@/;?]/5F
M(/'O/L >$<DRO._S[???VJ1&CR'MM[<?'ZWU* /G?SOW3KR49IWV^'/&_P"N
M^-/?HD.M?STFWVM*G- ] 'I_HCMU[>OXZB_KOXV^_D!9(>-Y'_J'KV*<!O\
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M:\ ?CVB?_P!-2X:R*@-R9)//3=/[/^T)2C34FXM["N@4T>$"G;A!=4XF5 %
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MGOJ4A_/Q]3\K(%5';SY<O/8/+1"U_'EKKRN>:>*CL'NT]_-,K^)\4S1V#RV
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MYZCY<M5@'NT$F/#19!;2W99 Y#C8=^P?#?'3F&=\]=3W#P]]_%3/LW^:9W
M$,[]-L!MC&>>>PAMG2 -!"2>),\23\_8W*=\COM@.V<CU^'YX[:"VG,Z\=?%
M1$?-<0#&<;>6-^?7OMV'U9'?1$V$ R _ESZ#G #OSQS'IHB8' ;]>WAVSN//
M8<9W[9SN.B)D<=QY@//H&.6P9W !Y;==\D0!'EC.!$.WMWYB.,CY#D,[Z(IS
MOC?X<P[9'?V;!MGF.B*.>=@Y#T#?_2ZA[,XWSZ]$3;; #OMD.P=<\^P>>.NV
M2)L ;8[#@>V^<AON #G 9'XZ(F/(!WZYV''4!\L8]PCD<Z(I$!VWQCD/N[
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M1]VB*!# [ (>>^_,=]AZ]\B. #KG1%R =PSC?KD-\;>\1'. Q[<"&B* #EU
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M8\PL#(.X$$&=.%EEB;C\I@V(-C?CN'RG1-_+W?KJTCBEN?C]E&_</</ST2W
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M1W$E2BL?"6FBMOHXG=)A(3S:P"D :F9266(@)YA5&:PLUE1UVM$"9+OR\KZ
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M\;\\<R)D< . ' !C(9'(B',0]@\@$<^6B(("& #?J&<;8VV[\^N<=>8:(IP
MCD._UT'8<YVYB.^_)(&ICM2PN;"8F# GC *QEOAQ;6;L,O;XJ_NKO,;JR D3
M8E9*V+*MGUWI7^&NJ@QNA;%2>M;VRKP54FR61ULL81A354L>$]-.!NRFYXS0
M6MUS.$ ]D_F[I[96O5Q=&@0TDU'OLVE3!=4=,1  ZH)@9G0!J;*Q5<6XW^)6
MH3)K*$_!-:-97FF&VU7,DYXE9 V&;"3);F*4[E +7FJ2!IJK20-KE+\B,J,(
MHEI%9>:[-Z&F.J.D=_%^4$CA ZP!!!W'4+7R8S$?F=^#I&"6 !^)<"?RO>'&
MF!' $QO&BR'LKPIV#X?SE[I;> H$LP>J1_>>Y4C5.,SNG+3C!IJ//E%R)6J=
MYB\BH.HI.J2J7<4!-=--"5&G)++*HI4J5*A&8]43U1U=>0@:\(');-'"X?#]
M:E3ZQG,Y[B^HXF9)>1.\F)UF][9$?/RP&WBY==PST'<1VYZJ+?=9U @.W/ C
MT\QSOR$!SUZ!YYT1,B(#C?UCC<.V^>?<0QMC/+1%.X=N>,]1'  . #ERSSZ;
MXY@1-LY -N_7.   #.,?D.=$0.>.P!G'3VX#F&!#&-P\M$48WZ]QWP CL 8W
MS@1^0#M@2)G.?(.8#T[\AP(XY9R.^>0:(@AOG.<=\;>8X\OCN.-]$4#V'( .
M #KGL(<ASMOG([AD-$4@ 9[AR#D/G[@QRW$!#/+.B*=AV'KGIY]\>7Y;\A$B
M@?S#?'(-M\COOOV'8 VY#HBD0 =N>_\ +D(CSVP.V1VSVP11YAG<!]NVW41S
MMC;J&1VYD70>&9HD+4XL3^U-KXRNZ-0W.K.[H4SDV.;>J*J)5(7!O6EG)%J1
M05746>G4DFD'%U#087514("ON)!M<<O9"AS6N:0X!P-BTB1''3[]F_7T\\##
MG:56JE/!#<<ZPJVH]2Y.%CY&4XS+ADEZLXRM2<35!SU@O%JU2XT*2JGRU#DQ
MD):<&GQEWQ6G-RBL2TBJUKH']H 0^!N-X(B_&=^]:;<+4PY+L'4Z*=:#LSZ#
MHF^620\@D MB"9W"+8R2]UN)F";AZ^T"LDVV=D,F5%(F.JX I)386XKN2-5*
M-9:N\Y9"5H123QB"IJ8Y!5#+C-9QQ5*!">IH!37/1G**E!TAMW-:XAPYAH!G
MG9W<LQQE&O\ L-H4A2<^ T/ Z Q8]'6!'1DDVS.8X$:V5WV*CB@X6Z:#;7/C
MIQ3V/(&DP;.W,DY 7LA;53BKT%J+R/9M),\1)2:J@1Q*[ZVMRK))3ID-R4A8
M4I:Z=2H>L RI:' ?F/\ $# !YQNF 5CJX#$89I=A7?B*/[U%Y!J-D Q3JAW6
M G1^?-^K><S[!<4EGN(] ZA;]]5HY?%ZBD\\M9,FM9#[JV\<3*0_S"905[+3
M/39357XJ$;L22KCSP%%2AC>'-*-)]57L?3NX$@Q#FW:=T"#KON!Y #5I5F52
M0TY7#\S']1[3,06.AX$_O9<IU!(NLAQ]0C[OYB&JS<B]H\Q[X+-%@9 F8UW=
M@3(X#8?5D-OCCW:1KSX:BWL]Z1S'GZ*,CV'X?/4_./G_ "2.8\_1,CV'X?/Z
M_,D#B/ ^GOY,CV'X?/4=YU^OCV;K[Q 2!Q'GZ*<CV_+Y^SWB.V^I]?OS]P$@
M<1Y^G?V<391D>P_#YZ) XCS]$R/8?A\]$@<1Y^B9\A'W?,-1NN>_3WY\Y2!Q
M'GZ)GR'X?/I_AI//EH1O(WV\-X[DCF//TW_S3/D/P^>I2.8\_1,CV'X?/3ZI
M XCS]$R/8?A\]0;R/=T@<1Y^B9\A^'SU*1S'GZ)D>P_#YZ>_?<D#B//T3(_U
M1^'GY^_X==1 L.WF=QF=1'IR2!Q'GZ>^29'L/P^?U[M3_+W[X\T@<1Y^B9\A
M^'SU&O9V>N\&-1:/!',>?HF1[#\/G^>A[^W4\>?NW!('$>?HF1[#\/GIOUT^
M^OIX[D@<1Y^B9'L/P^>I2.8\_1,CV'X?/3O[_?!('$>?HJ%N9;>'7>@DGMM/
MV<M[B4M;#FMW0F5B2;316-)J9<@5%B![>[-:PI.XM+FEJ+5MKDE2KDII9Z<N
ML$EI#A8@ZZ6W[K@BQW'C*J^FRHUS'7#A%IS3N+3'5/ BX\0M<D<:7 *IAP?<
M25)4T=T\=5C&96[$A0FOC:,TP$2&3^DI L"9Y&3A3M,\2)*BUC>^$()2WU4(
MWI <5)N>E9 $GI&@G*"-;G<=UIGSW,)5;7INP&*N[HRT$W-:D08(F(>PP#()
M/YK"0,K>$N[<G8G4WACO$]J'B:19K-<;43YT&FE1=VV*&J@HG[ZI'PEJ+AP,
MHQ.SS)+32"IU0T-LOII,H<G"M-2HT.'2,;#3J-P,^O"TZ +C5J-3"UC0?=AZ
MU%Y!&9L26SH7,F#!TO=9\ZPJJ:(FB)HB:(L<W_\ Y<=]P#_A-;S[ HK\^_/R
M'OSSMT'8/DNY1_LJ7_#9_P!(7D[59 <" [#2.!#?.0Y!G;I@>0@/<!$QR,K(
MJ8)A4-3QT^'IXE&2(FII4TJ(PG86HJ/**%JBM4LI/9:$E#8;2K4F&*% &):@
M/.KK--\9E0U#))L<Q! B18D<#:^_Q[%7(S+E#6AMY:!8@\09WR>TJ5D+AR]$
MQMR^(QI<WQFM(9&T*MC:U"2/UH2:2$5;(E.2U$M9B,BB@A)4A+(K(*+I+*&B
MBD*=0 0203)U.\^5NZ"HZ-E@6M(;^4$#JWOEM:=XN.Q<D\.B*5F<(ZDBL<3Q
M]V-6'NC&0R-A#.XGN-?I7 Y>VEI:4:PU>8(F+C#R3*E5=0U'B;4(ZGK2'9W%
MP$ D@F->%]=ZG(S+ER-R&9; RF3-P;:]W%=>N!P6M@21:N%Q6N,-YY"I!'*X
M\TU,*)2E-%0E4HVBI'4W)CTZBH3R#B4]!A)PB<7537^(0)!+I.8[SKV<([M5
M!I4HC(()D@@%IY9",H'8 >:[:V)11P?&^3+XU'ELD:"ZR6R0+&9M5/;:28%7
MI2F]U.3UN",LP*JP,+3GETUA77FD<U97WEQ%[21KV1YSSE3D9F#@UH<T$!V5
ML@;H)$B#<0=5Q=X?$7Y>E=7R+1UX<T256A1.+JRMC@N1HEQ=12](D5K$IRA.
ME6DUUE+""3*2U)==5!Y=855!H) AKBT<OG)!,]_#@AITR07,#H)B0"0#,C,0
M709.A!$F(M'366_@;DPHHLX0F)+XNV 5^S8ZMCC.I86_[N(_=_N#0>C,;TGH
M JJ GT"8OT>:O -(".@D$D.()N3,DGB9E0:=,M#2QI $0X9AX&0!&X#[5200
MG2$$I4I!*5,G++(3ITY5!))))5(4%%$DE4TEEEET4A30712%-%(!2%(!@!7.
MI)/$W]\>U6 #1E&@B+ 0 (@0 (WG?.]?0=@QOXL!R ?K<1QD.8CZ]%*Y;COU
M#D&.8;>>W00SN AGR B=.0\\  AOT$=_/ CG//KMHB;^[8.X]!W#<.@YZ=?(
MB"("(;[X$ $,CSQVP&?;ML/J(HQG(@(;CN'O#'/ [^P1WWY:(I .?/?',.FV
M VP'(<#YYY@&B('M  ]FW0-\>K?W9$*M$4;#UP'+?G[.F!QY@/+MHB#OU'/8
M QRY (;XSD>>0Z\M$4@& QG?SVW  YXYARSS]NB*C+@W#@MJ(@]S^Y4M881"
MXXE%8]R21N1#8U("/%264!JE370%9Z@VJA.D2$@8K7*C2DJ0DY0:656AQ(#1
M).Z"?E:W,[U2I5IT6&I4<&M:"3)CS-N[4[E@M5.>)SC)H BSA<BX5.')=693
M7>N6,19'$!=)GK&NBD^TMNGU*:5:Z.NB?^D0SNXB098:E4)5[%#$8^C< S96
MTH+HJ5)LT0&M.MR202!NF+QK9:6;$XH?LLV%PYNZL014J2)&1AG(#?KNC3\M
MP5E#8SAGLUP[-KB1;2)%I7V0F_?)G/WY:LE%RY\Z55>D.=9S/WTU=)Y(M-/J
M,/"EP<3$:2HTTMN1HT_A(IHY[WGK&VYH #1_N@"W.(E;-'#TJ /1MZSKOJ..
M:H\\7U'2YW83E%H:("OT(_/80Q@1QS'81V'GCKU#6, ">9E9^//W9,_GTZY$
M.@\AZ;CL 5=@U*)Y8R',.?GD-Q#OUVYAN.B*1Q@0P(ASQR\@# X$,B&V.OES
M(F_+&1ZCC #L(8'&PXV =QZX#;8B;8R(  \P\N61QMRZ]>VB*-NF^1#.!Z],
MB ]Q#< '?ST1-@SOG ;[>0\_7G.!'GG?G@B#G(;YVR'+(]0YAMN <L\LCC1$
MZY :<#L(=_;C<=]^70-$0 P&V!WSL.W7KSY[=<X\QT12/+D/,,9]?0 [!RY[
M=PT1 YA[0#V9WQC&<<L8V$>@:(@^X>8=^W(<!R'J/;(=-$4"(AZ]J=\AU'?'
MY#D?6 [:(IW\^H#UWZ=AQOY=.0;Z(H$.O;.1W ??ZMLAD1[9 ! BD1 ,#N.X
M=,^7ESSMT[!ST11G'?GN.<YY;8#J(#MD #..?/12#!GU^D*EYK!X;<F+N\)N
M!%8_-(@_IJD;U&I0THGQD=$WB"H"EK<XDJ$IW@-IH-*&HH:B3BRSR:J#BZ#*
M0ZKLS26NX@D'Q!MW1PTD+&^G3J-<RHQKV._,US06N[0;>2U]*^&"^O#!6:\<
M'\LKN+:T@1,4\)EXY,M4HFE%0%55:2Q=WG<7)[A!M%!=!+9"IH8^0;Q5U%)U
MT9*"DVG+G8\@59:=U0 1.G7'&!^802=9NM9K:^#(.&<:M&X.&JZ-!_=I5()9
MO+6.#@(L1-J7;WKAYXR7ZHLJJ;6'XL[3IZP$D[Q6MXH+.FF#354)58"H+F$!
M7G'%B<!=<UM1+$ZBBE24NJ-\!<P^B+N#J3IZP$LJ$FP:T?EXVWZQ*R_Z'M*S
MOV.)IMS.S@4\12(U: "2YARWZQID#B)-]8YQ<7,X=CD<7XTF]&Z0/[P6@9^+
MNW[(<G@P4&& G2!?N$HP5J[0.IYE10'RYJ%WM6>88)ZQTAE&$%,&GGO3$..E
M%QZY'ZAR[=T1O*U*S:V#/^E-+Z9 /XEK2&M;^Z*M%O\ 96(!< 0X7)!@+9$T
MNS6_M;>]L3FWO+,[(TSBUNS4L3N+:YMZPJ@](N0+TAIJ56D5$&%G)U*<PPDX
MJNDPNNJBH!'#(F"((N9W1:Y^YYJX+2,S2'--VN:X%I!%HUD<#-Q<+T?KZ^OE
MJ?IS[_<\]RCW[]^JC CU[].F_P"7?WYTT]]RF1P\]_WWCP(3 ]^O;IV_7S]6
MH,:?7B?I;0R-VZ4CANX[[W^W+M3?N'N'YZGZ_2Z6X'Q'HF_</=^O+OUY[AMA
M[\/?U2W ^/VU\M+&\SOWY<_/X_/1+7MV7T]5&^^_JVY?'?STY:CG?YI:UCSO
MKY63?N'N_7Z[#J)N>/OMCPTXQ9;@?'[>^(3??</+;]?KMJ??OW\DMP/C]DW[
MA[OUY?6=/?W^B6X'Q^VON$W[]^GK_+;W>>SN]^[);AY]GSOX\KSOW^'JVY\N
M>?7SVT2W#S[?/3E;11OGF&/5^O/4>^'\I/">*6C0SQG[>^*;]_AO^>,^S'EJ
M>SSD><);AYV^4QWSS3%7</=^OG^6FGOAN26\#X_9,#W#W?K[_ACGII\MY]]I
M21P/C]O#SG13@<C^7J\PZ>_UZ>_<I:-+\5'XL\P]WZ_7NQ'&1]>SWQXZI(X'
MQ^WOQF=!OM'G.I.DZ&?HH48J_K![OUU/OW[A6EOZ3X_9,#T'X9^OKU"T46X>
M:L-Q V43WEBB*EK<"XU<N$N RFU<YI)J,/B\L()J* M530/C61J0)!,8Y6SU
M^,AS9E9P"2*HA(<28[*XR!D= <#?,183,$QNC7O57,)BI3);5I.SL(,&PT)M
M(,W%@?GB 4*B]45 M26IMG?:TTD+-JK"FDQXME=%F*\9*U'4(A^U8I(T)WI4
MX^*INEL(>:R3P\1YU":Q<&&;&F\:;IWF.%ICCNLMPBGM/#%KB&UF$")@TZS3
MKQRND7/5.@)*V&</5Z:;PQ)2#VWEQRY,-5EQRY<1])XQ9Y$42%=#BVU5X,5Q
M>2IZ?VS&', &A4W'>@,K!<B6E%8'LRGBTSE/+AVC>N'#F.=2J#+5IG*\<]Q!
MT<"+R-]C!LK^ZHI31$T1-$6.C^.'MX\G)9R[BH,V^(>_6=N@[!\EW*/]E2_X
M;/\ I"\<0STR&=^G3<1P/Q#&! 0ST&5D3/<<9YAD,ASY"'LY^K.^B*=Q' XY
M>O.V_ES$/ZN=$4!OORV#IR <CG..N.X8R/4-R)D WP([=?\ K>K/4<<L>H!(
M@<@SG.>G3(^6-AQN._7?<-$0.X!OVQ@1Y=,8 ,X$1#E[=$00#;/K$-\ /4>?
M+GOW'<>FB*>7+&.H^L>?7EOD1[=LX(@;=<YZ]?RW]H]<;[9(HY9';ECGRY\\
M8SD0  VZ" 8P :(IWSVSGSWVW#ED,?'F&VB)@!'KVY#S#(9 =@R&1[^6,:(@
M]^P\MN^^?=GU@(YV 0(GJSUVZ\_+/+;N& P(9T1,8QOC'/&P9]>W,=L<MPV#
MGHB>X1'EUYAN._/EVY!CRT10'<!R.=PY=?Y8WR&?#T#1$'(@( '8.8YY!D1Q
MSP \M\_ 8D<1XI(XK'?B&XE(9P],S)0X-SS-[ESM><PVELU"B"G*X5T),652
M:8WL#75706D:&HFNE?*96ZF)([%FFFMP=EI?B3$*+,;G($Y6&YJ7+1?21QB)
MXD"Y(!UL3B6TA :7O<.I3IQF<=P FP.I<>JT2X]4%6+MKPM32YTP9+]\:R]F
MG-PFE92\VSL4T'&.-C^'ZNH!%&:U(%E!9-Q;I)2JJ:7.Y\A0^-&K$U+#D#2W
M$)U*FYJ%@+:(RS8U"9<8M,&X&I@&+C6 L-/#5*I;7Q8:]]RV@'32I7G1\%[]
MV9P-AU=3.?@YS@,CTVY;=!QL CWZ;<M]8HUF#.MM>W5;]MW8+1;A&X3PLN6
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M.PHN)(D2PQ4$WI@S#B-X,>?8H=M"FT,)8Z*U-KZ$035>XAHI-@GK!VL[NM
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MS:U&AA;?,'"00-T3?WST6?#8@UQ4#V9*E)Y94$@B8:00X0#(=-AK-@LE \P
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M#@!QG'D.-P >X]!#&,>S4$ WY1OT2!PTTY*<[B'3R# ;[@ 8[!S]^@ &@4
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M!79@W-?2<Y^=[*U2M6=!AQJ,#1 O:T>9)U60]E+*NEJY_P 2LP7O:)W37UO
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M/$7TA57;[C3N))+D0.%26V46:F^:2$J/_M)JE3BM5(C3T:M26HI3GM)11M%
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M,ZE$WWW#/0,^W&.61WW[;Z:)KHF*L8I#U8$!Y9$0W$.W/ ]>HZ @W"0>#O\
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MRR)+KB6EDZN7Q9FK(+E+*\-Q;9,X>"FL:$RMT0ICE"1P:#C?Z('=N,^[%F5
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MIKP_#V.JT'5OA?:SP[:&SV%N$JU8#=K;*(<*&(8'6J5*=/\ 98IDES7-&?\
M>(S[?P;*_0?$NRV 8#'/#L92I=9VR]IMR]/0??\ 94GNBIAGD$.ISD;-S5[G
M$W+B=8H]-(:G(776:C&N)W09Z32DYKH34):!AN*/I*J*/NYA!=*.2GDA7]V/
M*H4"4626-=?.HXZC\$XK%[.VD]U+8==M?';%K0YS:#KUL5LB02>D:YP?@VN@
MO8YS,Q<0!OU,%6^,L-A]H;.9TFV*'0X+:U(%E-U=K9I8;:@+@&.I/;-/&93U
M'L:_JM+IHV\#X@"F,6)MJ<8\Q>&*O0*E;734H-GEQ5W@3NKY06G\=2TDH[+4
MP44@8%"4#/0&&%G%#KI?#V&JYL;\4;9:W#XW:3 :;*Y:P;+V11S/H88EUZ;R
MW]OBC+9J$![06N7/VY7I9<%\-;'+L1@]GO/2OPX?4.T]JU>K6KC*X!]-I!I8
M9K@XBG>FZX)[$_,*M# B[--QQ?[[2:M&^WB7I3:*ZD5)%(&L%O:%!5=5-=#4
M!G[3?2Z*JJ*W0THD3:J"*RJ:[*8[;^U3\15@3LW!!^%^'J50$=+,MQ6US3<)
MFN1T&%<0T] U[H!J F=I.;L'9@V#1RMQ^*+<1MZI3&;(YL5,-LEM1A@&@":^
M( +@*Y:TN)I6]-C+KOY;%/#P$%5W;4HCU$0\8TBNFT  :C5T9+&K\:QVC-8_
M>V@D*ZC3&ZH],G*KJ].91KXIW^:FVZFT+LV!MVHUNT(D4=F[6)#:6->)RTJ&
M,'[.NZ(;5#7O>!E"V,.W_.?8[, 0';<V(QS\"+&OM#90)-7!,=!=4K80DOH9
M3F-+.QK7923X5K5Z2;QUUL)*U9: YP6&NUL75TK]#3'9Z6%11S$>:> "D;9=
M0'[/4T5C042Z4)E'HZCS*AUM[<I/V9B\/\4X%CJK*5)E#;5"AUSC-EN(>W$L
M:V]2M@#^U81UGT"]@,"%J[$J,VEAJWPSCZ@I/?6J5=CUJW4&$VDP%K\.]SOR
MT\8/V;YEC:S*;R"Z[OF1:A/;J<<.14[)J27*D5Z&QQ31)5268='XDSM,@++<
MW4H*JZ25KP^4ICVJ@P/2%IVK[X2--1HC3K8W;G^6-D?%YV;%78V$^'L33?CV
M2&8O:%9V'?T6')$FEAL/G%9PMTE8,(ZD#I[&V,[9&V_A0;2S4MK8K;F%>W N
M SX? 4W5&E]=IMTE>O'1B 0RD7:/!&9O$UQ$-]AHJVIF1JJGEY[AKZXG9&T3
M:HHI?KAS906/H:/1A4)C9$8Z74+Y.)4II+:XU'DJI8J4 I,1)E7YJITLQ$RU
MK6M+W"P8(%P+B3)!M'>5^IL1B&T6@ &I6?U:5)I@N>=8$@!K9S/.C1),75%V
M:X1(M';*SJ#7I*:[MSOB _:+_P 2\M=D@F47$E,A2?=U:!*!_B4ML1AJ 4L9
MMRU)ZR C3"SMAJ*E,YBI5&0ZJYSPYO5:PY6 &6FYXC0ZNF;=RI2PK6T'LJ97
MU*QS5GAL9G$"1(B TZ0;:@RZ]#\--R9-9B:_Y%U_'Y8OE+ D4JN&^Z4C/IIJ
MO_:!L /N3>>Y&#04NN_:YOK21^?M@U [/Z%.WSPA.>F=7 Y/:JT/ J-;)=^=
M@-FO U&EG"\Z@@VO>N'JNH/.%K%P(O0J7'2,%F$$G\S08>#-LKIW*MN*RS$P
M?S(?Q!V))14<2%C 6K(HD//I0(;L0)=50;-[%RM9D"A9IJC( R-KUH5T12<)
MF60)JTM-#A4<IN8"65)Z-X@$0<KK"0#:P+29M',JV*HN)9B* :,11DLF '@2
M32=QS"2TND-,VZRQMDW$L5QZ(8_P[<-KA*XVBEK:4KXMYJ:WJV"3</4%*6*F
MR3V77B?134QWZG+DWNL*(;"_2JHO'BW^:D>(DMA6*,K:?0 OJ00)Z("8J<#K
MH.TR!<&9.!^).-#:&&,!PC$.T-&G'6IN$']L\G+E_=I]>QA;%Z?X86 M870)
ML9ME::UD1)(HK/.2LD8B,2C:&DHJFHX^HLA*B0HR*0"JNL3#:@S4)QYGX]89
MW.G5SG1%[ Z@FT=O(:@K?)9AZ0 (ITJ0ZH)+6M9 X6UW'=I86PYX?XV_\3-U
MBN,RYS(XL\'943@Q<'UMY&B-2+8]#'<H"G^^\A9U=%)R">772@0GC*=222OB
M5N@+15A2MDKL%-ZI%-@IM-W$.>02"[^$G6 1$7!DZQ;4H,=B*OXJH#T;9%!K
MP0 PP757-_=>YUF@Z")LO%N"49P-WG>;[M9"@GA/O>\)S.(AF0D&F-UD+K*Z
MBD3;Q!($":BNE)#)M_FC!>7[L050VN9++/U-9A/[?JHNTBLS*?[1@FEQ< ""
MUW& +$R=T[A2I."JFLV#AJIBK3(@T*DF*V46 >;/$:D.F2LS[I6TMUQ%6HD%
MOI>0EDD$GS(3Z-<V*Z*C"P, IQ8)3&7E'69]S=V==0A?HX]H#?3(G!*C7)3<
MT4C5A#W,(=$.:2""#$")M.[2_-;U9C,12+7$NI.:USG#421E<9,2PD$1,&"#
M(6OMGXTI=P[Q5[X=K[,[S<+B[AQK;$K),K2BK)4\7S6\UJ4%O;AQ@XHJI$@,
MH*1UEWSK$S[K;MP:7I[6B6U.#/0?F-(U"'TG#HB>N3<4S:<YOEDR1>X(BXA:
M Q;\.U^&K"<4PY* :)&)S2*;P9B&NAM:+MC,0 1.7'"MP_K;*1-]?I\[))C?
MR[SU3/;[7")*KIHD$R5)J"$S P_>!J/;H% FT"8K!6.CT25 T(JEM2:ER=7,
MX_'4=G,7Z-K<M-O <0.)M??>0MO"X?H6.<_KUZAFL\1!J&"&L= EE,2QFL6M
M:58*]$C/XR;FK.$ZV[F>99"%N24_C$N*R**Z6]Q)3U4+$/#%'7M*912?(IA5
M2G478K;5'I8O!ZJX^M,*<Y0"4JS6"DT52WKNM2:=\_O$$D6'SG="UZSABZAP
M]-W[%K@<34&D"(I R(>3&>\Y9UT5T.)GA]>7-C@5U>'=N9HU?SAU)%1:=&GH
M)98_+X32F)3RBPDC!+02F*@TW9DA2%K+,I!+$Y0CCTF14DUM9OI%-]G->26U
M#,&XF)GA(U&G=<K+B,/U:=;#M#:U#KT\K8#FC6B^!</%Q,G-J=%>.P-^H1Q%
M6^23B'UJD"PA2>P3>$/9?W&8VVG+6/W>20*;LIG@5LTC85]!R50G4E%EKD])
M#HW5JFM<C5GU<S(0(L)R.DWWF=QU$0((!MPS4JPQ%/,QW6@,?3+B'L?'78]L
MCY$;C%EALXNC=]GK=EY=WA12Q\$=])(J>UCF8%1<:X7[WOJJHUT.7F?B*CMG
MKQ.)XK0/_HV2&7',4@9^SFR64"3ECI@ /[72 )S"+1.ID:G=, &"M)SV[/J$
MN.7!57.O:,-4UC6,M0SKE#2)O-JBL2R/'%A=M#QAW!:5[;:>'D+VK@X@3^B4
MH%@M#H36DD'$?)F1:66<EDEQ$50M]N$RY.6JCUN3*'$"$[G*%59=7GHF]$(+
MC!K.YEWY;[A$$"!:85Z/^DU!B:@'1L!&&ID1,DDUG1$O=84W 2UA@'>;U<4/
M$2?9YG9(/;IL23KB/NR>ICEDK94G"-;D\"4/WZ:RNDBH5#-;.!):JY!-9">!
M*<M"D!J2'_M9S0%5TI4\Q-0C+28)<X""0)L -2382-8TN5EQ.(-'*RE+Z[QE
MITP2&M)UJ. !ZC!UG$0-[I@SX, X+K:,W#K*;$W(HJN:LNS2YR"^\]=RJ2)%
M<JYDB$M8]S\55(FJ&1R;G4I(?!J4)P#"4;.PI68PFII)-U9U2H:C7QE#",K"
M;  WCF8N3>9!LC<&P4'4*@+P^36<Z#TCR 0_4@!KHZ,1U0!;4GRN&:ZLOBK\
MLX4.(-ZJ5WG@#?6? IRY#2F*XAK2HJP3LUPFLP?Z%1-FA/22T728$]9JMM?2
M@?:"_P!DOB4TL\3^T9^0F'@?^6XZ 1?*Z]R9 T 48:JZFXX6L(JL_LZ@( JT
MQ9KVD014,0YNHL8$RNQQ/VFE[?)(IQ4V(:07WPM(@4-4@B:02TU=];+K%-*Z
M5VF<CA\-%;TB-I&66P<%7IA:)DB!#0%#=(W814RS^R>88^0!> Z!#K;P83$T
MG C$46@UJ8.9N6]:G?,QQ$$NWM),@C@O-;[UQKC+2LD.LN\K5=M5B1$Z7OE)
M12IK7,*.K F66.HK I6U3]T54&(ILW&"6JBS*F7I5>%KFDHI&D: <7 3!#3<
M#7S)M:#;Q-16;BPUE$GH@&FJZ8+0 .I<S.:0[0P-9673X_0ZV<04O#TM:XG#
MHHU4>D/.$I$VM;:B)I(2IB"P"D  *:2DB)&FHJ./-J)2)23#C"BJZ 9G3 ).
M^;::^PMPN:Q@)(:U@D1H+;M-?O$JRUIF-]N!)%-^;@-2IH5."0UKM-#G4H2E
MD&@:CPU&.SDDKIPDFDV&FA>\^(!4M;10VL0G4B2N+&7%HEC3-AF<#K,VMI!!
MD6)!O:%KT&FHXUW@MG^S83.5A)@F(AQO(O;A<*[Q:8(FZG'% -,<>5 GG%TA
MDIF=C:_QJ**0V*0N=8@)X /HR5PB:/@H45AJ+R!%HN;F.9Y<^,=^?\KMV0DS
M '5)Y0-=;<8TTJ!Z:$3\W'(%@9H-"@TA06(4GI%!57I$RQ(:&1+4)S0I,*,I
M'G^&H:J*JJ11[DQX:>QP5G-#A!M%Q:\C33Z[EU6%P5F45-COX:'E  %GUA2%
M%#B2'X2W)+3U*5 'C.+IR*8\:B:_#^#)0TG\I%VQWJH-N@]!Y &W3D 9\09#
MEC;U:*RGKN([!GGMGL(!N/,-M@'L&=$49Y!C&X8'.<XP&>FV-^F0SRT1/F&.
M>0[\PZXZXSN(B&FJ*R/$-8:&\2%L'FVLQ^^(!./1/D2EK,8*256\G;&>"Z*3
MV'N98TGMDCC3G04L2GDFTT*B/O34OI.;'!<E/LQQIN#FP8U:2<IM%X.NER#H
M%AKT&UV9'6((<Q__ --[;MJ B(+3>1<FQL2L&X"Z*+\QFXW!EQ;MY2&_-OFQ
ML,>G)GK,9*;B14A;0-O^):T"\H"SVI0#RA1K%!C56*RWEQF\QK4>@I%N!3D=
M#(JLNQTEX),@W)8Z)$M,"1,B) T2A4_&4:N!Q8 KL;E&7_S@#U<0P3 L)/Z7
M ME9:<(E^IFX/$AX8.(%>2HX@;5,Z=V;9<!%+>WW]M$:J!L8+O,20 I))?DR
M@"8]=5A1C65'9F%*Q-22Q21AI&E5NE2G!8YP#A^AQCJQPC3MW+2;TE&H<+6$
MU&-EE3*,M:G^Z\ #\QF'-,9702#(6=U0X#8>>,[YVWY9SC/?U:HLS1)N-)BT
M7MK$3'#M7#(]Q^AQSSL&_O\ ?HKP. ]B=(N;>'@F1[CV^6-_\/;C1"!P''UF
MW\^Z4\0@/,0QW'?RY^?0.G7KHD \+\!;Q$>)W\-$\0XYCS#^?EU]?OQHF43H
M-#].>[L\)3Q#RR/KR.?5SY:*<HU@=D".W35/$/<0^OT]6X\@T491P!]_?ML-
M2H\0]Q]X[[_7;;XE.4<!X"UO?&_E/B'N/O$!_/XX'SZ:*,HX#P!'R\I'+>@5
M#D=Q'/3G^6,>S1"T0+ 1OT^<SWID=]Q#<>N>7(-OY;;AMHD#@#8;HUU)GZWL
M;IXA[C[_ ,^?NZ:*<HX#P_EX[U&:NX^\?CVT@</?LE(;P'@/93Q#W'WZ)E'
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M:E84"](2'^C2EI5U)2Z1\)9-%(B ^;QOPMLW%XJICJ-3&[.QE;_XC$;*QM;
MNQ)W.KMIDTGO%Y>:9>X:N*[V#^)=I83#,P51F"VCA:0_84-JX.AC6X:\D4#4
MRUFL)']GTG1MGJMW"H1XH[J5^-$J&'+XKZ M.5 %D)CYT'3%$UF&E D8@14
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M&-,(WIOR.(=>FZ X<R2,T<1([I U6MB*)<&UZ1+,11<'4Z@M(T=3<1<L<#!
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M0X=L[,DLV'I<&99#'+_TSMR'KV]C^MGXP_UC ?\ +,'_ -I/ZHO@S_5]H?\
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MYY#USSP&XY'<0WV'H >W1$#&<  YQN.>8;=^8"'Z8#?1%.V<AG8.70!$ Z
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MC X'F.-PSGH13MRZAOL'+(Y$.N,]@'?MC1$'W]<B(XP'EG([>P<YT11SJY[
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MF YCN("(7;H.P?)=&C_94O\ AL_Z0O(P.,<N7GCGG&_4=L;[#YB&I61,\QP
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MR(B&>V SRYX#;D(>_!%'NVSW'(#TYX$:NX\QZ9#8BG/+EV'.=NN0]P^T #;
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M4^>PCMUWY[XY!SR& P'Y:(H'(],X#;&0SN&^>O+(;^_8=$3<.H9SV\A'?(Y
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M'=Z^2?NTL_Y]-_UC?^Z^L!IG' ^7JGXIGZ7>7K[DI^[2SH>F_P"L;R_]D/\
M+F.F<<#Y>J?BF;VN_NZ^(^NB?NTL_P"?3>\W_NM,XX'R]4_%-_2[R]4_=I9U
M/3>P3?\ N@TSC@?+U3\4S<UW?'J5/[M+-_Z=-OGF)O7_ .I:9QP/EZJ/Q3+=
M5UHTC=WJ/W:6?\^F_P"L;_W0_E[N>F<<#Y>JG\4S]+O+U'S\=$_=I9U/3?\
M6-'_ .Y:9QP/EZI^*9N:[R'U3]VEO_/IO^L;RZ#_ ,3S\O7OOIG' ^7JGXJG
M^EW@-=X_-IS[+67N,[:<W H VLJL3A*\/HQJV L# '/BII_KAC&<[YU5S@Z(
3FTZ]RP5JHJY8!&6=8WQZ>B__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>g60414g03b67.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g60414g03b67.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1=T4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %UB^678X0DE-! 0      " < 5H  QLE1QP"   "   < @4 #%-E8W1I
M;VXT4%]V,3A"24T$)0      $#F6\_XI@5Z]%*7\;DB@6W4X0DE-!#H
M 0L    0     0      "W!R:6YT3W5T<'5T    !0    !0<W138F]O; $
M    26YT965N=6T     26YT90    !#;')M    #W!R:6YT4VEX=&5E;D)I
M=&)O;VP     "W!R:6YT97).86UE5$585    !0 0P!A &X ;P!N "  5 !3
M #4 ,0 P #  ( !S &4 <@!I &4 <P      #W!R:6YT4')O;V93971U<$]B
M:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7
M   !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L
M.$))300[      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,
M   7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
M $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B
M;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC
M 0       %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O
M=6) ;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L
M=                $)L9"!5;G1&(U)L=                %)S;'15;G1&
M(U!X;$!T            "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0
M  !09U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P
M(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D            0
M8W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M       ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO
M;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^
M-0 "  $#O_XU  (  3A"24T$)@      #@             _@   .$))300-
M       $    'CA"24T$&0      !    !XX0DE- _,       D
M  $ .$))32<0       *  $          3A"24T#]0      2  O9F8  0!L
M9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M 0 U     0 M    !@       3A"24T#^       <   ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H   X0DE-! @      !     !   "0    D      .$))300>
M   $     #A"24T$&@     #-0    8              ^P   <+
M  $                          0             '"P   ^P
M             0                         0     0       &YU;&P
M   "    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO
M;F<          $QE9G1L;VYG          !"=&]M;&]N9P   ^P     4F=H
M=&QO;F<   <+    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC
M90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M  9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/
M8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,969T
M;&]N9P          0G1O;6QO;F<   /L     %)G:'1L;VYG   '"P    -U
M<FQ415A4     0       &YU;&Q415A4     0       $US9V5415A4
M 0      !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L
M 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%
M4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M
M#T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU
M;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO
M;F<         "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L
M;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #
M  (_\        #A"24T$$0       0$ .$))3004       $     CA"24T$
M#      ,NP    $   "@    60   >   *;@   ,GP 8  '_V/_M  Q!9&]B
M95]#30 "_^X #D%D;V)E &2      ?_; (0 # @(" D(# D)#!$+"@L1%0\,
M# \5&!,3%1,3&!$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# $-"PL-#@T0#@X0% X.#A04#@X.#A01# P,# P1$0P,# P,#!$,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,_\  $0@ 60"@ P$B  (1 0,1 ?_=  0
M"O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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MI@V5N=W_ )*2G95;J%&5D8CZ<6[[-=8
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MP;AEE(UXE9U%S-W>6L%1MP+KN$20+@&D@F,  ZB84-KM?O;&N>:3K"&ALN=
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M"'"1@P? @CX$ J*)/B_X_3+1?KG-Y14IUBZ@"/UJ^3)T-V;&L(2UQ1L.V0Y
MF4^Z'B[MD8,':M,H= AS+)H2-4:D3EP(JFK"K4 : \@,(+<Z$&1XXDQ.!)C4
MJII4R7$L!+P0[&H.#X9@3&3 G0(]Q>A\\XAT+F_-**F,%-5F\.O5H7%K]G+6
MDU80DN-,5,_%6=*K=L.&?2./3KI)217YS3<(98)+=?96VRO<Y[7.=D%N3(
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M4*:L%Y%^5HM54H&W=TBN[A>1_36-AZIM\0!>V!@?!\N-]T**7\JAOXH$;?\
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MYY63*?1MU2EML*:9^+X6DZU#C))ZE%)V0B81,(F$3")A$PB81/\ _?\ A_\
M3"+1)XDV-'-N@<MX^)O/CN:YS OQRH4KHJO WR&IJK[(A%C\S=9IWE,>N*^1
MVOH7PQIT*+;FE%-W@B.G2X*3Y=^4XYVU1<USR*@= +F[^FZV0,FD&WAO_+/"
M".07#2(:]K+J9 <0T_P]1LZF&U2ZPN YYN(,96]O.)=RUB^1U_[9SV_^5LD5
MU0ND"-\10-\I 88"%0H?*-ZN]GK]IN<#;C)218;1!#02%C>+F=/#V6Q8N!%
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M!O"00X5' $&<@CQ!D&);\"X5O>YUT2[7<%>(I[IO595S<N?1[MQBXV_J,75
MY_6(MRE1/'R20Y)2P\%%;W1:M4:L6+;:K=.&'C$]TV?(Z32N6W-#2V&LMAK7
M@-XG&/6 /<<W$D#+B!@!6V>ZUSG!P+WW7/-,N=PM$D4^!HX8 !,@ G)*O+F*
MZ%PGQ@V2Q(BR1\*1&F.Z?EQWXC#K$I[6V]Z>D-.-J;?=UMEG>G'4J7K;3>];
M]4)]"*D7VCA$>+\3NC/$+56J>PX,*16R%H[9>.#P);[U7L6F1$6UT!B06.$Y
M^T[1"H\]"0-G4A4<HXAMAO>;4!-5H@G.C6-J'X.@8ZZCDL-HC=.DAN-2]U/D
M?O-!/D.9\E9/@W[C>,?RGYU_M /F;^^[VG?4K5G<;[+?H%*^55DPB81,(F$3
M")A$PB81,(F$5-+O;+%Y$6DMQSE164'YP"E;']DZL+7I*WE:_P"U\YHTS>MM
MOF);6_9/&&/=CBHRUL[]Q2],3-(# '.[QRUO_P#8^'0<^FL%:FI5.NT6N":G
M5!44+7P<1N$-'1$[2TRRCUWM2UJVIU^0^YM;\J4^MR1*D..R)#CCSBUJH229
M.2450?)_S&#<2++YL#%2R71S()B4,(RDM-5>NR#+[L(7.,.*4N9-U'4VZ0=A
MPHCJ5M-,M./(V^O3=F,N@G2=,R>L?2>OO@K"\6Y1 Y%3&0*)CANQE)<BP7>U
MR_51"UVTFK3Q8O+=7ZN;;4]O;$!E>][C06F&U;6][SKD.-QF(&@'0<@BEO*H
MF$3"+\9,F/#CORY;[,6+%9=D29,AQ#+$>.PA3CS[[KFTMM---I4XXXM24(0E
M2E;UK6]X1:H:O7^X]W\JPG:P4LB2X%6[W)D50P?EQX]>4$"1%!YKM:JTF7N4
M[().JFLCCS M"G9#BI[LMEV.XTSL;6L+3AQ F-9F8)CE G.- -22VR9BB81,
M(F$3")A$PB81,(L6NQXO5ZH=L &F'NAF!4%<N!2:O,K4"P6-Y*T)V.$R[B=K
M%89F+0I;C:C)\5#5IM2%2D+4A*I: 2 2&@ZN() \2 "?@"?!0XD D-+B!AH(
M!/@"X@3YD#Q6BCQYD]<M=YX+R>1SKR7$T'G][I-Z;\<^E]6\(85<X<("D-F!
MS]DG4@Y/\H[C7>4.OQ9_.:78:L')SB@ZLQ+D6?A0OC3VU+ U[KJ9<YKFFHUM
M<EY(C%PW0+L7.!( FT97!2WA=38656L:6G=N=0#61D26N-5P9'"")N N*] &
M<*_H+\MQV-NJ?VPSMY;.HZWMMHVZIC2E+TPIS:?C4SI:U*TWO>T:4I2OA]=[
MWLBCSIRA%=Y)T1Y<T)5 HF@V^4^3GVDES6O@(,8"1D229&[5IKZQ11<!M+DR
M=:P;6RE=CMO&!Z%3(C6MZ4:=2M6I4J3'U:M6HRG3IL::E2I4>X-8QC,E[W.(
M:UD&XD-C*SJ.93I5'O<VFQC'O>]SK&,:UI<Y[G_<:T N<[[H!/):]?LE.[\C
MZWP.[UOGG2:W>K'1NZ=WG7"$&NEPODP9!OO:NB6FFF'K3T,>*O%K$V@%(01#
MVZP06YQQ*)6YVVRD8A%C_P![TA]'>V^P*NS#MCLZOL'\71:_9S5%(MJ"FQC:
MC6FB^I3:^F7-#Z1<*E,.:7- <TG^1V)VQV9VM1K'LW;:.UC9ZSVUA2=4)87O
M>6$BJUCRUX#BRI;:^UUI-I VI9\ZO[:81,(F$3")A$PB81,(F$3")A$PB81,
M(F$3")A$PB81,(F$3")A$PB81,(M<OVB4JK5X-PB_65_C]C<I'4B<T#QGM\6
MW$:AUDN3H%I%^V)@4:B=4L3=VI,!^;:0!AOFEQ'B8+!S<V&+7+BGQ6]"27@7
MB6@%[(!8+AJ7.:+3H1<V3&3$'FVFT"FYUCK7DM8^2'FTB!:UYN'>!#'1!P-1
MD/V>D40]S'IMM"L4@!$Z%VJP7!SG/,*K?ZGS?ETMZG40+)JM2C]'HG,SAC11
MP+]^[/8XE#K <Q=;A9'H8Q#R)4B0V@FYH,FU@%SBTN<)<9<6N<,3:!<2&@ E
M3LT6.+;0'/)M8'!C#:T$-N:PD$@N)M +G&!JK\Y@NA,(J9>?-K,57QGO'T&U
M*J16SM.TN--36!UJU.39Q)<=(&N0B<\>Q"9<C+>F.E&G79<5N$IN+&=>?3\.
MM$"\$MN S$QH1SZG2/%4>"YI:UP:3B2+L09$2/JLZ\1>@"^B>/G-B R-,B?=
MVNBZ,09F)3I6R=.&0@LJ0PMO>T.Q)FH[<R.I._B;0_\ +NZ2^RZG5:@A[N<D
MGXG_  K 0 .@ ^ A63RBE,(F$3")A$PB8117T[MG+N-LAWNDVV%6='Y+D42V
M]&(3I,Q;&V=27DQ!<.;);AQ/F&/FIKK2(K&WFD./:6ZVE5FM<[03_8?$XSRZ
MHL,L'EAX\5W:&I'4ZV6ENZ3MD?5')5QGO+7K6T-)BU:,7<0ZKUUKX']-;2K?
MHO:=X#'G%IZY$?W,!%C.O)>Q6'>T<S\=^SV_X_\ LY.P"('-ZY)UO7ZKC)>U
MRVGE,[_;M:1V]ZU^Q*E>J=38!WGM'@#<1Y@ _5%5SR'&>>W1I=:16:RY0 $Y
MF8,F5^A=$ARI#3DU6FG95Q,I^B;=CKB/;:8;@[E#XR6)#J](E/,[7=IICQZE
MS<$#D!G)U$QR'4(MC?.J.#YQ2J[3*\+@B!P09&C;BCD*U'7,]M*R$Q3COJ_)
M?FS5/RI$N4M<F2ZZIU]:G%*WF1)<23J47WT&^5OF5/.W>V34P0@&&N5(5KT5
M(E/;WIJ(.@L[VG<D@1E+9AP8R=_$])>;1ZZUO:M "X@#4HJN<TX'"ZB8WWWR
M"JT<G?;#+&E*;42+DO8_F=4&+=D5H&] ;=CQ29A>G_JAO9:+(:01>]M,2,^B
M3I=RZT6-/"-2/O'F9Y#I'((KJYFB81,(F$5+;P4(^35V)<>J$Z3#XU3I[;':
M+D->6UNV%HZTO:Y97)S6]?&QK:4;M\Z,YOVF5;@;4W\2&R.@%@N/>/=&<?\
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M-S'F(WM(C-^W)3)<4QHQEV28$QC4\SUY>$=2.96BX;S01S"@#!<%V81,&_\
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M&OPYYF-#F2(+41_6C)? =;+7R8)(:&ESH (ET P)$F <%95K13ES;@',@$@
MN+@UMQ((#9,N,&!)&0H.I/4.\>/97F%4ZS2N)R^>=7Z8$H .50/)_KW6NBUN
MP7/XF NAXCM-!&SKC3A[T5"C+=?M0E=2 IG6.'69 F"1;C7+:;PXM=4N8TN-
MU-C6D#J6.,./*09,"9(5&OJ,+0YM,M<ZT%M5[G G00]HD :P1 S;"V1YSKH3
M"+^*4E*5*4K24IUM2E*WK24IUKUVI6]^FM:UK6][WO?IK7Y[QKHB\/',[M6^
M<?\ 2!^;]$K-F!&PO8>^^0 8C- F!Y6$[(O_ %/R Y**C2) ^5*9TN2EBL%H
MB'-M[?ARQTUE"H\B-)=_26P[#M>T_8GVSL.V;)M.S5NSC4VBDS::%2A4W.SU
M]C[5%5K:K:;G4W-?6 <T.:8=Q&"T>);3M.S[/]J'9FU[/7HUJ>W31J/H5656
MBI59M6P6/+'O#7-+*9+2&D2)&;C[B,_-J]M3")A$PB81,(F$3")A$PB81,(F
M$3")A$PB81,(F$3")A$PB81,(F$3")A%K!\L*Q8>F=]K?.BWV=OC?Y, W:!/
ML=+[)VZX1A\.&L,1&QK+0WW7/'CJ+E4,QY!N*7$#IAR/ M8E1$@(6_.#GAXW
MII$-87#:*E,W0YC&R3C#OYC)&HF)!QH5R5PY]1K/X>C5%I<U]1Q$$&"W^6^#
MD$"<B3R(%Q?'&OV6I\UC5FQ<.Y+X]-A"<V'7^<<5M3=LH\0"IJ+):(QI+/->
M5QALZ:1D$DRQ<>LN-MZ8:FJ)R79SC,;&H072'OJ2,N>(=/\ U/GSGW+>D'-9
M#J;*<$@-IF6QU' R.>(\9SB><HM%5/SAI!SH/B5Y!URM3+XQ87.2="G AO-Y
MY0?:+*<'T\W)!UB,L"RNPS(Y@RF S)# WHLT]I*0CSDD:0GCIVM%P;582&Q<
MT$N ( +A)S@0.9TU659I=2J %P-CB+2020TP,9@GD-=%%?G'9_(&E<%N9;FT
M:EE*E(Y380-F!$N?6RX7I$XA6#R)Y2%)%=&I0@:$B#D,H?>FP2<J'-^.0MJ6
MPM,9N:(87 .D&YI!N#6ZC66N)/O&%6N7M8XL@BTX+"3H<X<V!$<C'0Z*L/9
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M2!I8EJ()(21L2:\3B78 7M#G%@D<8$V]#$C0]#(U\%2I(IO+6"H;3#"8#O\
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M')LK;.EK!QP$*8:>)IBMBXK\U3#2I&HTU&L1[YQ'6<=5!T.NATDG3D "2>D
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MMMBDDTO)W+5:\7%UC.[;;!M!MBX">]/%TGE"KNS:&[RIA]UTBXBZZPF.['#
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M<)$NMLNR08FZS(!$78F%FS+_ &'=^O3,@;SG7,6:A77.;3FBMCW=YU\6X?\
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MN%E-=\,^;;KX+9RU>3&C6PPSZQ\7F/Y7:5]4^28^H?%J/VGY?6_F_>]=,?\
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M$RB1*6E<Q;NTRR)"2GT?G2G'9+G.@.<7!H@228'03I_OHH:QK22UH:7&7$
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M;S/)UZU(=BP@P4&-X:CB'P21<&-'':T%Y8YK9 +^* X%H!&JDUZCN*FUI82
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9 "[?(4IA$PB81,(F$3")A$PB81,(F$7_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>g60414g05i05.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g60414g05i05.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2+&4&AO=&]S:&]P(#,N,  X0DE-! 0
M    (JJ^B'0X0DE-! 0      !<< 5H  QLE1QP!6@ #&R5'' (   (    X
M0DE-!"4      !#'71?E=+5N]=N^.93 Z7E<.$))300Z      #E    $
M  $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E
M;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M  MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J
M8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M  $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X
M0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
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M4'AL0&Q<H^         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W @
M56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !!C
M<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M      QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N
M9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU
M  (  0.__C4  @ !.$))300F       .             #^    X0DE- _(
M      H  /_______P  .$))300-       $    'CA"24T$&0      !
M !XX0DE- _,       D           $ .$))32<0       *  $
M 3A"24T#]0      2  O9F8  0!L9F8 !@       0 O9F8  0"AF9H !@
M     0 R     0!:    !@       0 U     0 M    !@       3A"24T#
M^       <   _____________________________P/H     /__________
M__________________\#Z     #_____________________________ ^@
M    _____________________________P/H   X0DE-! @      !     !
M   "0    D      .$))300>       $     #A"24T$&@     #-0    8
M            !6T   6=          $                          0
M           %G0  !6T                      0
M       0     0       &YU;&P    "    !F)O=6YD<T]B:F,    !
M    4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG
M  !"=&]M;&]N9P  !6T     4F=H=&QO;F<   6=    !G-L:6-E<U9L3',
M   !3V)J8P    $       5S;&EC90   !(    '<VQI8V5)1&QO;F<
M    !V=R;W5P241L;VYG          9O<FEG:6YE;G5M    #$53;&EC94]R
M:6=I;@    UA=71O1V5N97)A=&5D     %1Y<&5E;G5M    "D53;&EC951Y
M<&4     26UG(     9B;W5N9'-/8FIC     0       %)C=#$    $
M %1O<"!L;VYG          !,969T;&]N9P          0G1O;6QO;F<   5M
M     %)G:'1L;VYG   %G0    -U<FQ415A4     0       &YU;&Q415A4
M     0       $US9V5415A4     0      !F%L=%1A9U1%6%0    !
M   .8V5L;%1E>'1)<TA434QB;V]L 0    AC96QL5&5X=%1%6%0    !
M   ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX    '9&5F875L
M=     EV97)T06QI9VYE;G5M    #T53;&EC959E<G1!;&EG;@    =D969A
M=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%4VQI8V5"1T-O;&]R5'EP90
M  !.;VYE    "71O<$]U='-E=&QO;F<         "FQE9G1/=71S971L;VYG
M          QB;W1T;VU/=71S971L;VYG          MR:6=H=$]U='-E=&QO
M;F<      #A"24T$*       #     (_\        #A"24T$$0       0$
M.$))3004       $     SA"24T$#      8=@    $   "@    FP   >
M 2*@   86@ 8  '_V/_M  Q!9&]B95]#30 "_^X #D%D;V)E &2      ?_;
M (0 # @(" D(# D)#!$+"@L1%0\,# \5&!,3%1,3&!$,# P,# P1# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# $-"PL-#@T0#@X0% X.#A04#@X.#A01
M# P,# P1$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P,_\
M$0@ FP"@ P$B  (1 0,1 ?_=  0 "O_$ 3\   $% 0$! 0$!          ,
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M@.6RL6OJ ,AA.UKG.C8L?J'UG?A9_H/QGC'TC(=#:_W7NL+AN8RM_LL_T?\
MP]GZ%.,/J.;D#,<\8F\$.#06N<TANS<VEU5WLV^Q]^5_Z!T?S:/#W1?;OJZ
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MV?>X;B/H-]ZLK!Z_UDU7#IE.,_(L<*[+]ND5.L;7[)8
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M)E16=>(H*3A597>5UGB#A8>FM+6VP]35_\0 ' $!  ,! 0$! 0
M  $" P0%!@<(_\0 7Q$  0(#!08$! ,%! 4&"0@+ 0(1  ,A!!(Q05$%87&!
MD? 3(J'1!K'!X10R\2-"4F*2!Q4STA875'*3)#1#58+3)3535I25HM3B)D1%
M1F-S=(6RLV1EA,+#Y'6CI/_:  P# 0 "$0,1 #\ _?QI"&D(:0AI"&D(:0AI
M"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0BU5W[VVOL1%3YG=28,\18R
MC"4Y!CDL3DJW-8H4$)2$#0AK,I4NBXT]0312F1EFF4@8!A@4%!493TV2R3[=
M/19[,B_-66 )"4C,E2C0!A1\301YNUMK6'8EAG[1VA-5+LTA(4NXA4V87(2$
MRY4L*F3%$G!(-')8 F/6MG="$7>B:":P!\3/K X"<70>3DM0D5)S*B52!Q1F
M!2I0+TQE(TGI%199U&::O")==%=46NRS[%/F6:T(")THLI-X*#D."%))!!%0
M0:BHALG:UAVW8+/M/9T[Q[':4E4J8Q0KRJ*%)4A54J2M*DJ2H @@B*M>7EHC
MC0Z/[^YM[*QLC>L=7AX=5A#>V-;8WIS%2YP<%RHPI,C1(TQ1AZE2H,+)()+K
M,,KIHI$0P 4HA*$E2E$!*0"222P  !)).0$>BI02"I1"4I!))+  5))-  (H
MRV=W+97E83)1:N<QF>Q\E::V*'2,.R1U3)7(@LD\U K%,976D5@F4IE5)"BD
MLPQ(I3*RZ:DR@DTS:TV6U6.;X-KL\ZS3KH7X<^6J6LI5@H)6 2DY*9CE&-GM
M-GM4OQ;-/E3Y144A<E:9B+R7<7DDAQF,BXBXNL(WAI"&D(:0AI"&D(:0AI"&
MD(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0
MAI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&
MD(:0AI"&D(:0AI",+^)/[0W@XX098R0?B.O8TVRE,D8 D[(TN$:G+V:O8A7J
MVP'"A1%HN^(RJ/OR%6G]B>H*49)&OV/LZJ*ZM$RIBTE2$DAP'R<\Q\XPF6B5
M*+3%A)9V8X:TR. W@Q=#APXI;"\7$&<;E\.]PT-RH.U29=#E[^@:)(R$)Y(V
MM[4ZKFL4LH9V1P,,3H'QJ45*"DE:2L%=)99]1I1Y9=5H7+5=6+IT.-,<S](O
M+FHFB\@N'9V(%<&?'E%_\AW#XAJL:0R \A ?>'UU#2$,AW#XZ0B<AW#2$1D.
MX?'W?GMI")R \A =(.!B89 .8XZ>_MI"(R'</CI")TA'BR21,L187>32-S0L
MK"Q-ZIT=W9S5$(6]N;T1-:A4K6*U)A2=.02277768:910 !O4&=62A4Q29:
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M2T__ +.XEOT_^]&^M_\ 2?XC_P"OML?^LK8?G.,8?Z.?#^>Q=EGC8;/UI+$
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MA=!K,I,;EHJ')"<?2C];;?P/;!\-ROBQ%H*T+%Z;8U2[JI5F,Q2$3C,)-YP
MHAA50 (J!R[%^*[*-M+^'3*\,@'P[3>*O%GA*5J1=K=20IDX-=8-C'Z<=?F,
M?HD-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$:V?M1;070O38!ABMO
MH\[S=B37#;':Y\ 8%($N\NA1$?DB9,F3H_O*,Q](:)@KB\@5L*=26I5%-8+4
MY:PYNH0JO=^'+98[#M25:+:_@I2L7@"H D-YDIJ4G T^=?A_[0MD;8VU\,VN
MP;#,LVU<R0I,J84H$U$M=Y2!,5Y9:J A1P9@SQJPX%.!MJX<N*6"QR^EN*XZ
MW76/*GMFK8.4X='XB,SN(MDEFZZ6+6UM>E$<.=&]3#3%\I8#U<O;V1Y?[7.Z
M5:T.ZQT05^GMW;ZK9X\C9LV?+V>62N4;P2K,E()-Q"B]  X#;H\/X)^!4['E
M6&V?$-GL-K^(95]<NVH2#-DH (ERKZ0!-F20HCQ"DE*6"20*?IR$:2Z!&H::
M*:0$:A$<4T@&XB(C@  .8B(@ =1QOKX^/U/!O;/7=&/<_P"+GA7M6)U-R>(^
MQD&-($:3DTINM!V5;14%7A&C[BO?"5E5059I$*2!$*L4_P"D( .B9,U7Y9<Q
M3Z(4<<,LXS5.E(#JF(3_ +R@GCCITC"2ZO%=]DE=(UVD,VN5PW325'QAPC1-
MPZ(DV3B4,[4H1+R*/X5*TL8>5J4&\%ZQ0@^[KJ:4IYQM9'LZS:QJZ42;<$^&
ME%H$MPI24E02Y8.0"SY'[1Q35;,FK3-F_A)DY*5)ES5IEKF(!<E*)BDE207)
M*00*X&D?F:E5[(A(QM_+9/>BVTX4WBH>TSO'Y&]50-;9Q>ME+VX/L&<V:6D&
M1='#5,G?7^7$/!<KH3G#)W"IV2)P2"?7^N? _P 8[,^&+%:K%;=CVB:JUSEK
MG6N5X2U3I)DINRU2YI0%70A04A!))("@2X'YO\6?#=LV]:[-:K-M60A-FE!,
MJSS%*EF5,\0WYLL( )2;Z?-F4DZ/^I'[-*<6KB/#);NU1?$98>XLC9CI :@8
M[;W@B4Z115A=Y"Z.<=AS:I0N0JE"=A:U!",H@A)0W-]5!C4R":S-Z$VO\R^(
MK39MH[9VA;K!8IEBL=IGF9(LZDD%"2D _P"Z5$%=T%D7KM&C]!V%)FV+9=DL
MEJM:+5:)$H(FSDJ<+(K3D::XM%/_ &G'%[<WAR8K=PJV=-$4<;N?S*E,NVO2
MD*B(N:PU,0E1J+D."<]B/GDE3.JU6U5O +"T+4RNRU&QNZFCVS7[_P  ?#.S
M_B7:YD;3MTNRV:SIES39RM,N9;25W3)E+*DE+YE+J9V23'D_&6WK;L+9OC6"
MR+M$^:5($Y*%3$64A+B9,0**!R"B!KBQ\7[*;B7O'>]IOG!KT26J;.]L7Z&/
M45EJI.E)=U<+N*EDQ2!E>ZT*% E5.#&\P=^\*H2SE9J%>C%2?52!%!>O]HWP
MS9?AC;:+-84B78[39Q/LZ/&5.4E*5&6J^5^=)*A^\HWOS)9) C'X'V_:-O;*
M7-M94JU6><9<Y2I7A E0OI"0Y! 20[,02Q$;<-?G\?:PTA#2$-(0TA#2$-(0
MTA#2$-(0TA#2$-(0TA#2$-(0TA%NW(:?OZO/_P /,Z"/^L..GF./EUULEV'>
MOI@T=\L*N)8_NC-LGUR#/N;=%G[@V0M#=2FFJ?6^C$B6E44T)7M0W$)I&W^"
MH:BZVN3(:4L@:C2ZQJK*-;W)-668(U4U!5J0M2:)=L!Y:#+$OQ=C]1"I"%N2
MD UP*DJU+,7!Y@YXESCB\<)\^BU)JRQ=_P"5LXT5 :1"[SI*;O0BJ@!'_,D[
MJH6,5R&D@:1P6:$R=RD^*0H;S2_'2-TS7#+EN#C<9!&_\PPI2C\XLE5JE!I4
M^8D D!$TB<D@%F2:K1C3S%CE0"+6/<RX@[;TU([T<-KQ*XZ%!A*R?\/C@7=9
M@-*Y_>7&W*].Q70;B#2?%4<E;(_,2T]5-18KE'B+$R @$FXNZ2PNJ#,V'F/E
M-!D7!Q%1'2G:*@&M,@@ ,52[TU U)EW1,)-/RNU:YQ8!F@O!??5?(2;)SNNT
MEQ5Z50CDQ=C)@\6*N730II.+5$36W)5#(8YUC[8\E8DG<%<Z:JJCR%*<:JC"
M]:_M4/>EB8D$LJ@PWZ[QJXTB#9ME6X*\-294QP?V"C)7>%02B\-<P7 T9[A0
M9GXQ^&F4GRR%O=N.+&-%,M#"1%[DT5V9NTB9A5%*525GG\20NUN7Q>H-3(5!
ME<@M_'BSBVY.B*<6\3U*T^BURIC!5Z411WOC^E(IO>I/$Q6V6*W+"&M"+0F4
M@)EHFH\*9= 8"^A-Q19R"SD,"7>,H8S]IQ9%O-2-'$A%;E<(<D//^X^*^$;&
MBVJM>!G@J+9[XPX^36E5)Q :3"*W:4,*T\L1J!OH\)@49&0IVED3,Q=Q(J7N
MXAP';$9BD>,LS)):T2ID@C$J252\0!^U2"C/ D&NXQL$C<IC,Q94$DB,B8I3
M'G5/0J;'V.NR![9G%*;2%9:A"YMJA2B5D&4"%=!I!YE%5(A4%0AOK(@@L00=
M#0Q8$$ @@@X$&AYQ[N0YYV[ZB)BS4"X@K.W0F\]MU 9VT2:8VR54HILS("W
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M%!0V2!MH?(JY-JT]H?$1*8MS;%-9R4\Q&B4TT%JD:8\LE12[-5G!J*%P>4"
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M ;W-X"NO/0QBF3:$,PFI;]Z\X#: 4[#N,,%^(*QW#=Q%7KX6^&GA;O\ R?\
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MZG6,4W+@KNY;ZH%?#3Q23-H:D]8'$VMXA6\R^T$.HH_"#<BF"UR8[Q1U-70
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MQJK,D=GKDQU<35+&$L],-=<@ME*9+%' @HJA]3U)S@1F=W["U(*5)2L&A2H
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MP,#D4P\8W%M: NE/Q%\.C?>F-IJ2J#+H\(ZQ2L?P)"H"3%C]8.X#@CD11@
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MWIJ]F::7G/@KKI\-0TO3?X >8'H[]>) C1I?\2AJPQ[[TCE_';P_^36#]?\
MQN.G3_\ =)GY=NHZ7IO\ ZCW[YT-+_C5T@+[>$/_ !:P<=A' 7<<\CTVS:4
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M4@<?F5YFV'D1)CN!9-QLM!)6Y.I44?V=7 U:EJ<4$K=),YM +%MS*0I[MT,
M5)5Y%8.0FOF?=AN&-%39B +RB5-2Z0I)2" 5JS0Q)K4,'QB^EQK[7'M3++G6
MIMEQ+RJY%I#6?A!6RJ_L@>H+-7WAVHO??E9;NY3P7.$+ 5%R2%5LRTLY9J9>
M@<F^!&*OYI]B$1K2MY-$H"@%% 209A*:^8(2%!+',NVN.Z+*F*25)0M2P?#
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M &S.O_S)-59'\9_I^\:.O^ ?U_:'\S7X_P#));[_ -LSK_\ ,CT9'\9_H_\
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M(?(4)E!9J5W8')"K"J@"S3#2*C"J[HF*ED*02"-].D56A,P75@76:@ +ZO\
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ML;/MGP8?@:V'\%L>R[3LU@5(M,BT2Y M4^TI22A:"HIM$PS?S)GH *%$LUP
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M4&%&\-8(&#L"JZ]UW%;3P2&\(=[I*[W#X7[F+[)7KH,-JDKO8N3KK2W*;U]
M4%'$W3LR[)4S6['4&4%%JDMS[;.!E?LJ2RS*::QJ$HS !XJ/$0 V6ITJQ>AQ
M&.!B19=F6TJ5(4)<W]\)7=6FC>:62 "10DI=J/@!DDQW[X\K%"23.(O".-.
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M5LQ*@:%(>VP<%5(?&IVQ8E.%*4G(A2<\"^[Z5;(_2*V-;DJ=" RBY-XWD@5
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MJN*%MW;GA?NVY.UV.#:\+M8ZXP+:ZY&]\/$B*B!W\8) 2#4MVK$O[<IA3NN
MRDFA>FN!;BE]K%,30"],-% A"E34AIB$*23BIM]')(#Y!QQSBQLFSK<%+L\S
MP9A'^)+(27- #)5^6K$@I<AP,VR5C_%-QHV*$E'?2T[!Q400BN@LVZ'#BF30
MN[3<CHH&BI;)[#S!]J8I$9X_ :H4VYGU*JHL3Q20J@2BB#<S+DJ:ZI2%5HI)
MN/7][%-,R^F^.&=L^VV8DLBT(Q'A^6:QP*D'$ZD=-;OM7$Y9CB161BZ?#5,F
MJ<74LLI>"IA9MS3+H9> ^WLI3("I["UMOYH5'9/'Y "EIC,ICYCPV)VAVD4.
M;6&MT1H7A2YIJ%"D$H4P"F\R2%(=Q6\'#'7$\'C@*TJ4Z7$Q )5+6"A837%"
M@%8TW/JT?G<^TC;X=92];Y>;AB2&2.N9M 3AI5QN5.:<VQ"UUD2..SE'/;</
M"TJ0(%2^<+5[DD@3@P>V7EJ'V)D-; WQQ?13]_L_;2=I;(E;'VM-G39D@ID6
M"9-6HV>S2DJHH)!"5JEA1 *@LA( & ;\N^(?AOXFLNV)WQ%\,ID#9%CLL[:&
MVK(A$HVBT+!(F2D%:21^++(#+0$,M0>@C>'P,<9;JZV'%FN*T(G)_A9L=M[9
M]C@K&YM\CNJ4@B#94GCS/&'AX=5%;S&ZRBR99(3'(B*1U"M3+Y0X,13<\J2?
ME]N[.LNS[9X-DM?XR64)5,G !DS%L2ETELW +*9B0'CZ;X+V_M3;^R%V[:VR
M9NR;2FTS9,NS3$S$F;)2$F7.2)B0IE.4$@72I!(Q .Q6S4,?(A%5:F7U(#)Y
M-I"\3V>UM9U2IL(DLC-*K_@;8N-2H5#BSPYD2LT(8W-4B2+'-EC3>N6I4ZH\
MTFCQ"7.X4' =O'UZ 0'.)J:#$DGC2@TB[6HB\4%<^Z$ LQ!)#<VZ,G;X9 XH
M0E4R&3.H*!0-9"YP2-*.M0"0A2IJ^\.2]&C*I)(,KK/4%TA3OD)2DJ(2D.3@
M. ?Y15:TRTE2S=2,27X9.8L[9WC0X6[_ ,J50>T-Z(E,YBD9CY";%TM3FV/I
MC&E4)TBMV1MCZW-:M>@2*5:4E8H0E*2TE:@D%%17M:,V,M:4A12R30%P?D8J
MF;+662H$L[5=N8C)X*@'<!Y<]4C2 U '4/S\L[=,[9[Z0AX@[_6,_ES[:0CQ
M#)/'2I$EB)CTV42E:RK9&ECPK"?XR>P-RU"VKGDMN\?WJIM2N#FWHC5GL_84
MJ59)/C$RKPA+%B6+#$Q#AP'J02!N'Z]M'M^(._ER'Y]O?J(F)SGEI"&D(:0A
MI"&D(:0AI"&D(:0AI"*#N=;2&7A@<GMK<%G(?8C+6P]K=F\[%)@4&8K3+T"D
M $YN=VI700Y,SJDJ+6M3HD2."(XI4F*,IWLUIGV.T2K59IBI,^1,3,E3$%E(
M6DN"#\]T8VB1)M4F9(GRTS94Q)2M"@""#N.8Q!R,?G$N5]F7P^R#B^CUB$,D
MNR](;6VH*O7=.?J)6UHI)3(9A(5\2X?8,V S,+?&FK^5T\;NW/U"XB- _G.3
MNSJU#M610SI6[[E>W-J_%%I&T-KS439DB2BRR2B6F6E(2 5K2D W5J+*6I+$
MJ 9A'Q<W96S?A^1^$V=),H3ILRT3/-?62JH2HJNBX  $ 'RMG1ZSX,.&&YE/
M'S/II_;U<6ZU@>$4IXM?#PN[(U4PF%=U+F0"+O$S;&YR<T2YM/;XJP.;,@=)
M*TEP]]-7+*V*LIU2U2(UPX+:ME>'>4H,XO%V-#DS[J:5:.BQ2Z&8$I?4!C4D
M4>F&+$: YQOLUYT>E#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0TA#2$-(0'?;0%
MH$/&GJ^-VXAP?<="]4X-LO<(GQ=VK+?5D:A$+E$N>5O$#:$JAH;#V1J96Q00
MJ7W$M32#<Z5)E%)#<JMBTKI!6V)W6AQ/]:P30$&6IJJ)2=[ %)8Z!W(YZ^5;
MI-]5ZM6&(#."00]=<V->$4)PJ\1?$-$;X\1UB+'\-RU2BN[4?Q76U0W.E%<,
M+M\$D6LD)O#2JC<B0QNJ5TF3X&Z:FQV%RBEB3O$S4(:YHE_BASDB\G;5F0F<
MF<HW0L $@.%* &+5#UQK'J['M"E2U2$B\4%W) -Q\LG#AB<0P?3"3C=^SMO*
MQK8;<6X)S^T0-YDL[DRZ/V2)>5Q$!GST<B,;U+@MC++_ !.)Q)X2OLQ(9HJ4
M\RQH:%9!*11/%5*AD9T_TOPSMZ5,*+#M&U"7(LJ"NSA:_"$Y3!!$R:&6HH0!
MX8) )J0"*_D7]HWP1/D)M.V_AS9BK3M3:MHEHVBE"4S42I"B\U<FSJ"Y:5SE
M)EF:4I420Z6=1/Z!_LVHO*H?P<VF89DQ2!C?4A4HIK&6E*DDI?6H)<^41N52
M%"N)3+D#Q)8U0SO"Y(L1HE19RJJLY$DK,%/1\AM^TIMFU;7.1._$2RL(EK%
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M43Y:I,PT25H8+8TNK!(7D6+'=0QM +CM^ZZ*:R[O6SJ+KI"NBJFR;Y72--0
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M4'2F7#=WK'H2UD(0 S!(^7'6.B846>762=10:2;144:492%19A9@#290934
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M3@H#];VI\8?"]J^!SL[9:!9+5/7)DG9RI2DST*$U"IUH!2FXH>5TS+P4Q -
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M,I)H000T\VN@K0>$H77N'&Z?*":X$!V>F- ^,;R[;:I%)J/Q* &\5(NSBEF
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ME4B'TMI'[!1&*4B[D<03Z5QPS K'F6=3VA!)H5J203H*!ZT!J*$UY1OB:VM
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M=QKHKH$L:O%0.OH$,FREW;PE'R[TN6?]'K6/ FC_ )2C3Q$T I4XUJV9?%^
MC] 5JF<R.VOMNP'44%G,<"A[.:66%%)=!K;'FY$91127^"FBFLD0I"C\ 4@
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M0]VTV#'H&O4_UJV,?_5Q?+:O'_\ 8!]#7C'G_P"K&U?]=RZZV%7_ +U\H?\
M8[I<'_C^2]O_ 'UY'+GC:;:?ZU;'_P";B_\ UK__ &&\^L1_JQM/_7<O7_F*
ML=?^=0_['=+@W_M^2?\ LN(S_P#WM\O=I_K5L=/_ ).+_P#6N&[_ )A _P!F
M-I((_OJ4VGX%5</_ -IKSSZP_P"QW2[_ ,OR3W6N)YAMG_WML;]^O33_ %JV
M,4_T=6V[:O/_ & 0_P!6%I=_[ZE@Y_\ (37+_:CD.AZ/^QWR[_R_)!ZAFUQ
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MRE;,D3:T-<F:H?<5<XT)HO#IZD8&>F2,RB$/BM.)"FF/N344M4%U1XR"@7D
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M_,:A@",Z146X75%2$**5!/DG2R@.%$)4M)(!( #8AQ@ 8S2:+MRI_P"'MUO
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MBWMRHBFCDS@DFG+,N@]Q&5P2LKR+XD8E1"I0H;$+E'U<:D;*O9TRI6R.JB?
M:\2IBA!(!24X;E5SS;41F;:N9=N)-9R9:@5!0(*004D,"'H6<C6D9I7LO\[V
MXF$!M9;VVB^[=VKBLTUEC-$RI0SPEI00NW81XB5R)\E3P0O(1 6YR^,,K.WI
MFM>J=75W+IJ!$WI5Z]-DA 4%%[@2Q<L]1@^6O/*L=<R>4*3+3+,R84E12*!@
MH DY8J#.*US%,3+D_:BV]MPMK;WJ"A''F)VXB%R[NPNY]U+96HN9#$DO;%CR
M3#(= I6]4N-U+A-#8W*ECHR,2IM9ZJ5+(C;)(XNCR0@*NF0I0)JHFB"$J4"1
M4N0U1AB#I&"K:F6P5+H$I4LK6D+!62'3+ KN 2QXFG"#<4MSY;Q1,$(22Q.M
MMF_<3=S8,A0A'V,@Q5;QGX-;?WDC"&E>#;0ZEUDS*0K7O[_4II<SRE-+6L4G
M-A)*0NRT)"+S&\$5/F<*OD$L=V H!D:EZIGK5- !(05S&=(=A*"D@@@5!J<'
M);"@R@NGQ8PVS[W>AAES ^EKK262:[Y-E"04A]=S6-R='^-#'843[2DU1)TT
MP:F>*FMRFDL3'.9Q+V-=5#M2!>:4%8!!(!64$N626!#T%&=Z/1GK&\RT)EJF
MI4AC)2%@9S$J+>5Z$I8%OYB](L]5Q>2IC3S_ .Y6]?YF]MM])#;Q0FF\LM];
M"WUKT[#:Z!3=P12.YGW(Q$G9Z%,D%LCQS@V/THD,B5KT](E,C?0J03<<^50/
MD!H%.JI%'?3F^M8R_$*2%DH"E>+X8"UIEB7=!*KQ#IP*2&%2&._)?AQOFQ\2
M-EX=>:.-BEE;975(T=;4H<FMZ% [1"5OT*?TZ9[8U*MH>VVA]CCE_"GIN/%*
M[MGW-R)H)I4>QH@@I64E\ 0"&IKKC3NG39YJ)\L3$W2+\Q"F+@*0H!DJ8 @\
M-PSB]OBJ[C\>X;\OR^0:1T!(T&F&G'O>8>*KGD=]O+IR\_KKI$74X,*5WYX[
MN\HGQ5?/GT#.=M_U'IY:0NI],,RS5I]!GOB/%5W\M^?KRS\-_EH.G"%U.FII
MAPQ;K3'?$^*H-\]-LXZYW]PAS']=(74FC9U9\LN8. ^D/%5L(#T'.W+H/EOM
M\<;:,.Z?*  !-.#UWTT:O3.+5W?L=:7B B1L'O) (W<&,UF>W)1/R(#%36NI
M /9NC"[IZD[Q'7E.(!6D>6)P;G5(8%)B9849334$I)0?*2FC4-"^HSPS?YQE
M/DRIJ66D*=KI.*3B""*CD:Z1@@\<-W%-PY :OX=YP/$E:M+4%9=A+ZR(&ZYT
M;;J*JZA06NOX:G45R$":3 +1,-Y4CB96G3)TH7#;J?'4;>]+6 )B2)G[JA5)
M<G\R6%T)#/="7#YUA*G6RR43,-IE@,J4ORJ2FE)<V\Y=S18.@8 /A#Q,S[AM
MXCHPKA:^"O\ !.-58%-N+76_GA4@LK?Z,2Z9I%;>0KID$?4$KGRUK4C.<GV4
MN\?>97;AU9&Q8E--<%"M&D/TEIFRUN2%RF# >9!Y+O!-"6%&Q&1$6F=8+?+N
M7"+83X:$K(3,O*_*Z@R52TW57RSEDW:.#<2QMO+O\#UT6>[MQX 9Q8Q%C@:*
M%MDHLT0?&KG6@3J$Y*>:/J>R[FY'M%U:95]W:*')P8).EDK2VL@IXK!J 6N*
M9Q3#^(#(4$@,Z2,2V8=P2QW @;VZML3=JVP614\RY\FR2?#E)DBX4$(0A2RD
MAEJ4A"1>H2$@$1O'L?Q%67XC8M5+K-7 8YJW)3@1O:%&8<BDL4=?#XC&*9Q)
MT)12>'/Q&X',TE:6QQ+ /:"G]G5375Q+0N666D@[\#P,>$A:5ATDEJ$$,01D
M06(/)HO7JD7B! !# [@.D(M%*N'^QLZ*<")G:&V\J+=5Y3JY4O\ #6!U%:YD
M ;24X**UJ$ZLQ;12<=12J&KVW@..I&L:33 JZ?QEKNH1^)GW98:6GQ5L@:)%
MZ@W"D>;_ '/LGQ)\[^[;#XMI6%VB8;+)*YRT_E7,44.I0Q!)<&N,7'88^Q15
MF;8Y&69KCT?9TA*!I9&5 E;&EL0IZ H(1H&]$42D1IBJ "DLA.4670'*D,CK
MG)*B5*)4HER2223J2:D\8]!"$2TI1+2E"$ )2A("4I2D  ) H    !01K"XI
M8O187BNLQQ%Q\"6Z'\1KLU<-%_$!8TT$KYC6UO#EP\7%K+$OPU/")X0NUIW!
M2)M!JYMFD:*- X&)(73[VP[3<FKLZBP6+R7+,H/@-_'Y5\';=E"D)GH2Y'D4
MP+D%@,P   :CG%-014HM#Q].T61C2FA'%G9QQGM2(O'LB+VV(<(Y''YT H0P
M2?+[6RZ+D*:BA&A35;R@TTL#AJ-,]3:*'*9E,"DMJ"]2U34C%P -PCS-G*(
M14 C-JD.#DXS)8D"H.(C9#2(#W\AZ9\\]/V'7F1ZRD,]V@26(.[B3K2NF.$2
M/,?GZ]=(H.GV[I$:0BV43/\ YJDS_+Q$#6IL.4Q2+58 :#"T"CPR%S*$ Q52
ML=201$&A55XD[=L( :(!HH7$A.9\RAIH..+\HH/,HJTH.^\8N;K.+PTA#2$-
M(0TA#2$-(0TA#2$4'<ZYD&LY 95<ZY,A11>$PQH4O3^]+ZQ M.D3@ 4DIR:
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M"5J:#W#5QUCB#.F)M@=)G.<NU)QK>VMK3#5;"E8X[0^/<LI>7BAC+V5)25J
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M:-7$:C:ZC") @-+H\74N2BT A200P98%0*YN,#@YH^>$<AERYBK\I9E3,[I
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MQZD]L/>@H?U3\\_Q=X=:A>*FX6]M;\7O,3ISJ7TP<X^T>B@!!4;Y+DT.F60
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M_P#5K<BWDFBD1H%*;4(&!O\ WL7I+J:"K;JE^RQRC'^ZYQ_-,E!Z4"W P?\
M,SYCUWU_;/@6A#%+V2ZM[IU-N)^[T<4&+XS*[KBS$Q*!.)](%G++96FC+<TP
M"'+!*H*H+??X4[RV@"P$9+4%7A#DFVV;.<'RIQ8&N%*4<-P &9ST18$27*R9
MB@]2]7YT RRC-^FBFFBFFBD**: "FBFD II"FD III"FG 4TA2     >$-@
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MW'ADCB@O-11L+M,53;EE,)KJSXR5CNSR9RI\-7LQJ<3*Z-JQ"BZR$E"<"EG
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M?]I'PM\4?$4S92_A_:(L:+$J;,GH_$3+.53**ES $?XZA=*1+44IK4L[6/\
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MV^FVX  "'0>H#G&.GI[^L1<@$$9,17IGV8THV2A"Y\X%^)ZPS;36?)F"=?:
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MT[RY=M!AJ/7VAGRJ^&-QZ<^> S\N8:AJ@T<9[L^%>G,B#;QZ^W?"L,^0_+H
M>>-_WT;K776G>56@V\>N_<^7RAD1Z#[\?O\ /2N[<'RZ?+"FL&_F'K[0 1[#
M\OEO^7IWT(%"<G[]X-O'K[0R(=!]V/?USZ^7/2C4;)M,>VU,&WCU]H>+R'X?
M08]-@ZX#3ASWY=\&@V\:X]],='AGGL. #(C@.0!SV$?KWZ.V) U!+YY&GMI!
MMX]?:/-1/;,YGJDK:[-;@J0U>%:F1."-4H1U>(:?"J)(/,K(J\0#3@T*1\0"
M&,@(:&@<NSMN>F'!LM^<5"D$W0M).XN>@KZ1Z0"%7+?<:1P(#@0R @.!'<!
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M;ZA3T8XELM"='%/I%D@$G$TP9OJ1UI&&<!J&Y/&3>J<5T%*&&P\&B5BXN?\
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M/G[=84K0[JX>D1OW#X?U_7\M3]?;TPZPIH>OVA^+N'+MW]_;IZY\HICOS?'
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MZ7-%%C^:A8TI&1%!=)=%!95-!91=%)99=% 4T4444A111133BFFBFD "FFD
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MS1JURC=TZ'K]H;]P^']=.+C/'YUP](4T/7[0W[A\!_?Z]^AJ"XU&]MW&E(.
M00#3>,>G>Z,8.)#A=BW$ D8)"D>7*VMZ[>&J7&TM[8F413+80YGEC[5N7%&^
M%-+H"]&4EE2VWS\*B/R%& >,I*XD(7-%O9[3-LB@J6I5UZHR5G7 G3'=PY+9
M8K/;D%,R4"MO*M_R*J LAJ@.QQQ? $QAFDD39><'O@SXWK?Q]BO :UFN*-(D
M-7$0*\[$R&E_=KN6$E0FIW5K=VI5[!T6QXAP1W$MBZ"4=56:@I1/:KZJS6F3
M;99! O$ *0K@1A0MB 2_6A^)MEBFV":$S%.@,TQ((O5&!J7#@D @5<"*VA/%
MW+N"ET:K0<8<BDMPK5O)BMLL-Q,(F%QE$R>5+<VJ7(FT=Z8O$VY8]+;C$-:!
M2,9N QLI[5/$:(RJ0ELTF*5'.OA;0V892C,DCR*-49H)T.#%Z<S@(]K9MLFV
ME<NR^$N;.6G]D9:5**PX"4%*0I5^I9Z$.Y$;%; <04#XD88NG%OBY"F;6F2N
ML0=V^4,IK&\-D@9R$"M6B/3B<J2**01NC>HH4MZU:E 5%20TXIP2+D:7QYB%
M2E%*V! ?&C1[,R7,DS9DF<@RYLI5V8A3.A3526)#C/3"+XZI%(:0AI"&D(:0
MAI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0BW;E3_GZL<B'^7,Y<O\
M2'?EW[]=:I-!0:#=G7?0%GKC1GCO060D,/RIJ17 =T^<=+'F/R_;Y#MY:O\
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M5)411@^+8#EK7$1P(F&SRRE2KH39$34$BA6I[Z<R5.$T8YD8UXM/$'<IIO!
MY-.[U2&7Q=UEW"]&$S':2[,";I+#76Y4&MDC5P:Z?#3+XDB5S5EE\HEJV7N]
MRH!()%+6R/O(&LK<Q)(PKH1P4 H6$)!4$+(*KS4.+W@W!^.-(1,4)B57[Z;\
MM("#YTJ,N6JZM) )!425*1DP21%*V6XC^):42NW\OD-Y;>1623NXE](M.8/(
M;W+9HH8&^)-%S*ZXZFX8V/AZ0+;?.5GE488713)UMS02O#<TKZ97()$9-&CP
MV4B6AV22!=:AHHE-X!S@2X&-"685BJ)LU:DD3$WE&8%GSAKH4P 9V%#0451R
M'C)/[/V\<L?YV?;JX5RY7<R8NMD([<BJ1L5Y(+?2QLK3IWM.S+Y_&G=MB4/N
M#:Q^EBMW35D6QD3 RQPAL1*_Y>3+E3*Z*2LYJ6%]F25 $E)<&KAB6<&KL7;K
MT619*R%**E&4%N%I5+5>8WP!^T!4#1*F =F>*0NEQ27HLU=231)]F*Y1'.'*
M[[O>^\B]4RH%%4@X1;HOT&C<$0FGIT1 I44%-NK<E>F7I*:7%15PS*"UYZDM
M8KJ462B6M .%\%*27:\EKQQS<:XX4>*3)T^7,NDN)9,U= RD3 0B6[4""27#
M$W$N3>+X_<3[O>-]M6^,MX)\]L+N[V#X:;X2LMN+B[8IB#I...E&X51@QX4,
M*BLIFMI%'%JCR>A0?6DI.AZ5W7&JU!CD>MF6$(5^4*%Z8AB30I05/B?WM:MT
MC*>5JD^8D RY4XLP)>>ATN1D*$"NK17D)+FEN@N_>.$WNN*8!7VHD(MT$9H=
M(\KM[*X/<2X%F;>3 R0M29BI*?W:3M,K6O!<D+6$JFUP3M9T>J;$I2E.N.%*
M2DI2/V*U4S4$S"#KBE+C"E:$N0E0\28A:E VQ/F+?E6907=#"B@2:X.+K !L
MO^+]I).XJ?L^W99-7R*(TT_OBWEID3HRMK4].JFRC\K;&9;_ !1M5&JE+^8A
M-CU*)&J3JU[<YN*- )*\U.K3YRRTN:+KFZA6CD3$C4?Q%QOJ*-'1:@/Q%F5?
M*75-:A/Y9:R'=QYKS5SQ>-=UG9K?'APX6.$:56NN'/9Z\7!X'N)N7$VSD]38
M]0TN46IM$T3RTZ6(QI"R$J&HZ/N%7\%.(;CCULN1J#J7S^)NR@E45NH(7-FW
MA= F2@7>@6NZ2"]6!:I8,X8N8YD&9(DR5H*BI4J:HI9R2B7?0G-G5Y017#'/
M,+@<NC=J0WG3QI_O'"+DPJ1\/R:X[DUMW$ IXA)'3)CI/'T3).TCBU\/MI6"
MVK%)T#A(4#A!#WDXDY8WMBB(1MN3-,E4FXS4BX6 37%BQ #N"2Y'(OCI'395
MS#-"2L*!EA2@E25+O$D7BU$XU!%7P+$1\;BWD7DWMXCUDXXI)799XLK>2P\3
MLU:AD2-#TW3B&R^*6R>#BU=KR6PV4W2-NY,95,(12]-RE2HAG\& ]@,:UL=>
M#E$I#HEW4!5Y*RLWGNM@58$,,WJ6-:Q"US/%F$K*+DQ*$RZLH4R'\;L^6*<B
M,9K$<0/$9/B[<2&=70A-;C>&%7U_M8M@JOHNF[Z08S0"9."]C9+!M?#\P56,
M=[52MM:6!::\W+K0 W4KV*3N4PECRSNU=UH0D$7314IE7%!)*C><+O$*-X8!
M.&;!CS2ILU2+Y(=<N;>=:5/Y%$IN!(6&8,HFE7QC(K[+'(#+.8?_ &*/V=M6
M_P#^CXX_$.> S@.0;ZSFFH&#JF$A@]XJ#-B:);"E'WQTV*I6P %RSIH^-PDN
M[YJ?G&WVG(AG([Y[>G;;XZS;<.R_S8\8]!3 LPHVO'6O2)QYCT[?M_CG?; :
MC'2GH=U.O;0^X>OOWQ>&/,=N>_/?T\^G+IJ>\.].&$'W#IW]\X 'F(_#MWV'
MZ$>>H?O2F>61SI3C$N/X1Z^]>$8/\9Z@V?U6:X66RHPQ3Q"W"1?SV2G&GVR.
MQMM#DDSNBK-,R(ID[S2ECT&I,"BH33I?033@:Q&G26P!FL]T$#(DEJ9;_49Q
MS6DA=RS@T6H&8<"$H(42<\<=U"&QS>H+H+HH++I LLNBDLLNC 44444A3133
M3C%--(  !2'X0 ,  !G.2<!NH<*,2 ">8:FNL='Y0U#F"=]6&%*L*.P&8#<L
M8ZCS[Y]WI\_/4[^I&Y\JG&C8AX/N&&GKQ]-T,;8R/+RSS[_7ZZ<GKTIC7Z0>
MKL/5NC\X8Z9'X_N'Y:F#YL.GL?G$XQU';;?'^/KYZBA;J,>^'480-<AR?W;O
M6L8G\9\*L+*K%2)UXA#7%GBT'4()4P3J+BX);AV\FI2LIMBTIMLZ,J=0\-\S
M*=W!*B:@2$GIW(Q8+6[)%K4L6)#M)*YLN:E4DLL5J2$M>#N,-8YK9+DS9"Q.
MEWDTH'<4))%:&F&9 <%HT@K6GBPN-=:R;+Q22YILRX+(D\Q_AOE5Q;3IZ$5W
MD<P6I%KR;<$(Q<"AIMUQ(D,49BB@;4T.R=I=TQCZ6Q*15G+T;/\ 0(GR[:D2
MU3+JT,5BC*(8^5F+$L*.1EBT>7LNWVSX9MDRV2I$F:F=9UR)"YX44I*BZ5$"
MJ%@$EJ7@&!UV&6:N%.?LYQ(A=WWP^YO"%)9"YO)5["(XW-$IX?9U.7X]YD*>
MZ+*P$E)'"RC_ "5T<'5NN G*-=+=K706:6_>XN6B?FWBVALY1)G222  "FI=
MM"2<.-6+EW)S.TYL^TS9UJ*2JTS#,*T!O,JI<,*9#0,!7'=,WN"!V0HG1K6I
M7%M<4B=>WN"%04K1+D*PJ@](L1JR*S"%252170<G4$&&$G%5T&%UU45 (^"0
M10ACH8[P0<"#PK'<TB8:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:0AI"&D(:
M0AI"&D(MNZ!_VP6#M_S]?7SZ\N>!^L:W3@. ^4>G*/[- K^49?+@X[>.A\<?
MIGYZF-.C_5O2&XCOD<[^8_6-(4#LP:FX=O#O@=OK&?/Y9TAHXKV[;O5H!OU'
M?\Q\N8[9]X^>D#3(4^0WX"K=-T.G+'7S']^?3]-(9XOEN'MAG]8>7P^N0>OE
MI#?U[Q/#? !W#IN&_IR$>FW^.D"*'.AIQQ SK^D,;#U\^G?OVY[;=0Z@@]=-
MV>FFN^N1R+'O[=Q],9#/OT@_+7=Q=BW+6&P^N0Y8Z]NH]-N^<CD=(5'!CB^6
MN0SKI@&$.?,?C[QY\_=U'2&& Z<AAASR$2&<C@<=>>//I@/AMUY:1!9@X?+!
M]V;GK7+&(#&V=O/RZ]-(DO5J[M^6< Y\_/.V>VV>0^N.X\LZ0.&&YJMK5L1P
M?,#%H"'IMV#TWY<OKKN@#QKJ>-,<>\J-]^F?+&>FV Q^77STA2F;;W;.KE_G
MENB0S\,#S .0#[]LYVWZ\QTB"W5Q@3B1RJS5IE@(CEY"'?;S\AY?XY$ TB<=
MX.E=V\8_HP)@&^P=1^O=M[N8==(&E3D.^=>>!RB/KZ^N6D3WWWC$XWZ<_3'K
MMM_33ZQ#TSPXOZU^\!'( 'KD1'U\\=NF1'2#,2># #AN?7-@(D,[8QOU[=\]
M.7/RP'4<H@M5WIEKHV>.&]SD&C] SW#?'P\_,,:1.?$MH:/UW;B\.F-AQR'?
MY;!Y\_=YH9O4/B*>M3NPY[F!]P8\_/WAOZ;AOOD4'',ONW<C3C0THPG?/+</
M7IW#L(;8VZ<@YHBFM#PST.H-7KGB<(SS#'].?+XYY].ND2V;_?#'HV&>4?(]
M,F6D'HU:<E6C5DG)525466>F5)CRZBSDZ@@VFHHX@XJNHLXDRFLLRBJJBND:
M:A 3M7OCRBJ@X(H30LSU]>6'HXIETMW;Y\!F!Z@T.> C:0Y!'@<XRRKP8$*A
M+2A4(F4%2(W^%)#T--*,Y,A]@2:E $]=%1/X-0%9!1!T=BXX%P=]:"D9&6"S
MRTFZ/*Z 6!Q <%G>HZX1S_L]@/\ 'FR4_P D1 9.R("VMGD?\M,W\>:&PDH4
MY3:V/'W'^(-Z$HBNHDM(E4%)Z":A+I+"BH:1@E1%W]T@F[B"14T<!B2SL[]8
MBX@*OE(ON$A;"\*,SD/@ &!%*4I'CL"2T[A.)NZ1A!!#[D,"ENCMP79G;&7^
M<6]2N9FR0-C-)W5*G!WI%2Q.#2ZI$3@I$*VY4B4E4"4854 %?[QH7<&N_%\!
MS9^EDB45&Z %  .P):M#3,5T?UAM0VFMB]-C RM<"@;_ '+=7$&QK9FIBC;C
M.'IG:ECXZUE)V],D.?7)N9TRYS6&5TJ%!"(E0H,KI*"NK5C5GJS,]6;!GP;*
M*_L4J";H2I52P J"35DM0AQGSI'>G)EN8['9A,[B%Q)MC".*G4SN12E,UT-5
M$+90<7$XB2KW$JHDR.-8.#LM%,X5UMZ45S@>!98JE-1CS4 >A-VH#$XD4+$X
M'!WK!00RE+2FZS**DBH P4:$@#BVD=9$;:NY!DN3HJ(3-3FJK^SN<D@D:'LQ
M(%;>@DG\F2.DPE0/W>IMD3>\_P "7>)/4F>$ZS[OX5855P+R3B0 3IB::.Y%
M"7<FF&("6L.D2U!L@[AWP4X(</I1]\>RD@T(0-M+,AA\61,]#H@>Z&I&P-*9
MMI>6PU&>V.]"$A)0EI<V\YN;SD*^DH%20U C,3FEUI2:J)O,<:L0*U; A]"Y
M#9UWQ:ZP:Z '%+H9\BQ%2&#'$,-T=]ZC<<D@-O\ ,3 R/P,SHD?&?^--:!T!
MI>T U"A>&W[\0>"!T155UBD<$OLE:<:ZA).H&H<JU =B*[QBQW. 2X]:B"D$
M@*2"0:. 2#J'&-<<6I'R1Q.*-]+%2WQJ/H:8LF4(8Q2C9VY+3'$:PDM,K2,(
M$IZ 9TRI.24G4$-_W<H\DHLHVFN@NFD#FM3YL:_F(+A]2#4;W,+K-Y6"</+^
M7A2@;+"N^.M'H7#XA6Y#$8E&HO4]+:G%ZJC;"UL=3NX59\:]T%L2)17K!\=7
MB5JQ..J"NK)GXAT)I4NWTT<TPY1=*$(!NI2@D,/*,\@P&.8]-?JOAT0=7YJE
M+G%8VXR=B+.*8Y&N8VQ6_,Q1]-=)Y;4[J$IC@W4'4UUTG4(U)--85UA6 A4.
M8!I2@8@L6IF#N.8+;QIG<!5>*05!F44@J#534A^'I%+O".T$ =3)2]-D B3Y
M<5Z:(0ID2MJ86IWFK[(E%")EC"UU%,2L?UKNIH+3(6Q6H4UJC*:"RRJQII#0
ME5!>\H8M@P& QW8TPY0/AR_,I#%1N @5)4"6<!PX>A<'.*P9XQ&X[[0&".L;
M#[1&UMIE+.T-[7[1N8DU2)D05_<DY UHVA%4*1K2UY);THBG24$E"-(R2]27
MT)+U)KZMQ,2 E+70QH'%,  !RJ(]BKG@/]GIVSMY8[YVQYZ1HG"O\7>]]&J\
M>"GE,96R9TA*5^:SI>QL;+)7B.%JR:WEM8)$L>FYA>%J"FH3R&]W6QU]2MZD
MRD"E)[2O**JJJ2FA2B+X"B '4'HY.=<J.1I'MXWQSW[\_?RW_/2-'H^%-,.6
M-/E'*CF/H/3MO\=L!Y_.%%@3C^L0H./EQ8M]=(P3X=C:+U<17$!Q-'%U'QJ+
M+#.%RRRNHO\ S=7&[>.YKC=:5MQE8UT'IY/= T]A(7I:J"5;= TE5(GEUT&!
MHH7$IE@W20%G@K!W)?#D]0\<,@>-.FS2Q0?(@Z@4F/3&^+O -I&=>1'J.VX=
M^0>?(,<^?7':D=[-D*T-:,].9?##+1XW_/GY\Q_KI$T^6&[ ?:&_(.6_+KWR
M(<\ /PTB*8G&F.6C X.1UAWY?/?(;= Y<\[9\\Z0TQ]*,:YG'!JMN:'?'7WB
M !\\!\P#IN&D-'RY DGHY]"<Z&.NI1I%I5)*U,F5E4*$JJ@I406H+H5(5)2Q
M$IIH-HKHI/1JR"524ZD -3J"2CBJJ#***@0(!9TN 7JU"';'/3J\4'=FT5N[
MZ0!^MC=.,()9#I$104N;5U-5)J94F-!0W.[0O)J+6LS\SK*"E[*]MAZ5S:7
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M750303'J233*?O- C>4+RP2QEH-Y8JZ@$NV(Q?+,-&%I642V0_B*8)9J.<>
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M/T?-LH%#DT#$N:!^%15LGINB**22J1I**H+I' "!=%- #X0\-/B"GPY_"
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M!7</:& [CT_UAY;^?P]^E?G]N4'.@_I'M$X#N.WF//L._P"?PQJ'.GSYU;7
M9BL'.ZNX<*4^41@.X_[P_OJ>^Z]MC!SN_I'M# =Q_P!X?3OSSJ*[L_JU:Y-E
M[0<Z#7 <=.Q#\..?K^(?=OGKJ:Z=]]ZS737]T<\LO2& WW'XC^^WRU%?MGF^
MX[L!]8<TPZ#AI6& QS'XC^>=3Q]_ITS,'+X#^D<-->\(8#N/^\/[Z=YX;]#W
MP.=!_2/: 8Z;^\1_73UW]\!V(%\PW)H\I_8625,;Q&9*TMS]'9 V+F5]9'=&
M0X-3NT.:8Q$XMCBA4T5IUB):D.-3*DQU%91Q)E=!E(TB(:AR%!22Q34$8CA7
M-FKR.@)2H%*W(50BA!&\'L8QJ05M+[P#2UJM[+ESA(N#"<.Y#':2XCRI.7KN
M'&0NBBA,U6;N:[+/:F*+6NJ@^E!:Z?.ZP:X\HJ3P.3GU)S8^Y&:%IJ5%+"8"
M'26=:6)OHS<.S!G8;X66TKLTP2)K&1,-V5-4H#PR:J0L5:61@I5')2* /[L9
MF+K]GI*U\G:R5SMP-39Z4.UQH>VD'KCN%B4/2RM8[77A").!YPV3?EZ@]RN;
M$$- %01<>HG,;2T-!\C;RX($[R@$S!1"V;Q1HH$T6D9<8QM]C-F6NTR;ILRF
M5,0"!X:E5,P48H.8_= !#WJ9]VKXY.'J]=W3;-VTD3S)GRN.O<H9I,DC;I3
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M;^9CKOUY.<O71L(-A45WGUI]X9'L/R\_/XZG7UXT^D&WCU]OM 1\A'GV_?\
MQU&Z@I@">&Z@^9R:IMXRUSY==(9Q_JCU[#[N?/MC_!CGO]CSKQZN;>/7VAGG
MM4'PZ<^O<-MO?H.1Q+YZ>F#\F$&WC+7/EU@ YZ"'KH6 +X9U/?(1-VK.'YZ/
MBT!'R'TY]M^8^_'NVU#@#'WZ8]><+I8EP0'?MHU[W\O[<.Z4_<N$?@^=DQ-T
MR:$@WRON"4AYAW"Y$UX![2JH#:#6R37R?DM1A4'MT)OB;:1-E,KJ0M#>64NN
ME-TA:V85 JZ@#4$5I]!I')-FJ6KP;,III=*UNXEBCD48K_A=P#BT936'L3;O
MARMNT6PMFV*43(WGK'-S<W1:H=Y++9.[GBLD,RESZMK-7/TID;A6:O=G1895
M68;72230G1)TR4DHE1).K@9 :!LGK1M\:R92)"0E(<L;RC^92C4J4:.237H,
MHO'GR$<?KVW#Z#?IFK'7CZFG5MPPK6-6PJ*]U;NO%HR/8??C;Y^_1M,^]_R@
MPU'K[0S_ ':OE^_Q_34_++O+@/K!OYAZ^T,_W1^7[Z=[\L^5=?F;^8>OM#/]
MT<^[]\#GY8U%<C3-_IWGN @V\>OL_7E 1\A^7Z".FF6M<\N6/'J(-_,/7VAX
ML_ZM7/L ?KY]NGKH'&)[PSKOQQ+5:LW?YD]3[=\Q#//:K&X= S\1Y:<6=QU]
M](AMX]?H(9\A^7[Z8/EG^NG+CF8,-1Z^T/$(=!W]/GOCX\]&!Y=^FZH@W\P]
M?:&1[#\O7OIQ9Z/G\ZXX._6#;QZ^W?6&=L^&KY?EG/?UT#.0". RU[U>#97A
MZ_-FAGR'Y?OY_GV'3@WR;++3CCID;>/7?NW=N(>+^Z/RZYQUZ>?OYZ-OS'TI
MS'S>#?S#U]H9\A^ >77/RZ<^^C5^YW^^+N[0;^8>OM$>+^[5\ _?4F)N_P R
M>I]HG/\ ='Y?H.H(?4/BQY=&B&WCH?J/O%N;A6CMM=6W,EM)/(>SOMO):UJV
ME[C!B:E(@.3+#:E-9J;[B*<YN<2%PTN2%T;C$K@@="B7)&I)6E%GTP+R5!0-
M0 U!75Q0<G]HJN6A:+A8.HDEM<WT._7)HUB1PV263F/_ "-^)Y5_:##IVVN[
M5P^7BEJ5.I07HAE*(T72T=R1K3TMM-X8>RF?<S@/_#="+I?YL24?QDB0H$^R
MB%@3$%E(4"I(!!!<>9V#@ 4%6!P&$;6.T%Q8+:!,0RA+FKPFI)_PIBL+X3Y0
M'HD XN1<GATNV[<%TYC/#-=E[<7;AIG3JGCW"]=A]4F+#+6/ZNKP-O#7<=[5
M5FJSVI1X:PLO-7M28:K34_V?.ZS[\@8#E]9B!,3XB&O@F^D!GSO)!9R"]X 9
M@AP"WGVJRJL,U@%+LZR#+F &[)*R3X*BSA*11"C0LSBD;B $!Y#GZ_/RURQE
M$Z0AI"&D(:0AI"&D(:0AI"&D(:0AI"+=N.?OZO8!_P X-ZC_ +0^0[A]=M;)
M:Z*[SUSZ,_8[D-<3B/*,MW$?>.EOV#XCOZ[?7SU;6OVZ1>FIZ?>)S5V#\^7K
M3\?UU##]"V+X]XPIJ>@]XC?L'Q']M*-\F^G+3E"FIZ#WAOML'Q']OK?2C\,M
M-^#X0IJ>@]XG([[!TZCTVR.VW/TW]-*:Z^IP]&Y0IJ>@QZQ&:N6 ^/KOR\\?
MIUT  S?*I[S]MT&3J>GWAOV#X_T#KJ84U/3[G*)WP.P=,[C@/E^?<=1N=M/J
M*XC#WT4U/0;LGXYZ1&_8/B/[:<^=/9J?2%-3T'O$YJ'H'KD=_/EUZ^F=&;7-
ML/; 9/PTA34]/O$;]@^(_MIOKT=Z8L/UHPQJ\NIZ#WAOV#XC^WUG33Y4W_?I
MQA34]/O$[]@Y=Q_;\_31OF2'S./8IF<6,*:GI]_?Z1'XL[@'Q'K@<AMVZ#\M
M,68L!INHW#L0IJ7X?.L-^P?'^FGH>\J'VAY=3T ^IAOV#X_TTSQK]-],LN>^
M%-3T'O$CGL'^]Z^6_J& _4.I;1OTX'4PIJ>@]XC\78/]X?VU 8UH0V8K^E'P
MX4AY=3T'O#?L'Q_I]?G+C7]06^=-_P U-3T^_P!?LW[!\1_;0-]^C-4L]*/7
M2%-3T^_>L,CV#X^GE];^6G+Y98/]&S@R=3T^\-^P?$?VTITW8=-:4X4A34]!
M[PR/8/7(]_3G\O?HWT.0ZMO<Y8\84U.^GWA^+L'Q']M"'[R.7#VJ]8>74]![
MPS4 \@V\_P"FI-84U/3[PWWV#X_KCU^&HSSUSS?IAGI0!X4U/3#U^N>YBW[!
M\?/TY8WT88\.);#'/C6##7TW<=:0_%V#XC^VC;\QBW(=UWO"FIZ#WB=^P?''
M;R^N?70-7U[]-S4P,*:GI]^Z\XS5V#OS_P#K?ERT8.=<#P[SW;H4U/0>\/Q=
M@Z]1_;XZEL,VU[QAY=3T'/.&_8/B/[:#Y\/INPW0IJ>@]X;]@^/]-1NU-/G[
MZ;A"FIZ;Z9Z=Z-^P?$?VT(?/O/K1\J0\NIZ#WA^(,;![Q'?Y:-C7=DX?L=!"
MFIZ#WAOV#X_TTYX]O^D*:GI]XG\0= #&W/J'NTH>]:YY&HPW4:'EU/0>\1^(
M>@?$?VTH">7U^KD^NL/+J>@]XG?L ^\?V#?GSP&VCTQYN*_K]84U/3[QQJKI
MHHJKK&FBBBFJNNJNH*::::0$:JJJAV   ,B(B  &XB :@^8$&E6IYJONWT_6
M)=*2#>IK05-&J?6-:<SO_<_BYD<@LMP6N]4<MRRN*B.7GXS*TU"R-,=)57W5
M^@W#>(4'HK@W3(&LU(NF)GM8+ %)1@FJ'I]I3-Z;42O"92QYE!P@L35BZA5G
M:H-:@QP*G+M2C(LRRA(44KG,#=JQ3+=PHY$_NE\R(S.L78FVO#I;MJMG:UB_
M@[ @-4N#@M5J#7.1RJ1N5=)SY,9B_K!K<9++I"L 5[V^.1ABI6IJ *?9)BDZ
M<FBG6;RBYHVG#>,-*".R7*3(2E" ' <K-5*+NZE&I)J]2[Q=_?IOZCO^6HWG
MAINP/>^+4K7/(4]2(G([;!\1_;]@T  UK]]!ZGF84U/0>\1^+L'Q_I]==-W'
M&N.N[0>T/+J>@]X9'L'Q']OKRY:9XYX..G3WQK"FIZ#WB?Q<\!CKN/EY!_7/
M/1Q@"'PHV7MI"FIZ#WB/Q=@^/]-"V.FY]]..!;'#&%-3T^\-^P?'^FC>HKD3
MQP+](4U/3[P_%V#XC^VF3:C'[PIJ>@]X;XY!\?Z?7Y3J/IV\*:GI]X;]@^(_
MMI^G?*%-3T'O#?L'Q']M-T*:GH/>&_8.??IWY!\-10[QQ[?A"FIPTSTQ/6'X
MNP?$>OJ'PT[Z>G%N$*:GH/>&_8/C_34TZ'UQA34]/O#(]@^(_MTTW5[Y-"FI
MZ?>&_8/B/[:A_?OH>E84U/3[P_%V#XC^VC?4YORS?] T/+J>@]X;[[!Y;C\]
MM-3]_3M^D*:G?3Y5^8]HG?L'3J.WNQCX\_+0Y,0[%L*_5N$*9D]![Q:"^UC8
M#Q%6S?;67&0*%+([BE6M[HVJ*V^11&3M1P+(Y-(B\$@*ACE<8<RR71E=4_XB
M%!(E*"U"$]4E/))EJ*Z$UH<P<07?@-*,Q,4FRTSD!"BH$&\D@MX:Q^68AOWD
MN[4!(&IC6I'JUT@/F7 MQGMC3+IP=%5YS!*5*4&V+\2UHR32DA-P(]0360+-
M<*,F&H4]QXVVFD+HE)Z4DICAW\"=&E4EU9E)G20;H(*DO0*ND'-M1JQPK'59
MIZ+3+78;<;TXHNNL!(GRTB[+6E0+!=3>(8@J2^0C(SA(X@)A:>=-'!GQ(R-?
M(7E4D6F<,5\GX: JO1"V0@33+>35T&DDDR_,":RA,<Q LO\ M"BZ:B7)*:G9
M/(2:*3)84CQD4&,Q&:'+!3?PDTW'K'E3K.NQS/"6YEJ)\%9#.!4H/\R1U&;B
M-IVN:*0TA#2$-(0TA#2$-(0TA#2$-(0TA%N'*H0<%@9# 'F#@=N8CR]XY[C\
M=;IP'#YUCT9:09<NAJD5QZ_+01TO&/ETZ#^^-O/&IB]P;\\Q[/7<\/&(#@0Y
M#OZ?7+2%P$.#B*<>\8>,0SD.X!M[A$=]N?QY"&-&[[^4+H)H>-7QJPI7VJT1
MXQ[!]>_MI$W!J>^6L/'5Y9SRP.?H>7?2%Q.]FQ<-V,=(>,?+X#]?'2%P;_3V
MB?&/E_7;GORYXTB+@W_:N%,<'B/&._+';'+W^>_7IZ:1-P4%>-*_I]1C#QU;
M<AV^OW]^=0PP;-^>,+@KCWI2'C'?EZ[[?GY8Z:EN^^,+@ICPI7Y;WSAXQ[!]
M?7]-(7!J>_IV^+_7?N&/0=_GSWU&?=/L6X'&,Z:'=4>T-\<PSZ#^_P"NA(%3
MAWECZ90 <T!ZCYMWA  '8.H^[KCY#MY==]1>#D:</?[[L8F[F&9G(>N'#$\&
M@&1VSGKMY!Z^?J&<<^<%0&_(5<\S7=O,130DZ CVZY=8!OD [X'EL(]/+EJ0
MH'*@.HQ>@TPJ#4:.1 @ 5\M'\RA0;Z1\CCB4Q)JA0:40G)+K../-KI+)))+H
MJ,,.--K$*"BBRZ:JZS*Z@HIHI&NH0I 1 "7-#2@Q+DN^1II3YM%+Z2]13.\#
M\L.?TK29]Q;>IBC3E,\AB<E/088>:?*&0DLDHJFJLTPZLQ=30705334)E==0
M4T!34(B  (A)"F("5/P+8M0Y4K0TY1'B2P[K0PROI!]3UITBE#+_ -B"JAH,
MO9:,JL,"-!MR(=14 "&<B%3T @&.HX^&^B0LDN@]"[@OT%3I$B9*/[PY+06Z
M<?>/F'$)800R%\+/CMS"Y<,QC_\ +0[>>K%*OX%&NF?-JQ-^4328D<5(T=_S
M!H[">_5C%0^%/>BTRBH!I :2+C1 T0&L<4AX:'BJK-0Y"D,9$0$ S@=5+C%"
M^G+(^D09DH$B\DM7_$ECZ_KZ14R*XUO7*FBMNG<-<*#1$"JD4G9%5)@TB/B"
MBHA<8%8A@?$%(CC&_75KJL;J@XS!=LH>)+R6C,_F&'7+6*N)-+4%EG)S2CB#
M*0K+-*KI,+,HJQX:BS*!&BND>85!4-.-P'5+PH:OH^..0+;JX'%HN"@NR@JC
MBZ1AGKZ/'T]-A^'P$?A^N>4OJDMQ'O[YB):CN ,&)<YXL-SCUAG(;"&.?3IM
MZ]?S\]* A@U*>8'&M&+4SX!G#1%,'#G#EQ[U:)$!QT#&.>_//3(;[>OEJ H"
MAIS&6NE-=^YS<WP9Q\Q''\7/(;YZ=_?J:-2HR:N&$"VA'/[1P&JK(\MML=\#
MSQSY;8SZ>4Q>ZEAC6KZ.,'PQJ[<=[QCUP'N'W=<_60SI$W!DYYCGEV=(>,?+
MIZ?F&.G/ST;TB+@WY\?D7SPW0\8^7KVSRSCR[>\<Z0N#?PU;%GWZ\@T!K'L'
MY_M\.>C=^GRB0@:GY>_7" 5B/J/IOS\PW'ECMOOG1N^$04@$FK<]VXTQ+ZTI
M#QCU /@/NZ\OKSTB;@R)ZCGECWNB/&/E\/ZZ0N#?U^T3XQ\@^/U]!YCI"X-Y
MZ=]G<(>,?[N^.X?']=&]X7!7\U.%>$/'4.P &W[^OGY_#2%Q.+EL>72+/7QX
M@;1<.,-KG5X)DABC,8J*;&A()2ISD4J?5(A2@C4-B[2G72"621R-JH)0LK"W
M+UQ]==(^QH* PV@E*EEDI<@G%PD,_F)P;BS5K'/-G2I(>8L 8C-2GR"07HQ?
M.HC"<;?\0?'<94MO>BEG#/PD*!\;?P_H':IGOO?!O T*RE-]).P+*Z[:0AP(
MHHJ&U<1=*Y(YIE!R>82%*7_VHUJ"B23<(6LBJ@'2#@6!>HQ!U(=S& ES;625
MA4N0"&02RE#)1!_=+L1C1G8M&Q>(Q.+0",,<+A$<98E$8RW)VB/QJ/-R5H96
M=L2TC2F1-S:B+)2I2"Z1$0I*+I :JJJZO%7754.+5*B2HDFI))KKK7ND=J92
M$)"4 )2 P  HU,6]-7,5$-8]@[<MAQSWR'T._F;GQY_-_I$A WZY.-*-VT/&
M/EG(Y[?'/QU,+@U+9:[\H@*ZN>VP\_F ?+'Z]=&%=^/?.)N)W]L']7^F43XQ
M\N?IUYYR(8\\\](BX-^''DS ON: UCOC'/8,#G'Y:,,<^Q]8FX*.^%2X9_G#
MQCY?/Z^NN@ &$+@W^G?>41XZMN6_3'NV]?KS0N)KC3-^=>'>Z?&._+Y[_7GC
MTT8=]YYZQ%P4Q]*=[GXP\8^6>?RR.^?E\\Z0N#>V'JPHWKZ-#QCY?#\]]M]&
M^OK^L3<&_K]JTA[0=^7P'?Y^GUS-ANP^4+@W]1[=_)XQST]0 =A]-O=R_34-
M1C7CTB+G$5-'&&5:_7ZP\8^6WS_7W<PZ]<S"X-]7Y?3G@<LF>*KR'\^74 'Z
M';GMI"ZG>/ECD2.Q7"L1XQ[!\!_?UT8:881-P:GJ/;A$^,=^7??/P]>FD+@I
MCIEUW \<X>,>P>[?]?C^6D1<&IYT^G3YP\8^_GRP'(?D [_MI"X. PQKCRQ%
M&^</'5T#IY]O4=OS#MI$W!J174>PJ>W@-56_+8>F?/ZZ#\]&!IWW\H@)33&H
MS;=WF/2(\8]>XYZ?OR^/ZP0#0Q-T"H.5,_U?I],=>)GARCG$G!$K"L=5L,GL
M.=BIG:&ZC$449)[87$;B#BVF2-0&#06XMYH&UM\GC*RL6B51Y0M97(OV:B@X
MF4J\,O52264DU"AG34L[TI&4Z5?"2DE"T*"Y2W8H4*@D@7BDDA*DY@EZ"FOI
MKJ3<3\1F_#1Q'-!MN^(RT:]D728(@X'M;HR/[>HJ56ZXCK$2.O*XB/O"U&+S
M%76GQK6%R+<X7*"*S4ZU.NU?PSXLNB%N"]0K*X4DMC0*#7<W>O5+F2]IR%V:
MTI";1+(*ZL0I)=$V6<0E1308T8D.T9/\/?'$],I#IP_\32%2JXH[>H2E",Z+
M-!:)AXA+?UFBD9[R0D5!Z9F8RC*Z?X?<>.KEZ48=*R5!"0M0UN\=^]93)."Y
M?^&LT=W032ZIQJS<0-8\D6>TBT?A%(O3C>*% 79<Q":F8,TI Q!JX- XC8I;
M^9)I_$&27I&]:UIWI.<<6A7^PJ4$BG5J$9G^53&G)E!!IB:LY&J(-J+5)#"%
M- 4@;X*<""DD'$%C%""DE)()22"4EP2,6S9Z5 .Z*QU$1#2$-(0TA#2$-(0T
MA#2$-(1;IRI 5ZP1$?\ N@S;?I4/ECZR'/6R26%,N6+!ZO5L6;./0EJ(0B@_
M*,JX#V]XZ04!YC^7Y?J'74NQJ17#OKZ1>^=P[XQ'@I\_EJ>/9[ZPOG=WSB?
M&>O?X^?/S#?4/AGBYWC=UB+YW:=C#C2'@IR'3OV^'Z!H^.HR?IUA?+-^H[WU
MAX*?/Y?MRY9Z^>^E:U'>M1CRYPOGOY]TW81'@#N/R_;ST?AOK4/AWT>)OG0>
MOONAX*0W_7;Z]_KH7;3DYQT]G%3N, LX&@U K]1Z1T'-T:&5$<XO+DWM+>0
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MD(FF70XNKDN!E9112HV<<>%S&,LXL@ "BD]"W76CK92-(AD1H0%5U" >,:@
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M;*P18% VGXT.)1G"O%2>B+\4[A<=-XJ@S0):.YAUS$"BD!J ::3DQX#L%7C
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M+S_0>7YZ8'CAAO[SY1+JK4[\V]H@1HH"JNH::0I :JJJA"D*:0 1&H1$0"D
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ML9'ERWV$$( .1' ;!MS]W+.WPW#X"@<#W\HME<2R=GKO(*FNZEK+>7%05!6
M)IK#H_):"AJV]HGJ=V]68F. /]$XBLHV@1S36 B(ZA*RDLF8H.0<1B<,1OY<
MHR7)LZP1,EH6E5&%TXT &*DXF@.]G$8D*?LX>'R, L<;.R>]G#2HK]HIK-LO
M>>7,$<2'!FNI2,$ERR7VU\%&:JO8G1&M$%'CI]B%([7$U3W61,!%7 *E8EG
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M;(OXK(S*JZP"LRJMS$3# I,KS4%(A!7,/[Y ;!+"N>6#4:(399"7/A()HZB
MM2FS*IB5*QKCQC("D*: I++#PTT4A3113M312      &*:0 ,!2& QL'36:@
M27&E0HN[FN6!I&S*&!  H$D AN@ &Z \^0#C&PXZ]L\QY=<=.8[6Y ;A@(D!
ML(@>N1\_(,YQC.!R !@,!D!$>>X A#U#   _$.H@&0QL///+;.D(GRP ;@//
M8?3ER'&?7/7="(#&0Y;=A$-L" ;#W$>?/?WBA$^G?YC@ WWV'F/7?/72$.7,
M>?(0YB&_8!Y9VQC]T(@!ZCMT#(CC8.OGGGD VW#EI" ]A^/ITY#G?'/.1$>N
MVD(!@,;=^09]/Q"./GOR#2$2&-@[9V$ Z\PY8#&0S@>X8TA$!T 0WP&!R ;A
M@,>89WZ[],AC2$2/OW'.V,AY@'[!U$=(1QZ]LXQG<0W'EGE^@\MMP0CET'IZ
MATV[AC<,;8#?;;HA'$<TYQC&P#@,#WSRQ\]LAI"'/(XY!CED<@//? ]<CMOO
MG2$!W$0Z<]@VSSSGF.PARY^0:0B=LX^& 'W8W$,AOOMU[B.D("/( \\XR&1P
M..H9R.>N_?2$!#KZ#C&0Y8Q@1 <[^\0Y<@TA#;O@!#'+'<!#(B.!R.?WWTA$
MCN(8Z9R( /,,;>8#@=L] TA#&>HXQC?KL._S_+EC4%02SO6!(&);1P:MHP/J
MT?,TTH@LPX\TLDHNFHRLTXRDJ@JBC(U5UF5XIH+I#(U5U"%--.<[9'4!22,:
MZ,2?0$>L5O !S0:F@89N<N,8<3KCYX9H<]GPZ/S)PO3<4D#:1MGP\QMZO;-:
M#R1"FI,Y(X E=VN,U^TJH*]M+79A24&5T@8?0 5XV$F:H!59:2WF*@EW?RT+
MOG@P K'*NW6<*N2UF:M_R2D*F$N]"$CR[R6 + FL4@9<;CUO!733;6REO.&&
M)*RB1HF7$6_TW!N32F4U5#6K;;.VJ=ZH^@6ITXEG$II5=-.=2HJ%.O:"@+,I
M&IERD&JC,4"' #BNIH7U<-R>*%=LFG]E*DV<'!<U5^8!G^S02'-/S*=]SQQ+
MX!H_/C:5_%7>B\/%0HJ44+#(C,) $"LL2I* 0*J269MG3&HRN)(R/L:)D?,5
M >*KQJC/$/BMXJDL)2$2P,P]\EF<JRX!L\R\3^!"R]HG*M/\DP!,M!HY2E+"
MIK5R2*EJ1F?"8!!+:L"&*6[AD6@D8;2Z24$>B# UQQE1E4AX +3-;0E2(B0Q
M2 "-! #6.1J&H1$=54M:ZK45$BI)->S'4B5*EI"$H2$LUU*0A+:, [[W9FI%
M7>( R&PAG&X=M\#L("/EW[B&L2DDN D#3+GW[Q>KFHNY @$/J0Q!SI6+$7BX
M8N'J_P DH3WBL_!9X>E"O^'/#NQ)J),SUF %-9K%+4-*23,2BH I_P NS.R(
M\1II$3/P@(:A<U(9*[HH+H'E(?,/S;!XQF6:1._Q94HD8*2A(7QOM>2H9721
MZB,7C^"V\%L*JEG#!Q:7'CC>D*#[A:?B#)JX@;8B":G*1H0OCXM:KNQ=K\
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MWEN^^^IB?+_-Z<N_>C\77P^[//\ ;EO_ (Z=X1'ER?TP[>G-\HMU=6TT!O5
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M629%9&YFB-*^[]KTU:5')JZO9J9?&SFN9%$F*AD(IL9J4D"9+!ND>88L<S3
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M7?AEKB^Z'BJ[XY[8Y>7+]?7EN8:=]DPNC1\*OU./T^T^*K(X$=P[ &P]\!@
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M?'H//OI"'/M@ SRY;B( /+;&.X" 9VV$4(#G =<8SSR.?+&V>6<[9$.>D(G
M\L@  &1 0R&^<!G/3&D(@,=-^G/GC..@ (\N?KYBA#.P (@ X  V[]]L8[@
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M7"-)%F3(1=%X*429JW<S%X*4KB^!U;"D7Q''N].@@/7(9#K@-]OA$=-*,&8
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MSTA$B',.X[Y$.VPASYB !Y= #2$0 [[YZ#V'8  1$.WOQMR[H0SG !C'3;J
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M53E@/:Y'[$B>12HENE28B@2DZP:Z*A;9$W458$6U^3%BJ+"D,)%E*UOKQ4E
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M-QV#EOMC'<-Q$>>_3.=(1 8#._+&>0=@$0Z] V#;.P;[ A#.,\\9Y[CD,=Q
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MN>VW7IN ^_&D(9Y9\(=,<NFX<\8Q@<;AG;/(=(0$-N?7IMOD,=^HYSY<M(1
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MX74,?=9 3:N/SE;<7B,_M2>(HYRPF3N;M08H1L#-&HJGBB-::W*Z7I0I4-Y
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M$UMW!A<7%FC3"T/L:DB/+TSI'=FK<$1Z!]((6&)*TX)HE(3,\-:DD&^4E((
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M./+&_3S'H(CC/ST >M.H]X1.!'&X\_(!#G[NP=N?NJ]"<  [D$4#ZMI!\\>
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M7J:JC%*DP0H"F222Y.0&34 'T^<9RI*)(9  !))8-4ES'4D%C+62F72N=/\
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MXC*3?XO(,A>52R'QP^:> 74:/;F,JD]%_!_!_+X!7[8&JE132=34KF"@+@I
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M_?G*FM)$'QV:WMT9P;Z5E+4;2I=&1K5?>ST)JXFI*!1"DLDPXLR+RR&)9RY
MPX5>E,JUC<2T!8F%)"TBZEFHG3#(DG$T)BO>X '80P..G,0VVY!MGKJ(TPQ+
M][H<MM_+SVSVYB(;YWYX'2$,!D1$<X'T .6 #I_7&D.Z]UX9QB+Q.\+W]LE<
M=N9;21%VNXE+8%JC[7722I1/(/3G#2<XVZN*W$UDC++72LPJ@A\9%5=2AL/J
MH>V$U(YD""G5$Q@4+%Z6H75!Z@$_F3_,#75GW@\UHD*443Y*_"M$I3I6F@+
MT4C]]*RR5#(>8%TAL;F];&N,Z(/-M;E-SS8WBFL/(6YS<T+&YT$SZR]RDI!O
M\KW5MB^"%'\PP"2%5'*8^\B2H8)='U"^,R)+6=2YH"X+R68WD&I71UH-+AKB
MG$.PTT-TF5M&0J3,'AVF6Q42/-+F.6F2\U(_*!DL%C4B,RN%KB0D<W<'BQ-^
M4S5&N)>W;<2M>4[648BBUW(4)WW-LO#;.E157[9C=# H3RJ-EGJ7& R6HUG<
MQK0JF1Q<J+EI%U:"Z"Y8UNOEQ'#,8F.)'BHF3+/. \0$72D,)@%0I(? BK5(
MY1FED!R'/&P_7;XYU4<7?#H/UC4)5B!ZCM_K$Y#SY=A_;^H^_1JO]2PUX^@&
ME*PW#J/>(R'G\!_;Y:GOV@QW=1[^L,^0]]P'H/Y^7/4'#%L&+N^F/9U@Q_0C
MZ9:G" 8WVY\]L<M^H?6_GJ85U?(5?'(,89#MS'_9$.N>VVXYU'>\?-\OFY@0
M=?4884KN;TB<AY^\!Y>HACW[:,:8XA\L'.N9H7^\&X<B"<6:D1D.P_ >F_;Z
M]=3WWW]S'=U&?.&0[#_NC^VHK1VW_;O?NB6.H_J'O#/K\!_;Z^&C5[^6_,](
MACNZCWAD.P]^0_MIZ<#]MW"I<',QU&F(]X9Y\_@/RV_+\M*]_;'Y=*FX=1[T
MYPR'8=_[H_MIV'/;\/E!CN_J'O#(>?P'W]/+\M3Q^?3Y]L(,=W49<]_SWP'&
M>6X?W1'YXU%:]Y#O#.%6QH?Y@/1X9#S^ _MICGV]<,V?FQI!CNZCWAX@[#OV
M ?RQMCKY<M*\J!OF7Q?GOJ:08[NH]X9#;81[?A';Z^>F7>#[M1SX08UJ-]1[
MU:&0\_@(?IH7^P.7'URKG$@%\0-]X4Z&/(>V9,](ZDQ](>, JJ),  \9=78!
M$, %6V0Y9P(@.!#4 ,:D,Q ZC 9/3,E\<8B\I)\26#XB2"DN,,\-0#HP.46R
MAM+C&YRVMY@C34>L+2GAXA\!Z8^KP4&T8'&-_&',:?\ *%5;A4%,* ()S W>
ML=T_P[59#.(\\M"EBF!PN'2[CTJ<ZMDG_?YV_P#3CQQW#QCD,".!ZYZAMSU9
M. X1G(_P97^XGY1XO+8 W\M@W\M^W8>0YP&^IC0%PXSB  1SG81Y^GEO[NVP
MACGE$P[B/0 Y /R[=0Z8$,\^2$,X$-A]=Q[XZ"/+.,#\L#I"&!\Q#GN%0CMC
M.X;=,AG?I@-5*KN(-<,*^L*Z<W '"I%8!@1' X]!'MGH #SVW'KTVU:M7!&X
MM[_.(>K8'1QH^()'K3-A6 @//..F>N>> Y9#TZA@-QW@$$@5!.1!WZ Z91(+
MEACH<?OR>)  \O=SQML.0 <9R&/[N.6VA4!B?0^S^D0XK7 L7I7@ICKDU.$0
M.?/F&=\9#H&>0<P#;<=]3$[\C@=8D $=QV]!$.7D.0'OMD!';?2#'3Y<\35A
M4QB#QMR:31:S2%3%)(]15S<+@0YF/=H\O.:W0MO7J%8*R2%R<:3R - HL:_9
MB'CHHJ+K"LJJNBK](_LLV?8=H?$T^7;['9K=*D[*M<]$BV2D6B3XH$HI492P
M4DI<I2XH2&JQC\P_M9VA;MF_#")]@M5HL<V9M2R23.LDY<B<479A7*ORUA=U
M7E4IQ4I8AJ'6_P#S)=?_ ,N][0 >]Q'D1QSSS 0] #?W;_O/]T?#PQ^&?AT?
M_E%D_P NM-7RC^=A\0_$A<I^(MMJ&HVG;/S%A=K-!?,N &Q52(_F2ZVV;\7M
M#IC^T1Y_6OGSZ>G+3^Z?AUJ_#/PZ,J[(LHX?N<^!!+9R-O\ Q*33X@VV3=O?
M^,[4:88^,Q(.+:4P>)_F.Z__ )=[W8[_ -HCSY?W_/E\=\:?W1\/?^;/P]Q_
MNFR,#F_D=ZX4/&']_P#Q(S_Z0[:!_@_O.V7SD6'BL07Q=F.=8?S+=;E_;O>[
M?_XHCSGIU&O  &W4.8Z#9'PZ:_Z,_#S. _\ =-DKP%Q\Q5NM&A7Q!\2)*0?B
M+;0)!+?WG;";H:M)K 48&H<9- ))=?./[>+V;"/_ (Q7CD&^<>/(]<[#GH/(
M-/[I^'J?_)GX>QK_ ."+(X&I\E!QXG$0_P!(/B3'_2#;;4()VE;#><X ^*Q(
MH#B'S=P(_F6ZX#@;\7LW';_W8CU@0SOC->?3?(^G-_=/PZ?_ *L_#U*_^*+*
M 0</W../2D/[_P#B1V_T@VT2EW VG:R0QJ+HG$N 7+ @ @F)_F.ZX;C?B]W+
M/_OQ'G8.G^O\]L[;;Z?W1\/$L/AGX>S_ /HFR8#?<]Z$%@(G^_\ XDR^(=M,
M]"-I6QE.*@?M<0,20!TCB$FNL([7WO;Z#<1Y[<_](0VSRW[CRP,G8_P]_P";
M/P[4M_XHLOT1URA_?_Q*"_\ I#MH@9_WG:PWFS>;6M<*XB.?\QW7#_Q\7MY=
M;BO'?8/],=_(,CY#OJ/[H^'O_-GX=P#_ /@BR!N/EX]#G%1\0_$A<#XAVV1>
M*7&T;;=)%,?%8!Z.IJ\#$?S)=?&]][V[?_%$>1[#N/B_/D'D.@V1\.G#X9^'
M2_\ ^Z;(,-Q0,*NU332+*^(/B1./Q#ML8$_^$K8O-@X1,42^5&S,/YDNOG_W
M^][=N?\ [L1Y'MR'Q]P'//W9U)V1\/9?#/P]_P"J+)_D'8;&(_T@^(S_ /6'
M;0K5]IVL\R!->A+8&IXQUJY]=Y@7Q]Q)O==U=51*HFG,2.DY=5R!2G6R-L1J
M25:4VL"U!!J<\PNLDWQ%F /A,IJH$:1JO87PY/D6J6?AO8,M[':UIF2MF6:5
M-246=:DJ2M"+R%)4Q"DD*!<@NQB]G^)/B5%JL:QM_;*O^56=*DKVE:EI4"M+
MA253+J@;K72%)(+$$$MO:=A$&MQ$<_\ <"P!#F(B*4T SC',>N,=]?Q[51 !
MO%W!8DB\H.%: ,"V. >/[1+7"1=";AQ*2?RD'S%G+XD!WH0 (PU^S?WX$.%,
M0P(?V-1$/,?\SJSCOC;X^8:UFN)JWH]TC_LAB:.]<,2Q#1S[/(-CD"KIEL:%
M@$*7>4Y#$>84223_  X1FM^'EXM\CSR&_P L;XP "&1V#.^LW?\ *"H#,"GJ
MQ]/D8['TJ,'%:\!7TB0#;?<1 =^F_3ERW["'RT?KI1_2!H0"X>M0S!G<OAEU
MB #8=QYB  ([<L>\-NO+'QF&;"NC8&)P.<[<ML]!W$<=_<&1#S#<XP</IG!Q
M5R$D9$U]''K !R..V^,[^>X"(8Y;=_3 P2W,L.,,,<3@'23H* G$TKF1DY@.
MV R.X[]QYXQGS[8 ,]-3J,QB-/IT)B'.AQ Q2,2PJ2 >1,,=0QN'SY#TW ?,
M-\ /+&H)8AW#X$X'G\XEN7,'U!([K$8R.,AD/ERQML.<8WR(<PU,2006-#R/
MR<=#$]-A^'ISP'KG&^_N'4.&<TJS''I$>O?M7A$!@!\/;'/(["..6^X@/3//
M< SC1Z.Q89L6K#L/0'5B63R=](Y!G._QZ>[KOV''(,!J+P+ .2<@#$7A6K-B
M^7'[/$!O@<[ASY_# @'QZ" <^>A6!KT(?JT3B'&'$!^!) )_E>]NA\!'?.V<
M!VVP(^_\\9M"&W+ED '(9#RV[8V]W/;2$,"&1Z9'.P[=QY;CC'8,C@<CSJ%
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M)TJ=CZBD+48*X!-55&+?855$U@/S>VMC#95GLWX3;'Q#:OB&WVA-GV<H[4F
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M"!<EA-T,Y4+Q+,2V& J,S@2]1SILIFGQ+5-F*7E*0HI1)0*!%U*@%*'[RBY
M).-(PWNY;B[4)NW)[.?9E3^ZK+*8)"5;_?\ 9YM=5ZN-9R-IWIH.5PRWT.HO
M 1<D^+<0$QIJ(>8ZK:EZ*-QN/DDN<T:G%(ZMY6M4E"DO:&"3664BZX=BK6EX
M @E_,[^4@\D^7-EK5*L$Q85+2E4\&8I<M*5X!!4[35TND85!#*=.0'#[PJ\)
MO$1:MCN<4Y\2$GEBZM8U2U\N%Q)W\07=AMP6,^IOEL6E2=CN$QM<:E<9?2E*
M%P;69D;6DJLLH]K2?PQ0DKKS6N:A0<("0Y0;GYDJ-"?-C@-ST)>.BSV6S6F6
M%GQ5+8A9,U?B2Y@_,E8!8K3B0S.S$O%<M\MN?P63J*0^[L^DEWN%JX;TWP^&
M7DGAY3C<>R$Y=C:$D<A]W).G3I@F,$F;D82SQ:X;FF*>V&0'HV28+G).YM[P
M3#)FI6$) F(!4 *7J58U9@2PKA@ S:!4RRKN3%F9(F%,M$U;/*F$BZE2@":X
M)(#N0#BXV*FFE$DFJ#S2R222ZSC3C*Z:2BBBZ1KK-K,KJII++H /%774(4@
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M W#GMSWS@/V'4_B+3_M$[_BSO^\UKQB/PME_V6S?^CR?\D3[(D,?Y$K?./\
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MP'Y#D>7/ 9V0B $<=L!SV#D(AN.!#'S]=(0VP.._, YX#.P#GW=-\@(\M(1
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MZCT#L(8W'FA$@ ;C5U'IGGD>G?YAV >:$,\QW$.O(>0 &_GU[8Y=P0B1#'(
M''+?J CM@.V_Z@.D(C<1#.!#&1ST'?R#H(;#R#XBA !#?H'7 9#'Y;#D!P&X
M#UP(@A$>F>X8P..HACH._+KRSC(:0CD ASY;]=M_WZ#[^FD(@1WP'0,B&W+E
MC8!\AZC@1\@TA .?(>_,0QY8V#?&WQ'2$ SM@ V <>?3;.X!D0Z[ARQRTA#.
M^=^6=PQR'KL/(, /,1R';.D(D/<.,X''7KD.8#D>6^VV 'FA$" !OCET_/E\
M-QQS'<.:$3MN&V V'D&V-OAG >G/NA'$!S\<XSSW[Y#W (8$0$=(1/3D.![8
M'.>^?@.0#YX!")QWY '+IMUQD=ASUWVTA#.,_#J(B #ORY8R._?&1 0TA$
MCS'?;(>0!MRY#G<.77GRTA 0QD>0CMCEN.,8';.!W]!WTA$XR'+IC',.N-P#
M]0QZ\T(8 <XSL.1WYB&.H^G(?ED!!"(QZY$1VQC?ON(Y#ON(#MMG2$,[[]N?
M?&!'?;81'KMMCJ.$(D1QG.WEG; CC(]0QUP.,]>>$(@!SD0'XXZ;[[XY;<P'
M(CGELA#D([8#<>6_3._( ''7?TVTA .?O'OYB _,0WQ\0$-(1ASQ7VFDCE_*
M?$):)""B]UD07*V]I+'V07-MJX5%&SRTSB(%UTG5O:!.+I$#CJ#!:IDWMAY
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MW0S_ ':OE^^G"IICEC77#JVKP;^9/K[1.?(>V?3F//KSWV[;B&E>0^67!N>
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M.89V <9QI"'+Q=\YQ@-L^[<0YCOOC.>>D(;\]MN_R$1#<1W$.V?=E" XVSC
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M&V/VYAG?<<;;BA# " >NW/&VP[#V[<]AQUTA#;D 9Z],=^0X#_6Z#RQOSTA
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M0@ XR'3;EC(9V#UY9Y9Y &=(0'GR'., (=O(>>0#(X#Y[:0CCGEUY"'(<9$
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M1T\PP.V=\YR/(0WWP(>6<8TA'+D/GY8YXZ=A  '&V!#&1TA$;^FV?3<<\P^
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MOSVR ^F.?0>^D(<O7.=@W'8>G/N///3;EI"(R([[@&,]>6-\CC<<\N>V1#?
MZ0B-_+F(YWY!S[B',=P\\<PRA$[<^61 ,#MZ8\P 0SG.PXV#(:0AO2/3F&>_
METQ@ SOCD [AL (0V'H ]-L[X'I[^8Y  $0W'2$-@#D'ISSON'( $>@!N(B
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M?YXR/, 'EOJ4X#A'7(_P97^XGY1X?J'3(YQS'(#@!SC(XY?T&8U@ B';MC(
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M1'L.D(C(Y'("(ACET_4<^?<0'&^4(!G;'0>NW,<#L&=\\AW#<>H9TA$Y$ V
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M[P@ZL&Y71N&G#TB0"GH(=<8[[\OEG'3'; 1WE^M?IEC WLWR?Z/WB^;PS3W
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M ."[#G'6_D!A[KO^(HZ__J?H,AR'2^=W?.+?C9VB/Z3_ )H?R P]UW_$T_\
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MR P]UVW_ )Q1UY[^Q^N?/2^=!Z^\/QL[1'])_P T/[/V$>8KNO\ \$T]>?\
MX'2^K=#\;.T1_2?\T/Y 8>Z[_B:/^I^MPZCI?.[OG#\;.T1_2?\ -#^0&'_:
M7^Y32'Y$Z7SN[YP_&SM$?TG_ #0_D!A[KN__ '11US_T/G]8#2^=W?.'XV=H
MC^D_YH?R P]UVW_G%'_4_'2^=!Z^\/QL[1'])_S0_L_8>Z__ (FGR_Z'R#2^
M=!Z^\/QL[1'])_S1/\@,/^TN_P")H_ZG2^=W?.'XV=HC^D_YHC^S]A[KNO\
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M^\/QL[1'])_S1/\ (##W7?\ $4?]3I?.@]?>'XV=HC^D_P":'\@,(9W7;_\
MG-'_ %.E\Z#U]X?C9VB/Z3_FB/[/V#GE=_Q-/_4]>O?KI?.@]?>'XV=HC^D_
MYH?R P]UW_$T_/\ R._OTOG=WSA^-G:(_I/^:'\@,(]5W_$T_P#4_/2^=W?.
M'XV=HC^D_P":'\@,.,978[?>*.^?_A.E\[N^</QL[1'])_S1/\@,/==_Q%'_
M %.E\Z#U]X?C9VB/Z3_FA_(##W7?\11\_P#([Z7U;H?C9VB/Z3_FB/Y 8=PR
MNWY_YS1_U/STOG0>OO#\;.T1_2?\T/[/V'&,K\?^DT_]3I?5NA^-G:(_I/\
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MRFKP9\(@ $4XJIR( (#G B Y#&%]6Z*+M4U:[ZKM[<&Y8]YQ[?\ +K=_T_\
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);M0QIEU]8__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>g60414g14k89.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g60414g14k89.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[3>T4&AO=&]S:&]P(#,N,  X0DE-! 0
M    -YB^%",CA"24T$!       /1P!6@ #&R5'' (   (  !P"!0 I4V5C=&
MEO;C M0F]X+3%?5"UC96QL7T9U<V]G96Y?:6XM=FET<F]?=C$ .$))300E
M     0(EC,R8#8?_AN&I (Q[.C9#A"24T$.@     !"P   !     !
M +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0
M!);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I;G
M1E<DYA;65415A4    % !# &$ ;@!O &X ( !4 %, -0 Q #  ,  @ ', 90
M!R &D 90!S       /<')I;G10<F]O9E-E='5P3V)J8P    P 4 !R &\ ;P
M!F "  4P!E '0 =0!P       *<')O;V93971U<     $     0FQT;F5N=6
MT    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L      BT
M 0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O;V
MP      $-L8G)B;V]L      !29W--8F]O;       0W)N0V)O;VP      $
M-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP      $5M;$1B;V
M]L      !);G1R8F]O;       0F-K9T]B:F,    !        4D="0P
M,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!OX            $
M)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT                0F
MQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL0'+
M *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G4',     4&=00P
M    !,969T56YT1B-2;'0               !4;W @56YT1B-2;'0
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M09       $    'CA"24T#\P      "0           0 X0DE-)Q
MH  0         !.$))30/U      !( "]F9@ ! &QF9@ &       ! "]F9@
M ! *&9F@ &       ! #(    ! %H    &       ! #4    ! "T    &
M     !.$))30/X      !P  #_____________________________ ^@
M  _____________________________P/H     /____________________
M________\#Z     #_____________________________ ^@  #A"24T$"
M      $     $   )    "0      X0DE-!!X       0     .$))300:
M    ,U    !@             'A0  !U,          0
M         !              =3   'A0                     !
M                   !     !        ;G5L;     (    &8F]U;F1S3V
M)J8P    $       !28W0Q    !     !4;W @;&]N9P          3&5F=&
MQO;F<          $)T;VUL;VYG   'A0    !29VAT;&]N9P  !U,    &<V
MQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E    $@    =S;&EC94
ME$;&]N9P         '9W)O=7!)1&QO;F<         !F]R:6=I;F5N=6T
M ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960     5'EP965N=6T
M *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,    !        4F
M-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG          !"=&
M]M;&]N9P  !X4     4F=H=&QO;F<   =3     W5R;%1%6%0    !
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M5#('-21T(               $  /;6  $     TRU(4" @
M                                                 18W!R=    5
M     S9&5S8P   80   !L=W1P=    ?     48FMP=    @0    4<EA96@
M   A@    49UA96@   BP    48EA96@   D     49&UN9    E0   !P9&
MUD9    L0   "(=G5E9    TP   "&=FEE=P   ]0    D;'5M:0   _@
M 4;65A<P  ! P    D=&5C:   !#     ,<E120P  !#P   @,9U120P  !#
MP   @,8E120P  !#P   @,=&5X=     !#;W!Y<FEG:'0@*&,I(#$Y.3@@2&
M5W;&5T="U086-K87)D($-O;7!A;GD  &1E<V,         $G-21T(@245#-C
M$Y-C8M,BXQ               2<U)'0B!)14,V,3DV-BTR+C$
M                                                       %A96B
M        #S40 !     1;,6%E:(                     !865H@
M  ;Z(  #CU   #D%A96B        !BF0  MX4  !C:6%E:(        "2@
M /A   ML]D97-C         !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M       !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M                                      9&5S8P         N245#(#
M8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="
M         N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V
M4@+2!S4D="                             &1E<V,         +%)E9F
M5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
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M\ 5 !9 %X 8P!H &T <@!W 'P @0"& (L D "5 )H GP"D *D K@"R +< O
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MT+"PT.#1 .#A 4#@X.%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,#
MP,# P,# P,# P,# P,# P,# S_P  1" "@ )P# 2(  A$! Q$!_]T !  *_\
M0!/P   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0
M     !  (#! 4&!P@)"@L0  $$ 0,"! (%!P8(!0,,,P$  A$#!"$2,05!46
M$3(G&!,@84D:&Q0B,D%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ
M-T-A?25>)E\K.$P]-UX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T
M=79W>'EZ>WQ]?G]Q$  @(! @0$ P0%!@<'!@4U 0 "$0,A,1($05%A<2(3!3
M*!D12AL4(CP5+1\#,D8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%53
M9T9>+RLX3#TW7C\T:4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X
M>7I[?'_]H # ,!  (1 Q$ /P#U5))!?9?ZNRNOVMDN<[@C;HUG\K?M24U,L6
M=2PK*:FOK9;+1:US?S7?G-WLW56;-EM?J,WT_GUJC1T/*IS&97VB^*[1::6[
M&UOAEE6RW?;<[:SUOT6S9Z==='\\^IEZU>FO=9A5O<W8YQ<2R=T'<[V[_SD8
M/ ?L<1)G;.A,?2]NB2G"JZ%U"BNFFC.RZJJ&L:&@UN+BT;;;'NL>[<Z_\ G?
M=_-VJ+.B=:]1WJ=2RO1AH8UCF[S#'5V>KO?[/<[]#Z;WV?GY%MN5^L+=MR\6
MC;ZUS*]\EF]P;($3MW?2^DA_M/IW_<JG_/;_>C:G*OZ+U*XB>H9C6BMC-C75
M@;V ,^T;FO9;OMC=8SU$S>B=38T,KZCF-8UH8&DUG23N]SK-WT7?HW_P Y7_
MPE5=5->O\ M/IW_<JG_MQO]Z;]I]._[E4_]N-_O0M3D.Z#F. 'VK):X-H:;0
M6NMG'#-GZ6VY_Z&RZFO(MI]/?99]H_6-F0KG2L+(Z7194/5R198;2ZU[9!+6
MM>QOO=[-S-_P#;_/\ YU6_VGT[_N53_P!N-_O3/ZGTW8X_:Z0 "238V  /ZR
M5J6R+Q=C,J9ZC79M;@QU;@U[ 6[O48YWT;&;O9_+6./J[EAS'#)OJV^EI2&L
M!])U=OIQ9?D?H'NI_F_I[[LC],^N[T%I46.W]-8&@UNI+A8'#D,;[=G]5WT]
MROVD!A)!('8&.4@IPW]%SI><?,RL<6V67/#"QTOLL=>W5UGM94QWV?T_SZJZ
ME ]&ZV;PX=2RA1SH6>INW^KMVEWH^CL_ZYZG[F%^JK;:]NP"LB")W?$^Y_'^
M;[?IH?[5Z8XEHRJ28F!8W@CM[D=5.79T7J+V55_;\UK*FN8^'5DV;G.L8ZQS
MG;VOIW>G]+WL8E7T3,9372[)R+0RX7S:0[7:YCFMF_?^=Z]6ZRST<EGK>E8M
M3]J=, /ZW2-I#3-C="?S3[OI)SU3IH)!RJ9 DC>WCQY2U4X]/U>R*F4 9&27
M4/K>8=#'>D\6[/2-[VL]7Z-W\Y_.66?Z+TD_ZO9-@(.5DUM)M)%98"\7^V[[
M0YUK_5N],;*;6^EZ7^@6Q^T^G:1E4D'OZC?_))?M/IW_<JG_MQO]Z%J8=.#\
M:JG ?O<:JO;:\@N<&0R7^Y_O\ <KJI5Y6+?U!HHNKM+:7$ACFN(!>P!Q:T_P
M E74E/_]#U5)1>]C&.>]P:QH)<XF  .7.*3K&-(#C!<8'Q@N_ZEJ2G/&37A=
M%?D7.!;2VQQ<X$R0Y_TFM:S_J%R/3/KKEOZK6<MCFX>2[960=!/Z/U=6^YWT
M%L?6N\5?5&_:[=ZSC6-9W![W!WN'\CWKG^K4BGI=#V'6NROT6Z>TLL92"W^L
MS^<4T,F*'MQR1)ES.0X8']WAAQVPY9RC*(CM\TO[O%''_W;WKW ]2I[11=,_
MU\=6I&GGQ"S9 S*@QQ(]&YIW3](OQP[W>US??[OH_\4KPU:"9(9VUG<W3M]-
M1$,R0D#DPD2 )*0U D0?!.@I2I]8_Y(SO_  O;_P!0Y7%3ZQ_R1G?^%[?^H<
MDIJ=-'ZIT8S ^S
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M1U-48FESA(BFI__$ !X! 0 !! ,! 0             ! @,$!08'" D*_\0
M1A$  @$# P(#!00'!P0!! (# 0(#  01!1(A$S$&05$4(F%Q\ <R@9$CDJ&Q
MP='2"!4S0E)3X223LO%4"18T8G(70X(E_]H # ,!  (1 Q$ /P#W\<4IQ2G%
M*<4IQ2G%*<4IQ2G%*<4K!'4_O>"Z8>GK</4!8X\B8BM3T.=MZX45U(Y$X='B
MY3#P3)+B5MB.34PZ!%I+<;<;$];]86VM#649N11F61(QP78+D^6>Y_ <U;ED
M$4;R$9"*6P/,@<#\3@?"M0E"L'IN[/K+4_5[7KOT[;+!V<Q1KR5T0,4.*HH\
M3K"^XCY$9F*W3/2K$TU<8>MR@TG),SLRX%'OH.PTJRD!#P,EEL+(,\)612FY
M1/N+99<@YC Q@D'&.3QR,YK"4WY5)MT3!PI,&W&%8C_.3W"G)]/_ -L &J;4
MW+Z0/<OI+-V=(W3=U&T+0E-U?H/7FW!VKEI6J[-=*/L**Z!*13AS[@T@TIR1
MG<$Y)P>:.PT.MD9A25H7B$2W2V2:6-I&:1D]URO &0?H5+R7,EU)#%(D:I&C
M^]&')W8X[@]S\O3SK,O2-Z06VLTKK1K772?0*ILSH!M/LO;M]H8YX-*NM'E(
M8N9IMT@X.1<<D!YFR-1I8C4 *E"Y"0*A1HZ/$-D\10]$UNNZ$P;BMPN45OO*
MP."I/8@>OS^9K@N6VSBX**UNV'=<A67&0P![$]L9//%6OZ)_K<ZC.L?976[C
M?,#\ XG7-TU(_JG594)$1LYKFE;%KUPL4;#V61"%:E9BPF0(=9/FESK[I $N
MX>*.'$->*,'JNH(X4@Z9W%E<.V20S*0"0/(9) ]1@GGDQ9W$L[W'4&T(R;$P
M,JK*3ACW+$8)SV.1Q6,_2.=8O4-JGKJT5TW:YZM=-=(&LM@:"GMBV79>Z:;0
M[!5Q+/#V:U@B!O2-S,AT"O30L2%&@BMS([:BL9<0.^ZXI*JK>&-X))&A>9UD
M"A8V8'! ).%![?*J;J>2.XCB6:.!&C9F>158 @X Y*]^W?OY5)7575^/T^Z$
MU[L#J>ZLZ)UB#;SZD8326JMM].= JH-/1,VT)4;#U4YFH6.0AB&XJ?K5G=F[
M"@]XD-9@\<\'XA.6WAZDC+%$T.R,NR2L=V%Y)&1GD$8XP?7M5Q)^G&K33+,)
M)1&CQ( NXY !"DCN#DY[^0 J0MSZ_>F[7>R^HC5UYL4W69CI=U5!;EVU,R%?
M*=K<=2[&Q'OQ2X8R/<-D)V8)5* BMPX46HQ\XAL,5)#[C:%VEMY66-E (E<H
M@!Y+#OD>0'J?*KK7$2M(C$@Q()')' 4^A\SR.,53>GWT@&G^H.Z2&OA:1O?3
MUM&U^UM>*C=_:EG-7L6K6CI"!<7:LRY[QT*;#(=<0I:2Y$"1RRDDAL!P<"1<
M$F2!XUW;HW&[83&X;#>A'!_$ CXU$=RDK;0LB';N D0IN7_4N?+YX/?C@UB"
M@>E_Z-]C;&I]&B#]K1-8V5<R=<ZIWM:]2VRM=/VU+Z,7F/54J+LZ3':!DI=T
M_"@A\&A1H;Q7EL(+RX2(E^IK295)PI*C<R!@9%7U9!R //T\^*H6]@9E4%@&
M;:DC(RQNW;"N>"3_  ^5=O<?I;>DS2=^V[1; UN6SCZ$&PWN78>O-0VBY:LU
MM:"17GXB@VV\QS>(R(N$\4VW#10Y6$0JK 0W"'38,BP<.(2TFD5"-@,G**SA
M78 X+*IY('<_#D TDO88V=3U#TQ[[+&S(IP2%+#@$XP/+) SFJ[LCTH_35KN
M TM)C1&Z-G6'>NEX'J)J>MM/:IG-B;'A=)6"%&G&-D7>O0[ODU>MA#$^KR!!
M<BXZV8,:T*P6V&^\@MK*Q<$H@C<QLSN%4N#C:">Y^7E4M=Q*(\!W,D8E540N
MPC(SN91R!SS7?OGI1.D:ATKIMV)FSW"ZU#JR3:6])R.N:#8[F?9I2IC@^O5Q
M59BQ<VMBT%S$B+5(^O-P9$JNU+<ARQ@W&'W&X6UF8RK@*8<&3<P4*#GG)XQ@
M9SGMS4M=PJL3;BRS9Z952V2!R,#WLYX P3GBLN=)W6;I_K'@K[)ZQ%OE<G=5
MW0O7VS->;3II]"V)1+6(WEW,79*T>X0H-UU"'THPV4^IH@0T$M(QX10K5$L+
MPE0Q4AU#*R,&5@?,$57#.DX8IN!1MK*ZE65N^"#_  K'=^])#TT:QB>K25NT
ME;H171=,T6%W/%/UM.9CS-F+CT4,^H XD>]CB[-F3$S'EI<#SX%J60VRE/?-
M2VTK&$* >N&,9SP=N=P)\B,'^%4M=1()BQ(Z!42#'/OXVD<\@Y[_ #K%^]_2
M1Z8%U?(":POUEK][O71-9^LJAWL+6XU[BM?ZJ8B%.0]YMM9-F(YDH]$LZP -
M4"',N2$LA484\*GS'4UQVSE_>4$+,(67=M+/YJ#Y<?YL<9SSVJB2Z0)[C$,\
M!F5MN[:F.&9<CSX SR01D5&"I^EAMHO4?T'].CU*ONU:YO;INUULJ_;BA-'V
M<">O-DV'38@R MM0J<-($05;UV"?*MSNSY1E<V%0\MR<*^4(U!%$%73:#ISR
M95#'*RJC2 @!2<@D@$MQA.Q8<@596\/5MXL,XEB5VD$; L6 P0HR O(+<G9Y
MG S5@]*'IIJ]!TC:9O667LJ2<KW5[LC4*-JTK1THO4&JZ,T9!QNN0=F7FO1H
M-<C9&0,^$"V665S5K(#'P;(1Z!%@O/S+9DLG1V\PK(5+^^S8);8I.X\8]!G\
MA$-\ KF<OQ,R;Q&>FBY 7>P&!DY]2?Q&=CO4KZ2[IRZ8MB%:FL<=M[9VQ8*H
M8V)?*KHO5T_M$[5VO%8\7PXV2]$99 JU?2SE);KA);IPX#HD@0"T#(1Y!6/'
M;22KO!15+;5,CA-S>BY[GG^ YK)ENHHFV'>S ;F6-&<JO)RV.PP//D^0J\Q^
MO[IHE97I,CZM;9&Y ]:KEK;T58JS#/EP$HJE1K$E846)\UR//K1,?AY<>2 ?
M'>T0Y@0Z+D PS!'FTT]"4=7*[3#CJ GD;NV.^<]\CC&#GD55[3$>CM;<)\],
M@<';R<YP1Y]QG@CN*B1UG>EGJ&C] ]6UUTE2K1?=I]+^TJUHZP 6&F33M A+
M]:"%J9G;1*P,D@H>A@QP9[3<T^3#LR-J*K-522(58AGV[L-HTDD2NP5)5+@@
MC<5'! !'WL^7)P"<'%69[Q8XYFC4N\+B,@@A0QYR2.R@ ^]P"<+G)J?^J>H2
M%O?3-"]2$]7[O1X+.O9J\6.%OU.DJ/<(H2I#RF;"4749A29"/&,]B'2T!ZPO
MP2<$5%2;#F1CF5YL/&5E,8*L=P *L&4YQCWAP>X!]#FLA)0T0E.5&TL=RE2
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M2Z]5"&MHQM.BCW1RK@YL54M@U6R6HUAV5>KJH]$$T-A,EF/4!EP=F^+2$L(
M'ZI@$HEW>X21G&T+]S/&<Y\N_>PUY,JFX+1]$3F(P[??"@X+;\_>&"2N,8Y[
M<#?!UO=3L;T;]*VY>I&1AL6->M:TP5#5Y9"A&9RT3TQ&56IQ992$K=&CBK).
M1:)4EAMP@:,P80PTXZTE"L"&(S2I$#C><9]  23^ !K83S""%Y2,[1P.V2>
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M2%NZ--%!Z=WSK_1FF-)Z4LVYM-[!U819:!K"G49UUNWU:6A0,3A=0@8X\^*
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MI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI42=F_9@=+7['/4C_P!+3O(]/G_
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M8:PEEG*6DKRXKPMH4K&3%'=ZG>;%9I[NX,CEY9 &D9$:1V>20@;MBL1DY8C
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MM.)4IIYM#B,YRE:4JQG'*[B"2VGFMYE"RP2/%(H8, Z,58!E)5@"#@@D'RJ
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M@;AA.^V'<ARME)*C2@V<ETI82[9"B,0D8.<5?BE#Q*Y9) 0%.PY 8<N%. 6
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MURW>>W?4+9+=='6>6U29V=A<37&V259$8KNMH<+&D?=#)C'#;C7VFC6#"-'
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M3C))B<1D<<EMT;!#1*D\]>>!?"$MG9Z-.NI6>J1V]Y=ZE->K!<K<2W=S"(&
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MSAPFT,_&,G:,C.:S%J*W:;LULS+4"G4B)V%:;6?!U;5MVIMHVG%Y9R.,Y6+
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MTLMLK2^I:UI3?G%L%@]G>9V,*FXZJ(@2?<VY8MK,6C"A2&;:Q)(V\9, GG(
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M?>XZM2\^_/+\]S/=,CW$KS-'%% C2'<5AA01Q1@^2QH JCR J  !@  <G
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MDDC+".W08_3R$[G2YD;+2;2(\9XSFKNW$+L_8$=%)]LUN5IMDV'8[L$"R7$
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M1(94L9+* JAT>WF=[:^ZCLT9B?J&#VA6]_:$"($ .$UO"Q<&5>498;+!BG1
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MGBB*G:]2=.DIMR2Q(2%4;,D,&U]51JDC/8,J]B+ 65X4-,.UZ,3Z])(F,O>
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M4=O,WVC:%<:AXVBBZ3"UN;J"V%[+J*RS7,-Q<&* R>TR$Q21OU8 0#"$$8R
M#7MC290FF0LVU62 ,Z1QE8T98P[!%4 [3D$ C>Q//)P-JU7N$9U%:GE<@QDG
M@":KD6Y'R[KQT%#60J1A1)@4V$DHPM$NU$MR+B!2U8]6-8RT0.XUXTJ3GJ^Z
MM)/#VJP[Y8C)!<R]2)0DTULL<SQ,DT<B=)IBF74>\C95P:VJLLJ9!R&4$'.,
MY ((QSCGSQ\JA38+18*#UXHL4P#!&66)Z)*\/+!(F6X> 7(F;ABHT_U:9E_#
MED1EPAU8>3.SY64,L9QY[N,9PK>U@O\ 5#;0O.EO-)<M"YAZLXCCCDDCW0P_
M>9@H#A.$!9APM5$D+DX) Y&<#./4]N2._EQYYK8&1.U*O7Z7D9G9Z12BXFNQ
MJJ-)S4>U%Q+T@8ZS%R(@*L(*:/GB%>IMN+=4V6II+;*/&G/>I8+JXL(8X=,W
M*DMQ+[;%#(TLJQH&EC>095HX%PY  * Y/>HRH;EN< $<8Y)P?7)/J>PX\S5Z
M24=4XJ1)OTJ'# RD7 $QA5K,9&9,"K:"$R903TFXG#K,6DIE)KS*G,,8>;P\
MI/B3C.,..2ZEC6QB>:2*6=9%M49F1[@KTE=8@<&3:=@(&[!P*JPN=Q R >>,
MX\^?3BJ?1;)+6J+-EI*&&B1%RYC==($EA9@:?K6$,.1-C8($_*VFI5IU;C8R
MLY6VA"<JSGQX[7+VVBM94BCF:5A$AN%>)X6@N26$UNROR3$0 6[$D@=J YY\
MO+SS\?D1C]M7KS#J:M:X2MCAX51M6KF+5+8-CV,1.9 >,[B$%M,G&>M$_E6/
M41EN%>5VRM[R_+1]<K',FTBMYIMEU<>RQ;)&ZO3:7WU0LB;%Y]]@$SV7.34$
MX&<9^'UFN[7JY U@!<?7H6-@0R#"Y0@&+%8#'7)23RBI$MQMA*$+)+*<<>)?
MSC*WG5*<6I2LYSRFXN)[EQ)<3R7#JB1+)*S.W3C&V-06)(55 "KV4< 4  [
M#G/'J>_YU7.6*FG%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*\O=:_\ &M[C
M[O\ Y-F2]_\ ]_.M?=]WBE>H3BE1;ZV/L4MY_K%/_P#LXW%*D56_SNP'^98K
M^(L<4JFL2%@+M<Q"'5EINICQ(!,?8W#AW\2DD0XK!D8N*RG+S"0D)2YZPYW;
M>RK"4XQE/,IH[=;6&9+DF[:619+8(R]*-1[DG5SM;>21M'([FH\\8R/7\_AC
MC \_/X5Y,/3-4^4GI69D@"K#'4G15A&IU8BRIA<G"C2-T+>LMCL)+A)#DZU8
M)60/'!A8\D9<4N(&>Q'R"4A(%3ZM^QRYBMX8 X@DO-=A-U<2I%TIREH@@@@1
M540-;011L\\B,)>LR[T)<L>O?&<37$,F[<J6:F4(S!H'5L95N=RRR,RK$K*5
M" \C.3C"DCL1.N:P+'SLJ6-&0->$P)) X0.P;D7S7#@<^[#>"VE9RL;LM"48
M[*PE2EXSY<_^H%[+)X2T&*YMH9;F76;F*VN(2YMW@A18YK6<$ P:O:NN!/D
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M<93G].MI UGIUO:K/+(+2U@MDN+@".4I"BQQF82*Q641A8W#KNR"3R3CKW[
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MJ7EW+;6=G!>0W!MC:3P7[7*80:-'+)'*([SV8>T-U9'@9F$O48D@;^)@J1)
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M0_WQ[1/*J&X=$(>]0!$VJ(-^V+?'WKA/A/Q$FHZ5!< DJ;>-XT6':.B41?N
MLI$;>]G<21[RE@03P( <J461<)(I0#$6,23(*[XPXPUC&<(>0M*7<9RCZU><
M*;5C"LX[Y\/.P?[,/V&ZXWC[P5XFU&5+&WLM0FFU'1[@,)Y;:.*4Q*K1/[T;
M*%>:)V1R"H4X)%:OQGK$]QI-_I>E0R7.I7\:VMA)"Z)_U,[K&A+2*50HQ)#[
M2!M)()Q6I=VU'3W4C!W4*%J5U*'MD26BNW@- E3G'R3<CAAV,=#K KL8^[EM
M<B]YXK#K>5N+4C&5YY]@-66-M)N[=Y[NR22VE3VBR)]K@2-"6:!L,QF" !2
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MXI3BE.*4XI3BE.*4XI7E[K7_ (UO<?\ T;$E_+G6G]?=^[]KBE>H3BE0/])
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M_>-TABCE,4B#K(T8ZBN[D%61659202S'@C!-9$NW3'+Z\JU8J>T]%[.N^PQ
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MJ<3V7X\YQ=O;P7JP22"5[T!Q=W4LID-R?=6$A2HV=*-0F 6!_"H (X& H[
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MA*AA&5"SS*RH0O!((Y9K;Y[([RD-LH\H!Q"DL.K:7X/(0(M&,J4G&%K3E*/
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M;B/3[?0+ZTUA] NTT^RNK62TBUF4/;7MRZ2"!GB60BU4AMZJ-Y(( RD]GVR
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M%C&,[ASR >V#V&,GRSV&,XSYX]*ZE\5ZEJEF+$:4UK[1->V\3^UK.(>@[DS
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M(XNE;Q38MUMXY)"^8T ZDC,5+*&KVEIUQU;06=K;3:?(KQJ[1E(XU)#2,Y9
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MWYCKOFI7G*\XYYKOFOK.SGL7U"WZ-SJ#S76F6L@:-)XE_1SD(#'TRK[(MKG
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M[F:U$[W1BD"G?[-)T5M9$ V;9,L<=O(_]M?PGX;TWP!:V[QZ;+J+2W$.FG4
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M8]H8AU$I+5'8>[]\#9)0E_+?;MEQ.%<O^TW'LWL?6?V7K=?H9_1];:4ZF/\
M5M)&?0]LU&!G/GC&?A]"J_RQ4TXI3BE?E>%90O",X2O*580K..^$JSC.$YSC
M[>,9[9SC[? [\\CS';-*MJG VB.@!!+C,A3\^VX6HN4CP<QHK[;A3JQ$-B9<
M=RWE@53++BO'GS'$*<]V%8QC)O'M9+AWLX7@MR$V122=1U(4!R7P,[G#,!Y
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MLT;"Z3C?9D)$9^,+8 +-I@P:Y*[6G\S4@3@2H9'(M=IVK8:NR&8T. ZEG%:
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MR<2RB EV:[G#3B,C&D"M%/XQA3S66UN*94RROZUCZU)"E9QE:4)Q[O'.O?\
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M&+8<DG R,<&@R.VU6)C+.BL@5E95.X\2'ABQ4+E. ,X.3D2EZ:IR]V[0UIC
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M2>OJ\Z.D-?16LITR5@HY-4TJ,9.PY]*B8B8KBZ.Q/E&.PPD^*?40I<Q[4"B
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MR@SY",%17F)LB,"5UQO"*[*",;BJEAD ^7<@'G!\JO&1FAC?.PNT89A_E#,
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M&95W0Y1F4]LJQ4X],@BH9$<8=5<9SAE##/K@@\U3']'Z6*N[VS2=0:N(V01
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M"TU2JD-*!(8.8K*E0+3Z8K.1."S')+,21@DDG(SG!YY&><>O/>@1!@!% !R
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M0IQAIQMQ.,K;4M'UW%/H_6/Y5\EO2!5V#-?CI/IOZJQBQZ29L1YK.K0%^"I
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M'/GS^1 _?7(9UK>H6V HY?3%U0LV6S1$].PL?FA0"O6XRM.Q+,T1YZ;?D=K
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M^RA5NOESH$CM2<V /'7J;MIN/4G9R-%8:A?92< INM=G,?24H(Y.K[SF0LV
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MS?I=QN/HOZB?TTVCU;]=_P"JGQ=5_P"^%[^=+9OTNXW'T7]1/Z:;1ZM^N_\
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M4VP6]'LB.D;PR,W5FZ0#J%*^Z22V">1CRX(^/%5"[D1Y4GB53##U28V+!LL
M NX @'(&2."#WQ5#Z,O2^V/>?4-I71FW(?II\SJ8H4_=M8%=.&\6MLSFM)J
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MN]/H%Q2GU;NF_P!#V^_X-N]/H%Q2GU;NF_T/;[_@V[T^@7%*?5NZ;_0]OO\
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MK<=^#QY\\>G-1N7CWEY[<CGG''/J"/GQ5TRDK%P@!$I-20$1&")2HJ1E#!P
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M*N1P,_D!!JW6@UF8:5ZLDMQAMUYL93W@P\MIIQQ+>5*0VM6,)RI6N;0$[L2
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M5C'?&,*JK;YQ2G%*<4IQ2G%*TL=4^KMQPN^>KKJ5U#5+C9IF Z?]7Z^L=!C
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M3^S^5/R.*&]_;JQZUL=_N=0=F_\ Q.WVNWZGNXJ:?D<4-^-CUK?J_5!V;O\
MO^#_ %?)Q3\?W<_L_=3/HXH;/_W676M_"#LW_6C/%/Q_=_*OGY'#"^__ +['
MK6]__P!,'9O_ ,3^OZG%*^_D<4-^-CUK?P@[-[_U?K/Z_O<4_'\./Y9_;7S\
MCBAL?_=8]:W;[GU0=F[?]#_GXJ/Q/[/Y59&SN@(2IZWV!:8KJQZT<2E;I-JG
M8U3V_P"RNLHD(J"/."<<:4CPN-MDL-+4TKNAS"? O&49RGBGKY^G\JJ/H8ML
M;(W?Z-GIFV;MNX3%]V!9JU./6"V3[Z29>7?#MT]'CO'/I0C#KJ!!6&<K\.,J
MPWC.??GCTJ:VB\4IQ2G%*<4JS-CCOE:\O@HK+Q)1-,M XPX[2WB"'WH,YMEE
MAEM*G'GG7%);::0E2W%J2A*<JSC')7[RY[9'?@=_7RJEN5;'^D_N-:"->4CJ
M-Z9X3I-I\/KG;UUU[0NF7;V[-42]9J[UCNFK[I.=+1C=JZ>I6,G!"T)L,?M$
MM,QIV,LH3K1X-F(UN@$A-&&#,SW,<IE8LBLTJQOD@*XZN1)D>148<CTWY]XX
MUZK)"(0$=E6)Y$(&2C&(YBP?1L;,\88K@;1FKUNU=5=MF(1R:^-VXQNO-X1N
MP=6V>:K-[GGP,SG0GUOP,S)Q=GMG3[H63FHEO80M2C\(?H"(2)M=B!@X@MX2
M=A@5PPC ;;L4LFU@"H!Q/">PD?DJ3YY*C..]2#*V,[V"R!E)#><$P)!:-.-V
MWG;@,<9(Q4C8*,ZLZY+PTP3NGJ.M3<)(>CLL;T'/U>D*AK 9OG=(.ONJ.'FF
M8C5D6>[7Z?KP9VP.PP$@ G6+QIEE/>8;]5>%MDQ$'W(QD7 [ME=B%HL9<\EB
M!DCWL #XW!UA@EY#@VQP0N&ZC@2@C:.%7)X(V]SDUC/H=HVY];3E.;KE$#N6
M[([IHDX7?YFU=6V3I]A*GN[%^UH?.5U6[(76\T9N)6Q9(S:6PB[">!M@N1E8
M4*UUVQTRI;$Q&DUS,C!B3M0R@QA'60F/:P!V%ALVC8N,J!RI4LM4P!U( 7<X
MB(D+J8P)-RY&\+[^[WVS[Y) (*@X-"W7T_[ENA?73<+!K^F$TR>WMJ,K9<%7
M]*R]YWV1K\/IFZ:@]CW#I4VY*R4.F4F*/) 2[E.&&U67+F354L'L%\&\O1T,
M!$;HO1 )W"-]I+A8]W5E*K*H\F'#>^!AAD%>:I>)R;ABHVF5"P$99RO2BW-"
MW!)!'&%.<''O<5+_ *>=*W _J+ZI=GR4?K4&G%=5;M@A1[IH(R1V188YC0&B
MV(ZRT?;<C=HA$1!,SHRV@5"T2;:$E82?&;D<'/O8BK<KKLA4%BW1 .UQM'OO
MPRA3DX__ &'!'&.]^)"9)7.W;UB1NC]XCIQC*N2,#(\E/((^6+.@[I&O8E$Z
M/]H[%QK:D$:@JLI-Q%8J6D);7NXI*1ME*L5((@-QWV<NTL5/18D=8GYJ4@A:
M;7/:UNB:S,E*&1!-A$U3RJ6F5=QWL 27!3W6!RBA1@\8SD\%@.]46\# 0LVU
M=BD@*A5R64C$C;CN SDC:,D D<8KEL-*<7U1VX8K65I-WM+]<.F]HZ\VDUK>
MQEQT7TVP&F-90%Q?9VZU!N5F!J8T/%[?UU(TXFSAEDV^U+QB!=?N(9AP,.F/
M>&SH,C)N )D+L1E<@DY*MD ^ZO)P#0K^E(V'J&='5MIQTPBAL/C & ZD$]SV
MY%4SJ?AP[[LC8LU'ZVNEIV)MG7'2=GI$O2=07<MVISM6VQ;;'.+:M!55QC3<
MI2Y<^%V%=LV\RFF*K>0GR\&HA7A 49*JHW!51I>J-X&0R@#@-[X(]T8R<Y'G
MFDOO.QVDEUB$+%"<$,Q/< J0<,<X./7M7!?]-VW3^TY RB>UK%0:=:M87:YS
M4[KZPS];&G)+;6SK?KSX1URDE"VC<#^IC]I7;9UUFXX^)/9G ^GR6D'6$5FY
MR4C*N'4 \,P90 P#8"J#@MPH?:% .1CJ <D8AHV1\J<J"K,64D9+N5W!2"VW
M<S$\<A#QAL[8-96*Q6_6VOK9<*L31K;:*/4[%:*4:M;AE/L4W @24W5BW'&V
MG%DU^3)*B7UN--+4Z(M2FT*SE.,5P S!3N 8@-Z@$@'\1S68I)52PVDJ"5]"
M0"1^!XJ^.4U53BE:^/1Z_F1U=_M[^HW^-5?D#@#Y"E;!^32G%*<4IQ2G%*<4
MIQ2G%*<4IQ2NJ>P02$8.(8N/*?&?9&/;::?<"?<:4AHI##Z5,/+'6I+J6GDJ
M:7E&$KQE.<XXI6M#3$/.0'3=UQQ-DMIEXFA;MU&8-L\A%Q4*5)+<I*7$9<CH
M5IB.'PPTM Z/(;2IQ#6''<J=4I650//]_'\ /05(GH1[?47]+7;\!.L_W_@K
M&]^*#..?K]I_>:EAQ]?7_-36N/J[ZPRM73D9K"E2K6O9^3$NDW8MFW&A6RQQ
M<'7M?0 MCLOP0JD. J4NDRY$&)? FD-XI(;@9HI<P5+,8AG.PO"?A%-3ADU*
M]A.H01O9PV^FVE]:VTDUQ?SM;VWMEW-((K.$3)M>'/MKAT=(5B/6&!=W?1P@
M81,5E8N\;R86)59S'&GO2$*V0<;<C!R<*?+#:^NZ2GY>_LV&Q5R6I_4 3:H*
MV%BU>PT^0UM(.$OQ,7MOX. 6"40];K55#%M3[42$B)DH!>(O*WI/!.!O3UKX
M%2"*Q-O;7,5WH*6L]JCW-O=QZC'M6632?:7@C*VEI=*&@,TAECN!U#MBV[N$
M/XB0,2\J-:WKS0RR)%)%+:X&U+F2(N[,\L9&XHBH4V@,&!6II].WI4TDJL+]
MQLFF*5!35GI\M9SZF%<-5[AFW1ENHK$%'(@<#Z^FVXQJ.B*Y9Y6:G*97VZ^R
MO$F\0,_YB>&^(?LN*"W6SMM9O9X;:\BMDNGM-4TB ,![7/(9]VH0F4R37-K%
M##=SFX8&-590#L[#Q);3ES+/9QQM(A8?I+>X]_(B3:1TI'&%CDDZBQ* "QVG
MC<74O2.@W,R)&H$>3LO!T?5*= 2WP+L6N=<;7VF_/CQMX5KC;%N?3328^N@C
M3Q M<-+3*31$;EFOG37B3YG4-U]GCV:2O?R+INQ[J\GA]L@U'4-*TP0-+9#4
M=*M5-XLEP[0*UPBF.%9 ;A(<8'((M2CF/Z$/,#M17$4D4,T@D*2]&XD'2<+A
MB &);:=C, 2-F <A7X6>'I,;$DQY1L9*6A'LZNFCU[#>)-AJ061-#!(@V)@P
M^1P5[/>+1*'IR6<AAYIDAY'7#QW$T#7LDJR*DD5J>I<(UQNZ3-&!"SF=H4CC
M"B14Z:>[&6!*K6QR VT @D%LA3M[C.6QMW$G.,[CR<8!-79S&JJORO\ O%?_
M %*O^;/%*T<^@+^Q3W[^WTZQ_P#?#-\4K>1Q2G%*<4IQ2HQ]:6R;=I[I,ZB-
MI4$]B+NM#U+<[-5I(D)B28 FXN'(?CS'8\G"AC$#$)0]D9].67O!X',91G..
M*5%^C=-G67:J33K.5Z2?:HY-CJM=GB6&="=/V662)>(#D'VFLJJN5>4VZ0M+
M?BSE7@PGQ9SG'?DY^7Y"HP/4_F?YU=7U)W6+G_Y2W;/S!]/F/^:J\9^7Y"F.
M.Y^>3FOGU)W6)_E+=L_,)T^_17C/R_(?R^/U@4Q\_P S_/\ YI]2=UB?Y2W;
M/S!]/GT5XS\OR%1M^+?F:^_4G=8G^4MVS\P?3Y]%/Z_J\9^7Y#US]?#CM4X^
M)_,_SI]2=UB_Y2W;/S!]/GT5XS\OR%-OQ/YG\_KCX5\^I.ZQ/\I;MGY@^GS]
M7]"O]?D^3C/R_(?+T^N_>FWXG\S]<?\ O-/J3NL3_*6[9^83I]^BO(S]8'UY
M_6!3'Q/Y_MX_]?#.:^_4G]8O^4MVQ\P?3Y]%.*8^)_,_SKY]2=UB?Y2W;/S!
M]/GT5XICXG\_KRX_;WYK[]2=UB_Y2W;/S!]/GT5XS]8%,?$_F?C]?@/CGY]2
M=UB?Y2W;/S"=/OZ6?T*_I?\ /CY,Y[L_6!]'\:8^)^63\?Q\_6L,^C!WKU![
M'VOZ1'3>^-L.[C1TM]4 >H]?VXZG5:FS!%9508*P.^UPJD$#&$%N2$B\OSL,
M^)*,82GLC.$X4['S[>9S\NY^?E^/%3/TYW^J/ZP,?:^$&E>W[NI8O/V\8_2^
M[CB@\_G^7UW_ !J57%33BE.*50K/$GSU>F(:+L$E59"2 ?$#L<.T"]*0S[J?
M"@\%J3%-CW"6,_7-I+%?9SG^_;SQ2M.-CCBHCT/O4I%'3,E8C(T/JM!*GYA(
M29::?$WUL9AV4DDQH@$=@XY;>22L @AB8?<7@<5AK"&TJ@'/;X?P[_&MN^M_
M\'E#_6;6/]BA<5-7IQ2G%*<4JVXNWUR9G[+5XR305/4]R,9L<>E@MM<8Y,1[
M4I&I6\\.V,1ZT ^T0G(CQ"6\+\#V6W<*1C(DM;B&"WN9(RL%V)3;R;E(D$,A
MBDP Q9=LBE??5<XRN1S4!@20#RN,CGC/(_95R<QZFG%*<4K%>]/\">W_ -C&
M^?R7E.*@]C\C\*UE^@._Q3W23^M6R_J?GZLW]?DXJ:W$<4IQ2G%*<4J!7I)-
MA;'UOTO2LMJJ[RNN;A.;"U72A[I!B1)LU!1UQO4- RY<4S-A2,9@_$>8^@9T
MH(A#3BL+PWE6,9PI]?7U\ZMI70WNS*E93Z1[K$2G.<^%.5Z95E*>_?&,J^*[
M'?.,>[OVQW[=^V.^>*CGX'\<?P-?CZAK=W^4@ZQ?^5IC^B[BG/H/S/\ *GU#
M6[O\I!UB_P#*TQ^]_@N_^W^GQ3GT'YG^5/J&=W?Y2'K%_P"5IC^B[BG/H/S_
M .*^_4-;N_RD'6+_ ,K3/]%W%.?0?F?Y5\^H:W=_E(>L7_E:8_HNXISZ#\S_
M "I]0UN[_*0]8O\ RM,?T7<4Y]!^?_%/J&MW?Y2'K%_Y6F/Z+N*<^@_/_BGU
M#.[O\I#UB_\ *TQ_1=Q3GT'YG^5??J&MW?Y2#K%_Y6F?Z+N*<^@_/_BOGU#6
M[O\ *0=8O_*TQ[_U?^Y=_P W%.?0?G_Q75/Z(=X" F%(](_UB*6,(0^C"LZ9
MRG*F6EN8PK'Q78[XSE/;.,9QW^[Q3GX?M]/EZ_#M^567Z%[?FX>I+H1J>S-Z
M7<S8FPOC2WM3C;9(1\3&'R<30]N6VH0&3!80*.C<$M0\0&V^ZP(UYSJ5N*3X
ME<5/GCY?MS_*LJ>CU_,CJ[_;W]1O\:J_%*V#\4IQ2G%*<4IQ2G%*<4IQ2G%*
M<4KJG/$CA%D!AJD"V!GW1@$/,C+-(;;4ID5)!*D#L*?<PEK#KZTM-Y5XW%83
MC.>*5K3T[*3TUTY]=$E9:L12YDB\=162ZV5+Q<Z_'>&BM);2Y*0KK\85EYO"
M7\9%><2WASREJRXA7%0/_?S^?GY?7 D-T(_87]+7[!.L_P"2L;_S<D_P'ECR
M^N?/O0=OS^/G]>F*DO88&/M$%+UR6P4J,FX\J,/2$:7&EJ$,:4R_@:0 >'-#
M>RVM6$$"OLOM*[+;<2K&,XNV\\EM/%<1%1+#(LL9=$D4.A#+NCD5D<9'*NI4
M]B#0@$$'L00<'!P1C@CD?.O%1Z3+JDWB;MO:]7LD!&P="JMWSI6FPD/<RY6/
MMFO==S9RFH_93,7:#2I)Z;]3!E#P2F*W-8=>90846T)Y*_9'V;>&-#72M+N;
M:YEGO[JR_OF]GELTBDM=0OX4!DTXRVRK&(0[Q(Z-<PX!**C-N'7GB'5;V$W'
M4ME6!;F.WB E8I<1(&=_:!')[R/C&PB)@#R[ 8&FXF1L]F)-DRI(\_#N BS?
M-(**8::B6L#QS3V3'7LJ&C!$MB!)?<>\L=*64YSCW9[FC@@@18XX40('4%45
M&Q*=TARB@!I6]^0J![V3QY=<W&I/U,S2G>\L81&;<K,AQ$BH22P7G:#V Y[&
MKJKUID@2/9(2&03[',Q<C(O24A&"5A^S!33QM?ECA"HA88L1&(-(9>!6\D!W
M#OK#SK8Z/5\X=S:1NHD?+I;Q2Q1K&DK7"VTD(2XC1TE#-+)L4AP"X(VK[QW#
M.L[]]VV,HIFD61G=E6)I4D#HTB%64(AR"@(!'?S%;^>@+9VMUC:.T;L6V525
MUC3+;<^I/:CM,FK$"FJ[% .0RS%[K@#(F?AINDP4^F'"@;")/1XYQSD<>K+L
M>PX67T'X]TS40^N:WI]I=1:E>6EGX=TM;R&WD-UI[1DF71KA98)8;V: 323V
M[P2,B+(G$C!5[*T2Y@>.WMFD@?I&XO;KH/(#%<-*Q9+B/:ZM&CN-C]7#%$;9
M@9/I[KUGN>U-<$3,$%(:BL1<U*@Q3EIBHNSN8BH2ROA#SK<>%*ICSHNWPH6)
M*&>3(I6U'RPA2TX>;RSSS3<6UGI>HK#.\>K0)#$\HM99+8=6:V#M 9'C,B2V
MDS]*8=,@R1NH]TYKEJLTB$A6C.Y@N\ D@-@. "1A@,KDYP1D#M60!:K$!V>6
MM["3?;<W%14,>IR2D'0% PI$B2#@>*=)7&AD)=E"_6"Q16BBT99;*>>0,.EO
M!>ZF>VAM#LZ,$LLR 1QK('G$:R%I0G5=<1)M1W*(=Q4 LQ-S R6YR0!W., D
MCCMGD\]ZN%?]XK_ZE7_-GF/4UHY] 7]BGOW]OIUC_P"^&;XI6\CBE.*5;T/)
MS9LG8A).NNPX$6>P-"2;D@&6BQ!N!,/O2#0PRE/QZ6"G'@LL&82\M3&7DI\M
M:<YOS1PI';M%<+-))&S31=-T-LX=E5"S#;)N0!PR' SM.#5()R01@ \'(.1\
MNX([<^F:N'EBJJA1Z2#M]05U<=_D^(?87^PR??\ N?+P?R[?O_CVI4D-.?X(
MM5_L<4?^3$7Q2LC\4IQ2G%*<4IQ2G%*<4IQG^?Y4IQ2G%*<4K1_Z*C[,/TU'
M[?,+[OX):E^YG^OZ?%*V+Z=Q_P!\=U@?:_X0:5_W217O_=_5^Y[L<5 \_F?W
M_7?S^&*E3Q4TXI3BE42R%3@4#+%UF+$F[ ."^[#Q!\BJ("D3THSD<0J32*<H
M%AU?9+A*0R5-)[JPRYG'ARI6G"RD2Q?H?NI4J>C&(:;)#ZKGY:(%/3*#QDD[
MOK8RS06))+ V#VA2,N,H+P.QZPE&'?*1A7APH/KZ\OE6W;6_^#RA_K-K'^Q0
MN*5>G%*<4IQ2OPEII"W'$-MI<=RG+JTH2E;F4)\*<N*QC"EY2G&$I\6<]DX[
M8[8XR2 "20,X!/ SR<#L/X^?J5?OBE.*4XI6*]Z?X$]O_L8WS^2\IQ0]C]?R
M_>*UF>@._P 4_P!)7V_^"ME]_P#]_5FXI6X?BE.*4XI3BE:X/2H?8LB?LYZ
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MN$D##+HN0*RT)*\G++[K':5RPX8@'R)Y&,C!X)J_E_WBO_J5?\V>8-55HZ]
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MA<+_ /"K2X2.C*4_(IY&/_*Y;M=/OKX2FSM9KD0*&E,2%Q&"&(+D [00K'Y
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M?%'(3$S*YV&16,3[E&)(MC@94-M)%5%0<9SP<C!(Y'K@C(^!R/A6]>8FH:O
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MG%*<4IQ2J%/6>NU9D$FR3D7!#R<K'P4<]*FC@M'3,J^D6,BQ5D+;2\>>2I+
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M.>GN88,I!!1XFW(P901Y'2S6\;,BQB"MT$TN65NKIUB9.G66F0-1I!T8Y8I
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M;SV+RN5,RVZ9-Q&-QDZI&QW\V)*YGWIOI<V+\?%3"E9^L:43IW7<7%:IT47
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M&>=W=L!3@]QR$X\'BRLJSEN:P*ZX/B02_AEQ;6$JRJ:W+ZW_ ,'E#_6;6/\
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M,MK<2V%GJ$J6%G#+*TM];6:SW8$I#$R+U(C<;"H$:LZA%) SVJA]P#L@WN5
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MAM[;VJ2^74Y(Y6M(HWZ4[VB?HC;L\<[ $M646W@21NI*EQE2^"2X&SIC&\D
MJ"<G< P&3Q;NH^G.AU2G:N5:=635%VM39"<,MYK^T8B\FTJNOR\W*WK:3"K$
M1(.*K&TCP"XH]\8'%GS!2S,642VX _E&1JWB&_N;S4O9M4AOM*O(X4LT73);
M%+VX6&&*QTMO9Q&/:M,1TFC5I/9NO$TBH0ZYMV\"(D9>+9,A<N3)U&0LS%Y
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M5X.O,CMJ=?=;9:3E.%..K2VVG*U80G"EKRE.,J6I*$]\^]2L)QWSG&.2 2<
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M74KD$<<UBZNXGMS!''[*DTIN)F5NI#LA<L0A#"3*%B"H82\Q]F.?+$B?BP+
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M$CI/7B"%#9@B,DX=2UXLS]C1A:U*\.<94J6QGMA7A2E><XQ\O?MVSGE2Z98
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M8YCI'=V%W:/97,?M<@AFMI-/N0\D4DXPD1DC;=%<#=LDC)#*20WF2)4JVX<
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M.5VN9>0L@ &1GN!C;QDS%#UGI@[)30&OM8F9C25QIK8E4JI*@#&4-N. E):
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MXRM:E9QWSG/*9YY[F5Y[F:6>:0YDEF=I)'. ,N[DLQP ,DG@ 4 "@!0 !V
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MRS+W,#W,QD8V4-K*#,SVKR7"Q1F0)&K)TBT;&5(XV+@@3NP#E6P&"K@%BP.
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M<,_/W=VT< 56H(&&.X^9QC/X9.../V^=7%S'J:<4IQ2G%*<4J*VG?LCNK_\
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M.$(QC.<_+S%FFEN)9)YG:2::1Y99&^\\DC%W=OBS$D_$U(         [ #@
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MCRF,^#ZSQ8[95G'-;=202W$LEO +6!W)BMQ(TO27'W>H_OOV)R>><>55*"
M3N(')[9/KBN&T5G%H&C!E3MC@,1DY%3GG5N21&OGYBB4DXB9)QP8K!,+(93Y
M$F$E+2R1\J;2^UG/BY5;7/LS2MT+>?JP2P8N8S(L?54J98P&7;-'G,3G.QN=
MI[4()Q@D<@Y'?Y?(]CZC(JH24#"3!,29+1,=)%P)_M2$).#8)?B9+U=X7U^.
M=>0M89?JQ#X_K#&4.^2\ZWXO M6,VXYYHEE2*62-)X^E,J.RK+'N5]D@4@.N
MY5;:V1D ]Q0@'&0#@Y&1G!]1Z&JMRU4TXI3BE.*5KX]'K^9'5W^WOZC?TO\
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MD<CKJ-K(4M+>X5%6XW2R3.BR6B9A Z]N'+REB(B$8)(QV@T!FR!L898@G(X
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MUTEUMAA",Y===<2RVVC/NRI;JU)2C&._]]E6.WVL]^W,<!F("@EB0  ,DGT
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MBCD+2G"5.+[^$KBZEG+(9YY8%GGFA6>0NP,[ R2,,[1+*$0RLOWF4'/ KO(
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M2MF6>5BJLS+%N98P9&#(KJ?07AJQ.;.)V$P2-HI@&CB?:MNR&;,N(D3<1RQ
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M4M9-+-V\&FWES;37<87>A> E8YR@!=C"CN513SV )Q0HNX2;075653Y@,06
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MO:ZGBK7_  QI%WJ%O:7,,TUX.E$;6Z5A(MVBO$1&(S(,2%50 $+N0,/-O_\
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MY;:0G.>R<<IEN)YUA6:6258(Q#"'8L(H@Q81H"?=0,S':.,DGSH !G  R<G
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M]L9^&5<[=_N=_:7;O]O]3W_)Q3(YY''>F=N:IQCOG9NOL8S]O-SKG;W=N_\
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MJ]\F/ES^:/R8^WG[7&".XQ3(]>/7R_.H:^CH."DZYU92$::)(QYG73U%$!G
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M Z )*Z?\0NK-5B@:;LB9.5291(=9%GBT:\LE*2*OU9EEE!*S)D286HE! Z2
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M'1W6W%*?7[_Y5>W%*<4IQ2G%*<4IQ2G%*<4IQ2K:>N%;'M ]+?E1VK,5#/V
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MSEF9N21N8G&?3/;\*NI&D8 557@9VJ!G\N_XUV-LZ$T?OJ.B(C>&G]9;@BH
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M ,Z>R6O_ ,>'_MI_*GY'-Z/_ /$DZ4/X/VJ_HMR?:;C_ 'Y?^XQ_>:>R6O\
M\>'_ +:?RI^1S>C_ /Q).E#^#]JSZ+<CVFX_WYO^X_G^/_KRI[):_P#QX?\
MMI_*OOY'-Z/_ /$CZ3_X/VJ_HM^E_7OGD^TW'^_+_P!QOYT]DM?_ (\/_;3^
M5?/R.;T?_P"))TH?P?M5_1;D>TW'^_-_W'_G3V2U_P#CP_\ ;3^5/R.;T?\
M^))TH?P?M5_1;CVFX_WYO^X_]5/9+7_X\/\ VT_E3\CF]'_^))TH?P?M6?1;
MD^TW'^_-_P!Q_/\ '_UY4]DM?_CP_P#;3^50[ZH/18:9V[+4O46G^E/I+TKJ
M2S#R$AN_?-<TUJMG<D1"QY030VN].1OP*=:KEJN;3[^7]GF.DII\2)(.Q 'P
MC<B7LW8[IU!=Y9I&& D9=MA)[LYSR /\HQDGDX)JQ+9QN52."&-&SU)!&F\
M$>Z@QP6_UD':.PS@C:7J/4FN=$:WJ.H]2U2,I.NZ+%(AJQ6HA#B1(\3#SI3[
MBW7W'BC3Y X@J2E9,Y\F0E9,LN1D"232GWW,5W:1F=SEF.23YGZ[#R'%9B(D
M:JB*%51@ ?7?U/F:R-RFJZ<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G
M%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4
1IQ2G%*<4IQ2G%*<4IQ2O_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>g60414g14k99.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g60414g14k99.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[20:4&AO=&]S:&]P(#,N,  X0DE-! 0
M    (_Z^DA0X0DE-! 0       \< 5H  QLE1QP"   "    .$))300E
M   0S<_Z?:C'O@D%<':NKP7#3CA"24T$.@      Y0   !     !       +
M<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0    !)
M;G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I;G1E
M<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    , %
M<@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !     $)L
M=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M  (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7     $-P
M=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B;V]L
M      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L      !%
M;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0       %)'
M0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M      !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
M     $)L9"!5;G1&(U)L=                %)S;'15;G1&(U!X;$!RP  0
M        "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0    !09U!S
M %!G4$,     3&5F=%5N=$8C4FQT                5&]P(%5N=$8C4FQT
M                4V-L(%5N=$8C4')C0%D            08W)O<%=H96Y0
M<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O
M<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M"V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  $#O_XU
M  (  3A"24T$)@      #@             _@   .$))300-       $
M'CA"24T$&0      !    !XX0DE- _,       D           $ .$))32<0
M       *  $          3A"24T#]0      2  O9F8  0!L9F8 !@
M 0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U     0 M
M    !@       3A"24T#^       <   ____________________________
M_P/H     /____________________________\#Z     #_____________
M________________ ^@     _____________________________P/H   X
M0DE-! @      !     !   "0    D      .$))300>       $     #A"
M24T$&@     #-0    8              -@   -X          $
M                 0             #>    -@
M 0                         0     0       &YU;&P    "    !F)O
M=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M $QE9G1L;VYG          !"=&]M;&]N9P   -@     4F=H=&QO;F<   -X
M    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(    '
M<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG:6YE
M;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y<&5E
M;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC     0
M     %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M    0G1O;6QO;F<   #8     %)G:'1L;VYG   #>     -U<FQ415A4
M 0       &YU;&Q415A4     0       $US9V5415A4     0      !F%L
M=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC96QL
M5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(;W)Z
M06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC959E
M<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%4VQI
M8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M"FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M  MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
M #A"24T$$0       0$ .$))3004       $     SA"24T$#      9Z
M  $   "@    )P   >   $D@   9S  8  '_V/_B#%A)0T-?4%)/1DE,10 !
M 0  #$A,:6YO A   &UN=')21T(@6%E:( ?.  ( "0 & #$  &%C<W!-4T94
M     $E%0R!S4D="               !  #VU@ !     -,M2% @(
M                                                        $6-P
M<G0   %0    ,V1E<V,   &$    ;'=T<'0   'P    %&)K<'0   ($
M%')865H   (8    %&=865H   (L    %&)865H   )     %&1M;F0   )4
M    <&1M9&0   +$    B'9U960   -,    AG9I97<   /4    )&QU;6D
M  /X    %&UE87,   0,    )'1E8V@   0P    #')44D,   0\   (#&=4
M4D,   0\   (#&)44D,   0\   (#'1E>'0     0V]P>7)I9VAT("AC*2 Q
M.3DX($AE=VQE='0M4&%C:V%R9"!#;VUP86YY  !D97-C         !)S4D="
M($E%0S8Q.38V+3(N,0              $G-21T(@245#-C$Y-C8M,BXQ
M
M  !865H@        \U$  0    $6S%A96B                      6%E:
M(        &^B   X]0   Y!865H@        8ID  +>%   8VEA96B
M   DH   #X0  +;/9&5S8P         6245#(&AT=' Z+R]W=W<N:65C+F-H
M               6245#(&AT=' Z+R]W=W<N:65C+F-H
M                                             &1E<V,
M+DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R('-P86-E("T@<U)'
M0@              +DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R
M('-P86-E("T@<U)'0@                            !D97-C
M "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M,BXQ
M               L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%
M0S8Q.38V+3(N,0                                  =FEE=P
M$Z3^ !1?+@ 0SQ0  ^W,  03"P #7)X    !6%E:(       3 E6 %    !7
M'^=M96%S          $                        "CP    )S:6<@
M $-25"!C=7)V        !      %  H #P 4 !D '@ C "@ +0 R #< .P!
M $4 2@!/ %0 60!> &, : !M '( =P!\ ($ A@"+ )  E0": )\ I "I *X
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M6J9:]5M%6Y5;Y5PU7(9<UETG77A=R0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M03H34E=4$UG&%89'B;U%8M21\8SCT52*B7W<9^3[N>GMMN_9WJ,*\V3QTSH
M&E&=RUCK//NTU*;X4M^(C"@<>57D$M SGK;9#3PT\E$CL2D7Z&Q<(0>X"I<K
MFQT>0 TC,6(/#<<\89GO8]W7B/)QHO+SCH)*0Q#_ +OE_:&F[/J*1F,H6XZX
MW!6RNMQ%3<*PTM*$N,5^792TA"U#+<6MU:D^C_I7NF*5]JYUHIE'5QBLQ6RT
M<7@#F>G9,UL)SP2&L0MR> 0.!K@/4_U$V\\:;@Q(=&('.4Q4^-DE))/3#8@$
M%8L1X#+#,  !T%CYG>[?W>:XQ<\9B/UN"Q-:BWN8$02SJZX.L'#V',>&Z?*+
MHUN ;: L2 @V""W@3PH&>P(.26W#NB"D$HI3?/I'N/94,F19H<MA$=5;)5 8
MWK"1^B+XZH[-)7[CE462-[$!=D0S*[JAMG:'J7A-URI0Z)<;EW5BM&PPD2?H
M0O)\)90!9>A%9S'*D$W0K,L;(CL)?.JJU8VCHT:.C1HZ-&CHT:.C1HZ-&CHT
M:.C1HZ-&CHT:.C1HZ-&CHT:.C1HZ-&CHT:.C1HZ-&CHT:.C1HZ-&L+V#L>@Z
MFJ4M?-G7.LT"EP+.")BTV^:CZ_!1S:E80W[S)29 PJ''W,I9&9]3+Q+ZT,,-
MN/+0A2NAC[V4M14<;3LW[DYXBJU()+$\A^O3'$K,0!Y9N.E5!9B "0ENWJ>.
MK2W+]J"G5A',MBS*D,2#Z=3N57D^RKSU,> H)(&J]_)OVE'BUK(R2KO'B@6_
MD+-A.N#ILQ9&-<ZW<<1E25/ R4H#)VR7;0I/BG":G&B%-YPX-)J;RE:KWVY]
MGO<F11+&?OU,# P#&M&OZ1R(!^DD<<D52(GG_E4CJ00T8/C5/YOUKP=-GBPM
M*QEY%/ L2,*-(GS\R%TDM2@<'WK1*W@K(0>=0\;+]I,Y\6YTINBP&D-4 .)=
M;%S#4V3M4P.E:F\H=</N,]+1A!+.$K2E>(%@9:7,^J(K*4JQ:N/^S_L:H$-R
M3,Y1P>6[]V.M"W ;QVZ<$,JJ>02!89AT^'X)U75WUGW?9+"LF+QR$$*8*C3R
MKS[$O;FFC+*!X(@"^3RK< Z0;_G]>Z+X_P#;Q7O_ ,.:@_\ TG_/]_3W_<3]
M-?'&!E^G/]]LOY_^N)_[_P#-]6C^ZIOS_GP?_+<3_P#H?7ZZ</K/VE3G74WA
M6]@5#1VUHY&&$%Y.JTS3YQ]+3:T.+9DJO/CQ(Y!#F4.NK77"6$Y1E# S*%9Q
MAAR/V?=DV@YHV<UBY#R5[=J&W""2..J.U TI '@ 6%)^K$^=/-'UHW=7*BW#
MBLA&.GJ,E:2O,P //2]:9(U)/N3 P\> .3J9/B][2#Q)VV;&UO?E2MG&ZQG+
M;8^.FO)ONL\/K\$X]YLD.$!8HE"W,XQZLA3_ (:,C/J%RS2$J5BI]Q_9^W1C
M$DL8*W6W#70%NPJFCDN 2?EKRO)6EX4>R7!*Q\+">5YL?!^M6W[[I!F*MG"S
ML/,W(NT.>/=IHE2Q$"?8O5[8_K2C@\6 J7=Z;L>L1%UU_:J]=JA8!$G0=HJL
MQ'S\!+AKSE*28Z6BR"@2VO,E2,J9>7A+B5MK\JTJ3BC+E*YC[,M._5L4K<#=
M$]:U#)7GB?CGIDBE570\$$=2CD$$<@@ZMZK;JWJ\5JE9@MUIEZX;%:5)H95]
MNI)(V9&'/@\$\'D'@CC64=)M*-'1HU6U]I@W=;Z%Q2U1J.LGEQD5NW91S=V>
M$=4S\5K5"BF)AFN%+3CQ4$?8).%E2&L+3ZRH)EI>%L+>0K0?V>,/4N[FRF6L
M1K+-A<?'\$K#GLV+\CQ-9'X/'7BFB4_03L000#JE/6[*6:N"QV-@9DBR=V1K
M15BIDAI(DBP$\$=$D\L;N"//9'T)&LE]G9XFZGHO$"#Y0XA(B:W'N>:NK!-M
M*';)E:K4:M:I*HA4^%>=PK,6,85 %3TPX)ADB4=D@V#G'QHP!#*;U[W/DKFZ
MIMM":2'$8B"FZU48K%:MVJL=M[<P''=*).E>$.66-8F9 &D<GMZ-[?Q];;L>
M?,4<N3R4UM#88!GK5JUAZ@K0D_X,.\#S2,H5Y Z*Y(C7BQ+U0NKEUX5FJU9N
MD'(UBX5Z$M5;F!G Y: L<4#-PLF*[C*7!CXR28)"+87C/@II]AQ&?Q\/'&.N
M]:S9ISQV:EB>K9A8/%/7EDAFC8'D,DD;*ZL/Q4@_3V)UQGKP6H9*]F&*Q!*I
M62&>-)8I%/@J\;AE8'\""-,YXT]N7B)Q%V3L;:VAM5 TZV[)2T,<_DXV4$K,
M1C+;YD!2!Y)TE59@Y60:1)R,>&[EMTE X[2F8P$  66;AW_NK=6.Q^+S>3>W
M4QY+(HC2)[,O+!)[K1A19GBC;M1R.!PO4Y#2O)(\:P>RMN;<O7,AB:"UK%T!
M22[R)6B)ZGAJ*Y/P\4DGZR15)Y(5 5B1(U?'U#-2O7PXZTRVMUYQMIII"G''
M'%I;;;;0G*EN+6K.$H0A.,J4I6<)2G&<YSC&,]>@$D  DD@  <DD^  !Y))]
MAKPD $D@  DDG@ #R22?  'N=11<AN]AV\..DB= 3.Z$;,M<<X^P96M+13FP
MGAR1T.9<%(L09 =(8*0\W@5T5ZTH)8(7A)#+2$/+;L[ >CV_,_''8BQ(QM64
M!DL9B44 R'@AUK.'O,A4]2NM4HR@E6.J_P SZH;.PSO$V2.0L1DAH,5&;A#
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MP=,WA%J;4UA/F<;0SL&D J5E:%82VR@BB)\?-YWCDY1G*[]P'VCEX6'<V 8
MJ%>YA90W/T)./N2+SR/)(O<\C@(>?%,YGT+;EY<%F5D^;J2IEHNDCCR +M1.
M&Z?Z@>ER">3)X\L/<W#WI>S[*1X^P7KU(:A$DF1!A[VZK<NBIYOS92Q&Q=O0
M28=4%FMMJR+&1\]3YS*4Y4N.\J%(S-ABO2+U7BD-$4ERK1,[/148C-P>/,LM
M3I1;8C) >22&Y7'@=SV.HI^D?4GTYEC6VUL8]9 JI<8Y/$3@DE8HI^MFKEE4
ME8X9JTWN>C@'FS/VR^[MISN&1Q-.(BL:JY"5Z)5*6#61\DB0CK!&#*;:,LFO
M9E:!WYF*&<=95)Q1HHTW"9?3AUN0CT8EWLZ^HOI7EMAR+<27]*8&>4109)(S
M')7E;DI7OP@LL,K -VI49H9PO(,;GLK>&Q_43';O4U'C_1^9BC,DM%I \<\:
MD!K%*4]+21KR.Y$ZK-"3[21CO'PN_3N6;T[VW=KMUTI\&4VO/U#3WOHR\MNL
MQ%K.?D;0QA6/GAN5JE?G(5_P^?H23GAE.?!6._HCB(<MZ@XQK"J\6+K7,MT,
M.09:L8CK-Q]6BM6()E^H:,<?7GEZM9*7';+OK Q23(SUL;U*2"(IV:2PO(XX
M$M:":%O(^61OKQJ+SV8;C;5WJYO;EC+A#'VQFRLZ1I9+R$N/5^-%A86W7,H7
M"T?D2)Y4W60LDH5ZR1(PH9"D,F$I>LC[1NX+"SX3:\+M'6>NV9NHI(6>0S35
M*:N01U+#V;,@0CCJD1^"R*5@GH;AH'CRNX)4#V(Y4Q59F )B7LQ6K3+X\&7N
MP)U>#TQL!\KGFVOUES6A='1HT=&C59SVF'CO6;1QFUMR3%C1F;YJW8D51I&8
M0UA!1] O0LMG,:6ZG'F(1%VL&(*C$/9RD3XK,Y9RG)CN%Z(^SOG;%?<.3V^\
MC-2R6/EO1Q$DK'?HM".X@Y 4RU9)ED(^^8H>?N#5(>MN'@FPV/S:HJVZ-U*<
MLO !DIVTE(C8^[=NRD1B\_+W9>/OG2E^S1_F!77]I:_?X%U?TW?:&_;BE_DY
M0_C<EI?Z)_LG;_?EO^#Q^D4]J)_-UXR?UTV3\/\ V,7T[_9P_I[<G[GK_P <
MFFWUS_H;"?O27^&;_?\ [M+/[-EIZ#IO!RQ[70"+]J-Q[<M#ATLEGP-76Z(R
M'5X*(=>4GS*'"EF[1(M-H5Z6')AU7AZF5>#3]H/+36]XUL67;X;$8JMT1=1*
M"S>+69Y>GG@,\)JQD\<],2_3C2[T3QT5?;%K(]"]_)9*<&3@=?P]14ABB)_Q
M4F^)< 'WD/(YYU8<ZH?5R:.C1JM-[3Y!!$\0-$65;*524+R-"B12,^;SM@3^
MMK\3(L8\,^'E?(@(MU6<XSG&14^'AXY\=#_9QF<;JSE;G]7-M]I67QYD@R-%
M8V\^Y59Y1Q[?.>=4CZZ0JVW<3-Q^LCS(B5ASR(YJ%QI >/IU0Q,>.?N?ASIP
MWLZ]G,G^VS6(PKQRW3-N;4K(2E*RK*A'Y0"V8^6<Y\N$DV@EM*<>5/E1C.$^
M.<Y4P^OE=(/4*Q(G_K>*Q=A_PZDB>IX_T*J_Y^=/'HW.TNRXHV((K9+(0)^/
M27CL'G_3L-X_/GR2=5N>\_=+7R>[L5JU*R<YD6K6/5_'FABO.> L8J29A7)%
MS"%82E'O5SMLT6^]G[RVLL)4O+;+:&]!>D=*KMSTQIY-EX-FODL_>8*"T@C:
M8(/SZ*=2%54\_,'\>3S2GJ7<L9O?]VB&\5YZ&%IJS$+'RL1+$>W#W+,K%B1\
MI Y^7@7Q]):?I.@-2Z]TQKF+9AZ9K>K1-5@@VDX2M8\:,EIX\Q>/O$24J7[Q
M*2ACF5/&R)A13RUNO+5G$V8RUS.Y6_F,A(9;F1M2VIW)) :1N1&G/W8XDZ8H
ME]DC1$'A1K6.*QM7#XZGC*48CJTJ\=>)0 .0B\&1N/>25BTDC>[NS,22=*ET
MVZ<-'1HUU#P I4$R,DQ!CXZ1%(!/!,9;($-"+:6P4(4.ZE33XY##BV7F7$J;
M=;6I"TY2K.,_<;O$Z2QNT<D;J\;H2KHZ$,KJPX*LK %2""" 1YU\NB2(\<BJ
MZ.K(Z, RNC JRLIY!5@2"#X()!UKI;-H>%XS]ZJKZ3K+.1JK2^;6I<U,12UN
M9!JECOM1M=:C?5<\7'?AD+.@Q_JN*4MS(V5K4I6<J5O>OFI=P^D5G,6#U6;N
MR\K\4W '7:KT+=6S)P. O=F@>0 > 'XX'L,:RXJ/">I,6+@\04]U4!77DGHK
MSVZUFO'Y^L<,Z)_H\^?KL9>L"ZV9JO[[1[NN3UKP.C-=PI+@Q>]]L5JG3"FG
M,MN+J5:#D;U+M84G&5901+P-:#(1A2,.B%$-.94TXMMR\_L_X>/(;UFR$JAE
MPF*LVXN1SQ:LM'1B/MP"L,]EU/N'52.".14'K3DI*>U8:,1*G+9*O7F(_P"3
M5@]R0>.?O2PUU//@@D$\'@T*?K^CK:NLK:.C1HZ-&CHT:/K/1KPD#R2 /Q)
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M\,O6+;;KG]*_Y4;4WX__ !;3C]W4,]<23ZCYCD\\5L2!^0_1=7Q_KYU)_2,
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MIO8RX$9 TB@!F59$D/2EB*.1>J.RKIGOZ]M[:T2.58MISVE9U;;>2:UM.F6
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M2C<$]"R1X S[X*S!'R4(B\2+[-4>L>U<SNS::5,(.];HY*'(M1#B-[\,=>S
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M>P8:\3GM$D,LKS61LTFQ=6I\.EC+7_@8[5M7>K5Z:MFXSR1QR0M-+*E5H:\
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MK<,)#F,I:J85<C1BA>S++B8X8K77V?[XWZ51A(8B'^2.TS!D)X=02K %3^5
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M6Z;CCI'@,I5O)///!#O1]'=E5"K3UKV29>#_ #Z]+T%A]6CIBHC<_57#*/8
M#QJ6#4.@M):!@OLSI35-"U="*2VEX*DUB)@??,M8PE#DB2",T9)OXQC&<D2)
M!3ZL^*E.9SG.>JPRN<S.<G^)S&4O9.8<]+W+,L_1U'DB-78I&O/]6-54>P &
MK"QN'Q>'B[&+Q]2A$>.I:L$</7QX!D9%#2'Q]YV8_GI7.FK3CHZ-&CHT:__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>g60414g19f75.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g60414g19f75.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[23,4&AO=&]S:&]P(#,N,  X0DE-! 0
M    )+"^DY(X0DE-! 0      &$< 5H  QLE1QP"   "   < E  "')R-3 P
M-#DS' (% $!-:6-R;W-O9G0@5V]R9" M(%!R;VIE8W0@2&]O:V4@+2!3+3$@
M4F5G:7-T<F%T:6]N(%-T871E;65N=" Q,3@T #A"24T$)0      $'_/CME6
MLS_]O'1SP$HW+M,X0DE-!#H      .4    0     0      "W!R:6YT3W5T
M<'5T    !0    !0<W138F]O; $     26YT965N=6T     26YT90    !#
M;')M    #W!R:6YT4VEX=&5E;D)I=&)O;VP     "W!R:6YT97).86UE5$58
M5     $       ]P<FEN=%!R;V]F4V5T=7!/8FIC    # !0 '( ;P!O &8
M( !3 &4 = !U '        IP<F]O9E-E='5P     0    !";'1N96YU;0
M  QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"24T$.P     "+0   !
M   !       2<')I;G1/=71P=71/<'1I;VYS    %P    !#<'1N8F]O;
M    0VQB<F)O;VP      %)G<TUB;V]L      !#<FY#8F]O;       0VYT
M0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O;       16UL1&)O;VP
M     $EN=')B;V]L      !"8VMG3V)J8P    $       !21T)#     P
M  !29" @9&]U8D!OX            $=R;B!D;W5B0&_@            0FP@
M(&1O=6) ;^            !"<F1456YT1B-2;'0               !";&0@
M56YT1B-2;'0               !2<VQT56YT1B-0>&Q <#2X4         IV
M96-T;W)$871A8F]O; $     4&=0<V5N=6T     4&=0<P    !09U!#
M $QE9G15;G1&(U)L=                %1O<"!5;G1&(U)L=
M     %-C;"!5;G1&(U!R8T!9            $&-R;W!7:&5N4')I;G1I;F=B
M;V]L      YC<F]P4F5C=$)O='1O;6QO;F<         #&-R;W!296-T3&5F
M=&QO;F<         #6-R;W!296-T4FEG:'1L;VYG          MC<F]P4F5C
M=%1O<&QO;F<      #A"24T#[0      $ .__C4  @ ! [_^-0 "  $X0DE-
M!"8       X             /X   #A"24T$#0      !    '@X0DE-!!D
M      0    >.$))30/S       )           ! #A"24TG$       "@ !
M          $X0DE- _4      $@ +V9F  $ ;&9F  8       $ +V9F  $
MH9F:  8       $ ,@    $ 6@    8       $ -0    $ +0    8
M  $X0DE- _@      '   /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H     /____________________________\#Z   .$))300(
M   0     0   D    )      #A"24T$'@      !      X0DE-!!H
M S4    &              4A   &8P         !
M      $             !F,   4A                      $
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M     0      "6AO<GI!;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N
M!V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX
M   '9&5F875L=     MB9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO
M<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG          IL969T3W5T
M<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/
M=71S971L;VYG       X0DE-!"@       P    "/_         X0DE-!!$
M      $! #A"24T$%       !     0X0DE-! P     &B\    !    H
M (    '@  #P    &A, &  !_]C_[0 ,061O8F5?0TT  O_N  Y!9&]B90!D
M@     '_VP"$  P(" @)" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,
M$0P,# P,# P,# P,# P,# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4
M% X.#@X4$0P,# P,$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,
M# P,#/_  !$( (  H ,!(@ "$0$#$0'_W0 $  K_Q $_   !!0$! 0$! 0
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MN"-P<HG$Q38^TU,]6R-]FT;CM^A[_I>S\Q0-U&,PT4M)=17+*& R6L AE?\
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M@/?;867VW#_"/N9_.;U;Z3U/.?\
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$!_\  $0@!Y@)= P$1  (1 0,1 ?_$ !\  0 " @(# 0$
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MVHH]%INH;[3G@FVJKN#=^I]+!#U*MHD@":?VG;&JHS98QL6V9'%X8-]W,B1
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M .?'CX2MU:%I;5CDLIO>0&M<07!N8 D N,"3I[52I593:XES9:USLLC,<HF
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M[4[)U/NO46A-1Z!1O"\[7H^S=@-)F[6#:M' @6L"-&&%,/33-8L+)"3.D7J
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M3X$LV]'R\EMU(Z,\I*O'K(3ZV,<JUCX,!SLI() )&NYCPU4FHP1F<ULB0'.
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MTV0TKK4-K+6U,NP>O2&*47J-X$VF#.C%3E4G4([.<NDE8]I[Z8S09B*/5N#
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MJF2JXM>AS],OP2L&!,$5J2##2,)#GCXY^G/ 2[;D'"S33932D9JX9S' 4V@
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MH[,HL[,D1<NUJ!K:4.:QM21&1P=8:ET$P;^%[3M>D7&J<KZKV &34$"3H&R
M;$=VFBRCMMI*V[D[^]2HX6];GU.'$=>^T*BFR]-O#Q!(?,E6C0^1M:)6(Y5[
M4"AQSS;,V2@=(AM3B&1"G8;N&X<KS6F\-HU1#2<[##A,@3?4:2-(.HT5:M(O
MQ%$@O: RH"YA ,F(D^6D7BQM"USW)Z25+773O>(ZN??4WIL/=VV.JZMIW38Y
MB?LG8][!UG?VKX+ N=]'#84&#5:M5EE\LAP (4&%CG"A&0Q[1<N7FU.L34:7
M96L8UT-:,K02#/9N)VMIL!$J:M$-88SN<YU,%Q,N(:X:FU@!?F+F5SNP@FE.
MOW=*[V_>VI8[FD+3UAU_0]"$ >D3.P*)4S N[[4*;PUU'KU'J-CCUJS;!19:
M$=S[P)AXO$*%]&,RYKX1V'@W.^BUM,CK.LFH,[6%P,9722"0TC0=VMPC\E.J
M349V"P!A#7/AQG,,K0?2D7N;6(44]!T:7H,[T_V-VQU?<8^B!/7[LQ3=; K-
MKZQ[.5H$]L+L"W=-656YU<($MABL')W7+Z)U\-FS!?@3D-,H<F5&E2DPGM:A
MZP5.K<,^=A,$#. PAS@;3>3:) O)5&-+'4W5&DL#'-;J<H+I:'- O: +$B1<
MJ;OHW+'4-6:$A5G&OKUK$%M#M[VB':GI)+6EN#205?+[-V+=*FT<#X")^X
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M*W/)RJL32M0$D9 -P.Q#+EI+,C0D@4FU"P/%8%N4M@-,%V8,F3($6)B;QKD
M":II"H6NH.S/?FG, 6LC,)_"<8WT&PWW1]"B+7L#O8:OFH&+!+G=$>JU)JA"
MTT?Z2<E+SI;:B+76ZY(*C'O:R\&(P!L\.$KS,20CAVY[6'V8*4T<X 4PUT?Y
M14DZ2);!D28B9'=WJX;+JTM+OM#(G?L$0-@9U-M5K70\>IZIGZ)NO<;6%LM=
M1N_HR.JFKM:SS>G[CM1D#<*^ ,N[PU(6!"*U9B=<O5Y6:I4U40P-@.6M@*\(
M5*>E!78G)>0\OZHY?MKW&\=DNMX@;Z]TP(JPN9E-=IRFA2#00#! .<6GM20-
M? C>=7HV3HS6W4+J5J4]4+S1K)::WL[-=J)RGVA,JM#ZK<[ 6>$7$G]'/C:L
M0BAR@UN W8R,%T\]AYL.HBZR]XRKR:M0R'"1+@01<#:9]G);X<AM*FV"##H!
M:1$$F#($$"T<Y5EGSYBNA.$3A$X1.$5>GI& !VP4KK$R!"%SKHSO9U,.$F0P
MV83='A1.R&)),Q.;A,O*B"QK&/;SR$C#<.&S_)9+S3?E7-:.K[@?:J@,QH6D
M;[]VJY\0'%K T3]MIDZ:!T_]E3YVV:U]1NKG?+5.Y=(W2Q]DK3V@O6U:U?6M
M16PV+.TXYM0*9U1LR!NJ-7WZ>&K^O=6OC*!-#2+= )C90(G3DA5K,JCS>JFT
MN?1>U[!3%.' N!((!!:6&7%SCH0"(&H MRO)91K,>QSJI>YP(;(<'.[)SV$-
M; ()!T@&1-C%BMH3J;N[N/&VQ,W+1Z1VR*5K9.N-_:RUC;-CQ:8;9T]6-1'*
MM(E52E["36KQ5B%+BVZI(M=5FUDI!-0TM^_OPB8W&&4U6TLH:XTQ!82!(S9I
M(, R-P9$:ZKHGJGU<V<"J0X/:TN#88&D6!(N+ B"=(E9OZ.8WNVR'>R1JZ77
ML-L31#UEUW%ZX7/LM3J_0=@6(9$JLW.QRD:L"J/KDM'KC]K?C- YU@J I\A
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M16URG%ICH4YB[J-1@S.80.=C'B 21YPJ-K4GF&O!.VHGP) !UVG5;C+[GU4
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M%-N.$\U"9*;CCK=B TTX_*S6IA;#$=MU]>4LMK<Q=U&JT9G4W :G20/X0!)
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M&?>4W.-PYP(DP+PV=H"5GG-2I92\DEU1K-,C;C7;-E'/6.Z'%EOIR)Z/O?\
MU>V)4KSK,9UG[(:0!;#H]W>KR[N,Z'[.WQ4+A7GRTRC66WUJ4*&:NF6*@F'
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M,/3!DA\5FK2H4Q3H/,5_3/V V^9K@YCIT%\P\SE(Y0>:SZOMN=]Z]N5[>9L
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M8@P02MH4O5M$U\2OYFG5V&"*[3N"[_?YD9Z:ZY8[@Z$#5UTW+1+E2&V9*@H
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MIBN6:U::U*$GT2QD+L)@4L, I&L*UF-:S@6O$+6:%U<6.0=/3P0K)BR1B4W
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M:!#C.QAXR#E<""YT4@"T!SFM$Y0T]8"2=+,EMN^/'4KEJG*7D-<[*W,X$4R
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M+<?JU:'",&_&5:#:3ZK&/I,<QE6LVBQYZQ[.QUCVA[A+:;27U"U@+AIQ#BN
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MGUHO02MI]!E_/0.N?_FVW?\ B3V'SUY\*_[AN-?[> __ ++"K]-T,_=1PO\
MVL3_ ,CC%_0!O%^I&LZY.N.Q+=6Z-4ABHJ"5GMIL;7@ Y4Z6Q A)G%RTF) B
MYESI4:'&P\^C+\I]F.WZSKJ$*^0<-A<3C*S,/A,/6Q.(J9LE&A3?5JORM+G9
M6,#G.AH),#0$[+WY7Q%##4W5L15IT*32 ZI5>UC&EQ $N<0!)( DZK0_X<?3
M#/\ \[#KEX^W[]&N_']L//+_ !6Z2_B#C']78O\ 5+@/'>"C7BO#_P \H?IK
M)*AVQZO[ L@NG4/L1I.Z6TVX^T&K-5VA2SY\J[%B2)\EL<(%FI4^:N/!B2IC
MZ8\=Q346,_(7A+32U8Y\5P#CF"HOQ.,X/Q+"X>F :E>O@L12I,#G!H+ZCZ;6
MM!<6M$G5P"TH\7X5B*C:.'XC@JU5Y(92I8FB^H\@$PUC7EQ, FPT!Y+>1 J.
M$Q'9Y6;%&P6,)4_,GR&8<1E*UI;3EV3(<;9;PI:TH3E2\84M24X\JSC&?%M8
M^HYK*;'U'N,-93:Y[G&"8#6@DV!7>][*;2][FL:-7/<&M'B20!YE8S]\K7G^
MSJG_ .^8+_U[G1]0XW]YXK\WK?H+'ZKPG[YP_P#34_TE],._4<A*8A0+A6)T
MV2YAJ-$AGQ,F5(=SC.<-L1V9:W77,XQG.$-H4K.,9SC'PY5^$Q5-I?4PN(8Q
MH)<YU"HUH W+BT #O) 4MQ6&>X,9B*#GNLUK:U,N/@T.D^ OR66)5A6/.,_U
M\9_>SGG.MUYX1>%><XSC'SSC/C]7Q\.$5$,C2&WHH6V5NBT'>A:BL6@'M+=E
M,VS7=<(*VBW!NXVO]Q6.KZGL%<"U_P"^,,M^OV-LRBD)TF<KAYE^D!G)D4\0
M*CD].9A(+B,Q!:PM)EO8(&8$Z Q,:"3NN,-> 0UK@&NS$%H[1ZP.&4\MS;D-
M I\=<]>[$54MME14VRZ.$;"['WC9=$KD^I5]!\10"@&OA7(1&IV&#/C5A5PN
MPJR;+5!5&B&F/NB:R4CP2$XI!:IF8U[2]HJ@, +<Q:"8US-@_P"-MEY'AM7#
M8>MUN,P0QF'FH?J5U:KALV9L,<:M&*C2QW:@&'$09"ZT?IQ1Y85J>KP#9^1:
M"4?NWV%Q*.RX T9)GJ<UGI]QM3L$1'B#F,L,+:CXQ&CMI7AG#J\*=6M2O>/P
M'%IXMT@<UH:#@,+#9+LH.(?8$W,<S=>M/A3?1JT\!4H4!AJ+\7B33PXJ/K"D
MPTZ<,ZRIVZD?A.N=UUJN?2*].P!H(79._(S/P[2=@O&,8_S V/EC_P"L*K<]
M(_#E^T?!OY6?[<'6^A>P_@X_;?&G_P#3G_\ -8;Z%._\DTX\]:^NW]/ E_6H
MAO..?D_@-,<>XO\ R4S_ )RB?F7FOA+^X>%_EM3VT2NF#CY?KJ_?SSZ;=J?$
M_*O4(N!X!=A?\C6_#O%L_'_[L=N_XRM4\]-_#>(Z,</'_P"M8;_D^)+][\'5
M^.XC^3:WLQ&'"MF_)*/\Q'K'Q^F0JW_%YLSGKSX$K=*\6>7!<4.Z^)P:_4_"
M1^TV%V XC1,^-#$!=(+'PQC'V8QSZG.ODWY O32O@_(Z7\\*(?U/VR_[.43G
MJ/X9_P!R3/Y3PG]FJOVO0']T#/R3$?+37>YY\I+WFG"+\+]?U<^IXRKX^,9S
MX\_#/C'G.,XQ\?'SQ\N00#8HJ+ VF-F  ,T#4];;Z.ZTKUNU=LW;M&VU4];Y
MLQVZUKM=4=F6H5K G5@U?SLT:_46KW;#3'O]@"663$J \--=L1@X.SURR"2\
M!QD,R.= &1P&:9 $D3OK$0N0L=LUQ;G:]S7 "[7AQ+<H&8Q, R"=>:GYU\U_
M?U:WN+PB;9-%QK?O/:^PJK7)E4K>38BE6FQ3)(V(2K)V&4B5UZPD%3[PX,]E
M&*0%G4Q2K,.?F?#;SSTVN[;!5[ ;Z3F@.$7!;K:U[&3:R\KPRO@\,:SL;PX8
MYCVO;2INQ-?"]4]S@6UIH$%Q !;U;NP9)C1=8STXF+'7-8Z*@3K84-EF^S_=
MI!(]EF&#D%7$V+6JVG9$ $U"&L*:;<PRE$6.TWG",N93EQQ:L^]/@,ITJF*Z
M2E]*FX=3PP@5&-J9?MF.'9+P8D 3$$P)D@+U1\)]0?YJ=1#J--U3'EM,/<[(
MV,)D9F,.>& EH<Z\>*ZY'TX;RXEW)@IEU*%MI<^D)>7$MN*;6XVE>7?6PAQ3
M32EHQG"5*;;RK&<H3G'T1]38:(^I\/O_ .12W_W?;8^Q>INLJ;U'^3G#YR=S
MH0NT_P#D8PC/G6ON)B=.FS$L@='Y;Q*DO2,-^N0VEA7J8=6OU?6RE'K>KXSG
MU<>?AC'/0?PZT:=*ET<ZNFRF'5>) AC&,N*>$(]%H) !W.LD1)GV7\&A)Q'%
MLSBZ:&$(F]^LKR;W$@B><21-UM'\DNVZV5.O]2'*K:;'65$#6WTS55\X4"JE
MI8@:]6QB3D;*C>WPSEYWV.'O7PWEQSU/5]=?K</P'X7#8FOTB&(H4:^2E@"W
MK:;7Y)=BR<N86)AI)OI&EET?"74J,;P@,<YH)QA(:YS9CZF T(TG?:5U./OJ
M[2S+;GYV7L%4YJ.[$;FJNEDS+;BON,O/QD2,DO:HCO.QX[KK*5X;<<CL+6E2
MFD93]!_6SAW[PPG?_D](SXRV_<O5HK8@ Q7Q#.YM>H.5[.W79;_(UMVNEKW?
MV68M%OM-ECQ-64]^*Q8+"7,LQGG+7*;6[';)2Y*67%H_,*6VE*LI_,YSX^'/
M2'PVX3"8;AG!78;#4*!?CZX>ZE28QQ'U/9N9K0XL$9@TV!).I7L7X-ZU5_$>
M),J5*CP,'3=#ZCW]HUP,W:<8F]A$2>:D-^2:YLV!J+JPN#,EPEO;(V AU<20
M]'4M*:P$RG"\M+1E6,9S^9\^?'G.<?7SPWP&TJ=3BG'@]C'QP_"@9VA^7-B3
M):'2)L!,2!,:KR?PDN<W#<*RN<W[?B)RD"1U=.Q.L2 2 ;\K+IZ_3AI2T.Y,
M%<NMH<:;<R0EY<0VXI&7&T+]MZR4.9:;RM*<XPO+;>58SE"?'T@<-A08&&PX
M D?L-*8-B)RGE%O.5ZESU($U'DP/OW02  #K-HMRU%UV,_R-23)3NW6[FIQ&
M?,;1UU(.-MRIDB0A"_ODZ^3A:4O.+PE7C*\><8QGPKQ\L\]+_#?1I4^CW"C3
MI4Z<\9;Z#&M(#L%C"!+0)!R3!GY(]@?!PZH>,8L.>]P'#7R'.)&8XG#P0"2)
M !$BY&NJ[J//F1>YUU OR3W\+[U&S_\ 1+;/S_VXH^?J^/PQC.?UN?1GP$_<
M_2'^.P']FN>1V!V*]1?"6)Q7"QI.'Q/]Y35-'4I[7]WU/LC1MYKP"[2[#L>@
MWJG4V;V''==3\X^ !6X X[6[!;-:VC7U@D3(-C<%/!K-:@A+"Y,?-6&2YDB;
M(:]B]*1B\'Q+ \7PM6IA64L%C,'B<6WA+N+8>E2KU:%2*[*6)H8FA!I9FU*-
M.JP-ZSK7TV]EWXOAAHUZ&)P=6FVN:M?#UJ-+ZM^HJKZE-M2G]J?4H5:+S%3*
M:;W->XEO5M<5C_>[WAS:@YRT]:-P]:;FV(  "X79UQ<N<<I5Z+4ZK0:=FIKE
M:VH4J8P( 5IEB=89)^W+M$EYN8^61)P_)F]'0T-;P^HRAQSA_&\,Y]2M3=@,
M*,,^E6Q.(K8NN<1&)KP7U*QR4NKH]6UI:QCF !N7&B[ZJ ?@,3@*S64Z;Z6*
MJFI+:5*G0IA@-"B0 RF,SVYLYETR'3/O7 07&UOI6RZMD=JMO5*FZ])0X.T
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MQ'L,K4XU]V'8C&487[7&&U8=4VO+N&U^$I4WZGES#B/97P1"H[IK@Q3>*?\
MD6/+CD#Y9U,%H:2()F<U\H:3!7X[I^6CH\_,TN_RO"Y0'98.9T$F#(&D6F=;
M+I=82_\ #S(1_P#%\_R/X9SA"O6SC'K_ )G"EY2KQ\?&,91]?GGUHVEB#$XE
M@B 2:'I$4W!UNLL'/+'S,-CJVP"5Z-EHME),$^D0+Z VY @&>_76V/T'[!![
MTF77UJ"08B3W!FY&X<QZ#F6Q&F*T9L9N/)=A)EQ52V69'JONQ<2HN7VTY93)
M9RK#J?7?PJ,K_$?BQ?7:X!_#C4 I9<_^784$ ]80)J]OT3#>P29#A^IZ%EIZ
M3<-[!#O\J([1AI^I<3$DV<,A+8&][1"[17IR1%_8]&KO=XA=0DX:@WJ)V5!9
MICT*1)A)O&N!RXC4_-JEIC/+MS4VSXEYAR$X%2V:OF,I<3-@D^A/@N_=MPG*
M0U_5X[(]W::QWU%7AQ9;, )L2-=;0?9_3C-\7,621'6X7,,ID@XBG8',(@P;
M@DQ $F1T$<I?Q_\ +I^2\8_D?GQG*$XQY_-X\Y2K&58Q]?K>KYQX\Y^OW4\0
M9(Q#-'012#@"6 "3U@!+:C7/LTY@<L@"_H<%LW!.ALZ)$F=B+B!, @WN)"LR
M]#K&-RO22]9(X,O$$%WRVRFAA2:*68B#YR],;%Q&ER1B"(Q1!F,Y_)'(J2$+
M,G'\CQ(9Q^;Y^#^$QE9O0KCA?4:]G54&E@IY9G%84-[6=UVNS.)OFS  -#03
M^AZ(G_Q%PL1#NN>0Z9THU,T Q=VPFTS%EV]O3,C;@UZ.+L](GVH5-#_00K.1
MC%8<A2U)G;AUH]6$Y*JL$I.%5X;'+P"*L#O\L,DG&((P%P,S"G?.GP:A[NFO
M VTGBG4-:L6O(#PT-PF(+NS82X2 2;<B 9]N]-"!T<X@7#,/\G:0+&3BJ,'4
MSEF8\[+^>SE+_CQA]&/'G/Q:QY_S^,X3G\W_ /%;QE&<^/S6<X5XQX]7/V0:
M>)_?#+B1-%L@%[7-%JD%S& L-H?.: 00OG\%MNPZ#OFM9I!LVP.:#RV'-3U]
M%RU/<](;U#Q#GLQGOOUUA?M78>9*<,H>?<DM>QQ*C9]9^$EZ(V[[3Q&=<3+R
MA[+>6'/QWP@,J_$[I$36948>'U@6BGE+9J-RG,'&S6PV(NX!Y,N(7GNC5^/\
M': 6_P"6T223(  =()/I$ON+R) N!*_I5)SC.,?'&?'PSXSY\?B^&<\^+AH%
M]&+]<(G"+%KK=:KKJKF+I=SHZM58!&3*+FBK^(\.&RX\U&93E7A2W9$J4^Q#
MA1&$.RITV1'A0V7I3[+*Y +C N>7MOR$7)-@+Z*"0!),#W \R; :DV"^+7VQ
M:5M.KP;G0+#!LU:(/3XL8G!R\C&)HF?(%EA\N)*:CSAQ,63B2AY,80C19X^;
M'>BRX[+[:V\""TD.$'W]YFZ!P<)!D:>8V(-QYKJ&^GG_ -#X)^+N]V SG\6/
MO5Z9^.?Q<]Z? 7^VG'_R#"_\P]>M/A*^Y.%?E&)_NZ:ZQWG'VX_9QSZ37J-=
MD_\ (S.<?A1]@L^?A]X1C'GZO/WPJM\/U?Q<](_#E^T7!OY6=_R==>P_@X(^
MN^-$W^MSK?\ \G#J>'Y)ISC'6OKKYSC'^;@3_M#-\_)? =;CW%SRX4W_ )NC
M\Z\U\)?W#PO\MJ?W,?*1ZUTO\9Q\?CCYJ_?SSZ<.KO$_*O4($ #D(788_(UV
M<?AQ;.^KSUCM_C'XOOE:I^K\7/3?PX?N8X?:)XUAH'_\/B/T@^:_>_!U^WN(
M_DVL?+ZHP_R2!YCFK9OR2AG_ +B36'P\_P#=(U7S^+_,^V7C_E_K<]=_ G^Z
MO%B#^TN)_P":P4>N?^Z_4_"1^TV'V_R^E<]U'$E=(+SC[<?LXY]4'7R'R!>F
ME?!^1TOYX3/S]O7_ &7C_P#W=#_AYZC^&<'XHLM_[GA?[-5?M.@)GI WE]28
MB_G3^2%WN>?*2]Z)PB<(L3O%YJ6MJL6NMY/#ZU5PC;#A(N3=RU&85+EQQ\&.
MA*$N/RII A+B#AL"(R_.(D)46!!CR)<AEE<@$F ))[]A<GE823[2H+@T23 L
M/,F /,V',D#4KT4+85-V?5X%TH=@'V2L%%RVH16 MS#:I(Z;(&DX,F/):CRX
M!(62ARQQ,;.8CSQ\^+(AS8S$AEQI(@@P1!]_6._1 01(]^X]XW"Z>GI\<X^X
MO2OQQ\>TO=O./CCY?3NK_CSWY\!/W3TE_B.%_P!YCEZO^$O]CX/_ +>._LX1
M=:3SC[<?LXY]%KU0NU/^1A/C:^Y'CX^:_HWQ^/\ R3VEG][GH+X>?V'HW_'\
M2_NL&O9GP9_='%>[#X2>[MUM5GOY)\SC%<Z>?[>;E\_B_P CM<X^/Z_[V><?
MP$6Q'22;32X?'?\ =>BW^$S_ -G\<9[#A974;\X^W'[..?1*]6+LY_D8W./O
MY=GOC_\ HGIG]MTOGHOX<_VJX'_*%?\ Y8_2%[%^#;]L^)?D%+V8@3ZI$^(4
MHOR3MG'WG^JGQQ_HE;!_M9!\\%\!5N*<?G]X8/\ YIR\K\)7W/PK^.Q/]BFN
MG3C.,?/./GGZ_P >>?23M3XGY5ZD&@O-HE=CO\C09QCM[O#.<^,?@Y$/CG^F
M5K[GI;X<OW/<)V_SQ2MX8''SZI /M7L+X./VXQO\G'_F:*[K_/E]>YUU OR3
MW^?WJ-_0EMC\7_?FC8^>/C\LYQSZ+^ HQA^D7=6P!_X*XVOH2O4?PE?=7"_R
M?$_WE-4'TGO!VQUQ4QE%HV[;36ZD'&-!AP*!'!>YL"V9");4)7MQ#SLEAN4V
MW)2F4X]X?;;=\^NVA2?;6,Z(]&\?B:F,Q7"Z%?$UJAJU*K^LS&HYI8YXBJ U
MSFDYLH <3+@2OPE'B_$\-1;0H8RM3I,&4,:Z&Y)+@W0F Z"+R(ULM WJ]V[9
MEK,7F^')=DMA]YA\P;FIC(E3G8L../CK=1$8BQDY:AQ(["<-,-I]5I.<XRK.
M59\S@\'AN'X:E@\'2%##406TJ0<7!@+BX@%U]7$WW)7#5JU:]1]:L\U*M1V9
M[W$DN,  GE8 0+66)<ZE13Y]%I_/#^H/].FL_O2N?D>GO[C>D?\ )>(^0+S/
M1S]T'!_R_#?WK%_2>SC&?AG'GZ^?$J^CU^<-H3GSA/C./CY\Y_4^O/\ ^3ZN
M$7[X11Y[0:]MFRM5)#45D1,M]<V)IS:  2?(/B0M@FZ@VY2=H9K4\K'@%'!7
MW0QZD^'B%<CIK0HA,B$7XSS$5Q&;,(:Z3I#@=HEI -M@2#Y+.HTN; B06N$[
MP08]_9JM>:PT%8R]-OSVT9UGUY8MG[MLVXI@+5&T;.!EUAB:&%5 %6Y%SJ3E
M9EFL.U\ /-V2(RCZ%^ZF=,3%63:&PBLF7N#BV+@,:V;W@:B;P=M+;*:8(#BX
M07/<X"9@'23I-ILM&[4]$7TYWC#<'[>@;IV% 7<2]]1%L?8S=S[;-L.BQ04L
M::]VNT56)DT8%&1'EK4YG+41I/G.,<\EPKCG%N!U*U7A&.K8&K78VG6?1(:Y
M[&NSM:7%KB '0;:Z&=N/'\+P'$V4Z>.PU/$LI.+J;:K<P:YP +@#:8 OKR4+
M)GH$O1\H[ 5^O,Z0V9G5S^G[>8*R\;KWLL4B^P[I1H0&.Z?S=\K8GN5Z=9'&
M!&)K:9<=J5,S%>S!2ZSYOX_],ID\?QQ/,U&D]\DLF1L?#1>-'13H] 'UJPIC
M^!_C;NY*;FB?1)].NLI.P&-"C=SZM)6J%#'6*95NQN\HSQ:"/?=DP8LM4B]2
M<*:C2'W76\)PC.%.*SG.<9\<\7Q;I)QSCM.C2XOQ'$8]F'>ZI1%=P=U;WC*]
MS8 @N%CS@2N[ <&X9PQ[ZF!P='#/J-#'NIMASF Y@TG4M!N!L5S6]O1:]5>S
M0^OBM]XW?M,=59DXA78EJ[';PE-")I)EF/.D1$L7F/E+DEB,PV[E658REI.,
M8QG'GF'"N.<7X'4K5.$X^M@7XAC65G42 :C&$N:TD@V!<?6M,=PS <2%-N.P
MM+$BD7&F*HD,+X#B/$ >H*"I3T!_H]&MX44%"TELI6N9VK-K%++*1N[>SHUJ
M["K=IJ'26))K-Y4N%-?!&M@.P1:9C""C$4A+7'DY$)=B><^R!TRU^,&/&FCV
M0(Y=A>-^*O1^9^M>%V^\.QW[4>SV64P]&^B#Z6]:K$6MNB >X=860Z%573!B
ML=B]Y1ID\(J;$(J&OK?O4C&8RIT"'*4A*4YR[';SZV<)\9\5Q7I+QWCE.E1X
MMQ+$8ZG1?UE-M9P(;4+2PO #0 <I+9&H-Q8+NP/!N%\-J/JX'!4,-4J-R/?2
M;E<YDAV4F=,P!CF =EF.\_1A=8.RX,-6=\/[RV@ KQ;)X*+M/8[=\F,.,*A2
M1RB$9+%X84F1F%+D1O64I6/9O+QZORSSGX7QKBO!*M6OPK&U<#5K4Q2J5*)#
M7N8'9@TN(,-#@#OX<]<?PW \393IX[#4\2RDXOIMJ7#7$921%Y+;6(TC10(L
MOH#_ $>L7<^JPHG26RUZ_*T_:\RZ2&=V[VD#V#XF9K9ND-3C/W<.+%OR&"=N
MS!AIEQL%<,RUJ;D_1N,L><^R!TSM/2#'B+6J,,^/VL'SU.Z\9\5.C]O\UX7O
M[#K_ /' WT%N2E_I'T//23K?;)=YT;7=NZTMA -(KTXW6^Q.\69DH)*F02$D
M6]F3>I+:XC\P9!D.HRCSE<9OX^/.,^.XITHX_P :H,PO%>*8G&X=E45F4J[@
M6MJM:6AX :)(#B!-@"=UV8+@G"N'537P."HX:JYAIFI3!#BQQ!<TF28,#U 3
M"M!9;]DVEOSE7JXQC&<YRI6<8QA.,J4K\TI7P^*E9RI6?CG/G// 7W]PO*KV
M\(G"+4>_=>3=M:0V]JX;.CC"6Q-;7:ECB,S#N8<(A9:V1#PI,W#"5OJA,R9;
M2Y:&4+=7&PZAM"E9QC-F$-<UQ$@$$CN57MS-<WF"%H76&G]CW$QN:Z[E&.:H
M(;.%ZDJ4&NZKV@<R<%"M4CS4ITZJ^UN#4YL*98+):S<)B*-3ZZZ>)")*.LS"
M4\,-M4<TAH:20"XR1'I&0!N;:DQ?2RSIM<'/<X 9@P  SZ+2"3'.=-K+7VUO
M1<]7MYPK(+V])WKL 3;5U%P^,L'8_=C\4B]15G'*H\_[&Z,.J6&79#2HGEW*
M$*G/*PG&5YYV<-XIQ#@^*&-X9B7X3%-8^F*U.,X94$/:"08S#<++&X'"<0H_
M4^,H,Q%',']74$MS-G*[Q$V/^*@?LWT"'H]Q5LT)$I^D-EO C^W"0?9KD/=F
M]R;$2BM:2W(<AR"<I5Y?R"@*V*%H$5!9+L)3A*2/"^\J085#E_H?L@=,[?\
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M)V(WLT5$/D!DT--<B.O7YYM"I(LC.A.94VK&6)+J<8QG.%8X\?TRZ3\3PE;
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M+;:*S DLS;2"$&#MPAO/N2#<'$UU]:H<'GMN!O%][@$6U$B(LI#Z;>PT@1,
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MY4<$%0"4]7K>9Q"' CQYLS/K8PKS*DMNOY\X\^5_'X\P)DDC0DGVKJ @ &\
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M>%,)5H]76+3UZUYU_J56G[BL6YU7+>RYA6J0MLU)TQ*F.ZUIS#ARM2&A4%L
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M%G%3V$2&]APMH5H]$)WP]%+3(,M-;BQW,Q&Z"4%DI5FTVEA=:U,N(.;-F!
M; B#_A.DYNJ.%6,Q], 1Z(9E[1=,RX$3M&\77%1-U;7U>&[-+)[6LVR8^DJG
MH/?](-FY6OCN=EZXLY6YP[C-B%J&#$"187:,>FG8M7HDP<Z3I<M(\Z)L!(86
M'#PD9 XTX9E+BYAB1! L2)FT@F!??="]S15,Y@S*]IUD&SFW!U$@<IF;RN=O
MNY[G:->V&XL;@V)2K*?[!=A]5:?U#J<=29%[V#8]1V0[JJF5^$4N00T.!UZ"
M3H%@VGL0B7ALB8D0YXLUB@50%]$E8:T @900&T\SC< / <2>^'90>Z=3:2\E
MI<7%I+Z@:T"YR.+0/ 1F='.";+C#G;[903LWUJTW:C1:OPQ)+[A=S.P-37N6
M$V_L2=UNN5Z)'JE:?N.<KT?6]4MT&OLCEA3;90N9DV)9>**K--]^-2*(=3J.
MB1&9H#V@AN<-B"9F) !$G75#6<'TVG<0_LD@NR9I! TGD>42M4Z6[#]DVM-[
M>ONP+O8WCH+JMJSMK3$'B&N;) N#0V9<[+?'1S%(KPM&O:;L<($!U=O71]\\
M8JC))^=6[-)*C24W%G4V%S T1F?D) (RS  ,^E>\BUMY5&5*F4DN[74MJB8(
MW)TTENQO)D:6D5L?;]C-US85N([@V)0HF.P=HU-K+6&HPE2E;3V+/H]56!#T
M6O2;0+,0!A:P; CV38AX_.A,B(=$@A<68Q7::(L).304R' 99&1KG.-PRYS$
M[7%AX3-R%HY\@NSD0\M:UL2ZPB)U[1DS%C&BP6=LCLQ0-C:VM6Y+Y"-4RFU[
MJGKO:]>U)LBHQ2<K=>S)TD/;+!-U5C5AXY:JT8LEGJ7B&/O5 G,5 81/58&8
MPB1$1)#'-(8"'$N(D PT$P))@$#76_K5"Y[7-+G.+6BF'97"[G0)+0)(D^+A
M8+&Z/W.V/M&1W>LL&Q6.LJUSU^HF^=.:[LFL+E1U4:+6)>YB4P!>R5QJ(APN
M4OT:FTU5]8:D.1!T4T9K5(E3LU$E:'[/I!K:5KE[FO=F:0;@" "2!$WCS-E+
M:SGFM%LK Y@<TMCT@9)',<K2%<)6#2+)7 -A;8=BMG0PLRW&?QX>C-E(,><A
MA['C'AUE+^&W,>/@M*L<YR()'(D>HKI:9 /, ^L+G.0I3A$X1>%9\8\_+Y?+
MX_/.,<(H-6V^;:MKO=1- N(VCS]+QZW0*4^7KJ++"%%6=65O<5PO/T/](",D
MRY43L4=6:X@A.=""R%2CD) PC'E&AI'4-;]JD3GF9T](M%O*^LK/,X];$=FP
ML=0T$^)O\G-0UVMV'WY5*+K&_P "U[!+2(/373VV00*A9U3(A7#;YV2IJU*W
MD+LV,6J/3[2RH 'JCE6C#HA C/N,(%)7>XU4B-Z-IM+B !^R/9<W@-);&\B#
M/M7.^H\!CB23U3'91-WN)!)C0<H%N1VD BS[.7V0^XT1OH[9*#N6A]BH0"Q0
M7]:E@5-VG0[&#AA*Y5*\$$-V*K2-1"TV,79BEI+68==+ UF%8HHDHP.B2:
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MN0D!;@&KM<:G3E"!I6M2),N 1C22<"9IE:!2)!.8G,+B0'18_0LY<35 ,98
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M$"#=@EBF8\NIY7-:UH<YSW@"3'9-@>X"23K 4!Y<TDN+&L;3)-I)<,Q.F\@
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M ZR ZH8A^^^TL&L<US6AP<.M=+@(RM,-@W-C;OL3=4+JC7-<YP+1D:0TW)<
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M+!PS01)$#Z<>(:J[9=@M ZIWFNM6TQM3:1J_;3GU.NVZ(W0P&"%4I%,TTR1
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M7-G2;2?LL<)?1GWQZ=/..Z_@6,-<)L@+!$%Q=3S-, !S2YP/X9-Q,;0Z ;7
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M:B%7&"K4K"&(:_=,CW7E.OO8(M.$I .G[K&D*3* X#5ZW58H%EOV4C:Z\VY
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MKYN,@$FDM95+;=R Z^+HN4FI;!GWK&00^*(BGI[V99H8-A'I)<L^1<E.Y5
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M\:C06DVHS*LU;"WB^M#L#!D1FOV.0U*%AZ?.DQR.7C$8.U)26*$HKL!DR]B
MQ!4D;)=E$7S;!H(>B;99J46:LS6I*Z.=&R#[K5:EO5F\@@%N%Q+)(;S*8 $X
M@8_&@GY+7MF!TZ/,D-)4TVC&2*?L?4=7O>OWJQ6];:D-UW67W87>3.$=NHD[
M%?5:(-?B%"!F8FKIC)BK35!*($>6]&0MYN0TRI:Y&<((HH]%_P":^Z__ -,0
M5GX?'YM2>$7<3G^U]SD^P1EQ[V+OLF\.^QRXY[)?J(P]XS[+*E^$X<^3?GU\
M_#&<<;CO*@S!C6#&UU3-UNUEKW9=NU4&N.D'K-=']:.V;L7;MH:JW5$V-K/<
M=0M-0LU,& >P.XBA:R&FAU@66$0@-3MYN!.9K35Q$SH%>D^X3]W.>UI[0$D
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MF8J&('Q!L54N:\N1,E*CPF66<R)<AQ;\E_*,NOO+6ZZI:U95E?<D]Y0 "P
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MG")PBIN[:!*Z"W+:K/;!;6_#%1ULN]&P1#5&W(QF@ZE(62V2PP7[[6@I;T*
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M49H$/5>SWW74.EV$/,FU0BZ41#&.S_?8V&TM+$2D+1[7HIL>YA#7P,KCESM
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M\_H4DNDW.O/Z%*[I#\.SVM<>,?.U9^&/'_@98?QYQ^OXY1\EDDDW^C?U*#)
MDDW/S;^I6T]W_P"9DV-__#K/]MH'^MCYY_%S%GI^0_\ J4+KT>K_ .3_ +G_
M +>=$GF?65,GF?65(_J)CQV2U+\OSQN_+'C_ +T$OG\?E_R\AQ)!DDV._<DD
MZDGS78[YSJ%\3PT?)<R[(A17W,XQCVCS#3J_&//C'K.(5G&,><^,>?&/.?AR
M9(T)'@2/D4%K3JT'Q **83%B.-0F4-92TYAEEG"&D^TSA64X1CU%-(4I>?\
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MTGF/\CM0X_\ V^X9^O\ U/7L_5GX?'Z^*4WCN^0[#_MSM*A5'83X^7C]C/\
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M,U\83CE2DFT!%)S6GK5#H0^.\"?;EIZ*HAN\$@@90,EM'&;S:X\]5RTC-0W
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MSG96M8W,XNRL:(:T23#6BS6BP%@%,?A53A%5WZ3S\Z6J/'S^Z.R?/Q_K8/\
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MO);6])S^<G5O]%1S^P[/(I>F+P(,^S<V\?9=2/GUY*G+QG[<_P!;^#FT _\
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M.FQEUA=S-JIN N*W[6-@9BNQ[7%#>SQ"C>W]RCW>:1M+:/>O;^UP6FON9?\
M:JCJ3$S'0DBFYK$Y-TIK #*!7O3NL+)LNERCA!G8A;:M])6 !+)EQD&<BB Z
M,8U,*8GY$O,P(5FAV<NWEA,YZ:/3(;CQR+#NJ-K8NO=W0=A;K=>J[\NZU1@@
M/JX]D0%DE((C$(D9C"(C; X4X<F,.E90X7%B#(DF4ZS!B1V$H1PB[=_")PB<
M(G"+5&[]N@M$ZS/[0L8>RGQ0&96!ZPM/'Q2ME)3K=;05,$1!(Z9/%QY<ATO8
M(&%,JG,KRQ[7+.'G\-L.V:TN=E$ P3?2P)^0*KW9&EQ!,18:F2  /,J+3_I
MZ+ -0JL8U3N0);H;>VIVQZT3@ZW:E:> Z6&ZM/W>RWPHULMVNR0C57W'1+.(
M?HQFY22XHHZU&AX*PY Y&G4N-P6D=D"^I?,=X(RF9CFLQ7; S!P/:D1Z)9$S
M\WJ65Z&[UZ([ ##3P:UA*,;$6,34L ;E=]3E9,XW91J258;"E==;(N]2L+Y5
ME3K20HFT/'XL^%-&DAH^0AK+U'4W-,1FN?1U@1,B+?X6E2RLQX,&#WZ&;B-)
MU'R+7M3W9V*J5C[(E]O6N@[ U]UJ/A0A\%J#K_9P5]M XWJJ@;*EV@8Z;["6
M^-$9J4:[R7"==AA+"7.C*[)4$7]+$88A-BUA%/*"#4#C+GR+.(%A3$3$"_E>
MU0]X-0O<US6$6:P@QE!-R\S!-["PGQEYIK;M>WG1(FR:9"-MTTY.)IIYHW 9
M'-72N0YCD4;>JXPF9)DO4VUM-9*U(F0:'2C0)Z&9:@-0)\)Y^CFEA+3$C6-C
MR/>-UJQP>T.$P=.\<QXK0VLMA=AS79O8FM+%9-26O5NN:Q"GV8I5=;6VI6 '
M<[G,R1HM ^FBNU+@+.%QM&8S:;J^W7@J(L0_278+.<6)]D58M:*;77S.) DB
M( O \9\H[UFUSS5<V6EK1>QD$W:)L)RP3KOI:9H<S6RQRVD3XFNF)]6 L6>Q
M1H+S@4!)+,@8I0EG'J18LPT_'F-BH2G5)5,G)A3WX\5#SD4?/DI9B/R "0"8
M!(DQ-O#W\#HH<2 2!) ) -I\U7'8>V'8E/3G5'::OUW6<?)#4OWR]C@,UG9%
MW?)V!R&-EBZ+58=:?@XI=6(H<..V#<ES*D U"C#!\TM5"(Z>0FA]<C!4+"71
M(#38:Z%W+4&VFAE8&H\,8^  1+AJ0Z?1&V74$R-)E69CYC!&##(17X\J+.C,
M2XTF(\B1%DQY+:7F'XTAK*FGV'FEH<9>;4IMUM27$9RE6,YQ(@D<B5N#(!YB
M5]G"E.$3A$^?SX18=L*YC-;T*Z["-,S9 :B5.PW M&&M,/D'QE:$RS,]F S)
M?B1W9KD2&ZB*T_+BL+?RVEV0RWE3B9 )( U) 'B;*KG!C7..C02?(2H<1._%
M;ERZ[7?O&[\B[#N%BI0BHZRGA-<0K=8 6Q*-L_853OC#S^SDU4;59E>TUL?Z
M09.687:09"M28!BM0GWX>)%S3(FX( =<;Y2 ?.2/FFTY]<# #722P1'X;2Z?
M( _XZ+U:>]))UEW'<;-4A=N'5I@ "*VB#:K3<]5,UJPUL+:!5/GET*!;"/G*
M=A1P\#;'"MG!:*=,Q2T24)&34M$40)=1>P7[1D P#:1;;>#ZPC:S'Z& 1()M
M.EHYW\X,+Z9>R.R;O: 7KD#L?2YC5QG5Y?>0Q@?I>QS;:1J(J]5JNL4<=;\]
M@X=9E%C0H_AV#?UUU@0U*2S*74G(;BD(13ZK-!#@[*9?('9!)@,&][N\BF9_
M6Y<P+<F>S+W<0!F+R)T AIE;FT'V6I_8MNS2J, NP^!3)@^O6>=; <8&T)V#
M[%YVW:R=:^DY<J1<];/IC"[XF''?KHTQ.:%#+ 8FPRS0^KV%D9OOA(UNW8WB
MQO'@K,J-J9LLPTP21%]QXBT^*U]?[_V*#=GM7:TIUCU(6H=X69MMCKA#6UMQ
M<J;JJDP <*U'9E^C;30"?.'+K80("G0%:]8:>9+3Y;_O3-3)OS) 86.)S @0
M""V,QTL1,<]]=55SJ@J-:',AUR"TR&#TCFS =PL;^HS/YFME\A!]^+!F28T5
MR=)CQGGF(33C#+LQYMM2VXK3TIUB*TY(7A+*'9+S3#:EX6\ZVWA2\$4"@&^.
MR-YT3:KX-K^M*-=Z=NC<]*N$/[G]C[JCUZFZMM=PKT7%5I5#17K5M*ZE)00"
M*D1($ZJPD?29<]!8FX%PZ^4U+&M<T$DAS&N!%KNTF= -]2L<[W,>0 '->YNQ
M$-)'F=+#N[U*;0VQIFW=*ZJV@2@#A)2^T"K6HN($D4%AX<N9#Q)I41%((^$E
M H@[)'J4KPZAR.II_"7D.)QFX%KG"\!Q G6-O7[V5Z;L[&OM#F@VY[^^HO*V
MUR%=.$3A$\?'/S^/];]3A%A6R+R*UCKV][).LSY(/7U-L]W,QA;+$@G(%50)
M./$6!S$J1#CO3WH<!YN&U(F1&')"FT/26&U*=1(!<0T:D@">\@*'.#6N<=&@
MN,:P!)40D=\JXJ>!K;VCM]PM@VNVU"NUG6Q )KJ#:RX>^TO8E_JEZ]M)V8W6
M!=4GU[5-]Q,;.V(5:0I:OR@YFLP9RV&GKFD0'$.:0V9C<M=E</;(^=8BNTEH
M+7!SR !%P"TN!,:6%QY25\>G/23]8MR6VR5<9;QU7C! A"SC;3;+EJIBN6*M
M"[(,J<PNE0#85@-4Q2C!L(B %VB&H=C*Q2\20-#RLL%&ATOHO9J),P0))'L_
M[*65V/N# V)M/DOJD;'[)N]GXVN VQ],F=8$-63]YC(XW2UAE6TG4XEY%5Z+
M1QUN7V%BUJ06+"R:785]<K[(C$KV4A=5S$<4EN.QU6;*[,']63G!$D$CLY&Q
MH;3L(F82:G6 !S2S*'P&7(O8'/O;;<K<^@.RU-['Q[1/H0.Z0A=-F#Z]8B5J
M!, X\"_^P==M^M?9J(R)DBWZSE(8"W],>,X!%GY7T*-.F" XTP,JYCF0';W'
M>-G>#MK[*[*C:F;+,-,&=0[=I[VZ$Z':5KV\; [$!^T>L=856Q:F+4*ZM';C
M9J]+UM;<7&EZLIP\5 .&IE^8VE@$^;L%W.!0-2@JU\PV_'G%I;WO#55(O2Y
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MI'TB^KPK4MPWKS;8?-7I>RKQM5! ;0F$Z>&ZHL<NG6R#=Y2MA>Y32JK0R/&
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MIUI25MNMKQA2%MK1E25H4G.,I6E64JQG"L9\9YBND&1(T-PO?PB<(G")^O\
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M0"'572=32RTW.=!<,L92"T2X@@P29L-3:><%2*Q=6:P'*PAP[0&9SLH<"+:
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M(=$^&$/00A =!)AHDY$I@44BLDQ[<:>C$C$A[P" 2 XR8C7GS'DH+&$@EH)
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MA[28!5NS =BDH!O=R78]JHUXITK9\:TTH[.*B8;#L%[6.+06QD_!W)S%LB\
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MV*DQ.4_:+JQ$,IJN0V3@@/;;%6P9?,T-6"TRNP1CG,'D%Q(T)MX+HIAP8T.
M! T$P!MJI$\JKIPB<(G")PB<(G")PB<(G"*'_92N;'7L[K!LV@ZV.;0B:GN^
MQREKK]:.TD&=0-MVH[92ALN N^V>HA9:6C)F'F8RDNF4W%PX\TP_E'J9NTC*
M\$QFB+3H9]_\%C4:[/3>UI=DSV!:/2;&KCYVY0=579V ZE=H-F![E-&ZO%,D
M=P6?>.Q(E?&6JK$7=-W>QU;55(U>\4DV.V!*:.(O"M>3;;9]C4:I;,NM0N1\
MJ-HRT#2!4\:V94I@MF>R&C0]K*<VP)@S$&8 LL7TJC@X@07%YB9(+@&BS71:
M,Q(DF8D 0>4&:=W)L38>_=8QC1HY6-=Z/+68?" ;%?K9V!VE[%ZF%T6YTE=[
M^CK$$%V"F1*I>;[%FNQ3X\<3[ C"9&(B'B$MPYS,K'0)SY;-$"FTD@QS-I.L
M\YM+6/+G-DD!LD3J]X#8)G[V"8!(@D:"\[>BFM=E:HU";J&Q:PU46F+^9FT8
M,XD!#--4V8'KR\/66OTFXWC6]7+O6E-H4@-K8Q%J3@GZ,,H! S98T.9RJEKG
MRW2!,:3OL"?.=-2MJ+7-8 [RV,> MZ@+R8NII<S6J<(G")PB<(G")PB<(G"+
MQG.<8SG&/.<8^7V_BX156;'T_ONRB^\NC@^G93H3M9L:?)KFXR5OH#%%JE0M
MVD=1:Q,V0H$:LDG8[]AJLRHV,H'"PZ4I@J2B!FLF1D28^4@;![9IDD_:VD$1
MKVG.B=IS0+&(OK;F<QY%5L6J/$&=&Y6C-Y9?$DQH HZV[JMO$ANO86Q-AQ<Z
MDUE-C]HA6QMM1KI7H4+[@K$ L,K2UX<L,J^6'8]@129XJI628*L@^B5W6=BC
M,Q*+2W:[$64A7%1F6 W,X]6 TR9+7$N)D0"08L38 ]RHZF_,XN.1O;&8. $$
M!K(.;,0T"8(!FPD77%D]"]H][:,TWNV71S!3=6S">P]TV&MLVH1"IU.M%R&T
M(/IJ)8ZM;R^O;0#'US7=&K4=_8.K[E7=MZW+.6)0*I'I-L--1)+J;'U&B[6C
M(-"#$F;SN=+SKX3EJO:QQD.)#CVI L!&VH$SI>\W*OF'8F8'P<$4L)(8AQ<3
MDQ5NN14S,,(]Z3&<?QA]QC#_ *^&5O8PZIO"5.8PO.<<Y?!=?BOLX1.$3A$X
M1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$7C*<9QZOCX?+QPB\)0E&/"<8QC[,<
M(OUPB<(G")PB<(G")PB<(G")PB<(G"+\J2E7CUL>?'R^?XOX,<(B4I3CU4X\
M8^SXYQ\?U>$7ZQCQCQCY8^&.$3A$X1.$3A$X1.$3A$X1.$3A%XSC&<^<_OY_
M>^7G[,_/'U<(O.<><>,_7^M_7Q\>$7X2A"//J)PGS\<XQ\O.<YSG/CY?/.<_
MJYSPGOZU^^$3A$X1.$3A$X1.$3A$X1.$3A$SC&?GC&?U>$3A%^$MH3GRE.,9
M^?GX_/./'GY_/Q\//V<(OWPB<(G")PB<(G")PB<(G")PB<(OSE*<_/'U^?GG
MY_L_C^7RX1%(0O&<*3A6,_/&?K^'CQG[<>/AXS\.$7E*<)QX3CQCY_X>>$7G
MA$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$7YRK&,^,_/.,Y_6Q\^$7Z\X^W'
M")^MX_8_Y,YX1>//V_#_ )?/P^KA%YX1.$3A$_P_8_\ R\(O'G\6?ZWP_K_O
M<(O/")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G
M")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB
M<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(JM/2+=M]X=6K]U*SJ6K0+Q5
M[G:MK%]V5#([WRQE=4:NI4"XVZ;39"%XD,6.N5W!RQP(<=J0X:?&-"L,.JDI
M:<Z*%-E05<Y@AK<AF.V70,W\&YGP%US8BJ^FZD6W:2\U!J2QK<QR_P *0([B
M;3$<=O;N5>@&R=Y1M4V.K&==UGT6-Z[C:V,,C8I>,2OX\_:H]5/))8=\$ZO+
M"C1CZ1?PCRL+4]EW&7<XP92!:TN!#CB&TB)M!$GSG<'1'UB'N:TC*,.ZL#S(
M,#RT]MN6.:G[K[.[@']8ZBZOV6DJ(4:C:BO7<[>[\" =!T@C<*[&*OZ@UA6<
M2\Q#6R[)/B&T%2Q!N54]<0!\N',;+V?&!$*SZ(I!SZ@,.<YM)EY(!]-QM#=A
MJ3<JK*QJEK*9!+6M=5?8M!('8&LN)N;0(OR4U>WV^S?7?3K=FIM>'V[9EVO.
MN].ZFK)F7(@@S&S]L6T72ZGFPS(B<R8U=$2B;EAL.8?LI3H41/8B/1Y#K4AK
M&DSK'P3#0USW\\C!+HFTQ82#<A;5JAILD7<XAC9_"<8$Z6F.2T[6ZSZ0_6][
MUJ;L^V]4]E*%:+-$"[@I(O5([3!+600G#EN+O&M+(N_&WK,,K!1N&P3JUL8)
MGS8=YUX5.9)83';$T2UT-<R!+=YCG^#S$7"J!7:YLN;4:2<U@W(.Z!+HTN09
M[EFA/OOHL99" R6QLC%)$;#QJ4UN]C7%E=T<'V/FP-5!RKS]CIC9&-YC7!Y%
M0(6!MEVI#+1E8(C8(A)M<?#JJF@#9+<P;F!=$3);8BPGPC61-C6:"!#LI,9\
MO8!F+N-M?GF(48"/<+=,7<9:DM3Z_@'!])_1NJC*% 6,R?O2'NL0/:A"&J1[
M;&5'%6R?(>9-Y3[=J#E$+#7J(];.AI-R,<)[5 U#/X0>6_,L>O?G<V!;$LI?
M[KFSZ^_Q&RD5W1[/N]8K%U1*E;56*7K._P"\CM3W!8K4U&3 '4(-HW;.P'7V
M2$EQO J2V=IP5:9+.''Y#:7![+3CDM"<UHTNM%6)+F,#F@:DEX:/$7]<;+2M
M5ZHTK@![RTSI 8Y^NQ[/J)L=M.:Y[.;GW3JO?'<7[H VE>I(O3FPK!U^:DTQ
MF\[&L8ZJ SA.1V(O0G!.*J*%1]$KFT_3T"2.-EQT;"[.6'2IC,)%GTV,+*7I
M59 J.F&-)( 8T:DMOF),3I(%ZLJN>U];T:0!+ 1VRT ]LC8.B6C6-8.FL-F]
MV-S5A[?/W+V.OEA= #>B^GTPQ+I[,!PDQVNW.Q2MI%)XMV7(<C9-UIU+X0<[
M(=76)COEI^2XUZV9;2:0R09/73?_ $8!%["UYT^19U*]1I<&D&.H()'^D<0>
M7*T^:DFGO%K;6TFZL; NMJV#,)=LKKUSH=?I.F;"X?&70%0XMVBZMC# 4D[.
MN4M@?$(.QKPB.-AE99./!?AP&H+DI68HN,90UHZL5"7.  $Y9OS.US/LVZ]K
M2X.))ZS(T-!)) F+#4>-]!=9C%[^:'=UG8=CS&]B!I=8VO!T24U:6US9H^YE
M;E+QA<\%K<=KEF+),%K%8!9H88#9&9EBI862LQ])I&Q)LF.ZIV<-EEP79L[<
ML#>9B-^>EE/7LREQS"'9(+3FS<@-96?Z$[9:P[$VC9M'IT"^U^[Z;55&-ET_
M8M%.T2PU6?<X9,@"'S()QEG,EZ3 %2)R9 Y<P;(@OP)T&?+AS8[ZX?3<P-<8
M(>"6D$$$<Y'/UV-E9E5M0N#9#F1F#A!!-X(Y\]N]2<YFM$X1.$3A$X1.$3A$
MX1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$
M3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X155^D6]*?1?1V'
M=7A+GJJW[%<V@,M!. _6#(82V,;K$L-$?:EX*I4IY<M1AI32F,82VEE>%><J
M3S]YT+Z!8SIFS'5,-CL/@A@7T6.Z^G5J]9UP<06BEI&6+\]KK\KTBZ4T>CU3
M#4ZF%J8DXBF^IV*C:8:&.#;YFF3-S&T:DVK;_P 4X:/_ $K^V/\ ?G4/^BY^
MY^P5Q;\>8#\UQ/TK\U]DS"?BRO\ T[/T$_Q3AH_]*_MC_?G4/^BX^P5Q;\>8
M#\UQ/TI]DS"?BRO_ $[/T$_Q3AH_]*_MC_?G4/\ HN/L%<6_'F _-<3]*?9,
MPGXLK_T[/T%N[K;^2 ]1]D=\:LT0$Z^;(K);:=M'U* ?*VBL31PJ20PYEN7,
MC16\2'F6_9Y]=#.<.9\_F?/C.,^)X[\#_$^!\)Q_%JO%\'7IX##OQ#Z-/#XA
MCZ@9'9:YQ@:[V&Z[>'?"!A>(X["X%O#Z]-V*KTZ#:G74W!AJ.RAQ;D$@$B;B
MW?"[!7^'^'V\]0+V$G")PB<(G"*&&_-)W/8G:'I7LL.+&D:)IHIV"=V0N=-A
MMNQX.Q=1NTZOMQQ4GRX8;FEG,QIK+"',1XRE/2$^QSGFC7-#*C3.9P;E/(M<
M#[W%IA8U&%U2BX1#"XNGO; ]?JY[*M<3Z-G?&LMG]V@%&F"K+U[V!T-W)H'J
MF*)'(T8QK\MM$Z=N#.G9V)B\2&J?6;;8#V:H:DJ<ABZH0$A797KB\M-[FNQS
M*!,MJ"JU]:! ,0 X6UC74SLL&T*C:E:X--U,MI Z@N])I[I,C0>I2)@]*+OH
M&C=3=H]5J;4JKO31>MZ+JW;VKQ\T=7*GO35TU@;*V533!Q"/HQ-S 7&07V#0
M+P0]MG%B<.12$A^#:IKC=.M:]U05"[(]Q(<9+F026[GLF;@*XHNIMINIAH>Q
MH:YNC7BV:\:S>2#R"E[W#T39^PNEDU^BF!=6VK2+UK7<VHS-DCR9( 9LW4MQ
M$W>LQ+,T,R_)6 -O"WZS8'86);\429FS(L:<\PU&>SI.#'2;M(<QW,M<(=$Z
M'ERVA:U6%[(%G-(>R\0]MVSW3KMXK1\"S>D-V_;-9UHQIJJ]3:96;F L^X=A
M1=O5+<!2_P!<KZGI,[6^LJW"J*5#QEXFIB0S%KN*018'7<SDB1JC2XTAJ2*3
M02'FH3(:TM(RS$$G>-[\^XJLUW$#*VF):7$.S$Q&8-&6P,>VW-0.'>CIVA7
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M(-L:[5NG5AP@[UDJS(BC7:)L<0$E5J@6IZ37C-Y&#!80U<X$$P*(V2(%1*A
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M)K@UKM>U[75!(<9(W5H5O[N#(ND*?LA?8?TG,Z)LRT;:H<8!.[.ZR=CPI>O
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M6F!S+VQ\J^;[JJQ_LC _^UQ__6..HK_Z&K_1O^A1U]#_ $U+^D9]*?=56/\
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MK/C'Q5G.<YS\<YSG.<\S^R#TS!D=(,;.NE#V#J8'@++3XH=&_P 4X?S?7/\
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M,#G0:X\[ETD^9[M%[/RLST?'Z3;KO^UA6?\ J/(^./2O_6+C'Y_B/UBGXM\
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M*'Z"?@4].<9QG'5#K=C*<XRG.-'ZSQE.<?''C.*Q\/&?CC[,XX/2;I(?_?\
MC7]:8W]>GUDX-^*N'_F>'.O_ .VN3QU$ZHX^76;0'U8_T'=>_5\OE7N9?&#C
M_P"/.+_UEC?UZL.#<(%APOAX'(8/#_JUY_!%ZI?I9M ?M/:]_O>X^,''OQWQ
M?^LL;^N3ZS<(_%?#_P SP_ZM/P1>J7Z6;0'[3VO?[WN/C!Q[\=\7_K+&_KD^
MLW"/Q7P_\SP_ZM/P1.J7Z6;0'[3VO?[WN/C!Q[\=\7_K+&_KD^LW"/Q7P_\
M,\/^K7NC]3>K41SVL7K=H:.[X\>U8U#K]ISQXSCQZZ*]A7CQG/P\^/M\\J[C
MO''"'<:XLX<CQ'&'_P"\@X/PEIEO#.'@WN,'AYOK_P"7OH>Y<FUUFZXL.M/L
M:!TJP^PXAYEYG5M':=9=;5A;;C;B >%H<0O&%(6G.%)5C"DYQG&,\H>,<7((
M/%>)$$$$''8H@@Z@CK8(.X*T^MG#?Q?@;7'^28?4:']CV6[$(0VA#;:4H;;2
ME"$(QA*4(3C&$I2G'C&$IQC&,8QCQC&/&.>-UU7=IHNH)^2>_P _O4?Z_P#*
MCMGX?_SFC<^B_@*CZGZ13<=;@9'=EK+U'\)7W5PO\GQ/]Y35,W36,T=I^QZU
MKE>N W81VR50R(L>T],$MS!5ZG@![.Q<0@*)#UCN&)5S;M@E5>>0GRJ9'>,!
M(T@=#LH]#4P0?]D]*BZCC,%6Q?U94X,,/B*=7#X+B3>'53Q%[J3L+5K%V,P+
MJ]%M)M=K:;*^5E4A[J3CVV?A^&-8ZE7I474&8UU6E4IU,1A3BJ8PM-M05J;&
MBCB<CW/+"7&CVJ8+0\>B^.O9LCKXIN^[2M90AL&LIS7(4G *M2J979UR&U,$
M.V,:J]-FQH,NHU4_L*+9S=8K,D>,= @IX\6L4*S%^CHOG.C[,8SA.$;C7.?7
MBLYN>LW$U689]>H_"4J^(:7#$5Z.%=1I5Z^9_6U6/>:E0N+CS8YU%V+K&@&B
MG+!V06,=4;38VL^G3+6FE3J5VU'TZ1:.K8X-AL91(.H5#N=;-*T^EU:_C*I0
M;4"-&J'IH?L^@ZRN.W0(TD99(&HNO(!6O6G9_O!08<@!)EDBER1^4)FC*M])
MKA9CM^%Q.+Z+8;BF(Q.(P=3$8RC7;3Q?$C@,3C<-P^LZDPMIU,4]E2A@8:^F
M]XH9&TVN:ZN6YR5O2H<4J8.G2I5FLH56N?1PPKTJ%7$,SN#GMHM+*N()+7L8
M7E^9P+*>9PA?CT6?\\/Z@X\>,_?IK7P_'C$K&?JQX^/U?O\ SYIT]/\ X-Z1
M[?YKQ%N\ #Z?FLMNC7[?\($R1Q##@^/7-B>9 !'E<#1?TH.?$J^D%4QWT<KS
MF\]2Y,$MNZW@5K7Y.]VW>>J<4BP,T&O5K8U,E!G;Y2+G3;:ZNHQ+0F(1EWNN
M,/2:4G+TJR"I-/E&BH7>D3D(!:27 !AU)C8C3YR+&0%R5XS $N8T-S%[0+$$
MZR1ZX,3LIQ]2YU?*=6NMY2IBUA*P3T3J8G7@SA;)]T8&(T0#-&0G3RHT-1QR
M-#>:9<,*AQ<DW$+FYCLY?]FG)X(<X'6;KHI$&FW+,0()U(YG69UE2$Y573QC
M[,<(HR=GOY7Z._JF](_VS*X4'5OC\Q4F^%*<(G")PB<(G")PB<(G")PB<(G"
M)PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<
M(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")PB<(G")
MPB<(NH%^2>_S^]1OZ$ML?L_3-&_@Y]&? 3;#](3I]NP%]/O:QU\I\EZB^$NV
M*X6>6&Q/]Y351'3EEFY:+W-JQK.V5EYVQ=:7R .T-?-<5W9YY-9"744\,31[
MA:@EHV<%:R?3/BBZ:,+S:^<8BDW6\-R%,O\ [_I7GPW%^%X\# &DW!8W"/=Q
M;"XZO@:3J]3#.ZXXBC1JT,)4BF6N?B'4F/IN<,Q D?C>%AM3"8["DXH$U<)7
M:,'7P]/$/R-K-ZK)4JLJXD=L/%.EG+'-D@D@+4'=2TT"\;@D6(#7MXTRY28M
M>"7P-O0,(&V1MRIU"JT\>>+.#GU%S-OL204ZQ7LN6'CWB]A(2B4:*VN8ZPWY
M3HEA\?@^&C#UJ_"<5AFFM4P53A%:O4ID8C%5L0^E]LBBRA1%5M+#-ID]72:U
MA(# 3S<8J4*V+-2E3Q=.H6M;69BV,96S4Z-*FU[BWM&H\L<^J7 $O,Y9<9GS
M3L:OJM8T0<1N7KOMBR:VU]&CU3=8_2G<6Q[&U-$C6FX3V*T#!5@*)U';K'2,
MSG#E'?VZ($%A1 K%:L4=RM0*W+Q^.Q7U;B,3Q>C];^,8&AC,<37X75XEP&EA
M>(N=0PM-U:K6J.?CJ%'$!K*5<8*I6IN;3J"F35?5:/+TC0I4<&1C,%B*E&@7
M,Q0PG$GUL,.LJ.-$-8UF'JU:3@ZHQU=H(ZR)RM8Y0Y]%IGSZ1#J%GSE6<[IK
M6<J5_GE>?>LXRK'G/YI7G.<_'/Q\^,YQ\>?K.G8CH3TA$92.$U@YHT'9$1W6
M(',7 A<'1L_Y_P"$7)GB&',D $_;F0=3:-()%M3"_I0<^)5](*F;O!M&_P"H
M[]"B6#8T6H@[1*,SZ2/J^S.QLFW%0S[E;%2_NCJ>H^L&TV 8M@])BC 33Y9R
M%)EE'&8DJ3-E/18_12 > T,,Q<Y&V'F^)C6P]>G)6<:9DORAQ  S5)OL UA
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M@"Q(2Q/O*6\;$"QH\<-)+DPH4*+'8;8;R.IL!<V!)'K-SYKH;Z(UTW !\P+
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GA$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$7__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>g60414g19p60.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g60414g19p60.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[29>4&AO=&]S:&]P(#,N,  X0DE-! 0
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M5     $       ]P<FEN=%!R;V]F4V5T=7!/8FIC    # !0 '( ;P!O &8
M( !3 &4 = !U '        IP<F]O9E-E='5P     0    !";'1N96YU;0
M  QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"24T$.P     "+0   !
M   !       2<')I;G1/=71P=71/<'1I;VYS    %P    !#<'1N8F]O;
M    0VQB<F)O;VP      %)G<TUB;V]L      !#<FY#8F]O;       0VYT
M0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O;       16UL1&)O;VP
M     $EN=')B;V]L      !"8VMG3V)J8P    $       !21T)#     P
M  !29" @9&]U8D!OX            $=R;B!D;W5B0&_@            0FP@
M(&1O=6) ;^            !"<F1456YT1B-2;'0               !";&0@
M56YT1B-2;'0               !2<VQT56YT1B-0>&Q ;8F9H         IV
M96-T;W)$871A8F]O; $     4&=0<V5N=6T     4&=0<P    !09U!#
M $QE9G15;G1&(U)L=                %1O<"!5;G1&(U)L=
M     %-C;"!5;G1&(U!R8T!9            $&-R;W!7:&5N4')I;G1I;F=B
M;V]L      YC<F]P4F5C=$)O='1O;6QO;F<         #&-R;W!296-T3&5F
M=&QO;F<         #6-R;W!296-T4FEG:'1L;VYG          MC<F]P4F5C
M=%1O<&QO;F<      #A"24T#[0      $ .__C4  @ ! [_^-0 "  $X0DE-
M!"8       X             /X   #A"24T$#0      !    '@X0DE-!!D
M      0    >.$))30/S       )           ! #A"24TG$       "@ !
M          $X0DE- _4      $@ +V9F  $ ;&9F  8       $ +V9F  $
MH9F:  8       $ ,@    $ 6@    8       $ -0    $ +0    8
M  $X0DE- _@      '   /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H     /____________________________\#Z   .$))300(
M   0     0   D    )      #A"24T$'@      !      X0DE-!!H
M S4    &              2Z   %T@         !
M      $             !=(   2Z                      $
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M     0      "6AO<GI!;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N
M!V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX
M   '9&5F875L=     MB9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO
M<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG          IL969T3W5T
M<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/
M=71S971L;VYG       X0DE-!"@       P    "/_         X0DE-!!$
M      $! #A"24T$%       !     0X0DE-! P     &\$    !    H
M ((   '@  #SP   &Z4 &  !_]C_[0 ,061O8F5?0TT  O_N  Y!9&]B90!D
M@     '_VP"$  P(" @)" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,
M$0P,# P,# P,# P,# P,# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4
M% X.#@X4$0P,# P,$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,
M# P,#/_  !$( (( H ,!(@ "$0$#$0'_W0 $  K_Q $_   !!0$! 0$! 0
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M^:LAES7#Z53F_O,6=E8UM%A9D,,]MX(/^=HY 3B= =41RQEH#KVZK_;>
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$!_\  $0@![ )= P$1  (1 0,1 ?_$ !\  0  !@,! 0
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M5>UJN<OXFM:JJON1$555$362*&6>010QM)(W(A$!9B%4LQP/@J@LQ]%4$D@
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MO-4AF[UZE%"D<KFC&QK60T<R.]:>8HP@2%0$B=FC(XD>[=&[31V[HKZ1^O\
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M;.(;$,$E=)%=XL<KW#KBD=&X@(F. CQE&?(UKFSH/*L4ZP31N?"2V%[7-E=
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MNY_#Q^%>??K7_CYZNUQIIIIIIIIIIIIIIJ;4*<W=1\/]TP?Y"8UUBG_D)O\
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MI:T&',O>@CC$C\H^)1\ACQ;%QZBFKQ I<BS"^QG*/6J#)W4M5-D!TA26%/'
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M;4N1&3D'!C022J?4-&I#*<$6MY(7Y^OW#X?CJM\#Q7+;\AX]#AYN4MN>X16
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MBEWVN3<98HVC,HR-*D+,J.A8 9CHBV=R=8]M1?24]#:682DTAXIIQ;7W5A)
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M8Y##*57D8Y%:.1&59(W4JZ*<9V4D6097.1C*GPPSY&1\,CR/F-0]%_V:J?\
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ML8P80%(9P>1P^3I9AB2,!EX3.@Q"JF2NH)D4K$S<N1C($HRV"ZB-20P76/\
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M3+$RU^Y/0B"5B\:,\J6'BKJB2.38[\P8LH;&N^]"AMNU4C?Z?V:Q7CVF]O7
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MXJ.CFF\(6&09D*33PQPOF56JUB^%!'(0YB.[WZT$FDL[@CPR2!>XX42*N&5
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M =)DULX6WOIWG&5DG^ZXT$M=26@9 $,-M'[%:-8Q1Q>MGL/00F31HP06>W5
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MNJJT"6-EE%+6!C6)D$222-E.WQUG2%5$%QX7@FVNJC0!9A(K&5+,@@93;K)
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M6X/802(S2R58F]94B5N#AE*LWNMS(QS;N952!<JK-RE7R0T(&"I/C',D?'R
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M6XLN+7&'$UN(TH[IH5H_L>,$7(5F'?P,V6Q(MJ^4><?M=..*P:9J(#"KO?\
MZ";E678MRKPQRK;COE]RG<AC:-D,]<EAEF6-(V#*YRLA9P1S.OH_Z*C6[6Z5
MEKJL\$]69Y55<-7FADAJQ+A0RK"U:UE#E09N2$=QU72Z!9L5GA$.:QS_ "29
MK561%Y]\J\]W:J>3E9R[M1$Y5$Y3Z$@LJL302!4#)A;$<8,RLO(KR;.2AY$2
M<?>=0H/A<'UR2,G!7T _-^8^2_ '[QZ^<_*<.9,Q&N5.R-Z.[)$[E:_A&N3M
M>B*Q7*U[51&JBHCD5Z-5>-5FH3JD$DBA8VC=PYYE';BLH56 *%G21"J*V5Y
M.5/C5G('./7/O#XJ?3SZXQCSZ^A]?.H9KWQ2Q2L>L<R.<YO8KF2QN3E$=W\H
MZ-_T=JHJ^_E5\]8)4[42\@GO%@8BI+#(QB0.,)D-X4>,>=78RI4^0?# ^0?'
MR/J#\?7]/C4818EVAI!]J8<>47,XBP,((>2:3,OFLTLTLBNGF57(OB3+W+RO
MGSY:U1%'%%'%#&B<%"(J*JQIY "J%&/(/O8 ']N)(HXHEB@BCB2->,4:*$C1
M<8*JJCW5_P"2!CQC'RZ,F:U&]K^]5Y145KEX1%X3ARM7S?RODWS1$\^51-;K
MQP 0/S61U+!H45HV'!U[98XP[2>00@RH&"0? J5SGW?ACP<9^W\/D3CY>?.H
MLDD24<"%@,(I0R3*47$\MTQ[I'=T+IHYB918WP-1T;$$'&[^Y?&[W]JIJQ1]
MJQ*9)9&!>-8H^*#M$*0^,*LC8)!PY.,8&!JU5=6D8RO(C<>$9$86/B"&"%(U
M=N1\L9'?'CC@9!C8#C8@IJ^(TQ@!KX)C0HB9F"DSC>,@LY(S7)#-,,V61T$C
MVN6#Q9$8YO<[G=F@J(T5B6%)YD@*LQ5@86D+')<J'Y29B8\'*#PC*WIK5>-&
ME65H8N['S6*5T5I$1^/=2.0C*J_$!QD<^*D^0-3:B/B"G):;:7U:*17V4"RX
M^L7K99#X'-#%,BG,#C?7D$^&PY?&DD:,LBL@G<B1.YUBM);=62.M/8EE0B*U
MW"4+'#E&$;#N*OO(&Q[P]X@:P6D>5(^Q7J3/%/ W"X'[21A\R21,D<K":-.7
M9]T+SX\G0>=3O&=S;?&QG!@QP,E:R-L1L38)RTD%65 >[VC"=#!!"I!2R1UZ
M5\D[9W)-(Z-K$UH7-C@GF+/*60R-F(!B&4D"0XA9,L_!2IE>7CA2H][6&_LU
M>ZW-R2#R)C8LL>) G<(,#1,TC".,*9C*HX>ZH))U75M)1U6W\^*V>-;<ORQ\
M0.3 YE77!MGE!419D(LE(/)0V1=$OJ@K)2BP[B =K(7230QJ7'&Z3F1)/+N(
MM0V-S]D5I*[TY84BKQ<(RXE99D68%VRJF(LW+PQXGQR:XMV-X2_#>WD;>&FV
M^3;9J\4-!6BB>1;<HN5X[@$DG&..6J\@+<49A&S 3#9O>K[714C[(&N/B29I
M<-N5C\-[DP$@PDL X=#:%75:3C23++)&ZRJR(C@_'4H5[9XHD2N^; VX =HR
MHRH4EACG:"LPD<$R6(4@<66! Y)*.#87X%LX>HNF_P L1%8)I8"5$?LZ6VJ4
MI%:59));,$=6PEWCA2L%B,Q2F,12 H['4Z!WZ4'/<SM-N=L-LJVGR\V.S$Q[
M.*],L&J)JA5L8#X;'*[62-U@^6$F>>,N4@(F8N6"()WBLC74FZ?C?;:$>X[G
MNTEJDIBDLTIEKB5)B8@@BIP*RJ$91E<2#@K<T .L4G2S3;7M\&\;WO,MBA$8
M'M[7(U%IUL%8V@[-.N6,"J5164"58T#/)@$BBZS=XVH?DUI2U]75&Y1=1%DT
M<%/";BXU7"1+9MK!H33I9U$EM25FEJS(3 Y6C .\1'B1L3HR;$LSPUYY&G6M
M7*)*TQ6S+/($C#YA7@72$ *X=6!+JP;GYW['3T,ZT(;,UF:*A7:)+;66CW!Y
MC&L!FDDB@"B3V>/B+$+0S R2 ?RC$W0Z@<QM:_&L%VZ2DGK:ED>1;B0&7E=7
M"761MW%=6NCO2:X:N 6I&.@IV'4H_JL"#UTP\<:SHU"I^=TQME>Q9W+<6L"6
MPO9H)#7EFDA1MK,@>NCAY%8Q]Z03LS,7:)^14X4<7I2BDMS<]U-A))O\3VEH
MZK2-6I#;4D8U4LR33/<>(SB.9^XZM*)& 4R,HPW?*JS.2->UWSNWO1'IVKY=
MK57S>[ERIY-1>&\^_P!WH,#J)"U8,K,7[<<ZI,RQNI0(I8?6,69E&0I ][P=
M>BJ@XX(&?B0",^/7YCQ\CZ@^FNJ.[VL;)-(K45W'*\M3N1.&MY5%Y5R<*GN1
M414\D7B\2"18XI9YV0-(3SY.%$BC@BC/YS2+Q<8XC 90?75V /(49P/7P?Q/
MV#[?GKU=&Q6]B$JUZR(UK6,X8Y7JK%='(B^)PUB+XB*J+YJC55?+70[,"QM$
M+ICE$R*D4<3K [2_5&2&4?6!8X@W>5P,^\JACDZ G\[CXXDDY&1\1X\CR?M_
M'SJ[6V.W+\QSFJJK)64-!7AR9+D-I9N@K_5<1IQH;:SGBD-D%'>>=6HV*K@6
M5GM XL2&!SWD1M?'>H;T52B[[5 TZMBE19!)/:EM6)C!&LQB4F,Q2%1,JJ1'
M"<X6,Y$8W[?H]LVN>>N?;;<LWL-.M >Z9-QG:2&&-A&'810RJQF/$]I(G##W
M3K)?J[ZQK;J!,J\*Q2G'PO9K!YU"Q3&:]O@26D8C$$!MKYT#1X)7I!&^:OJV
M0H+6)/-PXF>1Q"P7H+Z/STXL^XVW?<]ZO3(;UNP3)#7ED<O) JOW%12%,;R\
MN3JH_FJ%U'ND>C*^PI^4;?&?>[5?$\P1<UDDS)-!!(09V9Y6S8LNP:=_S5B4
ML&P:<KW<HK'/17*WN[G(C%17.5$=\UB]K4=W?%$7RXX15]1CJRYF2.E*_>F8
MA@\D<4$T3.P4%>U$Y6(,).:A0ARO >]J>+C /+&%'JH+-D #P/(R2/GZ>I]-
M><XDJK&]Z/49[EB0AC5DB?*C5<Z%']K4<[NX\1'+Y)R]CE;PNN@-JN<J[6W:
M:O*S0BW O=@:=E#&'F%\E)#PE#'B5#R*W$9ULQGW6(&" ,JW@A?7T/V??\,#
M5<!X$4"\V?)+BEQRL!!%-4NP];:.9,=%%,E?6P11.(L;&(:?QG-'9X#%B5CR
M6-5KUF=3HZ;;9[,V^7]KVNC7K13M+9[WLDTUI>?LM6(#OV[=>!^Z#75@I C[
MH5RVL4DP/ 11R3.S<0%P"H7.&=B555R,$Y))^!\:I3,<W (JOL0Q<*$;'AC_
M !Y[66-B7>2/&69@)5K)&B1QQ#MEG>()&Q/!0C].DGD:V1(]U)U13GH?X.;#
M52#9X+*O+N$J(-RWIJQ=:UFZR*JHJ<Y'BB4 J)!W&=AG6>&NP<3S,6E*<0@/
MU4/(AG$8QG+$+R8^O'P #JWU%_V:J?\ QB'_ .<1Z\^G_D9?]!OZM9I_Y&;_
M )J3_L-K]/SY-C^MT&K_ /+$;MI^8?%/]*K^77)V#_W>GWC]L::YFQC_ !$?
M;(3_ -2/_P!?QU\=/RFI.[TO^_*?3A6QZ)^#G:G%_-?P(G/NUVP"3CYD ?CC
MU_'Y:[&M#UA+".OJ J-2%C8O6)$7O=/,UB)*Y'HUJ]G>KNQCDY:B(CE5R<ZZ
M=]X8L4ZH B1(>])D.9K*1XE=7X(>T)"XB0@@  G+9.K5\^\?/K@>F!GQ^)&/
M/Z/'KW%*J8V/F>)*\UKQV#P2.\0!\*Q31E.(5KHR$E\18)1TB<C45)&N7CM3
M7&9968*'"QD/S8#$H;DA0)X*<>/,,67.2",:Z4$M".-Y)*\DEI9(1#$[<J;P
MF.9;#3\6CG[HD,+P")@@Q('R.(U=O;2OM4D6SI)!*ZT;#+$ >1:P".#/A[)1
MY!VD03N'-GF6-1BXE&:(C7/<5#&KWMX&_3U0BP6TFF@9U:>&*M+*)(7+!Q)V
MG16B1>0EB82&3P.VS #7I7T=[?NSRR[AL\E.CN"0314KUK=*E5JEV)4DA:NE
MF*=XK<TG;]FM1F 5>#LUB-"S#:C!7DY..57X]BN(U+Y<9QRZM!)"2*_+K?(F
MN&L;6>S'8+'(F1UCW$E,(D&\>]<LHP' LIJ+\_R2K2=);6X;A8"W;M6!U19J
M-:G[\-=8'YE?8Y\HA0-QK*%>7+"/7Z.UZ<V^06*VR]/=.[8TFQ['NM^M)--3
MZAW+>N4-S<9;\"0+(=[H$33K.T7=W:0O#6*PFR&D6?75!B>.VV0Y!8;CVENH
M=993B6T_K=QAU=D1]B+2"00648S\?N*LA'EMMZ^>>5TWBAQ->"3X4>[M%6YN
M-ZK1J0[/! ))X4DA7MUMQEIQ12V7D>+G[7!.@$9@D5%X%9"!*.3<;K/>-EZ9
MV#=>H-[N=;7MQ:IM]Z>O>G:QN?2]+>[=JIMM>"M>6([/N%"<R6!?J33N)1-6
M0/6DX+AW@5/955N%D91Y>58[=U;)CQ*\DVJ"0:=Y$EFIU2Z)1<E;B/,-A<UL
M2*O,,;/ >"R6>/TC>;5>S5FV^.&/;[U2<QPR3I'8EY1K&L'9L\A+1.X@-'6G
M;P0S$R"5@A^7.B=JW+;-UI=1V;]CJ38-XV^*>Y6I6;&V51!8:R^XM=VPQFKO
MXZ941V]UH1CDI2.-8&J(\J9!V)-;D6;7N88\2??8S]D0=%'E&;DEG0XY/5M
M-7(:>,X"OJ<765R#!ALDBE6*.P#\$P5_:Q89&MBGM=;;+:14[WL,EKV/;$CB
M:ZMAI8?8[+0RRV+W%><K^\@8PR\XG&3KW*W+M>]]5;KU5L]BWO6QC?:^TIO?
M5=BU;BV&3;(:EP;UM,5ZG3V[8.[((:L2M%(R)<K-#;@?W#4L@9TC;*>4V:R%
MPH><$2.AQ\;))<@.LK 6?*";2@+*EFNLAL(S 1S[D0\@BF6N>I+XD<-(_0$L
M688Q$L3[FRRR&W;:HM6."&1*,<%M(PM:G$R2R1UGC1+(E54Y88:D$M>VR6[3
M6I;D/2T+TZT6S;/%O<N\6;ERO-U!-?VB::23=-YN1S5:]G<X;4UC;35F>4IF
M-C:C%1K"&U#RK&;RFR19*(.SJER.N#J+;#K :9:$H(H<DQ$KA1W609X,UI%:
MOLQ'S&0P267B(Z0[A) :S[==K6=OXVI(;(IV)+-7<H7 N13(5BQ8D8PR02K
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M*Z4V&R'$+C,JYK-JA^K(7,@9CXF(SSOJMY]VJM1VF])MY2=(;(C@1T:61Y)
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MJ>51WTKQYKE>3\UH@8W))[Q(5N7'$BA1XX#^:>(;)][)\:SX'''YWCX@>?\
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M\JG;VHGDG+514EK0EFB2*)A,LBQ]L!V#RA03E22W'!&< */S0",XERL?)/H
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M<[>7;'ID_ #X*/ _;J1<KYKS[_)=<S677&FFFFFFFFFFFFFFFFFFFFIK1?\
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M,VJ]V6O8GQQ6)K?YZ3=J-0JLB1R,40R.^&!L,; 8B8*.6>++D#YX/J"?Q'P
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M8^T?M_L']>-<?:K^25_#?_JG_<F[*?\ HE73)^1_9^_3 ^8_;^[3[5?R2O\
M; =4_P"Y-V?JETR?D?V?OTP/F/V_NT^U7\DK_; =4_[DW9^J73)^1_9^_3 ^
M8_;^[3[57R2Q$15Z@.J;S^""[LJJ>?'FGVI$X^G\6F?O_@9_C[=4T^U7\DK_
M &P'5/\ N3=GZI=,GY']G[]5P/F/V_NT^U7\DK_; =4_[DW9^J73)^1_9^_3
M ^8_;^[3[5?R2O\ ; =4_P"Y-V?JETR?D?V?OTP/F/V_NT^U7\DK_; =4_[D
MW9^J73)^1_9^_3 ^8_;^[3[5?R2O]L!U3_N3=GZI=,GY']G[],#YC]O[M/M5
M_)*_VP'5/^Y-V?JETR?D?V?OTP/F/V_NU+;';GY)D"R-\&]?5O:+(YS597B[
MEH^)&HB]\J';9!-['*JM;X;I'*J+RUK?G:KJFI3]AGR3K[Z/67^Y<[_J#III
M]AGR3K[Z/67^Y<[_ *@Z::?89\DZ^^CUE_N7._Z@Z::B@<:^2B5AHM@'NEUE
M(2',PB%'!YVYKGQKW-:J)@L?**ODO#VK]#D]^L<L8EC>-L\74J<8S@^#C/C.
M/3/C5DL:RQO&V0KJ5.,9P1@XR"/T@C[-?:9Z,#:CIAVLZ/=NI^CZ3-9]A=U/
M6MY,/+W!).(R<V//(A"92S&6(XI@<<T08ZPA2PM6!J*B*YKD<N.M72K$(H\\
M5Q@G&< !1G 4>@^6L=:NE6(11DE0<Y;&?S57X #T4?#7YX/RD'S],/U5?XC9
MO^39';U-;&L^L"^B;T>_51Z03/+C NFC;MV4RXO7P6^:Y9=6@.,8'@]65+)"
M(7E.5VTD0 4IKX2/4*D5#KZRC$/GKJHN"O.D'::R2ZT/0J]<O0YM=%OAN7C&
M!YYLTVR%I[C<S97.P-Q,:Q:S.):$$-E+8!*RXIX"3W,KH[:6J?1I93B5TMG&
M>:&-.TUJK$IRS8EFA<*C>5;^FFB0.147A?F3S1O7X^:)QY<\\*G.-I54X/+T
M]0CL/NRJD?$?M^6L;RHAPW+Y^$=A^E5(]/\ 9DZBOL;L5]S@?\YUO/YO6^=4
M[T?_ "_U4O\ <U8+$9]!+^JD_KXZY3&K'_?."3Z/]U*Q/YR]4[\9_P"$_&&4
M?UIJO?C^(D'_ -*4_P!2'1<:L?>C@>./>MI6?Z#-._'G'UGZF7'Z>&-._'\I
M#_\ 1E_J* _LUS]C5C](7^=:S_I6G?3.,2?JI,?M75/:$_HR_JI/[NN/L:LO
MI!_SI6_]+T[\?_Z3]3-_W>J]]/E)^JD_NZ?8U9)[U"_)9UO_ $M=#/&/A(?N
MAE_N:I[0A_FR_JI!_6NN?L:L?_D+_.E9_P!*T$\9_I_JI3^T(1^W06(C_3^[
MM2Y_0$)UQ]C5C[^X%.?@MG7*OY>"M#/&/4O^JE_N:KWX_P#EC[XI1_6FNCL>
ML$7A%"_#_NE7K_*A*IJO>3X!S_\ 3<?UJ-4]HC_Y?ZM_[NN/L?L./>'S\?\
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M%^/*>Y%]_GY?E7G506S@'E]_^W!U4%LX'K^&3^)]?W:@T\%'<*B?2O#47R_
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MB25K>U\KU8V)K6O65\D+8^Y96=VB=TI*_#OKW.914'O%S\>(7(*^N2<  -G
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M-@F:>H')(!EVF\Y)C\@L*]N-AC(!_-UE'M">5D64#^9*,,?NE7T/^DA!^8U
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MBJ>98D!U++*O>*49&V58H7/;^F0-EG5$5L<9$K7)^G1/?!)'*_U3:NH=OW2
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MB6DSQ3),Q_S?8OVZL\\5Q[D-RBDB6#'$D?*2&RR2*>& T?$PO"QXE%=&52K
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M0!A'_P"3DAL$J?AJVG"I[TXU"M;&FFFFFFFFFFFFOUY?0X_K6O0A_DV;;?\
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MDFE=%)\X;MOUFCU3MU(101U[L-J$V9(X_KK,0CD4RR1<Y$"0)*8H6XB1E4G
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MDK0[J35[FY[&V3SI;M1K/8>.(G/&'<8()(;"?FEUB< . 3AF';*6%\$%(Y?
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MKT+7%V20DR5H3'S1>TXDE'O("Z@1@2 (G(D#N16+4M<1S3-'#5MB +%97N/
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MJJ+PJ<:Y.^[8VS[QN>U\Q)[!=LU!(#D.D$C(CG& "R@,1XP?! (.KE9I$20
M^^BL,^@R <>/OTA<^:9K^)&-A5CH?#[D^>J-6->[M1%>Y%;VHG*\*U>?G:XY
M],>//P/R)\_'TQG]&K6\*0<'EG.?EY!\>?  Q\O&IA#5,L)_ A FFF19'20C
MQ2.G1L7+IY'MC3N1L+4<^:1>&QM:][U:B.XQ-+VQR9U"^[AF( R?0 G R2?
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MJ)26C%-G\6%?6(2YHY8/ 0!2&JUS7/[>K$$>2%)@EB->XPCDFP!W!&P0LA4
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M'(Y$5.%X76S7GFJRQV:\SP6('62&6-RDD<D9#(R.I#(RD A@1YQC&-7G&#D
MC!!!\@@C!!'Z=5+G<"75/49HL4<=B:8939"Z%J,85;!1P$#6;F-:C6S6@)'<
M0L:-;(6*1-VHZ146<]2,N][-M/5O;1;UJ>SM.^&)>"3;C42.:&\R !%EO590
MTW'BKSPRR!<NV,=8\'D@SE557B']&-LAD'DG",!@^F&'Q&-6HU!];FFFFFFF
MOUY?0X_K6O0A_DV;;?\ ,D.FFOSY?E(/Z\/U5_XC9S^A+;W336C3333337O
M]&JYO/'?PGFG*>7=[_P>>FFL@:J1HFWV(!QN<J7%]D%E)&]6L8^>#U"NAB1[
ME1JJV&"=41Z\-69W#N%34PWS-7Z/>G(%/%-RWG>MTG(7.6II6V^$,0.1,:]P
M@><=PD>#KC6%Y6IWP.4<4:Y4$GB%9PQ'KD,Y'@'(\><9UN[V?WMV_P!E>F/
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MBB+V))F"HD>,-R8^ /A\<9!^>NO<LU*=.S:OR0Q4H8B]F6<@1)$?!Y,<CR<
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MD4912IXDVDW+V8QS,-T<4I=\MQ;JP'@SF2LPK;T$RL.N]Q*86FKQ),JN:S'
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MS*0A9!BRE4:W9F$DL0[4)DDE")]5!W.,TG'O0CN*A9%C97),@58^97C!@[D
MBOGJ K"H3)+0KN'I&14BR*!&'!.AG?(;)*;CXU8PF2L,E\$>=4-8]S9AWQQY
M)=J[S)-*DWLT,6'G[MD?6&1QQ54C41VI)N(F5074=OCE&&<PH78HA,:\HV^-
MRSV)(GD0S.S1F)V>%N%CN.@>O[X1F5\$D,;69'O_ $>)6#O;5J>6/3LJ1F!
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MRP@BH*"TLK&S(]K>O3P,6O*E@+$'K^V:+;F*TLDFW*[1QND4\A6<1/9=1,X
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MJU'*O/'T>[7TC#Q "J  HQC&,!F)(& !@M@_'\/A]/0<,*% 4(,*, 8R<D>
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MS=[B7K(Z19%\P@K[K:O'<-T-CVZ[&UM);\DD3VXEX8-:20!20/<C1"5&,84
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MB!ZC!] ,>@/P]#KRA&G5RHC43M7GE.5Y;[T7R3A47CCW^[X+QPM0"2 !DDX
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M;BU?-E-MM=N;M @P58U$@A6"-F*DQ+ \KE\.5.'[D$]FMN%!X+?Y0E:(C_\
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M-V6TC<H454 /U050H$7)XB$DC"H5=@BL495 ;W>?*.8A>28M88F!HSW7D0Q
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MP\\.S4IR6=SBVNS/!'1V\SM/0]IOUZ=5PQEACGMRDR;G).SJX46%X11\7C5
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M)HTCFD00*59.V%CBD8Q&"!P9(I>*QQ]W*H_EFP2 / [5RI5MB2!(9R@KIW#
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M%:W,/:=NOUVH68W6$VK566.&,WYD)D=*2=R2.W'R0-$!*)5\++QOMG.WB*6
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M$6$8]K$ ;<%1QU;HS"0/66$2(C-FY+&C(K6&KS0J;2(7:&&955XQ'/(8I%=
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M-["QM%'%$QXHNDKJBV?J-M=TK#'<@*"K*?$[6ZN8:%Y R6Y^,9$8[)\>I*^
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M'$V]DEHUHZBO*@ :7;[*QK+#<"E8V8PSE&49]2K.D:K%+[C$DJQR%?)R03Y
M/X^GO#QX%MX9561&JOFKD:OFJ*U>4\G<^:?A1?-./=KSID&,C^W!'\8UN,I
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M<8.&4*'SZ@^H!QCQKVK:UL24H)K5>.G=FAC>U$K).(YRHYKW%PLH#<BK#U7
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MMY:WM;+QVM\DU]@;E0?9H.GNF"07Z3Z8V+I^R5XE?RA3J+-NF..%PFYV;<>
M6!X9#-DD_1W1VWR[?L&V031F.8P&>:,@!HYK<LMMXFQDEHGG,1)))*<O&=8L
M+;ETY\5A6D.')B16JY/GQ31O16RP$PN18YQIF*K)X)6OCE8O:YJIK:V/=]PV
M2Y'?VZ8PS*2KJ0'BGA88EKV(FS'-7F7*2Q."K#[0")FD:NI5UY C&"1]^0?@
M1XP?A\_&HKV?295/$322#5=_.]RE8W/,Z" F='*YQ%(>4Y@LL4W*=E5.0AT,
MG$8ZFQJB1S.SM>V=5<;730K[=O,[<;?2\LL=>.23'OV-CN66B@:*0D8VV:5;
M*-R6N9EP!<3+ I4JSQ*!B08)0>F'4$M@' +*,8SX4>##3QE5C9H#(91B87+&
M^"9CXY8WM5$>V2-Z(YCD\OFN1JISYHOEKS^Y3LTK4M2Y7FJV8&*3P3QM%+&X
M\8:-P&'SSY!R""0<ZQJ5E(*$$')&/0'U^'R^7Q\>-4V\E'2<]R^2IY>_\?/*
M\JOY_H]Z:MX''P'V?QXUL!?'P^1]!^S/]7QSJ9Q3N8U.WW+YI[T_#_M_MSC*
M@G/[A_']?[-8R 3Y;!^/C/D>/&/ZOZOA-CLBLK-P\MH:0=,$ )6"2DRK+)!7
M 1^"&(Q[OG) +#Q#!&JN2.)K(VJC&M:F%*T4081(L:O(\KA1C,CG+N0/&7;)
M;TR22<YUKPU((0ZP1I&LLLD\@1"H::9N4DA \<I&RS-ZEB6/DDFEB;,A))6M
M=PDJL;]*IV/;(US%XY:O+4YX]Z*J+SRNMI8E(4GX9P/GD%3GY^/N^S6ZD287
MQ^:3]GJ"/3X^#\3Z^?OF=::Q\?JU@I) C YXA(XB$':(4LDDP\[D2*19X82)
M9Y'C*K%G\5R>*Q>%3%+&0W*((K]Q6<E.1=<*KJ"6'%F15 ;!XE1X./.&6,Y+
MQ\$<R*TA*<BZ8".F21P)4* ^"5X^A&O AWAI(C%D5BJJ-Y^:Y&^?'=VKPB_'
MCGR5?-??J\#./3/Z1^'S_1Y^W.-7J,^H!]/(\Y.?.,CT^'V?#P1BF372RO\
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M;.2>68TI&UHLI:,($B1CF3NA.W;+0LWIJKK-,DU>.UB6E**ZR=M%CF@2Q56
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M$EA9G='>=YYF9I 5+%I,PZJ@%R*/+,8Q^[;C5>;;O%%KJ<01:>!E'73"R#5
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M?$U%[G-<B\M<W]4BI\4^*+^'R^GR^.(H#Z8(^(/D>/AK"5!_F@@_#U)'V@?
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MCPIRWO+K@]1]8#:Z0;;JJ;QNTCQPIL]5I;4ZV %DL1V&HK/V.W"3('= K<"
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M>Y8^WV2%YH!BF[+I,(O,6)-P4XD"T$S&LQ;+;S*]L"[20(U^-CY]1TDMGX"
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MYCUPLS//:'=/9O L*P7&:J@M *_'"JNRW,:*219=E:MZICHLYM6=P5R) YL
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MHP!MJ;^CS4/&0\5QLS)K&WS4FJM)'X_4D#ANKZTM\!'KMM- (V-C5EGBH8I
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MG ]/3)]!PH=NZT@BB@BW#;NW%&L: @95%4*HR:9)P%'DDGXDDZJ7[6GR@?\
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M_!^[XZTQ[=;A;0=3VZNT6.[)Y%M/METV=+&:Y19;.4 62XE79SOCN_78MFF
M 2X'A<%FV[QW9[%1LJR8J.P+"9:;CW#AB :V'&:]ME:[)4QJ>?,NXPPQE50_
M:,@D_P#5P./KG6J.+D",JJ(<KCPS./L/G'W^OQ]-6TV-ML?-V"]$M@N,V%?)
MO%BW4/.F:X^,5 _+J&RQ#;K?8'J/FR$%DCK2M1EY86 N336$43)SKD",ASY;
M(3Q#?GSDD\"@XD^A8 !<9QGXD8^\#QDA@+$H_.[GO<?EDDYQ]XQY_$^<WJ]+
M#<=2\/3_ +GU5!@NT)O3Y,S:%V19G:Y[E 6Z(1B[O82\B*IPD;#2\=-'98MK
M(89RLL$?(*09,^%D@\,<]L 0L,L0_G QX]/B?EC/V_VK!D"G"H8_!)+$,"K!
MA@>A\CR,^GQUM_'_ +A%]/AL1?R-1/YD36#6UKVTTTTTTTTTTTTTTTTTTTTT
MTTTTTTTTTTTTTTTTTTTTTTTU;[='"9MP\(NL1ALF54ELT-$/D&4MHZ"GBFJJ
MCMF'63O0=8^/&;QWH[SX5%JI*L&'P.?/Q^S5KKS5ESC(QG5A0]A-X:X,8$+?
MZX&#"'A%$&@K3F10##QMB@AB8EVB,CBC:UC&IY-8U$U>7!.> \_#X?U:Q"*0
M  2GQ]__ *'\1J!VG)SRCWRR?;_*\[N,P$I\40Z.4R2>,5Y14E"3'*P24@E8
MY(83I1^[QG=R*]?)'JB'*D JO'S@CU\XSG./3[/TZ(6$O!F+>YG'X^OR\_L^
M7KK,?O;]/\B_ZM8]9]%>U/C_ "+IIKM[]---------------------------
M--------------------------------------=>U.>43A?I3W^?X^=--<\+
M]*_R?ZM--=7M56JB>;E1$\^$5$5?/S3CCRYTTU\P?I&_1 ](6P_2OO\ =1&#
MP[F,W#QD4/)*U]QFL5C1^T+W-*4(])ZU*6!TPZP6Y?@Q>LM6-_A.5ZHQ>?;N
MB_I#Z@W3?=HV>XU'V*7-=RM4)+VX:SLAY]P^<HN3QR3\!D'7F_4'2VV4-LN7
MJYM"="C(#('3E+,H;*A%.,.<888^WXUOTL^G)Z)MGNFCI\VGRR+=[[*=LMD]
MK<!R1U5@E:96+?8AA%)C]O[.*DR@:0H'U^O(]5)=! Z>#LE=%&KNQ-+>_HNZ
MGO;SNEVN-N[%K<+=B O<".T,LSM'R0H65N+#W!RP1CSZZV=NZPVJI1J5I%ML
M]>M%%(4@4KS10&(]\$^?.3Y\Y/PU?O[H1Z!O_B>]O\'59_7'7,_W).KOZ.V_
M]-/_ '.MS_#K9?Z%W_HX_P"\U<S9KTV_1COKNI@6SV#,W;^RW<;):[%<>=<8
M*!7U*6MI+X(OKYT>3F/%'[O[I,T:96-3E(W>>M+<OHSZGVJA:W*VE$5J<33S
M&*VLC!$&6XJ$&6QY"Y&<'SX\[%7K#:;=F"K$MH2V95ACY0J%YOGCD]PX&1@^
M#@D9'D:V_1JKF(JKRJ\_SK_-[M>?:E>N^FFFFFFFFFFFFFFFFFFFFFFFFFFF
MFFFFFFFFFFFFFFFFFFFFFFFFFFM0G7MU4=-#,FK]KKO<7>C -U=@,JQG=-=\
M=GMHL@W-Q3INR.SHK>HK#MWK."CML1$Q_(\-R>[ R3&;OO\ 6L7N9")WULRA
M%Q[$4<F.6 48>\I."X!!\?/! (\?(_#.M::2//$L0R^0P]%/VG/CUP?[?(U7
M729T,9#MS;[9[A[D=3MAU"T>W,&?9)L904V"XYM]M_CUCO2=<WN59_)%36>0
MV&8Y!;5V57-;0V!]RE7245V?!65W<4TF.UY<@A4X$X#DLS$\?0><> <>,_/S
MG58XL%69PX )10H !/DOX]6\_G8S\<C.-;0$3A$3Z$1/]O?_ #ZPCT&-;&ND
MT,)$4D!$4<\$S'Q30S1MEBECD:K'QR1O1S'L>U5:]CD5KFJJ*BHJIIIJR&.=
M+_31AU[791B/3OL9BV2TY/KE1D6.;28#1WM49V/C];K;>LQ\6P!)[))&>.*1
M%+VR/;W\.<BWF1R.)=R/D6./T9QJP1H#D(@/S"C/Z<9U5M-L_M/CN;7FY6/[
M9;?46X>31.@R/.J?#<=K<QOX7NB?)%=9,'70W5G'(^ =\C##9FR.''<]'+!'
MVVEF(P68@>@+$@?<,X_9_6=7!5!R% /S &?TZP]]*5_W"V]J?!"-J.$^"?\
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MU1?Q0NI+ZM-.R_\ 2B_6?^73OI\I/U3_ -W3]$RZ=/V*=47\4+J2^K33LO\
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MK%^&?W?^H\F@LQMG D./7ZJ3^[J=?HF73I^Q3JB_BA=27U::IV7^<0^^0?V
MZKWT^4GZJ3^[I^B9=.G[%.J+^*%U)?5IIV7_ *47ZS_RZ=]/E)^J?^[KRG])
MQTWC0RD3XQU.P001OFGFFZ1NI"**&*-JODEED?MJC&1QL:YSWO5&M:BN<J(B
MKH()#_0/W.#^[3OH/A)^JD_NZEM!Z5'I9RJFK<CQFLZC<AQZY$B/J+RDZ4NH
MBUJ;,&=.Z ROL0=N)PS!9F_.BG'FDBD;\YCW)PNJF!P<$H#]K@?O/[/OQJ@L
M(0"!)@^A[4GG_JZF_P"B9=.G[%.J+^*%U)?5IJG9?^E%^L_\NJ]]/E)^J?\
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ME_\ O0^I)/\ T:?[?CT$,F?6,_=(#^[3OI\I/U3_ -W4DQSTJ_2GE].)D.*
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M&BX))PI)'(C )/J/ Q\ /.KG]5V#;6[K[)Y%M7NON$#MQBN>G8L&[(B+['Z
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M Q(\S$DAG'GB<Z*:&:-S9(I8W.8]CD<USFJBK35WKJ&LK>JIH8B;>R JQYC
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MCYX./'VZIR&<9&?EGS^C^/V:QU*IMA7=4M=U 2;S8K%N#4[1VO3ZF&KF>'L
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M$Q"7/L,OL/BRO+,(6^%C"ER;!K$:GRRN%4F&0QM+;E 6*511HC)J]UD*,VS
MA*E*J2Z^SB$/&P X.<9QK,PR",XS\1ZZTS;0;L6W3/Z.W$Z+;>CSXJSR/J*Z
MBMH,?RG&L#SW>0W:^DDZA]Y(SMR\CI,6J<JRG('XIC]03)51F"&_9#F4U%7W
M)4 1]C8#;+J))B250!4R"0.3% 0,GQY/K^G/SU58I" I+$M(,@$X"ELDX]"
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M)!.#GY?+[_49U1,.45E P'Y+C*EEP"?ZB#\L?<,U_1V.>/T_7./AO5V(X5U
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M3T^Z-&7U OE"KH'6S*/'8,JAFQLS,JUVZ)UX2[((!S@/7[_==F .0)5# CP
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MSF*=*U..'JY$1-8&P&;'](C\,G']>LZ?FK_HC^H:UL5NT^U.X6_> [==+>"
M"5/3EU'7&\_43U0E0-+NR-R)BLD/RC93'\Z(8[(=P,VRVQR1:_=!\E@1CF%8
M6+'C1Y!%Y)74]?F#<48R'RZ!47YG PV/EC./CYS@ZPX!<*@!"-EV.<YR<KYQ
MX^/Q!^'QS$U.U&V.X'4%MW@'3%@@0-)TU=0E[O#U!]4143"L@/W%L'9)8Y%L
MACV<%1OR'</*,L.RE:[=.::P(QK",)#@Q @B:[;6T]53)"%G..:D*@\CUQR
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MV]7O4WM:#A,$.5CQWV,;+;8UJ7=(#NEEUK91E-VSPFAM[JSO @,<0;)=Q,V
M@'HPRSPB+2HNC+ !BW&-&!('JQ)],9]X? CT /VZLEXY*@%I),XSY5 %QR/K
MQ48/KZM\/GBOGNS^Z^2;I=8E 7CNP6[55L#TY[%;<$7?4@'EF09%E^WH>R\^
M3Y3582_'[:G3:VQSC*XLIN+G=?UF]+9D(5,R.A+^QM"AKPR<(_+ N[> , $M
M@$_' S\,_/&?3'Q?+Y ]Q1DG)! 7/N?:<?AZ9&=3W%@]LNHJAZY\_P!R\/BG
MHZGHMZ;K#:2#<1&Y!D^VFUF2=-MYNB*=59%<M(M KV#<(B[.MLL$*BMC<DQ(
M,LDQQ=*(Z&ARIC7P<R,K<?"M[^//GT(\?+XCYZJN'YL0/$:\ <\U!7(S\/)\
M_?K<1T^6V17VP&RE[ESYI<LN]I=M[?)I">?6'Y!98?2F7+YTX1WC.L9B72HJ
M)^F*[E$]R8'_ #F_TC_6=;*?F+_HK_4-:S<WV?VQW2WQJ]F^FO!0'Y+MOU18
MYU(=3?4_8Q>O6>"94!EHN?'[68UG4[)+O(]R<OK'C8@1BP)LF.;<[7E>R[SP
M%DIZ.;*&*KRD) XXC7 P<>,GY8]>7J?MUA90[<4&2&^L;)RI/H!\S\A\@/OU
M4V:=,VP&\W7908?2;$;,4F-=/U-1=1F\F4T^V>'5^69YO-GM_D#=I,8M\D"I
MH+B>OJ/L=R3=++8Y#'NO+9^$MLE)#E.AF*[I&6#'ZS*C))'$9!(!\>OC]&J&
M)&E&$4!,LQP 2S>GPSX'G5AW8QC\G35DF_!%#3+U(#^DUB2/.7UXCL\%R$7K
MPK=FP<4CO/#6WCJ4V8D;@S*/UA*]F&E3#(,@;E>W(/S^/@*(2<? Y7.?/J<^
M?P.K0?<Y?SN_C)]< ^!\,8'XYUOF8JKSS\/_ '_[?DUJ:V]=]-----------
M---------47N)MWAFZ^%Y#MYN%0C9-AF5 ^S<@HC)2H1K('QX2?5YI0IQBF-
M\<>&3NAGB?RQ$[N%<BU#%2"/!'X^O@_L/G[-6LH92I]#_8<C]HU0&[O3;LUO
MH^@FW,Q&2Y.Q<>V!H;>JR3*\-OZ^KOX18+ZC;D6$WF.7D^.WT0(3+S'"K">C
MN$#$6RKR5&@6.JLRC ) SG^/X^_5&16QD9Q@#Y@#[?X]=23.NDKI[W%I,(QW
M)-N 8ZO;>BEQ7!8\6M\EP$O&L2(!$K3,/K[; KG&K5,0L *\ 6SQ28Z7'K2$
M$-EA6$^KPJP'<9PQ\^?Q^?\ Z8\>-.VAQE0<#B/!]/E]WZ?O]=7TQS'*+$*"
MEQ;&*D"AQS'*JOHJ"CJAH@JNGIJH2$&MJZX(=L8X@0(<$(PH\+&1PPQ,C8B-
M:B:H22<GR3JX  8 P!\!J1[@[<X9NIC)&&[@40V2XN79XW<DTQDI4(TUGB&2
MU.88V8YX4XQ"2562T51;0M29(Y)P8F3LE@=+%(!(.0<$?'0@,,'R-=<NVXPO
M.C,(L<MHA[HW;C,!\^PD@B0J-^/Y@)2WN.CW@J"S0-E)BI<EO &QEM(%6*PE
M<Z!960R1@2,X.,@@_<="H;&1G!##["/0ZM7FW29T^[B9_%N?F&W8EOF238V2
M>5[<RBOI<C*PTI#<1*S3$*J[!Q#.BL8+;'/CY.945[/3R0P+7O'0>!(ZAV"\
M03Q\^/O]?T_+5I1"W(J,_P!OSQ\]9%-8UON1.?IX1%_D35NK]49;[=89>YKB
M>XMI1#%YK@U7D]+BE^^0EI5-5YDE.F3B#11SL%>RW2@ITG>0/-)&@,?J[X>^
M7Q*\B 5SX)!(^9'IJG$$AL>0" ?D#ZZQGIO1_=).-Y<W.:+:HJKR=,R(W!4\
M'<+=&$63,3+M^1F7I-.W-DI2B3+M[[$V(BNE$,F>]I(\D3W1K>9I2.//Q]R^
MGRSC/\?<1C[,><\2#G/AF'G[@V-7(K^EG86LW:EWP"VXK8-RI;<[(DNDL+Y]
M8/D]K4)C]MF .)2VK\-K\TMJ/NJ+7,0,>&RFRK7RA'6\\$LK'V\VQQY''IC[
M/EJ[@O+ECS^S[\>F?M'K\=9"ZMU?JVL6SVVD9VYMB[#Z@DG>:(.#=%IT3[ 3
M-A@,<;B(PEW7'R$@3AMQIJ4\HC!HQB0U<PJ*9SWN=7D? S^;G'V9]?\ TU3B
M/)Q^=C/VX]/_ %U;W;3I+Z?=HIK@C!MO!0Y[W&DPHV:_O,HSB2#"$>^3[!J9
M^<W>2+CN#][^Y,-Q]:S&45D7^Y2I!"D=2['&6)P<C[#JT1H"3Q'GP?NP!C]F
MH[:#I>V,V&L+.UVKP=F.65K55^/RG%Y!E.4%@XS4SSE56)8_/EUY?28OAU82
M3-/7XAC2U.-!RN:\>KC6./M,[/ZG/G)\#)_$?VY^S&BQJA)48SXU?QS4<BM7
ME$7CW?@7G5NK]49@>W6&;88\N*X'1CX[CZW&29![-%E*GA2YR_(;3*\D/1YL
MY,WBVV0W-G9SM\7PF3%R,'9# V.)E22QR3D_NU15"C \ :H:WZ<-E+["\[V]
MM\!JC\/W+R^PW S2FFGLD9;YQ96=?=$97$9&:RQJ;V*XJ:RUKK*E,KB:BR $
M-J9 B8(I6UY-D')R!@'XX^7[=4**01CP3DCR//S\:GFU&R^VVR%'88[MICKJ
M&ON+DK(KP@RYOLFOLAR R 40F\R3*LKM+O*,CMI P 06GWEP>5$"$&#%+&(*
M/#&9F8Y8Y(&/AZ?AHJ*@PHP"23]I.JRRS%J#.<6R3"LKK8;G%\NHK;&<CJ"'
MS1P6E%>@3UEM73R#R0D,A- *G&D?!-%,UDKG12QO1KTM!P<CU'D:N(R"#Z'P
M=6FW!Z9=E-T*;"*/,<.>0-ML.X/ ;"BR3+,,R?$ I:L>E* H,RPN]Q_+JX"R
MJ@Q*^X!@NVB7(@H\-K 8V&/MN#NI)#?G>O@'SY^8^W5I12 "H/$8'KZ>/M^S
M[_7SJ59#TD]/62X1@VW)FVX%7B6V4A,VWHN'W&28#;8;,>.0):/QW*<'N<>R
MFK]MC%EQ9"@UTQ,@0F=;I#EED5P.P)(/D^IP//W^-4,:$ $>G@>3XU>/!L'Q
M/;7$,?P/!:"MQ?$,6K8:F@H*F#U<"M @[E9#"Q5?(][WO?.21/)*265+,45-
M,3-+*^A))R3DGXZN "@ # 'H-0^;[>X=N17U%5FU&/?U]%E6+9O4C$RDQ,"R
MK"KL/(\6N8W"3CO<13W=>'8#QRN>-)- QI$,T2OC<!(SCX@J?'J#ZCS\]"H.
M,C.#D?81_'W:M5NGTI;!;U7T>3;E;?"Y!=K50X]9&#W>38\S*,9'(E,@Q;.0
M\8NJ8'/L5A)(*FBQC-AK^AC>68YE<WULGQ;E=E_-)'KX^_QJUHU?\X9_@?N_
MJ^0UX[D=)/3SNYD%9D^?[;@75O64M;C*O'MLBH*ZZQ:GL)+6HQ/,*/'+BHH\
MZQ.KL9B#*[&,TKKZA#G*+</7L0LE):!W48#'&2?T_P ?OT,:,<E0? 'Z/3[<
M^?G_ %#614,,<$;(86-CBC:C(XV-1C&,:B(UC&-1&M8UJ(UK6HB(B(B)JW5_
MIJB[C;?"K_-\/W'MJ$8S-L KLIJ</R"24II5'79M'4194(-%'.P26.YCHJEI
M"E#D/C]2C49T/=+WU#$ J#X;&1\\9Q^C)_3JTJ"P8C)'IZ_O_P!OVC7:@V]P
MS%,DSG,:&D&K<DW(M*>ZSFWCD)>1D-GC^.5F(TQ1:3S20Q>S\>IZVM'B#C''
M2,=9G1.*G(GE$D@ GP/3[-5  R0/)\G[=6I@Z3.GP;=-V\XVW(,6?OR,G-/7
MF7&3?8^F;&5SZ@K.F8(MVN!1YV15R2@39O'C+,JD&DDC?;N21_->;8XY./E]
MWP^>/LU;P3/+B,^OXYSG'IK(M$1$1$^"(GYD^.K=7ZH0?;3!0LJS7-H,<!;E
M&X]1CE!F]I*DQ*Y)38E%=CX[66 I$DP*C5L&1W<3&0BQ+/'83-+4A$C1E2Q(
M49\+GB/EDY/[=6\1DG'EA@GS]WIG^K&K2;;=(O3QM#D:95@&W0=-=04I^-54
MMA?97DH6*8Q:S03V>,8)3Y3>W5+@.-'2##-*Q[":_'Z8B(8:"0%T$$,;+B[D
M8+$^<G[2/F?4_P"P?(:H(T!R% ]1]V?!P/0?>//D_,ZFNTW2WL3LA>'Y)M=@
MS,:LSZA^.Q/7(LLNP:+&Y+*.VEQ?#:?(KVWI\$Q:2R@&-DQK"P*"D>0&%(X!
M5"$\&C.S !CG'IX'[M55%3/$8SZ^3_:=7_>C53YR\(G"\_%//_3[M6ZNU8VR
MZ;]C[C;2XV?L, J2=N+W);S,S\<6>T8QN79%F1^X5ID]=:Q'QW=-D#LVLC,G
M!MZ>R /IK>5A-,0 X<=(:AF!#9.1^S^S5G!.)7B.)\D8\'/\>?\ ;J7@]*FP
M(&U^1[.1[=@%8!F%JN09776]KD-[<Y)DJ3UQ4.57N975N?FMIEP9%-33UV6&
MY%-D59-3U,E=9BNK 5@KS;(;D<CT/RT"*%XX\'U^W[<^NJSVHV7VUV1H["@V
MTQQ:$*XMR<@O2S+>^R7(,COBX1AI[K)<JRNTN\IR.U<(&&"P^\N+ F$ ,,"&
M6,,4>&.C,6.6.=7!0HP  /LU1>]'2IL!U"W.,9!O%MR#FEUA@=O7XO9D6^1U
M)=*'?/#DN1PY:&YJ7-99/K@5+5_>Z9!(&N<K8VM2Y9'0$*Y4'U "^OX@G^/O
MU:\:/@NH;'@9U*2NCCIP-P+%]M)=MXXL2PF[L\CPZ$/)\SK\@Q>ZNFF1W)U#
MFH&1#YK5/MH#S!;*(+(81S0B) 28I0U2!'<?);D>1\$^,_+X#Y?+^O0QKQ"X
MP!Z?9YS_ !^C4SR'I0Z?<GP7!]MK';2G%P_;+N7;L''C+K$++"7RAS@&28QD
MN)6=)DU,^U#**&NY ;>&2\A**CMW&H3/XE [ABP."1@GQY_9X^7C3MI@+Q&!
MZ#]NKP83A.)[<8G08+@N/U>+8AB]=!4X_C],*P.MJJ\=%2(86!B<-;RYTDDC
MU?-/,^2>>26:221U"23DG)/Q.K@ !@# UCEN-T,]+FZV?WNZ>=;9SV^?Y,+3
M@WV1@YUN-CI=H'0"*#3#$CXUE]. L%:*KXQHV"L8Q99Y.%FGF?)<)9%'%6P/
ME@'U.3_;_P"G@XVAC<Y93GYAF7_LD?QGYG5Y[?9W;C(,4PO";O&8K/&MOK?"
MK[$*X\ZT(=37.W109N&V33I#W6)A=(6 )/#+8EF.)EB[C_6E?)WVAB"2#Y.0
M?AX/W:N**5"X. 01DDD$>GDY]-4+NGTH; [TY(-ENY>WX^1WT-2+CYI++W*:
M,3),<!L)K4'&LYJ,=O*BHW!QD*Q*++$QS. <@I!I3CU@!C0XM)JAV48!('[_
M )?+[QHR*QR1Y\?L^'W:R!:-#'$R"-B,C8QL;&QM1C61L1&M8U&HB,:C41K4
M:B=J>2<<)JW5^L.L/]'YTE8!D]=F&&[5S4%]4Y*[,0"0MPMT?4X<FDM77<]K
M)32YK)2E2E6KY#BXBJ^48N>21Q,$R2/:[(99&'$N2/3'X8_J\?=K%V8@>049
M!)SYS^P^?AZY]-=L-]'[TE;?9+5Y?ANUA%#?TN2/RZM)#W$W2<%#D<UK)>$V
MLM,3FL]*5,7<3D6)L1E>0.:3/-(5%,LLG<,LA&"Q(QC'PP/ACTT$,8)/'R3D
MGDQ\_BQ^ &J^JNDWI_I-T7;R5NW((^?>WKG*QCUNLE)HJS+LB%F"R#,:7!RK
MB;!:',;X0DL>ZRVDQL#(K1AIR'6<ZFEK-;S8CCR.,8Q]GRU<$4-R ][Y_?Z_
MB?CJ]N68O19OB^189E *6F-991VN-Y!6.G*%;8TEV%/6V@+R09Q3(&%@DSCO
ME%)@(8V1712QO1KDMR1Y4X(]#X_M!'[#JX@$$'T/\?#&L:]KNAOI=V9NJ^_V
MWVR?CI]34G4 $,N;[B7M-!2V%;)3EUB8YD>6V^.R!2UDT@;!Y:N2."%>T=(E
M:U6WO++(??8G&/D//X 9^\_HUC2&-/*J <8]2?'XD_C\]5'MATC=/6S-Y]DF
MV^W(=%;0TYN.5,AEYE.2!XKC5G/ 398S@M3D]Y<U. 8W83BB2&X_A0-!3%^J
M"M("E:- V.C.S>&8D:N6-5] /CY^_P">HO:SI3V#V5R0W+MM-OQL;OBZDK'Q
MREN\FNAL>QPZRBN#<9PJJR&ZMJC L7+M!Q3RL:PH"@HIR@PY9:]RB#>$9V88
M9B1X_9Z:+&BDE1@^?G\?7&JSWBV5VTW]PBPVVW<QB',<&M3*BPL,?(L+BKA)
M.H+,6ZIR'ET=A66#75]J$'80)&6UB$C0R.:Y8V\%=E(920<?9^@@YU5T5P58
M9!^'D?U8.J7V:Z9-E-@#+T_:C%#\;*R08$2YD,S+.LI:6/6R$2A1LCS#);^(
M189"R'+("P:29).V9TC6,1M6D=_SFS\?0>OSR!G]N/LU:D:1YX C/K[S'_M$
MZGMEL)M#<T.Z>,6V"T]E0;V7<^1[I51WK10F7WI%#C^,OM#F3$/48R.EQ7'1
M1I:QP+@I:<,X/P+"-2G4Y-X\_F^!]FKN*^1CP<9'P\>===I-AMK-C0KL+;/&
MYJ9V364%ODMK:Y#DV8Y+D)X8,-8#->9;FESD.46S:VN'@ JX#[<@:K!C:)7P
MC0<LT9F;'(DX],_#.JA0N<#&<9_#TU2F]?2;L!U$7>)Y)O#@7V6WV"B70&(V
ML>3YCC9M$)D3@77D 4^*9#1.1MI[, :6Z17OEC%AB5WAM[=%=DSQ8C.0<?'.
MK'B1R"R@E<@'SZ'^,_'4E,Z,.G _"\1P"; #H<?P*UN;O"R@<]W'J\PQ>QR/
MQ4R"2EW#K<N%S\&"[CGE'M@1LGC .$2,(D642*&%E0[@D\CD^I\'^O3M)Q5<
M>%SQ]?&?7X_Q\]3K(>DWI^R;!,)VU.V[#KL0VW(D+P$7%+G)<'N,0)(%*!L)
MZ#+,+NJ#+:Z>Y$..@OYA[QLF0,,+]N.L%(E5[FX);D<GU/C^KT_9JIC4@*1X
M'I\/)^/C5W,"P+#]K\/H, P#'JS%,.Q8!E908_40+ !7!,>^3PXVN<^226::
M24DHF>24DPN:<LJ:8F>65]I))R3DGXZN  & , ?#6.^X_0STO;L[@WVZ>=[:
M26^?Y.)3 7^2!YSN/CA5H%CP?L^C%)@QC+J<!T-:(LD8K&",;&Z8B54=,5/)
M+>)I54*K$#/H H_'R//^W6-H8V8L5]XC!.6SC[/> ]#\OZM3K-NC;INW$=02
M9?MO%:28[B55M^/+!DV9U$MS@E*KEK,*S>6ER*NDW%Q(9TDTKL<SY^2TY$Q)
MDQ(<TIA3IK0[#.#ZYSZ'.?7UU<8T/J,^@'V8],:C]RNDGIZW>MZF\W!VW NK
M"GH@<5C06WR/'JVVQ*L-=8UN'Y938S<4U-F^'UYSYB@L3S$"]QT28DMX];'Z
MV2DP.P\!B-&C5B"0/'CXCQ^!&LB(H(H86#Q,;'#&QK(XV-:UD;&(C6,8UJ-:
MUC&M1K6M1$:U$1.$1-6^OKJ_T]-8<@^C^Z2:G,2L^K-JB0,J.S0O<0VQ W"W
M0$A,S0^Z7(CK\NI@S6.F(*-N5<<7%+7O$)>JQ3C/@58ER=V7B%YGB!@# P!\
MO3/RSY^'C&L79CY%\'DQR3S?R3]G+ _ :R5H=N,+QG*LXS>BHAZ_*MR2J$W.
M+J.4F0K(2,7I(<<H'EMGGEAB;5TL$0(\0D0\78CY)&/GEEE?CR? )],_M_;^
MW60* 20/+>OKYQJU<G29T^2[IIO/)MT([<#[(HLR<;[;R=,>DS6&M]CPYQ-@
M;;I,"FSB&L1!(<REQE^3Q1HU8[5KVM<EW-@O'D>.,8^S.?7UU;VUY!L#(R?Q
M^?\ 7K(O5NK]------------------------------------------------
M------------------------------------------------------%\D5?H
MTTUK9Z_LCW5S6SV0Z3-@MQ+W:_=;?&^RG++G.\7.]0O<(VHVDQPB]O+EID+9
MI@(K_.[';W#(Y%A=&?!=6@7<J)*B9H@HY.ZY4#'IGRW@>,CR/4?:/Q&"9F)1
M(VXLV6R,>%7SDY^!P1J9X+UU4(71;@W41N#3WEKGDA6/[09/MCB(8968V_4L
MS)H=KKG:VAK"S QH+D_<J L0-EB8(,'4R-LS)HQ8GR:&(]TH, 8+!B3@+@$'
MY^0?'C/S^>@F B#G).2N,>2P)'D9\>F2,G'GXZB,$Z\7D[P7NR6^&QN>=/.6
MXKL3E'4/DEKF&0X7E&%#[=XQ>5-,185>4X?:6(ULK?:);[./P BJ<BE.%)%?
M'/6F&C#[H=71U+!/&0P8Y]01@>GKG[LZJ)AR*NI0A2_GTX  D^N?&?/@?9J"
MQ?T@"V!VU-_G73]NCMALKOSDV-XCM)N_D5Q@9X]C<YNG.WWV=X11Y$=EFW%?
MGRN'@QLVV&.[#;&K"R**@(,1L=#%@'#*Q R5&<C'KZ@?A\]!-Y7*$!B K9'G
M.<' /H<?I\>=7@ZTMP:;;39RORB]L]RJD";=G8_'6%[4Y!78UE;CLJW8Q/'Z
MX2>RM SQ78P898PBYA7MA0JTQJ6TK@YAR28IX[8T+M@8\ GS]@^S_9]^KI&"
M+DY\D#QZYS_LUC?N+Z2V' KOJ0AK>FW=_-\*Z1\U#QS?;<"@L\$$I\<QTG&,
M=R>7)\?KKS(*VVRXJOK[R4FQQNK':575U5-8GFBM.JH#<@@R(R70&09 .<_C
M@:QF<@N C$1D<CXP0<^GG]).!^W&PW)[V(S;;(LEHC'I$1A5I<T]A"KHI.R6
MCG/KS('>3XW]KX9XW>3F.[5X14XUB PP!^#8/Z?.LQ/N%A_1)'Z,C6FSI,Z9
MMY-Z>BK93?JFZX>L"AWUSO:&HSD0^WW5"R_;IN:%U\Q8L%S@.38O9@V>+S'Q
MPQ6%4\MA$@2RQQ&QO7E<\CJLC)VX^*MQSP'+ \9S\2/PSC&M6.-FB5^[(&*E
ML9!49\X QD8^P^/3TUD-LYU[[A;A=/?3%EF/=/>>[P[T[V8/?V^0T."^R,5V
MXQ:UVZLW8MGMIDNXV96 N.XO76&2BD?8E1^/<7]G#.D< <D(9!C;6A"R.#(J
MH.)#-\0PR,*/>^.#\L?CK(LS%$/ ESG(QX!&?!)Q@D8/I]^,C594'I#<7-Q?
M';[*-K<[P8^/J@I^DW=BCN#\6L7;0;C9"..N/6UQ=45I8TE_A5V=:XS7 WU0
M8CEER6M=.'"Y)X6V]AN1 8'$9D R?>'KX!'YWKX.!CT.-7+,I&2K##B,_F^"
M?CX8^/TG[-3C>GK^P/9G(=XL=+P[*LIFV@/V.PXLRE,QL&OOMV.H&Q,%PG;:
M"ROK.JJ:0JOJDILERW(;^QKZ>BH\AJYN2BY$$4D1?A[P4/R(\,?" \B<#]&#
M]^/C5YE0-X)X<0<8 RQP!D_I)^ QZYU>?87??,-UK7-,8W V*W#V5RK"HJ$V
M3V_/2Y9@.65&3#E$UMC@>YN*3E8QDTP?J) V14[7!W% 2X3UL-XIPA4MKH$Q
MQ=7!^(#*1X^*N%/W8R/MU<C%L@J5(Q\58'/G(*D_CD @^,:R73S1%^G5FK]-
M------------------------------------------------------------
M------------------------------------------------------------
M------------------------------------------------------------
M-----<.]R\?0O\VFFM8EET)TW4#U8;Y[Y]5&'5>4XD+0X!M9TX8Y!EE^/+1X
M10 FW^<9-9_8Q:4ZAV69YS>E1LK2)B'P5-!72SHDTK6LS"7@BK&2""2['&2<
M8 _]?L^/I@,(=G,@!!P%'_)'[S@_?]VL0=Z^D1_2Q7;LLPK)<"VIZ?UZB^EW
MJ@Z<Y\_R/(),,QKJ7Q[*0\=RS;+.#$&R"]H<'W32NHI69V4XD"@M+PB<Y[7B
MQI/D20/QR"6XNCD>3Q/\[[QX!_\ 7&)X0F2"%C#K*,^G-<Y4Y/@-DG)\ C!&
M/6,AK=T>K_KFW+P/=JIV\V_J[OT<VYVU1U'M7N/'O ?@3-T-Q<<&"NLPRD7'
M\:IX+K)5%LK+&<8AB=(M#CGM HA'V$L8],K%$&7+'N!@"I7)48.!D$@?/]&<
M>+2IEF(8* 87C)4AL!B"2?AY/S]=1FS_ $$9U1'; 85<]%W2UAUGM'E6#6.X
M_4A-E$^<#Y[4;>20306^VFW<8=7?T&?Y:;7UUJX_+9@ZS"3G&3AKD;HA625:
M;\\B1R'! 494#./7SYQ]GZ?G<L3'M@Q1CBP)8D/GCC! ^!8>?/ID>GPV-]<6
MRV<;\[(5V!;?#5Y-^-O#L+FLL=I815HR4>WV\&'YGDDB$R->QQ,5'2G2"#(B
M.*);$.QS72(J88G",2?Z##TSY(P/V_H_1K/,I90!_24_@#Y_9G\<:Q?RSI$W
MFN-H_2KX:&!C[KKJXR[,+K9YC[V&,<P&YV*P+ 079 0L*MHI%R&@LHY8YTF6
M(1L)7+FRHU+^ZO*$X.(Q[WVG(_=Z_+5AC?$_IF0^Z/L^.3\_E^W[=BXF,7$.
MS@^&+' EY%MO#C#XDF11_:C,7CJE:TCCM6'UM%3QE3M\/],XX\M868<^7G!;
M/Z3D9_J^_64*> 4^O#CG[<8UJMZ?<8])?M'TK;8]+F/=.FQN*7N#;9A;;#;V
M91U#SW=/43# R@?9@W;[&MM"+6S*"\?UX&A]O##DDP1P%VL$#WN3.YA9V<NP
M)/(#@3@D^F<^?/\  ]=8%$Z1B,(O@8+%_GXS@?$?QGX2S.N@G<K;^KZ5-M\7
MP\WJ<Z<=EMF;_ LQV;GWEL]D'Y'O!;75==-WNOH12(*',@BGNR,:?&+JRF]@
M.NY2ZL2UD=/&]W0Q<GW7=E;EQR  ,  9P!X\CT'C5#"P[8!+(D9!4L02Q.<G
MYGX8_#Y:I:MZ39MF^BOT@."=0 ^S73SBV[6;95NMM?)@F5,3!\"F!VYPZZP9
ME28?78]:2Y)@N;X+$5*5'4"V>1V53+D-:$U]@P>.X29FB9 S\0%;P,E?0YP!
MX(^>/AZ?!V@L4@<A>9!'G.&'IZY).0/G\O.-5QL)L'OOD_H^ILCO\+VGW-W]
MZHLY#ZF-\=MM[*-I&#YY4YK<4Y\FUT[S0K3[$[$#:RKQN@Q6V+J[07%<AK8I
M7!QQ=Y M'>,384LL: JA4D$9\D^/7SGQ^'IJL:2=HE@I=SR<$9!S\!D^ #Y&
M?]NKT="_3/N'LMNCNMF$>W<G3AL;E.&X?18ITU1;R6>\5=6Y_4VU\?E&Y=>^
M20C&\#$N*BQI<;%QG%C"(3XJ=UI905\C0PV62N'5 3R9,@-QX^,8\_$GY$^<
M>/3&KXHRC,P7@K  )G(!!/D8\#.<X_VZV?:PZSZ:::::::::::::::::::::
M::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
M::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
M::::::::::::::::::::::::::::::::::::::::::::::::XX3S_"O*_CXX
M_F1/Y_?IIJ19/BN,YM0VF+9CC]-E.-78D@-QC^05HEO36@4O'B"V%:?%.&9
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E----------------------------------------------?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>g60414g21f34.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g60414g21f34.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[3U44&AO=&]S:&]P(#,N,  X0DE-! 0
M    /3B^%6<CA"24T$!       %QP!6@ #&R5'' %:  ,;)4<< @   @   #
MA"24T$)0      $,==%^5TM6[UV[XYE,#I>5PX0DE-!#H      .4    0
M   0      "W!R:6YT3W5T<'5T    !0    !0<W138F]O; $     26YT96
M5N=6T     26YT90    !#;')M    #W!R:6YT4VEX=&5E;D)I=&)O;VP
M  "W!R:6YT97).86UE5$585     $       ]P<FEN=%!R;V]F4V5T=7!/8F
MIC    # !0 '( ;P!O &8 ( !3 &4 = !U '        IP<F]O9E-E='5P
M   0    !";'1N96YU;0    QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #
MA"24T$.P     "+0   !     !       2<')I;G1/=71P=71/<'1I;VYS
M  %P    !#<'1N8F]O;       0VQB<F)O;VP      %)G<TUB;V]L
M!#<FY#8F]O;       0VYT0V)O;VP      $QB;'-B;V]L      !.9W1V8F
M]O;       16UL1&)O;VP      $EN=')B;V]L      !"8VMG3V)J8P
M$       !21T)#     P    !29" @9&]U8D!OX            $=R;B!D;W
M5B0&_@            0FP@(&1O=6) ;^            !"<F1456YT1B-2;'
M0               !";&0@56YT1B-2;'0               !2<VQT56YT1B
M-0>&Q ="9F8         IV96-T;W)$871A8F]O; $     4&=0<V5N=6T
M  4&=0<P    !09U!#     $QE9G15;G1&(U)L=                %1O<"
M!5;G1&(U)L=                %-C;"!5;G1&(U!R8T!9            $&
M-R;W!7:&5N4')I;G1I;F=B;V]L      YC<F]P4F5C=$)O='1O;6QO;F<
M      #&-R;W!296-T3&5F=&QO;F<         #6-R;W!296-T4FEG:'1L;V
MYG          MC<F]P4F5C=%1O<&QO;F<      #A"24T#[0      $ %"9F
M8  0 ! 4)F9@ !  $X0DE-!"8       X             /X   #A"24T#\@
M      "@  ________   X0DE-! T       0    >.$))3009       $
M  'CA"24T#\P      "0           0 X0DE-)Q        H  0
M !.$))30/U      !( "]F9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &
M     ! #(    ! %H    &       ! #4    ! "T    &       !.$))30
M/X      !P  #_____________________________ ^@     __________
M___________________P/H     /____________________________\#Z
M    #_____________________________ ^@  #A"24T$"       $
M$   )    "0      X0DE-!!X       0     .$))300:      ,U    !@
M             &3   !E0          0                         !
M            94   &3                      !
M       !     !        ;G5L;     (    &8F]U;F1S3V)J8P    $
M    !28W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<
M   $)T;VUL;VYG   &3     !29VAT;&]N9P  !E0    &<VQI8V5S5FQ,<P
M    %/8FIC     0      !7-L:6-E    $@    =S;&EC94E$;&]N9P
M     '9W)O=7!)1&QO;F<         !F]R:6=I;F5N=6T    ,15-L:6-E3W
M)I9VEN    #6%U=&]'96YE<F%T960     5'EP965N=6T    *15-L:6-E5'
MEP90    !);6<@    !F)O=6YD<T]B:F,    !        4F-T,0    0
M  5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N9P  !D
MP     4F=H=&QO;F<   94     W5R;%1%6%0    !        ;G5L;%1%6%
M0    !        37-G951%6%0    !       &86QT5&%G5$585     $
M    YC96QL5&5X=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$585     $
M    EH;W)Z06QI9VYE;G5M    #T53;&EC94AO<GI!;&EG;@    =D969A=6
MQT    "79E<G1!;&EG;F5N=6T    /15-L:6-E5F5R=$%L:6=N    !V1E9F
M%U;'0    +8F=#;VQO<E1Y<&5E;G5M    $453;&EC94)'0V]L;W)4>7!E
M   $YO;F4    )=&]P3W5T<V5T;&]N9P         *;&5F=$]U='-E=&QO;F
M<         #&)O='1O;4]U='-E=&QO;F<         "W)I9VAT3W5T<V5T;&
M]N9P      .$))300H       ,     C_P        .$))3001       ! 0
M X0DE-!!0       0    %.$))300,     #,#     0   *    "?   !X
M !*B   #+G !@  ?_8_^(,6$E#0U]04D]&24Q%  $!   ,2$QI;F\"$   ;6
MYT<E)'0B!865H@!\X  @ )  8 ,0  86-S<$U31E0     245#('-21T(
M            $  /;6  $     TRU(4" @
M                                     18W!R=    5     S9&5S8P
M   80   !L=W1P=    ?     48FMP=    @0    4<EA96@   A@    49U
MA96@   BP    48EA96@   D     49&UN9    E0   !P9&UD9    L0
M"(=G5E9    TP   "&=FEE=P   ]0    D;'5M:0   _@    4;65A<P  !
MP    D=&5C:   !#     ,<E120P  !#P   @,9U120P  !#P   @,8E120P
M  !#P   @,=&5X=     !#;W!Y<FEG:'0@*&,I(#$Y.3@@2&5W;&5T="U086
M-K87)D($-O;7!A;GD  &1E<V,         $G-21T(@245#-C$Y-C8M,BXQ
M             2<U)'0B!)14,V,3DV-BTR+C$
M                                           %A96B        #S40
M !     1;,6%E:(                     !865H@        ;Z(  #CU
M #D%A96B        !BF0  MX4  !C:6%E:(        "2@   /A   ML]D97
M-C         !9)14,@:'1T<#HO+W=W=RYI96,N8V@              !9)14
M,@:'1T<#HO+W=W=RYI96,N8V@
M                          9&5S8P         N245#(#8Q.38V+3(N,2
M!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="               N24
M5#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="
M                           &1E<V,         +%)E9F5R96YC92!6:6
M5W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$              "Q296
M9E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M,BXQ
M                            !V:65W       3I/X %%\N !#/%  #[<
MP !!,+  -<G@    %865H@      !,"58 4    %<?YVUE87,          0
M                        */     G-I9R      0U)4(&-U<G8
M $      4 "@ / !0 &0 > ", *  M #( -P [ $  10!* $\ 5 !9 %X 8P
M!H &T <@!W 'P @0"& (L D "5 )H GP"D *D K@"R +< O #! ,8 RP#0 -
M4 VP#@ .4 ZP#P /8 ^P$! 0<!#0$3 1D!'P$E 2L!,@$X 3X!10%, 5(!60
M%@ 6<!;@%U 7P!@P&+ 9(!F@&A :D!L0&Y <$!R0'1 =D!X0'I ?(!^@(# @
MP"% (= B8"+P(X D$"2P)4 ET"9P)Q GH"A *. I@"H@*L K8"P0++ M4"X
M+K O4#  ,+ Q8#(0,M S@#0P-/ UH#9@-R WX#B@.6 Z(#K@.Z \<#TP/@ ^
MP#^00&!!,$( 0M!#L$2 15!&,$<01^!(P$F@2H!+8$Q 33!.$$\ 3^!0T%'
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M 4#@X.%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,# P,# P,#
MP,# P,# P,# S_P  1" "? * # 2(  A$! Q$!_]T !  *_\0!/P   04! 0
M$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0         !  (#!
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M7C\T:4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H #
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M>Q!^M3<Y^%6W&K-E6^<C:X,+0T%['NWNK9Z+7M_2>__1K P^E=2SCNPX#:[
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ML[HF)E4YU]5C'U,
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M1TAGAY:BUS5#1$53569V=X*FIZBRU0I68X.%B,;3V.+_Q  = 0$  04! 0$
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MY_[A_=QQ\_.G@R>Z:@=4K'2.?69\HJFI?_S#O]KG&/J=0?56/BC2'\;;>;]
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M,]P>3\;UDH-?@HN!7!*W58HKU4IP*Y>E7<E21*J")-=<*#;RT(;:A)3$H)Y
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M>1_/!$_H1IW+'Z!O_K_?IWK_ .G=_M)_=H^*S-?QMMY'\\$3^A&G<L?H&_\
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M#T\^?61SZ5G[_?[CJGQ\? JGQ\? HTI1I2C2E'W^_P!NGQ\>RGQ\>RH@O/\
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MG:/&;]JLDNT=(K&;N$%4UDU!3.4VM1>3\Y=Y&1OR.A.\=.=;:R_FK?/Z>/\
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MCD =52ZI.V_4?Z50D* !$Q'/?//?_6>L4[78* %+V0X*    '   !P' !T
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M9*%%2E)2C2J $D@FKT3;O=L:? *YNH"!A#GNW$R1NJ'40^4BL1-4H\@(<&(
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MR$1]#KPR<ZRB6T4W=69W7V<"H\LJCR29D@0?M7C1H_AYB':JV5C8\#B/R?<
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MA(;\2R70"2X-9"S@5] _)TVZSP)2'>'NV2OG+BPMQ+B?G04$P\D/$N&  @F
MV2F41) C9Z6S&L-4LTUS*[";CWDID>KQK&4H@"[-:32%0=MX!*V0HJM0B%($
M\3+Q<=,H.IF+<1"\2609,Y4DQ*J1G2?(]Q]ZV%YP7^3;N[:=NF[E-S:-(6FU
M6XCNE&Z4I20AI0:24+*O"K4F 5 '1?*7P=I\V_%/GUO;NH85;KM[AQ257#:%
M:TFW2@*4MQ)<6%H"2%)TDPE)-50*.Y4BB3CP ),"* 1PV$WB94Q#E,'B$DVJ
MJK8I$%03,*!#NUW+=191,$5FZ;9W]"*<>!2KNH;V4F=3Q!!\0""4C20)2"LJ
M"L:2F#XR$ME)3K.LF4J^B@#&#]:2=C *=(P=1(PX;-9M%LJ59RD#1VHH0R8O
M6*Y52H.&:J2Q"G9NB%%-PH8$SF*4QRH+"15,I0,4ENY2@A2AW;A."XVH*"5-
MK0L)4VL"%F02!.E4$ 35*E,%0(20I(&0E0(U!25I)2M,2F08,P1L9&VKM$G[
M?8H2EU*,?V64LLNBQKE.CR-0=RTN= RJ;$CR3?-(]&.3*U<RKCQR[%FU!%PZ
M?2!(Y%9$-5QGB%CP'AS_ !'B#JF^'VRD+6VAM:U*6M02VTD!1)2I9$(("=1E
M:M,BL_AME=\7NVK&R:#EV\%)2M2PD#2%+4XHZ4@*"1E:0#H$!()J>OH=LO25
M"S[:,>3+M%.K9TAH E>KY54ES4V?A*Y.Y J[1-T8B1S,)F$D[XA(%*HHS;3B
M,+"P:?J]B*ROS3V]9;XBXOC=JUW#(6T!;9)98NFPZVHGZ(U.2M24'0A3A0F=
M,GT+Y-^T##/&+OLZIO0JZ-ZZBX(@W-_PU[YI=E0&/&RTE2"3J4EKO7(6\4I]
M/FO,J]PHTI1I2H.^CS_<]3W\J+>]_7*SMJ>X^FG]4S_E(J"W_-J_6O?YJZG%
MJ"IZ!\A_V?C]FE*\AN?Y&P7+?C<DS@H\<R64\K1K=0PB<RE@C<M47$>/$DS]
M2I.VU<B20[0Q0 Y4.]2*/!S@;U2P2ECLRB8[O^2+^Y4<07'E]TD$\C"B(Z><
M&OF+CKSEY\I+Y"B;A':KL]PUE,Y%I:VR[AX $_0[Z'#&$D DYSZ\@\@]GS>[
M7E=?3M4'^F1EI=3(VVZO+F71KB-3RU8F*?(@SDK,22Q[$K.!#GL"_KT(\61;
MB/!RM+6_ O)%%./;/D38ME\8XL^X4_.F;%I-LDD:BAUX]^I()DZ=#040# 6"
M8%>5_*HX^.&\/:0#W#ETXI\@8U(;'=!1V$ZE1)$E,=)A!L.R0KBC>SB&7,3F
M-R0W>X6F_P!\(QEU< ZC#H@ =D'2.0HC'9![9BB,6O*F3 _=' O:_+!PE%WP
M!/$!AWAKS3B('TFGEEFX'+(*[=4Y.E*C$ QROR:<05;<8^:'+=ZVZVJ3]%Q"
M$N,F.<Z'4#D"J)E0GUGZ^7J]^HTI0/S??[>GW]NE/17B*=K24^>PNK*FJG89
M^>MDA;D5R\.$;7-SLJ]MC=TF?@Z;M&P.Y-%TD?@Z3A-1$W9,4P!]M=DFV/\
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M:7$(6$%.M*5 $$X4!S!  DC&",3S F*HIV$3J\"/8*8W =1'L]> ^<>. YZ
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MI)0$-)$@A,E7>G2!"8!)('IX33313(DD0B::92D(FF4"$(0A0*4A"!P4I"E
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M%]*<N0-R]=Q;&KB':@MM>*HB.F4DA$1.V=9$S8\RP9Z)B\)^.@Z%37A  RB
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M5)M'=?!JWUBP]^5X9'U'/1<MWQ8]P#1^9/P#IQVRL79BM7@EY!JX,5!<4U1
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M;#'4O)Q4T:F3UFKLVUH-FLLTXC",TV9I/%S2L7)2/1?Q3-63K$A4$I1O..$
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M5XR2"8!(Y&(W@8O93L?PWLC:.V=@MU]=R_W[US<:.^4 C0A!T)0 A !*$
MZR02J3.G;,$%766:XVN.?5F(*SFZ=JF)H]T_4&$K\%5:=1X"ZUVIB_6,,=4H
M',,=DJ(B(-NH6*@C,7D5 (,:^UBF#;4.2K2!!44YQUF-N>D@;3Y&21U0(,Q
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MC(KUGB?$!8#B=XA*G%L65NT"D>%#ZGGPVVLC ,OMK4 9"8"MVQ5N.^/8C(9
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MPT;9;4,'$Q%E6HU;B)U]>;#!23./)5(U*(?N2K2DHQ;M522[@NHN&<2NN&7
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MS2(4G)=4"MY1]94&[EN[ZQ?:WB[_  UOA:.[3H2EI5PVD=\MA( 2TK!"4@)
M*DP<"""23YW:_);V>1VE>X^ABYN;A]:WF[ J6ZPW=.*U.7" D]\XI2B5!"RI
MI!4HE)&G37"1LK7\21=<CX&8:VC(D<ZBC$<JD1=M+798)XY=R=ADWCH%&B3
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MN#Q:VBW5WLN"(5"<DD(N*7C<&Y^NK95\\?QT5'1[A:J7AX#.1E926CXN(:O
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MC$YUB+_=+F)P5A+*1[F1:&D6"9B,W?@Y)^T*L@8C5XY;E26-.Z2%!,DPVV"
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MC![M2;AO,1]4^B3D&O3-Z2#+5:Q%LKW /9Q\5&7O6-K7B:@1*:I22=GR+DZ
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M @40W";A"#P(@/7N\HD ?K ?F -.\5U']E/X5;W0B \_'/\ +N 9QS/([3F
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M[)R&$H^701U8X@.(4VH I6E2%@[*2I)2H>L'XVJ]M6A25R0I*DJ21R(4#/G
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M$I&I0/B,JY@"5]^_SAF)Q_YF>>?^NS;OKAQEHC_O4^G*5?'QGL6OYXC]4?\
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M'OFBY!37:O&;I)9LZ;K$,)%4%TSI*$$2G*8!XT!C8JZB,9]I^ZJ$ @@Y!W!
M(\]Y^Z?13,9:K.&*GA"RI72L1T5AS'+2-R5,5JLU]-*-;,<5S\=DYN1K5X%D
M!)%J25J[5RZ@6K%0DTD"\:HV<$>J)J7H4HKP25JE(),;@C<GG.>@F*B<2T&E
M:D@(3XR ,>'2H8']7:,^\,!*;K-FS23F,,6"(C6DLS@JVPE,72&+O%.7+Y&+
M@INKXQ+46T6]]96R/866#4AZHBQ70:.GAX]@J61CI1JRO[MZ)'7<*. <ZI*H
M@Q!P><XJ+O[8$H(@I &@H),X\(2/KP=B 2#B9%<-XW5;+8>?+!9%A8V/M!*L
MA>I*%MV)54;##!C^"N,_!1TM&2\(63;V>&AZ];'%3:IMURMDU6X1+Q$MKKWK
MMH=(!U2)TDA4X\,F9.,B>7JHI^W2K2I&8)TEL:DD20%(()!.DQ.Y!$X,=]SN
MUP1#W%A!!C6VLG$@E996667Q3*QEFC+]#7/%2%5J[NI+PJ5@=6J^2^XV L=:
M?))=E-Q;/'/5FSB:EG#!W;I$Z@1M!.-)!).<P-,'$["G?M@F6U9DJ5H(45I4
MF $@))DN C$9'4$N+0\K;?<HWF>-6Z<FM:TZ4C9[W:IO&)H16$CHFZV6FEK=
MXL<U%-'3:QPMSQ79V"U:?K+.8MW25GADD46L<Y6HI+B0)5 D:0"=SD 1DP"-
MNL#:I$K:<4HI0"=,K46P( )!2HD3(4E0C?!GF:;"=W5;375:0<SE#L4K&^JX
MJ8;5Y]@*POY(*+7*W,Y#J]Y2KCNM&=$H;&NM[)/UJ8!L5%F\:S,0R0;6DKB(
M/4-NR84!$22K$R01)W4#R\SG>HR\P1] J&(3H,:0"08@>$)!/+$2,BE];\VX
M>PSD.Q^)QR:-*7#%=R3.9.JM08'3D*\I;VM"KE9>R$>S0>J^"44;O$3RCU"%
M@X0HO'2\?'-'3EO:$+4-YA4:22(,$J,3M(R1S&,"KE/-H/T#!;U%24P2"=(3
M]$$G(P5>7,"F789NV46QW5+O5\=2=H)&K*O*JVI^%)64BY:T9,K<!E>1=LX*
M,@CMIJ]LJK0&]ND),C=:5@FD"[,5[XU_'H2$FEU,@G>9\1&D!0$#,"2=AF>?
M6,N6YTJ"%*T@*04M:I*M#AQ/B/A!*N2$J(/A /4M6]79EX2WM("IP^1;1=H3
M'5DLM-9X_CTY3(:%P)0Y&&9SA9.*$L_.UZL9!K]E=1TTDZ59L0D6C18TC#3#
M6-=R[*941&H DS$:@8A6,@ID[9R"(#O[;Q0D+)"5*2$B5%1$3D>*"%8Y1&:?
M[)]^VT8_LP1M^I$6J\H=2<9/F;$AB-U9H3%M:?MK =O8[%8XRNR+2HC/$QU/
M(-%@62<.SU<J;H4DR1IE[ EPB4J$$X3J(*I'(3R&2 ?;&)EK90?$B0E.K5H!
M" 9U:B$B =,;SU@4Q\3GW:QDVXX@3H^',?7LECG7E>:6>1JE:83&.I^HO\<P
MK1DDT=UJ17(X:0UDJTC&*QDJT1;13"(0:JE J'@9-#@"M2RF!L%$B()G),3I
MCED#&QJ)+K*UITMI.LG) 3I(V$%)@D$?ZC,X%L68N<,7\6XQM0EXR6G36B4C
MEJ?7E&,E9C <#6)^T/'BW>SAP.<#RSA-1^;M& 7 ]HW, 609U*VC(Y?VJR.Z
M;S*$P3,:1!.\^1&\C<[TNB@!"@1,I4TR@!"D(4"E*4H !2%*4  "E
M Z   .K9\SG?'_NSZZDQY^6/XX]]?11'D.H^8<_?Z-5!R,JW'+^-4J&FP[I@
M*4$!$/\ */WE^W_G=YNU>[AS<CP-;?JD>8K'M8[LC8=\_P L_GE]8-3*Y'S
M?Q]?OY]0^?W]8Y'VE>S^/F??616HGJ_7[5$NX"TPD/9()^"17T+/Q;*9B7A4
M5TW*(.XZ01<,W (N447"0+(G!-=))8@ HF0Q:A6DR%*D" 8V]'B_A5" H$$
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M]\1E*,W39-?L$\0DF1<I *J4-7V-R;NV;>4@-N>)M]J0KNKAI1;>;D'9#B5
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ME^)[JY=O+E^Z?6IQZX=6ZXM1)4I2U%1))SN?PQ7U3;,-VS#3#20AMI"4)2
M $I"0('D/;3\:QZGHTI4+; NBAZ0K&1EE4T2FV:YO*!E3E3*)OU;-OX\ )Q
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M+" T[!)/=+GD/HGED^\55.HK;!  [Q'0F2L)&W+/XB=[A=<]70T:4J&&T?\
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M'9ZR!]'<<SO/*.D;SSQ@4 )G5CH ?;/6?N/KI]*?2:=CV!956B5:OTZMQQ3
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MWJ42V5!W&RUJO\.X*&MHS8H0)6-:^A,)'6(.?+4/56K>OUN2EOP)R)&Y Y[
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M;7#$TS7IEJ,ZB@R6FX-Y&.9HQ)!F@+(!C7XL[@"-) .=1].W(U0/K*=1;3$
MB%$R% D0"@=/V1-.?M[WB6W/MHH=?;XLJ,,VF6F6I>T3S7**UB81L7C<F&TF
M#FG)MZ&T=6%Y/.\SQS)XTL2=&-#DKTR[05F6CR&4D+5MA 42HD@I  'VM6\Q
MMIS$YZU>ATN%(TB#JDD] F"!G?4<$S@\JGWJ*IZA1/?YQ?%?\BS/7_7CMSU(
M/S1_6)_PKJ$_SA/ZE?\ C1R^/?4G\ARYHFLNP2,)'$F<L2@H @44@=IJF=+
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MV50Y7]8E';ZMR9#&1E(EZW.HB<H D*YIA25)/B2H&4J21D*!R"#N-IBK@I2
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M"HXQ-$L#/T)-YCJJF3(.6W3)NJSM4PH7%BCA6/C,EQ!\:Y=6TF&TJU'!4 ?
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MFJ<>P:LR-DGSA-V]20(W23*BF\=(HN71$P*5PNDDJJ!SIE,"2>9]L_?\#E0
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M0(W!!3F).XVGSJPV,S?A>:0!U#Y=QA*MC$%0'$;?JH^0$@%$XG!5K+*IB4"
M)Q,!N * F$> '65J2>8QYCI_']M8FE70^PUIY7<?M\A%BM97..)&;U0W=H1Z
MF1*F:3=*^Q!G&)RQW[QP;R(W:ME5CCT(0P\AJU3C:02I:$CF5*2 !YR8@_<3
ML=[DMN*("6UK,@0E))^ZJY-VN2H^EY=PONFQO1,MKQE:E#5C*%R6KUTP_2;3
M7WJ\86M5MQ>,G(4ZE2\6\*>;< JT1L,-)NF<4P7=QTGZEE(_"7?VH*4H6'5S
M^;9&LJD':)YD0,$":S465P4+UM=TVH0EQTZ0%><Q&<R !)&8@59A0,<Y6SY
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M0M/D]:"#D X  _;$*0#T^@0YXY_)KG-8T[P) .>7D3SWC./?6[[L:@(&Q.#
MWCI[?XX@=Z23<%N#VX5"AV[#GP59P$HZM,/:9:S11WS1&S&8QCFCP[IZ#A/U
M)%S3=*V@I())$7-+L(5B@^05>)LY+J.R_#.%\9>OK:_O?F3[=DX_P]2W6FK=
MQ]J2I#[KJ50-$J !05!*AK!$'0=H+R_X8S:O6=LFY:<N4,W24(<<>2VYX4J9
M0W!*@L@%1D)"A*3N(+^BYRFDO9LB7G.N9(R/@*2R;4G$L;E7),.,ZQLU[9P=
MES(F92P6J4<)R)&]1QP\59(K-U&I)V6DU6")K*]?R<O:I[@]QQ%"N!-(19BT
MMVW.[8#"3<M!27%*R4N*4 "76PE*]R-I@[.L<2:LUCBSBU7)N'%H[Q:726G/
M$@I"4C1@@%M4D;IP*M;W);GZ5B3;]EC*<!=*P^>U!%M56#Z-=-[:U@\@VF1C
M:S5T9N*@3O7ZP1TS/Q<M+0Z27K(\,W=*)(" E,/.LLN/NMLM-E;KJTH;1@%;
MBU!"$"8 U*(!D\YD"MZXIMIMQU:TI;;2I2U'9*4I*BK$G !/A!.(C>O.#E&:
MQ[D*_P O,8^IDK"XX2@:K7HOX=A%R%LN\G5XAO&RV3[-X0[YJE/7M^FK,2Y1
M?R'CG9"6)5WZTG95%/Z2^3SLW?\ !^".VW&D6[RKJZ<N1;E#3Z6@M+: DN$$
M. A&K$H$^ G)/AW;+C5IQ+BC3_"EO-I8MFV>^2I;2G-!<45: 1H/B S"L>+D
M DF+1").U5B$O4KB/>(R4<[A3'AWL9)-S@HVE(M[&F:NXV3;*@"K:18K-WC9
M4"JH+)J%*8.Z>X7PVXM5V3]C:.6C@A=LJW:[DC]6$A((Y$ $;@BN3:O[UE]-
MRU=W"+A!E#R7G XD[X5JGED9!&XJT';5Z4RX878MJ5GUA>,QU5R[;H5RYQSM
MA*Y#KJ::*PNXJ>/-+Q_PR8&33)(,YR;GF\\T*A+)2<I-BM$H-_".V/R2K^="
M[[,!MMEY*BOA[JU@)?&0BV<*%(2AQ(,)><2$J!"5P0!ZYV9^49(8-OQXK6ZV
M1HNVT)*EMQXE/H!22I$?2;22H0"DJ!4;H=N.Z_$NZ"%F9+'CR3CY6NOO!3].
MM:$=&6Z*35(1:/E%HV/E)=LYA)5(XC'R\>_>,5'*#Z,660EHV18M?'>.=G^*
M]G;L6?%K8V[RFTNH(4EQIQ"A,MNH);7I,I6$J)2H$$"O3.$<9X?QNW-UP^X[
MYL+4A25)*'$%)(\3:@%I"A!22,@[[TA]^W[GUC_*'V=?UN<(ZU37T_\ E7_@
M56>_] ?K&O\ ,34S=1U-1I2H8;1_V[;X_P"6?8?ZOVW74CFS7ZL?XUU$W])[
M]:?\MNIGZCJ6C2E>73?=N5?[M<X2%6@ES+[<]NUR?P=8C$5Q-'9>S97GBL/8
MLARAB%,W>53&TJ1_5J&CV';9Q.M;'<B"X$E;\+Z5V.X$D(_E2Z1*I'S9M0D<
MH6=6)!(@:3B3,U\[?*_VY6A9[*\,?+94D*XK<MJ^@V4*6FU"DF9<2 IT @A)
M;1/Y0U$*SNY!]%NJZLRD&3R8481?B(I%X_;J1<H_;L999M*)L$TF+IK%K/5#
M&>)-C-3$*[2%5(@*:[]]2U-J:4DZW2E(T2X"%*2%:5! @Z)$* *0<@DS7@-D
MVTBX:NDNH<:8UN*2\4-+0MMM2F0IHN$J"G4HT!O4%@:5 2:V[EX]CU6L#6XE
MD\4:1R*QROI->*CV# AA9LDO$(1LPY5<N1;N ;I%9]@$F;D[AVB<&Y'%ZE*0
M4MM(!A"3*U%#:$C2A,J2EPDS  *?H^(F)(QT-MO)7<WCRT!QXI'=LAUQQU1U
MN*A3C*$(1K3)+F2M(2@Y*6GN<I-9 90]+K;IA4;N:5?S9)QR9:7=T&R8QFH2
M4BIV&;,UXAV[?)SZ]>E("17<1)"1JZ+]P@*ZR,6OKK](XC;'A\(2JX#J7)EP
MM%G3*@ELB22M)0LJ2"DJ$'":Z?L^^>S/$6NT 5</,V*[1=JE@"V%^U>I=_)O
M+6' V$(0X'VD!Q0>2$2$CO!>)CKTS=<KT3)-=VN+%,/2$;7IE_$Y'IUC-=\0
M6^8A(5W)I0+AZZB(.TX\L-G79C'UN*L$/*PCZ3<-8AO<'4HZ:-''E7%>RW$.
M&0LA+S"E:0XT=0$D#Q#=.2-P-XKZE[+?*5V=[3GN&75VE\EM;BK.[3H=*6Q*
MU-JDH<"1*B4K)T@D@ &J6SV2T5[$LU?K(V/(9'L36Q9#GF"11.M,94R5+O[6
M_B6Z?/:5<2MYLRD4T3Y'M'612(4"]D@>I6R$<(X$B2!\VLRI9,?G%MZH F!+
MBB#&QDP1O\O\2<<[9=O'@W*T\3XP+=N 21:H=2RE4&8TV[16=A.9$DB\+>'M
MM:X8]%+0Z*AW3V:VJLL%7Q[*)D,8'TU5;+!L<P6,3" F(>=@+3DF2<K"'(FD
MUC*"!#*&#R/A-ZI''+>[4HRY=>,_T75:5$XSX5<QZAR^M.U7"&KOL=Q3A24^
M <*<0RD  )7;LZVL#[*VT\\'/(56)B*X&QIN>VG9+(?N48;/-6I,LJ8>RD:
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M@ZD[SZ#V1N..7/%&.*=F^QO#%!BZ6GYSIN3W96(=2;E^\*2K0O22E"]!4 $
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M))^+8S+UM).+HJS:*(J<*UV(OF[]D*<;7:)<2I3V1*4F8TQN8WY<Q@U[F_\
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M)]A]/P#4+\7"$/DO=+7C !?!YV;3;0! "BLPM^%\0V,SHI1ZBD,T]G&)5.1
MZT>X !$2& N>A8+;9F1I5D]=9'WF<^D\ZA;9)4\)@AP1G$%M'+T@@[9F<[]W
M)+UG'9 VS663(EZEA\\M(2<46(55'PN4<7Y/Q!"-7!#@9(R,E=[]4&!RJ%$A
MS.$RCSSQJQWQ-. <AJ$0#X2@^L"%'U8-6/M%"4+)! <A4C[25)CSR1CW8SV:
M?Z,3:/4K58;(K2I"WQLRTD&$11;O(-9ZCTAE*(JMGB51BAC&C])<C=8Z$3(V
M"5L$I6D1[%8>PP"<3;F][;=IK^QLN'W'%'OF]B6U,]WI:>6IF.Y4^\@!QTLP
M-!4K!$F3FN<M>RG ;.[NKUFP;[Z["TNAPEQI*7/SH::42AOO/KD"3L"!BF#L
M_H>\8.Y%\YI68,A5B-<"HI'PL['0%R;Q!A$>Y:(2)TH*;?QK<.R0H3$G(32Y
M"]IU/+K&,L;JK+Y8>UEJRVT\FPO^[@%VX84E]:0<ZUM.MH)(D:M ,P3.:YZZ
M^3/L]<.+<:-W::R2$,NI4T@DSX4.MK.G^B5P, 0*<O$_HJMN%1A'3?*[-WG*
MQ/'0+FE9Y:9J\#&MT@*#9E!U" L'@VX$,47*TC,OY^:5=JK A)M([P\:WTG'
MOE%[3<<?2Y\\7PYA _)VM@M3+04)&M:Y+CJS/TEJ(2/HI3.=IPCL3P'A3.CY
MJB]=).JXO$AQP@_50GZ#:?ZHU&2%$["P3'V.Z-BFHP]"QO5H6ETZOH*-X>NP
M#))A&LBK+JNG*A44@ 573UXNX?2#U<RKR0?.'#UZNNZ755/Q3SSUPXMY]Q;S
MSA*G''%%:U*.Y4I1))]-=6TTVRA+32$MMH$)0A(2E(&P    %1EW[?N?6/\
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M4RC"HTFMLG]KMCY(@E,HQKL+)NDD^%%$B)%$X52A2C"1/4[ >D[#U^BJSD
MJ4=DI&I1VV2,G?D/V5':4W4Y7M/>AB; JT3&B8Q$+5GNUI4(CI$1'NI*'H-/
MC+_<'B!@X$T7=5,82Q1'LJH(B'(R=T$B5K!SE*!J/MVGUQ-9;=A>.P>[#*3S
M>,*'GH3J(D=8(V(F0$NI=-VTD':>9>P] B?D?#U7!<V<6XF >$_'VC,M@*[[
ML>@K^JV/>\ ;PZ7/8U=I:'U5*\RH GU 8]IQYYK+'"%GZ5S!Z):$<]B5*/3>
MLIWC=O&%[;/*^&;$"?!O"VG"%A:JNNSQREZTJ^9(I)B*GEX@(*0!+D3^%5
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M7BB=)A1@"O$?EC;>=3PYE"2MFZM.*,]W(TNW8;9>M4IU2"\E;2EM)^DLI+:
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MRKV3@/R2\,X+VB/'C?7%VIIYZXM&'$I 9<>*DE2U@A3A2A:@DPD"<A9R?0Z
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M$E.EF-LE8Q]D_(L><Z[;)66':=WMS%VI_P ,O6_&M4*[04U^"@K&XYKU1AS
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M>R5AHK4']R5D#2I$C<1DIWR#GT1,9Y51!6THK:5H,>-)DMN#GK2,E1$ +$J
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M<KJ 91R\=-F+)LFN\>N6[5!54FUXA?VW#+1R\NEE+;<83!4HDPD(D@:M4;J
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M>)*(&+P0R#@\HJ)DQ+_P?8/V0+V>SQP''7(9MB$K: 4A0E*FWUE"DDSLE92
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MG"2T#0+ID9\XVGYU;>I:.C7%)% A\O8#4\:[6M-DJT0T8%.D5N=PO*$[*[A
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M _LG8>WT4=/>/V!^?_9^1I5]H^T_C0^?IYYF@1^<1^G_ &CII/VI],\MN?\
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MK)2$ZM#8U']6CT?=[JUUNMU3:TI<*&N_N2D( 2L@W#BAJ49(/4((B<<A5I=
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M!_>VG"D52IU>&*4J$TQB+O(4IBS>/FL@JQ;HGA4,@5B:M$>1VI*P<%()2*[
MY5V:;JNATDQM,3 ZQ\28\YFHC=,I"2% DI0J-\+($C?Z(6%$;P 2-JVYMUV
MTEWAG60H5I#-8"K3R5H<N4"P,@%IG,JP!8=BH1<\B:?KCS#-^5N,6YC6QZNS
MAG;F5.B2/F0C&AT<I,Q&,8DYD;<^57=^W/T@/HD>94"0(&Q'3[MJD(W<-W2"
M#MJNBZ:N44G+9PW4(NW<-UR%517062,9-9%9,Y5$U"&$ATS%,4P@8!U&=>00
M?1%3 DB1L0(QB.4>_.^_G769QD?'J.U63-!JJ]5%=XHBF4AUU!,8PF.(<"(=
MM113L!P3O%55>SVU5#&H0H[@XVQ\323@$G  $]-Q]_OJ'.P( # ,X'( 'QF=
MZ8@ \\==X&<0'GV\^T/9QJ5TKU#?\VUL!^B1T%8UI(9)_P"_?C^]4?ODU-34
M<K\_9_"LF3$<M_V?PK(!R(!^725^?L_A3._2#,>H9Z8]%1B-NZPP8D&5K,B]
M?SCF[-?4[:2JA92%4H<\2N3)K&W=VALG#$6DCD+&BZ6_PHAR$."#I1)J>4MN
M"<S D&!XI$B.7H]!FH/G""-4@J.KP@I)!28(4.1)(C&3M)KXF]YNVN$<,45,
MH0$@BXM:%1D'T2Y(_95]^\J62+E&OI=0AR*FA)>-Q3<6L3*1",NB_?L2E0 6
M1'C]G0(=(F.6Q $YCRG,;<]XH;EK[<C4$[8D@D$<H)"@",&#!WIU['F/%=2"
MG&LE^JL03(()'I1W,NU[NRMECQ29)&+435.1>)!6=@D%9CM%BT%YR&06=IKR
MT>1Q0=X20$@E.\<LQUZ\JD4ZA.G4I("\IF # WVV .>6<TG)G<?@ROLH=_+9
M,K#9K88ZORT&<'*SA66C+5!3-G@'S!NT16<.FLE7*[/3R2R2)B)Q$-)R3@46
M;%PLG6'#LF<Q,8Q@YG$'&?7!Q5JGFT@$K &%3,_2DI.,R1)!Y@5W9?/^%H&4
M;0TODFK,Y)W,LJ^@T&0!4PR\BRJD@Q:K*(E51;$=-KW3.X=N546BCBUU]F5Q
MXR69-U0#A!(3M!QGG&=\0"<=-Z%]I) *Q)P.>2, ^9VZ^ND]3MT>#;K0HG)$
M?>H^-K,NV!RFI8B*PK]F'P:GKB*,DP= 59FN2JU>>GQ(?D@Q<8Z=D4.D0IC"
MEP&-.KS D';F#',".L#>K4W+:TA6H '.>4@G?T JP=@2,TJ*OG;#]VGVM5JV
M0:Y,V-]&$F&<.V=F*_<L5&3:5*9)%<B0G<C#OF$YX#D9#U!(1\X+8(E\S>+T
M4'$CQ) R1G&Q@[GJ"#RG$S@7I>0HZ0L2=AL3I$^OPP8Z9BD7"[L<!3+:U+'R
M##PSREVBRU&P0DPNFA.MI>LWV:QLY*SBVBKUS+IO[/".&\:E$@]>F3=QR;YH
MR?N18IUTN@[23RC8&/VF,GF.N+?G+1!\?T209!$02G$;QI,G)@B8@1SPNZK
M<[,VZ$:9%@T5*8P@)J1E'RY6D!(P-D@Z1/1<_7YQ0WJV;AE6F1Z6@J]8N#E2
M>SK% Q1!P@=1H<P8P9P!.VKUYTGF/50/MDJ3J *-,DP 0H)((.)W$F><<\J1
M3<)@]&<7K:V4J6WF6J5B5>-',TU;$8EJ1K&%B(^=N%$V3)>+2I]L>.&[IPDX
M-&5J>ED4U(V*>.T4.Q.D$3$_!YU=WZ"J-8*A/G&DYDQR(.YSF-ZT:.Z7;PLX
MKS(F7::5[:GQXR#9+/SMGKI\G*0,(9NX:N44G$8/K6U59B0\HFR347L]<*0Q
M@G8H78H<$XF(D1UGF/0?8>8JT7#1( <3*B0!S)D \NI SU\S3^CYCQT_%[.O
MF//WX$ 'IJR5_P"@'WYG;K@XW-3>+SY';IL:Q]_O]_IU25^?L_A0ZHS,><P/
MPJ(F^#_B-B>@!_E$;/\ [0W9X5]H\_9] >[B1J=>R1X7=HG\TOSY<ZP[[^;J
M_KM?YB*L+U!45&E*AAM'_;MOC_EGV'^K]MUU(YLU^K'^-=1-;O?K3_@;^/+:
MIGZCJ6C2E&E*-*4:4HTI1I2C2E&E*-*5 '>SF#*.-)G%\1C>S2M<^$-5S)89
M'U0\P=%*R$E1V=&5KK:3E\\N&=:;5\%K!(>N&\*^:61R0Z"K%4B#1TJE*T@*
MU:I@%.P)@$D$P,XQY=<5 \M2"G28)"SND Z0#'B$9](/G345W?CD1W*JD88_
MK]OK[*(I5TM<Y*6J1I;V,JL[C[:/+OB4FHI8_EWKN14D=P\E+-8&XV)LZ0/!
MK1[JSHHR+)I!7=T/M022 #R(UY)SCPYYCSJQ+ZB3B0D F1I.0@X!SNH[].5(
M62](=DA%T^N;2MT:4@5JW09^M8YK62&4BX9+63$6[W(RL!E2>6QRI*U&X&/B
M*E1=DJL6V>&JLDT%\SG)ABXDX64O[A(&5$'4H$QN 4 $#,@ZB1M('+-"^H$D
MI $#$R<A9@[0H:<C;/L=USOAM58LD)0Y'%^*:[8&V4H*CWQLYR\^B8^2=7G<
M3%8:+(8;(YQHS>9)G&BMA)>+G%2C*GKQ:TI#QIWDDK849=.SNA&K42"@J'AV
MA!4 K)@$ITCTCI5>^4%!.E .L),JB=2PDE(B21,GSYUML^;VY;%F9Y?#!:K#
MM&_@JF2NVM"Y"XL<U89DS&:?Q"5;:T.V0M>29ULDJX.>\2]><RK1HL[KA'JA
MT.ZHAK4D*)@9GR YQZ>?JBJK>4E13IP!OG?'D1.?HS.T:I,(["N_/(5GRACW
M#EVQU5'\Q89&:8VJVUJ\%:-XM=U>,NP5=2KU=FH&.4GVT,RQH5E9@"3:2H/E
M9@S%@]6KKM&1N6R E:@2-/(B9A*20"#N9,3B 2>4VH?)6E! ,Q)! (DJ&QC:
M!,29, &#5INL>LJC2E&E*-*4:4HTI1I2C2E0,OH<^D,Q.'OV9YX#_P"^S;OJ
M4&&B<8=2?/Z*M_+IZZHUB[0>C1_S&_OJ4?W^_.J=YY>_^%;/5MY1SZ;1$1&8
MWWS--[D#&5:R6>D?"A SQK1;LWO;&.408.XZ3DVM<LM:1:3#209O$G,<5K:'
MCP$TBH+@_:L52KE32425J'#R!V.Q(^[IO4:TA>F1(2K4$G(."(,[C/MI$YEV
M]U;,\/&0,E+SM3C(VK7ZE"UJB< V0=5?(E.<TZ6B3HRL)*I,TV"(QTI#JQ9&
M*S1_$-$%3N(I=_'.ZI<*283),;F2"DS),3.(@\JL<:0X$@R D* @C 4(@"(
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M?L(=M,XUE%ZY(13_  _%LW#ZON8R;8)O;)"1LFRB'3-E'7)=6G!2"HH\*B5
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M^_Y/;%WGE[_X5DZCY= >8]>_E]]8,<B93**&*0A"B<YSF I"$* B<QC#T H
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MBDDI(D"1'GD=.?(_!BJNM^CAEJ_CT8*"LU(H-_<U\*6]OE&A7*#\::WVE4C
M2-?2.HQCU5(9]D&EHY*?P"I0CR*.Q5(HYG$ D%9OG"9,DD8P0<?E-0B-)PG
MSON8)-8(M%!,!:4D@IE T^ H"2#@SD [#!/E3^5/: +';[7\(69S7I:(;Y@J
M^1IJLND&4E3"UB%O4/:I.A1T9$U"CU]6#DVD4X(I%M:/7:^Y=2S]%W#J-UW2
MSN-3H*BH B04@Q! ZY.YF=SOD=9$VQ#002)#J5JY@@*!(^BD9$Q(.8DFHX6?
MT:-@>U^IP-;N]<A(N,IM"BK57F31!G%6G(<% 7.O3&6G3J9J5Q MSCVTS7#5
MR:2B&UJ,UAA8M;957#.&EF4G?@$RG<R($D3I! @IF0F2">>QG$1M"0D!>G2
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MU?[U'Q(J#_#)NY_I8YS_ $RU0N*/U6AZ&P/VTTJ_2O?WJ_QH^)%0?X9-W/\
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M9) <:<;2MMU!4E0UMJ()!!,XK?06:MY=E8(24'9SO6CQ51"-,:I4%FO,+HJ
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MM%[1C]H-;5&;%0WAEWKSU>>QD;>C%:EY,WJ#)_.-C$#8@@[3\''.K^ *'3D
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MZ9! \\\\1/.N<X^T5)8= D(*DD].8S6IV3.4X*I9?PVJ(IO\);@LK0*;900
MY:IDB=-G6@*(DYY%BA3\IQ4&W6 .P=Q!O42\';J%+D72"EY<B)SZ9C;EB>50
MVB];",@D2DQRTSOZ8]IBIH>>L:LFHD/=D^#7S^0D5&MP26DG[Z1<)MKI.(-R
MN9!VL]<BBB5P)4DS+KJ"1,OR2%$"AT ..Y9^4/M&RRRPERQ*&&FF4%=@PI6A
MI ;1J5 U$( DG<[[UQ#OR?\ 9YUQQU2+T*=<6XI*;UQ* I9U+*1I.D%1.)/6
M2:C_ (WH/H^<Q3ZE4Q3G*M9%LZ3)>2/7:;GEM8)L(YJ=--V^)%QDRX>JM&JB
MR1'3A-$Z3<RR(+')WI.9C\HO:4;JX?!$S_)MOS^/PJ$?)[V;,@)O9Z?/G/W/
M*?PI^/B/8*_^!N__ )]3W_\ GU3_ &C]I/M\/_\ V;;U=_L[[._8O?\ ZYS]
MRM/&;/\ ;=-/)Z/B)&RR;ZK2J<%96;'(LNY<P4TM#Q-@2BI9%%T=1A(*04[#
M2Y&KD$UC1TI'NP(*#M$YZGY1NT@B5</SD?\ PVWS[_=[:H/D\[.'9%Z8Q_/G
M<?\ 1UGWUN/B/8*Z_K-W^?\ W]3WLY\_U_V?BZZI_M'[2?;X?_\ LVW_ !\J
MK_L[[._8O?\ ZYS]RM.CL]VWN)Y_5T)"S*V2)B8F=DH)/(LN>680D\[F8^%E
MG; KH7+>/EGU=GF<>[43*@[<0TDBB<YV:Y2/]H_:6)U\/ F)_DVWSSC/3?V>
MBG^SSL[,:+V8D_[\YU(^S3[8GP90<+A/? AO+IGLIHTTJM,3<A,K*^J2O2L2
M)&?*J @1()!V)BI 7MF4Y,(]DH!S_'.T?$NT!M3Q%3!^:)=#(88;8 [XMEPG
M0!J)[I&Y,1YFM]P7L]P[@(N18!\?.BV7B\\ITGNM>B)  CO%R8DR-@(IT)B7
MC:_$2D]-/6\;#PD<^EY:1=J BT81L:V5>/WKE4WR4F[5JBJNLH;H1-,QAZ!K
M1 20.O7%;PD $G8"3 G;RJD_&]BK>7-LV":Q 6&"F;)NRW7U3(-EB8R;C922
MB8C(.>)W=/>(&;;L'*ZS%]7\15*RUYZT=D3.U4AE62Q2"B8A=G=*2SPUP8DM
M!*8W*E\L[D GVQM6JMDJ?XD@XT]YJ)(Q &#RC(/O,8Q>#B7.6*<Z1$C.XIN+
M"W1<3(!&2"[9M),%6[D[=)T@<6<NRCWIV3UJLFXCI-)N>.DD1.HP=."I*B3D
M[FTN;-247+#C*EMI=0'$Z=2%B4J'D173</XKP[BS;KO#KQB\;9><MW5,+"^[
M?:(#C:P,A221/+.#3L:QZV%&E*-*4:4HTI1I2C2E&E*-*4:4JFKTGV1-W\#=
ML14K;:M;6-<FXY]-7L]6"8C)*<81SMP63C(:T0%:FI6'=P;!-I9)ATA+5T[2
M+;I-B+O&\T_%EU' AP=-I?/\298>=86VIEMUY;;CJ5)*0VTD2E7C(4HJ21X8
M) FO-.VR^U:^+<&L>SUW?6=O?L735Q<VMBS<L6CS;K*Q<7;KKB"A)8*TMH20
MHD*4@+5"#)F-WPXGK5,H=/K=@M.ZO,9,?T=U-0.$*^SGYI\^DZU&NRV.\RSF
M3B,<8E"R"KZ[299$NE87%N\[,:W?]V4AM*W9/W+BRRR4-*6HI*B0A"2HD)U*
MW@8!YQ)KN?GK-G;M)N;@//(:;2XI*0%NK2@!3A;2825J!44C G&,5$C<E4=Q
M6Y&#M-ND,.[;L-6*-HLLQJ-@G7%MSSF:/)%@\GH-%IZA5Q/1:Q/M9<ZRL6HE
M+Y,81:LE)()J23"5E&S[>VO"[AEI32KQQ+3B@MQEHPVM204@K"@4J*0<2")S
M!BM!=7]B_<M7?\G6[MVRA;3-T^TVNY9:694EM9;*V@LY5I4!YYS ;8["FQQ+
MY6D''I 38BM<>&/8?Q4<QV[-&EHH=QQK2,K5N0=_JMU"[ ZEFCFTR<0^5;]A
M=BYC70BH8D@HL[Z/C5_<=H&;)CB2F%-<,06;86[+3&EHMMHT++:=:]*4)@$A
M(R0!-:CA;".#+NWK!+J3?+4Z^7W7'M3FM1U)"E0DDR20"I4P20*6T#B:S9?W
MSV^X4[>Y%Y(M.-JWA3*;"XV2G8KN;=_?_'V*%;UXT7B9;%4<2"BZK2H-2;80
MKMBY>)6DZ:KI$[V0%6C%_<,<"N^S;7<'AUT0XL*MVG'T/%:5]XA_2%A>  5E
M10@D((!S5ZW;=XI;\=<[SY^P=*2EYQ#1;2DHT+8"BD@DRI(*4F 3)&+8V>?-
MXN/SB>^X=Q9GFO(<BXE\$VF0QGD(Z9!^4HTQ9EQ]*TY\<2 )S)#GJ.6[8 F@
MW<&. !R;O 5#+#H/1*Q&.@4/#O@ QZZZ5GCS:B \C2>91)])TF"//<#'KD%A
M[=CA;-4RXIT!/2-6R?'L1D9C#^2X.1Q]E2+9$$"K2 5"Q)-74[!HJ""0VJIJ
MV&I+G$H,YUR4Q3&TUQ:OVQAYM2=X."%1G!!@[UNF+IBY ++B5]0,$1O(,'V>
MG:GX9V*OR$K*0+"=AGTY!E:'FH9G)LG,K#D?D,HQ/*1R*YWD>5ZF0ZC0SM%$
M')"&,B)RE$0A*%I2E2D*"%3I64J"508.E1&DQS@F.<5,%))*0I)4 "4@@D [
M$@&0#RG>MSJVKJ-*4:4HTI1I2C2E&E*-*4:4HTI1I2C2E&E*-*4:4HTI1I2C
M2E&E*-*4:4HTI1I2C2E&E*-*4:4HTI1I2C2E5Y^DNL5<H^ ZWDEX_2;7_&68
M*!></1@' DA;[I#K2*=AH,:8W9335O&)7>2:R[>.5$6,3'23N:?*D;1IQUO.
MSME?\0XM;VG#6%7%P[K_ "22E,MH0I;BBI7A3I2DD$\P ,FM-Q^YM+3AEQ<7
MCJ66FPDZR"J%J.E  3).I1C /7E4,,?[L\:N-V5.O^+&UKLN&\\5N!PQEK)X
M52:@L=5G+<-(O9# I%9^<9,$7\_.C:+9CBP(QJ2Y$Y*<QBP=R7?-FS#6]XBR
MH%04E0<94I*P=TD&"DB,$$$0)R!-:'AS@  UI*' E38!&4J&H&9.\SOUBK@]
M::MO1H-Q.W.J&8,;QCTU3UBW:%FZM;4,/SEPNF3+IEO"6W::98IP2U-CG&Q:
M-D>RXCD<?O(IID&H0T1;W<O#0TS*P4(^>WM%LD^62F'+PTNTC)B-FUIU1C23
MDC8CT>[RBH0V=(5)U"3I@#).>?K'JINCFW083KMSO42G9H::)F7'D!A+&]E?
M2=3K^2"9DQ\3#THTBZ#/YES+(MTZKE.8J>5)5K*V0\N5O3;%.MX>*^$\OXT2
MDXQS.^P'4B(P3\&"&L21C.Q$3(S F#[)'0XIQT\"Y7H&0[JE8Z?G++N'#S-@
M:-4*9D)2*OETO3+;=M"I&/,JV"34OU0EI0P2F.LOP/K^2GCJUJY23:R.VB3<
M6]CBZZYC*1@=-M4D1!$@;Q_"J:% [$C.VTZ1GUJDQ&\[\T6.-M]7PTQRJXC[
M@VR'!26*X6T9*2F9*?K$DQ)MYBJO<K2O.*Y@85MO3W.6G$BZE\:QF"9*06F6
M+B_/)<PNH]VBU)B/#&3R],1$GUGU4(<Q SJWR!$;G/G_ *Q-2EV<XZME7RED
M&T3V,LJT%&4V^[;J;-2>4KBC<75JRA3)_.K_ ",\AWWPUN;E5LFXMT,[>RXJ
MQ;*QOI-699,UA<.'CBQ9D1(.21'(9W\_;RS5Z 0<@[;F=YY3RB.?7I5B6HZE
MJ$6]*7<7: J^U*MOWC6R[D5Y&%N3R*5!-_4]OL"9DKFFT*+EY-'FG(9^PQ77
MW@E$Y+5D2)=(IK)1KT4<FU:[UP3]%.5'R'W_ .E8MV]W31@C4K !ST/J)Y>0
M.U5!Y,VEYTM6YB.)MR3R;G6L;;VT#5BS5FF<<Q#BM95M<5$2$K3I_)C$^/+K
M8H6N8H"I>L%9&9EIF%B;F_BHV73G#,&X]':O=ET-\29[0/706+(#AK5LVIQ2
M;I:U@/&%!!4WI20EXAM25*(!, :4M<?<78O<':MR@W2C=N/K"4=PA*3W<$=Y
M#A4H%;0UI( \(E1MMV#>CZD-H%YS!<YFT(S WA*%AJO%Q5FLTY'L82*47[][
M(I6=@@\9/W+-I6X]E$HR4U'PC6(<E8O1&17'7)\7XV.)6ME:MM*0FV0@O+=4
M7'77TI4G4E9)*6X40$C2-AIQ4_9;L5_V?XMQ?BKERTXN]>N&[)BT:%K;VU@\
M^BX[IUA("';A+J,/DJ.E2S]):C5HFN?KO:-*4:4HTI1I2C2E&E*-*4:4I-W"
MX5;']6G[O=Y^*JM1JT4\G+%8YQZA'1$-$QZ)G#Q^_>N#D1;MT$B"8QCF 3&[
M)" 90Q2C5*2HA*0228 &Y-44I*$E2B$I DDF !YFJO;[E*][AX:9O=VMLUM@
MV=PS)Q*^&6F5\>99RY6$$Q.:TY'MZBT;,X0QI*-A3<QE-@7D-DV88*(KW"PU
M(CIY2#]-8\';;"7KN%+(D-F-($3XYP3Y';TF!R]_QAQ9+-IX4ZM*EP2HD&#I
M&\>>V-Z8_;?2LV.X2RT?;!3JU@K;"[MSZQ8WRSDRIR*5J6K=B9Q[R388SP8?
MU _=Q03_ *XD*[D#*<S7_&1\BR=EI-Q9%"1D,]R]0V"VV@'2(3L$C_E'(;#/
M0YYX+=DMTA;JB 0"1.3 , D$]?V2-A+=ELAQ-+MA'-$YDK<;*+B8[];,=XDW
M]4=**<"H5'$=2^">&F#<#=H$2-<?@Y(B)45GC@ $PX*[EY>ZSZ!Z/]9]>\UG
MMVS*!] ')WSY>\9YYIV*OMEVX4EBE&T_ 6&*PP1*)4VL#C"E1:)2B)A'DK.$
M1[0B)C<B<3"/(\CJ$J4>9]O[*FT)^RGV#T_?70M6U';!>4A2N&W;"%C^5VR+
M2V+:2\=H*!^Q6:OE807C1<O[Q=LNDL3]X<NJAQ8R%J$?TC^-4T(VT)]@IL)+
M9I#5XB;O 66<LX&DFH"9K"QUI?9+Q:XX$!*Q?XKRJYM4%%Q!NSV%6^.W>/9(
M"F.9K,-%C J$[=V\@B5:@#)"LS[>?0[\I FH7+1EP'PZ5<B/6-^@WY^0J(^Y
M>ZRF,,>RJN]O!;>XP]016F<>9]P0G830"-Q3X:UY47:3YOE';%>)%^JU:LK0
ME9)6E,A7!-3*Z#E<L2?-1<LW"%(=;23$:5)"@J1RWS@#D! ,C K 5:OVZTK:
M68"@J052 "9F"#]$9TC8D)S3>;-,<6OT?M]B\L[C["2XT3(V.6M1L&7ZZ*RS
M'$=HM-CC+(_-F@JRKAQ.U%T^9148QS=']RUC7ZDF]R!#Q49*GMB>9VEXC?\
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MHTI1I2C2E&E*-*4:?MI1I2J-/2';B]WU)W$U^BX9L#V@X@AZM S&0;,,4/\
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M BL4\;XDGCZK<V[/\A]UI3=AQ!<#Z4!964ZM:DJ6>Z" D0 5E56 (^D2VF)
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MW-"U(64&R="TI4F%)"TG02DI5!5"DDR..[=/KM^ K>;">]9OK!QHJ"5)2L7
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M"$3**KD2,H\-UEVY9 W;G#&#;6"WGW+-DJ45-VZUJ4R#,J'Y,I)"E*4B=&J
M(Y-E-TI=NW>O=]>MI0FX<@0X^@:5JE.(&T@1*3&XGTE1[!E%,&,7&M4&,=&L
MVS!@R:I$1;,V3-$C=JU;HI@5-)!N@FFBDD0H$33(4I0 H &N<)DD]3-= !
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M!!,UIV!QUR\X>GA5PEFT0\M?$@^AM04TO3H5W9.LJ)2XF$.)@J!!@17I!#D
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M8T=-[8GSNV77$[E@9XVFTI3)*0/J= 5"63J,P!,9R822(DDF50! .,[54K>
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M!R*2Q2=ERW3[PIDCE.F)R" =KD-CP?B]WP.^;XA9=UW[;;S0#S?>M%#[2FG
MM!4G=*L$&00#RSK^+\)M>-62["\[P,.+:<46G.[<U-+"T:%:%QD201D2 <Q4
M</B)X:_^-LB=?_E0W#\D1SKK/]I7:']%PO\ ^B/_ *WNKE?]G/ )GO>)_P#U
MB3][!]FVW2@-B>&@_P#??(O_ )T(<^WV^J/G^G3_ &E=H?T7"S_^I*_]>J?[
M.> ?I>)QT^=HCER#$<A@X\J/B)X:Z_\ 9;(O_G0W_P#T1^3C3_:3VA_1<+_^
MB/\ ZU#\G/ "9+O%#_\ K:/_ -WY_&YG'Q$\-<<>M\B_7:4/_P!$=/JXT_VD
M]H?T7"__ *(_^M3_ &<=G\?E>)X$?SMO;H?]WR*S\1/#7_QMD7ZK2W#[?^Q'
M]_S^?-3\I7:(_P#"X7_]$??^6SZZK_LYX -G>)B.EV@<HC^;[1RK [$L,B E
M&6R+P(<#_OH;]0]W/JCV^0^WW" ]=!\I7:(9#7"__HC_ .O\<\4_V<\ /_&X
MGRWNT$#U!C'J@SG>I:5>NQU0K5>JD.58L16(.)KT45PJ9=P6.AF"$<R*NN;@
MRRP-FR0**B "H<#'$.1UPUY=.WUW=7KY27[NX>NGBE.E)=N'%.N:4R=*=:SI
M$X$"NVM;9JSMK:T8U=S:L-6[6HZE=VRA+:"I4"5%*03  DX$5!GTE4_93;;W
M.)*##O+-D3<#;JYBRN5B,-&#(R\!WZMTRH**<O(1<:*3;$M2NP":0?-6*CYQ
M'L5UTS/D0/2V05NI $P9C$8ZSB#TY\JI<N!MI1) G'M]I], [U6I\?Z\5S<7
M;)RV8ZE6%UP_MMRM2*4[/3I"HI5W)V1WU9MQRVVGVF=F2C*-*UBVLR+)O V>
M?@'\?:TF3*??J2T:$GN;O@]]?V:;U%LZKA=I=V[-]<(&6U/*2@)2/I+("D@D
M I;4XWJ@K%:1/%6.&"Z0V^P.*N</O+BR9>5I:4IAE;R>](A*$2@DRI*E-H<4
MG"3%R7H\=S]TW2X-/;,@56;@+56[//5.3DY2&"#0LHQ<J_18R*+%(A&2,GZI
M3CSSZ$7WD.G(N!5C5$D%RL&7-\?X6SPN\[EAXN-N K0VLCYPRDQI2^$G2"M)
M"D09*=P%"L_L/VEN^TW"C=7EF&'V5(:7=,!7\GWRU)47';!3GY1333B5,N!4
MZ5IPH@PF>FM'7:4:4HTI1I2H=[VMM]PW/8E:4.F7SX&2$;9F5D78/EY1O5[J
M@Q8231.LVU2%.+X(@';YM,)"=C.L"246R6<P#Y5)JX8]#V7XS:<!XNSQ&]X8
MUQ5AH*'S=U21H4HIAYO4A;9<1!"0XA22%*F,5I.T'"[CB_#7;*VOG+!Q9!+J
M$E06D3+;FE25AM4@J+:@O$"9(JE#;[B7(M?V];))V=SM;)JGJ[A<(N'F) K%
M!84N,=.LQ%DD&1)MM56MZ?##79!L]8KR=@,"SHB""C!(O)-;V\=%PR]<H2&D
M/J+R6D!(2VAU97W:8$:1K"<0" ,#$<_:I+5PVRLE:FDAI3I4HJ6M"0E:R"2"
M5J!5),YS7H;UH:W=19W<3Z56Q]5K$J@J[+$9*K#PC--0$BO%TVDT#9FZ./7U
M>[<"DVDR%$%%(Y5TFF(*'*.NU[#VJK[BMY:)<#9N.#W;9<B2A)-OK<1_WJ$:
MELG8.A). 0>+[;7*;/A=G=*1WHM^+6SO=S <*4W$(7((+:B0'$Q*D2!F#4+R
M6&2R0W8R)XQS8Z?*((PU[I,!%!(.\;S!2$:M+E28AHD=Y#Q+DO<2[-*/!*+5
M?IRM6D0!LLR%;T+YHSPA;S7?(M.(,%5SPOB5T_W;?&+?47%\/XB^X0W<7"/%
M;N%V7DM%B^9\0=". ^=.\5#;W<&YL;A*+?B7#[5D+=X2\4I0F_L&6_';,J)2
M\@LJ2RMSO[1X*3W.KB0Q==,8@2-:L?!6V6=.G$GD1RQ<?!W'U(8.U6I))O-N
MFHLXZ6FS)+2#Q=,P3D9'(,(=HFA,RKY@G<KC?#N-E3SKI<L+="$,\(2ZGYYQ
M;B3J$K+*[9MP..V]L%)90D_[L^\IZX6I5O;M.FT<'XAP@!I*"W>OJ4M[BA0?
MFG#.'H)0'4W#K9;9??6E3RM"0^RVAIA #KSC8[Y\IRU["0@:4J*<W .D5Z\Q
MD&S9VOF&!;M6["68W..<)JM[);7/ABSK!JX36649NI6%9"HX91!5(!P)CA9:
MNN(B;:Z0I-VXTM;:.SUVI:G6'.'.H*5V=@C7\V><20D.-L/N -+?B4\9=XD'
M+;AZ@+JU4DVB%MH=<X[:A ;>1?M'4B\O%E!N&&URHH<>80HNI8-=$,1N8A1?
M)[:AS;Z <M&KBJX_<PDL]?(7A^JNW/ 3<8=MX]2L5MXU?22+YV0&U@CTH:+,
MLLZ?2A&4O_:!NX2G@J^*6S=RAQ;=[Q9NXMVVE\-:2ASYW;/!?=)O;QI;3"FF
M_':NFX>TA#;*G(_Y"<8)XPGASZ[9:$*L^%N,OK=3Q!T]V;:Y:CO?FMHZAYY+
MBM2;EON&C*EN);[2&47\2JVH5JM)AF)=L[+8+VW43%SC>P/S-QA8BNO(TI",
M("#,T;HW./AR%:N/6,LR;(G5A&*BMJN"-/!?%;&RBWMUMFTX8L*[OC%JT%BY
MN+QM[+MW=:U'ASK\K3W-NZXL)N'$IN3QAQK1PR\O0;A]MP7/$4%&OA=RX4?-
MV+5;0AJVM=*1?ML>$AVX;;2I3+4I^7Q)<;VS<OI2 <0-E@$W)+G+$B5$X:QU
MHK-=ZTNL&>.0"-GI0J#=9H\0@C*JV BL1*M4EUEIIZ3)8X_P_A;B&V;I-U9W
M90>',%])N;.\[U"'.'7(=47;5DJ6%MKN@E-J1<,K4@(MVCBO<$ON)-K6[:JM
MKJU"Q?O]S#%Y9EM:F[ZW4TD-7#J4ITN"V)5<I[EY 65ON5:+A<.,/8H#W8VH
MP?\ V8B]>,=H/_P]QO\ _2_$O_\ <>]W3RKV?@.>!\&/_P#*N'^>?FC,^^F#
M]( Z09;1,P.W"J+<$&M.4;KN%"(HH/PR'4?5BZBJAR$2*C(BU4[PQR@02@;G
MIQK6LR76XWU"/C\,]*V#T=TY.VDUH*Y9:U%;UZQ<7D^P;P%<V8;@IFQ2:2Q'
M;%M",<K;>)(T@X7:BL)4F;5M).@ A5#*) J*93"40&3CP*T6J4B5*>4D #)4
M0 !ZR('6HN"+#:[IQ1"&FVBXI1P B2X3D8  4HQMF=C$[L49GQEF^ON+/B^U
MM+3$,WZL5(&3:R,9(1DBBFFL9E*PTTSCIB,<';KH.VY'[!N+IFX;O&W>METE
M3\]=6ES9.EFZ86PX,Z5B)D X(E)PH$P3$YK<\,XOPSC-N+OA=ZQ>VY)'>,+U
M04J4DA22 M!U)4 %I3,$B1FG0UCUL:-*4:4IK9/+,!&O';$6L@NNR=+M%N$R
M)D%9NJ9%3L&,<W:)VRCV3<!R7@>.>FK]!@'&<_&*S$V%PM*5I""%)2H>,3"A
M.1RP1]U)]?.46B/ZW69QT7GS;+1(&X]X%=/VI?8/')P'H// ==-!ZI]O\*&P
MNP?S8(ZA:?+\8&<FM6KN)B4!$%,?Y"5_Y3-&G."B'T&N*)_J @F'W<ZJ&C'T
MD<N9._JSZ=JL-G=#_@JSYH_:H5KU-T=.;C_AM(RRU#VF3I"DKP'M^3 R,L<>
M/<4IA-^] W3FO=*ZH_M <XYQ_&K/FUR!)MWH_J@^OPDX\]N>U=4^\'"K<!&1
M4R;$@4O:.:0P;F@B*?'':[QTWH;AH4"\_*/X@2>8@<0ZZM+:A]D^A23^WV].
M=1E#HW8?'I9<_8D[<^6#72-OCVG(<^LLW5*O  @!QMI9>G%3$1X#O3VJ,ARI
MASTY.8H>\=5[IS[),]"#]Q-1E0$ZI3&^I*D_>!TI5P&[/:S:3@E6]R6!IQ?G
MLBVB\N4%ZZ*81X[!VJ$^=PF?D>.P=,IN?9JA;<&Z%?V35.\;VUIG:"0#[#3U
M1%BK\^@5S!3D/-MCAVB.(B3922!B]!Y*JS763,' @/(&$.H>\-6D$;@CT@BK
M@0=B#Z"*:K(>5'U)NE3@4HQ%_&2J22DJ!2*#**C)2 1$<G$&%P@U[U!X)572
M3@BWB$E$T2*-%#D5/<E&I*B#D>B-I$\\\JR6K<O,W+H6D&W0A>DXU E05)\H
M$1DDY@4]H=0 ??JRL>C2E<3@5P06%J5([D$E!;D7.=) ZP$$4BK*IIJJ)I&/
MV04.1)4Y"B)BIG$ **E5.>C.W62NY&_;V(M;#EMQC\ =PS]&ZJVV2CG(L\DJ
MU6K4V>H,)ZL343F$ZLOCY_(2<ZY/$J+,I^KG1A4Q?NBLLA]KNPT=05J;!$=)
MF9\Y]4$; $XEJ]WI>A"DZ7"#J@>* "D#>!IP< @B!5M&L>LNC2E&E*-*4:4H
MTI1I2C2E&E*-*4:4HTI1I2C2E5_;V8M3'<QB?=DQ(?U=B%Y+T3-(IB82%P#E
M%W"(V*SN"!R!B8OO,#1;^^=G ?5M)C[\=+@SLP&VW"+GN+D-J,(?A'2%[I,Y
MC$@D9@\MZU'&+;O[8N 2MDZ\3)2)D")ZSD>7.FBQQ:(_ 6YN6Q=*R+5ICS=D
M]E\F8E,L[031B\W0<2T-END-$C'[16M^@&D5E" [H11<6=ODSOC$>2<4B\W=
M^U"@ZD#.%1U'UH\Y YGF<&:TG#W@4EH[CQ)\TF0,XDXCU>=6#:UU;*C2E&E*
M-*4:4HTI1I2L"(% 3&$ * "(B(@   !R(B(]   ZB(] #2E5E&RQ3,B9(R?N
MUGI5L3 >VVIW?&V+[("@.HZPR3)VB^S[DF%*D8Z4@T&7K$'BBGN6P&=O7=3N
M_JLRT=:FHNMM9M=VV75$ JG<XTIDDC;;(.>N1@UI[UXN+0R@!0!G'-0V!Z S
M,9Y'D33L[;-C&-)^'@]PNXG&QYK</DB9E<KVF+LUBLTC#TQ6V$,2IX\>4P9D
M*/(N,94 M;HJ[E[ /!7EH%W*I*=\JBHGJ;CM'Q8V[_#6+^X:X8X^73:MJT-K
M5X1K4  <Z$&)TR 0)S6[M> \-2XU>/6;#M\EKN^_6DJ4E!U>$!1*9 6I.K2%
M $IFK"J31:=C>ML:?0JU#5&KQAG1V$# ,&\;&-5'SM9\]52:MB)I@J[>N%W;
ME40%1=PLHJJ8QSB(Z)UQQY:G'7%N.*RI:U%2E&(DJ,DXC<\A6WM[:WM&46]J
MPU;,-R&V6&T--("E%2@AM 2E,J4I1@"22=S2KU94U&E*-*4:4HTI5 LTM\"]
MIV96B:8BZVC[LKE;Y!!$ %5G5<)[L&F?XX"D)R8/$X9/$.#E*!3"@^,"91 2
MB;M;<A[AK<$G\BE)DXE.#.3R$DGE!%<4^ SQ%T@3^6D#R5N<;C5_K5SJ"Z+E
M!%RW5370<))KH+(G*HDLBJ0%$U4E""8BB:A#%.0Y1$IBB!BB(" ZU6U;7>F.
MW$8CD\TT!&H1$ZQKSYO8X:>2?R+!>2:&"+%QVVZC9LZ9K<JE<#V5"K!V#%#D
MI@$==-V5XZSV?XJ>(/V[ETV;1^U4TTZAE9[Y*(4%K0M,)*,@IYXY3SG:C@CO
M'N%IL6'V[=P7+=QWCK:G$PT7 4E*"%>(+D0>1F.4,F^Q+*+14%VF6*>T7 !*
M"S:KV)!4"CP @"B5D(<"B !R4!X'V\Z]!7\I?"'$E#G!+U:=]*[RT6GR\)MB
M,'G .\B*X-'R<<40H*'&+-"AS1;W22"!&5!8G!(R2.G.OL^Q?*JC<6I\MU-1
ML945C-SUFR&0,J8PF%443644^\$PB8QQ*)Q,(F$W/.J)^4G@Z5=X.!W:5P$A
M:;JSUZ0("=0M@0 (]$<JJ?DXXFI)0KC5L4&3H+%YID[F.\W/JGH375+L)R24
MQ3ERC2BG*(&(8M1GRF*(#R4Q3!8P,4P" " AP(" #R \:N_VF\+,C^1[X@@@
MS>VN0<$0;?:)]/OJW_9K?B!_*MD (((M;F01D;*Y>G?E6P'8_ETRBBHYBK(J
MK) @JJ->LYE%$ YX144-:!.HD F-PF8PDZC\D.=1CY1^"A*4_P @W.E*M24B
MZLM*5'ZP'S4B3S, ^>]7_P"SOBNHK/'&-:AI4KNKV5)&P)#@,#V1(((K7AL(
MR.'ED^D>?G\$)WG[/A'P/T^?S].-2_[3N&&9X/?3M_/K;I&_<>N1.:C_ -FO
M$,?_ !:SQL/FMQ&_IZ8 (P (V!KG5V*965:E:#EVJ @B50&R85JR=VV.H!@,
M=!,;+V$C?*,/:(4!^4/ _*'5H^4K@X5K' [L*44ZU?.[,E0$1K(M94,#>1[:
MN/R<<44D)_EFV(2%:4AB[$$@CP2Z0DR<!,>B!%6-TBO*5&EU&J*NB/E:S6(&
MOJ/4TA1(\/#132.,Z(B8ZID2N#-A5*D910R8'[ G.)1,/DG$;H7W$+^]""V+
MR\NKH-E066Q</K>""H !12%Z2H  Q( F*]3X?:FRL+&R4M+BK2SM;4K2DI2H
MV["&BI*224I)1(!)@<ZB#Z0"":Y%P[3<#JR+^+7S[G'$=&*\AW"3:::PU2LZ
M6:KH[BEET'2*3QM1<564Z*ZS9PBDH8AE$C?)*,=JC6^@9@'48W@>?QB8S%7W
M:]##AYD #TDCET]OLJFRT;,\\O-VULK>"/A)F6LT3'V.:M9Q598UQ?!,)/(\
MO8)^=JN17-(6QXWGX@]2CH:PS#]G%)6)\C/ Z3.\N#.!E'?26[G9ANWXD.T#
MES\Y39I_DANW;4I:;E:E?E@M)#1[I2&_"\-!0I4 J":T;C/'GW+3^2FK8VRK
MA:>)%]00VJV* .Z*%?E-+B5K!4V M*DIGPJ5%VGH_-BSK9HSRDI,VHEJE[_/
M1KI%VA.VF:2*PC&ADUG[H;28[MG*3SY4[U_')N)1M&F13292SA-=4A.1XUQM
M7%DVB VIINW1*M:@M;CZPD..E6D$!02D!.PS$5G=D.QZ.S#G%'UW#5R_?W$-
MJ88^:-,6#:EKMK3YNA1:4IE3KI[X#4H*TGZ,FQW6AKMZ-*4:4IOI?'-7DEG#
ME5FHBNZ65<++-ES$.=98XG44$%"JD[1SG,8?D\<CY<=-7:E==HZ<MJG%W<)
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M:E"DD8(. ?, B1(.V.HY5WDW+9904D7+=54$4ES)IKI'4!!?M]PL)"G$P)+
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M((,Q47[5LCVG6Y\O,NL%46N65QVN\N>-V"^)KX(F$#=LMZQ@YJ%N*H!@ Q5
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MQJUG1&.=5J,-'UBQ6S/^0*W/,RS\&XA6MT,RF)--@F^@G+1ZNP;9"$MHA2C
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MEJ3$$W-3]$E-QZAQ-W#I2A;(JHJ $.)"**@[S2A)M0.)>V";AF1P"8@<4NH
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M:I)/%$#;C]G,S(JL.R9#(V,(^-SC&Q:B8=D74)*U-I#YSAE$R_KA7;?',<9
M@_)="8IPU>!!(0\0(RE1"9W.4Q!)Z[QB=XG5>6K\B[M(5S4 EW)R#J3"T3N#
MG'+IV<9W4RCH\?MVW>VA-Q$CV'>+\CRS7+Z$7W8\@SFZWDX4LVUU-$0[LL>C
M>J^1ND4R";=($R%)12<_E&=(CZ2 4R<20,@@SC8YSFJ)L[)^?FERI!YME0=
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$J5__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>g60414g23y10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g60414g23y10.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2?Z4&AO=&]S:&]P(#,N,  X0DE-! 0
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M @ %, 90!T '4 <       "G!R;V]F4V5T=7     !     $)L=&YE;G5M
M  #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[      (M    $
M    $      !)P<FEN=$]U='!U=$]P=&EO;G,    7     $-P=&YB;V]L
M    !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B;V]L      !#;G
M1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L      !%;6Q$8F]O;
M      26YT<F)O;VP      $)C:V=/8FIC     0       %)'0D,    #
M   %)D("!D;W5B0&_@            1W)N(&1O=6) ;^            !";"
M @9&]U8D!OX            $)R9%15;G1&(U)L=                $)L9"
M!5;G1&(U)L=                %)S;'15;G1&(U!X;$!LW08@        "G
M9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0    !09U!S     %!G4$,
M  3&5F=%5N=$8C4FQT                5&]P(%5N=$8C4FQT
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M      !    !XX0DE- _,       D           $ .$))32<0       *
M$          3A"24T#]0      2  O9F8  0!L9F8 !@       0 O9F8  0
M"AF9H !@       0 R     0!:    !@       0 U     0 M    !@
M   3A"24T#^       <   _____________________________P/H     /
M____________________________\#Z     #_______________________
M______ ^@     _____________________________P/H   X0DE-! @
M   !     !   "0    D      .$))300>       $     #A"24T$&@
M #-0    8              _0   6P          $
M       0             %L    _0                      0
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M0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX
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M       0$ .$))3004       $     3A"24T$#      =70    $   "@
M  ;P   >   - @   =00 8  '_V/_B#%A)0T-?4%)/1DE,10 ! 0  #$A,:6
MYO A   &UN=')21T(@6%E:( ?.  ( "0 & #$  &%C<W!-4T94     $E%0R
M!S4D="               !  #VU@ !     -,M2% @(
M                                              $6-P<G0   %0
M  ,V1E<V,   &$    ;'=T<'0   'P    %&)K<'0   ($    %')865H
M(8    %&=865H   (L    %&)865H   )     %&1M;F0   )4    <&1M9&
M0   +$    B'9U960   -,    AG9I97<   /4    )&QU;6D   /X    %&
MUE87,   0,    )'1E8V@   0P    #')44D,   0\   (#&=44D,   0\
M (#&)44D,   0\   (#'1E>'0     0V]P>7)I9VAT("AC*2 Q.3DX($AE=V
MQE='0M4&%C:V%R9"!#;VUP86YY  !D97-C         !)S4D="($E%0S8Q.3
M8V+3(N,0              $G-21T(@245#-C$Y-C8M,BXQ
M                                                    !865H@
M      \U$  0    $6S%A96B                      6%E:(        &
M^B   X]0   Y!865H@        8ID  +>%   8VEA96B         DH   #X
M0  +;/9&5S8P         6245#(&AT=' Z+R]W=W<N:65C+F-H
M     6245#(&AT=' Z+R]W=W<N:65C+F-H
M                                   &1E<V,         +DE%0R V,3
MDV-BTR+C$@1&5F875L="!21T(@8V]L;W5R('-P86-E("T@<U)'0@
M      +DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R('-P86-E("
MT@<U)'0@                            !D97-C         "Q2969E<F
M5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M,BXQ
M     L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3
M(N,0                                  =FEE=P      $Z3^ !1?+@
M 0SQ0  ^W,  03"P #7)X    !6%E:(       3 E6 %    !7'^=M96%S
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M $_@4-!1P%*P4Z!4D%6 5G!7<%A@66!:8%M07%!=4%Y07V!@8&%@8G!C<&2
M99!FH&>P:,!IT&KP; !M$&XP;U!P<'&0<K!ST'3P=A!W0'A@>9!ZP'OP?2!^
M4'^ @+"!\(,@A&"%H(;@B"")8(J@B^"-((YPC["1 ))0DZ"4\)9 EY"8\)I
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MA2J,2I-ZFIJARJCZL"JW6KZ:Q<K-"M0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\
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M=3W>12P#*Q] ""1H#W'?+*?CDK4K,S,7F2!V4C85&"D@@?ZQ![[.ON,[J[M
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M6K,]7KF*-+;O321UDMSJ$\NNGPRQP*S,I,A+&3F<EG3XQC&,8QC&,8QC B
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M!\ %9,.A' !\S$ BO3J(^*;*2UPR.3)5;RV]XF),9/\ Y2>Z'[=U_#+"&^R
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MA=X7PSR-^3E*?BSCN/XFY.]J:E?@Y \W0\YFEEJ1U*]26O>>)B8X)(K:1R*
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M?N^GJOW/22<FPW9(^E7_ &B ZV3\X&_J>YU[ ^VAVT<SC$3D7.( XC72:Y0
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MYQV%Z@/0>H  !ZC\A$?Q]?CZ]>O7TQH?08SDQ0,'0?4.O7^/^/[/EF<8 I0
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MH/<;[?@2/;>,8'TU]2?IHZ]=G\/<:_'&,;W]O4^O;[ C^&NVO;Z8QF"/^_\
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MW[$'U'V/;-8FU8N/B/:)Z,C(OS;=NCP_Y(2GD#KF4C&9'NW^-K0I(M$YC'9
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M2_\ TMUU>"ML'>J<#!9W38Z?B+0C9T! I1.1(O[*]'@!=+:AZ>@?HOH'X_\
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MF9RH4JO03LY"W-/-,J2F".!EC)5(V=W,:R,29%<*@610NEV2&.]=L\+2YR#
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MLAQJ3E7R5TS5[5?IQY9[FZH^O=C/HRKM+%99)161G7T>Q4\H20?*G7%HFV;
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MY!SMLM:.OY*1$)Z-H$^Z@JE5[ DP<-==P5@+38QRQ8S16B\>8DTZG8=(,H)
M[*0_8;[Z+ ]3 :V=$]\DP=(N6P68L1"0I8[(* ENC9&E(TI ^4?*#WS&9^5W
M%OB_[6;VC9^3NSJCKV*OVE^'\?6V%K9/Y(+9[GHEN&?C8V*81<JM)K)MYB/1
M78 V.HZ\\@W316.KV9[$,LE2NT2DE99M]+#Y=E0I(W[_ #>Q/;^?@S0Q7+(E
M?IZHH"H(.B 'WH@$>^F[^G\<CCQ!D=SZGA?94U5C,;%TW0=Q[Q]IW=JWKKRM
MC;>%J![JG9VP---++K-H7Q)UO!.C-[S5:D[C7Q@7=L%XML5TY1Z>Y0CFT3IR
MD=16(*C<BLBRE2-=^Q5G]A[^N]4/6HJ=/5&CRVV"ZT/+*NT8Z1VUZ,%8;.O0
MGMED\%>1N\:KMR+JK+;D[ROVKL+0O):8J]TUGRMO^UZ;;+O1:Q)VRM/^2/$_
M<\&>[<<[(-ACH^F5E2OM]<,0FI#[+C7)=J\>>6S8CC,;,%$2(\>T>-4(!V"(
MIT8^:"/F.R2==0;U.>:\KK($+F:1HY=-'*SAM#:M+ Z$P'>U ';>@0WH..#G
M*?:24E3MD..1-FOTJXXD<A=G<O-:Q?)'9'([;ZUCJ%14G6=FBM(V/1<7K/B?
MLNF7I#[-5ZDS5I95JPQ$@V@XUM:46"3V231*2R"-5!F1(9##'$I4G0W)YIDE
M4H0?1M'W7,P3-V8OULL+O/&)I)64@$DK&T:I$ROL $IL'0V!O+)XP\E]BS.P
M]T16N.5E\KM"V%[+G8VUHZSSO(O9G-N?U_NF&L5< E[N3=G16XTO<]5K=B-(
M7W6&GJW)A1XYV@[79KNF[1!MZDB4*A>(,RV(U*B-(0RD'Y0W7\R,>P9]#WWO
M>O,4S-)(J2L$>L[@^8TS*P8#?2%^5E!)*(NP=A1V RY-%\I.0U)U#S9JFIKG
M:-M;GK?"%+<%4V'J3EK9^9>CO>C"<2A'ET9Q&S6$ULG3>\'T+)3%I+0G]D%A
M*-X4%%:"T5B8[Q$D4;20&1>B-INAD>'R)='UV$ 5D'8!@ 2=C>LS'-(([*QD
MO*M<.'28S1=>B!HN>M'(&RK'L-'6SWGA[*/9EFM7(._U^G\@(W;NE3\=*#:[
M+5_Y4NV>9$G6MOR%C60;VQ7:=TTW0:[KN4N=>-*$M^F$K$K.Q4S$-Y<*Q'L#
M*$81[2Z12\123S& /E+""@'=>D.2W2WHY0$@D=1[9(ILQD;IE#Q^6I*F9YR'
M).F\QXQT]2@!H^L])&PH]]_>0<L<8QC&,8QC&,L]]6Y0LF\E:].DAEY,&XRC
M=W&$EV+I9LB5LB]31\W'K-GH-DTFYU"N3MU4D4@5:F.F"@SH[4)A2"U6-A8B
M_DNDY@D178NT9;RY5>/K9F Z592S:< ZR*\$GF/)!,(3)KS%:,2HS*H4.!UH
M5?I '9BI"@E2=YU,J:FR6AW7O%PZ>1\Q)3D@[=)IF6EGTG&NHU4R@) DBU(B
MDND5!-!+PTT&J3<"_%4<R7VD2PGE(B2UXJT*(S!8(X9DF0#JZFD+%"7+';.[
M-]!F$J!#$W6S.DSS2.P!,KR1M&20-!=!AT@#2JH49CQ6!GUYIA#,T)IM"L;P
M2Q^7<LHX(U%NE*+2J[E*<([.LZ;.E5#J,HDK--\U7<^&Z6,@V*8+-;55:\L\
MC5WLR\<U3JCDE\YF:!84C:L4"H\8 $E@R&-T3J107R"8)FF2)%E2%+@L$%%"
M "4R,1,) 65CMDB$?4I;YCH:%>C]7F8R+!][X:*>[)Q2:;J%@&J4J]%87A54
M9F9\RHZD#E3>JD05(1J1,2)F5;N!(F"<>3ES)#+%Y#@S5EKLOQ4AKQ= CZ6K
M5RG1"I,:EE)D)[]+IU-O>G']$D;^8A\N8R@^0@E<L&#"64';'YB%*J@ /<$@
M'*TE0T B:[$+OC+MX):3.J;P?#,_2E(Z7CE4! %A!L!$I8Q@. K"(H@7H'>)
MBQFY%S/;G2,(UE80--ORFAFKR@]U^;?D $?+^\3Z@;W"FOEP1,Q98?,WV ZQ
M)')&1V/RZ\PGMOTUE/C]=+,TE6RLLP5;$B7T2R%M6XUB^!-ZT%F#F3?I'.K(
M.$$3&[?*DBR*G$QURJB;[NV7DUD(<02*YGBGDZ[<LL?5'()"L$; ")78#?69
MRH "%=9K2B5!0RJ8Q$\2A8(TDTZE-R2+^^RJ= JL8))+ [PZUJBY(H;WF4'1
M!KRK%5:-0=MD'$!$K1'^E,G*ITGS5\W<+>,W,9 Z0F R2X*$*H&4Y9E('D_L
MS\4LBK,Z.RV9UG^250#&\3HO2^F#:/4A!(PU ,"?,T_[ HW0&4-#$T6VC8D.
MKJS;4G8[:;8!'<-#?>ZE683$6#IP_%XZ*:JQAH!RCY?RY&"L$"I%%&R?HX(<
M\J9T#KN4%P9,W@AX_6*>>)/AY>A(O+C(O3BTC=?691:Z" ['Y640!.C0"['5
MGHU',1C,L>V?J8?#1_#L-=/1Y&]]('<$S,X<D]1'RY48ZE>[(%G$,IE^Q=,'
M;U\U?1P$:-TEWRRRZB 1!_,,31:9EQ20C5@6*BB4OA+D6#QPUR\@9K+SR5XI
M$D2.)XY27<I&BH&\\!)/.8("TR])9B25(^7/4=3RH4B65U9'>170*BAG9F*B
M+NGECJT(^X [;S73L$TZ'M*M9(3Q&*B[?@YN<B$A'F4(W?IGW[HCO7!DL)UH
MU8  J:S?S+M,P_?2<F)]Q.C\1BK^K8FK-+TO>B+PS %H2()U \U=+,'#-INB
M-@%TR[T<L^$,_P"LV6=8^I:4NI(RVI%,\/?H/>,C2]0V^SW# :&2V_N_M_=\
MOS#^&<'G8YS^'[O[_P"[&,8QC&,?P_M^?^7]N,8QC&,8QC'X_P!_Y?P_SQ]/
MS[GU_/IK&/KZ_P L8QC&/^_Q_C^?Y#\,8_/Y_/MCZ'Z^6,?D_GVQC&/KZ_'Y
M8QC&,8QG2X_U=?\ X*O_ -PV3>-_TC0_XVK_ ._'D:[_ .#M_P##3_\ M/EG
M#\1_,?XY][SY2.X&R?H==_K]]_AV'OK[\8P1H#?OW'\O7\-_;OW[G0QC';W^
MOL/;W]>_\_7^'9C,^FNV_76_?8UZ=_0^_OZ8QF/3^OV!(_/X^W;>,9G>_P"X
M;T-?3OV]M]C^.,9CU/?7OZ$ ?;Z]OO[_ %[$XQCU_GW/KOL/J??N0.WT[^S&
M9W^.M[UOMKOO0[>O<?\ SC& ?7>]:]/3M[;T.^]^O;ZGVQC'?>_OVWOU^NA[
M]AL?<=M8QF/7W'T[_<_]]_D8QF?OO7T)^W?M]-$>W?N.W?&,Q_+\>_U_QW[_
M -.PQC,D_4>HWZ:_CZ'[DZ.COUQC,$#7I_'?W]O3?;L?[AC&#H^_OZ:]!L_G
M6_?UQC/0&_4]NP]O76A_CK7T!.\8SSK\D]_S]/Z;[XQ@[UO\?;Z:_C_W^I)R
M8,5_LR-_Y!G_ -.GG"3_ -M-_P"K)_SG.DC_ +./_<7_ )1GOS5GO&,8QC,*
M[JX]:BY UPU:VE3HVP()D4]V2W8+2Q02ZGQ<0<\V\.1CS=P%.JW37%D\$A$W
MS5RB IC>\!XFYOPS;%OAK\M5FZ?.@WUU;2J0>BS6?<4HUL*Q421]1,4D;'J%
M+S?A[B/$-8U>5IQV4 /E2_N6:['_ %J\Z_M(C[D!NAM .CKVS\_O)[V6&UM4
M#)VG3JKO;%#;BLZ/%H()DV#!LBB)@(O$-RE1LZ3<@E*=Y ID?+=3+'@&K9)1
M8/TOX0_3'PO->52YQ4X3DFZ4$S,3Q=E_0E+#?-39CO\ 9VF,8[ 678@'\]^*
M?T4<MQ/G7.%+\O07J<PJH'(UT'<AH5TML $ /742=B3 !LB$R-]4+JQ75XHO
M#3AH]["(QQ6CCSA7CK9$#8ACO+@D*OF2FB%?YDX"H"J@-^T%NTH?1&XT-S Y
M?K00"6.P92Z>68TXJS4$H;J(Z")A\P/3TJ7WTDYPBWE'$MQ?3(;'0]=8A$_F
M+(_)5[9CT$4]1\EMCI)ZW*#1UN<?&'V5>TMI&B[5NM9WJJBN 2=IP@D1/L*<
M:'(!R E'*D5;55)<IA#S$ZFM*(B3K]GQ(JDX#YQXN_3+P_#B:EP"Q\WR2=4?
MQ&V'%5I 2"3,I5[K*1^[7*Q'8_SG:E<[WPM^B;E>5,5OG&?B>/;I<5P%/)6$
M.B!Y;AEJ*W<%IU,P]!!HA\W_ .F=!:GT%6R5?5U/C*VR-X9G[U,AG4Y-.$P
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MC&,8QC&,9K+VW_ZRW5G_ ,C.Y_\ \?M$96<W_HQ?^/A_]F?)O$_Z3'_!3?\
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M,8QC&,8QC&>5\[38,GC]8#F19-7#M4J8 90R;9(ZQP(!C%*)Q*00* F* F$
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M/% K1QOW)#]1E( '[1AZ'V TJC0 V!O/GMBU+R$R2VY1)(F@D914CB#>IBC
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MAOJ4: &M;ROY7CDJ<;-8:1YK7FU09G/IYEB-) H)/[RDKMBS$'MTGMGYQSN
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M (>OY&,?W_P^OQQCUQC&,8SJ672;D%18Y2$#TZB/J(_'H4H=3&'I_5* F'Y
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M4,Q&.M3V40@GH/2I*BT\L^5\R":G@]_8;H".6Z0K%N_RA26[>O8#?;W[8,B
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MW$; 54P=>JINH)%Z?$2@ @900_$.A!Z"/4P )1GP4)9"#("BG_5 )D;>@H
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M8??^[UQC,@?;Z@[!_P"OKK?IW&MZ]\8S&NV_O]?I]/YCZ_7>,8]3K8[DG?\
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MQ 1SL*]JO:025Y4E3W*GNI^C*=,I^S 'W],X:S3LTI##9A>)N^NH#3 >K)(
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MT"@KY(E_#%%6[0II@--,WS3/[,>H=HP1L=*!>VNIF/<\E<NVK[;LS;CV"E=
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M-T4?/$FHR,LX[GTL\?OE%G*FMBVR#W/J21LG[[(V->F]]OKFT!= +\JCL -
M#?J-:UW]3OU/IVUN_P#B:L8G-3BDF3M[5[ML4JO4![NA-#[54)TZ].G0Q?7\
M0Z_'TS1:W\'9^G0FM>A_;1^GM^/]>^\LN'W^M:/<ZZK)._7?PDP ].WJ>WI_
M3/T_9S>?0<8QG("(#U#'Y^OKC B(_'Z_/\?VX_E_  ?G\_7,[/?9)V=G?<[[
M^Y_'.,9C&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,
M8QC ^O\ 9^KX#U >H?,!^>>XY)(F5XW9'0]2LI*LK?4$=P?;8]1V/;/+HDJ-
M'(B2(PZ61U5E8'V8$$,/L=YW$6,4/O!W@'Q'^L'J(!ZCT WR$>O0?B/<(AT'
MJJ'B5E COJ6 [?$( &].P>-1IB==BFB>WRD[SC^3\*1R=4W&L(G[EJS]31ML
M]_+<MN,_[*L&0'6BHTHH5PM"5.J=AMIX6RV9.NQ#V7/7Z;"N;';)@&2!EQC:
M_7V?^F2TPZ OA,8]#HJZ7,1,@AW ;.NAGALQB6"1)4/HRD'1]P1ZJP]U8!@>
MQ .</8@GJR-%9B>&5=DHZZ)'U76U93VTRDKZC>P0/=JSVB7$6_66H:L'9Z^N
MML64(Z*@M5[MI5ZTA?YB8< W:H0\)7MJ5RJ+V"27=*IMF[6OGE3N5S FW\4P
M],XZ>"8/+)T$IYCDLI#JNW/[Q4GI(]PVB,N(;,++%'UZ=D4*CAD9M  E0P'4
M.X[KL??)TY%R5C&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&
M,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,ZE5T$ **RR2/><J9/%4(F!U#
M?T2%$XAW'-_5*'4P_(!S!('J0-^FSZYE59M]*EM D]()T!ZDZWH#W/H,PO;I
M.Q2\TNZJ46@LZUM)-U7:ZLHHV=2Y'T:W>R\ SCB,5TG*3J+<-NQ=VZ: 61(W
M,@!O+F%2%,TCOU0H":S@N2Q#,"NW1%Z3LE3V+,OS$:['>=#0AJ00*G(3LB<Q
M ZQ*L =8#'.T=>U),949.B>-B5CCDW"7#:+#IRFQG6$G!M[!'F4>L'4>$@AY
M9%1=PJB*0JBDFU2*HN=R @*0MBD,KXY11[14#M&6KJR"122I7J&@2=:WZ#OO
MVUZ[[922UI8++U90L<L<ODOUL%16ZNGJ+G0"=^H.=*4(;>N^0'W-P:KN[[HY
MW519"8XI;Q.U(FEMO62# ;?=2-B $<PW3453_8/95:0,1$1@K8QF)U!NF5&(
ML]:6 1)A))9@%GC4UP& AE'5+HZTP<'<!]3TH2>_S:((R0XK4"S4K,KWSTA[
M<!,5-0O=HFB=>J\N_225853IW$"2KB-\ONK<'&5\G7N:]&:0=0(=!E$<M-7,
MY68T+/'.8B**FQX<2O[5H"7<F.3S V\TKKSS)E@8[",4"-B:)N.ZMO48N-_V
M#](F7_=.PLH]-=.GUO:;&S9T_$*'IBY%! _91:C#-5<DGNY(ZJQ/J?,+1+O7
MGGVP?[46<AI;A8O8HF6C96!?;3X]23&;C7S5]$O8YQN"F*-W[22:JJM'#-<A
MB'1<HJJ(JE.4Q#F*("..+5EME2"K".==$'>Q$X(T='8/J-9*\0.K<1(ZL&1I
MZ;*RL""/B$((921HCW!U]-[S1YW+N#?=$Z"8_P!<P=5A#_RE'H5,!].@G QP
MZ]#)$'H;+G0 ] 3V_CLZ!UW_ #O6<+LD]^WN?MH '[^WI]=9=5*0(G;JMV@(
MB:R09C&'J8YS!)M0[CF,(F.;I\Q$>@ !0$"E ,\%CKTU['Z:/H-:^GIW^OUS
MT -CN"=_79^OJ-?U'_>2_+\ &Z58?E[LV=T^ _\ ]2V]Q]?0?7U'TZCT_/US
M"GN3KOI3V]AT+]#^&R#_ $.L]'T ^7U8'?N>MM#^_P!>_P!O?(@'1Z"*B1Q1
M.8>I@ ![#CT_]HF @!A'H =Y1(H = !0 SUOV(WK?S>O^'IW]]^OIZ#/.M[(
M;0^Q/]=D:^@[#L!F:.'ZPR'./B]&MBBZD(FP;'L$FU:=SI2/@_T*[)B F'R:
M0&48QIY63CHY-X\(BW4?O6S5%5590I1T6P%IV3OLRHH)[$MYT9Z1]3KN=>FC
ML#+'AB6Y>D I)46&8CN%4UY5#-H?*">P]-D@ ]QO]1><WGT/&,8QC&,8QC&,
M8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,939F9
MAZY%2$]896.@8.):+/Y69F'K:,BXQBV(*CAZ_D'BJ#1FU03 3K.'"R:290$Q
MSE#USTH9F"J"6/8!023^ &R?X#,,RHI=V"(!LLQ 4 >I).@ /<D@??(H0FW]
MU\HW@PO"RF,QHBPJM9+E_MB,E8_3$:4#G275U)4?_1EJY 2:)BG%F^B'%<U<
M=<@'6OSXI3,'%Y0BGHN)FL- QT?AX^DR.H/I.&#)&"/9@T@[](7YM\AR_*5+
MT9JUZZ6QW'Q<H(AA8CN8 "KS,/\ :C98@=?/)W"^=AP!<L.>G$[8%N?[.WG.
MZFI.V=O[-Y+;555>M9B\*,H?7&K-54.$CRMJ+J^"AS6NY[!2H=(B8QLH,%$S
M$XYFI=NE)JSFL%HIR.A/-95\I-CY6+2.Y]2W<*NV/OH=MC.86KJ: DO(8E9F
MF?U+ !$0:T O2S'2C6UZG+/HYNIR'D_&,8QC&,8QC&,8QC&,8QC&,8QC&,8Q
MC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC B >HXQE G[&PK
ML<>5>E749-W3)N]5:D*MY!)XX2;B]=E\0ADV;4%2KNU"@<Z3<#*@F<I1S7)(
ML8ZFWH%0VM'I#'74WN%'J2._V.2:M66W,((N@2/'(\2R$KYK1HS^5&>D@R2=
M)6-3H,WR[!UNCS%KD$)8T%6X0+#*(1J4N](I)(Q3)FQ<JKH,BB\51<BL[?JM
M70-D4T13*1 RKE=NF9(ROAYCUF.)#(X0.VF50%8D+\Q!!9NDZ&M:&R1DFO1B
M> 6KEKX.N\SUXB(&L222QJKR:C5X^F.,21];EB=L%2-SU=.(@G*;8[#*2.PF
M*2,/(Q;>/@BV=$@-8&3C%'C2TP7<?O;1]@3>^"[*Y0.FZ>LA;*LUSD0[2P_,
MADD=["J$*JL9DT1$Z;6:+9&DD#:[@@L""I[ Y>_#\C4IP0\1,[6(9I9;9H.P
M>U#.$>C:T"&FJ&+JC*,I2*4.)5#-E<IM/L"T6E-Q=EDH1Y(@]CG2TG&)R*\W
M QT@]:U>6=-7RC99I.EA/+$(]6\0RR!DO/,U#E I=D$+]*R+(T;'J5@R]77&
MK$1$AB"K^7KYCW((ZAD;DK]43M5GJ0VHX?*E3R9O)6M;EAC>]"CQ*Z2UC:\P
MM$-*K]7DNH[G+-9K<95(=K"Q)%B,VH','CKJ+J'66.99RN8RAA AW+@ZCA4B
M14T054.*:1"CVY+BB6% B#0&SW.R2>Y)_$]^W;*.[<GOV9+5AE:630/2H4!5
M 5%&ALA5"J"Q9B%&R=97\V9%RR-AW/7U%JDI.[/L-9K5,*1*.EI"W/&+*!4+
M+K$C$8YV>1,5HX&37=$8I,3@H9XHN#<J*@G[!C6KM6A"UFY9AJP(5#33R+$B
ML[!$'4Q'S.Y"HH^9F("@DY8\5PO*\_=CXOAN-N<M?F25XZ5"O+:L/'!&TTSB
M*%6;RXHD>25R J(I9B "<UL[A]FJQBF-A><1)>I:YA;,#]2\\5=F0)[CQ"V@
MB_,==_'A1#%<N-,24FX.956>UBU+"&<CYF:H<^H(F"83'*09U;S% "68CT6(
M]>GS['6 .VG[@=@P]H$$T]4%("CUW),U&PHEJ2@]R/+8'R23L]4/3MR'=7UF
MB397%A:L74M'JT))\8]V/_,>[.)F^[(5_K#92K0""LIQ)Y)]KB$L:"Y5$P:4
MF<<.WL4=TUCI"!UPR2 <]^;)&-S 6(_:S#_:KK1 L0ZZM^G4P#>QZF[9[%6M
M<)-$M2L#M^KKC@PR,>HJ*=L KUN%8*DA;Y01Y<?2-1ZC)"0INQ&56OM;G=?W
MRM247)3-&N+ T58&K5J_24.]9% ZT?880YDC%;62M/I>OO>@"TDE@] VZ5D$
MD;K*C$D.A#+[;]^I3Z AP#]0#D)Q)%(89XWAF4;,4H"N1Z%AO2NNSV:,LO;L
MQ&9AY0[.K4Q.PDVJ];,F30MZBDA,<RRSN0E=\;<FV4>Q02 SF0?O"33=-@Q:
M(*O'ASI V06.H0#D1B2%!([#??Y0% )._0#1[G0(V ?77EW"ZV0#[#_:9F.E
M !VS'J'RJ-]7U[#,F:$X"[ZWX#6>O197CMJI<Z*J3F6CVJVZK?'' #'4@JG)
M$<L=;M')>XB$M>V;VRD PG"BMBF;/\BSWZ]?:Q?MY>X/M$F_79T#(1V("=*@
M]NH]]7-'@KELK)9W2K@J=$$VI1[Z1MK #W'5(K/HZ,2Z#G>!HSCCIOCC7EZ]
MJ6EQ]>&2,@M8[$N=>6N5P?H%$J<E;[=)J.IZQ/2 90K<9)\LW8)*&;1K=FT
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M<TW]ZGC<?QD=&7XMII[O(O&8Y>0MNKSF-B&>*%$1*]6NS!=UZL,,3="M())
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M\1'E5< ]\!^*(^8FD&SLR@L6KU46+9'L3.U6,3O"(M0#Y6D=HE<ND.](O?J
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M;$TD,IRUL&Z*0JY[F$[1KM98>(=RTCKFT+,1C9UC!V-I, UE6[5[#R\/.)D
MHE6(#?7P/"'Q#QWB.CSO$WN)\SQ+/R=3J)66I<FBA>2:A8>/HF6*R)F69%D@
MDCE":('2)/Z0?'<7Z.?$GZ,N>\ >*N"\7K5_1C1\)\QY?[>ES7$4;=R*O6Y_
MC4F6>G+;H25/,J2R16ZEJD9.KK7J?9-Q_P"+M>T7+6ZZ/KS?=N;5OS2#C+?M
M'94DQ?6.0A*RDJC7Z_'M(B/BH:%A(P'#A<K5BP*N\>.%',@[=&(U*V[GAO#\
M'$RVK;6[G)<C=6&.SR%]T>P\-<$00*(HXHHX8^IF"I&"69F=F)&O@WC3](5[
MQA6XOB8>(X;PQX;X1[D_%^'/#]>:#CH+G(,C7KTKVI[5NU;L^7&ADFL,D44:
MQPQQ@R&23V7^?/\  B >HXQEKI72K.)U.M-9V-<S:B3Q0&#9RDX5(+ R0.D%
M?",8J3I(%>X6JAB.!(FNH5,2-UA3U":(N(Q(A?N>D,"?E.B.Q[$'V/?L>V3'
MX^\E8W'JS1U@T:^:Z,BGS03&5# %D;I($@VFRHWM@#@7D5Q$T;R11CYC8$(\
M@-@U1LK]A]V4*7<4;;^NCB)U?'J]_B!1DD8\%3&6>5R8][5&6 5$9R!DFJBJ
M!I"R%%93TM&W[\<@#QL!O]Y6V-Z)^8:8>Q&AD$(?,5XRZ3+VCDB9DE!)!"JZ
M$-ICZIW5]Z(()!UXN[1R<XSKKH[2K\[RRT!%?<#DSI^EJH[)JS AS]5MKZ9@
M4G 75G'(AUE=A:0:OV)$6ZKV4HD,0'"J4%JL%HL:A\MEV?+D/[&0[^98)VUW
M '[C_*=*!(6WG3)RMWCUBCYA%?K8!98RIMPH0-->J1KN(=QIMK)H,S0@?-DF
M==[+U]MNJQ]WUC<J[>JG*%,+2=K4HUE&(JD]%V;@[=0YV4BS4 R#^,>D;R,>
MX*=L]:MW!#I%K9(I(G*2(R,/57'2?QT?8^Q&P?8G.@AF@L1K+7ECFC;>GC8,
MO8 D'1V&&^ZL P[=@<O?/&;,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8
MQC&,8QC&,8QC&,8QC&,LV_[%H>JJM)7?95OKU&J40EXDA8+/*M(B-0$P#X2
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MD8DM(DC(9(W8DDM&R$_7+I(0B1"D(4B::92E(0A0(0A"@!2E*4.A2E*  !0
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M &5%9.DB)I"Q1#OH3I0LQ7J-V@ % "E  *4    .@  !T  #Y  >@!F[(/\
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M^JE\3474<+O9_H,>MLEDA:,"VJLBZ"R;Z9H_H(Y-'8__ !;*P.AH#,4!>BL
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M4$$$2 FDBBDF4J:229"E(FF0I2$* %*   !GGU]<U : 'T_A_0>F=V,SD?\
M>E<N\N]U1/T>M(VMY1-A$M#^'5G(^OBX8!6K!$F!.0D0.@50'$FW$"%25.)0
M,/9V@)B_(OTJ\-XHOVOT>\SX6X-/$-GPGXS_ %[<XQN5I<.TU-O#_.<6?+N7
MCY(=9^1A/2$=BH;Y=;9>P\)WN+K)XAJ<K>;CXN6X5N/AM+4FN>7,;U.SMH(=
M,P*5W&RZ $CN?3*$]KVU=MV&E_;NG1&N*92[3'W9RP2MJ%MG;1.P9%A@&0C&
M1[.-BXAD]6]X/#*N'SAZHW;MR(-R]ZH5EGA_'OZ0N7\,'Q7X<X_P7X9\,\_3
M\4S4D\0P>(>8Y[EN*$OZHJ-\!3K<?Q_&5+4B\A9=[-VQ;D@KP+! OFR"5'<\
M/^':7*_JCD[7-<IRE";BHYVXY^-J4*=OH%R4>=8EGL698E->-0D21K)(Q=^R
MGI3UKLQNPW>I6Y=.IV.T;1;W>E2(KIKLY%DPA:H@$?,IM3*+MXV87AY")D$Q
M(#E)JL#I-(_\V0WE?!?C:*G^E-N%Y"+P_P WSWC^OXI\+7FF6:K<JTN(\+P_
M!\FE<RS0T>4FXB[QEV-D%A*LYG2)B45O1YW@WG\)B]5?D:/'>'WXKE:_05DB
MEFL\BQFJM)TH\]5;,-F%M^6TB>66'=A;UEK6UMNRU%;6/4D%KM2J7&MVN2O:
MEMAK))H(UQ\F^6BJ@6*9(28&FS) S5<R9V+=LQ45\9HY5,1,M-S?"^/_ -(O
M(^$H.;_1[Q/@QO#WB;A/$5SQ8_B3C>=O11<)=CN3<;X>6A4@O \PT?PLL]UZ
M<,5&2;SZL\KHBS*-WP_X:K<N]#Q%<YL<CQ=WCZ_$+QMJA79[T)A2QR9L2M P
MI@^8L<"2O)*%*2Q!3U>Z(9;BU_?=O2$-J)K=86\W-I9(N4&_5VOG(V1K$'"J
M(*L7[=TX*<7$:JIU.*?W3!T)T^\,BC!^D?PAXP_21<XS]'2>*.*\5^):7-\=
MR">+N$XAQ##X<X?B9(I*EQ)9PPGH2LI/0.DC2=^HZ[$OAKF>'\-PV_$<O%6^
M)XN2C8K_ *FN7%9WOV[(99H98T*^7,@/8[;?IK652X5;8.Z&5#K5SH2=+J'V
MS6FMA1J5Q82ZKN%K;#SU;CDW4*9@NHG.619LHZ(T JL>G#^.9<IUD.L[Q)P7
MB_\ 296\(\+XD\)CPSX=_P II>4\941XCI\A+8XS@Z@M\%1CL<4]622/E.=E
MKSS?#E)::<4)'D#2Q Q^-O\ #^%Y>7O<5R[<GR7ZK6KPU@\;-56&U>F,-Z=H
MK2SINK15Q&9#TS&T5"_(V)313*DW+7MZU)"N$I*)GCPUR9O;-,O"2= GVBK>
M7[%;%+/B XAI%*+G&C5J*1G2S,2??4!,N>^0_1;!X:\3^#/%OZ/N-ECO\=S$
MG%^)J]GG.1L+>\&\S6DAY)5;F>0M+YO&7X^-Y>O! 4:>2FR:=RB9B#Q;-RG&
M<UQ'B.TKU[-,6>,DBH58C7YFG*LE4E:5>$^79A:Q4D=PPC64$:7K!\:B&\(&
M-G*--:TA]W1"[^8-7[9,V^$C4W41*NW+EC'7*%F8]=<%H9)R$>J[BDWY'[%N
MD*;=)P)N^,R_I4XFGRGA3DO!'%_I0XR:WR+<3X@Y+Q+Q?'I8XV_:L3TZ'BCB
M^1X^60R<5'.*,MGCHKL=NE!$\==9^I9-JGPG;GJ\M5YZUX5LI#5%SCJ_&VK#
MQV:\4<<\W%VJLR(5M/&;"1V6A,<LA#2%=:M(-2[,H,)QO+7:^TV'(ZF5NZT_
M'DL#*O->EKBGC9NRBWLV"IACH=62,PCR&0.H,=&MRJ)H"IT)S?\ ]SSQOX/X
MS]"?ZEXB#QI<_1ZWBEN9J1\O3X2$#Q!QUB&"MQUCE#KX'C);C4Z2&(R? TH>
MI(BP460\1\'S%KQO\;;DX2#Q$O$+2G-.6\X_5UF%Y);$53HU/92#SYF#:,\T
MG=SMCF^"L.U;&[6AK)J4VOXQ['2" VECL&NSSN-<':J%:G;Q[!BDX,OXPD%)
M8#"1!0I5%"F*'3/J7$<WX]YJS+QG-?H\F\(4;=*Y$W/5_&'!\O/2F:NZP-#3
MJ0"9I?-93')W2)U#R*5!&<I=I>'J4:6:7B+]<SPS0L./EX:[2BGC$J&56GEG
M=53H!VO3U,-J""=YA^9B-[3%"?ZHM>JJOL)\K%O*XUV?+VV(3@7J*[=1FTML
MM7W<<O86<PV042=O&4<FY.O)(&4:/T2JE.E\YY3COTL\GX1M_H]\0> /#WC&
M>3CK'"0^.N1\1\>O$VXY8&JU_$7(\+/1EYFKR<,3I9M5*23F2]$7J785D66+
MI*UCPC6Y>'Q#Q_B#D>&B6Q%<DX&OQM@W861UDEX^K>CG6E+6=@8X99S'T0L!
M)"[*0THZ-7EZE3*I5G,BM+.*Y78>$7E%P,5:05BV"#([PY3G5.07!D15[#*J
MF(!@*9100$X_=O#'#R>'_#? <#-<DY"7A>&XSBI;\P(EN24*4-5[3AF=@T[1
M&0AG=AU:+L06/!\K=7D>3Y#D$A6NMZ[:MK FNF%;$SRB-=  A _3L  ZV /3
M+IR]R!C&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8
MQC&,8QC&,8QC&,8QC&,8QC&,8QD6^1FF;S>Y;5NU-0S5<A-QZ1G)^3J*=R;O
M5ZA:Z[<84(&[T2RK10#*Q;"P,T(UVTF6"3Q>*F(:-=@Q<$(;LY_G.+MW)./Y
M#C)H8>3XJ:62N+(<UK5>S'Y5NE.T>WB2=%C9)D1VBEBC?H<%@?H7@;Q5Q'#U
M_$7ASQ/4O7/"OBZG2K\FW%20IRO&7^*M_&\/S/'I9'PUF:C,]B*:G.\*6ZEN
MQ#Y\3,K984)5^7>V=D:[G]N!3M#:XUC.'M;JF:EV?:+K8=L6$D:]C(V-MM@-
M5:"Q8:\8>>7DWM65C9DT^^18D?G22;)G2B15O$G(WJ4_)&MQ%*A,U@U>-OV+
M<W)2^6\4<=J8UJ*1TTZS*]?RIO.D"!V41C+BWR'Z,O#7!<[1\,'E?&?.^(*:
M<<G+^*/#W'</2\,TC:BM6;'%T%Y/G)I^;L>1'6AY(6:?P,#6/)5VE8-C#4M(
MYMZ$+M*L4_4_'^\5BU[UW)M*"G9W>%OJTN:+V1>96SL&4C"L].V!LU=LVCQ%
M)P",JZ(*WB%*<Q2@<];QE/Q7PHY"O6XSA;E>SS'*\C#--S-JM*8[]R6RB/"G
M$6%5T5P&U*XZMZ.LZ;Q-R_Z(_&K>'.0Y3Q-XVX?D.,\&^%/#ERG3\'<7R546
M> X:MQT\T%N7Q91DDBEEA=XRU6-NC1*@D@71MS7W*V[R_%K<$+0--DVAIRS;
M3EK?K]]M6RH4\[.X5M]4(8(2[I:T7DWRX1ZR$H_(ZJ3 K=V95@DHX2(#Q25R
M5/Q':E\/\G#2XKX_C9^0>W2?DK J]%FN]:'R;8X_S'8(1(X:JH#$H"P 85?A
MGF?T;\16_2-X7M\YXJ/AWQ31\.5^*YN'PSQ[\H)>+OP\I;^,X=O$4=>)//62
MM"8^4E,D829@C$QCQ;RU_P NN1W'/;6L;9KS2E"MTF_U1*4$D%MNSVN$F5ZG
MM&LW6PM[+(O=75]U7TTXRM)HQBK&/FS/7;PY%TF9$ 45U<S1\2<]P7)<?9H<
M52M22<9)3\GE;%F&4U>2KW)Q.[<97:#25P(RB3"1G(8(%V9'@_F_T9> O'OA
MCQ#QG/>+>9XJO!XEK\VUSPOQW&W*B<GX=Y#B*+\?7B\1WX[S&?D':PLT],11
MQ*4:0L0,\:UM'+J3ML>RVOI[250I)T'QI*>IFZ;3<[ V<)LUCQR36 E-2U1F
MZ2<O@00=*J3;<S5L=1=--P<A43W5"QXDDLHG)<7Q56ITN9)JO+6+<X8*2BK#
M)Q=1""^@S&4=*[(0GL.*Y_COT9UN,EE\->*O%G*\N'A$-/EO"7'<31>-I%$[
M27:_B?DY8VCB+/&JU'$K@(6C!+"3H=>GK\?GT^'7+[. QC&,8S&5MV(>H6>%
MB9"#<JP4K'O7:T^V5%8[15D8!<I^[4T3+KI,FPE>O#(G.L1F91TF@HDR="6+
M-9\B6-'C/ENK$R@]E*D;!76SH'J)!V%VP!"MJYH<1^L*5F>&R@M0311K39=>
M:LH^1A,6"HTD@,,88=)DZ49E:2,''UC5]SW]U?XER=Y#NJO"/IM-DJ=5"2JQ
MW+V-EY!J=N8>]6#3]RRR)T3 <[<7Q0.'BATCRGHL-.AZT:&,R!6V&B+.CN.Y
M'R HX*^HZM[[9:4U-CBDXN=!%82_;2JTB]+07ECAGKQ2!^VK9%FLP8:5A"2I
M"$9V.PF%H'[$D:S$G-1TE&R&NK8DT<O6"\>5RB\B)9_.$3,U;*134ZT?+%<K
M$<R+-/J@FY,_*!LD,4, 5W=61JTW26'1L&-WD[C<>^EM]W7N =G7F/X9;0Y(
MR5X:LT$T7+T"\<<ZS=#1V:\-5B'<6)%66NR*4AD9>MD$1(R:C2Q?NF\G8)68
M=G,JQE'%;&4,XK+:9;)MS@=JB9JB[7:M7B!7+-LY7,T(Y3(\!H1<>H21!U,'
MD=SLAS$6ZH@X ]!H$@,.I0>W;97?I3GD/)C>"K!6C 66!+H@"7GKR,PZ7<.R
M([QL8Y&C0.4)CZROK?@  ?#^(_+\\D969\>,CXP-_%3\<4Q6!'O+XOA ;L%3
MP^O?X?>/;W]O;W?=Z]?3,;&];&];UOOKTWKUUOWS/2W3U=)Z=]/5H]/5K?3O
MTWH$ZWO7?+<5N=70G4ZRI,LRSJH@1./[C"H*ID?,%;F4 O@$<G0Z+)M5%2N%
M$A!0B9B"!AUF:(2"(N [;TO?N1[;UT@_8G9]ADL<?=-5KHKR&JH),NAKI#!"
MX4GK,88A6E"F-6^4L#VS!I[A+6>/6DW:I9&M J^^VT.]@BMZY7H!JJX!RU4F
M!3-+O;,R2217[(LKTHN@ #LV!?"6R!YTDBERRO#MQ8C9.F../1#(9"/,:11Z
M](()_P!D9TOP$%*801HT5SIB_5EF*R7NV[CB,QNM8:ACHS%R%:81$Q]Q+,Q(
MRYFT3-UF^4?QI \U77*%A@HB1>J&&99H/XPDRE$2)S!UD44C0"9V4B;M= 45
M$'Y5#D1<*;@KQ3P;8R1MYB([$F1>I>L(Q/[RCHV"?F[:.\AM/7N\7R92(5[:
M/3M6(HQ_FTC13-6:Q  -0,WQ9$D.RA/SQ$#:KEA6O1+F73G'30'4BW1(BS4<
MJ*N$F':*@F5CVRIS-V3E8#]J[ILDFY6(4J:BIB% N2S&A<.5VR_NDDD+]U!)
M53_Y@ ?;>LHEM6$@:LDACA=B9%C 1I=@#IE=0'D0:VL;LR*=L%!.>*YTBF;'
MK$Q2=@52N7>G6!H=A.U:V0L=8:],,E.@G;24/+-G<>]1$P 8$W#=0I3E*<H
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M;C)IURJ54G'#3]P(MM>W1X&$/*;GWG7'7EX.+DD#'))T'4@H*&;K TD=CR!
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M6>,XZOS+%Y39]DLV%X1@S<(RD,0R2Y'!1<P:Y/=ZOG&IT'C=% X 8QE#%D)
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M)Z0 23K0 ).>'D2,=4CH@) !=@H)/H-L0-GV'J<JZ:A%2$52.11-0A5$U$S
M<BA#@!B'(<HB4Q#%$#%,41 P" @(@.:_3USWGUC&40+-6S3AZP6P0AK*1J5\
M>O!+,!G",3?T7AXD''GRM3=![7 MP1'Y'S;Y,WE>?Y4OD=71YWEMY77Z]'F:
MZ.K7^KO?VSQYD?7Y?F)YFNKR^I>OI].KHWU:W[ZUE;S5GO&,8QC&,8QC&,8Q
MC&,9P @/P$!_(>O\,8SG&,ZUED6Z2B[A5-!!$AE5EEE"I)))D 3'444.)2)D
M(4!,8YC 4H (B( &9 )( !))T .Y)/H /<G!( ))T!W)/H!]3@%D1("H*IBF
M8@*E4!0HD%,2]P* ?KVB02B!@. ]HE]>O3UQH[UH[^GO]/[^V8V/J/R-_P!W
M?\,X070=(I.&RR3ANNF15%=!0BR*R2A0,FHDJF8Q%$SE$#$.0PE,40$HB ]<
M$%258$,"000000=$$'N"#V(/<' ((!!!![@@[!'U!'KG;F,SC&,8QG0X<MF:
M1G#MP@U0*9,IEG"J:"13*J%22*914Q2 914Y$TP$P"=0Y2% 3& !R 2= $GO
MV V>PV>P^@[G[9@D#N2 /J>WJ=#^9[?CG?F,SC&,8QC&,8QC&,8QC&,8QC&,
M8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,8QC&,
M8QC&,8QC&,8QD>>6._J_Q;XX;DW_ &4Z8Q^L:)-V%JS5,) F+ " ,:I7B' !
M[%[':'D/!-C"':5>13.H8B93G+;\!Q$_/<UQG#UP?,Y"W% 6 WY4);JL3$#N
M5@@629M?ZJ'*[E^1BXGC;O)3$=%2!Y>DG76_98HP?]J20I&OW8=CZ9^7;V55
MLD>(/+KCG)WW<5=O3;VHNHK!:MJMH^W0,TM2.2B]NL%^IC&QL8F0<NHF5FJM
M9HBO%;RZ19!:YW">CON)Q1BI?=_'\$?B3P[S4=/C)ZA_1_R<5;CF>O-&+7 K
M7BH6FA:1>F2.&S7DFZHV*"K7B<GJ?YOE7A*5N$Y?C#8O16$\6499[@$\<AK\
MP97MQ1NB[:,O!*L2>9TN\\LBA1H@;>+OS+YS[DY!\G]4\%-7<>9FJ\05H*NW
MN8WK.W1O.;1V1+0JT\XI&O$*HLQB8-1DFU=0PR-J?(L!EDD%W<@P9/?]$^<U
M?#?A7C.(X*_XLO\ ,QV/$:S6*D7$0U&CH4(Y1"EJ[\2&DF,C'S1'7 8Q>BLX
MT>RGYKGKW(\K4X"IQ;P\.T<,\G(3V%>W;>,RO7KK G1%Y:Z0R2LP\S]X*N]1
M2Y>7/DI+^T>]E1::GI^HUGDA8M%<A$EM9['O +4:BV:4J:[6P+V2X49I/KSU
M>JZ!W\NDG76II*P-V[2.3&*>/55670^'*W"Q^"/T@U[/(V9N%AY?A2MZE5Z;
M5N!)^J!8*]MH5BFLL(XW\\LD#%W E5 )*CFI^3?Q/X1E@I11<G)Q_*CX6W9
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MN]7,T<^8SQ7A:'C.;_1[ G)7Z7/<X@Y&\\/PV^+K6#(>.>JLL#GXB6%6:46
MZ@K\J@,O2O\ .RW>-\82O1J6>+XIO@ZJRF8B_/"J-;$Q5T A25D16B(/J=EE
M(RYW_-SE+'[NXG<.N+FH]!BOMG@9K_>45(['EK[%576+P$UH]5!TI".IR;F:
M9"0D,A%1$"W9JV.1F)"..]LS9BB]7'7'X5X)^*\1>)>>Y/E^GCO%USB72E%3
MEL7TT) R^<(8X[4LLGF2S,1"D:R=,!;H7/9YWE%Y#B.$XJC0_P \\.U^25K+
MV(XJAZC&0?+,KO!&BA$B \UG*@RJFV%FP_M?-R0_##:&RK]IFD.N5-!YDO\
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M-GZ+X\Z(:40NUMWA?K&O:]ELIR8INO\ 6^KX^&<6NQN*U6Y:OR]JGW\K9ZU
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MT4QXY4;6?$[=%0OM)V#1-ST#6\>I*P<K4)A.0,S>L(V2KCJ4C7R JB5O[X;
MA*MXN3-XWD?+K7/!_I)Y_C[DC<S<Y#Q%Q=FG;HW.+O<C,8IHK,13K1I%G6.2
M-M$$1'<9DB!4/L5G*^"N)MUXQQM>GPU^"S7LUN0JTH_,C>O('",L;0,\;#L1
MYJ_,%?N5T>C8GL[^2T+N#>FV.)?+>#T2;EC$5QMR#K\[J4+HU9W"&KR]==;.
MU(_3M40_K-C=M7+I=*-D5G22,@]<R)YE19./389I>,>$EXWB>-\1>'9>67P[
M+.W#S0\E\*SUI9UG''\DAJRK8KAE4&5.ERJA!&H9RV;7ASDDO<A<X;EX^._6
MZQ#D8Y*7Q 66*!H?BZ9$\313$$'I=G4,68-\L87)<+[.N1@]^\(=UN-^7.]*
M</\ 6>S:#*+[.3DKK?\ ;4CLF(>L7=FFKW(V$5XQ5B\?KN$(X\;+I(L$VL.S
M<-6K5$P0I?&2R\1XIXI>(JU%\27Z%Q%H%*M3CDH2HZ5X:BP$.&1 C.)(B6+2
M,&+$9)3PWY?(\'?/(6+!X:I;K$VP;-FXUM2K326FE#(REF.O+<:"H-*!F-[Q
M[+&1N-!]I+20W4R8&Y_;"K5Y:2(T)9P75Y*_*,9$8URV+:T!MQG(,_#*Z37K
MP)"<#> ?MZ#+J^/!6N>";1XLR#P?5FK&/XP+^L!-UZ<-\*35Z2W[I%C?3OJ&
MR,CS^%/.K^)Z_P ?TCQ%.DW7\-U&GTA=KTF?]N3K]XF+U';ME.VA[,39C3:%
M&WWQEWM1M=[;8<?Z/QWV<VVCIJ+VCK_8$#1XV+C86[,81[+-WE9N42E&-O)]
MJ\HT=M6;"-75;-@E#2VVAXYI/0M\/SO%6[G&OR]OF:#<=R;\?>IS7&=I:K3B
M%UGJR%_GVJ,K%G4%NCH\VO"]E;D'(\5R$%:VO'5^-M+;HK;JVDK](CL^6TJM
M%8C"@(0[J5 C) +LV:;=[.UO?^ DQPPO^X[#>;?)L ETM^3T!'MK!'[/8SZ5
MHKMV85^$=QI&;6N2K5DRCHE&:!^:OMO=SJ><.%UWQZRMXQ-/Q='XGI\77J5T
M?RSP\,KM ]!XC!/3>:996;SXV=I)&C*^<QD6( !1,E\."QX>?@[-Z:>5D##D
M9$7SDM+()HK"QQ&$ 12*O1&) QC7H:4DEC;L7[-&-@/9H6/V?4'LHJ,K;ZI-
M,+3N1[5U7CF=NMJN/VSL]SD:W]H$W3D[U^=5FU8K68Z[6-18,QD52,B==TOC
M>2?QQ#XQEH@I6M020<8MCI2&I5KBO7J).( H"1@%F$"AG9VZ!U9KC\,)'X8D
M\.I:TTT,R2WC"6+SV)C/+8:$S;8L['Y&F/8!2Q UEUT;@*]IO*_CYR8-M!K(
M(Z.X9PW$Y:GEJ2K9:R+Q#Q1U]N$IP;"N2*1< <$_L^:*?G3Z=WO@_40R/;\6
MBUX>Y?@A0,?ZU\3R>(A:^)#>0)(RGPGD_#CS"N_[;S$!'81+[[JWA\U^6X_E
M#;ZO@>#3AC (2OG=$@D^(,GG$H&U_8]+:/?S">^0#Y6<!*QH+A3S"4O,SN#:
M1=E\VI?FA5+'QZUO'2>RM$6:QO8=O"3K2H35X9IWF*HP-72=I>,9:%>N8"9?
M/6K*(".4E&O6^'_%]GE?$WAD58N,H&AX6C\+V(>9ORQT>8KP1S&6"2U%39JC
MW2R?#JT<B).B*7<L%:@Y7P]#Q_"\V99+MLV^>DYZ"7CJBM;X^:5XA%(L,EH"
M<50K>:ZR1,T3,0$ VN ^$L[>N3?M2M%[V:[YV-RQAM4\;=B1&S=M2_'J6X[:
MYH<A84WD15]>5ZKR,>V0<6EXZGE9>PODY&47FU3.5X\Y(>"!%E;>*(:O!> N
M4XA^)I>'9K_/4)J/&Q\Y#S=ZW'""T]R:S'(3\.@C$4"^5&$"Z?<LI)K>"EGY
M3Q71OKR-KFHZO%6H[-U^*DXJI7:0ZBKQPR#7G-Y@DDU)*[=7;4<>UFY[=^EV
M78''#CC6*LG9DY)[S<T60\Q4HYQ)359:KQ=\9J69LF@U=D;&A%72+Q-X[2%D
M@X30%P/8/:;F?T3VZ]'G.9L637\M?"_+ZCLR+'%.VZQ%<DE2?.Z2A"'K*EBN
MM;%YX^@FL\9QT< FZOU[QY9X$:22%!YVY@%5R A();6EV"WR[S+^L_9^[JD.
M0ECY+\K.2T1O#8<3IBTZ'TLWJNK&FMJW1ZO;4W*<]<9B(0GICWI=IXCE4D@F
MS<,XYLDY?H-EU6AXMM#5M_Q?QJ<+!P7A[A).)IR<I7YCE'L<B]ZQ;LUB#!6C
MD:&,14X"-H&1Y&*1LVG\QI)M;P]=?DI.4YCE$Y">.E/Q]!(:2U(:T-CM+.ZB
M69WLRCY7(=452RJ.D@+[:'[+VGL?9H(>SAV??G5RKX0\ZS4V/ 0!:S(M)AWL
MB2V97)^+@W<I/)H.:[-N(XIVR\HX1E4&+ANN*+9^HBGYM^.K3^.7\;4*<=6<
MS0N*,TILQF):,=&:"258X"RS0B0=2HC1]:LIZD7/4'A6NOA=?#%NPUB'RY$:
MRD8@<NUE[4<JQ]<@4QR,IZ2SAPNFWU'+-I/LY^0MTW#Q]V%S0Y:1W(&K\2Y,
M9[2=/JFJ&NN%;%<VS)BRB=C[:EAL,\M,V.,(Q;K$C(M-)DK(()/QD"$=2[&4
MDV_&7#5N,YFEX7\//P]CQ%'Y/*6;'(F\*]5I'DEH\:GP\(A@EZ^EI) T@CT@
M4$(Z:8/#G(3W..L\WS Y*/B',M&&*H*IDL!0B6KL@FD,TJ#OT*$0NH<D]3JU
MAV/V5N_JZPY :8X[\QFNI^)?*2X72V[,UC,ZAC[?=J079"!6NQZ]JFZ&L48W
M90=SCA6B10E(LAZZP%-1B+^0.^>/9</CWB)WX?E.:\-MR'B+@*U6M1OQ<D]6
MI<^ ):C-R500.TDM5R)"T4P^(< 2=*!56-+X4Y"-.2H<=S2T^'Y>:Q-:JO12
M>Q6^+ %J.C8\Z-4CG4% )8G, ):/;$DR)6]FU6(/;'LZ[EKB[?92B>S^J^S*
MI#4J0@334I?V6P:+&4XCYY949:+2AY1LY8+STLZ]RR19E^_< 5%AU[QIAXUL
MR\?XUK7:PL6_&5CC[,MI)?*2F]*[-;*I 8I#)&RR+#&@FB\M44DOH#+)O#4*
MW/#,]:?R*_AR*Y"E?RNMK,=FK'57<P=/+90AD=O+?J8]NGN<DMS&XKTSF;QY
MO/'V\RLK7H^VIQ#V*MD$5(TY4;36Y=C/UNR11%A(FJM'RT<W\TU,JW]X1BSZ
M.\RU\V+A*E\-\_:\,\S3YFI''-)6:19*\Q80V:\\3PSUY-;/3)'(0#INA@K]
M+%0#9\SQ,'-<=/QUAGC281LDT>A)#-#(LL,J;[$I(B]2]@Z%D) 8Y"G7_L[]
M_6W?.B=T\U.543R";\532CC1=.I^IV6LH]W:9%BTCQV7LEV6>G%YBU)I,(]T
MC%Q9&L6TEHUE(MGA4S2+&1Z:WXQXBMQ'+\7X7X"7AF\0>6.6LVN2?D'6NCL_
MZOH(8(1#6!=E\QRTKQNRL.L)(E)7\.7YK_'WN<Y9>2/$B3X"&&FM2-IY$5&N
M6M22F2;2J5C4B)'4,O8LIDOP]X?.N*]NY96=Q?4+J7DUR+M>^4&2-</ FIR5
ME*4"UE9P>9E@G%&70?\ TJ1&**L @'N](0ZC2>(_$8YZMX>KBF:OZAX6OP_4
M9Q-\3Y!)\\*(8O)ZMD>63+T@ !^V6?#<,>)FY>4V?B/UKR<_(]/E"/R/-T!"
M"'82=*@?M"$)]"IT#F,N4'!_:=YY&TSF+Q9WE#Z.Y!UK6LAIVQIW2A%V%KK8
MVNGLNM.,HVP1*$O"2<=*04L[<R+"3:.'GCJ)1[8Z#9-LHJO-X+Q10J\+:\->
M(.+DY7A;%Y.3A-2V:=^E=2/RFD@E:.:-XYH@(Y(W1= NRL=].1.4X&S8Y.'F
M^*OK0Y**HU&03UQ9JVJK2>:L<L8>-T>-R62168@Z!4@:.(K%[+"[VW2>O(^S
M<Q-I6+EGJO>LGR0H7)JS1HV=C4]A31F19.I5W5LY/NXJ&T^LTCVC=*A1TTV8
MI/$32(=6CAS!JV,'CRM6Y2[)!X:XZ#P]R'$)P=S@:[_#M8IQ=1BLS\A%"LDO
M**S,QNO"793T:V!((LWA6:Q1K+-S-R7EZG(-RM?EI1YPKVG&G@@IR.8XZ'2
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MM#X@=[OFQ\ERG$SP7FI/!'..,%">4UZ[2*QIEZ[58',KENAY#+.NI))V<@N
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MDG4@9DZ&D6>/NK7X&>K'%+<X<HSU9)?+6>.2A)2LQ),.I$E42AXG8&,E.EB
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M(9#'* 2C]/3(-]#$C69RU5SEX^;?L[6F5.:N!)^6J,I>J6:T:OV12HK:=1@
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M<W+%7@XV:%YZLUB]2ADN)%9DJS+3K23K8M2PS1.)HH8GDC0QR,H66,MM_75
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M>N4$$S*&*0#* 8Q@+U'/DO#SQ5^6XJQ,X2&#D:,\LA!(2**S%([D $Z5%)(
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MIID*4A"@4  ,,2Y+,2S,2S,Q+%F)))8DDDDDDD[[]\R % 50%50%55    T
M -   : &>%E 0<:\D9".AHM@_EU4UY9\R8-6KR462)X:2TBY0236>JIICV$4
M<G5.0GW2F OIGII)'5$>21TC!6-&=F6-6.R$4DA 2=D* -Y@(BEF55#.078
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>g60414g23y11.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g60414g23y11.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2[>4&AO=&]S:&]P(#,N,  X0DE-! 0
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M @ %, 90!T '4 <       "G!R;V]F4V5T=7     !     $)L=&YE;G5M
M  #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[      (M    $
M    $      !)P<FEN=$]U='!U=$]P=&EO;G,    7     $-P=&YB;V]L
M    !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B;V]L      !#;G
M1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L      !%;6Q$8F]O;
M      26YT<F)O;VP      $)C:V=/8FIC     0       %)'0D,    #
M   %)D("!D;W5B0&_@            1W)N(&1O=6) ;^            !";"
M @9&]U8D!OX            $)R9%15;G1&(U)L=                $)L9"
M!5;G1&(U)L=                %)S;'15;G1&(U!X;$!O^<K         "G
M9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0    !09U!S     %!G4$,
M  3&5F=%5N=$8C4FQT                5&]P(%5N=$8C4FQT
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M      !    !XX0DE- _,       D           $ .$))32<0       *
M$          3A"24T#]0      2  O9F8  0!L9F8 !@       0 O9F8  0
M"AF9H !@       0 R     0!:    !@       0 U     0 M    !@
M   3A"24T#^       <   _____________________________P/H     /
M____________________________\#Z     #_______________________
M______ ^@     _____________________________P/H   X0DE-! @
M   !     !   "0    D      .$))300>       $     #A"24T$&@
M #-0    8             !E$   9-          $
M       0             &30  !E$                      0
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M0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX
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M       0$ .$))3004       $    !3A"24T$#      D0@    $   "@
M  H    >   2P    D)@ 8  '_V/_M  Q!9&]B95]#30 "_^X #D%D;V)E &
M2      ?_; (0 # @(" D(# D)#!$+"@L1%0\,# \5&!,3%1,3&!$,# P,#
MP1# P,# P,# P,# P,# P,# P,# P,# P,# P,# $-"PL-#@T0#@X0% X.#A
M04#@X.#A01# P,# P1$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,#
MP,# P,_\  $0@ H "@ P$B  (1 0,1 ?_=  0 "O_$ 3\   $% 0$! 0$!
M        ,  0($!08'" D*"P$  04! 0$! 0$          0 " P0%!@<("0
MH+$  !! $# @0"!0<&" 4###,!  (1 P0A$C$%05%A$R)Q@3(&%)&AL4(C)!
M52P6(S-'*"T4,')9)3\.'Q8W,U%J*R@R9$DU1D1<*C=#87TE7B9?*SA,/3=>
M/S1B>4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1
M(" 0($! ,$!08'!P8%-0$  A$#(3$2!$%187$B$P4R@9$4H;%"(\%2T? S)&
M+A<H*20U,58W,T\24&%J*R@P<F-<+21)-4HQ=D154V=&7B\K.$P]-UX_-&E*
M2%M)7$U.3TI;7%U>7U5F9VAI:FML;6YO8G-T=79W>'EZ>WQ__:  P# 0 "$0
M,1 #\ ]"R^D79'5J>I-S+*116ZEM# -I;8'^N7.^EZCW_9;*W?X/[)_A$ =
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MX<D>(?O5ZOL:;OK+]96_\ >IDD'MO'_D4;I/UF^L5G5L"JSJ60]EF516]CG
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M6>H;:H<
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$!_\  $0@"7P)= P$1  (1 0,1 ?_$ !\   $$ @,! 0
M   %!@<(! D! PH""__$ ',0  (" @$# P($ P,%!@L"+P(# 00%!A$'$A,
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MR]K6]QU'6(W?5,=GMBNWK-JMJ>1RF%J?EU2S*$YNCO%FNJ5IM&MQEK&Z+/"
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M78^H62[;2=>1F=5P$1^9Y7**QOJ1 Q2.QI@H9 #W&Y021\4?[_8]#S,)HD0
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M&*BB-QZ??3+KIONS]0]*Q<=7K^2H6-CQ>/S.#RU'3HG,)>^%VDXQF,U/&7O
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M^F;6:R\ZK0S=5>U;%='#XJAFYG XZ,Q=K96<8,FU5)/+"PM?NFZ8GZUV^O\
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MQCZ^"7C7T;+$/5FD-+(5[5<Y68MJ1*(IV$F) :V>1BR@H*8*)]5Z?49%=D$
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M-UO2-TUTRJHOYO(W\;I%G"C6SV?SVOOMI5?\91-#&R!$$1=7!-5N;<&YY-V
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M]R0@.X]4L;@JAL$[%#IQJXCE87!P3*Z]JW&[FZD@Z(E9N7I5>R &15G5G=K
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M95DDX#J9[D<4K+YO+[)DPJ>X;J@ W<[GKC,AF,H^)SQ=UK(76LLV#CB#:9%
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M[/7G_*3XT_\ 7D__ +K'_P#B77G_ )//V/\ _L3IG_O<S_[HZX_W2[WU<_\
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MUE-CZ.]*-AS=QF0S.>Z:Z-F<O?= 0V[D\IK&+O7[;86(+AEFT]KCA8 $$<P
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M]\GQ_MCT>6/ZD7Y;%_\ @W_/H/@7P2/_ ,V-(^1_L4';V/X;_2N/?H_W4?\
MB,_]FY[F/_CM;=_Y4X_]GZ/+%5LB_P"P+_L_X='^HO@K_P!E](]__P B@XKZ
M[*_G\?(ZXG^*-_$:_P"S<]S/[S_[]O;HY^_],GS$1\_'_+Z/+']2+_W:_P#P
M?^)][Z]_U%\$_P#LQI XO_Y"@N@/^K_?SWKKG_=1_P"(S_V;GN8^W_7;V_\
M\J?^'_5_L/+'_FXO^P/\/Y=OIUX? O@D?_FQH_?_ -"@^O/X.W;Z&^M_'X=7
MWE^Z_P!Q'O.ZEZ;UU]Q/5[JWJF,]NNT;%C]>W_=\[LV)I9ZKU!Z:X^MEJU+)
MW+"$WTT<CD*B[(!#1KW+"H*!:<2AD(%2]J@E@!M '%$FZ )["N31]NLE^V+P
MUX>T?P]@9.DZ/@:?D/JT<+S8N.D3O$V+E,4+(%M2R*U$,. 11OKVB>F?7S?T
M>CHZ/1T='HZ.CT='1Z.CH]'1T>CHZ/1T='HZ.CT='1Z.CH]'1T>CHZ/1T='H
MZ.CT='1Z.CH]'1T>CHZ/1T='HZ.CT='1Z.CH]'1T>CHZ/1T='HZ.CT='7$\S
M$\??B?1T=:">IL;?TUZM9[3MOZM6Z5[!T+&^[(ZK[I_X@64U[5-8#-8$C+9,
MI@Z5S4,';HXW9L-L>2U]ET?R+473M&3K4=46.1)XNUDW;2!V!"QJ"?U/';FO
M<WTQ(J0@LH8AF*EG/I %V:J[[BQ_#ONDZN;%N.JZ5D<YJ-KI[AIQJK60V#<.
MJ&6O8S3-%UC&T;>0S6VY:MC038S:L57J]\X@LWJU5ZS98N;-B:]8S8U4 GFS
M] .3]/IT[<L!Q0YY)[ ?7]/Y\>_5<>AO6;J%NG4#+:G4ZX^W?W"4-<90_MXK
MI_INV=)MHT6MET668S*8U.0WSJYK^_T&6ZS,;?J5\EK+<-95919RMO*U&X<^
MW4 7L9+X%D,"1WY[_P"':NDTD8L%WQO[F@0P!['X(_\ #WZ7/=3[U.D_M49I
M&-W/,8O^T>X[OTPP4X.]8RU%M'3M[W^CI>:W<;-'!9A%E6K5F93,3B2E%C)S
MBRI@ZK]0NS'D<;2;J!X5C[58%\W]+[=>RS)%5GNP6J)[\>P/^;^.M6W\=/<M
M9Z@^T?VN;GIV61G=8V'W/8F]ALO7782B_4+HAUV5#U+MI19 98LQB'(6?(S^
MGB8F<R^UD$>"M2!!!$N%P:_]*A/]G'7T7_HLLK?;%H#*;'W/62.#W&EY)^ ?
MB_\ QZ\S$_?_  ^9^?Z1/S$?ZN)XB./C]_GU\@=?K$.0/R'7$1Q\?OQ\\Q$\
M3'[1_P"#G[_?F>.)]'7O1,?;]X_K_MG_  _PGY^8C^O'HZ.B8XC^O^,?,1_7
M]N/G_E^W'Q$<G1T1S^W[1\\QSQ\<?T_\''Q']8Y]'1T3S]YY_P .?GCXB?O^
MW/[?T^/G[S!T=<??]N/]4?[/_'_C]^?1T=<_M_3GF.?W^.)F/C^O^J?Z?;Y]
M'1T<\?//SQQ_R<<?OQ/Q]XX_;YC]_1T='[?'VYB.>./GB8^?G^GS^_\ 7XGT
M='7/^''W_P!L<\<?$<S]H^WS\\Q/Q''HZ.N/CC[?,??GC]_O/]?C]H_V_P!>
M3HZXYF(G_D_K]_OQ^W[?^T]'1US'$3$_?G_P?/SS'S,_X?\ L_1T='''/W^?
MO]OCY^.?GXY^/F>/W^_HZ.C[\]W^/Q\Q\\?$_P#/YY] [C\^O&['\NOT%_;W
M_P"^$Z(__@BZ;?\ Z&X;U]ZZ+QH^DC_^F8'_ -JQ=?AWXP_^B[Q3_P#M'KG_
M /,\KJ7_ %)]5SH]'1T>CHZ/1T='HZ.CT='5 />YBO[0[#[?=?M4\!O&%O;5
MO-G*]$MJWO-],,!U/G'Z6XZ-MNXX_%Y'!V\IHSWEF\;I.VG3Q&Q+LW<U5<>8
MU''K]*Q_AD(!X"\@75L./U%_J ?;IO-6Y 6-$D[=Q2Z!Y# K1^E\@GOQ4S^V
MO4]]Z;>WC#:_FGXC9]OQ?]O\I@L)5WO+[5A,1CLMMVSY_0^F2>I6=Q[LWGL;
MHNO7\%T^#;\EB3MV:V#_ # L9Q 5?7+D%SW':[%'M7;@#MV[_/?KN,%8Q=7[
M<V/IR+X^3^O4!%UZZL5^H>*U(?<A[0LQOF;S>=P-'H'2TO?4G.?UHE#G-.=U
MMJ=1\T>*SV/:]>/C+9KH[4^NR@NQ]731NI?51V$!4L4?:!98%;YX H\?PY^G
M7'F-OV^8A:R-A5@./^EWOZ=OJ?>^65V.MK6J9#:]G58QU3!X*SGL\C'5,CL=
MJBC'T#OY--&C@\?;RV<?6!3@K5L3C+%_)& +I46V'+KRB+^G?_P[]+DT+/\
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M7P"/K\BZ^+K_ #=CCT=%=JNC]/TX[FJYX)O]./2K^%O_ .GSZL__ !+FW_\
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MF?\ 7_R??^O'[S\\\3/]8YGU\@GN?\_V<?PZ_6 =A^0_SQQ_#KC_ &\_\O\
MA/\ 7_7_ %_\4^CKWKF/DI^W/$_O]^/\9Y_;G[\Q_J_8Z.N(_>?C[?O_ +/M
M_P"Y^..?VY]'1US$3/Q\?ZXB)^_/W_>/O_LX^(GXX.CKB?WYG]_GB>?_ !SS
M\<\?OS\\?;Y.CH_>8^_W^W[_ ./[_P#@_;T='7/$3_A$_$?:/]?WCYB/Z_$S
M]OW^#HZ.)CY^/B)X_P!?,\?[>?GC]X_Y/1T=<S\<?M]YB/Z\_?X_:)_I/[<Q
MS'Q'HZ.N/_!'^,_[(C[1''SS/'[3/^'HZ.C[?XSS\?//S]YX^\?>8_U_Z_L=
M'1\3Q\_?[\S^_P#6?WXGYYXG^D_TCT='1,_>..(YC[?T_I\_\OS'Q/WXY]'1
MUQ/Q\<_M'_A_:/Z_?G^D_?\ ;T='7/S\S/WXGF?OQ^F?O_S_ *Q_A'H[CVY'
M/QURWX3_ )]^OT%_;W_[X3HC_P#@BZ;?_H;AO7WIHO\ ^)])_P#J9@?_ &K%
MU^'GC'_Z+O%/_P"T>N?_ ,SRNI?]2?5<Z/1T='HZ.CT='1Z.CH]'1U1KWPZ;
MJ&Y:QH];<,9NV3JT-@R%FFO2O;#J/N>>FRS'"F67\%MW3;J36U94@4A7RU2E
MC+%UA'2*TX!\/I:$D,0-O/LSE :!/[I!->POO[=(3A2%W7[U2!Z[<D$$#X_7
MI\^RC#[1@?;AI6(VW6&:ADJ67ZA*Q^(L:!JG2RXW5O\ */MA:7F\CTWTK'8K
M7])R6S:A.$V'):Y7I*NXR]D[%?+DW+!=:?,A!=B"3S[F_P"!LFOS-]=0CT"Q
M7TH>W;MQ]?S^.W6OKI=B^EU?WE[7H.R]-^IB>K+.O.R;NM.(ZX>WG):.K3<+
MOW5+J1T]S+>G5CK"SKCB]6;FNIN4ZM;!A TG\P;U"R2[AU9TS$8'"8]0EO+!
MW"MM<@\W[6;YK@$>]CWZ;IM$S#:X._@F12*NQ2W8HFZ-T!7/?K=CZ;]/>F9J
M'3W3]#L[G<U/#!B+/4+<KW4'<6A;OVIS6WY'$83!7<RP;UJR%0W8G7<-3FIC
MQJ4 &D+5U >ZRUWI)-7["A^77(4+=?O$L?S-7_8.OSL?Q#7_ ,]?Z_?_ 'H=
M#/\ Y4&I^GV+^!O^N?[!^G^>?;KZL^P__P"A?/\ _JO-_P#:V+V';\_IW]NM
M*/\ X?\ #_'YX_U\?^X].>MI ^G!XOX-'V!-G\_RX'7'_/\ Q_?_ )_U^W'H
MZ O!_P"-@^QJNQ/TNC^?1_S_ .?_ #_]R=%5[\@]^_L/S[$\V+_45T>CH-W0
MKF^./;D?''Q?U-$'GG_G_3_G_7_EYY]'7E]Q_,V/T_CS9KGD]<<<?^T]'7O
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MB?\ :'1P7])YCGB>>?O]_P!_W_K'^/Q]N#8_]5O^R?\ #H\^+_SB?JP'^?\
M//7,#,3'Z?M//[?\_O\ UYG[<3'HV/\ U6_[)_PZ//A_\XG_ &AT<3S\Q/',
M_:8F?GC[S//[1_M^T_?T;'_JM_V3_AT>?%_YQ/\ M ?Y_P GKB!G^G_B_P ?
M_:_Z_B/F/1L?^JW_ &3_ (='GP_^<3_M#H[9_I/^,1,<3'_+S\_'^K[_ .'H
MV/\ U6_[)_PZ//B_\XG_ &AT=I?T_P#%/_L__F<SQZ-C_P!5O^R?\.CSX?\
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M_P#1O^7]G7GWS!_].Q.U?_)4'Q7_ )SM[U[\7]>/[.[!_P"J+,?]K;<?X_\
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MN;^LW\3_ (]'@3_U,/\ V&/1T;F_K-_$_P"/1X$_]3#_ -ACT=&YOZS?Q/\
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M ^MCJ5=P04% M364M@]PS(EP8S'(S(SQS$S'$^H-C9)^23_$]6)12J#[*!_
M=*/KSKKH]'1T>CHZ/1T='HZ.CT='1Z.CH]'1T>CHZ/1T='HZ.CT='1Z.CH]'
M1T>CHZ/1T='HZ.CT='1Z.CH]'1T>CHZU >YSHOKO6?K+UNNZ=T;VS:MVT2][
M;L?D\Q1]R_N'Z8XK-=1]DV34Z^%S]CIUT@VG#8U>%Z/=,<G&[9'J'_*V&+M
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M(^TE(E+QZ;'(H8IQGHY<U992L %+1L 'L1WKJM:M]KVGZ4@,FG9$K[N5B.X
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MJC"2-8_$>)\\J$>9M87_ %KVDT20% /?WNB"2/B[CH^+)(TL"M%DQ12!XQ"
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M=0K+Z9!Y8#%7!4D!2-P/2)>0;G1.,JFAQ <L1<"&Y$"AB&RI8)CR@*AA4UF
ME;7";9*9"3CTY0I&M2'<IK:5Y0GD63[C^L;H'Z5TVRER'F5M+C*.&9LM,@U.
MJL%]";N0I-;0!Z@.#W!3:U)F4(Z\C<FU#3E:;).,J4! E9M$':12)")-8F86
M(*)D_P P?U>E))!$5=-I0J+V@ ,.^TD]@#P#SVYZ?X6/]_4X\HF.0KVJ.[,(
ME3U2/M)HVH;T\ +=@@7TNY++V20CP(EF+A3L?1Q[E.2I51BG@#E%7;XA>I]I
M]B3%@.FP\XGO6<C*46T,VXT>#=V=U^X-D\#CN*4]3>=J&?D8./%' )L,[L6.
M)AL\N(K2N-K*%<LS.6%,[, =W(Z]DGX4D!7I/O/4M:8!6S]$Q*S7,C7<?^6=
M3)8V?@1A@!*0/MDN2@B[IYB!TWP,VZ#/Y)(FB%&A0V,0*[@<_KWZ^8OMNA2'
M*\-QK D)3!S [H[,96\Z$EGW=F' (!/-WSUZB^O?3N[U>Z&=9>E&,R-3$Y+J
M9TKZ@=/Z&5O*<^EC+NX:IEM>JW[B:_\ /;5IOR*[%A:?YQJ68K_7(^K\C;65
MN]$'K")%WHZ @%E(Y]K]^M"73K^%#_$QU?VX8OV7/_B!]+M0]K\87/:EF\)H
MW1*O?WE^G;7G,MGMIP539LO7QN8B,W;SN60^Q.P(:NG;*G!,HP5,WC9,)E\[
MR6,F[=9?CC@<5]!^M\UTP7$R%B$(F3RP"-HC(-$DGDMP>3[<=J/;K>][=N@^
MA^V+HCTUZ"=,ZKZNE=,-7I:UARN$MF0R!IEEG)YS*M2M*79C8,O9OYS+N2E*
M6Y+(6F)2E1 H&DCM([.W=C9Z?HBQHJ+PJBA_G^7S^?7C:_$N^)/O:Z4W9L54
M6*OMYU$TA:L!'FXZA]1N5JK$)1S/=,DQL2N8CX^5EQB/VC!FUC&&QV']'\E5
M)JII:L\4!0ON3?Z]?2WV-ND7AS.F:3%#IKJ"*/(<@LS8^,&I 0#:CACV(%?(
M\X^=?"7WAKVJ\!)I!Y5@"5KM&M<O\CRD^RJN6S C7/EC [I7V1W1188PVRP6
M8]EKD@ [0/J2.=W;GW/.K:QD,DN7Y4XBC9HU>6-0(E8LI8L; VK8H ;NW<7T
MR,TA%?A<99%BNVO#( 7 2ED/)!)=K"3+> 'M$OYO)#)+B8&)E\$2%@?N[*P-
MEMO)#"F!- UR?CM7R>J/KR0X\;1MJ<>1%) 6V+(=BR;EVMM!""1=I4 +8#5Q
MU@NS][(KQM/'M^B%5$L<UT0N/(D^99#R6B#F'#) SN\QF$@GD8DI]/$P8<<S
M9&0K/<@D52""I]5!03S1[#L/@@5U$9_B7.SX-,PL!H\<8N%]Q:2,!6EB+;B9
M'4*S%F6V8DL;%@W?69YQ"BJC<F/Y+(*N"8A,\B,C!,$9F"*9*>XIX+@NV8F(
MB/20AWR^=""+'J#"_<=N ;H"C_;V#.76Y1B#3YI5<Q$@.M(; H\ TW)OU ]P
M">+Z;S;[HDQK+; P?,',1,M,)Y\<3')]G[=\S$%/S,S\QZDD@1P#,Z[MO(!'
MI![7??\ (=AQW[U:74)38120":.TG<>.P_7O_/VZZ!K6F$QM@AK^6(X$BDC'
MGF2GY+Y[>9XYB)XCGB(^(5\V) J1AI-IY( HGBOT/Z"_GD=-MN1-ND<A+'*L
M38 N^YX%?P^G2@M^-QF-.JA\-L/,&FTU ]O 2R( &%)&M<$V9)2Y$3F *1[@
M&?2#1Y.5D!]I1 *JRH[#DBN_!!-GF@:%]/3E86'IHQR=TLTI9I"-YVF[ )LJ
M!? 78#7/O:45IC'<000,3Q$3SP1\S\<R(P/S,E]BXGGF?F.'0Q0JDDDF[XOM
MQ]3\?PZCAJ<1E.TK8[5\BSVKF_Y==3:M]GZF?'><RMBS$N)B.[Y"(F?U1/\
M>CG^D1/'RL&QE[42 %(/%UQW/!_S\=,<C49]Q[L.X )JK^@^GU/85QUD4\';
M?#28)%VQ^F1)@SVE\1S,0,3R7$<Q,SQ$\QS!>D9<W'A(4$7]2#]>_P"@-GBJ
MYY Z\AE>8>8[;0-U"SR5'T_AV_PZ=%/439"F70$B@B(E]Y3,A,?I%LB0% \E
M'(Q/,Q''/,>HV?5D7TP'CL..+N['!Y'-'D_%"Z4$3.RY,X\UV)0A7)0(O8_A
M-]AR0.W<]*HZ75(;A&M4FF(8H4@< :I7WS_PL=T&'!1V3#9DH_5 S\2@VL2
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M1TLV8$D;825L$WV'//O\"S^O:ZZZUVI(N(D1C_C3$\?J_>?GYCF9_:.(_?\
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M!<F#3'L[>^12S]<'(D0Q%!&A8E20H)W F^_8<BK%G^%<=NH'6L"3'@<X?I8
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M3)Y2.;-[F!]-J00I6EY [#I[X?:-=ST%J.:JN7DZ2(8YV/5<'' 31B0L4LA
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M.;![^W3RQNIE8M5D3$CYY( :00018$1/QF4%';WQ(2)SP,\_'[^HF34Z#,K
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M0*9XCF)\DQQ,QWSV\<_>>A/QZ;)  (X[F[%'WX]C[_3KF4;B-JD[JHT-M?\
MC]#1]_893L*QPN),",2(H,!F9)OA;#IF _3$A/Q$!,\_\;XB.83$]\D=P"#[
M"QW)^A!]_P ^:Z3<JNU6)4@^I?FN3R#_  [WVX[=-^QAK)]D]JQEDE'CY,60
M<?I 9$XCX.?USSQ!<%VS\_#J/(*$'VX[T0/K=^P)^/KVKI8,=M#NR[A?!KFO
M@?XW[])&0Q*J_P!-+E#+RGL%)%,AQ/(R9PN(F>2GB(@2B"^"F..?3F+*D8N
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MZ@.1^G-CCGZ$>W'7/G8!3$R4Q_MF8_>(XCXB)CF(^?O_ *O7(C0@<@'WYK_
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MNF3(FD/<HS,U)$@$8;R+"*26,;GZ;BY\FYVD&YU?8TI\L;5K;M H$BS8OO\
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M$ $&K5R#P +-G@4 *'MU\^_;?-B2:KI"82SF&#&RX1-."K3,DT>]A'9"*IH
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MY$SF1(N8@!F(XB>(1FR56+=Y@W$V!9-&ZYHCN/8<W[$]2F-H\LTPCQH78BU
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MXCFUU!B:=F9.D-@".6;#G\ER[BRK$1EC&NT65:PS  <DC>OL4\-:#KNEZO\
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M1G9\7C<B:LA8MY"<:R,*Z_7:2_,MQXVM]'9*N2Y\+/H@)==A]Q,5Q'KE\>2
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MA\2$>6(Y@XB(*61,A',C\P/J,,TC2%70@BA=@KSW_3D>W?\ (=+-'&BG9,'
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MEG9?I7J>1V^51V3,^1+2=$PLED+(@B NY$CZS[Q^"=<BVV?]EC#"C3 J0-Q
MO@CO8(]0XZWG[))H%\.9B9$RQ%,J:6!B[*T<JA65PHL-R*Y /!Y['KSA;C;!
M K-61_,76Y%QV"BT-HFGVFU+HL!"U&O] R03(F,",$00(C"Z7$7)5X]@4<40
M !R ?DW5T0>39KJU:G,991-D9/WX-W::W8MP2 S<JMV!R*    ZC^<@]AU+
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M\R_O$8[>(B.Q07 5BS;;7G\OX\_GQ^?/6>>%,W),X@<469F!*GMM+<$\#\-
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M8&2@\_/6*-F)-(!9HG;[$D#@\D$FK^:JA:M T9=0CR,G*9EQX8'=B+!L\![
MY*DAJ-#;?)XZF*MC\0BL3[N)'&U*Y$WZ9;"LI$%6?E1?52ZS;"&**"@YF8F9
MF"@2+F'D$S2;PU[ZH7R"1[<\?7ZBJHB_L;P-]F^G:%HV-F:OY68\46/DF<!
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M]N<DZK9!(/I%E8"A=?5"HB!6J&8ZKY4B$246JH#"1@W+<1LY9!8(!(!!-$@
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M/5)T;33CQ??2H&V>120*])&U0>PH;B .">+Z3^F%01S$NL#$PM:I6LEEV+K
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M'(((/')ZJQ:>=IAD D(BQG@5)0<K6)$<#(!$=OC"2[>Z.!__ '?Q%PBB\I4
M_J L:JR?3=\W9JZ^.>23U\LZGJD^=DRY#RG]JS,JJY=8Q?\ NR+XH6?F@!Q9
MO&*S(0-'^7/A&9441*V<!$B827'Z_B8F(B>WR#)1^F8Y<K"7(D)()YJ['TKZ
M7=WW!_3J%ES"JF,KN6B!V)[?E_#GI6Q3TKN@\1[Y<!U+0'W29RZ"E#)[27 >
M/F>XP9,K@88'!K"0\D0[&1VK:=R$5P*-\=R>QY]SV(X,-E[S"\@C'<4:]N:[
MUVX_7CJ3D6*%W%QD'E999K*9@,RMKO!(#8 EU,A G_+4NSS421'))F[79/\
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MR!ZE/'(_P/\ #GC]>M3WXFNPK_='(H1"%6+'M_Z2&JXUMH?IY'.=0((2%)P
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M:'ID"D=O@=J/3CHS/A!XA)]A3+%C,=PKD#$Y'B9(AY&8B"B>>Z/CF/AC)PS
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M9C#J9D=;M13AJB(4Y>%*M^)@-G'V+H*,"/O%_F8QR(Q/!&#(IV[;"F2-[68
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M*9(2H'%T1ZAW85Q76#9PC;V*>R[5RZ\8BU8$6C3)E0; 0#_IH<9^)=@.Y)R
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MD,?A*>QY3'X53MHSX8=&5O4,)05%>L><RRL>IU3'5D M<-S%@4BI3@2VS 2
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M\N-B?L_*,,<$13TT 02Y)%ENXY;DTI![]5;[.]->#7?$F/.':9<I"K&P3O\
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M;CF<C7-='R&$^.Y7-P0A4D,P8E5D4I(!\A' )LK&0!A$V:01,SMZ8J#$'N&
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MY2O' %,<.:4$(1$S)D,CP$\3$3$#,%,<3S\\QQ]D39'<T. 3^Z.>1\=Z[_\
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M'%3(BOS"JL"?ZP:QQV^>W/'O0Z@':L#4F_XA:,D+0.%<@;6V(A4PX8./T*0
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M9=RMN6O36[RVNQP.;L$5W]^:ZM6#J>CZ)''E:CBP9D4\;H!$ZL\1E4;9%!-
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MDYY(AF(GYB!B(9%2"UJ5(!'JHFCP:'OW[5?-=,WR(LE88$D+3-E4&(J([G)
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MB/,=\=_;V$/'(^O$Q=H])!1>!7!OG@=A0''P:Y';K3_OT*;V/GHTD@(KE00
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MF0EJ!IAPJT+"UQ\VU=6/[:]+PM2TK&BS,>')ATY8SCPC'1BDJ6OWE)BK'S9
MQL;O0 /2!0ZJMU6]Q_N.ZG:SC](ZG=;-ZVC5->L4CQ>MY_:;5NBFY1KMQ-&S
MD# S+(Y.KCW,HT\MGG6;:L<;ZPV1K%"SON)GR2Q1QNQ=70DBN' &X,5]-U36
M*)^..WPQD:'%C9CYN#%#A,C,!35* X=*Y)VAAQQ0-'CDW5UE!U8^]_8F>%-
MA(&0T'<D/:U)&L9&1B)B3"([N)[9$O3\2JYVH.:/S?;ZT38^ ?D^W2APY,=E
MDF"H:6W0AMZGN";*K7N#0-US5]?,LJRHTJKQW3(NACB&(D@+L[04'<4>3O"!
MB&-6$R1>/F2(0A[LN:'! O\ "1=DD#M7)X)KOVZ&EQ95./%&%F9E<2R D%D
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MX)DB4SWS/$EZL"8*R,%$=+&>7- G@59[_BYKCM\T!K&%ID.F1O&8D1R J@*
M  U @'@<@FNW\;Z3UA:?13?=WQ4L-<@'D4]L&D0-D''S,3!&$#,Q,_/S,<Q,
M+E8M[1K6]0"0 "#\=JL=R?\ (Z>B>>-C#N<H$VK7-!@;X]_?GY'7$D7FJC44
M/C&N(%R?E)[P_2T^9A?C\A1W>.8XB"&8(H*"GP[*8R#:VX<<@!>X-"[[]_:O
M:B.DI(<F6,+$P:-5-61NN[-\BK/T'!^>>GPCQY"BR"OG-JLB38F8!4 /=/Z
M-;)EL1VJ*>_X&>(F.1]1DM1RH1$ CFOF^_-$"B02!P2:^.>H.5GQ2B,0SLY!
M ]KKCDGF^_/ ' ]RGU[]E,JAKR4I)SSXR.2:'$'',C(QW$/$1\S'^$_>.Y<>
M-KV#<6 /( "GD5S=59X_/ZCJ6J P>9)&H91P:/)KN >+!]ZL>XZ>>.N^5E=]
M2"X&!F>P9F1$2(B[^(F>^1B?DOF9X[IGYB8R6$*6$G _3OVX]JXX_N[]0.40
M8%A_WDS;N-I-AB>&'<CFS=_ -'BR.+ZKYNCCEX;%^8[&1''H"HM4"()JO6U+
M(F @ELD1@1F1[I&3_FP#9CU&F",MOH<*Y9F/N1[&Q7/?MW]^_6:Y_AV'*^\G
M457RHF.Q1M"BQW]2D U=&^/RXZN'THZNY'7')RVWO32OPVNZLO)O8P'KBPL3
M-(1,E\U@[2@HD([B(1B?B(B;$653'%N\FG#B,*&[6H'%=_FQ_+K)?&'@S"U*
M),? @0R*8O*F !=0DJ,P#&Q904PHV.*YZOWT[]S6L;I5;5>VM0OU<H&/!"$\
MUV5GOE-:VNS-@9<LY^"$4#XNT9.>6@,TO4/"SP.\L#M(OE>82Q4D"BQ&Q0M%
M;H EN!0YJ\UU[2=6T%(1) KX^Y$!5*<7?XBK;: %4 .PY'5K*-A#T2]9 95Y
MD'<3$@LHC]0GQ/(D/,<Q,_;Y_IZI&2LD,IC8,H9B 2*(LGGMP/KSVX^B>/(D
ML/FJ59DK>/W1[,*[BC['ZF[)Z1LFEDE-VFPIF/Y;E+*"B0B9GNB(CNCX*>>9
M+NB(^)GGE]C,%"PR %2 5;D$D$D43Z3^+D\\=O8"*U".2SE8SL6 \N6-38V]
MR=J@OP#\_P ATTK56E?F18VPO@N8+D0,I^T<A(3'WG]XF8XXGYYGU.P33XVW
MRX8G4&[()M>UDIP#].3VOOU6)X,3++"26=+]R0&)OW!!/)/N.![\7U7WJKC\
M=<[\=28&,R]=4H_,G&T464F)PI5@@B9AC#'M$8\8SS$$8043ZN^BMDE4R)ML
MD,Q4[5L!#WNF)/*@BCQ8'T)KHR,3%SWQX\=6D@38\KV?,4CTL2 0"+KVJQQ\
MTAVO5<E5BE19CE)RPE99<OK;/^^%*VN&5UVQ[YKI8A39!+^ &>^%L[B9$S;X
MW5R6!M!>Q;LV"+)'Y5_,]NVAZ5K6.RM&N\VC*ZD;NXHT0*KW)[_!OIK[=JF8
M=0)UUT7O)AZY69.RDK2TBM2:C+4J84>":95G%$\$@.%2,R+(A=9%9Q&;&^SS
MQ=B@."3\4!?)_7J8T;5ON[">*$A_O:PA'W%"K$601P&H=_X>Q%=-@U3&6L>5
MNE8.Q9QX2? \FN&/,%BX8(9X+DS_ %%,S'(Q/ZAXGT*\8<DC:2 #V- @4.+-
MU?8 "N/?K6=+U[S<F'$>)@[7*[%7V 1A2PL<$4>.3?Z6*U;-D;FO-^B! K98
M'E]GF9[UJB0FO$_/; %'>4=G;W'\3/;'ISB8QR$<EF 4\"^;-4?CGD<GD <>
MW6IXK8^5+ R$-7!J^>!7?^?)L?F:C$\RRW:20=\M3 D!1,+GRP,3#>V)^2B)
MD8@N)'[_ '^?4DN,(D)/[QY/>@"+';D<6#R.W/'5]QQ%YL<:*H\M+/L"35'Y
MXKF^W?K[HMLL-A.&&"QL'!3(L;#"DADADBDQ"(*0_1';Q$<S)1Z2E1%'I(4[
M3QV%#FB .?I?S\=.)<ITC8 J45N10)')Y[<<CY HGVZ?E*H5BRA30:*5*B"\
M)!!D$@1#'D+D>2B)&>Z([H^((9XGU!9+E$9@>[ @&_<@'Y^;^A]CU+Z'DXF=
M/LDB)>)&)8@"Z':ZH T >W%T?<23B*YV&5R("IS6>LDBF9)<K4N!8!<?\4PB
M)@P)D,DN1Y[9F89Y"K,$'FJR^L$<V>2;YYODW78CWZE]4&/DX9R<J;[G/ J)
MB^6U*D<8"KPP+"@!R+N[_*3%O6RN/Y;,IF>%?4RAAK7$01',&0P)0(Q^HR'C
M]8C^KYB6WJ5MK$,3SY1:J4\ 6>>YX^@[D=44X^-,AR$CD4Q!G^]1/MB8Q^L@
M[HV8ROM-\E"2"0!?3@%UD*9FP3KN$"*'#QW! Q)P2X'MD1<4]Q0/= ?ID>.W
MCTW=0CBZ*I2E5_>8T ?J1??G^\R.#DG4Y%:(329#[)&ER3<D&+!;#RMJH%L6
M.11!-<5TWQI6$TYR%N14;%69<M)E) V")BBEAP4#7D@2UY%,$1\Q @<# ]J%
M8M&NX,NU@#[KP""!SP"=O/R;OD3TVM*<J"2&-'0R&&1(E;9"-C)&\7!(=Y_+
M>0DL-A>@"5/56NI6.JL2"K+DUKPV+*R9VN!4"3([2$(40,$A:@7LB8;*QCF"
ME1'%OT+)D@8T&>,@,03R./>S=V"0O;DFAU;M3T_%U32,>1L@0ZDA$ A52NTW
M_O);4G_K6R_ JC7K&_":X4L+JWOC0QBR:W9N@;6+!RG2 MP/4RQ79W((ERNQ
M6>IH1S#0*34X!,)];GX3R3E8N1(5VCS$JP02-I]CVH@@\=^U]81X[TUM+S,/
M'>597\ERY0@K?[(DBB:!W6!^?T)TW_Q\%B?\7#W53 R10OH5!07]S_I<.D/$
M041,P4Q'/'$\S \\Q/,5OQ8U:E*OL8H_J>%L\$T1=7^8NJKJ*TB(OCA@.S/S
M]+Y_O_7B^M:>J5J87:IMK1)B3%@<R #]0X/&+V"4L\RUG 1*#)<,CCGF.[G,
M-4D=XY &-"K7D^D<@70 ^01QR>+/6N^!,2#^D<5)XB6G<K&5!(=F+*N_V_$N
MT [211JN>K2837;- CQF;K545;%9-TB17<,5:\M-Z+)?2\Q,=Q2H@"6'(E(S
MV&,C%3>3\,B$[@Q2B1ZKH,.:I15W5=Q\'K[4T#P^^F)%%JF/C8V*8TR4DQT9
M'$3$,A<[G!-=MI!!_$+%=19O&W7%Y=>'QF0<Q9PJO87##-5L%07BCQL!8RL5
MEP1BP'KD941#(S$S&E80DW3.H!OCMQW)-CWN@ >*)-\UU\M_;;JV/E:I)CP.
M)8X6 <H3N9E4G@=OPD6U V.:KJ ;N92N[!4GW:JCJ2JYV^!86K<M.36I,0B$
M8X^Q3(2Z&N081!PV!AGJ[?= \04*A*U6ZS5B[M>2>0+]^2* Z^;<836TYI 9
M2B!?Q?O 6-U#@VUB[-<5STOVA@ F:JQ$ED;X(Q%PN6SN!Z;$2'!K9(P,)$8[
M.2\?!3)3['ALIMC:\#:>.000>*]_?^/T\EQXY22Z GN&8;CQS\7WKB_FAUBO
MO+LK+\LN2E=J9:&)? \57%!#]+78R(%M,Y(A%93!B8+\A0P8DW( 1MQ0[@-K
M.H)OGN19HCV(KW[]^FZP,#M*U'?% BN_MQ0"UP>W8?'4F=)+N0C8$X2[10ZC
MGVKQ=Q5Q:24(OB?H[JTO%5;S4+4"36*<+GI9V P#F"]1V>ZK$TB[KC!9=M7?
M(*@\D!A5$U54"+Z1R]$@U(PJ)?)<.(RQJPC$-OYXX('P:'O7$V%;PV.>EF2P
MTJ0#3HYO&U+HUG5;M:P=-UG&G8KVF5$I\JC\+1NR+%01_P IDKBO,[2[)&W#
M<"3?(^0I^#VOXYYZ:IITL$N5@P943-!(!!))PS+>WGE0]E6K;R?ROI$<K%JL
ML=7=$TEO4U5B:++,W5R1RA=U,"AE>"['+=*E$L'*9^D D.Y(@W3BB016ZMI]
MRI]R>*]SV_*3QWG\H&.2FB/(1'"6H(Y+'GW[?F3[]).2P%89;9Q2[I$(RX!-
M5=7?'?8*;"% 3>:XFB B1*!"9GF?B8A0.4 4M8-#F[YON1\#^'UKA6/+>5C'
M,+4$\_//)'O[DWQ1NK''3XQ6,4:FJRM5;UU9<!H9290N5L@X8KU:\J8R)LU%
MN+_3%*,FE643)Y+R.]'(4$$;C1-FU/O9-<$T:XJ[YKJ"GR5CE"(:%BRO%"[)
MX-D4"/S^+Z4'8ZKB*EBV[%K*SD44YJQ+K==:3>8T1EY5F)E9)=68XU^2:ZW,
M#O0*_@N5!+"@I6F!"A2011XYL=SV)' /-&DFR9,B91#D2"*)@07H$A/W3QQ?
M'L"?SKIP4<H-G%Y'0\LO*-PZM@S5FF*Y\E_%YN[4I'C;5%C)55R!L>?TCT7"
M4NY7$:Z'U&+IGZ4VC=N4T2D1H;>45R9 YH$6H!##U"KVM9'4?FPR&>'4UMYH
M?/2F-Q+&;]81:);DT!==^>W2 V&U[F<"J16+JLH_!G=M!],7%NLN:S+"!:Q2
MQ8JO:IG!DPI$GP32)(&'&VO+8EE4#<!9L5?%T+O\[%@<=2@\J>*..6-9/,@W
MA7YWL5NS] >W''Q[]23B,(2]RQB$&RZ6*V7"ZAF[EE$0=NNF+LU,C96/!RG(
MKKJQ=B#GDEXQ#&,F&2/I,$NA<A1O7S8XP2"=^QF4<\%0"]_],U?45+D"'!$1
M!(D0NC\T/+E\JF/(VJQ]^2:[ =17C<=9NT\FT&@ U0R-JY:)A0(5ZM5TV+%D
M/VCZP>4]HRQETEJ5$.8$>N-OJ/?D\"B!=B@INZH$?'5C:=83BQ*$</&MM0OD
M>W;Z_GQ]>FEG+M1N3QU;'TQMNQN+#$G:OS(P]V&0QK;,U D!AS8#P1%IEE:T
M E(@/9)$MZ=IW;E! 8A2>S=N2.WN*X^2374MA1SE=Y95N4B(&N-W'IH@757[
MW[=8C;=G( IOZAI5KZ[:%-5":4VE%D@@80H@5VOK5W.E0I@RA/C,B8DRGER=
MI"D[""&H]@P7MR:YH6*JS7!Y=1*,3*_;".5RH4,58FAQ9(_>Y[]S7/QUDH\U
MBA;R<RE;$YNOC:Q!$0)%DQN/7$1\@"NZHT7K !%@0(G_ '(F4P-@6KV@ D&_
M8&[)HWP"/FNYOKR<H^9)&%56:%I:"UZD *,+^.3?%\?ET\LZM.!HXA UK*T8
MI:; R]GD[Z8PZO -)<]L"RZIC.Z/B7H1$<Q#(GL$L^X[?VG/''(]SR1VX_+O
M9ZKV&#E/.III#,$!/-<\\<V35UW_ +XRPD_61978'^9$%(@')#"J5:]37 \1
MW=HKLP!E$C/,0Z"B8F9ZE8KRI&TD6:_^:HGVNN?CD<$\6O*#1+CJ/PJFRN.S
M@*/8GYOX[\\=?5B&DI5P%K*SD'-IQ'(>&)(%H+B)&5 ED!+ ()&9(BD9B)F/
M7.Y0WT7DUWW"CV_^:J_H.!72,$,DK&![;:-U_P!9;W"ZJZ/MQ[5?OAU*3HJE
M;M6($*;4(>9'+IL"'D$ETNWM^I!),[&%(BM<N &,X(8A4%6-+PILCZDU=C_Y
MF^_-=)Y<1AD78BEB"NXJQ KX YL5P:[\&^EI=2I?9'YCCZJ*60_,RJ-4?^EU
M[RL=;C% UU0:R^ *HSZJO$>,X I=!, /2JH!8(/9;8BN+YX[7=<_RYZC'R\F
M!'R<:><O&ZJT4C7#9/-*JAQ]/45'O]6E5Q%MGUQ@<A4KO; ULBPHD*ZWN4Z1
MND0+=X^T9/MF.Q9D4OF%%Z\E"H_I +D V!2FP*-5WY-\\U==[LT&H19*H,B1
M1)L1G!/ ) / NQW'?]>DZ_0$#7!!%8S$&0+.WRRLP*>[Y(8:ID$,@81,%',]
MY\\^N(Y"U@BR#1(']O\ G^-\/?NX!5X'78>UD=C?/>N/I?\ BBOKF460F(8+
MPG^[$=I!VP0=I1,R/CGM+C^L3S/[0XC?8ZMR=IL@&_>Z]OH/;BND)80S;6Y'
MLRU1Y_L]_@7['IG6*+ZU@Y;$%4;,*#OB)X@HY[3F.(B>WF8F8^T_UF(]34>0
MDR@J3O7D_3ZUW_X]N.[2>!4.U%W?!HCD#M[^Y_B.A5:5, N8%:PF)C_TWVQS
M*^8X_4?V@8Y^9F(^>?3H,"!9J[/QSV//?^?43E(H46"K;AP 3?)!["ZY[=C7
MUZ&O-!)2/<+&=PRM<S$D7QW 7$S,<1'Q$Q\<S/Q\>N2HD!L T>#7;M]?Y\?E
MUYY<L:+*];0+ 7OZC5W8/YB^!V[]._&&**Q=R9 72H;+K"R.1GDB(5R)!RCE
M<00Q'E$QB?+Q,P47D1 RKZR:XV6FVQ\K5D\W9']W7IR"8VC&.H4G=YI619:/
MLCB4)L;W.RQ73UP.7K8C'7X764]?G!\D9$$362)"V6$<PXBF'&7:O]?8)3R4
M#(^HK4<9IYHD!8 J0 J@<GM0!KO[_- <GJ<\/:C#IT,N2$1'6;859W(D7;M]
M?/L"3?L6N[Z<%.\RPQ5BK7M*BPBSV"IG $TQ)8)KMB2%L2,DHYF1@1;$3$2O
MU$-"L9=7*TC*&)!J@ 2&!' /%U9(!H>J^K^V5/J$.+)B),DN3%*52%TW.9%*
M7!8=R?45IE8 T2 .R^P/IJ%+$MQN3I9F+?=;AP1Y>TAEL,5$][%2Q!<#(J$)
M$BY*8*9]-RSO-)DB5&B"D"K"WP OMR..23V]S74A]UQ\/3,70VP9\?5O.\V9
M'8?>O+8UN8L 5W79(C !-T??[BG5JG8( LS5JI$%TFMA;[%-@E+']\"4"9K[
MX Q*)F(,  HGB?-X8(:4NY)+@D!6!X'% #V-^_)'?H*F">>$ID28N.&5%D="
MTV,23:,T9)<(2+53?)-@6 [52Q;K --BQ?"JX9"REC^Q#V399(I$@*U*I_T=
M9B0&,J@BF>9Y\$95')E4A=[>6A(LJO')N@>Y]OIWZ4\^&7/QH<?%:!,ORL9,
MR52S1EY%0EMH4':K%0"O<=NU>PC\.#C;E+V[>XE60?%MI]=ZC5M@P9))/0-;
M\4G"6\*800,DH_UJ^ *([>(W/[+IHFTO/\M"@&5$"*XORB31/<637)KZ>^4^
M/\3.PM86+*S$R#Y1,;AP#Y88!=P)-$KM^#QR.M&_XE(<BK^)*%ZO80M8] .E
M=:JM]JC$Q<+*[R;7KJ6G3,"A1"?F\/!/)0A)'!3"?C-@-50;2UXI8G::V%>%
ML>Y( H\4#ULOV*C(C\-961'*D:KJ+K&'9!4C*JM( QYVK0_.B/<]:>>E-!,P
M7TMFQ#JTIN9JT16*T%$.D*WT[";!V4$39F"8H(8+&PQ(B$F>=Y18(Q8 [@:%
MK7J'P>+HV;^.21W^UOLZ@@:(B&9MZNDF7)OD4%@1M"G?3JI?;^'9M)+*%!ZG
M/J%5LW*N3HH6RH@E*MY!OC2JC7:L&6?.M:N7,D4S,3"U2WF(F1*3""BL5DI9
M'8$L2JB^>#P. 0!VKM_?UHOCO%:;#S('1XHDB,LKD#R48*79U4'=("BTQ'<[
M=WL#K]V&FB1MO-!(2:>,>\'^5OG2ZJ+E/7(\S#X<V8+NK*49G*9<*C5-VT\D
M)#1#;OQ#CM1HCGBB!QR3QR/?\\]1R,?(U'5%99XSCF=<>R:8B2@#QS8W'O2@
M_P &42+5E=!(*,S+S!3CNDR-1V"@( .T>V?JIL3)1Q+)(I(1F(DYA6 +\< +
M\?!M>/;;7'L:[CINR2S8^-W=RLI%DVRAB!?8_B)[T3Q?U^!K^.N5HA@C6V!4
MV2@TS8@5L\,SW1+"6,&3(6/</<'Z^.X9ZLO2'A2"& L&N1?:@#8KVJS7PH$$
M&,N2>)XS2,"-H84://-"[KBZ^M)HM9:LA,_S&2424CR _/[<<C CR/; S(B,
M<1/8/V6:-8HSM%"B*/)/M[#G@_\ $D]1*S2Y.3$"Q9FD#,X!H"P3?L .>]"C
M7Y.=]2/K#5-^G8,:M0W>%LNKB+*ZR: N#N!I4R(%-E;#[VP8 9E]HIY'15'E
MOMWD7[D_NWSP&!^. "35<W0XT4N0S#)B8F"($"BH/E('^I*L!?)!/ )OGFL[
M(UV-35(FK7+V$28EB26A9$URQ<$P(0 L9R0@0AW3,04?'DL<3H#5$J*![W?-
MG].XX/?OW\@;,A9HXY 4!:G%454<DAB>!SQ=^X^>K!^WG9Z>'ZBZWELM:IT*
MF/M18K/O5YM8]%I F\>ZLUDJ=$2/<-9BV=[.0."$H'U7=:QB<<J@WLQ]8'<1
MF@2:]@2+KBB#R;ZS3[2L+)S?#V4N+B,[2;XRX9Z,C(5.X!J"'CG\Z'4T>Z#K
M7LO5/J+3%.QY++4*>-JJQ2VD@V+KMDK2D+&JJJM0I-Q'(*6M2#(D $UUJ],-
M(PH,;%ED:/;^U;EB10'R?>R2 "/R((-YKX"\(Q:#X<,^=A18>2[#SW,LC KM
M!X#,* :QS?'L0>:[;YE]AM_E.'S5^S9C"*;XT/LD]-8[0):8K5,RNK+I%1N%
M8A!F,$<<_>6T^&%1*Z+2R-Q\5N)-&SN[>QK]>M*T:##@D+XJKOF6_.7BQMI=
MU>U'N?GGFJC%TV#6<C$ J3"!AO,Q'Q\^/O\ C]4P4\#,P,1Q'Q\>I92E[>23
M>[V^>_)HT/CJ3R<>1[ED<'8H9:/?U+Q].3VX^G6?5<R%=BC^8B0E!K'Q2PQ4
M3B7$P/S$S(01CW%'ZH(O3=D6]Q![DAKYH$@ U[5[#W]O?I3),(DD\KF3RHE(
M%&B+W&QP30[U9'Z5D=G$S$%XA8U;(F2[8[9B!F.Z>8B8GNXGCB..Z/V]>EMQ
M%@':"M@ \\>W>JKGZB_GJ-02E757HE^/:P;[<_V]CW/3CQ58ILL7+)84I83)
M44'( 1R/)=\@,EV_':4P$#,%W1,Q$LLJ3:BD@ ;Q\^WQ5D"[/ )[@^]<3PPN
M%#[6D4DV"!M8D\D]S\U=?F>N\JGCEG<V75ER7,SP)0!!, !%)<EV>,9GXGCF
M>9F..4S*"5  5B!]0>00?8@42.:]J''(88Q 7D.\;;)[<&P.217([]J_+J7]
M1N5,+A+5\ZJ;+ 6M8S86IJ 8X.T1,3$X%@CRT(^.Y@1!04?$P.8KSR^7NJWO
M@$G@UP17%6.3P 35CJIJ^7%JPE@*F'R]M,$(IP?=U87R*JB#7:SUGZ7L\X_8
M:&:NTU7XQ]A,*JL.1KM*8[8\G;(Q(K[9F0(3B1Y'M*)F/74V.(XB$(HBCW)O
MFZ'<\F_^'4-K. ^9C3XHF*-)OW[;&UBI!HW7 -DUQU='$X'+]4RN9\JXOKON
M]M:DI(^-$RH)!2TK$5"J&.0M"%Q#?TP(*@8B/45L6,*%8(YLL;J^>#SQR/G@
M>W:NL7U?Q!C^$9A@Y"R2@1L5E(+$-&?Q;B05MB0.*/'MSTK5<+>Z?;86#.]6
M#+4K/@B:3%-6H%2)ND')82ID6?>8)A]X1$1^GF.F&]7W#]F&"E3W+5PUGV/O
MP01^AZ996HP>)-+3-BB\R(Q,[!N]"Q[_ !S^HJZOJP:]]ZQX/,8V,-L-YM*T
MH/&*&?3TVIL"/:3:_P!05?O8<=H'XP:QLB)20?$1K:;ITP8RP1';N(W1QE^:
M))+(7(KG@T*]JXSLPZ&N+F7$<?(7A76>1;<;OW0Z@][X]Z^.KS]/^J%2*J&;
MG"J-L*E67V6D\)L.,I![F5?,WPIB97RV)8LIDB&8CB!I&M^'I95O!DV R-L3
M:"HLBMKM6[BC2_D#W'5+TO**9V0'Q'F@4>F='ED+&R2'3=2G:5YHFC5=2=&.
MUW:ZJ,[@W5C1>B'JMUC\HMCF)B>[F1@A*."#XD9CL*(*)CU7HLW4-,D&+FJQ
M\@$L&4(Q-W?L;/%#D41]>E<O1<#42<K&58)I&IC3%PPYI@>%([T*/()'S6WK
M)$83(8:;BDNN6+#J*[EBE!I8FQ J*&RL##A4ER1-&)7)1$% SQ.A>'\A,V&6
M2$E%5?,E3>%-[:(% ^UFK]Z/QU5FTZ:+.;'FV/D,2L<S1 ADYM37#-M'QQR#
MVXK7MJ\:\XQN>OS1QUBM%J78!"<C82I$ Z*0B]M28E7@ AKR^?UP$R(2(%ZL
MF--(C#8/,+'R_P!J;5%8#U<<>D,2?<T..K1I&G!\.3+PHO(DQ_,D87N,JPC<
M8E#%CND(*C:5'J]S=U(VJ]>6S/IJ[$NU1JP(5'M97H7AKF8NA=FH!%$\P,0Q
M*SALL[I&2[RF9V-H0X&W]J%-D?A+*M!@2+6Q1J^#7)]]#TO29Y<'"R7TY,9)
MYHY61@2;W79NJ)!)O\P*/456+T4B:K(N=68^FAPV!),5[D-A;1\:UBD&!,SR
M+!&/&0D!B1%!1T"&OU#DGC^V[]KJNP/%GB^KJ,28B)\2"F1EB<BP2K 71JS?
MQ\]^JW]2=BQ%UP5@KF;JX"$]Q* #81R;2&1@S,8B0F()@S,P<3]ADI3!@G"L
MV[TL!1%FN?[^>_\ #J^:+B2XSISM;:+4FC\^QXYOV]JYH@0_66ZVVS92 1X!
MCO9)$( ;99 *F#F?YGC2PY'Y$87)3\3ZDY/0D4;VP<D  #@T+-\<<@>W<]:%
MBC>N1.[[#%&IW75J;XKO5C^8/>B5? ):YJ0 9<3VK4*8[1F2E@Q"SGB!7P7R
M,S$3S///$^F><%6)C84JIHW?TXHV;'!KBA\W:$"R39,,1\QUR)PJJ!Q1H79K
M;^($77T''4ZIFI3E?TT")TP[',EQ%Y'=A0P0&()35<]LI[Q@!CN* DY^:@4E
MF),K$JQL T* /R.17U^@ZL^3K&#I &+I6(SY17R9<BB68G\8(>U](/[JH1?>
M^3G4K FEC)*RHZ]065F&(#'TP$<M$@,)[HCNF%E/<11)S]HB(;3 ^8 @6BQ!
M (.XT!P>*H\&Z%D7[=6?2-.Q,S37EU>7(;)Q\=<@1O 71(V!N,AG%)0 #TQK
M]!T\,;<LECS-<.53BRID>>8%?C;^HRF>.3:P(@)$(%7P4" E'=#9PGFKOIWH
MK:\D,!0]AQ?-]O<]5O*Q53%R!C1MCP"5?(C;<T>2KL"P"L*H)9- @ FVOJ3L
M-D*]>I9&ZN;C;58J]+S?3]M,W1 D?:<=TSX(;"S"9()8!]PF,=T?E1.S1B$&
MHF#R=SO [GOSW!H?V7U(^%,W3,9]:BU=RF7F:=+@Z6Z11QI%+(RJI)CH5M!'
M/)L#WHM?- $TWE-E_%,2)HAX3AHS)&VL30./'$+GD9'^],G\3$QPK#*#( $I
MGL FR 0&"FO^L /?N>U<K0:,^'OGDE40XRXZ%:II9/,1W<$D$D+S5<@4*Y)K
M]OQU7T+-S&N*+#+)@2WH!W*FI 8\\'W*69J(H5"E!"26LXDS*)78-,#B9$FY
M %BB5]^"*[\<GN3\ #J\QZAIDN-D3:8\DD<\X$DDT(:0NJ*6#BV"*UGA2 /<
MD]>KO\*BBJ.G>]"V@!6ZULG0]=H(4:8[ZF+ZF+ Q ^1D7"1.[EE(]Q' BM8@
M$;GX$D=L;.C8VL<\6VCNK<CDB[^:O@'M]>L@^UK%@BGT')A1D?+Q,LS;@1N>
M.>-0U$#@@BN>W''6E3^/0N(_BX^ZQC&SV$KH5VK+M[%\>V_I+Y#XF.2F1")^
M>8B8CB(F?F&\7,3J4R*"6J/D63?E1T..PL\\=K^O5+T4O]V4(>[N#\5NZKUT
M7]F'N#Z@:UAM\P^JUHQ&Q5+>2T+$Y;9M,Q6Y=1*6.8Y5R[T[Z>Y_.XO<-[IA
M]+>%#M;P^4K764KL5+#74WJ"BYNE9L\9,4*\J2%9_+>4@B_*7N]&P2H-$%3V
MKK=OL[S=(Q<F&34\R7&ECF79D+C-DX6.7>E.9*-J8ST&*^87C*D.>]=3/HO0
M_?>L.83TZZ4:U_;+<J6(NYA^(K%6QEZKC\.:)S#+J\M=2I)ULE;7111F?K,E
M??7Q^/3:M-"N=1P<#-S\J7'A@<2QEA(KT-NVQ0)YW6-C6 ?:JZ^P_'WBGPOX
M3\+:9ESYC94THC1'&T+(K(CA46-G0@DN6D6AL#  A&;JJVK="NIG5;9\KCNG
MVH9G8+.&PZ<_F,KG[V/TG :M5F:BOK]LV7=+^O:WA,1:MO"OACR.7HQDF7:(
M)\EADUAM^E:9/D@Q+LC$?#@;3S=<5Q=T/?N;'?K\\-?UV/)U#5,F5S.T^H2K
MBL3N$<9'^[0CN.QN[X%\UU6KJ?I&_P#3K<\OH?4;7KVK[IK1#1RV%R"4IM55
MO&,E3=YDFVKD*=RG<1>Q>2JV;=+(8JQ2M8^U8H,KLFR+#]V81/="@#7JW 57
MSSR>1^MGFM0QJX<QT S%V)/"D]ZOW!-,._Y]1Q)C'$&<S,<Q,?I[?O/]V1GY
MC[Q,=O'/,_X^E*[U7S_#DWV^*]_UZ\>,*2"P9AV%CD?F!^?S^A[ D1]O;\=D
M\ 0Q_=B3F8F)^(B>[F?O,Q$_TCUYP.35'O9^G^%_/Y&^N!&20+-;J^>+^/D_
MW^Q',BZ_<LL561:;-JNHC(:[Y)LUCGF//7Y@&5W#R)":269R/!<Q''J$S9 N
MY1P&I178@]QP2""3R">/<'IP<!5(D4+N"V.3^+W)[=^>.P!/ZS8&P9&S76F_
MD&WJ3Z1"Q-JXUYUF0TH8^K)S)+83I"P9H@9L"R9;S)%'JO73,M'@D*:H<@D
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MLLB19&QD:R:KRLL\:P;%#(?3",0 +KE+H%4$=AA]%6/^[VT6H@UZ3$Q'/P&
MLWP2..!Q)X$@,DHRWD:;'53%Z2 $8 (!?!!)KTT>>?GIB8O4<W;V/"+&FU#=
MC8=;!LR<1C%W79A*\/BL@MU[PUFTFM>JTRT9"B65WSWC^LA3?)C1G64H3L4%
M48$*HLMNK\)']7OM//-7<HD;*TYY-/$N0V'YS9- J8W1%R%"J+WN4#1<'\9
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M>172DK+^)=2F'B7*V%+^PB"&C)3$0XXF),NS]$R/(]O'<///+4XHW/*6+7;
M5='D@<WQ\#N.:)/1)E)D1P0*GE.D1C+G@ [B+'-7[^_MQWZ<^-R$*O-&>UE9
MZ'^5@R*@5V5K"%A7 P(8GLX'GDB[FE,%SQ(H2Q^;&K$ ;">"#9%@\D$?H*Y
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M$P,R41Z;RZCCA@@9@Q8"E&XK7N6'[HX))(H5Q79MD>&=2QA&CXTA!QEWHZD
MD%FJB31HCCF_CWZS"5D:32J6,99 X?%7\O&L^9=90)=T0F!D6&E<Q!1,2R6?
MKX^?7"^5(;65220=VX6 :%$]Q;$\=O;OU7<G$DQ-TKXQI0$*[#^("@1Q_P /
MGIQX'&J4RNVT<"HV*:; [H$#8 3X)_3$^58D0M7QS#.!B9^)]-9IMS; ;HD&
M^] ]Z)[?!'?DBNW5,U**6*#(FV$O*CE !6TF^/G@&CP.PZO;TEVRQK3<7;Q(
M7#K4VC8(YYFH601-8F.(!_EL%""7-D"B6-4,I*(YB)8Y-L2*3>4H"@1[4?S
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M8#ZAI^*R96.R*0X2,*P #&@* V\5SR:^G5?]AS=WBQ],IX4X:34<^226'?\
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M^MOMR30)H"W^$DTM,'Q+JN9DK'E:1IJ-I.!M1AF9F2YA60$@F\;=YO -E1V
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M8H@ "V-5P03[]?).1-%&"A0">-WY8<M( P+'W9FM39[=CU5;^(BJID/<E0R
M6QPOYSTCZ3,N].[UC'7;_1-.#TJCJV*Z1Y>U28)7,MI^ UW$L*,OXMIA6034
MV<(SJ<@9JZLY5UE N0Q1EHP.5=C1!K=QS1]N>;/4AH<:SLD.2XA#;[+'BPA;
MD=P?>K%?/'6OBUX5\$LY."(A(H7VP,?$"7(D4_KCG@8".R(Y@BDIX1A+L/4-
MI/-7W_.P*/(OY^ >W>2F/"W[.0S&R&('^'SQ8YX/?DGK[J1$ 4C_ #!C[ESS
M//=SV\EVQ$Q$<S!<2,1/QS$QZYF%$CL37?WX^@NCVXOGZ'IO&P=AL&ZJ[\?'
M%^UGY(_7I[8"V%9L=L$9>6&0(Q,D8SS!#!1Q,%,3Q'$\?;B>?4)F1J[!CV *
M]P *XJN;!^O-7].I<;T16VD+7J%$B[L77T/Y?0=2/6+PD#TM1V5)!J^"@V 3
MH6EB7J$I/D0(9&3 5&,1S^J)X@W0#<&4F[&X]B%-V+'/(]OR(XZ;&2*=?*#;
M)"]V.>">S"NWYWR.!?4A8:WW6"6:".GE<3<1+1:\(J.9$)MV0\8, D# +"TF
M9B8KV0YX[1F&HW;218 =0#0- $7P37M?YC@BJZC]0Q(L;@S*90H<(#PY(W55
M42#Q[@77;@2AK.+QUP,.JFN/S#&%<&HZP=I#*:SN3D,837H([?TQ6)M!8>I%
M\#%R^8 A;!]N2BR, :9P0*L$[0I(6Z#?%T!WNB#U2\C)>3*\K)!2*12LBL:$
M@L$*P)IE(LGV!]C?4H%@JEK%3+)KUK<CC#D"1:(BRMHLFB+ST6:H"C'//$VZ
MJ#&%U618(S37%+3%)&:0%SZ1;J>!6Q K#U V7VFV#$T1Z2>JY,_W',6*)C.D
M=/&H)(B8$5M'L1=]@>+'<=(V02C)8>,+64K'7=<*C=Q-[ZMK*18NYD7NBG<2
MY#5!7*&(QS6%)*K]B3-*Q\HB1MO)E)"V67::/K /8W\;3_TB#WYZ>*QT_,CE
MI\F/- DR0JBPTBJ'86=Q))%@"^Y[#K.P(UZ-E61MJ/$8]N7OLK,RZ_I[F+RK
M3,G)1D/#]'D,=2:I-S*4KQ4I%>1IC59#+RG'S(ZJ-F[8S1QI?]8 @!@."'?=
MM4\UM:^Q'2CXN9FB6+ 67-EQ6,\D./R1$I$M3V>\06AP.PYX/3?MZM:Q-"IE
MLCBLA7P]+)9K%4!R9,K,O,Q[<@S!*!\A VPJW+3:UVPOL4JOCKZ+$JLR*Y;2
M9V.'>,2)(ZK&75#Q8V*S4/<D$A:+410 -]730]#U/6<E,>*EDD@^\F'G=CQ9
M$F\+*!R"P.Q3V!//U4=7T3?MP3336R=C'53HIPM[+99V057J:\RVBE5;D;*J
MIV3UJKS5QN3M%7M5TA4!8*;/ DQEU[%QY"K@2R>9N'E[3M\M;9@#QN"[FVFC
M78@][ZOV,ZIFXIRX,=<2%?O#P8N6D@F;*V*3!%P 9F<JT8]0(H@FR>E//]/<
MG.,P?Z&V,32;L,8[+\-;4O>;++%ZP::8A;*2ZU5B^X):(/58(%-MKF(\ZZLD
MC*C".0E-T6X;E9%9BP'%K(L@KNI96'.T]:EX-^PUQFRPZP^*<U\2.?[J][HD
MF$;QQR!2I5E]3'@]JKYR=8P.-K82S6VVQEMEM8G6&:YJM*Y8LVJ&#Q_GM/%M
M5MC(A;J#BW'-K%XM5>Q0>=BP+O%S$L\R,O(DDW*54-(#(2 "6,94BP "=I]1
M]S9^.MF3[!\;&GT>;&&/I^",J6/59\>-U3);=$ZX\K-Q)N%!48<JS#G=?4L4
M.GFI6^DJ,BS(LH6JVTW<=&*MXVW87DJ&:'7DV[V-O*M%4"QC<74MMR(/7C9F
MNG%(58LM= HA9-0RX\]X+\Q?NRR W^%HUD9(E6@0QD922"?R-@#C+^SG3=.\
M<318FA86IQ3X"9S%W11 L4>1!*LX%K%BRML\CTV,B,VH84V7MM#3L-T6TK$X
MG'XQ^R3E]HS[\_7M5+&>5KMG8RQV)P-VK(W&X3(I-.2RL5EM<U5%E>XETR\H
M'W$;)EU7)DFED&-]W@B2%@1$9U6Y712QH,1MW5ZMU?4IZ?\ 9,F=XQUG5=0@
MGQ=/E@T['QM+:#?%%F5<\ZS$"/-@>$R1Q/$MAF4MR3;.VQ>C[EHF+IW=9/ [
MWB[CBM9/$^9>O[13"IA*:7VL)+N,=GGC6?=R^P+8R,G8I5I.L5JS9LKDHY,J
M/+9PXF@(5 I"*V.B[J (&YPI-H#5 T?GKG2?]'HZ3K>HIC:JTGAS5)G>2&02
M29..[A7<)(7"&(LK?L33+O[V.4.OI><WK4Z^I83%8H6:P&T[YG,\Q-*KF,TM
M"JKVA8MPFJ\U8S&U4TL/@E6+$6L@[ZE:BLO[8]ESH\/(,LV05\TQ8\4;&E#.
M"05 )5O,*L26JO8\V&7B#[$M&\/2-G9N1/J&-EZAC8>#CICDLAR2P#;2658T
M5:8@@6030NZY93I;F:N&RE^K4:%560HT;5MB7/10KR%RVJJ]T R8N9!@&P8(
MI)J*1D$2(F?J>AU8!XXY0'<INM"O(O:6VB@ /CGDU9OC+O$'V):E@YDT&'DQ
MQE96GCQV=O-,3<JM(I)8+WY%GGIA11R>,Q5LZ^-L,?D[3,8F%K-D*73^G:YI
MS"CGOMA8!58(/NE<6C(!7Q,R:SPR$N9%(;A18!%\^Y!H$ &A]._?(]1TC*Q,
M^/!GCFBEQ27EB<,!*JT+"L W<@<T+H]SU] $8W%XG."/8RM2O8['L9SWMS'U
M=YDD'(R'?2JW:=P>1'CD#B(YB27))[45% T.!5>_YW8L^_Z08$DN5D8",T;-
M++D]J/E&-04(-$#T'V! )^#TY,54F_LNO8.P#;-?#8O'9+)+6,N=%JB89:^N
M1']9M?6@Z0)#N85MBZXP9\<<%F 9@JDF0H 2%O<-H(/L0;8?0<<=X_(2''P9
M\@GR?-?REE7\2J')*+\@F_K1/MQT[UA>''9VP-1C<G8MQB\=6!!-:^Y:93;E
M+?A4$M5C,+CJXXPJR1\;+%IA1 &5B?7"T"!8:Q=T*39NVK?;>Q)-U>VS7 '4
M1*T,TD$._8(0'?;^*964GUC]ZK]C_#L/JG1)5-]G*7H.VE+;M^^VT7:B&LK*
MD+=BN#%EE"-,"NA6:5EEOZ=$FQJI(>S3.!=794=FL DG:3>SG\1H<V?CIO)D
M2QF3%Q4(B8$!  4MR5!(H[2>]4#5T1==+NS;YAL/IM#'T,38:[++R*A9E)I6
MZJJ$S21CJ]/6CKS1KV+'A5<"]:&RUA<6$+!S+,-%W>99<$*0PV_BW42=\A.X
MA=Q4JM _D+ZC=*T'+GSQ.S/ \#6U$A''8 H"%)/M8/?FJZ@"AJ!7ZM[)3!)L
M-O4L7@L'605JQE,G=826$)\<5:Z;(=K1+B)+N6A7$D +;EXVFS1))%4.* !Y
M)/-5[D5\]7F35I,>2'"D1W&PEG!NDCY9N 3V%\G];Z8UVD*?,$5BAQ00R/:H
MR[I*1Y$ER:2(>)[HB9,9_OC'/'IPLTB, Q(44:))'SP._/O7!]B:)Z?1M!DJ
M6QV5Z[BA=V+L7?'O?\*NVE:H"L^&_P DAGDX[(DPCNDN"'F!G[\=L%'VB.8^
M_J8Q\@2J54_AX_/CO\\U_P .>6.7"RGU*1W/ ()/;V_+FOT/%]887FD:TFN>
MU<LE(K@H(S*2CNF1GCNYF/[T0,1/$#'[N6C4"R19H-?QSP;_ )$&K[]1YBF;
M<][PH!4DT0W%<'G_ ,/UZ<RZIA6/(6FI"N'@!2NV#8?E"&?RQE@R?;$S)? B
MOA9$8C,%Z;.MDK&*ON>U<GCMR?:^WTYZ17*<MM8C=VNNQ'-W_A^E=/+7\U2J
MD )MV*\BF(8QQUY2S^\4,>FPN51^B.WLETQQ,<D93)>H/-P+;S'1W!-*L8Y7
MGL"#_ U["OCJS8&MZA'']T@.#'5LIR2:/?DBN2>/<U=GY'72RS;&2E\-2::;
M#F)@%1+F$1%)F(@<-F(B('O#QC(Q(2,_,<OA*D7 ==Z_OJ2P'< $GZ7P>??Z
MIR:WD)+&&\J3R95D9<>1TB=@P+!P@6T(! O\/;F[ZE2EE<;D5$+H'',:R #(
M2X.VI':YK_'6\32:3O"(!8)@RN>3[XA@R,'/@21?@/F+QZ3=GN.:/;FZ/Q7N
M>KSHWC/!R3+#DXYCRV95CG4W%'';.^TT U[=MDBN"?;KV*?AOF*9[;.O<K:+
M4_Y;*,C/?!\LG0M=AQD4R10QC(F6!+&0,Q$B7!3$;+]EZ'^C=21@ 4S8Q1["
MX%( X]A5_7JF>.V63-P,E7+QY.&TJ@$DJYF?S-QHBRQ''';GK05^)I0I_P#$
MPF77%U5J]N_2?O@R[G,AF6Z@2/TR CR,*97(',R*P[ADC_5QZ>^++748R$9@
M<8@U1 -4-Q)_+\OULZ?]E"1R>'<P2920 9QX8BSZ&K8*LN2.YOBJ[<:.]#VE
M.L96LQ1LHH>HJIS5X9?LC9%M==IAR<#!AW]Z4$4(E@00P/>PRH.5"THLJS5Z
MAQ0' :A1#'L+H>_R1?TOX-U_%T/4%+J4C=/+$H ,K;J5)"2.ZWO X&ZN]]7C
MT79*5_#8JAB<XVZN[3-5ZF-0"?BK(A:.<:T)!S'.>]LM*\%B2*HJ5P,/*)FJ
MYD!$CN\1 0 HP>O,L>IAR%%6!MH7?Q5_6WA?6H,S!Q<;&U1I(WC,4D2Q!FQV
M"7Y)4@EVD=[=PQ 53MICS#'57364[*;DBTA96-H'X$TP%E?ZA]--9,SW9"B=
MJ96MHM\H%YV-[N!$76+EJ!2D]]I&[=8-!S8!"BN_;BO?CKYX^VGP<L#1923/
M,)OO+/&L*Q$,L3NBU2LT=BE<TQ*<WVZK'EJ#%V(;4KMNG22EOE-017KWS'R=
MDSQ_IQ+(&J@&#"R>J9)3%_H]6S$F8QG>RK;=OE":%CG8#P0 1Q8N^3\I8TT.
MF/&RX_WPINC)<GRHI2=W%5O9*[$4#W%"NHZ*E?MW%)0ES[-PDQ5#F9)K''"5
M+&2F8Y[Y\<S,S _(2 $)#ZF4DB"'E3ML,%%FQ9- 5WH5P!?(-&^GDF-EY63
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M*51/M:BFR\-8;=>TB7 RN28;9D%2##(RX<==DCB(AED0RD;#3;G1J]6]EW;
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M'"B/X%2P3,"$Q)&<\RPBF>Z9 XF9'CAS$%'<\$&KKL30YXX_+WJJ]^%@VRE
M!8_B35\[N;!(]_8_ETG>5P$*^>_MCM.(G@ED,1\#'/)S$S^HHCXF>.>(&95*
M]Z)(/;W#<^_/'ZWV/7K8Q))YW&P* X/MR!Z3?ZCFNE0,FF%P02Z95XY,8?$%
M,<Q'!"<3*HF1/YF2B)&.8B9XA-\<,"& !YJ@>#V!Y%>XL?J>.>D@)8&!92R
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M"&#S!AR41\S,1 Q';,QR7ILK.H$FX, 6L@BAQ9Y[&@>W!)[@]-9MLJ"QML\
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MNS02RE=KV2K^=I0IB'6S%P1+%C9 I(I%<.^U[6N JVQ^!M):C9(/N/F_7_\
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M[T[:<9KMMCD*9*\/;V&C6K7+15AAJX36*VT$-8$L7)-)WDZ*JXT9S,,A6NI
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MP7K^CYF1#FXC[(@+)B9:8, >0O( #']![D#K/PE>UF$4W8E7BJ+S*JV2RPQ
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M03SRM 5\T(%#"4)NDVL%*_CVA2I)H'OVZR@L Q0NN*L3CG.>"$5R, BVV!*
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M@% ).TT!18C\(OX]^V;[-\R'4]0U+'DFU/5LK*9EACC"PX>.)"K".>,NJVB
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M66%PRV9"HHK!41@B*4^9$K*QV (6NQN4*IH$@^E@!6[;U4<4ZIDYDC9LLF'
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MZZ5I<E:L5J>#F$7%5$-K5'2E->8%<L"(/-\-X[PL=/EBBD!+R@(H+@M;*2H
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M/7,O*^YXT@ CQ=L<86N"S* 0H"@U=V>1^IZ<5E'YC00C@Z8*JW+!7[#Q14;
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M\SOS"&*8=^J(L@4Q#$L6ZNHA)Z8:IM5R],R'(:)&1]ULQ8%1MM> #P2!9!W
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MECZ0+IR00IC[&+I(IG1MOM FPML-6V+,UZ3@L6FN5+!B&.%)999@<B)6@5B
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M2Y&3?E:=B@3*H>1K3_FUNY)Q5(6B,J@29'3<K"AA@QX)A#&%C*C]H@1$,:L
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MBX\$)B!R=I]<DNX,!;$M50SL/66<-<BK7KTZB<;D%U[9J52NN**UHS&W1=7
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M]+1YLGG8LG(*FV+0L!6B$+D6,&Q*X6H86"B9XX\1!*I$.R0F &(8'$=/3O\
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M$C$Z=K&MZQC\;F=FQ6J/U?-9)FT;7A=9RK&[(U-?$$A$D2>J:ACRPXZ0.)9
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M"P^N=8UR+:=(3ECR[[/E4<P)LE3164B!$N&=W SF+JJ>?Y<CDE*5D<;2K-[
M!:H4!?8WW/6*>*/LTC1LA,*;=DP!FDB7:H5>35NRDF@>"3QR">084;1M):]M
MZ&J)2N[P!$,$9D>$@0 V1$2+QS\#P0QQ/S$>K+'/#(J"(JX-\C@GGU&RH[>X
M/;K$T@DQ)98YD9/++1DD;6W*:XLD'D>P_AVZP!^H5"W ,SYB($=TRI9$OCR=
MKI'L( *>(9R7:R(Y\<RN96I&5@2*4'?V+!3_ -'Y(]@.1[FB.E%@9E]9(CR?
M]PS':)6K;3/0!6^]L>?CK:Q[?Z6/ZA]+]ZT_+Y(_[1=(-0Q&0QY0R7))EW,7
M[>214M5CLUWJIHK<1(E /6)V*_DA0R6?:QJ<6#DX43Q2B/6LR>"(J0OX%4*S
MJS F@&H%2!78=8KXT^SOQ5X>U]_&.BQX#:5ILF(=<)L21391J!8Y%! ,K.H8
M6I9J(#!K%).K,X'+=8=IM4Z#YPF7R=Y+Z0]RUK:#"A!B8JD!/M%?=VS$S,S,
M$!3/JR1//'IRD2J)\<HRR$ $IQ:$7S[T:_3VZT+P=FS'3!!F2%I,UY79=Q-/
M*S; F]23M9E(&WBQVN^JO;IBFR-]4B"0#(^$:<C_ #Z\UX8,0)$(MD>>9(AF
M>[M*9XF/FWZ;DC]@Y-"2'<[<T;OO[=S0''MW'5NCFGEQ&TZ8M.<>:U4K;%@;
M&T@ <]R *XON.HUK5K)NKT/ SRP\H2?_  <G#)"! 9.?' 0P8GND>^((HF9B
M>T9UGA,;N&4^GD=Z)L'VL_ KBS8['I62:=4BBE@G(5S3 !6459VDT." 1Q9]
MJ'5I<1LE4ZNMXA>*;<91LAC'#Y[*;%^T3$/$;-NF32E:I2, WGD?"9G!D1"&
M>38<J9$\Y<!7MQM4$*A+52FK/<51]B.+/7T5X(UI<F+3,J,Y^0DA73FQWED7
M<8S%(MF,D[.Y8D[K4WU[.OPQE*5:E[N\EW6I#,9KHI;B+297!$..ZE+:U+Y%
M<VE$V#7Y"2J1)4JB#A<,+2_LZD#XNJ**]&5&I'N#Y;$6+/MWY[W\CK&_]*%8
MQK?A>1%E0S:=G,1* &M<B%6IJ4L ;[J.UB^O.?\ B$__ )[U[L8_<E=!OG_^
MVKH['_@^_P!OW_Y'^M _TA,>#2Q<?_NE//Z5W[U7L+^<\3G'3M^)_<?/U_+K
M2Z<2,1,%S,<QQ$\\\S,Q]XG^L?;[\3_CZBQ1NU  '/T/]P[_ *^_3L@[1QVN
M_IS_ ,.OKO@8_P#7OB/O]_G]HXCG_9_3[<3,3YMLFN!9[W^GM^77'7Q!C,SS
M^F)YF8G]/WC^]S^W$<3\1'S_ %]>E2*L;J^#?'Q7OR?X#VZ[0<T>QX/OS==O
MGO\ V]NNPH@1#]4?,3,S$S,3//VYCF9^WQ$\<?O$Q/KP<EB%[&A= =C?%5P?
M\2>_2TB!0K(P%CD\#CD4>.1Q\<$5?2G3R;ZDAVQ'']V)^),>(F((8G])3$\%
MQ,#W1':4CSSZ;O"DK," =HN[]^_)/]UCWOH+L -Q!4_6N+]K(Y/S?)XKWZ6E
MY=0Q 3##B?U_I@3*!&2G]7!?IF.?B!..)YXF8B.6CX[$V37MW(OCO]0>/8CG
MI8O9V[MJ[> &!HU[UP">/C]:("E4RRI[K55)!"P./$?ZH(X$IGR#)A$QVB4C
M,'^T=PE,E)<G&LT>3Q1 ' ->_)%V!V]S[#IL\OEJP5BRD$D42%9> #0XXL\\
M$?4\NG$;A..4%JIE,G7<$U3):+,H%R^_BS68SGPF'C "A<C P4!*N3F)AA/I
MP;<&B#;P19%DKR%/ !N^QLU7JX'+4Y4LI1&\I(U8?MBJ[]S ;@ 2!L&T =GL
MD\COV7<ZJ,@^VACNQ[6/2%<6H6B+!>;P(9Y/-(J[Q'B>X>(C]1R9%+=,)_+4
M.@5E&VF.[A!0))]()OZ<W[=2.Y(+1)%D#$.75-H)DY95 (L@FK ]_GGI<K;K
MDT :*N2L&MH05NK8;VKDUR+A(EL3,$TGBGA@')C(?I/Q,(?2;Z9&X/F1*0Q!
ML FSPO!OL%O\ZYOIHLKPSK+$[1M&'6-HW</&CN'=550*+2#?987\BZZ>E7JI
M>_+\M2QV*P .=1KUT99H';;CQ0V#M?E!9UF3\%VY$+2ZY6D&K49+IS7 V\HC
M18H90ZHJ[KW*HY92IY<C8>.6"BC8%^QZ9YV9E9K)!F:KJF3CQBHX99R8E(:]
MNPL5H@F^W';FNFVS>=A"A:QCKE,*961M.=71C0LNLSVR8/LA7"XY$2M1K23I
M0DA[UJAI,@G*:;!P50 G=R=QJS7!)/?WH5=@](R^2LL;EG8QJJQUN 4"J"JK
M+P."+HDW[\],NWEV9$CAUA[F_"A<PR,3_EPH0'ND($1 8 8&#[OF2F.!B7,6
M(D!]*JBJ;(%<@FV)JR;)[]_;MT^5YG)F=GD+*(J8-8 6AR2>*'/)Y /'(Z??
M2C6J>Z;AA=3RFU873J&::U)[1L2K3,3CV)K,?7BW] A]J/*Q(TT>((F;3TBU
MGZF'$;JDWE0-)&CR-&1^S3@D$@,>?D$D_P =M5U+XI_HZ'-U-L.?,*PK)Y&.
MMRLX*JAHD4JJ ')X(!//2]>RR<5?/7:%%A*QN0?7O7,A8AE_(,JN-,(.4+,,
M?QX>9KU&M:AT?S+EN%Q)PS8T;[L@@*7 V1JM* 1^(;J)!.ZRW!'%=JT/!?5=
M2QL.5B4BFQTE"1M7E$W:V#6\4-_ (-?7I[7]HUV]J.JX&ACV8/8D1F(RN=99
MMV V8AR1/I)(;%B:M)F,Q[$T:P5TTT6Q%PLAIFN08Q8$SY,\SA9855 (@B@H
MVSU-N%E@W<[CQ0LCW:9FMZAX;7*439/DYD21K.[DIBNEC?'N&U2UTWNWQ='I
MJ;5?M6<'K>M+KQ7I89>8R;C>/;<L6LUD9$VW62E4K>=3'U?GZIU.05"0/D!Y
MFH8XDD,H/9%V*H]*TH!JK)-L/:Q8/'J'6=0:AEY,^H9N5DM-D9<S)YFX%3$5
MC5(B!=*P4LPY-CZ@%YX:M<RVH&F]?/*6 S-:M.N6@<937G U"JY.M=!S;->S
M5/OJUHK46=OTK1;-^O)X\TF,8(L$J4V@@$40S $@U9(]1!XHBZXN'GD7"U(?
M=E\E7#R.J"@\C(-T@N^Y';@_R 8-W!"%V,14-S4K@9%%Y<K=+7+@30E]5;%/
M@O'#D/3$)8)HB1\YL4 TD:)Y@LM?'O7(YHF_I1Y[FJZG,7(DFBY;RZ 8NW95
M/-DCM=?E=COU\Y&FU;P(F(LLLG5JC'PA@@A5:NE@N5 K9XO%"C(P,NXN"[QB
M>WR.?>;_ -R%7\)LD@W9J^+_ # ]ZOKH.49R'.0!R&1AL[C@V0;_ $%?V9%V
MJ^I2O5;;#?+)IBAO:1/:B[#KBG3,D*1D0@%V&>7OAK5%^J8F"\$D(?<*2R2-
MU4*K^(-WS?OP*KKA(\K(D\R&*655!N.*/S&^A- L OO7R*([])&2U>Y7J4WW
M*-KBR,RJS%=XK<QC&UI18L3$K"S(1$1(D0%X1:+"[IF%(<^!IFC26-CQNVNK
M'FC87G@'OP:NN.I:32=?3#7/?3\Q<=KIG@>-6"]P6%;C^8[ 'VZ;MBJOO.I(
MFLE&M4UVD L60\\3$3VP2V#'(S PPXD)E7?$1+X2FP]H5Y._D BOI=$'D6*'
M/(NS&"%V1BZ31DD5^%6[W0L@GZU9_LZ^J3S')L)@D"&N4WQDN3$84<'#5P7;
M/ ?KD^P>)CNF>"D9CR1E$0)V$J2"5XK<>1^O8>_;\BX:.1(5D -$GA_Q&B.2
M0!WHV>17SQUD&LZ1$AQ<V9$FP$?KF&D$%#H+GF0A:X-?P,E!R78,C REO5O4
M#^SL >U+[C\[-4+YJR1WYBA:1=ZH 4%.H!8$_/![51Y%=^.PZ&.(3"PP.19X
M@X[C@?&EQ((9Y&.UJER/:41,%!1//Q$%R8E( W>Q(_#?*V .>Q(;@]O@7UW$
M7!98R4#&GKO5CBN39^>?Y=9N#Q[\QD JUV+'ZB3(C:U:X6I4FX3 R*/(7;W@
MM*>YYG"P ))D>DI]J)M JC\$GM1^@)X/(Y)/N*Z)<@XBF9]S; QC4GL>?;@W
M?)_*CSU+-K%U+-7%8K"E:9:4W+)RMB$$T &ICH/ZT 'RBFO1INLC5%8DUL"R
MT\U$]10TWDH&=48 V%)YK\A5WW^!V^G4%CSY"Y63ES%C%/"J+W*(6E3G@EJ*
MFC?)[ =-G6Z=$%"C*DIR[EFY7@OIV6LA7PY1%2]D4*0\$F['2++X4;%I4O=3
MBO+EPPF"N[(IC925L>K;PNX@E01QZ6NMP'%D\CIUJ#YCDM %"1A'HV P6B%Y
MY -41WY[&NNG,XB[@W']553F*O<G'B^CW%6LC$-8MU+(I2,R]$15)BK-<FJ-
MCJS5G'$QU%Y;5& 64@LKE[:SR0UV +WD4>P%T>FZ9B97/G)BS#\:?N=QP" *
M^#[_ $[4U79)8!;J/1Y31<L5X^H@I:"!"4%#H4](R9PI4=LA,AXR%4=K"[G
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M';'<0S*(Q6*J. -M4:!)[@BC[U9!-\UQS4NWB9OOTTD<KT)7VE6N-05 8=^
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M$Q/=62:Y-JP/OD_-+!88%!3;/ ,8CBU3:  ^4CD $5N60\W[\BSQV^>.E?\
M2(U"741X#DR=QRH]&S8Y79D8R(LV*(F(0T+ 8\][W<W?7GB_$*=L?Q>O=CR4
M1,IZ#?,P7$<^VGH_^\1/VY_V\\?OZ>ZRW_QPF_ZL7''/[-17<7R+]_CXZP3
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MI73)5YH5UF-0W'XX%AF<E#94WN@?UG+&B4RR1B1!4#QZ[GQLI!Y@$=F]X7U
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M*I%%>"1\>Q(]^>+]_P S:XU0G6JA,.=P$\),9E?ZB;$*D264$(&$F(S/;S/
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M0U':I$6.I<A&'EA04Y])4,+/73[K/;]@.I'2PNL&BG_:G.:GAJU'>\7CJ_\
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M)[IDA".(_?D9B(YX_5QZ:2R.U$NWZ&A\55_4GC]1ST\@A3F-8%NR0S>QKO9
M/;@< ?D;Z[&4ZX%$H!BV\24,@BA<EW3(Q'$S$Q'Q,1)#S''(S$S'KD32$4QX
M'S0(KZ&C=?P/'Y.&CAA*^4JI-W9H[ 9N0"2"0>>?I_:C%CFN<4D7;R1QW,GM
MXXF>(YF/GYGG]H_>/Z0[7*,:  $D <CO5?/Q[_6K/44^G-/.SO9')!8@T2;L
M'DWP.W]@KK%C'L9,P(3VQ/!,$>8YX^2GYX^/F/CGYXB.?2@R5 L@WSP3VL]K
MY^E7^5])G39F<1Q[OQ4Q %5??<!8%=S['ZFN@\*PA. ,&2/,S$#,$7S$<Q$_
M'$<S,S\\?/KD9J@@,H%G@W5?W]QVKOVKGI;^AI@'*2"8J/\ =BP3P"1V-4/[
M^?8H%JC92P@)<_RRD.R)[I'CY*)GCY[?GGC[?;[<<.UE#@>L&Q?QQ^O/\^FO
MEK&U%0K!MI% &[Y (/MVXYN_8])S5M'B"C]/'=$3]X^..?B/CB?B9^_/^KTH
MM ^Y-\5[^WY]JX]_?OUX&9@5-*0:L@61[6:/\^?CGJ5]>VFUK."*%0+PR(>)
MBF3!+" 4)K,D_P!UC .),(.) #&#D2B(GU6<S3QG9P:RGE$&Z_%SSR3\U_"O
M:QN/AWQ?F>&?#,L$#>9#JD92:*P5#(I:-V4_B(>R+L*18 KJ+SNVLC=;;L-9
M9LO,F--QD1F?,]TD13\S,\SW?$<3$?M'JR+"D")&@"JJKPH%6;^OQ?Z\'YZQ
M?,U3,U'(R,W*D:6?(FD8EF+,JEB0O);L;(Y-"@*' RHL,Y+N_20\1/\ Z[$1
M$\S/,_;X^)F)_P#!QZ0#V%\#O[F_CW^./?W^6&Z0^H-WLT:L#M0]Q^8^3QTH
MKR=BH'"FD$,&0(N1CO[AF%C \<SV%)$LIYXDI^\3Z;2XT<G+*I[$"O<$$WS^
M\ !V X^G4O@:EDX3;(\B0"0 , >!NX.X?K8L\$_/489RHQ5]KQ@B4XC9#)F9
M'DI_7$]WVF3@IC]^)B?Z\SF)(A@"$@,O&T@77L?DT*'8B[L"AU#:E%,<II02
M8VIBU[>>Y)_+OR2>/KTEC8:KX ^TH^(F9^1B)GXC_7^\<?''[?:77EJPY6UO
MW'Y?YYY'Y=-%R9E!"R-1/>_BQQV//%\_G9Z^UY"VKB/J&0,\?W9B>9B?GYF)
MG]YY_K]OM\>N6@A/X8Q?_2 K\^Q]O<^W\1XN7.+W3,%H@A&IKKM9[77/2JG,
M'"1"8/S#,R3BF2Y'XXB1F(B(CB?F>8^>(^T<-SB(6LT%K@ 5S^?<^_\ "_:N
MG,4\@:UDD:P1<AOXX (JJ^*[DWTLOW6Y--5&);-=10<#W!$<R/8<C$K(P$QD
M9)8L%<F/? "9&1HIID7F%^+)-FOGGD_Q[B_;D 5P<QQO!=:LD#D^WP#P:H&B
M#\5W. _:[#V2UOE.9B(F).!'F!$>8%8C CQ$? 0,1'/Z?GTH-.C I11W6.*O
MFS\<]_<_/UZ%U"10%9E9?=2-P->YLD]C7?CXYZM-[?/;M[M.K8T>J/1?VF=7
M_<'INOY]V/?=U+IAU!WC3CV+%HJWHQ.4OZKCFK-V/F[C;MC%S=5+%-0%D)KV
M)%BXTL21.B[EWC;O2MPOAB.]6MCBB.HK5&.H8LV())<9948!L<E'%J1P0P-D
MDU1X('-CJ=.J7L__ (MO6-B8WOV>^[Z_BZMZWD<9K5'V\]3L1JF)LWV2VVW%
M:[B]2JXFBU_=(-<FKYS#B#:4\S/6%HF%@,\F/B 2R*%?)==V2X_=4R,=Q6Z.
MT$#W"BAU"Z;H.#HJ;<& *S4TCD^N1SRSR$FRS<W\GDBR"(?G^&1_$:[>V?8E
M[N)CLF/CV^=4H^_/S\ZS$_UGX@O^3U)>2_\ 58?]8CZGW//Q[?R-27ERWNVD
M6;LD<CO7:Q_A^738VS^';[]]'UG8=TW/V8^Z#5=2U3#9+8MFV;8NAO4C#X'7
M\#AJC<AELSF<K?UNO1QV-QM"N^Y=NVWIK5JZ6.<P0"9CO:P .TT*![<?7@GC
MV[]'E,#8 /-CD\?R^?H:^3[>SO\ "%S,^S_W0\QP4>XZ@,Q]^..FNL?O_C_C
M\_UGTXQ^ WYCGZ\WQ_GO].E@H(%CFA??O[_']G6K#\3R1#_$JKR$E!#[>>EL
M'P<=Q0>6WJ.0B!DA[.TH.9F>8F../VHGB0(VK(&[?=15CB_8'MP0>U]Q] .M
M]^S>1U\-S&-B"N>Q;:1=5N%<?0$T>W'%]>>>H%JO;E,?!-47 \\ T&1)\\R)
M>14R,<<1(S,3Q'WYK<X5X%958BP+"D\KQ7M1-78]_H0>M-TX9<6<T3@JTD>[
MG@,C\[@30((.WB_?W//;8AB)D3GN'D&"<0,(8+0@&^)A1(EXW>0)@)@8,63S
MW"0^O(DM 0K;JX%=BIL6!SR*HD$@_F.E<MS'(4E4T7')H H5I@&)(L? H#OP
M;ZQ#$"3_ 'BF.X8B%#$@'>9Q,E,Q/<;(CA8<A$R)3/$_,K*9C(;CKCDGN2!=
M"B* /<]^XZC)3$L"A2Q:*?S%1%&VC(3N)-V67: .W XOK*?:BRZY=L+$FM-K
M(7 _30LH&/& +5$+%0S_ "P6$?I$1F)'CCTB(Y%VQ;6 )IB #P2=QL\\>_S_
M !Z>&<229.9*@9Q7DCE:V@;: !XL[:Y( ["S0H;-D/(V5NAL+(1%<$0@@2&
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M"3?\^.U&^FDZ11^7""Y82!I: (^OMV [#MS5W?74]3?.MY22U'/?#5Q(RR1
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MQ?!/';C@==,?A@?X>T):C^UWN&D6L%I'.Y:7+0(8+_@C_P GL0'=)<G$#,%
MQ$0/W]=KX.T\,',^98X%3M5?!!!5OR*_6^U-O^4S7ONSXIQM**NQ<N<(%PQ]
MU._CXKX_+K"#\+I_#U4?>K>/<FLNZ2GMWG2XB>Z>9B>.G4<\\S\S,\<_$>E7
M\*83BC++7SQN^E'_ #?3&+Q_KL3!D;''OM$;!3V[@/9[>Y/UZ55?ABOX?2JC
MZL;=[ABES5-BP>YZ;+U"N&1*0D>GPA*C(P84&!%#%+-9+GO[V[^"M-<@F;*
M%U4K#O\ D1\F_I7UZE(OM5\30PR0JFF%97WN3A(6)'8!B2W'M9/-D@GD<_\
M0QG\/Z1@2W7W&G ]W;W[OII=LSS\Q$]/..8DI*?C]1<$?=QZ\'@G2AVER_\
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M:7/^^?7H8F>8B.H&&YCYYXYG4)_?UU_JIIO];(O_ .F']+^:_P##I/[YD_\
MGG_($C_C^?/)_/H_Z&;_ (=O 1.3Z\SV3\<]0,1\QSSQQ_9+B/\ 7QS_ (^N
M_P#5;3:X.0#[LLH!/Z[3WZZ&=E@49G(^";'7W_T,Y_#IXF)O]>I^)B)GJ'B.
M8DHXGCC4.V(^(XX&"_J<^O/]5\#_ ,[E?^]([=KH"S]>O#F3$WNH_3X_+]*O
MXOCKKG\,U_#LGLYRG7R87]A_R@X61G^O,3I\S_X?]?/KW_5?3^?7D<_,EG]3
M7)^O7)RL@]Y6KX!H==L?AGOX=,<=E[KP'$Q,0'4+$Q]OZ\ZE,3$_O'$1/^'K
MC_533^?VF5S?_/$5?OV/([B_^/2XU"<%"IVE#8()-_0W??W_ )5T,_#0?P[F
M&+/S/KR,C// [_AN)^.../[(?'^R?]?,>N5\)::JE=^0P((&^1FJ_?D_V5[_
M *$VI9<[H[2L"C!AM)';V_+Y[_QZS*_X:[^'K6&Q"LEUTB; R$F6]80C 9B8
MGQD6H3V%,24=T<%$3Q$\1'I*3P9I<C(2^2NSL$EH$?!#!A]; !L6.>GF+K^H
M8B9"1NI&2*D+J6-"OPDD[>/C\_S0[GX8[^'+>XE^2Z]<Q$_(;_A YF2DIDN-
M/YGXF(B(F(CY^)B>/3Z#PUIT%U]X<4 -\\A(K\B/[..H^;.RIQ3RF@20  *N
MN]43^=^_/7 _AC/X<4(%$W^O9 ,<#W]0L.4C',3$#/\ 9")B(F.8^?B9GCB)
MX]=_ZO8/F&0>8"2"0';GZ]^#^7\3T@TLC !F+58Y)['V[]AWKM]/GI_Z&%_A
MO=TD5WKU//',1U#Q4<Q'[3_[J<C\_OP,>NSH>'[>9^KM_<?X=OSXZ14%01N)
MN_Y]Q\_SZZF?A?\ ^&XPH+Z_KX,1SR,=1,3V\S'WC_W4NZ)B8C]YB?GX^?CK
M^A,/_P"6?]L_I_#KT B^3S]3\V/X?^%=<A^%_P#X;8SS]=U\GYB>/\HN)^T<
M<QS_ &1Y^9_Q]<MH>(W%R 7V#M5?J3[<>WY\#KWKDOPP'\-J9Y^KZ]QQ/Q'^
M47%S\<S/$\ZGQ/W_ 'B?CXCB/0-#Q I%RF^Q\QOI\?4?ET6?EOU8G^T]?)?A
M@/X;TB(AD.OJY$^Z"'J'B.>(F)B.)U'CXXXB>/\ 9Z\&@X@/+3-WNW/-_4'K
MKS)!RKE3\CO_ .)]S_PZQW_A=OX;-B(AN0Z_E/SS,]0\+\\QQ/VTZ/\ ">/G
MY^9_I':Z+CH;CDE7_P":OWON3?SQ?U[]=/-+(H5W+  <FR;'OW_S\])1?A8?
MX:A=W^^WN#CNB8CCJ'@^(Y^__P!)L?''QQS'[?//W<C 10 '8U7<GV_(\_6^
MDMHYX[\G^WKIC\*U_#2XX_-O<'\<\<=0L''WY_:=.G^OW^_KHX2^S'ZW8_E?
MT'\.DS"A]J//U[\_/M[?D/@=$_A6OX:,QQ^;>X7_ !_\\3"?/_YF_P#.?0,%
M/=G!]B&/;]3_ )'7@@3N19^>W_'^?;KC_H5C^&?^^6]PTSQ''_GC87X_V?V-
MXX_P]>C#C'[S_P >_P!3]>@P1GBJ'Q_A\?GSUS_T*S_#0G[Y7W"S_KZBX3_V
M>FS\1^W[Q/SSZ/N4?]9OTX_O/Z]>?=XO=?TLCC^-_K?]IOXG\*M_#.F9_P!]
M?<+//WYZBX2>?_S-C_W'[?MQU]TCXY;]23?M\@?R/7OD(.PK^?T]_P!>]];4
M?8-_#7Z _P ./0-VZ;^WW(;VW7-]W!6[YO\ MOFZ&?O!F58:E@Q&G9K8C%BF
MG-*A7F4$EA>>6L\O!P(K1QK&"%[DV?C]![>_OUT(Z]_Y?\>M@3WJK(=9><+1
M74Q[F3$S *4!,8<Q$3,P(#)3$1,_'Q$SZ4 LT.YX'79- GX%]:N&?QKOX7B6
M,2SW;:>+$L-3!_LEU.GM,"D3&9C2)&>TAF)F)D?CF)X]./NF0>T3?3E0/XWT
MV.9C"P95!%@BFNQW';Z>W'6PCI-U7Z?=<NG6J]6>E6RU=PZ>;MCSRNK;-2K9
M"G5R^/7;LT2LIK92I1R"@BU4L)[;51#))4E 2$B4HLK(Q5A3#N/CW]NG"LKJ
M&4VI%@]:.OXV_P#%[ZP_PO\ 9/;SANEW3'IYU"K]8L)U&R>9=O-O8:S,6[3+
MVH5*2\=&$MU@-=H-CLG9FQ!E!5TPOB".)X_3_/\ ;_+^_KKCW)'Y5\_7Z<=^
MM%?_ $6;[MXGF?;9T!^(GF/S7?9^9^)_^"D3$1]X^\?UCUS9L-P%H@CO9[ W
MW_*N#_+KU=I)!+#_  %_/'/:[_,]NLS'?BOO>!E;<UJWMFZ$MA:2M/BID-\8
MQ5>#!4&0EDR[8\K4A)%$#RU?SR41/$\HQT#.0=S  71%B^WOP/Y\UTE-+%$+
MMB?@_P#B0/[2?YRYTW_$_>YK;ZF]V\_T0Z*8$M4Q:+E.LF=V=-BR_P"J#MR!
MLR[&5:2WA7KDQ"+#H8X")<*[V#"ZCJN1AF%HXUDCE>K)"A1[62>+^?K[]NH'
M5=:DP8\5HL<R+/*L;.SJ@4$$GV)OCX (/Y=/?6/Q%OOAV:SKU/'>V_H=?L;1
ME(PV%"O>W:L_*6;:;%C%7<=5NY11MQ-RK3LY#\Q=X:@40&P1BKD_4?/XI3'&
M47"5!C^<7)H)6XD$7;#BNUCO74/E>,L?&DFB.UGA3?2.#^$$D-:V.:!Y!YKN
M>I=]SG\=_P!\/MWU*ENS?;UT2R6"L*Q(W2O93;1L8K)VY:NYB'S0R95WV/E-
MFN2F>-=>O=ECC)<"43X7\>X?B++;$A96=9'4%>0R@MZP:"[!M(X-W[$&^HWP
MW]HD.M:DVF9.$V)D,'^[V^X2^6K2/RJ\$(H8KQP+ZHZ/XK7W<%CZV0CVZ>WG
MMLG:7%;\]W*;23I^+R2Y 9J7+6WS#].P@@7RMWCF?&4>KX^0 RJM435G]; [
MCC^T@>_6A_>4!((:K[_F ?KV[ #Y'O=)X_BR/=K(<Q[:N@GDF>($LEOTS/\
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M;Z=.'/?BGO=!C+FMU<?T#Z'WXS6 P%^T3<CM:CKY3) ,Y!%8JV;MJ91J.[P
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M)!,'=?X0DY%;5FLE]\SS#_3=5;,;:\8B!_"3Q\U]"*KG@^U7T]T[7X-0-(&
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M-E$L[+4$N 44$!<$,QZMT>M/N99$C!!H%2?[ 3]/?Z>_5EE\-8C;%Q\B1F=
MQ!4"N_N6!K]+'2('XJ?W7-.TI?MRZ$RU5;S)@<IO$]Y@9@U7:66YEO,1VJCD
MI^>V)GF(>_TD!M&P$D62+X4UWK@5^7OTP70%8SJ9J:,5&O<NP[^W;Z?3I0Q7
MXJCW*&A,YSVW]*JSV7!09XNUM;JRJ\A$G8*+.:!\FF)@I1XQ-DQ*X)93!>N)
M=1?GRP!7)W#@ <W?>S\&OU'3&?2,A(08HF:==VZ,DC=7(HTUD@52K9L<=3%@
M_P 2E[A,J./LGTW]O$X]V17B[CZU[?HR/U+J\V5'5U^Q97DA6"26+H<9S]2N
MT"R-8J(J_G>(]1P@S'%CD040R,=NWO;'81VL<'O[UU6\6;*RLIL9L.;$976(
M?>%9=[\@E R(64D58]^WU;G_ $2;[U+-VW2PWMPZ$9AF*0#<O-;)[S(TU&N3
M^O;X\DZ58WM);2MG/B0H@-IQ$S/KN+Q:@B66:.,[U#!(W5F0GN"%9B2"#R+'
MY<7:CIN+!')]Y.=&ZINWMBR"(N> %)4#:I[DGGG;9!'3\M_B+O=;3US&/'H5
MT/O[5LEFTK#8^KF=P+'XT:-JQ1R*<Y-6Q?D"IO2-A>0C(UJ+J+(>$L!3F*:_
MZY2R2-Y6&/+4E;,@LGGD!PA- <@6 2+KJI+FPG*RL=IBDN-&\GD"%[E%@1A9
M/5MW'==JQX_7I1S?XE+JIBL=7'_)%TX5F1QE->1*X_9@PU?8%7;=',C6M)M-
M7<PP?2Q:Q]I%UK#K%-AO\K^ZS7Q=K#2[(\2*57#E6VTJ[>UD/9]S?(X(-43U
M)#]JDKQ8F0I2>*!%>>-_-\R))-ZJL 86S% ILBKOFND+/?B./=53Q"<S@>@G
M2G+D6.FY=Q3*V[4V8JT(66?1V,A<S--=MEFHI.0IJHU+#CJO&6P!+[&N(O&W
M[9(YTQE7<(W<3 7*Q "^H*/<#@W=BK',EB^%_%CYBZ?GZ)D8>9EJ,O!B<.2=
M.*K_ +1(#&A!+G@T0$H^Y/4-8'\4?[J<IGL+CLAT Z&XRA;RRL?D73?W([2J
MY615-FI+\Q6IF;523%"ZRM?Q$E(Q,<V6?5GBC!$:DM$DH<,I4!Q8^G:^_P!?
MITMF:)/BXT\_J,F*TL4L!(,C21@@NBA4)C) *\6?UKI?U7\3U[I-@VL=;L>W
M[HK51+<A,WHR>VK;]/3(@B/ W*&L[4L\7<FJRQY(9*JOG9V\LLG7,C&PWR6\
MEBG<*18W7M#;F L$?J;%]NJ]KTZZ%I&%FY"2+F9K?L,60>6S()2K$[BQ]"T2
M2HO<*N[ZM-UU_$4]2.DNL5U8?HGJ.>WL;?T-A=_)6:> R1U&-#(9#$X^,NG:
M%XDC62JUFY0&0<AZGEY.P?5>T?QEJFIY(0X,28X!)E&_=3,0EEE1 :!M5#>W
M/N>M%3+U?%^\QQK1%@!UL"CSZE7WKDCWJNJ3,_%7>Z.LQ16?;1T1&NYW*A7G
M-U.P=8!,2GCZ^0ASVP )@A[1DIDH[8YFZC,R'0F,1A@#6X\D@\D#C@=JK];Z
MDGT[)2-6<!7;=Z+7TBZ%FQ9^*X([U1ZD5?XI[JA8C'W:/0?0+C$X]=S8M0;?
MV6CFX;SXW(P.8@KF+L]LF%AGU2!*LH&>02$9/U'#4M520B:&%86)$<@(-D6#
MZ1R0>"/CWOD=0\IS(6D#QJ0JBO4!^\HLCU=[/ -_RZD75?Q&?NGZHZ]M&U=,
MO;ITWL4-:"G=N8O/MV6;]6G=<^JND-W#9BXO*WTLK/L/\>.QIS2 K(5H >[U
M ZUXZA\/Y>%AZBT*/G,5B;F^/<@ CGC^P6>.IK2O#_B;7XL^70M%R=232\5<
MK+\F["$G=M.QA2*"Y'!H5[BJZ;3^*6]X.MIH7!]N'07(8ZW$UCR Y#J"BH&6
M2D&6\8IQ7X6]R!-9P0%,?S1AL+XGU;\'5/OBWL1> P]3<J5#*>0M$A@?PD=N
M>2.H3$R1-*<>9'BE!:R>0.3QQ8M2-I[<C@\CKTB?P>/?SU&_B+^V'/==NIFH
M:CH^<Q_5'9=&JX/3792QC8QN$I8FY6NN;EVMME:LQDY@N)%,K4LP'DBF91&+
M+9J[/;D?Y_G\]/YH_*?:K7[FP;'TKBO[^>MI.P_^D#.<_;\HR7/_ .1.]*K^
M)?\ K#^WI%OPM_U3_9UXT_X26.]]5CVIVV^WOV4^S?KQT]CJYU"$-^ZX9K&T
M-Y/-"W%?F>(*O98+8Q.-B:\X\Y^"FP^(GXXB1R/*$G[269& 7TI= 5Q?(%_Q
MKZ=1&(LYBN.+'<>9)9DO=^*Q^MW=]>N_H?4VZETAZ<UM_P!)T[IQO(:GB#W#
M1.GII9I&J[*^L+\WAM8;7B$NP]3(LL!4>'/G"?,1$1D4QS46-$L+X)[D?7J7
M2]HW *:Y"]@?IUXV?Q=_,[W[&QC]]2Z[_O,?_!GI?\?$3^_'W^W^J?29(')(
M KL>NP+_ ,_ )_NZ\;L 92(Q^J2*!&!F"_5'/,3',R/$1,\D,1QS\\Q/ 0KK
M=V+LD< $<FS[$>_Q\]>*06VA@&^OTYL_('?J4].JY.G@LWFL'F K9A%5]NY7
M3=54;0U[&F@;%ZR;"(K VLB^O4K8Y2&.L$I3?TJ#O]1>1LFR8D97\@ $R654
M..PO\[(ON157?4)F/>0(A;6>2O*BR/>Z]Z!!()_0]/;I9EJVIQE]B1*6[*=6
MY@Z%;+.QYH!F71=J-REC'W:=_P#,DUZXL:5@"!M=[ZS%%R@9]1NKX[3,,9@/
M)V"3T\L2"178>PH\_P!O4/K<,F2B8LJ-Y2M8:)0[ACO!!4;3^][.!WL>QNAB
M^L&<S6&7G-/UYU39->3CZ6S[50VC$O73;^7V\9A&X3 -H5"J9*\A5SLLU6.
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M98MV8(R*JFPU^NK]0YO.M0U_6M2UAL.#$R1C8X*M.(V2$[2K@HPB:/;Z2MD
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M!EED*E,Y6-]PUBVJLU;"\];@X;7:0++PF($(E';%XTO+693&&#%5#6#9 )H
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M,GEN0++H00VT[AP*_3J?/;)TUN;ZK?%8W<$ZJ7Y+2Q%RB6'3D;5O'9FT3 ?
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MG4\71H:.>"BJX[#RP-3+[53M7B[;5MF+R&4=C&>7Q4JMO',^G%A_IC6OL_\
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M121%R<N67&959V5SMD93>Z3M0(%!#=#L>.I'$T'7-/CR<74-8EU/%F9'Q'R
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MRM#%XW([!EK0HI8ZN^Q1PN,JC3Q&-QN.4NH#!JS:;:L/0EE:9R[T#V '  '
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M7*]>H_(5U+.$+RG9,.2WO6T3FN3&&G]/IEXCTF"98\V? .?D8]M"H)5G8-0
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M2Q,22=<<P2+-"RU4LB[E9'.Y:#*; /%\CMU]3_9U_KM]F'AC5]?PM)?.BU?
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M\,,4HE+$DLP(&U5'( LCXOV(!Z]._P"%JM+;[IO<]6K$@4UNA&&&RB)MM?\
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MZ.4M9&VL20VW)G./&U-LBKP%NTI*K'\D1-7,F81'$5SQ2\T6@938H8SND@H
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M=JR-(K*I1KO<I"L3=FSS0Y^GO'O@#PIG>-_"VK^!_NDL^HYF-FYN-BSPYN+
M8C'D%2L>Y8Q)ZXBC*5+<>JZZQ-ZZC9QG5&1Z?:L]&P88NS**NU:!9#.'36BT
MU;Z];@62$HA%.JN]-FPMS&*KEV<2GI6E0'14DU'.)AE+$2/*5CLBP/639-\<
MD >W7'BWQOK;?:!?@[PP$UG3((X\E(L#=+EI"S.^Z*)&)#(U*RD;E#$J0!TR
MNIONTWFJK+8BQK-+6RR&-5A[XF-UURG-F1.PY'FCS4W,@CK2$JB*_$*[I8/;
MZF=)\ Z/-)%GX\WG21R1Y$#QNI4.K%@!WH$]Z/(^>W5)^TG_ $FO&*XDVA9N
MC0:7'-"^GYD#PNKJT@\N8R*5&VJV^I"03VZC[4>AM3J/TXV_=HLV:FP8=SJ^
M,QV/50L8^Q]%0I6VNN%"X:X;WU0R@@E<(D'(@6=L0N9S_$61IFNX.GK&9H92
MBN_(102BL">QX(KGG]!UGOAS['L?Q]]G7BOQ=BS?=\O0HY<HXT48=YD2.>:1
MU*$$"HR!Z2;)]JZK11V#-1K0X0LW9/#!8!@T"L/.BJQVDQ)$DBA4F$@(^180
M4>*(@RD.8NF1C8@RQE?=T$\JJ7>, $DJH#'@$V ..]DW\]?/V#J^M1Z%)I,>
MI9#86-EN%QFD,D,92R69=[+P[M8 6B3[F@W?J:@S/->1MPSN\A $K(OJEP$P
M7(?RN\0*2GR&/,E(D/<7I\8W)5E)"6!LY'.T62?;N/X@]5_S\='#-CA)P)'&
M2 #'N\RK-FP*-WR>+['JU&B;[T@Q_2W8,'NFHKR>X7"OLQ.=KXY-O,VFW*G9
M08>==D*]K%_0,@99(\(E A(B9D8^J3J>D:W/K&-F8F4\.'$R[\<-(%D!)_=)
MICN-@GX!Y[=?1OA'QI]FNF?9_K6D^(/#RZCXKS4E^X:A$JJT:ND*I^U 9DV.
MN0Q(4VK4=M[NJQW+=55?$?3 53(5LBNTC+5?(3E")A]/YK(L,(E#QAZ)1 /6
M<DXRAO:4VZ."2;[VN1212XY#124"6 4%N]$':3[CDCD=_G[)SL3&_HF7&0PY
MV'J*RIEQDDH+D(7S@%Y4E:;CGD<#K9UF=IP^:Z?=*NK&PZ=4M8.I>/&[9>R#
M*^6S%W&?0Y+'K<U(P3LIC?S.NI[D6'%8J6(JE"&<S(XG!A9&-J.L:-B9<T#/
M)')A("XC9F>56H J  (TNC1+<UU^B.H>*]-U;PA]G_CKQ)X>Q=8TS"C.G^))
MW,61D''BAQHX228G9B))I9%!(()9A5&D+V+;II5'^)I[99TW&T<OK&R>ZGHC
MC\+-VK8HV,6.0ZD:DL;&-1!?Z.O&62:=8K$2=L5'! 'E[O6MZ3INH'$TQ-0R
M"F5C-'++)"6(G$9WF-P6M0U,I-G@_A]^OB+QIXP\,8VO>.<C0-%QY="UV#4<
M+2H,F%0V"^>CQ1Y$"!?V3XC%)$L*0$(! /7ZF\?;_P ']?MZN?7SR/\ QKY]
M^O$M_$_U[7,;[Z^MM_>Y:>*O[=@LGA+983+7,7A;F:PNFZ[9RV1<"[N*FU7'
M\JHU+QTEKI#9&O:L>1BX]?/_ -H;^)FU^9-"*A8L9'G3[R8GEM24]*UZ4IB5
M8D-NLT"!U>OLNSOL3PM:\52?:SCY^4R:7AMID,"$1>:(,X*P<N U.R%E !4@
M?-G2OG9P3-O;H&C8S6L75V'.CC76*Z<7D&JVNG9<*LYIMP<;7S&HT\@\6T<Y
MKF-L1K]D[:UJ0-MM>8=H\C:0&U82MGIAH)#;L)@0R"-1P&\IG8AR+%7?6%Y\
M^/B:WG:YHF)(FEP:M-F:;BY$@Q@,92OW<R-M((DIDC!47( @/OU$/5#"]0M,
MJ;UL]C%8[(83*]2KV.RV&#(7*C[N1UNC75F=DQFNF_ZJ_C\7:RE@+3FT:M:D
MY]AC!([C!]/]*AP,R/!TY\F2*?$Q-ID>'>A%M44C,R ,!1/J)L\]N+M!KV3G
MSOK1$8>:L[+@>/R?(>?81'),22#N=:.P'N*KJ=O:AK5'?:^S:SL.N'E*>P:J
MW9:&VWZM,L:_)8I2&V-;=EF9/Z#"Y.S@V1>JXXR"_FZP5S"F]<J=ZI/CR'(P
M5P]0Q<HXOD9BPF.,M!*T9\L-(N.&9G6CW%BR+/8'Z ^R;QWX*1-<T_Q9X3@\
M394^GSOI^0,L9D&'/ME"@K)CL P;RQM+[AMKDBC5S=]$V7!;(F!;5KWL#G-U
MR>N,4=0LQDK*;@4KK$W(3-JS6PMBG5J4*AFQ^.L!;L5)4ILS.BX.IP9&F0))
M4WF08IEEDC"/S&0=[@VP8L35 CN>UC*]'&1/XORLW!@R,1_.,D&,,MON&&D$
M[,A@B$:) R!5$C"BP5-U4!U.?M>=I^VKWC(=2K-NUL%AM=E;.W O6ZUXW/$[
MJLB56#*YF."7%"/I7IJ(K><^V7D7JB?:#!J<,VC?T-%PAXA"U*^]13(18VLW
MN0+Y//O]$_9;XN\&:5KOB7_E(U3(CQ]0PGB:9-4:+&%%$)<!PA 'H8DCU!B
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M#CF6^ #)M-QWV.!#0\9+"JB%1><7$AR,&/)0;WDC>0VY;=(FW> FZE')%
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M.=G );A7  K:.UF^"5(Y['I1[E#5K$U1NDNT?/+&+4+6=LK ID.\U+@@%?\
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M*-5:9N9"5USCOE=8#(5J<3"$9%2SG@W'Q!0+0+LYB(*S_>HXXYI1)Z54A18
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MMV'V+=ZHNW"A&DZRQBA+2]'P-,T_37<PATR<F244K[]LDA95Y0M0! HCVH\
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MK6[5/-JOKN*0FG%S'HMIU^O0_FO<R^@7.H]7R(YHI-/Q\/!>-29QD1R/YPW
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M%=X(8F;?"\)59 5:1-ZE0=BL)![T-H([\#LA@MI^%CN%RV&IJ%924D38*#@
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M]1)8BZ;D7M- ?7L:[<=6IS"CC$WLYYXRJK84;V1^D"OD*3%,97H*JMKLR#K
MO*$29V9M-N+2#%QCS@2,:3LDER2K[E)=F0=@23?(^A/T/N!5GJAQ2(<QBIKF
MR"1_._GVK@77%=5DR^9M#EP?C_!7&O<MNJDB8J*0L',B%H)<C(>,(E:IYY#]
M41\Q,3<,;%3R?+E+$A.Q8_'8\\D'X^G;J]XT!GA((X9*(*GW%?YOG].GWB+@
M9O%$^,H^'J"N+8FX"" VL6DOI!4]K"@CA2;!,8B&H I+@N)F(R%7!D">6+<W
MVLF[([]CW-^]>_O"YD?W>3:* ]N :]@.3WL=K-=OKUZB_P *?1*A[G_<XHK@
MV!_R#XB%5Q-A> 8ZB8B38/E*3['',]LEQS \"1#$3ZF=.E\XNVPH0 "*J^!7
M^?\ QZF=)-H]]S1OCGZ\?W_/TZ]D7NAMOH>V?W$7ZS(59H]#.K5RNV5@Z%/J
MZ%GWI9*FB:VP#%B4K8!@<1VF!#,C,C*H>*1#V:-U/Y,I!_D>K!A2O!F8D\9V
MO#DP2HU [7CE1U-,"IH@&B"#[@CK\LW7^K&X[OIL=*?R?$9C#9K)7KMNU1%>
M)S62MV77<S:19N+8FK0,;)FXCBD+6!$5U,@"DUY;D:-IVG9<>LAY//AVA$9F
M(LMY8"VW.U2>"/TXZ^V-$\>>*_%?A>7[-1'@9ND:SDM-DN5@@E)C83$L\+0T
M1)CQL15$@C: 3U"VN;3L_3:SDJ6JY^YKCW+=3N6<830&V!0:V*,VM)+Z\GS,
MV5+,4%$>,IB>?5CR(,/4UBGF@\Z3B2S8(.X[32D$=AV[$]CUE6BZWK7@S(S]
M/T3/?2"$EQ'DQ]K)+$U;EW2B5GC.XTQ)NC1[VY,'IMK;WTZ^)NLSV7MHOY:W
M]+YC\(UJTM8%P_+8)GB4%AS7"J2J&?;(LG@2C,_4L;! \^/9$C*G(! [&QN[
M\=Z/'>CU;=&\(9GBK[O_ $5EG/UF:"?+R74F/T1QB20,J*JFV+GU#O\ '%1T
M&%O4[EFO?K!<:N\]=E@L\HV%"SM&RL [O+*F24%,2!<K&2$9@@B;.9#-%"\!
M(!3=:&K4!2#P".;^A![<\]9NVBYF%-)BZA$FZ/+VRW[[&IA8)!)H>Q_+JP&U
M:D[0NGV#R=W6<9;MY%TMK9RO895NXU&40BY:QMZFU+D$2CL=JG Q<]C(D#@0
M#BGZ?JO])ZQD8HE8KCM14\T18 OW[?H/D"^MVU_PQF>"? N#K65HV))-J:IY
M.=#+YDL<$L;NJ.@-!B**5]>Q[5.N=^3SM=8__0XS%@X*"4J8G]7#IB2B5@*E
M]T%SQVP,1'=SH,0,.,690#(/?N2O8GD_!^*(/7RYGR+JFMPD,U0IM<IRL>YF
M=B=MU>ZC5D_/'3O1A+5>O&1Q41*/I;+;]JRIB!2=8_T*59\\)M2U?)&HX!JX
MB?Y+A*2&/?*PV94E<;RX4 L 2; JB+-5VY-^Y(%W#&T#5((YLW38)VQA$SR9
MCJQB5P!PS6%%?A _.@">C"/=;EUN[(76HK+L'*B<U=,'DQ2U !6$"F7A(FI2
MI,ER/,1VC(^B=8Q0B]-W>VZ]^>P%T:/:^W/-]Z/ESOYN1JD?WORT+QAW("EF
M\FU]2V#NX'/;X[]X(O)39*GQ75;KSBG()K#E;7WGVP9 D)0VLZ*XF+!(_$Z(
M,9B8'TDGW<!0XWR6?439! ->Q (KD>WQTNV-J 3.R(6;%QF\A6@+,2/,ED]1
M))L2)M7VX4?6TU05:64$B0YOYA*GN=YH(FL5^MY,EB(6KLLM:+9;R2YCRB,^
M.8E8W(@=JVQ$USS1 %#M\>_M1%5U"1K'IVHR1K'+(,I%WLEL%:-WD 8"R-I"
ML!1/'(]NE&O>QP@H,E<( LV&*QHGW0%4X\A,9$B/@\@J2A)#/CA\C!$V#9R*
M#I(WKA4E0 & />_?D&Z^!^7;O,Q9FG-"F)JF8T3R9DH@W(Y$=M+1L(P H#D@
M#CEN3UD6:SGM*I3AU^N-53ZKO^!-BY>(A88N#?*C:1ROQD?8LU&<_$#V^(\4
M:NTC*H W&R >#VYLGZ#N3W[&ECCY<L\>-C Y,;A5A*$4ZDD!Q= %U*MW[GL.
MW2ONW1G;=?13RFXX+,X1&2 "Q]^PH+-.S#"*:PRT&!/E?6("F!/R@//Z)$2B
M$]/\3X.1E-CXDJS2PVTJT#M4D*._U(-_]'L!T\\4_9%XITK#BU#7L#(PL.?;
M)B9$ME)"1N4*58T60&N0?P[;Z7/;_LVP:MU*#:OJ'938$L7A8Q;P=;_/:5OM
M%J/JNTWH9"J-2:YU@;*HK@,JD._O2\5Q8^9H[XS4J.=[."?2Q+;KYXNB. 0/
M:NPD?L*U34/#WVAKXGA,SZC@DX^/INP$943(B,L@"FU\L$K[T Q)YZECJUU6
MSW5#<<7@[TV=?QE?)HK6:CLU;G&5;C'+Q\9*S7NJJ+4S&P1P?8MW<L7,-L=X
ML&L:/HN)H^"<R&(3LN,32\DA8V-"CWNC\V.;''6O_:;]H^H^/_&>FZ9E@Z)C
MIEQX>5&Q:*&*625(1,ZL1>P7=#GM3<#IC=6NEK-#VZKA,!E#ZAV+J$V*\8FD
M?YK,O&HVNME6HZ^MC6J=WID&-AE9#28:>V(B5T#5XM3PV;(QVTXAG43.-H8(
M."0W %GO9H?)OJE_:?X#E\&ZSB:?I.H1^*Y,V&'+:' $LC(968;"/*2["EBJ
M@@ \&B.GWT4V+J)TLS6>S-'1;.3KIQ:_[182ZTL9DTU6'+:MJ4&!.'L.) 2!
M9S"^9A93Q,1OB+!T?68L6#*S0TAG QI ?Q2#LO YX'Z?-$]77[)O$GVA> ,G
M6,K3/#<4V,N!))J.+D(/,QH H83T\D<P93^[V(YVGJ!NH6XYC>JH7,E:(:-#
M(VFHQJWC..J=[VV)17J>,32OO(I89,8QYP9&<<1W6?2M*P]*V0QJ!(T-&2CN
M-HILDDWS[]N>:KK%/''BC5O%LN1GYF0S8ZYDI^YKM6&!A*Q>-8P!LVD[> +
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M;[/O$>G>(I?M-QWP)UTY1IN4T<@27)B97?R7V.I++8H,:4-=$=1EHV9N:UU
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M(0X.!(L3RG,G67&:4J=@1#$ #L](:R3PM ? /3;S]@L94JTK9.J; 3X\E0T
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M*?J@N60>--]B1;6J]BR*S 2,9QI&%CZYF09.KR01ZN&23-QH$DB DW)L !+
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M:=BO:R=FXU<2E%6G76N61WK^7WA?&C^[MJ<D)AR<B<Q-"P  6*,+'O52>1L
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M6E?E5A5%V3=E[F-I3 MM4OY,G'B@8@?-$MI>;CXPDS)6==KB!W+-M"-Z0X#
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M&$E;9L (,@R7/=$**9A]'T/ TF"7&@B+-DC]MN=I1>_<>'X/%7P!?\]'\?\
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MZY5AQ!1%L#Y/I*PRE!@)E"Q:L8?Z%E:'I?B/+P%,KY<H:15=G9"S.***S%0
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M"":[U?G.*Q6R>VD:W11EG\G3CYL;9C8?R;'U**\CGJK!S+?/#6'#K';B7#)
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M)<3[Q'EG<MR,Q)86-J'O8-\57?YN%NO71,.F^'K6:%_+_4M8JY<QM^A"Z>7
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MBOBSY&/"J.SD%]UN[N2I4@T*OL]^E6L;'ULT7;--_MC4PF-HVKF9Q&MUJ2C
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M:I.C]32HD_%RFU;8XV)M<S9LI3];*QEL0B?&>E:IDS>$DEF0;7!CVG_>DKN
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M*6,"..,4U"A2?GP.!S7%?SPN#4$R?O R4DR\W*D,D;25N,DI+'F^-S$?-]B
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MP1/Y67H7B'3-8QE@)828V3DX4<*RC:P%IY:-RQL*58%:!_51^T<??B/V^_\
ML]6X]C7>C76%=>.W^)ST'TCW(^_3>.GNN8_&:+]5A5V.I_42^63K9C-Y37KV
MF6UX+3DX%<6,QE;Z+F&KY$\S?74Q^*18>BN)+,B^<OM'\6/X(S]?UF=)=0CD
M^Y08>!!$))(Y'BD+2GS'5%5O2+4'DDL?<U[#\/+XJ\9G2DU%<"6'"Q\AQE;!
MC9$;+(WEH39W+L*O8)MU(KCJGN/ZP[7[?\KU+Z']+MDUC%8A# U@[FPT[NQ"
M>3I,OZ4^UA*J!16BX[&Z^U;)\EC%$61M60A9J@0S4Z#H_C!]&\0^(,*>7)@(
MS\6,QI$V*9?V]S %CN1'4D%"11%T!UQJIS/!V9DZ=X;Q6R\&5Y8M5> ">'S#
MM!96](56=4L&^%'SU1+JLG;LM1Z:Z;696QR>FN(1LS;"1#%;50I$SRY'';;?
MQMB^VNG(XT*I+R%-:\'>IU$PZS39V O3--R<*),N<22SP32-%$FZXY'( 1D
MK:1Q9^:)YY,%#ID^FY&1/EQQXDNL.F7AHYJ3)1@K/(L9/ I7X'8)Q=DF<=/H
M%U&Z/IIYCJ(C&:=H4MC$ZQ@+ 8S$8ECL!%^<GL;+5<[Y4+63S%RO11A;@$5%
M(.*T=HY.<_U;-RM.US&&+H@<9+1OD9LL;;I)/-6U5D=>0@)-U:DU[=?1WV;_
M &?^%?%/@[Q;D^)/&V3I>?@8N7D8VCMY$4,D:P9#P5YL;LYD$?964@7\BD+I
M779?R>I[!U)8M^W5]>OZ[D-E:U5RME,>!2B=+F;B:2,C;S&!3=O,L5%D U:0
M*\T,08LN;(((LV3!CCB#"&6:&&,J54ECYCL2R \@"V 470%WU\I^(-9&*ATB
M'.S-8P,;+\J&')E'EPQ+-&LGW?:%J)BI%GFHE//NV]=MSL5&H6>Q>1P>9IN?
MK>JYC+6<K1P=?6OSS)[$DM@R=7$VL#1JUK=]=''^,(-BS77OUT%XG64I)(3*
M,4SQNV2><975)I)&4* H862#ZN._< 5U9H]!UJ72OZ;T##R,C2X,=!FOCQ+D
M8^/:EF69K4  HXXL^F[NK>O5O:]:RN+Z,EH^#Q=/J!K(9K6;W]D[%;"XR[3N
MVKF*S5K'TK-EEC)4'23<G60U!F3?K*H/ "CB-T;2<W$U+58\O*>73Y##/"9C
MN:%1NE +%>#N%,0 "/;L.K5J6I0:MX=TO3<C%CT^?%5GFRRP7S90VY45O4#N
M'IY4A?8BK.;T%9KM?2-ZK['IU8]PRN;1D[NR$C7<?6G Y2I(XVK7HYAJ+%%V
M1N5AR,_1/-8(.*LL&ROO]17B;2-2U;7=/RL'5)L."+$D0Q;B8YI%G4F4,$*[
MD'[, VQ ;N*'6I?97]IGA_P1INLG6O#6#KJY4!QPF0LGF8;.$1:92I"LH\P$
M#DD-1-WKZWC8<1TMZF9ZAFL/:JU4IJ6:M[ W0Q^RJN54-M]N*;DVYO$N4MSJ
MJQ$J)?5Q$/(*[VD ZMI^E+J>EX2AQDRHPQ\SS:,9785)8E1[*3Z=IL=^P&7R
MY<^=G2:CI6)AXZ2:@<_3<>!)9QBN0QC&3Y@C!C57*MM8D%5[V3U83&>_'-=7
M[-;3-VO['E,MG\5C]"UW(9 \"W8-;6UU8"7E,Q3P>"QM\,HJI')67 -4+/:P
MTD(N]5W%^SS$\/ID2X./CX\<<SY(:!G EE<\G:=QX/ L'@=C[O/$^%K>IXPU
M#-DCU+)6-8),2& I%&ELV]U$JD=[)+-=@T/9-VWIWCNI6#O95FD8C*'KFT(J
MZ]LUZ%8S/9>+EC\O_P!!V&EFU8;(LI94(1%6PI0J.8->3MB9)%[CZEG:>ABA
MG8/E ^:C_M&1F HF/:A"E.WIX!!-\CK-,?*TO$RVQY9E4F&\O#Q=PPL0(/+1
MF+$LCL0!*"SFR" O)#\T;:"P>"PVFW<+E,S%RYD*;[[P?=IX;,H![IQ^0L+6
M#J-TF4#!=FG?O@?;(5!&%S)5;6-&R]2RAD)FK$$C)9 P64T" L<96B')VD$D
M41?/(W7[*?M3\+^!M%\8:7J/A32-2DU)"N%)EB03F"8S*F7"R/[ *P-$F_2"
M>.K'= ^@G4+W&4MRV+I-1M8G4,<93DXOYM#,/L%^K?R17:R3HILY.C?[YMG4
MLVJ>6K?ERJ:S65CEDQGB7Q?HOA%=,P->U"%),ORHH8K5<B1R(U"HM6_)/I%$
MU=\FL;TR'6M8CS'TS#E+??L[*CQDDD;'QXI9GGAH-M*JP()]7[H-BNH1R^X6
M,CT\R6 P/6#1-EQ^D4;^DCKIX[)>'$Y5%FJ5JWC;+]=UV[>R5 G6*M=?TN0?
M8N)BEPT6L:4QA>'\.'.34Y-(59<Q$RXIY"JOY3JLL;R@%A1!5CM-<V*(ZN&7
M]JWC#%P,?P;J&5J2:7$H:HH8VQW>OP*7<&AYCJ!5[5!% CJV?ML]X?2OH[TL
MK=(NH-5AKK9"-JUS&U<-.5+,!;*I1"CM"=AR5O'TRR-EOU]=:;%5Z$"U*J5:
M:[#;EOVA?9MX@\3ZY%K_ (?U%L-5Q9,*>)IJQDD4M,)85A1G8H',;AMRDD@T
M1U:/LR\0XD.!JV)/I$N9&)8I4R J+*H>+:XD)H+?E\ "ASWKG-][7O<Z!]?O
M;[K%NJ.?9GU;E8>C%>6EC%ZH2U%3V&G4RP57G;HUJ_TUFK34$)[/IEL-D@4>
MFWV4?9'XM\'^(YI<O4H,S&S(VD225YY \C*I8B%?P@T-HI>X)_%73O7O&>GZ
MQA2Z3C8GD^6X7>!=;6( +*:!K@T#R#=\56/!>VOHQU1Z5[%U,Z1]5K'4W8<!
MC;>>M84\?B_+C[.-QOU5?"9>J_%(9"WL2VH.7QO8B&(\,0#6=X7/6/&WB#PW
MXJTW2]5T3R-.SC&DNH2JPC+-)(A:,A[!J/A*X)NP"#T_\,^!M/\ $7A_Q#FR
M:TZ:SAR2K@X.,R!"B!9 A9PKVQL'D**( -\T<5E"TW!1G-:Q=W"9K768NO?O
MQ27C#PN0MVEJQZ:S\DBXT62]2VR^M4BZ7</D=)3!1I\<'WZ1T:2.;'RH6;;6
M\R1.MD* #:['"^JC9-7SUD@?(Q=073\J4/DX[JJK1 &1&>>:X.]0">!R.WMB
M;GU.Z@=8-DM]0]MS-?//PN"JXLJS<DZO?L7D3:''V,4%-]2Q9LT0>R&^,J\&
MDVC$093,*:3H6F:-BR:9AXZH)9WR)!0VU(Y=PPX NS8-U7;N.IK4_$.JX63I
MF5]XSUU!!;38QW?=DQ=C8Z$E@XCDC.U2NXG::%D#J$-ASNVYZIAL>."O[%G;
MNX:Y.*LY7()5M>(S=$P93>,E+K6-HLF5UKEKF!BNM<PS[LBT:?A:3C)FD3PX
MN"V+(LI,8J?<A+**"@\71VD'OW[(:GJVJ:[JT&=K.3D:GJ&1"%A$TK,Z1DHJ
M.0QW *2GILD5P/3?6TCWQ[5UF]P&+Z;ZIU:Z?X3IMEM1U(>W,8;:5[#_ &E.
MYCU8Q45K$O4JD'DP;;%BD VK1M<F1*),8]8A]G<6B>',_7L_0M3R-7QM4U R
MOC2>E<%XU$>Q%95[JF[BS9)'QU]'^$_L2\8>-](3#RQAZ+!IF,<A<W*;R9LB
M(+)+MO:V]1;?A0#\(L$FM-2]&HX7.,O9S)B=?'6*]@#J [QNIKOJIB.48$OM
M5ED$C PA+K$#P':LSAH_1*ZPTV(GEP.SS#G<:0 ]E-@-==Z% ]8%XJQLC3<K
M,T?&&-*N$S0294%[G=63=W/))8#< OOQP:FOI1T5N==-@W2OK>0P.&M:SB$Y
M=0.2^R^S-S(6JU *9V/ RNH !3#LWC.4H8HF <D4KK'B#Q"GA; @ES8G?[[E
M>6A'*K92R3V .^NXX!Y)ZN'V2_9?G?:?FYFEX>?'@9&GXDF5%]Y_Y]XU9BBL
M 11\LV11[=NPBK [QO'2/<&7<193B=FU6YD\1D<*]2[(9)0Q>JY==TP\<VD'
M-5J;O!B'!PR.V1GU8,G2M/\ $.GC&D#R8N3C[O/WA1"SA2*L$7V':O[>HC3-
M2UCP+XG.1$Z1ZEI&226@W[9C%(RV[D [21="@>>_7Z"_X>OJC8ZP>R?9-R?A
MT8)KNLVTX]M%%GZM4/I8G "]@G#3%<,8R3%00, !!SW')SZDO!6@Q^'-);3(
MI1+''D2,ILLX#,33L:#7W% #OWZF_'?C3,\>ZRNOY\<294N+#!(82=K^0HC#
M$%C1X-\"[]^_4"?QW-9"WU!Z1;3F=??E==J]%^I^JU'U=@LZ^YVW9S;-&R.%
MPT.5857L-OCAF%4BXLUU36VR$]\?%?\ M RIDRM(Q\>58I1*,@EH?."Q#S$E
MD:^%1%-$@[N;Y[=?.7VK9 @T_2U8(!/J"1AWVG]H$<H ILM1Y(KMVOFO,)L%
M[5'=2YZ5ZS<W3<Z5'&Y'";+N.#UU.?S2NI^2#)S0S+\QBKSFY;(:<%\JTLJ6
M58>T(G/T-*T)RR"C,XPDS<@X\$SOYJP,PCC^[ *SK9;T^9M\P'\1+;6)'/6:
MQX4>D:;%FS8\/D)G>:PD)B9AYJ.J+ZSO9ZVH5-L19# T(ZU?IMU(H93I\L<A
MG,SC]$RS0K6BQE.JZWE+^+O6,@#[T5[E(,G4K#9KIIY"ZBVI)PJ&L8D50XEU
M/"4SR[0JY,:!J(8)$C)&-R7N,?KHDCL0;VD=*MJV@G%U?(CQL('5<9L=(CD*
MK)-Y!10?VBD<TQH D@MQ1/67FNF^9JZS8#(9]R*^4VC'V&[OF:.27-7,91#;
MN1JV2FO+LM;PQXC'U*=9-H%2>0!'=V* H0^_029!9$W-'C'; K*5980FU@ :
M'F(; :J[@"P>FFE:UC[=.F&+'+B8T./@F.BY6?&2*)RB@[BJF-Z86*7M1%X6
M.P>Q(UJA=VK-9"[KM':LCI6)POY/CQJ]4\)4JV+S,[E:;[-#(X5"LM;UB@XJ
M]B\]M3+7+L- :1@U>00!VCB54R3 LQ<%JQB'VA5)&TAUY]1%[!8/<V3/ATR)
M)\F"-,B3( DSBU;\=8E'W58B"SBP7!7G<5!/:S8B]A5[=C,:.<N*UK9F4]A8
MN^607CZ^4Q%-[<ACCRN,FQ@V0_&E2C'T!PK+M*I8LS/+E0P/4+YQQW><?[5C
M@P*T:H&>-W)5JDC#*!("&<25>VA768'6\2++$>")W8RLWENDD:>53L2K;:VA
M4/X;#<<\68!RJ<QTEJ[,62P=2<10PF%6C-9376IK[#DK&OY;,X^QK6.*PVJR
MGS3LJ3L=BO-G+MHO1\#8)42T7D:B\2QNRM+&Q=$8*R%)40K,RD$$$C<JFA8W
M=^KMDPC5DPX-/G$<\@3S2#1IMH +$WM;DCG\^>>H=UW(5=]U*>H& NF.R:^O
M'4MNUO+U\7EZP6,FRIAAS;*)G88BKF0=0QZI&A/T3F0HC$AB9F,K';3,D8K0
MF99[$4Q4,44 N$!(L=R02>2*'(-V'*T^31E.'EP-/C#$Q\@3@6OFRM(TB =K
M14&XV#=63QTF==M=G&=*=/VFE:QS=??O.7QF/U[&V$Y&GC+&/QU:^W(G*:K&
M+3;5;E"@EE-2.PPL+87:1JZ++MU'*QB"-T,4Q=K&\%G1JODU0-6>Y H@].O!
MNJ8^9K>;AF-80L,3!V 4A=M6;-@A@2*N[!'5/,-@]BV*7JIIN609=J8LCQ]
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M?R(B'7;=6T:D$;2#QP4(86"./CJ_B-CZ>;IMFN8K<,FA& K9/)W=@S6P7BK
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MXX"KM/(-K<DU7)(/ Y][^._/R.L@_I..=HM/QRSI%"8T!) M5M+%U9"D]P;
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MG!7ZMAI+<%B M5\@B(;7!05JT\A8D,KPKX9UO$;%S)Y668JZH Y$,@XM/4K
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M]CWOW!-&;<9E=OOSJVS;D%2MC\3;\N'=DR.P-FRAT*#$Y=,JLNHRM2)=%,Z
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M%4:5.HI#:WYE8@UD4&M9$"K#):!24,C,G$S/+F7#:7RHS^S2MS!1[%B26-T
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M\7UG[3O$T33(QA!5A%NW,R%@TFXDW3*  *[^XYO9U[$]ZT_->^3V"8O5M>+
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MHNMZ?KGB;"EQHO#T<$@R()8X8,F2'RI"&5=JOOYLE K*19;CJ)>CW\1KW?\
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MM/"O@,=6P]NC>UW*U,?@\UD,+L.6NO5CSJ.QE6,C+C;99D;M-2ZXS#&CZ?:
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M\+2]/B=(C@:>^/&B0QK,SNNUG<+)N=KL+N;CU>YYM>WIEF*6V:T&8R:<$?\
M9C&['AJ-K*4<N_256Y14FFBED&  U\C75)X_&/<P*++7EO5ZW=R=2EU6.7[P
MB0[+S)<:1EA8>9M>;U%E4VH""]O>CM7M5#SM,^Y8+93-]\FEF8R0+'NR3?F@
M;8K/I*E2?59)OVXMOT'T7H)G#O4NINUV@WVOKSJU95;$Y"\&8R-RB5>A8SB*
M0170^K3L5FA;BTU16'"\;"#2 C2O$69XFBU&#4-&73<S!1XTR(7RI(J]8#"+
MRH'$B,1(^UC&2P(NJ;J=_I#2X/L^U;1->T'5\#/R':3 S1@,76.1,EX7_:-&
MP<;HU"QDCTH>!N'5<^KV;VJY?QO3NCL&+V[#8DZ^,U7#X+'Y6JFEFL:FW4Q6
MOWLM:A#LU7KFV2G-7++$5VDUI6UFN!FT8+XTJ22/BR029"M)D.Q#,&8H&VH=
MI10%I5%$* 2#?,!I_A[4]!@QM1GS5B,D49BBR6<!H0 5WV5_:+L" #<-MG<3
MU&V05NW4?.5$Y+521F[V"HT'4UT<YDTXAN$1"T(%EU]T[N5S(/@IH?5%KLQ*
M.]\ 3&3).^GZ;"K22Q1JX,D;,6WN#1#%6[!C1/%CL >+D(L:36\O? ^1)'&P
M\[9"[Q;U_$%];$* .#M '<D6HZ8.SW]XR::6ILL7L#.K/QT#KWTH?D5@J+,E
M]<63H4F6:B54V%_.G&5%4^Q+8L3W%R3O&>+;'.SK*DUE2-SG:*K8K=ZYLFO>
MJ(!Z[@A. ,R1R56,[2[(I0,0!9#6UGL.>#WJJZLEC/;CUQW7VUYW<-1J838]
M.R5J]GLMA$WTT<MF,GJUAU.YF-8&5-?&#11N7;!USMXNW'T!L-*P9PRJ9'CG
MPGI7C'$\.YN5)C:ID+&(!L38D<BO,JS[I$V;RA53S1(5A8'2VD^$-0U;?XBR
M,!,K2<!D;SL:(SN YL/L"JC$"8$L74 58)4@P%[+]+]U>U#U&TG1]CV+!Z)B
ML)DD;?42[7LPJ*A!;KE2PK<I;R(U[V2:YR&?DU=36L"'_4#)+9-H\9R^$L.?
M SLK3M/R,\%6Q<AU-EU((<N%(VJ2FZG8[3V[]:'K7CG+T7P\,/PUJKJ,F>./
M*P8Y%55Q8V0Y221;F"R"-U5%,8)/I;D$]3'T.]N'2+=>H3M7]QN=1AM.C2=P
M/"V[6==378VD;",1=669O495CLHCP" T?$;5W$6!2#:[/+ZIOC'Q?XHT318=
M3\(8:9N3).KR1&*-V\B(U<$2QR.ZNE%"5-KM+%#QTA]F^/X<\1ZEJ,'B">?3
M/*:%5,RI%#+YZ)(&:7S8SR) 6H&V/'8]?7M^]KF@C[FHZ:4-QQ[^G.(V&%=/
M]FREO5RH9$6!:%)6&3> \GGQ7<&ACZ$_3_4-2+[=8$3W>GVL>,]83P>OB$:4
MTNI+BQ3SX,<;A_,8;I(Y4$6Q!P+E* JS 4!0ZKWBL:=%X@/AG3LQ#BRSR1>=
M(J!7B!9%=&MF%@<,7Y6KYH=5^_B1^RK ^ROJCIV)QV\9K?JF\87,[RG^T*E5
M<C3R3[Y4[LO&A$H--AJJ@5^SO%XTQ$I[ER1ROV*_:=E_:;X=S,F70?Z&EP<S
M^CY(92Z([)%&6>+<B$K^+E@;N@3UH&#H.GZ0(][?>UACQW2@I)(+V>=W LD@
M$D$GN*ZI9TIJNS5W8(JP9T2PEA5S(SC";8*\ZDF5@-6QW5E0BU,+\H+"R8C)
M+*)_5.GZR$Q(5WR,DK?@6-FJKH =N#Q?;@D5[FH>*-51@65]JI.=J<@4UJ/Z
MOS=#OW]^N[9<3D=FWO 8K%THRPYUNO8"@Q%2M05%JV0XY<WABHE=:V^XQ;;"
MKTIN2:N'.@)63.\?*AQ]*R9GFVR8\#R"(AI#(J+NL5QRPKGM['][J6\'9.9D
M308B0&:*35/NZ3RAA'&KA$Y<JP6K) W  T>1Z2]NJ/23;NE$[EKKKGG78J8:
M]B;=(ZU1=Y>&S3WGEK"<BV"&S03XQDJI3Y5S,+Y[>WU#>'_$&'XB:!X\;=4F
M9!F+.@#1H@50H"@@_O41= ]Z/5Q^T7P?G^!/%.F9XS,9<CR\;48,K3YO.(.4
MT<D:.Q"E'B(4LH-!E(7CGJI6=V7.[=?B]L65M9?))4"57K=YS2BDGD02#;!3
M,*@1$024C/$EVQ//K0<3!Q\3'*X4$4:,3M5&V+WW7P!=DW9'/O[D0VJ:]J>N
M97WO6,Z7.S-J*V5D22,Z(@ B169F<TM"@:H>WN_.D]MU#+9RZFPZJBIA7?4.
M&XNK(IME"^&UCI9 KREE')*57AL",R#(YF/4?K,A6)<=TMY*'H)'L??WOCY[
M=^J=XAE@R%BC,+2R)1!4&F((_$-IL=N&%"Z^HD(*",S;J6J^=1M$K*S89CV6
MCHM_O.)WFKI[;8U;*Y;2&N@QML[UO57&9(A@%E;3HU4X_H W$O3%>0.-W-@\
M\$<@FN:,+%.=[0F&3"DF:-6EC,D(95[LSH%)O=5%B#0'TZZTZ[9P"RR57 KI
ME2:VEEJ9UKCBQ[L@"/IZ/U)Q84PWJ(5KA[2-,%#&G/E-B^FSH9IX<>><#<HE
M :4+9WD"X^!87B]IXODU1L^'X<UW/TG,UO&QGGTG#REC?)\ABP3RCN8NM C<
MCDAF)(YVDFRU\%TNV+*ZOO'42453QFL7AJ96C<(B>#K!RV&(@8,+0U>U*6+6
MQ\<-DRE2U,*'TVN8$6I8&E7)YLZD1GRT,?X35ONX!XJE[=:#I'V9ZYX@^SW6
M?&.G30#3](DC3)5G*9*JX2Q%"!ZR YX++\ @W4.WEK>96JY*EDM)ALB37$Q_
MP8"(3R(P$=A1/'$D,\3\1,6B)E10K(HL5Z0.]<FR.YLW[GOSSU18%\F'9&-R
M@[=S2N#8 !H$$@!K  -?4W9_0F_"T#S_  Z]I,B[^[W"[['<4S/S&%U69CB?
MM_>B?\>?F>?B',5[>:[\57;BCP3WY^+[UUZ=S5N)NNVXFKL]Q5][Z4OXX?N8
MU+V\=3.AP;7:SB4[;TSZE3BRHXT<OC:V>PV8UA^-;=QR[E1]DK4N*M =ZDC$
M01VZPP13FWVC>!M2\9+I1TU8B<')1LG?,D3F%B_IC9@P!9C3-L)H*%-BNLY\
M>:=E:BN-'BJTDBH2JAD"J2Q]3!V <<"@> :(Y/7E'M]=.D^Y;]U1VC*9_*Z]
M1W:GALM@E9+6;+UXK;*"#B[%_#X'Z[#W,/D2LY2M=K$@WV:]NMY+S).[ZXC\
M#>(L/$Q<>#"A?RF,3[<I"7A+ DB9MDBN" RL*456T;C66YOA?7H1I^3AX*Y6
M1C,69#DP1LLI6-0P'FQH C1AB/Q$!04/4.9'J/T[=B[.)U[#ZAHR]IR.35N3
M-1TJQCJ9(LM"W4S..H$!LJE26I%*IC*MI*Q=YH_D5))KI!_"?B:1XWF4Y:XX
M(Q$R<J$5:FXI&0(S(S$\F^..QKJQ'3/$6;/C9&KQ0Y9C57"Q21!(7%-LY95+
MJ10*@CN>_21NO6,#L8' ZKD,MG=1Q%:QC[5[9VO5GLUC3NLMTPRQ8]=.I;MT
MUM%-=5FC9H4X0L%KL"N"<KB^#=9E\W(R\*"#))#(F/)$T:.$KT[F;: 0M,M$
MD&R:'7B>#4DGU">:)P<P$A"X!W2!V?E054J7*@[C8 XOCJ2;76O0[.*KU0RN
M3Q_D^K1?Q*]85FL4_#S%(,7A+<6+&$==2E6+QWYK8(@BS->$U4*2QXN:GP7X
MAHC[K"X"VK',2.3?Z[8NJGMO;R['ILEK;:5JR^!_$&+J,F7"5=4..<8K/$"J
M(',H*L/0]E5W,K%A?;GI-H=0^EM?.G65EI'7YRTV,9.6P&4)6$G)IE.2NU/R
MQ3CI8ND3[%JGK5?%6Z]>WW.JM83 E7<WA3Q%)%'YF(CSK&QF:+)@W3,JVD;;
M@O!VJA8LK M8/<&7U#0=?R/O$T6%#)E.4*N9HDX5XR2QW+=*K=J9K NCR]=W
MZB]*L:K$X/%]9,GU3Q*6XF\G+9#2=MJ97"V\ #&UDM7FK6)J75-;(UJWBJ.3
MX)4;TJ<HG>HW#\)>)\@RSS:(FFRMYHV??<5A(KNS;BT+,2#=L6)D+T0 O(;8
M7AWQ LDB9&#$ZR*;?S8@!>P;41I38I#9W^]BN!U'D]6.G->[=RN*Q,IVC/*;
MDG[&^SDL30U[+)RIV*DU,9@L#^9,O6*QM.\T<O<QY%%)0# +>HI(>#_$;JL;
MQIY*+M6(-!O:P02TCR&PIY5:4F^3W7I:/PSK--"^(L49E=@\<R,R+(*9;,E
M=ZV]MQ(KW??2SJ5K3]QO9RM1'8<Y0UW8[UN;AY2ACPH4&U\D>9KA8:$U[::A
M9/RJ>ZU8L,A-50W)M@A,=JWAO5<## RKQL:2:#')C>-Y':2PJ4BNP'%DCE0/
M2P%W!^(_"6N/I,V'B)'$<J>"/SI9%<+OE7==,S=@"I H'NIW$E#L];-<ZSN9
MG'6+^1NB#<'7=EQRY82HQ]0,ACZ-'#0JJRD[, LP=EV9%ZL=(GP(#:!(-)=%
MR-."P;54!1*=@!F( (\QF+.64<G9Y8!8$V*]1C>$]?\ #FGIA9CK)'. S3JS
MEA8IB08@')'-V#56H%DO>KU$ZH=+.HFUY/1KV/URQC2S&8ZFZDU([5KES7]8
ML5I<_*MH(@ -49!K:MFG=:[ZFTQ7%-B3"(Z;#P=1QHTR(I<AE7RL69P\4QFE
M+(2J\;?<$% I%->VK<8>BX+8D\>? 9?.8_=W+4IHC;2F102' %AB1=@=9NE^
MX8M4ZUYGJ26'OVK^?6&R(HI?78V\_861ATJ^I\'YK8Q8.O6,K<Q*^PJMQ50N
MPTI-_I'.T1<S1QILA=8D40.WJ5U, +J;%#<VP*=WL31-\I9V@Y&+HC?T6"9!
M.9RLK. 5:*4_NAC1=EW"N:'J!YZ?/NXV[4=DW308Q;<;M5S*DW-[W6TR]82W
M+XO7CQ]-&,O6U'8%&P5ZUAJ:46:_T5*4K-M9TVB&&7AS#GQ<;*CWR11PJL,
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MB20CL%LL[6SDDOZ5)L"WND94VD>(_O0QO]FR8W RDYCF86UJ0^PA%(0D$&V
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MI/$UBB;XH7S56>*!/N6?VM>/_ .L^+&F\%9F1)X?@(.&^3@38TQ%FUD1E#\
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M'%5LOA^GN=;E5W5)OU9NXZGL&:52G$Z]E+J) DT+;&.F6I&>6'XXR2?[5O\
MY,SM,\):]K'AW3\I\3+\087D#&+PR^7/+B8S,<C+QX7# RIM!*WMXHYS+]H+
M$Y&3AZ%FYFCXLWDSZHKLB; Q!ECC$#Q&,KM=&ER8:#J)SC%Q2%KG0"G=T)'4
M#<>J.H]/\79VO-:?71EZ&>R[+&6P0B=P4MUZED5,5(29+<)2HA""%A08Q+W4
M_M(EQ]<?0M(\+:IK^1'I>%JKOBS8F+LQLX7%OCRWB=&'I#[K(9@"JFQTKF^.
M94U+^CM,T.?5&7&Q\L,D\D,GE3P8TP+0##G\L(,O'5C)*&,C%=H"DE3U_P!N
M&,R^K:YMF2ZR:/K6/W+9-AUK42R^/V6%9VQ@,L>*^K&Q7QK0H5+Q36M*/(C6
M*NFTH7Q#1-<--0^U#*P]3U#2L?P9K.HY&D:?@:CJPQ,C +8,67BKDLCH\A,C
MP M'(8@UR1L10*])97CG-@RI<6/PW//)B8F/EYBIDRF3$63'@R)Q*D.#,%&.
M9Q$SM(%+(S *H-0/NVGYC0-MV'3,^* S.M92UBK_ -*TG5#=6/B'56D"B96>
MN0?7,U*826!)K Y(8T30M:PO$6CZ?K6 9/N>I8R9,"NHCDC#6&CD130>-PR,
M 2+%CBJO&DZC#K&GXVHPK)''DH6$<A DC9&:*2-PC,FY)$=+1F5@ RL0PZ:_
MJ6!'N+_4_P ?\UU(;0.0.?;D_P#'IPZV^^BQDCQC/'>C#V"K1(&R&L"S48*2
M 5.60LE<<Q8#Z>8B8=R$R!5/QEY0TA6E)5!F8]D<@<242"U"N]BB#VYXZA=;
MB@DAQ$R$<Q-FH7$;NGX89J)*R1&MQ!VV18!JP")*R_3YW4702R.57:TO9T!^
M9*L8S448S%9>#FLO%8Y:-:J8NK<3:99:_P"OI0N,8-!K\E-B75H#-(=47"R
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M"D_A!L,J%;90&(']4T1TZR=+U7."8^G$1(9/4K@2.5+*"#YBOV -'CL+NND
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M<"F23'+@"U()4\7S?(L=N]U?5GUW[/\ 5]#\,Z+XEF:*3"US'7)B*$DA"JN
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MS9*5)"0PL<>D$?IS?OQ8/\;YQR3?E1/(P )4D*_]8?U:%^YK@^W!]T1:C:P
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MR*Q#,:B1X[XK:3(GJ>V(+<@\5R+%WT7(\K%5Y73=(@?:#ZEW*+1F_>=6X)
M('Z].WIATX(,*_-YFQG<,_,HYP95K58*-^I%VI:AUTV-,C03@:M>._39L$U3
ME=@"X?49KNMF*8XF)Y3K&"K^:IWH2:_$=H/:[6P#8)' Z3FRI9<E4QL?[V!9
M>-+#J%%[]YM0%VD$5N8D%30)ZVO_ ,.OKWTB]NV1ZAZGUQT1#=/ZB4ARH[/>
MHXK/Y/"6ZDV*UJOD,=S]12P60IV:V18?A#Z>TE+Q8]93(8C]JGAKQ1XIP=.?
MPMK>1IVH8>1'++&B.(YHBPW*L@** T9<,2U4*!%@&-34\.'*R)\S'^]1[7C\
MI%(?'9T:,V#R:+<D ]@?B];7NKJZUNO7/=-OZ;JD=6V+,V[6$H%<-EBG23;^
MB3WILRMM:HV"38J#YS6E+ 4N93$2&N^"9LK \/XV#JS@YD"()Y5*TY*"]L:N
MU$L/=A0)'/M(Z+J.)'BB& $;;*!E:(7M7:;D%%2JU9.TGN>:ZBS'X%V(NIN6
MAM4Z*\/?3DZY5;%53+)*885464$FU%A@DD^PR;$'^A93]XGI,D2*T;L"X9N\
MBK<9)57I@220";%5R-HYOG-R!EQ*$19PV5M7:Z%4:!PS%V!*MR?PJ; _4].[
M'YROONH6--S-;7]>MX)U[8J>V$FP-N]3,%0C! UAOE0NF8:;^8>9BJ2F08V)
MA?N;Z7J"YL$KY6/.HC?'1CP_ + C:I4%BU4+YV]:3IFW5-$71<J?"P6PF.2,
MQH)&+K0=8EV$"V\L $J#;78OJO,JOXVY<%X652I;$J"XJ!E3VS$P))L+6Q82
MJ(;#.SN8!P4?M/JZH8Y,=7*^674-M)-WSW*V./J?;ZUU4IH5.24B+2"!N)+(
M21EX]*L=PON/?GGWZD7I5H]3>=RK8K8%Y*,45<+61LXQ+F1C*$/ FWK)!5:5
M6BH3$GVF3XJWD[B+B)&(#Q%JS:/I9GA93D^I8%<@!VVL:L,I'(XJKOWOB]_9
M[X<P?$OB/$TW4VGBP)95;,R($9AC0;D661]L<K%(U)<C;[$D&Z"%U#U_!:EN
MF0P>$R:<OAJMOOI9$21>-2B.(F&G58:F $!$B81R8L NZ(GL].M!S,K4-)CR
M<A?+R6 M.:W$$<=R18X/<<@@]>_:)H&E^&O$V5I>BYJZMHL$BR+FQ H22BH8
MF5P"2I=F8F,!B!5"[6<3I-/=\UB<)I%X\ED+M!UO*?5UWJJ8^%R8F5J4K8:Z
MRH'R!(CWCY(YY^9]<-JL^EXF1/JD301(S!!8<R"SRI125!6OQ "C[#I30/ B
M^-M;TO1/"V5'E9^=%NE=[BCQG]1*N9#"I8!& IA9KCM:/DZVR=-,[?P#KEG$
MY/Q0B_%#(#])D LP#J<DXS"+->0[F"XUJA)]G)<QY8<P' UW ARTC#A2&CC/
MI<7R!;!01VHT %^3STVU?$\7?9=K6HZ')EOI^:C/#FS1R>;#."S QA897:R+
MY/:SS0Z]^7X7!MRQ_#SV]]QKF&WW$[^0R^3D_G#ZOWE'DCN[#/DAGN."C]4'
M,%\3D!B6,(@*!>-IYK]0*/Q8/T]NJ=+D9.9(V3/(SO+W9A9)%V>>:Y]^?GJ<
M_P",)_"RZB_Q'-FZ)9'3NK&I=-\;TMQ&Z4KR-EP66S+LC:V:QKUD+%*,980
M*2K#0IXV"$X(@),,B3@7>/.<:=G5!(9DCBV%RE!'=R?]VXL;P1R+JKZB,_#D
MR)$D#J%50M,6%&SR-H/>Z[ \=Z[Z7A_"_P#7X8YL>Y[I"L9+@23J6XN@OO\
MW88RN7/,<3!P$1$\P4_;T_75)&9PD ]+ ']J1P;Y'[.N*_P^.FATR16 ,L?/
M;_>_/R#]:[>W;M?$?A??<)!G#?<ST@@1DQ U:KN#.\H S$8$V)[9* D2DIB!
M*>(DAY+TH=38ULA![!@TS@=N_ICYLD<77N>>Q+I,Z[=LL3;A=$.*YX[AA^=
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M$VY<PUF^(7!H)*ICM5/JL#PMB?TVVMC(8LSD+!1*DFS1M *M[%DU0_+K7O\
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M2@YQU9*76.Q$K8QS1YAD! Q2O$.EMKF;C:A&8(PD7W9?-5GDV"7S6(<(*N[
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H(%<D2V<+PP/&I#-N)JV)[FN3^OY#J,"HHI+ YL$D@<U0OL+![=?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>g60414g23y12.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g60414g23y12.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[3M(4&AO=&]S:&]P(#,N,  X0DE-! 0
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M)O;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N0V)O;VP
M   $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP      $5M;$
M1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !        4D="0P
M    ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!OX
M   $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M  0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL0'<T/7
M     *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G4',     4&
M=00P    !,969T56YT1B-2;'0               !4;W @56YT1B-2;'0
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M))3009       $    'CA"24T#\P      "0           0 X0DE-)Q
M    H  0         !.$))30/U      !( "]F9@ ! &QF9@ &       ! "
M]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4    ! "T
M &       !.$))30/X      !P  #_____________________________ ^
M@     _____________________________P/H     /________________
M____________\#Z     #_____________________________ ^@  #A"24
MT$"       $     $   )    "0      X0DE-!!X       0     .$))30
M0:      ,U    !@             '.   !X@          0
M             !              >(   '.                      !
M                       !     !        ;G5L;     (    &8F]U;F
M1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P          3&
M5F=&QO;F<          $)T;VUL;VYG   '.     !29VAT;&]N9P  !X@
M &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E    $@    =S;&
MEC94E$;&]N9P         '9W)O=7!)1&QO;F<         !F]R:6=I;F5N=6
MT    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960     5'EP965N=6
MT    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,    !
M  4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG
M!"=&]M;&]N9P  !S@     4F=H=&QO;F<   >(     W5R;%1%6%0    !
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M   *    "9   !X  !'N   #"  !@  ?_8_^(,6$E#0U]04D]&24Q%  $!
M ,2$QI;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0  86-S<$U31E0
M  245#('-21T(               $  /;6  $     TRU(4" @
M                                                     18W!R=
M   5     S9&5S8P   80   !L=W1P=    ?     48FMP=    @0    4<E
MA96@   A@    49UA96@   BP    48EA96@   D     49&UN9    E0
M!P9&UD9    L0   "(=G5E9    TP   "&=FEE=P   ]0    D;'5M:0   _
M@    4;65A<P  ! P    D=&5C:   !#     ,<E120P  !#P   @,9U120P
M  !#P   @,8E120P  !#P   @,=&5X=     !#;W!Y<FEG:'0@*&,I(#$Y.3
M@@2&5W;&5T="U086-K87)D($-O;7!A;GD  &1E<V,         $G-21T(@24
M5#-C$Y-C8M,BXQ               2<U)'0B!)14,V,3DV-BTR+C$
M                                                           %
MA96B        #S40 !     1;,6%E:(                     !865H@
M      ;Z(  #CU   #D%A96B        !BF0  MX4  !C:6%E:(        "
M2@   /A   ML]D97-C         !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M           !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M                                          9&5S8P         N24
M5#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="
M             N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W
M!A8V4@+2!S4D="                             &1E<V,         +%
M)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
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M(#K@.Z \<#TP/@ ^P#^00&!!,$( 0M!#L$2 15!&,$<01^!(P$F@2H!+8$Q
M33!.$$\ 3^!0T%' 4K!3H%2058!6<%=P6&!98%I@6U!<4%U07E!?8&!@86!B
M<&-P9(!ED&:@9[!HP&G0:O!L &T0;C!O4'!P<9!RL'/0=/!V$'= >&!YD'K
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M/P)!\D321\)*LDVB4))3@E:"67)<<E]R8G)E<FAR:W)N@G&"=))WHGJR?<*
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MP,#Q48$Q,5$Q,8$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,#
MP, 0T+"PT.#1 .#A 4#@X.%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,#
MP,# P,# P,# P,# P,# P,# P,# S_P  1" "9 * # 2(  A$! Q$!_]T !
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M7.L8^Q[:V--EEAVM: 7.<X\-;^<YSEL4]9/V&OIMM;VWML95( 8T18S6__
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M!L(KJK8^UN]QAI /H[K&CZ5;M@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M$ZMBD&1$])_ OX/5WPWI:^NZSK*7YFN-)5P6:U5$DIHYDC5BM=,8H4DE5HP
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M",>_C)&,?3WX^OOB9C&C(UK5Y3P^O[>'.3^?^_\ LZW_ ,_Y_P G6S#QQS[
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M# U&M,[]Z,:>"HJ#8OFCE147Z_FLYH+6]O)^8R*D*B2AI.Z040* '!*X0>D
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MQF2VJ,:I)&5%8SA&I[/Z ZEEZNZ2M%\J8%IJZHBE@N-/&P>."XT4\M'6QQL
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M$<BJG*(J*J?3E$7W3G^7HU@>?U R./X8QY]SYQGW(U+3\-_O]B]DN1Y0/(L
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MTU1:*&G@I)JG;FB6"%YGJ$F).TN6E8%,%BV/3QJ'F5]Z65>UV194:X9'"2.
MEG92;4C?61SE'&'*]5S%Y1KF,'XMX;PCN>%ZF$;T5<'6.B@ME7&HDA6&%Z=:
MI000I,892PY&Y@H;<"20#J8E%M57NMM J4\SJ:I*6"* 1D, >X8R%Y3)W\X
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M^LL0%S(7)7:0< #!'T!X.=7O\'Y)JY:.S0V])VCJ9Y)7F >%89'[K%@<@D*
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M0NBAV& <?7^L"5Y( .0,^DG'OC(UE)HW8HIY&?<?U>"."3P?J!G!QG6]9O\
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M&L?4'35EZIMSVN_4$-QHVD698Y=RF*9<[)H98FCEBF0,P62-T)5F0Y1F4O\
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M;MZ=Q4X&&WD># ?A[:NJJ6X72._UZ55FJ622DJQ4M/(DX+F(T\2HW8C*2_\
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M2#XTU5^Z7Z/O<EFBGAEJJ*:,W2)FCIJ"G>5:>?,YVNDDT#R11%@HD:15!8Y
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MHB_ERG6[(5"G*,&&04=7]R.=I.TY'AL'[:U1XY W;=9 A*LRL#A@ "N02,@
M@@CCQKQ]:ZV S^OGC'W'U'/&<#C[>^<@XSD%I')*K:>QGA"BJ18D4LAS&-:K
MW%48FO)Z+6HJN-X^DWZ.>BJB+R>>&-@LDL:,? =U7/V!8@$_;.3[#7&:IIX&
M59JF"%FPJ]Z1(P68\*&8J&<G\*\.200#SK#E$4!'B,-XBB<K"#>U6O8Y%X5K
MFJB*U47V5%ZZ @@$$$'D$'((^H(\Z[  @,"&7&<@@@KCC!&,Y^O@^_WZ^LZ"
M2?U.?'/Y_0>#C/( QG&CHT9S[GG))QCC[ ?K]?<Y&6P=&C.?'@<X\9Y^W(^W
M.,@>,@:.C1[^,C/C!/TXQGCQ[@<#Z<:.C6!C&3R2?'/(_P >3@G/O[^#HT9'
M()QR.1[CD'[\\\\Y]\:.C0?IX.3P.<^WZ9\$?R' ,@WPU,9H+KN5IK>^NX=4
MS#J>RR*!&DG%'6VL&#;!!#&XQ!L7TFRR22LX(Y[1>FQB^:KU"^O9Y8K!+%%!
M),:J>&"3MABRQ%B\F"@)&X(%!Q_6YR 1JF_CS<JVA^'M=3T-'+5-=YX+=-)&
MC2?*PR;YFF90KGU&%8ARO+\L,<O?^*QOS76>ZXP+!<3DXGDEKC&9Y &?;PIX
M"W%&5U;4_-0(P(IWH6!.11MEGD,]%LF$%L15*V0]+DI>H+G=_AA8I)*>T6JV
M&NJ*:CM$31_ME3$ ):JMA$6(8&VJ*187B+1OOF4@P)'4W]&?X?=1=-5=YOUT
MDK*.BN]'3""WS4P1:KMR.\=9([QB5&CWNL*K,2ZR2%XU41EH&O\ G_>ZA^O7
MQ))R,XR!QQG//]A./TS]^2O<K6L5?PL55:G"<IY<<^_'*_3VY5>/RZSDD >P
MSC@>_GGR?UUG=P/.1@GV^I\>^1^GN<:^B5\"U57X5W:URO/X=U_7^V)VYUC6
MX& !XXU<$Z-9T=&C7GF3(E?$E3Y\J-!@P8YIDV;,.*-$AQ(PW&D2I4DSF!CQ
MXX6/*8Y7L$(;'$(YK6JJ9 +$*H)8D   DDDX  '))/  Y)UJS*BL[LJ(H+,S
M$*JJ!DLS$@  <DD@ <G3$;K;E[W#YCEFL]?OK&:BK!1FR]J8WDE1E./;"J9L
M9T&[@1B5)FGANJ<DB7V(FH'$-6Y#.I[F1;7):?'[C!\I?X*!:-8IZA)?FBN]
M:::)H3!(LCA68%B\BF-8Y4)2/)DP =H<L=17/5/+!3N@IU(5JB&02]Y&1255
M@NQ#N+QL%9R F=PW;=:AD(.TSMWD:VU[FD&D#)O 0<?Q4F;1B9%75-77S(8H
MTJ7:Y"A<8PZH'<K7"BQ8CZ@+[ HWU-4L>#,+![O43R,6:5LDDYW$$GECG')/
MDY/DCDDXT4]N,D<KT],'CIUC[I5 VT.VQ!CRQ)SA5!(4,>%!QJ^Y=18WL_(,
M4J-'V246?551(S0&=4V061,5P7%K^,>-7'I%KY,P-#DFPR1)M)B]MAC:V364
M;\PRJ9]]P8 \3R_99Y!')'(S/#*G;DC+'UIO23:3GE5=$D .Y0Z(0,@$)6@0
M2*R*L4T3%U8* 4?:T?( &"59T/@[68>"05<[$\B?28+8Z+S#.5RG;6NYUC/R
M6G&&7]WXE264Y U6+TJ+(LHE318L5A<<IJ$MG\T.MKXMO61"8K;8_9SVZ[0
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M%4QJ2T+R02)*BN%+QL'7*G.EM1;ZJEIZ6IJ:>2&&NC>>DDD0JM1''(\4DD;
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M7(TE3-7S\G$5R.<1SE<Y[N7JYSU5?=R^2>Z^Z>*__&7G;(P!CD8 //@9XQG
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M\Y2%P8)2RL%/I'D1KVUTM\T<%%64SQD1RL[NZL49F+(6CC94;' 8' 0J6.2
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M*D''OID6!]K>]L(J]P-7;R^5AF.6V^KX5,^\LGQ\2)611XG2-H9>0X7KG$;
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M %*IKB.; K)93 :\G2A/O,>((:$D2M6)+.'[SKX/JL,?74L[(HHZL9B=A4L
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M-:_U/%KE$[W5%5R.1B>?3@E)7U%1$]$\=1'7)$)!&80H=SLQ41R$I',.75B
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MST)*DM?$&Q98R 8C@OU#(M&*IC;:FN2*2GHJV6E^9*3N4IV;Y2IJH%%2P*0
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M.+P5!^(A>#E\T5>2/]3GQ;X(U$\%3EWFJHO#5ZCUO"=TDL ^TA$VGD'EF#>
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MG0]F.%?WD@#>I=\.OAQUYU5UN;;:;=\K#T]54,]\DKRUJ_90II 4HZKOA?\
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M)&$< ,B&5':)<#\,;* ,X'.F[O<XCU<Y5<]RJKE7ZJJJJJO_  ]3/^[@?D/
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MSIM:6FK+;3UMP@J=@B802(\LDA"14\,"K).]1-+^Z1-A()+;7QMU9&S#X:B
M[3L(UMI;"M::RM,D91&V;E<^4:7DY($NO(6TK2Y)#IYEU<-DV90CGPR/KAR8
M\(5>](\1YA,\%6[XXT]'\3^H+_U7>[UU'%:IJNEZ:H(6BAM23F40QS/;96BI
M8"*;>:><O,\;%JA,S]M!](TZ)/Q ^$/1]G^']);>C*_J:"UW/J>KKQ)/<H*!
MZ=ZRNHQ5)&]1-.]4(J>II>Y3J(XY::7MA7BU-C]G_P"V2F[7(V\L(BSJ*VR(
M^+:NDY5;U$8X36,]MEGOH&DK)3UF@9&(P$("N\6,"0RB$\[_ #]6_!;XG_\
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M6NCW$0RF"6$X[>4$84Q@B,>YKFD47I&5&MY1K57CIXM$1J6IH[@GS$3S_A@
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MY%_/K)& #GSGC\C_ )^FM?  'GSCZ_IP3Q[_ &QP>-=76-8P?L3DCCW_ (#
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M)X0O<='.<USE:[R\>E<M]N=U>OO]%TY+^RC*6GEI762&D!1"8DD1B%:)!ND
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ML!._)QN"AH-=+M)\/8*.\V?IZEOU19ZZDJ?V9).8#50Q3!V190DDK_O(TWH
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M)$,-//*0I[S,V%:($*9%0E$?!48W%L&MLQUZ'(STFV<O8F/,C13TF/SIP05
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MM<UR(YKD]T5$5/IUAE5U96 96!5@0""",$$'(((\@C&ME)4@\\;<><@^<^V
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M4B<:N]05A+B.E1"20E>C@DZ]Q?#J,W*V0=3W#IZ+IF[W..:-[0O?WT4$-5+
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M4'LCLN[S9!S')VE=S:O,4A7K_0%VIPKGO5R\?]*J\)[^R<K_ #]6F   !X
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MUA$&[O$L9$<:J,XXPF\.<T;1#&4WCYJ]WD97B:YR+S^%R-X:Y4Z16*F$\Q;
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MK&Y?K_=_GSH_TY/V>_Q2^Y/_ +\ZP_SCZ-&Y?K_(_P"&C_3D_9[_ !2^Y/\
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MD9XQ"_=VA3C$A&-CD@^@\@8)\ZP!/MD?9ZS_ .].[D'IY*B*RZU@O/"(O/\
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M ,D@ >23@?Q.O'<Y]@N.OQ<>09IB=$3.+.'284.YR.GK'Y?<V#&E@5&+MFS
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M0FYMNY\;%9AV_P"C(=YG_8+_ (A7_<<:_P"3NC6GZ'^7^.C_ $9#O,_[!?\
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MY\+KXCN+_$\T+G.\\6U1E^F@8%N[+='6^'YM;55Q=)?XABF"918SUD4X0Q@
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M_LU3ZUKVT]LTG[/B;N1N]9Z]QO?>(UFR<MQ'?%3256-[8C9UCG<?DU1@S&;
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M9,HA,<KA8W9SK"#;G\"E977,*67TJ^EDE'1?QFZ5DK*:GZEHX3))01BEN:H
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MINV;6ZP,LK%+EV8%L(UE7V%E*DQWW%A+LRFC<?<9]\#Z<\D9/T^N.1[XUO\
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M689GILHR"EL)<&I1DV9C<6+$^?D4R6P8;+/40R!#B-7R?Q(=[8VD\%2R;58
MD@!CR-VS=KB/A;UFEED>'I"+J'MU)J!<>D:Z?JFX/!4V^JBB'S/3-7?.G?V1
M;:V"*HK \$-SFGF$$5::0R24:LS;T-C% N(28=Q7GDMLJB;37]>:/=W$@\J:
MRKBEAY#&--B0Y8#W>3-.6-#)1/2O@Q[/RG)7855;_C'[;  $R*Y0( <DE59E
M; 2.(!'&[)8H  T$^3JK9+(;K;ZA)50TM;1RT#P5ENI/^"4QJY(:V@%+')/'
M/)!0S]T5,5=&:B7MN:=JE"+SL?[.K6_RRQNM':[9DFU(9*;+R5\*=6ERRJ3)
MXVQ"0+6)6S@@6"7,*,>5R7(  29(P]JA&V\\YI/$#R0,@#G.<#/ \8Y!((_F
M",Z:13RRQS5$44A@@4--(V-BEGCCQNPBEB\L>(UW.%;<045F#C\1H*7!J&HP
MBBJ646/4<3[FHZT9[&RC?*#%)/$#'L+$QI7 8<20^2"6X_I.((+)I?%OK9 )
M#$<[0"? P,A?'ORP''/DD >"81!8Y(Y-[,$ &$B>(QH ZO&FX-EBHBGWJTBQ
MN[Q*S82N;]E=_@2]VW^Z3=Q'^3?0O6NDH_O/]I_S_9JS5T:SHZ-&CHT:.C1H
MZ-&CHT:.C1KRSH,*SA3*VRB1;"NL(LB#/@30"E0YL*6)X)427%.P@),:2 CP
MG 9CQ&$]XR-<QRHNKHDB/'(BR1R*R.CJ&1T8%61U8%65E)#*0002""#KI#-+
M3RQ3P2R03P2)-#-"[1RPRQL'CEBD0J\<D;J'1T8,C ,I! .JZW>)\%ZX)<VV
MP.T:77D@V!C3INFLAL1UKZXY'/*46#9).(R 2O>]R)'HLCD05KFH1(]]+"Z/
M7QO/G6'P;>2:6OZ5>/9(S2/9ZB01]MF))%#4.=G;R?3!4,@09"SD;47W3\*O
MZ6-/#34UF^):3K/ B0P]544#5 G10JJUYH(09A. "7K:".;ODKOHHV$D\D,F
M9=OG<AJZ9(J\ZTEM'&C@*YKI,W"K\U<90>;7OK[J+"-46,9RNY4\";+CD\6.
M8543WI6NZ5ZAMSM%6V2YP,I_$]%.8SC.2D\:-"ZYY+1NRY ]0]_7EF^)/0W4
M$4=1:>KNGJ]&3B.*[T2S+OVD"HI))4JH9/3Q'-#&XR<K]/'C.G=\9X<-;ANG
MMKY/9&*K$'28)DL\+1KXM1Q2 K'BC-83R]:1(,..)G#B.8C5<G&DZ;O=<4CH
M[/=*B5G(_=4-2Z <<EEB.W!_$S$*![\:5W+K[H^S(U1=.J>G*"!4R6J[S00,
M6))(59*D-(2N-J(K.QX /&)6>USX,NV<ZMJS*.Z&P36N%QW@._!*:S@V^?WX
M&.5R09EA +.H\2@F;X*4S)5M<H-31?NVLD.9.#;/2WP9N57+%5=3R?L^C4JW
MR,,J2UTP!![<DB%X:5"/Q,K2S>5$<38<>7_B5_2UZ?MM/4V[X>PF_720.@O%
M53RTUEHG(QWHH)DAJ[G,I!VH8Z:D+;9?F*E 86LIX'@6':PQ"@P+ ,>K<5Q#
M&( ZVCHJD'H0X44:N>Y?=7ED2I)GEE3ITHAYMA-/(FSI$B7(,9_I&AH:2VTD
M%#04\=+24T8C@@B7:B(/XEF8DL[L2[N6=V9F)/S^O-YNO4-TK;U>ZZHN5TN$
MS3UE94OOEFD("CP J1QHJQPPQJD,$*)#"B1(B+MW2O39HZ-&CHT:I(?;0?\
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M&HGH4>6.GJC)+46R.6UTJ%)'>.-D:2:%UCB0RSJPD+R1R:R!$KD]P'AB 67
M5R'8Y\D' (R3A?MSI2HF2:!GVE'20LFQJ9;Y(@5I*V-D$P\RP^8+>1Q(, IK
MGC<LK&<@AO8=!.%.I["$5&2XQ HWO!?8XYIWIZE(J?=WI&@4(FT0,<DIM(VU
M-.X*Y!2:.091@VN@="0 P)/(&[.>2/&<>01CV((\C6HWT6JI-TNC5M7)%"@:
M?N8=].'*O(S*2JRZ\'.FVR60X-LD8C(>OC-@O3Y4,FQ".*DQDL31=*8FFFLV
MZ253))=HF@0K"S2RTD!C2/MM)$7!>X*7'J*(2Y382=8#!9@<!@BY8,6*D%@2
M&P0<$)@X8$@\$'D-+V&.#>4=6 %6[%\=E5&:Q=@6H-M7MMC]FF6G-99-"JPE
MS<+X26ME7W$L,2%0Y!-LBBLH=;4EB"CR+246\A996:1*R9)J;Y&%[1!%/$U$
M33P&7-"0_:22.-G>>GCC4HTDH9BL>94JJ&6)29*64PP3EHZAE8154<5; X>.
M3(WQO%.H!+JVT$*RXTT?12V:;0VU N\@JXJ56]\1MQ)('$!$?AM?VEZ_Q[$U
MFRV7\>E(R]I[MT1<XG'J[&++DDR8PJLHI(I"F9HU%ZD@IG97)61@S-(:QWM-
M36!$:G#H87IPPI%:6(JHIR9%(*=:.G64T@+NTM14-1PQI&Y7]Y$T<,^8!/.[
M133PDPQ4KRRKD1'N';J09N;S36-W45LZKBLQ^BCQ)]N&)79.&3BUM9PK&1DT
M6\H,CR?84&#;5S,PGJEI;7%M<?=5KE\6]C'/(KXD2*TP_?L[R=TQ5"PIOCEC
MDC618XVB:CBH),2&"-!' (8PRTP15'=U-EZ:KXZ"W1RVJ6.2:OO%M22NGEMU
M)+=HJ=4GH'BK[A0E*VD/R,E5+\Q0/"U73P5%%7LL,,WBPO.:*TRO8&1W#8UK
M#RO:^<2IMS49+D6%AB"U7AT#60 SR0YB1!XQD,[5T^:.#<V[/DPKD;'AOHDZ
MXCC1+%+$N(T*H28MLU/3UI]3^I$62(_\(A29F9X54MF%@(6V,9GU39':T=*V
MJ.MD@N/3?P_Z5GIZ$++":E^L[U4]8_.*T52)V:-^I[=;XBE'4QR2K3Q-+%-#
M '=X*PR8^-X[8UE@6?\ I#-GV +IP*N(2GQ')XDNX@29D0M85(H\/^>K:V!'
M%"M'V:4]2[(9X&V5M*BMS]IY6"1]M$2-.VK,P>:)%B9LO(I9ZAU>1E#+L:5U
MA3"(FJSCI**WU=RIKLR2U5O,L;T\@J=L]PI+JD<M#3S4<F'AGI4D26LJ)*7M
M1O,\*R3Q4YGT+$X3WY!L++)Q[>XUKD];1D&[(C*,]):1:&Z)E-G:5N4W9@P:
MY\8E>",E;54IH;K3[D-3R<;J8,FJZ-,.U3HJA*J"1V#H[$-&7C,,42QH"K+)
MWG9V=]X"[2D@;NOM[I28+/9T-OI[Q$M51U-%;*&!Q<EDKH(:%WN=LHUDN$\L
M,<4"TT[U<(_9TER-<]PNLT!VZKF4MO(MD@GEGR3";+,"TZMCY/-B/R"$LT60
M3OEI8*!+LIBY<*+-H(,^;0UZS UV-V8Y$%QJ[@Q=BFXKM=(8R3VT 0(BQY*D
MA0JQC=(PWN5+R@DG<BJ:*ILU) 7AV6J^06VHKT6:W?.-15TZU])2I,)KK)1(
M7M<\M'52P4U;)&C/64*TTT4,_*Z7((U6N<554Z6LNR!;FPS(),C%+>6.PC45
M"E--)#+;5=C;QF DS:2'8U<R1+L&4N.PIM4LB1;MW0(S+$HVN%9#*K=Q 0TD
MC3*5"E$5,+(0SKL[DIR,+I/3M;C/+:+K<52C6$4U+=;=20W&"%H?F:N'MQ5Z
MTE8D%=73+%4RTM7;V@2::HFI:[M+22=.,YA1H*SF.IK]THUI40,YEK1Y ,9\
MKL)L'"H<"!2V![Y&4+%829*C5-Q)K\;CC"DQQY\FU](D@*X7O0L50M%MD0J8
M@LDKYDRA$H8!51TW2EB5.T1[]Z^BN4ST,:K#!2&GN$MF@FJJ#YJ"W4R?M@5-
M544D-&DU1402X2NJH8IZMT:/9$D,4<61QL9+2%D%%6 I78XQ,9@1U0!A6MM6
MSJR,#(K:V21*D*(UA!1B5T:?7AER!0WR92SHEK!FIS9AZ"W<+*KX]0VKZB8U
M4%<[0Q9GVGG=@;2I!S<T^2JZ&Y2/417.>6X5E5N424U/5TU3(**EI'A["OV3
M'%'+/3SR04[L(D5):2>F7!2 5HK]V,4D=D=C+=EQEU-82KI+&X&2TAEC,DWP
M;F1$'!!51(=G65DD=P*SQJN)@LJ/C-1(/7'["->PTK$NQ*K$Z,H1,(K/F)HN
MX[*T@C<@Q*DC+,C3YRNJW.Y.8*RO=8XOV9/2VR=:*DF%/)V+A3Q-30)''%32
MU55%6++4CMU*5U0U^'>N--%4%H]/C6G<SFVN?U.N:5QKZ!$DMKL#Q6#C.8UK
MB2(#;S/*O;&+7MS5FPD$48P!B@DU)A>%E8A">SL84=ZNIAE@9D5B88I6A69R
M^QV7<RQR0RI%(DQ&6*L@90 "N 6-RTG5?6E!1VGIB[=5U<-QIXC730=17EKQ
M9'IWA<4'3TG25?1023W/YJ4AKBLEVIJF1J>F^9CHZ:<PJ9.QC]')T&KU+M[=
M(95V^K90#N-H1+JG-&+1TU@4,:9O'$MKK-11W-!*>ZNBQ?6E97 IJIS95?9I
M5ID1I4>1HHFV%S(J1/N4 L0S"(H A"R<@MM$3NX52A9D7J.GJS))UST;T)'#
M3K,:JHINE6MU1)4&ZUM L9BZ OO1[4\ZSTE3 J5SL'2A:JD-0*F%9]HV3;]P
M6GL'S?-&;$PW8M/AN.9!DTZJR/55K09#(@5%);73A SC&LTA8P"0858L1A&:
M^EBBSY41L@0PE&U_",0R.B;"C$J.)-RG) Y0KNP<\^L<9QDC27IF@^&_7-]L
M=@/3=^Z7KK]<;?:(*ZT]845QMT%37UU'0+*;!=[#4W61(GJQ.4?J2)I8(9FC
M9W1L0N_99AB%V5]W0PO>1C/B4]Q;/(C&C=RW76AV\<->1%3A$7RY;RJJGBG'
MNGX]O[,?WG5*C^\_V_D-68^C6='1HT=&C1T:-'1HT=&C1T:-'1HT=&C1T:-'
M1HT=&C1T:-'1HT=&C1T:-4G/MFL(DW6W8*T;FHK,X[@U7RYXX6AU,GY?S==H
M8'FW;/ZN,D_<,0/UVG_TUJQ&.?TXS_GS]1_=J@U)BEBO\2-5/V._)?\ SI^7
MUX7^3K62)XFVL-:D8'!XP?//CG@?GP?;W(UY^N>L'_R]SXQP3QR<'/OP ,#1
MT:,8!YQC],XR?8^??WXQR,ZV;%G(VP<J_P#R?'\ZJO\ .GY<JO\ -U(.FI4A
MND3N,J,\?7((X_4X_77.09C91YX]_IG)\#'Y'D^_W7.D>LF3' Y$5%<GC[?1
M.>45>%7^Y_)QS[K[>@[?,TR1@@8(7;C.<$C!R#Y]N?XY\MW]8@^0/OQ]N3S^
M>!_=I7#-%7 $_P!56D\6JC?9?Y%]^./R_;Q[+[>W4C8"%00Q#8R!D<8/&/OQ
M[Y_,9YSY)'M_GWS_ &#@CSXREV67LB<]8SG(H1I^%%:B.<JIPODJ<?FJ\<<)
M^]Y_+F-7NM9X7B+##*5YSSD$8.W['(_0>V@  CV .>//V/C['C/T'CC3>,B&
M@[!W"\^3&JO/UY3V_N?3Z+RJ?MZ\Y7E E?-@DY;//Z#C[#Q_+3FN-B^ 1X)^
MN,_P\<_7'!&IX/LP_P#5FNV7_:MW _Y =C]->MUQY  !S['ZCW^GVP/Y'7U4
M^C6^CHT:^?9]LP<K>X_LI<G'*:3V0J<HBI_KZK/R7E.@''.L$[<'[X_\_P!/
M\^VJ;5)$6;8B13^CX/\ 6\D<K2N<Q?-$$K5:OGRB*JM5%8WER?3KM G<E4;B
MO.[(_%QSZ3D<_?.1YTHHX^[.H+["I#Y!*ME<G*$8).0#G.0!N!R,!V^JK^)$
MO)*WN4"9"KH+I48<_,;.F?$DQXKC161X@".%.))E#&!PCJQKD*O/EQXNL"PU
M:1U3FLN*"**(21BHN<].T;I&60)""5F+.%&UR!SC#9.K2Z9KHXZR0UMVC[,$
M/<C%3=ZBF,3QQ;T5( QCF9Y JE7(SGP02-/CTILO7U-1YUEMQFT&0&LK9\N+
M5R;9B>NZ)"?.B@"A)GZLUI:O)51?28KI!_!/WZJQ+'M-[MU-0U]?^T()!$,]
MLSJ3L4[@4!+#<\A9% &6<87)) N/I?J2ST-!=;I)=J:188G987JD&0B]Q=@:
M1L-/,S0(-I+28 )8X&S:^W>';P26%;!+5TWWH*J&R1(_7/)*< !&/"UBL,Q4
M>SP]0S_-7.9XHB<JX6GJ-+^@EA1XH#.M."YVN2Y"-E,;64A@1]=V"!I?9NLO
M]+%6:"-X*-JE:4*[;6)E*1,'50!(O.0K$YW$$8R=9:MTF;]*93J.WDC%;OD2
M'195/'MZ^*LH; &Y#/,8'ZM@FD0ZA0@?+D?'"+TJ>QI!52.E0RPN&?UP+-&K
M.,;!W'9"P"C:< @G( .EB=+&*O<PU+I#.DC_ +ZCCJ(8RX964+,[)N 4,'P&
M3=E>1DOKK%QRAD5]+/A/^16O9)<2+ CDAI(*]PD]>4\H5')&@5<8*H[Q&\2H
MY45$Z5.*B5'> [9%?: S%?0!DA$5"I!XQC R-3R-54B)4(4*#E!M7R1C X!X
MR1@8X'MD(5LTPLEF$H:ZB9"D@@%6-9I61H\&<8[T9'868$/FLP:!(Y6HPKU:
M7GS7VYZ&F,D<T.)&D>/N++*NZ!7SC8)V+,K9.2JJHQSQR-,UTI_F^[2)"R3&
M NE1) HIFD)PL?S/++(N&) !(QDDC44F_KN_Q>O ZS(*V9(N[!E=$B1@B@L@
ML_>R%L!"8<Q7,4/BUP'H1BD(XJ*U$=575%;/;:<%PM1W*EXT55Q$(^3N$JKD
ML0!@,OJ&X^Q.O/\ UC<JJT4JO(BU?<JI(XU5=D7:VL=XF5<L3M 7*X8;CGT\
M3_?9*;59WQ#-GHL:0%9/9SL.4_U H@VN9MS0S41"\\JCO7<H?9/-C7O5$5..
MH!<*HS6R)>W(IDJ(Y6W(%4%8Y@,-Y((?T< , QSQC58W6N^8L\"]J5#+50SL
M6CP@*PSC ?/(;N$Q\>I0QXQC7T2>H]J)Z.C1HZ-&CHT:KG?:EWL?\)+//!S7
M>.\=$,=XN1WB]N:L1S5X5>'-7V5J^Z+]4Z/I_/\ @?[\:PW@_D=367?;_@^>
M5IIEI+R2!,R08I]I)IK2/%(1ECK)-86< 228$P885CB1B1C^ _G S%2=!F1)
M#&.:]45]K:%8$B2GD2GC1(EFB9@#'7BY12':Z%GCJE#+D["F4='4G6C1*V<Y
M!8DD@_5-A'_UOZYY!UP9VRZ]CWEODM?.R>IOK.[K\DC6=7.JHA::\KSVAF6D
M,#*18=K/.RYM(1I>61LDDLK);ZV*6-!8( ^IZCKVAAII(Z:6"*&2G:*5)7$T
M$@B!B=C/OB0&")PE(U,ID02,&?+''93)89!)R",#!YY Q@^3^(-P<>  $X-V
M:XO)R)8Y+I0:L!6H&%@D2+8_>#;;^A_1:[;<S<@L+RP#*G#J\?K9:&931Q&D
M0X3#Q'D^^)EXXCJ^J6GW"$-<S)N>N=H]G:^?GN'92".&,I&9:B1-IF<A7<JX
M'92#3Y=<XSA!X7G.=@3.XL?8#V'@??*CXMH76,*2.PI$OP2Z"UIXY#N *@8^
MXPVWV%<!FB@1Z&FKGMD6NT,IER9E-"#43G%AK 5HHBH1NJKY<G4QS& I/%,V
MT,9R(:R*WQ%&D:>:3*Q6RE55F<S( XDR7XW6- <@$$$>VW)4L<X 4')=LD#!
M_32=6>214V=N%+6"6952M9X#BEO!C2*G)0.K(%GELRUL#)9VL299T,>HV(EG
M<PH<(LPL #T.(;T%#LUR4I:UVD(ZB07"X5,;NDM/^\DBI42(=N*2..9Y;?VH
MVD<(KL,%AN>/,<KQ3&:-FCDB[31R1L5='C8NLB,"K*T98,&4AE(!!! S'V;-
MJ?$,@PREL(<2/$@6./YA&K(6N:JMP2NM:UN674S*&Y,278C@&A442%]ZS:<-
MY>W=)Z<^BHP'..NK)ZE!)4P5T\.=\J5%-)(;A(]?+'(*2G2G:F"1&4R3%NTM
M0T,$,R]J>H95[DB>6HFD^6%1+-,M/&L5.L@9XH(D>67M0EV*Q1HTKR=N/C=*
MT@0,[91K3Q_O/.]]%Q:_Q^77WNQ) (!+>L@P!SJZ?H#M0DQZC'J2]O*Z%89+
M7P8696%=59?/QZ'()!-(FQ8942"YO:."%;I!64\J".NIVDCA<R,)C25!DDD>
M&E8I#*[T:M+21U<N7],CCUAWHJRY27.WU]'/(:ZF%.WS;RU0[$5,U-30RU%0
M]0TL,*1A89!W((88%6-!&A5 \[3.?'^_[?*"V+I>'U9\P!D]'#R$UM\K KJN
MRN<3PV\LLO"\F?5M[C^73+W&98+NJAQKLTV@JZ<4%MW,6,WRG:FBBII8D2HD
MBCJ5D5 JJ?W%-*8H8!$M))WZ5EF$D*'MHKN97>(K9=!::*^0&.UR3_-&LM%H
MM-376]:6:X35U=65M?U"DU)4ULE*+4&HJ"HCA_;4DE-(E9+74G8CI9%4T5\E
MCV#ZWDOK\>Q2TSV-A4[)YECDTM\RR=/F%N\SDIC,.@GT4)KLCR8&,1#S[>3'
M/*G3($N-C]@VU"=G99)8IBTL[_*B=Q&\*=N,SQ@QF.62HCE+2JIE<)","-7'
M>.P:<OB5(E5UKU%3T\<EUHJ&IN%LL\UFHSNV6%UMEIHKA6I&M1+36VVVMJQE
M58YHTXBD>@[%3'O$6\QLV)FE0JZC''L+!)M$?*L>ERZ1[Z)T6^H(X<2:^L'B
MU/307BJ<5R=LNKJ@7%4^9"DXW,LXX+?C,LG=BEF)<O&C.8Y$>0NRE&:6;:_=
MED=!/+%)W) DNURS!B&FWV^MAN%5:*6HKH7M$M3:ZVGMM6;9/%17":6EN(HJ
MP2SRW0RB:>*OHX('DJ( H^6NUOHM]$H%J^J$*I)G>07BV\_-(]>RKK+7&["!
M+EMRV;?XF9<<.?)B%K76&/)15CO UU6,AFDFCUSZZRN:Y*@8L6AACD @=F!2
M4B,=LQRNS IAE#B4N&[:DK@CA-(5%0PK8++#34-'#;8YXKG515=#6[/V914U
MTI:>Z+#;HVJ):>XM)6T\J)!<HYC3H]8M;14U86LW6>.3ZG#H=O50'&ML-J*2
MJM6.KX% Z>6=.BQ:Z=+>,R7S:,]K74(*=J3J*1=53[L"1YD:8/=DG$2R&' 8
M3%G4AS*%*1LQ4!B(^X.26*.P?MD8*Z3VMNHKY-=[O,U9<6I:2XUM<U-N:JG=
M*=7<U<$&V&>B>H^2K;E\]&%JZ2W3K3RR30RQ-KN69>8&1.I9;,H!81I>(R),
M TNWCR05E6RR/ N(F4"RZMPFQ,3),9<_*H=:T\L]8\=!95+K2[:-V8HPK*RB
M.5#O0';B-F<!63UQK(I5),H7X5L/^ 9+O06=*^PRU226ZD$E+=Y8I(EMU1.E
M3--2"2EJ;+3VBXW^G@-!7]JTS/((C4)+6T5>D-"QC]+LJR3)!A);S<5BL)#U
MS-H,IQ;/VS:[)+]M?;3+],;(R$E>*BN03:^L1\58V46-%D**:)_3N,0YFS1P
MK*RH)HT4S]R*:G7N0KW<(A&0TLBJJY+%4$@<':JR,$--;8K91(T-)6W6MEDO
M]+5V^HL\U(M/0/%0PT-;=27:HI:BDG@N-<J8N%JI*JV0M3U$U3%<F@T@T+,J
MN=3.PF=DN*8[54-G)(?)Z^_N7KFT"H6S#9.A4EL[(,O@R:JTF$MHY!9M46]A
M%C0#7L*YBU#YVZ&*5E:I6)R[@=J Q0,8<=OAV7LP$/&.&[;^MG$91F.GR:HM
M@M5ZIZQ:.[7J6MIXHJR.6"2GAM%5<UCDH":ZG4451'.(4H)Z9K+/;Z/>RTT]
M**V*GU7$<K/:W5.+*138B8E<64G*,E-67EG'S.FPW8$6!5W-D>1CU%+L+>AR
MZLL);BV5<*+C%7+EY91'CP)U%6W766G]&:=8RDXV0J\D23*PCCW.5[Q$2RK*
MFW!*R%6CS)VI'5PN,$5'1W-*>LDJ*ZIH:-Z2U6X1T]%8Z_JCIRZ3U%CM[TTM
MPBEHY;&L$,R4E5)6W.LCM]MN\"U,M0]#[LIS++]38D>S!<6UA;2<G)@$)DNK
MM,WQ^O/>LB6D+-;8>.9,:W7#JP;:6)3W4N?!L1UZRHLS%IMK:@8FAC@GF!.X
M4^T2-L CE&'9.T!(HC><Y,C(K.N#@3;5R-[%9:/JZX?L][79Z&MBM"]22 7&
MELDU>EMC:GGLM#)6VM8J>LJY?GXJNECM[P&OBAJX:R"BIV$CD*N]HSRWX>^K
ML+FB-!KX5@7,#19^-OB77W7'0S[B[9,M9[,D9+/&J:BQ^=D6\T0 2HF/55A2
M3;9&=R,LRRF-_4R-3H8Y(W0ML&U.VJ$%$9I(W81JVX&21705W76BODM\E=)'
M0PU JY@M+2/(:NH2#OSUJK1T@DIT2S@/\Q*T-#' D<BQ25C0U0HT'WL]YM*[
ML]2#)JXL#4><QZ<!/&5DCX^3T\])-$5L1TNAK\,Q@TJ'CMM!K)!9D&YHJPDD
MD&#"IS6NZ';*H&PDO&A91Z 8V3]XA)!:2787WL &223 )<A;(^&L*CK?X=R+
M6SU,T_7-CKZQI7,-O[M%6!HIY1,D-QJ;Q71O-<;>]7'' ]%4R)$:FH>NCI8C
M/LLK5;V5]W7+%8UWQ*NXQS.6JB*S^AWHAJ*WV1%:BM<WE/;EJI]45.D.J&!R
M,DY.22<YY)R>?OY^OUU9CZ-9T=&C1T:-'1HT=&C1T:-'1HT=&C1T:-'1HT=&
MC1T:-'1HT=&C1T:-'1HU2X^V,M:[7?89Y(BHF:=P"^Z<_P#Z#U/S_P '/_'^
M74EZ=B23YLN,[/E\ C(.>_G/\!KC,2-N/HW\L:H87,1"L?PU&HU%5J\?L3E4
M_N\?WT3GCGWQ=Z?,K,D81<'& ,<>?[,^WN1H3&,-G/'\?<<?7Q]\:T7J-Z/?
M/'DY]L$9\$@_GQ[^P.-'1H]R3YYXY]OU)/O[@<>?;67HRJ.P"G*(TGDQRKQQ
MPK55/=?9.51$_;^SIPM<@CKJ<D@*9 &SQP?/\L_K]\:P0=K8P<C'D9&/X ^Q
M)'MR?.G58# BR"M(YZ>;F>+456_5JISSRJ*CO9>.?JG*?S>G[!!#)%"48%3$
M K$ YP,>?S'G(\C[$MC$J"V"3GGZ^3[?K^F>?&MPR"J&]'#,5&-9^L16N:G"
MM3RX=]41%_+GZ?RKT[U=.%8AF QSP<8P,\^WVQ_YZ$.Y0<8_S_9_+Z:22\KA
M,<XHGH1%9YKPYKE;XHJ+RY/;\E=[(BJG'/UZB]SHTE1Y!DLBEA@CV4X/ /Y\
M9\^X\;>#D>_G[C^(X_SYT@N0O\[!Z>W#6HWV_O\ [?Y?Y.O.MX;=<)\'(#$#
M'YG/\\Z<UQVU^N <?D?\!_;[9U/%]F&:Y?C,]LSD:JM3%NX'ER(O"<Z"V/QR
MOT3G^7ILP2"0"0/)P<#G')]N2!^9UE00>1[8!^O\^?L?H!KZJ76-=-'1HU\^
M_P"V7-8[N.[*_4>C&II'9*\\*JJOZ=5O"(B(OU7CGGCVY]^LC'N<:, GDX']
MOVXY_L'UXU3!:YS%1S7*UR?147A??V7W3^3K&N08KR#CW&"?)P,,>/OGD>^>
M#@[U@F.&R?)X5(>3\J.46.281[^7+"#_ $U(1KD:1?5=%&1 I[-]56-(YK/)
M4<K51-<*^"E+[!(P,C$X(C0;WQPWJV A<C&X@,0,Z?;);GNER@HFE[:RNK3,
M3SV4'=D (#'?VT8(,8W$!B!DZ6$LXX&UV".+(C8S"F/KS2_2B*677LMI%CSY
M,:XCY 222*)2HUODUC'N4:<=25Y744]DR\5%'.T4D[+'NEA6H>8<A6;<C.=N
M0H) R".-2^29U%+T\"\-NBJ'@DJ'6/=- *EYQAMK-OC9SMR%7<J[B5SA].NL
M@Q^\K/Z'>#5K&PJRMC69YT=Y!R7S?6E/DH]\N1X(HP1 F>YK43R*Y&KPUK4L
MZU55)/ +1;(5V4\22F6,D$N2^X%G?&X"-6.  -WUXU<-EJZ2KIA8K/3)VZ:)
M)VFA9@Q<F1G4F23;E5B$G"CU-QGP%^K]EQ<'PJ/EV!6#+T-%*C0K60K6D]:-
MCIVV-G#E?/,$J/&">]'/BHTA6%1&E<YC/&0SU=$EJ$M'(:H0GM32Y8#MPDR3
MHVXJ 560G<HW#@ Y"ZFINU+06>*KM4_S9IG6GJ9/ZNRC83U$4HE" %4J&&Z-
M=W)]65&.C5G<AAET.OQFPF1ER4,5'.CQ_FU.:"PQ2.<I))&Q/7"\S_-$<U%:
MX?CYHBHU/;.H:"J84)J%^="EUA4>4X7<6(\Y #C<>"I7.>.-AZXM4Y2VS3J;
MDB!A#&22T8. S%SC<K'U#(X9< \G6A[;[ADQ*P-)D02G<^QFEQ=0M9YMB158
MV,^:BR!L\V_,*A$:A6+^'A'.\ND5YZF2V(%FCW@R%H.V/4VT;=S9=1_6.X8Q
MXXTS=2=;BW$M)%N G<T6Q06(08#."X4X#D-DD8( SDZ8?LG; \ZQ2'76M+!2
M521(46%/(^0QS8D**2.^,C02/3>V1_2Y"E*%YU?'8K"(BO1];WJ_P72VB.6F
M7NPK"$=R0 L4;(4&R3)W;E)9E#>D;2!G-/\ 4/5$-XM(AJ*2/NTR0)%))N4=
MN"-T*+VI>0P92[,N\E5PV"P-@O[(A-BR?B/[7'&$ "A[,-A^H,9)+W>;MOZ#
MY\4*YS$:U4X?]%\E;X)X^74"EE1Z=51(T*M'N ,A9CL;D;F*@#'J\<D;>,@5
ME/-%+2JL:11['B#!6F9B2DF2-[,@4$8;D>HC: ,X^CITCTW:.C1HZ-&M'V*W
M8CL4GIJTV*BS)'QUK_TR#8EHWA4J-F,*ZK*R2"2@%<2&5PI,=9 V!D ](KC!
M-&JUGVEC7EMAGP@\B0-R"":R[A]4YEL>GBQGV=7=YCF&7BFW"8[-FDC2,>HX
M&1$E3X0 0WGL1D<:V<6TF6%A*-:M^$_Y]]6=Z/\ ZBT__:NO_P#K0/1K;64Z
M-&O,QRQUBQ7>N9%"YGS97Q^7$ P:(TR>8BDD26*4R+'C.$B .XJ@_4M)L>=S
M<#D>D \!B?'! 53A>6SEEP#R0:UJQGL+7#;3V36%=$N60 V SDB6\B($M8&-
M)GS(4Z1Z?WG(BF$4 Y4FR$-2Q V,1Q6O[JA#,9(\X,18J0K1AB)"51&0 F-6
M5@<+$3AMC@8RFPN@D9DC+*'9$#NJ$@,R(SQJ[ '*JTB!R "Z@E@R<^7C)6[@
M+2R*6BO[S,:Z!6UDDK71XE>#6.L,9G65'6@MJZ?:OQN9+ND@4D87',H<8HZX
MC?.+,/E,26COK4ST]/12R2R1@EGD-RN54D<LABE6,U"1P[YB<\,P[N<-I Q8
MM$BP"2:>(++,458SVS$06E81K%F4M(9 %7MHQ= ATR;/Y-)-S.KQN+.DW%CD
M%S48Q"Q&MJ*:9? =K"RI+";E656N>,KEJ(<]U]>4K;>_N*0M%Z=U,C1FD-:U
M&.RRF[T5&U4L)B:."6J>J[C1(\=P29%I*:.G)69H"L-1\O"DS3%XP"VQ)*A?
M00/)WX:JKHUM]'(XQ6/655#%73;,3(ENCJYP]8*!86K(X'IG2*&"IFC66!D3
M^FU' ')VA:2K/#("9_DV";+AU * Y:2;=W6#2->S:S&K2A PU02I/K^CJ(MZ
M8%>>_?:*&':1K"ZK"6&BUG:(=DJ)4CGFII:B6;OS]N"GM7:EGBF95F[[3S-)
M"JRK"L9+0A8Y3"JMJU$=QKZ>EIJZ*IJ(Y9*:*FFBL_:IXY9ZFI:3NK.85AI(
M)'IP*Q!#4QQ,\U8B&&=Q.0)CN08!F4F!52K5<PHY5;B%O4 C56-T?Z<9<W7.
M&0H--!NI:_>-%DV:R10@V,VW+1W-,Z13J04F\6#$*[O1HR/)'OW1QU33+*U7
M/(56>,.\L2C8L"H_>V0+(LF"@E U<7P^[E-UKTL3WK=2=.U\]U_9,5325E+\
MITG9)[QUA6FK@A64QWY+(\-3148F:HI).W7S_)I;$K%7@YW3VEC@YX%+BCAV
M6)HS,\,L:*EQ^)B&21BXT&!99!)N:B88$#&UAR[RBRV+*D4=Q; CV-=5A:8D
MV$WFF>.&I1]JJM2I5M[S%UC,Q,2B-EWY+%) 0'V X?81NXU%NG:6M9[IU/+4
MPFH3IZ_4==4227RVW2*K:HDM<,=5&B5MXB>BI*GI]UCJ*""I>CN$LU9 M*^Y
MZIRBT*')\V#AA)&-8<>^B0:=D'$)^59=8/HL-K7MRFT/ K[2#"QFRD2H5);O
M&Z\MZ-]@Y:I:F)7P"\:XAYEA$BK)4BF,YC+_ "\3'/[N)(WD#@85Y1R%E4*H
MR@D=MN-@I:&@M%IJ+NYK*A)9Z&MKY[S2I;[>EXZCJXZ^BAJ'2B6LO="H:6C5
MTMM(TM+4U%T%;<JTT6S8Q.OLHQO+K;,K.OV#B=_/D M</I!U2V>,X=EU;D.0
M9720;V'<MR;(!5<FRJZB"*KIZO(%)BI(N.BGL.^R>DFC2)HEB#I)@^MMX#RQ
MR"(,JM$@4/M8X);&\"0JP9=*ZQZ"@N5NI;52'IJ[6B*FJ*"]UTLWREQNUJ>S
MP6.NN%O>*KL]KGFA@J:VJGJJ^IM3K=DK*TT\:PP#7XV1XQ1XG09#2SQR U]<
M<&":\G9/2XW*EY9.R#]&4D7=Y:Q!7-G/QBEPXL4C5F74UE?:S43#&?<^.#B;
MA6DF;DJ6E8.ZQ;D2/9OC5%WLBB5W;TMA5('[XAG(55-KO,]=<K1=*(.T@I*G
MJ+JF&EN-UE_9=)0+<:WY&@MT8I8*2NJ;Y35*U$%+0K4U5-3Q"YAZZX?-<[*X
MN,GS2!.L+FO+B)+AA:6727T>^S,,68YV."G5<:)&NW#I;RRLTQZ([[W+&B-M
M!W#\M!,KA1*O?MP+ C)%NF509Q(!'$Q<%A'Z9<;D"@L!'&_ Q%M))1T$ MEO
MN=N2&MI+C-02TD,57;:FDM"SVZ..YS&OJ*^EMA>OI*2G%UE>6"ICJ6HI;<MM
MDCK#+6ZS/QZ+B(,?3-\FS[(\.H[>Y%/%<8Y\[D.*P*J5A=4^KB)C+JT-#33+
ML5T"R9A,*5A;L2K[=*J_BPJ6((O9ZE)0K4]-!3'$?X& 0S8E[;9D,KS%(P<M
M*-[2R'=&K&,Z4VF*XW*HO45$;,_45UM\'RK0700VV^PW"&\UU;43BL@BA:Y-
M3U-KDML5YJH;Y37;]E&:DJ7K[CLW.KK;.V'C]WBQ[RIIYUY<@R_'ZTM?D$"<
MVTG0I=%F#8/WO(OJF7$KY8C/Q^ECG."36RZC*FC.7[T=PE!1")D5B4C:"4J8
MW[:AUV!NRJLK%0=\V"5*M&N/2$)N-N@K[K;JJ:AJKC1T,1HZNK:HI&H[A34[
M"ZV6=VV6^LA:JCG@%=WE@!JDJ[?.T4*4913&*W%XM+2-JK!F=UF'S[#%\Z)E
MJ1L8RO',=S&RLLUN[ZP 8L6SMZS#L5-EM)"QZCD3P6-9?QVQ+*WM<=B2J16(
M:AIMKCLU$B$TT!#LS2*B04Z($3"2RR.CHTG;VO&99,*^));U#U')FZU4E,]E
MI;R]OO5!<>G)EO/3MRN%DIX[9)1K4S--2TZW2X45DJ[E=*F)YH):62@6BM]-
M7U*S;-BF-4.-AG5/ ,SR+)-68F*ZH[F1D=K88])QV?)JSSP938NCU$#U[4-(
MPKY4HT['LGJY,.IJVPO2K1ZL',G8E*Q1PU#R [0%F+Q!U!B@5I"AC#>N)&#)
M('9B"K!LO?4-7=J:FZGH(ZNTT5)U%>Z>UW2W"QT,4U)7E9GIWMU41)55E.:F
MM?Y"KDI::Z6IT^9G2LAJJBHWO0]U%QG#+^+D&2F'7X[7Q\8A7UJ2[S2RK+2(
MVVM:TLX]DR70ON9%=#H,D%##)L9293:RL5/&#%K,8C2$=6A;LLL:@/N.P&-7
M8+C<S !74;GVJ&5 T(1QN)=])>MJ::\=2Q&W4#5-?7UAO-514U/2]/6B>AJO
MD:"6GMD5,\-;)005 NMKK*I66)*6D>[+*LE9<T@VJX9<=RS+*IQM; &@8[IQ
MSY'ZHZZ\VF!U8R!)Q;!PRS,2-@=^=EFR=L_((<BUO!V%D+!"Q*LL#,FI!^X]
M3 =UN,;1B,[LEFP-N]<C]VGI4><D[=:4#6_X5&FJ+DU-+\1]E-&EJ.^LHNCV
M^:>HI[QU')&)))NH[?'\JU/TK03I2T3TM,_42U%9'56,PW?98"/+V3]V[R.<
MYR_$F[A^5<JN5$36VA41.5_)J<(B?1$3A/;I-_/5&#_'[9Y\\\\^>?/G5F?H
MUG1T:-'1HT=&C1T:-'1HT=&C1T:-'1HT=&C1T:-'1HT=&C1T:-'1HT=&C5,+
M[8BT:ZY[$5>J<IFF_?'GC_YCU2J_7]G"?\'\G4XZ-2G<73Y@J JTA7+ <YJ<
MXR1GVSC2:IR A7.03X_+Z?;^6J&EY*"",]&HSR5%:B<MYY<G'"(J(BJB<K^2
MJG/[.>L]0U5,BF*$+GP#D$CCG@X()&?<'ZC.M85/EL\?F/[!Q[>/H?II-_KU
M!M=O.2, <CZD_4^?H>3GDX]SHZ-8 SCC.?KSR![^V/MYQX]L\QO49&$;RBL>
MUR<>R\M5%_\ -UE258,/(((]O&LC/Z$'/G&.<GQQSG^(X\Z6C',G)&$$T8RL
M(WQ5/$BMX>B)RCE1>5^B\HJ>Z?MY1>KCZ9ZL6.FBA=OWD8"@[]IR,<DG[^V2
M?MMTDEA.XE1D'G&/?Z#C^.0,'@ZW^9EI+" 09'K\T3Q:]_GPO'*+[+[KQXIX
MK[\?M5>K"-YBJJ<L)5[AQDEAD9P/KG!/&?M@8SI,1C@#!\>/'_IR?O\ KK1Y
M]PD6*47DCGN:]J+Y<JB.547V^J\<KPOLJ_E[HG$/OO4D=#1S4Z,'GEC9(\.&
M9%?TEB/K@G;XP<'C!!ZPQ,Y'T!Y)SSCSS^?D_3C&=:748?<Y=8N; BR#JYW+
MU&(CT8WZ\O<U%0;53V5SN/=%=Q]>JSL_3-UZEJV^4@D9"Q,LQ1S&GN<L 021
M]^2<YYQI9++%"!N(!QC:"!GC SG['VS].=6>_LVVD&X;\3#M_P IEL\YHJ+=
M 6/<%6>BLK2V>A>C2.<JO<K".:YW"*B.5OT1>K>ZB^'-'TO\-[M<90LEQ+VW
M$CQ!95$MTHXV"DDLJ;2P XW9+'V&FJ*YB>YQTJ\@K(20<@%8V;&,<'@<G!QC
MZZ^DOUYWT^Z.C1KY]?VS+^$;V5?V$]D?X]UG1K5O 'U./;^6>,\<:IA]&N?(
M'.<<_4<\X^@R,?S_ (;!C$J5$NHA(9"#,]21T>,[([T')&Z.5/5(J-:UP2O:
M]%5$<Q7-]^>.E5')+%4Q-"S+(24!5@C8D!1@&) 7(8@DG&"<Z<;9+-%6Q/ [
M),6,09)%B($J]MU#,=H!5F4D\$9YTZ#6>)ER!;N0<\8B.\8+&2YT*(>,][F(
MP\>1,.,3GN>3Q%Z;2.4G]:J<=3SI^@-5\[+/(C;B*90\D8DC)(]:2.VW<2V%
M*YYP1G@&S>E[::OY^:HD5]Q%*HDEB$D9)!#QRN^PL6<;-H)+\\ZS.+V,W 8N
M2(\P$C6(IP&CG1I1QR8QH[X1AB?&>(;WL5"O&3EPE<_E&NX5.G"@)LL%=W)%
M$<C2L@E1V+(8Q$5)4@,?2Q&T <\ ^-.MM+6"FN)EE7LRO4-&9HW?<CPB)D)0
M[6(VL1M')?(R,ZU*#M&3(P>UQ!\%C88Y]]+8XSG.@E//KX (JCA(YI1S(1HB
MF#(>]6(IF?JU\'*K+%U SVFJH'A55#U<D;'/9WRQ1A-L1;<LJ-&"KDA0=N1D
M$ZC\'5!FLM;;)8%2,-6O$228#)-!$D6V')=94:-760D ';QZ3E"K%[@RHTV0
MIVE<13J\4D2,<-JL02,'PX@WHY"*JO=^+E.$;[*L0D+*ZRN6#L2^X.O*Y 4@
M9+*P.203_L\<#,$G9ED29S()2QDW+(N"HP%V@#<C;MQ.3SQP#I<9+[_-JVRM
M!VI+T%"WSDR)3W.E1P\.\0H4KAM(SECE7TAO1..>?IU+IC576EJ)8JH5241+
M,T@;NJ-I]&]BJL"%)](\C\M3RH^<O-'4S0UHK8Z!F=FD5^^H(R(^XX1"N%R=
MJD9 QDD'3>[:ZE36)"D 2*QKQO57C(TW+$<WR?RONCN5^C/?Z\_LALT\CCMN
MH !'L0Q(SR>3YS_GVKRIJI90(9$5%&#R"&)7(RV2<YR1P.?;5IO['S)1OQ)=
MQPT:[DG9IL62KN4\/U6XM!C1...>?UOUYX^O\G7(2$1/%SAI$<_3T+(,8^OK
MX/YZX)-B!X!D[I8Y"<\>A9%'W)]9Q]!KZ2/7/7/1T:->2?/@U<&99V<R+75M
M=%D3K"PG2 Q(,&#$"^1+F3)<AXP1HL8 R&D2#$8((F/(1[6-<Y#SXT>/.L?C
M62X[F>/TN68C>U&3XOD=;#N<?R*@L8EO27=38!9)@V=5:0"GA3X,N.1AHTJ*
M8H3#<U['N:J+UD@@D$$$<$$8(/T(/C6 00"""",@CP1JO1]J<(C/A*9NU4>J
MEWEH=C5:-[VM5,Q]3DCFM5HF>(U:CR*UBD5@D<I",:['T_S['Q_GQG0W@_\
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MU$Q([S1:T;<=HQYR#CP/ #;B000?  ).2.<9U'!L&I$W6%%LK*;O+*"NOZO
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MWRD6DN186TT7R2@*.7,L)\F?+F <R0^=+)+>7Y@JD77))R3D\>>? P!SG@
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M2#7E'&'&:9 (@@O]0B1QB ( RE(4\@S$$)CU+*,9YI#B/)YE52(C7O(K\DY
M&!D9YYR?& <DCC'& //.>,;.[R-ND=G;:B;G8LVR-%CC7+$G:D:JB+X5%55
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M*-9V/Y725F14DQ0O0@5E55O%F0)"B(B$&IH[U&]$<WAR(O602IRI(/U!(/\
M$:P0&&& (^A (_@=9&GIJC'JN#24%56T=+5QAPZRHIX,6LJZZ(%/$46#7PA
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M8[]\B*C7)[^[>47C\OS5%]VRMA$L;*1Y!\C.#CSC^'CD>=-==")$92/Q G!
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M'(P!SGR1[Z\71)<;G)"MT[S3]]4#?*F7\4R@@OZ1'&5 W2>H$9XP.9-<>UB
M-&E9'<QWR('GDF4#?-OJC1KT8Y'+^!$$BM;PB*]7N1$\N.K32Z_("&,EB6 B
M0%LABO()4>,L2,_[.,YU:]%TCWJ!J>-XA\M&9I@0H90_! )Q^'=X\@Y.3C(C
M9[LM8XS2QII&O!;-8K)RE^1"K1R_4>HQJ]7F1CX[A(5K47ECG^2>/DJ=0OJN
M17AJ)=HWSAVJ$3DJ>3DG@XR!Y\>.-1**QPV>X]VDJ1/$KK)*%R&R,9.!P?&#
MSSGZZK;=PM;2'E"F1'/C,.$S1/EL9!<58CT>JQE>_P#7.:Z0SE!K[>2*O'*=
M>7+E.DM4=G<=T:10 I;:F]PHDR.%W(<'SYY.-6-+=:"K6F>61XY$C].XL6+K
ME2" ",>DCV&,Y]]38_9PI\EV^=Z5)W<M@:6@/&BMX=XDSBD8WS)]2.3P<G/M
MQ^S\2\3CI2XR55/)2R,&^6"E1CD G')QGZ>_G/VU:_2-SFK:/L-('BA0-$,<
MC+%2<\G!'MD^=6^.I;J7Z.C1HZ-&CHT:KH?:FOZDEG:?MW?H9/\ _=&='@C'
MU_N/^>>/UQK#>#[^/[?MS^>-6%Z/TP4%/[M&(-/7^ZKPU@QP@^ZN5?9K6I[J
MJ_1.57K))8DGDL<G[DGZ#ZGZ:SKV"*V?&BRXLE[ 2!-DB(!8I6G#( Y0N0BL
MDB>/@K) W@?P][!<O(!2"+E@49D9?4I*D-N!4JPSP"I!X*D'P"> 0"#SXUK3
MTAWDR-"DNFR)D2))(2QKA/?019C) JVV@B*=DB"EDTL25&:.4,UO A3)[(TB
M,DHR]=QW(8R^$4,RCML<3,"ADBDVY63M$,K@J1"[I'O#[1K:3MF5^T)!%N<Q
M=P@N(]WI$A4!#)MP&*@#.[: .-,DV5 O,US*-5,J9@J_%\=EE2'CCC-G Q6S
MVNSD<RPAVD9\#([[^A6YTPMA.1T&Z*YDV&DR-)C),*"6&DH#-W%,M74P@-5+
MZ35);AAEB>([X*;]J90)&0T*9#&-P3M$NRKDC:1-L,-<K&.5.U*!#.I19=P5
MEJ.T(P4=7D$@6$B5D8-,V' O7OI:JG9338U:^794%9L4%!A-I2V=J^WA6LZV
MO)S/O.5 L8M90DG8WD,6+17(22:6*DG[L:9LEII8DAK*B9)BQ@$<CT)DK(ZE
M855D1(59:=&4RR[:F!N]#D3-M[I0*;9'!47&VTZ50H%JKF@J'1ZQ%IJ=I*:2
M$1]N*HJY)(G[J0J/F97F6(+DJLLF6Q:31DD5D?&<8%D6Q,>G&SG.K="K&MLT
M@8]B5,R[KHF5,FQ!6+JRORS*ZG%K!"G"UMC5V[([X5G]VF:*YFVU]0L@IX9S
M0TL,3*>S3-+6//$&1LI&9%H(9:F-<!6!5P2H<S^W45<'Z;M?45RF%@:BZGIK
M.L([KTT]3!56F.OEM45)+7]B6Z7&C]4\/S-1'2U='!/!)!NIM\U3@N+2-B;@
MVO'QR_L(U[1Z#O[:LK(]M;9 /.;S!J;7>=UE=<BBBL?GY57CN#63;ZMKTF3X
MS+FQJ8\"PGQ+:%#)\K)*2\9,LTK<810A!9"(E.U0FU@8MVV,E%;(&TV1.+AT
MY9+;THMSCIJBZ=4]=3Q5USGIXJ$6/I>CZ?INFY:V*JDDIYH'EH+[$M+55/:[
MC4Z5<U1#!44DSR1QK2I;D6(3AUU5KL6$W[$=#K(]F>9;.OY$PD&W"ROB0W6-
ME1K-GS\:B7#+$S[J[L&?<WK58*KCGT1SI(S3K,N58@%!L&QXP7+,N5"E^V%0
MQHA)RI:M9I**XU%+7"GJ:WJ"KNML;NR55130FWB@6FE>"8-(]-!07&6F@H;E
M4PM#(E-311"N--<I:GMM]CNQ0$"@PBMR7*-MY[,;DM;@5X*##LB58WAKI.39
MV9L*&W7&(BKX\.LEW,ZO]84ZM' QRARO(3.@7O$*'_&$6.(;.XI<C)YVH"[;
MVR&8 8!,CEBJ[=G>W])"ZSU=SOU?;K3T98(S;:SJ"@)FHQ6.LU3%:NGU!EDZ
MIO32SO4044-60U*T=1=+E9[:DE52I]KG'+BHFFVKL*QAYMFXY3<'F2[1V.4^
M)0ZUF:LQAL37LF<-T'%,:J[2%%D3J"HC&R3)[MM!*NLBLYWR=)7]7VNO9B1E
M)S+Z=[,0$W[60 EGQN)D8[%4L JA3(9%U5=J.=%Z5L /3O2S4T=\IZ6G2YU5
MZFN,EF:Z&IZG>&<37BZW"DJS2TE76&*UVFD_:,5OM]/ \]9.N<VCR.= R>DL
M[S'\OD.G6,VPB3<84%::%\M%LJB@LJR/-R"*_P!,*4T%9<@$"[FP 29=6C):
MK.;PRN%.W:/2H.\;PQW NF0K> Y(&4!(W 94:@45?:J>OLU?2T5WLB+20PTL
ME/=7ED659GI:ZX15<E+;^VS2O5U444<LU-%4,L$Y>E6:F.WXA9T>8069101X
MI:/(8SFRC$04*WB6U'.)4RZ2P@ KF2!RZF=#GP;<5C;DFU5M!/5N@C5AO1)
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M 8^7%E+D%IDALPG7$6TB206M=/-DT@]TV1738KX\TCGQU$W\":"1U8,&((&
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M![_Q](TM\,A(XWA)!Q&0=U;8/1EG!%(X,2!Z<>XBQ)+SP&X.T;]I# \+D$,
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M+)2(]Q'.'QPP3&(Q_HL5W*\*USF^[4Y6$75()J@K"!V8>4!089SSOYSX5B.
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M)B4ZXGD-9>3/)?5:BD:KU:]4_P!55K?%?9./!6\?FBIU]"N@?A3TOT+00)#
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M3%X]N53ZL$EOD**N!O&?4!P00NT ;1R!N!.X^1XQJ,36HO$J.FXA2 1S@%5
M!4KD8PP)W,&R. 1G2FT&VO\ W.HG/>XY),/EHQE5R)%\E1/4]F.:A%(Y4X5J
M<.14YY1"UNG9Q%M&_P!+#)( W-P>./(.?<^^1G49GZ0BGD>-4(+;'VE]F,O@
M^^,$ #Q]?KKT9AN3[L86*D[U)7R[7_@\%;%<]"(H5<KE5'*Q&D541JHY_'LJ
M==VL]0LO;)1P2"67/O@_<9YQCW/UQH@Z#I:.H0*%E"%2S DJ6R"/P\$+C')Q
M@?QQVF,]L,KRJRM),Z0U(?C%\$F%(+B2QJE>T9'-8)SFHC.1,16HBN:O/"]>
MV?Z,]DBIJ&Y593]Z8VARP4902IM&",X!4$#P=H'V,AJJ-Z95;D!#%"A (P@3
M)X&?ICDX_,Z?;7R12(PW"(I.6?B5RJYR_P JJOY+[<>_TZ]0."&((Q]AXX_S
MSIFD5MQ#>^#[\C'U]\_4?<:L+?9Y/X0V^?[#%?\ X\4W5!?T@/\ W?L7U_;$
MG\/DI<?P_EGG4OZ._P#::S_Z"/\ [0ZMK]>4M3_1T:-'1HT=&C5<_P"U-+Q\
M)+.U7Z)N_0ZKQ[_3-&?DGNO\R<KT?36&\'[X'\3J7-W=ABM$VV$_#,UF8?@6
MT-1Z(S'/@?HQ'IJ?/=J1M< H>*FPR.'D\O'ZJ?M/!:W)K<5,CZV5<F+#@V<"
MHN)L'+ J2#C*D@X((R#@X8$J1]""01R"1K.MW[=>XO7?=-B%UL'6SK0F-8SL
M3*L(AV$F;6NC9"_'Q@;%R>M^X+JTBS,8R>EN:_(,=';N!8_(3X$NQIZNR$P,
M<!(## ]0P<JI. P;*D@E3E1ZE(;:2I.UF!-*-,%/:RUAUDITW("2V4L>;:Q)
M5-74U79R2VB?(28L!J6KZBE,C!,K3N=<V576UEK:4QW2K2 H1P2A9!VD*RO&
MC$F4KL0EBYD 9R"26&U [E$VD(5QIX ()9GDIZ>HI*AHC!)25\YJH(IHXQ-3
MK44LE)#4U\:(QGQ-3T<AJH(;AVTCJ6N[#U!CGZ4TF50$L*W,VY/.MK*MFU9G
MT^58]6M/CLP]A?W:Y&*'*905WWTX==;B/;5@03KS&N1EMJR2T=UF2EJ() KT
MCTT4(GBEC6:CG8BJC(AA^6+Q+/(T),D3I%(SQ0SE6,,NE,:BI:&G1XG-.9Y*
M:EJ$>43M4!*>2FID"R'YFH!4QF(Q3;D21)8YHH'3:QPXVO,S<^A@RLHA7U#<
M6-IDT.76V=Q!^][<<&EC6 X&("EY) R/)&7-J<\R\!"HKRYLGR6@I(GWS7H7
M,E?31B9C#)"Z0I$R-%%(:>#N2,=]4D4+P0,D4:QP@RQQQA!W9#$RJFD@>*M=
MI:6E1*RFJ*>B J&*+/4!:@6^=S5SPF-8X.^\HJ)98(E,LLDD*+*Z2' @T<)X
MHHG"BQV%>@Q"<5PXXU(04:.".-7J&(%4BP8H!.<.,(,<3'*UJ*PN[2,68Y8X
MR?<G !9B3RS'+.Q.68ECR=-P,DSJA;<SN0N]U10\KY)+N51 6.69F55'+$ $
MZ;)VZR23-I=Y\LHD 65W!:_D$"WYGQ"0_9QVL%>)OSL.OF>(W.5J?-P(4GV_
M7Q(Q?,+,'@D#D GGC^XD?P)'W.MJF)8:B>%',B132Q+(>UEUC=D5SV)JF#+
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MD;,6,L92 .CI!90F>("N9YHU>$Z]1&6NEI8IZ-OEQF>*-A-5(<*2IA1S)O\
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M&0NWH106?/! &23SG'@X]^,#.G&AJ32R)5)@/"V\[@<!0.=W(.TJ2#R,C('
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M&9AGQ_ S'N8I*BW]M8 CHTCO".XC&%I%4N,2"(#*X.&V;1C;N!U537JQH\-
MI>FFJ:J2AIS405"4<U7&I?M1U?RW:)3G#@% R.H?,;J-5,.YRZ<2O0;K"TO;
M*'#HJ<(7CEK*D&<&/&1A6!YD.1[1/X<5'$?^L*BM14U,M';E^8+B*&D@FEJZ
M@G,8B159G)4L G&X9VX4<##'5E].],WWJ"JL]FL5!+6U]TK:6VV^)9H!+<KA
M4N(:>&E!ERS23, 'PJC ).,:4NGA;9['=J:YV[+JL;D6*_?38%4:T;/#+B%K
M_NRZB31UY02 .6';> Y(G$".0]CF*9XE8YI2X=/_ !+M%XL4,U8(D$'>F[!A
M*,93+3O$T@8-B2 L5(W%0=RA6P;/^/7]&[KGX:V*S4_7C6NA_P!)GE_9ZVJZ
M07&IBGM)I9YQ41F,*$1JB&.0QEXV[A2.<-ZU<%W-=[U5W=TU3AOW%:Z[Q"IO
MZZRN)+;>-;V4T*"$*8(<=8U9&3TD=*?$:0Q6%*R.Z0HT56#:ND>@7Z%>:I$T
M=SK:F%HT;LM#&I5G,>0&F;^LN\@J?Q!<:\DVCHRX=-W)KQ+-37&L%#4T]#1]
MN1(*>639^^,Y#R?O#$@D"PJ51V4&3:&,>%U50<6,"S@M">!*(8U4R1/@RY)X
M@I3PL^?BQ#O(!ZH-WDTX(RE3]=&:X+F/6R8)I*U6BE)211ME9(W4*Q7PC.N#
M@X\%\8PQW<:L6DGEN >FD+)-&$2H*12QQK*T:L>S+*BJZC<"#&SA3Z7(<,NI
M&L+QGL>;VD9KFN2Y7'/NH\3*$IJQ\Q]9DL*V!*/'Q:#'Q@$N9$6OM!L@3K<Q
M#SP1@S)PA6 5BM>VKJ^J^(9ZVMUNHZ'_ /-U32M/4%1+ \3+NJG:I8(XE@.^
M.!5CC9RB.T;"3"P"JDZM/4E/1I'5+21U%*NV*)I;=)!LC:JEDK9*=-Y0M.B,
M>T[-%&HB+$;XEOO(\&[AVU-*) G5\R/-@R8;O0-$F12M/&DQWC5JH816,(-_
M*JCD;POMQU<CP1U%.]-.BS0S1/#,C^M7C=2KHX(QM93M(^GT.KWL-QN%AJZ.
M\4-144ESM53!7V^JB=HYJ>LIY%EIJB-_Q))%(JR(5(PRY)YYVS(LISFDN+Z;
M>6:6]KFU5&2QN9R!LYA(9)$:4-(TTK5=$D 6(.(=@/'TA(\"-:Q4Z;(+7:JF
M"CAIH3!36R=V@IXBT47="LIWQCB127,BEN2W).<@R^@^+?5U=4]4WJHN372[
M=3T_[-O%RND*U-Q2.&IIYT-'-,&:D!["11]D*AISVPH 7"?GLEE$1YRD,4KT
M]0QB.(1WT_$1[U5SE1J<(BJO#41.?9$Z>HXA$@1$"(@P%50JCR3@   9R3CZ
MYU!JR>KKZJ>LJY99ZB=R\DLKO-([8"@-)(6=@JJ%!9C@  84 :_3D:]Z?+(K
MG>/XU15X_)&_L7Z(O*?S)QQPO6P^YX]L<G'G\L9/V_4YTC52,B3*G. ,8Y]\
M\8\_^OT]Z,8YH/2(KR.1BO3Q5?UG[WQ]DY3V5$7CZ+_,J]:\^K<!CG&/)'WU
MH&9=^X #)QXSCZ@Y]_/W!\^,[!"LDFJ.M5K6O<Y@VE7V8BH[W<YWU1/KS^2)
MRJ_3I#41F(-.,D*&8KR6/'  'D_X8!YUVI*-)92=Y5W(7UL!&H9AEF/T'IR<
M_4@>^M[V'A$"EIVW6-DM9T2O-&@7,TT9K(/S4EC_ $C0B,(XCHY#1Y+?*2(#
MW<#<QCD<[Q8;%>:FJJ327%:>*6HCEJ*.%&)E6.-@6CG4C D$;HP",X WABI
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M!JCXE7GV8X%>QU<T%_54,MIXX.FQ,<RC/T"LP'YMQX]\ CZ$ZY;Y#RL1*_\
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MO\D8]JHJHJIQQY)SXNX5?=$Y3Z?SN! V\ L1Y&./[,X^_M]CIPG@,42LRA^
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MMM'0!$2U6Z9MU?V:FJ^9EJ*JY\B7YA1'"(P(A@[=();2ZY2JRD'(,V5(8^(
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M/ !3#2"S(,2UC'48U@R3$C20*5[6H=LH;P1VJ-R\$5\H'BBJB>3T<U$M??3
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M%Y;^-GIH[][Y=--<6-3%'N]#QG<@'(*L65\\X&5V<C!W$<G&G^VQK';JVN$
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M8Y?!_HL,<K!D<@U)R_W>UC'\:BE(I3!3/+3AY0SO3\2XVL2<\D!F5%8@$@'
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M,2/M:0[<%$C+=UR!G .67DZ@OQ(N5QM'3\<EEJ$H9:BO@I))4@27L03E]TJ
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MXT=9\>-&CHT:LK_9GOX1/<=_86I?\>:SJD_C?_J6S?[TD_[I+JP_AU_K&O\
M^I+_ -O'I'?M''\/7#_[6K7W^/FUNG'X,?\ NE4_[[K/^Z6_27X@_P"O(?\
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M[I4RK-'31S%9)TWC8P,A52%8C<#@ D#)YR0//G4<GMX5U?F)1U(JN Q&A%'
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MN(]!L:XY2/-(<\[R/<OL%%1PPS,M)&DD\G>FD:%!)+(5"[Y&V;V8*H4%B<*
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M8V9H42*2&*.-9W2:I%040P EXFY_B/Y(/,*]-9TE3,J:4<05W<9%#><^7@A
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M5ZP"YQ6"EJ&I)&91!4PT]B5*67#!?FZD,OJ!%4'(A5=:>1"JAV'IR?1>]]@
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MSX+8ECX*&M:Z*A2MA:Z6F&\&B:1ZVU1U51'2S+LPL<ERCE:>1>Z&684:Q*T
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M.2/.?;G$6&T]*P-^TV0,S7 895UCGM)D-V.TIP$?9BRO6JU55<63'M<^8.-
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M2&WXL2*$LF5*DZUS,$>-' QQ3'.<M*T00A&UQ"E(YK!L:Y[W(U%5#_2+I_\
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M:1&*$JP# ;258 Y!PGZYHZRJO,4E-25-1&*"%2\$$LJ!A-4DJ61& 8 @D9R
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M$K-WX3M#.B@M@$X!S@$^VK?F+9OA^;QY4O#\FH\FC03,CS#TEE%LA13D9ZC
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MW^O_ -]G7XGV=_X."/:].S&I1S>/%?Z,_<;[<+RGM_1@XXY_)4X7Z+[=':C
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=@$_UF(!9LY))R><9.-/8ZY:[:.C1HZ-&CHT:_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>g60414g23y13.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g60414g23y13.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2+@4&AO=&]S:&]P(#,N,  X0DE-! 0
M    (L2^B0 X0DE-! 0      &$< 5H  QLE1QP"   "   < E  "')R-3 P
M-#DS' (% $!-:6-R;W-O9G0@5V]R9" M(%!R;VIE8W0@2&]O:V4@+2!3+3$@
M4F5G:7-T<F%T:6]N(%-T871E;65N=" Q,3@T #A"24T$)0      $'_/CME6
MLS_]O'1SP$HW+M,X0DE-!#H      .4    0     0      "W!R:6YT3W5T
M<'5T    !0    !0<W138F]O; $     26YT965N=6T     26YT90    !#
M;')M    #W!R:6YT4VEX=&5E;D)I=&)O;VP     "W!R:6YT97).86UE5$58
M5     $       ]P<FEN=%!R;V]F4V5T=7!/8FIC    # !0 '( ;P!O &8
M( !3 &4 = !U '        IP<F]O9E-E='5P     0    !";'1N96YU;0
M  QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"24T$.P     "+0   !
M   !       2<')I;G1/=71P=71/<'1I;VYS    %P    !#<'1N8F]O;
M    0VQB<F)O;VP      %)G<TUB;V]L      !#<FY#8F]O;       0VYT
M0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O;       16UL1&)O;VP
M     $EN=')B;V]L      !"8VMG3V)J8P    $       !21T)#     P
M  !29" @9&]U8D!OX            $=R;B!D;W5B0&_@            0FP@
M(&1O=6) ;^            !"<F1456YT1B-2;'0               !";&0@
M56YT1B-2;'0               !2<VQT56YT1B-0>&Q ;VNV0         IV
M96-T;W)$871A8F]O; $     4&=0<V5N=6T     4&=0<P    !09U!#
M $QE9G15;G1&(U)L=                %1O<"!5;G1&(U)L=
M     %-C;"!5;G1&(U!R8T!9            $&-R;W!7:&5N4')I;G1I;F=B
M;V]L      YC<F]P4F5C=$)O='1O;6QO;F<         #&-R;W!296-T3&5F
M=&QO;F<         #6-R;W!296-T4FEG:'1L;VYG          MC<F]P4F5C
M=%1O<&QO;F<      #A"24T#[0      $ .__C4  @ ! [_^-0 "  $X0DE-
M!"8       X             /X   #A"24T$#0      !    '@X0DE-!!D
M      0    >.$))30/S       )           ! #A"24TG$       "@ !
M          $X0DE- _4      $@ +V9F  $ ;&9F  8       $ +V9F  $
MH9F:  8       $ ,@    $ 6@    8       $ -0    $ +0    8
M  $X0DE- _@      '   /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H     /____________________________\#Z   .$))300(
M   0     0   D    )      #A"24T$'@      !      X0DE-!!H
M S4    &              8R   &,0         !
M      $             !C$   8R                      $
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M     0      "6AO<GI!;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N
M!V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX
M   '9&5F875L=     MB9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO
M<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG          IL969T3W5T
M<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/
M=71S971L;VYG       X0DE-!"@       P    "/_         X0DE-!!$
M      $! #A"24T$%       !     4X0DE-! P     &$,    !    H
M *    '@  $L    &"< &  !_]C_[0 ,061O8F5?0TT  O_N  Y!9&]B90!D
M@     '_VP"$  P(" @)" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,
M$0P,# P,# P,# P,# P,# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4
M% X.#@X4$0P,# P,$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,
M# P,#/_  !$( *  H ,!(@ "$0$#$0'_W0 $  K_Q $_   !!0$! 0$! 0
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M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                     /_A0"5H
M='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O #P_>'!A8VME="!B96=I;CTB
M[[N_(B!I9#TB5S5-,$UP0V5H:4AZ<F53>DY48WIK8SED(C\^"CQX.GAM<&UE
M=&$@>&UL;G,Z>#TB861O8F4Z;G,Z;65T82\B('@Z>&UP=&L](D%D;V)E(%A-
M4"!#;W)E(#4N,RUC,#$Q(#8V+C$T-38V,2P@,C Q,B\P,B\P-BTQ-#HU-CHR
M-R @(" @(" @(CX*(" @/')D9CI21$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W
M+G<S+F]R9R\Q.3DY+S R+S(R+7)D9BUS>6YT87@M;G,C(CX*(" @(" @/')D
M9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z
M>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O(CX*(" @(" @(" @
M/'AM<#I#<F5A=&5$871E/C(P,C M,3$M,#=4,38Z,S(Z-3 K,#4Z,S \+WAM
M<#I#<F5A=&5$871E/@H@(" @(" @(" \>&UP.D-R96%T;W)4;V]L/E!38W)I
M<'0U+F1L;"!697)S:6]N(#4N,BXR/"]X;7 Z0W)E871O<E1O;VP^"B @(" @
M(" @(#QX;7 Z36]D:69Y1&%T93XR,#(P+3$Q+3 W5#$X.C Q.C Y*S U.C,P
M/"]X;7 Z36]D:69Y1&%T93X*(" @(" @(" @/'AM<#I-971A9&%T841A=&4^
M,C R,"TQ,2TP-U0Q.#HP,3HP.2LP-3HS,#PO>&UP.DUE=&%D871A1&%T93X*
M(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(" @(#QR9&8Z1&5S8W)I<'1I
M;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @('AM;&YS.G!D9CTB:'1T<#HO
M+VYS+F%D;V)E+F-O;2]P9&8O,2XS+R(^"B @(" @(" @(#QP9&8Z4')O9'5C
M97(^06-R;V)A="!$:7-T:6QL97(@,3 N,2XQ-B H5VEN9&]W<RD\+W!D9CI0
M<F]D=6-E<CX*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(" @(#QR9&8Z
M1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @('AM;&YS.F1C
M/2)H='1P.B\O<'5R;"YO<F<O9&,O96QE;65N=',O,2XQ+R(^"B @(" @(" @
M(#QD8SIC<F5A=&]R/@H@(" @(" @(" @(" \<F1F.E-E<3X*(" @(" @(" @
M(" @(" @/')D9CIL:3YR<C4P,#0Y,SPO<F1F.FQI/@H@(" @(" @(" @(" \
M+W)D9CI397$^"B @(" @(" @(#PO9&,Z8W)E871O<CX*(" @(" @(" @/&1C
M.G1I=&QE/@H@(" @(" @(" @(" \<F1F.D%L=#X*(" @(" @(" @(" @(" @
M/')D9CIL:2!X;6PZ;&%N9STB>"UD969A=6QT(CY-:6-R;W-O9G0@5V]R9" M
M(%!R;VIE8W0@2&]O:V4@+2!3+3$@4F5G:7-T<F%T:6]N(%-T871E;65N=" Q
M,3@T-3DV.# @,C$\+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z06QT/@H@
M(" @(" @(" \+V1C.G1I=&QE/@H@(" @(" @(" \9&,Z9F]R;6%T/FEM86=E
M+V5P<V8\+V1C.F9O<FUA=#X*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @
M(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @
M('AM;&YS.GAM<$U-/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O;6TO
M(@H@(" @(" @(" @("!X;6QN<SIS=$5V=#TB:'1T<#HO+VYS+F%D;V)E+F-O
M;2]X87 O,2XP+W-4>7!E+U)E<V]U<F-E179E;G0C(@H@(" @(" @(" @("!X
M;6QN<SIS=%)E9CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E
M+U)E<V]U<F-E4F5F(R(^"B @(" @(" @(#QX;7!-33I);G-T86YC94E$/GAM
M<"YI:60Z-C)!03 S,$)&-#(P14(Q,4$Q13-%03!!-$5%0C%&.3(\+WAM<$U-
M.DEN<W1A;F-E240^"B @(" @(" @(#QX;7!-33I$;V-U;65N=$E$/GAM<"YD
M:60Z-49!03 S,$)&-#(P14(Q,4$Q13-%03!!-$5%0C%&.3(\+WAM<$U-.D1O
M8W5M96YT240^"B @(" @(" @(#QX;7!-33I/<FEG:6YA;$1O8W5M96YT240^
M>&UP+F1I9#HU1D%!,#,P0D8T,C!%0C$Q03%%,T5!,$$T145",48Y,CPO>&UP
M34TZ3W)I9VEN86Q$;V-U;65N=$E$/@H@(" @(" @(" \>&UP34TZ2&ES=&]R
M>3X*(" @(" @(" @(" @/')D9CI397$^"B @(" @(" @(" @(" @(#QR9&8Z
M;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @
M(" \<W1%=G0Z86-T:6]N/G-A=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @
M(" @(" @(" @(#QS=$5V=#II;G-T86YC94E$/GAM<"YI:60Z-49!03 S,$)&
M-#(P14(Q,4$Q13-%03!!-$5%0C%&.3(\+W-T179T.FEN<W1A;F-E240^"B @
M(" @(" @(" @(" @(" @(#QS=$5V=#IW:&5N/C(P,C M,3$M,#=4,3<Z-3,Z
M,CDK,#4Z,S \+W-T179T.G=H96X^"B @(" @(" @(" @(" @(" @(#QS=$5V
M=#IS;V9T=V%R94%G96YT/D%D;V)E(%!H;W1O<VAO<"!#4S8@*%=I;F1O=W,I
M/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@(" @(" @(" @(" @(" @(" \<W1%
M=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N9V5D/@H@(" @(" @(" @(" @(" \
M+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E
M/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^
M<V%V960\+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T179T
M.FEN<W1A;F-E240^>&UP+FEI9#HV,4%!,#,P0D8T,C!%0C$Q03%%,T5!,$$T
M145",48Y,CPO<W1%=G0Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @(" @(" @
M/'-T179T.G=H96X^,C R,"TQ,2TP-U0Q.#HP,3HP.2LP-3HS,#PO<W1%=G0Z
M=VAE;CX*(" @(" @(" @(" @(" @(" @/'-T179T.G-O9G1W87)E06=E;G0^
M061O8F4@4&AO=&]S:&]P($-3-B H5VEN9&]W<RD\+W-T179T.G-O9G1W87)E
M06=E;G0^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IC:&%N9V5D/B\\+W-T
M179T.F-H86YG960^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @
M(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @
M(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYC;VYV97)T960\+W-T179T
M.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T179T.G!A<F%M971E<G,^
M9G)O;2!A<'!L:6-A=&EO;B]V;F0N861O8F4N<&AO=&]S:&]P('1O(&EM86=E
M+V5P<V8\+W-T179T.G!A<F%M971E<G,^"B @(" @(" @(" @(" @(#PO<F1F
M.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E
M<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYD97)I
M=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IP
M87)A;65T97)S/F-O;G9E<G1E9"!F<F]M(&%P<&QI8V%T:6]N+W9N9"YA9&]B
M92YP:&]T;W-H;W @=&\@:6UA9V4O97!S9CPO<W1%=G0Z<&%R86UE=&5R<SX*
M(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z
M;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @
M(" \<W1%=G0Z86-T:6]N/G-A=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @
M(" @(" @(" @(#QS=$5V=#II;G-T86YC94E$/GAM<"YI:60Z-C)!03 S,$)&
M-#(P14(Q,4$Q13-%03!!-$5%0C%&.3(\+W-T179T.FEN<W1A;F-E240^"B @
M(" @(" @(" @(" @(" @(#QS=$5V=#IW:&5N/C(P,C M,3$M,#=4,3@Z,#$Z
M,#DK,#4Z,S \+W-T179T.G=H96X^"B @(" @(" @(" @(" @(" @(#QS=$5V
M=#IS;V9T=V%R94%G96YT/D%D;V)E(%!H;W1O<VAO<"!#4S8@*%=I;F1O=W,I
M/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@(" @(" @(" @(" @(" @(" \<W1%
M=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N9V5D/@H@(" @(" @(" @(" @(" \
M+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z4V5Q/@H@(" @(" @(" \+WAM
M<$U-.DAI<W1O<GD^"B @(" @(" @(#QX;7!-33I$97)I=F5D1G)O;2!R9&8Z
M<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(#QS=%)E9CII;G-T
M86YC94E$/GAM<"YI:60Z-C%!03 S,$)&-#(P14(Q,4$Q13-%03!!-$5%0C%&
M.3(\+W-T4F5F.FEN<W1A;F-E240^"B @(" @(" @(" @(#QS=%)E9CID;V-U
M;65N=$E$/GAM<"YD:60Z-49!03 S,$)&-#(P14(Q,4$Q13-%03!!-$5%0C%&
M.3(\+W-T4F5F.F1O8W5M96YT240^"B @(" @(" @(" @(#QS=%)E9CIO<FEG
M:6YA;$1O8W5M96YT240^>&UP+F1I9#HU1D%!,#,P0D8T,C!%0C$Q03%%,T5!
M,$$T145",48Y,CPO<W12968Z;W)I9VEN86Q$;V-U;65N=$E$/@H@(" @(" @
M(" \+WAM<$U-.D1E<FEV961&<F]M/@H@(" @(" \+W)D9CI$97-C<FEP=&EO
M;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @
M(" @(" @>&UL;G,Z<&AO=&]S:&]P/2)H='1P.B\O;G,N861O8F4N8V]M+W!H
M;W1O<VAO<"\Q+C O(CX*(" @(" @(" @/'!H;W1O<VAO<#I#;VQO<DUO9&4^
M-#PO<&AO=&]S:&]P.D-O;&]R36]D93X*(" @(" @/"]R9&8Z1&5S8W)I<'1I
M;VX^"B @(#PO<F1F.E)$1CX*/"]X.GAM<&UE=&$^"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"CP_>'!A8VME="!E;F0](G<B/S[_VP!#  $!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0'_VP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1
M" )> ET# 1$  A$! Q$!_\0 'P !  (" @,! 0            @)!@<$!0$#
M"@(+_\0 =A   00" @ #! $'$1 .! <1! (#!08!!P ($1(3"105(3$6&#E!
M459X%QDB(S<X87%W@9&6F+>XUO *)#525%A9E)6AL;;1T]?8)2<H,C9(5W22
MM+7!U>$I-$*7,T5':(:(IJ?%QO$F0U5E<H=$1F9G=H2%_\0 ' $!  (# 0$!
M              $# @0%!@<(_\0 2Q$  @(! P$%! <%!P,"! 4% 0(  Q$$
M$B$Q!1-!4? B87&!!A0RD:&QP2,S<M'A!Q5"4E.2\21SLF*"-$.3TA8E-39U
MHD1CPH/_V@ , P$  A$#$0 _ /OXXB.(CB(XB.(CB(XB.(CB(XB.(CB(XB.(
MD0.]'9POJ7UTM.U("OCW#8!LO6-?:HIQ:W&P[1M'8,V)6:;%R"VB0WDQ+4@;
MF4F?=RF"E1$<<@1U!2F<\LIK[QPIR  68C&0J@EL9ZD =)3?::JRP&6.%0'H
M78@*#R,9)Z]!U,BGJVT>UTUUNO4,7V%J/73>>F-H$&@;!E=#!S51L.@#DAH(
M%E37[U/ "VNJL$O)%?2&-*SYS0YF0FF2V@F):UQIBK[&=&4#:'!(<]#]D$#S
M&=OO/A*D.K#H+!6R-]HIQL^\Y)^'QZ=(S:X[.>U:[+;1[MB==;#T^CZEU;[-
M[6TK7:AM2D;$;G[9'TNP2[,$R_8:U870T%F1 @HA![K4<V[)J6\IL(7.5HL[
MO3(E)L[PO;7NRI]E3G X/7X#G/CCI6MNIL>[9W86JPK@@YP!G&<X)]^<>X<3
MS9O:S[>OW4SJ3MG4]7U7I^X;_P!R3FD-N[$WAF>.TEU[L]-P0+.%3AD9)PSZ
M6+0>RV[3%SDN*P@;+H4BL@O'O+<#3*MEBMO8)6+%"8W,#\?=R<>6,R3JG:I&
M4(K.QK+,?91@.O/4>'7D]!)W>S3[5;4[7Z=V+8MN1M"(L.LMY[#TZ!LC4C4P
MWJ3<D+2'8YD38^NUSITB<3 RKYA0B2FC28\AP'UQ76END1X%5]:UL NX!D5M
MK AER.AR/CCKQSGF7:>UK%8L%!5F7*GV6P3R,\C/7!Z9QX2">X.\?<61[X]G
M^L^KM]=)]!T/1<3JR5@Y/LV!*Q\A9\WREQ,W(!Q<J/;XMB3)C)$@ITA#83/N
MH10#:_47G+J[DIJ^KI:]=KERPS5R,KUSG..>/F)0UUYOLK2RE50 XLSGGGP(
M., X/F.??97JWLS'U<OK5HO?VS]?W3LGV"J5QME3E],P-C>U/?8FI#F6,V:J
MTP[B4!CHINIKCWQW)28PF6(2Z[&*(;>:QG69"=[(K!%.#N(R,],].?/ /XB;
M*V ;%=D+L,C8#M;D D9)\3SD\YX\9Q)3VBO5"&J&W;O(; D$0^E-U$==;B(/
M3+>;8#=TLD-BLZ_IM<#AGYF[S9Y#F$ )K 4D,4AL@A)&!127VI%-A*@+DNN]
M1D?9_P QYP!\<2>^KPQW<*VTG!^UY 8R3\!.YU;WWZP;7I&V;W&WTNFQVAFT
MO;IA]JU:S:NMFL1W@')0(NVU:Z1<3,@AR8#3C\46T*2/)*;<&#<>,0L=,&IP
MRK@$L2 %96Y'4<'CYX@75D.<D;,;@P*D<GJ& /A\_NSC?7?VD?4CM!>E:TU?
M?Y=J\%0#ENK-?O=&N>N3+Y3F\N>:VT'-TA(9NVP>$,OOY?B5ODI$8(-4*D08
MA]O)Z+$7>P!4=2K*VTG. =I.#Q,:]178VU20<9&Y2N<'!(# '&9JZ0]L/T'C
M96;CG=L3CX,3<FM? VP#6FQ#J+;;AF4%AS(*CW4:M.5JW&Q1AHSLDB&DB,-Q
M:US8^285A^0;GZM=_E&<;L;ESC .<9\CGSQG'(,Q;5TJ3RQ ;:2$;&[)& 2
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ME116'2D G,<JHTQML96RH4E23D98#@ X(S\Y;J=5W=6:\,[IO4=<)D98C'0
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M-:]C2I2\L_!*I2(B+)M9\T&2E0<O'.1([\&:G(4S@$K*&50M-CN45?:7KD@
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MNS$L.Q:(1%N5&UFX_B8.-JPQ'SJVAI8]Q]\,0D0E]',_K"666$L:]R"M'Y)
M'F 1@'J>?'Y3$Z=T2K*BW:[.Z'H=QR>2,@C/&<C (Q+%/95Z"W-I.I]B9G9F
MNF]"TS<&^9_8NE^M3%BB[(SI6C2 S:,QOK0)!=>AGYXO*#"*Y!$?#8M0:5M#
M!N%."LT:FQ7*;6+E4"LY&-Q'0_=X>'3)FQIJW06;AMW.65<D[02<C[_'R]QF
MG*Q[.Z!VO[2OO'N?M#UMI>P],WNM:+8TG9;\#5+3'FS%?I ,+=<P\4H\V9B'
MF" 6 S'9*,CD%X':R*LEI"7,YF\KIZJZ[&5@7+A>![1Z9ZGI[LY/'E6NF#ZF
MZRVI61U55+#)XSG((XX/KB=[W#T!N#5O:?V?/8?K#UU=VQJ_J]5MKZKF=0:X
MG*=3)BM5NZTL>I5%=;&MDK!P:8.&9RIE;#1:4@L LM.I8'?]Y9QJ=62U+'VE
MR&#$9Y&<\9&2> .?&975LME#UJ"$!7;G Y(P,C. ,'_#@8\>@A#$='^TLYUL
M[H1VX.GXMSMVWO:"&=D8?7,%O*%J-QB*E+!AF$7;2^Q(HAR&>O=6)+/AHD.W
M*K@,HSF4(<'>;R" ?<;J^\IVV;52DULVS.3@@;E/X8/&1GQFN:;&JN#4Y9K@
MX 8AL<996R,,,<$ ^'GE>55^B7?#=75+O9H6Q6/=U?U=LF%UF[U?JO;G8E(N
M>Y?JJI,W&VBSC6^S4$N? AJG8'886MQ3!TH]Z;6 3G0!VQC"#7?TH]3@+N4M
MO* A2&''LGQ4^1Y]TD47-7<A+%6 ->\Y;()X<C&<D\C'&#D\S><-I+MMW [/
M=0-@[<ZS$].J%TXUOL:%LL^9>J59)F^6V[49JC_4[K<.ER$@X/18C(K4L*?,
M+%86"Z:(CQ)2R@FLV)778%86&U@<$8"@'.>2>?7E+ EEEE3,G=BI2I;=DMQC
MJ , CD>1Y\1*>]@V#9M2]G3HGJ3FDZ@MVO=2]UJ>% =CM=[PUK?(;:A<EL"U
M34(#2Z)6)"0NL=;76K<^NR+LP<0N(@@_=WV%F3*!Q=E-K7-:&89I/LLI& %
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MW7%CM$9:>:$6/S>W4IJ:[;$U>J[/1[*]/WCFIK*T#,B!BMU:;7=7LJ52 &8
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ME%E)5 RAAXL,IK,;&R1( #&4N)=(=V--:>SSJG347JM#;-=K*+&35:W4._\
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MDRL,Z:W +6BR!<,D+AW"H]]"E^J*P8TDA]/KK&?QC#*TI2TAM#:$I]%K._\
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M&WDYZ,6]HD'KGD^/C+/A.9R(D:+I%A0?8K45A@1U_5!:HFY5VT@B/E",2%6
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M">:;Z@AWNQJ77,$/AL^LWYMCM0)4VGT]#WG3MIZ]23:+T6^^S>K:Q*[@,"]
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M8&?,^(YXSSG(XXZ2R?I9I[)49K&H!DYJ,M3IX"^6 F >"))(BJN4%)1^4N2
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M=00(2\*^^PO(+9V96>S>V*[-3V-JF-FEUE7MK4S*0FMT+%@A+*,6T,1N0%2
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MU'G$@,A"^B^A93BL,XO-FJ.B.KU&KN!UFL:^D)M;O-504%U][ JU;+7<.Z9
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M:J;FHL6U!6S+N %J+8N65EW;'!4LN=R$CV6 ;G&)/WCX<&76P,!#U>%C:_!
ML1L-"AL 18#&%Y9"#%;PVPPUZBUK\C2,82G*EY5X?2K/,+K'NL>ZUM]EC,]C
MMU9F.23@J.3R<\9B:KG+M0JT+/[:BX]N94W*1E%N<^"0V*N+ @+ 5%F.R&9%
MYAMT.JG24B^2P"RZ:1ZCR!6R5J;3SH5:;5WM5V<]G=82S5::EUR'LMJ5PJ%.
MC:A4K"[V"+M!.WK(Z'.,DG!Q[NN?+&.?AS[MEV*8/B(\8R+KYEE?(DHD-P$
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ML]2U=; W6V[72VE!M%^J8.P"55U!JZ@X#VVV;PJ[4,L6L#D@YS@9R,CP(SC
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MT(><3C/@O/C;7;95WG=NR=[6U5FTD;ZV^TC8ZJ<<B00#C(S@Y'Q\YW7*L =
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M#"2QLH)6I0K[*G$MN94VGY5=6M5C5K;5>%"GO:69JVW*&PI958E22K9  92
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MX]GY^@ P^V(SYE>DRCS*\>9KNU^TNTCG6ZNV_DMM)"H6.<N40*C.<\NREB,
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MU.&4GH&!_&8MG:V.NTX^./E^<U=TNK-AI?4+J_4+;#2%=M-7T#J2OV. EAG
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MYPI!YP/.:.JK8LKY7;M9,.Y55)Z/U ;RQUYZXFJ/9/=>;#$[O9W#6:SUWI=
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M:QME+<FYS+]?C8L*+UM/ "6N&&Q(+09*B% -EY9;+);:\KK?B]?K'3C]<_\
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MTO-Y/EQ)FZ^(CB(XB.(CB(XB.(CB(XB4L>T<^R$^Q8QX_P#&2WSG]'\[_/\
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M$T23G+KR%*XC'Q]>O1YFPJ1UQT;KC6=CTW2M9UB"U?;Y"XREGI+(:B8.=/V
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MRNLM[<T$XP\FJ1XTG+^\/IOWD'RV*4TIG"_'#J_,C&<9Q\TC(]?KY3"<=_\
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ME'DPG&,8QX8\.(G6EUFOG30-C-AX\J<C8F6@0)1\9ITP2&G7XPF9C&'5IRI
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M]_K0\CNZ_P#67_:W\OQCO+/]%O\ <L?7F[,_L>?>+^YW5[_6AY/=U_ZR\_\
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ML6P4/:&RA)_796!&A-9R]HF@=DCX+%ABHBP0(XT^)=<BFI+=R!B2"%! ;'B
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MP.G];>UY[IS^B^N';&WZ3Z]!Z"VOV*A^O%ICH.?ON=F.2$S9Y:%5;ZX*:X]
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M.!X$=?CF>5IZ_P!1F.L\[U<KKQ52H<AI,W1,&^+YI0VM5)VD+H<8X/[^]YI
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M;:,X7G/ESX\YNMT=NAU>IT=K5V6::UJK;*'[ZG<N 2MH !7=[.?%N![K58,
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M<A94P? QYY9 N4.#^0(5T-"&UI3XGLP=Y]%+=2CZ VU4,BBA7^K7:;ZZU-E
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MMNE1""?3Y#(V"A;-(L5@,MM6?6\WU.9BGQWWTI68$^,8GS-OMK5V>WL/K_K
M _ZO3:35,R\H]MNGK:YE.2/WP<, <*X9>"")A7]G'(P6&#U')P#\B)BF(=R
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MW9M/0^D/U#4:_0)4JZ30Z;LY-*NI"W'ZY;H5:N\ BS4D&R]&IJO%=59#+84
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MVJBG0/J-58-19J-1J++VU%%S"A=*UCHEI1E4$;F&#'9EBQ#,1C>I.<'&  >
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MJ<H.U7H>_24:G36:BA=(];_6=7JA4=])%9+4NRMGAMH7VIG;E@.2$S[3 CX
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M6:Z2@B28!(\7GV6E9TEU-[6ZMP%ONU.\V7&L-8&[T7-J*B,-4Q9 =ZA2$+#
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MSY\M)RFKNZ--V=HM=IM=:G:5FLU26:9 :SIZ*JZNXU*6  DW-9=6<'C8? F
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MGGC'.#C'N\R?+$[O3DI04W*=#3;:W;]BVV/;N(SU<R1-AQNKX\DB H++-@6
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M5]"^A6K-&FUBM[2#6::RM> RWUTZB^EJ\GJ;JJBZ#]X$P1-74+DJ>![)!)Z
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M D%0QW;01C,F:IM\K 0SU1JFWLCVI>P]JXC=?,1-,F%@19T6.?<:LS//B$S
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M/*MLI<*,(?*(7A&%/D///.94XM:L^">Q['S8S.^%!+L6;"*%4$G.0JJJC)P
M !T$NG8?CWE8S]'L]_:6?N8)7_QGD?K SXX^_/Z1^/>5C'T^SW]I9^Y@E?\
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M=!QQ%>I'IK6C*I.UXSY%93G/A39;.,9\,_/P^GP^>?N?/GK?HD,W:WC/[*@
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M'$1Q$<1/FA]M9^:<WC/^]5J&.QG.?#P_X2'_ "S^S]'T9Y^B?['R/[M8>/\
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M!85U]NAO]BW9W=E]EP>MQM;O*2NF2QJO9S:W>E@5"R=*N>[SCV>/C@ CK\?
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MGUJ<DU0(29&6PTMN?6RUD,):2%X(<9\Z,^#7J*QY>(GBW=UH&B5N7MULZ_\
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MW[#=R-YU23CVA.W=RUK>Y2F1=;8A1*Q9*532:W8I9V08.?Q/R5YEC"K-*&N
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M).?1Y).W3U$/4FZML@U[F;!(."0<'P'/7D8&84$ZB[-=KA;$P5L*JN0#RH8
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MPH\AU_/GX\RU*U0NPSESN;)SDX _#''Q,\ZQT!K34%SW/?:/&'@63?ET"O\
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<Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$3_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>g60414g23y16.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g60414g23y16.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2 :4&AO=&]S:&]P(#,N,  X0DE-! 0
M    '_Z^@9 X0DE-! 0      &$< 5H  QLE1QP"   "   < E  "')R-3 P
M-#DS' (% $!-:6-R;W-O9G0@5V]R9" M(%!R;VIE8W0@2&]O:V4@+2!3+3$@
M4F5G:7-T<F%T:6]N(%-T871E;65N=" Q,3@T #A"24T$)0      $'_/CME6
MLS_]O'1SP$HW+M,X0DE-!#H      .4    0     0      "W!R:6YT3W5T
M<'5T    !0    !0<W138F]O; $     26YT965N=6T     26YT90    !#
M;')M    #W!R:6YT4VEX=&5E;D)I=&)O;VP     "W!R:6YT97).86UE5$58
M5     $       ]P<FEN=%!R;V]F4V5T=7!/8FIC    # !0 '( ;P!O &8
M( !3 &4 = !U '        IP<F]O9E-E='5P     0    !";'1N96YU;0
M  QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"24T$.P     "+0   !
M   !       2<')I;G1/=71P=71/<'1I;VYS    %P    !#<'1N8F]O;
M    0VQB<F)O;VP      %)G<TUB;V]L      !#<FY#8F]O;       0VYT
M0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O;       16UL1&)O;VP
M     $EN=')B;V]L      !"8VMG3V)J8P    $       !21T)#     P
M  !29" @9&]U8D!OX            $=R;B!D;W5B0&_@            0FP@
M(&1O=6) ;^            !"<F1456YT1B-2;'0               !";&0@
M56YT1B-2;'0               !2<VQT56YT1B-0>&Q ;RFZ8         IV
M96-T;W)$871A8F]O; $     4&=0<V5N=6T     4&=0<P    !09U!#
M $QE9G15;G1&(U)L=                %1O<"!5;G1&(U)L=
M     %-C;"!5;G1&(U!R8T!9            $&-R;W!7:&5N4')I;G1I;F=B
M;V]L      YC<F]P4F5C=$)O='1O;6QO;F<         #&-R;W!296-T3&5F
M=&QO;F<         #6-R;W!296-T4FEG:'1L;VYG          MC<F]P4F5C
M=%1O<&QO;F<      #A"24T#[0      $ .__C4  @ ! [_^-0 "  $X0DE-
M!"8       X             /X   #A"24T$#0      !    '@X0DE-!!D
M      0    >.$))30/S       )           ! #A"24TG$       "@ !
M          $X0DE- _4      $@ +V9F  $ ;&9F  8       $ +V9F  $
MH9F:  8       $ ,@    $ 6@    8       $ -0    $ +0    8
M  $X0DE- _@      '   /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H     /____________________________\#Z   .$))300(
M   0     0   D    )      #A"24T$'@      !      X0DE-!!H
M S4    &              3;   &)          !
M      $             !B0   3;                      $
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M     0      "6AO<GI!;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N
M!V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX
M   '9&5F875L=     MB9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO
M<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG          IL969T3W5T
M<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/
M=71S971L;VYG       X0DE-!"@       P    "/_         X0DE-!!$
M      $! #A"24T$%       !     ,X0DE-! P     %7T    !    H
M '\   '@  #N(   %6$ &  !_]C_[0 ,061O8F5?0TT  O_N  Y!9&]B90!D
M@     '_VP"$  P(" @)" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,
M$0P,# P,# P,# P,# P,# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4
M% X.#@X4$0P,# P,$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,
M# P,#/_  !$( '\ H ,!(@ "$0$#$0'_W0 $  K_Q $_   !!0$! 0$! 0
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MN38,FQH?<]UCH#:_;OL+G;5Y17_-M^ _(O4O\6'_ (G;?_#5G_4U*3FX@8]
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MXN$<7
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$!_\  $0@!WP)= P$1  (1 0,1 ?_$ !\  0 !! ,! 0$
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M4O5RI%&C(&8DB'IU0I%<\*A1DL6$63&^/VQA"WF79 6')Y"H=K8,48J(:#Y
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M*RVU2C?5"V^/,UTK<HF?>^H%Q3BG;F^PEP/C&%16.:?LTJ7.HZ&DYLX:3L_
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MTC1Q*7,7:[BC5VF,\@7H'-(WF++B ;U-QR(_LZ)4I36!9>=:99,PYK@<T/\
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MWM+(8YTEF>[,/?.4PR]E<-<T94OO?EI<3>;<F69S1FN+Y#2"7.:" XN!<"6
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MU9VL#V5FH_X[LF?YRT_-?@Y_8.2/_+[K_P#4GY;RM_:N4/\ Q5YZ?;D]6=K
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MQ6IN-KWNR1\OM=,?U"A$UU6M NQ.\]:44$HB419.^1D[I[I"_#]^\?VNYG6
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M\+XLFBN1W98FKB_'SU^QZW'R%P/BZN>*F>]>I4+W*]2WWL(IDYAA@%HR1*+
MNI>+6V+[1I+LS.</!$1.N/7UJG=;&P%G9/AIM"QL]^7&8G"3)KC!)Q6;BO(O
M<E$6,PW19DQ-A*6Q9GE,(*R@V:X9=K*Q6K6F/AD--5*,Y+<I1R'S102U6O*
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M6/R?=HK21/VZ5AIK:"P1*(E$2B*6CU*[]E^M/\',%\?^5,J=/A\?PUSKQ_\
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M=K[6_P 5W5VWX+48N'\/6_=:G\=?7T9L)[G9S\&SH @?;.F:8+BZTG.,ZST
MD#;MG3-,%Q*JJ1*(E$2B+9:<C;W,G2'[7*_Z9RBN&>,SEWPD^7-]&L%U5P$Y
M)Y'^)MO2K=9-*P59<M=;R_/=2L__ 'APQY&8)7:'$]'Y@Y(U]WRI_P#)7NF[
M$[QN7,7&/'YVY3UYEPTR?>^ZT-3MV4QP6&FMH+!$HB41*(I:/4KOV7ZU./\
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M?QF#F3*=&LYR=T+AL+3R$V3R6Y"I2'@TM:G98CL"]454L6"TM&M=,&9#?",
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M2E^:DIAAK?:X)5[8J4$F5[ .SP\#. EI:T@.(((P)P,X@:#S>6\N:6%KG!E
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M_:UO<N9R\G,AK)^!7*[@UY;R;Z59*Q<*.3N6O)E\^H?ZO,M76/ 1#O"-=\C
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M5-)@  [1$D2,!&$D(*5B1 H =$:<# BNF-$('-N(AN''FWYA#<1VV ><1[X
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MR9%0!(R0-D;4JIWF*J32Y2D9XE8QHU5TB-6)3V^TQ*=:?50V3P\,(AQ =$X
MB9)T"*E4Q;V;F&T:9;) (TD:-ZZFYZ_\(-L<%XO;IT1($<U=H%(<<2-K8,<9
M"B;^Q1MLESF4_L^5)/!F^VRZ.OT:<F2QJ>'17+2Y.P6Q!*^BOW*B+%Y_9C-#
M@09Q) PVC' :5+[(89$.!#LTM<,T@@$X$ZA17O%F6FEV&6[]:99;?;UP#;<
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M??CL//L'?$>GAQJ%3$R*1&(.,U@XP-9.FE5"IB9%(C$:<3!H2!KVR*JH;[\
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M@S6A@Z!AS4)G76-C8-MAV'@&W?[W#8-OGZ $1#;:$"(,&@C7JI CKT DB(:
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M"*KJI:"=B=YZTHH)1$HBR=\C+W3S2%W_ $_OVWQ=S/IZ*P'C0Y"<(/DC=O\
M76>A97P(C\ZLBUJ+XV!K[URV5M<.KJU66<I!QY/W6M[EO.7@_N<R&LGX%<KN
M#7EO)OI5DK%PGY.Y:\F7R?\ (?VTK5U#SC_IKOD8#^"Y&=CT_2<E%*E$2B*O
M0/C#YKJE=^KXP]:G9B/'9ZUM.M"'K(M'_N8<$>#^YA&*X!X6<J.$/EK*?IEL
MNNN#?O!D;R9<?1;)76UCZO:41*(E$2B)1$HB41?FZVV\!MN +K1#8;;@ 0'Q
M@/#Q4W3.B#'G4" 1! (U&H6/3D_P"USUVV@   <H'G8 "T    (YC4   #@
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MS3#F%<.@TYMN?@'?Z>G<!X[<W/L'#HWWII$3083)FDR")@TQS131(*E%($Q
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MG[AUA1E0VWX["/2/'8.??B/1X.@1Z=M@N4B=$C$U@8S75OP)TQ M0-8Q.G&
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M!\D;]=9K*^!'*K(ORMOT7=/8K975PZNK599RD'<_=:W1_8N9RX][][F0UD_
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M'O!P'AX/&(!P"KE &.\8X[! --0WF**U84WD#$3.$""8T=)B FW#P!W_  @
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MG17#3.DD;ZA0D 3)C:#'5,&9J=FM+?JK=^8!  'B #Q 0VX\?%[_ '@"&N=
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M#YM^ _FYN:KB2W XB1I&[":'[*:K70TBE1JIS5@^I4ZX-PVWYM@X=\=O?YN
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M_:Y7_3.45PSQF<N^$GRYOHU@NI^ G)/(_P 3;>E6ZR:5@JRY:ZWE^>ZE9_\
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M3?@/C ?@W_GJ5VC1!!).S^*BUC@1(CO@9.SIUZEM.]"'K(M'W3_8PX'$!Z!
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M?@#^FNBCQ\Y%I_0]\B!_661(V>"*#5,+3O\ )3EG]\N0BGA6FC ^#I[;:#R
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M8CKM)H[?$)$YLC6O?HH:Z('PR-/"M$2>Y,)CRUW7-CM>T+##D%[DW77(5UQ
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M!_=[SC'M;?OIZNV6>P!U\_%EB;]-].XCX:Q^<_[BC[(/[O>/F,_^Q/5VRWV
M.OGXLL3?IOIW$?#6/SG_ '%#V0?W>\BL>UM^_*>KMEGL =?/Q98F_3?3N0^&
ML?G.^XH]W/[O>/F-^^GJ[99[ '7S\66)OTWT[D/AK'YS_N)[(/[O>/F-V_W]
MG5K3U=LL]@#KY^++$WZ;Z=R'PUC\YWW.CSPGL@_N]XT#P&Z?\>C2<$]7;+?8
M Z^?BRQ-^F^G<A\-8_.=]S'S;4]D'X"\;LQOWX\]=">KMEOL =?/Q98F_3A4
M#9 ?UUD=Q?\ <3NYI_-[Q7^XT1OEX'V:86.>8:O\\NVC/E1,QH5^9<;RO&&J
MZ&QO&<4E9;2UY*QE%E :; 60I,A;'=Y:6^]S&2R.\M$0]K"#;)$;UZHNY1=:
M5Z&6+!;79I+7-M+,ET21,/K,:($TC29@SY'6]IW"]OAS7,M1F-)!(!+*0"6R
M:C'2LB]NNV6B ".@'7SOT_O98F_3?S50[D/AK'G<^>?O*'I7K]D'#N%N3IAK
M2!SYXYM<&BKZNV6^P!U\_%EB;]-].Y#X:Q^<_P"XGL@_ 7C37,:,/\=.>$]7
M;+/8 Z^?BRQ-^F^G<A\-8_.?]Q/9!_=[Q_EM];Z<\)ZNV6>P!U\_%EB;]-].
MXCX:Q^<_[B>R#^[WCYC?OIZNV6>P!U\_%EB;]-].Y#X:Q^<_[B>R"/\ =[Q\
MQOWT]7;+/8 Z^?BRQ-^F^G<1\-8_.?\ <3V0?W>\?,;]]/5VRWV .OGXLL3?
MIOIW(?#6/SG_ '$-X(_W>\<UFW[_ %43U=LM]@#KY^++$WZ;Z=Q'PUC\Y_W$
M]D']WO'S&Z?\?-OHGJ[99[ '7S\66)OTWT[D/AK'YS_N)[(/[O>/\MO5GRGJ
M[99[ '7S\66)OTWT[B/AK'YS_N*'L@_N]X^8W3_C_AI3U=LL]@#KY^++$WZ;
MZ=R'PUC\YWW%'V0?W>\:?U&_?ZT]7;+?8 Z^?BRQ-^F^G<1\-8_.?]Q/9!_=
M[Q7^XW[Z>KMEOL =?/Q98F_3?3N0^&L?G.^XAO!']1>#NLQ3?WZ>KMEGL =?
M/Q98F_3?3N(^&L?G/^XGL@_N]X^8S[Z>KMEGL =?/Q98F_3?3N0^&L?G/^XG
ML@S'L>\?,;O_ &T]7;+?8 Z^?BRQ-^F^G<A\-8_.?]Q.[GX"\?,;]_M!3U=L
ML]@#KY^++$WZ;Z&R'PUB?\3ON?;N3V0:_H+Q3^XV>@/)]2>KMEGL =?/Q98F
M_3?3N(^&L?G/^XGL@_N]X^8S[Z>KMEGL =?/Q98F_3?3N(^&L?G/^XH>R#^[
MWCYC?O\ 3JTXIZNV6>P!U\_%EB;]-].Y#X:Q^<[[BC[(/P%X^8W[\>?U)ZNV
M6^P!U\_%EB;].%.XCX:Q^<_[B&\$?[O>#N8W[Z>KMEGL =?/Q98F_3?3N(^&
ML?G/^XGL@_N]X^8W[Z>KMEOL =?/Q98F_3?3N(^&L?G/^XG=S^[WCYC/OIZN
MV6^P!U\_%EB;].%.XCX:Q^<_[BA[)Q_07@QJLV_?YY_!/5VRWV .OGXLL3?I
MOIW(?#6/SG?<4?9!^ O'S&[?[^B*C'8GJ[9;[ '7S\66)OTWT[B/AK'YS_N(
M;P1_N]X^8W1_C3U=LM]@#KY^++$WZ;Z=R'PUC\YWW$]D'X"\?,;3?W_1$RGJ
M[99[ '7S\66)OTWT[D/AK'YSON)W<_N]X'^!OWT]7;+?8 Z^?BRQ-^G"G<A\
M-8_.?]Q/9!^ O&C^K;6?\>C3J3U=LM]@#KY^++$WZ;Z=Q'PUC\Y_W$]D']WO
M'S&_?_AIA/5VRSV .OGXLL3?IOIW$?#6/SG_ '%#V0?W>\_Y;3U/3U=LM]@!
MKY^++$W'_MP^>G<1\-8_.?\ <4?9'_47C&/ ;C\_GI(BJ>KMEOL =?/Q98F_
M3?3N(^&L?G/^XGL@_N]X^8W[].>/.)>KMEOL =?/Q98F_3?3N0GVVQWYSH^A
M/F3NYB>X7C33N8FG^/H3U=LL]@#KY^++$WZ;Z=R'PUC\Y_W%#V0?W>\?Y;9Q
MC#/3U=LL]@#KY^++$WZ;Z=R'PUC\YWW%'V0?@+QOS&QO\.O,GJ[9;[ '7S\6
M6)OTWT[D/AK'YS_N)[(/P%X^8W[_ &W0GJ[9;[ #7S\66)OA^WA_3X*=Q'PU
MC\Y_W$]D'X"\?,;T>'^&U/5VRWV .OGXLL3?IPIW$?#6/SG_ '$]D']WO'S&
M_?[:83U=LM]@#KY^++$WZ<*=Q'PUC\Y_W$]D']WO'^6W7'[?853U=LM]@!KZ
M^++$WZ<*=R'PUC\Y_P!Q.[GX"\?,;JG]N3S#%/5VRSV .OGXLL3?IOIW$?#6
M/SG_ '%#V01_N]X^8W[_ &YPK8]:'* 939M)VH=VAFD77+B*5MV))HLCV47N
M"8S:&>!.Y+,IO12ER<V[+KPO0(F8X+5BA4C:G!0265=<4D/O "[I[*P#K5C3
M:V)!<) <ZHU5:*QS;52M[R\65HYMA;M+6DAS@UL1K[_S++M!U:I?"H>N6GWJ
M5BV+1]6K4FCUQJA4I:4AR@\R[IO--OO,O'INN$:\YQ.\]:]C?!;-3FC;HUKM
M-04R41*(E$2B)1$HB41*(E$2B)1$HB41*(E$7EN8,,X]SO$DD'R8SGOD;0S"
M#3M,B3NKHSF62;'$M:)Q$5PJVA6B5WEMTD8FQ::BO.N1KRR+D:XA0D..)OF:
MXL,M,&".8B#YBI+2S;:-S'B6R#&UI!'G 7J0<  .]4JG7CF5LZP##+OB)DFZ
MER3+\WY1:</0*UO;3G M5-7IF?'Y"F<C"1 &U!<WQUSO,<#@N*+-L)*$!N.M
MVF:QS@X@48,X[IA2.>UA8#B]V:W?$K]3W.<!QODC"F*I.I<B9;GY]E\=QV0D
M;3E:%6YP>'.$Z?K'1<6(%-913 V*C4QQX#:I4VV)K/V=X" ,<YKG 2&1G;),
M#SJ#K1K7V;#,VA<&T,=Z)*]@ZX-M]ZE515HBIN'GXA'Y@HB\V<,NX_;<FIL-
MGOUE^35F.GS*Z6(ID:]2XG0.//K1&7%\ TE+>ALM]'7MO;4:,U66N7J+SQ1I
MCBDBLPB8-)$@4D-G1)T*4O#3!F8)  DD#M%8ZE]G'TU09&@\4GC8U25B;I>P
M-DA1,TS8'"*2QL3.J0M82BD4:=BB7-B>$]AH%KVM>46K1*+3"3[+;[+@"!$$
M@Q0Q0R.D4409 ,$ ZZ'G'5K7<=P[]045T/'60&W)3 KD+4RRYA3(Y-+(J8BF
ML8=(D\&K(?(W*,KG%,UNY)"H]A=%;8<OCCR79<B?610A=T!AJ-83?=$B-(.Z
MJE8[.$P14B"(/X[]*[WN'?YN>H*95HB\ECF:H-*<PY+P:TJ7"^?8GC&.Y=,$
MI[<<0VIV;*%TKLBAB%SN$2%YY]T,>^W$Y0!<B M.)HCVQ8 3%A# _P#5<2T:
M3(B9&C%4Q:--H^R'A,:UQ&QTP>D'L5ZU4JJ*V"1Z.L 2N(YS@SY$%JJ-ZCL@
M->4,MHK)1)DQLAFC-;"[6]S2K$[J4L8BB0Q]%0%O8ST" ST/,$Q-<*U9V>IW
M5X+"#5C<UIP@5Y])5(V-FX/!!BT(<Z#$D$&?,%<_5-54HB41*(E$2B)1%X9J
M-U#8^TN8K=LPY/LDIL4:'>+L)B6'QU=*Y(N=YE(VR*1YO:8^V@*YR5+WQX;T
M99":VXT;CM[;+A +1GLV.M'!C8DR:D-%!.)5.TM&V3<]TP"!WH+B9P  JO*,
M,ZUX=FV=H8"S82U80A<O0N*\N09:TWY'QK"R+&U,*HQ.KE4D;$S4F6*K+1+;
MTIIUIJU0-I! 77W %1?9%@DN8:Q#72=]-&U2,MVO( 9:"9JYA ITJ\G<._W_
M ).??O;>&J:KJNX=^B)1$W#X?/;Q^"B3V[=:IN'?\PX?/1%7<.^%$2B+PQ5J
M0PZFU!,NEVV8H%N;GF 2#)PPIN$%RUEAD=7Q]M/=9)>GNNL8A<E<C1 Q)7#L
M2EX)3N"E&7>G1&F5/F.S#:0<P$-G02=70J?=&]T[E,O+2Z-4:SMD?C*^WBG-
M$'S*.2+82I<5 XIRI+L-R[T0;CF[L$VA/H?Z/)D/9A'MYO*]$TH)W$K8E2(W
M]8 =8-0<TMS9_6:'#<>VY&6C'YV:?!<6&=8@TZ=^Q>L5*JB41=#QQD%LR;&0
ME+2RRY@2"]25B]#IO%W6(/W;$6D+E'%BST&>24ZWT*<%38<N8G+L?:SRS*$+
MJCNO2+";QF<TM,&#0&A!%>U5*UX<"8(@G$$8:5WO<-]MPW_GJ53*NX=\**$[
M^@JFX!PW"BBFX<V_>^7FHB;AS;^#S^;Q\.>BA._H*KN'?"BBNB90R-&<08WG
MV59F<J3Q'&T.D<ZE!Z!)>O7$Q^*M"M\>#4:$H0-6*BV]$HO(2EB!AYH6E6?L
MK@J(!<0!B3 YU*]P8USC0-!)YNW8KZ\.E;1.HA%9PP&'F,,RC;'*F0U41>E4
MF-$B;$KNVF*$U^]Z<^]&L)N-(O'KB3!N+NXVC0B"0<02.A1!! <," 1SB=&S
M4NQA< \P^'S_ )N>H**;A\WRCM\]$71,@Y!;<<M;,ZNC++GTE[F,0A1":&1A
MTE;@C7S-^11Y [.J)I)//;8PU*EQ2Z2R%3;:W,#.2J=' PM*G,O"($F) H34
MQ@I7.#1)!-8H)T].W4N][AS;\>]T\>;<.CW_ !5!3*N]%"1V[8[,5YXFRM 5
MF5';"B:0D'9.8H(S9+=XM8F6BH00F0OKS&F1\4+!3 W 6YO<>?$*9+:LN7"+
M8H.O36)Q*-,C!B8,3$Z)U2H![2XL!&< "1.@X=,%>AU!3)1$HB41*(E$2B+S
M[*^+X7FO&LXQ'D5L.>8)D:,NT0EK2G<%[2>X,+XD,0N20IS:E"1R0WGIC;[+
M52%4G5$B/7DFV7@%P3,>YC@]IAS3(,37<5*]C;1CF/$M<(<-8U+NC8W)&AM;
MVE 6)2%L1)&Y&5=?>9<4D1$%IDY8F&77&&#8259:-]]UU]XAUUUPW"(U+BI@
M($# 4"YM$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(L6?*<.K?$G7D_\
MBR16G9H1 M?V('&:2AP-M2LL6:GV(Y%B:!W?G$X;$C4TW/[ZTMRAR6FDHTQB
MXD3CK O"O1=P3W9H-76+@&S5QEI@:Z E>2]$ W=QD!ML'.=H:T-<23J%(G;&
MFO U(S*(9%Y07DRXQ!)1'9@^0V2:F,ERQNC3TWO:F-P<S KM$4<C>[&Q0I%K
M;'*221I:&Q4M["2XK5%Q".\XPHP+8V8+;"\9P+<X68$@B2'$TW3YU+:EK[S=
M<TAQ:;0N@SFAS(&&LZQA)HL?6.XJ],NDC3?J_LRMFYPSD=R@[?!+GQVS+DEQ
MC]V,Y/K^E>%GS&:B"JY,9"ED07PQ0?:8F5,!S@"\2#RG$LM$C((K@A]J^S+6
M9G<01#6@YPLPX.!C&9'/NBBT.;8LM<YQ?W;-,N,%KK4C"8PB-0%,(7:)P*2:
MZ=^4:U<Y"SQE*):I-.F9]3C-BDQHS%,XLVX5'$#LX)=/F.VC%35(4$$>6K);
M>VQA2YIY+$7P[)HS12*HUQN-2B1  -M+"S:T/LGM:7=Z*D@YYSHD1L-(G:CI
M=9VUL][F6MFYX9FN/>B UD,F#G S!$@D1!"[5!V&,:CM46MJS5)F?)<'58[T
M[Z0<B-D!8LYS_$3+B9]EN"%CSD3*#2V1J6,!!3G')&C2D6*W$M8TL"L33%Z*
M]0^C<= ES+.R%FQI:ZTM07%H<7 .@"2TTB:<YP"FH^UMNZ6A!;96+@W.+6M=
M#\Z@-23!)T0*1CT;2\G6Y3U8Z0,WYH72@,S2CDD%^0%3LLFDQCQLFEK9D.)Q
MYIDBF*I'] RFGR*'K E#M&!:+F8QX<K7]8S"\MZ%<CB^&LM6,CN;;PP"@D9Q
M$G 4DT.X;1!DNM+%[R<]U@][A)Q&$5&@5US*XVD2'.&JC(FC& YGR7F5_@2_
MD=<,Y0D\6:,QY+AY$SR0MRFK8B9E+':(RAD?GIX2H%RV^XU4YW@X+1;E;J"V
M]I;03PM8LVVQ:UONI[0<T$ !L@ $;XP4EDWNIL6VCG1[#:\MSG YV<1G%P(+
MC4QH(QF%\[3VV2=HT]\E]JD5Y<S7)LWY,UAQ7"$\EDJR]D!\;91B!=(,TP0(
M"ZPI;(#(*J;4[!#(R=Z)7QSTPJY$W&REP=U3\X.2Y4<X%]O9YC UMDYP :)#
MH:0X'7,D$1J4UD#W.[V@>]SG6X:XDF",YS0"-   I44J979&G(4+>]*[.AGO
MZHN9M2\XU@:X\9Z;8"CU 9@QL<Z*4VI?(J UYG#O!9_%CDF(,4L+,TJY"]OE
MRM'%F)$FCL:!*Y/B%"KF=9N[MWH#;-ME9.M'9K7$2QL  @RYXH)(Q).M1SQW
M(!Q+K1UK:BR:7EH)#R*G#-;B1J!I@N?DG%N2\!VZ#-'S3D-_U"1_++GGZ89H
M=IAJER1AUIS#F9DCD.<X_CHK*K.1/9DPPMJ1.S^ZP_$3:N1E2-#%&^Y\5.JP
MAXN>8!S;0V]KF9A;F-9%DUP8PYS>^;$9QI+B))FN*@]KF=PL0_N@<'N>3:N:
M'.!% ^NLPV10+K?ICS&RMZ'3M-\K$PO3U)N41Q?A>:IL;ZD<@Y2EN$\?R+"C
M_-'K3](-1#W'8-,6]JFV5FJ%-B&],]'2.+LF1C8(,@0E"VIR7>.)>&S:"P+A
M+ T/<UY[X-P,-.K]6,94,YV:&.?%E[(#'.8\N+&Y@)8YY$PYTUDP'5-9%ZFB
M7'6.\4<H3K[@F,I>_P ECK)B'1Q88SR.</V0EV/G%1=GU2?!R9'*7=]D0H$Z
M<U+(DC4ZNZPUGLD8H$?:K82A1)J=JYSKO9%S0/TEI$ -T#1T= K2E:P8QEZM
MPQQ=%E8@R2XB,Z!)Q@'FTK+]7D7N2B)1$HB41*(E$2B)1%B^Y8!*[+M%RY&P
MNI;"^*\^:5$S,^'-Y;L4S.JC4=C,EO=36HTY,4YEMZN\E7>WF*4Y:VPD4UYY
M5IHWV^FZ%HMN^&<.YVDB8GO#I&'VZL5Y+Z";#O79KNZ6<.B8[\33:%Z>7CS5
MAC_%F?73,&J!HS<4;AF=60YLBF"FG#SM'9(GCKHH(>$[TP322+7$^ZVRTA(D
ML(2WIU(EJR% G66VC)G69?9YMGF@/$RXNSA(T&@IO50-M0Q^?:9\L.;WH86F
M,9$=8BH,JQ>&YS4.T"Y!-K2Y9<'&4Y);(PZ3U,EF*MP>9PBCVA3(8RQ9,"27
M ]7)2VO(5S6<[^C8+!LEI*<U1N[)PO+KE@S[Z0T!K<_-I0 V@S<W11IBF *\
MC;26W YY+G%I?4R2+ ETZ<9QQ.X1XGIJ=Y3B3)^F?(>0WZ:Y<3YFS'+X)$M7
M&$=4TLFL+U$O\Q0Y !CA^>],N41*N@[<TF(0-M,QLT*$.-7Z,-]A"]CCQ;@6
MJF=#V/S8[UC2YEI9AI:!$N8]HJ8I!B9BM2I;,N8YI(+L]SFMM+.U+Y,FEHU[
MFD:1WH,4"ZZ@=G)OT+8AU[-&:\HNFNJ69RQHVO2=5EN<JVR2SJ6Z@FR#3O3"
MIPB;(C8"BC,=B:Y[8TT/1PM*ZL94=*DI*@EPM4N9PP;6TLBQIL19DM.:*PPD
M.SH!!)S14P"8V*$GN#+8.<+=UK9DM)(B;0!S,S.( :P.PT N-25U#4L]M#]H
M]Y034UD341E'&^K> :@\R8OB*)CSK-X:9!(U&LF)XEB?$3!BYKE+;&#F*>XY
MM:Y(:X7Q=0].ZN2JIH2[WJVM.O23,EMK8V;+-KK,V8>9:'9Q+)=+B*P9%* #
M;*A:'.L+>U?:O9:"U+!#RW- M &0V8@M(-0)FDTFX'+*G+N<]6NL")2./))*
MP8#BN(QQHG>M;F4M*-N,H7(,4-TK=\SL4=Q_#'M%*U[G-5<A3K,C/ZY60R#%
M$T3*1HR$CD+M(W,;9L()EY>#%FU\D.@-DBF-#JV"L[NZ/M;4$#O!9@%UJZS$
M%I)M(%#)IK)7)PG&IAJISSI6A&HS,4KR&QNO)G&3Z9CA_+63H' ,N2DC-C-'
M6/(2U5#U6.'AX,<6!42[W'BWM"58Y*+#^TS$!"0FH%PL[*T=9L@]W@9S 2T9
MA,5D8Z,*CGF8#:VEDVT>3_-\XACW03GD9TTDT$3!@Q6JR"<EW(Y3(]'42LE\
MKD,U<XGDS43CA#(Y:[*W^3+8SC74)D^"Q E[?'$X]P>5S=%V!H:[W)><<N5E
MHBS59QRBXPVZC>0!:F !G-8X@"!+F F *"I."]%T<76523#[1H)QS6O( .ND
M5))*Z!)<9P" \J?IK>8;$V2/O61=.>MV7SQW;D99;M+9(?-=(B4'5_<;@O6N
M1Z=$22@06J3S"6UO()0-Y25&463;$%QNSVFK1:,@104?/32=>E0<T"]V9 JZ
MSM),:LT"3JI0;\%C&713'K9B7EC-1*7,^0(GGK NJK4M)\3V1S+TOC2''DX9
MV9C?<;HD>.F:0H8P_GY<F1::,N]DGCSY9-$=Q49"TXAK!,7Z 7%]VL\P%CK*
MS!EL@@B7&8P$2=R\@:W-OEHUQ%HRWM"P!T=]0- %<8 %*S&"D'J)IEI'@)AG
M,?QB3D#,*F#0IW48P42IOQ\2X21W2LETD;+Y.[H'-"Q S]N.JL!5(#P.N;@;
M[;+#E-AA?A( >6D@ .(D2Z@,2->S!7#.?W)KFM+G%K3FD@&2!B3AMU+[>&I9
ME.9PVQZS!B1-A68"Z+TM\*2Y!:,F%6-A'8>T73TS,C4S(;[E_7G=<A!$!J3L
M&QAE_90ZV#@ 8:[.&LC-YHV*9A>6@O:&.K+9#HK2HI@H]N#BY3GZ;Z ,9Y$R
MCEU5")UD?E7+<BM#)E:?Q=7/&?'N:7"V&1V0/T:D33(362/WIT!*!(E=4W8&
MM'<PE76LBYP0*?<Z+-MNYK6YP;8 2 8S@"2 <"=?0K=9DVKKNQ[G9I=>08<0
M3F$YLD08%($KK2^&/,&TD9RSRUY>STLR9IAY1-QPU@A\>,XY1<DT&Q%'-5L*
M@Z;'JAB52B^/S-G7QZ1/S:\K)XV21[=VY:D:%SJ<U,K(C01D&U;9YC U]B"X
M9HG.#"<X0-<$U%,4 <+!UIGO>]MJYK9<1 SP #H,"A)Q&U>H/[-"YD1RPN5Y
M_J+RQ'<BZ:<S9"<,-VM6>)[$T6"S&C"L-D\'>8Y#6F5-[$X6S2:V'M-S:^L[
MPV2&UJ,C+>A 5;H0M N:+J!9M+7V</):.^[]P,F#&8*R-=9A' .]E%UJ0]EH
M39@/(#2;-I; F()(Q!'2O1L;-N1<T:G=263\F.F4#\BX)T?:-,T0##K1D?(,
M6@K#G^3XFR')I 8XP>-R%J:)$<HDC F8%##($3DRJTBES3+VM7<M&XN1Q#;.
MS:W-S'6]LPN(!):"T U$X5&D:A53,SK2VM'/SI9=[!X:'',SRUQ<(F*.H0:P
M!)H%YW$12033[R<6K#&6=<HSK4WJ/S%IO8,JJ'O,4VF+=G%-EHZPG/D'>L6.
M<B<(0R-N.$2J0+VY/&8JR*<7^DQ,44>W]KKA4S4=:6UF]K18M8\@AL06U9!V
MN#=AFE% 2VSL+9CW.M7OLFO#G.@YQ#7]X9C-;-  *:UV.)SS)[KEW'')=63R
M>VR_#VLR39.G,Q4221*):_Z(( G;M0.-BGN4FKA>UZ.72/($#P:X*SEYOHBC
MC#^W*C#@$\JZ!:W,=>8:0ZPLPUH$ 6KN]?2  6@9PB-Y4P>\O%V!=G-MG.<2
M>^%BWOFF22>^-*FHD8&EOJ"3ZCY]B+)6J98X12#9PCNH/(+"7FV:ZZ,L10G%
M,@B6='6)1/"KOI99\9/4"*BJE@;V2*&XZ46.KCD%O>2YD8X7O#\C6I*D6;2V
MS&>6E@.:VQ:XO.:)(M*D=]_#51#K5S76G>LM&O(#S;6G>]\0 ;,-(,C1 G6O
M6<]1F,9UQ%RN^3M0>7,@1?*6!7++V.L<QYNR_-8;&<7XT;\'L#GCA*CQTTR!
MFBLA:\VN#XY^BRF5QU[-FQ;K>TDF;HR"4LEF2Q]V:Q@>UV:7'-DDEYSA-"($
M4D8#!3V@:\7M]H]S7M#FM87$-:"P"0 8(<2:D'9I66]@QBLS-R?<-Q6UR9ZA
M;O.]*,)CC%,(Z[.+(]Q9_<,7,Q;#(6YT:%"9Q2GL[N")PZY*?9>;:GN)$;BS
M+[;O+G9EN7$ AMH2010C.,@C=H7MS"^[AC3!-B TC02P00001&PZ5BVQ?JTE
M>H QRS+.IWD> 170'H5G16I8("9;>](]8LH3R"'3\NR-J[3H[*)!BV/XFE4A
MBK?)4"YH2.D]8G0Q-:2=:=7H=9!AS!FEUM:AK<Z@[F"' @X0XTW FFGR-MG6
MCBXYS1=[ FT+>^)M7 M<TBH)#6R)Q.ND=2PNLEV+]5W)VJV9AFF+VW4.MG:.
M4'Y!ULS74%D_/T,OT^3.;(Y7DC%2B]VQI&S")0UQY[MD$6D"L6=\5%L#,22U
M'WE)IG@/L[;.@N89 ;9@-9WP%'B"ZE#--<T5-DMM+L6R&N+\X.M2]S@YA<,Y
MA<<T9PKB=&F5UK%L=>HYH.TN:DARAF=XS+F;7!IIA<YECYF+)3JF6P-+KJMB
MB&&(8TLE!T7:66R+(BF)QM;F=*J?T9[B6^J7"QS5V&1<<ZWM+/-;FLLGD -%
M"+.213G_ !4P]SV=KGNSK2VLPXEQH#:^")H)$:8C'!=.U4SUQ>\;:J-5&,QR
MT8MQWGV:Q6*:F,I:S9/C!RATM@N14$1OQGA;33CHI;%W>(-SDA5Q]B89ZVL+
MO-VT]6]RHQP%64X7363"UUE9O_6;)8VRS@YKFDYQ<<#$3$'7H!IVKBYMJ]O=
M.\>1W1UL X.:^ UK+,@%HT!TG&="]\S-CM1D!JY9?+KYD_-Z65Z;I8\OF K(
MUFG)L28<5R&':3<:9"1OD>C4:E#6P*52^1'V&.*5\;75M,3%J4Y")/Z+/5R^
MDUQ:;LP!D/:W/EC3G O,S0UBDXJK:L+A?'E[\ZS)+ '.:&YMF'-  ,.$Q2(Y
MR5QYA'6-7JWU-995Y9=<-91>N2 Q;DAOS"KFD]]!X#,Y*&<8N\9(NAK8]*&Q
M6R1!$WMK]>T-\=5MK O2*Y0TM:.2KUSHLCG'N-FS-#FB\VDM  D4I,;3%>C3
M SW:V<;0V;G76S<'X@$YX)@S.;2FB231>QZ$U;MB+4Q!\4Y"BT\ADLRUIZDL
MHCKI!-5<@U/::,ZHX.[PA0[Y?O0Y*.49/QO/;BI(D(;EYI"&-R9L?'%$J<GQ
MU0-HI)+?OFES2"UK\V39YCP<T2TP((&_;OJ7:6VH8X.!=9S(MA:,?K?FN=G!
MQ,@@-@9HG&F<BO(K@E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B
M)1$HB41*(E$76Y?#HGD"-/,,G4:8IC$9$B,;7^,2=J0OC ]-YVPF(G1I<B%*
M%<FONMMO$E0099U]EEX %UEHA$$@@@D$8$8J#FAP+7 $'$%>2X6TJZ;-.1CT
M?@;!F+L1JI':66_+8%#62.+W<DDP324S@O;TA2Q4D)-$3249I]R4DT1,**LO
M$;JG?;6MH +2T>\-\'.,P-0V*G9V-E93W.S:PF)S1$[X7;R,*8A31!JQ^GQK
M"28,Q2HB<,L2+CC99'FJ8II@;D%/)T#3:F!&E?29R>?+BG,HJU79(3C':TT%
MEXFC)G&9DS$3LB.I3YC8#8$ R!MF0::ETV4Z4=,\XR>U9JF.!L3RC+3(<VJ6
MO(C[!H^Y2U*J90L!D5@\JD)BLY6R@66#,K4&&J6H"R^T#4_8[.MF%K:M;FBT
M>&P1$Z#,Z*8G")FLJ0V%BY_=#9,+Y!SBT3(PJK?5')ZX3G&I'/\ GG.F/\69
MH3Y368;6P-CF\ :G]=CL[&4)/BCL)3D\VKBU14F4]HN!J5,F2I0M;TI:TE88
M02854-N_,LV,+F9F=,&A))@C53GK54_8UFZTM+2T:U^?FQ(J !4$Z9,;H5U4
MLP/A>=RR SR8XN@TDFF+ 7VXXE3M'&Q6^PDIT2]HN)$;<C$XJFM,L2;)STJ8
MRQ/>6  )6X (4@]PD!Q&<037$@R"=LB56-FPEI+02T0"= (@CH7.B.&<30%>
MQ.L)QQ#(HY1B -V*HZO8(\V-2MDQHT+Q=&N!M9Z-.28BBC>XW"N2,:>ZQO(5
M?MY9%I@!=1SWND.<3+B\SI<:%V\A&V;&F6M (:&BGZHP;N$FB_@APCA]LC4*
MAK=C*$(8IC>3IYI (XEC;60S0V7)%CHX)I)&V\M-:F9WI.N>WA62XHBR51:A
MS7&V&!>I-&Z&<9)DRX03K&I1S&@ !H :9 U&ID=)Z2O+IAHCT?Y");$TYTS8
M1ER=E7RIT:"9#CB+NQ;:Y3E_/E,R7HK%C<:"97)Y(J4OKX>5UICDZ*#EJNXT
M\RZ\9Q;6HF+1PSLV:XYO@BLX"@U:%(;"R= +&D-+B*#%QEVVI7)(T7Z2DN,7
M/"Z73?A=-B9XD/IN<L=I\=Q@F)*96"5(ALDUS*4W6HRY 6C0I$I;P478XED)
MRBK%-MEH!06MH'Y^>[.USV_A0)W"RS<S,;FS.;%)&'1VI1=N;=-FGYGQ*KP,
MUX7QFAPJO3*4B_%B>&,-D%7DK5(+58K8X"'T-5J%*VVU<<K4$&*C%MA:RXX5
M)=AH0[H_/S\]V?\ M353=S9FYF:,TXMBAW_;BO[XDT[X)P*2M(PMB+'N+2W-
M VM;F,'BK1'3'1 SK'EP;$[F<VI2#G"Q"ND+ZL3W+##KRU#LO-"[KU)@W0<]
MS@ YQ(& )H%!EE9V?@,#=<8G>3))VRO9:E51*(E$2B)1$HB41*(E$75)G!89
MD1EMCD\B[%+V&QU97RUGD38D=FVUXC;LC?6!S!&M*.([>9GIO0NK:HZSLB1>
MD3JB;K#2K+@B"09!(.L*#FAPAP!$@UUC!=I&RVZT;+K0NLNM&VZVX NMNM$-
MAMN =P$! 1 0$-A#AMM4$@$0<(CF5M\%T<Z4\8R<R:XZT[8<A,N,DIDQ"21C
M'T:9GHJ3FMCVS7O29P0MQ*E(M%IDLA;PO3&%66I7QU*ML"U<H[).;2T<""]Q
M!T$F%3%C9M(<&-#FS!BH)F3O,F5S(OI*TPPG*#CFR'X!Q)&<MNJIU7K\B,D$
MCS=+#W!^L-+?7$'A*A+5$.#X6>?8\KT]Y2MTL/.M7G*+33 N&TM'-##:/S!@
MV1 \W7(\RB+&R#B\,:''$PO[(=*.F=LRTHSRWX&Q.BS,J4J5Q^34T%CQ,R,<
M5I(IEKKZ.%H+5EKNL377)U;O:8#FJ(NN)/5F%W#:(VEH6YA>[-U33&8W3H4!
M86(?W06;!:"8>&C.J(-=U-RQR9WY,C(^?9]DFV<373@_07)\H-.79;?-.;:H
MU?1'%*]P0K'+"L3R>WO+=&A9RFU*JB##-G:/+),T11Q-2'IW1404I'T,O#6-
M: +26@PT6A%GG']8@5- *$Z%YK2ZO>YYSK.'.!SG,!M,T$G-SM0DP<:\YR,Y
M8TH::,\.,?><TX)Q7E)YBR>U&P.TYA+#(W)L0VF@H]#B%KDB4*+FP5%H*+FT
MTPQ!>?N=<GN,$;A\[;2T:"&O(!,F*37L%Z76-D^,^S8^  ,X Q&&,U&@X[5Z
M@CQW V^4()J@A\;1RYKB 0!MDB5G0IWE!!P<$[K;$4:\DBP]-';7)(E76-!-
M]B&Q2G).M)"\NT0E+B06DD@DN()Q)$$G:1I4X8T$.#0"&YH(&C5YERH?"8AC
MYE"-P:,LD28 <WQZ!FCS:E:FT'>3/*^12%R!(C+*)[=>WYT<7AS4]9V58XKE
M2L^Z\X\R^X229)DP!.P8#F40T-$ 0))YS4JJR%Q%QEK'/%\;95DUC3,_1V/2
MI0W)C7]D892I95DD9VMTO+%6B;GU5'&!0ZI"#;"5QS,VF*++[DA(V),$28)!
M(T2,.M0S6YP='? $ [XGJ7BCAHYTI.T_0Y5=-.N&G#)+;*%DV1SA7CV,GR<N
M8+U1:Y3)KW<QNN6'O8KRK%Y3BH,-4IEX"M3&$JKKC1G[K:0!GN@-S0)P&,#2
M%)W&RSL[N;<Z<XF,3$2==-:N2YJIJJE$7E3!@S#457Q9UC6+X*Q.4(53E=#U
M[5&FI"KC*S)CA>[9#4L9Z=-88VG39S,O72<Q+<7>\JK[CUPG&"-U3%SB""XP
M0T$3B&X3KC:I!9L!!#0""XB-!=X4;]**<&X;61B0PI7C"#*8A+9B?D*3QH^-
M-1C(_P Z52!)*U$N=FVY,*5=(CY*@1/QKLH*O6WNJ1.NN.%0588 .<#(<9@B
M9K!I'G3,;!$""<XC"NND::JTS'?)W8-:\L9LS%ES'>)\O3;(6H9ZS; 9'),>
M-"^0X[;W&*P5D11PEU=RW ]6:V.\//?DB@L24B56OL/1I$ZPLU0;.ZV<6V;0
M2!9LS1!UDDGGF-<*D+O9YUHY[6NS[0/$@4( CH(FNFJO=;8)#&:5R:=M478F
MZ:3-"P-LME2-M2IWZ2-\6+7DQM$\NA9=JMP3,13HY%M1*DTPM#8N56I[2P/,
MZZD22UK23#22!M(@GGI*K!K020 "Z)C3%!T+RJ(Z4=,\!R6[9DA.!L3Q3*SZ
M8XG.N06&"QYLE:L]X$;GA2+PD0%*BE+Q===<[*"+RCW.Z^^Y<8H&^\;IS:6A
M;FE[BW]F:?CMF5(+&R#L\6; \20[-$B<8.CF7I!&,\>)<AK<MIH3%R,H.,53
MP=PR"4R-Y<P6PY(Y"\)8NJD-I .A[$0ZCZ(%-ABFY)8K"T\"NR66W6RYQC-D
MYLS&B<)4^8W.+LT9QH716F%>9>8NFDG3 ^9839V>, 8C<\R(UR%T3Y*6P..J
M)A8[-9=A38\B]&(+E9CRVE%EE-[N;?>Y(2RR[$JHJVRT G%K:!N8'N##^K-/
MMZ#"E-C9%P<6-+AIBJ_62M)FF+,DO19 RO@+$N19LWM1S&DE,Q@D>?WLMG.)
M4$"VWKW% >>>C**5JK4I*BXVU$*D^Y'V"XXP;H-M+1HAKW-$S .G9OI.@@(Z
MRLWF7,!,$2=LSOQ.,KW1H:6M@:6QB9&](U,K*W(FEH:T!!:5 VM;<F*1H&]$
ME)MM*3I$:0DI.F(*MM+))+L+LM"VT "3%3@   8  #<%TF.X@Q5$2I\3%\<P
MI@)RH_O$JR62U1II1$SZ22!-:C?7R7E$);"Y YO"2RU,Y*W.U2<M( 2U%QE@
MB S%SC$DG-H*U$80=BE%FQN< T#/J[^]OZ5Y5CS1=I)Q*Y(7K&>F_#$%>6M_
M+E#8[QG'T;:75M?R6YU:"')O<4K>6L0G)VM]>6]/8E/*)3HW1>G)+L*5'6WS
M.M;1]'/<<-.HRI18V33(LV@C Q4+TDG"&'D\-CF.T^,H.3!(A)&J8Q:(%1MK
MLCL>E;')1F+/(F=IM3 C;WEKE8C(D+@F*+4IGD1<"C+5(]DJ7/>"7!QEP+29
MJ01!!WA3=S9FYN:"T'. (H#,@C<:C5S!>9N^BG2)()Q)<E/NFK";Q/ID4X%2
MJ6N>.8NM>W\79-<B=5#FM4-IABE:YH[[TKBON_=JU.882I4&EWW6C.+:U  %
MH\ 1%< *16H$:H4AN]B22;-I)))D:34F,)FLXSN"];.Q)B]0@R.U*(!$3FW,
M-ZHW*J$UA;KTN1#%L=1Q)89,B;B!+D%ZF+MR"/GW.5J@3&A&G07[IRK"PIR[
MO>^,L\$SAC]I*J9C>^[T'/\ "FLTBL[%UQXT[8(D,SB&1'S$6/7:=0&*+X)#
M98OBK0I?8["G1 M:W&)-C@:EN/(C:MN<G)$<R]=<WBG<%Q8)PM6* ,B'O (#
MG $R8.D8&=84#9V9+7%H):(:2,!AU4W+Y.']*^FW3\Z/KWA#!F+<4O$F)M2O
MSI!(6QQM>Y(K% JRV\]4VHR#P;"U8BJ+;"KRV^Q3L?:F T+;PBY[W@![BZ-<
M=)@"3M1MG9L)<UH:75)$UWKWRI%.E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1
M$HB41*(E$2B)1$HB41*(E$2B+",^ZH-3F*-7/*:*,=XBNSUC["D=T^Y$=&R9
M9Q58W9(5'4V C)+(X_C!HOA&02G.72>Y"Z/JMN[5B;$:H1DGND@N7N"4JO5W
M*S=96!+\QSR]L0720Z 3!&:"::=:\!MK5EM>0UF>UG<W&2&PTM),35T 2,!4
MZE[++>4U:7%]QY%<)13%CT_2[ F/-1<@4:@M0C%ITC<7A^5$JA7 XLC<S8=D
M9RE$_?"FUX.5-C>QIV%@0(TZ]UD)?HDWIE$HN[JYQ=X3F#,LW/DMQD @C?@5
M.Z]MEH:& N8'GNEJ+, .\$ EISR8-!&!JOBHN4_>LCF:2V'3YI[MR7-M5*'4
M&D%K?\LMT2C>))?IM>V"/9$;YG+&.&SU.[Q5,Y+WJQOEL90+[GFQ#'KV5D<"
MY:08UQ-WS1:E[\WN>; S"2[/$C ]Z<)!J#,I[++C9"SLL\VH<?# S<PB<14&
M:&@TU"]&:]=^17W&$P5LNFA6HS]C3/*G3WE/%Z_*+:TXSQP_I61#+1R1*LWJ
MHE=:APXXPQV8WYEE(8]O?G)4^-C $3)<3#A(@;%K7-FTBS>PO8\,)+H.:6AD
MSG3(B<=,54_LAQ:[-LYM&/S',SAFM) (+GQ&;FF20":$ $JR34SRD&<97I/U
M<I<81K'$)SIIVG6GA@E<JQ%J+19.@A<,S%-61,B?(1D!#B]M5*9&L/3KH/)X
MB[Q>..472.JJ1(WU8I1(D*RM9V%FVVLL\E]G:->0',<QTM835ID8P14B(7GM
M;S:&RM(:T6EF]@=FOSFYKG #O@,3@9 KTJ]Y[UCZCW><Y"QMA+2?&,IRK 42
M@[CJ"N<]000A@:,BS.)D34,0XD=U&)'L_),C01U6A<;GN1MF-&$;'5F3K#F]
M0X&6(O.+%@:TNM,T/DL&872)B34 "9%*XF%6-O:]\&6.<;/-[IWX;4B2&B"2
M<TAU0!!%8(GA-'*$NN;%N'XWI"PZWY=E^3\#)=1SZ1DS))F'8QC. +Y"IAK8
MSR=[:H)E%U63UUFC3)(VDCK7'#42<R,/;DO>DR(E+V[$V.:'%[PT->&"A)<3
M60*4B.G=,?9)?FBQ8+1Q9GD%X9FMJ))@GPJ8# KNF-=;[P^Y-QUC?,N")1IW
M5Y'P%D'+[<?D"1)KUB*5X=F:>,Y7QP>@+9$2146QL3HQ9"C,M1NQI,MA3F8Z
M^@;-:A.MN/L0&N<RT;:!KVM)']\2TQ4C4= )B9HIFWB7!KF%A>Q[F@XGN9AP
M-(!TC21)B*JS:%Z[=0F4M4&D^=68[:<=Z:,GZ2]0&<G>.OV7%=JTW'<=R-CM
M.T9@=F5/B<.V7]NQ\K9Y%%XB#U:@<&_(;R4=(FLY@*5/M4V#&LM07DVC+1EF
M(:""\B<V9D F03L%*J@V\6C[6R(:!9.LK6T,DAV:'  D1HQ %3,KT#'?*Q-L
MM<L(2>1X]Q='<+:B9Y$X#CYT8]2L4FF=XTJR.M!MQF^98P,@B*#THM$M<%#4
MC<B&3($N>(0<[H0DS>2%KEZ&2ONKFAT%Q+&RZ;-S6",0+22#&N!,'155&WMA
M+/!S+2,PBT!>2< 60",(QH<:E9AZ\J]:41*(E$2B)1$HB41*(E$2B)1$HB41
M*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1
M$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1%8T;I*?;
MYKK_ )4$Q:>PZRH7"HM'T@MRP380=%<*.6*C5;N9V;K'0I6M7VNQ92("+BTA
M=R:X1-N P*PM?:!%+%V=OEP<>KUZ5YA8.!O)SA-N(!B<T9F:-M*F,*\RM63<
MFG-<?+L3S7'"K37D29Q_2_B#3;E".:C<2K9K!G\W#;4H0Q3)4%<$"OTQ1)Z3
M>BCT@=6 TE:VR9G/;+%*QJ7M!2PZHZ\9P<"'-_2/M&ECLRCR"6N @0(]5(K3
M%U(+3-F\]R99O[HW.!S!0M!-"XF30Q@#I7E,XTY:@\1ZG>35B.)9[!7+),"Q
MGKCDDLE[YB,J+X>E2V7+L.KW2&K(GC8YHM@$?.]%C$L+5(ECN^H@B[0H=[I6
MJM>#%LS;2S=9VQ>T@.?9 ,#^_@!U07%TQ0'5-**0V=JVWNX:1G-L[7.?F0P2
M6@-AL13P9),"N$#U>:<FCD260]._/V1L59+S#(=5#CJIS%#\F8]>5NFK*[FN
MQ[;B]BQ>[PA._K7FV(8RBZ./*X*ZO)LE5'2B-E/SPRW&N8DMD!>0TPUKFM%G
MW*S+7=^P9V>XAQFKB#G5&,80!$W1[AG.>USS;=V>"";-Y#"QK2R10#-Q)J,Z
M)76GCDNLIR''.L^,J<D8-B3UJECVG.Z)LV+\0+X+C#$K_I^EBR4M\?21A)(%
M:MZBKM>4U)5CX"QN?%*Q0].PM*0HQ SI@O '<.]/Z(ODETEV>-9WG5HYHFZ/
M(MX>P&U+"W-:6AN801@["1,172K@+=,^L.$3K)V3\.99P(P2C4M&,>JLZLTM
M@<Z?HS#LSP^#(( X91PZ+?*FI>YM3JP-C.G&"3;L(7*(^WKC92 K%J0*?=6%
MK&N8?T<YI!Q!,PX3KT@SH4QL;=KK1S+1LVH;G@LF'AH9G-,@P6AO>F@BA"Z[
M#= &0=,CEB"7Z1<B0BR5P+3LWZ;)VU9QCS^XQK)<>:I:Z9 :9_<MA+JWNL:F
MK;-9'+G$Y&2F=&9Y;).>TF7-ES8A74-L+0%MJTD9Q>W-/@F@@@R"( P@R,=*
MB+NZS+763FAP9F.SFD@B9)%:&9/.=RM4UVX)ELDQ9I0TEJL]SK)>MN39@<G@
M,EML6=D2W]1_,GI[A>II?>8F%R;()B.+XMF#ZS,;4JD:AP2'QS'[22:K<U25
M2-6P>&NM+3,;W+-(+208(JP@&KN^ ) 'F!5*WLG.%C9E[S:AX=+08AP+7R[]
M5N;, DF=XB_O,&CJ0R?-> )[C9W@;-CB 80R;IAR1CF3,[W<8Y82R??C\%X8
M^<V%:F3LTJ944#3MK84\(E;,8E67"9:7<1;;=3;;0U[7"KK46P(CPV@T,@D@
MR-.A5W6!S[-S2W-;9.L7-(@YKH[YI&!$5$00=85O.%>3@RCBV[!F/%$HTQ68
MJP%*(R[M^28SIS84FI3*47@I@&P^$3F0O0N\78%%H$MJ:7Y C92F42<MI!6W
M%19U<U+B1&TMVOSW0_/?,@O.8"3H&,#1(I*D9=G,S&RS,LW @A@#BT$P'4B0
M"03%:;0LQ5>9>Q*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)
M1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(
ME$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB_-]]I=EU]]UMEEEHW7W7"%MMM
MMH;C==<(@    (B(B  '$1HBQ\Z;-?<9U(Y3S7'&-GQXPXDQ9DA;B",Y3/SM
M"WB09,R$C<R6LA&TXN;D +6B.R0VQVNA$@.E+@=+?097:VLX"!MR>O:V#K(-
MSISG-#X#31I$R78;_L@GSV=X%JYP:T9K7%@?G RX&",T5&'JVJ^)9-8:W'R)
M*X2V,H5,0:4S_+$ZQ]:TI\88EMBTQ$]2$D]588RM*LML<C$KBY6ID:BQO77$
MG7@D4"71@F(!.<8%#4C$#61J"KES1,D"!)DB@.DZA1?)A&5,8Y,8E,HQQD6#
M3^-(E"A(LD,*EC#*61(J1E@<K3*G5C7KD*<],3=:<>2<?8845=:89;;8(7#%
MS7-,.:6G4005*'L<"0]I Q((@;]7.OYP++&+<J)G1;C')$#R*C8UPMCRK@TN
M8)8F:7$ N'M!R/87!>4A6#;;=<"93<4;=;:-UM@V@(T<US8SFN;(D2")&R<<
M5%KV.DM<#%#!PW_;A%<%\Z,YQPM-72YCAV7L8RQZM=U[!<T1J>Q9\=+7UK1G
M.#FRB@;'54J!U;D"=0N7-_8NVTB,@Y2H)+)*,OM%CQBUPWM(ZPH!['>"]IK%
M"#75O7-29>Q.OGBS%J')V/EF36Y,*QPQVEF4=43E"DM)L47*5<3)<;WY.GM3
MF%GW'&H+"[23"S;K@+,LN$6.#<XM<&G!T&.G#2F>S.S,]N?$YLC.CQ<?,N$N
MSCA9KD#7$W++N,6^4OCZNB[-&ET\BR5_=I*UFDIW*/-K.>ZEN*Y[;U"A.0M:
MDR8Q<E//()/(L,-+MN!KB)#7$1,P8A#:68,%[09+8FN<-&_9I-!5<E_S'B.*
M2YEQ_*,I8[C<\D@$C'84_P UC;/+7X%)MR=.+-''!R3O#GVP?;<01VDC/[,=
M;<65UU]MUH0#7$2 2-8!42]@(:7-#C@TN /1/;0O2 $!XA4%,E$2B)1$HB41
M*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1
M$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E
M$2B)1$HB41*(J76VWVW67 %UMP#;=;< #;=;<&P@(#P$! 1 0'@(<*>9%&@]
M)46Q3A";Y32X^11:*XIY;\Z?Y'?HW";4QT;PO!\O&I;7YP(86OT3/A,0)?+5
M)0)DZEO96Y2L6)B24MBDP+AGAUH 79P==,P!V <6P )-.^TXJUE@;9%T9H;?
M"]V8V7%@?6@Q&D[!J7W<NS'#6IV=<IY,43GE-XP2\8,T%)D^3L4X\,EU[@1"
M\HY3>7&<QJ-2E*B:LJXQA[M86HR,D;B'AN?XBQS%M;T[Q?:60HELYLVW?P<[
M/MB0YP;$YK1WVAQS>]-<(I5'D6S[T6YY:66 :6M+I +I,& 6 DYPK(#J2O(7
M!>^Y(Q)K<BV.XSA_4!$E,4TEO^4M0^C#'$XQFCR_C2*9V1&Y9PO(\=)GY_B;
MKE1OP:1,USI9C54>L519Y&+OR0E0K8VLF80'V1)>UT6@#;1W=,U^:<P@Q6I:
M)(TC:H N(M6AK7@9A=:V32T.87 /9FX%T!TALXQC1>FY[;(EGO(,I7<E&V,2
M92@T#ZF(+EJ480CGI$A[HZR!MB)>G_%ZER;VM@9C,M-SNFEJJ.M-UUDHA*$]
M3Z)^A*9>269+9DL#?9%1W4$9Q+B!#I(()S6DQ.B-84UH&VCB;L1 L7,?F&!(
M@M#F_K. D XB8)K"_M&Y3H]EVM#DP4.D3';?#9G$8?J$BLL6->(GW'%L3-)T
MXOMC%CS(2QSC#!8OF[.^%.:XYD6*'%Z:+ =UZKL!3\0>X1+;1MG>.ZN#FYUD
M02\/&:7SG-+7.I%()&-10*5KK%UI=C8M+'9EJT@--G7,$M<"!+@8(I3$$Z+;
M<'Q:QPQIILP](<M1.,:MHMJ!@3O*,5P71DX*M9L5S"TY+L=I]/9KE-ZS:QBI
M@T@3V/#E/LO/:(B(2?&CTL)2HUPK4##=4>Z7/<&39FREI=:#,(S09:R"!%8%
M321"D8'9EFW.8'YXEO<'.M@Z<2_/ $Q,P 10-.!N,R[@: +]%O*T9,58L87'
M+(ZT\U/4;FRN)I5TZ0WQC(&.E$351=^.0F/K>E:CS5RYK]!U1*<M2N<U107&
M+58F4F6GZ:ZC.A@LV!XD!DB9S@:&F,]<*LZRFQO;LTEW=[1S"!+Z%I:6ZB'"
M1JB16JZOK3_4Z@F<-7#RB<L>RK(D[NQ7(9#I5U78,>7=ZU".4?QU#D<.4Z-L
MVXT?4V2DMRXUH3,*5M2)W>R)9+0.ZQ<W1] H,7&S66<6,'? ,:\9]DYE)<XG
MNC'N&=2 #A @UQDM@&OM",TESK,FSMF$Y\M:/T3H)T&E8.,8B3#&E:Q?'6%>
MX-2AB7K69L5KF16?:J5,ZQ2B(.4M:E39=?8H/;SK[TAQ]E]]IIA-QEMUP7 (
M^!V)K-36E:XTIT45S9X+:104U4VU7VZ@IDHB41*(E$2B)1$HB41*(E$2B)1$
MHB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$
M2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1%^!+
M+&VZP;+!LOZ[K[1M#K;NO^JZZW;:[KN:[<!W 1 > C10@5IC)Z9GKQQ5+22K
M+0LL+LLM"VVRVVRVVVVVVT-K;;0M  "VT.   ; '#FX4Q0 ##0(YA@J%$$DV
M]824659N(]859:79N([B/6V@ ;B(B(CMN(CN.XT0 #"FB!AT8+I\]@,=R/!)
MACJ0EKR8Y.(^]1I\%B=%T>=[$#\@/;EJAK>V<Y(YM+H62HO-1.:!20M1JK2E
M)!UAI=MP1#BTAP@EID!PD'8141K!!!P(JI7,#@1@'"#%#M@B()&G8#H"M7Q1
MHD:X#DR#97GN>L\ZAI/B>+/L/Q!9F-VQ_>VXY:I.D1-C^XH$N.\>0 R3RUU9
MD!+(LF4[/E$A,:C%*<%UMZ@TV^J^V+FEC6-LVO(+PV>^+<,9B#6A@E4F7<->
M'N>^T+1# XCO,!2 )H(ETD#6KV.P$]D$[L1?91MZP30LM P;-P'K1O .N&W<
M-]A':J.O4=$TZ,%7@3,"=>E?L++  ;>MMVN$1N#8! 1'G$0'G$=N.]$@>M?B
MXDF^^PV\HNXPO<2[[K+;KR]PV'K+A 1LW#@/6B&_31(&H+^M%%*(E$2B)1$H
MB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2
<B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>g60414g23y17.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g60414g23y17.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1[X4&AO=&]S:&]P(#,N,  X0DE-! 0
M    'MR^>0 X0DE-! 0      &D< 5H  QLE1QP!6@ #&R5'' (   (  !P"
M4  (<G(U,# T.3,< @4 0$UI8W)O<V]F="!7;W)D("T@4')O:F5C="!(;V]K
M92 M(%,M,2!296=I<W1R871I;VX@4W1A=&5M96YT(#$Q.#0 .$))300E
M   02M!7QOQ5NH+"G,?Z/(X2LCA"24T$.@      Y0   !     !       +
M<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0    !)
M;G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I;G1E
M<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    , %
M<@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !     $)L
M=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M  (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7     $-P
M=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B;V]L
M      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L      !%
M;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0       %)'
M0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M      !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
M     $)L9"!5;G1&(U)L=                %)S;'15;G1&(U!X;$!RP
M        "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0    !09U!S
M %!G4$,     3&5F=%5N=$8C4FQT                5&]P(%5N=$8C4FQT
M                4V-L(%5N=$8C4')C0%D            08W)O<%=H96Y0
M<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O
M<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M"V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  $#O_XU
M  (  3A"24T$)@      #@             _@   .$))30/R       *  #_
M______\  #A"24T$#0      !    '@X0DE-!!D       0    >.$))30/S
M       )           ! #A"24TG$       "@ !          $X0DE- _4
M     $@ +V9F  $ ;&9F  8       $ +V9F  $ H9F:  8       $ ,@
M  $ 6@    8       $ -0    $ +0    8       $X0DE- _@      '
M /____________________________\#Z     #_____________________
M________ ^@     _____________________________P/H     /______
M______________________\#Z   .$))300(       0     0   D    )
M     #A"24T$'@      !      X0DE-!!H      S4    &
M  2P   %;P         !                          $
M!6\   2P                      $                         $
M  $       !N=6QL     @    9B;W5N9'-/8FIC     0       %)C=#$
M   $     %1O<"!L;VYG          !,969T;&]N9P          0G1O;6QO
M;F<   2P     %)G:'1L;VYG   %;P    9S;&EC97-6;$QS     4]B:F,
M   !       %<VQI8V4    2    !W-L:6-E241L;VYG          =G<F]U
M<$E$;&]N9P         &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -
M875T;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI8V54>7!E     $EM
M9R     &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG   $L     !29VAT
M;&]N9P  !6\    #=7)L5$585     $       !N=6QL5$585     $
M  !-<V=E5$585     $       9A;'1486=415A4     0      #F-E;&Q4
M97AT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4     0      "6AO<GI!
M;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R
M=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX    '9&5F875L=     MB
M9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO<E1Y<&4     3F]N90
M  ET;W!/=71S971L;VYG          IL969T3W5T<V5T;&]N9P         ,
M8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/=71S971L;VYG       X
M0DE-!"@       P    "/_         X0DE-!!$       $! #A"24T$%
M    !     ,X0DE-! P     %#T    !    H    (H   '@  $"P   %"$
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MTX[/^%8YGVC9^?5=_P #<G4;:JKJS5<P65NB6GQ'T7#\YKV_F/9[V
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M9&>"DI.5F*+8_\0 ' $!  (# 0$!              $" P0%!@<(_\0 4!$
M 0,# 08#!@0$!0$%!04) 0 "$0,A,4$$$E%A<? %@9$3(J&QP=$&,N'Q%"-"
M4@<5,V)R@B1#<Y*R%E-CHL(E)S0ULQ<F-E1T=8:3TO_:  P# 0 "$0,1 #\
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M9-V^$CGK29B8^L2TLQ>-W+Q-1FI$Q5UJ$E+*.BHHQC"S0;Q\JW;R3516 QQ
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M9Y5^QC'181_7GLS(OCU#X:T1=H< 9T?,R(OD]18S:+.I$ND/(!=3<1$F:9D
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MVE ]=BS;FN-QE36">L<I/RTF^8?6$7&FB4X3Y^*NZ"T-]V+#>,CWVN-Q$_E
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M#1+9FY+XP@I:U6PQ%P!E76 L&K<:1KR+<'*%8UO3WD35X-,P+BW>S"\G,/\
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M6:[VN3;PM7I\!,6BQS#P_@TBH* CW$K+R+D_OXH,F#5PY6, "()IF$ $?;)
M+B&M!))  &23@*'$-!<3  )).@%RO)30YY2X0EGY#;"A3(;;Y)R45?'Q9,BQ
M9C6.J6;9ZEI[139-0?!HUIE4D"3MJ2;>*#W9UHO,J!3@Z1,GLO&Z?9@RRF2
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M1]$FP>TB/9UY"PJ/ <)$.F0&@#$0>( P,#,75/8L)#B"2,$N<8][>M?4V)U
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MBD*:*WI[@ MR\XT@&!(!&M[25J7SZG!@ZQ.H/0X41_X_?Y?D/RZZZ^8]_P!
M^P9*A9VL(*KSL:5$.S)N"JC[#T!$0,J<QA#Y% I! 1]OP*'N(9!ZQ<?-2+7Y
M'X@CTXJ_G%B#6.\NUI69E9$(9C542)E(#=P_;K.Y^??-#%,<RK9TO,1WB=02
MK X2<I.2$<)J$)KUR):)DB2?.!]"L] &Y,X CS)D8M?S5Q<P+87G;SBL#RO[
M;^C^>1 (&F6')J_S20."&52+%LN(W(^+E#*ID.F<45%)V/:&,4Y1*JZ1]^Q
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M!2L9(Y"$64'^2U> (-UA$WW2)G%%P<WL" ]@(\+:?#]HV>7%OM*=_P"8P$@
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M6'BIR2FI^L4NRR;:SP[!A989[;:I W%>#EHU2WQJ%E&4 V&J&MJ.#2' &Q
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M!HW8DNY/Z<?&,IV1<*RNK[R^$#$0HU\<%0DG/;.G6^Y+"9-*'MIO&Y4:'!T
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MO8>Y(<USO:%MB2(#-YQ-A$8D""9B<G6&T^^0YKFM%,/&\+DN?NMB'._,"+$
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M2S2.L$Y6)VO.(*W'KZ*IQ=K+QL5-E46>,VS@(M1RS<+@0#I>=FDM(<,M(,Z
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M= ZYM0 !KF!P#R]MX@G(,"[;"18GBI=1))(>6[U,4W6!EHF,X/O&\^7# 1W
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MQ'*R)9)N*JY ^)262<*$<F20M@0! YD^7+&L3S5#<R8]->(U&NJX1#OVZ]@
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M2I[@))EQ^ S \]=5$._!6/MZ&35,9-%/6QC1AAZZ%9>SN2S8I@;LHBF1"O\
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MAY45&Y93CAN,G9R'2(BB:@V15%P=<R7HE4(X9IJ F4WKHD(54Q$P41.:]/\
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MVG>;BP$W@ZW%\VQM,VVLT;KVBJ-#(:\7U)]T^G,W)GKFY?7-DX.2_P##SE;
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M_D>UW2<P3!M8VM.8/ J?\CN/OCIHKK\G.5,ICG,!2E 1$QA    #L1$1Z ,
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MA$PB81,(F$3")A$PB81,(F$3")A%4&[O!?6R=7$WD!7RC4GY FR K0O7[!]
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M,(F$3")A$PB81,(F$6N6\_A5;";_ ,CR!?\ \[90G7]/EU_Q_+,^S7VG9_\
MQF>?O?'LZ+#M!BA5./Y;OD53K/58^6GSORQSN%YU,9G08%N=I@9B\Y,(F)U@
M:?#/2;=;P1=$QWWZ#X(F.QI\N^<!$Q/??TLB8OSQ'Z'AA$QCOB.^O,(F!D>7
M/AR/#GT1,=X^N1Y91,COY]]W)D\N?4]_/G%B9")D^N/K\OJB8ORL#SX]?TS:
MY1/EC/?WN3IQZHHQX=N5TX[G?NTA/6E9'?-NK$(J</,R=>T%JBET=E%D ?\
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MTYJ(4_%.48'#KY]E=)#^S\NLQUX]A5'&D\6XENLP+&_U,+)2,5:9_P#B,_\
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M8!L?+TO;[HF-9OG(GX$ZQQ1,"=+3S@'Z(LS74_6L$&EUWZDO&E$ _(7B/?\
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M3";F_BC9FU]@H;8&_P W9*PHN-I.S;0'.8#RHUV.BYOM)72_#FT&EM]79?\
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MX6A$QUY<NR>/S1,:F=<3US)C2;HOAC%*43&$"E* B8PB   ![B(B/L  'S'
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M%1^6?\Q\BL;+P\1+\[HQ*6BHZ42)Q(F%2IR+%L^3*I_#)"$!0I'*2I2G O8
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M<^B)D1]?@B9/&.%_+GZ<)-D3'TMW89YWLB9&?T'V1,GN>&8'+U,:81,COO\
M1$R1S\N?#XY\T3'TL/C]43(1,GO S;X=Q=$R,=RB8[[[]$3)CYF_'$ <_O=%
M4?EC_7'%W^=QJ;_)5TR#-NHCIO<O.?54?EG_ #'R*_*_7\?*._FB3'_KFA/;
M^G\OQ_+,EQ$&;-CS#N8Q>,:=4/\ KM_\,7UN(XC ORZ7&GZ4Z^SW//O^V1W
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MT.KRVTXRL2VN26;8T55WE#@F5S:W*ME@Y.1L2$:X<R:;=1TBJBY*B[$VM?\
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M;CL>XS5RLS:PO&*L7*-"KQRT(R%N2//)+E<.W @6,P3Y\=1'RF\W4&GF#$@
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M3$Q(!^)GI9=W46X->[TH<1LC6<^C8*Q,"X0]3TEF<G#RS!8S68KECB'9$I&
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M8.,V68UQ+2RJY&/Q#90B*#?T57+05ER)AY$31!1)9L84DB$*1+R[,4A2E[$
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MO+##!N^Z;=3$&T1)G,6$+Z'X:YK:5,%MR#K,F+3I%A@76]\7$0_AU= (=_\
M6C8@^]^R2@?Z?;W_ #^8_D.>4_'_ /\ EGA@O?:*P]:'S$6X&Z]I^ S/B'B6
M2/X79X)Y;0"2/ET@+AUJ0#R2B8F$O;=L'D'[%%_F/M^'7S#V[_>.2#'A'AQB
M8V+9A U_[/3%A(TYSP6=W_YCM_+Q#:\<-^PY\8MFTG-\J.F8G7F<RB0-R@!>
MO?R#TQ >A'WZ'W$0'OH>A[ZSPOB1$F!#@XR1YCLQGA*]=X>1##J9R,"9^ P=
M+]5*SCH5$1 ! /3* !^(?K" ?N'KOYCW^P SSU410KX_(_X,-_IIPX!>AH.#
MMHI6_K9F+^^TQG0#CK93 N(A((?[ @/]\Z_Y]_+H ]OW>_OGG*<[E09E_P V
MR!]%Z%Q]YO\ QDCS'&?C*VPOZI?W!_BS36ZW Z#Y+[A2F$3")A$PB81,(F$3
M")A$PB@+9]*% ZMEBT>T5#>4JW3 ?T2IA]WQ"@ ])J#U\4 ?J*=+"'B=4Q.U
MX=M<@;/4<01_IGC_ +3)%Q_3Q$C,3RMMV:)K4P8)FH!QT<!PT*A3.MWWWJN8
MF3Z<L7SIKC4=43'?7ZZZ_1$QWCN?. B8Y3W?OS1, $GGP,WBT6_0"$3([U].
M_643$?OWT1,(F$3'?V1,GS[Q'=D3(XW_ %[YHF3\3<GX>NLQU15'Y8_USQ=_
MG<:F_P E73(X3H1-IM-]#/6_HJ/_ */^8^1[YKO;/T_N20W;"[IT]?\ 6E8D
M&FK'^KI>&V3KFT7ED[9.[<SMB<G'*UC9>O%V+E)=F5J=-R>02.D<QRE3. "%
MP;6AIU.)CI/TGG,"7 EP<" 8(F)M:V@XCC?JOQ]G^<'_ (VN*WR_M?-M?_Z7
M_P _SRMS\3]T]_BV.A!UB;VTGS\GV?YP>W_9:XK?_P ?-M?E_.7_ #_X/VX
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MPB83]!WT;HO78C[^;\!--FWM89=4##/0$&<Q81I(G TZ/BSC_"^T>P&FY[1
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MM2Q_LQL#0:D>ZV?Q'3+W.<8#=ULY(X"]A"/%-Q(K14,59HBF!"+*)NC  ^B
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M^78=F,DF =9VJ'B-*K:I_+J&.;">1)]WSU7)K[%4IDNIC?9:TB1]3W8*,Q[
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6")A$PB81,(F$3")A$PB81,(F$7__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>g60414g23y18.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g60414g23y18.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2&@4&AO=&]S:&]P(#,N,  X0DE-! 0
M    (82^A8 X0DE-! 0      &D< 5H  QLE1QP!6@ #&R5'' (   (  !P"
M4  (<G(U,# T.3,< @4 0$UI8W)O<V]F="!7;W)D("T@4')O:F5C="!(;V]K
M92 M(%,M,2!296=I<W1R871I;VX@4W1A=&5M96YT(#$Q.#0 .$))300E
M   02M!7QOQ5NH+"G,?Z/(X2LCA"24T$.@      Y0   !     !       +
M<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0    !)
M;G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I;G1E
M<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    , %
M<@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !     $)L
M=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M  (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7     $-P
M=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B;V]L
M      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L      !%
M;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0       %)'
M0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M      !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
M     $)L9"!5;G1&(U)L=                %)S;'15;G1&(U!X;$!RP
M        "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0    !09U!S
M %!G4$,     3&5F=%5N=$8C4FQT                5&]P(%5N=$8C4FQT
M                4V-L(%5N=$8C4')C0%D            08W)O<%=H96Y0
M<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O
M<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M"V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  $#O_XU
M  (  3A"24T$)@      #@             _@   .$))30/R       *  #_
M______\  #A"24T$#0      !    '@X0DE-!!D       0    >.$))30/S
M       )           ! #A"24TG$       "@ !          $X0DE- _4
M     $@ +V9F  $ ;&9F  8       $ +V9F  $ H9F:  8       $ ,@
M  $ 6@    8       $ -0    $ +0    8       $X0DE- _@      '
M /____________________________\#Z     #_____________________
M________ ^@     _____________________________P/H     /______
M______________________\#Z   .$))300(       0     0   D    )
M     #A"24T$'@      !      X0DE-!!H      S4    &
M  2P   %E@         !                          $
M!98   2P                      $                         $
M  $       !N=6QL     @    9B;W5N9'-/8FIC     0       %)C=#$
M   $     %1O<"!L;VYG          !,969T;&]N9P          0G1O;6QO
M;F<   2P     %)G:'1L;VYG   %E@    9S;&EC97-6;$QS     4]B:F,
M   !       %<VQI8V4    2    !W-L:6-E241L;VYG          =G<F]U
M<$E$;&]N9P         &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -
M875T;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI8V54>7!E     $EM
M9R     &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG   $L     !29VAT
M;&]N9P  !98    #=7)L5$585     $       !N=6QL5$585     $
M  !-<V=E5$585     $       9A;'1486=415A4     0      #F-E;&Q4
M97AT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4     0      "6AO<GI!
M;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R
M=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX    '9&5F875L=     MB
M9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO<E1Y<&4     3F]N90
M  ET;W!/=71S971L;VYG          IL969T3W5T<V5T;&]N9P         ,
M8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/=71S971L;VYG       X
M0DE-!"@       P    "/_         X0DE-!!$       $! #A"24T$%
M    !     4X0DE-! P     %N8    !    H    (8   '@  #[0   %LH
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ML^G^E1&=%>YN.RPT45XA+L9N/2T
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M*6-[!<7/!94#K+-%9W+6UPLQ=B'D93'<+H"Z8FWSD5Y=5^D1G6/2(WUU3ND
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M:,L3"&-T-[:AI5FT7%HV"X(!<*XWQ"_N[VTG6WMS/;/?<#D$<A62T$\]LKW
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MK+Y"U%,>TI%BSD&\N!U@V'N],/XY)3(8HPDFF&CLCJ)7;NE>CAW9[@'%N/\
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MPFVC-G,R$7J6W^L0O<R#-MI(G)96).>:'LM>77!)ENN)<0@O.(&;B,]JIMQ
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M!=!R%[Q)X>$\)XIP[M/'"\;R\%L^&\03AMX>\8TO+JSF%E,V!AH&CE6$;YB
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M+=!WQG&21OUVZ^(!%$N%*Y?"$NR*!DDZ6TYP![L_WG(Z9[JCIWT;QW2FT5W
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M5;?*B[QPOG"*K]RNIMNJNZ6W66<*[;J*J[[[9VS]?+Q >I)<,2HTJFHZ449
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M.@.1GP)W.U>'C/PQCX9\<_'QQX_#Z,8\/N_7X?O?N\Z 2!@';\O=Y5B0,DC
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MBXBAE<1AG$G-4,RZ0 A!)KS^(<)C:\_6KK+=)!P>ZX:]A!$&EN4N'5G,9+J
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M;:Z?=5<!]M_(0TU^.=]A2OM>?AA$6KGZ \/S/]:@G )W/NW/PKV@IX/(F6"
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M.&SCSWS[,_:36%,:#[2%%L-DZ-;@MLY\/;I;:$%9B]/'Q^VW5B+R<%LZX_\
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MJ2,#T(7&>O@Q!\/+RK*$^PD;;-\KR:!W;#]D]<[N-"E,V >0:)ZZYVW5>%X
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MP9D5FVX29J9VV59/K3L8O*9\N.5WWWWR+S(=1FF=LX29IZXQKC-I'?9FV\%
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M@Y:N$E$%T=]TU=-M-MM<@2-P<'S%00",$ @]0=P?LJLD&Z+],:U+#9!!NJ]
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M6W*)ATKCT.K.%0UH]<)ST_)Y**C N+1MNIF:21[HLFFH7(:Z<H(E/+4ZLMK
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M/#![%R!  \OGD2%-WZBSZ+&M4M6VU_29"P+$$!9 %"HH^D4JQP$QDC&^-6
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M=9F@XWU3(CE7="K  ^?AD$C;.Z]1D;C(P?#H<1J&,Y&,LHW'5< [9R!DX#$
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M76RVB:NZ6K=[N@ME35)39/&F=M4]\XQKF1C(STSO[J@Y((&Q(V/E[?LJ(AM
M1Y,<P3(S"ZU2&C)KH_43[!W;ZM1YJ@GAUNGX3I/'DW7QOMIX)Z8\N<>&FN/#
M7%N8? )_PXS^.G>J\L>)?/C]))U^]7=^P'$?OMN[\H.[OT]XYC>2?\./_EIR
MU\W_ .))_P U/L!Q'[[;N_*#N[]/>-;>2?\ #C_Y:<M?-_\ B2?\U=,C0$=4
M8/M!\PNM)_NS<ZLE5.P=V^K3=[(J8;;J8S.U,9TT6SIMOC*>^,ZXSXZ;8^UR
MUD^"?\-!^2TY:^;_ /$D_HU2E"&)X9"XB-E3W4E*!\8 LI(1T6W<:/S[44T0
M,/=%U$D%%]'1'1ROJMN@CNIJIC?9)/;;.F*591@ $Y(&"3G<^)WWK*.*FG%*
M<4K7GW2M"Y:\DL0UHN9XC\T^0\VEKT=8[NFA_6W2(PY0<ZDTNMM_+#\:N9BR
MBS=ZV4>%:==E/<XUYAS)A&R2HY3;>)48-K P649&OFG.1I3&8_')UXR<:36<
MK,(VT&)9 0X+ELE0""NQTA<G6S%=0T *VY1Y[J<C:%NUA+XU?T/A(-\49;QG
M$EJ29/)36UF1&6P@004F$"(E1PN2"F&V\@)Q_=F:9*JI$ JQ :4+C';-YM1@
MJE2C$[9(8$,C!F&EATS@!NZ2,,,X.0+!28UU/&Q=#J$1D[F[+I8O&BZB '!C
M:1-+KEA('C2K(ST<J(*.R03&[0 1%_,(=)*ID*T-IP'&8VO5<O@T3@<E38P\
M?)\,&MMEV$)CA)Y:;MX2:+D!K-LO!5@3%@&:W$YR,J#A@^Y).H$D;D'NY/JD
M$=?.L5A*@:60$$[F)&R"J(0VH'6-*+E7U(6!.G#,#/\ 6/5 1 )<Z+EY&VF<
M/$@K(B]=0<C%&2#>,1VV;086Y-&4B).211.:.L2@+'V<;>>ZH[H& !6S5XU,
MEW#PZOF\F1TP1@E@3X+I&!C;8>VKK$%Z'*[X7&  S:CG.<[YQGPP.HS4C];V
M[=I3,0:M$$6S5LM*&[9LW2T0;MVZ,PD":*""*>-4T44D]==$TD]==$]-<:ZZ
MXQC&.)/7/CLO7VJ*F(80#R+#_P"HU./*5I5&^]#.<O8W1^D-5FR Q*\?6S]:
M$QF])@HG$/L,W(BUS((_UT.1VS7H',X6AFF-F!9N-:GM@;HGJJBCJGMT0% )
M]94$P@1ZADZ^?">X2=*MH#Y+=W1K7J16\;1"VXB)##K:TC6W$D,TLAF%_8NP
MMWA91;S>CK.S32YC:V6>W YT\3"C 2\_2*0H76D1C%3V!*G@*LRHH[I8L!F)
M?>1%65(V3)XM.7,O7"^#ER9LH/7L8W 3*V(U8HG)9]%)E!21)?%K;6Y<+!CK
M4'(8#4H &M5*X+ DX)/<5MAJV ..!?2&!*!2L4*R.9'5&.0B%8U<JTSK-(HT
M1%I>6))3&(HY'20Y'</<*)RR76)$V,YF%5C*91US*+3JDO5#M_.(WIV6-Q3<
MK )"K'QL*@[\UK#0=O6:\&PX\+!-*\(NXX-@Y=[9 " D6&!90^5(4,6![RJP
M5@OK$$L 25P/6+=VM=)8%UE"!+?65D60R23<X1&)?HU16TL9P3E1$F@R&3N5
MXL![,=P++>6NZK N9GT*K+-LI!)(^H;W 9EA@'7O3XQ%X^6CCKW2YP6:.K>O
M20"(V,2CQV?*P(,+8N6S)L_]YG2) H;9FQG#:@.],"3@=#IC^.=LBN5)9GUD
M9*J"%/+().F C8XWRTFV^<8\*EP-?_;%J^<!W4$L&1B3DHJ\55,Q=T)+@9*1
MQ//85M'K5D]G!- S-O59!C3S_P!O8M9@RA>";89M+  751=V''4T(1G*J1JU
M#4#C" KIWRV6SG&=]LUH'DW!#'==+:""1KPVH8P-B,=.F?&HDLNQN_7V%#8,
MHE8.AR74)\H4I77="'"$U%W)+Z4W?#Z=8 HO[2^C85O/L%VSZ?KX:%821;AP
MYB5"'15@3TLHBU ]W:0 !F(4J&.23G(V _:'7._@)<Q/J9@Y"!=*9.7C<MIP
MI'<<*-R#WL '<IN/"X<:AQ6KOUOM>!K'#GU^=LK>T8:I86]=G?.=\J^L\WK,
M[Y\V=_'.WQ\><_S/Y_T_O-= Z#W>6/P\/=7I<5-.*4XI5,+FZI'[OGTJ,2^T
M6#BMY#64GK0+!%X$Z=&J\2F<.-Q:52Z"2GY=MX^SFQO<QKEQ(SU=R(BTC;1:
M&B5QP@Y(]RVR2Z$"A!D.'+9P6P<A6.,Z-AW00">\<D B#J8!6$31J_,"M"A<
MDJ%*F7:0QD YC#!<LQQD@C%%^E)PI(I%+SMQ(NY%:I=HXOG8=728P-.@0AS6
M.@,/#ABTR).:[=,@56"H\[+.2DVR_:')&]U8M"*H5R#GGD((PO=5BR#4>ZS+
MI8^3:AISD;:1I(!;-S),UL+1I-4*W#W2 ZLQRRQPQ3<L!@H$R6UN'+J[#T>+
MEE 91)8*+ @@;L+9R@<.+%*$ZEJ!Z2W&CVC'<@]4F]Z9W>/MVJ*67;K?.=L[
MN%\J*[9VVSMOG.<^.>3H ))PVVYZ:0/$GR^&!X5B-I2  !H!.W4EC^6/[Q4\
M<I6E.*57L31V".I<E-IE:BIXE+)J2UQ';OMH&&; 2$P./(DP9APDK#B1V!T3
M7",%VC >BW2<MEM<;N<XRZ6MJQT Q@=54GPSN5WW'PVK,1C?);.3T=U !Z
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M9\I!D0A!9L6$B%6LJ3'ZD1Q&6G+!@R*24Y:MOE5U*PQ_M#3IR2>X2,=,;(6
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M=E8J:XHO+;#L_;51NHI*'I1*&)ZD98YV@;7,H)/6TB?=V$:C6X<X TH06)1
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M-Q$"%G<&VO224160]8Z?&PXK)I&$A=?0>&MY=(:HG]/M)CH(B /U$GBD;L(
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M_D!_?M)S8WE*UIQ2H@H[]9)3^56]_P##A8?-)#EA_NXA\(D']*I'ZI_CE_\
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M]44<];.)8WA;=8.WWFO8?7 H;B&0^((;CT]M<J)[E429/.^VV%"*FF-=-</
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M2JD@ =%EBCD"D!XT;*C..5J*<4J$J@_7#?G\MKK_  7U=R3T7W?U-9Q]9?\
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M8"$DL'4%BND8"B3E]=6=6=P IR/'IG-)(712)"7)"E!'E Y!? DUYVC&HYC
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M;-@_^?0W][W7.:?JON/YUVVG1_>OY&NQZ4#_ ,7?W._VNUG_ -&7W/I.P?\
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M @C4QHU>Z;KR0ADH<<%%@S/=GLE'(Y('N'JA34*%-Z+$637T!8HHP3J8+J8
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MZ,P&=L@;^&1\15N4 H8H-))4,5&"RA2P!Q@D!E)&<@,,]17K?-_H;^LE4?\
M:VAO^)>.9)^^_P!YOG4:$_=7[H^58O)ZTZIPG ':95]U^B>LJDHF&1C,DB-=
M!,2*8'MEM0<5!Y)#VV"TC,[-G&HH(P]>2(;(+8:-ELI;XU!I#T9S@9."=@.I
MZ] *@B-<9"#) &0 ,GH,XZFO"DL#Z?L"!:$&8QUQC\J]T %G(5_'JS82$<RG
MQY2$0LFJ*<M$"""$HE^<QJ+N%$DTCDDT]RBU')+'L^)^E(#?2$9P&[Q&H G
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M'8 V@)X6YG& H+AR%P<'(7<G /3?.2!D#/6HCP2[!"NIANPTE\ ;D=1CU1J
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MN4DTM,8UY$RJ#E?K)1MC& W=QC'@?=Y>-(7>0LSXR8X7.%51KD4L^E5 502
M=*@*/  5LKYC713BE.*4XI3BE.*4XI3BE.*527LWV4J6-;_87D,(WMEW*["H
M&J9Q%BT$/R*LQ;'L!:,5@C)E.I+F,F80R*8CYLA+!T8/NT-R*;,*U>Y'?*F.
MK$=8XV8%@0-*NWK $A!O@$@GKC;)Z[8!(QD=<,N V#&&5L $2.J #/K,-8;2
MH9M(+8 !(AN"3'HC.PD8J=]256&-7\:BR!4'$.OQ>1UA%V#F13>604.:-NJX
M'LX^@[/CY=* VD@9"T&LD*.B"BC8I*!RYJ\D4T,CJQ*LC.""RAL[!MM17)R
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M/[%4A:;W$ JG8P-TCD(!26/!R5>2N AG]=JOGT6$EX+K( (0<8C TF$<@,Y
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M^E%S@ 9(SL!DG%9/%T/1V6#N[J@30-9+A!TUL[#889ZTIAX.<F]':N8+9Q,
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MBX!TGJ8<Z-UW"[KFKJ/1&149K>-?):0YUO))G3^T>LNN5)$64C>QB-.C8%6
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MF!Y#X"GR*AOWI1G\0BOS3C)\S\33 \A\!3Y%0W[THS^(17YIQD^9^)I@>0^
MI\BH;]Z49_$(K\TXR?,_$TP/(? 5XTCJ^"R6/G8X[C()JU/AB@5RY9! Z3UN
MW*L5V"R[-51BJFFZ22<;*-U-TE--%==-MD]]<9US(9@003D$$9)QL<[U#(K
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KI4=[O$,I PZDE7(&DN"4)4@FY7,JTIQ2G%*<4IQ2G%*<4IQ2G%*<4K__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>g60414g23y19.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g60414g23y19.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[13 4&AO=&]S:&]P(#,N,  X0DE-! 0
M    %*2^4H0X0DE-! 0      '$< 5H  QLE1QP!6@ #&R5'' %:  ,;)4<<
M @   @  ' )0  AR<C4P,#0Y,QP"!0! 36EC<F]S;V9T(%=O<F0@+2!0<F]J
M96-T($AO;VME("T@4RTQ(%)E9VES=')A=&EO;B!3=&%T96UE;G0@,3$X-  X
M0DE-!"4      ! < OX08.%%,:,>@>4A-]L5.$))300Z      #E    $
M  $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E
M;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M  MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J
M8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M  $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X
M0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
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M4'AL0'!E!B         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W @
M56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !!C
M<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M      QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N
M9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU
M  (  0.__C4  @ !.$))300F       .             #^    X0DE-! T
M      0   !X.$))3009       $    'CA"24T#\P      "0
M 0 X0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &QF
M9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       !
M #4    ! "T    &       !.$))30/X      !P  #_________________
M____________ ^@     _____________________________P/H     /__
M__________________________\#Z     #_________________________
M____ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M  0     .$))300:      ,U    !@             ":   !B<
M 0                         !              8G   ":
M           !                         !     !        ;G5L;
M  (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG   ":     !29VAT
M;&]N9P  !B<    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E
M    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M!F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960
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M;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
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M_\0!/P   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0
M       !  (#! 4&!P@)"@L0  $$ 0,"! (%!P8(!0,,,P$  A$#!"$2,05!
M46$3(G&!,@84D:&Q0B,D%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%
MPJ-T-A?25>)E\K.$P]-UX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M$0'_Q  >  $  @(# 0$!            " D&!P$"!0,$"O_$ %H0   & @(
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MMS5RQ8>LWKRX:6C826-+JH&D&36+B+A9 <M6[E)FY!R1=VDJHT;'2!DTG/\
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M1N507#<R:Z29R[J#6OJ!K_NPXGR:3^2TUW/;3)9]Z6@3WD!1-Y%<]]D.M/\
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M6P;]8']HM<PA'BX=FC8L)&1-&UZ),[>&AJW'P\/\VZ!@"ZA[LQG8 !H'1K1
M'Z]2C&Y1&Y)))YDDDD_73N[UN;,5FF$3")A$PB81,(G]_P"GVPD@;F$PB81,
M(F$4<;[Q$XU;0NBNPK]IVGV>X.5(1P]F)!JY 9%_654E*W+RC!NZ0BY6>KX(
MI-X2?D63J:BV) CV+]!B(MQS%1[1E#B!KIISWY<UK=2IN<'.:"1J/'KXK]5Q
MXI<>;ZU7:VG5M??"O=IW8POVBTK"S:-VM#)&-LMA96"#D8V=CWE@CFZ#&;(Q
MD6S:49HI-GR"Z)"D"![QIF.P;KT&PZ:)V3#!+1(=F!$CYNNA_;N68U#2&HZ
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MMEL2ITBIT5M,LZA!,(!K8+/8+G-(QZ9DR2-IM4@I*V*;<@8YQ.^EY%95X\4
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MBPA*]UMY8%JTQL==<334R@.H=*78'ET (0#&,K' X%V4$P,4RH?"*)"F*(@
M#WFAMW9OJF@+FB;@3_(%1O:::D99G8@S$ =5P1B%I4N76E&[LZMRR35MF5Z9
MN:0$2Y]#,'D:MV$P03 .F9E.!O7SE$.O<!#W_7V_,/0<VZYCJ(Z<Q[/5<X>O
M@NQC 4.Q$ ]>OWC[!^_,O?HH2!OX+S1DDR+J(F,F'E(!R?>#L?0!$!#OU$0'
MT#W'L #\<R+8:7=.I &7F>NGI^*UFHUI(+VS_P!F [,.Z2T-).D .GGLM9W3
M>&LZ"SD7-GNU=CE8Q$%GL>+Y)S)MRCU]PT6S,O(@<?.40*+?S" ^?T( CG47
MF-8;94[A]:\MVF@PN>T56.>" 3#F YF@#67 <]-"NIQ'B'!L+94??8C:T#2;
MFJT7/#KBF--Z-,NJDZB0&'37:2HQ6'Q!]5,W ,ZK#6VZJ.F#AQ%/XR+3C()X
M];_& T>K,SR\:V9"11 R#MRZ*FW9*K(@LH'F*.>4N?B-@=![64A<W1J4GOHU
M*3:3+6H6 R?M5>K2IL:'#*YSB V020)*\E=?$S!F/;3PZVQ#%#4I.?1JT+?L
M+:I6:'AUNZO=.I4Z9:]AIU*M0MITW.IYRW-!T"MXB-^G)#Y6%K>K:3'/F[HS
M22OMW^=<QQVJ?E%9XTK*3P#I+.%42MFJID'C@A7)P32(D05O*T_BG4N;BU8Q
MN!V-"XHW+G5+W$V5;EIHO#,_9V?;4RV2,K2X%Y:X!NDKSE3XF8M<5:C+:PPC
M#:;Y[&MBN)9^Q(IDEU6G9MJ$M<\L#*;G,JN;VCBU@8W/KUYS,VS.(5]=YO\
MT]2PES2:$FG"TBP6!W!(,RG5;O7/S1035</ Z:H-4?.F4X$54,H"GPT^#3^(
M6)7%'"ZAXDP"V9>B^[?LK&ZKU6BWGLC3S_=<=G-C74B1H.JK<<8[<"D:O$^
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MI%(DBBDD0"IID(4A"$ I0  PJK+L(F$3")A$PBX$0#W_ +^@C_8 X1? RP%
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M)TFUCV*7Q$T@5=KJ=%2**JJ:8&,( !C@ B&4!L2""08T GU&@\-%'.+2 6D
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MHA]JJ:V5I25OIEXJ<>RL)KI_ W>E[(H;!DUD:O14/AR-/A;M$G26C-;U:"G
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M:015KEU:H2.;C4D$^4<MEVEC\-^$K/YJN&_Q"I(.?$ZU2]C*0YI;3J$460X
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M:ZX/,U"V,=GVI64H\C"7_84C=8>0@9O3$56)Z5F*;13U>/4C;!#S\53U73:
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M!Z>]?#DN<*K\CYXWCVJSQVNDV;-TSJK.%C 1)%-,ACG44.("4A"%*(F,;HH
M'J(>^0N#07.(#6B228  U))Y!8/>VFTN>[*T:EQV &I)T,"!N5'\G+CBZ)>S
M\BM'E-V("4^TJ:0P"4P@("0TL4Q1[ 0$!*'L(#Z=9UQQG"02#B-FTR1E=<4F
MD$<B"X$'EKTT74'B# P2#C.%AS1#@Z^MVN!UD%O: B.A$CQ7DVSEWHFNZTV/
MM:*V34+W6-60HV"XA0;+6[,[BXP#A_++ SEA0;@9(%5B&>+-RJ)(+F((_#$
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M#AH:@5J5L4J\Z=+-'1CL"-VXQ#>*6:O"SSVP*Q+&",T<IRSEFNE\(23K'O\
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M?';2O;=CC6'L=7O,/:6W%N"<]YA[W9KIDZN>^D!VU%CB07-+1J1&;0U(@KM
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MZ* !UUW^?;2<T">L"1X'<;\EB6-( (D Z#6-]-!O'?I^5E!2@4.@_;^?YCZ
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MVA7[-57&NJ[9+)5WLTY;KEU,YOE[L;5)S6HTKM+:\ZS)'PD5*N-?'-)0;($
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M@(] 2- .4#?\UCE[(7[$7+[H>M6L'?I[_P"]3OWZ]1_N'J'IA7W^WFH6>%0
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M=6HBL  IY*!50*< 'S=* $6'F*(AT(!T/E$0 0$"B77_  3!X _A>'P"2/\
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MA$PBX,4IP$I@ Q1]P$.P']V$73X27K_)D]0 /YH>P>WX>G70==>W6$7<  H
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MOIK6_-S>MT\/AW;:!KIOKC1UNU-OC:6T[)LJ1C-NS=Q0T9<:I<Z^MIIEK!M
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M(DEWKI^KF,!P\UNU?3JO&=]44'5ZSK07%6@ZWK7(MB[LA7J4GU&.J9=>T>\
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M3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB818%LZ E;10K;
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MOJ-8QA$@F<WR@ F97Y^^+> 8D+NAQ%AKV"I09V-2E;@,N33%*H>UJ5'AS33
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MF?"'+]Q)!BIZ)O&RG_W:R:GO^TAC!F8>PB0]I W(<"!Y@K8*E,[/:>X.!)\
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MR<)T_P"$NVG?708EM'.9,$D==YMM)>.0Q*)4-?T4I>P$"DY=NA !'W'H]3,
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MJMS@I*MV%I%3T_5Y!W#R[91G(-FM@JTG#6*(57;*G2!]#RK"00\PF;NDC]&
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B)A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A%__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>g60414g29a76.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g60414g29a76.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2R04&AO=&]S:&]P(#,N,  X0DE-! 0
M    +'2^$3@#A"24T$!       (!P!6@ #&R5'' (   (  !P"!0 ,4V5C=&
MEO;C127W8Q.$))300E       0XU55E0WQJ$P?=#D.(R-SBCA"24T$.@
M !"P   !     !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0
M    !);G1E96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0F
MET8F]O;      +<')I;G1E<DYA;65415A4    % !# &$ ;@!O &X ( !4 %
M, -0 Q #  ,  @ ', 90!R &D 90!S       /<')I;G10<F]O9E-E='5P3V
M)J8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M    $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P
M X0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M   !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
M  0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F
M)O;VP      $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,
M !        4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&
M]U8D!OX            $)L("!D;W5B0&_@            0G)D5%5N=$8C4F
MQT                0FQD(%5N=$8C4FQT                4G-L=%5N=$
M8C4'AL0'7@           *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M   %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W
M @56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !
M!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M        QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&
M]N9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! !7@
M    $  0%>     0 !.$))300F       .             #^    X0DE-!
MT       0    >.$))3009       $    'CA"24T#\P      "0
M   0 X0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &
MQF9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &
M ! #4    ! "T    &       !.$))30/X      !P  #_______________
M______________ ^@     _____________________________P/H     /
M____________________________\#Z     #_______________________
M______ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M    0     .$))300:      ,U    !@             $R0  !04
M   0                         !              4%   $R0
M             !                         !     !        ;G5L;
M    (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&
M]N9P          3&5F=&QO;F<          $)T;VUL;VYG   $R0    !29V
MAT;&]N9P  !04    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6
M-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M  !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T96
M0     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T
M]B:F,    !        4F-T,0    0     5&]P(&QO;F<          $QE9G
M1L;VYG          !"=&]M;&]N9P  !,D     4F=H=&QO;F<   4%     W
M5R;%1%6%0    !        ;G5L;%1%6%0    !        37-G951%6%0
M !       &86QT5&%G5$585     $       YC96QL5&5X=$ES2%1-3&)O;V
MP!    "&-E;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M    #T
M53;&EC94AO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T
M /15-L:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G
M5M    $453;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&
M]N9P         *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&
MQO;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
M   C_P        .$))3001       ! 0 X0DE-!!0       0    ".$))30
M0,     "'7     0   *    "9   !X  !'N   "&[ !@  ?_8_^(,6$E#0U
M]04D]&24Q%  $!   ,2$QI;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0
M  86-S<$U31E0     245#('-21T(               $  /;6  $     TR
MU(4" @
M         18W!R=    5     S9&5S8P   80   !L=W1P=    ?     48F
MMP=    @0    4<EA96@   A@    49UA96@   BP    48EA96@   D
M 49&UN9    E0   !P9&UD9    L0   "(=G5E9    TP   "&=FEE=P   ]
M0    D;'5M:0   _@    4;65A<P  ! P    D=&5C:   !#     ,<E120P
M  !#P   @,9U120P  !#P   @,8E120P  !#P   @,=&5X=     !#;W!Y<F
MEG:'0@*&,I(#$Y.3@@2&5W;&5T="U086-K87)D($-O;7!A;GD  &1E<V,
M      $G-21T(@245#-C$Y-C8M,BXQ               2<U)'0B!)14,V,3
MDV-BTR+C$
M               %A96B        #S40 !     1;,6%E:(
M        !865H@        ;Z(  #CU   #D%A96B        !BF0  MX4  !
MC:6%E:(        "2@   /A   ML]D97-C         !9)14,@:'1T<#HO+W
M=W=RYI96,N8V@              !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M                                                          9&
M5S8P         N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W
M!A8V4@+2!S4D="               N245#(#8Q.38V+3(N,2!$969A=6QT(%
M)'0B!C;VQO=7(@<W!A8V4@+2!S4D="                             &
M1E<V,         +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14
M,V,3DV-BTR+C$              "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:7
M1I;VX@:6X@245#-C$Y-C8M,BXQ
M!V:65W       3I/X %%\N !#/%  #[<P !!,+  -<G@    %865H@
M!,"58 4    %<?YVUE87,          0                        */
M   G-I9R      0U)4(&-U<G8        $      4 "@ / !0 &0 > ", *
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ML)$ DE"3H)3PED"7D)CPFD";H)SPGE"?L*$0HG"CT*5 IJ"H$*F JN"L4*W
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MD:66E9N%H'6E9:IEKU6T5;E5OE7#5<AES672==>%W)7AI>;%Z]7P]?85^S8
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M@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,#!$,# P,# P,# P,# P,#
MP,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.%!0.#@X.%!$,# P,#!$1#
MP,# P,$0P,# P,# P,# P,# P,# P,# P,# P,# P,# S_P  1" "9 * # 2
M(  A$! Q$!_]T !  *_\0!/P   04! 0$! 0$          P ! @0%!@<("0
MH+ 0 !!0$! 0$! 0         !  (#! 4&!P@)"@L0  $$ 0,"! (%!P8(!0
M,,,P$  A$#!"$2,05!46$3(G&!,@84D:&P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MJZ4?'C?)WI3?'P-9UFV_9LF;'^=5_(&OJ28^LM0 ]!+INE3?M^83/IV"GO\
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M ,N.^=L+=O7&>QKMB>,_X>:"7M)_;%^IYP_:2M?.'247Z/X^MT74SF/)Z?\
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M;U4U*W&!@9:;9?L,\G_O 9J.UUT!X@- !92P:>YM[*KZ1C&!]!(P='V:X12
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M<C48M 2'(JJ)#%7 E/\ L_\ RB2W3'4.A=0;L^%:17@TW52!^<VG:F(&7/;
MG8Y'&<T'5ZVG&NZ-J^C8.'N'MC?:>#_9O+'QLKVY:%!SCT.)L:6\4SG/=[
M:$-(%]V!>74HTQ7=LQ$0U,4ICJ3K6JO%K3$D*D<JBJ,K4FRJ11,18A3@!3<M
MJO36NZ*VW5-+O;(9VJ]Q;R1Q.<D?-SE3!)VX,<K9],UOK#6=)U1<Z=J-I=G&
M2D,Z-*N!D[X<B5, \AT4CUK>3*-X@WVH0(]GI^PRKH!]*#)-G4[<H*GG^VU;
M_1^T J ^?D)TP53,'F42F#SS3$RIW+#''<D?MY%;.N\^J?#P7K/K/;6ZM:"
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MK2MVU79^M[R4IJ;?*A9S& 3>R@[#%23DH /D(*-6KI1RD8!$ $JJ1# (^0@
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M"NU9;9G-FN'%H5= _&\T^-<:UO\ \1(K[=*04O&N756M#IVBN +)G?2CHGM
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M'$QS@XXYJQBL=NZ[DH=G.6VJW>G0;P!,C<6L:WV!KAT4 *(J1M\U^YL$4_1
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M*4Q2L3N="HVQX1Q6MA4RJ7NN.@$',!<:]$6:&<>HHD'VT7-,WK)01(8Q?,Z
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M]!@CRVMZ'8<$#(G& HQSS4?K7I;O[6SH\AL#DOE7L6+CQ]HA>N9+O.<E;W4
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M8K<]-:FS!HV$H(?\FSR[3<1[T$+8F#)M$D7&:[I%S:W,FOZ- L]PT?A:SI+
M&#6[$#:X*$%?;HH]W@N58RKF)@V=DGGCZSXXT7<-*U/H;1L[)S/#ER<."479
M!F,C-;$\/S8DG)J*2NH]PPK(7]EEN;%[:_4:R3$2/;+IVPR0V2J*2Z4JXC=M
M^R].]3:M;:I<:-JT21]5VJ@W=CO2*RZQLTC CU'3I7"01ZVMN@9&RD&I0Q^!
M<>$8E?3?--:T+3KFPBU.PE=]!G)%M=[7>[Z:N7<E[.]C7=*^E>,Q#H=TMA(Y
MEAWH[)>3D\-7Q;=@:&ML9Q5XB\H9D:)0A(W5_1,S+(2T>I"3*:)J6%YN2"[F
M*MFO+1'.&3B@;Q8OG,.^CW+!.R/U45QG&O*=<?)U9ZO;2=4=%1[A(97O]%CB
M,;B6(GVKV6V($EO>V[AEO-*91(LBOX"!@(GW_2W6=SITZ:#U.X78(TM-3=PZ
M%'Q[/[1."8Y;69"IMK]6*,"/%8@^(/54FHFLFFLBH15)4A%$E4SE.FHF<H&(
MHF<HB4Y#E$#$.41*8H@("(" Y\_D$$@@@@D$$8((X((/((/<5Z^"",@Y!Y!'
M8CXU^\I2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2NLF86&L48[A;!$QD[
M#R"1D'\3,L&LG&/4#?M(NV#U)=JY2-_J362.0?WE')(I98766&22&5#E)(G:
M-U/Q5T(93]H(-6/&DJ-'(B2(PPR.H=&'P96!!'V$57CLGPFN&K]-KW&NZF7T
M-L50QE&^Q^:+//:(M;!P=05E';=.@O(NM.'2JHBJLO)UV0,JKY*J>I0I3!V5
MC\H?5=G$+:?41J]EV:RUR"'5K=U P%8WBR7 4 8"QSH .!P37-771W3]Q(9X
MK(Z=='D76E2R:=,#SYOYJR1%B3DEXVW'ELUK"1X\\0;5#-1KH;NV*WQ4TB@F
MWU/WAJZ,V,@[03 QB%D-S4'X!?72XC_A"=["/@, D64,8R0D5S?Y0]%:I@:U
MT>VES-]._P"E+YK3!.,[=*OA/9A?7"RICL,9R,;\C]36'.E]1B^C7Z-KK]JM
MP2./I7]KX5R3W&61AR#CCF.M@M&YM6O%)#I+PNMF5U9!7V9MV>')L1+8S54I
M!(+B53U5&.*C=8)B0XBY'XG$RRWL2BH8GK0, R#ICIC5.>G^MK*.1AGV#JFV
MDT>52<@)[>OM%E,Y''E*#.!GD"J?E_7[#C5^F+F5 <>UZ%.FI1M\6]C;P;N)
M1WY#G;GU&#LK4/=.D[G*#7=.>(;6V-K:NB1I],]G596@W8DF*@D"(5D[DVH-
MJD),JO\ @"A#IS1U?5\CF.F'GK-3Z#ZKTV,3SZ'<7%J5WB]THIJ5HT8&?$\2
MQ:X6-,=VE$>/4#BL^RZMZ>OW\*+4X(;C.#;7N^PN W'D$5VL+.W(XCW_ &9J
M?*&X^A*J@FXO6@$KM#BDDJ6UZ,MC*S(O4CD]?MV50G CIY5(Y! Z9DG:X'\P
M(3U^93FX]D )4L58'!5U*D$=PW!P1\/CQ]_1 @@$$$'D$'((^(([UQ-<=HZY
MV7MPFGHZLWR L"S=^"*MIA4(@Q):)8*R,K"2$8+U>2C'K)NW>$,9V@5([AHJ
MCZB@=N=>AC(!.0<8[9['@'./7C[P<_&JU,++*4Q2F*4Q2F*4Q2JH?$?3E4+C
MHB=B*;!*K5A&9GW.R+4KN4]7K#1OM314<J>9C=3VVGQ[H->EE3=%MY&]/GJ5
M9)H]W9*C'EF(Q]*Q65;XQ("QYXVC9D^1SP65CYL>&0N,[P&.#6)<YW(0HX!.
M\E\#SH.R$<J/G<D\;,CD B;_ "D<I^8N?5"5].JE/IK7!_HV@UL+-&$$U2BC
M&C4&UMDYJUD2;&$4TC6:7DK"J0"JS+US)*.5302^\DYSYVYXYY/PP/V #X<5
M/%[N/C'D7@ @#CMR2?VG)[GFHS;4Z?L#3;6M8.C[$BZA+2;=E*RN@-ITN/I<
MT_I3*Q6&-N-ZMMIL<N2P1",VRC$8;1T+4H896R79A)N9&.M5.2L3NCRK$"C$
MKGT#J2PW8&%  P<$Y<DX"D8P2,Q/*0ZA6"GN4< ':"0S$DY (XC Y+<\KG'-
MY1Z VE9]-W&4LZ,OTSLBF6ZOP\NOIZQ:%?5F9^D=(J-G$M M99C4U#=Q$(E-
MF=2\9/RPVN'=.U(\']E9_")%[26-0X (C5@2-X<,,,1YAAF!.."  ?@.158I
M&*$G,C*5!V%,<JIX)*+@9.03N';GC.=<GV&9M.Q.SYN?HEGUM*.NB*:1Q4+B
M^I<C/QI6W*'-K=%5X[U];;Q55"/T4DW[4&%D>JIM7"1'J;-Z5=HC24 )" P8
M;&Y&['O7_K!3_E58B2\Y*E3XB\$J2/FH^^UF'^?:IHY#4],4IBE,4IBE,4IB
ME,4IBE4N=3:/M/%VR-@=G<^4#])//VTFSHO?W(S"-:R49=ZVZ;+-)[?VN*N[
M*>'4O\-$KNE-B5L[=*-V! !(.I(47RLC*E]0Z?U:WZHLK/IC6;SV'6-/9?Y'
M]1O(R26LZL&AT>]G4B06<L@464^XO9S;%0%0B5PVKV$VA75SKNFV_M6FW8/\
MH]%559+B)E*R:E:Q-Y/:8T)-S$0%NH]Q8ABSU4/UUQOI>(U)4MHZ]LRU]\./
M8Y59_2>\:Y'.KQ<>"K'<GRJCROV2,5(M-7?D.T6%RYCKSKZ8'XSK>PKO56Z#
M.U(NR77T?IOJ;4Y=1N;"\@6SZVLL0ZKI4[K:VW5T%J@VS0R B*UZC@@57M;R
M+$5] %#,]N4-KQFM:'8+90W=M-[1TO=#Q+#4(E,\_3LD['='*IS)<:)/(S+<
MVK^>UE+$!9=PGR_@CQ'=L^'W<&/)?:)G<[HEA'Q#VC;&CI1Q>"ZRHLX9).J7
MVDVIO[TKMOD^P(*)*0%DC5']CU?ZS5J:;JMF3!!QB]7]%:=UC;/U%TQMAU9W
MD6[LI(Q:>WW<6XW-G=V[;1IW44)!$L#A(+_'C1,&=F67I[J>\Z:F71M=W2:>
MJHT%TKFX%I;N<0W-O,"QO='E!!CE0M):<1.,*H/K8@YR%LT-%6*MR\9/U^=C
MVDM"3D*^:RD1+Q4@@1TPDHR29*KLW[!ZV53<-7;595!PBH15)0Y# 8?G:6*6
M"62">.2&:%VCEBE1HY8I$)5XY$<!D=&!5E8!E(((!%>R1R)*B21.LD<BJZ2(
MP9'1@"K*RDJRL""""00<@UVF1U?3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*
M8I3%*8I3%*TUMWG70F_HP(?=VFM9;78)IF3;$OM*KUG78 <# *D6^E6#E]$N
M"^LXINHURT<I&,)DE2&$1S9Z;K6KZ/)XNE:G?Z>Y.6-G=30*_P!DB1NJ2*?5
M9%93V((K!O=,T[4DV7]C:7B@$ 7,$4I7(QE&=2R'X%2"/0U -?PDM7Z^64DN
M/]_].\8R'O"CU.OZIVO.6C4SM\<#B12<U-LQ:UUZ4;)*G,H1BW<1C<H'5(F"
M8&**?7CY1;^\ 3J31]"ZG3 4S:AI\4&HJHQQ%J%B+>:,D  L5D8X&<XYYT]&
MV=L2^BZCJVA-NW^%9WDDMDS9S\Y979FB9>_E4HO)X[8B-RESSXL% \42R73?
MMJJ.S^<$JO.P\SN<*CJ2F([#A0K16E+<P%,J)!M=5V">P(1)K854I8\6+";;
M+S$M&JP .MYK]]\F5UT3&=%TYM.ZEDFA9;,27]S/:/XP:Z2>]N?F;BR\$R"W
M()<LT)\.-UE":K2+;KJ#JB0:I>+>:&D4JFY*6L$5PGAD6[16L)\2&Z\7:9LC
M8 )1O=3'GT-9Y#7HM,4IBE,4IBE,4JGWH/4'05PZ+G):5TAT)N#3R^V8QT\C
MJ'TI4*#K^SZ#:<VQ\7&T1#7<QT#K@K2V0O5 K[%D)]S6HF5D(=B5L%NDX<4*
MTMEQM&(@-\:OM.,QLS"3Q<EMPC;(,7EQNP#^;G)K"D21I23'(Z;^RRJJF/PL
M!=ID3!$GF)QD_P!;'EJQCFZ'V)7>?-(0&W5'ZVTX35%!B-B*RLPUL,HI<XZK
MQC.QGDI]D[?M)N0-*HNA>R[9^]1D7(JO".W)5@6/CR%3(Y3Z)9BO&."3C P,
M#'88&!Z"LJ,,(T#_ $PJAN<^8#!YR<\^N>:V2^J54DY=G8)*LUZ0GHX$ CYM
M]"QKN78@U5.X; SDEVRCUJ#==519 $%B>Q54.HGZ3G,8;<D# )P>XR<']578
M!() )'8XY'W&NTCXV.B6P,XI@RC&@*KK@UCVJ#-L"[I8[ARL"#9--+VKAPHH
MNNIZ?6LLH=503'.8PT))[G/WU4 #L,?=49M"_?/VY^(2A?E%YGR63W</Z#?B
MO44?O)_TU_"C[_\ .V*E-D52TQ2F*4Q2F*4Q2F*4Q2F*5_! # )3 !BF 0,4
M0 0$!#R$! ?D("'R$!^0ACMVI5'.W]?._#&V#=-QTZI*WGPV][RCP.K-"M8C
MZ0L^=K):0"/E=W4*J&1<HNM46 %A:[4HK1N9M&HKA(QC%:/29Q\3ZMIMXG7=
MG:Z9<W(M.M](C7^3^K-)X+:U!!AX]*N[C(*ZA#@MI]VS!G(V2,'+/)P-[;-T
MI<W%]! ;CI?47/Y8TX)XBZ9+-Y)+^WA.5:SE!Q>6RJ0N=Z*4PJ0.ZZX[UWI&
MCUZ7;3,G>/#5O#P+GI+>M'*-\V#X=5SV$":K6Q5]4AW;G8_'>PE9!LC<Z*[7
M?,$&CHP"FA/ECG]KZ[ISJ6^U6[FB,4=IUS:)[+JND7>+.RZUMK+@P3 A5LNI
M;-48VUVH1RR @M#O2WY_6=$M;&WB8.T_2L[>/I^H6V9[GIF>YP1+$P+&ZT2Y
MW#QX&+*H/ #[7DUAR)U]O?PN]CET9N2,->^=I6.^GJ5;HT@I;8-KKJ43-)#T
MMQS/&.?Z=Z8>L_:V#9.FDEPL&OD1D+/!M"Q[6U(1>?U'TWI/7UB=6TV06FM1
MR&S,]TGLTK7L7D_(?4L/_P )JBMB&RU,@PWA"02N7:W,F#HNM:ATE=?DZ^4W
M&FLOM'A6Y,T:VSC=^5-#D)_G%@R@R75B"9;8;I8UVK.%]:6N=C47;M'K.RM9
MVJ&NU#N44WFJS:*^\(^BI>-<@($606)Y&(HDH51L[:+D1>,7B+AD]0;NVZR*
M?SM>V5WIMW/8W]O+:W=K(T4]O,I22-U[A@>X(PRL"5=2&0LI!/LMK=6][;PW
M5I-'<6\Z"2&:)@R.C=B".Q'9E.&5@58!@0,US%J>F*4Q2F*4Q2F*4Q2F*4Q2
MF*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*57EV%>=I1.W-*46BV7
M;\3!V6A[?LL[%Z=G>=J1-2,K59O5#"#>/K?T:R=P3QE'L[3.)#5*JHTFG)WY
M9R0%S'Q*9$9X@I5RP0D,@!<2, "&R L?.20.3QQ@<DUCS,P9%#. 5<G88U)(
M* 9:3CC<>%P><G@8J;6N32!Z!2CRRL^O*'JL":16M<A59:SJO31C872E@E*,
M4E,D9DZPG-)/:H0M==.Q66AR@P.@ 0M])L8QDXP"!W] >0/@#S\>:F7.U<YS
M@9W;2?UE?*3]W'PK,\I5U,4J+.A?OG[<_$)0ORB\SY+)[N']!OQ7J*/WD_Z:
M_A1_\X_US4ILBJ6F*4Q2F*4Q2F*4Q2F*4Q2F*5PY&.CYB/?1,LQ9RD5*,W4=
M)QLBV1>L)&/>H';/&+YFY(HW=LW;=51!RV7341714.DJ0Q#F*-R.\;I)&[1R
M1LKQR(Q1T="&5T92&5E8 JP(((!!!%6LJNK(ZJZ.I5T8!E96!#*RD$,K D$$
M$$$@C%4<NXP_A27M]1[>Q-<_"FZ"GWL(5O8&_P!(V/&E]OKA5K(56R-Y(CPK
MOFK8CM\N@ OP7CJG*OET'R:!WCE>Y>K*_P#V@VB75L_LWR@Z/"LN86\!^IK.
MT&]+B%D*E=<LE0'*X>YC4%20BBUX%D/1]PUO,IGZ/U*1H\2_.KH5Q<$AX9=^
M[.E7+,P&[*P.Q#8W$SQAZRY*J7*%?;U:Y%M=N\,ZTVMM<-6[2I+U[+[F\,;;
M<\]1=0NP-;V5L9W,R//TQ-+LW#YBFZ>)1(+>EPBZ>'15MV^Z>ZCN>H9FN+;V
M:VZYM[9K6_L+I5CTOKK384*RV5] VV)-8BB#B-]JF0C@J@(M]5K.C0Z1$(IA
M--TK+,)[2ZMV+7O2=[(0T=U:2KEVTQY-I=06$6>0P/SL9]#[=Z4\,'>(5%.-
MCMD4+92)M@.=9:^5:EU+UE1'""#I;HKBU=(_P&H;Q90RK:4V=SVQ7:05M;B1
MQ2VONAJPA7M[J^FZ'UYI1N=[V-Y8GV-;^\W?E'IV\#%1HO5 ;YZXTIY0T=CK
M+AIK9LBZ;=[0TVJTZ\U3I/4# %2YMKHFY-I;;19ZS;D*QU/02,QPZ@L9#W>F
M(RQSCS6X(,(C]4VA=^:GZ9U=6MQ:6MS"YT2TMQ49R+,3).X]\CZ2R,#/1JP%
M>P=AAW!A:RT-(I(O63@OD=,4SI*J?/VKZ1J&A7\^F:I;/;7=NV&1N5=#RDT+
MCRRPRKYHY4)5QV.00/7=.U&SU6TBOK&99[>895E[JP^E'(I\T<L9\KQL RG@
MCL3N+-;6;3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3
M%*8I3%*8I59O==,B]E[+TK2+'3[)=:Z2D;;M2L;JJ@<]["W$TG(J<U1$P;Y"
M-W[7+.U8:T$9YZVL[VKQY/:6E:D(6UXA6Q62<Y$+%4=@<'<@RS2*F"&)&8R/
M/Y1@$_1#8!.,8TZAG0$$C:YPBQL^<J!Q(#A.>2!PVW<0*FSH:)ML#I'4<)?8
M2#K=VB-;TN-ME>K+&%BZ_!V%E7H]O+Q41&UL35R/8,'R:S5!G7S'@VQ$@1B#
MFCR-S#$Y!=RI)4LQ!.22,]SGG)[\\_'FIHPP1 P 8*H(&  0.P XX[<<?#BM
MLY95],4J+.A?OG[<_$)0ORB\SY+)[N']!OQ7J&/WD_V2+^#&?^M2FR*IJ8I3
M%*8I3%*8I3%*8I3%*8I3%*QBZTNI[&J5DH5[KT5;*;;X9_7K-6YQHF^B9N%E
M&YVK^/?-50$BJ#A!0Q!^PY#>E1(Y%2$.6>UNKBRN8+NTFDM[JVE2:">)BDD4
ML;!D=&'8@C[CV(()%13P0W,,MO<1I-!,C1RQ2 ,DD;@JRL#W!!^_U&#5,VO)
MN4\-S8,5QIT@^5O_  )NYZ\IW+NY;Z"<XSU5(3R3A,_*^\'TD59LM5W;4Z[3
M6UFF2?#W$6<T*]5^'-GK>I>FWL,?6]E)U-HB"SZOTI%N=?TRSS$^H)"01U!I
M21X83JP5KZ"+SK)\ZHWE&N>&M9'Z6N4T/5&-QT[?N8-'OKC$BV;2!LZ/J#/D
M>$5RMI+)E2F8SY%(ACGU'RU5N-*]+:OVS VC9?A3;#M:,U"SD,M(2.WO#5VW
M)R!CP>P->3J*;V>1T^:=?BHBNV(\6JSARM'R#>13DG4;L'=Z#U!<=331W^G3
M06/R@V=LT,L4HC73>N-.1/G;*]A8I"=2\),$,5%P K(R>&KV6NU;2(=$B>TO
M(Y;KI"YG$B/&6:]Z6O';R7-K( T@L?$;(P&,!8KM969)XJ5F2Z=\/?HR'F*;
M/5V]V7<:+.<JDTQD&<3SKXG5"]BB\CGL=+-5W-=U3V_'0SQ)5L_1<&A]Q.G+
M9<AI2=FTU-J]!/'H766BRQW,,]I!II>*XB>-I-:Z$N\LKK(C 3ZATK)*I#(R
MK)IBAAM2*(_D[30MJO36J(\,D5Q+>@20R!U33.K+; 961PQBL^H$CP0P/AWY
M;(WR/_._3'RQU;J+K[6:.R=42KP#,7R]>O5&L;0T+L#5UWCC&1FZ-L&L.#>_
M0%BB'2:R)TUBG9R")"R$4[?1ZR+D_AG4'3VI=-WQL=1C7SH)K2[A;Q;._M7Y
MBN[.X7R302*001YD)*2*K@J/4](UBRUJU%U9NWE8Q7%O*OAW-I.O$EO<PGS1
MRHP((.58#<C,I!J2F:.MK3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8
MI3%*8I3%*8I3%*8I3%*J!Z(OM$LN_P!.A]'<TRVXJE3^AW\% V1_Q[O/<3&E
M<^V/D.LW5>S4NY:_UY8ZX[E9GIF,:TB<!-W/22,:JZC7\&S1C6<U%9<2N$+1
MR!"T>2/&C3<XE*X968' B)8<#GD'T.'(ZF3;+&7VRD F&1PL9B#95E4CF0!2
M<G@D$?"TW7B=31H=,2H<,I7:2G5X,E2@%JW+TU6%KA8UL$-%J5*?C8><K)V,
M>#=L>!EXF-DHHR8L7K%JX040)BMG<=QR<G)R&R<\G()!R?4$YK*7&U=HPN!@
M8*X&.!@@$<>A (K,<I5U,4J+.A?OG[<_$)0ORB\SY+)[N']!OQ7J*/WD_P"F
MOX25*;(JEIBE,4IBE,4IBE,4IBE,4IBE,4IBE:OW/IG6O0>L+AIW;M6C[EKZ
M]1*L18(*0*/I42,8BS5\Q<IB5S&S$4]2;R4-+L54'\5)M6K]DNBY;IJ%S]+U
M.^T:_MM3TVX>VO+2020RH>QY#(ZGRR12*6CEC<%)(V9'!5B*Q+ZQM=2M)[&]
MA6>VN$*2QN.".X93W1T8!XW4AD=5=2& -5<\_;-N7*NR67AP]MR@;%UUL"/E
M*[Q[T/>6K5_#;NH0MC,G'/\ M]9VD:*';E9AW"40U%^F1GL.&.W1*B$HYC4)
MSOM8L;;J"Q?K;I:/V*]LWCFZET:U8I)I=YG<NL::$(D_)T\BF5MA+6<NXD[%
MD,7):;>3Z/=KTQKSBYMKE'CT/4[@!DU"WQM;3;TME/;84(0;\"ZCQQO*B2-/
M1'.U8X@KUFU)N"H2^Z?"&W!. =]%B$C-W_P_;_-R!SL+?3Y1#WJQ!IT9R0.]
M8R$>9>8HD@L?T^]'=/&U\WFBZU<=53P:CIES'I?RCZ;%A''AQ676-G$@#VUU
M&Q6'\I"&,(Z/MBNT R5"JUGJ]3TR'08I;*]@>^Z+O9!O3#O<]-W$C';/ ZYE
M]@\1MP9<O;,>,@LL\2;/5-_\4[YHE]JNVH%]>+ZQB(_G#KZ6>M_T!]Y:Y,T2
M>UGG+LI]'."0,%O5M!D1:ZHZ!([9H6]H5F$S+D<$+8J]T5O<:/U1I%W9W&G2
MI:VC2OK?3<:M^5^D;[>4GUOII9%\:726ERVH:.5=K9M_A1E3X$^FEAU+0=1M
M[B&\C:XN%1-+UJ1A^3NHK4J##I>N,A\*/4!'@6>I;E\< ;WSB6+T.<?=GZ_Z
MWK,ZBRB9?6FZ=;/B5W>&@;N4&6PM46U/S379R+-5-L>7K;]5-1:M6Y@W"+G&
M/H-Z64BF]C&?C/4G3%YT[/"6DBOM+OD,^E:Q:'?9ZA;'D,C MX4Z @3VSMXD
M3Y'G3:[>E:+KEMK,4H5)+6^M6$6H:=<#;<V<V.592!XD3<F*=!LE7GRMN19C
M9S5;NF*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2
MH7]4;NW;K*=H%5T[0PL![TTE6K^Z.-=WW9D+1)%K;==LEY2R0]#D8=1E&P.N
M9K9&PF["7FX=QL*7I$3K6I/4K-:&BJ4T2(P8NV-O.W<JEAAC@%L\LP5> =H8
MN>!4,KR*5"+NW9&=K,%.5[A>V%+-R1NVA0=S"I$:=LMNN>I]:VZ_5WZ(W>S4
M6K3UMJXM7C$8"Q2L*S>R\2+"057D(\63Y99 8Z077?L!)[F]65<HJG-&X4.P
M4[E#$ _$ \&I$)9%+##%02/@2.16R,MJZF*5%G0OWS]N?B$H7Y1>9\ED]W#^
M@WXKU#'[R?\ O%S_ (,=2FR*IJ8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*C]TY
MS1JWK34%BTUMJ*5>04P*$A"SD8J5E:J+;8P3K5V\TJ: AW$':JZ\-[S'OT/U
M%D3.HR01>1,A(,76XT'7=0Z=U*'4].D"RQY26&0%K>[MI.)[2ZBR!+;SIY70
M\@[9$*R(CKK=5TJTUFREL;Q"T<F&21#MFMYEYBN(),9CFB;E''IE6!1F4P;Y
M6W[>:[>9KPXN]?A-BW&SK$HEJ79\['(&I'9VDDFJS)Q*$:215V"^RX6'];#:
M-)<'=KO"D=S2)7[,9%R'5]0:/:36D76O2/BPZ8T\9U&QA<BZZ8U4L&6/?'AU
ML99//872[0N5B)1MBUH-(U&XBN'Z8ZAV27RQ.+*\D4>!KM@ 5+@/E3=QH=MY
M;DL6\T@W+N-16W1I2!\/^(MNJ]L4]]O/P?=X22D?::M+HR-FL?#5LLTH4[:7
MB5TS.9Y71;N?<I/XZ2C%4Y[6MC4;2<8Z+->A2Z]!I>JS=826VH:=<II7RDZ2
M@>VN(C'!#U7;P1D-'*N%A&K+"I1T<&&^AW1R+X1Q::B_L(^G$GL[R W_ $3J
M#;)H7#RR]/S3/Q)&03(=.,K!E9/G;27$D;!A\]$7<&H-B<D[$U)<";S"-A3-
M(N)X<\2WVZ,Y7'=8EVZ3VM<G=XNHKVL5==46&/\ =F.OMP.A6)$L$FLFV4"-
M9OHFL]'IFI6745EJ-J=*WR!GDZKZ&VF*X%Q$Q2XZAZ160B2UU"%\O>::H7?(
M6C(,C))<:6^LKG1KFRF&H!$(2/I_JLD21&)UW1Z-U$R I/9RJ,6M\2=J[6!"
MJRQ7G<:]PQ_1+RRZ;VQ4CZ-Z\U4V0_2QHN:>$6%RQ/[)-KLG5LN8YD+WJNQ>
MU;NXN?B5WWPPCYDUDEU4'L-+S?E'4W2CZ*L&I:?<C5NG-08_D_5HEQM<9+6.
MH1@9M-0AP5DAD";RCL@#)+%%Z!H>OKJ;2V-Y#[!K5F![9I[MG<IX6[M'[7%G
M+PR2(6V;E5SYD9Y]9R%=%3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8
MI3%*8I3%*8I3%*I(\032FK4=WU:TS,56)NU;B=UI&1/:M2\.C%0$*UN^FM%-
MWY;[N?D?<^QK;(H6#:=1DW</)6!TTA*DQL3TDK#,8JNUZ2S('<H54L @/9IL
MDX=_HI*B@84C..3@<DDC!N442*Q )?:.4@X&Y$^D\3LQ!=203@+DY& #:+S'
M*P$YSGHF9JK1PQK4KJ/7K^ 9.XFG03AK$.ZM%K1Z"D/KR)@:#&BDU.D0K2DP
MD34TB 4*]',XGW1 F-)D2.#W#,#R3R#CNQ+?O$GX\UE1$&.,CML7'"CT^"@*
M/N  ^ %;RRRI*8I46="_?/VY^(2A?E%YGR63W</Z#?BO4,?O)_[Q?PHZE-D5
M34Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2HF]B<CT?K_ %@E3Y^1D:7?JC+-
M[KI?<58,9K>=/;+B1*O!7"KR2"K9V0J3I%!.:B2.V[>:CBBW44;NT6#]ET/3
M74=WTW?FYA1+JSN8S:ZIIEP-UIJ=C)Q-;7$;!E.5),4A5FBDPP#*71]-K>BV
M^MV@AE=[>Y@D6XL+Z'BXL;N,@QSPL"#PP =,@2+P2"%98^\A=.6+:SR_<2=J
MUBN0W6.M:VO'WJNO&+1?7W2NI9))6(;;EUTQ?-B1\]4[4R4,SNU<(T,2OS*S
MV.>QT<BJK#Q6YZDT&'3EL^J>E[B:7IZ^G#VDR.RWNAZC&1(VFWS*Q>&YMW&^
MUGW?/1A71W($LFNT75I+QKG0==BB36+6,K<1LH]FU6S8%%OK5& 62&9<K/$%
M(CDW(5491(?;%UNCX:Z-IUWL:K.MX^$)NQZZA;53YUB]N4OQ?,VU^ KB9NH#
MR4E^>I65<@Z25;F/,Z_FCMY"/6+,%(M;NELKX]<&WO+*X72OE(TM5EM[F%EM
MH^J(K=#CD;8X]9CC7:0WS5Y$"CKX61;:2ZM5Z6$UM<PMJ'1=^S)/!(K7#Z%)
M.W/E.YY-,=VR,9>V<AE.X SQ)Z#YY5Y@+JEW.;5LCWEJ+>1LGPGXC-,=A:]F
M\02=C]*U6U9NN98G7)M3DFU?$$HZ(E))RYBH^'>J0KKW5NZ9 /1:-K(UXZ@L
M6GP)U!(KQ]6]%72BWL>JDAR+C4-+BDVG3^HK?87EB11(\B"4%BKFM-J6E_DH
M6;27DK:1&5?I[J>$B6[T!I>8;.^D7/M>C3;MB.Q*+&WAMM!6K>..^Z)J]6\O
M+?5T/ :NZWA(-&:A5(1\5SJ7IFC @*S+;W/EE4$&EAAY5BF,G*U9%968@/\
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M#1XS=('40<M7*"B:S=PBH=)9(Y%$SF(8IA\B='C=HY%9'1F1T=2KHZDJRLK
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MBA>_21[+\I5KC,%IU]:0<?0AM^K;:!/4^6.+6H8ESGA;I%[;!FTXOY_HJ?\
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MBE,4IBE?A5)-=-1%9,BR*Q#I*I*D*HFJFH42*)J)G 2G(<HB4Y# )3%$0$!
M1#*@D$$$@@@@@X((Y!!'((/8T(!!!&0>"#V(^!JD>T14_P"$;M.4V73XZ4F_
M#3V_:P?[5H<0U=23GC+8UF?$17V72XIL198NC+3)N$OI=68Y($ZC(K^_0S7V
M9VL9(>IV\D/RC:?'8W+QQ=<Z;;[-/NY65%ZGL8$)%C<RL57\K6Z ^SSR'-R@
MVR/G<Z<%,DG1EV]W KOTK>S;KRV0%CH5U*X!NX$ )&GS.?GXE&('.Y!@JC7*
M!]#ME4T!_P"[MZH%[K@&#S".L=4M]3LL: @/D/O<5.0,[$O 'Y@Y82+!S_\
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MB#)X#-I82U_)<=0=+J;+7+=Q#K_3UT?"6\DCSNAN8S@177#FTOT4+-R'*DS
M6Q\D]@:OZ^HC^R4HLM5KO3I(]8V[IRZ-O@^R]/WEH99"0JMT@%O0X;F*Y;.O
MA4LDF,;,MD3JM5".4'S)EYWU%TW?]-W:077AW%K<H)]-U.U;Q+'4K1@&2XM9
MAE6\K+XD9.^)F 8%61W['1M;M-:MVE@#PW$#>%>V-P-EW97 R&AGC/(((.QQ
MY9%&5.05$K<Y^MQ3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I54_B'M)F<V)HRMT
M5VK6-@FK5WOC>['W3K33C!M7M1;.T'LAO7EE-M:*WG5K*]=[$@-?6%DDSB(B
M1B4JV^)+2!JE-3S1UE08"R%@"N0N-C.<NDBY\CH1A=PY)!SVR :Q+D%FC53M
M?!8-O5.$>-L>>.13Y@I' /!!X)K?7A^;BKNV>=JPPK=(?Z^9ZLBZ'K\*\^N2
M.PA38/=0ZWV55W 7-.+@7$U(+4O85:"R#(P,,_8VI.<8&:N&;=G*2,<Z%)"2
MV[=N.=NWLS(?+DX&Y3CD@C!^($ENX:, *5V!5P6W'!164[N,DAAG@<Y],$S>
MR&IZ8I46="_?/VY^(2A?E%YGR63W</Z#?BO44?O)_P!-?PDJ4V15+3%*8I3%
M*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I6%;'US1]NT2UZRV56
M8JY4.[PKROVFLS2'O$=+13Y/T+(*E 2*HJIF CAF\;*(/8]ZBW?,7#=XV073
MRK*]N]-N[>_L9Y+6[M)5FMYXFVO'(AR"#V(/*LK HZ%D=65B#!=6MO>V\UI=
M1)/;W$;1312#*NC#!!]01W5@0RL RD, 14OH38=X\./;M3XIZ,LTG:>8=B28
MP7$71UF<&77KKD1$6'+VWYHY2(-I^):^EOK"Q/#(-I^);DB&YDRH)1-<]$U>
MRM.M=-N.J-$@CM]>LH_%ZJT6 8$X[/KVFQ#DPR-EK^%=QAD8R-G)DGXW3[JX
MZ8O8="U.5YM)NG$>@:I*Q+1'\W2+V0\"2,8%I*Q E0;!V"17$SD'#6:%EJY8
MXF-GJ_/QKZ&G(.89-I*)F(B3;*LY&+DXYXFLT?1[]HLLU>,W*2K=RW54163.
MF<Q1\UBEE@ECG@D>&:%TEBEB=DDBD1@R21NI#(Z, RLI!4@$$$5VTD<<L;Q2
MHDD4B-')'(H='1P59'5@5964D,I!!!((Q5)XA<_![N0F*%COGA>7NQB(IA\1
MLEMX7M=CD \SD\_>Y6<YWFI5V(J$]3I_3GCCVA 5?JG"[>H_S7Y2;7GP+/KV
MT@X^A!;=66\"=CC;'#K44:\'RI<HO.$ ]DX3Y_HF;^EN.DIY>V'EFZ>EE;C'
M)>32W=N<[F@8_P!8_P XD?U)R.^V[.U'M;BB]US7G6M:K3-U4KZP<)/M7]':
MY=-VT@WUAN%*+4.RM-/L3)-H%<MJ0KR=<4"-?QSOV3",6C-)H'4:Z;#<]+=4
M6D]YT[/.RW-FZE;_ $2]5F1K_33( UO<PL6\>V.(YO.KKEY!)L]7T9KV2'7M
M!N(K768H@T-RA#6FIVI4,MI?!,K/!(H7PIAEXO(R-A4VPXC4![6L4OT?S"8.
M./%BYR;(5/>VF+L HQ%^9LRH@.NMSP[8$DM@:IMJ3=N.N]MQB"\A$('AE4WB
M2\7$EC.FD/\ )>&/1-=_]I?D\UIFN-)U2UPTEFSDD7NF2MDV>HVQ9O;=.=@D
MC>*-I#R>)I5'Y=EDU323^1.L=,40:A8W'"7*H/\ PM_&,"YLYL VUZ@+(/#(
M8%4"6.\<=KUGJ)G:*/::O)Z6Z=U(JE$[TYWN"J9;52I4/9I%GH%?]1*WZZG#
MJ).JU<XD%F#QF\9 Y%!9RV]YXGJ7I>?06M[JWN(]4T+409-)UJV!]GNH^289
MAR;:^A *SVLF'1E;;D*VWI]$UZ'5EFMY8GL-6LR$U#3)R!/ _ \2,]I[63(:
M*>/*LK+G!(S-_.5K?4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2JH_$LL%=A9?226T
MK0UB=..V6Q'4A#!N/F+3$H_V1%NZ"K3)EM+=(2D:E/,X.#<W1)U'5%5!6.>2
ML;(2YU_.+(CE6X)#[ 2X*X.R5\*0V1\V"1DA<9[\C'K6'=%04\0XCPQ(WQ)E
MAMP<RD9P-W QCC/.!5@VC5X1_J'7$U7E%74;8J96["G)NYRL6F2FSS$,R>FF
MIBV4M9S5;9+R95".I"SP#MY$SC@YI&/=N&BZ*IL=\AV!X(8C&" ,$\ 'D ?
M\CUK)C(**1V(!R2&)SZDC@D^I''PXK:V6U?3%*BSH7[Y^W/Q"4+\HO,^2R>[
MA_0;\5ZAC]Y/_>+^%'_SU_Z"4V15-3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3
M%*8I3%*8I3%*8I3%*8I3%*T[OS0NK^F=37#2NX:VWL]$ND<9E(LSF]B^CW:9
M@6C)Z"D"E,O$6&"?$1DH66;>2[%\W24 #I^T24V6D:O?Z%J-MJFFSF"[M7WH
MW='4\20S)VDAE0F.6-N'1B.#@C"U'3[35;.:QO8A-;SKM=3PRD'*21MW22-@
M'1QRK 'D9!KOY2WUM#F/;L3X>_9ED7L%@=-':O'O2TN H,.D->1()E+1[8_5
M4.W:;WH311M'S#%=4CFU,"LY$A73QU'R]M[3J'2+#7M-DZRZ8@$,*LHZET.+
MS/HE[*3_ #NW0>9M(NV#/$X&VW?<AVJKQ6W,Z/J-WI-ZG3>N2F61E8Z)JK\+
MJELF/YO,Q)QJ-NI59%.#,NU^6*O-:_-0L/9(>4KUABHZ<@9R/>1$U"R[-O(Q
M4M%2+=1H_C9)@[36:O6+UJJJW=-7*2B#A!0Z2I#$,8H^>Q2RP2QS0R/%-$ZR
M12QLR21R(P9'1U(975@&5E(((!!S7821I*CQR(LD<BLDD;J&1T8%61U8$,K
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M0<,,HP*L08G\9=3[-B=ARO"_:*[&/ZLU[$'DZ)L)%$(ZI]8:G9"HC'[1I0F
MC8ER9-$ )L:H(&][CI)%]*-&Q6:4JTA>BZGT"PDLX^K.F S]/WLFR[LB=]ST
M]J#8+V%UZFV9CFRN3Y7C*1L=QC:73Z'J]TET_3^N%5UBUCWV]R!MAUBR4D+>
M6^>/'4#%W #N5PTBC9O$=ETW"0]EAY6NV&*CIV G8Y[#S4++LV\C%2\5)-U&
M<A&R3!VFJU>L7S595L[:.4E$'""ATE2&(<Q1X:*66"6.:&1XIHG62*6-F22.
M1&#(Z.I#*ZL RLI!! (.:ZF2-)4>*5%DCD5DDC=0Z.C@JR.K JRLI(92"""0
M1BJ5#J7+P@;KY>BP7CPO+W8?EZ0D;':^%[;8Y#S-Y>7O<K-\ZS<JZ,82>ET^
MI3UT'H,H[.8MS]0_FWRDVW>&UZ]M(?[$-OU7;PICX+'%K,4:\<JERB\X0#V7
MA?G^BY_Z6XZ2N)?[<L_3TTK?9N>32G<_:ULS>I/S\Q.K^1*7V#7=?[FU'L(F
ML>BM>,4;9S=T_0%V<DO&HR387[6(F%69EV%]U+<&SLQ)FO.S/8YY'R+EU'@8
MCQ\VDN:Z>ZDNNFI[S3-1LS?Z+>,UMK>@W@:-7*-L:2(, ]GJ-LR@QS+L=715
M?Z*,F[UC1;?6H[:^L[@6NJ6RB;2]6MRK% PW!'*Y6YLIU;$D3;D9&)7Z3!H2
MHNJQX@X&Y@ZSAG?)_B;<U^5OUY?:*Z.PF4730P%CMY<ZV=95$]VU3:%6B:EP
MH2[Y<[-(%XZ5!I(QS&=CNJ*W'1N->Z=E7J+H77![->VEVN^(J_O-)UJ  BUU
M" ,1;7@1=QVO'N1VA?0 Q=2YTG68SH_56E'QK:YMR5D!&-FH:9,<&>SE('CV
MQ<X&5?#*LBR2Y<[,V)![-;<6]V1L/0.J6+-937&PXI+W#4O6E3CO-,EUUH]4
M309Q=Y!!,%KEK53W9\P>BL^A6*#%1:%@]'K_ $S936#=4=)227F@.P]NLG.[
M4>G;A^3:WR9+R6F3BVOAN1DPDKE@)9MKI&N74=TNA]0I';:NJGV6Y3RV6LPI
MQ[1:L0%CN,<SVA(96RT:[28X[0LX*NLIBE,4IBE,4IBE,4IBE,4IBE50;A>\
M_);CZ<B^HY*MZ_G+0A38+0CYQI2AS]DFJBVUI .7-[UC/3NK+M);2VLIL*1N
M%2D*6HI;C0T+1Z2T;Z^9H2WQ2T92!]D9B!;!8R#>P .X@*X#KM3;M(;RY+,-
MW'&&_A;Y1-M4G:(SL4DKM'F0E&+/NW*5\V H\N#S/;F]2YK<^Z15V+66-,OJ
MNJ:"I<JE&0K6M,*W93UB,-,PK2N,C'9UY&.?BNU+!-3F;Q'LQCT3&3;%$8),
M>(^T[EW'!)SD9[Y]<_'UK)BW>&FX!6VKN &T XY&,G'/IGCM6Z<LJ^F*5%G0
MOWS]N?B$H7Y1>9\ED]W#^@WXKU#'[R?^\7\*.I39%4U,4IBE,4IBE,4IBE,4
MIBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4J'G9G']5ZXU]%QWQZ1UM
MN/6\P2[Z$WC6"^RN6I-BL (K'S$<X3.BL^@)!5!NSM=:57(SG8PH )F\DSC)
M!CTO3'4EQTY>R2>"E]IE]$;35])N.;74;)\AXI%((69 S-;S@%XG)QE'D1])
MKFBPZU;(GB/:WUK(+C3M0BXGLKI>4D4\%HV("S19 D3X.J,NL^(^P;1MF2N/
M-?2L%'ZT[4T4W;([.I3<_L8#9-7.<C:%WEJ158$_CFOK84S=5Z1H4ZU3F798
MF42:$=18N<[JKIJWTY+;7-#F>^Z7U9F-A=-S-97 !:72M1 SX5Y;X8*6.+B)
M?$0L5DVXN@ZW->-/I>JQK::[IX NX!Q'=0G CU"R)]Y;3<%@N3#(=C@93,^Y
MR#A;/#2U<L<3&S]?GHYY$3<',LFTE$R\5(MU&C^-DXYXFLT?,'K555NZ:.4E
M$'""ATE2&(82CR$,TMO+'/!))#-"ZRQ2Q.T<D4B,&22-U(9'1@&5E(((!!!K
MHI(TE1XY462.161XW4,CHP(965@596!(((((."*I2$;EX/EQ+Y?26^^%[?+&
M(")OB5DM?"EKL<CYE+Y@+R4FN=)R5=F HF(L]ID@Z*4ZBT@N4;OZB/9OE*MO
MZ"TZ]LX.,;(+?JRW@3X>6.+6H8E^*I=(N %C'\TX7Y_HJ?CQ;CI.XE/'GEFZ
M>FE;/]IGTMW)_M6[$#EB/'G+U1R?J[MO7M*M5?N2U,V?4 :7_F_IO63UJXM-
M!F7K9%_$S=?FF"Y4++2+"@9K\?K:CTT-98E4ITEFKXC"3:<IT_U#?]*WMU;S
M6HNK"YW6>MZ%?HPM[R)6*2130N,P7<!W>#.%$L$@((9"\;;_ %C1K37K:"6.
M<P7<&+G2]5M&!FMI&4,DD4BG$MO*"/%B+&.9#D$,%=8,QEDK?93>3\.OQ*Z:
MSUGV'26Y;5J_8M0=&KK'::<'[0T#T7RO=S(HKQ%MCS,A?V>G-?\ -QBS23:O
MHA:);6" KO5R0S],LG6G0]RU]TU=-[/?V-ROC-IYEQXNB]06FXB2V??L@N6.
MV0-&5D$C0S3\^DL6N*_3/5, M-;MQXUG=0GPEN_#SX6J:/<$92=2N^6 >:,J
MZNC1B1(]H:+ZKV]R]M*L\;^()+-7LG97?P3F7L4&P1-"Z':("5*.IFP5#G.P
MHV]T&XMT7,8\=@RM[HP#'N%W[J,>6C7ZMT_INO:?/U+T=&RQP+XNN]-;C+>:
M,S9+W5F -]WI!.2LB*7ME'G5461+?+T_6+W2;N+0^I'#/*WAZ3K>-EOJBC 2
M"Y[K;ZB!@,K-MG/*$LRF6W+/.J[.F*4Q2F*4Q2F*4Q2F*4Q2H$]+=/;ET9M:
MIUBO:[UG=*?;*=:)F+9%E^CK%M9[)5R1IK20DE:/H?EW?#N$I\.-B,Q<S;]%
M>/D)"4ADE):">D2BIN>*)'4DLX(8 X6/;@AN,O+'R<9^SG@]QCS3/&R@*A#*
M2.92^05R=L<4A"C.,GC)'(X!EOJJ;LMDUEK^Q7,L<G;)VG5V7LJ<3 6^J1:4
MW(Q+5W)I,*UL!C%WF!9I.U52(1-PC(VRL$RE;S4>RD$W#9*)@ S =@Q R03@
M$XR5)4\>JD@]P<5,A)52<9*@G 8#)'. V& ^Q@#\0*CQ<.D+ YOFJ&6CE]0;
MCUY?%K4M.RU;NCV<GH>!UFFX<[0GXU6KLYFLOT8!=Y3Z<PCE),D@XO\ <X2'
MD4XV/4=2;.\( K[PZLN,9  RWT00<$9&YL_U03S49D)9!'L=6SD@Y("_2(QQ
MQPOZ1 . <CAZ:ZN<S>J[)=][UA_KBV4^PP4);J%6J)MRT3]65L];@9^#0>0:
M-'4L\P5VG+J*$G(.$=P0-4P*[<L))I+1\?5XL,%0A@P)5BR -@D'G.!V[$Y^
M&>"4<I*%I!M92-RJKDKD @8P2>_<#'W<U\^2;W7-D[ [.N%34F%8.2Z(IR30
M\]5K33),3L.4>;F#GV]>N<- 6%F4'+=4$5'D6W3=(@1TU,LU616.E4JL(.,A
M&[$,/>OZJ2/\ZI"P9YR,X\1>X*GW4?HP!_U^_P"$ULAJ>F*4Q2F*4Q2F*4Q2
MF*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2H%]N<<N^AX^G;7T
MY9TM2=?:)=.+#H3<;=(0(DY$ISR>M=@)(IG4L&KKNB=>+L$.Z2>)L/?5I%JT
M=(JRT3-==TMU*NBO<Z?J4!U'IO5E$.KZ8QY*\!+ZS).(=0M2 \,JE2^P(S*P
MBDBYW7M#.IK#>64HLM;T\F73KX#LWYUK<@>]M+@925&!VABP!&]'[;BCL5IT
M_6;-5;U6%-2]/:7D4JCT/HR66#XM3+01/R0L$"*AS*3FNK@D7XO3K*U.[9.F
M*X-!?.EF_O3F/JCIIM!G@N+2<:CH.IH;C1M6C'S=S;D\PS8XBO;8GP[F!MK*
MXW;5#;5OT+6QJT4L-Q%['JUBPAU/3W/G@E])8^29+6<8>"52RLIQN)&3,J<@
MX:S0TM7+'$QL]7YZ->P\W!S#)M)1,Q$R391G(1DG'/$UFCY@^:+*MG;1RDJ@
MX054253.F<Q1YF*66"6.:"1X9H766*6)F22.1&#))&ZD,CHP#*RD%2 0016\
MDC25'BE19(Y%9)(W4.CHX*LCJP*LK*2&4@@@D$8JE("W+P?;B)@&R7SPOKW8
M_,Q/^)62V<+VNQR ^9TP_P Y)S7.LS)NO-0@"N]IC]R*A"*O5E/IGZAFU^4B
MVP? L^O+2 X;YN"WZLMX4^B?H1Q:U$BG#'"72+@X0#V7A<3]%39^=N.D[B3)
MSNEFZ?FE<9/YSOI<C$D@9-NQX!)^>L"Z:Y@TOW/J*O-I*9,W?LACMAZ&WWK:
M603N6M;0J@VDZSL36MPBEP,+=?T1SQ=!H^&*L4>FW*L;UI,'K3C]"U[5.D]2
MF9(LHV^RU?1[Z-O9KZW!:.XLKZVD7&1EU!9/$@<M@8+HW1:MI%AU!91!WPR[
M+G3M2M7 N+24@/%<VDZ$'!\I(5MDJXSV5E@A5-C-MLFE_#!\5RE5B4V=:(IP
MWU7M,[,(G6O5]=B@%.-O&N)<H-QHN]:[ZD'<W5HYPQF(R9$LG6_2V=I,B];<
MV3:=X?7GR>W4\=A!(#J&GA_$ONGII.9+2^BRWM6DS<K%<.K121>2;E2]<_#<
MK>;^D^KX(7NY4Q:7>W9:ZQ$GT+BU?CV?4(^\D*%71_/#A6"CG:]WIM[PV[I6
M^>>T+9+[+Y6M$LWK7.?;4V!E7U/5<&]E":>ZC>D**,9+MTP(QK&TG!DHJ>;(
M@M+*-R)RP56V]TG3>M[6?6>E[>.PZ@MXFGUOI:+A+D+S+J6@*3F2(\O<6 S)
M"QQ'N+1^T76VH7O2T\.FZ[,]UI$SB+3->DY: G CL=7/9),>6&[/DE &\KYQ
M%<XBLBY12<-U4EVZZ2:R"Z*A545D52@=)5)4@F(HDH0Q3IJ$,8IRF Q1$! <
M\Q(*DJP(8$@@@@@@X((/((/!!Y!KN 00"""" 00<@@\@@C@@CL:^F4JM,4IB
ME,4IBE,4IBE50>)+<*Y0K9S_ &6?G3ZV(9W(593;+W<^W=-P[&$OFU-%TVQT
MM.0U5<Z,E,2QHR9/ME9M:IE=NRJ^H;&[AX21-\6E:WE6REA(H&[C(78CDE4=
M@<.#C) 3RCNXR><'#N6"M&Q.T?1+[W089XU*Y4J">=_)[(<#U%@'/TW(6716
MG;#*PD_6Y.<UE2)5_ 6J:L-DLL0[?UR.<N(^<L%N1;6N;E&RBADWDK9VS6PO
MUBF<S+9O(J.4202##N,@X8C*@ 'GT"^4#[N/AFLF,Y1"002H)#$E@<=B3R3]
M_/QK.)*F529FT;'+0,;)S*%8GZ8F]?MRNA"J6IW"OK) F06];92-FW=<@E9)
MNHB<KL8MH17U)I 0;0Q P"0,AL?:,@'[QDX^^KBH)R0"<%<_8<$C[C@9^ZN@
MUGJ/6VFX5[7M95"*J$3)21IB1;QH.%%9"2%DRC$W3YZ]7=/G9VL5&QL2P*X<
MJ)QT1'1\4Q(WCV35LE5G9SEB20,#[!]PX[\GXGD\U145!A0 "<G[3]I//;@?
M <#BM/Z%^^?MS\0E"_*+S/E\GNX?T&_%>K(_>3_IK^%'_P ]:E-D52TQ2F*4
MQ2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2JVN
MV>1[Y;+/6.O>2'\92^T=-1JK:%,].#.I= :[(?WJ9T5M8A%6R#Z*F2$/]%)M
MXJDO69T6RR4A&)&2E8CN.ENH[2W@GZ;ZC22ZZ7U-P90@W7.CWI\L6K:>2&*2
M1''M,2@B>(,"DAS'+R^NZ-<330ZUHS)!KMBI";CMAU*V[R:?> $!DD ^9D8@
MPR8(91ATWMQ[UQ0^P-7GNE;825-O-4EG5*W-J"T%%K>=.[-AC&;6&E6J/62;
MN"BV=HKJ0\J+5NA-1H)N2H-'A'\:PU'4G3EYTW?BUG>.YM;B-;K3-2MR&M-3
ML90&ANK=P67E2!+'N8Q297+*4D?8:)K-OK=H9XE>"XA<P7UC-Q<6-VF1);S*
M0#E6!V/@"1?, #N59-SD'#6:&E:[8HJ.G8"=CGD1-0LNS;R,5+14BW4:/XV2
M8.TU6KUB]:JJMW35PDHBNBH=-0AB&$!T44LL$L<T,CQ31.LD4L;,DD<B,&1T
M=2&5U8!E92"" 0<UMG1)4>.1%DCD5D='4,CHP*LK*00RL"000002",52NFE<
M?"!N9Q*-CO/A>WRQ^L0\W]CM/"EMLDD(&\P-[W+3?.D[+/"#ZP.Z>TE\X.*B
M:CU7VMV]0)MOE(M1[BTZ\M(0/S88.K;>&/TQMCBUJ*-.Q"K=(HP0@VVG"XFZ
M+G[RW'2=Q+V\TLO3\TK^GTGDTN21O[36S$\<YFL<Z'YTT7W!I5"GWDJ%BJLX
MA%W/6^QZ9*H(V2G3HMB/ZGLO6%RCQ7-&S#(%F[^,DV*J\?)LSBT?H2$2\<-5
MN)T76M6Z5U0W-IN@N(C):WUC=1DP7,6[9<6-_:OC?&Q!22-P'C8;D*2*&'3:
MGIFGZ_8B"XQ+#($GM;J!P)8),;H;NTG7.R1<AD=2593M8,C%3 +7&YK)29\_
MAO>*-&UV_)[-CGE3T3T3/122>K>MJE_A-T:E<2+F,UIV_(E-5BF^B%W**DY*
M%:R4&^/*N(&5M?87NEP74(ZWZ">:S-BZ7&KZ+#(QO^G+GDFXM2/-<Z/(0Q60
M*1%&625/"6:.VYRUO9H)3TOU:D-R+I&BT[4Y$46>LP# $$X.5@U*,%=R$CQ6
M >)B^QYNABK+M/PC)QC4MC/[9N#PT9>3;QM(VDY*]L^R>,'$F[3;Q]/V2**:
M\K;=%@Z<$:5NW)D=RM13%&%>IG(6(9RDTD&G_*-"]S9);Z;US%&TEW8+M@LN
MJ%C4M)<V.2([;5MJEIK;RQW!S*I'SCQQI+=]&2+#=-->]*NX6WO#NENM"+$*
MD%WW>;3\D+%.,O!]!QC8'NE@9Z#M4'$6:LS$98:[8(UE,P4]"OFTG#S,1)-D
MWD=)Q<BR56:/V#YHLDY:.VRRJ#A!0BJ2AB&*8?+YH9;>66">*2&>&1XIH94:
M.6*2-BKQR1N R.C JRL 5(((!%=U')'+&DL3I)%(JO')&P='1@&5T=2596!!
M5@2"""#BNVR.KZ8I3%*8I3%*8I5<79^Q86@;<TV$]=-603*PZMWU!#7=_P!S
MG=?Z9FT99UJV)E7Z]E@BRQ#WUA"2,C&0D%-51\WF*O.7%.*M%1>HN$[#D0J6
M1_*YPR<QKN?@.0,'\W/<@\$*2&XQC3,%=,LHRCC$A*H<E1W&?-C( *G(+8(Q
MS,/0D66#TAJ&&)?DMJ$BM;4J/)LM!ZO)-[Z1I7H] MM;2+N4G';YM/E($DV>
M/)N8>.4'":SJ5D7!U'BT3G+N=NW+-Y<8V\]L #!'8C Y]!VJ:,81!NWX4#=G
M.[COGGO]Y^^MM995],4J+.A?OG[<_$)0ORB\SY+)[N']!OQ7J&/WD_\ >+^%
M'4ILBJ:F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4
MQ2F*4Q2F*4Q2JJ^P^;-JZTVBGW[Q3$INM]UR(;1>^](HK"QKW7&I8@A!/ R"
M*1#I(;?J+%$5M<6PB!Y)8J"=<=?$6GN,8KZ!TUKFGWVGGH_JB3;I$TC2:1JK
M /-TYJ,AXF0D@G3;ASB]M\A!DS+L;>XY#6]+N[2[_E'H,8;48T":C8 [8]:L
MT'NV !Q>PJ,VLP!<X$3;EVK4UN9>E=6]9:@K>Y]22ZC^O3A56<I$2"96=EI=
MIC_0E/TFXQ'M%%H6T5YX;W628+")3E%!^R6=1CUD\<<OKNAW_3NI3Z9J,82:
M(AHY4):"ZMWR8;JUDP!+;S+YD<<@[D<+(CHN^TK5+36+**^LW+1R95XVPLMO
M,G$MO.F28YHF\KH?L92496.Z9V"A;/"R];LD3&S]>GXQ]"SL',LFTE$3$1)M
ME64C%R<<\36:/H]^T66:O&CE)5!PW54153.F<Q1U<4LL$L<\$CPS0R)+#+$[
M1R12QL'CDC=2&1T8!E92&5@"""*SI(XY8WBE1)(I$:.2.10Z.C@JR.K JRLI
M(92"""01BJ42FN?@^7("*#8[WX7E[L8%2,(R%DM?"UJL<EY 4YC"[EYSG>;E
M7H!^L9Y(4UXMZB@L_6.%U]2_FORDVN0(;3KVT@Y^A!;]66\$?I]".+6HHT_L
MI=+\$'\UX3Y_HJ<#YVYZ3N)<#Z4LW3TLK>O#22:9([?%F@8^I/SUH.[M'Z,[
M+TB^UYLB*AMBZNOT4PG(.9B7R"ZC55=K[Y6KW0[.P.L:-F6*;HDC 6&*7,4Z
M2QDSB[C7KMJYX'2]5U;IG5%O;&26RO[21XI8Y$(# -MGM+N!P-\3E=DT,@'(
MR-LBJR]9?V&GZY8-;721W5I<HLD;JP."5S%<6\JG*NH;='(A[''*L0:Y=6[Q
MV%R!=8CAWQ")5#96HMC@YH_-/75O8-G57VQ"OVRC)'2'1(/BKQ<5M-*+5-%M
M9>7 T1L6.3.H\76DS.G+WMM0TJSZDM9.J^C8S8ZE8[;O7>G+9V6XTZ5&#G5=
M%"8DDT\R#Q&CC/BV3G"A4VJG,6>H76BW"=/]2,+JRNLV^E:U,H,5Y&P*BPU/
M=E$O AV!W\ERO+$N2S:7X^\.[MSE7Q#;58:KN(L+X<[-WLJ2H^E&^R+=.UMI
M7KP63E:W0H/5\ZX?Q]5E:=;)1"1<6=LJ@#EI$N?='SD)]]&EVG4O6?2O4'1E
MM#/IIEZU9+&.[U1K*VBG>:TV1SWDU_$J/<1W-O&46W(.UI5#(/!22M?HG3&O
MZ/U--+%?[.F%:[:WT\7,TD2Q7&]X;:.TD9EA:WF<,9@1E4.UB)&0>@3/':])
MIBE,4IBE,4IBE57]I7>P6_=6H=3:>NJT]>Z_/PZL_I^%VU>=(JRLP6V:TV@Z
M9O[Y 1Z52L,V\Y^INWF@:PF[*G9F%=N2.S8>I2Z,2VEXG)A ".SC"E3AR@?C
M#(/*3D#Q"GF QD;21G!Q)V9G1$;+ C*;VCR0R.?,!@GPU<;,Y ;=M(&181IR
MOW6J:FUI6-D6 EKV#7J)58:ZV5-VYD"3MIC81DTG)0LB]:L7LD#V12<+A(O6
M3-Y(>OWQTT;+KJ(D@<J78J-JEB5'P!/ ^ X]!P.U9*!@BASE@H#'ODXY.?7[
MZV1EM74Q2HLZ%^^?MS\0E"_*+S/DLGNX?T&_%>H8_>3_ -XOX,?_ #C_ %S4
MILBJ:F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2
MF*4Q2F*4Q2F*53UTUIS8_%>X+'W[R75I&UU&S"BZ[<YAKI2E3V=6&(*'<;SU
MG%%%-LUW+2VQW#^9:)%*2[Q /?:BG)JR*TKZ5H6IV75&FP=']17$=O<P97I7
M7IN]A.^ NDW\G=M,NB%2)FS[))LQ\V$$?%:K8W.A7TG4>C0M-#+@Z_I,0 %W
M"O?4+5!@"^@7+.O_ ,0F<X?<7LXTUN/6_0&L:;N+4=IC[EKV^0Z$U79Z..(D
M704$R3AF\;J 5S&R\4]2<1DU#ODD)&'EFCR-D&[=XU61)PFIZ9?:/?W.FZC;
MO;7EI(8IH7'((Y5T8>62*12LD4J$I+&RR(S*P)ZJQO;74K2"^LIEGMKF,212
M+GD'@A@<,CHP*2(P#HZLC ,"*SF;A(:RPTM7;%%1T[ 3T:]AYN$EV;>1BI>)
MDFRC.1C))@[35:O6#YHLJV=M'*2B#A!51)4AB',4<2*66"6.:&1XIH726*6-
MF22.2-@R21NI#(Z, RLI!5@"""*R)(TE1XI462.1622-U#(Z,"K*RD$,K*2"
M""""0:I1\[GX/ES #?2*]^%W?+'Y%/\ \0L5KX4MEDD?,2'*7WJ5F^=Y^7>F
M,0Y".7E,?N/9'];]=,UY]1_FORDVO]#:=?6D']B&WZMMH$[CA8X=:AB4 Y*K
M=(N1A ?9.$^?Z*G_ *6XZ3N)?[<LW3TTK_\ F>33)'8G(!:W8X/F.;BUS9NL
M=+]6::E:%L"%K6U=/;1KK1P)"N$).&FHB202D(6Q5Z:CUC"@Y2 [67KMCA7B
M3IFX*UD8UXFH5-7//;&_U3I_4X[NSEGT_4K"9ESM,<L4B$I+#-$X\RG#1S02
MJ592R2*02*["[M+'6+%[:YCBO+&[B!(R'CD1P&CEBD4\$9#Q2QL"IVNC9P:I
M$X:MGB@Z8[SEN*]AT_8&Q>'-9H[ B*7O#9]1]I))ZUCF[Z3U#+I[I8L(^*O-
MF6*I7:B\KJBK^1:LUI(CB.C5*ZZ68^J=5VW06J=(IU1975E9=5WQLI+K2;"X
MPAOG9(]2C.EO(\EI /G[E9]J(S+&5=Q.H?@.GY^KK'J)]"NK>XN>G[7VI(-0
MNX29/9%#/8N+]0B7$N#%"T7F=07!4&)F7T0YXQ7IM,4IBE,4IBE,4J!.Q..-
MA6?:4_L6D=)RVNV,SN6O;Y;U4-5TRVH1FPX#2D!HH'2<Q,.T7[J*>5" 165B
MEB%22DG"RR:@E I<F64!0IC#80IG<1E2YD].QR<9'I6.T+%BRRE07\0#8IPV
MS9W/.,>A]?LXJ;M<8R\9 0L=8)SZ33K&*8-)BQ?#6L-\=DV[9))]+?"&1U&<
M9\0<E4=>X-3G;M/:^P1,8A"B,1P22!@9.!WP/AD\G%3C( !.2!R<8R?CCTS7
M<Y2JTQ2HLZ%^^?MS\0E"_*+S/DLGNX?T&_%>H8_>3_WB_@Q_LJ4V15-3%*8I
M3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I
M3%*?;]N*52EMFEVKPM]LV;J724!*V+AO:M@^.]<Z%KC51ZOHVTR1TFSOI;4,
M&V()DJ\IY-S;4IT<D)$V2(RS-'X<V9#3_4=.NK?K[3H- U2:.'JO3X?!Z<U>
M=@HU:W3++H>I3,>9ADC3[ESRY$;'>S^T\)>03=)7DNK6$;R]/WDIDUK3XUW'
M3YGP&U6RC SX1X-[ O 5?$4;0/!N(IERJFQ*G7+W1K!%6NG6Z'86"LV2#>)/
MXF;A91N1VPD6#M$QDUF[E!0ARB @8HB)%"D4*8A?-;JVN+*XGM+N&2WN;:5X
M9X)5*212QL5='4\AE8$']HR.:[:">&YABN+>1)H)D66*6-@R21N RLK#@@@Y
M_P!>:[&<@X:S0LM7+'%1T[7YZ-?0TW"2[-O(Q4O$R391G(QDDP=IJM7K!\T6
M5;.VKA)1!P@JHDJ0Q#&*-D4LL$L<T$CPS0NLL4L3,DD<B,&22-U(9'1@&5E(
M*D @@BKI(TEC>*5%DCD1DDC=0R.C@JR.I!#*RDA@0002#Q5*1AN?@^W,1*6Q
M7KPN[U8A$2%"0L=LX7M=CD?6<Y +[W+SW/,Y+O%5#D CI_3'CDHD%5Z<X73U
M'^;?*3;<F&UZ]M(0!]""WZLMH$P,_1BAUJ&-0 <JETB\X4#V7A29^BINTMQT
MG<2^FZ6;I^:5LG@;GDTR1V)(P6MV.<Y)\>ZZ%FH>R0\58:]*QTY SD<SEX6:
MB'C>1BI:*D6Z;N/DHV0:*+-7K%ZU62<M';951!P@H15(YR'*8?+I8I8)9(9H
MWBFB=HY8I%9)(Y$8JZ.C ,KJP*LK $$$$9KNT=)422-UDCD571T8,CHP#*RL
M"0RL""""0000<5V>1U=3%*8I3%*8I3%*8I3%*8I3%*BSH7[Y^W/Q"4+\HO,^
M2R>[A_0;\5ZAC]Y/_>+^#'4ILBJ:F*4Q2NF<6*OLW$NT=SL,U=P$.UL,ZU<2
MC)!Q"0#T\LFRG)=%5<JD;#NSP,X1K)O"HLG!X:6*DN<8YX"-<'C@\G X[GC@
M?$\CC[1\:ID<\C@9//8<\GX#@_L-<Y!^Q<L491L]:.(QPT3?MY%!RBJQ78JH
M@X2>HNTSF;JM%6YBKIN2*&1.B8%2G$@@;*8.<8Y[8]<_"JY&,YX[Y],?&N0D
MJFNFFLBH19%8A%4E4CE43534*!TU$U"")3D.40,0Y1$IBB @(@(#BE?O%*^+
M=PW=H(NFJZ+ELX2(LW<-U2+(+HJ% Z:J*R9C)JI*$$#$4(8Q3E$#%$0$!Q2N
M,G*Q:TH\A$I)@K,Q[&.E'\0F\;GE&,9+N)-K$R+Q@507;9C*.H69;1SM9(C=
MZXB9-%LHJHP=%28.,XXY&?3(QD?JR,_>*ID9QD9QG&><'(!QWP2#S]AKGXJM
M,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4KC/63.29NXZ1:
M-G\>_;+LGS%Z@DZ9O6;I(Z#EH[;+D40<-G""AT5T%B'262.=-0AB&$!N5F1E
M=&9'1@R.I*LK*0596!!5E(!!!!! (.:HRJRLK*&5@596 *LI&"K Y!!!(((P
M1P:I)=)S?A!;0/(M$Y6:\,3<EP]4JS3([DW/#6S+7) 4)%FF0%W'U>;I,O0*
MZ;%**=*F%RF0]FX<)-[AZDIB^4BPV,8XNO-,MOFW)6->J["W0>1R<#\LVL2G
M:V0;J)?,-JLUKP1$G15V7 >3I.]FRX&YST]=3/\ 24#)_)D[MYO2WD/&,@3W
M9Q\@PEF#&5BGK22BY-HVD(Z18.47C!^P>(D<-'K)VW.HW=-'3=1-=LX04.BN
MBH15(YB&*8?+71XW>.1&CDC9D='4JZ.I*LCJP#*RL"&4@$$$$ BN\5E=5=&5
MT90RLI#*RL,JRL,@J00002"#D<5QYN$AK-#2M=L<3&ST!.QSR(FX298MI*)E
MXJ1;J-)"-DXYXFLT?,'K555L[:.454'""ATE4SD.8HW12RP2QS0R/#-$ZR12
MQ.T<D<B,&22-U(9'1@&5E(92 0015)(TE1XI462.1622-U#HZ."K(ZL"K*RD
MAE((()!&*H&XQXW\1/EKQ![9782V*Q?AC1+[9;Z@45_L5M;*Q&U&U%E)JD4J
METV7F)*YU>QU:T2C()&37:1\4>/BYDB4E(MY)FV=>P=3]3=%:_T;;S26P?KN
M1+!+R[6R:WG>YMS'%=W5S=1Q):SP7$$;F.,,\@>2+*(T;LOG&A:%U/I'4L\:
M3[>DT:[:UMFN1-"D$V^2WMX()'>>&6"5U#N0J%4<!F5U4^@W/&Z]*IBE,4IB
ME,4IBE,4IBE,4IBE19T+]\_;GXA*%^47F?)9/=P_H-^*]0Q^\G_O%_!CJ1EC
M8R\G RT? 3IJQ-/&+AO%V$D:TF#0SU0@E0D"Q;\09/Q;'$% :NA!%7R])_D.
M15-5?]XYGZQG=IT:U,.F5'L7!@V]ZF5(HM5<POL7BBSHK:A0"2E4LH/4#$36
M&5<-@D2?\/E2F8((B:4.F,;,?9WSQZD\@#[,_$8/-*FUKJMWFLQ+UG?=CJ[,
MDUY$SEI,*U.#J!F+ 6S=(L:#"!,9LY KA)=U[VL/MS"Y%$?\-%/(R03P-HQV
MR3S\>:5";HJ$V7!;,Z5EZSJ"_P"S&._./:%INC.J,2LKM&6QZ9/=,J.H:X.)
MVQP8U>,DFVZ:F[861VDM!%;LK"#YZS<L&C:0GC*$1Y=5*2L[;L_1(CP5P#D^
M1LCOVP.^,:4-F7",PDA6-=N#AE,O!R1@$..3QP?7OH"T<N]).*A/UA.=W!+*
MRLGL+3;B$C=QV>(UTKH]3P_9FLUP82FI6R,K$,D]Z@809V%I)#M;XSDWSA-6
M6:5)P\0"02QYR0@P%<'8"V_QP3DX)/S1;C)4@#NP%1O'*0P!<Y+I@.=NPP8&
M%R  9<>;&X?$+6&?H-Z[9:=8R%9?])0C@-V4>+FZ5-[2V-;;8QYNKW-<1%Q4
M/7JY6NIM-.6LFSWXHA)6V8JFXZU>YM%I+FF9>YU-M]%96OB1;N1&?(Q!"*H\
M0RDDDF)\_-\*"A49[ \U0QS;!M,BX=05+,Q$:Q  *!+'SXG)8.&/).X<5R6-
M#[Z6VCSXA9T][.HV 3YTA-B6UE>'L/!3M.=0A8[<CZRUZH].I4JNVB,=3+]A
M9"N:#OZZ2DQ%MKI3=GP<8E&J0HM!LDQLR=Y4$9(.?( 6BW$'N/-&,<,A]6VX
MW19W\&,,0Q (QYR0LNT'N#E9#G!5AW&"ZLT7WW3$><ZK5)+;- BJ+K?GBJP;
M&;>RUYJE7<4PSEAOR*V2J?K>M5-_'V%PVER5U[/Z3W:]8T29HZ&JW-;E8 (J
MNU=X#XI(0[GD/  8@\QE1X1(/(SMD0$AMP(/-J1W"^$JEE")&,$EAD9$@8^,
M!@XXS'(0"-N#P)H\.ZVV=5=G[5N&Q:7O6MO+!H/EVFSLYO39C+9KZU;7HD_T
M5(;3=TM^A?;TK%4Q-]=X)_&QS0*M6?5,*+5:J0\><Z&0S,I5 IC.'E(")LPC
M",)GRKD^4]\GCDDU/ KJ[EA("8XE)D8/EU,I?:0S8'F&!Y1SP!@U97F/633%
M*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I706JJUN\UJ?I
MEQ@HJSU.U0\C7[)7)QBWDH:<A)9JJQDXJ4CW1%&[QB^:+*MW+=9,Z:J2ABF
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MFI_@F.&8JN55UQ],*"?AM8-_TQ4[(&9&S] L0/CN4KS^W-0UOOALZOO=8UO
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G.?UL"<^O?UJ>)"B%3CZ<A !) 4NQ4#/8!2 !V X]*D'D=2TQ2O_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>g60414g31r68.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g60414g31r68.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1CV4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &-J^8V(X0DE-! 0       \< 5H  QLE1QP"   "    .$))300E
M   0S<_Z?:C'O@D%<':NKP7#3CA"24T$.@      Y0   !     !       +
M<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0    !)
M;G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I;G1E
M<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    , %
M<@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !     $)L
M=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M  (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7     $-P
M=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B;V]L
M      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L      !%
M;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0       %)'
M0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M      !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
M     $)L9"!5;G1&(U)L=                %)S;'15;G1&(U!X;$!R\YF@
M        "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0    !09U!S
M %!G4$,     3&5F=%5N=$8C4FQT                5&]P(%5N=$8C4FQT
M                4V-L(%5N=$8C4')C0%D            08W)O<%=H96Y0
M<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O
M<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M"V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  $#O_XU
M  (  3A"24T$)@      #@             _@   .$))30/R       *  #_
M______\  #A"24T$#0      !    !XX0DE-!!D       0    >.$))30/S
M       )           ! #A"24TG$       "@ !          $X0DE- _4
M     $@ +V9F  $ ;&9F  8       $ +V9F  $ H9F:  8       $ ,@
M  $ 6@    8       $ -0    $ +0    8       $X0DE- _@      '
M /____________________________\#Z     #_____________________
M________ ^@     _____________________________P/H     /______
M______________________\#Z   .$))300(       0     0   D    )
M     #A"24T$'@      !      X0DE-!!H      S4    &
M  $4   #O          !                          $
M [P   $4                      $                         $
M  $       !N=6QL     @    9B;W5N9'-/8FIC     0       %)C=#$
M   $     %1O<"!L;VYG          !,969T;&]N9P          0G1O;6QO
M;F<   $4     %)G:'1L;VYG   #O     9S;&EC97-6;$QS     4]B:F,
M   !       %<VQI8V4    2    !W-L:6-E241L;VYG          =G<F]U
M<$E$;&]N9P         &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -
M875T;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI8V54>7!E     $EM
M9R     &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG   !%     !29VAT
M;&]N9P   [P    #=7)L5$585     $       !N=6QL5$585     $
M  !-<V=E5$585     $       9A;'1486=415A4     0      #F-E;&Q4
M97AT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4     0      "6AO<GI!
M;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R
M=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX    '9&5F875L=     MB
M9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO<E1Y<&4     3F]N90
M  ET;W!/=71S971L;VYG          IL969T3W5T<V5T;&]N9P         ,
M8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/=71S971L;VYG       X
M0DE-!"@       P    "/_         X0DE-!!$       $! #A"24T$%
M    !     ,X0DE-! P     #J$    !    GP   "X   '@  !60   #H4
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M2[#IG6^E=6K]3I^2R^!+F P]O;]+2_;=5_UQBLR,H0@<8'"8W*5"7K_2$F,
M2)$MP=K_ $7+^JY^MU5^3A=?;7;10&^AFM(W6$_FM%;6-LK:QONLMKQ[F/\
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M?7;L_P# O2_2Y%2& DS'$![9HD_FKC'IT/J%A]327%V?XLL1
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MIUJL<:^_@/)#+8^OUG/L".#R2A[;FK\Q5J[*\3U<Y=,L4_C CB5CGC01$=Q
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M=FRLE3*X5.(F&5@7T)&H%,M(VA)(AE 3VYO0K/XQ)+6 M19ZL@+FJR"GDU4
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MU@;HDM-&P*O,9U>.$OR(A$TBCK=62U>  4 *4  H         &P  !T  #H
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M&KINHFNW72.=)9(Y%$S&*8!&G\D;Q.\4J-')&[1R1NI5T="5='4@%65@592
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M(,@T;%?M"V/E+F7CJK0R#IKQ%?D$[2NS2V3LZO@*D=RW$DN9LQAII&4$TD<
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MB#1LC GD&-E*E?T>DCZ:VJ\-_(\5_-K'^JI<?FM)_"2?RV_XCJZ2?<7^2O\
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MJW:57(U9J5V%+%:PACEB<<AE/L01PRNIX9'4AT<!D8, 13.UM<AO4C@*TO\
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M CZ=-O+;;<0V$=M@';IT[B [^G431KZ_(!'Z>?UV'K]_WCP:-8$._D'7??H
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METV;L\1"@]?IM')FQ4%-+!XU<QEZU"6=J\,IL3VK 3O2Q5*=::]=DBB+)WK
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ML@PGAD%4(I:#E,VUY*"83>PMU+-AOL.F>J"]'5';.XL(BITM2LGK$[12F0.
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,"XU--'!HT<&C7__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>g60414g32m72.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g60414g32m72.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[4!(4&AO=&]S:&]P(#,N,  X0DE-! 0
M    0"R^%D*#A"24T$!       /1P!6@ #&R5'' (   (  !P"!0 I?F%I+3
M%F-S0S-S U+64Y,V0M-#$P.2TX935A+6(Q8S9D.3DY-C)D-U\ .$))300E
M     0L#-;YVK&AWC0L(-GV\%X]SA"24T$.@     !"P   !     !
M +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0
M!);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I;G
M1E<DYA;65415A4    % !# &$ ;@!O &X ( !4 %, -0 Q #  ,  @ ', 90
M!R &D 90!S       /<')I;G10<F]O9E-E='5P3V)J8P    P 4 !R &\ ;P
M!F "  4P!E '0 =0!P       *<')O;V93971U<     $     0FQT;F5N=6
MT    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L      BT
M 0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<     0W!T;F)O;V
MP      $-L8G)B;V]L      !29W--8F]O;       0W)N0V)O;VP      $
M-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP      $5M;$1B;V
M]L      !);G1R8F]O;       0F-K9T]B:F,    !        4D="0P
M,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!OX            $
M)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT                0F
MQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL0'+
M *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G4',     4&=00P
M    !,969T56YT1B-2;'0               !4;W @56YT1B-2;'0
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M09       $    'CA"24T#\P      "0           0 X0DE-)Q
MH  0         !.$))30/U      !( "]F9@ ! &QF9@ &       ! "]F9@
M ! *&9F@ &       ! #(    ! %H    &       ! #4    ! "T    &
M     !.$))30/X      !P  #_____________________________ ^@
M  _____________________________P/H     /____________________
M________\#Z     #_____________________________ ^@  #A"24T$"
M      $     $   )    "0      X0DE-!!X       0     .$))300:
M    ,U    !@             &E@  !0P          0
M         !              4,   &E@                     !
M                   !     !        ;G5L;     (    &8F]U;F1S3V
M)J8P    $       !28W0Q    !     !4;W @;&]N9P          3&5F=&
MQO;F<          $)T;VUL;VYG   &E@    !29VAT;&]N9P  !0P    &<V
MQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E    $@    =S;&EC94
ME$;&]N9P         '9W)O=7!)1&QO;F<         !F]R:6=I;F5N=6T
M ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960     5'EP965N=6T
M *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,    !        4F
M-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG          !"=&
M]M;&]N9P  !I8     4F=H=&QO;F<   4,     W5R;%1%6%0    !
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M5#('-21T(               $  /;6  $     TRU(4" @
M                                                 18W!R=    5
M     S9&5S8P   80   !L=W1P=    ?     48FMP=    @0    4<EA96@
M   A@    49UA96@   BP    48EA96@   D     49&UN9    E0   !P9&
MUD9    L0   "(=G5E9    TP   "&=FEE=P   ]0    D;'5M:0   _@
M 4;65A<P  ! P    D=&5C:   !#     ,<E120P  !#P   @,9U120P  !#
MP   @,8E120P  !#P   @,=&5X=     !#;W!Y<FEG:'0@*&,I(#$Y.3@@2&
M5W;&5T="U086-K87)D($-O;7!A;GD  &1E<V,         $G-21T(@245#-C
M$Y-C8M,BXQ               2<U)'0B!)14,V,3DV-BTR+C$
M                                                       %A96B
M        #S40 !     1;,6%E:(                     !865H@
M  ;Z(  #CU   #D%A96B        !BF0  MX4  !C:6%E:(        "2@
M /A   ML]D97-C         !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M       !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M                                      9&5S8P         N245#(#
M8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="
M         N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V
M4@+2!S4D="                             &1E<V,         +%)E9F
M5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
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M\ 5 !9 %X 8P!H &T <@!W 'P @0"& (L D "5 )H GP"D *D K@"R +< O
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MT+"PT.#1 .#A 4#@X.%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,#
MP,# P,# P,# P,# P,# P,# S_P  1" "@ 'L# 2(  A$! Q$!_]T !  (_\
M0!/P   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0$! 0
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M7=HUYQX\?WD7'/^+JTM&+5]8;',G:VKT21/N=M$
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M!#%'X3='"FP,)BTB.Y4$($C)(0;@"223<V ' N<+MEF?S"AA"1R)&'*[R\@
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MV-D%K=XCG5[AOXK*OJ/ <*HLF!G@XA:>5,CN!.&H>-D7S'CD18RH#*5G5MI
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MPH$J9D[3B_:-7VME)C.F>M(*L-,2T<8C<F-CM.X1-[MB;]EMQ;MQSB,TC+
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M-_D3?Z,?G]\,U!_HCZTO]QKJN_[)O![/)_%%_G1?Z\'M,?\ #-_D3?Z,?O\
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M2;*'AQZEM--+32PDE+,<0C8KXQ9%A8I(Y!4(@<74^\"P7@FW%SUYQ&TRJ\:
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MU-A'E1CP;$D9L.6&0 H#$84;G!5@+E6 O:Y! OZ7M:^ .A-@RDVO8,";'H;
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MT)(#J2.2 P) '4D7X_'#3Z"ZO-+=0NG+/>>,9/58_@-+DF:X]=6&5Y!C->E
MF&99;XJ^SR*5%NIM710KQ*IE[3K/L!O/265;+>C%D(U'/$Z.$()8A2  >=RA
MK 6N2+V/'4'#$E21/,! 4%@22!;:Q7GFPO:XOV(P^]/G.$Y#BS,XH,PQ:\PH
MD*19#S"GR"IL\6?70VD=+GLR"%+/4NA16B*Z1*;+4 &B(I2-1CN&%6!VD$'I
M8@@W]+=<2!E(W!@5Z[@018=3?IQB/^&=5V$;#ZDY6@L%?1YC3"Z>Z;?</:>*
M9A49'C5D"UV;D^M38O#%3CEQ2R:^7C19\BS%=%9S(]@Z"(H'&?(T3+&)&NI\
MPIM*D$656OSZ@]+?'$:RJTAC6Q'EB0,""#=F6W'I:_UQ*GQ%B7"\&#"\&#"\
M&#"\&#"\&#"\&#"\&#"\&#"\&#"\&#"\&#"\&#"\&#"\&#"\&#"\&#"\&#"\
M&#"\&#"\&#"\&#"\&#"\&#"\&#"\&# [_,TS#,A=.HM#ZJFL@;BZO<VH.F?7
MTY[3O#11\]9,/L;+YZ1%28&KQ/5U5F-K*FQE0L62V"HWL*0:^+%,%\S>UBD0
M,C ]]OW5_P#R8J,5ZEF\ORTX>8B-3SQN^\W'95N<0K/A_4?T8]6?2GNO;$WI
M^?J?8>)T7E_9!'T7A>PL2K\6JY ;/).GNYR@&99CEL<T>CS>K+AL.V"2O; K
M,OF09"27R8" FO'-%*B"3<I,XWLK7[2 65;7!!/4^Z#ZX@*RPS1.WE[644YV
M*R@#DQ%KLWW6NHM8 .?A9H^FBXZ)J?2>@]8;NUHN=^8-3]1(9FP=>8S6$@]5
M[M_GVC<GR39F3VZ3L>RJ3K"/22SY3>Y+<9 37=OJ\0JGNLHBQJ5SI!,7=D;;
M3F,[6/\ XO+"\*!R-]^  -V_G#(C $1'7=4"2[* 1+YA<W<GA@EKG<3M*<<@
MVQHFIW:NKFZ-UUAL'$:G/]?^>?L6/LO$Z&HKZG(,;I+>^ZKY6LQY+ B0XLD-
M/)Q81/V0]RUT =2$L>L48!$$U\FXEV:Y5J%=K$D@D"(-8GO<<_'UZX;'M C4
M6#+F$FX"P(!,Y6X'06(M?L1ZX<[ \"R8O5AA/E?S*:T=IOI[ZH<\ZWHTCVQF
MX\7IL]G7;$T/@*2RM0=C&I^I/8]W1FK2.+Z<#6XD1&Q@QVJQF'E-4@^_)$L)
MO8GS+E7/XQ*#<]VZX>JGS5I2"$CE:<'L8N&1;\6VRN0 .R?+$&^I/8&N\FZ>
M>HV[I&]+6G=B/ZA\IS"1H4&M<VVMU[5F44&_(I+78&RMKY-GP[W5@VP:@V8K
M;0,+FX?CF%%A8S1W[8TB.!LT:L'C!\UU\L#S"R)!8QWVJH6S#FUBP)///4P.
MRE);>6C>86,>QI*@$27WNQ;<O W!MI55 MP,2<ZK:FJ'EWG!Z\UE6457NK+[
MGI.V22AQ_$"S=@97TTNI=*$ZA[_':C'7T>2YAB<[MR F>UF.WD,^0S'V,65-
M!;3ARTBB/NTC,24 F6]_=$MW\H$FZJW(VD@V!!M88DE!!JU0#>S0O8+N9HO<
M\Q@!8L-NZ]B+\K>YQCHU+.V+FF:3NB[?6@=@[+KNB/J/QPD'H?Z6YNI\(=$O
ML/!$UABVW\U'O;,*JDV!7YN*)/U+CK<7DYI G R44QM'5R23&+<*J^='(JF:
M,_OY [&Q!<J"BFVW[YOM-UZ], !=F\B6)G$$J_N(BBCBR"1M[ ,&Y1;;A[W0
M8<'!L@Z#;[=?E$572_08+ VEA6;7E+G<'$,7%4YI@=.WI>VE'O\ $MXEC5\:
MRK,YD9E#$8-9G!5R*=8UN66L%I@OM99VD3A*HR%BC*"NYCM;]ZEFC!/*V[C@
M CX6># TE&(@NY'(8*O*#R9+K)Q[K7[-9KW]3>R+XQ^,CA>#!A>#!A>#!@*&
M]^G#$NJGS!^IC3^9/FU4>^Z =#S\5S&K1PK[ <^Q_?FU[?#<[QB<QPBQ+_%+
MV/"LXS@2 ND@9(KI#UA3I(R6TD:*")U[327!Z,I1 5([@C@_GUQ1DB$M1,AN
M :>.S#@JPD<JP/8J0"/[8&BN1]2VV!>:93[?P7*1;FUU@/0%K#J-J]?0[)\O
M9^!:RV=F:;CS#74>I!%LIE!M'30[++ 5]?&B')4WEC5QHK0>DQ]JT:&F*$>6
MS3O&6M[C,B[ W:ZOQ<WM8'ISBO>5Q5JZGS%6F23:#9U1G\PH+W8.ES;KR5ZV
MQ+[9-YTP[$W5C]]Y?\?7LW%,4Z*NKVMZFL@T11PJG7T;7]IJV.+2N$9Z?'H,
M"@)FX,]CRK+&\9L&+F%'70;XLN)"@/<U\*B14(GW;C-$8PYNV[=[[+<WVE;
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MQ6PD @8*14BB4D=!14$@!.&Y6%"C _NV*-Z.80?"*UR*US47E/!\\''X=/\
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M\&#"\&#"\&#"\&##(=32JG3=U!*B\*FD-KJBI]T7]@[[Y\/C_P#)'_\ -?\
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M<V@<*522X(C5T]9U?.F1"K[0;W**?WSS6;W@=XL5(/4 =#U&&BF   =A:!8
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MQR;%9&4.CD$J25.Y;[6##D$7([BQ/&$DBWLCJQ1T# , ""K6W*RG@@D ]B"
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M@S;([&WGY(*]M,BR*!>1[RTL[!PQAL)5G,-*EI'&DHC_ $F(WRUG.HM2Q?;
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M^NKTD,A7,-[7J9W2PWP-ZM5CTS%CFIWM:KD_5O*?//'@P8>$/F$^84LD-?\
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M"MA0GW7X.*5,61-ADD^)8KS)$93NVU4:*6/)5P2R7/:X!-[VOVOB&:T#R^4
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MP'3@!!937P1E@3:T+D_Q9,/%+"L71GC8UJHDYKN6M55<GY5E6650 I%@#:Y
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M-EJQKUD%:I1E:@FM0;E<J)*8)0S*5(*JKF_ VL;*;_$]NN'%2!?M\QB?%?\
M31[-NLDO2Q=OR38G33'.+)J,4'[EU<.:D)%')F6A4$4YG,$!BQ#/>1_+1O\
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M.9K_ "O_ '_OT[6XQ8"T;U@YE28QE6Z,HWEBV0Z4RR)3W29Y3WM "CC3)AW
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M,+W(] -<JKVNYY56I_/^?]7RG@P8Y(ULM=#'7OC250:NY>T2(Q[5?W(J</\
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M7.<JJKP[ 6Z@>OU]?E@QB:>YO*&2V716=K2S&*O;*J)DVM/_ #^"PRA)\?\
MT2<)\)\>$)O@Q(#%NK[JKPD3@8IO[;=&!T3V*AAYG>M$L9'*]!^F^4]J.1RJ
MJ%:C3)S_ )3X144-86L/0\<_S^NO7!C7G;4OLCQ';,7-\@O,FRO.).$3F7>1
MSK&ZLIW[.7,XTN(Z?,=*.A",M6RQH8K -%".UKF/<%A)?<]GAL3YF\76XL!?
MG_W=^/POSQ@^OKZ_K@H7T[PW)YP72*[TG<)8[3^R*B-1=*[#3N7G]$5?Y_R^
M/#7Z=^OU?Z[8,&'^LK5W](W0,C&N<JX7U!?")RG_ (^U']_Y?V_V^&+O_P
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M&R3L()AV.C$C#(T[6=CW-D)Z?7-)^$]3JK)8\VH,XI:*8O-'+#4TIJANB=@
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MZT==%&&4&9/L6RY/LX'J/<@O4&1<@V4U^U76(E2.38\=."+7OST^&)V@8;>
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MJ0<5%>L'KNV'NW:L3:%?:4L.!D6/UDF=2QZ>H?%=.@FD1Y$?(X<I; \N1(0
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MO=+;ZTT;VH)@D6)*$TK%0)PN"B(/M&;Z<S?-_/CC6C@I9CYE/',SU*(KQ6
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M+F )N(Y%7A532B@(*/8J\ROCR6D$-?'G?[+M&N6Y;XT1YG%)+)F?C=JULO\
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MIJN9"Q DH67<TD7E;F]I"-N1) 07 W @\Q,D&W]VS>54QG]XR[6C206W!2
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M]U>/NBP%AB 7 L>3?K:WS'ZCZ./0N^CN=)=T']12RA$"]>J:PX:1RN7C^C'
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M?I\,)B9/0-E73-CEOB<K.WX=594.^F-O)NQ@QGP'UA0.'')5V5M7V&,5Z#5
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M_F;<7Y&+!_TI50R'YK$.4D@QG/T'MIO!7=R)W,H7*O\ ;RGW_E]_GY\8_<Q
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MGD2B]6'5BV4]SE31N+*-J_IVYL;O<J(Q&ISZC.WEW<J=W"*B*J42I7:IXL"
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M"F@G0[6ELWP)()4*2R3&(U\-H7KZ9QL>B=Z<*B+PJ\^' V&T,0I%B/\ :_\
M+G\L*&([G^?\\6&.FWZB7J1UB_'X^[JLVYH='16-?[Y;P%#D=A</KVPJBUL+
MB+"98']FX$<A0K-0)U"CW 80\AYGB0J H)L!8<#H!86[^G4_EA+_ *\XQ-AY
M\=]E&PF9=L/I\QG-L7CV;Y</$;?,;V0X3&O.X(3R"?X1."GN"=XYLV0!6-"$
M8Q $@EV;*M7YID]$]'2,J!YI',H%I%B>- 41N=A\Q2UQSR1?%J*NJ(%"1[2H
MZ ]1R3<<<=?SL3?IB8>3_4O[8V>*MJL88/1%'4Q($6/CT&6DL,B-7L,C:P=Z
M>0-:^L/%)['TV@;(8,(R,E][1H';])U_ANF72SZK_:$N=2RU)D5*62>F*R-O
MCD38VUI+L;^9L!*V8%;70U]0K($AA=2Q,KL2'L>H2W'-AUY^-A@4'6YYC3.L
M39%@3,\)J,=U^S& 46+AHLKL,KO,<MZ^0Z55Y*"?+EO"892./'L:1L=1%AS)
M/$]3CB.!K\VK9:G+Y=.J]+E^1^T35 >'*:2HGJWB(:B%1%,K+"%*V+4QC8"1
MPVX$@ODJ$J'"SH?)LP.TDD'JK;"VUC<"][FU^;<8&$_,["DG28])>SG1T)^2
MQ@^^K'21,7\A4"A^\:HO*]JKWL7X:OYEYUZGS_/*/<*'/,TH5<W,5%6U5'3H
M1P"D%+-"@X)&T^YR?=O:V+FHZ2>4//"LZK]P.!9>EF -[$"XXZ@V)(OCT0?I
M [N7>]"W4/)ES)4T@^J&>-"S#&.5$76> O<WN.][D3N555$7A7*J_=55:N89
MGF6:2)+F>95>9S1IL2:LEEFD5+D[ \KNUB;M:_4^M\3A(XQMB4(@Z*!8#Y#_
M (O^F+:/BAA<+P8,+P8,+P8,+P8,+P8,"U\Y;J$E=+'E_P"V=ZPJ^YM3X/=Z
MY*E?09(?$;26*YSNBH9 09#%C2Y%>PD>S*R2X('D/&<:,QPW&0C%7;N!8,;&
MZ[+;@X^X;-=2 UB0001<$$'"KPP-RO(]Y?O+SU7XCJ/CCS#MH;@Z/MEY8'(*
M?IWRW44*PN03\BCXQM>3D(I(3=Q;1T"NRBDE,ARI)22) 7-L&QP(3TF1D%PB
M;AI:HTPM?&VKAF<T4E)4T\<E WNT;RLQ6:4O*K-<%PD-,M,D=_O/<VK5OMCY
M=7G)Y(XLZ"N:2MS93-$[6;:#%$03^\*LW2Z@@&WO"V'Y*,7IUQS25G?0%Q3]
MC,DRLE=#;<V)XN0AQQ\V1(979!*4K(EK.KC#-(FI$%#4+Y0Q.3]\)R]-U4E&
M\^7T>B0L>4T]!'+))3PRLLM5L5693*ID222XW^86;>':]K8RN5P9XV2T[YI4
MQ5,A<%DA0*"W5P .@WW;;SM!%S>Y-J#%,8I<.P8L#66 UE@"JQFZN,4@5UO&
M!09!;2S39T8O+(YPQ9=I-(@2G*9QF,1AWB0**YO%ZK?F68K-FU7,Q2J2*8S(
M6,"K92=AV^9Y:7VBQ'%NF'.4FK D\AB&\#RGONC'=2.@]3;Y\FV ::#J^J39
M>S+W9.\J.GPXE@>]K/Z,KN-#K;H9Z^3'DXVV-<-2NC#BP#SO91BRDA3;(813
ME9[=[Y2]@SZ#1N64L$>4Q1U,T4407.(T!C5)0ZSHR$,P>0AG.QF5"S("&L,9
M>2F@6,L2B6+*G4L0.C%]S ;A8[1TZGG'%AEOJ_J/R'9-ILWINK\RR7',]G8?
M;2KN)7UI[!:X!)EA6X_%D'OWWN(UE1*.:P< PH)7Q#CCR3N5Y!Z1G6F\NRVE
MBDRNKBJXJR+VF.!&WO2;O=>&2X0!FE5Y2H%@']VP  PC")V;:1[IMT '/(];
MBQ'/;G%:'S!/+$U'"V#>9=I>CEZDQG*K2YLPT$:VC6N.TB0V(>05E5;BARZB
MCF$*T\0S;61'])7-C#[6HP>F)20LA,\RP.O16N2YN>FT'A>#V_GB&144+M/)
MO^/?TZ_RZ=L +@59*2+*KTF0II(\Z0WW%9*#*C$Y:)J/#(!R(BN5BJG"HB(K
M5^5\5&&URH.Y1>S#H>>/K^6(OKZ_3&1C?^TJN52JG8=$]5S6\.X5>Y_'/:Q%
M7Y5'(O'"JOA+ \&UN]\&)9=%O1G2;Y=7WV:YM'A8M(OTJ?P>DM*J)/EE])&"
M9.O;%KJZD8^0X:G$6/(D#A^I*<K&N&KK-,E.]3 D\QA@::-9I=N[RXRX#R 6
MLVQ26"][6[\*I 9;]+B_U^!Q:,VYIGIHT7T]:@A8QTNX_A&&U9*5^07%I?RR
MFEW$-)MA(FQ+Z+7MM<]OS>@XTY>Z- [?\BQ[(XHZ=:T%2Y8V:RTCYINKY-Z9
M5#-04B^T[@0K*Y:R+MNVXG=<<"Y)&;RR.F:4EG4L!<*S$#KTO8\<]>+_ #.'
MJCFS;9?3?E/5I@N.P9>6$RFVQJOPJGK:6V;@5#4EKXGNI$&1111/#,=);<&F
MR"R9AXKVPW"-$ QK,_)IK):+5$6F\[:%LOABAJ8*F<F%*AY%+>5N4FY#JT8N
MUK]2+D8>D<;$3B(M&XWA3:U[V(O;@CH1:Y XZV!=L+Z4\+ZX^CK3UEU#8E&I
ML[DT8K.,7&X3L7O,9GO;(J9#QOJ^0A9:BAALS5DZK)%'.E"&H"$8Q%TAM256
M@]99Q3:=S$'+G:T='4%)X956S7A+&VT$E/<;=8$J0#Q0K8J83 %!(KN)%0K(
MH!87LALI MQ:X%K<\"X)_, \L71.H-4[0@3,WO\ (,AK*!;&OQJRM*!LQ(D6
MW:!^2F_#I\@]7"BQ6^Z[I1HWO$C2 DA"68B ZIE^LSK*C-#J"DI(-.U.X9A6
MD3Q+"(T$A19'B5=ZNILR;@EQ9R!9I9*6&&!JFGIG#E" A:P.TFU_D>]R+#XD
M"I=^$=*H9]U%L,CW"^(&*]M%.H:+$Y@),]IG,YFML["N(E>YC6*A@(Z2O"HC
M7HB.\<OU/1^'-/5I'IW-<[:(5 CJSY4-71^4%4M49;+4>7*W/[L%D"DQG;QR
M<32R23(S5:I'('(54-QL &T-U][K<<CIUQ:J^DJJ-81.I#J/GX3EN2V]_)TO
M1AR&@O<4CT\:LBLS)SJ^9 NHUU8,LW2>",D1WPHCX[T[FO>Q4YT?.X,FCKKY
M)79E6T:QA5DS6"&&J+N=TG_A=@R(4 %[$;N]S:5]HL%.[N2  !:]A;D\W]3;
M\<""\ZSI;W3@/6WMK8VK*[-\XUSEMSE%ZS.\:Q'*"1<?MK;+,AF97A5U:,HV
MQ!V6,W3Y,<<N"<T654'KI/N62228T?8=6ZSCU'2Z=84K4<F49)3Y1.CLK&5H
M6=%E4K<!3'%&Q!.X/*P VV+4*"C2@%08WW&JJ7J6%B"C2?>7@] 1QVL3QB.O
MEW>5-U(]6<#,=G1,Q)IK7^&3Q4\F^EBD/R:WLW166A0UM":17S)D./#*(KCN
M]=94APHT492DX9B,@J,SH,SHJB@K9\JGE=DIZV  E6=64#:S!6C<MMD#';M)
MX-K8R2))(0MO=;@\"Q4]>IY^(!X]!@PW2)]/?G75)J[*]FY#U+;9P^DI[R_I
MJ./D./%K!73Z>(*9,GR&?CZDIX1CD,(A7B>U#-(]OK<<NVG7&6B@U'2/69Y4
M9YFU91Q/F5?[@:,."B10>4;+95 14+!!Q8\#$U721!8A#* RG8 ;74(>&')
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MO4XL_>6#UF],>4Y#C6II693]4S)-/:GG2KY\C&9]D$(X[Y%33381BT"S9_\
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M$M;C'U_X4OY32M[OV8WIPGS\Z8Q[[I^O_MV?''\_TX^?MX3!CY_\*9\IE?\
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M6W3RG0A#,(U&1FRC$:BD\9^JJLI>@R*G2&0U,*U<TSH#=F6=]Q)%B1N' N0
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MHSBQ!*M9@;#L;GOYBY(L1U('?CB_')L;?#OSTY(MU1Q\8Q#I'W#:ZL=CDN%
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MO3MU^-^GPOWXP)GZ;[:V&3O-,TY@6O=-XCA=*?"]Q29>56AY>8;+L?9X#;%
M,V66*1P5<0CFM]>!155<(R*YAB'&O8U"3ZGX]?KKZX<?A\/Y\_IBV=]03@G[
M9]!6?SO;^O\ L=BVQ\E[D&CU#[3!;9/515Y5G:G^<G]2?R\></'S4D>G\_\
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M7J&DD\PFS,SG>%LA8>[8&V)E7WF6]7NQ=/UNF[?!\HR77U-*A%HWV&/&=90
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MB=:Z*<R.DZ&\4B/LVNC G=QN YX#6'4V'QEUSB03@+C$RZ)$D-0A8UC $PT
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MZ?'#1P1W7I=XXD!K'._=#')>K%<Y47\K>.[Y54;W<+S^GS\*BSH"")&C*,'
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M3-29E!UME^OLCB'E-D2*[ )-;3A4BK'G"<ZNKY;'$-)$U%.(\=C'C5583O\
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MHQ-.O6O24ZBFDF58Y9::)?,,R-+YD:E=R*-ME90J]5MN# =/K<N,($A*B,D
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M1J/Q=S6L"HHWL?9*&POM-HS[.O(YL@Y XQCJ/.7S>MK*="'_ &0E+1,JECM
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M&@U$UZ.14:LK:CE3ER(KN$<UO<J\JUB*J(J^. .R;3L#$22&4.S7 '*F)1U
M0\7))/<#C%DL"S64K?D@F]C<\'@<CU[\]+8'KY^>W<DU_P!;^48G#R\V"T>8
MIFKLBOJC'(]EE4ZKC9[:^G00K5L8EI!@2'_G>"'+A1S2.PDIQ6H@W<V\,!-0
M9]K^JCJ*G+*AM9U<U+4P,\;*WDC;, I7>L@9P2"-Q"@D[+8YMX?.Z:@\1&,K
M-?/*- I-UC$9S1MJ"_NEO-]YK]%0<;<9;H"\ZJ948X?3>=Z^V!.P7"(T&#@T
M_#L>RG+LGJ@UO,)9U[+I85E9+8SXZ-(97PAA$4:,9WM16-[=F.<4%=%YLZYF
MV<@6EK)ZS=%F/(#-Y/DH8BH)D(+R<\WW6)ZI-41R^\8[2 $*U[<6L2;<WYN>
M?A?#X]5'F_:>VM@LW5MKK7<N>42DKY@;*XA9-B=I%M*:0LD4KUI^'1SC.CVL
M9*:X?H&Y5IA*1RE\1:/U1F.D*Z@JJ#V8BGCJ(YUFAW^?YY<@DW! 0,!8@DVN
M&6_%98Z>:.2EJD=Z>H4QR"-_+?:W4HQ#;6!L03>Q'8'@6&)^:)/T_<S5TW@Z
M4D6QJYD')*O),NA-F9)5B:4X@6$P,N.0)HOJ$=&BQZ6,IWN:.0V41&-'NN>^
M)AU319M2YWEZHS;3D,L3%#03!5#S2%@6GWL/=6/9M%AR;DV(/9Z6):=J./RH
MF/D-"?*<J00K3L=WG2<"_06Z*O%MDA?4"]6N,83;Z_PC&<!HX-E(O2.NLFK@
M9W,A@M%*\ (5+*_#Z#FN(YC8DF;"F/"B(54<U$&G*?/G N)#NZW^N<0;AV'
M-QT_L?[CL<!AVSNS8VZ,DL\MV9G5QEU_<S'3K*1/FPX453O>CT:&KKFQ8$8
MWM8@HT>*(0FL;PQ>WGQ*]=6O3BC-7.:3<7,!D=HR[&Y;86VCX<7^('&$9W86
M+$@ @"Y ^7'3':H;8<NJA5;'F$]0*CS& 51<,(J(T3SN8.0CG.:OJ,<Y&]O=
M]_X:ME'"@A>P/)YY/ZWPW'5S^X'*I3US6RPRHLF&T9G#*(#T$X1FD2;V-CQG
MKPY!C4WJ(Y&=O*O;X,&))=*GF-]4_2!D$:\U5M"VL:UL%T"QP;+[F7D.(6$4
MKQ%(-($F8XE<5IQ#(*37ECE&K414>U$1'*[+?GTM\ /AS^?%NHM@P2VC^H.Z
MACENB9K@]-E0;>K93MA2<KLCPJ& ^>V5/!2)([IH&6!&]LEI)KXYF*K2B1$;
MQ,CL=Q()7C<Q87C7GW@+ M;TN#\<*+]0;$=#>UOCZG\.<$8Z0OJ.]1:9Q&UP
MO9?3'<9E"M;,4V3*QK("5Q!+VM:\DB##=90I[!M&WAPUB'<)C >F1&H]9*BN
M>M>/SIYGAA7RHYY4955>R;"QOWM[Q^'%L#2!EL:AI'!X01D#X^^68$CY&X^/
M."^V7U'71YL?69VZM#M7%\G@0&O!BD:H69.DQ7 :TXE9+JBN<QCB#COD<O\
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M^6L+'C'B_HH:SF\.XI*^KH:;)]>95FU2*3_R5,<"2JL+'>EE61EF!]ZSQ+8
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MS]CR/)$JA69%W*G[]6*AK\E.#\+VU9/+POL_R*#CNH+JHC6$R'+DFC99,]K
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MZD7#6'4V-NG.!2\=]CVW<D<^O-_7O8?D;=>!(UMZWNG3)0YR.Y]]'E';+?\
M"(B/D*]"KVHGPO?\IPG*\?,9DE!+Q[5+DE]S/O;<;MOL2#?OZ]^N%#.!]XW^
M!(Z_TXM^ OAV<2W#MC#SQS0,DDV38J.;&#?6%G9A KD1.X0S3'*%41%7\KT:
MBKQPOPB;/IO66H-(I4?L"JBH(ZIMU53+2TDRSR$*/.8ST\C%K  #>%&V^WDW
MCJH%KZ<4LSLJ!_,#[V%FXXXXZ@<D'\0 !C,]V#FVPW!?DUF28$3^]M<*5,96
MA5RN_..&Z2\3BC]1R#,]'%&U5:CN.$2#/M3YQJ9HY\ZS.OS&6)RZ1S^RTL4
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M.!!KHAWV!ORB>P3#'%.::H"AS3S!&%PQBD"D>H;;8CX@X<R.MMR,M^EU(O\
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M_6O_ *_!@Q\\I_-/]J>#!A*G*<>#!CA7CXX_Z47^S^7_ #HB^#!CU*_IM/\
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M-?W<6HV=F4&./\J-_((%PT:(C>&HG;PC4X3GCPEAZ#!CZO>J/J7R5KFW^_\
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M2)']B$@H1&N="9([7';&5SE$(S@L8QYF,1$>@V-3[JUJ)QX,&.O?PV#HYA9
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MJ;[%/!4+?>53LS<@'HNB=7)I==6N&\N7.=$U^1)('$;A*GV19H@Q(NLVQ59
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ME_#]D46Q\,RB]R/+M7Z[JKRDMK\\S*K3"7Y#3UT\4QM%2U);&&:Z+;*%L)C
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M.XE%5LM605EI#<\A%>W;];P:-&84_P#V=)(:?V<^WF1I'7V@,-A0R6/*$[P
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M3J4ONB/?^8C7L'Z*0RQVB<YS'M\<X\<:TS:DAI'C\DTV6PQ$D ;P\T\P9;6
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M9;B'S"J-17).&;<K$D)Y)7:T9C2- =ZB);!GM4-7^T*4U*T[4T43K3I"R[0
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M;BS1MN(>*Q-F(&ZP(Y%C=J::G6G4+):<!;J"3>XN3NM;@W'7XV/?6-:6F/Z
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M4]1$@5S 5-\3SQ+1N-XS:1EI;2YG1HI6)%DW,8)O>10.9Z+YL48T$YYW-0Q
M,<U6O7T4(1&(]_AG5?VN_$3465YQ0A-/Y1D54)8:6DGRQZZOI86&Q(CFABD1
MJHPAP:R.E98I#QY?NOC[&:7_ .G7X4TNE,NEU3G.LJK5SY?%^TLPTUJN33T(
MJ69):F&A]ECD=:9&#H&DF3SH@"47<=A$<+Z-,6O<*!,RO(;W',GOO?W_ .&U
M,@5+:1:V+(:&,QI9JV=M$:KF F_X,:O!']:.CX[WN[_&H^'/B)XM4&D-<^(&
M4TND,PTCD$CQ"LS_ $_3ZC$^91^7YJT]?2QPP10EI!$IC:9"Y!9CO4#XY?;D
MUEI'2?C=2>'7@_JO/9<JR/*DRK,JY-42Y_E^:5E=$9J^FK)/:9*"LEA$;1R+
M)[S;*A#'>.2S/YAY=>)YC<3(M)U$;"A38$);&=BY,AIKR;&>&*XL5KVR#))$
MZ2U@F,;(@%0?>-7.7U$<G2])?;LU)FFDY/,T)656?9?YOM==E%;#I?3=1#%=
MO)H1644JR5D: J:&F>=Y65FB!N1CC=!H7Q:TWEVE]7Y]H+*LHT'JRNBBRSQ%
MS?2&9TV211YA5K!2M5YCE,%1!#3&8LT,\JK+40 /!%,I5VB-0= ==F&([(CX
M;M_8<W(:=D^UK:2WJJ6KJKV')(**(=BZ%*G$:<TYS(!7*\4:.IXQ6N8)LAS=
M\\,_M2:R\0-<Z4T2VEJ.@I]0)+-F5;)JPF2&GW,]6\$5;E%#!F,ZT;1/'#%6
M+))(TD*1!P1CTE]K'P8UQ]D?3^CO$+Q$K-(Y[IO4M<^7U53HZ#/*YJ&9*>FJ
M5DD2LR^A:E5GJ6:G01S1F)&9IE8,%&?O/I>V5J:0*%EU=9UQ7F/+6).KH<=K
M7E8$A'CEP),F$;ECD[@CD/4:(U>QJ.7QZ7H%T_K*BSROTGK*AU7E^69U795F
M:T$,</[(S*CV+4TM1M*R[U!3:[CRW!#Q,5;=CF.G=9Y9J&ERFNHZ/,:1<QRB
M&KH8\UH:W+9JZB:JK(!F-%3YA3TT]11/605=*E3#&\*STLU)O\ZFF1(T+#>$
M#5>]Y5<U&-!RQ58Y./E.QR,_A:B+S_+CE>.5T:HRQZ621'=Y8E0E)'(*[A:R
M;N%W6YL2>!P<;LK[^4))4 ,IX9#R KCBQXXOU[=.-VBX1+F&K89)1T?;H,R0
MF%")!#8->\CWE<B<L8QY5:U6H]C48WN[O&2TUI^+/JF.D9I&:64)Y<4ZQ$A
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M(84794LUXBTJO3I$1,804.Z8,#I$P:3 0C9>05Y2/_*^RN:Z0-[.7('L#!H
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M/5@2JJK5P9P4:H)4<[$8=[BC*QPFN[N/#S3S'EB-XN0 !N-K@&QZWYYZ?'C
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MYY1>U4<B\_/C?[2N:9GER^"+Y5&SS5'V@-+T=8039<KD.;K6DC:P_P#])NP
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M_M;_ +DTS%ED'G1PZA7-,OH(Y$G:2"1YVRJ*,/)?;-.M-3LL*H@1A+9?DO\
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M\;W9B4*C(JR(4R/ED8TD#92CBQXTNKMH\)0H(CA%.R>CG<0!/(XA!M+XG$K
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M(S>J\G:)Q4YG+,OFB5#:!I2(6W'<R#M>UR;7Y"CY#&/-KW^-A>U^MN;?@.I
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M/1K6TO G6%W>V\@S7]R>LXJJ\CFHO+$3M\4:V52NQ%4KN!WCKQ>W4D\]^>X
MXPV1=MNG7K;YVYN3R.?[8M<>=!5?B'0#N%_*<PKK><MKEXY8],2S]&KQSS\<
MK\_*?;E%543QJF;:+.J::G15)DR3-*74:.(R[(M-([N;!ELK+,$+7-AR5/('
M$?$^NCI,MTR\EKS>(-%3*"2+AJJK# =+G<BD ^G!MU\H\F.*KG*L^0CE555K
M5)_$J<\(WU$1$Y_K3A%_L3QG)!9V'2QMCM"VVBW2PM@OW0;Y-NU>LBBJ<M+E
M-WA..9+:EI\=EEQJU?$E'9\,DS+V5'-50AG(,C(H&AE%(OYC&BL<WEF%^O\
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M=X!*S%4BS+#.:B/AN846#;$MVS;^K!DE;;'>>12P6@"8P(IS&MF\Q6C'"&1
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M4K?6GP98_421#>"/&-)BRHDB.I2,42]L@S7DY)!XB0Z!TSXDZ=JLOI<WR3Q
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MN.MNG XYZ#K\,60//QV%*Q3H R0,0X +E>YMKX8<ISH #(TG&MCB,XY55&C
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MQR7IH=1[FUWJ#"[:CW7 VC*MJB5JIN8(*;7+@QH,-X+%V6F5[),HI%2*)K4
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M"B KT,KWLCOFP"<]XU"H'*CM0CDEC8/$RJPYNUK6]!<CF]K=\5U8J;CKT_/
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M+&_@PN%X,&%X,&%X,&%X,&%X,&*@WU86*6^2XIT5.JJ27<^RR7<ZRVPPNDE
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MZOE#_3@<*G]\TC(J_/*]0NIU5$_DB+C/']GA#65!ZQ+T_@;]/3X>F&V/\)_
M&_2WI^/3''_>@?IODYY\S..J(BN^>HC5'"<?=5_X-<+Q]_ZOOX@::9+[TMW(
M8-V/>Y/I;UPMV_AXXZ CI\1]"W3'R_R@?IOU[3?WS$* 4?*+_=!:L<QR\KR5
M"+C2MX3[<-X:B\?/*^%::0B_E@7YN 3U_'^?]<+=AV/XW/U\?C^0_6^4!]-^
M]J.;YFD=S53GN_NAM4<.X^RK_P &D^W"_P N>>5YX3PGFRFWN$CMPWXV^O\
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M>%%1G0UT_)RJ+\TLE5Y3[<*MJJIQ]_[?G[^#"'YD?E_4''83R5_*71.$Z']
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MAP#+S>MN[TPCKEWE1PMK;+H*BRR[8+H]77YODL*N-12]@Y.D>*V&&Q'']@K
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M -NP7IUZ6YPX@'KC[]9OV]1JJW\W*\?*._7A/Y+\_;_7^J2),P8;C<6]!^?
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M\(JIL#+/X?N[_P!Z_P _"+_-?!@QE[3.]TAAL.WJFOF(4<!5KW;'RUT\;9\
M,]'/XA/'VP'$6!,5)3WI.&\;.]J>KX,&."%N3=:1HXV;CVC)5@T;ZX\^RQ62
M&L1$60Q$M&+Z95_.URL8BH[CAO'"&#'2O-Q[M?5&5NZ-FQN21T4Y-@98U!(I
MF<N7_&KE;\*K55S'?V?;P8,=D>?;G'C[KE_4SE,TP0B*VEA[#RW\5*JSFQ&B
M8U&"8KV"YEN1DWYC+W*[O_)X,&.DF[MUJO'],.T.4_\ G_RW]/C[K:K\??\
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M7*KDX1%7CG[(GRY4^?"CR*41P.Z&(*IBIZ<3U$P0BT8DVQ;(G X*22AEM87
M!+J:F@BB$<:SH8!:QB<L!RUV9B#S]X]^3M%@!B(&^-F56'44NRB"JR3+.3+I
MZAYI,28P-C#!&GRY,R%)Y0T>/',%T>+WM9),5"IZZ12@?ZA^S]X7KJ+.:[-<
M_.>Y/E.4T=)5TB2P5&609S)F#U<<$"5[34JLD8I)YIA3R3R"T*[%$JEOE]]O
MS[22Y*-'>&7ANFBM8YW7UN89CJO,I5H-1U.F:;+EAI(<LIJ,),*7-*Z:IJ1)
M(2C40H765&D<K'8&^E.V_F&U\[ZTS93/H)(ZN@TPE;%QW$:#%H,9DF?L3UW*
MRAJ:MDEY'A9R^6TDA?DBN52O<O?=99;0Y1#04%!%:!:FOFBF#3S*\,GLZHC5
M50YDFEC=)=ZE0(U,;!W,I"_(/3N0Y5EF9Y[F-&E:,QSBH$^:3UM5-*U3*'DD
M&RE:5Z>B6FEFJ(@E*B)(K*6^XJ(&7SK-LR*CKARVN!M3+,$M&0;>)$K"TD6_
MU[9#CY[FH0FO@29YG1#O5SHY);<:M6L"@D<]&M>C?.?@7109;!X@_P#CB.8^
M(&>5S2JBEV=YB&67CD+N#)R;$N  &N8-"9K-F,VJ1(?=HL]FH8N;MMIXEZW%
MMOO@K8DW+DVXO-[RA.O[3>!,RW#=GWFEM1;5;5U#PW>61H=+692UQ7GDI56Q
MK2#3MQ^TC@')A-JBQ(3V35 D41F 0_>99(C&0LUF6QL%';_\K$6Y%AV%P.W0
MO,XX OW(-^3Z$CKV%^G';%FW$NNGH]R7%!1)G5%T^?M,>Z21=U M@8PZL)($
MD@[7L2JMBMBQW">CE?*D :XS )^1',:Z@LX>07W (NT$$,P (X.[J2?2]KDD
M&]\*TA((([=;W)OVY_3H.<0CWUYA'1T"QR^1D75=J#%XF*TSJJ%C438U=*N[
MV66(Q[9=5)BU<Y#0Z^6Q9#H3!*CSH1[9+)I6M'=,U.!9G!!ON90%-N]C>X-K
M@'FQ -NV(@VU@3>P()^0 OS\^EK6ZG%>V=U==$5SKS;D7-^HK8FTLRMI3[2M
MS7&]69!;55:>++E3?P*3,L;:LI3U(@O 5A!N :0D\@GFC-&*$[>].:XH\HKJ
M2J@I(A'31T\$L!E*B>*GIHZ=)'80L#62[/-FJ2/WDS%O+!.)YYH9Z',Z+<4.
M8*0LH4EJ>X]VR_X[$=-R7YYP#KJEZM\0V]&2IQK6H4!"M3G@9/=E8*VE#,<A
M2/=$$CB08+. )65#;*4& Q2H0DIY.]N"DU)D^6:=S/3U#4YAJ.JS;4U;J-\Q
MU!MF;*?;I4D.696/WD\4-/Y2Q+*U0$D9I9A2Q&4QK7S*LS'.\\7/\R_8U/70
MZ6TKI&GBR+)QD^6O0Z4?,S2YE69>U97K4Y[F2YD8<VS+S8_:HJ:G'D1E,1LB
MS$D4P3^BT3Y0_59#"U2-&KWH[L&CN]ZL&K43E45$141'(J(OC0G+;V+<,S%K
M$AK!R6 N @-K_P ()L>.^&RMOD9N?>L3<@\D FVU54+>^U0+*MEN;7.6N\G#
MC:4E]^&P;9E)95TE];.8(\8Q1N1%%(&YJC<J.<CE85KT:Y/SM5J\):H*F*DK
M:.LDIUJ!2RB5H&<H)EZ["P5BO2X.UR#T'&$1]O\ A!_K\^OX>F#F>77YINI,
M1RZBQS:=B[0-375J.J<IJZ?\2JY=J,\9PAV=C6E26#W#6'>)]A&=7C.5S7EC
MB;Z;\[F&=T69UTU9'ET>7+,1_P"G6;SD]T6!WF*'FPX]R_?%CSPP V 6X^]?
MBQ/-P/C?] !@_P!I#J_Z!<(V-L+J-M-OUN:V=S&I Y!9S;S'8<22.463)>RN
M'>R%;'@0QB$U[:./+G&,Z=)+)&=7,*UZF.1$$4RT]KEFY;=Z"UUX')Y)Z6(Z
MX 5?@^Y;D&PL>O'(6W4]/TO@ENK>O7I^WLZ-=8IMO6U9C0K(H:^K!EE0.>]I
M$>BM&266.%0>F :_FB,BL>1O#R'(QS8[TT:$><9)" -Q%B>O-MQ(Y/6_3KT&
M$90.0U^G'T>_R[VYQL>Y.I325%7DC1&5J1"13GAYO+MJ&T@.@N>(I9,>3%EG
M,.2-CDFLBRFK%,HG(C0(92 2F"1 RF57-@2B@C<>A&ZYXYN" #?CMRSI\;<_
MW-[=>I/<X\_7KZ@:EW7NK/\ 8&-YC58YL*ZR>T[P2\:GX[KG9L5CG2@W..9K
M),2O_:<(# @6 IL6+5VBA$>)8N.KU,ZNV3)&P;82!P%.UK<CWC:Y ]+FW M8
MX0V6YMS8"W3CZ'Y#!"/I;J.YH_-1BQK:IL*YR:%VKV+*B&$%[>VDX>&3VK&D
M")_$(L<Q1$8J.8]47XQ%6&6%02;$BP(( Y[$]>1VN+'#6(L>+7M>_!X/_/>P
MMZGFVYYR62NI^@S;HFN49+FVWC2]R.X3TB89GXGH[X3N[E1CNWE$56\=WCS'
MXV9+!G*^&/G*&;+/%O*\TB!&ZS4K9C[P[ @NH!O==W -S;3M1:EDR"CI)H[W
MK<[@RUE$GEAPU24V$@$D-MZ6MTN>F/*L[QM=V^L->/R_+V\\_;]7?'V3X_VH
MB^/1;*J,53[J\#Y6^OZ8W"155V56W*#PU@+\7Z#C\L<[""^>2B^?A4]1%7[_
M ,D^%_UKX;AF.QZX$3_*CXXY_C;^O^O^M/\ ;X,&/WU@\M7U1_'RGYV_/Z?S
M_K_]?@P8_)$D'I?Y5OW151')_)?A?E/A%X54^Z\<<+]E,&,WE)-2CCPG5MSF
MAK0@H"S(YJZH]F![H(WV+ &98*<BI8=[8_?&&CHS4[G,+^3P8,;)5D"S'(A
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MYS"DK=014.54N:9A54^1Q5];'!12%J<N8XY)V8=@>*19X'5H(M3(<7TP."
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M'CS$%E\1ZDL:RJJT1C9$VXAQW/(Z AGQA$'^X$QSVO>]40@_'H;PJ\-\PAU
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MI!*D6?,-)D@:%(Q98QA:X3TD(5\AHG!:U0DK%]YW*"0A1B+B_'3@'O<$"PX
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MR[X7XY\4;D\L"">H!^/!XZ#K<\=^O&&'DD^OU\<?5ED1::.R?"GGC3:Z= (
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M>'([V!I6+D-$@%[L18_^T&Y!OU(!Z"_&'E>G/3H.UN.+=3\>>MC@K>DO)_Z
ML 3U;SI6U42GLQ/$C,XKOVLR&G[8_ #RYRS2Q89S20G"L<!93@!+%:Y"O]1Y
M[+K$L(2)"\@87(4'<.AX()M8W)'%^+BYPH')MRWKUL.O(%K7/].U@'%V1Y0_
ME]7$%EKC/2=K&-9]\=@VU\.OKZCVXI#/=-LP/=80E*=BM:9@:[U0-89B!$BM
M<-L+!SY4J!58>]=2&'%QM%P2.+ $DF_4]<.5"6 (( []+7];"UKVO\>+8K&>
M=/Y9^B=3T&.;<TWJ6TU76UE5:AS.%BK:^PA3I"'#$H+)V,5\@1J^ND3%-&D6
M[8['D&QTIX%C=Y67#2T^R3S65%1&*,3M#,%)  XN;V%NO)L03AS0 =QTN+#]
M;]?YCX$XT[Z5?#;>#YG$2^2@NA5(=%[4BEN#UDYE<*1)92*",2<0*1F'/Z15
M$)2]Y4$3L:O8O&"J HIP0#<L"3U'?KV^''<>M\0.".#?DD\BWP!Z>G%N.>>E
ML6E/.XU#BVY.A7)L,D9!*QV_+NK:ME@C!R*P5=D&<LK,]:_&KN?;3(@JN!>U
M\F[C GB,KJVU6ND.CR0A?#/L.C=6G3685YK*=JRFSG(\PR"=D9@::EJHE$4@
M(! :,Q1)9A;;O4%2;C&U>6T]<D/F';)25<5="UNK1,S/'<]W++QU(4FQL<>;
M?;:0Q&IV7(U-M.+>Z8R9DZ+6EOXN10-BU%1.LFB_#G7\*K>,,BM>XPDE3\?M
MSDBL59"5YF<@9I@9W]Z0W<DEC:U^>. 3;BW%S;I?%[CL !V Q92\O'Z:[7?4
M%@$'/-Y[&V"PL8UC&/C>!1OP@]V=#@2#(%(R9D=@Z0H"N6-9U\E[CF:YCQ(C
M%<CK'L"?PPE_H_G?\N?[<X(+L+Z3GI?EUL0^%;%VM@4B1V,>VZD4^6((GIG(
MCI)&6BQ!M-Z3&#<TJ)W%&O'RB>&D[;7XW':/4MZ >O7ZZ*.>!R?K^_3TYP/V
MY^E5SJJS1E8;J)C1<8ES'H&4_7H9EK'K1%<(<@@?VJBQ3R)/W:@C"<YK7+VI
MVIXD\N0@D(Q %S8'Z[8"".HM\\1MW!]-'O\ HL+E95IC;^MM@%@-NY2PLBL%
MQ21>"ARV1Z^MKQ\SX$"WE!19 &2[<T.<D@ H\EBJU[CRY+7V/:]K[3:_6WS_
M +'"@$] 3WXYQ7;VCH[;.HKR?1;*UWD>*6=).D5]HVTK9JP02XLA8I1-LHI'
MUQ1^HQR#.*0\)D5'C<YCD7PA1AR5('U]?\84HR\E2!ZVX_/IC]J0.%55KR2)
M11M@C8D/E7B:KD8K6C0(V/8C$:Y/E2_Q)W<<(OAN&X^LEC/_  .R,XCW-(.,
MY8Y7<1VC:@A*UXNWO>JJU7?Q#=\\HU?E?!@QN^B>DOJ&ZC+ZCQ;2.H,TSVZO
M["'7U[J:DL14XCSCOC@+,O)?HU4*&PC54\D\EHAL8][U[6.17!'*;PK%!U8*
M2!^-L+8^A_(X-F#Z<CKKP=]/&V!EF#8%59*".>Y7&\FL;LQI[ ^O#I0":M'5
M7%C'5YF/>RT-$C>J1ZF3O1O@"L0"%)# $&QY!%Q^8YMUP%6 N5('J00/SQ/K
M2WTHUKL4(Y&6=3+\8DQ'L6?#D8W 2_&\S$<(;XP+B>,#'MY*TCY[B\*1R!>O
MRKON$(_NL4,@4@W*!K%P.05!%@PX!_5+,?NJ2?@+_(]OZ?/$]-=_2SQ]82!9
M+BG6)MD5M$CB<&)'6?CL6*4CA,:626';#=,8Q/7<$#([1\>FR0U4<G*JP8*5
M8$-<@@7##Y_ <7^&$+ 7O>XOQ;G@V_I^7.(3>9UY'6Y,,TI8;:QCJXWCM<5#
M=5D?(<+R;'\R=25D)I22)MG'C!L0"<RKC,<87HPRE-(1HPN[RH4:GU[^I';H
M>H-NYN.._2]R_P /Y?G\OUZ\8J)YK;9I:.F8S:9C8Y'6U<SV<25>0G!M'QZP
MQ&1/7?8LD6T11<K_ (%)F%>%RD83A45/#7 M?N2+_'@]O]L+CTO_ *6P!(WE
M*ZU 0K"J/9VWT16-[5:G[:3^4<J*J.57<N14:S[_ ,*+SXCP=[_+]+_WQ8L\
M&#"\&#"\&#"\&#"\&#"\&#%=SZF#=,[170;@>7P,;KLI+-ZC,/Q]];96F04P
MVCLL%V0]TH%AC-C56H90?;)Z*CFL$CG=Q&/[6HFQZ6J*NES:.6C>6.8QO&KP
M&TZF0J@:$[7'F*Q#)=2"P (L21@]0Y!E6H\LER_-Z"FS"FW+*L54"\4<J[E2
M0Q;E28@,5\N4/&P8AD;IB@=KW:(MA[6MMCY+=0<$Q_%*=+\.(3,RRJX';V2#
M%5 KL<9DDZ^MYWOI*OGV+94YH0-=+5YF"((7C:M0Q9AFN1')Z'):G-*W/0,D
MS+,7ABEFBH9\P7V[4M=),@8T])'OBAIXB-N9$2!=O2WH632^C==:7S"3+1EN
M34=5-G!DT_0O0Q05NF,K?-,GHZU\F-"U*E?GU'E](RH5+15,Y!VA@Y+M=[#C
MWN/1+*9'2,!L=A!#AV4<S'#08BK[9@#$(1C6E]1[Y" *+M>QXE5&.)Y%\8O!
MR/PTSJ&*DU=D6>I54X=:0I[/.$8#W9TAEOOL>2#<DCW>EOK?]G/_ *C>G?&"
M?-=.ZPT1G^1:FR9'DGS#2^2YIGNF*U(0P\F.;::S+:RRI&8*ZJK$GFN5>(';
MC9+*YBRY#'P_PN<V9RPQC6AF$C^@16^C($VN<2.]'.3L"B.0R<&1/2:I6Z)D
MFA:O,$@,><Z9R_VA=PIGS62)X YOY;JT_ND=2&! [6YQUC,OMZZ R09CL\-_
M&N;]GRRQECH+.<NCD,?!*O(TR@'DAE6_(ZX8+8>ZF8-8B;(K*E8SV$8EI^UV
M*-KTD,:CGPP%+/5YRC:Y.]%8-&O[AM0B-[E[;I[[,T^>423R^(NEJ::1GO2I
M6^T% KV4^;[?$6,@!:PCL.A)MC@>9?\ 5?T>DDT5#X&>)%X'V>V9O3U]&TQ)
M][F3)'0(INJKY[/?@+8@%N[3JK)2A:VDJ,7N8<STV/23L3$AE>0BE1ZI&KYM
MJY@Q>FC6O*2*Q7(GYAJ1J-V.B^RAEJ5GFYYKRADCC81QP97-14=5*MNL<^8R
M5<(NV[GR'((X:^-&U!_U8<[KH$;1_@['E%;"#&'U-#J"LB9P=WG1197%DX=2
MK!-I\PED.YPFU<1HV/U4;'"AFTSL'KQ&!)KY8:V;7Y%+<&0QS7%:_P!:7$BF
M] BA4T)BJ).] F81Y%\=ERCPC\/?#A\MS_*:>#,L[RN0U%-59OGD&;.LP ,=
M1)2TT4=$LD;$;2*9@K$VD#6MY*\1_M5^-7CYE^99'JW4>=9;IW,7#5&FLERI
M<ARK8W C,ZPIFU;3W'N+65\C*HW #<Q>'TV]FY+)GVEI+8>TL9CCR7(-C54G
M8K?A@T:@F-8UC$:Q$9PUO/+N57%ZES&;/,TJLUGJ:NNK,PEA?,JC:L=#3R0J
MZ4M)#&%6Y6(N0RV51>PN21R'+Z:.@IX:*!=M/2J8P92WG[N#>Y)9EX]Z]R">
M2;\_+C@BP%&20T,EX'N$KT?P[ERM5!O1J)W=R\)RY.Y51&NYX1<2JPPU-*\J
M1/&'7B:$3Q!F(6.22$D"18Y&1V4FUE-P1>]QU+*5 !W D@@>\"+,HON4E@;#
M@B]ASA^M=]6.V,4KJ_&R6E+<T,0TGV%;=54$@(+2"5#^TDQ10K,*$>GK)&%8
MLB%D\D*%Y'.?XSVH=*Z8\3I:*MUO!2U6;1PG**3.<CJ9,KG@HJ*,R01O1TVV
MGJY(RS>4)HY "Y46W6QM7AOXH^(?@AF-=FOA=J[4>F?;D)S+)C*N;Z?J"26E
MG;3.<+79!'4N@V>UPY<E;:P68&V)_:PZJ<%R:K!"RE^.XM;C>C)$V9<";22A
MH,CBR5DHTLZ"3N8STX2PI"HJHKY:#1Y6\"U[]GC,,F1ZW1VIZ/-8&MY63!*<
MZAV@L2WWP\MMMB B$<':>,?0[P__ .I['35&49%XPZ%S1)Z\+%5:CTC2.]#'
M3L%1:NNR.9)Y5E<$&4PU<5(=SJD2%53#R0=[XK)?'BX59T>1SBL*^97U5S3R
M) V :YTB4XK)?MW,=W-4?<93OY;^[1JN<G-LN\'M;9M2',)(X8*:,.?*SJ:F
MI6.WD$QNT;V!X )#7-R+ 7[5J#_J0?9WRS,JBD\KQ1S](1$IS#*- YIF&G8
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M>!(PL_RH=78Y5*6&2>)::[IL=R2T2##:^9),*QA*.Q]20X!X3 ]QWSRU=//
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M\6-B+'GGJ;#I?K?@8:_1?4_N?I]V"79.N,MG1;V?^YOPW"-NJS*(CT(A8M_
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ML[HKU:YA,G%F9E4)Y85A8%P .1S>XY%NG6WJ;<XEW#T/(!OQTYZW/J?4<_/
MHNM?=>.=1:XIN:MQR]Q>SR6XR:G%5VN:S,L0-%C8*@4<GMBABPJ25*LITLIH
ML49G&:ULDT@WK,[+M4]X$8%@3N -R>%/P:U^][DGO8X#<#\^2>EB;#D_A?D'
MO<'!5/I6E3^^EPN%^/Z!=L+Q_+\E!_+X^/G_ %K^J\^,1FUFH$;@L)$%^XN+
M\WYN3Z^GR&(9^WX?UP8OZI16M\O#6JKPO_L@NPTX<G*?^T&XE^W"_P D^/\
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M:+RG2E YXX5?Z0MF_*<(G_YW?=>$55^ZJJ\K^9W,(SW,UW;9U4,V]E2"!%+
M  LBQA6X ^\".W3C"O30R1+ R#RE;>$!*C=Q[QVD7/ '-^.!QCC?].[Y0[T3
MNZ4('Q\HJ;"V:B_;C[IEZ+]E\5JC,JRJD\V:4&2P!9(XH[@7M<1HJGKU(O\
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7QA>11A8J,&B-3CPPDGDF^#Z^OSQ__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>g60414g36l36.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g60414g36l36.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[3&@4&AO=&]S:&]P(#,N,  X0DE-! 0
M    ,82^$F=CA"24T$!       (!P!6@ #&R5'' (   (  !P"!0 ,4V5C=&
MEO;C1/7W8Q.$))300E       0[DJ<#\E'ZH&M3;9'M"SHYSA"24T$.@
M !"P   !     !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0
M    !);G1E96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0F
MET8F]O;      +<')I;G1E<DYA;65415A4    % !# &$ ;@!O &X ( !4 %
M, -0 Q #  ,  @ ', 90!R &D 90!S       /<')I;G10<F]O9E-E='5P3V
M)J8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M    $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P
M X0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M   !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
M  0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F
M)O;VP      $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,
M !        4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&
M]U8D!OX            $)L("!D;W5B0&_@            0G)D5%5N=$8C4F
MQT                0FQD(%5N=$8C4FQT                4G-L=%5N=$
M8C4'AL0'+            *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M   %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W
M @56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !
M!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M        QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&
M]N9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! !+
M    $  0$L     0 !.$))300F       .             #^    X0DE-!
MT       0    >.$))3009       $    'CA"24T#\P      "0
M   0 X0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &
MQF9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &
M ! #4    ! "T    &       !.$))30/X      !P  #_______________
M______________ ^@     _____________________________P/H     /
M____________________________\#Z     #_______________________
M______ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M    0     .$))300:      ,U    !@             '1@  !V0
M   0                         !              =D   '1@
M             !                         !     !        ;G5L;
M    (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&
M]N9P          3&5F=&QO;F<          $)T;VUL;VYG   '1@    !29V
MAT;&]N9P  !V0    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6
M-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M  !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T96
M0     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T
M]B:F,    !        4F-T,0    0     5&]P(&QO;F<          $QE9G
M1L;VYG          !"=&]M;&]N9P  !T8     4F=H=&QO;F<   =D     W
M5R;%1%6%0    !        ;G5L;%1%6%0    !        37-G951%6%0
M !       &86QT5&%G5$585     $       YC96QL5&5X=$ES2%1-3&)O;V
MP!    "&-E;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M    #T
M53;&EC94AO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T
M /15-L:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G
M5M    $453;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&
M]N9P         *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&
MQO;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
M   C_P        .$))3001       ! 0 X0DE-!!0       0    ".$))30
M0,     ";G     0   *    "=   !X  !)F   ";+ !@  ?_8_^(,6$E#0U
M]04D]&24Q%  $!   ,2$QI;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0
M  86-S<$U31E0     245#('-21T(               $  /;6  $     TR
MU(4" @
M         18W!R=    5     S9&5S8P   80   !L=W1P=    ?     48F
MMP=    @0    4<EA96@   A@    49UA96@   BP    48EA96@   D
M 49&UN9    E0   !P9&UD9    L0   "(=G5E9    TP   "&=FEE=P   ]
M0    D;'5M:0   _@    4;65A<P  ! P    D=&5C:   !#     ,<E120P
M  !#P   @,9U120P  !#P   @,8E120P  !#P   @,=&5X=     !#;W!Y<F
MEG:'0@*&,I(#$Y.3@@2&5W;&5T="U086-K87)D($-O;7!A;GD  &1E<V,
M      $G-21T(@245#-C$Y-C8M,BXQ               2<U)'0B!)14,V,3
MDV-BTR+C$
M               %A96B        #S40 !     1;,6%E:(
M        !865H@        ;Z(  #CU   #D%A96B        !BF0  MX4  !
MC:6%E:(        "2@   /A   ML]D97-C         !9)14,@:'1T<#HO+W
M=W=RYI96,N8V@              !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M                                                          9&
M5S8P         N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W
M!A8V4@+2!S4D="               N245#(#8Q.38V+3(N,2!$969A=6QT(%
M)'0B!C;VQO=7(@<W!A8V4@+2!S4D="                             &
M1E<V,         +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14
M,V,3DV-BTR+C$              "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:7
M1I;VX@:6X@245#-C$Y-C8M,BXQ
M!V:65W       3I/X %%\N !#/%  #[<P !!,+  -<G@    %865H@
M!,"58 4    %<?YVUE87,          0                        */
M   G-I9R      0U)4(&-U<G8        $      4 "@ / !0 &0 > ", *
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ML)$ DE"3H)3PED"7D)CPFD";H)SPGE"?L*$0HG"CT*5 IJ"H$*F JN"L4*W
MKS"PL+(@LY"U$+:0N "Y@+L O("^$+^0P2#"H,0PQ<#'4,C@RG#, ,V0SS#0
MT-)@U #5H-= V.#:D-PPW>#?@.$PXN#DD.9 Y_#IL.M@[2#NX/"0\E#T$/7@
M]Z#Y8/LP_/#^P0"1 F$$,081!^$)L0N1#7$/41$Q$Q$4\1;1&,$:H1R1'H$@
M<2)A)%$F02A!*C$L,2XQ,#$R,30Q-C$X,3I!/%$^44!A0G%$D4:A2+%*T4SA
M3P%1(5-!56%7@5FQ6]%> 6 Q8F%DD6;!:/%K(6UA;Z%QT701=E%XD7KA?2%_
M<8&QA &&48BABO&-48^AD@&449:QF1&;<9W1H$&BH:41IW&IX:Q1KL&Q0;.Q
MMC&XH;LAO:' (<*AQ2''L<HQS,'/4='AU''7 =F1W#'>P>%AY 'FH>E!Z^'N
MD?$Q\^'VD?E!^_'^H@%2!!(&P@F"#$(/ A'"%((74AH2'.(?LB)R)5(H(BKR
M+=(PHC."-F(Y0CPB/P)!\D321\)*LDVB4))3@E:"67)<<E]R8G)E<FAR:W)N
M@G&"=))WHGJR?<* TH/RAQ**(HU"D&*3@I:RF=*= J BHU*F@JFRK/*P(K-B
MMI*YTKT2P%+#DL;BRB+-<M#"U!+78MJRWA+A8N3"Z"+K<N[B\D+UHOD2_'+_
MXP-3!L,*0PVS$2,4HQ@C&Z,?(R*C)C,ILRU#,-,T8S?S.X,_$T*S1E-)XTV#
M43-4TUAS7"-?TV-S9R-JXVZ3<D-V WG#?7.!0X4#B,.,@Y!3E".7\YO#GY.C
M8Z=#JR.N\[+3MK.ZH[Z#PG/&4\I#SC/2(]83VA/> ^(#Y@/J ^X#\A/V$_HC
M_B0"- 9$"F0.=!*4%J0:Q![D(P0G)"M4+W0SI#?4/ 1 -$1T2*1,Y%$D5519
MI%WD8B1F=&JT;P1S5'>T? 2 5(2TB12-=)'4EC2:E)\$HW2GU*Q$L,2U-+FD
MOB3"I,<DRZ30)-2DV33=Q.)4YN3K=/ $])3Y-/W5 G4'%0NU$&45!1FU'F4C
M%2?%+'4Q-37U.J4_940E2/5-M5*%5U5<)6#U9<5JE6]U=$5Y)7X%@O6'U8RU
MD:66E9N%H'6E9:IEKU6T5;E5OE7#5<AES672==>%W)7AI>;%Z]7P]?85^S8
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M@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,#!$,# P,# P,# P,# P,#
MP,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.%!0.#@X.%!$,# P,#!$1#
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M4,N#2W>)VF)'E[4E.!?35CW5X]_4<EV15ZEKK&!VF\X^K_ '._FVC8VK_@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MT^$6)4148H*3L[2UTO$D5I7#U A%=":BHZ08-6-U@__:  P# 0 "$0,1 #\
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MK=[61!X5GH6>;QUML2+Q=5*(2ZK4YJ5#*H\4Y,AQWA \X':E-XT/1J4P&=0
MQ(!#*PS#4J2K, P!%P3<24K4ZC,J,2R@$@JZ&Q) 8!U7,I(-F6ZFVADH,SFL
M8B,1&(C$1B(Q$Q></BF,PJ821$62<LC\7D#XD)4Z&).:I:6E6O(+4!+&68(D
M9J< 3=%F%CV#8M!&$706I47('B0/>9#&P)\ 3[A(#UOVBU6-W%_B?<'(-Y]
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M46F[J[J+K3 +&X%@;[ [[$D"Y !.TNU5$9$9K-4)""Q-R+7V! W&IL+V%[D
M[ =;*AC'8,1J]W=_1TSGC))WZ'-ZM(M)2R)+#1M/LE1MCL)/IJ/>VQ,]H7,;
M!I9IY/9@N#PE0GMC0[*D50K%2P%U4@$^!:]KC>QL==KZ7N1+%E#*I-F8$J+'
M7+:^MK7%[VO>UR!8&9WE9:,1&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(C$1B(Q$8
MB,1&(C$2GR5''22X.V'?)!WC'B \:JZJV%%G[Z[;JW6\?IW92DU  6NI2=^G
M\LD_GSBM=U8?'DA1HA[;2@D]0T7"@6LU1F/FW,5=;Z:*![SXSD.M3%W&JTT1
M?-.66V_/9@3Y6Z3Y^S_J[FC[6+AN_P"N8=9@J[5+44[?2U%Q<1"?=0?4.C2K
M<,W/]W)HWTIMD_X&]EFXSXFE6_2OH3O:\EDUVH\VL.4^;/4&;FZ7S'O9>7M?
M6U_*_65PR5^30/.3)RZ9R\D@Y<HTS<S>VF;+KO:;9X;F%@YG]JEH9@ ;W?5"
M;UH0M!WO_P#A;K/UZZ[UU_[/<RM;\%A?DG_WKRU#\/C/E:?^YIR--^K*G2<M
M>TY,O9!)W2EU79P<?FVTD\+1J%\G! WF6\BVJ2N#.0C&!1H]J:5JEU,5%BWY
M%,C.7""8!.( KT\_*PW+(#^D52E[6S!:)%[^=AKIMYS.KDYN+YE^7Z+1SY02
M<N:O<BVN@UTU&XGQ3!7R+XLQWC7(['NBB.T#XGOETT'#J^33:L6"-7ZQN$QD
M;7&ZKL*JY1$G%V@]IRB':<4TC&L#&&.0+&%$[O:)R2C)4JRK**54U J5,/5"
M5&.5R:9 !+*ZD!D5MK787-B-A#&K2%-FJ4\31+TPH*!:HS%0KJRDJY4ZGNJ;
M7:^EC]7&=%S+6W?VD17'60\:F")'<XY>2Y*KCBEG264I)&.G:<">O:R8=+8X
MRJ6DA )M&F;UVBU)RXI:$]:!,<3X45#1Y>&Y@J$BCID*@6YE0V.8$W\Q%'F\
MS%\HTP/2#<N&)!Y5/4!2 1Y'WSC*NX_LO"CF5P"K:R9D&5PXKC]RMBU=V)(6
MQ)'6!TY<VO;L=MB<@:&P*E6U1!ZF$+<IBWP=C"O,4GL+>OCK8J<%6E(5$O4-
M:C795L>91+*"2PI(A1;G<@$+F)OJ0>EQ"4Q0K8=&:Z\NL Q%@:SU%J-87(4D
M9BH&RAA>28Y.+&I_[1WLY(Y!STJVTX2=R,G%F%M(P'ND9X].U/.T7//F@4O?
M.01J46HL@B",@== 2KY.W;-;="4MZHPK*EIA\06]5A35;]:@<$9?$A,Q-NE[
MS6L0<3A0NKJ:K/;<4BA!S=;%\EAU(\IRT:^W VW_ /T[Z3_WA[HR#_%%_P#R
M&_W:21_'7_\ Q:?^]JS)I(8./]J35'H(T6A6=PFN%+8J CU%GHJFN.J5=:OC
M@$&^@CFU;:5@,[<>:'O:*?%Q(![#KNA@:X9[_BUDR_ZZ/G'SY%-O*2=,6EOQ
MZ%3/_J/3R$^S.X'M,L*S"=,8B,1&(C$1B(Q$8B,1&(C$1B(Q$ZU]M!>I3V5M
MM3@#F2T6K:W:6(GV5O3BAT\;8IPT]HY%JUC93BU&*D ER6%1.$0QB3,QBQ#H
MQH84B$!Z4L83 >073%("+JN'(4 [J<*SG76V9F8D^))M/&.2<(S7[S8N[$C9
MABPBW M?*JJ+7U WERE/5MR_C$W2.MQ\L:YMN$%H7 E7#(YQJ1UDZ*EYZ?8&
MY:7*R;;EXTQ2!1T/.2:9#M+0:V3L]/U\37([4B+)29&ON:F<6\+9%]]YVHM8
M-=ZJ.MCW5I9#?H<W,;;PMK-$=D*:5K@35@=F "+V=\BNH1##H77?)"V>FNF]
M]?@_:Z[WE\5^';\VG_NDF>#_ (NOY];V_AJF_G>0!VUU+)0<RHA:%C3&EGF1
M]LQX=(W9$VYK7D59?#32M3O=>/\ )=R#0XT!B<CF]QC(TTC(.:G=:]I&;>TZ
MU>C5$]'? HE55P,&<Z&]VIM5J @6UN+@]W46)V$YQD)Q 9F0G'=QU LE04J1
M4F]Q8[=X6)(&YDKXQ8E[\?>75.5KS(D7'GD("65+?<BK7DM$*Y#5MR5-&J[9
MHY*+(U8T6VZ29E;:\F"!&S)#)%$75G0*I.UMC>Z-0M^1\/(JE2E4:D*E/*],
M-39LZ.6)"A6LI+*;FQ!.4W\3-@U2G61*QI5,R5"E15R5%"V+!E)892 +L"HN
M "-95\*7<G&^%-O:;#XE3(!8>4:WFNKN<VSJU.6F</91$$M4:K7Z6Y3L*>:9
MTG'4EE>P$[0:,+DJ$4@$D"D$(X/3:GF.&YJ_@A1"96_# Y\V;U;\VX)_)/MG
M+FJ9!BN4_P"%-<OG7\ 5R9<M\]A2L<MO7%_ RZ6U9&W^WR[/J<P%P2KDUS59
MR>ATB<6L0%":456DA4#M:*NAQY6Q%J$#-,6QD,95F^H4^YBX$IS0A=SP'\:#
M[QB VF1J3 '<-F9"/G4F_L$[7/W_  [*?76JIMU3*K@^P,!8],WG+'LYYTQB
M(Q$8B,1&(C$1B(Q$8B,1&(C$1B(Q$8B,1*95RD^3,?;ARZ0[V.5,S=)ZA;"S
M^FSFJL(/PW8);#6]+H6M#*;E\@LN=28.@]"CU[ZN.UL0NN]=EK>A ;&SG?UC
M6*GY[*!\TX@;^GD[J2@_-%!6 \A=V/M,R;@M5W-,OCMP]?U',2LCJPU25 NP
MJV#Q:1$OFX/N Q16"%^S[Z<HS0N@&/867<L]C6QB5!V[>A-"WY+5:[T>96'*
M?-GJ#,:NF;,=2O+\=<M_*_66PZU^70)K)DY=,E>3KERKW<W-(O;2^7SM-A]G
MN86"R.THT,P -[[0:?[UH0@AWO7TG*1]?3>]>K*U]L/\@OU/4^W]TG#>MB__
M ,IO]U1D5[W45 1R=[635_)92KI5=P?XHM%F;A*,]=)T$0?'2]V9V?&HE,()
M@!QXA?Z>4K-Z,);T3<I7J"3TZ8TDS9,_*PO+(#BO5*WVS 4B ?;MYWM,GR<[
M%\R_+.&HA\N^4FL#:VNQW]VTY.3K>2?&$OBVZVQ<=$<_N,,NOBB8+7:B6UDQ
MQ+D#%WZ</:2-U=9U9R&*.3S!+/>X<2Y@D+BYIH\P2%3&TSR^(')/H"M45"\N
MKS<BO0JA*C-E8FF55;NC V9 UB +L+V%H8U:/)+O3Q%)JE-5S*!5!8V5U925
M?+<$D*I"W(VD9N1K)R$YIVYS?GM+<<9%:[)"$$=XO<9K<:[6K"$)JUM#CK/$
M5MS::L[',7A"]/ABJ^&Z,-*YQ90%DN#17_H@A8>=L\A/I3*45H*]0(6)JU4R
MLV9*JY%4D:#[W<V.Q>9U.97:NR4BX6U*D^9!E>DV<N Q!_"!0;#7EVWO>9=N
M<AT7(/ACP4Y<1,@#780^4W$!P;&@D(O2;#/)K;#10EX5UW=Z"J+&"/S6T88[
MI1@",:(LX\TG6RRQEXI3-.M7I,>[RJP)Z%54NC>&ZHP.WS36I5YM##UE%F-:
M@0-RK.XIU%]H#.I!\[RY3.2=T8B,1&(C$1B)C3A,X>T*S4#K+(TV+B- V<B<
M'UK1*R=&EA-+V:F4JBCB]&%# 8#O@UWRQA&'J$6M[1/B^F+7W[NX;\IV3Y]B
M(^F+7W[NX;\IV3Y]B(^F+7W[NX;\IV3Y]B(^F+7W[NX;\IV3Y]B)S33(H^_Z
M/VQ/K.]:2[+TIVTN:)RTGV;W]E:/VC/.T5LS18_#T9W>_P!P?=Z]W?1$YC$1
MB(Q$8B,1&(C$1B(Q$8B1I?>.S<X\@U]TI%;8-DL.F5M(WE 7AK\^TV)'FQR7
MO%?NV_KH4Y;I&!2*<1U>2N2JTSY&)DH2G"),9F\)F@J'EA-;J^=&!]4D ,/8
M;*=]"+]3?,TQS"^EF3(X(]8 DK[KL/,'R$UFF[,WL]$:A.K2<*^,Z92D.*4)
MCR:>A)9I!Y PFDG%#"T:$ PHP 1@$'>MA$'6];UO66])KG>M4^FW[YGZ+AKW
M]'HWWORUO?QVF8V/P0X77!,WJQ;4XLT184\D8T8WZ83"LXJ_2-X&WMZ5J0B<
MG9Q;3UBL21L0HT"?9QH]E)$I! .A90 ZA:]9 %6JZJ+@ ,0 #<D 7ZDGWRS8
M>@[%GHTF8[LR*2;"PN2+G0 3;\3I"G8(<-1#*P@L8.-@49JPTQEC+2W[-K:%
ME.!,2@AOETH-&Q2.$NSH4SL0]";D!;@L G3@"H-T*A=FW9CWBVI)[S6S-[38
M7.YL)H$1=E4=U4T '<6^5?S5N;#87,TU77 OAK4D^3V?6W&^JHA.&]0L6,CT
MTQI. ,75N(1@7JX8U'".986J6%F&E*5$4;F8XXDXXDP8BCC "NU>LZY6J.PV
M()W V!ZD>1O,UP]!&S)216%[$*-+[E?R2>I%I(J,0*%0I9+7"(Q5AC2Z>291
M,YJK96Q(W*)5+53>W-*F2/QJ8HL;F]'MC0UH#7!7LU2-(WI"!&;+(+"',LQL
M"20HLH)V%R;#P%R3[9H%52Q  +&[$=3:USXFP OX #I.)M*I*PNZ'.%?6_ 8
MG9,)<S"#UL9F3&@?FD:I*+8T:XI,O)."E<4)F]FH'))LA>A.^O)%!)NM#R5=
MD;,C%6%]0;'70CV'J(=$J*5=5=3:X8 C0W!L>H.H/2852/&#C[QO2O*:CJDA
ME<#D9I)TC<V%K#N02(:76PH]/\F7C62%Z*0A$(" AS=%1"  A@1ED $(.Y>K
M4J6SNS6V!.@OO8;"_6PUZRM.E3I7Y:*E]R!8GPN=S;I<Z=)LLJ!0HB<KK-)B
MC 58CE%V^$.$V+:T@9.MA[2Z+WMLC*EYT5I<<R('AU<G-(VC.VE(7+E2DLL)
MIY@A5S-ERW.6Y;+?3,0 3;Q( !/@!+Y5S%K#,0%+6U*@D@$^ )) Z$GQ,U3$
M:/,;.0MI\AY2]IGV22N)1&JZ_;TJ(U*F@-4Q<U5(US/XAR@[T@_2^P'IZD,B
M=2BDA)S:WPYF G%['MK%=R]Z:TP+ ,S,;WS,= =M J@ "YU+'K*!+5&J$W)4
M(N_=07)'@26))/A8=+F0>9S2,1&(C$1B(Q$8B,1&(C$1B(Q$8B0]:^'5<F*.
M1<,GL>AEG<?N0%@M%QJJ?F\82OS0Q6<J WG3Y7Y=SVK:W&/R61QF-6$WHC4)
M:IHG*R6.(3SB7)"6@U-5OO94E7IJ4SJ;$J/5\[@$KO;*%'28\E#S%8*].HP?
M(P# ,=6T-Q8D!AIHQ8]9]M>\"^%52S%DL.L>*M"P&=1H\]3'Y=$ZQBC'(650
MJ1J&]0<VNK>V$+$9IZ%6J2&C(- (:=0<4+>P&"ULU:LP*M4=E.X+$@]=1?QA
M<-AT8,E&DK#4,J*"/80+B<,1V=' M+(B9<GX?<=")00]@DA$@*J:' =RI 6O
MTZ%O):\+5I0%R Y:TN"LT9H_2K6C]#\3ZK)Y]:UN;4M:ULQM:UK6OM;2WA(]
M%P]\W(I9KWS9%O>][WM>]];[WF\':@*.?XU8\-?*DKMYB=P/ZJ56G''2),B]
MEL&3K$K4B4R*6MRI&:E>WLQ,Q,I6G1<6<M+]$MHRCP#1)Q%T%1P58.P9  I!
M(*@7L 1L-3MXGQFAITR&4HI5R2X*@AB0 2P.YL +GP'A-95QP<XBU(U39FK[
MC[6S ALB.*X=.^\QA=ULIAJXH9*N'.[J^FN;HIB*@HP8#(OYP+%OO"WIOT+?
M7+-6JL5+5'.4W74Z'Q &E_/>46A10,%I( RY6[H.9?R23<E?+:2''#8F9$!U
M^9&F,<%''-P\</$UH]QL44$V>A=QO;-X/H_T)MHWZ,]&>!Y/R/ZU\+P?J,SS
M'-FN<U\U^M[WO?QOK-<HRY;#+;+;I:UK6\+:30<)XT,$0O!+:J7;,WQBO:59
MZ%H.MH\T!:H_5D)-<43Y.U",D!FTWI*7+F&$,A1"!*C1,T6@#&A2Z&8N<=:T
M-4E"FI+.7J,227(%EO\ FW8ZW)+>0F8I**@<  )3Y=-0+!%)NUAXFRC3HH'C
M)09E-8Q$8B,1&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(D:1\=&H-ZV=9X%#6N@U\
MU,V5W=M9/+4%P:I>]1,Q<V126 V88))HQ7!I')(+-&Y8C/+?V9'#-!.3Z83R
M5VG,.15ZTV+(P-BH-B1Y]X!EVL2WC,N4.8SZ9:B!:B$:$B]FWM<@E6TU &NF
MNMT/9I=GPV+4;BW<+N-*)>WJDZU"L2T_"B5"16D- >F4IS0- 1E')SBP&E&
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MFT\E[9\ZY;^&:]K^5[S+W"Z*=:9O%ZR=;8K1MLB;MGIJ%U\X3N+(YO+V;05
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M3==;UOW=9IR:OQ53Z#?NF7/H_'4O]HG[YL>!6W5-JEN9U7V=7MD%,HTI;R;
MII&Y@6TF+@GB1%N8X\Y.(4 U@4RD24"K90E 4Y^RM#T49L-61TMF5EOMF4B_
MLN!+JZ/?(ZO;?*P:WML3-A966C$2&I/VPAQ_D:LOY[7_ #7^8'RI_469?SY^
M2'Z[296936,1&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(C$1B)@[[9U:Q9P&T2:PH
M/''4LLHXQL?98P-#@ D\/>)-&B<'!.I"6<'ZHHP16@F!]8-[UZ\D*QU"DCQ
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MO;Q;\@L: Z OE2./MAQ*TRYH."!=#JP)# A2@NP8]"!\QV!)F8Q%,@FSC12
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M=4^C\;D'*7C+#N242%45N6'9F[D3M?"CD5>EC5N^VP0$^U(4U6%6")UJB12
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MG.J.J'*S$#*J @V:Y.0 D#4[S!4J(V<4JA4%@$9T9^^%#,69R"H(( +FP)(
M%@.'K3BMR%K.(PNAEM;*Y*F?GGL_9B]W6SRZ AA=9>U>;J=)L2(+&YYDS99#
M@I+-J%<& &Q6$/;.ZCG !.B^. 2N@\EZM-F:H& L*X%,ALS<TOE.@R_C@L"P
MMETS:"$I5$5:94F_()J KE7E!,PL3F_%.7*NN;7+:\D7RXJ>8MZ:%3U3R&N)
MXCIO+WANM!4;DBIX->)R''EU3"=,UDJ6VJ&^P]H&4U24M;!&SPU>)2B2Z<UK
MBEVJ3*<Z3@W7EH#R:XSC/FTHOJ;L5UV-E&\O50@!N8Y'.H'(<F7\-3TT0-Y^
MM+'\YYTQB(Q$8B,1&(E=O::>]_8?XSF#^[\KS2GZWS'_ +_-_P!K1*&<VUVV
MTU/E[>H.G[/-&+]>ENGAL0-K G<B]KVZF(P;@@:V^?2Y-OG'34WMN8EGW9<?
MLHV3_ %/_>%N_P#/_;F=064>9_??W1+NLQB,1&(C$1B(Q$_(P , ,LP 3"S
MB 86,.A@& >MA$ 81:V$01!WO0@[UO6];WK>MZWB)U_.2^N/\.Y/V#4#I-^
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M):FY#)DN6J>H .Y<9,P '>]8>)4*3J9?#+40%7SV"4_7.8YR":EB225U4;D
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M+3&&1B'2!1"U5/S)[31:0S&:.TBAS6ADT<)6K"]JA0T\KK05E1C]Z*FS%AE
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MJMP3E"YT!ON6L=38FPTMOIAEU'*GKQAU"G2N--$39D'L">Y>.?.\1\LC++]
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MJGMV_N.K3_5\D_[RY;EK_I>RXO?IIE\M=]Q\Z/U3V[?W'5I_J^2?]Y<<M/\
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M005M8W\)AO%_CM/9U)PV;R-9.3D:L6+6%$YXY.=QRWCBK37 XQ6,R=AKMN]
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MWU K*#O_ ( ??7MM<8BUJ>Y_P=U,T-4:$Q"('>"YM^C'9MVK:BC5@-:0-FU
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M5/T.Z*BV,T0;MK, !B.\,'LTAPM$Z&F***#H6W/J/P5!9JO6Q]=F".V2/J4
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ME'DF#)$/1H2SBAB#H(P[WO3HU0MC2J;G=&!M9;;VZC7K;PO'I&'^/H_[5/\
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MW]V$_/;T^PEF<G!T>AJ@KA.JU0I3&#/7^= !6%2/>S0*0 . ()@0BU5:U50
MM1P + !CH)+4:3$EJ:,2;DE0;F][Z];Z^V<$?P X2J2AD*>+-(J"#-:T82?
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M^RTR1>_6)&A=2MQH1RJ8-O*X(TZ@R57E$GW,G_(E_HYE-;#P'N$>42?<R?\
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M0:S(K+XN&0$@>FUOD$,L-@,4LKFH<%;0\)G1#MR7DE$*C<ZJ*F1D)*5$SKF
MS#O,I!MH2&4ZBP/@#<3:E49\ZN 'IOD;+?*3E5PPN+@%7!MK8W%SO)4YE-8Q
M$Q>:R11#XG().DC$EFJID;%*]+$H:D1+I3(E)(?K#0Q)G-P:6T;@M-V DD3B
MZ-S>3L6SEJY*E+-/!*BY N%N;7:]AYFP)L/($^4JQRJ2%+$#15W/D+D#WF:
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MO4EJ4HRW#2@Y.XDH#DAR0DM"6:2><HBHRLY9,^NI-1@S%KW)) '[3YR]-65
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M)9LEE5&V"V(S$$+NHN2Q'$<#(BL;'5*92M<+ZGDC-PPK2#W@X6)4,YA+ _\
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M4K)7+D@W)6RTHC-8BRM4J;T1 6R3REE4P611M^"Z1@EL4MVF0U(YM"IL+-)
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M&2F%2)HE4<<?+G#3J/(/C$L7MBSP#RS"#O+JC/". ,L?=&$0=&5E)#*5(W#
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M)])K"WC>U3IU)U\98^@-;RFE$<D6@4M1;<F-3.)B_:XL]O F ,E:8Z'''"6
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M1B(Q$8B,1&(C$1B(Q$8B,1&(C$1B(Q$_G/\ ;V?;3.1OWC4'YF(#GVK\$/\
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MF",1>[ZJ?0@"<P"U[.(_T[S,\)6!QUH7GNZ+P'5:F3!V'>]*0&;5)=G(RC5
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ML/\ %K[#_+,9_;3+VGZ&Y[/]C=&UZ:I5R62.C.X(W1M5ALF'&"2KV]06K1J
MEGUB:29LE0469H!Q1A0]@T$P @;$'>=7X5^W=:G4I5.-9J=5&INGH. 4,CJ5
M9;KA@PNI(N&!\")>G\'?9.DZ5$X<ZO3=71O3,6<K(0RFQK$&Q -B"/$2U,CC
M;/B3R3A\SN5BD)1I9@DY^^-7@'A+&$6R3O XW$G>$;K6P&>$<49W!"[A@!]!
M:]?FHOQ-(>SF?MJ&?L>4=^=6/M*?H%,"2LUKIK6NN]]-=.N_=W_U[Z=-=?\
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M[/+NY*S!'*W!S=%\>4+EZY4<(1JA6J/-/.,$(PPP0M[WN!5J@ "I4  L '8
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ML8 &EB$'6AAWM&M^IT^;?VZ6O[2.I(DZ=5_-^1?'ZD&"E? E#E4J&:,<]JE
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M3<XB;EP2%@42]&J$3HE42,8@BQ((!%P2"+B]KB^XN"+CJ(# D@$$J;-8WL;
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MSB4D/"6$VF( NI4J00PTI+2L5-B"JDW(\?FUM+X;-9PX8,"I[U5JUU*@@AF
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M48CS8(7=[PF]E;4>Q=S8A Z[3)B][[@AC$'K_F[$+>NFQ;ZB2=R3[8F0!"$
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MG76M[U^WO$:;Z;]?(ZG;>][=-;]9?WV'7V.Y&_?M9_T$VQ+29/:-S=##T''
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M1B(Q$8B,1&(C$1B(Q$8B,1&(F#R.S:XB&M[E4]A\=WK80]QZDC0W&;$,LPT
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MI<_G+Q;3G^7%:28P7>[O?(C<O/(Z][8?^7*8!D]/V^O?Z=W>A:WTWURW+?\
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M]H)QG ;HHJ2R-4'6M;--30V0[+3[V8(ON'A-1E'!%KNZ'T 4/6PB#K6]C[P
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MNVU^>)EB3AYQF1*"U)-/Q<9A7?[@56W1<GWWP" +Q$BYQ4)3=Z"+>P[-)'L
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M$1UU\.OQZQ$==?#K\>L1'77PZ_'K$1UU\.OQZQ$\XB,1.H?VI?OW[>^]:_\
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M_F:?T0/T1[1+AG\6*E?D P?,_P#KWCGUOC'^D9/H]#XFG]$1[1+AG\6*E/D
MP?,_^K7XL<^M\8_TC'H]#XFG]$?ND7^4'#;BG&DU""C_ !\J=E$^\GZ8C3R)
MLAK.BVZ1YX=UQ3JRK]D)@>:;'$HL!:Q$;WB%  A"8 6M:Z:4ZU4Y[U'-J;D=
MXZ$#?[?WS.I0HKDRTD%ZB V4;$F]_;>WS^$E![1+AG\6*E?D P?,\SY];XQ_
MI&7]&H?%)]$1[1+AG\6*E?D P?,\<^M\8_TC)]'H?$T_HC]T>T2X:?%CI7Y
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MBUO\0=WIA?&1XC$N9U*=:E5EG)W$#HTK$A"ML.T+-TR92&#JPNK $7L2IN&
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M,U6CP_AU+'5L+P\\5QSXC%G"T<-@>><.A3)1Q%2OB:[I5%&D!2IJ*3M5JK=
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M%LB=HQ,9^QQ4;\\ "J05ZBF#WN-DIS5IQB ;[Z';:8ABW+!?F,JF[!2H-R2
M+A2UANQ47VUM>:8= O,*KD5GN$+!F%@ ;D%@+]%!-M[W8VE_:_(.J*.=X"VV
MQ)RX,ALAV7Q^.2Y^2*T<#(D:0E*>DC\DF@RO8]%'20%J3 1@J1KVTB0*D*UN
M;5!SD E(?DM-G#%1FRV) ]:QOJ%W(%M;7MN=)J]1$*YSE#&P)T6_0$[ F]A?
M<Z;SW4O?-:\@V202JIW=7*(<PRIPB*:9EM+BCBDM7-25">XND#>UJ<A',XNF
M5+1M()4P#6,"UV;G1(W."S2$PW9T:F0& !(!M<$@'8, >Z>MCK8B$=:@)0W
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M/$Z"8U,1AZ0S5:]&DMB;U*J(+#<W9@+#KX=9@1W*'C40GTJ,Y"4EI.(9Q8#
M6I!C=&F)QD 4%E:*?!B-,3C4IPG@+",1.SRO$T'Q =>L<!XX20.#\4N "1]S
M\6+ WL3>D+ Y6L3O8VV,YSQ/AH%SQ#!6N0#Z50U(M<#[YJ1<7\+ZS%EG,KC>
MF6;1)K%'(1Z;E#J)3"X9/YXU@;TB$;HJ4F/,*BK^T%!3-(/3!X#%P32F<PAV
M& +<I3J3>A>S7&RN=L%R1G6F%Q6)PF$J%V?EJHI8K$4:I+5/O0LEC5#4QWU9
M1F.+\.8VIXCG:9LU"E7Q%.P7/?F4:52GZEG];U"']4@G@7?FK4K>H(0ML9NZ
M1.!KH)I,2(:.LMA B4%.;*R*S'!TGD?A[$B(;GF2QEK<MGNH34"F0M(E1129
M0-05M2[+\1=2[U^%T4%,5 S\5P-7.#3JU4")A*V)JN:E*A7J4\M,AUH5 I+
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MB?0S@R1AA05FX#/]U_[/A17V< KP5K:C.ZS!/QQ'_C &&BE@9")!L/1OVH&
M@5>4^3/89;7]9<V6]LV6^;+?3-:U^LMSJ>?EW.:]O5;+FM?+GMES6URWO:;[
M=/L:X_>*O^KF91=Q[1^F:-L?8?T2+' 3WB7"K^25QQ_,[#<TK_AZWRM3]=IE
MA_XO0^1I?J+):YE-HQ$8B,1&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(C$1B(Q$8B
M,1&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(C$3B7E^8HXB,<I"]-
M+"W%:,$:O>7%&UHBPE%&'FB,5+CB" :*(*-.,V(S6@%%F&"Z  (6M*5&M7<4
MZ%*I6<VLE)&J.;D*+*@)-R0!IJ2!N1,ZE6E14O5J4Z2"]WJ.J*+ DW9B + $
MG78$S3:KE/QJ2&%D#ONH5"DXPLHE&VV#%W9<::<(!9!12%K<EBLPT\PPLM.6
M G8SS!A+)",>]!SRB]GN.N"PX/Q(* 27?!8BF@ %R2]2FJV4"[&^@U-A.!N,
M\(5@IXG@2[6RHF*HNYOJ+(CLQOTTUZ35$@YZT$TFA)9QSV8]\H1Y#@RP-\88
MNL)\NO7$'-L]L4N#0!U(<&MI>79G5-DI5I7QO:%YS,<N& DH[R%'LAQBJI:H
M,'A@+!DJXNE6KJ2R(14PF".+QE,I4J4Z=5:F'5J3U$%4("2.2MVCX=3("#%U
MR<UF3"U*5(Y59^[B,6,-AG#(E1T*5F%1:;%"QL#H]][6GC%&R70Q],$SF-2=
MW4')'*X.*:=:=IIC3;+ EI4A7(=2H4'.C4[(2FHDHL1RMW$J8/#+>V]>WIO*
MT?@ZX]B#3%("H*K4E5TX;VA* U,14PW>8\%55%.I2<U22 E++6)Y3HY\?5[:
M<)HA^9=#3%0E6QO!PQY=%*_=5>)L6SI444[7+5,U*PJ*5D7Y5V[5 QU4N(-?
M./Z<@O2],E-3WK*IVY!6M[ZV,1YI[=55&S9B4H#2G$^1M!B"8FZ>V%G<NX<W
MN T*55Y[#_!+QBNJD4N+LUU9@>$X?"4^6]&I66S\0XMA*RO>F*-17PPY-6JE
MPZ!V7Q5;X0N&4F=>;P\  A2,=6Q+9A42F2R8' XFGD(?FTRM<BHB.,R-8'30
M>VW6R90L3PUY52E(:K8DB555G"&_YL<2%SF3Y&%PVYTDUK1%.YJ!M+6ADD9,
M715O [+GG<35-B=Q9UJD_P G_!6E *<33&';+79AQ#M3P?#*>7A:.(IYTH</
MQ!1>;4>AB E>IR4I#$"H4JJHX1V_YA?D,^(7[P%.$X!Q&KK4KU:3V>KC:(?N
M(M2@6ITN8[FB5#(2<1-[37D/8*)E1QVJNTFDRQ]9XVM6HH1QNJ:IXRH5/$9F
MKTN+9)C(V&0RE$T <(TUN,4="';8W:,-\X Y*59B=&,KJ'8/@N">LU?B'8J@
MM*K71'Q?&^(<1KJM+$8.E3YN%H5:&':L4KU$Q-,TR*6(J80HJAF!YV[7<3Q0
MI)2P7:6J:J4&88;AF&P5-C4H8JH_)KU5KU5IYZ--J#YP7HIB<S,0"<;D'*SG
MD]19P4(>''+%&F*0/"W3LZ<VV>$+$PD%%-,S\V)$@=$[L80W+U1MIB1 ,"4Y
M,[@GA?=&!,!&#:AV?[(TL135^TW9UV-2DIIT^RKXE&#\5?"E [(U,-40#AX<
MW-.JAQ1L3G*MQGM#4PSNG9[C* 4JC\U^/B@4*X):P?(K\PA"?2BA%F0\D7
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MK4JL6JU'J,226=V=B2;DDL222222=R;[SL2G3I@+31$4  *BJH  L  H
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MKC[FV<E^,][C?G!6A-:Z'F4TD[HP 2)RU 5\@)E->0HA(@5['Y=(:D4KC3%
M# &$% UHP7LW@_'*G%JE:F_ ^.<)%%%<5.+8;"T*=8LV4I1.'QF*+.OK,&"
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M<*"=\/A,?B6 OT](-,'3H1\_6>[VL':YF_7#.U%K5*,?U0DZ;A'6IR<G>_\
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MN?,'PC_ROXG^9@?^!P\XG@B\57+^/MD4=/H#QNN-]<K4;IU$*VO/D9-^-TH
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MKD:!M42*73"3KG!Y>7'36TM32DT:>!$V-#8WM36D1-Z-.F+.[.06MH+  !5
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M,[*RLK<W,C*T,[8T-*!"@;DY1'U6;N7()   "A5%@H'07).Y)-R22229=$"
MV)))NS-J6.US8 ;      ;3;F5EXQ$8B,1&(C$1B(Q$8B,1&(C$1B(Q$8B,1
M&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(FO+=_8
MGL_^+R:_W;<\O3_")?;.OZ1*OZC?FM^@R@>%K.9(^%G9ID3Z/<9DM#:L/LW
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>g60414g38s95.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g60414g38s95.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1U.4&AO=&]S:&]P(#,N,  X0DE-! 0
M    '3*^='0X0DE-! 0       \< 5H  QLE1QP"   "    .$))300E
M   0S<_Z?:C'O@D%<':NKP7#3CA"24T$.@      Y0   !     !       +
M<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0    !)
M;G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I;G1E
M<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    , %
M<@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !     $)L
M=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M  (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7     $-P
M=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B;V]L
M      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L      !%
M;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0       %)'
M0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M      !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
M     $)L9"!5;G1&(U)L=                %)S;'15;G1&(U!X;$!KMK @
M        "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0    !09U!S
M %!G4$,     3&5F=%5N=$8C4FQT                5&]P(%5N=$8C4FQT
M                4V-L(%5N=$8C4')C0%D            08W)O<%=H96Y0
M<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O
M<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M"V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  $#O_XU
M  (  3A"24T$)@      #@             _@   .$))300-       $
M'CA"24T$&0      !    !XX0DE- _,       D           $ .$))32<0
M       *  $          3A"24T#]0      2  O9F8  0!L9F8 !@
M 0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U     0 M
M    !@       3A"24T#^       <   ____________________________
M_P/H     /____________________________\#Z     #_____________
M________________ ^@     _____________________________P/H   X
M0DE-! @      !     !   "0    D      .$))300>       $     #A"
M24T$&@     #-0    8             ! 8   5V          $
M                 0             %=@  ! 8
M 0                         0     0       &YU;&P    "    !F)O
M=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M $QE9G1L;VYG          !"=&]M;&]N9P  ! 8     4F=H=&QO;F<   5V
M    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(    '
M<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG:6YE
M;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y<&5E
M;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC     0
M     %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M    0G1O;6QO;F<   0&     %)G:'1L;VYG   %=@    -U<FQ415A4
M 0       &YU;&Q415A4     0       $US9V5415A4     0      !F%L
M=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC96QL
M5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(;W)Z
M06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC959E
M<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%4VQI
M8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M"FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M  MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
M #A"24T$$0       0$ .$))3004       $     SA"24T$#      3'
M  $   "@    =@   >   -U    3   8  '_V/_M  Q!9&]B95]#30 "_^X
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MI!]CK_TN3P
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! 0$! ?_  !$( ;X"70,!$0 "$0$#$0'_Q  ?  $  @,
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MG[>V'URS+I_+RR=FI.B6G'N)9^^E21D*S;R3QR^176/5.2Z. D5;#7?3M_\
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M6JKPPKCB_,C8FRQ=$$>1OO"#J\'F-9@LI*M"0#B_( +8NA0\>S>(1TI\8PH
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M %*       >5)<27%SBXDDDDDN)()<3S)(LGM7I@QK0&M:T-: UH#0 UH%
M"@    !H!0 I>8     X %1LLE6^]M)6!LARV<)R[;-6DY+4;C>&Q+EYP6X;
MC9A<]AP#:7:14,FDRE6Z4*=LA.RA!D(,D?)+"YZ2[I0R2)D\@]P#0#64DCN)
MYJLQL<7DB\XRN[Q55X+>]MV]$VE;L#:D"V%G!6S"Q=OPK,RRS@6D3"L4(V.;
M"X<J*N%Q09MD4A6<*JKJB43JJ'.8QAQW68   &@ H*M^HC17ITU1R=KW'EJR
MGKB][(2<-K/R-9EVW;CC(]N,G9E#N8V-OBPYJW[B+%+*K*K'B5WZ\;\(54<
MU!90YS6,E?&?,- [@@$'Q!\!JJY((Y=7#4<P2#ZQ\WKNO=Z>])F!M+L3<L9A
MZRSQ#N]I!&5OFZ;@G[BOB^;WD6R!VK1S=E[7G*SMSS@,FRBB#!J]DU&3!)5<
MK)L@+A<5#Y9)",SR0W[(% -)-DBMB=%+(HV AK:S"B3J2.\E5MF_!,:%IV>E
M91?%,['0$_-FN.XL76]E3*=MX7N":.Y*\6>2V(8.\&&/W)'+HA5W3 L"G&NC
M]+X0S4*<Y39#$2@5F!T^T0"X;4 :NA6FO:JSA83NV[%$6:(LNH@5>I-^K9=#
MH6%B+;AXNW[?BV$)!0D>TBH:'BFB#",BHQ@@1JQCX]BU32;,V3-LDFW;-D$T
MT444R)ID*4H %)))))LGF5> &@- H   =P56,QZ&M..=+[4R5?-JW&UO&2@F
MEJ7=*6-D7(.-RY&M%@JLLQM3);.P[EMYE?UOM!<.46\?<[>2*DS<N&!#@Q64
M;FL;*]@R@@@70(! LV:OMYJIT$;W%Y;YQ%.()&8#0 ]H^>97\#_0'I6?X5QU
M@(N.%XO'^()9]/8H5@+NO" O7&TY(R<E+NY6RLB1$ZSOBWW:[R6? J+">326
M:*E8+I*LD4&Z82O#B^[+M[UON4F%A8&536ZMK2B.:\D%H+TQ0&*,L8;2LB6E
M[6SN!/KR3%SWU?%T9!R2=%)-!FI=62IZX']\R QK=,&\2G\?)MXE ZZ4<BU(
MY< J=*]S@XG5OV:% > 4"",-<TBP\4Z^8N_1\U2W3=N#,97Q<N';ON6WU'\_
M@2<D+CQ:]+*RS4MNS$I:S^RWKI1LT>HM9<%;<DGC$$9E%^@F97X2FF5T0BQ8
MSN >+T?]KOUOWK/(WS/^35O=I7NT6.%TNX,)J+4U8%L1D&>U; #&2E]@]E/'
MFM '1'8,QBA>_$GP[_!D:?'/Q=\;_%I"Q@O?@  WIUC\@CS'(#8;RO?WIU;,
MYDKSR*S:70Y>K3]5K#+^@+3+FR^;@R-=UL7?#W;>D0QM[(K_ !QE3)N*V^4(
M&,;BS81.2HW'EUVW'7LV:L!^+4E9YJ[>A%@6+%T,>FFV)FR>5C<K7>;V$ UO
MM8TW5;\/$]V9S=3H:)%]EUV<ED^1]%VG+)ME8TL25L$;9B<,))(8?D\:7!<>
M+[KQ>W3CTHE1I9%WV'*P%R0+%]&(I,95@UD@92Z":02;=V=%$Z>+99&$D&\U
MY@XFC?,CY]BR=#&X-%$9132"00.R^SQ7O]/VE7!NEY"]D,*VBXM?ZXTW&W+?
M#EY<ES7._N:Y(V';P@7!*R-T2\P^=34BV;@ZFY-1P+R;E5W<O**NI%VX<J'R
M/DRYS>44T=@4QQ,BS9+\XV;-ZK#LUZ'-.N?LD,\Q7_;=T(98BK*98^@<CV3D
M?(&.[QMRU6,U-3I8^ FK(N2"=11G;RX9E*3<-C%6E(]\>.D#N62:"*1DTD;<
MC2"V[RNU%]O;_I2/B8]V8@YJJP=:L&O8+7L3Z)],"F!$M,RF)H13#J+X)I.W
MSO9H98EU!(GF?JY+>027U9!?_P <*'EAOCX^"Z32!SN!E1,80$)I _K,Q#O6
M*[*JJT&E(8F9<F45STU\0>WO48;T8X"P=)WC<-J6]<EPW??T A:-VWSE+(%\
MY<O>6LYJ*QV]G?55D>X+EF&-J)*N%5S6_&N6<8X<F*Z=MW#E%%5,^:20@N=]
MG5H% 7X ;]]?FL601L#@&WFT)<2XD=EG8>%>P+4;#P86D2)Q_:.-X:UL@PT+
MCF[9J\L83$1FK+<=>^+I"X8IG!S,5CN_&MXIW;:5IR$0P:L'5H14NC;:Z:8+
M*QIW0 N$]=(2YQ(MP < -"!L2*&JQ^BPTT9:RFVT3;;JP.P:;>JENC!NCO3]
MIRNR[+ZQ+9\A WC?T!!6_?ERREX7E=DU>R-MR$S)Q4M=<C=D]-.YZY4W4_*
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M/C(J,:JO9"0?.E3%2;,V31%5RY75,5-)%,ZAS 4HC4@$D "R30'>H)#02:H
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M: YP+FC9S1IKN31'=S[+O4;')).U[)<S6N(=*06EXH^;5U8UT_U7V %V
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M*RA#/(UJU>J]+I*KJ&* E@.>8PPB\A!:<W,$'6JK:JVH* Q@<YY^TYN0D#D
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MIC ICKN]39U)\2;[M=EG.-<=6GB.P+0QC8D<>(LRQ+?CK8MF+5?O))2/AHI
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M,XK.YG>VA[?GT+Y[M4./;7Q1?(:==.NN'PG^J_5]*IG2B\*8WU+(&C+..(
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M.5D#GRJAJQ1XF%N5GT8&]+<XDUWU=D;GV'GU_P!*3+7&S;WK]FA.:<)IRHO
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M<D2V(?;H=-HJF3BD8H6>57AIP?2[$8A@<(>)PP8R-Q #2YT8B> 1N0Z.W_\
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M=>Q/7\CR>XT1.S<1Y=A Z^H>CW?3QHB=^X^@G+YG/S<>[;B^?GY\44<>L1[
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M''<1'LHBCCON(%^:'5Z>_;S;\J4.P(FX_B_-"B)N/'[7<?Q0]?;1$#?\7S%
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M3NU?2C8EPJW995HW4JU%BK<EM0<\HR'Y7P526C&K\[<#'*!S%2,N)"F-Q,4
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MDGZ-$3CV_DD_1HB<>W\DOZ-*&U:=B)Q[1X=Q?7\GCYZ(O.UW^%M>(_Y2W_!
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MB<!DQ,.74N:'?6D7= M<9+&H+=;!UZ%: M0R&IS2EB3*"[LKNY30*=JWX7I
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M1$Y#Q*'#N-S\YN #V;#R]$:]H]7ZHIX[?:AW_)'AU<]]^/'LV'MJ=>5(HW[
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MD7;ZD)3?\)GV\_AK?L_5Y:S9]KT:K!^P\?R*K!\G<0V$>6_RS=0[;\/S<-N
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MMZ1_S_G'\U/C\_KZ:Y(FQ>H-^ _?GY[\M^[ER\HT]/S\@^U$^3Q#AM^^/MN
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MM,Z9G N%L)S8SB#G-#02"&=7 +H:V[%  :WYU50OH"T;)MFR#9,FR39%)!(
M(  ":) 3* !SV I0 -Q'D(<-JXQB9/I$\\K[<Z6>::R;L2R%X-C>R2?%=6@9
MU4$,0T$<4<5 4 (V-8 /#+K5"J%+^G8>P?F%[>?YZK^?6K%HC4Z&VG#/Y@Z6
MX87RB8! .CL);*G!*(;<C 8 ,4>H0 0X@ U9AI9(L1$]CGL<R4/9('.8YCFD
M&FN:00TUJ 1=WISKQ#&30.CE:V5KF2M+'@9,NFA!:<VH!-C1P&]*B&A1<V*L
MFR^('BYTHV]L;V-?MM$7.8Q5EUK8C9@Z#<3B/C5"QLR\35, F,<(,QCFW3,)
M>Z=.Q_M-Y/\ H[TF9];/PXMPN/<!G< 2<+.]X&M_2H6.%Z#K;) -KC?0L_[/
M=->-\!DID6-#I\(TZ-.7J\3A6M(-&\'(]KG#5Q8&5;58OPBLUBB$T8Y]/F@5
M@LJ3L=Y")I,6B#R45NN651:62:%:KJH(JRS:[#P[]D=59%)J9H+MPJFV;K'#
MF?02#B<_2K@_]%L!Q#)^M<XDM8(!7TCK'"R(S""TT#YSA0)71NE<N$CX)C_I
MA<8GL$3!>IF+LV'<T@Z.$HS$V"(VNJR0U?+SX/[PGTYI'N,8R^[.^N#84Y 6
M)8DI),Y)=E=ML6K94S>LA$N8=-<CJ-F?BU.^I%N2'=?%WPAE&1S)M)LA*HLI
MWGI?Y+,)Q^?&<4P6+?AL?B*EZAT,<N%FECBH$O&25G6'*"YI?;@74;-<RX!T
MRQ/"&0X27#LQ&$ #6T\QXAD>:QE?YS'@-+G!I8/W@  OL^M*Z(.]K6MR\[:?
M)2EMW9!1-R0$DB3=)]#3;!"3C'B8&*4P%<LW2*Q0$ ,4#[& !*-?E_$X:? X
MJ?!8F,QSX>5\4S2"T,E8XM>PEW)I: +)LDT2NUX>:+%PQ8C#O:^*:-LD;@ZR
MYCQ;=1IH+%4"-0YH.BKKK(P_BS*N"<D/<DX^M2]W=DXTR3/6@XN:#8RRUM3/
MU'R*GQI"JNTE#Q[\%&;0_P );"13=LB83;IEVK8\MDC YN(+0 2;T:>8RW>M
M]O)92-:Z.2Q;FM=1-@77(F@3HO#HUPUBC%>"L:RF-\=VC9$A?.+\83-Y/K9@
MF,2YN>7"SV#D)*<69HIGD7H+R,@L#AP*B@*/')A-TECB;.5Y+W @#*YP)L5>
M8@ &Z.E7KI6IT40M#8XRVPX,!(HBJ:#KVWRTY]^MLP =N!=N'X >OAV>SOJO
MY^:69-DG>];[4^5^#^2'LHB;#V#YB!V\^KR_1O1$V'B'1_(+U]H=_;QHB;#Q
MX=?64/9PZN 41-A[![OD![AP]G51$V'L_(#GZ*7\T?GX\D38?P?/T ]E$38>
MSF/'Y >8?5W41! =MNCYN@'+T>_;1$V$.K\D.?+L[@]^9$V'K ?FAYO?JZJ(
MFPCU;A^\ ?5^NB)V!MQ[.@'+Z1Y41.(AR'S%#Z0\]$3CV#\P/?M]7F(G'GL/
MS0Y=OOZ:(IX]@_,"B*-A . ?D!Y_[^NGS\VB;#S !X_B!M^?;S<Z(@AV@.P_
MB!SY?1PY]VU$7F; /PIKPV_QAOOPVY*DX!U</<-QJ';'P*ENX\1[U="J%>E$
M2B)1$HB41*(E$2B)1$HB41*(E$2B)1%\RF0<1ZQF[AS:>C.Q,2:R-.&.?")2
M>I6W75OY?MC&^0,9Y!MN^KCNK*N"KW)?"T? R3-C>]SRI(JXX60?RS)BH07D
M8]*X0(W^@Q\.CI2^-_4=7198(-4\$=P'FD"]#>R^8Z.6\D36R1"?.?.RD$&\
MI)[]R-!6W,]8M%&#<_VW>^?]3&J@+(A\V:C']@LAQSCN0=SMK8JQOBZ(EHRR
MK/)<KM!L:X[A46N&:E+GF&Z 1[F0<$"..+8O1#5E>PM8R.RU@.IW<XFR:Y=E
M?Z#;AC>'/DEKK'T*&H  T%\_'0:UNNA-4K82B)1$HB41*(JHZ\/N(M8/\6'.
M_P#5?=%6P??P_P 6/\854_W,G[CN7<?5X_FLZTO?<SZ=OX"\2?T M^L9/O)/
MWW?B*F'[J+^&S\(6]*P5B41*(E$2B)1$HB41*(E$2B+!\C<+0E/WS/M'_/6_
M9Z/?>LF?:'I6#]AX_D55\>8]7'CP'MVX<MOS!SJY5*._\P_1S\U$3N_-^?EY
MJ(@?JX!W[=]$7S(^&>N]U+:V=%>/FPF6):)+7O)P@3?9 +RRS'1:ZRG'Y.S6
MQ$Q$PAL(=$H<3;!VCH5_4?)YTQQ[A1G<,*U_/+)##AVL!L7E?,X$@DVXDU2Y
MITH<<3TLX'AFFQAX\-)R.5SII)7@-HZ]6P ;5J7#0+Z:^ ]W4' 1'B7MW[-^
M'57%-203JYM-O8%K#65PLDZB^1!WUN^GDD6164&Z[3ES$@]I!(JCX]G/;/ !
M=VLW359@!XQ*V6;N]'!.(D3.F[DI1,QR[B'.T$. \0 Y!VZ(\>X]"S_1?DNZ
M9\3'FR8IT^$8X@V_+!%  --0#C7-':;YVN/=*ZXAY1.BW#A9BPS8<0X [!\\
MDSW$7H<N%::.X#;T70LO+?ARZ@XB(=O/<=ZX>/M.[- .X"Z'HNEUXFQM6IOO
M/][E]I3[>P??KY^7OVRU^1R]?M]BA5SU(XQR_ENRWUC8RR?9V-HBY[=N^UKY
M5NC&CW(3R5BKGBTHI ()1I?-FD@G3!LM+F47<)31'2KIF8$6H,U"O98YD;@Y
MS"_S@2+KT#UFBH<'/;E#LIRN%Z;.J]#6U7OV^CG[D3'N7]-EUZ?LKY'R-:.0
MF=DOK:QJE(6=CB0QZJRM*+8KM_@LVD\OB\PG'SZ&6G"%>)GBR)&(*9FZA3)^
M*[GY,Y8N/]&NE?1"0'Z^"?%X1KG$@/E:V-Q!(!:V+%QX=PH#1Q(LE<:Z?P2<
M%Z0='>DK7M#63Q8>>VC08=YFH!IH%^&?*RS8IHMILA6B\(?IMG=76DV]<96(
M]9DO!92!O.R@>. ;1LO+VX[)(H1#EX<01;IS<>=Y'M7BYBM6SURS=.3$;)*G
M+S_H3QJ+HITG@Q>/:[J6G$8+%-;J8 ][8GORUM%D#G :D!U DKH?23ASN.<$
M='@W,=(X0XN $_>L#7/8&[T962@"Z:'&B10*^.VQ= >KG(&6W>%8S"=Y15Z0
MSB')=/U0L30\%9\9-N':+"X+BGEQ-&(PCA./DG+)VR</5)A*/=DA$9)R0B"G
MZ@Q73KHKA,!_23^,X62$Q9H8H909W90<L;80"X.HGS740;L@"UQB#H_QG$8H
M85G#\1U^:GE\;HXXSM;I'?5AK;()!).I%Z!=W+,SMX2?P<]KV]CO.&G6(U!8
M!L"%C+>@+^Q.JJI)PMM1"";1H5Q(1;%PZ^"QK!$B)2WC9,&Z6,F)E)]=,?'C
MQW&<'Z ].YYL;PGC3^#\7Q$CY7X7B#:BEQ)-EV60MS"04?JI'\PT Z'W.%XC
MTIZ*Q187&\,.-X?&P,C?",P#3J&MGB! +38 DC!V)-;:UU>^'-M2\<6J6)IO
MQ_(*R>0;3GH2^Y?*; &86<UFFSJ%=1,1$P4TLE-3"K%9P[2EC2Q8J/(JP$[.
M1<G>L8_9Z/\ D7E.)Q$G'\=$<.R1GT1G#7M#YQH72.=(UQB93@.K(<;!) L%
M8\4\H+I((H^%X=S79'.G?C&%P822!'&&2-!+3=O=E)H "P58#P3WA.GF?9&W
M]+64[8A8&\K9L5LUQW<UM [1B;KA[(BFK)>'F(M\[>N&%R-H1H65(^9NE(N6
M2:2@"TB5D&J#_P"'Y0?)K!T:P@XQPF=\^ $S8\5AL0YKY(C*?-FC<.K;5WF#
M6C4M^U9(^AT5Z7R\3G'#<?%&V1\9=AYH6EEO8W,62YBXBV#S//.HHBJ*[V<P
M 0Y=7#CL/+AOPX<!]E<?%T-;T&M5?HO33EV^I=$(U(YV=ZY>SU>A./N'Y]_;
M37M'J_50@^KR"//R>??WWE$Y!^H>75PY^_(*(F_KY<!X>7W"FOPT_77V(IHB
MCM#\P[<?4/>/GIK\C]44^_+K]GOO37Y'/U^SVHH[?+V#[CY>H/31%/7^H?IY
M411W\A[P]/E\U$4^_M^BB*.OC] ^?CQ#J_OIKSKU5^918C?E_P!EXNM*8OO(
M=S1%G6= $:*3-QSKHK**C2OW[2+9F=NC_(2!S(OFC-(3; ==PDF ](P;M20!
MK?S\G8!02 +<:V&U^OLH?(6H,;:O-,F8;I;V5BW.&.K\NQTW?.T("VK@:R4F
MHUC4_'/EBMT3"82-$MU' \!3+L(E^VVDQS- +X\HO4V"*TU&NO.S1"ALD3_L
M/!K0BC>;LVH>ON/=8[WY?1[CV5"R4=GL'W#S\^H:(GOR'N]_[AHB>_(>8_3W
M_J&FOR.?K]GM1.7Z@'O[-_?RTU^1^J*?I\GT>OKX41>=K_E;7_C*'5_]*3K[
M^&W?Z0AUT? \NX]ZENX\1[U=&J%>E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1
M%\_.-<#ZEK.U%:M,<Z2?"38$LE/ZY4YFS(>GIKIQ)D!EB)_E&2>223A])360
M'BD5/3:##X9<,5&R,=&C(>-E$K5@$9%LW'=<^-T<?68>0@-#1)G+<Q&P RD:
M;@WV:55_/:R1LDPBGC!<72&,M+LH=SN]"#N*%DZF[*O'X-W+&0\WX]N[(]UZ
MQ<8:NK<D):,B+=?8[PT&%W^.Y>*;OSW/;UZ6ZYF)&9),O@>PCINSF6<6X9M&
MX.6Y';621<51,UK2&MC<PU9S.S!P-41YK:^;5^'>^1I>9&R-)(%-+:JP0;W(
M/,:$:<@ND=4K92B)1$HB41*(JHZ\/N(M8/\ %ASO_5?=%6P??P_Q8_QA53_<
MR?N.]Q^?9NLZTO?<SZ=OX"\2?T M^L9/O)/WW?B*F'[J+^&S\(6]*P5B41*(
ME$2B)1$HB41*(E$2B+",B_L1D^.WRF?_ #Q#R\^7+A6;+S>C7P_UI8/V'C^1
M57P-U=( XCON?VCPV[ "K!?8/63X\O5^2J4=+?[_ /+V_/OU>^X4U]'C^G9W
M_%%/2_&#YX>VFM"M_'N[:/N^")TAX?*WW >1OI#?G[]M->P;=I^'M^*+Y*]>
M%_6O<7A.,PR%T33&.9X?L?"MM6THY.JH9V_9WOB6X9YNV3226,"L:QO"]W[@
MO#H,HMXN)@$13'MCV?T;Y(L$UM"3B_$'2%IL%[.LD=J37FM=%&X7KKK:YDY[
M<7T[Q!)&3!PY;WRED+([/?<CMJ (L ZKZD,:Y4Q[F"V$[QQE=D3>=KK/7<<G
M-PRZBK([Y@8A';4IE4DS^-;F4(4X=$  3%V$>D%<1<'"1S2*)L@-<;<?M:$T
M.1'>-/'IS7M<P.&H%$D@$764 "R==NT6J7V8<UY^$$R%+;"JTQY8"<0V5V$Q
M$71FL(Q53 W(ISK3,N(%X&_W3\>NZ<5;_1?D9X3AVNJ3B^-AF.[2]CYY\9J.
M8,,$3775W1.U<=X>?Z1\JO$YBVV\+P\T='4-ZN*'!C*=A4DTCFUL>1!)71(#
M<_E!SW^V]/7Z@Y?1PQM:D:@N)'A3?_W9AZ!IJNQNY=UM\<M:^FSS.RGI;[_*
M_*^C<?H\U3KV#NU_33VK% -R#I^<3?3Q^FFHV ])/P**O&J>P0R1@G($$DB"
M\DRB37'#!_NBH2EN'"52(B __+/46R\<'1V,)'IR!OTA(;W'DWXO_0_2[A<[
MGY8<2\X'$YGY0Z/&_5![B/-+(YNI< 1H:=FV7D.GG"QQ+HQQ*,,S286)N/A)
M )C=A27S$:672P=<S<:'6CE7KM(N00R+@:QY)=?QLK!,1M&9Z2FZA7ENB#%N
MJJ._2%5Y%%C9 PCMN9V.W+<;O*;P8<(Z8\1:V/+A\>1Q&#2FEN(:7R!M4!DG
M;*V@?LM!.I(5/D]XK_2?1? 9WYL1@6NP$QL$DX<@1G4EQ A,0)(!+B=*!6&X
MO !UM:L.T<5:7P$=QX#TLSASX".W >.X;^2O"V/H\) 'VY"/-W)H:D@FAIW
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MGM5@:775:=J\"[M!JBJY<KIMFZ)!467<+)H(I)D 3&4455.1-,A0W,8YC 4
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MF'Q4,CF/AE8X/!.C0X=8"+%M<PN:1J"'51)"^^C"&J;3[J-C22&%LM6E??\
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M)Z\K&CO%0>27-[WTG+*74A>[:81/;XHQ,;\!2(BHGD<L74Q]6TVT.>3J79]
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M&XIB]C!P_%R-/_,(7Y*O_GJN_O50_!ZP!HK )994IO&W5>-Q3 JF ?&'0;?
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M)CDD+V-#G:N: +[2  HGABZJ2V#[#]0!>K3>M&OD*V&E_P"YHT[[?\!>)/Z
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MNE%)^P5%2 L,C:;J.>LNI<;X!PGI_P .EZ2=%"R+BT;"_BG" &L?)(6V0UA
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MH&1Q'I=TLXM6TTT+""2,L^*?6O+ZO"LT/: -!IT2  #AN&WG]F_5MY_1PP
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M=\@CUB&QA#S\!_NWJY5*>768/Y1NOS]=$7X.?H@(F'8I>(B8Y@#8 W$>([
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M"L4RAD2"F7Q"2(F7\;U;RUXICN.\*X?'E#,!PL$-&[3B)G4*V R0L&FNFNA
M'./)- 1PCBF->#UF-XD6EQV<V"&,D@\_K)7;]NG-=">/6(]7WQNKS]7;7&%U
M91MU[FW_ 'QM_IHBG<>TVW[\W/T_GHBCMXC\XW'?MX]HC[C3Y^?3HBGCPXFX
M?C&X>3C1$X]IN_Y1N//O[_IHB<>TWSC>VB+\F$>T1VZ^F.X=^P[AV<.._#@-
M0>\D ^;HT.L.H$&Z ]-WZ%(W::!(<T@%Q:*%DDU6QK7<7V6N$GA Y.2>:@G#
M-^W*V9Q%J6^TAE ;D3.]8N$G#]9R=8 Z3D0DG3UL4QC&*F5OXL@ )3;_ *Z\
MD<,$70S!OA>Y[YL5C),2'.),<[)3 6Y3?5@QQLDR  ><7'[17YD\I4DLO2S&
M![ &Q8;!PP5H#!U390\:#."^65IE-EV0-NFA8WHQS ABG+C-.X+D+ V-<[-[
M'W%\-45^*B.$VRJT(_6*0JA$5T7Y$VP/!(0J+5RN154B)CF+N^4CHY_M'T=G
MCPV#&*XG@WQ8G B-K!/8>!/&QTA:,LD3GDL+J<X,-%P%ZO0;C@X'Q[#2XC$]
M1P^<.P^-S&0Q@/ R2.C8'>?'(UN5^0EH>_4-<Z^^$9*QLRQ:RD/(LI2->(D6
M9R,>]2>,W2!^)%$'+8ZB*I#  [&(<Q>&V_#:OQ_B\)B\#,<-C(9\--&,DL,\
M'4S,>20W,QPS!M:YA5[6*7Z@PN+PN-@;B<+-!B89#FCF@E$L4E 9FYF$T\'1
MS:H&^97L./:(=P&'EYMNL?75/SW_ *Z^&_KN<03H*'@![E/'M-\XWMHL5'D$
M>W[8W7U\^O:B*>/:;YQN[O\ ?8/,11Y1'R](W/EVT12&_/<=_P!\;V\:(G'M
M-W_*-[:(GG-PY?*-P]=$3CVFZQ^V-Z>?IIXHH\X_.-V\.OW&B)V\1[/MC<>X
M>-/!%/G-Q'\(W$?3SHB@>\1X\.)C>CGQ\E$4\0ZQ  _&-Y^OWXT10&_+<WSC
M=O#K#W[>=$4\>TWSC>7MHB<0'F/SC<?+Q]O"GR$4;=X_.-[>_P!=$3MXCV#\
MHWH'C1%/'\(WSC>VB+SM/\J:\Q_QEN [B(\/&D[^K8/?A4.^R? J6[CQ'O5T
M:H5ZY'>&RTVY.U-:%[GM7$4<\N"[K*O2U\F!9\81564O&(MQ&78R\+$M40$[
MZ50:39IUA'% RL@O#@S:)JOUVB9N@^3+C6!X'TKPN(XB]L6%Q,,^"?.\Y60.
MQ ;DD>ZQD9F:&N<=&AUD@!>1Z:</Q'$."O;A6O?+AIF8KJF#,Z5K YCFM:/.
M<\!^9K19< 0 2:7^?8>W+@(\F(\\!,E?VXFZ6N%B:*?@[@46"A4'JLTV,W!>
M,29+G(BZ4?$0(W4,5-42',4H_L'Z9A"R)XGA<R3[DMD:YDI>TNCRN))?FJZ9
M9(U .E\$+'@NMCVE@.=A:15%MEQR@@M-M(HFS1 W7^E3X.W+F+LN:/<".L69
M 89#C[,Q98&/[BDD#G3E8VZ[2M"&BIJ+N*+<#\.AYA)R@*IVCXA3K-E4'K8[
MEDZ;.5?Q)TQX?C^'](^+,Q^#?@GXC'XO%0L-F-^'GQ$KHWPR4!+'1H.',$&G
M A?HOHUB\+B^#8!N%Q$<_P!&PF&P\V0G-'-%"QKV/::<TBAEL><TAVH(N[=>
M87WDHB41*(E$2B)1$HB41*(E$2B+A#E'4EX!N(R3D.&RG:>G-QDR+O6Z8W(2
MTSI=GYN67O5G,O6UTJR<TEBM\E*R!YI-Z+R33>NTWK@3N2.ERJE5/MM9BLH<
M'.#3M;QJ/"R3X5LM%TF#SEI#<]U1:0;.@Y:;\Q[@LJ\$RYPU,9:UR7/I.QV6
MS](%P7CB%;%<S]0;NR&5PWRULZ73RLA:"4M%QLZXL:.DCPSR*CWQ"L864F9H
M(9JR:R*C9.,3GRPB5P?,&',0;H$Z ]A[17K4X0L<9C"TMA+_ #=*#G 42-K&
MXO7QNUVTK56ZE$2B)1$HB4151UX?<1:P?XL.=_ZK[HJV#[^'^+'[7A4S_<R?
MN._"?G3W+.M+WW,^G;^ O$G] +?K&3[R3]]WXBLH?NHOX;/PA;TK!6)1$HB4
M1*(E$2B)1$HB41*(L(R+^Q&3_?,^[_/$.L?76;/M>CY^3[Z6#]AX_D55_8?-
MN/6'/K]_)5E$"K&E<OU52CCRW]>P>OS>@*:]H]7ZHM79ONLMB89RS>QU/$EM
M#&U\W+XT1Z($&$MB3D2FW'EL9N&P[#Q#;81V ?H\&PQQ?&N%X:K$^,PD9UU(
M=B&!P'9YN;7O6CQ608?A7$)[#2S"8@@W5'JG =ALFAOL0>2YB> XL]6W]$:-
MS+IB#K).5K^NU14=^DJBR5C+.3,(FV$P K:S@2#OS.<!'A70/*[BC-TJCPXU
M/#^'X/#'GE=(V5[B=; +9&.UK0 [%>6Z 1&/@CI2*&(Q<Y::(S-:V*,$::TY
MKA8N_&UX]<>I._"W_/8=M65<6_;$-&M8^XQ9=!)[<;J9C$'SUNY=?*5)$)L7
MR+$&:(I%<G^%J.3+)*-TD.F>2OH3PF#@V#Z18W#Q8GB>-><1AY)+D9@XX9'Q
MP]2U]-$N:,O,F4%OFAF4M)/,_*'TJXEB>*XW@F'FDPW#\%6&Q$<1<SZ9(Z//
M(9"UY<8FME:P1EU$M+W9@X$>X\'EFV=+.K81DB(NK>5C)>?MI<J*:3R-?H.$
MW4DS643*473)\DNX<E.OTU&SE J2:@IN/%IZWEDZ+8.3A_\ M1#GCQV'?A\/
MB_/)CQ.'=FCC.0G*V2)Q:/,RA[76X$L!6SY+>D&)AXA_L],X/PN)9--AQD;>
M'Q#6MDD D%.+)6-<2UP<0\6TAKG!=>0W$.O8>&W>''CMOYO?;\UZ\NT[COTY
MKO7M[TV]]P#W\M3KW>K]43B'T\!\W4//GW\Z(IV'KYB/:'EX]_+W&FO=ZOU1
M?GWY_0/T;>:HU[1ZOU1?K8P;<^.^W$.[?E37M'JY^OV>U%&P\O/S\OHVX^0?
M+4Z_'3]?BB<0Z_6 ^CF'FY<]PYT%]H] K\RBH+KX:X5;8Z7F,APURN;[&V[L
M1Q<^L^R[XNR5<W'&Q*S^/AI-2RK=GB-H=U*+,R&)/@S9G%PY^!.FZX+K$]CT
M4Z:<>Z*.D;PZ:.7"2O:^?"8MG689S\S&E[&MDC?'*67YT9%AK<P<&T/*])>B
MG".D38W8V.2+%1M(AQ>%<(YPUH-1R$L>)8K>2&N:2#GRD%Q6!Z1,9:7\L8B3
M8-K(FYJZOJ;L]?)JU_6-?EHRT5=4K#?"'S"W7UX6_;BI&K"23DT2J6LJY(D5
M) '[Q<RB*J_V.)^5'IABN(18N+'PX*/#YNIP^$:&X0M)L'$Q/=,[$.J@6O<0
M+\P-7RN'>3KHO!@Y</)A9L=).WZV?$/<V:-Q;E/T9S.J$4;3J&M:27:N<1HO
M;R6D_+>%WKBX]+V2Y)%F9<7;S'=UN4UH]\!=S&126.4(B0.H4I6Z8/V3!V1/
M;I373'I%]9A?*3T9Z3018'ISP2!KRT1Q\2PT3I!$:'GNT^D8<7;B89)F$D?5
M587FL3T"Z0]'IY<9T0XK,]H)D=@99&1ND\XD-S4,//I0R2QMD%&G$ZGWEGZV
ME+=ER69J0L28Q9="8II#,HL7SFVWHCL4SH&X_"'S5J;@9)=DO-LSE-XP7:9
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M?A3[W/8.@;4?+(K>)<3%GQ]D(@'VZQ,@71!64^2(/,=XR=?*'VV$J:9S@(&
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M9V93W@NU8.K8<.'#N!;MHYTVETY.<(S5:.%$FK]DR48LT'3=1T[(0YE2H(+
M;UW1#R4\8XAQ _[0X;%\)X?AH\Y^[9/BI'.TBB(<]K6_:+GD$M;L,S@X>8Z3
M^4?AF#P36<"Q&'XCC<0_+J)#!@V-(!EE#F#.7 U&P&G.!)(#:=SNT>7_ (PP
M?EAI,/<9V>R)<$[,IC>3 LDA-6:A>#LP.&L<J\DG#,MI1WCRM4XE1 5(^**)
M6KLPH FM[_I/Y).#3<)F?P%N(PG$,+$Z2&)\KL5%B7,!>6N;(2\2S:AKVN#,
MY ,=&QXCH_Y1^+X?'P_TP8L5@9I")"(8\-)A^L<&ES'1>:8V[EKV%V2@)&N
M"^@&)O*T9SH#"W1;DJ4^PE"-F8Y[TND'#H@U=*B;?L#<>7,=AK\Z8C@?&<(:
MQ/"L?A[)D+9,+. P_9<,Q81JZR1>FO.J[I#QGA&)%X;B6 E::(R8J!Q.86*
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M16=KFQ._*_KBJMZH-%-K2-LQT]AN*MJSIF$4<$D8ER^^*F%Q-70H@BF61DW
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MG^UX#O4_8E:<_P#@JMKT2'_M=3_O,Z;?\;F_E0?_ !)_L!T2_P"#Q?SL3_\
M,H^Q*TYCSQ3;7,>I_P!7E=AZM_+3_>9TV_XW-_*@_P#C3_8#HE_PB+^=B?\
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M[B'*E(^-:J-T&\)=[$QYVW0!/8DI&(!$G]_T.Z=8CH[FX=Q&/^D^C^)S,Q.
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M(VWQ0N;K.ZZ<R2?00AA&2!HRT)*%[=_Q@W_?AQ$.77Y-O?;D'H]W+9=23?\
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MN%D"QYP01=K+D^SP/CO$>CV.CXAPS$NPV(8 USBULC98B270SM>")(W:6VP
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MNU4CF.K)&& =A)]ZNB9(T?629]>SE\^*MQ5:N2B)1$HB41*(JHZ\/N(M8/\
M%ASO_5?=%78?[^'^*S\0^?>JI_N9/W'>X^OY*SK2]]S/IV_@+Q)_0"WZPD^\
MD_?=^(J8?NHOX;/PA;TK!6)1$HBX3>&>R//VLPQ9;TC+_4]C-XQN"X)QTY=
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MN/%K'@=11OL796^43I"0*Z#\4H_9 AX@=>PG^CZJ[U![-$#7UJ=,&Y=!660
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MX[_3ZMN^B)T1[!]]^7;RZJ(G1'L'WX=?T!UT2TZ)MQYCMY-N6_4'OZ*B@-@
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M.&G(G5:<-JH\,]%;FEM"&,90"[]((:X&@B.V^X%^#Y;DS"(]'<"EW$0VZ("
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MTYHHV .11^8/+T<AX[AR\M10[!\_D=?'5$X"'(W'JZ!MNW;EUAW#[)T/8?\
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M#:MI-4YQ&_9I(I$DTTDR$(1(A$R$('1(0I"@4A2E+L4I2E H% H
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M *:F&_\ 5*F2']O_ );OBG63?X<_S8_BGV3OA$/W,)'_ $U,.?ZI4R0_M_\
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MPL^?/[,3$'4/7_M=W -^7 !XB._8^H_;'^4[XJ+Q&OU#=/\ ZH_[-?0GU?\
MA&?W.%GU<]8F(NOF'"W?)OY [Z?4?MC_ "G?%3_6/V#1_P#='I_L_/@@W]X1
MD=]O!Q,PZ_NQ,1?GMWB._'AM^>GU'[8_RG?%1_6/V#>[ZT>WS/@H^K[PC(#P
M\'"S[1_[<3$''KV_8Z [T^H_;'^4[XJ?ZQ^P;_-'_8/6GU?>$9'8!\'$SX#L
M/_;B8AX\^/&W1#;JX=O5N%/J/VQ_E'XJ+Q(H]2WT2Z_ATWV\?1JYSJ>UNM<R
MQF UO!YD+DR8QS*Y780X:L\7&9JV3"7'%VK(R1I8MK_%J3A*;F&+4L>=R5ZL
M107":)D$E#E&*$L+^O>6AP:;BT#B+%5W7[SW.NFL1NA!<07 =9K0YWD/,UL-
M/1>TOJ]\(R'_ (N)EQ  ';6)B'_5T>'#EL.V_9M0=0 !UQT_^D[XJ;Q!_P#(
M;STZT#L_Y/97+?L#?_A&/W.%GOQXAK$Q#N''J$;=]^/+@%/J/VQ_E.^*?UC]
M@W^:/^SY[D"_O",?N<+/B._W8F(?6(6YMOVCOR'MI]1^V/\ *=_W(/I'.!O\
MT?\ :-]?92!?WA&>OP<3/F.X_9B8AX[!W6[V=?,>6X4^H_;'^4[XJ/ZQ^Q;7
M\07KMIET[]32?5]X1GC_ -SB9\N?V8F(=]N>P#]3OJ\N_5L^H_;'^4[_ +E/
M]8O[EM=TH^'SV"]'U?>$9V_WN)F'/_PQ,0CS[@MW< WX\?/O3ZC]L?Y3OBH_
MK&PA;?.Y17H\W\_0@W]X1G?_ 'N)G_IB8A$>WG]3O+@'(!X\^K9]1^V/\IWQ
M3^L:?4-KOE'OR^&X[5/U?>$8_<X60?\ YQ<0\-O_ +N[;=8;]O"GU'[8_P I
MWQ2\1^P'\T?]FO?V*/J]\(SU>#B9\N'_ &XF(.'#OMWNXAPY]04^H_;'^4[X
MJ;Q'[!O9]YS_ .G;OT![.:!?WA&?W.)GQ_\ 3$Q"''MW^IW;CV#Q\_"GU'[8
M_P IWQ3^L?L6]_U@N^[S38]'I3ZO_",[?[W$S_TQ,0[]G#>W=MN0]8[>I]1^
MV/\ *=\4_K&GU+?YH[_^7PW\+V*CZO?",]7@X60=?W8F(=^&VP"(V_MOQ]0T
MJ T.O(VU,;N6NIOGLHS8EIL0--;?6>(U\WES_4+5MB:H=;V2+NRS8]I>#T3?
M7%A*[HNQ\B-5]66+F*,1<4S:<'>S!FV<NK72;2B:MNW)$NS.HY5RV347.U44
M*X1623DQQ,#7&?1P);]6\V+(O5YT!:1R033/);U )::<!(!E-71):>1UH>%U
MKM/ZOO",]?@X6? ?_P",3$/'COOPMWU]_#CMM'U'[8_RG?%3>(_8-[?O0-/^
MC?N4?5]X1D0X>#B9@/9]F)B'M[[=VWZ^?/T4^H_;'^4[XH?I _\ (;_-'N#;
M]O?HGU?>$9'A_P!3A:?Z8F(0WW#B&XV[SWW'?AU]U/J/VQ_E.^*?UC]@W^:#
MX?V>WNT"GZOO",\/^YQ,]OXXF(=^._$=[=ZN/( X"%/J/VQ_E.^*B\1?W#:K
M]KW"]<IOY[*4?5]X1D>?@X6?GUAXAVY__P!NCU#MSZO2^H_;'^4[XJ?ZS^Q;
MX]:/=E_-?H;_ /",[?[W"SZO_#$Q%W#UV[L'GY>4*?4?MC_*=\5%XC]@W^:/
M^Q1]7_A&?W.%IPX_=B8A]'['>?;MV\P#D^H_;'^4[XJ?ZQ^P;_-'_:?#E?=:
MCZOO",_N<3/?B._V8F(>._';C;H\?0'(.K:GU'[8_P IWQ4?UG]@W?\ :C_M
M]NW/92%_^$9_<XF8!PV#[,3$7H_8Z/+;JVY\^6SZC]L?Y3OBI_K'.!O=]:/:
M<OSV=CZO_",\?^YPM!VV_P##$Q#ZO]KH>?NI]1^V/\H_%/ZQI]0W^:/?D]])
M]7WA&.?_ %.%D'EUB8A'K#J"W=QY;\^_LI]1^V/\IWQ47B-A WNN7W^9^:P'
M*>I#7/A#'5Z9@R'X/!*,L;&MO25YW7(-=6V+9-PR@H! \A(N$8]A:SE\\42;
M)',1NU0574$.BF0YAZ-2UL+R&B8V[0?5'4D'34_/L0OGC!>86TW4GK =+-Z9
M>SD/'L5FH/5KX0*X86(N"+\&.DO%SD7'S$<N;6AB!$ZS"3:(O6:IT%K/(JB9
M1NNF8R2A2J)F$2&#<!JDQQ D=<=-+ZMVXWV<5:)92 1 38O21NQVU-#X[KVO
MV3OA$/W,)'_34PW_ *I4R0_M_P#+=\5/63?X<_S8_BGV3OA$/W,)'C_Z:F'/
M]4N'GIDA_;_Y;OBG63?X<_S8_BGV3OA$/W,)'C_Z:F&_7_M2VIDA_;_Y;OBG
M63?X<_S8_BGV3OA$/W,)'_34PY_JEQ\U,D/[?_+=\4ZR;_#G^;'\4^R=\(C^
MYAH_Z:N&_P#5*F2']O\ Y;OBG63?X<_S8_BGV3OA$/W,)'_34PW_ *I4R0_M
M_P#+=\4ZR;_#G^;'\4^R=\(A^YA(_P"FIAO_ %2IDA_;_P"6[XIUDW^'/\V/
MXI]D[X1#]S"1_P!-3#?^J5,D/[?_ "W?%.LF_P .?YL?Q4?9/>$0_<PDO]-/
M#G^J-,D/[?\ RW?%.LF_PY_FQ_%3]D[X1 ?_ !82/^FIAP/IM*F2']O_ );O
MBG63?X<_S8_BGV3OA$>KP82/GUJ8;_U2IDA_;_Y;OBG63?X<_P UGY6?4"M5
M3?A ]:ENY>L'!LMX-8R&1<EVK>UYVE$I:P<6+M7T!CU:WF]T.EY5*RS1S%5D
MK=$,5%J[<)+O/A"@M2*@W6$N74QY2\36T%H)ZMV[@2!5GL*K.(E#V,Z@YGAQ
M ZQNH;5G4 "K%K:@ZG?"(\=O!AH\.W6IASCZ+2'C_=6.2']M_EN^*SZR:O\
MPY_F,_($CTA7=P]=&1KSQU;UR99Q>7#-_P B,M\?8V+>T-D0+<!G.2;"+VO&
MWV;"(E_CB%:QT]_BC1+XO^-/BMQTW3)=0U3@ XAKLP&QJK]I5S"XM!>T-)Y
MW7L'YK9E0LDHB41*(E$2B)1%1/4#ISS#(9]QYJLTU7-CJ(RW:N.[EPS>=J9:
M87&O8>1L87!-Q]U,6JTI::P3MN7':-T1YI.$D4&4FU=H2<BQ?M03%(]6MD&0
MQ/L,+PZQJ10HT-!KV>E4/C<9!*RLP;D(-BQ=\N=US&VYTK,M(>G.YL#0&4+A
MR9=D-?.;,^94F\Q9=N2V8IW"6FG/R,7#VW"6M9L9(.GTHVM.T+5MZ&AHLTJ\
M<R+YPF_E79DEI S=&)'YB /LL&5O+2R>T]O:5,,9CS%QM[W%SCV&@ !W4/\
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MU)2Y;DD4F:21'DU/22RKZ6DEP.Z?NU#KN55%#"89))()-D4 >8K0>H+$- !
M&A))'(W=Z=FNRU;8NE333C&_YG*F.L#XHLC)%P?&'QQ>]KV-;T+<KWXV5\?*
M].58L472?QHM_A9($%$OAZ@B=WXXPB-27O<T-+G%HT )-!0(HVN+VL:'$47
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MA<RJ*UP'L*T86VE9D[45!:%D5XQHW6=(L_'+? VZJAF[0%50;)) H<#2Y[G
M!SB0+H'E>I6+(HX[R,:VZNA5U\^GFMVUBK$HB41*(E$2B)1$HB41*(E$2B)1
M$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B+\F,4A3'.8
MI"$*)CG,(%*4I0$3&,81 "E* "(B(@   B([41>F^J:W/_G!"?\ ZJP_]HHH
ML=H]87]",W#..@+>6C%P46(W3%%^T5!1PH4QDT"=!4W26.4IC$2#<YB@(E*(
M .Q+':%[.BE*(E$2B)1%_&PD6$JU3>QCUI(LU14*D[8N47;90R*IT5BIKMSJ
M)'%)9-1%4"G$4U4U$S;'(8 (O[*(O"X<MFB0KNG"#9$IB%,LX5312 RA@(0H
MJ*&*0#'.8I" ([F,(%#<1 *(36Z\U$7\C^08131:0E'S.-8-BE,X>OW*+-H@
M4YRIE,LY<'312*90Y$RB<Y0$YRE#<Q@ 2@F@3V+^H! 0 0X@/(>T**5-$2B)
M1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(
ME$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$H
MB41*(E$2B+U<Y"QER0LQ;LVT(_AI^+D(678J'433>QDJT68OVASHG35(1PT7
M61,9)0BA0.)B'*< ,$@D$$;@V/$*"+!!V((]:^:;71X,G0WBW/G@YK2L' <'
M;EO9EU1KV)DN-:W#>BZ5U6H2RY*2+#/5'MR.5VZ'PY!)QXU@JT<](@%\?XL1
M(.]#B)7,Q&:0G+ :NO[S===!5=G>=5H3X>%K\. P /F%CMIKB/595Q,R:=-$
MNB*\-%EJX_TRH(ERSK6QNTMEQ!9$O.'1LS)3:"FVT#D!^T>2$R%T(Q$>=VS"
MV72C6->"Y!9<142(8*0^642N<ZPR,6.[;X=MD[JR1D4#H0UH&>6AXG4WW'4D
MGVK+WWA(<\WGE#4UB/3=HFFLSW)I:R-+6A?<S(YBM3'EINH=K#,Y2%<1,C.P
MZSR0O&Y5OCM!M:+%@[;Q;2(0D)6X$?C=BU&1AV!L;GS-;UK0YHRDD6:UK33Q
MN]-#HI^D/N1K(2X1&G&P.5T :(-$?EN%K#_JP>1;DT^M]86,M$%^W1I5MF/8
MNLM9!GLH65:5UVZZ:.6S"_26/C]PV?2M^1%@2BZL4^N [B :S+YF]^+6X,V;
MQXWR^BL#S$9V]9=-;E=1!V\[8$C6KT[2L?I;RP2B$]4 2]V=I+:[M"0.9 -\
M@K=9HUTS,-D;'6#-,&%9'4KFW(6-&F:EX(;QB<:65C[$<DX090UY7_>LXRD_
MBTUP/UQ9P$"PAY"6D3M7J@I(%20*ZI;%YKG2.RM:[)8!LGG7<!WWX*U\YS-9
M&W.]S<X%Z!M6 XW32[6K-&M+Y9QI<U=RF;;UR?A'+6))73_J-PXVMZ8O+&$G
M<T/>T3+6;=H/"VS?]A7K!IMF5T6K).(]VP<J'CXZ0AI)(K&39(K+(^,B2+(&
MN:[.QWV7:C7F"#KIMX@C13%,7DM?&8WM%EI(-CD17(K"O"99EN_%FG2-L_&4
MLY@,MZELKXZTP8PN!F'^-6U/Y:E56<S=* @8JB3BV[)C;JF(]PF(&1EVD:(&
M*(@8,L.P/DMWV6-<]W@T77I.G;V*,2\LCINCI'-C;W%QJ_ <U@><M3L-X/26
MT:Z0,-:>+DRXKERU;^L7$EJVG<L- /VLGB*!M$8EC*.9YLE% TGQN%23NV[Y
M.48IP3..F)]RWEUU/@II:TSF661X&4M<\D7HYP&GN Y[:;J'R"#JXFL+BX96
M-! %CYLGD :YK6=N^$LU+3F5+_TLFT#SY=7MDQD)>@8_9YPL9QB93%4XW Z.
M0);,B\<T;1Q$9!5G!)VZUMJ4F)"7?)I-TTR,I4T?)@8 V3K08W$B\KLP(^T*
MK7V"J-ZZ5C$2ESH^H/6@!P&89,I- D[-/=OZ*O7F;=<6,-0F@#,5\Y\TTW(E
M(X;U+V1@C-&GYSDA2*<065+<RG8:+1Q%9)M%N 3,)%/)R#GD7#5FW0EA:.XM
M8AF8_#%\FPN;,&L=]ICGL?5:9202#MMK?H4.Q = YSV$.9*UCV#7SLPJNT40
MX>A64RYK^RM;^K*^M&V"=*<QG/*=JXRLG*365-DVW,?66A;ERKOFLN\NZ;N"
M,6+ )1#I.)8Q3>.3GY.XWLL)$&#%M'.G55MA!C$KWY6%Q;0'G6-Z]!OG[U:Z
M=_6F)D>8@ DEP  .U]GMUT6<Z<\_6[X0/$FH?$69\*R>+KPL2Y+GT^:A\,7'
M-Q=UMH][*6^BL=:#NN%(BSG(29AI4'$3,-F[%T@Z;J+M0$B3&0=8N9U+F.:[
M,TT]CK[#L? BOUM(I/I$<C7,R.!=&]IUJQOZ>6O?:_B\&5EF[[[P5=V+LER;
MF<RAI0S-D72_>MPOE?&O;I)C.00+9UTO#CN<[Z9L64MPTHX4,<[V8;R+X1)\
M(\63+$- >'-%-D:'CLLCSJKE=TF&>2S([5T1+">T C*>_P TT:T!%=BZ+U0M
ME*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)
M1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(
ME$2B)1$HB41*(E$7*GPA5F7A=&H_P7<K;5JW'<,99^KUQ.7;(P<))RK"UX4;
M#EFP2]PNV+9=O"Q8N#D0!_)*-FHK'*EXWIF HWPD!F)!.KH'-'>210]BU<0T
MNDPQ O++F=W-#2">_4C06>Y>3PD-F7A=>5?!JOK6M:XKD9VCKMQS<EU.H&%D
MI=O;5O-8>;3=3T^NP;.$HB&;G.F1>3D#MV21SE*HL43  S"0(\0":N( =YS
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M)1$HB@0 >8 /E#>B*=@[ HBC8-MM@V[-@V]%$38.P/11%.P=@<>??1*'8HV
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D(E$2B)1$HB41*(E$2B)1$HB41*(E$2B)1$HB41*(E$2B+__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>g60414g46f85.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g60414g46f85.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2_24&AO=&]S:&]P(#,N,  X0DE-! 0
M    +[:^$B%#A"24T$!       (!P!6@ #&R5'' (   (  !P"!0 ,4V5C=&
MEO;C1.7W8R.$))300E       0%DYEZQ]?4*4?A-:1:-W3:CA"24T$.@
M !"P   !     !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0
M    !);G1E96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0F
MET8F]O;      +<')I;G1E<DYA;65415A4    % !# &$ ;@!O &X ( !4 %
M, -0 Q #  ,  @ ', 90!R &D 90!S       /<')I;G10<F]O9E-E='5P3V
M)J8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M    $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P
M X0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M   !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
M  0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F
M)O;VP      $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,
M !        4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&
M]U8D!OX            $)L("!D;W5B0&_@            0G)D5%5N=$8C4F
MQT                0FQD(%5N=$8C4FQT                4G-L=%5N=$
M8C4'AL0'+            *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M   %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W
M @56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !
M!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M        QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&
M]N9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! !+
M    $  0$L     0 !.$))300F       .             #^    X0DE-!
MT       0    >.$))3009       $    'CA"24T#\P      "0
M   0 X0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &
MQF9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &
M ! #4    ! "T    &       !.$))30/X      !P  #_______________
M______________ ^@     _____________________________P/H     /
M____________________________\#Z     #_______________________
M______ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M    0     .$))300:      ,U    !@             $CP  !V0
M   0                         !              =D   $CP
M             !                         !     !        ;G5L;
M    (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&
M]N9P          3&5F=&QO;F<          $)T;VUL;VYG   $CP    !29V
MAT;&]N9P  !V0    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6
M-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M  !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T96
M0     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T
M]B:F,    !        4F-T,0    0     5&]P(&QO;F<          $QE9G
M1L;VYG          !"=&]M;&]N9P  !(\     4F=H=&QO;F<   =D     W
M5R;%1%6%0    !        ;G5L;%1%6%0    !        37-G951%6%0
M !       &86QT5&%G5$585     $       YC96QL5&5X=$ES2%1-3&)O;V
MP!    "&-E;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M    #T
M53;&EC94AO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T
M /15-L:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G
M5M    $453;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&
M]N9P         *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&
MQO;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
M   C_P        .$))3001       ! 0 X0DE-!!0       0    ".$))30
M0,     "4:     0   *    !C   !X   N:   "3^ !@  ?_8_^(,6$E#0U
M]04D]&24Q%  $!   ,2$QI;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0
M  86-S<$U31E0     245#('-21T(               $  /;6  $     TR
MU(4" @
M         18W!R=    5     S9&5S8P   80   !L=W1P=    ?     48F
MMP=    @0    4<EA96@   A@    49UA96@   BP    48EA96@   D
M 49&UN9    E0   !P9&UD9    L0   "(=G5E9    TP   "&=FEE=P   ]
M0    D;'5M:0   _@    4;65A<P  ! P    D=&5C:   !#     ,<E120P
M  !#P   @,9U120P  !#P   @,8E120P  !#P   @,=&5X=     !#;W!Y<F
MEG:'0@*&,I(#$Y.3@@2&5W;&5T="U086-K87)D($-O;7!A;GD  &1E<V,
M      $G-21T(@245#-C$Y-C8M,BXQ               2<U)'0B!)14,V,3
MDV-BTR+C$
M               %A96B        #S40 !     1;,6%E:(
M        !865H@        ;Z(  #CU   #D%A96B        !BF0  MX4  !
MC:6%E:(        "2@   /A   ML]D97-C         !9)14,@:'1T<#HO+W
M=W=RYI96,N8V@              !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M                                                          9&
M5S8P         N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W
M!A8V4@+2!S4D="               N245#(#8Q.38V+3(N,2!$969A=6QT(%
M)'0B!C;VQO=7(@<W!A8V4@+2!S4D="                             &
M1E<V,         +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14
M,V,3DV-BTR+C$              "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:7
M1I;VX@:6X@245#-C$Y-C8M,BXQ
M!V:65W       3I/X %%\N !#/%  #[<P !!,+  -<G@    %865H@
M!,"58 4    %<?YVUE87,          0                        */
M   G-I9R      0U)4(&-U<G8        $      4 "@ / !0 &0 > ", *
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ML)$ DE"3H)3PED"7D)CPFD";H)SPGE"?L*$0HG"CT*5 IJ"H$*F JN"L4*W
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MD:66E9N%H'6E9:IEKU6T5;E5OE7#5<AES672==>%W)7AI>;%Z]7P]?85^S8
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M@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,#!$,# P,# P,# P,# P,#
MP,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.%!0.#@X.%!$,# P,#!$1#
MP,# P,$0P,# P,# P,# P,# P,# P,# P,# P,# P,# S_P  1" !C * # 2
M(  A$! Q$!_]T !  *_\0!/P   04! 0$! 0$          P ! @0%!@<("0
MH+ 0 !!0$! 0$! 0         !  (#! 4&!P@)"@L0  $$ 0,"! (%!P8(!0
M,,,P$  A$#!"$2,05!46$3(G&!,@84D:&Q0B,D%5+!8C,T<H+10P<EDE/PX?
M%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-UX_-&)Y2DA;25Q-3D]*6UQ=
M7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$  @(! @0$ P0%!@<'!@4U 0
M "$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D8N%R@I)#4Q5C<S3Q)086HK
M*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4I(6TE<34Y/2EM<75Y?569G
M:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H # ,!  (1 Q$ /P#U58O6*7?:V6^L<<
MO:VNMS;VTEQ!<_TQNJ>[W;O?[_ -Q M^NG3ZS9.-DD5%P<X-KCV.]-Q'Z;Z.
M];&7@XV:UK<AI<T @M#BT.:\;;*K P_I*W_GUN24Y3,3,R6-O99;<US&L;;7
MEC:=IJ<;*]E.W?:['_ $O_ !ER1Z9U0B!;D@R9)R@9!,[?YANW^0MG'QZ\:E
MM-4[6R9<2XDN)>]SGOESG/>[<BI6IPZL;JV'NOJJMS+6,<*Z;@
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MT2@W1F6%X?$V0U97EM4I-$5356)C9F=T=H*&A[+_Q  > 0$  @(# 0$!
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MS9D*&_C2/>6]8!44LS$'[H( P,9))( ''7D@9J[R; GJDO(0JIG'K$%B">0
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M@'M)&1G-[KU*:^3B-WJ!ICH'G^HF%85VWZ3=UVH%U(R7#\/=Q_2+5C'LHR>
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M"RL-I?J5&[@<=!DG%(9H]Z<F?YIVKZ2Z>]R6LV63;_%^T*PT0PS#'\2PJ/\
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MY;]XG^<?Z='ZB^7_ ,_KOP_K(TJ_L7Z=\O[O!\I/U*=RW[Q/\X_TZ/U%\O\
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MEE-A-#+N?AR_V%2-9#?5D6UMBY1ZUA]9DC:.VX8ZR(SG:O)PQQYA06./;@'
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M'W/M$2EPF=J*I@R",.%8$]#CF1FR?%16F+>4]V6QN<L+CG(*$J1S_>XC1/#
M9B#YJ+G'83K+ [J.YOO?TLH8;&OE#K!I3F';I#L\SB,8IJII55:&8?IWJ_I7
M?52V3E1AYYN<>\K:_);:N@VL"\H,3LTEC0Q2)RJSIW44#$]V8V63 ]97WED<
M'&6V^KE<D$;O$U)MW$LLZC$F]3'D^JR!%5E(SA<D'#8R"%/(&*FQKI$B97P9
M<ROD54N5#C2)57+=AR)5;(>9!QZ!)?KY,R \_#<(H[SL&7*B..-D<:0\R0.%
MI?C]>VMX=.F/9Y>RJSI2CI2CI2CI2CI2CI2CI2CI2CI2HC^Z73;O4U;INXCM
M]M= -%-=L$U:?R"OT)UUR+,L7PZ-H+B68T=77_"YGA,K'[#-;;*M-[^)+R?'
M,CP9ZPEY+):I%FRL??@HL?;B:%#')WCH5P9$"EN\()Z'(4*PP"#T&< ^.K*L
MSB1-B.&R(W) [L$#[PQDD$$@J>1C)4\A\FIO;_$U2[6,G[;<KOIM^N1Z.KIM
M+S&R4_O:3?1L:9K*W-WS1PW N8V01(>4 Z+QN-63 .BZ1@AK@60I*) ,8?=C
MV9Y7GPQQ69H]\1C8YRFTGQSC /&.0>:B-@>GAW+9HSH+F.I,;'8.H.NF:YW_
M .$4CPL@JY427IO8:F8#JMA^.4LB-+)K(6JVNT:Q?2+A6K,)JCS:[>4 KVI)
ML[9GB7O%4DJBC[.<$'=M96)'ADNS^]1UZUJ""4]VS;=[LWVC!SZI964#CU@-
M@3P.UF]U*!DG8=K1CO<YW*]\.EN.QE[@JO7["\OT/J++-X4?%]8-"_Y&,!P'
M573"XA.V;M)A5AEDF)D*U&2V\"!:P\CQ;$9<J2./-H:T$Z&..%C^S[LASM.4
M?>S*P.,D#(R 2""WC5C XEEG4?M.\!C!;U6C[M%=2,X4M@X;@Y"DY Q4VT1Y
MV1%C2'XKT%]^.R\]!DG&<D0W76Q-R*^Y#?E1''HYDK+IQ9,B,1@1,/O-*+A:
M=;M5'2E'2E'2E'2E'2E'2E'2E'2E'2E'2E1.=Q."=\&IF&=S':W'T0T>RW N
MX&SS&EQ#N);S>AQ&EP'3;/HD. 3FH^E9U$K+\KU*T^A+.;J+?'79L'+I4#'9
MTZPQYUJ4#>U&T*M'+O<-&%)C*EBS+_JMD *Q\#]WGK6K(LSK+%L0K)N59,@!
M4?C+)U+H,D8X8@<K3Z-6-!J/5;MLS/MSO)LF;4Y5I1,TV2[GJKUBS*3'DJJ?
M)W'$+DMO66D>#?LOB7,+*(V\)<A1>L".5D60<$-NP.G7)'N(X]U9V0-&8R>"
MI7/CTQGW^/OJ'RK]/+N;S&LT*RG4UO'8FI&N&<YU#]0SX2_K)C$W22SS_374
MC',=J)4>6K.0 U3Z#XKI#[59\6Y&I-2\DD^RU#:F/Q]LW$8+A<[8U4V^1R'"
MLI)X&.9"_O1:T_L\K;"V-SL?M&",;-RL ,]>(U3SPQ/ARH>8=AVM%1W0]RO?
M#I;0Q1[@:77'3W,=!*VTS6(QBVK>C4;1/"-/M7-+KNO<L7Z;#)F:.1\AC5>3
M6]?!M8.0XWB%B]*&@C\R@3H8HX&/[,HPD.W)1][,CC@$[>,@$@@D=35C;N)9
M9U'[02*T>6]5T[M5=" <+NP><9R%)R!BIL8$A^5!ARI4&1629,2/(D5LIR(]
M*KWWF0<=@R7H$F9!=D1'")AYR%+E1#<;(HTE]E0=+2_'Z]M;OX?7LJJZ4HZ4
MHZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4
MHZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4
MHZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4
MHZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4HZ4
MHZ4HZ4HZ4K4Q]1K534_'N]#6ZGH-1\]HZB%88<,.JI\PR&LK8@O:=8?(=&-!
MA6+$5A'9#SK[B-- AO.N.EN9D2J'Z^N/PIET?5_766S,D1=4=69+%<P,JP?8
MS?,'F8,8WVHH2)CC=F01F3DOL1P=>( )]YID25QP!549Z<Y'\^G3S/L ^7-3
M)U4[@(5;6W$S4?6&+47/Q25%I)S#-&*ZT6"^4::E=-=L1C35AR!)B4D9UWX=
MX5:=X&BCTIG/3V>[X>'R^-.+[+-6]5KGNOT!J[?4W4*UK)^IF.1IU=99GD<Z
M!-CN2MG(\N'*LG8\A@T\&T\V8$GU%>E/'X#Q]^>/B/\ .MPOI4T=*4=*4=*4
M=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4
M=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4
M=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4
M=*4=*4=*4=*4=*4=*4=*4=*5IZ>IC_?Q:[_\(X5_JTPSI2J#&H&>7W9A(I-'
M:ZVME<U=OW-?ZK$H+]CDDN@&BQ23I;(R"+6LO6KF"1K")EALJ8+3,Y*TCLO:
M8L$D5 X^OE^&*NN%U6I%!VC:^0-7JW(:C2Y6,,71JNS:%-@(FL;V=4TB4_IO
M&N6FGP(L%_31W,'*0$AN0G6EL5*2XPO2F>N>GT<>W@9/OQS@TG'8U_??=NW_
M !IXS_SO_O\ _1^G2GT?E]>7\]TSI4U'YK'ZJ7I\=ON27V(:R]T>G^ Y-C%]
M+QB]I;B-E#DVOOH)J$RM<;K\?FHZ]&)%1THY/,CX57-E15U(KZUFFEMXI=\T
M!(F14D_98<(=[;-BC>0H);!;@$UU^P[5=G]4U;4-#T_4X;O5=*9TU&SA2=GL
MW1^[99W[H0HP?U0#)DG[N:1]OUS_ $FG51&^]?3,E4D!-J?4']Y4W0?.&IY5
M/IUMX_EYC/7&1[*[!7L_ZX_I01D57^]/35I$\KRI]0?")MNJ[8:OA-TW7\-T
M5?JG2E8[-]?3T?*TN$[OKTIC%NH\7:G4-%W3ZILF%K^?C\_PWZD@@ XX.<?#
MCX?'KX4JA_N@?T;?Y^NDG_JK43_L5U%*_4^T"^C>J;IWYZ2JGYI5:BJG^C"N
ME*_?[H#]'#^?EI-_ZIU%_P"Q/2E?2?: ?1R7PG?CI,J_DE3J)_V*Z4K[_P##
M^^CK_/OTG_\ 5.HG_8KI2OM/7Y]'E?IWVZ4K_#[HU%W_ "^GZ%;]*5Z)Z^GH
M^DNR=]6E2K^7W1J+_F_^HKZ_PZ4K,*?UM?2NR %<IN\S3:Q% 4_]CU6>*2B*
M*JJ@%B(FNR(JJB"J[)].K%&'48]1I.H^XF-QZ^&1QU/@#2L:MO7F](>BDI#M
M^^32R!))PFA9?J=0A(G 44(1XX80KQ4A15153==M]]^A5E^\".<<C'(I4DNH
M>M&E^E&FECK%J)F-;BNF=1#I+"RR^Q;G%6Q(61V=73TDAUN+$D3>%C9W57$9
MXQ2)')C:NBV".&&O<7$-K$\\[B.)-N]R&(&]E1>%!/+,HX!Y/E7&ZOK&F:!I
MUSJVL7D.GZ=:"(W-W.6$4(GGCMHBY56/KSS11C .&=<X'-1Z7OKB>D_C5I+I
M;KO:TJAVD%Y8\N$D3-I3L=] ;<)IWX/%) "8BZ"$G+Y3Y-KLXVX(Y(76>W2Z
MB.^"3<4?!4D*<%C&P$@7R9D"G!() .+:7JMAK5C;:GI=P+NPO(A-:W*)*D<\
M+,RK)'WJ1LR,5)1MN'7#*2I!-J+UW_2- 1,^^#2X1-2$=ZG4%%)11%)$']#>
M2JB*BJFWT5%^B]9&1ER64@ @'QY(! X]C ^X@]#7(5^EZ[OI'""&O>_I=P+9
M4)*G4)45%5$1?&&K^*[?T]1@\\'CK[/?Y4JAE^O?Z0$$$<E]\^ED<%V5"<I]
M14'8M]EW_0I?KLO^9?RZG:V-V#@>-*MO]T#^C;_/UTD\?7_:K43\M_K^A6W5
M:5])]H&]&Y=]N_323Q_\RM1/^Q7G_)TI7ZGV@3T<%^G?GI+_ .JM1/\ L5TI
M7VGV@#T<U^G?CI*O_P ZM0_^Q?2E>@>OWZ.[A((=]^DY$OT1*K4/_P!JX6B?
MZ>I )X%*_4]?KT>%543ONTH54794^Z=1-T7_ .XKJ*4)Z_/H\E].^W2A?K]*
MG41?I]?IA7X?C^73IC/&>GM]U*^/_#^^CJGU[\-)T_\ G5J)_P!BOXI_GZ4I
MX7:GZ@'9SWP.YLSVHZ\XEK4[IRUC[V;!C$3(HRX\UE*VJ8^<Q;ZEJ$-+-:2U
M]CX57U'X)WWD;W;YR01P?('X'D'XTIK'<MZWWIS=HV8YC@6NVL5[B>4X+D!X
MO?UL;3;/+PANFD:)V+7O4]%+9LQ;!X#<?A&\P ;D3B;=<;'J=O+>26*).TT1
M82,(CW2;?%I,\ G !(Y8@#-=3L.VN@ZGVAU'LO8S7=QJVDEAJ*)I]Z+6T*A3
MB6^:$6:L^Y1&@F+R$G8IPV&LC]J)]&T]E#N#S<M_IMH5J]_V3ZY&NV5[)]J!
M]')40OU@,W1%W1%70K5U-]OK_P#*G^'\=NHSR1Y8_&E?:?:?O1T7Z=P&;K__
M *+U=_[)]32OI/M/?H[%]-?\V7^C0S5S_LITI7N/VG/T>C5$'7_-//T_\AVK
M2?Y__%3QTI7M_=-?H_\ C_R^9JN_Y:':M?3_ .Y3_OXZ4KZ3[31Z02_37O-E
MV_\ X':M?YO_ *E/K^:=*5]?W3-Z0FV_\O.;_3?_ .0;JWY_HWQ3S_W_ "Z4
MJKIOM+/I%W\\ZVKUYS)^4U&E37Q71/59L(\2&T3TJ0^X>+(+;3+8*1D2^/'Y
MIU5W5!ELXR!D#/)Z<#GY UK75W!91"6X?8A=(EPK,6DD8*B*J@DEF. ,?PK+
M*7[1!Z6F0M>_4:Q9W+C\^ R!T3U4%@SWX\1=/&! B5?H._)45-D7=.K5L Y
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M6FM2V\D>FW.I6\:2SV,%VX6"6YA26)I8D<R()(\H=ZUJ0:Y=OLO07*6L6?U
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MR0B657]?;<3N T9'KLZLK*I/%MX%5Y&3D9Z'P\<]<@?PZ1L]S&I&0U\^DIL
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M<?B/R]O/E4%FO,K)\SL4&-%D,4D.,DD(S %[!B9O&+[SNPK*=X 9&?RMMH)
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M\F% D0?<?:,0)I4%$1'51!^5?)DX(IM\G2E-RNJ&YQZ0[&G1'15OEL0"1MD
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M4T#WAD&D9L72:;SLZ!61(^&P?69@?N@,."<C<">I.#R,FM#.>G3P^O\ /WU
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M4#<B1"1418961BKJ58=5.,C/3H2/QI71[[V:EB5Z<NH(LLL))E:4:9D]):9
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MFR(*>-MNMGIQSQG.>N<GY>6/97'XY)\SY<],?+//^!K&-6<@*GIX\893<$+
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MVDD9MZ ;&&U$568*0Q+;BQ4'&/HL4!A41EBRB&.,J<$$;$9N>0<N2<CQZ'C
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M*T/!AX6Q(F21M6SV762S2(_L6N($Q@Q+<LZ'GP5EP/'UL[AR!U.=Z3M)>W
MO[#0M0++AY+C3(+69U!#*TTNF16TKRQ.JO$A8VTNP0W*R0.Z';$]+_*X5;VY
M.Z9V46%%RS3:\.!*CNHS'F7E?;.QW:N<X1DQ\5/E/./U4=QYQ$>DLPV.8"0
M.W'&B<(I0$[CDY()XW,V3GD>?0<>%<7>7ESJ$O?7DS3OM6-2RJBK&GW56&-4
MBA !SW<,:1(V1$H0 4XS6W*,9Q^P@8_0U%/%G\X<^>]#KX<,QE.*=?$:&R:8
M;5J=%B)(!QMN1[P5[SC1 C+P(5PK=WWF5V!F3<71>5)&2I(8+P06*A<C&<UJ
M;AG;GD>'D.M-EU6C8388O:EBQ0W\@2A1[>IK(YJI*V\P^R,Z,[6_% XX$F(D
M59<D&&UW>; 76^I"L>[D.T(YV!V&2 .2 !DX'M&,<C-3DGJ3[LG ]PZ#X#V5
M']<X($9B*[D7N17)"JY' 6R=?E(6Y.($=Q4X<38%'WG"]M$>/B9DI+T;:CG'
M[54;@KD;L$$,N<'@X8>ZE1W]P_;_ $&15+EQ6+"FV;UBK;C3*J\LLY0JV@(Y
M[#:D+(I( '$8!MD&U]OSNZD$*"-A."<C/)!)SCV\GCKU\:@_CX?B/=X^7SJ#
M_4_1N\Q'++RLD5I?=CZNLBY(56R%&7E8:%!)"(^+A.#N:J2@XJ*BHJ;9T=U1
M9&+]W^UB78P!#  L".'_ +PP<8)R,]2 &.HY\?X_/Q]OG6QO]EIPZ-AE]WK0
M&!)7'JK0%U]XD5%<-9&K:HGGRO!%VY;)NFWC\>L!!"H3O&1A5;=@* -I&?5.
M1U(YXY\,SQ\>A_A[/'W^?A6MI]I,9;<]3;5]QQ\&3:@1R:;,7"*219OD#2LM
MJ J(G[9F\I.*((#1CR]PFP.I)&W"Y#$@\CU0!D-UY!QC'7GV5!)&WC.YBIQ_
M< &0Q]C' ]F<FH#'F."\3'=55%XJB[>?QV1=EV3QY_IW_.:FOU60]@O9:('T
M/<GA(MD;1-T!6T0D^4MB$U3=5\+L@^5*5#375&ZPMZ+[=S;A+AS%E4\R)("-
M*II)ILZ5>\\V\VC4KC[<ZOEM2:ZP;44E1R<9CN-JD'!!PIP0<,JNIQYJP*L/
M8P(]E2?8[JOJ#W+8G*TT_3?21U_)JH<?L6<GI;JCRB+'=<1)4L8;%Q*JK1UK
MFZZR4)V+#<DFV2#'5?:"@CC5BX10Q\=HS]?GXUM2:CJ,MNEG-?WTUHA39:RW
M<\MJG=@B/;;R2-".[#,8\)^S9F=-KL6.R!Z>^$Y)A\C#L;>?F7L*AHJ:M<LI
M3B Y8K3-16FY4L0,V_>F*PX1*#IBV\:\72%$);$9Z_R'R'%:8.? 8XQQC\,#
M'&/@?;6XU@64U):?4]N]*]N-%A0X\EQ\@%67B1IL6S4E%$5"<!%%5W;52#SP
MZ#@>[\*=,XY/7'O_ "_SZFF0:K:R)8Y?+&,+,N!!:D-Q+!$<^!<919#C[:D)
M.1UE,-F#1L-$1&@"\ZX*BC*NH_+Q]O3W_0- ,9]IS39=15I<YB3!.P=)LY*2
M'9++SKSDN0K8M.(B$JMA'95UV.TS':CMM.(/M@X? 4>'P\./EGCX5-,TU"J:
MS$FF:R-7([*42%H59:18L1440*49>ZVRZ1$1?[&0S(B%SDI&#ZS2HM.X/1:M
MS!E\H"-E)1IP'HC;1BRT)>X7^QS<13)Q3)!Y![;*B*( \T<455(/)'7X^SR]
MWE_C%U_(M<Z=92 R8JB#KKWL@XR;:J!,$"&.Y*X:N<R'B@CQ%M50B]SBVJ/6
MW>0V_#.3U_#R./B*E8]$W&6F_5+T@O3'9^+A.K["DX H:.2=.<A:,!+DA'LV
M#:$2BO%$ !'95)52N[/.W&!C&<_'P^5;XC'[I_\ IG__ 'I]2>OP7\A4)T;_
M &W_ #-:=WKX:CI'[Q]/<)204<Z?3ZFOV_;=5''7K-^7'$1 41540BJNW-%)
M-U11V3?Z-?6L*^BS0[T1 3/VNU*W>7G<R&P1HXSSC:C1LXXSN9N>@'S6PTB>
M+TM:]K;7#O!==D-+L(K0JO=1O:W5U,\H.-Q>1I8RQ)P!%'M (<LS*#J1C1XU
M"=MVE89LX80;AVUK9+E0\J-*"/A:N1GZ[VS;>- ;<?:?;7DVJ\!02^<5],Z^
M'S]WM!]Q''CYC+6,/R_(NV1N!C554W&LNBAG-6LEXI\':9AA460XXZS3G0_%
MQRRFEK6%5B%/A3H]P,?>+-I93R%)E8#$Z9-NZ1YZQLI*$D_>.,G(\,^&>.E<
MN-2ANXH8M7AGO6LXDM[.>*5;2:&W0R;;9W6&<WD(,A96?N)80 D<@0L*]M)-
M?,"B=X>"YCIFQ;20M69SN:U4G&,@QF+61Z6WBOU,2Q:MH$$H,T1D6%4+2Q_C
M'&F4)QQWX5MQRB0R]X)YV5I%7NU6(%5VDY+'..AZCQZX'0VN+^T73SIFGPSQ
MP2W27]U-<LC2RS112P00+LR.YMUFF968@EI78Y9LUT2-+L@JLJT[PS(Z*<]8
MT]UCM980)4EQ'9*L2(P&+,EQ"+G(C*I1GU4E)'630EW3QM5P]4.HEO K(+XR
M'&V]X,N5*1UU&A<CA&D1H[(;HJ$ZY,?9X"FR(J<C7BG$GR_#QX^/T:J0,@X^
M(/0^WGRZY]@Y\(V+[16/FEA9W%6^RD:1(5UZ,K@*U'==D.$RA.%X(2:)Q%5"
M1S8]DXD2B$$_QS\/>1[?SZ=;4W3-]/ZG3M]()-Q3)QNPF692@7=H3<;AL\&R
M;<1 %##;9$5$=,Q)3%$!]?CS\<?C2F"ZC2,)RA\:>771$;>Y.H^C3($;[Z";
M;8(6WM\O:15^8D4RW050?FFE-4S;"L2QAPCJ(S2&C^YJ\""K6ZB+2@6W)!55
M--T3Y'&Q7EOR455( R>N>N<_0]_A[J;;DN!U]Z^XXTBUT\P7VC;43AR2,E53
M:>1!%@C1$X(2"FXH*E\J;*CJ1SY<9\L]?$X/'OZCCE%<DT2R@5<>9E2YT0^'
MNM^TC.R+\S>SC9$*J*\D!U/E-$)>($*BBI!XSCR\#X\>/CSR<GJ?>;"FFK9P
M561&1UZ1LWS>8\J\'A&Y@INHO"NZ;BOS*BDBBJJBJC)XX\?F1R<G  S@CWYX
M(.0F-SI V$MI5CJ+$MMQID7&D(&3<$D$24MT4D56F#V^4>(J*J6Z]*D$\@@Y
M\\<?#/X$\=,^W? ]&FI2A]-+MEIO"+6L:C1B%!X[*.M^H9>4Y%LJ\N2IXV55
M3;QU(Z_!OR-5DZ+_ -I'_P!X5*5U%9*.E*.E*.E*.E*.E*.E*.E*.E*.E*.E
M*.E*.E*.E*.E*T]/4Q_OX==_^$<+_P!6F&=*CGZ\./?Y^P^[QKS[5=&NWO*,
M=NM1=9]6].X=K2V3T#%M%,KS&;@3652H[$-\+7+<L@5=S:5>*J4HV@BT%6]:
MV;T.0S]X5C8^XZH/,\>'7(]GS_'C/ABO[F(>8Y?CCE_==Q?;'=8GA+45C"]$
M-&<LMH]50P9=A'@I$P[#$Q*KKY$F*W,*9:VUG8/W4N%&E2)EC,<;;;)]9X^O
MPQ3X]<@8/UR/.DR[&_[[[MV_XT\9_P"=^?\ 1TIUQU'Y?7CS@_B*W3>E37-&
M^T":+=S&O7J/:FV6%Z$Z@Z@,P:YVDJ;;3K2*SG.VU!C.<Y=60WI\K$,>3](Y
M-1#@K6NW]BLZV^%@!"FV#K%<PU&VYKV:>WMK61F:&U4B!&EED$99YG<IWCMW
M:,9G;N(]L"N6E6,2.[&BQQHSNJ*K2??90 7/JY9L#!8A$4GJ51<DD'.MY<T5
MOCUO-I;VMG4UO5R3B6-39Q7X-A!DM)LY'F0Y(-O,/!O\S;C8FFZ*J;+UJ5>O
M @$D%$3947=27?DJ*HKM^2(FWY?5555^B=79]RHNU1LSR,Y;..O/LI60UF7O
MT#:F]"9L&&B56V7A'?D7+;=1V5!12550-U+D2ER40X4I2B4=K27S#+L-\(%J
MV*.-MR'D8$7"5%0.7E$;YBGU+D*F.YN((H*E9U1=Q6H&FMJR^%D[*&.I <>:
M[)2NF-A[C;>S1&A;(K: CP<'$V0VR!43I3 /49K9T]*?UG:G#8E7B.H3MA!A
MP@EQ/@V'FYD26S/;:;C%'CN26%<<C23>7=0+9B9S#@;'%'M^OKZ\348^/OYJ
M4?5+OK(+N\*+8G'J;VR;R((H-M$$:3:-'O(5.;J19#<:='C.)$<(0<F24;+Y
M]T+D;N3AN".HQY>T9J<^7U[_ *\*;Y+[JF8TR.41USXRU>"0BH;?D7%11)P!
MV-&T_>=%PEW5$!25M7U551N+]!W>.2/O!@??C&,>W)&:5ROUMJ,WBE2P9#MA
M>M>](LK#=9+#$%T6G7&!$7E4)1O-N&K38M @&2$J""GU95+' JU(X.:PLHR&
MZJWIR.1:R(X]*-]?=5Z,!\19(5/BAN@A-(FQH"<-Q5-T6581/N8E0N<E<$@D
M%1UR.I ]E/'ZQS_E]9ID>I;<"\R";&I(Q,,MR([3-C\.PZV+CAFB$+8O$I^W
M\JJ1(  !>' \<<\"),R228E422B2/!#)'M&R<[<95"6; (;U".A)$'H<>WK^
M9Y' ]_3I3<-0(K,F3"1Q&W?;BO-/(:J(G[LAR&GM-N&1-JJQ.'M >YFTXXVR
M9^Z:<\=*U.YM2&@N(=-BGEE_:H(IS;0P6[3&/K&2ID5LE-S,Y4EBR[=9KB*)
M2-X:4E!M4';SUSDY_$>[PK=&[]<FSO%O3VUULKK&-,\BP==%].J.NI[EB[MS
MM0RBWT\QG(6+R($FJ;!AF/<7+M)85<V#9P)K%19LDS*C*J<!97MS87$%]I]Q
M-:7-O*DMO/$P66,C/&<,"'0F.12"&1G4\&LLT,5PABGC26)QZ\;C*MAE9<C_
M *K!6!&"& (Z"N1;8*I6;A* "OPL8A1$+845R2B?OJ2KMMMNJDOYJJIU@9MQ
M)( ))/&?%BWB3TSM'DH \,UE\ .@&[ \ &9FVCV L0!X# YZU50P!213%5W\
M>-O*;*GXK^2^?I^2>>H&,KG.-PW?[/CC_K>7A4\8)YR,8 ^.?KSJXRHRN@7
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M5H24-V-*'DK$AYYEQ%9-E0?7U[JGIC%6GOXUNE8]=,-TU@+M0=6V3\J*][@
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MYQ01BB+OLJ"HXAJ[[PAR-P5%&C)"$^)(B)\@]6+;E1=JKL&,CJ>?R/4CYYJ
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M,#<(@,"%5$A(50A)%5%145%5%ZD]?@OY"JIT;_;?\S7-?^U8.*'JG"J*J?\
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M8/0W1$A O<>B0G7$= G6G65 31%<$I4>L3YHP^ !/E]8\*B3D*/#O$(]X/\
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M*D4:32-#$ ^1%&S/*5*JD?KR,%5BHSQQ@'DA@F3T"EB0=Q\ ,?GX]=N;[.Q
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M,]/;2Q8*.!9-=#=7#3%)D$<67ED.N.LB;C+KKBDVXGN@@.H9-O(K)&32 *.
M0(97JU++&?PF[D'#N!IK!Q%<9BV<66E:^C:$J,)N"MJZ3:J9*X^ONN>"-QPD
M0NE*M$>F;Q>PD/U[Z/5X/*NWQ)2F5$O ^X?-4)05?H1\4)$-45%W)2LG694R
M:Z5*>-H1^93=(FT4=@5$&.V.PJ4AS=$5!'B!((HHJH=1^'/Y'^/UFE8/78]*
MR:2X]#!II@5\.27 CL\>6R&1&8_(@[(JH2"FVR;"B=32E3JL09CFE?!59TD
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M-.SIJ,[W#WKF1G%?*PVY*.1L22,LJ,Q(#+(%;UMT9("'<.? G#8VU+37 $B
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M(L5:J,D!8X/MRI!.<&\8F(CC0#!CD,BMGQ.WC'L*@YS60P*9))"21+$(BO@
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M* YPA0$)CGD $Y!R"22>2:JT 8 ;F!]<,1CUA(07\/5)(&",;1P/#$B  +8
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M / @_7]WUUX+_G@NO_@=O_\ FR?_ -/[OKJ?W4WJM_-"T]_K3R3_ +)=3_S
M:=_^X[W_ / @_7J?^>"Z_P#@<'_YLG_]/2]]K'VC?4GN'[D=#-";+M>P?&8&
MKVJ6%:>3,A@ZCWUC,I(V5WL.G>LXT!_&8S,QZ$$I7VX[LAEMT@0"=!%4DX?7
M_0G9:-HFK:LFO74[Z;I]W>K"]G"BRM;0O*(V<3$J'*[2P!(SD ]*Y'1_2C<Z
MIJNGZ<VCP0K>W<%LTJW<CF,32*A<(8%#%0<@%@#YUM=]>>J^Q5J6=Y_VC'5O
MMO[K-9NW'!="=+,MC:59Y?88-]D5YE$.3.*FEN1R<DMU\\&6' X(#QBTC2OJ
M:(#33:..:5JU^TEV;Q+>.%9WCLUB#M*T*MZD]PQ=HP'7HJ ,&Y8**XG3)-9D
MEU,ZM!96\"ZA-%I*6CR232Z=&<1W5\[NT:3S8RL,*^HI!D*L"E,^OOM5_=/C
MLDX\_M&T:16U1=TR7-T]UO\ QG&#6P5MU$1/ B6^RB6^R%QW:Y:L5?\ M;W<
MFT!O-]I&C3[3*$KJ+D^;L.(*?0D19KFXK]"5$)!5?Q1-UQR][L)A*"3(P)$9
MUQXD[9(SQY Y_*MFU:T68&^AN9[<<LEK=16LQQGU$>:SO(P6)'KLF$P<J^X%
M<+G_ &PON4@MN$79WHV1LJBN-EE.="I-^54@5)9*J^/ \5Y;ILJ_AKXU _\
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M9LO_ ,W-3_R\_P#RP?@OC_OMTI7TGVS7O!\;]HW;;]?_ -.:G;?A^*Y#]?\
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M=\YED$:F,.L9"$@[I-S* F!NZ YJL;^V ]UA[;]JW;PB+^5UJ1]/QVWOO/\
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M$5&9EC&YL%F'5B5 )/7) &!Y8P.M5C1460(H42N7<J.689 8MUZ*!P>@/MS
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ML%&2<#IS5* HJ[*BIOOX\?7^/U^B)LB?Y^J5-?0HJ#]/.^Z)YV\*B?Z-_/\
M'Z_3I2O=M40MTW55_#\/"JOY^?.^_P"/E?/TZ4K\M9A!"E& -^6$;3Y$1/F(
M 5=D0?/$_KY55%-_/5F)8@G;QC[BA1P,<C')\2?$\]<U(.,].F.?KK2<NN>\
M:G[8-IL \&Q003B(COQ1=MU4>1K]2)27RJKO!.3G 'L Q]>^H\/C_GX_P]W2
ML\JVR"-%1%\("+YVW^;==_PV3\4\>47\?KU%*OS0D9-@**O,Q3Z?XRELB(O\
M4V_R^.E*SN,W[;1!LJN;BB+]=D\"GY<45!V5?"_39?"[J5[_ #(FQ)L6VWT)
M%4ME3<E7RJ[IO]51-M]_/A2OQH53==]^**J((BI%O_C)R7;Z[;)Y3;?9-]EZ
M4K9H^R4WE92^I3KM<V\B)5UU=V8ZBR)LQWF(K'AZJZ,RI$ASD1GR:CM.O.HT
M"#[+"DC2*CA*) '/ 'UX#_*JA2">2<G@>7L ^OQIUWK94_:/:]_^I>I>9QM6
ML@N,L@Z7([889;8,YBMO6PM.:*O&+#B75#.LX;QQV(#;L\SF)%<8GJ5>\*M
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MXXH-#O8KOLAHEO8O%I79(07EQK$KPJM]<QZ7=6*VUG$CM.SRS7DEQ>2RI'&
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M=-OL6M8KB)&1L,\L<**CKO0@0M/-&I*^J7BEBR&0D=-L;0WUW8V:*C-<W5M
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M.4'%77!Y-FK[#A;D\:#GA@::*5X(9Y/LRAKB2*)Y(HU.0IE9 5A7((!<@9R
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M&Q1%7Y55!%%)5*SVDT7M[.M.ZF6 Q(1";K;7)>0,JIFCKI<T!2)45!;1=O\
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MQV-G58\U#*KKK6,K,JOC5K+L&SQAIAMAL'X=?8%,?@2E7DXK[PFB@8*UZ/\
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M22'#,K$JC%E!0\-D;]]K.D7-I/!;:1>VTT@41S2ZW=7:1D.K$M!+$J2;E!4
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M(>TO;A--TV[U'3YH);73(;RXU!XYPCV_V:)'C" ,#(LP>9'?#=WMQ@HSD/\
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M[MQF6S)X 1<B]EU=Q$D42$414+?;COYV/PJIR1!I@\@C!4,3RI V@LWK [<
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M:X^V)>Y[W'VG''$8;1PBX,@C;37ED $6A /B4C$,1*1W@1696 5]I VL4X8
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M<R#9/M.B_P"RLA'.K=F^R-_HFIQW@L.R%O&XD2YET^#5VOQ&ZDE+66]O)XH
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M-S5P+?XF/25E@XEF+)Q'@:L2)Y&VWH,)HYR.K\*RXZ:%J)?+:R13(8!(HE>
MRKM2R$HVM%;F50T,L:DHNPJ0AV9VHH7=DT'7(BBR:5J(+*&C+6LS]XK=&C=8
MPDJMC.^+*-U&.!4,&LVD&J-;"KJ<FK*^"Q8B!'N&)+\RM%TU:B$ W2$<60ZS
M(04?^&=FO,F3J219V-1UI+PW ,:/+<W*KF.<R,8HT'@\Q?O&E']S!8%< G(
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M$GXAN.KADP,&%*<G-S!,WV6HK<1\GG@]IM/?+@GSEXGCE:'8Z,3ZBS+LDVL
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M=>1QQ6; 04C4B12+]B*$9*2HB+QZQVHM8A';.KQ6"&,=S;JHV)#&\<2HA94
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M/JC)SR!CBI"J3N^'@.G3ISQX<U"'DNGM(RT_#AUT=?O)U#G+%9%Z<CDEY]'
MD*RV@M-\@!M 5SBWOL0J:HJ844HK2JS;F8Y&>.>#P "/G5F ;D_A@?6?K'-,
M^UKT0OI4>-)KX;K3:/-Q(ZBVA$#/N"T@,B#:(NSB @H2%X<#947][&22I4^)
M))\3GV_CTSFH&0,8]@\/GUQYG^?%-4O>U+,[R1(BO.2#A.FZ)HY'(4Y,JVC@
M<E1!5249"IQ^=%;1$\HO5%0("!G!.>>OEX8\JD'/X_@?+K^'\,L\U"TKS/3K
M([*#7F\+$5M38+VE(FXPH^*"3@[ I\(PFVBILB*AER$20LJ@X)'NZ>?NY\O
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M[AN XD+V?]K:9^.Y$:EM)7U[T6%*?]ZW7C.!T)'W@#P=I_NMY-SBJ9...H'
M8<$]<'H0#SG:,YZ8Y(B,S_U2</?B9&./8C@^48G9V\C(!QJXR*YI,BH[5V(L
M(UMJFS-ABT]J0"2DCQILN8V^)#))Y/;/K3M+)+.2X>.XO9A<-N9;N[DN54C@
M;$D]5,#@;>F,UQ5II$5I<RW4=U?/).Q>1)[I[F+G!*1I(!W:+C:F"2%]M0P:
MO][>HN99/?7%K=NLC-20L.+!D$<.) >,26"T7O>ZC"*7R"^?+W!4W/<<,B7<
MKE<>_P ?'S.?H]::].U2G3OAI,MP3-+:$3[C#B*8,O&@&!"I+LGO_MT/;='
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M>:9MK5E,EN-\>0BV33S:G&%!%QSVO;>D\")U20@:D/ T/LDCK3:J:@K8\K2
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M4IA6N>EL&R.;9_# 3;S<)'9'MB.ZNE*C$((I(A)\*@,_*/\ ];3=%(B7J02
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MMJ8.MJVH[.&2J4X=-6W**$V<V%)<K[NK-6C857H[CL=$%YM44D]MX'@YDV2
M8%R$@%LE7H!D@>)( ]Y.!^-*2G-=3(F7A"!M'G4<AQ1)40S4TCHK:@2(?..[
M&$8XN*GNDK9NK^ZNZ[%N;2-YQ=I*X,:B-8I%4B02*6R2X()0$9\C@9;BA'AR
M#R/X#'QS6T+]E&N;F+JAWH,5E!]_SZ[ M$F666[)BO\ ?K9F<99&F24DS#*.
M+M;7'(FI$V0IAP%BJ\P[*;<2UU);R.@M[8V\8WON+O(S]\1*8R7&,6Q8PKM.
M"$]4E<$U"D*V6+9\\>1Z>7Y>?MUYO6<<GV7JC]\=#!$WY,_7&_CQXXDNQFE?
M6NH*KY7]P3V$0^8D%$V543K6;J?>?SJ5Z#W#\JAJ;8OH=O8#738Y*DB-&=:D
M/*@MOS7E]EE =^1514XH2$B\3^7?Z+%32D9'I#JQ(*+95V(Y.2N@C2&S!DG%
M<101T21]L%;3Y"3]XMCW3;;I2O+'M'=<;B6$)FKL8K@[J*RWG&4;3CXW5>7C
MDB 7)$425-T12'=2LGDZ0ZI5#\6/,?EP[$W5"4(@4N.V8F0<P=;(A=3;B? =
MB4%55!%3I2LTA:$ZJSG!%<OIA%QL#<:.')"0(>%W1J1"X$2+OMQ<0#4?E)5\
M"I2EXUHSE>!/I<2K@KMM5$)40H30MJA()DX+$=_D2M^/!%\J>2'\%4I=4:QN
MXA-MJVT^ZK*>\RK#L=1^G@E4Q#9"4D1%,%!.2HBKYZ4KRIH;%0+S3L%EIMQS
MWX\N*\O)HD44%'FR%T"!6^2;@!<MMQ/?9>G)SDECT)/)]WX_C2G>:19C6 ;(
MR>,:5%?;=C3HZ$ZZ#[9_LSVXKX%M/F;-G9$\\?E':8SW;H^-^S.%<DK@@\8R
M./'KG('/7)CTPHZ^'''/MQ]8J:W1/5/35^-"9N@CK/L8Z.2YO)OV'%.,X+DD
M'S5":,D<V]@Q0FU474#B@(%LLV[<S !!M#^OD;_NQ;LB- ,G"D' /F<P .#@
M#X>?P%.@Q2STDCU3D2NNX4.YC/H<2QD>T*RXY(+H0T<;>DBA-;F1DRH/#[AK
MR01#W+*B[BIE1T9,J"TJQK)D^J1&RYD^Z">F"HQUS-7&N_0[,[QIJ3<U\-([
MT:,EM"D,S?=9 U5U)#((_P#*RZ3X*X0&;3Y%[;(@2,J<.BK&W!XD:,YW(Q&W
MKTQQQR3G.36,LB2+N)!DR!T_NC/''YFI=>TC"['3N^EY/!;8S)O]",@?HV,7
MG07V+R.[*KY,=F X[+$&99OQ7HCK+HQA;<.*C[(N"Y(<3/&PC[L$%(U5Q@<N
M  3YDYSD\>X5D'AG@G&?#&?9GI]9K10^T@3#:]7WN3V,F_\ Q>T/7@1"G%2T
M4P1%14W5-_F5-T545=]MT\]8SU^"_D*JO(SYD_F:U\(H[M-KQ7<1%45$7SR;
M'??SLO\ F\=15JN<=51=E3;^E//_ -'ZK^'^?I2KPCA<1 T$04N7/SR_)?"^
M.**J[^?"^5_+I2J2=$1]I>)B0HBJ*CY\KMMR\+X3Q^7GI2LOTTMHT:P*!+5"
M0T0#CR!3VR!5#]JPZB(0D/S;AX0EXJB(2\E?7U]?.E//Q33"LRL =H9_PME(
M15CM2%92+/,!(GZ\212=&<P/MFF[9HZV\#J**JB*^OX_7LI2[:>Z,Y:R\:+(
MF@VWNA1W45IU@^2(J""*0;-JB;-DZ7/=%! \KUGCE[L8 !)/.0<CW'W<^/-5
M(!Z^[Z]V3[.3FIQ>PGMBB2+G].\D5)+K A6P$D.D!"_*8$G_ &!%P%4B: @<
M>02>%MQP 5%5"Z"YN% AB(,;,6;(.X$D9(P1Q\#TY)SBH"#V_''CX\>/UY5/
MABEI75U<W62JUY@W5*&(&)2/;;:4_:>.0"N"#0LMBRB;MJIJC:I[O%HKSQQJ
MV=SF,J/6)4G=CUEZ8QY>SJ?.04!V[O7ZXR,\^8\3Y'Z*$:A1&"G3G%!H8[SC
M\4DCH^\@QT?5&GWU5L!8;/;9S;D 2#!L7G&U1PM9E*X]H##/D>15J97F\]J*
MPCLE?=:)) ;(+J-H+(NQE;,C 3;7VQ:'B0JID3;C9$*H112HV]?-2;#&:>PF
MLO.OPGF2D-F\*?['1ODZD<V7.*M\%%M2%.2@J'LXJ&B)L6]N9B0#@#/D#GKX
M_C[ZH201CI\\9&><D$'KU(&/<:B+U0D+:50V\\@9M;IUZ/ ]XT&/"B2N,C<W
M# N#;Z (L\0+]HK:$JJ2KUCD1XR4+$#.1@XZ>?AGSXP1CKC-%YY\L#()Y]_C
M\\=?'J>B[Z(39->E5V:M$FQ-Z>WX$GY*.HV:(J?PV5-MOHGT3QUC^)/M/6KU
MR_\ OV_:=\'=XA*J(/=5W&?Q1-]7,I1-MD^OA?Z?]*610Q8%U3",W/F.GCTI
M36P%5+\$1$_SI^&^^WG?Z_1?X=5I50V\O+824$WV55WV\+]=D55_CX0EW\(B
M^-U*N;;H(B>Z0EQ) 1UDT/?;9?W5XDB*/T511$W5$\IQZ4KU?L6U;X-@O-"1
M!<)=U%43?=$153YO&^Z>?K_'I3J0,@9SR>@P"23XXP/"O W?;1!('/B3%%(G
M$X["X(D.P*FZB8DABJHFZ$AHFVRJ^O.JHP=0RL&!Z, 0#SC@'GYU4,HJ I.I
MXVV!37YE#943QOL.R+Q3=$\[+]%\JM6+9#?O0'/A(#B [L).N["9-ION(#R1
M415^I%]=OINN_2E);DF5V4C_ &'\0I/& ^ZX@\0: E5$)>*JG,EV79 V%%1=
MN7'92E"TUJ)ZOQ9#+T=YXU$VWD*49;%L2B8FVR!)XX$?-%3Q\Z+L72E2::9*
M+E<S%LZTVWS%#&5 C D1Q..PN.^^XX.XIY<5HR$PVX@2+MU8 ;&;/(* #SW$
MY_(?/FE/BT^EQ\>^%)B.VTVB?+( VD]Q51=EW1":).*[;EP)%1!7=$7>#P2/
M(FH/0XY/AU&/#^?3'L\ZD\T)RIZQ:"*LE]08C-N&AR'ME;0]U$P8;#;W$- ;
M3ELH\D%>((@X]B*S2!0&8 ,W/., >SH .!X4SSCP\_<<$>WW^[XR^]E,QE_N
M T@*M5@Y)Y!:&<5Y^8TI(QAM\!."+XN*K,=MQA2^'!QD93B(Z;3[Y&.Q(DXC
M20QYCVX$@/"X\''7/NQQX>-36Q5C[MR]35SV11($"]=AQCMH57+=GUT6P)AM
M93$*:_'B/28S;RF++SL9@W 02)L2543%3C)QT!Q]<"N=9Z\/^%-[F/\ >Z2_
MZE=/.O:_HC_L!H?OU'_S.\KR]Z1?[7ZK[K+_ (&VIG78QIYA6JW=!IS@.=X5
M.U*K;^-FX46F\&SMJ,=0\_K\ RBUTUP:SOJ(F[:@H<KSZ#CE'?WD21#^Z*>=
M-GR+"NB,2)\;LO:V\NM/T"]N[2Z2Q>%K7OKYTCE^Q6;WEO'?74<4H,<TT%FT
MTL,3*PDD14".Q5&X;LU:VU[K-M:W4#722I<B.U5G3[3<K;2O:V[R1X>..:X6
M..212NQ6+%D +!Y_<KH[K!BVC.H%KDOH\U/;?35D6 EAK;$:[F3+ Q*_JXH3
MF9.:ZI9#AK@V<AQJA%VSJYT9T+7E$0)117V^K:'J6FW&J64<'I)DUR61G[O2
MV;0_^E_L9&*E;:PANAL4&8".16!BP_J[E//:O9WD6GW32]AH]*1%3=J*_P!8
MG[/^U0;@9KAX2')[O)5AZXQ@D$-;],W_  A?97_RF-'O^FU1UV/MS_8WM3_N
M'5/^#EKA.R?]I]!_WK9?^.E=0;KP37K>N0UZP3W_ .%*[]VD\J7=+J@*(NRH
M2CE;R\=E\^=D3Z[;*NZ;?5UZ<TI@CC*" *B[J:"HIOMX\;J0[JH;*O%/HBH*
M*J^4Z4KV1H'41IWRT:<5540D0O\ *BIX3?;POT3Q^"J5C,V$ZPIB($7S*IQU
M38"0EW0VB$QXJFRJJ#^.Z)Y\(I6!2H,@W93L0R"0XBB39+L0GQV4A+?YE,4\
MHXB$OGR2;=*5B9.V%>G!U#!>9 ^A^1W3?=5+Z;*J*BHB[*B_5.""JE7.-:*I
MJXCA(* U_C>%12'W&U3PB#N JJ<5W)%5-U5552LNA6PI&<:4.)+NZA@.R$!\
M5XF2+R$@=\HJ_+LJ;\5VZ4K.,7R@F59<Y&AB@*_LJ(CB"B"3A"G!$='BCJ."
M2."2(NZBO(5*7J'=M6E?)9<;AN6+48W_ (@@ '947F@MRC(E<;-U"(!1UM$?
M!S\ <-%%@GD \=?9[Z5:CRB(,"&MDZLF&P^TA!'EHW;5!M<08D0Y2(0%'51>
M9?CO"8&:%(!L3D$:A\_=2D<RR]^.LK0H+SMLV+XFR^: DA\"%UTS?;%Q4)U%
M;%#-M34N3A<E0 15*3VO?W?(FD<;<+94%I>#(-IN2>7.*J7-.2\4%179-C\=
M*5OX>M\[Q^SI>G4X:C\TOLL551/E52[8L]5=MU7_ "*JKY^F^_5T4,&RVW !
M!(SSG'0'X^?AXFHXW+DX&#_#V9_/IG'%:*\39SX@A15Y/NKOY5$%'%7?\D1$
M7YOKLNR)]5ZJI3#@DEL)L(P,_P"L6'4 CIT^-3XD>(ZCR\O/CR^LU+!DVO)-
M]^7S)^*^414_Z_&_Y_3J*5<Q=0OD-$/W$XJAH)"GE%7]Y-MT5$7=-_&XJJ(J
M]*5B5[2S# RK'%:)Q2]QLE5&R\*J(A;^VV*KNNPB/U1$5$^JE86-I;P_V=TR
MZK;.R-3."NMMA\HD/A5%%';9#$1)1V3?PJI.#C.#CS\*5D4*V:DQG9%=,'>.
MV)DP/(G30B$E1$(5%!1%7;ZHI(G$45-BBE934W+IDW\5)=;%=^**#(*XA(J*
MAD3:._*J[H@DNVWRJ*;HJE9!9WSRK&%EP6G8NS;4HE5OV@V+]DX;?$76C4DY
MFXRX0H1*1%TI5EB^^3J27IS/$%<+A[INHC:DA :$V"[)R,D1.2KL)J8BG'DH
MO+;3ZJXSNZ\\\8^ \?&JU+AV/8L2FW"'VW&WA?Y(V8'R44;3954U)' 10!.:
M(B%Q06R);G9L4#/>?WL],<]!X<_76GU]?7^"QNYC)M<>,11EY:^2DF0D4@:E
MQ/;5"^)1OY$=0F=Q,T!4,"V?! %5&G0@^1!\^0<]/KX4I-[2Z8*2_-JY++L,
MG&'W8P_(ON[ ,E$%%)67#5.:*AB)$0H";BHCE5HR)%E16[S&#@A@PZ!2.@SU
MX)Y.#4;@6*X.0,DXXQQQ[QU]U;D/V15QAS57O+%I#<$--](5"0:D+B@YDF9D
MC#H(XK:JVJ$H&@<U%50BX<!2C&7"*Y;:H;:K# !.W.W@'G SDG@?&I/W6^O
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MLZI<=;G/ ^K;J@AHV#K8J)(B\7H:.@0<E+8E45(-U41'=.E*NL75J%\0UQG
M#9BJ/,A),E%5W E4#3QS55^4T'Z(*)^*J57SLXJGT67'B1'GW$Y^Z2B/[395
M(49) ;3ELJJHINGU5-T1.E*JJ+-&I!*DR$,=DE51)DI!>4\(?LMD:*J)Y4D7
M<?/E$\=*4IF/6U38OMLQK@)[_N"(18I-1B%SR*#(<<",]R14397"7<15!5$5
M252G<8#(S>(]&%QE8D,>+3#C\>4XGMEX144'5;,Q\\24C(U%5547;J"<#/UU
MJ.,CG'NQSX^7QXIQ#627%:["&==R8L='%5"<KYB1V_>^5UX"5@FN1-D*(1.$
M:CN)%X54V1O%OG>>Z$FXQCHS84'/&>1M!QY<#QK&L,0E:X[M>_>(0F7D,(E+
M,J#I@!G8CVG..F')Z:Y'1,O-O.Y/,-'E;XK' GE!'40O?,W'X8@VIM-(@_M.
M/,1^7<UZF.0YF92D2LRL8U_O $D!<@\@\\\>')(%"8W;83R@R1TQGV].F>!R
M,'..*V$/2KR:NM-3+"JKKX[)8>"77Q48R+=SX:QQYJ+, &S;C #2/R&7.#<O
MD[)'VGH_"0#\RRO)%F4$N\[SAAP LNYMA&!SSS@8\C15Q(2.!L"@8_U> <Y]
M_P!<#3$^TH2>'K#]RP%_BT&AB?Q\Z)X"6Z_CXW7?^C^'G6/7X+^0K(O3XG\S
M4",922.RNWU::^N^W[B>$^G^;\]^HJ:K&B52WV3PO^3^/X_Q_P#I_@I5>ZX1
M((J #P0DY"&Q&A[+\Y?4D'_$3P@[KX\]*5XFXYP5!+;Q]$_'S]%W7S]?'X[]
M*44?,+9MT6) N BJIQE$G4WV5=A55Y_@I B(I"JCX545%*>QHMGPQ77*V<LD
M) &#C+#@N,A8MM_(GPZ&F[$Z.J$XQQ4T>$B90_W!)2I6])LI@6?P;LB4S)A.
M "M31\N./"0(D.R\HC#Y#NB%P!2,5'Y$_>J5R<[F'L!'Q\/'CZZ03TZ?/'^?
M\R*E1T<RN5BK=7'J'"%E7VYL?B>PFCS;C9MF>Q(TNRDO >*-JRI(I<UX[%OP
MS#KQX]>/'V^'@>F,T!S]9_&I.M/+8,J=;.;+>C39$!AV,V\\V@$ZR+SPLQP1
M%?5#!Q9#ZH3B/O*(M*!DV'6.8AH%3)SW[$$'G[QX/B !QP/;6%K=6F[XNX;
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M\*N!DT1" B6ZM"KJ$J*//D2;BGU05;4$)%\^XA?5$3:I&"1Y&K9/B<CP'/\
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M(^\ ;J)"*JC9BGRDJ$B*BHJHF^Z*J=64@')7<-C+@]-S9P_GE<C'/A\X))&
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M$:D6VR$A\=BV4%5%+J<>P^_P_P *C#[L@ILQC;QWF[S'.=O3PQU')Y">O.*
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MTY?K'62CI2CI2H$_4EU_UFPOO:T6T>Q+6'NMT[TWR#MMS#/[JF[1](,?UEU
MLLNJ=0XE)7V-AC=MB>3R8V.M54I^-8V;(,L19:5;)*CDS<]ZV1#"[E(6;O54
M&9RB@%2< AEYR!]=-"XD<7$:!Y50Q,Q$,8D8L' !(*.0,9&0.#U\,H7I%WQ=
MSF2Z.=FLNUUJN[>[O_5@#MHR^9?8MBV)ZLW>A\>)DC]7ANOF$0*PJ["M1)S#
M$:==U=2S"G,5_P!SNE-<DO2GGKO!&'FP@ %KWBX)*!^,M&Q)++Y$D^/A6-)Y
M62#+G)NS$V5"R&,!L+(H V.1@G !Z<"I/^^G634W2[6GT[<:P'+9^-T>K_=M
M!P#4FNAL5[S65X>[@^1V;E'..;#E/,1BGPXTE78#D25S9%$?0%(5UX$5DN2P
M!*0[E/DVY1D? FMJ=W22V"M@23;7''*[&..1QR >,'X9IX^D&;ZAYU5YA-U'
MTBL='9]%J/F.)XW5665TF7.9CA5#.;C8UJ3&E4333-1"S.*9SHV.SD.UJ ;5
MF<X;A"O6%U52NUPX*J20"NUB.5(/4J>,]#X5F1F8'<A0AF !(;(!X8$$\,.<
M'D=",U'%VT:[]WF5^I7KYH]W"IBF&X)4=M&*ZD::Z087;-9/ QF!::IVN,UU
M]E&5.4U;(M<[NZZLDRKAFM=/'JV%+KJV$VY)A293N>1(A;1O'N+&1E9V& <*
M#A1DX )\1D]3X5KQR3&YD23:$$2LB+SC+L-S$@98@9P#M ..2"3]>K?KMW>:
M$Z1T&4]O7Z*85@,+,]*6=3=6)]LU,SIM,KU<Q+"X>!8%A\BGL*Y'+9NY2?DN
M57<EN/%H EU=1'6WE-RHTVL<4C,),EMKE%QZOJHS%F.0>,8 &<GD\#!B\DFC
M0-%M50R!W)RWK2*H55((YSEF., 8')R,K[K_ %([[M6UUIM ;+MCS+4#*]7*
MW%D[7+#%<OC!2ZVY?9Y/4XYF&$7,V3BQMZ8VN",6GZ2V$R8>45\S' CS2=KW
MYS$5*Q6XE0R=XJJF>]W#E%P2K#GUMQ]4#@[O,9-6FN>YD6,QLS28$6T\.V0&
M4G'J[ =Q)R-OMXK"M<M>>\C&/48['M,+"-AFFW;3JAE>I^/2:O'LA3+<OU:N
M,:T#F9K;R\E=F8W7M8QB&*93)8JL7AP'8M[>S:F=>W#<:OEUE:Q9$A-O.WK-
M(H4\C 3,F!C!.25!)\!D >-5DDF%S GJK$S.#@Y9\1D\C&% ;&.<GK31LO[Q
M.[:#K+F?<#3ZR/-Z48;ZHT#T](_;([B6)?H;:8$=95T,O/)&3.5GZ:_IW(RR
MU#(([K=R,&-#96(K#E<2P4R"*+8$*99K4W'>;CN#9)VX^Z%P-IXSSY\UB,TN
M]I-YV+="W$>!M*D!2Q.-P;<0>N,<8R34@GIBV7=K.TUU';[NHFHHYNSF=,]$
ML-08KM6+UA+PVD+-JK$:F7!8?;Q2ER]JR;KK:KFSL+N5EN.X2$*GC_#K@N1%
MN7NMNW;T4Y_O'!)'&2N,CJ/[V36S;F4JW>AMV1U!'.T;L9 . V<'H>HP*DTZ
MUZV*.E*.E*.E*U+.X;O+[I*'4GU"K>B[A>]^DL- -;,]Q[1_'=(>W;"=2.W*
MDI\>QZBMZ>MU7SVUPJ9^C4)FQG2BR%;"\1ZOQ@HULK<DG 9?Y6.&(I;@QP$2
MH"Q>1DESN()10PSQC''+9'LKB9)I@]R1+.#'(PC5(E>+ 0$;V*$#G.[+#"X.
M/$RN]M_<KJ[J9W\XU@%_J+29)IQ?^F5H[KO)H\)<KIVGDW57*=11JL@S3$[8
M8BVDJKL(9.PZQ'+ XBUJ,'\*+^[BZLD:+ 6"D,+F1,MG=M"@A2.F1U/'4UMQ
MRL]QM+ H;:.3"X*[F8@L#C)! \^GA5VU#[BM>\2]3#5+2C!JZZU6Q#%?30#7
M+$.WZ#;8[C#.8ZPM]P$S%8ST3*[>O=^Y[2XH6FJ$95C+=IHK1)(<A>Z*NK"Q
MQFV1V(5C<;&D()VH4SR >0#SP,\<=:-+(+J1%!=5MN\6,$ L^_'!/0D  9./
M8.M/EU-/7K,>W2]>T?3%=)NX7)]/(+^-!J+(7(,9TWS6X@0GK!B^E4M9:,79
MXF<BP89D1JJ966-E!C.O1'*UYUM<"[!(-^7C#<[<@LH/AG!&?;@BMA]YC.PA
M)"O!;D*?;C.<?*F >FSJ7K[F&KG=%A^2=P-UW9=N^FSNGV/8+W!9%A^*XP-U
MK-\#9GK-AV"VN'5E349IA&*SAK&4MQC/M5M@\%5!L+!H9$IW8N%C"1,(Q%(V
MXM&&) 3C8S!B2K-SQG..2!D5K6S2%Y5:0S1KM"RE54F3GO%!4 ,J\<@<'(R:
M2'6C/.^'3?O?TFQBD[GJG.LHU:[D(JTW9Y@V%4%K@V&=BL*(K&1ZIZK9+-Q>
M%FF*9G!F1Y8A>'>O5%K?$S68T_9M!+JZ^R+"T+DQ%0L?,K,0S3^"H,E2/9C.
M.3@\FLC3K,@$H8O*,0JH*B#'+.<;PP.3G.TG 'L<)IYZDV5YYW;/=E!]K>5T
M6MN*YEEO\JAR\Z9?P+!]#J.LH;'%]<J[+?T+C'EL#44\A@UF,8@S44]BS:JL
M6XM*\"%Y:-;A8N^[U2A5=@QZS.2<H1G@K@EFR1Y9K(MR6F,'=,'!;<<^JJ#&
MV0-CD.2 !P<YST)IOV(]WW>1A_<9ZAC_ ' P<.HJK0OLRJM>]*]#,/M1RF@Q
M1(YZAS*W]),M6HJ)V0YA?LXY'<RAZO<2ABM/1X%.(C#*0Y<PPF.WV$DR3%'D
M;U2?N9P#G"C)QD9SUS6(33":X$FT".W$B(IR!R_); )9MHS_ '0.,=335L:[
M@O41C4U;IG5ZYY3KMGO<YV!Z0]YN//Q,$Q:JRS2>XNM9L I]6,5TVAX-4U5E
M;T;>E>3WCF/02"7DYW%.RN-O1+=]L7LK1V^2VP1K%.\!]8D. C;6<L2 =X&3
MP,'GCIC22XPJ]X9&EMTF'J@=W^T4.%"@$C:QP#ELCDFI\>T67J?-[:]'I&LT
M/)X6IJXA&9RQO-#$LK?EQ9<N+$L;]M8-=)B65M5LP;617640+JK*9]W7KLJX
MBSI3VC*%$CA,;<\8Z8\@<G.#QD'!\.*WXMW=KOSNQSNZ]3R>!U'./#I3C>L=
M9*.E*.E*.E*U'NX?/^X*YUR]3"WQBP]3'*;/1?4RYB:4VW;3JW#J]!M+$KM+
MZ'(H,74#$+:X=LY%= MG'+ZWKL;QZ:W)Q\WVFFTEND3?*QK$([;=]F D7+B5
M"9&]<@[6 P"1P"2,$9]IXF1Y"]V0+EC&^$,3@(N(U8!E+9."22-IR. ? 23]
MC>ONH6KG>Q51KG6>;JEB%SZ7W;3J1)>IY=Q7Z>7VI5WF-A79AJ!28;/8K&*2
MUO)<>2Q*)ZBJK5AAM*V9$AK&6&SKSQJD.0@0_:95YP6"@>JI89R ,=#@G)%9
MX)&>XP9"Z_98VXR%+%N6 (&"?'QP!FLRS#57N#K_ %2^X# =)YCV;NT/IPXG
MGFG6C.79K:8_I?8ZG2-<)=0-O.;;*3 I;"?6"E;,R!BO*<L( C&X3.PI4)']
MEC9O5S<LK.%!8+L4X'3//.,U<O)]KE5/6Q;(RHS$(7,CC).#C(&"<'CPJ0O6
M2)F61]N^3UK^K%7VS9YD.#P8$[56/]TW=?I=D=LU!8M9M2[D,^DJYQQ);\NL
MI9\V="5)#T.>TBR0:9+77 <':9%#9V\@L!YXR1QUQFMEP2A&_NV(QOX.TGRR
M0#[,_CTJ.STPLIU5H=:.]CMXU4U(UGOXNEF5Z7W.D^!]R600LXUOJ,#R?%IZ
M6NH%IGM(R[C=SAFHN3079F)4%;<V<[#F:Z3 NX]5-FBU*V+E5*0R(J#>K!VC
M&U"P/W0O!#*#AC@!N",CDZUJSB2>-V<[&0HLAW.$*\L6\59@=HR2,$$#I4<F
MO'<3WH: ]X+^:9M<=W-??SO4&Q'2W#,=<JF3['LK[.,_G,4>)TU:^W%^[)NK
M\]'GI3CD>0[D\.5'DRY8L/0)9,;$<4,D051%@0,['/[<3*,GV[!Y'CD>RM:2
M6:.4EN^S]I1%7'[ P.P4=."YSG_6!\Q4D^C7J(:[ZE][MYV)W&AV"T&H>D]_
MF^0ZVYO&S=Z9AS.A\*!BTO3'*]/*]5^_[7,\YD97 BW.,V[,=C#V?;FRY<[W
M7XL+7>W18!.)"0X4(NWUM^2'#'H%7'!&=W3 K92Y=K@V_=@%"Q=MW'=X!0J.
MI9B<$' 7GD\9;?CVOW>?I+K9ZJMWKAJ+CV59KHYV889K%ISI]@"7SFC^F=J_
M1ZH6]/5XS59&HRKN:Q]U5LC*,HLJZ'/R28#K3L9FKBU\5C(8X7CM=BD!YC&S
M,1O<94$G'3))"CG''4Y)Q+).DEWWC!BD"R*J@[%.'( R<MT!8G&23@8P WW!
MY'>4^T[V^:9]Q.MFM>2]S'INZ ]Y5@>;YM%LLGQ[/K?6C!8NK5)I5?%:8-^B
ME#FNFUIE%-CN,AF.-Q0G-1&(N44;SJ7$.["'_2-&D8CN9(?5! *[&*;AALE6
M )."2,\'@553-GNUD>0R6R3<D<-O7>%P5QO4G R!GH1R:V">T:BU*QCMKT>Q
MW5^#/K=1*3$(]9D,*VO)627+/P<N6S4_?EQ,R?-GI-\Y1A6.WC29CE4>#;.3
M*^)D-Q$BL3Y&C*5,CE""I/! P.G.  O&<X]49'.!TK?B#"- P(8#D$Y/LR26
MYQC/K'RR:<;UCK)1TI1TI1TI1TI6H!KSJ1W%3,T]2O-\5N/4PO,@T3[A]7*O
M3#--"M68D7MDTGJ,4Q_';ZO@ZAX99VLV\DU>,.2YU]D=;CV-38;F)R(;,<6W
MTDNL\M&L6VV!%J \:EED0]ZY+,/58# R  "6SN]F >'=Y2UT5^U$QRN$:-E[
MI %4@,K-E@#RP5#Q@#)J6#M1UUSO4[U"J^ME:OS]1M/K_P!+[0'51E*:;<0-
M.<BSG(\X1B[U(H<-FA!CTLW(FR=V5^H@6T2O=;K)C,<F#C-ZLL:K;Y"!6%U(
MF2!N"A00I;DD#W]:W(I"]P1O+*;6)QUVDL[!F /G@9]F*R#^5/7YGU*N]G!]
M-)TC.Y.']EVCN6Z4Z0YAF5I2Z:.:B6>07C)2'1$I,''7;M66(MM=Q(/Q9QP'
MW2<$!1(V1_9H&8;<S2*[J 6V@+CR)QS@$_$<4WR?:IU3UMMO&R(Q(3>6?J0#
MC..3@G'A3SNY?NCJ.TKM<O>X'6&O@0KK'\:QYE[$:ZWCI!M-4,F&#55.%UM_
M8%%B-5LG+)P07<AGDQ$KZ-F7>S>$:(\B88XC+((TR02><<A1DDD#/( S@9YX
M%9Y91%$9'P, <9X+'@+DX&"3C)P .3BH7.S'OG[AJ/MO]0756=J=I5W;ZS:'
M=P5GJ7DF&PM6&'L4:T,#"\.L\Q31:=#L+.+6X3CLA,H9P&6D?]&\@DX]8Q (
M[B8:#N301]Y;H%>))$"ABG/>%V"[\X.3QN\1G.,5I03R]W<-O29HY"Q ?CN]
MB,VP@D87+;3T;&,@YP[ZD[M.Z_O*[%]7>XKMSK=,]"J2_OM0FM(\LS6;:91G
M$#0K!Z;*8]_J++Q^B<D4D#5JROJ=NOQ3$9EA]RT2))N+BTL!:A1I6(PQPSI'
M)N<C;O5< %V(PN3D[<'D@$GH .M9A-+/;O)%MC!W;&;)8(H.7*\>L2,*I.!U
M)\*:MCFHFMNO.D7HR=O,_7_6;3V#W0Z-ZJY[K+JM@.9/T^K>566DFD-?D^.U
MWZ>SV;.S;&??6BV>0;JX_;Q8*,R3)L2),K)'&]Y((T;NG541AE%WO@G;TZ#"
M^ )X'2L*/))'8H9'7O8V>1PV'8I&"!NZ\DY8CG YR#BOSL<R#ON[D,C[%.XW
M(KK*\^TSJ,/M,$S/(&<H6BQ:59X)J)K[@N?9MG=-6ZC8J=QD&78FWI7*Q\BT
MUU,K[^^JI/Q,C"TA.VTV)Q!'W\8 5BP8 C) 94957U6P%.[/K(0"!ELX%H#/
M+W$A)9<;6()491Y%9B RYW#;C"N"<_= S6R!UQ]<A1TI1TI1TI1TI1TI7.3]
M>'_"F]S'^]TE_P!2NGG7MCT1_P!@-#]^H_\ F=Y7E[TB_P!K]5]UE_P-M3%>
MT/62O[?NXG3?5ZRN\LQJ-ALZWECD6#8K@6;Y712YV/6]3 MJ;%-367<*NY,"
M;/CR3AW!PS5AMURMLZNU"%81NU]I=,?6-%O=-2*WG:Z2->YN[B\M;>54FCE:
M*2XL2+J,2*A7,>[D@/')'O0]?T*_33-5M+UY)HE@9SWMO#;W$T9:)T5TANAW
M$A4L#M<J2,['1]K"?B8YZD>=Z.W6K7:IJ#V_ZU:)9Y<5K=A09MV4Z$]N6>9A
M=),^+JHLO$M4M)X&FVJ%S&EB#T$-.-3]1Y+UGL%>S]XD#"_'U'8FTU*+3NT%
MIK&EZI:1.8YK7M1JVM6EM%L"R,MS8:@]]I\3)D.;ZQL55,[SL4FOI#2]J9[*
M2]T:XTR_L)Y$#1SZ%8Z9<S2;MR*T-Y:I:W<@8;@MI=W;;ONC<0#$_P!EMAGE
MIZKO;3-U1Q\,4U&=[P=-0S;&6\.K=/4H<ECZ@5<:VJ2P>GJZ.KQ9R!+9<CNT
ML*HKF(+K9M)$:45'KZ)VF2SC]'NNK83_ &BR'9F_-K.;E[SOH&L9#%)]KDDE
MDN-ZD,)7D<N"#N-=,T)[F3MGI37<0@NCKEJ;B(0K;".7[0@D3[.J(L)# @QA
M$VG*X&..E]UX8KU90OE%3\^E*ACKO1CP9O3H-";[NY[LLC[;7<ID9/<=OSV0
MZ:U. WR2LV=U#ETEE)I=-H.4K33,L=6SE,Q[]B43B(3$J.\#+S.X;QMW>"*(
M2XP),.6'J[<C+E<X]F/96E]B4KW9FE,623%ZFTY8L02$W8)/^M2H/>F1+H]3
M]9M2M(>]'NHT*#7+4"1J1F&&:;2M)6\6'(7JZ%4@4%O)-,;^T"/'KJ^+$9!^
MR>-&FTY&1;DM?M.517ABD[M=JLV_.,D_W7 ZDGI5S;8>1TGEC[QM[!>[QNP!
MGUD)Z =2:5ZL[$Z3&I/<+:8/KCK9@.0]R&N&&:XYCDV(76/5-Y5VF(QJ6"_B
M='+;QU>&)93 I1@Y'$L G3I42=-98G1A,.%._)[L,B,(T:-00Q!#%CD^M]X%
ML@],CI5A;A>\*NZF619&((SE=HV]/NL% ;QY.",UD??!V:4/?)I15:/99JKJ
M?I?BT+,:?,K0],)F.PYF3R: ))T]1D/Z14-_%FT<&S>CW@5_PP-NV];62WE<
M6$R*1#,8'WA5<[2N'S@9ZD8((.,C.?$U:>$3IL+N@W!B4(!.WD Y##&<'&/"
ML=TN[)[W3^BPC&\D[N>Z/6"GQ3-\MRF[A:GYC07$?47',KP:/A"Z7YRS"QFO
M:LM/:/V7<DI:>,,1^-D$R5)<ENQS&.,O,&+$0Q(2 !M!&T@YW+ECACT)\JA(
M"H4&:5P"2=Y4[@1C:<*!M'48 .>2>N4F+TB.T#'=8(6MVC>'1-!<UI-+<LT]
MQ5S3#'L1@P<3R3*)&[6L%'&MJ&T5K4['*YR93T%I(.161H$Z0,BJE.*)C;[7
M,4V.Q=2P9@Q/K ?W#@CU3QGQX&"*I]C@#]XBB-@C*-BJ,%O[XR#ZPY /3!.0
M<U[8!Z4';QI&YVKWFDM[GFGVH7:U:7DV'J92RL?>R_6"OS,Y+^H-!K+(G4,B
M'E=5FDR7*E3$CQ:V73*^36.RJIH6A:EKN1N]#A667&4.=J;<;2G/JE0,#J/,
M&BVD:=T4+*T6[#C&Y]W+"3C#!B<D8ZXP1BG/2>T[3NQ[B-3^XJXG7EQ<:M:!
MTO;ME>%SCKEPYW"*B\O;MQ]EIJ U<):6BY!-@3S=M7(:PA:1B*R\AO%B[UN[
M2,  (YD##[V2 .><8&,CBLG<KWKRDDEXQ&5/W=H)/'&<G.#SX#&*1KM/].32
MCM+SQ[4+'M0]8=3;NITS8T2TS:U8R>IOX6D6C$;(1RAG3G!VJK'Z-P:K[W9A
MN'/NW;>V6+7PX;<UI@7QD7EN'E7:51<L7<J""[D8W-R1GKTP.>E5AMEA;<&=
M\+W:;R#W:9SM7 !QTR3EC@#.!4@_6O6Q1TI1TI1TI3".Y'L3:U\UQPKN%QGN
M+US[?-2L(TTN=*(=MH](P)E+'$K[(V<GLHUB.9X5EBDX_9182JL98X<(;*<>
M7,CSQS]VC1F..168/A]W# $ C:R^!-:\EN))!*))(W5#'E-GW20Q^\K<Y ^7
MORA%CZ0FD\C3*@PVKUX[A*?4*K[G%[N[C7X;W"[35G*M:TH9^/,WUM)M<*EX
MO'B0X<UMR% K<;A@S(AM.N./&]*)_)]K;<6,<94Q=R(\-L"9S@88-U\<^-4^
MQIM [R7>)>^,F5+L^W:"<KMX&!@*.E*E7>GD4Z^T6R75;NJ[B]<KK0C6^LUQ
MP:;J1*TU-QBWKL9M,9+&9/Z-:?X^)8U-9M7;"4VTC=G\>RRK-BTPALG7[1@.
M$BCC$B%&V[^F0<^LQYR,>6/#QJWV;)C9YI)#')WB[MG7:5V^JB^K@D^>?''%
M/&TDTTL],*S+:ZTU.U#U2<RC43+\[BV6H]K$MI^+0,IFMRXN!8V[#@P B85B
MH-K#QJN>"1)AQ7#!Z7()4),+L&((54PJJ0H(!(&-QR3ZQ\?#/A69%*@@LSY9
MF!8@D!CG:, >JO0>..I)YI-G.UK%D[DM1>Y^%EN8UF>:BZ"5&@$J% D5+-11
M45)D-ODL#)J)5JRLV<H:L+=SB_*L)5< 1HZA7BXAF<]Z>[6+ VK(9 ><DD $
M'G&./  ^WIBO=#O6EW-N:,1D<8 4D@CC.>?$D>SKG$=5.S&@UI[5:'M8U*U8
MU6RRNJ)NFUG8ZJ75I1V.J&4V>FF;T>=5MAD5I+HWJB9+MK&ABP[=YNG9)R"X
M\D98TCVWPLLQ24RJJ D. H!V@.I4@#.> >.:J\ DA$+N[ ;"7.-Y*,&!/&,D
M@9P![,&DA[E?3#TC[J]5,EUEU0U(U<3.PQG#<=T7L\=NJ2F3MPDXADT#,"RG
M29MFB/V\KR*^KVW<@N<I+(GI->\_4Q1B5_P[$>\=R\2!%5-N6+@@GO-P*@/S
MRJ@\ 8YYZU66U25R[L^["B,@@=T0=VY,#AB0,DYR.,8)!<?J!VOX[J;JCVKZ
MO97F&5RLO[5++-;G''8P4,2#FMKGN %@%[,R^(U3\0Y0S<M8S&/%2L,V3BCP
M*$(Q4QK*525 JXE"@YR2H5MPVG/PR<\5D:(.\3DG="6(Q@!BRE3N&.G.<#'.
M/"F^V'IC:(V/<<NOSN::MMTC^M4#N5L- 6LFJTT1L^XBKHTH(6KLNB.A/(?T
M@;C S.=A,Y*U3R;9AJ6_!..A0RN+EQ'W>U,[#'WF#O[LG)3.<8SXXSCC.*Q_
M94[WO-SXWB4QY&PR@8#XQG('AG:3R03S4CW6O6S1TI1TI1TI1TI43^:>E7 R
M;*^X:WQWO$[J]+\/[G\VR3-]6M,=/;?3"MQ.YFY;40\?R"$Q)M--K?(HT2PH
M8+%2XJ7!O?""HJX2D2EM+=8$8:&)S$H5&;?N !+#HX7()STK4:TRTI6>9!*Q
M9T4IM)*A2,E"P!  X8'VU7WWI6X7!U P34+0KN-[ANV:QT^[><+[9:>'I-9X
M ^Q+TSP6VG753&M96<X)EMA,L9%A,;D6,M)+:27H<=U&VS)]70NF*LLD<<H:
M1I3O#<.PP2-K+0V@#*T<LL6V)8@$*$;$)(!WHW.3R?8/BI$?T_H+>?7&KLGN
M/U^EZQ77:&[VA2-5$M<-K\S8H2U#F:CL:F0IU5B$%B)J3"MI:0HLUB,%$W C
M,?[2++0Y)T[\[0G=IL$O>[,-C.W;LZYVD9\=WMJ_V?UB_>R;VA[G?ZH8#=NW
MC"@;P?'&/93A-7= CU>[;<A[<[#574O'&\HP&LT^NM5<>LJMO4^97QX]?"O+
M1RWGU4VM^^\M@1)D2_G)5HK@7%DY#"(^;+C-$DV2"0(IPQ8(02GC@8SG .,<
M^ SFLDD?>1&,NZ[EVEU(#^T@D$ GSQQX4T#1/TT;+0C2[(M),0[W^\9W%["K
MP*EP\96;8A'<TKK,&RROR8X>GD>KPN! I6<KAP7,5R@#B24G8Y83XS:,27OB
MAS/<AV#F"'(+$X5O7+#&6RQ)V]1[<>588[4QJ46XG(PH7)3U ISA0$ PP]5L
M@G'0@\U:ZKTMVZ#N;SONBQ[O-[ML?RC4W4JIU!SS$J7*L)KL.RFOH+0)=%IU
M<1XV$A;3-/ZBH;'%Z^E=M2*/1<V6Y"27'))#=9B6(PPD*I56(8L,]6&6QN)Y
M)QU]PJ!:XE:43S N^YE!3:0.BGU,[0.  >//-7W#?2XTOPG7>G[I*S5S661W
M&M:M9AJ3F6J\VTQERSU'QK-*FNHIVB^64K>--8ZNE-145-?%Q:GJJROM,<<8
M^+K+=F2K;C4-<LR&(HG=[ BI@X0J2=ZG.=Y))8DD'/(Q@5*VJ+()=[]X'9F?
M(RZL .[88P4  V@ $8!SG)+D9':)IK9:[ZW:ZWLR]OIVONB.-Z"9SA5@Y7_H
MB>%8Z[D1$4((T%BY;L+B/DT^'9./6SS'L"RL1B,Z).%C[UMB(, 1NTBL/O;C
MMZY.,#:,<5E[E>\>0DDR1K&RG&W:I8],9R=Q!YZ4E/:7Z=VEW:3FDW/J/476
M#53)(NF5-H=@$O5S):B^'2O1+'KER_J-,<*;IL?H!:I&+0H[SDNW^\[1UN!!
M8"6RTV^,BTMPTHVE40;C(P0$;G(P6.2><> X'.*I#;)"=P9W(41J7(.R,'(4
M8 Z9ZG+$8!.!4@'6"MBCI2CI2CI2CI2HS=1?2G[>-2=0-7=09VH7<YBC^NU\
M[D.JF):=Z_9C@N!9A-D5$2AF-6V*X^L2'+BS::&U6RFY)O..1"<81X6R01V5
MNI%5%"Q'8,*6C5F')(Y/D3FM9K6)V=B909#EPLKJI. O12!T %>F5^E+VRW>
M4XMEN'9'K]H?88=I%B&AM)'T&UMRW3"*&F^#29TS'Z.>Y2N%9VQ,RK!^5*E6
M=C+>G2T"9*5R8AOF%U* 0P1\L7)D0,=S=3SP.G@!0VD.01O3"!!W<CIA5Z#U
M2.E9\/IWZ'K8Y+?R,JUNG9?EG;;6]K%WG<[5>]E9W*TUJ\H=S"+8?I<ZVMVF
M<+<O&3N6%+.8Y&XL*TB)RZK]H? &$VB0RA=HV[B,'CIMQX5;[/'DG+EFB$1;
M>VXHI+#G.=V2?6ZTXW4'073'5?1*U[>]2Z)W-]+[[$*_"KNIOK*>]86M55,P
M@@2Y5W'?C6B7D:370K1F[CR6+%FWCM63+S<D!-,:NR.)%.&!)! & 3UXZ8YQ
MCICBLC(KH8V&Y2-I!\1[^N?;YTUK"?3-[;]/\.SK%\>L]:4N]2\ATYO\XU3M
M=9,TNM7K]K2>UC6F"8V_GUI.E6<?$:88RU:X[!"+!FU$B3"FC(1WW!R-<R,5
M)V$('"IL4(-^=Q"@8R<]3DYP<\5B6VB4,%,@+%2S=XY<[""H+$D[1C&WIC/'
M)J\RO3?[6YW<,?<I.Q_,IV9EGK6K88E,U#RV5I,QJ^Q7!5,ZKLZ8OV1XNF=M
M06FFVK4XAQV7FFYC4()HI(Z?:)1'W8(V[=N=J[]N<[=V,[<^'S\*DVT1D[PA
MBV[?@NVS?C&[9G;NQXXJU83Z9_;+I]J-B.LV-,9_'UGQ753/=79FK<C,GI.>
MYQ?:F18\#-*+/[4X*1\EPJTKX<2%'Q9R#&KZ=ICW*1*Z5(F2)!KF5E*$C855
M-F/5 7D%1X$'G/B:"VB5Q( V\,S[]QW,6&&#'Q4C^[T&!C%+Z/:YI">K.M&L
MD^FFW&3Z_:;XQI/J;6VT]9F+W.$XI%NX4"K:I"9$(RRX>0V<:T=1\_C671%1
M;X;K3O7V(F<+&Q=<<$,<9.?@,>57[I-[R8RTB*CY.057.!CI_>.?.DV[7>P?
MMV[0KS(\ETBJLS>O\AQVGPAFWS[4#*M09V+Z<X[*?FX]IKAK^3V$XL<P:DER
M'7X-+"\DXC)2Y,KX:-[-I9Y)@ Y&%)("J%!8]6.!RQ\2?A5(K>*$DH#D@+EF
M9B%7HJEB<*.N!QGFGH=8:ST=*4=*4=*4=*4=*5&'G7I-=M^H&7ZN9599]W.T
M<#7;,;S-]5M/\+[@<TPW33,KG)68T2_"WP['SA0)4.VKHD>KF-O&<AVM9:B?
M$HVTUPV5NI%"#;$>[4*C&,%@ 21@GG())]_-:S6D3%R3(.\8LZB5U5BP .5!
M Y  /'05>\]]+3MNS'-<7SS',DUZT4NL.T@P_0FA;T$UHRG2N)&TPP1Z2_C6
M-2%H22?/CPG)/-PIT^0LEV/&D/H<EKWBA;J15*D(X+ESO0-ZS=3SQGX>SI4M
M:Q,P8;T(18QW;LGJ*257U2. 3]<UFE-Z>>B-*[J/8MY5K;89/JIH30]O.7YW
M;ZKWMCGTO!L;E6$RKL8V8/@MW'S)M^R?5S)UE.3#$61$ ]I%6#.YV\)A)&D5
M=@VAFQD;>FW@<=*G[/'ZWW\O&(RV]M^U22/6SG.23NSG-.M?TMP.TP*DTURS
M&ZG/\0HZJBJF:S4.N@9JW/''8D>)6S[@+^+-8L[8$C-R';*2P4ER83DKD+IJ
MO6+<=Q8':22?5XQGP&.@]E9=HVA2-P  ];G./$YZGVTS.S]+[M)GXAK-@,+$
M;;%\1[@-4:G5'5:EPVQ@8JSDQTSE5(BZ>K(IJB+-KM*CFTT*P?PBMDQ(1S?B
M70?;29*!W+]IERC9!,:%$W#.,Y];G.7YX8\C \A6'[-#MD7:0LCAW . 2,<<
M8PO RO0^62<K#I3V:Z)Z*4.NN'::P+[&L"[@;O(,CRS3Z)<H.&8W<Y;3.T>4
MRM.Z9(@CAK5_%<;?G5T!YRK:EQ8ST"%"!LFCJTSN49B"T8 #8]8@'(W'^]CS
M/QJZPH@=5!"R$EE!]4%A@E1_=SY# ]E)UF/IR=M>:Z'Z':#V$34"HH>W" U6
MZ.9IB6H608CJCAL5:8\=LVX6<8\]7SW&\@HG'*J_COLN1+**0J<<'V([S-A<
M2"1Y 5W2'+@J"K<Y'JGR/3Q&3CK53;1&../#!8ON%6967@CA@0>0<'SIU&D&
MDFG^@^F6%Z/Z5X^SBVGVG])&Q_%Z-A^5+^#KXZFX1/S9STF=/FRY+K\VPL)L
MA^9.G2)$N4\X^\9KB=F=F=CEF.2?;]>%9418U5$&%4  =< >T\GVD\FE(ZK5
MJ.E*.E*.E*.E*.E*YR?KP_X4WN8_WNDO^I73SKVQZ)/[ :%_]1_\TO*\O>D7
M^U^J^ZR_X&VI"NQF%H%3Y;B^>Y1W59AH-KE S5Z@P*HK.U''NX3'08OZR-1U
MN3R)^5:D8[11K49UU9-1(DO%+%RCD5T&^A3_ (U8Z0^5[6/K,EO<6EOV>M=7
MTE[437<LG:&;1IMT,C2R0*EO8SS-'LBC+,MP@E#O"R;-V[2[.+I,<L-S<:Q<
M:?J(N#%;1QZ1%J4061%C24M-.D0<M(X :)C&4616#8VJ]WZXKHU&S/62'G?J
M']P?<AW):4Y??8..-ZA=O-G3XY89+BV6+C>0UU9G4W7?*XV-4D 8=I-K"K<4
M<AR?@XT1J##&6C\?C.R%QJCVNF-:=B]&T30M1MHKO[19ZU'+/'!<6_?P.]HN
MD6S3RN6C5]]QO7<SL[E=K;W:6'34GOUG[2ZKJFKV<\D BNM/98FFBF$4J+<-
M>S"*- ':/9%M.T* N[(33L6U(S?5_P!47M1U+U(R"3E.<YCW4Z06^2Y#,8A1
MI5K8GF-&P4EYBNC0X31JTPTWQC16&T0$V!%W5>0[5V%IIG8+M%8V,*P6EMV>
MU.."%2Q6-!:3':"[,QY)/K,3\>NAV=N[B^[7Z-=W4K37$^KV3RRL%#.W?1C)
M"A5&  /54# '%=,[KPK7J^CI2HD,FU\[F-(-7N_VZU(RG$\DK-(.RNKU^TCT
MWQ"JL(^)XH4.[[A6ZR/:V-JY][Y3DU]#T_HYF671QJB T;WW+3U3<&J:GV.T
M(XW2W"@@O,8W8D$G/=\@ 8 &X@#.3U\>-0R2(]P6(8)"LBJH.%YDZY/)(4$^
M Z>TM]U5U.[G.S['8C<?N9U UGO==NT3)<\9N-4:W!+6+IAK?!U&[?\ !&\[
MP2!C^)8]&K\&"/KI/L&\*M_OFHB/8Q4?M'FY%@C^1%CE.3&J!)@N%W#<FV1B
MK$DDMZ@&1@\GIQC&[RPC'>LY>$D,X7U7#HH90%  Q(202>@QXY5C+4[E]'L\
MU?[:L-UI[@->ZYS2OMUUT9R"Q?T_L.X+&\5L-?;+!>X.@T[NH.-8C239U]IS
M12KG"X%A".SI;5NXBXW+^,=J66*#NW59"B1^M(F!NV$B,,A898\,<$CKQD<&
MKGO$9XP\CY2-\G&\ N5<*0%'*C(!Y!S@],>6D_>->8ID>G5+W)Y]G.+TVD%!
MG5;G)2,:M,FRC*<WL+J-)I#UHD:94-W0X[1:":'Y=IE.UHRF8[5X5!U<U0JH
MUA:LSL6DL(>($,8U!+E2.0 J]/4+$$EW#;!UV)TYJR2D%>\8@*&!R"23D8W[
M00-B%=Y^Z';KQ4SJ*BHBHJ*BHBHJ+NBHOE%14\*BI]%ZU*VJ_>E*.E*.E*.E
M*.E*.E*.E*.E*B%]4?O(O-)M.]1-)]%-4L6TXU@Q[3!S5K,LMM+JFAW>*88W
M8.0L:QK"JRSD =QJ+J==095?7LQX\C]&\)JLMR=]8]M^B+%KMVT09E:169"V
MT  X8^))'14!!/F2 #UQJ74Q175'575-[$D95><  ]68@@>0!/EG"N[G-M<Y
M&L62:I0C[S![/\"T,TYR=-0NT/4O0FBQ=\3E9]D^I^H5C!SFRFY'J*%1CA8?
M'C56"5<J4E;66LP5>)ZM:G3$J; A[GOF=AMF60GG8%4;1A<G<<L1[#UJLQ?>
MS_MNY5%.8FC !RQ=CD[FP-N H)ZXR>*=SWVZL95C7:_2Y#HSEV40<EU*SW1;
M%\0/3B+5RM5L\HLURVDE7^-:0ED=/;XU7ZC9%I\UD,K'[G*JUO'Z1N/-MK:?
M11H9W5;B@53(0X!"JY.[.U2 <,^""5#8R <GH,GBLT[%8@4)RS(%VX+L"1E4
M+ @,RYP6X'4D#)# L/U#[P<KT:R_%J^\[JK&PTO[ILNQ7*L1%-+W>\[!M,K'
MM\=R#1VKU$MX<"MTYR6%9ZS6^-Y1+R#"IN1196FUG30[C(+.'7YG&AYRL093
MB(;H@<Y;NF828?:#E@>[!&& .X$@ D9P!I2A4&7*2L"OJ=\JF/<@<CU""Y!R
MI/J$ DG=AT7;QWAAD^K-; UFSVQKK6PQ'3W27$\<QO&<DM--<AU"2QL<=S_5
MF_S&AH9F'8S%U)UKQS+=)-$F,EOZMK)(>FUO/Q5N:.8L 6*2+:IV+D!F8DD;
M@N,JH!.3M3#N0#@L ?NFLL<N6 9B/5"@ $@L#AF8XP-S>JF2,[3C.14J/6M6
MS1TI1TI1TI1TI1TI1TI1TI1TI6OIEW=IJ1IYKC=W.4:^:U,:X5W>M0:1N=HK
MV QF]$F>U_,M8:G37#\P^-33Q92)?85D%/G-3JNFH0.3\\G1\*2$Y'5RH7>$
M2LF%1-G<E^]W>OWH3<RD;L<,"I3;PO.>,UH&5U<EG??WP3N=OJ=TS[%;.SQ4
MA]VX9?"_]4R$8!F?<('J$:A:=ZF9KC$K3*1VW?I]IOIYAE9/CUV/1$UDFXM7
MWN4W=NXMAD6=W-/"%VX.)%J\>HVG6Z6GASECR[ZWP,J?9U95(;O-K,3DD[ <
M  <*">.23U/@!L*9._8,PV]WE5 /'KXR2>K$8SP .@SU./\ J)8_DL'":S-\
M$UQ[A\$U0R*RQ;171W37274&@P[$LXU4S[('H6-3LICV>$9/8.QJ5N7-R'+)
M\";%./@^*V3C# R(R/'-N06*E(RH!=V=22JJ.0OK 9/0 _WCSQ47&0 P>0,2
M$148*&9C@$^J3@9RQ'11TI%=2K+N<[8L[TTL,JU'UVU!THTETZT<DY3J>\.$
M/Z=YE7TDG4A>Y>PU>AN"SDLC4G*(CFGL/1VGI8[KS]])Q^JQ]YYXLP<?LHCD
M5L*BNS/A?6R,[.[VGIM!W;B?#.1C%4;O(F7+2,J*F6]7:V-_>;^,[B-NT#Q(
MQG!IU/9QW 5^I,3(<-S',+NSUU.US+.LUQ6RQ_*:_%\0:#+G<8MM.M,,HMJ"
MJQC/<?T1M68&EV8W6&65W&;SN!9SKAZ+.OVVCQS1E<$ !,!0002>,[G )*EQ
MZX# >J0!G!K+$X;*EB7Y8C!P 6(VH2 &"<*Q7.&Z\G%/DZPUFHZ4HZ4HZ4HZ
M4HZ4HZ4HZ4HZ4J.?4H]9*7U#NUM;/5V;(TFS?&.X2+2:/4-+]P44%S$M/\-E
MKD.:6OWG/FYWDLFYM[$JHGV:BAQNI;A1ZZE.X<M+RPV%V&WE]4;P8\N3DG+-
MPHZ 8'/4D^.!BL#;A<1DOZI60*@  X"98GJ3G..@ /3.34>G;%J5KIEVHF@?
M<YJ3'UOQ&@[AM<]4-,8^>,]Q#F4X?/L[-_5FHPK32U[2;"K<P;"=,,<DXK&K
M\4SO'K@M3W<KQJ+;9C%2FR2P),\JH%>)=C&-%;:(\$?<W,)@=S,=V2I&T!C@
MY K6C9RT<K=XO>2.F>\W GUP%,)&U5&T ,"'W 9 !)IU7;I@,_'.[#&:O1/7
M?7;6['M.\8SVC[W-2]2-2<GS?2[-M4Y<"L:P_$\1HKFTL\/Q353'LC^-R'(Z
M'2>%1X_@6(^WBV2\[2XK(8XI#F(EXT0LP,*JH5@O.XMC!*$8 +9+-R.,DY8D
MQ*-DDC[01,68LC,<8 !)57SDD)@*,J1R!5+WU:9Z[YMKN[FM7IIEVJ&@NEF@
M46PG8[A'>EGW:Q;IE\G+,INLTLF*O2^<U;Y?D,?#:#&X>*0\R/'<4DG-MVVL
MCCRF7$;F!T";2RJ[2'EH5E&-J[>6^Z"Q.=N3TR,5%PCL^0K,BH"0LS0G.YB<
M;?O$ #:&P.OK UB&6YWK%29SIOW;Z<UFI>2:.YG1:67VC[4_5F2QCV9:>:E]
MOKN'Z=]MMOH]-RV;,G:O93W'Y/B.HUIJ;,Q2>-5A[5A)L]1 :Q]_'Y4A4(:)
MBH8%]Y"@D,KY:3?@>H(P5"AL%L87)W""7!69=Q0A"F6X9'C(6,IGES(RMN(X
M ^_P5+P^QK7+%<^PQ=.VKO43)\^QVAB:AY)GN>T[]76:OQM0LJS!J=JKI@KM
MQ<.,Z6W.;X_EU;A5!,&CGXSC-=1UX8]"IG*:1,Q3(5.["A22H48RFT#"N !Z
MP4KN/())YK-"X8;<L6 W%B#A]Q8%DR3ZI8-M'&!CC&"7W]8*ST=*4=*4=*4=
M*4=*4=*4=*4=*5'7E;NL=!ZBVBR7NK,ZXTPS30_N6FXQH_1TR8]C5"N$2] 0
MC761RDLK";G>9V$W)KI&K6;]VU-#4%#K:&@ARW+VXO=@;#;OA,,KQ9<\DEA)
MD#@!5X''))ZD\ :QWBY0EB5*2X0#"C:8\$]2S<D>  / SDU'!VAYUK%G^5]L
M6NVML?7C&\;[R+G4W!I>70NYVVR'%\UN\EPO4J_J\"G=NS,.'2:'85C<#%;-
M-*<_TQR-O4:+/Q>N<S4(:Y'+-C8F"*LL:=V3#M..[ 8 ,@W"0Y+L2?75QM&[
MU<XK!"79HY'W@3%AGO2P)*N=ICQM11M]0H=W'K <FETTX[:+?(]1N\K*NUW4
M;6[&86D> :C=L>C89WW):\ZB4^5=R<S$%E9IJ'9!J7G^9UE=7:<VMO0:?8E)
MAUIK693#SK()T:?(K* (E&E 6(2+&2[+(^V-%Q'GU5]15/K#+,,\C:..:LL.
M6F,;R#8K1)NED?+D LQWLP]7A5XSG<3X59,?U=U"TFRG'-)LXQ_7R%A^,:Y'
MJ-!T=J,['6K6XH]O@+N0Z0]N%KJ&>HEI7W[C$G3W63N:U A2-3[EBHTYI=/\
M-F3K*#F(8X0JKJ7!3<4V[MNQ.&PSA< C[R1*0H!8L?#-2'9"$8/M#[@N[>_*
MY2,MG:?NO(V7X4*.=V*FMP'.,:U-P;#=1\,GK:XCGN+T.98Q9%'?B%/Q_):N
M+<U$LXDIMJ5%<?@3&''(TEIJ1',B9?;!T"%--E*LRL,%201[0<&MQ6#*&4Y#
M $'V$9%9;U%31TI1TI1TI1TI1TI1TI1TI1TI7.3]>'_"F]S'^]TE_P!2NGG7
MMCT2?V T+_ZC_P":7E>7O2+_ &OU7W67_ VU--[9KCLDQIBLR?N+?[I_Y0L=
MSF%>4D/16LTEF8;)H:@JBPKF[5[.;BNNQMWK6/9-S0B-_!C7K!)AWX@GT'L.
MNQ=JIS);Z(.S_P!BGM'AE;5)-16Z6:7O4<QBTB>+NQ&8RA8[M^_(V[<\3H[]
MFXE2;5FUL7<5RLD:Z='8O;F).[=-YN9$DWEPX8+ZNW;@YS2L=VVH_I\ZSY'K
MIK'IC^N/7:S:J9YE.HU32YW4Z*,:8U]WFN9NY'=U]C)Q^_L,J&JA0K*T9JRC
M#)EE*:@)+,FBD.)QW9RQ[9:7!I.F7_\ R9DTO3[2WLI);2353?O%:VP@B=%F
MA2W[QF2,R!MJ[2^T [16[KMUV5U"34;^R;7UU&\N);E([J+3ULEDGG[R16,4
MTDX149PF-S%@NXXR:3_TS?\ "%]E?_*8T>_Z;5'6]VY_L;VI_P!PZI_P<M:7
M9+^T^@_[ULO_ !TKJ#=>":];T=*4AMGV^8!=ZFZEZG7H65S-U8T:QS0K,<:G
MOQ#Q:9@V.6V?6S;341J$U8A/M"U&OH5J\Y:/1W8+<%N-$BO-/OR;]XP5%&!L
M<NI'7<=OMQQM&.//K5.[4LS')+H$8>& 6/OR=Q!YZ8X'BV?$/39T3I*/-<=S
M;.-;M;*K*]'Y^@%*WJYJ U>2--=';"57SWL-T\FTE)CLNJ-+"EQZ>.3VCMSE
MY2L;H''+XTK6A7(;AR00J)A^\.U<;GY]9LDYX)&!A1DX R:Q"W0!@S2."G=C
M>V=B<>JI !'(!W$EB0,L<"EGT"[5L=T'N,TS!W4S5[634C.ZK',;N-3-:<GJ
MLHR^-A^'%</8KB%25/CV-TE=14TW(;RT4&J59]M;6LRRO)UE)-LVZ/(7"C:B
M*N2%0$#+8RQR223@#KP   !5TB"%FW.[, "SD$[5SM7@ 8&3X9.222232=9/
MZ?\ I#E6%X7ADK*M3J]O':G47',RR&JOJ)C)=9<8UDR&IR[6/']4+"1C$MF;
M%U-RFCK+S(I^+1,5O(4B.L3&K6AK'7816$[ABV%R2K 8.$9 0A49XV@D#.1Y
M@U!@0@+EN P)!&7#D,X8XZ,0"<8/D13YQ$0$0%$$1%!$4\(@BFR(B?DB(B)U
MAK-7[TI1TI1TI1TI1TI1TI1TI1TI37^XSLZ[>^Z+$\QQS5'3;$)ESF>-_HO(
MU(C8=ADC4VEK@+E&/'LPO<=NIU=(@JKB0E47V8R//(VRGN%OECFDB(*,0 <[
M<G:3[5! /MK%+#'*K*RKZPQNV@L!["1[\>6:3C4[L"TJU'N;!V!G>L>E>"Y3
MB=!@>I6CFD>90,,THU,P[&JYZEJL?R#&F\?FR*"&F/OEC<\].[/"I-GCX-5<
MY]YEEM1E9W7'",P8LKN"75C@D@Y&>1GU@V#TQDU5X%?^\ZJ0%=%.%=1T!&,C
MCC*E21P<TI&IG:MB>JN.9!B^0YSJ975SN68'G&F+V+WE/CMEH#DVG5)!IL>L
M='9\#'A?J.2Q9D^SC9.N5Q+!V\O*YYC[AG?=#=5E92" N<,K9!/>!B2=_//D
M,;<8!ZC-6:(,""S8W*RX(!C*@ ;"!QXYSG.2.E>&FG:EC>EVGFJN'T^I.K5U
MFFM4BQL]1=<\HR.GM]7[J^F8O!PROO8]J..1L6J).,XW5UE;B]?58E#HZ<(+
M3[56Y*=E/R):4LRDJ@"<*@!" 9+$==QR22<MDYZT6(*K@,Q+DEG)!<DC&>FT
M8&  % 'E5BD=D6CXYIIME-%-S'$Z/3C'=)\9'37'+2KBX!F$#0>\N,GT7<RZ
M%,I)U^_*T[R6]LKRK=H\AHAMYKC Y2W?18D>.V[Y]K A26+G<02P[P . <XP
MP '(..HP233N4W*06 4(-H(VG824)R"<J22"",^.<##P^L59:.E*.E*.E*.E
M*.E*.E*.E*.E*98O8WIP]K YJC/U!UHML;74L=:HVA%IG3<S1"!J\V026L^B
MXVY3_I LR-; .1P<?D95(PZOR9$O(6.1YH-&WF[YMFW:@.W87"^N4_U2<XZ<
M9QNQQG'%8>Y7?N+.1NW["V4#?ZP&,^T#.T'D#/-+S_(YC7\N3^OR3KL<R?TE
M9T<*"DB%^CX8TQE\G-&YP1%@+/2[^]93C*R"LBA+"$&T@(\A/ECWG9W?&W<7
M]N2 O7RP*OL&_?DYV;/#&,YSTZY^'LK$Y/;K27,CMVL,QSK4#.KKMOR>VS/'
M+S)YV.N6.991;8!F&G7WSG@U6-5<"?+KJ7-KB76K10L>!BT")(,'66W8SUN\
M([P!542  @ X #!L+DDCD#KFH[L'NRS,QB)()(]8E2N6P #P3C&.:SC4O2G'
M]5OT'C93,MRI,*SRBU#+&X;\-JDRRYQ89<K%X>6L2(,F384U!DAU>908$.57
M^YDN.4,F8[*A17X$JJN5W8ZLI7/.0#UQSQD94]>"1XU9E#8SG 8-CC!(Z9R#
MP#SQCD"DTTK[5\%TDU-RO4ZCR+.;B9>IG3&.8QD=M5R\4TT@:I9]_*EJ96X+
M#@T=;:-Q<WU!"/DEJ636^2RH3D*#644BII8PURV:5F4*0HQC) .YBJ[5+$DC
MA>!@#S.22:JL05BP+'.[ .,+N;<P7 !PS8/)..@('%.9ZQUDHZ4HZ4HZ4HZ4
MHZ4HZ4HZ4HZ4I/,ATMPW*-0M.=4+F!(?S'2J+FL/"Y[<^7'CP&-0*ZLJLG&3
M 9=")8+,A5$%M@IC3I0R;)R,K9N&JV#$*RCHQ4GWKG'YFJE065B.5SM/EN&#
M^5-[J^PSMMI=2YVJM3C>60+^1>9CE]92,ZFZB+I]B6=Z@0+BMS'4+"--G<E<
MP;$<YO(N07:OY'14,.=&E6MA.@%$G3)$ARYFD*["01A03M7<RJ<JK-C<RC P
M"<< 5C[B/=OPV06(&]MJLW#,JYVJQR<D#/)\S6/:*^GKH9V_+7L:997W$55)
M54F14-9B,_N0UCN<*KX>3UUA76+\+$;++9%!&LVOO.58UMHU!"=677M7,)]F
MR8:D#+SO)G>$))!)[M Q(.?O!0?8>>1P:)!''C89  " #(Y !\@6(]W'!Z5?
M-1^PKMXU6DX[/S*'J7(M:73RBTGNKFFUHU6Q>XU+T[QT925N*ZO6.-9=52=4
M(/NS[25*>S!RTGRY-O;F_,(;.8#T+-(F0NW!8L 40A6/B@((0]/NXZ#RJ6@C
M<@L&SM"$AW!91T#D$%QU^]GJ?,TX&QTBP"TM-*[.11-M!HK(F3--J:$\]!QW
M')TK%Y6%QYK-#$-JL?DT^+6%I34!R([@4L6UGK7@R\\+K=-[>MS]_P"]YGG/
M7KR<$^>!5]B^KQ]S[H\!QCI[!P/+-8;HYVRZ0Z#W&4WFG%);U\_+(T&KD+;Y
M7DV31:+&JJVR&_J<,P^%D%K8Q,1PRJN\LR6TK\:Q]F!619-Q)1MA&&H;,:7D
M=P Q&!Y #)P 22 "S$* 2<GCWU"1I'G:,9\R3@ D@#). "3@#@9]U+[U2KT=
M*4=*4=*4=*4=*4=*4=*4=*4GUQIAA][J5A&K5E!D/9MIYC><XGBU@$^6U%AT
MFHLC$I651WZYMT8<UV8]A&/$Q(E-./0DC/#&)M)3_.P8A2H/JL5)'F5W <]>
M-QJI4%E8_>4, ?8VW(Q[=H^7OI!<#[&>W#3;51C5_$\4R&)D57<Y7DN*T$[4
M+/;C3? LFSL;!O,\CT^TQM<CF8)A=UDK5M:LV,W'Z&"8,6=BQ!2(S.E ]=II
M&782,8 )"J&8+C 9@ S 8'!)Z#RJBPQJV\ YRS %F*JS?>*H254GGH!U/G2\
M:9:6X;I%06>-8/7OU]7<YIGFH-FDJ=*LI4W*]2LPN<ZRZR?F377I!K/R*^L9
M#+*G[4.,3$*,#<6,RV%&9G.6.2 J] .% 4=/8!5U54&%& 2S=2>6)8]?:325
MY3VDZ+Y?C]S16=9D\1^\U6N=:Y65T&<Y;C>=1M1KVJFXW/O*S,Z*W@9!6A^A
M=A)P*-6Q)K5=%P<F\:8BA7LM-A82N""".$"8*@C:"" 01@\@-GKNYZU4Q(00
M0>7+Y!(.X@C(8<C@D<'H<=.*77$,2QS <3QG!L/JHU%B>&X_3XMC-)#5Q8M1
M04%?'JJBMCJ\XZ\3,&OBQXS9/.NND#:$ZX9J1+0DL2Q.2222>I).23[S5P H
M"@8    Z  8 'N%9%U%31TI1TI1TI1TI1TI1TI1TI1TI4(?=[Z$':_WE]P>=
M]QNHFJFO6-Y?J F.);4V%V^GL7&XGZ,XM2XE"^[F+S3R\M ]^!1Q9$KXFTD\
MICKY->TR3;#?U7LWZ6]>[,:-::)9:?H\]M9]_P!W+=17K3MW]Q+<-O,5[%&<
M/*RKMC7U0H.2"3T#6_1WI&NZE<:I=7FI13W/=;TMY+58E[J&.%=HDM9'&5C!
M.7/K$XP, -J_N7_LJ_\ MX=T?_K_ $G_ +)>N<_Y^NU/_P )T#_[.H__ .QK
MBO\ FDT#_P"(:Q_]VR__ *&C^Y?^RK_[>'='_P"O])_[)>G_ #]=J?\ X3H'
M_P!G4?\ _8T_YI- _P#B&L?_ ';+_P#H:5G0?[._VE=ONM.EFN.*:P=Q=ODV
MDN>8SJ!0U>0W6FCU%86V+6L:W@Q+=JMTSK;!RO?D10;E!#L(4DF2)&I+)JAI
MQVK^FCM'K&EZAI5QINBQ0:C9W%E-)#%?"9([B-HG:,R7\B!PK$J61E!QE2.*
MW=.]&6B:9?V>H0WNJ/-97$5S&DLMH8V>%PZJX2S1BI(&X*RG'0@\U/QU\?KZ
M/1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1T
MI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1T
MI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1T
<I1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI1TI7_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>g60414g53x35.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g60414g53x35.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1]:4&AO=&]S:&]P(#,N,  X0DE-! 0
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M5     $       ]P<FEN=%!R;V]F4V5T=7!/8FIC    # !0 '( ;P!O &8
M( !3 &4 = !U '        IP<F]O9E-E='5P     0    !";'1N96YU;0
M  QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"24T$.P     "+0   !
M   !       2<')I;G1/=71P=71/<'1I;VYS    %P    !#<'1N8F]O;
M    0VQB<F)O;VP      %)G<TUB;V]L      !#<FY#8F]O;       0VYT
M0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O;       16UL1&)O;VP
M     $EN=')B;V]L      !"8VMG3V)J8P    $       !21T)#     P
M  !29" @9&]U8D!OX            $=R;B!D;W5B0&_@            0FP@
M(&1O=6) ;^            !"<F1456YT1B-2;'0               !";&0@
M56YT1B-2;'0               !2<VQT56YT1B-0>&Q ;YYVP         IV
M96-T;W)$871A8F]O; $     4&=0<V5N=6T     4&=0<P    !09U!#
M $QE9G15;G1&(U)L=                %1O<"!5;G1&(U)L=
M     %-C;"!5;G1&(U!R8T!9            $&-R;W!7:&5N4')I;G1I;F=B
M;V]L      YC<F]P4F5C=$)O='1O;6QO;F<         #&-R;W!296-T3&5F
M=&QO;F<         #6-R;W!296-T4FEG:'1L;VYG          MC<F]P4F5C
M=%1O<&QO;F<      #A"24T#[0      $ .__C4  @ ! [_^-0 "  $X0DE-
M!"8       X             /X   #A"24T$#0      !    '@X0DE-!!D
M      0    >.$))30/S       )           ! #A"24TG$       "@ !
M          $X0DE- _4      $@ +V9F  $ ;&9F  8       $ +V9F  $
MH9F:  8       $ ,@    $ 6@    8       $ -0    $ +0    8
M  $X0DE- _@      '   /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H     /____________________________\#Z   .$))300(
M   0     0   D    )      #A"24T$'@      !      X0DE-!!H
M S4    &              .>   &.P         !
M      $             !CL   .>                      $
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M     0      "6AO<GI!;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N
M!V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX
M   '9&5F875L=     MB9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO
M<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG          IL969T3W5T
M<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/
M=71S971L;VYG       X0DE-!"@       P    "/_         X0DE-!!$
M      $! #A"24T$%       !     0X0DE-! P     %+T    !    H
M %T   '@  "N8   %*$ &  !_]C_[0 ,061O8F5?0TT  O_N  Y!9&]B90!D
M@     '_VP"$  P(" @)" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,
M$0P,# P,# P,# P,# P,# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4
M% X.#@X4$0P,# P,$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,
M# P,#/_  !$( %T H ,!(@ "$0$#$0'_W0 $  K_Q $_   !!0$! 0$! 0
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MEKZ\0V56,EKF.&,ZVMW[U=C?8]<=_BKZQU;-^L.11F9EV14[#?<:['2TV>H
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! ?_  !$( 5\"70,!$0 "$0$#$0'_Q  ?  $  00" P$
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MWMOWE-5K33L;U6VJ6L5AX]3)9@/4 'V@ _3GF>IS@# & , 8 P!@# & , 8
MP" %L\K+Z9>2[]QQH?C9&+B<HK4$*MN0R&47L35"=(AF\HF<80M:1N-K29^G
MFISX<>H-5 X$==5FFGHVOF?.&>JLZ-A5UVFQM-JE*C:F.>TH[SRJM*E6Z*:%
M4U3M8UJG?'!]N/02.JVR9PZ,<?(OF'0REK.E+R^-T?KMKM5!8?NVE9D(NIBE
MC>MHY#3W=9HU$K'-R;$+$:8THDABD\\PCRC-*&EG2]M))NK9:2EM)8[_ !!4
MJG@JDJ:FW"E.4E+>[C#Y\L2LG*U:T9RG$]VL"$M9#/)"8<['.$J9$937+5*
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MQ;J3:M;5553$[5-*IPP:;^,LDG*Z2EX>E6PZ=JSHJII:;AJ=I2G+;^+BV]_
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M(!X9X6L^EM9C^,KRR^6^&'9APP/KL_XNSQG[71BYQ^*H>..7$DUGF5C & ,
M8 P!@# & , 8 Z '@ !@''0/8'T!@'/0/8& <= ]@?0& .@>P/9X>KV8 Z![
M ^C '0/8'T8 Z![ ^C '0/8'T!@'/0/8& <= 'Q !^; '0/8'T8 Z![ ^C '
M0/8'T!@#H'L#Z, = ]@?1@#H'L#O\>[QP!T#V!]& <] \.G=[, XZ![ ^@,
M= ]@?1@#H'L#Z P#G & , 8 P!@# & , 8 P!@# '0/'IW^W ..@#X@ _-@#
MH'L#Z, = ]@?0& .@>P/HP!T#V!]& .@>P/H# '0/8'T8 Z![ ^@, YZ '@'
M3 '0/9@''0/8'T8 Z![ ^C '0/8'T?U]HX Z '@ !\V .@>P/H# '0/8'T8
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M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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MI>J<#!WU 1!># & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
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MN/3)]M4>NXEB889ML(?R4\,VEQPA]F.'"#*W@I& , 8 P!@# & , 8 P!@#
M& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@%D>1\$LNSZ/LBO:@L!
M%5EAS"/',#!/US8N=RHUJXGD)W=82D;')G<BUYK'NY(VQP;W-$N:'!2F=49^
MBA&4. 8>6/B5S!,Y%6M5;Z%"LM02#LTT/&]%(:SINWHI"4K,J?+S8XI"8I()
M-:4O1)9]%W1_;I++=W!4^&+88X-VA;(WN:L']5&_QX7KGJ*I6$)IS/AX/PSW
MH\_65R!KSLZ.+Q= 7K ;&X]VU0$UY(N<_JV6Q.N*W:^-<5< <19K.=F]/!["
MWG\K;69! M*^?)-NYLSH8[N6K6E1J_-'X[\>6$$8*=^&'7[E/6CW>V-XST1[
MWJ?Y._:TC^M^I.7?#B,D6CH"[23%,!]S11J-:]3=58)/13&T/0]]12>5L3W#
MMU[PF%P(GQX]?$SL!X!ZNX, YP!@# & , 8 P!@%#.EF5XQS:-5J\SF(--A3
M)$ZN40@SE)&=#+Y2VL1?GGIPCL;5+"G=Z1M!7]E<U#:D4E(2P\M3N5KWX![K
M]/(5%GF*1V2RV-L#_/')8S0AE>7QK;':8.[>W*'A>U1AN6JB%;\XHFE(K=%:
M)K*5*4[>F4+#2M$Y)AFH%C;;YJ\1Z%E2"#73R3I.KIDY%ISTL7G-E1../WHJ
MH>B58I:W)T(6(4*D>H)URXI,C.\G?S9^WD;= )&M#NU2!J;GQB<F]Y97=$G<
M6IW:5J=Q;'-O6%:GI%S>O2&')5B-41OH<G4IS3"3BM]3"]]M-@$0.QP!@# &
M , 8 P!@# & , 8 P!@# & , 8 P!@# & 8\HU^%7N'\@B@OT^\@\%3^13^-
M5W4&0W!2, 8 P!@'H*G1M1'ITJM>C3*5FWD)$YZDDD]5N.VNH:)RC-]3#]O*
MWUU\DK78?*VUU\=@ 0/?\< 8 P!@# & , 8 P!@# & , 8 P!@# /'81UU$0
M[Q .X/CP#%F^=IQ'&/G*T<,3Z<N;=_<HJ]K= )KEV.?%KVGG34PL4G:%!:W:
M*J:<=(>5,IH?-#GDE:C21@]&H:B';JT[)QC?F5;#=+KPA.,U/9/-=)YV)VG,
M7@'-6$\/5-/7.X2631R;JO16^N'96^O;NVO\22P=]A9Y2X(N[UH_QG6VI*\2
MA<]-ZID(K=40L;DRL[1(H$1\5N5@XC>_'KQX,RE:CU !]H /=X=X8(.< 8 P
M!@# & , 8 P!@# .   Z] \1ZC\8X!B=[8WOXSU-^6SPR_3M%< RQ!X!\@8!
MS@%%6-.$-:P64SUR9I5(4$39E;TK8X/&W.82YT(1Z>7NCCT89B5#J^.AP?K4
MS>A),//W[M=>G40 CIQ&YL51S3CLBEE1QJX6F.1QRW:-WFSJIE=<-SRXIG)W
M9G5)&ELA2DI7\Y@>&-Q:I 4WG&G,SB3Z(O+)-WUTQX[ 3 P!@# & , U\NTH
MX_RSD1VCO%MBK*7&P&[:\XC\@[@H:: <;HA8+>@5HT^HC /Z;30XIQBS^G6.
M<3E+>J3+"#F!_<=P2''E$:@*J:HG!.<Y4]F*X^S*3PD_)QMY76YV/E@FLBB&
M6#'>6U\UQ=U:. !H\U==,)XX6&USV$.1 G'FZ%HW3JX,:D_<3'.-.3,Z;:E;
M+!++CAU^/&>>Z1$3O48/K79OYYGNQ&"W7PMGO*X;/X#J^;E6<@;YLJX3+XI8
MZMK MAPALY4%;-]:V%4EBK(\_O 0)M(%B:D,7=G&/;-W0IO0%'F*//21F^&7
MCQZR>79AJ>-OW,NK/Q6D-@+JNCMEV6W;P2T4)S+.*.E:Z2'2*34B[QE8V-;A
M$R8$O>Q2M<=7:N!R%L5I1*=W1&8F5[B&YS,B. , 8 P!@# & , 8 P!@# &
M, 8 P!@# & , 8 P#'E&OPJ]P_D$4%^GWD'@J?R*?QJNZ@R&X*1@# & :\G;
M1]K_ 'AV:-E4G"ZHK6JYX@L^$264.ZFPBY;NK;U;*_)FE.F;AC<E8B03FD'[
M&&^DE'G><UU\@S73KJ,-PI]77]9733M3,[OK-;RY^W^NN]K9XZW+.^+?%EPF
M'&J:O,VA"D^.S1PW5*W:+NS"4VN"QTEZQP3MK4[+FN;-A;6J0G)Y?%XZ[>='
M=O+USSV^67/ZOV[ST5-*52Q<J-V'/(GK07V3?RVMN]J5JIYH7CNVL]FVW6]?
M.SBU$V6#F@;)G,6:.+UK<*N>*4H+DJ5R-/2>DIST_I!9?GB32_*TVJ5<M*(G
MG]10Z$DXEOQR-VC4.X!ZCUZ!XB/R^'AZ_'QZ96>9S@# & , 8 P!@# & , 8
M P!@$(.2#SS$6W13=;<9WFOX)$))!+?E=EV=950RBUH^RO<1>*K;H'$2-(_8
MU<)V5SE:263-R3BN<UARXB*J 1I T2JS=(X>Z?V$J(<IO*,8C/')SW<=Q12R
M ]I:VI3USAR^XAHD:8L35"M9Q GZ9*G*UZ>48>>?ROU**+U]>^^VNH>L0R<=
MW=/M04)XJ5PF/7#+<0A\YW6,@DKG%.;W#M:CB$HGL.D.ZOAU9+1LW/M9R!5%
MIL682Z\IT1IC>Q/J,]$H>2M#&DWH6>F6G)SBC=XQ\+Z^'K[ W2\DUUS[$6FA
M%0<C+EG$OG,6Y&<#Y#8D$NIU)DDE4<%[!1RM%<-2Q@NM%KH0N<N3Z5R<3HK%
M)'K%DKTW&*F<MO=S$Z)7OZ69L9(G")</-3@WQ\=I=%RX>\TWF8;V"ZW1P:<)
MSO(XI+MI:KX.S8^0>^:"M#JP0YZ!U,Y3[+-%T;97U[;6@S0W75$D>'4HG375
MP5^=##GOW_5V\>1=C[6?:<A_NM.)G^1S8O\ ^Z[! ^UIVG/^%IQ,_P CFQ/_
M -UV =Q3*CG7&N1A,%OZ4U/:=-NM-2.5IY_6%*2>JBX]9#9,XFT-$0=%+[;U
ME$N>[S&W.0O!)!*9 9KJU#OY[;4L=-XQP]S^OUQ/5C.$83/2FH[$3SR2!@#
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MTJ=:0A>41"H]&#DV;KDJ0Q:U*S$YAS8ZIM#6YW0[$.36J6-ZI,J. K00 ?$
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M@# -'C[+"^'OB3^**>_GDW917EU/OI/6C)]/L1J;9Y%9)GA7]^1Q+_*9H?\
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M>NZDJEKSJ2V#T6@FK4U=V)$IBK1E:[!H)JM(PNRY2F)\L0U TXK0L=NX-A'
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M)$PL+.H4.S) (F_3F8."(T=$IY+%%(PC7OSPK\@\=Q(;4AQVA.IAXZ@65OL
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M\,V:\W=_%UD4_P NX;WQO"PRC/CVHS/J.W]C26Y:4O>*S_B+KF^&)7 =  1
M/#N'KX#\@]X=_K\?'NS9E8N8:4MRI[,%EPB(Q+HJB'AZTO=QGAZCR >O@'0>
M@C\_=Z^GKZ]_Q?-DM*%#JR<2VE$/=@GN_84K-*(EU)Y-XT\7.[@3 [/3K]HF
M0^ _V\;NZ=?'J%@.W0.H@'=ZO5X]/9G\]'GI)OSA==_RUA,3NIM'BMZPPG+&
M,V=4/-R2_>HT#&?I+V_^U2WW8/AE,DY_+$/$ ^;Z/:/KS5+VF<RSG(G8-J N
MWNZ?VJ+  ?GBKJ']?CR[]0/GOJC#:?V1Z&Z/OA8++?GRW\,;=UO<:JZQO/\
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M^^/YO?O#QK_D>RLZ:^:M^"RQX?NYI7MBZ2:+><#\_P"T^BM']UH9T,V3,(#
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MP@/CX^'=T^+O]G3KUZCU'(</=&$J%GA.*Y/?DL<LPLL)>.,O+QZYX$P^ST^
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M5%5;0-'PKG<$52D'59LUDS!QO&N9 B8-S 0^7Z>I9FQP<2RPT'44Z4W8=P$
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M7KX] ^K/<^<YP#P,_O9G[C;_ #1P#YX58_M3U_A%-?SS?\TM\HOSRT[^>/\
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MH6;B?E+/UXE_>1NJIZ<TFMIO^Q-4XN,;W=MSY-(WK-0$  !_KWYD,V*.< 8
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MNU!7^SC5%O?K)H:.7]D+N^6[@HQ1;FN'S5UC?'0FD_U2VW^TVI*L^#*N_P"
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MT[NGR]>_V_%T^7IWAZPQ*2B$WQQ[G&/,EQFO7$\_$$KNRB^^0YOC[6+C6/\
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MX_B5_P!,UX\M'WQT-^96OZ>HQB&0M.9,R)J+P]:JR&K=FU:M340,VZ,S8##
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M13^+3W(YDE=;_L1^;ZPRH&ARY=U@7D'7PY)<D0^B\I[]>6EI*?AMM"_F;O\
M!YM=)J/Y3TEKKI>6_P"Y%EPN=AS0SX\\T^G!=S;+"6QO3GB\.YLLKR,[J/LK
M^#9_^D)PS]+0_P!]='?GMV_34%QZFXZSZ&_/*,\-U3RYGN:] +T$0'H.FH!T
M'O\  >\>G=W@/K[_ (ASI#0DZ:9_F<^+X.=_7N,TU5)-YO&KEC+WO<M_##I/
M/NV .H= [_7[ 'IW^SQZ]>G],Y.:<5QC#GR>71G"4(A0U#SSB<5O7![_ &'6
M0P!#E5Q3$>G[<9\'J$0Z5K( ^3KT^/KFDWGZX^0W2#XWZZ)P\%_";LGNP;S]
MYL+YLN'E1T6L<+&]N7F_X+>'FMRB-SQ,V^W7J/LZC]8_]O\ 'G!7'W]/B3IZ
M<?/U_F^+)Z]W9CE[>D$L.RB^^0YO?O#QJ_D:RLZ:>:M^"RQ^G-*X?YMTQZS1
M;S@?G_:?16C^ZT,Z&;)F$!@# (=\_8Q8,SXA7;&*O(>5TQ=XV@)(9HW(28G)
M)*PDR5C532(QR1J%S82SR"7PPA_C#&M,<$0:.KLDU]*('<#-0R,(T9XE5[ >
M34(*K[A#=++-C.6-!WK1,KD<,F3W5,1XYRBNZ].M^*VY)')_?X/%)Q3TG26H
MZL3 ]*S)>T6!]KP^&J71)L9N$1UXSCNZ"K:<;LHR4YSG@THPPPPQ6*-GS7]B
M'CX!X].O\7=DE)S@# & 8\HU^%7N'\@B@OT^\@\%3^13^-5W4&0W!2, 8 P#
M1X^RPOA[XD_BBGOYY-V45Y=3[Z3UHR?3[$:FV>1629X5_?D<2_RF:'_2G%<F
MG-=*[P?6VU[]=1^(/JSW/G.< \#/[V9^XV_S1P#YX58_M3U_A%-?SS?\TM\H
MOSRT[^>/]#9'<KS</P(^3OZ!L_T]L7 RR3-Q'-K^^)L;\7\ _E&29TF\RQ+[
M&]8\/[MI?JJ]R.*_]4-Q\K>C.6K.CX_Z:]>]E[,W:.?YW5:??+\./ROJ!_/)
M-F"?.1_!-I_\6S_UI>6HOW^L?R-K_3L#=5U\ ^0/JSD)3DNA=QG>K-]+[SJW
MW_:-Y_>IQ_T0[/2R_CK'\K1WD/Y-?XK[T?/MICX,8A^]G_.#LV0TQ]\+?I7<
MC0/7KYW:>^D+;O1<_/S"TS/[]CJ?"%SM_P"2<:?Y/MW,I:J?>BQ_+6_].LVD
M\DWS37TE?>ZP(N=J#^$OY&?B_P"/GYDK\PUY<ONK07Y"^=]F=@/,(^;WE!^F
M-"_JMZ(6Y@2OY3ZNY'00L-<7[9:-_&69^9TFS9[S4OPJ6'YK:?\ B-#_ .J"
M?@:T7_E-=OU*\ES%;>@<B-2'!$E7$!MH8!*Q.4I)\YH ^3OYH[3?3RM?*V\G
M8=>H=1Z>(YU=M[&QMZ:K.WLK.VLW4VZ+6BFTH;Q4NFI--J7&&!Q*HM+2S<V=
M=5#RFFITOU-'02_30N(2<LO370LN./!9>FFH:Z:::-BC733777H&NNNH!KJ
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MJ/3O$?#N'U>(>WUAW]?9[71+489;Z=[Y1$=G.%*B$DTWU0\U/3T8]DP^SU^
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M]?GGK_[0NO4Q_&V7JHM(GFHQZ.DZH>;@H\E&@/QKYV;2:)Q9J@9S+/\ (?X
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M['[B-G_"I[1^J!M7^"#S]_R4YG_TK$KGV/W#9_PJ>T?J@;5_@@\_?\E.9_\
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M:4A<I;1:2W<'L_8LHSTST#80\P(@KC[J#M:@ /\ O<=*CW!T#[K5S$?GZ4B
M /M#N^3(GD^G#WSZ@0F[0Z-=K'SWXEV;Q;4\'*:K8FQAC0[S GDPXR0QK][T
ME:I$ :L^]2-&JKTH6P$H]5Y'F@-$W]?Y'D;2#5U_[F,[4_\ \S*HZ?%8:KK]
M Q@!R)Y/U>\#_N8SM3__ #-JC_&$L_\ ^7'$O@_5[P9B>R"[/'M6^RDFETS!
M'QBJ"Y][?C,3C>Z%1>ZZ&ZL>L7='=S!5J<77#_LN%8+J)(E;%I@) D-PW,\X
M(:IY-=GL;!G:#E#VM(__ ,.*ENOM^ZV= #Y_[2/]>[)!"KG3&^UBYIUG"*[4
M<'J:@&L.MB,6?JZ$\FG!_P!E^T<;9 W S^B;U$V>C@J!\$WTOSYOFQ3^3Z/O
MYSRB_"\67I[*JRQIVE&U@XZ,>KOP/R-.Z+6F]$7[1;MG=U?;!V/IE3MNSFJF
MK:V'53M-;.3:Z3']^IY=JQ_@Q5%\][+0#Z?M<Y^1^XW^,5)<[.E]SGU&'_WD
MK)YZP6BWS\ I]EX^H?J>7:L#_N8JB_Q[+?YZY#Z<AZ%>Z\5/_-C_ ,6\?O(6
M/_&*M?\ -Z?_ .Y4>LMLJ[+#M554_<YOMQWJ347"+,\;%N"[58@2#2Y.[CZ6
M"D:_#R_/@[>:\R)6OF_,!N!FWEB&N4/)WK9]@:TG-Q>DOW05WP]/3=W9.P=;
MP=5%JJU5Z3)PULX9P7CH7R?6>A]&?N=3I-V_\+M;SZ9W9V;?I:+*AT[*M:HC
MT4SM8S$*)??!V97:IAW?<W5%T$ ZB-YK/$/DK[NZ_)\X>K)O[^--3C['JY:_
M])4)=<76.H_3>J*C[NE_D7W.OV[SC]3*[5+O_N;JD]?_ (\U?_5\/7YP#Y,G
M]_&AX+5ZI9_[Y4O=CG=6\<</:0]3Z93^')O\@YQ49^E677T(N_Q[X0=JO1,%
M<85IQ5J*2:KIQ-9CZ?M?JQN$L9@_*WS9 )'VME0;^@[*13@>!H>?#4#/-%=?
M(#GMY9O(%9>5SR@Z;U[KUBM-"5:8KHJ>CEH^B_*[^CVE"O+O=@[3:54SZ.EX
M9-O#:3R<^6.TU!U4N&K%.@Z-)4W&JU:O=5^=W=IZ1IO[5\'M'3L[*2FMYOJO
MD-#=JSW].&U/C[/[HI;\_4?M6]/XPS%B\S>[;]=[9?\ ,U#_ /Y OK^N7M&O
MFG0G]*\_S1,HZQ.+7:M3V 3>#CQ#J!K]^,3D$8%Q#D*M4BA!\:E39Z6"8*Q*
M \4PJ0- D3-/.#J&GG-.OE!^OH'S2[MH/3>B-,+7.VMWHO25RT@K#]QE1Z9W
M.\6=OZ)VBOMIZ/;V-G;:^+,PTFC\W3/G#VFE=%:1T9]C%%C\/N5ZNCM?W25H
MK/X18UV7I-GX/2VZ'7M*E.:H=,K,RBQ?D-VL\9C,=CNO9V4NL]P6-I9O21Y8
MNA6RD&Q 0B]($G[2N_FO/>8\YYORM_(\OR?+VZ>4.XJF8C!9.?5&?[#6AN6W
MQ<G>CR?[6H0[^SDI4 'IX<M701#O]GVDOI#N[O7Z\=3]7O(Y8^OOW&"=3V>?
M:L*'^</@\8ZATVF5CV-8.R<;W6=$&U@S=^F>S9J9]KGJHU;-GL4 *1T*%3JG
M \221,$K3\B]:+5XMJK7TKIVTELJSI<1AG/#>8FUF\EUGK%IF]Z7>EZKJ[TK
M&;%72FV5'HK&BR45NVHS5$N*5#;SS/+]3S[5CI][%4(C\5[+NGK\!"N1_K\_
M7P6AL%]OJW_R$O4JU&_]B1^!^\E9?^GZ_P#J%/\ ]3'8D458O9B=JM/X1)(:
M/'"HVT)"W;H!7A>"M4*4-S"]_. G"ORO._L.@Z^<TZ@(_K@SZKEH[X)>[M>?
M356GP>WL[;T>PJ=OT=:K=.U4TE,0FWAN3R?ZFA_)'9Z)TG<](K3E5O\  [96
MJL7<MA5M)J'6K:IK/.&^$'L!V9':IAJ #QOJ7N#N#[>*L 'I\M>!]0"'7Q\,
MV27EOI22^QYX4J6M)+)J=UT?KC<7C5JA2W/PY3B\+">:Q=HHSW=DG/ZF3VJ(
M_P"YOJ4.[P^WDKZ?2->]!^8<G]_&B$OL=?+^R-$QUW2.SWE+U/EN-(*E?FU3
MQZ5;JI]>'J/69^S![55IM.JK*TXXU&?M6;R_.P-(W@KU!V%\C3A'A(%6%>["
MD!/JN%5Y8$'"9L6!733RO+#"7EYTA3Y;=1[SJ;58UZOJ\V]E;._^DHO]5+L;
M6SM4E=_X,FGL;,JN5+PA&0_)G>_WN]:+KK'12M)N[6=K9_!:F[JJU:6==FVK
M5>F:?QI7Q,<9>+)M?:&[5OJ(CPUI\?DY%K/^JW^;-$EYF]VS>O-M/T+1/:M(
M*>F%SQ-G5YR]I_Q4H_\ >O\ _P K\<1]H?M6QV^\VJ /C^Z*6_\ 5:'U!D?U
MG%WB?LXMF^#T-0]_%Z0CF1_7+VB7S3HZ/W6;]?P1O+EZBZ/%>)=K!QEL:[K
M3\(:<EVUQ(:V1[MAO)AP: 8_M>(Y&DU,U4:5*X"O%S"0#OMKL4E%+Z*&H"<!
MO779;R7:@4^335:SU:HTC7I94WZ]7SX6[NKLYO7HEL.R]+;84*R^4J\74VZ5
MOP9Y0-<JM>=/U:;JN*T?-UL+LK!6WPC"QV_C>E]%8MSM[Z.EMRR<'W4/:U=/
MP<=+=?9]UHZ=WQ]?M)=,R/U=>'OGU%D$]^-TWON>P(UZY%5!'*3G>KVL2%0^
M+ST^QFXQE*2(3$;KN_J(S%-RU"E4<N3&(0;=M2=$A9P*3!4"64!(/ & , 8
M\< AG?O&&;SRV(-R"HNW45*77#83)*O7O#] ";/A<XK64.;8_&1N4Q':30U;
MZ9&I(TIY'$GMJDK>>@6J'1&X)G1M<C4Q3V$SNW3,<^F"Y?&>@6OC?5Y<!2R-
MTFS\[2N9V)8-@/J9$B>[ LJQI*XRV;R]R0-VA;>VBZ/3F?HW-"'44;*RIFQG
M3;F$("S-@;;<LD#@@8 P!@$5N7_,&I>$E6M]PW3K*@A2Z<Q:!&*8BR$OZYN<
M968MU2NB]":XMQ@,;<2WJE;LI1[+%J=,4.Z9O6;CYO!*3J:2S?[2L9YR)KN
M.7'QO7*'%\*Y+V"FKBLGB+DH'=D5.RRN9E:*)U<G'W13Z$QU9%H,[[I7-NT<
MS#U:AL++2;)E1BL@07T\[IUZ=>H^/3U]/ !$/$ 'X_CP )N@>(]/EZ>KU!W]
MX_$'Q>T, \P'J'7VX!S@ 0 >X0ZA[!P#Q$.@"(=W0/ /#NZB'=X?1@%C:IY
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M[Z1NN%G(FHU<#BDZEAQ)ZE)#6&;-CM)8EK,'!.F5&L\:=WAJ=WOT8XIG2KU
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M7;B--SE=-N<7*>@6XM5R3XS=H5<KW'60L *VN6J'6J*0-M:@'4P '0[2<M"
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ML2BTC3$.:9._QQD>R$[VF!$\IR75L2KRB'='J&NJ1S*T/U+7I@U "%6II0
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MP3;^<3 V/SHUJG1$"8P1,3^CJB_,&".Y7D;#UP077   .@!T .X #P /9@#
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MM[(:N3%NRYM:SD*=S<4;=N8"Q2A;E#FVD+UA!.Z=(<X(2E!A>ZM/J8!VN ,
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M1K3HBZ:;T;1J]?[U3<[[3558J\65M=Z;.UBBJA[5%-I:)8Q%;E&O39</:&&
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M*J5J'%=NG( 35"]S<E>YBMS=W1<<J<W=R4F;J'!S5JUAVPF';8(\<.XN;@#
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M$S0O;8 .\Z@/@/7 & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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MBL1,W0B4I9!#-8@XVO('U>8G0L;AJ?HV#8+I)E3H8*5/OI(E#XH7[FZ;+S5
M[ >]9\9XM-2*LXU<<>HQ$WN<X0Q>H&&Q&.#:(U=BOVRM>WL5?-D@2>9WEKMN
ME6K$R%@)]U%FY!Y^I9FVF^^ 76=J_@L@12%O?(?%WI!+T:1NE:)WC[2XI).W
MH"]R4*&0)E:,TIY2(B3-R4B9QT4%)BMMBR="]=A 0/;B,,B, 8$,5@T7CT-C
M+7J9HVQZ+,K;'F-OT--W.,T1-+2F1H$NIAV^YI@$)] W-WW,VZ[["(@5+@#
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M!@# *<?XA%93Z-[YHTP2+T(3=D0/C.W.P)=C@T T4X."91Y@3O-E^<$KR/.
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M[)-3IS"G78!7%F$$[Z'Z[%:#J!WX  !T#N , YP!@# & , 8 P!@# & , 8
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MNBUQ"<(ZR3F , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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M(2^_UY^.>\NM?_!*86P]<B]J\Y"+:>AW+6 MT,OB-:5PV3ER<5[-#55?H93
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M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
%P!@'_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>g60414g55l64.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g60414g55l64.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2D@4&AO=&]S:&]P(#,N,  X0DE-! 0
M    *02^$% #A"24T$!       +QP!6@ #&R5'' (   (  !P"!0 ;4V5C=&
MEO;C M0F]X+3-?4&EP96QI;F5?=C$R #A"24T$)0      $(NUVIV*?&OFSC
M2S/R9F +PX0DE-!#H      /<    0     0      "W!R:6YT3W5T<'5T
M  !0    !0<W138F]O; $     26YT965N=6T     26YT90    !#;')M
M  #W!R:6YT4VEX=&5E;D)I=&)O;VP     "W!R:6YT97).86UE5$585
MH 00!D &\ 8@!E "  4 !$ $8       ]P<FEN=%!R;V]F4V5T=7!/8FIC
M  # !0 '( ;P!O &8 ( !3 &4 = !U '        IP<F]O9E-E='5P     0
M    !";'1N96YU;0    QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"24
MT$.P     "+0   !     !       2<')I;G1/=71P=71/<'1I;VYS    %P
M    !#<'1N8F]O;       0VQB<F)O;VP      %)G<TUB;V]L      !#<F
MY#8F]O;       0VYT0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O;
M      16UL1&)O;VP      $EN=')B;V]L      !"8VMG3V)J8P    $
M    !21T)#     P    !29" @9&]U8D!OX            $=R;B!D;W5B0&
M_@            0FP@(&1O=6) ;^            !"<F1456YT1B-2;'0
M            !";&0@56YT1B-2;'0               !2<VQT56YT1B-0>&
MQ <L            IV96-T;W)$871A8F]O; $     4&=0<V5N=6T     4&
M=0<P    !09U!#     $QE9G15;G1&(U)L=                %1O<"!5;G
M1&(U)L=                %-C;"!5;G1&(U!R8T!9            $&-R;W
M!7:&5N4')I;G1I;F=B;V]L      YC<F]P4F5C=$)O='1O;6QO;F<
M  #&-R;W!296-T3&5F=&QO;F<         #6-R;W!296-T4FEG:'1L;VYG
M        MC<F]P4F5C=%1O<&QO;F<      #A"24T#[0      $ $L     0
M ! 2P    !  $X0DE-!"8       X             /X   #A"24T$#0
M  !    !XX0DE-!!D       0    >.$))30/S       )           ! #
MA"24TG$       "@ !          $X0DE- _4      $@ +V9F  $ ;&9F
M8       $ +V9F  $ H9F:  8       $ ,@    $ 6@    8       $ -0
M    $ +0    8       $X0DE- _@      '   /____________________
M________\#Z     #_____________________________ ^@     ______
M_______________________P/H     /____________________________
M\#Z   .$))300(       0     0   D    )      #A"24T$'@      !
M     X0DE-!!H      S4    &              -^   '9          !
M                        $             !V0   -^
M        $                         $     $       !N=6QL     @
M    9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG
M        !,969T;&]N9P          0G1O;6QO;F<   -^     %)G:'1L;V
MYG   '9     9S;&EC97-6;$QS     4]B:F,    !       %<VQI8V4
M 2    !W-L:6-E241L;VYG          =G<F]U<$E$;&]N9P         &;W
M)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R871E9
M!4>7!E96YU;0    I%4VQI8V54>7!E     $EM9R     &8F]U;F1S3V)J8P
M    $       !28W0Q    !     !4;W @;&]N9P          3&5F=&QO;F
M<          $)T;VUL;VYG   #?@    !29VAT;&]N9P  !V0    #=7)L5$
M585     $       !N=6QL5$585     $       !-<V=E5$585     $
M    9A;'1486=415A4     0      #F-E;&Q497AT27-(5$U,8F]O; $
M (8V5L;%1E>'1415A4     0      "6AO<GI!;&EG;F5N=6T    /15-L:6
M-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%4V
MQI8V5697)T06QI9VX    '9&5F875L=     MB9T-O;&]R5'EP965N=6T
M 115-L:6-E0D=#;VQO<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG
M        IL969T3W5T<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N9P
M         +<FEG:'1/=71S971L;VYG       X0DE-!"@       P    "/_
M         X0DE-!!$       $! #A"24T$%       !     (X0DE-! P
M  'FL    !    H    $P   '@  ".@   'D\ &  !_]C_X@Q824-#7U!23T
M9)3$4  0$   Q(3&EN;P(0  !M;G1R4D="(%A96B 'S@ "  D !@ Q  !A8W
M-P35-&5     !)14,@<U)'0@               0  ]M8  0    #3+4A0("
M
M   !%C<')T   !4    #-D97-C   !A    &QW='!T   !\    !1B:W!T
M "!    !1R6%E:   "&    !1G6%E:   "+    !1B6%E:   "0    !1D;6
MYD   "5    '!D;61D   "Q    (AV=65D   #3    (9V:65W   #U    "
M1L=6UI   #^    !1M96%S   $#    "1T96-H   $,     QR5%)#   $/
M  " QG5%)#   $/   " QB5%)#   $/   " QT97AT     $-O<'ER:6=H="
M H8RD@,3DY."!(97=L971T+5!A8VMA<F0@0V]M<&%N>0  9&5S8P
M 2<U)'0B!)14,V,3DV-BTR+C$              !)S4D="($E%0S8Q.38V+3
M(N,0
M          6%E:(        /-1  $    !%LQ865H@
M   %A96B        !OH@  ./4   .06%E:(        &*9  "WA0  &-I865
MH@        )*    ^$  "VSV1E<V,         %DE%0R!H='1P.B\O=W=W+F
MEE8RYC:               %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M                                                    !D97-C
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M(#?@.* Y8#H@.N [H#QP/3 ^ #[ /Y! 8$$P0@!"T$.P1(!%4$8P1Q!'X$C
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MC0.="ZT3S1OM(_TL'31-/&U$G4R]5.U='65=;8UUS7X-ADT
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M6M45'"":J];++UDK;JWVY%)325M72T<)42U=1#31%R5023R+$A=@&*J&<:B
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M+1B" 0M&N2\](:*FJJK-6J5ILS:HFJHJ.9HN+3<6.2G6& 2M2T\8N$>1Y!I
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M2R3 N-Q9T'F+<@N9RC,<_P 4S=DB8",/S6Z.H%]MTIQ0W+Q]E&XNTD[;'$"
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MBHDJ(6.5RQI1K9S&LJQS(0@DX;^D;YGF6>,$[@7<)5SUO3Y/2,!8MD:#R)T
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M)6CU.@"N\R,%<I+.LJH_#9#"<IYIP[E [C[(,JW9<G2>D81QEVTK!8CR@Q;
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M_>[?M?;UK.!-;T8IO,%&Y\QT&^W3PQF<>#[]%\HG[V(G.]\VU!6%2M* [O\
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MHM$J5NK==1)!*U%/C=7C6ZZEEM.-U>-:U[:\=<(S%V9CS9BQ]9))^<XZL *
MHY  #KL!8;XT7%<G#M@'EP)$A&'DM& A..QU8=-T8O*X.7?XTQYD;&H23%HN
M7B[@?=)" /)98B=>CK1S5])1(,^@Q9O;3-QJYQY+&Q )+'4MPPU,K$7OR!4
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MQSD.1Q(]+;&>([[9$3$/;VSHK;>3CBI"ZCN^VY2E7BE[BO.XJ7<[CK[KV?\
M8J[39ODN69G2]J4I*>MHX:B&F,F8 P1R(&6,B-Q&--[64:=MK8^49SV_R++<
MTKJ"HR.2HGI:AX9)A'2$2.IW>[D.;DW!;<?%C7_Y_ILM^LCDGW#A7_5C[WM4
M\5-;C^9CM=U[8I\$N9\OS^?ZO/&M_G-[.?ZNR^OA45_[7UW\3CGY_KLN[/\
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M.9#LFW8/=P4"RJEB\@ZD9%QMXR 4EMDDQ)4'!9A;N.R9F?/,9+2QQ-F66@+
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MPTPPTPQE3$']<[O["NOW8/\ EV?@XZUN:?Z.GXY?[$F,_+O\^WXIO[2?7?\
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M9UKFAJ&IZF*GHIZ:.9*69IG@IRVAYY)I((*J5T%1J@[U'&9(XXT*.\"R#O\
M,Q1V(9^G8Z>[9AA"%/\ <G&H7@8Y&IJ\R_%W> \E(P!C-IX\89!1&EP<H')V
MS9^#5 X]2' )9#; DKD*RZZCK,H^Q^6S5.3TCTF>R1U29'456;Q3TJ9;4)F]
M$:QZ6D5Z(O%+ Y[HDPFK-<U-5&6GA4*$QY>T5:D&8U GRN-H&S:.GRZ2*H-;
M"<MJ>[K/4E:@*Z2@<=X^'3!8YX D\A))BT^Y3O*&)VY&'%6./LJGX[NSQYAX
MIG7'6/\ (B6%".)S;/;\<F9AN/"2'(]!F4!%V;[H,,C*T_>L'I>.&CJ*CIR*
MNAY"_2=A*#,2E5&];ET,_9VLS*/*:VLHCFJ9C$^<14T9:6&BUY?(,J[V\XHU
M=8YHH2%63O*6I^U-92%H'2FK'CSBGHI,PI::J% *.09>\K%4DJBE:AKQ D)J
M"C-&\ERR&!\IX]WT93R#D46V?S/;UBB%]T89.!(MD(!,5)_G"#[A\A3!GC]Y
MC=\,FJ%0KT= VD4'T<>@B;LS>0?1#0O2%QY-)5G@5O9.@HJ*0K2YSF%5IS2*
M6HHIJ7N>55>2T=,U8E:CTK<57K&J'([W2M%1F#A=ZG)#9<&?U=14H./EE) 3
ME\D<55'4&HKJ?,ZJ=:=J5TG7ALM.D2@FGJ%DJ>+Q!3Q %<38]Y0O<^;Q)-9:
MA;MTRO,*[+9+NM##HR-ED"%XD*1B14$/X/E'FSG*#N1*/ ZKP_&+6=L#)R![
M%#P-9N(:N*'Q6QK>QF0PYE2TS-G.7TO\J(.STKSO3UDN8QSP<5*N@_R2@6'3
M*%@G+]ZCA6HAE#2,O!DPJ3M)FTU#+4!<MJIVR)LWC2,3TZ4CI+PV@JSQJLRZ
MDU20E1 TAAD32H/$3[93Y27<-C3+N1HNI",7EXE$L3$LH#VPJB)0VU"0G&&$
M,IR$E)R0O*3TN%?S*D[F\("1,]C6,5C+E/&TJLD\T8RBHM=0=A\EKLNH9Q59
MBE14YBE [."D32U5?FN7PI!&^7K'*E*:.EJI:F&NGXX-=3FGIFI]857:C,Z6
MNJH33T;P0T<E6@1E:01T]+EU7(TKK6%HWG%340)#+2Q<(BEG$TZ3</'>'17G
MH46LI7A<E16VEW97\E9SZ4NIX*]M*5[=?*2+$@]#;XL=Z#< ^(OCJ9QOR@>:
M92;QO&B^WYR3DY['V-Y9*HS"KQ39ZZID3'F=\@C)+"3.1I["8NZB*PK&T2N<
M-7YE<V%*.YG%E+C!42U=4R&@0:B)+#4P4L#S5D4@A0Q!NQMR! !VOC&6=SI!
MCNQ520MOND=@1J8"WH@$$W!N-R,9#@6_QA(,-@YB9]!+O)]"!]S,,8Q,E5])
M $9 QDW)T'*L5H9?R)D^E2HX-$XNL_IW$^DLNC]J5KE%S8DK!A],@7T[ ,>1
M)-N=K6 NQMT!Q4L]T#$#5<ZE!W L2-K\SM:^QN+7Q' '*"DV\;RT-R:UQSCC
M,.*<- I2\Q]*7[N,$BV1TC^84)6S&@CYUN;?1.L(A$%R(*097+E1$<FR2ITD
MI6Y*K>3!Z2Z=3(S$:@+C39"-P+7NQ!\2-O.!,;-J 5E0$@@B[:G!L";VLJD#
MGZ6^,D9*WA7-I+=Z7.1,"B,5V#3%&N8YNX*2R%2&<Q,6!D!;&8$C#)8):O3L
MF#38#?''0IR>*LG46G+9K#YB_02&CJ5BVW5RUQ=5L"%)L&-P3L0;[ ;K=A?%
M;2F_HE O1C=@2 "5&DC<AA;GR;8\L7V+[U8"1DD) 2/(&'@*I:<9WA$Q;.YH
M)&$8J7QW.C$:@ 9^U*'4EPY^7BA#A[<*,MDGQ1=N\4$,FZ""J*4&%@&LKFP0
M@Z38AE!8\N0) N.77!902MRHNSJ=[$%6( W/,@7MUZ;8WFU9Q>PTPPTPPTPP
MTPPTPQI!GW=P6PEE!E'T<<DI5C@+"B13(\S;7I#64;FAX<<?8JB]TF*OF,5$
M*2)[%%X^7L/KMNY7V0<=DK7C4;<3JK>2(.MRP!)&D<R1<!CI%R;7VM[TCF1B
MS)+H:VDE0/2/(!B"5&HV47M8WY:E/*^(^8W_ $/$0_;K,;8,9+,,_O3[1NH.
M+-FS$#Z%Y.$B1A,<_D0\!?*R*A W4L!$H,A#N214'(C(FBSEDP%%9$!+2+J
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M'-2S-J3?*-$*Y6.Y9N4O511I9*KI6+K?1R*=,V6][-5.<S9EF"9D:SNZPR&
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M3+$*@7)*Y9W* 42K(6PJ(* 4B4HR[-,)1YP@.OG"<Z."RDX@ANVK^+PLZD+
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M4NM305NL%''-&'K4C]F =#R=3ZF'TXHGVX_ @UZX9/,PXX1M8)G[S!&LQ 7
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M*E1&DE*1&6,+Q,.,3*K A2.U+ N'&&"H46@P=P.N!N,C90F@$:'#) !$:#9
MGI^9CXH,%-UUVK9E'$#=HI&K.UHU6HVJN@P8IJ4;)\!F^9OFU5'5RA^*M%04
MLKRRF:2>6CI(:9ZB20JK,T[1<0ZM3#59G<@L>NH*):"!X$*F-JJKGC5$$:1)
M4U,LZPHH) 6(2:!;2#;95&V,U:U>,W#3##3#&5,0?USN_L*ZX?=@_P#%QUK<
MT_T=/QR_V),9V7_Y]OQ37_.3&RFM#C=8:88:88:88:88:88:88:88:88:88:
M88:88:88:88:88:88:88U@W/;4X5NLC@Z)SN7Y#CH!JU/C2@B'D(NH%E(B2-
MFC4BPDD<G$2F\9=NF]C))2/R=H&832).%7J\4DH50B0JYWV0]H:KL].]124U
M%-,S0O')4I4"6GD@9F1X)Z2II9U5BQ$T#2O2U"A1402Z$TZK-LH@S>$05$]3
M%'ID1T@:$I*DH"LLD53!41$@#['*L:SQ$L8I4U-?#3ODW<(7SH1.!,NRS&[H
MO*93D&$QT0>B3@5!<FS2(UB$ER'$S9Z#FI^--F$>BD),,I-'4'*R]NA)"L3?
M/[.=7:+VWS;NDE))3Y=/QZ>GHJJ:6&I$E704M3WF"BJ8HJN*C>*(WACD%*M7
M'3,T$=2B&V, ]E\OXZ3QS5D7"GGJH(DDA*4]740<":IADDIY*E7D'V5XS.U.
M\]I7A9@+?"'<G9#85;@U ?GO/Y!AM_E1V90P29MP*]%DS\E79+&3,O9V8(0L
M/RAY:D83KD*^K;)B59?,7:,T3(R%X]JJ>VE55>VQ?*<G1\YIX::JDB]MTDCA
M@#"**F;VW)AIU)C/<AJH3W:F4TI2%4Q5!V;@@]KPM?F#+ELLLT"2>U[(\DQ!
MDDG R\<2=OL@[UZ-6./.1/JE9CE'(.TB,R3#NXO&<9/%11'/\Z+99=&3=6Y1
MH!R2M2(.PZ[5DR:C%;XPP+P2.N5Q:R[A^LAUBEUG7IT:(8%%VCGI\SR6OGAC
MD3)Z6/+UBBO&TU".\K*&=VD'>'CJYE$@4(#H/#]$ZLFKR:*>AS.DCD=&S&=J
MLR26=8ZK[ T9"J$/"5Z>)BA)8C4-6XM")+R?N-I4)R7&7>4<\!X)DRS)3M3&
M0"="&F/X3)<P29.:9#E,/#+Q%RN[)F);4B>8,9T]F<:CA$V;<QF/AE"2W#+@
M[8UT$E#.M!E$M70=Q45\U)*]9509; :6B@J95J5"I%3:(7>D2EGG2*)9YI0@
MQ8D[.4LB547>\P2FJQ6$TD=1&*:"6OEX]3-!&T+$N\VN1%G:>*%I)#%&FLXL
M<@Y,W;Q-FKQ]D8QE;(.1R>1@^32^93DU1#9'*&PKS$RK<6XK!0L0A+>-*B\(
MXW 7AQT,96-1T?0>BEATCYAU.Y#VZSJE94HH\OHZ%**6ACRR*E,E"D4J9@&D
M JY:FJ,XDS2MFXKU3%I)BL@>&\)H?LOELVJ2H>LJ*IZF.J>M>H$=2[QM2,L9
M[O'! L!%#3)PD@4 1AT*RVD%$1Y,C!Q*2P^0*37+*3>+1_"H%\!L>8U7:3"N
M!I@7GT,-GY$_QB\GXD\_EIPD7EC^!3*&62)1>Y!TWL:UO1OK3MUFR0U,(I<N
M+3S9I,DI2N#4OMO31T=5%#"E>M')"E/$D=,E7351@ U*Q;?$/V7H9)(7-16Z
M8HJ")HPU,1/[75$E5!)+*U*:E97GE=YGIYX.(3:P&+]9R=.';XRK "$]S<8Q
M>S(1-Q#<5%)P+7Q[CP/$,HA<ML8M%P2460N>AW4C CQ:SV:.Y;*!L1M5B\;D
M0(6K<EJT>VN9\<5B4F51U[I4"JS&.DD6MK9:B@ERYYZB8U!"R+#,\@2E6FIW
MJ2*B>&60 XJ7LS1"+NS5%?)1H8>[T;SH::FC@JDJUABC$(+1F2-$O.TTR0CA
M12QH;8@D:Y)?:B!8"PK^_*DLCHL83:W #V0'+)F5-&,;Q7%1*8FWT2'Q<\4E
M#Z(QI^V>KN#%1+]>;3:Y\(<MRS1L-RY_9$[0S-)(HR^GFDDC;C14:N\<45=4
M9A'2Q+4O411TZ5,Z,H$?$04M+HE5HV:3'@['9/"%7_*Y8U5P8I*DJKR/2PT;
MSNT*12M,\,3!B9-#&HJ-2$.JILGMHVUI[>4LCH7S$U-JS$K FHHI(E474@;0
MW&.((%B6*LI"2;LQS<U)'*$.?2 Z:0',$G9 \H@FUM3:6*JZ//<\.=&B/=HJ
M44T=8TD< *PM55^95>8U#PQL[F*!34I#%$7<JD(8M=K+M<LRSVN[U]GDGX[T
MX1I2#((:6BIJ.(2, JO*P@:21PBAFDM;T03BVSDX]O+0>'9!7&18\XCX<F "
M& \N3L*BPQR,P^*'AS%1Z)?,V[4T.B;MV]2396VV'IM/)$RHT-GDWS'3]XDZ
MZ2";D$;$W8\@1R+?$%'(8SN E@ 6%A8;[@6 L-N1 W\R3S-\5,AV!8Q(/V16
M-3+(D,)M90O)Z/1I(0_5:NBD[93^1+"+2(=6QD2,E!09C1V^M+CV L4W10#7
MN'#]R["=K$$*P*A;6(V"Z0#8[@#X;]<28%Z,R[WZ'[K4;7',\K[[;6YWD6-=
MANW?$N1HQE"%1Y\SD<0"E 0'K!429L8-B:DRI19J4*!G4H8+LAT^E 5!,;(6
M3%X,(6VFF95XV;O$Z6F=E9219K7Y]-)\;'=0=P3MM8;8E845E87NH(%['WW4
MBXL&(V(%CO?%E.[!\1/(BSAT?>&0;"RD8%D73Q6\L]<Q,&&P)%B@<>LU<A+Q
M9,_$MNL&CZYN^Y^BW;$)7>H'?6&Z(-9$S7).YW(Z68F0@];@&1C;;>V^V])@
M33I&W(&^Y(&@6V(.X0"_@3XXX&\GIM] &3<EBJ,GB,F*R4C*V4CC+B,"S( J
M^EHZ;(W,7ED4OJ:2$R%@NX%5FULL<(-3!8:NX<CUFK9H,[FP-B+ $&Y! !'*
M]AL?N;<O7>1 @O:ZF]P18$&]Q8VWL;VU7YGX*]AL#P"&B:<.C]DXCHQH$1 #
M'867NFIP0R;)SQ-HH.-7MUB%CMM;D60<QRX6<7*\T?:ZHXL;*6N(XSDW.DFY
M/+J;=.7W(Y8"","PN-M.QW %^1Y_='KSWYXV$PMB&*X(QN"Q="UB[F.Q]W)'
M[1P=<M'A5=Y+)2:F)E9TNQ8#&7!8V?(JH(M6#5NU;WI-4$;$D;*:H=R[%FM<
MVY<M@ /$\@.9Q<1 BA5O87Y\]R2? <R>0QE/5.*L-,,-,,-,,:RY9VBX0S7(
M"4QGL9M)39X)%QX=,J)BUI%&8V.;2!DZC4;=D1A!%A'Y&QETL'RT2LV=LY(/
MDI5B437:7MD6UQ)70 *;"Y-M[$W!N0#S!52#S%ABV\2.26&_*]A<"Q%@2#L0
M2".M\0\SL4P9(HWA:-'DI.:1P0N:5A),N0#DS%$Y#(0TJ)MUG3X X0#66'XY
M'WH5Q"6L2(11N%8!XD\!@K%1:LB9P7(L-=K@ @; @; [[$WO>]R3<[XI,"$)
M>YT7"DV)W(;J-K%01:UK6%AMB(1CD[\+06-S$7%B,G(FY:FNNY,Y#>)2QBX+
M5C<DC3=P>"A+(4H9&WM).1O,#FA8([+W5I?<7:.KKGFJC.Y() L#R78\P=B;
MVY"VQMB! JA@";MU;TM[$;@:;BQ.UQ\>^)E-MD6*,BPS",(EY[(1$3@Y$)>*
MZ.1-;:S0P%*1<_229 1>B2"!V1$I'%6ITJ:03'DWSPI(47#M1@=)-'%(F8%R
M HUWOM[D&XLIV( !L!RV!Y@'$F%2J*2UDMU]T00;L"""21<G8[D<CBXC]G<%
M"XUQ[BH!.\I@XKCF9K3D:W9&8HX1,D[GSDFQ&'P12%D8@M& )!Q80C4:%1H0
M(CQ-@*+B&S0N*8/FXRL69B%)86Y$6VM<$$-<C8DDD@D&^)$2A54,P"MJY@W/
M@P(((',   $ BUL6P#LEQ[&'405 9"S&-8PHA8Z#!4Y4 <"J,&$6!P6,AK['
ML1=/&R$)A0%&,PTX+>CIF"8DCSM"47F39$HN,S&]U0D\S8WYEB>?W3&Y!N#M
MM8##@@6LSBQY7'@ !RZ 6!&XWWN;XSWB?%$=P]&7<9CKPR3L)R S*C)<^NP5
M*%SYY>Q<F1<I!QH4*TO<7)I<] 0'&M5%++WBR"I!T]>.:&8N;FVP  '( <AN
M2?C)Q6B!!87.Y))YDGJ; #XA\^^/YMG*D"BBW*)[S%4AK]5._<#D*ZQ1-FXO
MLOMJ96X76WVIUMNMKX*TK6E=>Z>P$T2=B^S0:5%(RBC!!901]B'2]_7\'COY
M3[8PS-VHSQEBD(.836(1B#RW! W'F,:%=3&/8HE]PNO]%KK^\0??H_SU^G'-
M<"?[S+\F_P!&'4QCV*)?<+K_ $6G>(/OT?YZ_3AP)_O,OR;_ $8GN+\,92S-
M/HOC#&D(/RN<3$HB(  V#!:U5TZ5I=?>JLX7M2:L6#-O8L\(DGJ[=B.8H.'K
MUP@V055MPZ_-\MRNCJ*^NK(*>DI8VEFE=Q95'( "[.[L0D<:@O([*B*68 Y-
M'EM?7U4-'2TLTM14.(XT$;"Y.Y)+ *JJ 69F(55!9B "<>_7DN^34AW)^8N=
M7/GR,KSOD1B,5RG,FUZ_53>C3GN&D,B2"MJ-4XV$<KK77$G*"9.0/[E"+NUJ
MUH,%#?&OL@=O*KMIF(T(:?)Z%Y/:ZE8+Q&U>@U54D%@9YD"@(I*0J%C74W$E
M?TIV1[*0=F*)@S+/F54B=]J%OPUT^DM/ "!]BC):[D:Y6]-M("QIV=%?H.SV
MWPKO]G;UHSK[_AU\^ON+>(-KBW.W0>JU@3:Y\,=?]3ZN7]WS8N7R_#[_ ,J^
M[&WP F]P+^K8@FWC<?,!B/K\?U_9CCA\N-?O=_\ %^+3QMR\[7WVOM>]CU'G
MX[OKR^OQXM[WZ)$_9&__ "63X]OR^_H>=N?,;\]R>?/?S%^GJQ4.1]1_6/KY
MXN'AKWN/@K[79][CJ?U[EKCJ#X=+>>QN1Y"G"OWO:X\?O?B[?<X:<O*]_#8@
MVY]0>1&PM<VMABWJ?35E6GA'DN]6G9P<B>/;]NO>_GU'Q'GZ_P#"PVVL+GPV
MGZ^7(_KZ?#BX>UX/WO:_!P^]V<0ZWY\OV'<'?F#L#?U8CZ_7ZWP\'WO'^*O'
M[=/=TO;;U^5O+E>WER-^5QA]1^S$ABGTP,?I,/\ MQC4'G]?5X#GSY#%U.1]
M?[!C^:]RK3A=MRDN\9=LLJW63SC*JIK(*7I*V7<4+:UL43NMOMKPK6G&E:5X
M5K3PUU[K]CT!NP_9D, P.54]P0"#[KF#L<>4>V+,G:K/"K,I&836*D@CER(L
M<:*QJ7R.(G1$C DKFQ8&[;O1JCMLR+LTUFMZJB-CD28;/Q)!I2Y=>BC BQ=,
M5[%UTUVZB:RMM_63TL%3#)!-'JCE4JX5FB<AK7TR1,DB,=*V='5P0"K @$:"
M"JGIY8YXI")(F5D+!9%NI) :.0/&Z@D^BZLIN;C<XO60LI3_ "I)GTOGDD=G
M#Q!H-'++VH,1+%$6&%,08<2-"!&HT&(#B@PL<,'"1(YD-9,639LV:I)(V6TM
M4674670)34<"Q0HSN 2\KEY)'EDD>:9I)I9'E=Y'DDD=V=F9F)).+E7F%973
M/454[R2NJJQ&F--*(L:(L482)$5$152-%154 * ,0N]^_OX\]Z[OXN:O:\]R
MM=Q>5X<7=>-]?RS7A3BO_P ;7A3C?K*X<8Y(@]'3[E?<^]Y>Y\N7EC&,DAYR
M.?2U[LQ]/WW/W7^US\\<7/GM]]RE[QU??=<XNNON<+77W7.[:6.KKKJWUK6Y
MS;2EKBM:UJM;2EJG.I3AJ=" 6"+;T=M(MZ.Z]/N3[GPZ6P,DAW+N3Z6Y9C[O
MW?7[K[KWW6^,C8SS-DC#\DNEL D*8J07(*(4?$P4=E=B55';1_W6W8RX0='M
M2B+UBT=M"[=HD59.4+%F;Q!3C=7 K\JH<S@%-60EX0P;3'+-3DZ59 I>FDA=
MHRKLK1%C&ZG2ZD;8RZ/,ZW+YC/2S:)2K+JDCBJ  Q!)"U$<J![@$.%#@[A@<
M=C_(ND7YCE(\8%BKQR1*%!67")(@\6O<.WS]] ).Y>/'2ZE;E%W+EPJHNNLI
M==>HK?=?=6MUU:ZXSV38TB[$9A'&JI'&^7(B* %5$K*=54 6 "J  !L  !CI
M>PSM)VII'=BSR)6LS$W+,U+,S%B>9)N2?''N1UY3Q]]PTPPTPPTPPTPPTPPT
MPPTPQDS%+:UU(W2=RSE"E [F_GM5U&ZE:T>,+>;6].M+JV5YW&MO'A6ZEM:]
MMM-:W-/]'3\<O]B3&=E_^?/XMO[2XV!J);TK6E296E;;K+;J5+.:5MN4K2EE
MM?ZIV77UNMI92O;=6ZE*4KQIK0XW6/WU,G[(&/*CO^'IAAU,E[(&.WO?FHZ_
MAZ88=3)^R!CRH[_AZ88=3)>R!CC]E'7AX_\ Q_=][VM,,.ID_9 QY4=_P],,
M.ID_9 QY4=_P],,.ID_9 QY4=?P],,8 E671L29YY)%42K<=A%./+.7EQ\HM
M0PB=C J17*7MFC!=PR[DN)=QTL0L(7KT2HO_ %+GU2LK"$Z+'W>KYMM_+K?:
MWJQ;+@:]O<6)/B"+_-OXXQ=(][^W"*.@C(U+Y:S>&4W%ZK-PI5F\#K"% Z,N
M%$69 JS=.9+!U9+%;)1#P*)J7(^B82H)!%TJ$5!]8@D-R -O/GX>H-8V)L-C
M<C:]+5$:D D@GR\+7'/F+BX%SN+7WQ+$-TF('43:2=J1FJ[XP<$A8O!+'XRW
M(\L1/3QAC,-) L/5D:9%*(D9N03!I20WU.-1O17>/%6P^B3M:GA->VVP))OZ
M(LI:Q-N=A>PN<3Q4M?>]P NVHW8*"!?D2;7-AC%#'?[@.0WC2$/-R&1Q>ZPD
M_-'&YYK9W$!]#)L_&#;.Q$BZ')I25<"^8J#946B)J+MTZ%Y<-!C%FCAS6:>0
M7#"Q&UC?<W (WL>O0$'I?%(J(VL5-QS.XV%K@\R!?P)! W8#%)7E"L MZ+%"
M3B;CHDZ91OT+R9<_&ZMI4=(O<QM)1'QO&56#JK0NW"<NO<$+"[@=*5D4F4*7
MD#PA'TCSN[^5][BQV'H6)VZZQTVZVZ1WF/K>VVDW6S'T[@;_ '.@F]['[DFX
MOF/&6XR)Y>RKZ X4.FSB+*026S$;D0HY("1,B6AV06..BS*.,'-G=KMFU/7E
MVCMZ1H*=)N!-JC<6[$E!I9S0T11=1(O=5*@W(NI8$V\1Z_@(.+BR!VT@&UB0
MQ! -B ;;;BY(/(@CE8WQM'U,G[(&/*CK^'JWBYAU,G[(&/*CO^'IAAU,G[(&
M/*CO^'IAC\*"VR5+:JE"J=+[Z)V54+N;*77W?\&RWG*4YU]W@MIQK7P4U(!/
M($V%S;H/'U87 YFV..JVW2=#UH4Z;F=)T76[CI.CX\.?S.DYW,X]G.X<WCV<
M>.EC:]C:]K]+^%_'"XY7W\,<4&M+J)UM+$ZT6K6U&M##BM%;K>-;J)UHKPOK
M2E*\:6\:TX5X]ZNEB+W!VM>XY>OPO?KB+CQ&_+SQ^K!3=6E:IDRJE+;KK+JV
M%G-]+;[:\+K*UM4K2EUM>RZVO;2O96E-"".8(N+B_4>/JQ./WU,G[(&/*CO^
M'J,,.ID_9 QY4=_P],,.ID_9 QY4=_P],,.ID_9 QY4=_P /3##J9/V0,>5'
M?\/3#'%PA&RVZZXB7MMMI6ZZM2CKA2VE.-:U_)]ZE*<:Z88U :;Q<)H-0Y.:
M.,GXU"3$"E+\:FY<P6?L\GPA460/7S**-8&6FIA@&8QT<M(S#6;BXA(0(!1(
MN;!CV/3+(W>"^X%F*FS &VE@;:3J"[WV%K@G8$G%H3)8$W4,+J2/=#<W&FYM
M87WL0-R!OBVR7?#MSC)$$/OD&3C7H@L'W,W$?B<R(7L[WF0:XS<-C@B]HVDD
M>(#91:HV5%FPC F7HG<WB[.0%+DQU\B"0@[#;G=A[W5<&]B+'F#8=;8@SQ@@
M78W\%;WVG<6N+'Q&_2]CB^L]YFUETY((+9B4'HCQ"$CN)O5SW4BL:>0U_/1I
MQ0TS;.Q8E$O&@LB>!Q4A=!Y&5NC9Q)@$7JSI56.#)M9;W-MB";WTD6YW!M>V
MPN+G?#CQ>^ ZWL;6(+ W%P+@$B]CL=L7YWNCP"U:XX)ISJ6$P65A4C*0T^#
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MEB ^06#'S 1&)'('C= "#*$FC@R;^CRMU7>X!!&^X.H6(ON0.9 PXT1^Z_\
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M\+W/<U5:^Y\>>X\;C?PYD[VWW-K8C5Y#XA;]5_GPZKL]>E/*#C^%V>_V^]J
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M(K1V29SE$5*2;-CEG2AT@)?.HK9+CELIDQA2HRH2QNXO>PTJ0 2Q"D%Q<("
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MKK&OA 3[_5W6Z/:/V<;_ /4DGJ]JJ7?XVO?KX8UOM%[%O]*Q?UF_[V'S+?\
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M+2@S(79"..I>P="48L1=LAH62"$RUXIDWM14H^7M<:-)$ 4,MR%E%][C4K
M;V-R>O+GSQMVC<EB&V+QD#:QTLA))L3<:2;#8["V-=(/@/E$'05JVR%FJ7-R
M3 >5<57CTU%BE'4TODV TER-;U"DMH3B)( -S8^ "GZ@IBPO(-[:PB(]WC0
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MFP(%C<'W19MU ! %]@+C$D3"VSD:MP&%R+DK8GW("[,=KL.?W6+J-PSR@:Z
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M,L4:#"HMPY;N62;IIUD.3<H)*/FEJU+1NILRD>D4Y;%@;$ \CN#\1\,5+(C
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M_P!3Y;TY?_I</F.,#T[T=,?LKD/Q_3^2^7_A>>\@+?RASKIUVKN> [3YD/\
MLLKYW_ZGRWGU_P#TWUY8?,<8'I_[W3%*>'_=7(?%^G_M>Y[U7\E\O_"\]_\
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MIC%WA5!9&N],BBS@F,W:,;.%8J>3!21< V+' YLD\C&[K9:N4FZ$!Q82\T)
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M]"^R[O76;V]S%UM>%>%>%U,D5I7MI6G97OTT[S)[V+Y&+]S$BG3W\_Z3.?\
M_9CHSSU(H3B?,V3,:L;MTAAG")>8CK8H\WY;ID'3]$<YN1L<N$4YLK8FJK2G
M&^RU2^E*]ZZNO0?9WV(J/.\BRK-Y,YE@?,:*"K>%,MI'6-IE#%%=F!(!) )
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MOL^&DYZX?XUPAD0C(7^19%2<R$@9'R4^C,XI0*/QRNDW"W/ L=&K]$$<N5Y
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M:61D@B4B)78/=V #8KFRW)HZV-9I62JE>HJ%C,MAM-+63._HVC16E<@RLH*
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MK[;+JO>^Q/6V,_+N-WBT&C5H.LO[GAAEU VWW.FUM[V/*^(&6P[:\W913)]
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MO>1JFAJ9"JRR2(L+M00)W4+W=4,@6/T]KU/V<HJ::"99:AVIO1B#-&ED$%5
MFIHXT<RJM9*W>-0G9EC)?T-[4?VI0J0/B3M>2S-)(BNJ]O35*I$R=A)4)& 5
M7:DH+MWTI>IVM8>%5[D?F'*5Z_=M;[KDW5J:%ZF[99A2QQ1I24#&)1&"(#%"
M8UJ*NH""D@>.CC)>NJ!KCIU('#L+J2UJH[+T=1)*[5-8HD8R$&59)!(T--"6
M-3,DE2XTTD)T/*RZB]]F 6\A]M,%$-F+3NLJ00;$0)%U80[@7J2H$#2</<Q>
MWU9])>P(62PFY<H4OIS%>BL0N33HI13'F[59C,TCZ(8F>*IB0Q<5>%WB>DG$
ML8XEA+$:*%48@W ):YL1>B[.4,2HNN60+)!(VOAGB&&*JB*/9 2DG>Y68 BS
M6L0+@QMIM#Q^W5"KK2&:O5QHA^*(.G)9"KR07O%)1<F2*.$V:=>LVJ<K?-DW
M:-EE]6;0:T_(H-UK'.4_;7,V$ZK34$:RSQS1(D+A*8(*,&*%#(?L3-1QN48V
M$CRO[IE*8Z=E*!."345KM'"\<C-*I>=F:J*R2-H%I%6J=0R_<)$EM*L&S'C+
M&8[&0\ZQ8%'I6Z0'$3SQ=XS$L+4G"$< 1E-%JU#,1[-%"C*.LU;J40JI>Y5<
M*7*5I?2VW29MFLN;2T\DD,<(IJ=J>-8WFD)5JJIJBSO/)+(S<2J<7UV"JH"B
MV-MEN6QY;'.D<CR\>83NSK$EF6G@I@%6&.- -%.A-EN7+&^]ADK6JQL<32"?
M3E;['K_M[76JS?\ T9/QZ_V)<;7*/])?\0W^\CQES7.8Z/#3##3##3##3##3
M##3##3##3##3##3##3##3##3##3##3##3#&G&[O(N0L=L(2_@TB>!&ZJDG=&
MF0T/8[+2&\<R'*"!(8H2A4SCU"ESA=S>A$B=8P^F5O/:AI2,7'.+5^\[#Y5E
M>:29C'F-+'4,!1I3R35!2"E$LDHGGGAAS"@JC#I1%:MA%9'0;/44<JRKIXSM
MAF68Y;'124-2\"DU33QQPAYJDQQQF**"62AK:82@EV6DE-*]9NL-5&T; P5/
M,TTN.Y!<2G)$OQZ5%+9$M:0-;#=)"'C<!#1>A&(Y"=+MV"110H04N;$+>DE1
M008-O+H*R#V/VRSA#8G(,O[OEBT64T.:03+E1?,ES_NL]7F=16<*ORM%>4PB
M&)0\1TT<,\%/&,QDJ#&ZJ^O7.ZXSYB:O,JS+IHFS()0')>\0TN7PT@DH\Q=E
MC$AE<Z)-ZN:&::3N20AU+K!(]FO-#PAA=[9.24B%'G)JY:+LHXU5E$D%OIF9
M9"UY48 8V*P]P3@,6:BGT]#P\M''EEJCZYC<ZOO%N"6RJNS_ &>CBS^/VNBI
M9J98 M9)5N*.EFCH('F6BIZG-H:](LRK'FCRVHKH*N,E8^)I7C)#@T^>YXTN
M3/WV2IAJ6F)I(Z535U$4E9.L1JYH,MFHVDH*1(I,PAHY:60!GT$D1O),\<Y>
MRO=@"1G#LF(R*4-\L8V@S3(CL&@,%.Q4X,XQ$G3,?!/H1"G3%K&%)6<$K,SH
M<DNRD@E\D[(NTD+V3+ S3(LD_E-24U-214E$^2YMF+Y6E2\TZ39=!G$]-3U-
M3'F->DCU8HJ>97IIX4DI)HV2)"XD?.R[.<V/9ZIJ)ZF2HJDS;+*!<Q:!8XGB
MKILKAGGIX)*&A:-:8UD\12HAE:.IAD#RNJE4Q"+W!;A["^1D61LM)+FC?*%:
MLF@$;*%H&SCV;@,7''5@ K'<7?!G K&KP\:#!GTBR3=-5!MCW@.HV49.MW+V
M8[+&#*VDIX:36^3V>2IFHUS*2J[/5-9+3+4S9I61SK-FT=-3SSQ4N5#+Q*8_
MLNH2)IXNT7:,29@%FEJ2B9I>-*>*I:@CI\]@I(JAH(LNI)(3#ECSSPQ25.9&
MM,8DM$ 4:3S7..9X^4A"V,9G+,JQ!8?EEB[*F,;#0[R1%'I7&T$QL]L<M08E
MH381J;3VQZL?#C@HLP&'&DW#!U02J]OQ<O[.]GZJ&O7.*"BR6O$N2R1PT^;S
M5$=+#'#FN99K&R/43O!)5Y?EQC%-/+4305$M.RRIQA&+]=GV>4\U&V5UM5FU
M$T>;(\LV5QP23RO-E]!EKADIXEF2EKJ\.T\$4$4T,4P>-A$TA^4&W 9Z(E,*
MNCETJ7AK**X[B^9SZ4+%),UYWE >:1N/NW?<"2H=:&D7V-'E6HUA4/<UD1ZA
M=-.T=9T;,>S'9J*'M!'3BC7,)*W-*S(*8U\Y<9;D\M.W=D02LLXS"*/-DURR
M<</2TQ@+&7>JA[19_++DKS=Y-$E+EM-G<XHH0O?\UBG!J&;AAH30R298^B.,
MPE9YQ,!P]M[\%S SD##>,9K(;$K3DGA,>,%;T$N@;NGSP<@HN_;(4[$&I&^M
M7[9&G&U)!RG9;6M+:5K\X[1T$&69]G&7TI;N]'F%5!"&;4Z1QRL%C=ONGB'V
M-VYLR$G<X[O(*V;,<ERJNJ ./54---,572KR/&I:15L-*R&\BK]RK "X%\96
MUI<;?'YOK6EE];>VZEMU;:<./;2E:T[/#V^#3#'3O M[^Z,0GC(QEG"IQY'E
ML0RFN3% V.9P->(Y=:MXO,8F[%HCP\C=T '8A-H-&K1K=@M2R='Y.-O?6O8.
M1&ZRVAB.K0XOK&GT@?0W!)O;D5.]^5B>8QBK-( I92?1L]E8>GL1;8FQ! (
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MS)SM,36+'<< 5(\2"IQ+T5(RDVKE2'DHX#3CZKLT%)LBS.V]D6!JE(X,@%R
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M W/6W+G;?3SL";;8O[W>_M>8OR@E;)]%BXF4H0Q4,/AF0BIDC(5[Y0G5M&Q
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M2Q22,DD;J2K*1R-P0P!'I,VJ[J89N=A-"PNJ0>:A$6Z,UAJBW/<B7BEM;;2
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MD$B(%CQH@HBW;-:/"I)XX39-&;%)2QHT;()4,Q8W)N>7@ /  ; >0&*PH46
MMO?J=_6=\>6/=[@O-A_<_G4R#P_E R')Y*DKP:5%0&5$!I!HL^ON1=,GS04L
MV=-U;?R2:R"MZ:EO;;=6G;7VAV([1]GJ;LCV=IZG/LFIYX<JI(Y8)\TH8IHG
M6,!DDCDG5T=3L5900=B,>2>V609[4=J<^GI\FS6>&7,:AXYH<OJY8I$9MF21
M(2C*1N&4D=0<:Y?,Z;@?J&9@_P &LR\RZZG^579?_63(?ZXR_P#YC'-?R9[1
M[_\ 0.<_#EE;S/\ \'IOZ_#G9\SIN!^H9F#_  :3+S-I_*KLO_K)D/\ 7&7_
M /,8?R:[1W_ZASF_/_JRMO<?_ O]=^5\2B%[2MQDXE 6*L\0Y !K&'EC6XS*
MHA(H['Q:/;>X?E2Y08W:-6K9"Q16ZWI+G+BMMK9F@Y>+(-U,+,>W'93+:*HK
M9<^RNH6GC+\"BKZ2KJIFY+%!3P3/([NQ"C8(MR\C)&K.N9E_8WM)F%9!2)DV
M8P&9PIFJZ.IIJ:);$M)-/-&B(B $G<LQLL:NY53Z1]L>V.#;98,G'8XE83DI
M.QNXF,P<-TTR4A))V=MEG_#49AF2EZMHH5:JI8V3O4554</5W+E;R)VR[99E
MVQS(UE66AHH"ZY?EROJAI8B3<G<"2HD !GG*@N5"JJQ(B+ZA[*]E:#LM0+2T
MP66JE"M6US*%EJ90.0YF.!#<0PWL@)9BSL['8(K]"6=G??"J_;J49_;]KO>&
ME-<?UOL=P+F_PGI\-^?GN<=1X[G;E\?EY[\[#SQ<J4IXO!PK[?@_HX\=.74"
MPZ"UR#RN/#J=KD#UX'^_X_KOAV^[][Y?+O<=3X<[<P;G8"PN=CN+;VO\0&(_
MN^M_V?1BWO?H@3]D;_\ )9+Y5K_1J#T(\SL=AZMMO5S M<C$C[K_ ,/[1BXZ
M<]B+G<]>9]7/;E;:V(P^7O?+A7P_B7N3X;DW!YGEROR/GX[[VPQ;U?IJR\75
MQ/LX?W2)^7#AIU!(\;D;>HW&W4'XM][">G7F/5U^?Z^NO[WR_%^]J=K?K-^N
M]KW!OSWWL>FP)$8>+Q^'Y4_GU!\+'8'GT!(WVMX^?JP\?U_7^[$ABGTP,?I,
M/^W&-0?K_=]&+J<CZ_V#'ERW XK)9?WR[@XNP,!X\W8RJ:R<T=/.;6PX4# -
M$W;YQ=SKK.G<*750:-&U%$K5'+E*JZ[9K8NY1]H=FLXBR3V/>S-7)!/5/)0Y
M=24]-3(7EFJ*DZ(T%@=*CTG=K,0BMI5W*HWDOM!E,F<]N^T5*D\-,J5E=4S3
MSL%CBA@4,[&Y&ICLJK< LPU,BW88:RAML)8M@:>0"4WC!P4_FLD@<?MCZ!5X
MC(S,4+D&1D@(*7M$A+F-I#&X\FW,IN[^ZG17J5%I<^$FZC][E/:F+-\Q.6Q9
M?5T\T>7TF95'>3#&U+!6P1R013PAS,E696EB>G*?8TA[PSB.>GXNFS3LR^54
M'MA+7TTT4E;49? *=99%J9Z2=TGDBETB)Z585BE6<-Z;S<!5,D,_#R,$V9$U
MS2(4W.0#!4X,CA.+.J5>(-W8J=R['\*@<F><Y@[NL$R$W-7UC9A=W&\49Q,Z
M0J\0:IL[GNLJ.W,*T[U%/E]3(*:6JBK$LC.DV74.9YAF-(EI$!GI8,OBU2#B
M)Q*VGB",YD$>RA[%.9EAJ*^!#/%324C>DBO%75F745#5.2DEH*B:ME"QG0Y2
MCJ)2ZH$#QA?:3)&4?,DR,QCS$V%#R9XZBZC \X=HG(+ V&1IW&")1FP<!PQ*
M, "XH<NH4=MTG<M<K1MO3IF:[JF6O;*EDJH(8J&JDIZB>D1*P24RQM3YCF,F
M59;61122I//%65,$TJB&-V2B1:MMI$0XI[(5"4TTTE;3I-#!4N:4QSEQ44-#
M'F-=2RRK&88)*6GFBC<RN@:K=J9;M&SXHX/M9,349CYU;.8V&(Y "&)@W&/Q
MTDO0#P8%=/$R!\G(T1=8PB]M5QV>M1 +EVSQ6U4??1:WI7EK&O,.U\-!+F:G
M+JN>++)X*%YHI:75/F-3[6F*FBI3-WMD*YI3%JE8&C4B4:3:,R6Z#LI+719<
MPKZ>&7,(9JQ8I(JG3#00=_$E1)4B+NH<-EM0! TRN08VOZ3B.0S':^%A>,9O
M+'$R1D)N(,RJZ+F,/1Y*(E^XLFX^A359H[L;U<W(+B9DY>.$>GM7:%&J;5;F
M41<HWXM%VMGKLVRZB6@>EIZZ2%66LCEAK8->49IF#J\9;2&6:@2-&TZ7A<NM
M]2,,BM[+0T.6U]4U:*BHHDE8/2R1R4DQ3,\OHT97"EM+0UC.PUZEE4(;:6!N
MW)V)V*[K(,G?SN;<(FG'F**)W=D3+74X7IW6WT[:<*\+J<:<:5XTK6E;7LFB
M_8[,1_WU!R)'_P"N@ZC?%?L>G_TIH2/O5;M8';NLW,$6//YN7(8](=&#>G>N
M=>/Z/??&=>6RBGG?P]TWTX]%ZVM;8>I5'ZAAU>WX5IQ=<*_W>^^,Z:1<'>X_
MVF^G#4;6VMX:5Z?!_CUPZO;^-UV]OT>^[_>X_1.FD>>VWNFY<[<\-1\OA53\
M.XY^>%1[>OA=?=[[Q\>W\L]O;V]N@4#Q_.;PMMOMMMMAJ._+?Q53Y]1X[^O'
M'5[;QNON]_\ &?EV>+4Z1Y_&?IQ.MCSL?_=7Z,<]P-^WM==O]W/OC'M4][4:
M%VY[?[3?3YGX\078\[;?[*_/MORZX=7MO&Z^[WWBX>N?%^_W]-(\_P YO&_C
MXX:CY?FK]'U&W+#J]OXW7W<^^,::1_M?G-].&H^7YJ^-_#QQ,H,-:WEUK;JN
M^'5ZU>P@0MK]$-?#:ZMKP]KCP]KLIPU>;BU,EK[S*-V)_P"SDZ$D=!OS^,XV
MF4$FI>]MH6.RJ/NXQT VWY>.^,L=4,O&]\J$_CFN=QT6'5#+QO?*A/XYIAAU
M0R\;WRH3^.:88=4,O&]\J$_CFF&'5#+QO?*A/XYIAAU0R\;WRH3^.:88=4,O
M&]\J$_CFF&'5#+QO?*A/XYIAAU0R\;WRH3^.:88=4,O&]\J$_CFF&'5#+QO?
M*A/XYIAAU0R\;WRH3^.:88=4,O&]\J$_CFF&'5#+QO?*A/XYIAAU0R\;WRH3
M^.:88=4,O&]\J$_CFF&'5#+QO?*A/XYIAAU0R\;WRH3^.:88=4,O&]\J$_CF
MF&'5#+QO?*A/XYIAAU0R\;WRH3^.:88=4,O&]\J$_CFF&'5#+QO?*A/XYIAA
MU0R\;WRH3^.:88=4,O&]\J$_CFF&'5#+QO?*A/XYIAAU0R\;WRH3^.:88HVR
M -[S.XW]7?2-&S]/N8Z]7Y[%[56C-[9T3^_G-'=4%J-G-.**]45>BOOZ._@P
MQ]5F0EM<E:X=+(7+WV)(VK&GZ5RREZB:-B:5+WUM5+[UED4K++.-URBJ=E*5
MNOMI5ACZ*#!Z5ERBJCI-.RE;K[U"Q*RRVVG?K==<]I;;2GAK6M*:88*C!R*:
MBRRKI)%*R]5554L233233MK=>HI?<]I;999;2MU]]U:6VVTK6M:4I6NF&.;1
M8^ZRU6U1W<G=912U2TL2K9=96G.I?;?1Y6VME;:TNI=2O"M.VE>&F&*=DW"D
MFUCP<]O?M%:W43=,CCYTV4K9=6R^EBZ#]1*^ME]MUEW-NKS;J5MKPK2M-,,5
M75#+QO?*A/XYIAAU0R\;WRH3^.:88=4,O&]\J$_CFF&'5#+QO?*A/XYIAAU0
MR\;WRH3^.:88^-S$58X2:7N%[72Z2ZZ#:XR0M<+(-KD+'*R2-7U%%$F][EM8
MNI9;6Q*YPA:I6VJJ=+F&/MU0R\;WRH3^.:88^2H\6A5&BR[A&KA6C="BI@@G
M5=>ZV^^U%&E[VE5%;K$U+Z)V<Z^MME]U+>%MU:,,?7JAEXWOE0G\<TPQ0/[(
M^+HUN)DK1UKYX@.97/S[MG1X0=5K:U8M:N""='#QS=;=1!JESUUJTK1.RZM*
MZ6)Y"_7X/'$$@<R!Z]L4*9*&+*MT$9&/57=D'PEHBG*[U%7147;?>2&-T[2E
M;UR ZQ-2]\R2I<Y:6V7W.$TZ6W5I-CX'E?D>1Y'U>>%QXCG;F.8YCU^6+@.2
M!%V:!$20ZS'NK;KVS\<>>/6;BRV^Y.ZY!TV?JH+6VJ67V77)WW4I?;=;6O.M
MK2D$$;$6/@< 01<$$>(W&.@?<1RCN6L79RRICL)#8&]$PV:FX^.=DU)HH0<-
M1[JY%%5XHVEK=O<XOMIQ4N1;I)UK6M;4[>RFO2/9GV'NSF==G\GS:IK\XCJ,
MPH(*J9()J-8E>5 S+&'HI'"7.P9V-N9./@/:+V5<\RC/<TRR"ARJ2&AK9J>*
M26*I,K)&UE+E:I%+6YE54'P&,-?/6LW_ -H>-/?G7M__ "S]OP\>/#PUUO/Y
MBNRO](Y[\O0_\AC2_P \W:+^C\GZ\XJRWP?Y9\ %MNG/#YZUF[CQ] >,_P#[
M]>*E/[<_:\.G\Q79;^DL]^7H?^0P_GF[16WR_)^O_95EQ\/?+[^OE\6)+#N5
M<R!9)PU9[CZ)K0^]Y8F?I%W4L:'TF"E*V7N1=Y.3OF"CAK=6UQ1LY0ML=V)W
MMNZ&ERU'2.'F'L%9*:.H]J\TS-,P$9-*:V2FDI3*-PDRPTD4H1P"NM'O&2'T
M2!3&V70^S-FIJH1F.6T#41D J.Z+4)4B,[%XFEJ9$9TOJ".MI "@9"P8=X<&
MDL)R3% TVA1JA^-'V=CT829$R-;%$[Z<+T5TKW%BS1XV4I>@\9.4TG3-RFH@
MX2353NMIYNS/+*[**VIRW,J>2EK*60I-#)S#"UG5A=)(Y 0T4J,4D0AT9@1?
M[W09A29G205U!/'4TM0@>*5-P1R*L" R.I!61& ='!5P&!&+V5&-*-;:TJ[I
MP?"Z?3 A7ODV=*]]S6G>KV5I3C2O;2M*TXTP;':]R#8'?QWV'/D;=>OCC,!/
MEUY@=?@_N\=L7'JMI3UWY0(^/]-5^W]_LU/(;DCJ!<_LMSWWZ<COR7/EX<AU
M^##JMI_=?E A\:_!]O4W'B>8ZF^_7J#?GMX_&O\ 6P^OP8M[T8THY$_1?:04
MI7B0?U_L81KZY[*\:4[W#C3C3O5K346&V_F-]]ATZ=  +7/B.0D&^KU> \1\
M/PD^?/%PZK:?W5X.'YHD.WLI_=7VO;[_ (=/(&UO,CSZ@6M;<V._0#E%_5R\
M/[OBMR&V'5;3^Z_*)#XU[_X]1;F;$7OUZ?MW(WW!PN?+XA]'C]=\4"@QIUHS
MM_+?"H\E6M>L'_'C:X$TIV]U<:<>->/#A2OA[U-0!RZW-O/I\'7;X;VVM-S8
MVL-_#QOMYCU^5L5_5;3^ZN_[(D/C7WN]J=ASN#<[=1X;^1^']6(N?J!];^?/
MSPZK:?W7Y0(>[WNZNWQ=[[7#4W'6]^NYMY\B;C8#U;[[#"_J^(>KP_5^O$JA
MK=)N^,VI=)S;F@BZO2K+K7<>F,4[+EU%+J4X4_X-*TMX\:\.-:UK2=OKS\_+
MZ/'GBXG(^O\ 8,>8+.D0RE+]^.>D,0/R8:7!IG*SM3XJ0K19P"%-K6K)\_N.
M-G31RS35J00'5HW5JLYO>IM;4[[5;J:]F]GJW)Z'V.NS;9W'#/13Y?04_=IJ
M9:Q*B9PTD<0IV1TD8<-I?272HC+W!48\GYY29M6]O.T*9-))#5PU]7/WB*H:
ME>")2J/)QT96129%CLINQD"V.HX@DCV];JC;06)EAA\9[M,#VM\9D&4&9)R$
M<($\@ FIDX*)'%TQ P:_BT_;==KTHU9V)%%$UZ(/[[U]C2]INQ\$DTU%#'!P
MX)7%7391)$E0K1994/!3S14RF>:6.LRQ^[KZ;EH0RZH@%U]3V>[5SQQ0U<QF
MXDT2FFJ,T61X&$E? DT\,DY$,43TM>IF8:(P)2&"R7*FW[<)>QL)UFUMEB P
M024,+Y,8)QA"'PN-0N41(JC)O1%<DHU "9B!<Q]DFTL2#I='8'7[L3O9(#VC
M[,B0Q=P)+33Q"!<ID-6U=7U>84=;"U)W4,'JIZ&H2ID+DSL29UT$2-4>S_:'
M0)37HI$44G&;,4%*M'14M#54<JU?>""E/#6P-31A+0BRP$N-"U5NVS>!8..
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M:1^R1+&3@]P"/R"Q&P0BRN9+O$V3M_>O)F2]EC50=C=5W%[[V%^7, B_P"U
MAD .J1F.Y !((O>]B3SN=B;6 MU.,S9,VV[D\@PO;\.$;AWL!ET+=MY+F4P
M*SQLA-),6DD9E4P'!;!TD87^@E95M+XS&H^5X+1R.F1#8:209B7(HI"R1JTA
M,88$V0$*;+8@7N"=6X)(-R1ON;XK:.1ECL^EANY&K=B06MORO< 'D#L;"QIW
M&U7+9'!F,<2R^:03*Q*,S,J3F$NR<SD4AEK^&O'SUZ@"C,V?=9& \A7M6:"S
M4J:#Q;E>/)N@X%O''"S0NP<1-;,%*@K90I  /B5Y$=0+G>U]6(X3<-4+*UC<
ME@2;> 8WL?$V!MRL=\8\B&P^<15I"0+AW@"1 (\3C:II<EC@DD:-)0")8WC$
M1+.G7=;MTN]D!3'S2=Y4#LB@)*<FV49!/3_H>$EDI%49P=1],$@@686&IF8C
MIRU64D'2+FU[6"$BP] @$?<[FP4 GUZ06 MJ-A< ;[F;<,0$\)X^?1$H_ NE
MB$UF,Q38Q@<Z'Q^/IRXPJ96!">[UER+MDU?.';E!=]=8HA8\H-;(HCQ[).VS
M(X=KB^P WYFPM<VV^FUSN<78T*+8VYDV'(7Z#Z^73'E:WI_GL=P?ZJ4J_=]^
MO<_8'[2^S/Y'H_\ =#'C3MQ]M_:+\J5/]OZ,:PZZ['*X:8?7Z_7?'U007=+H
MMFR*KERY530;MT$[UEW"ZU]$TD44DZ7**JJJ76V)IV6W7WWW4MMI6M:4U#,J
M*SNRHBJ69F(5551=F9C8!0 222  +G;%2(SNJ(I=V8*JJ"S,S$  * 2220
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MH259@?(7:K,:O+>VO:*>CD6-VKZJ*17BBGBEB<J6BFAG22*6,E5;1(C .JN
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MNQ@]L1<W"BPY_1*K9XW54$$6)! (N"01<7(N/$7!%QU!& 922 02IL0""0;
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MT1S!W"C9<DNH5D UVN'5@U!.VA0-18@;"Y8MSL2-R VYU #D=\2*8*  Y)
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M2TEB#0RM=%CKN-&(EC\LQ<K"5D&3[NZ!1'I23![>P&O156!\S:D"AK+:U@2
MP8 VW (+ B_+TCMSL=A>C+%;MSN0+@K<7VV(!^'2+]!;<^6;>G^>QW!_JI2K
M]WWZ]S=@?M+[,_D>C_W0QXT[<?;?VB_*E3_;QK#KKL<KAIA^WS]7/ZC?U8YI
M=6RM+K;JVW6UI=;=;6M+K;K:\:76UIPK2ZVM*5I6E:5I6E*T[=.?/$BX(*G<
M'8@[W'4<B/'ZG'I?Y.G*.:LF8;N6RJ'=+AP;AN+A$_)N+["LR&HV*).4W;5>
MVKA_U*HDFUMDEU]+"URM6]W=#X>_=*>/?9:R7L[DW: #)*A%J*M7GS+*X4'
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MQUCES,QB(SU8H9N**F9(UDKZBI,9569JGBN9+J9"M^2MR2CJ:F&2DCAEIN[
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M%HM1A'$J(/&TE8!I!8DD"_I;"Z@W)"&VY*D"]@+W).(#3F]E%@6MZ(!V8@
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M\\1PD ("@7ZCGRMUO?;;>^VV+J2VR8&-1_&,6-XRC1H'AL*$CV-F1-NLZLC
M>.^AZ\,Q;5O6I<Y;L7,3C3Y%-]5U90D#&$>;W:T17L@2R L0QNY);S)O<^LW
M/QG$\-"%&D60 +Y 6L >=A8?" <?2_;3@V\+$X_;CT6W%0>3$YG%4F+TT/<B
M98:1>MB\B3),2;<FY+DVI%^T?/7KQRNZ9O'+1:Z]LLHE<XCW)U;D &X!N!N!
M:UK B_+GOAPTL!IY$L-S>YYF][DFY!OTVY8M;;:;MS8O1A!CB>,L'(=R9<C^
MX.L63=*V0MP;(TP59-7Z3-X%(#XS'A:P%XW<!+1 06)2'IC63=K9/%D-QJ.]
MK\NE[=.8N3?G<D\\1PH]O1&U[<^MKCGRL +<K #D,99A,"A^. =L<A !C'0U
M';D@HT96JW7.7[VZVYT_?.G"B[Q^^<<Q.Q5X]<.'-R2*"-5>B02LLH+%C<FY
M^OQ8K"A18"P^OQX\QV[#:CN-EVY3-TGC6'YF9 ',BR,D(*LF":C0@P</;[T'
M3:^J]M;TE;*TNLK6VE:T\&O8'8SMOV2H.RG9^CK,_P NIZJFRNEAG@EFTR12
MI& R.-.S*18CICRMVN[(=IJWM/G=72Y+75%-49C42PS1Q I)&S>BRDG<$;@V
MQKY\Q=NI^H9//#_8U*ON_P#*/O:Z;^<+L3_K+E?R]OUK]?AQSG\ANUX__I_,
M?D1^]X'Y\/F+]U/U#)[Y-3^,:?S@]BO]9<J_2-_BTWP_D-VN_P!7\Q^1'[V)
M;!=A&YV8RP+'26-#L+&D7=J9&4R9NDU#A6-E.>Z>N.:XN6<J6)6W4;,FUERS
MMS<DA;5.V^Y5/!S/V3>QN7T-15Q9Q2YA-%&3#14;EZBIE.R1)==* L1KD<A8
MT#,;D!3FY=['?:JNK8*:7*JBABE<"6KJDT001BY=V(8LQ 'HQKZ3L0HM<L/1
MC@3 L$V\0-E!H,QI;;3HW1XZY33ZXDQCHZ6+E"J]EM.==7A6QHT3KW,P;<UN
MWMI;2Z]3R7VG[3YGVKS.7,\REY$I24L9;N]'3AB5A@4WMO8O(WIRN2[G< >F
M^SW9[+NS671Y?E\?(!JFH<+QJN;2 9IF YVV2,'3$ME4<R<M%?H2W]/"O\J,
M]<[<&VVY(MY;^5MK<AS\=K'&]Q<>/XN_P\/O?>[/%Q[VG/X;CI?:VYY7/4F]
MO@N"^;Z_#\^'X/E[7;Q_HTY<CO:VWF1O>PV^>]AN,,6]]]$B?LA?[G8+)5^U
MP[]?'3[T;'U[CYO$=.@'I<MK\C(^Z]7[1BX>+W/%[GO>Y_/IZN5ASML;\AN;
M ^8/GL2<1]?''/[_ +WWO'[W?XZD; '?KU YW%[V\]CY-R&&+>K]-67V/)_N
MD33L_?\ %J-@;@WM?SW'7GRZW^;$]#YVZ^OYO'SMBX?+Y?>]_P!SC.WA;<$$
M6W'ER-_VDW MM&&GGL!;;:X%[^ '6XW!'/RNQ((I],"_Z3#_ +>9U2?K^O;8
M;&^V+J<CZ_V#'D@WP?GM]P'ZHYK\*6O<_L?_ &E=F?R32_V3CQKVY^V_M#^4
MZC]8QJMKL,<I]?KRP\';][\7ATQ/46^??X]OV6]>&F(PTP\]OKY?48:8<_B^
MO/&\?)T?GKX+]B)K_P"J1?Y?+AK@?9-^T[,?QU!_QT&.V]CW[::+\36_\++C
MTFZ\NX]%8:88:88:88:88:88:88:88EL,;(.BRJ;A*Q:RC%:^EE].-.?19O2
MEU*>.E+KJ>Y6NM5G O2H.G'6_JT28VF46[T]_O#6]>N/]E\59S(^&HS,0^/I
M!,H6&FY_N&@B+D3#%L8>7%'"S0191HHM;>BH:>-W+(&DXZ%0T];.&@JUXY06
M2LYP1D@L%8@<SZ73S\MK^&U\=$64$*6 )Y"^_E\?3QZ8R-U.+I_R%O\ K-1I
M'GN;\SS^/%6(X$+0:2.BC("\$EG(5TZ9%DV5W3T8/618L!>LW"EM.BL=,S $
MN.=-Z7U6;NF"]BUEE>;6Z2MK7!%]^9WN 0>>^Q&_AZL0"#>QO8V/K!(/S@C$
MCZG%^L6_ZS^?46'G\9^G$X=3B_6+?]9_/I8>>_F?IPQ3NV0%@U<OGR3!FR9-
MUG;QXZO3;M6C5NG<LX<N7"M]B2"""-EZJRRM]B:2=EU]]UMMM:T:;VYG<6%R
M=^FU\.7/'+5B"?-6SUDBQ=LWB"+IHZ;536;N6SA.U5!P@LG=<FJBLE?8HDJG
M==8I9=;?;=6VM*Z%1UOMXD['X\,??J<7ZQ;_ *S^?2P\_C/TX8QR?R-AJ*R\
M+ 9),86$FDA[AZFC)(PQ:%WM2SM<>'I:T56M41J;(MG(X%:YZ&ILBV<#Q5'C
MQ!5"R1&2"P5B/'TK;<]_(<_ <[8I+*#8L ? D7WY?'T\>F,C=3B_6+?]9_/J
M+#S^$D_K.*L1@(;@,E)'@X!^'+DHP\N'2!JQOZ:\0_L7<-U&+V^RG1HO$UFB
M]BS:M]5DJV4JK9;;>G6^=.FQL1?E<G?SL3N+<C]&(N#R(-N>)/U.+]8M_P!9
M_/J+#S^,_-OM\&)PZG%^L6_ZRFEAY_&?IPQ:2BL3"J"4BR@L<J=*H@@UCN^Q
M&XF8<-G;U :SI=6G3O%6C!ZXL1LXWW)-5KZ4X67:!>=@=MSN>5_7XGY\02!:
MYM<V'F;$V^('%VZG%^L6_P"L_GTL//XSYGQ\SB<.IQ?K%O\ K*:6'G\9^G##
MJ<7ZQ;_K/Y]+#S^,_3AB%3.7XMQTB.<3R212((%G"C08K(BC(58]70LM5<6M
M[GBR726-4K[%':U/ZBU3OLO<J)6WVUKL*#*,RS5I5RV@K*YH%5YEI899C&KG
M2FH1@V+L"J+[IR"$!((QA5N99?EPC:OK::C69BL1J9DA#LH!;2787" @N>2
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M2')/7"*5Z311^RL7O3N=(44:>N]AUNVU_AVOOA<<K[GD/&W/%;U.+K_R%O\
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MU]>=MO\ @<R?^4QJ/;D_>!^?_=Z_KS>TQ_"!\D?XF.?F;N4:^O/VX? YD_\
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M59512^ZM:W7UKKH*;M=GU'!%2TN=Y[3TT"+'#!#F]5%#%&HLJ1QHRHB*.2J
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712)'5S>X*H4%K#8@L^]Q>X(YVMMO_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>43
<FILENAME>g60414g55y66.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g60414g55y66.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2?V4&AO=&]S:&]P(#,N,  X0DE-! 0
M    )]J^$" CA"24T$!       #QP!6@ #&R5'' (   (    X0DE-!"4
M   !#-S_I]J,>^"05P=JZO!<-..$))300Z      #E    $     $
MMP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E;G5M     $
MEN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L      MP<FEN=&
M5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J8P    P 4
M!R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $     0F
MQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L
M   BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<     0W
M!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N0V)O;V
MP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP      $
M5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !        4D
M="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!OX
M       $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M      0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL0'!+C5
M         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G4',
M  4&=00P    !,969T56YT1B-2;'0               !4;W @56YT1B-2;'
M0               !38VP@56YT1B-0<F- 60           !!C<F]P5VAE;E
M!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG          QC<F
M]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P
M +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! !!+C5  $  0$$N-
M4  0 !.$))300F       .             #^    X0DE-! T       0
M >.$))3009       $    'CA"24T#\P      "0           0 X0DE-)Q
M        H  0         !.$))30/U      !( "]F9@ ! &QF9@ &
M ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4    ! "
MT    &       !.$))30/X      !P  #___________________________
M__ ^@     _____________________________P/H     /____________
M________________\#Z     #_____________________________ ^@  #
MA"24T$"       $     $   )    "0      X0DE-!!X       0     .$
M))300:      ,U    !@             ".@  !FP          0
M                 !              9L   ".@
M !                         !     !        ;G5L;     (    &8F
M]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M  3&5F=&QO;F<          $)T;VUL;VYG   ".@    !29VAT;&]N9P  !F
MP    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E    $@
M=S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<         !F]R:6=I;F
M5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960     5'EP96
M5N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,    !
M      4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG
M    !"=&]M;&]N9P   CH     4F=H=&QO;F<   9L     W5R;%1%6%0
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MEC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&]N9P
M *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&QO;F<
M  "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,     C_P
M  .$))3001       ! 0 X0DE-!!0       0    !.$))300,     !W#
M   0   *     W   !X   9R   !VG !@  ?_8_^(,6$E#0U]04D]&24Q%
M$!   ,2$QI;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0  86-S<$U31E
M0     245#('-21T(               $  /;6  $     TRU(4" @
M                                                         18W
M!R=    5     S9&5S8P   80   !L=W1P=    ?     48FMP=    @0
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M(@245#-C$Y-C8M,BXQ               2<U)'0B!)14,V,3DV-BTR+C$
M
M   %A96B        #S40 !     1;,6%E:(                     !865
MH@        ;Z(  #CU   #D%A96B        !BF0  MX4  !C:6%E:(
M   "2@   /A   ML]D97-C         !9)14,@:'1T<#HO+W=W=RYI96,N8V
M@              !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M                                              9&5S8P
M N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D
M="               N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7
M(@<W!A8V4@+2!S4D="                             &1E<V,
M  +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C
M$              "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@24
M5#-C$Y-C8M,BXQ                                  !V:65W
M 3I/X %%\N !#/%  #[<P !!,+  -<G@    %865H@      !,"58 4    %
M<?YVUE87,          0                        */     G-I9R
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M$+:0N "Y@+L O("^$+^0P2#"H,0PQ<#'4,C@RG#, ,V0SS#0T-)@U #5H-=
MV.#:D-PPW>#?@.$PXN#DD.9 Y_#IL.M@[2#NX/"0\E#T$/7@]Z#Y8/LP_/#^
MP0"1 F$$,081!^$)L0N1#7$/41$Q$Q$4\1;1&,$:H1R1'H$@<2)A)%$F02A!
M*C$L,2XQ,#$R,30Q-C$X,3I!/%$^44!A0G%$D4:A2+%*T4SA3P%1(5-!56%7
M@5FQ6]%> 6 Q8F%DD6;!:/%K(6UA;Z%QT701=E%XD7KA?2%_<8&QA &&48BA
MBO&-48^AD@&449:QF1&;<9W1H$&BH:41IW&IX:Q1KL&Q0;.QMC&XH;LAO:'
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MLNNZ>\(;R;O16]C[X*OH2^_[]ZO_
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 /_A0D=H='1P
M.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O #P_>'!A8VME="!B96=I;CTB[[N_
M(B!I9#TB5S5-,$UP0V5H:4AZ<F53>DY48WIK8SED(C\^"CQX.GAM<&UE=&$@
M>&UL;G,Z>#TB861O8F4Z;G,Z;65T82\B('@Z>&UP=&L](D%D;V)E(%A-4"!#
M;W)E(#4N,RUC,#$Q(#8V+C$T-38V,2P@,C Q,B\P,B\P-BTQ-#HU-CHR-R @
M(" @(" @(CX*(" @/')D9CI21$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S
M+F]R9R\Q.3DY+S R+S(R+7)D9BUS>6YT87@M;G,C(CX*(" @(" @/')D9CI$
M97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z>&UP
M/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O(CX*(" @(" @(" @/'AM
M<#I-;V1I9GE$871E/C(P,C M,3$M,#=4,3@Z,S,Z-3DK,#4Z,S \+WAM<#I-
M;V1I9GE$871E/@H@(" @(" @(" \>&UP.D-R96%T941A=&4^,C R,"TQ,2TP
M-U0Q.#HS,CHU,"LP-3HS,#PO>&UP.D-R96%T941A=&4^"B @(" @(" @(#QX
M;7 Z365T861A=&%$871E/C(P,C M,3$M,#=4,3@Z,S,Z-3DK,#4Z,S \+WAM
M<#I-971A9&%T841A=&4^"B @(" @(" @(#QX;7 Z0W)E871O<E1O;VP^5&]U
M8VA5<" W+C \+WAM<#I#<F5A=&]R5&]O;#X*(" @(" @/"]R9&8Z1&5S8W)I
M<'1I;VX^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @
M(" @(" @(" @('AM;&YS.F1C/2)H='1P.B\O<'5R;"YO<F<O9&,O96QE;65N
M=',O,2XQ+R(^"B @(" @(" @(#QD8SIF;W)M870^:6UA9V4O97!S9CPO9&,Z
M9F]R;6%T/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$
M97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z>&UP
M34T](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]M;2\B"B @(" @(" @
M(" @('AM;&YS.G-T179T/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O
M<U1Y<&4O4F5S;W5R8V5%=F5N=",B"B @(" @(" @(" @('AM;&YS.G-T4F5F
M/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R8V52
M968C(CX*(" @(" @(" @/'AM<$U-.D1O8W5M96YT240^>&UP+F1I9#HY,CDR
M.#$W,48Y,C!%0C$Q0D$X.#DT1C$P-3<S0CDY,CPO>&UP34TZ1&]C=6UE;G1)
M1#X*(" @(" @(" @/'AM<$U-.DEN<W1A;F-E240^>&UP+FEI9#HY-#DR.#$W
M,48Y,C!%0C$Q0D$X.#DT1C$P-3<S0CDY,CPO>&UP34TZ26YS=&%N8V5)1#X*
M(" @(" @(" @/'AM<$U-.D]R:6=I;F%L1&]C=6UE;G1)1#YU=6ED.F)C8S@P
M864Q+3EC-3$M-&8V."TX-S!A+39E864Q8C%B,C<S-#PO>&UP34TZ3W)I9VEN
M86Q$;V-U;65N=$E$/@H@(" @(" @(" \>&UP34TZ2&ES=&]R>3X*(" @(" @
M(" @(" @/')D9CI397$^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A
M<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z
M86-T:6]N/G-A=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @
M(#QS=$5V=#II;G-T86YC94E$/GAM<"YI:60Z.3$Y,C@Q-S%&.3(P14(Q,4)!
M.#@Y-$8Q,#4W,T(Y.3(\+W-T179T.FEN<W1A;F-E240^"B @(" @(" @(" @
M(" @(" @(#QS=$5V=#IW:&5N/C(P,C M,3$M,#=4,3@Z,S,Z-38K,#4Z,S \
M+W-T179T.G=H96X^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IS;V9T=V%R
M94%G96YT/D%D;V)E(%!H;W1O<VAO<"!#4S8@*%=I;F1O=W,I/"]S=$5V=#IS
M;V9T=V%R94%G96YT/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z8VAA;F=E
M9#XO/"]S=$5V=#IC:&%N9V5D/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*
M(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C
M92(^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^8V]N=F5R=&5D
M/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IP87)A
M;65T97)S/F9R;VT@87!P;&EC871I;VXO<&1F('1O(&%P<&QI8V%T:6]N+W9N
M9"YA9&]B92YP:&]T;W-H;W \+W-T179T.G!A<F%M971E<G,^"B @(" @(" @
M(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP
M87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T
M.F%C=&EO;CYD97)I=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @
M(" @(#QS=$5V=#IP87)A;65T97)S/F-O;G9E<G1E9"!F<F]M(&%P<&QI8V%T
M:6]N+W!D9B!T;R!A<'!L:6-A=&EO;B]V;F0N861O8F4N<&AO=&]S:&]P/"]S
M=$5V=#IP87)A;65T97)S/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @
M(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^
M"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^<V%V960\+W-T179T
M.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T179T.FEN<W1A;F-E240^
M>&UP+FEI9#HY,CDR.#$W,48Y,C!%0C$Q0D$X.#DT1C$P-3<S0CDY,CPO<W1%
M=G0Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @(" @(" @/'-T179T.G=H96X^
M,C R,"TQ,2TP-U0Q.#HS,SHU-BLP-3HS,#PO<W1%=G0Z=VAE;CX*(" @(" @
M(" @(" @(" @(" @/'-T179T.G-O9G1W87)E06=E;G0^061O8F4@4&AO=&]S
M:&]P($-3-B H5VEN9&]W<RD\+W-T179T.G-O9G1W87)E06=E;G0^"B @(" @
M(" @(" @(" @(" @(#QS=$5V=#IC:&%N9V5D/B\\+W-T179T.F-H86YG960^
M"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F
M.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @
M(" @/'-T179T.F%C=&EO;CYS879E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @
M(" @(" @(" @(" \<W1%=G0Z:6YS=&%N8V5)1#YX;7 N:6ED.CDS.3(X,3<Q
M1CDR,$5",3%"03@X.31&,3 U-S-".3DR/"]S=$5V=#II;G-T86YC94E$/@H@
M(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE;CXR,#(P+3$Q+3 W5#$X.C,S
M.C4Y*S U.C,P/"]S=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \<W1%
M=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!0:&]T;W-H;W @0U,V("A7:6YD;W=S
M*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @/'-T
M179T.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @(" @
M/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP
M93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N
M/F-O;G9E<G1E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \
M<W1%=G0Z<&%R86UE=&5R<SYF<F]M(&%P<&QI8V%T:6]N+W9N9"YA9&]B92YP
M:&]T;W-H;W @=&\@:6UA9V4O97!S9CPO<W1%=G0Z<&%R86UE=&5R<SX*(" @
M(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@
M<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \
M<W1%=G0Z86-T:6]N/F1E<FEV960\+W-T179T.F%C=&EO;CX*(" @(" @(" @
M(" @(" @(" @/'-T179T.G!A<F%M971E<G,^8V]N=F5R=&5D(&9R;VT@87!P
M;&EC871I;VXO=FYD+F%D;V)E+G!H;W1O<VAO<"!T;R!I;6%G92]E<'-F/"]S
M=$5V=#IP87)A;65T97)S/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @
M(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^
M"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^<V%V960\+W-T179T
M.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T179T.FEN<W1A;F-E240^
M>&UP+FEI9#HY-#DR.#$W,48Y,C!%0C$Q0D$X.#DT1C$P-3<S0CDY,CPO<W1%
M=G0Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @(" @(" @/'-T179T.G=H96X^
M,C R,"TQ,2TP-U0Q.#HS,SHU.2LP-3HS,#PO<W1%=G0Z=VAE;CX*(" @(" @
M(" @(" @(" @(" @/'-T179T.G-O9G1W87)E06=E;G0^061O8F4@4&AO=&]S
M:&]P($-3-B H5VEN9&]W<RD\+W-T179T.G-O9G1W87)E06=E;G0^"B @(" @
M(" @(" @(" @(" @(#QS=$5V=#IC:&%N9V5D/B\\+W-T179T.F-H86YG960^
M"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI3
M97$^"B @(" @(" @(#PO>&UP34TZ2&ES=&]R>3X*(" @(" @(" @/'AM<$U-
M.D1E<FEV961&<F]M(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @
M(" @(" @/'-T4F5F.FEN<W1A;F-E240^>&UP+FEI9#HY,SDR.#$W,48Y,C!%
M0C$Q0D$X.#DT1C$P-3<S0CDY,CPO<W12968Z:6YS=&%N8V5)1#X*(" @(" @
M(" @(" @/'-T4F5F.F1O8W5M96YT240^>&UP+F1I9#HY,CDR.#$W,48Y,C!%
M0C$Q0D$X.#DT1C$P-3<S0CDY,CPO<W12968Z9&]C=6UE;G1)1#X*(" @(" @
M(" @(" @/'-T4F5F.F]R:6=I;F%L1&]C=6UE;G1)1#YU=6ED.F)C8S@P864Q
M+3EC-3$M-&8V."TX-S!A+39E864Q8C%B,C<S-#PO<W12968Z;W)I9VEN86Q$
M;V-U;65N=$E$/@H@(" @(" @(" \+WAM<$U-.D1E<FEV961&<F]M/@H@(" @
M(" \+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R
M9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z<&1F/2)H='1P.B\O;G,N
M861O8F4N8V]M+W!D9B\Q+C,O(CX*(" @(" @(" @/'!D9CI0<F]D=6-E<CY4
M;W5C:%5P(#<N,#PO<&1F.E!R;V1U8V5R/@H@(" @(" \+W)D9CI$97-C<FEP
M=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @
M(" @(" @(" @>&UL;G,Z<&AO=&]S:&]P/2)H='1P.B\O;G,N861O8F4N8V]M
M+W!H;W1O<VAO<"\Q+C O(CX*(" @(" @(" @/'!H;W1O<VAO<#I#;VQO<DUO
M9&4^-#PO<&AO=&]S:&]P.D-O;&]R36]D93X*(" @(" @/"]R9&8Z1&5S8W)I
M<'1I;VX^"B @(#PO<F1F.E)$1CX*/"]X.GAM<&UE=&$^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"CP_>'!A8VME="!E;F0](G<B/S[_VP!#
M  $! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0'_VP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MP  1" #2 ET# 1$  A$! Q$!_\0 'P    8" P$               $&!P@)
M @4#! H+_\0 ;1   00! P($ P,$"PD(# 83 P$"! 4&!Q$A$C$ "!-!"111
M(F%Q%18C@0H7)#)65Y&5EJ'4&!DX.4)9L=/P)28G*"EWP>$S-#8W14A25'B7
MM]$U0T1&1V)GA[;Q4U5H<G:#LM(J26-T=9*U_\0 '0$  00# 0$
M      $%!@<"! @#"?_$ $@1  (" 0,# @0$! 0& 0( #P$" P01!1(A  8Q
M$T$'(E%A%'&!\",RD:$5L<'1"!8D0N'Q,U)B%R5R-)(U-D."LD53<\+R_]H
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M));+#D'QX]\=7U^<?CRB>:E?_P G#7'_ -F.4>-&+B6+_P#R)_\ S#IQF_\
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MFX=D,"\#(%DA8]99+; A)4A?6C<@?E"2)CD5_P PNVPTQBJ5]JHVX/\ SIO
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M%B0,#\I0#!(SY;W^OOXSR(Z6"/1B82X"!3),[!@2_J$D@''\H4C@CC&>K?\
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MH?Z=&Y?K_GT/[^;\(3_.%^6;^GT;_4>#!^A^OCV^O1N7Z_V/^W0_OYOPA/\
M.%^6;^GT;_4>#!^A_IT;U^O]C_MT/[^;\(/_ #AGEF_I]&_U'@P?H?W]?IT;
ME^O]C_MT/[^;\(1?_P"87Y9OZ?1O]1X3!^G1N4>_]C_MT/[^;\(3_.%^6;^G
MT;_4>%P?H?Z=&Y?K_GT/[^;\(3_.%^6;^GT;_4??X,'Z'HW+]?['_;[=#^_F
M_"$_SA?EF_I]'_U'@P?H>C<OU_SZ']_-^$)_G"_+-_3Z/_J/"=&Y?K_GT/[^
M;\(3_.%^6;^GT?\ U'@P?I^_V1T;E^O^?0_OYOPA/\X7Y9OZ?1O]1X7!/@'^
MG1O7Z_V/^W0_OYOPA/\ .%^6;^GT;_4>$P?IX\]&]?K_ &/^W2NP#XR'PMM4
M\WQ/3;3OST>7G+\\SO(*K%,/Q6ES>/*M\BR.\F"KZBFK(WHM^8GV,TX8L4*.
M12F(QC>5\&.@,I\'^Q_VZ=WS"_$6\B_E.S>#IMYE/-3HOHGGMGCD'+J_$]0L
MRK\?NYF,64^TJX%X"%*<A'ULNQI;:&"2GV'GKY3$Y$[P=+N'N<?GD?V_?T\]
M1RO?C)?!VR>N+49+Y[?*+D-28@BFJ[S/<9MJ\I8Y&E 0D*>R1&(0!6M*%[A*
MX9&M>Q4<B*B@D>"1^7'2$H>#@_F,C^XQ_MUQROC&?!QFVM3>S?/5Y0I=W0LD
MBHKB3G>+GM*4<P*@ECJ; HWRZUDD"J"0V&8"'"JB*CV*K?!DX(R<'SR>?SZ3
M*<'CY?!QR/R]^DC+^*;\#6?*DSY_FS\BDZ=.D&ES)LRVT^DRYDN0]QI$F5(-
M7/,>0<KGE,8KW%*1SGD<Y[E55#,. S ?0$_[])B,D_*F?<[1]?.<?7WZ4$3X
MO/P7Z_'Y>)P/.SY-(6+6#9+9V-1,PQ"-03636HR8R73!CLKI#93$1DEIHST,
MU$:3JX\)N;(.XY'ODY_KT8CP5PNT^5VC;_0#!S[^<_EUK,&^*]\$;3$$R-IM
MYP_)#I[&L2H>PCX1D.#8F"<9J+TEFBH84!DHC45>DAVD<W=414WV\#,S8W,S
M8^I)_P \^/MT*(TSM"K]=J@>_P!AS^SXZ/-?BO\ P1]2?R=^V+YP_)%GWY'.
MLFI_/3(L&RG\ER5Z5616I>0YWR)E5K54L7TGJK6[N56ILH9E_E9E_(D?Y=#>
MFV-P5O<;ESC^HX_?MTMH_P :KX1L0 8L7X@7E6C1HXAACQX^I=$$  B:C!""
M(;FC&,;&HQ@V-1K&HC6HB(B>,?/GI0R@<'CZ8_T X\_K]\==>S^,_P#""NH$
MNJN//SY3[6KL(Y8D^MLM1<>G0)T4[58:-,ARO5CR0%8JL($PWC>U5:YJHNWA
M>1R#@_4'G_QT$H>#@C[C/C_/]^W29PKXM7P4=-8$BJTZ\YODJP&KF2%ERJW"
MLHPK%H$F6Y-G2I$.BBP(YI+DX<<HW%5.%?X"S-_,Q;\R3_GTB^FN=H5?K@8_
MTYZR?\7#X*AJVVIB>=+R6EJ+VQ6WO*M^588^NN+9Q6'6TM(+HJQK&Q4PAE6;
M+$:3ZHF$<3K8BH988.6!]CDY^^/\CTN(^1A>>3P,'VR?;WXSP<\=;0?QB?@W
MBN09$/SS^4!F01*UM-%O&9SBK+B-3M57-JH]FT39H:UKE5R01G;%1RJY!=7/
M@R<8R<><9.,_7'0"@.1@''L/;Z>./'C_ 'ZW9/C7_"1*QXB_$&\K1!D:X9!O
MU-I',>QZ*US'-<]6N:YJJUS5145%5%39?">/'2[E/N#D'C[>^1_OYZ3D/XOW
MP9*['Y&)U_G=\G$#%I0Y09.-0\RQ&-02!3NI9HSTX0,KC#EJ]RRFDC.:=7.]
M5'[KX7)SG)S]<G/]>DRF,<8/MCC]1C^WO^O6SC?&8^#Y#J14$/SY^4N)1 A-
MK04T;4'' 50:YH?0;7BKA-;$'"0'Z!(K H!!?HD&C?L^#)SG)SYSGG/UST93
M&/EQC&,<8SC'TQ_[\=)G"OBR?!,TVC3H>G7G)\DV P[25\]:1,+R7",7C64W
M9467/!1Q((IDG97)ZYV$+LYR=6RKX4LS8W,QQXR2<?EGI%$:YVA5R<G:NW)S
MGG  _,GS[YZUD'XI/P,ZMERRM\V7D3KQY%;"O\@'"MM/8K+V\CJ5P+FX:"N&
MEG;!<<S@V,U#S1N*5S#(XCU<%W/_ 'MQX.XY'Y9ST 1#@*@R<G"@9)]SQY^Y
MZW5A\6WX*EMEE1GEIYT/)98YS0120:',YV587+RRDA&]7UH=3D4B*2WK8I?F
M#^I'AS "?ZQ>IB^H_=-S $!B ?(R<'\QXZ7^'G<0I8>&VC//G!Q[^^..NK$^
M*_\ !&@YE*U%@^</R10]09P71YN=1<BP:-F,P#F-&\,O)PPV7<@3V-8QXS3G
ML<QC6JU6M1$-S8V[FV_3)Q_3QTG\/<6PN[QNVC=_7&3XZ[EU\73X*^1WU'E.
M1>=3R7WV3XPIUQG(KG+,-M;['7241LA:*WG1CV%0IT38RP)$=2IP]7)X4%E!
M"EE!Y(!(SSY\\\GI2(V()"D^Q*@X_4CC_/K<47QD?@ZXO7CJ,:\]OE%QZI"0
MQA5E'GN,5-<,LDCBG*.' 9'C,(8KG$,]HT<1[E>17.7?PA)/DD_GST HHP,
M?0#']@!_EUC%^,;\'*%=6&1P_/7Y0XN16P0QK6^C9YBX+FSCQFC9'!86@ALF
MS0QV!"P I)R,$P0VC:UHVHADXQDX^GM_3HRF<\9\9QSCSC.,^>L(7QB_@X5U
MM:7]?YZ?*% O+U MNKF'G6+1;6W;':C8[;2Q ,<R>@&)T!268OI-X9T^ DD8
M).!XY/'Y?3].C* DC )\D#D_K@^_/TSTG\<^*]\$;#KRYR?$?.'Y(L5R7(WO
M?D.0XWD."T=Y?$*7UWONK:LA1I]HYQE]9SYT@ZJ55(J]:JOA2S$8+,0/ ))
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M;6HP- E=)1&TTPBO3[$$317\O,>/2>8"N F(@U$@T]GD818X632 )8@BP;<
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MBI/FL=7XY$@6+GHV)X@-?N+N/M_6-9L:^T:PV.Y*M:ZU*IJ-NA!6/:TLM7\
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M.[:VJ=S4:9U:>MWEKNKZ7!.9+&S0QIUQ7EN5FR?PT5G1YYT@:+:K3P1LK94
MMDQO(]M(_5*W)IXD;YL0>G)N#KR,;X2P'L2 !G Z0WF&\HOD>U&RKSFZ_P!G
M:1,(J-$]<M5-+,PJ<6OH==C=CDFIUI@M=Y<\RQ>NK0+6P\>H2WN<SLEJZQX8
M-B+"O5+Z<<DYSG'1>Y^[M-A[2T#\.;<VKZ+1U"K-:@D-I(--BM-KU2T7(<V9
M3'4%:1U9D-K'D*>MB"Y?A%.OCU?7ACD#,N641JQG5\$,7;" '!P21[YZ&1?#
MF\E\+)BP68+8TV3TUSYB(6CFD!?,/2V$OS@XGIW@>/W.E&<0\@:Y).)#SR_L
MK,:"QY\&'<MK"5]$,)QF(GE!WYW9)6#_ (B.2":'0FU34UT*9!VM;OWI8-2I
MO WRV_P5=%<M-N:$N'G+K@=8+J5_8&9R4983-+^'(_!L\A]6,J"?4*J!D\A0
M<\Y&4"GP[/+6/RZVFH6=8;7::YJ[.L9D5E92:[3,_ET\&S\T%?I7D>F>17#*
MV#@TFRQG"ITET@..GM<BA.@0<HMKD<>U6L Z?\[ZZ=?AH4IY-1J?A)EEDDT8
MTTD=.WGU.'4(8LO;2*>VL<8:9HZY>1JJ1>HJN?4ZC::P$B=I8Q$^X&#9N A+
MK*A(W'YL AL YP //4C/)YY=/)GCNM^0:HZ3Z6E>S2GS*ZYZ#VUGE.O=780-
M,L.P#3"^J\:U6MZFWB5T?*6:V9+.G5L*K:(T"K-#"''Y+Y(3'+'>ZM>[MDTF
M#3=1U QOJ.@:+K"+4T*6.74;>H:E"UK2XFC:1JK:5517=@P=Q([S87 77NV+
MKPK!-*<RPPS 1P-_%>25<P_+N,8B \YR03G/'3)T?DET5\S>8::6-Q9QLD/C
MK_AUU&I<EFH.#X<S']",W\M0K;4^8X$;\@172*W+X]10P)XP3LC#,*&G(MA:
M2'N(]6.\-7[?J7HXZQA,Z=]3:<G^'W+AL:U1UYX]-BR/5?$]4R3LA*0R*K2
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M9YXQ[D#C[''T/CHVG_+/ZG'CSY'CK%&KMU;+LW;?9-^^R)OLO'/UVW5>W@+
MG''.<'./_J]\?0X Y ]N@ D$@$@>2!D#QY^GGK%-OI[\*B[]E3A$7W_D7GMM
MQX7GZYXY!X]CSP/'G[?0Y\)T7MMV[_CQ]>WOVW^O&_@QR2/J#X^O]O'DCS]O
M).K!OA.I_P ISY NW'F]T 3\/^$O'=ME]_ISRG]7C%CP/.",_F??(]OKQQGZ
M^0H\_H?\CU>G^S+U1/BG:4*J+_@4Z7?UZNZ]]_"#)! ]\?O^N/Z_;K)_/Z?Z
MG]_^<=4 >4*-@EAB>JM'G,6C?&S"=@^"P[&T%$=+HCY6F15T:YK)$AKC170+
M=U5)D2 .:QC!-4SD&FWBON]&U*.WH]G3FL;Z*:AJ+Q0M($L+2%65X)50[7]6
M#UT5&!R6(49/':/_  K5^Q;W;OQ.T3O>KH;UN[[?978]74=4BJ-<T.QW2W<>
MGU=9TZ>=#+4?3]7.DVK,\)54BA'KD1^9'Y1I7HO?8[IS@4:%279M.?VS:9X*
M6QKZ2XU-S'$L6QZ8ZO)<#3YMT>XR25:,A/1SBFB@04/I([[$7IZQKT%G5=2D
M:Q7&J'2+ :>.6Q!I%"[<M()5@)V;J]1(?4'\H=MT@('/0'<OPS^#VLZ%\.NP
MZ5?1=7G^'B?%+1IH]%U#3]'UCXE=X=I]K]MW6H2ZS&K6WK:QW-8U6.A)DS34
MZXAHE9&!"%A^7OR[QLBCU-K6V*'R7+L/Q-]8S.0I^U[/R3 9F178)4L(B);&
MQV[BI!9\T\;>HGH37D>-6O<&[D[G>J\T+PA:M&]>$S::_P#^,XZFI)5KE$9E
M] 6Z[^J?3#' #1@ Y$,J? GX!5^XJVEZK5U,3=Q]W]G=I2:9'WS5![ N=R]A
M6NX-:CMVHJTG^+2=N:Y6%%!9:%,N8+CO-&0RU/H7HQJ' TBEW%I'EV<;",6I
MK^%"NXU4D 4#$KRPH(3XD83I,Z5F-S%6!(G *LF&L4<( OG; !6Z([@UW3)-
M<6&!TA;4;D]:62K)/ZAENP16) [,$C2E7?U$C<!'W-(S;(BO4M;X*?!_O[3O
MA)<U/6H+.IP]D=LZ3W!2I:W4TL44T_M+7-1[?I/5@C:U?M]XZU5-&Q=K2FQ3
M-9:44'XS4()U;F?Y=_+\=VH<Z*W(*8>E4*/E^5TMG/E1I$N@M,.G.AU%4LT+
MIHW@SF-"BM/,Z)A:ZS&PK5.#J>YQ]R]R*-,C<5+!UF5J-*Q#$KB.Q!>B$EB<
M1MZ1#Z<TK[(R8Q+$2IVG'4!M_ ?X%6C\0;U2;N/1U^%NGU^[>Z=$U2]/5GMZ
M)JG9]PU-)TDVX#=22#OJO1IB>XJW7TW5HTD031%CH?+;CNG^9Z)7^ Y"'&ZZ
MWU&U$M\?HLEL10VV>/6%9B%?D%$=M@1OS<6O-*A3(,A6["*Z:]BL4C]EV>Z;
M.IT.X*NIU#;DKZ5I<-JQ5A+^E9BFO25K*B-3L>94D2501E1&#X4=,G_#QH/8
MG>/P;U[L'N./MO3]9^(O?^J:!H?<^IQTAJ?;VHZ9VC1U_0YOQT@_%UM,GN4[
M>GSD,(9GO-'R\F"].8Z7Z(ZR7VGF#XZVKH')@-U&Q:YJB0H890<$SA];;RK\
M<<:K)E7&+PY]M%++13L-TN1[VO<CF.EJ_<&@U=4U"UZMD'4Z[W:\X=]C:EIP
MF@2L7/R)!<DBA=4^3&1A2 >K>[L^&GP7^,.O?#WLGMPZ9V_(O8.M5NV-9TN2
MG3BMQ=B=\3:9JUSN&.M&7M6]8[6HZCJ]::U_U"S;7W2+(V6N7R_Z 6N)%O*J
M-81,9LZO(;D6HLG,H;AXS;0LU=24N%2:8@QBE2K"C:&>\AVI-ZY*R&=$8:HU
MT/<?<D-P5IO2DN0SU8&TI*+AK<$E#\18U!+ +%$BL$QA5Q& FTG>W5<?_@.^
M!NJ=J2ZYI?\ B5/MK4=([AUJ'XAVN\*+Q]M:O1[S?1-$[)N:,\<4=JW?T-8+
M\LDH%QGM_B8PE2$JJOH_*KI=89]D51981^1<,J30:BLMI.HYI]E?ULV?,BQ\
M\AP*Z$1(T60 (S$+828]& C6^F(Z'5K-.QWCJL6F59HKRV-0G22:6!=*6**M
M-'%%(^FO)+*N]T+,H$:/.PR25P"TKT7_ (8_AWJ'Q [ATK4.TCHW9>E6J&CZ
M;JMGXC27]3UW3+NI7*E?ONE2TVA*E>I9K0Q6'EOSU]%@DV*L<ZS,L;>XMHEH
M=,-C- W'[')<J+IQEN>*$>9CK4RJXIKVUHJO$(H B0< QX\9ET4K"_,F2,@1
M"09W>'.[KW<$:VK1L0TZ:ZK0T[<=/,II06*T%F:\[$XE56<P*I78"Q+-N4#J
MO^U/@]\&[TG;N@+H^J=R]T3?#GO#OHPIWI!IR=T:QHW<&KZ#I/:%.%*^VA+8
MK54UN659S:G2N(HHEBG/3W:KZ<8/GET#$_5B1A3+H,*LHX%I0M(EO6: 1)M-
M&?< CM)*D+?QHL [TF)!FFZVH)IC=:,&BZMJ&GUWN%9'*5C)-9D@LG^#-W-+
M'9;T6.U4%5WF4%/4C7!)VJ5ZN7XK?#OLOO;7X^V(;%2J+>MQ4=+T*CJN@HR:
MKI?_  _:?=T6LVJPP+)9L2=Q5ZVFV9/Q8I79PZ)%'/*7#;5?ERT'HK/&*G,*
MZ?.L+PNCN.6<:/FT6(RCO<XILB+E-B9\8<E"MIY]4%!1&F;'"5S1F*X3W#(Z
MR]S]PVH;DU%XHHJZZ[:A=]/=S8KZ=/3%.) [(09XYFW/@LP#;0""17VE_ +X
M)Z'JO;FD]X5M2OWM:F^#G;VHUZO>M&FNA:UWUHW<,W=6HV)*\%L2IHM[2Z_I
M55D6&O)(D=B9XW*-%37K"=/,?JM-\DT]AR:>%EU)>OLZ:==LO94*=CV46-&.
M626@(ZC=:18H)CX[8XA-(]_R[&@Z4\3#MV]J=F75JNIO%-)2L5A%82L:J21V
M:D5DHL99P?1=VC#9)('S$MGKF3XV=J=A:)IOPY[A[!K6M.I=UZ'KCZEHU[7%
MUZW3OZ%W+J>AI9FM)!5,;:G3JU[K0&O%&CNYKJL)7J<&-Z8X?JAI7H;49G$K
M]+L>%,PVLG4Y(>!1_P!M"7-H+JQCW^)9Y$8_*(=I?E9$B914W1BPJR1,CC:P
M$R&(2]BZ7VYHW<W;'9M?5Q#VU1AETNO/59=&5>XI):-N=+NFZQ%OU""U=<11
M:E7M,T=:25!B.2-5Z^9FK]UZWVEW;W]:T9K'>&H/!KMRM<AE[A?_ )4BKZAI
ME633=8[?E9-+LU-/C::QI%J@%L7(J\[@O'8=E1%?Y8]/YV!ZHY)DF!DP"RJJ
M#-+&EITU!EY!;8W:XKA,/(:^!9"'5)5 !>3"N>*)=V!;N5&D&CQ8\<M:^05F
MK_#K1)M$[FU'4])_P&Q5I:M/1JG6Y+MK3[>F:9';AKVE%<5XTO32?P8[<K7)
M062)$,.2^WOBCK]77NT-+TC7D[C@N7]#@U"V>W8].I:K2U;7;&FVK55S9:V9
MM/KQX=J5=*,+QK+8=TLJBQ'\RF.Z<X5GJX7IU33H$7'JVH;:VLZ^2\??6-K4
M0+@DD#61@ K@PW3G0F1A/.I$&A2D0BN:E7=^4=!TK65TO0:TT45.G3-JU->6
M[^-LVZ<%MY$"(L==(C,85C1I"=I9F5OE%M_#;4NX]<[?_P :[DM5YIM0NW_P
M=.#36TXZ?5IWK-!(92\TDEIYQ66P972,?/A T>UC?!'Q#RE/T0KR'J&IK>3X
M,1K_ .66BTZ33=9?Y71BY(2:Y_YT_MUMLE43)?RCC_D?J<V9ZR*WQR8L_=G^
M-2[6)T9?BH8V(?4#J!A_#,%CVE16_P (VX9MK;?6X!(.>G@M>_$-_-Z U@'/
M\3U,8X'@KZ!4^<CYC],=)^R^&+Y7L#M;VWU"K,C?ALO6+5R1IY'K]6,?CS,Q
MT)Q#RC9)K+B-I!L8H;9T9]_J%0%JXU_+K]Y+&OK60"N&Y%VH_B#W#?6&#3E@
M-M=+TU=0>72[/ITM:L]RP:58B96,0?TJ,KV&A23 VK)ZFT]>HU.W(42+&?20
M2MZ3Y29K,<17#!=V(W9A@X&"3QUI4\C'DHU8)756D^%SL$R1LWR.9O)!FOF#
MD2<=NZ7S18O<WF8Z8 L!X;,LJ<.'+60X\&]# R#*)EK,D17QQ(>OA@]$[L[P
MTQ7FU:RMVOZ?=M132T#9/'-H%A(ZFHLIM>E+^+5G/X<F&#:JE6;:['+\;>BR
MTCF1-MQ,I#AE:!_X<IR<?.!C;\JD<_7&]R_R&^1S3'4.TF91A&3W-+*QOR>O
MBZ=1-6KC%QXSD^O&K^HNE6?*:POJ%^:+7XU78W492RCOHT.[J[!Q(=I,C09#
MA,\*O=_>6HZ?&M2S!%/%8[ESJ+Z5'9_%UM&TJEJ5,".&9*JRVY9Y:WJPEHV4
M9C1I$ZPCO7YH?E< [[.9!"K;UBA25.!\NYF+)\O'D 9'3#>1ZB\O^@WF5\_N
M-:CT&*9]I#IO7FTNCOS:!1WTC\RKSS9Z6Z27>24YI<<HV9'"P&\M;4-M3C%*
M$0!949X1)NCSW@^NZUV_V98T^6WI^IVW&IR+3>Q"!=A[<NZA#6G"88UWOQQQ
M-%(1O)5",D ^]XV9Z]%HV=)7(E8H,$2)7>5492>%:0!<'R#@>>IQYIY9_)AB
MFB>DGDQS V(7$W$/-U@VD.?ZYX82FAY9/U&UNT9U?R['[=V1BBEM;/!L,R"_
MTNI;2 <BU[Q4$L1&@D!$C8A1U_NZQJ^L=WPI<A2SVM/J5'1;L<K5H:>D:O0J
MSQ^@S!(KMNO!?G0J/4S,A^9>>M".S?::>VH=5:HTL<$@.P)#*B/P3P[H'(/C
M)!&<]-)A'PVO)N/*;C3NRIL@U+N]-]3=-M"/,CDU=K'6XC7:&>GI$W+-8O,/
M\O,@C2=C%+J">VQ.MK;;>B&/#9<-72;>U$K7&U\0.Z)*M;4(FAT^OJ6G7M;T
M"&32I+4NM ZF:VEZ&64_P[,] 1W)9(SZF;"D'TT+=>[ZC>*I(&$221R3UU,)
M=I09E2&O@>2$RS/D$AL\ =(G&/ATZ!W%EH'!P_2U^H^G^0Z.P-4;S7>UUVL*
MZJU4RP^$Y)>99I3C&G.#8U?Y3(OL,N8<6+'I<5'%ND93S8F1V0#648[=VQWQ
MK446N26[QT^]7U1M.KZ-'H?J/IM<7((:^I6;]J:*OZ%J)I6::RQB 96@C<QL
MIS;4K $QDE]*3U-BUQ"&,2[T43,[' !!SALA2.,CCK8V7D.\AV(ZHFTZR,63
M28.>^>3&O+UC>3KJ[#JX6G6G=MI5I5JM83CL?3D%D,XEK?W^G=1:6I8@(H+5
MEA8K+M:@:OQ_YO[VGTD:C62".2GVC/K=BK_A<LC7[Z:AJ&GQQ*3.&AC$$<-^
M2*/?(WI@(%BE/6(OW7B292HV4VL.HBW&602F)1]5RH]0@>".,@G,@]8=']*:
MK03!=+K?#@Z!TL#0Z)1Y9IK.S/",RR&GK,B^(AI15642]SRSII=Y&*[%+^?E
M,(L*7475-$-%#9S),"!+CR6;1=4U675=3U%+$FNNVJM+6U".G<IU6D@[(U&9
M##3218BOXRO'6<.)89'YC59) P\:\]@RO*',V9-X8QNJ96C(RX4 #:) JD#D
MD8QR.HV97\.?RPZ$U>9Y/K'B.46A<1J_._G]7@T'6"GJIN4X?HUJ-HS7Z#Q#
M6=9%NSU8\LQ#-+N5,*D5+:YKI<6VA@AJ**;P^U^^>X=:EK5M'D@C%F;M*F]U
M]*GE2M8U2EJ4NMN(Y6@$OX2>I'&@)$<+_*_J;B.ME-0N62$A8(&_!Q^HT+</
M)'(9SA]HPKJHSP,?7/4=?/\ ^5GREZ7:2Y_E7E^H\AQK(-+_ #/8SI!+?>ZF
M!SM,TQ7.]%(>K [2/!;55:5(L2N)#\5A&BOG.FQ!/);RY%D3<#SV7KW=5[4:
M5?7I*\\&H:!9U)?0TR2A^#M4]7;3A$SM)+ZIM0+^)96]+:V/2C$8YV=/M79)
MHTL\K+7>4 1[#&\<IBP2<G<ZX<@X )./E\P4\O\ H7;Y]56.9,2K-75$LT:#
M5V4@P@W-G%A,EG%))'. T6)"8>,9Q?4:ARD8'_L*'>SH_L[M^O=$VL7O2DJ4
MG*Q4Y,D6YXXQ(PF 966O'NC+[&]20N$12-^+5[5^'NN=W59[>F-6B"2RUJ[S
MR^GNM1Q+*1N4,8S&DL;H\D;0Y!$A5-S"7FL1+7)]/,<NLAQ(S\BB38]';LKB
MM'8!D(^2XC:OT!3XI8YT PHRE$4@!$*-5:[])XG4.JMN%(Z9.SW!G\)0$:V4
M=96"S1C9.(MU=%"2R1@-'DM*'&>KB^,.DWM7^&^C=S:S4A@UO0[%31M1M32!
MQ$=LB25Z[P9K6*\EL"=%,ID@+^F%7."E<;TOQJ^P9(5@6+20YF74]A+K9%L"
MSM9*5@Y<:/72+(<8%>H91I[G^F 4@<95.,KU.]1Q[4TSLS1M5[96I:>'3Z\F
MM4+4]2:ZEJ_.:GKHE66V$,)CF>P6*QB1(2KJQ,C83B"W>L1:L'6"U*\>F6T6
MQ'#BKB>2!VE""4NLJ^@%*OL=P0R8C#.R>SS5#&[#)+/$;_!L6OL5$UE+'D3X
MY8]I0O"\(73*:TJGPY(!PF!>,0!*D<^Z.*CVKT*S=V]U:+<U9]!U7M_2;NCQ
MJE.&6:,0V]-.U40U+598Y4BAC3*A2$9B"YVA@2'M^9:U>Q2U74*%M"9I7KMO
MCNE_49ELU;@LQ/ZDC[B65I4 *1NF0PB7J-@@,</'M:&5)L<3M9!@ULN6-HY\
M*:$0BR*2U8-7!'/BB*,S#!>^-/AE%* Y%4P T'W?VPF@VEM:?-);T:Z["G/-
MM6>"5521Z-P+E/7C5M\<D;&*Q 4ECVMO2.3:9J+VS)3MB.+4:T<<DT<99HI8
M9"R1VJ[, WHNR.KJPWPRHT;9'IO(UKDVW147?CA>5]DY3VV_K7A.-T\0T9/)
MXY/VQ[G'YCSSP!DY)STZ_K_X^W1;]NWT^[95_'?9>=]TXXV1._@QR2<\><^<
M@#'MC/C'///)!QT=#[O?MO\ K7?N[MWYV3?GMSX4>//CG^PQ[')Y'&3@XQ[#
MHZ^B3^PD?\'[SX<;?\,6CVWX?F3E>R]U]OO^[QYMY_?')X\#'Y8'7JG@_GUX
MW?C(?XU_XC7//]V9YA5]O;4S(>/OW_THGW[9KX\<9(\'W&,_ICS]"?UQ?S^G
M^_5:A6N>-6H[;J5%5VRKV5%V1>.-T[?<J*FWA"H/@$$>WVY&2!SY\^>"#R>L
M5(!Y&?\ 3\OW^O6/2=-D^85$5J(G"_O47J1-^OLB]OJONNWA-OT]C],'/U\9
MSR<^^,9^@RWGGEO&!R",9! QCP#R!X'L!G/6;72VH1&RGHC]U*W[721-TX>U
M']+T^Y45-M]^_)L (R%SX!(\#'.,XQGP<8/@ ^<9"5P'&^0!\[@'(#Y\[\8W
M9^^?/CK%/F47=)#D7=NVR*G+$V;V>G[UO";_ +U%VX3;P8X/\N/?CC^N.<G\
MP3D^1T"5@>"XY!X8CP,*<> 0,;2,$>QYZR1\MB.:V4]J/39R,W1'-WWZ7(C_
M +3>-]G;IW7OSX78,YX&#D$KX)]QN/Z?VQ[]*)G4,H=P&4*RAR RCP#C&1[\
M_08]AUO+W)LER:-1Q+RX+81<:J T=%'*(+ UE2$I3CAQA"0;$&ISF,5SD<0I
MB.>5[WKOXU:]*M5:Q)7B2*2W,;%AE#%IIR I>0MN.X*JJ!_*%   '3SK'<^N
MZ_7T6IK.HV+];MS2X]%T.O+Z:Q:9I<4T]E*=5(HXU6,V+,\[LP:66:5Y99'<
M[NM"C9"+NAUW5455Z5Y7]ZU7?;[HB)LO=-DY\;.T?4<9]O.!D_8\G]<9P>>F
M3U#_ /=Y!SG!!'C&,>!X/GD\];XV3Y/)QNOP\MR=V-5=I-NH-0U@FQ@VU@$(
M)D]>A&D-(*".$*$.0OI#9TB]-'/ZM<4JR6Y;RQ(+4T*5Y)R'WM!&S,D7.0JJ
M[LV% ))RV<##Y-W1KMGMVCVG-J5E^W--U.[K-/2,QK5AU34(8*]N^0J*\MF6
M"M!"'E=_2C39"$5G#:+>5U^K\V3U-MD<JNZD;MMTHY2=?3T\=/5TJU4X[)X]
M]GM@<'QCC.?.,$8S[_7/T)Z9C.Y;>9)"^T+OWL7P  !N)SX^7[#@<=&KY:M:
MU9+U:B+THJ.V3=>51/4Z4[\[(B;JJ[;N<JKL&3_+SR>.?Z8R3@9Q]N?;K$S.
M< O(0O@>HV!SD8'@>_WR2<YZQ3YAK/3;(5&)]KH1%1O5LB=2MZT3J^J[;KVY
M39/!LY!(&? X^N?! ^@S_G]P2L%V!GV9SM#E1G&,X'OCC)R<=9]<MK5:DEZ-
M<O4Y$1VSE;O]IR(3953=4ZE3=$56HJ)NGA-N>>,^WUY]N?KYQGQT"9P"H9PK
M$%E#D!B 0"V/) ) )Y'///7&B'V7]T*FZHJ?8Y16[JW95?NG3NJ,VWV^[OX7
M:<>W./;W)]SC@Y//].>D]0\?S9&"/F(\#Y3QCQ[8QCV\GHF,,PBO:?I<[ERH
MW;V7E-G(N_VE7C955554[^%&\'()!!XQ['D<'/MSSG.3GWSTA92""N0<^_G/
MU_/'/GK+]T[._=#E1[NI^[55'KMV>G7RB;=7/OROMX4%\GYR2W\P);##S\WU
MR3[^_CGI"4./E!V@ 9 &,?3 R/R'&,\=!WS+D7>0Y=T5%X7?GA?\O??[*;_<
MB;IMX&+,>6)S@9)8^WC)R2,8]\#/Y] ('A1Q[\#Q^F/?]3]\=<3 E9NK#*U7
M*J*J-1'+U<*F_5NB+]RIW\)@\X(^IX\8^I'@_8>.>EW#CY?H!SQQ^G/GWZY6
M+('OT'5F[7,W1FRHUR*CFHO7NB*CE1S>RHNSD7P;201\I'& 1]^",CC'G(\D
M9Y(Z3(^G]QY!SGQY]A]!XZPZ3(G3ZW'_ .9S[+_Y7O\ R<\>#:<8!!'OC^I\
M<G''WY&/?HRO_P!/]_\ QUG^ZD1S$D.1K]NMJ;]+E;^]56H_H56<[*Y-V]2[
M=U\)MR0>,C."1R <>.,X/&!C'MCZF5_^G&/'/WR><9'//!Y]^N-P2N144RJB
MKNB*G;;Z(K^R)QMLNVVR;*B^%(/.3[X&<\>WMP,\<?0^W2[AG.T?V_V_RQUE
MZ9MD3U>S4_R-N$5-MTZT1>43A47\.5W /H1G./?_ $XY'GC&//.>DW#SCG.?
M/O\ T]O_ 'G PO(NI>H<'3>XT@AY7/C:;Y#E=7G%YB@11F0;?*:.OF55/;SR
MH/YV26M@6$\,(#Y3H8/G)!AQT.1Q?&FVGU'NQ:D\$;7JU>6K#9;=ZD5>=TEE
MB3G:HD>-"Y"AR5"D[0!U@4B,BRF,&1055O=0?('' )P3]<#\ND)^ZNH;EEE5
MPFM:)RJ[=C6[HU&*K]VHW==D:J(G\OC;V8##C!/( _FS]>.3^?)X^V<\KS\H
MYSGV^GT'.2/?_+K)$D/5C5D.Z>M%1-G;=3G-ZE1J/Y<[9.I6IU.XW7?;PNPY
MS@9( P![#P.!@?0?K@YZ4$$C"\G ]O.>.<$^^<_7'GGI;+I]F(JV-:EKYD2!
M9M4T0DH1XH9H!N(-)0E*K1%&A4<-CD<JH]CN%^UXD\?9VORTX=0_P]TKS[C"
MTP$)=!\ID7U67"$@ <@G ( 7GK6GLQ02!)@4)4."R-_*QX(^4$ACNPRC:1D
MDCK06]7)IS-C_/M+Z@44C1M<G0[=%]-Z=?*-=TO8CMD1%1R-:Y5\-.IZ<VG3
MI"\L<TAC1VV $Q.X):-O(++Q]MI!^7G&4$XGC]01E!O*J6QE@N/G&,D @D9_
MFR/RSI4:?LA]]N%3H157NO\ Y6_"=E;MQ^/+=AA[@?3R/H,^/OC)Y/Y=>Q(^
MAQ^?CWX&,#/N/TXZXECO5Z$4G4Y'(Y?L]^G;NO4J^W?W7NJ\^#;SR?<>WOQ]
M?Z\\GSC!STNX8P!Q@^X'^F!^0_0>W3B87@&2YY(-%QVJE6#HK&/EDC"<5L9A
M2(,?6B;(USW*J;N(B;-<KMD;OX?M$[=U37VL?X?7DEAJ*CV9U0LL(=PD8(4_
M,SO_ /&@!)PQP ">LZU>>Y8AIU(FGMSL5BB5E0$*-S.\DA6..-0<L[,%' Y)
MZM0TK\I.A)<*II66UDZ_RBM59^4DC7<Q@VJX)8SXS( !@$6NAD>V6Q@GOD&/
M"5I);X\IK4MA/AEHU"S3K:A/<L2RQ1-(Y/HUS:=58UDVKN6$.67U7(WA<JP)
M"MV#\+OA]\+M>^'::YJ.F-J_<&BV+%WN2*IK-EI*]"%IZC-^!2.&&Q%"FV\8
M*CR.9X!%-,\,ZGIUJ;3#1)<8R=D'3##%$DP+#DDTL=\H07G#$]8<B2.1,CQP
MSR0AHP1H;7#L7>J17!9TVHG9':E5H:7^#Z:WXB&(!UJ^J)YD;YE#3$/DB5OG
M23G:N,Y.(?I=CM74NV^ZM5H=L:3'4I:I;K6X;M>O!9HU9RM.O;#@3V8X(=02
M@@BD2OZ4.HS%YD9,AB['RWZ3Y?C.2DQW$BTF1NLI\ZJ97VIQO;'8QC2PP)+F
M%KTAA+UF!'/":=1^F*.9'G<@M'4OA5VA:T\O'I4VG2;IH8KE>ZT9:R&Q&&65
M;$)SZ8(1UC $K 2+D8IVG2I=TUNYFT&K6_Q<6Y-9T_1HUEDGATJ.-#;K4W-N
MK"M:O-,S0>O#+8:.&.*)79WW)O3_ ,A>#Y[C?Y3'JA?XQ8CN#UEU56%%&F.A
ML&HF!"]L><%O_;3Q$9.(5T,P5ZF(CA*BP"W\'=/]:%ZFK7_PV'-I;%>MZU>6
M$.]BN'298FD6/9-&XW"6*1&5 &QU+OAW\-]/[U[/U/4IM6MZ3W)IVIFI)I)J
M^O#<HSB&&A91&$%F)#J#6*]J:0O7KM792R.I+!WPPLP=-N*^-JGB$F17R'#B
M#CP;200T=1@>&5,"!I3Q&.^8&UWI#E[.:3EW0B^(^GPBU9XA.-3JQQ2F3T7F
M@L(CH,^F&D)V+(=KET^95&TB1@_3YJOP.&DV]0HR]U4+%ZD0!2J5FL6PI$1]
M6S5CG]>&-C-&(_0CM/(1)Z<;%,&+FN_E3SO06/%G7T^COJF5)-$99T$HYA@.
M).IK)094>*8#CKN@V]+E1XS,<B*QJJQ=Q_#?N/MK2H=;NK6EI3SO 6KNY>+'
M_P $DR2QQX6R@)C](R8P0Y7(W4IW%3T_0^X+?;L&L5-7LTXX6GGI+*L"RR@^
MI6/K*DHL56PEE&C 5]RJ?EY>+X3R?\ISY ?N\WGE_1-N4YU,QU47NNW'&W\B
M\^*_)X]^22<\?8CP,\_3]1QTV+Y_0_GX/5Z/[,OW_OINE.R[?\2C2[?V3G5W
M7O\ 5_\ ?_7X1<<Y^V,>1^7O]_T_+.3^1^7^IZ\D(QF%]EAU:BJB[=.Z+SNG
M^5LNRJJHNR+OO^'@VYR?./H,\'(/!(('L?K^767J'Q\P&<\,1R/R]_\ +ZCS
MUS(^6UR.;*>QS7*Y%;U,5KUVW<BH1-G+TINY%W7A%54V3P%01C .>,8)RN ,
MGSP/8>/.,CCI5F=2&5Y%96WJP<@J_G<,8P3[L.3@'SSUCU2E<KOF7J]7J7=4
M7J5^R_:WZNZHJ\]U3Z\;H% &,* , 9 P/;'Y#[ C(]L9Z#,Y8NS.6+;R=Y)W
M'_O)\[\YR2=W."2#QDTDQNRME/141%3;?NWEJI]O?J8J[M7NU>4VW7<*?7'N
M#D'WXR<C&".,^X&/;I1.ZD%6D!&T@AV4@J25(P>-I)((Q@\CGGI00,LRJKIL
MCQ^!=&C5.7#KP9'%:,2K; JY:3H(9!WHX_HAEHR0HQF&PI&#4J$40T;K2T:L
M\U6S)"CS43(U9SG^ TR&.5E4';N9,INVDA20-H)R^Z?W;W!IFD]PZ'1U2S6T
MONN.A%W#53TV_P 4ATRV+U&&S,\;3F*"XJ6?321$DFCB>8.40JFAC,)$:PRM
M1%ZD3941%54^TBH]$1WMU(J+MQO[>-DKQGSGY?\ 7'//GVQ_GU'_ %"/!8 '
M< &P,XQG 'DC'/D>QZ4N,Y;E.'SS6N-71:RQ/66=0^8$8G'2OMXSX=B 3S-(
MH''BD()3 09F-<Y1E:Y=_&O;HU;T2PW(5EB6:&QZ;[MOJPN)(68*P!".JD*>
M"1\P('+_ -N=V]P=I7YM3[=U*QI=^?3=2TA[4'IF8:?J]62EJ,$3R1N839JR
MR0F:'9/&KMZ4B$YZ3W5+])0_,O02JKW"1'>DKUY1ZL1_0KD7EKNE53A4[<;&
MT [N-V, D#.#Y&?(P<^<<_?PQB9PABWR>DS;C'O;9N]F]/.TG[XSY!XQG/UI
MZ;[SC[JQ!KN\B*K&<M:NQ$^RWCI;^]15X3E?"% 2/E4Y.? P"<C/ QGCDCGK
M/\5,,_QYB2H0_P 1SE%(*QDDY*+_ -JGA<<>!UQHZ6CFO;)>QS$1&N9NQ41$
MVX<TC53?==]E1555WY5?&17<"#M(S@C&<X^HP<^#Y_3 Z\EF=&#HSJZC"NKD
M,HSD[6\C/OCSY///62$FHJ/261'(J*UR*Y%:K4Z4<BH1-E1%V1W=-UV795\)
MM&""%'!!!'L><??//!^^>3THGD#!@\@92&#"1@P8# 8'RK*"<%<$>!QUD1)&
M[%6:I'+T%<]4>CVD3JX<JO:JN8BKNNZHO4O2JJO@"^P' !Q@ @X/M]N1D#/W
M'2>L[$LS.3D<ER2>#\Q;DY!S@DYY/WZXG1RF8K2&X8SJ:QS7(JHYZ;H/=Z\[
M]NVZ*J[+W\9[."20. <<@D$@?+D<GVQ].DW$D#GC.-S9 X//OP<YX./IUV"@
ML!](C&>WTF(9C#(X2M8]6.8\2/<U5]1KF/;T_:<Q5>B*C7*U6,@PKE@!AE#$
M_*"<@A<_+DXS@9'6 ,9R0%))*L0,YQD'<2!G R!G(YP>N)22UZ^J4]?47J(B
MHJH1RHJ(XB*_9[D151%>BJB+]GOOX4M*2V9&.\Y;+'#$<98>"1G@\G\CGHQ&
M,8C7@8& !@?0<9 S[# ! QUU21WD=UO+NY=D_>>R)LB?OM]MMMOK]>_C JQ.
M2<_4\D_3]2/Z^!UD' \#^_D_TZY>@R;*AMD1O2GV-MFI[*G7^&_=%W15W79?
M!@YQP2.!P/\ 48^OWR#]^C<!X'W]O/\ 3]1X_0<=9N=)?MZDAS^EJ,9ZB.<K
M!M14:-O4151C416HS]ZG9$WV\($QX"^2> .2??@>3GW^Q/CC'(_^G'G.,<DX
MY\8_MYYZ)J2&KU-.J.:C=GHU45J-VZ=E:_CI]D1./;;;A2#[XY]B/SR /!SC
MGV8$9\]&5SX./<9X_+QR/KG_ $Z-ZRGN<]TA[G/5SG/5JN<JN55<JN<]RKNJ
MJJKNOVEZN_/@"XX&T#CC  ''  \X'  QY]N.ER/_ *?MYQ^7@#Z>WMU@@SHJ
MN]7;J:J.^PNSMU155R=:[KOLO/94X3OX3G)Y&?Y?/)]O?SG]\XZ7*G@KC[CS
M_E^GTZ4F(93DN!Y7CF:XM:-K<EQ*^JLFQZQ?!@SVP+JDFBL*R<L*R#,KY:Q9
MD<1D!/BRHY.A&&"4:N8OA:K07*L].RGJU[4,D$\1+H'BF0I(F]"K@LCD;E(8
M \,/?%U2165DRK(4;[AO(.,8!.?&/L <8QR;*<JS+)<ES#)[Z;<Y-F%U:Y%E
M%S+=O+N[J[G&LK:?.5JC&4TZ?)-).B#1GJE56,:G2B+7K05J\%6O%%#7K11P
M5XD7"0Q0H(XT0 $!410JG)P!P?/2*J(JJJ *@ 5>,* . .,@?D>?RZT;#36>
MGT32C0._I="N:@NM-GJ-&D3H5Z)]OHV5W^5V\>IC\Y53G .1G('UR,8'/GCS
MCK+*G.5SGSSYYR![<9_WZXE0Z[+ZW947]XJ;JW=$5=G\*F^^Z;;+LN^^WC+!
M/& /8_?&?S!_/&<^/!Z7</H<_ICZXSC('M@<8_//6;R2WN<0DESWD55<][5>
M]RJY'*KG.>KG+U)ONY55555W\ 4CY5VJ%YP!C'ZX_P!?KCWZ3*__ $_;R!]?
M8 ?O'6WIJ*_RBVB5-4V3864\C  &-A"D>[9-E>57.],3&,W(1[FB$)BN>J,1
M-][3-+NZM<@T[3:\EBS8D6..*)".6;!=S_*B)\SN[$*J@L><XQ>6&)#)*R11
MKY=BH SXSP!R< 8YR>/?J1FH7E<O,$TF!J,?)Z^Y*S(VT5_15T,Z-I/6 I84
MMU@<['3$?)":+)].O"&.KHA!R9#)/2*4]V=CW^TDA6]9KS2R*OJ)6W%(GRP9
M-[A3(4=2C.$"DDE<K\QF\/9=FUV$._Z%R"[0BU5M+O5HHY1-0;9&T,\S.H&R
M??P%4[24+'YNI>^6.II,=THKYL.S)>@F3Y-X=JQD@'K'$CPJR?'?'22;YD5>
M>(YDB6Y6]4<[9 QL$QZ++^VOP>D:!':666W%,S6+#-'Z<<&X+$82-LCN(Y8R
M'D782K!E^5>.@OA!I$<O;=58;L-@6+<VHPU__AMQ2LL-6V HLJDB0+"0QF0@
M!PZQA3M9W<UK*6\T_P OB%22![9S["/\O^ZI+GRV 9)^6007(]ZC>1 (P9""
M<S='J1C=I#)7TBSKFG:A$2CVM/2!HZR/)*!<'IR)%)&I(!W2,F Y'\(LRL@'
M4I[IALW?A'\0]$NQN/\ #=9MZE4FL680)%JM#8)8,54!?3P/E3&V4*9-^[J'
M6.1XL8E?C=79W*C>@[&2"$\DL=&R"1BG!^2'!.WYJ=+:TS+-DR*8;"J)>H3G
MJZ8:;#4JB#2J5BPBQJD[0Q2-*M-(R<I^&*R;I;,AW"R9HWY9"2.5^?4V\S-8
M*0@!2JF3$?JEU4IF8$[8UW.#"T<A8@,IX&6'O'*>]M7R7%]4D^21PBHKSB]0
MSU&P[W]#FF1NS'HY.I'JK7=+NU3ZN%L:SJ7XN5V=[+,L 597B5W_ (2O(738
MQ3 P-Q5_D;!'3K&<1H4  VX+#A<CG/@C:"2?[GZE<1:.;?Z?9JY\D9XD"ACY
M!'&A8#G0K3%S!!'-("YZ3&RB519</TA1W,F1Y#I)"$2.16R&UIAU7M'62DWJ
MQU-.BU!8I&@+U[6D$(CN&8RB=Z;2PM'&A657,A+8)#/:L)3U'3)MA6=KHH[U
M21@T%T$OEN8_3$T<$@9B KQH@(9PC1.,YSR.>[IZW*KEZ=D;U.W<JHC?LHFZ
MIV1&\?3GQ0).[<>/F.20/<X. /MDC SC''MF3DDDDXR22<>"<_;C^G7$J^R>
M^W?=-_O[\[K[KV3P@!_(#/ Y(R/'UX^F.2"3[=)T?/XKQMOLJ[IQLFR]]]E7
M^O?W,#C\CDX(X/N>!QC(_P L>QU]$G]A(_X/WGP_YX]'OZ\)RM>/]OQY\8MY
M'Y?J<$C)_IUZIX/Y_P"@Z\;OQD/\:]\1O[_.9YA4[IM_WR\A7M[K_LGA5\C[
M?GG_ & Y_P!^L7_F_,?^/].JV?JJ=]N4^]43E-O?J3]??Z> \8^F<CSX&< Y
M/C!]A]L$YZPZQ3C=$VYX]_JJ<I^"]OP7OWR/."<\<XS]L\'_ %'/GV\'1[+P
MJKV^Y?Q3V[KRO*=N5X\)QS_?W\_3GC& IP>3P,''1T7OQQW1/O[_ *NRHF^_
MOOOW\'L/Z^_RC S_ $(S@_3'G'1]?]O_ %@?O'1ILOMSOQQOOM^/?9.-MTX7
MZHG@/'UQ@9' Q].!X.>?!Y''!/1T6VW=6^R;;K[<]D7\?U]NZ;KD'QG/)R /
MR]_T'Y>3YZ.ME45%K>V$2IIH$NULYYQ18<"#'+*ERCE5>@,< 6/*4C^=F#8]
MZ\JB;^$Y.-JL3R0%!)XQ[#<3@ ^ !@<>".MW3]/NZM=K:=IM2Q>O7)4@JU*L
M3SV)YGSMCAAC5GD=L<*JD\=2WQ[R1:VVN'Y7EEO50\23&<:DY2RCR0QX%Y:U
MT,J))^5@?+D='(,:N)_NA\MNQO*(BHY)#IW:FN:E +4-40UL2E9+;F#U?1A>
M5O21T+-PFQ254;F7G;R;KA_X>N_H] US6]:K0:!)HVAKKRZ1J8FCU:[I[65K
M[A6CA9J?SEF4WF@W;""JGS#EPWL54>FRIWV5%5%3\%7E=O?WW7;C?Q'R1_<C
MG/'U^@XS@8/CP3XZH@@@D$8(.#]C].L-^Z;JF_?=>_\ [N?WV_.W95Y\)@^<
M XY&/'!)Q[?IQ@YY!\A/W_4?K^_H>@O?9.Z]]O\ 1SPGNB<<)PONGA1[GZ#(
M\??GZGQGS@GD> >CK)=D7A4>FS5ZMW(B+PJHB.1J\*Y6JJHJ;HJMW1=_"8QD
M<9(QCGZ'W.21@>WN .ESGZX'C/[QSY^OU\=8]N_._?LN_P"O?CCO[\IPJ>%'
MOCC\R1C/'@\>?'MG/(Z3H?7G=.43E5[)OLGUVX5>-N$Y\ QD'WXSP,^2"3[#
M/C .>3QQP=#E-]MUXVWV7GV3\/I^K;GG<&,#/L1@<'&/)R//!R?IY^AZ/W[_
M -/W_7H)Q].4]]DX7[]TY_'G;CMW#@^?OG'VP/&"0,^XX!&?/1^_W^_?H=]N
M4X3NO^C9>^R;_P"A.=MP@Y. >3^1X^X' /CGVR?<D'07W[;(O";\>_M]?==]
MN>Z<[>!?;ZX.3]O/DX^H\9]O'!Z.C^B\<<*G;?E>-^WWKMMPO*KX#@9'//(S
MDXP,9QY'G \G/MP.CHMMN5_'Z[]EV7GCZ[JGO^&Z9SP.1X'D8X/U'/'')_IY
M!^_WX_3_ %Z/?A.%V1=MO9>RJGZU^J_AOV0QR<D9QY\8QD9^@&/],D'!)]?]
M3_ZR>A^I$]]_N3GA43;CLNR=^? ,#W)]L?0\##?8_<C@8Z.ARNRJF_;VWW3;
M?WYWX7VVWWV7=5\' R/S.<XP<XQ\OYY_(@$<#HZ&WM]-U3=.Z<;]T[HG?A?N
M3P$YP?<\'!/!]L<XY&<?0YR?/1^_\_W_ )YZVU/;2*2Q@VL)PVS*Z4"=$4\<
M$H3)$<B$$]X)#" *UKF-56&85CMD:YB[\;5&Y/IURK>K!/7ISI-$98TL1^I$
M=REH9D>*0*P!VNI7SP<=! 92I9ER1RK,K#R,JRD,K#((*D,,9!!&>K3=(?.S
MC>>UH\"UZQ:F(QD= PLIC44>75*UBMW%;U  $6O:=&JCY]6 HFD(JOBL3=[>
MA.T/B?!JLJ4-9B:I+)\UB6&,V-(M<_,\].99EJ.3Y;YJ[#'S557/5KT>^NW]
M7T1] [_[:T35GKTDJ:'W.M$TM;TU8HQ&E>W<TSTK=JL55/2E EDKR[I'KVA(
MX$4->Z6BS?7[\A8"F)UU7<PJ.+3K2V49<?;ZD%"$5LD$2,C9!"^JP@2 )*24
MYH%ZWJQ/$5[]TR+N;XBUM)T6728DO5J$%:>*:K#1+F)V9Y)*C2Q),3F,QAI'
M:3:ODJO536(Z.F+8%*5[52)G='2:W<+%R#MC>Y1TZT4!. )*B$)@$O\ SLB(
M&B.46FHX=. 4\B!9PU*:<>RD,C0OD1JA5FCEO:QCHYE=T (-SU,]6#&GJ*C?
M##)V%J"=S/V]/5GIB@!+=N6I/^G:F7&VU#*J;9$F+B*(HT@=R!E1G;L:-2U#
M7K5?3M/CCEU&W)+%!7D9:NR6)'D>.<SL@A:-$=G64HV04QO(!EQ;>27%WQ8!
MW:E1ZZ?'")MA41Z1A2]3AJYS!G6<U[BH]$:)SP(]['*1J.;TJ^::A\.]$GMP
MJK:K4JP*D7JU*=:5;2JQ#RJ9+<+*,@ /(22K*"H+*O5TM\$A5T6&Y)\0^V/\
M?9%DO]OV5MB?3YI(C(M1)H$G,TP8;5C$";P#)$SP@2,M,!PVJTNKIE92MD,!
M(,)\J=(.+\HG:+[0)$WL $1Y7)\L$2HX;W.7I>JO<EI=N:'2T'3FT_2:V:DD
ML,]NS;8-,[1L%CFDE&V-?38D1PQ_("Y(+?S=5$"G;EFS8LWIX+ACDK5EIR)%
M:E0QI(!+6S(R5K)5&]1I/578 T:L65)+:5VD$D2[..5(99MCN?%8U"%COC#8
MX;U*U!O&X+C':PI%0!'&(WH0Z;M<U]W6)#K=&>18UT^2*.-) W/IQE0REMJ[
MIU<;E*J$.2&*YW'K?_A=OZ8.R^[A6U"ZO==5;%E:S+))7,<E>=HV>%5E0T9C
M.J6))#%8_$C, LHAB'4R.08WKW)8D"/630'@EC]92RU-914+UD1[PCD.#*)\
MR C'/6(X8W/&P[3>C-=*MU=7J)0EE,K:;B46H00Z['*UD#"0JIP_IRQDMX+;
MO.VI/B=#K>@7M1[Y33M(IZ%W/2N:/9T*V\DUN2UJ]&*>U:,<BUEN""T!>IV$
M+?AV$?J0QS(ZJAL:FMA6 FG.T8)-@!PY+7;L1LAZ#49!*YB^L5R?:&-6M>K7
M=3?M*KGUI%&G7X9E61)CZ]=BT87>%8JCHQS'/(8R!Z>#P?\ Z@>J#[%O/4[W
M[;LBT]*)]2K5+;1JQ"U[$\<;'TT8"6%-^3"YV.,*WRAAU):*2@ :LM*&NNUR
M*:EB$QH2GK5DJKECC+:"ZW!>]CQM<A!L1I"*5A&)]MR5U+4>_J<=^.]'5@K1
M0UI8$EE2O<C6,,B685"QW'JX/HO)_'C0L@D,?R#Z54+/:6D:=ITFC=M]T:IW
M1KDVNV&L0PG3[4$S2_AFNSS.Q_PU+<B+ZXJ?]'9G!D>"*59F'-=:OU6 F=%#
M*B2\NBP3%L6Q2$EUN.1WF>:("Y6,Q13;$<E?F:T"/'+=TM<8K M%'26UXJ-Z
M6:"69X=-JPI8FD:)F:1O35"W!]2JMI"(Q"03-'GTT!?U&YS^)'Q)?LOUI%BT
MNY\0M2DMUY*>G7#-4[:@%J26I3O'TVH:I<TZQOMP3+OEBE*?B)@L4<'4%_,[
M+)J)H9+G LI)I^.6H\G(!P4:.WK9"BA2I?6C&.=\H62Z2158Q51YG;*O4B,W
MQ>J1Z[\/[,VF.R)I0K:@*RJ%%BI WX:1D5E4^A")]ZE55@8<,J]<9Z9/;'<U
MBYJ4CV[.JR3M9N2RF2=KL[26&:=V9V,LQW,VYN25P0#GIE/A.JB_$X\@/W^;
MS0!4_7J9CB*N^ZKW3CQQ*PQ]#[9 QCW _7.?_63/1Y_1O\CU>E^S+_\ &FZ4
M_P#H4Z7;\KLO_"]KWPNWX_=^//A%_+]<>/[_ $SQ@_7''63^?T ]OJ?WGKR5
M-1%5$7?953W1-NW*JG?A-T7CM[\^,CD#/&?KR>,G@9&!CP1_7!QG#]_OSU(3
MRZ:0+JSG'R,N+(E45)"2UO 1CCCFDQW21QP1F'=NH!&,1%DF&U7AA!EF9T*-
M2-L3X;]HP=UZW(NH^I_A&EP_C=1]-_3:2/U%BBK^ID^F)I&^=A\XB27:=P!Z
M;=0?4)I]+T71=O\ CG<%^/2],+Q23I%,X,DMATC!#"" ,RJ[I&TIC61MIPTP
M-3OA[VMD<-_I-D6+C#/CFD3,/N9=G6NJ3BY2+4SI3;1TX9T57B#-D,,)$:WY
MJ7N1XY'W;\-M]S\;VQ%%#3L*)/\ #I)7'X9L LL,LKS2R*?(#L2I!RS ]7_+
M\!.ZZ\<-:E<759((X(YK=U8J<EJ5DA#3A*Z&O&C2R%7!V%"N0,$!4=BGPV=;
M,A"0L_)--<9>(#3FBVV1S),L+7RDCC&0554SF->5%0K7HYP6L<-IBB*Y!+$8
MOAYW!(<'\%$QVJP:SO9&9G7#^FCX. IR,\-@<Y 6'X#=Y':UPU:J$R?,#-84
M+&I<C?'!Z;LRJQ18W))4AU4<];R7\,75QAY<:%GVF4\T: *:UHIN1#]17L1[
MXFQ<>&41AJKFN(X/RZ/:_K.UHBN9MK\,=?9&?UM/R!_#4S3?Q&R> 37 7)!Q
MN!4_7GKVL? GN&$.1J6FG8^PEELH,@$9+F(@KA5(*Y)$J<<CJ)NHWE@UQTN2
M2;*<!MTJHQ&L?>TR#OJ/I*Q" ,^QJG2@ $8.Q!))4!$;]E[&$:YK8UJ7:^OZ
M07-_3+$:(.954218#%2WJ1EPH+ \R!2><CV-9:EVAKVF00VIJ,DM6P\J06JQ
M$\,QB&YO3,>6_D^?!4';R0,'#!*QR*K5;SNNZ;_3?=5V5?WNW;GC=>>_AA)'
M]N/&./('&,$>X^P(' ZC.#G!!R"<C'(^O'GCZ=!7.Z&L7IV:Y[T7I;U*KT:B
MHYR<JB(S=&JJHU7+LB*YVZ8')SGP!CQCV_/G@$X/'D8R$Q@^X./]/I_G]NB5
M$7Z^^_"*N^Z]TW3OPB_3A$W7CP>/IDD8.#C 'Y'CR,YY!)X'1_I^_P#SC_ST
M%1/;WYVY3W1.$Y3G;Z]O;CPH)Y^HXR>1QDX)\\9QD#S[D<='01%V[\JG;Z(J
M\<[HGOV^_MX"<YR.,GGCG'TXSSCSD8QYXZ/RZ'NB.5=E5-^5_7LB<;*O;NNW
M*(O'A, @\#C/L!]/<Y((']_)XZ.NU*F$E/:\BL5[1!$CVL8/9H!M$Q.D36,X
M:UJN?TJXC]WD<][GN7-G=]K/RP  .W!"KG !QYX/OGW\](%51A0<$LQR6/S,
MQ9OYBQQSP,\  # &.N CWO=U/<KW.1%<YSE57(G;ERJO"?3;ZHB;>,.6)8L<
MYP"3D_3VX^GV]OH>E\> !SG@?O/Z]<:)VY]T394W]UV_EVY1%7\?;PI)Y&,8
M'L2!P!G@9&?IGP,9Z7_7ZG]_UX]^CV^]%5%7C;;G9-^$[IQLNR<JG'??P$X!
MX/@<Y)XS]_?G('W^V.DZ'">Z)[HNW/\ 5[<[M^BIM[>$&><\XP,9P.,DYSQG
MCG'L2>CH*B[INONB_1?N]D[[=^^R<IOLG@!&#@>/UX]S[_7&/')Y()/1^_W_
M 'Z+?;^3C]>^ZIQ^"\[+MLG;PH&3[_?/N 1Y&?/G/!&2?!X!T/;A579/==D3
M[ME^[;A%7?9>Z)R?]V" /'CR2.?(\?GP<'G['1[;\;=]]DX]MUV555=E1-^$
MYW7G[P\8)YYY./'&,XXR"1Y_IST?O\^?WY^G6Z@8WD%M$F3ZREL["#7>DEA-
MAPSR(L+UT50I+D"&X4=QNEZC]5[>OH?MU(U?&[4TO4;Z32TJ-JU%7P9Y*]>6
M6.'=N*>JZ*RHI"G:6(X&1CGKS>:&*1(I)HDEEW>G&\B+)($QN,:%@SA<@,5!
M R.>>M::')C\G"06VW_9$]/??V3JV]MTXV]DV^NM)%+$0LL3Q')P'5@1CWY
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MJGLYM=(&]NSQEAR" <UVR-VW5FZ)VYXW395YIU2C+IFI:AI\R%):=RQ6>-B
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M<QO)3M1L\$ZJVW<JR"1 Z&1$W#ICU1$79-E[>_"\*OM^K=5V7\$[0X'/.?Z
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M='#PU6PX*%,]B?-A(BM.]KAHQ'*V&Z?V=W?JVJQ=R=PQO4:-U>&E'Z%6U,0
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M(YYP![D^Y.BY]^?N]_9.?Q]N_?C95W\)[9' \8/OR?'U)P../;.1T>?[_O\
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M:]QQL8G[H"(8C.<Q!/(4K'.*B]2^.FM$DEUBCI9UJ(C4((HY[14*AD))#2O
MFT"40^@LNQE)G=RT>=W5S:7K6O\ ;/:5N[:EB>/6=&OZ=6EFA=;L4,D+QZ9#
M)8V2Y*,DUF)G@5FA,0:R5"A9/8,'&K+ YA#A<\$.N$%RM&+TQ.AM$R,2*Q'H
M5KRJZ0V2)Z.#(1KGOV:7K;'W_&1:U!'5;>CS8*+(Q<(TKAXI%D4!B8BD@5=P
M4@ MG.WL7L:+LS6?A%K-[6:KA:&BQ$V&@KB 6JD%<U+6GB)VL1"27\7':C=
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M%]!5BB]%R"<<WI]*.Z5R[X[VK]WFF*^AU=(CI&?:\4IFLSB;: )Y-D8")MW
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M# XP#Y/@CD<9Q['ZXS@8Y\G01=]E^]-]]U3??C;E>=O=>WW=_"$'V/@$C'!
MQGZ#C)_SP//2CZ?7 .>/'U]_S\??I[=+=$,HU9@W<^C/7P8F/I&;*DV!3,^8
M/*ZU"".P(S/>Y&-5QG=+4&BLY57(U9=VWVC/W'#;G74*.G)6V1Q"UZIDN3L"
MS15HXHWW,B .[%UQO4*"<*7[1^V=<U]+,ND:=+<@HB-M0L!XXX::3EUA>4R.
MK%'9""8U?9PS[$R_3<E-=X9<V$*)8RJJSKI<J'*+6RS@<A0&< C&G ]CB"5S
M/LJNZ*B]:)NNRL_J:KV]J-J&O=GIW*TTM666E8EB):)RA*O$4+(=NX;O*XR
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MR:E:67:_I,$>1Y%0,P0J0JY5#DJ%<EO4+<D+A2//3CJ%=4E]:P%]/"QQHB,
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M4UXXUVII] K' KQQM+9E$8CL6'4LIUGD]P_5.[U,J[[")-W2XC33@_G+<O\
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MAN_XNDQ3U*E@F3* @AH)23)7=2,J5;83CU(W&5,BT/NC7>WIHY=,OSHJ.?\
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M7KV+4@AK036)6("QPQM*Y.<8"1@L<DXR  , 'C/0S*HRS*HP3DD* ,9R2<#
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MX0REQO6+TW"AE<X((3)+!GU(6-/D$]*5(TG#R6(9=S1&1=J;T14+([!ER5*
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M6)-7T458G<K^(L+JE26.(%?F VQ22$^%5&9LHK#J^6!9$O\ '<;>&&<)Y-;
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M>1]L^_V SSP<'ZCZ?^?'^7/1[[HOWHB[KLFZ;[<_3C;;CZJG/A<8(]\'P,D
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M11(H**[(,&E3*V1ARH[8[',<D9JE5W#7+U\*QNZ\=T_#[D7Q6%0N5?=R-[
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MH;_++Y9:UX,4E,?&L1A"*RF5$6XG5T8;%F6HJ21:4LM]6!CR?D\0BI9R7Q!
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MI7:I=-A4,53=SD AATEN."":6."XEN.+ ]=4,2D[B&#(2X4J5)RKNK @@@Y
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MGDK3HZ."7'QJ]H[:OHJ?*"0IXYXG9'53HSI3/R5+.UOJV$&>TSIT%SR1498
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M-&]SB1R+']-[LEMW=/L:)'=OKJ4T45F6572GID[-$8_QD_H>E,ZY9&6,$!E
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M4Y\N1*K EZ*.)'#)6OB5L27)(DD7R0I2S8(5<X30-"WM;7AHW8O:5#X/]J1
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ME5[\6GTF&VI#$L>HV71I)&"HJNJ]PQ!JY=9#.,AT^0*@5+\R19P7AZ12QE:
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MZS^I&T:Q>HH"#,^6)'9/'J(TR+:/*];&%"FPXAR$$UX S'--);OZ#GJC/31
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MAK&30_,%"&'9S:@:/: DT%>-_0QKD:LI[L^(7_,-WM7X<]OQ#3M%H:+=T*I
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MI$>$%'H-BK)?+?'$QYGN([U'/4K^E7^(;V#)J6I_$+L^#3*WJVSW+0E7:0J
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M0SXP2#(!IHH7ME-?*9)8P 6)(<1SS];T<K7M5L6?4;URN*\TE.-%$=>)6?\
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MY@.:MUKXU:'2?19NUJ<D6J0""M?2*--*T1Q#$L210:?$;<TZ,(W*2/-#)%
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M*O**OO[[?[)[\^#D^/(\'&/<9X.?'^?MD#)T-N5[_P#5WYW]_KQLB\[[)X/
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MQ!-(P4DNTH+,%4$#E54' 7^7K61D240AWN84Y1-0IBL<%I1"8]K!.8\;C&B
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M\#<$8\8X_+G]?Z]>J>#]<_O_ %Z\;GQD%_Y6#XC/.W_',\POZ_\ A+R'O_\
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M;=6^S=MN-MDX3[*=D]DX3MLB^#AO)R><<DYSSACYXQ]?;@>P/W^_Z]<:IO\
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MV]S7F]O[Y$WV151';[MX<[I5';HBILG"[;*GMSXR!QCD<')YR?;/@$$>_G/
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M20 :(QI'JUTH<I1M1Z1UZ3[!4K0,1_6D_A[CTFZ"(6MR@I'#8GIUX7D>2)$
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M>?MG\OR_V^G_ (A$B(G]7;?W3?C[^_?C=>VV^V7@>W&2,XR,'G\QG'@ X^^
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MYKZZ=/''+7V<4E@%(,:?'?8-AS'-'-8>RA.D A-D30/B2&E>Y):[ +2W>_\
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MG@Y'1T7RLGVCF3[T$3A4XVWV^ONB_>O;A<@CDY^Q(]^<^."!^7C \\GZ?O\
M\]'\M)7?>.9-T3_XHBJJ\?5/;;[MOO3QCG&!D>3^0\_3ZYX\_P!> ?O]_P!O
MWY"QY.R_N<V^R+_V%_LO/^3LN_"KMQLJ^_*J,9X/OQS[$8'&<C R!X.<?H=#
MY:3[1S[>R>D3CORGV5_T>_=.%\ QCR,^Y^OCCG''V! ./?D='Y^WZ?L_GT/E
MI.W$<W.W81-NR[K^]3OOV_%-M]O"Y&>3XSYQD<@ >_CSG[Y^O1T$B2G+TMC2
M-W.39K0DY7V39&N7E=N$[]O9-D!'G(R//U/C\L^.,Y/CWZ/RZ"1I&_\ V Z?
M_JB<[<>R<JJ=U3[^_?P$G'D'.<\CC/Y\@ XQ]?MP.CKZ(W["5&0>@'GP0C'L
M5=8]'E1'M5JJB83E:;\HGT_E\8''&/I_?)./[]>J>#^>?'[^GZ=>U^1A^)2S
MFE2L7QV3)D$>:1(D4E88YS$<KB%,8D5Q"D>Y5<\CW.<YRJKE55\)UGUP_F/A
M?\$,7_F"I_LG@Z.A^8^%_P $,7_F"I_LG@Z.A^8^%_P0Q?\ F"I_LG@Z.A^8
M^%_P0Q?^8*G^R>#HZ'YCX7_!#%_Y@J?[)X.CH?F/A?\ !#%_Y@J?[)X.CH?F
M/A?\$,7_ )@J?[)X.CH?F/A?\$,7_F"I_LG@Z.A^8^%_P0Q?^8*G^R>#HZ'Y
MCX7_  0Q?^8*G^R>#HZ'YCX7_!#%_P"8*G^R>#HZ'YCX7_!#%_Y@J?[)X.CH
M?F/A?\$,7_F"I_LG@Z.A^8^%_P $,7_F"I_LG@Z.A^8^%_P0Q?\ F"I_LG@Z
M.A^8^%_P0Q?^8*G^R>#HZ'YCX7_!#%_Y@J?[)X.CH?F/A?\ !#%_Y@J?[)X.
MCH?F/A?\$,7_ )@J?[)X.CH?F/A?\$,7_F"I_LG@Z.A^8^%_P0Q?^8*G^R>#
MHZ'YCX7_  0Q?^8*G^R>#HZ'YCX7_!#%_P"8*G^R>#HZ'YCX7_!#%_Y@J?[)
MX.CH?F/A?\$,7_F"I_LG@Z.A^8^%_P $,7_F"I_LG@Z.A^8^%_P0Q?\ F"I_
MLG@Z.A^8^%_P0Q?^8*G^R>#HZ'YCX7_!#%_Y@J?[)X.CH?F/A?\ !#%_Y@J?
M[)X.CH?F/A?\$,7_ )@J?[)X.CH?F/A?\$,7_F"I_LG@Z.A^8^%_P0Q?^8*G
M^R>#HZ'YCX7_  0Q?^8*G^R>#HZ'YCX7_!#%_P"8*G^R>#HZ'YCX7_!#%_Y@
MJ?[)X.CKD#AN(1S"D Q3&P2 $88!PT=6,P3"<CQE$5D5KQD&]K7L(QS7,<U'
M-5%1%\'1T=MAV(WTELV]Q7'+J8P+8[)=M1UEC)8!CWO8!IYD4Q6A8\A'M&CT
M8UY'N1J*YRJ='6K_ &L]-_XOL(_HI0_V#P='1_M::<?Q?X3_ $4HO[!X.CHO
MVL]-_P"+_"/Z*4/]@\'1T/VL]-_XOL(_HI0_V#P='0_:STW_ (OL(_HI0_V#
MP='0_:STW_B^PC^BE#_8/!T=#]K/3?\ B^PC^BE#_8/!T=#]K/3?^+["/Z*4
M/]@\'1T/VL]-_P"+["/Z*4/]@\'1T/VL]-_XOL(_HI0_V#P='0_:STW_ (OL
M(_HI0_V#P='0_:STW_B^PC^BE#_8/!T=#]K/3?\ B^PC^BE#_8/!T=#]K/3?
M^+["/Z*4/]@\'1T/VL]-_P"+_"/Z*4/]@\'1T/VL]-_XOL(_HI0_V#P='0_:
MSTW_ (OL(_HI0_V#P='0_:STW_B^PC^BE#_8/!T=#]K/3?\ B^PC^BE#_8/!
MT=#]K/3?^+["/Z*4/]@\'1T/VL]-_P"+["/Z*4/]@\'1T/VL]-_XOL(_HI0_
MV#P='0_:STW_ (OL(_HI0_V#P='0_:STW_B^PC^BE#_8/!T=#]K/3?\ B^PC
M^BE#_8/!T=#]K/3?^+["/Z*4/]@\'1T/VL]-_P"+["/Z*4/]@\'1T/VL]-_X
MOL(_HI0_V#P='0_:STW_ (OL(_HI0_V#P='0_:STW_B^PC^BE#_8/!T=#]K/
M3?\ B^PC^BE#_8/!T=#]K/3?^+["/Z*4/]@\'1T/VL]-_P"+["/Z*4/]@\'1
MT/VL]-_XOL(_HI0_V#P='033/3A%W33_  A%3E%3%*'=%^O_ &AX.CH?M9Z;
M_P 7V$?T4H?[!X.CK?4^.8]CK#BQ^BIJ(4E["21T]7!K&2'C16C>=D( &E>Q
1KG-8XB.5J.5&JB*O@Z.O_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>44
<FILENAME>g60414g57l65.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g60414g57l65.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1G:4&AO=&]S:&]P(#,N,  X0DE-! 0
M    &;Z^99 X0DE-! 0       \< 5H  QLE1QP"   "    .$))300E
M   0S<_Z?:C'O@D%<':NKP7#3CA"24T$.@      Y0   !     !       +
M<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0    !)
M;G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I;G1E
M<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    , %
M<@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !     $)L
M=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M  (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7     $-P
M=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B;V]L
M      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L      !%
M;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0       %)'
M0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M      !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
M     $)L9"!5;G1&(U)L=                %)S;'15;G1&(U!X;$!NXK @
M        "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0    !09U!S
M %!G4$,     3&5F=%5N=$8C4FQT                5&]P(%5N=$8C4FQT
M                4V-L(%5N=$8C4')C0%D            08W)O<%=H96Y0
M<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O
M<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M"V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  $#O_XU
M  (  3A"24T$)@      #@             _@   .$))300-       $
M'CA"24T$&0      !    !XX0DE- _,       D           $ .$))32<0
M       *  $          3A"24T#]0      2  O9F8  0!L9F8 !@
M 0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U     0 M
M    !@       3A"24T#^       <   ____________________________
M_P/H     /____________________________\#Z     #_____________
M________________ ^@     _____________________________P/H   X
M0DE-! @      !     !   "0    D      .$))300>       $     #A"
M24T$&@     #-0    8             !#8   86          $
M                 0             &%@  !#8
M 0                         0     0       &YU;&P    "    !F)O
M=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M $QE9G1L;VYG          !"=&]M;&]N9P  !#8     4F=H=&QO;F<   86
M    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(    '
M<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG:6YE
M;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y<&5E
M;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC     0
M     %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M    0G1O;6QO;F<   0V     %)G:'1L;VYG   &%@    -U<FQ415A4
M 0       &YU;&Q415A4     0       $US9V5415A4     0      !F%L
M=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC96QL
M5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(;W)Z
M06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC959E
M<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%4VQI
M8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M"FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M  MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
M #A"24T$$0       0$ .$))3004       $     SA"24T$#      /J
M  $   "@    ;P   >   - @   /C  8  '_V/_M  Q!9&]B95]#30 "_^X
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MKW&ZII?2PU[=U=N2S]$RWW_S?_J-:")!&ZG_T?0>CUO9;E;[!<XV$66"PO\
M<TENS:YC?3]-OZ/^=L5CJ_\ R==\!_U354Z'O^U=1W@-)O)('C-GTOY;OI?\
M1Z'Z/_#WPR,+-Q^FY'VC
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                 /_A0D=H='1P.B\O;G,N861O8F4N
M8V]M+WAA<"\Q+C O #P_>'!A8VME="!B96=I;CTB[[N_(B!I9#TB5S5-,$UP
M0V5H:4AZ<F53>DY48WIK8SED(C\^"CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O
M8F4Z;G,Z;65T82\B('@Z>&UP=&L](D%D;V)E(%A-4"!#;W)E(#4N,RUC,#$Q
M(#8V+C$T-38V,2P@,C Q,B\P,B\P-BTQ-#HU-CHR-R @(" @(" @(CX*(" @
M/')D9CI21$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R
M+S(R+7)D9BUS>6YT87@M;G,C(CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R
M9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z>&UP/2)H='1P.B\O;G,N
M861O8F4N8V]M+WAA<"\Q+C O(CX*(" @(" @(" @/'AM<#I-;V1I9GE$871E
M/C(P,C M,3$M,#=4,3@Z,S4Z,#4K,#4Z,S \+WAM<#I-;V1I9GE$871E/@H@
M(" @(" @(" \>&UP.D-R96%T941A=&4^,C R,"TQ,2TP-U0Q.#HS-#HP-2LP
M-3HS,#PO>&UP.D-R96%T941A=&4^"B @(" @(" @(#QX;7 Z365T861A=&%$
M871E/C(P,C M,3$M,#=4,3@Z,S4Z,#4K,#4Z,S \+WAM<#I-971A9&%T841A
M=&4^"B @(" @(" @(#QX;7 Z0W)E871O<E1O;VP^5&]U8VA5<" W+C \+WAM
M<#I#<F5A=&]R5&]O;#X*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(" @
M(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @('AM
M;&YS.F1C/2)H='1P.B\O<'5R;"YO<F<O9&,O96QE;65N=',O,2XQ+R(^"B @
M(" @(" @(#QD8SIF;W)M870^:6UA9V4O97!S9CPO9&,Z9F]R;6%T/@H@(" @
M(" \+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R
M9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z>&UP34T](FAT=' Z+R]N
M<RYA9&]B92YC;VTO>&%P+S$N,"]M;2\B"B @(" @(" @(" @('AM;&YS.G-T
M179T/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R
M8V5%=F5N=",B"B @(" @(" @(" @('AM;&YS.G-T4F5F/2)H='1P.B\O;G,N
M861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R8V52968C(CX*(" @(" @
M(" @/'AM<$U-.D1O8W5M96YT240^>&UP+F1I9#HY-CDR.#$W,48Y,C!%0C$Q
M0D$X.#DT1C$P-3<S0CDY,CPO>&UP34TZ1&]C=6UE;G1)1#X*(" @(" @(" @
M/'AM<$U-.DEN<W1A;F-E240^>&UP+FEI9#I#,S$Q049$048Y,C!%0C$Q0D$X
M.#DT1C$P-3<S0CDY,CPO>&UP34TZ26YS=&%N8V5)1#X*(" @(" @(" @/'AM
M<$U-.D]R:6=I;F%L1&]C=6UE;G1)1#YU=6ED.F0W9&$Y86)B+3!D-3 M-#DV
M8BUA,V8T+30Q,6$W8C-C9# S-3PO>&UP34TZ3W)I9VEN86Q$;V-U;65N=$E$
M/@H@(" @(" @(" \>&UP34TZ2&ES=&]R>3X*(" @(" @(" @(" @/')D9CI3
M97$^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S
M;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/G-A=F5D
M/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V=#II;G-T
M86YC94E$/GAM<"YI:60Z.34Y,C@Q-S%&.3(P14(Q,4)!.#@Y-$8Q,#4W,T(Y
M.3(\+W-T179T.FEN<W1A;F-E240^"B @(" @(" @(" @(" @(" @(#QS=$5V
M=#IW:&5N/C(P,C M,3$M,#=4,3@Z,S0Z-38K,#4Z,S \+W-T179T.G=H96X^
M"B @(" @(" @(" @(" @(" @(#QS=$5V=#IS;V9T=V%R94%G96YT/D%D;V)E
M(%!H;W1O<VAO<"!#4S8@*%=I;F1O=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT
M/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC
M:&%N9V5D/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @
M(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @
M(" @(" @(" @(#QS=$5V=#IA8W1I;VX^8V]N=F5R=&5D/"]S=$5V=#IA8W1I
M;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IP87)A;65T97)S/F9R;VT@
M87!P;&EC871I;VXO<&1F('1O(&%P<&QI8V%T:6]N+W9N9"YA9&]B92YP:&]T
M;W-H;W \+W-T179T.G!A<F%M971E<G,^"B @(" @(" @(" @(" @(#PO<F1F
M.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E
M<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYD97)I
M=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IP
M87)A;65T97)S/F-O;G9E<G1E9"!F<F]M(&%P<&QI8V%T:6]N+W!D9B!T;R!A
M<'!L:6-A=&EO;B]V;F0N861O8F4N<&AO=&]S:&]P/"]S=$5V=#IP87)A;65T
M97)S/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @
M/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @
M(" @(" @(#QS=$5V=#IA8W1I;VX^<V%V960\+W-T179T.F%C=&EO;CX*(" @
M(" @(" @(" @(" @(" @/'-T179T.FEN<W1A;F-E240^>&UP+FEI9#HY-CDR
M.#$W,48Y,C!%0C$Q0D$X.#DT1C$P-3<S0CDY,CPO<W1%=G0Z:6YS=&%N8V5)
M1#X*(" @(" @(" @(" @(" @(" @/'-T179T.G=H96X^,C R,"TQ,2TP-U0Q
M.#HS-#HU-BLP-3HS,#PO<W1%=G0Z=VAE;CX*(" @(" @(" @(" @(" @(" @
M/'-T179T.G-O9G1W87)E06=E;G0^061O8F4@4&AO=&]S:&]P($-3-B H5VEN
M9&]W<RD\+W-T179T.G-O9G1W87)E06=E;G0^"B @(" @(" @(" @(" @(" @
M(#QS=$5V=#IC:&%N9V5D/B\\+W-T179T.F-H86YG960^"B @(" @(" @(" @
M(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S
M951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C
M=&EO;CYS879E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \
M<W1%=G0Z:6YS=&%N8V5)1#YX;7 N:6ED.CDX.3(X,3<Q1CDR,$5",3%"03@X
M.31&,3 U-S-".3DR/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @(" @
M(" @(" \<W1%=G0Z=VAE;CXR,#(P+3$Q+3 W5#$X.C,U.C U*S U.C,P/"]S
M=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!
M9V5N=#Y!9&]B92!0:&]T;W-H;W @0U,V("A7:6YD;W=S*3PO<W1%=G0Z<V]F
M='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @/'-T179T.F-H86YG960^
M+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @
M(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B
M/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/F-O;G9E<G1E9#PO
M<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<&%R86UE
M=&5R<SYF<F]M(&%P<&QI8V%T:6]N+W9N9"YA9&]B92YP:&]T;W-H;W @=&\@
M:6UA9V4O97!S9CPO<W1%=G0Z<&%R86UE=&5R<SX*(" @(" @(" @(" @(" @
M/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP
M93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N
M/F1E<FEV960\+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T
M179T.G!A<F%M971E<G,^8V]N=F5R=&5D(&9R;VT@87!P;&EC871I;VXO=FYD
M+F%D;V)E+G!H;W1O<VAO<"!T;R!I;6%G92]E<'-F/"]S=$5V=#IP87)A;65T
M97)S/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @
M/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @
M(" @(" @(#QS=$5V=#IA8W1I;VX^<V%V960\+W-T179T.F%C=&EO;CX*(" @
M(" @(" @(" @(" @(" @/'-T179T.FEN<W1A;F-E240^>&UP+FEI9#I#,S$Q
M049$048Y,C!%0C$Q0D$X.#DT1C$P-3<S0CDY,CPO<W1%=G0Z:6YS=&%N8V5)
M1#X*(" @(" @(" @(" @(" @(" @/'-T179T.G=H96X^,C R,"TQ,2TP-U0Q
M.#HS-3HP-2LP-3HS,#PO<W1%=G0Z=VAE;CX*(" @(" @(" @(" @(" @(" @
M/'-T179T.G-O9G1W87)E06=E;G0^061O8F4@4&AO=&]S:&]P($-3-B H5VEN
M9&]W<RD\+W-T179T.G-O9G1W87)E06=E;G0^"B @(" @(" @(" @(" @(" @
M(#QS=$5V=#IC:&%N9V5D/B\\+W-T179T.F-H86YG960^"B @(" @(" @(" @
M(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI397$^"B @(" @(" @
M(#PO>&UP34TZ2&ES=&]R>3X*(" @(" @(" @/'AM<$U-.D1E<FEV961&<F]M
M(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @/'-T4F5F
M.FEN<W1A;F-E240^>&UP+FEI9#HY.#DR.#$W,48Y,C!%0C$Q0D$X.#DT1C$P
M-3<S0CDY,CPO<W12968Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @/'-T4F5F
M.F1O8W5M96YT240^>&UP+F1I9#HY-CDR.#$W,48Y,C!%0C$Q0D$X.#DT1C$P
M-3<S0CDY,CPO<W12968Z9&]C=6UE;G1)1#X*(" @(" @(" @(" @/'-T4F5F
M.F]R:6=I;F%L1&]C=6UE;G1)1#YU=6ED.F0W9&$Y86)B+3!D-3 M-#DV8BUA
M,V8T+30Q,6$W8C-C9# S-3PO<W12968Z;W)I9VEN86Q$;V-U;65N=$E$/@H@
M(" @(" @(" \+WAM<$U-.D1E<FEV961&<F]M/@H@(" @(" \+W)D9CI$97-C
M<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*
M(" @(" @(" @(" @>&UL;G,Z<&1F/2)H='1P.B\O;G,N861O8F4N8V]M+W!D
M9B\Q+C,O(CX*(" @(" @(" @/'!D9CI0<F]D=6-E<CY4;W5C:%5P(#<N,#PO
M<&1F.E!R;V1U8V5R/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @(" @
M/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL
M;G,Z<&AO=&]S:&]P/2)H='1P.B\O;G,N861O8F4N8V]M+W!H;W1O<VAO<"\Q
M+C O(CX*(" @(" @(" @/'!H;W1O<VAO<#I#;VQO<DUO9&4^-#PO<&AO=&]S
M:&]P.D-O;&]R36]D93X*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(#PO
M<F1F.E)$1CX*/"]X.GAM<&UE=&$^"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"CP_>'!A8VME="!E;F0](G<B/S[_VP!#  $! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0'_VP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" &C ET# 1$
M A$! Q$!_\0 'P !  $#!0$!              D&!P@! @0%"@,+_\0 6!
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M7]19)Q,(+6%@D6\V+9P_"9*1C@Y[2TM:" YV9U[;C8#PU)ZK)D3@YI<Z^5I
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M0,@^3<O(4?.,7:B = >X"P<;;6_QT^"&-A)):+G<]?-7*K=+J=.4LBM6KT3
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M:/"H.'" +^"NL0_H87BN)8-4BLPNMGH:H-+#-3O+"YIW8]NK9&Z Y7M<+@$
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MV5$;&4E07@V(#S!'(Z^SY', L"!='E?5(_2O:2:9V Z:$3UWO-Q.<;=LM@3
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M?//*;R32R'J^1[SZN<5L,IX&>Y!"S_PC8W]&A=R4A"@!2E* ![@    _N
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MH CUZ=//SZ]/]O3(.@OIIU\Q_P ;)T\/G511;/[:+@CJ/D [XZVV^V(+/"V
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M1)RB$>O%I(&E\L;F.#6.#WEI<2>Z,H([O,W/7E;XF1.#VN+FEK X-MO9UM/
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M8@5-.]I[K@]@[N8$!X:X@VLO(QO"HL8H)J20Y7Z2T\H]Z&HC!,;VFQL+G*X
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MKKYG5%;4SU<[_>FJ)7RR'4GWGDD"Y-@" .0764]+34D;8:6"*GB;LR%C8V[
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M<@]C;LQ-)7J[ U*$C*W5X6*KM>A6:,?#P<(P:Q<3%L6Y 309Q\<R20:,VJ)
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M6"R2598U*K-9"<8Q;B;F6S1P<SARS(-L36.+R\.<&MS96C4V(&_*UP51.][
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M"%* F,8P@   B(@&2 7$!H))-@ +DDFP  U))TL-;Z*"0 22  "23L -23X
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MP^U-6SVHT7MCJAXF#B!K];ML=LR5;.JHV.>OQJ\+"'AF3-1214>5.RN8]P:
M6O#1;F"#N!?H#^FF]S,S)&-+B[M&%QN?=((.FESO8$G6W)9!;PY$VS45B85Z
M!XM\C=X-)"#++*V?3\3K%_7HQ=1V]:#"2*MUVA2),DLDFT3?*D:Q;ED#-ZT,
M1\9<RZ"&#6!PN7M;K:Q^&O6VO)9R2.:2!&]PRDW&P\CU\#;E;FK#]DP[._X
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MU#F*0A0$QA H".<HUI<0UK2XN( #022YQT  U))V U)70N<U@+G$  7))
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M=V02H\A^6*ZNJ]=I(J@4$).N4=NLI;;JR5*85DG4:\3.@*9".8LY51%/H/\
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M:*03.C&H';B(R2M&[VPN;K?27OLQ>1=4W[HQ)[5GJ*T8B="P13 K@5EH-E9
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M][W.>][W&[G.<XDN<XW)<3<G>^Z[&.-D3&QQL:QC&AC&,:&M:T;-:UH :!R
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ML9>,:JF,#=-K2+JTC(DI@,!O08MX^7!--WWR]!Q7(_B;AC >)&MS5U(PX)C
M .8U-.<U/,_2^::-Q>ZX]YX  L0O-P -P7',4P=]FTLX;B% ]QT[&0 /:'$V
MRM):VXM;LWW)&H](3.9B9%D$C'2<>_8"!Q!\S>(.F8@D(@J/I2!U$>B0@(*#
MW_F=![W3H/3Y<^.2-_9R1OCDYQO8YK_#NN:':\M->5UW;9(Y&=I')&]GXVO:
MYFQ^\TD:<]=%'/R7[6[@IQ=-)Q=OW1$72ZQGB)+:]U0"=_M)'J0&$8Z14B%_
M9VNO>\ %.A9IZ&53[Y3"3YQ0-V6"?1]Q5CW9OI<,EIZ:0BU77 TL.4B^9K9
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M/H@>_9T9^!O_ &T]2OD;E;28XW=ME,VM2!*/152RT5\DW((?E=%H]>0[Y2B
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M%SK6:TE04[%YL[UYU3$I3-"6MUPUXDIJ.(NV\CKG'.D=^[,8D5,F^9Z1UXB
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M,I2$*!0  ^?.)>XN>2YQ)<YSB7.+B;DEQU))U).I.I78-:&M#6@ - : T!H
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M_6!P$!\P'KYYD'N&SG#XE06-.[0K>/.)^DE5C.HNN2-7>&#_ +75[+8(A4!
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M=*W$= 'R#OHF35.4?I'H<PA[A#WCDY&<Y6^0!U^)&@_KX)G?RC<#XD?VOO\
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M"=+-(M?8;@ :;V69OR9'9[?J;\>OPUKOPG]G_/4<K[>;\Q_K\]?FP5WLU/\
ME,]$^3([/;]3?CU^&M=^$QV\WYC_ %3V:G_*9Z)\F1V>WZF_'K\-:[\)CMYO
MS'^J>S4_Y3/1/DR.SV_4WX]?AI7?A,CMYOS'^J>S4_Y3/1:?)D=GM^IOQ[_#
M6O?"9/M$WYCO5/9J?\IGHGR9'9[?J;\>_K_[M:[\)_P]V/:)OS'=-_GUW3V:
MG_*9Z+4>S([/8?\ U-^/7X:UT/\ !ICMYA_J/^)O^J>S4_Y3/18?<U.S?X@0
MVN]7N-6\0-3M9MURGXJ1<^>G:PCE'Y]?2F^:,PV&A)EBV"BQ:NO4%Y9*TJ.
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M_P#D;\>OPTKO^'HG3([>;;M'^O\ ?=/9J?\ *9Z)\F1V>WZF_'K\-*[\)_\
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M2"#H2">5P;$70/:0"#N,P!T-K7V^1XJM6S]D\.X3:NVSE1JJ*#I-!=)4[98
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MI%P<!&,H>'C6I!$2-F$9'(-V3-N41$2HMT$TRB(B!0ZX))-R23U))^=M.BD
M 6  '0 6WOMYZ^:XJE0JBK^<E%:S7U).S1C>%LDB>'CS/[!#,TW:32(G'AFX
MN):,:I/WR3=@_4<-$4WCLB:12N%@.N1;4Z;:G3Q\_%"T$W(!)%CIN.AZ[+YI
MTNG)*5=5*J5M-2D-E6=+4)!QA3U!HLP)%+-:N<K4#0#9:+33C54(D6B2D>0C
M(Y1;%!(%SKJ==]3KY]?BHRMTT&FWAY=/D[KG05>@*O'%B*U!Q%>B2.7STD9!
MQK.)CRO)-ZO)23LK)@BW;%<R$BZ=/WRX)@J[>N5W3@ZBZRBAA).I))ZDW4@
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M=JU#6J(*[0Z^"Z"-G&3YF#E'O&\)<$053[QNX<.H]9!(V)'D2/T4%K3NT'S
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M6O5X_II1(\$\+$LFD<8791$KD3-A]( 1!7O@."YSC<DD\B23;6^G35 UH%@
M!:UAM\1L5U-4TSJ"AQ4_!4?5>N:;"6L7(VB'JM)K5?B[)Z8BHV=A/1\3&M&D
MN#ELLLW7"01< J@JHB<#)G,469QM=QTVU.GEJ@8P7LUHOO8#7?\ R?T52>Q=
M. ]95"IUH%*4BHWIJ@0<8!ZDW6CPB5D*P<&O>@$58LI8U5**%H11@4&9RBW
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0V5S0  #H = R%GLM<(O_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>45
<FILENAME>g60414g58r91.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g60414g58r91.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2.$4&AO=&]S:&]P(#,N,  X0DE-! 0
M    (VB^D&0X0DE-! 0      "T< 5H  QLE1QP"   "   < @4 &5-E8W1I
M;VXS7T9I9W5R94-?:5!30W-?=C$ .$))300E       0,<1]87GWM4Z:__YG
M@>2]=3A"24T$.@      Y0   !     !       +<')I;G1/=71P=70    %
M     %!S=%-B;V]L 0    !);G1E96YU;0    !);G1E     $-L<FT    /
M<')I;G13:7AT965N0FET8F]O;      +<')I;G1E<DYA;65415A4     0
M    #W!R:6YT4')O;V93971U<$]B:F,    , %  <@!O &\ 9@ @ %, 90!T
M '4 <       "G!R;V]F4V5T=7     !     $)L=&YE;G5M    #&)U:6QT
M:6Y0<F]O9@    EP<F]O9D--64L .$))300[      (M    $     $
M !)P<FEN=$]U='!U=$]P=&EO;G,    7     $-P=&YB;V]L      !#;&)R
M8F]O;       4F=S36)O;VP      $-R;D-B;V]L      !#;G1#8F]O;
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M(%5N=$8C4')C0%D            08W)O<%=H96Y0<FEN=&EN9V)O;VP
M#F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O<%)E8W1,969T;&]N9P
M       -8W)O<%)E8W12:6=H=&QO;F<         "V-R;W!296-T5&]P;&]N
M9P      .$))30/M       0 [_^-0 "  $#O_XU  (  3A"24T$)@
M#@             _@   .$))300-       $    'CA"24T$&0      !
M !XX0DE- _,       D           $ .$))32<0       *  $
M 3A"24T#]0      2  O9F8  0!L9F8 !@       0 O9F8  0"AF9H !@
M     0 R     0!:    !@       0 U     0 M    !@       3A"24T#
M^       <   _____________________________P/H     /__________
M__________________\#Z     #_____________________________ ^@
M    _____________________________P/H   X0DE-! @      !     !
M   "0    D      .$))300>       $     #A"24T$&@     #-0    8
M            !'8   :           $                          0
M           &@   !'8                      0
M       0     0       &YU;&P    "    !F)O=6YD<T]B:F,    !
M    4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG
M  !"=&]M;&]N9P  !'8     4F=H=&QO;F<   :     !G-L:6-E<U9L3',
M   !3V)J8P    $       5S;&EC90   !(    '<VQI8V5)1&QO;F<
M    !V=R;W5P241L;VYG          9O<FEG:6YE;G5M    #$53;&EC94]R
M:6=I;@    UA=71O1V5N97)A=&5D     %1Y<&5E;G5M    "D53;&EC951Y
M<&4     26UG(     9B;W5N9'-/8FIC     0       %)C=#$    $
M %1O<"!L;VYG          !,969T;&]N9P          0G1O;6QO;F<   1V
M     %)G:'1L;VYG   &@     -U<FQ415A4     0       &YU;&Q415A4
M     0       $US9V5415A4     0      !F%L=%1A9U1%6%0    !
M   .8V5L;%1E>'1)<TA434QB;V]L 0    AC96QL5&5X=%1%6%0    !
M   ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX    '9&5F875L
M=     EV97)T06QI9VYE;G5M    #T53;&EC959E<G1!;&EG;@    =D969A
M=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%4VQI8V5"1T-O;&]R5'EP90
M  !.;VYE    "71O<$]U='-E=&QO;F<         "FQE9G1/=71S971L;VYG
M          QB;W1T;VU/=71S971L;VYG          MR:6=H=$]U='-E=&QO
M;F<      #A"24T$*       #     (_\        #A"24T$$0       0$
M.$))3004       $    !3A"24T$#      8Y     $   "@    ;@   >
M ,Y    8R  8  '_V/_M  Q!9&]B95]#30 "_^X #D%D;V)E &2      ?_;
M (0 # @(" D(# D)#!$+"@L1%0\,# \5&!,3%1,3&!$,# P,# P1# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# $-"PL-#@T0#@X0% X.#A04#@X.#A01
M# P,# P1$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P,_\
M$0@ ;@"@ P$B  (1 0,1 ?_=  0 "O_$ 3\   $% 0$! 0$!          ,
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M=:V")42VS\U\?UA(_#8H^,^'V+Z<5O3?K)Z9%O46VN)ES&M].>/HW-8]]/\
MVV__ ,$5G(Q_K [(<_'RJ65;CL:YLPPAOYNW^<]O^D_](JV+[]@L8QN16[4.
MJ<)(\6M?[/\ P93HRJ+Y#'0]OTZW M>V?WJWPY'B.]#[%4YSL3ZPV8^Q^94R
M[U)WUM@;/2V[/<WZ7VOW_P#%)GXGUCWL=7F50RNMI#FZ.> WUWOAOY[FO_\
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MW^WW?G,])EB!UC&?1U>A]EEFW)<'>B]Y,7,L9[MD[&L=OIV?VP
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M0U+!-#4W.$9'8F=R\"@V2%979H*6HZ7A\?_$ !X! 0 " P$! 0$!
M   ! P($!@4'" D*_\0 21$  0,"! ,%!@0#!P(%! (# 0(#$0 $!1(A,09!
M41,B87'P!Q0R@9&A%;'!T2-"X0@6,U)B<O$DD@DE0X*B-%-SLA<U8V32_]H
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M2UOT&Q,:Q747\7%?B+[YSE6E)M^A%Q$:U;M4G#MV^D9!R@U:M6J"JRBBGD"
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M0_T3)!5?V%4-[?"9A"JULG;N\;L4+8:===+07<OMV]NA0F2X^Z4MMI[I&91
M)@;D5D]<(9MU7*DN+0E 7E:;4XZH&(RMI[RCK) V$G85#W2_4FZ[Y5?+GG5C
MB-MDI[.8"KV?0%ZABE\N$/28.WUQO:X=_:9.OQCY*#2&&7,N[_$2MQ;*,Y!
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MHW453'R/-<:W-G<8UA3B'6KFW1@>!MOFW=0X!V; #[14VI02ZD2E220I"M"
M:]' &GV["^24*:=5B&(*:[5"D3F4.S7"@"4$P00"")B:J6P'*U$]%]/9?^1+
MLM']D*5V.L3_ +F7F[5'65*NO9%VEN)'3MALD^1>ES:[Q(X+UFQ5I1=K&UMP
MNUDY!N>79)O?H6+W\V7& _%,#7@MU@K*.&K6UN,.%PE@%@K9999RW324JD/L
MO@*6^ IM*NS64\U96T/X)%GB";]O$%*Q5YUJY[)2Y=RK<6N65*B2VXW\+>9*
ME=X3C=@R30W'6KK$OH$;J43)5Z7[;IKU'5NO>R:OBDJZL&V6=U7R7-MF#T=3
MH%^>PQ6IL]M*=/D&2T.[%Q#S<4=LJ=>]G$+,8UC@LW+!:'FN'B+C#\7PVPQ-
MM+6&,)>-N;Y/N%W9I=*O?&/>4+#B2EUIP* %:K9\X?AW;)N$J0K$I;N;*ZN+
M-15=.*3VONZO>&7R@ L+[(@I.9M:2DFI:9[A%H[&[%T#C>P>'ZE2Z#%=/M!5
MN="D[/K:T+"VJMZ&S+GT9<[;)RY+(9^\C&T=<(BJ72=7G(_VL(V02=&A5 YS
MM[B[&"X;Q:O!\5L+F[<XDM1;W:&,.#KMN_9$WB[:W;;+(0EPN6[EQ:M!I??<
M04]H#7IL6*[^[P=-]9OM,)PETN,K7<E*76[@AE+CJU=IF*,KH;=65I&5*@<M
M:OCG>K-&V>X MF'8 N@4GUA6FK6R2#-M!-2V&*RNES#J'LAK\2+-6'E8DV,N
MU6:-F\HLF6+:NY-RW0B6Z;M3><3AY]\Q<7V$&TNO9P;"W1[[9BZ7B;=DV'6A
M:%8?0^VMM25*4V#VBDM@EPE(H:-PDVMBJWO \SQ0+AU78/=B+53R@A9?R]F6
MUA04E(5J@%1 0)K1M>B7-SLNW$S.F[O,=R(SU1]!;8II<.PTV1SFHYK&:U'N
MKM'OK,Q65SBNUB+CG-A6O<#,@W?O6TS!.7"#R+4;BS]5UU-M;84;VYPEOAMS
M@.R5B=BZNQ1>W-^O#EBV<0PH)O7WG%I:3:NM%20IMY(4EPJS:027GKWW=F\7
MBJ.)+E-I<(3<*9:MTW0+J%.@FW;;2DJ+J5)F%))24ZC.)3$7-"M?;:G4K'->
MB-*7]1?';? 2$33]2>PLCUS6T6ER+9XPL94'E:DXTLBI*RK]4CMQ+(Q9'#B2
M7+%MA*EK-XH+NWX>NKO$L.<LAP;B5L\ARXL$N)QD6EP@H4Q*7D+R!"$#*$%P
M (3VAD[!M>P?Q!EJVN4/?C]FZ@I:N2@V(=:U#D%LI"RI2CF*@@RHY8%9+KE
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M_;Q=MTV4+>#=\6&+UY??0M"DM]DTI:"%.$I1+E3>V#JF\<O U<F]8Q9E5BM
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MK;JT( S%7BX<EM%[P^$L7C-T7;H8BX\'@T_<I:5)"G24/*&JBMF4I0I 423
MMW],E!]^Q':>21,(TB:[U=H9'-0*'AK^R871-BX4CO ?&+!2T,K"*8HB*1G
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MQ.F!@(82CJNLH#ZEJ0GM4YD9X[X0I05E"]\IT44@P3!,&C2RIE*4J5V9*5%
M4H(S@90K*#E*DB1,3',37NY! .X^WT_7Z])K,@'<?;Z?K]>DTXGE^F@Z ZQ\
M@>8\Z3R_30= =8^0/,>=:XT$Z/QQQ/(?4 9P8   $P(B5,#";^HICE*!?=X
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M*AU*TWBT/B1E9IE=F[78I)0!%./@J]&N9>6>G /N)&K!FX7, ?<03$ ^X\D
MJ( U)( 'B3 J"0 2=@"3Y#6H,=.NW6K=@K]=:IJ63US,FZV1Y'V S-G!V5_8
MYYMF.Q2M_C:S#Z@#J.8,(F_F9TA"P+Q\&9U&MV<W^'&7.\B7*R]SK24!)2HJ
M[RT*D #,C+.7_3KSUTJIMQ2U*"DA/=2M,&3"LT9M )TY;5-^)O='GIV8JT%<
MJI-6:O>!GZ[$V*(D9V# Q@(49B(9O%I",]QS%('UK=#R8P%#[B <I*5  E)
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M?V^1Q,2ZRZ!-> W;76%N(_#'5W>&DP[8W*G7%6J>:[&[R.N*2D"/='2M)_\
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M*-(R,9K* @V<NW)F[)LY<I9H0I9A(V$DD@  ;DDZ "1J>9 &I%8K6E E1WT
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MN!*4A(44=HM92%$ C,$I"I A,>)4=2 -*3W\RE$D!90A 44I)!R2HIU,F>H
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MS(TS/NSV62]I=."M&$'(S*U6?RCPY_81G$)6QI!A+O5#@()LXTSIT?P(E1$
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MH,Y$VUC"/X%-N<KI>908H-?<NJF4UK)4'6RG?.!'4$P0? @D'PFJG@DM.9C
MRG7F#R(YS.T5O'%):V3^-9+.WUFK'7F:S*ARUSCUR"FNQMDC5HIY8F:R8D(*
M:K:76>(J)B0@D.0Q1*40\!@L +4$_"%* \I,?:LT$E*2=RD$^<:UB&V=INN?
M7%HW=;GM&>YD9XG\T?&V:QL6T_*) ;V"K$5I%1>PRZ93 ('/&QCHI/ ^\2@
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M8G)=J<P>#J,TKB](F8133?+  *F1;[YGA_IR()_[LX'VY<IJ9N/\K/GG6/\
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M<(IE$3J% 9@]#IOI3,/VY?G'K3>O!>YG4M0@'+V1Q0R9A,4#!H]6$IA+X]P
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MHQ:,W6(%XR<S+R/7KUYU((.U6:$[I]2%!6*GV2Q8YVXF!<I-#K1A2$IQ((*
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M Z#PF?GT\/+6.L6:*!Y0.0 UZ;R21MJ#76&[YU,].WK5$S@DWCIZ;1L#%,A
M(1(CM%,%2G*(A[3@N@N)R!Y+X'R ^?(!8E4G8>&_6# )Z$[5JNI.GC('ERG?
MF!)/+GTR_I+08ZV=JT;1-B0\=4Y$[]@V.B*J*\FW%N*2RX>/'AN!C&02\&.=
M<"G\!\7!5E C:.?A\^D'[\Z-).<J.Z=1$P3,Z]=?&=(VTKLR7F-8J(M9E)LP
M5]I$G4JW<H"3Y6B@>%P$_N 4S(E/\I 'R8?C]I"_80-43))Z].I\M>GUF3RV
M5&23 $\A.WK33I5='J.R&<:#A#MA5TB/K/FLE&RIFYF2Z3J-;&649O3-EE4
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M_J%,("0[2XQ>:^JV66>7:CQD\"!DC*E62GF96HN12.8"JI)!\0@8I!]HD/X
M/!>6HVGS\9$ [[F()\:H>T$C4D1'U_.8G8:=:S#T>(F&&8T:P/DR.EC*FB2
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M.:3:9]L=!BXC6,,U<*E^(I453+KK%0*<Q%%%%_)# <GN$$4Q,/M*8/.95E(
M U@'QW,QMSUW$;':C8GO2="0!IT^N_6(U!'2YJIMHA":<-F38@,FY54XY=($
MQ64.!Q,?R8HE$0 YQ_I',;P'CQ^HA':$ :1]=S.Y,\^9TY@U9'SY^7ET_P":
MH$[M9DG7>QSB\N!<,%+!9*L":'Q$,A)NRNT$7*QSD$H?(";<H_*!1\&3]AR
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M9/,[F2=ID_0ZUV#O3OK=)K^$/5)D5$7+V1=!,K(^Q)8SM4QTQ1.HF8I#$:I
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M7M 3OH1'KSJI?KC67%QV6N0S=TFU A73P53E$Y%"LTA<$3$H>/)C'32* "(
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MJF E3$@D$Q3 /-?$<,Q+!KDV>+6%U87("5%NZ:+14VH2%H2H=X*'PG,=0>A
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M%**4K!,$IT(S $B4Q*2?].?,>8'.1A6")D1]Z@![41'W"'@!$1 #% !'V^!
MPF_7V^ #P(B ^=4&)T )D\S_ #0!.Y.TF!J9@;&3ETA6;370I@ZR"E0D0>4G
MGKK-=8CUFZ:U;/;*[2(!2/:I 69LX33^[>7@+"=$XF\?9,'$?)K)*#]A]OYA
M\A]AN1$0KPC3F/TWT\=-ZUGD$PK9.51)V.D 3S'V.GA4/O3NV6;Q6.M\O2*9
M 6:[/K.J[D9&YR[N"J5?KL:@5NBZE',:BK(N5I!^Z5:L&3;Z<5OIWJQUTR(
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MG1:1\*1G(R(64:.*.J9P^_N 5CL;.Y62A,B4,J4B<JT+"<X2K*%9%*2.T2H
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M!A)$Y4%!*514H-%$/LF)@,  <2AX-Y^X&'S_  YSA"2205::?3>/V@SKI71
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MHTD],N^S^-9.6L#%TQQ"1]=B(6$;L8IIID924]"1]-*^PV__ -.Q_P#A:_\
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MX;ZCTO)9^W_#86A7>#7B(]M\A4&#%W6XB3.S02.(^QH@HZ631;^[PDW $TQ
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MH*0H?(!0,;QY^0!$A_<;XS%$//\ 1Y7/>/=$QHK<IUY:D G6#O&D[U820D@
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M,B(Q:(NF=0S*W7&RVB+C8NCQCE].JJNFHIPT8V164!P]025.N@4[=(ZJ9Q3
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M[^52FZ0=Q:ADS**HME<K(PCOV-W#-^NH9&.,H)TU7;-9RX53.1RHK\RJ2()
M4GV,@4Y0-S%0*IC21"I"3IK*52-4F-E:#E$U<VN$D*(*2=4Z=X:>&:/ &.<5
M9[$=LJ):X.5<9TJV?2D*Y,BK#/7Z+)RDDU45(X-[@.<ITBF2$Q/C,)3$ IO(
M_(3W8D<B #IL !MR D 08B-JS!21 $1HD) @#H -]]Y)UU.D5';O5VEO%:HU
M=7J;R*CH^P,2-%BD=BX>/'XMG(NT6Z2!?8LW(FN511TJ8I2D$@?&<3>WDA )
MS$F=AIMI.FFOUVGPJ%2G4>$S.DC70^/2NO/L%JL+.A5/0FSL[*QPFU,Y!FNS
M;D9J [C:LLY1,8R/L$RH%+\1E3^53$ ODWD/)LY(D_(@[ @2<L&9)WY'2(,F
MM1< I, D$F=>O,3&D_I'*K4.B'JLIR=FCLSUY\W^9\HBG$R\]*E1>(OG:GL^
MC:O'J2:+T%C'][<JC@RY?IQ03 Y! "UEL2%Y1*3F!.4F1$&8UTT F(G34"K4
M.A1@R%F)RE0$:@:3'+4[GF=(JXM/=G*UVEGLW-,6E#;0RBY#JH"DU043( .%
MG$DHL1 AT2D,Y.F)Q\H+B4P 5/Y#@ 3!"0.B$A*=-9RCF8U.NOSF\I"!.D'6
M1UY_?URKK5^H7VES[O"FI1*YJ3/'*ZY<23*P_M559X(F;:MP=M8U5"0BWAV/
MP+*"5W\BQ3_4-OA$X-%!.B2S*D&!.G6(U@1I/701&TB-*H6L$%).A/+ZC>.A
MY$ZZ5J"G=XF_52>@*]BU!(B: 7=,;/+LY-=L>X3,+*+H*RB2S1?Q(1<D BHT
M3DD5E4DU"))@"*904S DSF()@"=DQ([N^4'YS/*L XE,0!( U\ .>L<X.F^\
M;U9YU@]5Q_M:ZV9[#"(5.;M4F]C:P[!8R\4\;/U 1C8^2<&,BHWD!^4J/RD2
M30=^T!$J1S@4,2D)DIF3F)U@*)UE0&A(UT5F\( TN0X%$J4$F1H8((^\3T,;
M]=(POOOW LN1Q]<Q3-7C12X0$41"V+BFHO ,TY%%!\@F9$P"X<OI1<_UAQ^8
M"-D +\B0BN !7!*<RBI1G=42!I TB!M @0!K6*G"DE.A,<Y'+K/+EMMRJJ?+
M+!8KV&G6"TP%8CI@E39%>2=89),"R@N= JCA$';5-)(P+-"$5#Y#+*>\JAA'
MP?W^<TD1  W2HR)E29 D;$ F1L9 )D"J0I68$Z>4;00F#OL#]XF==WU)UESQ
M>N);!4C7>%KYW*,4S=2\^S9M&D@X,[>H'0B'Z!D_G7^0Y7+4J:HG,B"HF(DD
M!>IP#C7B/ABUN+3![QJV:N7 \ZLVEHZZMT-(:#G:.,E<A"!W#* 94$"36+UO
M;W*TJ?"W"E.4-E:NS D%1" 0$E>F8B"1YJ)[ /5K<>NK?)I*C]<JS7<T?1IW
M N8B(;"H]>/TU#)!).%7IEI>:%\F5+P]>.W*H)B5,3$^,A>>'C.,8KC]V;W%
M[YZ]N1&5;N0A $=UM"4!MM)(U"$:G7<JS;++;32.S90EM)<[3*D  &0=9D%.
M8)(220(  "1 XOL+W"5J%?A:(6P0C2UV..*V7EYF.*_1AW9!!916RQ:*J"T>
MV(FLB5+R<JCCXU?RIF*(\\]L$D9PH9E)0 A&=2A !*4@I2G+MH(@0 (%7$YX
M2LE1"=5:9E$1*E0(DD28 $SH!77WMA73:U.U)9^G-N7C%%&6DHMZL5K--9".
M(@\79O6RQ54T7[=4QB@5410*H* B/L$.>U;WJ,"QBWO<)N&K\V+S-S:W%Q:J
M2VIX-H6Z%VZE$GLGLS!43*DLA:"@* &@XCMV'F5DI2Z%HS)@+1*@)03(2LI2
M$DJ"@03(T$;PZVT[I!7M#KEKTJ"MLBWBYAD9.JSDXD[J@/S"<6C^6CAAP<R4
M>T=I(*JMEW[ADJ14 ?MUVH"B;OL0]LW%U_AKV&D6ELMUOLEW]JPZU=%"@<P0
MM5PM#14G13B&PY,E"DG6M2WPFP:>1<=F%NHU!<#:Q/\ N4@DB0DE!5V9*0%)
M6"H'L,)[+"19F\[59:(BLT1K:J[5NP9L&];CO:U(5#Y'#46[!JB83_,1,B:8
ME%)8 */YP'Y0MUUU9==<<6XM:7%J6XXXI2DR 5+=4MQ1[VN91UC:O9D1()T&
MI*LQ(\3$G]- (  JD#N)O<[V3-;D8"QI/(B'H^BLFE/7@E&DM*/STB6CD)"'
M>LDW*,HF=?XRM6:QFQA275<$$RA@1YN62;,MWGO#]PU=!I*;!MEE+B7KIU]I
MH=NHD);0I"W!I*UJ&B4I!G6?4X,I;6 E/><4G/VB 0J0D!)2H@ *3,P=_"%7
M7.U3KU*/H5BA3UZQF57CG*%M@'9LZN!$T2'C9&;F&WL>TFP1YBJ1;FS-HV21
M>, ;JOVXF0^=3N>*?9O9\3<*-X1[3+-DL86476!<187C&'-<1X%;9$A5JPAT
MOB_LW'""K#GPI"224D$("/.P''.(^%^(F^*O9GQ3B'!/%*4+MG,1LFW';;$[
M9Q7:JL\7PVY2NVQ&T#H[9IMP#L7#G:*9(JTGK[F<8VTK*=G?:/0KK!TZV3$>
MUSFJHH-Z?6;25RM"(R:DTM)*O[#*QY4)%-H^=Q3$H.UVJ[5%$%#K'YK"5<'<
M#\,7W"' V"W5B,54Q^)\48C?,W&,8PTP5J+=^IME:6FE+4I2;-A264)( 3)-
M2XUQ)Q#Q%=<:<<\6XGQAQ==A2;C%,56HMVS94I1M,)MB?=\,L9@BVM4)22(4
M5)$"Q/MYWYJ>1+J5RN&J*%_LE920@D+9/*5Z&>.G"*J'U3M^@SD3D;1IU6R8
MID:E%<P#[50\^0YQ*# &YB>8!C;XM=XWUV_E@5[*W (),J5M!2H"9$:)2#\L
MH&L"NMSV?I&BY3U=ZSKW]Y KV.\=I>WM^*]J:RZL,O&VC/\ !W#8S-9PW;.%
M" +4R8J*H)G.4@&\"(^1^R>Q!<<;:QW<&Q$$1I.>VTCF8CG'E%<CQ=AQQ+"3
M;N04KO;9P3  "$N)D;S&8]=SY5VQ?1L6L4AZ=?5>9D]CK>N0#W#,HCZJA6JS
M#0:6<-ZY28FOS6<2LK#SLU^T\_4YR/>P<Y)2"<3)MI6.>,GT6U=)+))_(7S+
M[Q/-YT_5Q76NL0 $) V"4CZ "K1N55E47M-ME8U:8@<DS;=\VK^G1-A_E!=4
MZ3:Q5V?3\-F5EFH)TV?U-"PU^PMXVO:Q!QZKN7AI:-<MI^DO(5RL[8EG8MP]
M>OH:F%05 '*"$E4& 2"0DG:2 2!N0#T-2-@FDFPA(=C-RH3TRSBH]I+S@,4(
ML)F3;M$47\J$8U,=M'!(NB*O 8MSG0:?-].D8R:91%45RG%*<4IQ2G%*<4IQ
M2J1O7!"N&QC&233)VX?!I[Q:(=M $3L12@%A?& 2J)B195$R0MU"F Q%4@$I
MR&\",B->4C3SZ=(/.:Q4-C!,'2/S]>7.H8QW=RHTRXTQA!SML3I"$)#F>/U3
MNWRA)$HJH+MGJ;]9RX%N@U,@LHN@N'A95<5"&\<A2,NH))/Z#3D(WYS'GK4!
M8,"(]>7YUNOLGV:F,*BA"JJL)*UZ:U4EHUZD"RY(J+*@@5&2=G<^\5@.Y.59
M!%) &RYQ4]Y#$2$#  =-HZ&-S'+P,_M61, 0#J==/TT/7\_"J_;]VW9['G-)
MSS?*+=;<C2A%1&P52Z+1CF5<*I^U=]*QSA$B3M54Q/D%)5<2-U@$&PIIF$HY
MA(&H^6H.LGEOKL .8(F(-5J.81E,:S UVTZ]?'2*C'HC5C)V&R-H\K].&&;<
M.H>-D71U5&#910HM4EB)'% 7:#82HJK)^0,H4XE-X]H!;G.Q@A.4B!O^XY#[
MUC$   B)^*)TZD>&OA.E<_C]\L^.S[*RU=99!=$ 3E(Q0RIHV8CA,51Q'/$?
M<4HD.0@_$J'L625 AP-]A\U.$*B/'S$@;;'GH:R1.L1ZG[_U/**F7Z@-PFYB
MQT"ILG9V-'6H=8OT&Q8 8B02\LXFD/K!,E[1$Z"35!)(">$D_9\J92J>3<Q2
M$R9GZCQ,2?M.Q/38I2M)\1H#X#4'EKZ-0HA[7=C4W6HB5L%BF84]2AU_P]\\
M<NF)U$K[2A(()*J'+[DRB( )@$0\")?'W$;$Y1.I /(Q\I$;&8Y;STJHGE!,
M\P.>^YYZ3Y^-;1SCL*OG^0I5*%JA$)=*PGFADUUSD0>,CJ%(X;.T4036$P(%
M,U1^-0H 0$E $!]X&R"4J< 5,020(!G2-3M,:Z'D1S-6H6,NN@&W4^<3^AJ>
M+GLTZ5ZHM=B@&LG$65*7?9K$,#K Z9-)DBJ(J.3J^P5W""4=\3Y QQ\$\?3F
M((F$Q*@D'-KH# DC[F->O+>LPL&4ZG0&(W_IYQ)ZU774^P&Q45:WGA9]O()7
M\Q3W%C9XEO8XR>$"N$P*];/0#RF*+M=N9+Y 1^$XIBF/C[9!"9DDB#IM.P^I
MG33Q@]:.T4DF$S,=>9/GIY]"3I4-=RDE[#I!Y^4BHB->*1-;54:UR-)#PK8J
M<"S9@FQBT!%%LB)")G.DF)OY[Y%2^T3#XL"@- =MOF!$;S//R\:Q49G16N_G
M,CKSG;D=MHUH46ZH@F1H)O<;^F*0D*93W?F$H@4/=]O;[A 1'W?J8H>>25@F
M>[]M=!.IGK\IBL0!KW53R,:@28VC\SM6<T2]7G+;1"V^ASCZMST*^1>MS-SN
M5V#L03$BC65BA4!A*1[L@&3<-GB9RF*8! I5 (<N)RGK,\H$])T/R @1J#I-
M2%E*DR"1$0H3KO U'HQ(VJ<;.^X;KEZ'1(7/VN4ZDTS?7']NKJ+5W)Y]IEC6
MH,TR:H1C=B9->#7>-74O)O57"C0A21Z+4JJRZZ0DCNF8U&\;C7:=-]-?WJQP
MI(!"3/,C2-1H.1,GI.NXUJ.D9 H),E/G8_"Y<F4.=(A3'0*80 0.D8QSG^PB
M >XQO>)@$3 (B/(! Y<YT,SU()\ 9TG7J:CQUVVV'(^4\M_#K5E73_8+\M7+
MSE2Z[>4:5S-[3;*45\DJNNWE8@6I@9D*HH8%B%2=?.F82'.@9N42@   %@A*
MB#WI W'Z[ZQUG45:%*.V730S^?V\!OO$5 2V2$I>I=U8;.X?R4Q(BB+QZLNJ
M5RH9)---,!$/'L(0I?8FGX B9"E(4H" ^0RB3J1MM\IG8[\_+G6"P21,C3^4
MQU\#Z^W+L)VUUFLMHN$LDU'1DVE+I2[1-?YE7Y!7!($%%5BG431*FJH %1,0
M0%4PE$!-]LY B#U\M)Y]/UK &)T42(G:=8V@^M>=3:]/75[">YV3')E)>7IK
MFOS=BBF+\ZQ_HY2,/'JN&Z!SB)S-WS4[E<$ $ (X1]XC_.J&#!0'0B -N?S@
MC\M>>LBU"B=MB23(U!^OAZ@U%&Y:5?+9?3:"_G))M;8^1^6 D&YCE4@"LG2J
MC-O'%^X($; /M$I **GDXJB)CF$8 2.1TW!C3Y:: D<M>4ZU"R9UY;>7U_*.
MG*LTI.[WV4U:DO+Y6LZOSR1N=5;+S\Q2HIM9@,,DQ:-W)Y=@@@X55;$*F)3.
M4W!O"28?(!0*!<QD!B#N)VD:[GE C?3D3J36!, \M#KX:Z#40>?U YU&5E%/
M8B8>OX"2F(1TZ47("L3(.XU0K590#*-A<-5"*G;B<@?D$0)[2@!B_EY R#G\
MY&PY?/RUYSI4=Y6TB-!/C,=>NW7:"#4B\4[-;=B_S)-YIS/5I)=!>0@YHBCM
M)XP3]I7+-DL)RN&QS-P.0ADU (=0$O)/ >!A24D@F9&V\^.D:3RY<XJU*EDP
M((\=_K/CX^%;.[S$DWVMU6[18 \H=]SR$FZ;[4Q^%!,R**DDQ(H3W)&<(+.P
M*<4P X^TH' 03#S*<J9U,$3/CTU TUG8G7D"*. Z'](_4_IX3J# +L44B/6&
MZJ*@+8#;!@/O,OY2(01>7P/'DPE  ]WV\^0#[_IYYVGLZ=;1QSPV5K0VE-^%
M*4M02D#L'A)4>Z "0)*AJ1$B:U+P$VER$R2IE8 B1(B-(\=@=1RVKL<_^3MJ
M,E/3X3^D<5-=4NZ;@5X%>HLI5YA)<=!FCI%N5G?2;YAIDV=J9NK'VF#:1+")
MK*D%27#->4JS^1>^;QJ0>+^)BE25)..8F4J2920;MV"""09WD&.E;%H"+6V!
M$$,,@C:(;2(CU\MJO<YS%;%0]C^N<!E.[2?8.)N,J+"ZR[]G;,^'-,=.R=6_
M1YZI5N M,3<*SG5:T]BM!K*OV\L:?N=I92<78IF1ED3OVQ'XYJ5F2A,1D! .
M99D*45&4J4I(()TR! B<P43-;CUT'[:UMRRE!M$N(0ZEZZ47$.N+>6'&G[AY
MALA:^X+-JT096IYMYU?:)F%S"M.G%*ZMWK?PS^1[.9THU8/G288=#I'4:M'"
MY/<%XO0F(8Z)#>T2D4 PAY 0 P"(>/',TA)F9'CI'+:>?V^>M4N&"-"=.0\Z
MJ"CJU8$BII%;61NV*N@X*BFC(_$"Z8F*14J9?!"'(4YRE5-X.F!S" @ ^>9C
M*/(1S,;_ #&F^VDS54_[NAV!^W([:;[>=A'5G1+BZD[#0[8^?)-7=)G"5.Q3
M#<Z#J&F$02(V9IR)R)BH#CYB.$BB<#@9H0H>X!\!"@DP9UB!J-8WZ#GX1ORF
MK6IUWB?YM_(>'UY]:AW 5^:/:JVNK#2RIOQY@JX449/ ]ZZ[Y-5RZ4\I>3F,
MJ)U!,8WCR8WY0\>0E&4#<G7E&DQ$SK.D;#>8Y54N,R@0?"-!I.W2)\1]-=2H
MU*56$ 4@)8PE^_N-&O? #X P># C[O/@0\E\@4!$?X^>1*1IO.\P9.G.?V&]
M9?7Z?N)Y1IKKY&L^JB=PIKY*8K+:?BI)!0OM.BS>^Q8A2@8$%F_P&36;G$/8
MJ0P&)[1$/ "/D2PDZ@QH(V'E^V^U9(5E,:GJ9\=O/P^]2D[)RLCH:.5VYDSD
M%TY*C)IR<6C'R!6T186RX#)$2(HW(0RBR3M%-0Z8&#VHE(8Q1)]I&5,23UT$
MQJ!X$3L9$::C6*R<4K40!L03\YVV^WYU"':JW+%QF*11@I(5#:L90$TV#TYS
M>*>X$3F]Z0B)!-[?)@\#[BA]Q#R E%$:2),Z$;=8ZZ;;?.J""2 03N=-!)Y$
MD[::5$!"IS*JJ)QKTL99-4JI3#$O"BDJF8 (H43-0]ABF$! 41]P  >! /(#
M 4D"-8^1YGQ)@;\Y@>!J(YY8($ P02(UV!U,[D[QO!JSRQ7;07W0&A5MRXMK
MBRR.F34/)+JL9Q-R\J;%.5<LX]U)';^UZB506WU!065.**"":P"0X^Z?X8@@
MG3RU$D3!UZ<M.4[5<5RU!"B25"-X CP_2?I KV/4)97Y4%J_*+(@42_&,4\/
MX IRD-[#_3E 0 //W*'W 1\ /](14@[E1,;:$<M.<:2 1$1OKI0<P.@5)Z\^
M?2>O+7330UCEDJ$JI;;#YK4H<6EDG/I%E8UX(D#\4<B IF^G]P!]@ 0\!]OX
M"(>>0%!(TU&N\$P>D?K!&NV@,[B2@DG?4^'3[?KK7+0\59HB2C9-K!2Z+J,D
M&,HR.2-> (.HYR@[0,!O@*8/YYN'D!#R8H^1\#YX*DJT(,3IJ-)TDZF(_("@
M!!!"2!S$'KX[Z>7EL:F7W6K]FL>QFO4A6ET4M#H]1N<>E"M7[AK].M'_ $A"
M*.C-_:HNB6/2.Z]J9?8*I"@0@^!"0&X(DF8W(C?<B1!_2!KK.;FJIA4D 0-@
M,HYQSW^?*M=8[79QO#:4D$#)) M7($A2A&O2^XI+G7/>'YTB^X0()#^2^3"!
M3&.'CSP<HB-=-1(CEU)UY\I@U WV5J1N-9UV 'R^=9LA69A/P<8:35 ON'P6
M.<C_ #9?/C]$OO\ </X>/N(^?/G[9)*!T,;#0Q&LZGE\M.=3(&Z3.FL3SVD$
M^OONO F]BK&KT"4BJ]8'CA"TQ0'C8]L9FM+M%W)4G$1[W/P-?:\1,9$#NUDR
M 93W'6)X 2X*"#)).NX!'2-"?7B36:05&0" #N?7EY_(U^-=1G[)J%[GI"N6
M%HN^M4R!V3MHJ9U'$:NU&R+(YVIE4#&;IH$0,*"ITC D!B&,!O(R(B 2!J-X
M,'4B1R)$]TSKO4.*RKGO:  01&O.)ZF)(\*U+9JW,'F$RDAI,$BQ< FF48]X
M( 3\%9>\"B*8CY*8#>1$1$# )1^WZR2.:N0$DB8   \@( G6-3),G"0?Y5<R
M1K&YW$QR_2N-3K4I[R@K!20BD(&*!XQV/DH"(";W?  >X?M]A_0/S!X'P/)E
M.Q4J!($E,:1N.NNNL_*H$"2,VN\<AR@;:^$_*I:U>5N#7K!H-4&JVMY#O[O6
MT&TUX3!I")KH%<.(@6CA0D@)9 [8%@5;-U4""D9)0Y!5\#64HDZGGL1'CH=>
M6P$B9TF#< I03J(CG,^9T@:R!X#0:U'YDUM-:B[G.P+.;C)V(S^_/8I^W8+G
M5:R"56DC(+ID5151.H50 ]H'*8ON\@ #]@Y/=*<I)4D$+"2= I,D* @0H'7-
M\28$*2-:Q42A0("@4P00I4$@F! (&N8\OJ9JLF1@=/NL_-VBX+6J0>OGR\@N
M<S>0$KH7*RBRYA(5$J+<?>J)@0;HI)@)_P":(0A \BH*(*E+42HJ4I92I:B?
M\RBF4@2!*,I(2"23*C65+4%)(.4P2(W4/YIW"@!J4PGJ-34SNDMMGLBV"H1[
MQM-1%"L$H6,LQ'T?(.HYH+X#"VFRIJ-SE3<HNB-R'5*7S\"BI1+X @DQALP.
M\D=[92MSS)*BHD[[P)GP%C94DDDD]08C01ML-!,\S/G6#=C8^[7/:]$F)Q*7
MM2?[<V)DP>JLWBR*$&QF'*<(BP2(D3X6:<<#<Z)"%+Y$/D.)CJ&\YE8YYC!@
MDD$D" -S),#<[UBM1*U0DF3F$C0:#00(W\9U^=9OV,>SJG27IN2R/9915EV(
M[5,&(V%PY.X;1C?.<,(T9MU'X@L5HC^<K=,?<!"^XI/L'@/K'L6<0WQJ5+4A
MM)P;$#F<4$I5F5;$ *)$*T@">1!G0UHXFE2[$#*I9[5'=@G;.)@:['4_M7<H
M])8\V?TT^D0S[NL/'0=;<H*S4J;=XV8)0A*C%E@6DB1Z]?J'LS.'!DUM;A)5
M%HYL:4FNR9,6JB31'Y*Z9==.\NN'ZK5YUZZ=AY#\JL/Y74U#=GUSKN2[O*=B
M8FX2GT%UFG;.WY\&88ZJV>W#19VJU6MVF)N58SNM:>Q7@%G<DVEE+!<K6SD8
MBR3C^31%ZC]<;-2LR4#*!D!$@K)4"HJU"E*2(),!"4#4D@DDULO7 >9M6NP:
M;-JVMKM4.72EO)6ZMX=HE^Y>8;R*<7E3:,VS:BM2W$+=4I9F1S"M:G%*<4IQ
M2G%*<4IQ2OE=L6+\I"/F;5X1,PF(1VW1<%(80\"8A5B' IA#["(  B'V\^.*
M5\7[/0 _K!PX_;Q_\6,OT_J_X#].*0.GK;\M*]JD+#K"45HJ-5$A"ID%5BU4
M]B9?L4A?>D/M(7^!0\%#^ <4KU?L_ _\R1'_ %:S_P#!XI7D8""$1$82($1_
M41C68B/^<?AXI3\ @O\ F6)_ZN9_^#Q2O8K"PZWL%:)C513("9/E8-5/8F41
M$I">Y(?:0HF,(%#P4!$? ?<>*B!T%>L("" #%"%B0*8/:8H1K, ,7R!O!@^'
MP(>XI1\#]O( /Z@'%(&T".D5X_9^ $/ P<0(?IX_#67CQ_5X^#BD#H.FW+I7
ML_!(;X0;_A$9].!Q4!#Z!I\(*#]A."7Q>SWB'V$WM]P_U\5->O\ 9^!_YDB/
M^K6?_@\4K\FKE>./D\#"G'P >31;$P^ #P >10$? !]@#^ ?;BE>/V:KG_,$
M)]OT_P!ZF/V__L<4I^S==_Y@A?\ JIC_ .!Q40.@^E?HM=KY!\D@H<H^!#R6
M,9%'P8!*8/(( /@Q1$I@_02B(#Y 1#B3UI Z#Z5Y_9^!_P"9(C_JUE_X/%('
M0?2O8E"PZ!A.C$QB)Q*8@G28-4S"0X>#%$Q$@'VF   Q?/@0#[@/%('05Z_V
M?@/^8XC_ *M9?^!Q4P#N)I^S\#X\?@D1X#SX#\-9>/O^O_J?X_QXJ('0?05[
M$82&;G^1O$1B"@ )0418-4C@4P>#![R)%-X$/L(>? A]AXI &P K\?@$%_S+
M$_Q'_P"+F?\ ']?_ %/%30(""*8#EA8D#E$#%,$:S Q3 /D# 8$?(" _<! ?
M(#]P^_%1 Z#Z5X"OP(?I"1'_ %:S_P#!XJ:?L_ _\R1'_5K/_P 'BH@=!7M4
MAH=4B2:L3&J)H%]B!%&+4Y$2?^PD4R0E3+]@_*0 #[?IQ2 >7CZ^E89>,@R7
M38%2JZ3EV=:#6%7;605KEWI-:M<"H_8_+]$]/$3T8_CS/&?S+?2N3-Q6;_*I
M\1R?(;RJ:YFCT&BYE6H^EYM2ZGGU.B3.SQ=3H]<AZG6HT[]XO(/C1\% LV$6
MS,]?NG+YV9NU3%R\<+N5A.LJH<RE99Q2L,O6?U/2H/\ 9NYQJ\M"BZ3>F9H2
MTU#"HNF@Y;%^5S!2$:[51%!VX34:JKG:J@<#*HG,FF8BE9/'1[.)CV,7'-R-
M(^-9MH]BU3]WQMF;-$C=JW3]PF-[$4$R)D]QC&]I0\B(^1XI7V<4K\B0AA\F
M*4P_IY$H"/C^K[AQ2O'QI_\ )D_U2_[.*4^-/_V"?ZI?]G%*?&G_ .P3_5+_
M +.*4^-/_DR?ZI?]G%*?&G_R9/\ 5+_LXI3XT_\ V"?ZI?\ 9Q2@I)C^J9!_
MSD+_ +.*5X^%+_DD_P#4+_LXI7GXD_'CXR> _0/87Q_H\<4KQ\*7_))_ZA?]
MG%*?$E_R2?\ J%_V<4I\*7_))_ZA?]G%*\BDF/ZID'Q^GDA1\?\ 9Q2@))A^
MB9 \_KX(4/\ W<4I\:?_ "9/]4O^SBE/C3#]"$_U2_[.*4^-/_V"?ZI?]G%*
M?&G_ ,F3_5+_ +.*4^-/_DR?ZI?]G%*\_&3QX]A/']7M#Q_H\<4KQ\:?_)D_
MU2_[.*5X^%+_ ))/_4+_ +.*4^)+_DD_]0O^SBE/B2_Y)/\ U"_[.*5K32<1
MQ?9FL4QV#(LPU9E!.'+J$9Z30:I>FL,Z>II(O',4WM$3*)1SAVD@@DY6:$14
M7312(J8Y4R "E9%1Z#1<RK3"F9M2JEGU/BS.CQE4H]<AZG6HX[YVL_?'804"
MS81;,SQ\X</'1F[5,7#M=9PL)UE3G,))W,[#7H! 'R&@\*E2E*,J45&$B5$D
MPD!*1)Y)2 E(V   T K+>*BL.O-!JFD01JU<HY:5A3N4W:C-"6F8<5%DDET2
M?(Z@Y"->*(BDX6(HV.X,V6 _\ZD<2D$JE9+'1[*(CV$5&MR-(Z,9M8]@U3]P
MIMF3) C9JW3]YC&]B*"2:9/<8QO:4/<81\CQ2OLXI3BE.*4XI3BE.*4XI3BE
M.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4X
MI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE
M.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4X
MI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE
M.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4X
MI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE
M0?L_=J)KDWK=.-DE_5O>>;5E6$U*KNI&E-3:G:]C8-)6G3<#*,['*LX"G!#J
MO[%,R%G_  ^<BZU#R#Y6MGD@;PRZGZ^OTKF<W[X]8[Q T5>R:SGF1W^\N92'
M;8[J&BT*N::QM,!>['E\]6PKQK&JK,.6>A5"R5AB^@C2$=..XM12(<.DU"<4
M@]*F/Q2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4
MIQ2G%*<4IQ2G%*<4IQ2M(]CMXK'63%K_ +K=*]=;-4LV@'MGLL=0(1O/6-*"
MBT3NY>418O9*'8E91$>BYDI%R\DV:*#-LJ8IU%Q1054K7CGN+FC7=V^#F@;X
MH[4O,3D[K2$HB'-F49L4]E+K;X?*9"3-826<EI?9<V2LY7S>IN:@@I)1$ ZL
MZ%EDFT.92I0M9>*?+*-V,G'O%T@,95!J];.%DRE,!#"HFBJ<Y *<0(83%  ,
M(%'P(^.*5R'%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2O!
MC%* F,8"E /(F,(  !_6(CX  _S\;[4K'H:WU.Q)NUH"SU^<182+V(?*Q$S'
M22;.5C5OIY&-='9N5BH/V"_\R\:*B5PV5_FUDR'^W-A^SN[8H3<VMQ;J<;;>
M;2\RXT5LNIS-.H"TI*FW$]Y"TRE0U22*I;N&'@I33S3H0M3:RVXA82X@PMM1
M22$K2=%),*!W%<Q]<R\>?K&O@//D?J$O >/L/W]_C[#]AY5V:_\ (O\ [3^W
MB/K5F='^9/\ W#]ZXJ$M=7LL<28KMC@9Z)46<MB2D-+Q\G'G<,G*S-X@5ZR<
M+MC+-7;==JY2!03H.$%45"E43.4+7[2ZM72Q<VS]N\$I46GV7&G0E:4K0HMN
M)2H!:%)4DQ!2I)$@BL&GV'VPZR\TZT2H!QIQ#C9*5%*@%I)22E22D@'10(.H
MKG@$# !BB E$ $! 0$! 0\@("'V$!#[@(?80YK[;U;OM7''F8A*6;P*DK')S
MCMBYDVD,=ZV)*N8UFLW;NY!O'F5!VLR:KNFJ#ETFB9!!5R@FJ<IUDP-:&7BR
MJX#3I80XEI;X;464NK2I2&U. 9$N+2A2DH*@I24J(!"3&!<;#@:+B ZI"G$M
M%:0XI"2E*EA$YBA*E)"E 0"I()!(GDN55G3BE.*4XI3BE.*4XI3BE.*4XI42
M=%Z>T;0)72;0E;KU4;O?]"QW5HVX5YQ6EI'/[_AT4PA:7-5-A/UJ:A'#=Q&L
MEF%EB+3&V*.FX^6EV)D6R#M,&ZLB92!E (GO:R08(!DE,)(,90#WCF)$1UR?
M66ZJU7&]1](QI2FTS*M<[['1Z=@NTXT>/K3:YJ^[WGMIG[#<Y^O40M:-*V2[
M6BSV5=L\F*7$HRDZ_2J\(=$Q(Q&#I&W3ZD:?/[5 $S_3QU\OSZ[3V[.344XI
M3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.
M*4XI3BE.*5IOL1CD?V&P79,'EIIY6XO8\SNN:2%@CFR#U_"L[I7W\ YE&;1R
M=-NY<L4GYG"""ZA$E5$RD4,4HB(*5HISTOB'/8'^6(VA304]?7Z]V*D,I&#B
MS-7FZU?##=>(JU?M:*WXDA6 SY**?.::6..=6ZP<784;"W8@^@7JE47^G%F%
M5Q[U]>^U-H*+>%IIL2LDG'U2.LD?,1T(X<W[)7+H"Q;2V6)]!+N7CUX[,TG&
M%>?G%RHLE'G;*%6&.GB>>LZ';>/MM]9/+3E]?'EZ'.NU3R:BG%*<4IQ2G%*<
M4IQ2G%*<4KUG523\ HHFF(@8P>\Y2^2D !.8/<(>0( @)A_0H" CX >2 3L"
M=AH"=3H!\SH.M02!N0.>IY=:ASM?J =2<#(\1O.QUAW.LP."E2I[M.X6GY2@
M/\PK%P1W7T"IC![ &468I@80]RA0\B'9X'[/>+^("A5A@MTBW7$7EZ@V5I!_
MF#MP$=H.?\)+A@: USF)\7</X5F3=8DPIU)(-O;*%R^%#=*FVBK(=?\ U"@>
M.HFLM?UM6UNUE&MYC1:+!9ZI6I%=.R[G>5*.96<:K X37=O:['VUG%-3,$5D
M6L*JFXD'[M5,?K&BP),5_J"/8<JTP@W.*7]^_B0N6@;; K 7P#"QE*$(NG+-
M;RPXI*E7"2EIM /\-Q,N)XW_ /DI%S?AFSM;5JT4TO*_B=W[K_%3W@I:V$72
M&TY H!HYEJ5$K082K@;1ZPVO*.PB,TJ&-Z3->X"F9YK$[=?B^\QBE*4CA]6J
M*U6*)C@0JK95P0YO($ PB4IMBT]C6#!';XI>XWAC$'O8F]@>'F-3)2W<WZDF
M!FA820-XWK5N/:)B<J;LK?#+UZ82+)K%;D';;M&K0*C42DZD; :GB*IW@]6Z
M9MSFVEZGRKVG2,6VCFE0=9)=8Z&8.6KE192;:OCN$K*I(O4U!:N$W3]Q&@B5
M 4&:2B1UE;;O@7V0,V:;3^]S+=XVZIQ5XG&;%Q]Q*T!(86WD5;!ILC.DH:2Z
M59@5D* "VXEX_=N#<?@:C;J0E 85AURAE(222ZA1<[;.X#!*G%(   0"DDY1
M8>WOK$SKGX:UU';U9F83$%RCG<T^> 0X_99']H[21N59(H_D*NV%$QB^3E]H
M^ UK?@[V,VZ,USQ@;M>ARJQ-A"9&X/NMH593&L*S $0=*N?X@]HCB\K. AEO
M,>^BR=4LH/\ ^>XRYAR, $[B*U]$Z'ZQZEFO[VNU?:%Y60_906K.YTK((VJ1
MRA(I0'?T3)ZBJP0046]WN)678*'*!%9Q4C\"$YOO8=[&4VN'MW%U@B66_>LR
M[*]QAV[<!=&4N.-K#I6$QE][0H @A@=G6DBZ]HRGKA3+6)]HLL0+FVP]NW2
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M4@B(B8E4@ E2:S6D7^Z3BYP\),H>H?CS&<G%%C>"I_!&>#&-Y$H>1,&SA'M
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M5$52$,8R9P+R1;<" Z4+#2E*0EPI5D4M(!4@+C*5)"DE209 4"1!%>]F25%
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M$^44,(B;YY$Q ^Q2D*4"E#E,7XHQ['83B6)/O,)T;LVRFVL6AI"6K*W2U;(
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M*95XRBXETZQS$:5&%3(R1T/8P>//>JF*CJ0DHN@5J<6D9%PMX.]?/; M(.W
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M=NJ6*SMNKQ-1_8VZ;GEUN;.OV61?FD7J$?'E?D>R#!LLP]\6_536,BW.8(5
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M<.3B:,'5<I_$%LE]+&54Y!)@K R9RD%805!90"K+E )OY$0* F,( 4 $1$1
M   #R(B(_8  /N(C]@#GA[[5Z=03["]]LIR>!ND?FPN]ZURM0\@]#.LK92%T
M/#K-$S?(\O4Q6FDI&U"(CC *\D>4<I/_ (4E$FK-580]O>\.^S_%\7N+)S$P
MC ,(N7FT'$L66W9!Y*R(18,W*VG;QYT=UH-)+<D*4L#0\MBW%5A8-W#=EFQ7
M$&6UJ]SL$+N2T4@RJZ<82XBW;0=5]H0N)"4DS%$M(U&RV2&F]?(]=IVQ6N7C
M1_VS>,$1?TT+ 7Z39^Q;R.,X<(_M05\1I@W6:!=+@95)HYD&B:)D7BZOWN^P
MJUMGK?!BV@V8N;##19-N*#=[[OW\$X:0YE0KW4ME>/\ %#Z4G*5);4I25(2C
MY9:W[SS;N(!7_4=C=7OO)0DJMNU*DXEC*D%1BX"PG"<$941,*4D)()-]OI\]
M=C=;.LE)J,JQ,SNUG!Q?]!!905WB=IM7QO5(QXZ.'S.5H&."/@U%51,919@L
ML(^Y4PC^?_:)Q&.)N*+Z[97GL;7+AV'91E0;6TE =0@:)3<.]H^  (2XE/\
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MR1TG#1=,WM]ITU""9)4GD $#E$0\CY 1^WCDLKK2RDE:7$E1(*<BTD",L0%
M[Z&28@[5TDMN(D%*VU $$$*0H&((,E) T,C0;@S-0@[A]/4=XC6E_P LGG64
M]C:2DJZH>FUQRK#/I+XDQ.%2MSM@ +2=;D%4T?:+I)V>.<)IJI)+M#O6#WN.
M#N,#@+WX?BK"<6X;O<J,0PVX2E]M"#(%S:)62&WT?'#:D=H $E04 1R?$W#
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M,Z]8XM^452 1:(60<%4]WQ*^4S"7D;?!>/.'XN\,ML32R9S/X0ZG$;1:=?\
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M !1;2MIM*U!04M&AJT- _P J**OL.G\B29_8H %4)[R ;V*  B '+Y]I@ 1
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MOV%PK*'$A(S+97E>:F"% %5>GI3"O[1!7_L_9V;EI:^S=G);HYJ^3^)W!Y1
M)K062P'Q" &;_P#FND2PNT_(^^0GW)SB(@7Q/'#[=I<8=PM:K2NTX7M/<W5M
MF47&+W!3<8Q<3,*_ZHFW0>3=ND :F<>&6U7#-UCCR2E_&W_>$)4(+5@R5-8>
MU'*6!VRMY4\34W><-73TXI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4
MXI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*5!HJF(][JO6:IM> Z9%M6!H[7Z7#:
M3"SL'&N$PCW$/$W"N7_/+ \K(2I8RU.V:M6?VF-O,6A(N5):HLFP$=&4K=^$
M]9L-ZS0TO7L+H+//H.==-WLG%Q\M8I)FLZ:B[%)5%&?F)8K'\[YVJJ1A],FX
M6746<$55$#@I64;!DU6VVA2&?VY6991SJ5JUCC9FN2/X19*S;*+:8:\4FV5V
M2%%RDTG*M;Z]"ST89TT?1ZKJ/3;2<?(1RSIDX4K2C'IAF#3*[UC3FRZ?,432
MJ[,1%RCY>X%=+R]AM=^NFF7W21<$BT/I="T"WWJ6?6F6:)H19VK.$C(>$AXZ
M);-@D&""-P01\O+6LVUJ:<0Z@PMM:5I,D0I"@I)D$$:@:@@]"#5'GK\9U"R7
M8CTQ]#"-CDYRO=CJ+''DRLI$)-RT?:_D[=%HJ^94:89*MVWSN3H(S5WJ9$1<
M.#1S:9755:\QT_;USVF/ 'I6 G7UII^IC^E=GSDTIQ2G%*<4IQ2O6<GN ?(>
M?O\ 8/X"'CQ^8!$ 'R/]?V^P>?/@0&.8T'@KFGQ_.")WVJ"/UD#G(@@]=*X:
M3KD#.,U(V<@XJ8CE2?&HRE6#.0:G)X !*=LZ251,7[!^42B > $/ @'+6KA]
ME:76G7VW0<V="U(4%3,@A8,DZ_,]35+ENRZE3;K+3C:DY2E:$J!3_E((((Y
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M.X_:79&W%T^NWLD,VZ2[W'%I;=3;+0I,$K<4\V$$*9(G,:CCG$=]=X0NSO\
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MB.(X,[B5B\U"<ZG$*MU*0G6&72W:JR',HJ(@S-S3M?V7E#I?LO9.G?;:*3(
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M;\]/EU)6?HL"JPCY:;?TZ-!>Q+FBSD^B38 LLZ:  *EF#!5!B0"8TD@P">I
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M$XJU;7CNLG6NPQRT!#JL)]+&LW72G&2D<W.TETUR0*I%DY) R;PBI55"J%6
MY5#@8#"@>B8^FU*^6[=4_3[S2ISU\T3KOU,HU)J[!25LENMV7937JW QJ(D(
MH^EIF5A6L?'M2G.FG\KEPD0RJB:91%10A3#ZUBE1+RWI3Z;V/[UJB%C:]6+?
M:^WMNJNI9)DMFS_*$7-9KC;.V-;9PV:QCA-XM)05H&F6"V,U(YC&I2CM&P'8
MM7IHN1=$D),%4$@$ GD)S908\ 8GH:S#3BFUO!"BTVIMM:P#E2MT.*;2H[!2
MTM.%(YAM70U-W]QOI=_9,ZW_ -RN=?X=Y$>?U/[UA4(NP_37TU=!?5J=!'J9
ME#+ICN%$UK>4(>BY&5JA&$KMECX[-->.@$<%5A[6%@;2Z;>?37%TK%L3$BG
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MGS%SLF<=GLKV:J95-62%"?08U&OYYFS'/J7/IP"I88T7!N)2#?NG,_,O\IT
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M6VJ?#2(,)*QRZ-CBE(1A)?(N5!Z]>O*E9JOV\H=@SBFWO,$75I=7C;J_@[&
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MM=@RFI[CFMLRB\ED3U.Z,$8V:+$O?PZ1%L@^:2*?TKWXE_IU/J62 B?XC^2
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A3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI7__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>46
<FILENAME>g60414g64p33.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g60414g64p33.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2B,4&AO=&]S:&]P(#,N,  X0DE-! 0
M    *'"^$#4CA"24T$!       %QP!6@ #&R5'' %:  ,;)4<< @   @   #
MA"24T$)0      $,==%^5TM6[UV[XYE,#I>5PX0DE-!#H      .4    0
M   0      "W!R:6YT3W5T<'5T    !0    !0<W138F]O; $     26YT96
M5N=6T     26YT90    !#;')M    #W!R:6YT4VEX=&5E;D)I=&)O;VP
M  "W!R:6YT97).86UE5$585     $       ]P<FEN=%!R;V]F4V5T=7!/8F
MIC    # !0 '( ;P!O &8 ( !3 &4 = !U '        IP<F]O9E-E='5P
M   0    !";'1N96YU;0    QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #
MA"24T$.P     "+0   !     !       2<')I;G1/=71P=71/<'1I;VYS
M  %P    !#<'1N8F]O;       0VQB<F)O;VP      %)G<TUB;V]L
M!#<FY#8F]O;       0VYT0V)O;VP      $QB;'-B;V]L      !.9W1V8F
M]O;       16UL1&)O;VP      $EN=')B;V]L      !"8VMG3V)J8P
M$       !21T)#     P    !29" @9&]U8D!OX            $=R;B!D;W
M5B0&_@            0FP@(&1O=6) ;^            !"<F1456YT1B-2;'
M0               !";&0@56YT1B-2;'0               !2<VQT56YT1B
M-0>&Q <L            IV96-T;W)$871A8F]O; $     4&=0<V5N=6T
M  4&=0<P    !09U!#     $QE9G15;G1&(U)L=                %1O<"
M!5;G1&(U)L=                %-C;"!5;G1&(U!R8T!9            $&
M-R;W!7:&5N4')I;G1I;F=B;V]L      YC<F]P4F5C=$)O='1O;6QO;F<
M      #&-R;W!296-T3&5F=&QO;F<         #6-R;W!296-T4FEG:'1L;V
MYG          MC<F]P4F5C=%1O<&QO;F<      #A"24T#[0      $ $L
M   0 ! 2P    !  $X0DE-!"8       X             /X   #A"24T#\@
M      "@  ________   X0DE-! T       0    >.$))3009       $
M  'CA"24T#\P      "0           0 X0DE-)Q        H  0
M !.$))30/U      !( "]F9@ ! &QF9@ &       ! "]F9@ ! *&9F@ &
M     ! #(    ! %H    &       ! #4    ! "T    &       !.$))30
M/X      !P  #_____________________________ ^@     __________
M___________________P/H     /____________________________\#Z
M    #_____________________________ ^@  #A"24T$"       $
M$   )    "0      X0DE-!!X       0     .$))300:      ,U    !@
M             %W    ^0          0                         !
M            /D   %W                      !
M       !     !        ;G5L;     (    &8F]U;F1S3V)J8P    $
M    !28W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<
M   $)T;VUL;VYG   %W     !29VAT;&]N9P   ^0    &<VQI8V5S5FQ,<P
M    %/8FIC     0      !7-L:6-E    $@    =S;&EC94E$;&]N9P
M     '9W)O=7!)1&QO;F<         !F]R:6=I;F5N=6T    ,15-L:6-E3W
M)I9VEN    #6%U=&]'96YE<F%T960     5'EP965N=6T    *15-L:6-E5'
MEP90    !);6<@    !F)O=6YD<T]B:F,    !        4F-T,0    0
M  5&]P(&QO;F<          $QE9G1L;VYG          !"=&]M;&]N9P  !=
MP     4F=H=&QO;F<   /D     W5R;%1%6%0    !        ;G5L;%1%6%
M0    !        37-G951%6%0    !       &86QT5&%G5$585     $
M    YC96QL5&5X=$ES2%1-3&)O;VP!    "&-E;&Q497AT5$585     $
M    EH;W)Z06QI9VYE;G5M    #T53;&EC94AO<GI!;&EG;@    =D969A=6
MQT    "79E<G1!;&EG;F5N=6T    /15-L:6-E5F5R=$%L:6=N    !V1E9F
M%U;'0    +8F=#;VQO<E1Y<&5E;G5M    $453;&EC94)'0V]L;W)4>7!E
M   $YO;F4    )=&]P3W5T<V5T;&]N9P         *;&5F=$]U='-E=&QO;F
M<         #&)O='1O;4]U='-E=&QO;F<         "W)I9VAT3W5T<V5T;&
M]N9P      .$))300H       ,     C_P        .$))3001       ! 0
M X0DE-!!0       0    %.$))300,     !X[     0   &H   "@   !0
M  R    !X? !@  ?_8_^T #$%D;V)E7T--  +_[@ .061O8F4 9(     !_]
ML A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,#!$,# P,#
MP,# P,# P,# P,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.%!0.#@X.%!
M$,# P,#!$1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,# P,# S_P
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M=A$_R6,]
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M8V31Z^[8\953UI51"!Z:A2-A7=>3$#]M>//CR#O[8J[2>C&78$F1F(.BR*2
M"1^00?M^-#VZ+^M--[:W7DO=SH_6V[;N_P!5=MO=!75NF<UV[E.QLZS?"<NM
M=$T[N;UV';BJ,OJ-CLV>G\QRZR@PJZUR&YKKBDR/*,!RYN95SG39Q=E41.5
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MU[Z5Z3#(7VPM@W^29A=0F ?:KZQC%*PI3DR!.ZV,PX(BC0&V;QY+L=$_T"@
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M!)?J\>CZIQMB;[%N4] ATF7YG$LIS3=8$]HG2D,@7M^'7.7)Y%M;U D&.AY
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MU.C*+L5VAT]'F6-5=RH,E/=5][M&TV-D]9*Y>I[FJ;\8S>1S#5U:+$UTQD;
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M)Z<4$*A[-NPQ2K6C8\0\\@5B.1^F.)%>:9OHAC=OIZB6KD-15Y\I)924@KQ
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M4DRF_2D2'L2PK7FN'G'@]&.B."[A),EXLM#RS]H"B(G3?++Q3$)ORN(KL?\
M\+8MS >YUXE!Z6X[3/DG (Y9&4'>Q^B"O%]];\H3^V]>PZL_<5GN08/KSV>#
M'$#9VQ+^EUAJU9\8ID&-F^8OG$B7MC$3CW51A=2S<9W>Q?(2D4>+V3+7F\;;
M9ZL55BLVN5@,:E2&6[<XMP+5ZZAC$K;\/9D,=6,Z.I)E)\ ];<C/)!7U!KYF
MPZUJNUY 3R[XR$:(*PHKSL"/*QD??S>-7ZWQS4V#4.!XN$LJVE8?)^?923FW
M-]<V<N1:Y#D^0V+B(]:9'D][-L+Z_LW_ .-86]A+E'PKOBD>[;EOV9;4W'G(
M5 5 %CBCC4)%#$@\)%#&JQQH/"HH'6ZK6CJ01P1;XH#MF.WD=B6DED8^6DD<
MEW8DDDGJ_P#47J1T&]L[;CZ[QZ?/IJP\NOXT>T>8QZL)]V6^=4U']U&%R/%?
MA!8MR+"L$*NQGU+\MB0^]$?<*(;1G1_?].E7PG6%KW-9/=;*VBC!:[_=V!@V
M/4A8S!8C9^W"GMV=GLAK]26:5>E[!(,0 Q@-S!I',C@5\IF'-ARFCKS_ -?]
M/_7S_?CJV=^=OC^E^QON$S&F;H,1BZRUW:YYCH@,.DK(N4XO.CY+C8Q/%@Z]
MFXL<JBU[=2[.A3X+N12X3UI7V<<I$20=>_W_ '_?_P!#SMZ\^K/AO=2<+7F<
MT<W$-IU+C%:\S@MI8W='31S&!BUC<9/-D^G=-VSJ9+1(-_<T4MIS(\>AG4SL
M<RRRCQ9)_?\ V^_^7Y_;HZWX.UVYK>OO&9M/ S1V]<D4K\1['0HXK=).A5V)
MYU#J[FBO,FJ)>554RNB,0'<DMHS$[&AGT9+)>A7JOG1_\_\ Z?6DW1SNPL-^
MHGD6I<BPW:14&=;ZT;KV)G<&CKV]/V>:Z9O&MZV+;]I"5ML<@CZWTOC;MDU7
MG*H(F7W^6.1(E5.RMY'V^(98VR$VG8Q8C(KX'T(;<(H*[$'8'_$L/L.9C \M
MU!R:+)#CT20^J^2K-*KA0HAK3+;18B&+/*S1.67@O%%Y N.87UC)\(G_ $Z4
M=3NE^WWL?),9@XSKW6BQ'-R;;LI6.X$4V,EA78K7P8XRLQVED5>CC12<8UU3
MO-V#L4W&&;[*;#$<+67#DY7$DML\95AF>:U<#_PZ@BS6^#%'G9FXUZ,3A6XS
MW'#*I )CA2>?BRPL.E]^Q+&L=>MQ-RTQC@Y#DL05=RV9%V#Z==>+$; >5HHM
MJ9-B]:JU;C&H,.A8?C 2WVVY$RTN[ZVD+/R3,,GMGEF9!F&66QB+UQDV0V)N
MS[6P>04)PPC16HT"-$B,1KMR:_8:Q/H'BL<4: +%7@C'&*O @)$<$2Z6-![
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M9V-K @UM1DWZ'F4');;(L@ERJ5W,JR97)8P7<1M9AC+OPC1+6;K_ ,WFK*-
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M5E5#=OFA&,_:.2Y<Z,S4ST;8;06ZBW2MR!MZ4E7'8/TWACOUTJLFMQCH]O\
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M^<U?QIE9B+00RBS(<L?/_0>/]?M_?MUZ?'_T^MW/7O1U.CHZG1T=3HZ.EDW
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M(\^GL+&KNH5K&D->V.C^_P"_[_\ HYYJM@,,,1H\5J-%C>?HQ8P^WBBABX)
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MY,SLWM]QW1+E/A=EM#*8VD<WRS<VC<>WS<EDEULRQBV>U86)9_/Q'+L\$\E
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M.CJ='1U.CHZG1T=3HZ.IT='4Z.CKH65I64T-ZQM["%5U\<?.1.L9;$*&P/\
MZ3TF2XTRT/\ ])PQ'GXY_'62(\C!(T9W8Z5$4LS'\!5!)/[ $]8LRHI9V5%
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M>Q"20)J\R$QRQD@J2AVC@QR*LB.HEU;<-N,O$2"C%)HW4QRP2  F.:)P'C<
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M ,CHP*NC ,C JP!!'5SZT=;NIT='7XJHB*JK\)SRO^''YYZ\W_G[_P#8;_\
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M./R!U_RH1(S&E<<^8XR[U9V_EI\LY19(K/9QFFFD>YC_ /WDS M<J#9/JRE
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MRT MM---"@-M-M@B"#;8"@  H@B*(*(B)TG)))))))))/N2?))_<GIF
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MF%2/</.1"NOP>4@ _?V\ZZ.]'40<?I:BAJXX1:RDK(-1716Q06XT&MBM0XC
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M+DG>^%W[*+\*<*R[9=#5K+J)_4"ET%BR)<_<<=U/[O3O)D-C^WF'L,;9B/\
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M/'1M5)JO,$;/*/UC(!K1*@;!\]>6JXM0^B3Q'JP2$Z!V()XY^)!]@_IA2?)
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M:(_47J3U.CHZG1T=3HZ.IT='4Z.CJ=>$;_O^_MT'S_?_ *_Z]3HT![?W[_\
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M"WJ/[:''7[[UKIBG\W*ME3GFZ.MU\_/!+)9D60U91GY;0C&:!GU41N.^K:"
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M&5<9E:Y _%CT4AR/CKV/S+>#8.JC;45EAZ-(@QFT5YQ[P3T_ 3,;;B\]0I_
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M8XB&E*K15\>[1M:HQU^,:I8:/:D.H!B/)MHO[=7'MF#Y2O)4^9GLFN(T+3>
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MP'@<(7GXPH$AVUU^V.X<=-ALI?R,U?$8=(C5[5RO\/A62NKR/(T=>3/-L!9
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MH0UZ!GB2,+$1- 6)4'0 /3*^W:V6IBQ<GS&,=N$27LCA_D66.%5B50IRT/,
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MSO7DL47O6^0YR>HS5:U:50-($E7DXT>1:,E?('CQUS6]W#CZS-,8F^65R^^
M4\M$ JK$$_41]6O.O;8Z=K6>E,.PF)&G-X;&S3,XBN.$]<2"C8O6*HHBA,1'
M64FRFDY7T&S^U_Q-P"%%3KD^2S=V7U(/XI-C*-A8XY%JEGN6E1^2!4 =%C!
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MXZ4Q3YJE*[%5,E1X1&-_01PIQR2<M@G^<$8_;DW+KGHM*O1K9VJL,3PG!)I
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MU)%/)"JA?Y)D1;$@=0&5S C,!L/]EV6,EDH9XA$\8@X)Z9+L0HT"$"<2)64
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MUF78.!CT-X#13=;*0\LZUD$/ $W&$0%?O'@?@N6'+69+8@KQ>G6&SZ"Q VY
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M4;EN(M4I,8,A7:*/ZV:?TP5A"H&^G>WWHE=DK7YGGI-Z)K58E=PO'TDC,@V
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M8;"ZN':7<D& GJ]P8I+47<-1?4Q^12RU>_2CC0+'8CEK*LJ-IN/KJQ+@E?\
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M:&Q8B=$BMP%Z\ZUY %$K&*:0\D25X8R><@5D]6/$7NT[27OXSFE7N;'2%8H
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MT9)[ XF.O IL7%??)9C*I5:S!O8[,A7>B-=3Z61M9&H<?3I*3)XW%$OK>_E
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M4APOA41I?A1N$^%>YB\.*<.<K8YX!+:ER60@M4:8$DB/+)%6C]2$J/K,\@X
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MAD#WII36,B3CQB9*3WA%==D/1!0N505==%$X7D?'CI9AVQZVWOU,[$U@%?\
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M1[<?&O7$LA81@.HV>"@$ =56;$C$SRQ]OV[UFVO)'FB:0SLR+XY3HJ<P 5)
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MD=G)4D-LE@2Q.NO65] /8=/L3%^Y"?40:JM2NL]71942M@C$<1UV#FA"Y+=
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M)HB#ZC:+U0CD,BZ2XFGE+F/P=NA#\_CJ4[1U\B.>N-J55Y-$2D;^FDB$D#D
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M3L+O:Q'66R[3(\FB-X;,QS#LGD8ZU!F.5\>RK0N]C4;XK:PU]4$?I$:9\E]
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MK@!-!X0_%?G;N+X.?[0.$[FR'=G;0P<UJ2 FQD,397M^Y=O.6:8UXJK S1R
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M-:X!->"%V.N=9;X7?#[!0SV;[Y6.$(3))#DW4(!H<BT"1-*VR /5,I^K0\Z
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M-/-76PP1HYH60N4)90!TFR%OL'&O+6?'WH(8=":6I!$E0Q2<N,ID]91) P#
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MC);9!4%?'U=<\[>[LH]W+:R%%KYC]12RW8HX55Y#(SB&-9)&0JX99E<CBX4
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M (0?+>? &SK1/6Z33_<5%Q7M0V30TTERQV72QK-FEI[&BL[N PRZU$A3GIJ
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M[37K%A))*UBW+)*[!2L>F9F4;5'Y<I.:JR@R!+>=S3[3SO(,SQ'$K#$H.0R
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M+,-ZFZR1/2E:-&$<@)BNQ2ABZ<0K<)"37)^PV[CRUY\I-'<QC!C61)"9JZ%
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MYEKO:I>LD$,LE>5JOJ*RPZ*Z*R>%8*0&&MZ/L!U=L;;HPQ!X2P6$!54C07@
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M#Q,KZ1DJ(*#W3XAT_AKWYB>W/B!W)12K-@V@NX^PTM%<G')(3SIRQ5IK$MB
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MU6BV5ZABX^1J:BO'F2$JKY#Y*J\=7:2:M(5CK)%&L0(,<2I&!R.P2B *N]>
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MR'DVX5A*\./E!X:\B^?/@OQ9,9AL EBA'7A8JMB+YJ5WY1/'S'J%@2?&O&@
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MWCF(I.-\J"-K]I*J_'4G.6LE!EW]'MVYD*Y2%4MUQ&58\-LNF8'Z68J0 68
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M\EPG*?X_"V-YGK1&PT;NH'Z8E+.!H>-:T?\ Y []NI;6)(5VZ,4&]",%F/\
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M4F0XA$@"D/V$IYH$4%5Y%<5P 0O]VJ=23WI\0\_8_B%7'H*=GTG]2.E-Q16
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M3QD#P\Z@J3B?=YJ"\6+.? U>WQZE#N_*2,CLDB7UK6D>8*C_ ,J2I50*GU
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M2:S(KMQ$Y!X*YV!LDL2.NQTIJ?;>#EN)A3<E56:6%;ZVDAC(TK"Q-(RDD#7
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M#BT%0]X)X3IP_P !M](I_P 15>=]H0?#H$"<]4WO"&I>D$7;%NY6K+*LENG
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M<.A15:-6R'XLY$218 7R2B3;C3G]1<'Q^;J/AEV#C,@D9[AGRE@(IY2WWBA
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M, ?MYT>E=N]];0V5=+>;*RK)\ZEJX*A&E7$F.RTGP*LQHT16XK+9^ (+3#
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MBL7XU]7L60>H]*E$8)($U5?-?,B+[_+^94_Y<\"G5WH# (Q$CQ3&/PJ1@A5
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M&206;,<@)= 69B&D)8@_X2/.] #R!L"UAV4U^1V+=ML7!ML5\^K1#CT[6;P
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MO'F+-R3B!-!:LL8V )'!>8)D4,I4J0J\O&P0=KCE>GFFLIL(>VMPM64*3Z+
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M&' <\RS56!V,;%M!8*SD,B3#G,;!S=R/DV4U\MLG'O7K -\&61=,_-[U&#_
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M$40\14D$OE%^%Z@YC%06;;3-9=9'1-Q:!5>*A 5.][(4$C0'DG?G8L&7[?\
MG<E)=DMS^F\<2BL"HAC*(%+K_B#,!Y;8\ZUUI B9YC^0MLQK+6<#(+9]U04V
M&75=\5^05/%4+S55^4Y0?SSRGX4/C[-0,T64:K%K?EF4GVV  Q!UK_I._?\
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MXQ7(S: J\$V$A45%_AGYKPDGQ\CR"R9Y;5D."S))\H9$\DB0KSY[8?XBN_R
M.JM:[9GR#M8.:GRTHD/J>L\:,H'DR+Z?!5;8UH #\DZ -OQ7-L6HHHK*V]!Q
M=B8Z\;TS',)@P[-ALR0D07Y[+4D5X5>7! "%?%0/R^4BVH[5@E1B3,R:X+/?
MD,3'7^*-.:'?W#*P()&O?43(=LEV#P47RC(J+\M>EFGA;BNCLJX'O^GBVA^X
M]^S=;EUE%C.N5^TML[+)L%92+D6=1:;'3=1%42&&W >M3:4E%%88>)$$U47.
M4YZCU\7?BD+O2Q&/Y$$_+8]IK(WH'^9N.(>WAV0C\KUMK]NYC(JM:7M?$894
M.UGK0-),(P-^!-,\2OHG>ROZ0-:)ZI^%ZR[@MG(]EF$X=K%*243JQSM,QBVD
M@415\!D1[&:XZZ2CXJ(266B7C@?!%ZN-7NOL# QM5[DK9NW<9"%EJ594B4MX
M#*8H"J\-:+!R0QWL>-:KL&'Q[/2FRV4D> !6@1:5+SK9"))Q#Z)T&C4@G[\M
M[/.-=O6VH\/G,K[6.(74IP&HLBEP/W4ADT42]2/=0[^)"B.?!"O+BF0HJ("(
M?/5%M]S8B6V9,95OWJ4;M(8I\B\3&($D))7D@DFD\  E0ODDE_!/2F?N; XV
M)X8*67NJR .F0:"2N68JI"SK&51=D%B'/'_$%!\6#,=#YGCEO#F3^Y*IB9-/
M$)#MK)2#226W([:-QU9.;:38CK;;'I"I&J$BIQXJ7W=2X>],;F:#)#V.]2O$
M2C&))YS,.1# )P20*VB64QD$DE2- E3=RF.]1:E/"1W:TI1YJ%>9IZD3N-[:
M6)>*DC9!$@8'QQ\>:O\ ]G^TR>XEWN7=RE3EKS+$,9CZSX$EEF+&)?2&,W6S
MU85U5^'C<!4/E/ 05>%ZU\*?C;@?AO922;X7FX)CQKVZT1K9*I(H.WB^=62,
M&1OUE6C( .N1ZG4NZEPLDD<'9U>+TR'86&LS&3U/I(205Y&=B-$> 4(&R0".
ML4WHWMMS?,AJ[')<EV#?.'S&JJ)MC&Z@W$;X)BPM;,I9NHZ(^?*.L-^*IPYS
MX]3OC#\?.Z^^88SCL!1[3PE/BTMBY8DRN5M<".+M'4CK+"D9("Q1EW)7ZG==
M@N9>\^Z)(TEKPK0KRGTX8BL<<BNQ_49)G=3]6R%: )Y'C8!%LG:?TW@%L..0
M<,TUB-R\B*PQ(D6.S,CDH"KXK-!B#+@-/BB?8T0O"R?*M@B*BEP2'+Y3+P?-
MR6LU?@\Z?T$PT*[/U&'UIDL%?NS$IS&OJ.]!<<WW*\OJV\IGITB/\Y()JK8]
M68 F.5XD6,J=_IC;8 VZ ^>K=_L;P9NJL9$?709->S8"S2=QS"LAQBV=12%/
M09LYATU8TRO'EX1JTX_*H8\ERG2V++9".VK-DQ2IK)Z#+9RM.S&VAR^J&$S2
ML_VW)85O&B- =/[/?5Y*(QU7(V<=-(G-7C22:LJ:*>H1&DLOI['Z_3X[.N0/
ML3=?8\Q25:0,!TCCV*2$>;E6-EFEHMK,:FLHA-2DK(<:RD-/MGPXVKBQ4,A(
M@_/*+LFP>R9\CW%;LQ.I2&MBH(Z221OX9&M22Q"8,/#%';0T-#75%O9JYD(3
M#?RTN19"WJ2V!9OQ#18D+7]%(H /90]>0C]+\AT5,=RR]PTG9^9[2J;X+FU=
MAP:&!"<9>CS$:]9RN@Q8L@K(FVFP+A3C- @H@H:%RG2V?MN+-1,F-[9L5S70
M-\ZSI)R12#ZD\CQF+GI@WEI78^Y/OU%?)S)'!=H6+/RR@PVX2M@132* 'E!:
M5'@]P.,4=>(C81%.M*9LO8.H7]@16[$LUFRYUHT,R),Q6_>QUULW5$FB>?FN
M/&^GP,<')++9*GP;0BG'7<1VWW7>P92#&82G7H5)(XIH;]2K;>0@,O**0;:4
M\='C&V@=<""#U(QF'RHI3Y:CD(@ [2L70AT5N6M%GE+C9(8/*68#RVR>B#%Q
MK4+3MK*K:W<4)941B4]!JJUZ#5.-$HN@VP8K*@M1S\D$/>S'1$/$1533YH4M
MKN+^3!.>VW$<KQ+)8G,TZLNU8LC+"[R#7UB*-"3OP!H#8)["-(YRADG1 970
M012'DHY"1E+NB>?H\;'L>1V.J[_M5VY:0K2-B>C)^-XEBK+D9C*MFW2U]9$K
MU!$7VM@S-H(34,E1#/T#GR/4)0%"X0>G6,[3J9&S%$,U_$<SD)!RQ>!Q[323
MSC6GF417Y!*JD<#(T490#9!X[VU\'C3\O:-V6\A8O%)5:S8>,O([-%%)NO7Y
MM(6+Q"%BS[*_?I3:=R@QVUL+#+]G8CC--.GA9VSF(0IV56;)N/>LH0+W]VK4
M>77%$6!*Q<<9)4$D0A4>NES?#+XC_*-=K=C=R68H ($GM0+2J\F80H9(Y+48
M92S %U@X$$L"H!(Z18-W.T5QN+[9RDTZ((47(Q"&"0( "SP(T,PXKMMK( ?N
M=;'73VSN_1'ZH%G(K-J[ J8S#<6)/S*=;65;[;[.) 5-=,HW80HYR(@;9!P*
M$K(?CK7+\)OB!@L=%9S6.Q.,,X-B9,>U59826TJ2NYLQR\AHEE)))\L/.K!C
MOAM\0L9A6R-6WC<#45Q&E.N4%K6M;>61'9.1)^@,P!]F(WUTL/[F8K#+E-J#
M4,ER1<.,HV[&Q=X0CRF!4(;S*V3EP^A@1H7+!L@1(BO":\\5.YV\VUDR.2;C
M7Y;C^=50\;Z#JZ5A"A70U_,Y:'L1XZJN2[161)I^Z<Y1_06DDFEBDGTH)8I*
M0A!)WRX %SX/+>@T%''[W .'>7+F&UD"6RS+)K*;B@AB$<B\QCRXCS[$MKP\
M14F8R-N J_*(J<)[VWVUVWWE?LX;"(LMBG"\LWH"RI!0A#\O,62&>0LY"@2.
M6U]SK?.\M%V)1A:4)F9Y924B9#&TCHK_ $R1P3&60IS4$>I7 UIM*"";=FM9
MWPYLC%CB6>Z[JPJXR^I08#<1O=6*@*J(I+<>"7Y$O BY'G-,"OCZ@JGRM(2'
ML#MJ_/C\WA,C(R67CLG+5K?IAT?3@R,C1#6F*<DVP)\D'Q>NR<MVG7NU[>5Q
M]K,Q@QKPMV*L0KIH !:F.:*64 @%^0G.]@\!XZ ZZ0[]LV<L:,LER;#:B8VE
MED-[E^6UKU(/JDI38[0SIMJ\Z0 )J QHYH/V)Y@/SUT6++_"*Y\G)AZ$-G*P
M1JE6CC:;^M&5#%7G]&-(VCY'3,678T%;W![SW9WS\%W[8%7#]B@Y5]B:U2CE
MH<&* %I)L@L7J!W!#1PF64CRB;(WE<?KMNT#,.%J_+,ERN)@\T'<@E; N\/E
MX!D]W"^X&:JI>K:BWCU!."^T^Y(FH?BC9,/\)RJ/*R8YWGASE6OCVN.*\:X:
M"XF6K1S(0!(\4DZI-K1$C+$4+:*L=]._@_\ [)>?^*./N]R7\)C<-AI*[7*6
MBTEV9E9^$DL$\_HL?3XJR2*%=O4!5E;B!A<[;[ALIR;)O=;0H-?6<1N$%U3:
M[+$X\7V:NFC#8#)<F2YJH!$@MQY$MP!_ #QRMLP.!^'U6E$MO%9'+3509:HS
MANHOJLJ<F,I8HSDM]3\T!\_2NF(Y;W_\-L5\+K.1HV\<F4N22/%&MR**#DGJ
M*#PBQ[QPK$%4>#&-J"7)8'HCS7M[I35E?BK^^=MUUS$\ID7*)L?#-= VZB(<
M.1(2%3S["(XB^IY-V;,8D\4Y7R1%JF0/:DE^6R*G:V$M0,.(QZ?/912%/\Q?
M5EL,C@>R^D7 WL> .N48B?&Q*DF1^0P=%)"8TJ#)66$OJD!8]M8IH5?RS$;1
MM[((V KE?;?W,4JM9K&K-5ZX50>B"UCME32[=EJ8GH.BC;,FYGV3C@.(VV#(
MN/@2>2<\JJV+MSN_L)EDQUNAE<Y8V[^I8@N05=!5*+RGK101%"KN721-DZ U
MK5J/=N%K%E.0REW>@KVI<9)$?!&S'6/KQH%WIY$51Y)8'9ZK\CM)[E9>-S<A
ML\MV&Q31*PK"054_61$G0$Y)42MG6T"U=YX_W#T,#_JK*(OS%'>G:R9+Y6"G
MBC/)8]*&O.+-CA*/(C,T:- IUK9,J^^N1/@;J_<^ B5I5HT;B_29+-B.0I'S
MD$:R<BI+Q!B%YPB38^K]/GI9&M5Y+#MVJ>W9RN0HNH5?"RO:-#CL>6!DAODY
M!C2+!\?,C15!DXSS8J@JBN*2]7ZCD*F3D2()4A0(P88S W+TPV3^EV].!1Y\
M/(LD+$#F=>3<,;=QU]%;=&0R%='%U8B8CYTH>S&6V0/NJ^Q\:T.F2US1T-9:
M2,?2-V_85:/@"29F1S)^;V?B*H@(%K<3K&'%)"'GQ:AMGYBI*(BJ\47O6K>C
M?@ECNFS4 '\C<&-4(I(\)46+FNO 1G 'W)&AUT7'=TX_MZ%F:+NVX?'\BK#1
M$?\ 0!8PVBOC_/W!'6<VW@EQ/C0DM.ZO5N.06R;2!'J+!P8? H2HGZ=7-,MQ
M!'Y'U!95T?R+H?A97:$O;ZPM&O9V?ELJ@]665WE64KKP7YR.W,__  @: XZU
MKFW=W?N/R%A#6^&^6L3<B5LNBBQQ)^IY RJG+W.DWL>0".E:NM&8#%"197'=
MKK>[F.*3WMHM#F%E-<,^33TW!; 72<7A"=4E!%5%(B3E5>S9BSZXAJ]FY7'P
MKX#2S5(HR/'U>SL%UL@$!M>-[ZRQG=62,:+#VCGB2%4-SJ)%#H:(?UV@/@
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M^<B$0I*ABYQ.;).$5LT)LN%3P7^[VE</V)4"SVC]6EC21643.005B41CGQ+
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M$KF6HW ES%*W _02K+KR"-[LW0AR6/LI0K/C+&U>-JJ%)QO1/#CKGR')1RV
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M,2X1$,:03\&\2,TC)K^6P\EG,VENG7F=U,*RP+MPMY5I/CM*KEI13Y;<N<X
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MB<#/7A>6UELE:@C"039&W8E$*@#PBM.T:JI5=*$X$ ;&AKKV/!M&I8DC0V2
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MEE>M5]&:3@A10TG-O!7P= <@-$ZV.K+_  JFR1JD)WP"E')*ZV6X\2= ;)(
M'OKWUOK%U^92G9L<[%DO;QS'D? A(FQ5%\1=\E5M>.?D51>>.57JK=I0X"AE
M$GR8CLPG?*O(%*.Y/ZG#$!@#O6_;?CV/6BSVZ\L7JMSC@37)4D9$90-Z8#7(
M:\#_ #]NKD4J]GV@VS]7FLO%'FQ]"#1R)CQDJJB\B3RO,^F8?'CX$G/\J?CI
MUWIW?0LS-1[=LQ8N*->+0.T?RA.BIU&CE=Z(W[Z\'7@](1#C@QC@GJUI8R1R
MD9-<AXWPY(QT=;TVO&M^YZO46D:B,M6L?7>UZ!E41P)QS7 :<:1$4R1)M?P/
MDG*DHN*US\IPG"IQ^S:EL,RSY/$67)/AH^15CL;#1,H\?8@ _@?;HCFV3!+E
M,?>\:U$H##>P-\7;QH^/._R?OU^3=B4OHK6P,2LCLA^',D??K!N$9_E2.$AB
M(HQW17D?=,^$@O-1)Q43CKRG2O5IX[,>42L W)(H#810WWD73JQ&M[4[&AHC
MWZSDQI,$EDS'<6V1"TGI<P/IY1C7(?\ 2"W@:8:Z.%5K++,_UEBFO];:ZR"1
MG^=9387,NTM)DBR9'$8,5N- _4;AP72BQI%NU-<+U5\/0:\?D?A+)'WEBX)[
M5WN[N)YL7BJ4]9$CA82SS3HKH1ZCJFT+:/D'?#SYV:9%GI,7DFR&1S4+P1N%
M%"HL9LO9"K_)%$MR8!6+$CDP0&0^-'IE=5]C6K,'DS'=D[ M]GY/5M [D.!Z
M=K8^1UF,R'"/TVK&]FPVZ^'(;5$]=N4\TZ!@0H _'7&\QWWE,J5&%PL.%J2R
ME:EWN6P].2ZF@=Q5HI&L3#C]2_3&'!!T1Y*[N/X@Y2ZWJ4HH<?CY8^<=^N9I
MI610%VQ9U@02-L#TELH"I3GR! :RITPWDM;9A'U[8XEKQBO,8.:;.S:;"KZL
M4126?"JJQ(=5)])57AZ>DV.B_:A*@^'53NYRM4L116<E!>S D_F8GMZ@DUFQ
MX!$4KR-)-&-:8@-"_$;&@>1J5#N/,U8HKM+(&R+)TUB]6W31N9 1;+CDTC,!
M&/E4D =N/#EK06O+K%1BL8CB>85.3/53KD5+; ,%C3)LH&U0)!'?G&%J0(-B
MI-E'CH*^7*N+Y(75CQ]-D=[EBG;J_,*CF&_??A"WNJ?+QET0DG3[=M:T/;J7
MD\YW1DS%-DJ%6G' C 1V[Q@2TA\K*89W68*2-HI2%@/JXCV-3SO/L@QBKBX]
MH'2&1Y#DLV.)7^<Y_B%KDUY)FJI(]7TL:&Z-1 AF8M/,DZTDMIQ"%6R;7E9-
M.D9K<EGN#.10TXW85L?C[,=2FD/@I/99T-F6<;=9 DB5^( "<O/7F-Q.'RD8
MGSV5J5ZA9"(*60AA=9 #ZD8F!T8^+#2B&6PQ\_, #T^DJS&#WFYE-DL7&MLZ
M"6;)N/1F,8FQ6&H[8KR?L&/ 6&V@^?-&/)!3[N>%YN%:;M"NJLF6IO%ST";2
MMR<GP/4U]1)V OJ$G?X\==0H4OASB88GJW:D;$@ O-$\K[ UN4KS?>MG>@"
M2/N ]5]M^^+]UZ5;T\BMA@JN2'[:S6NCQP140R>"6H/"B)RI<-+PG\OE\\/#
MW)A:I0U3RD0@Q^E"K.64[4KKP='1'[CV]NG%ON7M:M&L44XD=P%58H1(&\>
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M&":?D&-#(S3NWS*RJC5Z!&L\=KJ['JB0;R>HL2).O EP&FW.'2]A!8!!%4:
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M7U@K(S$?I"'8\^/NY.3S"0*^.I9',H'$1C@K%9B=$?I,LZMO8)99.1(&E;V
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MG% /K4:4 $>07+$'7@+.V:\.$P&SF;EOU'D85J(>V(_3/"0<$$C RS+).>7
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M<LBI%8L=S1:>.^Z#$=ZQ*\N8;_JDJ)P\-8'MR7^ZA*XJ\<H*_(]<G7O7"O8
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MMO>AY^P^Z(]HO_RD=.__ %NA_")_^KR/QS_]R?GKXZ^(7_YD]R?_ .,E]_\
MXD]]>.OI/_9K_P#T[?#'_P#V6#__ )K/3H9%>4&U<&[S:NVU]@M6.J;0[3"[
M.GQZ+!OX<YS([IB;+G78J4VRD6+D%9,MQ]U$=*;*94%CJPVSS6G5M]OY;X9S
MU\SEK![@KI7R<%FX\M.2(4J[11153J.*.!90D:JIX^DC;#<V;ZGSN5PWQ'[1
M_P!JC&9/LOM#'I\-\E/?[5R&+PL%3-076S66CM7+F5!:S;L7Y:1GM2.ZB0VI
MXV5HO32,R7]OC&?8KI[MCS98=?%V-H'![_ <B>!/5I=C5D9]B V3BJO\.RC-
M!&$$1''41^ VJN60>-=J5[^(R/<G?6+$LTF&[NRM/,4D)XV\-.Z/*VOS [ER
M26"GA,VA =]+S.2[>[S[>^&?P![M-:E7[Y^#/:.:[-SDB#U,3WQCZ\L=-"S$
M_1=@B6%54*\@6:DK,]]>*1?4$B.0]_##=45<BX'A<5PAY\"<8KG&C4%5$514
M@7QY1%XXY1%ZZ=\('67L]9%_3)E<HZ[UOBTX8<M??1\C['Q[:Z^4/]M*%ZWQ
MG->0@O!V?VM"Y794M%3DC8J3Y(+*=$^=>_GK<3HB.QL7LZ[:.V:RL(\*'W"=
MMW<G34Y2O_B[>=XGEV.W&*SR%!)PRJV9%U8D#8D2MQ7"\"44XY#W S8OOGNW
MNV.-G?MCNKM.>P8QM_X;>HV:UV,'QXE/H1C9UR8;\$]?FQF>=/N+,9R*(R28
M?-8N1E!T6@FA?U5+$Z D>&*+9UQ#D<EVP:O]\>10I':GN+6U$X!XQH?>N@M.
MX\#(@#81\<P7#+&Q\D;7P]=NUN)T5\D04$X@-J**T:]2_A[6D'>?;^5L BYW
M'V]W+GK1(/(M;R=Q(O)'(K\O#&Z>2.+E@?JUUEVK Z=P4;L@;U<KBLID9223
MLR39&('R=^5AY#6^08$[V.K[W W&@J?OLP:7E/:UN#8^T(L_5;M1L_$[;('L
M9@34.(M!+7'(AQZN6>,NJU)G@])%MWVY%(;<$2 UO;%;N6Q\.LDE/O#"8G#N
MF:6QB+U:LMJ6/^:+*_./RE1;8VD9"$KRTGV/4?%_Q1NU;D<&>Q=.D5NF3'V#
M"MN1%0-*BLT;2 V%!6, [;D-%>6Q1L<Q.BQ/:7U::O=.47>4XK/PK"[[-+S"
M(E7"RD<9R3'\MO/TZG@3G'JJ-=4=//CU$4)AG&<6$S(?7AY42?9NV+N)^"LN
M IUZ5M+N1K4*^1DFEIBS4FIUC)/+$JSO!8EC:=BBAE]0JH^D=2K$\LV-[ ..
M@BALQ79H:R6&<UWMQ6ZJ"61QQ<PSS@R2<?*!Y$0[4'K6UO;NA[?8W;'"[5.V
MC%]G#B<W/QV!E.6[:ET3EU)FLM(C4*J@T$F1!8;==9@^HZVS7--,P3%(LJ38
M29J=6[?[2[E;NZ3O'NRYB6NQXPXNE2PB6!62)F+-)-)919'8<I.*DR;:0'FJ
MQHG5XQ.!S!SK9_.6*1L+6->&O0#^F"RF,L[2*"0$+D;:1V9Q]:H@0^I?]C=_
M_!IWX?\ UYT-_P#T#9W74>KOUO&[I/IT;"VUW4)W2:MO<+QK.ZZ%C;6.Y#<9
M'E=1=4TR@IUJ0E10J<:NH0D+9O(T2*1*#Q*8H2KQRWN+M;O/)=P29+%9^C0Q
MZK7^4AD@DDMP.D2K.RR>F50/*&<!2=JQ!\]<O[H[2[HR>;_BF#S28Y!%"J*U
MRS%PDBCX$_+QTIHW#';'E*02=E1K77T?:M]2ER"^,;NZJZNV)M?:RG,ERB^@
MQWN41#<@R\$KP?;\>4\#Y1%^Y$543F5C,=\2Z%N-K&?P>4HJZ^K7MTC%*R [
MTMB*J\JDZ .I"I!T1^%([4^*7E!WG @)0^J9I9FT&^L"-\8JCDOL1(2#KP0"
M2%<F[)/K(6MC5R:;ZCV,TK$4"6<PS06/HR7/,E ?;GB3HN-^GXBI$ZT2$BJ@
M$A?%NS=CN?+J$BH]NXE(B5C;%6<A7FG5E7;SRM48AE8$!4&A[@_8V.GV[WC
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M#C$+.?;]:KY\@@$':W;O>2V$GJWNWJ4<1&JL->R89A]UDU#&8_J);DHD)]M
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M-'JYT?[-']67&:.LQJA[WNV^LI*:O8JZR!'?V-Z<*!%:1F/'9</49O(+38H
M&3I.)PB^7/SU<:G?O=U&K!2JYJ>&M6A6""-8JI]*)%XJJN\#..*^ >6QH>?
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>47
<FILENAME>g60414g70n10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g60414g70n10.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[5LJ4&AO=&]S:&]P(#,N,  X0DE-! 0
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M4 <@
M                                            $    "     0
M$                         U X  $)*1$T*#        ) *  #9    V0
M               0   %94   D;0  + $  ( "  !@3P  !&H  "P!  "  @
M  8$\   1J  !65   )&T  "P!  "  @  =@(  /0!  !@3P  !&H  "P!
M"  @  =@(  /0!   L 0  @ (  '8"  #T 0  8$\   1J  !8 E@"&
M
M
M
M
M
M
M
M                                      $"<
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                       @    ,    #          (  0
M                   @ #
M
M
M
M
M
M
M
M
M
M
M
M        $  0    ,    #     @                         $     0
M    ,    4 0   P         !                               #
M   @    $          0              9     $   !65   )&T   $
M !    5E0  "1M   !     @         !     0    $
M                          DP              0 H   $    !     0
M                         !     0   /__                   *
M                        $                          0
M                            $         __\
M(                    !          $
M   %94   D;0        $   !_    ?P   '\   !_          $
M       .<#  #_
M !
M                                $               H
M              YP,
M  !0    $          @         "     0
M      Z ,        !          $               (
M     !          0               $    !
M                    $    !     0                         !
M                        0   !D
M            $         !                         !# &$ ;@!O &
MX ( !4 %, -0 Q #  ,  @ ', 90!R &D 90!S
M               00*#-P U X#WX$# 0 ! .H*;PAD  $ % ']_P(  0
M$  0!, &4 = !T &4 <@
M
M$    "     0    $                         8S,&H0$  0
M                                   #A"24T$.@     !"P   !
M !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96
MYU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;
M +<')I;G1E<DYA;65415A4    % !# &$ ;@!O &X ( !4 %, -0 Q #  ,
M @ ', 90!R &D 90!S       /<')I;G10<F]O9E-E='5P3V)J8P    P 4
M!R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<     $     0F
MQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X0DE-!#L
M   BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P   !<     0W
M!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;       0W)N0V)O;V
MP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F)O;VP      $
M5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,    !        4D
M="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&]U8D!OX
M       $)L("!D;W5B0&_@            0G)D5%5N=$8C4FQT
M      0FQD(%5N=$8C4FQT                4G-L=%5N=$8C4'AL0'+
M         *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M     %!G4',
M  4&=00P    !,969T56YT1B-2;'1 5H            !4;W @56YT1B-2;'
M1 :*            !38VP@56YT1B-0<F- 60           !!C<F]P5VAE;E
M!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG   # @    QC<F
M]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N9P   D$
M +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! !+     $  0$L
M   0 !.$))300F       .   _H   0"\<<C^    X0DE-! T       0
M >.$))3009       $    'CA"24T#\P      "0           0 X0DE-)Q
M        H  0         !.$))30/U      !( "]F9@ ! &QF9@ &
M ! "]F9@ ! *&9F@ &       ! #(    ! %H    &       ! #4    ! "
MT    &       !.$))30/X      !P  #___________________________
M__ ^@     _____________________________P/H     /____________
M________________\#Z     #_____________________________ ^@  #
MA"24T$"       $     $   )    "0      X0DE-!!X       0     .$
M))300:      ,U    !@             & @  !E<          0
M                 !              97   & @
M !                         !     !        ;G5L;     (    &8F
M]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N9P
M  3&5F=&QO;F<          $)T;VUL;VYG   & @    !29VAT;&]N9P  !E
M<    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6-E    $@
M=S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<         !F]R:6=I;F
M5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T960     5'EP96
M5N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T]B:F,    !
M      4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG
M    !"=&]M;&]N9P  !@(     4F=H=&QO;F<   97     W5R;%1%6%0
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MEC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&]N9P
M *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&QO;F<
M  "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,     C_P
M  .$))3001       ! 0 X0DE-!!0       0    &.$))300,     $!\
M   0   *    "8   !X  !'0   $!@ !@  ?_8_^(,6$E#0U]04D]&24Q%
M$!   ,2$QI;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0  86-S<$U31E
M0     245#('-21T(               $  /;6  $     TRU(4" @
M                                                         18W
M!R=    5     S9&5S8P   80   !L=W1P=    ?     48FMP=    @0
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M(@245#-C$Y-C8M,BXQ               2<U)'0B!)14,V,3DV-BTR+C$
M
M   %A96B        #S40 !     1;,6%E:(                     !865
MH@        ;Z(  #CU   #D%A96B        !BF0  MX4  !C:6%E:(
M   "2@   /A   ML]D97-C         !9)14,@:'1T<#HO+W=W=RYI96,N8V
M@              !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M                                              9&5S8P
M N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D
M="               N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7
M(@<W!A8V4@+2!S4D="                             &1E<V,
M  +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C
M$              "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@24
M5#-C$Y-C8M,BXQ                                  !V:65W
M 3I/X %%\N !#/%  #[<P !!,+  -<G@    %865H@      !,"58 4    %
M<?YVUE87,          0                        */     G-I9R
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M$+:0N "Y@+L O("^$+^0P2#"H,0PQ<#'4,C@RG#, ,V0SS#0T-)@U #5H-=
MV.#:D-PPW>#?@.$PXN#DD.9 Y_#IL.M@[2#NX/"0\E#T$/7@]Z#Y8/LP_/#^
MP0"1 F$$,081!^$)L0N1#7$/41$Q$Q$4\1;1&,$:H1R1'H$@<2)A)%$F02A!
M*C$L,2XQ,#$R,30Q-C$X,3I!/%$^44!A0G%$D4:A2+%*T4SA3P%1(5-!56%7
M@5FQ6]%> 6 Q8F%DD6;!:/%K(6UA;Z%QT701=E%XD7KA?2%_<8&QA &&48BA
MBO&-48^AD@&449:QF1&;<9W1H$&BH:41IW&IX:Q1KL&Q0;.QMC&XH;LAO:'
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M$5#PP,#Q48$Q,5$Q,8$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,#
MP,# P, 0T+"PT.#1 .#A 4#@X.%!0.#@X.%!$,# P,#!$1# P,# P,$0P,#
MP,# P,# P,# P,# P,# P,# P,# P,# S_P  1" "8 * # 2(  A$! Q$!_]
MT !  *_\0!/P   04! 0$! 0$          P ! @0%!@<("0H+ 0 !!0$! 0
M$! 0         !  (#! 4&!P@)"@L0  $$ 0,"! (%!P8(!0,,,P$  A$#!"
M$2,05!46$3(G&!,@84D:&Q0B,D%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D
M235&1%PJ-T-A?25>)E\K.$P]-UX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK
M;&UN;V-T=79W>'EZ>WQ]?G]Q$  @(! @0$ P0%!@<'!@4U 0 "$0,A,1($05
M%A<2(3!3*!D12AL4(CP5+1\#,D8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU
M2C%V1%539T9>+RLX3#TW7C\T:4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B
M<W1U=G=X>7I[?'_]H # ,!  (1 Q$ /P#U5))))2DDD+*RJ,2AV1D.V5,C<Z
M">3L;[6R[W.<DI*DJG[5Z?+&FX-?9M K<"UXW O9ZM3AZM.YK?\,QB)3G860
M6MHR*K2]I>P,>UQ<T'8Y[=I]S&O]B2DZ2222D=^3CXU?JY%K*:P0-]C@ULGC
MW/A8QZ5UHW.?7EBMC76NJ+7N<7A]EV53ZK7L+&-IL?CT[&>IZM#/IU_P RGZ
MGU/IN554ZO)-3J+?5KM=CV6UD-;8Q]OT6-?B['O_6VV?9_^%5*KI/2!>W&9G
MO)#C31M!#FV4N#-]MX_1?:J=K\3$MVU?H?U6FNWT45-L]*^L V[.H$DD%^YV
M@=#?TC6BGWL9=Z[_LOZ/[17Z5/KT^F@-Z/UIP&3]O8US7&RMYL=:P.+17ZC]
MU===C?I.JJV^GC[_9_I$/%Q>EMH>QF:\.R'U4UN%+V4NW&WT:*JWSZO3\E^]
M]WHW>E>_U?UC]*@8^!T88UV4<ZZW'IKK+FBFT;&FIU--S: -WH-9O?BV5U?H
M6;_P!*DIV.F=/ZQ1F,OSLD75,H=7&\GW.=4YNYGI5,L]/TK/UMWZ6SU?YK]_
M7:YKFAS2'-<)!&H(*YG(Z+@EX=?U3:]] /I96A+#9['7XUEE/ZO[J\>RI];/
MTM5/\ A5L]-R^GFJO#Q\AMCZ&BH-/M>?3#6.=Z;MKG?UF>Q)27J1:.GY&ZUN
M/NK<T7/=L:TN&QKG6?F>YRQ'8/7V[AB93\JF\,L];U&-W:8M 8RUE?Z)KJOM
MEUEE./]"O%]/\ 6/55WJG4,"^A^.+GLL9<S8]N/;<TVT6?:"QC:V?K/IOQ7M
MR/0L_0_P"$]-98Z;T@O#3U'U ]VV&,,>K:QEK"YU<UMQ:;,S'R<)G\SBY&5_
M/>IDL2"FV.E?61Q/JY[=>7M,..GTF#TOU?BNOTV^IZNS[1^CLN]-2/3>M[7V
M,ZG]#>VLEP+0 6AOK?HO<^O];]3_K/^A5:O$Z92<HOS[F'6@WLK>P-+[&X]C
MF7N;95=D69&S]HY%7^'_26?9T"GIG2@_)/VUY&.UYNHJHL:QNVVT/^S8_O]3
M&HRFOV,K^T>G>SU/6_2)*;]_3?K+:Q]E><VFVUSCZ;7$L8R6/IKJ>:/I5_I=
M]OI?IV>G7_ ,7NL<US0YK@X'\X:@_<N:=TKIUGH9!ZFZMME=KZ:\DEA-4>T>
MC<^BS[/35^CR?49^GQ_P#1_P XM7I.1TW'QZ>FTY+'OI'IM'T-Q$N/HL/TF?
M\ %^I[$E/_T/54+)R*<:A^1>X,JK$O<X@ #S<XM:J74^M,Z=<&65%]3:_5NL
M!$M:7MH;LK^E:[>_Z/_5V?HT#.RJ>H?5_,=?2]K0UU=U+7MW2(]K+F.]/W-+
M?SDV9,82E5\()^Q,>&QQFHWZB/W?TG+ZC_ (S?JU@9 QG>O?80"?08UX!/T6
M%WJ-]SI:_^VJF=_C0^JUGJ8+Z\Z7'8'55@$GZ3=CC:/\RSV/\ \,STUP63BU
MV_6O+K8&UUUO:*W6G1@].MK=[OY#%.C"QK<VZQ]C&75MK;67"9+W.K<[^JQG
MO<K.#![N.,[KB(_P 5;/)")-&P-1WX2>&+T]WUN^H>/<ZNRCJ%C@UM0&W2 &
MZ5_I6;6N_<^A_H_31_^?OU'P.J.R649AR&#9N%0<TEWT7-WV;MVU_I+D<CI-
MUG7\?":*[+6[G;VN]A+0STSZCOS&[TU_3:QUQU+S6;,:I[WOF&N-8]KM?I/U
M<VK^6G>P"2(SZCA_V1_2_YR!DA6XVXO\%[Z_\ QL_5BBPUV59D@ DBD1!&[_
M2K5Z%]=>D==S_L&$R]MWV?[5-K UNP.94YDA[_ -*UUK/:O)\_IA;U:BK*K:
M'&ESW"000-IJ=W;^<Y=7_B\KV_6EQ//[/N$^7K8B$^7 C.8-QB1P>,9<.O_.
M2)1.Q!O4.[U/J7U)Z<UE&?U*VMFK*Z@ZU[12X0_%8*&6;<7;_;_P %ZWZ*MB
MA=]<O\7HRZLF[J!]6I[KZP:L@C=:UONV^A^[7[&?F+@/K3@XC.KX.+CN?92^
MIY<7M]-Q/J6.<S;#?;[=JJY>"Q^=0;!MC<7M'!V>YH_LN>HN6A+-A&4:7PZ'
M^NOG[8D1"7%&_23H91_>X7T-_UE_Q<L<,6[J5EGI>VBM[<APJD-]+[+%6VMU
M/^ M;^F9_I%-OUM_Q<8E.3@,S_ $Z[VBN^IM>1#BUOH^H-E/\ /6U[-]S/Y[
M]&O/'=,
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M-7VYM%EN/6&,DCMMVWP]J$H8%8P=Q%I(97?";,TX=7Z>C)ZBQ5;OMV@$$$,
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M>DJW/<WA$DQ[7>2['+JAJ:GS::8\0"QIG>?\#9R25]\16DBF1C['$F&ZPH9
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M:"*I521S)"K,UJ C;6"D*02;%^2*/VZPN1+<+/&BQSL%6F)=2REE+#;7S >
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M!HI"""9I&10PL?(][6-543@$F@+)X 'DGZ='D@"R0!YLGBOK?3&JMQZLN=5
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M7.,-&B6&LJC)F-D69\;8(Y9&%*I=@JBR> "0/\20!^YZ-9E12S&E4631-#]
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MA?+9N64 7+1FH=CG(A+E54#8P;@LA!LJ2*Y%K[WUJLHN?<BXTZQAG<D.A06
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M228$!A0YY5[;8!KBWHZ2['NK2&#&1\@N*Z/%DEG6TE3.S;CY(:5)#<; (V\
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M9\FA5]4#YI?_ (^OM-__ %5.3O\ ^;[8>E$/_P!KY7_WL7_Z9Z(G_P"OB?\
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M(4D!,-DDB8.@@5:XC9-P<$,!\Y).\$6#8NZH]%1QRJ8W.0SWS*KA=C K8V
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MJ^DO<IUKG]6?1OS&LK%;6"90#,(8P)C62Q2RR$33GI. @CDC65%)*V65EOR
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M% \;DVV29BN8BZAHNBJU?MBK_B']/1.KE3]NUKE[OTN1$VT&J=""@>P37/\
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MMB6*["\+T>Y9'I,U6L[$5\6Z'M?^_P#?CKB"?Q8_M6&I(Z /DZJ1N5KN[45
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MBC7SGOJ<QMK!K'L$?! P2N+((*E@'B@?)*U/3UH_;NLZ_,(-(P)\R3;N?TP
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MACQ; 9I?24,PCCY:EMN J@USXKKBU068*#^8U?@<G_?'[=&2U%J?!-7:K:(
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MO]WZ?I[Q!L?']3)GB>,LKI XDD5K/  8?F;Z?7INQ?169YI^8X(S(ZC@T@W
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MPRP'>]Q[XUF)2)&010U/\3.UFP]*R=61EQL$Y&(TL<,*/(7GD6,$,-I6/U'
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M@J&0"3W,>Y=Z@_F3<-RB@038A/<W9>;/VKBZ)HNQ)],.!^%,VU5,>"T9],L
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MMBHK6M1BLGP9T>"'4<[72RRSMV[A8\K*Q9%ES,R1RJ\DK(L.%&T@)-^M2JH
M ZY[AQILO2IHHZ!F=23S>Q2HM? )MJY%"B0+KHNN19"1DYR'D"0BS0!L%1D"
MKXDCB8D43&HKE7KV-1'.55<O1$[NWHB7VQC"(JFPS!O!!%>2?/F[ _8#SU5V
M@:)/I!RT2228;9C<I!<F1PWE0@(6@%X_K7/$E?C[ZF&$FM(ELF=469LW9$K'
M0OZ(YJ,155LO1R='I]N1.GZ&IZ-$@#&G4*#X(OW 'WY'O]ON3TB_L[6SEN\9
M;T&8<!?F'((H[O?ZD'^G/5@/9C \'OA<4BD<BMFUKOJ+MZIU1T.F-EJY%1?M
M?J9J]47HO5/W5%7US'_$%"/QN@9:@ '&RL4<_P#;-ZW X/DD'_+P>KET>.=-
M)@$]B0,2P?\ -1H"OM\O/WOGP#Z+OKG/I;UC(RX3/XMC7EC'NW,(@ [.< C'
MHF*M:;)395%8C&R2DV9)\9+Q0I:PUK"U%MH#BUNX+2!S1&^6>L:=VO)EZ_ _
M8.A29&7JVNSQZA(H.3BKJ DA>.+9BI%L@G_YK&8H)L9E5<:2!KEZH.?OS/@>
M6*/+</#+)$6+2L7C2:2E(>=E+&,F,L1\Q()!4>GUE7]U%Z2\F:"=4_J3Z2U%
M+W+TZ-;)C4;^B=/W7JG5557=$54_Y>GW;,30]K]NP$I6/H.E8Z*L84!),*&1
M"6K<TBB3:Q:J  !(!'5]8KF;$QYF*L\V)A2E@?E/J84#CF@; :B37-@V.FAP
MGJ2IR,KFD'51B'5XD!#D?\=TR+,Z1JOZ=B]D;T>J?;^QZ]O[HB]=? ?36BTC
M6\B6#8)<_'C3(6RF2F+C%']-N Z([ ;AX8T2.DNNZM)HVC33(0'GR8RJBRP4
M!OFV\"PP'-DT1SST4VPI:X'!H6PQ!3%2'R$$'P^-Q9#&I'% +"U'>6 *%(I7
MNF1O9-*CV1HC5DZWY$NTLO@> IN@;MB?9FNJ%V >;(!ZH:;7M0U/NI,C(DR@
MJXXC6,@B-"'),P/G<P-5X^4?4]5UV8\6'%K^4AS8X&U!DCGN5B-B2,62147N
M_3^S>U.B_?5%3[7N1JU4!=&UAV8H(]/U!V8>0JXLNX\\<*#P11XOSU=&G9TD
M>I::R_S5DPUA8.2#3@ \CD>0?-W[^W58^'Q=.ZCR8"$F(BW_ # \Y3%8Y)O!
M(,U@LBM>C%Z3I&J-<SJCG=&.7JY(VU[\&8L:+M8XL+#\7BY1?48&^5XI<G'A
ME@9A_>26'YHW%J:<#E3UCNW*CBTK%Q]S('E;<VTD!@5^6R!7O[_7HF6H<'Q[
M8&?T&&7UF^IK[N(@* M(U>YME+!)^-B<URHJK*8QL;FJ]JJCU:CVNZ>K)SLI
ML'#SL_T),E\:-YF@A ,DD<0W.$'()V6PXYH4#QU5'Q [BU+MWMJ'4=(QUR6P
MCBO(LLGI1I#).B2SN=KD^DIW$*">>#5W6GEOK@O",8V7B&2P0C6%%5&0R)"3
M'X)/]E<4)*V1KW-2,J"2*:-%<KT;(B/1'=6^F#N$X6J=H:UD8\IFPLS0=0G1
MR'3<OX:21"=P5E*LH!4@400>1?5B?#SO@=UZ-C9GI!!EHRB-U E66&%TE0E1
MM;9*CU(IV2!0PM74FI_ ?PY"W(::*9@A3;*G&(*(;VCP,EKVM<J*BL1Z-D9U
M[F]'=OTOVU?5;? )4;MS6T:SZ>M+(;Y%R8&* + HUL>_IQ?1_>.M3Z%I+Y6,
MDDKE;,<9 D?8&(1-PH%JI6\?4T#T8#<6#:VP:@QG'L<N),ASIYBG9+>1K+\'
MX,@ [XPQ(U11NQ#72)%(/+.JMB>V>1'IVI;NF9FL9$VL+JFD0:;AXV4(-%DB
MSXLR74<(!@V;D10L?P;R.5VXLE2HJV][P>N>OAUW%WIW)W%J>KZGZV%H4@]'
M$TS)P3CSP9WXB)_ER)$CERTB@2429"J<?(DG'X<@0M=-]O7$./Z_S*Q)(0<6
M*CLII'IT[TD<-+#"UOTJ=7R.8Q.J_I[E5?V]$:OD0X>D:AF3G;'AX&7-(Y!I
M4CQW8D"N>:J@23^O75.FR3Q9+.'^25'8M8O<Z+Y'D ;.2>+H=#NX96 ?\Y6H
M,LK_ )Q5%"3"U6+XVMD)A\J.=T[>YR=.G[IT8O54=T]4/\ 6BDU+N*)GW22X
M.%.%-_DCRYQ* 3Y"R2IP/S DUS72;7,Z;!TO)DB9A)+*H)462K1. /'%D^?;
MR#R.BL2#MBE\$;^]CI4<U_[?I:QKD7IU3^ZN145$Z??7I]>ND\B,<MR-J\>>
M23XOVL@<_P#@]0WMO5Y7CBC<5)+([R*3R-I-7_4_4<^:\]>]B#?(D!:V)252
M.9%CC>DZ1RL(9W,EC?&]&$1M<U'-7JC7,_4Q7M5/)AEUC=C>T7Y(JP1P0;!(
M/MP*%<UU+-,[O"9&5@,$8&3Y>0:/!(O::''/->: KH;'(C%RXMSX:8]\,[[:
MNJPXWN:JM;\.T*<V&9O<]$6%I76!42.'Q>-K8_)$Y74#\0.W9,CXB=FY&'"
M^KYV#CRM(P,1?3L_%R7+CG_]61QROSNH'O?4@U+*63&_'D[%3#G;<O+;L=":
M \W\P"UYO@GD]:>=(8;K#5&I@<P@MA [$[%(YLDMI;6.>T0@VF:\NKJAHI(8
MY81+&8$J,&9I,;HH%E1DJ)&CK-34N])?B!J>EY>A88[*Q=+QWT[.]$F>?6US
MU<3O/.'B3'73]\0$"+,V42%= "P\JN[=;[C^*.L8^+)GZGD96#W?J&.NDPQY
M&)%CZ7C396.'E$(29I_4$4K3Y&083!O:-6#A'')6U@E[E<%>LJJ'97D<"N9_
M37XY1B12RM5&]6JUK_*UJ-=T3JB-^NGJP"R@%B.0EM0+U0L *#9KD<"R:'OU
MV3GY^5HW;<^8RLYP<"?)"<VS8N,TH6OF-MLV^]\<=3GR3XKOUIA-OF5#?ID-
M;6!.), +CCK21!8TCA56S2N8I\LACY(.V.-G@1LG>KUC61:E^'_QN^&WQ#[C
MUCM+M[64D[ET*2:+4])GC:'*AEQV"9"*C$AGQG95R4!WQ2 HP\=0SM;XL]R3
M:AV_@=PZ6=+BUN:./2,_'F.1C9;-O>*.0R)!)&[QI)Z0"3*Y62G 4=;J?;_)
M0W@APK,2-8D+XF\=B4B5Z2+$D^HL0E2-7HB(]6([M[D1$=TZI^_KDON:43=R
M=P3!2@EUS5I0A.XJ),_(<*6_O%;HGWJ^NM6O<VXVUG<?J;Y/]>J!>[Z@OY+0
MOR A"G*#L=&N)&AG5C6E8-+VM65CE:WRQPRJUO1%DAB?_FC:J<;_ ,2D3RY7
M9VV>6)5AUPD1RO&"Q?2EW$*P!(0N@)LA7< 4QZICXM9;XS:%L4$NNHFRMD;3
MA< T2+)!XJR!9XZS=\_)F1\!^180@HP@[8L'D; +!&- DB73X4<D<+6L1_CC
MC9W=$5&1L:B]&-1"OX:<81:]W/E,[2N-)QD::1S)(H:3,(0.UL Q9S0/DDGD
M])OA+J$L^HZM#)87\&DH4"E#(7.XK[DE4%FS0KQQUF8XGUY!>THS8D_IUM,4
M^9%3JQSY6LA9&Y_5&M5_D<K7?MT8[I]KT3TM^!&&TG<>K9YD?\/C84L;!Q8]
M3(GQE"[Q0!41LP'NO'!YZNC4(IVP,]H%9F:,H*!X)&WBOUL<>UGF^C)VV3AW
M(%>#7T4%4,(( V:1',DE(L!QW0$E)(D;7Q1SM2)%A[G1HYCION21[UZLD= #
M\X8[6 'U#&Q]N.3]1P!0%=4;V]VGJNGY^1FY<N1D22YDDBVKJD4)8,D8#$_D
MY^9:!L?*.F#93L=$0Y[51D<4JN^VM3M8U?[N^E;TZ_?3_FB>D 3@J2+-$>;)
M)X\&[NN/-?6KZO'%EDWX\BJQ(*(PY]JX-^POS7'[="GPN.3,N1=>7'!WQU6;
MY:=*[L:YKAP8*6,9ZHQ$5B^3ITE5B,[E<U%;]>N?.WU_MSXS:KDB%2FE9&H/
M(S4ZJF+%'A0-XXD:<DJ39&X"[%]*]1F++D2^!Z4IOCY;1N2 .1Q7M5CQT;K0
ME7@D^1PSYW8UPE</ 5/"/9PSSB$$PP]P\1*"O[DB25['N;*WQJD;XWHB.<YO
M2SCE%(I;6R!R-S"B#P;'/(/DCR#SRU\2-3[G31\W_P!-XV5D:C(=E8\L<4AB
M);U #,K+\R K=6"=R\BNOUN8X>PSZV:)8!60<+WLC*K8(!0I/#$V*-\+!Y'P
MHU\:-55CZ,?T1[6MZKU*EV11,(S\I(V[KNKOP?%<\F^?)\ /'PHQ,Z;3=*?4
M\.;"SWC+94,T@ED#L"6]20!0S'SQ0''[!XY@9+6R9#CE%-*JSA(>?.YZ.2*"
M%9V,C:]R)U17K$]SE3IT:UJN5O5O7G[X]:I!%A=O:50_$9,\NH,64M$,>#TX
M[-59=]P4 _+M)(Y4]= Z:KQ8TD;7M_$DH:JXP0#^Q(-G[W5>;M<=CZ:YT[C]
MBLB0EMJ*J((-C)&LE:UJP%/:Y&HQ',<UKVL5R]6K^EO3JOJZ^V\N+/[=T'-@
MC$4>7I.%+M%5&#C( E&J4,"O"CF_IU6W=L^H'N#8H9L&]UL=VPVA1   ""#R
M? //VZF%1(WI^O[7]3FJJ?2NZ_2]JHJ_;414_NG7]O[^E+'>[1@<$@&QQ1/(
M]N>3]+_3J7091Q,/&RY2R/&ID4#_ +BGR\>W !JK\_;IN9)3SS0(IT#E;- ^
M%'HY%1\78Z#IT1W7M:G5K.J(B(Q&IT5$;Z51XR*;CH5RP(XL_-[\'_7WL]-\
M'>^3.3%,7D82*%KV"FR"*L ^/)//T'0[>-[8J/<NQL6BA1?QQA@D9'?T7Q#F
MN5.C%1/UJURM14<COM?W3U2GPTB@P>\/B'I:( F-JLSHXX A7*,:1[?%#=NN
MZ\#D"^IED222Z9F^BVV28+(*]U=>% '%V1X\?3V!)0X5?%"CD[71R)TZK]N:
MC>B_WZ]>OVO7]2I])U3KUN7(:.V(KYEX]P#Y'%_?SS7W%]1G14SH@$=' BE8
ML2#;6;L_8?XT/IS]G0R1K)$B.\,R]W3HO1%5.CNBHG1?W_;JG3HJ]>O5/0$<
M<D89JW*/-GFOH?8$?IY]^BY-8SL'.EBC9S%++N%+X'@CP;''D$<>/O4CEB&D
M6L[5ZRR.8ZPIDEDDE>^21[K*+M<]\BO<YZ.^E<O551>U5Z+ZK'XNJ&[ U:,C
M:K3:8!L0&A_:&.:"+7FO;QYKCJ809IR,9_6,SEG5RH!+ _R^  !Q8%\> 2?'
M12> 7&/!<MT+KS*\B&LK8JUI![%T:%S0M;T,;&Q8T:Z5YDJ0K'#,&L,GE1[)
M^Y(T>GKG#X\?Q71_PZ:5VIVGI_:<VM:@^EZ--!GY\\N#I,V#+A2963",D02^
MCDQ+L4O([+&Y<. Y1#Q_KVI]\=P_$_O+3=)UO#TG1-%D7!>&/!7+U-YY(<1S
M,-TR2.I.1M3'2(.5VR!]I8J9$K%ZS$ ZJDK A*FGJ8#!9XA$$'KT6%@PK[%1
M?,DD%>Z!Q40TY\4+BR Y3(V$#R0%S<'?"7XY_%KXW?'#$[G[>TWN3,TS'[_C
M[DR]%BER=2Q=#T/5]'@T-,-\GT<?&,>G+C962CJ6CA&</4VRH05WQ2^&&B?#
MOMO0<;4^Y=#U[N#7NTXILK,P<A9LPZW^..7&FH1^I*Z9N5BRP[L=23&\1B(#
M(0N>3*Y@JRSNF0D,G'@LB9(Y&M5L<K&.DC[DZ=6,AE[_ "M3]+6HC41%545O
MNZR^I&0%\@T+\ 'CGR37[_KXZG?:TF2IT?(R0T4YP\1IE(/_ %I8XW>,T:!5
MMRF[YKGGG8]_#D'LL_:^P$^-/T$;AY /:O<KNY$VE?-1_5>BIW=O=V_[O7I_
MQ]<%?$C*3+[UU^6,4HS&B'-V8E6-B#]-RFO?Z]7WDR>K+ZE$;D0T3?.T7]/]
M_?H['J#])^JP\E>'>@N6\&#0;RQ:[R%VMK6WN\*-Q_/<\U_:4=E?5T=3;$CV
MN Y'C=C*IE=$T22,@F6)L+I6L8WS2]YD<LD6[8U;@ UJK @&QPP(X//14D,<
MVWU%)VDE2&92"11(*,IY''GQTU]!\ ^)_&C+B]A:HU8T389E=)3NV!F.6YML
MS-A*>;_MZJJR?8^1Y3;TM<0GZ"A:@H&(J/I$2DT:-:F7GED4*S?*#>T!56_J
M0H4$_0D&N:ZQ'!%&=R)356YBSM1Y(#.68"_8&NNCW#[;O"W?6S"MN[3TE5Y#
MG%LM.N4E#9)F>/4N>?R\D*4B;$Q3&\BJ<6S[\:P8:$=<LI[=SA1APYUF$@A@
M9E,B:-0JN0!>WA25OSM8@LM__1(]_J>@^/#(V]XP6-7RP#5XW $!Z]MP->W5
MVQ11@11@@AX PPX(11!!8HQQA1AXVQ0#CP1-9%#!!$QD4,4;&QQQM:QC6M:B
M(3T=U"/*&KGO.-7(.F%,GKB;;2>TZT<\97(0#,=A%X-$9 K'Q/289\K9HNR2
M-W>QO:]J]%1#J>'_ &AINH8!B2<9N%E8GHR?DF_$0/#Z3\'Y)-^QN#P3QU'N
M[9!#VKW+,0&$6@:Q(5/A@FGY#$'[$"CUC\)T=F]7<W^6';0NC:)%M[F/"UJ8
M(ZD2)]-9#. B-D.)L)!VOE')C@DE<)#,,Z0<..:5LT5+P?"18(\,CMW&QI<<
MX[/F*UR*,7)@G1F]]Y:.FDYE9"R,S(6'7#N+JC2Y>F*9XP\>2@F9!D#\499.
M"R29,L$?IV%79&3L+;B6",F6/W$!9#O<#W^$R3[.V1D :=47JB$AS1=45>B_
M2R*J+U;_ .Q?70^! V3E843LD!R,K'A9 Y?:9)$B9]S&[9B6/@EF8V23UZ#1
M*6:-;*@E U&D4\ E*(I#Y!)Y)8GWZN%KZIBKJ0,(?K$*$UL,0Z+W.ACB[!FP
MRN8O8Z1BQ-:]6N<C8T1$<K6M1._X(TP\;'Q(VWC$@AQ0Q-D^C&%'N2" O-G@
MD\GI]U/'61H1L.QH$D50+&T$H#Y*FQ8OP:X]CU)[E<UK%^NU6]R]'=>C>O3H
MY6JO8O<G5&N[7(U454Z*BJ:F11-F_;GZGP1?D4?8G^O4?RM%69?D"*3S\B '
MD>.*HW7M]/?J/-C2LAHR8Y%8U26.9VJ]&N>SQR.5J.7^[NGUT3[5%;_JJJ,=
MUE>3R0L;@U=71!(_;[^X)^ZC$TF?&2([;"NK'Y 2M5R??CR3X'V%D,_15(E9
MK7%AEC6)[ZZ$AS$:K'LEF6229KDZJJ2(]>DBJJJKEZK^ZHK/H"/IFB:1AE0&
M@T[%205M)D])6=F\V[,[%R;)8DDD\]$:EH^-GE [LK1V Y\E20R@$MNV@'@7
M0%C@&NIW%9W_ *G*J*JJU43Z_4BJJ.3JGTJ_2_NB]55$Z=/3O^*L!:HCP3=?
MH/J![DFN>1?/49R>V'C<RQNK1MP5%6*Y!*V39'@@>Q/MS^I(G1L<K5541%<O
M5/M$1%^T5?[]45$1/I$3_BOK'XCU&52*\U1KGCBO'BK-B_?H^#MZ+$B:<JC
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M2OQLB@R^W-'U&ZEAU!D@YKU(<C'+,VQB&!!"GE;&[FB2.CM2PQ!!NM259$(
M%@U=<'C:#R/;<!Y!Z] _US'TQ=8=\TW!BB[&N:9T&1H?;VY%B&V.B-*%;!;9
M"@2H4>(X@$&>OE.A4Z PB%[T25H"'2PRQLX.U'X<]QOEZKDK%@F*+)U"9O\
MFT#%$DD=2$90?YHX3Q1!WA0+ZXBU+)2+,U"Y%(AU&?'DVRPE@_XG(C:HA-ZV
MT-#(H?T]A8 !K( S/^Z:[Q\D\7B<B]5T?II$5$ZJO_P6A1&)]=5=W.<JM7ZZ
MI^ZJJ+Z[HT$O'HNE1':9%TW2T:CP'73\9:'!_*ON?-$@'V[/T<M_9> K*4)P
M=/"!B2#&<'&"N'JCN(:QQMJCSU.W'C$78]KC&(?B*++)5P6MD](6Q2.+LY2G
M0NG<G;*V18X/&UDR))VM<B]45BN[V[)QO["[5T'3MB)-'@1^NH\M-(HFF=J'
M+GU5+&K_ "@^!3UJG;RZI!4Z!H8S&5(JA:@^#=6U@V*  J@.IO5DSI%C6:3Q
M].C85<J-:WK]]$3JC6)U54;U3N[E<J+]KZFR9.Y!1-@?,:]R*\^]\>/ ]_%U
MQE]LQ8N6TQC2V?:@ 7=0/Z U[G]_OU!^^*\D_7^5ABR2,>ZG.15B7I(J,%F?
MXX^C7+WN1%16HU5[4=_9%7TR=QW-VWW%"M[I-%U/;M:CN_"2FKIJ\4#1NZ%W
MU)],P%)CD8,'CC"QFA2D\V>+L'V! ]NJ6<(@S3L[SBRE?/\ &#JJVM<QS7)!
M,KYTE@F5>C$\K6"JU$1%1&2/7JG7U2?P*ER),KNS,EG:0I'HV$25I91'_:*Q
MNP]FCBA"  'AK)LBS]3T]-1Q2)8C(L;+MHD;7 %D55EELGZ$*?IT5P,L@.6$
MP&9PA@TC'C$Q.<R2*1J(K7L>U4<US5<CFN1R.:Y$5%14^N@%E(<[K96LD7[D
M^Q_]J'[]1;4-!AS\.3$])760>@\4JB2)HF6FC>-B58-9W#Z&N?!@/E;+:7FF
M]@%RS$'V1%0^><B9[I29DA?&KY))G+WO<V-BL5ZKU5K>B_2>HMWNTD_:/<F/
MC+\QT;."*GRFEB9F'_\ !?\ >Y%^;Z<^VNTH=%B48\<,"Q%V7'B5(8HU],NW
MIJK!1_>- <FP.31@;@]C*UV%6]^YBP37MS'.+(U5:]( A(FQ/151J_\ :R.1
MOTJ-1$=U557U$?@O@2:5VBL[J =5S)LQ:-[H0D,$9-_EYCD '/!%>33AK>E1
M:EA1B12P!8FN:V6  .!9%GCGQ7N1?7J][D?.]\KU1$5SWN<O5&JO5%55^NJN
M_P#]?:^K;9RX\BC?(4 5^W[>3SY_2&I@0:>\:10E0'\B^6H\\V*X)_Q]QU7[
MD?1DW6G-@!"]5F2F((14<B*J N0N1B(O^9TK8W,CC1>Z61S8F=7.:BPSOF%\
MKM37L:)RCRZ9D[=JDEBB[]@%@D.$VL?8,2;ZLC18/7Q<EW5@T<+LOW"H&4&J
MX-$ UQU0KAK5SD;%L+I&*@D%#'7N614:BRJJRM:WO5'*K&-ZJB?7VG7]T3U3
MOP%P)ES-=U@H\$,6'!I\0X(EDDR$GF-_F!B]-0!X(?<:JNBYL,9V)*CJ#'2@
M"MWS(I11]0'L\\43YKCHL@K&(K'M_3U1/T]55K4[>KNWK_9Z_:HG7]^B=.GW
MTJTC.E,VZO?Z^XOCVKQXH<\=0IM.3$RF,4?IV0*L_**Y6_>R+OVJN.>N1*V)
M&)T14=U<C.CE_3_F=UZ?[W_#]D553_3T2V0X!4GY0!Q7L..//L>?/@BO?IQT
M[M^%YO65&60R$D_7QQY_I[_3JCG(6F+GV?I4R2![!R[*R@29DR/A+97/9.KF
M,8KFH@[N^,A?U*JJUJNBZHLE<=S*F1WK\.3O_P"EJVI3;5L.DL."DRAK-%)*
M'E;"W3$V!-,G3JPXL5U)6:++3]5,<1)4"Q0 -_7BS0L7/H";&2EKQI[ ^45L
M,;FC2E3R#L5\345T<#GNB:CFL:SHC47M:Q%141$]6A/ELSL+%V1? V@-P/K?
M-_U(ZKE>RM+PIY)X=.A21G;?*D,8D=K^9W945BS'YB2?/(XZ[UCWBJR>"5\,
M\+VRP2L=VR1R-5$8]O:B.:Y%1%ZI]I]KTZ>B!-363=^>2+ODT;^H^IHCBN!U
MO-H*YF,^.^.-IM?F0%""/[XV^"."/!\'@T9+VMR-SW-=3W&O;IE \$ZD;76%
MQ"$J7I4 \$2=SB5<[NGGF@9/-,YO>Z5\G3HCD1(CHOP]^'^@]RYW=VC]JZ5I
MW<NJ39TN=J^+BK%F9,VI3>OG2O*&-OE2T\K "V' 4=5AHWP,BQ.X]*U+^TM1
MR,?2\Y,O3]-R,B!\'%E4N(?2C7&CF6+%CD:.",S$(A(MB;.]WV\8OC\ ^#\'
MZT\/$/C=%TD3I(GCT[AK/UIT3H_]/ZDZ)^KK])ZXEUR)8=;UB%-X2+5-0B02
M'<^V/+F1=Y]WH#<?<V>NAY;]67<06]1]Q H$[C9 /@7X'TZ'I[R.!Y7F=AHM
M^,Y6_&W#8[M(%>@3S&-L3;K5QP-LK&FBH]X E3:@-%<GC)CN)?-)XH5AFJ;O
M[M''[G.CO/I@U X$V5P6"[(LF-$D4DLMJS+')0!.^%&6F4'KGOXY9R8A[:C,
M2L\IU.02F::,K'$,(/$HB(YE>2)_4(.WT=GY)75LW?-W!<LP?V\.1 F:9:_-
M+TPG$"'7;JT:G1(OR,3'P1 !+\."%L[)Y6,ACB8UDW16*]%>['8'94';69J6
M7BZ7%@#+@BP%61W>XT?(<.&+NQ<JXW,Y+&E4M2BFWX'9BY6N]R!-RHV##D1P
M-(TIC178.@D95W4 6-*H+!B%!8@CM]K/A3=;KP3(\K"#L)+<MF0D5'QYJR(1
MOXK&K0NI:6D[GV!J6%I631QC5L+D;%T-,("K1CS1^JOAQW4.U8\Q9(U,>=DQ
MR3DHS.X7,@QG:(CE2(RQH_RS1-,Q0==6Z;Z#1O!.2BS, S\6+I01YX!/@<DC
MVL@3KG6I=A:T6),NQ6WI!2V.D!/+K2X@2X$)D#\L4TT,:0JAD<HD@Q+1SABX
MGBF##DHZ!.E=,U[3-6-8N7%+*GYX5D'JH:LJRW=CDV+5J)5B.>AJ&C20+ZL(
M66-5!+@!A9-V5'C[7['Z\]1W78O;YA*;6T]796JB5UE9VS:D4@EX%* /Y;&U
M/>..2VOKPHI&OG.(C0>)7-:Y>^2-'+,_4(<"(Y$DB(0RI"LC"Y<AK]&&,$C?
M)(PH1J2QY/@$@S3L-@$DDC4Q@AW(%!0E%OW;@#@W]NJ"Z%PQ:G;&PIR(5;*,
M<:K'.7JZ); NNDE8BM>^-7)*(]KE:]RHO<B+T7KZK/X=X,</<G?6K*X:2?,@
MB>KI))B^;D)Q8!$K@4+\#P.D>7 DDV3&%^6<,K(;(*,A;@^!S5$&Z/Z=7NAB
M8K6]4<GTJ*]O1JJO3Z5>B)U_]O5.B+U_=>MQ)E,H(ODFQ?/''M^H\^W%=1+4
M.V(IG$L:HJ[:( JWH\'ZV:^O%WU]Y5:V+M19'N6)J*]RN>]$1$8U.Y5<O:UC
M>U$^D8S]OIO1-7FW!F)H FAX'/)_<D_3D\]::9HYQLI(UC D )L \$?*./W\
M6+NR.+Z$OR]KI'; $,C8]1#0BP4<K%<GR(F?(C^UZ+UF\J]B*B(Y6*C5Z(OK
MFGXZE,C6NV[]1S'I\L*HB[]LDF2S+\ET05*;R:^477/,NR<4XRXR$470;OJ0
M6;Z^_)\?2_J>B!Z# 97:VQ,2.%(D&J!VOB;&Y.QS52.17H[KVJLCFHBHJMZO
M:C?V^K[T)DQM!T;%A=1%#IF%"FVA_P!.!5(H$T;4V+-$$&SST1G=OQR2>M+
MS'8I+N"JD4 I7FJ ')!-T.;L]3JY6N:C>GWT7Z7JG1>OWUZ?:+UZ_P#!.O\
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M@ZL<R3KU[)XY&=S6OC=V/;(K7,E8^&5&JYO?'(US'->U'-<U>CBWC)W<\U3
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M )<Z#QE#3.;2VIYRNOR0Q"-T+4R2MD+*T8"6641%%+%ED)!=1=J]."XFGZ>
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M$5>_PO3!_,UJJG3Z>K>J=RK]IU;^Z^FK(GA_M:5"4$PTO D$9K?Z(RM10..
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M*8TK'[EBJCWOKK,A4<^27HYH9#_N2=\DSNG7IUEEDD5/M[G.ZN49:*ND:C7
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M \4)SK^]\3G(Q/Z:(WM:]BN1O<YK5\7=Y58WLZ/E:Q8V*Z-LCV.DC1[M(P!
MN@1N!(H7]+J@3? )L\D"@:6PX[RJ[!=Q1Q&:_P#H\7_]Z*]_M^_-^82V.."0
ME6PPR/>P8ABRP0RHLK9T4=['M;Y9%;'.Q&=LCV,?.BN'C<PMHXF);9;NJ@LI
M 8BQL)92": X)-@7MJR.CX)9X$.V4Q1AV;FRO"M8( NS^7]:LUY["QN(Y*3Q
M5QA@Y,\)7R&JI*.&D,KHP#7/G>6C"7'SOM)XX/C.& '+\WD(+)\56F3$)G8R
MQ1LBE=GY?F"2%TH!/D6-1$I;=OD9-I"H@,JT9Z>C'M=G5R"ZE>0"/G )-V3]
M@!YW<\>AMP:&E#X4\00YD:DPO&#0@TJ-;V-22#5>*Q/1K/\ =1',5$;_ +O[
M?V]</]TC;W-W&IVVNNZN/EO;QJ&0/EOG;]+YKJ(9%>O/7CUI:]N-[>W0"/XD
M6Y(JKKB&V%G7Y%9NU>]8T<B+"9JM5:CU:O3[>QRHBI]HQ53KV^NA/X<J,7=J
MB0*_J:*P4-3,H74[->ZJ2+-$60#U57Q&TZ'..DO- DP@_&A2R;]AE&.#M'@%
ME!6[!HD>+ZS3YS?EVW#'F"',YS6,Q[6DS6M:QC4<F5'Q_P"5&M:J]J(U/[(C
M6IZ<?XAD/]F=M$L23J>0IOFU(Q2P(]S1L>/' ''1?PXTR+#RM2>&)(U.-$C*
MJA00?5V  CBJ8 +1L\V>HNUM%$!JC H0X?CBMQJB2!KV]J+,16!F2MA8O1SD
MF=*R:5(T<G4@=\B]9XEDL/M[T/[#T1(E0*-&TX@(I10APXEO:"=A)LD,;!#@
MFU:KWBQ\DA2X<Q-'$4"J:L1J5"\T: ]O-60#U.5!BU]D,=,M127$K+.(R.":
M<0F2(DRNA68QPY,04<;AY7D010LE\TS#)&UTDZO\4DIN3FP8OX@S9$(]%E9@
MK*&6.0[4W*7+;@%9B5 !0>H%\@.D&(9'BVHR"1>2_ !%\D\<6?[UGBB>+#*O
M89*FWL1"(B&.A^4B(1#)%.^)K'2(Y\3F,?&]T:+(Z-6]8V.7KU:G>YQQG6:"
M)U*E2%)*L"%+4*!NO)H'W/OTVY4$BY#HH8L25H6;VV&855@$\_TY )Z@+$CA
M3-N9BX18D);5543D65&S-8-$Q9&I!T61&N65'K)U1'HK/TJG1?2'$GQ)=;UE
M4EAEGQL?2\:=49'=#65.%< DC9ZPL$ @DKQXZ09<3B-8PWSI);$-\Q$A<@%+
ML #P38):O LV#'>LJHCE3JU$3HJ_?[?Z?ZKT_?\ 9?W].;$"S[7[#_?B^:_^
M=8 [+L-V![F^:^G'OQ[GVZ_A)3(H2I'*C4A5$5JJO5SG*UK4;U:J=R*_O5/T
MHC6N5%5R(C@M%D4"[_R'N;\#V^I/^&LD,C>HQ8CZ\'S]@#Y^G5"N2B@EYEJF
M.6:-%FRM\DT:*CI&P-D#Z=S57JK'*B-<KD1.G7K_ *>H#W^L,FI=@PS,@![F
MC?:U6458R35<J&V@WP"1UM I!A+K8]>/;?S;B-UCD'V*\\^1[\=7VUI%'.^
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MJR ,A(5')*GF4X>KC&:T=2QYR19CZZ0H>RAZ(@U:;5^W=$U6)!D?CTQV(<;
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M7[8A[-PXH'T[&QTD;(@&0F;Z,#,YAEE.2T1B8V&41*" ..#:Z!LG(5H(SPX
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MJN0<F5$F$J,R'%F8.M*ID]5MR@VH!(Z=\+5L@RQCT?7= :+,-QL%2SNT;.Q
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M[\6+'0 .4&KMHZ$SZ/5&S-CTF:EUE& 8E;A%Z?98SC\,)%E1#T)T30:ZC=?
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M;2@CCE1\;FR2._NYJO=(U.O5RHU/T,>Q51CG(]'/_=?55.U;B30&Z_L!R?\
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MM2:((;:2I%CQ8<=,16RE+ %5!)OCV/\ O_WH@C%OPJRG-E_D.AM#2;G,*G+
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MV@C *T9Y13 G- ^<1)#$BN:T<2.9\TKVJBM;V]4^D]!(S-(L2M&"[A "+')
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M/&VOC48B 2",R"&=O255:UDD*%$3QJ(,LO9(U&HCI%<>/ 5A?)=5>5S& S@
M!4DD!\\G:A.T<U_0EI9)_2N?O7'GW _P'6IO/,WU_)I.?*[>;&<-J<1JBP<2
MPB@JDL(;0MDKZL\T^J@(KZ6S($(E!^&RUK3(?&2;<,F99/JIJJTNV!D39N)I
M$$.3/D9"J9<E)(UCQX&0R1&%F(9R82ID$(9U8;& HJ7S3FD!] ?WN9;8 *M$
MKRQ'M7(OGS70S^1&<5W(#3^<T%QC]-78K,)"S^E4@8[:0AB75;(PJ1C!F#1R
MPVTL,LCZ]))6S,Z'&-05L$"+4=/S63^Q,P9$<BS&)O4R(I IW;XS)L=J5MH
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M(/+G)"Q\HF"*H';BI02E7(%A8>$J &H"A$?Y=7Q)M'$/\S$EF5AEX\BE(\L
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MZY#+O+%LM!'K(Q5>9Y5R>PQE(31;4,NAQ<2(P&MI)YY)@):YX=@P..CK[%Z
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M]>R1G5BL?'VHBS#3=E1 +'DB%7EW-&TJ*PAD6B IXN2K)NQXYOHV(,6)"M0
M((%G]"#X]C?Z?6NM=G'K5^O<IQ2:GSN$7*:PP8^WR* RP.#,HX9B13IE_(Q4
MF2PPEQPGQWHDCQQQFF5U%5.B=7SV=E5S?39LZ!L?5T:7&SML:XOX4-Z>Q4](
M*(=R$DJHW?.!RS &@K/>("O\W^8&845V$C@$ GGF^/;G]NJ:\NL>P(.MAP#
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M8D"!)'KHS6W5>5)(+?V@0!LQ;'0@.>KZ1E:++ITDN*)(Y&D_#OZQSL;)8DA
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MD\;UA@C0GP.1JTK)S<?,9L4^G+DK^$R"5#U#(0DD='BPMK8H^_'1.,SB]K;
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MU;6L%22LK&EBE=FD003CPI#, O)M>".2*/ZGJJ/O%;-(S?7VIF; KR@MMX]
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M5\<TS66_F\+!8VS%G3Q.[?B 3$103,_I0S-=(D_EB<D\<;V=OKG#XX$G5](
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M%<G@#A@E27O>PR221%DAA<R%&D$!P>0J)JT[3Y]0G:"!%(5#(\A'$: BV!L
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M>.WMIHII%:CI%2&9K7R(WIU8U_66-RHJQS2H8I=4TV.;=Z,F7"DI0$DQLP#
M@'_+Z?KTWPFI$OW//T X\G_=T;X\Z&L#VY?VN$&CY0\@[(BP:D*JR,6>6G.
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MS48'(H79:R0/ ]OMR;ZD/@I[A^T-;9(%@V>F%Y=@V89'ARG0*)(9D-.ROO\
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MG[&U51"6G9IH2 &4AUX!-&A3'YOHP'MS8Z'81[2N\2\ARH*SM:Z%N+&5:WQ
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M*YV@S<S&A]'&R\K'Q\ET25=Y592SC<[V5!+ +=E0"%/%6%D&5-#_ "UF>,,
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M&I:--+$)YE:2D8X\LR;E<E#85AMH,6V\6 =R[372B9<C$D()>-6/Y4+ +S?
M8V#XY_QZY5KJ/7FN\A:<.# M_;NF?35ER15%UHM@.ZW8P+$6$*#%2S.(R)54
M>LEA&! #+2K6-)YXVZ+G9V;#)&9)Q%!),9'7\[B984:W(8N*@7ER>6:^&Z,&
M5/,NU5D(%61NNC=77GA3=_O]>LZO\0/D%EAW%K-: I6&27UMB5&TQP?PH!QC
M2&V$576L8V6!A5 R!:*UBA,=&)+"D3P@29"7$XR,8O$<J(&F5%%+(/2]-$BW
M9$C$Q RE-Z[0EJZGDDDD3+(J*RAT)!LM>X\D<WP>*H #Y3[GK4Q[;R=/;QX'
MIUZ].&W&1.O^O_F5PG[],Q-DD^3R>D9Y))YL^?KUS^?F=U^M.(.Z\VM8)20*
M6DHO/#%XT<[\EF6.5$3G.F?'$R*.<^.6>1[VI'"R1_WV]%FGP[T^+5>]>W].
MG%PY>8T3\*W!QYVNF*J:*@FR!QYZK#XSC/\ _JN[T;2XHYL^+2&GQX99'B21
ML?)QYW0O''*X9HXW"!8V+/M6N;ZRJZRYRZ^VEG]=KVGH[T2S.>4+(3953@P(
MB62L@A@B,?,L9;R8Y'3-4)"(1_&HYDXYKHQG],=T=E:%C=O]PRX:SG(PM.S)
MD,NG/C1%HH2/3,S6C;BS$/$S *M,%8CKAGL70/B-%WAV3F:GI^C#2YNX-#FR
MFQ-8&5EQXDD\.5Z_X<1HZ.@7TI()E1EDJ1'DCLC+_P 7ZY]I[G6%1S1K\$;D
M/>'74RRL'@!I1;RSFMC9#GO2$$<0-D\SSIY(816M=/)+&R-7^N/\?#R,N=<3
M!1GGB+*D:AG<^DU.6"J2%]P0&!L #Q?IRJ_B&'H!W!-+\IO:0&5C7@E6!(H?
MY=>E%DN58Z#2:LJ]3!4USCL#);>NFNC$6EKZN &TL+$AX,+2@H*VLI:1P-(<
M:T6JA)FKT@MFPD#*2J3'RE?),Y],(&C=?18N7$BH54,R%F]3@J=K$6:!L='G
M'F0D.C* 0H)'T]ZJ^;% ^]\UTT]NY?@P.)N_G#*,$K,>M+)0Y!";&NC.%,A.
MF/CC'-,*% Q: 9@\S@JQ4*>UXGQ1R/-(-"I^!@:@\Q$$&9DR 6I6)E^4V*10
M7O@CD$<$&NC(L>8.I7>Q%T AYOBO-W_C]..L[F$TNLMB>^KK78;KW'Z[6.LM
M1;!O+0RP/'@%JS6UF)XK4U<T1C")8;0TE2T%K#V06<D;)X'P#FL2)3GT/6<!
MHICAYB'*CR)TW0R*_HB14>4T#<0=P-X- 4Q(H]9?!R_4'R.6E5WK:;"H0"2.
M30L<^UGK8]CN3TDIULM.?2"F6MO,Z.*..(ILQE=7Q1$5KX1E%D(.2LKYRH U
M-AL804A/F!:/%.'&QR1.!'O5@0IL78^8_*UD+=@\"J]@2>>D;1RUR&X!!!/@
M@^_VOWHCFO;EFY9N_%\:GQ?$\@N0(S<SL[6BJ/QDQ'RBCAAWF1PPN:#/40R!
MCK 6P6:^%)/$&G/$'.''*!=O%BSNDLR1EU@4.X%718*+!Y 8F@0K?MULF++(
MK%5O:+*D<GQ^I) 'N+_PZQ X#4X]JOW2]+;.S89TF-8!FEIE5L2P:/\ 2E[C
M U0ZUCC*("'9)#+$9))*4<'$.0SRR3*YBPR/^B=M9NO/J)Q(&W8..DTBRJZ-
MOE21HU0!69RY0QIM4VQ\<-THQ,"7+:1%.STMN[<I'S/N"@#R;V_X'Q1/6OFP
MY,X/M:V'P_#%J" GU$EDRTO9!AB56CNQBAK!OQ2)"@Z\JEHLLL '3C1)8(&&
M?&2P6=WIO;19\.%I\M6B8R+&8_F9MU!F&[@'TV=00!]R!5$/@S0*2RV5)!4
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M;)5'C(^)Y, T[T[L+$U[MS(U7%G6+)P<.:2=SM,<C)&9$Y!%.$5BQ/(((/\
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M0-&(ML4^%.D=1(W\TM3>H)&I@25&\A7*EC[?EV$5TGF*[TE0*$4\C@W?RCD
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MH'9.WL.TME>38/E%T/D&"9A;FX1$@=C<U]7#66X.1'CS!SQDT2!NCC-L9![
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MBRQZUDSRL)6EDI#'NG5(F9F*J]1MZ@D9%59:L*RI&%LD.8)(<AG(#,Y6N+L
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MBSMEO"9(]VTJN-*&J8(2/YH]12 Z4"#?S CK:602!8U^9E %CV(&TCZ&BO\
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MM71  *3,W8OX-D%V1&]<D&R5+?W1Y(LUYX\]:N^,7N;Z#T5HB[GWH7X@\:R
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M,R34-3RY<G**B)9969C&BW2Q*3Z: "QPG(%FV+$MTTTLS'U9&E-A1ZED+7%
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M%V?E4 _,;\CGFCR0<8W)\@Z-_P"W6"Z:J=G56N:"<U45$15ZM1$Z_2HGVO\
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M(98E3^JR#YDA2,1517CM<J]K7>G$);HRK810S[1:UN5?G %5; <^Y'38 20
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MGIZ1%U9V(&X$_*;H$7^P ^X_R,)9=I"J9L&&HS+&<NDL9;"K@KC<8'D*GAJ
M;2HG$Q^S#R"6WJ;"Q)HW*'B\!Q*U@$[JB62L_!0BX_5=$:=KTSZ8LV!-&D4*
MRLV/FOM$LLD,L;2[HE280AWWS-&-S'=\WJ@RR2RE>,B,CYUH2 $&KW;;/ O:
M+)(!KGJDGO.\#\3U5MD_>N'7!KQ=I5 .=2TUZ-'#9NB2*K'DEO !0:N"IO(T
M,840 6)+-(^ PI9YYI%)DYNS,3U\F::),2!82ZY2L7,?X@2O,\F. "S8Y25
MA(\JW! '4/R(@)I B[?F.[D&Y-Q+&S[>*KCS[^/0D]N5.GM\<%4_;IP[XT)T
MZ]?_ )F,+_O_ '_Y_P!_4<DKU)**D;WHH"$(W&BH(!"_]H(! JP#TA842/H2
M/\>NF]R'![C8W#G:F(T1D(5A8G:X(26>-98I0ZG:.&6]D$]B1RJB'UP)07D1
MCEA4A)D15C1%I+^(CN;3>S_@[WEW#JT+3X.!CZ8LB(_IL),S6M.P<:0-OCKT
M<K)AE(WKN"%;YZMWX#ZGG:/\5^T]2TW+3!S,6;4GCR9(Q+&JG1]02:.2,_G2
M>%I(&7@E9#1!HC*-B7$O:6JK*7,,WS,+**FN-K8JH,6E@JW5OS;R@ABF*):B
M3'RH]Y\*SR*U5C+C8P=B->]>)_@/\>NQ.^/C%\/.WNWM*ETO.R\_4&R9ILUL
MD3#&[<UV>4(ADE5!LBCD6- @N-BS,P11V7\8N_.Z\[X6]_Z?KW="ZWIV=B:<
MN-A''6&9(XNY=%RXTEE2-%GGB2+*+RD@- ((E0-&2V-F]=&F2; 1J(U6Y.>Y
MZ_2HCTN;ACOV1/TJK>YO]NGTU>U$]>IDY18X45"C!!O#,&8,GR&R"?-6/;[^
M.O-EP 0HXV4M'R"H ()KDK6TV?(]_)TF?P_/&##J':>6\ILYPXO*<NU]BIB:
MV%C4=HM3>YM07-0(3.-):5\A]B8#/U\(4Z$!0NC:Z8=[^_UM!"']!Y!4/K,K
M/8L5M).T\D@>+%$UR?'64_,A]@QW5YJO?CZ_K_IT:>BPD^YR:#)@W8EF5C%D
M#;]^9FS6UF\_*HYCK.3'1,HJ%(IPH@#QR#JVEK#+N*Q%KX\?=:PUM7?3MM-M
M6A.$T7XF>""2/T$2 (8UA"!/4D2M[,0?YI4(PLLJEMM25,O$,8H7M6B3N(L#
MSM][\BN?I=T<L_O(Z59BG-3:&VL8P8W!\7VK6WF47&/.@9$+CN1$8Q(.7&\<
M>:1E<VW+6:9!I%8Q#GDL17M>G?4TX'J<$L09%!+6S+OL$@T1N%'D"OMP.HS(
MP,CT3RQ/((/-D'D?0\#S7MQPP/9GU-@]UE&P-X[+N*RKJM<4Q-9A0ASS8W6N
M97K6!L(AE"F@49E2)(Y63DS1!2'&""D*^.5T,SKH"2'48)$B$@1@6):-=@W+
M;_S&4$B^ .>>/%@_"8KDQ,!>TV22  ![FR/]>M!W WC=_-&ZL0FD2:I@/CO6
MSSV>*'RU=V,V.)5'L:R,QSJT.%EB4^%UA5F8\7#9"3*RRA"A@CO+NSNH2:+F
M11NLPCGPM@]2VQV:,KO^9/G]1U0$JV]=I8D*2QE.;E1& [&!8 CB^5-'YKX/
M('F^*X/N!KWL^&M+QUYP["KM0UQ,^(;(%7.*.K&?(<]+F[,,'MP '+/.3--(
M=(PQHLKEF8I<L*-5XZM7GF=YII!/(A#M4;L%*!G4 .P%"K-D\<D_7CJ'-99K
M'.X\?>SQQ_[]7+]L'@OBFL./^0[GVRLQ>W-ELQVMH<:%@CF,P_#3[ZD-;#!"
M>JBF7F3OA4*Q>*BR4HZCK,6*$\Z?U(NW)/P&4V5)C8\\D:%X(\EAZ>YF5#(-
MI/(1G-'S]+%=*L-_2D9B 2%^4'ZAA]/'@\_^W1RJ'C)I;.CK?##RUL->9;B1
MT0]?E5Q7Y'^(L(1W5 [JTX.HJK2>6R!D=85I=N,571BRS0C#"DOK[0=\UCN?
M=A28^W%.5!(Q@.*DD<<T,^T,&1ALWQMZA-D&J(/-=+LC,6:$K*0L@-*H /RT
M"#:@@7S=D&QR*HC#3R3XXE<9N0.1ZZ89.?2M2ZM*0J6!R%"ASP6T30C6.[FN
M(#*BE%;(C4:5&R$A4:LWC979%$@&P"1?UKW_ '\],O14_P"'[X<:IWCNHW>F
M\CJM^):ZL?'C^.W)$U;#=V_P+"5$B.=&X1LORD$AC=,L?A['=TC%G[D,B6R;
M6P*OBP/-7^I]OM]NME%GVXY_\?>OK_CUMNY \:,2R.XPO:&-/*J*:FKG#&"
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M?4GB>-9A&Z2L$62,,I5R"5#*Q;Y6HTP;@T*Z:W,7D%[D7&#%MA[9@(X'V.N
M\M7']2X>9CW(JWW%L _*,@=3:QU^#54^1A4]WLG)I":T$@>I^-41E_D;-SPZ
M0$DD?,,>/*RI_/W%;<W&$6A;-9%A17OS[>3T)I,B)6?^05!I%J3<Q)I5H&BQ
M/'T]^B<:<,VK8:KP"PWC5XC1[?.Q6H,V-28'+83X?3964*R>UJ: BT-LCB :
MV>10FDS'F(1)!)-"1+ ^)RIGV!F"$E+.TM0)'L2!XOI2A<HID #D L%L@'W
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MOUTH!.W,MV_D5?DVM@"0(#!AEC)"S"^$>Z@E BD<',//#B<E46TF.IN6$R
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MG;\&$F,K23.\'X@^H9&W,N1(DC1LPHLJ[$VF/TRS*&* ,R$M-6@,_IJS!0X
M+L'L@%7W\<J?I^AO@= 8UH(?F>\L-L*Q'3M&S6[OFRS1O>D$%<:TN"18G=[4
MC26&/HQ_=_G3Z=U15Y8[9T8=U_$-X2D^3@#4,K.SIGD!8X./)(;9W!LLY@B
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M9HFZ-'S]&Z8\56>4J%W$J: YLV*YOR;/^_&YCCSS*X_XW@U[CN6Y=1I99!;
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M_K()%D9"T0D"L7B60C:'90.">:ZB???;>HR=OZAFZ8B_CSCR''786=)"EAR
MI8*&LD<7]^I&W+A>,9SE5@!QVPRWR"LI*UUAD5I41'VM=&XF2)T\[&##R/'J
MZL=\39)&P++YGDM2!\;(D6.:#W)K^%VYC9?Q'BT30>X)Y<II].TG/_&XF-!'
M(XQ47*8(L\\L(664Q+Z*R2>FC4I/5??!OM7N>7%;-[GSLTXD;0IIQUK&_":@
M8E0B1LM-BD3F2T16_FF&.*64F21CT"^HPIV(<O\ (*25\,['DR&1N@16L8AM
M<1-)&C?%$G1A$DC>Y6,<YS554Z+T]5+\.-4QM3^*^N:CCQ^G#FXFIY4:!54
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MBHB+T_9/2Z5X'A8.R;&7:0=NW:PIMVXA2 #S?F^F30-/U=-55'AF">M^8JZ
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M!,G@C#4>TO IY!8"AQGCQ0HZ-T:3P!OA?$Q49 K%1?7%P<#+G<K32!W4H"2
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M,D,<I TQDI4:^2!DC6N:V2%)G21LX1[HRH,SN+4\B A\>;(;TR%V*4$A\+9
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M3&(K1;B(=PYY9$0\HM? /*2P<N*P($+AD1RM'DC[7N[/R/AMVW!,<0O$,AX
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M05UE:08[,LA]?4L!N2P"@7C2Q36H>YS)D9<68\:XCY$F([Y$R30M-"T+1O&
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M !H$(A&#=LN3+&R%2=BDD?,1RP-<^:\GV!]_)/2A9Y$(^8LOL":%FZ)KWK_
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M;=N0#"-%D@BLY9YL@R%1VO<L306R/?6#M);/&/62)+(AJPA.D:L53(=,E\E
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MTZ#59S;JQ@+([X66=J.EE\@R1 8A89T&EA5I!#K+>.3<$6@"I_-S9)L_:O\
M?L*ZR'VF@"#7YA?U\57BCY\=4^Y"46'@55]4XY@^/T<QN/QT),0%/2@O6"<=
M7QUPSQH6'+".E9XB!"H61M8]K1)71M:JGR39?H@22EU3YD%FE+<$@$D<@FZ
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MH=#ID;-54UML%4;W*F#Y8J-Z=W<J4)Z]O3HO7K^W3HO7KTZ>ENF__E' ]O\
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M/BQ\.>V^X^^<[5]4T+$U.>;3]/Q7:<QQLWHXZ^DPE2(9"["(PP28,XB6-W]
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MT5AZ,;3*6D =)5&PBA3< "W]T[6MB07DXLJ/3!^0T=U$#J$MU/Q 3+*Z#&J
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MCZ4=O^G'1B]2"V).OLU8>KZ>\$MJF_;8@5PCD97C5UBX8,,2YGGL8;4,B.V
M$&JHG$C17 M:>$94&BN<,W)2;)BD7<<=+16(((D/!M;("_E LT0"1R" 3(ZR
M,PA)"@\V*.YN6%'[?;CR.?(O?>"R@"O T(,^WF+^27>WL(D\)8) %32UZ0"(
M=7$#A60C'+8^>)A(8[7Q^4AC9!WQS/;(H<F9LV&(EXXU:1XQ0BI;+4]E6( \
M#D41QT7L8[Z_N"SR. ?'UOW-B_?Z=1S[$S-;[_X+;,P"UM8D*UYF!8>752V
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M8Y&VK-#,CX^1"7H[#+!+(BO5JS!AR!T1DXD.=!+B9 !AF7:]\4 0X;CW5E#
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MK5'HF$2APT1^=06!!HJ*/)_:_>^>>+'5W])X/QVO\N(*3F[D<%1E4]@6U_\
MT8\RK!JJR!$>R>='KGEFK)")!D<YTPKQX2)&ES3#0QRSLZ3[6R/B)^!S9=8T
MO'UG"U-9Y$49T6-EXN3O]&18EDA:,T>?0)/ +)N/R%YPI\YY"P5'9(R5)"H
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M*XT&XJ@.*N3(A[VC$#0M8Z?9?C5L1:L(<]R=R0,>C4[NC'37L?NS+[/U?\;
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M[5.J:EA8F9/V'//+%FK@0P&9<*7%;3$@]3YY(9<4Y2S/(X5G/RE>F&PO8_\
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M)CU&?1],C_$2IHY.3D.\*19.)CY$SQJ4D,;/NCB2+'7J'^ S6.UOC+VQW/\
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M;',^UD1?&U>KDZ6'J1/X01&6*-<K+P,;(R,E$>.+'DSH!--*S*2BQ("^]&C
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M0POI\;LADEC=B%>:9H^?Y;2.R423U0??FM-@]RY>.'< 08CT'<!2^*BDA0P
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M<:?H<6D)!BZ?@C66QL6+&QBS^D,;T\UVBE]1HY%D2!I66G0*-S0)057&B2V
MS.HVA<U0],8);#U1DT(=C!.#81E*SY,]6^9K71N8*Q(8#9$57%)(4QDL"M7=
M'\&'\20?*T73?_0?<6FY*MAC7I,IM*E.-+C2J9)M+;(5EFB>G>1782R+&(PE
M^HO5>I_\5[OS5.R=7[-[U^!N%J&HZ]H^HZ/G9FF967-IF3!J6#-@>J,=(\W'
M#[I?7,<LJH "2D;;=EL/9-K,'M_=BVYL/$:F&IANN->Q81U&CD&BLX'9_J%"
M;*41Z,5I!10[BI'+&Q>\EZJR-SG)Z] /B5VQ)H'PG[)Q-2R7U#6]%70=%S]2
M9Y&;+E@T7(BG>1G9C.!+B[8992TH0&V^<@<)_!V?4L;M[^QM3 66"3+RH<<3
M>N,#'FSI9X<'>&8#T,?*QT,:G9&5].+^4B];+_7-75O]95_=3R?,J3EKG[Z3
M6F0Y?'&%@HL3J=5:D@4V!XU)#9^649P[XX[4DZO,%@EF,%@ <>L+XYHXUY@^
M)G8,FO=Y9NHKJD.*D^+I]QO TC*8,>.%UL.H.Y$#I7S%FVD!0">4OBOFQ0=Z
MYL+\@:=ASLYBR-BN,4+'"&AAF,DKA P"J5 D0':;;K,W[WLQLV'<(CK$&>J/
M,UMGAA=:1'(V>NF+V#:ERA3,F9&])!I9UBE:^.)[7QJU[&.16I=/PSTXZ)V?
MI>ED^K)AOJ2M*5V%EDU?5)X&4<WNQ<B M5J&9UYVF[H^%.1^([&T7(6,QEWU
M")FIU$H_M'49JVN$==CGY0ZAP0 P# @-/VV,O(TQA&7YT%(HUW975Q:U+4C)
M?+:$ $#0""#(&4*]JCFM&(D^2I(A$3IH9P2X5?$O17P][7RM<E3*C9(L6*7^
MSLF50A<1G;.SDG]%7D$&Z LGJWM+Q7E<22'TXP23MI9#0/"75WQ9'M9'MT2*
MUP/8O,:E$S2OG,LMC5\EB^WIK?(R;"E)4E)K*.7')HHSJ^E>KUGJ&4EK-3/#
MF'KJ\*2S9.-$#=V)J6G=C93X$Y5-/G):&6+#$<H(8;_7 VM(B[E='B$@?YVI
M>07S-QH9</T"/3#*C12)\RE[^8.R$@L %LW?L?;JC_*KC)NO!>/&;YMF>OK*
MFQA@]K0SE%D5J& 70]8ZPF'/J$)DMPF,B5(5(-"#@=),QT4\L+D\A_<G>_;D
M^A:_A0ZCC29,FDYBQ0D,IE.1 T<:QNX5&>W#A0SD "U!HAG.'CXQEE?+M_PD
MB[!+:R.0510A\DCGCW' OJ>/:#U_=89J&MS>BK8")8:)Y-<TVN64%YZQVEI*
M^Q.<(=75X2J1V$%VE>6&]&0Q=XKI&D-Y<T!<8Y\,4H;')!=I'G!=AXK'3=_U
M-Q4C;;!0P\ ](L)5,B$L$KDL2%#?_1LFB;Y(^W[=?GE7B&5F[HRM@E$2;8&S
MU']+&\?LJ4&S:< "X.*IH+4<:Q),2:*>$D56F=Q4<XHG>.&Z>3KSM+,Q(]#Q
M/5R$"QB;G)F622(H[;C/*I(B7:RE21'M4HSC<X ETGJ2 M&%"[$#-7S4+)"$
M$<BQ=57!(!XZ/EPHUYL^IX>8O7Y3+:B4=K174N.QA,GHW@45E8>2U"MJ5I=L
MJY ?:"N-;$IS075]P4G@;XIPW<X?$34\)]>U&; ]*29)4,PGD&6L[H_\Q<5E
M"U&HI5+ A3&AYVJ5CVJS(#MQRC'E)#Y90#3<GD'@W[W].L,/-/&R,CY6;#KQ
MH6239!FD]2*YW=*-)*_.:J)G<J]$[FL:]LKE:YR]'JY.KE5*UDIW5WX+MND'
M&T(?[H'@<^Q/W\'ICNR";-'GF['T_P ^M8&1<"<FRSCI1WN(P$R9]%8U]'\6
MKK,C=#E]55UX%-3U^01D50H@"TTD,Q(>9#L7'+02$84H@,Q:N>RN[LOOO#TV
M>##R&W:9' 0K.IWXDU@R-%0%HR*J; ++.6%B^I-IN?&\<F.Y,*^G08?*+%D@
MD VO-UQ7(!H5T+G,=2[,P(R&FS#"<DHK(IZ0 Q&59+XK1$F49DM45 R8:U&G
M(8^ 4JOE(&+EBFC&DE?$]&]#:9K>CZBAFQL[%FC5=[E)$!1:LF1"0R%19;>
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M;IQ$LFT+O;:#8 9N  18 /UXL#D5P/:\6R>!6&95D)VQ2;R[CPBWLKW)<NJ
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M[[R<KN[3.XLN-Y'P(W6E8J6W1RJ:-T%'J?E! *@K[GH2:B\V?#ED*NQ=H"$
M@!6#4 ;'!-7P;(X' -;H_P!D*WJ<O*?N?)Z;*: H P?#\=KR+#'"KLAKZ]L]
MI<RPLN?A_A:PBR=-3-/ ?-D(]<+!<2".+,@G>O?&B;,Q8H=&PY,*2RV3/*RR
M.G@HF.5*<-( '=HV;TG)V)1ZQ ^GX<TD^.AFDF-MZJ+49 8"@0 =Q:P?L& !
MKKL>07LD522G7NO]@'4CK&/YL>//K:^Z;402V4L8 Y$;CZB4LN2N:P.P.8<-
M6SW<%A:1.$!5E<I6A?&K4,6&.#4<**;98>59&C=BUEA8$@"JY/IGTZ]/:O(
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M/97UYT$$-L4 !5D#-;D-&>-%&=(\\B2Y@"$F?2V;1FE@PD5U+6!9WFJ  HD
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MVW!!XY!OR![^1S=FS];_ &-TQL_L0I0:(.6(1$EAAJBR!GPMJYA)"+$&&,(
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M-_2P0#1-_*1TMCQRT9=Z";;0BE)H'SY!H'VK_3J\>3_'.&.H["QBE&-"-$)
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MOX#[SP^]>V-%Q-0P>SM3BFSVTR>#"UO&U/1<F?2=0F59]4Q4RL3UI<=L42S
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MBM.HA'C2"22-(+D1DHZ1)_3:-AA8N6JD$32Y2E"X_P#N32;RJ $;2FX;1P0
M .B4!+*I^9A0\6:\>XX/G_.O89)M><EL+X\\J.)V3W%E7.QW%\J OLN,9(Q(
M@*?)30ZN,HY7,G1KA?(01(JO<[QO5961NC:CTN?D323!7WQ2J1_RSJWHQ @4
M8Y& W'Z438/CZ%R ARM'@\#G[^Q]^M\ECD6)!7NN\\USG^(55+?54.4RDH6
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M)Q3DY$L&/#L*-%BQ?,NZ@_X8!_#$B-AZ9/SGY@#TLS,I9H84224@ %U9F(L
MCD$U?ZBZ'[=%:]N?/J+)^'&#[?H,G(@BJ4H<*M(9K>NLJJLN@W^>\#,HRK,
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MOCN31OX?LON?3=&P\;^R,K [.QUQ,'(Q,;$;'_#ZL7A_ R/D#U\>%9UD2**
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MK/;V-I69H.3IK/B'4-,,!CRUK9$^:^&\<:R9!3UQ)'*TP='CD$F[S^'G</\
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M50U/4BUT14D4(T1MK$*X>*1J,1F222:.FW'8%%;A5,Q"60+/-^X\?<=%FV(
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MP_! 6!-C#3*62^J8>T)L+SV5RR()$7X52)QC84G2-$8CNB(U8C\K$BP-JFO
MLC@"_'M7//GI .GL=GF;64U((7EV76)8<SX:I2,BLS9PT:K(TC!=.7,X95<L
M;>HJM8YR1HG5>U/6 %;T[I6 VWX5B2#S= G]?;S[6.B@T]'N6JXXA:YVH07_
M "YEYT6=C#9(+1E9*LI8 8H,H]T>^;+V8\C:M9H:]LS:6"[C((@8RS(FD]="
M?#/X?]N]PZ%EYNIS29>9/'EX#*D;0P:>%DA:-EE50KY2V"LNX,8V:OEOI]P<
M&$8IGF D]1^#N!958<@#F@IK<37''O70J;NQNL7R$NJH[NSID;;5S2(ZFP)K
M_/-5VKY02"OBS0I),'-&DXDDG5PLJ>2!['?:47JN''@:IJF%&']/"U#)Q$WV
M6V8TSQAS?LZK=U1()KIFE4)+*O@(Y"_1A9Y!]QQY'']:#_P>/*LTW'@=377-
MU893D>05R&6<-D?^=*AG4=I;GVOD^<KU%=)$KWS.ZL:Y&.?&YKG)(U1I(T8_
M*6&YE'.VQ=5XX/GQ^_C10+ /CZ?[OJ\7/&HRZTQ#%+F\PE^&%X:1B>+Q%#5=
MC4R6V+'Q%B55O;$$JJ6MA9&54DDELDT_Y%LS'+(YBH_U)==P,6'3\#*Q&&TH
M0PW#U&)9K+UR2&! W"Z(Z63J!&I"@7[T!=GDD^]> :X X/1I/X220B/W&M]B
M0F%QUJ\6=H3NKHR)&5\Q$&[M+"C$S!L5!Y"!1UE@%F5B200S311JD<CD6+-_
MTXA[[3N'O?'D>;\^?OTC]A^_^G[_ .GT]^O1)]%]8Z7H=#I>AT.EZ'0Z7H=#
MKCE_]T*_]7F_]V[UJ_Y&_P#O6_R/1D)J6(_21#_1@>O-'2FQDF8$$;,**0^W
M;6I6 M)ZF'-NV1NK91A7,9/- 2R:%?,R-88EEC;.^-[V-7@K^T]4C62:70]1
M2#'&0\TS0D1(N)9R-TM% 8PK';>Y@"4##GKZ89/CW\/V]/&_MS!.3F>G%!BG
M(A&2[90*0GT0YD5&8C<Y7:G]XBCT.SFLQLW,C7;E1/'+KS1ZHO=U:YCL#I%<
MYJ=JH[HG5.J*B]&]R(O5$]>D_P (:;N#X>[0[%)M(CDIE"1R*@)5@U;B0P((
MX%CZ"_F^[YF/_J;NO*2JE[@[AF4K95@=9SP#&5_.&VFBMW7VYEK%L#?D625
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M5/JS6!4RD$ZXP,B=R-:Z:?$,>FF<UC48QJR25SGJC6(C&HKNC6HC4Z(G3T
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M5-&A=<F' P$R8HU6.9H<)Y@\=F,++1D4!J(HD@\V3YQ;<UHECYIZ\$1W<R'
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MPPV42U]BVUJZXNQC*;&6$D!D;)&REND4A8\IVC(>!P2IOA?'  JN1^MF_P!
M97!%5?'']/\ ?V_IT%C^&.N);KW<N4Y4XOPWLXN;%!8,OD[XH:S<.B@(4F65
MD<BSK$,QQ#GQL<Z=9?T-_9$&3&(#Z0NPU\W[6/<"[OSYZ+9:4?6^?]_M_3SU
MHZ*TJ7RH]RWFU@6<;XY0X5AFI-;\7+/"L6TWR"V)JV@ .SK%,IDR4B6GQJUA
MKII3YJ,&=TC18I%G\\TCI'S.<FP<18\+*D;,S2AB\:L>"*'(\?[_ $;MGJY4
MZL\H5$A*JDCH 6#6:4CS0Z>NIKCD5QNY2;OX.T&VK_?HF2\4+7DQQ2R3D9D)
MM[DF&9A79(3KL[6VQ-@ 5I-]DV#RY630WHUM-6E75/22&5P\)\S$DGU<1R1)
M,4$=2B*41B@5(#;PMT#5BA0)KQULADBE> ,9+A,D)E:R"#M*,P!)4$J;(W5=
MWP>HCS[$.3/#[)N&>4F<V-X;SY,;WWMK/ -K: S"[QJ]T]G^-9,KB-T6&M-<
MUV,59.L\=U;6H3=U^95A# ZL  6.[:CK5@_K=3%*)@(42)$=D<6'4C\@9B2&
M+G@K7DFO '6C"6$P'UW>5Y%5XVHHRG_J%5 M=@M@00*6CR;ZZ3W";G<7'L#<
MV_\ ;O.S;^IM@VE]E,?!C3&AXI9=-356*UU&S$JO?%3=Z_GQRUM<IR>W@BSZ
M\S_)JS$J*LL4=27A$ ?PQ,XX20QQI CJ /7>0_/9)W&.FX  .T*I8UR.L9)D
MC$DC9#HQ)]!$ V< ;1)N6OF/YR2 H(H\7T=#6MID=YKG +K,&TC,MN,*Q6TR
MEF-&Q6>.,R.PH@"[QE!8P3$06%*VSE*2J-AGFB*!2">.61DB/<B8 ,P%T&(%
M\&KXL>QKSTN4DJI-65!-<BZYH^XOQT[R/^[S]%5%\,O14_=/T.^TZHJ=4_MU
M1?\ EZ+?\C?_ 'K?Y'K)X!/T!ZQ>"Y!O%EW5G&[LDFH@HL<4ZC@Q>H'?8EU"
M",M)Y[25"C&B7S&&// %4-S9Y87C&CQMDB=Y)-V=\.SBY4,?82KG3C4DQ\TZ
MGD&/'_&R2OB'\-Z8@9M.+0I!(RGY$8NC,0W5%K\2]6N/_FMNUH]Y:5G8H@B5
M@*6.BX$C,00"S#<" >LP/-F)R<V\"9^ILG\B:6C[HU<B-?\ R/3M3HJ]'=4<
MBJG<J]$3[7]U7V?^$BA>YNQ+ +KFZ6GRJ-@"I&R[F IF*LIL^./MU;_K))H"
MY7!$FF0S.I_,&D@25F?VW2(ZR'@%@X;P>;8:<K2#ILC=%/)#$Z"HI#)D58XY
MXIR)K%X\[V30I(U9J2.=(WM>U960R(L;XHI$F'\<^LKA]C]FZ,!"9M3[HR,]
M5EBCD,46E:9.AG7U$<(T;:C&M\;U9E/!*]=<?\-;1\+5_P"(K5-8R(EE;MCX
M:ZWE0*T7J%,K5M:T+"BFBD"L^-.D*9,:2Q%)!&\P!/S=69GKJV$)(&0P33I"
ML39>U$1.B??9T3]**GVJ-5.O1&]53UY>MM9%>C3C=&UFV6ZW-?YBSAV);YCR
M;H"O>^')RVE#R2.J6&8$\F^"6%T#]B* /@'RQLA C2A*E8QK7@(KT1.K4<WQ
M+U:G155$:JIT^TZ?_;VQ34\=>7<(WN2&-7SQ0\^;N_/'3D^25$Y)#*V--(HL
MBGB5V4VM43MY*_;W'$88E%\')[%Q(GB<;E_Y ICRX9965AE16VN/RM@;W/AA
MM \@+D[I'O<UP3(%8/)%*D_57QW[KTG7>SO@KHVFF22?2^PHI,EI!(HW9S0:
M=)$&(*F2*?2)_4VL2J21D!0Z'KS!_@N[%U;0/CM_$?JFK8KXLL&KY_;VGYR&
M!<3**]QZEJFI8Z00JH#8IR]&W2A0S/EFF+;NI5O#C;JP0: 98PHG,:O<U>YZ
MN7Z_3T3HBHBI^R_LB=?VZ<J,4 )-AQ:JJ\!2+!8GW!_NB^//GQZB8>.N'&#(
MZL64L[6#8'E1\U$"CN)]Z%>2>V:.(RM1)1HX"&JZ-R=7(SNB<CVN55:J-<YK
M6]>CF=55>B)U=U*-;?'S6;)O]3_I=CHHR2') 21GB^5@!5A7%$ "K"DD@ <5
MS[5!.8T 5AC.36$4C%MJ2T"+-&AC8LLF.6,@XC26-\BR2N$N%C'F6-CG*MG7
MHJ]K'(OHQ_!)WYI>-#K/8.88L?/U#(77=*E;U%DSFQ\7T]1Q6;:4K&QL6'*C
MW-'2'*(#&MO@Q_Q1] [I[?\ X@^P.^H\23+[+[I^'^I]H/J,2;L?1^[-(FU;
M58</*W%ECFU+1,K/S(W*)O?31&S-\BB4L%QB)M>"U4E\D 55":TF&*.6(L>H
M!B*A:D;WHKX)XGCRK)T7S,G<YC55J>N./C/K8[G^*W?FK0RI+B9/<^J)@R1.
MSI-I^+D/B8>2K,!:Y,&.LR 6%1T \4/2K^!_M_4^R?X:NQ\;5L-,#.U^/*[L
MCAB&T_@>X'3(TYY10999<-8G=&J1#MC8 +0D0O'JZ%L,L <<3VDQR/<Q7=ZJ
MKEZJJ].J]>J=WVB?O]?:^JUD0;5'L" 023Q[#VO_  Y^IKKJJ#4LB0R1O,[H
MT;TK"U!K^ZI+ <V10O\ ?S&F:D/C6R%=XFO>1"/%WM8[^FKF]BL15:B2=[W-
M8JN^U<B+^I>J'8$+RYL<:*SL6VA18MBQ5!8!.UK / ->+ HZ:[JF)H?:6J:Y
MEY$&+B:9I69J.5/DMMAC@QH7GG=]QHA8HVH$#YE&UKKIF8#-7$YUL@FO'\=)
M9UU7C]>^&1TS%BBML>(!;,\B:<ACYA,:G,)<U[VQE.2-J1QRL:G?O\3.E_\
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MR*B(BITZKVIU3UZA_P -VE#0O@7\-M+7<R:=H$N YD4,%$,Y10 U,7,16V'
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MEV1L@0>HL88EJJ^_8)46/X*XL#*MMH*P-SCX19"41!B)WC%>)JV,)SI)'/\
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MQ2QQH;#L1BK"%SG+,?R2GGE#I!;*MH+/R&#!5$(CBB!/R2"0$W;)[!Z1HE?
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ML?\ BFS),[ ^'^N)(<67OC2E[XR\$6T>%FZIHG;.F3E9 6#^G#I,:@*>?2)
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MSNC89VNB>K)&JU//;XC:2T_?O=;#$FD:77,OE8';<TC[T (7YBZD,@%EE(8
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M6 ;DDMPDC@F-U.V1/' 84/FY/^%>1T7'(P /%V/ H_>R*JKL<=9_O;GUKB^
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MLC6N:BI^Z^;OQ)3 BQ^_1FODIZ.+W%BX1QV].5<U]2SHHI9&VML1!,"6VN%
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M@[; 4&_K][Y'N.?]GQTUF_(M]Q9=1!VF/XX)581CU,XE13X;:KM1*RP. )&
MGNX9A6,<,2Z!&3OL71L)C)D)^3,H>ZE%QUE5)&;U' W5M.TU^4"[//DF_H*Z
MRY^0-7)//T(_2K!_\<_>WG#3(\8RWCOAU_AT@,N.FY!M2(&6M?#(%++7[<SJ
MML98)(&,B>DEH&:][FMZK(Y_>KG]SE;6V[CL;<M\-MVW]>/L;'WJ_?HAJW&C
MN'L?]_3QU:'UKUKU@<Y?>U!S[7DMMDOC+Q2R#)]$WFQK*]P6SM<AUSCYP&*Y
M HEQ/4?B;38<-@G\O6UA<8_7S20HXRHJ@#G1+/.YDO5W:OQUT--"T?&U[)==
M5C9</+=8<J0-C0".)=0=HXG5I,@GYHE((<,P18]J]1N?L[2LB:2?U6A$I9RB
MC\DC&R@&PTE@D$FQ=<\'JA7N:>V[S6$SS3F1V&C[0*JU9Q*T07L0^?)\&C$Q
MB.B=685>O(F7)W1D)4Y),VO+:$L\D,"/M7M;51O-;SQW/JF'JO<NOZGA2&7$
MSM8U#+Q)GC:/<),B0A!%,BN@"MN 91>[]NI+#"N/#%CQ-OBA@BA1C5DI&%/'
M'DB_;W/'CJ4?:G]P7 ,TTS;<<=]W-#/F%1534."P9I;.Q['LFKC'5(<0YN01
ML^,/.)&"R0^"V:35RQBP%O8-(LM@(Z]KY4TV1AXJ9$D60)BRQP0&>:4QJ9#L
M4/&S/M4T%W-?Y+8@=.^G. Z1!@2S$BSP*MO'BOEH\^3T>?B!<<4\FRVH;1;'
MB=D>-%?C+"O95Q6$MBF*UP2@8M;V.0XP4\*"*XO;V_ C&AQPBWLJ."Q!5*N\
M#JJ=V[EEUD0Y1GQ64>G&TFUHEDC7)9F^6,S)OW"-=Y)8#=1%KN==FS;7=50N
MYVBAY4&P2?L#QP1?GCKY[5Y"V.K<SY:;!/JP'X5:X7E#+++1R*LZ'([^F,L8
MJ.46D'CKB OB5\MEC,GSGV;SQJ <QDMG:W4SYB&T]\O!T;3L</-J,DY?$@1/
ME@>9 C^M+N9?28V=JM27Y(7I/,7E7'AC6SL4EF&W;]?^Z^ ;JKN^L<F+<M<1
MTAR#T+G\Y5M9 85;6U5M)C))E,'$SH2T%L)!5$B@<OP%[;1L0LI+I9(G*I$Z
MRHU&?NX9.GZRV%DB#\5IT&/CS) @5+"K\GJ@MZA%&FH>;\'E#E@Q3*I*V@H[
M26##@?MQX-&Q?'/.QLC;&FLE'P#-\,WQC60UFVJ<^ZKEQJ@$#C< ._'HIJJ(
M$^$J9&MA(%DFC.O#;@1_R?.5((@PPR*;,6;'BE,'HQ)4902%A)++0$Q(1?FC
M/L!\U@;A?6)I08P0@7P*!\D$V? \_P"R>I.HMSZT@V'C.+5L>2"99.*<HYT8
M,5KC #4#48""SBB93O"J8VJR0<3&"*&<QU4)&24T0@AI"5]TQ.3*YDW?+L2+
MY@1\H( <;KX/('W/%E.3]ZOC[WY'GQQ[$=!']SSD3@]/:Y"-:Y?6#UV(@'NK
MP093"'D9 >H\Q($RR2/Z$LKF5RN;%.UD'RX!6B#K-8+*ICR53!EB3'8;#_/R
M)0%W(U[ BDMR.16X7XKBNCFD]1"NVMM<WP?'%T/I[<W=CP.A5>V[RCP@4C>N
MM]A64E;<Y%2AYSK5SA7&H=D'RJ.XM*Z*6.-)0I(H(["6:?O1LP,I,3FL7[<U
M8STABB%N6$ECRVT@G@_I9'/UKSTE1MM\>15W57Q9X(H7]/\ 3K;+P,W+JH\K
M!=:Y/!>/N*;'ZZ\=+;@EDT1%J2*&V <&YBCE0V826&>21I37R)*QCTG1KV*F
M98W<&2*EF*D, +_ED[FKP+W57BN;ZW-UP0.!1OCWXKQ]!? -W[ =6*YNT=_<
M&Q'C9Y%4XI=4U/3(!4VH#NK3[EHL$<^/N(<64*DL\+?RJ!2/89-##,^ !7PQ
M*M.R$CCD4QQ-^9"[PDRK)56DY-*.>$V>;^;D@*( /1)9J&XC;578!O<:'W'O
M[ F^LMGN0<I\)T+S$X;82=>L.EQ?:5)DV:>=[DEKJ>UM"J)T5BCV.D';!,AA
M/=*B2I 4XB7R,D[W$94YF>."8!E6,5(#9((%;B.23=GGFB>D[L';:O"@$#F^
M!R"/Z#S=CK23@K([//,*SY+MUC2VU-13^& 82VLC*Q\LQSFB*29  72MFAC)
MCO6U0\T90H<*O9,&.!(LCE4X1Q52E7YA*7-%@*H KP2*YW<C]!1R25'L90RA
M2/S>]V&%+=^U#^M7T_\ >7(O4]&7M?!:PPL3/ \<'/2 7Y4@<@<5M,DX)4)5
M811PC70DMD*;*R8J48-&R0KW,$G'1XT4A>.9"'F]1(TA'RG>6 1@U&P&(;P#
MQ0/-@M;M>;-^!0LGP/\  _3_  ZQB>Z?S,Q#&MW\8<6$DF^/K^SQO,<V"=.X
MWQB&WY^2$FSI'VPM4J.4"4:O1S7"PC_%?"U4=&YTU"?(P9,=3.6G2:/*D94$
M;++"UE:!;DG=1OY0!\I!KHV1BFVB5D4J1Q9%<D\5S_E]JKK31Q:Q;C)BP&!Y
MSK2_QU@.3ZWP?,'LQFWKPY+R6Q.+L"+0K'6RPDQ%GRRD_)N:JPBA*(B*JI:B
M"*65'K\_N74M6AB&7/+.'E,:">4R&*)DC5F#E;<)2_)2\?K9-ES)IP%=CM"A
M5 "\ T&(X Y !_:^375DK?;M/G]36Q9%4)C<M'L7+@\5%++K"VV0%-7&%A6$
M#I7^:$=_X1]F,%$5.> @4T#6ENB8) P^DPD:+;_,!(5O/J $D.HKC<I!Y/CW
MZ2<\<D\F_8\DT:^G[U]+XH>7MD<EJ7?WOC;OQO&9X;&AT?PESK7"7[5#G,O[
MVOW'H86\*/L X6-LYZ]U:'3L+>0>U$ D@%+D#C@<Y)F2!B(]M&([=UV&L>0*
M%<@WR1_3K5_ _7_0]:S?2'HKI>AT.EZ'0Z7H=#I>AT.OE.QTL,T;)'1/DBD8
MR5O^:-SV*ULC?M/U,54<GVGVG[I^_H=#K!3E_#GWIZ:CR^;&O<RY"7^18_C)
M%A3T-ARNUU3_ ,UY*C[J.#&J\U.0QXU>YCA:&0HRWE!';'8V;$>TJL'&LMJ2
MSL@],$<EEMB#P>:H@CS9HT/J>LM^7YN1][KSP>>/T_T/FA+.'/ON;$RL-=U9
M;E>>T5V31A96W->:G'?)X[6IIR"9ZX.QC-WB60</7D''2 #N27XLAQ:C,8XB
M7OEO8F;A:;WCVYGYC/'C8FJXDLLD<,TS)'&PW%8<>.2:0CR$AB=C=!>FW5H&
MRM+SL=%#M-C21JI955BRD46<A .1^8@5=GGJX6->W%S5,IEQ^^P_!:T*&R%,
MB>5R&T \9[5@(@(E?&)LX]ZDB(Y& N:,][VGE(Y&,CZ^GC^*K"/Q*3LR;LV3
M,U-]-R<_'U'$;2M2PTQH<E8&@SBV;AXOK1QLDL<T,4DDE.C)&Q#-U=/\$7?W
M8W\.'??Q1[\[P[9;/U?N'L+$T7MK4-.@P,K5,?.P-4R,J32X,@YN,<##U:+.
MWY\SN5/]EXBH\)!,LK95[7O)L* >YP+%L9&C)<^.?'KS>6D6$N<QS(6V8)R;
M#^$^,EKXIC15E;\1SE4524D;"SD7OSX0_P#I?4$P])[AP^YL8P02&66*30]3
MQGDB5YH)\74X<!9(D<M^'F1F9XV4N!6_KK?^"K_B"?$[N$Z]VQ_$KV7/CS1Z
MGJ.9IO?W:8A[GT7&@S7GR\/1M=TW0LG4-8P)L2Q@XT^+IF2A5$$BR!6R7:LG
MM=\NB*0BRL<6QL^V1R('4T^\=#O#K1VE,2:RR&<S8/:1!.LK(@AZPJ.2-[V3
MS2J_M"E4]D_"6+N/"U<9G<.E:%K$42MHNF31Y6J3:A,KCU_5;18-0_"P+ )"
MKU(_JT9$$=GJ=?&__B#=U=G_ !9[0T[L+X=96O?!K"B9N]^\-8CG[>EUC)SX
M96QM*[5T_79-*RI)<"8XLD^9K&/AI*J9$>'BS5%+)^<$X+\Y<3+H!(=38455
MT1^3DP1G[\XXN(E;>Y!D!C2I(Q=H=\5BRIMWU\[X9'1(\@QK&*R617=_Z=VK
M\%<G1<Z#NJ!M9U77NVNW=$U;(G[9UF1\!M#[;P=!']C9)T830KNQ6RD>4NQE
M8;@ H'7@]\4.QN]^\>Z.\.Z=#[HS^UAKFM86OZ3I^D=P3X>GZ?E).-4>/4<?
M^UOP^9Z>IM&\<M-*J8>(T4^]2Y<MY[5O+$VZB(Q?6U+2X_9QB$V3;'<FCW@8
MX463*IT(Z![%=)/4BP(P@)O9,1''Y(G23-C9Z\_?B;\+\7M3N(:;VMK$7<6F
M38YR,3-U1TT/-B;UI4&+FPZG'AS/)&HA$N3C0/"[2':=RD'VP_A%_P"(1K:?
M!GNO$_B#AT[.^*/9DCZ;V=@=GE-1G^)>!#@Q_P!GJ)L/(R=-TG59LJ&=)O[8
MRM,C56C<)+Z<C,^L+]J#>F-FSY#=0XMD#Z.S98 @UVT=*L&*&@;Y(Y[5UCL!
M\,,D<\?>P-7_ !E;$DTIBJSP*W=J_"C,[IU/'TSN+N+MSMW RL-@S8>7GZSE
MRY9*@84$.!IS2E98V??*D;LU,BA-P=J0_BI_XA7QQ[I^%NH]A_#?X%=T]AZ_
MWG%EZ9J_<G<G=7:^F9V)IF2/3G?MDKK<#R9,L=Q?B)3$V*/3>+'>8AH>!OSA
MOR_S*B'H\3UUBK52\%.++)Y!\>XBB(Q8C6N=*Z;:[%[G2$0.=$U7)W1N5?\
M=5WH;\&>S?@W\&<4S:/GYF7KF7B?ALW4V[=[@!6-C \F-C__ &'1EQ_4A!4>
M?)(!;CQA^'OP@^*&9W5G]Q?$3$Q(<./#F&F:<FMZ;JC9&;ER-ZF?J,ZY4[-E
MQQ,VUE81!W)#24#TWZ#VX>4F:5>&6NPJK7X]C0% 8_<8D_>&EGV!]/&9,8P^
MIM*S9A0LL,*G,@<*24$?_LTGB\S?"V7EO^)3M+5N^/BQ'J/96ERIVWK.D8B:
MGW7%IK8D6D:@N5,,_*U/3<S'Q<[,E?'D&0<K%Q\KY8@DBNX Z]6/X4OCO_\
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M(9;L6G)Y!<;[$FO0H6 8D!#W[2'^0"8Z%TIL3 AXSY9)'R0L;*Z%)7I'P]^
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M-L]7(C1L<0*H!C>&8.K4S70/'-/.5@Q1XRR8TC&1-K,"29#7#MMLE5]0?RZ
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MR21Q?--SSX\"JL4N]U+B+=Z7N=6;UKZ\N'"]F8Y-CMNZQJHZRQJ\TQF>04Z
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MS@9&5)^)CU!Y<2.3&CQBL#+M02JDLAY15IPH#G<RBJ(<-7:.7'V#?O0 _.H
MVUP+LV![@ ?;CJ_W\'<.=7;;YOT1\!8A6/ZRTI5G FB2"D@VD.9[/C-%)2:*
M.52(_%$DK'(J1NZI^EZO:G/#UN:FW ,POS[FQY\ V/;].HF:]KKC[>W/'/OX
MY_\ ;=]ZUZQUYLF<C8=#E]TI&4"CR7&0FR5L4PYT4IJ65^>%!\9D@Z>9(B(G
M_,<SN:#"C22W0C21ROX+ER=;63*9=)F:+&FRUED22)XXQBIZTC.R2,JAD(].
MR#(]I&&=2!]'^B_Q&?#V'2=$@DUW%25M-TZ)$:/(#,YAB@ H0BKE&TDT #N/
MR\]#Q]WRMDIMWZ9IY%52:CC+I<"1ZJL?24/'HQE;U7NZ+Y(GMZ=41?MRJY6H
MU>W.S,B+4.T>VM0B ;U]&TO(0ARBJAP<8K8VG<Q#45(X\WUX)?&C-&H_%WXH
MY\5"/+[[[DGC-\-%+J^=(K \<4Q!) \'DDT!58+K;*=L9E5ZQQ:L).R3-\OJ
MH0E9$Z4-HC("&2S3+$J2M^,Q\I4S4C7K#$J-57JUOI^!61MS?*7E7R."#9VG
MGS[D?:_;JK@-S #W-?IUI>R#B8+@$%%B./5MDZUJPH<1(3+7U31ER:KJ*@J8
M$%)K ;NB5\\%F.$:,@<F/$5AQ!@\)KB0.M>W-03&T+3L61@F+!!CRM'B*?4$
M3$HTKOZ:[%W QL59V,@($99:>=X,>W$B-V^W924P\6+L @?4FSP!Y!/5 .:'
M!C9T^H\)Y%X'B5U:4F*M.QS/Q1HV7!=-)!(3/-91I7^>4:@0I9H!8#$;*,*V
M(I29H28VLI?XK?@%[@5\5@Q>!)3)&KL&24LT7JR-6Z8J093P"2;-@]1G6(VC
MR 6%,RBP/;S=CP/ZF_L;'0>\B?Y,'E9)!+%-#F%<LOE5S'1NCJ[='L2%W:O[
MI_5ZJBQJUB?77[JYF!KS[^?O_O\ ;P..FGJW?"/2&1;AV/16< \,&+X8.R\O
M;H\>5U0/.''WU5;YFJULMB<:Z)1Q$D;(Z.*:9R>*-RJ]]MZ:=4U6#&W[ 2"6
M!(KD>:!-V;]^/IS:G#B,^0L*E59AP7)"_P!0&(Y^WFO>NC'A8MA("54%[@>4
MPWQEY:V9.4R%MF@A!+/=-3028J'\@>)UH<*>D9TKQ7D?T7U<\"*Z0KI?+TJ;
M+CR,0:I@28N/AK!BQ&:46RT\C[FA"B.% 3(RD[0K%@%5CU,6QO5#PEE5 IV!
M6IH^"?G]O:CM)-?4#H///#C%FG&+?%V/;5DJ89GSX\GPR[C E$"-C)#")M:U
MT3G2_!MJ@@IL1M7/-\J""4,F6.-A<;5Y;U3$DP<_)Q9-I,<C;63=Z;J20'C9
ME3>C40K@;6HT3YZA>1!^'E:*RQ4D$\T>>*)J_J>/IYZIK3XSD^79=CN*XE5G
M9!DN42U8-135@\UA8V!I,[V0CB"P1RR22/<Y4[61]&)W.=VM:KE0*I<[0&Y-
M< DU]0 "3]J!)\ $\=%#R*\V*KST?.AX-YQQ4QW!\9V*?A6797L<NNR@JEPN
M6TMQ@1Q8K)&4QF9/CJ:*:T%@A?(?7!6,3H63L\)I+'N?%U#\&\*' TK5,YEG
MQLR8!9LB5D2DBM(=L#!L@CYSR\&T,#Q5 RG2,;; 962I#(+# W0!]PI'-T!?
MGS7/44<FN*^799I'.;+'@%FR_7U]7%_RVD4LI]S7B11,R.:K1YL9CR:B!OS#
M:U:F6<>+O0DR.=G80F^-$G]I:5I>3#()$QRTS J_J;99=J5LC9&%&PV\*P#,
MH VCK&MP2"!9-@"EP0J^>>-U> /;@^UT!0Z#32I+X+19_$U84%BE7[[>KI)7
M?2O:BL[?'T7JG553MZ+U1/7-'@F^1X-<6/\  C]./IU%R*)'T/5G>%NCLRWA
MN  NBJ@TPC#&R6^7Y/E-A#1XC210!6!04%KD942UPA-B0.R &!Z>6:7_ '&1
M-DG:]]O0P3:UIPF=HH!D([-SN)C^:EJ[8T!7Z7TIPU5\J!6O:')OV KP?-6:
M^OGZCHL>'Z.)SN0;7K*^$>PRIEI@P7Y:U "I)+29#8V#VTLR6L<?:^&51I96
MC%33UE:6$TAT'6;L+NB6#)[:U+&5URH1B1R-$5,K)"50K)&RJH#1[E8FG"G>
M&8&JF\T2/!*2BJ/1=$<D-N96X^8 &C8 /)(4"P1T"R^PS)];; SC LWI3*7(
M\6(-J+BL+BDBGC($MP87^%9&])H'HQ)Q2F(Z B"6(F%SQY&.=Q+(C0RR1/8:
M*21"/I3,./ (]QS^GV@#"F8'R&/[_?V^WGG_ "Z(M[7O$NUVSMB#;M[?U./8
MUAHUG84]78BRE7N2+% 8%(75BSL@KVUS2R(A(BIS4F)*5S!QY&1.<XW%*>J-
M[LE>'%#;^K78^H ]QP>@@^87X'G_ '_YKHQ'*?A19;5U!<8QA%=A%3<'83%&
M ZGELRW6^1-2&Q9':^(@@$8P>6J;$XH.*.%'&RD3QDMC@C].64<<HY$\T\@
MV2A?DKB[D?:&(NOEW?3S?1KDV3M<(1\K';1% 6O))\>Y'O7/7!_A'*NYIO<N
MW73W8)E8?0\*LTHB@#HTBG$-"W1I)3859]N1K9Y'*U7JBKW=6M1O3TRDW^O%
M\ 6>?_/[W[5T1UZ,WK7H=+T.ATO0Z'2]#H=+T.AU_%_9?^2^AT.O/XO^..\S
M<[DCFT[##46EXZ6]MI<@JV2U'GN4CN&PUD1Y4AJ1P3SEBR,*8L4(Z(Z$Z:7P
M,\M=5^+/PYQI-8,??N_.QLK4TQ\+\!E 3R1&<XJ-DR0PQQ'U(UAE!BIV<!6@
MH$^Y&C_Q%=[186AXW]BZ.V,=.TY)LE=7=6A41P1RL(VB521';*JM:E:MK(40
MON&A1B>YRVOG:C6!6^"A*USG1-C2(9T75SFMD=VL\?1?T.5K>K6)TZ-3UY^#
M<HR=:^'60P=&GFT28KNO>TT0*N?J&VC:">.:/GKPR^)DKI%WQE!_4::;6<U)
M(Z*NL[M*H0G\^WD$D@75\FNKF9=8L#P7$JO'JZ5 2V$RY);BP.9XB)$BA "G
M-C3LC',1)YE:]&-)D@6&#_LYV.=OXW.Y>Y,7)[5[=Q\S(P^V]2TR?.R,>%W2
M'4,[&RF CR-NU9C%"RN(I&8A0LFTA;ZDO_!Z^%_:'=?\0/Q@[Y^(,FFZUW1V
MLD&B]@=LZPZY+XL&2T,V7W?I.%F&3'$N"T+8+Y,&.9L.?+<QRQMM/3? /?6B
M1,D\CXV,Z11(U6HB+]]4Z][GJGVWO<J?W^U5?7F[*IFF8K[\LQ84#X^P_15'
MN!0]OJ/2*-(0M.H3Y/FCD#@+7R@/;%;(^<D[O/)'/"DM'V,9<?:^*&6)S49W
M*YJHU>J-<BN_3UZ*G[*GVJKU5%1=QC^@T36'8,+\C@_+8'-UY\WY%<]:[8<F
M"6)XMZ.I4AU0AU)&]&4V!O6P00;!/M8ZG^UW'88]K?#Z^B+A9F%E5A(ZV8GR
M2ZN"LEBK7V$KU8YA-N5" X&%YOE<.J2DO;))!!)Z+RXWU>.'3,S_ /)&F_C8
MGQ8PL,>2F7/DY!@DV@-M#9&YVC991%%'"K*DC+UX!_"/^ S1N_?X\OX@>[->
M[>Q].^$WPX^(^-G:+HR8DF+AZSK^JZ=I6N8>GX<>+(D8TW2(\L9,Z2*^-*9\
M=6B-N%AD*(.$!8O.K)I6^<B>1)'S2RRM<XA7JYR(KWOZ*KGJ[JG5WVJ]?1<T
MA=E4 *L9*A$/R$*56 !5I0(E#*H44=Y\4.O?O%PDP(H<?'B1,>)2B1+LB11\
M@!"@6H%&@ "/?[<8.S "4B)D+R'SL=$WN;U>B)VKT_WE1%5.O7N[NJ)]_?H[
MT\@@%BHB(_FJ2 KBS5UXVGGY:^_VQFXV/G1'$R0DL$JO'/BR1":*>*2-XI8I
MT8%9HI(W97256C()!4WQS1LUOK7(<.DOR"+),#J-AW-$^ 1#+<!U;CP4M7,>
MKE5+ 6"X4$F4@U&N'$!(^3,1&Y53KKX9=Z]Q]M_P^?%O/TW4)=V!/VIV[I,D
MDY0:>>ZM8@TW,;#8AO1]+%DDDA6/@3+$(]IV]>"O\6'\&/PGP/X@?AE\..R]
M"C[9T[X_]UC7.^-/P)(\+#R<30)GS-;QM.,"0R:>NK:4FHQMA02I%)*ZK& [
M!CP*\JWM2RKF_+)+LCVNFEL2FKY)'=B*C8T@2**-',[6QQPL9%$B=C&,1$3U
MRKKFJ9.I9V1FY.2^3-E9$D^49G>8Y$CR,Q]4R%F=0_*@M0^4@4!U[4_"KX5=
ME?"#L31>POA_VUIO:_;NAXT./@:5IN-#'"L>U0TN58+Y>5+NW3Y60TF1))9:
M1A8Z_#+0J'_8E@ED21_<BN1WD5Z=9%3Q]C^Y&IT3IU^DZK^Z)Z;C CHSB14J
MN!14>%#$DKRW)\>3]^K(=@)D;98H@/Y(L&J !H+]C9]O%=."L/.L,KQ=K(XG
MMLBHJ(B*8>1R%C6?^QR0O\3&HJPR2QDQ,>JL0D>!7_I8J.LCX.]U'LKXB]I=
MQR2M%#I6O8$V;(KKL;3FG2#/0HWRD284N0A>B1ZBL "@ZX/_ .)+\,M%^(/\
M&/Q[Q,Z%GR^V^P=9[[T2:+&8YN+KW9>-/W+I1P\WDP-D9FG)CRIN1#%(_J!T
M<H8S#!*J7SQC0V4-&5D>2>16Q3P5YYM?<D@(QI/8V [X\ 0\L4"22QAS3S2L
MCBD*G=+T1_&+W9JFJ][:7H3YNW2(.U-&UO!TX,/23(U89;SY94D&1F18\83%
M:58BBT0W7+'_  INTNP]0[2U#OC,TS0M1^)^G9>'IDFKS/A9^OZ7I T;39XD
M7'</EZ/CY>=DYDBNOH_C3\S,R1T9?!FJA:UD#D>B-&1W8Y[(XW3*[R._3U1W
MTY%3KT7]OKHJ>N*7DWL2;8BPHNZ!)-%O+_,6HFC1"W2CKV+D@R/79HUCB7U"
M!Z:440@J/ "BPVX^Q)/'OUU5-E0E#:5-U"++.,%8K/:CPN@5\P,[5'-&=',C
MX)H9X7J](YFK#Y8X7)TECBDC?M UG6^VM6Q-9T+-ETS6\!HY<#+ADDAMXG61
M(V].B5+*5:P;5F!4K8ZYW_BQ^ >B?Q'_  '^(7PNU;$P<[(UO1L@=O9.:0BZ
M+K\#+D:9JD,VV0X\\&6FUI56W@FFAD)BDD!^V3Y7#CF;;QJ\7*+")R7<6;H<
M:(Y.DN+Q7)R@"A&1L5(VGED3NG^+,U[(@6-?T:6U4[6_BM^(&9JO;GPV[4QL
MB*32]1[4TCNW/H@MDY4N-)AXGKD4KQ(HRFVM8=G%@A*Z\;?^'K_"=I_Q.^*F
M?\3?BQH&#K?;7PKTZ7MGMW2-0AARL*3XC3:G'/FY^1@RJ1E8VFZ7CXI@@G#8
MQRI4D91(J$\,6PKT!["V1]S.Y6)-*CIE5$5%ED5_<LTZN<JJYR.>YRJJ?W]<
M'OO=B!&"]1(KQ+M0)&FT*JJ H!N[OC[U?7T.1XBX:PQP2>GCQ11PHC@$I'$
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MN&"*('@L9JB- R)']DTXY2CDB.=(L+2CJ^I3SG)GF.3(6C!]8!PRP[MJD<$
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M:5K&L8Q.9EY<F7$28QC3$L0TZM$K1<J4*F0,6O<H7<I#@,%N-D92N9V=V+$
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M "UD9TT$]A9!CI=0AFQH9(&0)D"F,0&V$*P#-Z0\$ ,-^VQOW7Y/1>6'6@P
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MM@JUZ1P"L>"VS OB!+J26DA 1(9"WO"U:3"SA+.D;P9*F&3'8[%:*:E>(<@
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M:V*O<ALH*H5D#K*ZMS7O(.L["9)##9W*R-9YGM'A@';%#&C=B[LY !8DD
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M\+F=O<C557)T1.O5>D/@WA3Z=\/,#'RX6Q7_ !FHJZ2E0WJ)E3,K!5+$HRN
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MR#<$* @W^9MX)4C@BR3TQ>5?&C9&/>W1M;7NUA1!,I6[&*N9I;6*Q4^X ,9
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MH(],=<P]V_"F;N3^,_X/_%+-Q))=+^'/P5^(&#A3%%:&#N3NK7=!TZ%P6BD
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MSW.<[JP%6*U%ZIT14ZNZ+U17?J^G?OU^U^OI=T4AX;HD,@/'-W9\<#S]>?\
M'H_%<&5U(.UO6)(H&C&U <?;P15'ZCKFQC)-F>Q;!6J,Z?8.7*Z)7*]8^E\6
M]K'/?T[NQKT3JC6HYR=>B)T1%&2J_B2."D:E4<BV^8@\U0\^!5CB[OJ)]EXP
MTWL3M#"4.S+V]@.QD9F=M^.I%D@<A-M[:6J*@#CIPOC5S&MZ]4Z].J?NO[K]
M_P!OW1/^7HDBQ7^?].?/Z_J.GM7 8FJ)Y((H#]/?WZ;U]W"NK[%KT;^). .^
MT=V]HI$;Y.[L5K_U1(YJJU['?2=KFKT7TIT[/;2=6TG4HO5_$8&9!FP&(E75
M,>>&0FT*O8F@BHAA09S?C; OBSVDOQ ^$WQ0[';&BS!W?V!WCV\,/(1)(,B3
M5M"SL2"-U=2"?Q$D12[I@" 2.=P'M=AE5_ CC>$8UC21\3O&2>)SGQ/3^=\H
M=%+"YZN<Z&:)62Q.5>JQO:OU^WKOSOC4HM8[FS]6AE$T6I0:5FI*IL.,G2,"
M6[LFP7(())!!!)-GKYB?AU"N-V7H&& ZM@8LNG3*ZA'3)T[+R,'+1E% %,G'
MF7CR!?OU?GU$^IKUG&YV:MQ/*.4.T+"XQW'K.:8[%B_)8U=:7*TEF"XD*I"/
M)%E>D[H0 XEE[N]8A1F=W9#&C%<?PGS>Y$_MJ%G5,^,Q@J[J-D+MCFPL9%AH
MVYLD GQ9'7#7Q=UJ##^(O<4+RA'C.FJ?G ;8^D8#E.6!V,':TK:2S-5D]9.?
M?JK8JJVXZ5P\,, XF#7(HT$+$9!#%'D^0M8R%D:(R-L35[6,:C6-[4:W[3IZ
MR_;X[:D_L>2$%H,='W$,07D=RQ-A>2>;K]_8='_ ^=,OX>X$Z?E_M'484*T%
M,:Y,S@"C5!F8<4//!JR4#^'1J*;$=7+?O&#0S)29UE^>D[(;)_Y0EBQME;76
M;1G#@1$N\BP^<E%B#':QQ331-8+<%'0QJ3RX^6J-BS?(8@+?GWKCFV@H'/)J
MCX\GW'^_'OXZTWXK.!?%6XQ%&M?-!?8ZX)'@$$E3QUQ=3*:4TF=)&S%2 .C#
M?+ R):Y(F.(=-*YI#E+++& OK$Q$&HU(VFJY:[-W1%;19:[OC9Y'W$[C1_NC
M\HJ_ LUYL^/].J,^[GW'\7LSL(JX46:,K'WDBS-5;![B[&B&B[5E*(^"+#".
M\9\$#T@+)?.1)%&\B7R:*P3?N-ED9/F(H*2230 YY%'S7U//6C2NPK<0.  .
M!YO@<BR3_CT:3ALY7<1.+3E3HKN.NE7*B)T1%77&-JJ=/[=%^NG]O3?UIU9+
MT.ATO0Z'67GV[*>+(?>H]UN18$<S&MN".+1\?D29+6@9X7M57L:QC'#^.3HV
M7O3Z^G=?0^G^_P"O]>L'_4>WW'^[_?K2W:X^+D-2(+:A!H9#..=!)&QI3*RV
M%:KXB R'1C3*L$G?"V=K Y"('20RMBC(?&NRNR$$'Q['P0;X(]QS?Z]9#$&U
M)!-BUX/W'O\ 3W^GVZA&?4.I<B+&*ML0$AO!"BIAS)7S#VS3*&\97QSCV0<K
MGQ"6,U=#Y!T*B^;7N; 8/+'.2R,U,O,A14AGD6-BRLF]R"K62*W$\%C0NEOC
MR>CX\O)C&T3.5"[=A/R\\GCBB00 ;\#D]8^OXEG3^O:O7N.23-'_ )QAR\B=
M;*%BM:,S\(Z>"F8D?2/H%T$(:L2+!'W_ !U[7L>QNLGY8_<;1R2220.;OGWN
MSYOHDG<23Y)O_=WUMHUI]:XU^G7KTPG%/O\ U_ZB ^_176.GMZ'0Z7H=#K+-
MG^#CY?[]?(/Y54"?&#JC4ID<A[WH,UPVI\38^*=L5=9R/;)$5)&UD8LDTCI?
M&+(*6L),2C'DD604S4JM2^ I/E@5 8-SY+5XH=;*Y5E*FF6R"#1Y_0W^G[_7
MDU%+J7#*7)\3N-<05&,TEWD-@1DV-R7A#Z0J['J<CKK44*K%EM*.7(EM)8![
M:$2$9(X*@R?Y\LU:&(8I?,GDBD3+=\AT"B.0+'N L!0[[=Q !-6;Y->3:M\N
M9E82-OXX+>5Y!!% #Z\'VYY!OKNR\$UP;6Y$7YC2K%]AD8UC9I8)$%6R6-@2
M5;2 AG6"P0U=Q>-+C;7Q"DO)(*J?DBSUM+4R $K+,C![79P%7;R37]_DEN/T
M %D>2>B5E<GV'TH$V?Z\?M7ZV>AZ^V@=0#<Z>:N+!N85=UNN]5GFG='>=:\C
M,]C@@#R))(1)'&B NEBB4B5J->KN^61TDKL9+I(5D]13*UB2)4*A*"A6!)-[
MAYKP1?OT7(2S%C[U_D/KT>#TEZTZR6Y!IW#B,@LBY<7QF4F&Q,;!/)3U;YH8
MF'$2LABD<)Y(XHY)I7LC:K6L?)(Y$ZO7JX?_ %(9\N^:W"Y$@RF^=P+:W-*(
MJ&X$@CDF^2>O-G-[@Q_QF:'E4E\C)$H+*?4N9R=_S6_S$FS9LGFSUEI][*&)
MG,["!R%9'"W6&MHWN<JJQL#3"&/=]=&JU(D55Z]/TIU_U7UJ=/CTJ2;33 %;
M#9(%8@U4:)PI/T()H <$\'R>^?A]+^([([5F%_S-"P6' %[<3'56%?50.1Y_
M3CK8S[:VL*RTU!3U,AK1<9RFD'9;CB3'CPDM-F#)["#:@NLL$F>R-?B35Q%2
M^!4G=*21&OQX\PY0W2M2DI>TD"@> /)/(YHGW^W4R1WOBO!\C]/\N/\ 6_'1
M:<5Q4( ',*RFJZTF6/)C37"E2"LB&-M"0Y"7DO:0EC*'89'$59OM)D+-?/9_
M-6&11)X"=\F82F*25ZM4"BMH+ FJ'TKBA[C].LM\Y!8^10 %5Y;S[T"19_\
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MZ]/7$NOZ6NH]_P#<.G1Y4.#%_:FLLTLS*D4+8T^;*(P&*T'2-(XD4\?(J@
M==W]@Z<=.[/[5TL2EH].T3!PTD<EI&6##QU!E8@LTF]2&8V2RFS?6M7V:-G3
MYAQ2PO)C2XJPVNPFHLS2SUMW.BE#E:E?:1,@G$$40(BFLIS!DAGE-B*#\I;!
M8Y8"H5$(VB81Q%I66FD%;=OOP?J0H!%'Z"C74P3_ *7WW5?'CF_;]*_?HUE/
MD$\&+Y1<U[T)"?7#744+I27RE5Y=?9^8JM?5QS*TU5"D)A@*A_VAL4$*1Q$D
M1=N@C1VC62,_R@$%^X!N^:^M<>_VZP?(^UD<_P"?V_0']O!9FT[J< 4$K)9Q
MY:>2.QI"!$)'GJ/C@!QARS_*D/+,)=;.D(83#D$LY 3G%0G10SS(QJB-#Q%C
M0DS%PY]R%L;FL\4OGR./ XOK(%D #DGCS5\ ?;Z<&OKUC;W'@)&2>Z[Q8. '
M6(&HER#,#;%7 ^"&FH3+N>(Y(A2)&0Q--+C!:V5L4DLOVV%XKH'OQE8S&6-1
M()21; 7N1Z^9"#1)'!->YNR21T4_YMHY(8@CZ'@5^I/^_KJ(V5RMPFBCUOE9
M\Y,!$\N-T60#@.+NH:JP4:OM65P@U/ ^:]_*C%()'; BFTXDX) \I$$Q9 )+
MYI.@9NJX^0F-*L6R%IXPX0 QQEDE8L[* $<$43N(Y4$#I=CX$DZ$K(%()M2"
M=OL#=US=\?N0>KM4&>U!5#,71V$>3IE-?0$5J@L2-Q8UI-).-9L*4B6)1'TI
MM=8O>OA=\='O:J2%H)#&X\1UC3C\*T2E3&P^9:'RK\MT-W@#@<#V/2':]MP=
MR_FL@$70'!(/]+X(]NA&^Z=4S;+XM6N)UI,TI4&9/%EA56/6.$BCMT:G>CD>
MR0:;Y#'0S2),DL+46/M<QWK00RI$KR<D[B5 %*/%D@5\P-\#FO?CK4JU$UX(
MW'@__-CB_;IG_P -+@16A/;URNYS2(8-V8[>RB"R$LP9T&_^#;TI(V%V+5<(
M#\RS+\8KR!24(<^."*)TTB)Z)3YV 7D\MP/8<DCVH5]^@%9C0' %D\>UWQY/
M%GCZ>]]'N?EKF4TCC";2RM+HL7\41/9/IT@2\+"GBHY# JZ5K7#15Y[T*CJB
M"@A0WMZO_)0CE*@NXCTB!2DT1P1S?GR1]/\ /V.";A:U5?0&Z]_J:O[\U[]5
MYW5M JNRR"R#@J<@BH";.$V>LR49!A2U8R!X1CW700Q#IOG "C5EF'(L1#&J
M-(\ML143AAX\#(RO:32*WHH48^J I)8$"A6WFR#558-@](E:,JW#DC:*(-?6
MAP!=V;'].>L&/NHZGM/_ "N60"E RQ4696D-M52/5CXYF!8X1;ELZL<B+(V%
MPTTJJJ*Y)F*BJJ*JMI6GC0#FAS[CWOBO].!1Z1LNUBOTX^GC_*NM\'&W(@ZK
MC4 $L4;*L+&L'KJXPHX@,DZHB#K@+*R60 ,DD%897&^%8&R3HY6N;&*BC1OS
M+ BNK*V\D4WYC3?3D_<7]>17!ZR.*L_4^Y\CC]:(_P B#U/]YEF'6N=@:\()
MA=94]:;/*5]1*"M\*F/P_%B?"C'E2UQ)0 A$4G<KK!($=VF?%)P(GCBED"L4
MXW'@A"Q)"[>3R>* /(L>.#%1V4E1?'V ^Y-FB>?\*'69S^)@V!/<XMH;#(/Z
ME0?MG')Z\H:))WCG!+6G6HY)T!$K()(U6*"$&6(>2"0>>9KYXYFHR6]C84>;
MW9VSB3[1%)J^*TJ.#4D<;B0J5/\ =;:+OR..>B996Q8C,(][PAIA&?[[1J74
M5[^ :]Q[$=4<X@;IV1Q]WAJ6G,SNRAQ6W$I.D4606]KCU91Y($R1LL],)-.&
M0H[((Q31)HH)(OBPP,LJB.)#A^F_B)VAIV;H6HS8^)CQY49.2C100I+++#\N
MPO\ *2"C':-U6;*.0%+9V#WS#WY%G8TF)+'+@9.5@OZD)A?U,.1TW@,D8*N4
M(1U)#@J02* UTZ[RZRR;%M>V1PD=&/7A4<=M-(TB<&]&D93 4EF)=):D1D]8
M0S![93Y[ F:"**8AP+2!I9./\N+TY&B4C>[DE5/,=$DK= #;0\4&^]=/F0L:
M2.B<@%@+\@@$'S[V+X^OV/59M8ZE/K_>$!W2 *Z'&\IX+;<QDJ-THY#P+:/<
MO':Y @D)&EEAEC(#D/8,D2NB8ROD8V1_;U](Y5IKH#P./%U[>_Z_MR>DQ!'G
M_?\ N^C1^BNL=+T.ATO0Z'2]#H=+T.AU_%^T7_DOH=#KS"MM6MWAVU=D8?DI
M*4N3X[L',<;N:0LR*(^OO*>_L0;"NEB;*J_)%)A?$_L1[7)V.C<^.6-[_2?1
M\K#S](TW-Q)DFQLG"Q)(9ELJZ28T;#SR& )M&IU(9652"!0^5VYEID3AL!S4
MK@T@85ZE^0**DD$$&C8(/OU7GE_67.0^Y;C-/2RK^6R(36P$34(:*PQYM'&K
M0I97N\38RY&MC597QP]7=958Q%7UYI_$?6&T?1_B#F))DPPR1:W#EM \GSX)
M=5R(# L;>M&Q0N5W L(ZC!8KUV!\%^Y=%[#^)/P\[E[AS!I^A=N:_H^5JV6T
M9?\ "XL,R))*ZCYBD9<,Y]E!>R ;N'132S5OQ)6N@,K5D$)@D:C)HYAU5CV2
M(_HK7,>CFN8B?3NO5>J+ZXCG5?4:1&1DEJ6(J;#QR NKJPL%:/F[Y%#GKZ4L
M#.QL[&Q,O&E7(Q\K'@EBGC;?!,DD4;)-!(GR2PR(Z.DJ$HRL-K$=.<"&((=7
M&*R.-62-<LBHK6O5%<G5R(G1.U?I%Z_?VB]>J(4 *(/D@5^I\57(]N/Z^1T=
MDR-D2GT06(-KML&AQ=6?!\D5]Q[]1]EA8TH8, \B/C65[D>B.Z*B*Y5_U7]U
M:G[?Z_LWIZ682_S':C\J4;%&V(J^>. :^IKCHV8.J'U#M::2,<'=\J+?! /D
MD77Z$^:^.%>&?Y<3U>KVRNZ-:G7M>Q[D=U3HJ)T1.G3JB?\ VTVU!3OB/L4X
M(]_'[^_ ^_CHK$G)Q9&B=#MRIDE4D6&61U93]PR[2/:JZE&D8^*:6-(&O^T5
M7]R(Z->CD1$<O7JO1$5?W_WOKTCCL,1ML_T(Y\@^U>]CR/WZ*SV61(V,FT<_
M*02"./;V\D >>.OYD!*P VG?)T:H[D_0Y$>Q7=>GZD5%5%5.CNJ=%1?_ !WY
MW@799U'UW<CSSS]./;S?D%8BAGA8(+0LQ)%+2*3[CSY(YX/488G:_CR8I&HC
MWNCL6HU5_=SH!G-_;KU559U_;[5?[?:>G')%1!R44"0 LP-"U*DF@2/S"C[<
M#[];!%R<@P%@H./#(>1843N2:+ D >:!^]#D.>JF=(8,5(6C'EJY[D?U1%5Z
MHB1M5%5%5SG]'+U:J*O^B=?3205<K[J2"? X-<DWP>"./'GZ=.V37X9XUB)"
M*NT BP +W5S7RT15W]> .GL?#%\6)CW/3Q2(C7L54<[KTZ)T145R]$7IU<W_
M "_NG[+N];0/<&K^M\_J/)//)_ITR8[L)2RA?G4V& ->1Q8->W@$=0IGY4;[
M(2)TG=)'!$V1%57*U>]R]%5?W7L1KG=%Z?J5.J_W<].5BLCT>?EL^Y"T/>S9
MOP//'WZ+U"2-(L>%B!OG,E4+,=J20/MM-#@[1?VZDFN/=&*"_JB#-;"Q415_
M5W]O5>B=&HWM1%5/O[Z_7^K26(8^ %8@@CD$,>;YJK/M_P".G27'61I-MEV4
MR+XH*!:CS9)_:EK]G6LDK4DC:B*SHUP\J+U;T>[[;]=>BM_WNC43M3Z1/I$W
MY(*BJ\KSR/'N/I8^ET.#[-85;5B2&Y#BO% \CV(/@620>/!OJ.<TNWO'G$<W
MM1B,C<J+UZJUR2?V545>K4Z_?UT<BHB^CL;=)D+7A;K[BJ K]2"./<^:/3C%
M!'C8K9)))*EE-5Y_-R:YH'VY%#CJ3,J+6#,\FZ]SX2<PR9'=&JO;_P!<']5_
M2BJB=6M551%1.J+T^UZ%/:2R7X]1_KY#$>./L>1XKIA[=C6?MG0FX#)V]HI!
M) O=I^*?K5T37(NOL+1#G2.@=$Y?&LC7*B='*K?&O5WVK>C5141?I?VZ].OU
MZV<V05HCQS5B@ ?I^@%U=^QX4Q *'$@IMI \@?F]OS$GR2?I5GR#U09O@*LY
M)W*T>*%_57?LG:G5%5454151'(B(G]TZ?Z^M8VIF^A%#B^; 'GGFN?\ 'WZ5
M3PAX<4)S(T@)K_'Z<"QS?Z?3K;U[5#V2>WSQFDC1$CDP^[>Q$141&.SG*G-1
M$7[3Z5/K^W[>NM.PP5[2T0'R,>4'WY&5/?U]^OGP_BO-_P 1/Q5/U[BC\"O_
M -EZ?[<?[\<=$']2[KGGK!%[]='8:;]P39.7YM*36XWMW&L#S?"+7X!ZU]C7
MU6(46!W%?":@_P 6>UJ;_&"?R((\TLX8-E2FE,ABLQD?VE\%^Y=)E[%Q,!\B
M&')T.7*Q\U)7"L!EYL^5CS45%I*N1Z:[2UO&]D&P*]U_M;/U#5)<S&C$B90C
MJAR&BA2)E/))*A _  VL +/0-N?IL5AHCAQ9#2*3!)CVT)(YOKM="W<VQ.CN
MCTZ-1W3L3KT<B]%Z*O5OJBOC*S-\1-69-H!P=,46$?<AP\=G"[@5!4JM,.:-
M#B[EV@8$FFZ3B8<R^G./6E8#ZO*PY^]+?Z$>PKK:OJG8&%\P.".D]GZW'??,
M)P/%Z_*1'2UT]71%X=*!'D MO$R$ACK.1*VW"-;!VF3*("X@>$0J$H2N=.?8
MLBJPD"K^0@^JS$_(JD@\[BI()JE-&ZM\CXC?]5XY^OM_0^+\U[GJ<L(R:GNC
M,4?CY)MB!CV._% K0VUX1,A3PDI/YA$!4^KD=+"$ ]R21)(6D#5B!$\ILB$[
M7D(LC;55):$CN"262SZ:D#ADW?-8HEDKH 6"WL!S8/UK[5]S7/'5%.>HI40N
M06MW"DB5-:$YEPP8EM<:=;D(I,(=@R,R1MA M%8%3K.:;*P>8*">T?%-*+!N
M OX.4,I5K\-5^?TX!%$>_P P/VZU#7'(/^XBN: H <^//D<^]75]:2N*);3^
M+O&\YCD>PS0^HRF/14<CFD8#03-<CD^E14?U14^EZ]4],?1/4_>AT.EZ'0Z
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M4KLH-_E)'(Y]O%^#]JOBN@-<I?>YX?\ (''\3PJN]J36^HP\%K<XHP0JK-L
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MXE6QC0UU23D6<R)7QAJJBH":N4?D1%A158UPY<;UC<Z-SEC<K5:__JE^'O\
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MP[':'$<4IJS',7Q>FK,=QO'Z4."NIZ*AI0H:ZHIZJO%9&,#6UH PX808\<<
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&U/6.O__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>48
<FILENAME>g60414g75d41.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g60414g75d41.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2<@4&AO=&]S:&]P(#,N,  X0DE-! 0
M    )P2^F8@X0DE-! 0      &$< 5H  QLE1QP"   "   < E  "')R-3 P
M-#DS' (% $!-:6-R;W-O9G0@5V]R9" M(%!R;VIE8W0@2&]O:V4@+2!3+3$@
M4F5G:7-T<F%T:6]N(%-T871E;65N=" Q,3@T #A"24T$)0      $'_/CME6
MLS_]O'1SP$HW+M,X0DE-!#H      .4    0     0      "W!R:6YT3W5T
M<'5T    !0    !0<W138F]O; $     26YT965N=6T     26YT90    !#
M;')M    #W!R:6YT4VEX=&5E;D)I=&)O;VP     "W!R:6YT97).86UE5$58
M5     $       ]P<FEN=%!R;V]F4V5T=7!/8FIC    # !0 '( ;P!O &8
M( !3 &4 = !U '        IP<F]O9E-E='5P     0    !";'1N96YU;0
M  QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"24T$.P     "+0   !
M   !       2<')I;G1/=71P=71/<'1I;VYS    %P    !#<'1N8F]O;
M    0VQB<F)O;VP      %)G<TUB;V]L      !#<FY#8F]O;       0VYT
M0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O;       16UL1&)O;VP
M     $EN=')B;V]L      !"8VMG3V)J8P    $       !21T)#     P
M  !29" @9&]U8D!OX            $=R;B!D;W5B0&_@            0FP@
M(&1O=6) ;^            !"<F1456YT1B-2;'0               !";&0@
M56YT1B-2;'0               !2<VQT56YT1B-0>&Q <!.Z8         IV
M96-T;W)$871A8F]O; $     4&=0<V5N=6T     4&=0<P    !09U!#
M $QE9G15;G1&(U)L=                %1O<"!5;G1&(U)L=
M     %-C;"!5;G1&(U!R8T!9            $&-R;W!7:&5N4')I;G1I;F=B
M;V]L      YC<F]P4F5C=$)O='1O;6QO;F<         #&-R;W!296-T3&5F
M=&QO;F<         #6-R;W!296-T4FEG:'1L;VYG          MC<F]P4F5C
M=%1O<&QO;F<      #A"24T#[0      $ .__C4  @ ! [_^-0 "  $X0DE-
M!"8       X             /X   #A"24T$#0      !    '@X0DE-!!D
M      0    >.$))30/S       )           ! #A"24TG$       "@ !
M          $X0DE- _4      $@ +V9F  $ ;&9F  8       $ +V9F  $
MH9F:  8       $ ,@    $ 6@    8       $ -0    $ +0    8
M  $X0DE- _@      '   /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H     /____________________________\#Z   .$))300(
M   0     0   D    )      #A"24T$'@      !      X0DE-!!H
M S4    &              9#   &5@         !
M      $             !E8   9#                      $
M                $     $       !N=6QL     @    9B;W5N9'-/8FIC
M     0       %)C=#$    $     %1O<"!L;VYG          !,969T;&]N
M9P          0G1O;6QO;F<   9#     %)G:'1L;VYG   &5@    9S;&EC
M97-6;$QS     4]B:F,    !       %<VQI8V4    2    !W-L:6-E241L
M;VYG          =G<F]U<$E$;&]N9P         &;W)I9VEN96YU;0    Q%
M4VQI8V5/<FEG:6X    -875T;T=E;F5R871E9     !4>7!E96YU;0    I%
M4VQI8V54>7!E     $EM9R     &8F]U;F1S3V)J8P    $       !28W0Q
M    !     !4;W @;&]N9P          3&5F=&QO;F<          $)T;VUL
M;VYG   &0P    !29VAT;&]N9P  !E8    #=7)L5$585     $       !N
M=6QL5$585     $       !-<V=E5$585     $       9A;'1486=415A4
M     0      #F-E;&Q497AT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4
M     0      "6AO<GI!;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N
M!V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX
M   '9&5F875L=     MB9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO
M<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG          IL969T3W5T
M<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/
M=71S971L;VYG       X0DE-!"@       P    "/_         X0DE-!!$
M      $! #A"24T$%       !     0X0DE-! P     '(,    !    H
M )X   '@  $H0   '&< &  !_]C_[0 ,061O8F5?0TT  O_N  Y!9&]B90!D
M@     '_VP"$  P(" @)" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,
M$0P,# P,# P,# P,# P,# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4
M% X.#@X4$0P,# P,$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,
M# P,#/_  !$( )X H ,!(@ "$0$#$0'_W0 $  K_Q $_   !!0$! 0$! 0
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MVP7-@PTUN<YNO[Q9M1F=-Z>PM<S&J!KU80P:=QMT_-_,24XC,MY>VT=6>6@
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MV.]3T-CMF.P?HFNO].W_ $/Z.M/;:VFZ]K.KV4V.M.\6,+JVFRWTJ:ZO4'^
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MU.0YPI%_T&O(!GB.5C=8^TC#:,EU+GBTB*9@:,T?N_/5#J&T]-Z=,?S5O/\
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MS"WW.0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" )6 ET# 1$  A$! Q$!_\0
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MX6Z;).[O\1K#7&K:]:5'R=/3MMWD8>QKN+/;0C)-Y!5*"KTE(JPS!Q,OE6+
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MDXB1D5W$:65)[9=CN;:[GB'9GT\LG-HXYG3>Q!$"Q/5(57=-PY@%D,?SG1<
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ME^P:B=XQPXK<VSHTBV\DDEQ.8W.MP(^KA/?CYW"]HMVAI0 I>FL>#(%*  4
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M*F[-U])3;;KT=.Z3.N; QAG;P#N(A._6)DU.F2<?%6R;>C5:Z.@YI;ON7%I
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M<Q%2+K"<$TCHF#NJ%4,42&^U-T'!MZU$CB%ODU"*$*<ARG*8H& Q1 0, AU
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M _,78OTY^0W[NVPLL_SA^CI^HJC-'?GO]96;\JKIA%5[VG7YD=4^0_FEL7H
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M1$D@G.6U>2KU@BD(J-55/ 3DB$;$/,J;2]P:#'$R 8WQ-IX2MJS@UA):77$
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M>2&A;^P83&R:YKCE'%6B=G=1/:4G8+N:LVFQ\<4=@V=G5)Z/=S$-!/Y"3?\
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MRT>O3_>^(^/\OR=<FGO[OI15 =2_ /\ V?W\VZ7'_F ]$V[%,GB?$JR3LSA
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MFWAF, K).;63VAY5DYADU<N$LW,<S6(TD'V/H6H,[B.W_,J5Q#=\H& !#K]
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M!5P@H5V9P"18M,"KRHLD#D5-C6!Z)OIO$'U ?Q5'5&DB)-MX'$C=X\?4L_\
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MF"6BQ.NG;V%3!.@)[EAOO!_(Q_WLO'R7>W<D'@? KT7\-OSM6J?[BRGT]?\
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ME=U-U_W\M'TB'^U\1\.N*8F>[B>/ %()T$JG_O!_(Q_WLUCY+O;_ (5,'@?
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M0T0[2%>K)(V6Q(*4)",WNHUK"I7CA->EM5ZU3E*RZ9P2P*035[&B@P=(-2.
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MT!P=$$2//)X#SB&R#.LV\5R,#Y;ES2)S. IY3X',!IPMO( GT,$_J"]0'KT
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M!($@WUMU[_7W!(=QX^LP=#NBWI5,Z["S&*N#>=BD3'0F2-S*U]=<$7#ITBI
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M]^C*/T';]!4+*/:;^=(UAZ?FJF/4.H?UH)]&59J>SZ0BIO[O_J_XO_7FJFW
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MM(3FO-Q;N@Y.4CPBWS@[O5$F"S('*3L$01E-4O$4Q!=!(X*)IE4#N]T#@41
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M,QIQ971RS9R#:I.@*Y$6UC7924<Y2AE@3D%$GK0Q&Y@<(]_.#OF][\"=?%:
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M.TI+8%JVVWIJQJRR+,6VX-(QNPCD6+=J>:U8A*1,?8R*M$#G-=F((@4FML"
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M6Z1V9;X>].&TZPJWRCB_D75U#0CZ0?1;](\&VB9/9S& N8)#@P.F9S=$.(B
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MR?/.[\0>O_!;<7[$MKW]\?RCUS]$>0HQ2Y1?I-G]8\S%C0V.O=J+KY+Y2_\
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M*2\'0=9+S$:_C5:]%UR/B50L>O5&?OJGRAEF\W+S39N%KL[M7P):/N*SI:3
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MS"(.68WP=599Q:JE[CM46\NM4X75E1F-\[7LNKJ_>=760&T3J67L+I:(:QM
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M#*XE>W4,4_#NYVORFQ&+HAE3G<(T[6+L2QS<IH#W1292;SC7%IJ%X-*<[07
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M[]6_F,]06=/W_P"D=]"S[E%HF$3")A$PB81,(F$3"+R$?9/?YN.(/]ZVXO\
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MG11,[0>LUFX'%9-TW.0JI/O&+=39A,4^L2VDS#UW57 9BVFVDXO<!E=)#02
M6N!(@M=H?F; XO8&3G+V!L'*<Q< V' C*9B'2(-Y5^^[IWBJ\O>Q?GEENS#+
MN=K*3T;L-.'UOVA#QU\OXY5TSL15)RMS3:LST[[]3<E?V,$UTIB5!:0?.'*B
MZZI_C^RJ&W1A<$-FT^7AV4YM)^%+\=R5;3.$=D=3_!5&&O3H\T6 4IEC.BT-
M(@>XX]^ <_$^ZG<F?=;15%84Z&W7/Y_*]KAG:[FGU34)/.$<V]X+B+DGSQ]?
MM.@]>H@4>@^OH'4!$  .H#U 1#R'IU#J'3/M72+&$YIRR<T9IALR0 "9U,"3
MH(7I(@0!%G'30V,$<!:PL8%P%_4\TL8":%U2<3"0":DH9A."B:)B@6G10B8%
ME1!-(2@'4%%!!,@_;''N@.?@3:T?=;:GZPQ>_7^<U8TXFW7"_3VS?R=@/]RP
MO]Q350_%C?&IV7)%A,H\A-;5JOVF#LT5;H6^<R^(FRIG8]XE9BNM:4>!AM0K
MIV1_/Q[LLZS<+3\F9(_O5)JS9NI0Z?<P>'9.D#:(_!O$03/2,B(O968Y@JB'
M-&8&SGL#B>I@ .^YO<F-\WEOX]C+,'D9)LVS^.D&SAE(,'S=)VR?,W:)V[IH
M[:N"J(.6CI!0Z*Z"R9TEDCF34(8IA#.==>NJPR7C'QW)27&MBZ.U(&OGDX6S
M/*2&O*H%5=6--%-LE/+P01?NY292:I)-"29VYGA6:2;4JP-R%3"V=\R'$&(/
M6V(B-![<2J&FP@ M$"XXR-#.OI78G&D-.N[+4;FZU9KQQ;:!'-(>C69:F5Y2
M=I\3'IK(Q\7694T>+V$CX])RY38-(U9L@R(Y<%:D2*LJ!V9T$28,S?6=?'?Q
M4Y&R#E$B #OMIX;ET_D2 !7]:_@W_HOI^#KLF"PWWWYI^A5J>\_2-^E2"RJT
M3")A$PB81,(F$3")A%UBY52'O%9E:I/^]/=$R@1N\-"ST_5Y9,J:R;E)6.L-
M6DH>PP[M%=!)5%]$2C%ZB<@&2<$\^H:B%!B+[K^"I@KG*>>TU\B-G-')[1J>
MP-MF*CKNR;QHVQ-C0D30VLPX6<NG[_4$/M"+L;QO&*))Q5UV9;C*6QS#:XF'
M<19;#'&+UNIYP;N:6@7--S6$F[3))!-S<0 .]<K7Y'3#2'3 SM+Q G0-#K[I
MDDVONM@Y  1;3.P2J:H=;R*I6W92Z@9K1C=;8*ICI%1K2CB951BD6CY84ROU
M'YE&Q6)7(J-7H?Z$7Y6W< 3E%I=P_B(TMNNNA_F'HETCS?K'K 58=6U+=8OY
M.;8N7&N\WT)S8F^['M+336D:S@F$5<-C:OUS3*++4*BRMZ6@'=+AJI1%=;O[
M+*3!+-)3]ML=RFHV+AY67"/W+A+@'@68&N!/FMN;P3)DV[CI?GRG*'%A,EY>
MT-'GN;E! X" )B023)W3NU5JS>%7T7HNE&V9&4Z?H^E]=T^Y,G5/9WLSNU5Z
MJQL;+ND9U:P19E4B.&YFI3E26(Y%O[8"H^/W"Y$MDVS7,&2)'9UZ]ZV:UX8P
M9LI#0" T.TZSPT62>-A%2<=]$D65!=8FG];%56*F")55"T^' Z@) 8P)@<P"
M8$P,8" /= P].N0X0YPX.(]*M3_%M[%FO*JZ81,(F$3")A$PB811;YAIU*'T
M3>-DVUK<GJ&IX&7O,>UHVR;;JN6</(]@NB+5Q9JK(M$TXMRFN8DB2S-9>J(-
MP,_G(U1HS.LC>GYXO'7$]>EIN.*SJ@9"2"[*) !(/B-W&QM*B9H?D=<*7OY/
M0]VD(78#&WGH*$#8X78NM[M)5QY;ZOMVT-&3E]1=1ZF"Q-&Z&JI9M)IR,4K/
MPK1]7[$H\FHB:>NHG1[ 6Y@,I$D@@MF#<@$F-T"VI"QI5'!V5T$=$ M(<),Z
MN $D1?JNK(]C0DM9*!=Z] >Y_?L]4K'#P_RA:G>U_P!ZR<*]8Q_OUFF J.X<
M':Z(R;4@"9=EXR10$QPS%IAS2=S@?#VZET.!+7 :D$#M*J#U1Q1Y$ZZ5J&P2
MT"U6-UJ:TZ+D&FN-D[EIETV#>V^LM1[UU/-H5:^HE95* HT:?;D'=M;U2RN8
ME9.>@K8[?(U9>Q,T4>AU1AD$@9LPS-:0 '$&X-R3$&(UNN=M*H"#=P!9T7N!
MG*T@EL"!KOW3V*?&G-([#A-15VOS&PK;J6R+6_;5]F(77)]<SS2,^=C:%KV0
MQICB3O&OKDT?)4-G9DZVW>P#6'9O%&KI=,BS$T>FVP>X.>2T=&!!G6 !/'=(
M]/!:L8[( 7%KNEYH;:23%VD&-Q@>"[KQ@8N(S4PQSN6D9YTQVAOMJO-2Q(Q.
M4E54=[[((H_D$X:.B(DCMT8!6<%C8N/9%5.8&S-NEW4BR_SCV#U!6IB&@3.L
MD@ FYUR@#T=LFZD'E%=,(F$3")A$PB81,(F$45+%R8M$+89R#BN*?):[,X65
M>Q1+14&>CG-<F3,%S-U7<2K,[S@Y?V8RI#E DG#QCY,Q#$<,T5"F(%PT'W[1
M:;YNR/-U$7W=:S+R"1D>0+2W*1^U/ Z3Q 6%-^:"L6R8;?UDUW2Y>!ON_>(%
M\I+L]FG2MY8+A*1L4SJ- D7/OZ7C*NFT:*2K-1O7785:.EI&?G2+N'\M(R4A
M9K@ &N-@^8L1%Q/C?LW*CVDYG,$%U,ZV,F+$<8!'"=5@175]X5W"RW^CQ>NC
M?3;78# R_'P8?6(6U:22X[SNNE]JEI9+@:H+)$DY.-UP**DU[\-$Q8V))J>O
M>"Y&V:P;G$WZ8G>XNB;$6M&F_@J!C@\O##E):,MA8L@N(ZCKIQB=)IZ4U3NN
MHZ T32D[]':]GZ;K&LUZT0;NHQUY!K),XUHDG$I2A+#'(=RN($+!@LT,Z;/@
M9E=(K>&8G>R+@221,GC'HZ]ZV8UP:T9H@0;3/"]KC32ZR7QA372XV<?2.G .
MG)=(:H*X<%1!N1=<M#@"K+$;@=0$"JJ 90J(*'!(I@3 Y@+WA5/QE7]([ONI
MIV8R;G*V2!$VX+.>55TPB81,(F$3")A$PB811'N_(+;T/>K-5-><;U=JQ%;F
M6-<5LL1O33E>.I8758B[8O O:U/SS>?A9AI$RS5][LDVJ+UU$*M9UN@:)?LW
M*MPT1+GY9OYCC;0&TS)M-@%F7NDAK,\&+/:+Q)!DB\7B\CKLNDVK4]HOV^N*
M7(%UJUQ3KI!1NSX78ZKNRPUC?:^@YG6MLCH"$3>L99>(=(.[5*ME'JU2;*!)
M.?=RTR95*)8J,I#@&O;.8'*6Z@'I D";B1.[<H+274WY8<"Z;S'0<!)&Z8X:
M\5!B)XU;Z^36ED#Z,G(\_&76>G*5LJ"5F-;][D_/Z[Y":LV-.2]*60MZK65:
M'B=>6RZQ"^RE*BK)SFQB0KU%D^7LAVFO.,Z8+ISN.4B88,D"=XN=_#JE89'P
MR&D<T!F&F;*Z>O,"!._4WE3_ -#:PVJRUS<UR/Y;1#Z];VV?M*&J3N&IEGEJ
MO3K=,.'+"O2K)L^G:O'R<L\!>Z2:,))OR1\A.N(X[M9<CPQLGN!</?0T"9(D
MQK.I70QI#;$MEQ,1, Z""+0N_P#%]A*QE8V0QFYU6RRK;>FW$WLXM'LHI225
M^5*Y@7-'QQ2,VH@02I>&@4"=" ;IWC&ZQ4U$"!D; X6XI2F'R9/..N>[@I+Y
M1:)A$PB81,(F$3")A$PB\A'V3W^;CB#_ 'K;B_YVUYGZ(\A7XKE%^DV?^SBE
M\E\I?X_9'Z/%?M4UY@J:@Q<W"J-Y/WD,:O98)&0]S* E,>PJRC4COW2J8Z94
MY/V<RGL"AE"%([\(PG* "8/O&-%08/%%@:'C#UBSG&DT\PINC.(NR?.&\2%\
MR9D-2F'DAI>P.RGI92X Y;B\3!7H:Y-Z>Y02.W]NRL'V8_$VYU1S8[$O7]DN
MWTA+6.T5@BJ_NBY6*34Y P3V0N4Q%E;S-E>R]>8S+JPK/7$LQ%X=;Q/B^P,?
ML,;.V>VKRWY0X7$\U296P3 *6'HU3EYS"TJ0V?48S#M?-*E3IOYMM-HRD-A>
M[;2PVT3B,66\G=FOHDU33Q#L[ZKZ/2R5JE3W634KN;#ZKGL#C4DN!,A>;OJ/
M=#J CU ![P^O3Z/V/Q>OIGW,F6,.8D%H(),EPZ,28$F(.FY>BC43Q/'@X1!X
M1/5.Y?U.=.B@''_5QG1U"-@U!1Q<'2$Y52(!3(L53IF3ZJ%4*GWA(9,.^!@
M2?; &?@/:WY6VGO_ -(XO6?^TU)%K]?>OT[L[\FX#_<<+_<,54_!:9B+!LK3
MK27E+?(UBF4C85&XWMY6AZSK3\]+/1=#[';2NT)RI6:;F++:9_75VITC'&1C
M(.$0DV-@=6QG\L5(3PL:H(!B#.4OASC$EP@2-+3<Z0(5Z4%[9DP7M:2UHF T
MF2";7MUB5<3L._U/55&M>Q[W,-H"GTR$D+#8I=UWQ28QD:@9==0$TRG7<KJ
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MLPYH=8:0XVWF8/@+<59TJNBR;F6<J)HH()'4665.5-)))(HG44544,4B::9
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M*3).)P0D9,P@>Y"8+I8-Y< 9:R2/2/O^V[,_S"-0>9KW%\UAB+901?,+&XB
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M5(L:)=)G43*W4% BQG*/X&VH&_=?:0)RC[HXPET3$XFJ#87($3"_3FSI^YN
M@9C[BPMB8G\!3WP5&WBOS ON][;6:/+U/0-/5BJ.[F;M&TO>"NP9X\G'EAXE
M5K1(-E1X.$DJS"V!VYCI^P1%JM4/$']V197[AT^0<*<CZ8:"07$3T26P(XF_
M#J%UT,J%Y +0VTD9I.\0+#?Z(L-T\KK8752J-FL[*NSMO>U^"E9AI5*PW;.K
M)974<R7=H0,"W>NV#)67EE42,8\CQ\S:>U+I"Y=(( =4F0$D"0.LZ>CZEJ3
MF">H;U"UOS4L+F1<:]2T9*+[W1VFXU8GK1GL"K/*XH_9:E:[MD9=;9B2'NIF
MSC:,]:-G[!>&+,M;8^BX@\>,3*-+$?3F]Y> ,LS!)\[*+=>O8>(A9<[<-R'.
M7%H;-NBT.)S1$00.VR_"%Y\UJSGK4[7-;V9]K54=)QVR+P\EH*-=:QM.^Y5C
M!4RLOZN9RX>6!U"R\O"-KV\BGQ6=?1F6+J-/8"IR!&(TR)DB;P+F8 )@QP(M
M'A""K)!:TEA ET@99) ENL6U69>0=B@74;K:,;S40O(%Y!Z02,P1DF:CTJK?
M9,(*Z9FA%A7 Z()J>,04P,EW#=\ Z&[M6^^.[*?;MZM5-0B6"1/.-L")U.[A
MJI-Y5:IA$PB81,(F$3")A$PBC;R^+J@_&[;!-WM+J_U8:NI%MS37(6\;PLS&
M5C@9%K04-9"U>\BRWN\Y/=BR902*J,@(Q@/0&]/-G;EC--LT1/7.Y4J9<CBZ
M<H$F)FW"%49P!C]>,N2U5#5K1DG2$X6VA'N=[L7X<FO'- / 11@W&JH]KIXE
M=(U]H"24O+EU<UV8CT55DE.J737SY"7B'2 <OF =XFYFP, PN6@&9AS8(;!,
M/<XODS\HC34'7U7Y3$/%6&*D(2<C6,S"R[%U&RL3*-&[^,E(Y\@=L]CY!B\2
M6:O63QLHHW=-7*2B#A!0Z:I#D,(#QW%QJ-.WOMXKMU5;L-I#=.I('2%CJNLX
MJ^36M9_EQ$/]=1ULK=:$E>WQLF8MU)GXF4F#H5\$8AM&UYC-QWCHOF$+890\
M>UDGT5[FD-\[7.>"8!YL@D$DY!$6XQ>>HKF--[6LRM!+>=!!(MSAF03PGPM?
M0R(UGQWEJSI32>OIO9%]@)G6&GZ'KR6+KZREAX&3DZK6F$4_D4T744Y77*JZ
M;*IM'"G@*&8)MB*(D,4P9F7#,XY&F72,PG?.XBTWCBKBD2Q@+WM+6@=%Q;V2
M+Z+(7&Q+P..^B40455\+3^MT_%6/XBRG<I\.7OJGZ!WE#].\<P  &,(CT#KT
MR'^>ZP'2-AH+J]/\6W?8:K->55TPB81,(F$3")A$PBASRP<S,))Z%O#R(V)8
M]4T+:"]CVG :QB[38;'X:-3GD:#99"H4DB]JNM4JMZ4AY*;K<1'S2A71XBQ/
M(1]&UUX=O=E\PM)$"3&\:$D =Y6=0Y0TD.(#@3E!)G<8 )@=GT%81X"ZYKE(
MLVS)#4T)LV)TF^HVJX!O/;2J5MUY+[1V[ RNR'M_V4SHMXBX"QL?;X"P46$E
MK.YKT.TM+^(*BP3=HU_VM2]4DAN8MS7LV( @6)$F;3J=_&^=%L%Q;FRY6MEP
M@N(+CF$QQ()WVT@JPN[P$C:Z=::Q%666ILG8:_,0K"VU\K,T[6'<I'N63:>A
M@D6[M@,K$JKD?,/;&KAL#M!(5D%$P,0<@8(, P9@Z'MTLMR)!$D2(D:B>$SZ
ME5U1^"V[],RLK9:=L"K;.<4W?>L]LZJJ%T2C->14M"5GC=)\>[5&6>>H^OY!
M>$L+^(M,J[BY%*$MC9V[J\!(RWA2L_8GR>YK->&@MCH.#B+D$N!XGZ1%MP7,
MV@YKBX.!BH'M:;0,I;&FMY-Q)OQ"F1J3CT>%U57JOLF4E?E8%GV=?[$.M-C;
M'J$ UM&WMBV39EDAXU[6IFGR5@@H&5LR\/ O; P2=K,&17PQT6X?O&N9/>7.
M+H%X$$ Z #>"M64X: 29!<8!(\X[X@_5HNR\8XUM#ZI/%,SO5&L=M+?C-NI)
M24C,2!T6^^-D))F>RLNZ>RDBY,4H"L]D'CIXY4[RKA=54QCBJ3G,Q,-T$#S1
MN5J8AH%]^NMR2I Y173")A$PB81,(F$3")A$Z!\,0-8OQ18GWM3G6PM*[:H;
M*":6EQ=-<7.J)UB0LDC36-B"P5Z0BCP3FVP[5Y*UE"63=F8*3T>T<NXHC@7J
M""AT0(,@@$$F "#,3$=5I[%5PEKA>X(L8-QN.X]:KOJVEN0%+N%1VY :KO;^
MGT/9-@=T_CQ==UPMYV'!5RU:2&AS]AC;U<+S8ZTS0<WM-!VWIIK^X:QU9<SL
MZP40F9A6II[%U-P(S"\'.UI -R3F%Y=>S@.\KG;3>TAP#C!.5CG@D M:"0Z1
M8EH,$[S:ZEEJ+CU9ZUHS2E!L&R;U3K%0M>0=?L#77,[$(0J\PFS04D$2+3%9
MDUWK.+="M'1*Y"LBFCD4A.V*8P 3)SLSB>)_AP]M=5LVGE:UN9PRC<=;S?7O
MX\>/BZ[:] 6FU>&S85UW/@=GUQU2%PY,0[EP*3B\$%=R=,B1#KJB7Q%3E33*
M8YA$I"AT /U)Y$2?O:VD?_GE9W$2,)A3H=UM%\4\H7Y7P8_^68?^^JB>"IA$
M.O[_ ,/+IY?#^0Y]E#I@;R[4:B8$#P^M>B9>NW"-8TG<8[)Z]%[&/L8LO^HQ
MRE\__K/HWT /^Y62#SZ@/PS\T>73\K;"TOL_$N/&3B0VY-S&41)M)&D1]<\F
M@C#;6O/X?"\/BZO #M[U%3[)O#IOOC('QU':_@'I<2C] !^$/RCGL7D+_)6W
M=?RAA_1A21ZR.Q>)\I-]I8$;C@G ]]:I?7L"\R(  @'T?:] _!U\_P ?D/F'
MGGW,7@3$VD6(O-CQE?."W--R+GT6X\)\5ZQ_L7;H*_.(?7^A\:O4/_.WW^#\
M&?G;R[C\/R:UO1VH;DD^?@0+GJ$]I*^J^3./],=1P8Z_^DD^E;K[*!'HCPT#
MIZK;R_ /]3JOZ?A^#+^0DP_E%^;LXCJAV*TWW%C?3JD&OE,$OV0+>;C#) ._
M#C?VKR7CY /X 'UZ#]8>G^;/T--YWS/L-%\M( O F1>.)$KTX_8QOGO;D_UZ
M>6IZ=]87!</IZ_RZ9\*\NGY,V'^L,3Z<.!]$GK7TKR:C^?[2._W)2DQ?\<%[
M*,_-:^P)A%^2P',F<$P#OB0X$[PB! ,)1 O?Z#WN[WNG7N_; 'F'00#"'0_Y
M>G<J::]Q(WC QS ]+UBAK>%UH\TY9SZD=;ZLFQZGN;8FKMV5O8CN?J<K<7TT
MO0XY2IPLY#UM]8D8>7E9>QPZ%LB6,?3V$DKOG;\($D$<YE(<T%L$6,G0'4WF
M%R\VX>:" (.4N#PXA^;?IJ9.X;E-;2^CK8%%N:^PWUGUQ8]C[KV%N-S7*'=S
M-W=8:6MY[-$5>0L,(4&<HN2(9,96?)'F6C LSQ]["\?-D$7SG-[@2(N&M#9(
MUC?'7I!6K6&#,@N>7D Z2(B>S>(7F'[=R%)7]2Z'ADY&9EB,.3G+M$LC/R2T
MM,.P]Y4A3Q'\BN +NU@\3N HIY@D0A/0O7/OOD-,XS;_ %X79SH$M (=BS$
MZ"-T+Y;Y2!%/90DF*N, +C)@>Y#KONXZKS1] Z 'T!_+U]?Y?#/T3(G2W"3U
M[]8N;:=2^6%LWF^FEHX1/KGU1Z2/L9T/^^HWW^D*GY^7_#ZL>?IT_8SXCY<A
M_H38Y&IVB\DFY_U=UI.[=?3MF?H7DW ^ZV*M<[/<2=Y_#4=^N\JP#[)F\N+?
M'X/AR!/] !ZZWN7PSU#R'B=O;6ZME@^&(IKSOE+_ -1V9UXRH.[F3[>P7BX_
M+_U?BS].R0(E?(,HF>LF(M< ?0O1S]C0 '\U[O#S'K_,YR(AZ>OSEZ]_!]'4
M?7]O/BGESD\G]C'CM@SU'W'BNO?)\-5]"\G!_P!,XP?_ "UQ_P#^F@K)_LE_
MRX=Z3^ \DX?\'3IK+9/ITZ?Y_0.GIGI'D0_I-M']35?1B\*?H7LGE(_)6!Z]
MHLW3_L*WM9>)WH A_C>GEZCY_L_'KU]1ZY^HB9!$:SU:Q)/&8OUF5\:+1)@R
M)G2.!]>LS(CA*O<^QUPZ=H68 ]!T7LH?R^W53KT^K/DWEF/_ .#P(%]JX+T,
MQ'K^M>Z<@;<HZ5A?"8O]EI]<W7N^S\GK[JO(1]D]_FXX@_WK;B_YVUYGZ(\A
M7XKE%^DV?^SBE\E\I?X_9'Z/%?M4UYA:0_=1=TJ$FQ5.B]CK1 /VBR1XY-5)
MRSEFCA!5-28,2)(HFJF0Y#RAR1Q3 !GQBM@5$/O&,8VIA,53=!:_#5V/!SP6
MNI/:X?@P:EVDCH O^ "Z OF;'%E2F\&"RHQX/1L6N!'G='4#SB&\2 KT]E.^
M''''E(MR;V5QR[1'7]MD+K,;-KS637TN_P!5KWR:<O9(E@K=M9O))M;:\TL+
MM2;8Q+6[S3!WX*,;(2<E$'79K_(L WE-MK8(V%@MM<D<5AFX=N"J9&XVGC6X
M:D&L-.K0>RF^A6=2;D=5=08]LYZ;6/ (]NKG9&"VB<?B,#MZC4?4]T4VN.#=
M1YTDN;496@\[3;5/.-:*E0'S7/<PD&ES= Z)-:FH\>@VX%*&%;#(?/.-,&TF
ML8NWPO1:!12)PP0OL'NSV4%" ]!U[=XO]!]FSZGLL;7;@R-LC #%,<6L.SG8
M@T31#&!A<<0 [G9#LT='+EWKU7$G"<Z?<GNDTW $G%\T*F?I3E%%Q86D$28#
MIM$7/]-O3H-QX_ZN!T"AVHZ@HX.2) <RAD/D9%^,5,$Q!0RAD^\4I4^AQ-T
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M #,?8*U8VEM0E(Y"J%MDK"0)[]&)UN:1DF<.@UKJ]64<OG3D:I,DCI2[*=
MX &T'< "=][65>9B 'D,Z.9L279)@3>TF8\%E;?.L]<1/S<VR+U_28ZUK\AM
M+NE[.QJL$TL*SJ3V1#A).5IINP3DE'$@#AP#U8[DRCH%U@7,H"A^]5I/2N?-
M*L]K06.RM#C4:"0!,23K$]?BI<Y1;)A$PB81,(F$3")A$PBZO=+A4Z#696WW
MFR0=0JD&BFYF;)991E"P<4@HNDV26D)216;LF:2CE=!N11PLF0RRR:8")SE
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M=.\7]$7ZP_?PB=XOIWB]?AU#]_")WR?HB_XP?OX1.\7]$7ZP_?PB=\GZ,O\
MC!^_A$[Q?T1?K#]_")WR?HB_XP?OX1?0" ^8#U#XAA$PB81.@>O3S#T'X=?7
M")A%X#.VZ_LO\/?\ #CS_P LO>?J;R(_T9VE^NJ_[EAE\0\H7Y7P?ZLP_P#?
MU52UGV-NH[1ZUZ,O8S]C%_V&.4OZ9]&_R6D\_-7ET_*VP?U;B/WLKZWY-?\
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MI,VJ2I $"*)(IIG+U#H8 ,4A1Z&#R-Y^?0.H#]"^\DWFYGP40!H .Y;T
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M40AS.5V3LJ?G,#R<V[M6F_$;-V5CL;0;5?2-6A0?48*C USFEX&7, YI(!)
M-^)\7B-M;*V>YE#&8[#X>J:;7BG5J!K\CB0'92<T2#>(LM\AVIO"Y0C85N1N
M@&ZBI8 5TQWKJ]06II.QJQ<R0QB3QBJC6X,B=G<>&)@DVRQ8J,%>6(= .P\B
MN5G_ '?VI_9*O5/O?\^RZY_OHV!_6N#[JH/JDJ0.I>3]&WY 2]FT=*5/;<-
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M.R?S@O(8#:^SMJ&H,!BJ>)-'*:HIS+ _,&%V8"SBUP$3H5,42 ?NF'U#H/\
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M$:+P7]MR8!V]P^'S#IP X] (" ]?_#+U\.OQ_8'/U-Y$H^]G:4G_ *[KC?\
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M8Z=765BVW\ >-EY122N"&]+ BW=J/6Z,ERXY:K(H.EBF(HL@B&[BIHF,0YB
M"1"E*01(4H%\LZ/=E>&@&D T0(PV&!_XB*0+NK,3&Y8G"4"22*IDR?YQB([A
MSL#N 6(N.79[Z(K^L=?3\M$;YKNQ9:@5@+NL3E3RQ@952;7C6+N8;R+!GNAF
MDS6"4(<Z[-)LW306)X9$DP(! D8W$ S-+>(.'P[A>VCJ1'8=0;B"J#!4"T B
MJ#&[$5P>PQ5\1W&UE+5KQNUVR;(M&\_O8J""2:"0*<HN3"QP32(!" =9;;9U
ME3 4  RJJAU3CU,H<QA$P\[GN<2XY9-S#&-]#6@>A= IM: !F@  2]YTWR73
M/7*Z!=^#V@-BL"1=W#=UACB2!)0C-[RMY4%03?I(N44W*9&VYD.X9-)TX3(4
MO1,I%3 ! Z%Z:-Q%5@AI8!^BI'TEA*H[#TGF7!Y/55JCT!X"P1QP[/K156K;
M>T/H/>5>OHS.PXM9\;E!RIBY'Y/$O]B:UY$[4FXT4 ;K5AE!';K@W!1XU!N]
M4465<'75N[&5B2<U,CKH4>$;Z:S9A*0 );4!!,?AZ^DV_P!IZ#W0+*7#?CAK
MULBFW1G]ZE22*!" ;E%R85,!0Z] ,HKMLZIQ\_4YS&_#G.Y[GN+G99=<PQK1
MW!K0!W +H%-H  S0-)>\QXN/IE8BNW9\\9-CE?I7J.W3:&\HZ1>/F4MROY6N
M(YPZ;]TR"QHWYZBL"&1,F4Z7AMR 0Y>\4 ,(B/93VEC*5-M.F^FUC!#1[FPQ
M<!^>ZB7GK)<2=ZY:FSL)5>Y[V5'.<9<1B,0T$\<K:K6CL  ZE'S1?9?<5H9K
M,6&1U_MFO6R/V/MR.@Y)KR3Y25Z31IK?8=JC*=[*I'[B8J&8N*6E$$:/ [RL
MFP43=N7#I5RHNIJ=K8ZT5:9L)G"X4W(OK0/&W4LV[,PD&:3YDQ_.,02!-A>K
M>+:S/8I[ZUT51-2B0*<^V:HBFT<,DFESW;N?9C!)%TZ*\6.E'[*OUM8IN_'+
MU2?D;E?H(G5;(.4VRRJ)^&M6J5WFI5+2]UR6TZ=.>ZFUC?0NRE1IT6Y*8<&B
MP:ZH]X X#.YT!9BS):IA$PBBMO\ U_MN2NVK-KZ:AZ/:;5KZ+V75'=4V!:I:
MDPLC";,BZ^4\NVL4/4[NY1D:_.T^ 6-'*0 I2D,[FD$Y!D\*T\:[' !P-@XM
M,@ W;<;^[N["LJC'$AS8+FAP@F)S"%O]=\::[6]2:=UU9IRYR#_5FK*1K@\G
M4=E;-U_&RIJI L8IQ)&AZ9<(-DH=XY;K+I+/T74@DU41:*.SI-TBD%YS.(@9
MC,0#ZY/'VNI%,0T.N6@"02-.H$+!EY[*?@3L]]#RNR=$C?96OUJ)I\+)V[9N
MX9V0CJQ!$6)#P;9V^V JLG'1Q7"_LK8#>$B*R@D* G'KYK9_*;;^RJ+L/L[:
MN+P=!U1U4TJ%0,8:C@ Y^6",Q#6@G4@!>-Q6PMDXZJ*V+P5+$50QM//4+R[(
MV<HLX"TG0;[[HCG3^QF[/I39>WFT]Q0A@J+5Y20H0N;5L])B9NM4VRMC]W."
M74BCLI9P5@="LJL*+CJD02$ "!W_ '\\K8$<H-HS>?PWA[V/#O7(WDKL %T[
M*PT2(,/DVOH_C.O<IHZDX"<5]"PTG7=+4.SZM@IF3]]2L11MR;MKD?(RPM6S
M'WD\;1NQ4$UWGL;1JU]H4**G@-TDNO=(&>%VCMC:FUJM.OM+&UL;6I,YME3$
M%M1[:<DY 2V<LN)CB2=29\GA-F8# ,?2P>&9AZ=1V=[*9<&N= $D%QO  [@N
MM;;[-+A9OJ8C+!NK44AM*;A8T8:(E;SM;<MC?1L4+I=Z,<S<R6PEU4&8O'+A
MR*"9BD%=9100[QS".^SN46W-DTZE'9FT\7@J55XJU*>'J<VU]0 -SN $%V4!
ML\ !H L<7L796/>VIC,%1Q+V-R-=5#G%K))R@YK $D@:"3Q48XKL9NSR';-V
M:O.*$)\B$:!K9:NBK:]HECALZ\_M EO!H["[%56>%C$*6+Y ZZB;=$[!1--(
MSE4RODOOXY6P(Y0;2F3/X<Z;HMVRN(<E]@YC_HK"AL  97"^I]]?Z+QO4O-1
M]G[Q1T''2\1I37]DU9%3[U"2FHZB[BW77&<I(-D!;-WCY"-V(@1PX1;CX*:J
M@&,5/[0! OEGA]H[:VKM=].IM/'8C'5*+#3I/Q#^<<QA<7%C7$2&EQ+HXWUA
M>1P>RMG[/8]F"PM/#-J.#GBE+0YP$!QO!(  '!<%MOLUN%^^Y6*G-U:DD=IS
M$&P5BH:2O6UMRV-[&1J[DSM9BR<26P5U6[51T8RYT4S F*IC'$O>$1S;9O*'
M;6QZ=6ELO:6)P-.LX/JMPSA3%1S1 +H;)(%AP5<9L?9FT',?C<'1Q+Z;2QCZ
MH+G-:3);,Z$D]DF(44HSL9NSY/NJYLG?%&'^;Q'6.M7%?,>U;0+%C<U[5M9.
MWE;/ NH*K/RPC>CB^;'6.DW;GCE$TDS.E3*^2^_CE:6@';^TB0Z;UIM'"(UU
MXR."X/O5Y/YC_HK"Y8F,KA>3P<-WAWJ9>C.S\XE\:)*0EM":Q?ZL=S#R$?39
M*ILK:S./GUZVL[7A"V")5O"\5/-6!Y!^";&79/&*B3UV@NW51<*IG\5M/;VV
M-L\T-J;1Q..%#.*(Q#A4%/G,O.9)'1S9&21!.47U7D,%LG9VSB]V!PE/#&IE
MYPTLS<^3-ES](YLN9T!T@393,#R  ^&>)7D4PB811]Y :MMVPVNL[#KZ9KL-
ML#3VRVFS:B:W,9%]5)5T:G777DY!3R<0Z:RK5K*5#8-C09R;$SE:*EPCI S"
M10;K,7%V.RY@1+7-RD"Q%P9F^\?YJCVEV4@@%ID3II$%<#KKC)4(W6-:INUX
MJK[,L#"=V%=IF87@A:PYKGMF\SNQKTM7(IX]E',5!JV.PNT(AFZD7SQ"*:1Z
M3IZZ<IJKG%YS%S9&@\ !]"AM-H: X P7'?JXR=;^*XJ9X&<,+(#8+)QATE8_
M8U)!5F-@UY6YHS-26>J24F9J:28.3-_;WZJCQV"0D!=P<RJ@&/T$.K#[1VAA
M0YN%QN*PS7.#G"A7J40X@0"X4W-S0/A2L*^ P6)+3B,)AZY:"&FM1IU"T$R0
MTO:XM!-R!$K"S7LU>'9=RS\JOP^X^CKU?651CXM,VLJ">/"Y-;3=7,Z9*)!@
M9T@\-"/*Z"\B=DF@Z1*V;).EE&:R2'2=N[9( ^ZNT9DW&-Q(,1O_  GJ7*-B
M[)#R?N9@((M_-:%CI\!9XK'!_A_23/34WC9IFI&D0;ED#5F@UZ!,^*U%86I7
MAHMBU%T5L+AP+<%Q4!$5UA3[OBG[W+B-H8_&!@Q>,Q6)#)R<_7JU<DQ.7G'.
MRDP)(@F!.@750P&!PV8X?"8:@707&C1ITRXB8+BQHF),3I)C5?5FX1<0[J#,
M+EQOT[;2QQES1Y+-0Z_/%8F<@D#DS,LHR= U%P""(+BAW!6!%(%.\"9.D8;'
MX[!ESL)C,5AB\ .-"O4I%P$Y<Q8X$P22)G4]2FO@<'B<HQ&%H5PPDM%:DRH&
MEP ,!X=$P-(TZS.$7O9K\,S[7K<FWX>\>@I#?7UU8RY"ZNH1&)K4\L=!7KIE
MHP8X%W#LL2RLX-WY&BB31$SENJY0.]12<=@V[MD-_*VT9G3W77(B#>[]9TOQ
M7*=C;*S#_1F @#_LE 7O$0SV!69:WP6X<4UTN]I_&72E3>.T :NG=9UY6H)R
MZ; H54&SAQ%Q[559 %2$4!%0YDP4*4X%[Q0$.;$;3VCBVM9BL=BL0QI)#:]9
M]5H)$$@5"X"1:0)X+HH[.P&&<78?!X:@YPREU&BRF2)F"6!I-[K?67A3Q*N;
M=NSN'';4=L9M%Q<M&EEI,'.M6KD4S)"Y;MY1HZ20<"D<Z0K)%*H*9SD$W=,(
M9GA\;C,(]U3"XJOAWN&5SZ%5])[F@R 7,+20+:G<)T5J^!P>*:&XG#4:[6NS
M!M:FVJ [>0'AP$Z:*.UC[-/B OM[5TG$\/>/I:''UK9S>YIHZTH#=@>9D1HP
MTX7L4=BFXDEB RLOL;A!F[)'=7'CJM?;$O'[!MW;0:6_=;:7]MQ'&23^$N39
M<AV-LK.V-FX&.D3_ #6CK$ ^9J9OJLYU[@9PPJ+\TI4N+^CZM*';*,S25<UQ
M5X20,U6.DHJV%[&QK9R*"JB")U$?%\(YDDS&((D*(85]J;3Q3.:Q./QF(I2'
M<W6Q%2JS,-#DJ.<V1) ,3!/%=%'9V PSS4P^#PU"H6EAJ4:-.F_*=6YF-!@Q
M<3"EBDDF@DFBD4")I$*1,@>0%(4.A2@ >@    !] !G NU?IA$PBBYR!H&T)
M.W:;VOJ"%J-LMNJI*]MW%-NMKD*1#SD'L&HJP+ERWLT=5KDJQDX679P;XJ*L
M ND^B!F6I'#=T=KXEVD06NL'1)&MC,"QU^A4>"8+1);) .DD0.'\/%?>L.-D
M36=-:<US;YZXN9C66O*[4'<A1MF[.U[%2+^.C&:$H[*QI5KK2;YLJ_27-'*R
MZ#E\V9"FB!T@%0@PYTN+A:3VJK:313:QTG* -2.O4$;U@S8791<"MLO*_(;/
MTG(WZ0JM5B:177UKW#O.8=P]2@1<&AZ^Q7=;*,="+CS.W1VK4@@FD9PL) #O
MCGFMF\I=O;'I/H;,VIBL#1J5#6?3P[VL:ZJ0&E[AENZ !)W < O'8S8>RMH5
M&U<9@J6(J-8&-?4S$A@)(:.EI))A1IK78L]GFKMG:+*8XK-@H[.$UL>E&6ON
MY48\TFZ1MPV\&+XNP"*O5BJ(0/MJ:KA<K01;^&5'V@_B>1/+KE=8_?!M'-))
M//"^A!C+VKB')38&9T[*PN6&P<KI.L@]/33<)G6RFGISL\^)O'IA-1>CZ'<-
M5QMC>MY&=84C>6^H!K+/VB!FS5V^38[-2!PNW;G.BD<XB)$S&*'J.>'VGMS:
MVV7TJFU,=6QSZ+7,I/Q&1[J;'',YK3E! +ND1QNO)X+96S]FLJ,P&&9A&U7-
M=4%$N;G<T$-)EQT!('!<'N/LS>%W(24AYO>&K+#M26K[%>,@Y"[[IWM/.HJ/
M<N =N&;%9[LM11NW6<@"ZB1# 4RH=\0[WGFNS>46V]CTZM+9>TL3@:=9[:E5
MF'<UC:CV1E<X93); C^)6>-V+LO:+V5,;@J6)?3;D8ZKF<6MG- Z0WWO-U%F
M/[%;LZC[8MC%SQ6:?(='7] <P9C[!W*1@-K<V/9*-J*W>AL(JR[LD0UJ NVI
MUU$FJ)F2J:21WBQU_)_?WROB/O@VC))G\*(BT 0VP-["+1HN'[U.3TG_ $5A
MH@19VLF??:Z7ZS'5+73/9P\/N.PV,=%ZXM&J!MX1 6@:-NW?$ ,\$![S]R^]
M!8[,2%W[K]]2WL7BB8$/>#KN=/%-GB=I[>VQMDTCM7:%?'FAGYDXDLJ&GGRY
MPQQ;(#\K<PDSE' +R."V1L[9IJG X2GA36(-4TB]N?+.6>E[V3':=Y*UW-V<
M?$#D0%?#>>NK5M8M4&2-6RWC=V^)\(0TP#()08WV[9BOLPOPC6'M7A]/%]D0
M[_7PR=&S=O;8V-SOW+Q]? \_EYTX<MIFIDG)F(;)RYC' F=5&.V/LW:7-^[L
M)3Q/-!PI\Z7G*'P7 0X6) )ZP%#Q[V+'9X%W/7(]OQ7;#KY;6=S=2QB7[<AH
MTMR;VNA(5TJ\@.P!71?#"N;.9LS*Y(BY0!VLH@J9JD='ROW]<K_^\&T2>)K2
M3KK+3QOQWKQ_WJ<GLY/W*PT1<0^"3QZ5S;7Z"I=:3[-;AGQOG7]ET3JR;U;-
M2R+%M+O:CN#=D<,NTC7@/V;*60^<51M)L4G8>*+%\BNT5ZG(LBHF<Y#>,VGR
MAVWMEE.GM7:6)QU.DXOI,Q#PYM-[@&N<T ""0()WZZW7=@MB;*V:]]3 X*EA
MJCVM8]]/,"]K3(:9<;3N$2IUYX9>43")A%'[DAK2U;+HT&G1#P9KM1-EZTVI
M5X^T/WL56YZ2UU<(RQJ5N:EXV-FI"&:3\:UD(E.::PLRI#O'C64&*D2-#,U;
M-,&^A!![]_<J/9G XM(([MRZAI_C_(1]!GV6V5%&EMO>VM@[BL<;K78-YAH:
M!E;Q,O'+2MQMI@5J'/6*/A(,T>P=OI*+C&TS+(NI@()B8[9)O9[A(R3#6AHF
MYL#?AO,6MN4,80TYH)<YSC&Z3,#?%AO74-A]G'PVVXV9L]J:B<;&9QTS-V&/
M:W79.V;(@PG+*=N>?E6:<K>G)6SV8,T:FD%D>X9R+=+Q.OAEZ>1V=MS:VR75
M7;,VAB<$ZL&-JG#OR&HVF7%@<0+AI>X@:=(KBQFR=G;0R>[<)2Q'-.<ZGS@+
MLA>&A^6]LV1L]BB](]COV?X;EI[=IQ,JGR /K/9"T^*<O>QC N"=IU62H@Y7
M&UBJ1^,*K=Q8I%4*FJW"1.H0QDD3$\K]^_*V/Z0;3F?^T$6CJ"X/O7V '?DK
M"$1$Y#/&)S3%MT>M2=U5V;O##1DQ(V#3.F_FMFY>.]TRLK1-@[3K$A(QGM"+
ML(]X[B;NU7<- =((N/9U3F3\9)-3N]XA1#QNT>4&VMK4V4MI;2Q6.ITWFHQF
M)?SK6/(@N:'"Q(D6L."[,'L79>SZCJN"P5'#5'MR.?2#FN<V0<I.:8D D;XN
MNR[6X'<6MZ1$9 ;FU[-;1@X:3]\Q,3>]I[>L\?'2WLKAC[Q9-)>^.D6SSV-T
MY;>T(D(KX"ZJ7>[BARCAL_:^T]E5'UMFXVO@JE1N1[\,X4G/:'!P:XM D @$
M [UKC-F8#:#6LQV%IXIC'%S&ULSPUQ&4D NU(L?X!1&E.QV[/8-JTU%IQ.J7
MR+/0MDJ6'N3-\%A\J"3^JRU '2PVSQ"/!BE+J+%,JA4U$0D3*%.9)(4_,??M
MRL@__B#:<DC7$.TO/A;7C9>.^]?8$M V3@PT _[,ZR"!=VADZ=:DGJKLV^%V
MC)N0LFF]-!J^?E8L\))S-%V#M*L23^(.[;/CQKMY$W9JNNR,]9-'1FRAS)"N
MV15$HG3((>/VCRAVWM:DVCM/:>+QU)E3G64\34-5K*F4MSM#@<KLI+9$6)&]
M=F#V+LO9]1U7!8*EA:CF&FY]'.TN87!Q:>E!&8 WX#<%VG:O!/B]O.$CZUN2
M@SFT*]%2A)N-A+UM3;MGC&,PFT=,$Y-JSE[VZ00?$9/GK4CI(A%BH.ET@/W%
M# /-L_:NTMDU7U]FXVO@:U2GS3ZN&=S;W4RYKRPN G*7,:XCBT+;&;-P.T*;
M:6-P[,338[.QE4O<UKX+<P&87RDB\B_&%#6V]COP 3V/JI*$XG57Y)*JW4;N
M#>7O1V()IUPIJX,BJ>UF42ZR_>]D\(Y!.N'</WBCW<\S]^W*R' [?VD9$7Q#
MB=>/9*\<>2^P"X$;*P@$$'\&-(MJ3WQKO4DM9]F/P=TQ9?EEJ31C76ML]WNH
MD;'2;WL^N30QCXR)WC 9&,NK=T+1R9N@9=#Q?#4%%,3%'NAG#C^4FWMJ4#AM
MH[6QN,PY>VH:->L7T\[ 0QV7BT$QVGJCJPFP]DX&J*^#P%##U@US!4IM(<&O
MRYA))LX- .^! A3N01(W1203$XIHIII)^*HHLIW$R@0O?66,=94_= .\JJH=
M10W4QSF,(B/A%Y71>4?[)+U;L[8MTXGK:]US?+XC$UG;24JI3*?8K0G&JNY2
MB':IR!X*-?E9J.2(+'0(X%,RQ453)@8J1Q+][\BFT<!@:?* 8W'83"&K4P!I
MC$XBE0+PUF(S%G.N;F#21);(!(!@D+Y7Y1L-B*]?91HT*U9K:6*#C3IO>&N+
MZ4 EH(!(!B8D3&]>9+^9DY)#Z\>=Y?\ %'L ?_W>S[M]\&PCKMK91_\ ]AA/
M\5?-ON?CAI@L6/\ ]M6W:>\3^9CY(_>\;R_XH[__  >Q]\&POZZV5_ZAA-^O
M^UWI]S\=_P!BQ?#_ %:MIP\Q:&XQ\DQ 0#CSO/KZ_P!B2_A_^[WKT\OY=,'E
M#L*'$[:V5,:_=#":_P#F]RC[GXZ0/<6+G</<U:2.$9/:%_3:TBV<,]-:F:/&
MZ[1VUUG0VSIJZ140<-G*%5BDEV[A!4I545T52&2624(51-0HD.4# (!^'-JN
M:_:NTWL+7,?M#%N8YI!:YKL14+2TBQ:09!%C-NO]);.!;L_ M<"US<'AFN:;
M%KA18' @P000001((NLHYPKL3")A$PB811MY5VVZZ]U!8M@4FZ,*B^J+<T@9
MFZHB5^>W1\[#W36J+ QB]MJ"#6Q6VUR$'!0CE5\NFK)/FS,Z!2N15)9@EP!$
MC>.H"2>X2>Y4?(:<KLIW$B;FPMUF LG:G;;&:ZYIJ.W9&O2VS@KL6:]2%2C'
M,/6%K,HW*K*D@8]X^D72,8V<G,U:'7=J*N4D"NCE1,N*"4.C,<OFS8:^G>K-
MG*,WG1>-)ZED3(4J+6S=G[2JW([COKZ+BZ@EJG9KB_1ECF7;V2=W1[/P&NK;
M;XR/B8M)HVBH6'8'K[9=_+.)&6?3*D@FP;1L2A'.'DE8-:6/<2<S<L-!XF"=
M0.[QE9N<X5*;1&5V:;WD-D <>Z..DKHVD=I[L/R!O&FMR/ZS(I)ZZA]B5*5@
M*),4N&D72UF>QMJA:',25HL0[&K-+C96B,Y^PO6-8EF%AG$#GCEV,^S;0=G-
M;D:]NLAI&:3QDB(:>H$R.!"AKG<X6D@M+9;T<MYN 9.80=>I3>_E^]F:U46N
M75RV/KG5+Z]ZVND56IR'=,(J,@)"@EO3G85OM\K&U+7M)BDSVVJ%AGMANDS$
M0X21CR":1)'QUFQ46R@FO3:'. ()&I@Q &I-CH.-I6=0EK20[*=!8.))T '&
M>%XE1R7W9R@H.[:)5-NE+':H:LM!T&U;/JFIHYU2KSN[9/O",GT&LE);::VZ
MD5:0MC^GU:N+1U'O+:(DY$Y;++LD'";A.Q:PMEDS+CE+A(:/-GB3V VWRL\]
M1KP'B&@-#G9;%Q!S&<UAI$ _0K,"CU* _$ ^GK^SF2Z%]81,(F$3"+0  /0
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M95 26'<UX)[(^N3W+&=TUKM;7D]RDO\ HW5U&LEBOU-TVAK*M2#J!A8"3V#
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M"\9B[7\&6$Q&8NWQ>^E]!$<$R/ :! FLU\3FR- ,@$QX#C$$ SVK6>E+!/\
M''A_735F.C]AZ"M^IX:^.)I C:7;%U',DB-CK1DHNV.]?M+/,U\++'J$5(A9
MFKF+FCJ*>.BKD.>,]4B2'AT1$"8@1N $\3KONKM82RF' !U-S;G6VI!OYPUB
MQZMW;4]0;<MO*2#V/<J54H2L4Z%VI2I"R-=@3-L@-CZLNQ@<5NJ1NH)V.5B:
M1;3OV\%*[.M[19FXFE:NC (+V>O3"*%8C,T,+09<2TQO:0;NGAEW1,D7LF5Q
MJAQ%@'-G,8+3\@D@&8D]77"X:?U/:X*E:1U:QC$$+$?FE;MM,W<,'B1U2UXW
MWKM#=3N2<+(H)(,4Y+7TLRH*K3NE($S=4(4HJIG.J8'@EQ=>6 'K, #Q(/IX
M*'-@4VM!_&$R-&@YR2>P.CM76Z'HRRV?C'Q6I0P4:797'[:VGV5YDI](&DF
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M "09%P\^:"8MKZ)+'N<XNRD$$ 9G$ =F5HD[[F;<%C=OQ2O=2H6PZ^THFK:
M_P!W7#CG5&NO^/3"0;:NH4;JRTI35HW"]</X"ID86B6KC9XHHH$ @9%6IZYJ
M!9FQR16TH<:@+FDEQRATN==Q+P;<(!-M+255M(M:0 UI<YDM;9H#;3$ZD 3
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MG*DRW*FM:(YJ^J49"I6.#4]O<JO;*XK<"XE+F\1-58@Q].<!>PDYG!YJ%Q:
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M=TT#N>6B-24(+(S=:\L 0>J=06*N:O=4208.FTJ78MILLA6NL>HWLIWEC2/
MR#23;LU4^@-!-(0V'-(+@#(N9DZ V' QKQ7(]SASISN:YCQE;F;!$,-@6S&M
MC.IW1'*3/:#;:3V1(4VIZGKEU;3<5R1-KA"*/L*/&>L''1E)OGT"VMUDK$)7
M;A(6=6!E:X]0IS-U%4FTJLV"MCM"!%US0:,-#G.BX!&\22 2 9U@1Z2#:17=
MF( :X /( #@3DU ,1X2=-]CN[7VA]Q>5)GM/4E!K5MU#,V#:J]<NKQU:YA=[
MK[3\;18^PVV5JM'BK#=XVMN]@RU[KK^_U^J7&!H\;4H:4G8E^-OCTV\BB)RE
MW3 !<)  G-:"3< 7F/0K&L2 YK9:7$!TR'#HR1 FQ)':TJU>(D&LO%QTNR61
M<M)1DV?M'2!Q41<-'B)'#9=%0Q$S'1514343,8A!,0Q1$A1^U#"()[3[;UT
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M>Z_5;?"TF.JL/)3T.[-;&23<*/2+2Z'-%[6!O )G72V\G5#7=E#@V0XD :R
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MU 59_*"&;0Y(^8]C5*15I[P;N!;*%*H@*9R@.2Y[W$%SG&!:7$^C3=XJHIL
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M)TY<*)@"@$*+W%SG29=K'MZY3FV$!I:"&Z2-)U\5(9-,B1")IE*1-,H$(0H
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M2(CZU#PBU4IM:@8F%K[60C7TF8C923F966FWCV2<"YQRB8RSEBT3$WUO \%
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MQFM7&(Q0>'^>P<^_*UX!RD%J\%BR:F)J/=6HXB7-_"T*;Z=)SFM!EC7T:!:
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MG:W9>TWLYUFS<>^G)'.-P>(<R0)/3%,ML-;KG=C\"UV1V-PK7P#E.(I!T$D
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MN!),.+8OYI/ =QDJSY^Y.R8.WB35R^4:M5G";)F" O'AT4S*%:M0<K-FXN7
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M"( 4I0+U[PF$0 H!U$1$ #J(AF1\F?*)MW8K8 '$[:P0 [3SL#O5QRUV3 _
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MH7Y+?9&/#A%!NN;47*,"."J&#KK^F)E*!%!3'HJIL8$U0ZAU$R)C@0?M#]%
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MVZ%7[S>38_ZL9_Y^*/KKE=ZKO9<=GK5RNB1G$/1[@KPR1E??U,9VDY11*8I
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M@BIL_ U!>U3"4'B^MG4R+[]YWK';_@;PGDRKE><2>-QQ<B05CIZ4UTV6.*8
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MG^2SE8T?@V;,KF) H[4PKBZ-PS.8)[P.M=0Y>;!,9O=U,;W/P;X:.)R.>8[
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M%BMUUFX;*NPK)(N#(N"H*J)@8A%A07!(QBG%%0 [AOTUY#\WWO[:RN#'#:I
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MBJOS1]I/GBLGWO\ N[]2:O\ XT\9?E-\4YT_%5?FC[2?/%9/O?\ =WZDU?\
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MBJOS1]I/GBLGWO\ N[]2:O\ XT\9?E-\4YT_%5?FC[2?/%9/O?\ =WZDU?\
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M^0(4!Z@  .$7UA$PB81,(F$3")A$PB81,(F$3")A%H)2FZ=0 >GI^#\6$3H
M>@ 'Y,(M<(F$3")A$PB81,(F$3")A$PB81:"4IO4 '\?\O3\'IU\\(G0 ]
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M3B3N]GA)*1LLM)24BL$#!VFDKQE7<K*JOG7@MJ;<VJ-M^X\/CL'L_"X?&X?
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MCF07X/%M!F"[#U@+"3JP: B>T<0KMQN#?YN+PSHURUZ1C7@\\#X%=D;3T&]
MHLYB+=@8.\46S]JN!B_HB^$J?J'F'F'4,R-&LV<U&JV-<U-X]):%JVM1<8;5
MIN/!KVD\-QXV7) LD8 ,50IBCT$!*/> 0'T$!#J A^'X>>9$$6(@\"K@@Z$'
MLOJM>^01 .]YCY!Z^OEY>GKY^F1(]NO3Q4K7O%^(?E\OV\E%KWBCZ" _1Y"
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MRG\FK0,O(&L"-QVIB'--HO-<D]NNA%US'8G+,_\ Q12@F_\ -6C?J(I-((U
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MF\D.3;9C95 S\)]=_AGJNCNB+\5V1IV6G9XL4O"1X@:..7J(B9Y3&<BK]/\
MX^0,Z7Z!UZ=/$Z=.@=/(,Q/+GE@3/WQ;3!ZJP'#@P#<M#R5Y.FQV3A3VM>?_
M ']:W7\[ [/?[SW0?_%["?\ _#(^_CEA_P!X]J?VC_\ Q4?>GR<_JC"?-?\
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M^A6(_P"-U(./??K7X..&',-N00@NU#WXU,3R0&=TMQNL8%#Z/& ^O&!EQZ@
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MCWMWM;LMS#&\!_/.CM#=VFY#R4JM!YOE%M]KHLYV-+X.ZT,F=\NNOQ_G:N^
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M%^V:[8/Y>LF*2D.'*=HL=SVI6JTQ7]PU1WL.P$ 7;XITV_2^6T_?P]K>D6M
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M.IEQ]U8U['XBIG<7=-U-K&G+.40QI#0 <Q$CQ-:JVO6?5#*-(O _!4 \4Z8
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M17C#U9$S!9-\JN11D9),S4Y10,0HIB4+.> X@,ID3K!,]AS3[=JAC"YH+GU
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M.'V5K\QSK[M.]OU\1W\',9Q\!G@?M)S1^-J_.'V4^8YU]VG>WZ^([^#F,X^
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MN?RL&R4=2I,8V!KLNMK#9B=?D65SG'RB==BEY"+:!8B)QDED-)DRT-)&[I3
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MT/)VM_"1TQ<+/)-V/?<Q:4/<U)$0)RAI,7AID;NP3)L!P$9BG#B[,Z,Q=EW
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'A$PB81?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>49
<FILENAME>g60414g83s13.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g60414g83s13.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1S 4&AO=&]S:&]P(#,N,  X0DE-! 0
M    '*2^<S(X0DE-! 0       \< 5H  QLE1QP"   "    .$))300E
M   0S<_Z?:C'O@D%<':NKP7#3CA"24T$.@      Y0   !     !       +
M<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0    !)
M;G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I;G1E
M<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    , %
M<@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !     $)L
M=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M  (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7     $-P
M=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B;V]L
M      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L      !%
M;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0       %)'
M0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M      !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
M     $)L9"!5;G1&(U)L=                %)S;'15;G1&(U!X;$!N]OG@
M        "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0    !09U!S
M %!G4$,     3&5F=%5N=$8C4FQT                5&]P(%5N=$8C4FQT
M                4V-L(%5N=$8C4')C0%D            08W)O<%=H96Y0
M<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O
M<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M"V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  $#O_XU
M  (  3A"24T$)@      #@             _@   .$))300-       $
M'CA"24T$&0      !    !XX0DE- _,       D           $ .$))32<0
M       *  $          3A"24T#]0      2  O9F8  0!L9F8 !@
M 0 O9F8  0"AF9H !@       0 R     0!:    !@       0 U     0 M
M    !@       3A"24T#^       <   ____________________________
M_P/H     /____________________________\#Z     #_____________
M________________ ^@     _____________________________P/H   X
M0DE-! @      !     !   "0    D      .$))300>       $     #A"
M24T$&@     #-0    8              ]P   8:          $
M                 0             &&@   ]P
M 0                         0     0       &YU;&P    "    !F)O
M=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO;F<
M $QE9G1L;VYG          !"=&]M;&]N9P   ]P     4F=H=&QO;F<   8:
M    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC90   !(    '
M<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG          9O<FEG:6YE
M;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D     %1Y<&5E
M;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/8FIC     0
M     %)C=#$    $     %1O<"!L;VYG          !,969T;&]N9P
M    0G1O;6QO;F<   /<     %)G:'1L;VYG   &&@    -U<FQ415A4
M 0       &YU;&Q415A4     0       $US9V5415A4     0      !F%L
M=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L 0    AC96QL
M5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(;W)Z
M06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M    #T53;&EC959E
M<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%4VQI
M8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO;F<
M"FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L;VYG
M  MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #     (_\
M #A"24T$$0       0$ .$))3004       $     SA"24T$#      2C0
M  $   "@    90   >   +U@   2<0 8  '_V/_M  Q!9&]B95]#30 "_^X
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MORJ_YTM:T-=)+FNK&WZ&WV?V$"=:H^?_ '*:% V!?3]K=25:O&RF^CORWO\
M3W>I+*QZD_0W;6>ST_\ @TJ\;*;Z6_+>_P!/=ZDLK'J;OH;MK/9Z7_!I6?W3
M^"[A'[\?^=X_U?Y<;925:O'RV>D'91L#-WJES& OG^;^@&MK]/\ J^]*O&RF
M^CORWO\ 3W>I+*QZD_0W;6>ST_\ @TK/[I_!'"/WX_\ ._K?U?Y<;95'+Z8^
M^YU]69?CO< -C'?H].#Z;A_U#V(M6/E,-6_*?9Z>[U 6,'J;OH;MC!L]+_@U
M92!\*1( ;$2\K_[IY^ZNQG6\?I#<G-V7XMU[KMTM&Q]%6SU/W_TSW_\ ;/\
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M/HQL1A<^T7Y+Y-MHU))U=MVSM;N04U>I8-<
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M 0$! 0$! 0$!_\  $0@!?P)= P$1  (1 0,1 ?_$ !X  0 " @(# 0
M       '" 8)! 4" PH!_\0 81   00" @ $ P(%# P(" \ ! (#!08!!P (
M$1(3% D5(18Q%Q@B05$C)#<X5V%Q=X&7MM4R6'-VD9:AL;6WV/ *)29"4L'1
M\2@U14=EDK3A&2<S-$-$4U5B@H:4E:*H_\0 '0$!  (# 0$! 0
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M7)PBUKXIFU,]TG]5Y[4=@?L*WHD;<R8/#VH\H^?N[7+KBH7)7X)/>YK/RAE
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M0*% GH&&FSZ898G!6FGC87.<UMM!) (+@'"ZX(/(//0]3TM8OG:UKB 30)L
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M<?%/19 \J_6+%1YFQ#"('D69(5+*,A*X!P ;;B3NH[A?6C=4?0@US56H,+7
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MG^RD0N<UH>ZR  #7:VNY;P."T5=GY<A6PO'4X>Z;>,VNN\/Q[A=UZXW+Y&F
M;);0OKV?L X<#YAF784I-JS>W&W2O:8S#XC490/)>ZSAC%LI:S:&B]DC;O\
M^,J^W:J^I69CMP=?>,].["X_K8[UQW6MB3HFE"?BI6?JI&"UA%VN5=B>^%AG
M;3UCU!>["$&%<(2ORU.J.\;/-EV*OB6&Q0[$H\"7K6;D($8Z6Q5K="D$ KC)
M\ZF-;3K:US14C@WGD$M'>R[\^W?'R!N)&VBX.(+07$WUOH* JJ-W9]KFXZ,W
MW.L+/U\QV0D0^O)E+W)2:G18S6T2):(Z)VS"6B% CKI=W[(8U=(77*;4675
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M\7LO2M8:M-SL,36YFM5:+"*K=M1"SY[M6:)CPZD#:(F&9;7FY['AS2:Y:2X
M4XL#@>/4W0[\=U@UDC T@ TU[0WDT'&V@V#TH#T[<!856.J'9+1NI=A::K&N
M0]H$]A^JNK=/S5PA[?5H:M:JVC"5N[5"\'V<:SR,/8)/7H\=<V):M&TV'LD^
M<5#&1YM?C<GBF(DR,>6DD-+'.<.+L&A^?'H>./GAY;VAPJ_,:T'I0(/<'KUK
MGIZJ_?9;K[JJ]: L@>P*F!;R=<Z;NP-9.DG3VG@7!Z6XTZ2A(1@K;CA*XD)U
MS#R7$^=E/AC&,JQG6)ZGYG^ZVP* 'H/[*2NKW[6?KM_$7J3^@%?X4J=.$3A$
MX1.$3A$X11UMC:M'TGKVT[/V--CUZGT^*?EIB1(\5*PTUX)9##81XO&R4@0I
MH&,CQTK)//('#'0MYY"%9,9)++#!"QTL^1+'!!$P;GS32NVQQ, LESCQTX%G
ML:U\O*APX),B=U,8!P!;GN) 9&QO\TDCRUC&]WN XM?(-^*]V#K/;H7LK<G9
M'1U6[6W+9-BDX&;#/.MM<UK8Y$^W1E9EX^+,P*3<Y"'C43\'"X66R%>08R+.
M!-(5[%?TN2;P-IWV5^*_ CX<K(U/&A=XFU'5<3R9&.U>?/@B\[!E/.0S3)YL
M; V;#Y^.)'Q![7V[5\.^ _$.NPL;I<\4&3KVI2Z7)"^&%LF-][#M0+YY9(?N
M\4>/C1.\W*DMT3872.=MLB;^MG3C;4O?-CW?;VN-W0^Q&-V5R0U(';*':5UJ
MRPL_LI1ULG=E62MC($0)$UE3RS61)V'!.',)0.LIM#*<?BG3? 1?J<NMY./J
M8U&3+QYL:"7'F;BN=+.XY$F7*UC7?#  ^3;*QCG.>T;@0#^B=:_XO?M0@^SV
M?[%M PFMQ/#G^B^'=,\?Y6'._4_$&G:9EL&;E.A8T:?BX4K(1%C2-A\^33Q&
MZ3;/(\C%^@.GZ)8KNF>VW/3C.WA>QE9IU1UP?B4AG+15)2:%-N,V4VXAJ6FD
MQ\(F?#,2X6D-$>@HL]IXD/U\1X>\(Z)%K0U"6?(^_29^)''@ND(8\33$YKB6
M@3.(V.#@^0 ->[>'$@CS3/\ CE^UCQG]F>E?9MJ[-)TK5M.U;1M-G\0XN/,S
M6-<T[3)=Q$V+,#@0.>V)GWB6#'87M@!:V+?)?T\IZNZ%SC&?P<0_U^OT)EO#
M_2'^']_QY]S_ -!TC_T&+DDGXI.I-G^?U*Y7_NH>/>_B3+/_ .IPOUO&-I^*
MYH7]SF)__=2W[_\ Z0_?_P W'^@Z1_Z#%_\ *D__ -T_]U#Q[_\ G)E__,X7
M_P!BKI++U Z^VBO35<,U\ .'.19\22^&;+,F,L2 KHKCPKV3UX;)92[EQAS*
M%82XE.5)5CQ3G7RO#&B9>//C28+!'D120O+9)6N#9&.8XM=O.UP#B6D#AP!7
M1TG[8OM%T?4]/U7&\13/R-.S,?-A9/C8;X7R8\K9FLF8,=I?$]S=LC=P):7
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M+]G&N>(O%F;X3\&YVF8NI:MGY.D93]=D;##%-DN>R<:1]P+(62#=(W"^]%L
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MR-?6B#VA3M>Z)O4=8UQ1M@NET$L]ON;D@!B+CY=$>-"R&<+VM <7?S.);;0
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M<4R5VW+5>U>IK;/WR* L<A)E6(BIZ]C;5(;$V?!^K6["$5%$MS<PW"..@G/
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M\@KL!11P1APA&4#B",-#"CM)PAH<=AM+3++2,?1#;3:$H0G'T2E.,8^F.$
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M^4>2.!$Q$8.LDPPES/CGR--(5G"&TK==7E#33:W5H0J0"X@ 63T 6+G!HL]
MJLN]Y=5&4?4%UIE1VWLM[=M"DMITVE4&F"RUX9UQ")BOG=QGXB0G8D*)C8QZ
M=A@E"*E7YJ3DI(>,@HJ6D/5&:L$3MS@2&[3M)-UN]. 39/'18>:V@19MNX 5
M9;Z\D#CF^>*^5\:Q]]]&PPD/,PH6P]@U(K6E.W+:KK0:@J9K6L=6W[)N:I<]
MAO&R,5*18<DQ%3)KL5$1<[9(R-A9:3E80$ )TC@1./H#N<T DV2T60  ?[(9
MFCLX@ $D5P":%V12L!NYUM_1VWGF5I<:>U1?W&G$*PI#C;E0EE(6A2<YPI*D
MYPI*DYSC.,XSC/*3T-^]_O\ S]5:#?*Z+J]^UGZ[?Q%ZD_H!7^2BG3A$X1.$
M3A%KY[2;KNMLM4=U4Z\DMN;.NC1+%\MS7N%@:MIV1PU3$@:6&XVX))L1\L 4
M7Z+[)P;,E!Q(;\;8+E5Y(>[ PX]2DR'Y4DD.C::6G5\B*VRY$CVET&B8,G(_
MU#.;9ED:#]QPQ)DO ?Y37<'/R)<V9VDX,AC- :AEMIWW:)^VX(S8_P"]2L<#
MUN&(EY >^*^3K;5=<CJBWUWU&^5$:6I2SA]R;/26T).[$M:WLKLU4B9B/:%'
M268ZAYG8]BCT"!5J/]"B5% )0Y*JER]6U+(\39TD4;68FEXS(\*08G\&"#'Q
MF"*'1M-:"XQ8^/$/*R90[>+>P2.R99I8_KFBZ=@_9[I>!K&9C0R>(LB%F1X7
MT.>-LD6FXTC2Z'Q+K,#P+D>7-FT' D!^\R-_U++9]S9BQYW+$%SVQ814*<DR
MH=-ZXV+#/2\(W\E?['HC5)956*04(ZR5#]?(YD-,;,6,%D=_;N'7(NJEC:]$
M(E[QM1QLBC9%&QL<<;6L8Q@IK6M :UK0  T "@ *7B,K*R,W)GR\N:3)RLJ6
M2?(GG>Z26::5Y?++(]Q+GO<YQ+G.)))Y-FUB_:<0#7VV.NNRX@$**A]'2-9(
M)$!';#CXFA7RY0>A[4I XS;; D16ZSLU^QN--I9'&9KK3GEPEA"<9GY7^_R_
M?-*C]_O^G^RK3H_L+I4#XIO8WK5%VBR%?/V8"]5E'VZMR:P/NF$KK*=JU,:*
MQ8E0\J25#,14LXR8"MH>1@K%$I9RT"*VC[#K7A_6)/LR\/>(Y,7';Y#I\+)/
MW+%^].T>6=W^F9)E\D2Q-9,Z2(%CP7,F@E+K<XGEQ9<7^H38@>=VUKP"XD&2
MKD:.U[=I]OBZ$<;L,?=_V_7/\N?KSX\.G^>:]K[KJ**MZQ$O8=*;<@*^&1(3
MTYK.]1$("*I*2C)>1K$H''##J6MM*7WS'F6FE*<1A+BTYRI.,>;&EJ4<DVG9
MT432^67$R8XVC@E[X7M:![EQ %=R/F.=J\4L^E:E# USYI<#+CB8TTY\C\>1
MK&@D@6YQ %D"R%I7^&SKJ2U$!U\H6R=6V"B[PC-L;<=M,[8*S[)XRK/ZMF"H
M:NN7+&7!95]#<G"2(M9:/?)9$:]ZT&D>-(<&\+X?@9BY>#%-B2X^=]^S!)))
M 8MT(T_<V(RNV[BUQ#Q$+<+\RJLKY?X$P9=+CTG#SL#(Q-39J&I&>66(C="[
M!+H879 ^%Y#9&N;$22 "X#@K?[SZ0OL*<(G")PB<(G")PB<(G")PB<(G")PB
M<(G")PB<(G")PB<(G")PB<(G")PBI=VCA+I-;:Z3KJ)T*&+"=C#YVU,R<Y&1
M4B?71=,[2#.8@(\\AI^PG):D'%DQT:T68,!@F4RPVR Z6-T,3[V,+5W8L^5"
MS[KBLRV8^-!-%/C.U+"+XLN:6-[\2(O;&]DL+F2/F9%%OVR.!Y>H19DD^FNQ
M97QLCS6R936^74L 8YKV/\PAP9M<YP\JWE^W@"W"Z"?[%/\ !C_-SGKJ+]X1
M.$3.?#&<_HQX\(>/W_E5GW3VZT=H&ZZ_UUL>P3(EUVDZH>BUV"J-GM,A/D^_
M$C&Q1FZ_%R"4$D'G###,/*;=?<7GTTYPG.<<O.UC"T^:''R'2F;(KRHXH9)7
M.MVQHI@/+GG:T=2>W1<'5/$FDZ/E8>%FS2MRM0);B0Q8T\[YG;VQAK1#&\6Y
M[@UH)Y*F.@7^O;*KK=GK.91,>J1F8AX>:AI.ORP4I7Y4N$F )"(EQA) (D*2
M!)'<;(81E66\+1E3:DJSMXF7%F1>=#OVB26)S9&&.1DD,CHI(WL=3FN8]A!!
M'HNIAYD.= ,B R;"^2,B6*2&1DD3W1R,?'*UKVN:]I!!';A4^[8]G[CI/8NM
MZ/'V73^FZA<*Q9YZ1WIO^$MLQK1JQ0\I!QL/K(1RMVBC1T3:9H>5,G\2-GN,
M8+\KBG6(F,FS%DI W6,W@FB:XIM;OG1Y(_OW]+)9"SBPT5>YP);U'%CO[$=.
M;6 [;[!]OJCU_H^\X-KK9#.R4WK&E62KFQ]KVI#RTSL?=4+JF-O-%V!2MH5>
M,>H\A$6:$ND7#R$,5.MCY?AY*2'.4I0AK6ES@=U-#CQ0/PM)(-CU%=/Z*'/D
M:T.^#DM!!!/+G!HZ.XH];Z^QX6;=A=H]H-!ZC9V%-;(ZVKE8UGY01!L:2VG*
MR.Q[]/33H%#I6LX$;?8)R9RQK(BX)B--/F5D2JRI99<9$-O-!Y,;&YU4_P!;
MWM%-[D_ >G["E[I6-+K8>E"C=GM^(#_<JU^ES]K2NJJ))[QB:G [;D:X =?8
M&C+D':K!V MO)!,/$/RAD@<0U&(<;"((=-);(,8(>&=4,MGE3@ XAI);V)(/
M] /Z*QA<6@NK=WH$?H2>?51YGM9J56X3=)#*NA]HBK/'T::G(V@VR0H,%>I6
MJL7:-ITW=Q(MV!BYPRKE"2C2"RF@$^[%!=.;DR60EY^6[;OMM58%_$1ZU_D@
MGL"L?-;O+.200":X!/07?]O[K@_CBZ#;HE"V69;"XZD['UI?-NUN;/@9D=K-
M"UK$1LY;YB28]HLJ-7'1LJ&^V"0S@TW*EM!L/.MJ1AY3]Q:!9#@T_-QH?3W0
MRL#=Q/!!(]]O)'I==K6./=X])@TW-TFH_;%?'5>JEKD6NS>G]@!W.4M%^CER
ME(&@ZNF#>DYX6T#(].+.A6CQ_>YS'&+$/:('9GRG70+3P76#8H&CR/0]5'G-
MJZ=U K:;Y%CGIR.>JY/X[.DW8&+DX]G9$Q9)2RVFGXU;$:QN)VVHRQ4<>-,N
M(,[06XS$Q!LUP&;@3CY632-#."V&N.@2)GV@AL'0(GDU0 H'<2-M$T#?S3S6
MT#S9)%5\5@7TO]_G6/SGQ!.N,0* 8$?L.VLF:T)V^5BD:IO]I?K^O(NQ3-4L
MD]:Q(R"=*JZZC/U^8B[3#S;(4[#G $!/1BC6U#8")Y]!\6T60 35\$\$5[]T
M,S >YX!) X )KGT]_99F-W(TC([' UI"GV^PR)IE)BB+-7J%;9J@PLWL>OAV
MJBPEAN0$4]#PLA9:_)1DF$HUYL!AJ3C6I$T(D\1AX8W!H<:H[N]GX31-"^+[
M]$$S"[:+)^'D"V_%R!NZ61V]CZ+ (GO5J<&J5^1GI*R7J=DH6Y7&8:U'J'8\
MZW6:#5+S8Z85<K- B,6.7K,&*?7I"-]U)&.DSYL1,GU^/? &?9"@1N)["Z )
M[D@$ <79ON!W]$$S:OD]ZH6&@D%Q%C@59(XYXM=Y+=\NN\782X)J6N4Z#%9U
M:[8+M6=>7"P:[K,9NF.B)/64[8+O&13\#'0EJ'G8SVL@LI38V'U/GI%"8(*:
MR$+R+^$'XN"X _":/!/6T,S!ZFBVR!Q3NA]P?:U< ]HH@(Q@$OV!KPI#0AWH
M-E>R)<:6A@OVSN<-$>W=RE[T',X;>\GIKSA*LYY4K.H]/[*L@4AMVE;LUA3+
M/LT*]UJ^5C9IQPKE$AJT8!(4U%.?C"!#XHQU2VW4SIS10[[*DKQAE:%(4C.%
M9G:6\-(((YNP>M_(<>YZ<];KMS7,!.X.W#H+XKG@=E:7F"M3A$X1.$3A$X1.
M$3A%KN^('(1=-C=.;/@=GW#6V]JM;[!!:5%HNI#-]SVQB;;7'<7'7KVH(YX(
M^RPI\/""SDC+"S-<55WH &3<L(+2ELF70V=[0T%KP \D[:IPHV>.OK8Z'W5$
MU#:[<6N:3LXNR011'4]NA]NZCCHE9"MJ;@V-L7=.R+]8>S-;H,-3%:WOW7R2
MZQYUYJB;GWYMJ4K- EIZW&6@*X6:)2F6NWVRL3#1-?"A&FX=3+C)N4PVM#6M
M:&W9+7[[)]3]#0''7TH8PG>]SG$EX&WXF;> >2!?2SSZ_FI#^(SK4JTZP9V.
MYJ+JMM>O:4K&R+Y:&.S%,L5S=B(B-@P9<K\'PL TOT)&2%@RFY5)JV6B5"PZ
M$.)PVZI&,+@'!I=(TN(:W80.2?YK!XK]]%E,"18:PT"7%X)X'( HCJ1[UU6M
MDW0.P]*435_8J^]&OA:5ZLMW'4!]K;HM'M9=\H43=+K6(86?KQK@0\+,S];*
MG 3L,11[R\D,*=A\S*VF62KRYA<YC9)K =1<15M]::.#1ZUU6N0]H:\PPTXM
M' .ZG&O4]!S_ %JE]'?-);ZI]VZZ[;%[$Q^LHNF[1K=&@Z-=DWJRU.X:Z*V+
M5-CR4,.A=+#LD6%=Z,0]%56=\;.U$OR!<5*3@<(3)!/HB&6G+(WM99+;)  /
M=O-FOG0]53-&YX #@ +)!'!/%'IVYZFO7BU2/0.H.U?6*M=9[]9-3G;RM%8Z
MT7+15LH>NBZ'4+!29(ZY5:Z43W2[CL)NMS43C,3*P-ML439%$,ONQ,H/7W@F
MRDCVO?'*7_$6 O#Q8ZF@"..E"R/G^5;6RQ[30?3"W@40220: KCH>._58K5^
ML79+1&I=AZ9AM2D[5D>QG5'5>H3;76[13(VJZIV;#5F\T^XM7#%GGX6:?H44
M'=!IN E:G$6$Z2^3RD?F&%-+C\$29&.<UV\ QN<ZCU<#5%O'4D<6..X4>6]K
M7"MQD8T$B^" !SZT+-FN30ZFMB78K25/M'7VS@V<BX/OT+3-T BB*[L78E%;
M(6+2GF5O2HE(M->%FTNKC6'$L3;4BTPE3[3*&VR24.ZIYL]N>O\ ?H/T"VFB
M@!Z =%(/5[]K/UV_B+U)_0"O\*5.G")PB<(JB=L>Q*]-UH:MT\8F<VU=DXCJ
M;!QHK4D<(X>6/$"2ZXYQYA!1),J:-$5J.(='%EY\AK)Y<?7(RRS4,@QLG4\^
M#2,%\<.1D,ER,C,FO[MI>G8X#LS4<LBR(XH]P@;P9\C9"RW.XY&IYLL1CPL.
MG9^4"([&YN-%=/RY6CJUA^&)A_\ %E(;PQLCFU^TGJ*3J6+)KR)G\JVE9$AV
M#M/N]B06>_4@I#)DN'J.DV,A@9;UDR/(24B;,.-!D1&9>5V5+1XD[;X,#%.L
MZE%FR0>&M $N-HNE LER7. G>^4WDY62]I?YFNZJ6"><EQ;@XIAB8X-9CAWT
M?POH&!X0T3&\4Z] S.R,M\[O#>CY0+CK.=&^Y]=U5CBQ[M#PL@[&,+:U?.8_
M#9_W6#-<S,ZO7P.TL>%4*<$FI](:<\3 8%C,%1Y/9UZ(>R*^!&OM98>%Z\CG
MM$-R4JV0^5O@E!+27<:P623L:88(L>)D$$;8HHFAD;&"@UK>@]3[DDEQY<22
M2O.:EJ.=JV=E:EJ63+F9V9*Z?)R9G;WR2.ZD^C0*9&Q@#(V-;&QK6M:!L ""
M#C0Q8Z/%'! !&9#""#8:&$#$&;2R,**,PA#(XP[*$,L,,H0TRTA#;:$H3C&+
M5I*K>[^M1NX(?8XIVU;J,W=M;W+7B(%N*U[F$$A;.TA[V3;RZ4J?Q@>0%#>8
MD,3>)<?#7F8/;>\'</W?=/[=.+_3NJ>:_P"F=#VQKW7/:6BMUJF]BI:%J&TX
MR=&USJ^-%!V[&8-EIV+LDI T@&U'QDM9I&>JE]>7-*G)2)4]EPO$J$&2S[W"
M\>Z@S#CT?4O/R]%EQW8&;CG4-3D>[#FCB@>8(YLU^*R;';$R;#;Y(ABF;6P1
MO>TZKL2'<961L9*#N8\-:"UPW5;@W>02?B&[IP"."K;=?NR\[N^6E8)^DU*J
M35.$C4;(KF=DER]PHT\5)VV ,K\E6\T*,QD@&=ILFRR:Y*C1DO%/!SD&9)1Y
M0RW^3KOA_'T6&+(;F9>5#F22_<)SIK(<7,@9'B3MGCR/O\AVO@S(B6B%\D<K
M7PS,8]KMMD4OF$MH!S0TN <'%I.X$$#D46FKZMIW0B[:O(6XRZAMSTG%H4EM
MWR8<])><9PASR*_)7Y%>"O(KPPKP\N<XQGQYY@]#S7OZ>ZM/0UUKC]GC\U7*
MQ:&E[+'69F4V"23)RLN);X"68KD9&G5.^0L;%Q]<LL04*^I].(Y,2.V;'NY6
M-+@D248?AP ]\=?&FTM\S91)E.?(YXGA?Y,;3#E1M:(9F.:+&TL:7-W4]I<U
MPHTN+-I,L[9Q)F.<^61N1%(((HW8^5$QK(9HW,(=\'EM#FDD2,<YCB6N-9UI
M_81=]KA3<_'MPEZJ$H14-@U]M2UMQ=JBVF%OD1[CN$.D5Z?")"L=7-<;;<,K
M\M'NOM,%8('9V]/RW94)$K1'E0.\G+B!_!,T ES1U\J5I$L1[L<!9(*W-/RW
M94)\UHCRL=YQ\N(=&3L +BWH3%*TMEA<0-T3VD\VI8YO+?3A$X1.$3A$X1.$
M3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X14O[(U5^R[^Z0E,72-K2Z
MKM^_V14 8-+NG79EC2]X (B8DF/$(!#("'D'9$K,R2 *3'M%"L//DNH%=W\;
M%EFP-6FC=FM;BQ83Y#C9KL;'+'YT+=N;B@@9\3W[1'$6O$,H9.0-MCDZABOR
M,S2I6S^4W%R)971^8YGW@&+;L+1\,E-+SM>0 :(NJ-S\?3&/X,<T%UE^\(G"
M+A24<)+QYL6>AQP*0%?#+;:((%<6.2TIEY#9(CK!0ZU-K4E+P[S3S><X6TXA
M>$JQBYH>US'66N:6N )!((HBVD$<'J"".Q6+V-D8YCQ;7M+7 $M)!%$6T@CC
MN"".Q"U6]DOASRNPM\]>-WZ8M5>J#VCYD:P%UV\D7BT,621C;%%3\>VW(OSA
MY4:(OV"Q"T#I1G.',/)PMQ./#R.H^&729N)F:<^*)V.Z)SF94N5*'R0R^;&=
MSG2N#36UP:64.>;-?/M=\$.S]8T35=.R(L8Z1-'D/@RG9<XR'Q3LF8 \RR.8
MT[-K@VC1ODE7 TYUW IK2[+>,"R6RY"[72\2DE6)VZ@U=@^V6B8GF@XZ"-G,
M@NBQXTDV$I1D?^NG65E.,^JYYL=33M(9C;I\G:_-?DY.3(Z&;)$#79,TDNQD
M3I0RFA^TET=N(W&SRO3:9HK,0&?)(DS9,G*RI'PRY+8&OR9Y)MK(G2[2U@>&
MC>RS5US2]6Z-0;FLUXC+[I_;-<K?FIQ-&MVM-KTN7V5J6S1RY1<O&V,>M1-T
MI1,%=(M\@T!^99-.8G((EN)DP,X CBQ?0,>P M>TGG<'-X<#TJ_2NW8W7==A
M['$[FD5MVN:X6T\V.#?/Y>IZ*+HWI,F'ZH0G6L&^L)+#VQ5-N2EJ;J3,=!JF
M(OL1#]@9Z#K-' F&Q*I5R3P#*Q5X825*9K,4^$XM4HL-U!4NE+GN?0^)I;T[
M%NVSTLGJ2;Y4"*F-;?(>UY]+#@XUQQ9] /:NW(WKULWMLGL)K[=--VSJH"O:
MMK!0U"UQL_4EHO<36]A3#QH\_L\4FN;8H+9EE?KKHE;@UR@!OV9 7-.1+C14
MZ6\DQ[6L<T@VZK<T]1Z<\?H?HCXW.>UX((;T#KJ^H/'<&_7KT5AJ UO0*?8C
MMF2E"L,*/1073K%3JM*U%L^_O6BQ>[:C8J6O5S-&@V*DFO(=%-6IUN6]R:--
M2#4BY%5_ [:XL&ZHUP*]N]_3T]LV[[IU$5UYZ\<?2B;//3V)JC<^D-HM7:B.
M[!B;&IE>##O=+NCA\#K4ZO;H?A*B#%C%ZGE-D5:[U^!N.N+.Y&.-R3.P*):Y
ML&'EI*% D4MIBC(JP2D1N9S1[=6_.NMCM2J?$YTC'@BFNW>_?@=./4$\BZHK
M#:3T'VQ6XR@5&5[!58ZCZ:U-N[3VJ1(_2X*YL>"VN##Q\1.7M=HM]HK-QF*J
M%"A %QOV8C*]8Q4$*+CF'#EX'DRM-D,(+G-<18XH@T"".*'7K9X4>2_BW M:
MQS6BKO=ZW\@/DH>D.B&[-45ZFCZUN-+#G9+LMH2VQU<UKK*T1FC]6!:\$ORY
MR]JUA8]IV=\?-M(G8\&[C56QU.+Q% 0@\0())BKF",O.:XD.#B QXMS@7$N/
MKQ55TY^ILK Q/:&46V9&[J'PM8T'D C@W5DWVH>DD7CX;4C?"8S9-IMVH;YO
M%_8&QKU<U[*TH1:]*3[>QJUKJHOPD1KK-^#GZZJJPFIJ$W7+ B[2$LZ^#.JE
M<%,60AD3$35\(W!FT-X(W$ [CR;'Z5T'RS,%TYQ:7[BXGD 6".*H]/7J>I4H
MZ\Z(XH$-:HH*ZU<=-JZL3G7DD>KZOAZ/7P)RQW'8=TE;I%5>NR;$7'Q'S"_.
MCBUI&'9!QJ/P7*V>4DS2CEXF6R.. \.Y-N]Q9YY_19-AVW6T$M+:VBN277=F
MZ)[VL#)^'I;%[2U;>P]J4F-;UZSHYG-KAM5GUK=B(K3\55XZ6HD;L:J7^"CY
MG7VQOLX0B6AME578!4)'66PQ4>:0(N(3#Y>=8<"T\E]6>/C-W7MTKV]U'DFV
M<BFAMD"G?#T ('(/>_IT"[&K=%]N:H#;?TMOFIUNR637<_JW8LE;]3F6Z.D(
M K:&S-DU&Q5&-%O\ ] VVGJVM:8K*94V?KT^ET,L^*9R&D=V#*'$[FF@0X$=
M>!M /KP!=4>B@0N8!M=SM+7%Q+NI)XOB^>XY[] LIBN@X59UAN#5-9OZA:_L
M*M=:ZC6WY* 4<=6(7KG2Z+3 ,2CC4P&B?,L0=*;(=?81$-@.FYQZ)6&/%R#)
M982T'9OH4.2XWR:LT:Y//Y!9B'@@DF]MV3?P]#U')[^JV(X\?S_?RI7*N=__
M &R?77^]'?7_ +)K7D]C\Q_=5N_\2/\ ]O\ HK&<A6)PB<(G")PB<(G")PBU
MY]_I@?5\9J+L/$[?H&IMBZMM%AKU)'V=5+9>ZGLQG9,$D"P:X35->X<V&58)
M%J C9N$DZ6'*RT6J!+R3$G1)4@A%T32\N9M<6D"W-+1L /4EWPBNHOCCGB[H
MG.W:[>&$$U8+MUBJ ')O@<$$7P;I1OT6O178_;U_[ ; VYK&U;2I]!C=0#ZH
MU?0]IZX&UI49R>^V!4O:HK=T9 ;(G9>XRL4&B,EB*[#5L("!)#B6S#7I0A&4
MP# &-:X-)LN<YK]Q [%GPT+Z7Q\[40N+W%SB"0*H-<T"_P#RNY[?OA;192,C
MIN,D(:8!$DXF6"*C)2-D!VBP)&./86*:":*^E;)(A8SK@Y [J%-O,N+;6E25
M9QF@$@@C@@V#Z$*\@$$'D$452&F_#DZP4>T5>Q1T7LJ8B:)- 6/7^M;ENK:]
MUT_0IZ)?P5"2U2U?:+=*5",+@2DMDU[.8QYF )9')AF07QAEM9F5Y!Z6>"[^
M8@\FSSS^7T[5^2P&^>U GX01TX]NW/\ :KV^.,_=GQY6K4X1.$3_ '_W_P /
M"5^_T_HHLWG^PEN+^*S8/]$I?D'H?D46/=7OVL_7;^(O4G] *_R44Z<(G"*'
M]V[CKNDZ47:9M31!SR2Q:Y"K,8CU3,L/'&2CC;\@5G D/"QD< ;,V6Q'J;C:
MY7H^2F3W$L"92NB:61CH(<>"3+S<R=F+@X<(N7*RI;\N%G!JZ)<\BF-!<>P.
MCGYS,*$/KS)I7>5C0-(#IYB"0V_Y6- +I9#\,4;7/=THZWM35J^76^E[4LI2
MU[CM4?FPQ,W/@Y&AM$ZNE07PE;0EJ_*^7Y#<K1"9EH33FO)=YV3I-)(,D[:.
M+8;/MYR:VM2R':/CS>%=)R&9.L9IAR?%6M1L#X8W,<XQ8&-)>UV%ISV[<6!K
MB,O+#\U_F0102/\ 8>#?"^%@8,WC;Q?NFP73OBPL /?#/XDU6!@(TS"()DQ]
M$P1*QVI9GPF*%SL:!QU#+_AS/1Z4)V1A0Z?5FI6#Z7Q3S[QTR\6ZFU=PIQTY
MTF;/DY-S&))W1,T=DHBR39"AYG?IA)#;*V-29<=V7IXN)#AP-@A!#6N<7%QW
MR2/<2Y\TLI^*265Y+I'N+G.=R>O&EK>M9NOZC/J>>]AFG$;8XH6>5B8>-$T1
M8N!A8[3LQL+#A:R#'QHZCAB8UHL[B=B8HHP(PX00PX88C#0PH@K+8XPPS#:6
MF!QV&DH:989:0AMIIM*6VVTI0A.$IQCFRN4O?PB<(M:?5.*)KO8'M!I FZ7#
M .G+\Q?*K4\V=Y,3FL[XFK9M<4OY0A.%.0K,M89BJC,*S[)I=5<;9;;=P[A<
M5U /O\K)/]?S47T^7OS_ ->O7Y<+7-K33FYNL_Q"=M]K[?>K1<M=S,H@S;\&
M%2]VQC-:UE<<6R/K$^4;/&/AS\7IY-2@LE/3SIXRZN].2-<"R1'MC)^]9VJ:
M#XB\":1X2PL6'&U/ C#])?)JVF32S:A%Y+I89(XW^:QVKC)RA"RAMR8XF2D?
MB'(CQYHLZ7+?+NCE #V^2]H:T#X:?TMFT;C1!#N2OH]$*'-%',$>:)%*9:(&
M(8=2^P^P^A+K+S+R,J0ZTZVI+C;B%92M"DJ3G*<XSSX.YKF.<Q[2Q[26N8X$
M.:X$@M<" 000000"""#T78Z]%R/OY!_/]\HJE]A2Q=*ND]E69I=<@X:+!KFY
MULX$RD[7ZY!;$7:V&#6GQG[+KF6EUR8&%L%NRM=.L4$V&8<3#(&X6J.^X'_5
MHBYC&!D.>& .=)C/DV,EC:6O#I\:60.8"T[XW21CEP7GM9D9I5ZYYOD01,9#
MJ9XIV(7[8\@-+7!TV))(',!:2^)TD8Y+0O?UUW[1MNJ*;@-NHV"8;FTR<$,F
M)%C1#JA!VER%$L424+7HAF58<8+AD'$#&%CM$',X]$93R6\9:5JF-FND8S..
M3+<[FQF,,(@BG=$V45#%U!C#@2:)Z<VFB:SB:D'&+4FYKG'(DA B$0=C0Y#H
MFS,+8F"5I#H]SFN< 7#AI5K?X?ISMKT*>.,_=GQX1.$3A$X1.$3A$X1.$3A$
MX1.$3A$X1.$3A$X1.$3A$X1.$3A$X14M[ URMS_9[I&7+W V FZS;=SS]8KK
M$2,:'<GTZI/BY$$^2>E0WX;,6')_-0W!(Z64>XRX(\@-O.2<;#(,.7#RY)SB
M?>(),1V)YV8^#*W.?(V88F,T[<O='7W@/%01#S!R0N-J$&++J.C/FF8R>"?)
MDQ8W&GRN^[U((QO9NV,-N^&0@.L 42+HX^['YOIC_?\ -_FYKKLK]X1.$3A%
MB%ZOU.UG6RK??;%&5:LA%Q !<U+D)% &+GI<&!B&7GE>.$9.EY($)I6<>3#I
M"<N*0WA2T[.%AY6HY#<3!@DRLE[9'LAA&Y[FPQ/FE< .S(HWO/LTURL7.:P%
MSB&M%63P.30Y]R0/JLNQG"L85C/CC.,9QG'W9QG'CC./X<<U1^^O7N.0.BR5
M#>UW:.U:5V1K/7,/.:<U7%7NM6BPN[E[#/V(7669F DX*-C]9Q3T%(0 R;I.
M-3!$VEV;LT6P/#1;ZHX"=*4\P'='&'M<X[W4:#8QSTZDWR.O "I?(6O:T$#<
M+MQX-=0.#7N>/EW6"[A[#=OZ1HNE[LB:KU^@%24QK2F6BGSLI9=@-/6'8VY8
M;547;:7=J/8XZ%D:(?'66#N<4.> U/8CGGH^20'(X4P/+6QEY;\? )[ \"^1
MU_IT*Q,DFQKP  =K0+W&W.K=8X+>0>M][67=@-L]I]":C;V3/VCK1@J'%6!+
MQ**5M:1,NEUF9QR.HM.UM#AW1F0,G+,LJ(@Q(PMTI\J<(>(2\-&I5D=&QDC]
M@\RB;)!%@ <DUT_IR!WM'OD8PO)9TX W=3TH?YNNRMAI:3VG-:JHDQNV K=5
MVO*5T&0O58J!A<A7J].&)R0]"QYQSQ#Y>8UIQD0LCW!##IS1*A"'Q?0=76X-
M#B&FV@T#ZJYA<6@N !([?O\ -0].]U= US9U@U+*SEL:LM1N5.H%QE!]<7XV
MCTVU[#!@3J-&6N_AUTBGP.+3BRPXL67(S#(7O2L#%OC*3G/,O+<0' "B">HN
MAZC]]1:Q\UH<6\V#1]/WT]/91]7.]-)CJ<7,[+B;5]HD;&[10#%>U9KC8>RS
M!:#UWW]>M/NW:<%J4+8"(<)Z/K<,=*%'N#,$2\B6-##O-L988ET3@:'(^'GW
M<W=7Z&OH.JQ;,"VSP:<:'HTUU]_\_7);'WYZS5DSVY=JL\D /4]<7Z7LM=UK
ML2R5&LT;;#3CU#N%JM,+6#H.MP$VAM:DF2YHBA&T/OF-,#AG/#0(GGL!R0+(
MYKK2&:.P.O -T. [@=?6C_NLIFNXFCZ_LD?5\G(W)F6(OT)JM5E1K38+VMQM
MEV04,N"HQ6R6:XNE,V"31( L,,9FLCMR!8\624Q)NI$S C<6[N.EU?-=S7I_
M7MRLC(T$#GGBZXY_7]%FNENP>N=_B6&4UFY:)*$K<N5!$V"7I-LJ\!*2L=*2
M\)+BUJ7L<1&!6;Y),P<E%S#T&Z<Q'&LH8)<;6\UA<.8YE;N"1:EKVOLB^#7(
MKFZ4W<Q6:<(G")PBKCL#Q_&3ZZ9Q]_V1WWC_  BZT_\ ?S,5M?TL;:/UYKWZ
M?2U6[\<?I\?_ -7_ *JJMDUI?W.Z];UFQVA[*Q]'M6D-E[B,@0;C4&Q@;' [
M2UU!QD5%K=H+[PU8&BK9*!XBW7"25MH#RJ0RMA2G;0X>2YWEL)#PV]O0%I-C
MW_3CV51!\\,\Q]%A?5\<. _H#^?1>\[O;?Q-:7#;!NIM956E![QM^CJ-.7_L
M%'5$"7D*#?MAT:T6NV9*HCYD/$J*H2DUVOTT/85SFCY+#:X"/A039]G'RFDA
MN\V6[C3;/K0!(%CW/TI29G[2[:VMVT'<3S==N??IT71:^^(+L7<D3JD+4.AZ
MS9KUL3\9863%F-O&URBP!G6JYT^GS!H-G>UH98)V"N+EM&+KA+E,AY1A2@V9
M6)$8=-.C<W8^S=N<Z@&$6T _Q!P"!=5S\ZL<$*&SO<!M8TGX[(=;?@-<7M-D
M<]ZZ<\UU,E\3M3177PEC449 5G=VMM:[!S-;+V:QKT1PV]V ZOS=$U_99*HD
MZWM=QU_\O7,3D7:+[KXF9C9"&36QY$N1PPSB(1\8+G L- !NX\4>>;H@U8^:
M&9P+?A%. )MU=;! (OF_7@5ZA29&=VM@E7&7=E-$"1>E(?M,?U,*V0QLP4^U
M+NQ-X:UY5+6+K[[)C-.4V5MDC P,JXNUM3D0?*.DCP\K#QKTH_'EM&T;K>6!
M^VJX/-7\N_S[T#EYIY.VFASFWWL&AP3U)[?3UJJ(WQ+[EI'KAJ"TW6&I.R)]
MW2/X5;I)7'<<94=@W%EJQV4(V-H>OJW2[G-2TL%&0BRG9:T"4:H.K=#!#G"W
MFY=V*M\@/D>T<4Z@!6T<7^(GFQ[=2JS.61M<[FA;B;NB:Y:#Q[=> 37"M78N
M[U\B;IL/Y;HZ-D]/:IW)I74=TOI&S4Q]L=(W=7]22D-+5NA)IA@TBFMG;<AF
M;"'(6V)PY'L9*ARI M9,>%7Y3:;;CN>US@*Z;=W!]#\*R\]WQ':-K2T'FR"[
M: .HY!=SQTZTI8Z;;0W'M2G[5E]QQ=<CI.O=A-V46M_9N?5.,YJ]+OTS7H\$
MGS5&JX'7"^P5$#$*:/)F11&IDX@8LUT$;"5C6E@!NXV$T2.2!?I^^>ZLB<YP
M<75PYP!'H">OZ?J.RKGW#WQJ*)V5JN]Z^[(]./PU];;/? )K36]-^U'7PTM'
MW6O-UZS1>9IE=BF=?;#A7(\%4+)GU.182*3.0<H.*++N%,61QN(=N9)L>W\3
M!\B#U JN]V >_15RO;;2UT>YCB2'GBJ(KY]_:K]%[^H.P4]C.QUP[ 6'8?5A
M-LB--!:OA]/]<M\0F_9N.JSUS19I&Y[-N,5$U=+BUS#8<358D.N+C(5DF6=5
M-$G33PS,2-+(PW:^MQ)+@ .1P&BK!JR>:^8HI$=\AD)9>S: QQ=QN+C9X:>"
M*ZU[4KV[^B+78-%[E@:($Q)W::U9?HFHQQ);P Y]ED*M*B083IHQ(;X:"I)X
M9E1+)8KC'G]5)#.4^HFIA#7M)( :YIL@D"C?-#GIR!RKWWM=0L[30%79'8GO
M]0OGT<T5U6OE+TQK#1VJ>[7XRPU\U U=PMF*[;5,2&@1+; JW,3NNTV*4B=:
MQ]=73&K9ALJFRR3"Y;,0B@9=6Z*E6\9)6E[MT/ED&MHC==FQ0()Z];Z6;KOH
M[6.#6M;+YEM)W;Q5&R;L#@^IHW?-VMQW0EJW,:5GQIUC9HU.&V_L\;23.Y/M
M'^$M&DV;!E%(Q9,W);EQ4RE6)5-87:UJGUTY->7(*4M259U)OQW;22 7;>FX
MW8Z?TXZ+:AO:;W5N.W<>:_K^?Y*['*E<G")PBBS>?["6XOXK-@_T2E^0>A^1
M_?"+'NKW[6CKO_$7J3^@%?Y**=.$6)W>Z5_7U8EK99C,AQ,./AYY333A1A3[
MKB6 8R, '0X7)S$J:ZQ'1$4$R\=)R)(P0;+Q+[3:J,C(BQH7S2DAC!=!KG.<
MXT&L8UH+GR/<0UC&@N<X@ $K7RLF+#@DR)G;8XQ9X)<XGAL<;1R^1[B&QL:"
MY[B&@65I]DYRV]D=L$3TP#%N 1#A?RV!L$B.71*M&ULY!,F9<"12$1\AK36<
MW%LRFQW1BT(W'O&&C=;1DF/0M134Y(;8DR/#<3<CRV/\;Z[AN&'C/<'-\(Z!
MD _][R!MW1:AJ3',-L#9! YK(WATS)L?M^#O"\6H_>?&7BXSX/A_!_@LB90R
M,[+XDB\.:.YP,3\_*#&S:GG%DD6G8X,TK9VQ8F+EV*UGK5KL-%I"87-M=5E2
M[LU89:PM+8N7=NUY2S@NZVE_'MG1.OA#K R86(0,,SMV/$""# BM&1T/'[(Y
M^%ALPHO+:YTLCR'SY$CB^;(F( ?-*\]2: :QM,B:!'$UL;6M&QX@U[+\0YS<
MF=D6-C8\3<33--Q068.DZ;&YSL? PHK)9%&7N<^1Q=-D3OFRLF67)GED=L>'
M&'#89%$89&%&:;8&&';0RP.PRA+3+##+:4MM,M-H2AMM"4H0A.$IQA.,8QN+
MB+W<(G")PB^=*&^$WV,JWQ=MP]Y-?=Y[6,S,4V!M$90K[7YBX S =HD;%"N:
M9NXT1:J:$;I^LLUMXNFM1*PY>%-)AW_;.EP)1]A(L7ZS?%![:V/XL&^.J_:K
MJ&#I+4Y,!4J"-?2)@ERN5V:A1[:10IR5O\^S&4^X0O8,B4F1:'7HA(\VA] 4
M*"W83HBS.X EI#VEP>T@M+206N'0M-\$&C8[@'J E?T/7G\^Y_=K<QK5]SKW
M?@]#39)"M77)V0.Z\SYSBE#U\EAMV1F=!FF.J5GW$&&T98-7^LYAP^DCRM:8
M;PJAH?DO4:B!KN$[6XFM&I8C8X]>@8*,[20R'7&L JIW%D&I;>&9CH\@_#F5
M'2T^6[8;VN),9)!HD68Q7I1+!W (%U9MYXX\?#Q^OZ/\O/+ @_I8]+5RK7W"
MT[9.P/6K;FFZA(0T79+[6,P\0?8736(4<M,B :A4B_' R9K(ZDB+1EP< MQ*
ME)SZ*\>..<W6,.7/T[)Q(2QLDPC#3(2UGP31R'<YK7N%AA (!-D'L:X7B;2Y
M]:T+4M+QGQ1SYF/Y4;YR]L37"2-_QF-KW $,(W!KB#7!%JF_4WK[V7UW1M)P
M#,OIRLN:#HVU]5.RJ2[9L06_FR^Q:\:<@F <@=:$5,$=VFDH$F!;+/E^8@9Q
MV&<;]<;'GM(T[5HF8CFOP8/N$>HXI<3+D_>'39K)'M,?EXQA8UT)'F"61[@+
M# #2\UX;T;6\'#TJ#S=.A=H^-J6 7AT^6,M\F;$X[HC%ANQXP<>P]DLCS;=S
M>H6;=ONX>VNK6D[%>KKHV0=D 92O1<?9->;"KLA2B,RTH.)G+\M9:H[9H$]3
M:EY]C(:SE8MQ:L!CV/+RFB<[FJZQGZ=BET^ YKRYC&Y./D1OQR3N-DR1^;&X
M[>(W0/:;+=Y')V_$WB;.\.Z3/F96EO<YDD,3)\3+B=CN,C]ME\T#IXGT+V/Q
M)&$VT3$T3*?4G;VR=B1L5G93 F2+7I[5^Y8 T.S!3N$0^Q/G^&HLT0/6VOT1
MLB#B(0HE+;DZ.]ZJ,L$L80OUMC1<W+R&L;E@N=-A8V<QX>UP#9W/8(RQN/ (
MW-# XBY ;)!%$'I>'M0S<R&%V: 7Y6G8>I1N$S)*9E^81"6LQ<8-=&&MW'XP
M;X(Y5P96:AX(=)DW*QL.(IQ+*290T8 =3JDJ6EK#Q3K3>75)0M26\*\^4H7G
M&,X2KP[LDD<3=TLC(VW6Y[FM%^EN("]#)+'"W?+(R-MUND>UC;-T-SB!9HT+
M2)FX>>&R9"2L=+B)<4RHF,-&/82ZE*5J:4Z*ZZVEQ*5H4I&585A*TYSC&%8\
M4<D<K=T;V2-_YF.#ATNK!-&B..JF.6.5NZ*1DC02"Z-[7ML=1;218[CJNSYF
MLTX1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A%2[=@NOS>WO3%-C>G
MV[K&A=AYB@(CY)D>$>>:I5;C; S/QJX<Q^2\T7)Y?BW6):(3'EC.+?2?@AME
MO98_"&'DLGEQ6Y;LC#=A12X;ILF8AN7Y_P!US-I;B")A#IFDM.0TL8"0T@\;
M.&"=6T<3O(S <UV$P,#@:A:)R7D$Q@,</PD%YH<M!JZ&/NQ_!C[_ +_Y>:WZ
M+LK]X1.$7 E8P.:C)"(D$.N R@1,>8A@HH)]8I;*QWTLF!/#F"NJ:<5ALD1]
MDEA?@ZPZVZE"TYQR/BD9*R@^)[9&$M:\!['!S26/:YC@"!;7!S7#AS2"0BU/
M]Y/A<L=I*55*)J_;,CI6&CIUV=MV)I_9.T_M8L9A#<$#D.>VF!&@"193A<BO
M*@S""#L1[S3PGLLI?^G^"_M+D\,YN5G:EI<6L2R0-AQ?*;I^FG%W$F=V^#3G
M2/?(T-C'Q-:UF\%KM_P\[/P3EQ-B9*80';G5N=NH?"*W#@'FO6CU 5M>OO4Z
M U%3-;"W"?G+_LZC0L<!*7_%MV9'1]FE8X=06)PBG2NP;'$,D&CX0X:(]DP)
M9N7GV66&UM,,^5UWQ/D:MEZB[&@@P=-SII'Q8'W33I'XT<CMYA;EQX,$Q#77
ML<-KPRFESC;G;44.QD8>]TCXVAI>7.&XBN2W<1V]UV6Z-/[BM-Y N^K]CTX>
M+)I)-#N6H=RT^;V#J:QC9EES$5;8Z%A;=57H&Z1SA)\7(R"\2HEC@'Q(LX4=
M<4 8UYII:.NZ^Q::/;\OR*S>UQ<'-('%$.%BN3TL<^X-_FHKB>DI$-U+@^M
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M6[+[(W]4Z'%WVTNZI!E)VQ%R-"L\M1#&08O-ZJT6^.WC#"28$28"!F1VC9D
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M1C'S2RLAW?"?AL^*\J;7=8GFTKP=H3HLC(S@QIF<'V(68,$A:,K7-1 ='I&
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MV+(E*=8\UD&''>3*M_\ %O@TT[E&&VRS6_-G!"LXU"0;/:R?U]OU6V!0 Z4
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MUO% L%]7@\N';<WFN2+Y-2OA-_%MFNU.N]O&[8ZN;HU9BK;:MTG"V&CZ\O\
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M297,DB#O,;1#:%^>P8)I)8,#)SY,O'TQP<8'8XW9):V2-@F.YXD9'YAL.ZN
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M((!( [F@1=B],=E;MMC6E:O$;HJYRV)-H\,R3B)W6\= &2T%+'5Z:>AV+!?
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MWRA -/&;D?<O(#0T0_=?,\@Q5QL+-M=!W7U1NG8#6"(8>,(QTC;"P1@!VX?
M&AH%\T!5]!2LAC'AC&/T8QC_  <YRW5^\(G"+B2!+X8!I8P),H0,*^0Q&AN"
M-%R#S+2G&PQG#R0PFR"5IPRRLLL89+BTY??:;PIQ)%K?[:=I-TZZC:H'6:%8
M-4?/29!PFU6UNAV'+ZHSV2VH:);A;#;8D9XE)#KYSDPRT0L1GRQ2,KP22+FQ
MF\GFJ!/7_(_/\K[I\_2J_/\ 9]58O0VZ]B[*IE%F;-IVU1R["'XGVX0VEBU1
MU#3I++<\)%&7'-O9BY-L=LL9C,$^0E)2,LX(#PV6YB11(]"1^2<WV_/]_P!5
M%EXL<#3/B&ZOE+=-Q-8BK/U V[7*_(STB)$Q\M8(C;^I)T^%"*.>8'(E1X5:
MI7(*',DJCV"RD-J9%(6W:&W":!+O-'3K6PW\^:_54.($S0YU QN'/2R1S9X'
M /N?<6J5::NNU+)=(.E:6VUC75([$]P._MC+V!!U:I70R>JU$>A%P$O1B+7&
MS, E#EC%DA6I=0,K&F ).\@I#N8\H;)P:&[G"R(X:%\ GJ#1NQ7'/'OQ=;'&
MZ:Z@^28W1/'!#AV'(/M5][6 &[V[!)P5V!>W-AJ_U;X>F\942O8J=0:IUAO&
MN=T'TI-J<@WX]\]EV6)A(NUS$=&2+8X[HR8L7V\(IP-RP11D[-O!E:W=?-%A
M<2>G6^G'ORH+I!;MQ)V.( '<. '!%$\<F[(N^1Q(&\>PW;S6.Q[QJJ VLY(/
MZ4TG3]N/7>TB=:*-%["D[K*WHLHN_"WR3I[@^I:JBO1]-2WJP>/LX;R#SY^Y
M$RI$6,]$<<;FM=7#G.#A\1+6BJ/'')[DCZCE)))&N+6WPUI!)ZN)Y!![ >W7
MCU7'VSW=WG$;;B96K760%JT'OKK+IZTT<. T>SJU@O:).K6=B5.1L%HMS^][
MU<!Q;Z=*P%FUI7HJF1@0H"BF99@&<D'(;"W:ZA_*YU\@T#32*;MY%=2+Z<*'
M2O#V\UM+6GD;;<!P0?B)H]18Y([6L/KVX>Q6N 0-4T[:5NLTIM'MEWG5+7=E
MGK_#6V!1JO:APT71Z\1M)J&UV,7;T29UT(%E8^<EQH*$/BZC%1\(.@B(R+8G
M$N-?#'%0^(;G.8++MH+N'<"@.U]R(#W@%O/,LH/+10:\ "R0WXFDGXNW .[@
M]I<NR^_-LZ?N\+<]Z:RTF]5NF-UVE)GQ 6NKC [YFW[SNC693"YE,S/PX%>B
MJ_K^M%6N(U?.)F8NX;,#%%LB8^/BQ)+$1L;(T@;P7@<!WPCCGD U9/XAT[7U
MR,CW--N#"&75AQ)(/4V!V]:ZT:I7*M&T+CK'I-U,<I5EC*%(;!$ZMZKD]FS4
M:#,1VLH*]04!'2=Q<CY=QN%?D&\(:@H)4]ZL(Q8YV((E13@VG@2:@T&1X()
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M'H;[%L1U+ZQMS8S*(M"9_%B?(ZZK#(<>F?4=B\@M-I:C\H;(RM_S*Y/[_?\
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M11!O/<]9T-KN5O\ 9&3I1QH@&%JU3A6TE6:^76<(3'U6C54#*DJ.L%EEG6
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M;)DPF)>;/BX=P>0FGH:$<D9*-@V3HMN:E!0XPF6BQ2GCQPJQNNN]=5#MU?"
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M#O+^?G<'5):8UY3IRT5ED(QR4DHHK(,S$"2T@*[:)2 ./B:TL#N/PN!%574
MFC?KZJHQVZ]WPD[BVKMUW=WQ]!VZJ[G*E:G"+$;_  ,[:J/;JS6+:90K%8*W
M-0L)=HX :4D*E*2<<0&%8P(XUQH,TZ&?>1("#EKP,X0.VE_"FO,G,M(!!(W
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MJM6LZ"5LV]!0ON*A1,28E:5/S1;C T>-(RDPIAJ'CAG"4G31#C;IPL:(;[,
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M9%%1N[WR]]N<KF89D<8.PR>78$K3&(CM&X/^/NTEW'<G815WSR>P"DPO$CI
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M:IJVJ:YGY&J:SJ.;JNI93FNR<_4<F;,RYW,8V-IFR)WOED+6-:P%[W4UH:*
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MJ9,O&1T?4"Y!,B0Y;E2L$.3*Q0[6;8207@/V$BPX78 Z\MLBZ()%=3?0K7G
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M\4>4 %RX*Z^&_G#)*$+_ "LLN^+:\XQA:5)\4YYFM94N%I>9E0$-FAB#HW.
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M(\I"8_/RDKW,1^L,2)7@'H22XV1R"[J1TZ\6#Q_>#"PUP0!MX!X(: &WWX
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MB>YTF-/)"YQ=##CQD.V6-L+*!H@GE39SIKJ)PB<(G")XX_3PBJ1WJ_:L;/\
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M6YQ-!O?DGIQ\ZZJ!^@MP;VIUP![ 13,^%V1[O6>2B+),S$<T*72*OK8N1IR
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M]=\(GXQ'7_\ =ST[_.;2OZ[X1/QB.O\ ^[IIW^<VE?UWPB?C$=?_ -W/3O\
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M\ ,6&HV9'RVJ0$83\SI-KA;E"844)&MO*#S,P(&) /*O0D0,DQY25C%/(5%
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MS8N7Z[C'I:DH22?VS&54.!*K#;,^XD#7T,5A:U1PS^3@1LVV6F1X>>IYJM_
M'3CVZ@< J&EI#BX;2&-V-_"T$$@;!R?^7U[<\VOH*J+LN]5*P]8$>E/NUZ%=
MG&_#"?3EW(T9<DCRIRK&/(;E]/AC.<8\/#&<X^O-4]372S7YK<;^%M]:'7KT
M60\A2G")PB<(G")PBH)VOB-?6G?_ %*J6[@:I+Z6E&M\GEP>P&HPBB3.V8FJ
M53.O!9H&=\T')2(U.,VY*P04BT]E!$:1(AH25'MNMVLW!DA8/B^&JZ]3]?G2
MIE#2Y@>:93B;) -#@'FN.ON:65_#Z*(+ZHZ]S@H@Z &G-IQM -)?=*45JR*V
MU>8W5;PQ3RW%E1F=>BUM,*3YU)(AD@/MK6TXA:DU>8:]!^=#]/3_ "D'_AM[
MBW4;OBSW]S?]/170Y4KE^9SX8SG]&,Y^GCG/TQX_=CQSG^3&<\(OGEK3)>IA
M9JUZNE.MF[MI]BJ9WKL4-L#5^K).N=@Z-:PX?9FR(V7G[I,64ZT2\#&V=,3J
MB8AY:G4TJ#L!=0BQU+4RZR7MD[@;:8]ICW FFNZ--4#?KU '?H"= !K.::YS
MA)1:WXF@ D$DV0:%<<D$D4.EK>J,+I2K=C=, =9$U)JE6CHVW9=LYHST<X#.
M2K%NUTWJ2X7=<6O*3[S-LR.U$9GIKU;%,M,3'O7WL!JRU@^_+(<"*D.PD4:J
MC1[B@/:_6^+H]N]NSJ6 R"[Y]QTNSR;)-=#U6V[FNME1AN.B-[)UU9:>1:;A
M40)0+/S.2HLU]F["5&C>)!T*S/,CO2,4%-CMJCI(R%>C9ML%]_$7+1I2D%-R
MTTX$"R""!ZG]5@\6TCGWKTOGT[7WKU!6HK7,-K>TT/X3%0WP'59?2A_3.SRJ
MH38V(TNB3.UX;5NCFZE\X$GU.0LE,1U"D-JRD&W(I=?&2/*28.4$!K>;V3?\
M8L'Q%[?P@&F\D\WP.G(N^O0<:P%^1YE%H8XG=P"[L*LWWZCT[J M;AZBNE+M
M".RI=>E:+3.@TQ-=:I#89XSWRRFL;N[$1[E]U^?./+(9N8E)@=!-#VF%>18Q
M(I5,4,4VB5867DZQMV \RT^N3M#&?BXX8;)[\W9I8@@WO-'8-EDU>]P):>NZ
MZ Z7?'2SOOT<7:C]*Z@.O2247<S5U *N*#$9;+1:B*I$NV%)3:ORD$)EUF8>
M2K\I+F%8S]<9YJN_$[_UC_5;C/PMY)^$<GJ>.I]RL3[049O8>B-EUPBTW&J
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M.2;==KK#),FY"P4U9I-+3Y8X+>1(*N 2DU(K]P4SA;4> 2ZVUE;ZT89:<6F
M+X'5":%_OJLQ0O"T)7C[E8PK'CC.,^&<>./'&<8SC/AG'CC.,9QG\W" W^_W
M^_=?OCC/W9Q_AX4J*K7NO6U-5L0>7L22)/5-&$V/?*_!1TK9+-"4^03.JC)/
M[.P 4C,2#LMFM3B(J-C0RY.1<CGFQ W5*:PN=IH&C1- ]K]%B7-!(L6!9'<#
MM?I?O2DP(UB0#$.'ROVYHS!;'K-.CN^B2TAYKU&'T-O,N>1:?.TZVAUM7BAQ
M"5IRG$?W4@W^5_FN3XX_3C]'^3&?\V<?X>%*_?NX18-4]CU&[S5[@:Q)*E3-
M;V-FH6U]D4E,:#9W(>.G2(,>3<:2%(R$9'2T8N79 >(Q%DF-@&J9.;?'9R+2
MVKXW"QZUV/R/98AP<2!_*:)]_3\J/[YSCQQ^G'^'',5E8'4K#82^UZP6ZZTB
M-7)JG]?_ &<^TJ"X*: CFOM7&/2T/B*FC@!X>?\ .&RO)WR,Z0^5/^423P(4
MM+.9HT#V-U]*O^J@.!-?O]^_3\Q?E?[W7=94JR[!MKY8M6J$25.V T&./EWP
M(<!/JR,AF/C!RSR!X\5+IAGMAGG&1&'W\MY2TKP $D "R30'NA- D] +/R'7
MJLECY "6 "E(LP:1C9(08^//">;)#-",900(6*0TI;3XQ+#C;S#S:E-NM+0X
MA2DJQG,$42#U'!0&Q?6^1\NRYG"E.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A
M$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.
M$3A$X1.$3A$X1>I_&,LN^/YFW,__ -%?[_G_ (.2.HOI8M8N'#O7:1?[_8[+
M2-I*Q3]/^!E<+55)N5K=FKG7SM+-5^P0<@5%S$++QMRVV5'RD7(A.,E@GA$M
M-D"EC.MOL/(0XVM*TXSR]]')''&]@KFJ^$$5Z>GMZ*AMC%)!-B-YLUVL^GZ?
M3HL$W(#L&\9^(Y>2-\[\K+_7;KOI&_ZAA*+MBWTZ!K=[QU[/O,A93(Z#DA6+
M#\VF(H/,C!S>#*^8ER2?,C"#CL&#VLV@P-#&D2/?>YH)KS"T4;OH*[=%02XB
M9Q<\>6UA #J'Q,:>E=+OYW?%TO.\6_</6$JN["H&T=P;,N.U/AJ]EM\6R#V+
M>;!>J]);CUC$:;LM6N%5I<F^1 4MT0J]6 1RO4J,AX B&P)&HB/,.VYF &RV
M'!C )0P;6 D WQ5\@51 /-_49NW1D.:7$NBLASOAL#\7L:Y]![]LHZW_ (?J
MKMCJ19\S$W%UC<@LLQ>I'9W>9[>X>_X8S7$G9\677FM)>'' A;7"3 T59&%:
MWQ!PT?5WI>+-C7A%B.#8OV;9&VTN: &EK-M=/YB*-UT'J?=1'YFZ)W_-^(F2
MP>.NRN#U%FR+5L.\UB,D=@]<],P#V[[%9;\_L^T-ZCTQL832:-@P5$A()F3/
MO>Y4V6K62J5FGFVF*D&H6H'%2]HD#&6WX\@"-(\*XA0>[X !7+F[B+O\(_*_
M[J^8G<QH#G$W\+2&V..2215=17?@]0M5\.+.[CT]2ZWLBZ[*/1JCXQM*TM56
MP.Q5^N\I6Z;)R-).(K+VUXXZNS-ZDZ?)R$F%6+E*-*L%;5Z[4-),.9<)?V)
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M=JH>E*E>P3D2-.AKE:8E$6PQ5I&+DW0P9"%@RA79(C"FT-!=0ML+3SR-Q/-
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M*'FQY$6% &;FO*;\(8ZYMG+0> UKJ'_RJ'/;LL67(X%Q>*A#A3SU+W#G@78
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/$X1.$3A$X1.$3A$X1?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>50
<FILENAME>g60414g86j37.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g60414g86j37.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1X*4&AO=&]S:&]P(#,N,  X0DE-! 0
M    '>Z^=F(X0DE-! 0      !<< 5H  QLE1QP!6@ #&R5'' (   (    X
M0DE-!"4      !#'71?E=+5N]=N^.93 Z7E<.$))300Z      #E    $
M  $       MP<FEN=$]U='!U=     4     4'-T4V)O;VP!     $EN=&5E
M;G5M     $EN=&4     0VQR;0    ]P<FEN=%-I>'1E96Y":71B;V]L
M  MP<FEN=&5R3F%M951%6%0    !       /<')I;G10<F]O9E-E='5P3V)J
M8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M  $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P X
M0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
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M4'AL0'&X           *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W @
M56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !!C
M<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M      QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&]N
M9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! #O_XU
M  (  0.__C4  @ !.$))300F       .             #^    X0DE- _(
M      H  /_______P  .$))300-       $    'CA"24T$&0      !
M !XX0DE- _,       D           $ .$))32<0       *  $
M 3A"24T#]0      2  O9F8  0!L9F8 !@       0 O9F8  0"AF9H !@
M     0 R     0!:    !@       0 U     0 M    !@       3A"24T#
M^       <   _____________________________P/H     /__________
M__________________\#Z     #_____________________________ ^@
M    _____________________________P/H   X0DE-! @      !     !
M   "0    D      .$))300>       $     #A"24T$&@     #-0    8
M            !&X   4F          $                          0
M           %)@  !&X                      0
M       0     0       &YU;&P    "    !F)O=6YD<T]B:F,    !
M    4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG
M  !"=&]M;&]N9P  !&X     4F=H=&QO;F<   4F    !G-L:6-E<U9L3',
M   !3V)J8P    $       5S;&EC90   !(    '<VQI8V5)1&QO;F<
M    !V=R;W5P241L;VYG          9O<FEG:6YE;G5M    #$53;&EC94]R
M:6=I;@    UA=71O1V5N97)A=&5D     %1Y<&5E;G5M    "D53;&EC951Y
M<&4     26UG(     9B;W5N9'-/8FIC     0       %)C=#$    $
M %1O<"!L;VYG          !,969T;&]N9P          0G1O;6QO;F<   1N
M     %)G:'1L;VYG   %)@    -U<FQ415A4     0       &YU;&Q415A4
M     0       $US9V5415A4     0      !F%L=%1A9U1%6%0    !
M   .8V5L;%1E>'1)<TA434QB;V]L 0    AC96QL5&5X=%1%6%0    !
M   ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX    '9&5F875L
M=     EV97)T06QI9VYE;G5M    #T53;&EC959E<G1!;&EG;@    =D969A
M=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%4VQI8V5"1T-O;&]R5'EP90
M  !.;VYE    "71O<$]U='-E=&QO;F<         "FQE9G1/=71S971L;VYG
M          QB;W1T;VU/=71S971L;VYG          MR:6=H=$]U='-E=&QO
M;F<      #A"24T$*       #     (_\        #A"24T$$0       0$
M.$))3004       $    !3A"24T$#      3N@    $   "@    B@   >
M 0+    3G@ 8  '_V/_M  Q!9&]B95]#30 "_^X #D%D;V)E &2      ?_;
M (0 # @(" D(# D)#!$+"@L1%0\,# \5&!,3%1,3&!$,# P,# P1# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# $-"PL-#@T0#@X0% X.#A04#@X.#A01
M# P,# P1$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P,_\
M$0@ B@"@ P$B  (1 0,1 ?_=  0 "O_$ 3\   $% 0$! 0$!          ,
M 0($!08'" D*"P$  04! 0$! 0$          0 " P0%!@<("0H+$  !! $#
M @0"!0<&" 4###,!  (1 P0A$C$%05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"
MT4,')9)3\.'Q8W,U%J*R@R9$DU1D1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6T
ME<34Y/2EM<75Y?569G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1  (" 0($! ,$
M!08'!P8%-0$  A$#(3$2!$%187$B$P4R@9$4H;%"(\%2T? S)&+A<H*20U,5
M8W,T\24&%J*R@P<F-<+21)-4HQ=D154V=&7B\K.$P]-UX_-&E*2%M)7$U.3T
MI;7%U>7U5F9VAI:FML;6YO8G-T=79W>'EZ>WQ__:  P# 0 "$0,1 #\ ]522
M3.<UHEQ '&NFI24NDDDDI2'>YS*+'M,.:QQ!\P$1,0' @B0=""D%//NZOEL]
M)QS,:MSJFN=7D2W]Y[K/T;&[/T;'_P"%V/\ ]&Q$=U+J@L&Z_$J9!+?4;:T%
MIGTWVE[6^CN].S:QWT_\&K&7BYE=N_%IPA4 RNOU6'>-Q<Q[=S?;L_2_0_KH
M;^G]2+=KJ.G%C9#9J<(;)?\ 1.YON=]-$D$DC35 %  ZZ-C$RLF[*K#LG'LI
M#'!S:9)=8-AY]S6,:RS?]+\]6LK,IQ6M-A)?8=M53!N>]T3LK8/_ #BO_">Q
M5\)M6+477MQZ[-Q.[&9M;!CG^7HJC'NR;[LP>[<YU-#AK%5;O2>UO_'9-=ME
MG[_Z'_0I4FV\,CJ;AO;B5M:>&V70^/Y3:J;JO_!U+&ZA7=:<>QCL?):-QILB
M2T:.?4]A=7<QKOI['?H_\+Z:ICJ3Z0&C:6SP028\=#[6N_-4LG'?EXQR*"&7
MUDVT&?HVLG\[\ZNWW56?\!;8@I/U;(NQ\,V4NVOW- , \GP<LYW5LIF1;6W,
MQ7@6/:VIP>ZSZ=E55+&4L8Y[M]/I/9LML9_.?I?8MAAHS<6NQS ^JYK; UX!
MT(WMD%9MN)U$W/K%.!LO<]WN8XD@$EGJM_PC_>W?_+3K'"!6H)U11LF]*"/]
MH=3;8YMN3A5&8AV\-D$AWIO=L;=^Z_:_]&]7L')LMR+FV7U6@@/H93K%1+VM
ML>_\YSW-V_\ 6U3?T_JECMUE'3G..I<:W$SMVZ[O]?36IC8]=-;(KK98&!KC
M6T-'[Q#?Y&]SW;4U*9))))2DDDDE/__0]56+U;[)F6U-9?C/?47,-%[AM))9
M9NTW_1]+T7MV>^JZZKU*T;+ZIG49CJ:NGV9%30(L;(DD!W=NS;^9]+_MO]%Z
MN59C5-8*?V/> '/=8YKW$.)&[:ZQH?D/HVV_F,W_ ,]5779^EKL2GH.G.I.%
M2VF\9+6,#/6!G=M_1EW+OSF([WL8QSWN#6-!+G$P !RYQ7/XS\O"R;,G]GW7
M6V,J8;/4>YS@6>ML>US-N^FYUM6_^;V>FK67EW9&)77E8SJ/5R65/K)W;F ?
M:/I%M?Z*W9Z-OM_TJ2DEF5U/*9ZV*T8^*[Z#W,+[GCM9Z)+/0K=^;O\ 6N_T
ME%25#>M-:;!<VX#BK(8*R[QVVT[?1_ZYCVJMU#J618WTFN%;=IL?LD$@$-;4
M'_2]SC[OYM!Z5F7,RJV>H?3>XM>USB6P&O?N;ZA=L<US?S45)\WK=SZ_2PL.
MV_)KMK;=02VOTB',>_UKK)H]M?Z5GI/N]:K]+5^B]Z9U6?D&<G)+!_HZ!M_\
M&M#[/^VJ\96<QK6=38YO_:FAV_PFE]?IO_S<FQJ=.CLM+5'3,&=SZA:[]ZZ;
M3_X.;58Z:ZC'-^&YC6^F77X[0 )JL<;'>G_Q&0^RI_\ H_T/^F8I(=U%=S0'
MR"P[J[&$M>QT;=\
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                      #_X4);:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O
M,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(>G)E
M4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE
M=&$O(B!X.GAM<'1K/2)!9&]B92!835 @0V]R92 U+C,M8S Q,2 V-BXQ-#4V
M-C$L(#(P,3(O,#(O,#8M,30Z-38Z,C<@(" @(" @("(^"B @(#QR9&8Z4D1&
M('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M
M<WEN=&%X+6YS(R(^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T
M/2(B"B @(" @(" @(" @('AM;&YS.GAM<#TB:'1T<#HO+VYS+F%D;V)E+F-O
M;2]X87 O,2XP+R(^"B @(" @(" @(#QX;7 Z36]D:69Y1&%T93XR,#(P+3$Q
M+3 Y5#(S.C Q.C$P*S U.C,P/"]X;7 Z36]D:69Y1&%T93X*(" @(" @(" @
M/'AM<#I#<F5A=&5$871E/C(P,C M,3$M,#=4,38Z-3DZ,3,K,#4Z,S \+WAM
M<#I#<F5A=&5$871E/@H@(" @(" @(" \>&UP.DUE=&%D871A1&%T93XR,#(P
M+3$Q+3 Y5#(S.C Q.C$P*S U.C,P/"]X;7 Z365T861A=&%$871E/@H@(" @
M(" @(" \>&UP.D-R96%T;W)4;V]L/D%D;V)E(%!H;W1O<VAO<"!#4S8@*%=I
M;F1O=W,I/"]X;7 Z0W)E871O<E1O;VP^"B @(" @(#PO<F1F.D1E<V-R:7!T
M:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB(@H@(" @
M(" @(" @("!X;6QN<SID8STB:'1T<#HO+W!U<FPN;W)G+V1C+V5L96UE;G1S
M+S$N,2\B/@H@(" @(" @(" \9&,Z9F]R;6%T/FEM86=E+V5P<V8\+V1C.F9O
M<FUA=#X*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(" @(#QR9&8Z1&5S
M8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @('AM;&YS.GAM<$U-
M/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O;6TO(@H@(" @(" @(" @
M("!X;6QN<SIS=$5V=#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4
M>7!E+U)E<V]U<F-E179E;G0C(@H@(" @(" @(" @("!X;6QN<SIS=%)E9CTB
M:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E+U)E<V]U<F-E4F5F
M(R(^"B @(" @(" @(#QX;7!-33I$;V-U;65N=$E$/G5U:60Z9C$Y9F$P,C0M
M.&4Q,2TT-S=B+6$Q.3 M.3ED861D-V)B-#4V/"]X;7!-33I$;V-U;65N=$E$
M/@H@(" @(" @(" \>&UP34TZ26YS=&%N8V5)1#YX;7 N:6ED.D-&-S8S-3,W
M0C$R,D5",3$Y0C(P13(Y-D9&,#(X03A"/"]X;7!-33I);G-T86YC94E$/@H@
M(" @(" @(" \>&UP34TZ3W)I9VEN86Q$;V-U;65N=$E$/G5U:60Z9C$Y9F$P
M,C0M.&4Q,2TT-S=B+6$Q.3 M.3ED861D-V)B-#4V/"]X;7!-33I/<FEG:6YA
M;$1O8W5M96YT240^"B @(" @(" @(#QX;7!-33I(:7-T;W)Y/@H@(" @(" @
M(" @(" \<F1F.E-E<3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R
M<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA
M8W1I;VX^<V%V960\+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @
M/'-T179T.FEN<W1A;F-E240^>&UP+FEI9#I&-#8P040V.$5#,C!%0C$Q0D$X
M.#DT1C$P-3<S0CDY,CPO<W1%=G0Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @
M(" @(" @/'-T179T.G=H96X^,C R,"TQ,2TP-U0Q-SHP,#HU-BLP-3HS,#PO
M<W1%=G0Z=VAE;CX*(" @(" @(" @(" @(" @(" @/'-T179T.G-O9G1W87)E
M06=E;G0^061O8F4@4&AO=&]S:&]P($-3-B H5VEN9&]W<RD\+W-T179T.G-O
M9G1W87)E06=E;G0^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IC:&%N9V5D
M/B\\+W-T179T.F-H86YG960^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@
M(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E
M(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYC;VYV97)T960\
M+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T179T.G!A<F%M
M971E<G,^9G)O;2!A<'!L:6-A=&EO;B]P9&8@=&\@87!P;&EC871I;VXO=FYD
M+F%D;V)E+G!H;W1O<VAO<#PO<W1%=G0Z<&%R86UE=&5R<SX*(" @(" @(" @
M(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A
M<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z
M86-T:6]N/F1E<FEV960\+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @(" @
M(" @/'-T179T.G!A<F%M971E<G,^8V]N=F5R=&5D(&9R;VT@87!P;&EC871I
M;VXO<&1F('1O(&%P<&QI8V%T:6]N+W9N9"YA9&]B92YP:&]T;W-H;W \+W-T
M179T.G!A<F%M971E<G,^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @
M(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*
M(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYS879E9#PO<W1%=G0Z
M86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z:6YS=&%N8V5)1#YX
M;7 N:6ED.D8U-C!!1#8X14,R,$5",3%"03@X.31&,3 U-S-".3DR/"]S=$5V
M=#II;G-T86YC94E$/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE;CXR
M,#(P+3$Q+3 W5#$W.C P.C4V*S U.C,P/"]S=$5V=#IW:&5N/@H@(" @(" @
M(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!0:&]T;W-H
M;W @0U,V("A7:6YD;W=S*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @(" @
M(" @(" @(" @(" @/'-T179T.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E9#X*
M(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z
M;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @
M(" \<W1%=G0Z86-T:6]N/G-A=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @
M(" @(" @(" @(#QS=$5V=#II;G-T86YC94E$/GAM<"YI:60Z0T4W-C,U,S="
M,3(R14(Q,3E",C!%,CDV1D8P,CA!.$(\+W-T179T.FEN<W1A;F-E240^"B @
M(" @(" @(" @(" @(" @(#QS=$5V=#IW:&5N/C(P,C M,3$M,#E4,C,Z,#$Z
M,3 K,#4Z,S \+W-T179T.G=H96X^"B @(" @(" @(" @(" @(" @(#QS=$5V
M=#IS;V9T=V%R94%G96YT/D%D;V)E(%!H;W1O<VAO<"!#4S8@*%=I;F1O=W,I
M/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@(" @(" @(" @(" @(" @(" \<W1%
M=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N9V5D/@H@(" @(" @(" @(" @(" \
M+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E
M/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IA8W1I;VX^
M8V]N=F5R=&5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS
M=$5V=#IP87)A;65T97)S/F9R;VT@87!P;&EC871I;VXO=FYD+F%D;V)E+G!H
M;W1O<VAO<"!T;R!I;6%G92]E<'-F/"]S=$5V=#IP87)A;65T97)S/@H@(" @
M(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R
M9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS
M=$5V=#IA8W1I;VX^9&5R:79E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @
M(" @(" @(" \<W1%=G0Z<&%R86UE=&5R<SYC;VYV97)T960@9G)O;2!A<'!L
M:6-A=&EO;B]V;F0N861O8F4N<&AO=&]S:&]P('1O(&EM86=E+V5P<V8\+W-T
M179T.G!A<F%M971E<G,^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @
M(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*
M(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYS879E9#PO<W1%=G0Z
M86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z:6YS=&%N8V5)1#YX
M;7 N:6ED.D-&-S8S-3,W0C$R,D5",3$Y0C(P13(Y-D9&,#(X03A"/"]S=$5V
M=#II;G-T86YC94E$/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE;CXR
M,#(P+3$Q+3 Y5#(S.C Q.C$P*S U.C,P/"]S=$5V=#IW:&5N/@H@(" @(" @
M(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!0:&]T;W-H
M;W @0U,V("A7:6YD;W=S*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @(" @
M(" @(" @(" @(" @/'-T179T.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E9#X*
M(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.E-E
M<3X*(" @(" @(" @/"]X;7!-33I(:7-T;W)Y/@H@(" @(" @(" \>&UP34TZ
M1&5R:79E9$9R;VT@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @
M(" @(" \<W12968Z:6YS=&%N8V5)1#YX;7 N:6ED.D-%-S8S-3,W0C$R,D5"
M,3$Y0C(P13(Y-D9&,#(X03A"/"]S=%)E9CII;G-T86YC94E$/@H@(" @(" @
M(" @(" \<W12968Z9&]C=6UE;G1)1#YU=6ED.F8Q.69A,#(T+3AE,3$M-#<W
M8BUA,3DP+3DY9&%D9#=B8C0U-CPO<W12968Z9&]C=6UE;G1)1#X*(" @(" @
M(" @(" @/'-T4F5F.F]R:6=I;F%L1&]C=6UE;G1)1#YU=6ED.F8Q.69A,#(T
M+3AE,3$M-#<W8BUA,3DP+3DY9&%D9#=B8C0U-CPO<W12968Z;W)I9VEN86Q$
M;V-U;65N=$E$/@H@(" @(" @(" \+WAM<$U-.D1E<FEV961&<F]M/@H@(" @
M(" \+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R
M9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z<&1F/2)H='1P.B\O;G,N
M861O8F4N8V]M+W!D9B\Q+C,O(CX*(" @(" @(" @/'!D9CI0<F]D=6-E<CY4
M;W5C:%5P(#<N,#PO<&1F.E!R;V1U8V5R/@H@(" @(" \+W)D9CI$97-C<FEP
M=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @
M(" @(" @(" @>&UL;G,Z<&AO=&]S:&]P/2)H='1P.B\O;G,N861O8F4N8V]M
M+W!H;W1O<VAO<"\Q+C O(CX*(" @(" @(" @/'!H;W1O<VAO<#I#;VQO<DUO
M9&4^-#PO<&AO=&]S:&]P.D-O;&]R36]D93X*(" @(" @/"]R9&8Z1&5S8W)I
M<'1I;VX^"B @(#PO<F1F.E)$1CX*/"]X.GAM<&UE=&$^"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"CP_>'!A8VME="!E;F0](G<B/S[_VP!#
M  $! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0'_VP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MP  1" &  ;X# 1$  A$! Q$!_\0 '@ !  (" P$! 0            <(!08!
M! D# @K_Q !E$   !@(! P(# P<$!P\.#P ! @,$!08 !Q$($B$3,10502)1
M80D6%R,R<8%"D:'P&"0S-U*QP24G-#8X5UAW>)>8M[C3X28U0TA58G)UE+71
MU=?Q&3E%1U-C9&9G=H*#DJ+B_\0 ' $!  (# 0$!              $" P0%
M!@<(_\0 31$  0," P4&! 0$! 0#!0D! 0 "$0,A!#%!$E%A<? %(H&1H;$3
M,L'1!A3A\0<S0E(C8G*"%20TDA93LA=#<Z+")2<U-D5498/2XO_:  P# 0 "
M$0,1 #\ _OXPB81,(F$3")A$PB81,(F$3")A$PB81,(F$4;[#VW0=5$A5+W.
MC"$L+Q2/AQ",F),7CM$J1E40)$1[\Z/8"Z/*C@J2?*A0 QA 0#K=E=A]J]MN
MQ#>S,+^9.$IMJXC_ !J%$4Z;B0'$UZM(&2T@!I)L9 UY':O;G9?8HH'M+%##
M#%/=3H?X5:J:CV %P#:-.HX;(<"20!>Q-XQ#G?6I8^BN]E2ES81%)8V%&INI
MV6:R<:BG8W4VVK;2&*U>L49!5^\GGC2*9((M%#/'KE%)MZHJ%YU\=V9CNS<0
M,+C:/P:[J-+$-8*E*H'4:[!4I5 ^F][(<PS&U(O(!$+8P7:>![1PQQ>#K_&H
M-JU*#G[%1D5:+]BHPM>QKI:ZTQLG,$A9BE[>UCL9HQ?46\5ZU-I%Y,QK92%?
MIO3$DZZ5J>=BGJ2?*T;*Q)'S,[^,D4VKYL1TW.JW*59,3:9:YLR"(^OTMGDM
MT/:X @S,Z'2YM$J1@, CP @(_P!1_P N55IU][)W!Y\^W]?X_P ,(M:A+G4[
M([=LJ]8HB<<,417=A$O4)!)!,DY/UI4#N&IE6_J-[!5;'"NT 5%9I)0T@S<I
MI+-SDR8.?6_V4 @F ;Q/A,>X6R\AX\^_MD)(/7$CZ%?!V\:L&KEZ^<H,V;)N
ML[>.G*I$&[5JW3,JNY<+*&*FB@BD0ZBJJABD3(4QC& H".,X S) ',H2!F8S
M/EFL#3;C6M@5B%N=/E$INL6)DG)0DN@BZ;MY*/5,<J#ULF]0;.#-G $%1LL9
M$I'"!DW" J(*I*'D@M)!$$6(0$. (,@W!6S9"E,(F$3")A$PB81,(F$3"*+K
M]N;76L92OPUVGS1$E:0=?(&J<1.2BD@+)5JBY HP\8_(AZ:KYH0/B3(]XJ\I
M]X$.)>SV9^'^V.V:.*Q'9N#_ #-'!;'YFI\?#412VVO<V?S%:D7;3:;R-@.^
M6#<B>-VI^(.R.QJN&H=HXL8>KC-O\LSX.(JFKL%C70:-*H&P7L!VBW/FND\W
MSJ6+U]';2E[K&Q%$EY9."C)Z30D6";V96EG,$A%H,G3-.24?N)=FY8MVH,_5
M752$42G3$JAM/'=G8WL[&5<!C:)HXN@*9JT2^F\L%6DRLPE]-[Z9#J51CNZX
MQ,&\@;>"[1P?:.$I8[!UA6PM8O%.J&/:'&G5?1>-ES0\148YMVB8D2+K-TS;
M6M-BM8U]1;M7K6UE@G@8K0C]-\4ZU6=L&%D9K@ER9E(P3V4CVLK&OBMG[%=T
MFDX;$-W 74+7-F1$&.&NHL<CEN*W&O:Z"TS.6? ^&8SWJ0@, ^ '\<JK)W%^
M\,(M:@;G4[2JNE6K#$SPMF+&255B'J,@U!A)/9>.9.DWC4RK19%P_@)EH4R*
MRG:M'.2' HD#F2",P1S$* YIR(/(RMEY#GCGS]W_ */OX^O'MD*5CIB8BJ_%
M2<[.2+.)AH6/>RTO*2"Z;5A&QD:V5>/Y!\Y6,1)LT9M$5G+EPJ8J:2"9U3F
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MUSZ5>H*[RNRKR^;Q-9<[9F[;9I[7-&V<"!88PMND2K5AD:?GJ ZJUSE92LZ
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M@&^R'!HC03,6&0I'1ENJDHUB/>4VI6'6-6&JQT[I.-V$ZB(+8*4"\ZKRGG1
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M20+;]<]!"IK;NN_2R,@YB'^_8NVS2'EW6-=/9;9DV@H/<4$5JIJ]E99%)<_
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M.0;766Z<)JGUP,).]QN6[+Q52F&Q% ,5P-&6N[]  -Q&J' $S=!FPP;--C0
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ML$#G?/C$!,\C*O%E'LK(G3 1!,7L@X<."I 82H)G(@F/IID -1QVB3O/IH/
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M]3??%)L"H6?XU0&& EX#:9 , "Q,@'?SGG,FJX$T@]PH4B)=LACG%\D DF\
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MC?F-#NWA9*=5])^VPW%R-'1_2=.\+;42-"))6ZTWJNJ&X[-$TRS1+[4>_(J
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MV= =4->N99-QKV:?,9R <(-+YK*WQKNO7.H22I.XL=<Z7*E0E(APJ4IACY9
MBD9,-B ]@9>4C%$G*N&OA:&):6O$$"&O$;3223:\P+V@C@96>CB:F'<'4R3)
MES#=I$1(XP<Q!RXKT4I.R8.Y)E03,$?,E)W+13E0OJ'[0Y,HS5X*5VB' B/8
M4JR0!RJD0.TQO.8O!5<*XSWZ<]VHW+@'?VG2]CH;KOX;&4\2(^2H(EAMF)[I
MUMGJ-5(N::W$Y#[PPBT^=V'0*LL#>S7FGUU<> !"=LT+$+"(\\ "4@];G\\#
MQ]GSP.6#7$2&N(W@$CV52YHS<T<R/NN_ VVJ6E(SBL6:O6- @ )EH&:C9=(H
M#QP)E(]RX( #R' B8 'D,@@C,$<Q"D$'(@\B#[+8<A2F$3")A$PB81,(F$3"
M)A$PBZDA(,(EB]E)1ZTC8R-:.7\C(OW*+-BP8LT3N';UZ[<'3;M6C5!-1=PX
M74(BBD0ZBARD*)@*"8$G(>'NJLTCK4Z?-@6W;\-6]BTI_3=+T?6EZM6WVMYI
MK[5@Q^S)38L0S9)6QE..(]J^@G>N)$DX$BJT10&4BB(JK**+D1R.I/:&2UTO
M) ;!VK1_21-YM&<+$VLQQ?#@0P-)<"-GO9"9SMD=]E)#[J-Z?(^F0FPY#>.H
M6= M#E5C7+J\V13VU2GWJ+@6:S*'L2TR2(DG23L!:+-F;M99)P H*)E5 293
M9=<;)D9V-KQ?=>W-7^(R!WFPZ0)(N0)($YVO;1:'H^2Z=H2 E9RCUW5.JG%(
MH;*IV**@IS6IG%.T[JNU[+K]%3FI"DS4I#PVOXMS$[ ?5IHZD$&5<4/:8MXW
MBYR,L<<RLX/D DNO8P8)<!,2!G;GFJL=3@D;+2  0'3#1,3?_5ZYK#;7K_0U
MU!7BI:[W$WZ<MI[,0BAEZ34+=(4.?O\ \@G&))-5:O13EVK95*_/1:)'[MNR
M2/$S48D#ARB[9I]P2TU:8<6A[6Y$@'9F\B<ISG]T=\%[FAQ8YP&TT$C:CAD8
MZ*C;9\WT);(N^F>D>?I&CMOOTK18J5 :_A4==V NAWU*US8;:9%_76#L9C7:
M3B!J3NNLF\4R8+&4].-71(Q37*G9AJLVJK7.86@$F\G:(;J(B^O@J/\ @/+*
M3FM=)( &0@;QD#$6L8X+2]E6WH=C=STGHDL^H='A!:MUL?93PTQ(:CI5)T;6
MK2ZD8**B(NOR$M%SWS"[N&AD9Z&K<2FS^1SD+(6<Z\?8695I:*I8:P+N\=G4
MEQB3O%@;G/0657FCMBBYC-EC0^Y: T.) ,2"!(,G4\E;RO\ 4!TOQ;/6=5J^
MYM&QS"ZQ;)AI^N0FP:&T:6F&8N#5Z.9:[B6,NFC,QK5VQ/!L6]=0<-47+0T8
MW(59 4"8MA\$[+B 8)C4Z3O*S?$IPV'LAPEL$7 W1H/19&8ZE^G2NV"2J=@W
MUIN#M,,TF7\O6Y?9M+C9V+95T'!K ZD8EW-(OV:$(5F[-+*N&Z9(XK5P+LR(
M(J=K8>1(8\C0AICG.4<90U:8,%[008() (M.O!274;C4K_7(JX46SU^YU.=;
MB[A+-5IB/L$!+M0540,XC9B*<.X]\B59)5$RC9PJ0JJ2B9A Y#%"""#!!!&A
MZUS5PX.$M,@ZJH\L0+]U]PK604:GKO3%TUGOB""P_JT-@]2-SL5,BI]0YSB@
M@\KM TA?H=JL8I%TXW84N7O]!T8#9!W:)(SJ/V2-[6!IMS<0)X0L1O7@Y4Z>
MUGDYY(R_T@WXJ3+%U(5U!95I18=Y>U$1,5292=I0E-*8AA*8J-C=(NUI4H"'
MAU7H>:CN0.F=\FJ0R80VF3)-@(TDW$BTBT<?#.)=5#; ;1](];Z1IKN4&;5Z
MP[A1ZHH5#7L*E<+8Z"J:[.QM:U@CR6R0:.W3=_8(]Y7JR[4K\#',9*PS QBS
MMVJPBEFR:*)W!%B7;2!/S6&<B"> @GUA8CB(:3LW&47].'KN7G0O*DJ8N>'C
MVRV6?6-/6>QS9Q5E9Z=?B)WT]..0(1=P^>E!%)%D'HM(F.:L8R,;LHQFT9);
M$:"S1D!NBX,ZG>..5E@FX-Y)VMHWVLLI,^!F+QFL2C>)$G:FX:,G#8AB&]+M
M<$-RFH54H@JHJL/<4Q0$ICE/P8 ,(#QQDP9M!Y Y>6=@<HTXB9XS$;K>6_/G
M*W&%GYRJR*6W=9O$(G8L0T!Z9)#U&3"YQD80JCRC7ANBHH6:@Y02KM&;IVFL
M\K+EVVFX,[=ZU*9Q#F[0#2+1W2+D'* #Q'G<3FI:2T@@@$23N-I.F7G<7(7N
MS3+5&7JGU2[P@JC#7&M05JB!7)Z:XQEABVLLP%8@"($5%J[2%0H"(%/R "(!
MSFB1!(W$CR*WFG::'92 8U$Z'B-5L2B::R:B2I"*)*D,FHFH4IR*$. E.0Y#
M )3%,41*8I@$# (@(" Y"E>1'2\R)3H#:>DB&*+?IYWKLO4T,F "46M)*^9;
M UE'>F(CZ:<1K&_4Z(1 GZH4F!!3X*/:7U6&J?$P])QF2V"-Q @GQ-_MIYNL
MSX=:JW0/,<C!'C>_'?*LUF98TPB9.F=]U[?3H<43(WST>/JB81,(F$3"*,=H
M::UGN6(:P^QZE'6)*,=?,(&2,9S&V2K2H 4"350M42LQLE3FT^PGIR]>E(Z0
M( =@.!3$Q1@M:ZSFAPM,YQN%[\K6U 23(():0  6D@VR-M;]9*!U=']1M*43
M#5G4M^=$&@!2)53J.HY-CNTFY$033;--ET^<U[=3@D8I3$>VTMYDCE^PX>+\
M ;-1^!H.)(EI.X CRG(C,&8OG=9VXFLV>\'#0&?(NDGQ$0-#D?HDKUPLUBIG
MU_TGSB9#>)$^XMOUSU./90\ &B[/V@ \&%N%E-W '9\07GO#!_PUO_F&.4V.
M>>?B5<8Q]B:;)$?U.(MX"/7D!99TM>ZT+*^9KRNYM/::CVZCAPJCJ#6$E=+:
M9RY;':^NTMVTYM:KM7#1-54[9=SJJ2 7'I.#(E,BF4+-[-H@RYQ=P@-W;I]A
MSNK.QM4V:&LOF"XQN@6OS/B8$;I0^GVATBR.-@/%K+LC:[YNJS?[=VO87E\V
M(HQ7,8ZL5%3,J'PE0@#B8 &L4>-K%9 "$[8<#%*8-ZG2ITFAM-C6P()&9XFP
MN<SQC=)U7O<]VT]Q<Z?ZC+?!ID Q;,[]2IQR_777Z53'CUNZ_8F$3")A%P(
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M4"*5-UK.>!-\W,!L=8/E/!8'$BK6%XV:<>#7FT7SG?.7+;Y"9[3';,2)I)$
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M>$3")D[^NC[^A)D=:_1$QUN]T3")CKP1,(F/7@B8ZZZY(N! !'GCR']?Z_\
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MK ZY<-9.6F?7@H/52404415(9-5(YB*$. E,0Y1$#%, ^0$!#C,GS6VK#^Z
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MD(F.O=$QOZZ_9$PB_"B9%4SI*D*HFH0R:B9R@<BA#@)3D.4P"4Q#E$2F*("
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M1,(F$3")A$PB81,(M,OD\$#7G2J9^QZ] 6#+@>#%47*(*+%\@("@B!U"FX$
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MK/\ 9[.8XU:M7O!A$"01M.<;P/.-8,:K7Q;VAE&C;:8V2!!V !#6DB6R 0"
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M7S8-ELDK%6_J$;[KK^OH>WRZ>OG;NOP-$0I4Q;ZPJQ;$<66MV6J&F4&C)^I
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M/ HH*"@CQSY_N29/W!XX#VSU6%I_#PU)O^4$[Y> [(9#U7G<0_;K5'3/>(\
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M+S6O>FXJBC2P;FB5%XJ[;E334%-Y Z6=""3FM49?M.WE=N@49";0,JVULFW
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MH8;\SVB'4L(PNIX:HP@XC$EI&VRDUVU3?1:9:^H\%M,G9!>Z6CA=HXQV!K_
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M$3")A$PB81,(F$3")A$PBTW8)A)3YH0^J+<O\#O&Q1_GYXS:P0G%4?\ 5_\
M25K8LQAZEX[L>N74?0U1STW777U7 3)OG[\.?6B)D(F$3")DQ[3EQCAYW1,C
MUZZ")D\;7W:<.76]$R$3)SCW/K)STL(F_)$R.N?7@B81,(F,^INB8^F:+@?
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M144DP$ *7ZB/[1S#Y,<YQ\G.83&.(B)A$?(\*?B$O=!FX&8%YMIUQ*[8:&@
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M9^L3'R^RUITW5'M.RFH5DY Z'8).]0.W-7Q3JM>@RDUM7#.IESZQ?L_#=-A
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M)9''FL-@Z>'(<0'OS+SIP:,H%M9,7A>BKXFI7D$[+-&CU)=8^ BT@DZV0 .
M /N#^O\ 7W'Z^<W"9,[\^NKK67.0B8ZOT$3")DYFTGWZZ@(F0B81,FT'?:/J
MB8G[9_KE;JR)D(F,LO-$PB<A]^3X'*WUTY\M]D3(1.0^_P#'^'WXO'#TE$PB
MB#;NN9VZI4NST2T(4;;&I[<E?M86][$_/HEC.A#2]9F8.T09'D<O-4VY5.P3
MU6LT:TDXU^5E)DE8F08S<5&/$,=6DRM3=3?,.$2,P="%9CW4WM>TPYID#0Z0
M>$3]E'U#U#U3W.5GGU9UQJ3IWDK"A=ZY+[DBNH#9^ZBT%ALN;CK5M.1Z?-(V
M37%-K-,LM[L#-A/G?S%B"+@YQLSD',196K)6%D>%B:8PSQ3>_P"(0UK@&@"8
MG9%0WV@//0&)*ZM$NKM+F,%.207271-W&FV !,:S?,Y+U(UIKRKZDU[2=84I
MF=A4Z#6(6I5YJLJ9PY)%P3!%@U.\=' %'C]=- '#]ZKRL]>*KNEA%58XCHN<
M7$N=F3)C)=!K0UH:,@("WC(4IA$PB81,(F$3")A$PB81,(F$3"*M6U8_X6S
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M1Y&"N<A$PB81,(F$3")A$PB81,(F$3")A$PB8ZZZYHF.BB8156WO_?PZ)_\
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MTQ"/=DM=N2DC,STN]?2LG9)B_-OGDG-NG1W"XN'#1,J+,Y$$Y;5<TAP@0X/
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MAG&RH/%E(]15H (S,V'V/GG?ZJ0"-VGH23Y@^>Y>S.3P,CK6^X]3*L@CQ[Y
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M-FB(/]0D^!F#YQNE2&3(DR,QLNMXQ%M3*MG4=\LJ?4AF'MUU<VC70)R;J4?
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M<#D$PI3")A$PB81,(F$3")[^^$55[_730$\J**8ECI$5';,0#@A#&, N&Q>
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M(YJ4.I?IQMMJKMM=:XM.[+-;]@2'R0E2?;[L%4U%6F5C]1G*S=B@4UC*+T>
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M&86#$416IEL N%V$Z']E4U1)1!11%8ADE45#I*IG 2F(H0PE.4Q1\@8I@$#
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M93-&EI.OLZW;>9L+ <6:LB,=$W6]6A=HE#2$,N^AY1:NV!S-08%8A'77Z(
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M3"*J^]A_S\.B@/\ \;]C_P#):WV'^7*NS;S.=^HWQ&^%1V;>?V6L6Q/<NO\
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M!X#D0$>!]O'C_P"(!'Q>RX,_X&)/"]2A.F_?IE-U[S\!EIH]IM%V_'PN0/\
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M,?%YB !$V,P<E-ND5VY7,49!J/H.'K<04<"(G!8%@X],0'@ )W>YN[D1X$>
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MIBJ !O;_  JQ%\_T71U0HB#IVF*1N14;=QB\!W&!),1'R(B'D1X^_.UVCM?
MH&;BD#?_ $VSW3J=Y,K'@QW@XN!FHZVH@@:^8YWR5^Z2;]5VB4"B'9R/UX 3
M  #^/@ Y_H\9\X[1^;?KPT\M8D[PO:8+4[@(' D@SOC,F?'520D!1DFX@ @(
M.6?//D!Y71#_ "@'GZ9PJ_\ TS^7_P!2[^$)_,T\C\UN3#]<^&HR,C@'^:JH
MAY ?2'S[!^J2_KP/[^//CAMO1T^9V6MVKNN'?!Y$^<+9R?LA_7ZCFHMIN0X
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MQ'9]3!T>UL#B*SL26UJCZ.)IUGMI,>:==I<"US:-.6U*;XV>ZYLF>O\ BO\
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M/BT2ZF7 9%S'ES9S^5PDG):#_P %X=E5S\)BJE)CGEXI56AX:XDF&N$'9F"
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>A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$7__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>51
<FILENAME>g60414g89g69.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g60414g89g69.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2-,4&AO=&]S:&]P(#,N,  X0DE-! 0
M    (S"^D @X0DE-! 0      #T< 5H  QLE1QP"   "   < @4 *7YA:2UD
M83%F9F,X92TR9C%D+31C8S8M838S,RUB-C5B.3%F8V,Y93A? #A"24T$)0
M    $*Y"\Q=2J"GF0_$J<J.^_@ X0DE-!#H      .4    0     0
M"W!R:6YT3W5T<'5T    !0    !0<W138F]O; $     26YT965N=6T
M26YT90    !#;')M    #W!R:6YT4VEX=&5E;D)I=&)O;VP     "W!R:6YT
M97).86UE5$585     $       ]P<FEN=%!R;V]F4V5T=7!/8FIC    # !0
M '( ;P!O &8 ( !3 &4 = !U '        IP<F]O9E-E='5P     0    !"
M;'1N96YU;0    QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"24T$.P
M   "+0   !     !       2<')I;G1/=71P=71/<'1I;VYS    %P    !#
M<'1N8F]O;       0VQB<F)O;VP      %)G<TUB;V]L      !#<FY#8F]O
M;       0VYT0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O;
M16UL1&)O;VP      $EN=')B;V]L      !"8VMG3V)J8P    $       !2
M1T)#     P    !29" @9&]U8D!OX            $=R;B!D;W5B0&_@
M        0FP@(&1O=6) ;^            !"<F1456YT1B-2;'0
M      !";&0@56YT1B-2;'0               !2<VQT56YT1B-0>&Q <L
M          IV96-T;W)$871A8F]O; $     4&=0<V5N=6T     4&=0<P
M  !09U!#     $QE9G15;G1&(U)L=                %1O<"!5;G1&(U)L
M=                %-C;"!5;G1&(U!R8T!9            $&-R;W!7:&5N
M4')I;G1I;F=B;V]L      YC<F]P4F5C=$)O='1O;6QO;F<         #&-R
M;W!296-T3&5F=&QO;F<         #6-R;W!296-T4FEG:'1L;VYG
M  MC<F]P4F5C=%1O<&QO;F<      #A"24T#[0      $ .__C4  @ ! [_^
M-0 "  $X0DE-!"8       X             /X   #A"24T$#0      !
M !XX0DE-!!D       0    >.$))30/S       )           ! #A"24TG
M$       "@ !          $X0DE- _4      $@ +V9F  $ ;&9F  8
M  $ +V9F  $ H9F:  8       $ ,@    $ 6@    8       $ -0    $
M+0    8       $X0DE- _@      '   /__________________________
M__\#Z     #_____________________________ ^@     ____________
M_________________P/H     /____________________________\#Z
M.$))300(       0     0   D    )      #A"24T$'@      !      X
M0DE-!!H      S4    &              -9   %1@         !
M                  $             !48   -9
M  $                         $     $       !N=6QL     @    9B
M;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG
M  !,969T;&]N9P          0G1O;6QO;F<   -9     %)G:'1L;VYG   %
M1@    9S;&EC97-6;$QS     4]B:F,    !       %<VQI8V4    2
M!W-L:6-E241L;VYG          =G<F]U<$E$;&]N9P         &;W)I9VEN
M96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R871E9     !4>7!E
M96YU;0    I%4VQI8V54>7!E     $EM9R     &8F]U;F1S3V)J8P    $
M      !28W0Q    !     !4;W @;&]N9P          3&5F=&QO;F<
M     $)T;VUL;VYG   #60    !29VAT;&]N9P  !48    #=7)L5$585
M  $       !N=6QL5$585     $       !-<V=E5$585     $       9A
M;'1486=415A4     0      #F-E;&Q497AT27-(5$U,8F]O; $    (8V5L
M;%1E>'1415A4     0      "6AO<GI!;&EG;F5N=6T    /15-L:6-E2&]R
M>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI8V56
M97)T06QI9VX    '9&5F875L=     MB9T-O;&]R5'EP965N=6T    115-L
M:6-E0D=#;VQO<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG
M  IL969T3W5T<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N9P
M   +<FEG:'1/=71S971L;VYG       X0DE-!"@       P    "/_
M   X0DE-!!$       $! #A"24T$%       !     HX0DE-! P     &)P
M   !    H    &8   '@  "_0   &(  &  !_]C_[0 ,061O8F5?0TT  O_N
M  Y!9&]B90!D@     '_VP"$  P(" @)" P)"0P1"PH+$14/# P/%1@3$Q43
M$Q@1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,# P,# P!#0L+#0X-
M$ X.$!0.#@X4% X.#@X4$0P,# P,$1$,# P,# P1# P,# P,# P,# P,# P,
M# P,# P,# P,# P,#/_  !$( &8 H ,!(@ "$0$#$0'_W0 $  K_Q $_   !
M!0$! 0$! 0         #  $"! 4&!P@)"@L!  $% 0$! 0$!          $
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MYN-DC*#W/<77
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M-(T.;K]N-=TSK_8\Q%W"SVNYQVX!9&6E+(:'\FH4R=&!$DH?XA276I'X%-J
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MR;CLC)!O#NCR)KSY1C;[S[JUY0+D$D)>DF2=JYF(F8],?2L.ZW,>9K @#<G
MYXGCN:S3/(CM@*O,1LS.\.%F-@P  \9"7%.Q]/)L,2"''D1 3$?))F,$B8!B
M##(@%QE:'0XDPN,%<:!*?'<C9<04['H)DC:N"3S./O\ 7-3O8F=[4@"#N1($
M8[^G'M[5FT;S2X!PY]AE(OE1Q8 D;9)#S-F-%W/K-HB=E1(6+K@LA)NIL6%%
ME,0,'$1#3SN5+0!&AC8S[;"$X@M/& 6W(&!Y%8R3Z>I)JP<9DD.-R2)A:<F(
M'?T$"H;8V9VCQ07(T39W!H,)QZ)?P.'L'3XB6'8$>="@\AJ'FFE@)AXZSV*(
MC&PE#M@PLW)PHR&HHQ\-=MMS_=>_Z5]XGMG(!^HGFJ;K;^\SV_K)[3'?W/YU
MW>-W]JG!DF?^K?!OY,S7GJG*_P#GO2V6)"MDP(E5*A2@\RGPW8\NKQ\?62V%
M,>DJNQX$&1[D6$*(TVW./*]@R/*N09G!B><_7/--UO,[F9(C\2.(CU] !]*X
MB=Q=J%+$4/G;?"%QN%D2I:/R_L34!+K<B:Y%O&%D$$33A![I3T% O$?/=)2\
M[ P3KB5+AHQ0K;<?W7LB/PKXS[>Y_,^IJ=S']]K&?QI[D'.<R8Y]JR,GDCVS
M#!3 BM_</'Q)",MT,<,[M?5:V2HJ^V9-SND>^C,_X<$M%L0BPS;*L91(2R<&
MOX6]C"NHV7'.QV9!_"OE(A/;L,#VJ2MC@K:@R(W)[F2.>Y,UR:[R<[:51M$W
M=:OR X=5^W63,AF<L<1M+4P,O)?5Y),U,8?.'G$/^F9FDIF9E+:D)EYA*961
MP2?C!&(+;Y !;=(' *%_0=NPP/08% M@&4K:!/<*3,3GOW//J><UQ#.1O;&/
M7(N&;WX9D.2Z;JB4=<V=J3+L@G9#D6[?\&.8F\+(_.BX2(S9_=4K,TF-$1(>
M^AE"<3L?QY'<;8\B\;?P]NW:HWL&?.T9G^NDSNB>_>!^5<2U[^[7%[MT1?KG
MNKA1:;K!8C<1-IGMBZ>E)P-,*<Y)PB4R!<PZ0ZB$E'G9.%0^MU,1).N2$=@8
MQ:GL@BX2"D)> ,R E8&<'$=Q@^HP:%;!.XK:)$9*DSZC,_<5PJ_NWM6U6\&;
M,KVYN%D5L Z4L$V_<1MFZFQ8,3%L),,L\J-).3JR 9"PDR)[LR6$L=^2R:4D
MM;J"'4KDIN"-I0\4P!&U<0.!$<"!'T%2"P#(4V#F#N3,GF,]\S'O78VOD)VO
M[U%RD+<]X\,+3$S5K1>94">V=J24&-N2(AB Q9WFRYQW'UM4",U".2"?22]#
M^Y&.K6$^^PY 1< @A#H($"$KXF8XXG,>M05L'E;<$[LK3S'//H?R-=M;^4/;
M6O\ 5!J+=>07#JT4T%4<Y'5F9VCJ4V%BWH=OVH@B) =F\L11,2U_)Q9,<@8B
M/;_@#<93]NH#;X,A#H/J$KG[F,^]25LD!)6U&(!4G[0)_**^5.Y-]M+7C66*
M)O\ X<5 =4!'57(]<VCJ6('S6XJ1GI>/A/CA3;+/TX>6M-DE,#>CVW)*=ECG
ML.%'DNN247"OQ(=.2K*5G) $\<P /H!0+8'"VA@#"D\=ASQG[S6?:=.X3;3J
M=KUAH:;X^[%IXWY4D+C3=8V&FVR,!5#Q,!6J3(3,=73S\1[L7$:^K<56#7TL
M.A,5"+:C'6E0[&6*K\4$*6%I.8*@0>23$@=R2?J9YJ4^$H%*"A0P2$D*'H)@
MG^Z(](%-MUCK)1TI1TI1TI1TI1TI2]V_DYJFG.0S9\L>XJ6GAH9SU04^"F/'
M<RY@R7>7(10Z208[*6L$H"R01GY#.6FEISE6+!),P./R^Q_D4J11ME5>4K]E
ML,*6X<+5XPN2D,2 Y5792@4(H["')"U#PT>*RML1W#L@40U'@IQE\XD=A*G,
M0!) ]2!Z_L&34$P"?0$^G[3@4IT+SAB ZYAW95,_*EZ=FW(3%.A)>8D?ISQ(
M-&5!NS>;[3M6VK TI-[!K\&F2K-,M4)EDAJR"2Q=?>68+E+1GRF1$R8'&Z8A
M2A@))R09Q$UC#HCS"#,0#ZQ&3'KR <9[@5W\/S<UZ3%R9TO6+D([%V"5J2E1
M(<;*QTE;P[8#5HZI1!!,G%2+TS)N2\01@R1B(NK!_)(038T-CI??CPE2!C(G
M.,1,GV@'B3[5(='<'!C[S'K]/S_)JJ5;8N^5&MW2$;D&8FTPL?.1[$L"_&2C
M TB,V2V/(QY&,/!FL87[)(ZO5AMY"\(<<1Z7%8R"DD'D&*N"% $<$363]14T
M=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4
M=*4=*4=*4=*4=*4=*4=*5^/;;_\ AH_^E/\ ]NE*@SD7N$316KI.[I&KALX_
M*P%8J439[ -4X26LUEE1HP%F3GWQRL1L5&"N'6&<,:$*?$@(:5+:'=4/Z<W0
MG>J#($$J($D >@[DF /<BJ+5L3.)D 28!)/K4./<U:;,0418=;Z^N=_B)F<T
MC !3H;U)AX(B9W-(:H*&K [DW;09G-I@Z-MJ#MY#14()5WG&2*\Y:Q)<<]@&
MWA&2%*2D@+,9)A 5G X)21S/>(BJET1Y03)2)\H$JVXYYA0/$=IG%=7&<\=8
M$TV GW:G=CY^6J-3M*ZM&B4N.E"&;?4]76R$^EHLUZB8\C$Z%M$1$"*F8>,D
MBZI=XT9)!]=6R7)95)$I DB23V*@>!.-IG'<'@T\9,#!)@&!$Y"2(D\$*]9P
M1$UU%8[@^M;!.QT6YKS8S8-KL%3'I$E&QM?EW#J9;-9Z/V Q=;%$,6!N8A6(
M]W>$%&2$)&@V"<;&%=DV0GT-20\:+*@"93@&<D00I:8!B#^ F3 J \DG\*LD
M1@'!2DR<X_%/<P)YD5/>C][C[OD+$_&TF<J]5&J>MKI3I2RJ@T25QK.R!+)(
MP]D'CH.9G6XR'D(V&#,C19<F/LK6#'QIZOPI@OQUT6C9&03*@8F 4P",@29Y
MC'H35TKW$P($)()[A4F?;'W]:8;VV_\ X:/_ *4__;JE7H]MO_X:/_I3_P#;
MI2J_K;SFBM>W:4JEXHSD6,%L^^UV).CRW)$FW:[H.J-C769LE<%=# '?ML7<
MZ&'3YRJ.G8$BX^YTNPDSC2+"T$)F#4B4F?*DF<0I2D@ F>""2#[$1B3A+NTD
M*$>90'.4I2HR/4R ".P(,Y%9['\SM>/7%5-FZ'L:GOQ)8L7>IVS,ZZ9K>MIL
M_P#4Y8$1;I")V'+OOK,%U18C\2U1#M-<#!,A'Y.9!^64@"I:4!,@R) $RH>7
M@1_S#!@X, XFP=!,$*&8),0#YN3)_NG(D#N:^)_-S4S=Y/H5?KMQO4E@"$*K
M$K2G-=2]<O9T].:Y@ H.NS#NP FHV529M*K$O8N[=0 Q%K-E63G@6Q7S)\)6
MW<2 ),@S(C=DXR/*>"?WP\5,P 2<1$09VX!G!\P_%'>L=AN<E.=LUB$M])LE
M&J$'(X%5:9=59,'"BR*[IR5!L%EQ%V4M<&*N=V[%U-X <:8);DG(XI;S8;D@
MH"2R8&TA1(F!/_-@2,X3/V/TJH=\Q!20D'G!QC)@XR8_C7$E.?%$$D'8QC6.
MQ!R8F9JP]H>FLT <. @)&=1 W65><A;Q/ON2VM3LY"M51<'&LJ9%21HZ./PV
M^XT\%7]Y.9B-QDQ(Y PKL>(R:%X#^JH9 ,QW.>#,CT(!]J^['.JJV*%A3*5J
MG9A<Q)VRM0LE&66/J4&/6*[,W75M5)N4K(L7"0#EH?V]IQ'TUJE/6R3S+BR,
M;-1T-B)EWPG@D&%*2!!((DR840 (&?+F8$=Z>,(D)5R!!@8)2)YX.X1$^XI\
M<)2G_I2E/G]_&,8\_P#RQUAK-7ZZ4HZ4HZ4HZ4HZ4HZ4I,.2.R>)D%*55&[U
MA6&4+9*'AV(Y$U.KBXWY#>#CC!X KV@QE$90A>5MN2!N6<H%'*2&M+.TZ)T?
MU#KJ+AW3[(ANWVA2[EQ%J%K4"I#;1?*=ZR,DB&T I+BT;DSK^J=3Z-HZV47E
MV-[TD)827RA"2 7'?"W;$@F #YU$'8E6U4,ZW;*2'3S;"S/Q)%/K]=<EY"49
M/3*B!UT"+6<X:6\VX6^ZPF+'<(4MWW7R&D+7GW5Y5YUU^UN;9PM7##K#@4I!
M0\VIM6Y"MJTPL#*585'!YKNFKABX1XC+S3S92%[FUI<3M4-R3Y2<*3D>HI.G
M;GH2J1$(G/#6QP3$:);MA P#6F=11Q5<JL"-3YJR[) CT69D=_#F):M.FP=4
M7+;0Q)Q[8,G2QI:/&%ZB%DG]:"3"9W+,DR-O&.#E4)CO!IN0(/AD<G\*<  $
MGGT]).(CBNW1O?BU(U+?\H-0:_(UO24F:WL03%<UFB/F"Y66EX$TY*CIP:%
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M\CMC+#,?BD21/B*/;@G=.V(]HB<',O1=:XHP >[3H^SUE$<+,B/;ARO94G)
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M:K6N8&&VO,T-BY5J%E0W*7!.5ROVF'CK[ 1<Z<$W6 ID"9CVI.9S%@)7FQ%
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M* 8R-O$@"3 ''V$ A R!C"N21(CS<Y.!DS,?6<'K-!X>ZTNNI(N&L%<AK=$
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MR )&"#,"9201GZ@?R35/!1),',CDQY@08^Q(_P# KOK3&]LRY@B@3^]=$$H
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ME-#V*676Y+.NTIA<2LY?CSVP(T;5=*$B6D/IR(W'G$^IR1GITV2%Q1,R!F1
M  /F[1&=Q/\ X%1X2 (SQ$DDF,=S,82!BL@UY9^WOK*<B9^I<C-*XEX*)Q6X
M$B8Y,5VR*A:H,"F-B*A%)G;U(?#J]>"]]J AF? L8HV0(:3DDXEYPI:E""1!
M,F !)[DXY/<]ZD-I201,C R3 XC/8=JE87D;PR F+3-HY)\><GW-$8W8?D;P
MUV\P:W$1RHL)O KUG4RRW@):FG4M(3A_U94[A2OOU63 ']WC[F?WU: "3_>B
M?L(_=2X#07;-8.ITDYR#U#)R-"*$<K,A.<KH^?. CHQ%:;A:Y@N9V(<0JMPB
M:?7,1T1AQ+'D,]1F2U62U9G+^*N") !Y 2D9SG Y,F?K["*>$C'.."5*/ICG
MC 'TGU,]M7ANVU5+91;O%[ZTBW.:[6DBH.%\E:X7'QI35=<J;1S<:3>%@*,3
M!.O@$$)82N10MK,K\Y0$9D%XJRE29$*YP,YGD#.?R[10-I!!S*>,G&(XX_G-
M.Q0]TZ<VH3(!:PVSK/8YD0PP5*B4.]U:WDQ@Q+BVAB)!BO2LBZ$P0ZVXTP\2
MAIMUQ"T-J4I*L8QUDJ3.E*.E*.E*1+8W)+:%6DKY MAZJJ1D%N28I$!/V@J?
MG*XFG0G&R4W\Q(6+VSZ4ZBRV'$,]&.BA&-QM5 ,)+P[;%P2LS.9+:2$GS&4S
M @'=O",?BP)]),#B1&$N*!4/*(5 F8C85YXR<8^O,4P%'L.TI8T*PVD"*C*+
M)0=FG4#MQ_M3D:V2W0Y.F"&91.'$ND#1QUWCYE"(AIPJ1B6#<HBFB08QVA"1
M(!.X$#G']8*[1$P1G@_6KI*CDX203[CB.\\3..1]!6=UG8-/N!LA'5V90?(1
M8H1IX*PY  L8.1=,8!+4/)""/*&*>CSF6GVT+;4Z*\CU84C..JE)'(JP4"8!
MSS2!;Z[6?'_?I%&*M5AW">Y4KR'9#$VS<VUM@LR=9<6MRS4J-8N5TEFJD)9E
M-QWR9:M(CY,-,8*@1U"4XPG=-)ZZU;2$W2;=G3D"XM5,I+&G6-H4/B S<N&W
MMD&X4R"N&WMR%^(K<,UU%UHMM=>$7'+A7ANI7YWG')3_ %D)W*.W=C(R(Q3=
MU/CU1:=3[S1P9G:$W!;"ARH.>Q?-N;(V2</'F19\00U R&P+-9"J][@<D1AS
M$0L1MYY S[[;K@K&4:U?:D_J"VEO-632FMVWY.PM+$*W$$EQ-HRR'2"/*5A1
M2"0" 378LVZ&4J0E;JPKGQ75N$"(A)43M$=A44S?&C9MA&&^J[[#(E,TZWZR
MD9-&G:T,E[7=PCZM'GBQP L^R,)<?-90:JQ2GUZN)+.>;CZ)&QK>(YSB!Q(X
M0>0H><_B$Y.,C/ @^JC5O#)Y7V*9VY@@#&>8'>1GBOS7^&U<@XK=\"Y;I$Z&
MW1*1Y)0:H]UER)BPKU:+XX"26J9(?E9$@RWRD)F6#S7VFH$.%3B+7,BR,U+B
MZ24&(* 1SR2D)GC'$]\DYB  ; "A/XB#](,CO]IQ^=?S87#V+N:RXV*N+E=I
M;K4(^-4"(>3FV&I:"&C01U%2V+=%29U??"B1$&0*G&2"B'3W2)IT4M(3!+I'
M*9.<S',]H(G//IB**:!X40,&,GCWD&,<>N9[5">TN"5RE:JJ.I5ZK5FGBV):
M&D2;_!#P(DN'8JA=8(JTW%-9BY42YVBERMG"+U,.U#56,UU%QH8$7DEJ,8&.
ML'1.4D#!A)G@C G@$ A623/UJI:5$!0//XL8(,S$@F8C V\CBI/%X-UQFPV:
MQDWJ5D#IJ:G+!&/FQKQI<'.REO%MP%G:(D9XYK\Y0RV7H0>S1 D"2]"(BAE,
M-O1?R"Z^*8 VB( .>0!$8C'MGZU;PA),^L8XDS/N>TX[5GEWXH5Z\7B7MIUT
MM@L9/%J=EJ4P1C-8*#-BQX2>C_AX=;]MN:C2;4\X\WC#PL]:B+ TI1\<#Z0=
M*4A, QW//,C\L?81Q0M@J)W$ \CM[_G71M\7[Q$LTP6K[J%C@=4V5R8U/'S.
MKH>;'K\23$72#(B;06)8X*<N)C,5<G@(Z6;F*ZTEJ+#,FXF?FGC9<AXB3,H_
M$ %PHB2"#(P0,B2(/."!BGAG$*_"?+Y1@9P3,GGU QP:^$IPT@ETH.L5VZR=
M?FX^H:^KPMT8CR 9[ZU1IV6EW;<X=3)VD2X<I."S<E"N#U^9@1XZ(>Q$"Y7
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MW&R<:0]\MFH< GRRK<L@S@;P 04QGCUSP015BW,#<0(2#C)V&1F<3WQ45M<
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M7''8/+O@$]O2UTVE4V/[>/$N. H5P5!.4B>!;U/)V^+KUB*O1Z )X9V20.#
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M[;_%G@UN\>T(WIMF,,O;M72[ TF<LIFMXB#F"94 =MU*_K$5,W]3*'G&9%F
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MO$F^^@9;[+L!7;!;IS"@9U]I+@:LJ9:4R_A)*G<HRIV2D))',&/RD ]^?J3
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MLBHK5%$>:9V)+%BM%X%E9*1E8\H8.&CW1G#2@XD";E3V5!Y6_&,/K?ZR)25
M$J2D03DB<#F 9CC 'K5%2#WCZF/0R.TY /$<9S6R5I;LD]LYZLQ<_*0=^E+4
MZW'ORT'9]L6N*LT$%B(,Q(#R$?5C(,)9JIH5O&'LD9C%QKC3>&!WFW6\E)V$
MI/\ 5,8GZ"(SFJ;E#O\ Q_?Z^G^@I->\9P X"<;-65#8&K;/FDWXZ=)JXL//
M[2VA=XF:@)>+/23%R,,$J=G!?I26VSVA(7,&(2^K"98ER/;=:=C[\GO[]L_L
M'^]2DDS(F1P  /OG]H-'(.B5>5_#^\!Z_FV,JQ7[7L6S5[9,?#WE^J@.0=]V
MF8ZNRL-5YFP1-=.P0D*1E#J]AZ-(&P^'E]C[F\MB^N+>VN[5I20Q?HMT7 4@
M*)%L^BX9*%'S(4'$#()E)4E0,@BI;27$J*?,V5;#,1O$'& 9&([]B*;#C%V:
MN)UAXV468M$O<OJ-GAHJ[V?-2V]LG(#ALV Q*Y('&CKG%PB8I"CE? (+AEGO
M -H(,?(D77UIXAQ_,\9GUG&#/YFK$Y/! X_=B(Q[21G,\F,MO]G#MD5)Q$.9
MMB\,66T6B,BBXX?:+0[\21D1XM392Y]J0#:"7A&769RSY=:9,<:;P8XM2P'<
MC:4*!!(!.3)(!!_?)P 9^G<-Q/,<$9D>YX(R<#\JU7>2VBZ7HO;4]5:)M2O;
M,K8\G,#13\9)1YE@CP@W1W!F+*N =*@UE(;)P$Z2"8V-(& G/-1HC"4-8J\V
MEL)AQ#A4).R3L))$*E(G'$2(/K66(CS R)QN@<8$\^Y]X&)K%]0:NJ>V=BP-
M4NNU:KIRNF-M9D+=:V23&F4/FC"I9BX]C++!1V??]WVC).)"0PT\^\9C+:&W
ML: 53!2#G)@3P(DQF2")Y/,1F%#ZGM$Q/[?]ZVW=,=D?MES,]ABR%[>/@,1]
M8DHP^Z[#^@1UF7,UPU]YF'+JD5$J>?&EQ62I!#/M-NMEI$B3GTL^HC(I&V#(
M()4F1)RF)$X.#$\@UBF./<8]_8_;\O44R6YNSYVQH#CQL!<D/.T#,559\UV;
M?W;L)]<?+"1KIX4L/#35@D )E$4^E#F&IH0]ASV_;="2C.%9K@S'T]L>U-RI
M'?M@"<^_/\9I0?PRL34F.2/,F:JMW@;0Q):UUZPH*,3L-X\5@2VS:!I*2E+U
M7HGZJ_)I\K(+$)0XZ:DASZ-%AK%:Z#D_M]0?XCF/3CV%E]L\"/\ >)GUD_2M
MR3J:I2K<RHRY2&AKBNG6B.@7!P\,343,U*BW.(N4+,/,PAM:,@]@+&A9-XEN
M14]%P2).&+M,NR!6&)>.7+I+:R-$;Q()]""1!&9Q^_@<G%8W9V&#]1 ,@XC)
M ^@[G%1AP0UV;K6$V7"QT59!]?D3U=,J,U=M.HTE<)F1Q"+$L[,E6#F1[7*Q
ML0H:&$@['91([WAG'H*$COI5?9EI>SQW%))!5!F%;A'8@C ),R!/J3FH:$;L
M$ D$$IVDGO(YQB"?M3\=8:RT=*5$@'\^]J_NDH/^<=E=7_LQ_C/^5-4_M#_@
M'^952WU2KT=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*4=*
M4=*4=*5P).4C(0 F4F9$&)C FLO&2,D6P""*RG]W2"B7&F&6\><8RMQ:4^<X
MQY\YQTI4#:UY&TW9^RKG0:\\V^Q7@0S8.82I:6K(VUE+-@6*V\EI:6XPP@1A
MCPWG);/R#&LJ&2A?5BDA(4>_;N.?]/X<TIB.JTHZ4HZ4HZ4KS[K91#K?W@.1
M%>B^4;VI23.8VYB(]>M;B%0;"$05=+><9"6QB=J(YMM/+-R!'BFL@["@HZ/R
M8 [C$80V\#($R"2)P"/YG(Q[]HJY(@8R #^P#L<?3'8SV-\VQ^TMK;D;&N1V
MX^??."?ECQ76E@3&[8F3U_[F1''/:C8-JEP,2S#K0RKVHY0@S#GV2AGU9;]0
MC:8)[<R>.)]<=_SJNZ/ZH,9X,_L.<_0?E6OGR=['>O=9TFX773G+VFRK-,M,
MK6#P=S@OT.*.>AQ\O2&0+A$LRD8TXXYZ68OYP;$;-/*2P!*O/.-)5&TF!*1N
MQ*C Y[_3F/0@S JR5$D3/8\#Z&?MW[?NHPAZVH(QV*.D!$.QC\P(^_&R DB&
MLF.)?9PB,D&<D!&LEO,YPT2EQ]EYI>5-96A2<9QJ,$_[CT&>/4Q!].),Y!QR
M>_I/IZ??/N*L-X$]NT[DD++[%=Y-T736:G#N6.&1#&GV.[Q<FRZMV.,FQ@2H
M>,JX*\,.YQG,\7-/%+' ;AL/D)3UG#2E *!3),@ C<=I($C/I(DC$'%5R %<
MR( 'OZ8B<<0/OWV"-1=@T@ZO$WM?<OWXWL6==+?^J:ZLQ4>Q8YG OS8=UZ1.
MGT2)V3&TLK]XB7=SC*D,I(:?:<91122,*P3_ ,TF2?4=P00/;V-8R>T8& ".
M.WY]S[YBJ9NY9PUWOHJ8K<UMWEA9]C15AAO$NC:L?MMN;@6\%NBA#-15@%L0
M-C?*>02H63AV(M#,BI;Q&01WU2.( @3)(QSR/2<3GW],P.;@S, "!G$S/_C
MC]]8PNFAS/*?4D#7N2Y&KXN4T_P.:B9JMS@>K-H1.<\2..T8+*61XV-+1*M&
MP[/R0ZQ5KG?1H8\_)BQ#%,2 IEDP29)$@@$01), _2,GM]:CCD#$QW!/?$\
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M31ZSB)K8&7(ETIMF0Q ANQ<=!16"6%9,FY>P1:PVLMOCQ[[1+"LY4-%: H%
MY3!(*C 1&(, E8(G$@S$9J1M&[G)QQW'$@XS'W)FMAS1/8@Q? '=DVON:[KQ
M:Y7Z>AJRZXG#8YPR/,$9=C1G2I2=>.:0(^IP+$?F1;& ^*H=+(K>6?$*2M)_
M6#:03,D$R>Q(..1SDGMZT*NP$QQ.,D@S _8/0^AJM#N7<#>1VAZ]6[3L7F#>
MMBPPY,Q!&16YD;:RY%PL6\)'MRKA92+;6KD@YTB/2ZB%B7''<Y%(#<E4C8?:
MC;/TX(_+/[ ))^F0:D&>!D=P.<'':)]N?RJ?.5T5$L]DKM-,U_9<378X+9.W
MFA[';XI,'*23!%FV4F537'<QMWBJQ.L*^5F!GY:5A%"MM#'.2,04\_'L3_/K
M48"C/OQ _G';/H>]/_P)X<F;9XGT=NR]POEV%29P)XG,=J3?T PH!S+KHKD+
M)2(5*E"I2"C4_(&:91<)B*<<:4^'[(.&\XDI&8)(.1."!CTQ ..<F?>A(G '
MWGC\_P"%09R>_#^\93;/5Y""YI;?(L^P\FBQQ>TV@-E2*B(\(F1),GIAC,1)
MCAM(]H?(YF67GBLJ$$4^4[[+< 3D=A/V_G^'I3<?0"(XYQQDSQ6LOR5XIRO%
MO:1%'.V9K#90J\RZ0)G75F=D2VF 2,I:#M-=E XZ:JTPXQEE1D84(OXCZG14
MF.+97U54I C;!&(((Y/<$ <3['FKISR3ZY SQWY/:3]/:L-U_I S<FP:O1(J
M]T6G/2<>%E^P[ L3D'  O&G"!X%9S' 2,N<\E\MM*AA(XMU/MNN.N##(]:3:
M2LJC:F I1W&)@%1$GO@8 &:E29X,F)CL(Y@8S'?(]QB-D_1W8G1=)>,UZ9W$
M[6)2:^F+E1*O46)&"D(&?F(5J19.8AB;-*QT6M3B'AFB"!0S6FTH2XL8A_ S
MF13*TR%00)(4" "3A1 Q/ G!GOB*H3';/&8@@8P0 ?4#CT[XD+EEVB-Z:DU7
M<F===P_D5;]<"4XBV9QL([9,_6Y27"P^T[7W9.CSA ==;)RPQZB9<)Q/EY&'
MHLE+."%4B>Y_A'/;MZ]XGM4!0X@3[<CW]3'8X]Z^_P"& K@]<Y!\QPI2Y(M%
MV%UU0HRQ,1L6:F'CLQMRL RT$6&43%'R]AS((,:DL-0) /M-,$ILTD2^\*&$
M#^/?/U_UHH\>PQZ1VC^/OCM6YKU-5J&^0D%%V?2FR8":8+*BI6LF"'#@4JX[
M&,=86MI2DCT?7TC$76S.>4XSB+K<D')O>,J9?3A"L9L@D*21R#/(3_\ F5@?
M4U18E"AGCL"3^22"?L1]:6K@I'2\8!M1CV;2;3US=8<JMIMFMMXZF.F7\Q!:
M+!&LT_?E_O=N<'@B4!YQ8HWZ+7Y-4IF/&%*/A)(GK(]'EX!@R I"HXC*$@9'
M;/$SFJ-3YN>1!(4F?40I2N/41)/M3\^<8_?.,=8:S5^?6CU>CU)]?C.?3ZL>
MKPGTXSGT^?/C&5)QG/CQCU)\_OCI2HF _GWM7]TE!_SCLKJ_]F/\9_RIJG]H
M?\ _S*J6^J5>CI2CI2CI2CI2CI2CI2CI2CI2CI2CI2CI2CI2CI2CI2CI2CI2
MCI2NOE9:*@H\J6FY("(BPF\O&2,F6P""*UC[9<(**<:891YSC'J<6G&<YQC'
MWSC'0 G $GT%*B?.Q+1<\Y'U56,O1ZU>A6P+LP?"U1#>?MDF A\H8L=PSC&,
MJ96.U"P1./2IJQJQG..K0!R?L,GZ3P/VD>AI7/B]31KAPL]?98_9%D$7AX4J
MPML-5^(?QG.<.5ZG"XQ Q3C?GTLR#S$A.81C&'9A[/G.8W&(&![<GZGD_3CT
M%*S<&GU*,.Q)QM6KD?))R[E,B#"1@AR<OI4E_."QQ6R,9>2M:7<X<\N)6K"_
M.%9\I/J:5D744HZ4HZ4HZ4K0QY1=J?N*2O/_ )3<CM4:EJDC$V7>&YKIJJ>(
MW'Q]&*4JUSM@<JEF7"6V^MOQ14.H\2<0)-1#4B.2*T*L04KU/"Q)!&)!!E0,
M;3V!G))F,?G5@1@02"""H&-L9@B,@F>.W)BL:V%PP_$ ;0SANTR9PXWQ&0L1
ME0Y'<:]?1;8[*4)]"(ZA[$K@GEU3:5$N9:RX2YE2GUN95GJ3)/OB>/H!]S [
M3Z]JN-G,=O0D8YB1^=0YM?M6=Y_>6(M&VJVY>VH:.!C8\6?Y/Z)+ :9C4.LB
M/_3,[8Q&_4$,.^R[))#0:4A"%EOOOY6\Y4@F(XF<'F>8[=^9I*!(^W!_GG^'
MI4+L]C#N>CCM"M:)J"FVE*7AS'(CCNG/E2\KSYQ^I^?'IRK/VQG.,_O^^<XZ
M%.9]C]\'W'KZ^@Q$U 7 $Y/W_P!/SY..\UG&L.SCW;M/V0"W:ZUQ&U.?!?'6
MZ3"\F=%1OU$<8UD[$9+-Q^W!DR44^^.SDN.*RX*2E&,.M*\8SB94""DP001!
MCMWP8C^<Q4 IC//L#GTCM/O S--C7>*/XA*J3I-@B)I\<LDC)+HCG(#B^]"-
M9\IRE@& >OBX:(":2G#(X42&"*,QY9'9;;5E.2BHDG[GO/YCU@<U/ZO^9_G\
MZP??O;Q[S_*"-88W?K>E6^1BY*(-KYR-R<68=48R*#-B2[.'(B_A%$.3CDC%
MD&.$OD)4J&#0E"$,L8:L%2#/XBK=R"-L 8[Y(GTXJ1M3G(^Q[Y]*Y.P.RYW)
M[%NJF;/IW'R"ML%4M(\8JUA3.WM$$CDW;5_%W4>N;'#>U)WQT;.82\UN5$6:
M4(1'/,1BI./3*BOQZ#JDD1"=P)@P0"!!R9$<P(!)S.(JA(D8)!49@P4@@^8R
M,C $ $Y]C6>W/@;^(TOD9'P\W$VH",C8]$8P'3]T\<Z VXPA.4*?,71KK7GC
MCG4Y\/'ENOF.X\86]G&,8P,GU.1F1(]\_?UD?6K?J_YD_OJ&MB]HOOK[;KT#
M5-E4"W7.NUN/;C(N'G>1FGS ,",$.%#_ #A%;1P/*%#.NN88D9-HN22VK#.3
M%,MLMMP0KL?S/'[/VR>>/291_(/\^N/?TF8-9_#_ /=H%86,SQA!6VX\I[U?
MK9HE&4YRE"?'C]1L_;^#SYQGSG_VQG(ID@XXSWX,_MXXX^M0%0(F>(Y&/R/'
M^OM.1T[L3=XJASS-JINBY&IV0=U]3$U7.06G824;:)5A1+")"*VB$4D<E.,M
M$,I>2E]O.4.)4G/IZ %(P3B(C!F?H?MZ=_6FY,R>9[3QR.P_;.?;AP@.#/XC
M>*L3MEBXJS1A;F6\(CP=S<=&:^,TTVEIID2N_G14,/A*4)4X^T&DLHCW#3""
M#GWR'+$K4940>_/?GN#W[\\4\G[_ %[_ ,?>NMWCVZ._)R8KA=;WKIJ.NXC8
MHSD)E6Q>,T8\!.,S4::N:>,CKH(>\6Y%,RD4G/RLLML29+;8R$$OJS(42"%3
M)(((@#&Z9&3,$1G$D=HJ04#@_L/O[>].'RR[5W.;97:4[>W&"F:=%E=V:,O.
MS)C9]1<V-K&.;KD=89J_F1#[=@D[@)6YC)0TY&KRS"R\@ZQ\C*"&VE,OI;C\
MN#CU] #V^]4)DD_6/?M^T>L#UQBD[K?;T[^>L*0G5.GM>8U_KQF)K@'PJ_LO
MBT!*K.BZ[&Q<\>'9L6C-J#8LDT-(3I3:99E\IX[W3$I?RXVF I12)24D@$I)
M!@XD2,'/I@QD\&I!20"9!(!())(.,2,&.._L>]8/_P"&9^(&7#6N >CMDDQE
MU6(Y8&2N4>J'WR'026"6%B'*VQDZ,Q_(88>8C2112!7'6"!W4*QA,0<Y,'L8
M^XX/Y#\\XM*.<"/8_P /V4LJNP+W84GN26.-@!)3WO*?<>WAHI3C[KZE+=>=
M=<V2M;CKBU>M:EYRI:O*E*RK.<]()$$P?4=Q],?S]2*B4@DB,\S//,S!_+%?
M%7X?[NNDO)<(XTQ^,)0O&$_KAHI>,94I*O/E.R$Y_HS^WG&,_?[?;I'<=SG]
MWH>.W;/IBFX$YXCC."/L/7WXIN(3MR?B#:Y7H6LP<)<8V/@B72A"6^0^D29M
MYQQ;JF63K"=LDR:,C 4.Y;CH-X[,(!GUD#1S1KKQ+D[EP 8, QG(GG@<>U3*
M#^[@_7$5,KW%+\1K+5U%.ME09M=7<6PS(@3&QN+))1D9[B/J$>V<[:'%"XD1
M<+#?(::R0EI6<MN(5E>5V0H@IW92#*HY/TP/IQ@=R>(\D_GZ]_M^415@/8%[
M=7+OA)M_DG:>2>KA=>06PZ+3H:HD,WK7EK5)2,59YF2.&4'2K78WP/CAF,.>
MLQ#(Z\KRVP\ZM*L8@<#^?]/W"JK()!![>];0W2JTO/)^E6;8>I9VGP.Q:%K*
M.GLC1MFL.PJG(6Z&>BBRQF6(?((FP=>B^S-R:@HB3"ECY*.GXDXVNO1RLRF'
M6[MJ"5 E)41, &#QD_A5P,@B"#F<51P%28E*02)*A(B>.1R8!GD&*ZWCQHJ9
MTP7L(N4/U6VQ=3JX4#5]+ZH+TY1('Z%%/QY1WY6?O=[9-L<ZX\A4M/M%1[Q8
M$="1KX[S<0,]U*U[]OXL3E2MY,^^U, >F>]$(VE1\OFC"4[1B<QN5D]S4"[?
MXZ7>7*V23%4O&S*[:-Z$["_)-AO2<IFP9CC,7K4.0;)M1Y0D6'3=J&Q\[&P7
MNAM5N)A43U+CG)J#KD29=*P D3!"8F./U@)&.92,F#,P>21C4A1*B!N!5,$\
MC9$R3B%<#&)@<2P=,X]1U.MHFR431LO=VZV0%),$IB@X:7L1H2<24JY(LP;U
MA#8EI-V1D),=LI\4\TP:5D8X^1AXQ;%"X2"F(3,CF0!P.8,"(^_K5TH@A1,F
M([9/K,3_ #-<NCE74K=UT5=H2K0AB=5Z^2$S5;3+6D9\;-NV3E;A1$O3Z>Z*
M^EW^%++0IC:T?QY(;5_)]#'AB"3YU3( S">()GZX^E!/B&8!V" #.)/<@9GV
MIA.L=9*.E*.E*.E*.E*.E*.E*.E*.E*.E*.E*.E*.E*.E*.E*.E*Z25LM=@V
MCWYJ=AXEF*#'D)-V2D@PFP 2W26!3#%DO-X'&)>#*9'>=RE#[HS[;2E+:6G"
M#Z4J,OU"M=USAC5E9SF+<SE*MA7@<^'K.&L^<?)KT!Z1[';LX\>IES"8"")3
MZ5L3[R<^G-H _$?L")^YR!^TCT]%=E%:GC%'"SUZE#MCV85>'13K&V.F$B'\
M9SE+E=J(J4P$.XWZLI:/R,9.>C^%^7?_ 'Z;C$# ]!W^IY/WQ[4J5NJTHZ4H
MZ4HZ4HZ4HZ4HZ4KS:N6KVF(7N?;KI<OJ.(B2!.15^G9JV?79J=S+/VZ4?GRI
M"8IMVL+U5,0$Y*ES04?'YCF"#,M--BJ$^,(-L/PLNM-Z@O$)U'2DWUR-4UFR
MMB=2;L[1"M*UB]L67%L*907U_P#IFDNH5=.K4M+JF;=1*&AN/56DZ=H.K65I
M9NNKM7.G>D]6=<=(?5\YK/36DZQ>(\J4#P47E[<L(;VJ+:&V@HJ(45/9M-S@
MF#Q.U_6J%=]36G9!NXY5-I9G54:%N>(22@U#1T4[62C") RM_-$CWABEI(CD
M'ED,Y>2I:FU>W6VHV2>KM3LM<&C:=I[^A,ABV#]LNS?6+@I4/$'AH2_"E M>
M5PIA24XD:PM:@RVBW*KPI6DH6]M:6OSN%PN%>T0D*2D),RF2 >T.<E.WUP^A
M>/\ ,[:,V_JO4UT&S&M/!P.S(,QL*3&:AV96,'US%ORA]C08M;XT8S5QV7G)
MA,G('2@$2EH$+R'6[#IEFXN46;UU:CQ'7F!)N&ELK=6$-MA0#J#N"G 7%+*4
M*2T%+"$D9;@6Z5%*)2J224K4M$$DP H0-ID&) 3$$YK7E:#&PLAN-.>D04%$
M(%-='=!62PASPV\L1Y]YQG+C>$N*:4ZXI&5>CRO.,9SI9@'!X) Q@I$PKU@Y
MG)XX,B..!CU^T?L[9[8]\R:L;[=F@.+FW;J8O>.QP_FB1EG=9UU(6"&H@CT@
MVV:-'ON2T\9\NT(8SEB0>C*V,(<*VK!&'R%!.LN]M86=@^;=#MTM3[SJ$&U;
M;4VI*-X3M7<K4EL*4@[Y:;N#.%(%62E*MOF.]2P"-L@ *Y)P#Q GZ"9)-W>C
M=5:1IN_..VN0=!<>FZ99!1G+B$77:M=PY6(7(R0\_;,W>V/V&PJ^!%AC2C<>
MY8'HT4M(T8]@I\LL;KU%[IWHYGIK7ULOM+U.VW*LO$N]UXFY;\!3=D6@$*<;
M7<D,*'@I+B23L0(GDOM[2V&4)=:4ITW"X"E-PD!I*2#(!<"4D;0/.03Q2;]S
M3C%QCURY*2FJ;3HJVM_FLUVCP<%.5FO"MB./GR15;EYRKRT8L];3QA(T;'/D
M#F&)#%:;E0QA6%.=I?6#6O\ 3*&]0T*UT?6+2W0G3G[_ &Z*U>WFYMOP$J=%
MN7!=- N):6M*?&"%D#<M5<)UNWM&S<I%PZJXN6TO,)*[E+*W4%"U-E&X6S##
MC:-Q0%("E[22K=,DZ7VUS:XT=ES2<MQ/L5LUQ>)'FGM\2Y%1494W7R*4JA"2
M(JB,76.D $Q:Y(<,IDT1.,O>A"L$J84K"O"G4*8?5:N@-W <=:\$J3N4XR%%
MX-E*E!P-%*BI2"H0DJF*NBVN'FWGF6'W&;="'+AUMEQ3=NTXXEEM;ZTI*6D.
M/*0TA;A2E;BTH!WF*<FG+[RVP-1U;9@W<%M--<DM?CVR?3+Z]U=-0<*4)#"E
ME /O0=4,+2DO'RCB9M2TQP+C3P3(I&6\*QL*=-T=ZR93:W6I.:N_<6;#=N;=
M@VY+J4!]&"72L*DL%).XA270G<E52IMOR[5B2/,#*8)( ()A.T"2K,@1VS5?
M]IY;=_&$@L6JM\B+_LJLK5-9:D-?535\Z:MBOCLF29.().OFIA]I@,ALM?TX
M20]L?*EN*3A/G.'J+IZ\Z>OODKAQAX^ V\7;8.[$;RH%#J7]KC3@*95(+1!!
M;.%!,NL!J#A25 $%)D')'()29B4P9(CO(I',=[WNM9?)9SS$O"%LYPE3:ZCJ
MK#C:\9RE3:TXH?E"\*2KU)7C"DJQG"L8SCQUT!,<D#TS^T\?O_,Q6#8>WUSS
MS@'MQGZX/:N_J'>4[PM\LPE.HW)[:%LM<DO \7"0-!UM-R9SRL-OY6U&":[(
M<RVP.E[WG/&&66_42^XA#2E83Q/?N,B?21^Z/4>U G'X3CF3'>9S';'?UQWL
M U+M;\2%NZ. DJ?MS85=BG$/I(FKS^A<*T\Z%)D1!I'TYRC_ %D )F0'?%7E
MZ)?PE\9Q*#',N--+OX;HA9;5L*B@**805"93O. KUS^$%0FK! ,E0*0"-RLP
MF?>"(^IF<?6&>2G-?OD\4@$F[;YES,7\F:/K<>.%7]8D/3$O&/-I->@T'ZWC
M79FNX$4Z:/:(E@R*7AMH=]P9XT'!/=ZOH@TMBPND:C8Z@Q?VJ7PNT4O_ -.\
MN";5Y+H20M*,I40E14%H*$D";*96E.X@ %1"2%)7N$F%""821ZY,<8S8WS]N
MUSY&]EGA1MC?F\K3"31YFH=@7?8494Q)V8G)Z8CMTU<]XJ KLQ26VTE,F1;Z
MLAJP-[D6RR@)'O$EL:[\W:-7FG6=T^BV_2=RY:L/NM/NM)>:L[J^APVP6^A*
MFK1U*2AE\*64(4A"274=KI6@W^J6'4&I6G@>#TWI:-5O4/+6AQRW=U33=(2B
MU2$E#C_S>J6I6EY;+:+?QG-ZEH2TO7GXPZ.D=XVIBM/;?*-K<O:X*+$D(JR2
MT9."N.G&1K;DS%S8B#(H @209D#%BJ,9_D&Q62B'D8<;]8Z3Z5TK4K#6W;V\
M:U&UM&;2];?TM%RTI2FT7P<LG%WEBV;=2P6EN(0KQ5!+"P-IW#J6R572&"TM
M+:E7 WK*0MQMAEEPJ0A*RH$FY1L40$%0<&[]4L"P3;?:V;HFW9K6<1M;>Y/Y
M/IK=SM4F6UEP,X,@8)2"JB*AEJ1)K01L@*(9-/NGO8>:D1W@Q6H\R6&PM]%:
M?>Z:SU U<J9MKS4S;6^CL.MWMPEB7/\ TZKY8MD-7;@;\5LK9"4-E(+JU.(G
M.RVA:PVI3A6EI+BI20A4E*2D'.U0) 6"1M,CD2:UN5/&+=/'>;<F1+M,W/4,
M@4 NJ["C9Y]L.08E@PI :/+91-E^B2$08EA2A'3136F?J [R6W'6!=,U'0+_
M $T7KC[/@LVCP:6BY<99N27'?";VVY7O7!(#A0DA!DJ@ QC<:6DR1"2ORC</
MP\@X,J&)"A(.#B12J06=H6^>B:Q5;!:#YV?-S'@ LV,L=PU:A7WE"-NDR(S.
M7'FV58;:R[AQU?I;:0XXIM"NC!)44XD&#[$&#!X/;:>YSZ"L93!F223C) &.
MYYQQ^S/>[N@]I*_AZK<N^S-\7R%V*;K^RWAZC03DJQ'LQ-?%62=")M4JS*_4
MYT<)I#AWPX=J-9<<^,#('-,I-)[G1M,;U+5-/L+AXV[=[<M6ZG4!"E(#K@;"
MD[E!*B%&=FY)/K$D7:1O5$GA7 3DA),)3QN,0)SD0#,4RNC^SIK+9NAH?:I.
MU-M1\D?*2XAC-MN[T8R?F/D,1^0:PY&Q<<A\AP@8X=LU]$KE,BV\.]'+9$PH
MW9=5T/3>G=7U+1;EH:T3;-&SOFGG[-RS4^RIQ#R[=*W6GG$*+0+2E^"IE165
MI<6$"C0WA)4TZVM045,DH4I!!6WM6L  I.T.?A"H.1&:1[A+I+96HN[EQNJ;
M3%]E*31^4%+K;UB=E):Q19#()S#&3;!(BM,1D:9+.9^4[%F"A("<)P".DIIA
MLHC3;NU<M'BRYM)\-#B2A:%@H6G<DDI40E6/,DD*3W'%0XA2%0J)@$@&3D3/
M\\<17I'=<6L=0-R?BR)O0&TXD:I/7A9]7?'<K8X]G.)*%64+\TT:*I,I!W.>
M)@P\/SP]:J4S%66S/QC<!!2 <G)"OMW;,+3G;GG$?<D$ '@D@@#)Q5%_@.)]
MH)[CL()CF 9,8J$^$T*97HW942S(7BUUEB:KSL%L&\P._*<;82WXDA<S"A5/
MD#=+G/I$JZL >;16G8FM3;TRN&R [-U.8.)N\9*<)!@RD%!C."2@ 2<X.1VP
M156OZT21B"0L3ZB%DG'KWGVIY>L-9:.E*B0#^?>U?W24'_..RNK_ -F/\9_R
MIJG]H?\  /\ ,JI;ZI5Z.E*.E*.E*.E*.E*.E*.E*.E*.E*.E*.E*.E*.E*.
ME*CRZ[!$JSX4%%QY%IO,TVM<#3XQUMLPAE*LM+EI<M:5L5^M".^$GSQZ?8;5
MX&#9.D'& GI GV'<_P \TJ!Z[Q[NSNY<;AV';:C:72QO8*JF*J2_&1"&1,MQ
M35=,DI)_X[T&3_$+)NQR"B4/R3JVQGY-Y2+%0V[0"([SS[D1WQW[#TJ9Q'\?
MX?SP*;OJE11TI1TI1TI1TI1TI7X<7AMMQS.,YPVA2\XQ^^<)3E6<8_[Y\=*4
MC^N>85IOT#KB5>X]6NN%[QUQC8^C&3KY03(C8 _Y>AK?FK&S DE\BG6QRI2Z
M[(*%-0ZHTF-AIU*99)T=D-W,IH)*AO!V*VKA*I3DIF#R)Q@SD8K$ETJ"3L(W
MC<C((. 8[02#(!]#4Y<?]ORV[J3(722H)E!88MUFK$4P18X6TB6,2K'9ACK-
M"2T'X%)@B9X68C(TK*$MRC43F9C7"X61BSRZ+2$$ *W8!."(G,$'O$3]8JR%
M%8)(C) S,QW!])D>\2)$5H-\\M-1^W^[MR<%DH#+E?D;9'HB\HF289XJP05%
MJPKB@OA/)/(87("E$23[2&AV5(5[AXBT??L/@9TBW<Z;>7>O,K&E(ZFZYO[9
MTW3;*[M:^NM;?;9;9W"Y>92TI]#BF2C:6F]JQ!2><SJ:M>>W)45OLLM6"2I2
M@4(TIE&E(VK"2F$&V0E(5,!HCUIB.07:QX_ZUT+I+9,? B3,QL*P341:3ZU/
MV[Z&+(.I<(B8)EW,ZH<1X5H.0#PU@<4F1]@DQ:4Y94TW[)I6A](:[U%U!8O:
M W9LV5LQ<VR$W=RRYL,MNOI;;>3 *]JS!6TVL@ 9S!0;9*;=?BW3P?::\9Q.
MQ3B%I)4M:$!*6P%>4!/(223,U$N_.T3H6IZ!NVV:YO6SU(VM'PJ(XV^)%DZB
MMQZ$97*PEX%C&4V#6TM];Q(Q\-[[EP3( C R+"W1CG&Q?)M>TA.FW2@RVXVV
MYN6QXSB7T/-@B'6[MMIMM\%"DF4@%)A"DA8-7?9#:U)@A)RE4DR#C$J,Q'?)
M^E4.0T,,*IP%PX*20U)%!O&QQ*R02T,)6CU"E^ECWV'/2M;+R$I2XA3:\95C
M*?&N*Y..  )["1!S,SD?OK"D8[9SZ#V^F.?><U91VW^WSJSF'?SHW8>VI>.
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M2M9NF&[II2&R$%A.Q#C+ZSL#SH2BY4G:DSNRI.]MT(VJ4TXAMU24G<8$@;I
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ME/E#!V>"$):; S*N7%)4E4D*5NX$ R2!MV[2DJR4D2H@2J9-*+R@[>P'*20
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MW1>TM5[;72%:>#AFUM[RY905-H;E 0X=VTD 00!G3<**7$LAJ)@J0I!<2F(
M7M)&X9Y 4$F)"0!576_:QQ&Y,VEB=W3WUPK0ME( PT"+P9W;#5X8>,8;'#:9
M@XFTC1ZGFFFD_P"_FLE2+J\Y6^8ZO[XTI;SKP'B.J6#YH5P9',3@YP1$2?6L
M16LP#F")\PR1Z^I(D9G\YF C.&W;'0R/[/>/@@B6C6R&B4<(=]86E:,+RE*?
M:MB%(4G.<*2YA2<IRGS^^<>G$ !P?S[DR!SZ9$""<S%"2<;8C/XN(Y^G/?\
M*NWAN O;_MY?M0/=U;M!COK<6W$\!N0\R2O"<^7'5?$LY#F<)SY4MQ6<X3YS
ME:L>?O=##CRTM,M.NNN1L0TVXZM7FV@)0@*),^40.X'>@WDB 3[8S'/&1].U
M23/=IOBE5FP%V'N2VJ'Q*1"9V-2?VX^3 [TA"JP1E,F(PJPX>("5\4GP\TVI
M&<#O9_9E?I[1OI_6G;=^Z;TC4%6]LHMW#HM7H96E0"D." M*AN!4"GR@A2O+
M%2?$"DI*84L**0<%00 5$"<A,B8]:8?MI<(>%('.?B[9M2]S*/W#=Z]LB/NE
M9UVUPWW10D79-1$F)\^,8NMELSD!!8= @9?VY$YLAG#X+PS3!)6,#JZO:4QY
M2G<D* ,@E)) 5GL8,'@D'-55OC(@>L<\?ZCC_6M];I6.EOY<PGUKCOLY;,96
MI*0@X!VR1CEJ#UP3'11$(ZV:5,L%;<PK7$')Q\4B1<C;%;VR(*!*RB3D@I(,
M9Z-+R-&%IR1)C!5W[>3S$$QA.3VCFJ.?@5Q@3G;CWE6 8G)X]^*C;A',5*:I
MUO*IRK;F,5,01+F+7*\6I)W*Y>M1\X ^&GBZ0]"C,R$%)P\FC-M0U+E@FQQD
M;AR,>0O,O;@1NB<C <'!@_\ N 'D'CO(/%5:B#&[D?B\/N)_L_8CG[=ZG/<N
ME8'=4=$Q%ADCX^- 'O8)C<:AC!4@!?M87;5TDP@I]+F!'!8R[FR(CWL$)P8(
MPAQE33CG54K*)COM_-*@H?M%64C=&8Y!]P4J3GZ3(_+O7&UMI2-IB['8;-)"
MW79MQE)24L^QD5\"K2[V9*&K];3'P2(IU\NNQ8T#5*\,D4.6><</">EEOX**
M5ALI95 &$@0$R2.2<SSDGMQ [42@"28*B9*H / &(XP!WYS764FIQU2W=<Q8
MX^SGMEZKU^0XY:+A:;@2VM-NV2WA I5JF)@@-C*<>I0XCK+*W,Y<6VI?\74D
MRV)C\:N !V3V  J (60)_ #DDGD]R3CVI@NL=9*.E*.E*.E*.E*.E*.E*.E*
M.E*.E*ZR:FHJNQ,C.SAP\9$1(CQT@>4O#; HK",K<=<5]\Y\8QX0A.%..+RE
MMM*W%)3E2E(@-9;+NNZX3?=A^@@UC(WQ8.AV,<QRQ05<0P6B'-6Q\)T&+M"G
MR5S[K67EDQSLB5$++:RE>6[D@)*1,]SB"9S&>(Q[\]XI3E=4I1TI1TI1TI1T
MI1TI1TI1TI1TI1TI1TI1TI1TI772Z$N1,HVK"E)7'&H4E.?2I25#.ISA.?2K
MPK.,^,9]*O&?&?3G]LPHD)41$@$B>) [^U60G<M*28W*2F8F)($Q(F.8D?45
MYO7'[CYIZ0N>V:Y7=6L[/:@)T^G253L-[E[#8(M=7LKA#4O,CQ=$UZ/%"2"V
MP1W P#I5!ID*7ZY-J(67'R&]_#_3-&Z@Z(7U%K75>G]-Z?K6BV+RWF;K3D(L
M[J]T]6IM)N+C7$"S-QIB4NW/@/:?=V#J4>.''5V<V_#^++0Z*ZYU'I1K5GFK
M?IWJN_L6-7<L$/6NMMV=Y=6B[5.GV]RMU3[[:&5/;2E+95%FH.W =MY4V?P.
MX?M3OK@YN\5=C\MN2LD T :)ENZKD5XD:</#S$Q9I"*CX<1P10#I,H0[)MNX
MRB:R+E$JYN+/05M?VEG>:;HMEJC=QJFG-%P=6+8M3TRY;J+G4%K?-Z+J%OJE
MT]O^8%E;-V%J[NEA^U*4,5U]YJ=U;V^E*T]"M99NE7B7]00AM:S<M)*6&7[
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M%PRD,W18,+4Y:):<=1,I;< =>9W0H&=JB\H I;:<5Y:R-L*6N-I"0)6O 2A
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MY.!COVI8N$^PK5:IB\AQD!.XU,Z-5):O$VG=[>WK36)"5K0TV\F6.LJ&]B(
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M[$N7*7.8%GSWJY RZ9,2)!.X)!"09S!42I7&28'8",F&A"9@P0(*CYB!Q(
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MSKT<6,?EOK=FUN%,,W+=VE 1-PT-J%J4A*UI((!4MI2RVM<J"MH@X@2M)"B
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MD>1:#3DH" ;G5#2.27VY61.=?4I) AD>]'-,L,"O."HCY!&(M;ZA32/$].^
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M@I&Z%$I(!@CB:F;NW;5[;EHX=^]JPCCX?:")&H/4V3TE#<>K?9JR)(DE-O&
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MA7A/IQXSC./Z,[JWTYIURC<E6I7C:"[!3K&J/-I4@C<D*1=% 4-PW!,$!0)
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M,^,8Q=OIBV\NTZNI$[DD:KJIDJ.W>0FZA.24)5 W@F))J"TT$S,':2KSXVI
M63[@ !:NR0 3'-<J2[G?+P)*%DP6B6T8;\(=?X?\<$HPI2TJ=Q_*:L2O#F4_
M;+>$)\J4G*D9SCSC#_PWH[\J:5?O!M) 4WJ]^ZEM:C#A)3>*+:U000"D%0\Z
M3Q61VW+2PT\'&W7&FW/!=WH6ME2B6G-B@%*:.TE"LI.TD'$BWW;?.?<-0[+_
M !IY0DUG5]IMI6X[S"S 3^FM/-4T2.1L6^5N+>CZ@5KN4J-9*PVP'[DA 0$<
M<<:MY\LI]9I:7_#^KWK?3.LK+1VH+.J7ERP%7+[KKP%OI#VHJ4'%J<6ZO]2=
MV]6$;B2F!7:Z9I%E>Z5U+?OW;C#^C66G7-C;I2DB\=NM6M+!UIPK4E82TP^X
M_N;E06V$E.R36O\ Y[S/+]659S#\6\^YG^/&>(7'?*E9]65?Q>=>X]>/5GU>
M5>?*OXOW\YZQJ9M@1YMP@I/]56X*(&T'.V([<DY&*Z"!ZGT_$1)_/G]\_2A7
M>6Y@I\X3"\7,8\9SC&.(''?'_P#&=>_T8^^/_7[^>L+B&D04S!,$B/7 G@D^
MF#GC%"D1F?S//TS/?C]V*YK?>*Y=N$N-"B<7B\>,XPM?#?CJ'YSC.<XRG"J&
MXMS&4XQG/VQA/V^WW\XIM3)!.1!S Y$@B9P1P?OP14I0GS9((D CR^G]Y6??
MM[UQ<]Y#EVAPO#@G%U#C;K.&1D<...;C;Z%)1ZU9*Q0L>GVTYRO'\#F59QE&
M,X^W0)1,$\QQ&0<\\9DQ,?MIM0%$$XG !)./OZ9![?E7X_\ &8Y@?PXQ$<6_
M/G.?/^R#QWQX^^/&<?\ +[QCSCQ]_P"C^KK(EMDD"%3(E4C"2>2=L#!Y.,]Y
MI">Q)Y[G$<<&/3W'O7(_\9KF.VAT?Z7Q?;2XM&76<\1./*4K<9]>&LN-?I^G
M"UM>XYAO*TYRCW%^GQZL^>2BW848WF=Z@#NR8) @1S&,"23]B"$R!GL#DS]/
ML?W?:MHS:///DIJ+LKZ4Y=ZU=H\1M<NA:CF9\P+7=<!J30=BG[U&2S#%/A0X
MN#B8O#PD4@86-'!'$>?>6/A+A3OKU/7M6_1=_H5JV4!&K:ZC2U%Y)4HH5I>L
M7^ULA2 '9TT$$I4"WO&R2"G9NGM*TG4+'JRXU%UYM_2^G']0TE+3B4)=U-&N
M=/62&WPI*E.LFRU#4%^&@H5O:;<*]K:TJUH"/Q"7=8(*)?1R9CPFR"'GFP@]
M.:14*&VZZMQ HV3-?%F*''0K#+.2BBB<MH3E\A]WUNK[OU@R?0QVY&(_;[5J
MH [I/M /^O[J,?B".ZYG&<_[3[7[>?'Z,:*_;^OS^FWC^O\ I_\ 3S]_$>;,
MQ[<^WUQS/''I24>A_G[URF_Q ?=.<;8Q_M6/I,6]_&.K1G'S "6\*7C'KD%4
M=)"?*/;SE/P,^%J7CU^E&,K$GW[\03';UR8QP,QS% $G.0)[\?G/YY)]!$BO
MN5W^NZN,L51/*?X[#CZ4OJ%TEH,LA#2DKSYP.3KT1&<>4YQZLO(QA6,)]7C.
M<]0"2#Z"<XGC@SB<\\8^]64E('!Y'!,\_4<\5PE_B!^ZKAQQ+'*/+S6'7<,N
M/:4T,T\XSAQ?LN.M-:X=;:<4UA.5MMNNI;5ZDX<<QCUJG,Y/H,1^V>)Q@$FH
M\G$&1.#,^OK^_P!,U_,?B ^[ I.5HY.(4C'CRM.EM&92GSA6<84K&M,XQGPE
M6?&?WPG.?Z,^!)S$3) !!!QSWY_G&0$)YVF/7./V_ND4^7:Y[SO<3Y'\_N-.
MD-O<@6;9K;8-QFHJUUS&K]1P2I4$.CVJ988Q+5ZB1DR'[<A&AD>L&0%=7[.6
M'',LN.I5(GO/TQ'[IC]OK53&8$")DSZ@8R0>:WM.IJM0!RF*P%Q\VH7FLYMV
M1ZTIU$*A^T#/X<0<%EJ9$?HZ%W=!]8<]%FC_ ,EY:MRCH@=-9(%FU DM7;_&
MG,9YP>W&<9XSC.<51S\"L3CW]1G&9'(C,C%0OP9J%<J-0MXL';![L[F0@P7I
MU59W+7I%B-C8XA$/ N8W)/SIJHF+208_&1]83&0@14C+G%!NS<S)GF7>45*$
MB!F "DCG)\N">))R<=HJK0 !$SQF% ^P\W8=H]^]//UAK+1TI42 ?S[VK^Z2
M@_YQV5U?^S'^,_Y4U3^T/^ ?YE5+?5*O1TI1TI772\O$U^+D9R=DX^%A8@(F
M2EI>6,'CHR,C@F5D&'R!Y;C(H88K#:WB"2'6V66D*<<6E"<YQ=MM;JT--(6X
MXXI*&VVTE:UK40$H0A(*E*42 E*0220 )J%*2E)4HA*4@E2B0  ,DDG  ')J
M@C7%CY$<V>7%ZU;L3;-^+X1Q,C)W?7,M%ZQ%UL_MNOED%HK%8$N\?7*_8&H
MB*38F'K< 8.98(6&;,AG8]ZSQ\H+Z7J".G^GM&TVZMM/M_\ BI2BS<-.7KEZ
MUIERPV@O/N6I>=MR^DNLK:MWDK0R\X4K!7;+0=>MSJ%[>7+;EPO]&!(6VH,I
M97<(6HA*$N!"5^&=BPM:8*T"!"7 :OPKU>@:E!1-8J\-&5ZN0$>+%0D%#!#Q
ML3$Q@326! (\ 1MH804=E"6VF66T-H3C&,8Z\U>>=N'7'WW%O/.K4XZZXHK<
M<6HRI:UJ)4I1)DDDDUL"$);2E"$A"$@)2E( 2D#@ #  KN.L=6HZ4HZ4HZ4I
M*]QP<SQ]ODARCU[%GRM/EV 1>4&NH05XLJ<K46PD2/W=58@1M;AFP=<Q[;0]
MF"';R3=-<#OAXP3.5:L,.[+ISK>KVJ-#O'$-W#96K1+QT@!IY9W*TQ]Q1\MI
M>+)+"CBWO"%8:?>(Z]]"K9TWC0)0H 7C0GS(3@7"$CEQH?B$>=L$<I!IOX*<
MAK/"Q%DKLH!.0$_&@S,),Q13)T9+1,D,V9'R,>8.MQ@H(T1YH@8AE:VGF7$.
M(5E*L9ZUYUIQAUQEYM;3S2U-NMN)*5MN(44K0M) *5)4"% @$$$&N<E25I2M
M)"DJ 4E0,@I(D$$<@C(-=KUCJU'2E'2E'2E'2E'2E'2E'2E'2E)UJW:D)9M\
MW:A!<B9Z[_E@(58-/-B];"@2,BVJ<&M8C<I!ZV@9.336'<0RVT1<_P"XVXEY
M1CL@.V:AOO[[IK6]/TRWU:\TQZWL;DH\-]128#J0IDNM!Q3K =$["\V@*P 9
M4D'IK37=*O+]_3K:_;>NV-P6R 1);)#H;<*$H=+?]8-K40 29 )#B]=!7<T=
M*4=*5\G_ #EA[QCSGVG/&/Z\^C/C'_O^W55_@7,@;521DC!X]_2I!@@S$$&1
MDC/,=XYKS[2KO4B>2&\I:<"BHB4+VW?QSW&2IP@J4EY"U2<BLDV-?.D8].,9
M:8\K !CV B2!/+>%DJ<ZP]4=%=8:I_1U^$>D]$M:G=VVA]&Z(]J^E6J;1#C3
M6G=.VFGH>8?+:-65<W#&IN?-:?;W:&KC3V[P+9.Q0<^@/Z*_6?1&G=2W^J_$
MMZR4>H-.8_1NI:Q;.7-C9W%Q=LWZ[9YMNW<TL6C5SIEM<-WNI,KN;6_5:K8N
MD),LM-.6K1)^N\J)DJP&^&TRZ3%6"N9DI>3/'<*'E&A3B()3B1%K7'N1K3&6
MAFU,*:=4@OP0[YST[TOUVKHG3]!^'9ZOT;K.WU*YUGJFPT^^7I8U?3[NULAH
MMQ;WUGJC=NTUIK3Y=3IVH"P6_;WKSR';FXM[=3V;7.OM#:_I.]0:S\;.G6?B
M#\,]0L/^'>@NHM%TG4STSTJBWN4/I9?TM\,L7^IH<:O;3J"\9N-4NK>Y8"K$
M)L7%6S"R7^Y\2GM>R3-HJQ\O?I9XQZ(E*['S==)C1OH[2!$2SDB%!QV T'>I
MQ2&A)_+C#R&TM8;'P4[[;\%^D?C[I'43=]U?UH'.AQ;(;O\ 0-?U5CJZYO;A
M:EHNG;+5+=Z\NM,=MW$2BU5>-,0%-W'C.(4:\Z^-O5G2?5NLZ58_!OIJTZ9M
M-"-PS>ZNQI=CH6C:BP-1N'&[=K3;>XU6_P!6><TEQE*[R\_0UU9:BTX4A5K<
MBU:JFEG8Q$D5]/2IF.Q_$,C"5+1AIS&4)2WX_P"I.'?4K'H1Z4^XKQG"<)SG
MZ&U#Y<7;XM]Z+:9:$&/#.4@220 HDIR3"LGN-5;42E!,%4#<4C!64@*C_$1,
M8 DP#3S:8MG%P*NI8GZI+0MQ1GW&K#.$/3E7+-P8(X]AD%(BF1!"0D%NMH>C
MEN#)&9RN7(R[@;/CGQGT;XSZHFR<^%>O6MAH<72-5T>Q2-#UIQ12X\R]:ZO<
M73AN$*8#:'!:W&G;@A)%B0J4;W\)=5Z(T3J#5+OXJ:2]U#I3S7_PA%C8(U#Y
M%/AO>*AVPN]0M[9R]^:;MQ:WEVWJ3)+SZ#;6NQ-RJP>G[(TK*D!*+/IY"848
MLZ$17]?OQCQ9(PSIIN$G+JD(/@>1CR)2OO.#.+5A7LR >&EQ;4P/Y+H>@_TB
M>G^F^O\ 5>MG-:U/IY?1^KZ=^A-;ZF<UN[U'4;QE&FZ>NS^1U.Y<TP6+BQJ-
M[>HN+=/R8<94EYQTO,OB,Y_1]U[6?A_H?P0Z?UOH[J34/B+TW^F>L=6N+QK2
M-%T?](*;7\[8:_JNK?I%Y-VFPU+3F%V:D)V)L;AU2+A6DN+1ONP4YZ)P I3>
M)/#3Z_;'9 :.S%G95%OH!S)M>LA;KKV$."13GU-#7OOMJ88:><3UG]%C0NK?
M^)']9:%VST<M3UK>N.*U-5A?:O8H8-JV;33;^W2U=,VS]X\AZ_9N-(2Z^&;=
MM5T[9!'UC_2ZU_H*XZ5T[1F4V-YULI[3W+%YNP8^;L=&47+LJN[QW35NM:<]
M<VMNM5KIUU9.A:07G$6BKANX:?D@;&Q/X=#2H!H$L9!R&ZK"V8.T0/"R:,HW
MK;317%/EQUB0PALM*,N(=#<>>'QE"E,.J]U&]?%#3DN_$[0[I+3RFM,U*]N/
MUC:@IL7?2MU:!3H*G"E$W1VEPJ4L; L!9,?GE<ZE<6EYIUFE2?#U5QYBX#:Y
M0I%O:O7J(E*,(>822G:0D@A)(A5?7MSM=O6J<>Z+;R.$^WMJ;*S$'#3EV:XM
M; W%$RAKA#^'Y(&SIHV8LMA0Z64"N1F6(S.$FY2F/RA J<S9:(2K8/-)'EA1
M(P4@D%,=Y G(P378P2<00.<F8^HB.WI/M6$\KMO=N!F+NDA&\&I3,PIJPC.O
MS/$FY:T?B$EPRQ@#&3!2Z^Q@T><>0<Z7(R=?92WY9891A#:G>?9*T)+Z5ZHB
MY+"5M^+;6D>.\A*PM2&UDI\-) VE0(5GD]Y,;'"!#FQ26B25)"R1MW @R8$_
M8R8K6FFI&C2%FF"*'7)6M5U_+> HN8ET3I;*$K=RE3D@Q'@I:2IK"?+:U$X]
MS"\-D+2K"4];J;VG/W&[3;1RS8\-I*F7'EK*7TI(N%H0ZI;S;3SA\1II^XOG
MF4^15XJ0VF#&Y0"I&Y<$I;25)WG9(:EK<AHMI<4WL0M9*D--IQ4_<7M@\1J9
MM1)O*/3]EV'55FNJ65"ED'Y!;?BQF0$+I*9VDCR"1BTNO.NEV$M#J2&U(B"<
M"89*X;*F4@AQLJ\WX@HD@9Q!Q'<YGM4;I41WQ^P?SZDSZ#&P[J';_;M@[1K&
MKZPXO2,A'N!14A+Q=SX,3UKL]NC"3VR%6>#E(>F3$H7-,!)QAMH*/"I[TD*T
M]'2&&EJ<8[FV7HX9N/F+>^-P$+5;.6Z$K3NVDH2^DD!*"K_W%)E022H)40*R
M (*#(4EP$ 8&U0)!)Y$&#[^I]H0[M4=Q2AZG5(K3G"_8-$LDO+KL,S*SVAC-
M3*+B1Q3'B&19ZQZVD)@5;9[B'RA67X\<A@!YN7D6FL)CIGC)@';X4D+("TI!
M3(Y.1D>AD1Z@8J@QF ?:8^W?L#Z"8G!-/'R?/1&?AO\ 6(T:,0+'GZ?TJ(\,
M3@=P@<)V\VTW KRAO##N&2@QV<.-);2YCTN>TSE>6D>>]5Z>+W6.DG5-*6G3
MNJ6;Z4S#2AH'4MF%D @!/_K=DD1*TCO75WFI7%C<6C+"BE&H7C-E<@0-S+K5
MU<[3Z@N6;:@G&4CZ5I0 (2<YED./(,?PCUJ:&#4^O"/5A.5J0VA><(PI24^M
M2<)PI2<9^ZL=;5'$0#]L\P20/X$3CT-=B#'(5/WSGL"9/Y3ZUE<K3K+ !#R$
M]2K!$ '.88!,EH,N.')?]6<Y0(X6RT@IS&$+2I#65Y1_^K&,YQGJ")/)SD#(
M@]CGZ'W]NXG='8_3$Y]@>\UU#),*DN.:;CW$GLE^EPMLM'L.8PYGQAN-S&I*
MPXE/A&?!GWRG[-(\YQD01(W3[0<''<<>TX_?21N$@^QB.>>?M_XYS<:8J47(
M5\RW5ERVUX>5=?D8!N7,KV9%EX<UME.9<1ATAC++WH(6.RILAW+:F%.LH<4X
MBJ1DS@B,<'L<P)CW(//.*E1Q]X^L]O\ 3C/)K8BX]\G^TS':ZJSE(T")$;#A
M*I,,&0UQXX2&R!\7<T134<=-W)J5OTC.1L&>ML]DM$S67,QOO.E"N$J'CP^9
M9FT%RP;X/*LPZDW0MU!#YM_[9+:U80LH"AOQMG<>":JW&].^=G]:/IZ IF"1
M@$8P#$5=WJ?ESPCM&HV'XG7[\9;IFMC,V:NTOCA;XDE\S(J1S#&8:#I5B:,A
MIY8C98==BI>9<>#+2*\DEW#ZE7OD62+RX3I[B7;(.$VSJ2M04RH!322XXVTI
MQ;2"EEQSPT!QQM2T@I4DF'4)0XH(4%)G$&8D#!DF/6)X(]ZU^."P%-"[VF@G
MX34]^US$E[UV&548:1J<3K6OUH2P4?85@#AETW%0!EA5JBR?E!@3!\3- Q>0
MF/IK( @P2>)@'Z_P_G^8J#,&3(]HCGN>_K$=P3R:]"'J:I2Q\P,A1^@M@6AR
M$CIV7KD&3F!#D8F;L.'#; X/67AH^MP,K"'6.;D!)9X& @53$0++39$> ;,P
MH9!$H)D:G>!) )SD#C.200 (DF#B8!-8W/P$P"1Q(G)QP"))F ) GD@5A7#"
MG+I];NPZX>U0^39R->PU:M0&ZA(>]H!QOUBQYETN>9EI/GTN&MDA)'7X8RP[
MZL.8L\K<4_AX_JJW?P$?3/UJ&A .",]T[?V29IT>L-9:.E*B0#^?>U?W24'_
M #CLKJ_]F/\ &?\ *FJ?VA_P#_,JI;ZI5Z.E*BW;VYM>Z-J2[CL.:^FA.F,1
M$'$@C/RMHN%C.]28NITNM@I=EK1:)=U.6HZ%BAB"GLX6\YAD1@@AKFV&GW6I
M/^!:MA12DN/.K4ENWMF4_CN+I]9#;##8RMQQ02.!*B$G"^^U;HWN*B2$H2!N
M6XLX2AM \RUJ. D#ZP)-*NBB6G>:A=J\P\Q6MM.0Y8LU1^,\Q.1K<$PH-Y)<
M/;N1DWDAN(M]K2O""@]9LDFZ\J;R!UR&;981D2,?W[3Z;)2M.Z:;?O\ 4WDJ
M:?U=AAU=PM)&UQC1V DO6S!DI5>%*;Q]),"V:46U<![8I'S.J.M6MJ@A26'G
M4(:2<0JZ<4I*%KG(;DMI,#SJS6,43N(4^T;ED=<D4]V(HC1$W'P%Y .)FG'T
M031+C4B; 140\H:&E6 W%B/ DFJCT.!K+3D9PE\':=1^%]]9Z"UJB+T/:B4V
M[ESISC:+=*3<E"2RW<O/)"GV5.)"TN);#I"PWYPA+FI677]K<ZNY8.6I:L@I
M]#-ZA:WBKP LAQ;+32B&G4H)2I"E; 4E4I*BAQ(C?VCYU[ T9MO7;YF<X3\!
MRW0@DCA6?V0J/-,'-0O[_P#0IC"\9\XRGSC/6C/=,]0VZ=[NB:HE$3XB;*X<
M:CU\5MM;<>^Z*VQK7M%?.UO5; JF"A5TRVL'T*'%)6#GNGU]#7#)Y$Z5%V&!
MJM[84%^>9+ ^!(EMPA]A;YC*" @G)=EAR&8D36'&G1(]^0;,)2\QAIE2B&$N
M73TOKZ],<UA.F7/Z/:*][R@E*PEM12XX&%*%PIIM0*5NI:*$E*MR@$J(H>H-
M&3?HTPZ@Q\ZYM"6@5*25+ 4ALO)260XM)!2VIP+5N2 "5 '-Y;8VO8'.<3E[
MID+E.?"L2UHA([*<XSXSC/S#F?&?/V^_]/VZZ]G2M4N/_E]-OWYX\&SN'?\
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M%VZX%I<#:@/UK:4 L%:3N3YW!V44DBFE Y":&E5>T%N36#[F?.,CKN]<8?\
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M8NE>G7CL,)=2&"?#"#J!<$%:>(4EM>.G:0[</MH4Y;H+RT DA00 5)0(! 3
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M_H-CJT:@+*F2"BXX9#I+';:%JNK:)<_.Z:\+=Q 45[FV76U@@ I*'6W)"TD
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MJHQ(C$>]"F H9/PTEV2=D76S&#NXU6\8N6=,99TEO35VEFAI]QI3FV_<A/\
MZI3;B06UK *BGQ'1YH2O8E &5Q04EL%(1 ,'N4Q $!(DC:<J4522,XK5W[B>
M]N6.U]U/B\H=,@:>L@TDQ\.LN4MT,MGVQ\K7F-M\VB0-EART'MD%N0\RF(=<
M^)Z16,BLMHZE;A6A*"EH!L$;DHV*5,_C7)W1[SGM-1N)2  ("AD;<Y[Q]0>
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M--+===<7EQQQQ:M@Y6M:UJ4M2UYRI2LYRI659SG(IY(B8 ':(]/?TX_*@4D
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M0</PWY7_ .<6R,9]C,4U]6\Y8MWRL_\ $_=__.^5X_9C^0]/4E>! 3[^1/\
MI^[WJ DR<J@0!GGU_P#-9-^D5<_M#M+_ !CVI_J_J-Q]$_\ 0C_MJ=O_ #*_
M.C](JY_:':7^,>U/]7]-Q]$_]"/^VFW_ )E?G1^D5<_M#M+_ !CVI_J_IN/H
MG_H1_P!M-O\ S*_.C](JY_:':7^,>U/]7]-Q]$_]"/\ MIM_YE?G6%U;49F9
MS9.++8-I?1DW0#&OO^<.Q,?^4/TZH.3?N';L$*_\^YN_\4ME4AC_ *6\_2DQ
MB4R5\0$\9\B>9/MZ14;>?,KV\WM^S,^E9I^D5<_M#M+_ !CVI_J_J-Q]$_\
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MD@08![QF?3)_A[Y$6A/]TCC]OW/Y#/M7W;[L?<4=^.A/-[DK@M;V,+Q^I!V
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MER) $7B$C).>G)*/BL9^"&?,RI@[#9$B6X]+RE$-2HG]4DY).25 G).3 'T
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MB!G+2\74K$*U6JS8/RE8[ X1$%LHA8&U?5Z_FM3$HI> HV?3.PRH<MYF01*
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M)K/$'VUMQW>?A:BU!:S>I""ZAINR5YV0]YI-?AOR/#1L5%D$!LLI3%&6]PK
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#5__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>52
<FILENAME>g60414g90l07.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g60414g90l07.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1PB4&AO=&]S:&]P(#,N,  X0DE-! 0
M    ' :^<70X0DE-! 0      &$< 5H  QLE1QP"   "   < E  "')R-3 P
M-#DS' (% $!-:6-R;W-O9G0@5V]R9" M(%!R;VIE8W0@2&]O:V4@+2!3+3$@
M4F5G:7-T<F%T:6]N(%-T871E;65N=" Q,3@T #A"24T$)0      $'_/CME6
MLS_]O'1SP$HW+M,X0DE-!#H      .4    0     0      "W!R:6YT3W5T
M<'5T    !0    !0<W138F]O; $     26YT965N=6T     26YT90    !#
M;')M    #W!R:6YT4VEX=&5E;D)I=&)O;VP     "W!R:6YT97).86UE5$58
M5     $       ]P<FEN=%!R;V]F4V5T=7!/8FIC    # !0 '( ;P!O &8
M( !3 &4 = !U '        IP<F]O9E-E='5P     0    !";'1N96YU;0
M  QB=6EL=&EN4')O;V8    )<')O;V9#35E+ #A"24T$.P     "+0   !
M   !       2<')I;G1/=71P=71/<'1I;VYS    %P    !#<'1N8F]O;
M    0VQB<F)O;VP      %)G<TUB;V]L      !#<FY#8F]O;       0VYT
M0V)O;VP      $QB;'-B;V]L      !.9W1V8F]O;       16UL1&)O;VP
M     $EN=')B;V]L      !"8VMG3V)J8P    $       !21T)#     P
M  !29" @9&]U8D!OX            $=R;B!D;W5B0&_@            0FP@
M(&1O=6) ;^            !"<F1456YT1B-2;'0               !";&0@
M56YT1B-2;'0               !2<VQT56YT1B-0>&Q ;[?.X         IV
M96-T;W)$871A8F]O; $     4&=0<V5N=6T     4&=0<P    !09U!#
M $QE9G15;G1&(U)L=                %1O<"!5;G1&(U)L=
M     %-C;"!5;G1&(U!R8T!9            $&-R;W!7:&5N4')I;G1I;F=B
M;V]L      YC<F]P4F5C=$)O='1O;6QO;F<         #&-R;W!296-T3&5F
M=&QO;F<         #6-R;W!296-T4FEG:'1L;VYG          MC<F]P4F5C
M=%1O<&QO;F<      #A"24T#[0      $ .__C4  @ ! [_^-0 "  $X0DE-
M!"8       X             /X   #A"24T$#0      !    '@X0DE-!!D
M      0    >.$))30/S       )           ! #A"24TG$       "@ !
M          $X0DE- _4      $@ +V9F  $ ;&9F  8       $ +V9F  $
MH9F:  8       $ ,@    $ 6@    8       $ -0    $ +0    8
M  $X0DE- _@      '   /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H     /____________________________\#Z   .$))300(
M   0     0   D    )      #A"24T$'@      !      X0DE-!!H
M S4    &              -P   &0          !
M      $             !D    -P                      $
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M     0      "6AO<GI!;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N
M!V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX
M   '9&5F875L=     MB9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO
M<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG          IL969T3W5T
M<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/
M=71S971L;VYG       X0DE-!"@       P    "/_         X0DE-!!$
M      $! #A"24T$%       !     0X0DE-! P     $88    !    H
M %@   '@  "E    $6H &  !_]C_[0 ,061O8F5?0TT  O_N  Y!9&]B90!D
M@     '_VP"$  P(" @)" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,
M$0P,# P,# P,# P,# P,# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4
M% X.#@X4$0P,# P,$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,
M# P,#/_  !$( %@ H ,!(@ "$0$#$0'_W0 $  K_Q $_   !!0$! 0$! 0
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M:-7/## F>WTOS5H;W!VI) /$JB,'+$']H7N/NW[RZ'$G<(;7;0
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MV"=">(*SM+CA\1DF*#1%4EDU1$9C@X:BHZ2FPL/'_\0 ' $!  (# 0$!
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MK*WR% OC<"9[<BKW6)PA4I691YM&&6I:/PXWDL5MQQ;'K&_6>7SH\U3*RXW
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M+;(G4$./QSCF9)=X  5%&<H@*KGKN/)W$C'L&!BD4.QG)RY)![QCEB?$ =%
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M!_C+X]-_S>Q_DVP_9Z>CM\XO?Y0N_P!93Z-0/UZ[O_*-[ _QE\>F_P";V/\
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M<GC^YCGC'4]0?.GS?&_5>Y?]/;Q_M'RWXDMOGVO?_<6L_MM1]+_S6R_%+/\
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M, B5>PP@8+GERA\,=DAI:VG4*S@Y\?'GGQ]M%(.<>!Q_3@CPQD?H Q7TW0\
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M'PSSTXZ\^%8R//PS]&<9]V>#Y5)'5_\ HJ;L_8IIG_US:W-7M#_<FD?Z5_\
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MD9(R"!@'&5!)!!P1=!)-;S)- [Q3Q,LD3H2K(ZY(8$<AEY(^G(Z$8=#ZNHD
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M>IIDLAR;B.:/;Z.DAY-M(&,I8F,+@&MMZ%^EV#_;Z[+_ /M$;/YP[S^UV/\
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MJU?6&Y"P@<<J.C#X8'V;UJ4BQDI))ES@V6U.J;2R_(H05E.4YRA:<);RAO\
M0<W--[']G=&-N=-TN"T:STZZTFV,;2$PZ??79OKJV7<[#9-=$RG.2IX0JHQ5
M5SJNH78<7-U)-WD\5R^_!+3P1""*4G R\<0" ]2HYS5G+U=1#1HT-Z ;;'B8
ME$"$@,Z4CU8@V\^9$,6Z"<.](Q>,^;/L$@X4-G*W,J;SEQ?FYMU\'78^\@L;
M>72%2+3K-=.MA;75Y:-\7([2"PGDMKB*2ZLR[NQM[EY8R6;U<$ULQ]H=7C>=
MUNV+7$[74G>)'*/26 #7""5'$<Q  [R/:V .>*SH8<<,48(-AD40-AD848=M
M+3 X[#:6F6&6D8PAMIIM*4-MH2E"$)PE.,)QC&/7VUM;V=O!:VL,<%M;11P0
M0Q*$CAAB01QQQJ  J(BJH4< *.*Y$DCRN\DC%WD=Y'9CEF=V+,Q)YR223SSU
M.3S7UY?4*QB[_P Y-P_8Q/?XI-YYWM=_>MVA_B?4/YM)6_I7W2L/]KM_^*M;
MBH_2X_;_ '<\_3*]![A^:O 5RYFE.*4XI3BE>;_I.J,T5HJ WN/7T660ZJWR
M,W5-0'L:#7+7IUD"0J78>E.#+PI)8ECTE9+JI82DJ04=&QV,X\R$\OMVP_=]
M!,"@\,.>4/T-^<\'-47 ^UE_O?KGVJ/E#'4G;G 'C@^%2-$;'OVE-8MV]487
MV"T!!T3%QJ^PJ5*BD[98UZ)"+G8[YP5>Q& 1FQE UEH=0UPKMK;M5IQEK!-'
M*EUORLE#:&<@D*Q;!&/5W=#TZ=!QBI!BBY/K* "#_"P?,'J1[.OOJ/:3Z6GT
M>UUK,;9U=FJ!1VI2,&EA(7:I)^K;,\$4TAX=T.!O(4(=,-/MN-K'*@$2P)B5
MH4&40A259F;:<''=L<=2O(Q[Q_3CQ/A41<PG'KA2>@;@GP_?\M3!U@[9ZS[8
MS>YI/4<\98*7K.Q5JBI-,KT_7<'S9=98MQ\S'BV6+B),B'D ;%$"QAWLF CV
M8Q<C'N/A&L/NP>)HPN[C<"1SGH<=02"<]>>#UJ4<JREPN<(0IR,<D9R,]01T
M(X(KGM3J]4]^2VP!=Q,1\SKZV1U;J4C5EQ@^'YRC5II<ZW#&SQ+[YD&(=<9R
MPG29E7;@;$8,%7F<6$8>-]01A79,;"0P.<@\'RXQ67C5P0_*D8QC'OY_?'G7
MF96=[WWKIOAS3G1Y_8/?OK]642CVU-3!GL68SJXQ&BY(8@=;]F;1+#U^YGEX
M2X'$Z%N%CL5KCUC,!1EA@15N,(V-BR*7EVPL1E3XN>."@X4'S_-UK5#-$P6#
M=/&!RO\ B#/17/!(\5)ST^G8**I/7'N5+S78_JEM>V=7>T=97F#V/.U^$&J^
MP(F4C?T3M'[1]?;BRU#7%@-6589>MD2B3P/ALNHW5D!3)+E8+Q#;*BO&W*@G
M/AC*R*<@^8!QQ@@FICNYCOBD,<HR&XY')]5HVX/&/6P"?.O+;<=TI^N^\NN]
MK^DAUQK,"IU;75XEH/:NBH^T(I':?<VO!H2S:L%W-K*;D$$PEWK579D7=5U&
MT-64>=MTW#+AK*1 9A&N;2*Q@(@9LD@E7QNC4YW%"#G;T#= ,G!STUG8+<*U
MPJA5& R$[)'R-JR*>C="%.>O7&17K70=%=QNPU< V]N?M-M_K)-VX=N?I_7_
M $/$ZL @=15^03@B!K]]G;UKFY3FQ;XQ'+$7='"GXRNA3:CHJ#B&016B7M8R
M1(2BQ)+@\R.7.[!QE=I4 '!(SR<\\==I4FD =I&BSR(XPA"@\C<64DG!]89Z
MYZ\5;-A]+.W.W&:1KO;?:O6NR]4U79^N-I?/.3ZZ U?L2#(ZSN,/<HP"M6JG
M7:+US"'R[\.F%D;7':\CCF820E1&HQ_!BO*66-,LL9#$$8#G9DC&2#U\" >G
MY\M%*^U6D5D!!R4Q)D>1' R,@G ->K6,>'\L_P#;S6&?'S/MK9JO,TIQ2G%*
MIGX9]_A[L^_X>'W^*5YQE>;<OI-HT/\ 1$U7ICUW)FG%I3C([.Y>STJ_#@-J
MSGQ2LN$U'0)=?N_1,L7M/PP^K&;ODP_ZQLCP.$R#[P2<>\51\JX]D<8S_I,<
M]/, #Z#7HWE/BGR^/A[O#Q_!^+_LY35]0KK_ *]:HUGL3:FVJM6L-[(W1+ 2
MVP;E*R,K8)^51$@,1T/!AR$X;(OP=4AV&//%5.$4!7XY]\E\6/;<>4KDF=F"
MJ3ZJC 'A[_?[:@J*K,P'K,<L3R3[,^0\!6I&V/=VNV1X>[_P):)_RO[ 9_=]
M_P"'GK]/^X,/\9WW\WTZO*ZA]V;C_8+/_C7E?+F*A3BE.*5K5V)LDM7I7KJS
M%J!PBR=AJQ6Y7VV'AY92HLREW\U](+LL :Y#FY?CQLMR\0L&68:2\.P<V.44
MT]Z/0(8Y8]7+[\Q:8TB;'9?6%U:*"X!PZ .<H006VG&5%<76)7C;30I7[9J$
M<9W*K\-;W)X!!*$E0-X((!(!Y->;'7+1&U=R]<M(0K&KNOU(J0UKKMR;WD'8
M):2W<T%2]J.6E1,-!#:TB1HFSS.8AROJ.?V(<()$G%//)D,9R KW6N:O8:9J
M^IR-?ZI<SM;-:G3&1%TTM<6/<GO'>X;O(HRXF"K;J6= H(QFO*Z7IMU?V%FB
M6MA!"+KO_3P^Z^V17+EE 5!AY"#'EI"H3UF(R .]L2/K]>I_9;8P$=I7>.FF
M-P[ M6W*G>\3>JNRM%MD%:?"=A*A?@'3GY:1AI"(01J08L6HR3\)B C*_/%!
MD1Y#D+.2>>;2;-OC'3-0&FP0V4UH$O=$N;=H24>> A!&L@(%US*BN7+@$ G%
MPL,4=_<J+.]MC?2O<Q7 -KJ4,BSXVP2J#DAU/=$J'*G &"V-H]4 :LN.^.V!
M^W8JK2=V1)41J"C]C"111<;U],U34SX!,4%84O($KI5M)ON;.\*G#3]F8D69
MAUU8@B6^)J#7]MI>AQZ8TZVVVZ[YM/9P'U47DBRN3%@LR1"'NT?:!&5*#82:
MZUD+&XO=5;4$A:7[08TO-A/H)A0JJI)@*I]8.Z<EAZV&P!GL!L"AZ[Z4VK8?
M6N/D)JDZVUCM6=U='S2K$>U)YH^+8^"P&Y.$.34A5'I:+=;KJV2<AD57$<FO
MN)A_D[PYLUE<W7::&SUDQQW5W>645ZT1C"CO^Y#J1& L<K(=K >L)2=P+YKH
M17-M;Z#+<:8LABMXIVM>]#.3W9<JP#@EHU+!A@%6C48(4@UKMM'<&U]*4**,
MBNRSFV;-M""TV2&%(535 DY1Q+YL6M5*?VA3Y 2/J-)'IY;%E8@ZS&;*1*Q@
M=D>AY J=.CF)H$GOV.F:?J=XZ2Z-\706,E_%WBRW3179MH'D@M)T=Y9GN/4[
MV5[7$C0A@$4D%>)=W][86R-'J@NY;R.V<H4A,D!GD3O9H64".* !A'&D^ KN
MNX#G.-S-KVV?:M>TG9A\U)B5'MQUGD*X[>IS3$CM"+S98V^N2D+;0-)D_( \
M8E46#)U:3DHF)E9$:3/&>2:U&,EJV8+;3HXKJYLHDBDGT#5EG6VAO(K)^YEM
MPCP&]^V;QN*S!&9 50\,W-+7-[(T,%XQ=(=5T\Q-+)#)<IWJRETF$)V@'&4+
M '9NP2!6X?1?.,]5]3^'A_P%PQ[OO7ZU>'YOA^+GD.U?&LW@Z$+:Y'E_8T!'
M_P#:1]&*]#V=&-,MO].ZQ^-3_5SFMN.>9KOTXI3BE2/U>_HJ[MSGW^-3TS[L
M_;[7M?W_ )^:_:'^Y-(_TK[_ /&K:T'^ZM3_ -&Q_P"[<UO!X8^S'XL<\O7I
MJ^3J<*3E&,*QE7ACS)QE/AC/Q\%)SCPSX??_ .SF#S_1QG!K!Z'W5"^D>OFJ
M^O%>EJWJVMJAQ[%8YNXVB8D9&4L=KMUIGS7SI.P6VW3YDE8K)*.N/999+F)$
MIT4!H<$7+0@[+2>CJ6K:AJ\T<U_+WAA@CMH$1$A@MX(EVI%!;Q8BA3^$0BC<
MY+-DG-:5CIMGIL<D=I%L[V5YI9'9I)I97))>65R7<@':NXX50  !6A-"_2;!
M_M]=E_\ VA]G\]?>_P!KL?XLTC_E5G7DK7_"?XQU;_F=S5+EL>MT65H,-/NE
MM%[)M^:16LCC9?95.8K=AM>4G.X<;P&)B(K$HO)2O.G#Z66<IQZWS)G96,]Y
M%=20A2EE ;NX!/K&(2Q0C8,$EM\J^H,;@#FL75Y#:O;1REE:YF,43 94.(VD
M._H NQ6\\D\XQSG+;C;B$.-K0MM:4J0M"L+0I*L>*5)4G.<*2K'O2K&<XSCW
MXS[^:+12 OE'RK%6RI&&R.#QP3D<>WBMI60[0K*=P]3!!W<$^J1\K@$\> S1
M;K3:,N..-H;3X9RM:TI0GQSA.,Y4K.$X\59PG&<Y^.<8^.>%BF)PD<A;R56S
MP W@,],-[L&HM)$!EI(P/-F4#KCQ..O'OJB7F%+<;0ZTIQKRY=0E:5+;\^,Y
M1EQ.,Y4CSXQG*/-C'GQC.4^./'F=DH"DJX4_))! .WJ03QQG!(Z'CKQ021DD
M*RDIG< 02N22<@<C.23YY)Z<UQ;=8?\ -ZA]IS#3BFG/5+0O"'49QA32\H5G
M"7$9SC"D9\%)RK'CC'CCQGW<ZD!HI<D J&5@<<\@$=#GJ..OMJ.^-N5D3"'D
MJP.TD@8R#P<C&.N<>.*Y(=9>3E3;C3J4K6VI2%I7A*VU*2M&<IRKP6A:5)6C
M/O2K"L*QXXSCD5212 P=#MW#<I&0>A&[;ZK?XPZ_34]RL,J0X5B#M((# @,#
MC(W X!4\^8XK7'8G9RHZUE*[!2](VU+6"WV^UTRI5^M4$R6F;(93H!NS34O"
MA9+&5(5Q$/EXD6994H<K 1R6\8]F7SOV?9^YOTEE6YL(H8+:&YGEN+ONHX4N
M7,,:.0CGO@X(:+ (R"6W-BN3<:U!;,D;PW<TDEQ-!%'#;[G=H54O+'N9 8BN
M,$%@=A&,+5G:[AZD^:=FLD@%L*"EZE;ZU0)76LW09Z-VDY=+JV(13:[&4MUA
M1LN5:QC6"H,J.<)BBQ6S"ER#(\>>X-:W9K41<P6Z/9R1W-O-<17T5RAL1!;G
M%Q*\YY58VXD##<IPNTC!J U^R[B6=UN8Y+>6. 6LL#)=&68%DC$*\9D4%EVD
MJ5&<Y(%72N=J]72L;LDZTM6W5)NI(..M.P:[M2MDU>=@ZM+MR:X>R#CLNR84
MY#RKL/)A@DU\^46N3#=B76FY-38JZI^S]\CV:0F"_COY7CM9K*59T>1"J21L
MS"-D9,AF#JJA#NSBI0ZU:.EV\BS6S642O/%=Q&-TC8Y#* QW*Q(5=I8EB !S
M7"C]HZ3=+G7J-(5#;&MYJZ!21U!5M'7\G3(^]L1 F9&2&KIA;KV$S D7AR6=
MKLVW#6'$6P2?B*R,*0IM=Z#=VEM-=+<V5U';L$O/0;Q+E[7<PC F4HIV.Y$8
MECWQ[_5+CEJQ;ZU;7-PMNT%U \X9[875O)$LZ@ Y1\GD+@]VX5L#/D*V36\V
MSGS/.H;2I26DJ<6E&%+6K&$(3E6<8RI>?<E./>K/NQXYSCQX921P>[5V\6V@
MG@#G=@<XR :ZNY4/VQ@HX"[R%!.?5QN/4^&/HJJWVD+:;4ZVAQ[SX:0I:4K<
MRVGS*]6E6?,ORI\<JPG&?*GWY\,<@D3D,P1BJXW'!*#//K, 0HXSD^1!XSB3
M.H9$+JID+*N2 Q*G!"@D$D$$$#D'W5!L=V)UQ)WL?70C\RJR%;*N&J&FW(M:
M OG;1]? ;-G4++R]E.(]-7D15BF^3P(/RX&EM"D*<YV7T.^2S>^81&%;.VOC
ME@76"]G:VB(3 ]?O5964<(,-DGBN<FK6C7(LT$HE:YN+494[.^M8UGD&_P %
M*,@!)7><@@#D3QCX?R_-][[.<,_*'EZHP?<.M=4?^?O\?RUL=U QCZ!X/W8_
MGUW+C/W_  W/L#'CG]WG"UW[JW0\O1_RVL!/Y2?IYKM:'SI=KQ]^_)<2C-;,
M^&/LQ^+'.376K"MAT2$V;2+9KVR+F&:]<Z_*5N9=@)R5K<SB-EPW@C/DR>@B
MP9B(,]0\O#1T>6.0TKPRASWY2J^UN9+.Y@NX1&9;>5)HQ+&DT>^,[AOBD5DD
M4G 9&4@C@U1<V\=U!-;R[A'-&\3F-V1]KC!VNN&4^1!_(2*C*5UI1=0]=++K
MC6U7B:92:CK6QQ-=KD&(D2-C 680[.&VTXRI;SSSJG7S#"%NEG&//%F/$%/.
MO.^2^$J[NM0[*=K[V]GDN;FXT?4Y)II3EV=K=SGP 50 J(H"HH 4  "M_L_;
M06=YI5K:Q)!;PW5NL<: JJJ)5ZY)+,22S,Q+,2222:LF?TJ?_._=Y\GM_P"T
M0XZ=VG_=%>KD^6WOKCRZH4XI5<9SC/\ +W\8'E60<>?T'%<"\YR(3G']:D_?
M\/YGG_L]_P"#G/U4L-+U+!(!LKH#DC/]CL,#\U7VP#7$&>?ML.<_ZY>I^G\O
MMK4RA6VZU*D:X9+D8B3C)W4T]+Q028E\8B')J=<C)"-R\<J0=5*X-')PB10X
M.+A)"<9%RAG&$<_.G9?M1VK[-]FNQ\<]_87]AJ_8?7=0T^V:P>.73+CL]I*7
M]F7NQ/))?>DI(!="01*DA/=*D8P?H.J:;IFH:EJY6&:WEMM<L8)V[]6%Q'J%
MVT,HCB"*EN80I,84Y (5MV,5EMNVI98:+"* 3%*)(TO)WY6'Q5NM_+@Q=89&
M3Y4D)5B/6F6,\S&<Y<5E*,I?QZM?G])VB^$7M!IFGV$]IZ$;B[^#:3M3()H0
MZC5M^EQIA1(N+4&[FWH"#DJ X*BN=IO9^QN+B:.<3[$[1)I8*N@(M7%T3_!;
M[;M@0AL%5R2!ZV:MTY=MIP;NQ4+GJN2F@5>"NRLXJY#:I9F6;E77*_X?+2TB
MC#?(I6&Y).7S'?:F/.G&6%X>YM_VL^$/37[5(^M:+,.RNB:-VED<:%L-_%JR
MRR'2B#>L+>& VTR+=ION) \9D.U7(N@TK09QI3"TO5&J7MWIP!O4*P-;&/;=
M8[G=(["9<Q8$9"/C;R1]K?M2TQ,O*%1!;!D7!V*M0Y4:'59(N*0Q*/P;$BQ,
MW(HF/##GFU2ZU, 1#4C@5& D%I=?>?0//M%\)':&QO[JZTRXCFL-.U;1+">P
MMM"N+C3HQJ!LA=PZGVAGFA6#44>^/<VMBLZQJL(E#NS[,:=H%C/!#'<1-%/=
M6=W<1S/?QQSEH%N&B>VL(UE:2W;N<-)<&+>=W=[5"L_<3?KXDYR7</@E0#&X
MU:WQ!IAWL&/Q94RW$-23DOF1SZLX9QY#B&6P/9WD-.>MSYWL89VQVT[9)<_&
MTE[I3:-'\(D?8XZ2--873V=U<K:+=MJ!N,K<0.Q98TA6-@NZ3(( K&CZ2T9@
M$-UZ4>SS:L+D3@(DZ0M+W*VYB"/&X!RQ<LH'!\#L2OX_R^W/[OQY]Z'D221P
M2?$CRQCCRX!\P.E>';J><\GG(/Y@!GSQXYKCS-8IQ2G%*QB[_P Y-P_8Q/?X
MI-YYWM=_>MVA_B?4/YM)6_I7W2L/]KM_^*M;BH_2X_;_ '<\_3*]![A^:O 5
MRYFE.*4XI3BE6^5BXZ:C)"(E@AI*+E 2XZ2CC64$!'@'#N"F!&#.X4T0*4.Z
MXP0PZA;;K2U(6E259QQT((X(.0?$'S!\#0]#X^P]#[Z\XNC$L9IFP;-]'Y?3
M%OR>@_-:-!&R+CCSM[ZD7*5+QKMQ#[^?$^0U+)+D--V9M*&\L,5ZLF.X>1,M
M$OWS8?;,O&_AQTQ(!SC!Z-\H?3XXK7A)4M QSL *$\ED/GGR.5\>G6L<ZLK
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M3R1YX8\Y.3GGQ/G3*<9\?'Z_S8Q]7X_?_P##CO#G.U<D@DG)Y''GXC QY#C
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M'ZC2G,@$$9!'(ZCVTK8[J!_0(@\?7\]MS9\/O?31L#W\X>N_=6ZYZBW/U6L
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MY$DV9L!\I-29A\F>8<8;)R)A9!)#CCKRLJ]W+N+B6ZGDN)V#S2D%W"JF2 %
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MI'V6S^^+L+_:?C_HM['?--1_EW6OVZL?'VI_?8?Q.S_44^A>D?9;/[XNPO\
M:?C_ *+>QWS34?Y=UK]OI\?:G]]A_$[/]13Z%Z1]EL_OB["_VGX_Z+>QWS34
M?Y=UK]NI\?:G]]A_$[/]13Z%Z1]EL_OB["_VGX_Z+>QWS34?Y=UK]NI\?:G]
M]A_$[/\ 44^A>D?9;/[XNPO]I^8_Z+>QP_P34OIUW6C^>_I\?:G]]A_$[/\
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M3&Y;/:]?2K!*6B*]<*E?Z&#$RZO4MO>$>2AI"@CT.*SW.WO@W)C3<I! !!8
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M5C*OE2:C8LA5?AD(3C*G'IJ=7'10[2?T;KYC;:,94K&,RC4.ZIYLN?8">3]
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M ;+Q9A&6QQVG'G$(S*,%I% QSD $XY. .O&!XD],U5,<1D\\8/ R>"#P/$^
M'B3CQJ"D>DYT1Y<?^"WN1GW?'[BSLO[_ +_]#;Z^6^CR><8Z]98QT.#U;FJS
M=1CJLWA_U,O.1GKMQ^7P-:N=B^V^O>WEUZJ]5*A4-X5B,V[V5H\OL8O<.BMH
MZ>KTQKS2T=/;PDJD!*[%K-? FY6T3NOZ[&*A(YXHPB(7*Y<8]GPM7+$A:(22
MDQG8AV@.KG+>KD!2>@)S[Q54DPF,42!P'D4ON1E!1"&*\@ DG&!XX/!P<>W2
M,>"4X^S&.:E;W[_57+BE.*4XI3BE4\<>_P!^/=\??CW?AXID>?7I5>*4XI3B
ME.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4
MXI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3B
ME.*4XI3BE.*5 7:3^E^VE^QS/^, N3C^6OOJJ?\ M3^X?G%3VGXY_E_XRN5K
MT'N'YJMKX&/.#BOOLL.%.M-..-BLJ90Z2XA"E(8:60XRPAQY6,-H4^\TRE2L
M9==;1A2\9I6J/7/>NR=I5^\G[!UL/6+'6M]W+53M:J,R%8VZW"0;,83'2MEF
MSRXH61+&'/0U8GJX,4.U(N8&A0Y4%K$H_-U52NU@=R!AGCGD$8\\CIGZ:JBD
M9PY9<;9"@ YX&.2?K\NGTU<=$[HV+LK9W8^DWRC1-#'U%;:?#5$,2<1/S<I7
MK13QK&/,V@H/*H<.4/6]DD>(AW3&(L!T84N2,D$E89RZJ%C())922".A#$?T
M5E'9FD5@!M( P<Y!4$5I#"=]-IR^TSZ7&RNM9^<3VTN>AX?1<7IK;C=XE]?T
MO:CU+L=\'W"FXR.O6S*C1V#-D6+VNJC1#(D41"OOQYIHCR;3" F[#8*!@VY,
M9('&W.>3[?;TYK7[\LVWU2>]*["K%BH."01QD=?=G(/2MAIGTB^DJW:-E5*?
MK^R(F7UKKS:>S2AGX:KORUBJNG)F)@[D]#U(&XF7N)+<+FXQ^L#7RK4WYX1I
M.).MKD0O![E7=-@'C!QCKX@D<XP>F.">:N,Z*6!R" 2!CD@'!('L/[YXK(7.
M\-/R:?4VM5[I7M<&X2U.>T]BO5!R\X^1]?06T#K1EYF]+IOS58I=GK\CDM-O
M^4UR$J#7&HI5C(;BLY$1.#N0*1G=N&T#<5Y(\=P(Q]/3FL]\O@&+'.$QAFPH
M;@'PPPY]_E4<:1](96KQJS55QN--MZ2I^G:1DMM7&HUYC.LM36S>@L.Y3Z]8
MWINRHMK>2UV"!).5#0MG8JD3/0\K;CXD I1#0Q') *_PB!GDA>N!S]'/-02=
M616.<G9NP,X,A&W../X0SCH.M=]7I(]8IAS;)C4V_EUL.BWK:F)U-.J. "=7
M:LL2ZQM"^L8<OS9:8:BR:@UR !0HUEG0)(,^FP5F%]I='P(F.!E02P7D_P (
M\@'P!YY\OKJ7?I@$!F!4L,+GU5X)\*R:P=W8&CUB5M9]$V5LJ*3N^YZ6C5:V
MK5.$D<6R&MH]5@:H+7[9M0&>MLW,DOK5'EU< C,D+'RDN=!5D$5;:0B8D@E5
MPH<[C@ $$CG!Y.,#VUDS*!G#?*V].IST'//45A^V?2,T:@YW#5XNA7DG9>N]
M8;MO]:KU@Q389BXEZ1A7I2Q!YB<75V^0,,K*/; +'9:A!0=H@1R9>F25A'(A
MU2DA"2%)8!6(YYXW' SQQD_T'IFL-.JEAABP!..,';U&<]1[<>RLL@^[$:0>
M?7GM?;*M^Q%R#/J-54BIUSYVUR)C]*Z7VK<"YF3E]D)JLL'75;AK83TF%,Q3
MILK/QE4@82?,!>FY3!B8$\KMS@,3@'UBH\,YR.A K F!&2&R<>J%R1ZH8C@^
M1]N#Y^'8@/2"::M<U!#5JO[-FJ=/6G3%,;VD+6(QF@Q]C[ 56JVO5<;).'V$
M2VMNS[%SK\0=D6IE8KDV>R-8ODL5U@Q['=.,@X! <X)&2$)#$>S(X\\CSJ0F
M1L$9Y*#IXN 5S]!_/6]?QY75M:X=N?Z7;9G_ "7%^'_22%^/WO#F5^6OGAOZ
M/_"H2?)^E?\ O"MC$_!/X%?NXYBIUY\^DOAS0.N"=ZP(1!UMZD;&U_VB@&0V
M_.63&ZOFO6;'BV\)QYUM3FI92_1#S./%*\EMJ4G.6TYQ;#R^S[XK)GCJWR>O
M3G'/A5%P,1[QP8F$GMPN=P'CRI/'C6^T)+1T_#1,[#F,2$1-1@$M%2 J\.C'
M1LB*T8"8.XGQPXP4*\T^RO&?!3;B58]V>5$8)!ZC@U<#D CH0#]=7/BLTXI3
MBE:C=R^P=FT#KFIHUO7X:U[GW-M.DZ,TO 64HL*JO; O;YJVIFW%1V%23-3J
M5=B+!;9](&$FF!0BXT1Y@HYA]%D:!RV3@*C.3C/3P]YJF:1D"A0"SN$7/0%O
M$].!U-0>Q6?2):EM6O[*=O?6G:&MS=WJ\'MG5CNI*SI,VI4N>D&P)Z\ZNMHU
MU/?D'Z.A[$LY5KGB8)LL.(6*!)#S2A4/YS$P([MT."5<$L"0,D$#.!@<<]/
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MNHZ]OL5;Y.+U^%KN0G+1<GYN/$E82-9E8*HC)1-NJDRA$)5E-J-%#G$Q=2K
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M.L_LE/BK2/G&H_@8/TT^?^Q?ZWIG^&_]-Q]FO;GYAV4_&=9_9*?%6D?.-1_
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MO)'*K.H167U"<!AXUZ7LUI\.H7-VDEJ+QH=.N)X;<RM$)9T("*75T(W9Q\M
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M@B,4ID8OLD=1*&1,<E"X&3VJ/NJ,M\]&P2AX9AZ=C#)2(Q"VL*RE#H";8(>
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M_P#&5WY\)[0_^L+7?_AOLY_/M>KUUA]Q+7^,-0_X.GUU>1J5/Y?;S!Z'W4K
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MS%/''V\4IXX^W'%*U'A/^"G?V=;%_P O;)S\VZ)TUG_XL[9?_M9K5>[N_P#
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M*4XI3BE.*4XI3BE,_#/A]G%*\S^U<U ]?.X/4?L]89N*J-$NH&R.IFX;3.2
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MSH<L+8L (]IC\,1Q#)K:HP<\-UDA/L3[B!T%0M?A>:^6.STW1K75-:;M#;:
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MKXM[B!Q,M[$QD+K<R2M+WC,65PVTJ$"!: :J2&%B'?N5J.@!(*2KT7#O.1+
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MP63UH(91% CE!WLH4$N  2&V\?I8AFBI)T-<Q8TG/TH2M1  ,<VN2)M<,3+
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MW/G:/]<^@O\ FS8G\+X^-] ^:ZK^%M?T4^*=9^<:;^#N?ZU/N?.T?ZY]!?\
M-FQ/X7Q\;Z!\UU7\+:_HI\4ZS\XTW\'<_P!:GW/G:/\ 7/H+_FS8G\+X^-]
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MLBJ\MJ%9D.Y58A6*J2!D@$CR/0U3:'J]Q%)!)<:<$E4HS+'<EU5@064%@I8
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M!ZKRDG9D3'6MBX%;'W+8R0Q1QQ;1+V.'!P#4<DB)*?C5'JPR.;-@,1/C+^U
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M1+&CFS#65F$# &OM,86MH5]>,-JT8G$<B.1D*P8@=>#X>WRSQGK6_*A>-T!
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M&?+/-89?MD5+6] NVSK-*H8I^NZK9;G:Y )IV2<!@*G$&SDV^T($EXDL@6/
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MUTQYB(>K9TZD%. I]U,)(32(8(]#S9&!W:X"W=SA1R0G7KP2<CW9_H/&:LN
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MJT3-/J\O9H'&,0=BDX"*/G8;&%J<PF)EBA'9".3AQ:W,)$(9QA:UJ_3*SG-
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ME:?'-\WMC#T&.&W&.,%X4K!+2ALMOX5G#J5^.?'.3G.3GSR<_70*H&  !Y
M#ZJ[05/J<;B$Q&UF C\5D!V*K> 8B/%Q7XM]IAE^-A/4#H^2H]YD89IT,#U
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MR$*])$$/&/R+D68$Z"X<\6004\7EC)#A#[SZW%.NK4H"1R"0>F03T\J84Y&
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MM(IBC\CACN?S#&%^M;LBC[V14W!=Q^4>@ !))^@55/+W,3R[2VT#U0,DY(
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M@4.CZ(<U!T6O0,?8@K8[>7;WMBO-:SU[LBR1%>+BI,>#ITW$1=N*R#8),.P
M2I9,: J !1''2!I8(V[@$N6F5B,85002.O4\J>?HZ9R>>4=\RJ@6$@$$G+9
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MSKB9WRWU!#V'14EK_64SV\C^U-+ZLP1<<?9HG24SG86IR=YP>X9$(EZ2M\5
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M0TG8&!(JKR#8)3N<K KH) LK*Y*J%QN7& 2PQR<GU0,$XQQFL23NK]V3$K*
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MJ,);78MI@C(3@UD<C)&TC;3_  $5E4\]=W3G:/ISX\$57)"K2HBY'\-SDGU
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MM[=W1M)=LLL!!VZNWYO>LDJ9N$#M[631E>J5\(%F7'I:N64=%<E*Z>^2J%0
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M'^5=P;/V90K10; 3+"1C<=%5:)#C+"&Q7XJ!"4+$1%<B(="'L)?-<&9CN
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M.,@].,'.35G>*-Y9TVJ1[",C(#>WR YQUJYUGN[U6N&LKON*!W152-=ZS,"
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M1SQWAT7[E"C:RY%JX//1MY.!CG)'3J<GIFJ=A9FRN0UW$XR/X(49)SX#'4\
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MF,$*$=5*HY(99 KH6\<YP>@..<$X)S69#EF= P+Q< HQ5\*1@X'JX.!CJ<9
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M[5<K!(VFUVBR6"4=<-EIR?GY4^2/*<RVC+K_ )&6666VVTR=V<[F.3@#@ #
MZ# J*(L8VH, DL?')8Y).?$FII\B?AX?'Q^O/U_'Z^1J=/(G[/SY_?XI3"4X
MQX8Q[L_A_P"W^7C[_CQ2J90G/QQ]_P".?W_S?#BE5\B?'Q\/?^'/[_%*>1./
M?C'P^_G\/V\4KEQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<
F4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>53
<FILENAME>g60414g93j37.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g60414g93j37.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[22X4&AO=&]S:&]P(#,N,  X0DE-! 0
M    ))R^DW(X0DE-! 0      &D< 5H  QLE1QP!6@ #&R5'' (   (  !P"
M4  (<G(U,# T.3,< @4 0$UI8W)O<V]F="!7;W)D("T@4')O:F5C="!(;V]K
M92 M(%,M,2!296=I<W1R871I;VX@4W1A=&5M96YT(#$Q.#0 .$))300E
M   02M!7QOQ5NH+"G,?Z/(X2LCA"24T$.@      Y0   !     !       +
M<')I;G1/=71P=70    %     %!S=%-B;V]L 0    !);G1E96YU;0    !)
M;G1E     $-L<FT    /<')I;G13:7AT965N0FET8F]O;      +<')I;G1E
M<DYA;65415A4     0      #W!R:6YT4')O;V93971U<$]B:F,    , %
M<@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7     !     $)L
M=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L .$))300[
M  (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,    7     $-P
M=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP      $-R;D-B;V]L
M      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B;V]L      !%
M;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC     0       %)'
M0D,    #     %)D("!D;W5B0&_@            1W)N(&1O=6) ;^
M      !";" @9&]U8D!OX            $)R9%15;G1&(U)L=
M     $)L9"!5;G1&(U)L=                %)S;'15;G1&(U!X;$!P/%8
M        "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0    !09U!S
M %!G4$,     3&5F=%5N=$8C4FQT                5&]P(%5N=$8C4FQT
M                4V-L(%5N=$8C4')C0%D            08W)O<%=H96Y0
M<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O
M<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO;F<
M"V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^-0 "  $#O_XU
M  (  3A"24T$)@      #@             _@   .$))30/R       *  #_
M______\  #A"24T$#0      !    '@X0DE-!!D       0    >.$))30/S
M       )           ! #A"24TG$       "@ !          $X0DE- _4
M     $@ +V9F  $ ;&9F  8       $ +V9F  $ H9F:  8       $ ,@
M  $ 6@    8       $ -0    $ +0    8       $X0DE- _@      '
M /____________________________\#Z     #_____________________
M________ ^@     _____________________________P/H     /______
M______________________\#Z   .$))300(       0     0   D    )
M     #A"24T$'@      !      X0DE-!!H      S4    &
M  8_   &9@         !                          $
M!F8   8_                      $                         $
M  $       !N=6QL     @    9B;W5N9'-/8FIC     0       %)C=#$
M   $     %1O<"!L;VYG          !,969T;&]N9P          0G1O;6QO
M;F<   8_     %)G:'1L;VYG   &9@    9S;&EC97-6;$QS     4]B:F,
M   !       %<VQI8V4    2    !W-L:6-E241L;VYG          =G<F]U
M<$E$;&]N9P         &;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -
M875T;T=E;F5R871E9     !4>7!E96YU;0    I%4VQI8V54>7!E     $EM
M9R     &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&]N
M9P          3&5F=&QO;F<          $)T;VUL;VYG   &/P    !29VAT
M;&]N9P  !F8    #=7)L5$585     $       !N=6QL5$585     $
M  !-<V=E5$585     $       9A;'1486=415A4     0      #F-E;&Q4
M97AT27-(5$U,8F]O; $    (8V5L;%1E>'1415A4     0      "6AO<GI!
M;&EG;F5N=6T    /15-L:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R
M=$%L:6=N96YU;0    ]%4VQI8V5697)T06QI9VX    '9&5F875L=     MB
M9T-O;&]R5'EP965N=6T    115-L:6-E0D=#;VQO<E1Y<&4     3F]N90
M  ET;W!/=71S971L;VYG          IL969T3W5T<V5T;&]N9P         ,
M8F]T=&]M3W5T<V5T;&]N9P         +<FEG:'1/=71S971L;VYG       X
M0DE-!"@       P    "/_         X0DE-!!$       $! #A"24T$%
M    !     0X0DE-! P     &?T    !    H    )P   '@  $D@   &>$
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M\:"4*[J%%-K*B'N-D;7,:7-U.SZ34E.5U(YE.596_J IJ>'6TMAY<TPXG?Z
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MZ38^OW?SO\A:QPL"=CZJW&QSG[7@.DNUL=#Y3,Z9@5O:^NAC7,^B0-=)_O\
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M?I?F*G=5@46T'*$
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                      #_X4$>:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O
M,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(>G)E
M4WI.5&-Z:V,Y9"(_/@H\>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE
M=&$O(B!X.GAM<'1K/2)!9&]B92!835 @0V]R92 U+C,M8S Q,2 V-BXQ-#4V
M-C$L(#(P,3(O,#(O,#8M,30Z-38Z,C<@(" @(" @("(^"B @(#QR9&8Z4D1&
M('AM;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M
M<WEN=&%X+6YS(R(^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T
M/2(B"B @(" @(" @(" @('AM;&YS.GAM<#TB:'1T<#HO+VYS+F%D;V)E+F-O
M;2]X87 O,2XP+R(^"B @(" @(" @(#QX;7 Z36]D:69Y1&%T93XR,#(P+3$Q
M+3 W5#$X.C0W.C R*S U.C,P/"]X;7 Z36]D:69Y1&%T93X*(" @(" @(" @
M/'AM<#I#<F5A=&5$871E/C(P,C M,3$M,#=4,3<Z-3DZ-#$K,#4Z,S \+WAM
M<#I#<F5A=&5$871E/@H@(" @(" @(" \>&UP.DUE=&%D871A1&%T93XR,#(P
M+3$Q+3 W5#$X.C0W.C R*S U.C,P/"]X;7 Z365T861A=&%$871E/@H@(" @
M(" @(" \>&UP.D-R96%T;W)4;V]L/D%D;V)E(%!H;W1O<VAO<"!#4S8@*%=I
M;F1O=W,I/"]X;7 Z0W)E871O<E1O;VP^"B @(" @(#PO<F1F.D1E<V-R:7!T
M:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB(@H@(" @
M(" @(" @("!X;6QN<SID8STB:'1T<#HO+W!U<FPN;W)G+V1C+V5L96UE;G1S
M+S$N,2\B/@H@(" @(" @(" \9&,Z9F]R;6%T/FEM86=E+V5P<V8\+V1C.F9O
M<FUA=#X*(" @(" @(" @/&1C.G1I=&QE/@H@(" @(" @(" @(" \<F1F.D%L
M=#X*(" @(" @(" @(" @(" @/')D9CIL:2!X;6PZ;&%N9STB>"UD969A=6QT
M(CY-:6-R;W-O9G0@5V]R9" M(%!R;VIE8W0@2&]O:V4@+2!3+3$@4F5G:7-T
M<F%T:6]N(%-T871E;65N=" Q,3@T-3DV.# @,C$\+W)D9CIL:3X*(" @(" @
M(" @(" @/"]R9&8Z06QT/@H@(" @(" @(" \+V1C.G1I=&QE/@H@(" @(" @
M(" \9&,Z8W)E871O<CX*(" @(" @(" @(" @/')D9CI397$^"B @(" @(" @
M(" @(" @(#QR9&8Z;&D^<G(U,# T.3,\+W)D9CIL:3X*(" @(" @(" @(" @
M/"]R9&8Z4V5Q/@H@(" @(" @(" \+V1C.F-R96%T;W(^"B @(" @(#PO<F1F
M.D1E<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U
M=#TB(@H@(" @(" @(" @("!X;6QN<SIX;7!-33TB:'1T<#HO+VYS+F%D;V)E
M+F-O;2]X87 O,2XP+VUM+R(*(" @(" @(" @(" @>&UL;G,Z<W1%=G0](FAT
M=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O=7)C945V96YT
M(R(*(" @(" @(" @(" @>&UL;G,Z<W12968](FAT=' Z+R]N<RYA9&]B92YC
M;VTO>&%P+S$N,"]S5'EP92]297-O=7)C95)E9B,B/@H@(" @(" @(" \>&UP
M34TZ1&]C=6UE;G1)1#YU=6ED.C8Q-C0R968Y+31D,V(M-&4S82UA-&8T+6(P
M,C$V,30X-F0T9CPO>&UP34TZ1&]C=6UE;G1)1#X*(" @(" @(" @/'AM<$U-
M.DEN<W1A;F-E240^>&UP+FEI9#I#03$Q049$048Y,C!%0C$Q0D$X.#DT1C$P
M-3<S0CDY,CPO>&UP34TZ26YS=&%N8V5)1#X*(" @(" @(" @/'AM<$U-.DAI
M<W1O<GD^"B @(" @(" @(" @(#QR9&8Z4V5Q/@H@(" @(" @(" @(" @(" \
M<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @
M(" @(" @/'-T179T.F%C=&EO;CYC;VYV97)T960\+W-T179T.F%C=&EO;CX*
M(" @(" @(" @(" @(" @(" @/'-T179T.G!A<F%M971E<G,^9G)O;2!A<'!L
M:6-A=&EO;B]P9&8@=&\@87!P;&EC871I;VXO=FYD+F%D;V)E+G!H;W1O<VAO
M<#PO<W1%=G0Z<&%R86UE=&5R<SX*(" @(" @(" @(" @(" @/"]R9&8Z;&D^
M"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R
M8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/G-A=F5D/"]S
M=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V=#II;G-T86YC
M94E$/GAM<"YI:60Z139&,D$V.#E&-#(P14(Q,4)!.#@Y-$8Q,#4W,T(Y.3(\
M+W-T179T.FEN<W1A;F-E240^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IW
M:&5N/C(P,C M,3$M,#=4,3@Z,#$Z,3DK,#4Z,S \+W-T179T.G=H96X^"B @
M(" @(" @(" @(" @(" @(#QS=$5V=#IS;V9T=V%R94%G96YT/D%D;V)E(%!H
M;W1O<VAO<"!#4S8@*%=I;F1O=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@
M(" @(" @(" @(" @(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N
M9V5D/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @
M/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @
M(" @(" @(#QS=$5V=#IA8W1I;VX^<V%V960\+W-T179T.F%C=&EO;CX*(" @
M(" @(" @(" @(" @(" @/'-T179T.FEN<W1A;F-E240^>&UP+FEI9#I#.3$Q
M049$048Y,C!%0C$Q0D$X.#DT1C$P-3<S0CDY,CPO<W1%=G0Z:6YS=&%N8V5)
M1#X*(" @(" @(" @(" @(" @(" @/'-T179T.G=H96X^,C R,"TQ,2TP-U0Q
M.#HT-SHP,BLP-3HS,#PO<W1%=G0Z=VAE;CX*(" @(" @(" @(" @(" @(" @
M/'-T179T.G-O9G1W87)E06=E;G0^061O8F4@4&AO=&]S:&]P($-3-B H5VEN
M9&]W<RD\+W-T179T.G-O9G1W87)E06=E;G0^"B @(" @(" @(" @(" @(" @
M(#QS=$5V=#IC:&%N9V5D/B\\+W-T179T.F-H86YG960^"B @(" @(" @(" @
M(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S
M951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C
M=&EO;CYC;VYV97)T960\+W-T179T.F%C=&EO;CX*(" @(" @(" @(" @(" @
M(" @/'-T179T.G!A<F%M971E<G,^9G)O;2!A<'!L:6-A=&EO;B]V;F0N861O
M8F4N<&AO=&]S:&]P('1O(&EM86=E+V5P<V8\+W-T179T.G!A<F%M971E<G,^
M"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F
M.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @
M(" @/'-T179T.F%C=&EO;CYD97)I=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @
M(" @(" @(" @(" @(#QS=$5V=#IP87)A;65T97)S/F-O;G9E<G1E9"!F<F]M
M(&%P<&QI8V%T:6]N+W9N9"YA9&]B92YP:&]T;W-H;W @=&\@:6UA9V4O97!S
M9CPO<W1%=G0Z<&%R86UE=&5R<SX*(" @(" @(" @(" @(" @/"]R9&8Z;&D^
M"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R
M8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/G-A=F5D/"]S
M=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V=#II;G-T86YC
M94E$/GAM<"YI:60Z0T$Q,4%&1$%&.3(P14(Q,4)!.#@Y-$8Q,#4W,T(Y.3(\
M+W-T179T.FEN<W1A;F-E240^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IW
M:&5N/C(P,C M,3$M,#=4,3@Z-#<Z,#(K,#4Z,S \+W-T179T.G=H96X^"B @
M(" @(" @(" @(" @(" @(#QS=$5V=#IS;V9T=V%R94%G96YT/D%D;V)E(%!H
M;W1O<VAO<"!#4S8@*%=I;F1O=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@
M(" @(" @(" @(" @(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N
M9V5D/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @/"]R
M9&8Z4V5Q/@H@(" @(" @(" \+WAM<$U-.DAI<W1O<GD^"B @(" @(" @(#QX
M;7!-33I/<FEG:6YA;$1O8W5M96YT240^=75I9#HV,38T,F5F.2TT9#-B+31E
M,V$M831F-"UB,#(Q-C$T.#9D-&8\+WAM<$U-.D]R:6=I;F%L1&]C=6UE;G1)
M1#X*(" @(" @(" @/'AM<$U-.D1E<FEV961&<F]M(')D9CIP87)S951Y<&4]
M(E)E<V]U<F-E(CX*(" @(" @(" @(" @/'-T4F5F.FEN<W1A;F-E240^>&UP
M+FEI9#I#.3$Q049$048Y,C!%0C$Q0D$X.#DT1C$P-3<S0CDY,CPO<W12968Z
M:6YS=&%N8V5)1#X*(" @(" @(" @(" @/'-T4F5F.F1O8W5M96YT240^=75I
M9#HV,38T,F5F.2TT9#-B+31E,V$M831F-"UB,#(Q-C$T.#9D-&8\+W-T4F5F
M.F1O8W5M96YT240^"B @(" @(" @(" @(#QS=%)E9CIO<FEG:6YA;$1O8W5M
M96YT240^=75I9#HV,38T,F5F.2TT9#-B+31E,V$M831F-"UB,#(Q-C$T.#9D
M-&8\+W-T4F5F.F]R:6=I;F%L1&]C=6UE;G1)1#X*(" @(" @(" @/"]X;7!-
M33I$97)I=F5D1G)O;3X*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(" @
M(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @('AM
M;&YS.G!D9CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]P9&8O,2XS+R(^"B @(" @
M(" @(#QP9&8Z4')O9'5C97(^06-R;V)A="!$:7-T:6QL97(@,3 N,2XQ-B H
M5VEN9&]W<RD\+W!D9CI0<F]D=6-E<CX*(" @(" @/"]R9&8Z1&5S8W)I<'1I
M;VX^"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @
M(" @(" @('AM;&YS.G!H;W1O<VAO<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]P
M:&]T;W-H;W O,2XP+R(^"B @(" @(" @(#QP:&]T;W-H;W Z0V]L;W)-;V1E
M/C0\+W!H;W1O<VAO<#I#;VQO<DUO9&4^"B @(" @(#PO<F1F.D1E<V-R:7!T
M:6]N/@H@(" \+W)D9CI21$8^"CPO>#IX;7!M971A/@H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H\/WAP86-K970@96YD/2)W(C\^_]L 0P !
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$!_]L 0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\
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M:(C4Z:D+:;F>AF;OS%W*1[9[YJ+[S-=ZU1= R*?NC.Q;J+%5!J5003%QV.Z
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MB3Y(+B-\ 38;_>5MB(D"2T7'RJ13D1DF31^B10"E4(B\;I.$R* 43%!0I5
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M,&^@=)M.XS$+2BYSG/!<7M 9E?DR@DYLP'&($]HXK#[AK?;VP?*;[R3U3O\
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M;9(RGN3B7\UKVGJ5K7C8HF'LLJF@!1,0H#E7N::1 (AKVM:+ST6C,;S8NO\
MPM:F#S[7$7?3>XF(U?+1W-CKF9TMU_.:;UO >4'T9);3Y06SB775.(6W&C;8
M]0M-5I[Z7F5=OZP5;TY>4N-7M<6LUD&:#R8,Q18)/E%(-)=)VF@W<)+32DT7
M@,#SSH,&?)RWT<+\+>E*Q:*["ZH:8YMXD&#,M(GHGKM(XZPHI0+A(NN]K1U#
MN-DW;II3RE?!*T4;DY;H]?URW5/V396M?FC(R]J)'0T;?XW73N,B*K!VN#AX
MZ#3B$TJ^T263A!7/J TEI>UK'&C4Z$RP  9,N\%PF02=-UXRZ65[6%SV\_3+
M7$$.)=.:=Y@VN)$SPC(-@:8UT''#G1R!"G,5=X5#RE5MD*+LU5!9:Z4TD3RH
MURP:(TV;.)GU=C%6<G+@^80ZC5C*#)R!Y%%T*YA"@J0^B) ;S(#AN)--VL;Y
MC70\-5<MZ-5^0EW/F+P8);)B8$-+NT3N*QKF PXVGU?Y4)+D^A73<NW=SV.[
MT9ZQ)KCM-YJ9*CP Z%'2PF*,JYUV@S2ED+P2F]N$1?I["&]@5$)$1FGG#Z!I
M^1E!?H1F$YIO:.!\UU%4LRUQ4/3+G9 02Z &Y P3<&+D$=VJ^AK76P:9)K,]
M;,+%'N;W5=?T6R6*KIG4&3B8*S,W;2 DW:8IE3(VE','+)-3%4,8QF"X&(3L
M@(\CKESMQ<;VXSQ*[&'HM&_*)L1N'%;9RJNF$3")A$'Q 0]^$53?,-#8#CF9
MK<NJ@6+LHWD_.=J&OED1(0Z=X6FN/P57NEE>B";KTT#,S85C%3!0I3'^ 4PA
MT4R!2=)$<]2D;\HF?XVX=O+5#C6;E^IJB>!BP $23N ,VE0)T\/#X-_^2I8Z
M!81\9NIHM>V&_BQD5-Q]O:6<O&J\#/,^0"CQNW67VN6\!.N&Q;LHK;C&+;G4
M>(Q2SM131XJ9<1FZ39;E <",H<Z(TM W\($7(R::)?ALEJDG-9P,\V29DD B
M+"\ #0+?FDM]T7C;Q3;<3MJ<C(CA3R+TQ8[?%2LW?*;&3*MUB3[&L=B;7[74
M5<&A8'9\-LR&E$9 ']96EY1A,/GT>Y:H2S7N3T=3=4J%[&\XUS03D<V&D-@@
MVD9=#8W&L"5HQX8SFW/<QX<XRYI+B"XD$6Z0-HBT0 (4_P#R?5YVIL7C1 6W
M;ZLB]LDE=MKI04S*ZX)J5_:->,]F6ICK6WN=?EBH4]>-;*0C!V$$%XUJY7+)
M Z7*=185#YU@QKX8(&5I(S9H<1TA/49'<M:#GOIR^YSO ,9<S0XAKHZVQ^S0
M4:$D./LEK'FC2-@^4%VSIRYS')'F0@7C94;35'<58DGVV+H>*AC:R;T60V%:
M6>PR&2:RT!$V9NXL;22<,&2K))T'8ZKDTRVDU[0UDU2",IWC-(;T3H3Z%R#)
M%0&L]CG/><@$AP)^@6F0; VD\0"L^Y#R%ZLFO=^R.P*877-WF/(O:!4LU%A6
M;J)94^P.-Q[ "0K\9'"<ZT/Z*,(-D(PYS.HHB2;%4YCMNT:K2.B)!_QBH03J
M00=9%[Z&T;N*EX=E>2(<</3%@8D$2 VY%B.R>*WMR"TNXTCM?;58X;TP]#NU
M\\E9OV3*PUTV5835RV#4]D:LCJO8SBS$%IW:3>,M5J;0-E>'<65[*RI>_?.%
M3%$M6N#@WG#(;7:+D6;#MQW2!N,"QLM',R$MI]&<.=!\X%L=Y /@8$DKQZ;;
M\&R<X>![GAVA1TUF>F.1#;8HZ]2.4C) ]&HQH!':94R]MKM 7#><\^1M $O9
MRH2(6$H@BS[-7&H*=8/(RES .D#)#CH+P!H+SIP*AK:1K433$$-?,ET@%HB0
M=28()UXV)"O*H-_IVT:C"WW7]@C[53K&W4=P=@BSG4CY-LDY6:*+-3J$3.8A
M7+=9$W:3*('3,7IX9SD%I((@C<NP$.$@R%F&0I3")A$PB81,(F$3")A$PB#T
MZ>/3I\?7V818#,;.U=649![/["H5>;L9XM9E'<S;*_$H,[/Z,0F"U]\N^D&Z
M3>=]#N6TGZ*7.20]&KHO>X\V4(H,P[@=)%CIQ[.O15S-&]HDD&X\H"X/6!&M
MXCJ7H1FW]-VE"7+"[2UI86T+$NYJ?"*N]6ED(J!:% '\K, SDW!&,0V(< >/
MGO=,T2G#OE2@8.K*X$6()( L022; =9.G6F=AD9FF 20"# WD@;EG2(0SF+2
M4;^C%X5=F15%1$6JL8M'JHE5342.3M-5&:B E4(<@B@=$2F*(D$!R+SU^>?2
MIM&Z([H]BQI]>M:PE2;W62N5'B*&1!LNUMKZPP,?42ME3 BS60GEWB,,""AA
M!)LHFZ[LYA B1A'PR8=)$&38B#)' C7Q42V 9 ;J)@">KK7+6^ZX?U$]X972
MDO*&"*CM2X-;'!.*D#<B_=K.CV!%X>'!$KD>[47%WV"KCV3&!0>F(,Q!FUKS
MU6U[%,M()!!%R=(XDG=K<KP5C9VKKVNYCJ9L.A7)TV0%P[8UBVUZQ.$&PF!,
M5W+:*D'BB2 G,!.\5(5/M& O:ZB 8+7-U:1.D@CTI+3H0>\'WLO7M6R-24B6
MA8V[WW751G9/JG7&%KM5:@9>0[TPMQ)"-9A^T>.^\. H"5B13MF 4A 1#LX#
M7?-!OP!OX:Z^?K4$M$ EHC0$@1V Z:>9>Q:KYJ^B*M'%XN="IJ\R10&"]LL=
M>KRLHDP,D=4K-68>,SO4V)G:!C@@94K87*(F[ K$$P FP!,;A>-Y]J$M&I:)
MC4@3P_8NLB]RZ6F_/%X7:VKY?S K L@K%WJJ2 ,B2<DTB(P'AVDHL#8DA,/F
M,8R[X2%=2+QJS0[;EPDF<6NM+3U2#J!-K;A)[$S,,G,TB!)D:'2>HS;M6SDR
MID(!4BD*0O@!4P "A]H"^&0K  6 @< OWA$PB81,(L0O=*B-A4^TTJ97E6,9
M;J[+UF1?UZ4>P%@9LIEBLQ7=0L]&+-Y*'E&I%A<1TDR73<L7J:+I Y5$BY()
M!!L8,P;CO"@B01<2(D6([Q>RB'0N-E.U-LN V1MKDQL#<-SUEK.UQ.N@W1/Z
MUAT=>Z\?KUUK=K4#2HU2DGG)-TG'UZ'L>R+B:9D4VBI&:TBV-*+BYN7EPL+9
MKD">D+@2!8C6-RR%-K'!Q>3E9 #B--"XS<DFQ)[%)"*W=HF;D8Z&A-O:FEI:
M0<I,8F*BM@4]_(O7CD_<H,X]BSEU7+ERN<X)(MVR1U53&!,A#"(!E2QUR6NX
MDEI\3;SK0.98!S=P !'<!!\%L6)E8*81>*04G%2J#.1?1;]2*>M'Z3678+F0
MDHYX=HJJ1&19."F0?-%Q*Y;+%%)=,AP$H5_CW<5((.A!@D6XC4+PM9RN**S3
M=I,PRJ]?7!*Q(H23%1:$<*LD9(J4TFFL)XU92.<-WY2/@1.9DNBZ !05(H:8
M)BQ,V'7N@>A+"=!&O5V\%C]/V3K'8BD@>@7^B7E2&.#:6-3[57[,:+55$X%;
MR(PK]\+)0YD5 *DY[HQC)' "B)#=!:X:@CM!'I4 M.A!/403_!=V,K5$[(2"
M&2KR=O<Q!I4D,+R.)9'$"B[\U-)%CN\"36B$7Q@;B\!$S)-V;N14!8>SD;IW
M"T[AU3H%-IW29[3&OA:5Y$GU:>S,A&(.X-W88AHP/*QZ2[!>9C&$N9TI&'?M
M2F,]9M),[!Z=B9P1-%X=DZ,@*AFZHD:"3I>^ZVM^K>ECPZ^_VKNBIID,8Y2%
M*8_3MF*4 $W9#H':$/;T#P#K[ \ PI7[PB81,(F$3"+\*)IJ@ *$*< $# !B
M@8 , ]2F !\.I1 ! ?: AU#'8H(!U5?FS>&%/L4Q94KWR3W,PTGLS9T'<++H
M::M=*]0+'='\]#O&52CK-.U5SLV'I]HLT='++:SKE[80<I(KK,6#!%L^48J:
MBI8 4VAP:1G$R!K, Q(O>(N;"\XNI GI/<6EP(:2($?-GRC)C>?!2CE-X\?F
MRKV%FMPZ=079N%F$E%2FP:4DLU=LUC(.6;YBZERJ(.&SA(Z2[9=(JB*R9DU"
M%.00#,!WE .TU .A''@0M"^G<%S+&X+FV(X@G4>9;!C+%4WSIO%0T[7GCU2%
M8V!K&QLI'.71Z[(*'0C9MNS;+G6-"OE45$6,DFF+!R=(Z;=8YB&*"#K!@&"8
MWC4=HX:JT@F)$D3W<>Q>VM+P+699P[B4B6]@E&;QW'Q*SYFC,2+",.W*_=,V
M!U2O7C2..]:E=KH)*(M#.VX+'3%PF!XBTQ8'7<";#O.G7HDB8D21,;R![)6+
M$VCJQU<3:^2V+0'.P&PG,>D)VZNK7! 4T#*J&4K19 TTEV&XG5.)F1>RB)CB
M($$1&<KHG*8C6#$=O"5&9A.7,TN%XD$]1B97?SDK5(8\2YL<G 1)WDJUAX->
M:>QS 7<Y*"9)E%Q2CY5(7$K(B0R;5DT$[QWV3$124[(@$ $Z"=]AXE22+ Q)
M-IWG6W6O+(/ZVWD(6.E'L*A*RSET2NL7[EDD_DGK%DN^>%AFS@Y7#MVSC4G+
MMP#$BBS=DFNX4["!%#@[-$M(TF\<>N/6NV(W03,4Q$B%,0G=D$"@ D(/3X!?
M\DO@'P0Z!X!X>&%*\V$3")A$PB81?@Z9% Z'(4X (& #% W0P#U*8 -X 8!Z
M" ^ @/B AA% #9G"NJ3[J_2-^Y';G8: M%R3VSL?2\]:*2.LEGD5)1MFDF3F
MX6"IN=B5?6;N2A&\K.T>)OT94SI^?( W:1;MRT-H*L -8QO. 0'@.S7TL+3$
MWB^]8NI DDU'Y20XM)!:"#Q(S &UI($6A2NF]R:3K4D[@[+M;5L#,MR-3OXF
M=O53BI5%-XS0?,C/&$A*-W:1'3!TV=M172*59FX072[2"J9S5#7P#E=V@&)W
MQX>9:%S!)+FC0$D@:@$3W$1U%90:YT5.&BK2:UU,E>G%6#.#L1IV'+#2Z\LN
M5&+:Q4N+H&,@K)N!(C'H,W"QWBPE3;%4.(%R(,D09U(@S;>1U=:F6V,B]@;7
MG<#UKOGIXU%%9[(G8I-VB"JSAV],@F@V;)$%5999=<03103(05%%%#%(0A1.
M8P% 1R 3N.O#>=-W@A U(%MYBWBL3I^PM:;&;/5:!>:/>VD2X(VD5J?9X&SH
M1KOJ84V[U6%?/B,W/5,XD27,DK\ W9+\$>DD%NH(FQD1/ >A0"UU@6F-P(,>
MSJ7JEV;J=2W*:Z)L/7I[X F45HI;=7#V_M%3\Y.=2L!(#,]02#S@YC,?]C#O
M3#V0[6(=$P8XP8CM[_.F9I);(G>+:^M9,@^K,I*23%L]A)":@.X;2S-!TQ=2
M<)Z5:D>-4'[=,ZCJ-&19"FZ03<$1\\;"59,JB0@;%P-X!\#'ICS*9$Q:6P.R
M=.R?.N[!),IQ4*F0#B %$X$*!Q*7KT*)@#J(!U'H'7H'4>GMR%*_>$3")A$P
MB81=#9*]'VB$F:_)@Z*QGXF2@WZC!X[C9 C"69K,G@L9)@LW?QSKN5C&0>LG
M"#ILL";A!5-9,APD&"#USI(MQ4$2(XVX&#P*A=0.)M7UCL;4MLV=R2VON*2U
M@RL=<T%7=QS^O$$ZZZE:JZC9Z216K-/J5@V5=D:(RDX]2RW62L\RR@#3;P3$
M67>R&7+W.#H: '1FRC4[NR>';Q*S%,!P+GEQ$EN8B1 B=TP";QH8T4BD=W<?
M)I]'L6^WM.2TFJ]0;131'8%)?OU9%RJ1NV08-TY95PH]<+G3002;D%=58Y$D
MRF.8"C4M<-6N&DR"-TCS:=2MFIGYS#WCP_8ME&L-<3G4:N><A$[*XC%)I"NF
MDV!9U>'0<E:+2R,0*X/U8Q%V<C51^1N9JFY,5$RH*F HUB 71;0F+3P)5I$Q
M(DB8WP-\+J[7:J%08M2QW>RU*E0J*Q$U9ZU3,-7(Q)=<3=VFI*R[EFU(LMT.
M!2&7 ZG0X !O') )L 3U"3I;S*#E%SE%]3 OV\87NQL]5)V$2M$1-U^9K;UB
M9ZWL,=)QTC!NHU(#G.\0E6RRS!=D0"*'.X(X.@4"',)P[)A!?2\SIU]G%3(B
M9$1<VB+[^&OG72T[9&L=B^?JZ_OU$O01"A6LHI3K57[,$8JH)NRVD#PC]Z#-
M10R)^RBY%,QA2-T*(D'H+2-6D3Q!%^]0'-==I:>L$&W<N^@7E9G(YI/UEY"R
M\1+I^DF,O!.&+Z-DTW)2AY^U?L#JMGA'!2DZN4E5 5 I>IS  8,Z&=UCU:>&
MY2 -P%I&GCZUWA"$3*!$R%(4/84A0*4/M 4  /O9"E?K")A$PB81,(F$3")A
M$PB818'M.VGH.LMAWI-OYVI2Z/:K8FTZ"(.CUR#?3!&P@7X0@N9F"0@40,(&
MZ (#T$) S$#22!XF%#C )X GP"H;VW3)0.+_ )) R>O*IOVZ;2Y%U?;URIU]
ME(R'KFT-@[@XY[TV;='%FF92 LT<BBI-V1^\9J.X&41;H1L9&MVZ3=%L*'6P
MG/BB3EBGEAH)@->T=&X  C>+]JXJC3DP\-#R7YB"0T.+F$B21/#2-."D9M.A
MS]:X@<[Y&Q\)=!\6U3\0-Z,F%DU);Z?:I>SIKZYLZSR$E/5S5FOW3*.;&:-'
MP"N]D$7+DB(>:IJ()JYDV#4I 5'5?QK8:YI !G47,1K.L&)E:',*54&DVF13
M?!:0;1QRCTD]4JQ'4 E'BSK$/B^8%2^G3P#K\SR, /=\?C]SJ&4(_&D'ZR#/
MVMZU%J(X\W$]>2?4J3=.:HDMI<8/):R%*^83M;8&I]&W*[H<3]]3BD5 ;3K<
MRUB*L_OT&=*(M2;"TZY=N&S2&FIBGSL,T]:7:*BL4Y62='V<X-J59#FYGR'L
MU;O W6(/$=BYFMYQE ]!S@QWXNI<.!D$Q<;A,@P!I-EU^[E]?Q'$_P J#3F_
M'>Q<8-R+Z^T]>=H:"1LM/L>I7K*7FEX"L[(U(XIR+*LBE>O5R5BKHN:/AGKJ
M6KT<,Q%MW)%%E[ .YR@X/SL#GY:@!#B=7!UQ);-KR+2=%5X:*-=H9D=#,],$
M%HN "R!'2ZU))AHBY;1W=QFL^N^ 43PL;Z;VNSV->-R.)71,189RDM*U/14M
MJN'A-+34]+6!ML!>39-)@MB690<:Q9G>J%=/2M4!@ORMJ!]<U<S2QC3F(:<\
MAW2)N!;?KOLM13SN86T>;@ASGV!(#8CHB2-]SN!TE9OP+T-I/D%H6T[MWQK*
M@[<W1NG9V[";CF=DUF'N4Y"NZ]M:YTV,U8U&Q-)%W6:W0*Y#14#$5AB9BT9I
MH#(IH J^%<]*SG,>&L<YK6M&6"1F!&KHU)F#/ !3293>USGAKGDN#BX-)&[A
M:P&\]1@K&N.^L]<[!XG\HJ3>*C5-NTOC3N7EMJ3CM9=C0$1?)*$UE5$"+Q,9
M7[#9&<H\.WITR9_0V<FT=%45:4>-2,LH+%'NSG$5*;F@M+F,+X)EQ/E&+03P
MW:6(DPUC7TZ@=E>UCJH9(!R@$P 0=UK[[$+=7"'C/HZP^3XT9%$U;08)[N;A
MYK*L;$L5>J4#!V2SL;9K"$&75F9V-CVTG(/%7KD90'3MTLN$HFE(=YYTF54(
MK5'FLXN<79:A@$DB08._?$3J1JKT:;>8;  +Z8ES0)@B1H-TVZ]%OK@1L6S;
M4X?Z(N=T?'EK<O3C5ZRS*HB*T[-T>8E*-(3ZQA\#KSSFN'F%CAT*=5Z<Y0 I
M@ *50!4<!I(/B 3YRKT274V$ZP0>XD7Z[74O<S6J81,(F$7!O IA]G0!_!CL
M146;P?J[)XV>6JW#-&.XEXZ"W/QTJR#CH?U>UYH[2[0$XMD!OA-D9^_6R\W!
MZ*?8!X:88]X"B;)H*?4R6OPS;08<8F"7$Z]8%CP[#"XZG29BB9! <P$02 T3
M:)WSUK>O''5]L;S.II&;\FQQ6UG$,V<!(J;;J^PM>SMQK:K.&3>1UCBH5CHZ
MOR:TLH_2:" -[*R<LU'*CHKQ4[?LJTJ.!#OQ[R3(RD$ R8CRB/3)ZU:DPRPF
MA38,H.=KI(,3IE:;FQ"V9Y-WH% Y+>P/_=V<O!^(/^%B4\?B]WA]CIE:WE-'
M_5L,1&LW[_V[U?#^2^Q^5J?I3ZU#G85"CMJ'\J_JUULFH:N>[%Y5<:JM7Y>^
MNW+:F6:QK:<XZOX765E*Q>Q\D]@=J.HX-?S$=%.RR+V+L+Q!H@[4/YFXUG+\
M7<&ET,>2 +VUZB;F#-@!*R(S?&6Y@TFI3$N-KM8Z)OJ)MNE9?KB.@M;<L.."
M>[N&]<XH[/E&^PM>ZHVEQIN5/F-'[;=N*8ZF9S7>PHV*J-*N3-H2(KR]JHD;
M;:XJW8S$4=1C,@Y37*XJ[I4WY*KGMMF#P0YM[%ID@P3!TWP)%I: VJP/IBFZ
MX:YA&5]OG0)D &,T#==0_M7(FOCO^Y>4(;UC>DD^USR8B]:UJRQ.AMV3&H7'
M!RE-'^F-KR)=OL:.OJLL0O<)R_;X*[4MR3%M(5*"CW2J,@DY;CJVF0WF26":
M9?!>W-G +F@R9F--;D1:5F:@+^>AYBH&M(:<O-SE<ZTVWD\ 2+*VG>$H-"YB
M<*]@U]S^5[M>[.XYW9NT,!VUAKBFMK)O"CS#GNA[M=:GV#6TLE#NS ?S5C>K
M"@@<A)-4JG,T2RH/H@.'&0<MSKONNAYRU*+Q)SDL,&Q!:7 D=677KWJP',UN
MF$3")A$PB81,(H#;%>KWWRA>A]6RANW4]3<?=H<D&\8H/5K);(D;A4]/4^56
M0,4Q%U:C6+!L0[,X@/F;ZRMG90!=-LJEJ!%%SAJYX9/  9NWI:'J\^+I=7:T
M^2UA?'%V8-'A<]JK3XF:^ND]2=KR</Y.[C+R CE^5O+DJ>TMD;$HD!;9PR7(
MW9**K20BIS2MRDD4H90IHEBHM/NR.&35!9!-JDH1NET5B 6#G:C?Q=,Y PP.
M@.+K@6XZ+EI->6OBC3?-2KTG/$P7DC1IDP1NXW)UGIKYDA'>4_NK!"(80"##
MR>ND6B,%%@B6-A4VV[MI(IQ4>5L@U; QCBD!HS[ALW1\W23!)!%,"IEYW3S#
M3-^==X0-;FY NNALC$$:#F6G*-!TG2!VF-PF%[&]73%AY1SB?(2$BG$L&?%?
MF0\?RRJJ:"48R;3.@UG,@HNK^5))LT$SN3*J_E:94A.?X(#DM@4:DB_.4X[L
MTCLW=ZE_R[!FC\74MWB\]4<?2JT#Z@A-"<7J\XW1QLUGNOCO6G5=VNU\H=Q2
MNU;;;X1A#VMG=X+D%.Q5GKI;:XGURN&LO<IVDWZXIOH=Q*JM6:L:H#0FP)J/
M<UCW-J$P:+VG+)%VBY$S<3!M.JY\@8P&HQCJ8@C$,@.!-R\S)WW,Q!B2;+=_
ME!;= ;_WZ32!HW<D[ Z"T+8-HP5ATUI+;^Z0K_*C:# S30<I/AJJE6]*NO\
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M'YV<<,686!-P2]Y#*CFO+8YMX&5Q$=$$$W(TGOC18 !C>DS.P.D56$YKF27
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M/[G[?3"E5];<YCV'7')^M:1:URL/*XZ?ZDBIAV^>VD+*]7V[+6V+;R$7*1T
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M$PB81,(O6=J*I-EU$$A77324.B@"A$>_5*0PIH]ZIU(GWIP G;, E)VNT(=
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MF<:[VI2 7  G,T"SG$"#)+08(X$\".W&J&NAKB0(<?*#9,6 )(,^:]UN_A9
M5YAHBE6FEO-D-Z5L>NU2]5FE;+OD]LR0UVPEJG")*UJ%N=M?S%IE8-9TT5FF
MYY.;D&OG$FX5ADHV*6;QZ%*A.<@@2-X$ \+3KV >B;4@,@+9RFX#KD3UWF3?
M7P7=W/BY4KKL1Y>WMKO4='3E@US;KEKR+D(%.D7BUZDD6<GK^>GBO:X^M3-S
M#.XF!,Z:5BTUZ+G4:]#-YYC)(MEDW(/($6-B!.X$R>WOT0TVN<72;QF&XP('
MA)[5K]MP7URWBUHI6[[0>I0T75X/4[EW-UOSK1,)2;U%;(J47K([:I-DS(0=
MKKU8<(J7Q*[N7T35X"N2R[^ 9GCE[&J228%R2X18D@@Z]1-KP8X*O,M@B2=(
MXB#F$=ZD9JG5D/J:L+UR-E9VQ.9*PV.W6.SV9>/7L-HM5LEG,U/STN:'C86'
M17=O71DV[&'AXJ)C&"#..C8]HR:HH$HYQ=!( @  #<!XK1K0V8WDN,WN=3WK
MI=&E *_=1#X]S;J#VB/YG9]H]_V^OO\ N   ?;+]EOG$J&?.^V[TK=.55UK_
M &+LVBZNAVLU?[ C7(I](IQ35ZNU?NBJOU6SEVFW*2/:NUBF,W:.%.V9,B8
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MFQ8@]?K$8,63,C=JC4DN,G@!W  #S!7#0! TEQO>[B2=>LGNLL:X_ATUXY
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M@9 6][Q7H>K:.N%9@&*,7!UW5-@@X6-; (-HZ)B*@[81K%N4PF$J+1FV002
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MR[;2$JWCE52&,]$56RK%! 4T"E24*J83*&U-$;A!XS4/F-O85&2I))=(M #
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M6D8^V'9$*VSF'"S2.7792CTKERW2*LLD4L6Q?'3$B9BF[2Q4RFZ]"F,8!#)
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M+/\ C(H57C;Q]5*!P*II'51R@HF=)0"FHL"8 .DJ4BB9N@_"(H4IR#U*<I3
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M$3;23J?I F!-ND!$ "=+$J5_'-'2Z6NS_,,4?+512SV92:6G7EX?7%6['DU
MM0WISLU=QL4UM(_*"4B2Z*>FT&Z;%#L)L$F*9:/S9NGK &Z(U$1:+ZC578&
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M?_!2.''NTW>]O56C]T?O'_[67O\ T?\ 42".'B#ZU8AR*#IPVXO"'7M?E/B
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M>:/578N2MP11;T_95OFE2OA$ZS!V6(]'KMTQ5.\2!1 %;&FX"00Z-0V21UZ
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M"9TC4;&E4ME:>DYZ2C;*WAIV$GK$2LI3%/5AI*.5E8N!N4G,PAP0"9:/MZ)
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MJ'ZX\?\ 9_[V[/\ :S6D)<1_1[/G-[5(!-AZ8F^BI6$H=1\"^T?\G^7.D.:
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M6^9DJIA%^%/S!NGMZ?U^,/O=<(OGBWK1Y6F[HV*$BZXX[U=3NP9^P-M?<?\
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M2+SH7!T7-\D#=:ZYW52'974LO2\IQ&4B=00")(BQ(,ZZ%6E(HIHH%*V11;D
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MG8[C75Z=1%&<M;FMIFUUBKW9=DTBV1)>LNXV3MM??09WP&+-QYWK^.<@$<J
MW<'9 XU"Z8#@29&:3>;'R;QZEFTMSEO-Y8F'$3);&FL1,Z\(4Y1Z 'Q 'X.O
MVOL^WV>_KF2W5&0<[]I;#V9R&C8:>M>M:TM6M"0^J:[-:IM5;LE KUKY.*Z3
MV#MR?F+]2VT&I:Y>M3B-VK<:[-(UN%A&, W<QTE,1-X;)](I-RL.I)J$FQ'0
M8'92)FY($VM=<AKN+G@2UH:P@D?2<6EW5 $[^,\+ -(;&V!%0&X:ZZ:7_D(I
MJO?4OK*N3[)WK1G<IJKFH],NWGL_(3<SK*G22M1G+7*T-R\CC(RSD(5CY\RD
M)-&:E#8N EILS,P.(,V))$#4CC'<-T[,<<KOGAKBUI&\#S1P\%L;C],2,ZMN
MN3E:M-TQZYW1(BM7;$YKCN8CQ3U[KA$@/%ZG/V> .+A),CM$6$V] J"Z17 H
M.2JMTSQ&6"#T1<=_&ZM3).:1'2-NX&ZD1E%=05\H=_M?R?J[K/[VFOMYI2N^
M-+'U>?AU\5(U'\+[N_AU\51L(CX_"#X_:)?VP[/[77-8.L&.S^/BIC?TN.GK
MGSPK#-(?[1GD?^J,?WC3<S?=[>[AQZ@!YE!,F??T!5Y!X  =0#H >T0#X@'V
M=D??FI!-P#>_&+G>IB;]*]["=YWR%8]Y/26/!+[UG$TBN%(:C1\J1 Y^P5<\
M<,X[*B90I3"0JID0()P*8Q2F[0%$>@9E5$$=YTB-./ON4$1'7Q$>_JT*[_\
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M5'2YQ1'O55#F.!NT(9H:M0@ O) W$ ^D++F*0,A@!.IDWO-[P;]ZV)R>EKS
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M8TTO?MW:$B=3^43E[9;:@VVA4B/J:A75Y!PKO7916K@EE:OG;0K,2:D45,9
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M$IZ.>""!/2R$S$=$$6U.^=RR8QP=+B(;G#8UZ1!)M'"!O]*G,(=>GB(=!Z^
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M"QP,)0(JER2*L!<H))S"JR<5+;#M]WEIV,B)EH,O7W<4V4D&[QL0&LAT!@N
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MDY0.4Q!]A@$!^/P'WA\8>\,(M 53BGQNH[UQ(U+2&L()^[AI:NKNV5-A07&
MG4A;S<(DHJU4%M$3#<>XE8UOW3.10 J#Q%9(I2!;.^",SH,2,Q@QI(G=NX*H
M8P:-'#3=POHL!MG"+0DS1;!KBITFL:SK%[=TU'9B=*J5;:OM@U"DS*DU&TB?
M?O(YVN,2==95H@\2$)6'C5W32!=QO>D51GG'R"7.):21))@D08DVD6/$6*J:
M;"",H$Y9@ $AID VT$6X+=#S1>G9#84?M=_K2E/=DQ9698^ZN*[&JV%L:.9.
MHV-73D3("MYY&1SY['QKXPF>1S!X[9,ET&KE9(]<S@" X@'428-YN-#>]]ZM
ME;.;*V;7@3;2\3:3':MK^SV9"LF$3")A$PB81,(F$3")A%Z[QHW?M'3%XBDX
M:/&ZS5TW6("B*[=PF9)9%5,WP3IJIG,0Y#=2F*80$! 1#&FB$2"#H;%: K'$
MOC33&DRQJ^B]60S2Q51W1)M%I2H/LR5(D$TTG]/<BJT5,:KO4T42.X !+%.0
M00%=JH**8EMG?])VL^4=>.NO6J!C!\T:1I-N%]RQ&R<+]'2U<:4VMU&O:^J3
MO8>M=@WR&J-7KK4=E.=3V1I<Z;%VQ^[CG3URV:6>,B7;M^FJ68=QK-:$](),
M'JI2R*CP9+B3#@"221FU@S90:3""T-#07-<0  #ETD1?0+;Z6C=0([)/N!/6
M],)M$YN]4OA:]'ELIW PH5H7QI3N17&3-7"A73R@&](F@ "%,Y&, &V1F=ER
MYCEX28\%;(W-FRC-I.^RVME59,(F$3"+UW:WF[5RX[/:[ANLMV>O3M=TF8_9
MZ]!Z=>STZ]!Z=>O0?9EFMS.:T&"YP;/"3$J''*USM<H)CL$KY77'Y)?0;.G#
M?YSY<XH++(B<-XIE[?=J"3M"'S*3=!$"@/3J/3W^_P"[L^!%SJ;*G\HATFM,
M?@WZ0S?],&DQI??N7S)WPBY9_P""OG$?Y5>Q(^I&L=UKE>/_ %3*C]9XX^7-
M/^B?+?X$3_[1#_X:?_O57_"/_P#VK_\ VO\ ^%<#^29D0#K\YXX'IT_X<T_?
M^M/C_ @?_:(?_#?_ /M4CX1I,?@K7_WK_P#A5G_DS?*DD\HC/[:A":74U2&K
MHBIRHN5+Z6Y^F?6A[.- 0!(M0K'F'F7H;MBH*COSCSCL]A$4NTIZ-RWY!GD;
M2P%0[3&/^.U*U++\5^+\V:+*;\T\_5S!PJ 1 @BUK+V3D]RF_#M;$4CA/BW,
M,:\.YWG,V9T1&1D<=2K<,^>KVM,(F$3")A$PB81,(F$3")A$PB81,(F$3")A
M$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F
M$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A%Z,
MI^=LC^D7?[W4R]/Y2G]MOZ05*GR=3[#OT2OY6\E^>LE^GGG[Y4S]Z4_D*7V*
M7ZIJ_-%7?]H^M3DX8\8]7;QD864W1;+[7ZA:-X:JX]5>.UDP@5[-)WO:?IIT
MC*RDM92N8>NU:L1<(H[?K#%3,K-.GK9A%,"E0D'K3U3E1MW:.R65:6R\/A:N
M)H[-QFU*U;&/>*-/"X0TV&G3I4ASE:O6J5 &C,QC&M<Y[I+6N\KLK9^&Q+V.
MQE6LRF_%4<(QM!C7/=4KYB'$U"UC64VM)>9<XDM#6&'%NCMKZEJU4U?I/:U'
MGYZ5A-FMKA6K'$VB-9QTI7=FZQ4K2=U;12\>LNUFZ7)(6^ E:M,"5J_*5Q(P
MLLT(_AU'#OR>SMJ8C%8W:> QE&C3JX'XK6H5*%1SVUL+C0\T.<:YH-.NWF:H
MJL@L/0>QV5\#FKX>FRAA<0Q[CSPJL>QS<IIUJ7-YPTASFU*3F56%KY#LQ<TM
M&63] 7Y&;_1]RV_4EJ?_ $U>,^2_#=_DNP_[7COU.'7O'P>?Y5CO[/2_3*^N
M'/STOJR81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB8
M1,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")
MA$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3"+T93\[9'](N_WNIFE+Y6G_
M %C/T@J5/DZGV'?HE?RMY'\]9+XO[>>>'_TD^?O.G\A2^Q2_5-7YHJ[_ +1]
M:L?X&V&;T]6K_O>4W]5M,:V@=@:QKAHJRZ01Y$DN&T4&]KN%&E&.OG+V);04
MG16<'.RD9?RSD/+Q"\BI'PBZ_I"23+Z/RPH4]IXC";+I;(Q.T,=6P>,KMKT-
MI-V4<-@\U'#8AAQ.1YJC$/J4FOPSF.IN SN'1!7GMC53AZ=;&.Q=/#4:5;#M
MYM^&&,%3$15J47"B[*&FFUKSSP>U[<V1AZ3B-0<SMD5/95AHKZG[S9[9A8&
MDH*,J]=X[,.-=&U=%ED0D$(>I4>&L$W#N"S[^0DY28DTTV\DN\1(I*.Y)51
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MRCGLDQ;NV49%1T6+5I(OV[%)BDQ1?/$FQ'"E'F21F+@"8),\-_=V%:4_)!@
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MUDO(S>UM=61QYJI>&["I3[URHJK,03J(6L*0/SM"6NMY) +N-]/>%7G3O9J
M6W\J798TMY^Y2.USR%@)FH3,SM=:IZ?L-4V#8M86N+FKS&N*ZC;H J3TB5=M
MDRSJP3L?-0#IA8XHZ\/$R01[PR3R+:N6CE,F;A#H$N!;F!C=;=>(F"KA]I<
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MH]/$!\!]F5O(OIIK8^,>;T!3 X!>P0A$RE(F0J9" !2D(4"E*4H !2E*4
M           / ,*5H#CM^<6S/U_]Z_\ 65/Y9WS?LM]'KU[UG3T=_65/TRI
MY5:)A$PB81,(F$3")A%X''045 $O; 2#U)_E!U#X/B(!\+KT\1 /?U#":JBC
MC;3=?\BYRLTNU;*H3^@,H&S1=-X]Q7)V3MVQ=/03>1:)S6OAJ+;6-6<K(M(V
M$"@VWTQ<K46!JAYJO5":&&D3O'G2\E@/1N<I+BV),&#9YCJLN1C6O-WF!(#0
M^<N@(,M%]Q )WW5[@!V2]!$3= 'Q]@C][V9RZ"]]=/-YEUZ*J]GY0Y\^EMB+
M,*75'\!&LMAMM;LC35WAK#9+)3=J06H8)J^DYS7[2B3,5:+)/-WDXKKNS7"7
MUC'G9(6V*/(27<L=^9@Z\)Z@6YM)M&G D]2Y^?L26PT!U]>D'!H$C7-)/5&^
M94LM9;Y66C]IQ^\3T/7-EU%L5CKRSRC"U*#0Y1>>H=-V-7).$E[0S@'J /8&
M\Q[!W&R#8KAO,QLFFV6>LO-72N9;9I;)#FEPD7 #G-$Z_1F>OO.K7'I9@!E=
MEL9!Z+76M_2TN;3O@=SHBT5NX6'D).52>A[+"N=S1Z;>7@9)G+1JZC?1VET5
MR(O6"SALH=%8ITE2D5$4U"&(< , AAP@,']$GQJ//OHC2"7$7!=KV-:/2%(?
M*JZ81,(F$3")A$PB81?D_P"9-]K^O]?C]G4,(JF W(]KFTUH+9?'G:]M9-ML
M\C"7.RQG$2[7=H\J(7)XIHY>#M=:U\^9SK1:N*($7D(]S(N%DTT_3#D70'4-
MT@')+:H'1; YPBY'2!&D]7>3QYB^']*F2"]P)YL'HQT3(O$@W@S/8K3X%Q'R
M,+#2$?'+QC)Y$L7+&/?12\*^CV3EJ@LW8NXAVW:NXERV1,DBXBW+=NX8K)BU
M70251,0O-KUP3OF]P?6N@1  $"+ B+<(*[+S1KW9T?-F_=*"8RB7<I]V<QQ[
M1S')V>R83F^$83 (F'Q'J.))U,I T@1PA>;LE*40*  '0?    ]GV,*5HSC1
M] K6W^8EO])O<L[RC[[E2GY#>Q;URJNF$3")A$PB81,(F$7Y./0HCT\.GW>O
M7W?@\?;A%4Y6^1/(/7U^905HTIMV[56L27):.LCUELSBLY)9WU@W:RG-+RL5
MZW\@H2U-XFMZV3G(0(V7:P#J)(]812T*H#1(8_=U,079FML"&EKP=#8=&(ZY
M]<<K:KPX L>X $$AS""2;$@OD=XG4 ;E:RT5*Z;-G!F_<&7135%%043J(B<A
M3BD<R!UD#'((]DQD5E4A,'5-50O0PX+J7M=@O^27_HAA%XW =&ZX!T#\I5]@
M= _,&^+);JWM"AVA[#Z%IGC3_M<] _K*ZL_@-!9+_+=]IWI*K3^3I_8;^B%N
MS*JZ81,(F$3")A$PB81,(O1E/SMD?TB[_>ZF7I_*4_MM_2"I4^3J?8=^B5_*
MUE!$)62Z>'5^\#KX>']L*#X_8]_NS]ZT;T:0@D&FSL!YID$GAV7*_-3P"3/T
MCZ3U]W:=%:EQ%UM.V#36Z]$[%UUS89$DKEIK:<6MQJTJI<9.,7-3K@:#7OA9
M.U53O*Y;*O;&LS6(\[<_GGFR$_%RR#<'+:3^?\I<70I[4V;M7#8KDU5YO"[1
MP%2GMO: I4WY<10%3XKDP]:*U&O0=3KO!;E,T7M+FM<WSVS*;GX;&86K2VJ,
MS\)B&' 81U9S?Q=8M-5KJM(9:C*@=3,'Z33K,;.8>F([3DI1FL>RY7LBSS">
M<*ARGU*VU5(*&CW$6F0::W;7.W^F6A/.CA,K&.Q\R7-'$ BX.!,EYKDSM%V/
MIXLN_D^ PTQ_P%BW8MMP2/C!.'P_-.-N;$.#AFN (/%M+#MP]2DT#:,N:7?\
M(8889]R1# *U;.TP,SLS8< (-E=M^1G!_P!?O+4>O0/5+4XC[.HAZ8O'A]_I
M[/P>.?,_ANMA=A\?C>-/<:.'/K"]R^#P1BL?.[#TO'G%</S;2A+IN?3Y*_([
MB;V"G1]G>NK;H6@Q^[GU=F:/L/25^8U6[Z]]7IUS&&6E&%<FXZ?2>M"LP25B
M9R&E6-@8';?G^D8:\= @D2'D@0)BX@3<@=LW7TRL,SF %P(,@M:'7D:[[$-)
M!,$6X@S\T!5:[1]+:PJ%2:VQG6ZY2:[$0S:^,',5=2,F<:@FF>UQCMG'+L+
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M:#*;Z>%Q5-E7#C$"JTT*M5U<-YES *E"I4'.&C4SE@#B\BI3>,Y@AMTWY&<
M!OG+4.G4OJEJ?KU^( F;QX^/W.OV^N?./AO_ ,EV'.OQO&^',8?]B]O^#W_*
ML?-C\7I>/.:*Z?=C'@9'\DWP;1T%<[+N&4I4E*S%KK?'#>-ZA)B+%6B,U5GL
MIKZDS<-99HJ"-78A.-F\LI#-8P\!)3$6Y,C%O/S^SG<A+'-R@^22T7WF""=.
MV=PU7TU_,M?=CB\BY:QQB01<ML)CVJ>VHGM?D=9TA]5*G.T2L.ZW$K0%.LT
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MO,A#M((%R*:/TN=%,(UBJNW2\W2$J(G*H(K"3O3 !CB 0XR&1893QW/?Q5F
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M?^C$B2"0+F8C,8F<K8HN.V+V3=3+>(G$>BZO^[/W@AU[SP'M!T#H'0I![ =
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M(4LZO4L:("U7?."S3-T'5!Y3TW%O;**5YNJ_)6#P/@4YQGTAXQZ87)=C1AS
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M>*GW49 /BHRLFR:K%),<3V:^_8OPELR,4236]7-@@53NNA#Z^MB2Q05IJEV
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MP,OPH\M9_P"A8:>'_)/5![U[OM0__P!(<GAPQ.,_3JE4)B(>\/:'QA[PSZV
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M9%3><[^>J<+5(VBNH9TGL[6*;ERO8VM@6EBN7*NDC-W)6QXQH#<C=!$R *J
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MNZ"-1JLC5>&L,#I$DD!S@&#>3H)$DZQYU:U$2#66BXV48NVT@RDF+5^S?LS
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M]QZ5!8#O($98!@1(MX66_P!DS;L&C=DT23;M6J"39LW03*D@W;H)E21112(
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M1HN/,?R_S(5/RC*YQSW.7CG<\;XSYO&%J6'F#3$3S636TY<NNJTO*<-[GK:
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M[3453JV&M1RU<M=,GJ^[L:)48M:R0LZTF(N,7D!AUV,JLRE&&;'-:Z7-+AN
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M]<?H,(E.7@U[2SL=JJ=E@(=->1KC&2AZS+7-M-0=9GY-M**1ZJ!GJ#F]-T/
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MBGO[^_I"%WUMI<0\UXN;*.)NHE!Y.U1B7L].H"<RSOH0W00$Q#"(@/P1$!Q
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MO]XXV+\B'/-)0Y2C67)1 A0.<[E J8B#+J*($,N*O9'SGM=LY"&#SD2" "R
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M?$/')SN^D[Q,>&B+'5N#G&E90Z@4-REVQZ]VC:;05(GA["%-+F$H"/CT[0@
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MSKX?'$-^D1VB?0B\!K[RY;@/>:+U\_$!$>C#9B#<>R'CV1!\W .T?H/8-U$
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MZAU\1[/0?B$!R<O6WQ%NW]DHOV/+"MEZ&5U/O]!/K\-4^JI82)A_E&$K@X]
M^/H4P].OA@MC>T]A1?KY[B@E$/.:9N1B4?8=WJVQE(8?C O=HJF[0>WQ+T^P
M/Q,O6WQ1?L.86F4_\+5O+ "_[*=YK>ZIE1'QZ J)(94"B(=/ HF\1 .F,O\
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MI&+83\Q(W.UV]ZG M9A!K+C784+&C$13B1:,UW(-7#@C1!!1$#$5NOD7_P!
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M'B/AXCD2>/7W\4@<!PTW<%^TTR)$*FD0B:9"@4A$R@0A"E#H4I2E "E*
M     = #IA2OWA$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(
MF$3")A$PB81,(F$3")A$PBT[R(^@!O+]9_9?\#)K/(['_*VR_P"\<%_M-)<.
MT_R;C_['B?U+U_+\)[?N#_%G[HW:[S;POW^I?G)^@[?45Y<A9+\F_,C]S\(9
M9OE#O]!5F^4._P!!7US?D9WZ&_*[]7&L?X/6C/SQ\.'Y0V#_ &3&_K<.OJWP
M=_);5_K,'^CB%]/F?#%](3J'LZ^/NPB].0D6,4T6?R3QI'LFY0,N\?.46;5
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M")A$PB81,(F$3")A$PB81,(F$6G>1'T -Y?K/[+_ (&36>1V/^5ME_WC@O\
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M6,_&0<K?'[1KMQ&(%2GB:N*::; 7UL,S"9"W,.;I4:56K392:W*6M9D$EPR
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MR.(>X /+HPVOF-:C4YW#8BG5P['TJN$PC,%2+.=J,<TT6TZ1+V/:X.<]@<1
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M$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$6G>1'T
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M"X5L $.S%CG9GN&:^5O!M*E4I5VMJ8!FSW&DV*--]9X<,SXJ'GZU=S2=,H>
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M6V;K]))(AE%%5+E74TTR$ 3'.<YY$"E*4H")C&$   $1$ # V;M$F!@,:3I
MPM>9X1S:GX]@?^F87_Q%'_?6%2/*/C7$]]Z3Y!Z2CA;B0%P>[6HC4R/>=GL=
M\"\Z04^WVR=GM=.O;*(> AG0S86W*GR>QMJ/M/1P&*/#?S4>_CD=J[,:8=M'
M @\#BJ'^^NE^?'XEA[>3W'SY9==^'_\ < ?@S3^3G*'_ $%M?_X?B?\ TU'X
M6V5_I+ _^+H?[ZY^?'XE#_X3W'SQ]G]^77GXPX_D[R@F/P'M;_X?BO".;F>P
M%1^%]E?Z2P'_ (NA_P"HN2\P^)QP4$G)K0"@)$[Q42[BUZ8$T^T4@J'$L_T*
M3MF*3M&^#VC%+U 3!@\G.4 C_@/:U^.S\4/323\,;*_TE@=8_P JHZWL.G<V
MW+DO,+B<IVN[Y-: 4,0AU3%3W'KXW933*)U%#=FPCV2)D 3',(=DI0$QA  R
M3R<Y0#_F/:W_ ,/Q7_I(=K[*&NTL#_XJCOW>7KU+D.87$X4Q6#DUQ_%(H@!E
M W%KX2%$0$0 Q@L'9 1 !$ $>O0!'V .1_)SE#,?@/:QW_D_$^NF%'X8V3I^
M$\!/#XW0GAIGG7J7/SX/%'M$+\\OH(#*E[:11W!K\!5)U,';3 9\!4)U*8.T
M3M!\$?'J&1_)W;X!)V)M80)O@,3IK]6H_#6R+_\ "> L8/\ C=" 3N)SV/:N
MU3Y1\;%2]M/D%I(Y!3[WM%VG1S!W0].BG4L[T[ ]0'M_F?$/'Q#,_P !;<DC
M\#;4MK_B&*L.)_$Q GBK?A?95O\ A+ 7L/\ &Z%SP'XQ9,PWCI>3'I';;UD^
M'NP6Z,[[570@B/9Z*B"$J<>['M% #].P(F#H;Q#,G;+VFSR]G8]LF!FPF(;)
M&HO3%PM1M'9YTQV$/6,31(\0^/.LPC[?4Y8R1(NSUZ1.N4IT2,9J-=G6(;H)
M#I%;N5!4(<#%$IB 8I@, @(]0SF=A\0R<]"LS+(.:D]L$:@RT1&^=%NW$4'Q
MDK4GYO)RU&.GLAQGN7?@JF/L4(/7V=#E'^/,5I(XCQ7Z[1?;V@Z#[!ZA\?L^
M_A2G:+_E!]\,(G:+_E!]\,B1Q'BB=HH>TP!]T,E$Z@/@ AU]W4,(N<(F$7'4
M ]H@'W<(N<(N.H#[! ?NX1<X1,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$
MPB81,(M.\B/H ;R_6?V7_ R:SR.Q_P K;+_O'!?[327#M/\ )N/_ +'B?U+U
M_+[ O:#I_P"5X_<+T'[8#T'^(?9G[IW<)S1O@P"/ QKVK\Z$Q?K'O[^;56"Z
M$JE*IW&V<Y!.^/J')^W+;?5UDZKE@DK^6BZEK[.HQ5@CK/9X;6TU7+!(RVPI
M"4DXBLO):<;5]DG3IE--L[DW!.Y]+VWB,3B-N4MD#:_X#PHV>S&BO3&&=B]H
M5G5JE)]*C6QC:M*G3PH:VI6938:KQB:9):T2?,82C2IX&IC/BC<?6.(Y@L=S
MIIX9F0.:^HW#N95<ZN2]C":C6 47B'$F-<<NZ%5ZL_TU<:[K"3T:\W!JCU_L
M6F9*4L$JG2I)&^7:H-7T">W*N+>RJETAJQ&VV"C;,Z?R#9.4<F:R3^$5B7!^
M_DSC:^(;M/"UL8S:=/9^..'H;4ITZ=+XVPX?#UGLJ"A&'?B,,ZH[#U:E!K&.
M+&RQM3G ,=HT:=-V'J,PYPKL3AQ6J84EQ%)PJU:8+ \FHVE493;58VHYS@'&
M^3*5]%?Y&<^AORNZ?3SK'^#]HZ_MY\<^&_\ *&P(T^)XS];AU[_\'?R6U?ZS
M!_HXA7O\QTYEQQXNK.NTYK?)^1E]<14+6WDM/P")Y66V?38UA-$L-61<V"MN
MJHZ=)6IA9(QJ[7KSZ%;S1FCI%BH@I\/99[3FR@3,B=QCSKZ)5!+"  28@&1>
M>(N+3HHX< (NMU&8VYKJOTO9U27HD)J*&L".Y9"3G+_&S23&[-/4@MB$_J?-
MT>J1K".?4J1U\@-;DT+1)39WSZ4EGQT+U22&.+@Z2XG+EOI<Q<'W%E2BT-+P
M&%HAL DF+&0#]$3#=#O*LMS);IA%^3!VBB'OZ?<\0\?N>W':B^;_ )8<.MK<
MBMH\=+GKOC-%6: TOS)W?/7FS-;OK>OGOM'=[VFY^30F8V:5CY$J#"2JHP1!
M=A-.%$WRBJ$<HR<*=W]3Y'<HL!L?9>W</C=NFC4VGLOFL-0?@\95.&Q3&5:%
M%PJTVO8_\74DMIFE#0/H"?0>4&R,7CL=@*F&V0*M/"XISJU9N(PM/XS2?494
M<QS*C@YD.#CG?F&G1!)"^AVGNI5]5X-U.5PE1EEH]$7U9)(L9<D(L'4GH\DE
M&D38/"($*4"JM"$0$H@4A0 O3/F-=M-E:HRE6^,4VN(96R.I\X/I9']-L\'7
MWF%[U1<]])CJE+F*A;TJ6=M3FS]'.SHNCBVRPO:FBM0[MB'$'M77M7N[!PR7
MC@&<BFSEZV9N3$.Y;,9/L%D6*#@Z:8N46CI%)R! (X(JF)B&ZMG[4VCLJL*^
MS\9B,)5#@X.HU"T$M\G.T0UX%Q#@;$\5SXS9^#Q],T\7AJ6(;! SMZ39^@\0
MYAG>T@RJ9MD^0VK%3DY6_<']];4XP[&722!BS8W*6-2CG27;N#MW9HQL6SH,
MG2Y%5W#1.1>1A3=R@C$E;@<H_1\%\*&*KTVX3E1LS!;=P1?FJ.=AZ+,0 6EI
MR-+?B^8" '%@J7<34F%Z?BN1-*D\8C8F-Q&S\0UL-:ZJ]U.;7YT37$W)!<YL
MALMB5TL95/+[:'%).+MG'/E-$HJ.6K>)GG#-C)@T;@Y*V=2$Q-?,KEC+/S.T
MW0E/9)Q5%5@DV.J@VZE=Z/Q'P2;5+G5:.V>3[VM#G&DU]6DYSHZ+:=,8\2V"
M  RBT@R!)AM&TN76SPQC'8/:K"7,E[Z>=H$D.J/K'#.,YMSG$G4#4QZWI?/+
MF;=:2%-G^+3S7:3J3B3#,ZIM5)>QD$S(S%!XZA%H_83J<?/5N](_ "WU%-%R
M5>/<MO-U5&:'D]EX3X*]G5V8RGM\XT4Z=4_%]H8.O%9YGFP\NP+6L8W,1\@3
M$'--SP;1J<M<=2=0?L]V'#W,Z>#JM;D#8S97,Q#G$NL3%0@$%L3=O<:M\BAL
M3>K!H_Y=<EN3,@SD8B)D)&OR*M69OB3+9!P5.-1D):Z;3>J-(5XLN9J,M 11
MEF:A#HI-W)_RFN.^$W ;,Q%3^3G)_8+'L?4IT\73HU&\Y1)(+S3IX; EG.-#
M213J6=O<!=@N1N+QS&/VOM#:(!I NHU'MJ/;4RD ![Z^)!#02 31:[?8F%81
MK/R)O V@P[:$F]=R&U&;=-7\NV,]B3R1W2JQ50?*RM+@*;*++I)=IFDBX>KL
M_-Q[2K95T4CHOJ6-^$WE=BZKJM+&C %Q RX(5!3#!;(*>)JXA@!\HN:T/D@9
MB  /8<+R+V'AV@5*53%PTB<26 DN,S-!E'R1T6@R(W3,[*E_)!^3AF6A62_%
MBD,TTTB)$7AIF[P3X"IE[(',^A[.R=JK"'YM=58ZZAOAJ*&/U$>-GP@\LJ;L
MS=N8@F9(?3P[FF=9!HWM^Q=3^2?)][<IV>P<"VKB&D=A%4+!4O(Y<7*\8QM5
M7?D_I >SV2?,IY&[!ABI%#\RFFE-NK$AW9!ZB4ATSD\?A ;XN@_"'MVJ[-C<
M+L+:1M/Q_8V#JDQ:[F-I/,7(.8$$D@W6)Y([,;_DU?:6#(F#AL=4;PU%05!?
MLW3()7E/Y,R^P@_WOO*.<]*VD4!$C6R[0KVP&Q#]>T'93F:BS/V '_<'4/V@
M\#F-VC&&1RVPM4SC.1W):N8UHX.OA23! \FO4:(L!#18E0>35=D?%^4&V:4;
MJE=M6V\6;3UWFY7Z)PU\H5")@WJWE3;0NU1 4VR5YXQZEM;CNPZ@07DB1]&/
M7JX%'H9PHH45# )S$\0 (=RBY)5CFK<AJ#7:D8?;6.HLG[#:<"]P 0!UJ1L?
M;U(12Y2U7 &0*^!H53K:7.>3%[]EEZ3GBOY4]P0C8OE.J0U2(FH47S7AK0"/
M3G4*4.V=)2WJHB)!*/8,54H )C"8AO@@61MOD0T%W\BZSGDB&.V]C#2$<"&!
MUQJ""#&Z24.S>4IZ(Y040V/*&SJ6;PF(&Z\@+5\UP2\JHZ*EYGY6AVL?O3F4
M#YW.J5X" 8/#LGBY]Z9<HB(@"*A4R)A\(IC"/3.^CRIY#@GG>0-(1Y);M2O5
M)W014:T 1>?*)B3%ERU-A\I3!9RE>3)D&AD !X97/D[H(@#2Z\</P/\ *JMP
M<@^\K4];@IW8$$G'>K3YC '>=OH:3GF)FG9ZEZ"B*@JB/P^QW28F5N5/(<P:
M/(.D3TIYS:56F!)$1S;7EPF20Z(M%R8JS87*4SGY35&W$9*)J3K<AQ9!&X"1
MV1?9X< ^:*B )N?*M;\,H9,H*F;ZJUJW**G0.V9(Z:@+I$$W42@"HF*40*)S
M=.H\@Y5\F@;<@MDF"8S8[%GO(+""8UMK==)V#MDB_*?& [\M!H'<#6)'C[%C
M7]C4Y:]1'^RQ\J ZB(B!8B, .HCU'H4+(!2AU'V   'L  SH_EIR=W<@-A=]
M6K_Z169Y.[8W<J=H ];"?-SX]*[V,\FUR-31[,WY4WF3(+]\83*1;ZMQ"(MA
M O93*BZ0FE2+!T/VE_.CD-VB=E O8$3\]3EEL8F:7(7DZUL:/%:H9[6BE;J\
MZT;R=VD&P_E-M,DZE@#!X&J[NOU]G8H>2REGI5 M?E#O*)SPG4*8A&&_8^O-
MRD*!0 AD&M*==H1$#B=1-1(Q@, >!B]L:?RZ:R/B_)'DA2XE^S*U8D7B<V+;
M/:2[A<74CDL7 BMM[;M2?HXP4QX9'^_>O.MY)FCO!(24YC^4+EVQ>UVV3[E)
M*D;+ <HD.1;S&L,US)F()BF("P (&$!Z_%!Y>XN.CR<Y(,<+M<W8; X$:$37
M<V>UI%A(U4CDI0T=M?;KFG4': @C@3S$P>H@\"%C$MY%'B]/$*2=VCRRFRE3
M.D4DOR"GY$A4E! 5$P*\C%@ B@E 3E   X@': 1#KEF?"+MVFX.I8/8%-P\E
M[-BX-KFQ,92&:CC,^N'<C]F/\NOM%XX/QCW _:!%^O25Z >0C\GTYZ*3=/V=
M8G8$*GY_-;BO"SSNR!X) =H_9I=WVS** 44NA3J*=D"E,!0W_P *?+$6IXK!
M46_1H[.PC6G6Y#J;KQ:QXJHY$[!U?1Q%0[G/Q561V92WT)_8&?)O"(".K;H;
MH/7H;;6P1 0]W7TWUZ>\ $/M^S'^%/EG$?A##CLV?@P?U,:WTU@[E/\ (GD_
M,_%ZW9\:K1^EZ5DS+R'/DT6@J"IH%Z][8%  =[4VT8$^SUZBGYO=FW03=?A=
M>T'0I0* >/7%WPG<LW?\Z,;]G!8)OF%"%8<C-@#_ )+4=]K$UC/;T^I9A%>1
MI\FM$-'3)#C#7W2;LQC*+2ERV7*NTQ,F"0@V=R%S<N6I0*4#%*W53*543*E
MJAC&'G?\(W+-[@[\-UF1$MIT,(QKH,RYHH03N[++5O)'D^T0=GM?P+ZU=Q'9
M^-MQ%M1VSTSCR)_DSW*QUS<;4$S*" B1OLW;[9$O0H%_*T4+Z1)/KTZB!"%[
M1A,8>HF'KJWX2^6C0!^&'&)@G"X,F_\ W"H>1O)XF?B)'4*]:(&Z"\V7N-?(
MN>34:)&2)QIC%2F.)Q,[V!M=XJ B!0Z LYO*B@%#L^! ,! $3" =3"(P?A*Y
M:$S^&J@ZAAL(!X<PI'([D^!'Q(Q_:,1ZJBQB0\AMY-1Z)S(Z)E(T3)"F ,-J
M[6 A##VNBQ"N[B[ %0[0"': Z?P" )! ![6U/X4.6E,0-JM=UOP>$<>^:,&=
M\BZH[D7R?=_R6J/LXFN".PYY'&T=2QE?R#'DY%"'!+6EV;*G]BZ6U;L<R0B(
M"(IHNI%RT\0 2]#MSE*41[!0-V3%W'PK\M9D[0PS]9#]GX,M,]0I-CNCV9GD
M/R?+<HH8AO C%U\WBYY)[YG>O0+Y [R>!>WUI>PU.V0Q0[>RYPH)F$#=E1,$
MDD^ADQ'M$ >TF(@4%$U"!V<L?A9Y9D #%X)H!&F P^@,[VG70CSR LQR$V /
MF8PV('^.5;<#VBVOK75#Y #@&#D7*,?MA  7*NFT+?6:[,@E*0H)"D^K#HZJ
M'P.HIN%%RG$QQ-VNT(#<_"WRR(R_&,!!U(P--I_U2/XWN50\@M@$@EN,D"P^
M-'M^CK.^= !H%[K[R!W 5\B1$(;9; "@';4C[E&(++JAWG:6.J>K*G0$_>"'
M<,Q;-" 0@)MDP(0 HWX6.6;8_P :P9@1!P5./TI-IN>K352>0>P2(C&Q_:=;
MS<9#KOW7WK'9/\CW\"Y! R*+K=L682& KB/OL"+@IA*4.WVG]'>IJ&ZE[0$6
M240 3'_*N@@ =-/X8.5S/*;LJL9DFKA*HF=T4<53$#L$[Y63O@^V(2<E;:-,
M'1K<11(!C4<YAWF9OKU:+")'\CE\-7!CFCMG\BF(^;D12%>U4%V9'L%,0"E,
M36K01;&+V ,W$?$0-V5"=L.SUCX9N4ML^!V,X@V+:&+;T;0V'8Q_B".P+$_!
MYLL>3C=HB9/2=A7',?G'+AFM)&Z (XD1& ._R-OH1-PFM <B=P1::2R*Q&SZ
M(J<HB8Z9#%,<_F[:(4[X_:Z J0Y (D(IE)VA[S.AGPT;8#8J[&V74)%RVIB*
M;> AI-0V%B<TGJ6+O@ZP))(VCBAH,SJ-!S@W6);S8UO8"^LZKI7?Y'3:LP*-
M2YL;0@3HI*)M04II5BH"<3]"E]'7N([M,0,(*E0!+MB8_9%,I@*74_# RJW+
MBN2NSZ\QFG$DAQ&ABKA:G5K)&XK-GP?.I.)I;:K-$ ,C#Y2T"8!+*XS <( O
MON5VY/(E\PZF2*#7'E3=R181PG*DV=I[*C&3)(R9B $>VC-PNFY>T)U.J9FZ
M9" ;J4PF\<R'PE\G*Q?\;Y![,(>!)I_%'O=$#I.J8)CM!KFW+7^1VUZ0:,/R
MAK#+, _&*36WFS65W@WF;#C&Y=8X\F-Y86N ^-4?*:R$T"JA 2+8+[MYNJLD
MGVP(IT=L+25BI\,1.BW6,0_4 474[LG6[>6_P=5RSXUR&92B;TJ6#J!LC?#J
M!/9%NM0>3?*ND#S/* N)W&OB6DCA+@\#SC4Q)7J-.&7E\*J8R\3SBHTV#?LI
M-V\K;Y28*Z3[0@8[@EFU.[*F(%,(]X"IW F A0[(AVBZGE)\$U814Y,XFEOS
M,P=-L7N":6/#C%HM!$]$$PLAL?ERPRS:U-YF\XQ[CX5,-DN-Q#8'SC 77O:/
M^2-HELF=ML*BSYTSE-YK'.=!G.<$CF I!7G8J$[U%P3NSJ*JJE= '> (@<I1
M74\3\#-1QSX3&42ZY+V;5RB9L!2K/( ,6B-8MI2I0^$-@AE9M020(J[.!@&Q
MZ=+74W<9 7C96W\D70#<'$O28-Z8?. 75=#QLGD@Z*F!L5K&TIRZF4A!+M""
MARNTSE.07!4%"B4-'8?X%JQ'-XO$4R)$,_#-(Q,PY^(HN98;@W-'7IGSWPBT
M23S#JH$ !S=E/![F56NGCI.H.Y?B)Y>^7GJCA,ECXN0]IZ).P.#W5DV_;*K(
M-R&3#O=>K-C)JF6.8A%!6\R=*)D[I5%NDJNX/Y._!-6;GH\H*U'-<-^/TVN8
M#&K<3A@XQ>1.;6Q( 4-VQR]I&*FR^<B9+MGN>#WX;%$:B!   ,DQ=>-[Y3OR
MS$$J*<EY/Z)DBHF6(NLQTWO=NW*)5A33$5E[*4!%4I1.GV4SE$JB8F!-0#)9
M+>1'P:ULK6<KJE-SM"=H[-?$Z2WXNW=<D&!O5OY3\L*9)J[%;D $SLW'@R(D
MC+7>=;01-Q$WCMHWRVG-^(4,VO7DS=A'6;M%3.3Q;#9]>2,Y;!T64;A,:_F2
M';=K\V1-PX4;E^#WC@0$P9O^##DQ5OA.6V%B;\\[ .B;M$MQ=(FW]&Y, !6'
M+;;%, 8C8+B28AM/&L)C60ZA4B^DV@&^B]MG^2(7,<HN&P.#&S*P@1OWC9:,
MV$G,%743$G>E.,MKBKM4TR$4(/;0=/% ,<J:B).H''!WP/FI PG*K9E=QCHF
MC:#,0ZCB:\D\#E%O*X[M^$%K;XC8^*IL)@.YPM),$F6U:%. !IJ2-)U610OY
M),XS.%3)SVB-YQ!2D >VQ4HLP0%0Z 9(2GL<6J7X0B5,W=?"\!.5+M"!*5/@
M7VXT32VKLNK N2,4P=49:54WD6ZX6S?A#P! +L#B@"8&6I1<3UW+&Z2?*T!6
MZ8'\D)\"I$AQF&F[ZJ?N6ZR:$QKIFZ%?SCO!,5(T%99@@ CV0[PZIDDC]X3N
M#*]E7L>.J? _RM80*;MFUR9G)BGMR_:SX=@&_4VZ]W53Y>[%=.:GC6@"9YFF
M\'O;6<28CKXQNW/&>7*\F;(J))*[]E(HZH) 49/4.XR)%45,4O=J+LZ&\11[
ML3?EJRIR-B%*8XKB0.T/C*GP7<MZ8)&R&U  3^+QVSR2!O =B6DSN$2= )LN
MUG+3D^[7%U&:>7AL1J=W1INTWG0<5(J \IAP#LIFY8OEMH\AW+0KU,DO=XNN
M'*B<$A JY;$I%&;N@[X@'8K@F]3-VRJ-RF25 GAJO(OE91!<_D_M.!,EF&=4
MT_J\Q(ZQ(ZUWLY1[#J$!NT\+)B ZIEUT\H #ONMV1/*7C//=[Z$Y#:/EO-P(
M+CT;MBA/NX!7M=UWP-9]44N\[!^[[8%[?8/V>HD-T\54V-MFB8J[(VG3.L/P
M.)9,:P'4P3"[6[3V:_R-H8)TZ 8J@3QTSRMRLIJ)D2E.PD63TATR+%.T=MW)
M#)*!VDU"F054 4U"B!B' 1*8! 0$0$,\>]CZ=JC'L,D=)CFW&HN-1O&MC:RZ
MVU*;[M>QP(#@6N:[HG0V)L=QT*[$#E,'4!]GM^Q]WV?MY6=WJ/IT5I!T(/>G
M:#Q^QU#VAX] Z^'C[O'XOLX4KD# (=1\/MB'\0B'[>$7/4!]@]<(F$7Y[0"'
M7Q\!Z#U\/'[O0!^X(X07]_8@& ?B'[7@/[8"(>/V\(N0, @ ^/C]@?Y,(G7[
M _>Z?AZ!A$ 0$.H#U#"+G")A$PB81,(M.\B/H ;R_6?V7_ R:SR.Q_RMLO\
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MA$PB81,(F$3")A$PB81,(OR)"C\0?> ?VA 0_:R(O,GLW>"+D"@7V 'W@#\
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MPB81,(F$3")A$PB81,(F$3")A$PB81,(F$7   >P #K[>@=.N$7.$7   >
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M+0W4?9_?>U_X_'],.#2J#6F\3I+'"?,K<[3^L9]]OM0>6O%@/_"3T+\KVO\
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MQ/3E5U;LBSUAKY]9:Y0[=.UYEW1G /)R(@)"0BFHH$^$N#A^W01%$OPE0/V
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MO"Q5=K\0V(RB8.#CFD3$1C-+J"32/C6"+=FR;)@(@F@V122('YD@8)),FY*
M   " + !=QD*4PB81,(F$3")A$PB81,(F$7 AU 0'V" A]_"+"6^M-=M+3+7
MEK1*>VNL]'A$SEP;UF%1M$U%E*D0L;+3Z;$LM(L"D;H$!F\=K-P*@B4$^B1
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I1,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>54
<FILENAME>g60414g94u59.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g60414g94u59.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[1UP4&AO=&]S:&]P(#,N,  X0DE-! 0
M    '52^=0@X0DE-! 0      " < 5H  QLE1QP"   "   < @4 #%-E8W1I
M;VXT3%]V,CA"24T$)0      $.7EHA%55OB=F]8I@U=4M8TX0DE-!#H
M 0L    0     0      "W!R:6YT3W5T<'5T    !0    !0<W138F]O; $
M    26YT965N=6T     26YT90    !#;')M    #W!R:6YT4VEX=&5E;D)I
M=&)O;VP     "W!R:6YT97).86UE5$585    !0 0P!A &X ;P!N "  5 !3
M #4 ,0 P #  ( !S &4 <@!I &4 <P      #W!R:6YT4')O;V93971U<$]B
M:F,    , %  <@!O &\ 9@ @ %, 90!T '4 <       "G!R;V]F4V5T=7
M   !     $)L=&YE;G5M    #&)U:6QT:6Y0<F]O9@    EP<F]O9D--64L
M.$))300[      (M    $     $      !)P<FEN=$]U='!U=$]P=&EO;G,
M   7     $-P=&YB;V]L      !#;&)R8F]O;       4F=S36)O;VP
M $-R;D-B;V]L      !#;G1#8F]O;       3&)L<V)O;VP      $YG='9B
M;V]L      !%;6Q$8F]O;       26YT<F)O;VP      $)C:V=/8FIC
M 0       %)'0D,    #     %)D("!D;W5B0&_@            1W)N(&1O
M=6) ;^            !";" @9&]U8D!OX            $)R9%15;G1&(U)L
M=                $)L9"!5;G1&(U)L=                %)S;'15;G1&
M(U!X;$!UX           "G9E8W1O<D1A=&%B;V]L 0    !09U!S96YU;0
M  !09U!S     %!G4$,     3&5F=%5N=$8C4FQT                5&]P
M(%5N=$8C4FQT                4V-L(%5N=$8C4')C0%D            0
M8W)O<%=H96Y0<FEN=&EN9V)O;VP     #F-R;W!296-T0F]T=&]M;&]N9P
M       ,8W)O<%)E8W1,969T;&]N9P         -8W)O<%)E8W12:6=H=&QO
M;F<         "V-R;W!296-T5&]P;&]N9P      .$))30/M       0 [_^
M-0 "  $#O_XU  (  3A"24T$)@      #@             _@   .$))300-
M       $    'CA"24T$&0      !    !XX0DE- _,       D
M  $ .$))32<0       *  $          3A"24T#]0      2  O9F8  0!L
M9F8 !@       0 O9F8  0"AF9H !@       0 R     0!:    !@
M 0 U     0 M    !@       3A"24T#^       <   ________________
M_____________P/H     /____________________________\#Z     #_
M____________________________ ^@     ________________________
M_____P/H   X0DE-! @      !     !   "0    D      .$))300>
M   $     #A"24T$&@     #-0    8             !,D   44
M  $                          0             %%   !,D
M             0                         0     0       &YU;&P
M   "    !F)O=6YD<T]B:F,    !        4F-T,0    0     5&]P(&QO
M;F<          $QE9G1L;VYG          !"=&]M;&]N9P  !,D     4F=H
M=&QO;F<   44    !G-L:6-E<U9L3',    !3V)J8P    $       5S;&EC
M90   !(    '<VQI8V5)1&QO;F<         !V=R;W5P241L;VYG
M  9O<FEG:6YE;G5M    #$53;&EC94]R:6=I;@    UA=71O1V5N97)A=&5D
M     %1Y<&5E;G5M    "D53;&EC951Y<&4     26UG(     9B;W5N9'-/
M8FIC     0       %)C=#$    $     %1O<"!L;VYG          !,969T
M;&]N9P          0G1O;6QO;F<   3)     %)G:'1L;VYG   %%     -U
M<FQ415A4     0       &YU;&Q415A4     0       $US9V5415A4
M 0      !F%L=%1A9U1%6%0    !       .8V5L;%1E>'1)<TA434QB;V]L
M 0    AC96QL5&5X=%1%6%0    !       ):&]R>D%L:6=N96YU;0    ]%
M4VQI8V5(;W)Z06QI9VX    '9&5F875L=     EV97)T06QI9VYE;G5M
M#T53;&EC959E<G1!;&EG;@    =D969A=6QT    "V)G0V]L;W)4>7!E96YU
M;0   !%%4VQI8V5"1T-O;&]R5'EP90    !.;VYE    "71O<$]U='-E=&QO
M;F<         "FQE9G1/=71S971L;VYG          QB;W1T;VU/=71S971L
M;VYG          MR:6=H=$]U='-E=&QO;F<      #A"24T$*       #
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M# P,# P,# P,# P,# P,# P,# P,_\  $0@ EP"@ P$B  (1 0,1 ?_=  0
M"O_$ 3\   $% 0$! 0$!          ,  0($!08'" D*"P$  04! 0$! 0$
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MFM!)3Y[_ (U_YSI/PR?_ '57!+O?\:_\
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M=;(B01DC,C>6U-4D)4)18? F,T1BD96QT__$ !T! 0 " P$! 0$
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MP0,,/8KA5!<&%CVEP)!<T &[$B03CC[5)T5*U 1 1 1 1 1 1 1 1 1 1 1
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M3^^TNBI[&J6HJ5J B B B B B B B B B B B B B B B B B B B B B B
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M!M2T/826/<W%I&. G%;)N0W7[I-(;I-%6*VZ5K6BRVBM4;6HNIV<->T6>L\
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M-V,V9067[FQXIK!GATK;38'Q+\B)8>++2<;CC+9..!NDG*534>YEZ&9M):\
MNAP&%]H%Z 8Q;>PSNQ*X?PUE=M[#KLO<MI6DNRZ(\-59?4UELTWQ_NUCQ9&Z
M-D97R6A;!QUK4!KO%'/VT$VHYET5[\T7S;T;(Y;-5XN/;95@UI :+KL0\ 5
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M'.<QL\V61UZ]A")L'1#-LFF9-;"$A(/5"J)Q&"O&[W+[+>)<Y2BDC%CXK#M
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M?P\DONY':>J6<RN:$)$XDNQKO?B/BI*)YLI"8@,1WEM0YRKG1.P/7L*I)X)
MD0RJBHGF&<Z_-GEZ^=(YSE&KSY9^KF7LN(]TLJLHG-2C4JJ\2J1%NG#F2;$C
MGA7+MLCES$N5LH3J)<Q\L9PJNX29G,>%<0[[!'I(\FW;[]68]<C!/*=6SW:]
M?JA>.(YUVZ:WER5R0DJK(F;92ANP6:J1RS(L&H;$1AQB*1<*DEDE4G"4SF1;
MHIK2ZL7EQ&KS/,,HU[<\\]6R-4XI'.<YU>;++U\Z\D(]TCEOD\U*.>Q;R"*F
M%TX?&':CUP@NW=..[Q+?)7$4FBHTCRM<MFJC=TN:3;23HK9RWCR;-OOUZ_5"
M>4^KW:OXRO4+#O\ #9=#-HGC*+0C"*3>&0K?>6KUGA[A>R(%Q7L-33<IWI'+
M]%RV<5\F8YEY-@H_!W^'TSS#.=?FSR]>.>21SG*-7GRS]6&6:]D\<[.JY4+.
MRJ1%Y"/>IH$2A<I,V[,C0KB);95AU%C1\KELJI(*.U74HF=\[Q&24<0K,C1/
M,->W&=>>K5$#:"D<YS&SS99'7KV$+S*P<E,V-F9DCX;R3Q\J0R<3@KQLZ2?I
MHP[G)(LIRQL>=X@NS4:':RQU8MAA_*/43R2,A'D]OGS_ '8Y90\I]6/JU<T<
M\KUDHEZF@U1-9)M<[>(=1JKE5&OX7>NW'=.RGG6$8))N678]V5PU29MVD(;O
M[OOD,[\5EW.9YAG.O#FSRZ<<,\Y0<,2<(DQCSF !/0 .9?T/&O#X5P6?ET\J
M-8MN7)$H/.458]RX7=/DNTACXRZFTUDV<H1;"K))LU0-#,XEV9RZ<IYAKVZ_
M+JU>N4CG.K9J\FO7ZH7]#Q[HZ^52S4HF3,HC(8;$3A\H%:I1Z3(\+@RD2HX\
MEN'"9Y590R^9C$@NJFA+(QF$8U*/)[=N>?DV1JG%/*<^;S99>OG7BA'.T3-L
MJ3LJZP@]E72A5TH4I7B,BX=+-(YSW:(;F*R@TW"32*.T,U?JMV+4TR^EW1GK
MEW,\PU;<(UYZ]<R-@"1SG,[,9U99#5&.&).,^OY(?]T*W]4\[A;$$:(R_P"P
MKG>S/S)D3Q9S$]3_ '+RZ0Q<K%0*S+7.T4/@]?,C@B1$C8,YUY;,\O7SI!VG
M*-6>W+/U<RUR=,,U6+T:G,E;,@\437UE'Y2:'(PPW9X;VNN]KAL8C(CDV'W7
M_P!K[VY=9+U8[EEG[?7O.]IR[W->/NZO7Y^W.M4W<\D]-^*-SCX^CT>WHV+K
M3QW,N4T!$!$!%M%Z%GSH/$;TUM'W:7<:#OH\@MT?BMGZ_9%MVX/E=H7QBKU6
MNNR'S$/NR03]4TY@Z45)1QU\(UWMG+M\=F9M.+XS 90Q*P^&RQ(U)NBA"J$D
M'F9:(E#D8G9</3S#5M\V>O7KV$+JF.<Y'9KUY9C5JV@K^ZL<[4*Y*2=E4,KL
M631(Z24+DS-=HJZ47DFW;1"Q3/I(KA)%Z1V5U'$29-<Q[!@L9XJ[3S#,[=>K
M/(:M>)DG"$<YU;//EKUZM@"]MNW506?JJ/G;LCQT1P@W<%9%1C$B,F;0S%CE
MJS;+G:J+MEI(YI)>0>8>R#PB;M./(Q8,H[=/;F4]NCMSJ G23R)VN@(R.ED8
MN/UM/[!BX[;FP)35]:W"GJJFLJS;K%$75"E7*K7>HX6<[)@Z%2U+99ZA88*A
ML[<ZN4DQ2;PIG[*^S]\D27!I+&AQ9?=(!;+2#W)<Z 07$7=<+SVD_BP# :70
M]Y:U]P $AP:X.$W@!):0T$N(PD8^Z+O9LSM77UXMQ7L9;:E96FFKD;9C#6D%
MKH]JV_:M15M;><$L\KE?K,3L<E,M;"/:^KY*-<KE?RLE1'<S).**?#7*TM#'
M-$0X%XNWBX!@>;A@EQ;>$\68@!P O8XV5Y>UQS!N&]=NR\L!>,A>NF.-B)-T
M'BD#:,/,O4@(HE;0]U_Q-] .4'U338M9WJKTT_:Y5/[]1Z*OL;VR\VN6HJ5J
M B B B B B B B B B BP)RK]R]R1^(3</W>6(9T^^4_\;?T@JZW>JO_  W_
M *)7/-3_ .ZW6OH!3?L[&B']V[_$[VE9,[AO^%OL"Y^,5D@(@(@(@(@(@(@(
M@(@(@(@(@(@(@(@(@(@(M:?3$^;,Y@?%BC]JZX-YWM.7>YOQ\]6K]CS+4]W/
M)/3?BK<O^/1['F76ACN=<IH"("("+:+T+/G0.(_IK:/NTNXT'?1Y!;H_%;/U
M^R+;MP?*W0OC%7JM==E&.'5U4@(@(M>7/#2>P;BUU_M_7NT-IU9QJ.>-,6:G
M5/D'!Z$K<S53U6]0DC-HSUHH%WK*=RCE;6V,WS8EJ[ 24.U<,Y"<C'+>.>HW
MT7M!<QS6F^(#C3-0@@M($!S3!C&)(V$$JBNQQNO:YXN&2&U!3!;#@22YI$XZ
MX!RD+$?1]<CN+=LG;5#U#:W(*Q;>V9.%C'?KF+ WN"]F=ZU@GJBM<U+L^C$D
MN/M^85R-6G9=\UU+<[)*&0)*S$WC+1D11IG7IU  2RF&-$_BQ$!QB7-=^,;)
M@"^ ,@%70JTG.=#JE]Y /"8@EH[ECV_BW0"2;CG'.<L-M(\J]: BB5M#W7_$
MWT Y0?5--BUG>JO33]KE4_OM+HJ>QJEJ*E:@(@(@(@(@(@(@(@(M5W28=(O.
M\ T]/*0NK8G97Z43W@CC$I:'E;\C^I$M5,EE'+2&E^^=^]4:F%,'PAV'=2>+
MVG:F\0H).H;=>SR$E:J/9&EZ^"S4_G1F/P8"8[!Y\O4?X^=<&V?T_MTV9K38
M>N''&FKQ+?8%&MM(7E4=E2SM:,1M<!(0*L@DU/44".5&1'YG*;<ZR)5C)X3,
MJG@V3XR:;KFNB;K@8RF#,*'-+FN:<+S7-)G($1(PQSYE]RK^$,7:L5FNUM/C
M#57:=>@HB#3=GV;+I'=$B8]NP(X.D6G'*D98K?"ADRG/@F39+@QL8Z\P3))V
MDGSE&@@ 1D ,Y.0 U>?4%]WV1I>O@LU/YT9C\&"%,G8/.?<ML'1G=(A.<_8_
M<;V:U?%:TSJUY16K=.+L[NR8F,7!"VJJG7,[AXC+/+'-:3*G@F%\+][/DV4^
MQQ@Y!VS^D#MTK:0"E 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1:T^F)\V9S ^+%
M'[5UP;SO:<N]S7CYZO76I[N>2>F_%6_KZ*ZT,=SKE- 1 1 1;1>A9\Z#Q&]-
M;1]V=W&@[Z/(+='XK9^OV1;=N#Y7:$\8J]5M"[*,<.KJI 1 103Y\0[&4H^F
M7=IHJ=UU;6N0]#M6X'"6H$][R]/H4%"6]YBQP^LCUZW*2A7EM+5:=99YA5)^
M7HU)M=GNT,WC9.OM;#"WT##G@&'.IN:R7W 7$MP+I$<62!(!< #@2#1: "UE
MYMY@J-<_B<(0T XAL.GC0";INM)<((D?O&"P?IEM&T;$XCIRZ:1H^R82R\7K
M;L_3QM:S57E)6D3,)>H?6T5/4VESCFCTQI/.JO3K^XKR$N_8V>YU(UCL4?$'
M>KQ4%P-$@/+2*@8^\'"007$.<+SB)<V8! , F I\<N)!<QK@:1?3NEI+2'!D
MM:;HF&NC(ELD!3K%*O0$42MH>Z_XF^@'*#ZIIL6L[U5Z:?M<JG]]I=%3V-4M
M14K4!$!$!$!$!$!$!$!%6)\(Y_9^)/\ .W3_ &:P!1K'0?:U5?04H"CV^7M[
MO+B!!LQV?P/[\.8H">OGYM2M)>#B_N+ES_5M(_4]J I5F8$0$0$0$0$0$0$0
M$0$0$0$0$0$0$0$0$6M/IB?-F<P/BQ1^U=<&\[VG+O<UX^>KUUJ>[KDEIOQ5
MO6**ZT,=SKE- 1 1 1;1>A9\Z#Q&]-;1]V=W&@[Z/(+='XK9^OV1;=N#Y7:$
M\8J]5M"[*,<.KJI 1 10,Y\H>6:1JRM*M_5O /\ <4,ZV'H6)V1!ZTN>_:$Q
MI.P7[NA566GK32XR4<Q,TPB-G2U1E+1 Q-VJ^N;%5Y&0.TD%V+N^A@YQ[DW"
M&U"TN;3<2WC& 2)$L! ):7!T82**^+6B+POB]3#@USVAKC=$EH,&'%I(#@TB
M8*XKP$91L--\A(2I4Z0TKKEO/Z]D:9QPL>Q*Q>K;K#RE5GB<Y9W\33KOL6M:
MT@MEOV!'=?H4/;7K4B];FK<JSC)"VOFA9KDD4RXWW0X.J!I:'XB "YK2XM!@
MN(G$#4HL\<>&FFV6EM(N#G,PB2 YP8'1@P$C NP+B%L='G7H0$42MH>Z_P")
MOH!R@^J:;%K.]5>FG[7*I_?J(YJOJ#?>I:BI6H"("("("("("("("*L3X1S^
MS\2?YVZ?[-8 H/ER/;#7L57T$UGMV'T@H"GMV\R H'M[#9JC]^: I['MCVUJ
MTEX.+^XN7/\ 5M(_4]J @[:E9F!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!%K3
MZ8GS9G,#XL4?M77!O.]IR[W->/GJ]=:GNZY):;\5;UBBNM#'<ZY30$0$0$6T
M7H6?.@\1O36T?=G=QH.^CR"W1^*V?K]D6W;@^5VA/&*O5;0NRC'#JZJ0$0$6
MKSI*M/ZZO##1,W*ZAX\6/8$]N"'U5"[@WWI]AMB#UJTL=)V6ZK,=)0RTI7L2
M\??=B8KVKJ]$V&<]2T==]DPMB+&.[&PA<9]5F>YI> ^H&AA>64WEI<0YLQ@8
M+6R\D"2&1DO):J;'BG+*9<7A@?58'M9>:Z 1(D.=# "8O.!S@'@O1'V6OS-,
MVJRK*/'K$?A+3=M?8XXZ/JVD*]6K+>==EE+5K'8D+69B=[SN#6TZU>P]M9R4
M@5Y#PSFJY7CXE[)/HQI-K!#FD\(.[ X1Y?(:Z YA('$<,1 @D'$J+&1=>!P1
M +">"IBF 7-Q8\ N_&-(@R9 +<!DMOH\B]B BB5M#W7_ !-] .4'U338M9WJ
MKTT_:Y5/[]1Z*O3DWL?(I:BI6H"("("("("("("("*L3X1S^S\2?YVZ?[-8
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M\JLA,L6*5,=;$D96Z.+"]F(U=]F$<59!+.LP76NO4;P$/%-[?"AL,!SCNKH
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M0$6T7H6?.@<1_36T?=I=AH.^CR"W1^*V?K]D6W;@^5NA?&*O5:Z[*,<.KJI
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M%A(<&N:2(<"?!:M*Z+L-04K;I*P6.JY@J-I6JV6>SU"PES0\,JU&.+"YK@'
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MPG+W>.K/DKTG[TMQCK3>'Y(Z0_S!:O\ 3]&+GC?:Y16/Y(H=;MJKEC[8OER
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M_P!S&W?BPOWV4EA[]%?TIHWQ^Q]8IKRV[^96SQ6T?J7KJ9A_1 9#H"XQ02B
MB BS]Q0]U+QK^/[3GWB5P?C[HOZ TY\CZ3ZE77Z>A?Z9T3\IV#K5)=K4/Y[K
ML5 142_"<O=Y:L^2O2?O2W&.M-X?DCI#_,%J_P!/T8N>-]KE%8_DBAUNVJN6
M/MB^7("("("*^KX-%YO2U?*9V1]B-5CD/?RY9T/D.P]9MZZ0WK.2Y^4K7^A9
MU83'QM?2%K3Z8GS9G,#XL4?M77!O.]IR[W->/GJ]=:GNZY):;\5;UBBNM#'<
MZY30$0$0$6T7H6?.@<1_36T?=I=QH.^CR"W1^*V?K]D6W;@^5NA?&*O5:Z[*
M,<.KJI 1 1 1 1 1<)B=EZXGK?8-?06P*3-7ZIH(.K31XFUP4C;ZTU==EW9S
M8*TS?K34,@X[='L%I%DV35[9+LS&[0G7):X .+2&G(D$ ]!R/D6(<TDM#FEP
MS:""1TC,>58 VA[K_B;Z <H/JFFQ8SO57II^URP?WZCT5?8W]REJ*E:@(@(@
M(@(@(@(@(@(JQ/A'/[/Q)_G;I_LU@"C7Y#]';,>755]!(CW<W;;/K0$,P8..
MV)UXX8R?IV("&=7;MEY4!2K27@XO[BY<_P!6TC]3VH"*S,"+&&[O]S&W?BPO
MWV4EA[]%?TIHWQ^Q]8IKRV[^96SQ6T?J7KJ9A_1!N0Z![%QB@E$!$!%G[BA[
MJ7C7\?VG/O$K@_'W0_T!ISY'TGU*NOT]"_TSHGY3L'6J2[6H?SW78J BHF>$
MY>[QU9_Y>M7I/WI;C'6F\/R1TA_F"U?Z?HQ<\;[7**Q_)%#K=M5<H?;%\N0$
M0$0$5]7P:+S>EJ^4SLC[$:K'(>_ERSH?(=AZS;UTAO6<ES\I6O\ 0LZL)CXV
MOI"UI],3YLSF!\6*/VKK@WG>TY=[FO'SU>NM3W<\D]-^*M_7T5UH8[G7*: B
M B BVB]"SYT'B-Z:VC[M+N-!WT>06Z/Q6S]?LBV[<'RNT+XQ5ZK7791CAU=5
M("("("("("+4KIG76P4-PZ^K#37%PHMSU-M7G=<]B;=G:$Z2I-JKF\[]>)G6
MRL)<#J,8W8IKHXLU"O3^KPDRY<UO]'ZT-;/4Y(1T*DY];W-N.-YKFO;0#6!V
M(--K0Z6CN8APDC&]+9DE>2FUU]HND.8^NYSRWBD5'.+8=/&O2TD F+L.@@+.
M\[QMY2V#8^OMFO.5^OB3NN(B]PT(@CQ@,5BNVV G6DY@[U/.],G441+5V'<\
MD.3!,J+Y/@_C%QBL5*0:YO!/AQ:2>%'P9R_%\ZL-.J7-=PK):' ?BC\*)_K.
M;UK(?Z->8/PJ-8_1<5_/<8WJ/Q3_ $H^S65VM\:ST1^T3]&O,'X5&L?HN*_G
MN%ZC\4_TH^S2[6^-9Z(_:)^C7F#\*C6/T7%?SW"]1^*?Z4?9I=K?&L]$?M$_
M1KS!^%1K'Z+BOY[A>H_%/]*/LTNUOC6>B/VBP[*+<RX_?]'TP7DCJE5C;M/[
M2V<M.FXS.2NV3O7ESU!5FT2FRQO'**S>31V:Z>+N3+D4;*1+=)-)4KI0R6<4
M>#+^#?@]K8X0?":\S/!X'BY1CBL":W"-9PC,6/?/!'X+F-B.$UWCYEF+]&O,
M'X5&L?HN*_GN,+U'XI_I1]FL[M;XUGHC]HGZ->8/PJ-8_1<5_/<+U'XI_I1]
MFEVM\:ST1^T3]&O,'X5&L?HN*_GN%ZC\4_TH^S2[6^-9Z(_:)^C7F#\*C6/T
M7%?SW"]1^*?Z4?9I=K?&L]$?M%"?F)T7NS^<!* 3<_+.,:XUN:R&KWJ*X]LX
M/)\VG$)B3\H]_P!M37><%Q ,>Z]EAMV7C./'[7M"]FO4?BG^E'V:@LK?&L'_
M $O?4*A%[' K7POK3\S<%^/!-ZC\4\_]7W4PERM\<WT7_P"UCS;O@^\#K35&
MS]CM>5UDE7.O]>76[-XMQJ*%;(22]4K<G.HL%G*=X54;I/%&!6ZBY$E#I$4,
MH5,YBX+F6FBYS6\$\7G =]VD#XOMM6+Q68Q[N%:;K7.C@L[HF.[PF%R&G^#N
M5ZSU*KV17EM9FBMAKL).*-4]/0:J;926C&K\[<BAKT4RA$3.,IE.8I3'*7!L
MEQG/5@7402.!=@2.^G48\!2UM8@'AFX@'O4YC;?Q7(O8X%:^%]:?F;@OQX(O
MT?B7>E__  IN5OCF^B__ &IQ<.^C$VEP>:[ ::8Y913I+9+BLN;#FZ\>F<X<
MBE43G4HO$=EAMJ%PV*8MA?\ >L*E<Y5SAODF4NS-A2+U'XI_I1]F@96']:ST
M7NJ!33_1KS!^%1K'Z+BOY[A>H_%/]*/LU-VM\:ST1^T7Q+-I;EE:ZW8*M*<J
M=<%C++"2L!(F:\8#I.BL9E@XCG9FRI]YJD2<8;N5,HJ'24*13Q3&3/C&2YMH
M6AEGKT;13I.X2A5IUF7JDMOTGA[;P%,$MO-$@$2,)&:KJT:E:E4I.JMNU:;Z
M;HI$&Z]I:8)J$ P3!@XZEH4]BQZN^&!?OFGKOXR'U[\.>ZX?^UT/^;5_VE?.
M/P3[GORG27IJ/V">Q8]7?# OWS3UW\9!^'/==^2Z'_-J_P"TI^"?<]^4Z2]-
M1^P6%ZQX-OKFP;XV]IU3E1=FS+6>O]+W1K.$UC!*.I5?:DGMR/=L'#,UM*DV
M2ARZT:JMUTUE3N\RJY54T<-4\JYG?QW7!C7_ '-H?C.>(^Y:^%V[_P#:UWO4
ML!O5;GS4>S[ITEQ6L=/#4<;Y>([QJN#SK-'L6/5WPP+]\T]=_&0P_#GNN_)=
M#_FU?]I6?X)]SWY3I+TU'[!<KH?@RE%UU>*9L&O\OKF>>HMKKMQA"R&H8!RP
M-+UB79S<:5\W3O#=1=GEXQ1PY1370.JCDY"K)F-@Y?/;-^K=5;;):K'6LVB1
M1M=GKV6J66>LUXIUZ3J3[CC:' .NO-TEI ,$@Y*^S;U^@K):;/:J5IT@:EFK
MTK13#ZM(M+Z-1M1@<!1!+;S1> ()$@$9K>W^C7F#\*C6/T7%?SW'R2]1^+?Z
M4?9KZ)=K?&L]$?M$_1KS!^%1K'Z+BOY[A>H_%/\ 2C[-+M;XUGHC]HM77-?H
M097GMM.#V_O'ENZ:VROT6,UZP3HNBXR B,P,5.6*P-3N&<ALR<64D,O[/)85
M<%=IIG;E;)E;D,D=17?MRV^3IO<AH^MHW1-GL+K/6M;[:\VNG4K5.&J4J-%U
MUS*E$!ERA3AMTD&\9Q@:AI_</HW=);*=NTA:+4VM2L[+,T69U.FS@V5*M0$M
M>RJ2Z]5=)O 1 @028?>Q8]7?# OWS3UW\9#9?PY[KOR70_YM7_:5^'^"?<]^
M4Z2]-1^P6(=Z>#7ZXU#KIQ>&7*N[33A"WZOK.(]UK"":(F2V#M"G:^<N\KI6
MY8^%(UM:%9)!+Q/%<+M$VZATTU3*$S9OX[KGNN_<VAQQ7F?N6N>Y8YWY3KB%
M@_>JW/L;>^Z=)'C,$<-1^$]K3_4:IE9>]BQZN^&!?OFGKOXR&'X<]UWY+H?\
MVK_M*S_!/N>_*=)>FH_8)[%CU=\,"_?-/7?QD'X<]UWY+H?\VK_M*?@GW/?E
M.DO34?L%M0X8=')N'@CJ1_I;27+&"=4^1NLS?%U+QQV;3TSB<G(R"B7I$WL?
MMZ#0*QPUKS#*#<S,RB:IG!S+G*H4B?S[=/NIMFZW23=*:5HT&VEEEI60"R7J
M-+@J+ZM1I+7FL;]ZLZ2' $ 88$G<M!: H;GK#][[!6J.H<-4KS:&BI4OU0P.
MXS#3%V&"!=D8XE2V_1KS!^%1K'Z+BOY[C7;U'XI_I1]FOV;M;XUGHC]HL,<A
M^'_(KDWI;86AMC\K::C1]EPA8"QJUKC62+G2,2OV<CC,:_=;IDF[5?O#%'&5
M%6+DO9Y.7Q.LV#%_4T+IFKH'2EBTO8:+#:[#5-:B*[C4HEY8]G'8UM-SA#SD
M]IF,5X-*:,;I>P6G1MJK$6>UTQ3JFDP,J!H<U_$<YSV@RT8EIPG#6M,'L6/5
MWPP+]\T]=_&0^G_ASW7?DNA_S:O^TK0_P3[GORG27IJ/V">Q8]7?# OWS3UW
M\9!^'/==^2Z'_-J_[2GX)]SWY3I+TU'[!8:U#X-KKG9CW<+1URINT3C6&Y;)
MJUJ=OK&"<YEFD%7ZG-)R[C"EM2PU<.#V-5 [5/*J29&J9RJFRH8I<W[^.ZYM
MS_9M#F\P._FM?"21'\YYE6S>JW/O-2;3I$7*A8(K43( :9/XC/')9E]BQZN^
M&!?OFGKOXR&'X<]UWY+H?\VK_M*L_!/N>_*=)>FH_8+-_&_P>.)XL[NH&_M9
M<N[ M>M;23V5KR5GTO"RL"=U(0LG KXD8]KL&,<.4NXRKK)")/FYBKX24R<Q
M29(;\K3F^WNCW0:*MFA[=9M&BR6YC*=8T*-6G6#65:=87'NK/:TWZ;9)8["1
M"_0T5O=:&T/I"S:2LEHMQM%D>Y](5GTWTRYU-],WVMIL<1=>8APQ@\RW+_HU
MY@_"HUC]%Q7\]Q\QO4?BG^E'V:WN[6^-9Z(_:)^C7F#\*C6/T7%?SW"]1^+?
MZ4?9I=K?&L]$?M%G?7L/?H.NE8[)NT-?[+AZZ5/8(*EFH3 S%3L^Z,\0!K-;
M<E6;>*IVCSRN;O/:%_[,AXG^/!Q:3Q6EHV%UX^>&^Q9M#@.,X..T-NCS2[VK
MG(Q62 B B B B B BC/M_<=]A-FT'1FG:K4['LN\4Z\[(>RM_L$M7Z53:#0)
M:F5Z1DG^("$G9N>G9JQWVOQ4! ,THQNHV3GIA]-M"0R,?+6,8"USWEP8US6\
M4 DN<'$#$@  -))QU",9%3WN#FTV %[@YQO$AK6M+028!))+@ !&LDB(/#I+
MF)7-7046WY&56P:XV*SKU@M^Q:W1H>S[FK.O:!7;/+5C]+ECN-(K2Z-=U78<
M1"U@@IJXQM9G$H,LHI,U^-7JML)#9<"7$\&X.;(:TNAA<XB;@:XXN&1 )$Q!
M,B8X8- X1I:Z"7!H+PUK21?) P88D$@&)D8&/AW'G+QRKLK='S=E<++:]>1.
MZ(!E+L-27\T=/V74M>>WS8VJ:;L ]14B)FPFAJ8>Q+Q$"_D&<FP@#2K?+\T(
MJ5J%"H0V8 <6$R]LAKS#7N;>D-DQ)B"8,$J#7IB\>,2WA!@QV)8)<T.NP3#;
MT F0)$PE5Z0;0MF@C27=-J-95BQUVWFJ^EIG;+MVTONSZU2;94]51*RE)9>J
M78,E WZ FT:_#H*O$*[F0LDJC%PT3+.V(T*@/P2#>(-]G<L+@YQXV#06D3.>
M DD(+0PC)P(N BXXD.>&N:W+%T.!C,#$@05D#5O*6I[CVBG1Z.Q=N(+&LYJY
M2$K-,INL6B M=9V9(:SL^O[+1[##QLS 3=?F(QXG)IR>&[E)RCXB;15FJW>K
M8NIEC9='=0(@@@MO!P(.((.!U[<PLF56O==;)%TDDR""'%A:6D @@C7YM:E*
M*U:@(H_:ZWQ&VQIR$E[0UCJ77M!;6N=!EIUY+]JP7@*92JC<I&WR:R[1FG#H
M(M+(ZP[;9.Z1:MHS+K+T^%C$1L=3(X,#C&HT.  QDN+0W,SES9Y*MM0$5"8:
M*;G-))PAK0XN. @0>?+-8Z)SLX_^3"/72VSXR4>35-@X*F2ND]M1VP+2KL9C
M:I#7DC6J.ZIZ=EE8&YHTBUHQ$ZE'DBV\A R<9-.HF19N&J<\"^8XIP))#VW1
M=(#@3, M+A(F<1$@A8BT4R/A DAH!8\.)=);#8D@P<<@1!A<!=\]].VRS0-"
MAH&>E:[>:G2I!Q8KG0-D1E5*M>.2$3Q@E]:6-D?7TIY,NC6XOY>NNX&Q=P:(
MV-NWB+">*A%I.P1>7 / )) +2[!KFD\6F:MX0[%L"01,C+& <3:&$AH!(+6D
MDM>&\:J*1:>+@Z](+3$$8X21E+UWFD7#;4+2DVJ*>8VHQU;-55D[@+O%H)TG
M9=P;42M*+HL:@^-6)^0FLO8>%K%M0K:V)&$G6TLI#M8":=1^/ U./>:>(7!V
M+3BT%QUX@""2)P(UE9<-3XET]V&EN!'%<X-$X8$G  QB#.17\ZES?X\7.JR%
MWB[%:F559:LOV[F\Q8-:;$KB,YJ762%87N-]KB$U6&3R<@V!K=#MF?D]LL^F
M767J,,R?YCWF4AH5 8($WVL(O-,/?>NM., \4S)@:R)05Z9%X%T7'5)+7"6,
MB\X2,1QAEGCL7+-=\IM1[5V!-:ZI#JWRTG!KS3%Q8#:]N[*AN9BM%C<V6 9W
MIY!(5A2>@C2S%-[%+22#I97+Q.-(_/%2V&.+J;F@.,8ZKS2X Y$@&8,&#[Q.
M3:K'NNMO$B<;KKLB)%Z+LB<IS! R,2*&"L0$0$4(-:<M+/=]HU.OS&LX2!U;
MM>W[YHFH+JQO;V9M\K8./L_/0E@5NE(7I43%UJ(M[:HVV=J3J(NEG=(QT2P1
MFV3-Y-=E&W.I!K20XES!3<\78:!4 (ATXD2 9 SPF,:&U2YP!: U[JC6&]+B
M:9(,BZ  ;I(XQRQQ,+G$KN9]&\IFFC873SIG)7'26P+ZCN6=6AXB M$IJF9U
MA'Q5'8DCL25MG(V)/NO+N7FY!E'Q4 Y<.(ZMIV&0=V D+ 8#2OE^3VMN"20'
M7I=C@"2W 3CF8PF34BL*88>,QSKY@ EA8+HS)B^))$#5.,<0XZ\M)GD+=):D
M,-6/ZC)ZDCY&O\ESSDJL9MK3=J$AAC'ZGI[HL0@AL4CR,:/KVK<6IHB)1H,U
MKJ62;N9"ZJQD!-2EP;0XN!OXTX^$SPSCQ<>+=.-X.![G&*=8U'%H86W 15D]
MS4PX@P%[#C7H'%+3 O0)K"E7H"("("*$E?Y86B6VW7(![K6!8Z:OF]]J<::)
ML!O?'SR\/-J:?KVQYJS.9_7IZ2TB(BER$AJ#9-:AY1I?968Q(0<*]=PI&-HZ
MX.XT@&DWC?;3;5+8$77EH$.O8N%\$@M&L3(QH%8WVBZ+CJCZ377C>OL#B26W
M0 WB/$WB< 8@X?VW#R&L-%WCK'4ENU30I376V-@5NB5![+;*CW.S+;/8ASW&
M0NM5U!BI2C!U1M924?'(V2:L-TKDXR?IJS,3#K$9U[%H,8',<\/<',:7$!O%
M F "^\#+IPAI&0)Q,'U"*C6.8TM<0&R[C.,%Q<&72(80)EP(S&J>&P_+?=<I
M8=XZ^)H:E2.W-2:YIVVT-85#=B%MG?(-GL$PW+K2]OT:1&0-1W6_J< [GZO!
M1$I;Z?+2$A'Q[VX1<(9G:I>328 QW"$-<YS+SF71( -X8DEDD F 0),3@H%9
MY+V\&TO8T/N-J7C!)XI-T /($@ ELF"Z,3FOC+R18\IH*>V?0JZZ:Z-7=,8O
M6%XFLOXR>V.]CR.T+Y*DJ+^-:.J]6JY8"%I\6ZD'1Y.=GH2UN/)C"%:0<C/8
MU:9I$-<1?Q+VB"&^")!()(Q(& !&,R!G2J"J"YH-S ,<9!=X1@@$ ' $XD@X
M1!,G!4K4!$!$!%''E!OJ5X[ZX2O41K.Q;,65L=<@W3:(?Q,-#UJ/FYR-B'EH
MM<U*.2*,XF.(_+ALTAXZ<FY>558QK6-2;+O96-LILX1T7@W D3)),8  9D\\
M 9RJZC^#:"&ETN P@  F"XDY <P))@1F1A[:/*&5TMN@^AH_2S>0V+NUS'3/
M&Y>%?*,*SMZ32;,VVWGVQIMK75O4(_TU'-T+A<GSI*P.+!KU>"/5,S%G[S6&
M.;*5]E\OAK)%2<V#X-T3Q@_N6Q$.F] AQP=5N/X/@R7/@TX.#SA?O&.+<$$D
MS+8B3Q5.XOC>+CQNKQNK'C>+U^+XW5[?5U^WU=?ZNOV^K]8H5Z_01 1 1 1
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MUL*3UM%,9ZWMXZ2GK$E4X2?E,LH>&L,K%.CRGB1+N*N-6\(+!)# \@D7FTQ
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M[^?C?OYGB.'J>$/F,^JG 4MCO25/K)ZQCC7_  M>_GXW[^9X</4\(?,9]5.
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M1$V$IL>#VCKR$H7&+8,0X7NT"]U!69BJHS\8ZPX@:1(0=(;S;:+2UH889$5
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M1ODA]236(; XN(ALW6"&N,R'.4>U-Y\F9^F:.EK7R)/KVV/^&7#NW<;K'?\
M<7)& LVR[Y;]<L)*]W&O:HU#1;U#\KM@R^PUEX;85!N2-OF4*LC#G0K,-&6-
MQ9Y*PTZ8=4NT[P%:LVH&MID-:UP :7O<TTF@$$.%T7LR8@4BI5+*1=5NN-"B
MZD7U*K2][FDEP8UKA6>7=TTWB&@8 .O')U]F+%J^?Y UB%VP^IU;G.D.N4AR
M7>[!Y%[VUG6*;5['H>)LVGE[;?J06PW_ $MK78]NS/(,+;$)TZ$M;JHU*E3-
ML1@XU"(-@T!PIDLDBS@4[M.FXDBH0^&NAKW-;!(AQ:'%T#,6N-PU 'D V@FK
M>JU6M:'4Y9+FRZFQSI (+ 8:TF.*?0M%\F+%I&R07*KDOM'%.DN(>V3\1;)K
M>X[WKL1O#9S[:?(2OOZRX?3]7H=JY'W2KZP9:(K5+A[_ %V:C-KTZ=L&PXR'
MM[2=E;4A+0 \&E39>%9G"APIFXRY2(.!<*8+^$+B"+C@&RT@!8N=>816K/#3
M1?P+FFH+]2_5!&+0:Q:P4PV\T\("7 .DE;*^3\!<)KA1PZA*=(J5JWFW5T>Z
M<7/+ULUG)59%OL_5_BSTC6CNXTLFS@EBX?/X]R_CT546ZB+AXU)DRI//2(%:
ML78C@[1(F[,M=@#!@GH*]5<.-&B&X'A;-!B8_&,Q(D2!GF%]G<-[VAQBN7$.
MU<C.1[66ULXWAM*(VCL=I4,Z;URR@Y_CY=$=:UC843'6>S0R[8^QXM-Q S4_
M((M%K/(P<<W00DTHT[N&-94;5%.F0X,:6M+K[I%07BTW0>Y.(&H$SJ4O<ZDZ
MBZI4XM]P>Z+C8--UT.$D=T!!.O#6M5.S-^[+QK[4NR+%O#9Q7BT'R-LM2U5.
M[EWUQOVM=Y&.Y>[E:4]?1T\RJULI>Y-U-:%'UBG1/'+<U)L#1A5T*T5K!M(B
M=DLE]3:;+SVAC8FF'.#*=5C1P+"14$AS&%Q)-5CA)G$D"/(^J^ZQQ>^2*A:P
MOJ47N(K/@TR&D5'A@#12>TB(P )4GIO;-F5W%-NS;:WI#\X2\UZI6:;QK+:;
MKZF%.'SW8E99/'RFBV:RVMYC7N>-[JP;&LNWU(9[(16WVJ\+B\,9=@RJY*@T
M7!Q&&CP)+JL-)X:Z2!?[H.X2&ADCB8P<2K2]U\P]_P!T<, *5YP;P!>T$BGW
M):*<N-2Z3?P+L+HC'JC>6W(VD[3K\#NK:VT5%:3I^;WCO+5FXMT7^6H-*QR'
MUQ5][V&_:*VK4)*X<3.41-16*^6!&A:TL3J"AZ[6+))0U%8.:=77XL>QMYI+
M&,ASPQCFL:''@W&F&U&F*M*\&B\\221B;Q"J8]X:\->]_%IFI4:][BUO"-%1
MSZ;Q-&K<<YUQIN@-,-$*2$;.R%]M<3K?C_OK?=SX>V'F/Q_J%=V; ;EV=8Y&
M7CI[0^\YG?>NJGOI]-O[U9]9MYB&UPY=RK>XRJ57N4W.Q=;L,-+P;-"#PBZ"
MZHQ@K"B]Q:6, PJ4PQSF 70X@OPNB6@$@@F;09+64ZE0T36IM#P]Y)FG4-1K
M:A)<YLAN,F'$AI! CY,:PY':SJ52ONI]C<B+[M]UL_I-M(U.L7W8]^OM;EJI
MI"H<IB<9Z^^IEEDGM=DY5C9=5:V<1]]E6"]WMCZ0=I3=HF&<P1J1--Q(>UC6
M7;,]Q:UH(<]U,U3> O1#G\4&ZT1 !&.(X5C0]CJCJEZU,:U[G.!:P5>"!:[B
MF"QG',.=K)F!E_HP;S=[3M.S(([Y@=J4I72<#,;!K,?M[DEOJ7KVWU["R3:S
M%KL6Y]?0-?TS?Y",/:6-ZTA#ST2\;K,X.29ZXK["(=O7>%I:T-'XLL=?(!N4
MZ8+8Q@,<2X3%UY!!DB^5997%SW?C ]MP%POU:A:^<+QJ- INB9I@@Y&Z ,=W
M0\:]R B B B B B B B B B B B B B B B B B B B B B B B BX%KO6=.
MU7$S<)28U6+C;#>K]LB506?OY$SBW;-M\Q>[E(E6D'#E5!*2LT])ODF")TV,
M>FN5FP;MVB**),G.+B"XR0UK1JP:T-:,-@ Z5BUC6 AH@.<YYQ)ESW%SCCM)
M.&0U+GHQ62 BXC?*7%;%J$[29Q]9XV(L3/#%^]IMNLU#LR"';)+F\DVZFRL)
M9H193*)4E7$3*LUU6QUVJBAF[A9(\M<6D. !(Q%X!P\H((/E"Q<T.:6DD B"
M6DM/D<""/(5[5.J%9U]4JQ1*9#,Z[4*; 1%7K$#'D,1C#0$$P0C(F,:E.8ZG
M8,F+9!NF95114Q4\&54.H8Q\B2XESB22223F2<RI:T- :T0&@  :@, %R00I
M0$0$6 -S\9M6;X?PDM>2WZ.F8&'G:VVFM<;9VAJ.8>U6SJQJ]AJDY):PMU3=
MS];EEXB-77B)E5ZU1<-2N&96JZBRBEC*CF2&W2"08<QKP",B X$ C:/*JWTF
MU(O7@0"):]["08D$L<TD&!@=8D8K,%4JU>H]7K=*J,.RKU3I\!#U:L0$8EA"
M-@Z]7XYO$PL/'H8SG"+*,C6C9DT2QG.$T$$R8SGQ1@27$N)DDDDG,DF23TE9
M@!H#6@ -   R  @ <P&"^^(4H"("("("("("("+^#ATU:)F6=N6[5(F,Y.JX
M6313+C&.O.3'4,4I<8Q[><YSC'4"2!F87SH6Q5^RMW#NNSL-/M6CQ2/=N863
M92K=J_132568N%F*ZZ:+Q))P@JHV4,59--9(YB8*H3)I((S!'2(]J@$'(@]!
MGV+[ A2@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@(@
M(@(@(@(OX.'39HD9=VX0:HDQG)EG"J:*1<8QUYR910Q28QC&,YSG.<=6,=8)
M(&9A8@L_(WCU22JGN>^-,U$B&,Y6-9]H4B *C@OM&RJ:5G&F$\8S[6<GSCJ_
MS&8IU'=RQYZ&N/L"P-2FWNJC&]+FCVE1[G^D]Z.JM84\I<V^,2N4NO!R0NY*
M19E,9QUXSC"5;EY90V<9QG'44IL]>.KJZQ8++:#E0J^5CA[0%2;996YVBB/^
MHTY=!4>+5T['165)51!URLAIA=+.2Y)5=>[:LZ1LXQU]2;V&H;N.4QG_ ".1
MX8F<^UXPL%AM3OZHCI<P>UP*J=I*Q-_KVGH#CLV-.WVK -J\))Z,FO$.>(LV
MY;T8N,Y*E5M1RK,ZF<?JP7-VD*>GC.?\O'4)C_SS@6#1MJ.;6-Z7C_QO*MVE
MK$,GN=_A8?\ RNJ/,_X4WPT9F4+6]"\DYW)?&[(\DQUI )*=6/\ #DV4M@3:
MJ>,Y]K.>Q/DOZ_%-^H6#1=<YOI#RN/\ XA4.TU9QW-.L[&,F ?I'/%1ZL_A7
M]>1,JG3.$LU(%ZS=BZL^]V,.;./_  Y5816JIS&,YQ[9BDDL]75U8,;K\;%@
MT4?A5P.AA/M<%4[3C/@V=QVWG@>QI4?K-X5=R'=X4Q3N*NF8#.>OL\V2X7>V
MY)C_ "\?$86F84SC_P \>)C_ .T6#15/76>>AK1])51TX_X-!D\[B?9',H_V
M+PG;I#Y;"I(>H\9ZJ0^,X35C==W20=)=?7U9*I.[-DVI\EQU=7CLC%SG'7DN
M<>T+!HRSC-U4_P#,T>QJJ.FK49AE$#5#7$CSO/L4>;-X0;TJEARKAKO^ JJ2
MG7U(UK3VITL)8SU^TFXF*A,O<=7^1C.3'QU>T;]?78W1]E&;"[_$]WT$!5NT
MO;"(O-;SM8W_ ,FN[:U'^R],+TF]LP?$KS-W&U[3K\;-:DXFEYQU_K\3-.B(
M+*7Z_:[/)/%_\/5U8%@L=E&5%GED^TE4'2-M/_N'CHNCUAH4>;3S>YGW@^37
M#EOR9L^,XR7"4YO;:$DW3*;]9$FSJT*-T4\_YII)$)[?^S[8L%"@,!1I#;%-
MGKP51M=J.)M%8[)J.]6*P//7F[6HQSVBXVJR'4SDRAI^Q2\R8YLYQG)CYD7C
MG)C9SC&<YSG.<YQ^L9AK1DUHZ ![ JG5:C^Z>YW225>]\%X\WULOY5U_^Z[3
M _"TG_.6_P#";^D];/H;^9G_ (S_ -%BLA#\Y?K("("("("("("("("("("(
M"("("("("("("("("("("("+X<W+/XI JK"LSEF4S@V<MH1Q6VZQ<EZNK!C6
M.P5]OUGZ_P##XJYL8ZL^/DOM=<@ YD#IGZ 5!)&0)Z(^DA8*M.V]XL"'Q3^*
M-WLJV,Y\3RSM#2M6:GZO\\K-[O97!>O_ "_[$;_UZAF&,.=5H_Y7G_Q"P+WC
M*DX]+F#_ ,C_  Y\%@&Q;_Z1! JI:ET=]&DSYQG""MBYK4R"+@V?:P=5",U'
M8LFP7_:RF1R3)^KQ<*DZ_'Q8*=G^%:'#HHD^UX53JEI^#9@3SUVCV-=^_F4=
M+%NWIQG1U,U/A'P[A$LYSV1+%R)F+0H3'7[7:*1I:@57.,>UUE22QG..OJQC
M/46P,L6NO6(YJ0'K)/L51J:0U6>B.FK/N4?K9=/"3)[*A*_J+@G2$C=?9GAY
MMY*O$\9Z^KQEK/?YIHIDOM>+_P!WDQG./\6#8]H6 :-&;J[ND >P#H51=I4G
M"G9AS D^UY4?;#3O"D9XBR3;9>A:TDMC./$KJ6@4CI8SC.,X1<RU&F'B><9]
MO!L./'Z\?[75[0L!T6/@U#SF_P#00/4JG#3#LG4F] IGV@J.-HXA^$YVA17$
MER.ET<*9SDQZMONC4Q/_ !8QU]D6J,:\9'Q>OJQA--/!<XSDG^6<V"MHQN5*
M>EA=[2>V:I=1TR[^N&.Q[&^:ZWZ>;)1YLO14^$&WC*Y+9OC9-I+XV4EV\US:
ML$JW2,8A5.QRU=W%9!#'9J)GP@5(A,$.0V"8*;&<V"UZ/&5-HZ*#?=[52;%I
M9V=8GF-H<1T9Y>]8#G?!]^ENM+@SNS0E2L3HWMG<SN_(*7<&Z_;_ ,2TA(N%
M,^W[?MF_6,QI"R#*\->%.%2=%Z0=BXM<=KJQ)]:XY[''Z4#WNM7_ #P4_P#_
M -QE]\K+M?\ ,/O4?>FW;&>D7B;P<OI/D\%R?7VK4\&,5,N3;BIQ<&.<WBD(
M7K<8ZS'-GJ*7'MF-GJQC.<A]\K+M?\P^]0=$6TYBF>FH/<O/V.1TH/O=ZP^>
M&G_\P'WRLNU_S#[T^\]M\&GZ0>Y>)_!R^D^3QXRFOM7$+DQ"8,?<5.+C)U#E
M33+UF<8QXQU#%(0OZS',4I<9-G&,OOE9=K_F'WI]Y[;X-/T@]R_DMX.;THJ6
M"^)K+6[GQNOKPCN.CER3JZNK)N\/T,9\;K]KQ,FS[6>O&/:ZWWRLNU_S#[T^
M\]M\&GZ0>Y?P]CI]*3[U&OOGEU[_ -8#[Y67:_YA]Z?>>V^#3](/<GL=/I2?
M>HU]\\NO?^L!]\K+M?\ ,/O3[SVWP:?I![D]CI]*3[U&OOGEU[_U@/OE9=K_
M )A3[SVWP:?I![D]CI]*3[U&OOGEU[_U@/OE9=K_ )A3[SVWP:?I![D]CI]*
M3[U&OOGEU[_U@/OE9=K_ )A3[SVWP:?I![D]CI]*3[U&OOGEU[_U@/OE9=K_
M )A]Z?>>V^#3](/<O!3P=;I2R$,<NHZ"L;&/:33W-KG!S^WC'47*TXDG[6,Y
MSGQE"XZL>UUYZL!]\K-X3_F%/O/;?!I^D"M@]!=PWWYP?XB7;4O(JKQM3O$U
MOVVWR/C8JS0%K;JUJ6HNM8-B\/(UQ_(L4EE)&MRR1F:BY7*9$"*G2*FND8_Y
M5NK4Z]8/IDEO!M;B",0YQ.!YB%^YHVSU;-9S3J@!W".= (<((:!B.@K<^/&O
MT$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!$!%
MJ5ONK^5K/:'*V=UJ;8%;AIM??&TM;>I>;@XYC<]LP^AN"E5TAF3277.O)1KB
M=J&[H3%?E\H5V3Q'2^+$S61-"KF]+7TKE(. <1<:Z0<&&K7<^,L8=3,C$:M:
M\A95O5BV\T$O>R"!>>&40SG@EKQ!P.9U+Z#.L<QYR\5"+=.=\0"ZVR]B.MN6
M)W=:$WT^_B6=>Y%R.I4J%'Q"[V]1524ES:3;S9(A2OD<Q2,)$VN+D;6O>'A$
MT0UQXAXK0P .O#&G?+IXI,7XF<9(,74BL7-[O%SKY)%V(J7 T R!/!@D1A!,
MRXK#R\1TAR6L,Q^4][SEBD6D7EPIWBDU&6@=F--86E"><)*L=VVB9M-6F;\]
MK:S K*Y:PU1#6"!.^;P,E095>#/G-"^.X#02/A$%EX1\ 72&@XPYQ!SO"5C%
MH#/ZPN,'4TAUPS\-Q+2XC %C01E=E?E@@ND"E(FU))U_9=CG%W]7MD?-VK&O
MHY*N6..OD-(QT16*@>V7>J/B1E><2CN#O532UO)Q<=",6=YI[G8+TTPA - $
M3= Q! D@BZ<28!&,2"7228(:(0BT0XPXN)!!,  AS< TD@X7B' -@ 2+V*XY
MR5V#R-X]PMR9VW9VWF-=EM9[0DM/N6=ZH[38<[R%0T3H)>F),'5AD8DUDJ;+
M9BVZ%GFN&191!W9YJ+8PU*DJJPBX^'RIBG4+88V0Y@?@;HIWWWI P#KMSC&!
M ,N!,G&J:K ^7O N/+(<V\:G!T[H!G$!]_BXXD  C*6_*"F[\N]MH3&%@]G3
MM:2EN'UCK):A,5F-I<+<*/R6BKKO&5W'%R4S%RTG&H4&(ICZOIMX^;PD:(LB
M<"W83ZF#OJJ9I@.DM!BJ#,DD&F0P,S$WB9RS;.$JZHVHXMB^1^)(@@ .;5#J
MA>"1(NAL8$X&!,*.LS#]( 6IQKB-;<B59F.H^NLW* ?3VNE277D0C6-KH[,5
MJUG@MCPLUK_6<A8'6LUJK+-(NU:M8239AY6U.K627)4M@-"2)IQ>==,.PIRV
M[(+2'.B](EKH)ATW0JR+0 (OS=;>$@S4X]^Z0X%K2;ETP6[6Q>4KN/,=RP)O
MJX2.Y7]Q0J2YMP'5AW,76W>NL1KO8<$MHQ*LV9GM!^Y7F(C6Q'S.2Q :AIJ;
MN0/9#["=O9E.H/Y*JH:5P!@$\3&3>FZ;\@MP%[*7G"+N$Q;3%:^34)CCX0+L
M7A<@AV8;G#&DF;Q, G8(*%Z$!$!$!$!%Q:[W:JZWJ-AOEXF6U=I]3BW,W9)]
MZ1P=C"P[(G:/I1_ELBNJBP8HX,Y?.LIY19M4UG;DZ39%54DM:7$-:)), #,D
MZE#G!H+G& !))R &LK[S!^QE&+.3C'C61C9%JW?1\@Q<(NV+YB[1(X:/&;MN
M=1!RU<H*)K-W"*ATEDCD43.8ABFS&6:G/)>V"("("("("("("("("("("("(
M"("("("("("("("("("("+#FS]+1&U'D4]DKWN.H'B&SEJDAK#;-VUPS>E<J
MIJF6E6E4E8Y"3<I93P1NY>$55;I&422,4AS8SFUY:" &&3/&:UQ\Y!(',L',
M#B"7/$>"]S1Y;I$^58O]:#5O?KY9_2BW%^)Q/"'P:?HV>Y8\"WPZOI:GUD]:
M#5O?KY9_2BW%^)PX0^#3]&SW)P+?#J^EJ?63UH-6]^OEG]*+<7XG#A#X-/T;
M/<G M\.KZ6I]9/6@U;WZ^6?THMQ?B<.$/@T_1L]R<"WPZOI:GUD]:#5O?KY9
M_2BW%^)PX0^#3]&SW)P+?#J^EJ?63UH-6]^OEG]*+<7XG#A#X-/T;/<G M\.
MKZ6I]9/6@U;WZ^6?THMQ?B<.$/@T_1L]R<"WPZOI:GUD]:#5O?KY9_2BW%^)
MPX0^#3]&SW)P+?#J^EJ?63UH-6]^OEG]*+<7XG#A#X-/T;/<G M\.KZ6I]9/
M6@U;WZ^6?THMQ?B<.$/@T_1L]R<"WPZOI:GUD]:#5O?KY9_2BW%^)PX0^#3]
M&SW)P+?#J^EJ?63UH-6]^OEG]*+<7XG#A#X-/T;/<G M\.KZ6I]9/6@U;WZ^
M6?THMQ?B<.$/@T_1L]R<"WPZOI:GUD]:#5O?KY9_2BW%^)PX0^#3]&SW)P+?
M#J^EJ?63UH-6]^OEG]*+<7XG#A#X-/T;/<G M\.KZ6I]9/6@U;WZ^6?THMQ?
MB<.$/@T_1L]R<"WPZOI:GUD]:#5O?KY9_2BW%^)PX0^#3]&SW)P+?#J^EJ?6
M3UH-6]^OEG]*+<7XG#A#X-/T;/<G M\.KZ6I]9/6@U;WZ^6?THMQ?B<.$/@T
M_1L]R<"WPZOI:GUEQ"_<27#6E6=?7VS>2=HNQ(9[BKP%LY=[KKU8E)E1+*;)
MM8)EE(SKQA$95/@\@LTAY!R9L11)!L=50F<9-J<87@P-G$BDPD#F$#'9BL74
MN*;IJ.=!@.K5 "><R8&W KGW#;C0WXD:!J.DT;M8KZI!N)F6?3$Z^D5V#.1L
M4DO,/X&DQ4D_E%ZKK^#<N5&%0J_E%^>*BDD^^R$C)KOI!UC5J&J\O( F!@ "
K8$2X@"7'-QC$[! 65&EP-,,O%T29))S),-!F&B8:W4 !),DRD%:M0$7_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>55
<FILENAME>g60414g96c86.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g60414g96c86.jpg
M_]C_X  02D9)1@ ! 0(!>0%Y  #_[2X\4&AO=&]S:&]P(#,N,  X0DE-! 0
M    +B"^$8"#A"24T$!       (!P!6@ #&R5'' (   (  !P"!0 ,4V5C=&
MEO;C1-7W8S.$))300E       0IFO9O>&<.?[DI^,.UCMP$3A"24T$.@
M !"P   !     !       +<')I;G1/=71P=70    %     %!S=%-B;V]L 0
M    !);G1E96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT965N0F
MET8F]O;      +<')I;G1E<DYA;65415A4    % !# &$ ;@!O &X ( !4 %
M, -0 Q #  ,  @ ', 90!R &D 90!S       /<')I;G10<F]O9E-E='5P3V
M)J8P    P 4 !R &\ ;P!F "  4P!E '0 =0!P       *<')O;V93971U<
M    $     0FQT;F5N=6T    ,8G5I;'1I;E!R;V]F    "7!R;V]F0TU92P
M X0DE-!#L      BT    0     0      $G!R:6YT3W5T<'5T3W!T:6]N<P
M   !<     0W!T;F)O;VP      $-L8G)B;V]L      !29W--8F]O;
M  0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS8F]O;       3F=T=F
M)O;VP      $5M;$1B;V]L      !);G1R8F]O;       0F-K9T]B:F,
M !        4D="0P    ,     4F0@(&1O=6) ;^            !'<FX@9&
M]U8D!OX            $)L("!D;W5B0&_@            0G)D5%5N=$8C4F
MQT                0FQD(%5N=$8C4FQT                4G-L=%5N=$
M8C4'AL0'7@           *=F5C=&]R1&%T86)O;VP!     %!G4'-E;G5M
M   %!G4',     4&=00P    !,969T56YT1B-2;'0               !4;W
M @56YT1B-2;'0               !38VP@56YT1B-0<F- 60           !
M!C<F]P5VAE;E!R:6YT:6YG8F]O;      .8W)O<%)E8W1";W1T;VUL;VYG
M        QC<F]P4F5C=$QE9G1L;VYG          UC<F]P4F5C=%)I9VAT;&
M]N9P         +8W)O<%)E8W14;W!L;VYG       X0DE- ^T      ! !7@
M    $  0%>     0 !.$))300F       .             #^    X0DE-!
MT       0    >.$))3009       $    'CA"24T#\P      "0
M   0 X0DE-)Q        H  0         !.$))30/U      !( "]F9@ ! &
MQF9@ &       ! "]F9@ ! *&9F@ &       ! #(    ! %H    &
M ! #4    ! "T    &       !.$))30/X      !P  #_______________
M______________ ^@     _____________________________P/H     /
M____________________________\#Z     #_______________________
M______ ^@  #A"24T$"       $     $   )    "0      X0DE-!!X
M    0     .$))300:      ,U    !@             %XP  !=(
M   0                         !              72   %XP
M             !                         !     !        ;G5L;
M    (    &8F]U;F1S3V)J8P    $       !28W0Q    !     !4;W @;&
M]N9P          3&5F=&QO;F<          $)T;VUL;VYG   %XP    !29V
MAT;&]N9P  !=(    &<VQI8V5S5FQ,<P    %/8FIC     0      !7-L:6
M-E    $@    =S;&EC94E$;&]N9P         '9W)O=7!)1&QO;F<
M  !F]R:6=I;F5N=6T    ,15-L:6-E3W)I9VEN    #6%U=&]'96YE<F%T96
M0     5'EP965N=6T    *15-L:6-E5'EP90    !);6<@    !F)O=6YD<T
M]B:F,    !        4F-T,0    0     5&]P(&QO;F<          $QE9G
M1L;VYG          !"=&]M;&]N9P  !>,     4F=H=&QO;F<   72     W
M5R;%1%6%0    !        ;G5L;%1%6%0    !        37-G951%6%0
M !       &86QT5&%G5$585     $       YC96QL5&5X=$ES2%1-3&)O;V
MP!    "&-E;&Q497AT5$585     $       EH;W)Z06QI9VYE;G5M    #T
M53;&EC94AO<GI!;&EG;@    =D969A=6QT    "79E<G1!;&EG;F5N=6T
M /15-L:6-E5F5R=$%L:6=N    !V1E9F%U;'0    +8F=#;VQO<E1Y<&5E;G
M5M    $453;&EC94)'0V]L;W)4>7!E     $YO;F4    )=&]P3W5T<V5T;&
M]N9P         *;&5F=$]U='-E=&QO;F<         #&)O='1O;4]U='-E=&
MQO;F<         "W)I9VAT3W5T<V5T;&]N9P      .$))300H       ,
M   C_P        .$))3001       ! 0 X0DE-!!0       0    +.$))30
M0,     ".$     0   )X   "@   !W  !*8   "-H !@  ?_8_^(,6$E#0U
M]04D]&24Q%  $!   ,2$QI;F\"$   ;6YT<E)'0B!865H@!\X  @ )  8 ,0
M  86-S<$U31E0     245#('-21T(               $  /;6  $     TR
MU(4" @
M         18W!R=    5     S9&5S8P   80   !L=W1P=    ?     48F
MMP=    @0    4<EA96@   A@    49UA96@   BP    48EA96@   D
M 49&UN9    E0   !P9&UD9    L0   "(=G5E9    TP   "&=FEE=P   ]
M0    D;'5M:0   _@    4;65A<P  ! P    D=&5C:   !#     ,<E120P
M  !#P   @,9U120P  !#P   @,8E120P  !#P   @,=&5X=     !#;W!Y<F
MEG:'0@*&,I(#$Y.3@@2&5W;&5T="U086-K87)D($-O;7!A;GD  &1E<V,
M      $G-21T(@245#-C$Y-C8M,BXQ               2<U)'0B!)14,V,3
MDV-BTR+C$
M               %A96B        #S40 !     1;,6%E:(
M        !865H@        ;Z(  #CU   #D%A96B        !BF0  MX4  !
MC:6%E:(        "2@   /A   ML]D97-C         !9)14,@:'1T<#HO+W
M=W=RYI96,N8V@              !9)14,@:'1T<#HO+W=W=RYI96,N8V@
M                                                          9&
M5S8P         N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W
M!A8V4@+2!S4D="               N245#(#8Q.38V+3(N,2!$969A=6QT(%
M)'0B!C;VQO=7(@<W!A8V4@+2!S4D="                             &
M1E<V,         +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14
M,V,3DV-BTR+C$              "Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:7
M1I;VX@:6X@245#-C$Y-C8M,BXQ
M!V:65W       3I/X %%\N !#/%  #[<P !!,+  -<G@    %865H@
M!,"58 4    %<?YVUE87,          0                        */
M   G-I9R      0U)4(&-U<G8        $      4 "@ / !0 &0 > ", *
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ML)$ DE"3H)3PED"7D)CPFD";H)SPGE"?L*$0HG"CT*5 IJ"H$*F JN"L4*W
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MD:66E9N%H'6E9:IEKU6T5;E5OE7#5<AES672==>%W)7AI>;%Z]7P]?85^S8
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M@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,#!$,# P,# P,# P,# P,#
MP,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.%!0.#@X.%!$,# P,#!$1#
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M:&EJ:VQM;F]B<W1U=G<
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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M8H&8H>'P1V=QI['5_\0 ' $!  ,!  ,!              $" P0%!@<(_\0
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M*(0 \6R0/<DF5P+"D)7P2 -3!78$KC8,&(#%?2@2P( )%T;K:Y\<%F"JSJA
M?(I4J"5#_6L@*020"!8JZ:JM"O:DTO;T:G#=0,"QMCL^P^L$V"U(NFK=DYG:
M?V_V&UIJBUYL,'6=YM,C6U_@B;Q&RY5+DF 3&.FA\F(HI-%6,<$U_)BNHO9
M7+=!E\Z8V<464:EM>:[;>\7E^5J^D8R++X?SD;R/E1&L*QTL W)J-D<R"!.<
M'MR4JOLZ@O;K83M>5;Y.E MLQ'<<C5VME]CVMN*%IP++TV8B*'''[L7!AUR)
M,Y+$%F<N0\^EII:\9^%JX@XENM97U(4$DGWTH)Y;U-/&T\,,S59QAJ.P+,!I
M'N!8@7TYS!M&=\)=HU!2A\V* [ =BI6[[[UNGC-'G*E#I%PNVO*]8-B2;\.L
M9>RKKE>HQO4 H3?E*R7*2X4^P1:E"B$"Z<L(L^#2S'=,81<@+@Z@K$+IH"RP
M<E>@(&JP-Y"<1: ;9,NML1&,C264%M5DD*I0!]R2+"BVVFM%[P; G;8M-,L.
ME;_K>O"974B'7XY6#0)5UD6K?Q2U03%'ML'.R94,:E$X)@-&-BF%Q1V APLS
M-+PRE;=EC@4(&#JQK*206TUCTTP\H)W.XZV.5&1X[%B#C9 #A'FTW>0D%2 Q
MJJJ^E$[BKSB;[0G5[M-8N%6J=IL4;.J=4;1-8(&*#1Q%%1N*X%:76:OL:TW>
MW Z[3S@@E6+G)N6)4Z2P AU(@TVHB6(UX68J,#:BI(%,R[!FU:!9*A020;4#
M;<L.5&K'B%TZ@I(T(YLJH76Q4!BQ !72Q;?8#E9 ,!&O:92CPX/:J3KXM'U>
M_P!=.[FS;K=@A76.P"%3MG4^SU&INN5"2.V6Q5;Y7)$HO*DP9$#WN+:<6N@R
M6" 6! O*0^@X:B59AK\3"JJ0RV,H)W!6P16XZ4U[Z;S/%;:@IT^'G9F!1Z;"
M5%+3TP-V#UL;KO5CR'>BM"C\UV=JS8:-3M[-V'I,3N9N337:\;VSK$=;GK+7
M6*TFR_+&"%?L%%M5""VL@&CCB%V$JANM0P,\18B.0PD@4RZBBN4WL*Q%&ZJZ
M(8B]E/4V!KXXOV6T:V0."""R@D@ &ZM66R -0]""<NZ[]M8._+ BN2=57W5T
MXSIW7F_J4FYS::0S:=6;*E%X ,HXFGV6Q8KY^).#/(+ULLM$F+%GBY#,J2\Z
M0B#(R8O#%ZE:G;&:#"F6KY@6-]B/?)QYO$-%&2T7(NHJ;5[KV2:((W!Z$;W8
M%3-I]O-O/O:7)U*RS*/2]T=H>P^JQ,VH:)M._+O!U[H>G;($Q)\:B4Z*;L!H
MC<=D:M,V1XC!$*C@:*>&1YL2.X()%9&R85K)8#,F/$U,ZXUO(5)MBR\E8 ;[
ML/>)B^9[2CI5\N1!6)LA"XU??2NYU,A-U04C;K)YUANK8\G=V@M8E[:6N5<V
M/I+L[L8Z8NNC[-H>ZN&]6;(Z\52J1U4*X0@UAKX^+ V/:TN*GAVL6)MP47B.
M9AHCNR<V1=&1J *MB "N'%.N0GS*2#[(VO;<'>:+D;Q,2DE@^/*Q+8VQFT;&
M!2L 1[9L'GL?C@>Y>Q'8D=<^Q]0UD'E%ANK-D=<@LB;2:(S?]E5/6.PZ!*M&
MR;55*&^4B)V-:QQ%F$P*#-L$'A@B<1.-5NV. TU\I*8\9&,L:U+D.[:5+*U*
M&:CI4]3MO0U"[$/DR!L@46%;&/*NI@K*2Q"V-3"M@.F^EJHP=9>ZU[@4G4OP
MOL97) BU=M['I:P;01UUO_W6:S3!W6Z^;>@5W:W78S6@-AI^V&;D &BYN!=:
MCB2%!E@[BR)#9,S88^XPBW)QFUQ!POB*4+>(J$KD!(9:)/M6#8LT#,FXAM./
M3D%-F*%CB?6J^$ST^/RE7L#H 5HT+F<:P[(]GMNW&I:'BGX%/D6NR;RM@#L2
M9TD=I)V]]>--#]'#V3]4TWL0AY -VLNS-T2:>S8;' G5:36->%[@(IDB/:@*
MH4/CQHI>B:" XPX8+D?6:+J-U"H#0(-L 6L&[KERNPQV%LY",A0J6QIX8M48
M[,7<J"05(4L%((FWV[OOM)2M-]UO<=J4^)LOI"',VQNWLZL'3@^YJH9T^,VG
M1&+)7)=APQ3;.)>66KMK=KDI8LS[M#L(L:"8*(!CB)B9\/E)7,0"I8VA#%6H
M@"P=B+Y<C?.1DR95QYZ90^ %K*6'4H'6QJ&D@V#1(-6 +H6WQ<]JZAM?7*N[
M'O(W: G=5RN6M"AR/2H%+(![>]KD_M6A$&(8LE/AH!L!]8WZKF6G<O2B)BSU
M&9'=@,BB+)/+2KKD*KI**K5J)M=01N8YVRGIR;U &NIT.(.P89&*V%TT2A=>
MI^JP/J2.76W?,IO'$1Q$<1'$1Q$<1'$1Q$<1'$3JBJ?M%S ?31RZ6G5%RVU8
M=:4G>&Z-TO:R^18&'0].4/>6[=;T\DS N5L!*L=C-B-.V>0R""//OOQJ;9"4
MI^',D@!)OJ/#@N &"!F1$U6=3LB,1L#0!8;GJP ZD<@XDC&69&<HN1WT:1I1
M,F11L2+)"'8>A/H)QHSO7M$5M+N_5K&(!E15#B1\]3AL<;D61M-P@5;40\OK
MRQ3O?GF2A$AL3?VEX@R2PF,\AFWRXN6W$067EC@4KA()!;_"]=():F (!&R.
M>5;#?>I5>(?7Q"G3Y=L0 HDA4M6)-$ZLB55;'><N6[5;M'^S8U;V(F'!$;<5
MKLN@JI9K'7=<$[;"9SL3LE2-16TO6-8"7"!<X2Q7#Q.57ZT-R1(2R_N<:)'F
MR%MQW8&-#Q#8Z.@#(0"U>SC9P"VU;@6=I9LN0<*F6QK)Q!B$+#SY%1B$%L=F
M) %FP!O-34G<JYK-WJI;$L!P\S4]^Z<UU5SQ'11G1^R;(#V?1"EF>5=-.[,+
M!['7:P@V$-B*[LF*%$LV7X83A!Z].=KI0O-EL(\I4 7C=B!D#J"IKRNH8$@$
M$K9JQ;;B$SM;!C>G(B G&<;$,I)M'((%@Z6H71%&B9EU?]H^!-@Z>3DZ#VX"
M+;@U_JC8W7^JDB>LG3>V@FX+2"IU=8]0;>)PBCSQQ*R!S5@:M9.*T/ILS)MM
MZ22A%*^/J>'(+#6I",RN:8!2@)/,6W(@5S.W+>2.)!"GPW!R*CX@2I+AR .3
M'21J!.J@ ;N[ P41[00]3V-I63=U)N@#[G<[MP95K.OA*26-_)#KWG0V&H$F
MP,7+X=-LCN=HN.UQX9)6'M \CF26E@7Q\.-*M^3ABJHRG4,7F)8;Y-?32=O+
MO>X-58)J/RDKK.16&GQCI 4G3C* "]57YMNA!WHR:$]Y):[;+U'CKQLQ&_T6
M]@! U NSZL]XFUQ_7N-FKOCMX:NCM)@@H '* I*&X7=,,W1^(%AP9XF4W8\T
M\';5XB^'5ZZ;GJTZ0*LDG?H-.Y(.TOXYLJ,3>)J T6H\I77JU7I K8B[U;<M
MYEAKM:@]U2K^_M?5LF!/[0+TN@:XK&Q(49$X-L/9VTA6F:LBZ#J^7G,*@ K:
M;CE[)#%'%N.!!T]J+/;DJ0XB!BK*48@A068J;!55+G22!S44+',B6.6\0R*"
M"Y55# 6&=QC&H G8$V:/(&0)KOL!M6\]E=LZV)[EM8 =KKL"C6X6J!NHE^ME
M2.5410M>VZ8JR[]%@)&O*J6.2#YV-*41/C' ;61R_=$+D0DRM&QJN)6"*=6/
M46.50P8LPVQEM1  &U&]S=3),KMER(7("92@487:P ILY "@)LWRJ1SJ3VG@
MVR$NV)\T?UO=JE2-/[9[):$K.OSHJ3;Y6J]('[E2K6 O+44J4D0+)8DUVB[-
M O$((V0BN;99&NC$JJLMUV7X:O" # ETQY"P-:W (*[ 4+9#SW2[\P JG% ^
M,2RL%1\N-5(+:,9*L& )-FE8&AL]$>4DVGJR.Z@:M5W8T_8>HMJ2;1K"SV"Q
MZMEU?&N@]?V!(I,BR:_%ZHMD&<7($JSBSM1ZG:6-D$IDV8 G.W8=9@<@,NJF
M<CX))4*ZTP 8'42NJF+*:HUN-/78@W8V'C@!BR/:DE2-(#:;4(;.UBFU7L=0
M(JC!>A.P>^KZ;-ZZ(;1;B[JFZ(M%PDZBWKUYL^D+O3=O!95:8&OZZ;]S12MN
MZ%S/,SA%MG@[Y<#U=RJJOQ;Z34?EK&7R8T6F"^36 &3('#(;O5^<C[6+50=_
M+L+ICR.Q92WGT$Z,F,HP<5[&U/CW )#,0:IC<[#=+;-';IT_JW;XF#(%C=H:
M]IU_A"Y:\.2Q;%MK\ ZD9+<2AM+DH=[]F%(6E"$+>86I*<)SC','4H[(>:L5
M/V&KF^-QD1' (#J& /,6+HR3>5EXXB.(CB(XB.(CB)TE1.]>]G4W)4^W:R&.
M!\6ZQTV&D2&)OW:Z"E(S2NJ*\Q+,G%;VO>$IG-/42<F9MZLNCL^]P9OQ%A,7
ML\%-J#;T&WY+^=E'JJGKLA^,XCG??=11)&P\Q'+#SV=N6G=Q_)<#1G8[8]RF
M[7]83]V>55\5"4]2M8IH 2Q:RM-AN.VZ_:=1V0A<-A5P!)-ZZ$T6I3S*3!87
M:'7[0J?D1\,)"(L7)\:J%WT7>[:B& "$,-*G9M1JMMJNQOMCRLVK8N1IM5"@
MJ27!0ZF M0HNR#O=;T+9ZLV)!VM1Q5X'A#E;:(S+",D +)\&^.""E6LI>J&H
M!!=>,6 &Z[&,!)S:'Q1HE"D,X:?8E.(<QX9,I5BI(-4;%T00""+ /(]0#-58
M.H8 B[%&K!!(-T2.8Z$R0N5EI&M>U/3JW:=K6Z'#?ED]RGJ[8[M'*.MSQD@C
M5Z57*"*Q!@/,>G%C) U83Z["\OX=G(>E^9&7<(18L2%'U 0*V-$EC^LF5"*"
MYYZR"P.XL*%Y?!1]LB6Q]0=262^E;N\_=Q$&T&:I9+YK>N7 B#U=L6RT84-!
M50]=:A!PVV3E"PP*NBI,*+,@!;".K5>A6D6<CB(;;=QE<*%\IH$*Q4%E!))
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M"@0V,,*GQ6UHX"@XZT*!2K1U57,V22222;W,KX*:,B'41EO6Q/F8L I)->@
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M@/KBR:Z1$IUUJE8NZJXJ5 -1\V$0>H-V V>-&QG$>OV$?7[,&G'E &AQ: $
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M8P---5E@2Y !*A38KH=6PWY<]Y=,I-VI.RL H)(#%AI._M#3ORY\IGO4"?\
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M SHPD&*P9#:78A&#)8SYO)A680%<E&K /H0;0D&]P0001[H<AL9(Y$@=0;#
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MHW7+8#H!9H"S0 )-DT+,NJ*MZ15\]R>I-"R:%DD 4!9H3 NJG[C43_>/O?\
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MHL)R9D,+D*;4:@-()W)8L%6@#3'22 :%59%U(.= 6V8Z"0Q %  *6:R1:KJ
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M:/4.M9JH.6J1H(CO]TN@AL735XMT:!)J(8I&F.S#4I*;$TQ$@#8P^2E]K90
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MR]:W;VO?)#J74W5H-JV0+;'^Z[7K)'K0@=5-J5VA62M5&JTL]>K'3ZN"%L5
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M&"%F.DK,;D>O/ZV2I.??C9<C.RUE[+$?,CW>(VQ$:88;@Y QLXL9- <\O(
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M%,.6O8FI]>U3KM)[";8Z\PMFB]R&C-X"&];[#V!K0=;+SK@KJ*LU\-5+/9*
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M 73=>15Y(ZMAX#T@=9"\F,:.$#A)R7;,A74A3S*R@JPLXRU>T23NYNR3R&P
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M+E80E3JP"$Z1.62R%8(0$''L>&7II0L2?C0($5KQQYY$I]II.<XQE7CG&,R
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M3,TZH%YMYH;DMZ^VF9BS4JXU"=92#A,F\IFY@7XMH?D*2\>KL_,*QBH3(O\
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MBR!0)!&K<U8JS.:$]]J"*>O,S:KPZE!Z7=-PU%4,.+OMTM)-N@=HQ?6*IEX
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MAH]7##X<]B8<= 46@7:I[7<1(;Q%1K?8*A5?DY6DJ^0A2HHY;^^%;U,5#*
M00I)/06S K_G+N>0!Z<^=JTJ&*,38:W   W-*I5O\UJ!]1)TZK%-JF]91#&R
M]D"-N1":HLJE;$9U:7TO9[("3#:B3IEOUT1E2X@F6^=BDIP&<(^'0RE7FAWU
MB(S[:YI*F4*&I5*'JNH.!U ##<[<[NC>_I?$7*VS!Q^:V@H2.1M231L;':P>
M0E; E<W*]6NS"!FN^P58DW0U!'5>MG=H0C!0R$ EK>4M=LJ]UF;8D_(BV[9
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M58@CM'@79M(1MDXCBN#(!#KNQ4+?FH$$\V3OYV=Y1PW ]I\06(!_O'C JV6
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M95F6XZD1ZL9G*9JUH7XL,RXTS+=B:K^ZGT9E"?W'[2#@"@>*X>V(QD;$=AE
M/%IC:T1N59+PE^0]]P5'[H\"1N"?R;,  6%V#VJ6)T6!3;'8$-_"3CU:!]M8
MK+[(WM)H> /=AQ&<ME*7=%SLS$PX+;\AI]>T;9,C8Q,:)/+=9-H;?]\;=0*9
M9S$& +#M?Z+@%.3L'M?(X=C>/B>%"A-3%5(' <.C>4H &Q$C20<MZGS5/9_?
MLLX3M;LM4*@#5P_%7JT@:A?&9V3S!B2N6CJ%8PH5$T)'5'VQ[V):L]R=.I<E
MX5CQC#]OLICH4H@\WB*C%];;BN,N+%(RI+3^5M0U-NO265D6SUE[P_1HM?\
MRSVD0O(%NS&LTH.HGA+:QXAYBBP("D(<56['[[,=^V^!%BB5_+U%62  N:E(
MI!=$T""6!;7M&ND7M;E+S+>[[5EI[$EZ2F(R7VFF%E&)41]B+F.^W.<;8=88
M>A.HR0DJCMRENMR)#Z<.YL>]7T=:= [HYR-*KJ.'L[7>E@S:E*V0Q# Z!94
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MAJ>HF'TN.);2KS2BXR=*<1X-(REIQY;2%>=2$)4XYE7!E[\]\LK,S]Y^V[8
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MY10/4@2.M?\ 5+K"+G64:0H6D;81M=@,[#K(]%;K$R:.H9A4!@2R/B.HD/N
M8;[:VX\Z"VD1EV7A$?*5+\%7;)D-4V1: 4^9MV%W]ON.\HN+&+L(226&PO2>
M7V#E<E'YJ'67Z@]2?D'7/T#E/$R?I'^\W[9?PL7U%^4?-0ZR_4'J3\@ZY^@<
M>)D_2/\ >;]L>%B^HORCYJ'67Z@]2?D'7/T#CQ,GZ1_O-^V/"Q?47Y1\U#K+
M]0>I/R#KGZ!QXF3](_WF_;'A8OJ+\H^:AUE^H/4GY!US] X\3)^D?[S?MCPL
M7U%^4?-0ZR_4'J3\@ZY^@<>)D_2/]YOVQX6+ZB_*/FH=9?J#U)^0=<_0./$R
M?I'^\W[8\+%]1?E'S4.LOU!ZD_(.N?H''B9/TC_>;]L>%B^HORD1 NKW5?&P
MC=P^1^B"U3V !IM5HE:9!U.1#19J40V'*N$L"G&'($\B8C&A$8FR):5.;34O
M CYT1&,1[G)DTA;R J26.IKHZ:OJ*HU?KM*#%BU$TA4@!0*YB[^TV/E)=^:A
MUE^H/4GY!US] Y3Q,GZ1_O-^V7\+%]1?E'S4.LOU!ZD_(.N?H''B9/TC_>;]
ML>%B^HORCYJ'67Z@]2?D'7/T#CQ,GZ1_O-^V/"Q?47Y1\U#K+]0>I/R#KGZ!
MQXF3](_WF_;'A8OJ+\H^:AUE^H/4GY!US] X\3)^D?[S?MCPL7U%^4?-0ZR_
M4'J3\@ZY^@<>)D_2/]YOVQX6+ZB_*/FH=9?J#U)^0=<_0./$R?I'^\W[8\+%
M]1?E'S4.LOU!ZD_(.N?H''B9/TC_ 'F_;'A8OJ+\I$]DZE]9X6T:A<YM&TG7
MZE6Z5=JG8*?/K=:@1#=GV)9M8OT$Y*9>0Q S-$-4FX! GO;#DZ0[;9L82XG#
MA!I^PR9"I4,Y)92"&8T%#:ASO?4I/387TE3BQZ@:0 !@1MN6*E3]@! ^.TEC
MYJ'67Z@]2?D'7/T#E?$R?I'^\W[9;PL7U%^4?-0ZR_4'J3\@ZY^@<>)D_2/]
MYOVQX6+ZB_*/FH=9?J#U)^0=<_0./$R?I'^\W[8\+%]1?E'S4.LOU!ZD_(.N
M?H''B9/TC_>;]L>%B^HORCYJ'67Z@]2?D'7/T#CQ,GZ1_O-^V/"Q?47Y1\U#
MK+]0>I/R#KGZ!QXF3](_WF_;'A8OJ+\H^:AUE^H/4GY!US] X\3)^D?[S?MC
MPL7U%^4?-0ZR_4'J3\@ZY^@<>)D_2/\ >;]L>%B^HORD?&]&]<:K>J"1I@W2
M^K+KKRQ)V,70.B5BO6:12(E<LX8JEU$1R$0BA'7"K,J80EHR*PV.<P^KS)2I
M%@^0AK+L&&D66(NQ7/:]J]94X\892NA2IU'D"11'_,'[);J)+BSXL:=!DQYL
M*9'9E0YD1YN1%EQ9#:7H\F-(94MI^.^TM#K+S2UMNMJ2M"E)5C.<N7.;<^4W
M'$1Q$<1'$2#NP&O;!L:EB1U9&U"PE:]>Z7=&ZE?R,T12;<S6#3,]X%8B8^L7
M25 CY1_TH.EMU0\E@Z,$N.0<MI6^S?&P5C9(!5A:BV%C8@$KU]XVN9Y%+*
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M0:YK2UW.8@.[7 NX'B3.NEE!Y\428)6+(BO6H@]@#[ID\)AL Y29YP8,A2)
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M[P-,<[U<T)7=3R%0';?%-:A'VW8ZAB M>(BG(T/!*Q6RG$)C4>05YR%V4 H
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MJRA?-=@YN&JB39L D&]Z)Z2!J)QL0;*8"377PN*O:J%$C:MK KE)OIE[[52
M O:2-B[.R4INY.A&M0&I\ *N#UL;J&X]#=7'=QKL0B-2XY.2ARU;(N9+)9LM
M%B4$J)6V)0)B0RD%ZA7%>G2H!3B&+DG5:/D\.C=#95%4=5]21+JV8C5J:UR<
M.H2@%(?'BUWY;]IV-@C21Z B9KTCWM>[GV(UA2K!O';>P"ULZ;W7:V_M=;%J
M$*OA=<=AAFP]$!"H2IN_(*KRA,6O8MEOK[=+@&S@D4%;!'%YD2+$R>-5S(H1
MV"*H7,%QLIO5C*Y*)\QN](.J@221TH6P9&;(BEV8M@=\BLM!<@?&"%\HJM3#
M39H4>H)[D^<D[8XB.(CB(XB.(CB(XB.(CB(XB.(CB(XB.(CB(XB.(CB(XB.(
ME'A_7W:9,'O43=V=.39&VX^:M"=#.7D77QFL@RKO*IE%57*VBF$QT09,LSSY
MDB,N+APN7MMV.I,QH35:JD#;6H*%=8T[_FV6.FS9OF!L"*%**YF8#&Y&35H\
MXJP6V6FI: 4[7N=5DEC=4!PFT-46O6O4C8)HMM39;FQ-5ZVW==:T:J^TMF#8
M F2ZNU7BI5Z6N79G2%^&:^BK$5,06OV2Q(R("-O$F(Z9\@<U*N&RJ BZ69%(
M*J;Y*3R\I;<D+5$[<KAD*XR2S:E5R*9J',@<[8+L 6Y@<A=2_G,)O'$1Q$<1
M'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$3&[E4:[L"H6JAW 8V:J5VK9
MRHV@,Z_*C-%J[9!DH,;&.R8+\6;';GC)LJ*M^')CRFDNY<COLO)0XF58JP93
M14A@?0@V#]AD,H92K"PP*D>H(HC[1.9@08@N#"&P&<1X(Z)&@PXZ5+6EB)$9
M1'CLX6XI;BL-,MH1A3BUK5A/BM2E9SG,<Y/*;OB) T;K'HV'M9S=<>C-HV&X
M:E6=,]5AM;M>CVZ< 559UV@T%XZY0!]ZG5IQX%-N\&L1[9+%2)4&08<CRI"'
M=/%?1HU>6JJA=7>DM6HJ#N%)H'I,_"QZ_$T^:[NS5D5JTWI#5MJJZVN3SS.:
M1Q$<1/Q24J2I*DX4E6,I4E6,92I.<>&4JQGQQG&<9SC.,X\,X^C/$2"=3=9M
M(:.*D36L*0FNDB(EBNH>D6*V61L%5HLQ9"-3J9$M1XW#H=*CSEXEL4RE, *L
MT^S%<0(2J)%RS=\CO[37O?("SZF@-1]YL^_>43&B$E5J]N9-#T4$D*O^2M#W
M2=^4EXXB.(CB(XB.(CB(XB.(CB(XB.(CB(XB.(CB(XB.(CB)$6Z]O0='TIW8
M)RJV6R585,1BV3*S)J++]1 YBRWI-K)1K;::M\2$P'F(\65 KCAJS.KG,N#@
M)!MJ3EFR+K;2" 3RN]SZ"@=_>:&VY$H[A!J() YD:=AZG4PL?"S[IL]'=B--
M]CZMFXZ:NT*WAFL0\SFO<2X(X)R1CYECL&JS8QXBQ!TDHJ52ACI$7&9)Q4JE
MCG94;'J\E\;XVTN*/V$'X$6#]AVY'>$R)D&I#8V/(@B^5@T1?2QOTF!I[(D8
ML7='QW5Y047U0Y5&1P>+;*V<S9R%_+$PU+K9 J,<=$5&WSGXP(J=!3)A-NM5
MB[4\[*)24%'8L2?#'DIK#79HBM/,@'<CG1H6016TKXA\]K16M@P-EK !(V#6
M!8Z @WOM#/8;LEK\]U W;\JY\&AV^QZV[(:_9IY(C@B^[<M>OW?5]D'B"<6(
MRP6'JM8.2V')+C#W" ^3!E2( ]]YZ''NF)O%0*-0#8VO8>5J8&B?0[@$U*OE
M4XGLZ6(R+IY[K:G>N5C8FMO3>NPOF$WCB(XB.(CB(XB.(CB(XB.(CB(XB.(C
MB(XB.(CB(XB.(CB(XB.(CB(XB.(CB(XB.(CB(XB.(CB(XB.(CB(XB.(CB(XB
M.(CB(XB.(CB(XB.(CB(XB=:WM!I-D"LZSNJK(" U"@V21:6H-D':A+0C)T3K
MS;)PT:&JV3KR\3JV8UQ5 +UJ4:$M*Q("NETH:@J&2IKO1@ .H5;,*VU@@%E'
MYK*#J)JCUKU$YN(L:#8 4D[Z*)TL2?.C45 NQTN63ZFF,W+2U5V&5(E;#<+5
MBQLV>RVF*(8NCCX>_P!U2BIV%(NET!8U-#(SC-=@5*?5 Y"F>C+ DXF3<<M,
MF9Y1I=E   J@.7LKN-VO4*-@D'F#533"=2!B26-V2 #LS;'9:TDD $ KR.]S
MDA'5O3 0)<:U!$W1=;OQ,\:M%?);@W&:!S"MG4?>/3X(DS?9\ #((SK*4,.+
MK\<7Z5@0(L<?#)VNUXB+'*Y()(M: .A :%4"0H)J@-[VL<B;D8D ( :F))&M
MZLV20-6QLD[5O1Y@5B?8.DUK7?3#L'4:B/=&@AFBMU/L,R214U/DS2]6M)HR
M5+'#LTF<.FS9D@0,&SALD0,&2TZ82)S94V4^^X1BV5&8V2Z>@Y$   4
M   *&T.H7$ZJ* 1_4\P222;))))))))-G>6PYG-(XB.(CB(XB.(CB(XB.(CB
M(XB.(CB(XB.(CB(XB.(CB(XB.(GRI248\RU)3C_.K.$X_P#/.<8XB<(Y:*TT
M^N*[8@34IM>6UQG"X]#Z',94G*%LJD8<2O"D+QE.4X5C*%8\/%.?#8</G(##
M!F*D6",;D$;;@Z:K<;^\3,YL(-'+C!!H@NH(/I5W<V1>]4BOL8E'KC50D7/C
MX22]A$#6,^&4ISX/3)C+?T*6C&?OOHRI./PJQXVQ\'Q>8Z</"\1E;ZN/!E<_
M)5)Z'Y2'XC!C%Y,V+&.=OD1!5U=LPZ[?&<?&VAK.:RF1#V)19;"\9RAZ-;0#
M[*\)_#E+C1!:%8Q_#X*SX?P\LW \<I*MP?%*PYAN'S CX@H")"\1P[J&3/A=
M3R9<J,IZ;$,1SF&E^RW7( O+9[?^DPCF'W8V4%]JT0:O$EC.4O1\IF'F58?9
M5C*76LX]1O.,X6G&<<ZL?8?;6;_ ]C]J9?*&_@^S^+?RGDWEPGRGH>1Z3#)V
MEV=B_P +Q_!8]R/X3BL";CF/-D&XZCF.LQCYYG3_ ,KJ_G6];/(S_CE_=SUA
MY6OP?XU7RI\&_P!EC]EG'X<?Y\<Z/[F>\FP_N>[<L\A^Y/'[_#^]]_LF'[N=
MB[__ !CLO;G_ /$.$V^/\-M,$F^T8Z"CUSVY7<_K$ET8IQ$QIK=NO)+C:VL+
MRM#;<8^\N0K&&U^5,9+V5YQX(PK.4XSUIW*[WY I7NQV\0X!4GLOC%!!K<EL
M( &XO55<S4YF[S]W$+!NW>R;6P0./X9CMSV7(;KW7,<B>U#]G;-\/1[G]=T>
M,G,3'O>S*[ _7<81GS9]^EQ_"-X.)SB9GPB9\%^#^?2<\FS=PN^B\^[';/LZ
MO+P.9K!OEI4VVQ\OM<MMQ>0[V]V35=N]E[G2/[[Q#?WVVPWYFASWV,Y*3[2[
MV>T5O+KO=3K*I.$K5X1]R4:6YG",>;.,,Q#+SN59Q^P1A&5.9^];2I7T<H.X
MW?)C0[K]N7L-^S>*4;FANV,#GS-T.M2Y[U]VAS[>[*^SCN')^P!R3[@.9V&\
MQ";[6/V<<%/G7V\U'*QA64J^$DR9Q37AC.<K?2&%SU1VL>'TO/8;9Q_"OZ<<
MZ5^CSOLYK^YOM)=K_A<:8;OEI.7(@8GH%LGH)D_?#NPE$]M\ ;Z8\OBD==QB
M5RO+J!.-S[73V=BFDOQ.R0DLRM?II< 4#;5B2ISQ3CR8R"H)'[[/G3G&/PY3
MG"\>*?IY?][GOI=-V'EQD"R,W%]G8#7K_#<6FW\AVYR/[L.[=!E[4QY%)K5A
MP<7F /H3BX=P#N-C1W&VXGXY[7'V?;2LH=WH4;5C&,Y2O278%.<8RG*L9SC.
MJ\9\,IQE7C_FQG/\&>2/HY[Y'EV2A^':G8YY&C__ &'0D#XF5_NQ[N#GV@P^
M/!=H#^7A)LI?M@?9XPDI7(WP5QA2LIQY-'=A7L^;&?#.,I:U0M6/#/CXYSC&
M,>&?'/T9Y9?HV[Z/87LA#6YOM7L8<_CV@)#=\^[:\^T'/^;V?VDY'Q"\&2/M
MFNW[7CV>KJ$.(WN3RAQ&%ISG278).<I4E*L9RE6JL*Q]ZM&<XSC&<84GQQ].
M.0?HX[Y#GV0GI_C3L?\ E_="NADCOEW;(!_=!A?KP/: /P(/"6".HYB<>[[8
MOV=33^8R]\F,.X5A&<8T5V*4C"L^/ACU$ZFRW_!^'S>&/%/CG'F3XW'T:=]"
M-0[(QT?_ /;=B@_(]HWU'24/?7NV#7Y?E)NK'9O:A7XAAP6FO??\HOE<^US]
MGKAM#GS@'/*M:D9QC4>\\N-92I*%9DLXUGEV(C"EI3ZLI#+><^.,+\4J\,_W
MN>^>_P#\'Y=?W1[*H\]@?RZF.QV4DCTW$T_NP[N;']T3O=#\CX^S6YV_);KW
MU1Z3\Q[7KV;^,K1)[34X:\A/G5&-5S88.9A/EPK'^!&*=!EYSE*L93C#.5*Q
MG'EQGC][?OMT[ XEQ];%GX+*OI[6+B77GSWVWOE(_NS[L#9NU\"&Z*Y,?$8W
M&P/F3)A5UV(-E0)K,>UT]F_(PK+?;#7V/(I&%)=@7&.O"7/4\'?3?K+:\QV_
M27Z\G"<QXWWOO#K7J-^:#]'/?<4#W>XW?E3\,1TVL9R+-[+S.] T8_NS[K_Q
MUP?V-D)%WN0$L#8V3L*W(GY&]KQ[->6[EEKMYJY"L.J94Y*58X,=*TY3C.52
MIH&/&2WG*L>5[+V&5X\<I<SC&<X-]''?A19[N<?RU4!A9J_S5S%K_P FM7ND
M_P!V7=?4%_=K@K)JRSA0?>Y30![RP'OF0AO:I>SF/*\L'N9H-G/CE/B8O0ZN
MI\<8SG/W]@R,3X?1]"O-Y<YSC&,YRI.,XY>X'?7#[?=GM<__ //A'S?^CXGV
M^G673O=W8R5I[=[-%DCS\2F/ES_PA6A[SL3L-]IFL7VB70B:IE$7N?U>=5(7
MA#./NYZW1YU*6I&,?KEB1A/BI*L>*_+CZ/'Q\/IYRMW+[WH&+=V.W@%%D_N5
MQIH;;[83>Q!VO:;+WG[N,0!V[V22>0_=#A1_+E_E]WJ)*E+[0=:-D'8E6UYV
M(T7?;-/2\N#7:7MN@6D[-1'PA3ZX@@'8)Q"0EE+C>7E,QUX;PM&5Y3A2?'Q_
M%=@]N<#A;B.-[%[6X/ A ;/Q79W&</A4FZ#9,N%$!-&K871J=O#]K]E<7D&'
MA>T^S^)RFZQ</QO#9LATT#28\K,:)%T-K%\Y.G/$SR$<1'$1Q$<1*$>T %LF
M:1J$9+IT:QCI>Y8:29^;K_>NU!U&A,:]V#,44,Z]Z^&:]=+77[0_&CZY/"3!
MAFC2AMS?:MT(J/5@=(WP7J:B12709%).I1LV2U!%Z@0-0K:N8PX@ J@*WY^9
M7(P6E8V5QD$@^R03I-[@C:3]UD%1@VD:;$C/LS,ONVHM.(M4S9NOUEC!VY6$
MV<,S:IN4Y9=G0"I@P0G$S$NX'21(V4ES#K3^()*(VWGD]MOL%6K4   +0!2
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MCB)!G8/89W6])%$ZZ7J58('[U2Z9FY7T?)*TRFQK.:9@/GK -BV6G.SF?+G
MD;&^5(-MPZ5%8>F*:\\61?&H9B""0%9J4TQH70--7KR.P,ID8JH(*@EE%L+
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-<1'$1Q$<1'$1Q$__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>56
<FILENAME>g63033dsp1b.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g63033dsp1b.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M:;K-QJRO'I^LP7-VHR8QO1?S*T 9TGC6XMKJ6VGD=9X3M=.>#_WS0 1^-RX
M,TP..O/^% $\7BJXD)V3.6'51N/\A0!=_M?4\Y=C N,@SOL'Z\_I0! ?$4PD
MRVI1[.G[HO(?Y ?K0 C>(IF/[F6^?O@!1Q^(/% $ \1Z@F2HE;=T\ZX! _[Y
M H C?Q+?-E)9[=1CHV6_K0!576+A_NWL2'T2+_&@!YU2^;!%U)C_ &8/_K4
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M1#^[,HX4D=__ *Y]: +-A=2)##<V<Y2Y.YIU@CW,PQA,KGCD?K0!/%I:7\4
M2&5R8VEE/41-UVD=3G P* &^:VGK;O;NT<UQ$RA)8R^W'(!7/!)QS0!5GFM+
M=U%VD-PDR*TI )991TSVZC\10 V"YM'N8(YXO+WL9+LS,"S,.<[AZ?UH NPR
M33O;V][/,R1([I(5VKNZ*H/?(QR: 'PZ0L4D*/#/;&XB=SN&!&03PQXYZ8^M
M %8W)OK=3-+$EJD19%DC*D2 \ D<MP,_C0!76^L&D5I;$[<@W"K]PRC[I(^G
M/XGUH L65W(D,-U:3E;D[WG6!-S.,87CZC]: )EL([J"W<0R/A#+(6Y$+==I
M[\]OPH R_$R/=^'Y+8/(EO-JTOFF A78J04 )'][!/TH PK&V2#4!?W>I:DZ
MVTMQJ,N) !NV98'Y?XE&W'8F@9ER3W]WJ+SRJ&U*<J&V\>6NTD1)_=1>!^&:
M -6&QFEVO-(DD]O\RRVTF)X" .5;KW/MZB@076H6LT;_ -I*6E6W>UW6\S6Z
MO&Y^960*RC)Z[<?2@"M>:_'(!!"56.95C=8<DS*HP!([99Q@8V\ XP10!UVN
M036WA&PC>1Q>1K]H*YP=I(''N.#B@#G+ &[:UL \T=PDKW>G&"01XFY,D)XQ
MA@2ZCUW#O0,SIM.@M;7[*;_4!&MN]J8S<KN\MFWG V_-\W)_ =J '3;S=1S"
M\U SR2P7#-]IR!)&N%.-O.!D>_'I0(%M8A T8U'4$CCCEA ,X)VRDF0?=_B.
M: $M=6NM#UI4M;]!%J5M]GE_M&8LI5$VJ%P/OX.!V)/O0,]3T\;1HHZ?O(__
M $FH$==2&>>>+PYM8Q$)B_G6X40SB!\^7+TD/"_6F!P-G*ZZ)I^T+)B->,[B
M/7D=3[CJ>:!&@;CRXUU35 R*^Z.VMX=J/<L ,XXPJ+QES^I- &0_B2X$A2":
M*R4L/W-B!'U]78%F^I(^E S0M9I-9CDMKC5-0D@(^>WDGRDOL>,XSVSSB@1<
MM8I;>22\?&Z$83GJYX'Y#F@#>U&XM#X0LK>YPX60APOWD!SM9??C]: .4_L:
M=Y0;9XIH@/E;<!CZB@#JK*P;3?#UQ=Q;9+G[@D7[J'T7U/7)H P+65UUA$))
MBF;8R$DAE;^H- %U]#N-+TZ*\%Q;0R17JRPI.&PZKN#<#G!SB@".WUV&96BO
M8Q:O+D)+YWFV^\Y #,0&CSG'.1SUH ZF]DB-ZTD\4C>7<VQ\M3AMXB?@_C0!
MEW/E-8F0I^]20@-;/^["D\D^C#C/ZT 9OA71(?$>LW<-_-,8H8FC(4\.,X&U
MNV,#H.: $\1:5'HGBE8;.:3RIMF2S@K$"3A"!SQU!/K0!K6TIM]-M9E3R&DD
M+F21?,\YEQA1Z?YS0!;O/*AGCB2S6 B5GD1V.23QB/WX!H Y77W%LS10^>D8
MD,)3>=[(1G('U'Z4 =)=^"M.C\'O=_:)1=?9E9I-P0/@'Y,$X7.<&@#"\-AK
MJ>..:*2<>81Y ;# +@C)[_AZ4 =+9SK.CR7$/VM8I1*&A0H86P?D]^G_ .N@
M#-N3&;(NZ?O%DV[K=OW:JQY)]".,G\Z ,_PKHT7B/6;R#4)IS'#&R$#HZ[L#
M:W;&/QH =KNEQ:'XJ-M9SL898_,(9@0F,X0 <_B>S4 ;=NQMI;"-(/*$@W>1
M(-YG+'!((Z<?Y-  _P!G,\%M]D\JW$11HPY\X9Y)7(^Z.?ZT <EJN][J*UWS
MQQSDHR#ED(( )7N.<X/K0!UNL^'K+0D@>VWM)/S*Y)^8@Q]!V'M0!R095MIW
MD >,Q2[DZ97?T^O^% %KP_:V"+]M9YI6SY2JT04%\9P,'C@<GOG% #+N>34W
MEF\N5=/C&50@QJ@ .25X).0>F>!0!!%+#' CS3L\"E62%=TF\ @Y4GMC- %[
MQ5,8;VYDC DM9PJ+(6)5(2O!'U/ZT 8UMJ=F-/BL;IFC>!E>VN5&X*5.0&'7
MMU_PH T)-3\/W49M766YG>3S!!:QY8G'7=_"/KB@")[^)I9?,\Z';&%B2SC\
MU%P>5/3/KN]<T ;6D6LZKJ.JW$>R[O(MD:%]WEJ%SDD]3Q^M %/:]KYMY#%;
M0?/S.R%Y23WY^Z.W% "QV%[>-YQMYIMW22[<@?@#SCZ"@#;L_!M_.!Y[E1GI
M&-B_F>3^ H W[/P986_)1#[D;V_-O\*!FY!I=I$J_N@Y ZMS^G2D!;6-44*B
MA0.PXH 7 H 6@ H ,4 % !0 4 % !0 =* "@ H * $H 0 #IQ0!'+:V\V?,A
M1B1@DKS0!EWGAK3[P8:,=.%=0ZC\^?UH YV^\!X):R<J<<^7)C_QULC]:8CF
M[WP]J5O@301S*3A0Z^6WZ\'\#0!2-W>P%+)]Y#-M$%Y'OC/TSV^E %_1I4L;
MV1OLT20JK^<D+'R^0%R-W;OB@#*: :5<?9ITN39*[20RVP#NV>J')^50>A'I
M0 W3-3LV2W&K6!G%K\JS1QAWB'^TO!8>A'(Z4 32:CH4#0SF8RQK-YT=O;J3
MYCX(4L2!M R3WYH RQ>W%[K$ER@5YIQM6(,2(XQ@;<_3/- '071BTW1]/M[N
M5A-YCR1R,NYH82/D+#T)SC\* ,5(C/=N@<27!3S ))=I(SC))("\X].30!MV
M3QWMDUGJGG[B K3-&,JK?<(S]X#G/MCO0!BV8MK37+BWB243(KQD.P;R\ Y
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M*,5]%Y+>=:72[EWCJIX*L* ._P!#\Q?#VG2?:7C,$^V2<C<7BC\Q1GURO'_
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MSV\LX\XW5VJMO48&WGIS0!#J%V+F.[>26W>[527-NZLH&]-N"#Z>M &!#++
M83'"[QX<,$ /\9P?>F!4N[=+R833_:1( % "H@4 G&.?>D CQR^28TGOF4 ?
MQ)_G% %G3)/[++QQ171B=AEB%'EG!&\8^M %JSL[@ZA]DFN%CN6 ;S9&)6;W
M#_3'Z4 20V;7<@C-W':3*#NCN5*G/U[_ %H VK72)HK=&OI=,8'_ %<@#,Q^
MB]STH ZJSTV2YC598?L]F!S'MVO,?5@/NCVH&;JJ%4*O '  [4@'T % !B@
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MK<Z]+9VKRQ[%N)R<R@<JH[#TI 8NN7<B0Z8JS,8Y(1(=W=CUR>^.* -;PC-
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M1<1LV_A>VBMXXY;B>5D&"WRKN_ "@9HVFEV5F=T-NHDSG>W+9^II 7,"@ H
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M8&-]T,T3X\MNQ1UZ'_)S0 ![&[E@N=;1BUN6*7\):-0Q&/W\:?=_WUX/\0%
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M@%H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M$UO(ML;:*)L%UC+!BTI'&[(&U!]W.30,[X4@%H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H R?$/B/3O#&G&]U&4JI.U(U&7D
M/H!6E.E*K+EB1.<::O(\_C^*FO:FS/H_A*:X@7^)0\GY[5P*[OJ=..DYZG+]
M9F]8P=B2P^,<<=X+;7=&FL3G!="25^JD TI8%M7IRN-8M)VFK'I=G>6VH6<5
MW9S)-;RKN1T.017GM.+LSK335T3TAA0 4 % !0 4 % !0 4 % !0 4 % !0
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M&ABCV@]0QRWXG@?@*]3#OV>&E..YPUESUXP>Q[%##%;0I#!&L42#:J(,!1Z
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MQR/IT\;&481E>&_;]3U,+5E*-I?>>LUYQVA0 4 % !0 4 % !0 4 % !0 4
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M2-8HP03'G[Q[$GO0!%I 2T$VI2CRX(%RFX]7/0#Z4 :'AKSKO6-*AY!:\64
M'((169C].V?4T >\VX*V\2D$$( 0?I2&2]* "@ H * "@ H * "@ H * "@
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ME/='HOQE_P"1*A_Z_$_]!>N+ _QCJQ?\)F#\._!P\1V\.NZ_FYMH5$%G;O\
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M>C/G@I'35@:A0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 AXH \U^)EL\<EC?(H\J*9DFR. LJA Q] '11_P*F!Y\DL*K)I,
MTGD^8P,;D857'KZ9H$0-9ZG9.L31F,;LY4YSSU![T =WX4MYKK%UJ=LLEN@R
MSRKR_' 'J: &W]^FI.EVD<<;0RA"J+C:G\)_"@"GK%V&G$]P?*W<* .H[8%
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MTKHRK&HDD)DSW  Z>] 'HGA+6;G7M!COKR&*&<N\;)$^]058C@_A2 W: "@
MH * "@ H * "@ H R=9\,Z-KZ;=3T^*=L8$F,./HPYK2%6=-WB[$2A&:M)'E
M7BCP)?>!C_PD/AR_F$$##>K'YXP3CZ,N>",=^]>E1Q$<1^ZJHXJE!T?WE-G9
M'Q')XD^$VH:G$H2Y-I*DRK_"P!#8_#G\:Y/9>RQ"@^Z.CVG/1<EV9F_!6. >
M&+Z1<>>UV0_KM"+M_FU:YA_%7H9X/^&_4]+KSSL"@#Q[751?CSIY3JS1%OKM
MQ_("O2@W]3EZ_P"1Q3_WF/I_F;WQE_Y$J'_K\3_T%ZRP/\8O%_PF=#X$B$/@
M71E QFW5OSY_K6%?^++U9M2_AQ]$=%6)H>-_%X8\6Z$PX.P?^AUZ6#_AU/Z[
MG%B?XD/7_(T?C<T@TC2D!/EF=RP[9"\?S-++_P"(_0,;_#7J>@^'4CC\,Z4D
M0 C%I%MQZ;!7!-MR=SL225D:52,;(B21LDBAD8$,#T(H \H^"851KX3E0\6/
MI\]>GC[^Y?\ K8X<)9<UNYM?&&=XO ^Q20);J-&]Q@M_-16&"5ZR-<5I29X#
M7O'CA0 M &V-.AT2*.XU6+?=N \5B>,#LTGH/1>I]AC/,YNJ^6GMW_R_S.A0
M5)<T]^W^9EWM[<:A=-<74A>1L#I@ #H !P !P .E;0A&"M$QG-S=V5ZLD]I^
M",K'2M6A).U)D8#W*D'^0KQ\P7OQ9ZF"?N->9ZI7FG:% !0 4 % !0 4 % &
M5K^I3:3I,EW#&LD@>-%5NGS.%Y_.@#B+SQ_X@LD5Y=/T]4ERL+,\@#N#C;G&
M!UIV QW^,.K01W/VC3M-CFA;8(C.X8\X)Z=/>@">/XKZQ-(QAL=+>%<#S//<
M!F) PN1R>>U &VGC'Q(+1+B>PT^%&!(;=(RG!(P"/H?RH$-7QQK;J0EMIKN9
M=B!7<Y!Z?C^%%@,6[^*^LVXC=-.TUH&<(9&F=0C8R<\<4#(S\8=2:2>.&RTV
M1D95C42OF3/4CCI[T :NG^/?$NH3&*'2M-D9<[A%<,Y!"@X''/49H LGQMK2
MSQQ/#IHYP^'D!48[ ]3V[46$5KOX@Z[9(LLMCIPA<E$??( 9!CY?0=10,R7^
M+^KP+=K<:=IL4UN=OEF=]S'.,].GO0!*OQ9UB0NT-CIDD")N,@G< G^Z..3]
M* -Q?&'B40>=<:?I\*?-\^]V0X)& 1W/I0 Q?'.LM$Q^SZ<S>9M4*[GY<=3W
MSGZT6$9=_P#$_7[%)-VE:>\MN<3H)7!C.<>G(R#S0,K?\+@U$R;%M=+;]SO!
M69R"W]T8'- 'IOAS5)=:\.V&I30B&6YB#LBYPI/;GFD!JT 4-5TR'5+.2VGB
M26-U*,C_ '74]5/U_3 /:@#Q?7O"%]I%Q*6@N;VT (2:-=\D8])5 ).!QO&0
M>^#FF!F:9>""7R/[:BMXNN'FQ@?0C(H$;^H:F?LD$UI>K=Q?PSJV]6([9_3%
M #M(B#^(=LIS;72!QGG"XR?R(H H:IY,MZ]_K$[Q+(?W%M"HW% >/HO2@"YX
M?U/3X]3C6S26,E=K13'*2 \$$]J ':Z\=AJ,OV*V,,D;;8PS%A'N&#@'OCO0
M!>\+:["=,EAU)MUM+*(XRR;F4XY8?I0!0U^98]0ELI=7MI1$W,,#88\9'R*,
M\YH AL+2?3[NWNKBQE2529+6TQB::0+Q(R9RD: EN>2<<4#/1K(ECHK,VYC*
MA)]3]FH ZND!YYXS6)]/VS" Q%K;<+B8PQXV2_><<J/<4P.0\+ZC/I]EI,JN
MY"1C]VCMLV GC'<9/!(_&@14F5]-GELE.)+*Y<(,8.QB9(F'L5/Z&@"[;?8;
MR<3I#*DS?,8T^Z3D'@_C0!'JU^=0O)$C#S"+Y3':PO*(0.Q*@@'VZT 92 R2
M.(VW,A&1RLB>Y4X/Z4 =C8R_;?#4SR'YHIXY)1GJ K#/U/% &*KW-_>QV]NR
M"[NI&6-B,B,#EY#[*/U(% ';0_#BQ\E2)KQ6;!<M>R[V/JW.,^N *!FGI7@/
M1]*N5NK>W N023,S-))] [$E?PQ2 Z:.)(E"(H51V% #Z "@#'\4LR>%-79"
M0ZVDI4^X4XH \Y\-HVH^*+>SU2VN;M(+)BCZA",E@$# 9SG!+<^AIB.Z_L'1
M@>-(LO\ P&3_  I#%_L+1\@_V19GTS;IQ^E  =#TENNE6OT\E?\ "@ _L+20
M<C2K0?2!.?TI@<EXIL[G3[R8Z1H%I=6Z::\CQBR0MYNXA60XY9>#M/50<<T
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MR&B:C#>^)K9$U%-1D2&4F1<X0$( F#TY!/Y4Q'99'_/(?E2&&1_SR% !D?\
M/(4 &1_SR'^?QH -V.D>* '>8V,%3CTH :&VG(CQ_GZT .\Q@<A6SZY.?YT
M)O)_@/Z_XT )N'_/(?E0 9'_ #R'Y4 &1_SR'Y4 &1_SR% !D?\ /(4 <=XX
MACFO=%,EM$Z*9B?,;&SA<,/4@X^G6F(W? Q)T!R0!F[G/R]/]8:0SIJ "@ H
M * "@ H * "@#G_$G@S1O%$8_M"W(G486>([9![9[CV.:VI5YT7[K,ZE*-16
MDCA)/@Y?6S8TWQ(\<9ZJT94C_OEN:Z_KL9?'!,YOJKC\,VD:FA_"'3;&\6\U
M:]DU*53NV%=J$^_)+?G45,;.2Y8*R+AA8Q?-)W9Z, %4*H  X ':N$ZC(\1>
M&-+\3V0MM2@W;>8Y4.'C/L?Z=*UI59TG>+(G3C-6D>=M\(]9T^8_V-XE:&(^
MN^,_^.GFNWZ["7QP39R_591^&;2-'2/A#;1W:W>OZE+J4@Y\OD*3[DDDC\JB
M>-E;EIKE*CA5>\W<VKGP!!-XUM?$4=[Y*V^P+;+"-H"K@ '/'Y5@J[5)TK;F
MSI)U%4[&CXP\+KXMT9-.>[-J%F67>$W] 1C&1ZU-&JZ,N9(=2FJD>5FEHVG#
M2-%LM.64RBVB6(.1C=@8SBLYRYY.7<J,>6*CV+U24<AXM\")XJU2QOFU!K8V
M@P%$6[=\V>N1BNBC7=*,HI;F52DIM-]#KZYS4XOQ5\-=(\33-=JS6-\WWIHE
M!#_[R]S[\5U4<5.CINCGJX>%35[G++\*O$J+]F7Q25M,XVAY.G^[G'ZUO];I
M;^S7]?(R^K5/YW_7S.L\*_#C2/#,PNRS7M^.D\HP$_W5[?7DUA6Q4ZNFR-J5
M"-/5;DW@KP2G@U;X)?M=?:BAYCV;=N[W.?O4J^(=:UU:PZ5%4KV.DO;.'4+&
M>SN%W0SQM&X]B,&N=-Q=T:M)JS/EWQ!HESX=UNYTVZ'S1-\K=G7LP^HKZ2C5
M56"DCPZM-TY<K,U6:-U=&*LIR"#@@UHU?1F:=M47M1US5=76-=1U&XNEC^X)
M9"P7\ZSA2A3UBK&DZLYZ29GUJ9A0!8L;*XU&^@LK2,R3S.$11W)J9S4(N3V1
M4(N<E%'U#X<T6+P]X?L]+B(/D)AF'\3'EC^9-?-U)NI-R?4]V$5"*BC4K,H*
M "@ H * "@ H * .=\:D#PQ,3P!-"?\ R*M &/X7N(I=4U!(KY+U8K>W3:H/
M[K[YV_KVI@=1D?\ /(?E_P#7I &1_P \A0 9'_/$4 &1_P \A0 H.U@1'@CN
M,_XT !?)R8S^9_QH  Y!R$.?Q_QH 7S&!R$(/X_XT 'F-S\AYZ\GG]: &\#_
M )9"@ R/^>0_*@ R/^>(H ,C_GD* #(QS$/RH \]\;6=Q?>*;(1V,5S:P6QF
MG61]J+C=@G^7N>*8';>#%5?!^F*GW!%A?IDXI ;U !0 4 (1Q0!0U73H=1LW
MAFB64%64HW1U(PRGV(X_7M0!YM9Z?J&B_:]+6QO+D2(8;?4 JLL,;<9F!.=Z
M#^$ [\#'6F!L:=I<&DP2V]M;VTL<N#)+--*)IB/XI&"<GV' Z"@"Y<R6]M"9
M+NWTZ*-<$M)<3!5)/&3MP.U C+NM/T[4M2DNDGM;:Y=<-)9R,6DQVD4IMD]B
M>?>@"J- T=)S)+?I>S08D\F>,QQ*1T9T526QP>3CIQ0!IR'3W=1/;Z=)),=P
M\R><F0GJ?N<T 132Z4@<K#HZ2A65)'EE<QY&,KE./PH UM.GMYVTLVMS'<1Q
MW2Q>9&<KE;?!H&=?2 \[UBQ-YXJB*QJ76PC"DG!Y+<#N:8A\4KJ\45DDT%ZT
M;IYRC<BJ,E@!W;I0!')<&X$#C5/*\T*D1?Y3;%3\W'O0!+]LFD/G2K)>6[7.
MTP,=A1UYWY'&/\<4 9>M60N-)>YS#^^W-#@@E@, XYZCGM0!ZBIRH^E(9!/8
MPW$BR.I#J000<<X(_K0!/&@C5410JJ, #M0 ^@ H * "@ H R?$^?^$7U7&!
M_HLF#Z?*: ."\*VZ6WBH*)()6FADED>W4*I8K'T Z#G'3M3$=W=W5K8V<UW<
MEHX($,DCEN%4#)/3VI#,BV\3VLMU9P7&EW]D+TD6TEQY>V4XW8^5B5.!G# 4
MP*L'C2TEL;?4)-&U.#3KAU1;IS"4!9MH)"N6 +8'3O0!T_[O^X__ 'U_]:D
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M?1?^^Z #RSZ+_P!]T 'EGT7_ +[H 38?1?\ ON@!?+/HO_?= !L/HO\ WW0
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M+_WW0 >6?1?^^Z $V'T7_ON@ V'T7_ON@ V'T7_ON@ V'T7_ +[H 78?1?\
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MB;[*7$VAZ@NQ-YRR?=]>ON/S% RA9?$#3]0?9:Z5J$F$+L<H H! YYX.2.*
M+TWBA+<1&71[U/-!909(\X'4]>!0(J?\)Y8"9H3IMZ) <;=R<GT'- %N+Q2D
MV_R='OI"B;V"NF0/SH J7?CNRL6C%SI5_&95+)EDY ./7U_D: +D7B;SE9ET
M2_4(F]M[QKM7&>>>.#TH JR^.;*")9)-,O51L8RZ?X\=* ')XVLY(V==-O-@
M'4NHS^OO0!8F\3_9\^;H=^GR>9G>F-N,YZ]@: .7U#Q3%XBO;1;#2)Y%BCF\
MQIF53%G;ALYX((Z=^G>@#M? Z>7H#IY>S;=S@+GI^\-(9TM !0 4 % !0 4
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M!SKS&26)K6::2^(9[CR(P#*.V/RIB,Z>PM;F2-Y2ENIA+W#.<XD[@J?RZ=Z
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MLK<B$W$,T"QH<Y + 8SDCKZT 6-(\+Z=/;FZTO7S>6[Y4NGE2HW0$9 P>@H
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M7GWH U8W$D:NH8!@" RE3^(/(H =0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M91N(RK#@9&30!TVH%HTU"U%N JVA3[*4/R*,$/N[\DT >DIT7Z4ACZ "@ H
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M.Z,::!=R&6YBM9(3;('7]YO!R=WH.30!Z2G0<8XI#'T % !0 4 % !0 4 %
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M@CLX$$9B"QJ-C!05XZ';Q^7'I0!-0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MX::X\MCOZ;1@@].Y&>@H YY?'VI'3;6Z.E#-P-RJ(+K( 3<>/)RW;YE!7WH
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M(+2_7T!.?SH Q?$>HQVMA>I'-(L#$!1V4$XV^_.* /5U& ![4ACJ "@ H *
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M\1WTU[<ZB6>XN?+AGMKU45/.;8=[OY)&S& $!P1Z'(!W- !0 4 % !0 4 %
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MI;^'Q#)=#[//&R1#J1&4QN_><1KG;G"@'Z '<*H10J@!0, #M0 M !0 4 %
M!0 4 % !0 4 <WX]D$7@K49"P4*$.3T'[Q: .>MKS[=Q</.T,<3-Y4 PP/\
ML?7CBF(E%I=0/BS^SM-;VW[E9&.\1_[0/ .#WH %M;F1(546R?OL63S$!^>I
MXZ@$<'KF@!EP;>P7;&D\#I*1]_/F]-Q]@>: '>%KK[7Y,ID+G^UG4D^H@/%
M'H-(9YYK-@;WQ3$5C#.MA&H.<$Y+<#\:8A8YV4)%9I+#>O$R[Q\T849+8'<C
MB@"-IVN?)==2$7F*%@+#9]G*M\Q(]Q_.@"87CRCS)E:[MFN=ODX\LK(O._([
M>OUQ0!E:W9?:=+DNB(@)2S18Y9P, G'KG/;O0!ZFO0?2D,=0 4 % !0 4 %
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MS2=V<_?Y]J 'KX2TA7B81S$H0SYN'/G,&+@R<_.0Q)Y_EQ0!N4 % !0 4 %
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M/(P>A/H>C#C@T ._M.XQN$BGG=Z+CIU/;/?L>#0 G]I7:C_6?=ZDIW'4D?\
MH2]NHXH 1=2N>@<\\ #!//(]B?0]&'O0 [^T[C[P=2/O8& ,'CKV!/0]CP:
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M3'0@D<L!@ANY[8/<?=/4'/% ##\JER",+NZY(P<'D]QZGMP^.M !]S( X 8
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M% #6!";QE2 3U.?E..I[CL3R!PW'- #MN&,>U3RRX ../FP,<X/4 <@\KD4
M+M5Q_"0V.3@@AN_I['LW;#<4 ,;Y 7(("KOZ\@@X/7N/4_P\-ZT */D8IM!P
M"H4*<<<@8ZX[KCE>V5H W[''V.(J<@C()VYY_P!W@_6D,MT % !0 4 % !0
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M>H&>AZJ>#Q0 QDP,;<*,@@IT[D;1_P"/*.GWEH 4%B_?=GV))(_(DC\''O0
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MDG!'/*D%<YSR1M'ZJ.OWEYH 3))!!SDY&#N.3P#GH21P#T<<'F@!PQM )7
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MD&/^ZU  I^4JP 3!&#D  'G(Z@ ]1U0\CB@!YR3SG=D^YR1SQT)QU'1QR.:
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MA)'4=''(YH >K]"']#Q)^ (8_DK?\!:@!& P1N7@$=U& <D8'( /4=4/(XH
M 3NY!+9.0>3D]>.A)'5>C#D<T .#=&5N?E((?KV4AOY,>OW6H W-/7;90@
M =%4J!R>QZ?3M2&7* "@ H * "@ H * "@ H YGX@"1O ^I+$_ER$)M?^Z=Z
M\T <WIUC+(EQ$C))(8LF-Y=N02.IZ@_SIB-*74H@)O*AFEA"I:A2@*+G WEN
MX]": &VE_'%%;8MIXQ%.1*854K*1_'G'*_\ UJ *6H0,$0^=;[II7<B!MRL>
M3D]<'@4 /\(0M!% C,S-_:TA^88ZP=AV% 'HE(9P]^8X=>:[D:/R[>SA,D97
M+NI+#"^G/6F(S0!:2"ZD2&6124$,;_.H;IN'8C/;_&@#&'B*2TEABCFE'V:0
M^4%CWY/4C)]/ZT 7]+O8;VVB@;8H:5IP[\HK8(Q@'/&#U]Z +-U-')H$L4LN
MU;>%G,JP\3J3\HSU&../\* /2$SM7/7%(8^@ H * "@ H * "@ H * *&K'_
M $/VSSQGC'<=QZXY[CI0!C98L, EB1C!!))''/0DCH>CC@\TQ##P-RX"@ \'
M  !X.>H /0]4/!XH 4$_=(]5P4XXY(*C]5[?>7B@!2"<'G.?4$Y(]>A)'X./
M>@"/)7)&,  \-@8Z @GH > 3RIX/% #^@PPP.0<C XZ@CTSU7L?F7B@!&4DX
M^;=G!!PQ)/Z$D?@X]Z $5^ 0WI@A\>PY/Y!CT^ZU #^0.^%/J% (/YH<_@"?
M1J (^!PP 49ZY4  Y/ Y !Y(ZH>1Q0 \')QR6R>, G)'/ X)(ZCHXY'- "^C
M*1V((?\ !2&/Y!C_ +K4 ,& N. H'NHP.H]0 ?Q0\_=H D^9B 0=_(P5R3D<
MC'0DCJ.C#D<T -Y RN1QD8;)]!@G\@QZ_=:@!,[1DX4#N,J,#]0 ?Q0_[)H
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M_:@#T9.B_2D,?0 4 % !0 4 % !0 4 % %#5Q_H))QA6!.1P/?(Y7_>[=>E
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MP#^8 /XH?4&@!^W=D,I##.04''=OE'_CR]_O+0 P;@1@'?P?EP22>F">"2.
M>C#AN: %5ODR-HXR,'  !XYZ@ ]#U0\'B@ ,;$XQSDC!0?\  OE'YLO?[RT
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MR0.&'S+S0 Y2"@()[88')R?N_-ZXX#=Q\K4 -("C(  QGH5P!^H /XH?]F@
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MW7JIY'% "$,&_B))]B<D>G0DCJ.CCD<T .1R0"I]"-K_ (*0WZ!C_NM0 I3
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M?NM0 T;5'W0 %X."H !_, '\4/\ LT 2%0X*E>06!!3_ +Z^4?\ CRCK]Y:
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M5'*GYEXH$/!R3D$DL1TR<D<^Q)';HXY'- "8P R''W2"&/T4[CT] QZ?=:@
M!VJ0<  =U(  ZC'4 'J.J'D<4 /*Y)!4[LD'Y,DY'((Z$D=1T<<CF@",X7YE
MR.AR#^ ()_(,>OW6H 485>=H4 _>!48!Z>H /XH?:@!Q4EB""6R5^9,G/4@C
MN3W7HW4<T ,Y#+@'.01@@G)X!R>"<<!NA'RMS0 X$%<' &,@\@  \>X4'\4/
MM0 ,IR05YY!4IGMEACU[E1U^\O- "#[PP#U7!!!.2.#GH20.#T<<'F@!5*E
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M@,6W<CJ22.?8DCMT<>] "(P"J01C"X(8\=EPQ_)6/^ZU "E5VMG:%P<@J0,
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M_)6_X"U #. IZ!,'MM& ?3J #VZH>1Q0!)]XD'(?)R-H)/'((]<<E>C#D<T
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MZW% #.%!&,=>"I (!Y&!R,'DKU4_,O% #P?FQ\V<^S$DCTZ$D?@XY'- "8&
MP(Z AM_'^R=Q_)6/3[K4 (I^0J0 N#G((  ZY'4 'J.J'D<4 2$$M@@[LG@@
M,<XYXZ$XZCHXY'- #!QM(;CY3PV?92&/Y!CU^ZU  I 7EEQCTVK@'\P ?Q0^
MU #V4EL8.[+#!4$DXY!7H2>XZ,.1S0 Q3AP0QSE3D,"0<8&">I[ GAA\K<T
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MJ?F7B@0\$LV"6+$^@))(_(DC\''(Y% !V##I@'(? ]%.X_\ CK'I]UJ &,%
MP4  !ZC  '7CJ #R1U0\CB@"0'YN0=^3D;03G'/ X)(ZCHXY'- ">ZG^Z1\W
M7^Z0Q_(,?]UJ &]$QP%"]^  #S[@ _BAY^Z: ),EFY!WY(P5!)..1CH3CJ.C
M#D<T -Y'(/=<88$], @GKZ!CU^ZU "*=N.@  Y!V@ '\P ?Q0^U #B"XP1AO
MFR"HSGO\OTY9>_WEH ;D[@=QW @@AP>2, @]"2. 3PPX;F@!58'^Z  .C$
M=.>H&>AZH>#Q0 ,,AOE))+ @KU[M\H[_ -Y1_O+0 F3N##).<Y#!B21@$'H2
M1T/1QP>: '@ED7!8CHFT@CT^7//J,-UP5/W10!$0%5=N-N 00Q  !XYZ@ \
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MX( X(P5(& >>!T /)'53\R\4"'@D]F)R>P)R?T)([=''(YH 0CC*GD8((/\
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MO0(1&^5>@'RD,&_!<,>1Z!CT^ZU '16(Q9Q#;MXZ;-F.3V[4AEJ@ H * "@
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MZE1_O+0 [DG(W;\\<Y))''/0DCH>CC@\T -V@,C(I[!2J?@ I/X@*?=3_#0
MJ, ,C'0$88@8!XY[#T/53P>* $9,+PHP,CE,8&?F!7T]5[?>6@8@^_\ =.<_
M4Y(_(DC\''N*!"J5VJ1C'RD$$@8_A.3R!GHW\/W6XH :RX4@@8P005(&,Y/
MZ#/)4<J?F7B@!X.6P0=V3U 8DD?D21^#CIS0 8&0>F-IR#QZ AOT5CT^ZU #
M. I7A5 QC:5  /(QU '<=4/(XH DW9/).[)ZX+9(YXZ$D=1T<<CF@ XSE2/X
M2"K?@I#?H&/^ZU # 55<' &,=P  ?S ![=4//*F@"3[W!!W\YX!)R.1CIG'4
M#AAR.: &G@@@YY!X?VPI!_0-W^ZU #<J@QE0 .#\P  /Y@ _BA_V: 'L ZE<
M'<"P(VY.3RWR_P#H2CJ/F6@!I)+9#8;.00VXG(P"">"2. 3PP^4\T *-H &
M% '<@8!XYZ@ ]#U0\'B@!"$0MR 1RW52.2<L.BX/<?=)ST:@!/NC&..01LZ=
MV!4?F5'^\M $@RQ.,EB>V"22./8DCOT<<'F@"(J$4$$ 8!#9(  Z<]0 >A/*
MG@\4 +QC!7'!!#)CW(*^G<J.GWEXH 4\L<;B2?8G)'Y$D?@X]Z &#" ,I&.#
MPW&.Q!/3T#'H?E;B@!XQ@YQMPP(*D  'Y@1V'J.JGD<4#!E.[(R6+'(P&))'
MY$D?@X]Q0($8#!!&/E((/3LOS'\E8_[K4 *5&W&U=N,$%2!@'GCJ #U'5#R.
M* &D$$@@G)/8$DD<@CH21U'1QR.: '*_.<Y!P00V<]EPW_H+'K]UJ !E7&#@
M*!@'!4  \Y[@ ]1U0\CB@!#P2"#N.05(R3GDC X)(Y('##YEYH ?OR00Q)!!
M#"3.#C ^;U]&Z'[IYH 80$_NA5QW*@ 'KZ@ _BA]C0 <*2"#CD$%<X/4\#\R
MHZ_>6@![?O$!)+$J0,GS,C )QC[PQ@E>I&&'.: &#);.3G.00VXY(P.3P21T
M/1A\IYH 52-HR%P /51@'@@]0 >AZH>#Q0 C1XS\O/*X*'GNWRC\V7_@2T (
M"2<C<23[$DGCZ$D=.SCCK0 HVA001C (.<# Z<GH,]#U4\'B@!&7"X*\8((*
M8]V^4=NY4<C[RT *K$L,@DYXZ$Y(_(DC\''O0 I&>0!P <AL=. 03^C=1]UN
M*!C, #!4 8((*D# .3QVQW7JI^9>*!#P<L1@Y)/8$Y(_(DCMT<<CF@!#P 5(
M&-I&UOP7#'\@QZ?=:@!%("E3M"XQR,  ')XZ@ ]1U0\CB@"1ADD'DG=GY022
M>N1T)(ZCHXY'- #<@$%6.,@Y5O; (/Z*Q_W6H 12JK@E=N.K$@8'8]P ?Q0^
MU #F^;/7=R/F7)R>H([DCJO1ARO- #0<-D9X.1ALG., @GKZ!NC#Y6YH >K%
MB.3OR&!#9.>@YZ$XZ-T;[IYH :0%7 "[<#C)4 #]0 ?Q0^QH :<+PP]1RI^K
M @?F5'^\M #P=V0,[L@\')R1P<]"<=#T<<'F@!A&% R%  P02!@="">0 >AZ
MH>#Q0 $#!5E Z@@I^+ J/S*]OO+0 XK\^?FW9SQR22/R+$=#T<<'F@!G Y7I
MQT)' X')Z8/ )Y4_*W% #QAN#CH1@IC_ '@1_->H/S+Q0!T-EG[+$6W9(_B(
M)_,=?KWI#+- !0 4 >:>'M*MH_',?V:^M[F2V9I9#;*2RKME0>82<#<7Z#)S
M&.V2&!Z72 * "@ H X#Q(B-KFH2-:F<P^1MU# SIAXSCG/3YOE]<-QS3 Z#Q
MI,;?PG>S#@H8V_\ (BT@.>8?;VMH;9)Y9XU9_,>4IYWH"?;&>:8BC.EH98WO
M&$0@AVS^6/F$A]^^: %ABM;*=)W<O/;OMN$F!8L#]W!!].* +D-K)87"7DL,
M3R#<GR2?=#8QN'8C.* )/#C*TL!4/L_M1L;VRW^H[T =[2&>9^(XI9/%$#))
MM1;",E,XR<MR?I3$7[0K80PWDJ^;''$R1R1ON?<>,;3U&!WH 9=7B*L4<MG)
M,+5%9_,0!IE=ONKQT!]* ++W"W?VFS;&9948&[4)'M!^ZN.XSWH Y3Q':F:S
MN2L[':W)4'< ""!D_7&: /8%/3Z4ACJ "@ H * "@ H * "@ H H:L0+,$X^
M\,'."#['H#]>#T/6@#%RI7:=H7;@$Y"X'48Z@ ]NJ'VIB$8-EE8$DDC##)R>
M2"!U..2!PPY'(H %=LJ03V(8/G)Z+SW/HQ^]]UN: %8!A@%0!D8R0 H/YA<_
MBA]J &D'=M_BSM(89//)! Z\<E1P1\R\YH >K;@"K'.0>&R<GH0>A)' /1AP
M<&@!C+CD;=N >"P4 =_4 'OU0\=* #@C:1D<J04Z=V!4?F5'^\M #N&8@[22
M,D'+$CU('## '(Y(P1RIH :0V>^2?4$Y/3GH21T/1QP>: %#?+D%0,9X; P#
M@$'J #T/53P>* !TP>PX((9<>[ KZ=RO;[RT -&[/?);U!.3^C$C\''O0 H/
M P0. 1M?' .%Y],]&ZJ?E;B@!K* 2" !R"", 8.3P.G/)4<J?F6@!ZMEL<[B
M?8DDC\B2.W1QSU%  ", @CHI!#XQV!![>S'I]UJ &'Y1R%"@'J"  #D@CJ #
MR0.4/(XH D#$G!#%LD$$ DD]>.A)'4=''(YH 3DX*GT((?KV4AC^08_[K4 -
MR H' 0#H<@8'Z@ ]>Z'IQ0!)RQP<ESD$$ DDCD$="<=5Z,.1S0 PDCY@QYP>
M'Z<8!#'\@QZ_=:@ !P!G: !QR5&!^H /XH?44 /(+Y!^]R"-N3GJWR]#[KW^
M\M #/X]PSOR,%3N))Z$$]<CH3PP^5N: '(Q95VY(!PFT\#J!MSR.A #=>5/0
M4 (<*@.%"  \$@8'H>H /0]4/!XH 3!7Y67CD$%.G=A@?F5'^\M #^I& 2Q/
ML221Z]"2._1QP>:!D9^3!4@*,$')  ' YZ@9X#=5/!XH$*,Y(*XX((*\>X('
MYE1T^\O% !@GG#$D^Q.2/R)(_!Q[T -Z?,N.@.0^!CH"">GH&ZK]UN* '!EV
MXP O(((Q@#E@1V /5>JGD<4 *P.XD9+9Y'#$DCGV)([=''/6@!$<  @C;\I!
M#].RD,?R5C_NM0 Y@NULX"X((((& >1CJ #U'5#R.* &'=NP>221S@DDCD$=
M"2.HZ..1S0 Y7V'CGH1M;KV7#?\ H+=_NM0 ,NU0"5" 8!.0  ><]P >HZH>
M1Q0 9;?C!W="",DD\D8Z9[E>C#YEYH <ISA@YYQM(;)ST7GN?1OXA\K<T ,Q
ML&?E"@=B5 Q^H /XH3W%  28QEAL'))*^7CW)'N?O#[I.?ND4 /<;LKT()&"
MO/JWR_JR]_O+0 P@AA@G?D$$'<<G@<]R1P">''!YH 56!'\(  [D# /!SU !
MZ'JAX/% ".AZ8YY&"GXL"H_-E'^\M "!CGC).>Q#')''L21WZ..#S0 [L",8
M&"""0, \<]0,]#U4_*>* &LI&> !R""N/<\#WY*]OO+0 JD[L9;.>#PQR?T)
M(_!Q[T *0-@(( &",/@#' (;M@]&[?=;B@!GW<@XQ@@Y&!@<G([ 'JHY4_,.
M* ) 6.,YR3[$Y(Y]B2.W1QR.: &G VE6Q]T@A_P4[C^08_[K4  95 4XV@$<
MY4  \C'4 'J.J'D<4 /.2V#RV2,'DDD<\="2.HZ..1S0 PYSD<C@Y#].,*03
M^08]?NM0 !E'!QMQCN%P.Q[@ _BA]J '$$\$'/((*Y.3R05]3U*CAA\PY% #
M<'&T@]2""N>>I!4=?=1U'S+S0 ]6)P2QWY!!W9//3YO7'1NC#@\T -(VC(PH
M Z#*C _4 'OU0^QH 3GHW3D<K[98%1^94?[RT .!+D#)WY!X;)R1P<]"2.AZ
M..#S0 PA5Q]T8&002H !P"#U !X!ZH>#P: %!R2I XR""O\ WT"H_-E[?>6@
M!2&). 2Q([AB21^1)'?HXX/- # <*&&-N <AB!@< Y/(&> 3RI^4\4 =%8C;
M9Q @CCD%-F/P[4AEN@ H * *?]F6QN[:Z<-)/;*RQNYR1NZ\T 7* "@ H X>
M\US78/'C6%E<6TFG;HA(EV4383]X1D,&)Q@CY6R21D4 4/$C60\7SQZAJUS9
M1R>3BWM@&2X '64<X.>.V0!U%,#H?'ZNW@?4ECD\MR$VO_=/F+S2 YK3[&5X
MYXT,<LGE<QM*5R"0.6ZCK^-,1I2ZA"/.$,$TL05+55*@H,X^<L>2/0F@!+34
M(X8K?%K.BQ7!$OE*I65A_%N(Y7_ZU %*_@(B1C-;[Y9'<BW)*L>3DXS@\=Z
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MOE  .3QU !ZCJAY'% #P6)P=V[)! &22>O'0DCDCHXY'- "$<94@'@@J_P"
M(/\ )O\ @+4 -RH&"0% ]P,#VZ@ _BAYY6@"3!8D'(<Y!RN23CD$=SCDKT8<
MCF@!AP!N7..HPW(SP#D_D&/7[K4  (7N !TZJ,#]0 ?Q0_[- #R-P((((R""
MN?=OE'_CR]#]Y: &$, &V\MURN[<,>H_U@P![D $?,IH >"QP06W9'1@6R>G
M/0DCH>CC@\T -8  MN4)MSG)  !X(/4 'H>J'@\&@!I^3((P 2"&3IW8%1^9
M4?[RT 2 LS9&2<CN&.2/7H21WZ..#S0,BVA0"& 7 (8-@  X'/8 ]#U4\'@T
M"%XP0<#&05*X&.X([>I4=/O+Q0 I!SW)S[$Y(_(DC\''O0 W.T!E8=B,-@8'
M (8^_ 8\C[K<4 /!SQQCD<C  '4$=0,]1U4\CB@!&#9.,EB>0<$DG]"2.O9Q
MTYH %? !#<8R")/P7YC^08]/NM0 K!=A!P%Y!SD  =>.H /4=4/(XH 0@[MI
MR23W 8DGD@CN2.HZ..1R* %5^1@YS@@A\Y[+\Q[]E8]?NMS0 ,J@CD; ."<J
M, ],=0 >W5#R.* $&<E3DMG!4KDG/)! ZY')4<-]Y>: ' @J""2>"K!LG)^[
M\W<^C'@_=/- #<!20F%QQ\N5P>@^]T/8=NJ'H*  '8< @*![J% .![@ ]#U0
M\'(H >4W<,"#R""N?][Y1_X\HZ_>6@",9)&-V[@@J0V2>F#T)(X!Z,/E/- #
M@1M[  9ZD# /!!Z@ ]#U0\'B@ 9.<$8QD%2G7NV5'YLH_P!Y: &J3D=<Y'0A
MCDCCGH21WZ./>@!>@R& X!!#8& >.>H&>AZJ>#Q0 C*,'IQN!!7TY/RC\RHZ
M'YEH 56)(Y8L>A&"<G]"2/P<>XH 4@'D<=#PV/\ =(/;T#=ONMQ0,CX48.,<
MY&W (!R>.HYZJ.5/S+Q0(E!RV,L3GV)R?;H21VZ..1S0,:>/G![ Y#_]\_,?
MR#'I]UJ! K  AN% (Y!4 #KQU !ZCJAY'% #_F)P2VXG'9B21SQT)(Y(Z..1
MS0 S)4!PQ/0@B3IV4[C^08]?NM0 J_+Q\H4#T( 4=?< '\4/M0 N!CC&,9[J
M, ^G4 '\4/M0 W&.#SV.5S[D$#KGJ5_B^\O- #U.X@@L&.,$-DDGISW)'1NC
M=#S0 PA57(QM SQE1@>G< '\4/L: #'\)SCD<K^+ J/S*C_>6@!PRYYW;N#P
MP)R>F#T)(Z'HXX/- #",#(Q@#((.T8!P"#V /0]4/!XH 7U5N.H(*\<?>&WT
M[E>WWEH 4@L5(9BQ( .X$DD>O0DCOT<<'F@#?T\C[%#MV[<<;2<?AGD?3MTI
M#+= !0 4 % !0 4 % 'COB*[C_X6HA\F&18[R!&\]7=5(,0R   &!D3DD]13
M Z7Q@ES#J4FHLDMQ!:(KI ]D'A##G<7W#)]R#C'% &]XT4-X3O%+*H)C&Y^@
M_>+U]J0'-W<0N9OLY>V"Q[X)V=M@=_5/3&>.U,1D7VM_99@\4<D2E# R D[E
M P2!T[9H 98:^TEW QWS_9X6\LD!&=3QG'<<YXYYH U[5H-/&(&2:'[.%\N.
M$L\18Y#'.02,G\J -#28UBOXHTE$VS4RKR 8W-]GY.* .VI#.#UEWCOKIUQ$
MGV*!7N0NYHAN;MWIB.?\2 Q68<VZ6Y>#>C+U=_7';(_ 8H U/!6CZ#<Z).]W
M# UR'8R*T@8PAACY<?=R 30,Y+3U@&I7"6I26V)!@5&8K*N[ +9YSC- CJ]0
M^TJ-1"+C%F057:8!'QC'OG/XT >CI]U?H*0Q] !0 4 % !0 4 % !0 4 4=5
M&;(Y&5!R<C(Q[]P/<<CK0!B,I9L<ELD<@$Y(Y!'0DCJ.CCD<BF(8&QDA>.#P
MW3L""?R#=_NM0 \;-FTXVXQD@@$ ]#W ![=4//2@!I4@[74DDE2"N22>2".Y
M(Y(Z,.1S0 JDC;RV[(PPP3D\#GN<=&_B^ZW- "LJE,JH  YX(4 ?J%S^*'VH
M ;M;H0=PXP4YZ9(([^I4=1\R\T /4[NF=W!X()R>A!Z$GLW1AP>: &E-H5EC
M.,X!1!C.<#:QZ=\*>G*GJ* $! 0=,8R#DJ, X'/4 'H>J'@\4 .(YP5]005_
M%AM_5E_X$M #<'=P"22,8(8Y(XYZ$D=#T<<'F@!5;Y<C;T!R#@$#@'=UQGH3
MRIX/% ",F!@@8&00R_B05].Y4=/O+0 @SN(VDG/LS9(_(DC\''N* ' \ C';
M!#8'H#GL.P;JI^5N* &LN!T& """N!CJ>!R!GDKU7[R\4 .!9FP22Q..@8DD
M?D21^#CGJ* #_:!]""K_ (*0Q_1CT^ZU ##@#!X49[%0 .3P.0 >HZH>1Q0!
M(#E\88MGIC)R1D\="2.HZ..1S0 A.1D'/0@A^O92&/Y!O^ M0 WA0> !@]B
M .ON #^*'D?+0!+C<=NT[LD<KDDXR>!P3CJ.C#D<T ,.2<CGH<[L\G@'<?R#
M'J/E:@!!\O08"C@X*C /YJ ?Q0_[- "D ECM"LF2V05(Q_> Z<\Y7[I.[HU
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M\QCP2W;IB@"[=QQIX>NIVM)$ADB, MTD!$>"#O+#J,T >E)T7Z4ACZ "@ H
M* "@ H * "@ H S]7XLP2VW##!S@@]L-V/N>.QZT 8P;J"%VX(Q@J, \\=0
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M* !E.X_*2V3D8W')'/'0DCJ.CCWH&"/T(/'RD$,>/[OS'\@W;[K4" JH0@J
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M8]N] $L]H0L]U-)'=-$RQ;)8_*CEE/5O<_UH YSQ-?QQ6UYLC8"1QPIY!SC
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M QAL@@@8!R>.P'4J.5/S+Q0 \$E@&R6SW&221^1)';HX]Z $ & 1_LG(8_\
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M)[_,<D?D21VZ..1S0 G0!E(Z*00Q^BD$_D&/3[K4 (" A#!0N#P5(  /(QU
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MMX+IA+"-]R9@L &"H4#Y6;+$C@@$\D4P'>+KM;?Q7*)[2X\TB/['<C(A1LH
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M#NW'JN23CD$="2.HZ..1S0 Q2>H'!VGAN?0$,?R5C_NM0 [Y3&%( &W R,#
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M( &>.>H ['JIX/% AV3D@C!P05*]NX(_FO;[R\4 &">Q)S[$Y(_(DC\''O0
MW)7E?0$88@8[$$]/0,>A^5N* ' KM[ <@@@@ #J".PSU4<J>1Q0 I4[LX))/
M(ZDDCGV)(ZCHX]Z $1QM&&XX(._ISA3N/Y*W;[K4 .8#!SC;@Y!! P#SQV /
M)'53R.* &X(;!!8[B.0"22.01T)(ZCHXY'- #D;Y0O+ ],-YG;MZ\?PG[RX_
MB!H 3:?E(QGY2I#=?[IW'\@Q_P!UJ $Y&[@!=O(^Z  ?S !_%#_LF@"0 MG(
M)))&"H.>.05]<=5Z,/F'- #!E<$$GE2,,#SC .3UR. QX8?*W- #0P1 ,@(
M.0Y4 ?7J #T[H>#Q0!(_.00 1G((!/3YOE_5E[_>6@!AR" 6(;((.X$Y(X.>
MY/0'HXX/- "A@01D#@?QD# /!SU !Z'JAX/% "2*<'C)^;@KU_O J/S9?^!+
M0 !L-U).>Q#')'KT)(Z'HXX/- !D;1@C&!@AB!@'CGL,]#U4\'B@8C+R<  <
M@@J1QWX';U7M]Y:!"JQSC)SGKPQR1^1)'X./>@!<?+D$#&#PW''0AOY,>GW6
MXH&-Y4\X P<@@@8SSQV [J.5/S#B@0Y2QQU)S[$Y(Y]B2/P<<CF@!"#P0<8
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M X@YXR23[$Y(_(DC\''O0 P$KA@>.",-@8' P3T]F/(^ZW% #QSQCC!!RN
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MN>H&>AZJ>#Q0 UEX/888$%<>[?*.W<KU'WEH 4$DXY+$\< DDC\B2/P<>A%
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M?W-[++-<^;>^3N\MP XC<.A VG[WS$D<G:<#.10!6F\&V$]M):O=W;V[)-'
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M?E.>O\04\T *O 7*[2,<?W2.H]<KZ]0/[PYH 1HSC:%!."NW &3G(  /\74
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M>F#[4 4==D2STFZL2D!2-R8L<')ZMC/'3]: /4$& ,>E(8Z@ H * "@ H *
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M$D G@]^Q- %_^RK=1\H<'C!W<Y'0_7''TX- "C2K<+M"L!@C /&.H'X'D>E
M =*MR<E2<G)!Z'/48]#U(]>: $&E6X(8!MW'.[)R._UQQ[CK0!;BB6%%CC7:
MB\ #H* )* "@ H * "@ H \\NMW_  E4LOV#[NIPI_;)89B!*?N /O8/W./E
M^?DYI@:6N7^C:;JK--H%Q/=S7=M&UTULP3<70*1*1@;<@X'<$=Z0%3Q%I=G/
MKEVLMSI*R7?E_O;FZV3VN !\B8.[.,CE>3WI@;GC60P^$;V1<Y4QD #/_+1:
M0'.JL5]'!;QQ01);H[I).V0#SD-WXIB(;A OEO>V\\Z6D C<)'@,3T8'\NU
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M;[)K>6'RTVPHC9#2!\ @]B<#O0 SX?:?K>CZ;8Z?J<&JQB"WV%)FM&MT;/\
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M1/#6GVVH7MS),EM&C6TGE%(& Y"E%!/IRS=* .DH * "@ H * "@ H * "@
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MS-9016D\*S0RPW/F[@>S#:,'!'0D=: +MG?VM^LS6DZRB&5H9"O\+KP5^HH
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MB.?U'7'2Y62/RQ-L*8B89:->,L?PX^E $=AKK&[A(&<1'[.L[Y)!]Q['I]:
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M3KL#1RSQ6&H2^2!G_0I$8[F PH< GU..@% &O0 4 % !0 4 % !0 4 % !0
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M>5/+_;6G^7;MLE?[2F(V]&.>#P>M #XO$&BS-.L6KV+M;J7F"W"'RU!P2W/
MSQS0 @\1:(R0.NL6!6X)$)%RF),==O//X4 4KCQIX?@6U,>J6MP+IG2(PW$9
M5F1=Q&XL .PZ]6'K0!=_X2#1Q*T+ZI9QSQQ>=)$UPF^- ,EB,\ #G/2@"Q8Z
ME8ZG"TNGWMO=Q*VUG@E5P#Z$@]: *EOXCTBXDMX#J%K%=7 S';-<QF1OH%8Y
M_#- %B\UC3-.EBBOM1M;624@1I-,J%S[ GF@!C:[I"3W%NVJV8FMANGC,Z[H
MAZL,_+U'7UH ;#XBT2XE,4&L6,L@C\[:ERC'9C.[ /W<<YZ4 1MXH\/K:)=M
MKNG"V=BJS&Z38Q&,@'.,C(_.@"]<WUI96C7=U=0P6R@$RRR!4 [<GB@""+7-
M)GGMX(=4LY)KA/,AC2=2TB\_,H!Y'RMR/0^E %:/Q3HQO;VSFOX+:XLW99(Y
MYD1B%0,7 SG: W7V- &G'<P2R/'%-&\D>"ZJP)7(R,CMD4 9EKXIT:^U1["U
MOX)I$16WQRHR$L6 0$'[WR'B@"2V\0:;=:K)IT5S&9E52IWKMESOX3GDCRVR
M.V* ++ZII\6G?VA)?6Z66-WVAI5$>/7=G% #4UC3)(!.FHVK0^6)=XF4KL)P
M&SGIGC- &1:>._#UY=FW3488_G>,222HJ,ZOLV@YY)X('<$'O0!J-KVCI/<6
M[:M9":V&9XS<)NB'JPSQU'6@"I_PEWA]$+SZS86\9;;&\MY$%E&U6RN&Z88=
M<'VP02 7%US2'GG@75+,S6Z[YD$Z[HU]6&>!SU- #-)UVPUM;Q["830VLWDF
M565D<[%?*D$Y&''X@T 4KOQEX:M4AN'U>Q=&F^SB1+B,B-B,G<<\#CG\* )M
M-\6:%JMO82V^IVH>_3?!"\RB1QZ!<YR""".Q!H <OBKPZPC*Z]II$C;$Q=Q_
M,W' YY/(_.@"<Z[I"W,]LVJV8GM\>;&;A-T>2 -PSD9) Y]10!8-]9K#<3&Z
MA$5MD3N9!MBP,G<?X<#DY[4 07FN:1IX8WNJ6=L%(!\Z=4QD9'4^E  VN:2E
MVMHVJ6:W+)Y@A,ZARF,[L9SC'.: 'V&JZ=JJ2/IU_;7BQMM<V\RR!3Z'!X-
M#(M<TF:YDM8M4LY+B)PCQ+.I96)P 1G(/M0 R3Q#HD,HBEUBQCD(8A6N4!PI
M8-QGL48'T*GT- "1>(M$FD$<6LV#R&+S@JW*$[,9W8S]W'.>E  OB30GM6NE
MUJP-LL@B:47*; YZ*3G&?:@"+3_%&CZC;V4B7T$,MY")XH)9464H1G.W/\J
M+MMJFGWMH]W:W]M/;1Y#S12JR+CKE@<#% &9+XQT47.FP6M[#?/J$QAB-M/$
MP&/O$DL.!QP,GG@&@!M_XTT33=5DTVZNTCGA:-9=SJ!'O#$%LD8 "\^FY?6@
M"VWB71XD>:;4K2*U58W6Y>YC$;A]VW!W?[)ZX![9P< $VH:O:Z=IRWK[YHY&
M58E@&]I68@*%]<Y^G?I0!6B\1V:6DUQJB/HXAD$;C4'2,9(R,.&*'/LQH 9J
M/B[0-+>&.YU6T$LKQHL8G3=\Y&&QG[N"#GTYH K6WC;2[O64TN'YK@QJ[G[1
M!B/=G /[S+' S\H;@CUH T#XET$6C79UO3Q;(_EM-]J38'_NDYQGVH @'B[0
M1<7L,FJVD(LBBRO+.BH"XRO)- &E<:A96EF+RXO((;4X(FDD"H<]/F/'- %4
M^(M#"PL=9L LZ%XC]I3#J,Y*\\C@\CT- "'Q+H*VD=V=;T\6TA*I,;I-C$8R
M <X.,C\Z )GUK2H[MK1]3M%N5C\TQ&=0X3&=V,YQCG- %>Q\2:3J-Y+;6M[#
M*4 VNLJE9>#G80><;3GTH TH)X;JWCN+>5)H9%#))&P96!Z$$=10!)0 4 %
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M?)<PK]L W,K,%VD@]%'& ,\JQP,9H H>,[J1_$EQ'))"5APJ122.&=?+#,H
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M1P=IR<\?AUH @U&V2\T)YLS2R2AV9"O$)7^]W&<=,4 >F(<JI]J0Q] !0 4
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MQF,)3[N&QO3V!R!3 K>'7\4Z(-!TV*&:&W>*W>1'MB Y?F7S-D#88$XRSH>
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MD8&!TH MT 4M1TC3M62-=0L;>Z$1W1^=$K[#ZC(X- "PV\UJ"J%73.0#P10
MC6DEQ*&G<!1T5: +:KM7:!P.!0!0DLIY)_.+(&SG SVH O)NV#?C=WQTH ;<
M6T%Y;26UU!'/!(-KQR*&5AZ$'@T -M+*UL+9+:RMH;:!/NQPH$5?H!Q0!&+>
M:&5GB8,&/*MQ0 GV5I+D33%>.BCF@"Y0!4NK>:XPH**@.1G.: (K#38K&>:5
M+>!)9\&65$ >3 P-QZG X&: +] %,V;1W'G0,%/=3T- #I8[B=#&=L:GJ0<T
M /2TB6W:%E#HXPX89##N"* (+?1=.LK3[-8V5O9Q9+!+>(1J">IP!0!)$ES
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MT:5$8H@&=I 25/KNQD$@9' H =K&CW'A74((KB:*Y2:, 9!)E/&XX.=ISTH
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MO4--ATZRG>UN;M8'NI$ CYA:3"_-NW#"\E<=10!!=^,-0MO%#Z8FD2S1)<B
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M)-V9,G)0\C/3)"@XH GM_&UG/YN=/OH0L,D\32+&!,J.$;;\_&&9?O;>N>E
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ME<9+8 QC/3(!U=G=1WMG#=18\N5 ZX96X/NI(/X$B@":@ H * "@ H * "@
MH * "@ H * "@ H :Y"QL6V[0#G<<#\: //_  .IBUZYEET:"RCU!#<6<@)^
M:(+&I">@R-V&VGYNG6@#T*@ H * "@ H \H\1W<T/Q#4R:E9@+>VRI'PT@5C
M& FTK[R$G/\ $I_AI@>KT@,+QAN_X1BYV1B5M\6$/1OWB\4 <W=6I^T7ME%
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ML;. ,=^E 'GG@^:X'BAK9XQ)!#$\=NQ68".+$9!0.3A&)*CU\OKBF!Z)2 *
M"@ H Y;5O%4UGJ$=C;0VK2&\@@/^E(S[6E16/E@[LA2?IU/ H CU3Q-;-JTF
MG7&F+<65M>6\$LK2C<DSE6C(CQD@$J<Y['K@T =;0!S_ (VD:+PC>R)G<IC(
MP,_\M%H YP"*^6WMXX;>&.W1W269L@$YX;Z4Q$,Z*NR2\MY9X[6#RW5$PKDG
MA@?3I0 6L,5J4>TMI6ELY=K>4H=)LG(&2.W0]Z +"(+"3[2ES;S3(S1.=N"F
MXC*D_P 1&<4 .\,2([0-$B)&=48!5/ _<4 =_2&>9^(K7[1XJ@<$[H]/3"XR
M.K<_7M3$7+::.PBBFB,4[B-EBA'RRJS9RP/\(P* 'R7-ZJ0)!:%XX@K0*SE_
MM#%OF!/MUP: '_;E<3I*_P!F@GG5C<.WG!F!Y3';OC'I0!S7B"Q2YT^Z95D:
M-6W'H!@$$<^F?Y>E 'KJG./I2&.H * "@ H * "@ H * "@"GJ6J6FD6HN;Q
MI%C9UC41Q/*S,3@ *@))^@H ;IFKV6KQRM9R.3"^R2.2)HGC;&<,C@,..>10
M!8CNH);J:V20&: *9%_N[NG\J &WE];V$22W,GEH\J0J<$Y=V"J./5B!0!8H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M!8G#-''B, J0./N^A'0@ [ZQA^SV447V:&VVC'E0'*+].!_(4 6* "@ H *
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M@ ;E!4 G) R,@$ S?%2WNF_$RPO"/*CN[B%8G5%<NH:-67YF.#E\\ ' )[4
M>L4@.?\ &I1?"=YYCE$S&"P&2O[Q>: .;OFB-P(KF[$446^W8RQ9\\$<L<=/
MK3$8&HZXR7*NBQB784*QL,M&HQDGZ#J: (]/UU_MD ')6(FW6=\DAO<=\'H>
MN30!T5M<)"7.GM+(%MQ%)"-J",,<D*1W!)_2@#0TR..+48HHC)MBU,IF089L
M6_)- ':TAG":SYQN[L*7^S_8K?SA#@2XW-]W_.*8CG_$YE^R^7)L+_9S\D8R
MZ-ZO^'7O0!J>"]1\/VVA7,=[):K</(?/W @2%A@ ;NIVC&!0,Y&PE@DU6=[;
M;Y3,/(#1A!&-WW67ID#CGUH$=3?F1TU&Y2X1@;5LW2R'#K@ )M]<@]OP[T >
MDIPJ]N*0Q] !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MUK5)9WTXK#%-)<;4G60LSA5ZX],&@#$_L%[P+<QH[+),RHR-M"MZE0./_KT
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M=D+Y0.N"0K@AAM/(- &?H5W<^&=;;3UC86R9+P(04B4D$SW,[#F0CD*.WYT
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MGW9;R%(6E'J(U^ZHZ#/- '1T % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 -D.V)R%+$ _*._M0!PGA*"UNM
M:MKWS[*&ZCMGW6</F>9'NVY#[R>5QCH*8'>T@"@ H \XU)3)XTMXH[>)T^VQ
MN)4BE#%E<%E!)*G:.3@=,]*8B.ZN1'XKFC:"Z:Q?4(6*"Y4('$\2AMNS/^L>
M-L9_AZXXH&:SQ:Y9>*-0N-/MY$MY;ZWW0B,-'<(R*KRER<J5"D8&!\J\'=2
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M%_=@AFQD-T&#0!&OC:[GUI-/MM'#K_'(7F;;^_EB_P"6<+@?ZHGYBHYZ\$T
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MURBQRBR:\%O;!(]S@B5/[V.O&1TH (+>=?+:TLOWEO+B"56\H2D\X*GK@Y]
M>: %9H[$!H;J4R12,C>8G3.-P3VZ\T .\,W N7BE!4YU5Q\HP 1!TH [^D,\
MWUVR^T^*(I$C<NFGHN1Z$L<>F<TQ$\5V+:/9:R,;EH67R)%^0#G<Q/J!C]*
M$62\D%K]B> ( OV)5QMW[L/NSS0 ]+Q&\SS $M9K@?-: [S(.2"#U7J>>@H
MR]3TP75N\SVN8'<@!R=L@/<?CGB@"_8>"&MD59;!-P3:&#!MO;/(Y/2@"S-X
M:NW.R+2K ($6+S6 \QE_B/3&3Q0 D?AN]C,?_$GTU_*D(C9E&=A['CK[^YH
MBN/!,6R-+?38P@W%F=\,&/X<@<"@"C;?#V2VE?.GP;..%ER#[X(X.,T :S^%
M62)TBTRVE23:"DP&(P.NW Y)]: (_P#A&[_[09O[*T[=NQY>T;/+QT^[U]Z
M)$\*"1%6ZTBV582QB$.!G/0-QSSWH R;KX?2W"Y_LZ ,IX7SB.?4$# H OVO
M@OR48-9(LAQ^\7!/8^GUH DG\.7;F8C1M.B$K?.4 +;!V&1C/]: *,5G%&]N
MKV&FM*$9TS&-QBY/TW8% $!T73+J"$:=I\CQ["[M(FUAGH?]V@"A;>&;6'>5
MT\;00=J\@_3/L>: -62'28TEC@@@GAWH9?/AP(AV"GW/>@!PL5^U23/9Z<Q
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M ,U?"UJM]O-F@+,V[ /3'.[MZ4 :4%GIEO#$L-LANO+<?9Y8<KG&26/MSQ0
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M+?75T[/;6QEB#MASN_=87)) X&1ZT :6BZRDL2+.S&+)9U7*N6.<$-U.<#%
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M=QZCB@"K=2J)\W?VE4C#V\:Q?/\ NQ_?SUZ_6@#F-0UF>XND2/%Q<",Y158
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M1^O7M0!W9W!C^\8>V5_QI#$^;_GJWYK_ (T 'S?\]6_-?\: #YO^>K_FO^-
M!\W_ #U;\U_QH /F_P">K?FO^- !\W_/5OS7_&@ ^;_GHWYK_C0 ?-_SU;\U
M_P : #YO^>K?FO\ C0 V17:-E\QCD$8RO/'UH \J\3ZG;ZOJEBMFDS"&%-QQ
MA9,'YB1C(QC'7FF(U+;9-IXB64/*DF[RKA/W:JV0,>XSD#^= &C?0+(L$<5R
M+Q8YO*!=RI@?C+'/7H?:@#F?$A>[N)9(9Y)\RB3SP,; ,YP#U_\ K4 =#!XQ
MTF+P8MF('-S]F95@"!-^."X(!5<YW#- SFM /V9EFEFN(T+[_.VG>R8 Q_AT
MH$=78HL$\K&^BM2TP1&12#(3R2^!UQQSZ=.] %">-K;2IX=_V:1I>(U._P Y
MEZM_LY__ %4 5/".MVGA[4-3?4DEBCF^=&";A$,GC/7YN/Q6@"AJU]'JGBR>
M\M[>4VZ/MV,N5/RX#  #!/IUH WK55NC8AKA9"IV2R3IED(Y)0X_SZ"@"U+A
M[VSNEN1+&$+)>%CF$+DG*]SC'Y<4 <;K *7$<^YS#&[DR%,AU."!L/&.OYT
M=7XD\7Z3>^&'M+:.9)F6,-$J;6MP3],9&,8% S'\/+]G2..:6:W+*R':A^<M
MG!/KUY_E0(WK.'%B8Q=PP3W"OBWB&(R .GID]>?TZ4 9UZ?+TZSC7Y""3]C7
M+"-3P<O]1]?IF@"KX(UZP\/"[BU-95<*,RB+.P \)D<G).: *.HWJ:GXKN;R
MW@D\@,4",-RC*X5@ .IZX[4 =%;!+F6Q)NED"C$DTRDO'M&3L/OG_P#50!:)
MSJ$%VET)$6$L+PL<QJ/X=O?^?I0!Q6I[H[N"X.YK>%V!8H&\Q2P(&T\<]/>@
M#J?%/BW2M1\.BVM4G$Q,651=K09Y]"">,$#UH&9GA]1%"()Y);8M$8]J+G<_
M/+>N,C/Y8H$;EO&/[/,8NX8I9HY'^SQ#$;*,#'IV/YT 9VHYCTZTA5BK*"?L
M8R?+5@1@O_D^M #O!/B'3]"TB>RU(RK,9@ #%G.5 V>^,9R?[PH YZRF:YU2
MYO%CFA65R4+#/DG=DA2!T [T =:AA:\:Z6Z58!#YHG9")ACY<'VSS]._:@![
MAH;F_FDN5C5X]K72_/YP;H-OL/\ Z] '(PW TWQ#:7]U;R20(44Q; YE90?7
MH>AH Z3Q1XBT366ALX[>>[AF8Q7#0YC:0*>(SQN*Y.3@@=:!F=::C?:(?,EC
M%]"Q3A%Q'+.PQ#;6ZD854');&>#GN* +5M8V5_XNNM<ENHKU SM$A;!W0 #:
MH((9%8D[QM.>N0: +46LZS!X#C\JVO9=>=A 5DMF!CE;+$_-@%5!.#G!P!GF
M@#&O/'7B2RM]*(T])'EMQ/<*8R&'D[Q<KUZY"%?J: -.&\\7RZSH]S# 9[8:
M=#)?1'$:.[EMVS/&]<*>O3KUH KV6FZ5X2U>>\759%B\Q5CBC(:-+>5CL#@@
MX02;OF4^F: *MS?7VI[)G'V!;0LBA$R+*XC7#PNH^_%(N"#[CVH U--\2Z!I
M_A*>VL[6:-Y%E:*T8D@#J=C'(5<G(S0!S_A\BW(FD>=$WB03%3O:/;@@_C^>
M.M CK+,)!<S2M?);9E4(ZJ0TA/.9,#KQC^G>@"G-&]MIEU#YGV:1Y<!5^?SV
M7)+>W;^= &/X:U*WT7Q2]Q?0R"*4L479N\D'&7SU]CCUH ;K>J6^M>*S?6:3
M36B[,AT.UALZXQD')QC\: -JU3[4MDIG6617V2-<)DH>N4/KCC^G>@"\^)+N
MSN8KH31*IV71)S" >1M/7@?X4 <;K6XW"SAW,2R.3,8\[E/.-IZCKS[T =1X
M@\7Z3>^%&M+>.9)V2,&(+L:W!.,YP1D8Z#UH&8WA_P#<;$FDGMR0R%D0AG+'
M@GU//X>] CH;&$+;;/ML5M-.) L,2XC8 8/MD_YQ0!G7?[K3;6(#RMKEC9J=
MP5>AR_;.#UH I^"M=L?#TMXFI+*&V9\T19\I03\N1R<G^5 %35[^+5?%DUY;
M02&W1MNQAE3E<!P,#!.<X/- &]:A;IK &Y60K\CRSJ2T9'S90_3C^G>@"V^'
MOK*X2Z$T8C9DNV)S$H_A*^O^10!QFLAO/CN [-$DCDS; =ZD@XVGC'4>] '5
M^(_&&E7OAEK.VBF2=EC'EA=C6X)X.<8R,=!V- S'\/K]FC1)Y)X&93&=JG+L
MQXS],\^GO0(WK&+R[39]MA@GF5R((AB-E &1GIDX[_I0!GWN8]-LXE.P@EQ9
M@Y"*<CE_Z]: *G@?7++PZUY%J8D5A&"9?*SY8'\&1\QSD$4 923F]UB\ODAF
MCBD9@H;GR3NS\I QT'X4 =:GD2W7VC[6!;+$7,SI^^^4%2H[X.<_U% #VW0W
MMQ<R72@-$";U26\P'&%V_P!?SH X]IUL=<M+VYADDMX]JLGEAO/P3@8/ .,'
M\* .A\;>)=/UJP@M-/,SS"8J9$7:RL%^Y@C+ YYQP,4#*VD$"QEMW8Q,\8"P
ME#Y9*CYMWKG'7U]*!&O(D:Z48Q*DK^4)I;)<HI!)P%/X]N?K0!D>($<VR6WF
MF>1;<Q&)3@1DC(RW?G_.: +W@CQ#I^G6$FGW*2M<M.%#"$9E)X"<=2/>@9SU
MFL^HZM/?V\,J1W,K1VXWJVR0-DHA'7 !Z<"@1U,:P3WKSI?1"WBBW-/E?-&!
MLVDYZ9/K^/:@"6>*6SO;R:>=(/D*-=LX_>Y'"8/< 'W]: .059K'Q'93S6KR
MJNT>0H61I]H+?=S\ORX;Z<T =!XTUVSUZPMX-+,DA\\IYP8)E]N1&-WWL[NW
M2@96TT+%IC1S2K )HQY,<C+Y3E<!B03DC(QGUQTH$;$UJPTI5\R.82()6LP=
MBN 22J>R@\X_KF@#(\06MU-:VUO&7N7>$PI$. &P. W?!Q^= %CPUXAL]"\/
MWEK>P2?:5D:/]XBQ^=)M/[LGU 7!)XH&8/AZ"97:<>:JD)<&4,&D6 CKP<XY
MX..:!'5P>5!>7=P]_#:(A202G"R$.1M\ST'&!G]>M $$]M/%9:A"TJVSN"2H
M8,9\?,9,$\* 1D]!0!AZ%/\ V/XF34+V BTDD8*,HX4@ ,X).?E[X]: )/&6
MMVFOZC:?V:DS(J;M^,+)\W(9<9XV]<_2@"[;;)+!XE<%UDWK!.O[H(3T]B,G
M'^10!N:2JQZ@B+,TNW5"K.1CG[/S0!VU(9P]^8GUE[>2.(K/:0+(T@.5CRW3
M'?.*8BB4BFG73Y)(S!/,3&\46&*@<,6^AQ0!D-H"W(2YF$*>?*RGSCAP ?O=
M1D?_ %Z -"ULAHXP4F6\BD$*!1N#(>I5<\@  ]/ZT 6?M#P6KR23QO?%Q%.7
MA',>1A, 8!H [1O*5R&>('T)-(8@,)Z/#^9H  8<?ZR'\S0 FZ$?\M(?S- "
MYAV[A)#M_O9.* $W0_\ /2''U- "YAR!OAR>@R>: #,(_P"6D/YF@ !A8X62
M$GT!.: $W0YQYD.?3)H "T6,AX3CW/% 'G=EHD$;QSRJ?LMUDNT+<1D>ISGT
M-,1IPR&=HA>,PMO+(CBDBZ2 _+SU(P : +3S17J1"[-NHVF66<)M+2C(4CU&
M* ,P1M<Q^1* )[6!I5%O'Y8R3C;GOU!S[T 9R>%TDECCQ;^;-'Y@YP^<=,$\
M9XXQZ>M &G;!K2.+[*+A+J5&\S*"39CH",\ ^O% %VTN(+=8PAAG5X]\RM'D
MO.O1L^@(H @N&6S87$;6Y+1L\Z"(R;7/&%[C/3- &??Z%'+%YB@/'$B28G8@
M$ODE5Q_GB@!UMI$6G&3S-[)L\Z!XFPK,>BC!Y/4=^E &DEQ)NDFGGQ=QJ'M?
M-@V^7_>)'7O@4 .O&@NXY61+>W\E0;?"X+NW+@CT)SB@#.O(EO;6YD )GA"0
M;8H]B,IZG;Z#&* *1\-+%<RK&L#26_[P")LLX'4?A_GI0!I R6R/#9-+&#&'
ME9T\P!C]X$\X./3\* -!;F"&.6.S2"2  -;"2/[A;ABQ]QGI[4 4;H0V1F@A
M:*2TD5(@5B)?.<L W;!&>: *%]H*R3W;%%>*V=8T,[$%QST/?O\ 3B@"6UTJ
M+2S(6#L43SK=XSA9&/0#!Y/4=_2@#1CN)$:6::<+>1@-;>;!M\L'KD#\J )+
MTV]TD\D2VT1B3;:IMY?/+ KTZYQ]: ,Z]B74+>ZE0L\JNEN1%&51U]=OMC'U
MH I?\(R(;B80QPO+:D'$#9+^N,GJ/:@#4!:WC:"QFDBC 261G7>N3G<"W."/
M:@"]]H@BCGBM8K>:) /LH>/&P-G?D^X/% %&Y$%H\MM$\<EG+Y<*%8LN<]1N
M[8//- &??>'HY;ARYB*>=Y"M,^'  'SCD<#F@"S9V0TE3\DRW<+B.,)R&4GE
ME4'D8P: -*UF",K32K)<F0QS[X<%H2?N #H2* &7'ERC[4IMHIS*JB/9N'E+
MT)7U''3TH SKBQ754@=5)-W,WF*RE8UQP"0.@/7VH J6V@K"1=)&C!&\F1;=
MP2!_>Z]^: -F)0DJ10&3[%;-((SY6XX*$!E<Y(.3C\Z ,B?P[9"RCB2X2)6@
MAM'B0%Q#;J^Z0#'),AX)Q0,26?Q%;V5S>122[WMKV\PK;AO9E6!!Z[5&<4 :
M0U'73J_E^8RVRZHL!;;D"/['N)SC[N_G/KB@#*B;Q!<65G+<SR1W!M;.91(V
M,SQR'S5QZLAR?6@"W8Z#IWFF*XN(Y;15N+?+YP]O(V]48=<JW0CH/T!$Y!NA
MY,Q)G@A,JM"FTL0 JJ6_B.,'//% &8GAE)FBCQ;B2XC# DD,&Z@8)ZGT^E &
MK9QM9I&;99XKR3*R!D$GE@8VDC. #TSQB@"[975O L9)BF$BEKE6CR9)1T(]
M@: (+AQ;,ETCVWF.K27"",R!6Z?+W&>F: ,ZZT1+QHXT/[HP>>3+]Q6/8$=/
MZF@!+'2XK12\T1CC:/SH_*?"[AP%SG).1[T :J7$A9I;B;%RBJ]JLL.WRF[E
MAU./4T 2W4MO>H9%^SQ>3'F%E7!>0_>!'3!/2@#+O(UO+:Y< ^= JQ!88MBD
M'J,=>,8H I'PRL=Q(D:V[20#S0(VRS =1@GM^= &FN^UB:*P>:,E \CNGF!7
M/52>0.!F@#0CO8+97AM!;O$4#VZ2)T<_>9CZ$$]* *%UY-CYD<)ADM7B"$+$
M6<,3\RANW8\T 4+[0EDN+H[5DBM=J(9V(WYST/X'Z=: )+328M-+%PY4)Y\$
MD9PK/V&0>N>._O0!I17$@9YIYMMVB*]L)8-OE'H2P'Y?A0!)>O!>12.BVL8C
MBS;D+@R.1E@1TP3G% &;=HM[;7<JY:>%4@Q#&41P?]GOC&/K0!3;PN(KJ5(H
MX&EM_FQ&<LWJ.3U% &D-]NCP6+S1*T:RR,R[PK9^8$\[< 4 7UO(+>.2&T6W
MDBVAK59(\88_>+'W!/2@"E=""R$L4)CDMGC6/B,L^2?F ;MCKS0!0OM"5[B[
M<HDB6NV-/M)(WCD<$4 3VNGC24;*R_:;=E$)3E7#'DJ >>#GIS0!HQW'V9WF
M>='O%E()EBQB$G[N ."??UH +T17&ZXA6VBE\P1PQ[-P:$'J5[D#TH S;JS3
M5526/+M=7!CD 0K'A3]XCMF@"G%X?6!WN(TC<P/L9;=\L1TW=?7O]* -E'$)
M^S1S.FFP2C):(,&C(YPQSCGCB@"T;B%[=[0);2)O\I2R%?+@QTSUSD ]Z *#
M)$;AM/:2-K6XG"(\<7S;0.'+_48Q0!2M=-2#4H=6FB5S%=#"2G$A P1CD9/N
M: &:3#-HR:*MU82EK">65E@B15 =  %"GGU_'K0 61-OI\L-U:%[O]VN6@1$
M1!(&V; ?0$DGOB@">]B$BK#'!YI;47N'>=!)YB%3R5SVR.!V4<4 *NZXU9]1
ML;>6.:\OTC$DD6%CC555C@'(W;<#V- %>+3+8R6DYL9Y(--EFA$4(5G\IV#!
ML!N#VW XQCF@!I$GEV"/921VMK$4G1(497!?<$$C$X X!Q0!>U.>24I;16[3
MQI!/;_N@(MJ/LVJ7)!7&W)QUH 8\SRRQ6T\3/&)_)M1;Q\"(1[2Q);NP!'0\
M#/- &?J.FSZII6G2S6,#WRM+%*US]YL1%8RP)^8Y.,]/4T 78HTL;E)+.RO+
M6^EFB:<I$"O ^;@-]SC'3@?2@"T\EFUU/<7%EN'VB"7RM@;>R(05P>N"W'TH
M KZC//=1ZIJ$\ ,UU;?9HX$0-(J@8WL,_*"2WRY/&.] %35=,74H;.&&R9HS
M;R2N?(0#<[*Q4.2-GW3GZT 2V6A0QO%<2HBVT_R2_9VXBQUW'.0,<T :43_:
M#!%>LXLL,JPO'RS=5^;J0<YH NZ-/+<WL<LTD<DAU-MS1KM4X@]* .WI#."U
MC2-1O=:M=0T^2Q:(6J(QFN"K!@2>  1W[TP)(++6E@BM)HM--F$*R11WA7?Q
MP0=G&,4"('T2\>,8M+*-S$8'VZB2"G;K'UH G73+^/S3:VUE:RD*D<R:@695
M'7JG4\\T 4+_ $7Q#>,[*VEJS'=AKLG)[Y^3/<_2@!;#0M:LF1_)T@R*#RMU
M]TGT)CSVH L2:%<W,0^V6&GRSM&5>5+\K\V<@@>7B@!5T2XW%Y]-TZ:220-(
M3?X! Q@ "/VH ;<:1K$JA%332 Q9=]R/D!/W1\G3% &;!X7UN*1MT>C,I!'_
M !\'GTR-F!C^= &N^FZG<1M#=V>ERP! (XUO-NU@>N1'T]J (F\/RO(3_9]@
ML<FTS1K?\,5]#Y>1]/>@"5=+OXQNMK+3;:4R%F9+W<'7& IRG'X4 95UX9UR
M<J571^"3M:Y('YA,B@"W::/KEDC&*+1Q,8]@D%QT_P#(?- $\NA23>8'TO3P
M7 )==0(.\=Q^[X'M0 Z+2+M,--8V,[M('E9M1*[L=, )@#CI0 75AK\ZJOF6
M+A69@9+SD9[#Y. !0!F6WASQ!#(Q?^R'&-O_ !]-\PSGD%,#\* -:6QUBXC\
MNZAT^6*-5$*"_*[".Y.SD=./:@",Z)<M,6:TM!$[B22,:B>7'H?+R!_C0!-'
M8:K"G^CPV5N[.S2;+\D2 C !RG:@#)NO#WB"=@P.DXR25-T0#GGJ$R.?SH N
MVFG^(K)&,/\ 9:3;0JR"Z.1C'7Y.>E $CZ-=F;SH[*QCE5@Z,-0/WL8/!3&*
M '6^D7-L8A'86/[M6*NVHDL'/\6-F/P]J *UYI/B"Z509-/9@FPO)=Y9CZGY
M/8<4 5K/0-?MV+2?V2Q+ G%VQSQUY3KS0!IO8ZO.PENK?3YY4?\ ='[>5"I_
M=.$Y_P#KT 1)HEU'*I6UM&CB+M"C:B?E9NY.S) _I0!(-.U6.!(K:&P@B\LK
M)"+XLCL3G=RF: ,F;PWXADE5M^E$8 .;MAC'<83GCL>* -6VL_$%NNQ5TQ5+
MY?;>'+*>J_<_6@!!H]VFQHK*RC>!RT##4B<9X.<Q\T +;Z-<VPC6.QL1Y<;;
M7.HDL)#_ !8V8H K7ND>(+L<R:<S[-A=[LEFQT)^3V'UH @L=!UZV(:1=)8A
MPV%O&Y('7)3K0!IM9:O.4EO;?3[F='^5OMY4!/3 3DT 0KHMW&R@6EF\<6\P
MH^HGY6;KG$>30!,;#54MQ#;Q64,)CV/!]N)0G.2WW,T 9$OASQ#),K[]**\9
MS=L",=QA.>/6@#5M;/7[=!&%TM49]TH2Z(WCN/N<?6@"%M#N^=EI9QY5HSC4
MB<H>W,?7KS0!873K^'S!:VUG;.%5(I5U LR*#SU3OS0!0O\ 1?$%VTC*VF*S
M$$EKLG)]_D]* %T_1]>LFC?9I6^/)7;=GY2?<IDT 7&TO4)V1[VUL)YF4K-(
M-092V>FT;.#0!$NB7PC8/:V4S[!$F[42 J#MQ'U]Z '7VG:U/:S6\"V A8 )
M#)?';& .V$S^- #++3?$-BI:+^RUG$819!=8Q_XYS0!+)H]S*LJ/86?[Q069
M=38'>.X&S 'M0 +I%WNWRV-C,\D@>4MJ) ;'3 $= #;K3]>N %WV+ ,2IDO,
ME1G@#Y.@H S+?PYXAAD=G.D.""H_TIOF!/0C9@<>E &LUAJ\T!@NH=.EMT11
M#&+XKL8=22$Z'TH C.B732$FTLQ%(5>:,:B?F8>AV9 H FCL-3B4F"WL;=VD
M+2>7?DB1<8VG*<"@#+N] \0W!#;M*)R=RM=L 0>V0F1S^= %NSTWQ#9*3%_9
M:S",(D@NCD'IS\G(H EET:ZF\Q6L;$!P&++J+ [QWQLZ>U $D>FWPFCE>QL&
M<%G+G4#G>>C ;,>G'M0!5N]*\0W*JK2V#D)M9Y+O+-[_ '* *EIX?\00 F4:
M0Q)!(6Z8@X^J<?A0!J266KSJ&NH-/EDC<>3_ *>5"+Z'"<T 1KHEU',"+2T,
M*,TD<9U$_*Y]3LR0* )%T_58H%BMXK&&/8P>+[>61R3G)^3- &1<^'/$4TRM
MOTDKC#!KIACG@C"=AV- &I;67B"V4K&-,7<P+%;LY9>X/R=Z $.CW:D&*RLH
MVBD\R _VD3@]\YCYH 6WT>YMS&%L+$[%9M[:B2WF'^+&S&* (+S2?$%V%#2Z
M>S>7L9WNR6;TS\GY^M %6S\/^(+<EI5TAB2K$+=M@D?5* -62SU><^9=6^G3
MRH^8S]N*A%_NG"<T 1)HMU'(,6EH8XF:2%&U$_*Q]3Y>2* )/[/U6.W6&VBL
MH(?+*R0B^)5V/\1^3- &1/X<\123*ROI)7&"&NF!&#P1A/3L: -2VLO$%LI6
M/^S%#N#)B[^\.,C[GMUH #I%X&#165C$\<GF0L-1)V^N<IS0 ^/2KR#<+6TL
M[=UB$<4RZ@2Z#N<%,9/Z9H IZAH_B&\,K(VFAW .7NR<L.A/R>F: $L-%UVS
M*,8]*+*Q8;;QCC/H2F: +IT_4YC')>6MA//RLL@U!EW*?0!.O^% $*Z)>QH0
M+6R8I'Y40;42 %SSG$?)H FN+#66A>WMA8QVQ156%KW*ICO]SF@#)/A[Q&;S
MSB=)(R",W;;@<<_P8.3ZT :MO8ZU'#':O'IWV3<3)&EX06)'8[.* (SHU\40
MK:V44JH8SMU(D%#VYCZ^] $BZ5>PAQ;6UG PC6.*4:@69 #DGE.] %._T;Q#
M=L[(VFJYP<O=DY(]?D^O- !I^C:]9-&^S2M\9++LO&^4_4IDT 7&TW4IFCDO
M+6PN)B&$L@U IN!Z8 3@^_M0!$NB7BH=UI92NL?E1[M0("IGOB/D_P"- $UQ
M8ZPT3PVXLH[<@*L+7NY8P!V^3G/O0!DKX>\1"\$V[22 =P/VML@XY'"8/- &
MM;V>M1P1VLD6FFT&3)$MZ1N)'8[.,4 1?V+=D(39V:/M,;[=1)!3TYCZXXH
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M8&D?] RU_P"_2T ']@:1_P! RU_[]+0 G]@:1_T#+7_OT* %_L#2/^@9:_\
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MEH 3^P-('_,,M?\ OTM "_V!I'_0,M?^_0H 3^P-('_,,M?^_0H /[ T@?\
M,,M?^_2T ']@:1_T#+7_ +]+0 O]@:1_T#+7_OTM !_8&C_] RU_[]"@ _L#
M2/\ H&6O_?I: $_L#2,?\@RU_P"_2T +_8&D?] RU_[]+0 G]@:1Q_Q++7_O
MT* %_L#2/^@9:_\ ?I: $&@:1_T#+7_OTM !_8&D?] RU_[]+0 O]@:/_P!
MRU_[]"@!/[ TCC_B66O_ 'Z6@!?[ TC_ *!EK_WZ% !_8&C_ /0,M?\ OTM
M"?V!I'_0,M?^_2T +_8&D?\ 0,M?^_2T )_8&D?] RU_[]+0 O\ 8&C_ /0,
MM?\ OTM "?V!I'_0,M?^_2T !T#2.?\ B66O_?I: %_L#2,_\@RU_P"_2T '
M]@:1_P! RU_[]+0 AT#2/^@9:_\ ?I: #^P-(_Z!EK_WZ6@!?[ TC_H&6O\
MWZ6@!/[ TC_H&6O_ 'Z6@ _L#2/^@9:_]^EH 7^P-(_Z!EK_ -^EH /[ T?_
M *!EK_WZ% "#0-(_Z!EK_P!^EH !H.D?] RU_P"_2T !T#2,?\@RU_[]+0 ?
MV#I _P"89:_]^EH 7^P-(_Z!EK_WZ6@ _L#2,?\ (,M?^_2T )_8&D?] RU_
M[]+0 ?V!I'_0,M?^_2T ']@:0/\ F&6O_?I: #^P-(_Z!EK_ -^EH /[ TC_
? *!EK_WZ6@"6#2--MIEF@L+>*5>C)$ 1^- %V@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>57
<FILENAME>g63033dsp2new.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g63033dsp2new.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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MBFM"5<2R19R#C[@<N![LH![9H6L>9?U_7WC>CLRYJFJII<4)-O-<S3R>5#!
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M]FDBM \(2=E5A(KQL_0-E>G4C\*'[M^;HVON5_Z_JTQ?,DX]4G][M_7]7/\
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M+>I<I/(ZR$E953"D@' (5NGN#1&\+6\_QW_(<O>W\OPV)V\-:2QC)MF'E@@
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MV[+71?T_U?WON)*[TW_I?TBSH]EIMK8[],?S8+@^:9C.TYER -Q=B2W  Z]
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M=SHGB&6.W@N(K^Y"&,1,MZH2,+,2QE!<>82@7!(8\=CR2#UBWOI?[E?YWO\
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MQYX+Z.UE\IWMQ>_O20Q\Q8W,QVY!&"#&,#&%/--622??]'^MKZO] D[O3?\
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M\<?:HK.XTR.-K>='+>;AB&6:*,@%&*D?.W()'3FJ4==?[OXW_P @?PM]5?\
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MEQ(L;G&,M&&VL<8&2,\#THV30/4@3PWID3VK0QS0&V18X_)N98\JOW0VUAO
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M=+?AM]W8'K>_G^.__#E_^S;40W42+)&MTY>4QRLC%B "0P.5X Z$4K:)=O\
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MMN!Q@1H#GG/%$-(6>^GW]>_Y_)"E\6G]+\/R^8R?2];GUR;<M\(WEDW3B^Q
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M/L+YK*47DEPJ*[+;V,T^T'.,E$(&<'\J2UV!Z#QK^EDWRB[&ZQ=4N%VMF,L
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MJ0\86EM'KU[':S02SM L<!4%&C 4$QEL'><\Y]Q2@M)-]+?C?_(TE\*:[V_
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M[VY$6ISZZL2R7;VYL3$AC&&90@.-_F<#G=CKQBIO:"?=7_"^GIYW%+=]+/\
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M)R3@=R23^- >9)0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % " @YP0<<'VH 6@ H * "@ H * "@ H
M 0$'."#CCB@!: "@ H 0D+U(';F@!: "@ H 0$, 5((]10 M !0 4 % " AA
MD$$>U "T % "9&2 1D=10 M "9&XKD9'.* %H * "@ H * "@!"0N,D#/ H
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MUFVU^_OK..[@;[0AB=KS*2*9G9R5WG*A''##KG S4QNJ=O7\G;\;>951IO\
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M>_9;>\CD:+R%1[W*RJ3-NR"Y!'SH1NY&>W-*#Y5"_E?Y1C^JZ?D6G^]YO/\
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MU8L:*L^N^$-=B@-[<QO*H@5K_P UFVQQE@LH<C!8-T;'8XY%5)6Y'YW^5_\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * (+RTBOK5K>9IE1NIAF>)OP9""/P
M-)JXT["VMK#96L5K;1B.&)=J*#G JF[DI6)J0PH * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@#)U36VTN]MK;^RKRY%QD++"8MJD D@[G4\
M$\#]>*5[7OT5_P"OO';;S=C)L/B#I%];V]QY4T4,\ZP*_F0RA6*E@7\MVV#C
M'S8Y(JFK:>OX6^773_AB.9;^GZ_/IK_PYIOXCB^QV$]M8W=TU[%YZ0PJF]8\
M ECE@.-PX!)YX!H:M)Q?0MJU_6Q#>>++6R^T22V5X;6$./M*JNQG12Q0#=NS
MP1R ,C&<U-]+_P!/T'&+DTEY?*^WYHM:;X@LM5O9+6U$A:."*=F9<+B3) ^H
M Y'N*MQM?R=OZ\B$[I/N:,T\5M!)//*D4,:EG=V"JH'4DGH*AM+<I)MV1#8:
MG8:K 9].OK>\A5MI>WE610?3(/7D55FA7Z&9>>,-"T^_N;&YO'2ZME5WB%O(
MS8) !7"_-R0/ES27O;=[?U]PVK;B:OXQT707QJEQ);1^2LWFF%RF&;:!D _-
MGMZ47U<?E^?^0)-I-=;_ (6_S$/C70%MKNX^V2&"U&Z21;:4KC.,J0OS =RN
M<=Z'HKOT_/\ R8H^\TEUU_+_ #1'_P )SH+8\FXGG!9!F.VD*D-MP0=N"!O4
MG!.,BFTT]?/\+_Y,5U;3^MOQUVW+1\4:4-&35_-E^PL6'F&%U( !).T@-C"G
MH.>U)KE:3ZE17->W];?YD@\1::=/AO5DG,4TABC46LID+C.1Y>W<,8.>.,9I
MV=TB;Z-]B"3Q?HD*2,]U(!&^P_Z-+R<,<CY>5^1OF&1\IYXI+5)K^OZN59[?
MUV^^_3<:_C/0X]NZXG!*EL"TF) !8<C;P?D;@\X4GI1;^OZ_'MU"SW_K^M5Z
MW5MQ9O&&B0"0O<RGRWV?):RON//W<*=X^4Y*Y QS2O\ U^/W>>PEKM_6W^:T
M-J*1)HDEC;<CJ&4^H/2J::=F)--70^D,* "@ H * "@ H * "@ H * "@ H
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M,HSY)(Y&%.<9QWQ3L[V]?PT_X;OT$M5=>7X_\.%QXVT:!%*M<RL0246V=63
M8X?<!L/RG ;!..E"5VDNO]?\/V#I_7E_F+)XX\/127$;7LGF6THAEC6UE9E;
M:S= N2,*QW#C ZTH^\DUU_X'W;H=GL= K!E#*<@C(-#5M"4[JZ%H&% !0 4
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M=.T2XDBF@OG"K)Y;+=/^\=-OR#YNIS@?[II+WOZ\VG]VK]+=E9J-FE_6R?\
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M2DH^[VT+U(84 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M\;E>]\#:1?VLM@+RXA#*2Z1&/[K-(W*E",$NV..PQR,T/75^7X#4K+3^MO\
M(LIX,T^(0^5/<(8B2/N'.3(2""I!SYK#\J<FY7]+?A_3$FXJR_K;_)"77A+3
M9M!MM'OKVYEA2;>KR2('D8Y^7A0,$$C  XI/5KO_ %^6_E84?=3_ *[?\-\Q
M8O!EA$\#+=79\I44AF4[]K(P+?+G.8QG&.I]L4I6;:Z_Y-?DQ)62]&OOW)U\
M/Z;<P6X29Y$MHWMU964_QJ6!('4&,#\ZAKW;=[?AL5=IOYO[_P#A]#*TWP7%
MI=O-/JNKM<L@.)?+6%(HAY>!W^Z(E^8GUS5WT\[IOS=PWO%;/1+[_P#-FG-X
M5M;BRMK8WET$@#KN4IEXW.3&?E^[P!D8;CKURE[K3[6_#83?,FN^OWW_ ,V;
M%I:I96J6\98HF<%NO7-+HEV#N/CECE#>6ZOM8J=IS@CJ/K0'D/H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@#G==\-Z=K%^AO-0G@:>/ROLZ.@$VT/V*DD@.W0X]
M1Q1'25UTU_3_ "*<FHV_KH_T(+SP7I-[<RQR7EP/-#/+;JZ8<,7P2"N0!YC
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M?_#CIO"EI<:;!9R75T3#(\PG#*)#(V26X7 .6)X 'M2TO\K?+3\[6^;'KO\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@#GM=\*IK=]%?&]D@N[4#[(Z9Q"<_.2N0&W#CGH.E3;?ST^7;\
MW?T[%7TMT_7O_P #U[D6B^%#HMS%<1-IPE2W-N6AL?*+#=NSG>>3SGU.#Q6E
M]_.WII?_ #(MLNW_  /QTW-_;=9_UL./^N9]?KZ5(P"W?>6'I_SS/O[_ $H
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M0 4 % !0 4 % !0 4 % !0!%+=6\)<2SQQ[%WMN<#:OJ?;WHWT!Z:LB&I6!
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M<].! P[C/\?IG\QUQ@G]?G_P/Q[Z)7_K^O7^EJFFVKV6G0V\C!G4'=CH"3G
M]AG HV22Z)+[@ZM]VW][N6Z!A0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % &/J.DS7M]Y\<L:@(
MFWS%W@,C[N5XR#GU'W126CO_ %LU^N@/5)>OZ?Y:F1?>#M0O&7R];^S(K%PL
M,!0!B%!X#XV_+D#'?KGFFK)KR_+7^O0;=TU_6YKZ!H[Z-%+"SHR?*J; 1D ?
M>(]><?@*:?NV_K9+]+_,EKWK_P!;M_J;%(84 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % $3RLC[1!(XX^9<8_4T ,%P^/^/28?]\^G
MUH 4W#C/^BS'_OG_ !H B;48T9U9""F-P+I\N3@9^;B@"1;HNH9+>5E(R""I
M!XSZT (+IB6 MI25Z@%>.,^M #O/?_GVEZX_A_Q_SB@ %PYQ_HLP_P"^?\:
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M[M?^!?\  ZG03J!T6V_M19%O<'S/-*%NIP3L^7.,=.*N5KZ&<;]31J2@H *
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@"GJ=K)>68BB*AEECDP
MW0A7#$?I2MJOZZ6_X(=&<N? LZ[FBU-8G,9B5DA;*J64]2Y/\.,9P > *>MK
M?U_7X^95];_UU_S]/+49%X%O;9?DUIY/W3(4(959F!!<_,<G+9_X"/K5*5I7
MMU^[6Y#5U;^MK?UY';]!4C"@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M'<(TBXZY4'(Q0M5=; ]'9FA0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 Q9HGE>)9$,D
M8!9 PRN>F1VS@T!Y#Z &2S10('FE2-2P4%V !). /J20*-] 'T % $<UQ#;(
M'GF2)"0H9V"C)Z#FE=(!([F"8@131N2@D 5@<J>C?0^M4TUHQ)II-#DECD=T
M216:,X< Y*G&<'TX(I#'T % #(YHI7D2.5':)MKA6!*' .#Z'!!_&CS#8?0!
M%]I@^S?:?/C^S[=_F[AMV^N>F*-@MK8D!! (.0>AH 6@!GG1><8?,3S0NXIN
M&X#IG'IQ0 Y65U#(P93R"#D&@!: (;J[MK"V>YO+B*W@3[TDKA%7ZD\"@:3>
MQ*I#*&4@@\@CO1L).^PU98VD>-74NF-R@\KGID=J ".6.7=Y<BOM8JVTYP1U
M!]Z \A] "!E+%0P++U /2@!: "@ H * ,/6]+O-0U/2Y+6[GLT@,ADG@\LLN
M5P!AU8<_2DE[]_+]4#^%+S_1F9<:=J-G)K%N-*;5AJ8 6Y:2)0!Y:IME!(P,
M@GY%/4\"AKFAR+3?7UZ][K;Y+4J+Y9J>]K?A^&O^90_X1368K6Y5[RYN8/M4
M3268:)5ND6.,%@Q7<K;E)Y89VXXSFM>9.47YM^GO-K[M_P"K&,8M0<?)+UTL
M_P#(WO$=EJ3R6]]H\2M>A'MFRP&V-Q][DC.U@IQZ9Q65KMQ>SW_KTNO5FM[*
M_5:KS\OGI]QA6WAG6K'4HM4MU@VPN+9+3R_WOV8#RP/,\S;C_EIMVYSWIR;D
MG?[5[^KV^ZR7WBMMY6^=M_ON_P +DNG6^LQ^%])L7T&ZBN=*\EV#RP;9]G#*
MA$AYQDC=@>XJYR4JBG_6J:"6O-%=7?\ \F3(;O3==DU+^UH;'4+8S732>5:R
M6K3QKY*(-WF$Q\E3T)XQ4+W6EY/\6F5)\R7E;_V[_,VM0L=1U7PU9P+]M@NQ
M<PN[S&#ST"R ESMS'G S@ _3M5;3B_7_ -):_,C[,E_6Z,*[T'7;:]$Z_P!H
MW=PE[YK7ULUJ)9(_*95&R0! 5SM/'/4>@F+MY;_?>.OW+[U][DKO[OUT^]_C
MY&A!#JMK?-J,VC7VHFXM1;%;B2V$\95F)W;6$>U@P^[S\HR#0[6<;;_Y6L_S
MZ[L.SOM?^E^6O9%=;'6[#5WEAL]2B@:* >5I;69ARJX*GSL/@=.,<4XOWG=]
M;Z^B[:]!-:*VFGZOY=17T+6;>U#V4&RZN);JWF.]<I#+,SK+UY*@Y Z_,:5D
M[0>S4;_+_-77W%REJYK=.Z^[_-+Y)CH].U72_$5X;2WU<:>\L1C6S-GY+*L:
M*=WFG>/ND<8XZ549-_%W?X^FI,DE&*CT5OQ?R'6UAJDD5K82Z/- +34'NOM;
MR1%2OFLX"!7+98''('!-2G91D_LQM;_MVWYBDK\T5U?ZW.AF\0:7965K<ZG>
M0Z7]I0,D=]*L+C@$@@GJ,\XIRM&7+<:3:O8K?\)GX5_Z&72?_ V/_P"*I '_
M  F?A7_H9=)_\#8__BJ #_A,_"O_ $,ND_\ @;'_ /%4 '_"9^%?^AETG_P-
MC_\ BJ #_A,_"O\ T,ND_P#@;'_\50 ?\)GX5_Z&72?_  -C_P#BJ #_ (3/
MPK_T,ND_^!L?_P 50 ?\)GX5_P"AETG_ ,#8_P#XJ@ _X3/PK_T,ND_^!L?_
M ,50 ?\ "9^%?^AETG_P-C_^*H /^$S\*_\ 0RZ3_P"!L?\ \50 ?\)GX5_Z
M&72?_ V/_P"*H /^$S\*_P#0RZ3_ .!L?_Q5 !_PF?A7_H9=)_\  V/_ .*H
M /\ A,_"O_0RZ3_X&Q__ !5 !_PF?A7_ *&72?\ P-C_ /BJ #_A,_"O_0RZ
M3_X&Q_\ Q5 !_P )GX5_Z&72?_ V/_XJ@ _X3/PK_P!#+I/_ (&Q_P#Q5 !_
MPF?A7_H9=)_\#8__ (J@ _X3/PK_ -#+I/\ X&Q__%4 '_"9^%?^AETG_P #
M8_\ XJ@ _P"$S\*_]#+I/_@;'_\ %4 '_"9^%?\ H9=)_P# V/\ ^*H /^$S
M\*_]#+I/_@;'_P#%4 '_  F?A7_H9=)_\#8__BJ #_A,_"O_ $,ND_\ @;'_
M /%4 '_"9^%?^AETG_P-C_\ BJ #_A,_"O\ T,ND_P#@;'_\50 ?\)GX5_Z&
M72?_  -C_P#BJ #_ (3/PK_T,ND_^!L?_P 50 ?\)GX5_P"AETG_ ,#8_P#X
MJ@ _X3/PK_T,ND_^!L?_ ,50 ?\ "9^%?^AETG_P-C_^*H /^$S\*_\ 0RZ3
M_P"!L?\ \50!;T_7]&U:9H=-U:RO)$7<R6]PDA ]2 3Q3L[7%=)V,+5=$U27
M7+K4K%YXY=]J(MEP5C90Y\W<F0&^4_Q ^W-3&Z37F_\ TE)?B/1RUVM^-V_Z
MZ:F1I.A^*W>.'5+N^$1F3[1LG,>\8;<R.)W8 G' 5.Q"BJTNK;?\#\=;=6#O
MK_75?I?I\RO)H'BR5KI+I[NY3SHW*)(%64+,K HS3G80H/1$S[G!H@[)<W]:
M._W^J]$4]VEYV_1?TGZEF>/7+>YTS3XKNY@?49)(FMYKHR3V]N&#>9N#'Y@
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M2@H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M]& Z4XW<5476W^:^X4DHOD?2Z_1FE>Z#H^I-NO\ 2;*Z.[=F>W1^< 9Y'7
M_ 4EH[HJ[M8LI8VD;1LEK"K1EBA6, J6Y8CTSW]:!>1/0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MO7O_ %M_D6].T6STIY&M#<@/U22ZED1><_*K,0OX 4+1<J!ZNYH4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % ',W%@FJ^,[^"YN;Y88+"V>..WOIH%#-).&.(V7)(1>OI0!:_X1/3
MO^?G5O\ P<7?_P <H /^$3T[_GYU;_P<7?\ \<H /^$3T[_GYU;_ ,'%W_\
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M_P ACQ/_ -A%/_22WH W* "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@##M?\ D>M6_P"P=9_^C+F@#<H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@##T+_D,>)_^PBG_I);
MT ;E !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0!AVO_(]:M_V#K/_ -&7- &Y0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % &'H7_(8\3_\ 813_ -)+>@#<H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MS.[;0N2SDGHJCKVH O4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M(AM(TC*.#D,!C&>.X(/>AMMI]B$DE8JR>%HI5VOJ=^WF)Y=R6=";E<D[7RO
M^9ON;>#CI33L[K[O/N.[^??^OZ^95N/ ]G=VL]M<ZA>30N6\M'$)6$-()"%'
MEX8$J/OAN..YI=$NUOPT'%\M[>?XW_S9H6/A^*RTM]*:X::P:$Q>488XL9+9
M/[M5 X.. .F>M.3YOP_ 4?==U_7]?J0'PCI]PZOJC2:JZN&S>I&X(4,%7:%
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M2&]6W_78LT % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % &=?
M^(-%TF=8-1U>QLYF7>([BX2-BN2,X)'&0?RH J?\)GX5_P"AETG_ ,#8_P#X
MJ@ _X3/PK_T,ND_^!L?_ ,50 ?\ "9^%?^AETG_P-C_^*H /^$S\*_\ 0RZ3
M_P"!L?\ \50 ?\)GX5_Z&72?_ V/_P"*H /^$S\*_P#0RZ3_ .!L?_Q5 !_P
MF?A7_H9=)_\  V/_ .*H /\ A,_"O_0RZ3_X&Q__ !5 !_PF?A7_ *&72?\
MP-C_ /BJ #_A,_"O_0RZ3_X&Q_\ Q5 !_P )GX5_Z&72?_ V/_XJ@ _X3/PK
M_P!#+I/_ (&Q_P#Q5 !_PF?A7_H9=)_\#8__ (J@ _X3/PK_ -#+I/\ X&Q_
M_%4 '_"9^%?^AETG_P #8_\ XJ@ _P"$S\*_]#+I/_@;'_\ %4 '_"9^%?\
MH9=)_P# V/\ ^*H /^$S\*_]#+I/_@;'_P#%4 '_  F?A7_H9=)_\#8__BJ
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0!G7^I7=G.L<&AWU\A7<9+=X H.3Q\\BG/X8YZT 5/[=U'_ *%/5O\
MO[:?_'J #^W=1_Z%/5O^_MI_\>H /[=U'_H4]6_[^VG_ ,>H /[=U'_H4]6_
M[^VG_P >H /[=U'_ *%/5O\ O[:?_'J #^W=1_Z%/5O^_MI_\>H /[=U'_H4
M]6_[^VG_ ,>H /[=U'_H4]6_[^VG_P >H /[=U'_ *%/5O\ O[:?_'J #^W=
M1_Z%/5O^_MI_\>H /[=U'_H4]6_[^VG_ ,>H /[=U'_H4]6_[^VG_P >H /[
M=U'_ *%/5O\ O[:?_'J #^W=1_Z%/5O^_MI_\>H /[=U'_H4]6_[^VG_ ,>H
M /[=U'_H4]6_[^VG_P >H /[=U'_ *%/5O\ O[:?_'J #^W=1_Z%/5O^_MI_
M\>H /[=U'_H4]6_[^VG_ ,>H /[=U'_H4]6_[^VG_P >H /[=U'_ *%/5O\
MO[:?_'J #^W=1_Z%/5O^_MI_\>H /[=U'_H4]6_[^VG_ ,>H /[=U'_H4]6_
M[^VG_P >H /[=U'_ *%/5O\ O[:?_'J #^W=1_Z%/5O^_MI_\>H /[=U'_H4
M]6_[^VG_ ,>H /[=U'_H4]6_[^VG_P >H /[=U'_ *%/5O\ O[:?_'J #^W=
M1_Z%/5O^_MI_\>H /[=U'_H4]6_[^VG_ ,>H /[=U'_H4]6_[^VG_P >H /[
M=U'_ *%/5O\ O[:?_'J #^W=1_Z%/5O^_MI_\>H /[=U'_H4]6_[^VG_ ,>H
M /[=U'_H4]6_[^VG_P >H /[=U'_ *%/5O\ O[:?_'J #^W=1_Z%/5O^_MI_
M\>H /[=U'_H4]6_[^VG_ ,>H /[=U'_H4]6_[^VG_P >H /[=U'_ *%/5O\
MO[:?_'J #^W=1_Z%/5O^_MI_\>H /[=U'_H4]6_[^VG_ ,>H /[=U'_H4]6_
M[^VG_P >H /[=U'_ *%/5O\ O[:?_'J #^W=1_Z%/5O^_MI_\>H /[=U'_H4
M]6_[^VG_ ,>H /[=U'_H4]6_[^VG_P >H /[=U'_ *%/5O\ O[:?_'J #^W=
M1_Z%/5O^_MI_\>H /[=U'_H4]6_[^VG_ ,>H /[=U'_H4]6_[^VG_P >H /[
M=U'_ *%/5O\ O[:?_'J #^W=1_Z%/5O^_MI_\>H /[=U'_H4]6_[^VG_ ,>H
M /[=U'_H4]6_[^VG_P >H /[=U'_ *%/5O\ O[:?_'J #^W=1_Z%/5O^_MI_
M\>H /[=U'_H4]6_[^VG_ ,>H /[=U'_H4]6_[^VG_P >H /[=U'_ *%/5O\
MO[:?_'J #^W=1_Z%/5O^_MI_\>H /[=U'_H4]6_[^VG_ ,>H /[=U'_H4]6_
M[^VG_P >H /[=U'_ *%/5O\ O[:?_'J #^W=1_Z%/5O^_MI_\>H /[=U'_H4
M]6_[^VG_ ,>H /[=U'_H4]6_[^VG_P >H /[=U'_ *%/5O\ O[:?_'J #^W=
M1_Z%/5O^_MI_\>H /[=U'_H4]6_[^VG_ ,>H /[=U'_H4]6_[^VG_P >H /[
M=U'_ *%/5O\ O[:?_'J #^W=1_Z%/5O^_MI_\>H /[=U'_H4]6_[^VG_ ,>H
M /[=U'_H4]6_[^VG_P >H O:=?W-[YGVC2;O3]F,?:&B._.>GENW3'?'6@"]
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M!@WGBJTM->&C"WN);G:K,T84JF[.TE=V\CCDA2!W(J;WC)KI_E<;TM?K_G8H
M:+XU%[I,,]]IUU%<M9+=X2,%9AP&,8#$@ D?>QUSTYK2:46[=+?CMY?Y=1/2
M7+Z_A_7^1);>.[&\=(K>QO);@S/"\2&%O+*!68LPDV8 8'ACW'7BIT6O2U[^
M2=@::]=/QO\ Y=2G'\4?#LL4\B.Y$2!T DA)D4L%!X?Y.6'^LV8S[&FDVOZ_
MX;IW_0;5G;U_#\3J=+U%-5L([M()H Q(\N90&!!P>A(/3J"0>QH:L2G<N4AF
M=?Z;=WDZR0:Y?6*!=ICMT@*DY//SQL<_CCCI0!4_L+4?^ALU;_OU:?\ QF@
M_L+4?^ALU;_OU:?_ !F@ _L+4?\ H;-6_P"_5I_\9H /["U'_H;-6_[]6G_Q
MF@ _L+4?^ALU;_OU:?\ QF@ _L+4?^ALU;_OU:?_ !F@ _L+4?\ H;-6_P"_
M5I_\9H /["U'_H;-6_[]6G_QF@ _L+4?^ALU;_OU:?\ QF@ _L+4?^ALU;_O
MU:?_ !F@ _L+4?\ H;-6_P"_5I_\9H /["U'_H;-6_[]6G_QF@ _L+4?^ALU
M;_OU:?\ QF@ _L+4?^ALU;_OU:?_ !F@ _L+4?\ H;-6_P"_5I_\9H /["U'
M_H;-6_[]6G_QF@ _L+4?^ALU;_OU:?\ QF@ _L+4?^ALU;_OU:?_ !F@ _L+
M4?\ H;-6_P"_5I_\9H /["U'_H;-6_[]6G_QF@ _L+4?^ALU;_OU:?\ QF@
M_L+4?^ALU;_OU:?_ !F@ _L+4?\ H;-6_P"_5I_\9H /["U'_H;-6_[]6G_Q
MF@ _L+4?^ALU;_OU:?\ QF@ _L+4?^ALU;_OU:?_ !F@ _L+4?\ H;-6_P"_
M5I_\9H /["U'_H;-6_[]6G_QF@ _L+4?^ALU;_OU:?\ QF@ _L+4?^ALU;_O
MU:?_ !F@ _L+4?\ H;-6_P"_5I_\9H /["U'_H;-6_[]6G_QF@ _L+4?^ALU
M;_OU:?\ QF@ _L+4?^ALU;_OU:?_ !F@ _L+4?\ H;-6_P"_5I_\9H /["U'
M_H;-6_[]6G_QF@ _L+4?^ALU;_OU:?\ QF@ _L+4?^ALU;_OU:?_ !F@ _L+
M4?\ H;-6_P"_5I_\9H /["U'_H;-6_[]6G_QF@ _L+4?^ALU;_OU:?\ QF@
M_L+4?^ALU;_OU:?_ !F@ _L+4?\ H;-6_P"_5I_\9H /["U'_H;-6_[]6G_Q
MF@ _L+4?^ALU;_OU:?\ QF@ _L+4?^ALU;_OU:?_ !F@ _L+4?\ H;-6_P"_
M5I_\9H /["U'_H;-6_[]6G_QF@ _L+4?^ALU;_OU:?\ QF@ _L+4?^ALU;_O
MU:?_ !F@ _L+4?\ H;-6_P"_5I_\9H /["U'_H;-6_[]6G_QF@ _L+4?^ALU
M;_OU:?\ QF@ _L+4?^ALU;_OU:?_ !F@ _L+4?\ H;-6_P"_5I_\9H /["U'
M_H;-6_[]6G_QF@ _L+4?^ALU;_OU:?\ QF@ _L+4?^ALU;_OU:?_ !F@ _L+
M4?\ H;-6_P"_5I_\9H /["U'_H;-6_[]6G_QF@ _L+4?^ALU;_OU:?\ QF@
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M7RL]?P7EK8NMJ6M3PDMJTS)>3W]J(5AC'EB,2;"I"YW?(!R2/;/-9U%^Z?\
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M?;5O_!/=_P#QN@ _X2S3O^?;5O\ P3W?_P ;H /^$LT[_GVU;_P3W?\ \;H
M/^$LT[_GVU;_ ,$]W_\ &Z #_A+-._Y]M6_\$]W_ /&Z #_A+-._Y]M6_P#!
M/=__ !N@ _X2S3O^?;5O_!/=_P#QN@ _X2S3O^?;5O\ P3W?_P ;H /^$LT[
M_GVU;_P3W?\ \;H /^$LT[_GVU;_ ,$]W_\ &Z #_A+-._Y]M6_\$]W_ /&Z
M #_A+-._Y]M6_P#!/=__ !N@ _X2S3O^?;5O_!/=_P#QN@ _X2S3O^?;5O\
MP3W?_P ;H /^$LT[_GVU;_P3W?\ \;H /^$LT[_GVU;_ ,$]W_\ &Z #_A+-
M._Y]M6_\$]W_ /&Z #_A+-._Y]M6_P#!/=__ !N@ _X2S3O^?;5O_!/=_P#Q
MN@ _X2S3O^?;5O\ P3W?_P ;H /^$LT[_GVU;_P3W?\ \;H /^$LT[_GVU;_
M ,$]W_\ &Z #_A+-._Y]M6_\$]W_ /&Z #_A+-._Y]M6_P#!/=__ !N@ _X2
MS3O^?;5O_!/=_P#QN@ _X2S3O^?;5O\ P3W?_P ;H /^$LT[_GVU;_P3W?\
M\;H /^$LT[_GVU;_ ,$]W_\ &Z #_A+-._Y]M6_\$]W_ /&Z #_A+-._Y]M6
M_P#!/=__ !N@ _X2S3O^?;5O_!/=_P#QN@ _X2S3O^?;5O\ P3W?_P ;H /^
M$LT[_GVU;_P3W?\ \;H /^$LT[_GVU;_ ,$]W_\ &Z #_A+-._Y]M6_\$]W_
M /&Z #_A+-._Y]M6_P#!/=__ !N@ _X2S3O^?;5O_!/=_P#QN@ _X2S3O^?;
M5O\ P3W?_P ;H /^$LT[_GVU;_P3W?\ \;H /^$LT[_GVU;_ ,$]W_\ &Z #
M_A+-._Y]M6_\$]W_ /&Z #_A+-._Y]M6_P#!/=__ !N@ _X2S3O^?;5O_!/=
M_P#QN@ _X2S3O^?;5O\ P3W?_P ;H /^$LT[_GVU;_P3W?\ \;H /^$LT[_G
MVU;_ ,$]W_\ &Z #_A+-._Y]M6_\$]W_ /&Z #_A+-._Y]M6_P#!/=__ !N@
M _X2S3O^?;5O_!/=_P#QN@ _X2S3O^?;5O\ P3W?_P ;H /^$LT[_GVU;_P3
MW?\ \;H /^$LT[_GVU;_ ,$]W_\ &Z #_A+-._Y]M6_\$]W_ /&Z #_A+-._
MY]M6_P#!/=__ !N@ _X2S3O^?;5O_!/=_P#QN@ _X2S3O^?;5O\ P3W?_P ;
MH /^$LT[_GVU;_P3W?\ \;H /^$LT[_GVU;_ ,$]W_\ &Z #_A+-._Y]M6_\
M$]W_ /&Z #_A+-._Y]M6_P#!/=__ !N@ _X2S3O^?;5O_!/=_P#QN@ _X2S3
MO^?;5O\ P3W?_P ;H YKQ+H&JZAXF%W!I9D\J>W>&Y1HO]6K+YBDNV]?XN$
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M)))$C8K#( "K!MI##<!P0<X/;C-0T[Q2ZV_'[@BUK?I?\"&7Q<+;01<2PO\
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MP1I\%A=V?VJ[>*XMEM?F9,QQJS,H7"]MYZYZ#.>Y=V2[-/YJW^1;?,[OS_\
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M]]_GK_F-N?"5E>:L;^YNKJ7!9DA=E*(S*5)4[=X&"?EW;>>E3RKE<>Z:^_\
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MOO\ UK>_WEK1_#5MH][->+=7-U<21B+S+@J6" D@9506Y/5LGWHOHUW_ *]
M>KO_ %J4Y/!&GRPRV\EW>-:M'*D,!==EOY@(8I\N<X)QN+8SQBE'W;>5ON33
MM^"\RD[2YO._S_ILU+_1H;\V#-/-"]C*)8VC*Y/RE2#D$8(8CU],4/5M]TU]
MY,?=CR^GX&<W@O3FM+.W\^Z'V*V6WA<.H9=K*ROT^\"@]O:J<FY.75V_"_\
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M'HM%+F"\N':60RSEUC'G,5"C(5 !@ ?= ]\U5]+=/Z?]=";:W_K^OQ-BD,*
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M/2;VUNDFE\0ZC=HN<PS1VX1N,<[(E;WX(Z4 :M !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % %>[OK33XEEO;J&VC9@@::0("QZ#
M)[T=4@Z7[$[.L:%W8*JC)). !2;2U8)7V([:ZM[VV2YM)XYX)!E)(G#*P]B.
M#5--;B3OL2TAA0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % %'6-)M-=TFYTR^CWVUPA5AW'H1Z$'D5,HW149<KN>96=[K&NW[?#B
M\N%(L6/VZ\60;KBU&-J@=0S9 ;T'UK2-JW[R2VW7=_Y=27^Y]V'7;R7^?;^F
M>KV]O%:6T5O;QK'#$H1$48"@< "DVY.[$DHJR)*0PH * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M;J2@_P"$LT[_ )]M6_\ !/=__&Z #_A+-._Y]M6_\$]W_P#&Z #_ (2S3O\
MGVU;_P $]W_\;H /^$LT[_GVU;_P3W?_ ,;H /\ A+-._P"?;5O_  3W?_QN
M@ _X2S3O^?;5O_!/=_\ QN@ _P"$LT[_ )]M6_\ !/=__&Z #_A+-._Y]M6_
M\$]W_P#&Z #_ (2S3O\ GVU;_P $]W_\;H /^$LT[_GVU;_P3W?_ ,;H /\
MA+-._P"?;5O_  3W?_QN@ _X2S3O^?;5O_!/=_\ QN@ _P"$LT[_ )]M6_\
M!/=__&Z #_A+-._Y]M6_\$]W_P#&Z #_ (2S3O\ GVU;_P $]W_\;H /^$LT
M[_GVU;_P3W?_ ,;H /\ A+-._P"?;5O_  3W?_QN@ _X2S3O^?;5O_!/=_\
MQN@ _P"$LT[_ )]M6_\ !/=__&Z #_A+-._Y]M6_\$]W_P#&Z #_ (2S3O\
MGVU;_P $]W_\;H /^$LT[_GVU;_P3W?_ ,;H /\ A+-._P"?;5O_  3W?_QN
M@ _X2S3O^?;5O_!/=_\ QN@ _P"$LT[_ )]M6_\ !/=__&Z #_A+-._Y]M6_
M\$]W_P#&Z #_ (2S3O\ GVU;_P $]W_\;H /^$LT[_GVU;_P3W?_ ,;H /\
MA+-._P"?;5O_  3W?_QN@ _X2S3O^?;5O_!/=_\ QN@ _P"$LT[_ )]M6_\
M!/=__&Z #_A+-._Y]M6_\$]W_P#&Z #_ (2S3O\ GVU;_P $]W_\;H /^$LT
M[_GVU;_P3W?_ ,;H /\ A+-._P"?;5O_  3W?_QN@ _X2S3O^?;5O_!/=_\
MQN@ _P"$LT[_ )]M6_\ !/=__&Z #_A+-._Y]M6_\$]W_P#&Z #_ (2S3O\
MGVU;_P $]W_\;H /^$LT[_GVU;_P3W?_ ,;H /\ A+-._P"?;5O_  3W?_QN
M@ _X2S3O^?;5O_!/=_\ QN@ _P"$LT[_ )]M6_\ !/=__&Z #_A+-._Y]M6_
M\$]W_P#&Z #_ (2S3O\ GVU;_P $]W_\;H /^$LT[_GVU;_P3W?_ ,;H /\
MA+-._P"?;5O_  3W?_QN@ _X2S3O^?;5O_!/=_\ QN@ _P"$LT[_ )]M6_\
M!/=__&Z #_A+-._Y]M6_\$]W_P#&Z +VG:M;:IYGV>.[3R\9^T6<L&<YZ>8J
MYZ=LX_&@"]0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0!F:_K</AW2)=3N;>XFMX2/,\A0S(I/+$$C@=\4KI-)]1I-WL/O-
M;T^PT.369KE18)%YWFJ<AEQQCUSQBG.\-'N$/?V)M.O?[1TZWO!;S6PG0.(I
MP Z@],@$@'\:J4>5V9$9<RNBU4E!0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % #)8XY8GCE17C=2K*PR"#U!I22:L]AIM.Z/%M -
MI/XU@T&:\FD\*6]Y))I8=/W4TZX/E[^ZJ2VT=ZNBW)*4OB2T]-=?7]!5DHMQ
M6S:OY/M\^O\ 3/;*D H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H P_%6G:MJ^D_V=I5U%:"X8)<7#,0Z1?Q;  <L1QR14N*DT
MI;=?/R*4G%-K?H5]6\&:??>$4T&U06B6RJ;21.L,B\JX]\]?7)JIRDY<ZW6W
M^7H3348KE>SW+%N_BB#2+));/3+K4 I6Y;[8\29&,%?W3$YY)! Q[U4G%N\2
M8II68?:O%7_0&TG_ ,&DG_R/4E!]J\5?] ;2?_!I)_\ (] !]J\5?] ;2?\
MP:2?_(] !]J\5?\ 0&TG_P &DG_R/0 ?:O%7_0&TG_P:2?\ R/0 ?:O%7_0&
MTG_P:2?_ "/0 ?:O%7_0&TG_ ,&DG_R/0 ?:O%7_ $!M)_\ !I)_\CT 'VKQ
M5_T!M)_\&DG_ ,CT 'VKQ5_T!M)_\&DG_P CT 'VKQ5_T!M)_P#!I)_\CT '
MVKQ5_P! ;2?_  :2?_(] !]J\5?] ;2?_!I)_P#(] !]J\5?] ;2?_!I)_\
M(] !]J\5?] ;2?\ P:2?_(] !]J\5?\ 0&TG_P &DG_R/0 ?:O%7_0&TG_P:
M2?\ R/0 ?:O%7_0&TG_P:2?_ "/0 ?:O%7_0&TG_ ,&DG_R/0 ?:O%7_ $!M
M)_\ !I)_\CT 'VKQ5_T!M)_\&DG_ ,CT 'VKQ5_T!M)_\&DG_P CT 'VKQ5_
MT!M)_P#!I)_\CT 'VKQ5_P! ;2?_  :2?_(] !]J\5?] ;2?_!I)_P#(] !]
MJ\5?] ;2?_!I)_\ (] !]J\5?] ;2?\ P:2?_(] !]J\5?\ 0&TG_P &DG_R
M/0 ?:O%7_0&TG_P:2?\ R/0 ?:O%7_0&TG_P:2?_ "/0 ?:O%7_0&TG_ ,&D
MG_R/0 ?:O%7_ $!M)_\ !I)_\CT 'VKQ5_T!M)_\&DG_ ,CT 'VKQ5_T!M)_
M\&DG_P CT 'VKQ5_T!M)_P#!I)_\CT 'VKQ5_P! ;2?_  :2?_(] !]J\5?]
M ;2?_!I)_P#(] !]J\5?] ;2?_!I)_\ (] !]J\5?] ;2?\ P:2?_(] !]J\
M5?\ 0&TG_P &DG_R/0 ?:O%7_0&TG_P:2?\ R/0 ?:O%7_0&TG_P:2?_ "/0
M ?:O%7_0&TG_ ,&DG_R/0 ?:O%7_ $!M)_\ !I)_\CT 'VKQ5_T!M)_\&DG_
M ,CT 'VKQ5_T!M)_\&DG_P CT 'VKQ5_T!M)_P#!I)_\CT 'VKQ5_P! ;2?_
M  :2?_(] !]J\5?] ;2?_!I)_P#(] !]J\5?] ;2?_!I)_\ (] !]J\5?] ;
M2?\ P:2?_(] %[3I=5D\S^T[*TML8\O[/=--NZYSNC3';U_#N 7J .<\16MU
M>:C916]R7C5':6RBOGM97Y&'#)R0.1@D#YNO I+=O^EO^?Z#O9)&!:>*+IKV
MVM;!GW7,4$*3:@6D,;%Y@V]58*Q_=X!7!)(R3Q5I<VWK\N5/[W]RUT!I1C?M
M?_TI+\+DB>+->N(7\@Z8'A@NYI'\IW5_)EV +AQC([Y./TJ6THN?1*+^^_\
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M" 2@*X;&24.>NX5KHV^U_P!>GE;II\R:6G+S=+?I>_X]^A++I?C.:WGLTO\
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MFFVTT][:^OE_G^NXU;5/K^'G_7>^FQ";7Q%<W\]PUK?V[S6QW 7R^6I* !4
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MX&..!Q2A=67F_NY=/Q_SZ"GK]R\M;Z_@94>F>*D\06<UY]KN(%<F1H)F6/\
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MK^FG<B5[-==%Y;*[^_;\3KZ0PH * "@ H * "@ H * "@ H * "@ H * "@
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MK; #Q)YK9/?!0<9()QRX*Z=]_P#@V_K;6VFI+=K6\OQC?^M_4[&D,* "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M,?5-?&G:G:Z=%IMY?75Q$\JI;F(852H))=U'\0H6M[=+?C_PPVK)/N3Z7K=C
MJMJ)H)=C88O#(0)(]K%6W#/&&4C/3CK0[)7OIO\ ?J)7O:VI>BECGA2:&19(
MG4,CH<A@>A!'44VFG9B33V'TAA0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M\O(;[K>WXZ_U\Q4U*ZL[.]>RTM+>Y>X5EVV3@/&6^\V!R<'/K[4*]DOO_P#
M;_GI^ .RU7]:M?EJ6;N":'#V.G6BRF%7CD^R$_O'DRV1Q@;B&/<<DT[>\UTT
M7RU_)?G;J+=)OL_O5OS_ $\BA'K&J02A/^$78%;E5@98<9A!"J1C(#8+XW%<
M#K[D7>S?G?[O^&6_^2;5F]>R_P ^[WUVZ_,GOY+R75X9)M#MGA,_ER-);-)*
M(RL9X*@KD$G/./EXR1RDE>S\_P"ON&V^5-;Z?K_2]=R*_1;753;Q>'X)+92
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M !0 4 % !0 4 % !0 4 % !0 4 % !0!@:V_B,:C"=(AB:T2%Q+O< L[ [<
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M%=46?<54AIO+R&P-WW.V>G?@^U4[6T_I?Y_\ ;^)VV_X?]+&U4@% !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
' !0 4 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>58
<FILENAME>g63033g0128091809718.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g63033g0128091809718.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  0 .T# 2(  A$! Q$!_\0
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(8ZR5_O1__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>59
<FILENAME>g63033g0128091810023.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g63033g0128091810023.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  , *(# 2(  A$! Q$!_\0
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M1Z1H NS_ &:&=/**CIM9NO7K7<^'?#VE:]!KE_J=G'<W,^I7*-(_554[% ]
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*?<P]M'^1?B?_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
